Psyllid ID: psy8260

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------
Protein Sequence
MSVSPPLVFGLELLETGRLLSRTLTDGTLSRSIVRLWTVYPASKLPSRRLHDHFNQPYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKGTYSLESLV
Secondary Structure (PSIPRED)
ccccccccccHHHHHHHccccccccccccHHHHHHHHHcccccccccccEEEEEcccEEEEcccEEEccccccccccEEEEEEEEccccccEEEEEccccccccHHHHHHHHHHHHHHcccccccccccccccccccccccccEEEEEEcccccHHHHHHHccccccHHHHHHHHHHHHHHHccccccccccccccccEEEcccccEEEEcccccccccccccccccccccccHHHHHccccccccccccccccccHHHHHHHHHccccccccccccccccccccccccccccccHHHccccccccccHHHHHHHHHHcccccHHHHHHcccHHHHHHHHHccccccccHHHHcccccHHHHHHHHHHccccccccccHHHHHccccccccccccccccccccccccccccccHHHHHHHHHHHccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccccccccccccccccccccccccccccccccEEEEEEcccEEEEcccccccccEcccccEEEEEEEEEEccccEEEEEEEEccccccHHHHHHHHHHHHHHHHcccccEccccEEEccccccccccccEEEEEcccEEcHHHHccccccHHHHHHHHHHHHHHHHHHHccccccccccHHHEEEcccccEEEccccccccccHHHccccHHHHcccHHHHccccccccccEcEEEccccHHHEEEcccccEEEccccccccccHHHccccHHHHcccHHHHcccccccccHHHHHHHHHHHHccccHHHHHHcccHHHHHHHccccccccccHHHccccccHHHHHHHHHHccccccccccHHHHHccHHHcccccHHHcccccccccHHHHccccHHHHHHHHHHHHHc
Coil and Loop (DISEMBL)
MSVSPPLVFGLELLETGRLLsrtltdgtlsrSIVRLWTvypasklpsrrlhdhfnqpySEICRGvidigptlskeSFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVfhsntcladfknVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIhsagiihrdlkpsniavneDCELKILDfglarptenemtgYVATRWYRAPEIMLNWmhynqtgvpfyfqdlkpsniavnedCELKILDfglarptenemtgYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEmlgtppaefmAKISSDSARKYinslplltkkdFRQVFKGANPQAIDLLSLMLELDSEKRITAEQAlahpylsqysdpndeptsppydqsfedmdlpvdqwkgtysleslv
Flexible Loop (DISEMBL)
MSVSPPLVFGLELLETGRLLsrtltdgtlsrsivRLWTVypasklpsrrlhDHFNQPYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKiarpfqsavhaKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDfglarpteneMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDfglarptenemTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHpylsqysdpndEPTSPPYDQSFEDMDLPVDQWKGTYSLESLV
Low Complexity Region (SEG)
MSVSPPLVFGLELLETGRLLSRTLTDGTLSRSIVRLWTVYPASKLPSRRLHDHFNQPYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIdllslmleldseKRITAEQALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKGTYSLESLV
Disordered region (IsUnstruct)
******LVFGLELLETGRLLSRTLTDGTLSRSIVRLWTVYPASKLPSRRLHDHFNQPYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDS******************************************************
Disordered Region (DISOPRED)
****PPLVFGLELLE*************************************HFNQPYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPL*TKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKGTYSLESLV
Disordered Region (DISEMBL)
MSVSPPLVFGLELLETGRLLSRTLTDGTLSRSIVRLWTVYPASKLPSRRLHDHFNQPYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKGTYSLESLV
Disordered Region (DISPRO)
*****PLV*************************************PSRRLHDHFNQPYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKGTYSLESLV
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MSVSPPLVFGLELLETGRLLSRTLTDGTLSRSIVRLWTVYPASKLPSRRLHDHFNQPYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKGTYSLESLV
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	427	2.2.26 [Sep-21-2011]
O62618	366	Mitogen-activated protein	yes	N/A	0.702	0.819	0.655	1e-122
O61443	365	Mitogen-activated protein	no	N/A	0.683	0.8	0.646	1e-119
Q9I958	361	Mitogen-activated protein	N/A	N/A	0.700	0.828	0.600	1e-112
Q90336	361	Mitogen-activated protein	N/A	N/A	0.697	0.825	0.593	1e-111
Q16539	360	Mitogen-activated protein	yes	N/A	0.702	0.833	0.598	1e-111
P47811	360	Mitogen-activated protein	yes	N/A	0.700	0.830	0.600	1e-110
O02812	360	Mitogen-activated protein	yes	N/A	0.702	0.833	0.595	1e-110
P70618	360	Mitogen-activated protein	yes	N/A	0.700	0.830	0.597	1e-110
P47812	361	Mitogen-activated protein	N/A	N/A	0.700	0.828	0.582	1e-110
Q9DGE2	361	Mitogen-activated protein	yes	N/A	0.697	0.825	0.587	1e-110

>sp|O62618|MK14A_DROME Mitogen-activated protein kinase 14A OS=Drosophila melanogaster GN=Mpk2 PE=1 SV=1

 Score =  437 bits (1124), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 223/340 (65%), Positives = 254/340 (74%), Gaps = 40/340 (11%)

Query: 82  SSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFH---SNTC 138
           S A+   + + VAIKK+ARPFQSAVHAKRTYRELR+LKHM+HENVIGLLD+FH   +N  
Sbjct: 40  SKAVVRGTNMHVAIKKLARPFQSAVHAKRTYRELRLLKHMDHENVIGLLDIFHPHPANGS 99

Query: 139 LADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSN 198
           L +F+ VY+VTHLM ADLNNI+R Q LSDDHVQFLVYQILRGLKYIHSAG+IHRDLKPSN
Sbjct: 100 LENFQQVYLVTHLMDADLNNIIRMQHLSDDHVQFLVYQILRGLKYIHSAGVIHRDLKPSN 159

Query: 199 IAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPS 258
           IAVNEDCEL+ILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHY+QT            
Sbjct: 160 IAVNEDCELRILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYDQT------------ 207

Query: 259 NIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEM 318
                    + I   G        +   + TR    P             IHQLNLIMEM
Sbjct: 208 ---------VDIWSVGC-------IMAELITRRTLFP---------GTDHIHQLNLIMEM 242

Query: 319 LGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT 378
           LGTPPAEF+ KISS+SAR YI SLP +  + F+ VFK ANP AIDLL  MLELD+EKRIT
Sbjct: 243 LGTPPAEFLKKISSESARSYIQSLPPMKGRSFKNVFKNANPLAIDLLEKMLELDAEKRIT 302

Query: 379 AEQALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWK 418
           AE+AL+HPYL +Y++P+ E TSPPYD SFEDMDLPVD+WK
Sbjct: 303 AEEALSHPYLEKYAEPSVEQTSPPYDHSFEDMDLPVDKWK 342

Kinase involved in a signal transduction pathway. May down-regulate insect immunity gene expression after prolonged infection.
Drosophila melanogaster (taxid: 7227)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 4

>sp|O61443|MK14B_DROME Mitogen-activated protein kinase 14B OS=Drosophila melanogaster GN=p38b PE=1 SV=1

 Score =  429 bits (1102), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 216/334 (64%), Positives = 249/334 (74%), Gaps = 42/334 (12%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNT---CLADFKNV 145
           +  KVAIKK+ARPFQSAVHAKRTYRELR+LKHM+HENVIGLLDVFH       L  F+ V
Sbjct: 46  TSTKVAIKKLARPFQSAVHAKRTYRELRLLKHMDHENVIGLLDVFHPGQPADSLDQFQQV 105

Query: 146 YMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
           YMVTHLM ADLNNI+RTQKLSDDHVQFLVYQILRGLKYIHSAG+IHRDLKPSNIAVNEDC
Sbjct: 106 YMVTHLMDADLNNIIRTQKLSDDHVQFLVYQILRGLKYIHSAGVIHRDLKPSNIAVNEDC 165

Query: 206 ELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNED 265
           EL+ILDFGLARP E+EMTGYVATRWYRAPEIMLNWMHYNQT                   
Sbjct: 166 ELRILDFGLARPAESEMTGYVATRWYRAPEIMLNWMHYNQTA------------------ 207

Query: 266 CELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGTPPA 324
               I   G                     E++     +  TD IHQLNLIME+LGTP  
Sbjct: 208 ---DIWSVGCI-----------------MAELLTGRTLFPGTDHIHQLNLIMEVLGTPAD 247

Query: 325 EFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALA 384
           EFM++ISS+SAR YI SLP++ +++FR +F+GANP AIDLL  MLELD++KRITAEQALA
Sbjct: 248 EFMSRISSESARNYIRSLPVMPRRNFRDIFRGANPLAIDLLEKMLELDADKRITAEQALA 307

Query: 385 HPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWK 418
           HPY+ +Y DP DE T+  YDQSFE+ +LPV++W+
Sbjct: 308 HPYMEKYHDPTDEQTAALYDQSFEENELPVEKWR 341

Kinase involved in dpp signal transduction pathway in the process of wing morphogenesis when the levels of dpp are enhanced or inhibited. May down-regulate insect immunity gene expression after prolonged infection.

Drosophila melanogaster (taxid: 7227)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q9I958|MK14B_CYPCA Mitogen-activated protein kinase 14B OS=Cyprinus carpio GN=mapk14b PE=1 SV=1

 Score =  406 bits (1043), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 203/338 (60%), Positives = 242/338 (71%), Gaps = 39/338 (11%)

Query: 82  SSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD 141
            SALD+ SG++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLD F   TCLA 
Sbjct: 40  CSALDTKSGLRVAVKKLSRPFQSMIHAKRTYRELRLLKHMKHENVIGLLDAFSPATCLAG 99

Query: 142 FKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           F +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AV
Sbjct: 100 FNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 159

Query: 202 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIA 261
           NEDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYN T               
Sbjct: 160 NEDCELKILDFGLARLTDDEMTGYVATRWYRAPEIMLNWMHYNMT--------------- 204

Query: 262 VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLG 320
                 + I   G                     E++     +  TD I+QL  IM + G
Sbjct: 205 ------VDIWSVGCI-----------------MAELLTGRTLFPGTDHINQLQQIMRLTG 241

Query: 321 TPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAE 380
           TPPA  ++++ S  AR YINSL  + K++F  VF GANP A+DLL  ML LD++KRITA 
Sbjct: 242 TPPASLISRMPSHEARNYINSLSYMPKRNFADVFVGANPMAVDLLEKMLVLDTDKRITAS 301

Query: 381 QALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWK 418
           QALAHPY +QY DP+DEP + PYDQSFE  DL +++WK
Sbjct: 302 QALAHPYFAQYHDPDDEPEADPYDQSFESRDLDIEEWK 339

Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Mapk14b is one of the four p38 MAPKs which play an important role in the cascades of cellular responses evoked by extracellular stimuli such as proinflammatory cytokines or physical stress leading to direct activation of transcription factors. Accordingly, p38 MAPKs phosphorylate a broad range of proteins and it has been estimated that they may have approximately 200 to 300 substrates each. Some of the targets are downstream kinases which are activated through phosphorylation and further phosphorylate additionnal targets.

Cyprinus carpio (taxid: 7962)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q90336|MK14A_CYPCA Mitogen-activated protein kinase 14A OS=Cyprinus carpio GN=mapk14a PE=1 SV=1

 Score =  402 bits (1033), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 200/337 (59%), Positives = 243/337 (72%), Gaps = 39/337 (11%)

Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           SA D  +G+KVA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF   T L +F
Sbjct: 41  SAYDEKTGLKVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPATSLEEF 100

Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 101 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 160

Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYN T                
Sbjct: 161 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNMT---------------- 204

Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I+QL  IM + GT
Sbjct: 205 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHINQLQQIMRLTGT 242

Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQ 381
           PPA  ++++ S  AR YINSLP + K++F +VF GANPQA+DLL  ML LD++KRITA +
Sbjct: 243 PPASLISRMPSHEARTYINSLPQMPKRNFSEVFIGANPQAVDLLEKMLVLDTDKRITAAE 302

Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWK 418
           ALAHPY +QY DP+DEP + P+DQSFE  +L +++WK
Sbjct: 303 ALAHPYFAQYHDPDDEPEAEPFDQSFESRELDIEEWK 339

Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Mapk14a is one of the four p38 MAPKs which play an important role in the cascades of cellular responses evoked by extracellular stimuli such as proinflammatory cytokines or physical stress leading to direct activation of transcription factors. Accordingly, p38 MAPKs phosphorylate a broad range of proteins and it has been estimated that they may have approximately 200 to 300 substrates each. Some of the targets are downstream kinases which are activated through phosphorylation and further phosphorylate additionnal targets.

Cyprinus carpio (taxid: 7962)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q16539|MK14_HUMAN Mitogen-activated protein kinase 14 OS=Homo sapiens GN=MAPK14 PE=1 SV=3

 Score =  401 bits (1030), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 203/339 (59%), Positives = 241/339 (71%), Gaps = 39/339 (11%)

Query: 82  SSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD 141
            +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +
Sbjct: 39  CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 98

Query: 142 FKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           F +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AV
Sbjct: 99  FNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158

Query: 202 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIA 261
           NEDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT               
Sbjct: 159 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT--------------- 203

Query: 262 VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLG 320
                 + I   G                     E++     +  TD I QL LI+ ++G
Sbjct: 204 ------VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVG 240

Query: 321 TPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAE 380
           TP AE + KISS+SAR YI SL  + K +F  VF GANP A+DLL  ML LDS+KRITA 
Sbjct: 241 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 300

Query: 381 QALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           QALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 301 QALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 339

Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK14 is one of the four p38 MAPKs which play an important role in the cascades of cellular responses evoked by extracellular stimuli such as proinflammatory cytokines or physical stress leading to direct activation of transcription factors. Accordingly, p38 MAPKs phosphorylate a broad range of proteins and it has been estimated that they may have approximately 200 to 300 substrates each. Some of the targets are downstream kinases which are activated through phosphorylation and further phosphorylate additionnal targets. RPS6KA5/MSK1 and RPS6KA4/MSK2 can directly phosphorylate and activate transcription factors such as CREB1, ATF1, the NF-kappa-B isoform RELA/NFKB3, STAT1 and STAT3, but can also phosphorylate histone H3 and the nucleosomal protein HMGN1. RPS6KA5/MSK1 and RPS6KA4/MSK2 play important roles in the rapid induction of immediate-early genes in response to stress or mitogenic stimuli, either by inducing chromatin remodeling or by recruiting the transcription machinery. On the other hand, two other kinase targets, MAPKAPK2/MK2 and MAPKAPK3/MK3, participate in the control of gene expression mostly at the post-transcriptional level, by phosphorylating ZFP36 (tristetraprolin) and ELAVL1, and by regulating EEF2K, which is important for the elongation of mRNA during translation. MKNK1/MNK1 and MKNK2/MNK2, two other kinases activated by p38 MAPKs, regulate protein synthesis by phosphorylating the initiation factor EIF4E2. MAPK14 interacts also with casein kinase II, leading to its activation through autophosphorylation and further phosphorylation of TP53/p53. In the cytoplasm, the p38 MAPK pathway is an important regulator of protein turnover. For example, CFLAR is an inhibitor of TNF-induced apoptosis whose proteasome-mediated degradation is regulated by p38 MAPK phosphorylation. In a similar way, MAPK14 phosphorylates the ubiquitin ligase SIAH2, regulating its activity towards EGLN3. MAPK14 may also inhibit the lysosomal degradation pathway of autophagy by interfering with the intracellular trafficking of the transmembrane protein ATG9. Another function of MAPK14 is to regulate the endocytosis of membrane receptors by different mechanisms that impinge on the small GTPase RAB5A. In addition, clathrin-mediated EGFR internalization induced by inflammatory cytokines and UV irradiation depends on MAPK14-mediated phosphorylation of EGFR itself as well as of RAB5A effectors. Ectodomain shedding of transmembrane proteins is regulated by p38 MAPKs as well. In response to inflammatory stimuli, p38 MAPKs phosphorylate the membrane-associated metalloprotease ADAM17. Such phosphorylation is required for ADAM17-mediated ectodomain shedding of TGF-alpha family ligands, which results in the activation of EGFR signaling and cell proliferation. Another p38 MAPK substrate is FGFR1. FGFR1 can be translocated from the extracellular space into the cytosol and nucleus of target cells, and regulates processes such as rRNA synthesis and cell growth. FGFR1 translocation requires p38 MAPK activation. In the nucleus, many transcription factors are phosphorylated and activated by p38 MAPKs in response to different stimuli. Classical examples include ATF1, ATF2, ATF6, ELK1, PTPRH, DDIT3, TP53/p53 and MEF2C and MEF2A. The p38 MAPKs are emerging as important modulators of gene expression by regulating chromatin modifiers and remodelers. The promoters of several genes involved in the inflammatory response, such as IL6, IL8 and IL12B, display a p38 MAPK-dependent enrichment of histone H3 phosphorylation on 'Ser-10' (H3S10ph) in LPS-stimulated myeloid cells. This phosphorylation enhances the accessibility of the cryptic NF-kappa-B-binding sites marking promoters for increased NF-kappa-B recruitment. Phosphorylates CDC25B and CDC25C which is required for binding to 14-3-3 proteins and leads to initiation of a G2 delay after ultraviolet radiation. Phosphorylates TIAR following DNA damage, releasing TIAR from GADD45A mRNA and preventing mRNA degradation. The p38 MAPKs may also have kinase-independent roles, which are thought to be due to the binding to targets in the absence of phosphorylation. Protein O-Glc-N-acylation catalyzed by the OGT is regulated by MAPK14, and, although OGT does not seem to be phosphorylated by MAPK14, their interaction increases upon MAPK14 activation induced by glucose deprivation. This interaction may regulate OGT activity by recruiting it to specific targets such as neurofilament H, stimulating its O-Glc-N-acylation. Required in mid-fetal development for the growth of embryo-derived blood vessels in the labyrinth layer of the placenta. Also plays an essential role in developmental and stress-induced erythropoiesis, through regulation of EPO gene expression. Isoform MXI2 activation is stimulated by mitogens and oxidative stress and only poorly phosphorylates ELK1 and ATF2. Isoform EXIP may play a role in the early onset of apoptosis.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|P47811|MK14_MOUSE Mitogen-activated protein kinase 14 OS=Mus musculus GN=Mapk14 PE=1 SV=3

 Score =  400 bits (1027), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 203/338 (60%), Positives = 240/338 (71%), Gaps = 39/338 (11%)

Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G +VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 40  AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99

Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 100 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 159

Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 160 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 203

Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 204 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 241

Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+DLL  ML LDS+KRITA Q
Sbjct: 242 PGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 301

Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 302 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 339

Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK14 is one of the four p38 MAPKs which play an important role in the cascades of cellular responses evoked by extracellular stimuli such as proinflammatory cytokines or physical stress leading to direct activation of transcription factors. Accordingly, p38 MAPKs phosphorylate a broad range of proteins and it has been estimated that they may have approximately 200 to 300 substrates each. Some of the targets are downstream kinases which are activated through phosphorylation and further phosphorylate additionnal targets. RPS6KA5/MSK1 and RPS6KA4/MSK2 can directly phosphorylate and activate transcription factors such as CREB1, ATF1, the NF-kappa-B isoform RELA/NFKB3, STAT1 and STAT3, but can also phosphorylate histone H3 and the nucleosomal protein HMGN1. RPS6KA5/MSK1 and RPS6KA4/MSK2 play important roles in the rapid induction of immediate-early genes in response to stress or mitogenic stimuli, either by inducing chromatin remodeling or by recruiting the transcription machinery. On the other hand, two other kinase targets, MAPKAPK2/MK2 and MAPKAPK3/MK3, participate in the control of gene expression mostly at the post-transcriptional level, by phosphorylating ZFP36 (tristetraprolin) and ELAVL1, and by regulating EEF2K, which is important for the elongation of mRNA during translation. MKNK1/MNK1 and MKNK2/MNK2, two other kinases activated by p38 MAPKs, regulate protein synthesis by phosphorylating the initiation factor EIF4E2. MAPK14 interacts also with casein kinase II, leading to its activation through autophosphorylation and further phosphorylation of TP53/p53. In the cytoplasm, the p38 MAPK pathway is an important regulator of protein turnover. For example, CFLAR is an inhibitor of TNF-induced apoptosis whose proteasome-mediated degradation is regulated by p38 MAPK phosphorylation. In a similar way, MAPK14 phosphorylates the ubiquitin ligase SIAH2, regulating its activity towards EGLN3. MAPK14 may also inhibit the lysosomal degradation pathway of autophagy by interfering with the intracellular trafficking of the transmembrane protein ATG9. Another function of MAPK14 is to regulate the endocytosis of membrane receptors by different mechanisms that impinge on the small GTPase RAB5A. In addition, clathrin-mediated EGFR internalization induced by inflammatory cytokines and UV irradiation depends on MAPK14-mediated phosphorylation of EGFR itself as well as of RAB5A effectors. Ectodomain shedding of transmembrane proteins is regulated by p38 MAPKs as well. In response to inflammatory stimuli, p38 MAPKs phosphorylate the membrane-associated metalloprotease ADAM17. Such phosphorylation is required for ADAM17-mediated ectodomain shedding of TGF-alpha family ligands, which results in the activation of EGFR signaling and cell proliferation. Another p38 MAPK substrate is FGFR1. FGFR1 can be translocated from the extracellular space into the cytosol and nucleus of target cells, and regulates processes such as rRNA synthesis and cell growth. FGFR1 translocation requires p38 MAPK activation. In the nucleus, many transcription factors are phosphorylated and activated by p38 MAPKs in response to different stimuli. Classical examples include ATF1, ATF2, ATF6, ELK1, PTPRH, DDIT3, TP53/p53 and MEF2C and MEF2A. The p38 MAPKs are emerging as important modulators of gene expression by regulating chromatin modifiers and remodelers. The promoters of several genes involved in the inflammatory response, such as IL6, IL8 and IL12B, display a p38 MAPK-dependent enrichment of histone H3 phosphorylation on 'Ser-10' (H3S10ph) in LPS-stimulated myeloid cells. This phosphorylation enhances the accessibility of the cryptic NF-kappa-B-binding sites marking promoters for increased NF-kappa-B recruitment. Phosphorylates CDC25B and CDC25C which is required for binding to 14-3-3 proteins and leads to initiation of a G2 delay after ultraviolet radiation. Phosphorylates TIAR following DNA damage, releasing TIAR from GADD45A mRNA and preventing mRNA degradation. The p38 MAPKs may also have kinase-independent roles, which are thought to be due to the binding to targets in the absence of phosphorylation. Protein O-Glc-N-acylation catalyzed by the OGT is regulated by MAPK14, and, although OGT does not seem to be phosphorylated by MAPK14, their interaction increases upon MAPK14 activation induced by glucose deprivation. This interaction may regulate OGT activity by recruiting it to specific targets such as neurofilament H, stimulating its O-Glc-N-acylation. Required in mid-fetal development for the growth of embryo-derived blood vessels in the labyrinth layer of the placenta. Also plays an essential role in developmental and stress-induced erythropoiesis, through regulation of EPO gene expression.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|O02812|MK14_CANFA Mitogen-activated protein kinase 14 OS=Canis familiaris GN=MAPK14 PE=2 SV=3

 Score =  400 bits (1027), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 202/339 (59%), Positives = 241/339 (71%), Gaps = 39/339 (11%)

Query: 82  SSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD 141
            +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +
Sbjct: 39  CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 98

Query: 142 FKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           F +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AV
Sbjct: 99  FNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158

Query: 202 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIA 261
           NEDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT               
Sbjct: 159 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT--------------- 203

Query: 262 VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLG 320
                 + I   G                     E++     +  TD I QL LI+ ++G
Sbjct: 204 ------VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVG 240

Query: 321 TPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAE 380
           TP A+ + KISS+SAR YI SL  + K +F  VF GANP A+DLL  ML LDS+KRITA 
Sbjct: 241 TPGADLLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 300

Query: 381 QALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           QALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 301 QALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 339

Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK14 is one of the four p38 MAPKs which play an important role in the cascades of cellular responses evoked by extracellular stimuli such as proinflammatory cytokines or physical stress leading to direct activation of transcription factors. Accordingly, p38 MAPKs phosphorylate a broad range of proteins and it has been estimated that they may have approximately 200 to 300 substrates each. Some of the targets are downstream kinases which are activated through phosphorylation and further phosphorylate additionnal targets. RPS6KA5/MSK1 and RPS6KA4/MSK2 can directly phosphorylate and activate transcription factors such as CREB1, ATF1, the NF-kappa-B isoform RELA/NFKB3, STAT1 and STAT3, but can also phosphorylate histone H3 and the nucleosomal protein HMGN1. RPS6KA5/MSK1 and RPS6KA4/MSK2 play important roles in the rapid induction of immediate-early genes in response to stress or mitogenic stimuli, either by inducing chromatin remodeling or by recruiting the transcription machinery. On the other hand, two other kinase targets, MAPKAPK2/MK2 and MAPKAPK3/MK3, participate in the control of gene expression mostly at the post-transcriptional level, by phosphorylating ZFP36 (tristetraprolin) and ELAVL1, and by regulating EEF2K, which is important for the elongation of mRNA during translation. MKNK1/MNK1 and MKNK2/MNK2, two other kinases activated by p38 MAPKs, regulate protein synthesis by phosphorylating the initiation factor EIF4E2. MAPK14 interacts also with casein kinase II, leading to its activation through autophosphorylation and further phosphorylation of TP53/p53. In the cytoplasm, the p38 MAPK pathway is an important regulator of protein turnover. For example, CFLAR is an inhibitor of TNF-induced apoptosis whose proteasome-mediated degradation is regulated by p38 MAPK phosphorylation. In a similar way, MAPK14 phosphorylates the ubiquitin ligase SIAH2, regulating its activity towards EGLN3. MAPK14 may also inhibit the lysosomal degradation pathway of autophagy by interfering with the intracellular trafficking of the transmembrane protein ATG9. Another function of MAPK14 is to regulate the endocytosis of membrane receptors by different mechanisms that impinge on the small GTPase RAB5A. In addition, clathrin-mediated EGFR internalization induced by inflammatory cytokines and UV irradiation depends on MAPK14-mediated phosphorylation of EGFR itself as well as of RAB5A effectors. Ectodomain shedding of transmembrane proteins is regulated by p38 MAPKs as well. In response to inflammatory stimuli, p38 MAPKs phosphorylate the membrane-associated metalloprotease ADAM17. Such phosphorylation is required for ADAM17-mediated ectodomain shedding of TGF-alpha family ligands, which results in the activation of EGFR signaling and cell proliferation. Another p38 MAPK substrate is FGFR1. FGFR1 can be translocated from the extracellular space into the cytosol and nucleus of target cells, and regulates processes such as rRNA synthesis and cell growth. FGFR1 translocation requires p38 MAPK activation. In the nucleus, many transcription factors are phosphorylated and activated by p38 MAPKs in response to different stimuli. Classical examples include ATF1, ATF2, ATF6, ELK1, PTPRH, DDIT3, TP53/p53 and MEF2C and MEF2A. The p38 MAPKs are emerging as important modulators of gene expression by regulating chromatin modifiers and remodelers. The promoters of several genes involved in the inflammatory response, such as IL6, IL8 and IL12B, display a p38 MAPK-dependent enrichment of histone H3 phosphorylation on 'Ser-10' (H3S10ph) in LPS-stimulated myeloid cells. This phosphorylation enhances the accessibility of the cryptic NF-kappa-B-binding sites marking promoters for increased NF-kappa-B recruitment. Phosphorylates CDC25B and CDC25C which is required for binding to 14-3-3 proteins and leads to initiation of a G2 delay after ultraviolet radiation. Phosphorylates TIAR following DNA damage, releasing TIAR from GADD45A mRNA and preventing mRNA degradation. The p38 MAPKs may also have kinase-independent roles, which are thought to be due to the binding to targets in the absence of phosphorylation. Protein O-Glc-N-acylation catalyzed by the OGT is regulated by MAPK14, and, although OGT does not seem to be phosphorylated by MAPK14, their interaction increases upon MAPK14 activation induced by glucose deprivation. This interaction may regulate OGT activity by recruiting it to specific targets such as neurofilament H, stimulating its O-Glc-N-acylation. Required in mid-fetal development for the growth of embryo-derived blood vessels in the labyrinth layer of the placenta. Also plays an essential role in developmental and stress-induced erythropoiesis, through regulation of EPO gene expression.

Canis familiaris (taxid: 9615)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|P70618|MK14_RAT Mitogen-activated protein kinase 14 OS=Rattus norvegicus GN=Mapk14 PE=2 SV=3

 Score =  399 bits (1024), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 202/338 (59%), Positives = 239/338 (70%), Gaps = 39/338 (11%)

Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G +VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 40  AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99

Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 100 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 159

Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 160 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 203

Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 204 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 241

Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+DLL  ML LDS+KRITA Q
Sbjct: 242 PGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 301

Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + PYDQSFE  D  +D+WK 
Sbjct: 302 ALAHAYFAQYHDPDDEPVAEPYDQSFESRDFLIDEWKS 339

Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK14 is one of the four p38 MAPKs which play an important role in the cascades of cellular responses evoked by extracellular stimuli such as proinflammatory cytokines or physical stress leading to direct activation of transcription factors. Accordingly, p38 MAPKs phosphorylate a broad range of proteins and it has been estimated that they may have approximately 200 to 300 substrates each. Some of the targets are downstream kinases which are activated through phosphorylation and further phosphorylate additionnal targets. RPS6KA5/MSK1 and RPS6KA4/MSK2 can directly phosphorylate and activate transcription factors such as CREB1, ATF1, the NF-kappa-B isoform RELA/NFKB3, STAT1 and STAT3, but can also phosphorylate histone H3 and the nucleosomal protein HMGN1. RPS6KA5/MSK1 and RPS6KA4/MSK2 play important roles in the rapid induction of immediate-early genes in response to stress or mitogenic stimuli, either by inducing chromatin remodeling or by recruiting the transcription machinery. On the other hand, two other kinase targets, MAPKAPK2/MK2 and MAPKAPK3/MK3, participate in the control of gene expression mostly at the post-transcriptional level, by phosphorylating ZFP36 (tristetraprolin) and ELAVL1, and by regulating EEF2K, which is important for the elongation of mRNA during translation. MKNK1/MNK1 and MKNK2/MNK2, two other kinases activated by p38 MAPKs, regulate protein synthesis by phosphorylating the initiation factor EIF4E2. MAPK14 interacts also with casein kinase II, leading to its activation through autophosphorylation and further phosphorylation of TP53/p53. In the cytoplasm, the p38 MAPK pathway is an important regulator of protein turnover. For example, CFLAR is an inhibitor of TNF-induced apoptosis whose proteasome-mediated degradation is regulated by p38 MAPK phosphorylation. In a similar way, MAPK14 phosphorylates the ubiquitin ligase SIAH2, regulating its activity towards EGLN3. MAPK14 may also inhibit the lysosomal degradation pathway of autophagy by interfering with the intracellular trafficking of the transmembrane protein ATG9. Another function of MAPK14 is to regulate the endocytosis of membrane receptors by different mechanisms that impinge on the small GTPase RAB5A. In addition, clathrin-mediated EGFR internalization induced by inflammatory cytokines and UV irradiation depends on MAPK14-mediated phosphorylation of EGFR itself as well as of RAB5A effectors. Ectodomain shedding of transmembrane proteins is regulated by p38 MAPKs as well. In response to inflammatory stimuli, p38 MAPKs phosphorylate the membrane-associated metalloprotease ADAM17. Such phosphorylation is required for ADAM17-mediated ectodomain shedding of TGF-alpha family ligands, which results in the activation of EGFR signaling and cell proliferation. Another p38 MAPK substrate is FGFR1. FGFR1 can be translocated from the extracellular space into the cytosol and nucleus of target cells, and regulates processes such as rRNA synthesis and cell growth. FGFR1 translocation requires p38 MAPK activation. In the nucleus, many transcription factors are phosphorylated and activated by p38 MAPKs in response to different stimuli. Classical examples include ATF1, ATF2, ATF6, ELK1, PTPRH, DDIT3, TP53/p53 and MEF2C and MEF2A. The p38 MAPKs are emerging as important modulators of gene expression by regulating chromatin modifiers and remodelers. The promoters of several genes involved in the inflammatory response, such as IL6, IL8 and IL12B, display a p38 MAPK-dependent enrichment of histone H3 phosphorylation on 'Ser-10' (H3S10ph) in LPS-stimulated myeloid cells. This phosphorylation enhances the accessibility of the cryptic NF-kappa-B-binding sites marking promoters for increased NF-kappa-B recruitment. Phosphorylates CDC25B and CDC25C which is required for binding to 14-3-3 proteins and leads to initiation of a G2 delay after ultraviolet radiation. Phosphorylates TIAR following DNA damage, releasing TIAR from GADD45A mRNA and preventing mRNA degradation. The p38 MAPKs may also have kinase-independent roles, which are thought to be due to the binding to targets in the absence of phosphorylation. Protein O-Glc-N-acylation catalyzed by the OGT is regulated by MAPK14, and, although OGT does not seem to be phosphorylated by MAPK14, their interaction increases upon MAPK14 activation induced by glucose deprivation. This interaction may regulate OGT activity by recruiting it to specific targets such as neurofilament H, stimulating its O-Glc-N-acylation. Required in mid-fetal development for the growth of embryo-derived blood vessels in the labyrinth layer of the placenta. Also plays an essential role in developmental and stress-induced erythropoiesis, through regulation of EPO gene expression.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|P47812|MK14_XENLA Mitogen-activated protein kinase 14 OS=Xenopus laevis GN=mapk14 PE=2 SV=1

 Score =  398 bits (1023), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 197/338 (58%), Positives = 240/338 (71%), Gaps = 39/338 (11%)

Query: 82  SSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD 141
            S+ D+ + +++A+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF       +
Sbjct: 40  CSSFDTRTALRIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFSPAKSFEE 99

Query: 142 FKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           F +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSAGIIHRDLKPSN+AV
Sbjct: 100 FNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAGIIHRDLKPSNLAV 159

Query: 202 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIA 261
           NEDCELKILDFGLAR T+ EMTGYVATRWYRAPEIMLNWMHYNQT               
Sbjct: 160 NEDCELKILDFGLARHTDEEMTGYVATRWYRAPEIMLNWMHYNQT--------------- 204

Query: 262 VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLG 320
                 + I   G                     E++     +  TD I QL LI+ ++G
Sbjct: 205 ------VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVG 241

Query: 321 TPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAE 380
           TP  E + KISS++AR YI SLP + K +F  VF GANPQA+DLL  ML LD++KRITA 
Sbjct: 242 TPEPELLQKISSEAARNYIQSLPYMPKMNFEDVFLGANPQAVDLLEKMLVLDTDKRITAA 301

Query: 381 QALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWK 418
           +ALAH Y +QY DP+DEP + PYDQSFE  +L +++WK
Sbjct: 302 EALAHSYFAQYHDPDDEPIAEPYDQSFESRELDIEEWK 339

Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. mapk14a is one of the four p38 MAPKs which play an important role in the cascades of cellular responses evoked by extracellular stimuli such as proinflammatory cytokines or physical stress leading to direct activation of transcription factors. Accordingly, p38 MAPKs phosphorylate a broad range of proteins and it has been estimated that they may have approximately 200 to 300 substrates each. Some of the targets are downstream kinases which are activated through phosphorylation and further phosphorylate additionnal targets. MPK2 is activated by upstream MAPKK/MAPKKK and stimulates MAPKAP kinase 2 to phosphorylate small heat shock proteins. Does not phosphorylate myelin basic protein or MAPKAP kinase 1.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q9DGE2|MK14A_DANRE Mitogen-activated protein kinase 14A OS=Danio rerio GN=mapk14a PE=1 SV=1

 Score =  398 bits (1022), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 198/337 (58%), Positives = 242/337 (71%), Gaps = 39/337 (11%)

Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           SA D+ +G KVA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF   T L +F
Sbjct: 41  SAFDAKTGFKVAVKKLSRPFQSIIHAKRTYRELRLLKHMRHENVIGLLDVFTPATSLKEF 100

Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 101 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 160

Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYN T                
Sbjct: 161 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNVT---------------- 204

Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I+QL  IM + GT
Sbjct: 205 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHINQLQQIMRLTGT 242

Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQ 381
           PP+  ++++ S  AR YI+SLP + K++F  VF GANPQA+DLL  ML LD++KRITA +
Sbjct: 243 PPSSLISRMPSHEARTYISSLPQMPKRNFADVFIGANPQAVDLLEKMLVLDTDKRITAAE 302

Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWK 418
           ALAHPY +QY DP+DEP + P+DQSFE  +L +++WK
Sbjct: 303 ALAHPYFAQYHDPDDEPEAEPFDQSFESRELDIEEWK 339

Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Mapk14a is one of the four p38 MAPKs which play an important role in the cascades of cellular responses evoked by extracellular stimuli such as proinflammatory cytokines or physical stress leading to direct activation of transcription factors. Accordingly, p38 MAPKs phosphorylate a broad range of proteins and it has been estimated that they may have approximately 200 to 300 substrates each. Some of the targets are downstream kinases which are activated through phosphorylation and further phosphorylate additionnal targets. Required for cytokinesis on the future dorsal side of the blastodisc, suggesting a role in symmetrical and synchronous blastomere cleavage.

Danio rerio (taxid: 7955)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	427
307214895	360	Mitogen-activated protein kinase 14B [Ha	0.697	0.827	0.712	1e-131
242015828	357	mitogen-activated protein kinase ERK-A,	0.700	0.837	0.701	1e-129
357625689	360	p38 map kinase [Danaus plexippus]	0.700	0.830	0.695	1e-129
112983386	360	p38 map kinase [Bombyx mori] gi|77799296	0.700	0.830	0.695	1e-128
383856425	360	PREDICTED: mitogen-activated protein kin	0.697	0.827	0.715	1e-126
307177584	360	Mitogen-activated protein kinase 14B [Ca	0.697	0.827	0.715	1e-126
332018452	360	Mitogen-activated protein kinase 14B [Ac	0.697	0.827	0.715	1e-126
315258191	360	p38 mitogen-activated protein kinase [Ap	0.697	0.827	0.712	1e-125
350407750	360	PREDICTED: mitogen-activated protein kin	0.697	0.827	0.712	1e-125
157118745	358	P38 mapk [Aedes aegypti] gi|82547878|gb|	0.697	0.832	0.689	1e-125

>gi|307214895|gb|EFN89763.1| Mitogen-activated protein kinase 14B [Harpegnathos saltator]

 Score =  474 bits (1220), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 240/337 (71%), Positives = 264/337 (78%), Gaps = 39/337 (11%)

Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           SA+D+ +G KVAIKK+ARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFH +  L DF
Sbjct: 36  SAVDTTTGQKVAIKKLARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHPSLSLEDF 95

Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
           +NVY+VTHLMGADLNNI+RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN
Sbjct: 96  QNVYLVTHLMGADLNNIVRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 155

Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLARPTE+EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 156 EDCELKILDFGLARPTEHEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 199

Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD IHQLNLIME+LGT
Sbjct: 200 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIHQLNLIMEILGT 237

Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQ 381
           P  EFM KISS+SAR YI SLP L KK+F+ VF+GANP AI+LL LMLELD+EKRITAEQ
Sbjct: 238 PRDEFMKKISSESARNYIQSLPPLKKKNFKDVFRGANPLAINLLELMLELDAEKRITAEQ 297

Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWK 418
           ALAHPYL+QY+DP DEP S PYDQSFEDMDLPV++WK
Sbjct: 298 ALAHPYLAQYADPTDEPVSLPYDQSFEDMDLPVEKWK 334

Source: Harpegnathos saltator

Species: Harpegnathos saltator

Genus: Harpegnathos

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|242015828|ref|XP_002428549.1| mitogen-activated protein kinase ERK-A, putative [Pediculus humanus corporis] gi|212513183|gb|EEB15811.1| mitogen-activated protein kinase ERK-A, putative [Pediculus humanus corporis]

 Score =  469 bits (1206), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 237/338 (70%), Positives = 264/338 (78%), Gaps = 39/338 (11%)

Query: 82  SSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD 141
            SALD  + +KVAIKK+ARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFH +TCL +
Sbjct: 35  CSALDKKTKMKVAIKKLARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHPSTCLDN 94

Query: 142 FKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           F+ VY+VTHLMGADLNNI+RTQ+LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV
Sbjct: 95  FQQVYLVTHLMGADLNNIIRTQRLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 154

Query: 202 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIA 261
           NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT               
Sbjct: 155 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT--------------- 199

Query: 262 VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLG 320
                 + I   G                     E++     +  TD IHQL+LIME+LG
Sbjct: 200 ------VDIWSVGCI-----------------MAELITGRTLFPGTDHIHQLSLIMEILG 236

Query: 321 TPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAE 380
           TP AEFM KISS+SAR YI SLP L K+DF++VF+GAN  AIDLL  MLELD++KRITAE
Sbjct: 237 TPNAEFMKKISSESARNYILSLPTLKKRDFKEVFQGANILAIDLLEQMLELDADKRITAE 296

Query: 381 QALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWK 418
           QALAH YLSQY+DP+DEP S PYDQSFEDM+LPV++WK
Sbjct: 297 QALAHRYLSQYADPSDEPVSAPYDQSFEDMELPVEKWK 334

Source: Pediculus humanus corporis

Species: Pediculus humanus

Genus: Pediculus

Family: Pediculidae

Order: Phthiraptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|357625689|gb|EHJ76051.1| p38 map kinase [Danaus plexippus]

 Score =  467 bits (1201), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 235/338 (69%), Positives = 260/338 (76%), Gaps = 39/338 (11%)

Query: 82  SSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD 141
            SA+D+V  +KVAIKK+ARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVF     L D
Sbjct: 35  CSAIDTVHNMKVAIKKLARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFTPEKNLED 94

Query: 142 FKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           F+ VY+VTHLMGADLNNI+RTQKLSDDHVQFL+YQILRGLKYIHSAGIIHRDLKPSNIAV
Sbjct: 95  FQQVYLVTHLMGADLNNIVRTQKLSDDHVQFLIYQILRGLKYIHSAGIIHRDLKPSNIAV 154

Query: 202 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIA 261
           NEDCELKILDFGLARPTE EMTGYVATRWYRAPEIMLNWMHYNQT               
Sbjct: 155 NEDCELKILDFGLARPTETEMTGYVATRWYRAPEIMLNWMHYNQT--------------- 199

Query: 262 VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLG 320
                 + I   G                     E++     +  TD IHQLNLIME+LG
Sbjct: 200 ------VDIWSVGCI-----------------MAELLTGRTLFPGTDHIHQLNLIMEVLG 236

Query: 321 TPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAE 380
           TP  EFM KISS+SAR YI SLP L ++DFR+VF+GANP A++LL LMLELD++KR+TAE
Sbjct: 237 TPAHEFMQKISSESARNYIQSLPTLKRRDFREVFRGANPLAVNLLELMLELDADKRVTAE 296

Query: 381 QALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWK 418
           QALAH YLSQY+DP DEP S PYDQSFEDMDLPVD+WK
Sbjct: 297 QALAHEYLSQYADPTDEPVSAPYDQSFEDMDLPVDKWK 334

Source: Danaus plexippus

Species: Danaus plexippus

Genus: Danaus

Family: Nymphalidae

Order: Lepidoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|112983386|ref|NP_001036996.1| p38 map kinase [Bombyx mori] gi|77799296|dbj|BAE46743.1| p38 map kinase [Bombyx mori]

 Score =  465 bits (1196), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 235/338 (69%), Positives = 259/338 (76%), Gaps = 39/338 (11%)

Query: 82  SSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD 141
            SA+D+   +KVAIKK+ARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVF     L D
Sbjct: 35  CSAIDAQHSMKVAIKKLARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFTPEKTLED 94

Query: 142 FKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           F+ VY+VTHLMGADLNNI+RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV
Sbjct: 95  FQQVYLVTHLMGADLNNIVRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 154

Query: 202 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIA 261
           NEDCELKILDFGLARPTE EMTGYVATRWYRAPEIMLNWMHYNQT               
Sbjct: 155 NEDCELKILDFGLARPTETEMTGYVATRWYRAPEIMLNWMHYNQT--------------- 199

Query: 262 VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLG 320
                 + I   G                     E++     +  TD IHQLNLIME+LG
Sbjct: 200 ------VDIWSVGCI-----------------MAELLTGRTLFPGTDHIHQLNLIMEILG 236

Query: 321 TPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAE 380
           TP  EFM KISS+SAR YI SLP L ++DFR+VF+GANP AI+LL LMLELD++KRITAE
Sbjct: 237 TPAQEFMQKISSESARNYIQSLPALKRRDFREVFRGANPLAINLLELMLELDADKRITAE 296

Query: 381 QALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWK 418
           QALAH YL+QY+DP DEP S PYDQSFEDM+LPVD+WK
Sbjct: 297 QALAHEYLAQYADPTDEPVSAPYDQSFEDMELPVDKWK 334

Source: Bombyx mori

Species: Bombyx mori

Genus: Bombyx

Family: Bombycidae

Order: Lepidoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|383856425|ref|XP_003703709.1| PREDICTED: mitogen-activated protein kinase 14B-like isoform 1 [Megachile rotundata]

 Score =  457 bits (1176), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 241/337 (71%), Positives = 265/337 (78%), Gaps = 39/337 (11%)

Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           SA+D+ +G KVAIKK+ARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFH ++ L DF
Sbjct: 36  SAVDTTTGQKVAIKKLARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHPSSSLEDF 95

Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
           + VY+VTHLMGADLNNI+RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN
Sbjct: 96  QQVYLVTHLMGADLNNIVRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 155

Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 156 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 199

Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD IHQLNLIME+LGT
Sbjct: 200 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIHQLNLIMEILGT 237

Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQ 381
           P  EFM KISS+SAR YI SLP L KK+F+ VF+GANP AIDLL LMLELD+EKRITAEQ
Sbjct: 238 PRDEFMQKISSESARNYIQSLPPLKKKNFKDVFRGANPLAIDLLELMLELDAEKRITAEQ 297

Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWK 418
           ALAHPYL+QY+DP+DEP S PYDQSFEDMDLPV++WK
Sbjct: 298 ALAHPYLAQYADPSDEPVSLPYDQSFEDMDLPVEKWK 334

Source: Megachile rotundata

Species: Megachile rotundata

Genus: Megachile

Family: Megachilidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|307177584|gb|EFN66664.1| Mitogen-activated protein kinase 14B [Camponotus floridanus]

 Score =  457 bits (1176), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 241/337 (71%), Positives = 265/337 (78%), Gaps = 39/337 (11%)

Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           SA+D+ +G KVAIKK+ARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFH ++ L DF
Sbjct: 36  SAVDTTTGQKVAIKKLARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHPSSSLEDF 95

Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
           ++VY+VTHLMGADLNNI+RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN
Sbjct: 96  QHVYLVTHLMGADLNNIVRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 155

Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 156 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 199

Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD IHQLNLIME+LGT
Sbjct: 200 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIHQLNLIMEILGT 237

Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQ 381
           P  EFM KISS+SAR YI SLP L KK+F+ VF+GANP AIDLL LMLELD+EKRITAEQ
Sbjct: 238 PRDEFMKKISSESARNYIQSLPPLKKKNFKDVFRGANPLAIDLLELMLELDAEKRITAEQ 297

Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWK 418
           ALAHPYL+QY+DP DEP S PYDQSFEDMDLPV++WK
Sbjct: 298 ALAHPYLAQYADPTDEPISLPYDQSFEDMDLPVEKWK 334

Source: Camponotus floridanus

Species: Camponotus floridanus

Genus: Camponotus

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|332018452|gb|EGI59042.1| Mitogen-activated protein kinase 14B [Acromyrmex echinatior]

 Score =  457 bits (1176), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 241/337 (71%), Positives = 265/337 (78%), Gaps = 39/337 (11%)

Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           SA+D+ +G KVAIKK+ARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFH ++ L DF
Sbjct: 36  SAVDTTTGQKVAIKKLARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHPSSSLEDF 95

Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
           ++VY+VTHLMGADLNNI+RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN
Sbjct: 96  QHVYLVTHLMGADLNNIVRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 155

Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 156 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 199

Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD IHQLNLIME+LGT
Sbjct: 200 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIHQLNLIMEILGT 237

Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQ 381
           P  EFM KISS+SAR YI SLP L KK+F+ VF+GANP AIDLL LMLELD+EKRITAEQ
Sbjct: 238 PRDEFMKKISSESARNYIQSLPPLKKKNFKDVFRGANPLAIDLLELMLELDAEKRITAEQ 297

Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWK 418
           ALAHPYL+QY+DP DEP S PYDQSFEDMDLPV++WK
Sbjct: 298 ALAHPYLAQYADPTDEPVSLPYDQSFEDMDLPVEKWK 334

Source: Acromyrmex echinatior

Species: Acromyrmex echinatior

Genus: Acromyrmex

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|315258191|gb|ADT91683.1| p38 mitogen-activated protein kinase [Apis cerana cerana] gi|315258195|gb|ADT91685.1| p38 mitogen-activated protein kinase [Apis cerana cerana]

 Score =  455 bits (1171), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 240/337 (71%), Positives = 263/337 (78%), Gaps = 39/337 (11%)

Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           SALD+ +G KVAIKK+ARPFQSAVHAKRTYRELRMLKHMNHEN+IGLLDVFH ++ L DF
Sbjct: 36  SALDTKTGQKVAIKKLARPFQSAVHAKRTYRELRMLKHMNHENIIGLLDVFHPSSSLEDF 95

Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
           + VY+VTHLMGADLNNI+RTQKLSDDHVQFLVYQI RGLKYIHSAGIIHRDLKPSNIAVN
Sbjct: 96  QQVYLVTHLMGADLNNIVRTQKLSDDHVQFLVYQIFRGLKYIHSAGIIHRDLKPSNIAVN 155

Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 156 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 199

Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD IHQLNLIME+LGT
Sbjct: 200 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIHQLNLIMEILGT 237

Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQ 381
           P  EFM KISS+SAR YI SLP L KK+F+ VF+GANP AIDLL LMLELD+EKRITAEQ
Sbjct: 238 PRDEFMQKISSESARNYIQSLPPLKKKNFKDVFRGANPLAIDLLELMLELDAEKRITAEQ 297

Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWK 418
           ALAHPYL+QY+DP DEP S PYDQSFEDMDLPV++WK
Sbjct: 298 ALAHPYLAQYADPTDEPVSLPYDQSFEDMDLPVEKWK 334

Source: Apis cerana cerana

Species: Apis cerana

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|350407750|ref|XP_003488182.1| PREDICTED: mitogen-activated protein kinase 14B-like isoform 1 [Bombus impatiens]

 Score =  455 bits (1171), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 240/337 (71%), Positives = 264/337 (78%), Gaps = 39/337 (11%)

Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           SA+D+ +G KVAIKK+ARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFH ++ L DF
Sbjct: 36  SAVDTKTGQKVAIKKLARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHPSSSLEDF 95

Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
           + VY+VTHLMGADLNNI+RTQKLSDDHVQFLVYQILRGLKYIHSA IIHRDLKPSNIAVN
Sbjct: 96  QQVYLVTHLMGADLNNIVRTQKLSDDHVQFLVYQILRGLKYIHSASIIHRDLKPSNIAVN 155

Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 156 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 199

Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD IHQLNLIME+LGT
Sbjct: 200 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIHQLNLIMEILGT 237

Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQ 381
           P  EFM KISS+SAR YI SLP L KK+F++VF+GANP AIDLL LMLELD+EKRITAEQ
Sbjct: 238 PRDEFMQKISSESARNYIQSLPPLKKKNFKEVFRGANPLAIDLLELMLELDAEKRITAEQ 297

Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWK 418
           ALAHPYL+QY+DP DEP S PYDQSFEDMDLPV++WK
Sbjct: 298 ALAHPYLAQYADPTDEPVSLPYDQSFEDMDLPVEKWK 334

Source: Bombus impatiens

Species: Bombus impatiens

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|157118745|ref|XP_001653240.1| P38 mapk [Aedes aegypti] gi|82547878|gb|ABB82553.1| p38b MAP kinase [Aedes aegypti] gi|108875619|gb|EAT39844.1| AAEL008379-PB [Aedes aegypti]

 Score =  455 bits (1170), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 233/338 (68%), Positives = 256/338 (75%), Gaps = 40/338 (11%)

Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFH-SNTCLAD 141
           SA D+   VKVAIKK+ARPFQSAVHAKRTYRELRMLKHMNHEN+IGLLDVFH     L  
Sbjct: 36  SATDTQHNVKVAIKKLARPFQSAVHAKRTYRELRMLKHMNHENIIGLLDVFHPGGNTLDS 95

Query: 142 FKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           F+ VY+VTHLMGADLNNI+RTQ+LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV
Sbjct: 96  FQQVYLVTHLMGADLNNIIRTQRLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 155

Query: 202 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIA 261
           NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT               
Sbjct: 156 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT--------------- 200

Query: 262 VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLG 320
                 + I   G                     E++     +  TD IHQLNLIME+LG
Sbjct: 201 ------VDIWSVGCI-----------------MAELLTGRTLFPGTDHIHQLNLIMEILG 237

Query: 321 TPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAE 380
           TP  EFMAKISS+SAR YI SLP   K++F  VF+GANP AIDLL  MLELD++KR+TAE
Sbjct: 238 TPNEEFMAKISSESARHYIRSLPKTEKRNFSDVFRGANPLAIDLLEKMLELDADKRVTAE 297

Query: 381 QALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWK 418
           QALAHPYL +Y+DP DEPTS  YDQSFEDMDLPV++WK
Sbjct: 298 QALAHPYLEKYADPTDEPTSSLYDQSFEDMDLPVEKWK 335

Source: Aedes aegypti

Species: Aedes aegypti

Genus: Aedes

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	427
FB|FBgn0015765	366	Mpk2 "Mpk2" [Drosophila melano	0.386	0.450	0.815	2.7e-109
FB|FBgn0024846	365	p38b "p38b" [Drosophila melano	0.370	0.432	0.857	4.5e-107
UNIPROTKB|Q9I958	361	mapk14b "Mitogen-activated pro	0.384	0.454	0.817	5.8e-103
ZFIN|ZDB-GENE-021007-1	361	mapk14b "mitogen-activated pro	0.384	0.454	0.798	1.5e-102
UNIPROTKB|Q90336	361	mapk14a "Mitogen-activated pro	0.384	0.454	0.804	1.8e-101
UNIPROTKB|F1RYA1	360	MAPK14 "Uncharacterized protei	0.384	0.455	0.798	3.6e-101
UNIPROTKB|Q6DJ17	361	mapk14 "Mitogen-activated prot	0.384	0.454	0.792	3.6e-101
UNIPROTKB|Q16539	360	MAPK14 "Mitogen-activated prot	0.384	0.455	0.792	7.5e-101
UNIPROTKB|O02812	360	MAPK14 "Mitogen-activated prot	0.384	0.455	0.792	1.6e-100
MGI|MGI:1346865	360	Mapk14 "mitogen-activated prot	0.384	0.455	0.792	2e-100

FB|FBgn0015765 Mpk2 "Mpk2" [Drosophila melanogaster (taxid:7227)]

 Score = 721 (258.9 bits), Expect = 2.7e-109, Sum P(2) = 2.7e-109
 Identities = 137/168 (81%), Positives = 152/168 (90%)

Query:    82 SSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFH---SNTC 138
             S A+   + + VAIKK+ARPFQSAVHAKRTYRELR+LKHM+HENVIGLLD+FH   +N  
Sbjct:    40 SKAVVRGTNMHVAIKKLARPFQSAVHAKRTYRELRLLKHMDHENVIGLLDIFHPHPANGS 99

Query:   139 LADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSN 198
             L +F+ VY+VTHLM ADLNNI+R Q LSDDHVQFLVYQILRGLKYIHSAG+IHRDLKPSN
Sbjct:   100 LENFQQVYLVTHLMDADLNNIIRMQHLSDDHVQFLVYQILRGLKYIHSAGVIHRDLKPSN 159

Query:   199 IAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT 246
             IAVNEDCEL+ILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHY+QT
Sbjct:   160 IAVNEDCELRILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYDQT 207

GO:0006970 "response to osmotic stress" evidence=IMP;IDA

GO:0000165 "MAPK cascade" evidence=ISS;NAS;IDA

GO:0004707 "MAP kinase activity" evidence=IGI;ISS;NAS;IDA

GO:0005634 "nucleus" evidence=NAS;IDA

GO:0006955 "immune response" evidence=IDA

GO:0008348 "negative regulation of antimicrobial humoral response" evidence=IMP

GO:0004674 "protein serine/threonine kinase activity" evidence=NAS

GO:0016909 "SAP kinase activity" evidence=TAS

GO:0006468 "protein phosphorylation" evidence=IEA;NAS

GO:0006952 "defense response" evidence=NAS

GO:0007165 "signal transduction" evidence=NAS

GO:0005524 "ATP binding" evidence=IEA

GO:0034614 "cellular response to reactive oxygen species" evidence=IDA

GO:0071243 "cellular response to arsenic-containing substance" evidence=IDA

GO:0071276 "cellular response to cadmium ion" evidence=IDA

GO:0002385 "mucosal immune response" evidence=IMP

GO:0042594 "response to starvation" evidence=IMP

GO:0045793 "positive regulation of cell size" evidence=IGI

GO:0009408 "response to heat" evidence=IMP

GO:0042542 "response to hydrogen peroxide" evidence=IMP

GO:0042742 "defense response to bacterium" evidence=IMP

GO:0050832 "defense response to fungus" evidence=IMP

GO:0048082 "regulation of adult chitin-containing cuticle pigmentation" evidence=IGI

GO:0006979 "response to oxidative stress" evidence=IMP

GO:0080134 "regulation of response to stress" evidence=IMP

GO:0008340 "determination of adult lifespan" evidence=IMP

FB|FBgn0024846 p38b "p38b" [Drosophila melanogaster (taxid:7227)]

 Score = 726 (260.6 bits), Expect = 4.5e-107, Sum P(2) = 4.5e-107
 Identities = 138/161 (85%), Positives = 147/161 (91%)

Query:    89 SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNT---CLADFKNV 145
             +  KVAIKK+ARPFQSAVHAKRTYRELR+LKHM+HENVIGLLDVFH       L  F+ V
Sbjct:    46 TSTKVAIKKLARPFQSAVHAKRTYRELRLLKHMDHENVIGLLDVFHPGQPADSLDQFQQV 105

Query:   146 YMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
             YMVTHLM ADLNNI+RTQKLSDDHVQFLVYQILRGLKYIHSAG+IHRDLKPSNIAVNEDC
Sbjct:   106 YMVTHLMDADLNNIIRTQKLSDDHVQFLVYQILRGLKYIHSAGVIHRDLKPSNIAVNEDC 165

Query:   206 ELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT 246
             EL+ILDFGLARP E+EMTGYVATRWYRAPEIMLNWMHYNQT
Sbjct:   166 ELRILDFGLARPAESEMTGYVATRWYRAPEIMLNWMHYNQT 206

GO:0000165 "MAPK cascade" evidence=NAS;IDA

GO:0006955 "immune response" evidence=IMP

GO:0045088 "regulation of innate immune response" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=NAS;IDA

GO:0004707 "MAP kinase activity" evidence=ISS;NAS

GO:0030510 "regulation of BMP signaling pathway" evidence=IDA

GO:0007179 "transforming growth factor beta receptor signaling pathway" evidence=IGI

GO:0007476 "imaginal disc-derived wing morphogenesis" evidence=IDA

GO:0016909 "SAP kinase activity" evidence=NAS

GO:0006468 "protein phosphorylation" evidence=NAS

GO:0006952 "defense response" evidence=NAS

GO:0005634 "nucleus" evidence=NAS

GO:0005524 "ATP binding" evidence=IEA

GO:0009651 "response to salt stress" evidence=IGI;IMP

GO:0071243 "cellular response to arsenic-containing substance" evidence=IDA

GO:0034614 "cellular response to reactive oxygen species" evidence=IDA

GO:0071276 "cellular response to cadmium ion" evidence=IDA

GO:0009408 "response to heat" evidence=IMP

GO:0001934 "positive regulation of protein phosphorylation" evidence=IGI

GO:0045793 "positive regulation of cell size" evidence=IGI;IMP

GO:0040018 "positive regulation of multicellular organism growth" evidence=IMP

GO:0042594 "response to starvation" evidence=IMP

GO:0042542 "response to hydrogen peroxide" evidence=IMP

GO:0042742 "defense response to bacterium" evidence=IMP

GO:0050832 "defense response to fungus" evidence=IMP

GO:0048082 "regulation of adult chitin-containing cuticle pigmentation" evidence=IGI

GO:0080134 "regulation of response to stress" evidence=IMP

GO:0008340 "determination of adult lifespan" evidence=IMP

UNIPROTKB|Q9I958 mapk14b "Mitogen-activated protein kinase 14B" [Cyprinus carpio (taxid:7962)]

 Score = 730 (262.0 bits), Expect = 5.8e-103, Sum P(2) = 5.8e-103
 Identities = 134/164 (81%), Positives = 151/164 (92%)

Query:    83 SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
             SALD+ SG++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLD F   TCLA F
Sbjct:    41 SALDTKSGLRVAVKKLSRPFQSMIHAKRTYRELRLLKHMKHENVIGLLDAFSPATCLAGF 100

Query:   143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
              +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct:   101 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 160

Query:   203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT 246
             EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYN T
Sbjct:   161 EDCELKILDFGLARLTDDEMTGYVATRWYRAPEIMLNWMHYNMT 204

GO:0000165 "MAPK cascade" evidence=ISS;IDA

GO:0004707 "MAP kinase activity" evidence=ISS;IDA

GO:0005634 "nucleus" evidence=ISS

GO:0005737 "cytoplasm" evidence=ISS

GO:0006950 "response to stress" evidence=ISS;IDA

GO:0007243 "intracellular protein kinase cascade" evidence=ISS;IDA

ZFIN|ZDB-GENE-021007-1 mapk14b "mitogen-activated protein kinase 14b" [Danio rerio (taxid:7955)]

 Score = 712 (255.7 bits), Expect = 1.5e-102, Sum P(2) = 1.5e-102
 Identities = 131/164 (79%), Positives = 149/164 (90%)

Query:    83 SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
             SA DS +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF   T L +F
Sbjct:    41 SAFDSKAGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFSPATSLEEF 100

Query:   143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
              +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILR LKYIHSA IIHRDLKPSN+AVN
Sbjct:   101 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRALKYIHSADIIHRDLKPSNLAVN 160

Query:   203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT 246
             EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYN T
Sbjct:   161 EDCELKILDFGLARLTDDEMTGYVATRWYRAPEIMLNWMHYNMT 204

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005622 "intracellular" evidence=ISS

GO:0006950 "response to stress" evidence=IEA;ISS

GO:0007243 "intracellular protein kinase cascade" evidence=ISS

GO:0023014 "signal transduction by phosphorylation" evidence=ISS

GO:0016740 "transferase activity" evidence=IEA

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

UNIPROTKB|Q90336 mapk14a "Mitogen-activated protein kinase 14A" [Cyprinus carpio (taxid:7962)]

 Score = 716 (257.1 bits), Expect = 1.8e-101, Sum P(2) = 1.8e-101
 Identities = 132/164 (80%), Positives = 149/164 (90%)

Query:    83 SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
             SA D  +G+KVA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF   T L +F
Sbjct:    41 SAYDEKTGLKVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPATSLEEF 100

Query:   143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
              +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct:   101 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 160

Query:   203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT 246
             EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYN T
Sbjct:   161 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNMT 204

GO:0000165 "MAPK cascade" evidence=ISS;IDA

GO:0004707 "MAP kinase activity" evidence=ISS;IDA

GO:0005634 "nucleus" evidence=ISS

GO:0005737 "cytoplasm" evidence=ISS

GO:0006950 "response to stress" evidence=ISS;IDA

GO:0007243 "intracellular protein kinase cascade" evidence=ISS;IDA

UNIPROTKB|F1RYA1 MAPK14 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 714 (256.4 bits), Expect = 3.6e-101, Sum P(2) = 3.6e-101
 Identities = 131/164 (79%), Positives = 150/164 (91%)

Query:    83 SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
             SA D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct:    40 SAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99

Query:   143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
              +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct:   100 SDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 159

Query:   203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT 246
             EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT
Sbjct:   160 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT 203

GO:2000379 "positive regulation of reactive oxygen species metabolic process" evidence=IEA

GO:0090400 "stress-induced premature senescence" evidence=IEA

GO:0071479 "cellular response to ionizing radiation" evidence=IEA

GO:0071363 "cellular response to growth factor stimulus" evidence=IEA

GO:0051525 "NFAT protein binding" evidence=IEA

GO:0051146 "striated muscle cell differentiation" evidence=IEA

GO:0048010 "vascular endothelial growth factor receptor signaling pathway" evidence=IEA

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=IEA

GO:0045648 "positive regulation of erythrocyte differentiation" evidence=IEA

GO:0042770 "signal transduction in response to DNA damage" evidence=IEA

GO:0042307 "positive regulation of protein import into nucleus" evidence=IEA

GO:0032495 "response to muramyl dipeptide" evidence=IEA

GO:0031663 "lipopolysaccharide-mediated signaling pathway" evidence=IEA

GO:0030316 "osteoclast differentiation" evidence=IEA

GO:0019395 "fatty acid oxidation" evidence=IEA

GO:0018105 "peptidyl-serine phosphorylation" evidence=IEA

GO:0007519 "skeletal muscle tissue development" evidence=IEA

GO:0006006 "glucose metabolic process" evidence=IEA

GO:0005829 "cytosol" evidence=IEA

GO:0005739 "mitochondrion" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA

GO:0002062 "chondrocyte differentiation" evidence=IEA

GO:0001525 "angiogenesis" evidence=IEA

GO:0000922 "spindle pole" evidence=IEA

GO:0000902 "cell morphogenesis" evidence=IEA

GO:0000077 "DNA damage checkpoint" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|Q6DJ17 mapk14 "Mitogen-activated protein kinase 14" [Xenopus (Silurana) tropicalis (taxid:8364)]

 Score = 707 (253.9 bits), Expect = 3.6e-101, Sum P(2) = 3.6e-101
 Identities = 130/164 (79%), Positives = 148/164 (90%)

Query:    83 SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
             SA D+ + ++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF       +F
Sbjct:    41 SAFDTRTELRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAKSFEEF 100

Query:   143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
              +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSAGIIHRDLKPSN+AVN
Sbjct:   101 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAGIIHRDLKPSNLAVN 160

Query:   203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT 246
             EDCELKILDFGLAR T+ EMTGYVATRWYRAPEIMLNWMHYNQT
Sbjct:   161 EDCELKILDFGLARHTDEEMTGYVATRWYRAPEIMLNWMHYNQT 204

GO:0000165 "MAPK cascade" evidence=ISS

GO:0004707 "MAP kinase activity" evidence=ISS

GO:0006950 "response to stress" evidence=ISS

GO:0007243 "intracellular protein kinase cascade" evidence=ISS

UNIPROTKB|Q16539 MAPK14 "Mitogen-activated protein kinase 14" [Homo sapiens (taxid:9606)]

 Score = 711 (255.3 bits), Expect = 7.5e-101, Sum P(2) = 7.5e-101
 Identities = 130/164 (79%), Positives = 150/164 (91%)

Query:    83 SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
             +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct:    40 AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99

Query:   143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
              +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct:   100 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 159

Query:   203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT 246
             EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT
Sbjct:   160 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT 203

GO:0005524 "ATP binding" evidence=IEA

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006915 "apoptotic process" evidence=IEA

GO:0000077 "DNA damage checkpoint" evidence=IEA

GO:0000902 "cell morphogenesis" evidence=IEA

GO:0000922 "spindle pole" evidence=IEA

GO:0001525 "angiogenesis" evidence=IEA

GO:0002062 "chondrocyte differentiation" evidence=IEA

GO:0005739 "mitochondrion" evidence=IEA

GO:0006006 "glucose metabolic process" evidence=IEA

GO:0007519 "skeletal muscle tissue development" evidence=IEA

GO:0019395 "fatty acid oxidation" evidence=IEA

GO:0031663 "lipopolysaccharide-mediated signaling pathway" evidence=IEA

GO:0032495 "response to muramyl dipeptide" evidence=IEA

GO:0042307 "positive regulation of protein import into nucleus" evidence=IEA

GO:0045648 "positive regulation of erythrocyte differentiation" evidence=IEA

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=IEA

GO:0051146 "striated muscle cell differentiation" evidence=IEA

GO:0005634 "nucleus" evidence=ISS

GO:0005737 "cytoplasm" evidence=ISS

GO:0004707 "MAP kinase activity" evidence=IDA

GO:0007243 "intracellular protein kinase cascade" evidence=IDA

GO:0006950 "response to stress" evidence=IDA

GO:0070935 "3'-UTR-mediated mRNA stabilization" evidence=TAS

GO:0006935 "chemotaxis" evidence=TAS

GO:0004708 "MAP kinase kinase activity" evidence=TAS

GO:0006928 "cellular component movement" evidence=TAS

GO:0007165 "signal transduction" evidence=TAS

GO:0007166 "cell surface receptor signaling pathway" evidence=TAS

GO:0000187 "activation of MAPK activity" evidence=TAS

GO:0002224 "toll-like receptor signaling pathway" evidence=TAS

GO:0002755 "MyD88-dependent toll-like receptor signaling pathway" evidence=TAS

GO:0002756 "MyD88-independent toll-like receptor signaling pathway" evidence=TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=TAS

GO:0005654 "nucleoplasm" evidence=TAS

GO:0005829 "cytosol" evidence=TAS

GO:0007265 "Ras protein signal transduction" evidence=TAS

GO:0007596 "blood coagulation" evidence=TAS

GO:0008063 "Toll signaling pathway" evidence=TAS

GO:0010467 "gene expression" evidence=TAS

GO:0016070 "RNA metabolic process" evidence=TAS

GO:0016071 "mRNA metabolic process" evidence=TAS

GO:0030168 "platelet activation" evidence=TAS

GO:0034130 "toll-like receptor 1 signaling pathway" evidence=TAS

GO:0034134 "toll-like receptor 2 signaling pathway" evidence=TAS

GO:0034138 "toll-like receptor 3 signaling pathway" evidence=TAS

GO:0034142 "toll-like receptor 4 signaling pathway" evidence=TAS

GO:0035666 "TRIF-dependent toll-like receptor signaling pathway" evidence=TAS

GO:0042692 "muscle cell differentiation" evidence=TAS

GO:0045087 "innate immune response" evidence=TAS

GO:0048011 "neurotrophin TRK receptor signaling pathway" evidence=TAS

GO:0051090 "regulation of sequence-specific DNA binding transcription factor activity" evidence=TAS

GO:0051149 "positive regulation of muscle cell differentiation" evidence=TAS

GO:0051403 "stress-activated MAPK cascade" evidence=TAS

GO:0005515 "protein binding" evidence=IPI

GO:2000379 "positive regulation of reactive oxygen species metabolic process" evidence=IMP

GO:0071479 "cellular response to ionizing radiation" evidence=IMP

GO:0042770 "signal transduction in response to DNA damage" evidence=IMP

GO:0090400 "stress-induced premature senescence" evidence=IMP

GO:0018105 "peptidyl-serine phosphorylation" evidence=ISS

GO:0030316 "osteoclast differentiation" evidence=ISS

GO:0051525 "NFAT protein binding" evidence=ISS

GO:0035924 "cellular response to vascular endothelial growth factor stimulus" evidence=IMP

GO:0048010 "vascular endothelial growth factor receptor signaling pathway" evidence=IMP

GO:0043536 "positive regulation of blood vessel endothelial cell migration" evidence=IMP

UNIPROTKB|O02812 MAPK14 "Mitogen-activated protein kinase 14" [Canis lupus familiaris (taxid:9615)]

 Score = 711 (255.3 bits), Expect = 1.6e-100, Sum P(2) = 1.6e-100
 Identities = 130/164 (79%), Positives = 150/164 (91%)

Query:    83 SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
             +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct:    40 AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99

Query:   143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
              +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct:   100 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 159

Query:   203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT 246
             EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT
Sbjct:   160 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT 203

GO:0000165 "MAPK cascade" evidence=ISS

GO:0004707 "MAP kinase activity" evidence=ISS

GO:0007243 "intracellular protein kinase cascade" evidence=ISS

GO:0006950 "response to stress" evidence=ISS

GO:0005737 "cytoplasm" evidence=ISS

GO:0005634 "nucleus" evidence=ISS

GO:2000379 "positive regulation of reactive oxygen species metabolic process" evidence=IEA

GO:0090400 "stress-induced premature senescence" evidence=IEA

GO:0071479 "cellular response to ionizing radiation" evidence=IEA

GO:0071363 "cellular response to growth factor stimulus" evidence=IEA

GO:0051525 "NFAT protein binding" evidence=IEA

GO:0051146 "striated muscle cell differentiation" evidence=IEA

GO:0048010 "vascular endothelial growth factor receptor signaling pathway" evidence=IEA

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=IEA

GO:0045648 "positive regulation of erythrocyte differentiation" evidence=IEA

GO:0042770 "signal transduction in response to DNA damage" evidence=IEA

GO:0042307 "positive regulation of protein import into nucleus" evidence=IEA

GO:0032495 "response to muramyl dipeptide" evidence=IEA

GO:0031663 "lipopolysaccharide-mediated signaling pathway" evidence=IEA

GO:0030316 "osteoclast differentiation" evidence=IEA

GO:0019395 "fatty acid oxidation" evidence=IEA

GO:0018105 "peptidyl-serine phosphorylation" evidence=IEA

GO:0007519 "skeletal muscle tissue development" evidence=IEA

GO:0006006 "glucose metabolic process" evidence=IEA

GO:0005829 "cytosol" evidence=IEA

GO:0005739 "mitochondrion" evidence=IEA

GO:0002062 "chondrocyte differentiation" evidence=IEA

GO:0001525 "angiogenesis" evidence=IEA

GO:0000922 "spindle pole" evidence=IEA

GO:0000902 "cell morphogenesis" evidence=IEA

GO:0000077 "DNA damage checkpoint" evidence=IEA

GO:0006915 "apoptotic process" evidence=IEA

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

MGI|MGI:1346865 Mapk14 "mitogen-activated protein kinase 14" [Mus musculus (taxid:10090)]

 Score = 707 (253.9 bits), Expect = 2.0e-100, Sum P(2) = 2.0e-100
 Identities = 130/164 (79%), Positives = 149/164 (90%)

Query:    83 SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
             +A D+ +G +VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct:    40 AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99

Query:   143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
              +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct:   100 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 159

Query:   203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT 246
             EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT
Sbjct:   160 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT 203

GO:0000077 "DNA damage checkpoint" evidence=IMP

GO:0000166 "nucleotide binding" evidence=IEA

GO:0000902 "cell morphogenesis" evidence=IGI

GO:0000922 "spindle pole" evidence=IDA

GO:0001525 "angiogenesis" evidence=IMP

GO:0002062 "chondrocyte differentiation" evidence=IDA

GO:0004672 "protein kinase activity" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0004707 "MAP kinase activity" evidence=ISO;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=ISO

GO:0005623 "cell" evidence=IDA

GO:0005634 "nucleus" evidence=ISO;IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005739 "mitochondrion" evidence=IDA

GO:0005829 "cytosol" evidence=ISO;IDA

GO:0006006 "glucose metabolic process" evidence=IMP

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=ISO;IMP;IDA

GO:0006915 "apoptotic process" evidence=IEA

GO:0006950 "response to stress" evidence=ISO;IDA

GO:0006974 "response to DNA damage stimulus" evidence=IDA

GO:0007243 "intracellular protein kinase cascade" evidence=ISO;IDA

GO:0007519 "skeletal muscle tissue development" evidence=IMP

GO:0008022 "protein C-terminus binding" evidence=ISO

GO:0016301 "kinase activity" evidence=IDA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0018105 "peptidyl-serine phosphorylation" evidence=IDA

GO:0019395 "fatty acid oxidation" evidence=IMP

GO:0023014 "signal transduction by phosphorylation" evidence=ISO;IDA

GO:0030316 "osteoclast differentiation" evidence=IMP

GO:0031663 "lipopolysaccharide-mediated signaling pathway" evidence=IDA

GO:0032495 "response to muramyl dipeptide" evidence=IDA

GO:0032496 "response to lipopolysaccharide" evidence=IDA

GO:0035924 "cellular response to vascular endothelial growth factor stimulus" evidence=ISO

GO:0042307 "positive regulation of protein import into nucleus" evidence=IMP

GO:0042770 "signal transduction in response to DNA damage" evidence=ISO

GO:0044445 "cytosolic part" evidence=ISO

GO:0045648 "positive regulation of erythrocyte differentiation" evidence=IMP

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=ISO

GO:0048010 "vascular endothelial growth factor receptor signaling pathway" evidence=ISO

GO:0051146 "striated muscle cell differentiation" evidence=IGI

GO:0051403 "stress-activated MAPK cascade" evidence=ISO

GO:0051525 "NFAT protein binding" evidence=IPI

GO:0071479 "cellular response to ionizing radiation" evidence=ISO

GO:0090400 "stress-induced premature senescence" evidence=ISO

GO:2000379 "positive regulation of reactive oxygen species metabolic process" evidence=ISO

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q6C4M9	HOG1_YARLI	2, ., 7, ., 1, 1, ., 2, 4	0.4305	0.7377	0.8160	yes	N/A
P47811	MK14_MOUSE	2, ., 7, ., 1, 1, ., 2, 4	0.6005	0.7002	0.8305	yes	N/A
Q750A9	HOG1_ASHGO	2, ., 7, ., 1, 1, ., 2, 4	0.4388	0.7377	0.7046	yes	N/A
P70618	MK14_RAT	2, ., 7, ., 1, 1, ., 2, 4	0.5976	0.7002	0.8305	yes	N/A
P0C431	HOG1_GIBZE	2, ., 7, ., 1, 1, ., 2, 4	0.4361	0.7377	0.8823	yes	N/A
Q4WSF6	HOG1_ASPFU	2, ., 7, ., 1, 1, ., 2, 4	0.4277	0.7377	0.8606	yes	N/A
O02812	MK14_CANFA	2, ., 7, ., 1, 1, ., 2, 4	0.5958	0.7025	0.8333	yes	N/A
Q9DGE2	MK14A_DANRE	2, ., 7, ., 1, 1, ., 2, 4	0.5875	0.6978	0.8254	yes	N/A
Q17446	PMK1_CAEEL	2, ., 7, ., 1, 1, ., 2, 4	0.5424	0.6861	0.7771	yes	N/A
A2QRF6	HOG1_ASPNC	2, ., 7, ., 1, 1, ., 2, 4	0.4258	0.7470	0.8739	yes	N/A
O62618	MK14A_DROME	2, ., 7, ., 1, 1, ., 2, 4	0.6558	0.7025	0.8196	yes	N/A
Q95NE7	MK14_PANTR	2, ., 7, ., 1, 1, ., 2, 4	0.5870	0.7025	0.8333	yes	N/A
P32485	HOG1_YEAST	2, ., 7, ., 1, 1, ., 2, 4	0.4388	0.7377	0.7241	yes	N/A
Q6FIU2	HOG1_CANGA	2, ., 7, ., 1, 1, ., 2, 4	0.4388	0.7377	0.7046	yes	N/A
Q6CJA8	HOG1_KLULA	2, ., 7, ., 1, 1, ., 2, 4	0.4534	0.7025	0.6756	yes	N/A
O59853	HOG2_ZYGRO	2, ., 7, ., 1, 1, ., 2, 4	0.4444	0.7377	0.75	yes	N/A
Q16539	MK14_HUMAN	2, ., 7, ., 1, 1, ., 2, 4	0.5988	0.7025	0.8333	yes	N/A
Q1L5Z8	HOG1_TORDE	2, ., 7, ., 1, 1, ., 2, 4	0.4419	0.7330	0.7330	yes	N/A
Q09892	HOG1_SCHPO	2, ., 7, ., 1, 1, ., 2, 4	0.4416	0.7377	0.9025	yes	N/A
O93982	HOG1_ZYGRC	2, ., 7, ., 1, 1, ., 2, 4	0.4416	0.7377	0.7308	yes	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.24	0.946
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.963

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	427
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-148
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-143
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-132
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-124
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-112
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-111
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-105
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-93
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-84
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	8e-79
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-75
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-74
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-70
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-70
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	6e-70
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-69
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-68
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	8e-65
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-64
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	9e-63
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-59
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-59
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-58
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-57
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	9e-57
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-56
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-56
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-55
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-49
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	7e-48
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-47
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	6e-46
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-45
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-43
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	7e-43
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-39
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-39
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	6e-39
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-38
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-37
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-37
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-37
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-36
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-36
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	7e-35
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-34
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	9e-34
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-32
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	6e-32
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-31
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-31
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-30
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-29
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-29
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	6e-29
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	7e-29
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	8e-28
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	9e-28
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-27
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	6e-27
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	7e-27
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-26
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-25
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	5e-25
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	6e-25
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	6e-25
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-24
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-23
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-23
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-23
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-23
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-22
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-22
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-22
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	7e-22
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-21
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-21
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-21
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-21
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	5e-21
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-21
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-20
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-20
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-19
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-19
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-19
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	6e-19
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-18
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-18
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-18
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-18
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-18
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-18
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	5e-18
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-17
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-17
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-17
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-17
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-17
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-16
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-16
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-15
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-15
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-15
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-14
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-14
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-14
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	5e-14
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-14
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	8e-14
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-13
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-13
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-13
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-13
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-13
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-13
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-13
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-13
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	7e-13
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-12
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-12
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-12
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-12
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-12
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-12
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-12
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-12
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-12
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-12
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	7e-12
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	8e-12
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	8e-12
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	9e-12
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	9e-12
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-11
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-11
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-11
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-11
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-11
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-11
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-11
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-11
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-11
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-11
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	3e-11
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-11
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-11
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-11
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-11
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-11
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	6e-11
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	6e-11
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	7e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	8e-11
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	8e-11
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	8e-11
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-10
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-10
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-10
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-10
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-10
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-10
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-10
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-10
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-10
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-10
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-10
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-10
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-10
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-10
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-10
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-10
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-10
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-10
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-10
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-10
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-10
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-10
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-10
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	5e-10
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	5e-10
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-10
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	7e-10
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	8e-10
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	8e-10
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	9e-10
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	9e-10
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	9e-10
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-09
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-09
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-09
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-09
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-09
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-09
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-09
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-09
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-09
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-09
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-09
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-09
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-09
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-09
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-09
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-09
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-09
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-09
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-09
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-09
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-09
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-09
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-09
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-09
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	7e-09
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	7e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	7e-09
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	7e-09
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	8e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	8e-09
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	8e-09
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	9e-09
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	9e-09
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-08
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-08
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-08
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-08
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-08
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-08
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-08
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-08
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-08
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-08
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-08
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-08
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-08
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-08
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-08
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-08
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-08
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-08
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	7e-08
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	7e-08
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	7e-08
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	7e-08
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	8e-08
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	8e-08
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	8e-08
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	8e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	8e-08
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	9e-08
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	9e-08
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-07
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-07
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-07
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-07
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-07
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-07
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-07
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-07
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-07
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-07
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-07
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-07
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-07
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-07
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-07
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-07
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-07
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-07
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-07
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-07
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-07
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-07
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-07
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	5e-07
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-07
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	6e-07
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	6e-07
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-07
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	6e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	6e-07
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-07
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	7e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-06
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-06
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-06
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-06
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-06
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-06
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-06
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	3e-06
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-06
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-06
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	5e-06
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-06
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	6e-06
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	9e-06
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-05
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-05
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	1e-05
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-05
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-05
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-05
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-05
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-05
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-05
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-05
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-05
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-05
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-05
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	3e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-05
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-05
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-05
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-05
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	5e-05
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-05
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	5e-05
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	5e-05
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	6e-05
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	6e-05
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-05
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	7e-05
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	7e-05
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	7e-05
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	8e-05
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-04
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-04
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-04
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-04
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-04
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	2e-04
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-04
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-04
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-04
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-04
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-04
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-04
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-04
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-04
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-04
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-04
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-04
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-04
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	4e-04
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-04
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-04
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-04
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	5e-04
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	6e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	6e-04
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	7e-04
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	7e-04
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	7e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	7e-04
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	8e-04
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	9e-04
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	0.001
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	0.001
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	0.001
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	0.001
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	0.001
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	0.002
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	0.002
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	0.002
COG0661	517	COG0661, AarF, Predicted unusual protein kinase [G	0.002
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	0.002
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	0.003
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	0.003
COG0478	304	COG0478, COG0478, RIO-like serine/threonine protei	0.003
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	0.003
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	0.004
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	0.004
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	0.004

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  424 bits (1090), Expect = e-148
 Identities = 203/337 (60%), Positives = 241/337 (71%), Gaps = 39/337 (11%)

Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 35  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94

Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 95  NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 154

Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 155 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 198

Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 199 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 236

Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+DLL  ML LDS+KRITA Q
Sbjct: 237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 296

Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWK 418
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK
Sbjct: 297 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWK 333

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  412 bits (1061), Expect = e-143
 Identities = 195/337 (57%), Positives = 240/337 (71%), Gaps = 37/337 (10%)

Query: 82  SSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD 141
            SA D+    KVA+KK++RPFQS +HA+RTYRELR+LKHM HENVIGLLDVF   T + +
Sbjct: 32  CSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91

Query: 142 FKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           F  VY+VT+LMGADLNNI++ QKLSD+HVQFL+YQ+LRGLKYIHSAGIIHRDLKPSN+AV
Sbjct: 92  FNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAV 151

Query: 202 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIA 261
           NEDCEL+ILDFGLAR  ++EMTGYVATRWYRAPEIMLNWMHYNQT       D+      
Sbjct: 152 NEDCELRILDFGLARQADDEMTGYVATRWYRAPEIMLNWMHYNQT------VDIWSVGCI 205

Query: 262 VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT 321
           + E  + K L  G           Y+                       QL  IME++GT
Sbjct: 206 MAELLKGKALFPG---------NDYI----------------------DQLKRIMEVVGT 234

Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQ 381
           P  E + KISS+ ARKYI SLP + ++D +++F+GANP AIDLL  ML LDS+KRI+A +
Sbjct: 235 PSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASE 294

Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWK 418
           ALAHPY SQY DP DEP + PYD+S E+ +  +++WK
Sbjct: 295 ALAHPYFSQYHDPEDEPEAEPYDESPENKERTIEEWK 331

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  384 bits (988), Expect = e-132
 Identities = 170/336 (50%), Positives = 217/336 (64%), Gaps = 37/336 (11%)

Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           SALD  +G KVAIKK+ RPFQS + AKR YRELR+LKHM HENVIGLLDVF  +  L  F
Sbjct: 33  SALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92

Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            + Y+V   MG DL  +++ +KLS+D +QFLVYQ+L+GLKYIH+AGIIHRDLKP N+AVN
Sbjct: 93  HDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN 152

Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EMTGYV TRWYRAPE++LNWMHY QT                
Sbjct: 153 EDCELKILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQT---------------- 196

Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTP 322
                            +    G +         +     H +Q     L  IM++ GTP
Sbjct: 197 ----------------VDIWSVGCIMAEMLTGKPLFKGHDHLDQ-----LMEIMKVTGTP 235

Query: 323 PAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQA 382
             EF+ K+ S+ A+ Y+  LP   KKDFR +   ANP A+++L  ML LD+E RITA +A
Sbjct: 236 SKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEA 295

Query: 383 LAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWK 418
           LAHPY  ++ DP DE  +PPYD SF+++D  +++WK
Sbjct: 296 LAHPYFEEFHDPEDETEAPPYDDSFDEVDQSLEEWK 331

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  362 bits (932), Expect = e-124
 Identities = 138/165 (83%), Positives = 154/165 (93%)

Query: 82  SSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD 141
            SA D+ +G KVAIKK++RPFQSA+HAKRTYRELR+LKHM+HENVIGLLDVF   + L D
Sbjct: 32  CSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91

Query: 142 FKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           F++VY+VTHLMGADLNNI++ QKLSDDH+QFLVYQILRGLKYIHSAGIIHRDLKPSNIAV
Sbjct: 92  FQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 151

Query: 202 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT 246
           NEDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT
Sbjct: 152 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT 196

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  331 bits (851), Expect = e-112
 Identities = 157/348 (45%), Positives = 217/348 (62%), Gaps = 48/348 (13%)

Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +  SA+D+ SG KVAIKKI   F     AKRT REL++L+H  H+N+I + D+       
Sbjct: 20  VVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-- 77

Query: 140 ADFKNVYMVTHLMGADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSN 198
           ADFK+VY+V  LM +DL++I+ + Q L+++H+++ +YQ+LRGLKYIHSA +IHRDLKPSN
Sbjct: 78  ADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSN 137

Query: 199 IAVNEDCELKILDFGLAR-----PTE--NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFY 251
           + VNEDCEL+I DFG+AR     PTE    MT YVATRWYRAPE++L+ +    T +  +
Sbjct: 138 LLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLS-LPEYTTAIDMW 196

Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
                    +V   C   I           EM G       R    +    +Y    +HQ
Sbjct: 197 ---------SVG--C---IF---------AEMLG-------RRQ--LFPGKNY----VHQ 220

Query: 312 LNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLEL 371
           L LI+ +LG+P  E + +I SD  RKYI +LP      + ++F  A+P+A+DLLS ML+ 
Sbjct: 221 LKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQF 280

Query: 372 DSEKRITAEQALAHPYLSQYSDPNDEPT-SPPYDQSFEDMDLPVDQWK 418
           D E+RIT EQAL HP+L+QY DP+DEPT  PP+D  FE ++L  +Q K
Sbjct: 281 DPEERITVEQALQHPFLAQYHDPDDEPTCPPPFDFDFEAIELSREQLK 328

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  331 bits (849), Expect = e-111
 Identities = 151/337 (44%), Positives = 208/337 (61%), Gaps = 43/337 (12%)

Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           SA D ++G  VAIKKI +PF + V AKRTYREL++LKH+ HEN+I L D+F     ++  
Sbjct: 28  SARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIF-----ISPL 82

Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
           +++Y VT L+G DL+ +L ++ L    +Q+ +YQILRGLKY+HSAG++HRDLKPSNI +N
Sbjct: 83  EDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN 142

Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           E+C+LKI DFGLAR  + +MTGYV+TR+YRAPEIML W  Y+         D+  +    
Sbjct: 143 ENCDLKICDFGLARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVE------VDIWSAGCIF 196

Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTP 322
            E  E K L  G                               +  ++Q ++I ++LGTP
Sbjct: 197 AEMLEGKPLFPG-------------------------------KDHVNQFSIITDLLGTP 225

Query: 323 PAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQA 382
           P + +  I S++  +++ SLP      F + FK A+P AIDLL  ML  D +KRI+A +A
Sbjct: 226 PDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEA 285

Query: 383 LAHPYLSQYSDPNDEPTSPP-YDQSFEDMDLPVDQWK 418
           LAHPYL+ Y DP DEP +   +D SF D DLPVD WK
Sbjct: 286 LAHPYLAPYHDPTDEPVAEEKFDWSFNDADLPVDTWK 322

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  315 bits (808), Expect = e-105
 Identities = 123/189 (65%), Positives = 138/189 (73%), Gaps = 24/189 (12%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT------ 307
           DLKPSNIAVNEDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT      
Sbjct: 143 DLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 202

Query: 308 ------------------DIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKD 349
                              I QL  IM ++GTP  E + KISS+SAR YI SLP + KKD
Sbjct: 203 GCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKD 262

Query: 350 FRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPPYDQSFED 409
           F++VF GANP AIDLL  ML LD +KRITA +ALAHPYL++Y DP DEP +PPYDQSFE 
Sbjct: 263 FKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPVAPPYDQSFES 322

Query: 410 MDLPVDQWK 418
            DL VD+WK
Sbjct: 323 RDLTVDEWK 331

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  283 bits (726), Expect = 5e-93
 Identities = 90/170 (52%), Positives = 123/170 (72%), Gaps = 8/170 (4%)

Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           SA+D  +G KVAIKKI+  F   + AKR  RE+++L+H+ HEN+IGLLD+    +   DF
Sbjct: 18  SAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPS-PEDF 76

Query: 143 KNVYMVTHLMGADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
            +VY+VT LM  DL+ ++++ Q L+DDH+Q+ +YQILRGLKY+HSA +IHRDLKPSNI V
Sbjct: 77  NDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV 136

Query: 202 NEDCELKILDFGLAR------PTENEMTGYVATRWYRAPEIMLNWMHYNQ 245
           N +C+LKI DFGLAR        +  +T YV TRWYRAPE++L+   Y +
Sbjct: 137 NSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTK 186

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  262 bits (671), Expect = 1e-84
 Identities = 113/164 (68%), Positives = 130/164 (79%), Gaps = 1/164 (0%)

Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           SA+D  +G KVAIKK++RPFQS + AKR YREL +LKHM HENVIGLLDVF S     +F
Sbjct: 33  SAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92

Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
           ++ Y+V   M  DL  I     LS+D VQ+LVYQ+L GLKYIHSAGIIHRDLKP N+AVN
Sbjct: 93  QDFYLVMPYMQTDLQKI-MGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN 151

Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT 246
           EDCELKILDFGLAR  + EMTGYV TRWYRAPE++LNWMHYNQT
Sbjct: 152 EDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQT 195

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  246 bits (631), Expect = 8e-79
 Identities = 90/197 (45%), Positives = 116/197 (58%), Gaps = 32/197 (16%)

Query: 254 DLKPSNIAVNEDCELKILDFGLAR------PTENEMTGYVATRWYRAPEIMLNWMHYNQT 307
           DLKPSNI VN +C+LKI DFGLAR        +  +T YV TRWYRAPE++L+   Y + 
Sbjct: 128 DLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKA 187

Query: 308 -D-----------------------IHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLP 343
            D                       I QLNLI+E+LGTP  E +  I+S+ AR Y+ SLP
Sbjct: 188 IDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLP 247

Query: 344 LLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEP--TSP 401
              KK   ++F GA+P+AIDLL  ML  D +KRITA++ALAHPYL+Q  DP DEP    P
Sbjct: 248 KKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPP 307

Query: 402 PYDQSFEDMDLPVDQWK 418
                F+D +L  ++ K
Sbjct: 308 FDFDFFDDDELTEEELK 324

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  238 bits (608), Expect = 3e-75
 Identities = 140/356 (39%), Positives = 201/356 (56%), Gaps = 58/356 (16%)

Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I  +A D+V G+ VA+KK++RPFQ+  HAKR YREL +LK +NH+N+I LL+VF     L
Sbjct: 36  IVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL 95

Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F++VY+V  LM A+L  ++  + L  + + +L+YQ+L G+K++HSAGIIHRDLKPSNI
Sbjct: 96  EEFQDVYLVMELMDANLCQVIHME-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 154

Query: 200 AVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L  M Y +            
Sbjct: 155 VVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILG-MGYKEN----------- 202

Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIM 316
                     + I   G        + G          E++   + +  TD I Q N ++
Sbjct: 203 ----------VDIWSVGC-------IMG----------ELVKGSVIFQGTDHIDQWNKVI 235

Query: 317 EMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF------------KGANPQAIDL 364
           E LGTP AEFM ++   + R Y+ + P      F ++F            K    QA DL
Sbjct: 236 EQLGTPSAEFMNRL-QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDL 294

Query: 365 LSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPP--YDQSFEDMDLPVDQWK 418
           LS ML +D +KRI+ ++AL HPY++ + DP +    PP  YD   E+ +  +++WK
Sbjct: 295 LSKMLVIDPDKRISVDEALRHPYITVWYDPAEAEAPPPQIYDAQLEEREHAIEEWK 350

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  236 bits (603), Expect = 1e-74
 Identities = 90/170 (52%), Positives = 120/170 (70%), Gaps = 8/170 (4%)

Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +  SA    +GVKVAIKKI+ PF+     +RT RE+++L+   HEN+IG+LD+    +  
Sbjct: 20  MVCSATHKPTGVKVAIKKIS-PFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPS-F 77

Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
             F +VY+V  LM  DL  +++TQ LS+DH+Q+ +YQILRGLKYIHSA ++HRDLKPSN+
Sbjct: 78  ESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNL 137

Query: 200 AVNEDCELKILDFGLARPTENE------MTGYVATRWYRAPEIMLNWMHY 243
            +N +C+LKI DFGLAR  + E      +T YVATRWYRAPEIMLN   Y
Sbjct: 138 LLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGY 187

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  226 bits (578), Expect = 2e-70
 Identities = 127/365 (34%), Positives = 176/365 (48%), Gaps = 69/365 (18%)

Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           S  D   G +VA+KK+   FQ+ V  KR +REL+ML    H+NV+  LD+      +  F
Sbjct: 18  SVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPH-IDPF 76

Query: 143 KNVYMVTHLMGADLNN-ILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           + +Y+VT LM +DL+  I+  Q LS DHV+  +YQILRGLKY+HSAGI+HRD+KP N+ V
Sbjct: 77  EEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV 136

Query: 202 NEDCELKILDFGLARPTE----NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
           N +C LKI DFGLAR  E      MT  V T++YRAPEI++   HY          D+  
Sbjct: 137 NSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSA------VDIWS 190

Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIME 317
                 E    +IL F    P +                              QL+LI +
Sbjct: 191 VGCIFAELLGRRIL-FQAQSPIQ------------------------------QLDLITD 219

Query: 318 MLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANP---QAIDLLSLMLELDSE 374
           +LGTP  E M   + + AR +I   P         ++  ++    +A+ LL  ML  D +
Sbjct: 220 LLGTPSLEAMRS-ACEGARAHILRGP-HKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPD 277

Query: 375 KRITAEQALAHPYLS---------------------QYSDPNDEPTSPPYDQSFEDMDLP 413
           KRI+A  ALAHPYL                       Y+   +   +PP+D  +E     
Sbjct: 278 KRISAADALAHPYLDEGRLRYHTCMCKCCYTTSGGRVYTSDFEPSANPPFDDEYEKNLTS 337

Query: 414 VDQWK 418
           V Q K
Sbjct: 338 VRQVK 342

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  224 bits (573), Expect = 4e-70
 Identities = 98/190 (51%), Positives = 122/190 (64%), Gaps = 24/190 (12%)

Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT-DI-- 309
           +DLKP N+AVNEDCELKILDFGLAR  + EMTGYV TRWYRAPE++LNWMHYNQT DI  
Sbjct: 141 RDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWS 200

Query: 310 ---------------------HQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKK 348
                                 QL  I+++ G P  EF+ K+   +A+ YI SLP   +K
Sbjct: 201 VGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRK 260

Query: 349 DFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPPYDQSFE 408
           DF  +F  A+PQA+DLL  MLELD +KR+TA +AL HPY   + D ++E    PYD S E
Sbjct: 261 DFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQQPYDDSLE 320

Query: 409 DMDLPVDQWK 418
           +  L VD+WK
Sbjct: 321 NEKLSVDEWK 330

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  224 bits (572), Expect = 6e-70
 Identities = 90/168 (53%), Positives = 119/168 (70%), Gaps = 5/168 (2%)

Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I  SA +S +  KVAIKKIA  F + + AKRT RE+++L+H++HENVI + D+       
Sbjct: 20  IVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPP-HR 78

Query: 140 ADFKNVYMVTHLMGADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSN 198
             F +VY+V  LM  DL+ I+R +Q LSDDH Q+ +YQ+LRGLKYIHSA ++HRDLKPSN
Sbjct: 79  EAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSN 138

Query: 199 IAVNEDCELKILDFGLARP---TENEMTGYVATRWYRAPEIMLNWMHY 243
           + +N +C+LKI DFGLAR      + MT YV TRWYRAPE++LN   Y
Sbjct: 139 LLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEY 186

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  223 bits (569), Expect = 3e-69
 Identities = 136/356 (38%), Positives = 199/356 (55%), Gaps = 58/356 (16%)

Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I  +A D++    VAIKK++RPFQ+  HAKR YREL ++K +NH+N+IGLL+VF     L
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98

Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F++VY+V  LM A+L  +++ + L  + + +L+YQ+L G+K++HSAGIIHRDLKPSNI
Sbjct: 99  EEFQDVYIVMELMDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 157

Query: 200 AVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L  M Y +        D+  
Sbjct: 158 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKEN------VDIWS 210

Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIM 316
               + E  +  +L                                +  TD I Q N ++
Sbjct: 211 VGCIMGEMIKGGVL--------------------------------FPGTDHIDQWNKVI 238

Query: 317 EMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF------------KGANPQAIDL 364
           E LGTP  EFM K+   + R Y+ + P      F ++F            K    QA DL
Sbjct: 239 EQLGTPCPEFMKKLQP-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDL 297

Query: 365 LSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPPY--DQSFEDMDLPVDQWK 418
           LS ML +D+ KRI+ ++AL HPY++ + DP++    PP   D+  ++ +  +++WK
Sbjct: 298 LSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWK 353

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  220 bits (561), Expect = 3e-68
 Identities = 140/355 (39%), Positives = 197/355 (55%), Gaps = 56/355 (15%)

Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I  +A D+V    VAIKK++RPFQ+  HAKR YREL ++K +NH+N+I LL+VF     L
Sbjct: 32  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL 91

Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F++VY+V  LM A+L  +++ + L  + + +L+YQ+L G+K++HSAGIIHRDLKPSNI
Sbjct: 92  EEFQDVYLVMELMDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 150

Query: 200 AVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L  M Y +        D+  
Sbjct: 151 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKEN------VDIWS 203

Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIME 317
               + E    KIL  G               R Y                I Q N ++E
Sbjct: 204 VGCIMGEMVRHKILFPG---------------RDY----------------IDQWNKVIE 232

Query: 318 MLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF------------KGANPQAIDLL 365
            LGTP  EFM K+   + R Y+ + P      F ++F            K    QA DLL
Sbjct: 233 QLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 291

Query: 366 SLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPP--YDQSFEDMDLPVDQWK 418
           S ML +D  KRI+ ++AL HPY++ + DP +    PP  YD+  ++ +  +++WK
Sbjct: 292 SKMLVIDPAKRISVDEALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWK 346

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  210 bits (537), Expect = 8e-65
 Identities = 114/346 (32%), Positives = 171/346 (49%), Gaps = 82/346 (23%)

Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           SA+D+ +G KVAIKKI   F+    A R  RE+++L+ + H +++ +  +    +   +F
Sbjct: 18  SAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS-RREF 76

Query: 143 KNVYMVTHLMGADLNNILRTQK-LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           K++Y+V  LM +DL+ +++    L+ +H QF +YQ+LR LKYIH+A + HRDLKP NI  
Sbjct: 77  KDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA 136

Query: 202 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIA 261
           N DC+LKI DFGLAR                          +N T               
Sbjct: 137 NADCKLKICDFGLARV------------------------AFNDT--------------- 157

Query: 262 VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM--HYNQTDI---------- 309
                           PT    T YVATRWYRAPE+  ++   +    DI          
Sbjct: 158 ----------------PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV 201

Query: 310 -------------HQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKG 356
                        HQL+LI ++LGTP  E ++++ ++ AR+Y++S+       F Q F  
Sbjct: 202 LTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPN 261

Query: 357 ANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPP 402
           A+P A+ LL  +L  D + R TAE+ALA PY    +    EP++ P
Sbjct: 262 ADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPSAQP 307

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  210 bits (536), Expect = 2e-64
 Identities = 88/161 (54%), Positives = 119/161 (73%), Gaps = 3/161 (1%)

Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I  +A D+V+G  VAIKK++RPFQ+  HAKR YREL ++K +NH+N+IGLL+VF     L
Sbjct: 31  IVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSL 90

Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F++VY+V  LM A+L  +++   L  + + +L+YQ+L G+K++HSAGIIHRDLKPSNI
Sbjct: 91  EEFQDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 149

Query: 200 AVNEDCELKILDFGLARPTENE--MTGYVATRWYRAPEIML 238
            V  DC LKILDFGLAR       MT YV TR+YRAPE++L
Sbjct: 150 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 190

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  205 bits (523), Expect = 9e-63
 Identities = 93/198 (46%), Positives = 116/198 (58%), Gaps = 34/198 (17%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENE------MTGYVATRWYRAPEIMLNWMHYNQT 307
           DLKPSN+ +N +C+LKI DFGLAR  + E      +T YVATRWYRAPEIMLN   Y + 
Sbjct: 131 DLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKA 190

Query: 308 -DI-----------------------HQLNLIMEMLGTPPAEFMAKISSDSARKYINSLP 343
            DI                       HQLNLI+ +LGTP  E +  I S  AR YI SLP
Sbjct: 191 IDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLP 250

Query: 344 LLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSP-- 401
              K  + ++F  A+P+A+DLL  ML  +  KRIT E+ALAHPYL QY DP+DEP +   
Sbjct: 251 FKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEP 310

Query: 402 -PYDQSFEDMDLPVDQWK 418
            P+D    D DLP ++ K
Sbjct: 311 FPFDFELFD-DLPKEKLK 327

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  196 bits (501), Expect = 2e-59
 Identities = 91/190 (47%), Positives = 113/190 (59%), Gaps = 32/190 (16%)

Query: 254 DLKPSNIAVNEDCELKILDFGLAR-----PTENE--MTGYVATRWYRAPEIMLNWMHYNQ 306
           DLKP N+ VN DCELKI DFGLAR     P EN   MT YVATRWYRAPEIML++  Y +
Sbjct: 130 DLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTK 189

Query: 307 T-DI-----------------------HQLNLIMEMLGTPPAEFMAKISSDSARKYINSL 342
             D+                        QLN I+++LGTP  E +++I S  A+ YI SL
Sbjct: 190 AIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSL 249

Query: 343 PLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPT-SP 401
           P + KK F  +F  ANP A+DLL  +L  D  KRI+ E+AL HPYL+ + DP+DEP    
Sbjct: 250 PNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQK 309

Query: 402 PYDQSFEDMD 411
           P+D SFE  D
Sbjct: 310 PFDFSFESED 319

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  196 bits (499), Expect = 4e-59
 Identities = 89/169 (52%), Positives = 108/169 (63%), Gaps = 17/169 (10%)

Query: 87  SVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLD---VFHSNTCLADF 142
           +     VAIKKI   F   + AKR  REL++L+H   H+N+  L D   VF  N     F
Sbjct: 24  TSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGN-----F 78

Query: 143 KNVYMVTHLMGADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
             +Y+   LM ADL+ I+R+ Q L+D H Q  +YQIL GLKYIHSA ++HRDLKP N+ V
Sbjct: 79  NELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV 138

Query: 202 NEDCELKILDFGLAR-----PTENE--MTGYVATRWYRAPEIMLNWMHY 243
           N DCELKI DFGLAR     P EN   MT YVATRWYRAPEIML++  Y
Sbjct: 139 NADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSY 187

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  193 bits (492), Expect = 1e-58
 Identities = 69/168 (41%), Positives = 100/168 (59%), Gaps = 11/168 (6%)

Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
            A D ++G  VAIKKI   F+S    K   RE+++LK +NH N+I LLDVF         
Sbjct: 17  KARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK------ 70

Query: 143 KNVYMVTHLMGADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
            ++Y+V   M  DL  +++ ++  L +  ++  +YQ+L+GL + HS GI+HRDLKP N+ 
Sbjct: 71  GDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLL 130

Query: 201 VNEDCELKILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHYNQ 245
           +N +  LK+ DFGLAR         T YV TRWYRAPE++L    Y+ 
Sbjct: 131 INTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYST 178

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  191 bits (487), Expect = 2e-57
 Identities = 77/174 (44%), Positives = 111/174 (63%), Gaps = 14/174 (8%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLADF 142
           A+D  +   VA+KKI   F++A  A+RT+RE+  L+ + +H N++ LL+V  +     + 
Sbjct: 26  AIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA----END 81

Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
           K++Y+V   M  DL+ ++R   L D H ++++YQ+L+ LKYIHS  +IHRDLKPSNI +N
Sbjct: 82  KDIYLVFEYMETDLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLN 141

Query: 203 EDCELKILDFGLAR--------PTENEMTGYVATRWYRAPEIMLNWMHYNQTGV 248
            DC +K+ DFGLAR        P    +T YVATRWYRAPEI+L    Y   GV
Sbjct: 142 SDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYT-KGV 194

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  186 bits (476), Expect = 9e-57
 Identities = 94/317 (29%), Positives = 138/317 (43%), Gaps = 92/317 (29%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
           A D  +G  VAIK I +  +     +R  RE+++LK + H N++ L DVF     L    
Sbjct: 18  ARDKKTGKLVAIKVI-KKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKL---- 72

Query: 144 NVYMVT-HLMGADLNNILRTQK-LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
             Y+V  +  G DL ++L+ +  LS+D  +F + QIL  L+Y+HS GI+HRDLKP NI +
Sbjct: 73  --YLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILL 130

Query: 202 NEDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIMLNWMHYNQ------TGVPFYFQ 253
           +ED  +K+ DFGLAR      ++T +V T  Y APE++L    Y +       GV  Y  
Sbjct: 131 DEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLG-KGYGKAVDIWSLGVILY-- 187

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
                        EL              +TG         P     +   +     QL 
Sbjct: 188 -------------EL--------------LTGK-------PP-----FPGDD-----QLL 203

Query: 314 LIMEMLGTPPAEFMAKIS--SDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLEL 371
            + + +G P   F       S  A+                          DL+  +L  
Sbjct: 204 ELFKKIGKPKPPFPPPEWDISPEAK--------------------------DLIRKLLVK 237

Query: 372 DSEKRITAEQALAHPYL 388
           D EKR+TAE+AL HP+ 
Sbjct: 238 DPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  189 bits (482), Expect = 1e-56
 Identities = 114/366 (31%), Positives = 177/366 (48%), Gaps = 74/366 (20%)

Query: 79  LIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDV-FHSNT 137
           L+FS A+DS    +VA+KKI          K   RE+++++ ++H+N++ + +V   S +
Sbjct: 20  LVFS-AVDSDCDKRVAVKKIV--LTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGS 76

Query: 138 CLAD-------FKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGII 190
            L +         +VY+V   M  DL N+L    LS++H +  +YQ+LRGLKYIHSA ++
Sbjct: 77  DLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVL 136

Query: 191 HRDLKPSNIAVN-EDCELKILDFGLAR--PTENEMTGY----VATRWYRAPEIMLNWMHY 243
           HRDLKP+N+ +N ED  LKI DFGLAR         GY    + T+WYR+P ++L+  +Y
Sbjct: 137 HRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNY 196

Query: 244 NQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEM-TGYVATRWYRAPEIMLNWM 302
                                    K +D   A     EM TG          + +    
Sbjct: 197 T------------------------KAIDMWAAGCIFAEMLTG----------KPLFAGA 222

Query: 303 HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKD-------FRQVFK 355
           H    ++ Q+ LI+E +          +  +   + +N +P   + D        R +  
Sbjct: 223 H----ELEQMQLILESV--------PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLP 270

Query: 356 GANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSP-PYDQSFE-DMDLP 413
           G NP+A+D L  +L  +   R+TAE+AL HPY+S YS P DEP S  P+    E D  L 
Sbjct: 271 GVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEPVSLHPFHIEDELDDILL 330

Query: 414 VDQWKG 419
           + +   
Sbjct: 331 MTEIHS 336

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  188 bits (480), Expect = 3e-56
 Identities = 86/193 (44%), Positives = 110/193 (56%), Gaps = 28/193 (14%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARP---TENEMTGYVATRWYRAPEIMLNWMHYNQ---- 306
           DLKPSN+ +N +C+LKI DFGLAR      + MT YV TRWYRAPE++LN   Y      
Sbjct: 133 DLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDV 192

Query: 307 -------------------TD-IHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLT 346
                               D +HQL LI E+LG+P  E +  I ++ AR+YI SLP   
Sbjct: 193 WSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTP 252

Query: 347 KKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSP-PYDQ 405
           ++ F ++F  ANP AIDLL  ML  D  KRIT E+ALAHPYL+   DP+DEP    P+  
Sbjct: 253 RQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVCQTPFSF 312

Query: 406 SFEDMDLPVDQWK 418
            FE+  L  +  K
Sbjct: 313 DFEEDALTEEDIK 325

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  185 bits (471), Expect = 2e-55
 Identities = 112/337 (33%), Positives = 152/337 (45%), Gaps = 78/337 (23%)

Query: 84  ALDSVSGVKVAIKKI-ARPFQSAVH--AKRTYRELRMLKHMNHENVIGLLDVFHSNTCLA 140
           A D  +G  VAIKKI     + A         RE+++L+ + H N+IGLLDVF       
Sbjct: 19  ARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK---- 74

Query: 141 DFKNVYMVTHLMGADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSN 198
              N+ +V   M  DL  +++ +   L+   ++  +   LRGL+Y+HS  I+HRDLKP+N
Sbjct: 75  --SNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNN 132

Query: 199 IAVNEDCELKILDFGLAR----PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQD 254
           + +  D  LK+ DFGLAR    P    MT  V TRWYRAPE++    HY   GV      
Sbjct: 133 LLIASDGVLKLADFGLARSFGSPNRK-MTHQVVTRWYRAPELLFGARHYG-VGV------ 184

Query: 255 LKPSNIAVNEDCELKILDFG--LARPTENEMTGYVATRWYRAPEIML-NWMHYNQTDIHQ 311
                          +   G   A                   E++L        +DI Q
Sbjct: 185 --------------DMWSVGCIFA-------------------ELLLRVPFLPGDSDIDQ 211

Query: 312 LNLIMEMLGTPPAEFMAKISSDSARKYINSLPL------LTKKDFRQVFKGANPQAIDLL 365
           L  I E LGTP  E    ++         SLP             +Q+F  A+  A+DLL
Sbjct: 212 LGKIFEALGTPTEENWPGVT---------SLPDYVEFKPFPPTPLKQIFPAASDDALDLL 262

Query: 366 SLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPP 402
             +L L+  KRITA QAL HPY S  +DP   PT P 
Sbjct: 263 QRLLTLNPNKRITARQALEHPYFS--NDP--APTPPS 295

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  168 bits (429), Expect = 2e-49
 Identities = 98/335 (29%), Positives = 138/335 (41%), Gaps = 100/335 (29%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTY-RELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           A D  +G  VA+KKI R          T  RE+ +LK + H N++ LLDV H+       
Sbjct: 18  ARDKKTGEIVALKKI-RLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE------ 70

Query: 143 KNVYMVTHLMGADLNNIL--RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
           + +Y+V      DL   L  R   LS + ++ ++YQ+LR                     
Sbjct: 71  RKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLR--------------------- 109

Query: 201 VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNI 260
                       GLA         Y  +            +H          +DLKP NI
Sbjct: 110 ------------GLA---------YCHSHRI---------LH----------RDLKPQNI 129

Query: 261 AVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYN------------ 305
            +N D  LK+ DFGLAR     +  Y   V T WYRAPEI+L   HY+            
Sbjct: 130 LINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIF 189

Query: 306 ------------QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQV 353
                        ++I QL  I ++LGTP  E    ++      Y  + P    KD  +V
Sbjct: 190 AEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK--LPDYKPTFPKFPPKDLEKV 247

Query: 354 FKGANPQAIDLLSLMLELDSEKRITAEQALAHPYL 388
               +P+ IDLLS ML+ +  KRI+A++AL HPY 
Sbjct: 248 LPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  164 bits (417), Expect = 7e-48
 Identities = 60/155 (38%), Positives = 93/155 (60%), Gaps = 11/155 (7%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           +G  VA+K + +  + +   +   RE+R+L+ ++H N++ L+D F       D  ++Y+V
Sbjct: 23  TGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFE------DKDHLYLV 76

Query: 149 THLM-GADLNNILRTQK-LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE 206
                G DL + L     LS+D  + +  QILRGL+Y+HS GIIHRDLKP NI ++E+  
Sbjct: 77  MEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGV 136

Query: 207 LKILDFGLARPTEN---EMTGYVATRWYRAPEIML 238
           +KI DFGLA+        +T +V T WY APE++L
Sbjct: 137 VKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLL 171

Length = 260

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  164 bits (418), Expect = 3e-47
 Identities = 72/194 (37%), Positives = 103/194 (53%), Gaps = 38/194 (19%)

Query: 254 DLKPSNIAVNEDCELKILDFGLAR--------PTENEMTGYVATRWYRAPEIMLNWMHYN 305
           DLKPSNI +N DC +K+ DFGLAR        P    +T YVATRWYRAPEI+L    Y 
Sbjct: 132 DLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYT 191

Query: 306 ------------------------QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINS 341
                                    + ++QL  I+E++G P AE +  I S  A   ++S
Sbjct: 192 KGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDS 251

Query: 342 LPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSP 401
           LP   +K   ++   A+  A+DLL  +L  +  KR+TAE+AL HPY++Q+ +P+DEP  P
Sbjct: 252 LPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLP 311

Query: 402 PYDQSFEDMDLPVD 415
                   + +P+D
Sbjct: 312 ------YPITIPLD 319

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  161 bits (409), Expect = 6e-46
 Identities = 99/361 (27%), Positives = 147/361 (40%), Gaps = 105/361 (29%)

Query: 84  ALDSVSGVKVAIKKI-ARPFQSAVHAKRTY-----------RELRMLKHMNHENVIGLLD 131
           A D+++G  VAIKK+      + V   R             REL+++  + HEN++GL+D
Sbjct: 28  AYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87

Query: 132 VFHSNTCLADFKNVYMVTHLMGADLNNIL-RTQKLSDDHVQFLVYQILRGLKYIHSAGII 190
           V+       DF N+ M   +M +DL  ++ R  +L++  V+ ++ QIL GL  +H    +
Sbjct: 88  VY----VEGDFINLVM--DIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFM 141

Query: 191 HRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPF 250
           HRDL P+NI +N     KI DFGLAR                                  
Sbjct: 142 HRDLSPANIFINSKGICKIADFGLARRYGYPPY------------------------SDT 177

Query: 251 YFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT--- 307
             +D                         E  MT  V T WYRAPE+++    Y+     
Sbjct: 178 LSKDETMQ-------------------RREE-MTSKVVTLWYRAPELLMGAEKYHFAVDM 217

Query: 308 ---------------------DIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLT 346
                                +I QL  I E+LGTP         ++        LPL T
Sbjct: 218 WSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTP---------NEDNWPQAKKLPLYT 268

Query: 347 ------KKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYS---DPNDE 397
                  KD + +F  A+  AIDLL  +L+L+  +RI+A++AL H Y        DP+  
Sbjct: 269 EFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLPCDPSQL 328

Query: 398 P 398
           P
Sbjct: 329 P 329

Length = 335

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  158 bits (401), Expect = 4e-45
 Identities = 92/332 (27%), Positives = 138/332 (41%), Gaps = 88/332 (26%)

Query: 90  GVKVAIKKIARPFQSAVHAKR------TYRELRMLKHMNHENVIGLLDVF--HSNTCLAD 141
           G  VA+KKI       +H ++        RE+++LK + H NV+ L+D+     +     
Sbjct: 33  GRVVALKKIL------MHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86

Query: 142 FKNVYMVTHLMGADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
             +VYMVT  M  DL+ +L     KL++  ++  + Q+L G+ Y+H   I+HRD+K +NI
Sbjct: 87  RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANI 146

Query: 200 AVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSN 259
            ++    LKI DFGLARP            +   P    N                    
Sbjct: 147 LIDNQGILKIADFGLARP------------YDGPPP---NPKGG---------------- 175

Query: 260 IAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYN-------------- 305
                                 + T  V TRWYR PE++L    Y               
Sbjct: 176 ----------------GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAE 219

Query: 306 ----------QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFK 355
                     ++DI QL+LI ++ GTP  E      S    + ++S     +    + F 
Sbjct: 220 MFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRT-LEERFG 278

Query: 356 GANPQAIDLLSLMLELDSEKRITAEQALAHPY 387
              P+ +DLLS +L LD  KR+TA  AL HPY
Sbjct: 279 KLGPEGLDLLSKLLSLDPYKRLTASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  155 bits (393), Expect = 2e-43
 Identities = 81/208 (38%), Positives = 108/208 (51%), Gaps = 43/208 (20%)

Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENE--MTGYVATRWYRAPEIMLNWMHYNQ---- 306
           +DLKPSNI V  DC LKILDFGLAR       MT YV TR+YRAPE++L  M Y +    
Sbjct: 142 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDI 200

Query: 307 -------------------TD-IHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLT 346
                              TD I Q N I+E LGTP  EFM+++   + R Y+ + P   
Sbjct: 201 WSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP-TVRNYVENRPKYA 259

Query: 347 KKDFRQVFKGAN-------------PQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSD 393
              F ++F                  QA DLLS ML +D EKRI+ + AL HPY++ + D
Sbjct: 260 GYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD 319

Query: 394 PN--DEPTSPPYDQSFEDMDLPVDQWKG 419
           P+  + P   PYD S ++ +  V++WK 
Sbjct: 320 PSEVEAPPPAPYDHSIDEREHTVEEWKE 347

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  151 bits (385), Expect = 7e-43
 Identities = 60/162 (37%), Positives = 90/162 (55%), Gaps = 12/162 (7%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTY-RELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           A +  +G  VA+KKI R          T  RE+++L+ + H N++ L ++  S       
Sbjct: 18  ARNKKTGELVALKKI-RMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK----GK 72

Query: 143 KNVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
            ++YMV   M  DL  +L +   K ++  ++  + Q+L GL+Y+HS GI+HRD+K SNI 
Sbjct: 73  GSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNIL 132

Query: 201 VNEDCELKILDFGLARPTENE----MTGYVATRWYRAPEIML 238
           +N D  LK+ DFGLARP         T  V T WYR PE++L
Sbjct: 133 INNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLL 174

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  142 bits (359), Expect = 3e-39
 Identities = 94/321 (29%), Positives = 133/321 (41%), Gaps = 67/321 (20%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM---NHENVIGLLDVFHSNTCLA 140
           A D  +G  VA+KK+  P         T RE+ +LK +    H N++ LLDV H      
Sbjct: 18  ARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDR 77

Query: 141 DFKNVYMVTHLMGADLNNILR---TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPS 197
           + K + +V   +  DL   L       L  + ++ L+ Q+LRG+ ++HS  I+HRDLKP 
Sbjct: 78  ELK-LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQ 136

Query: 198 NIAVNEDCELKILDFGLARPTENEM--TGYVATRWYRAPEIMLNWMHYNQT------GVP 249
           NI V  D ++KI DFGLAR    EM  T  V T WYRAPE++L    Y         G  
Sbjct: 137 NILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCI 195

Query: 250 FY-FQDLKPSNIAVNEDCEL-KILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT 307
           F      +P     +E  +L KI D  +  P+E E        W     + L    +   
Sbjct: 196 FAELFRRRPLFRGTSEADQLDKIFDV-IGLPSEEE--------W--PRNVSLPRSSFPSY 244

Query: 308 DIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSL 367
                                                 T + F+        + +DLL  
Sbjct: 245 --------------------------------------TPRSFKSFVPEICEEGLDLLKK 266

Query: 368 MLELDSEKRITAEQALAHPYL 388
           ML  +  KRI+A +AL HPY 
Sbjct: 267 MLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  142 bits (359), Expect = 3e-39
 Identities = 92/312 (29%), Positives = 144/312 (46%), Gaps = 66/312 (21%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN-HENVIGLLDVFHSNT--CLADFKNV 145
           +G   AIK + + F+S        RE++ L+ ++ H N++ L++V        LA     
Sbjct: 23  TGKYYAIKCMKKHFKSLEQVNN-LREIQALRRLSPHPNILRLIEVLFDRKTGRLA----- 76

Query: 146 YMVTHLMGADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE 203
            +V  LM  +L  +++ +K  L +  V+  +YQ+L+ L ++H  GI HRD+KP NI + +
Sbjct: 77  -LVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD 135

Query: 204 DCELKILDFGLARPTENE--MTGYVATRWYRAPEIMLNWMHYNQ------TGVPFYFQDL 255
           D  LK+ DFG  R   ++   T Y++TRWYRAPE +L   +Y         G  F+    
Sbjct: 136 DI-LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFF---- 190

Query: 256 KPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLI 315
                   E   L  L F    P  NE                          + Q+  I
Sbjct: 191 --------EILSLFPL-F----PGTNE--------------------------LDQIAKI 211

Query: 316 MEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEK 375
            ++LGTP AE + K        Y  + P       R++   A+ + +DLL  +L  D ++
Sbjct: 212 HDVLGTPDAEVLKKFRKSRHMNY--NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDE 269

Query: 376 RITAEQALAHPY 387
           RITA+QAL HPY
Sbjct: 270 RITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  141 bits (357), Expect = 6e-39
 Identities = 97/310 (31%), Positives = 144/310 (46%), Gaps = 51/310 (16%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
           A + ++G  VA+KKI    ++        RE+ +LK +NH N++ LLDV H+        
Sbjct: 19  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE------N 72

Query: 144 NVYMVTHLMGADLN---NILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
            +Y+V   +  DL    +      +    ++  ++Q+L+GL + HS  ++HRDLKP N+ 
Sbjct: 73  KLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL 132

Query: 201 VNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
           +N +  +K+ DFGLAR     +  Y   V T WYRAPEI+L        G  +Y      
Sbjct: 133 INTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL--------GCKYY------ 178

Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIME 317
            + AV+      I   G       EM     TR    P           ++I QL  I  
Sbjct: 179 -STAVD------IWSLGCIFA---EMV----TRRALFP---------GDSEIDQLFRIFR 215

Query: 318 MLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI 377
            LGTP       ++  S   Y  S P   ++DF +V    +    DLLS ML  D  KRI
Sbjct: 216 TLGTPDEVVWPGVT--SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRI 273

Query: 378 TAEQALAHPY 387
           +A+ ALAHP+
Sbjct: 274 SAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  136 bits (345), Expect = 5e-38
 Identities = 62/169 (36%), Positives = 98/169 (57%), Gaps = 14/169 (8%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
           A D  +G KVAIK I +   S+   +   RE+ +LK +NH N++ L  VF          
Sbjct: 12  ARDKKTGKKVAIKII-KKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE------N 64

Query: 144 NVYMVTHLM-GADLNNILR--TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
           ++Y+V     G  L ++L+    KLS+D +  ++ QIL GL+Y+HS GIIHRDLKP NI 
Sbjct: 65  HLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENIL 124

Query: 201 VNEDC-ELKILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHYNQ 245
           ++ D  ++K+ DFGL++     ++ +   V T  Y APE++L   +Y++
Sbjct: 125 LDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  137 bits (347), Expect = 1e-37
 Identities = 68/162 (41%), Positives = 82/162 (50%), Gaps = 28/162 (17%)

Query: 254 DLKPSNIAVNEDCELKILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHYNQ---- 306
           DLKP N+ +N +  LK+ DFGLAR         T YV TRWYRAPE++L    Y+     
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDI 182

Query: 307 --------------------TDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLT 346
                               ++I QL  I   LGTP  E   K +S  AR Y  S P   
Sbjct: 183 WSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS-LARNYKFSFPKKA 241

Query: 347 KKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYL 388
                ++F  A+PQA+DLLS ML  D  KRITAEQALAHPY 
Sbjct: 242 GMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  137 bits (348), Expect = 1e-37
 Identities = 63/182 (34%), Positives = 98/182 (53%), Gaps = 13/182 (7%)

Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVI 127
           I   + + +  ++F  A D  +G  VA+KK+A          +  RE++ L+   H  V+
Sbjct: 4   ILGRIGEGAHGIVFK-AKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVV 62

Query: 128 GLLDVFHSNTCLADFKNVYMVTHLMGADLNNILR--TQKLSDDHVQFLVYQILRGLKYIH 185
            LLDVF   +         +V   M +DL+ +LR   + L +  V+  +  +L+G+ Y+H
Sbjct: 63  KLLDVFPHGSG------FVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH 116

Query: 186 SAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE----MTGYVATRWYRAPEIMLNWM 241
           + GI+HRDLKP+N+ ++ D  LKI DFGLAR    E     +  VATRWYRAPE++    
Sbjct: 117 ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR 176

Query: 242 HY 243
            Y
Sbjct: 177 KY 178

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  136 bits (346), Expect = 3e-37
 Identities = 64/163 (39%), Positives = 93/163 (57%), Gaps = 13/163 (7%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN-HENVIGLLDVFHSNTCLADFKNVYM 147
           +G  VAIKK+ + F S        RE++ L+ +N H N++ L +VF  N  L      Y 
Sbjct: 23  TGELVAIKKMKKKFYSWEECMNL-REVKSLRKLNEHPNIVKLKEVFRENDEL------YF 75

Query: 148 VTHLMGADLNNILRTQK---LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED 204
           V   M  +L  +++ +K    S+  ++ ++YQIL+GL +IH  G  HRDLKP N+ V+  
Sbjct: 76  VFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGP 135

Query: 205 CELKILDFGLARPTENE--MTGYVATRWYRAPEIMLNWMHYNQ 245
             +KI DFGLAR   +    T YV+TRWYRAPEI+L    Y+ 
Sbjct: 136 EVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSS 178

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  135 bits (341), Expect = 1e-36
 Identities = 85/284 (29%), Positives = 127/284 (44%), Gaps = 56/284 (19%)

Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQ----KLSDD 168
           RE+ ++K + HEN++ L DV H+   L       +V   M  DL   + T      L  +
Sbjct: 47  REISLMKELKHENIVRLHDVIHTENKLM------LVFEYMDKDLKKYMDTHGVRGALDPN 100

Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR----PTENEMTG 224
            V+   YQ+L+G+ + H   ++HRDLKP N+ +N+  ELK+ DFGLAR    P  N  + 
Sbjct: 101 TVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-NTFSN 159

Query: 225 YVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEM- 283
            V T WYRAP+++L    Y+ +                        +D         EM 
Sbjct: 160 EVVTLWYRAPDVLLGSRTYSTS------------------------IDIWSVGCIMAEMI 195

Query: 284 TGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLP 343
           TG                      +  QL  I  ++GTP       IS     +Y  + P
Sbjct: 196 TGRPLFP--------------GTNNEDQLLKIFRIMGTPTESTWPGISQ--LPEYKPTFP 239

Query: 344 LLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPY 387
               +D +Q+F  A+P  IDLL  +L+L+ E RI+A  AL HP+
Sbjct: 240 RYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  133 bits (337), Expect = 4e-36
 Identities = 58/158 (36%), Positives = 85/158 (53%), Gaps = 14/158 (8%)

Query: 93  VAIKKI-ARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHL 151
           VAIKK         V  K   RE+++L+ + HEN++ L + F           +Y+V   
Sbjct: 29  VAIKKFKESEDDEDVK-KTALREVKVLRQLRHENIVNLKEAFRRK------GRLYLVFEY 81

Query: 152 MGADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKI 209
           +   L  +L      L  D V+  ++Q+L+ + Y HS  IIHRD+KP NI V+E   LK+
Sbjct: 82  VERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKL 141

Query: 210 LDFGLAR----PTENEMTGYVATRWYRAPEIMLNWMHY 243
            DFG AR       + +T YVATRWYRAPE+++   +Y
Sbjct: 142 CDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNY 179

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  131 bits (331), Expect = 7e-35
 Identities = 94/338 (27%), Positives = 138/338 (40%), Gaps = 79/338 (23%)

Query: 85  LDSVSGVKVAIKKI-ARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
            +   G + AIKK      Q    ++   RE+ +L+ + HENV+ L++VF  +      K
Sbjct: 22  KNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHAD----K 77

Query: 144 NVYMVTHLMGADLNNIL------RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPS 197
           +VY++      DL  I+      +   +    V+ L++QIL G+ Y+HS  ++HRDLKP+
Sbjct: 78  SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPA 137

Query: 198 NIAV----NEDCELKILDFGLARPTEN------EMTGYVATRWYRAPEIMLNWMHYNQ-- 245
           NI V     E   +KI D GLAR          ++   V T WYRAPE++L   HY +  
Sbjct: 138 NILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAI 197

Query: 246 -------------TGVPFYF---QDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 289
                        T  P +      +K SN     D   +I +  L  PTE         
Sbjct: 198 DIWAIGCIFAELLTLEPIFKGREAKIKKSN-PFQRDQLERIFEV-LGTPTEK-------- 247

Query: 290 RWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKD 349
            W      +     Y+                          S+S  K++          
Sbjct: 248 DW----PDIKKMPEYDTLMKDF--------------KTKTYPSNSLAKWMEK-------- 281

Query: 350 FRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPY 387
                K  + Q  DLL  +LE D  KRITAE+AL HPY
Sbjct: 282 ----HKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  130 bits (328), Expect = 2e-34
 Identities = 91/323 (28%), Positives = 136/323 (42%), Gaps = 73/323 (22%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHS-----NTCLADFK 143
           +   VA+KK+    +         RE+++L+ + HENV+ L+++  +     N     F 
Sbjct: 36  TKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSF- 94

Query: 144 NVYMVTHLMGADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
             Y+V      DL  +L  +  K +   ++ ++  +L GL YIH   I+HRD+K +NI +
Sbjct: 95  --YLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI 152

Query: 202 NEDCELKILDFGLARPT-------ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQD 254
            +D  LK+ DFGLAR          N  T  V T WYR PE++L    Y   G P     
Sbjct: 153 TKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDY---GPP----- 204

Query: 255 LKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNL 314
                           +D   A     EM       W R+P IM        T+ HQL L
Sbjct: 205 ----------------IDMWGAGCIMAEM-------WTRSP-IM-----QGNTEQHQLTL 235

Query: 315 IMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGA----------NPQAIDL 364
           I ++ G         I+ +        L L  K +  Q  K            +P A+DL
Sbjct: 236 ISQLCG--------SITPEVWPGVDK-LELFKKMELPQGQKRKVKERLKPYVKDPHALDL 286

Query: 365 LSLMLELDSEKRITAEQALAHPY 387
           +  +L LD  KRI A+ AL H +
Sbjct: 287 IDKLLVLDPAKRIDADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  127 bits (322), Expect = 9e-34
 Identities = 94/347 (27%), Positives = 138/347 (39%), Gaps = 121/347 (34%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKR-----TY-RELRMLKHMNHENVIGLLD-VFHSN 136
           A D  +G  VA+KK+       +  ++     T  RE+ +L  + H N++ + + V  SN
Sbjct: 24  ARDKKTGEIVALKKLK------MEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN 77

Query: 137 TCLADFKNVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDL 194
                   +YMV   +  DL +++ T  Q      V+ L+ Q+L G+ ++H   I+HRDL
Sbjct: 78  -----LDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDL 132

Query: 195 KPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQD 254
           K SN+ +N    LKI DFGLAR                            + G P     
Sbjct: 133 KTSNLLLNNRGILKICDFGLAR----------------------------EYGSP----- 159

Query: 255 LKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYN--------- 305
           LKP                          T  V T WYRAPE++L    Y+         
Sbjct: 160 LKP-------------------------YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVG 194

Query: 306 ---------------QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDF 350
                          +++I QLN I ++LGTP         ++      + LP   KK F
Sbjct: 195 CIFAELLTKKPLFPGKSEIDQLNKIFKLLGTP---------TEKIWPGFSELPGAKKKTF 245

Query: 351 --------RQVFK--GANPQAIDLLSLMLELDSEKRITAEQALAHPY 387
                   R+ F     +    DLL+ +L  D  KRI+AE AL HPY
Sbjct: 246 TKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  123 bits (310), Expect = 3e-32
 Identities = 90/307 (29%), Positives = 136/307 (44%), Gaps = 52/307 (16%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           +G  VA+KKI    +         RE+ +LK + H N++ L DV    + L      Y++
Sbjct: 24  TGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRL------YLI 77

Query: 149 THLMGADLNNILRT----QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED 204
              +  DL   L +    Q +  + V+  +YQIL+G+ + HS  ++HRDLKP N+ ++  
Sbjct: 78  FEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNK 137

Query: 205 CELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIA 261
             +K+ DFGLAR     +  Y   V T WYRAPE++L        G P Y          
Sbjct: 138 GVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLL--------GSPRY---------- 179

Query: 262 VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT 321
                 + I   G             A    + P      + +  ++I QL  I  +LGT
Sbjct: 180 ---STPVDIWSIGTI----------FAEMATKKP------LFHGDSEIDQLFRIFRILGT 220

Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQ 381
           P  +    ++  S   Y N+ P   K   R   K  +   +DLL  ML  D  KRI+A++
Sbjct: 221 PTEDVWPGVT--SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKK 278

Query: 382 ALAHPYL 388
           AL HPY 
Sbjct: 279 ALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  122 bits (309), Expect = 6e-32
 Identities = 96/324 (29%), Positives = 140/324 (43%), Gaps = 66/324 (20%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
           A D  +G  VA+KK+    +         RE+++L+ +NH N++ L ++        DFK
Sbjct: 26  ARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85

Query: 144 ----NVYMVTHLMGADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPS 197
                 Y+V   M  DL  +L +     S+DH++  + Q+L GL Y H    +HRD+K S
Sbjct: 86  KDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCS 145

Query: 198 NIAVNEDCELKILDFGLARPTENE----MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQ 253
           NI +N   ++K+ DFGLAR   +E     T  V T WYR PE++L    Y          
Sbjct: 146 NILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYG--------- 196

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
              P+    +  C L  L                   + + P    N       ++ QL 
Sbjct: 197 ---PAIDVWSCGCILGEL-------------------FTKKPIFQAN------QELAQLE 228

Query: 314 LIMEMLGTP-PAEFMAKISSDSARKYINSLPLLT----KKDFR----QVFKGANPQAIDL 364
           LI  + G+P PA +   I           LP       KK +R    + F      A+DL
Sbjct: 229 LISRLCGSPCPAVWPDVI----------KLPYFNTMKPKKQYRRRLREEFSFIPTPALDL 278

Query: 365 LSLMLELDSEKRITAEQALAHPYL 388
           L  ML LD  KR TAE+AL  P+L
Sbjct: 279 LDHMLTLDPSKRCTAEEALNSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  120 bits (303), Expect = 3e-31
 Identities = 63/171 (36%), Positives = 92/171 (53%), Gaps = 13/171 (7%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
           A D ++G  VA+KKI    +         RE+ +LK +NH N++ LLDV HS   L    
Sbjct: 18  ARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKL---- 73

Query: 144 NVYMVTHLMGADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
             Y+V   +  DL   + +     L    ++  +YQ+L+G+ Y HS  ++HRDLKP N+ 
Sbjct: 74  --YLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLL 131

Query: 201 VNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGV 248
           ++ +  LK+ DFGLAR     +  Y   V T WYRAPEI+L    Y+ T V
Sbjct: 132 IDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYS-TPV 181

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  120 bits (302), Expect = 4e-31
 Identities = 52/161 (32%), Positives = 86/161 (53%), Gaps = 11/161 (6%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           +G  VAIKK        V  K   RE+RMLK + H N++ L++VF         + +++V
Sbjct: 25  TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK------RKLHLV 78

Query: 149 THLMGADLNNIL--RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE 206
                  + N L    + + +  ++ +++Q L+ + + H    IHRD+KP NI + +  +
Sbjct: 79  FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQ 138

Query: 207 LKILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHYN 244
           +K+ DFG AR      ++ T YVATRWYRAPE+++    Y 
Sbjct: 139 IKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYG 179

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  117 bits (295), Expect = 2e-30
 Identities = 49/169 (28%), Positives = 89/169 (52%), Gaps = 20/169 (11%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
           A    +G +VAIK I    +S    ++   E+++LK   H N++     +          
Sbjct: 19  ARHKRTGKEVAIKVI--KLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKD------ 70

Query: 144 NVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
            +++V     G  L ++L++  Q L++  + ++  ++L+GL+Y+HS GIIHRD+K +NI 
Sbjct: 71  ELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANIL 130

Query: 201 VNEDCELKILDFGLA-----RPTENEMTGYVATRWYRAPEIMLNWMHYN 244
           +  D E+K++DFGL+         N M G   T ++ APE++     Y+
Sbjct: 131 LTSDGEVKLIDFGLSAQLSDTKARNTMVG---TPYWMAPEVING-KPYD 175

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  115 bits (290), Expect = 2e-29
 Identities = 60/180 (33%), Positives = 81/180 (45%), Gaps = 36/180 (20%)

Query: 238 LNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENE----MTGYVATRWYR 293
           L ++H N        +D+K SNI +N D  LK+ DFGLARP         T  V T WYR
Sbjct: 113 LQYLHSNG----ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYR 168

Query: 294 APEIMLNWMHYN------------------------QTDIHQLNLIMEMLGTPPAEFMAK 329
            PE++L    Y                          T++ QL  I E+ G+P  E    
Sbjct: 169 PPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPG 228

Query: 330 ISSDSARKYINSLPLLTKKD-FRQVFKGA-NPQAIDLLSLMLELDSEKRITAEQALAHPY 387
           +       + N  P    K   R+ FK   +P A+DLL  +L LD +KRI+A+QAL H Y
Sbjct: 229 V--SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  115 bits (290), Expect = 2e-29
 Identities = 48/162 (29%), Positives = 82/162 (50%), Gaps = 13/162 (8%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
           ALD  +G  +A+K +     S    +   RE+R+L  + H N++             +  
Sbjct: 19  ALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEK--NTL 76

Query: 144 NVYM--VTHLMGADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
           N+++  V+   G  L+++L+   KL +  ++    QIL GL Y+HS GI+HRD+K +NI 
Sbjct: 77  NIFLEYVS---GGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANIL 133

Query: 201 VNEDCELKILDFGLAR-----PTENEMTGYVATRWYRAPEIM 237
           V+ D  +K+ DFG A+      T         T ++ APE++
Sbjct: 134 VDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  114 bits (287), Expect = 6e-29
 Identities = 65/159 (40%), Positives = 91/159 (57%), Gaps = 19/159 (11%)

Query: 89  SGVKVAIKK-IARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYM 147
           +G  VAIKK +       V  K   RE+RMLK + HEN++ L++VF         K +Y+
Sbjct: 25  TGQIVAIKKFLESEDDKMVK-KIAMREIRMLKQLRHENLVNLIEVFRRK------KRLYL 77

Query: 148 V----THLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE 203
           V     H +  DL        L +  V+  ++QILRG+++ HS  IIHRD+KP NI V++
Sbjct: 78  VFEFVDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQ 135

Query: 204 DCELKILDFGLAR----PTENEMTGYVATRWYRAPEIML 238
              +K+ DFG AR    P E   T YVATRWYRAPE+++
Sbjct: 136 SGVVKLCDFGFARTLAAPGE-VYTDYVATRWYRAPELLV 173

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  114 bits (286), Expect = 7e-29
 Identities = 87/283 (30%), Positives = 129/283 (45%), Gaps = 53/283 (18%)

Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRT--QKLSDDHV 170
           RE+ +LK++ H N++ L D+ H+  CL       +V   + +DL   L      +S  +V
Sbjct: 52  REVSLLKNLKHANIVTLHDIIHTERCLT------LVFEYLDSDLKQYLDNCGNLMSMHNV 105

Query: 171 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR----PTENEMTGYV 226
           +  ++Q+LRGL Y H   I+HRDLKP N+ +NE  ELK+ DFGLAR    PT+   +  V
Sbjct: 106 KIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT-YSNEV 164

Query: 227 ATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGY 286
            T WYR P+++L    Y+ T +  +              C L   +    RP        
Sbjct: 165 VTLWYRPPDVLLGSTEYS-TPIDMW-----------GVGCIL--YEMATGRP-------- 202

Query: 287 VATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSA-RKYINSLPLL 345
                          M    T   +L+LI  +LGTP  E    I+S+   R Y    P  
Sbjct: 203 ---------------MFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY--LFPQY 245

Query: 346 TKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYL 388
             +         +   IDLLS +L  +++ RI+AE AL H Y 
Sbjct: 246 RAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  111 bits (279), Expect = 8e-28
 Identities = 58/171 (33%), Positives = 79/171 (46%), Gaps = 45/171 (26%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENE----MTGYVATRWYRAPEIMLNWMHYNQ--- 306
           DLKP+N+ ++ D  LKI DFGLAR    E     +  VATRWYRAPE++     Y+    
Sbjct: 124 DLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVD 183

Query: 307 ---------------------TDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLL 345
                                 DI QL ++   LGTP  E    ++S         LP  
Sbjct: 184 LWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS---------LPDY 234

Query: 346 TKKDF--------RQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYL 388
            K  F         ++F  A+P+A+DLL  +L  D  KR++A +AL HPY 
Sbjct: 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  111 bits (278), Expect = 9e-28
 Identities = 84/320 (26%), Positives = 134/320 (41%), Gaps = 62/320 (19%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHEN-VIGLLDVFHSNTCLADF 142
           A D  +G  VA+KK               RE+ +L+ ++    ++ LLDV H        
Sbjct: 20  ARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK- 78

Query: 143 KNVYMVTHLMGADLNNIL------RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKP 196
            ++Y+V   + +DL   +        + L    ++  +YQ+L+G+ + H  G++HRDLKP
Sbjct: 79  PSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKP 138

Query: 197 SNIAVNEDCE-LKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFY- 251
            N+ V++    LKI D GL R     +  Y   + T WYRAPE++L   HY+ T V  + 
Sbjct: 139 QNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYS-TPVDIWS 197

Query: 252 ----FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT 307
               F ++         D EL+                                      
Sbjct: 198 VGCIFAEMSRKQPLFPGDSELQ-------------------------------------- 219

Query: 308 DIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSL 367
              QL  I ++LGTP  +    +   S  +  +  P    +D  +     +P+ +DLL  
Sbjct: 220 ---QLLHIFKLLGTPTEQVWPGV---SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQK 273

Query: 368 MLELDSEKRITAEQALAHPY 387
           ML  D  KRI+A+ AL HPY
Sbjct: 274 MLRYDPAKRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  111 bits (278), Expect = 3e-27
 Identities = 77/327 (23%), Positives = 128/327 (39%), Gaps = 72/327 (22%)

Query: 92  KVAIKKIARPFQS-AVHAKRTYRELRMLKHMNHE-NVIGLLDVFHSNTCLADFKNVYMVT 149
            VA+K +A+  +S +   +R  RE+++L  +NH  N++ L D F     L       ++ 
Sbjct: 24  LVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSL-----YLVME 78

Query: 150 HLMGADLNNILRT----QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED- 204
           ++ G  L ++L+       LS+    F++ QIL  L+Y+HS GIIHRD+KP NI ++ D 
Sbjct: 79  YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDG 138

Query: 205 CELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE 264
             +K++DFGLA+   +                                            
Sbjct: 139 RVVKLIDFGLAKLLPDP------------------------------------------- 155

Query: 265 DCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYN---QTDIHQLNLIMEML-- 319
                    G         +  V T  Y APE++L          +DI  L + +  L  
Sbjct: 156 ---------GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLT 206

Query: 320 GTPPAE-FMAKISSDSARKYINSL--PLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKR 376
           G PP E      ++    K I  L  P L         +  +  A DLL  +L  D + R
Sbjct: 207 GLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNR 266

Query: 377 ITAEQALAHPYLSQYSDPNDEPTSPPY 403
           +++   L+H  L+       + +    
Sbjct: 267 LSSSSDLSHDLLAHLKLKESDLSDLLK 293

Length = 384

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  109 bits (273), Expect = 6e-27
 Identities = 84/288 (29%), Positives = 130/288 (45%), Gaps = 63/288 (21%)

Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRT--QKLSDDHV 170
           RE+ +LK + H N++ L D+ H++      K++ +V   +  DL   +      +S  +V
Sbjct: 53  REVSLLKDLKHANIVTLHDIVHTD------KSLTLVFEYLDKDLKQYMDDCGNIMSMHNV 106

Query: 171 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR----PTENEMTGYV 226
           +  +YQILRGL Y H   ++HRDLKP N+ +NE  ELK+ DFGLAR    PT+   +  V
Sbjct: 107 KIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT-YSNEV 165

Query: 227 ATRWYRAPEIMLNWMHYNQ------TGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTE 280
            T WYR P+++L    Y+        G  F+                    +    RP  
Sbjct: 166 VTLWYRPPDVLLGSSEYSTQIDMWGVGCIFF--------------------EMASGRP-- 203

Query: 281 NEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYIN 340
                                +    T   +L+LI  +LGTP  E    ISS+   K  N
Sbjct: 204 ---------------------LFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYN 242

Query: 341 SLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYL 388
             P    +         + + I+LL+  L+ +S+KRI+AE+A+ H Y 
Sbjct: 243 -FPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF 289

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  108 bits (272), Expect = 7e-27
 Identities = 83/288 (28%), Positives = 124/288 (43%), Gaps = 63/288 (21%)

Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRT--QKLSDDHV 170
           RE+ +LK + H N++ L D+ H+       K++ +V   +  DL   L      ++  +V
Sbjct: 53  REVSLLKDLKHANIVTLHDIIHTE------KSLTLVFEYLDKDLKQYLDDCGNSINMHNV 106

Query: 171 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR----PTENEMTGYV 226
           +  ++Q+LRGL Y H   ++HRDLKP N+ +NE  ELK+ DFGLAR    PT+   +  V
Sbjct: 107 KLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT-YSNEV 165

Query: 227 ATRWYRAPEIMLNWMHYNQ------TGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTE 280
            T WYR P+I+L    Y+        G  FY                    +    RP  
Sbjct: 166 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFY--------------------EMSTGRP-- 203

Query: 281 NEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYIN 340
                                +    T   QL+ I  +LGTP  E    I S+   K  N
Sbjct: 204 ---------------------LFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYN 242

Query: 341 SLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYL 388
             P              +    +LLS +L+ +  KRI+AE+A+ HPY 
Sbjct: 243 -YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  107 bits (269), Expect = 3e-26
 Identities = 60/167 (35%), Positives = 87/167 (52%), Gaps = 23/167 (13%)

Query: 84  ALDSVSGVKVAIKKI-------ARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSN 136
           A D+ SG  VA+KK+         P  S        RE+ +L ++ H N++ L +V    
Sbjct: 26  ARDTTSGEIVALKKVRMDNERDGIPISS-------LREITLLLNLRHPNIVELKEVVVGK 78

Query: 137 TCLADFKNVYMVTHLMGADLNNILR--TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDL 194
                  ++++V      DL ++L       S+  V+ L+ Q+LRGL+Y+H   IIHRDL
Sbjct: 79  H----LDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDL 134

Query: 195 KPSNIAVNEDCELKILDFGLARPTE---NEMTGYVATRWYRAPEIML 238
           K SN+ + +   LKI DFGLAR        MT  V T WYRAPE++L
Sbjct: 135 KVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLL 181

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  103 bits (259), Expect = 3e-25
 Identities = 49/160 (30%), Positives = 79/160 (49%), Gaps = 17/160 (10%)

Query: 85  LDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN 144
                 V+VA+K + +   S    +   RE R+++ ++H N++ LL V     C  + + 
Sbjct: 23  KGDGKEVEVAVKTL-KEDASEQQIEEFLREARIMRKLDHPNIVKLLGV-----CTEE-EP 75

Query: 145 VYMVTHLM-GADLNNILRTQKLSDDHVQFLV---YQILRGLKYIHSAGIIHRDLKPSNIA 200
           + +V   M G DL + LR  +  +  +  L+    QI RG++Y+ S   IHRDL   N  
Sbjct: 76  LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCL 135

Query: 201 VNEDCELKILDFGLARPTENE-----MTGYVATRWYRAPE 235
           V E+  +KI DFGL+R   ++       G +  RW  APE
Sbjct: 136 VGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM-APE 174

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  105 bits (264), Expect = 5e-25
 Identities = 92/343 (26%), Positives = 159/343 (46%), Gaps = 68/343 (19%)

Query: 68  IGPTLSKESFDLIFSS-ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENV 126
           +G  +   SF +++ +  +D+    KVAIKK+ +  Q         REL ++K++NH N+
Sbjct: 70  LGNIIGNGSFGVVYEAICIDTSE--KVAIKKVLQDPQY------KNRELLIMKNLNHINI 121

Query: 127 IGLLDVFHSNTCLADFKNVYM--VTHLMGADLNNILR-----TQKLSDDHVQFLVYQILR 179
           I L D +++     + KN+++  V   +   ++  ++        L    V+   YQ+ R
Sbjct: 122 IFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCR 181

Query: 180 GLKYIHSAGIIHRDLKPSNIAVNEDCE-LKILDFGLARPTENEMTG-----YVATRWYRA 233
            L YIHS  I HRDLKP N+ ++ +   LK+ DFG A+   N + G     Y+ +R+YRA
Sbjct: 182 ALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK---NLLAGQRSVSYICSRFYRA 238

Query: 234 PEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR 293
           PE+ML                      A N    + +   G                   
Sbjct: 239 PELMLG---------------------ATNYTTHIDLWSLGCI----------------- 260

Query: 294 APEIMLNW-MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQ 352
             E++L + +   Q+ + QL  I+++LGTP  + + +++ + A       P +  KD ++
Sbjct: 261 IAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADI---KFPDVKPKDLKK 317

Query: 353 VF-KGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDP 394
           VF KG    AI+ +S  L+ +  KR+   +ALA P+     DP
Sbjct: 318 VFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDP 360

Length = 440

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  102 bits (257), Expect = 6e-25
 Identities = 51/154 (33%), Positives = 77/154 (50%), Gaps = 16/154 (10%)

Query: 90  GVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT 149
            V+VA+K + +   S    +   RE R+++ ++H NV+ LL V     C  + + +Y+V 
Sbjct: 28  KVEVAVKTL-KEDASEQQIEEFLREARIMRKLDHPNVVKLLGV-----CTEE-EPLYIVM 80

Query: 150 HLM-GADLNNILRTQKLSDDHVQFL--VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE 206
             M G DL + LR  +        L    QI RG++Y+ S   IHRDL   N  V E+  
Sbjct: 81  EYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLV 140

Query: 207 LKILDFGLARPTENE-----MTGYVATRWYRAPE 235
           +KI DFGL+R   ++       G +  RW  APE
Sbjct: 141 VKISDFGLSRDLYDDDYYRKRGGKLPIRWM-APE 173

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  103 bits (258), Expect = 6e-25
 Identities = 62/169 (36%), Positives = 88/169 (52%), Gaps = 15/169 (8%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
           A D V+   +A+KKI    +         RE+ +LK M H N++ L DV HS   L    
Sbjct: 21  ARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRL---- 76

Query: 144 NVYMVTHLMGADLNNIL-RTQKLSDDH--VQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
             Y+V   +  DL   +  +   + +   ++  +YQILRG+ Y HS  ++HRDLKP N+ 
Sbjct: 77  --YLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLL 134

Query: 201 VNEDCE-LKILDFGLAR----PTENEMTGYVATRWYRAPEIMLNWMHYN 244
           ++     LK+ DFGLAR    P     T  V T WYRAPEI+L   HY+
Sbjct: 135 IDRRTNALKLADFGLARAFGIPVRT-FTHEVVTLWYRAPEILLGSRHYS 182

Length = 294

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  101 bits (253), Expect = 3e-24
 Identities = 50/164 (30%), Positives = 74/164 (45%), Gaps = 29/164 (17%)

Query: 254 DLKPSNIAVNEDCELKILDFGLAR----PTENEMTGYVATRWYRAPEIMLNWMHYN---- 305
           D+KP NI V+E   LK+ DFG AR       + +T YVATRWYRAPE+++   +Y     
Sbjct: 125 DIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVD 184

Query: 306 --------------------QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLL 345
                                +DI QL LI + LG  P       SS+     +      
Sbjct: 185 VWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPS 244

Query: 346 TKKDFRQVFKGA-NPQAIDLLSLMLELDSEKRITAEQALAHPYL 388
             +   + + G  +  A+D L   L +D ++R+T ++ L HPY 
Sbjct: 245 QPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 98.5 bits (246), Expect = 2e-23
 Identities = 54/162 (33%), Positives = 75/162 (46%), Gaps = 29/162 (17%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYN----- 305
           DLKP N+ ++ +  LK+ DFGLAR     +  Y   V T WYRAPEI+L    Y+     
Sbjct: 124 DLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDI 183

Query: 306 -------------------QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLT 346
                               ++I QL  I   LGTP  +    ++S     Y  + P   
Sbjct: 184 WSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP--DYKPTFPKWA 241

Query: 347 KKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYL 388
           ++D  +V    +   +DLLS ML  D  KRI+A+ AL HPY 
Sbjct: 242 RQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 98.7 bits (246), Expect = 2e-23
 Identities = 48/139 (34%), Positives = 77/139 (55%), Gaps = 11/139 (7%)

Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDH--V 170
           RE+ +LK + H+N++ L DV HS+      K + +V      DL     +     D   V
Sbjct: 48  REICLLKELKHKNIVRLYDVLHSD------KKLTLVFEYCDQDLKKYFDSCNGDIDPEIV 101

Query: 171 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGY---VA 227
           +  ++Q+L+GL + HS  ++HRDLKP N+ +N++ ELK+ DFGLAR     +  Y   V 
Sbjct: 102 KSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV 161

Query: 228 TRWYRAPEIMLNWMHYNQT 246
           T WYR P+++     Y+ +
Sbjct: 162 TLWYRPPDVLFGAKLYSTS 180

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score = 98.1 bits (245), Expect = 3e-23
 Identities = 49/141 (34%), Positives = 73/141 (51%), Gaps = 9/141 (6%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTEN---EMTGYVATRWYRAPEIML-NWMHYNQTDI 309
           DLKP NI ++E+  +KI DFGLA+        +T +V T WY APE++L    +  + D+
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDV 182

Query: 310 HQLNLIM-EML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSL 367
             L +I+ E+L G PP  F  +   D  +     L    + D  +   G + +A DL+  
Sbjct: 183 WSLGVILYELLTGKPP--FSGENILDQLQLIRRILGPPLEFDEPKWSSG-SEEAKDLIKK 239

Query: 368 MLELDSEKRITAEQALAHPYL 388
            L  D  KR TAE+ L HP+ 
Sbjct: 240 CLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 98.6 bits (246), Expect = 3e-23
 Identities = 51/141 (36%), Positives = 74/141 (52%), Gaps = 31/141 (21%)

Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLA--------DFKNVYMVTHLMGADLNNILRTQK 164
           RE  +LK + H N++ L D+ H+   L         D K  YM     G  ++N      
Sbjct: 52  REASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQ-YMDDCGGGLSMHN------ 104

Query: 165 LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR----PTE- 219
                V+  ++Q+LRGL Y H   ++HRDLKP N+ ++E  ELK+ DFGLAR    P++ 
Sbjct: 105 -----VRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159

Query: 220 --NEMTGYVATRWYRAPEIML 238
             NE    V T WYR P+++L
Sbjct: 160 YSNE----VVTLWYRPPDVLL 176

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 95.5 bits (238), Expect = 2e-22
 Identities = 45/129 (34%), Positives = 73/129 (56%), Gaps = 10/129 (7%)

Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLN-NILRTQKLSDDHV 170
            E R+L+ +NH  ++ L   F       D +N+Y+V  L+ G DL  ++ +  K S++ V
Sbjct: 49  NERRILQELNHPFLVNLWYSFQ------DEENMYLVVDLLLGGDLRYHLSQKVKFSEEQV 102

Query: 171 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR--PTENEMTGYVAT 228
           +F + +I+  L+Y+HS GIIHRD+KP NI ++E   + I DF +A     +   T    T
Sbjct: 103 KFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGT 162

Query: 229 RWYRAPEIM 237
             Y APE++
Sbjct: 163 PGYMAPEVL 171

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 95.4 bits (237), Expect = 4e-22
 Identities = 82/313 (26%), Positives = 129/313 (41%), Gaps = 51/313 (16%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRE---LRMLKHMNHENVIGLLDVFHSNTCLA 140
           A D  SG  VA+K +            T RE   L+ L+  +H N++ L+DV  ++    
Sbjct: 19  ARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDR 78

Query: 141 DFKNVYMVTHLMGADLNNILRTQK---LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPS 197
           + K V +V   +  DL   L       L  + ++ L+ Q LRGL ++H+  I+HRDLKP 
Sbjct: 79  ETK-VTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPE 137

Query: 198 NIAVNEDCELKILDFGLARPTENEM--TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDL 255
           NI V    ++K+ DFGLAR    +M  T  V T WYRAPE++L   +             
Sbjct: 138 NILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTY------------- 184

Query: 256 KPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLI 315
                               A P +    G +    +R   +         ++  QL  I
Sbjct: 185 --------------------ATPVDMWSVGCIFAEMFRRKPLFC-----GNSEADQLGKI 219

Query: 316 MEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEK 375
            +++G PP +   +  +        +      +  + V          LL  ML  +  K
Sbjct: 220 FDLIGLPPEDDWPRDVTLPR----GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHK 275

Query: 376 RITAEQALAHPYL 388
           RI+A +AL HP+ 
Sbjct: 276 RISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 94.9 bits (237), Expect = 4e-22
 Identities = 46/174 (26%), Positives = 78/174 (44%), Gaps = 22/174 (12%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
                 G    +K+I     S    +    E+++LK +NH N+I   + F     L    
Sbjct: 19  VRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKL---- 74

Query: 144 NVYMVTHLM----GADLNNILRTQK-----LSDDHVQFLVYQILRGLKYIHSAGIIHRDL 194
              +V   M    G DL+  ++ QK       ++ +     Q+   LKY+HS  I+HRD+
Sbjct: 75  --CIV---MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDI 129

Query: 195 KPSNIAVNEDCELKILDFGLARPTENEM---TGYVATRWYRAPEIMLNWMHYNQ 245
           KP NI +  +  +K+ DFG+++   + +      V T +Y +PE+  N   YN 
Sbjct: 130 KPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQN-KPYNY 182

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 93.9 bits (234), Expect = 7e-22
 Identities = 58/223 (26%), Positives = 104/223 (46%), Gaps = 34/223 (15%)

Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIKKI--ARPFQSAVHAKRTYRELRMLKHMNHEN 125
           +G  + + +F +++   L+  +G  VAIK+I   +  + A+  K   +E+ +LK++ H N
Sbjct: 4   LGDLIGRGAFGVVYK-GLNLETGDFVAIKQISLEKIKEEAL--KSIMQEIDLLKNLKHPN 60

Query: 126 VIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNIL-RTQKLSDDHVQFLVYQILRGLKY 183
           ++  +    ++  L      Y++        L  I+ +     +  V   VYQ+L+GL Y
Sbjct: 61  IVKYIGSIETSDSL------YIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAY 114

Query: 184 IHSAGIIHRDLKPSNIAVNEDCELKILDFGLA---RPTENEMTGYVATRWYRAPEIMLN- 239
           +H  G+IHRD+K +NI   +D  +K+ DFG+A        +    V T ++ APE++   
Sbjct: 115 LHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMS 174

Query: 240 --------W-----MHYNQTGVPFYFQDLKPSNI---AVNEDC 266
                   W     +    TG P Y+ DL P       V +D 
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPYY-DLNPMAALFRIVQDDH 216

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 93.4 bits (233), Expect = 2e-21
 Identities = 45/165 (27%), Positives = 85/165 (51%), Gaps = 21/165 (12%)

Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
            A D  +G +VAIKK+    Q+    +    E+ ++K   H N++   D +     L   
Sbjct: 37  KATDRATGKEVAIKKMRLRKQNK---ELIINEILIMKDCKHPNIVDYYDSYLVGDEL--- 90

Query: 143 KNVYMVTHLM-GADLNNILR--TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
              ++V   M G  L +I+     ++++  + ++  ++L+GL+Y+HS  +IHRD+K  NI
Sbjct: 91  ---WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNI 147

Query: 200 AVNEDCELKILDFGLA------RPTENEMTGYVATRWYRAPEIML 238
            +++D  +K+ DFG A      +   N +   V T ++ APE++ 
Sbjct: 148 LLSKDGSVKLADFGFAAQLTKEKSKRNSV---VGTPYWMAPEVIK 189

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 92.8 bits (231), Expect = 4e-21
 Identities = 56/179 (31%), Positives = 80/179 (44%), Gaps = 33/179 (18%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTE---NEMTGYVATRWYRAPEIMLNWMHYN----- 305
           DLK SN+ + +   LKI DFGLAR        MT  V T WYRAPE++L    Y      
Sbjct: 133 DLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDM 192

Query: 306 -------------------QTDIHQLNLIMEMLGTPPAEFMAKISS-DSARKYINSLPLL 345
                              +++I QL+LI+++LGTP        S      K+  +LP  
Sbjct: 193 WAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKF--TLPKQ 250

Query: 346 TKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYS---DPNDEPTSP 401
              + +  F   +   + LL+ +L  D +KR TAE+AL   Y  +     +P   PT P
Sbjct: 251 PYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEPEMMPTFP 309

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 91.8 bits (229), Expect = 4e-21
 Identities = 43/138 (31%), Positives = 73/138 (52%), Gaps = 11/138 (7%)

Query: 107 HAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQ-K 164
             + T  E  +L  +NH  ++ L   F +       + +Y+V     G +L + L  + +
Sbjct: 36  EVEHTLTERNILSRINHPFIVKLHYAFQTE------EKLYLVLEYAPGGELFSHLSKEGR 89

Query: 165 LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM-- 222
            S++  +F   +I+  L+Y+HS GII+RDLKP NI ++ D  +K+ DFGLA+   +E   
Sbjct: 90  FSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR 149

Query: 223 -TGYVATRWYRAPEIMLN 239
              +  T  Y APE++L 
Sbjct: 150 TNTFCGTPEYLAPEVLLG 167

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 91.8 bits (229), Expect = 4e-21
 Identities = 47/162 (29%), Positives = 72/162 (44%), Gaps = 21/162 (12%)

Query: 85  LDSVSGVKVAIKKIARPFQSAVHAKRT--YRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
               +  KVA+K +    + A   +R     E  ++K ++H N++ LL V     C    
Sbjct: 23  DGEGTETKVAVKTLK---EGASEEEREEFLEEASIMKKLSHPNIVRLLGV-----CTQG- 73

Query: 143 KNVYMVTHLM-GADLNNILRTQKLSDDHVQFL--VYQILRGLKYIHSAGIIHRDLKPSNI 199
           + +Y+VT  M G DL + LR           L    QI +G++Y+ S   +HRDL   N 
Sbjct: 74  EPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNC 133

Query: 200 AVNEDCELKILDFGLARPTENEMTGYVAT------RWYRAPE 235
            V E+  +KI DFGL+R    +             +W  APE
Sbjct: 134 LVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM-APE 174

Length = 258

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 91.9 bits (229), Expect = 5e-21
 Identities = 76/320 (23%), Positives = 122/320 (38%), Gaps = 76/320 (23%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAV-HAKRTYRELRMLKHMN-HENVIGLLDVFHSNTCLAD 141
           A +  +  + AIK + +         K    E  +L  +N H  +I L   F     L  
Sbjct: 20  AKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENL-- 77

Query: 142 FKNVYMV-THLMGADLNNILRTQK-LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
               Y V  +    +L   +R    L +   +F   +IL  L+Y+HS GIIHRDLKP NI
Sbjct: 78  ----YFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENI 133

Query: 200 AVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSN 259
            +++D  +KI DFG A+                                      L P++
Sbjct: 134 LLDKDMHIKITDFGTAK-------------------------------------VLDPNS 156

Query: 260 IAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIM-EM 318
              +   +   +D  + +      + +V T  Y +PE++        +D+  L  I+ +M
Sbjct: 157 SPESNKGDATNIDSQIEKNRRRFAS-FVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQM 215

Query: 319 L-GTPP----AEF--MAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLEL 371
           L G PP     E+    KI      +Y           F   F    P A DL+  +L L
Sbjct: 216 LTGKPPFRGSNEYLTFQKI---LKLEY----------SFPPNF---PPDAKDLIEKLLVL 259

Query: 372 DSEKRITA----EQALAHPY 387
           D + R+      ++  AHP+
Sbjct: 260 DPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 92.4 bits (229), Expect = 6e-21
 Identities = 82/285 (28%), Positives = 121/285 (42%), Gaps = 52/285 (18%)

Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQK--LSDDHV 170
           RE  +LK + H N++ L D+ H+   L       +V   +  DL   +      L  ++V
Sbjct: 52  REASLLKGLKHANIVLLHDIIHTKETLT------LVFEYVHTDLCQYMDKHPGGLHPENV 105

Query: 171 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGY---VA 227
           +  ++Q+LRGL YIH   I+HRDLKP N+ +++  ELK+ DFGLAR        Y   V 
Sbjct: 106 KLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV 165

Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV 287
           T WYR P+++L    Y+                          LD         EM   V
Sbjct: 166 TLWYRPPDVLLGSTEYSTC------------------------LDMWGVGCIFVEMIQGV 201

Query: 288 ATRWYRAPEIMLNWMHYNQTDIH-QLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLT 346
           A                   DI  QL  I  +LGTP  +    + S    K      L +
Sbjct: 202 AA-------------FPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK-PERFTLYS 247

Query: 347 KKDFRQVFKGAN--PQAIDLLSLMLELDSEKRITAEQALAHPYLS 389
            K+ RQ +   +    A DL S +L+   + R++A+ AL+H Y S
Sbjct: 248 PKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFS 292

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 91.2 bits (226), Expect = 1e-20
 Identities = 81/302 (26%), Positives = 139/302 (46%), Gaps = 53/302 (17%)

Query: 93  VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM 152
           VAIKK     ++    + T REL+ML+ +  EN++ L + F     L      Y+V   +
Sbjct: 29  VAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKL------YLVFEYV 82

Query: 153 GADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKIL 210
             ++  +L      +  + V+  +YQ+++ + + H   I+HRD+KP N+ ++ +  LK+ 
Sbjct: 83  EKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLC 142

Query: 211 DFGLARP----TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDC 266
           DFG AR     +    T YVATRWYR+PE++L        G P Y + +   ++     C
Sbjct: 143 DFGFARNLSEGSNANYTEYVATRWYRSPELLL--------GAP-YGKAVDMWSVG----C 189

Query: 267 ELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEF 326
            L  L  G  +P                       +   +++I QL  I ++LG  PAE 
Sbjct: 190 ILGELSDG--QP-----------------------LFPGESEIDQLFTIQKVLGPLPAEQ 224

Query: 327 MAKISSDSARKYINSLPLLTK-KDFRQVFKGA-NPQAIDLLSLMLELDSEKRITAEQALA 384
           M K+   + R +    P +   +   + + G  +   +DL+  +L+L+   R   EQ L 
Sbjct: 225 M-KLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283

Query: 385 HP 386
           HP
Sbjct: 284 HP 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 91.2 bits (226), Expect = 1e-20
 Identities = 93/316 (29%), Positives = 128/316 (40%), Gaps = 67/316 (21%)

Query: 88  VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYM 147
           ++G  VA+K I+   +  V      RE  +LK + H N++ L D+ H+   L        
Sbjct: 28  INGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLHDIIHTKETLT------F 80

Query: 148 VTHLMGADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
           V   M  DL   +      L   +V+  ++Q+LRGL YIH   I+HRDLKP N+ ++   
Sbjct: 81  VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLG 140

Query: 206 ELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQT----GVPFYF------ 252
           ELK+ DFGLAR        Y   V T WYR P+++L    Y+      G    F      
Sbjct: 141 ELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQG 200

Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQL 312
           Q   P    V E  E KI    L  PTE+   G      Y+ PE  L           QL
Sbjct: 201 QPAFPGVSDVFEQLE-KIWTV-LGVPTEDTWPGVSKLPNYK-PEWFL------PCKPQQL 251

Query: 313 NLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD 372
            ++ + L  PP                                     A DL S ML + 
Sbjct: 252 RVVWKRLSRPPK------------------------------------AEDLASQMLMMF 275

Query: 373 SEKRITAEQALAHPYL 388
            + RI+A+ AL HPY 
Sbjct: 276 PKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 88.3 bits (219), Expect = 1e-19
 Identities = 61/164 (37%), Positives = 76/164 (46%), Gaps = 32/164 (19%)

Query: 253 QDLKPSNIAVNEDCE-LKILDFGLAR----PTENEMTGYVATRWYRAPEIMLNWMHY--- 304
           +DLKP N+ ++     LK+ DFGLAR    P     T  V T WYRAPEI+L   HY   
Sbjct: 126 RDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT-FTHEVVTLWYRAPEILLGSRHYSTP 184

Query: 305 --------------NQ-------TDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLP 343
                         NQ       ++I +L  I  +LGTP  E    ++S     Y ++ P
Sbjct: 185 VDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS--LPDYKSAFP 242

Query: 344 LLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPY 387
               KD   V     P  +DLLS ML LD  KRITA  AL H Y
Sbjct: 243 KWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEY 286

Length = 294

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 87.6 bits (218), Expect = 1e-19
 Identities = 51/162 (31%), Positives = 76/162 (46%), Gaps = 25/162 (15%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
            +VA+K + +   S    K   +E R++K + H NV+ LL V     C  + + +Y+V  
Sbjct: 24  TEVAVKTL-KEDASEEERKDFLKEARVMKKLGHPNVVRLLGV-----CT-EEEPLYLVLE 76

Query: 151 LM-GADLNNILRTQK----------LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            M G DL + LR  +          LS   +     QI +G++Y+ S   +HRDL   N 
Sbjct: 77  YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNC 136

Query: 200 AVNEDCELKILDFGLARPTENEMTGYVAT------RWYRAPE 235
            V ED  +KI DFGL+R   ++      T      RW  APE
Sbjct: 137 LVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM-APE 177

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 86.9 bits (216), Expect = 2e-19
 Identities = 48/153 (31%), Positives = 78/153 (50%), Gaps = 13/153 (8%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           +G   A+KKI          K+  REL+ L+      V+     F+          + +V
Sbjct: 25  TGKIYALKKIHVDGDEE-FRKQLLRELKTLRSCESPYVVKCYGAFYKE------GEISIV 77

Query: 149 THLM-GADLNNIL-RTQKLSDDHVQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNEDC 205
              M G  L ++L +  K+ +  + ++  QIL+GL Y+H+   IIHRD+KPSN+ +N   
Sbjct: 78  LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG 137

Query: 206 ELKILDFGLARPTENEMTG---YVATRWYRAPE 235
           E+KI DFG+++  EN +     +V T  Y +PE
Sbjct: 138 EVKIADFGISKVLENTLDQCNTFVGTVTYMSPE 170

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 85.8 bits (213), Expect = 6e-19
 Identities = 52/169 (30%), Positives = 74/169 (43%), Gaps = 30/169 (17%)

Query: 90  GVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNT------CLADFK 143
           G   AIK I          K        +  +  E  I  L    S             K
Sbjct: 18  GDIYAIKVIK---------KADMIRKNQVDQVLTERDI--LSQAQSPYVVKLYYSFQGKK 66

Query: 144 NVYMVT-HLMGADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           N+Y+V  +L G DL ++L     L +D  +  + +I+  L+Y+HS GIIHRDLKP NI +
Sbjct: 67  NLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI 126

Query: 202 NEDCELKILDFGLAR-----------PTENEMTGYVATRWYRAPEIMLN 239
           + +  LK+ DFGL++             E E    V T  Y APE++L 
Sbjct: 127 DSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 85.1 bits (211), Expect = 1e-18
 Identities = 45/166 (27%), Positives = 77/166 (46%), Gaps = 35/166 (21%)

Query: 253 QDLKPSNIAVNEDCELKILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHYN---- 305
           +D+KP NI + +  ++K+ DFG AR      ++ T YVATRWYRAPE+++    Y     
Sbjct: 124 RDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVD 183

Query: 306 --------------------QTDIHQLNLIMEMLGTPPAEFMAK-ISSDSARKYINSLPL 344
                               ++D+ QL LI + LG    + + +     S  ++   L +
Sbjct: 184 VWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLG----DLIPRHQQIFSTNQFFKGLSI 239

Query: 345 L---TKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPY 387
               T++     F   +  A+  L   L++D  +R++ E+ L HPY
Sbjct: 240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 85.1 bits (211), Expect = 2e-18
 Identities = 50/169 (29%), Positives = 73/169 (43%), Gaps = 39/169 (23%)

Query: 254 DLKPSNIAVNEDCELKILDFGLAR----PTE---NEMTGYVATRWYRAPEIMLNWMHYN- 305
           DLKP N+ ++E  ELK+ DFGLAR    P++   NE    V T WYR P+++L    Y+ 
Sbjct: 128 DLKPQNLLISERGELKLADFGLARAKSVPSKTYSNE----VVTLWYRPPDVLLGSTEYST 183

Query: 306 QTDI------------------------HQLNLIMEMLGTPPAEFMAKISSDSARKYINS 341
             D+                         QL+ I  +LGTP  E    +SS+       S
Sbjct: 184 SLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE-FKPYS 242

Query: 342 LPLLTKKDFRQVFK--GANPQAIDLLSLMLELDSEKRITAEQALAHPYL 388
            P    +            P   +L    L+ + +KRI+A +A+ HPY 
Sbjct: 243 FPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 84.1 bits (209), Expect = 3e-18
 Identities = 42/139 (30%), Positives = 70/139 (50%), Gaps = 24/139 (17%)

Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILR-TQKLSDD 168
              E R+L+ + H  ++ L   F       D  N+Y+V   + G +L + LR + +  + 
Sbjct: 48  VLNEKRILQSIRHPFLVNLYGSFQ------DDSNLYLVMEYVPGGELFSHLRKSGRFPEP 101

Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
             +F   Q++  L+Y+HS  I++RDLKP N+ ++ D  +KI DFG A+         V  
Sbjct: 102 VARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAK--------RVKG 153

Query: 229 R-W-------YRAPEIMLN 239
           R +       Y APEI+L+
Sbjct: 154 RTYTLCGTPEYLAPEIILS 172

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 83.5 bits (207), Expect = 4e-18
 Identities = 46/152 (30%), Positives = 77/152 (50%), Gaps = 12/152 (7%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           +G  +A+K I      A+  K+  REL +L   N   ++G    F++N       ++ + 
Sbjct: 25  TGKIMAVKTIRLEINEAIQ-KQILRELDILHKCNSPYIVGFYGAFYNNG------DISIC 77

Query: 149 THLMGA-DLNNILR--TQKLSDDHVQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNED 204
              M    L+ IL+    ++ +  +  +   +L+GL Y+H    IIHRD+KPSNI VN  
Sbjct: 78  MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSR 137

Query: 205 CELKILDFGLARPTENEMTG-YVATRWYRAPE 235
            ++K+ DFG++    N +   +V T  Y APE
Sbjct: 138 GQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPE 169

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 84.7 bits (210), Expect = 4e-18
 Identities = 70/273 (25%), Positives = 112/273 (41%), Gaps = 51/273 (18%)

Query: 141 DFKNVYMVTHLM-GADLNNIL-RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSN 198
           D +++Y+V   M G DL N+L R     ++  +F + +++  L  +H  G IHRD+KP N
Sbjct: 72  DEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDN 131

Query: 199 IAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPS 258
           I ++ D  +K+ DFGL                             N+     Y+      
Sbjct: 132 ILIDADGHIKLADFGLC-------------------------KKMNKAKDREYYL----- 161

Query: 259 NIAVNEDCELKILDFGLARPTENEMTGY-VATRWYRAPEIMLNWMHYNQ-TDIHQLNLIM 316
           N + N      +L                V T  Y APE++     Y    D   L +I+
Sbjct: 162 NDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVIL 220

Query: 317 -EML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFK-GANPQAIDLLSLMLELDS 373
            EML G PP  F +    ++  K IN      K+  R       +P+AIDL+  +L  D 
Sbjct: 221 YEMLYGFPP--FYSDTLQETYNKIIN-----WKESLRFPPDPPVSPEAIDLICRLL-CDP 272

Query: 374 EKRIT-AEQALAHPYLS--QYSDPNDEPTSPPY 403
           E R+   E+  +HP+     + +  +  T PP+
Sbjct: 273 EDRLGSFEEIKSHPFFKGIDWENLRE--TKPPF 303

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 83.4 bits (207), Expect = 4e-18
 Identities = 40/132 (30%), Positives = 70/132 (53%), Gaps = 10/132 (7%)

Query: 112 YRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQ-KLSDDH 169
           + E  +L+  NH  ++ L   F       D K +YM+     G +L  ILR +    +  
Sbjct: 41  FSEKEILEECNHPFIVKLYRTFK------DKKYIYMLMEYCLGGELWTILRDRGLFDEYT 94

Query: 170 VQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGY--VA 227
            +F +  ++   +Y+H+ GII+RDLKP N+ ++ +  +K++DFG A+  ++    +    
Sbjct: 95  ARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCG 154

Query: 228 TRWYRAPEIMLN 239
           T  Y APEI+LN
Sbjct: 155 TPEYVAPEIILN 166

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 83.4 bits (206), Expect = 5e-18
 Identities = 81/314 (25%), Positives = 123/314 (39%), Gaps = 74/314 (23%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTY-------RELRMLKHMNHENVIGLLDVFHSN 136
            +++ SG  +A+K++  P  SA    R         RE+ +LK + HEN++  L      
Sbjct: 19  GMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA 78

Query: 137 TCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKP 196
             L  F   Y+    + A LNN        +  V+  V QIL+GL Y+H+ GIIHRD+K 
Sbjct: 79  DHLNIFLE-YVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKG 134

Query: 197 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLK 256
           +NI V+    +KI DFG+++  E                                     
Sbjct: 135 ANILVDNKGGIKISDFGISKKLEANSL--------------------------------- 161

Query: 257 PSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN-LI 315
                              ARP+   + G V   ++ APE++    +  + DI  L  L+
Sbjct: 162 -------------STKTNGARPS---LQGSV---FWMAPEVVKQTSYTRKADIWSLGCLV 202

Query: 316 MEML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSE 374
           +EML G  P       +   A   I                  + +AID L    E+D  
Sbjct: 203 VEMLTGKHP---FPDCTQLQAIFKIGENASPEIPS------NISSEAIDFLEKTFEIDHN 253

Query: 375 KRITAEQALAHPYL 388
           KR TA + L HP+L
Sbjct: 254 KRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 82.4 bits (203), Expect = 1e-17
 Identities = 54/156 (34%), Positives = 85/156 (54%), Gaps = 13/156 (8%)

Query: 93  VAIKKIARPFQSAVHAKRTYRELRMLKHMN---HENVIGLLDVFHSNTCLADFKNVYMVT 149
           VA+K++            T RE+ +L+H+    H NV+ L DV   +    + K   +  
Sbjct: 30  VALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFE 89

Query: 150 HLMGADLNNILRTQKLSD-----DHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED 204
           H+   DL   L   K+ +     + ++ +++Q+LRGL ++HS  ++HRDLKP NI V   
Sbjct: 90  HV-DQDLTTYL--DKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS 146

Query: 205 CELKILDFGLARPTENEM--TGYVATRWYRAPEIML 238
            ++K+ DFGLAR    +M  T  V T WYRAPE++L
Sbjct: 147 GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 182

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 90/315 (28%), Positives = 136/315 (43%), Gaps = 83/315 (26%)

Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDH--- 169
           RE+ +L+ + H NVI L  VF S++     + V+++      DL +I++  + S  +   
Sbjct: 47  REIALLRELKHPNVIALQKVFLSHSD----RKVWLLFDYAEHDLWHIIKFHRASKANKKP 102

Query: 170 -------VQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV----NEDCELKILDFGLARPT 218
                  V+ L+YQIL G+ Y+H+  ++HRDLKP+NI V     E   +KI D G AR  
Sbjct: 103 MQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162

Query: 219 EN------EMTGYVATRWYRAPEIMLNWMHYNQT----GVPFYFQDLKPSNIAVNEDCEL 268
            +      ++   V T WYRAPE++L   HY +      +   F +L  S    +   E 
Sbjct: 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE- 221

Query: 269 KILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMA 328
              D   + P                        H++     QL+ I  ++G P     A
Sbjct: 222 ---DIKTSNP-----------------------FHHD-----QLDRIFSVMGFP-----A 245

Query: 329 KISSDSARKYINSLPLLTKKDFRQVFKGANPQAID---------------LLSLMLELDS 373
               +  RK +   P L +KDFR+    AN   I                LL  +L +D 
Sbjct: 246 DKDWEDIRK-MPEYPTL-QKDFRRT-TYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDP 302

Query: 374 EKRITAEQALAHPYL 388
            KRIT+EQAL  PY 
Sbjct: 303 TKRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 84/309 (27%), Positives = 133/309 (43%), Gaps = 71/309 (22%)

Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDH--- 169
           RE+ +L+ + H NVI L  VF S+   AD + V+++      DL +I++  + S  +   
Sbjct: 47  REIALLRELKHPNVISLQKVFLSH---AD-RKVWLLFDYAEHDLWHIIKFHRASKANKKP 102

Query: 170 -------VQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV----NEDCELKILDFGLARPT 218
                  V+ L+YQIL G+ Y+H+  ++HRDLKP+NI V     E   +KI D G AR  
Sbjct: 103 VQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162

Query: 219 EN------EMTGYVATRWYRAPEIMLNWMHYNQT----GVPFYFQDLKPSNIAVNEDCEL 268
            +      ++   V T WYRAPE++L   HY +      +   F +L  S    +   E 
Sbjct: 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE- 221

Query: 269 KILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMA 328
              D   + P  ++                            QL+ I  ++G P  +   
Sbjct: 222 ---DIKTSNPYHHD----------------------------QLDRIFNVMGFPADKDWE 250

Query: 329 KIS---------SDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA 379
            I           D  R    +  L+   +  +V    + +A  LL  +L +D  KRIT+
Sbjct: 251 DIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV--KPDSKAFHLLQKLLTMDPIKRITS 308

Query: 380 EQALAHPYL 388
           EQA+  PY 
Sbjct: 309 EQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 81.4 bits (201), Expect = 2e-17
 Identities = 51/173 (29%), Positives = 89/173 (51%), Gaps = 29/173 (16%)

Query: 84  ALDSVSGVKVAIKKIARP----------FQSAVHAKRTYRELRMLKHMNHENVIGLLDVF 133
           AL+  +G  +A+K++  P           +  V A R+  E+  LK ++H N++  L   
Sbjct: 20  ALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRS--EIETLKDLDHLNIVQYLGFE 77

Query: 134 HSNTCLADFKNVYMVTHLMGADLNNILRTQ-KLSDDHVQFLVYQILRGLKYIHSAGIIHR 192
            +   L+ F     + ++ G  + + LRT  +  +  V+F   Q+L GL Y+HS GI+HR
Sbjct: 78  TTEEYLSIF-----LEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHR 132

Query: 193 DLKPSNIAVNEDCELKILDFGLARPTEN--------EMTGYVATRWYRAPEIM 237
           DLK  N+ V+ D   KI DFG+++ +++         M G V   ++ APE++
Sbjct: 133 DLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSV---FWMAPEVI 182

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 80.8 bits (200), Expect = 3e-17
 Identities = 43/162 (26%), Positives = 87/162 (53%), Gaps = 16/162 (9%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
           A+   +G  VAIK +  P +  +      +E+ +LK  +   ++     +  NT      
Sbjct: 22  AIHKETGQVVAIKVV--PVEEDLQE--IIKEISILKQCDSPYIVKYYGSYFKNT------ 71

Query: 144 NVYMVT-HLMGADLNNILR-TQK-LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
           ++++V  +     +++I++ T K L+++ +  ++YQ L+GL+Y+HS   IHRD+K  NI 
Sbjct: 72  DLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNIL 131

Query: 201 VNEDCELKILDFGLARPTENEMT---GYVATRWYRAPEIMLN 239
           +NE+ + K+ DFG++    + M      + T ++ APE++  
Sbjct: 132 LNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE 173

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 78.8 bits (195), Expect = 1e-16
 Identities = 44/145 (30%), Positives = 68/145 (46%), Gaps = 25/145 (17%)

Query: 254 DLKPSNIAVNEDCELKILDFGLA-----RPTENEMTGYVATRWYRAPEIMLNWMHYN-QT 307
           D+K +NI +  D E+K++DFGL+         N M G   T ++ APE++     Y+ + 
Sbjct: 123 DIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVG---TPYWMAPEVING-KPYDYKA 178

Query: 308 DIHQLN-LIMEML-GTPPAEFMAKISSDSARKYINSLP---LLTKKDFRQVFKGANPQAI 362
           DI  L    +E+  G PP    +++    A   I +     L   + +   FK       
Sbjct: 179 DIWSLGITAIELAEGKPP---YSELPPMKALFKIATNGPPGLRNPEKWSDEFK------- 228

Query: 363 DLLSLMLELDSEKRITAEQALAHPY 387
           D L   L+ + EKR TAEQ L HP+
Sbjct: 229 DFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 79.4 bits (196), Expect = 1e-16
 Identities = 51/163 (31%), Positives = 71/163 (43%), Gaps = 30/163 (18%)

Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQT-D 308
           +DLKP N+ +N++ ELK+ DFGLAR     +  Y   V T WYR P+++     Y+ + D
Sbjct: 123 RDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSID 182

Query: 309 I------------------------HQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPL 344
           +                         QL  I  +LGTP  E    +S     K     P 
Sbjct: 183 MWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPA 242

Query: 345 LTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPY 387
            T      V    N    DLL  +L  +  +RI+AE+AL HPY
Sbjct: 243 TT--SLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 72/311 (23%), Positives = 120/311 (38%), Gaps = 87/311 (27%)

Query: 92  KVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHL 151
           KVAIK+I    +         +E++ +   NH NV+     F     L      ++V   
Sbjct: 28  KVAIKRIDLE-KCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDEL------WLVMPY 80

Query: 152 M-GADLNNILRTQ----KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE 206
           + G  L +I+++      L +  +  ++ ++L+GL+Y+HS G IHRD+K  NI + ED  
Sbjct: 81  LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS 140

Query: 207 LKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDC 266
           +KI DFG++                                          +++A   D 
Sbjct: 141 VKIADFGVS------------------------------------------ASLADGGDR 158

Query: 267 ELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQ-TDIHQLNLIMEMLGT---- 321
             K       R T      +V T  + APE+M     Y+   DI    +    L T    
Sbjct: 159 TRK------VRKT------FVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206

Query: 322 ----PPAE-FMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKR 376
               PP +  M  + +D       +      K + + F+        ++SL L+ D  KR
Sbjct: 207 YSKYPPMKVLMLTLQNDPPSLETGA----DYKKYSKSFR-------KMISLCLQKDPSKR 255

Query: 377 ITAEQALAHPY 387
            TAE+ L H +
Sbjct: 256 PTAEELLKHKF 266

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 75.1 bits (185), Expect = 2e-15
 Identities = 48/168 (28%), Positives = 83/168 (49%), Gaps = 19/168 (11%)

Query: 83  SALDSVSGVKVAIKKIARPFQSAVHA--KRTYRELRMLKHMNHENVIGLLDV-FHSNTCL 139
           +A++  +G  +A+K+I    Q       K    E+++L+ + H N++    V  H     
Sbjct: 18  TAVNLDTGELMAVKEI--RIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKV- 74

Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHV-QFLVYQILRGLKYIHSAGIIHRDLKPSN 198
                ++M  +  G  L  +L   ++ D+HV +    Q+L GL Y+HS GI+HRD+KP+N
Sbjct: 75  ----YIFM-EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPAN 129

Query: 199 IAVNEDCELKILDFG----LARPTE---NEMTGYVATRWYRAPEIMLN 239
           I ++ +  +K+ DFG    L   T     E+     T  Y APE++  
Sbjct: 130 IFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 75.3 bits (185), Expect = 3e-15
 Identities = 54/177 (30%), Positives = 92/177 (51%), Gaps = 22/177 (12%)

Query: 72  LSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLD 131
           L K ++ ++++ A D  + V++AIK+I  P + + + +  + E+ +  ++ H N++  L 
Sbjct: 16  LGKGTYGIVYA-ARDLSTQVRIAIKEI--PERDSRYVQPLHEEIALHSYLKHRNIVQYLG 72

Query: 132 VFHSNTCLADFKNVYMVTHLMGADLNNILRTQ----KLSDDHVQFLVYQILRGLKYIHSA 187
               N     F  ++M   + G  L+ +LR++    K ++  + F   QIL GLKY+H  
Sbjct: 73  SDSEN----GFFKIFM-EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN 127

Query: 188 GIIHRDLKPSNIAVNE-DCELKILDFG----LAR--PTENEMTGYVATRWYRAPEIM 237
            I+HRD+K  N+ VN     +KI DFG    LA   P     TG   T  Y APE++
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTG---TLQYMAPEVI 181

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 73.3 bits (180), Expect = 1e-14
 Identities = 44/173 (25%), Positives = 77/173 (44%), Gaps = 14/173 (8%)

Query: 71  TLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLL 130
            + K SF ++F   +        A+K+I     +    +    E R+L  ++   +I   
Sbjct: 7   KIGKGSFGVVFK-VVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65

Query: 131 DVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQK---LSDDHVQFLVYQILRGLKYIHS 186
           +         D   + +V       DL+ +L+ Q+   L +D V     QIL GL ++HS
Sbjct: 66  E------SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119

Query: 187 AGIIHRDLKPSNIAVNEDCELKILDFGLAR---PTENEMTGYVATRWYRAPEI 236
             I+HRD+K  N+ ++    +KI D G+A+      N     V T +Y +PE+
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPEL 172

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 73.0 bits (180), Expect = 2e-14
 Identities = 29/90 (32%), Positives = 58/90 (64%), Gaps = 3/90 (3%)

Query: 150 HLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKI 209
           +  G    ++L+  KL + ++ F++ ++L GL+Y+H  G IHRD+K +NI ++E+ ++K+
Sbjct: 80  YCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKL 139

Query: 210 LDFGLA---RPTENEMTGYVATRWYRAPEI 236
            DFG++     T ++   +V T ++ APE+
Sbjct: 140 ADFGVSGQLTSTMSKRNTFVGTPFWMAPEV 169

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 31/144 (21%), Positives = 65/144 (45%), Gaps = 6/144 (4%)

Query: 103 QSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRT 162
                 K+  +E+ +L  + H N++  L        L     +++     G+    + + 
Sbjct: 41  TGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNL----YIFLELVPGGSLAKLLKKY 96

Query: 163 QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE--N 220
               +  ++    QIL GL+Y+H    +HRD+K +NI V+ +  +K+ DFG+A+     +
Sbjct: 97  GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156

Query: 221 EMTGYVATRWYRAPEIMLNWMHYN 244
               +  + ++ APE++     Y 
Sbjct: 157 FAKSFKGSPYWMAPEVIAQQGGYG 180

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 72.3 bits (178), Expect = 2e-14
 Identities = 38/146 (26%), Positives = 74/146 (50%), Gaps = 21/146 (14%)

Query: 114 ELRMLKHMNHENVIGLLDVFH--SNTCLADFKNVYMVTHLMGADLNNILR-----TQKLS 166
           E+ +L+ + H N++   D     SN  L     + M  +  G DL  +++      + + 
Sbjct: 49  EVNILRELKHPNIVRYYDRIIDRSNQTL----YIVM-EYCEGGDLAQLIQKCKKERKYIE 103

Query: 167 DDHVQFLVYQILRGLKYIHSAG-----IIHRDLKPSNIAVNEDCELKILDFGLARPTENE 221
           ++ +  ++ Q+L  L   H+       ++HRDLKP+NI ++ +  +K+ DFGLA+   ++
Sbjct: 104 EEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD 163

Query: 222 M---TGYVATRWYRAPEIMLNWMHYN 244
                 YV T +Y +PE + + M Y+
Sbjct: 164 SSFAKTYVGTPYYMSPEQLNH-MSYD 188

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 72.1 bits (177), Expect = 5e-14
 Identities = 51/160 (31%), Positives = 86/160 (53%), Gaps = 14/160 (8%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           SG+ +A K I    + A+   +  REL++L   N   ++G    F+S+  +    ++ M 
Sbjct: 25  SGLIMARKLIHLEIKPAIR-NQIIRELKVLHECNSPYIVGFYGAFYSDGEI----SICM- 78

Query: 149 THLMGADLNNIL-RTQKLSDDHVQFLVYQILRGLKYI---HSAGIIHRDLKPSNIAVNED 204
            H+ G  L+ +L +  ++ ++ +  +   +LRGL Y+   H   I+HRD+KPSNI VN  
Sbjct: 79  EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSR 136

Query: 205 CELKILDFGLARPTENEMTG-YVATRWYRAPEIMLNWMHY 243
            E+K+ DFG++    + M   +V TR Y +PE  L   HY
Sbjct: 137 GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE-RLQGTHY 175

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 71.3 bits (175), Expect = 5e-14
 Identities = 43/130 (33%), Positives = 64/130 (49%), Gaps = 12/130 (9%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           V+VAIK +       +  +   +E++ LK + H+++I L  V     C    + VY++T 
Sbjct: 31  VRVAIKILKS--DDLLKQQDFQKEVQALKRLRHKHLISLFAV-----CSVG-EPVYIITE 82

Query: 151 LMG-ADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE 206
           LM    L   LR+   Q L    +  +  Q+  G+ Y+     IHRDL   NI V ED  
Sbjct: 83  LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLV 142

Query: 207 LKILDFGLAR 216
            K+ DFGLAR
Sbjct: 143 CKVADFGLAR 152

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 71.2 bits (175), Expect = 8e-14
 Identities = 45/163 (27%), Positives = 81/163 (49%), Gaps = 11/163 (6%)

Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
            A    +G  VAIK +          K  Y  LR  K+ NH N+      F       + 
Sbjct: 24  KARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILR--KYSNHPNIATFYGAFIKKNPPGND 81

Query: 143 KNVYMVTHLMGA----DLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKP 196
             +++V  L G     DL   LR   ++L ++ + +++ + LRGL Y+H   +IHRD+K 
Sbjct: 82  DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKG 141

Query: 197 SNIAVNEDCELKILDFGLARPTENEM---TGYVATRWYRAPEI 236
            NI + ++ E+K++DFG++   ++ +     ++ T ++ APE+
Sbjct: 142 QNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEV 184

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 70.0 bits (172), Expect = 1e-13
 Identities = 44/160 (27%), Positives = 76/160 (47%), Gaps = 16/160 (10%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
           A D  +G  VAIK I           +  +E+ MLK   H N++     +     L    
Sbjct: 22  ARDIATGELVAIKVIKLEPGDDFEIIQ--QEISMLKECRHPNIVAYFGSYLRRDKL---- 75

Query: 144 NVYMVTHLMG----ADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
             ++V    G     D+  + R   LS+  + ++  + L+GL Y+H  G IHRD+K +NI
Sbjct: 76  --WIVMEYCGGGSLQDIYQVTRG-PLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANI 132

Query: 200 AVNEDCELKILDFGLARPTENEM---TGYVATRWYRAPEI 236
            + ED ++K+ DFG++      +     ++ T ++ APE+
Sbjct: 133 LLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEV 172

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 68.8 bits (169), Expect = 2e-13
 Identities = 37/139 (26%), Positives = 62/139 (44%), Gaps = 46/139 (33%)

Query: 254 DLKPSNIAVNEDC-ELKILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHYN-QTD 308
           DLKP NI ++ D  ++K+ DFGL++     ++ +   V T  Y APE++L   +Y+ ++D
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176

Query: 309 IHQLNLIM-EMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSL 367
           I  L +I+ E+                                        P+  DL+  
Sbjct: 177 IWSLGVILYEL----------------------------------------PELKDLIRK 196

Query: 368 MLELDSEKRITAEQALAHP 386
           ML+ D EKR +A++ L H 
Sbjct: 197 MLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 84/297 (28%), Positives = 133/297 (44%), Gaps = 49/297 (16%)

Query: 141 DFKNVYMVT-HLMGADLNNIL-RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSN 198
           D  N+Y V  ++ G D+ ++L R     +D  +F + ++   ++ +H  G IHRD+KP N
Sbjct: 72  DKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDN 131

Query: 199 IAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPS 258
           I ++ D  +K+ DFGL        TG+   RW    +   +  H  Q  + F  +   P+
Sbjct: 132 ILIDRDGHIKLTDFGLC-------TGF---RWTHDSKYYQSGDHVRQDSMDFSNEWGDPA 181

Query: 259 NIAVNEDCELKILDFGLARPTENEMT-GYVATRWYRAPEIMLNWMHYNQTDIHQLNLIM- 316
           N    +   LK L+   AR  +  +    V T  Y APE++L   +    D   + +I+ 
Sbjct: 182 NCRCGD--RLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239

Query: 317 EML-GTPPAEFMAKISSDSARKYIN-----SLPLLTKKDFRQVFKGANPQAIDLLSLMLE 370
           EML G PP  F+A+   ++  K IN      +P   K          +P+A DL+ + L 
Sbjct: 240 EMLVGQPP--FLAQTPLETQMKVINWQTSLHIPPQAK---------LSPEASDLI-IKLC 287

Query: 371 LDSEKRI---TAEQALAHPY---------LSQYSDPNDEPTSPPYDQSFEDMDLPVD 415
              E R+    A++  AHP+         L Q S P     + P D S  D   PVD
Sbjct: 288 RGPEDRLGKNGADEIKAHPFFKTIDFSSDLRQQSAPYIPKITHPTDTSNFD---PVD 341

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 48/162 (29%), Positives = 84/162 (51%), Gaps = 13/162 (8%)

Query: 86  DSVSGVKVAIKKIARPFQSAVHAKRT---YRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           D +S    A+K +A P    +  K+    + E R+LK ++H  +I L    H      D 
Sbjct: 22  DRISEHYYALKVMAIP--EVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH------DQ 73

Query: 143 KNVYMV-THLMGADLNNILRTQ-KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
           + +YM+  ++ G +L + LR   + S+    F   +I+  L+Y+HS  I++RDLKP NI 
Sbjct: 74  RFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENIL 133

Query: 201 VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH 242
           ++++  +K+ DFG A+   +       T  Y APE++ +  H
Sbjct: 134 LDKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQSKGH 175

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 69.1 bits (169), Expect = 2e-13
 Identities = 46/167 (27%), Positives = 81/167 (48%), Gaps = 13/167 (7%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
            G +  IK+I     S    + + +E+ +L +M H N++   + F  N  L      Y+V
Sbjct: 24  DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNL------YIV 77

Query: 149 T-HLMGADLNNILRTQK---LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED 204
             +  G DL   +  Q+     +D +     QI   LK++H   I+HRD+K  NI + +D
Sbjct: 78  MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD 137

Query: 205 CELKILDFGLARPTENEMT---GYVATRWYRAPEIMLNWMHYNQTGV 248
             +K+ DFG+AR   + +      + T +Y +PEI  N  + N++ +
Sbjct: 138 GTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDI 184

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 69.4 bits (170), Expect = 3e-13
 Identities = 40/150 (26%), Positives = 70/150 (46%), Gaps = 14/150 (9%)

Query: 94  AIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK-NVYMVTHLM 152
           A+K I       +  K+  REL + K      +     V +    L +   ++ +     
Sbjct: 30  ALKTITTDPNPDLQ-KQILRELEINKSCKSPYI-----VKYYGAFLDESSSSIGIAMEYC 83

Query: 153 GA-DLNNIL-----RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE 206
               L++I      R  ++ +  +  +   +L+GL Y+HS  IIHRD+KPSNI +    +
Sbjct: 84  EGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ 143

Query: 207 LKILDFGLARPTENEMTG-YVATRWYRAPE 235
           +K+ DFG++    N + G +  T +Y APE
Sbjct: 144 VKLCDFGVSGELVNSLAGTFTGTSFYMAPE 173

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 68.8 bits (168), Expect = 3e-13
 Identities = 48/163 (29%), Positives = 83/163 (50%), Gaps = 15/163 (9%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           S  K A+K+I  P +S+   + + +E  +L  M H N++   + F ++  L      Y+V
Sbjct: 24  SDQKYAMKEIRLP-KSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHL------YIV 76

Query: 149 T-HLMGADLNNILRTQK---LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED 204
             +  G DL   ++ Q+     +D +     Q+  G+++IH   ++HRD+K  NI + ++
Sbjct: 77  MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQN 136

Query: 205 CELKILDFGLARPTENEMT---GYVATRWYRAPEIMLNWMHYN 244
            ++K+ DFG AR   +       YV T +Y  PEI  N M YN
Sbjct: 137 GKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWEN-MPYN 178

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 69.2 bits (170), Expect = 5e-13
 Identities = 64/292 (21%), Positives = 110/292 (37%), Gaps = 50/292 (17%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           +KV  KK             T +E+  L  ++H  +  L   F + T L       ++ +
Sbjct: 31  LKVLDKKEMIKRNKVKRV-LTEQEI--LATLDHPFLPTLYASFQTETYLC-----LVMDY 82

Query: 151 LMGADLNNILRTQK---LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
             G +L  +L+ Q    LS++  +F   ++L  L+Y+H  GI++RDLKP NI ++E   +
Sbjct: 83  CPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHI 142

Query: 208 KILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCE 267
            + DF L++ +                         +    P      K S  +      
Sbjct: 143 MLSDFDLSKQS-------------------------DVEPPPVSKALRKGSRRSSVNSIP 177

Query: 268 LKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN-LIMEML-GTPPAE 325
               +     P+    + +V T  Y APE++    H +  D   L  L+ EML GT P  
Sbjct: 178 ---SETFSEEPSFRSNS-FVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP-- 231

Query: 326 FMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI 377
           F      ++    +                  +  A DL+  +L  D  KR+
Sbjct: 232 FKGSNRDETFSNILKKEVTFPGSP------PVSSSARDLIRKLLVKDPSKRL 277

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 68.9 bits (168), Expect = 7e-13
 Identities = 49/159 (30%), Positives = 86/159 (54%), Gaps = 10/159 (6%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           SG+ +A K I    + A+   +  REL++L   N   ++G    F+S+  ++       +
Sbjct: 29  SGLIMARKLIHLEIKPAIR-NQIIRELQVLHECNSPYIVGFYGAFYSDGEIS-----ICM 82

Query: 149 THLMGADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDCE 206
            H+ G  L+ +L+  +++ ++ +  +   +LRGL Y+     I+HRD+KPSNI VN   E
Sbjct: 83  EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE 142

Query: 207 LKILDFGLARPTENEM-TGYVATRWYRAPEIMLNWMHYN 244
           +K+ DFG++    + M   +V TR Y +PE  L   HY+
Sbjct: 143 IKLCDFGVSGQLIDSMANSFVGTRSYMSPE-RLQGTHYS 180

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 46/164 (28%), Positives = 72/164 (43%), Gaps = 31/164 (18%)

Query: 253 QDLKPSNIAVNEDCELKILDFGLAR----PTENEMTGYVATRWYRAPEIMLNWMHYNQ-- 306
           +D+KP NI V++   +K+ DFG AR    P E   T YVATRWYRAPE+++    Y +  
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VYTDYVATRWYRAPELLVGDTKYGRAV 182

Query: 307 ----------------------TDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPL 344
                                 +DI QL  I++ LG        +I   +       LP 
Sbjct: 183 DIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGN-LIPRHQEIFQKNPLFAGMRLPE 241

Query: 345 LTK-KDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPY 387
           + + +   + F   +   +DL    L +D + R ++ Q L H +
Sbjct: 242 VKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 46/156 (29%), Positives = 74/156 (47%), Gaps = 16/156 (10%)

Query: 90  GVKVAIKKIARPFQSAVHAK-RTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           G  VA+KK+         A+    +E+ +LK ++H NVI  L  F  N  L       +V
Sbjct: 27  GRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELN------IV 80

Query: 149 THLMGA-DLNNIL---RTQKLSDDHVQF--LVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
             L  A DL+ ++   + QK             Q+   L+++HS  I+HRD+KP+N+ + 
Sbjct: 81  LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFIT 140

Query: 203 EDCELKILDFGLARPTENEMT---GYVATRWYRAPE 235
               +K+ D GL R   ++ T     V T +Y +PE
Sbjct: 141 ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 66.8 bits (163), Expect = 2e-12
 Identities = 41/130 (31%), Positives = 68/130 (52%), Gaps = 15/130 (11%)

Query: 119 KHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRT-----QKLSDDHVQF 172
           + + H N++     F  N  L      Y+V  L+ GA L     +     Q+ +++ +  
Sbjct: 64  EQLRHPNIVRYYKTFLENDRL------YIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN 117

Query: 173 LVYQILRGLKYIHSAG-IIHRDLKPSNIAVNEDCELKILDFGLARPT--ENEMTGYVATR 229
           +  Q++  L+Y+H    I+HRDL P+NI + ED ++ I DFGLA+    E+++T  V T 
Sbjct: 118 IFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTI 177

Query: 230 WYRAPEIMLN 239
            Y  PEI+ N
Sbjct: 178 LYSCPEIVKN 187

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 30/135 (22%), Positives = 68/135 (50%), Gaps = 10/135 (7%)

Query: 115 LRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT-HLMGADLNNILRTQKLSDDHVQFL 173
           L  L+     N+      ++          ++++  +  G  +  +++   +++ ++  +
Sbjct: 53  LSQLRQSQPPNITK----YYG--SYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVI 106

Query: 174 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA---RPTENEMTGYVATRW 230
           + ++L  LKYIH  G+IHRD+K +NI V     +K+ DFG+A       ++ + +V T +
Sbjct: 107 IREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPY 166

Query: 231 YRAPEIMLNWMHYNQ 245
           + APE++    +Y+ 
Sbjct: 167 WMAPEVITEGKYYDT 181

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 17/153 (11%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
            KVA+K +       +  +   +E +++K + H+ ++ L  V       ++ + +Y+VT 
Sbjct: 31  TKVAVKTLK---PGTMSPEAFLQEAQIMKKLRHDKLVQLYAV------CSEEEPIYIVTE 81

Query: 151 LM-GADLNNILRTQKLSDDHVQFLVY---QILRGLKYIHSAGIIHRDLKPSNIAVNEDCE 206
            M    L + L++ +     +  LV    QI  G+ Y+ S   IHRDL   NI V E+  
Sbjct: 82  YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLV 141

Query: 207 LKILDFGLARPTE-NEMTGYVATRW---YRAPE 235
            KI DFGLAR  E +E T     ++   + APE
Sbjct: 142 CKIADFGLARLIEDDEYTAREGAKFPIKWTAPE 174

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 48/178 (26%), Positives = 85/178 (47%), Gaps = 20/178 (11%)

Query: 221 EMTGYVATRWYR--APEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARP 278
           +  G +   W +    E++L     +Q G+    +D+KP N+ +++   LK+ DFGL+R 
Sbjct: 89  KTLGGLPEDWAKQYIAEVVLGVEDLHQRGI--IHRDIKPENLLIDQTGHLKLTDFGLSRN 146

Query: 279 TENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIM-EML-GTPP--AEFMAKISSDS 334
              E   +V T  Y APE +L       +D   L  ++ E L G PP  AE    +  + 
Sbjct: 147 GL-ENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI 205

Query: 335 ARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA---EQALAHPYLS 389
             + IN           +V +  +P+A+DL++ +L +D  KR+ A   ++  +HP+  
Sbjct: 206 LSRRINWP--------EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFK 255

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 66.3 bits (162), Expect = 2e-12
 Identities = 36/134 (26%), Positives = 68/134 (50%), Gaps = 21/134 (15%)

Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCL------ADFKNVYMVTHLMGADLNNILRTQK--L 165
           E+ +L  + H N+I   + F  +  L      A+   +Y          + I+R +    
Sbjct: 49  EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLY----------DKIVRQKGQLF 98

Query: 166 SDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTG- 224
            ++ V + ++QI+  + YIH AGI+HRD+K  NI + +   +K+ DFG+++   +E +  
Sbjct: 99  EEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA 158

Query: 225 --YVATRWYRAPEI 236
              V T +Y +PE+
Sbjct: 159 ETVVGTPYYMSPEL 172

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 66.7 bits (163), Expect = 3e-12
 Identities = 34/130 (26%), Positives = 72/130 (55%), Gaps = 10/130 (7%)

Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNI-LRTQK-LSDDHVQ 171
           E+ +L    H N++GL + +       + K   ++    G  L++I L  ++ L++  ++
Sbjct: 52  EIDILSECKHPNIVGLYEAY-----FYENKLWILIEFCDGGALDSIMLELERGLTEPQIR 106

Query: 172 FLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM---TGYVAT 228
           ++  Q+L  L ++HS  +IHRDLK  NI +  D ++K+ DFG++   ++ +     ++ T
Sbjct: 107 YVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGT 166

Query: 229 RWYRAPEIML 238
            ++ APE++ 
Sbjct: 167 PYWMAPEVVA 176

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 66.5 bits (162), Expect = 3e-12
 Identities = 41/158 (25%), Positives = 82/158 (51%), Gaps = 10/158 (6%)

Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A+D  +G +VAIK++    Q     +    E+ +++   H N++  LD +     + D 
Sbjct: 37  TAIDVATGQEVAIKQMN--LQQQPKKELIINEILVMRENKHPNIVNYLDSY----LVGDE 90

Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
             V M  +L G  L +++    + +  +  +  + L+ L+++HS  +IHRD+K  NI + 
Sbjct: 91  LWVVM-EYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 149

Query: 203 EDCELKILDFGLA---RPTENEMTGYVATRWYRAPEIM 237
            D  +K+ DFG      P +++ +  V T ++ APE++
Sbjct: 150 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 41/157 (26%), Positives = 83/157 (52%), Gaps = 10/157 (6%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
           A +  +G +VA+KK+    +     +  + E+ +++  +HENV+ +    +++  + D  
Sbjct: 41  ATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIMRDYHHENVVDM----YNSYLVGDEL 94

Query: 144 NVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE 203
            V M   L G  L +I+   +++++ +  +   +LR L Y+H+ G+IHRD+K  +I +  
Sbjct: 95  WVVM-EFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTS 153

Query: 204 DCELKILDFGLARPTENEM---TGYVATRWYRAPEIM 237
           D  +K+ DFG       E+      V T ++ APE++
Sbjct: 154 DGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVI 190

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 65.2 bits (159), Expect = 5e-12
 Identities = 40/150 (26%), Positives = 72/150 (48%), Gaps = 13/150 (8%)

Query: 94  AIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM- 152
           A+K++     S    +    E+R+L  +NH N+I   + F       D   + +V     
Sbjct: 29  ALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF------LDGNKLCIVMEYAP 82

Query: 153 GADLNNILRTQK-----LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
             DL+  +  +K     + +  +  +  Q+LRGL+ +H   I+HRDLK +NI +  +  +
Sbjct: 83  FGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLV 142

Query: 208 KILDFGLARPTENEMT-GYVATRWYRAPEI 236
           KI D G+++  +  M    + T  Y APE+
Sbjct: 143 KIGDLGISKVLKKNMAKTQIGTPHYMAPEV 172

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 66.0 bits (161), Expect = 7e-12
 Identities = 43/128 (33%), Positives = 65/128 (50%), Gaps = 15/128 (11%)

Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNN--ILRTQKLSDDHV 170
           RE+ +L+ +NH NV+   D+F  N  +       ++  + G  L    I   Q L+D   
Sbjct: 121 REIEILRDVNHPNVVKCHDMFDHNGEIQ-----VLLEFMDGGSLEGTHIADEQFLAD--- 172

Query: 171 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM---TGYVA 227
             +  QIL G+ Y+H   I+HRD+KPSN+ +N    +KI DFG++R     M      V 
Sbjct: 173 --VARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVG 230

Query: 228 TRWYRAPE 235
           T  Y +PE
Sbjct: 231 TIAYMSPE 238

Length = 353

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 65.6 bits (160), Expect = 8e-12
 Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 26/166 (15%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHA-KRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           A D  +   VAIKK++   + +    +   +E+R L+ + H N I             ++
Sbjct: 34  ARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTI-------------EY 80

Query: 143 KNVYMVTH----LM------GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHR 192
           K  Y+  H    +M       +D+  + + + L +  +  + +  L+GL Y+HS   IHR
Sbjct: 81  KGCYLREHTAWLVMEYCLGSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHR 139

Query: 193 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML 238
           D+K  NI + E   +K+ DFG A    +    +V T ++ APE++L
Sbjct: 140 DIKAGNILLTEPGTVKLADFGSA-SLVSPANSFVGTPYWMAPEVIL 184

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 65.8 bits (160), Expect = 8e-12
 Identities = 84/309 (27%), Positives = 141/309 (45%), Gaps = 54/309 (17%)

Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT-HLMGADLNNIL-RTQKLSDDHVQ 171
           E  +L   ++E V+ L   F       D  N+Y V  ++ G D+ ++L R +   +   +
Sbjct: 51  ERDILAEADNEWVVKLYYSFQ------DKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLAR 104

Query: 172 FLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWY 231
           F + ++   ++ +H  G IHRD+KP NI ++ D  +K+ DFGL        TG+   RW 
Sbjct: 105 FYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLC-------TGF---RWT 154

Query: 232 RAPEIMLNWMHYNQTGVPFYFQDLKPSNI---AVNEDC--ELKILDFGLARPTENEMT-G 285
              +       Y Q G       ++PS++     N  C   LK L+    +  +  +   
Sbjct: 155 HNSK-------YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHS 207

Query: 286 YVATRWYRAPEIMLNWMHYNQTDIHQLNLIM-EML-GTPPAEFMAKISSDSARKYIN--- 340
            V T  Y APE++L   +    D   + +I+ EML G PP  F+A   +++  K IN   
Sbjct: 208 LVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPP--FLAPTPTETQLKVINWEN 265

Query: 341 --SLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI---TAEQALAHPYLSQYSDPN 395
              +P   K          +P+A+DL++  L   +E+R+    A+   AHP+ S+    +
Sbjct: 266 TLHIPPQVK---------LSPEAVDLIT-KLCCSAEERLGRNGADDIKAHPFFSEVDFSS 315

Query: 396 DEPTSP-PY 403
           D  T P PY
Sbjct: 316 DIRTQPAPY 324

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 65.1 bits (159), Expect = 9e-12
 Identities = 43/157 (27%), Positives = 69/157 (43%), Gaps = 18/157 (11%)

Query: 90  GVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT 149
           G +VA+K +        H     RE+ +L+ ++HEN++    V     C         + 
Sbjct: 33  GEQVAVKSL-NHSGEEQHRSDFEREIEILRTLDHENIVKYKGV-----CEKPGGRSLRLI 86

Query: 150 --HLMGADLNNILRTQKLSDDHVQFLVY--QILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
             +L    L + L+  +   +  + L++  QI +G+ Y+ S   IHRDL   NI V  + 
Sbjct: 87  MEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED 146

Query: 206 ELKILDFGLARPTENEMTGYVA-------TRWYRAPE 235
            +KI DFGLA+    +   Y           WY APE
Sbjct: 147 LVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 64.7 bits (158), Expect = 9e-12
 Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 17/152 (11%)

Query: 90  GVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT 149
           G KVA+K +      +  A+    E  ++  + H N++ LL V      L     +Y+VT
Sbjct: 29  GQKVAVKCLKD---DSTAAQAFLAEASVMTTLRHPNLVQLLGV-----VLQG-NPLYIVT 79

Query: 150 HLMG-ADLNNILRTQKLS----DDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED 204
             M    L + LR++  +       + F    +  G++Y+     +HRDL   N+ V+ED
Sbjct: 80  EYMAKGSLVDYLRSRGRAVITLAQQLGF-ALDVCEGMEYLEEKNFVHRDLAARNVLVSED 138

Query: 205 CELKILDFGLARPTE-NEMTGYVATRWYRAPE 235
              K+ DFGLA+     + +G +  +W  APE
Sbjct: 139 LVAKVSDFGLAKEASQGQDSGKLPVKW-TAPE 169

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 64.2 bits (157), Expect = 1e-11
 Identities = 45/154 (29%), Positives = 71/154 (46%), Gaps = 30/154 (19%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTG---YVATRWYRAPEIMLNWMHYN-QTDI 309
           D+KPSN+ +N   E+KI DFG+++  EN +     +V T  Y +PE  +    Y+   DI
Sbjct: 125 DIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPE-RIQGESYSYAADI 183

Query: 310 HQLNL-IMEM-LGTPP---------AEFMAKISSDSARKYINSLPLLTKKDFRQVFKGAN 358
             L L ++E  LG  P          E M  I            P L  ++F       +
Sbjct: 184 WSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP-------PSLPAEEF-------S 229

Query: 359 PQAIDLLSLMLELDSEKRITAEQALAHPYLSQYS 392
           P+  D +S  L+ D +KR +A + L HP++ +  
Sbjct: 230 PEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD 263

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 34/97 (35%), Positives = 59/97 (60%), Gaps = 3/97 (3%)

Query: 144 NVYMVT-HLMGADLNNILRTQK-LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
            +Y+V  +L G D  ++++T   L +D  +  + +++ G++ +H  GIIHRD+KP N+ +
Sbjct: 71  YLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI 130

Query: 202 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML 238
           ++   LK+ DFGL+R    E   +V T  Y APE +L
Sbjct: 131 DQTGHLKLTDFGLSRNGL-ENKKFVGTPDYLAPETIL 166

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 35/132 (26%), Positives = 62/132 (46%), Gaps = 12/132 (9%)

Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILR---TQKLSDDH 169
           E ++L+ ++   ++ L   F +   L       +V  LM G DL   +         +  
Sbjct: 43  EKKILEKVSSRFIVSLAYAFETKDDLC------LVMTLMNGGDLKYHIYNVGEPGFPEAR 96

Query: 170 VQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA--RPTENEMTGYVA 227
             F   QI+ GL+++H   I++RDLKP N+ +++   ++I D GLA       ++ G   
Sbjct: 97  AIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAG 156

Query: 228 TRWYRAPEIMLN 239
           T  Y APE++  
Sbjct: 157 TPGYMAPEVLQG 168

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 42/133 (31%), Positives = 73/133 (54%), Gaps = 11/133 (8%)

Query: 110 RTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV-THLMGADLNNILRTQKL-SD 167
           RT  E  +L  +NH  ++ L   F +   L      Y++   L G DL   L  + + ++
Sbjct: 44  RTKMERDILAEVNHPFIVKLHYAFQTEGKL------YLILDFLRGGDLFTRLSKEVMFTE 97

Query: 168 DHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT---ENEMTG 224
           + V+F + ++   L ++HS GII+RDLKP NI ++E+  +K+ DFGL++ +   E +   
Sbjct: 98  EDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 157

Query: 225 YVATRWYRAPEIM 237
           +  T  Y APE++
Sbjct: 158 FCGTVEYMAPEVV 170

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 64.5 bits (157), Expect = 1e-11
 Identities = 48/182 (26%), Positives = 87/182 (47%), Gaps = 39/182 (21%)

Query: 81  FSS---ALDSVSGVKVAIKKIARPFQSAVHAKRTY----RELRMLKHMNHENVIGLLDVF 133
           FSS   A D  +G  +A+K++     ++   +       +E+R++  +NH ++I +L   
Sbjct: 13  FSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGA- 71

Query: 134 HSNTCLADFKNVYM-------VTHLM---GADLNNILRTQKLSDDHVQFLVYQILRGLKY 183
              TC     N+++       V+HL+   GA    ++         + +   Q+LRGL Y
Sbjct: 72  ---TCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI---------INYT-EQLLRGLSY 118

Query: 184 IHSAGIIHRDLKPSNIAVNEDCE-LKILDFGLARPTENEMTG-------YVATRWYRAPE 235
           +H   IIHRD+K +N+ ++   + L+I DFG A     + TG        + T  + APE
Sbjct: 119 LHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178

Query: 236 IM 237
           ++
Sbjct: 179 VL 180

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 37/132 (28%), Positives = 70/132 (53%), Gaps = 8/132 (6%)

Query: 114 ELRMLK-HMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGA----DLNNILRTQKLSDD 168
           E+ MLK + +H N+      F   +       +++V    GA    DL    +   L +D
Sbjct: 62  EINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKED 121

Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP---TENEMTGY 225
            + ++  +ILRGL ++H+  +IHRD+K  N+ + E+ E+K++DFG++     T      +
Sbjct: 122 WIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF 181

Query: 226 VATRWYRAPEIM 237
           + T ++ APE++
Sbjct: 182 IGTPYWMAPEVI 193

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 46/136 (33%), Positives = 68/136 (50%), Gaps = 20/136 (14%)

Query: 111 TYRELRMLKHMNHENVIGLLDVFHSN--TCLADFKNVYMVTHLMGADLNNIL--RTQKLS 166
           T  E  +L+++NH +VI + D   S   TC        MV     +DL   L  R++ L 
Sbjct: 104 TLIEAMLLQNVNHPSVIRMKDTLVSGAITC--------MVLPHYSSDLYTYLTKRSRPLP 155

Query: 167 DDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR-----PTENE 221
            D    +  QIL GL+Y+H+  IIHRD+K  NI +N+  ++ I D G A+     P    
Sbjct: 156 IDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG 215

Query: 222 MTGYVATRWYRAPEIM 237
           + G V T    APE++
Sbjct: 216 LAGTVET---NAPEVL 228

Length = 357

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 49/173 (28%), Positives = 79/173 (45%), Gaps = 14/173 (8%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
           A          IK+I          + + +E+ +L  M H N++     F  N  L    
Sbjct: 19  AKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRL---- 74

Query: 144 NVYMVTHLM-GADLNNILRTQK---LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
             ++V     G DL   +  Q+    S+D +     QI  GLK+IH   I+HRD+K  NI
Sbjct: 75  --FIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNI 132

Query: 200 AVNEDCEL-KILDFGLARPTENEMT---GYVATRWYRAPEIMLNWMHYNQTGV 248
            ++++  + K+ DFG+AR   + M      V T +Y +PEI  N  + N+T +
Sbjct: 133 FLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDI 185

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 76/332 (22%), Positives = 136/332 (40%), Gaps = 83/332 (25%)

Query: 69  GPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELR----MLKHMNHE 124
           G  L K ++  ++    +   G  +A+K++     + + A++ Y +L+    +LK + H 
Sbjct: 5   GEVLGKGAYGTVYCGLTNQ--GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHV 62

Query: 125 NVIGLLDVFHSNTCLAD-FKNVYMVTHLMGADLNNIL-RTQKLSDDHVQFLVYQILRGLK 182
           N++  L      TCL D   +++M   + G  +++IL R   L +        QIL G+ 
Sbjct: 63  NIVQYL-----GTCLDDNTISIFM-EFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA 116

Query: 183 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH 242
           Y+H+  ++HRD+K +N+ +  +  +K++DFG AR       G   T        ML  MH
Sbjct: 117 YLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL--AWVGLHGTH-----SNMLKSMH 169

Query: 243 YNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM 302
               G P++                                          APE++    
Sbjct: 170 ----GTPYWM-----------------------------------------APEVINESG 184

Query: 303 HYNQTDIHQLN-LIMEM-LGTPPAEFMAKISS----DSARKYINSLPLLTKKDFRQVFKG 356
           +  ++DI  +   + EM  G PP   M ++++     + R  +  LP          F  
Sbjct: 185 YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLP--------DSFSA 236

Query: 357 ANPQAIDLLSLMLELDSEKRITAEQALAHPYL 388
           A   AID ++  L  D  +R +A Q L H +L
Sbjct: 237 A---AIDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 49/175 (28%), Positives = 80/175 (45%), Gaps = 9/175 (5%)

Query: 71  TLSKESFDLIFSSALDSVSGVKVAIKKIAR-PFQSAVHAKRTYRELRMLKHMNHENVIGL 129
           TL   SF  +  +   +     VAIK+  +            + E ++L ++NH   + L
Sbjct: 37  TLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNL 96

Query: 130 LDVFHSNTCLADFKNVYMVTH-LMGADLNNILRTQK-LSDDHVQFLVYQILRGLKYIHSA 187
              F   + L      Y+V   ++G +    LR  K   +D   F   QI+   +Y+ S 
Sbjct: 97  YGSFKDESYL------YLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL 150

Query: 188 GIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH 242
            I++RDLKP N+ +++D  +K+ DFG A+  +        T  Y APEI+LN  H
Sbjct: 151 NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVGH 205

Length = 340

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 49/155 (31%), Positives = 79/155 (50%), Gaps = 17/155 (10%)

Query: 90  GVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT 149
           G KVA+K I    +  V A+    E  ++  ++H+N++ LL V   N        +Y+V 
Sbjct: 29  GQKVAVKNI----KCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-------GLYIVM 77

Query: 150 HLMG-ADLNNILRTQ-KLSDDHVQFLVY--QILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
            LM   +L N LRT+ +     +Q L +   +  G++Y+ S  ++HRDL   NI V+ED 
Sbjct: 78  ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG 137

Query: 206 ELKILDFGLARPTENEM-TGYVATRWYRAPEIMLN 239
             K+ DFGLAR     +    +  +W  APE + +
Sbjct: 138 VAKVSDFGLARVGSMGVDNSKLPVKW-TAPEALKH 171

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 48/159 (30%), Positives = 83/159 (52%), Gaps = 10/159 (6%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           SG+ +A K I    + A+   +  REL++L   N   ++G    F+S     D +    +
Sbjct: 29  SGLIMARKLIHLEIKPAIR-NQIIRELQVLHECNSPYIVGFYGAFYS-----DGEISICM 82

Query: 149 THLMGADLNNILRTQ-KLSDDHVQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDCE 206
            H+ G  L+ +L+   ++ +  +  +   +++GL Y+     I+HRD+KPSNI VN   E
Sbjct: 83  EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE 142

Query: 207 LKILDFGLARPTENEM-TGYVATRWYRAPEIMLNWMHYN 244
           +K+ DFG++    + M   +V TR Y +PE  L   HY+
Sbjct: 143 IKLCDFGVSGQLIDSMANSFVGTRSYMSPE-RLQGTHYS 180

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 64.6 bits (157), Expect = 3e-11
 Identities = 64/286 (22%), Positives = 110/286 (38%), Gaps = 80/286 (27%)

Query: 156 LNNILRTQKLSDDHVQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVN------------ 202
           L+ I++    S  H+  +++Q    L Y H+   ++H DLKP NI +             
Sbjct: 219 LDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNR 278

Query: 203 ----EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN--WMHYNQTGVPFYFQDLK 256
               + C ++I D G      +  T  V+TR YR+PE++L   WM         Y  D+ 
Sbjct: 279 ALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWM---------YSTDMW 329

Query: 257 PSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLI 315
                + E    K+L                                Y+  D +  L+L+
Sbjct: 330 SMGCIIYELYTGKLL--------------------------------YDTHDNLEHLHLM 357

Query: 316 MEMLGTPPAEFMAKISSDSARKYINSLPLLTK-KDFRQVFKGANPQAI----------DL 364
            + LG  P+E+  +  ++ AR   NS   L    D + + + A  + +          DL
Sbjct: 358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDL 417

Query: 365 LSLMLELDSEKRITAEQALAHPYLSQY--------SDPNDEPTSPP 402
           +  +L  D +KR+ A Q   HPY+ +Y        + P++     P
Sbjct: 418 IYGLLHYDRQKRLNARQMTTHPYVLKYYPECRQHPNYPDNRSMLRP 463

Length = 467

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 62.9 bits (153), Expect = 3e-11
 Identities = 66/314 (21%), Positives = 125/314 (39%), Gaps = 86/314 (27%)

Query: 86  DSVSGVKVAIKKIARPF-QSAVHAKRTYR----ELRMLKHMNHENVIGLLDVFHSNTCLA 140
           D  +G ++A+K++  PF   +   K+       E+++LK++ HE ++          CL 
Sbjct: 23  DVDTGRELAVKQV--PFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYG------CLR 74

Query: 141 DFKNVYMVTHLM-GADLNNILRTQ-KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSN 198
           D + + +    M G  + + L+    L++   +    QIL G++Y+HS  I+HRD+K +N
Sbjct: 75  DDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGAN 134

Query: 199 IAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPS 258
           I  +    +K+ DFG ++                     L  +  + TG           
Sbjct: 135 ILRDSAGNVKLGDFGASK--------------------RLQTICSSGTG----------- 163

Query: 259 NIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN-LIME 317
                                   M     T ++ +PE++    +  + D+  +   ++E
Sbjct: 164 ------------------------MKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVE 199

Query: 318 MLGTPP--AEF--MAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDS 373
           ML   P  AEF  MA I             + T+    Q+    +P A + L      ++
Sbjct: 200 MLTEKPPWAEFEAMAAI-----------FKIATQPTNPQLPSHVSPDARNFLRRTFVENA 248

Query: 374 EKRITAEQALAHPY 387
           +KR +AE+ L H +
Sbjct: 249 KKRPSAEELLRHFF 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 62.6 bits (153), Expect = 4e-11
 Identities = 40/146 (27%), Positives = 63/146 (43%), Gaps = 22/146 (15%)

Query: 254 DLKPSNIAVNEDCELKILDFGLAR-----PTENEMTGYVATRWYRAPEIMLNWMHYNQTD 308
           D+K +NI V+ D  +K+ DFG A+      T         T ++ APE++    +    D
Sbjct: 126 DIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAAD 185

Query: 309 IHQLN-LIMEML-GTPP----AEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAI 362
           I  L   ++EM  G PP       MA +    +      +P           +  + +A 
Sbjct: 186 IWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIP-----------EHLSEEAK 234

Query: 363 DLLSLMLELDSEKRITAEQALAHPYL 388
           D L   L  D +KR TA++ L HP+L
Sbjct: 235 DFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 63.2 bits (153), Expect = 4e-11
 Identities = 40/158 (25%), Positives = 81/158 (51%), Gaps = 10/158 (6%)

Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A+D  +G +VAIK++    Q     +    E+ +++   + N++  LD +     + D 
Sbjct: 37  TAIDIATGQEVAIKQMN--LQQQPKKELIINEILVMRENKNPNIVNYLDSY----LVGDE 90

Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
             V M  +L G  L +++    + +  +  +  + L+ L ++HS  +IHRD+K  NI + 
Sbjct: 91  LWVVM-EYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLG 149

Query: 203 EDCELKILDFGLA---RPTENEMTGYVATRWYRAPEIM 237
            D  +K+ DFG      P +++ +  V T ++ APE++
Sbjct: 150 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 63.7 bits (155), Expect = 5e-11
 Identities = 73/261 (27%), Positives = 116/261 (44%), Gaps = 43/261 (16%)

Query: 141 DFKNVYMVT-HLMGADLNNIL-RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSN 198
           D  N+Y V  ++ G D+ ++L R     +D  +F + ++   ++ +H  G IHRD+KP N
Sbjct: 72  DKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDN 131

Query: 199 IAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH---YNQTGVPFYFQDL 255
           I ++ D  +K+ DFGL        TG               W H   Y Q G       +
Sbjct: 132 ILIDRDGHIKLTDFGLC-------TG-------------FRWTHDSKYYQKGDHHRQDSM 171

Query: 256 KPSNIAVNED-CELKILDFGLARPTENEMT-GYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
           +PS      D C LK L+    R  +  +    V T  Y APE++L   +    D   + 
Sbjct: 172 EPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 231

Query: 314 LIM-EML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGAN--PQAIDLLSLML 369
           +I+ EML G PP  F+A   +++  K IN       +    +   A    +A DL+ L L
Sbjct: 232 VILYEMLVGQPP--FLADTPAETQLKVINW------ETTLHIPSQAKLSREASDLI-LRL 282

Query: 370 ELDSEKRI---TAEQALAHPY 387
              +E R+    A++  AHP+
Sbjct: 283 CCGAEDRLGKNGADEIKAHPF 303

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 62.4 bits (151), Expect = 5e-11
 Identities = 36/133 (27%), Positives = 69/133 (51%), Gaps = 8/133 (6%)

Query: 113 RELRMLK-HMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGA----DLNNILRTQKLSD 167
           +E+ MLK + +H N+      F           +++V    GA    DL    +   L +
Sbjct: 51  QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE 110

Query: 168 DHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP---TENEMTG 224
           + + ++  +ILRGL ++H   +IHRD+K  N+ + E+ E+K++DFG++     T      
Sbjct: 111 EWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT 170

Query: 225 YVATRWYRAPEIM 237
           ++ T ++ APE++
Sbjct: 171 FIGTPYWMAPEVI 183

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 63.3 bits (154), Expect = 6e-11
 Identities = 42/141 (29%), Positives = 67/141 (47%), Gaps = 11/141 (7%)

Query: 112 YRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQKLSDDHV 170
           + E  ++ H N E ++ L   F       D K +YMV   M G DL N++    + +   
Sbjct: 91  WEERDIMAHANSEWIVQLHYAFQ------DDKYLYMVMEYMPGGDLVNLMSNYDIPEKWA 144

Query: 171 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-RPTENEM---TGYV 226
           +F   +++  L  IHS G IHRD+KP N+ +++   LK+ DFG   +   N M      V
Sbjct: 145 RFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV 204

Query: 227 ATRWYRAPEIMLNWMHYNQTG 247
            T  Y +PE++ +       G
Sbjct: 205 GTPDYISPEVLKSQGGDGYYG 225

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 63.1 bits (153), Expect = 6e-11
 Identities = 49/159 (30%), Positives = 74/159 (46%), Gaps = 30/159 (18%)

Query: 114 ELRMLKHM-NHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILR----------- 161
           E+ M+K +  H+N+I LL       C  D     +V +    +L   LR           
Sbjct: 67  EMEMMKMIGKHKNIINLL-----GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSF 121

Query: 162 -TQKLSDDHVQF-----LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 215
            T KL ++ + F       YQ+ RG++Y+ S   IHRDL   N+ V ED  +KI DFGLA
Sbjct: 122 DTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLA 181

Query: 216 RPTEN------EMTGYVATRWYRAPEIMLNWMHYNQTGV 248
           R   N         G +  +W  APE + + ++ +Q+ V
Sbjct: 182 RDVHNIDYYKKTTNGRLPVKWM-APEALFDRVYTHQSDV 219

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 62.4 bits (151), Expect = 7e-11
 Identities = 38/130 (29%), Positives = 69/130 (53%), Gaps = 10/130 (7%)

Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRT--QKLSDDHVQ 171
           E+ +L   NH  ++ LL  F+      D K   M+    G  ++ I+    + L++  +Q
Sbjct: 59  EIEILATCNHPYIVKLLGAFYW-----DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ 113

Query: 172 FLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR---PTENEMTGYVAT 228
            +  Q+L  L+Y+HS  IIHRDLK  N+ +  D ++K+ DFG++     T      ++ T
Sbjct: 114 VICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGT 173

Query: 229 RWYRAPEIML 238
            ++ APE+++
Sbjct: 174 PYWMAPEVVM 183

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 61.9 bits (150), Expect = 8e-11
 Identities = 45/157 (28%), Positives = 75/157 (47%), Gaps = 12/157 (7%)

Query: 90  GVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT 149
           G +  IKK+     S    K   +E ++L  + H N++   + +     L     +Y+V 
Sbjct: 25  GKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGL-----LYIVM 79

Query: 150 HLM-GADLNNILRTQK---LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
               G DL + L+ QK   L ++ V     QI   L+Y+H   I+HRDLK  N+ +    
Sbjct: 80  GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTN 139

Query: 206 ELKILDFGLARPTENE---MTGYVATRWYRAPEIMLN 239
            +K+ D G+AR  EN+    +  + T +Y +PE+  N
Sbjct: 140 IIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN 176

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 62.8 bits (153), Expect = 8e-11
 Identities = 71/297 (23%), Positives = 118/297 (39%), Gaps = 50/297 (16%)

Query: 141 DFKNVYMVT-HLMGADLNNIL-RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSN 198
           D   +Y++  +L G D+  +L +    +++  +F + + +  +  IH  G IHRD+KP N
Sbjct: 72  DENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDN 131

Query: 199 IAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPS 258
           + ++    +K+ DFGL    +        T +YR         H                
Sbjct: 132 LLLDAKGHIKLSDFGLCTGLKKSHR----TEFYR------ILSHAL--------PSNFLD 173

Query: 259 NIAVNEDCELKILDFGLARPTENEMTGY--VATRWYRAPEIMLNWMHYNQTDIHQLNLIM 316
            I+     + K   +   R        Y  V T  Y APE+ L   +  + D   L +IM
Sbjct: 174 FISKPMSSKRKAETWKRNR----RALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM 229

Query: 317 -EML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSE 374
            EML G PP  F +    ++ RK IN    L   D   +    +P+A DL+   L  ++E
Sbjct: 230 YEMLVGYPP--FCSDNPQETYRKIINWKETLQFPDEVPL----SPEAKDLI-KRLCCEAE 282

Query: 375 KRI---TAEQALAHPYLSQYSDPNDEPTSPPY--------DQS----FEDMDLPVDQ 416
           +R+      +  +HP+       +      P         D S    FE++DL V  
Sbjct: 283 RRLGNNGVNEIKSHPFFKGVDWEHIRERPAPIIPELKSITDTSNFDDFEEIDLDVPT 339

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 62.4 bits (151), Expect = 8e-11
 Identities = 39/158 (24%), Positives = 82/158 (51%), Gaps = 10/158 (6%)

Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A+D  +G +VAI+++    Q     +    E+ +++   + N++  LD +     + D 
Sbjct: 38  TAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLDSY----LVGDE 91

Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
             V M  +L G  L +++    + +  +  +  + L+ L+++HS  +IHRD+K  NI + 
Sbjct: 92  LWVVM-EYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 150

Query: 203 EDCELKILDFGLA---RPTENEMTGYVATRWYRAPEIM 237
            D  +K+ DFG      P +++ +  V T ++ APE++
Sbjct: 151 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 34/126 (26%), Positives = 63/126 (50%), Gaps = 8/126 (6%)

Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV-THLMGADLNNILRTQ-KLSDDHVQ 171
           E  +L  ++H  ++ ++  F       D   VY +   ++G +L   LR   +  +D  +
Sbjct: 68  EKSILMELSHPFIVNMMCSFQ------DENRVYFLLEFVVGGELFTHLRKAGRFPNDVAK 121

Query: 172 FLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWY 231
           F   +++   +Y+HS  II+RDLKP N+ ++    +K+ DFG A+   +       T  Y
Sbjct: 122 FYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPEY 181

Query: 232 RAPEIM 237
            APE++
Sbjct: 182 LAPEVI 187

Length = 329

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 39/158 (24%), Positives = 83/158 (52%), Gaps = 10/158 (6%)

Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A+D  +G +VAIK+I    Q     +    E+ ++K + + N++  LD F     L   
Sbjct: 37  TAIDVATGQEVAIKQIN--LQKQPKKELIINEILVMKELKNPNIVNFLDSF-----LVGD 89

Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
           +   ++ +L G  L +++    + +  +  +  + L+ L+++H+  +IHRD+K  N+ + 
Sbjct: 90  ELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLG 149

Query: 203 EDCELKILDFGLA---RPTENEMTGYVATRWYRAPEIM 237
            D  +K+ DFG      P +++ +  V T ++ APE++
Sbjct: 150 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 39/163 (23%), Positives = 81/163 (49%), Gaps = 14/163 (8%)

Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRT--YRELRMLKHMNHENVIGLLDVFHSNT 137
           I   A D  +G +VA+KK+    Q     +R   + E+ +++   H N++ +   +    
Sbjct: 34  IVCIATDKSTGRQVAVKKMDLRKQQ----RRELLFNEVVIMRDYQHPNIVEMYSSY---- 85

Query: 138 CLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPS 197
            L   +   ++  L G  L +I+   +++++ +  +   +L+ L ++H+ G+IHRD+K  
Sbjct: 86  -LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSD 144

Query: 198 NIAVNEDCELKILDFGLARPTENEM---TGYVATRWYRAPEIM 237
           +I +  D  +K+ DFG       E+      V T ++ APE++
Sbjct: 145 SILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI 187

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 45/159 (28%), Positives = 75/159 (47%), Gaps = 30/159 (18%)

Query: 114 ELRMLKHMN-HENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQ--------- 163
           E+ ++K +  H+N+I LL V     C  +     +V +    +L   LR +         
Sbjct: 67  EMELMKLIGKHKNIINLLGV-----CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTF 121

Query: 164 ---KLSDDHVQF-----LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 215
              K+ ++ + F       YQ+ RG++Y+ S   IHRDL   N+ V ED  +KI DFGLA
Sbjct: 122 DITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLA 181

Query: 216 RPTEN------EMTGYVATRWYRAPEIMLNWMHYNQTGV 248
           R   +         G +  +W  APE + + ++ +Q+ V
Sbjct: 182 RGVHDIDYYKKTSNGRLPVKWM-APEALFDRVYTHQSDV 219

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 46/159 (28%), Positives = 74/159 (46%), Gaps = 30/159 (18%)

Query: 114 ELRMLKHM-NHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQK-------- 164
           E+ M+K +  H+N+I LL       C  D     +V +    +L   LR ++        
Sbjct: 70  EMEMMKMIGKHKNIINLL-----GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 124

Query: 165 ----LSDDHVQF-----LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 215
               + D+ + F       YQ+ RG++Y+ S   IHRDL   N+ V E+  +KI DFGLA
Sbjct: 125 DIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 184

Query: 216 RPTEN------EMTGYVATRWYRAPEIMLNWMHYNQTGV 248
           R   N         G +  +W  APE + + ++ +Q+ V
Sbjct: 185 RDVNNIDYYKKTTNGRLPVKWM-APEALFDRVYTHQSDV 222

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 63.3 bits (154), Expect = 1e-10
 Identities = 48/164 (29%), Positives = 68/164 (41%), Gaps = 23/164 (14%)

Query: 89  SGVKVAIKKIARPFQSAVHA-KRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYM 147
           +G +VAIK +        H   R  RE  +   + H N++ LLD   S         ++ 
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLD---SGEAPPGL--LFA 56

Query: 148 V-THLMGADLNNILRTQ-KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN--- 202
           V  ++ G  L  +L     L       L+ Q+L  L   H+ GI+HRDLKP NI V+   
Sbjct: 57  VFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTG 116

Query: 203 -EDCELKILDFGL----------ARPTENEMTGYVATRWYRAPE 235
                 K+LDFG+             T    T  + T  Y APE
Sbjct: 117 VRPHA-KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE 159

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 49/157 (31%), Positives = 79/157 (50%), Gaps = 17/157 (10%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           +G  VA+KK+     +A H +   RE+ +LK + H+N++    V +S    A  +N+ +V
Sbjct: 32  TGEVVAVKKLQH--STAEHLRDFEREIEILKSLQHDNIVKYKGVCYS----AGRRNLRLV 85

Query: 149 T-HLMGADLNNILRTQKLSDDHVQFLVY--QILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
             +L    L + L+  +   DH + L+Y  QI +G++Y+ S   +HRDL   NI V  + 
Sbjct: 86  MEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESEN 145

Query: 206 ELKILDFGLARPTENEMTGYVATR-------WYRAPE 235
            +KI DFGL +    +   Y           WY APE
Sbjct: 146 RVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APE 181

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 37/121 (30%), Positives = 67/121 (55%), Gaps = 11/121 (9%)

Query: 122 NHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLN-NILRTQKLSDDHVQFLVYQILRG 180
           NH  ++GL   F + + L      +++ ++ G DL  ++ R +KL ++H +F   +I   
Sbjct: 54  NHPFLVGLHSCFQTESRL-----FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 108

Query: 181 LKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA----RPTENEMTGYVATRWYRAPEI 236
           L Y+H  GII+RDLK  N+ ++ +  +K+ D+G+     RP +   + +  T  Y APEI
Sbjct: 109 LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TSTFCGTPNYIAPEI 167

Query: 237 M 237
           +
Sbjct: 168 L 168

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 61.1 bits (149), Expect = 2e-10
 Identities = 45/144 (31%), Positives = 78/144 (54%), Gaps = 22/144 (15%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEM---TGYVATRWYRAPEIMLNWMHYN-QTDI 309
           DLKP+NI ++ +  +K+ DFGLA+   ++      YV T +Y +PE + + M Y+ ++DI
Sbjct: 135 DLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNH-MSYDEKSDI 193

Query: 310 HQLN-LIMEML-GTPPAEFMAKISSDSARKYINSLPLLTK-KD--FRQVFKGANPQAIDL 364
             L  LI E+   +PP  F A+          N L L +K K+  FR++    + +  ++
Sbjct: 194 WSLGCLIYELCALSPP--FTAR----------NQLQLASKIKEGKFRRIPYRYSSELNEV 241

Query: 365 LSLMLELDSEKRITAEQALAHPYL 388
           +  ML +D +KR + E+ L  P +
Sbjct: 242 IKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 40/169 (23%), Positives = 77/169 (45%), Gaps = 20/169 (11%)

Query: 229 RWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLA--RPTENEMTGY 286
            +Y A +I+    H +Q  +   ++DLKP N+ +++   ++I D GLA       ++ G 
Sbjct: 98  IFYAA-QIICGLEHLHQRRI--VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR 154

Query: 287 VATRWYRAPEIMLNWMHYNQTDIHQLN-LIMEMLG--TPPAEFMAKISSDSARKYINSLP 343
             T  Y APE++   ++    D   L   + EM+   +P  +   K+  +  ++    + 
Sbjct: 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMA 214

Query: 344 LLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI-----TAEQALAHPY 387
           +     F       +P+A DL   +L+ D EKR+     +A++   HP 
Sbjct: 215 VEYPDKF-------SPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPL 256

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 60.5 bits (147), Expect = 2e-10
 Identities = 44/155 (28%), Positives = 72/155 (46%), Gaps = 16/155 (10%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           + VAIK I    + A+       E +++  ++H N++ L  V     C    + +++VT 
Sbjct: 29  IDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLVQLYGV-----CT-KQRPIFIVTE 79

Query: 151 LMG-ADLNNILRTQKLSDDHVQFL--VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
            M    L N LR +K        L     +   ++Y+ S G IHRDL   N  V ED  +
Sbjct: 80  YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVV 139

Query: 208 KILDFGLARPT-ENEMTGYVATRW---YRAPEIML 238
           K+ DFGLAR   +++ T    T++   +  PE+  
Sbjct: 140 KVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFD 174

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 60.9 bits (147), Expect = 2e-10
 Identities = 33/102 (32%), Positives = 60/102 (58%), Gaps = 3/102 (2%)

Query: 139 LADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSN 198
           L D K   ++ +L G    ++L    L +  +  ++ +IL+GL Y+HS   IHRD+K +N
Sbjct: 72  LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAAN 131

Query: 199 IAVNEDCELKILDFGLA---RPTENEMTGYVATRWYRAPEIM 237
           + ++E  E+K+ DFG+A     T+ +   +V T ++ APE++
Sbjct: 132 VLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 173

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 30/159 (18%)

Query: 114 ELRMLKHM-NHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILR----------- 161
           E+ M+K +  H+N+I LL V     C  +     +V +    +L + LR           
Sbjct: 65  EMEMMKMIGKHKNIINLLGV-----CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASP 119

Query: 162 ------TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 215
                  + L+   +    YQ+ RG++++ S   IHRDL   N+ V ED  +KI DFGLA
Sbjct: 120 DDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA 179

Query: 216 RPTEN------EMTGYVATRWYRAPEIMLNWMHYNQTGV 248
           R   +         G +  +W  APE + + ++ +Q+ V
Sbjct: 180 RDIHHIDYYRKTTNGRLPVKWM-APEALFDRVYTHQSDV 217

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 47/163 (28%), Positives = 81/163 (49%), Gaps = 24/163 (14%)

Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLN-NILRTQKLSDDH 169
           T  E R+LK+  H  +  L   F +   L      +++ ++ G +L  ++ R +  S+D 
Sbjct: 42  TLTESRVLKNTRHPFLTSLKYSFQTKDRLC-----FVMEYVNGGELFFHLSRERVFSEDR 96

Query: 170 VQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE---MTGYV 226
            +F   +I+  L Y+HS  I++RDLK  N+ +++D  +KI DFGL +    +   M  + 
Sbjct: 97  TRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC 156

Query: 227 ATRWYRAPEIM--------LNW------MHYNQTG-VPFYFQD 254
            T  Y APE++        ++W      M+    G +PFY QD
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 60.3 bits (147), Expect = 3e-10
 Identities = 42/158 (26%), Positives = 70/158 (44%), Gaps = 32/158 (20%)

Query: 254 DLKPSNIAVNEDCELKILDFGLA------RPTENEMTGYVATRWYRAPEIMLNWMHYNQT 307
           D+K  NI +++D  +K+ DFG A      +   N +   V T ++ APE++    +  + 
Sbjct: 141 DIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV---VGTPYWMAPEVIKRKDYGPKV 197

Query: 308 DIHQLN-LIMEML-GTPP------AEFMAKISSDSARKYINSLPLLTKKD-FRQVFKGAN 358
           DI  L  + +EM  G PP         +  I++         +P L   + +   FK   
Sbjct: 198 DIWSLGIMCIEMAEGEPPYLREPPLRALFLITT-------KGIPPLKNPEKWSPEFK--- 247

Query: 359 PQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPND 396
               D L+  L  D EKR +AE+ L HP+L +     +
Sbjct: 248 ----DFLNKCLVKDPEKRPSAEELLQHPFLKKACPKEE 281

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 38/131 (29%), Positives = 66/131 (50%), Gaps = 10/131 (7%)

Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLN-NI--LRTQKLSDDHV 170
           E ++L+ +N + V+ L   + +   L       ++T + G DL  +I  +      ++  
Sbjct: 50  EKQILEKVNSQFVVNLAYAYETKDALC-----LVLTIMNGGDLKFHIYNMGNPGFEEERA 104

Query: 171 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR--PTENEMTGYVAT 228
            F   +IL GL+ +H    ++RDLKP NI +++   ++I D GLA   P    + G V T
Sbjct: 105 LFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGT 164

Query: 229 RWYRAPEIMLN 239
             Y APE++ N
Sbjct: 165 VGYMAPEVLNN 175

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 33/105 (31%), Positives = 61/105 (58%), Gaps = 5/105 (4%)

Query: 146 YMVTHLMGADL-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED 204
           +++ +L G DL  +I  + +  +   +F   +I+ GL+++H  GII+RDLK  N+ +++D
Sbjct: 73  FVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKD 132

Query: 205 CELKILDFGLARPT---ENEMTGYVATRWYRAPEIMLNWMHYNQT 246
             +KI DFG+ +     E + + +  T  Y APEI+     YN++
Sbjct: 133 GHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG-QKYNES 176

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 75/282 (26%), Positives = 122/282 (43%), Gaps = 46/282 (16%)

Query: 141 DFKNVYMVTHLM-GADLNNIL-RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSN 198
           D +N+Y++   + G D+  +L +   LS++  QF + + +  +  IH  G IHRD+KP N
Sbjct: 72  DKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDN 131

Query: 199 IAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPS 258
           + ++    +K+ DFGL    +        T +YR      N  H   +   F FQ++   
Sbjct: 132 LLLDAKGHVKLSDFGLCTGLKKAHR----TEFYR------NLTHNPPSD--FSFQNMNSK 179

Query: 259 NIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIM-E 317
             A       + L +             V T  Y APE+ +   +    D   L +IM E
Sbjct: 180 RKAETWKKNRRQLAYST-----------VGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228

Query: 318 ML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANP---QAIDLLSLMLELDS 373
           ML G PP  F ++   ++ RK +N    L       VF    P   +A DL+ L    DS
Sbjct: 229 MLIGYPP--FCSETPQETYRKVMNWKETL-------VFPPEVPISEKAKDLI-LRFCTDS 278

Query: 374 EKRI---TAEQALAHPYLS--QYSDPNDEPTSPPYD-QSFED 409
           E RI     E+  +HP+     +    + P + P + +S +D
Sbjct: 279 ENRIGSNGVEEIKSHPFFEGVDWGHIRERPAAIPIEIKSIDD 320

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 59.6 bits (145), Expect = 4e-10
 Identities = 36/141 (25%), Positives = 57/141 (40%), Gaps = 13/141 (9%)

Query: 254 DLKPSNIAVNEDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           D+KP NI ++E   + I DF +A     +   T    T  Y APE++    +    D   
Sbjct: 125 DIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWS 184

Query: 312 LNLIM-EML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLML 369
           L +   E L G  P        S + R  I +        +       + +AID ++ +L
Sbjct: 185 LGVTAYECLRGKRPYR----GHSRTIRDQIRAKQETADVLYP---ATWSTEAIDAINKLL 237

Query: 370 ELDSEKRI--TAEQALAHPYL 388
           E D +KR+    +    HPY 
Sbjct: 238 ERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 51/157 (32%), Positives = 74/157 (47%), Gaps = 23/157 (14%)

Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEM--TGYVATRWYRAPEIMLNWMHYNQTDIH 310
           +DLKP NI V    ++K+ DFGLAR    +M  T  V T WYRAPE++L   +    D+ 
Sbjct: 134 RDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLW 193

Query: 311 QLNLIM-EMLGTPPAEFMAKISSDSARKYINSLPLLTKKDF-------RQVFKGANPQAI 362
            +  I  EM    P  F      D   K ++ + L  ++D+       RQ F   + Q I
Sbjct: 194 SVGCIFAEMFRRKPL-FRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPI 252

Query: 363 DLL---------SLMLELDS---EKRITAEQALAHPY 387
           +            L+L+  +    KRI+A  AL+HPY
Sbjct: 253 EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 60.6 bits (147), Expect = 4e-10
 Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 25/198 (12%)

Query: 57  PYS---EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRT-- 111
           PY    E  R  +  G TL   +F  +  +    +S     +K   +  +   H+     
Sbjct: 25  PYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREA 84

Query: 112 -YRELRMLKHM-NHENVIGLLDV-FHSNTCLADFKNVYMVT-HLMGADLNNILRTQKLS- 166
              EL+++ H+ NHEN++ LL               + ++T +    DL N LR ++ S 
Sbjct: 85  LMSELKIMSHLGNHENIVNLLGACTIGGP-------ILVITEYCCYGDLLNFLRRKRESF 137

Query: 167 ---DDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT 223
              +D + F  YQ+ +G+ ++ S   IHRDL   N+ +     +KI DFGLAR   N+ +
Sbjct: 138 LTLEDLLSF-SYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMND-S 195

Query: 224 GYVATRWYRAPEIMLNWM 241
            YV     R P   + WM
Sbjct: 196 NYVVKGNARLP---VKWM 210

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 60.7 bits (147), Expect = 4e-10
 Identities = 37/125 (29%), Positives = 73/125 (58%), Gaps = 11/125 (8%)

Query: 126 VIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQ-KLSDDHVQFLVYQILRGLKY 183
           ++GL   F +++      ++Y+VT  M G +L   L+ + + S+D  +F + +++  L++
Sbjct: 58  IVGLKFSFQTDS------DLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEH 111

Query: 184 IHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP--TENEMTG-YVATRWYRAPEIMLNW 240
           +H   I++RDLKP NI ++    + + DFGL++   T+N+ T  +  T  Y APE++L+ 
Sbjct: 112 LHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDE 171

Query: 241 MHYNQ 245
             Y +
Sbjct: 172 KGYTK 176

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 60.0 bits (146), Expect = 4e-10
 Identities = 45/175 (25%), Positives = 77/175 (44%), Gaps = 27/175 (15%)

Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVS----GVKVAIKKIARPFQSAVHAKRT--YR 113
           E+ R  I +   L + SF +++      V       +VAIK +    ++A   +R     
Sbjct: 2   ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTV---NENASMRERIEFLN 58

Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDDHVQF 172
           E  ++K  N  +V+ LL V      ++  +   +V  LM   DL + LR+++   ++   
Sbjct: 59  EASVMKEFNCHHVVRLLGV------VSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPG 112

Query: 173 L-----------VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           L             +I  G+ Y+ +   +HRDL   N  V ED  +KI DFG+ R
Sbjct: 113 LGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 59.7 bits (144), Expect = 4e-10
 Identities = 44/154 (28%), Positives = 76/154 (49%), Gaps = 16/154 (10%)

Query: 92  KVAIKKIA-RPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
            VA+KK+       A   +   +E+ +LK +NH NVI  LD F  +  L       +V  
Sbjct: 29  PVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELN------IVLE 82

Query: 151 LMGA-DLNNILRTQK-----LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED 204
           L  A DL+ +++  K     + +  V     Q+   ++++HS  ++HRD+KP+N+ +   
Sbjct: 83  LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITAT 142

Query: 205 CELKILDFGLARPTENEMTG---YVATRWYRAPE 235
             +K+ D GL R   ++ T     V T +Y +PE
Sbjct: 143 GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 60.5 bits (147), Expect = 4e-10
 Identities = 37/127 (29%), Positives = 62/127 (48%), Gaps = 9/127 (7%)

Query: 122 NHENVIGLLDVFHSNTCLADFKNVYM-VTHLMGADLNNIL-RTQKLSDDHVQFLVYQILR 179
             E ++ LL  F       D + +Y+ + ++ G D   +L     LS+DH +F + ++  
Sbjct: 59  KSEWLVKLLYAFQ------DDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFE 112

Query: 180 GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN 239
            +  +H  G IHRDLKP N  ++    +K+ DFGL++         V +  Y APE +L 
Sbjct: 113 AVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPE-VLR 171

Query: 240 WMHYNQT 246
              Y+ T
Sbjct: 172 GKGYDFT 178

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 59.3 bits (144), Expect = 5e-10
 Identities = 40/154 (25%), Positives = 72/154 (46%), Gaps = 18/154 (11%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           V+VA+K   +    A   K   RE  ++  ++H  ++ L+ V     C  +   + +V  
Sbjct: 24  VEVAVK-TLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGV-----CKGE--PLMLVME 75

Query: 151 L--MGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELK 208
           L  +G  L  + + +++    ++ L +Q+  G+ Y+ S   +HRDL   N+ +    + K
Sbjct: 76  LAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAK 135

Query: 209 ILDFGLARPTENEMTGYVAT-------RWYRAPE 235
           I DFG++R        Y AT       +WY APE
Sbjct: 136 ISDFGMSRALGAGSDYYRATTAGRWPLKWY-APE 168

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 60.2 bits (146), Expect = 5e-10
 Identities = 45/163 (27%), Positives = 80/163 (49%), Gaps = 24/163 (14%)

Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADL-NNILRTQKLSDDH 169
           T  E R+L++  H  +  L   F ++  L      +++ +  G +L  ++ R +  S+D 
Sbjct: 42  TLTESRVLQNTRHPFLTALKYSFQTHDRLC-----FVMEYANGGELFFHLSRERVFSEDR 96

Query: 170 VQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR---PTENEMTGYV 226
            +F   +I+  L Y+HS  +++RDLK  N+ +++D  +KI DFGL +        M  + 
Sbjct: 97  ARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 156

Query: 227 ATRWYRAPEIM--------LNW------MHYNQTG-VPFYFQD 254
            T  Y APE++        ++W      M+    G +PFY QD
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 59.7 bits (144), Expect = 5e-10
 Identities = 38/152 (25%), Positives = 77/152 (50%), Gaps = 10/152 (6%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           SG  VA+KK+    +     +  + E+ +++   HENV+ +      N+ L   +   ++
Sbjct: 44  SGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMY-----NSYLVGDELWVVM 96

Query: 149 THLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELK 208
             L G  L +I+   +++++ +  +   +L+ L  +H+ G+IHRD+K  +I +  D  +K
Sbjct: 97  EFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVK 156

Query: 209 ILDFGLARPTENEM---TGYVATRWYRAPEIM 237
           + DFG       E+      V T ++ APE++
Sbjct: 157 LSDFGFCAQVSKEVPRRKSLVGTPYWMAPELI 188

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 60.9 bits (147), Expect = 5e-10
 Identities = 41/134 (30%), Positives = 67/134 (50%), Gaps = 16/134 (11%)

Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLS-DD---- 168
           E+  L  +NHEN++ + ++  S        N YM+T     DL + +  +     D    
Sbjct: 213 EILALGRLNHENILKIEEILRSEA------NTYMITQKYDFDLYSFMYDEAFDWKDRPLL 266

Query: 169 -HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT---- 223
              + ++ Q+L  ++YIH   +IHRD+K  NI +N D ++ + DFG A P E E      
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDY 326

Query: 224 GYVATRWYRAPEIM 237
           G+V T    +PEI+
Sbjct: 327 GWVGTVATNSPEIL 340

Length = 501

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 59.6 bits (144), Expect = 5e-10
 Identities = 35/130 (26%), Positives = 66/130 (50%), Gaps = 10/130 (7%)

Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRT--QKLSDDHVQ 171
           E+ +L   +H N++ LLD F+    L       ++    G  ++ ++    + L++  ++
Sbjct: 52  EIDILASCDHPNIVKLLDAFYYENNLW-----ILIEFCAGGAVDAVMLELERPLTEPQIR 106

Query: 172 FLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP---TENEMTGYVAT 228
            +  Q L  L Y+H   IIHRDLK  NI    D ++K+ DFG++     T      ++ T
Sbjct: 107 VVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGT 166

Query: 229 RWYRAPEIML 238
            ++ APE+++
Sbjct: 167 PYWMAPEVVM 176

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 59.0 bits (143), Expect = 6e-10
 Identities = 51/186 (27%), Positives = 84/186 (45%), Gaps = 30/186 (16%)

Query: 72  LSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLD 131
           + K +F  ++   L      +VA+K   R        ++  +E  +LK  +H N++ L+ 
Sbjct: 3   IGKGNFGDVYKGVLKG--NTEVAVKT-CRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59

Query: 132 VFHSNTCLADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILR-------GLKY 183
           V     C    + +Y+V  L+ G  L   LR +K      +  V ++L+       G++Y
Sbjct: 60  V-----C-VQKQPIYIVMELVPGGSLLTFLRKKK-----NRLTVKKLLQMSLDAAAGMEY 108

Query: 184 IHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM------TGYVATRWYRAPEIM 237
           + S   IHRDL   N  V E+  LKI DFG++R  E  +         +  +W  APE  
Sbjct: 109 LESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKW-TAPE-A 166

Query: 238 LNWMHY 243
           LN+  Y
Sbjct: 167 LNYGRY 172

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 58.8 bits (143), Expect = 7e-10
 Identities = 41/140 (29%), Positives = 68/140 (48%), Gaps = 12/140 (8%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMT---GYVATRWYRAPEIMLNWMHYNQTDIH 310
           D+K  NI +NE+ + K+ DFG++    + M      + T ++ APE++    + N+ DI 
Sbjct: 124 DIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIW 183

Query: 311 QLNL-IMEML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLM 368
            L +  +EM  G PP    + I    A   I + P  T  D  +     +P+  D +   
Sbjct: 184 SLGITAIEMAEGKPP---YSDIHPMRAIFMIPNKPPPTLSDPEKW----SPEFNDFVKKC 236

Query: 369 LELDSEKRITAEQALAHPYL 388
           L  D E+R +A Q L HP++
Sbjct: 237 LVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 59.4 bits (144), Expect = 8e-10
 Identities = 40/117 (34%), Positives = 58/117 (49%), Gaps = 11/117 (9%)

Query: 130 LDVFHSNTCLADFKNVYMVTHLM-GADLN-NILRTQKLSDDHVQFLVYQILRGLKYIHSA 187
           L   HS  C      +Y V   + G DL  +I +  K  + H  F   +I  GL ++HS 
Sbjct: 63  LTQLHS--CFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 188 GIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTG-----YVATRWYRAPEIMLN 239
           GII+RDLK  N+ ++ +  +KI DFG+ +  EN   G     +  T  Y APEI+  
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGTPDYIAPEIIAY 175

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 59.1 bits (143), Expect = 8e-10
 Identities = 26/60 (43%), Positives = 39/60 (65%), Gaps = 1/60 (1%)

Query: 177 ILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM-TGYVATRWYRAPE 235
           +++GL Y+ S  I+HRD+KPSN+ VN   ++K+ DFG++    N +   YV T  Y APE
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPE 163

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 59.3 bits (143), Expect = 9e-10
 Identities = 46/159 (28%), Positives = 72/159 (45%), Gaps = 30/159 (18%)

Query: 114 ELRMLKHM-NHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRT---------- 162
           E+ M+K +  H+N+I LL       C  D     +V +    +L   LR           
Sbjct: 73  EMEMMKMIGKHKNIINLL-----GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCY 127

Query: 163 -------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 215
                  ++LS   +    YQ+ RG++Y+ S   IHRDL   N+ V ED  +KI DFGLA
Sbjct: 128 NPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 187

Query: 216 RPT------ENEMTGYVATRWYRAPEIMLNWMHYNQTGV 248
           R        +    G +  +W  APE + + ++ +Q+ V
Sbjct: 188 RDIHHIDYYKKTTNGRLPVKWM-APEALFDRIYTHQSDV 225

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 59.0 bits (143), Expect = 9e-10
 Identities = 35/131 (26%), Positives = 64/131 (48%), Gaps = 10/131 (7%)

Query: 109 KRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGAD-LNNILRTQ-KLS 166
           K+  REL+++       ++     F     L +  N+ M    M    L+ I +    + 
Sbjct: 48  KQILRELQIMHECRSPYIVSFYGAF-----LNE-NNICMCMEFMDCGSLDRIYKKGGPIP 101

Query: 167 DDHVQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTG- 224
            + +  +   ++ GL Y+++   I+HRD+KPSNI VN   ++K+ DFG++    N +   
Sbjct: 102 VEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT 161

Query: 225 YVATRWYRAPE 235
           +V T  Y +PE
Sbjct: 162 FVGTSTYMSPE 172

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 58.9 bits (142), Expect = 9e-10
 Identities = 29/94 (30%), Positives = 59/94 (62%), Gaps = 3/94 (3%)

Query: 147 MVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE 206
           ++ +L G    ++L+   L + ++  ++ +IL+GL Y+HS   IHRD+K +N+ ++E  +
Sbjct: 80  IMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD 139

Query: 207 LKILDFGLA---RPTENEMTGYVATRWYRAPEIM 237
           +K+ DFG+A     T+ +   +V T ++ APE++
Sbjct: 140 VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 173

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 56/182 (30%), Positives = 88/182 (48%), Gaps = 19/182 (10%)

Query: 72  LSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLD 131
           + + +F  +FS  L +     VA+K         + AK   +E R+LK  +H N++ L+ 
Sbjct: 3   IGRGNFGEVFSGRLRA-DNTPVAVKSCRETLPPDLKAK-FLQEARILKQYSHPNIVRLIG 60

Query: 132 VFHSNTCLADFKNVYMVTHLM-GADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAG 188
           V     C    + +Y+V  L+ G D    LRT+  +L    +  +V     G++Y+ S  
Sbjct: 61  V-----CTQK-QPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH 114

Query: 189 IIHRDLKPSNIAVNEDCELKILDFGLARPTENEM---TG---YVATRWYRAPEIMLNWMH 242
            IHRDL   N  V E   LKI DFG++R  E+ +   TG    +  +W  APE  LN+  
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW-TAPE-ALNYGR 172

Query: 243 YN 244
           Y+
Sbjct: 173 YS 174

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 36/128 (28%), Positives = 69/128 (53%), Gaps = 9/128 (7%)

Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILR-TQKLSDDHVQ 171
           +E+ M+K   H N++     +     L+  K    + +  G  L +I   T  LS+  + 
Sbjct: 55  QEIFMVKECKHCNIVAYFGSY-----LSREKLWICMEYCGGGSLQDIYHVTGPLSELQIA 109

Query: 172 FLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA---RPTENEMTGYVAT 228
           ++  + L+GL Y+HS G +HRD+K +NI + ++ ++K+ DFG+A     T  +   ++ T
Sbjct: 110 YVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGT 169

Query: 229 RWYRAPEI 236
            ++ APE+
Sbjct: 170 PYWMAPEV 177

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 37/121 (30%), Positives = 66/121 (54%), Gaps = 11/121 (9%)

Query: 122 NHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLN-NILRTQKLSDDHVQFLVYQILRG 180
           NH  ++GL   F + + L      +++  + G DL  ++ R +KL ++H +F   +I   
Sbjct: 54  NHPFLVGLHSCFQTESRL-----FFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA 108

Query: 181 LKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA----RPTENEMTGYVATRWYRAPEI 236
           L ++H  GII+RDLK  N+ ++ +  +K+ D+G+     RP +   T +  T  Y APEI
Sbjct: 109 LNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGTPNYIAPEI 167

Query: 237 M 237
           +
Sbjct: 168 L 168

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 11/99 (11%)

Query: 153 GADLN-NILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILD 211
           G DL  +I R+ +  +   +F   +I+ GL+++H  GII+RDLK  N+ ++ +  +KI D
Sbjct: 80  GGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIAD 139

Query: 212 FGLARPTENEMTGYVATRW------YRAPEIMLNWMHYN 244
           FG+ +  E  + G V T        Y APEI L++  Y 
Sbjct: 140 FGMCK--EG-ILGGVTTSTFCGTPDYIAPEI-LSYQPYG 174

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 44/158 (27%), Positives = 76/158 (48%), Gaps = 10/158 (6%)

Query: 84  ALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           A D  +   VAIKK++    QS    +   +E++ L+ + H N I          C    
Sbjct: 44  ARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSI------EYKGCYLRE 97

Query: 143 KNVYMVTHLMGADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
              ++V        +++L   K  L +  +  + +  L+GL Y+HS  +IHRD+K  NI 
Sbjct: 98  HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNIL 157

Query: 201 VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML 238
           + E  ++K+ DFG A    +    +V T ++ APE++L
Sbjct: 158 LTEPGQVKLADFGSAS-IASPANSFVGTPYWMAPEVIL 194

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 29/94 (30%), Positives = 57/94 (60%), Gaps = 3/94 (3%)

Query: 147 MVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE 206
           ++ +L G    ++LR     +  +  ++ +IL+GL Y+HS   IHRD+K +N+ ++E  +
Sbjct: 80  IMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGD 139

Query: 207 LKILDFGLA---RPTENEMTGYVATRWYRAPEIM 237
           +K+ DFG+A     T+ +   +V T ++ APE++
Sbjct: 140 VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 173

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 42/163 (25%), Positives = 81/163 (49%), Gaps = 24/163 (14%)

Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLN-NILRTQKLSDDH 169
           T  E R+L++  H  +  L   F ++  L      +++ +  G +L  ++ R +  +++ 
Sbjct: 42  TVTESRVLQNTRHPFLTALKYAFQTHDRLC-----FVMEYANGGELFFHLSRERVFTEER 96

Query: 170 VQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR---PTENEMTGYV 226
            +F   +I+  L+Y+HS  +++RD+K  N+ +++D  +KI DFGL +        M  + 
Sbjct: 97  ARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 156

Query: 227 ATRWYRAPEIM--------LNW------MHYNQTG-VPFYFQD 254
            T  Y APE++        ++W      M+    G +PFY QD
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 42/158 (26%), Positives = 78/158 (49%), Gaps = 10/158 (6%)

Query: 84  ALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           A +S +   VA+KK++    Q+    +   +E++ L+ + H N I          C    
Sbjct: 40  ATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTI------EYKGCYLKE 93

Query: 143 KNVYMVTHLMGADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
              ++V        +++L   K  L +  +  + +  L+GL Y+HS  +IHRD+K  NI 
Sbjct: 94  HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNIL 153

Query: 201 VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML 238
           + E  ++K+ DFG A  + +    +V T ++ APE++L
Sbjct: 154 LTEPGQVKLADFGSASKS-SPANSFVGTPYWMAPEVIL 190

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 57.5 bits (140), Expect = 2e-09
 Identities = 48/148 (32%), Positives = 70/148 (47%), Gaps = 30/148 (20%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEM---TGYVATRWYRAPEIMLNWMHYNQTDIH 310
           DLKP NI ++ D  +K+ DFGLA+   +E      +  T  Y APE++L   +    D  
Sbjct: 118 DLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWW 177

Query: 311 QLNLIM-EML-GTPP------AEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAI 362
            L +++ EML G PP       E   KI  D  R      P           +  +P+A 
Sbjct: 178 SLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLR-----FP-----------EFLSPEAR 221

Query: 363 DLLSLMLELDSEKRIT---AEQALAHPY 387
           DL+S +L+ D  KR+    AE+  AHP+
Sbjct: 222 DLISGLLQKDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 42/151 (27%), Positives = 69/151 (45%), Gaps = 17/151 (11%)

Query: 93  VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM 152
           VA+K + +P    +  K    E +++K + H  +I L  V     C  + + +Y+VT LM
Sbjct: 33  VAVKTL-KP--GTMDPKDFLAEAQIMKKLRHPKLIQLYAV-----CTLE-EPIYIVTELM 83

Query: 153 G-ADLNNILRTQKLSDDHVQFLV---YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELK 208
               L   L+        +  L+    Q+  G+ Y+ +   IHRDL   N+ V E+   K
Sbjct: 84  KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICK 143

Query: 209 ILDFGLARP-TENEMTGYVATRW---YRAPE 235
           + DFGLAR   E+        ++   + APE
Sbjct: 144 VADFGLARVIKEDIYEAREGAKFPIKWTAPE 174

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 54/207 (26%), Positives = 88/207 (42%), Gaps = 18/207 (8%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN--VY 146
           +G +VA+K + +P     H     +E+ +L+++ HEN+     V +   C  D  N    
Sbjct: 32  TGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENI-----VKYKGICTEDGGNGIKL 85

Query: 147 MVTHLMGADLNNILRTQKLSDDHVQFLVY--QILRGLKYIHSAGIIHRDLKPSNIAVNED 204
           ++  L    L   L   K   +  Q L Y  QI +G+ Y+ S   +HRDL   N+ V  +
Sbjct: 86  IMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE 145

Query: 205 CELKILDFGLARPTENEMTGYVATR-------WYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            ++KI DFGL +  E +   Y           WY APE ++    Y  + V  +   L  
Sbjct: 146 HQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLIQSKFYIASDVWSFGVTLYE 204

Query: 258 SNIAVNEDCELKILDFGLARPTENEMT 284
                + +     L   +  PT  +MT
Sbjct: 205 LLTYCDSESSPMTLFLKMIGPTHGQMT 231

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 35/117 (29%), Positives = 63/117 (53%), Gaps = 11/117 (9%)

Query: 126 VIGLLDVFHSNTCLADFKNVYMVTHLMGADLN-NILRTQKLSDDHVQFLVYQILRGLKYI 184
           ++GL   F + + L       ++ ++ G DL  ++ R +KL ++H +F   +I   L ++
Sbjct: 58  LVGLHSCFQTTSRL-----FLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFL 112

Query: 185 HSAGIIHRDLKPSNIAVNEDCELKILDFGLA----RPTENEMTGYVATRWYRAPEIM 237
           H  GII+RDLK  N+ ++ D  +K+ D+G+      P +   T +  T  Y APEI+
Sbjct: 113 HERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST-FCGTPNYIAPEIL 168

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 33/97 (34%), Positives = 54/97 (55%), Gaps = 4/97 (4%)

Query: 146 YMVTHLMGADLN-NILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED 204
           +++ +L G DL  +I    K       F   +I+ GL+++HS GI++RDLK  NI ++ D
Sbjct: 73  FVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD 132

Query: 205 CELKILDFGLARPT---ENEMTGYVATRWYRAPEIML 238
             +KI DFG+ +     + +   +  T  Y APEI+L
Sbjct: 133 GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILL 169

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 57.3 bits (139), Expect = 3e-09
 Identities = 42/153 (27%), Positives = 69/153 (45%), Gaps = 30/153 (19%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTG-YVATRWYRAPEIMLNWMHY-NQTDIHQ 311
           D+KPSNI VN   ++K+ DFG++    N +   +V T  Y APE  +    Y  ++DI  
Sbjct: 126 DVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPE-RIQGNDYSVKSDIWS 184

Query: 312 LNL-IMEM-LG---------TPPAEF--MAKISSDSARKYINSLPLLTKKDFRQVFKGAN 358
           L L ++E+  G          P   F  +  I ++         P L    F       +
Sbjct: 185 LGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP-------PRLPSGKF-------S 230

Query: 359 PQAIDLLSLMLELDSEKRITAEQALAHPYLSQY 391
           P   D ++L L  D  +R + ++ L HP++ +Y
Sbjct: 231 PDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 58.4 bits (141), Expect = 3e-09
 Identities = 41/118 (34%), Positives = 58/118 (49%), Gaps = 18/118 (15%)

Query: 102 FQSAVHAKRTYRELRMLKHMNHENVIGLLDV--FHSNTCLADFKNVYMVTHLMGADLNNI 159
           + S+VH      E R+L+ ++H  V+ LLDV      TCL        V     +DL   
Sbjct: 204 YASSVH------EARLLRRLSHPAVLALLDVRVVGGLTCL--------VLPKYRSDLYTY 249

Query: 160 L--RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 215
           L  R + L    V  +  Q+L  + YIH  GIIHRD+K  N+ VN   ++ + DFG A
Sbjct: 250 LGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAA 307

Length = 461

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 57.2 bits (138), Expect = 3e-09
 Identities = 39/131 (29%), Positives = 64/131 (48%), Gaps = 12/131 (9%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           + +KVAIK I    + A+  +    E +++  ++H  ++ L  V     C    K +Y+V
Sbjct: 27  AQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLYGV-----CTQQ-KPLYIV 77

Query: 149 THLM-GADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
           T  M    L N LR +  KLS D +  +   +  G++Y+     IHRDL   N  V+   
Sbjct: 78  TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG 137

Query: 206 ELKILDFGLAR 216
            +K+ DFG+ R
Sbjct: 138 VVKVSDFGMTR 148

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 26/70 (37%), Positives = 43/70 (61%), Gaps = 3/70 (4%)

Query: 172 FLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA---RPTENEMTGYVAT 228
           F   QI+ GL+++H   II+RDLKP N+ ++ D  ++I D GLA   +  +++  GY  T
Sbjct: 101 FYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160

Query: 229 RWYRAPEIML 238
             + APE++ 
Sbjct: 161 PGFMAPELLQ 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 12/150 (8%)

Query: 97  KIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADL 156
            I R  +   H K    E  +L+ + H  ++ L+  F +       K   ++ +L G +L
Sbjct: 36  TIVRNQKDTAHTKA---ERNILEAVKHPFIVDLIYAFQT-----GGKLYLILEYLSGGEL 87

Query: 157 NNIL-RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 215
              L R     +D   F + +I   L+++H  GII+RDLKP NI ++    +K+ DFGL 
Sbjct: 88  FMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLC 147

Query: 216 RPT--ENEMT-GYVATRWYRAPEIMLNWMH 242
           + +  E  +T  +  T  Y APEI++   H
Sbjct: 148 KESIHEGTVTHTFCGTIEYMAPEILMRSGH 177

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 37/152 (24%), Positives = 77/152 (50%), Gaps = 10/152 (6%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           SG +VA+K +    +     +  + E+ +++   H+NV+ +       + L   +   ++
Sbjct: 45  SGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQHQNVVEMY-----KSYLVGEELWVLM 97

Query: 149 THLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELK 208
             L G  L +I+   +L+++ +  +   +L+ L Y+HS G+IHRD+K  +I +  D  +K
Sbjct: 98  EFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVK 157

Query: 209 ILDFGLARPTENEM---TGYVATRWYRAPEIM 237
           + DFG       ++      V T ++ APE++
Sbjct: 158 LSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI 189

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 57.2 bits (138), Expect = 3e-09
 Identities = 42/160 (26%), Positives = 74/160 (46%), Gaps = 12/160 (7%)

Query: 68  IGPTLSKESFDLIFSSAL--DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHEN 125
           +G  L K  F  +  + L  +  S  KVA+K +     S+   +   RE   +K  +H N
Sbjct: 3   LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPN 62

Query: 126 VIGLLDV-FHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDH--------VQFLVYQ 176
           VI L+ V   S         + ++  +   DL+  L   ++ ++         V+F++  
Sbjct: 63  VIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI-D 121

Query: 177 ILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           I  G++Y+ S   IHRDL   N  +NE+  + + DFGL++
Sbjct: 122 IASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 57.6 bits (139), Expect = 3e-09
 Identities = 27/70 (38%), Positives = 43/70 (61%), Gaps = 3/70 (4%)

Query: 172 FLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT---ENEMTGYVAT 228
           F   +I+ GL+++HS GII+RDLK  N+ ++ D  +KI DFG+ +     +N  + +  T
Sbjct: 100 FYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT 159

Query: 229 RWYRAPEIML 238
             Y APEI+ 
Sbjct: 160 PDYIAPEILQ 169

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 56.8 bits (137), Expect = 3e-09
 Identities = 37/129 (28%), Positives = 67/129 (51%), Gaps = 11/129 (8%)

Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQK---LSDDHV 170
           E ++LK ++H N+I   + F     L D   + ++ +  G  L   ++ +    L +D +
Sbjct: 49  ECQVLKLLSHPNIIEYYENF-----LEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTI 103

Query: 171 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE-DCELKILDFGLARPTENEMTGY--VA 227
                QIL  L ++H+  I+HRDLK  NI +++    +KI DFG+++   ++   Y  V 
Sbjct: 104 LHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVG 163

Query: 228 TRWYRAPEI 236
           T  Y +PE+
Sbjct: 164 TPCYISPEL 172

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 35/104 (33%), Positives = 56/104 (53%), Gaps = 9/104 (8%)

Query: 141 DFKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
           D K +YMV   M G DL N++    + +   +F   +++  L  IHS G+IHRD+KP N+
Sbjct: 114 DDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNM 173

Query: 200 AVNEDCELKILDFGLARPTENEMTGY------VATRWYRAPEIM 237
            +++   LK+ DFG     + + TG       V T  Y +PE++
Sbjct: 174 LLDKHGHLKLADFGTC--MKMDETGMVRCDTAVGTPDYISPEVL 215

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 57.5 bits (139), Expect = 4e-09
 Identities = 44/160 (27%), Positives = 74/160 (46%), Gaps = 14/160 (8%)

Query: 86  DSVSGVKVAIKKIARPFQSAVHAKRTYRELR-MLKHMNHENVIGLLDVFHSNTCLADFKN 144
           +  +G   A+K + +    A      + E R +L   N   +  L   F       D  N
Sbjct: 22  EKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ------DKDN 75

Query: 145 VYMVTHLM-GADLNNILR--TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           +Y+V     G DL ++L     +  +D  QF + +++  +  +H  G +HRD+KP N+ +
Sbjct: 76  LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI 135

Query: 202 NEDCELKILDFG-LARPTENEM---TGYVATRWYRAPEIM 237
           +    +K+ DFG  AR T N+M      V T  Y APE++
Sbjct: 136 DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVL 175

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 56.8 bits (137), Expect = 4e-09
 Identities = 47/152 (30%), Positives = 74/152 (48%), Gaps = 18/152 (11%)

Query: 92  KVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHL 151
           KVAIK +    Q ++  +    E  ++K + H  ++ L  V          + +Y++T  
Sbjct: 32  KVAIKSLK---QGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ-------EPIYIITEY 81

Query: 152 M-GADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
           M    L + L+T    KL+ + +  +  QI  G+ +I     IHRDL+ +NI V+E    
Sbjct: 82  MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCC 141

Query: 208 KILDFGLARPTE-NEMTGYVATRW---YRAPE 235
           KI DFGLAR  E NE T     ++   + APE
Sbjct: 142 KIADFGLARLIEDNEYTAREGAKFPIKWTAPE 173

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 56.8 bits (137), Expect = 4e-09
 Identities = 33/117 (28%), Positives = 55/117 (47%), Gaps = 19/117 (16%)

Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQ 171
           +E++++  +   N+I LL V     C+     + M+T  M   DLN  L   +  +   +
Sbjct: 68  KEIKIMSRLKDPNIIRLLAV-----CITS-DPLCMITEYMENGDLNQFLSRHEPQEAAEK 121

Query: 172 ------------FLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
                       F+  QI  G+KY+ S   +HRDL   N  V ++  +KI DFG++R
Sbjct: 122 ADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 57.2 bits (138), Expect = 5e-09
 Identities = 54/218 (24%), Positives = 93/218 (42%), Gaps = 45/218 (20%)

Query: 141 DFKNVYMVTH-LMGADLNNIL-RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSN 198
           D + +Y++   L G DL  +L +    S+D  +F + + +  ++ +H  G IHRD+KP N
Sbjct: 72  DAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDN 131

Query: 199 IAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPS 258
           I ++    +K+ DFGL+       TG+                H +      Y+Q L   
Sbjct: 132 ILIDRGGHIKLSDFGLS-------TGFHKQ-------------HDSA-----YYQKLLQG 166

Query: 259 NIAVNEDCE---LKILDFGLARPTENEMTGY-----------VATRWYRAPEIMLNWMHY 304
               N       + +    L   +++++  +           V T  Y APEI L   + 
Sbjct: 167 KSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG 226

Query: 305 NQTDIHQLNLIME--MLGTPPAEFMAKISSDSARKYIN 340
            + D   L  IM   ++G PP  F ++ S ++ RK IN
Sbjct: 227 QECDWWSLGAIMFECLIGWPP--FCSENSHETYRKIIN 262

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 56.2 bits (135), Expect = 6e-09
 Identities = 52/181 (28%), Positives = 84/181 (46%), Gaps = 19/181 (10%)

Query: 72  LSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLD 131
           L K +F  +F   L   + V V   K   P +  +   +   E R+LK  +H N++ L+ 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKI---KFLSEARILKQYDHPNIVKLIG 59

Query: 132 VFHSNTCLADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQI--LRGLKYIHSAG 188
           V     C    + +Y+V  L+ G D  + LR +K      Q + + +    G+ Y+ S  
Sbjct: 60  V-----C-TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN 113

Query: 189 IIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTG-----YVATRWYRAPEIMLNWMHY 243
            IHRDL   N  V E+  LKI DFG++R  ++ +        +  +W  APE  LN+  Y
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKW-TAPE-ALNYGRY 171

Query: 244 N 244
           +
Sbjct: 172 S 172

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 57.9 bits (140), Expect = 7e-09
 Identities = 47/152 (30%), Positives = 80/152 (52%), Gaps = 20/152 (13%)

Query: 84  ALDSVSGVKVAIKKIARPF-QSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           A D V   +VA+KKI     ++ +  KR  RE ++   + H    G++ V+   +  +D 
Sbjct: 21  AYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHP---GIVPVY---SICSDG 74

Query: 143 KNVY-MVTHLMGADLNNILRT--QK--LSDDHVQ------FL--VYQILRGLKYIHSAGI 189
             VY  + ++ G  L ++L++  QK  LS +  +      FL   ++I   ++Y+HS G+
Sbjct: 75  DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGV 134

Query: 190 IHRDLKPSNIAVNEDCELKILDFGLARPTENE 221
           +HRDLKP NI +    E+ ILD+G A   + E
Sbjct: 135 LHRDLKPDNILLGLFGEVVILDWGAAIFKKLE 166

Length = 932

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 56.4 bits (136), Expect = 7e-09
 Identities = 39/132 (29%), Positives = 63/132 (47%), Gaps = 12/132 (9%)

Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLN---NILRTQKLSDDH 169
           E ++L+ +N   V+ L   + +   L       +V  LM G DL      +      ++ 
Sbjct: 50  EKQILEKVNSRFVVSLAYAYETKDALC------LVLTLMNGGDLKFHIYNMGNPGFDEER 103

Query: 170 VQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR--PTENEMTGYVA 227
             F   +I  GL+ +H   I++RDLKP NI +++   ++I D GLA   P    + G V 
Sbjct: 104 AVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVG 163

Query: 228 TRWYRAPEIMLN 239
           T  Y APE++ N
Sbjct: 164 TVGYMAPEVVKN 175

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 56.2 bits (135), Expect = 7e-09
 Identities = 35/128 (27%), Positives = 66/128 (51%), Gaps = 9/128 (7%)

Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILR-TQKLSDDHVQ 171
           +E+ M+K   H N++     +     L   K    +    G  L +I   T  LS+  + 
Sbjct: 55  QEIIMMKDCKHSNIVAYFGSY-----LRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIA 109

Query: 172 FLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA---RPTENEMTGYVAT 228
           ++  + L+GL Y+HS G +HRD+K +NI + ++  +K+ DFG++     T  +   ++ T
Sbjct: 110 YVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGT 169

Query: 229 RWYRAPEI 236
            ++ APE+
Sbjct: 170 PYWMAPEV 177

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 56.5 bits (136), Expect = 7e-09
 Identities = 36/111 (32%), Positives = 56/111 (50%), Gaps = 9/111 (8%)

Query: 134 HSNTCLADFKNVYMVTHLM-GADL-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIH 191
             ++C      +Y V   + G DL   I +  +  + H  F   +I  GL ++HS GII+
Sbjct: 65  QLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIY 124

Query: 192 RDLKPSNIAVNEDCELKILDFGLARPTENEMTG-----YVATRWYRAPEIM 237
           RDLK  N+ ++ +  +KI DFG+ +  EN   G     +  T  Y APEI+
Sbjct: 125 RDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPEII 173

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 56.2 bits (136), Expect = 8e-09
 Identities = 39/137 (28%), Positives = 63/137 (45%), Gaps = 20/137 (14%)

Query: 93  VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM 152
           VA+K + RP  S    +   +E+++L  ++  N+  LL V     C  D   + M+   M
Sbjct: 49  VAVKVL-RPDASDNAREDFLKEVKILSRLSDPNIARLLGV-----CTVD-PPLCMIMEYM 101

Query: 153 -GADLNNILRTQKLSDDHV---------QFLVY---QILRGLKYIHSAGIIHRDLKPSNI 199
              DLN  L+        +           L+Y   QI  G++Y+ S   +HRDL   N 
Sbjct: 102 ENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161

Query: 200 AVNEDCELKILDFGLAR 216
            V ++  +KI DFG++R
Sbjct: 162 LVGKNYTIKIADFGMSR 178

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 56.2 bits (135), Expect = 8e-09
 Identities = 42/164 (25%), Positives = 73/164 (44%), Gaps = 9/164 (5%)

Query: 66  IDIGPTLSKESFDLIFSSALDSVSGV-KVAIKKIARPFQSAVHAKRTYRELRMLKHMNHE 124
           + +G TL +  F  +    L+    + KVA+K +     +    +    E   +K  +H 
Sbjct: 1   LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60

Query: 125 NVIGLLDVFHSNTCLADFKN-VYMVTHLMGADLNNILRTQKLSDDHV----QFLV---YQ 176
           NV+ L+ V         + + V ++  +   DL++ L   +L D       Q LV     
Sbjct: 61  NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120

Query: 177 ILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN 220
           I  G++Y+ S   IHRDL   N  +NE+  + + DFGL++   N
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYN 164

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 55.9 bits (135), Expect = 8e-09
 Identities = 39/141 (27%), Positives = 61/141 (43%), Gaps = 25/141 (17%)

Query: 93  VAIKKIARPFQSAVHAKRTY-RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHL 151
           VA+K +     ++  A++ + RE  +L +  HEN++    V     C  +     MV   
Sbjct: 38  VAVKTLKET--ASNDARKDFEREAELLTNFQHENIVKFYGV-----CT-EGDPPIMVFEY 89

Query: 152 M-GADLNNILR---------------TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLK 195
           M   DLN  LR                 +L+   +  +  QI  G+ Y+ S   +HRDL 
Sbjct: 90  MEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLA 149

Query: 196 PSNIAVNEDCELKILDFGLAR 216
             N  V  D  +KI DFG++R
Sbjct: 150 TRNCLVGYDLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 56.1 bits (135), Expect = 9e-09
 Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 30/165 (18%)

Query: 238 LNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLA---RPTENEMTGYVATRWYRA 294
           L ++H NQ       +D+K  NI +  D  +K+ DFG      P +++ +  V T ++ A
Sbjct: 128 LEFLHSNQV----IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 183

Query: 295 PEIMLNWMHYNQTDIHQLNLI-MEML-GTPPAEFMAKISSDSARKYINSLPL----LTKK 348
           PE++    +  + DI  L ++ +EM+ G PP              Y+N  PL    L   
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP--------------YLNENPLRALYLIAT 229

Query: 349 DFRQVFKGANPQAI---DLLSLMLELDSEKRITAEQALAHPYLSQ 390
           +     +     +    D L+  LE+D EKR +A++ L HP+L  
Sbjct: 230 NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKI 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 56.2 bits (135), Expect = 9e-09
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 10/158 (6%)

Query: 84  ALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           A D  +   VAIKK++    QS    +   +E+R L+ + H N I          C    
Sbjct: 34  ARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI------QYRGCYLRE 87

Query: 143 KNVYMVTHLMGADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
              ++V        +++L   K  L +  +  + +  L+GL Y+HS  +IHRD+K  NI 
Sbjct: 88  HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNIL 147

Query: 201 VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML 238
           ++E   +K+ DFG A         +V T ++ APE++L
Sbjct: 148 LSEPGLVKLGDFGSAS-IMAPANXFVGTPYWMAPEVIL 184

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 49/159 (30%), Positives = 70/159 (44%), Gaps = 26/159 (16%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           V VAIK + +P  +    +    E  ++   +H N+I L  V      +  FK   ++T 
Sbjct: 34  VAVAIKTL-KPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGV------VTKFKPAMIITE 86

Query: 151 LMGADLNNILRTQKLSDDHVQFLVYQ-------ILRGLKYIHSAGIIHRDLKPSNIAVNE 203
            M     N    + L D   +F  YQ       I  G+KY+     +HRDL   NI VN 
Sbjct: 87  YM----ENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNS 142

Query: 204 DCELKILDFGLARPTENEMTGYVAT-------RWYRAPE 235
           + E K+ DFGL+R  E++  G   T       RW  APE
Sbjct: 143 NLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRW-TAPE 180

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 46/152 (30%), Positives = 75/152 (49%), Gaps = 17/152 (11%)

Query: 92  KVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHL 151
           KVA+K + +P   +V A     E  ++K + H+ ++ L  V      +   + +Y++T  
Sbjct: 32  KVAVKTL-KPGTMSVQA--FLEEANLMKTLQHDKLVRLYAV------VTKEEPIYIITEY 82

Query: 152 MG-ADLNNILRTQKLSDDHVQFLV---YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
           M    L + L++ +     +  L+    QI  G+ YI     IHRDL+ +N+ V+E    
Sbjct: 83  MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMC 142

Query: 208 KILDFGLARPTE-NEMTGYVATRW---YRAPE 235
           KI DFGLAR  E NE T     ++   + APE
Sbjct: 143 KIADFGLARVIEDNEYTAREGAKFPIKWTAPE 174

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 54.7 bits (131), Expect = 2e-08
 Identities = 41/139 (29%), Positives = 65/139 (46%), Gaps = 25/139 (17%)

Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG---------ADLNNILRTQ 163
           +E +++K + HE ++ L  V          + +Y+VT  M           ++   LR  
Sbjct: 50  QEAQVMKKLRHEKLVQLYAVVSE-------EPIYIVTEYMSKGSLLDFLKGEMGKYLRLP 102

Query: 164 KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE-NEM 222
           +L D     +  QI  G+ Y+     +HRDL+ +NI V E+   K+ DFGLAR  E NE 
Sbjct: 103 QLVD-----MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157

Query: 223 TGYVATRW---YRAPEIML 238
           T     ++   + APE  L
Sbjct: 158 TARQGAKFPIKWTAPEAAL 176

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 54.7 bits (131), Expect = 2e-08
 Identities = 48/155 (30%), Positives = 76/155 (49%), Gaps = 18/155 (11%)

Query: 92  KVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHL 151
           KVAIK + +P    +  +   +E +++K + H+ ++ L  V          + +Y+VT  
Sbjct: 32  KVAIKTL-KP--GTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-------EPIYIVTEF 81

Query: 152 MG-ADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
           MG   L + L+    + L    +  +  QI  G+ YI     IHRDL+ +NI V ++   
Sbjct: 82  MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVC 141

Query: 208 KILDFGLARPTE-NEMTGYVATRW---YRAPEIML 238
           KI DFGLAR  E NE T     ++   + APE  L
Sbjct: 142 KIADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 176

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 33/206 (16%)

Query: 141 DFKNVYMVTHLM-GADLNNIL-RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSN 198
           D  N+Y++   + G D+  +L +   L+++  QF + + +  +  IH  G IHRD+KP N
Sbjct: 72  DKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDN 131

Query: 199 IAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVP--FYFQDLK 256
           + ++    +K+ DFGL    +        T +YR      N  H     +P  F FQ++ 
Sbjct: 132 LLLDSKGHVKLSDFGLCTGLKKAHR----TEFYR------NLNH----SLPSDFTFQNMN 177

Query: 257 PSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIM 316
               A       + L F             V T  Y APE+ +   +    D   L +IM
Sbjct: 178 SKRKAETWKRNRRQLAFST-----------VGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226

Query: 317 -EML-GTPPAEFMAKISSDSARKYIN 340
            EML G PP  F ++   ++ +K +N
Sbjct: 227 YEMLIGYPP--FCSETPQETYKKVMN 250

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 40/160 (25%), Positives = 71/160 (44%), Gaps = 20/160 (12%)

Query: 95  IKKIARPFQSAVHAKRTYRELRMLKH------------MNHENVIGLLDVFHSNTCLADF 142
           ++ +       V+A +   +  M+K             M   N   ++ +F++     D 
Sbjct: 59  VQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA---FQDD 115

Query: 143 KNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           + +YMV   M G DL N++    + +   +F   +++  L  IHS G IHRD+KP N+ +
Sbjct: 116 RYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL 175

Query: 202 NEDCELKILDFGLARPTENE----MTGYVATRWYRAPEIM 237
           ++   LK+ DFG       E        V T  Y +PE++
Sbjct: 176 DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 215

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 47/169 (27%), Positives = 83/169 (49%), Gaps = 22/169 (13%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           + VAIK + R   S    K    E  ++  ++H +V+ LL +     CL+    V ++T 
Sbjct: 37  IPVAIKVL-REETSPKANKEILDEAYVMASVDHPHVVRLLGI-----CLS--SQVQLITQ 88

Query: 151 LMGADLNNILRTQKLSDDHV--QFLV---YQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
           LM   L  +L   +   D++  Q+L+    QI +G+ Y+    ++HRDL   N+ V    
Sbjct: 89  LM--PLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQ 146

Query: 206 ELKILDFGLARPTENEMTGYVAT------RWYRAPEIMLNWMHYNQTGV 248
            +KI DFGLA+  + +   Y A       +W  A E +L+ ++ +++ V
Sbjct: 147 HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM-ALESILHRIYTHKSDV 194

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 44/156 (28%), Positives = 71/156 (45%), Gaps = 21/156 (13%)

Query: 91  VKVAIKKIARPFQSAVHAKRTY-RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT 149
           + VAIK + +   S+   +  +  E  ++   +H N+I L  V   +      + V ++T
Sbjct: 33  IDVAIKTL-KA-GSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS------RPVMIIT 84

Query: 150 HLM--GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
             M  G+ L+  LR    K +   +  ++  I  G+KY+     +HRDL   NI VN + 
Sbjct: 85  EYMENGS-LDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNL 143

Query: 206 ELKILDFGLAR------PTENEMTGYVATRWYRAPE 235
             K+ DFGL+R       T     G +  RW  APE
Sbjct: 144 VCKVSDFGLSRRLEDSEATYTTKGGKIPIRW-TAPE 178

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 46/177 (25%), Positives = 80/177 (45%), Gaps = 18/177 (10%)

Query: 71  TLSKESFDLIFSS---ALDSVSGVKVAIKKIARPFQSAVH--AKRTYRELRMLKHMNHEN 125
            + K SF  +  +   A      VKV  KK     +   H  A+R      +LK++ H  
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV----LLKNVKHPF 57

Query: 126 VIGLLDVFHSNTCLADFKNVYMVTHLMGADL-NNILRTQKLSDDHVQFLVYQILRGLKYI 184
           ++GL   F +       K  +++ ++ G +L  ++ R +   +   +F   +I   L Y+
Sbjct: 58  LVGLHYSFQTAD-----KLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYL 112

Query: 185 HSAGIIHRDLKPSNIAVNEDCELKILDFGLAR---PTENEMTGYVATRWYRAPEIML 238
           HS  II+RDLKP NI ++    + + DFGL +         + +  T  Y APE++ 
Sbjct: 113 HSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLR 169

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 42/153 (27%), Positives = 74/153 (48%), Gaps = 15/153 (9%)

Query: 90  GVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT 149
           G KVA+K I    ++   A+    E  ++  + H N++ LL V      + +   +Y+VT
Sbjct: 29  GNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLGVI-----VEEKGGLYIVT 79

Query: 150 HLMG-ADLNNILRTQK---LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
             M    L + LR++    L  D +      +   ++Y+ +   +HRDL   N+ V+ED 
Sbjct: 80  EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN 139

Query: 206 ELKILDFGLARP-TENEMTGYVATRWYRAPEIM 237
             K+ DFGL +  +  + TG +  +W  APE +
Sbjct: 140 VAKVSDFGLTKEASSTQDTGKLPVKW-TAPEAL 171

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 44/154 (28%), Positives = 75/154 (48%), Gaps = 15/154 (9%)

Query: 90  GVKVAIKKIA--RPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYM 147
            VKV  KKI   R  Q  + A+R      +LK++ H  ++GL   F +       K  ++
Sbjct: 24  AVKVLQKKIVLNRKEQKHIMAERNV----LLKNVKHPFLVGLHYSFQTTE-----KLYFV 74

Query: 148 VTHLMGADLN-NILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE 206
           +  + G +L  ++ R +   +   +F   +I   L Y+HS  I++RDLKP NI ++    
Sbjct: 75  LDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGH 134

Query: 207 LKILDFGLAR---PTENEMTGYVATRWYRAPEIM 237
           + + DFGL +      +  T +  T  Y APE++
Sbjct: 135 VVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVI 168

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 41/153 (26%), Positives = 77/153 (50%), Gaps = 15/153 (9%)

Query: 91  VKVAIKK--IARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           VKV  KK  + +  Q+ + A+R      +LK++ H  ++GL   F +       K  +++
Sbjct: 25  VKVLQKKTILKKKEQNHIMAERNV----LLKNLKHPFLVGLHYSFQTAE-----KLYFVL 75

Query: 149 THLMGADLN-NILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
            ++ G +L  ++ R +   +   +F   ++   + Y+HS  II+RDLKP NI ++    +
Sbjct: 76  DYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHV 135

Query: 208 KILDFGLAR---PTENEMTGYVATRWYRAPEIM 237
            + DFGL +     E   + +  T  Y APE++
Sbjct: 136 VLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVL 168

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 54.3 bits (130), Expect = 3e-08
 Identities = 27/70 (38%), Positives = 40/70 (57%), Gaps = 2/70 (2%)

Query: 172 FLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR--PTENEMTGYVATR 229
           F   +I  GL+ +H   I++RDLKP NI +++   ++I D GLA   P    + G V T 
Sbjct: 106 FYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTV 165

Query: 230 WYRAPEIMLN 239
            Y APE++ N
Sbjct: 166 GYMAPEVVKN 175

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 55.3 bits (133), Expect = 3e-08
 Identities = 29/79 (36%), Positives = 48/79 (60%), Gaps = 2/79 (2%)

Query: 144 NVYMVT-HLMGADLNNILRTQKLSD-DHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           NVY+V  +L+G D+ ++L      D +     + ++   L Y+H  GIIHRDLKP N+ +
Sbjct: 78  NVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI 137

Query: 202 NEDCELKILDFGLARPTEN 220
           + +  +K+ DFGL++ T N
Sbjct: 138 SNEGHIKLTDFGLSKVTLN 156

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 54.7 bits (132), Expect = 3e-08
 Identities = 33/126 (26%), Positives = 56/126 (44%), Gaps = 18/126 (14%)

Query: 121 MNHENVIGLLDVFHSNTCLADFKNVYMVT-HLMGADLNNILRTQKLSDDHVQFLVYQILR 179
             H  ++ L   F +        +V  V  +  G DL   + T   S+    F    ++ 
Sbjct: 59  ERHPFLVNLFACFQTED------HVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVL 112

Query: 180 GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGY-------VATRWYR 232
           GL+Y+H   I++RDLK  N+ ++ +  +KI DFGL +    E  G+         T  + 
Sbjct: 113 GLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCK----EGMGFGDRTSTFCGTPEFL 168

Query: 233 APEIML 238
           APE++ 
Sbjct: 169 APEVLT 174

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 71/324 (21%), Positives = 122/324 (37%), Gaps = 79/324 (24%)

Query: 82  SSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD 141
              L   +GV +A+K+I      +    +   EL +L       ++     F        
Sbjct: 18  YKVLHRPTGVTMAMKEIRLELDES-KFNQIIMELDILHKAVSPYIVDFYGAFFIEGA--- 73

Query: 142 FKNVYMVTHLM-GADLNNI----LRTQKLSDDHVQFLVYQILRGLKYIHSA-GIIHRDLK 195
              VYM    M    L+ +    + T+ + +D ++ + Y +++GLK++     IIHRD+K
Sbjct: 74  ---VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVK 130

Query: 196 PSNIAVNEDCELKILDFGLARPTENEMTGY-VATRWYRAPEIMLNWMHYNQTGVPFYFQD 254
           P+N+ VN + ++K+ DFG++      +    +  + Y APE + +         P Y   
Sbjct: 131 PTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKS---GGPNQNPTY--- 184

Query: 255 LKPSNIAVNEDC---ELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
                  V  D     L IL+  L              R+   PE   N          Q
Sbjct: 185 ------TVQSDVWSLGLSILEMALG-------------RYPYPPETYANIF-------AQ 218

Query: 312 LNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLEL 371
           L+ I++  G PP                 +LP            G +  A D ++  L  
Sbjct: 219 LSAIVD--GDPP-----------------TLP-----------SGYSDDAQDFVAKCLNK 248

Query: 372 DSEKRITAEQALAHPYLSQYSDPN 395
              +R T  Q L HP+L +Y + +
Sbjct: 249 IPNRRPTYAQLLEHPWLVKYKNAD 272

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 39/140 (27%), Positives = 67/140 (47%), Gaps = 21/140 (15%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           V VA+K + R   +        +E++++  + + N+I LL V     C++D   + M+T 
Sbjct: 45  VLVAVKML-RADVTKTARNDFLKEIKIMSRLKNPNIIRLLGV-----CVSD-DPLCMITE 97

Query: 151 LM-GADLNNILRTQKL-------------SDDHVQFLVYQILRGLKYIHSAGIIHRDLKP 196
            M   DLN  L  +++             S  ++ ++  QI  G+KY+ S   +HRDL  
Sbjct: 98  YMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLAT 157

Query: 197 SNIAVNEDCELKILDFGLAR 216
            N  V     +KI DFG++R
Sbjct: 158 RNCLVGNHYTIKIADFGMSR 177

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 53.8 bits (130), Expect = 4e-08
 Identities = 47/152 (30%), Positives = 68/152 (44%), Gaps = 24/152 (15%)

Query: 254 DLKPSNIAVNEDCELKILDFGLAR-----------PTENEMTGYVATRWYRAPEIMLNWM 302
           DLKP NI ++ +  LK+ DFGL++             E E    V T  Y APE++L   
Sbjct: 118 DLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG 177

Query: 303 HYNQTDIHQLNLIM-EML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQ 360
           H    D   L  I+ E L G PP  F      ++  +   +  +L  K         + +
Sbjct: 178 HSKTVDWWSLGCILYEFLVGIPP--FHG----ETPEEIFQN--ILNGKIEWPEDVEVSDE 229

Query: 361 AIDLLSLMLELDSEKRITA---EQALAHPYLS 389
           AIDL+S +L  D EKR+ A   E+   HP+  
Sbjct: 230 AIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 53.6 bits (129), Expect = 4e-08
 Identities = 38/159 (23%), Positives = 70/159 (44%), Gaps = 23/159 (14%)

Query: 238 LNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTE--NEMTGYVATRWYRAP 295
           L ++H   T      +D+K +NI V+ +  +K+ DFG+A+     +    +  + ++ AP
Sbjct: 115 LEYLHDRNT----VHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAP 170

Query: 296 EIMLNWMHYN-QTDIHQLN-LIMEML-GTPP---AEFMAKISSDSARKYINSLPLLTKKD 349
           E++     Y    DI  L   ++EM  G PP    E +A +             +   K+
Sbjct: 171 EVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV-----------FKIGRSKE 219

Query: 350 FRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYL 388
              +    + +A D +   L+ D   R TA + L HP++
Sbjct: 220 LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 38/128 (29%), Positives = 64/128 (50%), Gaps = 13/128 (10%)

Query: 121 MNHENVIGLLD----VFHSNTCLADFKNVYMVT-HLMGADL-NNILRTQKLSDDHVQFLV 174
           M  + V+ L D    +   ++C      +Y V  ++ G DL  +I +  K  +    F  
Sbjct: 48  MVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYA 107

Query: 175 YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTG-----YVATR 229
            +I  GL ++H  GII+RDLK  N+ ++ +  +KI DFG+ +  E+ + G     +  T 
Sbjct: 108 AEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTP 165

Query: 230 WYRAPEIM 237
            Y APEI+
Sbjct: 166 DYIAPEII 173

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 53.8 bits (129), Expect = 4e-08
 Identities = 31/102 (30%), Positives = 58/102 (56%), Gaps = 2/102 (1%)

Query: 153 GADLNNILRTQKL-SDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILD 211
           G DL+  L    + S+  ++F   +I+ GL+++H+  +++RDLKP+NI ++E   ++I D
Sbjct: 81  GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISD 140

Query: 212 FGLARP-TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYF 252
            GLA   ++ +    V T  Y APE++   + Y+ +   F  
Sbjct: 141 LGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSL 182

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 54.0 bits (130), Expect = 5e-08
 Identities = 62/208 (29%), Positives = 93/208 (44%), Gaps = 42/208 (20%)

Query: 235 EIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPT--ENEMT-GYVATRW 291
           EI L   H +Q G+   ++DLKP NI ++    +K+ DFGL + +  E  +T  +  T  
Sbjct: 108 EISLALEHLHQQGI--IYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIE 165

Query: 292 YRAPEIMLNWMHYNQTDIHQLNLIM-EML-GTPP--AEFMAKISSDSARKYINSLPLLTK 347
           Y APEI++   H    D   L  +M +ML G PP  AE   K      +  +N  P LT 
Sbjct: 166 YMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLT- 224

Query: 348 KDFRQVFKGANPQAIDLLSLMLELDSEKRI-----TAEQALAHPYLSQYSDPND------ 396
                      P+A DLL  +L+ +   R+      A +  +HP+  ++ + +D      
Sbjct: 225 -----------PEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF-RHVNWDDLLARKV 272

Query: 397 EPTSPPYDQSFEDMDL---------PVD 415
           EP   P  QS ED+           PVD
Sbjct: 273 EPPFKPLLQSEEDVSQFDSKFTRQTPVD 300

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 53.9 bits (129), Expect = 5e-08
 Identities = 39/146 (26%), Positives = 68/146 (46%), Gaps = 10/146 (6%)

Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEM---TGYVATRWYRAPEIMLNWMHYNQTDI 309
           +D+K  +I +  D  +K+ DFG       ++      V T ++ APE++    +  + DI
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDI 200

Query: 310 HQLN-LIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLM 368
             L  +++EM+   P  F    S   A K +   P    K+  ++    +P   D L  M
Sbjct: 201 WSLGIMVIEMVDGEPPYFSD--SPVQAMKRLRDSPPPKLKNAHKI----SPVLRDFLERM 254

Query: 369 LELDSEKRITAEQALAHPYLSQYSDP 394
           L  + ++R TA++ L HP+L Q   P
Sbjct: 255 LTREPQERATAQELLDHPFLLQTGLP 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 54.3 bits (130), Expect = 5e-08
 Identities = 45/164 (27%), Positives = 81/164 (49%), Gaps = 25/164 (15%)

Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLN-NILRTQKLSDDH 169
           T  E R+L++  H  +  L   F ++  L      +++ +  G +L  ++ R +  S+D 
Sbjct: 42  TLTENRVLQNSRHPFLTALKYSFQTHDRLC-----FVMEYANGGELFFHLSRERVFSEDR 96

Query: 170 VQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDCELKILDFGLARPTENE---MTGY 225
            +F   +I+  L Y+HS   +++RDLK  N+ +++D  +KI DFGL +    +   M  +
Sbjct: 97  ARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF 156

Query: 226 VATRWYRAPEIM--------LNW------MHYNQTG-VPFYFQD 254
             T  Y APE++        ++W      M+    G +PFY QD
Sbjct: 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 53.2 bits (128), Expect = 7e-08
 Identities = 36/121 (29%), Positives = 52/121 (42%), Gaps = 22/121 (18%)

Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNIL------------ 160
           +E  ++  + H N++ LL V     C  +     +  +L   DL+  L            
Sbjct: 57  QEAELMSDLQHPNIVCLLGV-----CTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAE 111

Query: 161 ---RTQKLSDDHVQFL--VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 215
               T K S D   FL    QI  G++Y+ S   +HRDL   N  V E   +KI DFGL+
Sbjct: 112 SGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLS 171

Query: 216 R 216
           R
Sbjct: 172 R 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 53.1 bits (127), Expect = 7e-08
 Identities = 42/157 (26%), Positives = 78/157 (49%), Gaps = 14/157 (8%)

Query: 88  VSGVKVAIKKIA-RPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVY 146
           + GV VA+KK+       A       +E+ +LK +NH NVI     ++++    +  N+ 
Sbjct: 25  LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK----YYASFIEDNELNIV 80

Query: 147 MVTHLMGADLNNILRTQK-----LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           +     G DL+ +++  K     + +  V     Q+   L+++HS  ++HRD+KP+N+ +
Sbjct: 81  LELADAG-DLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI 139

Query: 202 NEDCELKILDFGLARPTENEMTG---YVATRWYRAPE 235
                +K+ D GL R   ++ T     V T +Y +PE
Sbjct: 140 TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 53.1 bits (127), Expect = 7e-08
 Identities = 31/107 (28%), Positives = 61/107 (57%), Gaps = 2/107 (1%)

Query: 143 KNVYMVTHLMGADLNNILRTQKL-SDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           K  +++  + G DL+  L    + S+  ++F   +I+ GL+++H+  +++RDLKP+NI +
Sbjct: 71  KLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL 130

Query: 202 NEDCELKILDFGLARP-TENEMTGYVATRWYRAPEIMLNWMHYNQTG 247
           +E   ++I D GLA   ++ +    V T  Y APE++     Y+ + 
Sbjct: 131 DEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSA 177

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 53.3 bits (128), Expect = 7e-08
 Identities = 25/95 (26%), Positives = 48/95 (50%), Gaps = 12/95 (12%)

Query: 147 MVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE 206
           + THL         + +  ++  V+  + +I+  L ++H  GII+RD+K  NI ++ +  
Sbjct: 92  LFTHLY--------QREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGH 143

Query: 207 LKILDFGLAR----PTENEMTGYVATRWYRAPEIM 237
           + + DFGL++      E     +  T  Y APE++
Sbjct: 144 VVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVI 178

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 53.9 bits (129), Expect = 8e-08
 Identities = 30/93 (32%), Positives = 48/93 (51%), Gaps = 6/93 (6%)

Query: 170 VQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP-----TENEMTG 224
           ++ ++ Q+L GL+ +H  GI+HRD+KP N+ V  D ++KI+DFG A         N + G
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYG 370

Query: 225 YVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            +  R Y  PE ++      +   P     L P
Sbjct: 371 MLDPR-YSPPEELVMPQSCPRAPAPAMAALLSP 402

Length = 507

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 52.8 bits (127), Expect = 8e-08
 Identities = 37/109 (33%), Positives = 55/109 (50%), Gaps = 13/109 (11%)

Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHL--MGADLNNILRTQKLSDDHV 170
           +E  ++  ++HEN+I L  V  +         + MVT L  +G+ L+  LR   L    +
Sbjct: 45  KEAAIMHSLDHENLIRLYGVVLT-------HPLMMVTELAPLGSLLDR-LRKDALGHFLI 96

Query: 171 QFL---VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
             L     QI  G++Y+ S   IHRDL   NI +  D ++KI DFGL R
Sbjct: 97  STLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMR 145

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 53.1 bits (127), Expect = 8e-08
 Identities = 40/146 (27%), Positives = 76/146 (52%), Gaps = 16/146 (10%)

Query: 112 YRELRMLKHMNHENVIGLLDVFH-SNTCLA-------DFKNVYMVTHLMGADLNNILRTQ 163
           Y  L+ L   NH NV+    +F+ ++  +        +  N   VT L+   L   +  Q
Sbjct: 69  YNILQSLP--NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLL---ICGQ 123

Query: 164 KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL-ARPTENEM 222
           +L +  + +++Y  L GL+++H+  IIHRD+K +NI +  +  +K++DFG+ A+ T   +
Sbjct: 124 RLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 183

Query: 223 --TGYVATRWYRAPEIMLNWMHYNQT 246
                V T ++ APE++     Y+ +
Sbjct: 184 RRNTSVGTPFWMAPEVIACEQQYDYS 209

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 53.1 bits (128), Expect = 8e-08
 Identities = 33/120 (27%), Positives = 58/120 (48%), Gaps = 10/120 (8%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           +   VA+KKI     S    K   +E+   + + H N++  +      T       +Y+V
Sbjct: 24  TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV------TSFIVDSELYVV 77

Query: 149 THLMG-ADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED 204
           + LM      ++L+T   + L +  + F++  +L  L YIHS G IHR +K S+I ++ D
Sbjct: 78  SPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGD 137

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 53.7 bits (129), Expect = 8e-08
 Identities = 37/131 (28%), Positives = 61/131 (46%), Gaps = 12/131 (9%)

Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADL-NNILRTQKLSDDHVQ 171
           RE+ +LK ++H  +I L+  +   +       V MV      DL   + R+  L  +   
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKST------VCMVMPKYKCDLFTYVDRSGPLPLEQAI 188

Query: 172 FLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-----RPTENEMTGYV 226
            +  ++L  L Y+H  GIIHRD+K  NI ++E     + DFG A      P   +  G+ 
Sbjct: 189 TIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWS 248

Query: 227 ATRWYRAPEIM 237
            T    +PE++
Sbjct: 249 GTLETNSPELL 259

Length = 392

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 52.8 bits (126), Expect = 9e-08
 Identities = 45/165 (27%), Positives = 80/165 (48%), Gaps = 34/165 (20%)

Query: 238 LNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLA---RPTENEMTGYVATRWYRA 294
           L+++H NQ       +D+K  NI +  D  +K+ DFG      P +++ +  V T ++ A
Sbjct: 128 LDFLHSNQV----IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 183

Query: 295 PEIMLNWMHYNQTDIHQLNLI-MEML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQ 352
           PE++    +  + DI  L ++ +EM+ G PP              Y+N  PL  +  +  
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP--------------YLNENPL--RALYLI 227

Query: 353 VFKGA----NPQAI-----DLLSLMLELDSEKRITAEQALAHPYL 388
              G     NP+ +     D L+  LE+D ++R +A++ L HP+L
Sbjct: 228 ATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 52.9 bits (127), Expect = 9e-08
 Identities = 33/108 (30%), Positives = 59/108 (54%), Gaps = 10/108 (9%)

Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV-THLMGADLNNILRTQKLSDDHVQ 171
           +E  ++K  +H NV+ LL +     CL    +  +V  ++   DL N +R++   +  V+
Sbjct: 45  KEGIIMKDFSHPNVLSLLGI-----CLPSEGSPLVVLPYMKHGDLRNFIRSET-HNPTVK 98

Query: 172 FLV---YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
            L+    Q+ +G++Y+ S   +HRDL   N  ++E   +K+ DFGLAR
Sbjct: 99  DLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLAR 146

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 52.8 bits (126), Expect = 1e-07
 Identities = 46/165 (27%), Positives = 79/165 (47%), Gaps = 34/165 (20%)

Query: 238 LNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLA---RPTENEMTGYVATRWYRA 294
           L ++H NQ       +D+K  N+ +  D  +K+ DFG      P +++ +  V T ++ A
Sbjct: 128 LEFLHANQV----IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 183

Query: 295 PEIMLNWMHYNQTDIHQLNLI-MEML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQ 352
           PE++    +  + DI  L ++ +EM+ G PP              Y+N  PL  +  +  
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP--------------YLNENPL--RALYLI 227

Query: 353 VFKGA----NPQAI-----DLLSLMLELDSEKRITAEQALAHPYL 388
              G     NP+ +     D L+  LE+D EKR +A++ L HP+L
Sbjct: 228 ATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 41/157 (26%), Positives = 72/157 (45%), Gaps = 16/157 (10%)

Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEM-TGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           +D+KPSN+ VN   ++K+ DFG++    N +   YV T  Y APE +    +   +D+  
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWS 178

Query: 312 LNL-IMEM-LGT-PPAEFMAKISSDSARKYINSL-----PLLTKKDFRQVFKGANPQAID 363
           L +  ME+ LG  P  +      S    + +  +     P+L    F + F       + 
Sbjct: 179 LGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKF-------VH 231

Query: 364 LLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTS 400
            ++  +    ++R   E  + HP++ QY+D N E  S
Sbjct: 232 FITQCMRKQPKERPAPENLMDHPFIVQYNDGNAEVVS 268

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 52.6 bits (126), Expect = 1e-07
 Identities = 45/138 (32%), Positives = 62/138 (44%), Gaps = 27/138 (19%)

Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQ 171
            E  ++   +H N+I L  V      +   K V +VT  M    L+  LR         Q
Sbjct: 54  SEASIMGQFDHPNIIHLEGV------VTKSKPVMIVTEYMENGSLDAFLRKHD-----GQ 102

Query: 172 FLVYQ---ILRG----LKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE--- 221
           F V Q   +LRG    +KY+   G +HRDL   NI VN +   K+ DFGL+R  E++   
Sbjct: 103 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 162

Query: 222 ----MTGYVATRWYRAPE 235
                 G +  RW  APE
Sbjct: 163 AYTTRGGKIPIRW-TAPE 179

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 43/153 (28%), Positives = 72/153 (47%), Gaps = 16/153 (10%)

Query: 93  VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM 152
           VAIK I    + ++       E +++  ++HE ++ L  V     C    + +Y+VT  M
Sbjct: 31  VAIKMIK---EGSMSEDEFIEEAKVMMKLSHEKLVQLYGV-----CTKQ-RPIYIVTEYM 81

Query: 153 GAD-LNNILRTQKLSDDHVQFL--VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKI 209
               L N LR         Q L     +  G+ Y+ S   IHRDL   N  V++   +K+
Sbjct: 82  SNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKV 141

Query: 210 LDFGLARPT-ENEMTGYVATRW---YRAPEIML 238
            DFGL+R   ++E T  V +++   +  PE++L
Sbjct: 142 SDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLL 174

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 49/215 (22%), Positives = 86/215 (40%), Gaps = 40/215 (18%)

Query: 68  IGPTLSKESFDLI---FSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHE 124
           +G TL +  F  +    +  L   +G      K+ +   S+   +    E  +LK +NH 
Sbjct: 4   LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHP 63

Query: 125 NVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQK---------------LSDDH 169
           +VI L        C  D   + +V +     L + LR  +                  D+
Sbjct: 64  HVIKLY-----GACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118

Query: 170 ----------VQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE 219
                     +    +QI RG++Y+    ++HRDL   N+ V E  ++KI DFGL+R   
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVY 178

Query: 220 NEMT------GYVATRWYRAPEIMLNWMHYNQTGV 248
            E +      G +  +W  A E + + ++  Q+ V
Sbjct: 179 EEDSYVKRSKGRIPVKWM-AIESLFDHIYTTQSDV 212

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 12/95 (12%)

Query: 147 MVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE 206
           M THL         +    S+D V+F   +I+  L+++H  GI++RD+K  NI ++ +  
Sbjct: 92  MFTHLY--------QRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGH 143

Query: 207 LKILDFGLAR---PTENEMT-GYVATRWYRAPEIM 237
           + + DFGL++     E E T  +  T  Y APEI+
Sbjct: 144 VVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 38/147 (25%), Positives = 75/147 (51%), Gaps = 11/147 (7%)

Query: 97  KIARPFQSAVHAKRTYRELRMLKHMNHEN-VIGLLDVFHSNTCLADFKNVYMVTHLMGAD 155
           K A   Q A   + T  E ++L+H+     ++ L   F ++T L       ++ ++ G +
Sbjct: 37  KKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH-----LILDYINGGE 91

Query: 156 L-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL 214
           L  ++ + ++  +  VQ    +I+  L+++H  GII+RD+K  NI ++ +  + + DFGL
Sbjct: 92  LFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL 151

Query: 215 AR---PTENEMT-GYVATRWYRAPEIM 237
           ++     E E    +  T  Y AP+I+
Sbjct: 152 SKEFHEDEVERAYSFCGTIEYMAPDIV 178

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 45/184 (24%), Positives = 94/184 (51%), Gaps = 21/184 (11%)

Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHEN 125
           +I  T+ K ++  +F   L+  +G K A+K I  P       +    E  +LK + +H N
Sbjct: 21  EIIETIGKGTYGKVFK-VLNKKNGSKAAVK-ILDPIHDI--DEEIEAEYNILKALSDHPN 76

Query: 126 VIGLLDVFHSNTCLADFKN---VYMVTHLM-GADLNNIL-----RTQKLSDDHVQFLVYQ 176
           V+    +++      D KN   +++V  L  G  + +++     R +++ +  + +++++
Sbjct: 77  VVKFYGMYYKK----DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132

Query: 177 ILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA---RPTENEMTGYVATRWYRA 233
            L GL+++H    IHRD+K +NI +  +  +K++DFG++     T       V T ++ A
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMA 192

Query: 234 PEIM 237
           PE++
Sbjct: 193 PEVI 196

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 52.6 bits (126), Expect = 1e-07
 Identities = 26/89 (29%), Positives = 47/89 (52%), Gaps = 4/89 (4%)

Query: 153 GADLN-NILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILD 211
           G DL  +I ++++  +   +F   +I   L ++H  GII+RDLK  N+ ++ +   K+ D
Sbjct: 80  GGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLAD 139

Query: 212 FGLARPTENE---MTGYVATRWYRAPEIM 237
           FG+ +         + +  T  Y APEI+
Sbjct: 140 FGMCKEGIFNGKTTSTFCGTPDYIAPEIL 168

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 38/128 (29%), Positives = 59/128 (46%), Gaps = 12/128 (9%)

Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP NI ++++  +K+ DFG A+   +       T  Y APE++ +  H    D   
Sbjct: 124 YRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWA 183

Query: 312 LN-LIMEML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLML 369
           L  LI EML G PP  F          K      L  K +F +     +  A DL+  +L
Sbjct: 184 LGILIYEMLVGYPP--FFDDNPFGIYEKI-----LAGKLEFPRHL---DLYAKDLIKKLL 233

Query: 370 ELDSEKRI 377
            +D  +R+
Sbjct: 234 VVDRTRRL 241

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 38/153 (24%), Positives = 65/153 (42%), Gaps = 24/153 (15%)

Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEM---TGYVATRWYRAPEIMLNWMHYNQTDI 309
           +D+K  +I +  D  +K+ DFG       E+      V T ++ APE++    +  + DI
Sbjct: 139 RDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDI 198

Query: 310 HQLN-LIMEML-------GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQA 361
             L  +++EM+         PP + M +I  +   K  N                 +P+ 
Sbjct: 199 WSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNL-------------HKVSPRL 245

Query: 362 IDLLSLMLELDSEKRITAEQALAHPYLSQYSDP 394
              L  ML  D  +R TA + L HP+L++   P
Sbjct: 246 RSFLDRMLVRDPAQRATAAELLNHPFLAKAGPP 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 23/62 (37%), Positives = 40/62 (64%), Gaps = 3/62 (4%)

Query: 177 ILRGLKYIHSA-GIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM--TGYVATRWYRA 233
           I++ L+Y+HS   +IHRD+KPSN+ +N + ++K+ DFG++    + +  T     + Y A
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMA 171

Query: 234 PE 235
           PE
Sbjct: 172 PE 173

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 39/130 (30%), Positives = 62/130 (47%), Gaps = 12/130 (9%)

Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLN-NILR--TQKLSDDH 169
           E  +L+ +N   ++ L   F S T L       +V  LM G DL  +I     + L  + 
Sbjct: 43  EKEILEKVNSPFIVNLAYAFESKTHLC------LVMSLMNGGDLKYHIYNVGERGLEMER 96

Query: 170 VQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA--RPTENEMTGYVA 227
           V     QI  G+ ++HS  I++RD+KP N+ +++    ++ D GLA        +T    
Sbjct: 97  VIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAG 156

Query: 228 TRWYRAPEIM 237
           T  Y APEI+
Sbjct: 157 TNGYMAPEIL 166

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 34/109 (31%), Positives = 54/109 (49%), Gaps = 12/109 (11%)

Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDDHV 170
           +E  ++K + H N++ LL V    T    F   Y++T  M  G  L+ +    +   + V
Sbjct: 51  KEAAVMKEIKHPNLVQLLGVC---TREPPF---YIITEFMTYGNLLDYLRECNRQEVNAV 104

Query: 171 QFLVY---QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
             L+Y   QI   ++Y+     IHRDL   N  V E+  +K+ DFGL+R
Sbjct: 105 -VLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 152

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 44/145 (30%), Positives = 66/145 (45%), Gaps = 28/145 (19%)

Query: 93  VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM 152
           VA+K I RP  +        +E+++L  +   N+I LL V     C+ +   + M+T  M
Sbjct: 49  VAVK-ILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGV-----CVDE-DPLCMITEYM 101

Query: 153 -GADLNNILRTQKLSD-----------DH------VQFLVY---QILRGLKYIHSAGIIH 191
              DLN  L +  L D            H         L++   QI  G+KY+ S   +H
Sbjct: 102 ENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161

Query: 192 RDLKPSNIAVNEDCELKILDFGLAR 216
           RDL   N  V E+  +KI DFG++R
Sbjct: 162 RDLATRNCLVGENLTIKIADFGMSR 186

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 42/152 (27%), Positives = 70/152 (46%), Gaps = 20/152 (13%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF--KNVY 146
           +G  VA+K + R      +     +E+ +LK + HEN++          C ++   K + 
Sbjct: 32  TGEMVAVKTLKRE-CGQQNTSGWKKEINILKTLYHENIV------KYKGCCSEQGGKGLQ 84

Query: 147 MVTHLMG-ADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
           ++   +    L + L   KL+   +     QI  G+ Y+HS   IHRDL   N+ ++ D 
Sbjct: 85  LIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR 144

Query: 206 ELKILDFGLAR--PTENEMTGYVATRWYRAPE 235
            +KI DFGLA+  P  +E        +YR  E
Sbjct: 145 LVKIGDFGLAKAVPEGHE--------YYRVRE 168

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 35/131 (26%), Positives = 69/131 (52%), Gaps = 11/131 (8%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELR-MLKHMNHENVIGLLDVFHSNTCLADFKNVYM 147
           +G  +A+K++ R   +    KR   +L  +LK  +   ++     F +++      +V++
Sbjct: 39  TGHVMAVKQMRRT-GNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS------DVFI 91

Query: 148 VTHLMGADLNNIL-RTQK-LSDDHVQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNED 204
              LM   L+ +L R Q  + +D +  +   I++ L Y+    G+IHRD+KPSNI ++  
Sbjct: 92  CMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDAS 151

Query: 205 CELKILDFGLA 215
             +K+ DFG++
Sbjct: 152 GNVKLCDFGIS 162

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 38/153 (24%), Positives = 71/153 (46%), Gaps = 16/153 (10%)

Query: 92  KVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHL 151
           KVAIK I     S         E +++  ++H  ++ L  V    +       + +V   
Sbjct: 30  KVAIKTIREGAMSEEDFIE---EAQVMMKLSHPKLVQLYGVCTERS------PICLVFEF 80

Query: 152 M-GADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELK 208
           M    L++ LR Q+   S + +  +   +  G+ Y+ S+ +IHRDL   N  V E+  +K
Sbjct: 81  MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVK 140

Query: 209 ILDFGLARPT-ENEMTGYVATRW---YRAPEIM 237
           + DFG+ R   +++ T    T++   + +PE+ 
Sbjct: 141 VSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVF 173

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 47/160 (29%), Positives = 75/160 (46%), Gaps = 28/160 (17%)

Query: 92  KVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHL 151
           KVA+K + +P    +  +    E +++K + H+ ++ L  V          + +Y+VT  
Sbjct: 32  KVAVKTL-KP--GTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE-------EPIYIVTEY 81

Query: 152 M--GADLNNI-------LRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
           M  G+ L+ +       L+   L D     +  Q+  G+ YI     IHRDL+ +NI V 
Sbjct: 82  MSKGSLLDFLKDGEGRALKLPNLVD-----MAAQVAAGMAYIERMNYIHRDLRSANILVG 136

Query: 203 EDCELKILDFGLARPTE-NEMTGYVATRW---YRAPEIML 238
           +    KI DFGLAR  E NE T     ++   + APE  L
Sbjct: 137 DGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 176

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 51.8 bits (124), Expect = 3e-07
 Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 8/98 (8%)

Query: 146 YMVTHLMGADLN-NILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED 204
           +++ ++ G DL   I R++K  +   +F   ++   L ++H  G+I+RDLK  NI ++ +
Sbjct: 73  FVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE 132

Query: 205 CELKILDFGLARPTENEMTGYVATRW-----YRAPEIM 237
              K+ DFG+ +  E  + G   T +     Y APEI+
Sbjct: 133 GHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEIL 168

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 51.0 bits (122), Expect = 3e-07
 Identities = 38/159 (23%), Positives = 69/159 (43%), Gaps = 10/159 (6%)

Query: 68  IGPTLSKESFDLIFSSAL--DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHEN 125
           +G  L +  F  +    L  D  S +KVA+K +     +    +    E   +K  +H N
Sbjct: 3   LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPN 62

Query: 126 VIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDDHVQFLVYQILR----- 179
           V+ L+ V    + L       ++   M   DL++ L   +L     +  +  +L+     
Sbjct: 63  VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI 122

Query: 180 --GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
             G++Y+ +   IHRDL   N  + ED  + + DFGL++
Sbjct: 123 ALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 30/70 (42%), Positives = 42/70 (60%), Gaps = 4/70 (5%)

Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEMTG-YVATRWYRAPEIMLNWMHYN-QTDIH 310
           +D+KPSNI VN   E+K+ DFG++    + M   +V TR Y +PE  L   HY  Q+DI 
Sbjct: 124 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE-RLQGTHYTVQSDIW 182

Query: 311 QLNL-IMEML 319
            L L ++EM 
Sbjct: 183 SLGLSLVEMA 192

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 51.0 bits (122), Expect = 4e-07
 Identities = 52/178 (29%), Positives = 81/178 (45%), Gaps = 28/178 (15%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           ++VA+K + R   +    K   +E  ++ + NH N++ LL V     CL   +  Y++  
Sbjct: 27  IRVAVKTL-RKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGV-----CL-LNEPQYIIME 79

Query: 151 LM-GADLNNILRTQK--------LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           LM G DL + LR  +        L+   +  +   + +G  Y+     IHRDL   N  V
Sbjct: 80  LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLV 139

Query: 202 NE---DCE--LKILDFGLARPT------ENEMTGYVATRWYRAPEIMLNWMHYNQTGV 248
           +E   D +  +KI DFGLAR          E  G +  RW  APE +L+     Q+ V
Sbjct: 140 SEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWM-APESLLDGKFTTQSDV 196

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 51.2 bits (122), Expect = 5e-07
 Identities = 33/125 (26%), Positives = 63/125 (50%), Gaps = 9/125 (7%)

Query: 117 MLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADL-NNILRTQKLSDDHVQFLVY 175
           +LK++ H  ++GL   F +   L      +++ ++ G +L  ++ R +   +   +F   
Sbjct: 49  LLKNVKHPFLVGLHFSFQTADKL-----YFVLDYINGGELFYHLQRERCFLEPRARFYAA 103

Query: 176 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT---ENEMTGYVATRWYR 232
           +I   L Y+HS  I++RDLKP NI ++    + + DFGL +         + +  T  Y 
Sbjct: 104 EIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYL 163

Query: 233 APEIM 237
           APE++
Sbjct: 164 APEVL 168

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 50.4 bits (120), Expect = 5e-07
 Identities = 46/152 (30%), Positives = 74/152 (48%), Gaps = 18/152 (11%)

Query: 92  KVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHL 151
           KVA+K + +P   +V A     E  ++K + H+ ++ L  V          + +Y++T  
Sbjct: 32  KVAVKTM-KPGSMSVEA--FLAEANVMKTLQHDKLVKLHAVVTK-------EPIYIITEF 81

Query: 152 M-GADLNNILRTQKLSDDHVQFLV---YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
           M    L + L++ + S   +  L+    QI  G+ +I     IHRDL+ +NI V+     
Sbjct: 82  MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVC 141

Query: 208 KILDFGLARPTE-NEMTGYVATRW---YRAPE 235
           KI DFGLAR  E NE T     ++   + APE
Sbjct: 142 KIADFGLARVIEDNEYTAREGAKFPIKWTAPE 173

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 50.4 bits (120), Expect = 6e-07
 Identities = 39/149 (26%), Positives = 69/149 (46%), Gaps = 17/149 (11%)

Query: 252 FQDLKPSNIAVNEDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIMLNWMHYNQTDI 309
           ++DLKP NI +++   ++I D GLA   P    + G V T  Y APE++ N  +    D 
Sbjct: 125 YRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDW 184

Query: 310 HQLN-LIMEMLG--TPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLS 366
             L  L+ EM+   +P  +   KI  +   + +  +     +++ + F   +P A  L  
Sbjct: 185 WALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ----EEYSEKF---SPDARSLCK 237

Query: 367 LMLELDSEKRI-----TAEQALAHPYLSQ 390
           ++L  D ++R+      A +   HP   Q
Sbjct: 238 MLLCKDPKERLGCQGGGAREVKEHPLFKQ 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 50.5 bits (121), Expect = 6e-07
 Identities = 45/171 (26%), Positives = 68/171 (39%), Gaps = 39/171 (22%)

Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT-HLMGADLNNILRTQK------- 164
           REL M + ++H+NV+ LL +     C  + +  YM+  +    DL   LR  K       
Sbjct: 57  RELDMFRKLSHKNVVRLLGL-----C-REAEPHYMILEYTDLGDLKQFLRATKSKDEKLK 110

Query: 165 ---LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN- 220
              LS      L  QI  G+ ++ +A  +HRDL   N  V+   E+K+    L++   N 
Sbjct: 111 PPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS 170

Query: 221 EMTGYVAT----RWYRAPEIMLN----------------WMHYNQTGVPFY 251
           E           RW  APE +                  W  + Q  +PFY
Sbjct: 171 EYYKLRNALIPLRWL-APEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFY 220

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 50.4 bits (120), Expect = 6e-07
 Identities = 44/184 (23%), Positives = 93/184 (50%), Gaps = 22/184 (11%)

Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYR---ELRMLKHMNHE 124
           +G  L + +F  ++    D+ +G ++A+K++    +S   +K       E+++LK++ HE
Sbjct: 6   LGKLLGQGAFGRVYL-CYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHE 64

Query: 125 NVIGLLDVFHSNTCLADFK----NVYMVTHLMGADLNNILRTQ-KLSDDHVQFLVYQILR 179
            ++          CL D      +++M  H+ G  + + L++   L+++  +    QIL 
Sbjct: 65  RIV------QYYGCLRDPMERTLSIFM-EHMPGGSIKDQLKSYGALTENVTRKYTRQILE 117

Query: 180 GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE------NEMTGYVATRWYRA 233
           G+ Y+HS  I+HRD+K +NI  +    +K+ DFG ++  +        M     T ++ +
Sbjct: 118 GVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 177

Query: 234 PEIM 237
           PE++
Sbjct: 178 PEVI 181

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 50.3 bits (120), Expect = 6e-07
 Identities = 51/162 (31%), Positives = 76/162 (46%), Gaps = 34/162 (20%)

Query: 93  VAIKKIARPFQSAVHAKRTY-RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHL 151
           VAIK +   +      +R +  E  ++   +H N+I L  V  + +       V ++T  
Sbjct: 35  VAIKTLKSGYTE--KQRRDFLSEASIMGQFDHPNIIHLEGVV-TKSR-----PVMIITEF 86

Query: 152 M--GADLNNILRTQKLSDDHVQFLVYQ---ILRG----LKYIHSAGIIHRDLKPSNIAVN 202
           M  GA L++ LR    +D   QF V Q   +LRG    +KY+     +HRDL   NI VN
Sbjct: 87  MENGA-LDSFLR---QNDG--QFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVN 140

Query: 203 EDCELKILDFGLAR--------PTE-NEMTGYVATRWYRAPE 235
            +   K+ DFGL+R        PT  + + G +  RW  APE
Sbjct: 141 SNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW-TAPE 181

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 50.8 bits (121), Expect = 6e-07
 Identities = 39/133 (29%), Positives = 60/133 (45%), Gaps = 13/133 (9%)

Query: 111 TYRELRMLKHMNHENVIGLLDVFHSN--TCLADFKNVYMVTHLMGADLNNILRTQKLSDD 168
           T  E  +L+ +NH ++I L   F  N  TCL          +   A   NI     L+  
Sbjct: 130 TATEAHILRAINHPSIIQLKGTFTYNKFTCLI-LPRYKTDLYCYLAAKRNIAICDILA-- 186

Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA----RPTENEMTG 224
               +   +LR ++Y+H   IIHRD+K  NI +N   ++ + DFG A        N+  G
Sbjct: 187 ----IERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG 242

Query: 225 YVATRWYRAPEIM 237
           +  T    APE++
Sbjct: 243 WAGTIATNAPELL 255

Length = 391

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 50.5 bits (120), Expect = 7e-07
 Identities = 45/165 (27%), Positives = 78/165 (47%), Gaps = 34/165 (20%)

Query: 238 LNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLA---RPTENEMTGYVATRWYRA 294
           L ++H NQ       +D+K  NI +  D  +K+ DFG      P +++ +  V T ++ A
Sbjct: 129 LEFLHSNQV----IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184

Query: 295 PEIMLNWMHYNQTDIHQLNLI-MEML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQ 352
           PE++    +  + DI  L ++ +EM+ G PP              Y+N  PL  +  +  
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP--------------YLNENPL--RALYLI 228

Query: 353 VFKGA----NPQAI-----DLLSLMLELDSEKRITAEQALAHPYL 388
              G     NP+ +     D L+  L++D EKR +A++ L H +L
Sbjct: 229 ATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 50.4 bits (120), Expect = 7e-07
 Identities = 43/167 (25%), Positives = 77/167 (46%), Gaps = 17/167 (10%)

Query: 231 YRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLAR--PTENEMTGYVA 288
           + A EI+      ++      ++DLKP NI +++   ++I D GLA   P    + G V 
Sbjct: 106 FYAAEILCGLEDLHRENT--VYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVG 163

Query: 289 TRWYRAPEIMLNWMHYNQTDIHQLN-LIMEML-GTPPAEFMAKISSDSARKYINSLPLLT 346
           T  Y APE++ N  +    D   L  LI EM+ G  P  F  +      R+ ++   L T
Sbjct: 164 TVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP--FRGR-KEKVKREEVDRRVLET 220

Query: 347 KKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALA-----HPYL 388
           ++ +   F   + +A  +  ++L  D ++R+  ++  A     HP+ 
Sbjct: 221 EEVYSAKF---SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFF 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 28/74 (37%), Positives = 41/74 (55%), Gaps = 2/74 (2%)

Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++D  +K+ DFG A+  +        T  Y APEI+LN  H    D   
Sbjct: 154 YRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWT 213

Query: 312 LNL-IMEML-GTPP 323
           L + I E+L G PP
Sbjct: 214 LGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 37/131 (28%), Positives = 63/131 (48%), Gaps = 10/131 (7%)

Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLN-NI--LRTQKLSDDHV 170
           E R+L+ +N   V+ L   + +   L       ++T + G DL  +I  +      +   
Sbjct: 50  EKRILEKVNSRFVVSLAYAYETKDALC-----LVLTIMNGGDLKFHIYNMGNPGFDEQRA 104

Query: 171 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR--PTENEMTGYVAT 228
            F   ++  GL+ +    I++RDLKP NI +++   ++I D GLA   P    + G V T
Sbjct: 105 IFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGT 164

Query: 229 RWYRAPEIMLN 239
             Y APE++ N
Sbjct: 165 VGYMAPEVINN 175

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 49.7 bits (118), Expect = 1e-06
 Identities = 36/140 (25%), Positives = 63/140 (45%), Gaps = 21/140 (15%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           + VA+K +     +A   K  +RE  +L ++ HE+++    V     C+     + +  +
Sbjct: 36  ILVAVKTLKDASDNA--RKDFHREAELLTNLQHEHIVKFYGV-----CVEGDPLIMVFEY 88

Query: 151 LMGADLNNILRTQ--------------KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKP 196
           +   DLN  LR                +L+   +  +  QI  G+ Y+ S   +HRDL  
Sbjct: 89  MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLAT 148

Query: 197 SNIAVNEDCELKILDFGLAR 216
            N  V E+  +KI DFG++R
Sbjct: 149 RNCLVGENLLVKIGDFGMSR 168

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 49.3 bits (117), Expect = 1e-06
 Identities = 41/167 (24%), Positives = 86/167 (51%), Gaps = 23/167 (13%)

Query: 86  DSVSGVKVAIKKIARPF-----QSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLA 140
           D+ +G ++A+K++  PF     +++        E+++LK++ H+ ++          CL 
Sbjct: 23  DADTGRELAVKQV--PFDPDSQETSKEVNALECEIQLLKNLRHDRIV------QYYGCLR 74

Query: 141 DF---KNVYMVTHLMGADLNNILRTQ-KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKP 196
           D    K    V ++ G  + + L+    L+++  +    QIL+G+ Y+HS  I+HRD+K 
Sbjct: 75  DPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKG 134

Query: 197 SNIAVNEDCELKILDFGLARPTEN-EMTG-----YVATRWYRAPEIM 237
           +NI  +    +K+ DFG ++  +   M+G        T ++ +PE++
Sbjct: 135 ANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 47/170 (27%), Positives = 80/170 (47%), Gaps = 18/170 (10%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           + VAIK++ R   S    K    E  ++  +++ +V  LL +     CL     V ++T 
Sbjct: 37  IPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCRLLGI-----CLT--STVQLITQ 88

Query: 151 LM--GADLNNILRTQ-KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
           LM  G  L+ +   +  +   ++     QI +G+ Y+    ++HRDL   N+ V     +
Sbjct: 89  LMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHV 148

Query: 208 KILDFGLAR---PTENEMT---GYVATRWYRAPEIMLNWMHYNQTGVPFY 251
           KI DFGLA+     E E     G V  +W  A E +L+ ++ +Q+ V  Y
Sbjct: 149 KITDFGLAKLLGADEKEYHAEGGKVPIKWM-ALESILHRIYTHQSDVWSY 197

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 50/185 (27%), Positives = 82/185 (44%), Gaps = 42/185 (22%)

Query: 95  IKKIARPFQSAVHAKRTYRELRM---LKHMNHENVI---GLLDVFHSNTCLADFKNVYMV 148
           IK I+     AV+  R ++E R    +K +N +N+I    +  VF     L   +N ++V
Sbjct: 6   IKLISNGAYGAVYLVR-HKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVV 64

Query: 149 T---------HLM-------GADLNNILRTQ-KLSDDHVQFLVYQILRGLKYIHSAGIIH 191
           +         HL        G D   +L+    L  D  +    + +  L+Y+H+ GI+H
Sbjct: 65  SMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVH 124

Query: 192 RDLKPSNIAVNEDCELKILDFGLAR-----PTENEMTGYVA-------------TRWYRA 233
           RDLKP N+ +     +K+ DFGL++      T N   G++              T  Y A
Sbjct: 125 RDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIA 184

Query: 234 PEIML 238
           PE++L
Sbjct: 185 PEVIL 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 33/135 (24%), Positives = 67/135 (49%), Gaps = 18/135 (13%)

Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFK----NVYMVTHLMGADLNNILRTQ-KLSDD 168
           E+++LK++ HE ++          CL D       ++M  ++ G  + + L+    L++ 
Sbjct: 54  EIQLLKNLQHERIV------QYYGCLRDRAEKTLTIFM-EYMPGGSVKDQLKAYGALTES 106

Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE------NEM 222
             +    QIL G+ Y+HS  I+HRD+K +NI  +    +K+ DFG ++  +        +
Sbjct: 107 VTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGI 166

Query: 223 TGYVATRWYRAPEIM 237
                T ++ +PE++
Sbjct: 167 RSVTGTPYWMSPEVI 181

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 40/149 (26%), Positives = 70/149 (46%), Gaps = 16/149 (10%)

Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEM---TGYVATRWYRAPEIMLNWMHYNQTDI 309
           +D+K  +I +  D  +K+ DFG       E+      V T ++ APE++    +  + DI
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDI 201

Query: 310 HQLN-LIMEML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFR--QVFKGANPQAIDLL 365
             L  +++EM+ G PP  +  +    + R+  ++LP   K   +   V +G        L
Sbjct: 202 WSLGIMVIEMIDGEPP--YFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRG-------FL 252

Query: 366 SLMLELDSEKRITAEQALAHPYLSQYSDP 394
            LML  +  +R TA++ L HP+L     P
Sbjct: 253 DLMLVREPSQRATAQELLQHPFLKLAGPP 281

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 47.2 bits (113), Expect = 3e-06
 Identities = 30/111 (27%), Positives = 50/111 (45%), Gaps = 16/111 (14%)

Query: 108 AKRTYRELRMLK--HMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKL 165
            +RT  E R+L        N   + DV              ++ ++ G  L +++     
Sbjct: 41  RERTRNEARLLSRARKAGVNTPVVYDVD-------PDNKTIVMEYIEGKPLKDVIEEGND 93

Query: 166 SDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
                  L+ +I R +  +H AGI+H DL  SNI V +D +L ++DFGL +
Sbjct: 94  E------LLREIGRLVGKLHKAGIVHGDLTTSNIIVRDD-KLYLIDFGLGK 137

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 27/79 (34%), Positives = 41/79 (51%), Gaps = 3/79 (3%)

Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEMT---GYVATRWYRAPEIMLNWMHYNQTDI 309
           +D+K  NI + ++ ++K+ DFG AR   +       YV T +Y  PEI  N  + N++DI
Sbjct: 124 RDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDI 183

Query: 310 HQLNLIMEMLGTPPAEFMA 328
             L  I+  L T    F A
Sbjct: 184 WSLGCILYELCTLKHPFQA 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 47.9 bits (114), Expect = 4e-06
 Identities = 43/175 (24%), Positives = 65/175 (37%), Gaps = 39/175 (22%)

Query: 93  VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM 152
           VA+K + +   SA       RE  ++   +H N++ LL V     C        +  ++ 
Sbjct: 38  VAVK-MLKEEASADMQADFQREAALMAEFDHPNIVKLLGV-----CAVGKPMCLLFEYMA 91

Query: 153 GADLNNILR------TQKLSDDHVQFLVY-----------------QILRGLKYIHSAGI 189
             DLN  LR         LS                          Q+  G+ Y+     
Sbjct: 92  YGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKF 151

Query: 190 IHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE---IMLNWM 241
           +HRDL   N  V E+  +KI DFGL+R          +  +Y+A E   I + WM
Sbjct: 152 VHRDLATRNCLVGENMVVKIADFGLSR-------NIYSADYYKASENDAIPIRWM 199

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 48.5 bits (115), Expect = 4e-06
 Identities = 40/135 (29%), Positives = 68/135 (50%), Gaps = 19/135 (14%)

Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQF- 172
           EL  L   +H  ++   D F S     D K + ++ +  G DLN  ++ Q+L + H+ F 
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKS-----DDKLLLIMEYGSGGDLNKQIK-QRLKE-HLPFQ 167

Query: 173 ------LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM---- 222
                 L YQI+  L  +HS  ++HRDLK +NI +     +K+ DFG ++   + +    
Sbjct: 168 EYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDV 227

Query: 223 -TGYVATRWYRAPEI 236
            + +  T +Y APE+
Sbjct: 228 ASSFCGTPYYLAPEL 242

Length = 478

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 47.1 bits (113), Expect = 5e-06
 Identities = 36/147 (24%), Positives = 63/147 (42%), Gaps = 28/147 (19%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEM---TGYVATRWYRAPEIMLNWMHYNQ-TDI 309
           D+KP NI +  +  +K+ DFG+++   + +      V T +Y +PE+  N   YN  +DI
Sbjct: 128 DIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQN-KPYNYKSDI 186

Query: 310 HQLNLIM-EML-------GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQA 361
             L  ++ E+        G    E   KI     +     +P     + R          
Sbjct: 187 WSLGCVLYELCTLKHPFEGENLLELALKIL----KGQYPPIPSQYSSELRN--------- 233

Query: 362 IDLLSLMLELDSEKRITAEQALAHPYL 388
             L+S +L+ D E+R +  Q L  P++
Sbjct: 234 --LVSSLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 48.1 bits (114), Expect = 5e-06
 Identities = 27/67 (40%), Positives = 38/67 (56%), Gaps = 4/67 (5%)

Query: 175 YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP 234
           +Q+ RG++++ S   IHRDL   NI ++E+  +KI DFGLAR    +   YV     R P
Sbjct: 181 FQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD-PDYVRKGSARLP 239

Query: 235 EIMLNWM 241
              L WM
Sbjct: 240 ---LKWM 243

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 47.2 bits (113), Expect = 6e-06
 Identities = 38/146 (26%), Positives = 74/146 (50%), Gaps = 17/146 (11%)

Query: 254 DLKPSNIAVNEDCELKILDFGLA---RPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIH 310
           D+K +NI ++E+ ++K+ DFG++     T ++   +V T ++ APE++    +  + DI 
Sbjct: 123 DIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIW 182

Query: 311 QLNLI-MEML-GTPPAEFMAKISSDSARKYI--NSLPLLTKKDFRQVFKGANPQAIDLLS 366
            L +  +E+  G PP   ++ +        I  N+ P L    F + FK       D +S
Sbjct: 183 SLGITAIELAKGEPP---LSDLHPMRVLFLIPKNNPPSLEGNKFSKPFK-------DFVS 232

Query: 367 LMLELDSEKRITAEQALAHPYLSQYS 392
           L L  D ++R +A++ L H ++ +  
Sbjct: 233 LCLNKDPKERPSAKELLKHKFIKKAK 258

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 47.3 bits (112), Expect = 6e-06
 Identities = 48/173 (27%), Positives = 79/173 (45%), Gaps = 25/173 (14%)

Query: 252 FQDLKPSNIAVNEDCELKILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHYNQTD 308
           ++DLKP NI ++    + + DFGL +      +  T +  T  Y APE++    + N  D
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVD 178

Query: 309 IHQLNLIM-EML-GTPPAEFMAKISSDSARKYINSL--PLLTKKDFRQVFKGANPQAIDL 364
              L  ++ EML G PP         D A  Y N L  PL+ +        GA+  A  +
Sbjct: 179 WWCLGAVLYEMLYGLPPF-----YCRDVAEMYDNILHKPLVLR-------PGASLTAWSI 226

Query: 365 LSLMLELDSEKRITAEQAL----AHPYLS--QYSDPNDEPTSPPYDQSFEDMD 411
           L  +LE D ++R+ A++       HP+     ++D   +   PP++ + E  D
Sbjct: 227 LEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPD 279

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 46.9 bits (111), Expect = 9e-06
 Identities = 40/144 (27%), Positives = 63/144 (43%), Gaps = 28/144 (19%)

Query: 93  VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSN--TCLADFKNVYMVTH 150
           VAIK + +   +        +E  ++  ++H N++ LL V       C+       +  +
Sbjct: 37  VAIKTL-KDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM-------LFEY 88

Query: 151 LMGADLNN--ILR--------------TQKLSDDHVQFL--VYQILRGLKYIHSAGIIHR 192
           L   DL+   I+R              T K S DH  FL    QI  G++Y+ S   +H+
Sbjct: 89  LNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHK 148

Query: 193 DLKPSNIAVNEDCELKILDFGLAR 216
           DL   NI + E   +KI D GL+R
Sbjct: 149 DLAARNILIGEQLHVKISDLGLSR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 38/142 (26%), Positives = 67/142 (47%), Gaps = 16/142 (11%)

Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEMTG---YVATRWYRAPEIMLNWMHYNQTDI 309
           +D+K  NI + +   +K+ DFG+++   +E +     V T +Y +PE+     +  ++DI
Sbjct: 125 RDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDI 184

Query: 310 HQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTK---KDFRQVFKGANPQAIDLLS 366
             L  ++  L T    F A           N L L+ K    ++  V    + + I L+ 
Sbjct: 185 WALGCVLYELLTLKRTFDAT----------NPLNLVVKIVQGNYTPVVSVYSSELISLVH 234

Query: 367 LMLELDSEKRITAEQALAHPYL 388
            +L+ D EKR TA++ L  P L
Sbjct: 235 SLLQQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 40/163 (24%), Positives = 73/163 (44%), Gaps = 16/163 (9%)

Query: 230 WYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENE---MTGY 286
           W+    + L ++H          +DLK  N+ +     +K+ D G+AR  EN+    +  
Sbjct: 107 WFVQIAMALQYLHEKH----ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTL 162

Query: 287 VATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAK-ISSDSARKYINSLPLL 345
           + T +Y +PE+  N  +  ++D+  L   +  + T    F AK ++S   R     LP +
Sbjct: 163 IGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPM 222

Query: 346 TKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYL 388
            K          +P+  +L++ ML    EKR + +  L  PY+
Sbjct: 223 PKD--------YSPELGELIATMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 40/154 (25%), Positives = 65/154 (42%), Gaps = 26/154 (16%)

Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEM---TGYVATRWYRAPEIMLNWMHYNQTDI 309
           +D+K  +I +  D  +K+ DFG       E+      V T ++ APE++    +  + DI
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDI 199

Query: 310 HQLN-LIMEML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFR-------QVFKGANPQ 360
             L  +++EM+ G PP              Y N  PL   K  R       +     +P 
Sbjct: 200 WSLGIMVIEMVDGEPP--------------YFNEPPLKAMKMIRDNLPPKLKNLHKVSPS 245

Query: 361 AIDLLSLMLELDSEKRITAEQALAHPYLSQYSDP 394
               L  +L  D  +R TA + L HP+L++   P
Sbjct: 246 LKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 279

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 47.5 bits (113), Expect = 1e-05
 Identities = 22/47 (46%), Positives = 30/47 (63%), Gaps = 1/47 (2%)

Query: 170 VQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC-ELKILDFGLA 215
           +Q ++ QIL  L  +HS GI+HRD+KP NI  +E     KI+D G A
Sbjct: 257 IQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303

Length = 566

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 39/133 (29%), Positives = 67/133 (50%), Gaps = 16/133 (12%)

Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRT-----QKLSD 167
           E ++L  ++H  ++     FH++    D     ++T    G DL+  L       + LS+
Sbjct: 52  EAQLLSKLDHPAIVK----FHASFLERD--AFCIITEYCEGRDLDCKLEELKHTGKTLSE 105

Query: 168 DHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR---PTENEMTG 224
           + V     Q+L G+ Y+H   I+HRDLK  NI +  +  LKI DFG++R    + +  T 
Sbjct: 106 NQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT 164

Query: 225 YVATRWYRAPEIM 237
           +  T +Y +PE +
Sbjct: 165 FTGTPYYMSPEAL 177

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 46.8 bits (111), Expect = 1e-05
 Identities = 27/67 (40%), Positives = 38/67 (56%), Gaps = 4/67 (5%)

Query: 175 YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP 234
           +Q+ RG++++ S   IHRDL   NI ++E+  +KI DFGLAR    +   YV     R P
Sbjct: 180 FQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD-PDYVRKGDARLP 238

Query: 235 EIMLNWM 241
              L WM
Sbjct: 239 ---LKWM 242

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 30/90 (33%), Positives = 46/90 (51%), Gaps = 9/90 (10%)

Query: 156 LNNILRTQK-LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL 214
           LN  L+  K +++ ++  LV+Q+  G+KY+     +HRDL   N+ +      KI DFGL
Sbjct: 82  LNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGL 141

Query: 215 A---RPTEN----EMTGYVATRWYRAPEIM 237
           +      EN    +  G    +WY APE M
Sbjct: 142 SKALGADENYYKAKTHGKWPVKWY-APECM 170

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 46.8 bits (111), Expect = 1e-05
 Identities = 26/67 (38%), Positives = 35/67 (52%), Gaps = 4/67 (5%)

Query: 175 YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP 234
           YQ+ +G+ ++ S   IHRDL   NI +      KI DFGLAR   N+ + YV     R P
Sbjct: 221 YQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND-SNYVVKGNARLP 279

Query: 235 EIMLNWM 241
              + WM
Sbjct: 280 ---VKWM 283

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 27/77 (35%), Positives = 42/77 (54%), Gaps = 4/77 (5%)

Query: 165 LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTG 224
           L+ + +    +Q+ +G++++ S   IHRDL   NI ++E+  +KI DFGLAR    +   
Sbjct: 176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD-PD 234

Query: 225 YVATRWYRAPEIMLNWM 241
           YV     R P   L WM
Sbjct: 235 YVRKGDARLP---LKWM 248

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 51/182 (28%), Positives = 84/182 (46%), Gaps = 29/182 (15%)

Query: 218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLAR 277
           TE ++  Y+A       E+ L   H +  G+   ++DLKP NI ++E+  +K+ DFGL++
Sbjct: 96  TEEDVKFYLA-------ELALALDHLHSLGI--IYRDLKPENILLDEEGHIKLTDFGLSK 146

Query: 278 PT---ENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIM-EML-GTPPAEFMAKISS 332
            +   E +   +  T  Y APE++    H    D     ++M EML G+ P  F  K   
Sbjct: 147 ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP--FQGK--- 201

Query: 333 DSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA-----EQALAHPY 387
              RK   ++ L  K    Q     +P+A  LL  + + +   R+ A     E+   HP+
Sbjct: 202 --DRKETMTMILKAKLGMPQFL---SPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPF 256

Query: 388 LS 389
            S
Sbjct: 257 FS 258

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 29/69 (42%), Positives = 43/69 (62%), Gaps = 4/69 (5%)

Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEM-TGYVATRWYRAPEIMLNWMHYN-QTDIH 310
           +D+KPSNI VN   E+K+ DFG++    + M   +V TR Y +PE  L   HY+ Q+DI 
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE-RLQGTHYSVQSDIW 186

Query: 311 QLNL-IMEM 318
            + L ++EM
Sbjct: 187 SMGLSLVEM 195

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 46/185 (24%), Positives = 82/185 (44%), Gaps = 30/185 (16%)

Query: 218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLAR 277
           TE+E+  Y+A       EI+L   H +Q G+   ++D+K  NI ++ +  + + DFGL++
Sbjct: 103 TESEVRVYIA-------EIVLALDHLHQLGI--IYRDIKLENILLDSEGHVVLTDFGLSK 153

Query: 278 ----PTENEMTGYVATRWYRAPEIML--NWMHYNQTDIHQLNLIMEMLGTPPAEFMAK-- 329
                 E     +  T  Y APE++   +  H    D   L ++   L T  + F     
Sbjct: 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE 213

Query: 330 --ISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI---TAEQALA 384
               S+ +R+ + S P   K          + +A D +  +LE D +KR+    A++   
Sbjct: 214 QNSQSEISRRILKSKPPFPKT--------MSAEARDFIQKLLEKDPKKRLGANGADEIKN 265

Query: 385 HPYLS 389
           HP+  
Sbjct: 266 HPFFQ 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 26/75 (34%), Positives = 40/75 (53%), Gaps = 5/75 (6%)

Query: 167 DDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV 226
           DD ++F   Q+ +G+ ++ S   IHRD+   N+ + +    KI DFGLAR   N+ + YV
Sbjct: 212 DDLLRF-SSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND-SNYV 269

Query: 227 ATRWYRAPEIMLNWM 241
                R P   + WM
Sbjct: 270 VKGNARLP---VKWM 281

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 23/69 (33%), Positives = 39/69 (56%), Gaps = 5/69 (7%)

Query: 173 LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV-----A 227
           L  Q+L  + ++HS  +IHRD+K +NI +  +  +K+ DFG ++     ++  V      
Sbjct: 148 LFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCG 207

Query: 228 TRWYRAPEI 236
           T +Y APEI
Sbjct: 208 TPYYVAPEI 216

Length = 496

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 49/173 (28%), Positives = 81/173 (46%), Gaps = 21/173 (12%)

Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLAR---PTENEMT 284
            R+Y A E++    + ++  V   ++DLKP NI ++    + + DFGL +     +++  
Sbjct: 95  ARFYTA-ELLCALENLHKFNV--IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTN 151

Query: 285 GYVATRWYRAPEIMLNWMHYNQTDIHQLN-LIMEML-GTPPAEFMAKISSDSARKYINSL 342
            +  T  Y APE++L   +    D   L  L+ EML G PP  F  +  ++  RK +   
Sbjct: 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP--FYDENVNEMYRKILQE- 208

Query: 343 PLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI---TAEQALAHPYLSQYS 392
           PL     F +        A DLL  +L  D  +R+    A++   HP+ SQ S
Sbjct: 209 PLRFPDGFDR-------DAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS 254

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 36/164 (21%), Positives = 70/164 (42%), Gaps = 31/164 (18%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRM-----LKHMNHENVI---GLLDVFHSNTCLA 140
           SG  +A+K+I      +   ++  + L M     ++  +   ++   G L  F    C  
Sbjct: 28  SGTIMAVKRI-----RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGAL--FREGDC-- 78

Query: 141 DFKNVYMVTHLMGADLNNILRT------QKLSDDHVQFLVYQILRGLKYIHSA-GIIHRD 193
                ++   LM   L+   +         + ++ +  +    ++ L Y+     IIHRD
Sbjct: 79  -----WICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRD 133

Query: 194 LKPSNIAVNEDCELKILDFGLARPTENEM--TGYVATRWYRAPE 235
           +KPSNI ++ +  +K+ DFG++    + +  T     R Y APE
Sbjct: 134 VKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 177

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 27/64 (42%), Positives = 39/64 (60%), Gaps = 3/64 (4%)

Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEM-TGYVATRWYRAPEIMLNWMHYN-QTDIH 310
           +D+KPSNI VN   E+K+ DFG++    + M   +V TR Y +PE  L   HY+ Q+DI 
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE-RLQGTHYSVQSDIW 186

Query: 311 QLNL 314
            + L
Sbjct: 187 SMGL 190

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 23/81 (28%), Positives = 42/81 (51%), Gaps = 3/81 (3%)

Query: 161 RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR---P 217
           R  +      +F   ++L  L+ +H   +I+RDLKP NI ++    + + DFGL +    
Sbjct: 86  REGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK 145

Query: 218 TENEMTGYVATRWYRAPEIML 238
            +++   +  T  Y APE++L
Sbjct: 146 DDDKTNTFCGTPEYLAPELLL 166

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 29/104 (27%), Positives = 55/104 (52%), Gaps = 7/104 (6%)

Query: 141 DFKNVYMVT-HLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPS 197
           D  N+Y+V  + +G DL  +L     +L +D  +F + +++  +  +H    +HRD+KP 
Sbjct: 72  DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPD 131

Query: 198 NIAVNEDCELKILDFG----LARPTENEMTGYVATRWYRAPEIM 237
           NI ++ +  +++ DFG    L      + +  V T  Y +PEI+
Sbjct: 132 NILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 175

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 44.5 bits (106), Expect = 3e-05
 Identities = 16/32 (50%), Positives = 23/32 (71%), Gaps = 1/32 (3%)

Query: 185 HSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           HSAGIIH DL  SN+ ++   ++ ++DFGLA 
Sbjct: 112 HSAGIIHGDLTTSNMILSGG-KIYLIDFGLAE 142

Length = 211

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 45.5 bits (108), Expect = 3e-05
 Identities = 30/104 (28%), Positives = 58/104 (55%), Gaps = 7/104 (6%)

Query: 141 DFKNVYMVT-HLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPS 197
           D  N+Y+V  + +G DL  +L     +L +D  +F + +++  +  +H  G +HRD+KP 
Sbjct: 72  DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPD 131

Query: 198 NIAVNEDCELKILDFG--LARPTENEMTGYVA--TRWYRAPEIM 237
           N+ ++++  +++ DFG  L    +  +   VA  T  Y +PEI+
Sbjct: 132 NVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEIL 175

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 25/69 (36%), Positives = 33/69 (47%), Gaps = 3/69 (4%)

Query: 165 LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE---NE 221
           LS   +      + RG+ Y+     IHRDL   NI V E+   KI DFGL+R  E    +
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 180

Query: 222 MTGYVATRW 230
             G +  RW
Sbjct: 181 TMGRLPVRW 189

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 44.8 bits (106), Expect = 4e-05
 Identities = 41/152 (26%), Positives = 65/152 (42%), Gaps = 22/152 (14%)

Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEMTG-YVATRWYRAPEIMLNWMHYNQTDIHQ 311
           +D+KPSNI VN   ++K+ DFG++    N +   +V T  Y +PE +    +  ++D+  
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWS 187

Query: 312 LNL-IMEM-LGTPPAEFMAKISSDSARKYINSL-----------PLLTKKDFRQVFKGAN 358
           L + I+E+ LG  P    + I  D     +  L           P L   DF +      
Sbjct: 188 LGISIIELALGKFPFA-FSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPED----- 241

Query: 359 PQAIDLLSLMLELDSEKRITAEQALAHPYLSQ 390
               D +   L  D  +R T +Q  A P   Q
Sbjct: 242 --LRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 32/107 (29%), Positives = 51/107 (47%), Gaps = 9/107 (8%)

Query: 138 CLADFKNVYMVTHLM--GADLNNILRTQ-KLSDDHVQFLVYQILRGLKYIHSAGIIHRDL 194
           CL     V +VT LM  G  L+ +   + ++    +     QI +G+ Y+    ++HRDL
Sbjct: 78  CLT--STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDL 135

Query: 195 KPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM 241
              N+ V     +KI DFGLAR  + + T Y A       ++ + WM
Sbjct: 136 AARNVLVKSPNHVKITDFGLARLLDIDETEYHAD----GGKVPIKWM 178

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 44.4 bits (105), Expect = 5e-05
 Identities = 23/59 (38%), Positives = 36/59 (61%), Gaps = 2/59 (3%)

Query: 253 QDLKPSNIAVNEDCELKILDFGLARPT--ENEMTGYVATRWYRAPEIMLNWMHYNQTDI 309
           +DL P+NI + ED ++ I DFGLA+    E+++T  V T  Y  PEI+ N  +  + D+
Sbjct: 138 RDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADV 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 44.5 bits (105), Expect = 5e-05
 Identities = 39/186 (20%), Positives = 73/186 (39%), Gaps = 22/186 (11%)

Query: 231 YRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLA---RPTENEMTGYV 287
           +   +I+    H +Q  +   ++DLKP N+ ++ D  ++I D GLA   +  +++  GY 
Sbjct: 101 FYTAQIISGLEHLHQRRI--IYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA 158

Query: 288 ATRWYRAPEIMLNWMHYNQTDIHQLNLIM-EMLGT--PPAEFMAKISSDSARKYINSLPL 344
            T  + APE++    +    D   L + + EM+    P      K+ +   ++ I +  +
Sbjct: 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSV 218

Query: 345 LTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI-----TAEQALAHPYLSQYSDPNDE-- 397
                F    K            +L  D EKR+       +    HP     +    E  
Sbjct: 219 TYPDKFSPASK-------SFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAG 271

Query: 398 PTSPPY 403
              PP+
Sbjct: 272 MLPPPF 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 44.6 bits (105), Expect = 5e-05
 Identities = 36/141 (25%), Positives = 59/141 (41%), Gaps = 24/141 (17%)

Query: 93  VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM 152
           VA+K +  P  +A   K   RE  +L ++ HE+++    V     C      + +  ++ 
Sbjct: 38  VAVKALKDPTLAA--RKDFQREAELLTNLQHEHIVKFYGV-----CGDGDPLIMVFEYMK 90

Query: 153 GADLNNILRTQ-----------------KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLK 195
             DLN  LR                   +L    +  +  QI  G+ Y+ S   +HRDL 
Sbjct: 91  HGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLA 150

Query: 196 PSNIAVNEDCELKILDFGLAR 216
             N  V  +  +KI DFG++R
Sbjct: 151 TRNCLVGANLLVKIGDFGMSR 171

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 44.7 bits (105), Expect = 5e-05
 Identities = 37/119 (31%), Positives = 58/119 (48%), Gaps = 14/119 (11%)

Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHV--Q 171
           E  ++  M+H +++ LL V     CL+    + +VT LM      +L       D++  Q
Sbjct: 59  EALIMASMDHPHLVRLLGV-----CLS--PTIQLVTQLMPHGC--LLDYVHEHKDNIGSQ 109

Query: 172 FLV---YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVA 227
            L+    QI +G+ Y+    ++HRDL   N+ V     +KI DFGLAR  E +   Y A
Sbjct: 110 LLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA 168

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 44.5 bits (105), Expect = 6e-05
 Identities = 30/95 (31%), Positives = 52/95 (54%), Gaps = 8/95 (8%)

Query: 229 RWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARP--TENEMTG- 285
           ++Y A E++L   H ++  +   ++DLKP NI ++    + + DFGL++   T+N+ T  
Sbjct: 99  KFYIA-ELVLALEHLHKYDI--VYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT 155

Query: 286 YVATRWYRAPEIMLNWMHYN-QTDIHQLN-LIMEM 318
           +  T  Y APE++L+   Y    D   L  L+ EM
Sbjct: 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 44.4 bits (105), Expect = 6e-05
 Identities = 39/176 (22%), Positives = 72/176 (40%), Gaps = 29/176 (16%)

Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSG--VKVAIKKIARPFQSAVHAKRTY-RELR 116
           E+ R  I +   L   +F  ++        G  V++ +     P   +   +  +  E  
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61

Query: 117 MLKHMNHENVIGLLDVFHSNTCLADFKNV--YMVTHLM-GADLNNILRTQKLSDDHVQFL 173
           ++   NH+N++ L+ V         F+ +  +++  LM G DL + LR  +   +    L
Sbjct: 62  IMSKFNHQNIVRLIGV--------SFERLPRFILLELMAGGDLKSFLRENRPRPERPSSL 113

Query: 174 VYQ--------ILRGLKYIHSAGIIHRDLKPSNIAVNEDCE-----LKILDFGLAR 216
             +        + +G KY+     IHRD+   N  +   C+      KI DFG+AR
Sbjct: 114 TMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLT--CKGPGRVAKIADFGMAR 167

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 44.3 bits (105), Expect = 6e-05
 Identities = 37/131 (28%), Positives = 65/131 (49%), Gaps = 18/131 (13%)

Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDDHVQF 172
           E  +++  +H +++ L+ V   N        V++V  L    +L + L+  K S D    
Sbjct: 57  EAYIMRQFDHPHIVKLIGVITENP-------VWIVMELAPLGELRSYLQVNKYSLDLASL 109

Query: 173 LVY--QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATR- 229
           ++Y  Q+   L Y+ S   +HRD+   N+ V+    +K+ DFGL+R  E+E + Y A++ 
Sbjct: 110 ILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE-SYYKASKG 168

Query: 230 -----WYRAPE 235
                W  APE
Sbjct: 169 KLPIKWM-APE 178

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 44.3 bits (105), Expect = 7e-05
 Identities = 36/154 (23%), Positives = 64/154 (41%), Gaps = 6/154 (3%)

Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT-DIHQ 311
           +DLKP N  ++    +K+ DFGL++         V +  Y APE +L    Y+ T D   
Sbjct: 125 RDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPE-VLRGKGYDFTVDYWS 183

Query: 312 LNLIM-EML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLML 369
           L  ++ E L G PP  F     +++          L +  +       + +A DL++ ++
Sbjct: 184 LGCMLYEFLCGFPP--FSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLI 241

Query: 370 ELDSEKRITAEQALAHPYLSQYSDPNDEPTSPPY 403
              S +  + E    HP+  +          PP+
Sbjct: 242 NDPSRRFGSLEDIKNHPFFKEVDWNELRELKPPF 275

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 44.0 bits (104), Expect = 7e-05
 Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 33/200 (16%)

Query: 229 RWYRAPEIM--LNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLAR---PTENEM 283
           R+Y A EI   L ++H     +   ++DLKP NI ++    + + DFGL +         
Sbjct: 99  RFY-AAEIASALGYLH----SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT 153

Query: 284 TGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIM-EML-GTPPAEFMAKISSDSARKYINS 341
           + +  T  Y APE++    +    D   L  ++ EML G PP       S D+A  Y N 
Sbjct: 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPF-----YSRDTAEMYDNI 208

Query: 342 L--PLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA----EQALAHPYLS--QYSD 393
           L  PL       ++    +  A  LL  +L+ D  KR+ A     +   H + S   + D
Sbjct: 209 LNKPL-------RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDD 261

Query: 394 PNDEPTSPPYDQSFED-MDL 412
             ++  +PP++ +    MDL
Sbjct: 262 LVNKKITPPFNPNVSGPMDL 281

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 44.2 bits (104), Expect = 7e-05
 Identities = 37/141 (26%), Positives = 59/141 (41%), Gaps = 25/141 (17%)

Query: 93  VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM 152
           VA+K +    +SA   +   RE  +L  + H++++    V      L       MV   M
Sbjct: 38  VAVKALKEASESA--RQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL------MVFEYM 89

Query: 153 G-ADLNNILRTQ----------------KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLK 195
              DLN  LR+                 +L+   +  +  QI  G+ Y+ S   +HRDL 
Sbjct: 90  RHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLA 149

Query: 196 PSNIAVNEDCELKILDFGLAR 216
             N  V +   +KI DFG++R
Sbjct: 150 TRNCLVGQGLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 43.7 bits (103), Expect = 8e-05
 Identities = 34/154 (22%), Positives = 61/154 (39%), Gaps = 14/154 (9%)

Query: 238 LNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLAR---PTENEMTGYVATRWYRA 294
           L  +H  +       +D+K  N+ ++    +KI D G+A+      N     V T +Y +
Sbjct: 114 LAHLHSKK----ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLS 169

Query: 295 PEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF 354
           PE+  +  +  ++D+  L +++    T    F A        K I       +  F  V 
Sbjct: 170 PELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKII-------RGVFPPVS 222

Query: 355 KGANPQAIDLLSLMLELDSEKRITAEQALAHPYL 388
           +  + Q   L+   L  D  +R    Q L +P L
Sbjct: 223 QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 39/153 (25%), Positives = 70/153 (45%), Gaps = 31/153 (20%)

Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTEN--------EMTGYVATRWYRAPEIMLNWMH- 303
           +DLK  N+ V+ D   KI DFG+++ +++         M G V   ++ APE++ ++   
Sbjct: 132 RDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSV---FWMAPEVIHSYSQG 188

Query: 304 YN-QTDIHQLN-LIMEML-GTPP------AEFMAKISSDSARKYINSLPLLTKKDFRQVF 354
           Y+ + DI  L  +++EM  G  P         M K+ +  +   I             V 
Sbjct: 189 YSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPP----------DVS 238

Query: 355 KGANPQAIDLLSLMLELDSEKRITAEQALAHPY 387
              +P A+D L+    ++ + R TA + L HP+
Sbjct: 239 MNLSPVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 43.6 bits (103), Expect = 1e-04
 Identities = 35/152 (23%), Positives = 65/152 (42%), Gaps = 27/152 (17%)

Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEMTG-YVATRWYRAPEIMLNWMHYNQTDIHQ 311
           +D+KPSNI +    ++K+ DFG++    N + G +  T +Y APE +    +   +D+  
Sbjct: 129 RDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWS 188

Query: 312 LNL-IMEMLGT------------PPAEFMAKISSDSARKYINSLPLLTK--KDFRQVFKG 356
           L L ++E+                P E ++ I +    +  +      K  ++F+     
Sbjct: 189 LGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFK----- 243

Query: 357 ANPQAIDLLSLMLELDSEKRITAEQALAHPYL 388
                 D +   LE D  +R T    L HP++
Sbjct: 244 ------DFIKQCLEKDPTRRPTPWDMLEHPWI 269

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 43.6 bits (103), Expect = 1e-04
 Identities = 28/109 (25%), Positives = 55/109 (50%), Gaps = 13/109 (11%)

Query: 117 MLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHV------ 170
           +L  ++H+N   +L + H      +   V +  ++   +L   L+  +L + +       
Sbjct: 61  LLYGLSHQN---ILPILHVCIEDGEPPFV-LYPYMNWGNLKLFLQQCRLGEANNPQALST 116

Query: 171 QFLVY---QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           Q LV+   QI  G+ Y+H  G+IH+D+   N  ++E+ ++KI D  L+R
Sbjct: 117 QQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSR 165

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 43.8 bits (103), Expect = 1e-04
 Identities = 28/104 (26%), Positives = 53/104 (50%), Gaps = 7/104 (6%)

Query: 141 DFKNVYMVT-HLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPS 197
           D   +Y+V  + +G DL  +L     +L +D  +F + +++  +  IH    +HRD+KP 
Sbjct: 72  DENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPD 131

Query: 198 NIAVNEDCELKILDFGLARPTENEMTGY----VATRWYRAPEIM 237
           N+ ++ +  +++ DFG       + T      V T  Y +PEI+
Sbjct: 132 NVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEIL 175

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 40/158 (25%), Positives = 75/158 (47%), Gaps = 19/158 (12%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           + VAIK +    + +V      RE  ++  +++  ++ ++ V     C A+   + +V  
Sbjct: 23  IDVAIKVLKNENEKSVR-DEMMREAEIMHQLDNPYIVRMIGV-----CEAE--ALMLVME 74

Query: 151 LM-GADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
           +  G  LN  L  +K  ++  +V  L++Q+  G+KY+     +HRDL   N+ +      
Sbjct: 75  MASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYA 134

Query: 208 KILDFGLARPTENEMTGYVAT-------RWYRAPEIML 238
           KI DFGL++    + + Y A        +WY APE + 
Sbjct: 135 KISDFGLSKALGADDSYYKARSAGKWPLKWY-APECIN 171

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 42/151 (27%), Positives = 72/151 (47%), Gaps = 10/151 (6%)

Query: 229 RWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARP-TENEMTGYV 287
           R+Y A EI+L   H +   V   ++DLKP+NI ++E   ++I D GLA   ++ +    V
Sbjct: 100 RFY-ATEIILGLEHMHNRFV--VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV 156

Query: 288 ATRWYRAPEIMLNWMHYNQT-DIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLT 346
            T  Y APE++     Y+ + D   L  ++  L    + F    + D  +  I+ + L  
Sbjct: 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTLTV 214

Query: 347 KKDFRQVFKGANPQAIDLLSLMLELDSEKRI 377
             +    F   +P+   LL  +L+ D  KR+
Sbjct: 215 NVELPDSF---SPELKSLLEGLLQRDVSKRL 242

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 43.3 bits (103), Expect = 2e-04
 Identities = 18/46 (39%), Positives = 28/46 (60%), Gaps = 1/46 (2%)

Query: 173 LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT 218
           LV ++   +  +H AGI+H DL  SN  V +D  L ++DFGL + +
Sbjct: 433 LVRKVGEIVAKLHKAGIVHGDLTTSNFIVRDD-RLYLIDFGLGKYS 477

Length = 535

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 45/175 (25%), Positives = 80/175 (45%), Gaps = 27/175 (15%)

Query: 60  EICRGVIDIGPTLSKESFDLIFSS-ALDSVSG---VKVAIKKIARPFQSAVHAKRT--YR 113
           E+ R  I +   L + SF +++   A D + G    +VA+K +    +SA   +R     
Sbjct: 2   EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN---ESASLRERIEFLN 58

Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDD---- 168
           E  ++K     +V+ LL V      ++  +   +V  LM   DL + LR+ +   +    
Sbjct: 59  EASVMKGFTCHHVVRLLGV------VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 112

Query: 169 ----HVQFLVY---QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
                +Q ++    +I  G+ Y+++   +HRDL   N  V  D  +KI DFG+ R
Sbjct: 113 RPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 42.4 bits (99), Expect = 2e-04
 Identities = 22/54 (40%), Positives = 28/54 (51%), Gaps = 3/54 (5%)

Query: 180 GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE---NEMTGYVATRW 230
           G+ Y+     IHRDL   NI V E+   KI DFGL+R  E    +  G +  RW
Sbjct: 124 GMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 177

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 41.8 bits (99), Expect = 3e-04
 Identities = 25/76 (32%), Positives = 44/76 (57%), Gaps = 4/76 (5%)

Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGY--VATRWYRAPEIMLNWMHYNQTDI 309
           ++DLKP N+ ++ +  +K++DFG A+  ++    +    T  Y APEI+LN  +    D 
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDY 175

Query: 310 HQLNLIM-EML-GTPP 323
             L +++ E+L G PP
Sbjct: 176 WSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 42.5 bits (100), Expect = 3e-04
 Identities = 49/176 (27%), Positives = 69/176 (39%), Gaps = 42/176 (23%)

Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEM---TGYVATRWYRAPEIM---LNWMHYN- 305
           +D+KPSN+ +N    +KI DFG++R     M      V T  Y +PE +   LN   Y+ 
Sbjct: 192 RDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDG 251

Query: 306 -QTDIHQLNL-IMEM-LGTPP---------AEFMAKIS-SDSARKYINSLPLLTKKDFRQ 352
              DI  L + I+E  LG  P         A  M  I  S          P    ++FR 
Sbjct: 252 YAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEA-----PATASREFR- 305

Query: 353 VFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYL------SQYSDPNDEPTSPP 402
                       +S  L+ +  KR +A Q L HP++           PN     PP
Sbjct: 306 ----------HFISCCLQREPAKRWSAMQLLQHPFILRAQPGQGQGGPNLHQLLPP 351

Length = 353

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 42.1 bits (99), Expect = 3e-04
 Identities = 42/167 (25%), Positives = 74/167 (44%), Gaps = 19/167 (11%)

Query: 231 YRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLAR--PTENEMTGYVA 288
           + A EI       ++  +   ++DLKP NI +++   ++I D GLA   P    + G V 
Sbjct: 106 FYAAEITCGLEDLHRERI--VYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVG 163

Query: 289 TRWYRAPEIMLNWMHYNQTDIHQLN-LIMEMLG--TPPAEFMAKISSDSARKYINSLPLL 345
           T  Y APE++ N  +    D   L  LI EM+   +P  +   K+     R+ +      
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK----REEVERRVKE 219

Query: 346 TKKDFRQVFKGANPQAIDLLSLMLELDSEKRI-----TAEQALAHPY 387
            ++++ + F   +  A  +   +L  D   R+      AE+  AHP+
Sbjct: 220 DQEEYSEKF---SEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPF 263

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 41.8 bits (98), Expect = 3e-04
 Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 10/91 (10%)

Query: 218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLAR 277
           +E EM  Y       A EI+L   H +   V   ++DLKP+NI ++E   ++I D GLA 
Sbjct: 95  SEAEMRFY-------AAEIILGLEHMHNRFV--VYRDLKPANILLDEHGHVRISDLGLAC 145

Query: 278 P-TENEMTGYVATRWYRAPEIMLNWMHYNQT 307
             ++ +    V T  Y APE++   + Y+ +
Sbjct: 146 DFSKKKPHASVGTHGYMAPEVLQKGVAYDSS 176

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 49/189 (25%), Positives = 94/189 (49%), Gaps = 28/189 (14%)

Query: 229 RWYRAPEIM--LNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENE---M 283
           R+Y A EI+  L+++H  +  V   ++DLK  N+ +++D  +KI DFGL +    +   M
Sbjct: 98  RFYGA-EIVSALDYLHSEKNVV---YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM 153

Query: 284 TGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIM-EML-GTPPAEFMAKISSDSARKYINS 341
             +  T  Y APE++ +  +    D   L ++M EM+ G  P       + D  + +   
Sbjct: 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----YNQDHEKLF--E 206

Query: 342 LPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI-----TAEQALAHPYLS--QYSDP 394
           L L+ +  F +     +P+A  LLS +L+ D ++R+      A++ + H + +   + D 
Sbjct: 207 LILMEEIRFPRTL---SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDV 263

Query: 395 NDEPTSPPY 403
            ++   PP+
Sbjct: 264 YEKKLVPPF 272

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 42.6 bits (100), Expect = 3e-04
 Identities = 48/199 (24%), Positives = 84/199 (42%), Gaps = 27/199 (13%)

Query: 227 ATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLAR---PTENEM 283
             R+Y   EI+L   H ++ G+   ++D+K  NI ++ +  + + DFGL++     E E 
Sbjct: 106 EVRFYSG-EIILALEHLHKLGI--VYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER 162

Query: 284 T-GYVATRWYRAPEIMLNWM-HYNQTDIHQLNLIMEMLGTPPAEFMAK----ISSDSARK 337
           T  +  T  Y APEI+     H    D   L +++  L T  + F  +      S+ +R+
Sbjct: 163 TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRR 222

Query: 338 YINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI-----TAEQALAHPYLS--Q 390
            +   P               P+A DLL  +L  D +KR+      A +   HP+     
Sbjct: 223 ILKCDPPFPSF--------IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274

Query: 391 YSDPNDEPTSPPYDQSFED 409
           +        +PP+  S  +
Sbjct: 275 WEALALRKVNPPFRPSIRN 293

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 42.0 bits (99), Expect = 3e-04
 Identities = 36/169 (21%), Positives = 70/169 (41%), Gaps = 37/169 (21%)

Query: 241 MHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEM--TGYVATRWYRAPEIM 298
           + Y  + +    +D+KPSN+ +N + ++K+ DFG++    + +  T     + Y APE +
Sbjct: 116 LEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERI 175

Query: 299 ---LNWMHYN-QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKD----F 350
              LN   Y+ ++D+  L + M  L T                     P  + K      
Sbjct: 176 NPELNQKGYDVKSDVWSLGITMIELAT------------------GRFPYDSWKTPFQQL 217

Query: 351 RQVFKGANPQA---------IDLLSLMLELDSEKRITAEQALAHPYLSQ 390
           +QV +  +PQ           D ++  L+ + ++R    + L HP+   
Sbjct: 218 KQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 42.1 bits (99), Expect = 3e-04
 Identities = 34/105 (32%), Positives = 54/105 (51%), Gaps = 12/105 (11%)

Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV 287
           +R+Y A E+ L  M  ++ GV   ++DLK  NI ++ +   K+ DFG+ +  E  + G  
Sbjct: 98  SRFY-AAEVTLALMFLHRHGV--IYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVT 152

Query: 288 ATRW-----YRAPEIMLNWMHYNQTDIHQLNLIM-EML-GTPPAE 325
            T +     Y APEI+    +    D   L ++M EM+ G PP E
Sbjct: 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 42.7 bits (100), Expect = 3e-04
 Identities = 21/50 (42%), Positives = 30/50 (60%), Gaps = 1/50 (2%)

Query: 167 DDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
            D V F  YQ+  G++++ S   +HRDL   N+ + E   +KI DFGLAR
Sbjct: 239 MDLVGF-SYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLAR 287

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 45/175 (25%), Positives = 80/175 (45%), Gaps = 27/175 (15%)

Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSV----SGVKVAIKKIARPFQSAVHAKRT--YR 113
           E+ R  I +   L + SF +++      V       +VAIK +    ++A   +R     
Sbjct: 2   EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN---EAASMRERIEFLN 58

Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRT--QKLSDDHV 170
           E  ++K  N  +V+ LL V      ++  +   ++  LM   DL + LR+   ++ ++ V
Sbjct: 59  EASVMKEFNCHHVVRLLGV------VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 112

Query: 171 QF---------LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           Q          +  +I  G+ Y+++   +HRDL   N  V ED  +KI DFG+ R
Sbjct: 113 QAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 42.7 bits (100), Expect = 3e-04
 Identities = 23/62 (37%), Positives = 34/62 (54%), Gaps = 8/62 (12%)

Query: 163 QKLSDDHVQFL--------VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL 214
             LSDD  + L         YQ+ RG++++ S   +HRDL   N+ + +   +KI DFGL
Sbjct: 224 NLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGL 283

Query: 215 AR 216
           AR
Sbjct: 284 AR 285

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 41.7 bits (98), Expect = 4e-04
 Identities = 40/161 (24%), Positives = 76/161 (47%), Gaps = 18/161 (11%)

Query: 238 LNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLA---RPTENEMTGYVATRWYRA 294
           L ++H     V    +D+K +NI V     +K+ DFG+A       ++ + +V T ++ A
Sbjct: 114 LKYIHK----VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMA 169

Query: 295 PEIMLNWMHYNQ-TDIHQLNL-IMEML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFR 351
           PE++    +Y+   DI  L + I EM  G PP       S   A + +  +P    K  R
Sbjct: 170 PEVITEGKYYDTKADIWSLGITIYEMATGNPP------YSDVDAFRAMMLIP--KSKPPR 221

Query: 352 QVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYS 392
               G +    + ++  L+ + ++R++AE+ L   ++  +S
Sbjct: 222 LEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 42.1 bits (99), Expect = 4e-04
 Identities = 36/149 (24%), Positives = 70/149 (46%), Gaps = 16/149 (10%)

Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML--NWMHYN-QTDI 309
           +D+K  NI + E   +K+ DFG A    +    +V T ++ APE++L  +   Y+ + D+
Sbjct: 139 RDIKAGNILLTEPGTVKLADFGSA-SLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDV 197

Query: 310 HQLNLI-MEMLGTPPAEFMAKISSDSARKYI--NSLPLLTKKDFRQVFKGANPQAIDLLS 366
             L +  +E+    P  F   +++ SA  +I  N  P L+  D+   F        + + 
Sbjct: 198 WSLGITCIELAERKPPLF--NMNAMSALYHIAQNDSPTLSSNDWSDYF-------RNFVD 248

Query: 367 LMLELDSEKRITAEQALAHPYLSQYSDPN 395
             L+   + R ++E+ L H ++ +   P 
Sbjct: 249 SCLQKIPQDRPSSEELLKHRFVLRERPPT 277

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 41.9 bits (98), Expect = 4e-04
 Identities = 29/120 (24%), Positives = 59/120 (49%), Gaps = 10/120 (8%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           +G  V ++       +  H K    E+ +     H N++    VF + + L      +++
Sbjct: 24  TGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWL------WVI 77

Query: 149 THLMG-ADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED 204
           +  M     N++L+T   + +S+  +  +++  LRGL Y+H  G IHR++K S+I ++ D
Sbjct: 78  SPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGD 137

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 41.8 bits (99), Expect = 4e-04
 Identities = 23/97 (23%), Positives = 49/97 (50%), Gaps = 7/97 (7%)

Query: 122 NHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQ-KLSDDHVQFLVYQILRG 180
           ++ N I L     +        +V ++ ++   DL ++L+ + KLS+  V+ ++ Q++  
Sbjct: 67  DNPNFIKLYYSVTTLKG-----HVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEA 121

Query: 181 LKYIHSAGIIHRDLKPSNIAVNE-DCELKILDFGLAR 216
           L  +H   IIH D+K  N+  +     + + D+GL +
Sbjct: 122 LNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK 158

Length = 267

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 41.9 bits (98), Expect = 4e-04
 Identities = 21/54 (38%), Positives = 29/54 (53%), Gaps = 3/54 (5%)

Query: 180 GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE---NEMTGYVATRW 230
           G++Y+     IHRDL   N+ V E+   KI DFGL+R  E    +  G +  RW
Sbjct: 131 GMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRW 184

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 41.7 bits (98), Expect = 5e-04
 Identities = 22/74 (29%), Positives = 37/74 (50%), Gaps = 2/74 (2%)

Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ ++    +K+ DFG A+   +       T  Y APE++ +  H    D   
Sbjct: 141 YRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWT 200

Query: 312 LN-LIMEML-GTPP 323
           +  L+ E + G PP
Sbjct: 201 MGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 40.7 bits (96), Expect = 5e-04
 Identities = 14/33 (42%), Positives = 20/33 (60%), Gaps = 1/33 (3%)

Query: 184 IHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           +H AGI+H DL  SNI ++    +  +DFGL  
Sbjct: 108 LHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGE 139

Length = 204

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 41.0 bits (97), Expect = 6e-04
 Identities = 19/61 (31%), Positives = 30/61 (49%), Gaps = 6/61 (9%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENE-----MTGYVATRWYRAPEIMLNWMHYNQTD 308
           DL   N  V E+  +KI DFGL+R   ++       G +  RW  APE +      +++D
Sbjct: 128 DLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM-APESLKEGKFTSKSD 186

Query: 309 I 309
           +
Sbjct: 187 V 187

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 41.0 bits (96), Expect = 6e-04
 Identities = 22/88 (25%), Positives = 43/88 (48%), Gaps = 1/88 (1%)

Query: 150 HLMGADL-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELK 208
           H  G  L ++I +   + ++ V+    +++  L  +H  GI+ RDL P+NI +++   ++
Sbjct: 66  HAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQ 125

Query: 209 ILDFGLARPTENEMTGYVATRWYRAPEI 236
           +  F      E+   G      Y APE+
Sbjct: 126 LTYFSRWSEVEDSCDGEAVENMYCAPEV 153

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 40.6 bits (96), Expect = 7e-04
 Identities = 19/61 (31%), Positives = 30/61 (49%), Gaps = 6/61 (9%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENE-----MTGYVATRWYRAPEIMLNWMHYNQTD 308
           DL   N  V E+  +KI DFGL+R   ++       G +  RW  APE +      +++D
Sbjct: 127 DLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWM-APESLKEGKFTSKSD 185

Query: 309 I 309
           +
Sbjct: 186 V 186

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 41.1 bits (96), Expect = 7e-04
 Identities = 42/190 (22%), Positives = 82/190 (43%), Gaps = 32/190 (16%)

Query: 216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGL 275
           R  E E+  Y         EI+L   H ++ G+   ++D+K  NI ++ +  + + DFGL
Sbjct: 101 RFKEQEVQIYSG-------EIVLALEHLHKLGI--IYRDIKLENILLDSNGHVVLTDFGL 151

Query: 276 AR---PTENEMT-GYVATRWYRAPEIML--NWMHYNQTDIHQLNLIMEMLGTPPAEFMA- 328
           ++     E E    +  T  Y AP+I+   +  H    D   + ++M  L T  + F   
Sbjct: 152 SKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD 211

Query: 329 ---KISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI-----TAE 380
                 ++ +R+ + S P   ++         +  A D++  +L  D +KR+      A+
Sbjct: 212 GEKNSQAEISRRILKSEPPYPQE--------MSALAKDIIQRLLMKDPKKRLGCGPSDAD 263

Query: 381 QALAHPYLSQ 390
           +   HP+  +
Sbjct: 264 EIKKHPFFQK 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 41.2 bits (96), Expect = 7e-04
 Identities = 44/166 (26%), Positives = 72/166 (43%), Gaps = 25/166 (15%)

Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPT---ENEMTGYVATRWYRAPEIMLNWMHYNQTD 308
           ++DLKP NI ++    + + DFGL +         + +  T  Y APE++    +    D
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVD 178

Query: 309 IHQLNLIM-EML-GTPPAEFMAKISSDSARKYINSL--PLLTKKDFRQVFKGANPQAIDL 364
              L  ++ EML G PP       S ++A  Y N L  PL  K +           A  L
Sbjct: 179 WWCLGAVLYEMLYGLPPF-----YSRNTAEMYDNILNKPLQLKPNITN-------SARHL 226

Query: 365 LSLMLELDSEKRITAEQAL----AHPYLS--QYSDPNDEPTSPPYD 404
           L  +L+ D  KR+ A+        H + S   + D  ++  +PP++
Sbjct: 227 LEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKKITPPFN 272

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 41.1 bits (96), Expect = 7e-04
 Identities = 18/39 (46%), Positives = 26/39 (66%)

Query: 177 ILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 215
           +L  L+YIH  GI H D+KP NI V+ +    I+D+G+A
Sbjct: 135 MLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIA 173

Length = 294

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 40.8 bits (95), Expect = 8e-04
 Identities = 23/76 (30%), Positives = 39/76 (51%), Gaps = 7/76 (9%)

Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTEN------EMTGYVATRWYRAPEIMLNWMHYNQ 306
           +DL   N+ V ED  +KI DFGLAR   N         G +  +W  APE + + ++ +Q
Sbjct: 158 RDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWM-APEALFDRVYTHQ 216

Query: 307 TDIHQLNLIMEMLGTP 322
           +D+    +++  + T 
Sbjct: 217 SDVWSFGVLLWEIFTL 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 40.5 bits (95), Expect = 9e-04
 Identities = 34/141 (24%), Positives = 61/141 (43%), Gaps = 16/141 (11%)

Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEMT-GYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           +DLK +NI +  +  +KI D G+++  +  M    + T  Y APE+     +  ++DI  
Sbjct: 127 RDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWS 186

Query: 312 LN-LIMEML-GTPP--AEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSL 367
           L  L+ EM    PP  A  M  +     R     +P +  +D +             +  
Sbjct: 187 LGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNF-----------IRS 235

Query: 368 MLELDSEKRITAEQALAHPYL 388
           ML++  + R   ++ LA P +
Sbjct: 236 MLQVKPKLRPNCDKILASPAV 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 40.1 bits (93), Expect = 0.001
 Identities = 49/190 (25%), Positives = 87/190 (45%), Gaps = 29/190 (15%)

Query: 228 TRWYRAPEIM--LNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENE--- 282
           TR+Y A EI+  L+++H  +      ++DLK  N+ +++D  +KI DFGL +    +   
Sbjct: 97  TRFYGA-EIVSALDYLHSGK----IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT 151

Query: 283 MTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIM--EMLGTPPAEFMAKISSDSARKYIN 340
           M  +  T  Y APE++ +  +    D   L ++M   M G  P       + D  + +  
Sbjct: 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----YNQDHEKLF-- 204

Query: 341 SLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI-----TAEQALAHPYLS--QYSD 393
            L L+    F +     +  A  LLS +L  D  KR+      A++ + H + +   + D
Sbjct: 205 ELILMEDIKFPRTL---SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQD 261

Query: 394 PNDEPTSPPY 403
             D+   PP+
Sbjct: 262 VYDKKLVPPF 271

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 40.7 bits (95), Expect = 0.001
 Identities = 42/160 (26%), Positives = 70/160 (43%), Gaps = 23/160 (14%)

Query: 225 YVATRWYRAPEIM--LNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPT--- 279
           Y AT  + A EI+  L ++H         ++DLK  N+ ++ D  +KI DFG+ +     
Sbjct: 96  YRAT--FYAAEIVCGLQFLHSKGI----IYRDLKLDNVMLDRDGHIKIADFGMCKENVFG 149

Query: 280 ENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN-LIMEML-GTPPAEFMAKISSDSARK 337
           +N  + +  T  Y APEI+    +    D      L+ EML G  P         D   +
Sbjct: 150 DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP------FHGDDEDE 203

Query: 338 YINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI 377
              S+ + T    R + K    ++ D+L  + E D  +R+
Sbjct: 204 LFESIRVDTPHYPRWITK----ESKDILEKLFERDPTRRL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 39.8 bits (93), Expect = 0.001
 Identities = 43/159 (27%), Positives = 66/159 (41%), Gaps = 24/159 (15%)

Query: 236 IMLNWMHYNQTGVPFYFQDLKPSNIAVNE-DCELKILDFGLARPTENEMTGY--VATRWY 292
           + L+ +H          +DLK  NI +++    +KI DFG+++   ++   Y  V T  Y
Sbjct: 112 LALHHVHTKL----ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCY 167

Query: 293 RAPEIMLNWMHYNQ-TDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFR 351
            +PE+      YNQ +DI  L  ++  L +    F A            +LP L  K   
Sbjct: 168 ISPEL-CEGKPYNQKSDIWALGCVLYELASLKRAFEAA-----------NLPALVLKIMS 215

Query: 352 QVFKG----ANPQAIDLLSLMLELDSEKRITAEQALAHP 386
             F       +P    L+  ML LD  KR    Q +A P
Sbjct: 216 GTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 40.7 bits (95), Expect = 0.001
 Identities = 47/207 (22%), Positives = 71/207 (34%), Gaps = 54/207 (26%)

Query: 238 LNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLA----RPTENEMTGYVATRWYR 293
           + ++H N+       +D+K  NI +N   ++ + DFG A        N+  G+  T    
Sbjct: 195 IQYLHENR----IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATN 250

Query: 294 APEIMLNWMHYNQTDI------------------------------HQLNLIMEMLGTPP 323
           APE++    +    DI                               Q+ LI+   GT P
Sbjct: 251 APELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHP 310

Query: 324 AEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSL----------MLELDS 373
            EF     ++    YI     L KK  R+   G+ P   +L  L          ML  D+
Sbjct: 311 NEFPIDAQANLDEIYIG----LAKKSSRK--PGSRPLWTNLYELPIDLEYLICKMLAFDA 364

Query: 374 EKRITAEQALAHPYLSQYSDPNDEPTS 400
             R +AE  L         DP   P  
Sbjct: 365 HHRPSAEALLDFAAFQDIPDPYPNPME 391

Length = 391

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 28/76 (36%), Positives = 40/76 (52%), Gaps = 4/76 (5%)

Query: 252 FQDLKPSNIAVNEDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIMLNWMHYNQTDI 309
           ++DLKP NI +++   ++I D GLA   P    + G V T  Y APE++ N  +    D 
Sbjct: 125 YRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDW 184

Query: 310 HQLN-LIMEML-GTPP 323
             L  LI EM+ G  P
Sbjct: 185 WGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 28/98 (28%), Positives = 48/98 (48%), Gaps = 15/98 (15%)

Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTEN------EMTGYVATRWYRAPEIMLNWMHYNQ 306
           +DL   N+ V E+  +KI DFGLAR   N         G +  +W  APE + + ++ +Q
Sbjct: 161 RDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWM-APEALFDRVYTHQ 219

Query: 307 TDIHQLNLIM----EMLGTP----PAEFMAKISSDSAR 336
           +D+    ++M     + G+P    P E + K+  +  R
Sbjct: 220 SDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR 257

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 39.7 bits (92), Expect = 0.002
 Identities = 37/145 (25%), Positives = 69/145 (47%), Gaps = 14/145 (9%)

Query: 253 QDLKPSNIAVNEDCELKILDFGLA---RPTENEMTGYVATRWYRAPEIMLNWMHYNQTDI 309
           +D+K +N+ ++E  ++K+ DFG+A     T+ +   +V T ++ APE++    + ++ DI
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADI 184

Query: 310 HQLNLIMEML--GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSL 367
             L +    L  G PP   M  +         N  P LT  +F + FK       + +  
Sbjct: 185 WSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP-PTLT-GEFSKPFK-------EFIDA 235

Query: 368 MLELDSEKRITAEQALAHPYLSQYS 392
            L  D   R TA++ L H ++ + +
Sbjct: 236 CLNKDPSFRPTAKELLKHKFIVKNA 260

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 40/164 (24%), Positives = 77/164 (46%), Gaps = 22/164 (13%)

Query: 252 FQDLKPSNIAVNEDCELKILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHYNQTD 308
           ++D+K  N+ +++D  +KI DFGL +        M  +  T  Y APE++ +  +    D
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 177

Query: 309 IHQLNLIM-EML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLS 366
              L ++M EM+ G  P       + D  R +   L L+ +  F +     +P+A  LL+
Sbjct: 178 WWGLGVVMYEMMCGRLPF-----YNQDHERLF--ELILMEEIRFPRTL---SPEAKSLLA 227

Query: 367 LMLELDSEKRI-----TAEQALAHPYLS--QYSDPNDEPTSPPY 403
            +L+ D ++R+      A++ + H +     + D   +   PP+
Sbjct: 228 GLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPF 271

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only]

 Score = 40.4 bits (95), Expect = 0.002
 Identities = 17/54 (31%), Positives = 26/54 (48%), Gaps = 7/54 (12%)

Query: 164 KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP 217
           +L++  V+  + Q+LR        G  H D  P NI V  D  + +LDFG+   
Sbjct: 268 ELAELLVRAFLRQLLRD-------GFFHADPHPGNILVRSDGRIVLLDFGIVGR 314

Length = 517

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 40.1 bits (93), Expect = 0.002
 Identities = 38/157 (24%), Positives = 71/157 (45%), Gaps = 34/157 (21%)

Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLN-NILRTQKL----SDD 168
           E+ +++ + H+N++  +D F +    A+ K   ++      DL+ NI +  K+     + 
Sbjct: 62  EVNVMRELKHKNIVRYIDRFLNK---ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEH 118

Query: 169 HVQFLVYQILRGLKYIHSAG-------IIHRDLKPSNIAVNEDCE--------------- 206
            +  +  Q+L  L Y H+         ++HRDLKP NI ++                   
Sbjct: 119 AIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGR 178

Query: 207 --LKILDFGLARPTENEMTGY--VATRWYRAPEIMLN 239
              KI DFGL++    E   +  V T +Y +PE++L+
Sbjct: 179 PIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLH 215

Length = 1021

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 38.7 bits (90), Expect = 0.003
 Identities = 23/71 (32%), Positives = 40/71 (56%), Gaps = 4/71 (5%)

Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEMT---GYVATRWYRAPEIMLNWMHYNQTDI 309
           +D+K  NI + +D  +K+ DFG+AR   + +      + T +Y +PEI  N  + N++DI
Sbjct: 125 RDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDI 184

Query: 310 HQLNLIM-EML 319
             L  ++ EM 
Sbjct: 185 WALGCVLYEMC 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 39.4 bits (92), Expect = 0.003
 Identities = 30/100 (30%), Positives = 47/100 (47%), Gaps = 11/100 (11%)

Query: 231 YRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTG----- 285
           + A EI +     +  G+   ++DLK  N+ ++ +  +KI DFG+ +  EN   G     
Sbjct: 105 FYAAEIAIGLFFLHSKGI--IYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRT 160

Query: 286 YVATRWYRAPEIMLNWMHYNQTDIHQLN-LIMEML-GTPP 323
           +  T  Y APEI+    +    D      L+ EML G PP
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

 Score = 39.2 bits (92), Expect = 0.003
 Identities = 17/62 (27%), Positives = 33/62 (53%)

Query: 160 LRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE 219
           L   +L  ++   ++ +IL  ++  +  GI+H DL   NI V ED ++ ++D+  A P  
Sbjct: 194 LYRLRLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWPQAVPIS 253

Query: 220 NE 221
           + 
Sbjct: 254 HP 255

Length = 304

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 30/120 (25%), Positives = 55/120 (45%), Gaps = 10/120 (8%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           +G  V +++I     +         EL + K  NH N++     F     +AD   +++V
Sbjct: 24  TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATF-----IAD-NELWVV 77

Query: 149 THLMG----ADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED 204
           T  M      DL        +S+  + +++  +L+ L YIH  G +HR +K S+I ++ D
Sbjct: 78  TSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD 137

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 38.5 bits (90), Expect = 0.004
 Identities = 24/80 (30%), Positives = 40/80 (50%), Gaps = 11/80 (13%)

Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTEN------EMTGYVATRWYRAPEIMLNWMHYNQ 306
           +DL   N+ V ED  +KI DFGLAR   +         G +  +W  APE + + ++ +Q
Sbjct: 156 RDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWM-APEALFDRVYTHQ 214

Query: 307 TDIHQLNL----IMEMLGTP 322
           +D+    +    I  + G+P
Sbjct: 215 SDVWSFGVLLWEIFTLGGSP 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 38.8 bits (90), Expect = 0.004
 Identities = 47/166 (28%), Positives = 73/166 (43%), Gaps = 25/166 (15%)

Query: 252 FQDLKPSNIAVNEDCELKILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHYNQTD 308
           ++DLKP NI ++    + + DFGL +     E   + +  T  Y APE++    +    D
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVD 178

Query: 309 IHQLNLIM-EML-GTPPAEFMAKISSDSARKYINSL--PLLTKKDFRQVFKGANPQAIDL 364
              L  ++ EML G PP       S D ++ Y N L  PL       Q+  G    A DL
Sbjct: 179 WWCLGAVLYEMLYGLPPF-----YSRDVSQMYDNILHKPL-------QLPGGKTVAACDL 226

Query: 365 LSLMLELDSEKRITAEQALA----HPYLS--QYSDPNDEPTSPPYD 404
           L  +L  D  +R+ A+        H + S   + D   +  +PPY+
Sbjct: 227 LVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYHKRITPPYN 272

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 38.8 bits (90), Expect = 0.004
 Identities = 30/102 (29%), Positives = 49/102 (48%), Gaps = 14/102 (13%)

Query: 155 DLNNILRTQKLSDDH------VQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELK 208
           DL   LR+ + ++        +Q +  +I  GL ++H    IH DL   N  +  D  +K
Sbjct: 81  DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVK 140

Query: 209 ILDFGLARPTENE---MTG---YVATRWYRAPEIMLNWMHYN 244
           I D+GL+     E   +T    +V  RW  APE +++ +H N
Sbjct: 141 IGDYGLSHNKYKEDYYVTPDQLWVPLRWI-APE-LVDEVHGN 180

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	427
KOG0660|consensus	359		100.0
KOG0659|consensus	318		100.0
KOG0663|consensus	419		100.0
KOG0600|consensus	560		100.0
KOG0615|consensus	475		100.0
KOG0593|consensus	396		100.0
KOG0661|consensus	538		100.0
KOG0575|consensus	592		100.0
KOG0658|consensus	364		100.0
KOG0594|consensus	323		100.0
KOG0598|consensus	357		100.0
KOG0581|consensus	364		100.0
KOG0033|consensus	355		100.0
KOG0592|consensus	604		100.0
KOG0605|consensus	550		100.0
KOG0595|consensus	429		100.0
KOG0667|consensus	586		100.0
KOG0583|consensus	370		100.0
KOG0588|consensus	786		100.0
KOG0665|consensus	369		100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0662|consensus	292		100.0
KOG0597|consensus	808		100.0
KOG0616|consensus	355		100.0
KOG0599|consensus	411		100.0
KOG0032|consensus	382		100.0
KOG0580|consensus	281		100.0
KOG0610|consensus	459		100.0
KOG0666|consensus	438		100.0
KOG0198|consensus	313		100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG0578|consensus	550		100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0585|consensus	576		100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG4717|consensus	864		100.0
KOG0591|consensus	375		100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0694|consensus	694		100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0669|consensus	376		100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0604|consensus	400		100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0582|consensus	516		100.0
KOG0607|consensus	463		100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG0611|consensus	668		100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG4236|consensus	888		100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0664|consensus	449		100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0986|consensus	591		100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG0201|consensus	467		100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG0589|consensus	426		100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
KOG0586|consensus	596		100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG0671|consensus	415		100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0192|consensus	362		100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0612|consensus	1317		100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0668|consensus	338		100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0574|consensus	502		100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0577|consensus	948		100.0
KOG0690|consensus	516		100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0579|consensus	1187		100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0596|consensus	677		100.0
KOG1035|consensus	1351		100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG1989|consensus	738		100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG4279|consensus	1226		100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
KOG1290|consensus	590		100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0670|consensus	752		100.0
KOG0614|consensus	732		100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0603|consensus	612		100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
KOG4645|consensus	1509		100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG0197|consensus	468		100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
KOG0194|consensus	474		100.0
KOG0584|consensus	632		100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG0608|consensus	1034		100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG0193|consensus	678		100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG0983|consensus	391		100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
KOG0696|consensus	683		100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG2345|consensus	302		100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG4721|consensus	904		100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG1187|consensus	361		100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
KOG0587|consensus	953		100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG4250|consensus	732		100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG0695|consensus	593		100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG1026|consensus	774		100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG1027|consensus	903		100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG1151|consensus	775		100.0
KOG1095|consensus	1025		99.98
KOG1167|consensus	418		99.97
KOG1006|consensus	361		99.97
KOG1094|consensus	807		99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
KOG4257|consensus	974		99.97
KOG0576|consensus	829		99.97
KOG4278|consensus	1157		99.97
KOG0196|consensus	996		99.96
KOG3653|consensus	534		99.96
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.96
KOG0199|consensus	1039		99.96
KOG0984|consensus	282		99.96
KOG1152|consensus	772		99.96
KOG0200|consensus	609		99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG2052|consensus	513		99.95
KOG1345|consensus	378		99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG0590|consensus	601		99.93
KOG1025|consensus	1177		99.93
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.91
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.9
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.88
KOG1024|consensus	563		99.88
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.87
KOG0603|consensus	612		99.87
KOG1165|consensus	449		99.87
KOG1164|consensus	322		99.86
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.86
KOG1163|consensus	341		99.86
PRK10345	210	hypothetical protein; Provisional	99.85
KOG0606|consensus	1205		99.85
KOG4158|consensus	598		99.8
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.79
PRK12274	218	serine/threonine protein kinase; Provisional	99.79
smart00090	237	RIO RIO-like kinase.	99.77
KOG1240|consensus	1431		99.77
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.75
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.74
PRK14879	211	serine/threonine protein kinase; Provisional	99.73
KOG0590|consensus	601		99.72
KOG1033|consensus	516		99.72
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.7
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.69
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.69
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.68
KOG1166|consensus	974		99.62
KOG0195|consensus	448		99.57
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.54
KOG0601|consensus	524		99.53
KOG1023|consensus	484		99.45
KOG0606|consensus	1205		99.38
KOG0660|consensus	359		99.36
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.36
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.26
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.26
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.24
KOG0601|consensus	524		99.14
KOG0593|consensus	396		99.11
KOG0661|consensus	538		99.03
KOG0659|consensus	318		99.02
KOG0667|consensus	586		99.02
KOG0594|consensus	323		99.0
KOG0663|consensus	419		99.0
KOG1266|consensus	458		98.98
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.94
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.93
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.91
KOG0600|consensus	560		98.9
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.89
PTZ00284	467	protein kinase; Provisional	98.77
KOG1243|consensus	690		98.75
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.74
KOG3087|consensus	229		98.73
KOG0666|consensus	438		98.72
KOG0665|consensus	369		98.72
KOG0664|consensus	449		98.7
PRK09902	216	hypothetical protein; Provisional	98.68
KOG3741|consensus	655		98.63
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	98.62
KOG0658|consensus	364		98.61
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	98.59
KOG2137|consensus	700		98.52
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.48
KOG0671|consensus	415		98.38
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	98.38
KOG0669|consensus	376		98.3
KOG0670|consensus	752		98.29
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	98.26
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	98.25
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	98.17
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	98.15
KOG0662|consensus	292		98.08
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	98.03
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	98.02
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	98.01
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	97.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	97.94
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	97.92
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	97.92
KOG1290|consensus	590		97.9
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	97.88
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	97.84
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.82
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.81
KOG0577|consensus	948		97.8
KOG1035|consensus	1351		97.8
COG0661	517	AarF Predicted unusual protein kinase [General fun	97.77
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.63
KOG0599|consensus	411		97.62
KOG0576|consensus	829		97.58
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.5
KOG0984|consensus	282		97.48
PF01636	239	APH: Phosphotransferase enzyme family This family	97.45
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.43
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.43

>KOG0660|consensus

Probab=100.00  E-value=4.9e-66  Score=480.74  Aligned_cols=320  Identities=50%  Similarity=0.824  Sum_probs=290.2

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceE
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV  145 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~  145 (427)
                      |...+.+|+|+|| |++++.++.||+.||||++.+.+......++.+||+++|++++|+||+.+++++.. ........+
T Consensus        24 y~~~~~iG~GAyG-vVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p-~~~~~f~Dv  101 (359)
T KOG0660|consen   24 YVLIEPIGRGAYG-VVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRP-PSRDKFNDV  101 (359)
T ss_pred             ecccccccCccee-eEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccc-cccccccee
Confidence            3345789999999 55578899999999999999888889999999999999999999999999999976 344566789


Q ss_pred             EEEeccCCCCHHHHHhhCC-CCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC-----
Q psy8260         146 YMVTHLMGADLNNILRTQK-LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE-----  219 (427)
Q Consensus       146 ~lv~e~~g~~L~~~l~~~~-l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~-----  219 (427)
                      |+|+++|+.||.++++.+. +++++++.+++|+++||+|+|+.+|+||||||+|+|++.+..+||||||+||...     
T Consensus       102 YiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~  181 (359)
T KOG0660|consen  102 YLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED  181 (359)
T ss_pred             EEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence            9999999999999999877 9999999999999999999999999999999999999999999999999999873     


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      ..+|.|+.|+||+|||+++.+..|+++.      |+||.||+++|                 ++.++             
T Consensus       182 ~~mTeYVaTRWYRAPElll~~~~Yt~ai------DiWSvGCI~AE-----------------mL~gk-------------  225 (359)
T KOG0660|consen  182 GFMTEYVATRWYRAPELLLNSSEYTKAI------DIWSVGCILAE-----------------MLTGK-------------  225 (359)
T ss_pred             cchhcceeeeeecCHHHHhccccccchh------hhhhhhHHHHH-----------------HHcCC-------------
Confidence            4568999999999999999999999998      99999999987                 44443             


Q ss_pred             hccCCCCC-CHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC
Q psy8260         300 NWMHYNQT-DIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT  378 (427)
Q Consensus       300 ~~~~~~~~-d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t  378 (427)
                        +.|.+. -+.|+..|+..+|+|+.+....+.++.++.++.+.|..++.+|.++|+..+|+|+|||.+||++||.+|+|
T Consensus       226 --plFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRit  303 (359)
T KOG0660|consen  226 --PLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRIT  303 (359)
T ss_pred             --CCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCC
Confidence              477777 58999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCCCCCCCCCCCCCcccccCCCCHHHHHHHHhhhcc
Q psy8260         379 AEQALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKGTYSLESL  426 (427)
Q Consensus       379 a~e~L~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  426 (427)
                      |+|+|+|||+..+.+|.++|..++...+.+.. .+.++|+..++.|.+
T Consensus       304 a~eAL~hPYl~~~hdp~dEP~~~~~~~~~~~~-~~~~~~r~~i~~e~~  350 (359)
T KOG0660|consen  304 AEEALAHPYLAPYHDPEDEPVCQPIFDSFEHE-LTEEELRELIYKEIL  350 (359)
T ss_pred             HHHHhcChhhhhhcCCccCCCCCCCCcccccc-ccHHHHHHHHHHHHH
Confidence            99999999999999999999776655445555 899999999988753

>KOG0659|consensus

Probab=100.00  E-value=2e-57  Score=406.03  Aligned_cols=283  Identities=35%  Similarity=0.545  Sum_probs=235.2

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCce
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      +|...+.+|+|.||.||+ +.+..||+.||||+++............+|||+.|+.++|+||+.|+++|...      .+
T Consensus         3 rY~~~~~lGEG~~gvVyk-a~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~------~~   75 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYK-ARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHK------SN   75 (318)
T ss_pred             hhhhhhhhcCcceEEEEE-EEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCC------Cc
Confidence            345567899999999996 55888999999999987655444456678999999999999999999998654      45


Q ss_pred             EEEEeccCCCCHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCc
Q psy8260         145 VYMVTHLMGADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM  222 (427)
Q Consensus       145 ~~lv~e~~g~~L~~~l~~~--~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~  222 (427)
                      +-+|+|++..||...++..  .++..+++.|+.|+++||+|||++.|+||||||.|+|++.+|.+||+|||+|+......
T Consensus        76 l~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   76 LSLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             eEEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            7899999999999999764  58999999999999999999999999999999999999999999999999999876542


Q ss_pred             ---ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         223 ---TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       223 ---~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                         +..+.|+||+|||++.|.+.|+...      |+|+.||+++|                 +               ++
T Consensus       156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~V------DmWavGCI~AE-----------------L---------------ll  197 (318)
T KOG0659|consen  156 RIQTHQVVTRWYRAPELLFGSRQYGTGV------DMWAVGCIFAE-----------------L---------------LL  197 (318)
T ss_pred             cccccceeeeeccChHHhccchhcCCcc------hhhhHHHHHHH-----------------H---------------Hc
Confidence               3347899999999999999999887      99999999987                 2               23


Q ss_pred             hccCCCC-CCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC
Q psy8260         300 NWMHYNQ-TDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT  378 (427)
Q Consensus       300 ~~~~~~~-~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t  378 (427)
                      +.+++.+ +|+.||..|+..||||..+-|....+-....-+...   +......+|...++++.||+.+||.+||.+|+|
T Consensus       198 r~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~---P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rit  274 (318)
T KOG0659|consen  198 RVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQF---PKPPLNNLFPAASSDALDLLSKMLTYNPKKRIT  274 (318)
T ss_pred             cCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcC---CCCccccccccccHHHHHHHHhhhccCchhccc
Confidence            3346655 599999999999999998887765432111111122   222233478889999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCCCC
Q psy8260         379 AEQALAHPYLSQYSDPN  395 (427)
Q Consensus       379 a~e~L~Hp~f~~~~~~~  395 (427)
                      |.|+|+||||+..+.|.
T Consensus       275 a~qaL~~~yf~~~P~pt  291 (318)
T KOG0659|consen  275 ASQALKHPYFKSLPLPT  291 (318)
T ss_pred             HHHHhcchhhhcCCCCC
Confidence            99999999999755543

>KOG0663|consensus

Probab=100.00  E-value=1.8e-56  Score=411.18  Aligned_cols=297  Identities=29%  Similarity=0.459  Sum_probs=248.8

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      ..|+..++|++|+||.||+ +.|+.|++.||+|+++.........-..+|||++|.+++|||||.+.++..+..    ..
T Consensus        76 ~efe~lnrI~EGtyGiVYR-akdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~----~d  150 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYR-AKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN----MD  150 (419)
T ss_pred             HHHHHHhhcccCcceeEEE-eccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc----cc
Confidence            3477889999999999994 778899999999999765433333445689999999999999999999987642    35


Q ss_pred             eEEEEeccCCCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         144 NVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       144 ~~~lv~e~~g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      .+||||+|+..||..++..  ++|...+++.++.|++.|++|||.+.|+||||||+|+|+++.|.+||+|||+||..++.
T Consensus       151 ~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp  230 (419)
T KOG0663|consen  151 KIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP  230 (419)
T ss_pred             eeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence            6999999999999999975  57999999999999999999999999999999999999999999999999999988775


Q ss_pred             ---cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         222 ---MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       222 ---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                         .|..+.|.||+|||++++...|+...      |+||.||++++                 +               +
T Consensus       231 ~k~~T~lVVTLWYRaPELLLG~~tyst~i------DMWSvGCI~aE-----------------~---------------l  272 (419)
T KOG0663|consen  231 LKPYTPLVVTLWYRAPELLLGAKTYSTAV------DMWSVGCIFAE-----------------L---------------L  272 (419)
T ss_pred             cccCcceEEEeeecCHHHhcCCcccCcch------hhhhHHHHHHH-----------------H---------------H
Confidence               77889999999999999999999888      99999999977                 2               2


Q ss_pred             hhccCCCC-CCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCC--ChhHHHHHHHhcCCCCCC
Q psy8260         299 LNWMHYNQ-TDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGA--NPQAIDLLSLMLELDSEK  375 (427)
Q Consensus       299 ~~~~~~~~-~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--s~~~~dLi~~mL~~dP~~  375 (427)
                      ...+.+.+ +++.++..|+.+||+|....|.....-...+.. ..+..+...+...|...  |..+.||+.++|.+||.+
T Consensus       273 ~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~-~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~k  351 (419)
T KOG0663|consen  273 TQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKM-TFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGK  351 (419)
T ss_pred             hcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhcc-ccCCCCchhhhhhccccccchhHHHHHHHHhccCccc
Confidence            33335554 599999999999999999888776543332211 23444455566666655  499999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCCCCCCCCCCCC
Q psy8260         376 RITAEQALAHPYLSQYSDPNDEPTSPPYD  404 (427)
Q Consensus       376 R~ta~e~L~Hp~f~~~~~~~~~~~~~~~~  404 (427)
                      |+||+|+|+|+||.+.+.|.++...|.|+
T Consensus       352 R~tA~~~L~h~~F~e~P~p~~P~~~Pt~P  380 (419)
T KOG0663|consen  352 RITAEDGLKHEYFRETPLPIDPSMFPTWP  380 (419)
T ss_pred             cccHHHhhcccccccCCCCCChhhcCCCc
Confidence            99999999999999987777665555554

>KOG0600|consensus

Probab=100.00  E-value=8.2e-56  Score=426.22  Aligned_cols=301  Identities=30%  Similarity=0.476  Sum_probs=248.6

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcccc
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  140 (427)
                      .....|+....||+|.||.||+ +.+..||+.||+|++...........-..|||.||++|+||||++|.+.....    
T Consensus       114 r~~~~feki~kIGeGTyg~VYk-Ar~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~----  188 (560)
T KOG0600|consen  114 RRADSFEKIEKIGEGTYGQVYK-ARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK----  188 (560)
T ss_pred             cchHHHHHHHHhcCcchhheeE-eeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec----
Confidence            3345677788999999999995 67889999999999987665556666778999999999999999999998754    


Q ss_pred             CCceEEEEeccCCCCHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCC
Q psy8260         141 DFKNVYMVTHLMGADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT  218 (427)
Q Consensus       141 ~~~~~~lv~e~~g~~L~~~l~~~--~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~  218 (427)
                      ....+|||+|||..||..++...  +|++.+++.||+|++.||+|||++||+|||||.+|||||.+|.+||+|||||+..
T Consensus       189 ~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  189 LSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             CCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeec
Confidence            23579999999999999999765  6999999999999999999999999999999999999999999999999999965


Q ss_pred             CC----CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccc
Q psy8260         219 EN----EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRA  294 (427)
Q Consensus       219 ~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~A  294 (427)
                      ..    ..|..+.|+||+|||+|+|...|+.+.      |+|+.||+++|                 ++.|++       
T Consensus       269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aV------DlWS~GCIl~E-----------------l~~gkP-------  318 (560)
T KOG0600|consen  269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAV------DLWSVGCILAE-----------------LFLGKP-------  318 (560)
T ss_pred             cCCCCcccccceEEeeccChHHhcCCcccccce------eehhhhHHHHH-----------------HHcCCC-------
Confidence            43    367889999999999999999999888      99999999988                 444433       


Q ss_pred             hHHhhhccCCC-CCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCC-CCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         295 PEIMLNWMHYN-QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPL-LTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       295 PEvl~~~~~~~-~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                              .+. .+++.||-.|+.+||+|...+|....-....   ...+. .....+.+.|...++.+++|+.+||.+|
T Consensus       319 --------I~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~---~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ld  387 (560)
T KOG0600|consen  319 --------ILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHAT---IFKPQQPYKRRLRETFKDFPASALDLLEKLLSLD  387 (560)
T ss_pred             --------CcCCccHHHHHHHHHHHhCCCChhccccccCCccc---ccCCCCcccchHHHHhccCCHHHHHHHHHHhccC
Confidence                    333 4599999999999999999888732111100   01111 1234466678889999999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCccc
Q psy8260         373 SEKRITAEQALAHPYLSQYSDPNDEPTSPPYDQSF  407 (427)
Q Consensus       373 P~~R~ta~e~L~Hp~f~~~~~~~~~~~~~~~~~~~  407 (427)
                      |.+|.||.++|+|+||..-+.|.++..-|.++.+.
T Consensus       388 P~kR~tA~~aL~seyF~t~p~~~~p~~Lp~y~~s~  422 (560)
T KOG0600|consen  388 PDKRGTASSALQSEYFTTEPLPCDPSSLPKYPPSH  422 (560)
T ss_pred             ccccccHHHHhcCcccccCCCCCCcccCCCCCcch
Confidence            99999999999999997655666665556665444

>KOG0615|consensus

Probab=100.00  E-value=9e-56  Score=416.60  Aligned_cols=258  Identities=30%  Similarity=0.487  Sum_probs=201.0

Q ss_pred             cCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHH-----HHHHHHHHHHHHhcCCCCCceeeeeeeecC
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAV-----HAKRTYRELRMLKHMNHENVIGLLDVFHSN  136 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~-----~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~  136 (427)
                      ....|.+.+.||.|+||.|- .+.++.||+.||||++++......     ......+|+++|++|+|||||+++++|...
T Consensus       170 ~~d~yii~~~LGsGafg~Vk-la~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~  248 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVK-LAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP  248 (475)
T ss_pred             hcceeEeeeeecCCceeEEE-EEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence            45567889999999999877 578999999999999976533221     123356999999999999999999999764


Q ss_pred             ccccCCceEEEEeccC-CCCHHHHH-hhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCC---CCEEEee
Q psy8260         137 TCLADFKNVYMVTHLM-GADLNNIL-RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED---CELKILD  211 (427)
Q Consensus       137 ~~~~~~~~~~lv~e~~-g~~L~~~l-~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~---~~~kl~D  211 (427)
                            ...|||+|++ ||+|.+.+ ..+.+.++..+.+++|++.|+.|||++||+||||||+|||+..+   ..+||+|
T Consensus       249 ------ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItD  322 (475)
T KOG0615|consen  249 ------DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITD  322 (475)
T ss_pred             ------CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecc
Confidence                  4569999999 78887654 66779999999999999999999999999999999999999765   6799999


Q ss_pred             CCCCCCCCC--CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccc
Q psy8260         212 FGLARPTEN--EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT  289 (427)
Q Consensus       212 FGla~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt  289 (427)
                      ||+|+..++  -+.+.|||+.|.|||                                                      
T Consensus       323 FGlAK~~g~~sfm~TlCGTpsYvAPE------------------------------------------------------  348 (475)
T KOG0615|consen  323 FGLAKVSGEGSFMKTLCGTPSYVAPE------------------------------------------------------  348 (475)
T ss_pred             cchhhccccceehhhhcCCccccChh------------------------------------------------------
Confidence            999987642  234444555555554                                                      


Q ss_pred             ccccchHHhhhcc--CC-CCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHH-HHhcCCCCCcccHHhhcCCCChhHHHHH
Q psy8260         290 RWYRAPEIMLNWM--HY-NQTDIHQLNLIMEMLGTPPAEFMAKISSDSARK-YINSLPLLTKKDFRQVFKGANPQAIDLL  365 (427)
Q Consensus       290 ~~Y~APEvl~~~~--~~-~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~dLi  365 (427)
                             |+.+..  ++ .++|+||||+++|++.++..||..........+ .....-.+.    ...|..+|.+++|||
T Consensus       349 -------Vl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~----p~~w~~Iseea~dlI  417 (475)
T KOG0615|consen  349 -------VLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFG----PLQWDRISEEALDLI  417 (475)
T ss_pred             -------heecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccccc----ChhhhhhhHHHHHHH
Confidence                   443321  22 367999999999999888888877765553332 222111111    234567899999999


Q ss_pred             HHhcCCCCCCCCCHHHHhcCCCCCCC
Q psy8260         366 SLMLELDSEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       366 ~~mL~~dP~~R~ta~e~L~Hp~f~~~  391 (427)
                      ++||+.||++|+|++|+|+||||...
T Consensus       418 ~~mL~VdP~~R~s~~eaL~hpW~~~~  443 (475)
T KOG0615|consen  418 NWMLVVDPENRPSADEALNHPWFKDA  443 (475)
T ss_pred             HHhhEeCcccCcCHHHHhcChhhhcc
Confidence            99999999999999999999999854

>KOG0593|consensus

Probab=100.00  E-value=1.7e-55  Score=399.92  Aligned_cols=280  Identities=30%  Similarity=0.509  Sum_probs=229.8

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceE
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV  145 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~  145 (427)
                      |+....+|+|+||.|+ .|.++.||+.||||++..+..++...+-.+|||++|++++|+|+|.|+++|...      ..+
T Consensus         4 YE~LgkvGEGSYGvV~-KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrk------rkl   76 (396)
T KOG0593|consen    4 YEKLGKVGEGSYGVVM-KCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRK------RKL   76 (396)
T ss_pred             HhhhhccccCcceEEE-EeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhc------cee
Confidence            4555689999999998 578999999999999876655555566678999999999999999999999764      568


Q ss_pred             EEEeccCCCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC---C
Q psy8260         146 YMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE---N  220 (427)
Q Consensus       146 ~lv~e~~g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~---~  220 (427)
                      ++|+||+..++.+.+..  +++++..++.+++|++.|+.|||++++||||||||||||+.+|.+||||||+||...   .
T Consensus        77 hLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd  156 (396)
T KOG0593|consen   77 HLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD  156 (396)
T ss_pred             EEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcc
Confidence            99999998877776654  579999999999999999999999999999999999999999999999999999765   3


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      ..|.|+.|+||+|||++.|...|....      |+|+.||+++|                 +.+|.+             
T Consensus       157 ~YTDYVATRWYRaPELLvGDtqYG~pV------DiWAiGCv~aE-----------------l~~G~p-------------  200 (396)
T KOG0593|consen  157 NYTDYVATRWYRAPELLVGDTQYGKPV------DIWAIGCVFAE-----------------LLTGEP-------------  200 (396)
T ss_pred             hhhhhhhhhhccChhhhcccCcCCCcc------cchhhhHHHHH-----------------HhcCCc-------------
Confidence            467899999999999999988888877      99999999987                 444433             


Q ss_pred             ccCCC-CCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCC-CCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC
Q psy8260         301 WMHYN-QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPL-LTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT  378 (427)
Q Consensus       301 ~~~~~-~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t  378 (427)
                        +++ .+|+++|-.|...||...+.-..-..+.....-+ .+|. ....++...++.++.-+.||+.+||+.||++|+|
T Consensus       201 --L~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv-~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~s  277 (396)
T KOG0593|consen  201 --LWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV-RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLS  277 (396)
T ss_pred             --CCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee-ecCCCCCccchhhhcccchHHHHHHHHHHhcCCcccccc
Confidence              444 4699999999999998776543222111100000 1221 1234566677889999999999999999999999


Q ss_pred             HHHHhcCCCCCCC
Q psy8260         379 AEQALAHPYLSQY  391 (427)
Q Consensus       379 a~e~L~Hp~f~~~  391 (427)
                      .+|+|.||||+.+
T Consensus       278 c~qll~H~yFd~~  290 (396)
T KOG0593|consen  278 CEQLLHHPYFDGF  290 (396)
T ss_pred             HHHHhcChHHHHH
Confidence            9999999999754

>KOG0661|consensus

Probab=100.00  E-value=1.3e-55  Score=422.11  Aligned_cols=282  Identities=32%  Similarity=0.509  Sum_probs=239.1

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCC-CCCceeeeeeeecCccccCC
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN-HENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .+|.+.+.+|.|.||.||. +....+|..||||++++.+..-.+. --+||+..|++|+ |||||+|.+++.+..     
T Consensus        10 ~RY~~i~klGDGTfGsV~l-a~~~~~~~~VAIK~MK~Kf~s~ee~-~nLREvksL~kln~hpniikL~Evi~d~~-----   82 (538)
T KOG0661|consen   10 DRYTVIRKLGDGTFGSVYL-AKSKETGELVAIKKMKKKFYSWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDND-----   82 (538)
T ss_pred             HHHHHHHHhcCCcceeEEE-eeecCCCceeeHHHHHhhhccHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccC-----
Confidence            5677889999999999996 5567899999999998876654332 2369999999999 999999999987643     


Q ss_pred             ceEEEEeccCCCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         143 KNVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       143 ~~~~lv~e~~g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      ..+|+|||||..+|+++++.  ..|++..++.|+.||++||+|+|.+|+.|||+||||||+..+..+||+|||+||...+
T Consensus        83 ~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S  162 (538)
T KOG0661|consen   83 RILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS  162 (538)
T ss_pred             ceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc
Confidence            36899999999999999975  4599999999999999999999999999999999999999888999999999998754


Q ss_pred             --CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         221 --EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       221 --~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                        ..|.|+.|+||+|||+|+....|+...      |+|+.||+.+|                 ..               
T Consensus       163 kpPYTeYVSTRWYRAPEvLLrs~~Ys~pv------D~wA~GcI~aE-----------------l~---------------  204 (538)
T KOG0661|consen  163 KPPYTEYVSTRWYRAPEVLLRSGYYSSPV------DMWAVGCIMAE-----------------LY---------------  204 (538)
T ss_pred             CCCcchhhhcccccchHHhhhccccCCch------HHHHHHHHHHH-----------------HH---------------
Confidence              578999999999999999988888776      99999999877                 11               


Q ss_pred             hhccCCCCC-CHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC
Q psy8260         299 LNWMHYNQT-DIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI  377 (427)
Q Consensus       299 ~~~~~~~~~-d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~  377 (427)
                      .-.++|.+. +++++-.|..+||+|....+... .......-...|......+...++..++++.+||.+||.+||.+||
T Consensus       205 sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg-~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRp  283 (538)
T KOG0661|consen  205 SLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG-YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRP  283 (538)
T ss_pred             HhcccCCCCcHHHHHHHHHHHhCCCccccchhH-HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCc
Confidence            112366665 89999999999999987655432 1223333334677777788888888999999999999999999999


Q ss_pred             CHHHHhcCCCCCCC
Q psy8260         378 TAEQALAHPYLSQY  391 (427)
Q Consensus       378 ta~e~L~Hp~f~~~  391 (427)
                      ||+|+|+||||+..
T Consensus       284 TA~~al~~pffq~~  297 (538)
T KOG0661|consen  284 TASQALQHPFFQVG  297 (538)
T ss_pred             cHHHHhcCcccccc
Confidence            99999999999853

>KOG0575|consensus

Probab=100.00  E-value=4.6e-53  Score=416.47  Aligned_cols=262  Identities=28%  Similarity=0.427  Sum_probs=214.9

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcC-CCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPF-QSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      ..|..++.||+|||..+|. +.+..+|..||+|++.+.. ....+.++..+||+|++.|+|||||+++++|++.      
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe-~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs------   90 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYE-ARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDS------   90 (592)
T ss_pred             ceeeeeeeeccCcceEEEE-EEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecC------
Confidence            4588999999999999995 5677899999999997643 2345667788999999999999999999999754      


Q ss_pred             ceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      .++||+.|+| .++|..+++. +.++|.+++.+++||+.||.|||+++|||||||..|++++++.+|||+|||||.....
T Consensus        91 ~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   91 NNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             CceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecC
Confidence            6899999999 6888888864 5799999999999999999999999999999999999999999999999999975432


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      +.                                                          +...+.||||-|.||||+.+
T Consensus       171 ~~----------------------------------------------------------Erk~TlCGTPNYIAPEVl~k  192 (592)
T KOG0575|consen  171 DG----------------------------------------------------------ERKKTLCGTPNYIAPEVLNK  192 (592)
T ss_pred             cc----------------------------------------------------------cccceecCCCcccChhHhcc
Confidence            10                                                          12235678888888888887


Q ss_pred             ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHH
Q psy8260         301 WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAE  380 (427)
Q Consensus       301 ~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~  380 (427)
                      ..+...+|+||+|||+|.|..+.+||..+.-+++..+.....-.        +...+|.+|+|||.+||+.||.+|||++
T Consensus       193 ~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~--------~P~~ls~~A~dLI~~lL~~~P~~Rpsl~  264 (592)
T KOG0575|consen  193 SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYS--------MPSHLSAEAKDLIRKLLRPNPSERPSLD  264 (592)
T ss_pred             CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcc--------cccccCHHHHHHHHHHhcCCcccCCCHH
Confidence            77888999999999999987666666554434444444322211        1235799999999999999999999999


Q ss_pred             HHhcCCCCCCCCCCCCCC
Q psy8260         381 QALAHPYLSQYSDPNDEP  398 (427)
Q Consensus       381 e~L~Hp~f~~~~~~~~~~  398 (427)
                      ++|.|+||+....|...|
T Consensus       265 ~vL~h~Ff~~g~~p~~lp  282 (592)
T KOG0575|consen  265 EVLDHPFFKSGFTPARLP  282 (592)
T ss_pred             HHhcCHhhhCCCcCCCCC
Confidence            999999997666665443

>KOG0658|consensus

Probab=100.00  E-value=3.6e-53  Score=395.31  Aligned_cols=305  Identities=30%  Similarity=0.533  Sum_probs=241.4

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCce
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      .+.-.+.+|.|+||.||.+.+. .+++.||||++.....      -.-+|+++|+.++|||||+|..+|...... +.-.
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~-e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~-d~~~   96 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLR-ETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTES-DEVY   96 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEc-CCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCC-chhH
Confidence            3556689999999999976654 5699999999864321      123799999999999999999988764322 2334


Q ss_pred             EEEEeccCCCCHHHHHh-----hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCC-CCEEEeeCCCCCCC
Q psy8260         145 VYMVTHLMGADLNNILR-----TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARPT  218 (427)
Q Consensus       145 ~~lv~e~~g~~L~~~l~-----~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~-~~~kl~DFGla~~~  218 (427)
                      ..+|+||+..+|.+.++     +.+++...++.+++||++||.|||+.||+||||||+|+|+|.+ |.+||||||.|+..
T Consensus        97 lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen   97 LNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            56899999999999987     4679999999999999999999999999999999999999965 99999999999976


Q ss_pred             C--CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         219 E--NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       219 ~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      .  +...+|..|++|+|||.|.|...|+.+.      |+||+||+++|                 ++.|.+         
T Consensus       177 ~~~epniSYicSRyYRaPELifga~~Yt~~I------DiWSaGCV~aE-----------------Ll~g~p---------  224 (364)
T KOG0658|consen  177 VKGEPNISYICSRYYRAPELIFGATEYTTSI------DIWSAGCVMAE-----------------LLKGQP---------  224 (364)
T ss_pred             ccCCCceeEEEeccccCHHHHcCccccCcee------EEhhhhHHHHH-----------------HhcCCc---------
Confidence            4  3457799999999999999999999888      99999999987                 444444         


Q ss_pred             HhhhccCCCC-CCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHh-hcCCCChhHHHHHHHhcCCCCC
Q psy8260         297 IMLNWMHYNQ-TDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQ-VFKGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       297 vl~~~~~~~~-~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dLi~~mL~~dP~  374 (427)
                            .|.+ +.+.+|-.|+.++|+|+.+........-.   ....|......|.+ .+...++++.||+.++|+++|.
T Consensus       225 ------lFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~---~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~  295 (364)
T KOG0658|consen  225 ------LFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYT---EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPS  295 (364)
T ss_pred             ------ccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccc---cccCcccccccceeecccCCCHHHHHHHHHHhccChh
Confidence                  5655 47899999999999999877654322110   11234444455545 4567899999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCCC-----CCCCCCCCCcccccCCCCHHHHH
Q psy8260         375 KRITAEQALAHPYLSQYSDPN-----DEPTSPPYDQSFEDMDLPVDQWK  418 (427)
Q Consensus       375 ~R~ta~e~L~Hp~f~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~  418 (427)
                      +|.||.|+|.||||+..+.|+     ..+.++-|++...+....-+-|+
T Consensus       296 ~R~~~~~~l~h~fFdelr~~~~~l~~g~~lp~lf~f~~~e~~~~~~~~~  344 (364)
T KOG0658|consen  296 KRLSALEALAHPFFDELRDPNTKLPNGRPLPPLFNFKRAELGISPELVN  344 (364)
T ss_pred             hcCCHHHHhcchhhHHhhCcCccCcCCCcCCCccCchHHHhccchHHHH
Confidence            999999999999999887763     23444555555555555444444

>KOG0594|consensus

Probab=100.00  E-value=1.3e-51  Score=385.22  Aligned_cols=289  Identities=33%  Similarity=0.537  Sum_probs=237.7

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCC-ceeeeeeeecCccccCCc
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHEN-VIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~Hpn-Iv~l~~~~~~~~~~~~~~  143 (427)
                      .|...+.+|+|.||.||+ +.+..+|+.||+|++......+.......||+.+|++++|+| ||.|+++++.........
T Consensus        12 ~~~~~eklGeGtyg~Vyk-ar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYK-ARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHhCCCCceEEEE-EEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            355556799999999996 567889999999999765443334455789999999999999 999999998765433445


Q ss_pred             eEEEEeccCCCCHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCC
Q psy8260         144 NVYMVTHLMGADLNNILRT-----QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT  218 (427)
Q Consensus       144 ~~~lv~e~~g~~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~  218 (427)
                      .+++++|+...+|..++..     ++++...++.+++|++.||+|||+++|+||||||+||||+++|.+||+|||+|+..
T Consensus        91 ~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~  170 (323)
T KOG0594|consen   91 KLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAF  170 (323)
T ss_pred             eEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHh
Confidence            7899999999999999865     35788899999999999999999999999999999999999999999999999965


Q ss_pred             CC---CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         219 EN---EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       219 ~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      .-   ..+.-++|.||+|||++++...|+...      |+|+.||++++                 +..+          
T Consensus       171 ~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~v------DiWs~GcIfaE-----------------m~~~----------  217 (323)
T KOG0594|consen  171 SIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSV------DIWSLGCIFAE-----------------MFTR----------  217 (323)
T ss_pred             cCCcccccccEEEeeccCHHHhcCCCcCCCCc------chHhHHHHHHH-----------------HHhC----------
Confidence            42   356678999999999999998898877      99999999987                 3332          


Q ss_pred             HHhhhccCCCCC-CHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCC-cccHHhhcCCCChhHHHHHHHhcCCCC
Q psy8260         296 EIMLNWMHYNQT-DIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLT-KKDFRQVFKGANPQAIDLLSLMLELDS  373 (427)
Q Consensus       296 Evl~~~~~~~~~-d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~dLi~~mL~~dP  373 (427)
                           .++|.+. |+.++..|+..+|+|....|.....-..  +....+... ...+....+..++++.||+.+||++||
T Consensus       218 -----~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~--~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p  290 (323)
T KOG0594|consen  218 -----RPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPD--YKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDP  290 (323)
T ss_pred             -----CCCCCCCcHHHHHHHHHHHcCCCCccCCCCcccccc--ccccCcCCCCccchHHhccccCccHHHHHHHHhccCc
Confidence                 3366554 8999999999999999877776543211  111233333 556777778888999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCCCCC
Q psy8260         374 EKRITAEQALAHPYLSQYSDP  394 (427)
Q Consensus       374 ~~R~ta~e~L~Hp~f~~~~~~  394 (427)
                      ++|+||+.+|+||||.....+
T Consensus       291 ~~R~Sa~~al~h~yf~~~~~~  311 (323)
T KOG0594|consen  291 AKRISAKGALTHPYFSELPEK  311 (323)
T ss_pred             ccCcCHHHHhcChhhcccccc
Confidence            999999999999999876443

>KOG0598|consensus

Probab=100.00  E-value=1.1e-50  Score=379.38  Aligned_cols=261  Identities=26%  Similarity=0.386  Sum_probs=214.5

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH-HHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA-VHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      ....+|++.++||+|+||.|+. +..+.|++.+|+|++++..... ...+...+|..+|..++||.||+|+..|++.   
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~-Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~---   97 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQ-VRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTE---   97 (357)
T ss_pred             CChhheeeeeeeeccCCceEEE-EEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccC---
Confidence            4457899999999999999995 5566899999999998754333 3456678999999999999999999988765   


Q ss_pred             cCCceEEEEeccC-CCCHHHHHh-hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCC
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP  217 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~-~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~  217 (427)
                         ..+|+|++|+ ||+|...++ .+.|+|+.++.|+.+|+.||.|||++|||||||||||||+|.+|+++|+||||++.
T Consensus        98 ---~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~  174 (357)
T KOG0598|consen   98 ---EKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKE  174 (357)
T ss_pred             ---CeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchh
Confidence               5789999988 779988776 56799999999999999999999999999999999999999999999999999974


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      .....                                                          ....++|||+.|||||+
T Consensus       175 ~~~~~----------------------------------------------------------~~t~tfcGT~eYmAPEi  196 (357)
T KOG0598|consen  175 DLKDG----------------------------------------------------------DATRTFCGTPEYMAPEI  196 (357)
T ss_pred             cccCC----------------------------------------------------------CccccccCCccccChHH
Confidence            32210                                                          01234688888888888


Q ss_pred             hhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC
Q psy8260         298 MLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI  377 (427)
Q Consensus       298 l~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~  377 (427)
                      +.+..++..+||||||+++|.|.++..||.........+++.......       .....|++++|||+++|++||++|+
T Consensus       197 l~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~-------~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  197 LLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPL-------PPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             HhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCC-------CCccCCHHHHHHHHHHhccCHHHhc
Confidence            888889999999999999999988888887766555554444332111       1123789999999999999999996


Q ss_pred             ----CHHHHhcCCCCCCCCC
Q psy8260         378 ----TAEQALAHPYLSQYSD  393 (427)
Q Consensus       378 ----ta~e~L~Hp~f~~~~~  393 (427)
                          .++++.+||||.....
T Consensus       270 g~~~d~~~ik~HpfF~~inW  289 (357)
T KOG0598|consen  270 GGPGDAEEIKRHPFFKGINW  289 (357)
T ss_pred             CCCCChHHhhcCcccccCCH
Confidence                6899999999987643

>KOG0581|consensus

Probab=100.00  E-value=2.6e-50  Score=376.94  Aligned_cols=257  Identities=26%  Similarity=0.398  Sum_probs=204.7

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      .+++..+.||+|.-|.|| .+.++.|++.+|+|+|.. ..+....+++.+|+++++..+||+||.+|+.|..+.     .
T Consensus        79 ~dle~~~~lG~G~gG~V~-kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~-----~  151 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVY-KVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG-----E  151 (364)
T ss_pred             HHhhhhhhcccCCCcEEE-EEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC-----c
Confidence            456677899999988888 578889999999999953 345666788899999999999999999999998652     1


Q ss_pred             eEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~-~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      .++++|||| +|+|..+++. ++++|.....++.+|++||.|||+ ++||||||||+|||++..|+|||||||.++...+
T Consensus       152 ~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn  231 (364)
T KOG0581|consen  152 EISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN  231 (364)
T ss_pred             eEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence            489999999 7899999875 679999999999999999999995 9999999999999999999999999999875433


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      .                                                            +..+++||..|||||-+.+
T Consensus       232 S------------------------------------------------------------~a~tfvGT~~YMsPERi~g  251 (364)
T KOG0581|consen  232 S------------------------------------------------------------IANTFVGTSAYMSPERISG  251 (364)
T ss_pred             h------------------------------------------------------------hcccccccccccChhhhcC
Confidence            2                                                            2234566666666666666


Q ss_pred             ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcC--c---HHHHHHHhc-CCCCCcccHHhhcCCCChhHHHHHHHhcCCCCC
Q psy8260         301 WMHYNQTDIHQLNLIMEMLGTPPAEFMAKIS--S---DSARKYINS-LPLLTKKDFRQVFKGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       301 ~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~--~---~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~  374 (427)
                      ..|..++||||||+.+.++..+.+|+.....  .   +........ .|..+..       ..|+++++||++||++||.
T Consensus       252 ~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~-------~fS~ef~~FV~~CL~Kdp~  324 (364)
T KOG0581|consen  252 ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG-------EFSPEFRSFVSCCLRKDPS  324 (364)
T ss_pred             CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc-------cCCHHHHHHHHHHhcCCcc
Confidence            6677888999999999888777666654311  0   111111211 1222211       3689999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCC
Q psy8260         375 KRITAEQALAHPYLSQYSDP  394 (427)
Q Consensus       375 ~R~ta~e~L~Hp~f~~~~~~  394 (427)
                      +|+|++|+|+|||+.+...+
T Consensus       325 ~R~s~~qLl~Hpfi~~~~~~  344 (364)
T KOG0581|consen  325 ERPSAKQLLQHPFIKKFEDP  344 (364)
T ss_pred             cCCCHHHHhcCHHHhhcccc
Confidence            99999999999999986554

>KOG0033|consensus

Probab=100.00  E-value=5.6e-52  Score=366.91  Aligned_cols=259  Identities=27%  Similarity=0.416  Sum_probs=213.8

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      ...|++-+.||+|.|+.|+ .+++..||+.+|+|.++.........+++.+|++|-+.|+|||||+|.+.+...      
T Consensus        10 ~d~y~l~e~igkG~FSvVr-Rc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~------   82 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVR-RCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE------   82 (355)
T ss_pred             chhhhHHHHHccCchHHHH-HHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccc------
Confidence            3457788899999998887 578889999999999876555555677888999999999999999999877543      


Q ss_pred             ceEEEEeccC-CCCHH-HHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcC---CCCEEEeeCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLN-NILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE---DCELKILDFGLARP  217 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~-~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~---~~~~kl~DFGla~~  217 (427)
                      ...|++++++ |++|. ++....-++|..+..+++||+.||+|||.+||||||+||+|+|+..   ...+||+|||+|..
T Consensus        83 ~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   83 SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             ceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEE
Confidence            4678999988 66765 5666667899999999999999999999999999999999999953   45799999999864


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      ....                                                           .+..|++|||+||||||
T Consensus       163 l~~g-----------------------------------------------------------~~~~G~~GtP~fmaPEv  183 (355)
T KOG0033|consen  163 VNDG-----------------------------------------------------------EAWHGFAGTPGYLSPEV  183 (355)
T ss_pred             eCCc-----------------------------------------------------------cccccccCCCcccCHHH
Confidence            3210                                                           13458899999999999


Q ss_pred             hhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC
Q psy8260         298 MLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI  377 (427)
Q Consensus       298 l~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~  377 (427)
                      +++.++...+|+|+.|+|+++|..+-.||+++..+.....+....-..+.    ..|+.++++|+|||++||..||+||+
T Consensus       184 vrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~----~~w~~is~~Ak~LvrrML~~dP~kRI  259 (355)
T KOG0033|consen  184 LKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPS----PEWDTVTPEAKSLIRRMLTVNPKKRI  259 (355)
T ss_pred             hhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCC----cccCcCCHHHHHHHHHHhccChhhhc
Confidence            99999999999999999999998888888876544444444332222222    35778999999999999999999999


Q ss_pred             CHHHHhcCCCCCCC
Q psy8260         378 TAEQALAHPYLSQY  391 (427)
Q Consensus       378 ta~e~L~Hp~f~~~  391 (427)
                      ||.|+|+|||+.+-
T Consensus       260 ta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  260 TADEALKHPWICNR  273 (355)
T ss_pred             cHHHHhCCchhcch
Confidence            99999999999864

>KOG0592|consensus

Probab=100.00  E-value=7.6e-49  Score=380.97  Aligned_cols=274  Identities=24%  Similarity=0.353  Sum_probs=215.4

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHH-HHHHHHHHHHHhcC-CCCCceeeeeeeecCcc
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVH-AKRTYRELRMLKHM-NHENVIGLLDVFHSNTC  138 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~-~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~  138 (427)
                      ....+|.+++.||.|+|..||. |.+..+++.||||++.+.....+. .+-+.+|-.+|.+| +||.|++|+..|++.  
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~-A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~--  146 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVL-AREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE--  146 (604)
T ss_pred             CChhhcchhheeccccceeEEE-eeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc--
Confidence            3456899999999999999995 678889999999998765433222 23355788889999 899999999998764  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                          ..+|++++|+ +|+|.+++++ +.|++..++.|+.||+.||+|||++|||||||||||||+|.+|++||+|||.|+
T Consensus       147 ----~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK  222 (604)
T KOG0592|consen  147 ----ESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAK  222 (604)
T ss_pred             ----cceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccc
Confidence                5689999988 7899998865 679999999999999999999999999999999999999999999999999998


Q ss_pred             CCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         217 PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       217 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      .+........+                                +....             ........++||-.|++||
T Consensus       223 ~l~~~~~~~~~--------------------------------~~~~~-------------~a~s~~~SFVGTAeYVSPE  257 (604)
T KOG0592|consen  223 ILSPSQKSQEN--------------------------------PVDPN-------------QASSRRSSFVGTAEYVSPE  257 (604)
T ss_pred             cCChhhccccC--------------------------------ccCcc-------------cccCcccceeeeecccCHH
Confidence            76543211000                                00000             0011246789999999999


Q ss_pred             HhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCC
Q psy8260         297 IMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKR  376 (427)
Q Consensus       297 vl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R  376 (427)
                      +|.......++|+|++|||+|.|..+.+||.+.+.--..+++....-        .+.++.++.++|||.++|++||.+|
T Consensus       258 lL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y--------~fp~~fp~~a~dLv~KLLv~dp~~R  329 (604)
T KOG0592|consen  258 LLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY--------EFPEGFPEDARDLIKKLLVRDPSDR  329 (604)
T ss_pred             HhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc--------cCCCCCCHHHHHHHHHHHccCcccc
Confidence            99999899999999999999988666666765543233333322111        1224567899999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCC
Q psy8260         377 ITAEQALAHPYLSQYSDP  394 (427)
Q Consensus       377 ~ta~e~L~Hp~f~~~~~~  394 (427)
                      +|++|+.+||||..+...
T Consensus       330 lt~~qIk~HpFF~~Vdw~  347 (604)
T KOG0592|consen  330 LTSQQIKAHPFFEGVDWE  347 (604)
T ss_pred             ccHHHHhhCcccccCChh
Confidence            999999999999976543

>KOG0605|consensus

Probab=100.00  E-value=1.2e-48  Score=379.73  Aligned_cols=313  Identities=21%  Similarity=0.292  Sum_probs=222.2

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH-HHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA-VHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      +..++|++...||+|+||.||. |..+.||..+|+|+++++.... .+.+.+..|-.+|...++|+||+|+..|++.   
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrL-arKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~---  213 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRL-ARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK---  213 (550)
T ss_pred             CCcccchhheeeccccceeEEE-EEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC---
Confidence            4567899999999999999996 5678899999999998754332 2344567899999999999999999998754   


Q ss_pred             cCCceEEEEeccC-CCCHHHHHh-hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCC
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP  217 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~-~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~  217 (427)
                         .++|++|||. |||+..+|. ...|++.+++.|+.+++.|++-||+.|+|||||||+|+|||..|++||+||||+..
T Consensus       214 ---~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g  290 (550)
T KOG0605|consen  214 ---EYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTG  290 (550)
T ss_pred             ---CeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccch
Confidence               6789999987 899998875 46799999999999999999999999999999999999999999999999999964


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceee-ccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYF-QDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~-~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      ......    +-.|.--+....... ......+.. ...+..     .+-.-+.-.+  -+.........+|||.|||||
T Consensus       291 l~~~~~----~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~-----~~~~~~~~~w--~~nrr~~a~StVGTPDYiAPE  358 (550)
T KOG0605|consen  291 LDKKHR----IESYRLDEQMQINLS-EAKPSDFPKFNTPRST-----MSRREQLQTW--KRNRRQLAYSTVGTPDYIAPE  358 (550)
T ss_pred             hhhhhh----hhhhcchhhhhhhhc-cCCCccccccccccch-----hhHHHHHHHH--HhhhhhhhhcccCCccccchH
Confidence            432111    000100000000000 000000000 000000     0000000000  000112345689999999999


Q ss_pred             HhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCC
Q psy8260         297 IMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKR  376 (427)
Q Consensus       297 vl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R  376 (427)
                      |+++..|...+||||||+|+|+|..+.+||.........++..+....+....    -...+++|+|||.+||. ||.+|
T Consensus       359 Vll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~----~~~~s~eA~DLI~rll~-d~~~R  433 (550)
T KOG0605|consen  359 VLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE----EVDLSDEAKDLITRLLC-DPENR  433 (550)
T ss_pred             HHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC----cCcccHHHHHHHHHHhc-CHHHh
Confidence            99999999999999999999999777777776665556666655432221110    12357999999999999 99999


Q ss_pred             CC---HHHHhcCCCCCCCCCCCCC
Q psy8260         377 IT---AEQALAHPYLSQYSDPNDE  397 (427)
Q Consensus       377 ~t---a~e~L~Hp~f~~~~~~~~~  397 (427)
                      +.   ++|+.+||||+.+...+.-
T Consensus       434 LG~~G~~EIK~HPfF~~v~W~~l~  457 (550)
T KOG0605|consen  434 LGSKGAEEIKKHPFFKGVDWDHLR  457 (550)
T ss_pred             cCcccHHHHhcCCccccCCcchhh
Confidence            95   9999999999987665433

>KOG0595|consensus

Probab=100.00  E-value=2.9e-48  Score=366.23  Aligned_cols=257  Identities=26%  Similarity=0.437  Sum_probs=210.5

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .+.|.+.+.||.|+|+.||++. ++.++..||||.+.+........+....|+.+|+.++|||||.|+++....      
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~-h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~------   81 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGR-HKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDD------   81 (429)
T ss_pred             cccceehhhccCcceEEEEEeE-eccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC------
Confidence            4678889999999999999754 566779999999988766677777788999999999999999999987654      


Q ss_pred             ceEEEEeccC-CCCHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCC------CCEEEeeCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILRTQ-KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED------CELKILDFGL  214 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~~~-~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~------~~~kl~DFGl  214 (427)
                      +.+|+||||| ||||..+++.. .++++.++.++.|++.||++||+++||||||||+||||+.+      -.+||+|||+
T Consensus        82 ~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf  161 (429)
T KOG0595|consen   82 DFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF  161 (429)
T ss_pred             CeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence            5789999999 79999999765 89999999999999999999999999999999999999764      4689999999


Q ss_pred             CCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccc
Q psy8260         215 ARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRA  294 (427)
Q Consensus       215 a~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~A  294 (427)
                      ||...+.                                                           .+..+.||+|.|||
T Consensus       162 AR~L~~~-----------------------------------------------------------~~a~tlcGSplYMA  182 (429)
T KOG0595|consen  162 ARFLQPG-----------------------------------------------------------SMAETLCGSPLYMA  182 (429)
T ss_pred             hhhCCch-----------------------------------------------------------hHHHHhhCCccccC
Confidence            9865421                                                           13345688999999


Q ss_pred             hHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhc-CCCCCcccHHhhcCCCChhHHHHHHHhcCCCC
Q psy8260         295 PEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINS-LPLLTKKDFRQVFKGANPQAIDLLSLMLELDS  373 (427)
Q Consensus       295 PEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP  373 (427)
                      |||+....|+.+.|+||+|.|+|.|.++..||......+... +.+. ....+     ......++...+|+..+|+.||
T Consensus       183 PEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~-~~~k~~~~~~-----~~~~~~s~~~~~Ll~~ll~~~~  256 (429)
T KOG0595|consen  183 PEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL-YIKKGNEIVP-----VLPAELSNPLRELLISLLQRNP  256 (429)
T ss_pred             HHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-HHhccccccC-----chhhhccCchhhhhhHHHhcCc
Confidence            999988889999999999999999988877776544333332 2221 11111     1112356777899999999999


Q ss_pred             CCCCCHHHHhcCCCCCCC
Q psy8260         374 EKRITAEQALAHPYLSQY  391 (427)
Q Consensus       374 ~~R~ta~e~L~Hp~f~~~  391 (427)
                      ..|.+..+.+.||++...
T Consensus       257 ~~~~~~~~~~~~~~l~~~  274 (429)
T KOG0595|consen  257 KDRISFEDFFDHPFLAAN  274 (429)
T ss_pred             cccCchHHhhhhhhcccC
Confidence            999999999999999753

>KOG0667|consensus

Probab=100.00  E-value=2.8e-48  Score=386.49  Aligned_cols=277  Identities=31%  Similarity=0.498  Sum_probs=222.6

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCC-C-----CCceeeeeeeecCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN-H-----ENVIGLLDVFHSNT  137 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~-H-----pnIv~l~~~~~~~~  137 (427)
                      .+|+|.+.||+|.||.|+ .|+|..|++.||||++++.   .....+..-|+.+|..|+ |     -|+|+++++|... 
T Consensus       186 ~rY~V~e~LGkGtFGQVv-k~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr-  260 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVV-KAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR-  260 (586)
T ss_pred             EEEEEEEEecccccceeE-EEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc-
Confidence            367899999999999999 5789999999999999753   344556678999999987 4     3899999999765 


Q ss_pred             cccCCceEEEEeccCCCCHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcC--CCCEEEeeC
Q psy8260         138 CLADFKNVYMVTHLMGADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE--DCELKILDF  212 (427)
Q Consensus       138 ~~~~~~~~~lv~e~~g~~L~~~l~~~---~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~--~~~~kl~DF  212 (427)
                           .++|||+|+++.+|.++++.+   +|+...++.+++||+.||.+||+.||||+|||||||||.+  ...+||+||
T Consensus       261 -----~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDF  335 (586)
T KOG0667|consen  261 -----NHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDF  335 (586)
T ss_pred             -----cceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEec
Confidence                 578999999999999999864   5889999999999999999999999999999999999975  348999999


Q ss_pred             CCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccc
Q psy8260         213 GLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWY  292 (427)
Q Consensus       213 Gla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y  292 (427)
                      |+|+.......+|+.|++|+|||+|+| ..|+.+.      ||||.||+++|                 +..|.      
T Consensus       336 GSSc~~~q~vytYiQSRfYRAPEVILG-lpY~~~I------DmWSLGCIlAE-----------------L~tG~------  385 (586)
T KOG0667|consen  336 GSSCFESQRVYTYIQSRFYRAPEVILG-LPYDTAI------DMWSLGCILAE-----------------LFTGE------  385 (586)
T ss_pred             ccccccCCcceeeeeccccccchhhcc-CCCCCcc------ceeehhhhHHh-----------------HhcCc------
Confidence            999998888889999999999999998 4566555      99999999988                 44443      


Q ss_pred             cchHHhhhccCCCCC-CHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhc-C--CC------------------------
Q psy8260         293 RAPEIMLNWMHYNQT-DIHQLNLIMEMLGTPPAEFMAKISSDSARKYINS-L--PL------------------------  344 (427)
Q Consensus       293 ~APEvl~~~~~~~~~-d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~-~--~~------------------------  344 (427)
                               ++|.+. ...++++|+.++|.||..+.+.....  .++... .  +.                        
T Consensus       386 ---------PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~--~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~  454 (586)
T KOG0667|consen  386 ---------PLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKA--HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKAR  454 (586)
T ss_pred             ---------cccCCCCHHHHHHHHHHHhCCCCHHHHHhcccc--ceehhccCCceeeeeeecccccccchhhhhhhhhhc
Confidence                     367665 78999999999999998876542211  112111 0  00                        


Q ss_pred             ----C--CcccHHhhcC-CCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q psy8260         345 ----L--TKKDFRQVFK-GANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       345 ----~--~~~~~~~~~~-~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~  391 (427)
                          .  ..+.+..... .....+.|||.+||++||.+|+|+.|+|+||||...
T Consensus       455 ~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~  508 (586)
T KOG0667|consen  455 LERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGT  508 (586)
T ss_pred             ccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCcccccc
Confidence                0  0011111112 223467899999999999999999999999999853

>KOG0583|consensus

Probab=100.00  E-value=2.4e-47  Score=375.11  Aligned_cols=256  Identities=30%  Similarity=0.445  Sum_probs=203.3

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC---HHHHHHHHHHHHHHhcCC-CCCceeeeeeeecC
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS---AVHAKRTYRELRMLKHMN-HENVIGLLDVFHSN  136 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~  136 (427)
                      ...+.|.+++.||+|+||.|+. +.+..+|..||||.+.+....   ....+.+.||+.+++.++ ||||+++++++...
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~-a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~   92 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKL-AKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP   92 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEE-eeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence            4457899999999999999996 567778999999977664221   123445668999999999 99999999999865


Q ss_pred             ccccCCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCC-CCEEEeeCC
Q psy8260         137 TCLADFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED-CELKILDFG  213 (427)
Q Consensus       137 ~~~~~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~-~~~kl~DFG  213 (427)
                            ..+|++|||+ ||+|.+.+.. +++.|..++.+++|++.|++|||++||+||||||||||++.+ +++||+|||
T Consensus        93 ------~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG  166 (370)
T KOG0583|consen   93 ------TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFG  166 (370)
T ss_pred             ------CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccc
Confidence                  3489999998 6799888765 789999999999999999999999999999999999999999 999999999


Q ss_pred             CCCCCC-CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccc
Q psy8260         214 LARPTE-NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWY  292 (427)
Q Consensus       214 la~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y  292 (427)
                      ++.... ..                                                           ....+.+||+.|
T Consensus       167 ~s~~~~~~~-----------------------------------------------------------~~l~t~cGsp~Y  187 (370)
T KOG0583|consen  167 LSAISPGED-----------------------------------------------------------GLLKTFCGSPAY  187 (370)
T ss_pred             cccccCCCC-----------------------------------------------------------CcccCCCCCccc
Confidence            987542 11                                                           123345666666


Q ss_pred             cchHHhhhcc-CC-CCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCC-ChhHHHHHHHhc
Q psy8260         293 RAPEIMLNWM-HY-NQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGA-NPQAIDLLSLML  369 (427)
Q Consensus       293 ~APEvl~~~~-~~-~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-s~~~~dLi~~mL  369 (427)
                      +|||++.+.. |. ...|+||+|+++|.|.++..||.+.......++.......        +...+ |+++++||++||
T Consensus       188 ~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~--------~p~~~~S~~~~~Li~~mL  259 (370)
T KOG0583|consen  188 AAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFK--------IPSYLLSPEARSLIEKML  259 (370)
T ss_pred             CCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCcc--------CCCCcCCHHHHHHHHHHc
Confidence            6666666655 43 3459999999999998888888765433334332222111        11234 999999999999


Q ss_pred             CCCCCCCCCHHHHhcCCCCCC
Q psy8260         370 ELDSEKRITAEQALAHPYLSQ  390 (427)
Q Consensus       370 ~~dP~~R~ta~e~L~Hp~f~~  390 (427)
                      +.||.+|+|+.|+++||||+.
T Consensus       260 ~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  260 VPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             CCCcccCCCHHHHhhChhhcc
Confidence            999999999999999999987

>KOG0588|consensus

Probab=100.00  E-value=3.2e-48  Score=383.72  Aligned_cols=260  Identities=29%  Similarity=0.413  Sum_probs=211.0

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCc-CCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~-~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      -|.|++|+.||+|+-|.|-. +.+..||+.+|||+|.+. .........+.+||-+|+-+.||||++||++|+..     
T Consensus        11 iGpwkLgkTLG~Gstg~vrl-akh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~-----   84 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRL-AKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENK-----   84 (786)
T ss_pred             ccceeccccccCCCCceehh-hhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccC-----
Confidence            37799999999999999874 668899999999999765 33344456678999999999999999999999764     


Q ss_pred             CceEEEEeccC-CCCHHHH-HhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         142 FKNVYMVTHLM-GADLNNI-LRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~-l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                       ..+|++.||+ ||.|.++ ++++++++.++.++++||+.|+.|||..+|+||||||+|+|+|..+.+||+|||+|....
T Consensus        85 -~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~  163 (786)
T KOG0588|consen   85 -QHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV  163 (786)
T ss_pred             -ceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc
Confidence             4677777776 6766655 567889999999999999999999999999999999999999998889999999985321


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      +.                                                           .++.+-||+|.|.||||++
T Consensus       164 ~g-----------------------------------------------------------klLeTSCGSPHYA~PEIV~  184 (786)
T KOG0588|consen  164 PG-----------------------------------------------------------KLLETSCGSPHYAAPEIVS  184 (786)
T ss_pred             CC-----------------------------------------------------------ccccccCCCcccCCchhhc
Confidence            11                                                           1344567888888888888


Q ss_pred             hccCCC-CCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC
Q psy8260         300 NWMHYN-QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT  378 (427)
Q Consensus       300 ~~~~~~-~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t  378 (427)
                      +.+|.. ++|+||+|+|++-|.++..||.+.+-.....|....  .+      ++...++++|+|||.+||++||++|+|
T Consensus       185 G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G--~f------~MPs~Is~eaQdLLr~ml~VDp~~RiT  256 (786)
T KOG0588|consen  185 GRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRG--VF------EMPSNISSEAQDLLRRMLDVDPSTRIT  256 (786)
T ss_pred             CCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcC--cc------cCCCcCCHHHHHHHHHHhccCcccccc
Confidence            887766 459999999999999999888765433333322211  11      233578999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCCCCC
Q psy8260         379 AEQALAHPYLSQYSDPND  396 (427)
Q Consensus       379 a~e~L~Hp~f~~~~~~~~  396 (427)
                      .+|+++|||+..+..+..
T Consensus       257 ~~eI~kHP~l~g~~~~~~  274 (786)
T KOG0588|consen  257 TEEILKHPFLSGYTSLPS  274 (786)
T ss_pred             HHHHhhCchhhcCCCCCh
Confidence            999999999998766543

>KOG0665|consensus

Probab=100.00  E-value=2.1e-48  Score=356.33  Aligned_cols=313  Identities=42%  Similarity=0.748  Sum_probs=260.3

Q ss_pred             cccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEEEe
Q psy8260          70 PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT  149 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~lv~  149 (427)
                      ..+|.|.-  +++.+.|..+++.||+|++..++....+.++..||..++..++|+||++++.+|...........+|++|
T Consensus        23 ~p~~~g~~--~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~  100 (369)
T KOG0665|consen   23 KPIGSGAQ--IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVM  100 (369)
T ss_pred             cccCCCCc--eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHH
Confidence            45566654  4557899999999999999888888888889999999999999999999999998777777778899999


Q ss_pred             ccCCCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC--Ccccccc
Q psy8260         150 HLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN--EMTGYVA  227 (427)
Q Consensus       150 e~~g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~--~~~~~~g  227 (427)
                      |++..+|...+. -.++-..++.++.|+++|++|||+.||+||||||+||++..++.+||.|||+|+....  ..+.++.
T Consensus       101 e~m~~nl~~vi~-~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~mtpyVv  179 (369)
T KOG0665|consen  101 ELMDANLCQVIL-MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFMMTPYVV  179 (369)
T ss_pred             HhhhhHHHHHHH-HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcccccCchhh
Confidence            999999998876 4577888999999999999999999999999999999999999999999999987654  4678999


Q ss_pred             cccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCCCC
Q psy8260         228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT  307 (427)
Q Consensus       228 t~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~  307 (427)
                      |+.|+|||++++.. |.+..      |+|+.||+++|                 +..+.+               ++++.
T Consensus       180 tRyyrapevil~~~-~ke~v------diwSvGci~gE-----------------li~~~V---------------lf~g~  220 (369)
T KOG0665|consen  180 TRYYRAPEVILGMG-YKENV------DIWSVGCIMGE-----------------LILGTV---------------LFPGK  220 (369)
T ss_pred             eeeccCchheeccC-Ccccc------hhhhhhhHHHH-----------------HhhceE---------------EecCc
Confidence            99999999999866 66555      99999999987                 433433               66665


Q ss_pred             -CHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCC------------CChhHHHHHHHhcCCCCC
Q psy8260         308 -DIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKG------------ANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       308 -d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~s~~~~dLi~~mL~~dP~  374 (427)
                       -+.|++.+...+|+|...|..... ...+.+...++......+.+.|+.            -+..|+||+.+||..||+
T Consensus       221 d~idQ~~ki~~~lgtpd~~F~~qL~-~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe  299 (369)
T KOG0665|consen  221 DHIDQWNKIIEQLGTPDPSFMKQLQ-PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPE  299 (369)
T ss_pred             hHHHHHHHHHHHhcCCCHHHHHHhh-HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChh
Confidence             589999999999999999988763 456666666665555555544432            246799999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCCCC--CCCCCCCCcccccCCCCHHHHHHHHhhhc
Q psy8260         375 KRITAEQALAHPYLSQYSDPND--EPTSPPYDQSFEDMDLPVDQWKGTYSLES  425 (427)
Q Consensus       375 ~R~ta~e~L~Hp~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (427)
                      +|++++++|+||||+-|..+.+  +|.+++++..+...+.++++|+..++.|.
T Consensus       300 ~Risv~daL~HPY~~vw~~~~ev~ap~pe~~d~~~d~~~~t~~e~ke~If~ev  352 (369)
T KOG0665|consen  300 KRISVDDALRHPYIKVWYDPDEVEAPPPEIYDKQLDEREHTIEEWKELIFKEV  352 (369)
T ss_pred             hcccHHHHhcCCeeeeecccccccCCCCchhhhhcccccCCHHHHHHHHHHHH
Confidence            9999999999999986555433  34444677778888888999999998774

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-46  Score=370.22  Aligned_cols=323  Identities=60%  Similarity=0.978  Sum_probs=244.5

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      ..|.+.+.||.|+||.||. +.+..+++.||||++............+.+|+++|+.++||||++++++|..........
T Consensus        15 ~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCS-AYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN   93 (343)
T ss_pred             hhhhhheecccCCCeEEEE-EEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence            4678889999999999996 556778999999998765444444566779999999999999999999886544333445


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcc
Q psy8260         144 NVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT  223 (427)
Q Consensus       144 ~~~lv~e~~g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~  223 (427)
                      .+|+++++++++|.++++...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......+
T Consensus        94 ~~~~~~~~~~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  173 (343)
T cd07878          94 EVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT  173 (343)
T ss_pred             cEEEEeecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCCcC
Confidence            68999999999999998888899999999999999999999999999999999999999999999999999987666666


Q ss_pred             cccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccC
Q psy8260         224 GYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH  303 (427)
Q Consensus       224 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~  303 (427)
                      .++||++|+|||++.+...++..      .|+|+.||++.+                 +..|..               .
T Consensus       174 ~~~~t~~y~aPE~~~~~~~~~~~------~DiwslG~il~e-----------------l~~g~~---------------p  215 (343)
T cd07878         174 GYVATRWYRAPEIMLNWMHYNQT------VDIWSVGCIMAE-----------------LLKGKA---------------L  215 (343)
T ss_pred             CccccccccCchHhcCCccCCch------hhhHhHHHHHHH-----------------HHHCCC---------------C
Confidence            66778888888877653333332      266666665544                 111111               1


Q ss_pred             CCCC-CHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q psy8260         304 YNQT-DIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQA  382 (427)
Q Consensus       304 ~~~~-d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~  382 (427)
                      +... ....+..+....+.++.++...........+....+..+...+...+...++.+.|||.+||++||.+|+|++|+
T Consensus       216 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~el  295 (343)
T cd07878         216 FPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEA  295 (343)
T ss_pred             CCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence            1111 223344444445555555555444444445555555555566667777889999999999999999999999999


Q ss_pred             hcCCCCCCCCCCCCCCCCCCCCcccccCCCCHHHHHHHHhhhc
Q psy8260         383 LAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKGTYSLES  425 (427)
Q Consensus       383 L~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (427)
                      |+||||.+...|...+...+.+.+.....-.+.+|.+..+.+.
T Consensus       296 l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (343)
T cd07878         296 LAHPYFSQYHDPEDEPEAEPYDESPENKERTIEEWKELTYEEV  338 (343)
T ss_pred             hcCcchhccCCCccccccCccccchhhhhccHHHHHHHHHHHH
Confidence            9999999988887777666776666666777777877765543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0662|consensus

Probab=100.00  E-value=1.9e-47  Score=324.03  Aligned_cols=278  Identities=29%  Similarity=0.515  Sum_probs=231.0

Q ss_pred             eccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEE
Q psy8260          68 IGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYM  147 (427)
Q Consensus        68 ~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~l  147 (427)
                      -.+.||+|.+|+||+ +.+..+++.||+|.+.....++......+|||.+|+.++|.|||+++++.+++      ..+-+
T Consensus         6 kmekigegtygtvfk-arn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd------kkltl   78 (292)
T KOG0662|consen    6 KMEKIGEGTYGTVFK-ARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD------KKLTL   78 (292)
T ss_pred             HHHhhcCCcceeeEe-cccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC------ceeEE
Confidence            346799999999995 67888999999999976655555566788999999999999999999998765      45789


Q ss_pred             EeccCCCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCc---
Q psy8260         148 VTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM---  222 (427)
Q Consensus       148 v~e~~g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~---  222 (427)
                      |+++|..+|..+...  +.++.+.++.++.|+++||.|||++++.||||||.|+||+.+|++|++|||+||.++-..   
T Consensus        79 vfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcy  158 (292)
T KOG0662|consen   79 VFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY  158 (292)
T ss_pred             eHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEee
Confidence            999999999888754  568999999999999999999999999999999999999999999999999999876553   


Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhcc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM  302 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~  302 (427)
                      +..+.|.||++|.++.|.+.|+.+.      |+|++||+++|     +++.                          +++
T Consensus       159 saevvtlwyrppdvlfgakly~tsi------dmwsagcifae-----lana--------------------------grp  201 (292)
T KOG0662|consen  159 SAEVVTLWYRPPDVLFGAKLYSTSI------DMWSAGCIFAE-----LANA--------------------------GRP  201 (292)
T ss_pred             eceeeeeeccCcceeeeeehhccch------HhhhcchHHHH-----Hhhc--------------------------CCC
Confidence            3457899999999999999999887      99999999987     1211                          234


Q ss_pred             CCCCCCH-HHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCC-CcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHH
Q psy8260         303 HYNQTDI-HQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLL-TKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAE  380 (427)
Q Consensus       303 ~~~~~d~-~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~  380 (427)
                      .+++.|+ .+|-.|+..+|+|..+-|.....-...+   ..|.+ ....|.++.+.++...+||+.++|.-+|.+|++|+
T Consensus       202 lfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk---~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisae  278 (292)
T KOG0662|consen  202 LFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK---PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAE  278 (292)
T ss_pred             CCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc---ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHH
Confidence            7777775 5788999999999987776543211111   12222 22357888888999999999999999999999999


Q ss_pred             HHhcCCCCCCCC
Q psy8260         381 QALAHPYLSQYS  392 (427)
Q Consensus       381 e~L~Hp~f~~~~  392 (427)
                      ++|+||||++..
T Consensus       279 aalqhpyf~d~s  290 (292)
T KOG0662|consen  279 AALQHPYFSDFS  290 (292)
T ss_pred             HHhcCccccccC
Confidence            999999998753

>KOG0597|consensus

Probab=100.00  E-value=4.4e-47  Score=369.11  Aligned_cols=262  Identities=26%  Similarity=0.407  Sum_probs=217.9

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCce
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      .|.+-..+|+|+||.||++. .+.|.+.||+|.+.+........+...+|+++++.++|||||.++++|++.      .+
T Consensus         3 ~yhv~e~iG~Gsfg~VYKgr-rK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~------~~   75 (808)
T KOG0597|consen    3 QYHVYEMIGEGSFGRVYKGR-RKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETS------AH   75 (808)
T ss_pred             chhHHHHhcCCccceeeecc-cccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhccc------ce
Confidence            46777899999999999765 567899999999998877788888899999999999999999999999765      57


Q ss_pred             EEEEeccCCCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcc
Q psy8260         145 VYMVTHLMGADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT  223 (427)
Q Consensus       145 ~~lv~e~~g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~  223 (427)
                      +++|.||+-|+|..++.. ++++|+.++.++.|++.||.|||+++|+|||+||.|||++.+|.+|+||||+||.+.... 
T Consensus        76 ~~vVte~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t-  154 (808)
T KOG0597|consen   76 LWVVTEYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT-  154 (808)
T ss_pred             EEEEehhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc-
Confidence            899999998899999864 689999999999999999999999999999999999999999999999999998654321 


Q ss_pred             cccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccC
Q psy8260         224 GYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH  303 (427)
Q Consensus       224 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~  303 (427)
                                                                               .+.+..-|||.|||||++.+.+|
T Consensus       155 ---------------------------------------------------------~vltsikGtPlYmAPElv~e~py  177 (808)
T KOG0597|consen  155 ---------------------------------------------------------SVLTSIKGTPLYMAPELVEEQPY  177 (808)
T ss_pred             ---------------------------------------------------------eeeeeccCcccccCHHHHcCCCc
Confidence                                                                     02344568999999999998889


Q ss_pred             CCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q psy8260         304 YNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQAL  383 (427)
Q Consensus       304 ~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L  383 (427)
                      ...+|+||||||+|++-.+.+||....-....+.+....+.++        ...|..+++||..+|++||.+|+|..+++
T Consensus       178 d~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p--------~~~S~~f~nfl~gLL~kdP~~RltW~~Ll  249 (808)
T KOG0597|consen  178 DHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPP--------STASSSFVNFLQGLLIKDPAQRLTWTDLL  249 (808)
T ss_pred             cchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCc--------ccccHHHHHHHHHHhhcChhhcccHHHHh
Confidence            9999999999999999666666655433334444433333322        25789999999999999999999999999


Q ss_pred             cCCCCCCCCCCCCCCC
Q psy8260         384 AHPYLSQYSDPNDEPT  399 (427)
Q Consensus       384 ~Hp~f~~~~~~~~~~~  399 (427)
                      .|||.++-..-.+.+.
T Consensus       250 ~HpF~k~~~~~~~~~~  265 (808)
T KOG0597|consen  250 GHPFWKGKINIAELPA  265 (808)
T ss_pred             cChHHhhhhhhhcccc
Confidence            9999986544333333

>KOG0616|consensus

Probab=100.00  E-value=7.4e-47  Score=342.89  Aligned_cols=256  Identities=27%  Similarity=0.366  Sum_probs=210.3

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      ....+|++.+++|.|+||.|-. +.++.+|..+|+|++.+... ...+.+...+|.++|+.+.||.+++|++.|.+.   
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~L-Vr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~---  116 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHL-VREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDN---  116 (355)
T ss_pred             cchhhhhheeeeccCccceEEE-EEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccC---
Confidence            3446788899999999999995 56778899999999876432 223445567899999999999999999887643   


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCC
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP  217 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~  217 (427)
                         .++||+|++. ||.|.+++++ ++|++..++.++.||+.||+|||+++||+|||||||||+|.+|.+||+|||.|+.
T Consensus       117 ---~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~  193 (355)
T KOG0616|consen  117 ---SNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKR  193 (355)
T ss_pred             ---CeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEE
Confidence               6799999998 7899998875 6899999999999999999999999999999999999999999999999999986


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      .....                                                             .+.||||.|+|||+
T Consensus       194 v~~rT-------------------------------------------------------------~TlCGTPeYLAPEi  212 (355)
T KOG0616|consen  194 VSGRT-------------------------------------------------------------WTLCGTPEYLAPEI  212 (355)
T ss_pred             ecCcE-------------------------------------------------------------EEecCCccccChHH
Confidence            54332                                                             24467777788888


Q ss_pred             hhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC
Q psy8260         298 MLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI  377 (427)
Q Consensus       298 l~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~  377 (427)
                      +....+...+|||+||+++|+|..+..||.+........+++...-.++        ...|++++|||+++|+.|-.+|.
T Consensus       213 i~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP--------~~fs~~~kdLl~~LL~vD~t~R~  284 (355)
T KOG0616|consen  213 IQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFP--------SYFSSDAKDLLKKLLQVDLTKRF  284 (355)
T ss_pred             hhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCC--------cccCHHHHHHHHHHHhhhhHhhh
Confidence            8778888899999999999998777777766655445555554333322        34689999999999999999994


Q ss_pred             -----CHHHHhcCCCCCCCC
Q psy8260         378 -----TAEQALAHPYLSQYS  392 (427)
Q Consensus       378 -----ta~e~L~Hp~f~~~~  392 (427)
                           ..+++.+||||....
T Consensus       285 gnlknG~~dIk~H~wF~~v~  304 (355)
T KOG0616|consen  285 GNLKNGVEDIKNHPWFKGVD  304 (355)
T ss_pred             cCcCCCccccccCccccccc
Confidence                 578999999998654

>KOG0599|consensus

Probab=100.00  E-value=7.4e-47  Score=339.09  Aligned_cols=264  Identities=27%  Similarity=0.399  Sum_probs=200.4

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcC-----CCH-HHHHHHHHHHHHHhcC-CCCCceeeeeeeecCcc
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPF-----QSA-VHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTC  138 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~-----~~~-~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~  138 (427)
                      |+-.+.+|.|.-+.|. .+..+.+|...|+|++....     ... .-.+...+|+.||+++ .||+|+++.++|+++  
T Consensus        19 y~pkeilgrgvss~vr-Rci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~--   95 (411)
T KOG0599|consen   19 YEPKEILGRGVSSVVR-RCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD--   95 (411)
T ss_pred             cChHHHhcccchhhhh-hhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc--
Confidence            4445678888766555 56778899999999885321     111 2234567899999997 899999999999875  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRTQ-KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~~-~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                          ..+++|++++ .|.|.+++... .+++...+.+|+|++.|+.|||.++|+||||||+|||++++.++||+|||.|+
T Consensus        96 ----sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~  171 (411)
T KOG0599|consen   96 ----AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFAC  171 (411)
T ss_pred             ----chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceee
Confidence                3468899988 68899888654 69999999999999999999999999999999999999999999999999998


Q ss_pred             CCCC--CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccc
Q psy8260         217 PTEN--EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRA  294 (427)
Q Consensus       217 ~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~A  294 (427)
                      ....  .....|||+.|+|||++..+..                                         .+.+   +   
T Consensus       172 ~l~~GekLrelCGTPgYLAPEtikC~m~-----------------------------------------e~~p---G---  204 (411)
T KOG0599|consen  172 QLEPGEKLRELCGTPGYLAPETIKCSMY-----------------------------------------ENHP---G---  204 (411)
T ss_pred             ccCCchhHHHhcCCCcccChhheeeecc-----------------------------------------cCCC---C---
Confidence            7654  4566789999999998753211                                         1111   1   


Q ss_pred             hHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCC
Q psy8260         295 PEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       295 PEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~  374 (427)
                              |...+|+|++|+|++.|..+.+|||-...---.+......-.+.    +..|..+|.+++|||++||+.||.
T Consensus       205 --------Ys~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~----speWadis~~~KdLIsrlLqVdp~  272 (411)
T KOG0599|consen  205 --------YSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFR----SPEWADISATVKDLISRLLQVDPT  272 (411)
T ss_pred             --------ccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccC----CcchhhccccHHHHHHHHHeeCch
Confidence                    55667999999999988666666764321111122211111222    234567899999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCCC
Q psy8260         375 KRITAEQALAHPYLSQYSDPN  395 (427)
Q Consensus       375 ~R~ta~e~L~Hp~f~~~~~~~  395 (427)
                      +|+|++|+|+||||.++....
T Consensus       273 ~Ritake~LaHpff~q~~~~~  293 (411)
T KOG0599|consen  273 KRITAKEALAHPFFIQIAQQQ  293 (411)
T ss_pred             hcccHHHHhcChHHHHHHHhc
Confidence            999999999999997654433

>KOG0032|consensus

Probab=100.00  E-value=2.1e-45  Score=361.38  Aligned_cols=262  Identities=27%  Similarity=0.452  Sum_probs=215.8

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH-HHHHHHHHHHHHHhcCC-CCCceeeeeeeecCc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA-VHAKRTYRELRMLKHMN-HENVIGLLDVFHSNT  137 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~  137 (427)
                      +-....|.+++.||.|+||.||. +.+..||+.+|+|.+.+..... .....+.+|+.+|+++. |||||+++++|+.. 
T Consensus        31 ~~~~~~Y~l~~~lG~G~Fg~v~~-~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~-  108 (382)
T KOG0032|consen   31 EDIKEKYELGRELGRGQFGVVYL-CREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP-  108 (382)
T ss_pred             ccccccEEehhhhCCCCceEEEE-EEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC-
Confidence            44556789999999999999995 6778899999999997654322 23456789999999998 99999999999865 


Q ss_pred             cccCCceEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcC----CCCEEEeeC
Q psy8260         138 CLADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE----DCELKILDF  212 (427)
Q Consensus       138 ~~~~~~~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~----~~~~kl~DF  212 (427)
                           ..+|++||++ ||.|.+.+....+++..+..+++|++.|+.|||+.||+||||||||+|+..    ++.+|++||
T Consensus       109 -----~~~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DF  183 (382)
T KOG0032|consen  109 -----DSVYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDF  183 (382)
T ss_pred             -----CeEEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeC
Confidence                 4689999999 788877664435999999999999999999999999999999999999863    357999999


Q ss_pred             CCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccc
Q psy8260         213 GLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWY  292 (427)
Q Consensus       213 Gla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y  292 (427)
                      |+|......                                                           ....+.+||+.|
T Consensus       184 Gla~~~~~~-----------------------------------------------------------~~~~~~~Gtp~y  204 (382)
T KOG0032|consen  184 GLAKFIKPG-----------------------------------------------------------ERLHTIVGTPEY  204 (382)
T ss_pred             CCceEccCC-----------------------------------------------------------ceEeeecCCccc
Confidence            999754321                                                           133456788888


Q ss_pred             cchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         293 RAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       293 ~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                      +||||+....+...+|+||+|+|.|+|..+..||+.........+.......+..    ..|+.+|..|+|||++||+.|
T Consensus       205 ~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~----~~w~~is~~akd~i~~ll~~d  280 (382)
T KOG0032|consen  205 VAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTS----EPWDDISESAKDFIRKLLEFD  280 (382)
T ss_pred             cCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCC----CCccccCHHHHHHHHHhcccC
Confidence            8888888888999999999999999998888888876655555544444443333    356778999999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCC
Q psy8260         373 SEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       373 P~~R~ta~e~L~Hp~f~~~  391 (427)
                      |.+|+||.|+|+|||++..
T Consensus       281 p~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  281 PRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             cccCCCHHHHhcCccccCC
Confidence            9999999999999999865

>KOG0580|consensus

Probab=100.00  E-value=8.6e-47  Score=333.25  Aligned_cols=256  Identities=23%  Similarity=0.343  Sum_probs=208.6

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHH-HHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAV-HAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      ...++|++++.||+|.||.||. +..++++..||+|++.++..... ...++.||++|-+.|+||||+++|++|++.   
T Consensus        19 ~~l~dfeigr~LgkgkFG~vYl-arekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~---   94 (281)
T KOG0580|consen   19 WTLDDFEIGRPLGKGKFGNVYL-AREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS---   94 (281)
T ss_pred             cchhhccccccccCCccccEeE-eeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc---
Confidence            3457899999999999999996 56778999999999876533222 235577999999999999999999999865   


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                         ..+|+++||. +|.+...++.   .++++..+..|++|++.||.|||.++||||||||+|+|++.++.+||+|||.+
T Consensus        95 ---~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGws  171 (281)
T KOG0580|consen   95 ---KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWS  171 (281)
T ss_pred             ---ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCce
Confidence               5689999988 6788887763   45999999999999999999999999999999999999999999999999976


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      .....                                                            +.+.+.|||..|.+|
T Consensus       172 V~~p~------------------------------------------------------------~kR~tlcgt~dyl~p  191 (281)
T KOG0580|consen  172 VHAPS------------------------------------------------------------NKRKTLCGTLDYLPP  191 (281)
T ss_pred             eecCC------------------------------------------------------------CCceeeecccccCCH
Confidence            53211                                                            145567888899999


Q ss_pred             HHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCC
Q psy8260         296 EIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEK  375 (427)
Q Consensus       296 Evl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~  375 (427)
                      |++.+..++..+|+|++|+..+++..+-+||-.....+..++.....-..        ...++.+|.|||++||.+||.+
T Consensus       192 Emv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~--------p~~is~~a~dlI~~ll~~~p~~  263 (281)
T KOG0580|consen  192 EMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKF--------PSTISGGAADLISRLLVKNPIE  263 (281)
T ss_pred             hhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccC--------CcccChhHHHHHHHHhccCccc
Confidence            99998889999999999999887755555565555444443333222211        1468999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCC
Q psy8260         376 RITAEQALAHPYLSQY  391 (427)
Q Consensus       376 R~ta~e~L~Hp~f~~~  391 (427)
                      |++..|++.|||+...
T Consensus       264 r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  264 RLALTEVMDHPWIVAN  279 (281)
T ss_pred             cccHHHHhhhHHHHhc
Confidence            9999999999999653

>KOG0610|consensus

Probab=100.00  E-value=3e-45  Score=345.95  Aligned_cols=308  Identities=21%  Similarity=0.279  Sum_probs=234.6

Q ss_pred             ccccccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC-HHHHHHHHHHHHHHhcCCCCCceeeeeeeec
Q psy8260          57 PYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS-AVHAKRTYRELRMLKHMNHENVIGLLDVFHS  135 (427)
Q Consensus        57 ~~~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~  135 (427)
                      +...+.-..|++.+.||.|.-|.||.+. .+.++..+|+|++.+.... .....+...|-+||+.++||.+++||..|++
T Consensus        70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~-l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet  148 (459)
T KOG0610|consen   70 KDGSLGLRHFRLLKRLGCGDIGTVYLVE-LRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET  148 (459)
T ss_pred             CCCccCHHHHHHHHHcCCCCceeEEEEE-ecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec
Confidence            3445566678889999999999999755 4557789999999875433 2334566789999999999999999999986


Q ss_pred             CccccCCceEEEEeccC-CCCHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEee
Q psy8260         136 NTCLADFKNVYMVTHLM-GADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILD  211 (427)
Q Consensus       136 ~~~~~~~~~~~lv~e~~-g~~L~~~l~~~---~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~D  211 (427)
                      .      ...|++|||| ||+|..+.+++   .|++..++.|+.+|+.||+|||-.|||.||||||||||.++|++.|+|
T Consensus       149 ~------~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsD  222 (459)
T KOG0610|consen  149 D------KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSD  222 (459)
T ss_pred             c------ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeee
Confidence            5      4678999988 89999988754   599999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCccc-------------cccc--ccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccC--
Q psy8260         212 FGLARPTENEMTG-------------YVAT--RWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFG--  274 (427)
Q Consensus       212 FGla~~~~~~~~~-------------~~gt--~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g--  274 (427)
                      |-|+.......+.             .+-+  +..-.|..+.....                         -+..|.+  
T Consensus       223 FDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~-------------------------~~k~~~~~~  277 (459)
T KOG0610|consen  223 FDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKK-------------------------RKKKDESAS  277 (459)
T ss_pred             ccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccc-------------------------ccccccccc
Confidence            9998654211000             0000  01111111111000                         0001111  


Q ss_pred             ------CCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcc
Q psy8260         275 ------LARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKK  348 (427)
Q Consensus       275 ------~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (427)
                            .+.+.......++||-.|+|||||.+..++..+|||++|+.+|+|..+..||.......+..+.+...+.++..
T Consensus       278 ~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~  357 (459)
T KOG0610|consen  278 RSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEE  357 (459)
T ss_pred             ccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCC
Confidence                  12233344567999999999999999999999999999999999998888898887777777776555555443


Q ss_pred             cHHhhcCCCChhHHHHHHHhcCCCCCCCCC----HHHHhcCCCCCCCCCCCCCCCCCC
Q psy8260         349 DFRQVFKGANPQAIDLLSLMLELDSEKRIT----AEQALAHPYLSQYSDPNDEPTSPP  402 (427)
Q Consensus       349 ~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t----a~e~L~Hp~f~~~~~~~~~~~~~~  402 (427)
                            +.++..|+|||+++|++||.+|+.    |.|+-+||||..+..+-.....||
T Consensus       358 ------~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP  409 (459)
T KOG0610|consen  358 ------PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPP  409 (459)
T ss_pred             ------CcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCC
Confidence                  256789999999999999999998    999999999998876644333333

>KOG0666|consensus

Probab=100.00  E-value=2.6e-46  Score=340.98  Aligned_cols=296  Identities=31%  Similarity=0.459  Sum_probs=221.5

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCC---cEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccC
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSG---VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g---~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      .|++...||+|.+|.||++......+   +.+|||+++.............||+.+++.++||||++|..+|-..     
T Consensus        25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-----   99 (438)
T KOG0666|consen   25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH-----   99 (438)
T ss_pred             HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-----
Confidence            35667789999999999875443333   3699999976543333344567999999999999999999988542     


Q ss_pred             CceEEEEeccCCCCHHHHHhh------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCC----CCEEEee
Q psy8260         142 FKNVYMVTHLMGADLNNILRT------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED----CELKILD  211 (427)
Q Consensus       142 ~~~~~lv~e~~g~~L~~~l~~------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~----~~~kl~D  211 (427)
                      ...++++++|...||.++++.      +.++...++.++.||+.|+.|||++-|+||||||.|||+..+    |.|||+|
T Consensus       100 d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  100 DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence            256899999999999999853      348888999999999999999999999999999999999766    8999999


Q ss_pred             CCCCCCCCCC------cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccc
Q psy8260         212 FGLARPTENE------MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTG  285 (427)
Q Consensus       212 FGla~~~~~~------~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~  285 (427)
                      ||+||...+.      ....+.|.||+|||+++|..+|+.+.      |+|+.||+++|-                 ++.
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~Ai------DvWAiGCIfaEl-----------------Ltl  236 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAI------DVWAIGCIFAEL-----------------LTL  236 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchh------hhHHHHHHHHHH-----------------Hcc
Confidence            9999977653      34467899999999999999999988      999999999882                 111


Q ss_pred             ccccccccchHH-hhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcH-----HHHHHHhc-CCCCCcccHHhhcCCCC
Q psy8260         286 YVATRWYRAPEI-MLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSD-----SARKYINS-LPLLTKKDFRQVFKGAN  358 (427)
Q Consensus       286 ~~gt~~Y~APEv-l~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~-----~~~~~~~~-~~~~~~~~~~~~~~~~s  358 (427)
                      .   |.|-.-|. +....   .-...++-.|+.+||+|...-|......     ....+... .....-..+.......+
T Consensus       237 ~---PlF~g~E~k~~~~~---Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~  310 (438)
T KOG0666|consen  237 E---PLFKGREEKIKTKN---PFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKD  310 (438)
T ss_pred             C---ccccchhhhcccCC---CchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCC
Confidence            1   11111111 11111   2245789999999999998766543221     01111100 00111122334455678


Q ss_pred             hhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q psy8260         359 PQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDP  394 (427)
Q Consensus       359 ~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  394 (427)
                      +.+.|||.+||++||.||+|++|+|+|+||.+-.-|
T Consensus       311 ~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~lp  346 (438)
T KOG0666|consen  311 PSALDLLQKLLTYDPIKRITAEQALEHPYFTEDPLP  346 (438)
T ss_pred             chHHHHHHHHhccCchhhccHHHHhcccccccCCCC
Confidence            889999999999999999999999999999875444

>KOG0198|consensus

Probab=100.00  E-value=3.7e-45  Score=347.05  Aligned_cols=260  Identities=27%  Similarity=0.394  Sum_probs=196.4

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      ..+..++.||+|+||.||.+ .+..+|...|||.+.....  ...+.+.+|+++|++++|||||+.++......   . .
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~-~~~~~g~~~AvK~v~~~~~--~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~---~-~   89 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLA-TNKKTGELMAVKSVELEDS--PTSESLEREIRILSRLNHPNIVQYYGSSSSRE---N-D   89 (313)
T ss_pred             chhhhhccccCccceEEEEE-EecCCCcceeeeeeecccc--hhHHHHHHHHHHHHhCCCCCEEeeCCcccccc---C-e
Confidence            34677899999999999964 4556799999999876421  22566789999999999999999998643221   1 3


Q ss_pred             eEEEEeccC-CCCHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcC-CCCEEEeeCCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE-DCELKILDFGLARPTE  219 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~~--~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~-~~~~kl~DFGla~~~~  219 (427)
                      .++++|||+ +|+|.+++...  ++++..++.+.+||++||.|||++|||||||||+|||++. ++.+||+|||+++...
T Consensus        90 ~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~  169 (313)
T KOG0198|consen   90 EYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLE  169 (313)
T ss_pred             eeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence            578889988 88999998764  5999999999999999999999999999999999999999 7999999999987543


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      .....                               |                        .......||+.|||||++.
T Consensus       170 ~~~~~-------------------------------~------------------------~~~~~~~Gtp~~maPEvi~  194 (313)
T KOG0198|consen  170 SKGTK-------------------------------S------------------------DSELSVQGTPNYMAPEVIR  194 (313)
T ss_pred             ccccc-------------------------------c------------------------cccccccCCccccCchhhc
Confidence            20000                               0                        0112345777888888877


Q ss_pred             hc-cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHH-HHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC
Q psy8260         300 NW-MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSA-RKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI  377 (427)
Q Consensus       300 ~~-~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~  377 (427)
                      +. .....+|+||+||++-+|.++..||......... .......      ..+.+...++++++|||.+||++||.+||
T Consensus       195 ~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~------~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rp  268 (313)
T KOG0198|consen  195 NGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED------SLPEIPDSLSDEAKDFLRKCFKRDPEKRP  268 (313)
T ss_pred             CCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC------CCCCCCcccCHHHHHHHHHHhhcCcccCc
Confidence            42 2223779999999988888876666543111111 1111111      11134456899999999999999999999


Q ss_pred             CHHHHhcCCCCCCC
Q psy8260         378 TAEQALAHPYLSQY  391 (427)
Q Consensus       378 ta~e~L~Hp~f~~~  391 (427)
                      ||+++|+|||..+.
T Consensus       269 ta~eLL~hpf~~~~  282 (313)
T KOG0198|consen  269 TAEELLEHPFLKQN  282 (313)
T ss_pred             CHHHHhhChhhhcc
Confidence            99999999999764

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.6e-44  Score=355.46  Aligned_cols=301  Identities=41%  Similarity=0.702  Sum_probs=216.5

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .++|.+.+.||+|+||.||. +.+..+++.||||++............+.+|+.+++.++||||+++++++.........
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCA-AYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hcceeEEEEeecCCCeEEEE-EEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            35688899999999999985 56777899999999976555555566778999999999999999999998765554455


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCc
Q psy8260         143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM  222 (427)
Q Consensus       143 ~~~~lv~e~~g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~  222 (427)
                      ..+|++|++++++|...+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       102 ~~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~  180 (364)
T cd07875         102 QDVYIVMELMDANLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF  180 (364)
T ss_pred             CeEEEEEeCCCCCHHHHHH-hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC
Confidence            6789999999888888775 358899999999999999999999999999999999999999999999999987543211


Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhcc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM  302 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~  302 (427)
                      .                                                           .....||+.|+|||++.+..
T Consensus       181 ~-----------------------------------------------------------~~~~~~t~~y~aPE~~~~~~  201 (364)
T cd07875         181 M-----------------------------------------------------------MTPYVVTRYYRAPEVILGMG  201 (364)
T ss_pred             c-----------------------------------------------------------ccCCcccCCcCCHHHHhCCC
Confidence            0                                                           01123455566666665555


Q ss_pred             CCCCCCHHHHHHHHHHhCCCCHHHH-----------------------hhcCcHHHHHHHhcCCCCCcccHHhhc-----
Q psy8260         303 HYNQTDIHQLNLIMEMLGTPPAEFM-----------------------AKISSDSARKYINSLPLLTKKDFRQVF-----  354 (427)
Q Consensus       303 ~~~~~d~~slg~i~~~lg~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  354 (427)
                      +..++|+||+|++++.|.++..+|.                       ..... ....+....+......+.+.+     
T Consensus       202 ~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (364)
T cd07875         202 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP-TVRTYVENRPKYAGYSFEKLFPDVLF  280 (364)
T ss_pred             CCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH-HHHHHHhhCCCcCCCChHhhCccccc
Confidence            5556677777777766644433332                       11110 111122222222221122111     


Q ss_pred             -------CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCC-C-CcccccCCCCHHHHHHHHhhhc
Q psy8260         355 -------KGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPP-Y-DQSFEDMDLPVDQWKGTYSLES  425 (427)
Q Consensus       355 -------~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~  425 (427)
                             ...+.+++|||.+||++||.+|||++|+|+||||..+..|...+..++ . +....+...+.+.|+..+..+.
T Consensus       281 ~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (364)
T cd07875         281 PADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEV  360 (364)
T ss_pred             cccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcccCCCCCCCCCCccchhhhccHHHHHHHHHHHH
Confidence                   123568999999999999999999999999999998777655543332 2 2223445677888888776665

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0578|consensus

Probab=100.00  E-value=2.8e-45  Score=358.76  Aligned_cols=255  Identities=22%  Similarity=0.378  Sum_probs=205.5

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      ..|..-..+|+|+-|.||. +....+++.||||++....+..  .+-+++|+.+|+..+|+|||.+++.|-..      .
T Consensus       273 ~~y~~~~kigqgaSG~vy~-A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~------d  343 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYV-ARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVG------D  343 (550)
T ss_pred             hhhcchhhhccccccceee-eeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhccc------c
Confidence            4466667899999999994 6778899999999997654432  34477999999999999999999887543      5


Q ss_pred             eEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCc
Q psy8260         144 NVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM  222 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~  222 (427)
                      .+++||||+ ||+|.+++....++|.++..++++++.||+|||.+||||||||.+|||++.+|.+||+|||++.......
T Consensus       344 eLWVVMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~  423 (550)
T KOG0578|consen  344 ELWVVMEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ  423 (550)
T ss_pred             eeEEEEeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence            689999998 7899999998899999999999999999999999999999999999999999999999999987543321


Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhcc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM  302 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~  302 (427)
                      .                                                          .+.+.+|||+||||||+....
T Consensus       424 ~----------------------------------------------------------KR~TmVGTPYWMAPEVvtrk~  445 (550)
T KOG0578|consen  424 S----------------------------------------------------------KRSTMVGTPYWMAPEVVTRKP  445 (550)
T ss_pred             C----------------------------------------------------------ccccccCCCCccchhhhhhcc
Confidence            1                                                          234567999999999999999


Q ss_pred             CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q psy8260         303 HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQA  382 (427)
Q Consensus       303 ~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~  382 (427)
                      |+.++||||||+++-+|--+-+||..+..-...+.. ..+.....    +....+|++++|||.+||+.||.+|+||.|+
T Consensus       446 YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI-a~ng~P~l----k~~~klS~~~kdFL~~cL~~dv~~RasA~eL  520 (550)
T KOG0578|consen  446 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGTPKL----KNPEKLSPELKDFLDRCLVVDVEQRASAKEL  520 (550)
T ss_pred             cCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH-hhcCCCCc----CCccccCHHHHHHHHHHhhcchhcCCCHHHH
Confidence            999999999999998885555555543222222211 12211111    1235689999999999999999999999999


Q ss_pred             hcCCCCCC
Q psy8260         383 LAHPYLSQ  390 (427)
Q Consensus       383 L~Hp~f~~  390 (427)
                      |+||||..
T Consensus       521 L~HpFl~~  528 (550)
T KOG0578|consen  521 LEHPFLKM  528 (550)
T ss_pred             hcChhhhh
Confidence            99999943

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=7.1e-44  Score=352.71  Aligned_cols=296  Identities=42%  Similarity=0.738  Sum_probs=210.3

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .+.|.+.+.||+|+||.||. +.+..+|+.||||++............+.+|+.+++.++||||++++++|.........
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCA-AFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhceEEEEEeecCCCEEEEE-EEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            35688899999999999996 56778899999999976555555566778999999999999999999998765444445


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC-
Q psy8260         143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE-  221 (427)
Q Consensus       143 ~~~~lv~e~~g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~-  221 (427)
                      ..+|+++++++++|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..... 
T Consensus        99 ~~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~  177 (359)
T cd07876          99 QDVYLVMELMDANLCQVIH-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF  177 (359)
T ss_pred             ceeEEEEeCCCcCHHHHHh-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccCc
Confidence            5689999999888877764 35889999999999999999999999999999999999999999999999998643221 


Q ss_pred             -cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         222 -MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       222 -~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                       .+..                                                             .||+.|+|||++.+
T Consensus       178 ~~~~~-------------------------------------------------------------~~t~~y~aPE~~~~  196 (359)
T cd07876         178 MMTPY-------------------------------------------------------------VVTRYYRAPEVILG  196 (359)
T ss_pred             cCCCC-------------------------------------------------------------cccCCCCCchhccC
Confidence             1122                                                             34555555555555


Q ss_pred             ccCCCCCCHHHHHHHHHHhCCCCHHHH-----------------------hhcCcHHHHHHHhcCCCCCcccHHhhc---
Q psy8260         301 WMHYNQTDIHQLNLIMEMLGTPPAEFM-----------------------AKISSDSARKYINSLPLLTKKDFRQVF---  354 (427)
Q Consensus       301 ~~~~~~~d~~slg~i~~~lg~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~---  354 (427)
                      ..+..++|+||+|++++.|.++..+|.                       .... .....+....+......+.+.+   
T Consensus       197 ~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  275 (359)
T cd07876         197 MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ-PTVRNYVENRPQYPGISFEELFPDW  275 (359)
T ss_pred             CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH-HHHHHHHhhCCCCCCcchhhhcccc
Confidence            555556677777776666644433332                       1111 0111222222222222222211   


Q ss_pred             ---------CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCC--CCcccccCCCCHHHHHHHHh
Q psy8260         355 ---------KGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPP--YDQSFEDMDLPVDQWKGTYS  422 (427)
Q Consensus       355 ---------~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  422 (427)
                               ...+++++|||.+||++||++|+|++|+|+||||..+..|......++  .+...++.+...++|...+.
T Consensus       276 ~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (359)
T cd07876         276 IFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAEAPPPQIYDAQLEEREHAIEEWKELIY  354 (359)
T ss_pred             ccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCcccccCCCccccccccccccccHHHHHHHHH
Confidence                     224678999999999999999999999999999998777654433222  22233455555566665443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0585|consensus

Probab=100.00  E-value=5.9e-45  Score=348.56  Aligned_cols=265  Identities=24%  Similarity=0.350  Sum_probs=199.5

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH-------H-----HHHHHHHHHHHHhcCCCCCceeee
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA-------V-----HAKRTYRELRMLKHMNHENVIGLL  130 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~-------~-----~~~~~~~Ei~~l~~l~HpnIv~l~  130 (427)
                      .+.|.+.+.||+|+||.|.. +++..+++.||||++.+.....       .     ..++..+||.+|+++.|||||+|+
T Consensus        96 lNqy~l~~eiG~G~yGkVkL-ar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   96 LNQYELIKEIGSGQYGKVKL-ARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             hhheehhhhhcCCccceEEE-EeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            46789999999999998884 7788899999999987542211       1     124788999999999999999999


Q ss_pred             eeeecCccccCCceEEEEeccC-CCCHHHHHhhCC-CCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEE
Q psy8260         131 DVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQK-LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELK  208 (427)
Q Consensus       131 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~~-l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~k  208 (427)
                      ++..+.    ....+|||+||| .|.+...-.... +++.+++.|+++++.||+|||.+|||||||||+|+||+.+|.||
T Consensus       175 EvLDDP----~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VK  250 (576)
T KOG0585|consen  175 EVLDDP----ESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVK  250 (576)
T ss_pred             EeecCc----ccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEE
Confidence            997653    346799999999 444443322344 89999999999999999999999999999999999999999999


Q ss_pred             EeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccc
Q psy8260         209 ILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVA  288 (427)
Q Consensus       209 l~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~g  288 (427)
                      |+|||.+.........                                                     .....+...+|
T Consensus       251 IsDFGVs~~~~~~~~~-----------------------------------------------------~~d~~L~~tvG  277 (576)
T KOG0585|consen  251 ISDFGVSNEFPQGSDE-----------------------------------------------------GSDDQLSRTVG  277 (576)
T ss_pred             eeccceeeecccCCcc-----------------------------------------------------ccHHHHhhcCC
Confidence            9999988643211000                                                     00001223456


Q ss_pred             cccccchHHhhhcc---C-CCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHH
Q psy8260         289 TRWYRAPEIMLNWM---H-YNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDL  364 (427)
Q Consensus       289 t~~Y~APEvl~~~~---~-~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL  364 (427)
                      ||.|+|||......   + ...-|+|++|+.+|-|..+..||.+...-....++.+..-.++.      .+.++++++||
T Consensus       278 TPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~------~pe~~e~~kDl  351 (576)
T KOG0585|consen  278 TPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLEFPE------NPEINEDLKDL  351 (576)
T ss_pred             CccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcccCCC------cccccHHHHHH
Confidence            66666666554311   1 22349999999999998888888876655555555443222221      12468899999


Q ss_pred             HHHhcCCCCCCCCCHHHHhcCCCCCCC
Q psy8260         365 LSLMLELDSEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       365 i~~mL~~dP~~R~ta~e~L~Hp~f~~~  391 (427)
                      |.+||++||.+|+|+.++..|||....
T Consensus       352 i~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  352 IKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             HHHHhhcChhheeehhhheecceeccC
Confidence            999999999999999999999999864

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.2e-43  Score=347.46  Aligned_cols=298  Identities=37%  Similarity=0.635  Sum_probs=205.2

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCce
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      +|.+.+.||+|+||.||. +.+..+|+.||||++...........++.+|+++++.++||||+++++++.... ......
T Consensus         1 ry~i~~~lg~G~~g~V~~-~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~~   78 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCS-AIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS-RREFKD   78 (338)
T ss_pred             CeEEEEEEeecCCeEEEE-EEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccC-CCCCce
Confidence            367889999999999996 557788999999998754333344556789999999999999999999875432 122346


Q ss_pred             EEEEeccCCCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcc
Q psy8260         145 VYMVTHLMGADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT  223 (427)
Q Consensus       145 ~~lv~e~~g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~  223 (427)
                      +|+++|+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus        79 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  158 (338)
T cd07859          79 IYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP  158 (338)
T ss_pred             EEEEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence            899999999999888764 4699999999999999999999999999999999999999999999999999875422110


Q ss_pred             cccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh--c
Q psy8260         224 GYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN--W  301 (427)
Q Consensus       224 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~--~  301 (427)
                      ...                                                       ......||+.|+|||++.+  .
T Consensus       159 ~~~-------------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~  183 (338)
T cd07859         159 TAI-------------------------------------------------------FWTDYVATRWYRAPELCGSFFS  183 (338)
T ss_pred             ccc-------------------------------------------------------cccCCCCCCCcCCHHHHhcccc
Confidence            000                                                       0011234445555554433  2


Q ss_pred             cCCCCCCHHHHHHHHHHhCCCCHHH-----------------------HhhcCcHHHHHHHhcCCCCCcccHHhhcCCCC
Q psy8260         302 MHYNQTDIHQLNLIMEMLGTPPAEF-----------------------MAKISSDSARKYINSLPLLTKKDFRQVFKGAN  358 (427)
Q Consensus       302 ~~~~~~d~~slg~i~~~lg~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  358 (427)
                      .+..++|+||+|++++.+.++..+|                       ...........+...........+...++..+
T Consensus       184 ~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (338)
T cd07859         184 KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNAD  263 (338)
T ss_pred             ccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCC
Confidence            3444567777777666654443333                       22211111112222222222233445556788


Q ss_pred             hhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCC---CCcccccCCCCHHHHHH
Q psy8260         359 PQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPP---YDQSFEDMDLPVDQWKG  419 (427)
Q Consensus       359 ~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  419 (427)
                      +++.+||.+||+.||++|||++|+|+||||.........+...+   ....++....+.+....
T Consensus       264 ~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (338)
T cd07859         264 PLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPSAQPITKLEFEFERRRLTKEDVRE  327 (338)
T ss_pred             hHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccccccCccccccccHHHHhcCHHHHHH
Confidence            99999999999999999999999999999987665444333322   23334444444444443

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG4717|consensus

Probab=100.00  E-value=1.4e-44  Score=348.07  Aligned_cols=258  Identities=26%  Similarity=0.395  Sum_probs=210.6

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .|-|++.+.||.|.|. |++.+.+..||.+||||++.+...+......+++|+++|+.++|||||+||++..+.      
T Consensus        17 AGLYDLekTlG~GHFA-VVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQ------   89 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFA-VVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQ------   89 (864)
T ss_pred             eeeehhhhhhcCCcee-hhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhccc------
Confidence            4678999999999986 445677888999999999998887777778899999999999999999999998654      


Q ss_pred             ceEEEEeccC-CCCHHHHHh--hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEc-CCCCEEEeeCCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILR--TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN-EDCELKILDFGLARPT  218 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~--~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~-~~~~~kl~DFGla~~~  218 (427)
                      ..+|++.|+- +|+|++++-  ..+++|+.++.|+.||+.|+.|||+..+|||||||+||.+- .-|-|||.|||++-.+
T Consensus        90 TKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf  169 (864)
T KOG4717|consen   90 TKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF  169 (864)
T ss_pred             ceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccC
Confidence            4689999998 679999773  46799999999999999999999999999999999999864 5689999999998644


Q ss_pred             C--CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         219 E--NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       219 ~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      .  ...++.||+..|-|||+++|                                                         
T Consensus       170 ~PG~kL~TsCGSLAYSAPEILLG---------------------------------------------------------  192 (864)
T KOG4717|consen  170 QPGKKLTTSCGSLAYSAPEILLG---------------------------------------------------------  192 (864)
T ss_pred             CCcchhhcccchhhccCchhhhc---------------------------------------------------------
Confidence            3  34566677777777777665                                                         


Q ss_pred             HhhhccCCC-CCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCC
Q psy8260         297 IMLNWMHYN-QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEK  375 (427)
Q Consensus       297 vl~~~~~~~-~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~  375 (427)
                          ..|.. .+||||||+|+|+|-.+..||...+.++....+....-        .+...+|.+++|||..||+.||+|
T Consensus       193 ----DsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY--------tvPshvS~eCrdLI~sMLvRdPkk  260 (864)
T KOG4717|consen  193 ----DSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY--------TVPSHVSKECRDLIQSMLVRDPKK  260 (864)
T ss_pred             ----CccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc--------cCchhhhHHHHHHHHHHHhcCchh
Confidence                22333 35999999999999877777877776666554433211        123457899999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCCCC
Q psy8260         376 RITAEQALAHPYLSQYSDPND  396 (427)
Q Consensus       376 R~ta~e~L~Hp~f~~~~~~~~  396 (427)
                      |.|.+|+..|+|++....+..
T Consensus       261 RAslEeI~s~~Wlq~~D~~~s  281 (864)
T KOG4717|consen  261 RASLEEIVSTSWLQAGDRGLS  281 (864)
T ss_pred             hccHHHHhccccccCCCCCcc
Confidence            999999999999987654433

>KOG0591|consensus

Probab=100.00  E-value=3.2e-46  Score=336.36  Aligned_cols=254  Identities=23%  Similarity=0.334  Sum_probs=202.4

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      ...|.|.+.||+|+||.||+ +.+..+|..||.|.+.-...+....+.+..|+.+|++|+|||||+++++-..    ++.
T Consensus        18 l~~y~Il~~IG~GsFg~vyk-v~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~----~~~   92 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYK-VQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI----EDN   92 (375)
T ss_pred             HHHHHHHHHHcCCcchheEE-eeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh----ccc
Confidence            45688999999999999995 5678899999999998666677777888999999999999999999874211    222


Q ss_pred             ceEEEEeccC-CCCHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHh--cC--ceeccCCCCCeEEcCCCCEEEeeC
Q psy8260         143 KNVYMVTHLM-GADLNNILRT-----QKLSDDHVQFLVYQILRGLKYIHS--AG--IIHRDLKPSNIAVNEDCELKILDF  212 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~yLH~--~~--iiHrDLKp~NILl~~~~~~kl~DF  212 (427)
                      ..++++||+| +|||.++++.     +.++|..+..++.|+++||..||+  ..  |+||||||.||+|+.+|.|||+||
T Consensus        93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf  172 (375)
T KOG0591|consen   93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF  172 (375)
T ss_pred             hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence            4478999999 6899998853     469999999999999999999999  45  999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccc
Q psy8260         213 GLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWY  292 (427)
Q Consensus       213 Gla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y  292 (427)
                      ||++.+.+..+                                                          ...+.+|||+|
T Consensus       173 GL~r~l~s~~t----------------------------------------------------------fA~S~VGTPyY  194 (375)
T KOG0591|consen  173 GLGRFLSSKTT----------------------------------------------------------FAHSLVGTPYY  194 (375)
T ss_pred             hhHhHhcchhH----------------------------------------------------------HHHhhcCCCcc
Confidence            99997655432                                                          12356788888


Q ss_pred             cchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhc-CCCChhHHHHHHHhcCC
Q psy8260         293 RAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF-KGANPQAIDLLSLMLEL  371 (427)
Q Consensus       293 ~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dLi~~mL~~  371 (427)
                      |+||++....|..++|+||+||++++|.....||...+--..-+++.+.       +++..+ ..+|.+...||.-|+..
T Consensus       195 MSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg-------d~~~~p~~~YS~~l~~li~~ci~v  267 (375)
T KOG0591|consen  195 MSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG-------DYPPLPDEHYSTDLRELINMCIAV  267 (375)
T ss_pred             cCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC-------CCCCCcHHHhhhHHHHHHHHHccC
Confidence            8888888888999999999999999997777777654322222222211       111122 34688999999999999


Q ss_pred             CCCCCCCHHHHhcCCCCCCC
Q psy8260         372 DSEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       372 dP~~R~ta~e~L~Hp~f~~~  391 (427)
                      ||..||+.     ||++.+.
T Consensus       268 d~~~RP~t-----~~~v~di  282 (375)
T KOG0591|consen  268 DPEQRPDT-----VPYVQDI  282 (375)
T ss_pred             CcccCCCc-----chHHHHH
Confidence            99999985     5665543

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.4e-43  Score=350.04  Aligned_cols=300  Identities=40%  Similarity=0.678  Sum_probs=211.4

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .++|.+.+.||+|+||.||. +.+..+++.||||++..............+|+.+++.++||||++++++|.........
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCA-AYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhceeEEEEeeecCCEEEEE-EEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            35688899999999999995 56777899999999976655555667788999999999999999999998765544445


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCc
Q psy8260         143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM  222 (427)
Q Consensus       143 ~~~~lv~e~~g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~  222 (427)
                      ..+|++++++++++.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        95 ~~~~lv~e~~~~~l~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~  173 (355)
T cd07874          95 QDVYLVMELMDANLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF  173 (355)
T ss_pred             ceeEEEhhhhcccHHHHHhh-cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCcc
Confidence            67899999998888877653 58899999999999999999999999999999999999999999999999987532211


Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhcc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM  302 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~  302 (427)
                      .                                                           .....||+.|+|||++.+..
T Consensus       174 ~-----------------------------------------------------------~~~~~~t~~y~aPE~~~~~~  194 (355)
T cd07874         174 M-----------------------------------------------------------MTPYVVTRYYRAPEVILGMG  194 (355)
T ss_pred             c-----------------------------------------------------------cCCccccCCccCHHHHcCCC
Confidence            0                                                           01123556666666665555


Q ss_pred             CCCCCCHHHHHHHHHHhCCCCHHHH-----------------------hhcCcHHHHHHHhcCCCCCcccHHh-------
Q psy8260         303 HYNQTDIHQLNLIMEMLGTPPAEFM-----------------------AKISSDSARKYINSLPLLTKKDFRQ-------  352 (427)
Q Consensus       303 ~~~~~d~~slg~i~~~lg~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~~-------  352 (427)
                      +..++|+||+|++++.|.++..+|.                       .... .....+....+......+..       
T Consensus       195 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (355)
T cd07874         195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLF  273 (355)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc-HHHHHHHhcCCccccccchhhcccccc
Confidence            6666788888877766644433332                       1111 11111222112111111111       


Q ss_pred             -----hcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCCC-C-CCCcccccCCCCHHHHHHHHhhh
Q psy8260         353 -----VFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTS-P-PYDQSFEDMDLPVDQWKGTYSLE  424 (427)
Q Consensus       353 -----~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~  424 (427)
                           .....+.+++|||.+||+.||++|||++|+|+||||..+..+.....+ + .+.....+.....+.|+..+-.+
T Consensus       274 ~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (355)
T cd07874         274 PADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKE  352 (355)
T ss_pred             ccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccChhhccCCCccccccchhhhhccHHHHHHHHHHH
Confidence                 112245688999999999999999999999999999877655333222 1 12223334445566677665443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0694|consensus

Probab=100.00  E-value=2e-44  Score=359.25  Aligned_cols=261  Identities=20%  Similarity=0.325  Sum_probs=212.0

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC-HHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS-AVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNT  137 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~  137 (427)
                      .+....|.+.++||+|+||.|+++. .+.+++.+|||++++...- ....+....|.+|+... +||.+++|+..|++. 
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae-~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~-  441 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAE-LKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTK-  441 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEE-EcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccC-
Confidence            3455678999999999999999755 4568889999999876432 33456677888888776 599999999999875 


Q ss_pred             cccCCceEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         138 CLADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       138 ~~~~~~~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                           .++|+||||. |||+..+.+.+.|++..++.|+..|+.||+|||++|||+||||.+|||+|.+|.+||+|||+++
T Consensus       442 -----~~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcK  516 (694)
T KOG0694|consen  442 -----EHLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCK  516 (694)
T ss_pred             -----CeEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccc
Confidence                 5789999988 7887777777899999999999999999999999999999999999999999999999999997


Q ss_pred             CCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         217 PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       217 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      .....                                                          .....++||||.|||||
T Consensus       517 e~m~~----------------------------------------------------------g~~TsTfCGTpey~aPE  538 (694)
T KOG0694|consen  517 EGMGQ----------------------------------------------------------GDRTSTFCGTPEFLAPE  538 (694)
T ss_pred             ccCCC----------------------------------------------------------CCccccccCChhhcChh
Confidence            42110                                                          01334678999999999


Q ss_pred             HhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCC
Q psy8260         297 IMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKR  376 (427)
Q Consensus       297 vl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R  376 (427)
                      |+.+..|...+|||+||+++|+|..+-.||......+....+++..+.++        ...|.++.+++++||.+||.+|
T Consensus       539 il~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP--------~~ls~ea~~il~~ll~k~p~kR  610 (694)
T KOG0694|consen  539 VLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYP--------RFLSKEAIAIMRRLLRKNPEKR  610 (694)
T ss_pred             hhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC--------CcccHHHHHHHHHHhccCcccc
Confidence            99988899999999999999999777777765443333333433333332        3578999999999999999999


Q ss_pred             CC-----HHHHhcCCCCCCCCC
Q psy8260         377 IT-----AEQALAHPYLSQYSD  393 (427)
Q Consensus       377 ~t-----a~e~L~Hp~f~~~~~  393 (427)
                      +.     ++++.+||||+.+..
T Consensus       611 LG~~e~d~~~i~~hpFFr~i~w  632 (694)
T KOG0694|consen  611 LGSGERDAEDIKKHPFFRSIDW  632 (694)
T ss_pred             cCCCCCCchhhhhCCccccCCH
Confidence            96     588999999997643

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2e-43  Score=338.82  Aligned_cols=256  Identities=29%  Similarity=0.472  Sum_probs=183.8

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      +.|.+.+.||.|+||.||+ +.+..+++.||+|++..... ........+|+++++.++||||+++++++...      .
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~-~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~   76 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFK-GRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTE------R   76 (288)
T ss_pred             ccceEeeEEecCCCEEEEE-EEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC------C
Confidence            4578889999999999996 45677899999999864322 12234567899999999999999999998654      3


Q ss_pred             eEEEEeccCCCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         144 NVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       144 ~~~lv~e~~g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      ..++++|++.++|.+++..  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        77 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~  156 (288)
T cd07871          77 CLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP  156 (288)
T ss_pred             eEEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence            5789999998899888754  34789999999999999999999999999999999999999999999999998643221


Q ss_pred             ---cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         222 ---MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       222 ---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                         .....+                                                             |+.|+|||++
T Consensus       157 ~~~~~~~~~-------------------------------------------------------------~~~y~aPE~~  175 (288)
T cd07871         157 TKTYSNEVV-------------------------------------------------------------TLWYRPPDVL  175 (288)
T ss_pred             CccccCcee-------------------------------------------------------------cccccChHHh
Confidence               112234                                                             4445555544


Q ss_pred             hh-ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHh----------------------cCCCCCcccHHhhcC
Q psy8260         299 LN-WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYIN----------------------SLPLLTKKDFRQVFK  355 (427)
Q Consensus       299 ~~-~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~  355 (427)
                      .+ ..+..++|+||+|++++.+.++..+|......+.......                      ..+......+.....
T Consensus       176 ~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (288)
T cd07871         176 LGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAP  255 (288)
T ss_pred             cCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCC
Confidence            33 2234445777777666665444333322111111100000                      011111122223345


Q ss_pred             CCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q psy8260         356 GANPQAIDLLSLMLELDSEKRITAEQALAHPYL  388 (427)
Q Consensus       356 ~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f  388 (427)
                      ..+++++|||++||++||.+|+|++|+|+||||
T Consensus       256 ~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         256 RLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             CCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            678999999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-42  Score=341.04  Aligned_cols=303  Identities=54%  Similarity=0.919  Sum_probs=232.9

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .++|.+.+.||+|+||.||. +.+..+|..||||++............+.+|+.+|+.++||||++++++|.........
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCS-ALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             ccceEEEEEeeecCCeEEEE-EEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            35688999999999999996 45677899999999865444444455678999999999999999999998755433333


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCc
Q psy8260         143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM  222 (427)
Q Consensus       143 ~~~~lv~e~~g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~  222 (427)
                      ..+++++++++++|..++....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus        93 ~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  172 (343)
T cd07880          93 HDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM  172 (343)
T ss_pred             ceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccCc
Confidence            45789999999999998887889999999999999999999999999999999999999999999999999987655444


Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhcc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM  302 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~  302 (427)
                      ....+++.|+|||.+.+..                                                            .
T Consensus       173 ~~~~~~~~y~aPE~~~~~~------------------------------------------------------------~  192 (343)
T cd07880         173 TGYVVTRWYRAPEVILNWM------------------------------------------------------------H  192 (343)
T ss_pred             cccccCCcccCHHHHhCCC------------------------------------------------------------C
Confidence            4445566666666653211                                                            1


Q ss_pred             CCCCCCHHHHHHHHHHhCCCCHHH-----------------------HhhcCcHHHHHHHhcCCCCCcccHHhhcCCCCh
Q psy8260         303 HYNQTDIHQLNLIMEMLGTPPAEF-----------------------MAKISSDSARKYINSLPLLTKKDFRQVFKGANP  359 (427)
Q Consensus       303 ~~~~~d~~slg~i~~~lg~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  359 (427)
                      +..++|+|++|++++.+.++..+|                       ...........+....+......+....+..++
T Consensus       193 ~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (343)
T cd07880         193 YTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANP  272 (343)
T ss_pred             CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCCh
Confidence            223446666666665543333222                       222222222233333333333444555667889


Q ss_pred             hHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCcccccCCCCHHHHHHHHhhhcc
Q psy8260         360 QAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKGTYSLESL  426 (427)
Q Consensus       360 ~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  426 (427)
                      ++.+||.+||+.||++|+|+.++++||||+....+..++..+++..++++.+...++|++....|-|
T Consensus       273 ~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (343)
T cd07880         273 LAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAPPYDDSFDEVDQSLEEWKRLTFTEIL  339 (343)
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCCCCccccHHhhccchHHHHHHHHHHHH
Confidence            9999999999999999999999999999999888877888888999999999999999998877653

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-42  Score=341.61  Aligned_cols=322  Identities=66%  Similarity=1.054  Sum_probs=237.5

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      +.|.+...||.|+||.||.+ .+..+++.||||++..............+|+.+++.++||||+++++++..........
T Consensus        15 ~~y~~~~~ig~g~~g~vy~~-~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07851          15 DRYQNLSPVGSGAYGQVCSA-FDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ   93 (343)
T ss_pred             CceEEEEEeccCCceEEEEE-EECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence            45888899999999999964 55668899999998754444445566789999999999999999998876543323334


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcc
Q psy8260         144 NVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT  223 (427)
Q Consensus       144 ~~~lv~e~~g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~  223 (427)
                      .+|+++++++++|.+++....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus        94 ~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~  173 (343)
T cd07851          94 DVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT  173 (343)
T ss_pred             cEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccccc
Confidence            58999999999999999888899999999999999999999999999999999999999999999999999986655445


Q ss_pred             cccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccC
Q psy8260         224 GYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH  303 (427)
Q Consensus       224 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~  303 (427)
                      ...++..|+|||++.+...++.      ..|+|+.|+++.+                 +.+|..               .
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~------~~DvwslGv~l~e-----------------lltg~~---------------p  215 (343)
T cd07851         174 GYVATRWYRAPEIMLNWMHYNQ------TVDIWSVGCIMAE-----------------LLTGKT---------------L  215 (343)
T ss_pred             CCcccccccCHHHHhCCCCCCc------hHhHHHHHHHHHH-----------------HHhCCC---------------C
Confidence            5566667777776643221111      1244444443332                 111100               1


Q ss_pred             CCC-CCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q psy8260         304 YNQ-TDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQA  382 (427)
Q Consensus       304 ~~~-~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~  382 (427)
                      +.. .....+..++..++.++..+...........+....+......+...+...++++.|||.+||+.||.+|||+.|+
T Consensus       216 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~el  295 (343)
T cd07851         216 FPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEA  295 (343)
T ss_pred             CCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHH
Confidence            111 1112222333333444444433333333333433344444445556666789999999999999999999999999


Q ss_pred             hcCCCCCCCCCCCCCCCCCCCCcccccCCCCHHHHHHHHhhh
Q psy8260         383 LAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKGTYSLE  424 (427)
Q Consensus       383 L~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (427)
                      ++||||.++..+..++..+.++.++++..+.+.+|++.++++
T Consensus       296 l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (343)
T cd07851         296 LAHPYLAEYHDPEDEPVAPPYDQSFESRDLTVDEWKELVYKE  337 (343)
T ss_pred             hcCCCccccCCCcccccccccCcchhhhhcCHHHHHHHhHHH
Confidence            999999999888888888999999999999999999998876

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.6e-42  Score=343.26  Aligned_cols=315  Identities=41%  Similarity=0.661  Sum_probs=219.2

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceE
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV  145 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~  145 (427)
                      |++.+.||+|+||.||. +.+..+|+.||||++..........+++.+|+++++.++||||+++++++..... .....+
T Consensus         2 ~~~~~~lg~G~~g~V~~-~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~   79 (372)
T cd07853           2 VEPDRPIGYGAFGVVWS-VTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHI-DPFEEI   79 (372)
T ss_pred             CcccceeeeCCCEEEEE-EEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCc-cccceE
Confidence            56788999999999996 4567789999999987654444555678899999999999999999999865431 122368


Q ss_pred             EEEeccCCCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC---
Q psy8260         146 YMVTHLMGADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE---  221 (427)
Q Consensus       146 ~lv~e~~g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~---  221 (427)
                      |+++++++++|...+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....   
T Consensus        80 ~lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~  159 (372)
T cd07853          80 YVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK  159 (372)
T ss_pred             EEEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence            99999998888887754 56999999999999999999999999999999999999999999999999999754321   


Q ss_pred             -cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         222 -MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       222 -~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                       .+...+|+.|+|||++.+...++..      .|+|+.||++.+                 +.+|..             
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~------~DiwslG~il~e-----------------l~~g~~-------------  203 (372)
T cd07853         160 HMTQEVVTQYYRAPEILMGSRHYTSA------VDIWSVGCIFAE-----------------LLGRRI-------------  203 (372)
T ss_pred             cCCCCCcCCCcCCHHHHcCCCCCCcH------HHHHhHHHHHHH-----------------HHcCCC-------------
Confidence             2334567777777777654333322      266666666544                 222211             


Q ss_pred             ccCCC-CCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHH---hhcCCCChhHHHHHHHhcCCCCCCC
Q psy8260         301 WMHYN-QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFR---QVFKGANPQAIDLLSLMLELDSEKR  376 (427)
Q Consensus       301 ~~~~~-~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~s~~~~dLi~~mL~~dP~~R  376 (427)
                        .+. .....++..|...+|.++.+....... ...+.....+.... ...   ......++++.|||.+||++||.+|
T Consensus       204 --pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R  279 (372)
T cd07853         204 --LFQAQSPIQQLDLITDLLGTPSLEAMRSACE-GARAHILRGPHKPP-SLPVLYTLSSQATHEAVHLLCRMLVFDPDKR  279 (372)
T ss_pred             --CCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH-HHHHHHHhCCCCCC-chHHhcccCCCCCHHHHHHHHHhCCCChhhC
Confidence              222 223445555666666665543322211 12222222211111 111   1234568899999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCC--------------------CCCCC-CCCCCCcccccCCCCHHHHHHHHh
Q psy8260         377 ITAEQALAHPYLSQYSD--------------------PNDEP-TSPPYDQSFEDMDLPVDQWKGTYS  422 (427)
Q Consensus       377 ~ta~e~L~Hp~f~~~~~--------------------~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  422 (427)
                      +|++|+|+||||.+...                    ...+| ...+++.+.++...++.+++..+.
T Consensus       280 ~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (372)
T cd07853         280 ISAADALAHPYLDEGRLRYHTCMCKCCYTTSGGRVYTSDFEPSANPPFDDEYEKNLTSVRQVKEELH  346 (372)
T ss_pred             cCHHHHhcCHhhCCCcchhccccccccccccccccCCcccCCCCCCCCCcccccccCCHHHHHHHHH
Confidence            99999999999987321                    01111 234566667776777777776544

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.3e-42  Score=338.25  Aligned_cols=302  Identities=65%  Similarity=1.026  Sum_probs=229.5

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      ..+|.+.+.||+|+||.||. +.+..+|+.||+|++..........+.+.+|+.++++++||||+++++++.........
T Consensus        16 ~~~y~~~~~lg~G~~g~v~~-~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (345)
T cd07877          16 PERYQNLSPVGSGAYGSVCA-AFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   94 (345)
T ss_pred             cCceEEEEEeeecCCeEEEE-EEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence            35688889999999999996 45667899999999876544444456677999999999999999999998655444444


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCc
Q psy8260         143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM  222 (427)
Q Consensus       143 ~~~~lv~e~~g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~  222 (427)
                      ..+|+++++++++|.++++...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus        95 ~~~~lv~~~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~~  174 (345)
T cd07877          95 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM  174 (345)
T ss_pred             ccEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccccc
Confidence            56889999999999998887789999999999999999999999999999999999999999999999999987655444


Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhcc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM  302 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~  302 (427)
                      ....+|.+|+|||++.+...                                                            
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~------------------------------------------------------------  194 (345)
T cd07877         175 TGYVATRWYRAPEIMLNWMH------------------------------------------------------------  194 (345)
T ss_pred             cccccCCCccCHHHHhCccC------------------------------------------------------------
Confidence            44556666666666543211                                                            


Q ss_pred             CCCCCCHHHHHHHHHHh-----------------------CCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCCh
Q psy8260         303 HYNQTDIHQLNLIMEML-----------------------GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANP  359 (427)
Q Consensus       303 ~~~~~d~~slg~i~~~l-----------------------g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  359 (427)
                      +..++|+||+|++++.+                       +.++..............+....+..+...+...+...++
T Consensus       195 ~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (345)
T cd07877         195 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP  274 (345)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCH
Confidence            22344666666555444                       2222222222222222223333333333334444456789


Q ss_pred             hHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCcccccCCCCHHHHHHHHhhhc
Q psy8260         360 QAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKGTYSLES  425 (427)
Q Consensus       360 ~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (427)
                      +++|||.+||+.||.+|+|+.++++||||.++..|...+.++.++.++...+.-.+.|.+-...++
T Consensus       275 ~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (345)
T cd07877         275 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEV  340 (345)
T ss_pred             HHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCccccCCCccCcchhcccCHHHHHHHHHHHH
Confidence            999999999999999999999999999999998898888888899888777777788887766654

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0669|consensus

Probab=100.00  E-value=5.5e-45  Score=323.73  Aligned_cols=293  Identities=29%  Similarity=0.449  Sum_probs=227.8

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc--ccC
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC--LAD  141 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~--~~~  141 (427)
                      +.++-...+|+|.||.||+ +....+|++||+|++.............+||+.+|..++|+|++.++++......  ..+
T Consensus        17 ~~yek~~kigqGtfgeVFk-Ar~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~   95 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFK-ARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD   95 (376)
T ss_pred             hHHHHHHhcCCchHHHHHH-HhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence            4556667899999999995 6677899999998765433333334557899999999999999999988654321  123


Q ss_pred             CceEEEEeccCCCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         142 FKNVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       142 ~~~~~lv~e~~g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                      ...+|+|+.+|..||..++..  .+++..+++.++.+++.||.|+|++.|+|||+||+|+||+.+|.+||+|||++|.+.
T Consensus        96 r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs  175 (376)
T KOG0669|consen   96 RATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFS  175 (376)
T ss_pred             cceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccccee
Confidence            456899999999999999965  469999999999999999999999999999999999999999999999999998654


Q ss_pred             C-------CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccc
Q psy8260         220 N-------EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWY  292 (427)
Q Consensus       220 ~-------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y  292 (427)
                      .       ..+..+.|.||++||.++|.+.|++..      |+|.+||+.++                 +.++.+     
T Consensus       176 ~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~i------DiWgAgCimae-----------------Mwtrsp-----  227 (376)
T KOG0669|consen  176 TSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPI------DIWGAGCIMAE-----------------MWTRSP-----  227 (376)
T ss_pred             cccccCCCCcccceeeeecCCHHHhhcccccCCcc------hhHhHHHHHHH-----------------HHccCc-----
Confidence            2       345667899999999999999999887      99999999877                 332222     


Q ss_pred             cchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCC--CCCcccHHhhcC--CCChhHHHHHHHh
Q psy8260         293 RAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLP--LLTKKDFRQVFK--GANPQAIDLLSLM  368 (427)
Q Consensus       293 ~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~--~~s~~~~dLi~~m  368 (427)
                               .....++..+|..|-.++|.-..+.|.....-....-+..-|  ..+.+..+...+  ..+++|.||+.+|
T Consensus       228 ---------imqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~l  298 (376)
T KOG0669|consen  228 ---------IMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKL  298 (376)
T ss_pred             ---------cccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHH
Confidence                     122345778899999999998888887765433333222122  112222222222  2378999999999


Q ss_pred             cCCCCCCCCCHHHHhcCCCCCCCCCC
Q psy8260         369 LELDSEKRITAEQALAHPYLSQYSDP  394 (427)
Q Consensus       369 L~~dP~~R~ta~e~L~Hp~f~~~~~~  394 (427)
                      |.+||.||++++|+|+|.||-.-+.|
T Consensus       299 l~~DP~kR~~ad~alnh~~F~kdp~p  324 (376)
T KOG0669|consen  299 LKLDPTKRIDADQALNHDFFWKDPMP  324 (376)
T ss_pred             hccCcccCcchHhhhchhhhhcCCcc
Confidence            99999999999999999999764444

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-42  Score=347.26  Aligned_cols=261  Identities=23%  Similarity=0.285  Sum_probs=188.3

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcccc
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  140 (427)
                      +..+.|.+.+.||+|+||.||. +.+..+++.||||....        ....+|+++|++++|||||+++++|...    
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~-~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~----  155 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFA-CIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYN----  155 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEE-EEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEEC----
Confidence            4456799999999999999995 67888999999996532        2357899999999999999999998653    


Q ss_pred             CCceEEEEeccCCCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         141 DFKNVYMVTHLMGADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       141 ~~~~~~lv~e~~g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                        ...++++++++++|...+.. ..+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+...
T Consensus       156 --~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~  233 (391)
T PHA03212        156 --KFTCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPV  233 (391)
T ss_pred             --CeeEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence              45788899888888877654 568999999999999999999999999999999999999999999999999986421


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      ....                                                         ....+.+||+.|+|||++.
T Consensus       234 ~~~~---------------------------------------------------------~~~~~~~gt~~y~aPE~~~  256 (391)
T PHA03212        234 DINA---------------------------------------------------------NKYYGWAGTIATNAPELLA  256 (391)
T ss_pred             cccc---------------------------------------------------------cccccccCccCCCChhhhc
Confidence            1100                                                         0111234666666666666


Q ss_pred             hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcC------c-HHHHHHHh--------------------------cCC-CC
Q psy8260         300 NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKIS------S-DSARKYIN--------------------------SLP-LL  345 (427)
Q Consensus       300 ~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~------~-~~~~~~~~--------------------------~~~-~~  345 (427)
                      +..+..++|+||+|++++.+.++..++.....      . ........                          ... ..
T Consensus       257 ~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (391)
T PHA03212        257 RDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKP  336 (391)
T ss_pred             CCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCC
Confidence            65566667888888777666443322211100      0 00000000                          000 00


Q ss_pred             -CcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q psy8260         346 -TKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDP  394 (427)
Q Consensus       346 -~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  394 (427)
                       ....+... ...+.++.+||.+||++||.+||||+|+|+||||.....|
T Consensus       337 ~~~~~~~~~-~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~  385 (391)
T PHA03212        337 GSRPLWTNL-YELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP  385 (391)
T ss_pred             CCCCCHHHH-hhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence             00011111 1346689999999999999999999999999999886544

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2e-42  Score=331.67  Aligned_cols=264  Identities=27%  Similarity=0.437  Sum_probs=189.6

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC---CCCCceeeeeeeecCccccC
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM---NHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l---~HpnIv~l~~~~~~~~~~~~  141 (427)
                      .|.+.+.||+|+||.||.+.....+|+.||||++..............+|+.+++.+   +||||+++++++..... ..
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~-~~   80 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT-DR   80 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccC-CC
Confidence            467788999999999997654445678999998865433322233455677766655   79999999998753221 22


Q ss_pred             CceEEEEeccCCCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCC
Q psy8260         142 FKNVYMVTHLMGADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT  218 (427)
Q Consensus       142 ~~~~~lv~e~~g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~  218 (427)
                      ...+++++|+++++|.+++..   ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T cd07862          81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY  160 (290)
T ss_pred             CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence            346889999998899888754   35899999999999999999999999999999999999999999999999998643


Q ss_pred             CCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         219 ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       219 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                      ....                                                           ......||+.|+|||++
T Consensus       161 ~~~~-----------------------------------------------------------~~~~~~~~~~y~aPE~~  181 (290)
T cd07862         161 SFQM-----------------------------------------------------------ALTSVVVTLWYRAPEVL  181 (290)
T ss_pred             cCCc-----------------------------------------------------------ccccccccccccChHHH
Confidence            2110                                                           01122456667777766


Q ss_pred             hhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcC-------------------CCCCcccHHhhcCCCCh
Q psy8260         299 LNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSL-------------------PLLTKKDFRQVFKGANP  359 (427)
Q Consensus       299 ~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~s~  359 (427)
                      .+..+..++|+||+|++++.|.++..+|......+...+.....                   .......+....+..++
T Consensus       182 ~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (290)
T cd07862         182 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDE  261 (290)
T ss_pred             hCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCH
Confidence            66566667788888888877755544443222111111111110                   01111223344456788


Q ss_pred             hHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q psy8260         360 QAIDLLSLMLELDSEKRITAEQALAHPYL  388 (427)
Q Consensus       360 ~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f  388 (427)
                      .++|||.+||++||++|||+.|+|+||||
T Consensus       262 ~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         262 LGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             HHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            99999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0604|consensus

Probab=100.00  E-value=5.5e-44  Score=324.40  Aligned_cols=258  Identities=23%  Similarity=0.366  Sum_probs=197.7

Q ss_pred             cceeec-cccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCccccC
Q psy8260          64 GVIDIG-PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        64 ~~~~~~-~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~~  141 (427)
                      .+|.+. ..||-|--|.|+ .+.++.||+++|+|++...       .+..||+++.-.. .|||||+++++|..  .+..
T Consensus        61 edY~is~qvLG~GinGkV~-~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeN--s~~~  130 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVV-QCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYEN--SYQG  130 (400)
T ss_pred             hhheehhhhhccccCCceE-EEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhh--hccC
Confidence            345554 578999989998 5778899999999987532       3456788877655 79999999999864  3344


Q ss_pred             CceEEEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcC---CCCEEEeeCCC
Q psy8260         142 FKNVYMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE---DCELKILDFGL  214 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~---~~~~kl~DFGl  214 (427)
                      ...+.+|||++ ||.|.+-+..   +.|+|.++..+++||+.|+.|||+.+|.||||||||+|...   |..+||+|||+
T Consensus       131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccc
Confidence            56788999998 7888876654   35999999999999999999999999999999999999864   56899999999


Q ss_pred             CCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccc
Q psy8260         215 ARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRA  294 (427)
Q Consensus       215 a~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~A  294 (427)
                      |+......                                                           .+.+-|-||+|.|
T Consensus       211 AK~t~~~~-----------------------------------------------------------~L~TPc~TPyYva  231 (400)
T KOG0604|consen  211 AKETQEPG-----------------------------------------------------------DLMTPCFTPYYVA  231 (400)
T ss_pred             ccccCCCc-----------------------------------------------------------cccCCcccccccC
Confidence            98644211                                                           1223345777777


Q ss_pred             hHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcC----cHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcC
Q psy8260         295 PEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKIS----SDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLE  370 (427)
Q Consensus       295 PEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~  370 (427)
                      |||+....|+..+|+||+|+|+|+|..+.+||...-.    ..-.+++....-.++..    .|..+|.+++|+|++||.
T Consensus       232 Pevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~p----EWs~VSe~aKdlIR~LLk  307 (400)
T KOG0604|consen  232 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEP----EWSCVSEAAKDLIRKLLK  307 (400)
T ss_pred             HHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCCh----hHhHHHHHHHHHHHHHhc
Confidence            7777777788888999999999998776666754322    11122222222233333    455679999999999999


Q ss_pred             CCCCCCCCHHHHhcCCCCCCCCCC
Q psy8260         371 LDSEKRITAEQALAHPYLSQYSDP  394 (427)
Q Consensus       371 ~dP~~R~ta~e~L~Hp~f~~~~~~  394 (427)
                      .||.+|+|++|+++|||+.+....
T Consensus       308 t~PteRlTI~~~m~hpwi~~~~~v  331 (400)
T KOG0604|consen  308 TEPTERLTIEEVMDHPWINQYEAV  331 (400)
T ss_pred             CCchhheeHHHhhcCchhcccccC
Confidence            999999999999999999886543

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.3e-42  Score=335.56  Aligned_cols=262  Identities=29%  Similarity=0.462  Sum_probs=189.6

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      +.|++.+.||.|+||.||. +.+..+|+.||||++..... ........+|+.+++.++||||+++++++...      .
T Consensus         5 ~~y~~~~~lg~G~~g~V~~-~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~   76 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYK-GKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTK------E   76 (303)
T ss_pred             ccceEeeeEEecCCEEEEE-EEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecC------C
Confidence            4688899999999999996 55667899999999864322 12234567899999999999999999998654      4


Q ss_pred             eEEEEeccCCCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         144 NVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       144 ~~~lv~e~~g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      ..++++++++++|.+.+..  ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        77 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          77 TLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP  156 (303)
T ss_pred             eEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence            6899999998898887754  45899999999999999999999999999999999999999999999999998643211


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      ..                                                          ...+..||+.|+|||++.+.
T Consensus       157 ~~----------------------------------------------------------~~~~~~~~~~y~aPE~~~~~  178 (303)
T cd07869         157 SH----------------------------------------------------------TYSNEVVTLWYRPPDVLLGS  178 (303)
T ss_pred             Cc----------------------------------------------------------cCCCCcccCCCCChHHHcCC
Confidence            00                                                          01122355666666665443


Q ss_pred             c-CCCCCCHHHHHHHHHHhCCCCHHHHhhcCc-HHHHHHHhc--------------CC--------CCCcccHHhhcC--
Q psy8260         302 M-HYNQTDIHQLNLIMEMLGTPPAEFMAKISS-DSARKYINS--------------LP--------LLTKKDFRQVFK--  355 (427)
Q Consensus       302 ~-~~~~~d~~slg~i~~~lg~~~~~~~~~~~~-~~~~~~~~~--------------~~--------~~~~~~~~~~~~--  355 (427)
                      . +...+|+||+|++++.|.++..+|...... .........              .+        ......+...+.  
T Consensus       179 ~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (303)
T cd07869         179 TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKL  258 (303)
T ss_pred             CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhcc
Confidence            2 445569999999988775554444321110 000000000              00        001111222222  


Q ss_pred             CCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q psy8260         356 GANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       356 ~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~  391 (427)
                      ..+++++|||++||++||++|+|++|+|+||||.+.
T Consensus       259 ~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~  294 (303)
T cd07869         259 SYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL  294 (303)
T ss_pred             CCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence            245789999999999999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.6e-42  Score=331.74  Aligned_cols=260  Identities=25%  Similarity=0.446  Sum_probs=190.8

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCce
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      +|++.+.||+|+||.||+ +.+..+++.||||++..........+.+.+|+.+++.++||||+++++++...      ..
T Consensus         2 ~y~~~~~lg~g~~~~v~~-~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~   74 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLK-CRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRR------GK   74 (287)
T ss_pred             CceEEEEecccCCEEEEE-EEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecC------CE
Confidence            578889999999999996 45677899999999875443344455677999999999999999999887643      46


Q ss_pred             EEEEeccCCCCHHHHHh--hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCc
Q psy8260         145 VYMVTHLMGADLNNILR--TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM  222 (427)
Q Consensus       145 ~~lv~e~~g~~L~~~l~--~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~  222 (427)
                      +|+++|++.+.+...+.  ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus        75 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          75 LYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            89999999665555443  2468999999999999999999999999999999999999999999999999987532210


Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhcc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM  302 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~  302 (427)
                      ..                                                         ......||+.|+|||++.+..
T Consensus       155 ~~---------------------------------------------------------~~~~~~~~~~y~aPE~~~~~~  177 (287)
T cd07848         155 NA---------------------------------------------------------NYTEYVATRWYRSPELLLGAP  177 (287)
T ss_pred             cc---------------------------------------------------------cccccccccccCCcHHHcCCC
Confidence            00                                                         011224667777777776666


Q ss_pred             CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHH--------------HHhcCCCC----------CcccHHhhcCCCC
Q psy8260         303 HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARK--------------YINSLPLL----------TKKDFRQVFKGAN  358 (427)
Q Consensus       303 ~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~--------------~~~~~~~~----------~~~~~~~~~~~~s  358 (427)
                      +..++|+||+|++++.+.++..+|......+....              .....+..          ............+
T Consensus       178 ~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  257 (287)
T cd07848         178 YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILS  257 (287)
T ss_pred             CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccC
Confidence            77778999999998887555444422111111000              00001100          0001112234468


Q ss_pred             hhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q psy8260         359 PQAIDLLSLMLELDSEKRITAEQALAHPYL  388 (427)
Q Consensus       359 ~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f  388 (427)
                      ++++|||++||++||++|+|++|+|+||||
T Consensus       258 ~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         258 GVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0582|consensus

Probab=100.00  E-value=2.4e-42  Score=328.78  Aligned_cols=272  Identities=21%  Similarity=0.312  Sum_probs=207.2

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      .+....|++...||.|.-+.|| .++...++..||||++.....+. ....+.+|+..|+.++||||++++..|..+   
T Consensus        22 p~n~~~YeL~e~IG~G~sa~V~-~A~c~p~~e~VAIK~inLEkc~~-~ld~l~kE~~~msl~~HPNIv~~~~sFvv~---   96 (516)
T KOG0582|consen   22 PLNAKDYELQEVIGVGASAVVY-LARCIPTNEVVAIKIINLEKCNN-DLDALRKEVQTMSLIDHPNIVTYHCSFVVD---   96 (516)
T ss_pred             CCCccceeEEEEEeccceeEee-eeeecccCCEEEEEEeehhhhhh-hHHHHHHHHHHhhhcCCCCcceEEEEEEec---
Confidence            4456789999999999887777 56777888999999997654333 366788999999999999999999999765   


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                         ..+++||.+| +|++.++++.   .+++|..+..+.++++.||.|||++|-||||||+.||||+.+|.|||+|||.+
T Consensus        97 ---~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvs  173 (516)
T KOG0582|consen   97 ---SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVS  173 (516)
T ss_pred             ---ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceee
Confidence               4689999988 7899999875   46999999999999999999999999999999999999999999999999976


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      -.+...     |++                                                 .......++|||+||||
T Consensus       174 a~l~~~-----G~R-------------------------------------------------~~~rf~tfvgtp~wmAP  199 (516)
T KOG0582|consen  174 ASLFDS-----GDR-------------------------------------------------QVTRFNTFVGTPCWMAP  199 (516)
T ss_pred             eeeccc-----Cce-------------------------------------------------eeEeeccccCcccccCh
Confidence            432211     000                                                 00011456788888888


Q ss_pred             HHhhh--ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCC-C-CcccHHhhcCCCChhHHHHHHHhcCC
Q psy8260         296 EIMLN--WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPL-L-TKKDFRQVFKGANPQAIDLLSLMLEL  371 (427)
Q Consensus       296 Evl~~--~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~s~~~~dLi~~mL~~  371 (427)
                      ||+..  ..|+.+.||||+|+...+|..+..||.+--...-....++..|. . +...-.+..+..+..++.+|..||++
T Consensus       200 Evl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~k  279 (516)
T KOG0582|consen  200 EVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVK  279 (516)
T ss_pred             HHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhc
Confidence            88543  34777889999999999998887777543222211111222221 1 00111122344567899999999999


Q ss_pred             CCCCCCCHHHHhcCCCCCCCCC
Q psy8260         372 DSEKRITAEQALAHPYLSQYSD  393 (427)
Q Consensus       372 dP~~R~ta~e~L~Hp~f~~~~~  393 (427)
                      ||.|||||.++|+|+||++...
T Consensus       280 DP~kRptAskLlkh~FFk~~k~  301 (516)
T KOG0582|consen  280 DPSKRPTASKLLKHAFFKKAKS  301 (516)
T ss_pred             CcccCCCHHHHhccHHHhhccc
Confidence            9999999999999999987543

>KOG0607|consensus

Probab=100.00  E-value=3.3e-43  Score=321.66  Aligned_cols=281  Identities=23%  Similarity=0.386  Sum_probs=208.5

Q ss_pred             ccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCccccCCceEEE
Q psy8260          69 GPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLADFKNVYM  147 (427)
Q Consensus        69 ~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~~~~~~~l  147 (427)
                      +..||+|+++.|- .+....||+.+|||+|.+.  ......+.+||++++.++ .|+||++|+++|+.+      ..+|+
T Consensus        83 ~e~LGeGAyasVq-tcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd------~~FYL  153 (463)
T KOG0607|consen   83 SELLGEGAYASVQ-TCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD------TRFYL  153 (463)
T ss_pred             HHHhcCccceeee-eeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc------ceEEE
Confidence            3689999999887 5678889999999999764  445567899999999998 699999999999754      57899


Q ss_pred             EeccC-CCCHH-HHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCC---CCEEEeeCCCCCCCCCCc
Q psy8260         148 VTHLM-GADLN-NILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED---CELKILDFGLARPTENEM  222 (427)
Q Consensus       148 v~e~~-g~~L~-~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~---~~~kl~DFGla~~~~~~~  222 (427)
                      |+|-+ ||.|. ++.+...|+|.++..++++|+.||+|||.+||.||||||+|||-...   ..+|||||-|+.......
T Consensus       154 VfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~  233 (463)
T KOG0607|consen  154 VFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNN  233 (463)
T ss_pred             EEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCC
Confidence            99877 66654 55566789999999999999999999999999999999999998643   468999998865321110


Q ss_pred             -ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh-
Q psy8260         223 -TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN-  300 (427)
Q Consensus       223 -~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~-  300 (427)
                       .+...|     |                                               .+.+-+|+-.||||||+.- 
T Consensus       234 ~~spast-----P-----------------------------------------------~L~tPvGSAEfMAPEVVd~f  261 (463)
T KOG0607|consen  234 DCSPAST-----P-----------------------------------------------ELLTPVGSAEFMAPEVVDVF  261 (463)
T ss_pred             CCCCCCC-----c-----------------------------------------------cccCcccchhhcchhHHhhh
Confidence             001111     1                                               1223456667777776542 


Q ss_pred             ----ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHH-----------HHHHHhcCCCCCcccHHhhcCCCChhHHHHH
Q psy8260         301 ----WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDS-----------ARKYINSLPLLTKKDFRQVFKGANPQAIDLL  365 (427)
Q Consensus       301 ----~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi  365 (427)
                          ..|+..+|.||||+|+|+|..+..||...+..+.           ..+.+.++......-..+-|..+|.+|+|||
T Consensus       262 v~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdli  341 (463)
T KOG0607|consen  262 VDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLI  341 (463)
T ss_pred             ccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHH
Confidence                2366678999999999999888888876554321           1122222111111111223556799999999


Q ss_pred             HHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCcccccC
Q psy8260         366 SLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPPYDQSFEDM  410 (427)
Q Consensus       366 ~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~~~~~~~~~~~  410 (427)
                      +.+|.+|+..|.+|.++++|||+........-|+++.+......+
T Consensus       342 snLlvrda~~rlsa~~vlnhPw~~~~~~ekalptp~v~~r~~s~~  386 (463)
T KOG0607|consen  342 SNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALPTPQVLQRNSSTM  386 (463)
T ss_pred             HHHHhccHHhhhhhhhccCCccccccchhccCCCCcccccCccch
Confidence            999999999999999999999999887776777777776544444

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2e-41  Score=334.38  Aligned_cols=300  Identities=43%  Similarity=0.739  Sum_probs=216.8

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .+.|.+.+.||+|+||.||. +.+..+|+.||||.+.+..........+.+|+.+++.++||||++++++|.......+.
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~-~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCA-AYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hcceEEEEEeccCCCEEEEE-EEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            35688889999999999995 56777899999999876544555556678999999999999999999998765544445


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCc
Q psy8260         143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM  222 (427)
Q Consensus       143 ~~~~lv~e~~g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~  222 (427)
                      ...|+++++++++|.+.+... +++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus        94 ~~~~lv~e~~~~~l~~~~~~~-l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~  172 (353)
T cd07850          94 QDVYLVMELMDANLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF  172 (353)
T ss_pred             CcEEEEEeccCCCHHHHHhhc-CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC
Confidence            568999999988998887654 8999999999999999999999999999999999999999999999999987543211


Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhcc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM  302 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~  302 (427)
                      .                                                           .....||+.|+|||++.+..
T Consensus       173 ~-----------------------------------------------------------~~~~~~~~~y~aPE~~~~~~  193 (353)
T cd07850         173 M-----------------------------------------------------------MTPYVVTRYYRAPEVILGMG  193 (353)
T ss_pred             C-----------------------------------------------------------CCCCcccccccCHHHHhCCC
Confidence            0                                                           00112445555566555555


Q ss_pred             CCCCCCHHHHHHHHHHhCCC-----------------------CHHHHhhcCcHHHHHHHhcCCCCCcccHHhhc-----
Q psy8260         303 HYNQTDIHQLNLIMEMLGTP-----------------------PAEFMAKISSDSARKYINSLPLLTKKDFRQVF-----  354 (427)
Q Consensus       303 ~~~~~d~~slg~i~~~lg~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  354 (427)
                      +..++|+||+|++++.|.++                       +.++...... ....+....+......+.+.+     
T Consensus       194 ~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (353)
T cd07850         194 YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP-TVRNYVENRPKYAGYSFEELFPDVLF  272 (353)
T ss_pred             CCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh-hhhHHhhcCCCCCCcchhhhCccccc
Confidence            55566777777666555333                       2222221111 111111111211111122211     


Q ss_pred             --------CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCC--CCCCCcccccCCCCHHHHHHHHhhh
Q psy8260         355 --------KGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPT--SPPYDQSFEDMDLPVDQWKGTYSLE  424 (427)
Q Consensus       355 --------~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  424 (427)
                              ...+++++|||.+||++||++|||+.|+|+||||..+..+.+...  +...+...++.+..++.|++++..+
T Consensus       273 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (353)
T cd07850         273 PPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSEVEAPPPAPYDHSIDEREHTVEEWKELIYKE  352 (353)
T ss_pred             CcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCccCCCCCCCccccccccccccHHHHHHHHHhh
Confidence                    123567899999999999999999999999999998777654433  3344556678899999999987765

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0611|consensus

Probab=100.00  E-value=2.9e-43  Score=330.72  Aligned_cols=252  Identities=23%  Similarity=0.376  Sum_probs=199.3

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      +.+|++.+.||+|.||.|-. +.+...|+.||||.|.+... +..+...+.|||+||+.|+||||+++|++|+..     
T Consensus        52 kHRyE~~etLGkGTYGKVk~-A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENk-----  125 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKL-AYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENK-----  125 (668)
T ss_pred             hhHHHHHHHhcCCcccceee-hhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCC-----
Confidence            56789999999999999984 67888999999999977544 344566778999999999999999999999765     


Q ss_pred             CceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         142 FKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                       ..+.+||||. +|.|++++.. +.+++.+++.+++||++|+.|||.++++|||||.+|||+|.++++||+||||+-...
T Consensus       126 -dKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~  204 (668)
T KOG0611|consen  126 -DKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA  204 (668)
T ss_pred             -ceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc
Confidence             4578999988 8999998864 679999999999999999999999999999999999999999999999999985432


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      ..                                                           ..+.++||+|.|.+||++.
T Consensus       205 ~~-----------------------------------------------------------kfLqTFCGSPLYASPEIvN  225 (668)
T KOG0611|consen  205 DK-----------------------------------------------------------KFLQTFCGSPLYASPEIVN  225 (668)
T ss_pred             cc-----------------------------------------------------------cHHHHhcCCcccCCccccC
Confidence            21                                                           1233455555566666555


Q ss_pred             hccCCC-CCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC
Q psy8260         300 NWMHYN-QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT  378 (427)
Q Consensus       300 ~~~~~~-~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t  378 (427)
                      +.+|.. .+|.||||+++|.|-.+..||.........+.+.+.  .+.       .+....+|.-||+.||..||.+|.|
T Consensus       226 G~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~G--aYr-------EP~~PSdA~gLIRwmLmVNP~RRAT  296 (668)
T KOG0611|consen  226 GTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRG--AYR-------EPETPSDASGLIRWMLMVNPERRAT  296 (668)
T ss_pred             CCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcc--ccc-------CCCCCchHHHHHHHHHhcCcccchh
Confidence            555543 359999999999998777777654332222222111  000       0223457899999999999999999


Q ss_pred             HHHHhcCCCCC
Q psy8260         379 AEQALAHPYLS  389 (427)
Q Consensus       379 a~e~L~Hp~f~  389 (427)
                      ++++-+|=|+.
T Consensus       297 ieDiAsHWWvN  307 (668)
T KOG0611|consen  297 IEDIASHWWVN  307 (668)
T ss_pred             HHHHhhhheee
Confidence            99999998886

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.9e-42  Score=349.81  Aligned_cols=267  Identities=30%  Similarity=0.464  Sum_probs=186.9

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcccc
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  140 (427)
                      .....|.+++.||+|+||.||.+ .+..+++.||||++....      ....+|+.+|+.++|||||+++++|.......
T Consensus        63 ~~~~~y~~~~~LG~G~fg~Vy~~-~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~  135 (440)
T PTZ00036         63 SPNKSYKLGNIIGNGSFGVVYEA-ICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKK  135 (440)
T ss_pred             CcCCeEEEeEEEEeCCCEEEEEE-EECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence            34567999999999999999964 566789999999885432      12347999999999999999999875432111


Q ss_pred             --CCceEEEEeccCCCCHHHHHh-----hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCC-CCEEEeeC
Q psy8260         141 --DFKNVYMVTHLMGADLNNILR-----TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED-CELKILDF  212 (427)
Q Consensus       141 --~~~~~~lv~e~~g~~L~~~l~-----~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~-~~~kl~DF  212 (427)
                        ....++++||++++++.+++.     ...+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+||
T Consensus       136 ~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        136 NEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             CCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence              123467899999888877664     3468999999999999999999999999999999999999865 47999999


Q ss_pred             CCCCCCCC--CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccc
Q psy8260         213 GLARPTEN--EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATR  290 (427)
Q Consensus       213 Gla~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~  290 (427)
                      |+|+....  ....++||+.|+|||++.+..                                                 
T Consensus       216 Gla~~~~~~~~~~~~~~t~~y~aPE~~~~~~-------------------------------------------------  246 (440)
T PTZ00036        216 GSAKNLLAGQRSVSYICSRFYRAPELMLGAT-------------------------------------------------  246 (440)
T ss_pred             ccchhccCCCCcccCCCCcCccCHHHhcCCC-------------------------------------------------
Confidence            99975432  222344555555555544322                                                 


Q ss_pred             cccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHh--------------------cCCCCCcccH
Q psy8260         291 WYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYIN--------------------SLPLLTKKDF  350 (427)
Q Consensus       291 ~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~  350 (427)
                                 .+..++|+||+|++++.|.++..+|......+.......                    ..+......+
T Consensus       247 -----------~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l  315 (440)
T PTZ00036        247 -----------NYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDL  315 (440)
T ss_pred             -----------CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhH
Confidence                       233445666666666555444333322111111111110                    0111122223


Q ss_pred             Hhhc-CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q psy8260         351 RQVF-KGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDP  394 (427)
Q Consensus       351 ~~~~-~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  394 (427)
                      ...+ ...+++++|||.+||++||.+|+|+.|+|+||||.....+
T Consensus       316 ~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~  360 (440)
T PTZ00036        316 KKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDP  360 (440)
T ss_pred             HHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcc
Confidence            3322 3467899999999999999999999999999999887654

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.7e-42  Score=336.58  Aligned_cols=249  Identities=22%  Similarity=0.335  Sum_probs=193.1

Q ss_pred             cccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEEE
Q psy8260          70 PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV  148 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~lv  148 (427)
                      +.||+|+||.||. +.+..+|+.||||++.+... .........+|+.+++.++||||++++++|...      ..+|++
T Consensus         1 ~~lG~G~~g~Vy~-~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~------~~~~lv   73 (323)
T cd05571           1 KLLGKGTFGKVIL-VREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTH------DRLCFV   73 (323)
T ss_pred             CeeeeCCCeEEEE-EEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcC------CEEEEE
Confidence            3689999999996 45677899999999875322 223345567899999999999999999988654      467899


Q ss_pred             eccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCccccc
Q psy8260         149 THLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV  226 (427)
Q Consensus       149 ~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  226 (427)
                      ||++ +++|...+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......   
T Consensus        74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~---  150 (323)
T cd05571          74 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA---  150 (323)
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC---
Confidence            9988 6788877754 5689999999999999999999999999999999999999999999999999863211000   


Q ss_pred             ccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCCC
Q psy8260         227 ATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQ  306 (427)
Q Consensus       227 gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~  306 (427)
                                                                             .....+||+.|+|||++.+..+...
T Consensus       151 -------------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~  175 (323)
T cd05571         151 -------------------------------------------------------TMKTFCGTPEYLAPEVLEDNDYGRA  175 (323)
T ss_pred             -------------------------------------------------------cccceecCccccChhhhcCCCCCcc
Confidence                                                                   1112357788888888877777788


Q ss_pred             CCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC-----CHHH
Q psy8260         307 TDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI-----TAEQ  381 (427)
Q Consensus       307 ~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~-----ta~e  381 (427)
                      +|+||+|++++.|.++..||.................        .+....++++.+||.+||+.||++|+     +++|
T Consensus       176 ~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~--------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~  247 (323)
T cd05571         176 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI--------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKE  247 (323)
T ss_pred             ccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC--------CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHH
Confidence            8999999999988777766644322111111111111        11235789999999999999999999     8999


Q ss_pred             HhcCCCCCCC
Q psy8260         382 ALAHPYLSQY  391 (427)
Q Consensus       382 ~L~Hp~f~~~  391 (427)
                      +++||||...
T Consensus       248 ll~h~~f~~~  257 (323)
T cd05571         248 IMEHRFFASI  257 (323)
T ss_pred             HHcCCCcCCC
Confidence            9999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG4236|consensus

Probab=100.00  E-value=2.6e-43  Score=340.08  Aligned_cols=252  Identities=25%  Similarity=0.430  Sum_probs=201.4

Q ss_pred             ccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEEE
Q psy8260          69 GPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV  148 (427)
Q Consensus        69 ~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~lv  148 (427)
                      .++||.|+||.|| ++.++++|+.||||+|.+..-...+..+..+|+.||.++.||.||.|-..|++.      +.+++|
T Consensus       569 devLGSGQFG~VY-gg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~------ervFVV  641 (888)
T KOG4236|consen  569 DEVLGSGQFGTVY-GGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETP------ERVFVV  641 (888)
T ss_pred             HhhccCCcceeee-cceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCC------ceEEEE
Confidence            4689999999999 678899999999999987554455556778999999999999999999888765      568999


Q ss_pred             eccCCCCHHHHH---hhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCC---CCEEEeeCCCCCCCCCCc
Q psy8260         149 THLMGADLNNIL---RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED---CELKILDFGLARPTENEM  222 (427)
Q Consensus       149 ~e~~g~~L~~~l---~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~---~~~kl~DFGla~~~~~~~  222 (427)
                      ||-+.||+...+   ..+++++...+.++.||+.||.|||-++|+|+||||||||+...   -.+||||||.||.+.+..
T Consensus       642 MEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks  721 (888)
T KOG4236|consen  642 MEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS  721 (888)
T ss_pred             ehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence            999888876654   24679999999999999999999999999999999999999753   479999999999765431


Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhcc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM  302 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~  302 (427)
                                                                                 -+.+.+|||.|+||||+++..
T Consensus       722 -----------------------------------------------------------FRrsVVGTPAYLaPEVLrnkG  742 (888)
T KOG4236|consen  722 -----------------------------------------------------------FRRSVVGTPAYLAPEVLRNKG  742 (888)
T ss_pred             -----------------------------------------------------------hhhhhcCCccccCHHHHhhcc
Confidence                                                                       123446777777777777777


Q ss_pred             CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q psy8260         303 HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQA  382 (427)
Q Consensus       303 ~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~  382 (427)
                      |...-|+||.|+|+|.-..+.+||...  ++....+-+.-..++..+|    ..++++|+|||.++|+..=.||.|+++.
T Consensus       743 yNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW----~eis~~AidlIn~LLqVkm~kRysvdk~  816 (888)
T KOG4236|consen  743 YNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPW----SEISPEAIDLINNLLQVKMRKRYSVDKS  816 (888)
T ss_pred             ccccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCch----hhcCHHHHHHHHHHHHHHHHHhcchHhh
Confidence            777779999999988777777777532  1222222222223444444    4579999999999999999999999999


Q ss_pred             hcCCCCCCCC
Q psy8260         383 LAHPYLSQYS  392 (427)
Q Consensus       383 L~Hp~f~~~~  392 (427)
                      |.|||++++.
T Consensus       817 lsh~Wlq~yq  826 (888)
T KOG4236|consen  817 LSHPWLQDYQ  826 (888)
T ss_pred             ccchhhhcch
Confidence            9999998753

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.2e-41  Score=332.72  Aligned_cols=321  Identities=53%  Similarity=0.889  Sum_probs=226.6

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      ..|.+...||.|+||.||.+ .+..+|+.||||++.+..........+.+|+.+++.++||||+++++++..........
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~-~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSA-IDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             cceEEEEEeeecCCeEEEEE-EeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            46788899999999999964 56678999999998765433333455779999999999999999999986544333445


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcc
Q psy8260         144 NVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT  223 (427)
Q Consensus       144 ~~~lv~e~~g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~  223 (427)
                      .+|++++++..+|..+. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus        94 ~~~lv~e~~~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~~~  172 (342)
T cd07879          94 DFYLVMPYMQTDLQKIM-GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMT  172 (342)
T ss_pred             eEEEEecccccCHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCCCC
Confidence            67899999988887765 34689999999999999999999999999999999999999999999999999876544444


Q ss_pred             cccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccC
Q psy8260         224 GYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH  303 (427)
Q Consensus       224 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~  303 (427)
                      ...++..|+|||++.+...++..      .|+|+.|+++.+                 +..|..               .
T Consensus       173 ~~~~~~~y~aPE~~~~~~~~~~~------~Dv~slGvil~e-----------------l~~g~~---------------p  214 (342)
T cd07879         173 GYVVTRWYRAPEVILNWMHYNQT------VDIWSVGCIMAE-----------------MLTGKT---------------L  214 (342)
T ss_pred             CceeeecccChhhhcCccccCch------HHHHHHHHHHHH-----------------HHhCCC---------------C
Confidence            45666667777765432222111      244444444332                 111110               1


Q ss_pred             CCCCC-HHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q psy8260         304 YNQTD-IHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQA  382 (427)
Q Consensus       304 ~~~~d-~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~  382 (427)
                      +.+.+ ...+..++..+|.+..++...........+....+......+...++..++++++||.+||+.||.+|+|++|+
T Consensus       215 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~  294 (342)
T cd07879         215 FKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEA  294 (342)
T ss_pred             CCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            11111 11222233333333333332222211222222334444445555566788999999999999999999999999


Q ss_pred             hcCCCCCCCCCCCCCCCCCCCCcccccCCCCHHHHHHHHhhh
Q psy8260         383 LAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKGTYSLE  424 (427)
Q Consensus       383 L~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  424 (427)
                      +.||||.........+.+.+++.+.++....++.|.+-+..|
T Consensus       295 l~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (342)
T cd07879         295 LEHPYFDSFRDADEETEQQPYDDSLENEKLSVDEWKKHIYKE  336 (342)
T ss_pred             hcCcchhhcccccccCCCCcccchhhhhhCCHHHHHHHhhhh
Confidence            999999998776666667778888888899999998888665

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-42  Score=329.36  Aligned_cols=251  Identities=24%  Similarity=0.338  Sum_probs=194.0

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      .|.+.+.||+|+||.||. +.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++...      .
T Consensus         2 ~y~~~~~lg~G~~g~Vy~-~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~   74 (291)
T cd05612           2 DLERIKTVGTGTFGRVHL-VRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ------R   74 (291)
T ss_pred             CceeeeeeecCCCeEEEE-EEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccC------C
Confidence            467789999999999996 45677899999999864322 122345577899999999999999999877543      4


Q ss_pred             eEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      .+|+++|++ +++|.+++.. +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          75 FLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            678899877 7899888754 56899999999999999999999999999999999999999999999999998643322


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      ...                                                             .+||+.|+|||++.+.
T Consensus       155 ~~~-------------------------------------------------------------~~gt~~y~aPE~~~~~  173 (291)
T cd05612         155 TWT-------------------------------------------------------------LCGTPEYLAPEVIQSK  173 (291)
T ss_pred             ccc-------------------------------------------------------------ccCChhhcCHHHHcCC
Confidence            111                                                             2366667777777666


Q ss_pred             cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC---
Q psy8260         302 MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT---  378 (427)
Q Consensus       302 ~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t---  378 (427)
                      .+..++|+||+|++++.|.++..+|..................        .....++.++|||.+||+.||.+|++   
T Consensus       174 ~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~--------~~~~~~~~~~~li~~~l~~dp~~R~~~~~  245 (291)
T cd05612         174 GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLE--------FPRHLDLYAKDLIKKLLVVDRTRRLGNMK  245 (291)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcC--------CCccCCHHHHHHHHHHcCCCHHHccCCcc
Confidence            6777789999999999887666655433222222222211111        12345889999999999999999995   


Q ss_pred             --HHHHhcCCCCCCC
Q psy8260         379 --AEQALAHPYLSQY  391 (427)
Q Consensus       379 --a~e~L~Hp~f~~~  391 (427)
                        ++|+++||||...
T Consensus       246 ~~~~~~l~h~~~~~~  260 (291)
T cd05612         246 NGADDVKNHRWFKSV  260 (291)
T ss_pred             CCHHHHhcCccccCC
Confidence              9999999999864

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=5.6e-42  Score=335.24  Aligned_cols=253  Identities=22%  Similarity=0.341  Sum_probs=196.9

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      ...|.+.+.||+|+||.||.+ .+..+|+.||||++..... .......+.+|+.+++.++||||+++++++...     
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~-~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----   90 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIA-KHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE-----   90 (329)
T ss_pred             chheEEEEEEEecCCeEEEEE-EECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC-----
Confidence            356889999999999999964 5667899999999864321 122345577999999999999999999988654     


Q ss_pred             CceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         142 FKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                       ..+|++++++ +++|.+.+.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        91 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  169 (329)
T PTZ00263         91 -NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP  169 (329)
T ss_pred             -CEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence             4678999987 7899887754 568999999999999999999999999999999999999999999999999986432


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      .....                                                             ..||+.|+|||++.
T Consensus       170 ~~~~~-------------------------------------------------------------~~gt~~y~aPE~~~  188 (329)
T PTZ00263        170 DRTFT-------------------------------------------------------------LCGTPEYLAPEVIQ  188 (329)
T ss_pred             CCcce-------------------------------------------------------------ecCChhhcCHHHHc
Confidence            22111                                                             24666777777776


Q ss_pred             hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC-
Q psy8260         300 NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT-  378 (427)
Q Consensus       300 ~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t-  378 (427)
                      +..+..++|+||+|++++.|.++..+|..................        .....+++++|||.+||+.||.+|++ 
T Consensus       189 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~--------~p~~~~~~~~~li~~~L~~dP~~R~~~  260 (329)
T PTZ00263        189 SKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLK--------FPNWFDGRARDLVKGLLQTDHTKRLGT  260 (329)
T ss_pred             CCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcC--------CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            666777889999999999887776666433221222222211111        12336789999999999999999997 


Q ss_pred             ----HHHHhcCCCCCCC
Q psy8260         379 ----AEQALAHPYLSQY  391 (427)
Q Consensus       379 ----a~e~L~Hp~f~~~  391 (427)
                          ++|+++||||.+.
T Consensus       261 ~~~~~~~ll~hp~f~~~  277 (329)
T PTZ00263        261 LKGGVADVKNHPYFHGA  277 (329)
T ss_pred             CCCCHHHHhcCCccCCC
Confidence                7999999999863

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.2e-41  Score=334.33  Aligned_cols=257  Identities=24%  Similarity=0.342  Sum_probs=199.8

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      .+....|.+.+.||+|+||.||.+......+..||+|++..... .......+.+|+.+++.++||||+++++++...  
T Consensus        26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--  103 (340)
T PTZ00426         26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE--  103 (340)
T ss_pred             CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC--
Confidence            34556788999999999999998765554557899998864321 223345577899999999999999999998654  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                          ..+|++||++ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus       104 ----~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~  179 (340)
T PTZ00426        104 ----SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK  179 (340)
T ss_pred             ----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCe
Confidence                4678999988 7899988854 579999999999999999999999999999999999999999999999999986


Q ss_pred             CCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         217 PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       217 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      .......                                                             ..+||+.|+|||
T Consensus       180 ~~~~~~~-------------------------------------------------------------~~~gt~~y~aPE  198 (340)
T PTZ00426        180 VVDTRTY-------------------------------------------------------------TLCGTPEYIAPE  198 (340)
T ss_pred             ecCCCcc-------------------------------------------------------------eecCChhhcCHH
Confidence            4322211                                                             224667777777


Q ss_pred             HhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCC
Q psy8260         297 IMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKR  376 (427)
Q Consensus       297 vl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R  376 (427)
                      ++.+..+...+|+||+|++++.|.++..||..................        .....++++.+||++||+.||.+|
T Consensus       199 ~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~--------~p~~~~~~~~~li~~~l~~dp~~R  270 (340)
T PTZ00426        199 ILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIY--------FPKFLDNNCKHLMKKLLSHDLTKR  270 (340)
T ss_pred             HHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC--------CCCCCCHHHHHHHHHHcccCHHHc
Confidence            776666777789999999999987776666543222222222211111        123468899999999999999999


Q ss_pred             C-----CHHHHhcCCCCCCC
Q psy8260         377 I-----TAEQALAHPYLSQY  391 (427)
Q Consensus       377 ~-----ta~e~L~Hp~f~~~  391 (427)
                      +     |++|+++||||.+.
T Consensus       271 ~~~~~~~~~~~~~hp~f~~~  290 (340)
T PTZ00426        271 YGNLKKGAQNVKEHPWFGNI  290 (340)
T ss_pred             CCCCCCCHHHHHcCCCcCCC
Confidence            6     89999999999865

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3.8e-41  Score=327.19  Aligned_cols=163  Identities=34%  Similarity=0.578  Sum_probs=126.5

Q ss_pred             ccccCcccccEEEEeEE-eCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEE
Q psy8260          69 GPTLSKESFDLIFSSAL-DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYM  147 (427)
Q Consensus        69 ~~~lg~g~fg~v~~~~~-~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~l  147 (427)
                      ++.||+|+||.||++.. +..+++.||+|.+.....    .....+|+++|++++||||++++++|...    ....+|+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~~~~l   77 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSH----ADRKVWL   77 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecC----CCcEEEE
Confidence            56899999999997654 335778999999865422    23356899999999999999999988542    2246889


Q ss_pred             EeccCCCCHHHHHhh----------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEE----cCCCCEEEeeCC
Q psy8260         148 VTHLMGADLNNILRT----------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV----NEDCELKILDFG  213 (427)
Q Consensus       148 v~e~~g~~L~~~l~~----------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl----~~~~~~kl~DFG  213 (427)
                      ++++++++|..++..          ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||
T Consensus        78 v~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07868          78 LFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             EEeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence            999999999887642          248899999999999999999999999999999999999    456789999999


Q ss_pred             CCCCCCCC------cccccccccccchhhhhc
Q psy8260         214 LARPTENE------MTGYVATRWYRAPEIMLN  239 (427)
Q Consensus       214 la~~~~~~------~~~~~gt~~y~aPE~l~~  239 (427)
                      +++.....      .....||+.|+|||++.+
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  189 (317)
T cd07868         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLG  189 (317)
T ss_pred             ceeccCCCCccccccCCccccccccCCHHHcC
Confidence            99754321      122344555555555443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.2e-41  Score=323.88  Aligned_cols=262  Identities=29%  Similarity=0.443  Sum_probs=188.9

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC---CCCCceeeeeeeecCccccCC
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM---NHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l---~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      |.+.+.||+|+||.||. +.+..+|+.||+|.+..............+|+.+++.+   +||||+++++++..... ...
T Consensus         2 y~~~~~lg~g~~g~v~~-~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~-~~~   79 (288)
T cd07863           2 YEPVAEIGVGAYGTVYK-ARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRT-DRE   79 (288)
T ss_pred             ceEeeEEeecCCeEEEE-EEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccC-CCC
Confidence            66788999999999996 55777899999998865322222223345666666554   79999999998764321 223


Q ss_pred             ceEEEEeccCCCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         143 KNVYMVTHLMGADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       143 ~~~~lv~e~~g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                      ..++++++++.++|.+++..   ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        80 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~  159 (288)
T cd07863          80 TKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS  159 (288)
T ss_pred             ceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence            46789999998888887754   348999999999999999999999999999999999999999999999999986432


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      ....                                                           .....||+.|+|||++.
T Consensus       160 ~~~~-----------------------------------------------------------~~~~~~~~~y~aPE~~~  180 (288)
T cd07863         160 CQMA-----------------------------------------------------------LTPVVVTLWYRAPEVLL  180 (288)
T ss_pred             Cccc-----------------------------------------------------------CCCccccccccCchHhh
Confidence            2100                                                           01123566677777776


Q ss_pred             hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcC-------------------CCCCcccHHhhcCCCChh
Q psy8260         300 NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSL-------------------PLLTKKDFRQVFKGANPQ  360 (427)
Q Consensus       300 ~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~s~~  360 (427)
                      +..+..++|+||+|++++.|.++..+|......+...+.....                   ............+.++.+
T Consensus       181 ~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (288)
T cd07863         181 QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEES  260 (288)
T ss_pred             CCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHH
Confidence            6667777899999999887755444443221111111111100                   001112233444567889


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q psy8260         361 AIDLLSLMLELDSEKRITAEQALAHPYL  388 (427)
Q Consensus       361 ~~dLi~~mL~~dP~~R~ta~e~L~Hp~f  388 (427)
                      +.|||.+||++||++|+|+.|+++||||
T Consensus       261 ~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         261 GAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             HHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-41  Score=328.99  Aligned_cols=247  Identities=24%  Similarity=0.360  Sum_probs=191.3

Q ss_pred             cCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEEEec
Q psy8260          72 LSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH  150 (427)
Q Consensus        72 lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~lv~e  150 (427)
                      ||+|+||.||. +.+..+++.||+|++.+... .......+.+|+.++++++||||+++++++...      ...|++++
T Consensus         1 lg~G~~g~Vy~-~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e   73 (312)
T cd05585           1 IGKGSFGKVMQ-VRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSP------EKLYLVLA   73 (312)
T ss_pred             CCcCCCeEEEE-EEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecC------CeEEEEEc
Confidence            68999999996 55677899999999864321 233345677899999999999999999888653      46789998


Q ss_pred             cC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCccccccc
Q psy8260         151 LM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT  228 (427)
Q Consensus       151 ~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt  228 (427)
                      ++ +++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......     
T Consensus        74 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-----  148 (312)
T cd05585          74 FINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-----  148 (312)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-----
Confidence            88 7899887754 5799999999999999999999999999999999999999999999999999864211100     


Q ss_pred             ccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCCCCC
Q psy8260         229 RWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD  308 (427)
Q Consensus       229 ~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d  308 (427)
                                                                           .....+||+.|+|||++.+..+..++|
T Consensus       149 -----------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~D  175 (312)
T cd05585         149 -----------------------------------------------------KTNTFCGTPEYLAPELLLGHGYTKAVD  175 (312)
T ss_pred             -----------------------------------------------------ccccccCCcccCCHHHHcCCCCCCccc
Confidence                                                                 011235777788888877777777889


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC---CHHHHhcC
Q psy8260         309 IHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI---TAEQALAH  385 (427)
Q Consensus       309 ~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~---ta~e~L~H  385 (427)
                      +||+|++++.|.++..||.................        ......++++++||.+||+.||.+|+   ++.|+|+|
T Consensus       176 vwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         176 WWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPL--------RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             eechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC--------CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            99999999988776666644322222222221111        12245788999999999999999997   58999999


Q ss_pred             CCCCCC
Q psy8260         386 PYLSQY  391 (427)
Q Consensus       386 p~f~~~  391 (427)
                      |||.+.
T Consensus       248 p~~~~~  253 (312)
T cd05585         248 PFFSQL  253 (312)
T ss_pred             CCcCCC
Confidence            999874

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-41  Score=333.18  Aligned_cols=259  Identities=20%  Similarity=0.324  Sum_probs=196.2

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC-HHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS-AVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      .|.+.+.||+|+||.||. +.+..+|+.||||++.+.... ......+.+|+.+++.++||||+++++++...      .
T Consensus         2 ~y~~~~~ig~G~~g~Vy~-~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~------~   74 (333)
T cd05600           2 DFQILTQVGQGGYGQVFL-AKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDD------E   74 (333)
T ss_pred             CcEEEEEEeecCCeEEEE-EEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcC------C
Confidence            578889999999999996 456678999999998654221 12345577899999999999999999988654      4


Q ss_pred             eEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      .+|+++|++ +++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~  154 (333)
T cd05600          75 YLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY  154 (333)
T ss_pred             EEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccccc
Confidence            688999988 7899998864 56899999999999999999999999999999999999999999999999998743322


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      ...                                                             ..||+.|+|||++.+.
T Consensus       155 ~~~-------------------------------------------------------------~~gt~~y~aPE~~~~~  173 (333)
T cd05600         155 ANS-------------------------------------------------------------VVGSPDYMAPEVLRGK  173 (333)
T ss_pred             cCC-------------------------------------------------------------cccCccccChhHhcCC
Confidence            222                                                             2456666666666666


Q ss_pred             cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHH
Q psy8260         302 MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQ  381 (427)
Q Consensus       302 ~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e  381 (427)
                      .+..++|+||+|++++.|.++..||......+........................++++.+||.+||..+|.+|+|++|
T Consensus       174 ~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~  253 (333)
T cd05600         174 GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLED  253 (333)
T ss_pred             CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHH
Confidence            67777899999999988866665554322212111111111111110111111246889999999999999999999999


Q ss_pred             HhcCCCCCCC
Q psy8260         382 ALAHPYLSQY  391 (427)
Q Consensus       382 ~L~Hp~f~~~  391 (427)
                      +++||||.+.
T Consensus       254 ll~h~~~~~~  263 (333)
T cd05600         254 IKNHPFFKEV  263 (333)
T ss_pred             HHhCcccCCC
Confidence            9999999875

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-41  Score=337.44  Aligned_cols=293  Identities=19%  Similarity=0.277  Sum_probs=203.3

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      .|++.+.||+|+||.||. +.+..+|+.||||++..... .......+.+|+.+|+.++||||++++++|...      .
T Consensus         2 ~y~~~~~lG~G~~g~V~~-~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~------~   74 (364)
T cd05599           2 DFESIKVIGRGAFGEVRL-VQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDE------N   74 (364)
T ss_pred             CceEEEEEEecCCEEEEE-EEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC------C
Confidence            477889999999999996 55677899999999865321 122344567899999999999999999998754      4


Q ss_pred             eEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      .+|++||++ +++|.+++.. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        75 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          75 YLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             eEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            678999988 7899888754 56899999999999999999999999999999999999999999999999998754321


Q ss_pred             cccc--cccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         222 MTGY--VATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       222 ~~~~--~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      ....  .....+..+....      ....+.     .. +        .....+..  .......+.+||+.|+|||++.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~------~~~~~~-----~~-~--------~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~  212 (364)
T cd05599         155 HRTEFYRILSHALPSNFLD------FISKPM-----SS-K--------RKAETWKR--NRRALAYSTVGTPDYIAPEVFL  212 (364)
T ss_pred             ccccccccccccccccccc------cccccc-----cc-c--------ccccchhh--cccccccccccCccccCHHHHc
Confidence            1100  0000000000000      000000     00 0        00000000  0001223457999999999999


Q ss_pred             hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC-
Q psy8260         300 NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT-  378 (427)
Q Consensus       300 ~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t-  378 (427)
                      +..+..++|+||+|++++.|.++..+|..........+..........   . .....+++++|||.+||. ||.+|++ 
T Consensus       213 ~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~---~-~~~~~s~~~~~li~~ll~-~p~~R~~~  287 (364)
T cd05599         213 QTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQF---P-DEVPLSPEAKDLIKRLCC-EAERRLGN  287 (364)
T ss_pred             CCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCC---C-CCCCCCHHHHHHHHHHcc-CHhhcCCC
Confidence            888888899999999999887766666433222222222221111110   0 012468999999999997 9999998 


Q ss_pred             --HHHHhcCCCCCCC
Q psy8260         379 --AEQALAHPYLSQY  391 (427)
Q Consensus       379 --a~e~L~Hp~f~~~  391 (427)
                        ++|+++||||...
T Consensus       288 ~~~~~ll~h~~~~~~  302 (364)
T cd05599         288 NGVNEIKSHPFFKGV  302 (364)
T ss_pred             CCHHHHhcCCCcCCC
Confidence              9999999999865

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0664|consensus

Probab=100.00  E-value=3e-43  Score=315.94  Aligned_cols=285  Identities=37%  Similarity=0.639  Sum_probs=228.9

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceE
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV  145 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~  145 (427)
                      ++-.+.||-|.||.|| ++.|..+|++||+|++..-+++-...+++++|+.+|..++|.|++..+++.... ....+..+
T Consensus        55 i~PDRPIGYGAFGVVW-sVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPp-h~dfFqEi  132 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVW-SVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPA-NPSFFQEL  132 (449)
T ss_pred             CCCCCcccccceeEEE-eccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCC-CchHHHHH
Confidence            4455789999999998 567888999999999987776667778899999999999999999999887643 23344678


Q ss_pred             EEEeccCCCCHHHHHh-hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC----
Q psy8260         146 YMVTHLMGADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN----  220 (427)
Q Consensus       146 ~lv~e~~g~~L~~~l~-~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~----  220 (427)
                      |++.|++..||.+++- .+.++.++++-+++||++||+|||+.+|+||||||.|+|++.+..+||||||+||..+.    
T Consensus       133 YV~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~  212 (449)
T KOG0664|consen  133 YVLTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL  212 (449)
T ss_pred             HHHHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence            9999999999998774 57899999999999999999999999999999999999999999999999999997654    


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      .++..+.|.+|+|||++.|.++|+...      |+|+.||+++|-                 +.               .
T Consensus       213 hMTqEVVTQYYRAPEiLMGaRhYs~Av------DiWSVGCIFaEL-----------------Lg---------------R  254 (449)
T KOG0664|consen  213 NMTHEVVTQYYRAPELLMGARRYTGAV------DIWSVGCIFAEL-----------------LQ---------------R  254 (449)
T ss_pred             hhHHHHHHHHhccHHHhhcchhhcCcc------ceehhhHHHHHH-----------------Hh---------------h
Confidence            355668899999999999999999887      999999999872                 11               1


Q ss_pred             ccCC-CCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhc-----CCCChhHHHHHHHhcCCCCC
Q psy8260         301 WMHY-NQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF-----KGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       301 ~~~~-~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~s~~~~dLi~~mL~~dP~  374 (427)
                      ..+| ....+.+|.+|..+||+|..+-+....+......++.-++.+.  +...+     .....++.+++.+||.+||.
T Consensus       255 rILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps--~~vLYtlsS~~~~~heav~~~~~~l~~d~d  332 (449)
T KOG0664|consen  255 KILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPD--TQRLYKIASPDDKNHEAVDLLQKLLHFDPD  332 (449)
T ss_pred             hhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCC--ccceeeecCCcccchHHHHHHHHHhCCCCc
Confidence            1133 3457899999999999999887654433322223322221111  11111     12346889999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCC
Q psy8260         375 KRITAEQALAHPYLSQYS  392 (427)
Q Consensus       375 ~R~ta~e~L~Hp~f~~~~  392 (427)
                      +|++.++++.|+|..+.+
T Consensus       333 kris~~~A~~~~~~~e~R  350 (449)
T KOG0664|consen  333 KRISVEEALQHRYLEEGR  350 (449)
T ss_pred             ccccHhhhcccccccccc
Confidence            999999999999998654

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=6.7e-41  Score=328.16  Aligned_cols=317  Identities=47%  Similarity=0.820  Sum_probs=227.8

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      ..|.+.+.||.|+||.||. +.+..+|+.||+|++............+.+|+.+|+.++||||++++++|....  ....
T Consensus         5 ~~y~~~~~lg~g~~g~v~~-~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~~   81 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCS-AIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG--ADFK   81 (334)
T ss_pred             hceeeeeeeecCCCeEEEE-EEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC--CCCc
Confidence            5678889999999999995 556778999999998754333334556778999999999999999999876543  2335


Q ss_pred             eEEEEeccCCCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC-
Q psy8260         144 NVYMVTHLMGADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE-  221 (427)
Q Consensus       144 ~~~lv~e~~g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~-  221 (427)
                      ..|+++++++++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..... 
T Consensus        82 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  161 (334)
T cd07855          82 DVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP  161 (334)
T ss_pred             eEEEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence            6899999998899888853 56899999999999999999999999999999999999999999999999998754321 


Q ss_pred             ------cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         222 ------MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       222 ------~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                            .....++.+|+|||++.+...++..      .|+|+.|+++.+                 +..+   .+.|   
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~------~Di~slG~~l~e-----------------l~~g---~~pf---  212 (334)
T cd07855         162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTA------IDMWSVGCIFAE-----------------MLGR---RQLF---  212 (334)
T ss_pred             cCCCcccccccccccccChHHhcCCcccccc------cchHHHHHHHHH-----------------HHcC---CCcc---
Confidence                  1233566667777765432222222      255555555443                 1111   1111   


Q ss_pred             HHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCC
Q psy8260         296 EIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEK  375 (427)
Q Consensus       296 Evl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~  375 (427)
                              .......++..+...+|.++..+................+......+...++..++++.+||.+||+.||.+
T Consensus       213 --------~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~  284 (334)
T cd07855         213 --------PGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEE  284 (334)
T ss_pred             --------CCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhh
Confidence                    011122334445555566655555444444344444444444444556666778999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCCCCCCCC-CCCCcccccCCCCHHHHHHH
Q psy8260         376 RITAEQALAHPYLSQYSDPNDEPTS-PPYDQSFEDMDLPVDQWKGT  420 (427)
Q Consensus       376 R~ta~e~L~Hp~f~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  420 (427)
                      |||++++++||||.+...+..++.. ++++..++....+.++....
T Consensus       285 Rpt~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (334)
T cd07855         285 RITVEQALQHPFLAQYHDPDDEPTCPPPFDFDFEAIELSREQLKEA  330 (334)
T ss_pred             CcCHHHHHhChhhhhccCCcccccCCCCCCCChhhhhcChhhHHHH
Confidence            9999999999999999888877766 77877777666666665543

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.3e-41  Score=323.00  Aligned_cols=258  Identities=20%  Similarity=0.252  Sum_probs=194.1

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC-HHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCce
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS-AVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      |.+.+.||+|+||.||. +.+..+|+.||||.+...... ......+.+|+.+++.++|+||+++++++...      ..
T Consensus         2 f~~~~~lg~G~~g~V~~-~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~------~~   74 (285)
T cd05631           2 FRHYRVLGKGGFGEVCA-CQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK------DA   74 (285)
T ss_pred             ceEEEEEecCCCEEEEE-EEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC------Ce
Confidence            56678899999999996 456678999999988653222 22234467899999999999999999887653      35


Q ss_pred             EEEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         145 VYMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       145 ~~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      .+++++++ +++|...+..   ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        75 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~  154 (285)
T cd05631          75 LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE  154 (285)
T ss_pred             EEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence            78888877 6889876642   3589999999999999999999999999999999999999999999999999864321


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      ..                                                           ......||+.|+|||++.+
T Consensus       155 ~~-----------------------------------------------------------~~~~~~g~~~y~aPE~~~~  175 (285)
T cd05631         155 GE-----------------------------------------------------------TVRGRVGTVGYMAPEVINN  175 (285)
T ss_pred             CC-----------------------------------------------------------eecCCCCCCCccCHhhhcC
Confidence            10                                                           0112346777888888777


Q ss_pred             ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC--
Q psy8260         301 WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT--  378 (427)
Q Consensus       301 ~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t--  378 (427)
                      ..+...+|+||+|++++.|.++..||...................    ...+....++++.+||.+||+.||.+|+|  
T Consensus       176 ~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~  251 (285)
T cd05631         176 EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED----QEEYSEKFSEDAKSICRMLLTKNPKERLGCR  251 (285)
T ss_pred             CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc----cccCCccCCHHHHHHHHHHhhcCHHHhcCCC
Confidence            777778899999999988876666664332211111111111100    01123457899999999999999999997  


Q ss_pred             ---HHHHhcCCCCCCCCC
Q psy8260         379 ---AEQALAHPYLSQYSD  393 (427)
Q Consensus       379 ---a~e~L~Hp~f~~~~~  393 (427)
                         ++|+++||||.+...
T Consensus       252 ~~~~~~~~~h~~~~~~~~  269 (285)
T cd05631         252 GNGAAGVKQHPIFKNINF  269 (285)
T ss_pred             CCCHHHHhcCHhhcCCCH
Confidence               999999999987643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=5.1e-41  Score=328.35  Aligned_cols=249  Identities=24%  Similarity=0.330  Sum_probs=191.9

Q ss_pred             cccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEEE
Q psy8260          70 PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV  148 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~lv  148 (427)
                      +.||+|+||.||. +.+..+|+.||||++.+... .......+.+|+++++.++||||+++++++...      ..+|++
T Consensus         1 ~~lG~G~~g~Vy~-~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~~~~lv   73 (328)
T cd05593           1 KLLGKGTFGKVIL-VREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTK------DRLCFV   73 (328)
T ss_pred             CeeeeCCCEEEEE-EEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC------CEEEEE
Confidence            3689999999995 55677899999999865422 223345677899999999999999999888654      467899


Q ss_pred             eccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCccccc
Q psy8260         149 THLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV  226 (427)
Q Consensus       149 ~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  226 (427)
                      ||++ +++|...+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......   
T Consensus        74 ~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~---  150 (328)
T cd05593          74 MEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA---  150 (328)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc---
Confidence            9988 6788877654 5699999999999999999999999999999999999999999999999999864211100   


Q ss_pred             ccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCCC
Q psy8260         227 ATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQ  306 (427)
Q Consensus       227 gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~  306 (427)
                                                                             .....+||+.|+|||++.+..+..+
T Consensus       151 -------------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~  175 (328)
T cd05593         151 -------------------------------------------------------TMKTFCGTPEYLAPEVLEDNDYGRA  175 (328)
T ss_pred             -------------------------------------------------------ccccccCCcCccChhhhcCCCCCcc
Confidence                                                                   0112347777888888777777778


Q ss_pred             CCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC-----CHHH
Q psy8260         307 TDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI-----TAEQ  381 (427)
Q Consensus       307 ~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~-----ta~e  381 (427)
                      +|+||+|++++.|.++..||.................        .+....++++.+||.+||+.||.+|+     |++|
T Consensus       176 ~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~--------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~  247 (328)
T cd05593         176 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDI--------KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKE  247 (328)
T ss_pred             CCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCc--------cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHH
Confidence            8999999999988776666643321111111111111        12245789999999999999999998     8999


Q ss_pred             HhcCCCCCCC
Q psy8260         382 ALAHPYLSQY  391 (427)
Q Consensus       382 ~L~Hp~f~~~  391 (427)
                      +++||||...
T Consensus       248 il~h~~~~~~  257 (328)
T cd05593         248 IMRHSFFTGV  257 (328)
T ss_pred             HhcCCCcCCC
Confidence            9999999763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3.3e-41  Score=335.04  Aligned_cols=263  Identities=22%  Similarity=0.307  Sum_probs=198.7

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      .+....|.+.+.||+|+||.||. +.+..+++.||+|++.+... .......+.+|+.+++.++||||+++++++...  
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~-~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~--  115 (370)
T cd05596          39 RMKAEDFDVIKVIGRGAFGEVQL-VRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD--  115 (370)
T ss_pred             CCCHHHcEEEEEEeeCCCEEEEE-EEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC--
Confidence            34456789999999999999996 55677899999999864321 122234466899999999999999999888654  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP  217 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~  217 (427)
                          ..+|+++|++ |++|.+++....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       116 ----~~~~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~  191 (370)
T cd05596         116 ----KYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (370)
T ss_pred             ----CEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence                4688999988 78999999888899999999999999999999999999999999999999999999999999864


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      .......                                                         .....+||+.|+|||+
T Consensus       192 ~~~~~~~---------------------------------------------------------~~~~~~gt~~y~aPE~  214 (370)
T cd05596         192 MDANGMV---------------------------------------------------------RCDTAVGTPDYISPEV  214 (370)
T ss_pred             ccCCCcc---------------------------------------------------------cCCCCCCCcCeECHHH
Confidence            3221000                                                         0012235666666666


Q ss_pred             hhhc----cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCC
Q psy8260         298 MLNW----MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDS  373 (427)
Q Consensus       298 l~~~----~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP  373 (427)
                      +.+.    .+..++|+||+|++++.|.++..||..........+.........   +. ....++.+++|||.+||+.+|
T Consensus       215 ~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~---~~-~~~~~s~~~~~li~~~L~~~p  290 (370)
T cd05596         215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLT---FP-DDIEISKQAKDLICAFLTDRE  290 (370)
T ss_pred             hccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCC---CC-CcCCCCHHHHHHHHHHccChh
Confidence            5432    245578999999999988777766654433222333322111111   10 112468999999999999999


Q ss_pred             CC--CCCHHHHhcCCCCCC
Q psy8260         374 EK--RITAEQALAHPYLSQ  390 (427)
Q Consensus       374 ~~--R~ta~e~L~Hp~f~~  390 (427)
                      .+  |+|++|+++||||.+
T Consensus       291 ~r~~R~s~~ell~h~~~~~  309 (370)
T cd05596         291 VRLGRNGVDEIKSHPFFKN  309 (370)
T ss_pred             hccCCCCHHHHhcCcccCC
Confidence            98  999999999999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-40  Score=324.61  Aligned_cols=303  Identities=45%  Similarity=0.730  Sum_probs=215.9

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      +.|.+.+.||+|+||.||. +.+..+|+.||||++.... .......+.+|+.++++++||||+++++++....+ ....
T Consensus         5 ~~y~i~~~lg~G~~g~vy~-~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~   81 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCS-ATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSF-ESFN   81 (336)
T ss_pred             cceEEEEEEEecCCeEEEE-EEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccc-cccc
Confidence            5688999999999999996 4566789999999986422 22334557789999999999999999988764422 2334


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcc
Q psy8260         144 NVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT  223 (427)
Q Consensus       144 ~~~lv~e~~g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~  223 (427)
                      .+|+++++++++|.+++..+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~  161 (336)
T cd07849          82 DVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD  161 (336)
T ss_pred             eEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccccc
Confidence            68999999999999998888899999999999999999999999999999999999999999999999999875422110


Q ss_pred             cccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh-cc
Q psy8260         224 GYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN-WM  302 (427)
Q Consensus       224 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~-~~  302 (427)
                      . .+                                                      ......||+.|+|||++.+ ..
T Consensus       162 ~-~~------------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~  186 (336)
T cd07849         162 H-TG------------------------------------------------------FLTEYVATRWYRAPEIMLNSKG  186 (336)
T ss_pred             c-cC------------------------------------------------------CcCCcCcCCCccChHHhhCCCC
Confidence            0 00                                                      0011235566666666543 23


Q ss_pred             CCCCCCHHHHHHHHHHhCCCCHHHHh-----------------------hcCcHHHHHHHhcCCCCCcccHHhhcCCCCh
Q psy8260         303 HYNQTDIHQLNLIMEMLGTPPAEFMA-----------------------KISSDSARKYINSLPLLTKKDFRQVFKGANP  359 (427)
Q Consensus       303 ~~~~~d~~slg~i~~~lg~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  359 (427)
                      +...+|+||+|++++.+.++..+|..                       .+.......+....+......+....+..++
T Consensus       187 ~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (336)
T cd07849         187 YTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADP  266 (336)
T ss_pred             CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCc
Confidence            44556888888777666443333311                       1111111112222222222333344456789


Q ss_pred             hHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCCC-CCCCccccc-CCCCHHHHHHHHhhh
Q psy8260         360 QAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTS-PPYDQSFED-MDLPVDQWKGTYSLE  424 (427)
Q Consensus       360 ~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~  424 (427)
                      ++.|||.+||+.||.+|||+.|+++||||.++..+..++.. +++..+++. .+++..+++..+..|
T Consensus       267 ~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (336)
T cd07849         267 KALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEPFPFDFELFDDLPKEKLKELIFEE  333 (336)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcccCCCCCChhhccccccCHHHHHHHHHHH
Confidence            99999999999999999999999999999998877665544 444444542 356677777766655

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=7.9e-41  Score=326.34  Aligned_cols=253  Identities=20%  Similarity=0.286  Sum_probs=192.8

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHH---HhcCCCCCceeeeeeeecCccccC
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRM---LKHMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~---l~~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      |.+.+.||+|+||.||.+ .+..+|+.||||++.+... .....+.+.+|+++   ++.++||||+++++++...     
T Consensus         1 y~i~~~lg~G~~g~Vy~~-~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~-----   74 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLA-EYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE-----   74 (324)
T ss_pred             CeEEEEEeecCCEEEEEE-EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC-----
Confidence            456788999999999964 5667899999999865321 12223445556554   4577899999999988654     


Q ss_pred             CceEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         142 FKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                       ..+|++||++ +++|...+....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        75 -~~~~lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          75 -DHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             -CEEEEEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence             4678999988 77998888878899999999999999999999999999999999999999999999999998763211


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      ...                                                          .....+||+.|+|||++.+
T Consensus       154 ~~~----------------------------------------------------------~~~~~~g~~~y~aPE~~~~  175 (324)
T cd05589         154 FGD----------------------------------------------------------RTSTFCGTPEFLAPEVLTE  175 (324)
T ss_pred             CCC----------------------------------------------------------cccccccCccccCHhHhcC
Confidence            000                                                          1112357777888888777


Q ss_pred             ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC---
Q psy8260         301 WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI---  377 (427)
Q Consensus       301 ~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~---  377 (427)
                      ..+..++|+||+|++++.|.++..+|................+.        .....++++.+||.+||+.||.+|+   
T Consensus       176 ~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~--------~p~~~~~~~~~li~~~L~~dP~~R~~~~  247 (324)
T cd05589         176 TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR--------YPRFLSREAISIMRRLLRRNPERRLGSG  247 (324)
T ss_pred             CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------CCCCCCHHHHHHHHHHhhcCHhHcCCCC
Confidence            66777889999999999887776666433222222222222111        1234688999999999999999999   


Q ss_pred             --CHHHHhcCCCCCCC
Q psy8260         378 --TAEQALAHPYLSQY  391 (427)
Q Consensus       378 --ta~e~L~Hp~f~~~  391 (427)
                        +++++++||||...
T Consensus       248 ~~~~~~l~~~~~f~~~  263 (324)
T cd05589         248 EKDAEDVKKQPFFRDI  263 (324)
T ss_pred             CCCHHHHhhCCCcCCC
Confidence              79999999999864

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.1e-40  Score=332.60  Aligned_cols=296  Identities=23%  Similarity=0.293  Sum_probs=203.9

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      .|.+.+.||+|+||.||+ +.+..+++.||||++..... .......+.+|+.+++.++||||+++++++...      .
T Consensus         2 ~f~~~~~LG~G~~g~Vy~-~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~------~   74 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCL-ACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDK------D   74 (381)
T ss_pred             CceEEEEEeecCCEEEEE-EEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC------C
Confidence            467788999999999996 45677899999999865322 223345677899999999999999999998754      4


Q ss_pred             eEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      .+|++||++ |++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~  154 (381)
T cd05626          75 NLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT  154 (381)
T ss_pred             EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence            688999988 7899888754 56899999999999999999999999999999999999999999999999998754221


Q ss_pred             cc-ccc-ccccc----cchhhhhcccccCCCCcceeeccCCccc--ccccccchhhhhccCCCC-CCccccccccccccc
Q psy8260         222 MT-GYV-ATRWY----RAPEIMLNWMHYNQTGVPFYFQDLKPSN--IAVNEDCELKILDFGLAR-PTENEMTGYVATRWY  292 (427)
Q Consensus       222 ~~-~~~-gt~~y----~aPE~l~~~~~~~~~~~~~~~~d~~~~~--~~~~~~~~~ki~d~g~~~-~~~~~~~~~~gt~~Y  292 (427)
                      .. .+. .....    +.|+.                  +|...  |....  ..+-....... .........+||+.|
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~gt~~Y  214 (381)
T cd05626         155 HNSKYYQKGSHIRQDSMEPSD------------------LWDDVSNCRCGD--RLKTLEQRATKQHQRCLAHSLVGTPNY  214 (381)
T ss_pred             cccccccccccccccccCccc------------------cccccccccccc--ccchhhccccccccccccccccCCccc
Confidence            10 000 00000    11111                  11100  00000  00000000000 001122356899999


Q ss_pred             cchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         293 RAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       293 ~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                      +|||++.+..+...+|+||+|++++.|.++..||..........+..........    .....++++++|||.+||..+
T Consensus       215 ~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~s~~~~dli~~ll~~~  290 (381)
T cd05626         215 IAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHI----PPQVKLSPEAVDLITKLCCSA  290 (381)
T ss_pred             cCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCC----CCCCCCCHHHHHHHHHHccCc
Confidence            9999998888888899999999999887777777543322222222211111100    011247899999999987655


Q ss_pred             CC--CCCCHHHHhcCCCCCCC
Q psy8260         373 SE--KRITAEQALAHPYLSQY  391 (427)
Q Consensus       373 P~--~R~ta~e~L~Hp~f~~~  391 (427)
                      +.  +|+|++|+++||||.+.
T Consensus       291 ~~~~~R~~~~~~l~hp~f~~~  311 (381)
T cd05626         291 EERLGRNGADDIKAHPFFSEV  311 (381)
T ss_pred             ccccCCCCHHHHhcCcccCCC
Confidence            44  49999999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=3.7e-40  Score=322.26  Aligned_cols=294  Identities=50%  Similarity=0.862  Sum_probs=220.6

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .+.|.+.+.||.|+||.||. +.+..+|..||||++.+........+.+.+|+.+++.++||||++++++|...     .
T Consensus         9 ~~~y~~~~~ig~g~~g~v~~-~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~   82 (328)
T cd07856           9 TNRYVDLQPVGMGAFGLVCS-ARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP-----L   82 (328)
T ss_pred             ccceEEEEeecccCCeEEEE-EEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC-----C
Confidence            45688899999999999996 55777899999998865443334456677999999999999999999987542     2


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCc
Q psy8260         143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM  222 (427)
Q Consensus       143 ~~~~lv~e~~g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~  222 (427)
                      ...|+++++++++|.++++...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        83 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~  162 (328)
T cd07856          83 EDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM  162 (328)
T ss_pred             CcEEEEeehhccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCCc
Confidence            35789999999999999887789999999999999999999999999999999999999999999999999987654444


Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhcc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM  302 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~  302 (427)
                      ....++..|+|||.+.+..                                                            .
T Consensus       163 ~~~~~~~~y~aPE~~~~~~------------------------------------------------------------~  182 (328)
T cd07856         163 TGYVSTRYYRAPEIMLTWQ------------------------------------------------------------K  182 (328)
T ss_pred             CCCcccccccCceeeeccC------------------------------------------------------------C
Confidence            4455566666666543211                                                            1


Q ss_pred             CCCCCCHHHHHHHHHHh-----------------------CCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCCh
Q psy8260         303 HYNQTDIHQLNLIMEML-----------------------GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANP  359 (427)
Q Consensus       303 ~~~~~d~~slg~i~~~l-----------------------g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  359 (427)
                      +...+|+|++|++++.+                       |.++.++..........++....+...........+..++
T Consensus       183 ~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (328)
T cd07856         183 YDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADP  262 (328)
T ss_pred             cCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCH
Confidence            23334566666555444                       3333333222222212222222222222333445566789


Q ss_pred             hHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCC-CCCCCcccccCCCCHHHHHHHHh
Q psy8260         360 QAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPT-SPPYDQSFEDMDLPVDQWKGTYS  422 (427)
Q Consensus       360 ~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  422 (427)
                      ++.++|.+||+.||++|+|+++++.||||.....|...+. ...|++++.+.+++++.|+--+.
T Consensus       263 ~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (328)
T cd07856         263 SAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPVAEEKFDWSFNDADLPVDTWKVMMY  326 (328)
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccccCchhhcCCchhcccCCHHHHHHHhc
Confidence            9999999999999999999999999999998877755544 36899999999999999986554

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.2e-40  Score=330.12  Aligned_cols=290  Identities=18%  Similarity=0.245  Sum_probs=201.7

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC-HHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS-AVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      +|++.+.||+|+||.||. +.+..+++.||||++.+.... ......+.+|+.++.+++||||+++++.+...      .
T Consensus         2 ~y~~~~~LG~G~~g~V~~-~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~------~   74 (363)
T cd05628           2 DFESLKVIGRGAFGEVRL-VQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDK------L   74 (363)
T ss_pred             CceEeEEEEeCCCEEEEE-EEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecC------C
Confidence            467889999999999996 456778999999998653221 22334567899999999999999999988654      4


Q ss_pred             eEEEEeccC-CCCHHHHHh-hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~-~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      .+|++||++ |++|.+++. .+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          75 NLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             eEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            678999988 789988875 457999999999999999999999999999999999999999999999999999754322


Q ss_pred             ccc-cc-ccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         222 MTG-YV-ATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       222 ~~~-~~-gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      ... +. ......++.....      ........+.|.                   ........+.+||+.|+|||++.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~-------------------~~~~~~~~~~~Gt~~Y~aPE~~~  209 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQ------NMNSKRKAETWK-------------------RNRRQLAFSTVGTPDYIAPEVFM  209 (363)
T ss_pred             cccccccccccccccccccc------ccccccccchhh-------------------hccccccccccCCccccCHHHHc
Confidence            110 00 0000000000000      000000000000                   00011224568999999999999


Q ss_pred             hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCC---C
Q psy8260         300 NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEK---R  376 (427)
Q Consensus       300 ~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~---R  376 (427)
                      +..+..++|+||+|++++.|.++..||..........+.........   +.. ....+++++|||.+||. +|.+   |
T Consensus       210 ~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~---~p~-~~~~s~~~~~li~~l~~-~~~~r~~r  284 (363)
T cd05628         210 QTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLI---FPP-EVPISEKAKDLILRFCC-EWEHRIGA  284 (363)
T ss_pred             CCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCccc---CCC-cCCCCHHHHHHHHHHcC-ChhhcCCC
Confidence            88888899999999999988777666654332222222221111110   000 12368999999999886 5554   5


Q ss_pred             CCHHHHhcCCCCCCC
Q psy8260         377 ITAEQALAHPYLSQY  391 (427)
Q Consensus       377 ~ta~e~L~Hp~f~~~  391 (427)
                      ++++|+++||||...
T Consensus       285 ~~~~ei~~hp~f~~~  299 (363)
T cd05628         285 PGVEEIKTNPFFEGV  299 (363)
T ss_pred             CCHHHHhCCCCCCCC
Confidence            799999999999865

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=7e-41  Score=326.67  Aligned_cols=249  Identities=21%  Similarity=0.326  Sum_probs=191.6

Q ss_pred             cccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEEE
Q psy8260          70 PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV  148 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~lv  148 (427)
                      +.||+|+||.||+ +.+..+|+.||+|++..... .......+.+|+++++.++||||++++++|...      ..+|++
T Consensus         1 ~~lG~G~~g~Vy~-~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~------~~~~lv   73 (323)
T cd05595           1 KLLGKGTFGKVIL-VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH------DRLCFV   73 (323)
T ss_pred             CeeeeCCCEEEEE-EEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC------CEEEEE
Confidence            3689999999996 45677899999999865322 222344567899999999999999999988654      467899


Q ss_pred             eccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCccccc
Q psy8260         149 THLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV  226 (427)
Q Consensus       149 ~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  226 (427)
                      ||++ +++|...+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......   
T Consensus        74 ~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~---  150 (323)
T cd05595          74 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---  150 (323)
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC---
Confidence            9988 6788877754 5689999999999999999999999999999999999999999999999998763211100   


Q ss_pred             ccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCCC
Q psy8260         227 ATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQ  306 (427)
Q Consensus       227 gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~  306 (427)
                                                                             ......||+.|+|||++.+..+...
T Consensus       151 -------------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~  175 (323)
T cd05595         151 -------------------------------------------------------TMKTFCGTPEYLAPEVLEDNDYGRA  175 (323)
T ss_pred             -------------------------------------------------------ccccccCCcCcCCcccccCCCCCch
Confidence                                                                   0112346777888887776667778


Q ss_pred             CCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC-----CHHH
Q psy8260         307 TDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI-----TAEQ  381 (427)
Q Consensus       307 ~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~-----ta~e  381 (427)
                      +|+||+|++++.|.++..+|.................        ......++++.+||.+||+.||.+|+     ++.+
T Consensus       176 ~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~--------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~  247 (323)
T cd05595         176 VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI--------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE  247 (323)
T ss_pred             hchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--------CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHH
Confidence            8999999999988776666643322222222111111        11235689999999999999999998     9999


Q ss_pred             HhcCCCCCCC
Q psy8260         382 ALAHPYLSQY  391 (427)
Q Consensus       382 ~L~Hp~f~~~  391 (427)
                      +++||||.+.
T Consensus       248 ~l~h~~~~~~  257 (323)
T cd05595         248 VMEHRFFLSI  257 (323)
T ss_pred             HHcCCCcCCC
Confidence            9999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.6e-40  Score=340.04  Aligned_cols=284  Identities=23%  Similarity=0.353  Sum_probs=188.1

Q ss_pred             cCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCC------CCCceeeeeeeec
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN------HENVIGLLDVFHS  135 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~------HpnIv~l~~~~~~  135 (427)
                      ..+.|.+.+.||+|+||.||+ +.+..+++.||||++....   .......+|++++..++      |.++++++++|..
T Consensus       127 ~~~~y~i~~~lG~G~fg~V~~-a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        127 STQRFKILSLLGEGTFGKVVE-AWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             CCCcEEEEEEEEeccCEEEEE-EEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            356799999999999999996 5566789999999986421   22233445666666554      4568888888764


Q ss_pred             CccccCCceEEEEeccCCCCHHHHHh-hCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCCeEEcCCC--------
Q psy8260         136 NTCLADFKNVYMVTHLMGADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNEDC--------  205 (427)
Q Consensus       136 ~~~~~~~~~~~lv~e~~g~~L~~~l~-~~~l~~~~~~~~~~qi~~aL~yLH~-~~iiHrDLKp~NILl~~~~--------  205 (427)
                      .     ...++++++++|++|.+++. .+.+++..+..++.||+.||+|||+ .|||||||||+|||++.++        
T Consensus       203 ~-----~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~  277 (467)
T PTZ00284        203 E-----TGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTN  277 (467)
T ss_pred             C-----CceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccc
Confidence            3     24688999999998888765 4579999999999999999999998 5999999999999998655        


Q ss_pred             --------CEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCC
Q psy8260         206 --------ELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLAR  277 (427)
Q Consensus       206 --------~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~  277 (427)
                              .+||+|||++.......+..+||+.|+|||++.+. .|+.      ..|+|+.||++.+             
T Consensus       278 ~~~~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~------~~DiwSlGvil~e-------------  337 (467)
T PTZ00284        278 RALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGL-GWMY------STDMWSMGCIIYE-------------  337 (467)
T ss_pred             cccCCCCceEEECCCCccccCccccccccCCccccCcHHhhcC-CCCc------HHHHHHHHHHHHH-------------
Confidence                    49999999886544444555677777777776542 1221      2256666555544             


Q ss_pred             CCccccccccccccccchHHhhhccCCCC-CCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCC----CCCcccHHh
Q psy8260         278 PTENEMTGYVATRWYRAPEIMLNWMHYNQ-TDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLP----LLTKKDFRQ  352 (427)
Q Consensus       278 ~~~~~~~~~~gt~~Y~APEvl~~~~~~~~-~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~  352 (427)
                          +++|..               ++.+ .+...+..+...+|..+..+.........+.+.....    ....+.+..
T Consensus       338 ----lltG~~---------------pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (467)
T PTZ00284        338 ----LYTGKL---------------LYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLAR  398 (467)
T ss_pred             ----HHhCCC---------------CCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHh
Confidence                222211               2222 2333444455555555544433222222222211111    111111111


Q ss_pred             hc-------CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q psy8260         353 VF-------KGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSD  393 (427)
Q Consensus       353 ~~-------~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  393 (427)
                      ..       ...++.+.|||.+||++||.+|+||+|+|+||||.++..
T Consensus       399 ~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~~  446 (467)
T PTZ00284        399 IARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYP  446 (467)
T ss_pred             hhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccccCC
Confidence            10       012567889999999999999999999999999987644

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.6e-40  Score=323.42  Aligned_cols=301  Identities=46%  Similarity=0.746  Sum_probs=221.6

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      ..|.+.+.||+|+||.||. +.+..+|+.||||.+..............+|+.+++.++||||+++++++..... ....
T Consensus         5 ~~y~~~~~lg~G~~~~vy~-~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~-~~~~   82 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCS-AKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHR-EAFN   82 (337)
T ss_pred             cceeEEEEeccCCCeEEEE-EEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccc-cccC
Confidence            3578888999999999996 4567789999999987544334445567789999999999999999998764321 2224


Q ss_pred             eEEEEeccCCCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC-
Q psy8260         144 NVYMVTHLMGADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE-  221 (427)
Q Consensus       144 ~~~lv~e~~g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~-  221 (427)
                      .+|+++++++++|.+++.. ..+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||+++..... 
T Consensus        83 ~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~  162 (337)
T cd07858          83 DVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG  162 (337)
T ss_pred             cEEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence            5799999999899888754 56899999999999999999999999999999999999999999999999998754321 


Q ss_pred             --cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         222 --MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       222 --~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                        .....++..|+|||.+.+.                                                           
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~-----------------------------------------------------------  183 (337)
T cd07858         163 DFMTEYVVTRWYRAPELLLNC-----------------------------------------------------------  183 (337)
T ss_pred             ccccccccccCccChHHHhcC-----------------------------------------------------------
Confidence              1223344455555544321                                                           


Q ss_pred             hccCCCCCCHHHHHHHHHHhCCCCHHHH-----------------------hhcCcHHHHHHHhcCCCCCcccHHhhcCC
Q psy8260         300 NWMHYNQTDIHQLNLIMEMLGTPPAEFM-----------------------AKISSDSARKYINSLPLLTKKDFRQVFKG  356 (427)
Q Consensus       300 ~~~~~~~~d~~slg~i~~~lg~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (427)
                       ..+..++|+|++|++++.|.++..+|.                       .........++....+......+....+.
T Consensus       184 -~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (337)
T cd07858         184 -SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPH  262 (337)
T ss_pred             -CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHccc
Confidence             123445677777776665533332221                       11111222223333333333334445567


Q ss_pred             CChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCC-CCCCCcccccCCCCHHHHHHHHhhhcc
Q psy8260         357 ANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPT-SPPYDQSFEDMDLPVDQWKGTYSLESL  426 (427)
Q Consensus       357 ~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  426 (427)
                      .+++++|||.+||+.||++|||++|+++||||.....+...+. +.++++++++.+....+.+..+..|-|
T Consensus       263 ~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (337)
T cd07858         263 ANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVCQTPFSFDFEEDALTEEDIKELIYNEML  333 (337)
T ss_pred             CCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCccCCCccchhhhhhhcCHHHHHHHHHHHHh
Confidence            8999999999999999999999999999999998877766554 467888899999999998888877654

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-41  Score=331.84  Aligned_cols=286  Identities=22%  Similarity=0.330  Sum_probs=204.4

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH-HHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA-VHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      .|.+.+.||+|+||.||. +.+..+|+.||||++....... .....+.+|+.++..++||||+++++++...      .
T Consensus         2 ~y~~~~~lg~G~~g~Vy~-~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------~   74 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWL-VRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDE------E   74 (350)
T ss_pred             CceEEEEEEeCCcEEEEE-EEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecC------C
Confidence            577889999999999996 5567789999999986532211 2344567899999999999999999887643      4


Q ss_pred             eEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      .+|++|+++ +++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          75 HLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             eEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            678999988 7899988865 47999999999999999999999999999999999999999999999999998765432


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      .....-  .+........      .       .   ..+.         ..  .............||+.|+|||++.+.
T Consensus       155 ~~~~~~--~~~~~~~~~~------~-------~---~~~~---------~~--~~~~~~~~~~~~~gt~~y~aPE~~~~~  205 (350)
T cd05573         155 KDREYY--LNDSHNLLFR------D-------N---VLVR---------RR--DHKQRRVRANSTVGTPDYIAPEVLRGT  205 (350)
T ss_pred             Cccccc--cccccccccc------c-------c---cccc---------cc--ccccccccccccccCccccCHHHHcCC
Confidence            110000  0000000000      0       0   0000         00  000001122345799999999999988


Q ss_pred             cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC-HH
Q psy8260         302 MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT-AE  380 (427)
Q Consensus       302 ~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t-a~  380 (427)
                      .+...+|+||+|++++.|.++..||..........+.........   . .....+++++.+||.+||+ ||.+|++ ++
T Consensus       206 ~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~---~-p~~~~~~~~~~~li~~ll~-dp~~R~~s~~  280 (350)
T cd05573         206 PYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLR---F-PPDPPVSPEAIDLICRLLC-DPEDRLGSFE  280 (350)
T ss_pred             CCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCccc---C-CCCCCCCHHHHHHHHHHcc-ChhhcCCCHH
Confidence            888899999999999999777766654332222222222111100   0 0112368999999999998 9999999 99


Q ss_pred             HHhcCCCCCCC
Q psy8260         381 QALAHPYLSQY  391 (427)
Q Consensus       381 e~L~Hp~f~~~  391 (427)
                      |+++||||.+.
T Consensus       281 ~ll~hp~~~~~  291 (350)
T cd05573         281 EIKSHPFFKGI  291 (350)
T ss_pred             HHhcCCCcCCC
Confidence            99999999865

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=7.5e-41  Score=332.35  Aligned_cols=262  Identities=21%  Similarity=0.288  Sum_probs=195.9

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      +..+.|++.+.||+|+||.||. +.+..+++.||+|.+.+... .......+.+|+.+++.++||||++++++|...   
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~-~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~---  115 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQL-VRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD---  115 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEE-EEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC---
Confidence            3456788999999999999996 55677899999999864322 122334466899999999999999999988654   


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCC
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT  218 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~  218 (427)
                         ..+|+++|++ +++|.+++....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus       116 ---~~~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~  192 (370)
T cd05621         116 ---KYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM  192 (370)
T ss_pred             ---CEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceec
Confidence               4689999988 789999998888999999999999999999999999999999999999999999999999998753


Q ss_pred             CCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         219 ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       219 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                      ......                                                         ...+.+||+.|+|||++
T Consensus       193 ~~~~~~---------------------------------------------------------~~~~~~gt~~Y~aPE~~  215 (370)
T cd05621         193 DETGMV---------------------------------------------------------RCDTAVGTPDYISPEVL  215 (370)
T ss_pred             ccCCce---------------------------------------------------------ecccCCCCcccCCHHHH
Confidence            221000                                                         00122456666666666


Q ss_pred             hhcc----CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCC
Q psy8260         299 LNWM----HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       299 ~~~~----~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~  374 (427)
                      .+..    +...+|+||+|++++.|.++..||..........+.........   +. ....+++.+++||.+||+.+|.
T Consensus       216 ~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~---~p-~~~~~s~~~~~li~~~L~~~~~  291 (370)
T cd05621         216 KSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLN---FP-EDVEISKHAKNLICAFLTDREV  291 (370)
T ss_pred             hccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccC---CC-CcccCCHHHHHHHHHHccCchh
Confidence            5432    45678999999999988777666654332222222222111111   00 0124688999999999986655


Q ss_pred             C--CCCHHHHhcCCCCCC
Q psy8260         375 K--RITAEQALAHPYLSQ  390 (427)
Q Consensus       375 ~--R~ta~e~L~Hp~f~~  390 (427)
                      +  |+|++|+++||||..
T Consensus       292 r~~R~~~~e~l~hp~~~~  309 (370)
T cd05621         292 RLGRNGVEEIKQHPFFKN  309 (370)
T ss_pred             ccCCCCHHHHhcCcccCC
Confidence            4  899999999999986

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-41  Score=333.59  Aligned_cols=303  Identities=22%  Similarity=0.265  Sum_probs=203.2

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      .|.+.+.||.|+||.||. +.+..+|+.||||++.+... .......+.+|+++++.++|||||+++++|...      .
T Consensus         2 ~y~~~~~lG~G~~g~Vy~-~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~------~   74 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRL-VQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDA------Q   74 (377)
T ss_pred             CceEeEEEeecCCEEEEE-EEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC------C
Confidence            467889999999999995 55677899999998864321 122345567899999999999999999998754      4


Q ss_pred             eEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      .+|+++|++ |++|.+++.. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          75 YLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            689999988 7899888754 56899999999999999999999999999999999999999999999999999744321


Q ss_pred             cccccccccccchhhhhcccccCC-CCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQ-TGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~-~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      ...    ..|.....  +...... ........+-  .+  .......++.+++.....  .....+||+.|+|||++.+
T Consensus       155 ~~~----~~~~~~~~--~~~~~~~~~~~~~~~~~~--~~--~~~~~~~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~  222 (377)
T cd05629         155 HDS----AYYQKLLQ--GKSNKNRIDNRNSVAVDS--IN--LTMSSKDQIATWKKNRRL--MAYSTVGTPDYIAPEIFLQ  222 (377)
T ss_pred             ccc----cccccccc--cccccccccccccccccc--cc--ccccchhhhhhhhhcccc--cccccCCCccccCHHHHcc
Confidence            100    00000000  0000000 0000000000  00  000000111222211111  1124679999999999988


Q ss_pred             ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCC---C
Q psy8260         301 WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKR---I  377 (427)
Q Consensus       301 ~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R---~  377 (427)
                      ..+..++|+||+|++++.|.++..+|......+.............   +. ....++++++|||.+||+ +|.+|   +
T Consensus       223 ~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~---~p-~~~~~s~~~~dli~~lL~-~~~~r~~r~  297 (377)
T cd05629         223 QGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLY---FP-DDIHLSVEAEDLIRRLIT-NAENRLGRG  297 (377)
T ss_pred             CCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccC---CC-CCCCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence            8888889999999999988777666643322222222221111110   00 012468899999999998 77775   5


Q ss_pred             CHHHHhcCCCCCCC
Q psy8260         378 TAEQALAHPYLSQY  391 (427)
Q Consensus       378 ta~e~L~Hp~f~~~  391 (427)
                      |++|+++||||...
T Consensus       298 ~~~~~l~hp~~~~~  311 (377)
T cd05629         298 GAHEIKSHPFFRGV  311 (377)
T ss_pred             CHHHHhcCCCcCCC
Confidence            99999999999854

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=9.1e-41  Score=326.04  Aligned_cols=249  Identities=23%  Similarity=0.333  Sum_probs=190.6

Q ss_pred             cccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEEE
Q psy8260          70 PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV  148 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~lv  148 (427)
                      +.||+|+||.||. +.+..+|+.||+|.+.+... .........+|+++++.++||||++++++|...      ..+|++
T Consensus         1 ~~lG~G~~g~V~~-~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~------~~~~lv   73 (325)
T cd05594           1 KLLGKGTFGKVIL-VKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH------DRLCFV   73 (325)
T ss_pred             CeeeeCCCEEEEE-EEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC------CEEEEE
Confidence            3689999999995 55677899999999875422 222345567899999999999999999888654      467899


Q ss_pred             eccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccc
Q psy8260         149 THLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGY  225 (427)
Q Consensus       149 ~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~-~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  225 (427)
                      ||++ +++|...+.. ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++.......  
T Consensus        74 ~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--  151 (325)
T cd05594          74 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--  151 (325)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--
Confidence            9988 6788877754 568999999999999999999997 7999999999999999999999999999863211100  


Q ss_pred             cccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCC
Q psy8260         226 VATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYN  305 (427)
Q Consensus       226 ~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~  305 (427)
                                                                              ......||+.|+|||++.+..+..
T Consensus       152 --------------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~  175 (325)
T cd05594         152 --------------------------------------------------------TMKTFCGTPEYLAPEVLEDNDYGR  175 (325)
T ss_pred             --------------------------------------------------------ccccccCCcccCCHHHHccCCCCC
Confidence                                                                    011234677788888777766777


Q ss_pred             CCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC-----CHH
Q psy8260         306 QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI-----TAE  380 (427)
Q Consensus       306 ~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~-----ta~  380 (427)
                      ++|+||+|++++.|.++..||.................        ......++++.+||.+||++||++|+     +++
T Consensus       176 ~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~--------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~  247 (325)
T cd05594         176 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI--------RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAK  247 (325)
T ss_pred             ccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCC--------CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHH
Confidence            88999999999888777666643322111111111111        11235689999999999999999997     999


Q ss_pred             HHhcCCCCCCC
Q psy8260         381 QALAHPYLSQY  391 (427)
Q Consensus       381 e~L~Hp~f~~~  391 (427)
                      |+++||||.+.
T Consensus       248 ~il~h~~~~~~  258 (325)
T cd05594         248 EIMQHKFFAGI  258 (325)
T ss_pred             HHhcCCCcCCC
Confidence            99999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.5e-40  Score=323.83  Aligned_cols=250  Identities=22%  Similarity=0.339  Sum_probs=190.9

Q ss_pred             cccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCccccCCceEEE
Q psy8260          70 PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLADFKNVYM  147 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~~~~~~~l  147 (427)
                      +.||+|+||.||.+ .+..+++.||||++.+... .........+|+.++..+ +||||++++++|...      ..+|+
T Consensus         1 ~~lg~G~~g~V~~~-~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~------~~~~i   73 (320)
T cd05590           1 RVLGKGSFGKVMLA-RLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP------DRLFF   73 (320)
T ss_pred             CeeeeCCCeEEEEE-EEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcC------CEEEE
Confidence            36899999999964 5677899999999865321 122344567888888776 799999999988654      46789


Q ss_pred             EeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccc
Q psy8260         148 VTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGY  225 (427)
Q Consensus       148 v~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  225 (427)
                      +||++ +++|...+.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......  
T Consensus        74 v~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--  151 (320)
T cd05590          74 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--  151 (320)
T ss_pred             EEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--
Confidence            99988 6799887754 5799999999999999999999999999999999999999999999999999763211000  


Q ss_pred             cccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCC
Q psy8260         226 VATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYN  305 (427)
Q Consensus       226 ~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~  305 (427)
                                                                              ......||+.|+|||++.+..+..
T Consensus       152 --------------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~  175 (320)
T cd05590         152 --------------------------------------------------------TTSTFCGTPDYIAPEILQEMLYGP  175 (320)
T ss_pred             --------------------------------------------------------cccccccCccccCHHHHcCCCCCC
Confidence                                                                    111235778888888887777777


Q ss_pred             CCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH------
Q psy8260         306 QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA------  379 (427)
Q Consensus       306 ~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta------  379 (427)
                      .+|+||+|++++.|.++..||..................        .....++++++||++||+.||.+|+|+      
T Consensus       176 ~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~--------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~  247 (320)
T cd05590         176 SVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV--------YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGE  247 (320)
T ss_pred             ccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC--------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCH
Confidence            889999999999887666666433222222222211111        123468899999999999999999998      


Q ss_pred             HHHhcCCCCCCCC
Q psy8260         380 EQALAHPYLSQYS  392 (427)
Q Consensus       380 ~e~L~Hp~f~~~~  392 (427)
                      +++++||||....
T Consensus       248 ~~~~~h~~f~~~~  260 (320)
T cd05590         248 EAILRHPFFKELD  260 (320)
T ss_pred             HHHHcCCCcCCCC
Confidence            9999999998653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=3.1e-40  Score=319.85  Aligned_cols=260  Identities=30%  Similarity=0.484  Sum_probs=186.0

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      ..|.+.+.||+|+||.||.+ .+..++..||+|++..... ......+.+|+++++.++||||+++++++...      .
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~-~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~   77 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKG-RSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTD------K   77 (309)
T ss_pred             CceEEEEEecccCCEEEEEE-EecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeC------C
Confidence            45788899999999999964 5667889999999864322 22233466899999999999999999998654      4


Q ss_pred             eEEEEeccCCCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         144 NVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       144 ~~~lv~e~~g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      ..++++++++++|.+.+..  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  157 (309)
T cd07872          78 SLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP  157 (309)
T ss_pred             eEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence            5799999998888887754  34889999999999999999999999999999999999999999999999998753221


Q ss_pred             ---cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         222 ---MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       222 ---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                         .....+|..|+|||++.+..                                                         
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~---------------------------------------------------------  180 (309)
T cd07872         158 TKTYSNEVVTLWYRPPDVLLGSS---------------------------------------------------------  180 (309)
T ss_pred             ccccccccccccccCCHHHhCCC---------------------------------------------------------
Confidence               12234455555555543321                                                         


Q ss_pred             hhccCCCCCCHHHHHHHHHHhCCCCHHH-----------------------HhhcCcHHHHHHHhcCCCCCcccHHhhcC
Q psy8260         299 LNWMHYNQTDIHQLNLIMEMLGTPPAEF-----------------------MAKISSDSARKYINSLPLLTKKDFRQVFK  355 (427)
Q Consensus       299 ~~~~~~~~~d~~slg~i~~~lg~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (427)
                         .+...+|+||+|++++.|.++..+|                       +.......... ....+......+.....
T Consensus       181 ---~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  256 (309)
T cd07872         181 ---EYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK-NYNFPKYKPQPLINHAP  256 (309)
T ss_pred             ---CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh-hhhcCccCCCchhhhcc
Confidence               1233446666666555553333322                       22211110000 00111122222233445


Q ss_pred             CCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q psy8260         356 GANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYS  392 (427)
Q Consensus       356 ~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~  392 (427)
                      .++++++|||.+||++||.+|+|++|+|+||||+...
T Consensus       257 ~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         257 RLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             CCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence            6789999999999999999999999999999998754

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0986|consensus

Probab=100.00  E-value=1.2e-41  Score=324.07  Aligned_cols=262  Identities=21%  Similarity=0.310  Sum_probs=207.5

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHH-HHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVH-AKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~-~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      .+..+.|..-++||+|+||.|+ ++.-+.||+.+|.|++.+....... ..-.++|-++|.+++.+.||.|-..|++.  
T Consensus       181 pvt~n~F~~~RvlGkGGFGEV~-acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTk--  257 (591)
T KOG0986|consen  181 PVTKNTFRVYRVLGKGGFGEVC-ACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETK--  257 (591)
T ss_pred             hccccceeeeEEEeccccccee-EEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCC--
Confidence            3455678888999999999999 6677789999999988654332222 23356899999999999999998888775  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL  214 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGl  214 (427)
                          ..+++|+.+| ||||.-.+.+   ..|++..++.|+.+|+.||++||+.+||.|||||+|||+|+.|+++|+|+||
T Consensus       258 ----d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGL  333 (591)
T KOG0986|consen  258 ----DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGL  333 (591)
T ss_pred             ----CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccce
Confidence                3578888888 7898765532   3799999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccc
Q psy8260         215 ARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRA  294 (427)
Q Consensus       215 a~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~A  294 (427)
                      |..+...                                                           ....+++||.+|||
T Consensus       334 Avei~~g-----------------------------------------------------------~~~~~rvGT~GYMA  354 (591)
T KOG0986|consen  334 AVEIPEG-----------------------------------------------------------KPIRGRVGTVGYMA  354 (591)
T ss_pred             EEecCCC-----------------------------------------------------------CccccccCcccccC
Confidence            8643221                                                           13456789999999


Q ss_pred             hHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCc---HHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCC
Q psy8260         295 PEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISS---DSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLEL  371 (427)
Q Consensus       295 PEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~  371 (427)
                      |||+.+..|....|||+|||++|.|..+..||...-.+   ++........       ..++....|++|++|.+.+|++
T Consensus       355 PEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~-------~~ey~~kFS~eakslc~~LL~K  427 (591)
T KOG0986|consen  355 PEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED-------PEEYSDKFSEEAKSLCEGLLTK  427 (591)
T ss_pred             HHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc-------hhhcccccCHHHHHHHHHHHcc
Confidence            99998888888899999999999998777777543222   1221111111       1223355799999999999999


Q ss_pred             CCCCCC-----CHHHHhcCCCCCCCCCC
Q psy8260         372 DSEKRI-----TAEQALAHPYLSQYSDP  394 (427)
Q Consensus       372 dP~~R~-----ta~e~L~Hp~f~~~~~~  394 (427)
                      ||++|+     +++++.+||||+.+...
T Consensus       428 dp~~RLGcrg~ga~evk~HpfFk~lnw~  455 (591)
T KOG0986|consen  428 DPEKRLGCRGEGAQEVKEHPFFKDLNWR  455 (591)
T ss_pred             CHHHhccCCCcCcchhhhCcccccCCHh
Confidence            999998     67899999999976543

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.2e-40  Score=332.32  Aligned_cols=300  Identities=23%  Similarity=0.299  Sum_probs=203.5

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      .|.+.+.||+|+||.||+ +.+..+++.||||++.+... .......+.+|+.+++.++|||||++++.|...      .
T Consensus         2 ~f~~~~~LG~G~~g~Vy~-a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~------~   74 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCL-ARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDK------D   74 (382)
T ss_pred             CcEEEEEEEeCCCEEEEE-EEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC------C
Confidence            467788999999999996 55777899999999865322 123345577899999999999999999998754      4


Q ss_pred             eEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      .+|++||++ +++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~  154 (382)
T cd05625          75 NLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (382)
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence            689999988 7799888754 56899999999999999999999999999999999999999999999999998643211


Q ss_pred             cc-cccccccccchhhhhcccccCCCCcceeeccCCcc--cccccccchhhhhccCCCC-CCccccccccccccccchHH
Q psy8260         222 MT-GYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPS--NIAVNEDCELKILDFGLAR-PTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       222 ~~-~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~--~~~~~~~~~~ki~d~g~~~-~~~~~~~~~~gt~~Y~APEv  297 (427)
                      .. .+..+.....++           ...  +...|..  .|.....  .......... .......+.+||+.|+|||+
T Consensus       155 ~~~~~~~~~~~~~~~-----------~~~--~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~  219 (382)
T cd05625         155 HDSKYYQSGDHVRQD-----------SMD--FSNEWGDPANCRCGDR--LKPLERRAARQHQRCLAHSLVGTPNYIAPEV  219 (382)
T ss_pred             ccccccccccccccc-----------ccc--cccccccccccccccc--ccchhhhhccccccccccccccCcccCCHHH
Confidence            00 000000000000           000  0000000  0000000  0000000000 00112235689999999999


Q ss_pred             hhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC
Q psy8260         298 MLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI  377 (427)
Q Consensus       298 l~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~  377 (427)
                      +.+..+...+|+||+|++++.|.++..||..........+..........    .....++++++|||.+|+ .||.+|+
T Consensus       220 ~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~----p~~~~~s~~~~~li~~l~-~~p~~R~  294 (382)
T cd05625         220 LLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHI----PPQAKLSPEASDLIIKLC-RGPEDRL  294 (382)
T ss_pred             hcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCC----CCcccCCHHHHHHHHHHc-cCHhHcC
Confidence            99888888899999999999887766666543222222222211111100    012357899999999987 4999999


Q ss_pred             C---HHHHhcCCCCCCC
Q psy8260         378 T---AEQALAHPYLSQY  391 (427)
Q Consensus       378 t---a~e~L~Hp~f~~~  391 (427)
                      +   ++|+++||||...
T Consensus       295 ~~~~~~ei~~hp~f~~~  311 (382)
T cd05625         295 GKNGADEIKAHPFFKTI  311 (382)
T ss_pred             CCCCHHHHhcCCCcCCc
Confidence            7   9999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.2e-40  Score=325.78  Aligned_cols=260  Identities=21%  Similarity=0.295  Sum_probs=192.5

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      .|.+.+.||+|+||.||. +.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++...      .
T Consensus         2 ~y~~~~~lg~G~~g~Vy~-~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~------~   74 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQV-VREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDK------D   74 (330)
T ss_pred             CceEEEEEEeccCEEEEE-EEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC------C
Confidence            477889999999999996 45677899999999875432 222344567899999999999999999887643      4


Q ss_pred             eEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      .+|++++++ +++|.++++.  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  154 (330)
T cd05601          75 NLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA  154 (330)
T ss_pred             eEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence            678999988 7899998865  4699999999999999999999999999999999999999999999999999875432


Q ss_pred             Cc----ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         221 EM----TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       221 ~~----~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      ..    ....||+.|+|||++......                                                     
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-----------------------------------------------------  181 (330)
T cd05601         155 NKMVNSKLPVGTPDYIAPEVLTTMNGD-----------------------------------------------------  181 (330)
T ss_pred             CCceeeecccCCccccCHHHhcccccc-----------------------------------------------------
Confidence            11    112345555555554321000                                                     


Q ss_pred             HhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCC
Q psy8260         297 IMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKR  376 (427)
Q Consensus       297 vl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R  376 (427)
                        ....+..++|+||+|++++.|.++..||..........+.........   +. ....+++++.+||.+||+ ||++|
T Consensus       182 --~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~---~~-~~~~~~~~~~~li~~ll~-~p~~R  254 (330)
T cd05601         182 --GKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLK---FP-EDPKVSSDFLDLIQSLLC-GQKER  254 (330)
T ss_pred             --ccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccC---CC-CCCCCCHHHHHHHHHHcc-ChhhC
Confidence              012345678999999999888777766644332222222221111000   00 112468899999999998 99999


Q ss_pred             CCHHHHhcCCCCCCC
Q psy8260         377 ITAEQALAHPYLSQY  391 (427)
Q Consensus       377 ~ta~e~L~Hp~f~~~  391 (427)
                      +|++++++||||...
T Consensus       255 ~t~~~l~~h~~~~~~  269 (330)
T cd05601         255 LGYEGLCCHPFFSKI  269 (330)
T ss_pred             CCHHHHhCCCCcCCC
Confidence            999999999999864

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.9e-40  Score=314.72  Aligned_cols=252  Identities=22%  Similarity=0.317  Sum_probs=188.7

Q ss_pred             cCcccccEEEEeEEeCcCCcEEEEEEccCcCCC-HHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEEEec
Q psy8260          72 LSKESFDLIFSSALDSVSGVKVAIKKIARPFQS-AVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH  150 (427)
Q Consensus        72 lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~lv~e  150 (427)
                      ||+|+||.||. +.+..+|+.||+|++...... ....+.+..|+++++.++||||+++.++|...      ..+|++|+
T Consensus         1 lg~G~~g~Vy~-~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~------~~~~lv~e   73 (280)
T cd05608           1 LGKGGFGEVSA-CQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTK------TDLCLVMT   73 (280)
T ss_pred             CCCCCceeEEE-EEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCC------CeEEEEEe
Confidence            68999999995 456778999999998653222 12234567899999999999999999887653      45788998


Q ss_pred             cC-CCCHHHHHh-----hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCccc
Q psy8260         151 LM-GADLNNILR-----TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTG  224 (427)
Q Consensus       151 ~~-g~~L~~~l~-----~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~  224 (427)
                      ++ +++|...+.     ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++....... 
T Consensus        74 ~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-  152 (280)
T cd05608          74 IMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-  152 (280)
T ss_pred             CCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-
Confidence            87 788987663     24589999999999999999999999999999999999999999999999998864321100 


Q ss_pred             ccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCC
Q psy8260         225 YVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHY  304 (427)
Q Consensus       225 ~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~  304 (427)
                                                                               ...+..||+.|+|||++.+..+.
T Consensus       153 ---------------------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~  175 (280)
T cd05608         153 ---------------------------------------------------------KTKGYAGTPGFMAPELLQGEEYD  175 (280)
T ss_pred             ---------------------------------------------------------cccccCCCcCccCHHHhcCCCCC
Confidence                                                                     01123477788888888777777


Q ss_pred             CCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC-----CH
Q psy8260         305 NQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI-----TA  379 (427)
Q Consensus       305 ~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~-----ta  379 (427)
                      .++|+||+|++++.+.++..+|................... .   .......++++.+|+.+||+.||++|+     |+
T Consensus       176 ~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~  251 (280)
T cd05608         176 FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND-S---VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNC  251 (280)
T ss_pred             ccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc-C---CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCH
Confidence            78899999999988866655554321111111111111000 0   012234788999999999999999999     89


Q ss_pred             HHHhcCCCCCCCC
Q psy8260         380 EQALAHPYLSQYS  392 (427)
Q Consensus       380 ~e~L~Hp~f~~~~  392 (427)
                      +|+++||||++..
T Consensus       252 ~~~l~h~~~~~~~  264 (280)
T cd05608         252 DGLRTHPLFRDLN  264 (280)
T ss_pred             HHHhcChhhhcCC
Confidence            9999999998753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0201|consensus

Probab=100.00  E-value=3.4e-42  Score=327.45  Aligned_cols=253  Identities=20%  Similarity=0.350  Sum_probs=201.4

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCce
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      .|...+.||+|+||.||+ +.+..+++.||+|++..... ....+.+.+|+.+|.+++++||.++|+.|-.+      ..
T Consensus        14 ~~~~~~~IgrGsfG~Vyk-~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g------~~   85 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYK-AIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKG------TK   85 (467)
T ss_pred             ccccchhccccccceeee-eeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeec------cc
Confidence            344458899999999996 56788999999999975432 33346678999999999999999999887644      34


Q ss_pred             EEEEeccC-CCCHHHHHhhCCC-CHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCc
Q psy8260         145 VYMVTHLM-GADLNNILRTQKL-SDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM  222 (427)
Q Consensus       145 ~~lv~e~~-g~~L~~~l~~~~l-~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~  222 (427)
                      +.++||++ ||++.++++.+.+ .+..+..++++++.||.|||.++.||||||+.|||+..+|.+|++|||++....+..
T Consensus        86 LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~  165 (467)
T KOG0201|consen   86 LWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV  165 (467)
T ss_pred             HHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechh
Confidence            67889888 7899999987765 899999999999999999999999999999999999999999999999986543221


Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhcc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM  302 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~  302 (427)
                                                                                ....+++|||+||||||+....
T Consensus       166 ----------------------------------------------------------~rr~tfvGTPfwMAPEVI~~~~  187 (467)
T KOG0201|consen  166 ----------------------------------------------------------KRRKTFVGTPFWMAPEVIKQSG  187 (467)
T ss_pred             ----------------------------------------------------------hccccccccccccchhhhcccc
Confidence                                                                      0224678888888888888878


Q ss_pred             CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q psy8260         303 HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQA  382 (427)
Q Consensus       303 ~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~  382 (427)
                      |..+.||||||+..++|.++.+|+.+-..    ..++...|.-.+   ...-...|+.+++|+..||.+||+.||||.++
T Consensus       188 Y~~KADIWSLGITaiEla~GePP~s~~hP----mrvlflIpk~~P---P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~L  260 (467)
T KOG0201|consen  188 YDTKADIWSLGITAIELAKGEPPHSKLHP----MRVLFLIPKSAP---PRLDGDFSPPFKEFVEACLDKNPEFRPSAKEL  260 (467)
T ss_pred             ccchhhhhhhhHHHHHHhcCCCCCcccCc----ceEEEeccCCCC---CccccccCHHHHHHHHHHhhcCcccCcCHHHH
Confidence            99999999999999999666665543211    112222222222   22223568899999999999999999999999


Q ss_pred             hcCCCCCC
Q psy8260         383 LAHPYLSQ  390 (427)
Q Consensus       383 L~Hp~f~~  390 (427)
                      |+|+|++.
T Consensus       261 LKh~FIk~  268 (467)
T KOG0201|consen  261 LKHKFIKR  268 (467)
T ss_pred             hhhHHHHh
Confidence            99999986

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.2e-40  Score=323.03  Aligned_cols=255  Identities=23%  Similarity=0.352  Sum_probs=190.7

Q ss_pred             eeeccccCcccccEEEEeEE--eCcCCcEEEEEEccCcCC--CHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCcccc
Q psy8260          66 IDIGPTLSKESFDLIFSSAL--DSVSGVKVAIKKIARPFQ--SAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~--~~~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~  140 (427)
                      |.+.+.||+|+||.||.+..  +..+|+.||+|++.+...  .....+...+|+.+++.+ +||||++++++|...    
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~----   77 (332)
T cd05614           2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE----   77 (332)
T ss_pred             ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC----
Confidence            67889999999999996543  345789999999864321  122344567899999999 589999999888654    


Q ss_pred             CCceEEEEeccC-CCCHHHHHh-hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCC
Q psy8260         141 DFKNVYMVTHLM-GADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT  218 (427)
Q Consensus       141 ~~~~~~lv~e~~-g~~L~~~l~-~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~  218 (427)
                        ..++++++++ +++|.+.+. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        78 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~  155 (332)
T cd05614          78 --AKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (332)
T ss_pred             --CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence              4578899988 678988775 456999999999999999999999999999999999999999999999999998643


Q ss_pred             CCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         219 ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       219 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                      ......                                                         .....+||+.|+|||++
T Consensus       156 ~~~~~~---------------------------------------------------------~~~~~~gt~~y~aPE~~  178 (332)
T cd05614         156 LSEEKE---------------------------------------------------------RTYSFCGTIEYMAPEII  178 (332)
T ss_pred             cccCCC---------------------------------------------------------ccccccCCccccCHHHh
Confidence            211000                                                         01123467777777777


Q ss_pred             hhcc-CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcH---HH-HHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCC
Q psy8260         299 LNWM-HYNQTDIHQLNLIMEMLGTPPAEFMAKISSD---SA-RKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDS  373 (427)
Q Consensus       299 ~~~~-~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~---~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP  373 (427)
                      .+.. +...+|+||+|++++.|.++..+|.......   .. .......+        .....+++.+.+||.+||+.||
T Consensus       179 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~dp  250 (332)
T cd05614         179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDP--------PFPSFIGPEAQDLLHKLLRKDP  250 (332)
T ss_pred             cCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCC--------CCCCCCCHHHHHHHHHHcCCCH
Confidence            6543 5567899999999998877666653211111   11 11111111        1123468899999999999999


Q ss_pred             CCCC-----CHHHHhcCCCCCCC
Q psy8260         374 EKRI-----TAEQALAHPYLSQY  391 (427)
Q Consensus       374 ~~R~-----ta~e~L~Hp~f~~~  391 (427)
                      ++|+     +++|+++||||...
T Consensus       251 ~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         251 KKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             HHcCCCCCCCHHHHHcCCCcCCC
Confidence            9999     88999999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=5.9e-40  Score=321.16  Aligned_cols=262  Identities=21%  Similarity=0.324  Sum_probs=194.6

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcccc
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  140 (427)
                      +..+.|++.+.||+|+||.||. +.+..+|..||+|.+.... ......++.+|+++|++++||||+++++++...    
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----   75 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTK-VQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD----   75 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEE-EEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC----
Confidence            4456788999999999999996 4567789999999886532 334456688999999999999999999988653    


Q ss_pred             CCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCCeEEcCCCCEEEeeCCCCCC
Q psy8260         141 DFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDCELKILDFGLARP  217 (427)
Q Consensus       141 ~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~-~iiHrDLKp~NILl~~~~~~kl~DFGla~~  217 (427)
                        ..++++++++ +++|.+++.. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus        76 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  153 (331)
T cd06649          76 --GEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  153 (331)
T ss_pred             --CEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccc
Confidence              4578999888 6799998865 5689999999999999999999986 699999999999999999999999999864


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      .....                                                            .....||+.|+|||+
T Consensus       154 ~~~~~------------------------------------------------------------~~~~~g~~~y~aPE~  173 (331)
T cd06649         154 LIDSM------------------------------------------------------------ANSFVGTRSYMSPER  173 (331)
T ss_pred             ccccc------------------------------------------------------------cccCCCCcCcCCHhH
Confidence            32110                                                            012246667777777


Q ss_pred             hhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcC---------------CC-------------CCcc-
Q psy8260         298 MLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSL---------------PL-------------LTKK-  348 (427)
Q Consensus       298 l~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~---------------~~-------------~~~~-  348 (427)
                      +.+..+..++|+||+|++++.+.++..||...... .........               +.             .... 
T Consensus       174 ~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (331)
T cd06649         174 LQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK-ELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMA  252 (331)
T ss_pred             hcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHhcccccccccCCccccCcccccccccccccccccccchh
Confidence            76666777789999999998886555544221110 000000000               00             0000 


Q ss_pred             --cHH---------h-hcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q psy8260         349 --DFR---------Q-VFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       349 --~~~---------~-~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~  391 (427)
                        ...         . .....++++++||.+||++||++|||++|+|+||||...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  307 (331)
T cd06649         253 IFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS  307 (331)
T ss_pred             HHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence              000         0 011357899999999999999999999999999999764

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4e-40  Score=321.30  Aligned_cols=250  Identities=25%  Similarity=0.381  Sum_probs=189.9

Q ss_pred             cccCcccccEEEEeEE--eCcCCcEEEEEEccCcCC--CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceE
Q psy8260          70 PTLSKESFDLIFSSAL--DSVSGVKVAIKKIARPFQ--SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV  145 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~--~~~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~  145 (427)
                      +.||+|+||.||.+..  +..+++.||||.+.+...  .......+.+|+.+|+.++||||++++++|..+      ..+
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~------~~~   75 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG------GKL   75 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC------CeE
Confidence            5789999999997543  235789999999865321  122334567899999999999999999988654      457


Q ss_pred             EEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcc
Q psy8260         146 YMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT  223 (427)
Q Consensus       146 ~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~  223 (427)
                      |++|+++ +++|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          76 YLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             EEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence            8999987 6789888754 5588999999999999999999999999999999999999999999999999863211100


Q ss_pred             cccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccC
Q psy8260         224 GYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH  303 (427)
Q Consensus       224 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~  303 (427)
                                                                                ......||+.|+|||++.+..+
T Consensus       156 ----------------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~  177 (323)
T cd05584         156 ----------------------------------------------------------VTHTFCGTIEYMAPEILMRSGH  177 (323)
T ss_pred             ----------------------------------------------------------cccccCCCccccChhhccCCCC
Confidence                                                                      0112346777777777776667


Q ss_pred             CCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC-----C
Q psy8260         304 YNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI-----T  378 (427)
Q Consensus       304 ~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~-----t  378 (427)
                      ..++|+||+|++++.|.++..+|.................        ......++++.|||.+||+.||++|+     +
T Consensus       178 ~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  249 (323)
T cd05584         178 GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL--------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGD  249 (323)
T ss_pred             CCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCC
Confidence            7788999999999988777666643322222222221111        12234688999999999999999999     8


Q ss_pred             HHHHhcCCCCCCC
Q psy8260         379 AEQALAHPYLSQY  391 (427)
Q Consensus       379 a~e~L~Hp~f~~~  391 (427)
                      ++++++||||...
T Consensus       250 ~~~l~~h~~~~~~  262 (323)
T cd05584         250 AAEVQSHPFFRHV  262 (323)
T ss_pred             HHHHhcCCCcCCC
Confidence            9999999999754

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.9e-40  Score=320.32  Aligned_cols=249  Identities=22%  Similarity=0.302  Sum_probs=190.4

Q ss_pred             cccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCccccCCceEEE
Q psy8260          70 PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLADFKNVYM  147 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~~~~~~~l  147 (427)
                      +.||+|+||.||.+ .+..+++.||||++.+... ..........|.+++..+ +||||++++++|...      ..+|+
T Consensus         1 ~~lG~G~~g~Vy~~-~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~------~~~~l   73 (321)
T cd05591           1 KVLGKGSFGKVMLA-ELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK------DRLFF   73 (321)
T ss_pred             CccccCCCeEEEEE-EECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC------CeEEE
Confidence            36899999999965 4667899999999865322 222344566888888865 899999999998754      45789


Q ss_pred             EeccC-CCCHHHHHh-hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccc
Q psy8260         148 VTHLM-GADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGY  225 (427)
Q Consensus       148 v~e~~-g~~L~~~l~-~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  225 (427)
                      +||++ +++|...+. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......   
T Consensus        74 v~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~---  150 (321)
T cd05591          74 VMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG---  150 (321)
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC---
Confidence            99988 678887764 4578999999999999999999999999999999999999999999999999886321100   


Q ss_pred             cccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCC
Q psy8260         226 VATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYN  305 (427)
Q Consensus       226 ~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~  305 (427)
                                                                             .......||+.|+|||++.+..+..
T Consensus       151 -------------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~  175 (321)
T cd05591         151 -------------------------------------------------------VTTTTFCGTPDYIAPEILQELEYGP  175 (321)
T ss_pred             -------------------------------------------------------ccccccccCccccCHHHHcCCCCCC
Confidence                                                                   0111235778888888887777788


Q ss_pred             CCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC-------C
Q psy8260         306 QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI-------T  378 (427)
Q Consensus       306 ~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~-------t  378 (427)
                      ++|+||+|++++.|.++..||..................        .....++++.+||.+||+.||++|+       +
T Consensus       176 ~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~--------~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~  247 (321)
T cd05591         176 SVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVL--------YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGG  247 (321)
T ss_pred             ccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCC
Confidence            899999999999887666666433222222222211111        1123678999999999999999999       9


Q ss_pred             HHHHhcCCCCCCC
Q psy8260         379 AEQALAHPYLSQY  391 (427)
Q Consensus       379 a~e~L~Hp~f~~~  391 (427)
                      ++++++||||...
T Consensus       248 ~~~~~~hp~~~~~  260 (321)
T cd05591         248 EDAIKQHPFFKEI  260 (321)
T ss_pred             HHHHhcCCccCCC
Confidence            9999999999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.8e-40  Score=330.44  Aligned_cols=299  Identities=22%  Similarity=0.275  Sum_probs=201.9

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      .|.+.+.||+|+||.||. +.+..+++.||||++.+... .......+.+|+.+|+.++||||+++++.|...      .
T Consensus         2 ~y~~~~~lG~G~~g~V~~-a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~------~   74 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCL-VRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDK------D   74 (376)
T ss_pred             CceEEEEEEeCCCeEEEE-EEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC------C
Confidence            578889999999999996 55677899999999864321 112234567899999999999999999998754      4


Q ss_pred             eEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      .+|++||++ +++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|......
T Consensus        75 ~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~  154 (376)
T cd05598          75 NLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (376)
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence            688999988 7899998865 45899999999999999999999999999999999999999999999999998643211


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCC-CCCccccccccccccccchHHhhh
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLA-RPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~-~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      ...     .|..+.....     ...  ......+....    .+..+....... ........+.+||+.|||||++.+
T Consensus       155 ~~~-----~~~~~~~~~~-----~~~--~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  218 (376)
T cd05598         155 HDS-----KYYQKGDHHR-----QDS--MEPSEEWSEID----RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR  218 (376)
T ss_pred             ccc-----cccccccccc-----ccc--ccccccccccc----cccccchhhhhhhhcccccccccCCCccccCHHHHcC
Confidence            000     0000000000     000  00000000000    000000000000 000011235689999999999998


Q ss_pred             ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC---
Q psy8260         301 WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI---  377 (427)
Q Consensus       301 ~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~---  377 (427)
                      ..+..++|+||+|++++.|.++..||......+..............    .....+++++.+||.+|+ .||.+|+   
T Consensus       219 ~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~s~~~~~li~~l~-~~p~~R~~~~  293 (376)
T cd05598         219 TGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHI----PSQAKLSREASDLILRLC-CGAEDRLGKN  293 (376)
T ss_pred             CCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccC----CCCCCCCHHHHHHHHHHh-cCHhhcCCCC
Confidence            88888899999999998887766666443222222222111111100    112346899999999987 5999999   


Q ss_pred             CHHHHhcCCCCCCC
Q psy8260         378 TAEQALAHPYLSQY  391 (427)
Q Consensus       378 ta~e~L~Hp~f~~~  391 (427)
                      |++|+++||||...
T Consensus       294 t~~ell~h~~~~~~  307 (376)
T cd05598         294 GADEIKAHPFFKGI  307 (376)
T ss_pred             CHHHHhCCCCcCCC
Confidence            99999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=5.3e-40  Score=319.48  Aligned_cols=249  Identities=22%  Similarity=0.317  Sum_probs=188.7

Q ss_pred             cccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC-HHHHHHHHHHHHHHhc-CCCCCceeeeeeeecCccccCCceEEE
Q psy8260          70 PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS-AVHAKRTYRELRMLKH-MNHENVIGLLDVFHSNTCLADFKNVYM  147 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~-l~HpnIv~l~~~~~~~~~~~~~~~~~l  147 (427)
                      +.||+|+||.||.+ .+..+|+.||+|++.+.... .........|..++.. .+||||++++++|...      ..+|+
T Consensus         1 ~~lg~G~~g~V~~~-~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~------~~~~l   73 (316)
T cd05620           1 KVLGKGSFGKVLLA-ELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK------EHLFF   73 (316)
T ss_pred             CeeeeCCCeEEEEE-EECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC------CEEEE
Confidence            36899999999964 56678999999998653211 1223445678888775 4899999999998654      46899


Q ss_pred             EeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccc
Q psy8260         148 VTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGY  225 (427)
Q Consensus       148 v~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  225 (427)
                      +||++ +++|...+.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......   
T Consensus        74 v~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---  150 (316)
T cd05620          74 VMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD---  150 (316)
T ss_pred             EECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC---
Confidence            99988 6789877754 578999999999999999999999999999999999999999999999999876311000   


Q ss_pred             cccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCC
Q psy8260         226 VATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYN  305 (427)
Q Consensus       226 ~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~  305 (427)
                                                                             ......+||+.|+|||++.+..+..
T Consensus       151 -------------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~  175 (316)
T cd05620         151 -------------------------------------------------------NRASTFCGTPDYIAPEILQGLKYTF  175 (316)
T ss_pred             -------------------------------------------------------CceeccCCCcCccCHHHHcCCCCCc
Confidence                                                                   0112335778888888887777778


Q ss_pred             CCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH-HHHhc
Q psy8260         306 QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA-EQALA  384 (427)
Q Consensus       306 ~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta-~e~L~  384 (427)
                      .+|+||+|++++.|.++..||................+.        .....++++++||.+||+.||.+|+|+ +++++
T Consensus       176 ~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~  247 (316)
T cd05620         176 SVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPH--------YPRWITKESKDILEKLFERDPTRRLGVVGNIRG  247 (316)
T ss_pred             ccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            899999999998887666666433222222221111111        122468899999999999999999997 58999


Q ss_pred             CCCCCCC
Q psy8260         385 HPYLSQY  391 (427)
Q Consensus       385 Hp~f~~~  391 (427)
                      ||||...
T Consensus       248 h~~f~~~  254 (316)
T cd05620         248 HPFFKTI  254 (316)
T ss_pred             CCCcCCC
Confidence            9999865

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.4e-40  Score=326.60  Aligned_cols=291  Identities=22%  Similarity=0.311  Sum_probs=203.3

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      .|++.+.||+|+||.||. +.+..+++.||||++..... .......+.+|+.++..++||||+++++.|...      .
T Consensus         2 ~f~~~~~lG~G~~g~V~~-~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~------~   74 (360)
T cd05627           2 DFESLKVIGRGAFGEVRL-VQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDK------R   74 (360)
T ss_pred             CceEEEEEeeCCCEEEEE-EEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC------C
Confidence            467788999999999996 45667899999999864321 122345567899999999999999999988654      4


Q ss_pred             eEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      .+|++||++ |++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          75 NLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            679999988 7899988754 56999999999999999999999999999999999999999999999999998754322


Q ss_pred             ccc-ccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         222 MTG-YVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       222 ~~~-~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      ... .........|...             ....+-..         .+...  ..........+.+||+.|+|||++.+
T Consensus       155 ~~~~~~~~~~~~~~~~~-------------~~~~~~~~---------~~~~~--~~~~~~~~~~~~~gt~~Y~APE~~~~  210 (360)
T cd05627         155 HRTEFYRNLTHNPPSDF-------------SFQNMNSK---------RKAET--WKKNRRQLAYSTVGTPDYIAPEVFMQ  210 (360)
T ss_pred             cccccccccccCCcccc-------------cccccccc---------ccccc--ccccccccccccCCCccccCHHHHcC
Confidence            111 0000000011000             00000000         00000  00000112235689999999999998


Q ss_pred             ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC---
Q psy8260         301 WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI---  377 (427)
Q Consensus       301 ~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~---  377 (427)
                      ..+...+|+||+|++++.|.++..||..........+........   .+.. ....+++++|||.+|+. ||.+|+   
T Consensus       211 ~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~---~~p~-~~~~s~~~~~li~~l~~-~p~~R~~~~  285 (360)
T cd05627         211 TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETL---VFPP-EVPISEKAKDLILRFCT-DSENRIGSN  285 (360)
T ss_pred             CCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCce---ecCC-CCCCCHHHHHHHHHhcc-ChhhcCCCC
Confidence            888889999999999998877766665433222222222111111   0110 12368899999999885 999999   


Q ss_pred             CHHHHhcCCCCCCC
Q psy8260         378 TAEQALAHPYLSQY  391 (427)
Q Consensus       378 ta~e~L~Hp~f~~~  391 (427)
                      +++|+++||||...
T Consensus       286 ~~~ei~~hp~f~~~  299 (360)
T cd05627         286 GVEEIKSHPFFEGV  299 (360)
T ss_pred             CHHHHhcCCCCCCC
Confidence            48999999999875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=7.1e-40  Score=319.63  Aligned_cols=253  Identities=21%  Similarity=0.276  Sum_probs=193.3

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCC-CceeeeeeeecCccccCCc
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHE-NVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~Hp-nIv~l~~~~~~~~~~~~~~  143 (427)
                      |.+.+.||+|+||.||.+ .+..+++.||||++.+... .....+.+.+|++++..++|+ +|+.++++|...      .
T Consensus         2 y~~~~~lg~G~~g~Vy~~-~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~------~   74 (324)
T cd05587           2 FNFLMVLGKGSFGKVMLA-ERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM------D   74 (324)
T ss_pred             ceEEEEEeeccCeEEEEE-EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC------C
Confidence            677889999999999965 4667889999999865322 223345577899999999775 578888887643      4


Q ss_pred             eEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      .+|++||++ +++|...+.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        75 ~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          75 RLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             EEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            689999988 7899887754 56899999999999999999999999999999999999999999999999987532110


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      ..                                                          .....+||+.|+|||++.+.
T Consensus       155 ~~----------------------------------------------------------~~~~~~gt~~y~aPE~~~~~  176 (324)
T cd05587         155 GK----------------------------------------------------------TTRTFCGTPDYIAPEIIAYQ  176 (324)
T ss_pred             CC----------------------------------------------------------ceeeecCCccccChhhhcCC
Confidence            00                                                          01123577888888888777


Q ss_pred             cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH--
Q psy8260         302 MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA--  379 (427)
Q Consensus       302 ~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta--  379 (427)
                      .+...+|+||+|++++.|.++..+|.................        ......++++++||.+||+.||.+|+++  
T Consensus       177 ~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~--------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~  248 (324)
T cd05587         177 PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV--------SYPKSLSKEAVSICKGLLTKHPAKRLGCGP  248 (324)
T ss_pred             CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCC
Confidence            777788999999999888776666643322222222211111        1123578899999999999999999986  


Q ss_pred             ---HHHhcCCCCCCC
Q psy8260         380 ---EQALAHPYLSQY  391 (427)
Q Consensus       380 ---~e~L~Hp~f~~~  391 (427)
                         +++++||||...
T Consensus       249 ~~~~~~~~hp~~~~~  263 (324)
T cd05587         249 TGERDIREHAFFRRI  263 (324)
T ss_pred             CCHHHHhcCCCcCCC
Confidence               899999999864

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=5.7e-40  Score=326.21  Aligned_cols=264  Identities=20%  Similarity=0.276  Sum_probs=196.0

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      .+....|.+.+.||+|+||.||. +.+..+++.||+|++.+... .......+.+|+.+++.++||||+++++++...  
T Consensus        39 ~~~~~~y~i~~~lG~G~fg~Vy~-~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~--  115 (371)
T cd05622          39 RMKAEDYEVVKVIGRGAFGEVQL-VRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD--  115 (371)
T ss_pred             CcchhhcEEEEEEeecCCeEEEE-EEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC--
Confidence            44457899999999999999996 56777899999999864321 222334466899999999999999999988653  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP  217 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~  217 (427)
                          ..+|++||++ +++|.++++...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       116 ----~~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~  191 (371)
T cd05622         116 ----RYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (371)
T ss_pred             ----CEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence                4689999988 78999999888899999999999999999999999999999999999999999999999999875


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      .......                                                         .....+||+.|+|||+
T Consensus       192 ~~~~~~~---------------------------------------------------------~~~~~~gt~~y~aPE~  214 (371)
T cd05622         192 MNKEGMV---------------------------------------------------------RCDTAVGTPDYISPEV  214 (371)
T ss_pred             cCcCCcc---------------------------------------------------------cccCcccCccccCHHH
Confidence            3221000                                                         0012245666666666


Q ss_pred             hhhcc----CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCC
Q psy8260         298 MLNWM----HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDS  373 (427)
Q Consensus       298 l~~~~----~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP  373 (427)
                      +.+..    +...+|+||+|++++.|.++..||..........+.........   +. ....+++++++||.+||+.++
T Consensus       215 l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~---~~-~~~~~s~~~~~li~~~L~~~~  290 (371)
T cd05622         215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT---FP-DDNDISKEAKNLICAFLTDRE  290 (371)
T ss_pred             HhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc---CC-CcCCCCHHHHHHHHHHcCChh
Confidence            54432    45678999999999988776666654322222222222111111   11 123578999999999998444


Q ss_pred             CC--CCCHHHHhcCCCCCCC
Q psy8260         374 EK--RITAEQALAHPYLSQY  391 (427)
Q Consensus       374 ~~--R~ta~e~L~Hp~f~~~  391 (427)
                      .+  |++++|+++||||.+.
T Consensus       291 ~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         291 VRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             hhcCCCCHHHHhcCcccCCC
Confidence            33  7899999999999763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.3e-39  Score=315.31  Aligned_cols=277  Identities=29%  Similarity=0.450  Sum_probs=198.3

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      ..|++.+.||.|+||.||++ .+..+|+.||+|++..............+|+.++++++|+||+++++++....    ..
T Consensus         7 ~~y~~~~~ig~g~~~~v~~~-~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~   81 (309)
T cd07845           7 TEFEKLNRIGEGTYGIVYRA-RDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH----LD   81 (309)
T ss_pred             cceeEeeeeeecCCEEEEEE-EECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC----CC
Confidence            46888899999999999965 56678999999988643322222234568999999999999999999986432    24


Q ss_pred             eEEEEeccCCCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         144 NVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       144 ~~~lv~e~~g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      .+++++++++++|.+++..  ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus        82 ~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          82 SIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             eEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            5799999998888888764  46899999999999999999999999999999999999999999999999998754321


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh-
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN-  300 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~-  300 (427)
                      ...                                                          .....+++.|+|||++.+ 
T Consensus       162 ~~~----------------------------------------------------------~~~~~~~~~y~aPE~~~~~  183 (309)
T cd07845         162 AKP----------------------------------------------------------MTPKVVTLWYRAPELLLGC  183 (309)
T ss_pred             cCC----------------------------------------------------------CCcccccccccChhhhcCC
Confidence            100                                                          001123455666666543 


Q ss_pred             ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcC----------------------CCCCcccHHhhcCCCC
Q psy8260         301 WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSL----------------------PLLTKKDFRQVFKGAN  358 (427)
Q Consensus       301 ~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~s  358 (427)
                      ..+..++|+|++|++++.+.++..+|................                      +......+...+...+
T Consensus       184 ~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (309)
T cd07845         184 TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLS  263 (309)
T ss_pred             CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccC
Confidence            234556789999988877755444432211111111111100                      0011112223344568


Q ss_pred             hhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCC
Q psy8260         359 PQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPPY  403 (427)
Q Consensus       359 ~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~~~~  403 (427)
                      +++.|||.+||++||++|||++|+++||||.+..-|..+...|.|
T Consensus       264 ~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~~~~~~~~  308 (309)
T cd07845         264 EAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEPEMMPTF  308 (309)
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCCCCcCCCC
Confidence            999999999999999999999999999999987766555444444

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0589|consensus

Probab=100.00  E-value=6.5e-41  Score=326.04  Aligned_cols=257  Identities=23%  Similarity=0.331  Sum_probs=214.2

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      +.|...+.+|+|+||.++. +.++..+..+++|++..........+....|+.++++++|||||.+++.|..+++     
T Consensus         4 ~~Ye~~~~iG~GafG~a~l-vrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~-----   77 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALL-VRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQ-----   77 (426)
T ss_pred             chhhhhhhcCccccchhhh-hhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCc-----
Confidence            4577889999999999995 5667788899999998777666666778899999999999999999999886643     


Q ss_pred             eEEEEeccC-CCCHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~~---~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                      .++|+|+|+ ||++.+.+..+   .|+++.+..|+.|++.|+.|||+++|+|||||+.||+++.++.|||.|||+|+...
T Consensus        78 ~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~  157 (426)
T KOG0589|consen   78 LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN  157 (426)
T ss_pred             eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence            479999999 88999988653   49999999999999999999999999999999999999999999999999998765


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      +...                                                          ...+.+|||.||.||++.
T Consensus       158 ~~~~----------------------------------------------------------~a~tvvGTp~YmcPEil~  179 (426)
T KOG0589|consen  158 PEDS----------------------------------------------------------LASTVVGTPYYMCPEILS  179 (426)
T ss_pred             Cchh----------------------------------------------------------hhheecCCCcccCHHHhC
Confidence            4310                                                          223457888888888888


Q ss_pred             hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH
Q psy8260         300 NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA  379 (427)
Q Consensus       300 ~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta  379 (427)
                      +.+|..++|+|+|||++|.+.+-...|..........+..+..       .......++.+.+.||..||..+|..||+|
T Consensus       180 d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-------~~Plp~~ys~el~~lv~~~l~~~P~~RPsa  252 (426)
T KOG0589|consen  180 DIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-------YSPLPSMYSSELRSLVKSMLRKNPEHRPSA  252 (426)
T ss_pred             CCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-------CCCCCccccHHHHHHHHHHhhcCCccCCCH
Confidence            8899999999999999999987777676655555544443332       112234578899999999999999999999


Q ss_pred             HHHhcCCCCCCC
Q psy8260         380 EQALAHPYLSQY  391 (427)
Q Consensus       380 ~e~L~Hp~f~~~  391 (427)
                      .++|.+|....+
T Consensus       253 ~~LL~~P~l~~~  264 (426)
T KOG0589|consen  253 LELLRRPHLLRY  264 (426)
T ss_pred             HHHhhChhhhhH
Confidence            999999998744

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.1e-39  Score=319.16  Aligned_cols=250  Identities=20%  Similarity=0.310  Sum_probs=188.4

Q ss_pred             cccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC-HHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCccccCCceEEE
Q psy8260          70 PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS-AVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLADFKNVYM  147 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~~~~~~~l  147 (427)
                      +.||+|+||.||. +.+..+++.||||++.+.... ......+.+|+.++..+ +||||++++++|...      ..+|+
T Consensus         1 ~~lG~G~~g~V~~-~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~------~~~~l   73 (329)
T cd05588           1 RVIGRGSYAKVLL-VELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE------SRLFF   73 (329)
T ss_pred             CeEeeCCCeEEEE-EEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC------CEEEE
Confidence            3689999999995 456678999999998754322 22344567899999888 799999999998654      46789


Q ss_pred             EeccC-CCCHHHHHh-hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccc
Q psy8260         148 VTHLM-GADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGY  225 (427)
Q Consensus       148 v~e~~-g~~L~~~l~-~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  225 (427)
                      +||++ +++|...+. .+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......  
T Consensus        74 v~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--  151 (329)
T cd05588          74 VIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--  151 (329)
T ss_pred             EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC--
Confidence            99988 778987764 45799999999999999999999999999999999999999999999999999863211000  


Q ss_pred             cccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCC
Q psy8260         226 VATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYN  305 (427)
Q Consensus       226 ~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~  305 (427)
                                                                              .....+||+.|+|||++.+..+..
T Consensus       152 --------------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~  175 (329)
T cd05588         152 --------------------------------------------------------TTSTFCGTPNYIAPEILRGEDYGF  175 (329)
T ss_pred             --------------------------------------------------------ccccccCCccccCHHHHcCCCCCC
Confidence                                                                    111235777888888887777777


Q ss_pred             CCCHHHHHHHHHHhCCCCHHHHhhc--C--c----HHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC
Q psy8260         306 QTDIHQLNLIMEMLGTPPAEFMAKI--S--S----DSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI  377 (427)
Q Consensus       306 ~~d~~slg~i~~~lg~~~~~~~~~~--~--~----~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~  377 (427)
                      ++|+||+|++++.|.++..||....  .  .    ....+......       .......++++.+||.+||+.||.+|+
T Consensus       176 ~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~p~~~~~~~~~li~~~L~~dP~~R~  248 (329)
T cd05588         176 SVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ-------IRIPRSLSVKASSVLKGFLNKDPKERL  248 (329)
T ss_pred             ccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC-------CCCCCCCCHHHHHHHHHHhccCHHHcC
Confidence            8899999999988865555553110  0  0    01111111110       012235688999999999999999999


Q ss_pred             C------HHHHhcCCCCCCC
Q psy8260         378 T------AEQALAHPYLSQY  391 (427)
Q Consensus       378 t------a~e~L~Hp~f~~~  391 (427)
                      |      ++|+++||||...
T Consensus       249 ~~~~~~~~~~i~~hp~~~~~  268 (329)
T cd05588         249 GCHPQTGFRDIKSHPFFRNI  268 (329)
T ss_pred             CCCCCCCHHHHhcCCCCCCC
Confidence            7      7899999999754

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1e-39  Score=322.86  Aligned_cols=255  Identities=25%  Similarity=0.287  Sum_probs=182.5

Q ss_pred             cCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccC
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      ....|.+.+.||+|+||.||.+ .+..+++.||+|.....        ....|+.++++++||||+++++++...     
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~-----  129 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVA-TKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSG-----  129 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEE-EECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeC-----
Confidence            3456899999999999999964 56667889999975432        134699999999999999999988653     


Q ss_pred             CceEEEEeccCCCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         142 FKNVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       142 ~~~~~lv~e~~g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                       ...+++++++.++|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       130 -~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  208 (357)
T PHA03209        130 -AITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV  208 (357)
T ss_pred             -CeeEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence             45788899888888887753  468999999999999999999999999999999999999999999999999986422


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      ...                                                           ...+..||+.|+|||++.
T Consensus       209 ~~~-----------------------------------------------------------~~~~~~gt~~y~aPE~~~  229 (357)
T PHA03209        209 VAP-----------------------------------------------------------AFLGLAGTVETNAPEVLA  229 (357)
T ss_pred             cCc-----------------------------------------------------------ccccccccccccCCeecC
Confidence            110                                                           011234566666777666


Q ss_pred             hccCCCCCCHHHHHHHHHHhCCCCHHHHhhc-Cc---------HHHHHHHhcC---C-CCC------------------c
Q psy8260         300 NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKI-SS---------DSARKYINSL---P-LLT------------------K  347 (427)
Q Consensus       300 ~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~-~~---------~~~~~~~~~~---~-~~~------------------~  347 (427)
                      +..+..++|+||+|++++.+.+.+.++.... ..         ....+.....   + .+.                  .
T Consensus       230 ~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (357)
T PHA03209        230 RDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLER  309 (357)
T ss_pred             CCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCC
Confidence            6666677788888888876533211111000 00         0000000000   0 000                  0


Q ss_pred             c---cHHh-hcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q psy8260         348 K---DFRQ-VFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQ  390 (427)
Q Consensus       348 ~---~~~~-~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~  390 (427)
                      .   .+.. .....+.++.+||.+||++||.+||||+|+|+||||++
T Consensus       310 ~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        310 QPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             CcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence            0   0000 01245778899999999999999999999999999986

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-39  Score=329.86  Aligned_cols=256  Identities=23%  Similarity=0.269  Sum_probs=188.1

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      ...|.+.+.||+|+||.||. +.+..+++.||||....        ....+|+++|++++|+|||++++++...      
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~-a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~------  232 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFE-SSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVG------  232 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEE-EEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEEC------
Confidence            34688899999999999996 45677899999996422        2246899999999999999999987543      


Q ss_pred             ceEEEEeccCCCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         143 KNVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       143 ~~~~lv~e~~g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      ...+++++++.++|..++..  ..+++..+..++.|++.||.|||++|||||||||+|||++.++.+||+|||+++....
T Consensus       233 ~~~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~  312 (461)
T PHA03211        233 GLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARG  312 (461)
T ss_pred             CEEEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence            35678888888888887754  3589999999999999999999999999999999999999999999999999864321


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      ....                                                        ....+..||+.|+|||++.+
T Consensus       313 ~~~~--------------------------------------------------------~~~~~~~GT~~Y~APE~~~~  336 (461)
T PHA03211        313 SWST--------------------------------------------------------PFHYGIAGTVDTNAPEVLAG  336 (461)
T ss_pred             cccc--------------------------------------------------------ccccccCCCcCCcCHHHHcC
Confidence            1000                                                        00113457888888888877


Q ss_pred             ccCCCCCCHHHHHHHHHHhCCCCHHHHhhc-------CcHHHHHHHhc----------------------------CCCC
Q psy8260         301 WMHYNQTDIHQLNLIMEMLGTPPAEFMAKI-------SSDSARKYINS----------------------------LPLL  345 (427)
Q Consensus       301 ~~~~~~~d~~slg~i~~~lg~~~~~~~~~~-------~~~~~~~~~~~----------------------------~~~~  345 (427)
                      ..+..++|+||+|++++++.++..++....       ......+.+..                            .+..
T Consensus       337 ~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  416 (461)
T PHA03211        337 DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAY  416 (461)
T ss_pred             CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCcc
Confidence            777778899999999987643221111000       00000111110                            0111


Q ss_pred             CcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q psy8260         346 TKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQ  390 (427)
Q Consensus       346 ~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~  390 (427)
                      ....|.. +...++++.|||.+||++||.+|||++|+|+||||+.
T Consensus       417 ~~~~~~~-~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        417 TRPAWTR-YYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CCcchhh-hccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence            1111222 2246789999999999999999999999999999964

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.3e-40  Score=320.27  Aligned_cols=250  Identities=24%  Similarity=0.386  Sum_probs=190.9

Q ss_pred             cccCcccccEEEEeEE--eCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEE
Q psy8260          70 PTLSKESFDLIFSSAL--DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYM  147 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~--~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~l  147 (427)
                      +.||+|+||.||.+..  +..+|+.||+|++..............+|++++++++||||+++++++...      ..+|+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~l   75 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTE------GKLYL   75 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC------CEEEE
Confidence            4689999999996432  356889999999875433333345567899999999999999999998654      46789


Q ss_pred             EeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccc
Q psy8260         148 VTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGY  225 (427)
Q Consensus       148 v~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  225 (427)
                      ++|++ +++|.+.+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......  
T Consensus        76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--  153 (318)
T cd05582          76 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--  153 (318)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--
Confidence            99988 6899888754 5689999999999999999999999999999999999999999999999999864321100  


Q ss_pred             cccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCC
Q psy8260         226 VATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYN  305 (427)
Q Consensus       226 ~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~  305 (427)
                                                                              ......||+.|+|||++.+..+..
T Consensus       154 --------------------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~  177 (318)
T cd05582         154 --------------------------------------------------------KAYSFCGTVEYMAPEVVNRRGHTQ  177 (318)
T ss_pred             --------------------------------------------------------ceecccCChhhcCHHHHcCCCCCC
Confidence                                                                    011234677777888777666777


Q ss_pred             CCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC-----HH
Q psy8260         306 QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT-----AE  380 (427)
Q Consensus       306 ~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t-----a~  380 (427)
                      ++|+||+|++++.|.++..+|.................        ......++++.+||.+||+.||.+|+|     ++
T Consensus       178 ~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~--------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~  249 (318)
T cd05582         178 SADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL--------GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVE  249 (318)
T ss_pred             ccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC--------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHH
Confidence            78999999999888776666643221111221111111        122346889999999999999999999     78


Q ss_pred             HHhcCCCCCCC
Q psy8260         381 QALAHPYLSQY  391 (427)
Q Consensus       381 e~L~Hp~f~~~  391 (427)
                      ++++||||...
T Consensus       250 ~~~~~~~~~~~  260 (318)
T cd05582         250 EIKRHPFFSTI  260 (318)
T ss_pred             HHhCCCCcCCC
Confidence            89999999764

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.4e-39  Score=318.24  Aligned_cols=254  Identities=20%  Similarity=0.329  Sum_probs=188.2

Q ss_pred             cccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCccccCCceEEE
Q psy8260          70 PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLADFKNVYM  147 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~~~~~~~l  147 (427)
                      +.||+|+||.||. +.+..+++.||+|++.+... .......+.+|+.++.++ +||||+++++++...      ..+|+
T Consensus         1 ~~lG~G~~g~V~~-~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~------~~~~l   73 (329)
T cd05618           1 RVIGRGSYAKVLL-VRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE------SRLFF   73 (329)
T ss_pred             CeeeeCCCeEEEE-EEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC------CEEEE
Confidence            3689999999996 45677899999999875432 223345567899888776 899999999988654      46788


Q ss_pred             EeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccc
Q psy8260         148 VTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGY  225 (427)
Q Consensus       148 v~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  225 (427)
                      ++|++ +++|...+.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......  
T Consensus        74 v~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--  151 (329)
T cd05618          74 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--  151 (329)
T ss_pred             EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--
Confidence            99887 6788877654 5799999999999999999999999999999999999999999999999999863211000  


Q ss_pred             cccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCC
Q psy8260         226 VATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYN  305 (427)
Q Consensus       226 ~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~  305 (427)
                                                                              ......||+.|+|||++.+..+..
T Consensus       152 --------------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~  175 (329)
T cd05618         152 --------------------------------------------------------TTSTFCGTPNYIAPEILRGEDYGF  175 (329)
T ss_pred             --------------------------------------------------------ccccccCCccccCHHHHcCCCCCC
Confidence                                                                    011235777888888887777777


Q ss_pred             CCCHHHHHHHHHHhCCCCHHHHhh--cC--cHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC---
Q psy8260         306 QTDIHQLNLIMEMLGTPPAEFMAK--IS--SDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT---  378 (427)
Q Consensus       306 ~~d~~slg~i~~~lg~~~~~~~~~--~~--~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t---  378 (427)
                      ++|+||+|++++.|.++..||...  ..  ......+........   ...+....++++.+||.+||+.||++|+|   
T Consensus       176 ~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~---~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~  252 (329)
T cd05618         176 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK---QIRIPRSLSVKAASVLKSFLNKDPKERLGCHP  252 (329)
T ss_pred             ccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC---CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCC
Confidence            899999999998886665555210  00  000000100000000   00123457889999999999999999998   


Q ss_pred             ---HHHHhcCCCCCCC
Q psy8260         379 ---AEQALAHPYLSQY  391 (427)
Q Consensus       379 ---a~e~L~Hp~f~~~  391 (427)
                         ++++++||||.+.
T Consensus       253 ~~~~~~i~~hp~f~~~  268 (329)
T cd05618         253 QTGFADIQGHPFFRNV  268 (329)
T ss_pred             CCCHHHHhcCCCCCCC
Confidence               5899999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-39  Score=318.72  Aligned_cols=260  Identities=20%  Similarity=0.275  Sum_probs=189.8

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      .|++.+.||+|+||.||. +.+..+++.||||++.+... .....+.+.+|+.+++.++|+||++++++|...      .
T Consensus         2 ~y~~~~~lG~G~~g~V~~-~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------~   74 (331)
T cd05597           2 DFEILKVIGRGAFGEVAV-VKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDE------N   74 (331)
T ss_pred             CceEEEEEEecCCeEEEE-EEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC------C
Confidence            577889999999999996 45667899999999864221 122334467899999999999999999988654      4


Q ss_pred             eEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      .+|+++|++ |++|.+++..  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597          75 NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             eEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence            678999887 7899998864  4699999999999999999999999999999999999999999999999999864322


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      ....                                                         ......||+.|+|||++..
T Consensus       155 ~~~~---------------------------------------------------------~~~~~~gt~~y~aPE~~~~  177 (331)
T cd05597         155 DGTV---------------------------------------------------------QSNVAVGTPDYISPEILQA  177 (331)
T ss_pred             CCCc---------------------------------------------------------cccceeccccccCHHHHhh
Confidence            1100                                                         0001134555555555542


Q ss_pred             -----ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCC
Q psy8260         301 -----WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEK  375 (427)
Q Consensus       301 -----~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~  375 (427)
                           ..+..++|+||+|++++.|.++..||......+...+........   .+.......++++++||.+||..++.+
T Consensus       178 ~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~~~~~~~~~~~li~~ll~~~~~r  254 (331)
T cd05597         178 MEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHF---QFPPDVTDVSEEAKDLIRRLICSPETR  254 (331)
T ss_pred             ccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcc---cCCCccCCCCHHHHHHHHHHccCcccc
Confidence                 124556799999999998877766664332222222222111111   111122347889999999999775554


Q ss_pred             --CCCHHHHhcCCCCCCC
Q psy8260         376 --RITAEQALAHPYLSQY  391 (427)
Q Consensus       376 --R~ta~e~L~Hp~f~~~  391 (427)
                        |++++++++||||...
T Consensus       255 ~~r~~~~~~l~hp~~~~~  272 (331)
T cd05597         255 LGRNGLQDFKDHPFFEGI  272 (331)
T ss_pred             cCCCCHHHHhcCCCCCCC
Confidence              7899999999999865

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.3e-39  Score=316.70  Aligned_cols=249  Identities=23%  Similarity=0.354  Sum_probs=187.6

Q ss_pred             cccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhc-CCCCCceeeeeeeecCccccCCceEEE
Q psy8260          70 PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKH-MNHENVIGLLDVFHSNTCLADFKNVYM  147 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~-l~HpnIv~l~~~~~~~~~~~~~~~~~l  147 (427)
                      +.||+|+||.||.+ .+..+++.||||++..... .....+....|..++.. .+||||+++++++...      ..+|+
T Consensus         1 ~~lG~G~~g~Vy~~-~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~------~~~~l   73 (316)
T cd05592           1 KVLGKGSFGKVMLA-ELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK------EHLFF   73 (316)
T ss_pred             CeeeeCCCeEEEEE-EECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC------CEEEE
Confidence            36899999999964 4567899999999865322 12233445667777765 4899999999988654      46889


Q ss_pred             EeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccc
Q psy8260         148 VTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGY  225 (427)
Q Consensus       148 v~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  225 (427)
                      +||++ |++|...+.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......  
T Consensus        74 v~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~--  151 (316)
T cd05592          74 VMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--  151 (316)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC--
Confidence            99988 7899887754 5799999999999999999999999999999999999999999999999999863211100  


Q ss_pred             cccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCC
Q psy8260         226 VATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYN  305 (427)
Q Consensus       226 ~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~  305 (427)
                                                                              .....+||+.|+|||++.+..+..
T Consensus       152 --------------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~  175 (316)
T cd05592         152 --------------------------------------------------------KASTFCGTPDYIAPEILKGQKYNE  175 (316)
T ss_pred             --------------------------------------------------------ccccccCCccccCHHHHcCCCCCC
Confidence                                                                    111235778888888887777778


Q ss_pred             CCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH-HHHhc
Q psy8260         306 QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA-EQALA  384 (427)
Q Consensus       306 ~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta-~e~L~  384 (427)
                      ++|+||+|++++.|.++..+|................+.        .....++++.+||.+||+.||.+|+++ +++++
T Consensus       176 ~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~--------~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         176 SVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPH--------FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             cccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--------CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            889999999998886666666433221222222111111        123467899999999999999999986 58889


Q ss_pred             CCCCCCC
Q psy8260         385 HPYLSQY  391 (427)
Q Consensus       385 Hp~f~~~  391 (427)
                      ||||...
T Consensus       248 h~~~~~~  254 (316)
T cd05592         248 HPFFRGI  254 (316)
T ss_pred             CcccCCC
Confidence            9999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.2e-39  Score=317.18  Aligned_cols=249  Identities=21%  Similarity=0.306  Sum_probs=190.4

Q ss_pred             cccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCccccCCceEEE
Q psy8260          70 PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLADFKNVYM  147 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~~~~~~~l  147 (427)
                      +.||+|+||.||.+ .+..+++.||||++.+... .........+|+++++.+ +||||+++++++...      ..+|+
T Consensus         1 ~~lG~G~~g~V~~~-~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~------~~~~l   73 (318)
T cd05570           1 KVLGKGSFGKVLLA-ELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK------DRLFF   73 (318)
T ss_pred             CeeeeCCCeEEEEE-EECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC------CEEEE
Confidence            36899999999964 5667899999999875321 122344567898998877 799999999988654      46789


Q ss_pred             EeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccc
Q psy8260         148 VTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGY  225 (427)
Q Consensus       148 v~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  225 (427)
                      ++|++ +++|...+.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......  
T Consensus        74 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--  151 (318)
T cd05570          74 VMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--  151 (318)
T ss_pred             EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--
Confidence            99988 7889877755 4799999999999999999999999999999999999999999999999998863211000  


Q ss_pred             cccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCC
Q psy8260         226 VATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYN  305 (427)
Q Consensus       226 ~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~  305 (427)
                                                                              .....+||+.|+|||++.+..+..
T Consensus       152 --------------------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~  175 (318)
T cd05570         152 --------------------------------------------------------TTSTFCGTPDYIAPEILSYQPYGP  175 (318)
T ss_pred             --------------------------------------------------------cccceecCccccCHHHhcCCCCCc
Confidence                                                                    011234677888888887777778


Q ss_pred             CCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH-----H
Q psy8260         306 QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA-----E  380 (427)
Q Consensus       306 ~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta-----~  380 (427)
                      ++|+||+|++++.|.++..+|..................        .....++++.|||.+||+.||.+|+|+     .
T Consensus       176 ~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~--------~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~  247 (318)
T cd05570         176 AVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVR--------YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQ  247 (318)
T ss_pred             chhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC--------CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHH
Confidence            889999999998887766666432211111111111111        123468899999999999999999999     9


Q ss_pred             HHhcCCCCCCC
Q psy8260         381 QALAHPYLSQY  391 (427)
Q Consensus       381 e~L~Hp~f~~~  391 (427)
                      ++++||||...
T Consensus       248 ~ll~~~~~~~~  258 (318)
T cd05570         248 DIKGHPFFREI  258 (318)
T ss_pred             HHhcCCCcCCC
Confidence            99999999864

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0586|consensus

Probab=100.00  E-value=3.3e-40  Score=325.79  Aligned_cols=259  Identities=24%  Similarity=0.345  Sum_probs=209.4

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      ....+.|.+.+.||+|.|+.|.. +.+..||..||||.+.+...+....+...+|+++|+.++|||||+|+.+.+..   
T Consensus        52 ~~~vg~y~i~~tig~g~f~~V~L-a~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~---  127 (596)
T KOG0586|consen   52 SNSVGLYVIIKTIGKGNFAKVKL-ARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE---  127 (596)
T ss_pred             cccccceeeeeeeccceeEEEEe-eEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec---
Confidence            44557789999999999999885 56777899999999998877777777789999999999999999999998764   


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCC
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP  217 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~  217 (427)
                         ..+|+||||+ +|.+++++.. +++.+..++.++.|+++|++|||+++|+|||||++||||+.+.++||+|||++..
T Consensus       128 ---~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~  204 (596)
T KOG0586|consen  128 ---ATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTF  204 (596)
T ss_pred             ---ceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeecccccee
Confidence               5789999998 7888887754 6788899999999999999999999999999999999999999999999999865


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      +...                                                           .+..+.||++.|.|||+
T Consensus       205 ~~~~-----------------------------------------------------------~~lqt~cgsppyAaPEl  225 (596)
T KOG0586|consen  205 FDYG-----------------------------------------------------------LMLQTFCGSPPYAAPEL  225 (596)
T ss_pred             eccc-----------------------------------------------------------ccccccCCCCCccChHh
Confidence            3211                                                           13345567777777777


Q ss_pred             hhhccCCC-CCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCC
Q psy8260         298 MLNWMHYN-QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKR  376 (427)
Q Consensus       298 l~~~~~~~-~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R  376 (427)
                      ..+..+.. .+|+|++|+++|.|-.+..||....-.......+...        ..+.-.++.++.+||++||.+||.+|
T Consensus       226 ~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk--------~rIp~~ms~dce~lLrk~lvl~Pskr  297 (596)
T KOG0586|consen  226 FNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGK--------YRIPFYMSCDCEDLLRKFLVLNPSKR  297 (596)
T ss_pred             hcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeee--------ecccceeechhHHHHHHhhccCcccc
Confidence            77666544 4699999999999988887776543322211111111        12223468899999999999999999


Q ss_pred             CCHHHHhcCCCCCCCC
Q psy8260         377 ITAEQALAHPYLSQYS  392 (427)
Q Consensus       377 ~ta~e~L~Hp~f~~~~  392 (427)
                      ++.+|++.|.|.....
T Consensus       298 ~~~dqim~~~W~n~~~  313 (596)
T KOG0586|consen  298 GPCDQIMKDRWRNDLL  313 (596)
T ss_pred             CCHHHhhhhcccchhh
Confidence            9999999999997543

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.5e-40  Score=327.80  Aligned_cols=262  Identities=24%  Similarity=0.328  Sum_probs=192.8

Q ss_pred             ccCcceeeccccCcccccEEEEeEE-eCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSAL-DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~-~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      +....|.+.+.||.|+||.||.+.. +..+++.||+|.+...       ....+|+++|++++|||||+++++|...   
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~---  158 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWK---  158 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeC---
Confidence            3456799999999999999997654 3456789999988542       1245799999999999999999988643   


Q ss_pred             cCCceEEEEeccCCCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCC
Q psy8260         140 ADFKNVYMVTHLMGADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT  218 (427)
Q Consensus       140 ~~~~~~~lv~e~~g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~  218 (427)
                         ..+|+++++++++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       159 ---~~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        159 ---STVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKL  235 (392)
T ss_pred             ---CEEEEEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence               46789999998888887753 56999999999999999999999999999999999999999999999999998643


Q ss_pred             CCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         219 ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       219 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                      ......                                                        ....+..||+.|+|||++
T Consensus       236 ~~~~~~--------------------------------------------------------~~~~~~~gt~~y~aPE~~  259 (392)
T PHA03207        236 DAHPDT--------------------------------------------------------PQCYGWSGTLETNSPELL  259 (392)
T ss_pred             Cccccc--------------------------------------------------------ccccccccccCccCHhHh
Confidence            221100                                                        011134577888888888


Q ss_pred             hhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCc---HHHHHHHhc---CCC-CCc--------------------ccHH
Q psy8260         299 LNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISS---DSARKYINS---LPL-LTK--------------------KDFR  351 (427)
Q Consensus       299 ~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~---~~~~~~~~~---~~~-~~~--------------------~~~~  351 (427)
                      .+..+..++|+||+|++++.|.++..+|......   .........   .+. ++.                    ....
T Consensus       260 ~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (392)
T PHA03207        260 ALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIP  339 (392)
T ss_pred             cCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCcccc
Confidence            7777777889999999998875544444322110   001111100   000 000                    0000


Q ss_pred             hhc--CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q psy8260         352 QVF--KGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       352 ~~~--~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~  391 (427)
                      ..+  ...+.++.+||.+||++||.+|||+.|+|+||||.+.
T Consensus       340 ~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~  381 (392)
T PHA03207        340 PVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE  381 (392)
T ss_pred             chhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence            111  1346789999999999999999999999999999763

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.2e-39  Score=313.37  Aligned_cols=257  Identities=30%  Similarity=0.493  Sum_probs=176.6

Q ss_pred             ccccCcccccEEEEeEE-eCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEE
Q psy8260          69 GPTLSKESFDLIFSSAL-DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYM  147 (427)
Q Consensus        69 ~~~lg~g~fg~v~~~~~-~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~l  147 (427)
                      +..||+|+||.||++.. +..++..||+|.+.....    .....+|+++++.++||||+++++++...    ....+++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~~~~l   77 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSH----SDRKVWL   77 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEecc----CCCeEEE
Confidence            46899999999998754 335678999998865322    23466899999999999999999987542    2246789


Q ss_pred             EeccCCCCHHHHHhh----------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEE----cCCCCEEEeeCC
Q psy8260         148 VTHLMGADLNNILRT----------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV----NEDCELKILDFG  213 (427)
Q Consensus       148 v~e~~g~~L~~~l~~----------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl----~~~~~~kl~DFG  213 (427)
                      ++++++++|.+++..          ..+++..+..++.|++.||.|||++||+||||||+|||+    +.++.+||+|||
T Consensus        78 v~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07867          78 LFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             EEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence            999998888877642          247889999999999999999999999999999999999    456799999999


Q ss_pred             CCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccccc
Q psy8260         214 LARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR  293 (427)
Q Consensus       214 la~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~  293 (427)
                      +++.........                                                       .......||+.|+
T Consensus       158 ~a~~~~~~~~~~-------------------------------------------------------~~~~~~~~t~~y~  182 (317)
T cd07867         158 FARLFNSPLKPL-------------------------------------------------------ADLDPVVVTFWYR  182 (317)
T ss_pred             ceeccCCCcccc-------------------------------------------------------cccCcceeccccc
Confidence            987543211000                                                       0011234566666


Q ss_pred             chHHhhhc-cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCc---------HHHHHHHhc--------------CCC-----
Q psy8260         294 APEIMLNW-MHYNQTDIHQLNLIMEMLGTPPAEFMAKISS---------DSARKYINS--------------LPL-----  344 (427)
Q Consensus       294 APEvl~~~-~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~---------~~~~~~~~~--------------~~~-----  344 (427)
                      |||++.+. .+..++|+||+|++++.+.++..+|......         .........              .+.     
T Consensus       183 aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (317)
T cd07867         183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQ  262 (317)
T ss_pred             CcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhh
Confidence            66666543 2445568888888877665544443211000         000000000              000     


Q ss_pred             -------CCcccH----HhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q psy8260         345 -------LTKKDF----RQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYL  388 (427)
Q Consensus       345 -------~~~~~~----~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f  388 (427)
                             ......    .......+..++|||.+||+.||.+|+|++|+|+||||
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         263 KDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             hhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                   000000    00111245678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0671|consensus

Probab=100.00  E-value=9.4e-40  Score=305.99  Aligned_cols=280  Identities=26%  Similarity=0.428  Sum_probs=212.1

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCC--CC----ceeeeeee
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNH--EN----VIGLLDVF  133 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~H--pn----Iv~l~~~~  133 (427)
                      ....++|.+.+.+|+|.||.|+. ++|..++..||||+++.-   ..-.+...-|+++|.++++  ||    +|++.++|
T Consensus        85 D~l~~Ry~i~~~lGeGtFGkV~e-c~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF  160 (415)
T KOG0671|consen   85 DILTNRYEIVDLLGEGTFGKVVE-CWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF  160 (415)
T ss_pred             cccccceehhhhhcCCcccceEE-EeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence            44467889999999999999995 678888999999988632   2334556679999999943  33    67787777


Q ss_pred             ecCccccCCceEEEEeccCCCCHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcC-------
Q psy8260         134 HSNTCLADFKNVYMVTHLMGADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE-------  203 (427)
Q Consensus       134 ~~~~~~~~~~~~~lv~e~~g~~L~~~l~~~---~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~-------  203 (427)
                      ...      .++++++|++|-++.++++.+   +++..+++.+++|++.+++|||+.+++|-||||||||+.+       
T Consensus       161 dyr------ghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~  234 (415)
T KOG0671|consen  161 DYR------GHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTY  234 (415)
T ss_pred             hcc------CceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEe
Confidence            543      578999999999999999764   5899999999999999999999999999999999999731       


Q ss_pred             -------------CCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhh
Q psy8260         204 -------------DCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKI  270 (427)
Q Consensus       204 -------------~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki  270 (427)
                                   +..+||+|||.|+...+..+..+.|+.|+|||++++-.-    .   +.+|+||.||++-|      
T Consensus       235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGw----S---~pCDvWSiGCIL~E------  301 (415)
T KOG0671|consen  235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGW----S---QPCDVWSIGCILVE------  301 (415)
T ss_pred             ccCCccceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCc----C---CccCceeeeeEEEE------
Confidence                         235899999999988888888899999999999997321    1   12399999999987      


Q ss_pred             hccCCCCCCccccccccccccccchHHhhhccCC-CCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCC-CC---
Q psy8260         271 LDFGLARPTENEMTGYVATRWYRAPEIMLNWMHY-NQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLP-LL---  345 (427)
Q Consensus       271 ~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~-~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~-~~---  345 (427)
                                 ..+|..               +| ...|...|.++-.+||..|..+..+..   ..++..... .+   
T Consensus       302 -----------lytG~~---------------LFqtHen~EHLaMMerIlGp~P~~mi~r~~---~~Kyf~~~rldw~e~  352 (415)
T KOG0671|consen  302 -----------LYTGET---------------LFQTHENLEHLAMMERILGPIPSRMIKKTR---KEKYFRRGRLDWPEV  352 (415)
T ss_pred             -----------eeccce---------------ecccCCcHHHHHHHHHhhCCCcHHHhhhhh---hHhhhhcccccCccc
Confidence                       333432               33 334788898888999976665554431   222322110 00   


Q ss_pred             -----------CcccHHhhcCCCCh---hHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q psy8260         346 -----------TKKDFRQVFKGANP---QAIDLLSLMLELDSEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       346 -----------~~~~~~~~~~~~s~---~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~  391 (427)
                                 ..+.+.......+.   ++.|||.+||.+||++|+|+.|||.||||...
T Consensus       353 ~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~  412 (415)
T KOG0671|consen  353 SSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARL  412 (415)
T ss_pred             cccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcC
Confidence                       01122233333343   45699999999999999999999999999875

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.4e-39  Score=317.51  Aligned_cols=250  Identities=23%  Similarity=0.334  Sum_probs=188.3

Q ss_pred             cccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHH-HHhcCCCCCceeeeeeeecCccccCCceEEE
Q psy8260          70 PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELR-MLKHMNHENVIGLLDVFHSNTCLADFKNVYM  147 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~-~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~l  147 (427)
                      +.||+|+||.||. +.+..+|+.||||++.+... .......+++|.. +++.++||||+++++++...      ..+|+
T Consensus         1 ~~lg~G~~g~V~~-~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~------~~~~l   73 (323)
T cd05575           1 KVIGKGSFGKVLL-AKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA------DKLYF   73 (323)
T ss_pred             CeeeeCCCeEEEE-EEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC------CEEEE
Confidence            3689999999996 45777899999999864321 1222344555655 56789999999999888653      46789


Q ss_pred             EeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccc
Q psy8260         148 VTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGY  225 (427)
Q Consensus       148 v~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  225 (427)
                      +|+++ +++|...+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......  
T Consensus        74 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--  151 (323)
T cd05575          74 VLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--  151 (323)
T ss_pred             EEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--
Confidence            99888 7789887754 5689999999999999999999999999999999999999999999999999863211000  


Q ss_pred             cccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCC
Q psy8260         226 VATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYN  305 (427)
Q Consensus       226 ~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~  305 (427)
                                                                              .....+||+.|+|||++.+..+..
T Consensus       152 --------------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~  175 (323)
T cd05575         152 --------------------------------------------------------TTSTFCGTPEYLAPEVLRKQPYDR  175 (323)
T ss_pred             --------------------------------------------------------ccccccCChhhcChhhhcCCCCCc
Confidence                                                                    111235777788888877777777


Q ss_pred             CCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH----HH
Q psy8260         306 QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA----EQ  381 (427)
Q Consensus       306 ~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta----~e  381 (427)
                      ++|+||+|++++.|.++..+|.................        ......++++.+||.+||+.||.+|+++    +|
T Consensus       176 ~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~  247 (323)
T cd05575         176 TVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL--------RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLE  247 (323)
T ss_pred             cccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC--------CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHH
Confidence            88999999999988777666643322222222221111        1223568899999999999999999998    69


Q ss_pred             HhcCCCCCCCC
Q psy8260         382 ALAHPYLSQYS  392 (427)
Q Consensus       382 ~L~Hp~f~~~~  392 (427)
                      +++||||....
T Consensus       248 il~~~~~~~~~  258 (323)
T cd05575         248 IKNHVFFSSIN  258 (323)
T ss_pred             HHcCCCcCCCC
Confidence            99999997643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.7e-39  Score=316.02  Aligned_cols=250  Identities=23%  Similarity=0.335  Sum_probs=189.7

Q ss_pred             cccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhc-CCCCCceeeeeeeecCccccCCceEEE
Q psy8260          70 PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKH-MNHENVIGLLDVFHSNTCLADFKNVYM  147 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~-l~HpnIv~l~~~~~~~~~~~~~~~~~l  147 (427)
                      +.||+|+||.||.+ .+..+++.||||.+..... ..........|..+++. ++||||+++++++...      ..+|+
T Consensus         1 ~~lG~G~~g~Vy~~-~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~------~~~~l   73 (316)
T cd05619           1 KMLGKGSFGKVFLA-ELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK------ENLFF   73 (316)
T ss_pred             CeeeeCCCEEEEEE-EECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC------CEEEE
Confidence            36899999999964 5667899999999865321 11223445678888875 5999999999998654      45789


Q ss_pred             EeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccc
Q psy8260         148 VTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGY  225 (427)
Q Consensus       148 v~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  225 (427)
                      ++|++ +++|...+.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......   
T Consensus        74 v~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~---  150 (316)
T cd05619          74 VMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD---  150 (316)
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC---
Confidence            99987 7899988865 568999999999999999999999999999999999999999999999999886321100   


Q ss_pred             cccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCC
Q psy8260         226 VATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYN  305 (427)
Q Consensus       226 ~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~  305 (427)
                                                                             .......||+.|+|||++.+..+..
T Consensus       151 -------------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~  175 (316)
T cd05619         151 -------------------------------------------------------AKTCTFCGTPDYIAPEILLGQKYNT  175 (316)
T ss_pred             -------------------------------------------------------CceeeecCCccccCHHHHcCCCCCc
Confidence                                                                   0111235778888888887777788


Q ss_pred             CCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHH-HHhc
Q psy8260         306 QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAE-QALA  384 (427)
Q Consensus       306 ~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~-e~L~  384 (427)
                      ++|+||+|++++.|.++..||................+..        ....+.+++|||.+||+.||.+|+++. ++++
T Consensus       176 ~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~--------~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         176 SVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCY--------PRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             hhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--------CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            8999999999988877666664332112121111111111        123678999999999999999999996 8999


Q ss_pred             CCCCCCCC
Q psy8260         385 HPYLSQYS  392 (427)
Q Consensus       385 Hp~f~~~~  392 (427)
                      ||||....
T Consensus       248 h~~~~~~~  255 (316)
T cd05619         248 HPFFREID  255 (316)
T ss_pred             CcccCCCC
Confidence            99998753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.6e-39  Score=312.09  Aligned_cols=262  Identities=27%  Similarity=0.464  Sum_probs=189.4

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      ..|.+.+.||.|+||.||.+ .+..+++.||+|.+..... ........+|+.+++.++||||+++++++...      .
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~-~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~------~   77 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKG-RSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTE------K   77 (301)
T ss_pred             cceEEeeEeccCcCEEEEEE-EEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecC------C
Confidence            45788899999999999964 5667899999998864322 12233466899999999999999999998654      4


Q ss_pred             eEEEEeccCCCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         144 NVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       144 ~~~lv~e~~g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      ..++++++++++|.+++..  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        78 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  157 (301)
T cd07873          78 SLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP  157 (301)
T ss_pred             eEEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence            5799999998899887754  45899999999999999999999999999999999999999999999999998643211


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      ..                                                          ......+++.|+|||++.+.
T Consensus       158 ~~----------------------------------------------------------~~~~~~~~~~y~~PE~~~~~  179 (301)
T cd07873         158 TK----------------------------------------------------------TYSNEVVTLWYRPPDILLGS  179 (301)
T ss_pred             CC----------------------------------------------------------cccccceeecccCcHHHhCC
Confidence            10                                                          00112345556666665432


Q ss_pred             -cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhc----------------------CCCCCcccHHhhcCCCC
Q psy8260         302 -MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINS----------------------LPLLTKKDFRQVFKGAN  358 (427)
Q Consensus       302 -~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~s  358 (427)
                       .+..++|+||+|++++.|.++..+|......+........                      .+.............++
T Consensus       180 ~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (301)
T cd07873         180 TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLD  259 (301)
T ss_pred             CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCC
Confidence             2444568888888887775554444321111111111100                      01111111122334578


Q ss_pred             hhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q psy8260         359 PQAIDLLSLMLELDSEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       359 ~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~  391 (427)
                      ++++|||.+||+.||.+|+|++|+|+||||...
T Consensus       260 ~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~  292 (301)
T cd07873         260 SDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL  292 (301)
T ss_pred             HHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            899999999999999999999999999999765

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=8.1e-39  Score=313.18  Aligned_cols=301  Identities=45%  Similarity=0.732  Sum_probs=205.1

Q ss_pred             eeeccccCcccccEEEEeEEeCcC--CcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCccccCC
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVS--GVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~--g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      |.+.+.||.|+||.||.+. +..+  +..||||++..........+.+.+|+.+++++ +||||+++++......  ...
T Consensus         2 y~~~~~lg~G~~g~vy~~~-~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~--~~~   78 (332)
T cd07857           2 YELIKELGQGAYGIVCSAR-NAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP--GNF   78 (332)
T ss_pred             ceEEEEccccCCeEEEEEE-eCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc--ccC
Confidence            6778899999999999654 4555  88999999865433333455677899999999 5999999998753221  122


Q ss_pred             ceEEEEeccCCCCHHHHHh-hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         143 KNVYMVTHLMGADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       143 ~~~~lv~e~~g~~L~~~l~-~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      ..+|+++++++++|.+.+. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        79 ~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~  158 (332)
T cd07857          79 NELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN  158 (332)
T ss_pred             CcEEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence            4578999999989988875 456899999999999999999999999999999999999999999999999998754321


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh-
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN-  300 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~-  300 (427)
                      ....       .                                               ....+..||+.|+|||++.+ 
T Consensus       159 ~~~~-------~-----------------------------------------------~~~~~~~g~~~y~aPE~~~~~  184 (332)
T cd07857         159 PGEN-------A-----------------------------------------------GFMTEYVATRWYRAPEIMLSF  184 (332)
T ss_pred             cccc-------c-----------------------------------------------ccccCcccCccccCcHHHhCC
Confidence            1000       0                                               00012234555555555433 


Q ss_pred             ccCCCCCCHHHHHHHHHHh-----------------------CCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCC
Q psy8260         301 WMHYNQTDIHQLNLIMEML-----------------------GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGA  357 (427)
Q Consensus       301 ~~~~~~~d~~slg~i~~~l-----------------------g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (427)
                      ..+..++|+||+|++++.+                       |.++.+............+...........+.......
T Consensus       185 ~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (332)
T cd07857         185 QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNA  264 (332)
T ss_pred             CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCC
Confidence            2344455666666666544                       22222221111111111111122222223344445567


Q ss_pred             ChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCCC-CCCCcccccCCCCHHHHHHHHhhh
Q psy8260         358 NPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTS-PPYDQSFEDMDLPVDQWKGTYSLE  424 (427)
Q Consensus       358 s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  424 (427)
                      ++++.+||.+||+.||.+|||++|++.||||.++.+|...+.. .+++.+++. .-+.+.++..+-.|
T Consensus       265 ~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  331 (332)
T cd07857         265 NPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFDFSFES-EDSMEELRDMIIEE  331 (332)
T ss_pred             CHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccccccccccCCccc-cccHHHHHHHHhhc
Confidence            8899999999999999999999999999999999887666554 444545543 34566666655443

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.5e-39  Score=309.07  Aligned_cols=258  Identities=31%  Similarity=0.519  Sum_probs=188.9

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceE
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV  145 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~  145 (427)
                      |.+.+.||.|++|.||.+ .+..+|+.||||++............+.+|+.+++.++||||+++++++..+      ...
T Consensus         2 y~~~~~l~~g~~~~v~~~-~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~   74 (285)
T cd07861           2 YTKIEKIGEGTYGVVYKG-RNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE------SRL   74 (285)
T ss_pred             ceEeeEecccCceEEEEE-EECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC------CeE
Confidence            567789999999999965 4667899999999865433333345577899999999999999999998653      467


Q ss_pred             EEEeccCCCCHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         146 YMVTHLMGADLNNILRT----QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       146 ~lv~e~~g~~L~~~l~~----~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      |++++++.++|.+++..    ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        75 ~~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  154 (285)
T cd07861          75 YLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP  154 (285)
T ss_pred             EEEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence            99999998888877753    45899999999999999999999999999999999999999999999999998643211


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      ..                                                          ......+++.|+|||++.+.
T Consensus       155 ~~----------------------------------------------------------~~~~~~~~~~y~aPE~~~~~  176 (285)
T cd07861         155 VR----------------------------------------------------------VYTHEVVTLWYRAPEVLLGS  176 (285)
T ss_pred             cc----------------------------------------------------------cccCCcccccccChHHhcCC
Confidence            00                                                          00112345667777766543


Q ss_pred             c-CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHH---------------------HHHHhcCCCCCcccHHhhcCCCCh
Q psy8260         302 M-HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSA---------------------RKYINSLPLLTKKDFRQVFKGANP  359 (427)
Q Consensus       302 ~-~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~s~  359 (427)
                      . +..++|+||+|++++.+.++..+|.........                     ..+....+.............+++
T Consensus       177 ~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (285)
T cd07861         177 PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDE  256 (285)
T ss_pred             CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCH
Confidence            2 445679999999888775544333211100000                     011111112222223334456789


Q ss_pred             hHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q psy8260         360 QAIDLLSLMLELDSEKRITAEQALAHPYL  388 (427)
Q Consensus       360 ~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f  388 (427)
                      ++++||.+||+.||++|||++|+++||||
T Consensus       257 ~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         257 DGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            99999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.5e-39  Score=319.48  Aligned_cols=260  Identities=23%  Similarity=0.316  Sum_probs=186.4

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      ...+++.+.||+|+||.||.+ .+..+|+.||||++.... .......+.+|+++++.++|+||+++++++...      
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~-~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------  144 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKV-IHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHN------  144 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEE-EECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC------
Confidence            355778889999999999964 566789999999986432 333455678999999999999999999988643      


Q ss_pred             ceEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      ..+|+++||+ +++|...   ...++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       145 ~~~~lv~e~~~~~~L~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~  221 (353)
T PLN00034        145 GEIQVLLEFMDGGSLEGT---HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT  221 (353)
T ss_pred             CeEEEEEecCCCCccccc---ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence            4678899888 5676542   34577888899999999999999999999999999999999999999999998754321


Q ss_pred             ---cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         222 ---MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       222 ---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                         .....||..|+|||++.....                                                        
T Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~--------------------------------------------------------  245 (353)
T PLN00034        222 MDPCNSSVGTIAYMSPERINTDLN--------------------------------------------------------  245 (353)
T ss_pred             cccccccccCccccCccccccccc--------------------------------------------------------
Confidence               123345555555554421000                                                        


Q ss_pred             hhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC
Q psy8260         299 LNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT  378 (427)
Q Consensus       299 ~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t  378 (427)
                      .+.....++|+||+|++++.|.++..+|......+.. .........   .........++++++||.+||+.||++|+|
T Consensus       246 ~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt  321 (353)
T PLN00034        246 HGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWA-SLMCAICMS---QPPEAPATASREFRHFISCCLQREPAKRWS  321 (353)
T ss_pred             cCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHHHHhcc---CCCCCCCccCHHHHHHHHHHccCChhhCcC
Confidence            0011223679999999998886665555321111111 111000000   001122356789999999999999999999


Q ss_pred             HHHHhcCCCCCCCCC
Q psy8260         379 AEQALAHPYLSQYSD  393 (427)
Q Consensus       379 a~e~L~Hp~f~~~~~  393 (427)
                      ++|+|+||||.+...
T Consensus       322 ~~ell~hp~~~~~~~  336 (353)
T PLN00034        322 AMQLLQHPFILRAQP  336 (353)
T ss_pred             HHHHhcCcccccCCc
Confidence            999999999987543

>KOG0192|consensus

Probab=100.00  E-value=3.6e-39  Score=314.79  Aligned_cols=251  Identities=28%  Similarity=0.383  Sum_probs=193.1

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEeCcCCcE-EEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCc
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALDSVSGVK-VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNT  137 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~-vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~  137 (427)
                      +++.-..+.+.+.+|.|+||.||++.+.   |+. ||||++..........+.+.+|+.+|.+++|||||+++++.....
T Consensus        36 ~~i~~~~l~~~~~iG~G~~g~V~~~~~~---g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~  112 (362)
T KOG0192|consen   36 EEIDPDELPIEEVLGSGSFGTVYKGKWR---GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP  112 (362)
T ss_pred             eecChHHhhhhhhcccCCceeEEEEEeC---CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            4454556677788999999999988774   445 999999876555555677889999999999999999999975431


Q ss_pred             cccCCceEEEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcC-ceeccCCCCCeEEcCCC-CEEEee
Q psy8260         138 CLADFKNVYMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAG-IIHRDLKPSNIAVNEDC-ELKILD  211 (427)
Q Consensus       138 ~~~~~~~~~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~-iiHrDLKp~NILl~~~~-~~kl~D  211 (427)
                           ....+||||+ +|+|.+++..   ..++...+..++.||++||+|||+++ ||||||||+|||++.++ .+||+|
T Consensus       113 -----~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~D  187 (362)
T KOG0192|consen  113 -----GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIAD  187 (362)
T ss_pred             -----CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECC
Confidence                 1478888888 8999999955   57999999999999999999999999 99999999999999997 999999


Q ss_pred             CCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccc
Q psy8260         212 FGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRW  291 (427)
Q Consensus       212 FGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~  291 (427)
                      ||+++.......                                                          ..+...||+.
T Consensus       188 FGlsr~~~~~~~----------------------------------------------------------~~~~~~GT~~  209 (362)
T KOG0192|consen  188 FGLSREKVISKT----------------------------------------------------------SMTSVAGTYR  209 (362)
T ss_pred             Cccceeeccccc----------------------------------------------------------cccCCCCCcc
Confidence            999975432100                                                          1122356777


Q ss_pred             ccchHHhh--hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhc--CCCCCcccHHhhcCCCChhHHHHHHH
Q psy8260         292 YRAPEIML--NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINS--LPLLTKKDFRQVFKGANPQAIDLLSL  367 (427)
Q Consensus       292 Y~APEvl~--~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~s~~~~dLi~~  367 (427)
                      |||||++.  +..+..++|+||+|+++.++.++..||...............  .|..+        ....+...+|+.+
T Consensus       210 wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p--------~~~~~~l~~l~~~  281 (362)
T KOG0192|consen  210 WMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIP--------KECPPHLSSLMER  281 (362)
T ss_pred             ccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--------ccCCHHHHHHHHH
Confidence            77777777  457888999999999999998876666433221222222111  12211        2256788999999


Q ss_pred             hcCCCCCCCCCHHHHh
Q psy8260         368 MLELDSEKRITAEQAL  383 (427)
Q Consensus       368 mL~~dP~~R~ta~e~L  383 (427)
                      |..-||.+||+..|++
T Consensus       282 CW~~dp~~RP~f~ei~  297 (362)
T KOG0192|consen  282 CWLVDPSRRPSFLEIV  297 (362)
T ss_pred             hCCCCCCcCCCHHHHH
Confidence            9999999999998864

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.6e-39  Score=315.49  Aligned_cols=253  Identities=21%  Similarity=0.275  Sum_probs=193.3

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCccccCCc
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      |.+.+.||+|+||.||.+ .+..+++.||||++.+... ..........|..++..+ +|++|+++++++...      .
T Consensus         2 f~~~~~lg~G~~g~Vy~~-~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~------~   74 (323)
T cd05616           2 FNFLMVLGKGSFGKVMLA-ERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM------D   74 (323)
T ss_pred             ceEEEEEeeCCCeEEEEE-EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC------C
Confidence            677889999999999964 5677899999999875422 122334456788888777 578999999887653      4


Q ss_pred             eEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      .+|+++|++ +++|...+.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        75 ~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          75 RLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             EEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            678999988 6899877754 57999999999999999999999999999999999999999999999999998632110


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      ..                                                          .....+||+.|+|||++.+.
T Consensus       155 ~~----------------------------------------------------------~~~~~~gt~~y~aPE~~~~~  176 (323)
T cd05616         155 GV----------------------------------------------------------TTKTFCGTPDYIAPEIIAYQ  176 (323)
T ss_pred             CC----------------------------------------------------------ccccCCCChhhcCHHHhcCC
Confidence            00                                                          01123578888888888877


Q ss_pred             cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC---
Q psy8260         302 MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT---  378 (427)
Q Consensus       302 ~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t---  378 (427)
                      .+..++|+||+|++++.|.++..||..................        .....++++.+||.+||+.||.+|++   
T Consensus       177 ~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~--------~p~~~s~~~~~li~~~l~~~p~~R~~~~~  248 (323)
T cd05616         177 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA--------YPKSMSKEAVAICKGLMTKHPGKRLGCGP  248 (323)
T ss_pred             CCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------CCCcCCHHHHHHHHHHcccCHHhcCCCCC
Confidence            7888899999999999887766666433222222222211111        12346889999999999999999998   


Q ss_pred             --HHHHhcCCCCCCC
Q psy8260         379 --AEQALAHPYLSQY  391 (427)
Q Consensus       379 --a~e~L~Hp~f~~~  391 (427)
                        .+++++||||...
T Consensus       249 ~~~~~i~~h~~~~~~  263 (323)
T cd05616         249 EGERDIKEHAFFRYI  263 (323)
T ss_pred             CCHHHHhcCCCcCCC
Confidence              4899999999864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.2e-39  Score=309.41  Aligned_cols=258  Identities=28%  Similarity=0.477  Sum_probs=187.5

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceE
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV  145 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~  145 (427)
                      |.+.+.||.|+||.||. +.+..+|+.||+|.+............+.+|+.+++.++||||+++++++...      ..+
T Consensus         2 y~~~~~l~~g~~~~vy~-~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~------~~~   74 (284)
T cd07839           2 YEKLEKIGEGTYGTVFK-AKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD------KKL   74 (284)
T ss_pred             ceeEEEecccCCeEEEE-EEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC------Cce
Confidence            56778899999999996 55677899999999865432222334567899999999999999999988653      457


Q ss_pred             EEEeccCCCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcc
Q psy8260         146 YMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT  223 (427)
Q Consensus       146 ~lv~e~~g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~  223 (427)
                      ++++++++++|.+.+..  ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus        75 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          75 TLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence            99999998888887653  5689999999999999999999999999999999999999999999999999864322110


Q ss_pred             cccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhcc-
Q psy8260         224 GYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM-  302 (427)
Q Consensus       224 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~-  302 (427)
                                                                                ......+++.|+|||++.+.. 
T Consensus       155 ----------------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~  176 (284)
T cd07839         155 ----------------------------------------------------------CYSAEVVTLWYRPPDVLFGAKL  176 (284)
T ss_pred             ----------------------------------------------------------CcCCCccccCCcChHHHhCCcc
Confidence                                                                      001123455666666665433 


Q ss_pred             CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcH-HHHHHH--------------hcCCC------C-CcccHHhhcCCCChh
Q psy8260         303 HYNQTDIHQLNLIMEMLGTPPAEFMAKISSD-SARKYI--------------NSLPL------L-TKKDFRQVFKGANPQ  360 (427)
Q Consensus       303 ~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~-~~~~~~--------------~~~~~------~-~~~~~~~~~~~~s~~  360 (427)
                      +..++|+||+|++++.|.++..|+....... ......              ...+.      . ....+.+..+..+++
T Consensus       177 ~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (284)
T cd07839         177 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNST  256 (284)
T ss_pred             cCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHH
Confidence            4556799999999887754333322111110 000000              00000      0 111223444567899


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q psy8260         361 AIDLLSLMLELDSEKRITAEQALAHPYL  388 (427)
Q Consensus       361 ~~dLi~~mL~~dP~~R~ta~e~L~Hp~f  388 (427)
                      ++|||.+||+.||.+|||++|+++||||
T Consensus       257 ~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         257 GRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             HHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            9999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0612|consensus

Probab=100.00  E-value=1.3e-40  Score=345.69  Aligned_cols=275  Identities=22%  Similarity=0.298  Sum_probs=204.7

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHH-HHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAV-HAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      .+...+|+|.+.||+|+||.|.. +..+.|++.||+|++++-..... ....|..|-.+|..-+.+-||+|+..|+++  
T Consensus        71 rl~~~DfeilKvIGrGaFGEV~l-Vr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~--  147 (1317)
T KOG0612|consen   71 RLKAEDFEILKVIGRGAFGEVAL-VRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE--  147 (1317)
T ss_pred             hCCHHhhHHHHHhcccccceeEE-EEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc--
Confidence            34567899999999999999985 56778999999999875322211 223344567788888899999999888654  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRTQ-KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~~-~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                          .++|+||+|+ ||||..++... +++++.+++|+..|+.||+-||+.|.|||||||+|||||..|++||+|||.+-
T Consensus       148 ----~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsCl  223 (1317)
T KOG0612|consen  148 ----RYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCL  223 (1317)
T ss_pred             ----cceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHH
Confidence                6789999887 99999999764 59999999999999999999999999999999999999999999999999875


Q ss_pred             CCCCC----cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccc
Q psy8260         217 PTENE----MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWY  292 (427)
Q Consensus       217 ~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y  292 (427)
                      .+..+    ....+|||-|.+||+|.....+                                                 
T Consensus       224 km~~dG~V~s~~aVGTPDYISPEvLqs~~~~-------------------------------------------------  254 (1317)
T KOG0612|consen  224 KMDADGTVRSSVAVGTPDYISPEVLQSQGDG-------------------------------------------------  254 (1317)
T ss_pred             hcCCCCcEEeccccCCCCccCHHHHHhhcCC-------------------------------------------------
Confidence            44322    1233455555555544321000                                                 


Q ss_pred             cchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         293 RAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       293 ~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                             ...|+..+||||+|+++|+|..+..||....--++..++.+....+   .|+.. ..+|++|+|||.++|. +
T Consensus       255 -------~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l---~FP~~-~~VSeeakdLI~~ll~-~  322 (1317)
T KOG0612|consen  255 -------KGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESL---SFPDE-TDVSEEAKDLIEALLC-D  322 (1317)
T ss_pred             -------ccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhc---CCCcc-cccCHHHHHHHHHHhc-C
Confidence                   0236677899999999999988888887654444444443321111   11111 2389999999999996 8


Q ss_pred             CCCCCC---HHHHhcCCCCCCCCCCCCCCCCCC
Q psy8260         373 SEKRIT---AEQALAHPYLSQYSDPNDEPTSPP  402 (427)
Q Consensus       373 P~~R~t---a~e~L~Hp~f~~~~~~~~~~~~~~  402 (427)
                      |.+|+.   ++++.+||||.+....+.....||
T Consensus       323 ~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP  355 (1317)
T KOG0612|consen  323 REVRLGRNGIEDIKNHPFFEGIDWDNIRESVPP  355 (1317)
T ss_pred             hhhhcccccHHHHHhCccccCCChhhhhhcCCC
Confidence            999998   999999999998766443333333

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3e-39  Score=316.44  Aligned_cols=262  Identities=21%  Similarity=0.323  Sum_probs=191.9

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcccc
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  140 (427)
                      +..+.|++.+.||.|+||.||. +.+..+|..||+|.+.... .......+.+|+++++.++||||++++++|...    
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~-~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----   75 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFK-VSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD----   75 (333)
T ss_pred             cchhhhheeccccCCCCEEEEE-EEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC----
Confidence            4567889999999999999996 4566789999999886542 334456688999999999999999999998654    


Q ss_pred             CCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCCeEEcCCCCEEEeeCCCCCC
Q psy8260         141 DFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDCELKILDFGLARP  217 (427)
Q Consensus       141 ~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~-~iiHrDLKp~NILl~~~~~~kl~DFGla~~  217 (427)
                        ..++++++++ +++|.++++. +.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus        76 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~  153 (333)
T cd06650          76 --GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  153 (333)
T ss_pred             --CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchh
Confidence              4678999988 7899998865 4689999999999999999999975 799999999999999999999999999864


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      .....                                                            .....||+.|+|||+
T Consensus       154 ~~~~~------------------------------------------------------------~~~~~~~~~y~aPE~  173 (333)
T cd06650         154 LIDSM------------------------------------------------------------ANSFVGTRSYMSPER  173 (333)
T ss_pred             hhhhc------------------------------------------------------------cccCCCCccccCHHH
Confidence            32110                                                            011235666667776


Q ss_pred             hhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhc-------------------------CCC----CCcc
Q psy8260         298 MLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINS-------------------------LPL----LTKK  348 (427)
Q Consensus       298 l~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~-------------------------~~~----~~~~  348 (427)
                      +.+..+..++|+||+|++++.+.++..+|........ ......                         .+.    ....
T Consensus       174 ~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (333)
T cd06650         174 LQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL-ELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIF  252 (333)
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHH-HHHhcCcccCCccccccCcccCCccchhhhhcccccccccHH
Confidence            6655566678999999998777554444321110000 000000                         000    0000


Q ss_pred             cHHh----------hcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q psy8260         349 DFRQ----------VFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       349 ~~~~----------~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~  391 (427)
                      ....          .....++++++||.+||++||++|||++|+++||||+..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         253 ELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             HHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence            0000          001246789999999999999999999999999999764

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-39  Score=317.66  Aligned_cols=248  Identities=21%  Similarity=0.343  Sum_probs=180.3

Q ss_pred             cCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcC---CCCCceeeeeeeecCccccCCceEEE
Q psy8260          72 LSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHM---NHENVIGLLDVFHSNTCLADFKNVYM  147 (427)
Q Consensus        72 lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l---~HpnIv~l~~~~~~~~~~~~~~~~~l  147 (427)
                      ||+|+||.||. +.+..+|+.||||++.+... .........+|..++...   +||||++++++|...      ..+|+
T Consensus         1 lG~G~~g~Vy~-~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~------~~~~l   73 (330)
T cd05586           1 IGKGTFGQVYQ-VRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD------SDLYL   73 (330)
T ss_pred             CCCCCceEEEE-EEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC------CeEEE
Confidence            68999999996 55677899999999864321 122233455677777655   799999999988654      45789


Q ss_pred             EeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccc
Q psy8260         148 VTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGY  225 (427)
Q Consensus       148 v~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  225 (427)
                      +|+++ +++|...+.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......  
T Consensus        74 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--  151 (330)
T cd05586          74 VTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--  151 (330)
T ss_pred             EEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--
Confidence            99987 6788877654 5699999999999999999999999999999999999999999999999999864221100  


Q ss_pred             cccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc-cCC
Q psy8260         226 VATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW-MHY  304 (427)
Q Consensus       226 ~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~-~~~  304 (427)
                                                                              .....+||+.|+|||++.+. .+.
T Consensus       152 --------------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~  175 (330)
T cd05586         152 --------------------------------------------------------TTNTFCGTTEYLAPEVLLDEKGYT  175 (330)
T ss_pred             --------------------------------------------------------CccCccCCccccCHHHHcCCCCCC
Confidence                                                                    01123456666666666443 245


Q ss_pred             CCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC----CHH
Q psy8260         305 NQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI----TAE  380 (427)
Q Consensus       305 ~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~----ta~  380 (427)
                      ..+|+||+|++++.|.++..||...................+.       ..+++++.+||.+||+.||.+|+    +++
T Consensus       176 ~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~  248 (330)
T cd05586         176 KHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK-------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAV  248 (330)
T ss_pred             CccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC-------ccCCHHHHHHHHHHcCCCHHHCCCCCCCHH
Confidence            5678999998888776666555433221211211111111111       23688999999999999999998    799


Q ss_pred             HHhcCCCCCCC
Q psy8260         381 QALAHPYLSQY  391 (427)
Q Consensus       381 e~L~Hp~f~~~  391 (427)
                      |+++||||...
T Consensus       249 ~ll~h~~~~~~  259 (330)
T cd05586         249 ELKEHPFFADI  259 (330)
T ss_pred             HHhcCccccCC
Confidence            99999999864

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.6e-39  Score=314.29  Aligned_cols=302  Identities=47%  Similarity=0.798  Sum_probs=217.4

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCce
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      +|.+.+.||.|+||.||.+ .+..+|..||||++..........+.+.+|+.+++.++||||+++++++..... .....
T Consensus         1 ~y~i~~~ig~g~~~~v~~~-~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~~~~   78 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSA-VDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSP-EDFND   78 (330)
T ss_pred             CceeeeeecCCCCeEEEEE-EeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCc-ccccc
Confidence            3678899999999999975 466779999999987654334455678899999999999999999998765432 22346


Q ss_pred             EEEEeccCCCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcc
Q psy8260         145 VYMVTHLMGADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT  223 (427)
Q Consensus       145 ~~lv~e~~g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~  223 (427)
                      +|+++++++++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++........
T Consensus        79 ~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~  158 (330)
T cd07834          79 VYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED  158 (330)
T ss_pred             eEEEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence            899999998889888765 4789999999999999999999999999999999999999999999999999875433210


Q ss_pred             cccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc-c
Q psy8260         224 GYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW-M  302 (427)
Q Consensus       224 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~-~  302 (427)
                      .         +.                                              ......+|+.|+|||++.+. .
T Consensus       159 ~---------~~----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~  183 (330)
T cd07834         159 E---------KG----------------------------------------------FLTEYVVTRWYRAPELLLSSSR  183 (330)
T ss_pred             c---------cc----------------------------------------------cccccccccCcCCceeeecccC
Confidence            0         00                                              00111244555555555444 3


Q ss_pred             CCCCCCHHHHHHHHHHhCCCCHHHHhh-----------------------cCcHHHHHHHhcCCCCCcccHHhhcCCCCh
Q psy8260         303 HYNQTDIHQLNLIMEMLGTPPAEFMAK-----------------------ISSDSARKYINSLPLLTKKDFRQVFKGANP  359 (427)
Q Consensus       303 ~~~~~d~~slg~i~~~lg~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  359 (427)
                      +...+|+||+|++++.+-++..+|...                       ........+....+......+....+..++
T Consensus       184 ~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (330)
T cd07834         184 YTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASP  263 (330)
T ss_pred             CCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCH
Confidence            455567788887776664433333211                       111111222222222333344555666889


Q ss_pred             hHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCCC-CCCCc-ccccCCCCHHHHHHHHhh
Q psy8260         360 QAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTS-PPYDQ-SFEDMDLPVDQWKGTYSL  423 (427)
Q Consensus       360 ~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~  423 (427)
                      ++.+||.+||++||.+|||++++++||||.++..+..++.+ ..++. .+++..+..++..+.++.
T Consensus       264 ~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (330)
T cd07834         264 EAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPFDFDFFDDDELTEEELKELIYE  329 (330)
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCCCcccccccchhhcCHHHHhHHhhc
Confidence            99999999999999999999999999999988777665444 33332 357778888888776654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.5e-39  Score=315.95  Aligned_cols=249  Identities=24%  Similarity=0.369  Sum_probs=187.3

Q ss_pred             cccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHH-HHhcCCCCCceeeeeeeecCccccCCceEEE
Q psy8260          70 PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELR-MLKHMNHENVIGLLDVFHSNTCLADFKNVYM  147 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~-~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~l  147 (427)
                      +.||+|+||.||. +.+..+|+.||||++.+... .......+.+|.. +++.++||||+++++++...      ...|+
T Consensus         1 ~~lG~G~~g~V~~-~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~------~~~~l   73 (325)
T cd05604           1 KVIGKGSFGKVLL-AKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT------EKLYF   73 (325)
T ss_pred             CceeeCCCeEEEE-EEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC------CEEEE
Confidence            3689999999996 45677899999999865322 1223344555654 56789999999999888654      46789


Q ss_pred             EeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccc
Q psy8260         148 VTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGY  225 (427)
Q Consensus       148 v~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  225 (427)
                      +++++ +++|...+.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......  
T Consensus        74 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--  151 (325)
T cd05604          74 VLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--  151 (325)
T ss_pred             EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--
Confidence            99987 6788776654 5799999999999999999999999999999999999999999999999999863211000  


Q ss_pred             cccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCC
Q psy8260         226 VATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYN  305 (427)
Q Consensus       226 ~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~  305 (427)
                                                                              .....+||+.|+|||++.+..+..
T Consensus       152 --------------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~  175 (325)
T cd05604         152 --------------------------------------------------------TTTTFCGTPEYLAPEVIRKQPYDN  175 (325)
T ss_pred             --------------------------------------------------------CcccccCChhhCCHHHHcCCCCCC
Confidence                                                                    011235777788888877777777


Q ss_pred             CCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH----HH
Q psy8260         306 QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA----EQ  381 (427)
Q Consensus       306 ~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta----~e  381 (427)
                      ++|+||+|++++.|.++..+|..........+......        ...+..+.++.+||.+||+.||.+|+++    ++
T Consensus       176 ~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~  247 (325)
T cd05604         176 TVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL--------VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLE  247 (325)
T ss_pred             cCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc--------cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence            88999999999888776666644322222222222111        1123468899999999999999999987    58


Q ss_pred             HhcCCCCCCC
Q psy8260         382 ALAHPYLSQY  391 (427)
Q Consensus       382 ~L~Hp~f~~~  391 (427)
                      +++||||...
T Consensus       248 i~~h~~f~~~  257 (325)
T cd05604         248 IQEHPFFESL  257 (325)
T ss_pred             HhcCCCcCCC
Confidence            9999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-39  Score=309.10  Aligned_cols=256  Identities=22%  Similarity=0.271  Sum_probs=191.7

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH-HHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCce
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA-VHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      |++.+.||+|+||.||.+ .+..+++.||||++....... .....+.+|+.+++.++||||+++++.+...      ..
T Consensus         2 y~~~~~lg~G~~g~V~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~   74 (285)
T cd05605           2 FRHYRVLGKGGFGEVCAC-QVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK------DA   74 (285)
T ss_pred             ceEEEEEecCCCeEEEEE-EEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC------Ce
Confidence            567788999999999964 566789999999986532222 2234467899999999999999999887643      45


Q ss_pred             EEEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         145 VYMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       145 ~~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      ++++|+++ +++|...+..   ..+++..+..++.|++.||.|||++||+||||||+||++++++.++|+|||+++....
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  154 (285)
T cd05605          75 LCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE  154 (285)
T ss_pred             EEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence            78899887 6889877643   3589999999999999999999999999999999999999999999999998864321


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      ..                                                           ...+.+||+.|+|||++.+
T Consensus       155 ~~-----------------------------------------------------------~~~~~~~~~~y~aPE~~~~  175 (285)
T cd05605         155 GE-----------------------------------------------------------TIRGRVGTVGYMAPEVVKN  175 (285)
T ss_pred             CC-----------------------------------------------------------ccccccCCCCccCcHHhcC
Confidence            10                                                           0012346777777777776


Q ss_pred             ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC---
Q psy8260         301 WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI---  377 (427)
Q Consensus       301 ~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~---  377 (427)
                      ..+...+|+||+|++++.+.++..+|....................    .......++.+.+||.+||+.||++|+   
T Consensus       176 ~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~  251 (285)
T cd05605         176 ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ----EEYSEKFSEAARSICRQLLTKDPGFRLGCR  251 (285)
T ss_pred             CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc----cccCcccCHHHHHHHHHHccCCHHHhcCCC
Confidence            6677778999999999877665555543221111111111110000    112234688999999999999999999   


Q ss_pred             --CHHHHhcCCCCCCC
Q psy8260         378 --TAEQALAHPYLSQY  391 (427)
Q Consensus       378 --ta~e~L~Hp~f~~~  391 (427)
                        |++++++||||.+.
T Consensus       252 ~~~~~~l~~~~~~~~~  267 (285)
T cd05605         252 GEGAEEVKAHPFFRTA  267 (285)
T ss_pred             CCCHHHHhcCcCccCC
Confidence              99999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0668|consensus

Probab=100.00  E-value=1.5e-40  Score=291.74  Aligned_cols=282  Identities=26%  Similarity=0.500  Sum_probs=217.3

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCC-CCCceeeeeeeecCccccC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN-HENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~~  141 (427)
                      ..+|++.+.+|+|.++.||.+ .+..+.++++||.++.     ...+++.||+.+|..|. ||||++|+++.....    
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg-~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~----  106 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEG-INITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPE----  106 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcc-cccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCcc----
Confidence            356888999999999999965 4566788999998853     34567889999999996 999999999986542    


Q ss_pred             CceEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcC-CCCEEEeeCCCCCCCC
Q psy8260         142 FKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE-DCELKILDFGLARPTE  219 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~-~~~~kl~DFGla~~~~  219 (427)
                      ....-+++|+. +.++..+.  ..++...++.++.|++.||+|||++||+|||+||.|++||. ...++|+|+|||.+..
T Consensus       107 SktpaLiFE~v~n~Dfk~ly--~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  107 SKTPSLIFEYVNNTDFKQLY--PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             ccCchhHhhhhccccHHHHh--hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence            23445667776 55776654  35888999999999999999999999999999999999996 4689999999998765


Q ss_pred             C--CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         220 N--EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       220 ~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      .  +..-.+.|+.|.-||++.+...|+.+.      |+||.||+++.                 +              +
T Consensus       185 p~~eYnVRVASRyfKGPELLVdy~~YDYSL------D~WS~GcmlA~-----------------m--------------i  227 (338)
T KOG0668|consen  185 PGKEYNVRVASRYFKGPELLVDYQMYDYSL------DMWSLGCMLAS-----------------M--------------I  227 (338)
T ss_pred             CCceeeeeeehhhcCCchheeechhccccH------HHHHHHHHHHH-----------------H--------------H
Confidence            4  455678999999999999988888776      99999999866                 1              2


Q ss_pred             hhhccCCCCC-CHHHHHHHHHHhCCCCHH-HHhhcCcHHHHHHHhcCCCCCcccHHhhcC-----CCChhHHHHHHHhcC
Q psy8260         298 MLNWMHYNQT-DIHQLNLIMEMLGTPPAE-FMAKISSDSARKYINSLPLLTKKDFRQVFK-----GANPQAIDLLSLMLE  370 (427)
Q Consensus       298 l~~~~~~~~~-d~~slg~i~~~lg~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~s~~~~dLi~~mL~  370 (427)
                      +.+.++|.+. +..||-.|...||+.... +..+..-....++.........+.|..+..     -++|+|.|||.++|.
T Consensus       228 FrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLr  307 (338)
T KOG0668|consen  228 FRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLR  307 (338)
T ss_pred             hccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHh
Confidence            3444566665 688999999999985431 122211111112222223344455555432     257999999999999


Q ss_pred             CCCCCCCCHHHHhcCCCCCCCCC
Q psy8260         371 LDSEKRITAEQALAHPYLSQYSD  393 (427)
Q Consensus       371 ~dP~~R~ta~e~L~Hp~f~~~~~  393 (427)
                      +|...|+||+|++.||||.....
T Consensus       308 YDHqeRlTakEam~HpyF~~~~~  330 (338)
T KOG0668|consen  308 YDHQERLTAKEAMAHPYFAPVRE  330 (338)
T ss_pred             hccccccchHHHhcCchHHHHHH
Confidence            99999999999999999976543

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.7e-39  Score=330.52  Aligned_cols=267  Identities=18%  Similarity=0.248  Sum_probs=204.3

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc--
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC--  138 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~--  138 (427)
                      ...++|.+.+.||+|+||.||+ +.+..+|+.||||++............+.+|+.++..++|+||+++++.|.....  
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~-a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLC-AKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEE-EEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            3457899999999999999996 4567789999999987665555666678899999999999999999887653221  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRT-----QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDF  212 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DF  212 (427)
                      ......++++++|+ +++|.+.++.     ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF  187 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF  187 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence            11122467888887 7899988753     35899999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccc
Q psy8260         213 GLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWY  292 (427)
Q Consensus       213 Gla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y  292 (427)
                      |+++........                                                        ......+||+.|
T Consensus       188 Gls~~~~~~~~~--------------------------------------------------------~~~~~~~Gt~~Y  211 (496)
T PTZ00283        188 GFSKMYAATVSD--------------------------------------------------------DVGRTFCGTPYY  211 (496)
T ss_pred             ccCeeccccccc--------------------------------------------------------cccccccCCcce
Confidence            998753221000                                                        011234578888


Q ss_pred             cchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         293 RAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       293 ~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                      +|||++.+..+..++|+||+|++++.|.++..||..........+......       .......++++.+||.+||+.|
T Consensus       212 ~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~~L~~d  284 (496)
T PTZ00283        212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY-------DPLPPSISPEMQEIVTALLSSD  284 (496)
T ss_pred             eCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC-------CCCCCCCCHHHHHHHHHHcccC
Confidence            888888877778888999999999988766666643322122222211110       1123457889999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCC
Q psy8260         373 SEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       373 P~~R~ta~e~L~Hp~f~~~  391 (427)
                      |.+|||+.++++|||+...
T Consensus       285 P~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        285 PKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             hhhCcCHHHHHhCHHHHHh
Confidence            9999999999999998754

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=8.5e-39  Score=313.66  Aligned_cols=258  Identities=22%  Similarity=0.313  Sum_probs=188.3

Q ss_pred             ccccCcceeeccccCcccccEEEEeEE----eCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeee
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSAL----DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVF  133 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~  133 (427)
                      +++..++|.+.+.||+|+||.||++..    +..++..||||++... ........+.+|+.+|..+ +||||+++++++
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~   80 (338)
T cd05102           2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGAC   80 (338)
T ss_pred             cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence            356677899999999999999998653    2345678999998643 2333455678999999999 899999999986


Q ss_pred             ecCccccCCceEEEEeccC-CCCHHHHHhhC-------------------------------------------------
Q psy8260         134 HSNTCLADFKNVYMVTHLM-GADLNNILRTQ-------------------------------------------------  163 (427)
Q Consensus       134 ~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~-------------------------------------------------  163 (427)
                      ...     ...++++|||+ +|+|.+++...                                                 
T Consensus        81 ~~~-----~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (338)
T cd05102          81 TKP-----NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSG  155 (338)
T ss_pred             cCC-----CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCc
Confidence            532     23578888887 78998887531                                                 


Q ss_pred             --------------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccc
Q psy8260         164 --------------KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATR  229 (427)
Q Consensus       164 --------------~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~  229 (427)
                                    .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........     
T Consensus       156 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~-----  230 (338)
T cd05102         156 STNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-----  230 (338)
T ss_pred             ccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcch-----
Confidence                          3677888899999999999999999999999999999999999999999998743211000     


Q ss_pred             cccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCCCCCH
Q psy8260         230 WYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDI  309 (427)
Q Consensus       230 ~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~  309 (427)
                             .                                            ......+++.|+|||++.+..+..++|+
T Consensus       231 -------~--------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDi  259 (338)
T cd05102         231 -------V--------------------------------------------RKGSARLPLKWMAPESIFDKVYTTQSDV  259 (338)
T ss_pred             -------h--------------------------------------------cccCCCCCccccCcHHhhcCCCCcccCH
Confidence                   0                                            0001234567888888877778888999


Q ss_pred             HHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy8260         310 HQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALA  384 (427)
Q Consensus       310 ~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~  384 (427)
                      ||+|++++.+.+ +..||...................      ......++++.+||.+||+.||.+|||+.|+++
T Consensus       260 wslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         260 WSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM------RAPENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            999999986532 333332211111221111111111      112346788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=6.4e-39  Score=312.83  Aligned_cols=253  Identities=20%  Similarity=0.271  Sum_probs=192.8

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCC-CCCceeeeeeeecCccccCCc
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMN-HENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      |++.+.||+|+||.||. +.+..+|+.||||++.+... .....+....|+.+++.+. |++|++++++|...      .
T Consensus         2 f~~~~~lg~G~~g~Vy~-~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~------~   74 (323)
T cd05615           2 FNFLMVLGKGSFGKVML-AERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV------D   74 (323)
T ss_pred             ceEEEEEEecCCeEEEE-EEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecC------C
Confidence            56778999999999996 45677899999999865322 1223345668888888886 46788888887653      4


Q ss_pred             eEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      .+|+++|++ +++|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        75 ~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          75 RLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             EEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            689999988 7899888765 57999999999999999999999999999999999999999999999999998632111


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      ..                                                          ......||+.|+|||++.+.
T Consensus       155 ~~----------------------------------------------------------~~~~~~gt~~y~aPE~~~~~  176 (323)
T cd05615         155 GV----------------------------------------------------------TTRTFCGTPDYIAPEIIAYQ  176 (323)
T ss_pred             Cc----------------------------------------------------------cccCccCCccccCHHHHcCC
Confidence            00                                                          01123477888888888777


Q ss_pred             cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC---
Q psy8260         302 MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT---  378 (427)
Q Consensus       302 ~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t---  378 (427)
                      .+...+|+||+|++++.|.++..||.................        ......++++.+||.+||+.||.+|++   
T Consensus       177 ~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~--------~~p~~~~~~~~~li~~~l~~~p~~R~~~~~  248 (323)
T cd05615         177 PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV--------SYPKSLSKEAVSICKGLMTKHPSKRLGCGP  248 (323)
T ss_pred             CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--------CCCccCCHHHHHHHHHHcccCHhhCCCCCC
Confidence            777788999999999888776666643322222222221111        112356889999999999999999997   


Q ss_pred             --HHHHhcCCCCCCC
Q psy8260         379 --AEQALAHPYLSQY  391 (427)
Q Consensus       379 --a~e~L~Hp~f~~~  391 (427)
                        .+++++||||...
T Consensus       249 ~~~~~i~~h~~f~~~  263 (323)
T cd05615         249 EGERDIREHAFFRRI  263 (323)
T ss_pred             CCHHHHhcCcccCCC
Confidence              5789999999865

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=5.1e-39  Score=313.70  Aligned_cols=249  Identities=23%  Similarity=0.340  Sum_probs=187.4

Q ss_pred             cccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC-HHHHHHHHHHHH-HHhcCCCCCceeeeeeeecCccccCCceEEE
Q psy8260          70 PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS-AVHAKRTYRELR-MLKHMNHENVIGLLDVFHSNTCLADFKNVYM  147 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~-~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~l  147 (427)
                      +.||+|+||.||.+ .+..+++.||+|++.+.... ......+.+|.. +++.++||||+++++++...      ..+|+
T Consensus         1 ~~lg~G~fg~V~~~-~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~------~~~~l   73 (325)
T cd05602           1 KVIGKGSFGKVLLA-RHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA------DKLYF   73 (325)
T ss_pred             CeeeeCCCeEEEEE-EECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC------CeEEE
Confidence            36899999999964 56778899999998643211 122233444544 56789999999999988654      45788


Q ss_pred             EeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccc
Q psy8260         148 VTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGY  225 (427)
Q Consensus       148 v~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  225 (427)
                      ++|++ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......  
T Consensus        74 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--  151 (325)
T cd05602          74 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--  151 (325)
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--
Confidence            99888 6789888764 5689999999999999999999999999999999999999999999999999863211100  


Q ss_pred             cccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCC
Q psy8260         226 VATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYN  305 (427)
Q Consensus       226 ~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~  305 (427)
                                                                              .....+||+.|+|||++.+..+..
T Consensus       152 --------------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~  175 (325)
T cd05602         152 --------------------------------------------------------TTSTFCGTPEYLAPEVLHKQPYDR  175 (325)
T ss_pred             --------------------------------------------------------CcccccCCccccCHHHHcCCCCCC
Confidence                                                                    011235778888888887777777


Q ss_pred             CCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHH----H
Q psy8260         306 QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAE----Q  381 (427)
Q Consensus       306 ~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~----e  381 (427)
                      .+|+||+|++++.|.++..+|.............. .+.       .....+++++.+||.+||+.||.+|+++.    +
T Consensus       176 ~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-~~~-------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~  247 (325)
T cd05602         176 TVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN-KPL-------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFME  247 (325)
T ss_pred             ccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHh-CCc-------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence            88999999999988777666654322222222211 111       12245788999999999999999999876    8


Q ss_pred             HhcCCCCCCC
Q psy8260         382 ALAHPYLSQY  391 (427)
Q Consensus       382 ~L~Hp~f~~~  391 (427)
                      +++|+||...
T Consensus       248 i~~~~~~~~~  257 (325)
T cd05602         248 IKNHIFFSPI  257 (325)
T ss_pred             HhcCcccCCC
Confidence            9999999754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=6e-39  Score=314.19  Aligned_cols=260  Identities=19%  Similarity=0.258  Sum_probs=189.7

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      .|.+.+.||+|+||.||.+ ....+++.||+|.+.+... .......+.+|+.++..++|+||+++++++...      .
T Consensus         2 ~y~~~~~lG~G~fg~V~~~-~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------~   74 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVV-KLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDE------N   74 (332)
T ss_pred             CceEEEEEEeCCCeEEEEE-EECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC------C
Confidence            4778899999999999964 4567889999999864221 122233466899999999999999999988654      4


Q ss_pred             eEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      .+|+++|++ +++|.+++..  ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        75 ~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          75 NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME  154 (332)
T ss_pred             EEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence            678999987 7899998865  5689999999999999999999999999999999999999999999999999864321


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      ....                                                         .....+||+.|+|||++..
T Consensus       155 ~~~~---------------------------------------------------------~~~~~~gt~~y~aPE~~~~  177 (332)
T cd05623         155 DGTV---------------------------------------------------------QSSVAVGTPDYISPEILQA  177 (332)
T ss_pred             CCcc---------------------------------------------------------eecccccCccccCHHHHhc
Confidence            1100                                                         0011235555555555542


Q ss_pred             -----ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCC
Q psy8260         301 -----WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEK  375 (427)
Q Consensus       301 -----~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~  375 (427)
                           ..+...+|+||+|++++.|.++..||..........+........   .+......++++++|||.+||+.+|.+
T Consensus       178 ~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~---~~p~~~~~~s~~~~~li~~ll~~~~~r  254 (332)
T cd05623         178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF---QFPAQVTDVSEDAKDLIRRLICSREHR  254 (332)
T ss_pred             cccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccc---cCCCccccCCHHHHHHHHHHccChhhh
Confidence                 235567899999999998877766665432222222222111111   111223457899999999999776655


Q ss_pred             --CCCHHHHhcCCCCCCC
Q psy8260         376 --RITAEQALAHPYLSQY  391 (427)
Q Consensus       376 --R~ta~e~L~Hp~f~~~  391 (427)
                        |+|++|+++||||...
T Consensus       255 ~~r~~~~~~~~h~~f~~~  272 (332)
T cd05623         255 LGQNGIEDFKQHPFFTGI  272 (332)
T ss_pred             cCCCCHHHHhCCCCcCCC
Confidence              6899999999999864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0574|consensus

Probab=100.00  E-value=2.6e-41  Score=306.94  Aligned_cols=256  Identities=23%  Similarity=0.377  Sum_probs=201.9

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      ...|++...||+|+||+|+ .+.++.+|+.||||++...    .+.+.+.+|+.+|++++.|.||++|+.|...      
T Consensus        32 EEVFDi~~KLGEGSYGSV~-KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~------  100 (502)
T KOG0574|consen   32 EEVFDIVGKLGEGSYGSVH-KAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKH------  100 (502)
T ss_pred             HHHHHHHHHhcCCcchHHH-HHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccC------
Confidence            4568999999999999999 4778999999999998542    3466788999999999999999999876543      


Q ss_pred             ceEEEEeccCC-CCHHHHHh--hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         143 KNVYMVTHLMG-ADLNNILR--TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       143 ~~~~lv~e~~g-~~L~~~l~--~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                      ..+++|||||| |+..++++  ++.++++++..+++..+.||+|||...-||||||..|||++.+|.+||+|||+|....
T Consensus       101 sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT  180 (502)
T KOG0574|consen  101 SDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLT  180 (502)
T ss_pred             CceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhh
Confidence            35899999996 78999875  4679999999999999999999999999999999999999999999999999986543


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      ..+                                                          ..+.+..|||.||||||+.
T Consensus       181 DTM----------------------------------------------------------AKRNTVIGTPFWMAPEVI~  202 (502)
T KOG0574|consen  181 DTM----------------------------------------------------------AKRNTVIGTPFWMAPEVIE  202 (502)
T ss_pred             hhH----------------------------------------------------------HhhCccccCcccccHHHHH
Confidence            221                                                          1334567888888888888


Q ss_pred             hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH
Q psy8260         300 NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA  379 (427)
Q Consensus       300 ~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta  379 (427)
                      ...|....|+||||+..-+|..+.+|+.+-- .  .+ .+...|..++..|++ ....|.++-|||++||.++|++|.||
T Consensus       203 EIGY~~~ADIWSLGITaIEMAEG~PPYsDIH-P--MR-AIFMIPT~PPPTF~K-PE~WS~~F~DFi~~CLiK~PE~R~TA  277 (502)
T KOG0574|consen  203 EIGYDTKADIWSLGITAIEMAEGRPPYSDIH-P--MR-AIFMIPTKPPPTFKK-PEEWSSEFNDFIRSCLIKKPEERKTA  277 (502)
T ss_pred             HhccchhhhHhhhcchhhhhhcCCCCccccc-c--cc-eeEeccCCCCCCCCC-hHhhhhHHHHHHHHHhcCCHHHHHHH
Confidence            7778888899999988877744444443211 0  01 112233333322221 12347889999999999999999999


Q ss_pred             HHHhcCCCCCCCC
Q psy8260         380 EQALAHPYLSQYS  392 (427)
Q Consensus       380 ~e~L~Hp~f~~~~  392 (427)
                      -++++|||+++-.
T Consensus       278 ~~L~~H~FiknA~  290 (502)
T KOG0574|consen  278 LRLCEHTFIKNAP  290 (502)
T ss_pred             HHHhhhhhhcCCC
Confidence            9999999998653

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.8e-39  Score=332.95  Aligned_cols=266  Identities=26%  Similarity=0.280  Sum_probs=182.8

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccC--------------c-CCCHHHHHHHHHHHHHHhcCCCCCce
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIAR--------------P-FQSAVHAKRTYRELRMLKHMNHENVI  127 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~--------------~-~~~~~~~~~~~~Ei~~l~~l~HpnIv  127 (427)
                      .+.|.+.+.||+|+||.||.+.....++..+++|.+..              . .........+.+|+.+|++++|||||
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            35789999999999999998766554444444432110              0 11122344567999999999999999


Q ss_pred             eeeeeeecCccccCCceEEEEeccCCCCHHHHHhhCC------CCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEE
Q psy8260         128 GLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQK------LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV  201 (427)
Q Consensus       128 ~l~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~l~~~~------l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl  201 (427)
                      ++++++...      ...|+++++++++|..++....      .....++.++.||+.||.|||++|||||||||+|||+
T Consensus       227 ~l~~~~~~~------~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl  300 (501)
T PHA03210        227 KIEEILRSE------ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL  300 (501)
T ss_pred             cEeEEEEEC------CeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence            999998754      4578888888888887764432      3456778899999999999999999999999999999


Q ss_pred             cCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcc
Q psy8260         202 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTEN  281 (427)
Q Consensus       202 ~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~  281 (427)
                      +.++.+||+|||+++........                                                         
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~---------------------------------------------------------  323 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREA---------------------------------------------------------  323 (501)
T ss_pred             CCCCCEEEEeCCCceecCccccc---------------------------------------------------------
Confidence            99999999999998754321100                                                         


Q ss_pred             ccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCH-HHHhhcCc--HHHHHHHhcC-------CC-------
Q psy8260         282 EMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPA-EFMAKISS--DSARKYINSL-------PL-------  344 (427)
Q Consensus       282 ~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~-~~~~~~~~--~~~~~~~~~~-------~~-------  344 (427)
                      ...+.+||+.|+|||++.+..+...+|+||+|++++.|.++.. ++......  ....+.+...       +.       
T Consensus       324 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~  403 (501)
T PHA03210        324 FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFD  403 (501)
T ss_pred             ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHH
Confidence            0112356777777777777667777899999998877643221 11111000  0111111100       00       


Q ss_pred             --------CCcccHHhhc--CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q psy8260         345 --------LTKKDFRQVF--KGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       345 --------~~~~~~~~~~--~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~  391 (427)
                              .....+...+  ...+.++.++|.+||++||.+||||.|+|+||||...
T Consensus       404 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~  460 (501)
T PHA03210        404 YIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE  460 (501)
T ss_pred             HhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence                    0000111111  1346788999999999999999999999999999764

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=7.3e-39  Score=312.05  Aligned_cols=249  Identities=24%  Similarity=0.345  Sum_probs=186.5

Q ss_pred             cccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHH-HHhcCCCCCceeeeeeeecCccccCCceEEE
Q psy8260          70 PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELR-MLKHMNHENVIGLLDVFHSNTCLADFKNVYM  147 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~-~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~l  147 (427)
                      +.||+|+||.||. +.+..+|+.||+|++.+... .......+.+|.. +++.++||||+++++++...      ..+|+
T Consensus         1 ~~lg~G~~g~Vy~-~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~------~~~~l   73 (321)
T cd05603           1 KVIGKGSFGKVLL-AKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA------EKLYF   73 (321)
T ss_pred             CeeeeCCCEEEEE-EEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC------CEEEE
Confidence            3689999999996 45677899999999865322 1222334555654 67889999999999888653      46789


Q ss_pred             EeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccc
Q psy8260         148 VTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGY  225 (427)
Q Consensus       148 v~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  225 (427)
                      ++|++ +++|...+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......  
T Consensus        74 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--  151 (321)
T cd05603          74 VLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--  151 (321)
T ss_pred             EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--
Confidence            99988 6788776654 5689999999999999999999999999999999999999999999999999863211000  


Q ss_pred             cccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCC
Q psy8260         226 VATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYN  305 (427)
Q Consensus       226 ~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~  305 (427)
                                                                              .....+||+.|+|||++.+..+..
T Consensus       152 --------------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~  175 (321)
T cd05603         152 --------------------------------------------------------TTSTFCGTPEYLAPEVLRKEPYDR  175 (321)
T ss_pred             --------------------------------------------------------ccccccCCcccCCHHHhcCCCCCC
Confidence                                                                    111235777788888877766777


Q ss_pred             CCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH----HH
Q psy8260         306 QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA----EQ  381 (427)
Q Consensus       306 ~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta----~e  381 (427)
                      ++|+||+|++++.|.++..+|............... +.       ......+.++.+||.+||+.||.+|+++    .|
T Consensus       176 ~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-~~-------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~  247 (321)
T cd05603         176 TVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK-PL-------QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLE  247 (321)
T ss_pred             cCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC-CC-------CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHH
Confidence            889999999999887776666443211111111111 10       1223567889999999999999999976    49


Q ss_pred             HhcCCCCCCC
Q psy8260         382 ALAHPYLSQY  391 (427)
Q Consensus       382 ~L~Hp~f~~~  391 (427)
                      +++||||...
T Consensus       248 ~~~~~~~~~~  257 (321)
T cd05603         248 IKNHVFFSPI  257 (321)
T ss_pred             HhCCCCcCCC
Confidence            9999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0577|consensus

Probab=100.00  E-value=4.3e-40  Score=321.48  Aligned_cols=257  Identities=22%  Similarity=0.329  Sum_probs=193.5

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcC-CCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPF-QSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      ...|.-.+.||.|+||.||+ +.+..+.+.||||++.-.. ++...-..+++|++.|++++|||++.+.++|-..     
T Consensus        25 Eklf~dLrEIGHGSFGAVYf-Ard~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre-----   98 (948)
T KOG0577|consen   25 EKLFSDLREIGHGSFGAVYF-ARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE-----   98 (948)
T ss_pred             HHHHHHHHHhcCCccceeEE-eeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc-----
Confidence            34455557899999999997 5677899999999997543 3444567789999999999999999999887543     


Q ss_pred             CceEEEEeccCCCCHHHHHh--hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         142 FKNVYMVTHLMGADLNNILR--TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       142 ~~~~~lv~e~~g~~L~~~l~--~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                       ...++|||||-|+-.+++.  .+++-+.++..|+.+.+.||.|||+.+.||||||..|||+++.|.|||+|||.|....
T Consensus        99 -~TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~  177 (948)
T KOG0577|consen   99 -HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA  177 (948)
T ss_pred             -chHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC
Confidence             3458999999777777764  4679999999999999999999999999999999999999999999999999875432


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                       ...+++|||+|||||+|+.-                      +                                    
T Consensus       178 -PAnsFvGTPywMAPEVILAM----------------------D------------------------------------  198 (948)
T KOG0577|consen  178 -PANSFVGTPYWMAPEVILAM----------------------D------------------------------------  198 (948)
T ss_pred             -chhcccCCccccchhHheec----------------------c------------------------------------
Confidence             23445666666666665420                      0                                    


Q ss_pred             hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHH-hcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC
Q psy8260         300 NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYI-NSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT  378 (427)
Q Consensus       300 ~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t  378 (427)
                      ...|+.++|+||||+..-.|.-..+|...-+.-.....+. +..|.+....|+       ..+..|+..||++-|..|||
T Consensus       199 EGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS-------~~F~~Fvd~CLqKipqeRpt  271 (948)
T KOG0577|consen  199 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWS-------DYFRNFVDSCLQKIPQERPT  271 (948)
T ss_pred             ccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhH-------HHHHHHHHHHHhhCcccCCc
Confidence            0126667899999987766644333332222111222222 234666665554       45689999999999999999


Q ss_pred             HHHHhcCCCCCCCC
Q psy8260         379 AEQALAHPYLSQYS  392 (427)
Q Consensus       379 a~e~L~Hp~f~~~~  392 (427)
                      ++++|.|+|+..-+
T Consensus       272 se~ll~H~fv~R~R  285 (948)
T KOG0577|consen  272 SEELLKHRFVLRER  285 (948)
T ss_pred             HHHHhhcchhccCC
Confidence            99999999997654

>KOG0690|consensus

Probab=100.00  E-value=4.1e-40  Score=301.99  Aligned_cols=258  Identities=24%  Similarity=0.330  Sum_probs=207.1

Q ss_pred             cCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHH-HHHHHHHHHHHHhcCCCCCceeeeeeeecCcccc
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAV-HAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  140 (427)
                      .-.+|+..+.||+|.||.|.. +..+.+|+.+|||++++...-.. .....+.|-++|+..+||.+..|...|+..    
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL-~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~----  240 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVIL-CREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ----  240 (516)
T ss_pred             ccchhhHHHHhcCCccceEEE-EeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC----
Confidence            345688899999999999995 67888999999999877543322 234467899999999999999998777664    


Q ss_pred             CCceEEEEeccC-CCCHHH-HHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCC
Q psy8260         141 DFKNVYMVTHLM-GADLNN-ILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT  218 (427)
Q Consensus       141 ~~~~~~lv~e~~-g~~L~~-~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~  218 (427)
                        ..+++||+|. ||.|.- +-+...|+++.++.+...|+.||.|||+++||.||||.+|+|+|.+|++||+||||++..
T Consensus       241 --drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~  318 (516)
T KOG0690|consen  241 --DRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE  318 (516)
T ss_pred             --ceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc
Confidence              4688999988 677654 445677999999999999999999999999999999999999999999999999998742


Q ss_pred             CCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         219 ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       219 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                      -..                                                    |      ....++||||.|+||||+
T Consensus       319 I~~----------------------------------------------------g------~t~kTFCGTPEYLAPEVl  340 (516)
T KOG0690|consen  319 IKY----------------------------------------------------G------DTTKTFCGTPEYLAPEVL  340 (516)
T ss_pred             ccc----------------------------------------------------c------ceeccccCChhhcCchhh
Confidence            110                                                    0      134567888888888888


Q ss_pred             hhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC-
Q psy8260         299 LNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI-  377 (427)
Q Consensus       299 ~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~-  377 (427)
                      ...-|+..+|||-+|+++|+|-.+..||..+........++....        ++.+.+|++|+.||..+|.+||++|+ 
T Consensus       341 eDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~--------kFPr~ls~eAktLLsGLL~kdP~kRLG  412 (516)
T KOG0690|consen  341 EDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL--------KFPRTLSPEAKTLLSGLLKKDPKKRLG  412 (516)
T ss_pred             ccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc--------cCCccCCHHHHHHHHHHhhcChHhhcC
Confidence            888888899999999999998888878876543333322221111        12356899999999999999999998 


Q ss_pred             ----CHHHHhcCCCCCCCC
Q psy8260         378 ----TAEQALAHPYLSQYS  392 (427)
Q Consensus       378 ----ta~e~L~Hp~f~~~~  392 (427)
                          .|.|+++|+||....
T Consensus       413 gGpdDakEi~~h~FF~~v~  431 (516)
T KOG0690|consen  413 GGPDDAKEIMRHRFFASVD  431 (516)
T ss_pred             CCchhHHHHHhhhhhccCC
Confidence                589999999998654

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=6.9e-39  Score=313.66  Aligned_cols=260  Identities=18%  Similarity=0.245  Sum_probs=190.9

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      .|.+.+.||+|+||.||.+ .+..+++.||+|.+.+... .......+.+|+.++..++|+||+++++++...      .
T Consensus         2 ~y~i~~~lG~G~fg~V~~~-~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~------~   74 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVV-KMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDE------N   74 (331)
T ss_pred             CceEEEEEeeCCCeEEEEE-EECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC------C
Confidence            5778899999999999964 5667899999999864221 122234466889999999999999999988654      4


Q ss_pred             eEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      ..|++||++ |++|.+++..  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        75 ~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  154 (331)
T cd05624          75 YLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ  154 (331)
T ss_pred             EEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence            678999987 8899998864  4689999999999999999999999999999999999999999999999999864332


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      ....                                                         ......||+.|+|||++.+
T Consensus       155 ~~~~---------------------------------------------------------~~~~~~gt~~y~aPE~~~~  177 (331)
T cd05624         155 DGTV---------------------------------------------------------QSSVAVGTPDYISPEILQA  177 (331)
T ss_pred             CCce---------------------------------------------------------eeccccCCcccCCHHHHhc
Confidence            1100                                                         0001235555666665543


Q ss_pred             -----ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCC
Q psy8260         301 -----WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEK  375 (427)
Q Consensus       301 -----~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~  375 (427)
                           ..+...+|+||+|++++.|.++..||..........+........   .+......++++++|||.+||+.++.+
T Consensus       178 ~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~---~~p~~~~~~~~~~~~li~~ll~~~~~~  254 (331)
T cd05624         178 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF---QFPSHITDVSEEAKDLIQRLICSRERR  254 (331)
T ss_pred             cccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcc---cCCCccccCCHHHHHHHHHHccCchhh
Confidence                 234556799999999998877766664332222222222111111   122223457899999999999976655


Q ss_pred             --CCCHHHHhcCCCCCCC
Q psy8260         376 --RITAEQALAHPYLSQY  391 (427)
Q Consensus       376 --R~ta~e~L~Hp~f~~~  391 (427)
                        |++++++++||||...
T Consensus       255 ~~~~~~~~~~~h~~f~~~  272 (331)
T cd05624         255 LGQNGIEDFKKHAFFEGI  272 (331)
T ss_pred             cCCCCHHHHhcCCCcCCC
Confidence              5799999999999864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.5e-38  Score=304.73  Aligned_cols=256  Identities=22%  Similarity=0.294  Sum_probs=192.2

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC-HHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCce
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS-AVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      |++.+.||+|+||.||. +.+..+++.||||.+...... ......+.+|+.++++++|+||+.+++.+...      ..
T Consensus         2 f~~~~~ig~G~~g~v~~-~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~------~~   74 (285)
T cd05630           2 FRQYRVLGKGGFGEVCA-CQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK------DA   74 (285)
T ss_pred             ceeeEEeecCCCeEEEE-EEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC------CE
Confidence            56678899999999995 567778999999988653222 22234567899999999999999999887643      45


Q ss_pred             EEEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         145 VYMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       145 ~~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      .+++++++ +++|.+++..   ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus        75 ~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  154 (285)
T cd05630          75 LCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  154 (285)
T ss_pred             EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence            78888877 7899887743   3589999999999999999999999999999999999999999999999998754221


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      ..                                                           ...+..||+.|+|||++.+
T Consensus       155 ~~-----------------------------------------------------------~~~~~~g~~~y~aPE~~~~  175 (285)
T cd05630         155 GQ-----------------------------------------------------------TIKGRVGTVGYMAPEVVKN  175 (285)
T ss_pred             Cc-----------------------------------------------------------cccCCCCCccccChHHHcC
Confidence            10                                                           0012246778888888877


Q ss_pred             ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC--
Q psy8260         301 WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT--  378 (427)
Q Consensus       301 ~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t--  378 (427)
                      ..+..++|+||+|++++.+.++..||...................    ........++++++||.+||+.||.+|+|  
T Consensus       176 ~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~  251 (285)
T cd05630         176 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV----QEEYSEKFSPDARSLCKMLLCKDPKERLGCQ  251 (285)
T ss_pred             CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh----hhhcCccCCHHHHHHHHHHhhcCHHHccCCC
Confidence            777778899999999988866655554321111011110000000    01123456889999999999999999999  


Q ss_pred             ---HHHHhcCCCCCCC
Q psy8260         379 ---AEQALAHPYLSQY  391 (427)
Q Consensus       379 ---a~e~L~Hp~f~~~  391 (427)
                         ++|+++||||.+.
T Consensus       252 ~~~~~~~~~h~~~~~~  267 (285)
T cd05630         252 GGGAREVKEHPLFKQI  267 (285)
T ss_pred             CCchHHHHcChhhhcc
Confidence               9999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.1e-38  Score=311.60  Aligned_cols=280  Identities=35%  Similarity=0.583  Sum_probs=203.7

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCc-----
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNT-----  137 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-----  137 (427)
                      .++|.+.+.||.|+||.||. +.+..+|+.||+|++.....  ...+.+.+|+++++.++||||+++++++....     
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~-~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFS-AVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE   80 (342)
T ss_pred             CcceEEEEEecCCCCEEEEE-EEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence            36788999999999999996 56778899999998865432  33455778999999999999999998875432     


Q ss_pred             ---cccCCceEEEEeccCCCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcC-CCCEEEeeCC
Q psy8260         138 ---CLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE-DCELKILDFG  213 (427)
Q Consensus       138 ---~~~~~~~~~lv~e~~g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~-~~~~kl~DFG  213 (427)
                         ...+....|+++++++++|.+.+....+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||
T Consensus        81 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg  160 (342)
T cd07854          81 DVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFG  160 (342)
T ss_pred             ccccccccceEEEEeecccccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcc
Confidence               111234678999999889998888778999999999999999999999999999999999999974 5678999999


Q ss_pred             CCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccccc
Q psy8260         214 LARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR  293 (427)
Q Consensus       214 la~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~  293 (427)
                      +++........ .                                                      .......|+..|+
T Consensus       161 ~~~~~~~~~~~-~------------------------------------------------------~~~~~~~~~~~y~  185 (342)
T cd07854         161 LARIVDPHYSH-K------------------------------------------------------GYLSEGLVTKWYR  185 (342)
T ss_pred             cceecCCcccc-c------------------------------------------------------ccccccccccccc
Confidence            98643211000 0                                                      0001123566788


Q ss_pred             chHHhhh-ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCC----------------------CCCcccH
Q psy8260         294 APEIMLN-WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLP----------------------LLTKKDF  350 (427)
Q Consensus       294 APEvl~~-~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~  350 (427)
                      |||++.. ..+..++|+||+|++++.+-++..+|................+                      .......
T Consensus       186 aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (342)
T cd07854         186 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPL  265 (342)
T ss_pred             CHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCH
Confidence            8887643 3455678999999999877555544432211111111111111                      1111223


Q ss_pred             HhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCCC
Q psy8260         351 RQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTS  400 (427)
Q Consensus       351 ~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~  400 (427)
                      .......+.++++||.+||+.||.+|||++|+|+||||..+..|...+.+
T Consensus       266 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~~~~~~  315 (342)
T cd07854         266 RDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEPVS  315 (342)
T ss_pred             HHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCccccCC
Confidence            33445678999999999999999999999999999999987666555544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.5e-38  Score=310.54  Aligned_cols=267  Identities=18%  Similarity=0.238  Sum_probs=188.3

Q ss_pred             eccccCcc--cccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceE
Q psy8260          68 IGPTLSKE--SFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV  145 (427)
Q Consensus        68 ~~~~lg~g--~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~  145 (427)
                      +.+.||+|  +|+.||. +.++.+|+.||||++............+.+|+.+++.++||||++++++|..+      ...
T Consensus         2 ~~~~ig~G~~~~~~v~~-~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~------~~~   74 (327)
T cd08227           2 LLTVIGRGFEDLMTVNL-ARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD------NEL   74 (327)
T ss_pred             hhhhccccccceEEEEE-EeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC------CEE
Confidence            45788999  6677875 56778999999999876544444455667899999999999999999998654      457


Q ss_pred             EEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         146 YMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       146 ~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      +++++++ +++|.+++..   ..+++..+..++.|++.||+|||++||+||||||+|||++.++.++++|||.+......
T Consensus        75 ~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~  154 (327)
T cd08227          75 WVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINH  154 (327)
T ss_pred             EEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccc
Confidence            8888888 6789888753   35899999999999999999999999999999999999999999999999865422110


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      .....                                          ...+         ......++..|+|||++.+.
T Consensus       155 ~~~~~------------------------------------------~~~~---------~~~~~~~~~~y~aPE~~~~~  183 (327)
T cd08227         155 GQRLR------------------------------------------VVHD---------FPKYSVKVLPWLSPEVLQQN  183 (327)
T ss_pred             ccccc------------------------------------------cccc---------ccccccceecccChHHhhcc
Confidence            00000                                          0000         00112456779999998753


Q ss_pred             --cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhc-CCCC---------------------------------
Q psy8260         302 --MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINS-LPLL---------------------------------  345 (427)
Q Consensus       302 --~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~-~~~~---------------------------------  345 (427)
                        .+..++|+||+|++++.+.++..+|............... .+..                                 
T Consensus       184 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (327)
T cd08227         184 LQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTP  263 (327)
T ss_pred             cCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCc
Confidence              4667789999999998885554444321111100000000 0000                                 


Q ss_pred             ----CcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q psy8260         346 ----TKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYS  392 (427)
Q Consensus       346 ----~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~  392 (427)
                          ............++++.+||.+||++||++|||++|+++||||++..
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         264 RPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             CccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence                00000112234578899999999999999999999999999998753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.3e-38  Score=303.74  Aligned_cols=253  Identities=21%  Similarity=0.267  Sum_probs=185.6

Q ss_pred             cCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHH-HHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEEEec
Q psy8260          72 LSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAV-HAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH  150 (427)
Q Consensus        72 lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~lv~e  150 (427)
                      ||+|+||.||. +.+..+|+.||+|++........ .......|++++++++||||++++++|...      ..+|++||
T Consensus         1 lg~G~~g~Vy~-~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~------~~~~lv~e   73 (277)
T cd05607           1 LGKGGFGEVCA-VQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESK------THLCLVMS   73 (277)
T ss_pred             CCCCCceEEEE-EEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecC------CeEEEEEe
Confidence            68999999995 45667899999999864322211 223445799999999999999999988653      45788998


Q ss_pred             cC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCccccc
Q psy8260         151 LM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV  226 (427)
Q Consensus       151 ~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  226 (427)
                      ++ |++|...+..   ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......    
T Consensus        74 ~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~----  149 (277)
T cd05607          74 LMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK----  149 (277)
T ss_pred             cCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc----
Confidence            88 7889877643   358889999999999999999999999999999999999999999999999876432110    


Q ss_pred             ccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCCC
Q psy8260         227 ATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQ  306 (427)
Q Consensus       227 gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~  306 (427)
                                                                             ......||+.|+|||++.+..+..+
T Consensus       150 -------------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~  174 (277)
T cd05607         150 -------------------------------------------------------TITQRAGTNGYMAPEILKEEPYSYP  174 (277)
T ss_pred             -------------------------------------------------------eeeccCCCCCccCHHHHccCCCCCc
Confidence                                                                   0011246777888888877777778


Q ss_pred             CCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH----HHH
Q psy8260         307 TDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA----EQA  382 (427)
Q Consensus       307 ~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta----~e~  382 (427)
                      +|+||+|++++.+.++..+|..................   ..........+++++|||++||++||.+|+|+    +++
T Consensus       175 ~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         175 VDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE---DEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             hhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc---cccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            89999999998886655555322111111111111000   00001123568899999999999999999999    778


Q ss_pred             hcCCCCCCCCC
Q psy8260         383 LAHPYLSQYSD  393 (427)
Q Consensus       383 L~Hp~f~~~~~  393 (427)
                      ++||||.....
T Consensus       252 ~~h~~f~~~~~  262 (277)
T cd05607         252 RKHEFFKTINF  262 (277)
T ss_pred             hcChhhcCCCH
Confidence            89999987543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.8e-38  Score=310.20  Aligned_cols=251  Identities=20%  Similarity=0.311  Sum_probs=188.9

Q ss_pred             cccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC-HHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCccccCCceEEE
Q psy8260          70 PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS-AVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLADFKNVYM  147 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~~~~~~~l  147 (427)
                      +.||+|+||.||.+ .+..+++.||+|++.+.... ......+.+|+.++.++ +||||+++++++...      ..+|+
T Consensus         1 ~~lG~G~~g~V~~~-~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~------~~~~l   73 (327)
T cd05617           1 RVIGRGSYAKVLLV-RLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT------SRLFL   73 (327)
T ss_pred             CeeeeCCCeEEEEE-EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC------CEEEE
Confidence            36899999999964 56678999999998754322 23345567899998888 699999999988653      46789


Q ss_pred             EeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccc
Q psy8260         148 VTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGY  225 (427)
Q Consensus       148 v~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  225 (427)
                      ++|++ +++|...+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......  
T Consensus        74 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--  151 (327)
T cd05617          74 VIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--  151 (327)
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--
Confidence            99988 7899877654 5799999999999999999999999999999999999999999999999998863211000  


Q ss_pred             cccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCC
Q psy8260         226 VATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYN  305 (427)
Q Consensus       226 ~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~  305 (427)
                                                                              .....+||+.|+|||++.+..+..
T Consensus       152 --------------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~  175 (327)
T cd05617         152 --------------------------------------------------------TTSTFCGTPNYIAPEILRGEEYGF  175 (327)
T ss_pred             --------------------------------------------------------ceecccCCcccCCHHHHCCCCCCc
Confidence                                                                    011235777788888877777777


Q ss_pred             CCCHHHHHHHHHHhCCCCHHHHhhcCc------HHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH
Q psy8260         306 QTDIHQLNLIMEMLGTPPAEFMAKISS------DSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA  379 (427)
Q Consensus       306 ~~d~~slg~i~~~lg~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta  379 (427)
                      ++|+||+|++++.|.++..||......      ..........+.       ......++.+.+||.+||+.||++|+++
T Consensus       176 ~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------~~p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         176 SVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI-------RIPRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             hheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC-------CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            889999999998886666555321100      011111111110       1223468899999999999999999984


Q ss_pred             ------HHHhcCCCCCCCC
Q psy8260         380 ------EQALAHPYLSQYS  392 (427)
Q Consensus       380 ------~e~L~Hp~f~~~~  392 (427)
                            +++++||||....
T Consensus       249 ~~~~~~~~i~~h~~f~~~~  267 (327)
T cd05617         249 QPQTGFSDIKSHTFFRSID  267 (327)
T ss_pred             CCCCCHHHHHcCCCCCCCC
Confidence                  6999999998653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.6e-38  Score=325.84  Aligned_cols=256  Identities=21%  Similarity=0.284  Sum_probs=195.2

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      ..|.+.+.+|+|+||.||.+.....+++.||+|.+...  .......+.+|+.+|+.++|||||+++++|...      .
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~------~  138 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSD------D  138 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC------C
Confidence            44889999999999999976544444788999987543  333344567899999999999999999998654      4


Q ss_pred             eEEEEeccC-CCCHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRT-----QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP  217 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~  217 (427)
                      .+|++||++ |++|.+.+..     ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       139 ~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~  218 (478)
T PTZ00267        139 KLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQ  218 (478)
T ss_pred             EEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCcee
Confidence            689999998 7899877642     3589999999999999999999999999999999999999999999999999875


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      .......                                                        ......+||+.|+|||+
T Consensus       219 ~~~~~~~--------------------------------------------------------~~~~~~~gt~~y~aPE~  242 (478)
T PTZ00267        219 YSDSVSL--------------------------------------------------------DVASSFCGTPYYLAPEL  242 (478)
T ss_pred             cCCcccc--------------------------------------------------------ccccccCCCccccCHhH
Confidence            3221100                                                        01123457888888888


Q ss_pred             hhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC
Q psy8260         298 MLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI  377 (427)
Q Consensus       298 l~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~  377 (427)
                      +.+..+..++|+||+|++++.|.++..||.................       ......+++++++||.+||+.||++||
T Consensus       243 ~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~-------~~~~~~~s~~~~~li~~~L~~dP~~Rp  315 (478)
T PTZ00267        243 WERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY-------DPFPCPVSSGMKALLDPLLSKNPALRP  315 (478)
T ss_pred             hCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-------CCCCccCCHHHHHHHHHHhccChhhCc
Confidence            8777777788999999999888666555532211111222211111       011234678999999999999999999


Q ss_pred             CHHHHhcCCCCCC
Q psy8260         378 TAEQALAHPYLSQ  390 (427)
Q Consensus       378 ta~e~L~Hp~f~~  390 (427)
                      |++|+++|||+..
T Consensus       316 s~~~~l~~~~~~~  328 (478)
T PTZ00267        316 TTQQLLHTEFLKY  328 (478)
T ss_pred             CHHHHHhCHHHHH
Confidence            9999999999863

>KOG0579|consensus

Probab=100.00  E-value=4.4e-40  Score=323.28  Aligned_cols=258  Identities=23%  Similarity=0.403  Sum_probs=192.1

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      +..|+|...||-|+||.||+ +.++.++...|.|+|..  .+....+.++-||.||..++||+||+|++.|...      
T Consensus        31 ~d~WeIiGELGDGAFGKVyK-A~nket~~lAAaKvIet--kseEELEDylVEIeILa~CdHP~ivkLl~ayy~e------  101 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYK-AVNKETKLLAAAKVIET--KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE------  101 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhh-hhcccchhhhhhhhhcc--cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc------
Confidence            34577778899999999995 56778888889998854  3556677888999999999999999999887654      


Q ss_pred             ceEEEEeccC-CCCHHHHHh--hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILR--TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~--~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                      +.++|+.++| ||....++-  ...+.+++++.+++|++.||.|||+++|||||||..|||++-+|.++|+|||++....
T Consensus       102 nkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~  181 (1187)
T KOG0579|consen  102 NKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK  181 (1187)
T ss_pred             CceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccch
Confidence            3567777888 556666553  4679999999999999999999999999999999999999999999999999874321


Q ss_pred             ---CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         220 ---NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       220 ---~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                         ....+++||++|||||++..                                                        |
T Consensus       182 ~t~qkRDsFIGTPYWMAPEVvmC--------------------------------------------------------E  205 (1187)
T KOG0579|consen  182 STRQKRDSFIGTPYWMAPEVVMC--------------------------------------------------------E  205 (1187)
T ss_pred             hHHhhhccccCCcccccchheee--------------------------------------------------------c
Confidence               23345667777777776431                                                        1


Q ss_pred             HhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCC--CCCcccHHhhcCCCChhHHHHHHHhcCCCCC
Q psy8260         297 IMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLP--LLTKKDFRQVFKGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       297 vl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~  374 (427)
                      .+...+|+.+.||||||+.+-.|...-+|-..-..-.-..+...+-|  ...+..|       +..+.|||.+||..||.
T Consensus       206 T~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~W-------s~~F~DfLk~cL~Knp~  278 (1187)
T KOG0579|consen  206 TFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHW-------SRSFSDFLKRCLVKNPR  278 (1187)
T ss_pred             cccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchh-------hhHHHHHHHHHHhcCCc
Confidence            11234577788999999988777443322221111111122222222  2233333       55788999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCC
Q psy8260         375 KRITAEQALAHPYLSQYS  392 (427)
Q Consensus       375 ~R~ta~e~L~Hp~f~~~~  392 (427)
                      .||++.|+|+||||....
T Consensus       279 ~Rp~aaqll~Hpfv~~~~  296 (1187)
T KOG0579|consen  279 NRPPAAQLLKHPFVQNAP  296 (1187)
T ss_pred             cCCCHHHHhhCcccccCC
Confidence            999999999999998643

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=4.6e-38  Score=302.57  Aligned_cols=266  Identities=34%  Similarity=0.546  Sum_probs=193.0

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC---HHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS---AVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      |++.+.||.|+||.||.+ .+..+|+.||||++......   ......+.+|+.+++.++|+||+++++++...      
T Consensus         2 y~~~~~lg~g~~~~vy~~-~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~------   74 (298)
T cd07841           2 YEKGKKLGEGTYAVVYKA-RDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK------   74 (298)
T ss_pred             ceeeeeeeeccccEEEEE-EECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecC------
Confidence            567788999999999965 45667999999998654332   22334466899999999999999999998653      


Q ss_pred             ceEEEEeccCCCCHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         143 KNVYMVTHLMGADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       143 ~~~~lv~e~~g~~L~~~l~~~--~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      ...++++++++++|.+++...  .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus        75 ~~~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          75 SNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             CEEEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            467899999999999998764  499999999999999999999999999999999999999999999999999864322


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      ...                                                          ......+++.|+|||++.+
T Consensus       155 ~~~----------------------------------------------------------~~~~~~~~~~y~aPE~~~~  176 (298)
T cd07841         155 PNR----------------------------------------------------------KMTHQVVTRWYRAPELLFG  176 (298)
T ss_pred             CCc----------------------------------------------------------cccccccceeeeCHHHHhC
Confidence            100                                                          0011234556677776643


Q ss_pred             c-cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcC--------------------CCCCcccHHhhcCCCCh
Q psy8260         301 W-MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSL--------------------PLLTKKDFRQVFKGANP  359 (427)
Q Consensus       301 ~-~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~s~  359 (427)
                      . .+...+|+|++|++++.+.++..+|......+...+.....                    ...........+...+.
T Consensus       177 ~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (298)
T cd07841         177 ARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASD  256 (298)
T ss_pred             CCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccH
Confidence            2 24456799999988877654433222211111111111100                    00111122334456688


Q ss_pred             hHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCC
Q psy8260         360 QAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPND  396 (427)
Q Consensus       360 ~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~  396 (427)
                      ++++||.+||++||++|+|++|+++||||.+...|..
T Consensus       257 ~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~  293 (298)
T cd07841         257 DALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP  293 (298)
T ss_pred             HHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence            9999999999999999999999999999998765543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=4e-38  Score=334.24  Aligned_cols=166  Identities=23%  Similarity=0.382  Sum_probs=137.0

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      ..|.+.+.||+|+||.||.+ .+..+++.||||++..... .......+.+|+.+++.++||||+++++++...      
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a-~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~------   76 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLG-RKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSA------   76 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEE-EECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC------
Confidence            45788899999999999964 5667899999999865322 233445677899999999999999999887543      


Q ss_pred             ceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      ..+|++|+++ |++|.+++.. +.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+++....
T Consensus        77 ~~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~  156 (669)
T cd05610          77 NNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN  156 (669)
T ss_pred             CEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccccC
Confidence            4689999988 7899998864 5689999999999999999999999999999999999999999999999999986532


Q ss_pred             ---Ccccccccccccchhh
Q psy8260         221 ---EMTGYVATRWYRAPEI  236 (427)
Q Consensus       221 ---~~~~~~gt~~y~aPE~  236 (427)
                         ......+|+.|++||.
T Consensus       157 ~~~~~~~~~~t~~~~~pe~  175 (669)
T cd05610         157 RELNMMDILTTPSMAKPKN  175 (669)
T ss_pred             CcccccccccCccccCccc
Confidence               2234567777777763

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-37  Score=302.11  Aligned_cols=296  Identities=22%  Similarity=0.274  Sum_probs=208.6

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH-HHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA-VHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      .|.+.+.||.|+||.||. +.+..+++.||+|.+....... ...+.+.+|+++++.++||||+++++.+...      .
T Consensus         2 ~y~~~~~ig~g~~g~vy~-~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~   74 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFL-VRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTE------T   74 (316)
T ss_pred             ceEEeeeecCCccEEEEE-EEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecC------C
Confidence            467888999999999996 4566689999999987643332 3445678999999999999999999887643      4


Q ss_pred             eEEEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                      ..|++++++ +++|.+++..   ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  154 (316)
T cd05574          75 YLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSD  154 (316)
T ss_pred             EEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence            578888877 7799998864   468999999999999999999999999999999999999999999999999987543


Q ss_pred             CCccccc-ccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         220 NEMTGYV-ATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       220 ~~~~~~~-gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                      ....... ........+..                         .......+.     ...........||..|+|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~-----~~~~~~~~~~~g~~~y~aPE~~  204 (316)
T cd05574         155 VEPPPVSKALRKGSRRSSV-------------------------NSIPSETFS-----EEPSFRSNSFVGTEEYIAPEVI  204 (316)
T ss_pred             ccccccccccccccccccc-------------------------cccchhhhc-----ccccCCCCCCcCccCCcCHHHH
Confidence            2211000 00000000000                         000000000     0001122346789999999999


Q ss_pred             hhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC
Q psy8260         299 LNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT  378 (427)
Q Consensus       299 ~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t  378 (427)
                      .+..+...+|+||+|++++.+.++..+|..........+..........      ....++++.+||.+||+.||++|+|
T Consensus       205 ~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~R~s  278 (316)
T cd05574         205 SGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPG------SPPVSSSARDLIRKLLVKDPSKRLG  278 (316)
T ss_pred             cCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCC------ccccCHHHHHHHHHHccCCHhHCCC
Confidence            8877777889999999998886666665433222222222211111111      1226789999999999999999999


Q ss_pred             ----HHHHhcCCCCCCCCCCCCCCCCCCC
Q psy8260         379 ----AEQALAHPYLSQYSDPNDEPTSPPY  403 (427)
Q Consensus       379 ----a~e~L~Hp~f~~~~~~~~~~~~~~~  403 (427)
                          ++|+|+||||.+...+.....++|.
T Consensus       279 ~~~~~~~ll~~~~~~~~~~~~~~~~~~~~  307 (316)
T cd05574         279 SKRGAAEIKQHPFFRGVNWALIRHTTPPI  307 (316)
T ss_pred             chhhHHHHHcCchhhcCChhhcccCCCCC
Confidence                9999999999986655444444333

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=4.4e-39  Score=302.64  Aligned_cols=254  Identities=30%  Similarity=0.496  Sum_probs=186.8

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceE
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV  145 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~  145 (427)
                      |++++.||+|+||.||. +.+..+++.||+|++..............+|+.++++++||||+++++++...      ...
T Consensus         1 y~~~~~lg~G~~g~v~~-~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~------~~~   73 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYK-AKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDD------NYL   73 (260)
T ss_dssp             EEEEEEEEEESSEEEEE-EEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEES------SEE
T ss_pred             CEEeEEEEeCCCEEEEE-EEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccc------ccc
Confidence            56788999999999995 56777889999999976543333333446799999999999999999998653      467


Q ss_pred             EEEeccCCC-CHHHHHh-hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcc
Q psy8260         146 YMVTHLMGA-DLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT  223 (427)
Q Consensus       146 ~lv~e~~g~-~L~~~l~-~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~  223 (427)
                      +++++++.+ +|.+++. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||.+....... 
T Consensus        74 ~~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~-  152 (260)
T PF00069_consen   74 YIVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN-  152 (260)
T ss_dssp             EEEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT-
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-
Confidence            889988855 9999887 6789999999999999999999999999999999999999999999999999986321000 


Q ss_pred             cccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh-hcc
Q psy8260         224 GYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML-NWM  302 (427)
Q Consensus       224 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~-~~~  302 (427)
                                                                               .......+|+.|+|||++. +..
T Consensus       153 ---------------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~  175 (260)
T PF00069_consen  153 ---------------------------------------------------------ENFNPFVGTPEYMAPEVLQQGKK  175 (260)
T ss_dssp             ---------------------------------------------------------SEBSSSSSSGGGSCHHHHTTTSS
T ss_pred             ---------------------------------------------------------ccccccccccccccccccccccc
Confidence                                                                     0111234566667777665 555


Q ss_pred             CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhh---cCCCChhHHHHHHHhcCCCCCCCCCH
Q psy8260         303 HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQV---FKGANPQAIDLLSLMLELDSEKRITA  379 (427)
Q Consensus       303 ~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~s~~~~dLi~~mL~~dP~~R~ta  379 (427)
                      ...++|+||+|++++.|.++..++.................    ......   .....+++.+||.+||+.||++|||+
T Consensus       176 ~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~  251 (260)
T PF00069_consen  176 YTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILK----RPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSA  251 (260)
T ss_dssp             BSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHH----THHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTH
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhhccc----ccccccccccchhHHHHHHHHHHHccCChhHCcCH
Confidence            66677999999999777554443332200001100000000    000000   01123789999999999999999999


Q ss_pred             HHHhcCCCC
Q psy8260         380 EQALAHPYL  388 (427)
Q Consensus       380 ~e~L~Hp~f  388 (427)
                      .|+++||||
T Consensus       252 ~~l~~~~~~  260 (260)
T PF00069_consen  252 EELLKHPWF  260 (260)
T ss_dssp             HHHHTSGGG
T ss_pred             HHHhcCCCC
Confidence            999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.9e-38  Score=334.27  Aligned_cols=264  Identities=22%  Similarity=0.314  Sum_probs=197.4

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      +...+.|.+.+.||.|+||.||. +.+..++..||+|.+............+.+|+.+|+.++|||||+++++|...   
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYL-Akdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de---   84 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFL-VKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK---   84 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEE-EEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec---
Confidence            44557899999999999999996 55677899999999876544555566788999999999999999999988542   


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhc-------CceeccCCCCCeEEcCC--
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRT-----QKLSDDHVQFLVYQILRGLKYIHSA-------GIIHRDLKPSNIAVNED--  204 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~yLH~~-------~iiHrDLKp~NILl~~~--  204 (427)
                       ....+|++|||+ +++|.+++..     ..+++..+..++.||+.||.|||+.       +||||||||+|||++.+  
T Consensus        85 -~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~  163 (1021)
T PTZ00266         85 -ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR  163 (1021)
T ss_pred             -CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence             224688999988 6799888753     4699999999999999999999984       49999999999999642  


Q ss_pred             ---------------CCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhh
Q psy8260         205 ---------------CELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELK  269 (427)
Q Consensus       205 ---------------~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~k  269 (427)
                                     +.+||+|||+++......                                               
T Consensus       164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-----------------------------------------------  196 (1021)
T PTZ00266        164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIES-----------------------------------------------  196 (1021)
T ss_pred             ccccccccccccCCCCceEEccCCccccccccc-----------------------------------------------
Confidence                           347888888876432110                                               


Q ss_pred             hhccCCCCCCccccccccccccccchHHhhhc--cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCc
Q psy8260         270 ILDFGLARPTENEMTGYVATRWYRAPEIMLNW--MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTK  347 (427)
Q Consensus       270 i~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~--~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (427)
                                  ......||+.|+|||++.+.  .+..++|+||||+|++.|.++..||............+...+..+ 
T Consensus       197 ------------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lp-  263 (1021)
T PTZ00266        197 ------------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLP-  263 (1021)
T ss_pred             ------------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCC-
Confidence                        01123466777777776432  355678999999999988777666643221111111111112111 


Q ss_pred             ccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q psy8260         348 KDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDP  394 (427)
Q Consensus       348 ~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  394 (427)
                            ....++++.+||.+||++||.+|||+.|+|.||||.....|
T Consensus       264 ------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~p  304 (1021)
T PTZ00266        264 ------IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGPP  304 (1021)
T ss_pred             ------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCCC
Confidence                  13457899999999999999999999999999999866443

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3e-38  Score=301.59  Aligned_cols=258  Identities=32%  Similarity=0.542  Sum_probs=187.1

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceE
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV  145 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~  145 (427)
                      |++.+.||.|+||.||++ .+..+|+.||||++............+.+|++++++++||||+++++++...      ...
T Consensus         2 y~~~~~l~~g~~~~v~~~-~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~   74 (284)
T cd07860           2 FQKVEKIGEGTYGVVYKA-RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE------NKL   74 (284)
T ss_pred             ceeeeeecCCCceEEEEE-EECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC------CcE
Confidence            567788999999999964 5667899999998865433333335677899999999999999999987643      457


Q ss_pred             EEEeccCCCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCc
Q psy8260         146 YMVTHLMGADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM  222 (427)
Q Consensus       146 ~lv~e~~g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~  222 (427)
                      +++++++.++|..++..   ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++......
T Consensus        75 ~~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          75 YLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             EEEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence            89999998888887753   458999999999999999999999999999999999999999999999999886432211


Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhcc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM  302 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~  302 (427)
                      ..                                                          .....+++.|+|||++.+..
T Consensus       155 ~~----------------------------------------------------------~~~~~~~~~y~aPE~~~~~~  176 (284)
T cd07860         155 RT----------------------------------------------------------YTHEVVTLWYRAPEILLGCK  176 (284)
T ss_pred             cc----------------------------------------------------------cccccccccccCCeEEecCC
Confidence            00                                                          00112345566666554322


Q ss_pred             -CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHH---------------------HhcCCCCCcccHHhhcCCCChh
Q psy8260         303 -HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKY---------------------INSLPLLTKKDFRQVFKGANPQ  360 (427)
Q Consensus       303 -~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~s~~  360 (427)
                       +...+|+|++|++++.+.++..+|..........+.                     ....+......+....+.++++
T Consensus       177 ~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (284)
T cd07860         177 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDED  256 (284)
T ss_pred             CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHH
Confidence             344579999998887775544333211100011111                     1111222223334445567899


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q psy8260         361 AIDLLSLMLELDSEKRITAEQALAHPYL  388 (427)
Q Consensus       361 ~~dLi~~mL~~dP~~R~ta~e~L~Hp~f  388 (427)
                      ++|||.+||+.||++|||++|+++||||
T Consensus       257 ~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         257 GRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.2e-37  Score=305.43  Aligned_cols=302  Identities=35%  Similarity=0.630  Sum_probs=211.3

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCccccC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~~  141 (427)
                      .+.|.+.+.+|.|+||.||++ .+..+|..||||++............+.+|+.+++++ +||||+++++++...    +
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~-~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~----~   80 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKA-IDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE----N   80 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEE-EEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC----C
Confidence            456888899999999999964 5667899999998865443444455677899999999 999999999987542    2


Q ss_pred             CceEEEEeccCCCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         142 FKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       142 ~~~~~lv~e~~g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      ....|+++++++++|..++..+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus        81 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~  160 (337)
T cd07852          81 DKDIYLVFEYMETDLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL  160 (337)
T ss_pred             CceEEEEecccccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence            24579999999889999887778899999999999999999999999999999999999999999999999998754321


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh-
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN-  300 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~-  300 (427)
                      .... +.     |                                               ......||+.|+|||++.+ 
T Consensus       161 ~~~~-~~-----~-----------------------------------------------~~~~~~~~~~y~aPE~~~~~  187 (337)
T cd07852         161 EENP-EN-----P-----------------------------------------------VLTDYVATRWYRAPEILLGS  187 (337)
T ss_pred             cccc-cC-----c-----------------------------------------------chhcccccccccCceeeecc
Confidence            1100 00     0                                               0112235666777776543 


Q ss_pred             ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHH-----------------------HHHhcCCCCCcccHHhhcCCC
Q psy8260         301 WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSAR-----------------------KYINSLPLLTKKDFRQVFKGA  357 (427)
Q Consensus       301 ~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~  357 (427)
                      ..+...+|+||+|++++.+.++..+|..........                       ..................+..
T Consensus       188 ~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (337)
T cd07852         188 TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKA  267 (337)
T ss_pred             ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCC
Confidence            234456799999988877755444332111111000                       111111112222233444557


Q ss_pred             ChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCCC-CCCCcc-cccCCCCHHHHHHHHh
Q psy8260         358 NPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTS-PPYDQS-FEDMDLPVDQWKGTYS  422 (427)
Q Consensus       358 s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~  422 (427)
                      ++++.+||.+||+.||++|||+.++++||||.+...+..++.. .++... ..+..+++.+....+.
T Consensus       268 ~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (337)
T cd07852         268 SDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYPITIPLDDNVKLSVAEYRNKLY  334 (337)
T ss_pred             CHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCCCCCCccCCccccceeeHHHHHhhhh
Confidence            8899999999999999999999999999999988766555332 111111 2344566666555443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.1e-37  Score=297.58  Aligned_cols=256  Identities=32%  Similarity=0.532  Sum_probs=187.5

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceE
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV  145 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~  145 (427)
                      |.+.+.+|.|+||.||++ .+..+|+.||+|++............+.+|+.+++.++||||+++++++...      ...
T Consensus         2 y~~~~~l~~g~~~~v~~~-~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------~~~   74 (286)
T cd07832           2 YKILGRIGEGAHGIVFKA-KDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG------SGF   74 (286)
T ss_pred             ceEEeecccCCCcEEEEE-EECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC------Cee
Confidence            678899999999999964 4566799999999876543344456688999999999999999999998653      457


Q ss_pred             EEEeccCCCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC--
Q psy8260         146 YMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE--  221 (427)
Q Consensus       146 ~lv~e~~g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~--  221 (427)
                      |+++++++++|.+++..  ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......  
T Consensus        75 ~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          75 VLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            89999999999998754  45899999999999999999999999999999999999999999999999998754332  


Q ss_pred             --cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         222 --MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       222 --~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                        .....++.+|+|||+                                                             +.
T Consensus       155 ~~~~~~~~~~~y~aPE~-------------------------------------------------------------~~  173 (286)
T cd07832         155 RLYSHQVATRWYRAPEL-------------------------------------------------------------LY  173 (286)
T ss_pred             CccccccCcccccCcee-------------------------------------------------------------ee
Confidence              112234444555554                                                             33


Q ss_pred             hc-cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhc----------------------CCCCCcccHHhhcCC
Q psy8260         300 NW-MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINS----------------------LPLLTKKDFRQVFKG  356 (427)
Q Consensus       300 ~~-~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~  356 (427)
                      +. .+..++|+|++|++++.+-++..+|...............                      .+......+...++.
T Consensus       174 ~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (286)
T cd07832         174 GARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPD  253 (286)
T ss_pred             ccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCC
Confidence            22 1344567777777776664443322111100111010000                      011112223445566


Q ss_pred             CChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q psy8260         357 ANPQAIDLLSLMLELDSEKRITAEQALAHPYLS  389 (427)
Q Consensus       357 ~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~  389 (427)
                      .+.++.+||.+||++||.+|||++|+|+||||.
T Consensus       254 ~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         254 ASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             ccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            788999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.4e-37  Score=294.89  Aligned_cols=256  Identities=18%  Similarity=0.338  Sum_probs=187.2

Q ss_pred             cCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCcccc
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~  140 (427)
                      ..+.|.+.+.+|+|+||.||.+ .+..+++.||+|.+.....   ....+.+|+.+++++ +||||+++++++.......
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~-~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKG-RHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   79 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEE-EEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence            3467888899999999999965 4567889999999865422   234567899999998 7999999999986543222


Q ss_pred             CCceEEEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         141 DFKNVYMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       141 ~~~~~~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                      ....+|+++|++ +++|.+++..   ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~  159 (272)
T cd06637          80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  159 (272)
T ss_pred             CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence            234678999988 5789988764   358999999999999999999999999999999999999999999999999987


Q ss_pred             CCCCC---cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccccc
Q psy8260         217 PTENE---MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR  293 (427)
Q Consensus       217 ~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~  293 (427)
                      .....   .....                                                             |++.|+
T Consensus       160 ~~~~~~~~~~~~~-------------------------------------------------------------g~~~y~  178 (272)
T cd06637         160 QLDRTVGRRNTFI-------------------------------------------------------------GTPYWM  178 (272)
T ss_pred             ecccccccCCccc-------------------------------------------------------------cccccc
Confidence            53221   11223                                                             444455


Q ss_pred             chHHhhh-----ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHh
Q psy8260         294 APEIMLN-----WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLM  368 (427)
Q Consensus       294 APEvl~~-----~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~m  368 (427)
                      |||++..     ..+...+|+||+|++++.|.++..+|............. ..+.   ..  ......+.++.|||.+|
T Consensus       179 aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~-~~~~---~~--~~~~~~~~~~~~li~~~  252 (272)
T cd06637         179 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP-RNPA---PR--LKSKKWSKKFQSFIESC  252 (272)
T ss_pred             CHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh-cCCC---CC--CCCCCcCHHHHHHHHHH
Confidence            5555431     224556899999999988866655553221111111111 1110   00  01123567899999999


Q ss_pred             cCCCCCCCCCHHHHhcCCCC
Q psy8260         369 LELDSEKRITAEQALAHPYL  388 (427)
Q Consensus       369 L~~dP~~R~ta~e~L~Hp~f  388 (427)
                      |+.||.+|||++|+++||||
T Consensus       253 l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         253 LVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             cCCChhhCCCHHHHhhCCCC
Confidence            99999999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.5e-37  Score=298.45  Aligned_cols=265  Identities=27%  Similarity=0.468  Sum_probs=189.5

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCC-CCCceeeeeeeecCccccCCc
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN-HENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      .|++.+.||.|+||.||. +.+..+|+.||||++............+.+|+.+++.+. ||||+++++++..... ....
T Consensus         2 ~y~~~~~lg~g~~g~vy~-~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~-~~~~   79 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYK-ARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEK-NGKP   79 (295)
T ss_pred             CceEeeEecccCCeEEEE-EEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCC-CCCc
Confidence            477889999999999996 456678999999987654332223355778999999995 6999999998764321 1123


Q ss_pred             eEEEEeccCCCCHHHHHhh------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcC-CCCEEEeeCCCCC
Q psy8260         144 NVYMVTHLMGADLNNILRT------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE-DCELKILDFGLAR  216 (427)
Q Consensus       144 ~~~lv~e~~g~~L~~~l~~------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~-~~~~kl~DFGla~  216 (427)
                      ..|++++++.++|.+++..      ..+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||+++
T Consensus        80 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~  159 (295)
T cd07837          80 SLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR  159 (295)
T ss_pred             eEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence            4789999998888887643      24799999999999999999999999999999999999998 8899999999886


Q ss_pred             CCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         217 PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       217 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      .......                                                          ......+++.|+|||
T Consensus       160 ~~~~~~~----------------------------------------------------------~~~~~~~~~~~~aPE  181 (295)
T cd07837         160 AFSIPVK----------------------------------------------------------SYTHEIVTLWYRAPE  181 (295)
T ss_pred             ecCCCcc----------------------------------------------------------ccCCcccccCCCChH
Confidence            4321100                                                          001113456677777


Q ss_pred             Hhhh-ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhc--------------------CCCCCcccHHhhcC
Q psy8260         297 IMLN-WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINS--------------------LPLLTKKDFRQVFK  355 (427)
Q Consensus       297 vl~~-~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~  355 (427)
                      ++.+ ..+..++|+|++|++++.|.++..+|..........+....                    .+...........+
T Consensus       182 ~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (295)
T cd07837         182 VLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVP  261 (295)
T ss_pred             HhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhcc
Confidence            6654 23456679999999998775554444321111111111110                    11111122233345


Q ss_pred             CCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q psy8260         356 GANPQAIDLLSLMLELDSEKRITAEQALAHPYLS  389 (427)
Q Consensus       356 ~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~  389 (427)
                      ..++++.+||.+||++||.+|||++|+|+||||.
T Consensus       262 ~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         262 DLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             ccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            6789999999999999999999999999999984

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-37  Score=292.12  Aligned_cols=256  Identities=21%  Similarity=0.323  Sum_probs=192.7

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH---HHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccC
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA---VHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      .|.+++.||.|++|.||.+ .+..+++.||+|.+.......   .....+.+|++++++++||||+++++++...     
T Consensus         3 ~~~~~~~lg~g~~~~vy~~-~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----   76 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLC-YDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD-----   76 (263)
T ss_pred             cccccceecCCCceEEEEE-EEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC-----
Confidence            4788999999999999964 566789999999886432221   2234577899999999999999999998654     


Q ss_pred             CceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         142 FKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                       ...+++++++ +++|.+.+.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++...
T Consensus        77 -~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          77 -ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             -CeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence             3678888887 6789887754 568999999999999999999999999999999999999999999999999986432


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      ......                                                       .......|+..|+|||++.
T Consensus       156 ~~~~~~-------------------------------------------------------~~~~~~~~~~~y~aPE~~~  180 (263)
T cd06625         156 TICSSG-------------------------------------------------------TGMKSVTGTPYWMSPEVIS  180 (263)
T ss_pred             cccccc-------------------------------------------------------ccccCCCcCccccCcceec
Confidence            110000                                                       0001224567788888877


Q ss_pred             hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH
Q psy8260         300 NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA  379 (427)
Q Consensus       300 ~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta  379 (427)
                      +..+..++|+||+|++++.+-++..+|............... ..     ........++++.+||.+||..||.+|||+
T Consensus       181 ~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~  254 (263)
T cd06625         181 GEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ-PT-----NPQLPSHVSPDARNFLRRTFVENAKKRPSA  254 (263)
T ss_pred             cCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhcc-CC-----CCCCCccCCHHHHHHHHHHhhcCcccCCCH
Confidence            766777889999999998886665555432111111111111 10     011223568899999999999999999999


Q ss_pred             HHHhcCCCC
Q psy8260         380 EQALAHPYL  388 (427)
Q Consensus       380 ~e~L~Hp~f  388 (427)
                      .|+++||||
T Consensus       255 ~~ll~~~~~  263 (263)
T cd06625         255 EELLRHFFV  263 (263)
T ss_pred             HHHhhCCCC
Confidence            999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3.2e-37  Score=294.44  Aligned_cols=259  Identities=27%  Similarity=0.491  Sum_probs=186.9

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCce
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      .|++...+|.|+||.||++ .+..+|+.||+|++..........+.+.+|+.+++.++||||+++++++...      ..
T Consensus         2 ~y~~~~~l~~g~~~~v~~~-~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~------~~   74 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKC-RNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK------RK   74 (286)
T ss_pred             ceeeeeeecccCCeEEEEE-EECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC------CE
Confidence            4778889999999999964 5667899999998864432222334567899999999999999999988653      45


Q ss_pred             EEEEeccCC-CCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCc
Q psy8260         145 VYMVTHLMG-ADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM  222 (427)
Q Consensus       145 ~~lv~e~~g-~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~  222 (427)
                      .++++|++. +.|..+... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus        75 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          75 LHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             EEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            789999885 455555543 468999999999999999999999999999999999999999999999999986543211


Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh-c
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN-W  301 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~-~  301 (427)
                      .                                                          ......++..|+|||++.+ .
T Consensus       155 ~----------------------------------------------------------~~~~~~~~~~~~aPE~~~~~~  176 (286)
T cd07847         155 D----------------------------------------------------------DYTDYVATRWYRAPELLVGDT  176 (286)
T ss_pred             c----------------------------------------------------------cccCcccccccCCHHHHhCCC
Confidence            0                                                          0001124556666666554 2


Q ss_pred             cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhc----------------------CCC-CCcccHHhhcCCCC
Q psy8260         302 MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINS----------------------LPL-LTKKDFRQVFKGAN  358 (427)
Q Consensus       302 ~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~----------------------~~~-~~~~~~~~~~~~~s  358 (427)
                      .+..++|+||+|++++.+.++..+|......+........                      .+. .........+..++
T Consensus       177 ~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (286)
T cd07847         177 QYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNIS  256 (286)
T ss_pred             CcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCC
Confidence            3455789999999998885554444322111111000000                      000 01112233455678


Q ss_pred             hhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q psy8260         359 PQAIDLLSLMLELDSEKRITAEQALAHPYL  388 (427)
Q Consensus       359 ~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f  388 (427)
                      +.+.|||.+||+.||++|||+.|++.||||
T Consensus       257 ~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         257 SPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             HHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.7e-37  Score=299.19  Aligned_cols=261  Identities=22%  Similarity=0.314  Sum_probs=191.1

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCce
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      .|++.+.||+|+||.||.+ .+..+|..||+|.+.... ......++.+|++++++++||||+++++.|...      ..
T Consensus         2 ~~~~~~~lg~G~~g~v~~~-~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~   73 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKV-LHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD------GE   73 (308)
T ss_pred             CceEEeeccCCCCeEEEEE-EEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC------CE
Confidence            4778899999999999965 566789999999886432 333455678999999999999999999988654      46


Q ss_pred             EEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         145 VYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       145 ~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~-~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      +++++|++ +++|.++++. ..+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++......
T Consensus        74 ~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (308)
T cd06615          74 ISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  153 (308)
T ss_pred             EEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence            78999987 6799998864 568999999999999999999997 59999999999999999999999999987543211


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      .                                                            .....|++.|+|||++.+.
T Consensus       154 ~------------------------------------------------------------~~~~~~~~~~~aPE~~~~~  173 (308)
T cd06615         154 M------------------------------------------------------------ANSFVGTRSYMSPERLQGT  173 (308)
T ss_pred             c------------------------------------------------------------cccCCCCcCccChhHhcCC
Confidence            0                                                            0122456667777776655


Q ss_pred             cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCC-CCc-----------------ccHH------------
Q psy8260         302 MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPL-LTK-----------------KDFR------------  351 (427)
Q Consensus       302 ~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~-~~~-----------------~~~~------------  351 (427)
                      .+..++|+|++|++++.+.++..+|...... ........... ...                 ....            
T Consensus       174 ~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (308)
T cd06615         174 HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK-ELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPP  252 (308)
T ss_pred             CCCccchHHHHHHHHHHHHhCCCCCCCcchh-hHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCc
Confidence            5666789999999988775554444221111 11111100000 000                 0000            


Q ss_pred             h-hcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q psy8260         352 Q-VFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDP  394 (427)
Q Consensus       352 ~-~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  394 (427)
                      . .....++++++||.+||..||++|||++|+++||||.+...+
T Consensus       253 ~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  296 (308)
T cd06615         253 KLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELE  296 (308)
T ss_pred             cCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcccc
Confidence            0 011257789999999999999999999999999999875433

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1e-37  Score=297.66  Aligned_cols=254  Identities=20%  Similarity=0.338  Sum_probs=187.1

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCce
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      .|++.+.||.|+||.||.+ .+..+++.||+|.+.... .......+.+|++++++++||||+++++.+...      ..
T Consensus         2 ~~~~~~~lg~g~~~~v~~~-~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~   73 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKA-YHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVE------NR   73 (279)
T ss_pred             cchheeeeccCCCeEEEEE-EEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC------CE
Confidence            3566788999999999964 566789999999886542 333445678999999999999999999998654      35


Q ss_pred             EEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcc
Q psy8260         145 VYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT  223 (427)
Q Consensus       145 ~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~  223 (427)
                      .++++|++ +++|...   ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.+||+|||++....... 
T Consensus        74 ~~lv~e~~~~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-  149 (279)
T cd06619          74 ISICTEFMDGGSLDVY---RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-  149 (279)
T ss_pred             EEEEEecCCCCChHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence            67888888 5666543   357899999999999999999999999999999999999999999999999986432110 


Q ss_pred             cccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccC
Q psy8260         224 GYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH  303 (427)
Q Consensus       224 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~  303 (427)
                                                                                 .....||+.|+|||++.+..+
T Consensus       150 -----------------------------------------------------------~~~~~~~~~y~aPE~~~~~~~  170 (279)
T cd06619         150 -----------------------------------------------------------AKTYVGTNAYMAPERISGEQY  170 (279)
T ss_pred             -----------------------------------------------------------ccCCCCChhhcCceeecCCCC
Confidence                                                                       012245666777777666667


Q ss_pred             CCCCCHHHHHHHHHHhCCCCHHHHhhcCcHH---HHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHH
Q psy8260         304 YNQTDIHQLNLIMEMLGTPPAEFMAKISSDS---ARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAE  380 (427)
Q Consensus       304 ~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~  380 (427)
                      ..++|+|++|++++.+.++..||........   ................  .....++++++||.+||+.||.+|||++
T Consensus       171 ~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~  248 (279)
T cd06619         171 GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL--PVGQFSEKFVHFITQCMRKQPKERPAPE  248 (279)
T ss_pred             CCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCC--CCCcCCHHHHHHHHHHhhCChhhCCCHH
Confidence            7788999999999877555554432111100   0000000000000000  1123678999999999999999999999


Q ss_pred             HHhcCCCCCCC
Q psy8260         381 QALAHPYLSQY  391 (427)
Q Consensus       381 e~L~Hp~f~~~  391 (427)
                      |+++||||.+.
T Consensus       249 eil~~~~~~~~  259 (279)
T cd06619         249 NLMDHPFIVQY  259 (279)
T ss_pred             HHhcCcccccc
Confidence            99999999865

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.8e-37  Score=297.04  Aligned_cols=256  Identities=20%  Similarity=0.285  Sum_probs=190.4

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH-HHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCce
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA-VHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      |...+.||+|+||.||.+ .+..+++.||+|.+....... .....+.+|+++|+.++|+||+.+++.|..+      ..
T Consensus         2 ~~~~~~lg~G~~g~vy~~-~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~------~~   74 (285)
T cd05632           2 FRQYRVLGKGGFGEVCAC-QVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK------DA   74 (285)
T ss_pred             ceEEEEEecCCCeEEEEE-EECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC------CE
Confidence            455678999999999964 566789999999886532222 2234467899999999999999999887653      45


Q ss_pred             EEEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         145 VYMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       145 ~~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      .+++++++ +++|...+..   ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~  154 (285)
T cd05632          75 LCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE  154 (285)
T ss_pred             EEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC
Confidence            78888877 6788876643   3599999999999999999999999999999999999999999999999998753221


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      ..                                                           ...+..|++.|+|||++.+
T Consensus       155 ~~-----------------------------------------------------------~~~~~~g~~~~~aPE~~~~  175 (285)
T cd05632         155 GE-----------------------------------------------------------SIRGRVGTVGYMAPEVLNN  175 (285)
T ss_pred             CC-----------------------------------------------------------cccCCCCCcCccChHHhcC
Confidence            10                                                           0112246777888887776


Q ss_pred             ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC--
Q psy8260         301 WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT--  378 (427)
Q Consensus       301 ~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t--  378 (427)
                      ..+...+|+||+|++++.+.++..||....................    .......++++.+||.+||+.||++|+|  
T Consensus       176 ~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~  251 (285)
T cd05632         176 QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE----EVYSAKFSEEAKSICKMLLTKDPKQRLGCQ  251 (285)
T ss_pred             CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc----cccCccCCHHHHHHHHHHccCCHhHcCCCc
Confidence            6677788999999999888666655543211111111111111100    0122446788999999999999999999  


Q ss_pred             ---HHHHhcCCCCCCC
Q psy8260         379 ---AEQALAHPYLSQY  391 (427)
Q Consensus       379 ---a~e~L~Hp~f~~~  391 (427)
                         ++++++||||...
T Consensus       252 ~~~~~~l~~~~~~~~~  267 (285)
T cd05632         252 EEGAGEVKRHPFFRNM  267 (285)
T ss_pred             ccChHHHHcChhhhcC
Confidence               8999999999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.7e-37  Score=297.97  Aligned_cols=262  Identities=31%  Similarity=0.487  Sum_probs=188.1

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      ..|.+.+.||.|+||.||.+ .+..+++.||+|.+............+.+|+.++++++||||+++++++....    ..
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~-~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----~~   79 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRA-RDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN----LD   79 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEE-EECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC----CC
Confidence            35778899999999999964 56678999999998654333333345678999999999999999999876431    24


Q ss_pred             eEEEEeccCCCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         144 NVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       144 ~~~lv~e~~g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      ..|+++++++++|.+++..  ..+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus        80 ~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  159 (293)
T cd07843          80 KIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP  159 (293)
T ss_pred             cEEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence            6899999998899888754  34899999999999999999999999999999999999999999999999988754322


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      ...                                                          .....+++.|+|||++.+.
T Consensus       160 ~~~----------------------------------------------------------~~~~~~~~~~~aPE~~~~~  181 (293)
T cd07843         160 LKP----------------------------------------------------------YTQLVVTLWYRAPELLLGA  181 (293)
T ss_pred             ccc----------------------------------------------------------cccccccccccCchhhcCC
Confidence            100                                                          0011245556666665443


Q ss_pred             c-CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHh--------------cCCC--------CCcccHHhhcCC--
Q psy8260         302 M-HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYIN--------------SLPL--------LTKKDFRQVFKG--  356 (427)
Q Consensus       302 ~-~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~--------------~~~~--------~~~~~~~~~~~~--  356 (427)
                      . ....+|+||+|++++.|.++..+|..........+...              ..+.        .....+.+.++.  
T Consensus       182 ~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (293)
T cd07843         182 KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALS  261 (293)
T ss_pred             ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccC
Confidence            2 34567999999888777554433322111111111110              0000        111112223333  


Q ss_pred             CChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q psy8260         357 ANPQAIDLLSLMLELDSEKRITAEQALAHPYL  388 (427)
Q Consensus       357 ~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f  388 (427)
                      .++.+.|||.+||+.||++|||++|+|+||||
T Consensus       262 ~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         262 LSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             CChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence            48889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3.7e-37  Score=289.44  Aligned_cols=252  Identities=25%  Similarity=0.352  Sum_probs=190.5

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceE
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV  145 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~  145 (427)
                      |++.+.+|+|++|.||.+ .+..+++.||+|++..........+.+.+|++++++++|+|++++++.+...     ...+
T Consensus         2 y~~~~~lg~g~~~~v~~~-~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   75 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLV-RHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-----DGLL   75 (257)
T ss_pred             ceEEEEecCCCCeEEEEE-EEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-----CCEE
Confidence            678889999999999964 4567889999999865444444555678899999999999999999876532     1347


Q ss_pred             EEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         146 YMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       146 ~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      |++++++ +++|.+.++.   ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus        76 ~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          76 YIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             EEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence            8899887 6789888754   34899999999999999999999999999999999999999999999999988643211


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      ..                                                          ......|++.|+|||++.+.
T Consensus       156 ~~----------------------------------------------------------~~~~~~~~~~y~aPE~~~~~  177 (257)
T cd08223         156 CD----------------------------------------------------------MASTLIGTPYYMSPELFSNK  177 (257)
T ss_pred             CC----------------------------------------------------------ccccccCCcCccChhHhcCC
Confidence            00                                                          01122466778888887776


Q ss_pred             cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHH
Q psy8260         302 MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQ  381 (427)
Q Consensus       302 ~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e  381 (427)
                      .+..++|+||+|++++.+.++..+|................  .     .......++++.+||.+||+.||.+|||+.+
T Consensus       178 ~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~--~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  250 (257)
T cd08223         178 PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK--L-----PPMPKDYSPELGELIATMLSKRPEKRPSVKS  250 (257)
T ss_pred             CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC--C-----CCCccccCHHHHHHHHHHhccCcccCCCHHH
Confidence            67778899999999988855544443211111111111111  0     0112346789999999999999999999999


Q ss_pred             HhcCCCC
Q psy8260         382 ALAHPYL  388 (427)
Q Consensus       382 ~L~Hp~f  388 (427)
                      +++||||
T Consensus       251 ~l~~~~~  257 (257)
T cd08223         251 ILRQPYI  257 (257)
T ss_pred             HhcCCCC
Confidence            9999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.4e-37  Score=298.76  Aligned_cols=270  Identities=28%  Similarity=0.427  Sum_probs=188.2

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc--ccC
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC--LAD  141 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~--~~~  141 (427)
                      +.|.+.+.||.|+||.||. +.+..+++.||||++..............+|++++++++||||+++++++.....  ...
T Consensus        12 ~~y~~~~~lg~g~~~~v~~-~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFK-ARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hheEEEEEeecCCCEEEEE-EEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            4588899999999999996 4566789999999886443222223445689999999999999999998754321  112


Q ss_pred             CceEEEEeccCCCCHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         142 FKNVYMVTHLMGADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       142 ~~~~~lv~e~~g~~L~~~l~~~--~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                      ....++++|+++++|.+.+...  .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....
T Consensus        91 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  170 (310)
T cd07865          91 KGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFS  170 (310)
T ss_pred             CceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccccc
Confidence            3457999999998998887654  68999999999999999999999999999999999999999999999999987542


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      ......                                                      .....+..++..|+|||++.
T Consensus       171 ~~~~~~------------------------------------------------------~~~~~~~~~~~~y~aPE~~~  196 (310)
T cd07865         171 LSKNSK------------------------------------------------------PNRYTNRVVTLWYRPPELLL  196 (310)
T ss_pred             CCcccC------------------------------------------------------CCCccCcccCccccCcHHhc
Confidence            211000                                                      00111234566777777765


Q ss_pred             hcc-CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHH---HHHhc-------------------CCCCCcccHHh-h-c
Q psy8260         300 NWM-HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSAR---KYINS-------------------LPLLTKKDFRQ-V-F  354 (427)
Q Consensus       300 ~~~-~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~---~~~~~-------------------~~~~~~~~~~~-~-~  354 (427)
                      +.. +..++|+||+|++++.|.++..++..........   .....                   .+......... . .
T Consensus       197 ~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  276 (310)
T cd07865         197 GERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKP  276 (310)
T ss_pred             CCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhccc
Confidence            433 4556799999988877744333221111000000   00000                   00000000111 0 0


Q ss_pred             CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q psy8260         355 KGANPQAIDLLSLMLELDSEKRITAEQALAHPYL  388 (427)
Q Consensus       355 ~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f  388 (427)
                      ...++.++|||.+||+.||.+|||++|+|+||||
T Consensus       277 ~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         277 YVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             ccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            1236788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0596|consensus

Probab=100.00  E-value=5.3e-38  Score=305.58  Aligned_cols=271  Identities=25%  Similarity=0.345  Sum_probs=198.6

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCcc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTC  138 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~  138 (427)
                      .+....|++.+.||+||-..||+. +. ...+.||+|++.....+.....-+..|+.+|.+| .|.+||+|+++-.++  
T Consensus       357 ~Vkg~~Yeilk~iG~GGSSkV~kV-~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d--  432 (677)
T KOG0596|consen  357 KVKGREYEILKQIGSGGSSKVFKV-LN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD--  432 (677)
T ss_pred             EECcchhhHHHhhcCCCcceeeee-ec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC--
Confidence            344566888999999999999964 32 4557889988876555666677788999999999 689999999985543  


Q ss_pred             ccCCceEEEEeccCCCCHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         139 LADFKNVYMVTHLMGADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       139 ~~~~~~~~lv~e~~g~~L~~~l~~~~--l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                          ..+|||||+-..||.++|+.+.  .+.-.++.|..|++.|++++|.+||||.||||.|+|+- .|.+||+|||+|.
T Consensus       433 ----~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~  507 (677)
T KOG0596|consen  433 ----GYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIAN  507 (677)
T ss_pred             ----ceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhc
Confidence                5789999999999999998654  34348899999999999999999999999999999987 4799999999999


Q ss_pred             CCCCCcc-----cccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccc
Q psy8260         217 PTENEMT-----GYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRW  291 (427)
Q Consensus       217 ~~~~~~~-----~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~  291 (427)
                      ....+.+     +.+||..||+||.+.........                   +..                       
T Consensus       508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~-------------------~~~-----------------------  545 (677)
T KOG0596|consen  508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSREN-------------------GKS-----------------------  545 (677)
T ss_pred             ccCccccceeeccccCcccccCHHHHhhccccccC-------------------CCc-----------------------
Confidence            8766544     45899999999988642111000                   000                       


Q ss_pred             ccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHh-cCCCCCcccHHhhcCCCChhHHHHHHHhcC
Q psy8260         292 YRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYIN-SLPLLTKKDFRQVFKGANPQAIDLLSLMLE  370 (427)
Q Consensus       292 Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~  370 (427)
                              .+....++|+||||||+|.|..+..||-.-...  ..++.. ..|.. ...|..+.  -..+++|+++.||.
T Consensus       546 --------k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~--~aKl~aI~~P~~-~Iefp~~~--~~~~li~~mK~CL~  612 (677)
T KOG0596|consen  546 --------KIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ--IAKLHAITDPNH-EIEFPDIP--ENDELIDVMKCCLA  612 (677)
T ss_pred             --------ceeecCccchhhhhhHHHHHHhcCCchHHHHHH--HHHHHhhcCCCc-cccccCCC--CchHHHHHHHHHHh
Confidence                    112345689999999999996665555332100  011111 11111 11121111  12349999999999


Q ss_pred             CCCCCCCCHHHHhcCCCCCCCCCC
Q psy8260         371 LDSEKRITAEQALAHPYLSQYSDP  394 (427)
Q Consensus       371 ~dP~~R~ta~e~L~Hp~f~~~~~~  394 (427)
                      +||+||+|+.++|+|||+....-|
T Consensus       613 rdPkkR~si~eLLqhpFl~~~~i~  636 (677)
T KOG0596|consen  613 RDPKKRWSIPELLQHPFLQIQPIP  636 (677)
T ss_pred             cCcccCCCcHHHhcCccccccccc
Confidence            999999999999999999764433

>KOG1035|consensus

Probab=100.00  E-value=2.8e-38  Score=330.81  Aligned_cols=278  Identities=26%  Similarity=0.368  Sum_probs=202.3

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCc-----
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNT-----  137 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-----  137 (427)
                      ..+|+....||+||||.||+ +.++-+|+.||||+|.... +.....+++||+.+|.+|+|||||+++..|....     
T Consensus       478 ~~DFEEL~lLGkGGFG~Vvk-VRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVK-VRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEE-EeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            45677888999999999995 7788999999999998665 5566677899999999999999999886542110     


Q ss_pred             -------------c----------------------------------c--------------------cC---------
Q psy8260         138 -------------C----------------------------------L--------------------AD---------  141 (427)
Q Consensus       138 -------------~----------------------------------~--------------------~~---------  141 (427)
                                   +                                  .                    ++         
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                         0                                  0                    00         


Q ss_pred             --------------------------------CceEEEEeccCCC-CHHHHHhhCCCC--HHHHHHHHHHHHHHHHHHHh
Q psy8260         142 --------------------------------FKNVYMVTHLMGA-DLNNILRTQKLS--DDHVQFLVYQILRGLKYIHS  186 (427)
Q Consensus       142 --------------------------------~~~~~lv~e~~g~-~L~~~l~~~~l~--~~~~~~~~~qi~~aL~yLH~  186 (427)
                                                      ...+||-|+||.. .+.++++.+.+.  ...+.++++||++||.|+|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~  715 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD  715 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence                                            0347899999964 556677777664  67788999999999999999


Q ss_pred             cCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccc
Q psy8260         187 AGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDC  266 (427)
Q Consensus       187 ~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  266 (427)
                      +|||||||||.||++++++.|||+|||+|........            .+                             
T Consensus       716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~------------~~-----------------------------  754 (1351)
T KOG1035|consen  716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLE------------SI-----------------------------  754 (1351)
T ss_pred             CceeeccCCcceeEEcCCCCeeecccccchhhhhhhh------------hH-----------------------------
Confidence            9999999999999999999999999999975211000            00                             


Q ss_pred             hhhhhccCCCC-CCccccccccccccccchHHhhhcc---CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcC
Q psy8260         267 ELKILDFGLAR-PTENEMTGYVATRWYRAPEIMLNWM---HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSL  342 (427)
Q Consensus       267 ~~ki~d~g~~~-~~~~~~~~~~gt~~Y~APEvl~~~~---~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~  342 (427)
                      ..+..+.+.-. ......++.+||-.|+|||++.+..   |..+.|++|||+|+++|..|-..-+...   ..-.-++ .
T Consensus       755 d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~yPF~TsMERa---~iL~~LR-~  830 (1351)
T KOG1035|consen  755 DQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLYPFGTSMERA---SILTNLR-K  830 (1351)
T ss_pred             hhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhccCCchHHHH---HHHHhcc-c
Confidence            00000000000 1112467899999999999998877   6778899999999999977722111111   1111111 2


Q ss_pred             CCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q psy8260         343 PLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLS  389 (427)
Q Consensus       343 ~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~  389 (427)
                      +.++..  ..++...-+....+|..||+.||+|||||.|+|++.||-
T Consensus       831 g~iP~~--~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  831 GSIPEP--ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP  875 (1351)
T ss_pred             CCCCCC--cccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence            222221  334555667888999999999999999999999999985

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=4.7e-37  Score=296.78  Aligned_cols=260  Identities=19%  Similarity=0.203  Sum_probs=183.3

Q ss_pred             cCcceeeccccCcccccEEEEeEEe---------------CcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCc
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSALD---------------SVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENV  126 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~~---------------~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnI  126 (427)
                      ..+.|.+.+.||+|+||.||.+...               ..++..||+|.+.... .......+.+|+++|.+++||||
T Consensus         3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni   81 (304)
T cd05096           3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNI   81 (304)
T ss_pred             chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCe
Confidence            4567888999999999999976532               1234579999886532 33345567899999999999999


Q ss_pred             eeeeeeeecCccccCCceEEEEeccC-CCCHHHHHhhC--------------------CCCHHHHHHHHHHHHHHHHHHH
Q psy8260         127 IGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQ--------------------KLSDDHVQFLVYQILRGLKYIH  185 (427)
Q Consensus       127 v~l~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~--------------------~l~~~~~~~~~~qi~~aL~yLH  185 (427)
                      +++++++...      ...++++|++ +++|.+++...                    .+++..+..++.||+.||.|||
T Consensus        82 v~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH  155 (304)
T cd05096          82 IRLLGVCVDE------DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS  155 (304)
T ss_pred             eEEEEEEecC------CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence            9999988653      3578899887 78998887542                    2566788899999999999999


Q ss_pred             hcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCccccccccc
Q psy8260         186 SAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNED  265 (427)
Q Consensus       186 ~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~  265 (427)
                      ++||+||||||+|||++.++.+||+|||+++.........                                        
T Consensus       156 ~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~----------------------------------------  195 (304)
T cd05096         156 SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYR----------------------------------------  195 (304)
T ss_pred             HCCccccCcchhheEEcCCccEEECCCccceecccCceeE----------------------------------------
Confidence            9999999999999999999999999999986432210000                                        


Q ss_pred             chhhhhccCCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHh--CCCCHHHHhhcCcHHHHHHHhcCC
Q psy8260         266 CELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEML--GTPPAEFMAKISSDSARKYINSLP  343 (427)
Q Consensus       266 ~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~l--g~~~~~~~~~~~~~~~~~~~~~~~  343 (427)
                                      ......++..|+|||++....+..++|+||+|++++.+  +.+..++.................
T Consensus       196 ----------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~  259 (304)
T cd05096         196 ----------------IQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFR  259 (304)
T ss_pred             ----------------ecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhh
Confidence                            00112346678888888777777888999999999775  333333322111111111100000


Q ss_pred             CCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy8260         344 LLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALA  384 (427)
Q Consensus       344 ~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~  384 (427)
                      ..............++.+.+||.+||+.||++|||++|+.+
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         260 DQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             hccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            00000000112345678999999999999999999999943

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG1989|consensus

Probab=100.00  E-value=9.7e-38  Score=320.21  Aligned_cols=265  Identities=23%  Similarity=0.316  Sum_probs=194.4

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCC-CCCceeeeeeeecCc
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN-HENVIGLLDVFHSNT  137 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~  137 (427)
                      -++....+.|.+.|-+|||+.||. +.+...|..||+|++-..  +....+.+.+||++|+.|+ |+|||.+++......
T Consensus        32 ~~Vg~~~v~V~~vLAEGGFa~VYl-a~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~  108 (738)
T KOG1989|consen   32 FTVGSHRVTVEKVLAEGGFAQVYL-AQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINR  108 (738)
T ss_pred             EEECCEEEEEEEEEccCCcEEEEE-EEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccc
Confidence            367778899999999999999996 455566699999998653  5666778889999999995 999999999422111


Q ss_pred             cccC-CceEEEEeccCC-CCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcC--ceeccCCCCCeEEcCCCCEEEe
Q psy8260         138 CLAD-FKNVYMVTHLMG-ADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKIL  210 (427)
Q Consensus       138 ~~~~-~~~~~lv~e~~g-~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~--iiHrDLKp~NILl~~~~~~kl~  210 (427)
                      .... .-.++|.||||. +.|-+++..   .+|++.++.+|++|+++|+.+||...  |||||||-|||||+.+|..|||
T Consensus       109 ~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLC  188 (738)
T KOG1989|consen  109 SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLC  188 (738)
T ss_pred             cCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeC
Confidence            1111 346889999995 799888853   46999999999999999999999987  9999999999999999999999


Q ss_pred             eCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccc
Q psy8260         211 DFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATR  290 (427)
Q Consensus       211 DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~  290 (427)
                      |||.|.......+        .+=|+-.                        -+                ..+ .+--|+
T Consensus       189 DFGSatt~~~~~~--------~~~e~~~------------------------ve----------------~eI-~k~TTp  219 (738)
T KOG1989|consen  189 DFGSATTKILSPT--------SAQEVNY------------------------VE----------------EEI-EKYTTP  219 (738)
T ss_pred             cccccccccCCCc--------cHHHHHH------------------------HH----------------HHH-HhhCCc
Confidence            9998863221110        0001100                        00                001 122477


Q ss_pred             cccchHHh---hhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHH
Q psy8260         291 WYRAPEIM---LNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSL  367 (427)
Q Consensus       291 ~Y~APEvl---~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~  367 (427)
                      .|+|||++   ++.+.+.++|||+|||++|.|.+...||...-.    ..+++..-.++      -++.++..+++||..
T Consensus       220 ~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----laIlng~Y~~P------~~p~ys~~l~~LI~~  289 (738)
T KOG1989|consen  220 QYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----LAILNGNYSFP------PFPNYSDRLKDLIRT  289 (738)
T ss_pred             cccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----eeEEeccccCC------CCccHHHHHHHHHHH
Confidence            88888876   355677889999999999999777666643200    01111111111      124578899999999


Q ss_pred             hcCCCCCCCCCHHHHhcC
Q psy8260         368 MLELDSEKRITAEQALAH  385 (427)
Q Consensus       368 mL~~dP~~R~ta~e~L~H  385 (427)
                      ||+.||.+||++-|++.+
T Consensus       290 mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  290 MLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             HhccCcccCCCHHHHHHH
Confidence            999999999999997654

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=3.5e-37  Score=297.75  Aligned_cols=278  Identities=31%  Similarity=0.471  Sum_probs=197.5

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc--c
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL--A  140 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~--~  140 (427)
                      .+.|.+.+.||.|+||.||.+ .+..+++.||||++..............+|+++++.++||||+++++++......  .
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~-~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKA-RQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEE-EECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence            367889999999999999965 4667899999998865433222234467899999999999999999887543221  2


Q ss_pred             CCceEEEEeccCCCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCC
Q psy8260         141 DFKNVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT  218 (427)
Q Consensus       141 ~~~~~~lv~e~~g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~  218 (427)
                      ....++++++++++++...+..  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus        86 ~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  165 (311)
T cd07866          86 KRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY  165 (311)
T ss_pred             cCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence            3346799999998888877653  46999999999999999999999999999999999999999999999999998754


Q ss_pred             CCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         219 ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       219 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                      ........      .+..                                         ..........|++.|+|||++
T Consensus       166 ~~~~~~~~------~~~~-----------------------------------------~~~~~~~~~~~~~~y~aPE~~  198 (311)
T cd07866         166 DGPPPNPK------GGGG-----------------------------------------GGTRKYTNLVVTRWYRPPELL  198 (311)
T ss_pred             cCCCcccc------cCCc-----------------------------------------ccccccccceeccCcCChHHh
Confidence            32110000      0000                                         000012344678889999987


Q ss_pred             hhc-cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHh--------------cCCC--------CCcccHHhhcC
Q psy8260         299 LNW-MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYIN--------------SLPL--------LTKKDFRQVFK  355 (427)
Q Consensus       299 ~~~-~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~--------------~~~~--------~~~~~~~~~~~  355 (427)
                      .+. .+..++|+||+|++++.|.++..+|..............              ..+.        .........+.
T Consensus       199 ~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (311)
T cd07866         199 LGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFG  278 (311)
T ss_pred             hCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcc
Confidence            653 356678999999999877555433322111111111110              0000        01112233445


Q ss_pred             CCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q psy8260         356 GANPQAIDLLSLMLELDSEKRITAEQALAHPYL  388 (427)
Q Consensus       356 ~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f  388 (427)
                      ..++++.|||.+||+.||.+|||+.|+++||||
T Consensus       279 ~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         279 KLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             cCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-37  Score=295.42  Aligned_cols=259  Identities=28%  Similarity=0.482  Sum_probs=184.3

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      ..|.+.+.||.|++|.||.+ .+..+++.||||.+...... .....+.+|+++++.++||||+++++++...      .
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~-~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~   76 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKG-RSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTK------K   76 (291)
T ss_pred             cceeEEEEEeecCCeEEEEE-EEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecC------C
Confidence            45788899999999999965 56678999999998643221 1223456899999999999999999998654      4


Q ss_pred             eEEEEeccCCCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         144 NVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       144 ~~~lv~e~~g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      ..|+++|+++++|.+++..  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus        77 ~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  156 (291)
T cd07844          77 TLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP  156 (291)
T ss_pred             eEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence            6799999998899888754  35899999999999999999999999999999999999999999999999998643211


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh-
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN-  300 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~-  300 (427)
                      ...                                                          .....++..|+|||++.+ 
T Consensus       157 ~~~----------------------------------------------------------~~~~~~~~~~~aPE~~~~~  178 (291)
T cd07844         157 SKT----------------------------------------------------------YSNEVVTLWYRPPDVLLGS  178 (291)
T ss_pred             Ccc----------------------------------------------------------ccccccccccCCcHHhhcC
Confidence            000                                                          001123455666666543 


Q ss_pred             ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCc-HHHHHHHhc----------------------CCCCCcccHHhhcCCC
Q psy8260         301 WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISS-DSARKYINS----------------------LPLLTKKDFRQVFKGA  357 (427)
Q Consensus       301 ~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~-~~~~~~~~~----------------------~~~~~~~~~~~~~~~~  357 (427)
                      ..+...+|+||+|++++.+-++..+|...... +......+.                      .+..............
T Consensus       179 ~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (291)
T cd07844         179 TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRL  258 (291)
T ss_pred             cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCC
Confidence            22445678888888887664443333211100 000000000                      0001111122222344


Q ss_pred             C--hhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q psy8260         358 N--PQAIDLLSLMLELDSEKRITAEQALAHPYL  388 (427)
Q Consensus       358 s--~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f  388 (427)
                      +  +++.+||.+||+.||.+|||+.|+|+||||
T Consensus       259 ~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         259 DRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             CCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            5  889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=5.2e-37  Score=294.81  Aligned_cols=264  Identities=33%  Similarity=0.514  Sum_probs=189.2

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      +.|++.+.||+|++|.||++ .+..+|+.||+|.+............+.+|+++++.++||||+++++++...      .
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~-~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~   74 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKA-RDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE------K   74 (294)
T ss_pred             CceEEEEEecCCCCEEEEEE-EecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecC------C
Confidence            35778899999999999965 4566899999998865433333345577899999999999999999998643      4


Q ss_pred             eEEEEeccCCCCHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcC-CCCEEEeeCCCCCCCC
Q psy8260         144 NVYMVTHLMGADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE-DCELKILDFGLARPTE  219 (427)
Q Consensus       144 ~~~lv~e~~g~~L~~~l~~~---~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~-~~~~kl~DFGla~~~~  219 (427)
                      ..|+++|+++++|.+.+...   .+++..+..++.||+.||+|||++|++||||||+||+++. ++.+||+|||++....
T Consensus        75 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~  154 (294)
T PLN00009         75 RLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG  154 (294)
T ss_pred             eEEEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence            68999999988888776432   3578888999999999999999999999999999999985 5679999999986432


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      .....                                                          .....+++.|+|||++.
T Consensus       155 ~~~~~----------------------------------------------------------~~~~~~~~~y~~PE~~~  176 (294)
T PLN00009        155 IPVRT----------------------------------------------------------FTHEVVTLWYRAPEILL  176 (294)
T ss_pred             CCccc----------------------------------------------------------cccCceeecccCHHHHh
Confidence            21100                                                          01123455666666654


Q ss_pred             hc-cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhc---------------------CCCCCcccHHhhcCCC
Q psy8260         300 NW-MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINS---------------------LPLLTKKDFRQVFKGA  357 (427)
Q Consensus       300 ~~-~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~  357 (427)
                      +. .+..++|+||+|++++.+.++..+|......+...+....                     .+...........+..
T Consensus       177 ~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (294)
T PLN00009        177 GSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTL  256 (294)
T ss_pred             CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCC
Confidence            42 2455679999999988775544443221111111111110                     1111111222233567


Q ss_pred             ChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q psy8260         358 NPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYS  392 (427)
Q Consensus       358 s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~  392 (427)
                      ++++.+||.+||+.||++|||++++++||||.+..
T Consensus       257 ~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~  291 (294)
T PLN00009        257 EPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG  291 (294)
T ss_pred             ChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence            89999999999999999999999999999998653

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=5.1e-37  Score=290.45  Aligned_cols=255  Identities=19%  Similarity=0.336  Sum_probs=187.1

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .+.|.+.+.||.|+||.||. +.+..+++.||+|.+....  ......+.+|+.+++.++||||+++++.+...      
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~-~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~------   78 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYK-ARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR------   78 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEE-EEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC------
Confidence            35678889999999999996 4566789999999886432  22334567899999999999999999987643      


Q ss_pred             ceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      ..+|+++|++ +++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06645          79 DKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA  158 (267)
T ss_pred             CEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence            4578899988 5799988754 5699999999999999999999999999999999999999999999999998764321


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh-
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML-  299 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~-  299 (427)
                      ...                                                          ......||+.|+|||++. 
T Consensus       159 ~~~----------------------------------------------------------~~~~~~~~~~y~aPE~~~~  180 (267)
T cd06645         159 TIA----------------------------------------------------------KRKSFIGTPYWMAPEVAAV  180 (267)
T ss_pred             ccc----------------------------------------------------------ccccccCcccccChhhhcc
Confidence            100                                                          001123555666666653 


Q ss_pred             --hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC
Q psy8260         300 --NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI  377 (427)
Q Consensus       300 --~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~  377 (427)
                        ...+..++|+||+|++++.+.++..++.............  ........+.. ....+..+.+||.+||+.||.+||
T Consensus       181 ~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~  257 (267)
T cd06645         181 ERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT--KSNFQPPKLKD-KMKWSNSFHHFVKMALTKNPKKRP  257 (267)
T ss_pred             ccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh--ccCCCCCcccc-cCCCCHHHHHHHHHHccCCchhCc
Confidence              2235557899999999998866655553321111111111  11111111111 113567899999999999999999


Q ss_pred             CHHHHhcCCC
Q psy8260         378 TAEQALAHPY  387 (427)
Q Consensus       378 ta~e~L~Hp~  387 (427)
                      |++++++|||
T Consensus       258 ~~~~ll~~~~  267 (267)
T cd06645         258 TAEKLLQHPF  267 (267)
T ss_pred             CHHHHhcCCC
Confidence            9999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3.5e-37  Score=296.22  Aligned_cols=258  Identities=22%  Similarity=0.439  Sum_probs=193.9

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceE
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV  145 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~  145 (427)
                      +.....||.|+||.||. +.+..++..||||++...  .....+.+.+|+.+++.++||||+++++.+...      ...
T Consensus        24 ~~~~~~lg~g~~g~v~~-~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~------~~~   94 (292)
T cd06658          24 LDSFIKIGEGSTGIVCI-ATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVG------DEL   94 (292)
T ss_pred             HhhhhcccCCCCeEEEE-EEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecC------CeE
Confidence            44456799999999996 456678899999988543  233445678999999999999999999887643      457


Q ss_pred             EEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCccc
Q psy8260         146 YMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTG  224 (427)
Q Consensus       146 ~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~  224 (427)
                      |+++|++ +++|.+++....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ 
T Consensus        95 ~lv~e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-  173 (292)
T cd06658          95 WVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-  173 (292)
T ss_pred             EEEEeCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-
Confidence            8889888 67898888777899999999999999999999999999999999999999999999999998764321100 


Q ss_pred             ccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCC
Q psy8260         225 YVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHY  304 (427)
Q Consensus       225 ~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~  304 (427)
                                                                               ......|++.|+|||++.+..+.
T Consensus       174 ---------------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~  196 (292)
T cd06658         174 ---------------------------------------------------------KRKSLVGTPYWMAPEVISRLPYG  196 (292)
T ss_pred             ---------------------------------------------------------cCceeecCccccCHHHHccCCCC
Confidence                                                                     00122466777777777666667


Q ss_pred             CCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy8260         305 NQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALA  384 (427)
Q Consensus       305 ~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~  384 (427)
                      ..+|+||+|++++.+-++..+|................+...     ......++...+||.+||+.||.+|||++|+++
T Consensus       197 ~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  271 (292)
T cd06658         197 TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV-----KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQ  271 (292)
T ss_pred             chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcc-----ccccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            778999999999888665555543221111111111111100     011246788999999999999999999999999


Q ss_pred             CCCCCCCCCCC
Q psy8260         385 HPYLSQYSDPN  395 (427)
Q Consensus       385 Hp~f~~~~~~~  395 (427)
                      ||||.....|.
T Consensus       272 ~~~~~~~~~~~  282 (292)
T cd06658         272 HPFLKLAGPPS  282 (292)
T ss_pred             ChhhhccCCcc
Confidence            99998765554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.8e-36  Score=284.47  Aligned_cols=251  Identities=24%  Similarity=0.329  Sum_probs=192.8

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceE
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV  145 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~  145 (427)
                      |.+.+.+|+|+||.||.+ .+..+|+.||+|.+............+.+|+++++.++||||+++++.+...      ...
T Consensus         2 ~~~~~~l~~g~~~~v~~~-~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~   74 (256)
T cd08529           2 FEILNKIGKGSFGVVFKV-VRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK------GKL   74 (256)
T ss_pred             ceEeEEecCCCCeEEEEE-EEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC------CEE
Confidence            567788999999999965 4567899999999865544555667788999999999999999999987643      457


Q ss_pred             EEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         146 YMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       146 ~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      |++++++ +++|.+++..   ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~  154 (256)
T cd08529          75 NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN  154 (256)
T ss_pred             EEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence            8888877 7899988865   46889999999999999999999999999999999999999999999999988643221


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      ..                                                          ......|++.|+|||++.+.
T Consensus       155 ~~----------------------------------------------------------~~~~~~~~~~y~aPE~~~~~  176 (256)
T cd08529         155 TN----------------------------------------------------------FANTIVGTPYYLSPELCEDK  176 (256)
T ss_pred             cc----------------------------------------------------------hhhccccCccccCHHHhcCC
Confidence            00                                                          00122456778888887776


Q ss_pred             cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHH
Q psy8260         302 MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQ  381 (427)
Q Consensus       302 ~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e  381 (427)
                      .+...+|+||+|++++.+.++..||................       .......+++++.++|.+||+.||++||++.|
T Consensus       177 ~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~  249 (256)
T cd08529         177 PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV-------FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQ  249 (256)
T ss_pred             CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------CCCCccccCHHHHHHHHHHccCCcccCcCHHH
Confidence            67778899999999988866655553322111112111111       01111246788999999999999999999999


Q ss_pred             HhcCCCC
Q psy8260         382 ALAHPYL  388 (427)
Q Consensus       382 ~L~Hp~f  388 (427)
                      +++|||+
T Consensus       250 ll~~~~~  256 (256)
T cd08529         250 LLRNPSL  256 (256)
T ss_pred             HhhCCCC
Confidence            9999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=9.9e-37  Score=290.98  Aligned_cols=261  Identities=20%  Similarity=0.343  Sum_probs=187.2

Q ss_pred             cCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCcccc
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~  140 (427)
                      ..+.|++.+.+|.|+||.||.+ .+..+++.||+|.+...   ......+..|+.+++++ +||||+++++++.......
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~-~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   89 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKG-RHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG   89 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEE-EEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence            3467888899999999999965 45678999999987542   22334567899999888 7999999999985432222


Q ss_pred             CCceEEEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         141 DFKNVYMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       141 ~~~~~~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                      .....|+++|++ +++|.+++..   ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.
T Consensus        90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~  169 (282)
T cd06636          90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  169 (282)
T ss_pred             CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence            335678999988 5689888754   348888899999999999999999999999999999999999999999999986


Q ss_pred             CCCCC---cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccccc
Q psy8260         217 PTENE---MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR  293 (427)
Q Consensus       217 ~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~  293 (427)
                      .....   .....|+..|+|||++.....                                                   
T Consensus       170 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~---------------------------------------------------  198 (282)
T cd06636         170 QLDRTVGRRNTFIGTPYWMAPEVIACDEN---------------------------------------------------  198 (282)
T ss_pred             hhhccccCCCcccccccccCHhhcCcccC---------------------------------------------------
Confidence            43221   112334444444444321000                                                   


Q ss_pred             chHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCC
Q psy8260         294 APEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDS  373 (427)
Q Consensus       294 APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP  373 (427)
                           ....+..++|+||+|++++.+.++..+|................+   .   .......++++.+||.+||+.||
T Consensus       199 -----~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~---~---~~~~~~~~~~~~~li~~cl~~~p  267 (282)
T cd06636         199 -----PDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP---P---KLKSKKWSKKFIDFIEGCLVKNY  267 (282)
T ss_pred             -----cCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCC---C---CCcccccCHHHHHHHHHHhCCCh
Confidence                 012245568999999999888666655543211111111111100   0   00112467899999999999999


Q ss_pred             CCCCCHHHHhcCCCC
Q psy8260         374 EKRITAEQALAHPYL  388 (427)
Q Consensus       374 ~~R~ta~e~L~Hp~f  388 (427)
                      .+|||+.|+|+||||
T Consensus       268 ~~Rp~~~ell~~~~~  282 (282)
T cd06636         268 LSRPSTEQLLKHPFI  282 (282)
T ss_pred             hhCcCHHHHhcCCCC
Confidence            999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.6e-36  Score=286.72  Aligned_cols=258  Identities=21%  Similarity=0.304  Sum_probs=193.1

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC----HHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccC
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS----AVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      |.+++.+|.|+||.||.+..  .+|+.+|||.+......    ......+.+|+++++.++|+||+++++++...     
T Consensus         2 ~~~~~~ig~g~~~~v~~~~~--~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----   74 (265)
T cd06631           2 WTKGEVLGKGAYGTVYCGLT--NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD-----   74 (265)
T ss_pred             ccccceEeccCCeEEEEEEE--cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC-----
Confidence            66788999999999997643  47889999988643221    22334577899999999999999999987643     


Q ss_pred             CceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         142 FKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                       ...++++|++ +++|.+++.. ..+++..+..++.|++.||+|||+.+|+|+||||+||+++.++.+||+|||++....
T Consensus        75 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  153 (265)
T cd06631          75 -NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA  153 (265)
T ss_pred             -CeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence             4578888887 7899988865 568999999999999999999999999999999999999999999999999876432


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      .....  ++                                                  .........|+..|+|||++.
T Consensus       154 ~~~~~--~~--------------------------------------------------~~~~~~~~~~~~~~~~pe~~~  181 (265)
T cd06631         154 WVGLH--GT--------------------------------------------------HSNMLKSMHGTPYWMAPEVIN  181 (265)
T ss_pred             hcccc--cc--------------------------------------------------ccccccccCCCccccChhhhc
Confidence            11000  00                                                  000112345788899999988


Q ss_pred             hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH
Q psy8260         300 NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA  379 (427)
Q Consensus       300 ~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta  379 (427)
                      +..+...+|+|++|++++.+-++..+|..................     ........+.++.+||.+||+.||.+|||+
T Consensus       182 ~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~  256 (265)
T cd06631         182 ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL-----MPRLPDSFSAAAIDFVTSCLTRDQHERPSA  256 (265)
T ss_pred             CCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC-----CCCCCCCCCHHHHHHHHHHhcCCcccCCCH
Confidence            777778889999999998886666555432111111111111000     111223567899999999999999999999


Q ss_pred             HHHhcCCCC
Q psy8260         380 EQALAHPYL  388 (427)
Q Consensus       380 ~e~L~Hp~f  388 (427)
                      .|+++||||
T Consensus       257 ~~~l~~~~~  265 (265)
T cd06631         257 LQLLRHDFL  265 (265)
T ss_pred             HHHhcCCCC
Confidence            999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1e-36  Score=303.19  Aligned_cols=256  Identities=21%  Similarity=0.295  Sum_probs=186.5

Q ss_pred             cccCcceeeccccCcccccEEEEeEE----eCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeeee
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSAL----DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFH  134 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~  134 (427)
                      .+....|++++.||+|+||.||.+..    +..++..||||++.... .......+.+|+++++.+ +|+|||++++.+.
T Consensus        34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~  112 (374)
T cd05106          34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACT  112 (374)
T ss_pred             cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence            45567899999999999999997543    23345689999986543 233455678999999999 8999999999876


Q ss_pred             cCccccCCceEEEEeccC-CCCHHHHHhh---------------------------------------------------
Q psy8260         135 SNTCLADFKNVYMVTHLM-GADLNNILRT---------------------------------------------------  162 (427)
Q Consensus       135 ~~~~~~~~~~~~lv~e~~-g~~L~~~l~~---------------------------------------------------  162 (427)
                      ..      ..++++|+++ +++|.++++.                                                   
T Consensus       113 ~~------~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (374)
T cd05106         113 HG------GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRP  186 (374)
T ss_pred             CC------CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCC
Confidence            53      4578999988 7899887743                                                   


Q ss_pred             --------------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCc
Q psy8260         163 --------------------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM  222 (427)
Q Consensus       163 --------------------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~  222 (427)
                                          ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~  266 (374)
T cd05106         187 VSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS  266 (374)
T ss_pred             ccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCc
Confidence                                136778889999999999999999999999999999999999999999999986432110


Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhcc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM  302 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~  302 (427)
                      ...                                                        ...+..+++.|||||++.+..
T Consensus       267 ~~~--------------------------------------------------------~~~~~~~~~~y~aPE~~~~~~  290 (374)
T cd05106         267 NYV--------------------------------------------------------VKGNARLPVKWMAPESIFDCV  290 (374)
T ss_pred             cee--------------------------------------------------------eccCCCCccceeCHHHhcCCC
Confidence            000                                                        000112456788898887777


Q ss_pred             CCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHH
Q psy8260         303 HYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQ  381 (427)
Q Consensus       303 ~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e  381 (427)
                      +..++|+||+|++++.|.+ +..||..........+.........      .....++++.+||.+||+.||.+|||++|
T Consensus       291 ~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dp~~RPs~~~  364 (374)
T cd05106         291 YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMS------RPDFAPPEIYSIMKMCWNLEPTERPTFSQ  364 (374)
T ss_pred             CCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCcc------CCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            8888999999999976532 3333332221122222221111000      11235789999999999999999999999


Q ss_pred             Hhc
Q psy8260         382 ALA  384 (427)
Q Consensus       382 ~L~  384 (427)
                      +++
T Consensus       365 l~~  367 (374)
T cd05106         365 ISQ  367 (374)
T ss_pred             HHH
Confidence            875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.2e-36  Score=288.66  Aligned_cols=252  Identities=23%  Similarity=0.377  Sum_probs=185.7

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCce
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      .|++.+.||.|+||.||++ .+..++..+|+|.+...  .......+.+|+++++.++||||+++++++...      ..
T Consensus         6 ~~~i~~~lg~g~~g~v~~~-~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~------~~   76 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKA-QNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYE------NN   76 (282)
T ss_pred             HHHHHhhcccCCCeEEEEE-EECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC------CE
Confidence            3567789999999999965 56678889999988543  334456678999999999999999999987653      35


Q ss_pred             EEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         145 VYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       145 ~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      .|++++++ +++|..++..  ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus        77 ~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  156 (282)
T cd06643          77 LWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  156 (282)
T ss_pred             EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc
Confidence            68888877 6788776643  56899999999999999999999999999999999999999999999999998643221


Q ss_pred             ---cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         222 ---MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       222 ---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                         .....                                                             ||+.|+|||++
T Consensus       157 ~~~~~~~~-------------------------------------------------------------~~~~y~aPE~~  175 (282)
T cd06643         157 IQRRDSFI-------------------------------------------------------------GTPYWMAPEVV  175 (282)
T ss_pred             cccccccc-------------------------------------------------------------ccccccCHhhc
Confidence               11123                                                             44445555554


Q ss_pred             h-----hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCC
Q psy8260         299 L-----NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDS  373 (427)
Q Consensus       299 ~-----~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP  373 (427)
                      .     +..+...+|+||+|++++.+.++..+|................+...     ......+.++.+||.+||+.||
T Consensus       176 ~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p  250 (282)
T cd06643         176 MCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL-----AQPSRWSSEFKDFLKKCLEKNV  250 (282)
T ss_pred             cccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCC-----CCccccCHHHHHHHHHHccCCh
Confidence            2     12244568999999999877655544433221111111111111100     0112357889999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCC
Q psy8260         374 EKRITAEQALAHPYLSQY  391 (427)
Q Consensus       374 ~~R~ta~e~L~Hp~f~~~  391 (427)
                      .+|||++++++||||...
T Consensus       251 ~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         251 DARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             hhCcCHHHHhcCCCEecc
Confidence            999999999999999763

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9.6e-37  Score=291.66  Aligned_cols=263  Identities=22%  Similarity=0.353  Sum_probs=192.5

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCce
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      .|++.+.||+|+||.||. +.+..+|..||+|.+.... .......+.+|+.++++++||||+++++.+...      ..
T Consensus         2 ~~~~~~~ig~g~~g~v~~-~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------~~   73 (286)
T cd06622           2 EIEVLDELGKGNYGSVYK-VLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIE------GA   73 (286)
T ss_pred             hhhhhhhhcccCCeEEEE-EEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC------Ce
Confidence            467889999999999996 4566789999999886432 333446678999999999999999999987653      46


Q ss_pred             EEEEeccC-CCCHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCCeEEcCCCCEEEeeCCCCCCC
Q psy8260         145 VYMVTHLM-GADLNNILRTQ----KLSDDHVQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNEDCELKILDFGLARPT  218 (427)
Q Consensus       145 ~~lv~e~~-g~~L~~~l~~~----~l~~~~~~~~~~qi~~aL~yLH~-~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~  218 (427)
                      .|+++|++ +++|..++...    .+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++...
T Consensus        74 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  153 (286)
T cd06622          74 VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL  153 (286)
T ss_pred             EEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            78899888 67898888754    78999999999999999999996 59999999999999999999999999998754


Q ss_pred             CCC-cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         219 ENE-MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       219 ~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      ... .....++..|+|||.+.+....                                                      
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~------------------------------------------------------  179 (286)
T cd06622         154 VASLAKTNIGCQSYMAPERIKSGGPN------------------------------------------------------  179 (286)
T ss_pred             cCCccccCCCccCccCcchhcCCCCC------------------------------------------------------
Confidence            322 2223455566666654321000                                                      


Q ss_pred             hhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC
Q psy8260         298 MLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI  377 (427)
Q Consensus       298 l~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~  377 (427)
                       ....+..++|+|++|++++.+.++..+|..................    .........++++.+||.+||+.||++||
T Consensus       180 -~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  254 (286)
T cd06622         180 -QNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDG----DPPTLPSGYSDDAQDFVAKCLNKIPNRRP  254 (286)
T ss_pred             -ccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhc----CCCCCCcccCHHHHHHHHHHcccCcccCC
Confidence             0011345679999999998886665555322111111111100000    01112234688999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCCC
Q psy8260         378 TAEQALAHPYLSQYSDP  394 (427)
Q Consensus       378 ta~e~L~Hp~f~~~~~~  394 (427)
                      |++|+++||||.....+
T Consensus       255 ~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         255 TYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             CHHHHhcChhhhhccCC
Confidence            99999999999876544

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.7e-36  Score=291.92  Aligned_cols=256  Identities=20%  Similarity=0.321  Sum_probs=195.7

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      ..|.+.+.+|.|+||.||.+ .+..+++.||+|.+.....  .....+.+|+.+++.++||||+++++.|...      .
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~-~~~~~~~~v~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~------~   90 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTA-MDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVG------D   90 (296)
T ss_pred             cceeeEEEecCCCCeEEEEE-EECCCCcEEEEEEEecCCc--chHHHHHHHHHHHHhCCCCCEeeEEEEEEeC------C
Confidence            46788899999999999965 5677899999998865432  2345577899999999999999999987643      4


Q ss_pred             eEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCc
Q psy8260         144 NVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM  222 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~  222 (427)
                      ..|++++++ +++|.+++....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        91 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~  170 (296)
T cd06654          91 ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (296)
T ss_pred             EEEEeecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence            678899887 7899999887789999999999999999999999999999999999999999999999999876432110


Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhcc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM  302 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~  302 (427)
                      .                                                          ......|++.|+|||.+.+..
T Consensus       171 ~----------------------------------------------------------~~~~~~~~~~y~aPE~~~~~~  192 (296)
T cd06654         171 S----------------------------------------------------------KRSTMVGTPYWMAPEVVTRKA  192 (296)
T ss_pred             c----------------------------------------------------------ccCcccCCccccCHHHHcCCC
Confidence            0                                                          001124667778888777666


Q ss_pred             CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q psy8260         303 HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQA  382 (427)
Q Consensus       303 ~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~  382 (427)
                      +..++|+|++|++++.+-++..||.............. .....    ......+++.+.+||.+||+.||.+|||++|+
T Consensus       193 ~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ei  267 (296)
T cd06654         193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPE----LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL  267 (296)
T ss_pred             CCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc-CCCCC----CCCccccCHHHHHHHHHHCcCCcccCcCHHHH
Confidence            67788999999999888666666643321111111110 11000    01123467889999999999999999999999


Q ss_pred             hcCCCCCCC
Q psy8260         383 LAHPYLSQY  391 (427)
Q Consensus       383 L~Hp~f~~~  391 (427)
                      ++||||...
T Consensus       268 l~~~~~~~~  276 (296)
T cd06654         268 LQHQFLKIA  276 (296)
T ss_pred             hhChhhhcc
Confidence            999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.1e-36  Score=291.98  Aligned_cols=259  Identities=31%  Similarity=0.462  Sum_probs=182.0

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      ..|.+.+.||+|+||.||. +.+..+|..||+|.+...... .......+|+.+++.++|+||+++++++...      .
T Consensus         5 ~~y~~~~~ig~g~~~~v~~-~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~------~   76 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYK-GISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHTK------E   76 (291)
T ss_pred             ceeEEEEEEEecCCEEEEE-EEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEecC------C
Confidence            4578889999999999995 456678899999998643221 1223456899999999999999999998653      3


Q ss_pred             eEEEEeccCCCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         144 NVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       144 ~~~lv~e~~g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      ..|++++++++++.+.+..  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        77 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          77 TLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             eEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            5788999998888776643  45788889999999999999999999999999999999999999999999998643221


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      ...                                                          .....+++.|+|||++.+.
T Consensus       157 ~~~----------------------------------------------------------~~~~~~~~~y~aPE~~~~~  178 (291)
T cd07870         157 SQT----------------------------------------------------------YSSEVVTLWYRPPDVLLGA  178 (291)
T ss_pred             CCC----------------------------------------------------------CCCccccccccCCceeecC
Confidence            100                                                          0011245556666655432


Q ss_pred             -cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCc-HHHHHH--------------HhcCCC--------CCcccHHhhcC--
Q psy8260         302 -MHYNQTDIHQLNLIMEMLGTPPAEFMAKISS-DSARKY--------------INSLPL--------LTKKDFRQVFK--  355 (427)
Q Consensus       302 -~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~-~~~~~~--------------~~~~~~--------~~~~~~~~~~~--  355 (427)
                       .+...+|+||+|++++.+.++..+|...... +...+.              ....+.        .........+.  
T Consensus       179 ~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (291)
T cd07870         179 TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRL  258 (291)
T ss_pred             CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhcccc
Confidence             2445579999998887775554444211100 000000              000010        00111112222  


Q ss_pred             CCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q psy8260         356 GANPQAIDLLSLMLELDSEKRITAEQALAHPYL  388 (427)
Q Consensus       356 ~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f  388 (427)
                      ..++++.|||.+||+.||++|||++|++.||||
T Consensus       259 ~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         259 SRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             CCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            135789999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.4e-36  Score=285.11  Aligned_cols=260  Identities=24%  Similarity=0.346  Sum_probs=194.0

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCce
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      .|++.+.+|.|+||.||.+. ...++..||+|++....... ....+.+|+.+++.++|+||+++++.+...      ..
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~-~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~   73 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAI-CLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVG------DE   73 (267)
T ss_pred             cceeeeeecCCCCeEEEEEE-EcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeC------CE
Confidence            57888999999999999654 55688999999986543333 556678999999999999999999887543      46


Q ss_pred             EEEEeccC-CCCHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         145 VYMVTHLM-GADLNNILRT----QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       145 ~~lv~e~~-g~~L~~~l~~----~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                      .+++++++ +++|.++++.    ..+++..+..++.|++.||.|||++||+||||||+||++++++.+||+|||++....
T Consensus        74 ~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~  153 (267)
T cd06610          74 LWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLA  153 (267)
T ss_pred             EEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhc
Confidence            78888888 7789888864    358999999999999999999999999999999999999999999999999876432


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      ......                                                      ........|+..|+|||++.
T Consensus       154 ~~~~~~------------------------------------------------------~~~~~~~~~~~~y~~Pe~~~  179 (267)
T cd06610         154 DGGDRT------------------------------------------------------RKVRKTFVGTPCWMAPEVME  179 (267)
T ss_pred             cCcccc------------------------------------------------------ccccccccCChhhcChHHHc
Confidence            211000                                                      00112234677888888876


Q ss_pred             hc-cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC
Q psy8260         300 NW-MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT  378 (427)
Q Consensus       300 ~~-~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t  378 (427)
                      .. ....++|+|++|++++.+-++..+|..........+.....+...  .....+...+++++|||.+||+.||.+|||
T Consensus       180 ~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~  257 (267)
T cd06610         180 QVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSL--ETGADYKKYSKSFRKMISLCLQKDPSKRPT  257 (267)
T ss_pred             cccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCc--CCccccccccHHHHHHHHHHcCCChhhCcC
Confidence            65 566678999999999888666666543322222222221111100  000112356788999999999999999999


Q ss_pred             HHHHhcCCCC
Q psy8260         379 AEQALAHPYL  388 (427)
Q Consensus       379 a~e~L~Hp~f  388 (427)
                      ++|+++||||
T Consensus       258 ~~~ll~~p~~  267 (267)
T cd06610         258 AEELLKHKFF  267 (267)
T ss_pred             HHHHhhCCCC
Confidence            9999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.2e-36  Score=302.94  Aligned_cols=257  Identities=23%  Similarity=0.294  Sum_probs=187.2

Q ss_pred             cccCcceeeccccCcccccEEEEeEE----eCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeeee
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSAL----DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFH  134 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~  134 (427)
                      .+..++|.+++.||+|+||.||.+..    +..++..||||++.... .....+.+.+|+.+|+.+ +|||||++++++.
T Consensus        31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~  109 (375)
T cd05104          31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACT  109 (375)
T ss_pred             ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence            45567899999999999999997643    34567789999986432 233445678999999999 8999999999876


Q ss_pred             cCccccCCceEEEEeccC-CCCHHHHHhhC--------------------------------------------------
Q psy8260         135 SNTCLADFKNVYMVTHLM-GADLNNILRTQ--------------------------------------------------  163 (427)
Q Consensus       135 ~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~--------------------------------------------------  163 (427)
                      ..      ...+++||++ +|+|.++++..                                                  
T Consensus       110 ~~------~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  183 (375)
T cd05104         110 VG------GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKA  183 (375)
T ss_pred             cC------CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccc
Confidence            54      3468888887 78998877531                                                  


Q ss_pred             --------------------------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCC
Q psy8260         164 --------------------------KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP  217 (427)
Q Consensus       164 --------------------------~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~  217 (427)
                                                .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~  263 (375)
T cd05104         184 DKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARD  263 (375)
T ss_pred             ccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCcccee
Confidence                                      367788889999999999999999999999999999999999999999999864


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      ........                                                        ......++..|+|||+
T Consensus       264 ~~~~~~~~--------------------------------------------------------~~~~~~~~~~y~aPE~  287 (375)
T cd05104         264 IRNDSNYV--------------------------------------------------------VKGNARLPVKWMAPES  287 (375)
T ss_pred             ccCccccc--------------------------------------------------------ccCCCCCCcceeChhH
Confidence            32211000                                                        0001124566888888


Q ss_pred             hhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCC
Q psy8260         298 MLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKR  376 (427)
Q Consensus       298 l~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R  376 (427)
                      +.+..+..++|+||+|++++.+.+ +..+|..........+........      ......+.++++||.+||+.||++|
T Consensus       288 ~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~R  361 (375)
T cd05104         288 IFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM------LSPECAPSEMYDIMKSCWDADPLKR  361 (375)
T ss_pred             hcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC------CCCCCCCHHHHHHHHHHccCChhHC
Confidence            887778888999999999877532 333332221111222222211000      0112346789999999999999999


Q ss_pred             CCHHHHhcC
Q psy8260         377 ITAEQALAH  385 (427)
Q Consensus       377 ~ta~e~L~H  385 (427)
                      ||+.|+++.
T Consensus       362 Ps~~eil~~  370 (375)
T cd05104         362 PTFKQIVQL  370 (375)
T ss_pred             cCHHHHHHH
Confidence            999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.2e-36  Score=285.90  Aligned_cols=257  Identities=27%  Similarity=0.409  Sum_probs=191.7

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH-------HHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA-------VHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~-------~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      |.++..||.|+||.||.+ .+..+++.||+|.+.......       ...+.+.+|+.++++++||||+++++++...  
T Consensus         2 ~~~~~~ig~g~~~~v~~a-~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--   78 (267)
T cd06628           2 WIKGALIGSGSFGSVYLG-MNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA--   78 (267)
T ss_pred             ccccceeecCCCeEEEEE-EecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--
Confidence            567889999999999965 466678999999886543221       1224567899999999999999999987653  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                          ...+++++++ +++|.++++. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++
T Consensus        79 ----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          79 ----DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             ----CccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCc
Confidence                3567888877 6799988865 568999999999999999999999999999999999999999999999999987


Q ss_pred             CCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         217 PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       217 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      .........  .                                                  .........|++.|+|||
T Consensus       155 ~~~~~~~~~--~--------------------------------------------------~~~~~~~~~~~~~y~~pe  182 (267)
T cd06628         155 KLEANSLST--K--------------------------------------------------TNGARPSLQGSVFWMAPE  182 (267)
T ss_pred             ccccccccC--C--------------------------------------------------ccccccccCCCcCccChh
Confidence            543211000  0                                                  000111234778899999


Q ss_pred             HhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCC
Q psy8260         297 IMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKR  376 (427)
Q Consensus       297 vl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R  376 (427)
                      ++.+..+...+|+|++|++++.+-++..+|..........+.....       ........+.++.+||.+||+.||.+|
T Consensus       183 ~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~R  255 (267)
T cd06628         183 VVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA-------SPEIPSNISSEAIDFLEKTFEIDHNKR  255 (267)
T ss_pred             HhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC-------CCcCCcccCHHHHHHHHHHccCCchhC
Confidence            8877777778899999999988866655553321111111111100       011123467889999999999999999


Q ss_pred             CCHHHHhcCCCC
Q psy8260         377 ITAEQALAHPYL  388 (427)
Q Consensus       377 ~ta~e~L~Hp~f  388 (427)
                      ||+.|+++||||
T Consensus       256 p~~~~il~~~~~  267 (267)
T cd06628         256 PTAAELLKHPFL  267 (267)
T ss_pred             cCHHHHhhCCCC
Confidence            999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-37  Score=295.83  Aligned_cols=148  Identities=32%  Similarity=0.516  Sum_probs=122.4

Q ss_pred             eeeccccCcccccEEEEeEEeCc--CCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSV--SGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~--~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      |.+.+.||.|+||.||.+. +..  +++.||+|.+..... .........+|+.++++++||||+++++++...    ..
T Consensus         2 y~~~~~ig~g~~g~v~~~~-~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~   76 (316)
T cd07842           2 YEIEGCIGRGTYGRVYKAK-RKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH----AD   76 (316)
T ss_pred             ceEEEEeccCCcEEEEEEE-ecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC----CC
Confidence            5677889999999999755 444  789999999875321 122234567899999999999999999998653    12


Q ss_pred             ceEEEEeccCCCCHHHHHhh------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcC----CCCEEEeeC
Q psy8260         143 KNVYMVTHLMGADLNNILRT------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE----DCELKILDF  212 (427)
Q Consensus       143 ~~~~lv~e~~g~~L~~~l~~------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~----~~~~kl~DF  212 (427)
                      ..+++++|++++++.+++..      ..+++..+..++.|++.||.|||+++|+||||||+|||++.    ++.+||+||
T Consensus        77 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          77 KSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             ceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            46899999998888776632      25889999999999999999999999999999999999998    899999999


Q ss_pred             CCCCCC
Q psy8260         213 GLARPT  218 (427)
Q Consensus       213 Gla~~~  218 (427)
                      |+++..
T Consensus       157 g~~~~~  162 (316)
T cd07842         157 GLARLF  162 (316)
T ss_pred             cccccc
Confidence            998754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.1e-36  Score=290.65  Aligned_cols=257  Identities=32%  Similarity=0.546  Sum_probs=187.1

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceE
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV  145 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~  145 (427)
                      |++.+.||.|++|.||. +.+..+|..||||++..... ......+.+|+.+++.++||||+++++.+...      ...
T Consensus         2 y~~~~~l~~g~~~~v~~-~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~   73 (284)
T cd07836           2 FKQLEKLGEGTYATVYK-GRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTE------NKL   73 (284)
T ss_pred             ceEeeeeccCCceEEEE-EEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC------CcE
Confidence            67788999999999996 55677899999999865422 22234567899999999999999999988653      457


Q ss_pred             EEEeccCCCCHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         146 YMVTHLMGADLNNILRT----QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       146 ~lv~e~~g~~L~~~l~~----~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      +++++++.++|.+++..    ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus        74 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~  153 (284)
T cd07836          74 MLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP  153 (284)
T ss_pred             EEEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence            89999998888887754    35899999999999999999999999999999999999999999999999988643221


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      ...                                                          .....+|+.|++||++.+.
T Consensus       154 ~~~----------------------------------------------------------~~~~~~~~~y~~PE~~~~~  175 (284)
T cd07836         154 VNT----------------------------------------------------------FSNEVVTLWYRAPDVLLGS  175 (284)
T ss_pred             ccc----------------------------------------------------------cccccccccccChHHhcCC
Confidence            000                                                          0111245556666655432


Q ss_pred             -cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHh---------------------cCCCCCcccHHhhcCCCCh
Q psy8260         302 -MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYIN---------------------SLPLLTKKDFRQVFKGANP  359 (427)
Q Consensus       302 -~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~s~  359 (427)
                       .+...+|+|++|++++.+.++..+|......+.......                     ..+...........+..++
T Consensus       176 ~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (284)
T cd07836         176 RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADP  255 (284)
T ss_pred             CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCc
Confidence             234567999999988777555444432221111111110                     0111111222334455688


Q ss_pred             hHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q psy8260         360 QAIDLLSLMLELDSEKRITAEQALAHPYL  388 (427)
Q Consensus       360 ~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f  388 (427)
                      +++++|.+||+.||.+|+|++|+++||||
T Consensus       256 ~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         256 LGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             HHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            99999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-37  Score=292.39  Aligned_cols=258  Identities=32%  Similarity=0.540  Sum_probs=186.9

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceE
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV  145 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~  145 (427)
                      |++.+.+|.|++|.||++ .+..+|..||+|++............+.+|+.+++.++||||+++++++...      ...
T Consensus         1 y~~~~~l~~g~~~~vy~~-~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~------~~~   73 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKA-RDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE------NKL   73 (283)
T ss_pred             CchheEecCCCCeEEEEE-EEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC------CeE
Confidence            345678999999999965 4566899999999865433333334577899999999999999999987643      467


Q ss_pred             EEEeccCCCCHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCc
Q psy8260         146 YMVTHLMGADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM  222 (427)
Q Consensus       146 ~lv~e~~g~~L~~~l~~~---~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~  222 (427)
                      |+++++++++|.+++...   .+++..+..++.|++.||+|||+++++||||+|+||+++.++.++|+|||+++......
T Consensus        74 ~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~  153 (283)
T cd07835          74 YLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV  153 (283)
T ss_pred             EEEEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence            899999988898887653   58999999999999999999999999999999999999999999999999986432111


Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc-
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW-  301 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~-  301 (427)
                      ..                                                          .....+++.|+|||++.+. 
T Consensus       154 ~~----------------------------------------------------------~~~~~~~~~~~aPE~~~~~~  175 (283)
T cd07835         154 RT----------------------------------------------------------YTHEVVTLWYRAPEILLGSR  175 (283)
T ss_pred             cc----------------------------------------------------------cCccccccCCCCCceeecCc
Confidence            00                                                          0011234556666655432 


Q ss_pred             cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHH---------------------HhcCCCCCcccHHhhcCCCChh
Q psy8260         302 MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKY---------------------INSLPLLTKKDFRQVFKGANPQ  360 (427)
Q Consensus       302 ~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~s~~  360 (427)
                      .+..++|+||+|++++.+.++..+|..........+.                     ....+.............++++
T Consensus       176 ~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (283)
T cd07835         176 QYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDED  255 (283)
T ss_pred             ccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHH
Confidence            2345679999999888775554433211100111111                     1111112222233344567889


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q psy8260         361 AIDLLSLMLELDSEKRITAEQALAHPYL  388 (427)
Q Consensus       361 ~~dLi~~mL~~dP~~R~ta~e~L~Hp~f  388 (427)
                      +.+||.+||+.||.+|||++|+++||||
T Consensus       256 ~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         256 GLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            9999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.6e-36  Score=289.80  Aligned_cols=261  Identities=23%  Similarity=0.348  Sum_probs=190.8

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .+.|++.+.+|.|+||.||.+ .+..+++.||+|.+...  .....+.+.+|+.+++.++||||+++++.+...      
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~-~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------   81 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKA-KNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWD------   81 (292)
T ss_pred             chhhhhhheecCCCCeEEEEE-EECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC------
Confidence            356888999999999999965 56678999999998643  344556678899999999999999999987643      


Q ss_pred             ceEEEEeccC-CCCHHHHHh--hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILR--TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~--~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                      ...|++++++ +++|..++.  ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus        82 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  161 (292)
T cd06644          82 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV  161 (292)
T ss_pred             CeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecc
Confidence            3578888887 677877664  3468999999999999999999999999999999999999999999999999876432


Q ss_pred             CC---cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         220 NE---MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       220 ~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      ..   .....++..|+|||++.+...                                                      
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~~~------------------------------------------------------  187 (292)
T cd06644         162 KTLQRRDSFIGTPYWMAPEVVMCETM------------------------------------------------------  187 (292)
T ss_pred             ccccccceecCCccccCceeeccccc------------------------------------------------------
Confidence            21   122334455555554422000                                                      


Q ss_pred             HhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCC
Q psy8260         297 IMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKR  376 (427)
Q Consensus       297 vl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R  376 (427)
                        ....+...+|+||+|++++.|-++..++..........+.....+  +   .......++.++.+||.+||+.||++|
T Consensus       188 --~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~---~~~~~~~~~~~~~~li~~~l~~~p~~R  260 (292)
T cd06644         188 --KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP--P---TLSQPSKWSMEFRDFLKTALDKHPETR  260 (292)
T ss_pred             --cCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCC--c---cCCCCcccCHHHHHHHHHHhcCCcccC
Confidence              011244567999999999888666655543221111111111111  0   001123457889999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCC
Q psy8260         377 ITAEQALAHPYLSQYSD  393 (427)
Q Consensus       377 ~ta~e~L~Hp~f~~~~~  393 (427)
                      ||++|+++||||.....
T Consensus       261 p~~~~il~~~~~~~~~~  277 (292)
T cd06644         261 PSAAQLLEHPFVSSVTS  277 (292)
T ss_pred             cCHHHHhcCcccccccc
Confidence            99999999999976543

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-36  Score=288.76  Aligned_cols=256  Identities=23%  Similarity=0.386  Sum_probs=189.7

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      ..|.+.+.||.|+||.||.+. +..++..||+|.+...  .....+.+.+|++++++++||||+++++.+...      .
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~-~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~   75 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQ-HKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYE------N   75 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEE-EcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC------C
Confidence            457888999999999999764 4458899999988543  344456678999999999999999999988653      4


Q ss_pred             eEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      ..|+++|++ +++|.+++..  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~  155 (280)
T cd06611          76 KLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS  155 (280)
T ss_pred             eEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence            578999988 6789888764  4689999999999999999999999999999999999999999999999998764321


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      ...                                                          ......||+.|+|||++..
T Consensus       156 ~~~----------------------------------------------------------~~~~~~~~~~y~~PE~~~~  177 (280)
T cd06611         156 TLQ----------------------------------------------------------KRDTFIGTPYWMAPEVVAC  177 (280)
T ss_pred             ccc----------------------------------------------------------ccceeecchhhcCHHHHhh
Confidence            100                                                          0011234455555555432


Q ss_pred             -----ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCC
Q psy8260         301 -----WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEK  375 (427)
Q Consensus       301 -----~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~  375 (427)
                           ..+..++|+|++|++++.+.++..+|..........+.....+..    + ......+.++.+||.+||+.||.+
T Consensus       178 ~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~-~~~~~~~~~~~~li~~~l~~~p~~  252 (280)
T cd06611         178 ETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPT----L-DQPSKWSSSFNDFLKSCLVKDPDD  252 (280)
T ss_pred             cccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCC----c-CCcccCCHHHHHHHHHHhccChhh
Confidence                 224456899999999988866655554322111111111111000    0 111345789999999999999999


Q ss_pred             CCCHHHHhcCCCCCCC
Q psy8260         376 RITAEQALAHPYLSQY  391 (427)
Q Consensus       376 R~ta~e~L~Hp~f~~~  391 (427)
                      |||++++++||||.+.
T Consensus       253 Rps~~~il~~~~~~~~  268 (280)
T cd06611         253 RPTAAELLKHPFVSDQ  268 (280)
T ss_pred             CcCHHHHhcChhhccc
Confidence            9999999999999865

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.4e-36  Score=292.64  Aligned_cols=257  Identities=20%  Similarity=0.330  Sum_probs=195.1

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      ..|.+.+.||.|+||.||.+ .+..+|+.||+|.+.....  ...+.+.+|+.+++.++||||+++++++...      .
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~-~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~------~   89 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTA-IDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVG------D   89 (297)
T ss_pred             hhceeeeeeccCCCeEEEEE-EECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecC------C
Confidence            56788899999999999964 5677899999999865332  2335567899999999999999999988643      4


Q ss_pred             eEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCc
Q psy8260         144 NVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM  222 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~  222 (427)
                      ..|++++++ +++|.+++....+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~  169 (297)
T cd06656          90 ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (297)
T ss_pred             EEEEeecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence            578888887 7899999888889999999999999999999999999999999999999999999999999876432110


Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhcc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM  302 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~  302 (427)
                      .                                                          ......|++.|+|||.+.+..
T Consensus       170 ~----------------------------------------------------------~~~~~~~~~~y~aPE~~~~~~  191 (297)
T cd06656         170 S----------------------------------------------------------KRSTMVGTPYWMAPEVVTRKA  191 (297)
T ss_pred             c----------------------------------------------------------CcCcccCCccccCHHHHcCCC
Confidence            0                                                          001123667788888777666


Q ss_pred             CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q psy8260         303 HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQA  382 (427)
Q Consensus       303 ~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~  382 (427)
                      +..++|+|++|++++.+-++..+|.............. ..    ..........++.+++||.+||+.||.+|||++++
T Consensus       192 ~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  266 (297)
T cd06656         192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NG----TPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKEL  266 (297)
T ss_pred             CCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CC----CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHH
Confidence            66778999999999888666655543211110000000 00    00001123457789999999999999999999999


Q ss_pred             hcCCCCCCCC
Q psy8260         383 LAHPYLSQYS  392 (427)
Q Consensus       383 L~Hp~f~~~~  392 (427)
                      ++||||....
T Consensus       267 l~~~~~~~~~  276 (297)
T cd06656         267 LQHPFLKLAK  276 (297)
T ss_pred             hcCchhcccc
Confidence            9999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.1e-36  Score=286.10  Aligned_cols=260  Identities=22%  Similarity=0.329  Sum_probs=191.2

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC----HHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccC
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS----AVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      |..++.||+|+||.||. +.+..+++.||+|++......    ......+.+|+.++++++|+||+++++++...     
T Consensus         2 ~~~~~~lg~g~~~~v~~-~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----   75 (268)
T cd06630           2 WLKGQQLGTGAFSSCYQ-ARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED-----   75 (268)
T ss_pred             ccccceecCcCceEEEE-EEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC-----
Confidence            56778999999999996 456788999999988643221    12345678999999999999999999997643     


Q ss_pred             CceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCC-CEEEeeCCCCCCC
Q psy8260         142 FKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC-ELKILDFGLARPT  218 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~-~~kl~DFGla~~~  218 (427)
                       ...+++++++ +++|.++++. ..+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++...
T Consensus        76 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          76 -SHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             -CeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence             3567777776 7899988864 5689999999999999999999999999999999999998765 6999999998654


Q ss_pred             CCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         219 ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       219 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                      .......                                                      ........||..|+|||++
T Consensus       155 ~~~~~~~------------------------------------------------------~~~~~~~~~~~~~~~PE~~  180 (268)
T cd06630         155 AAKGTGA------------------------------------------------------GEFQGQLLGTIAFMAPEVL  180 (268)
T ss_pred             ccccccC------------------------------------------------------CccccccccccceeCHhHh
Confidence            3211000                                                      0000122467788888888


Q ss_pred             hhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC
Q psy8260         299 LNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT  378 (427)
Q Consensus       299 ~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t  378 (427)
                      .+..+...+|+|++|++++.+.++..+|....................   ........++++.++|.+||+.||.+|||
T Consensus       181 ~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~~p~~R~~  257 (268)
T cd06630         181 RGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT---APSIPEHLSPGLRDVTLRCLELQPEDRPP  257 (268)
T ss_pred             ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCC---CCCCchhhCHHHHHHHHHHcCCCcccCcC
Confidence            776677788999999999877666555532221111111111100000   01122346789999999999999999999


Q ss_pred             HHHHhcCCCCC
Q psy8260         379 AEQALAHPYLS  389 (427)
Q Consensus       379 a~e~L~Hp~f~  389 (427)
                      +.|+++||||.
T Consensus       258 ~~~ll~~~~~~  268 (268)
T cd06630         258 SRELLKHPVFR  268 (268)
T ss_pred             HHHHhcCcccC
Confidence            99999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3.1e-36  Score=287.08  Aligned_cols=255  Identities=29%  Similarity=0.503  Sum_probs=181.8

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCC-CCCceeeeeeeecCccccCCce
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN-HENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      |++.+.+|+|+||.||.+ .+..++..||+|++........ ....++|+.++.++. |+||+++++++...    ....
T Consensus         1 y~~~~~lg~g~~~~v~~~-~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~----~~~~   74 (282)
T cd07831           1 YKILGKIGEGTFSEVLKA-QSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDR----KTGR   74 (282)
T ss_pred             CceEeeccccccceEEEE-EEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecC----CCCc
Confidence            456788999999999964 4567899999998865432222 234468999999885 99999999998653    1245


Q ss_pred             EEEEeccCCCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC-
Q psy8260         145 VYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE-  221 (427)
Q Consensus       145 ~~lv~e~~g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~-  221 (427)
                      .++++|++++++.+.+..  ..+++..+..++.|++.||.|||++|++||||||+||+++. +.+||+|||+++..... 
T Consensus        75 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          75 LALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             EEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            789999998888887764  45899999999999999999999999999999999999999 99999999998754321 


Q ss_pred             -cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         222 -MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       222 -~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                       .....                                                             +++.|+|||++..
T Consensus       154 ~~~~~~-------------------------------------------------------------~~~~y~aPE~~~~  172 (282)
T cd07831         154 PYTEYI-------------------------------------------------------------STRWYRAPECLLT  172 (282)
T ss_pred             CcCCCC-------------------------------------------------------------CCcccCChhHhhc
Confidence             11222                                                             3445555554432


Q ss_pred             -ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhc---------------------CCCCCcccHHhhcCCCC
Q psy8260         301 -WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINS---------------------LPLLTKKDFRQVFKGAN  358 (427)
Q Consensus       301 -~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~s  358 (427)
                       ..+...+|+||+|++++.+-++..+|......+........                     .+..............+
T Consensus       173 ~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (282)
T cd07831         173 DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNAS  252 (282)
T ss_pred             CCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHccccc
Confidence             22345679999999887775444333221110110100000                     00111111223334568


Q ss_pred             hhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q psy8260         359 PQAIDLLSLMLELDSEKRITAEQALAHPYL  388 (427)
Q Consensus       359 ~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f  388 (427)
                      .++.+||.+||++||++|||++|+++||||
T Consensus       253 ~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         253 AEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             HHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            999999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.4e-36  Score=284.97  Aligned_cols=258  Identities=21%  Similarity=0.317  Sum_probs=190.0

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC---CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccC
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ---SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      .|.+++.+|+|+||.||+ +.+..+|..||+|++.....   .......+.+|+.+++.++||||+++++++....    
T Consensus         3 ~~~~~~~lg~g~~g~vy~-~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----   77 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYL-CYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRA----   77 (266)
T ss_pred             CccccceecCCCCEEEEE-EEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCC----
Confidence            477889999999999996 45677899999998864322   2233456778999999999999999999876421    


Q ss_pred             CceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         142 FKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                      ...++++++++ +++|.+.+.. ..+++.....++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++...
T Consensus        78 ~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          78 EKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            24577888877 6789888764 568999999999999999999999999999999999999999999999999986432


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      ......                                                       .......++..|+|||++.
T Consensus       158 ~~~~~~-------------------------------------------------------~~~~~~~~~~~y~aPE~~~  182 (266)
T cd06651         158 TICMSG-------------------------------------------------------TGIRSVTGTPYWMSPEVIS  182 (266)
T ss_pred             cccccC-------------------------------------------------------CccccCCccccccCHHHhC
Confidence            110000                                                       0011224677788888887


Q ss_pred             hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH
Q psy8260         300 NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA  379 (427)
Q Consensus       300 ~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta  379 (427)
                      +..+...+|+||+|++++.+.++..+|..........+... .+...     ......++.+++||+ ||..||++|||+
T Consensus       183 ~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~-~~~~~-----~~~~~~~~~~~~li~-~~~~~p~~Rp~~  255 (266)
T cd06651         183 GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT-QPTNP-----QLPSHISEHARDFLG-CIFVEARHRPSA  255 (266)
T ss_pred             CCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc-CCCCC-----CCchhcCHHHHHHHH-HhcCChhhCcCH
Confidence            76677788999999999888665555543221111211111 11100     111235788899994 666799999999


Q ss_pred             HHHhcCCCCC
Q psy8260         380 EQALAHPYLS  389 (427)
Q Consensus       380 ~e~L~Hp~f~  389 (427)
                      +|+++||||.
T Consensus       256 ~eil~hp~~~  265 (266)
T cd06651         256 EELLRHPFAQ  265 (266)
T ss_pred             HHHhcCcccc
Confidence            9999999995

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG4279|consensus

Probab=100.00  E-value=7.5e-38  Score=310.36  Aligned_cols=249  Identities=25%  Similarity=0.364  Sum_probs=186.8

Q ss_pred             ccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEEEec
Q psy8260          71 TLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH  150 (427)
Q Consensus        71 ~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~lv~e  150 (427)
                      +||+|.||.|| ++.|..|.+++|||.+...  .....+-...||.+.++|+|.|||++++.+..+      ..+-|+||
T Consensus       582 VLGKGTYG~VY-A~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~sen------Gf~kIFME  652 (1226)
T KOG4279|consen  582 VLGKGTYGTVY-AARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSEN------GFFKIFME  652 (1226)
T ss_pred             EeecCceeEEE-eeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCC------CeEEEEee
Confidence            69999999999 6789999999999998643  233344466899999999999999999886543      34556665


Q ss_pred             -cCCCCHHHHHhh--CCC--CHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEc-CCCCEEEeeCCCCCCCCCCccc
Q psy8260         151 -LMGADLNNILRT--QKL--SDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN-EDCELKILDFGLARPTENEMTG  224 (427)
Q Consensus       151 -~~g~~L~~~l~~--~~l--~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~-~~~~~kl~DFGla~~~~~~~~~  224 (427)
                       ..||+|.++++.  +++  +|..+..|.+||++||+|||++.|||||||-+|+|++ ..|.+||+|||.++..-.-.  
T Consensus       653 qVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--  730 (1226)
T KOG4279|consen  653 QVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--  730 (1226)
T ss_pred             cCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCC--
Confidence             559999999986  456  8889999999999999999999999999999999997 57999999999887532100  


Q ss_pred             ccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc--c
Q psy8260         225 YVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW--M  302 (427)
Q Consensus       225 ~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~--~  302 (427)
                                                                              ....++.||..|||||||-..  .
T Consensus       731 --------------------------------------------------------P~TETFTGTLQYMAPEvIDqG~RG  754 (1226)
T KOG4279|consen  731 --------------------------------------------------------PCTETFTGTLQYMAPEVIDQGPRG  754 (1226)
T ss_pred             --------------------------------------------------------ccccccccchhhhChHhhccCCcC
Confidence                                                                    011234456666666665432  2


Q ss_pred             CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q psy8260         303 HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQA  382 (427)
Q Consensus       303 ~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~  382 (427)
                      |+...||||+||.+-+|.++.+||..--....+.  + ...  ..+....+...+|.+|+.||.+|+..||.+|++|.++
T Consensus       755 YG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM--F-kVG--myKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~L  829 (1226)
T KOG4279|consen  755 YGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM--F-KVG--MYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDL  829 (1226)
T ss_pred             CCchhhhhhccceeEeeccCCCCeeecCChhHhh--h-hhc--ceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHh
Confidence            5556699999999988877777775422111111  0 000  1111223445578999999999999999999999999


Q ss_pred             hcCCCCCCC
Q psy8260         383 LAHPYLSQY  391 (427)
Q Consensus       383 L~Hp~f~~~  391 (427)
                      |+.||+...
T Consensus       830 L~DpFlq~~  838 (1226)
T KOG4279|consen  830 LQDPFLQHN  838 (1226)
T ss_pred             ccCcccccC
Confidence            999999754

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.5e-36  Score=283.82  Aligned_cols=251  Identities=24%  Similarity=0.324  Sum_probs=191.7

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceE
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV  145 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~  145 (427)
                      |.+.+.||+|+||.+|. +.+..+|+.||+|.+............+.+|+.+++.++||||+++++++...      ...
T Consensus         2 y~~~~~lg~g~~g~~~~-~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~~   74 (256)
T cd08218           2 YVKVKKIGEGSFGKAIL-VKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN------GNL   74 (256)
T ss_pred             ceEEEEeccCCceEEEE-EEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC------CeE
Confidence            66788999999999996 45667899999999865433444556778999999999999999999987643      467


Q ss_pred             EEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         146 YMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       146 ~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      +++++++ +++|.+.+..   ..+++..+..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++......
T Consensus        75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~  154 (256)
T cd08218          75 YIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST  154 (256)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence            8888887 7789887754   25789999999999999999999999999999999999999999999999988643221


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      ..                                                          ......|++.|+|||++.+.
T Consensus       155 ~~----------------------------------------------------------~~~~~~~~~~~~~pe~~~~~  176 (256)
T cd08218         155 VE----------------------------------------------------------LARTCIGTPYYLSPEICENR  176 (256)
T ss_pred             hh----------------------------------------------------------hhhhccCCccccCHHHhCCC
Confidence            00                                                          00012356677888887766


Q ss_pred             cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHH
Q psy8260         302 MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQ  381 (427)
Q Consensus       302 ~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e  381 (427)
                      ....++|+|++|++++.+.++..++......+..........       .......+.++.++|.+||+.||.+|||+.|
T Consensus       177 ~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  249 (256)
T cd08218         177 PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY-------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNS  249 (256)
T ss_pred             CCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCC-------CCCcccCCHHHHHHHHHHhhCChhhCcCHHH
Confidence            666778999999999888666555543221122222211111       0112345788999999999999999999999


Q ss_pred             HhcCCCC
Q psy8260         382 ALAHPYL  388 (427)
Q Consensus       382 ~L~Hp~f  388 (427)
                      +++||||
T Consensus       250 vl~~~~~  256 (256)
T cd08218         250 ILEKNFI  256 (256)
T ss_pred             HhhCcCC
Confidence            9999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.3e-36  Score=290.00  Aligned_cols=252  Identities=25%  Similarity=0.372  Sum_probs=193.4

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      .|.+.+.||.|+||.||.+ .+..+++.||+|.+..... .......+.+|++++++++||||+++++++...      .
T Consensus         2 ~y~~~~~ig~g~~~~vy~~-~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~   74 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLV-RHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD------S   74 (290)
T ss_pred             ceEEEEEeecCCCeEEEEE-EEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC------C
Confidence            4677889999999999964 4566899999998864322 223345677999999999999999999988643      4


Q ss_pred             eEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      ..|++++++ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        75 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          75 NLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             eEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            678999998 8899988754 56899999999999999999999999999999999999999999999999998754332


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      ....                                                             .|++.|+|||.+.+.
T Consensus       155 ~~~~-------------------------------------------------------------~~~~~y~aPE~~~~~  173 (290)
T cd05580         155 TYTL-------------------------------------------------------------CGTPEYLAPEIILSK  173 (290)
T ss_pred             CCCC-------------------------------------------------------------CCCccccChhhhcCC
Confidence            2122                                                             355566666666555


Q ss_pred             cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC----
Q psy8260         302 MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI----  377 (427)
Q Consensus       302 ~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~----  377 (427)
                      ....++|+|++|++++.|.++..+|.................        .+....++.++++|.+||+.||.+|+    
T Consensus       174 ~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~  245 (290)
T cd05580         174 GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKV--------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLK  245 (290)
T ss_pred             CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc--------cCCccCCHHHHHHHHHHccCCHHHccCccc
Confidence            566678999999999888766655533221111111111111        11234578999999999999999999    


Q ss_pred             -CHHHHhcCCCCCCCC
Q psy8260         378 -TAEQALAHPYLSQYS  392 (427)
Q Consensus       378 -ta~e~L~Hp~f~~~~  392 (427)
                       +++|+++||||....
T Consensus       246 ~~~~~l~~~~~~~~~~  261 (290)
T cd05580         246 NGVNDIKNHPWFAGID  261 (290)
T ss_pred             CCHHHHHcCcccccCC
Confidence             999999999998754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-36  Score=287.66  Aligned_cols=254  Identities=22%  Similarity=0.359  Sum_probs=195.1

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCce
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      +|.+.+.+|.|+||.||.+ .+..+++.||+|.+.... .......+.+|+++++.++|+||+++++.+...      ..
T Consensus         2 ~y~~~~~lg~g~~~~v~~~-~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~   73 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKA-IDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG------SK   73 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEE-EECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC------Ce
Confidence            4667789999999999965 456789999999886542 233445677899999999999999999987643      45


Q ss_pred             EEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcc
Q psy8260         145 VYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT  223 (427)
Q Consensus       145 ~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~  223 (427)
                      .|++++++ +++|.+++....+++..+..++.|++.||.|||+++++||||+|+||+++.++.++|+|||+++.......
T Consensus        74 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          74 LWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS  153 (274)
T ss_pred             EEEEEEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence            78888887 67999998877899999999999999999999999999999999999999999999999999865432110


Q ss_pred             cccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccC
Q psy8260         224 GYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH  303 (427)
Q Consensus       224 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~  303 (427)
                                                                                ......|++.|+|||++.+..+
T Consensus       154 ----------------------------------------------------------~~~~~~~~~~y~~PE~~~~~~~  175 (274)
T cd06609         154 ----------------------------------------------------------KRNTFVGTPFWMAPEVIKQSGY  175 (274)
T ss_pred             ----------------------------------------------------------ccccccCCccccChhhhccCCC
Confidence                                                                      0112346677888888777667


Q ss_pred             CCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcC-CCChhHHHHHHHhcCCCCCCCCCHHHH
Q psy8260         304 YNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFK-GANPQAIDLLSLMLELDSEKRITAEQA  382 (427)
Q Consensus       304 ~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~dLi~~mL~~dP~~R~ta~e~  382 (427)
                      ..++|+|++|++++.+.++..+|................+.       .... ..++++.++|.+||..||.+|||++++
T Consensus       176 ~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~i  248 (274)
T cd06609         176 DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPP-------SLEGNKFSKPFKDFVSLCLNKDPKERPSAKEL  248 (274)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCC-------CCcccccCHHHHHHHHHHhhCChhhCcCHHHH
Confidence            77889999999998886666555322111111111111110       0111 267889999999999999999999999


Q ss_pred             hcCCCCCCC
Q psy8260         383 LAHPYLSQY  391 (427)
Q Consensus       383 L~Hp~f~~~  391 (427)
                      ++||||...
T Consensus       249 l~~~~~~~~  257 (274)
T cd06609         249 LKHKFIKKA  257 (274)
T ss_pred             hhChhhcCC
Confidence            999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3.6e-36  Score=282.77  Aligned_cols=251  Identities=25%  Similarity=0.331  Sum_probs=193.0

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceE
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV  145 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~  145 (427)
                      |.+.+.+|.|+||.|+. +.+..+++.||+|.+.....+.....++.+|+.++++++|+||+++++++...      ...
T Consensus         2 y~~~~~ig~g~~g~v~~-~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~------~~~   74 (256)
T cd08221           2 YIPIRVLGKGAFGEATL-YRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD------NTL   74 (256)
T ss_pred             ceEeeEecccCCceEEE-EEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC------CeE
Confidence            56778999999998885 45667899999999876544555566788999999999999999999998654      457


Q ss_pred             EEEeccC-CCCHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         146 YMVTHLM-GADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       146 ~lv~e~~-g~~L~~~l~~~---~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      +++++++ +++|.+++...   .+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||+++.....
T Consensus        75 ~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~  154 (256)
T cd08221          75 LIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE  154 (256)
T ss_pred             EEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence            8888887 68999888653   5899999999999999999999999999999999999999999999999988643221


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      ..                                                          ......|++.|+|||++.+.
T Consensus       155 ~~----------------------------------------------------------~~~~~~~~~~y~ape~~~~~  176 (256)
T cd08221         155 YS----------------------------------------------------------MAETVVGTPYYMSPELCQGV  176 (256)
T ss_pred             cc----------------------------------------------------------cccccCCCccccCHhhcCCC
Confidence            10                                                          00122466778888877766


Q ss_pred             cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHH
Q psy8260         302 MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQ  381 (427)
Q Consensus       302 ~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e  381 (427)
                      .+..++|+||+|++++.+.++..+|...............  ...     ......+.++.++|.+||+.||.+|||++|
T Consensus       177 ~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~~-----~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~  249 (256)
T cd08221         177 KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--NYT-----PVVSVYSSELISLVHSLLQQDPEKRPTADE  249 (256)
T ss_pred             CCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCC-----CCccccCHHHHHHHHHHcccCcccCCCHHH
Confidence            6667789999999998886554444322211222222111  111     111456789999999999999999999999


Q ss_pred             HhcCCCC
Q psy8260         382 ALAHPYL  388 (427)
Q Consensus       382 ~L~Hp~f  388 (427)
                      +|+|||+
T Consensus       250 ll~~~~l  256 (256)
T cd08221         250 VLDQPLL  256 (256)
T ss_pred             HhhCcCC
Confidence            9999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.5e-36  Score=292.44  Aligned_cols=256  Identities=22%  Similarity=0.357  Sum_probs=196.0

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      ..|.+.+.||.|+||.||. +.+..+|+.||+|.+.....  .....+.+|+.+++.++||||+++++++...      .
T Consensus        19 ~~y~~~~~lg~g~~g~vy~-~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~   89 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFT-AIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVG------D   89 (296)
T ss_pred             ceEEEEEEEecCCCeEEEE-EEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecC------c
Confidence            4578889999999999996 45677899999998864322  2345577899999999999999999988643      4


Q ss_pred             eEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCc
Q psy8260         144 NVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM  222 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~  222 (427)
                      .+|++++++ +++|..++....+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~  169 (296)
T cd06655          90 ELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ  169 (296)
T ss_pred             eEEEEEEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence            578888887 7899998888889999999999999999999999999999999999999999999999999876432110


Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhcc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM  302 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~  302 (427)
                      .                                                          ......|++.|+|||++.+..
T Consensus       170 ~----------------------------------------------------------~~~~~~~~~~y~aPE~~~~~~  191 (296)
T cd06655         170 S----------------------------------------------------------KRSTMVGTPYWMAPEVVTRKA  191 (296)
T ss_pred             c----------------------------------------------------------cCCCcCCCccccCcchhcCCC
Confidence            0                                                          001123667778888776666


Q ss_pred             CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q psy8260         303 HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQA  382 (427)
Q Consensus       303 ~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~  382 (427)
                      +..++|+||+|++++.+.++..+|.............. ....    .......+++.+.+||.+||+.||.+|||+.++
T Consensus       192 ~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~i  266 (296)
T cd06655         192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP----ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKEL  266 (296)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-cCCc----ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHH
Confidence            67788999999999888666666543221111111111 1000    001123467899999999999999999999999


Q ss_pred             hcCCCCCCC
Q psy8260         383 LAHPYLSQY  391 (427)
Q Consensus       383 L~Hp~f~~~  391 (427)
                      ++||||...
T Consensus       267 l~~~~~~~~  275 (296)
T cd06655         267 LQHPFLKLA  275 (296)
T ss_pred             hhChHhhhc
Confidence            999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG1290|consensus

Probab=100.00  E-value=7.8e-37  Score=293.60  Aligned_cols=328  Identities=27%  Similarity=0.346  Sum_probs=217.2

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCC-----CC---Cceeeeee
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN-----HE---NVIGLLDV  132 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~-----Hp---nIv~l~~~  132 (427)
                      +..++|.+.+.||.|.|++|+. ++|..+.+.||+|+++..   ..-.+..+.||++|++++     |+   .||+|++.
T Consensus        75 F~~gRY~v~rKLGWGHFSTVWL-awDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~  150 (590)
T KOG1290|consen   75 FNGGRYHVQRKLGWGHFSTVWL-AWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH  150 (590)
T ss_pred             ccCceEEEEEeccccccceeEE-EeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence            3448899999999999999995 789999999999998632   233456778999998873     43   59999999


Q ss_pred             eecCccccCCceEEEEeccCCCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCCeEEcCC----
Q psy8260         133 FHSNTCLADFKNVYMVTHLMGADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNED----  204 (427)
Q Consensus       133 ~~~~~~~~~~~~~~lv~e~~g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~-~iiHrDLKp~NILl~~~----  204 (427)
                      |....  ....+++||+|++|.+|..++..   ++++...++.|++||+.||+|||.. ||||-||||+|||+..+    
T Consensus       151 FkhsG--pNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~  228 (590)
T KOG1290|consen  151 FKHSG--PNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDP  228 (590)
T ss_pred             ceecC--CCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccch
Confidence            96533  34578999999999999998864   5799999999999999999999965 99999999999998533    


Q ss_pred             -------CCE-----EEeeCCCCCCC------------CC------------------C--------c------------
Q psy8260         205 -------CEL-----KILDFGLARPT------------EN------------------E--------M------------  222 (427)
Q Consensus       205 -------~~~-----kl~DFGla~~~------------~~------------------~--------~------------  222 (427)
                             +.+     +..+=+.+...            .+                  .        .            
T Consensus       229 ~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~  308 (590)
T KOG1290|consen  229 AKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPR  308 (590)
T ss_pred             hhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccC
Confidence                   100     00000000000            00                  0        0            


Q ss_pred             -ccc------------------cccccccchhhhhcccc--cC-CCCcceeeccC----------Ccccc-------ccc
Q psy8260         223 -TGY------------------VATRWYRAPEIMLNWMH--YN-QTGVPFYFQDL----------KPSNI-------AVN  263 (427)
Q Consensus       223 -~~~------------------~gt~~y~aPE~l~~~~~--~~-~~~~~~~~~d~----------~~~~~-------~~~  263 (427)
                       ...                  .....-.+||-..+...  .. ......+..+.          -..|-       .-.
T Consensus       309 ~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~  388 (590)
T KOG1290|consen  309 INGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPE  388 (590)
T ss_pred             CCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCc
Confidence             000                  00000111110000000  00 00000000000          00011       123


Q ss_pred             ccchhhhhccCCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCc----H--H---
Q psy8260         264 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISS----D--S---  334 (427)
Q Consensus       264 ~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~----~--~---  334 (427)
                      .+..+||+|||.|++.....+.-+.|.+|+|||||.+..|....||||.+|+.++|.|+..-|......    +  .   
T Consensus       389 ~di~vKIaDlGNACW~~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~  468 (590)
T KOG1290|consen  389 CDIRVKIADLGNACWVHKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIAL  468 (590)
T ss_pred             cceeEEEeeccchhhhhhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHH
Confidence            467789999999999999999999999999999999999999999999999999999988777543211    0  0   


Q ss_pred             ------------------HHHHHhcCCCCCc----ccH--Hh----hcC---CCChhHHHHHHHhcCCCCCCCCCHHHHh
Q psy8260         335 ------------------ARKYINSLPLLTK----KDF--RQ----VFK---GANPQAIDLLSLMLELDSEKRITAEQAL  383 (427)
Q Consensus       335 ------------------~~~~~~~~~~~~~----~~~--~~----~~~---~~s~~~~dLi~~mL~~dP~~R~ta~e~L  383 (427)
                                        .+.+++....+..    +.|  .+    .+.   ....++.|||.-||+++|.||+||.++|
T Consensus       469 i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl  548 (590)
T KOG1290|consen  469 IMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCL  548 (590)
T ss_pred             HHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHh
Confidence                              0111111111100    000  00    000   1134667999999999999999999999


Q ss_pred             cCCCCCCCCCC
Q psy8260         384 AHPYLSQYSDP  394 (427)
Q Consensus       384 ~Hp~f~~~~~~  394 (427)
                      +|||+.....|
T Consensus       549 ~hPwLn~~~~~  559 (590)
T KOG1290|consen  549 KHPWLNPVAGP  559 (590)
T ss_pred             cCccccCCCCC
Confidence            99999987776

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.5e-36  Score=290.67  Aligned_cols=258  Identities=19%  Similarity=0.293  Sum_probs=184.3

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCC-CCCceeeeeeeecCccccCCc
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN-HENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      .+.....||+|+||.||. +.+..+|+.||+|.+..... ......+.+|+.++.++. ||||+++++++...      .
T Consensus         5 ~~~~~~~lg~G~~g~vy~-~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~------~   76 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVD-EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE------G   76 (288)
T ss_pred             HhHHHHHhCCCCceEEEE-EEECCCCCEEEEEEehhccC-hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC------C
Confidence            455667899999999996 55777899999999865432 234456789999999996 99999999987543      3


Q ss_pred             eEEEEeccCCCCHHHHHh------hCCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         144 NVYMVTHLMGADLNNILR------TQKLSDDHVQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       144 ~~~lv~e~~g~~L~~~l~------~~~l~~~~~~~~~~qi~~aL~yLH~~-~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                      ..++++++++.++.++..      ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus        77 ~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  156 (288)
T cd06616          77 DCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISG  156 (288)
T ss_pred             cEEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhH
Confidence            568889998776655432      35689999999999999999999975 99999999999999999999999999986


Q ss_pred             CCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         217 PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       217 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      .......                                                           .....|++.|+|||
T Consensus       157 ~~~~~~~-----------------------------------------------------------~~~~~~~~~y~aPE  177 (288)
T cd06616         157 QLVDSIA-----------------------------------------------------------KTRDAGCRPYMAPE  177 (288)
T ss_pred             HhccCCc-----------------------------------------------------------cccccCccCccCHH
Confidence            4322100                                                           01113455566666


Q ss_pred             Hhhhc---cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCC
Q psy8260         297 IMLNW---MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDS  373 (427)
Q Consensus       297 vl~~~---~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP  373 (427)
                      ++.+.   .+...+|+||+|++++.+-++..||....  .........................++++.+||.+||+.||
T Consensus       178 ~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  255 (288)
T cd06616         178 RIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDE  255 (288)
T ss_pred             HhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCCh
Confidence            65543   35567899999999877744444443211  11111111110000000011113468899999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCC
Q psy8260         374 EKRITAEQALAHPYLSQY  391 (427)
Q Consensus       374 ~~R~ta~e~L~Hp~f~~~  391 (427)
                      ++|||++|+++||||...
T Consensus       256 ~~Rpt~~~i~~~~~~~~~  273 (288)
T cd06616         256 SKRPKYKELLEHPFIKDY  273 (288)
T ss_pred             hhCcCHHHHhcChhhhch
Confidence            999999999999999864

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.1e-36  Score=293.44  Aligned_cols=257  Identities=22%  Similarity=0.399  Sum_probs=193.5

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceE
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV  145 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~  145 (427)
                      ++....+|.|+||.||. +.+..+++.||+|.+.....  .....+.+|+.+++.++||||+++++.+...      ...
T Consensus        23 ~~~~~~ig~g~~g~v~~-~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~------~~~   93 (297)
T cd06659          23 LENYIKIGEGSTGIVCI-AREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVG------EEL   93 (297)
T ss_pred             HHhhhhcCCCCceeEEE-EEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeC------CeE
Confidence            44556899999999996 45667899999999854322  2345577999999999999999999987653      457


Q ss_pred             EEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCccc
Q psy8260         146 YMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTG  224 (427)
Q Consensus       146 ~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~  224 (427)
                      |++++++ +++|..++....+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........ 
T Consensus        94 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-  172 (297)
T cd06659          94 WVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-  172 (297)
T ss_pred             EEEEecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-
Confidence            8888877 67899888777899999999999999999999999999999999999999999999999998753321100 


Q ss_pred             ccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCC
Q psy8260         225 YVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHY  304 (427)
Q Consensus       225 ~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~  304 (427)
                                                                               ......|++.|+|||++.+..+.
T Consensus       173 ---------------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~  195 (297)
T cd06659         173 ---------------------------------------------------------KRKSLVGTPYWMAPEVISRTPYG  195 (297)
T ss_pred             ---------------------------------------------------------cccceecCccccCHHHHccCCCC
Confidence                                                                     00122466777788877766677


Q ss_pred             CCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy8260         305 NQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALA  384 (427)
Q Consensus       305 ~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~  384 (427)
                      .++|+||+|++++.|.++..+|.......... .....+..    ........++++.+||.+||+.||.+|||++|+++
T Consensus       196 ~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         196 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK-RLRDSPPP----KLKNAHKISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHhccCCC----CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            78899999999988866655553221111111 11111100    11122356788999999999999999999999999


Q ss_pred             CCCCCCCCCC
Q psy8260         385 HPYLSQYSDP  394 (427)
Q Consensus       385 Hp~f~~~~~~  394 (427)
                      ||||.+...|
T Consensus       271 ~~~~~~~~~~  280 (297)
T cd06659         271 HPFLLQTGLP  280 (297)
T ss_pred             ChhhccCCCc
Confidence            9999875544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3.1e-36  Score=287.39  Aligned_cols=251  Identities=20%  Similarity=0.357  Sum_probs=184.0

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHH-HhcCCCCCceeeeeeeecCccccCCc
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRM-LKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~-l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      +|.+.+.||+|+||.||+ +.+..+|+.||||++....... ...+...|+.+ ++.++||||+++++++...      .
T Consensus         2 ~~~~~~~ig~g~~g~v~~-~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~------~   73 (283)
T cd06617           2 DLEVIEELGRGAYGVVDK-MRHVPTGTIMAVKRIRATVNSQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFRE------G   73 (283)
T ss_pred             CceEEEEecccCCeEEEE-EEEcCCCcEEEEEEEecCCCcH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEecC------C
Confidence            467888999999999996 4566789999999987543322 23445566664 6677999999999988643      4


Q ss_pred             eEEEEeccCCCCHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCCeEEcCCCCEEEeeCCCCCC
Q psy8260         144 NVYMVTHLMGADLNNILRT-----QKLSDDHVQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDCELKILDFGLARP  217 (427)
Q Consensus       144 ~~~lv~e~~g~~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~yLH~~-~iiHrDLKp~NILl~~~~~~kl~DFGla~~  217 (427)
                      .+|++++++.++|.+++..     ..+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++.
T Consensus        74 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~  153 (283)
T cd06617          74 DVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGY  153 (283)
T ss_pred             cEEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence            5799999998888877643     3589999999999999999999997 999999999999999999999999999875


Q ss_pred             CCCCc--ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         218 TENEM--TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       218 ~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      .....  +...++..                                                             |+||
T Consensus       154 ~~~~~~~~~~~~~~~-------------------------------------------------------------y~aP  172 (283)
T cd06617         154 LVDSVAKTIDAGCKP-------------------------------------------------------------YMAP  172 (283)
T ss_pred             cccccccccccCCcc-------------------------------------------------------------ccCh
Confidence            43211  11234444                                                             5555


Q ss_pred             HHhhh----ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCc-HHHHHHHhc-CCCCCcccHHhhcCCCChhHHHHHHHhc
Q psy8260         296 EIMLN----WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISS-DSARKYINS-LPLLTKKDFRQVFKGANPQAIDLLSLML  369 (427)
Q Consensus       296 Evl~~----~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~dLi~~mL  369 (427)
                      |++.+    ..+..++|+|++|++++.+.++..||...... ......... .+..+       ...+++++.+||.+||
T Consensus       173 E~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l  245 (283)
T cd06617         173 ERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLP-------AEKFSPEFQDFVNKCL  245 (283)
T ss_pred             hhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCC-------ccccCHHHHHHHHHHc
Confidence            54432    12445679999999998886665555321111 111111111 11111       1235788999999999


Q ss_pred             CCCCCCCCCHHHHhcCCCCCCC
Q psy8260         370 ELDSEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       370 ~~dP~~R~ta~e~L~Hp~f~~~  391 (427)
                      ..||.+|||++|+++||||.+.
T Consensus       246 ~~~p~~Rp~~~~il~~~~~~~~  267 (283)
T cd06617         246 KKNYKERPNYPELLQHPFFELH  267 (283)
T ss_pred             cCChhhCcCHHHHhcCchhhhc
Confidence            9999999999999999999864

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0670|consensus

Probab=100.00  E-value=5.3e-37  Score=296.26  Aligned_cols=285  Identities=32%  Similarity=0.466  Sum_probs=209.7

Q ss_pred             ccccccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCC------CCceeee
Q psy8260          57 PYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNH------ENVIGLL  130 (427)
Q Consensus        57 ~~~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~H------pnIv~l~  130 (427)
                      ...|+..+.|.+....|+|-|+.|+ .|.+...|+.||||+|.+.   ..-.+.-++|+++|++|+.      -++++|+
T Consensus       425 ~igE~LD~RY~V~~~~GkGvFs~Vv-ra~D~~r~~~vAiKIIRnN---E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~  500 (752)
T KOG0670|consen  425 RIGELLDSRYEVQGYTGKGVFSTVV-RARDQARGQEVAIKIIRNN---EVMHKTGLKELEILKKLNDADPEDKFHCLRLF  500 (752)
T ss_pred             ehhhhhcceeEEEeccccceeeeee-eccccCCCCeeEEEEeecc---hHHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence            4557778889999999999999999 5778888999999999753   3334556789999999963      3688888


Q ss_pred             eeeecCccccCCceEEEEeccCCCCHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCC-C
Q psy8260         131 DVFHSNTCLADFKNVYMVTHLMGADLNNILRT----QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED-C  205 (427)
Q Consensus       131 ~~~~~~~~~~~~~~~~lv~e~~g~~L~~~l~~----~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~-~  205 (427)
                      -.|...      .+++||+|.+.-+|..+++.    -+|....++.|++|+..||..|...||+|.||||.|||+++. .
T Consensus       501 r~F~hk------nHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~  574 (752)
T KOG0670|consen  501 RHFKHK------NHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKN  574 (752)
T ss_pred             HHhhhc------ceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcc
Confidence            776543      57899999999999999875    358888999999999999999999999999999999999975 5


Q ss_pred             CEEEeeCCCCCCC-CCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccc
Q psy8260         206 ELKILDFGLARPT-ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMT  284 (427)
Q Consensus       206 ~~kl~DFGla~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~  284 (427)
                      .+||||||.|... .++.+.|..+++|+|||+|+| ..|+...      |+|++||.+++                 .++
T Consensus       575 iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG-~~yd~~i------D~WSvgctLYE-----------------lYt  630 (752)
T KOG0670|consen  575 ILKLCDFGSASFASENEITPYLVSRFYRAPEIILG-LPYDYPI------DTWSVGCTLYE-----------------LYT  630 (752)
T ss_pred             eeeeccCccccccccccccHHHHHHhccCcceeec-CcccCCc------cceeeceeeEE-----------------eec
Confidence            7999999999765 457889999999999999998 4455444      99999999998                 444


Q ss_pred             cccccccccchHHhhhccCCCC-CCHHHHHHHHHHhCCCCHHHHhhcC--cHHHH---HH-------------HhcCCCC
Q psy8260         285 GYVATRWYRAPEIMLNWMHYNQ-TDIHQLNLIMEMLGTPPAEFMAKIS--SDSAR---KY-------------INSLPLL  345 (427)
Q Consensus       285 ~~~gt~~Y~APEvl~~~~~~~~-~d~~slg~i~~~lg~~~~~~~~~~~--~~~~~---~~-------------~~~~~~~  345 (427)
                      |.+               +|++ +.-..|-+.+.+-|..|..+..+-.  .+...   ++             .......
T Consensus       631 GkI---------------lFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~v  695 (752)
T KOG0670|consen  631 GKI---------------LFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNV  695 (752)
T ss_pred             cce---------------ecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEeccc
Confidence            443               3332 3444555555555655544432100  00000   00             0000011


Q ss_pred             -CcccHHhhcCC----------CChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q psy8260         346 -TKKDFRQVFKG----------ANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQ  390 (427)
Q Consensus       346 -~~~~~~~~~~~----------~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~  390 (427)
                       +.+.+......          +-.+++|||.+||.+||+||+|+.|+|+||||..
T Consensus       696 kPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  696 KPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE  751 (752)
T ss_pred             CcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence             11222221111          1236789999999999999999999999999964

>KOG0614|consensus

Probab=100.00  E-value=1.4e-38  Score=306.38  Aligned_cols=264  Identities=22%  Similarity=0.346  Sum_probs=210.2

Q ss_pred             ccccccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeec
Q psy8260          57 PYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHS  135 (427)
Q Consensus        57 ~~~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~  135 (427)
                      -+..+...++++...||-|+||.|=..+.+.. ...+|+|.+++... ...+.+..+.|-++|..++.|.||+||-.|..
T Consensus       413 e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~-~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd  491 (732)
T KOG0614|consen  413 EFAQVKLSDLKRIATLGVGGFGRVELVKVNSQ-KATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD  491 (732)
T ss_pred             hhcccchhhhhhhhhcccCccceEEEEEeccc-chHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc
Confidence            34455556677888999999999986665432 22589998876432 34455667899999999999999999988865


Q ss_pred             CccccCCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCC
Q psy8260         136 NTCLADFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG  213 (427)
Q Consensus       136 ~~~~~~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFG  213 (427)
                      .      .++||.||.| ||.+..+++. +.|++..++.++..+++|++|||++|||.|||||+|+|++.+|-+||.|||
T Consensus       492 ~------kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFG  565 (732)
T KOG0614|consen  492 S------KYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFG  565 (732)
T ss_pred             c------hhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehh
Confidence            3      5788888865 9999999875 579999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccccc
Q psy8260         214 LARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR  293 (427)
Q Consensus       214 la~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~  293 (427)
                      +|+...+.                                                           ...+++||||.|+
T Consensus       566 FAKki~~g-----------------------------------------------------------~KTwTFcGTpEYV  586 (732)
T KOG0614|consen  566 FAKKIGSG-----------------------------------------------------------RKTWTFCGTPEYV  586 (732)
T ss_pred             hHHHhccC-----------------------------------------------------------CceeeecCCcccc
Confidence            99854322                                                           1345778999999


Q ss_pred             chHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCC
Q psy8260         294 APEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDS  373 (427)
Q Consensus       294 APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP  373 (427)
                      |||++++..++..+|.|+||+.+++|.++.+||.....-.+...++....      .-.+.+.++..|.|||+++...+|
T Consensus       587 APEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid------~i~~Pr~I~k~a~~Lik~LCr~~P  660 (732)
T KOG0614|consen  587 APEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID------KIEFPRRITKTATDLIKKLCRDNP  660 (732)
T ss_pred             cchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh------hhhcccccchhHHHHHHHHHhcCc
Confidence            99999988899999999999999999777777765433333333332222      112335578899999999999999


Q ss_pred             CCCCC-----HHHHhcCCCCCCCC
Q psy8260         374 EKRIT-----AEQALAHPYLSQYS  392 (427)
Q Consensus       374 ~~R~t-----a~e~L~Hp~f~~~~  392 (427)
                      ..|+.     +.++-+|-||....
T Consensus       661 ~ERLG~~~~gI~DIkkH~Wf~gfd  684 (732)
T KOG0614|consen  661 TERLGYQKGGINDIKKHRWFEGFD  684 (732)
T ss_pred             HhhhccccCChHHHHhhhhhhcCC
Confidence            99985     89999999998654

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.7e-36  Score=285.57  Aligned_cols=255  Identities=20%  Similarity=0.311  Sum_probs=184.4

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      ...|++.+.||+|+||.||.+ .+..+|+.||+|++.....  .....+.+|+.++++++||||+++++++...      
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~-~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~------   78 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKA-RNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSR------   78 (267)
T ss_pred             hhhcchhheeecCCCeEEEEE-EECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeC------
Confidence            456889999999999999965 4567889999998864322  2234567899999999999999999987643      


Q ss_pred             ceEEEEeccC-CCCHHHHHh-hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~-~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      ...++++|++ +++|.+++. ...+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus        79 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06646          79 EKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA  158 (267)
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence            4578899988 578988775 45689999999999999999999999999999999999999999999999999864321


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      ...                                                          ......|++.|+|||++..
T Consensus       159 ~~~----------------------------------------------------------~~~~~~~~~~y~~PE~~~~  180 (267)
T cd06646         159 TIA----------------------------------------------------------KRKSFIGTPYWMAPEVAAV  180 (267)
T ss_pred             ccc----------------------------------------------------------ccCccccCccccCHhHccc
Confidence            110                                                          0011234455556665532


Q ss_pred             ---ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC
Q psy8260         301 ---WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI  377 (427)
Q Consensus       301 ---~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~  377 (427)
                         ..+...+|+||+|++++.+.++..++............  .........+. .....+..+.|||++||+.||++||
T Consensus       181 ~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp  257 (267)
T cd06646         181 EKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--SKSNFQPPKLK-DKTKWSSTFHNFVKISLTKNPKKRP  257 (267)
T ss_pred             ccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee--ecCCCCCCCCc-cccccCHHHHHHHHHHhhCChhhCc
Confidence               22445679999999998885544444322111111000  01111111111 1124578999999999999999999


Q ss_pred             CHHHHhcCCC
Q psy8260         378 TAEQALAHPY  387 (427)
Q Consensus       378 ta~e~L~Hp~  387 (427)
                      |++++|+|+|
T Consensus       258 ~~~~il~~l~  267 (267)
T cd06646         258 TAERLLTHLF  267 (267)
T ss_pred             CHHHHhcCCC
Confidence            9999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-36  Score=288.69  Aligned_cols=260  Identities=29%  Similarity=0.501  Sum_probs=185.8

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCce
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      .|++.+.||.|+||.||. +.+..+++.||||++............+.+|+++++.++|+||+++++++...      ..
T Consensus         2 ~y~~~~~i~~g~~~~v~~-~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~   74 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLK-CRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRK------GR   74 (288)
T ss_pred             ceeEEEEecccCCeeEEE-EEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEEC------CE
Confidence            578889999999999996 45667899999998865433334456678999999999999999999988653      46


Q ss_pred             EEEEeccCCCCHHH-HHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCc
Q psy8260         145 VYMVTHLMGADLNN-ILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM  222 (427)
Q Consensus       145 ~~lv~e~~g~~L~~-~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~  222 (427)
                      .+++++++++.+.. +.+. ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus        75 ~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          75 LYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            78999999655544 4433 458999999999999999999999999999999999999999999999999987543221


Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc-
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW-  301 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~-  301 (427)
                      ..                                                         ......++.+|+|||++.+. 
T Consensus       155 ~~---------------------------------------------------------~~~~~~~~~~~~~PE~~~~~~  177 (288)
T cd07833         155 AS---------------------------------------------------------PLTDYVATRWYRAPELLVGDT  177 (288)
T ss_pred             cc---------------------------------------------------------cccCcccccCCcCCchhcCCC
Confidence            00                                                         00112345556666666554 


Q ss_pred             cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHh--------------cCCC---------CCcccHHhhcCC-C
Q psy8260         302 MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYIN--------------SLPL---------LTKKDFRQVFKG-A  357 (427)
Q Consensus       302 ~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~--------------~~~~---------~~~~~~~~~~~~-~  357 (427)
                      .+..++|+||+|++++.+-++..+|......+.......              ..+.         .....+...++. .
T Consensus       178 ~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (288)
T cd07833         178 NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKV  257 (288)
T ss_pred             CcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCcc
Confidence            455677999999988777554433321110000000000              0000         001111222222 4


Q ss_pred             ChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q psy8260         358 NPQAIDLLSLMLELDSEKRITAEQALAHPYL  388 (427)
Q Consensus       358 s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f  388 (427)
                      ++++++||.+||..||++|||++++++||||
T Consensus       258 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         258 SSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             chHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            8899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.6e-36  Score=290.85  Aligned_cols=270  Identities=31%  Similarity=0.484  Sum_probs=189.9

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCc---
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNT---  137 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~---  137 (427)
                      ...+.|++.+.+|.|+||.||++. +..+|+.||||++..............+|+++++.++||||+++++++....   
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~-~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKAR-DKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEE-ECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence            345678889999999999999754 5568899999998654322223345678999999999999999999876532   


Q ss_pred             -cccCCceEEEEeccCCCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCC
Q psy8260         138 -CLADFKNVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL  214 (427)
Q Consensus       138 -~~~~~~~~~lv~e~~g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGl  214 (427)
                       ...+...++++++++++++...+..  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus        83 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~  162 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL  162 (302)
T ss_pred             hccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccc
Confidence             0112236899999998888877764  3689999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccc
Q psy8260         215 ARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRA  294 (427)
Q Consensus       215 a~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~A  294 (427)
                      +.........                                                         ......+++.|+|
T Consensus       163 ~~~~~~~~~~---------------------------------------------------------~~~~~~~~~~y~~  185 (302)
T cd07864         163 ARLYNSEESR---------------------------------------------------------PYTNKVITLWYRP  185 (302)
T ss_pred             cccccCCccc---------------------------------------------------------ccccceeccCccC
Confidence            8754321100                                                         0001123445666


Q ss_pred             hHHhhhc-cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhc--------------CCCC--------CcccHH
Q psy8260         295 PEIMLNW-MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINS--------------LPLL--------TKKDFR  351 (427)
Q Consensus       295 PEvl~~~-~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~--------------~~~~--------~~~~~~  351 (427)
                      ||++.+. .+...+|+|++|++++.+.++..+|...............              .+..        ......
T Consensus       186 PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (302)
T cd07864         186 PELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLR  265 (302)
T ss_pred             hHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchh
Confidence            6655432 2345678999998887774444333221111111111100              0000        001122


Q ss_pred             hhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q psy8260         352 QVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYL  388 (427)
Q Consensus       352 ~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f  388 (427)
                      ..+...++.+.+||.+||+.||.+|||++|++.||||
T Consensus       266 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         266 EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            2344568899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2e-36  Score=289.08  Aligned_cols=259  Identities=30%  Similarity=0.493  Sum_probs=185.1

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCce
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      .|.+.+.||.|+||.||.+ .+..+++.||+|++..........+.+.+|+++++.++||||+++++++...      ..
T Consensus         2 ~y~~~~~lg~g~~~~vy~~-~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~   74 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKC-KHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRK------KR   74 (286)
T ss_pred             ceeEeeeeccCCCeEEEEE-EECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccC------Ce
Confidence            4677899999999999974 4566799999998865443333445677899999999999999999987543      46


Q ss_pred             EEEEeccCC-CCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCc
Q psy8260         145 VYMVTHLMG-ADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM  222 (427)
Q Consensus       145 ~~lv~e~~g-~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~  222 (427)
                      .|++++++. +.|..+... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus        75 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          75 LYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             EEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            789998884 566665543 458999999999999999999999999999999999999999999999999986432211


Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc-
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW-  301 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~-  301 (427)
                      .                                                          ......++..|+|||++.+. 
T Consensus       155 ~----------------------------------------------------------~~~~~~~~~~y~aPE~~~~~~  176 (286)
T cd07846         155 E----------------------------------------------------------VYTDYVATRWYRAPELLVGDT  176 (286)
T ss_pred             c----------------------------------------------------------ccCcccceeeccCcHHhcccc
Confidence            0                                                          00112345556666665432 


Q ss_pred             cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhc----------------------CCCC-CcccHHhhcCCCC
Q psy8260         302 MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINS----------------------LPLL-TKKDFRQVFKGAN  358 (427)
Q Consensus       302 ~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~----------------------~~~~-~~~~~~~~~~~~s  358 (427)
                      .+..++|+||+|++++.+.++..+|......+...+....                      .+.. ........++..+
T Consensus       177 ~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (286)
T cd07846         177 KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLS  256 (286)
T ss_pred             ccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcC
Confidence            2445679999999988775543333111100000000000                      0000 0111223345678


Q ss_pred             hhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q psy8260         359 PQAIDLLSLMLELDSEKRITAEQALAHPYL  388 (427)
Q Consensus       359 ~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f  388 (427)
                      ..+.+||.+||+.||.+|||++++++||||
T Consensus       257 ~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         257 GLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             HHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-36  Score=283.41  Aligned_cols=261  Identities=20%  Similarity=0.373  Sum_probs=188.2

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCccccC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~~  141 (427)
                      .++|++.+.||.|+||.||.+ .+..+++.||+|.+....   .....+.+|+.+++++ +|+||+++++++........
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~-~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKA-RHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             hhheeheeeecCCCCeEEEEE-EECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            467889999999999999965 456678999999886432   2335577899999998 79999999999876443223


Q ss_pred             CceEEEEeccC-CCCHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         142 FKNVYMVTHLM-GADLNNILRT-----QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                      ...++++++++ +++|.+++..     ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~  160 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS  160 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence            45678999988 5688877643     46899999999999999999999999999999999999999999999999988


Q ss_pred             CCCCCC---cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccc
Q psy8260         216 RPTENE---MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWY  292 (427)
Q Consensus       216 ~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y  292 (427)
                      ......   .....++..|+|||++.....                                                  
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--------------------------------------------------  190 (275)
T cd06608         161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQ--------------------------------------------------  190 (275)
T ss_pred             eecccchhhhcCccccccccCHhHhccccc--------------------------------------------------
Confidence            643221   122334444555554321000                                                  


Q ss_pred             cchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         293 RAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       293 ~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                            ....+..++|+|++|++++.+.++..+|..................    ... .....++++++||.+||..|
T Consensus       191 ------~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~-~~~~~~~~~~~li~~~l~~d  259 (275)
T cd06608         191 ------PDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPP----TLK-SPENWSKKFNDFISECLIKN  259 (275)
T ss_pred             ------ccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCC----CCC-chhhcCHHHHHHHHHHhhcC
Confidence                  0012345679999999998886666555432211122221111110    000 01235678999999999999


Q ss_pred             CCCCCCHHHHhcCCCC
Q psy8260         373 SEKRITAEQALAHPYL  388 (427)
Q Consensus       373 P~~R~ta~e~L~Hp~f  388 (427)
                      |.+|||++|+++|||+
T Consensus       260 p~~Rpt~~~ll~~~~~  275 (275)
T cd06608         260 YEQRPFMEELLEHPFI  275 (275)
T ss_pred             hhhCcCHHHHhcCCCC
Confidence            9999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=7e-36  Score=281.23  Aligned_cols=253  Identities=23%  Similarity=0.368  Sum_probs=191.3

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceE
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV  145 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~  145 (427)
                      |++.+.+|.|+||.||+ +.+..+|..||+|.+..........+++.+|+++++.++||||+++++++...    .....
T Consensus         2 y~~~~~lg~g~~~~v~~-~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~   76 (265)
T cd08217           2 YEVLETIGKGSFGTVRK-VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR----SNQTL   76 (265)
T ss_pred             ceeeeeeccCCCeEEEE-eeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC----CCCEE
Confidence            56778999999999996 45667899999999876555555566788999999999999999999877532    12457


Q ss_pred             EEEeccC-CCCHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHH-----hcCceeccCCCCCeEEcCCCCEEEeeCCC
Q psy8260         146 YMVTHLM-GADLNNILRT-----QKLSDDHVQFLVYQILRGLKYIH-----SAGIIHRDLKPSNIAVNEDCELKILDFGL  214 (427)
Q Consensus       146 ~lv~e~~-g~~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~yLH-----~~~iiHrDLKp~NILl~~~~~~kl~DFGl  214 (427)
                      ++++|++ +++|.+++..     ..+++..+..++.|++.||.|||     +.+++|+||||+||+++.++.+||+|||+
T Consensus        77 ~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~  156 (265)
T cd08217          77 YIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGL  156 (265)
T ss_pred             EEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccc
Confidence            8889887 6789888753     46899999999999999999999     89999999999999999999999999999


Q ss_pred             CCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccc
Q psy8260         215 ARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRA  294 (427)
Q Consensus       215 a~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~A  294 (427)
                      +........                                                          ...+..|++.|+|
T Consensus       157 ~~~~~~~~~----------------------------------------------------------~~~~~~~~~~~~~  178 (265)
T cd08217         157 AKILGHDSS----------------------------------------------------------FAKTYVGTPYYMS  178 (265)
T ss_pred             cccccCCcc----------------------------------------------------------cccccccCCCccC
Confidence            875432110                                                          0112235666777


Q ss_pred             hHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCC
Q psy8260         295 PEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       295 PEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~  374 (427)
                      ||++.+..+...+|+|++|++++.+.++..++..... .......... .     ........++++.+||.+||+.||+
T Consensus       179 pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~-~-----~~~~~~~~~~~~~~l~~~~l~~~p~  251 (265)
T cd08217         179 PEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-LQLASKIKEG-K-----FRRIPYRYSSELNEVIKSMLNVDPD  251 (265)
T ss_pred             hhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-HHHHHHHhcC-C-----CCCCccccCHHHHHHHHHHccCCcc
Confidence            7777665566678999999998777555555433221 1111111111 1     1112234578999999999999999


Q ss_pred             CCCCHHHHhcCCCC
Q psy8260         375 KRITAEQALAHPYL  388 (427)
Q Consensus       375 ~R~ta~e~L~Hp~f  388 (427)
                      +|||++|+++|||+
T Consensus       252 ~Rp~~~~il~~~~~  265 (265)
T cd08217         252 KRPSTEELLQLPLI  265 (265)
T ss_pred             cCCCHHHHhhCCCC
Confidence            99999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=7.7e-36  Score=288.51  Aligned_cols=273  Identities=19%  Similarity=0.270  Sum_probs=198.0

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC-HHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS-AVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      .|++.+.+|+|+||.||. +.+..+++.||+|.+...... ......+.+|+++++.++||||+++++.+..+      .
T Consensus         2 ~y~~~~~l~~g~~~~v~~-~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------~   74 (305)
T cd05609           2 DFETIKLISNGAYGAVYL-VRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETK------R   74 (305)
T ss_pred             CceEeeEeecCCCeeEEE-EEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecC------C
Confidence            467778999999999996 557778999999988654221 22345577899999999999999999987653      4


Q ss_pred             eEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      .+|+++|++ |++|.++++. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          75 HLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             EEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            678999988 6799988865 56899999999999999999999999999999999999999999999999998742211


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      ......... .+.+.                                          .........|+..|+|||.+.+.
T Consensus       155 ~~~~~~~~~-~~~~~------------------------------------------~~~~~~~~~~~~~y~aPE~~~~~  191 (305)
T cd05609         155 LTTNLYEGH-IEKDT------------------------------------------REFLDKQVCGTPEYIAPEVILRQ  191 (305)
T ss_pred             ccccccccc-cccch------------------------------------------hhccccCCccCccccCchhccCC
Confidence            110000000 00000                                          00011123578889999998887


Q ss_pred             cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC---
Q psy8260         302 MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT---  378 (427)
Q Consensus       302 ~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t---  378 (427)
                      .+..++|+||+|++++.+.++..+|...................+.     .....++++.+||.+||+.||++|+|   
T Consensus       192 ~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~P~~R~~~~~  266 (305)
T cd05609         192 GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE-----GDEALPADAQDLISRLLRQNPLERLGTGG  266 (305)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC-----ccccCCHHHHHHHHHHhccChhhccCccC
Confidence            7888899999999998886666555432211112211111111111     11246788999999999999999998   


Q ss_pred             HHHHhcCCCCCCCC
Q psy8260         379 AEQALAHPYLSQYS  392 (427)
Q Consensus       379 a~e~L~Hp~f~~~~  392 (427)
                      +.|+|+||||....
T Consensus       267 ~~~ll~~~~~~~~~  280 (305)
T cd05609         267 AFEVKQHRFFLGLD  280 (305)
T ss_pred             HHHHHhCccccCCC
Confidence            89999999997643

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.3e-36  Score=282.94  Aligned_cols=258  Identities=23%  Similarity=0.391  Sum_probs=188.0

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC--------HHHHHHHHHHHHHHhcCCCCCceeeeeeeecCc
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS--------AVHAKRTYRELRMLKHMNHENVIGLLDVFHSNT  137 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~--------~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~  137 (427)
                      |.+.+.||.|+||.||.+. +..+|+.||+|.+......        ....+.+.+|+.+++.++||||+++++++... 
T Consensus         3 ~~~~~~lg~g~~~~vy~~~-~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-   80 (272)
T cd06629           3 WVKGELIGKGTYGRVYLAL-NVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE-   80 (272)
T ss_pred             eeecceecccCceEEEEEe-ecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC-
Confidence            5678899999999999754 5667999999987532111        11224567899999999999999999987643 


Q ss_pred             cccCCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         138 CLADFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       138 ~~~~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                           ...++++|++ +++|.++++. ..+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||++
T Consensus        81 -----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          81 -----EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             -----CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccc
Confidence                 4578888877 7899988865 56899999999999999999999999999999999999999999999999998


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      +.........                                                        ......|+..|+||
T Consensus       156 ~~~~~~~~~~--------------------------------------------------------~~~~~~~~~~y~~P  179 (272)
T cd06629         156 KKSDDIYDND--------------------------------------------------------QNMSMQGSVFWMAP  179 (272)
T ss_pred             cccccccccc--------------------------------------------------------ccccccCCccccCH
Confidence            6432110000                                                        01122466778888


Q ss_pred             HHhhhcc--CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCC
Q psy8260         296 EIMLNWM--HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDS  373 (427)
Q Consensus       296 Evl~~~~--~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP  373 (427)
                      |++....  +..++|+|++|++++.+.++..++..........+......  ...........++.++.+||.+||..||
T Consensus       180 E~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p  257 (272)
T cd06629         180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRS--APPIPPDVSMNLSPVALDFLNACFTINP  257 (272)
T ss_pred             HHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcccc--CCcCCccccccCCHHHHHHHHHHhcCCh
Confidence            8776544  56678999999999877666555532211111111111100  0000111223467899999999999999


Q ss_pred             CCCCCHHHHhcCCCC
Q psy8260         374 EKRITAEQALAHPYL  388 (427)
Q Consensus       374 ~~R~ta~e~L~Hp~f  388 (427)
                      .+|||++|+|+||||
T Consensus       258 ~~Rps~~~il~~~~~  272 (272)
T cd06629         258 DNRPTARELLQHPFI  272 (272)
T ss_pred             hhCCCHHHHhhCCCC
Confidence            999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.6e-36  Score=295.15  Aligned_cols=259  Identities=22%  Similarity=0.297  Sum_probs=188.6

Q ss_pred             ccccCcceeeccccCcccccEEEEeEE----eCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeee
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSAL----DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVF  133 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~  133 (427)
                      |++...+|++.+.||.|+||.||.+..    +..+++.||+|++.... .......+.+|+.++.++ +|+||+++++++
T Consensus         2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~   80 (337)
T cd05054           2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGAC   80 (337)
T ss_pred             cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence            456667899999999999999997643    33467899999886432 333445677899999999 899999999886


Q ss_pred             ecCccccCCceEEEEeccC-CCCHHHHHhh--------------------------------------------------
Q psy8260         134 HSNTCLADFKNVYMVTHLM-GADLNNILRT--------------------------------------------------  162 (427)
Q Consensus       134 ~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~--------------------------------------------------  162 (427)
                      ...     ...++++++++ +++|.+++..                                                  
T Consensus        81 ~~~-----~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (337)
T cd05054          81 TKP-----GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSD  155 (337)
T ss_pred             ecC-----CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhh
Confidence            532     24577888877 7889887742                                                  


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCccccccccc
Q psy8260         163 ------------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRW  230 (427)
Q Consensus       163 ------------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~  230 (427)
                                  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......       
T Consensus       156 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~-------  228 (337)
T cd05054         156 VEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-------  228 (337)
T ss_pred             cccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcc-------
Confidence                        2578888999999999999999999999999999999999999999999999875321100       


Q ss_pred             ccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCCCCCHH
Q psy8260         231 YRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIH  310 (427)
Q Consensus       231 y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~  310 (427)
                           ..                                            ......+++.|+|||++.+..+..++|+|
T Consensus       229 -----~~--------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~  259 (337)
T cd05054         229 -----YV--------------------------------------------RKGDARLPLKWMAPESIFDKVYTTQSDVW  259 (337)
T ss_pred             -----hh--------------------------------------------hccCCCCCccccCcHHhcCCCCCccccHH
Confidence                 00                                            00012345678888888877788889999


Q ss_pred             HHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         311 QLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       311 slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                      |+|++++.+.+ +..+|......+.....+......      ......++++.+++.+||+.||++|||++|+++|
T Consensus       260 SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         260 SFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM------RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             HHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99999987532 333332211112111111111100      0113457889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0603|consensus

Probab=100.00  E-value=5.7e-37  Score=304.42  Aligned_cols=242  Identities=24%  Similarity=0.369  Sum_probs=186.0

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCccccCC
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      ..+.+...+|.|+|+.|-+ +.+..+++..|+|++.+...      ...+|+.++... +||||+++.+++...      
T Consensus       322 ~~y~~~~~~~~gs~s~~~~-~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~~------  388 (612)
T KOG0603|consen  322 ESYEFREELGEGSFSAVKY-CESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYEDG------  388 (612)
T ss_pred             hhhccccccCCCCccceee-eeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecCC------
Confidence            4567777899999987764 56778899999999976521      233577555544 899999999998654      


Q ss_pred             ceEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEE-cCCCCEEEeeCCCCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV-NEDCELKILDFGLARPTEN  220 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl-~~~~~~kl~DFGla~~~~~  220 (427)
                      .+.|+||+.+ |+.+.+-+...+.....+..|++||+.|+.|||++|||||||||+|||+ +..+.++|+|||.++....
T Consensus       389 ~~~~~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  389 KEIYLVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             ceeeeeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence            5789999988 4444444444443347888999999999999999999999999999999 6889999999998875443


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      ...                                                             +.+-|..|.||||+..
T Consensus       469 ~~~-------------------------------------------------------------tp~~t~~y~APEvl~~  487 (612)
T KOG0603|consen  469 SCD-------------------------------------------------------------TPALTLQYVAPEVLAI  487 (612)
T ss_pred             hhc-------------------------------------------------------------ccchhhcccChhhhcc
Confidence            311                                                             1234566778888777


Q ss_pred             ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHH
Q psy8260         301 WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAE  380 (427)
Q Consensus       301 ~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~  380 (427)
                      ..+...+||||||+++|.|.++..+|..........+.+. .+.     ++   ..+|++|+|||++||++||.+|+|+.
T Consensus       488 ~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~-~~~-----~s---~~vS~~AKdLl~~LL~~dP~~Rl~~~  558 (612)
T KOG0603|consen  488 QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQ-MPK-----FS---ECVSDEAKDLLQQLLQVDPALRLGAD  558 (612)
T ss_pred             CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhc-CCc-----cc---cccCHHHHHHHHHhccCChhhCcChh
Confidence            7789999999999999999888877765543322222211 111     11   56899999999999999999999999


Q ss_pred             HHhcCCCC
Q psy8260         381 QALAHPYL  388 (427)
Q Consensus       381 e~L~Hp~f  388 (427)
                      |++.||||
T Consensus       559 ~i~~h~w~  566 (612)
T KOG0603|consen  559 EIGAHPWF  566 (612)
T ss_pred             hhccCcch
Confidence            99999999

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.7e-36  Score=286.32  Aligned_cols=261  Identities=23%  Similarity=0.296  Sum_probs=190.4

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCce
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      .|+..+.||.|++|.||.+ .+..+++.||+|.+.... ......++.+|+++++.++||||++++++|...    ....
T Consensus         2 ~~~~~~~lg~g~~~~v~~~-~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~   75 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKC-RLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSPYIVKYYGAFLDE----SSSS   75 (287)
T ss_pred             ceEEEEEeccCCceEEEEE-EECCCCeEEEEEEEecCC-chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc----CCCe
Confidence            4677789999999999964 556689999999886542 234456688999999999999999999987542    2245


Q ss_pred             EEEEeccC-CCCHHHHHh-----hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCC
Q psy8260         145 VYMVTHLM-GADLNNILR-----TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT  218 (427)
Q Consensus       145 ~~lv~e~~-g~~L~~~l~-----~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~  218 (427)
                      +|++++++ +++|.+++.     ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~  155 (287)
T cd06621          76 IGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL  155 (287)
T ss_pred             EEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence            78999988 678887654     245889999999999999999999999999999999999999999999999987643


Q ss_pred             CCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         219 ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       219 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                      .....                                                            ....++..|+|||.+
T Consensus       156 ~~~~~------------------------------------------------------------~~~~~~~~y~~pE~~  175 (287)
T cd06621         156 VNSLA------------------------------------------------------------GTFTGTSFYMAPERI  175 (287)
T ss_pred             ccccc------------------------------------------------------------ccccCCccccCHHHh
Confidence            21100                                                            011345567777777


Q ss_pred             hhccCCCCCCHHHHHHHHHHhCCCCHHHHhhc----CcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCC
Q psy8260         299 LNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKI----SSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       299 ~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~  374 (427)
                      .+..+..++|+|++|++++.+.++..++....    .......+...............-...++++.+||.+||+.||.
T Consensus       176 ~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  255 (287)
T cd06621         176 QGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPT  255 (287)
T ss_pred             cCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcc
Confidence            66667778899999999988866655553321    11111112111111000000000012356889999999999999


Q ss_pred             CCCCHHHHhcCCCCCCC
Q psy8260         375 KRITAEQALAHPYLSQY  391 (427)
Q Consensus       375 ~R~ta~e~L~Hp~f~~~  391 (427)
                      +|||+.|+++||||.+.
T Consensus       256 ~Rpt~~eil~~~~~~~~  272 (287)
T cd06621         256 RRPTPWDMLEHPWIKAQ  272 (287)
T ss_pred             cCCCHHHHHhCcccccc
Confidence            99999999999999654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1e-35  Score=281.83  Aligned_cols=252  Identities=18%  Similarity=0.233  Sum_probs=187.4

Q ss_pred             cCcceeeccccCcccccEEEEeEEe--CcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSALD--SVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~~--~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      ....|.+.+.||+|+||.||.+...  ...+..||+|.+.... .......+.+|+.++++++||||+++++++...   
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---   78 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG---   78 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC---
Confidence            4567889999999999999987654  3456789999987543 233445678999999999999999999987643   


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                         ...+++||++ +++|.+++..  ..+++..+..++.|++.||+|||++|++||||||+|||++.++.+|++|||.+.
T Consensus        79 ---~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~  155 (266)
T cd05064          79 ---NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ  155 (266)
T ss_pred             ---CCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccc
Confidence               4578999988 6789988865  368999999999999999999999999999999999999999999999999765


Q ss_pred             CCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         217 PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       217 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      .......              .                                           ......++..|+|||
T Consensus       156 ~~~~~~~--------------~-------------------------------------------~~~~~~~~~~y~aPE  178 (266)
T cd05064         156 EDKSEAI--------------Y-------------------------------------------TTMSGKSPVLWAAPE  178 (266)
T ss_pred             cccccch--------------h-------------------------------------------cccCCCCceeecCHH
Confidence            3211100              0                                           000123456788999


Q ss_pred             HhhhccCCCCCCHHHHHHHHHH-hCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCC
Q psy8260         297 IMLNWMHYNQTDIHQLNLIMEM-LGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEK  375 (427)
Q Consensus       297 vl~~~~~~~~~d~~slg~i~~~-lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~  375 (427)
                      ++.+..+..++|+||+|++++. +.++..||........... .......      ......+..+.+++.+|++.||.+
T Consensus       179 ~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~-~~~~~~~------~~~~~~~~~~~~li~~c~~~~p~~  251 (266)
T cd05064         179 AIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKA-VEDGFRL------PAPRNCPNLLHQLMLDCWQKERGE  251 (266)
T ss_pred             HHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH-HHCCCCC------CCCCCCCHHHHHHHHHHcCCCchh
Confidence            8887777788999999999876 4334444433221111111 1111111      112345678999999999999999


Q ss_pred             CCCHHHHhc
Q psy8260         376 RITAEQALA  384 (427)
Q Consensus       376 R~ta~e~L~  384 (427)
                      |||++|+++
T Consensus       252 RP~~~~i~~  260 (266)
T cd05064         252 RPRFSQIHS  260 (266)
T ss_pred             CCCHHHHHH
Confidence            999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.4e-36  Score=282.57  Aligned_cols=257  Identities=19%  Similarity=0.256  Sum_probs=187.5

Q ss_pred             eeeccccCcccccEEEEeEEeC--cCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          66 IDIGPTLSKESFDLIFSSALDS--VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      |.+++.+|+|+||.||.+....  .++..||||++............+.+|+.+++.++||||+++++++..........
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            4578899999999999876533  34588999998765444555567889999999999999999999875443322334


Q ss_pred             eEEEEeccC-CCCHHHHHhh-------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRT-------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~-------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                      ..+++++++ +++|..++..       ..+++..+..++.|++.||.|||+++|+||||||+||++++++.+||+|||++
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  160 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS  160 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence            467888776 7899887732       25889999999999999999999999999999999999999999999999998


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      +.........                                                        ......++..|+||
T Consensus       161 ~~~~~~~~~~--------------------------------------------------------~~~~~~~~~~~~~p  184 (273)
T cd05035         161 KKIYSGDYYR--------------------------------------------------------QGRIAKMPVKWIAI  184 (273)
T ss_pred             eecccccccc--------------------------------------------------------ccccccCCccccCH
Confidence            7543211000                                                        00011234568888


Q ss_pred             HHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCC
Q psy8260         296 EIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       296 Evl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~  374 (427)
                      |++.+..+..++|+||+|++++.+.+ +..+|... ......+........      ......++++.++|.+||+.||.
T Consensus       185 e~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~-~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~  257 (273)
T cd05035         185 ESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV-ENHEIYDYLRHGNRL------KQPEDCLDELYDLMYSCWRADPK  257 (273)
T ss_pred             hhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC------CCCcCCCHHHHHHHHHHcCCChh
Confidence            88877777788999999999988744 33333221 111121222111111      12235678999999999999999


Q ss_pred             CCCCHHHHhcC
Q psy8260         375 KRITAEQALAH  385 (427)
Q Consensus       375 ~R~ta~e~L~H  385 (427)
                      +|||+.|++++
T Consensus       258 ~Rp~~~e~~~~  268 (273)
T cd05035         258 DRPTFTKLREV  268 (273)
T ss_pred             hCcCHHHHHHH
Confidence            99999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.9e-36  Score=285.15  Aligned_cols=252  Identities=25%  Similarity=0.355  Sum_probs=192.8

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC-HHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCce
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS-AVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      |.+.+.+|.|+||.||.+ .+..++..||+|.+.+.... ....+.+.+|++++++++||||+++++.+...      ..
T Consensus         2 y~~~~~i~~g~~~~v~~~-~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~   74 (258)
T cd05578           2 FELLRVIGKGAFGKVCIV-QKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDE------EN   74 (258)
T ss_pred             ceEEEEeccCCCceEEEE-EEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCC------Ce
Confidence            677889999999999964 56678999999998654322 23456778999999999999999999887643      45


Q ss_pred             EEEEeccC-CCCHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCc
Q psy8260         145 VYMVTHLM-GADLNNILRTQ-KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM  222 (427)
Q Consensus       145 ~~lv~e~~-g~~L~~~l~~~-~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~  222 (427)
                      .+++++++ +++|...+... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          75 MYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             EEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            78888877 78999888765 79999999999999999999999999999999999999999999999999876432210


Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhcc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM  302 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~  302 (427)
                                                                                 ......|+..|+|||++.+..
T Consensus       155 -----------------------------------------------------------~~~~~~~~~~y~~PE~~~~~~  175 (258)
T cd05578         155 -----------------------------------------------------------LTTSTSGTPGYMAPEVLCRQG  175 (258)
T ss_pred             -----------------------------------------------------------cccccCCChhhcCHHHHcccC
Confidence                                                                       001123566777888777666


Q ss_pred             CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH--H
Q psy8260         303 HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA--E  380 (427)
Q Consensus       303 ~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta--~  380 (427)
                      +..++|+|++|++++.+.++..++...... ....+......    .........++++.++|.+||+.||.+|+|+  +
T Consensus       176 ~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~  250 (258)
T cd05578         176 YSVAVDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIRAKQET----ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLK  250 (258)
T ss_pred             CCCcccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHHHHhcc----ccccCcccCcHHHHHHHHHHccCChhHcCCccHH
Confidence            777889999999998886666555433221 11111111110    0011223457899999999999999999999  9


Q ss_pred             HHhcCCCC
Q psy8260         381 QALAHPYL  388 (427)
Q Consensus       381 e~L~Hp~f  388 (427)
                      |+++||||
T Consensus       251 ~l~~~~~~  258 (258)
T cd05578         251 DLKNHPYF  258 (258)
T ss_pred             HHhcCCCC
Confidence            99999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4.9e-36  Score=285.67  Aligned_cols=252  Identities=22%  Similarity=0.316  Sum_probs=187.3

Q ss_pred             cCcccccEEEEeEEeCcCCcEEEEEEccCcCCC-HHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEEEec
Q psy8260          72 LSKESFDLIFSSALDSVSGVKVAIKKIARPFQS-AVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH  150 (427)
Q Consensus        72 lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~lv~e  150 (427)
                      ||+|+||.||. +.+..+|+.||+|.+...... ......+.+|+++++.++||||++++++|...      ...|++++
T Consensus         1 lg~g~~g~vy~-~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~~~lv~e   73 (277)
T cd05577           1 LGKGGFGEVCA-CQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETK------DDLCLVMT   73 (277)
T ss_pred             CCCCCceeEEE-EEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecC------CeEEEEEe
Confidence            68999999995 556778999999988643222 22234456899999999999999999988653      45789998


Q ss_pred             cC-CCCHHHHHhh-C--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCccccc
Q psy8260         151 LM-GADLNNILRT-Q--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV  226 (427)
Q Consensus       151 ~~-g~~L~~~l~~-~--~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  226 (427)
                      ++ +++|.+++.. .  .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......    
T Consensus        74 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~----  149 (277)
T cd05577          74 LMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK----  149 (277)
T ss_pred             cCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC----
Confidence            87 6799888754 3  58999999999999999999999999999999999999999999999999876432110    


Q ss_pred             ccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCCC
Q psy8260         227 ATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQ  306 (427)
Q Consensus       227 gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~  306 (427)
                                                                             ......++..|+|||++.+..+..+
T Consensus       150 -------------------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~  174 (277)
T cd05577         150 -------------------------------------------------------KIKGRAGTPGYMAPEVLQGEVYDFS  174 (277)
T ss_pred             -------------------------------------------------------ccccccCCCCcCCHHHhcCCCCCch
Confidence                                                                   0011235566778887766666677


Q ss_pred             CCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC-----CHHH
Q psy8260         307 TDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI-----TAEQ  381 (427)
Q Consensus       307 ~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~-----ta~e  381 (427)
                      +|+|++|++++.+.++..+|..................    .........++++.+||.+||+.||.+|+     |+++
T Consensus       175 ~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~  250 (277)
T cd05577         175 VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE----MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADE  250 (277)
T ss_pred             hhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc----ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHH
Confidence            89999999998886665555332211111111111000    00112234688999999999999999999     9999


Q ss_pred             HhcCCCCCCCCC
Q psy8260         382 ALAHPYLSQYSD  393 (427)
Q Consensus       382 ~L~Hp~f~~~~~  393 (427)
                      +++||||.+...
T Consensus       251 ll~h~~~~~~~~  262 (277)
T cd05577         251 VREHPLFKDLNW  262 (277)
T ss_pred             HHhChhhhcCCh
Confidence            999999986544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.2e-35  Score=284.35  Aligned_cols=256  Identities=21%  Similarity=0.437  Sum_probs=192.7

Q ss_pred             eeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEE
Q psy8260          67 DIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVY  146 (427)
Q Consensus        67 ~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~  146 (427)
                      ...+.||.|++|.||+ +.+..+++.||+|++...  .....+.+.+|+.+++.++||||+++++++...      ...+
T Consensus        22 ~~~~~lg~g~~g~v~~-~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~------~~~~   92 (285)
T cd06648          22 DNFVKIGEGSTGIVCI-ATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG------DELW   92 (285)
T ss_pred             hcceEeccCCCeEEEE-EEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcC------CeEE
Confidence            3346899999999996 456678899999988542  223345577999999999999999999987643      3567


Q ss_pred             EEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccc
Q psy8260         147 MVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGY  225 (427)
Q Consensus       147 lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  225 (427)
                      ++++++ +++|.+++....+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++........  
T Consensus        93 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--  170 (285)
T cd06648          93 VVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--  170 (285)
T ss_pred             EEEeccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence            888877 78999988878899999999999999999999999999999999999999999999999998753321100  


Q ss_pred             cccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCC
Q psy8260         226 VATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYN  305 (427)
Q Consensus       226 ~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~  305 (427)
                                                                              ......|++.|+|||++.+..+..
T Consensus       171 --------------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~  194 (285)
T cd06648         171 --------------------------------------------------------RRKSLVGTPYWMAPEVISRLPYGT  194 (285)
T ss_pred             --------------------------------------------------------ccccccCCccccCHHHhcCCCCCC
Confidence                                                                    001224667788888777666777


Q ss_pred             CCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         306 QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       306 ~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                      ++|+|++|++++.+.++..+|................+..     ......+++.+.+||.+||+.||.+|||+.++++|
T Consensus       195 ~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         195 EVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPK-----LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             cccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCC-----CcccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence            8899999999988766555553322111111111111100     01112367889999999999999999999999999


Q ss_pred             CCCCCCCCC
Q psy8260         386 PYLSQYSDP  394 (427)
Q Consensus       386 p~f~~~~~~  394 (427)
                      |||.+...|
T Consensus       270 ~~~~~~~~~  278 (285)
T cd06648         270 PFLAKAGPP  278 (285)
T ss_pred             cccccCCCc
Confidence            999886544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG4645|consensus

Probab=100.00  E-value=2.6e-38  Score=332.52  Aligned_cols=259  Identities=25%  Similarity=0.342  Sum_probs=197.4

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceE
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV  145 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~  145 (427)
                      |.-+..+|.|.||.|| -+.+..+|...|+|-+..............+|..++..++|||+|+.|++=.+.      +.+
T Consensus      1237 Wqrg~~Ig~G~fG~VY-tavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR------ekv 1309 (1509)
T KOG4645|consen 1237 WQRGNFIGGGTFGKVY-TAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR------EKV 1309 (1509)
T ss_pred             eccccccCCcceeeeE-EeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH------HHH
Confidence            4556789999999999 467889999999998875444433445567899999999999999999984432      467


Q ss_pred             EEEeccC-CCCHHHHHhhCC-CCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcc
Q psy8260         146 YMVTHLM-GADLNNILRTQK-LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT  223 (427)
Q Consensus       146 ~lv~e~~-g~~L~~~l~~~~-l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~  223 (427)
                      ||.|||| ||+|.++++.++ .++...+.+..|++.|+.|||++|||||||||+||+++.+|.+|++|||.|+...+...
T Consensus      1310 ~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred             HHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence            8999999 889999997654 66777788899999999999999999999999999999999999999999975544321


Q ss_pred             cccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhcc-
Q psy8260         224 GYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM-  302 (427)
Q Consensus       224 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~-  302 (427)
                      +       +++|                                               +.+..|||.||||||+.+.. 
T Consensus      1390 ~-------~~~e-----------------------------------------------l~~~~GT~~YMAPEvit~t~~ 1415 (1509)
T KOG4645|consen 1390 T-------MPGE-----------------------------------------------LQSMMGTPMYMAPEVITGTKG 1415 (1509)
T ss_pred             c-------CCHH-----------------------------------------------HHhhcCCchhcCchhhccccc
Confidence            1       1222                                               22446888888888887543 


Q ss_pred             --CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHH
Q psy8260         303 --HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAE  380 (427)
Q Consensus       303 --~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~  380 (427)
                        .+...|||||||++-+|.++..||..-... -.-=|.-....     .+++...+|++++|||.+||+-||++|+|+.
T Consensus      1416 kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-~aIMy~V~~gh-----~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~ 1489 (1509)
T KOG4645|consen 1416 KGHGGAADIWSLGCVVLEMATGKRPWAELDNE-WAIMYHVAAGH-----KPQIPERLSSEGRDFLEHCLEQDPKMRWTAS 1489 (1509)
T ss_pred             CCCCcchhhhcccceEEEeecCCCchhhccch-hHHHhHHhccC-----CCCCchhhhHhHHHHHHHHHhcCchhhhHHH
Confidence              445569999999998888887776432211 11111111111     1123344899999999999999999999999


Q ss_pred             HHhcCCCCCCC
Q psy8260         381 QALAHPYLSQY  391 (427)
Q Consensus       381 e~L~Hp~f~~~  391 (427)
                      |+|+|-|-+..
T Consensus      1490 qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1490 QLLEHAFGKSC 1500 (1509)
T ss_pred             HHHHhhccccc
Confidence            99999997643

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=8e-36  Score=280.02  Aligned_cols=250  Identities=24%  Similarity=0.327  Sum_probs=189.1

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceE
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV  145 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~  145 (427)
                      |.+.+.||.|+||.||. +.+..+++.+|||.+............+.+|+++++.++||||+++++.+...      ...
T Consensus         2 y~~~~~lg~g~~~~v~~-~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------~~~   74 (256)
T cd08220           2 YEKIRVVGRGAFGIVHL-CRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED------KAL   74 (256)
T ss_pred             ceEEEEecccCceEEEE-EEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC------CEE
Confidence            56778999999999996 45667899999999876544445566788999999999999999999887543      457


Q ss_pred             EEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCC-CCEEEeeCCCCCCCCC
Q psy8260         146 YMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARPTEN  220 (427)
Q Consensus       146 ~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~-~~~kl~DFGla~~~~~  220 (427)
                      +++++++ +++|.+++..   ..+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++.....
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (256)
T cd08220          75 MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS  154 (256)
T ss_pred             EEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence            8888887 6799998864   248999999999999999999999999999999999999854 5689999999865422


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      ...                                                           .....|++.|+|||++.+
T Consensus       155 ~~~-----------------------------------------------------------~~~~~~~~~y~aPE~~~~  175 (256)
T cd08220         155 KSK-----------------------------------------------------------AYTVVGTPCYISPELCEG  175 (256)
T ss_pred             Ccc-----------------------------------------------------------ccccccCCcccCchhccC
Confidence            110                                                           001235666777777766


Q ss_pred             ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHH
Q psy8260         301 WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAE  380 (427)
Q Consensus       301 ~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~  380 (427)
                      ..+..++|+||+|++++.+.++..+|................       ........++++.+||.+||+.||.+|||++
T Consensus       176 ~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~  248 (256)
T cd08220         176 KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGT-------FAPISDRYSPDLRQLILSMLNLDPSKRPQLS  248 (256)
T ss_pred             CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcC-------CCCCCCCcCHHHHHHHHHHccCChhhCCCHH
Confidence            666677899999999988755544443222111111111111       0112234678999999999999999999999


Q ss_pred             HHhcCCCC
Q psy8260         381 QALAHPYL  388 (427)
Q Consensus       381 e~L~Hp~f  388 (427)
                      |+++||||
T Consensus       249 ~ll~~p~~  256 (256)
T cd08220         249 QIMAQPIC  256 (256)
T ss_pred             HHhhCCCC
Confidence            99999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-36  Score=284.39  Aligned_cols=262  Identities=32%  Similarity=0.514  Sum_probs=188.9

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC---CCCCceeeeeeeecCccccCC
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM---NHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l---~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      |++.+.||.|+||.||.+. +..+++.||+|++............+.+|+.+++++   +||||+++++++..... ...
T Consensus         1 y~~~~~l~~g~~~~v~~~~-~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~-~~~   78 (287)
T cd07838           1 YEELAEIGEGAYGTVYKAR-DLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRT-DRE   78 (287)
T ss_pred             CeEEEEecccCceEEEEEE-ECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccC-CCC
Confidence            4567889999999999765 455799999999875433333334456787776655   69999999999875422 122


Q ss_pred             ceEEEEeccCCCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         143 KNVYMVTHLMGADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       143 ~~~~lv~e~~g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                      ..+++++++++++|.+++..   ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.+||+|||++....
T Consensus        79 ~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~  158 (287)
T cd07838          79 LKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS  158 (287)
T ss_pred             ceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence            34789999998888887754   258999999999999999999999999999999999999999999999999886432


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      ...                                                           ......+++.|+|||++.
T Consensus       159 ~~~-----------------------------------------------------------~~~~~~~~~~~~~PE~~~  179 (287)
T cd07838         159 FEM-----------------------------------------------------------ALTSVVVTLWYRAPEVLL  179 (287)
T ss_pred             CCc-----------------------------------------------------------ccccccccccccChHHhc
Confidence            110                                                           001123566777777777


Q ss_pred             hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcC-------------------CCCCcccHHhhcCCCChh
Q psy8260         300 NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSL-------------------PLLTKKDFRQVFKGANPQ  360 (427)
Q Consensus       300 ~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~s~~  360 (427)
                      +..+..++|+|++|++++.|.++..+|......+...+.....                   +......+....+..+++
T Consensus       180 ~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (287)
T cd07838         180 QSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEE  259 (287)
T ss_pred             cCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHH
Confidence            6667778899999999987755444443222111111111100                   011111222333456788


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q psy8260         361 AIDLLSLMLELDSEKRITAEQALAHPYL  388 (427)
Q Consensus       361 ~~dLi~~mL~~dP~~R~ta~e~L~Hp~f  388 (427)
                      +.+||.+||+.||.+|||++|+++||||
T Consensus       260 ~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         260 GLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             HHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence            9999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-36  Score=285.75  Aligned_cols=258  Identities=36%  Similarity=0.570  Sum_probs=188.2

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceE
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV  145 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~  145 (427)
                      |.+.+.+|.|+||.||.+ ....+++.||+|.+............+.+|+.+++.++|+||+++++++...      ...
T Consensus         1 y~~~~~ig~g~~~~vy~~-~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------~~~   73 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKA-RDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE------RKL   73 (282)
T ss_pred             CeeehcccccCcceEEEe-eecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC------Cce
Confidence            345678999999999964 4566799999999876543333345667899999999999999999987643      467


Q ss_pred             EEEeccCCCCHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcc
Q psy8260         146 YMVTHLMGADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT  223 (427)
Q Consensus       146 ~lv~e~~g~~L~~~l~~~--~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~  223 (427)
                      ++++++++++|.+++...  .+++..+..++.|++.||.|||++||+||||+|+||+++.++.+||+|||+++.......
T Consensus        74 ~~v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          74 YLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             EEEecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence            899999988999988764  799999999999999999999999999999999999999999999999999875432110


Q ss_pred             cccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc-c
Q psy8260         224 GYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW-M  302 (427)
Q Consensus       224 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~-~  302 (427)
                      .                                                          .....++..|+|||++... .
T Consensus       154 ~----------------------------------------------------------~~~~~~~~~~~aPE~~~~~~~  175 (282)
T cd07829         154 T----------------------------------------------------------YTHEVVTLWYRAPEILLGSKH  175 (282)
T ss_pred             c----------------------------------------------------------cCccccCcCcCChHHhcCCcC
Confidence            0                                                          0011234455566655433 3


Q ss_pred             CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHH---------------------HhcCCCCCcccHHhhcCCCChhH
Q psy8260         303 HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKY---------------------INSLPLLTKKDFRQVFKGANPQA  361 (427)
Q Consensus       303 ~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~s~~~  361 (427)
                      +..+.|+|++|++++.+.++..+|..........+.                     ....+..........++..+.++
T Consensus       176 ~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (282)
T cd07829         176 YSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEG  255 (282)
T ss_pred             CCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHH
Confidence            455678999998887665544333221111110000                     00112222223334455668899


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcCCCC
Q psy8260         362 IDLLSLMLELDSEKRITAEQALAHPYL  388 (427)
Q Consensus       362 ~dLi~~mL~~dP~~R~ta~e~L~Hp~f  388 (427)
                      .++|.+||+.||++|||++|+++||||
T Consensus       256 ~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         256 IDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             HHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=9.4e-36  Score=282.42  Aligned_cols=255  Identities=20%  Similarity=0.249  Sum_probs=182.5

Q ss_pred             eeccccCcccccEEEEeEEeCcCC--cEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCce
Q psy8260          67 DIGPTLSKESFDLIFSSALDSVSG--VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        67 ~~~~~lg~g~fg~v~~~~~~~~~g--~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      .+++.||+|+||.||.+... .++  ..||+|.+............+.+|+++++.++||||+++++++...........
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~-~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLN-QDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             ccccccCcccCceEEEeEEc-cCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            56789999999999987653 334  369999887654455556778899999999999999999987543221112234


Q ss_pred             EEEEeccC-CCCHHHHHhh-------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         145 VYMVTHLM-GADLNNILRT-------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       145 ~~lv~e~~-g~~L~~~l~~-------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                      .+++++++ +++|.+++..       ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  160 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK  160 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence            56677766 6898877631       247899999999999999999999999999999999999999999999999987


Q ss_pred             CCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         217 PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       217 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      ..........                                                        .....+++.|+|||
T Consensus       161 ~~~~~~~~~~--------------------------------------------------------~~~~~~~~~~~~pe  184 (272)
T cd05075         161 KIYNGDYYRQ--------------------------------------------------------GRIAKMPVKWIAIE  184 (272)
T ss_pred             ccCcccceec--------------------------------------------------------CCcccCCcccCCHH
Confidence            5432110000                                                        00112456688888


Q ss_pred             HhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCC
Q psy8260         297 IMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEK  375 (427)
Q Consensus       297 vl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~  375 (427)
                      ++.+..+...+|+||+|++++.+.+ +..+|... ...............      ......+..+.++|.+||+.||.+
T Consensus       185 ~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~  257 (272)
T cd05075         185 SLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV-ENSEIYDYLRQGNRL------KQPPDCLDGLYSLMSSCWLLNPKD  257 (272)
T ss_pred             HccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHcCCCC------CCCCCCCHHHHHHHHHHcCCCccc
Confidence            8877777778899999999987744 33333221 111222222211111      111345678999999999999999


Q ss_pred             CCCHHHHhcC
Q psy8260         376 RITAEQALAH  385 (427)
Q Consensus       376 R~ta~e~L~H  385 (427)
                      |||+++++++
T Consensus       258 Rps~~~l~~~  267 (272)
T cd05075         258 RPSFETLRCE  267 (272)
T ss_pred             CcCHHHHHHH
Confidence            9999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-36  Score=287.56  Aligned_cols=257  Identities=40%  Similarity=0.641  Sum_probs=188.2

Q ss_pred             eeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEE
Q psy8260          67 DIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVY  146 (427)
Q Consensus        67 ~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~  146 (427)
                      .+.+.||.|++|.||. +.+..+|+.+|+|.+............+.+|+++++.++|+||+++++++...      ...+
T Consensus         2 ~~~~~i~~g~~~~v~~-~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~~~   74 (283)
T cd05118           2 QKLGKIGEGTYGVVYK-ARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK------GDLY   74 (283)
T ss_pred             ccceeeecCCCceEEE-EEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC------CCEE
Confidence            4567899999999996 45667899999999876544434456678899999999999999999987643      4678


Q ss_pred             EEeccCCCCHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCccc
Q psy8260         147 MVTHLMGADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTG  224 (427)
Q Consensus       147 lv~e~~g~~L~~~l~~~--~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~  224 (427)
                      ++++++++++.+.+...  .+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||.+........ 
T Consensus        75 ~v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~-  153 (283)
T cd05118          75 LVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-  153 (283)
T ss_pred             EEEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence            99999988988887653  789999999999999999999999999999999999999999999999998764432110 


Q ss_pred             ccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc-cC
Q psy8260         225 YVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW-MH  303 (427)
Q Consensus       225 ~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~-~~  303 (427)
                                                                               ......++..|+|||++.+. .+
T Consensus       154 ---------------------------------------------------------~~~~~~~~~~~~~PE~~~~~~~~  176 (283)
T cd05118         154 ---------------------------------------------------------PYTHYVVTRWYRAPELLLGDKGY  176 (283)
T ss_pred             ---------------------------------------------------------cccCccCcccccCcHHHhcCCCC
Confidence                                                                     00011245556666666544 45


Q ss_pred             CCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhc----------------------CCCCCcccHHhhcCCCChhH
Q psy8260         304 YNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINS----------------------LPLLTKKDFRQVFKGANPQA  361 (427)
Q Consensus       304 ~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~s~~~  361 (427)
                      ..++|+|++|++++.+-++..+|......+...+....                      .+...........+..++++
T Consensus       177 ~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (283)
T cd05118         177 STPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQA  256 (283)
T ss_pred             CchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHH
Confidence            55679999998887775544333221111111111100                      11111112223445578899


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcCCCC
Q psy8260         362 IDLLSLMLELDSEKRITAEQALAHPYL  388 (427)
Q Consensus       362 ~dLi~~mL~~dP~~R~ta~e~L~Hp~f  388 (427)
                      .+||.+||+.||.+||+++|+++||||
T Consensus       257 ~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         257 LDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             HHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=7.3e-36  Score=280.29  Aligned_cols=252  Identities=23%  Similarity=0.414  Sum_probs=189.3

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .+.|++.+.+|.|+||.||.+. ...+++.||+|.+....    ....+.+|+++++.++||||+++++.+...      
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~-~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~------   70 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAI-HKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKN------   70 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEE-EcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecC------
Confidence            3567888999999999999754 45578999999885431    256678999999999999999999988654      


Q ss_pred             ceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                      ...|++++++ +++|.+++..  ..+++..+..++.|++.||.|||+.+|+||||+|+||+++.++.+||+|||++....
T Consensus        71 ~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~  150 (256)
T cd06612          71 TDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLT  150 (256)
T ss_pred             CcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcc
Confidence            4578888887 5789988853  468999999999999999999999999999999999999999999999999986432


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      ....                                                          ......|+..|+|||++.
T Consensus       151 ~~~~----------------------------------------------------------~~~~~~~~~~y~~PE~~~  172 (256)
T cd06612         151 DTMA----------------------------------------------------------KRNTVIGTPFWMAPEVIQ  172 (256)
T ss_pred             cCcc----------------------------------------------------------ccccccCCccccCHHHHh
Confidence            2110                                                          000123566788888777


Q ss_pred             hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH
Q psy8260         300 NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA  379 (427)
Q Consensus       300 ~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta  379 (427)
                      +..+..++|+||+|++++.+.++..++........   ... ........+ ......+.++.+||.+||+.||.+|||+
T Consensus       173 ~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~---~~~-~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rps~  247 (256)
T cd06612         173 EIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA---IFM-IPNKPPPTL-SDPEKWSPEFNDFVKKCLVKDPEERPSA  247 (256)
T ss_pred             cCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh---hhh-hccCCCCCC-CchhhcCHHHHHHHHHHHhcChhhCcCH
Confidence            76677788999999999877555444432111111   110 000000000 1112356789999999999999999999


Q ss_pred             HHHhcCCCC
Q psy8260         380 EQALAHPYL  388 (427)
Q Consensus       380 ~e~L~Hp~f  388 (427)
                      .|+|+||||
T Consensus       248 ~~il~~~~~  256 (256)
T cd06612         248 IQLLQHPFI  256 (256)
T ss_pred             HHHhcCCCC
Confidence            999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=6e-36  Score=293.10  Aligned_cols=277  Identities=32%  Similarity=0.473  Sum_probs=195.6

Q ss_pred             eccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHH------------HHHHHHHHHHHHhcCCCCCceeeeeeeec
Q psy8260          68 IGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAV------------HAKRTYRELRMLKHMNHENVIGLLDVFHS  135 (427)
Q Consensus        68 ~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~------------~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~  135 (427)
                      +.+.||.|+||.||+ +.+..+++.||||++........            ....+.+|+++++.++||||+++++++..
T Consensus        13 ~~~~ig~G~~g~vy~-~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   91 (335)
T PTZ00024         13 KGAHLGEGTYGKVEK-AYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE   91 (335)
T ss_pred             hhhcccCCCceeEEE-EEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec
Confidence            467899999999996 45667899999998864322110            01236689999999999999999999864


Q ss_pred             CccccCCceEEEEeccCCCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCC
Q psy8260         136 NTCLADFKNVYMVTHLMGADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL  214 (427)
Q Consensus       136 ~~~~~~~~~~~lv~e~~g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGl  214 (427)
                      .      ...++++|++.++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus        92 ~------~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~  165 (335)
T PTZ00024         92 G------DFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGL  165 (335)
T ss_pred             C------CcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccc
Confidence            3      46789999998899888754 4689999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccc
Q psy8260         215 ARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRA  294 (427)
Q Consensus       215 a~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~A  294 (427)
                      ++........  ....                .      +...                    ..........+++.|+|
T Consensus       166 ~~~~~~~~~~--~~~~----------------~------~~~~--------------------~~~~~~~~~~~~~~y~a  201 (335)
T PTZ00024        166 ARRYGYPPYS--DTLS----------------K------DETM--------------------QRREEMTSKVVTLWYRA  201 (335)
T ss_pred             eeeccccccc--cccc----------------c------cccc--------------------cccccccccccccCCCC
Confidence            8754321100  0000                0      0000                    00001223456888999


Q ss_pred             hHHhhhcc-CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcC--------------C------CCCcccHHhh
Q psy8260         295 PEIMLNWM-HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSL--------------P------LLTKKDFRQV  353 (427)
Q Consensus       295 PEvl~~~~-~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~--------------~------~~~~~~~~~~  353 (427)
                      ||++.+.. +...+|+||+|++++.+.++..+|......+.........              +      ......+...
T Consensus       202 PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (335)
T PTZ00024        202 PELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTI  281 (335)
T ss_pred             ChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHh
Confidence            99886543 4556799999999987755444432211111111110000              0      0111223344


Q ss_pred             cCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q psy8260         354 FKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPN  395 (427)
Q Consensus       354 ~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~  395 (427)
                      +...++++.+||.+||+.||++|+|++|+|.||||.....+.
T Consensus       282 ~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~~  323 (335)
T PTZ00024        282 FPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLPC  323 (335)
T ss_pred             CcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCCC
Confidence            556788999999999999999999999999999998765543

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=7.9e-36  Score=284.91  Aligned_cols=250  Identities=21%  Similarity=0.309  Sum_probs=179.2

Q ss_pred             ccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHH-HHHHHHHHH---HHhcCCCCCceeeeeeeecCccccCCceEE
Q psy8260          71 TLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVH-AKRTYRELR---MLKHMNHENVIGLLDVFHSNTCLADFKNVY  146 (427)
Q Consensus        71 ~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~-~~~~~~Ei~---~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~  146 (427)
                      .||+|+||.||. +.+..+|+.||+|.+.+....... .....+|..   ++...+||||+.+++.+...      ...+
T Consensus         1 ~lg~G~~g~Vy~-~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~------~~~~   73 (279)
T cd05633           1 IIGRGGFGEVYG-CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP------DKLC   73 (279)
T ss_pred             CcccCCCeEEEE-EEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC------CeEE
Confidence            479999999996 456678999999988654322121 222334443   34445899999999888653      3467


Q ss_pred             EEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCccc
Q psy8260         147 MVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTG  224 (427)
Q Consensus       147 lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~  224 (427)
                      +++|++ +++|..++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........ 
T Consensus        74 lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-  152 (279)
T cd05633          74 FILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-  152 (279)
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-
Confidence            888877 7899887754 5699999999999999999999999999999999999999999999999998863321100 


Q ss_pred             ccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh-ccC
Q psy8260         225 YVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN-WMH  303 (427)
Q Consensus       225 ~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~-~~~  303 (427)
                                                                                 ....||+.|+|||++.. ..+
T Consensus       153 -----------------------------------------------------------~~~~~~~~y~aPE~~~~~~~~  173 (279)
T cd05633         153 -----------------------------------------------------------HASVGTHGYMAPEVLQKGTAY  173 (279)
T ss_pred             -----------------------------------------------------------cCcCCCcCccCHHHhcCCCCC
Confidence                                                                       01235667777776642 345


Q ss_pred             CCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC-----C
Q psy8260         304 YNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI-----T  378 (427)
Q Consensus       304 ~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~-----t  378 (427)
                      ..++|+||+|++++.+-++..+|........ .......... .   .......++++.+||.+||+.||++|+     |
T Consensus       174 ~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~-~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  248 (279)
T cd05633         174 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTV-N---VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRG  248 (279)
T ss_pred             CchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHHHhhcC-C---cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCC
Confidence            6678999999999888666666543221111 1110000000 0   112345688999999999999999999     6


Q ss_pred             HHHHhcCCCCCCCC
Q psy8260         379 AEQALAHPYLSQYS  392 (427)
Q Consensus       379 a~e~L~Hp~f~~~~  392 (427)
                      ++|+++||||....
T Consensus       249 ~~~~~~h~~~~~~~  262 (279)
T cd05633         249 AQEVKEHVFFKGID  262 (279)
T ss_pred             HHHHHhCccccCCC
Confidence            99999999998753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.9e-35  Score=279.51  Aligned_cols=258  Identities=19%  Similarity=0.307  Sum_probs=190.6

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC---CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccC
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ---SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      .|.+++.+|+|+||.||. +.+..+|..||||.+.....   .......+.+|+++++.++||||+++++++....    
T Consensus         3 ~~~~~~~l~~g~~g~v~~-~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----   77 (265)
T cd06652           3 NWRLGKLLGQGAFGRVYL-CYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM----   77 (265)
T ss_pred             cceEeeEEecCCceEEEE-EEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC----
Confidence            577889999999999996 45677899999998753221   2233456778999999999999999999875421    


Q ss_pred             CceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         142 FKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                      ...++++++++ +++|.+++.. ..+++..+..++.|++.||.|||+++|+|+||||+||+++.++.+||+|||+++...
T Consensus        78 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          78 ERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             CceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence            23577888887 6799988765 468999999999999999999999999999999999999999999999999887432


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      .....         .                                              .......|+..|+|||++.
T Consensus       158 ~~~~~---------~----------------------------------------------~~~~~~~~~~~y~aPE~~~  182 (265)
T cd06652         158 TICLS---------G----------------------------------------------TGMKSVTGTPYWMSPEVIS  182 (265)
T ss_pred             ccccc---------c----------------------------------------------cccccCCCCccccChhhhc
Confidence            11000         0                                              0011234677888888887


Q ss_pred             hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH
Q psy8260         300 NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA  379 (427)
Q Consensus       300 ~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta  379 (427)
                      +......+|+||+|++++.+-++..+|............. ..+...     ......+..+.++|++||. +|++|||+
T Consensus       183 ~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~-~~~~~~-----~~~~~~~~~~~~~i~~~l~-~p~~Rp~~  255 (265)
T cd06652         183 GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA-TQPTNP-----VLPPHVSDHCRDFLKRIFV-EAKLRPSA  255 (265)
T ss_pred             CCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh-cCCCCC-----CCchhhCHHHHHHHHHHhc-ChhhCCCH
Confidence            7667778899999999988866555543221111111111 111111     1123457789999999995 99999999


Q ss_pred             HHHhcCCCCC
Q psy8260         380 EQALAHPYLS  389 (427)
Q Consensus       380 ~e~L~Hp~f~  389 (427)
                      +|+++|||+.
T Consensus       256 ~~il~~~~~~  265 (265)
T cd06652         256 DELLRHTFVH  265 (265)
T ss_pred             HHHhcCcccC
Confidence            9999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-35  Score=279.74  Aligned_cols=255  Identities=23%  Similarity=0.360  Sum_probs=187.5

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      ...|++.+.+|.|+||.||.+ .+..+++.+|+|.+.....  .....+.+|+.+++.++||||+++++++...      
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~-~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~------   72 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKA-RDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRR------   72 (262)
T ss_pred             ccceEEEEEecCCCceEEEEe-EecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeC------
Confidence            356888899999999999964 4566788999999865422  2456678999999999999999999987643      


Q ss_pred             ceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                      ..+|++++++ +++|..++..  ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||++....
T Consensus        73 ~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  152 (262)
T cd06613          73 DKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLT  152 (262)
T ss_pred             CEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhh
Confidence            4578999988 5688887754  479999999999999999999999999999999999999999999999999886432


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      ....                                                          ......++..|+|||++.
T Consensus       153 ~~~~----------------------------------------------------------~~~~~~~~~~y~~Pe~~~  174 (262)
T cd06613         153 ATIA----------------------------------------------------------KRKSFIGTPYWMAPEVAA  174 (262)
T ss_pred             hhhh----------------------------------------------------------ccccccCCccccCchhhc
Confidence            2110                                                          001123455566666654


Q ss_pred             hc---cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCC
Q psy8260         300 NW---MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKR  376 (427)
Q Consensus       300 ~~---~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R  376 (427)
                      ..   .+...+|+||+|++++.|.++..++................  ...... ......+.++.+||.+||+.||..|
T Consensus       175 ~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R  251 (262)
T cd06613         175 VERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSN--FPPPKL-KDKEKWSPVFHDFIKKCLTKDPKKR  251 (262)
T ss_pred             ccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--CCCccc-cchhhhhHHHHHHHHHHcCCChhhC
Confidence            44   45567899999999988865555543322111111111110  000000 0112346789999999999999999


Q ss_pred             CCHHHHhcCCC
Q psy8260         377 ITAEQALAHPY  387 (427)
Q Consensus       377 ~ta~e~L~Hp~  387 (427)
                      ||+.+++.|||
T Consensus       252 pt~~~il~~~~  262 (262)
T cd06613         252 PTATKLLQHPF  262 (262)
T ss_pred             CCHHHHhcCCC
Confidence            99999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=5.3e-36  Score=282.87  Aligned_cols=256  Identities=25%  Similarity=0.397  Sum_probs=191.3

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCce
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      .|++.+.||.|+||.||. +.+..+++.||+|.+..... .....++.+|+++++.++||||+++++.+...      ..
T Consensus         2 ~~~~~~~ig~g~~~~v~~-~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------~~   73 (265)
T cd06605           2 DLEYLGELGAGNSGVVSK-VLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNN------GD   73 (265)
T ss_pred             cchHHHHhcCCCCeEEEE-EEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecC------CE
Confidence            466778999999999996 45667899999999876432 34456678999999999999999999887654      45


Q ss_pred             EEEEeccCC-CCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         145 VYMVTHLMG-ADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       145 ~~lv~e~~g-~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~-~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      .++++++++ ++|.+++..  ..+++..+..++.|++.||.|||+ .|++||||||+||+++.++.+||+|||.+.....
T Consensus        74 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~  153 (265)
T cd06605          74 ISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN  153 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence            788998884 899998864  568999999999999999999999 9999999999999999999999999998754321


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      ...                                                            ....|+..|+|||++.+
T Consensus       154 ~~~------------------------------------------------------------~~~~~~~~y~~PE~~~~  173 (265)
T cd06605         154 SLA------------------------------------------------------------KTFVGTSSYMAPERIQG  173 (265)
T ss_pred             HHh------------------------------------------------------------hcccCChhccCHHHHcC
Confidence            100                                                            00235666777777766


Q ss_pred             ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcC-cHHHHHHHhcCCCCCcccHHhhcC-CCChhHHHHHHHhcCCCCCCCCC
Q psy8260         301 WMHYNQTDIHQLNLIMEMLGTPPAEFMAKIS-SDSARKYINSLPLLTKKDFRQVFK-GANPQAIDLLSLMLELDSEKRIT  378 (427)
Q Consensus       301 ~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~dLi~~mL~~dP~~R~t  378 (427)
                      ..+...+|+|++|++++.+-++..++..... .................   .... ..++++++||.+||..||.+|||
T Consensus       174 ~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt  250 (265)
T cd06605         174 NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPP---RLPSGKFSPDFQDFVNLCLIKDPRERPS  250 (265)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCC---CCChhhcCHHHHHHHHHHcCCCchhCcC
Confidence            6677778999999998777655444432210 00111111100000000   0011 16788999999999999999999


Q ss_pred             HHHHhcCCCCCCC
Q psy8260         379 AEQALAHPYLSQY  391 (427)
Q Consensus       379 a~e~L~Hp~f~~~  391 (427)
                      +.|++.||||.++
T Consensus       251 ~~~ll~~~~~~~~  263 (265)
T cd06605         251 YKELLEHPFIKKY  263 (265)
T ss_pred             HHHHhhCchhhcc
Confidence            9999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=7.1e-36  Score=310.10  Aligned_cols=284  Identities=20%  Similarity=0.266  Sum_probs=180.3

Q ss_pred             cCcceeeccccCcccccEEEEeEEeCcC----CcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCc
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSALDSVS----GVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNT  137 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~~~~~----g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~  137 (427)
                      ..+.|.+.+.||+|+||.||++. +..+    +..||||++......    +....|  .++...+.++..+...|....
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~-~~~~~~~~~~~vAvK~~~~~~~~----e~~~~e--~l~~~~~~~~~~~~~~~~~~~  202 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKAS-LVNKQSKKEGKYVLKKATEYGAV----EIWMNE--RVRRACPNSCADFVYGFLEPV  202 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEE-EcCCccccCcEEEEEEecccchh----HHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence            45679999999999999999754 4456    889999987542211    111111  122223333433333222111


Q ss_pred             cccCCceEEEEeccC-CCCHHHHHhhCCC---------------------CHHHHHHHHHHHHHHHHHHHhcCceeccCC
Q psy8260         138 CLADFKNVYMVTHLM-GADLNNILRTQKL---------------------SDDHVQFLVYQILRGLKYIHSAGIIHRDLK  195 (427)
Q Consensus       138 ~~~~~~~~~lv~e~~-g~~L~~~l~~~~l---------------------~~~~~~~~~~qi~~aL~yLH~~~iiHrDLK  195 (427)
                      ........+++++|+ +++|.+++....+                     .+..+..++.|++.||.|||++||+|||||
T Consensus       203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK  282 (566)
T PLN03225        203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK  282 (566)
T ss_pred             ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence            112345678888888 5788888764322                     133466789999999999999999999999


Q ss_pred             CCCeEEcC-CCCEEEeeCCCCCCCCC----CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhh
Q psy8260         196 PSNIAVNE-DCELKILDFGLARPTEN----EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKI  270 (427)
Q Consensus       196 p~NILl~~-~~~~kl~DFGla~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki  270 (427)
                      |+|||++. ++.+||+|||+|+....    .....++|+.|+|||.+.......                          
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~--------------------------  336 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTP--------------------------  336 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCC--------------------------
Confidence            99999985 58999999999985432    234568899999999865321100                          


Q ss_pred             hccCCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCc---------HHHHHHHhc
Q psy8260         271 LDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISS---------DSARKYINS  341 (427)
Q Consensus       271 ~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~---------~~~~~~~~~  341 (427)
                                  .....++..+++|++... .+..+.|+||+|+++++|.+++.+.......         .....+...
T Consensus       337 ------------~~~~~~~~~~~sp~l~~~-~~~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  403 (566)
T PLN03225        337 ------------SAPSAPVATALSPVLWQL-NLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKL  403 (566)
T ss_pred             ------------CCccccccccccchhccc-cCCCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHh
Confidence                        001122334566765433 3566789999999999988766533211100         000011111


Q ss_pred             CCCCCcccHH---hhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q psy8260         342 LPLLTKKDFR---QVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       342 ~~~~~~~~~~---~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~  391 (427)
                      .+........   +.+...+..+.|||.+||++||.+|||++|+|+||||.+.
T Consensus       404 ~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~  456 (566)
T PLN03225        404 VEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDRE  456 (566)
T ss_pred             hccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCC
Confidence            1100111111   1122234456799999999999999999999999999864

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=4.8e-36  Score=290.82  Aligned_cols=267  Identities=20%  Similarity=0.277  Sum_probs=185.5

Q ss_pred             eccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEE
Q psy8260          68 IGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYM  147 (427)
Q Consensus        68 ~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~l  147 (427)
                      +++.+|.|+++.|+.   +..+|+.||||++............+.+|+++++.++||||++++++|...      ...|+
T Consensus         6 i~~~~~~~~~v~~~~---~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~------~~~~~   76 (314)
T cd08216           6 IGKCFEDLMIVHLAK---HKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD------SELYV   76 (314)
T ss_pred             hhHhhcCCceEEEEE---ecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC------CeEEE
Confidence            445555565555543   445899999999876544455667788999999999999999999988653      45788


Q ss_pred             EeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcc
Q psy8260         148 VTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT  223 (427)
Q Consensus       148 v~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~  223 (427)
                      +++++ +++|.+++..   ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||.+........
T Consensus        77 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~  156 (314)
T cd08216          77 VSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGK  156 (314)
T ss_pred             EEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccc
Confidence            88887 5789888864   3589999999999999999999999999999999999999999999999998764321100


Q ss_pred             cccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc--
Q psy8260         224 GYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW--  301 (427)
Q Consensus       224 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~--  301 (427)
                      .        ....                                           ........++..|+|||++...  
T Consensus       157 ~--------~~~~-------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~  185 (314)
T cd08216         157 R--------QRVV-------------------------------------------HDFPKSSVKNLPWLSPEVLQQNLQ  185 (314)
T ss_pred             c--------cccc-------------------------------------------ccccccccccccccCHHHhcCCCC
Confidence            0        0000                                           0011123467788889888653  


Q ss_pred             cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHh-cCCC-------------CC------------cccHHhhcC
Q psy8260         302 MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYIN-SLPL-------------LT------------KKDFRQVFK  355 (427)
Q Consensus       302 ~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~-~~~~-------------~~------------~~~~~~~~~  355 (427)
                      .+..++|+||+|++++.+.++..+|.............. ..+.             ..            .........
T Consensus       186 ~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (314)
T cd08216         186 GYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTR  265 (314)
T ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhh
Confidence            355678999999999877555444432111100000000 0000             00            000000112


Q ss_pred             CCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q psy8260         356 GANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDP  394 (427)
Q Consensus       356 ~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  394 (427)
                      ..++++.+||.+||++||++|||++|+|+||||.+...+
T Consensus       266 ~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~  304 (314)
T cd08216         266 TFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRR  304 (314)
T ss_pred             HHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhccc
Confidence            235788999999999999999999999999999987644

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=5.6e-36  Score=292.59  Aligned_cols=265  Identities=20%  Similarity=0.306  Sum_probs=184.3

Q ss_pred             ccCcc--cccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEEE
Q psy8260          71 TLSKE--SFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV  148 (427)
Q Consensus        71 ~lg~g--~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~lv  148 (427)
                      .||+|  +|+.||. +.+..+|+.||||.+..........+.+.+|+.+++.++||||++++++|...      ...+++
T Consensus         5 ~ig~g~~~~~~v~~-a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~------~~~~~v   77 (328)
T cd08226           5 EIGRGFCNLTSVYL-ARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG------SWLWVI   77 (328)
T ss_pred             HhCCcccCceeEEE-EEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC------CceEEE
Confidence            45555  8888986 56778999999999876544555556778999999999999999999998754      356888


Q ss_pred             eccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCccc
Q psy8260         149 THLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTG  224 (427)
Q Consensus       149 ~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~  224 (427)
                      ++++ ++++.+++..   ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+|++|||.+.........
T Consensus        78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~  157 (328)
T cd08226          78 SPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK  157 (328)
T ss_pred             EecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence            8887 6788888764   35899999999999999999999999999999999999999999999999854321110000


Q ss_pred             ccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc--c
Q psy8260         225 YVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW--M  302 (427)
Q Consensus       225 ~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~--~  302 (427)
                        .+..+..|                                                 ....++..|+|||++.+.  .
T Consensus       158 --~~~~~~~~-------------------------------------------------~~~~~~~~y~aPE~~~~~~~~  186 (328)
T cd08226         158 --AKVVYDFP-------------------------------------------------QFSTSVLPWLSPELLRQDLYG  186 (328)
T ss_pred             --cccccccc-------------------------------------------------ccccCccCccChhhhcCCCCC
Confidence              00000000                                                 011245568899988653  2


Q ss_pred             CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCC------------------------------------
Q psy8260         303 HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLT------------------------------------  346 (427)
Q Consensus       303 ~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------------------  346 (427)
                      +...+|+||+|++++.+.++..+|................+..+                                    
T Consensus       187 ~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (328)
T cd08226         187 YNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQT  266 (328)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccc
Confidence            45678999999999877554444432211111111110000000                                    


Q ss_pred             --cccH-HhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q psy8260         347 --KKDF-RQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSD  393 (427)
Q Consensus       347 --~~~~-~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  393 (427)
                        ...+ .......+++++|||++||++||++|||++|+|+||||.+...
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~  316 (328)
T cd08226         267 MTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE  316 (328)
T ss_pred             cccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence              0000 0011234678999999999999999999999999999986543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=9.4e-36  Score=285.11  Aligned_cols=243  Identities=15%  Similarity=0.146  Sum_probs=179.9

Q ss_pred             cccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHH-HHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEEE
Q psy8260          70 PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAV-HAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV  148 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~lv  148 (427)
                      ..+|+|+++.||++..   +|+.||||++........ ..+.+.+|+.+|++++|||||++++++...  ......++++
T Consensus        26 ~~i~~g~~~~v~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~--~~~~~~~~lv  100 (283)
T PHA02988         26 VLIKENDQNSIYKGIF---NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI--VDDLPRLSLI  100 (283)
T ss_pred             eEEeeCCceEEEEEEE---CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec--ccCCCceEEE
Confidence            5689999999998765   688999999876433322 235677999999999999999999987541  0122457889


Q ss_pred             eccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccc
Q psy8260         149 THLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGY  225 (427)
Q Consensus       149 ~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~-~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  225 (427)
                      +|++ +++|.++++. +.+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++.........
T Consensus       101 ~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~~~  180 (283)
T PHA02988        101 LEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKN  180 (283)
T ss_pred             EEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccccccc
Confidence            9888 6899998865 4688999999999999999999984 99999999999999999999999999987543222222


Q ss_pred             cccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh--ccC
Q psy8260         226 VATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN--WMH  303 (427)
Q Consensus       226 ~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~--~~~  303 (427)
                      .                                                             ||+.|+|||++.+  ..+
T Consensus       181 ~-------------------------------------------------------------~~~~y~aPE~~~~~~~~~  199 (283)
T PHA02988        181 V-------------------------------------------------------------NFMVYFSYKMLNDIFSEY  199 (283)
T ss_pred             c-------------------------------------------------------------CcccccCHHHhhhccccc
Confidence            3                                                             4445555555543  346


Q ss_pred             CCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q psy8260         304 YNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQAL  383 (427)
Q Consensus       304 ~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L  383 (427)
                      ..++|+||+|++++.+-++..||......+.............      .....++++++||.+||+.||.+|||++|++
T Consensus       200 ~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell  273 (283)
T PHA02988        200 TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK------LPLDCPLEIKCIVEACTSHDSIKRPNIKEIL  273 (283)
T ss_pred             cchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHH
Confidence            6678999999999988666555543322222222211111111      1124578899999999999999999999998


Q ss_pred             c
Q psy8260         384 A  384 (427)
Q Consensus       384 ~  384 (427)
                      +
T Consensus       274 ~  274 (283)
T PHA02988        274 Y  274 (283)
T ss_pred             H
Confidence            5

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.9e-35  Score=282.11  Aligned_cols=263  Identities=20%  Similarity=0.300  Sum_probs=190.0

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEe----CcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeee
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALD----SVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFH  134 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~----~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~  134 (427)
                      |++...+|.+.+.||+|+||.||.+...    ...+..||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus         1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   79 (288)
T cd05061           1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVS   79 (288)
T ss_pred             CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            3566788999999999999999976432    1345689999886432 2333445778999999999999999999875


Q ss_pred             cCccccCCceEEEEeccC-CCCHHHHHhhC-----------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEc
Q psy8260         135 SNTCLADFKNVYMVTHLM-GADLNNILRTQ-----------KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN  202 (427)
Q Consensus       135 ~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~-----------~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~  202 (427)
                      ..      ...|+++|++ +++|.++++..           .++...+..++.|++.||.|||+++|+||||||+|||++
T Consensus        80 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~  153 (288)
T cd05061          80 KG------QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA  153 (288)
T ss_pred             CC------CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEc
Confidence            43      3468888887 78999988631           235667888999999999999999999999999999999


Q ss_pred             CCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccc
Q psy8260         203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENE  282 (427)
Q Consensus       203 ~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~  282 (427)
                      .++.+||+|||+++.........                                                        .
T Consensus       154 ~~~~~~L~Dfg~~~~~~~~~~~~--------------------------------------------------------~  177 (288)
T cd05061         154 HDFTVKIGDFGMTRDIYETDYYR--------------------------------------------------------K  177 (288)
T ss_pred             CCCcEEECcCCcccccccccccc--------------------------------------------------------c
Confidence            99999999999987432110000                                                        0


Q ss_pred             cccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhH
Q psy8260         283 MTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQA  361 (427)
Q Consensus       283 ~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  361 (427)
                      .....++..|+|||.+.+..+..++|+||+|++++.+.+ +..+|.. .......+........      ......++.+
T Consensus       178 ~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~-~~~~~~~~~~~~~~~~------~~~~~~~~~~  250 (288)
T cd05061         178 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG-LSNEQVLKFVMDGGYL------DQPDNCPERV  250 (288)
T ss_pred             cCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC------CCCCCCCHHH
Confidence            001124556888888776667778899999999987643 2223322 1112222222111111      1112346789


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhc------CCCCCCC
Q psy8260         362 IDLLSLMLELDSEKRITAEQALA------HPYLSQY  391 (427)
Q Consensus       362 ~dLi~~mL~~dP~~R~ta~e~L~------Hp~f~~~  391 (427)
                      .++|.+||+.||++|||+.|+++      ||||...
T Consensus       251 ~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~  286 (288)
T cd05061         251 TDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV  286 (288)
T ss_pred             HHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence            99999999999999999999987      9999764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.4e-35  Score=279.32  Aligned_cols=251  Identities=24%  Similarity=0.358  Sum_probs=181.4

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceE
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV  145 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~  145 (427)
                      +.....||+|+||.||.+ .+..+++.||+|.+...  .....+.+.+|+.+++.++|+||+++++++...      ...
T Consensus        10 ~~~~~~lg~g~~g~v~~~-~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~   80 (268)
T cd06624          10 NGERVVLGKGTYGIVYAA-RDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN------GFF   80 (268)
T ss_pred             CCceEEEecCCceEEEEe-EecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC------CEE
Confidence            334457999999999965 45668899999988643  233455678999999999999999999987654      457


Q ss_pred             EEEeccC-CCCHHHHHhh--CCC--CHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcC-CCCEEEeeCCCCCCCC
Q psy8260         146 YMVTHLM-GADLNNILRT--QKL--SDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE-DCELKILDFGLARPTE  219 (427)
Q Consensus       146 ~lv~e~~-g~~L~~~l~~--~~l--~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~-~~~~kl~DFGla~~~~  219 (427)
                      +++++++ +++|.+++..  ..+  ++..+..++.|++.||.|||++||+||||||+||+++. ++.+||+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          81 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             EEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            8888877 7899998864  345  78888899999999999999999999999999999986 6799999999886432


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      ....                                                          ......|++.|+|||++.
T Consensus       161 ~~~~----------------------------------------------------------~~~~~~~~~~~~aPE~~~  182 (268)
T cd06624         161 GINP----------------------------------------------------------CTETFTGTLQYMAPEVID  182 (268)
T ss_pred             cCCC----------------------------------------------------------ccccCCCCccccChhhhc
Confidence            1100                                                          000112455666666654


Q ss_pred             hcc--CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC
Q psy8260         300 NWM--HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI  377 (427)
Q Consensus       300 ~~~--~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~  377 (427)
                      ...  +..++|+||+|++++.+.++..++...... ....+.....    .....+....++++++||.+||+.||.+||
T Consensus       183 ~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~-~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  257 (268)
T cd06624         183 KGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP-QAAMFKVGMF----KIHPEIPESLSAEAKNFILRCFEPDPDKRA  257 (268)
T ss_pred             cccccCCchhhhHHHHHHHHHHHhCCCCCccccCh-hhhHhhhhhh----ccCCCCCcccCHHHHHHHHHHcCCCchhCC
Confidence            322  456779999999998886555444321111 1111100000    000112234678999999999999999999


Q ss_pred             CHHHHhcCCCC
Q psy8260         378 TAEQALAHPYL  388 (427)
Q Consensus       378 ta~e~L~Hp~f  388 (427)
                      |+.|++.||||
T Consensus       258 t~~~ll~~~~~  268 (268)
T cd06624         258 SAHDLLQDPFL  268 (268)
T ss_pred             CHHHHHhCCCC
Confidence            99999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG0197|consensus

Probab=100.00  E-value=3.5e-36  Score=294.03  Aligned_cols=251  Identities=26%  Similarity=0.328  Sum_probs=187.7

Q ss_pred             ccccccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecC
Q psy8260          57 PYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSN  136 (427)
Q Consensus        57 ~~~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~  136 (427)
                      .-+++.+..+.+.+.||+|.||.|+.+.++..  .+||+|.++....   ....+.+|+++|++|+|+|||+|+++...+
T Consensus       199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~--~~vavk~ik~~~m---~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~  273 (468)
T KOG0197|consen  199 DPWEIPREELKLIRELGSGQFGEVWLGKWNGS--TKVAVKTIKEGSM---SPEAFLREAQIMKKLRHEKLVKLYGVCTKQ  273 (468)
T ss_pred             CCeeecHHHHHHHHHhcCCccceEEEEEEcCC--CcccceEEecccc---ChhHHHHHHHHHHhCcccCeEEEEEEEecC
Confidence            34577777788889999999999999988643  4799998875433   235577999999999999999999997643


Q ss_pred             ccccCCceEEEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeC
Q psy8260         137 TCLADFKNVYMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDF  212 (427)
Q Consensus       137 ~~~~~~~~~~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DF  212 (427)
                            ..+||||||+ .|+|.++|+.   ..++......++.|||+||+||+++++|||||.++|||++++..+||+||
T Consensus       274 ------~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDF  347 (468)
T KOG0197|consen  274 ------EPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDF  347 (468)
T ss_pred             ------CceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEccc
Confidence                  3689999998 6899999975   46899999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCc-ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccc
Q psy8260         213 GLARPTENEM-TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRW  291 (427)
Q Consensus       213 Gla~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~  291 (427)
                      ||||...++. +...|..+                                                          -.-
T Consensus       348 GLAr~~~d~~Y~~~~~~kf----------------------------------------------------------PIk  369 (468)
T KOG0197|consen  348 GLARLIGDDEYTASEGGKF----------------------------------------------------------PIK  369 (468)
T ss_pred             ccccccCCCceeecCCCCC----------------------------------------------------------Cce
Confidence            9999543321 11111110                                                          134


Q ss_pred             ccchHHhhhccCCCCCCHHHHHHHHHHhCCC-CHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcC
Q psy8260         292 YRAPEIMLNWMHYNQTDIHQLNLIMEMLGTP-PAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLE  370 (427)
Q Consensus       292 Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~  370 (427)
                      |.|||.+....+..++|+||+|+.++++.+- ..|+. .......-..+..--.++      .....+++..+++..|-.
T Consensus       370 WtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~-~msn~ev~~~le~GyRlp------~P~~CP~~vY~lM~~CW~  442 (468)
T KOG0197|consen  370 WTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP-GMSNEEVLELLERGYRLP------RPEGCPDEVYELMKSCWH  442 (468)
T ss_pred             ecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC-CCCHHHHHHHHhccCcCC------CCCCCCHHHHHHHHHHhh
Confidence            6677777777788899999999998776432 22211 111111111221111111      123457788999999999


Q ss_pred             CCCCCCCCHHHHh
Q psy8260         371 LDSEKRITAEQAL  383 (427)
Q Consensus       371 ~dP~~R~ta~e~L  383 (427)
                      .+|++|||.+.+.
T Consensus       443 ~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  443 EDPEDRPTFETLR  455 (468)
T ss_pred             CCcccCCCHHHHH
Confidence            9999999988654

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.1e-36  Score=285.61  Aligned_cols=261  Identities=20%  Similarity=0.250  Sum_probs=192.3

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      ...|++.+.||+|+||.||.+ .+..+|+.||+|++.... .....+.+.+|+++++.++||||+++++.+...      
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~-~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------   75 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKV-KHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE------   75 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEE-EEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC------
Confidence            456788899999999999964 556789999999876432 233456678999999999999999999988654      


Q ss_pred             ceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~-~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                      ..+++++|++ +++|..++.. +.+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++....
T Consensus        76 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~  155 (284)
T cd06620          76 NNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI  155 (284)
T ss_pred             CEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence            4678999888 6789888765 468999999999999999999997 689999999999999999999999999875321


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      ....                                                            ....||..|+|||++.
T Consensus       156 ~~~~------------------------------------------------------------~~~~~~~~~~aPE~~~  175 (284)
T cd06620         156 NSIA------------------------------------------------------------DTFVGTSTYMSPERIQ  175 (284)
T ss_pred             hhcc------------------------------------------------------------CccccCcccCCHHHHc
Confidence            1100                                                            0123566777777776


Q ss_pred             hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCc-------HHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         300 NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISS-------DSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       300 ~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                      +..+..++|+||+|++++.+.++..+|......       .................+.  ....+.++.+||.+||+.|
T Consensus       176 ~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~d  253 (284)
T cd06620         176 GGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP--SSDFPEDLRDFVDACLLKD  253 (284)
T ss_pred             cCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCC--chhcCHHHHHHHHHHhcCC
Confidence            666677889999999998775555555322211       0000111110000000000  0124678999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCCCC
Q psy8260         373 SEKRITAEQALAHPYLSQYSD  393 (427)
Q Consensus       373 P~~R~ta~e~L~Hp~f~~~~~  393 (427)
                      |.+|||++|+++||||.+...
T Consensus       254 p~~Rpt~~e~~~~~~~~~~~~  274 (284)
T cd06620         254 PTERPTPQQLCAMPPFIQALR  274 (284)
T ss_pred             cccCcCHHHHhcCcccccccc
Confidence            999999999999999976443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=9.3e-36  Score=283.77  Aligned_cols=254  Identities=21%  Similarity=0.317  Sum_probs=193.2

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCce
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      .|...+.||.|+||.||.+ .+..++..||||.+.... .......+.+|+.++++++||||+++++++...      ..
T Consensus         5 ~y~~~~~lg~g~~~~vy~~-~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~   76 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG------TK   76 (277)
T ss_pred             hhhhhhhcccCCCeEEEEE-EEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC------CE
Confidence            4566788999999999965 556678999999886432 234456678999999999999999999998654      45


Q ss_pred             EEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcc
Q psy8260         145 VYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT  223 (427)
Q Consensus       145 ~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~  223 (427)
                      .|+++|++ +++|.++++.+.+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++........
T Consensus        77 ~~lv~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          77 LWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             EEEEEecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            78999888 67999988888899999999999999999999999999999999999999999999999998864322100


Q ss_pred             cccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccC
Q psy8260         224 GYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH  303 (427)
Q Consensus       224 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~  303 (427)
                                                                                ......++..|+|||++.+...
T Consensus       157 ----------------------------------------------------------~~~~~~~~~~y~apE~~~~~~~  178 (277)
T cd06640         157 ----------------------------------------------------------KRNTFVGTPFWMAPEVIQQSAY  178 (277)
T ss_pred             ----------------------------------------------------------ccccccCcccccCHhHhccCCC
Confidence                                                                      0011235667778887766666


Q ss_pred             CCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q psy8260         304 YNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQAL  383 (427)
Q Consensus       304 ~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L  383 (427)
                      ..++|+||+|++++.+.++..++.......... ..   ....   ........+.++.+||.+||+.||++|||+++++
T Consensus       179 ~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-~~---~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il  251 (277)
T cd06640         179 DSKADIWSLGITAIELAKGEPPNSDMHPMRVLF-LI---PKNN---PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELL  251 (277)
T ss_pred             ccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh-hh---hcCC---CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHH
Confidence            677899999999988866655553322111111 00   0000   0111223567889999999999999999999999


Q ss_pred             cCCCCCCC
Q psy8260         384 AHPYLSQY  391 (427)
Q Consensus       384 ~Hp~f~~~  391 (427)
                      +||||.+.
T Consensus       252 ~~~~~~~~  259 (277)
T cd06640         252 KHKFIVKN  259 (277)
T ss_pred             hChHhhhc
Confidence            99999754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=4.6e-36  Score=285.78  Aligned_cols=254  Identities=20%  Similarity=0.321  Sum_probs=192.3

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCce
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      .|...+.||.|+||.||.+ .+..+++.||+|.+.... .......+.+|+.+++.++||||+++++++...      ..
T Consensus         5 ~y~~~~~l~~g~~~~vy~~-~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~   76 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKG-IDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKG------TK   76 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEE-EEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCCCCccHhhhcccccC------Cc
Confidence            4556678999999999965 456688999999886432 233445678999999999999999999987643      45


Q ss_pred             EEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcc
Q psy8260         145 VYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT  223 (427)
Q Consensus       145 ~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~  223 (427)
                      .|+++|++ +++|.+++..+.+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++........
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          77 LWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             eEEEEEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence            78999988 67899988888899999999999999999999999999999999999999999999999998864322100


Q ss_pred             cccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccC
Q psy8260         224 GYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH  303 (427)
Q Consensus       224 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~  303 (427)
                                                                                ......|+..|+|||++.+..+
T Consensus       157 ----------------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~  178 (277)
T cd06642         157 ----------------------------------------------------------KRNTFVGTPFWMAPEVIKQSAY  178 (277)
T ss_pred             ----------------------------------------------------------hhhcccCcccccCHHHhCcCCC
Confidence                                                                      0011235677888888776666


Q ss_pred             CCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q psy8260         304 YNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQAL  383 (427)
Q Consensus       304 ~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L  383 (427)
                      ..++|+||+|++++.+.++..++.......... ..   ....   ........+.++.|||.+||+.||.+|||+.+++
T Consensus       179 ~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-~~---~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il  251 (277)
T cd06642         179 DFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-LI---PKNS---PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELL  251 (277)
T ss_pred             chhhhHHHHHHHHHHHHhCCCCCcccchhhHHh-hh---hcCC---CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHH
Confidence            778899999999988866555443221111110 10   0000   0011123567899999999999999999999999


Q ss_pred             cCCCCCCC
Q psy8260         384 AHPYLSQY  391 (427)
Q Consensus       384 ~Hp~f~~~  391 (427)
                      +||||..+
T Consensus       252 ~~~~~~~~  259 (277)
T cd06642         252 KHKFITRY  259 (277)
T ss_pred             HhHHHHHH
Confidence            99999764

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>KOG0194|consensus

Probab=100.00  E-value=2.8e-36  Score=298.87  Aligned_cols=283  Identities=22%  Similarity=0.296  Sum_probs=204.2

Q ss_pred             hhhhhccccCCCCCCCc----cccccCCCccccccCcceeeccccCcccccEEEEeEEeCcCC---cEEEEEEccCc-CC
Q psy8260          32 SIVRLWTVYPASKLPSR----RLHDHFNQPYSEICRGVIDIGPTLSKESFDLIFSSALDSVSG---VKVAIKKIARP-FQ  103 (427)
Q Consensus        32 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g---~~vAvK~i~~~-~~  103 (427)
                      ++..++..|.....+-.    .+...+..+.|++.+.++.+++.||+|+||.||.|.+....+   ..||||..+.. ..
T Consensus       121 si~~li~~~~~~~~~~~~~~~~L~~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~  200 (474)
T KOG0194|consen  121 TISELVNYYKFSKLEITGKNFFLKRPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSEL  200 (474)
T ss_pred             cHHHHHHHHHhcccceeccceeecccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccc
Confidence            45555555554443331    255666777889999999999999999999999999877654   33899988753 34


Q ss_pred             CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEEEeccC-CCCHHHHHhhCC--CCHHHHHHHHHHHHHH
Q psy8260         104 SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQK--LSDDHVQFLVYQILRG  180 (427)
Q Consensus       104 ~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~~--l~~~~~~~~~~qi~~a  180 (427)
                      .......+++|+++|++++|||||++||+....      ..+|++||++ ||+|.++|+..+  ++..+...++.+++.|
T Consensus       201 ~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~------~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~G  274 (474)
T KOG0194|consen  201 TKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE------EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARG  274 (474)
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC------CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhH
Confidence            566778899999999999999999999987643      5689999998 789999998654  9999999999999999


Q ss_pred             HHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccc
Q psy8260         181 LKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNI  260 (427)
Q Consensus       181 L~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~  260 (427)
                      |+|||++++|||||..+|+|++.++.+||+|||+++..........                                  
T Consensus       275 l~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~----------------------------------  320 (474)
T KOG0194|consen  275 LEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKF----------------------------------  320 (474)
T ss_pred             HHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcceeeccc----------------------------------
Confidence            9999999999999999999999999999999999875431100000                                  


Q ss_pred             cccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHH
Q psy8260         261 AVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYI  339 (427)
Q Consensus       261 ~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~  339 (427)
                                              ..-.-..|+|||.+....+..++|+|++|+.+++.-. +..|+......+...+..
T Consensus       321 ------------------------~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~  376 (474)
T KOG0194|consen  321 ------------------------LKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV  376 (474)
T ss_pred             ------------------------cccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH
Confidence                                    0001235677777776667788899999987754422 222332221112222221


Q ss_pred             hcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy8260         340 NSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALA  384 (427)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~  384 (427)
                      ...-..+      .......+...++.+|...||++|+|+.++.+
T Consensus       377 ~~~~r~~------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  377 KNGYRMP------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             hcCccCC------CCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence            2111111      01123456778899999999999999988753

>KOG0584|consensus

Probab=100.00  E-value=1.3e-36  Score=300.69  Aligned_cols=252  Identities=25%  Similarity=0.388  Sum_probs=193.0

Q ss_pred             eeccccCcccccEEEEeEEeCcCCcEEEEEEc--cCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCce
Q psy8260          67 DIGPTLSKESFDLIFSSALDSVSGVKVAIKKI--ARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        67 ~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i--~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      .....||+|+|-+||+ ++|..+|..||.-.+  ..-.+++...+++..|+.+|+.|+|||||++|+.|.+...    ..
T Consensus        43 k~~evLGrGafKtVYk-a~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n----~~  117 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYK-AFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN----KT  117 (632)
T ss_pred             ehhhhcccccceeeee-ccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC----ce
Confidence            4557899999999995 788999999995433  2333456667889999999999999999999999876432    45


Q ss_pred             EEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcC--ceeccCCCCCeEEcC-CCCEEEeeCCCCCCCC
Q psy8260         145 VYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNE-DCELKILDFGLARPTE  219 (427)
Q Consensus       145 ~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~--iiHrDLKp~NILl~~-~~~~kl~DFGla~~~~  219 (427)
                      +.+++|++ .|+|..++++ ++++...++.|++||++||.|||++.  |||||||.+||+|+. .|.|||+|+|||....
T Consensus       118 in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r  197 (632)
T KOG0584|consen  118 INFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR  197 (632)
T ss_pred             eeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence            77788877 8999998865 67999999999999999999999884  999999999999975 5899999999997543


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      ...                                                            ....+|||.|||||+..
T Consensus       198 ~s~------------------------------------------------------------aksvIGTPEFMAPEmYE  217 (632)
T KOG0584|consen  198 KSH------------------------------------------------------------AKSVIGTPEFMAPEMYE  217 (632)
T ss_pred             ccc------------------------------------------------------------cceeccCccccChHHHh
Confidence            321                                                            11235666666666655


Q ss_pred             hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcC-cHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC
Q psy8260         300 NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKIS-SDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT  378 (427)
Q Consensus       300 ~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t  378 (427)
                       ..|...+|+||+|+.+-+|.|...|+..-.. ....++.   .....+..+.   +--+|++++||.+||.. .+.|+|
T Consensus       218 -E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV---~SGiKP~sl~---kV~dPevr~fIekCl~~-~~~R~s  289 (632)
T KOG0584|consen  218 -ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKV---TSGIKPAALS---KVKDPEVREFIEKCLAT-KSERLS  289 (632)
T ss_pred             -hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHH---HcCCCHHHhh---ccCCHHHHHHHHHHhcC-chhccC
Confidence             4477778999999988888887777654321 1222222   2222222222   33489999999999998 899999


Q ss_pred             HHHHhcCCCCCCC
Q psy8260         379 AEQALAHPYLSQY  391 (427)
Q Consensus       379 a~e~L~Hp~f~~~  391 (427)
                      |.|+|+||||..-
T Consensus       290 a~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  290 AKELLKDPFFDED  302 (632)
T ss_pred             HHHHhhChhhccc
Confidence            9999999999863

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3.1e-35  Score=281.88  Aligned_cols=252  Identities=21%  Similarity=0.266  Sum_probs=187.0

Q ss_pred             cCcceeeccccCcccccEEEEeEE----eCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCc
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSAL----DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNT  137 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~  137 (427)
                      .+..|.+.+.+|.|+||.||.+..    +..++..||+|.+...  .......+.+|+.++++++||||+++++++... 
T Consensus         3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-   79 (288)
T cd05093           3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG-   79 (288)
T ss_pred             chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-
Confidence            456788999999999999997653    2345677999988643  233455678999999999999999999987643 


Q ss_pred             cccCCceEEEEeccC-CCCHHHHHhhC--------------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEc
Q psy8260         138 CLADFKNVYMVTHLM-GADLNNILRTQ--------------KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN  202 (427)
Q Consensus       138 ~~~~~~~~~lv~e~~-g~~L~~~l~~~--------------~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~  202 (427)
                           ...+++++++ +++|.+++...              .+++..+..++.|++.||+|||++|++||||||+|||++
T Consensus        80 -----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~  154 (288)
T cd05093          80 -----DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG  154 (288)
T ss_pred             -----CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc
Confidence                 3568888887 68999888642              389999999999999999999999999999999999999


Q ss_pred             CCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccc
Q psy8260         203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENE  282 (427)
Q Consensus       203 ~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~  282 (427)
                      .++.+||+|||+++.........                                                        .
T Consensus       155 ~~~~~kl~dfg~~~~~~~~~~~~--------------------------------------------------------~  178 (288)
T cd05093         155 ENLLVKIGDFGMSRDVYSTDYYR--------------------------------------------------------V  178 (288)
T ss_pred             cCCcEEeccCCccccccCCceee--------------------------------------------------------c
Confidence            99999999999986432211000                                                        0


Q ss_pred             cccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhH
Q psy8260         283 MTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQA  361 (427)
Q Consensus       283 ~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  361 (427)
                      .....+++.|+|||++.+..+..++|+||+|++++.|.+ +..+|.................       .......++++
T Consensus       179 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~-------~~~~~~~~~~l  251 (288)
T cd05093         179 GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV-------LQRPRTCPKEV  251 (288)
T ss_pred             CCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc-------CCCCCCCCHHH
Confidence            011235677888888887777778999999999987754 4444432211111222211111       01123467899


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhc
Q psy8260         362 IDLLSLMLELDSEKRITAEQALA  384 (427)
Q Consensus       362 ~dLi~~mL~~dP~~R~ta~e~L~  384 (427)
                      .+||.+||+.||.+|||++|+++
T Consensus       252 ~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         252 YDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             HHHHHHHccCChhhCCCHHHHHH
Confidence            99999999999999999999854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.6e-35  Score=281.61  Aligned_cols=257  Identities=21%  Similarity=0.321  Sum_probs=186.5

Q ss_pred             cCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCcccc
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~  140 (427)
                      ..+.|.+...||.|+||.||.+ .+..+++.||+|.+....   .....+.+|+.+++++ +||||+++++++..... .
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~-~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~-~   94 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKV-TNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK-L   94 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEE-EECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc-c
Confidence            3567899999999999999964 566789999999885432   1234566899999988 89999999999864321 1


Q ss_pred             CCceEEEEeccC-CCCHHHHHh-----hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCC
Q psy8260         141 DFKNVYMVTHLM-GADLNNILR-----TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL  214 (427)
Q Consensus       141 ~~~~~~lv~e~~-g~~L~~~l~-----~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGl  214 (427)
                      .....|++++++ +++|.++++     ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus        95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~  174 (291)
T cd06639          95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGV  174 (291)
T ss_pred             CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeeccc
Confidence            124578888887 679988764     24689999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCC---cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccc
Q psy8260         215 ARPTENE---MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRW  291 (427)
Q Consensus       215 a~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~  291 (427)
                      ++.....   .....|                                                             +..
T Consensus       175 ~~~~~~~~~~~~~~~~-------------------------------------------------------------~~~  193 (291)
T cd06639         175 SAQLTSTRLRRNTSVG-------------------------------------------------------------TPF  193 (291)
T ss_pred             chhcccccccccCccC-------------------------------------------------------------Ccc
Confidence            8753221   111233                                                             444


Q ss_pred             ccchHHhhhc-----cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHH
Q psy8260         292 YRAPEIMLNW-----MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLS  366 (427)
Q Consensus       292 Y~APEvl~~~-----~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~  366 (427)
                      |+|||++...     .+..++|+||+|++++.+.++..++................+. .   . ......+.++.+||.
T Consensus       194 y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~-~---~-~~~~~~~~~l~~li~  268 (291)
T cd06639         194 WMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPP-T---L-LHPEKWCRSFNHFIS  268 (291)
T ss_pred             ccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCC-C---C-CcccccCHHHHHHHH
Confidence            5555544322     1456789999999998886665555332211111111111110 0   0 011235678999999


Q ss_pred             HhcCCCCCCCCCHHHHhcCCCCC
Q psy8260         367 LMLELDSEKRITAEQALAHPYLS  389 (427)
Q Consensus       367 ~mL~~dP~~R~ta~e~L~Hp~f~  389 (427)
                      +||+.||.+|||+.|+++||||+
T Consensus       269 ~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         269 QCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             HHhhcChhhCcCHHHHhcCcccC
Confidence            99999999999999999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3.6e-35  Score=277.49  Aligned_cols=252  Identities=19%  Similarity=0.294  Sum_probs=188.7

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      ++....|.+.+.||.|+||.||.+. +..+++.||+|.+...   ......+.+|+++++.++||||+++++++...   
T Consensus         2 ~~~~~~~~~~~~ig~g~~~~v~~~~-~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---   74 (263)
T cd05052           2 EMERTDITMKHKLGGGQYGEVYEGV-WKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE---   74 (263)
T ss_pred             CCchHHeEEeeecCCcccceEEEEE-EecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCC---
Confidence            4556678899999999999999754 5567899999988643   22345678999999999999999999987643   


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                         ..++++++++ +++|.+++..   ..+++..+..++.|++.||.|||++|++||||||+|||+++++.+||+|||++
T Consensus        75 ---~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~  151 (263)
T cd05052          75 ---PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS  151 (263)
T ss_pred             ---CCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccc
Confidence               3567888877 7899988754   34889999999999999999999999999999999999999999999999998


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      +........                                                         ......+++.|+||
T Consensus       152 ~~~~~~~~~---------------------------------------------------------~~~~~~~~~~y~aP  174 (263)
T cd05052         152 RLMTGDTYT---------------------------------------------------------AHAGAKFPIKWTAP  174 (263)
T ss_pred             cccccceee---------------------------------------------------------ccCCCCCccccCCH
Confidence            653221100                                                         00011235678888


Q ss_pred             HHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCC
Q psy8260         296 EIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       296 Evl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~  374 (427)
                      |++.+..+..++|+||+|++++.|-+ +..++......+..........   .    ......++++.+||.+||+.||+
T Consensus       175 E~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~---~----~~~~~~~~~~~~li~~cl~~~p~  247 (263)
T cd05052         175 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR---M----ERPEGCPPKVYELMRACWQWNPS  247 (263)
T ss_pred             HHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC---C----CCCCCCCHHHHHHHHHHccCCcc
Confidence            88877777778899999999988754 4444432221111111111110   0    11245678999999999999999


Q ss_pred             CCCCHHHHhcC
Q psy8260         375 KRITAEQALAH  385 (427)
Q Consensus       375 ~R~ta~e~L~H  385 (427)
                      +|||+.|+++.
T Consensus       248 ~Rp~~~~l~~~  258 (263)
T cd05052         248 DRPSFAEIHQA  258 (263)
T ss_pred             cCCCHHHHHHH
Confidence            99999998753

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.6e-35  Score=281.13  Aligned_cols=253  Identities=19%  Similarity=0.265  Sum_probs=186.8

Q ss_pred             CcceeeccccCcccccEEEEeEEeC----cCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDS----VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      ..+|.+.+.||+|+||.||.+....    .+...||+|.+... ........+.+|+.+++.++||||+++++++...  
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--   80 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN-AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE--   80 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC-CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC--
Confidence            3568889999999999999765432    23468999988643 2334455678999999999999999999987543  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhh-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeE
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRT-----------------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA  200 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~-----------------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NIL  200 (427)
                          ...+++++++ +++|.+++..                 ..+++..+..++.|++.||.|||++|++||||||+||+
T Consensus        81 ----~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil  156 (283)
T cd05048          81 ----QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCL  156 (283)
T ss_pred             ----CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEE
Confidence                3567888887 6899888754                 34788889999999999999999999999999999999


Q ss_pred             EcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCc
Q psy8260         201 VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTE  280 (427)
Q Consensus       201 l~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~  280 (427)
                      ++.++.+||+|||+++........                                                        
T Consensus       157 ~~~~~~~~L~dfg~~~~~~~~~~~--------------------------------------------------------  180 (283)
T cd05048         157 VGEGLTVKISDFGLSRDIYSADYY--------------------------------------------------------  180 (283)
T ss_pred             EcCCCcEEECCCcceeeccccccc--------------------------------------------------------
Confidence            999999999999998643211000                                                        


Q ss_pred             cccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCCh
Q psy8260         281 NEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANP  359 (427)
Q Consensus       281 ~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  359 (427)
                      .......+++.|+|||++.+..+..++|+||+|++++.|-+ +..+|......+.... +......      ......++
T Consensus       181 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~-i~~~~~~------~~~~~~~~  253 (283)
T cd05048         181 RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM-IRSRQLL------PCPEDCPA  253 (283)
T ss_pred             cccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HHcCCcC------CCcccCCH
Confidence            00112245677888888777677778899999999988743 4444433222222211 1111110      11234678


Q ss_pred             hHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         360 QAIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       360 ~~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                      ++.+|+.+||+.||.+|||+.|+++|
T Consensus       254 ~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         254 RVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.5e-35  Score=279.66  Aligned_cols=256  Identities=20%  Similarity=0.297  Sum_probs=185.9

Q ss_pred             cccCcceeeccccCcccccEEEEeEEe----CcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeec
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALD----SVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHS  135 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~----~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~  135 (427)
                      ++..++|++.+.+|+|+||.||.+...    ..++..||||++... ........+.+|+.+++.++||||+++++++..
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~   80 (277)
T cd05062           2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   80 (277)
T ss_pred             cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            455677999999999999999976542    235678999988543 233345567899999999999999999998754


Q ss_pred             CccccCCceEEEEeccC-CCCHHHHHhhC-----------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcC
Q psy8260         136 NTCLADFKNVYMVTHLM-GADLNNILRTQ-----------KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE  203 (427)
Q Consensus       136 ~~~~~~~~~~~lv~e~~-g~~L~~~l~~~-----------~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~  203 (427)
                      .      ...++++|++ +++|.++++..           .++...+..++.|++.||.|||++|++||||||+|||++.
T Consensus        81 ~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~  154 (277)
T cd05062          81 G------QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE  154 (277)
T ss_pred             C------CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcC
Confidence            3      3567888876 68999887542           2466788889999999999999999999999999999999


Q ss_pred             CCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccc
Q psy8260         204 DCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEM  283 (427)
Q Consensus       204 ~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~  283 (427)
                      ++.+||+|||+++.........                                                        ..
T Consensus       155 ~~~~~l~dfg~~~~~~~~~~~~--------------------------------------------------------~~  178 (277)
T cd05062         155 DFTVKIGDFGMTRDIYETDYYR--------------------------------------------------------KG  178 (277)
T ss_pred             CCCEEECCCCCccccCCcceee--------------------------------------------------------cC
Confidence            9999999999986432211000                                                        00


Q ss_pred             ccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHH
Q psy8260         284 TGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAI  362 (427)
Q Consensus       284 ~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  362 (427)
                      ....+++.|+|||++.+..+...+|+||+|++++.+.+ +..+|... ......+.......      .......++.+.
T Consensus       179 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~-~~~~~~~~~~~~~~------~~~~~~~~~~~~  251 (277)
T cd05062         179 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM-SNEQVLRFVMEGGL------LDKPDNCPDMLF  251 (277)
T ss_pred             CCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHcCCc------CCCCCCCCHHHH
Confidence            01134667888888877777778899999999987744 22233221 11111111111110      011234567899


Q ss_pred             HHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         363 DLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       363 dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                      +||.+||+.||++|||+.|++++
T Consensus       252 ~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         252 ELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             HHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.7e-35  Score=283.23  Aligned_cols=253  Identities=21%  Similarity=0.423  Sum_probs=189.4

Q ss_pred             cccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEEEe
Q psy8260          70 PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT  149 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~lv~  149 (427)
                      ..||+|+||.||.+ ....+|..||||++...  .......+.+|+.+++.++|+||+++++.|...      ...++++
T Consensus        26 ~~lg~g~~g~v~~~-~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~   96 (292)
T cd06657          26 IKIGEGSTGIVCIA-TVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG------DELWVVM   96 (292)
T ss_pred             HHcCCCCCeEEEEE-EEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeC------CEEEEEE
Confidence            57999999999965 45568999999987532  223345677999999999999999999988653      4678899


Q ss_pred             ccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCccccccc
Q psy8260         150 HLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT  228 (427)
Q Consensus       150 e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt  228 (427)
                      |++ +++|.+++....+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++........     
T Consensus        97 e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-----  171 (292)
T cd06657          97 EFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-----  171 (292)
T ss_pred             ecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc-----
Confidence            887 67898888777899999999999999999999999999999999999999999999999998753321100     


Q ss_pred             ccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCCCCC
Q psy8260         229 RWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD  308 (427)
Q Consensus       229 ~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d  308 (427)
                                                                           ......|++.|+|||.+....+..++|
T Consensus       172 -----------------------------------------------------~~~~~~~~~~y~~pE~~~~~~~~~~~D  198 (292)
T cd06657         172 -----------------------------------------------------RRKSLVGTPYWMAPELISRLPYGPEVD  198 (292)
T ss_pred             -----------------------------------------------------cccccccCccccCHHHhcCCCCCchhh
Confidence                                                                 001123566777777776555667789


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q psy8260         309 IHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYL  388 (427)
Q Consensus       309 ~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f  388 (427)
                      +||+|++++.+.++..+|................+..    + .....+++++.++|.+||+.||.+|+|+.|+++||||
T Consensus       199 v~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~----~-~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~  273 (292)
T cd06657         199 IWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPK----L-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL  273 (292)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcc----c-CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHH
Confidence            9999999987765544443221111111111111110    1 1123467889999999999999999999999999999


Q ss_pred             CCCCCC
Q psy8260         389 SQYSDP  394 (427)
Q Consensus       389 ~~~~~~  394 (427)
                      .+...|
T Consensus       274 ~~~~~~  279 (292)
T cd06657         274 AKAGPP  279 (292)
T ss_pred             hccCCC
Confidence            887544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3e-35  Score=294.60  Aligned_cols=255  Identities=22%  Similarity=0.309  Sum_probs=185.8

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEe----CcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCC-CCCceeeeeee
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALD----SVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN-HENVIGLLDVF  133 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~----~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~  133 (427)
                      ++..++.|.+++.||+|+||.||.+...    ..++..||||++... ......+.+.+|+++|++++ |||||++++++
T Consensus        32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~  110 (400)
T cd05105          32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT-ARSSEKQALMSELKIMTHLGPHLNIVNLLGAC  110 (400)
T ss_pred             eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence            3566788999999999999999976542    234567999998643 23344566889999999996 99999999998


Q ss_pred             ecCccccCCceEEEEeccC-CCCHHHHHhh--------------------------------------------------
Q psy8260         134 HSNTCLADFKNVYMVTHLM-GADLNNILRT--------------------------------------------------  162 (427)
Q Consensus       134 ~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~--------------------------------------------------  162 (427)
                      ...      ..+|++||++ +++|.+++..                                                  
T Consensus       111 ~~~------~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  184 (400)
T cd05105         111 TKS------GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQAD  184 (400)
T ss_pred             ccC------CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccc
Confidence            643      4578999988 7898877642                                                  


Q ss_pred             -----------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCC
Q psy8260         163 -----------------------------------------------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLK  195 (427)
Q Consensus       163 -----------------------------------------------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLK  195 (427)
                                                                     ..+++..+..++.|++.||+|||+++|+|||||
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dik  264 (400)
T cd05105         185 TTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLA  264 (400)
T ss_pred             ccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence                                                           136777888999999999999999999999999


Q ss_pred             CCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCC
Q psy8260         196 PSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGL  275 (427)
Q Consensus       196 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~  275 (427)
                      |+|||++.++.+||+|||+++........       .                                           
T Consensus       265 p~Nill~~~~~~kL~DfGla~~~~~~~~~-------~-------------------------------------------  294 (400)
T cd05105         265 ARNVLLAQGKIVKICDFGLARDIMHDSNY-------V-------------------------------------------  294 (400)
T ss_pred             hHhEEEeCCCEEEEEeCCcceeccccccc-------c-------------------------------------------
Confidence            99999999999999999998643211000       0                                           


Q ss_pred             CCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHh---CCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHh
Q psy8260         276 ARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEML---GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQ  352 (427)
Q Consensus       276 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~l---g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (427)
                            ......+++.|+|||++.+..+..++|+||+|++++.+   |..|.+  ..................      .
T Consensus       295 ------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~--~~~~~~~~~~~~~~~~~~------~  360 (400)
T cd05105         295 ------SKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYP--GMIVDSTFYNKIKSGYRM------A  360 (400)
T ss_pred             ------ccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCc--ccchhHHHHHHHhcCCCC------C
Confidence                  00112356678888888777777888999999998765   444432  211111111111111000      0


Q ss_pred             hcCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy8260         353 VFKGANPQAIDLLSLMLELDSEKRITAEQALA  384 (427)
Q Consensus       353 ~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~  384 (427)
                      .....++++.+||.+||+.||++|||+.++.+
T Consensus       361 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         361 KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            11345788999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.9e-35  Score=280.39  Aligned_cols=254  Identities=20%  Similarity=0.323  Sum_probs=192.6

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCce
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      .|.+.+.||.|+||.||++ .+..++..||||.+.... .......+.+|+.+++.++||||+++++.+..+      ..
T Consensus         5 ~~~~~~~ig~G~~~~vy~~-~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~   76 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD------TK   76 (277)
T ss_pred             hhhhheeEeecCCeEEEEE-EECCCCcEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC------Ce
Confidence            4667788999999999964 556678999999875432 233445677899999999999999999988653      45


Q ss_pred             EEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcc
Q psy8260         145 VYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT  223 (427)
Q Consensus       145 ~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~  223 (427)
                      .|+++|++ +++|..++....+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus        77 ~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06641          77 LWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             EEEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence            78999888 67899888878899999999999999999999999999999999999999999999999998764322100


Q ss_pred             cccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccC
Q psy8260         224 GYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH  303 (427)
Q Consensus       224 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~  303 (427)
                                                                                ......|+..|+|||.+.....
T Consensus       157 ----------------------------------------------------------~~~~~~~~~~y~~PE~~~~~~~  178 (277)
T cd06641         157 ----------------------------------------------------------KRNTFVGTPFWMAPEVIKQSAY  178 (277)
T ss_pred             ----------------------------------------------------------hhccccCCccccChhhhccCCC
Confidence                                                                      0011235666777777766556


Q ss_pred             CCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q psy8260         304 YNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQAL  383 (427)
Q Consensus       304 ~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L  383 (427)
                      ...+|+||+|++++.+.++..++.......... .....   .   ........+.++.|+|.+||+.||.+||++.|++
T Consensus       179 ~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~---~---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l  251 (277)
T cd06641         179 DSKADIWSLGITAIELAKGEPPHSELHPMKVLF-LIPKN---N---PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELL  251 (277)
T ss_pred             CchhhHHHHHHHHHHHHcCCCCCCccchHHHHH-HHhcC---C---CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            667899999999988866665553221111111 11000   0   0111234578899999999999999999999999


Q ss_pred             cCCCCCCC
Q psy8260         384 AHPYLSQY  391 (427)
Q Consensus       384 ~Hp~f~~~  391 (427)
                      +||||.+.
T Consensus       252 ~~~~~~~~  259 (277)
T cd06641         252 KHKFIVRF  259 (277)
T ss_pred             hCHHHhhh
Confidence            99999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-35  Score=282.63  Aligned_cols=261  Identities=32%  Similarity=0.532  Sum_probs=186.6

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceE
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV  145 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~  145 (427)
                      |++.+.+|.|+||.||++ .+..+|+.||+|++............+.+|+++++.++|||++++++++....    ....
T Consensus         1 y~~~~~l~~g~~~~vy~~-~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~   75 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKA-RNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG----KGSI   75 (287)
T ss_pred             CeeeEEeccCCCeEEEEE-EECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC----CCcE
Confidence            456788999999999965 45667899999998765323334456778999999999999999999876431    2468


Q ss_pred             EEEeccCCCCHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcc
Q psy8260         146 YMVTHLMGADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT  223 (427)
Q Consensus       146 ~lv~e~~g~~L~~~l~~~--~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~  223 (427)
                      ++++++++++|..++...  .+++..+..++.|++.||+|||++|++|+||||+||++++++.+||+|||++........
T Consensus        76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~  155 (287)
T cd07840          76 YMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS  155 (287)
T ss_pred             EEEeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence            999999988998887654  689999999999999999999999999999999999999999999999999875432210


Q ss_pred             cccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc-c
Q psy8260         224 GYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW-M  302 (427)
Q Consensus       224 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~-~  302 (427)
                      .                                                         ......++..|+|||++.+. .
T Consensus       156 ~---------------------------------------------------------~~~~~~~~~~y~~PE~~~~~~~  178 (287)
T cd07840         156 A---------------------------------------------------------DYTNRVITLWYRPPELLLGATR  178 (287)
T ss_pred             c---------------------------------------------------------cccccccccccCCceeeEcccc
Confidence            0                                                         00112234455556544332 2


Q ss_pred             CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCC----------------------CCCcccHHhhcCCC-Ch
Q psy8260         303 HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLP----------------------LLTKKDFRQVFKGA-NP  359 (427)
Q Consensus       303 ~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~-s~  359 (427)
                      +..++|+|++|++++.+.++..++.................                      ......+...+... ++
T Consensus       179 ~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (287)
T cd07840         179 YGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDP  258 (287)
T ss_pred             CChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCH
Confidence            44567889999888777555444432211111111110000                      00011122233343 88


Q ss_pred             hHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q psy8260         360 QAIDLLSLMLELDSEKRITAEQALAHPYL  388 (427)
Q Consensus       360 ~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f  388 (427)
                      ++.++|.+||+.||.+|||++++++||||
T Consensus       259 ~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         259 SALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence            99999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.8e-35  Score=280.02  Aligned_cols=249  Identities=21%  Similarity=0.321  Sum_probs=178.6

Q ss_pred             ccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH-HHHHHHHHH---HHHHhcCCCCCceeeeeeeecCccccCCceEE
Q psy8260          71 TLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA-VHAKRTYRE---LRMLKHMNHENVIGLLDVFHSNTCLADFKNVY  146 (427)
Q Consensus        71 ~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~E---i~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~  146 (427)
                      .||+|+||.||. +.+..+|+.||+|.+.+..... ........|   +..++..+||||++++++|...      ...+
T Consensus         1 ~ig~g~~g~Vy~-~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~------~~~~   73 (278)
T cd05606           1 IIGRGGFGEVYG-CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP------DKLS   73 (278)
T ss_pred             CcccCCCeEEEE-EEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC------CEEE
Confidence            479999999995 5566789999999886543221 111122233   4455567899999999888654      4578


Q ss_pred             EEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCccc
Q psy8260         147 MVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTG  224 (427)
Q Consensus       147 lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~  224 (427)
                      +++|++ |++|..++.. ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++....... 
T Consensus        74 ~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~-  152 (278)
T cd05606          74 FILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-  152 (278)
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence            888877 7889887754 4689999999999999999999999999999999999999999999999999864321100 


Q ss_pred             ccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc-cC
Q psy8260         225 YVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW-MH  303 (427)
Q Consensus       225 ~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~-~~  303 (427)
                                                                                 ....|+..|+|||++.+. .+
T Consensus       153 -----------------------------------------------------------~~~~~~~~y~aPE~~~~~~~~  173 (278)
T cd05606         153 -----------------------------------------------------------HASVGTHGYMAPEVLQKGVAY  173 (278)
T ss_pred             -----------------------------------------------------------cCcCCCcCCcCcHHhcCCCCC
Confidence                                                                       012356667777776532 35


Q ss_pred             CCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC-----C
Q psy8260         304 YNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI-----T  378 (427)
Q Consensus       304 ~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~-----t  378 (427)
                      ...+|+||+|++++.+.++..+|......... ........ ..   .......++++.|||.+||..||.+|+     |
T Consensus       174 ~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~-~~---~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~  248 (278)
T cd05606         174 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLT-MA---VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRG  248 (278)
T ss_pred             CcccchHhHHHHHHHHHhCCCCCCCCCccchH-HHHHHhhc-cC---CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCC
Confidence            66789999999998876665555432111110 00000000 00   011234588999999999999999999     9


Q ss_pred             HHHHhcCCCCCCC
Q psy8260         379 AEQALAHPYLSQY  391 (427)
Q Consensus       379 a~e~L~Hp~f~~~  391 (427)
                      ++++++||||...
T Consensus       249 ~~~ll~~~~~~~~  261 (278)
T cd05606         249 AQEVKEHPFFRSL  261 (278)
T ss_pred             HHHHHhCccccCC
Confidence            9999999999865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=5e-35  Score=279.65  Aligned_cols=257  Identities=20%  Similarity=0.321  Sum_probs=185.1

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCccc
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~  139 (427)
                      ....+|++.+.||+|+||.||+ +.+..+++.||+|++....   .....+.+|+.+++.+ +||||+++++++.... .
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~-~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~-~   89 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD-V   89 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEE-EEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc-c
Confidence            3456788999999999999996 4566789999999875421   1224566899999998 7999999999874321 1


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCC
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRT-----QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG  213 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFG  213 (427)
                      ......|+++|++ +++|.+++..     ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg  169 (286)
T cd06638          90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG  169 (286)
T ss_pred             CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCC
Confidence            2234678899887 7889887642     458899999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCC---cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccc
Q psy8260         214 LARPTENE---MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATR  290 (427)
Q Consensus       214 la~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~  290 (427)
                      +++.....   .....                                                             |++
T Consensus       170 ~~~~~~~~~~~~~~~~-------------------------------------------------------------~~~  188 (286)
T cd06638         170 VSAQLTSTRLRRNTSV-------------------------------------------------------------GTP  188 (286)
T ss_pred             ceeecccCCCcccccc-------------------------------------------------------------CCC
Confidence            98643221   11123                                                             444


Q ss_pred             cccchHHhhh-----ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHH
Q psy8260         291 WYRAPEIMLN-----WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLL  365 (427)
Q Consensus       291 ~Y~APEvl~~-----~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi  365 (427)
                      .|+|||++..     ..+..++|+||+|++++.|.++..++..........+.....    .... ......+.++.+||
T Consensus       189 ~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~li  263 (286)
T cd06638         189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP----PPTL-HQPELWSNEFNDFI  263 (286)
T ss_pred             cccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC----CCcc-cCCCCcCHHHHHHH
Confidence            5555555432     124556799999999998877665553321111111110000    0000 01122467899999


Q ss_pred             HHhcCCCCCCCCCHHHHhcCCCC
Q psy8260         366 SLMLELDSEKRITAEQALAHPYL  388 (427)
Q Consensus       366 ~~mL~~dP~~R~ta~e~L~Hp~f  388 (427)
                      .+||+.||.+|||++|+++||||
T Consensus       264 ~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         264 RKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             HHHccCCcccCCCHHHHhhcccC
Confidence            99999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.4e-35  Score=275.12  Aligned_cols=251  Identities=23%  Similarity=0.362  Sum_probs=186.4

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC---CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ---SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      |..++.||.|+||.||.+ .+..++..||+|.+.....   .....+.+.+|+.+++.++|+||+++++++...      
T Consensus         2 ~~~~~~ig~g~~~~vy~~-~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~------   74 (258)
T cd06632           2 WRKGELLGSGSFGSVYEG-LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE------   74 (258)
T ss_pred             ccccceeeecCCceEEEE-EEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC------
Confidence            556788999999999965 4556889999998754321   233456678999999999999999999987543      


Q ss_pred             ceEEEEeccC-CCCHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILRTQ-KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~~~-~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      ..+|+++|++ +++|.+++... .+++..+..++.|++.||.|||+.||+|+||||+||+++.++.+||+|||++.....
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          75 DNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             CeEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            4578888888 67999888654 489999999999999999999999999999999999999999999999998764322


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      ...                                                           .....|++.|+|||.+..
T Consensus       155 ~~~-----------------------------------------------------------~~~~~~~~~y~~pe~~~~  175 (258)
T cd06632         155 FSF-----------------------------------------------------------AKSFKGSPYWMAPEVIAQ  175 (258)
T ss_pred             ccc-----------------------------------------------------------ccccCCCcceeCHHHhcC
Confidence            110                                                           011235566666666654


Q ss_pred             cc-CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH
Q psy8260         301 WM-HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA  379 (427)
Q Consensus       301 ~~-~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta  379 (427)
                      .. +...+|+|++|++++.+-++..+|..........+.....      ........+++++.+||.+||+.||.+|||+
T Consensus       176 ~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~  249 (258)
T cd06632         176 QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK------ELPPIPDHLSDEAKDFILKCLQRDPSLRPTA  249 (258)
T ss_pred             CCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc------cCCCcCCCcCHHHHHHHHHHhhcCcccCcCH
Confidence            44 5567899999999877755544443221111111111100      0112234568899999999999999999999


Q ss_pred             HHHhcCCCC
Q psy8260         380 EQALAHPYL  388 (427)
Q Consensus       380 ~e~L~Hp~f  388 (427)
                      +|++.|||+
T Consensus       250 ~~~l~~~~~  258 (258)
T cd06632         250 AELLEHPFV  258 (258)
T ss_pred             HHHhcCCCC
Confidence            999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=3.8e-35  Score=276.86  Aligned_cols=248  Identities=23%  Similarity=0.343  Sum_probs=186.2

Q ss_pred             cCcccccEEEEeEEeCcCCcEEEEEEccCcCCC-HHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEEEec
Q psy8260          72 LSKESFDLIFSSALDSVSGVKVAIKKIARPFQS-AVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH  150 (427)
Q Consensus        72 lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~lv~e  150 (427)
                      ||.|+||.||.+ .+..+++.||+|++.+.... ....+.+.+|+.+++.++||||+++++.+...      ..+|++++
T Consensus         1 lg~g~~~~v~~~-~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e   73 (262)
T cd05572           1 LGVGGFGRVELV-KVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK------KYIYMLME   73 (262)
T ss_pred             CCCCCceEEEEE-EECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC------CccEEEEe
Confidence            689999999965 45668999999998654332 23445678999999999999999999987654      35788888


Q ss_pred             cC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCccccccc
Q psy8260         151 LM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT  228 (427)
Q Consensus       151 ~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt  228 (427)
                      ++ +++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||+++.......     
T Consensus        74 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~-----  148 (262)
T cd05572          74 YCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK-----  148 (262)
T ss_pred             cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc-----
Confidence            86 7899998865 4689999999999999999999999999999999999999999999999999875432110     


Q ss_pred             ccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCCCCC
Q psy8260         229 RWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD  308 (427)
Q Consensus       229 ~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d  308 (427)
                                                                            .....|++.|+|||++.+..+..++|
T Consensus       149 ------------------------------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~D  174 (262)
T cd05572         149 ------------------------------------------------------TWTFCGTPEYVAPEIILNKGYDFSVD  174 (262)
T ss_pred             ------------------------------------------------------cccccCCcCccChhHhcCCCCCChhh
Confidence                                                                  00113556677777766555667789


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcC--cHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC-----HHH
Q psy8260         309 IHQLNLIMEMLGTPPAEFMAKIS--SDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT-----AEQ  381 (427)
Q Consensus       309 ~~slg~i~~~lg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t-----a~e  381 (427)
                      +|++|++++.+.++..++.....  .....+........      ......++++.+||.+||+.||.+|+|     ++|
T Consensus       175 i~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~  248 (262)
T cd05572         175 YWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKL------EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKD  248 (262)
T ss_pred             hhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCC------CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHH
Confidence            99999999877555555543221  11111111100000      111234788999999999999999999     999


Q ss_pred             HhcCCCCCCC
Q psy8260         382 ALAHPYLSQY  391 (427)
Q Consensus       382 ~L~Hp~f~~~  391 (427)
                      +++||||.++
T Consensus       249 l~~~~~~~~~  258 (262)
T cd05572         249 IKKHKWFNGF  258 (262)
T ss_pred             HhcChhhhCC
Confidence            9999999875

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5.1e-35  Score=283.05  Aligned_cols=256  Identities=21%  Similarity=0.306  Sum_probs=188.5

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcC-CCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPF-QSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      ..|.+.+.||.|+||.||.+. +..+|+.||+|++.... ........+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~-~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~------   87 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFAR-DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE------   87 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEE-EcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC------
Confidence            457778899999999999654 55678999999886432 2333445678999999999999999999988653      


Q ss_pred             ceEEEEeccCCCCHHHHHh--hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         143 KNVYMVTHLMGADLNNILR--TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       143 ~~~~lv~e~~g~~L~~~l~--~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      ...|++++++.+++.+++.  ...+++..+..++.|++.||.|||++||+||||+|+||+++.++.+||+|||++.....
T Consensus        88 ~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          88 HTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             CeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            4578999999888877664  35689999999999999999999999999999999999999999999999998864322


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      . ....++..|+|||++.+.                                                          ..
T Consensus       168 ~-~~~~~~~~y~aPE~~~~~----------------------------------------------------------~~  188 (307)
T cd06607         168 A-NSFVGTPYWMAPEVILAM----------------------------------------------------------DE  188 (307)
T ss_pred             C-CCccCCccccCceeeecc----------------------------------------------------------CC
Confidence            1 223444455555543210                                                          01


Q ss_pred             ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhc-CCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH
Q psy8260         301 WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINS-LPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA  379 (427)
Q Consensus       301 ~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta  379 (427)
                      ..+..++|+|++|++++.+.++..++............... .+...       ....+.++++||.+||..||++|||+
T Consensus       189 ~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~  261 (307)
T cd06607         189 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLS-------SNDWSDYFRNFVDSCLQKIPQDRPSS  261 (307)
T ss_pred             CCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCC-------chhhCHHHHHHHHHHhcCChhhCcCH
Confidence            12445689999999998886665555332111111111111 11111       11246789999999999999999999


Q ss_pred             HHHhcCCCCCCCC
Q psy8260         380 EQALAHPYLSQYS  392 (427)
Q Consensus       380 ~e~L~Hp~f~~~~  392 (427)
                      .+++.||||....
T Consensus       262 ~~il~~~~~~~~~  274 (307)
T cd06607         262 EELLKHRFVLRER  274 (307)
T ss_pred             HHHhcChhhcccC
Confidence            9999999998643

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.8e-35  Score=276.53  Aligned_cols=251  Identities=26%  Similarity=0.368  Sum_probs=187.0

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceE
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV  145 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~  145 (427)
                      |.+.+.+|.|+||.||.+ .+..+|..||+|.+............+.+|+++++.++|+||+++++.+...      ...
T Consensus         2 ~~~~~~l~~g~~~~v~~~-~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~------~~~   74 (257)
T cd08225           2 YEIIKKIGEGSFGKIYLA-KAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN------GRL   74 (257)
T ss_pred             ceEEEEecCCCcceEEEE-EEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC------CeE
Confidence            677889999999999964 4566889999999865433333445677999999999999999999887543      457


Q ss_pred             EEEeccC-CCCHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCC-CEEEeeCCCCCCCCC
Q psy8260         146 YMVTHLM-GADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC-ELKILDFGLARPTEN  220 (427)
Q Consensus       146 ~lv~e~~-g~~L~~~l~~~---~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~-~~kl~DFGla~~~~~  220 (427)
                      ++++|++ +++|.+++...   .+++..+..++.|++.||.|||+++++|+||||+||+++.++ .+||+|||.+.....
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (257)
T cd08225          75 FIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND  154 (257)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence            8888888 77998887542   478999999999999999999999999999999999998875 569999998764322


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      ...                                                          ......|++.|+|||++.+
T Consensus       155 ~~~----------------------------------------------------------~~~~~~~~~~~~ape~~~~  176 (257)
T cd08225         155 SME----------------------------------------------------------LAYTCVGTPYYLSPEICQN  176 (257)
T ss_pred             Ccc----------------------------------------------------------cccccCCCccccCHHHHcC
Confidence            110                                                          0001236677888887766


Q ss_pred             ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHH
Q psy8260         301 WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAE  380 (427)
Q Consensus       301 ~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~  380 (427)
                      ..+...+|+|++|++++.+-++..++...............       .+.......+.++.++|.+||+.||++|||++
T Consensus       177 ~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~  249 (257)
T cd08225         177 RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQG-------YFAPISPNFSRDLRSLISQLFKVSPRDRPSIT  249 (257)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc-------cCCCCCCCCCHHHHHHHHHHhccChhhCcCHH
Confidence            66667789999999997775544444222111111111110       01112234678899999999999999999999


Q ss_pred             HHhcCCCC
Q psy8260         381 QALAHPYL  388 (427)
Q Consensus       381 e~L~Hp~f  388 (427)
                      |+++||||
T Consensus       250 ~ll~~~~~  257 (257)
T cd08225         250 SILKRPFL  257 (257)
T ss_pred             HHhhCCCC
Confidence            99999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=8.8e-35  Score=272.42  Aligned_cols=251  Identities=24%  Similarity=0.384  Sum_probs=192.0

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceE
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV  145 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~  145 (427)
                      |.+.+.+|.|+||.||.+. +..++..||+|++............+.+|+++++.++|||++++.+.+...      ...
T Consensus         2 y~~~~~l~~g~~~~v~~~~-~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~------~~~   74 (258)
T cd08215           2 YEIIKQIGKGSFGKVYLVR-RKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK------GKL   74 (258)
T ss_pred             ceEEeeeccCCCeEEEEEE-EcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC------CEE
Confidence            6677899999999999654 566899999999876554445566788999999999999999999987653      457


Q ss_pred             EEEeccC-CCCHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         146 YMVTHLM-GADLNNILRT-----QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       146 ~lv~e~~-g~~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                      +++++++ +++|...++.     ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~  154 (258)
T cd08215          75 CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS  154 (258)
T ss_pred             EEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecc
Confidence            8888887 5789888764     568999999999999999999999999999999999999999999999999876432


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      ....                                                          ......|++.|+|||.+.
T Consensus       155 ~~~~----------------------------------------------------------~~~~~~~~~~y~~pe~~~  176 (258)
T cd08215         155 STVD----------------------------------------------------------LAKTVVGTPYYLSPELCQ  176 (258)
T ss_pred             cCcc----------------------------------------------------------eecceeeeecccChhHhc
Confidence            2110                                                          001124667788888777


Q ss_pred             hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH
Q psy8260         300 NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA  379 (427)
Q Consensus       300 ~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta  379 (427)
                      +......+|+|++|++++.+.++..++................       ........+.++.++|.+||..||++|||+
T Consensus       177 ~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~  249 (258)
T cd08215         177 NKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ-------YPPIPSQYSSELRNLVSSLLQKDPEERPSI  249 (258)
T ss_pred             cCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-------CCCCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence            7667778899999999877755544443221111111111111       111122467889999999999999999999


Q ss_pred             HHHhcCCCC
Q psy8260         380 EQALAHPYL  388 (427)
Q Consensus       380 ~e~L~Hp~f  388 (427)
                      .|+|+||||
T Consensus       250 ~~ll~~~~~  258 (258)
T cd08215         250 AQILQSPFI  258 (258)
T ss_pred             HHHhcCCCC
Confidence            999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0608|consensus

Probab=100.00  E-value=2.7e-36  Score=296.86  Aligned_cols=303  Identities=21%  Similarity=0.293  Sum_probs=213.6

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      +.+.-|-..+.||-|+||.|...+ ...|...+|+|.+.+... ...+..-...|-.||..-+.+-||+||..|++.   
T Consensus       626 MdKSmFvkik~iGvGAFGeV~Lv~-KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDk---  701 (1034)
T KOG0608|consen  626 MDKSMFVKIKTIGVGAFGEVCLVR-KVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDK---  701 (1034)
T ss_pred             ccccceEEEeeecccccceeEEEe-ecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccC---
Confidence            344556677899999999998644 445678899998875432 122233456788999999999999999888765   


Q ss_pred             cCCceEEEEeccC-CCCHHHHH-hhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCC
Q psy8260         140 ADFKNVYMVTHLM-GADLNNIL-RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP  217 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l-~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~  217 (427)
                         .++|+||+|. |||+-.+| +.+-|.|+.+++|+.++.+|+++.|..|+|||||||+|||||.+|++||.||||+.-
T Consensus       702 ---dnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTG  778 (1034)
T KOG0608|consen  702 ---DNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  778 (1034)
T ss_pred             ---CceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeecccccc
Confidence               4578999887 88988765 667899999999999999999999999999999999999999999999999999864


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCc-cccccccccccccchH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTE-NEMTGYVATRWYRAPE  296 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~-~~~~~~~gt~~Y~APE  296 (427)
                      +.-..    .+.+|-      ...+.  ....+...+.|+..-     ..+|++.+.-.+... -.....+||+.|+|||
T Consensus       779 fRWTH----dskYYq------~gdH~--RqDSmep~~e~~d~~-----~~lkvL~~ra~~~h~r~~ahslvgt~nyiape  841 (1034)
T KOG0608|consen  779 FRWTH----DSKYYQ------EGDHH--RQDSMEPSPEWADIS-----KCLKVLERRAMRQHQRILAHSLVGTPNYIAPE  841 (1034)
T ss_pred             ceecc----cccccc------CCCcc--ccccCCCchhhcccc-----ccchHHHHHHHhhhhhhhhhhhcCCCcccChH
Confidence            32111    011111      00111  111233334454321     114444443222111 1234678999999999


Q ss_pred             HhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCC
Q psy8260         297 IMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKR  376 (427)
Q Consensus       297 vl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R  376 (427)
                      ||....+..-+|||+.|+|+++|..+..+|.+....++..+.+++...+ ..   ..-..+|+++.|||.++. .++++|
T Consensus       842 vl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l-~~---~~~~~ls~e~~~li~kLc-~sad~R  916 (1034)
T KOG0608|consen  842 VLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFL-HI---PYQGNLSKEALDLIQKLC-CSADSR  916 (1034)
T ss_pred             HhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhcc-cc---ccccccCHHHHHHHHHHh-cChhhh
Confidence            9999989999999999999999988777787654433332222211000 00   011357999999999977 589999


Q ss_pred             C---CHHHHhcCCCCCCCC
Q psy8260         377 I---TAEQALAHPYLSQYS  392 (427)
Q Consensus       377 ~---ta~e~L~Hp~f~~~~  392 (427)
                      +   .++|+..||||+.+.
T Consensus       917 LGkng~d~vKaHpfFkgID  935 (1034)
T KOG0608|consen  917 LGKNGADQVKAHPFFKGID  935 (1034)
T ss_pred             hcccchhhhhcCccccccc
Confidence            8   478899999998653

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=8.3e-35  Score=274.35  Aligned_cols=258  Identities=26%  Similarity=0.389  Sum_probs=190.6

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceE
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV  145 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~  145 (427)
                      |.+.+.||.|+||.||.+ .+..+++.||+|.+............+.+|+.+++.++|+||+++++.+...      ..+
T Consensus         2 y~~~~~lg~G~~~~v~~~-~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~------~~~   74 (264)
T cd06626           2 WQRGNKIGGGTFGKVYTA-VNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR------EKV   74 (264)
T ss_pred             ceeeeEeecCCCcEEEEE-EECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC------CEE
Confidence            667889999999999965 4556789999999876544444567788999999999999999999986543      457


Q ss_pred             EEEeccC-CCCHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcc
Q psy8260         146 YMVTHLM-GADLNNILRTQ-KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT  223 (427)
Q Consensus       146 ~lv~e~~-g~~L~~~l~~~-~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~  223 (427)
                      +++++++ +++|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          75 YIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             EEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            8888887 68999988654 488999999999999999999999999999999999999999999999999875432211


Q ss_pred             cccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhcc-
Q psy8260         224 GYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM-  302 (427)
Q Consensus       224 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~-  302 (427)
                      .. +                                                     .......+++.|+|||++.+.. 
T Consensus       155 ~~-~-----------------------------------------------------~~~~~~~~~~~~~~PE~~~~~~~  180 (264)
T cd06626         155 TM-G-----------------------------------------------------EEVQSLAGTPAYMAPEVITGGKG  180 (264)
T ss_pred             cc-c-----------------------------------------------------ccccCCcCCcCccChhhccCCCC
Confidence            00 0                                                     0011234566777777776554 


Q ss_pred             --CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHH
Q psy8260         303 --HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAE  380 (427)
Q Consensus       303 --~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~  380 (427)
                        ...++|+|++|++++.+.++..+|........ ..+......  ...+ .....+++.+.+||.+||+.||.+|||++
T Consensus       181 ~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~--~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~  256 (264)
T cd06626         181 KGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-IMFHVGAGH--KPPI-PDSLQLSPEGKDFLDRCLESDPKKRPTAS  256 (264)
T ss_pred             CCCCcccchHHHHHHHHHHHhCCCCccCCcchHH-HHHHHhcCC--CCCC-CcccccCHHHHHHHHHHccCCcccCCCHH
Confidence              56678999999999777555555532211111 111111100  0000 01123578899999999999999999999


Q ss_pred             HHhcCCCC
Q psy8260         381 QALAHPYL  388 (427)
Q Consensus       381 e~L~Hp~f  388 (427)
                      |+++|||+
T Consensus       257 ~i~~~~~~  264 (264)
T cd06626         257 ELLQHPFV  264 (264)
T ss_pred             HHhcCCCC
Confidence            99999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.5e-35  Score=281.35  Aligned_cols=260  Identities=19%  Similarity=0.214  Sum_probs=184.1

Q ss_pred             cCcceeeccccCcccccEEEEeEEeC---------------cCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCc
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSALDS---------------VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENV  126 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~~~---------------~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnI  126 (427)
                      ..++|++.+.||+|+||.||.+....               ..+..||+|.+.... .......+.+|++++++++||||
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i   81 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNI   81 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCE
Confidence            34678899999999999999754322               123568999886542 33445667899999999999999


Q ss_pred             eeeeeeeecCccccCCceEEEEeccC-CCCHHHHHhhC------------CCCHHHHHHHHHHHHHHHHHHHhcCceecc
Q psy8260         127 IGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQ------------KLSDDHVQFLVYQILRGLKYIHSAGIIHRD  193 (427)
Q Consensus       127 v~l~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~------------~l~~~~~~~~~~qi~~aL~yLH~~~iiHrD  193 (427)
                      +++++++...      ...+++++++ +++|.+++...            .+++..+..++.|++.||.|||++||+|||
T Consensus        82 ~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~d  155 (296)
T cd05051          82 ARLLGVCTVD------PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRD  155 (296)
T ss_pred             eEEEEEEecC------CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Confidence            9999987653      3567888876 68999888643            488999999999999999999999999999


Q ss_pred             CCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhcc
Q psy8260         194 LKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDF  273 (427)
Q Consensus       194 LKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~  273 (427)
                      |||+||+++.++.++|+|||+++........                                                 
T Consensus       156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-------------------------------------------------  186 (296)
T cd05051         156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYY-------------------------------------------------  186 (296)
T ss_pred             cchhceeecCCCceEEccccceeecccCcce-------------------------------------------------
Confidence            9999999999999999999988643221000                                                 


Q ss_pred             CCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC--CCHHHHhhcCcHHHHHHHhcCCCCCcccHH
Q psy8260         274 GLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT--PPAEFMAKISSDSARKYINSLPLLTKKDFR  351 (427)
Q Consensus       274 g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (427)
                             .......+++.|+|||++.+..+..++|+||+|++++.+.+  +..++.........................
T Consensus       187 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (296)
T cd05051         187 -------RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYL  259 (296)
T ss_pred             -------eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccC
Confidence                   00012235667888888877667788899999999986632  333332211111111111100000000000


Q ss_pred             hhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy8260         352 QVFKGANPQAIDLLSLMLELDSEKRITAEQALA  384 (427)
Q Consensus       352 ~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~  384 (427)
                      ......++++.+||.+||+.||.+|||+.|+++
T Consensus       260 ~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         260 PRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             CCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            111235678999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=8.1e-35  Score=278.04  Aligned_cols=252  Identities=18%  Similarity=0.254  Sum_probs=186.0

Q ss_pred             cceeeccccCcccccEEEEeEE---eCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcccc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSAL---DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~---~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  140 (427)
                      ..+++.+.||+|+||.||++..   +..+++.||+|.+.... .......+.+|+++++.++||||+++++++...    
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----   79 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE----   79 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC----
Confidence            5678889999999999998764   33467899999986432 334445677899999999999999999987654    


Q ss_pred             CCceEEEEeccC-CCCHHHHHhh------------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEE
Q psy8260         141 DFKNVYMVTHLM-GADLNNILRT------------------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV  201 (427)
Q Consensus       141 ~~~~~~lv~e~~-g~~L~~~l~~------------------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl  201 (427)
                        ...|+++|++ +++|.+++..                  ..+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus        80 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili  157 (283)
T cd05090          80 --QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI  157 (283)
T ss_pred             --CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE
Confidence              3568888887 6799888742                  236788889999999999999999999999999999999


Q ss_pred             cCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcc
Q psy8260         202 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTEN  281 (427)
Q Consensus       202 ~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~  281 (427)
                      +.++.+||+|||+++.........                                                        
T Consensus       158 ~~~~~~kl~dfg~~~~~~~~~~~~--------------------------------------------------------  181 (283)
T cd05090         158 GEQLHVKISDLGLSREIYSADYYR--------------------------------------------------------  181 (283)
T ss_pred             cCCCcEEeccccccccccCCccee--------------------------------------------------------
Confidence            999999999999987542211000                                                        


Q ss_pred             ccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChh
Q psy8260         282 EMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQ  360 (427)
Q Consensus       282 ~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  360 (427)
                      ......++..|+|||++.+..+...+|+||+|++++.|-+ +..+|.... ..............      ......+++
T Consensus       182 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~-~~~~~~~~~~~~~~------~~~~~~~~~  254 (283)
T cd05090         182 VQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS-NQEVIEMVRKRQLL------PCSEDCPPR  254 (283)
T ss_pred             cccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHHcCCcC------CCCCCCCHH
Confidence            0011234566888888776667778899999999987644 333332211 11111112111111      122346788


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         361 AIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       361 ~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                      +.+||.+||+.||.+||++.+++++
T Consensus       255 ~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         255 MYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHHHHHHcccCcccCcCHHHHHHH
Confidence            9999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0193|consensus

Probab=100.00  E-value=4.1e-36  Score=295.61  Aligned_cols=258  Identities=24%  Similarity=0.306  Sum_probs=194.6

Q ss_pred             CccccccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeec
Q psy8260          56 QPYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHS  135 (427)
Q Consensus        56 ~~~~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~  135 (427)
                      ..+|++..+.+.++..||.|+||+||++.++.    .||||+++.......+.+.|.+|+.++++-+|.||+-+.+++..
T Consensus       384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG----dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~  459 (678)
T KOG0193|consen  384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG----DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN  459 (678)
T ss_pred             ccccccCHHHhhccceeccccccceeeccccc----ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence            35788888999999999999999999988865    69999998877778888999999999999999999999998764


Q ss_pred             CccccCCceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeC
Q psy8260         136 NTCLADFKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDF  212 (427)
Q Consensus       136 ~~~~~~~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DF  212 (427)
                      .       .+.|+.-+| |.+|+.+++-  .+|.....+.|++||++||.|||.++|||||||..||++.+++.|||+||
T Consensus       460 p-------~~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDF  532 (678)
T KOG0193|consen  460 P-------PLAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDF  532 (678)
T ss_pred             C-------ceeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecc
Confidence            3       246777777 6689988853  56889999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccc
Q psy8260         213 GLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWY  292 (427)
Q Consensus       213 Gla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y  292 (427)
                      ||+....         +|+..                                               .....-.|...|
T Consensus       533 GLatvk~---------~w~g~-----------------------------------------------~q~~qp~gsilw  556 (678)
T KOG0193|consen  533 GLATVKT---------RWSGE-----------------------------------------------QQLEQPHGSLLW  556 (678)
T ss_pred             cceeeee---------eeccc-----------------------------------------------cccCCCccchhh
Confidence            9985321         11000                                               000111234445


Q ss_pred             cchHHhhh---ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCC-CCcccHHhhcCCCChhHHHHHHHh
Q psy8260         293 RAPEIMLN---WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPL-LTKKDFRQVFKGANPQAIDLLSLM  368 (427)
Q Consensus       293 ~APEvl~~---~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~dLi~~m  368 (427)
                      |||||++-   .+|...+|+|++|+++|+|.++..|+.......    ++..... +...+.......-..+.++|+..|
T Consensus       557 mAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq----IifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C  632 (678)
T KOG0193|consen  557 MAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ----IIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDC  632 (678)
T ss_pred             hcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh----eEEEecccccCccchhhhccCHHHHHHHHHHH
Confidence            55555542   246667899999999999988887776332221    1111111 111122222222334889999999


Q ss_pred             cCCCCCCCCCHHHHhc
Q psy8260         369 LELDSEKRITAEQALA  384 (427)
Q Consensus       369 L~~dP~~R~ta~e~L~  384 (427)
                      +.+||+.||+..++|.
T Consensus       633 ~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  633 WKFDREERPLFPQLLS  648 (678)
T ss_pred             HhcCcccCccHHHHHH
Confidence            9999999999999886

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3.9e-35  Score=278.33  Aligned_cols=243  Identities=20%  Similarity=0.239  Sum_probs=177.3

Q ss_pred             eeeccc--cCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhc-CCCCCceeeeeeeecCccccCC
Q psy8260          66 IDIGPT--LSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKH-MNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        66 ~~~~~~--lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~-l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      +++.+.  +|.|+||.||. +.+..++..+|+|.+.......       .|+..... .+||||+++++.|...      
T Consensus        16 ~~~~~~~~lg~g~~g~v~~-~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~------   81 (267)
T PHA03390         16 CEIVKKLKLIDGKFGKVSV-LKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTL------   81 (267)
T ss_pred             hccccceeecCCCceEEEE-EEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecC------
Confidence            344444  59999999996 4567789999999886432211       12222221 2799999999998654      


Q ss_pred             ceEEEEeccC-CCCHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCC-CEEEeeCCCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILRTQ-KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC-ELKILDFGLARPTE  219 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~~~-~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~-~~kl~DFGla~~~~  219 (427)
                      ..+|+++|++ +++|.++++.. .+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||+++...
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~  161 (267)
T PHA03390         82 KGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG  161 (267)
T ss_pred             CeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence            3578899887 78999988764 799999999999999999999999999999999999999888 99999999876432


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      ...                                                              ...|+..|+|||++.
T Consensus       162 ~~~--------------------------------------------------------------~~~~~~~y~aPE~~~  179 (267)
T PHA03390        162 TPS--------------------------------------------------------------CYDGTLDYFSPEKIK  179 (267)
T ss_pred             CCc--------------------------------------------------------------cCCCCCcccChhhhc
Confidence            110                                                              112556677777776


Q ss_pred             hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHH-HHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC
Q psy8260         300 NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDS-ARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT  378 (427)
Q Consensus       300 ~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t  378 (427)
                      +..+..++|+||+|++++.+.++..||........ ......... .    .....+..++.+.+||.+||+.||.+|++
T Consensus       180 ~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~----~~~~~~~~~~~~~~li~~~l~~~p~~R~~  254 (267)
T PHA03390        180 GHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ-K----KLPFIKNVSKNANDFVQSMLKYNINYRLT  254 (267)
T ss_pred             CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhc-c----cCCcccccCHHHHHHHHHHhccChhhCCc
Confidence            66667778999999999888665555532211111 111111110 0    01122357899999999999999999996


Q ss_pred             -HHHHhcCCCCC
Q psy8260         379 -AEQALAHPYLS  389 (427)
Q Consensus       379 -a~e~L~Hp~f~  389 (427)
                       .+|+|+||||.
T Consensus       255 ~~~~~l~h~~~~  266 (267)
T PHA03390        255 NYNEIIKHPFLK  266 (267)
T ss_pred             hHHHHhcCCccc
Confidence             59999999996

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=6.1e-35  Score=278.02  Aligned_cols=252  Identities=21%  Similarity=0.250  Sum_probs=187.4

Q ss_pred             CcceeeccccCcccccEEEEeEEe----CcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALD----SVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~----~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      ...|.+.+.||+|+||.||.+...    ..+++.||||.+.... .......+.+|+++|+.++||||+++++++...  
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--   80 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEG--   80 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC--
Confidence            456788899999999999976542    2456889999886542 233456778999999999999999999988654  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhhC---------------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEc
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRTQ---------------KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN  202 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~~---------------~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~  202 (427)
                          ...+++++++ +++|.++++..               .+++..+..++.|++.||.|||++|++||||||+||+++
T Consensus        81 ----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~  156 (280)
T cd05049          81 ----DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG  156 (280)
T ss_pred             ----CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEc
Confidence                4578888877 78999888642               378888999999999999999999999999999999999


Q ss_pred             CCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccc
Q psy8260         203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENE  282 (427)
Q Consensus       203 ~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~  282 (427)
                      .++.+||+|||+++.........                                                        .
T Consensus       157 ~~~~~kl~d~g~~~~~~~~~~~~--------------------------------------------------------~  180 (280)
T cd05049         157 YDLVVKIGDFGMSRDVYTTDYYR--------------------------------------------------------V  180 (280)
T ss_pred             CCCeEEECCcccceecccCccee--------------------------------------------------------c
Confidence            99999999999986432110000                                                        0


Q ss_pred             cccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhH
Q psy8260         283 MTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQA  361 (427)
Q Consensus       283 ~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  361 (427)
                      .....+++.|+|||++.+..+...+|+||+|++++.+.+ +..+|.................       .......+.++
T Consensus       181 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~  253 (280)
T cd05049         181 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRL-------LQRPRTCPSEV  253 (280)
T ss_pred             CCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCc-------CCCCCCCCHHH
Confidence            011234677888888887778888999999999977654 4444433222222221111111       11123467899


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhc
Q psy8260         362 IDLLSLMLELDSEKRITAEQALA  384 (427)
Q Consensus       362 ~dLi~~mL~~dP~~R~ta~e~L~  384 (427)
                      ++||.+||+.||.+|||++|+++
T Consensus       254 ~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         254 YDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHHHHHHcCCCcccCCCHHHHHH
Confidence            99999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-35  Score=275.50  Aligned_cols=249  Identities=25%  Similarity=0.385  Sum_probs=181.1

Q ss_pred             cccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH-HHHHHHHHHHHH-HhcCCCCCceeeeeeeecCccccCCceEEE
Q psy8260          70 PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA-VHAKRTYRELRM-LKHMNHENVIGLLDVFHSNTCLADFKNVYM  147 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~-l~~l~HpnIv~l~~~~~~~~~~~~~~~~~l  147 (427)
                      +.+|.|+||.||. +.+..+|+.||||.+.+..... ........|..+ ....+|+||+++++++...      ...|+
T Consensus         2 ~~l~~g~~~~v~~-a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~------~~~~l   74 (260)
T cd05611           2 KPISKGAFGSVYL-AKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK------DYLYL   74 (260)
T ss_pred             ccCCcCCCeeEEE-EEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC------CeEEE
Confidence            4689999999996 4566789999999986532211 122334455544 4456999999999998653      45788


Q ss_pred             EeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccc
Q psy8260         148 VTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGY  225 (427)
Q Consensus       148 v~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  225 (427)
                      ++|++ +++|.++++. ..+++..+..++.|++.||.|||+.+++||||+|+||+++.++.+||+|||+++..... .  
T Consensus        75 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~--  151 (260)
T cd05611          75 VMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-K--  151 (260)
T ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceecccc-c--
Confidence            98888 7899998865 56899999999999999999999999999999999999999999999999987642210 1  


Q ss_pred             cccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCC
Q psy8260         226 VATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYN  305 (427)
Q Consensus       226 ~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~  305 (427)
                                                                                 ...|++.|+|||.+.+..+..
T Consensus       152 -----------------------------------------------------------~~~~~~~y~~pe~~~~~~~~~  172 (260)
T cd05611         152 -----------------------------------------------------------KFVGTPDYLAPETILGVGDDK  172 (260)
T ss_pred             -----------------------------------------------------------cCCCCcCccChhhhcCCCCcc
Confidence                                                                       113455677777766655666


Q ss_pred             CCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH---HHH
Q psy8260         306 QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA---EQA  382 (427)
Q Consensus       306 ~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta---~e~  382 (427)
                      ++|+|++|++++.+.++..+|.....................    ......++++.++|.+||+.||++|+|+   +|+
T Consensus       173 ~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~  248 (260)
T cd05611         173 MSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPE----EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEI  248 (260)
T ss_pred             hhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCC----cccccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence            789999999998886555555332211111111111111111    1223568899999999999999999955   799


Q ss_pred             hcCCCCCCC
Q psy8260         383 LAHPYLSQY  391 (427)
Q Consensus       383 L~Hp~f~~~  391 (427)
                      |+||||.+.
T Consensus       249 l~~~~~~~~  257 (260)
T cd05611         249 KSHPFFKSI  257 (260)
T ss_pred             HcChHhhcC
Confidence            999999765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=5.9e-35  Score=274.45  Aligned_cols=247  Identities=24%  Similarity=0.334  Sum_probs=186.9

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceE
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV  145 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~  145 (427)
                      |++.+.||.|+||.||.+ .+..+++.||+|.+.... .....+...+|+.+++.++||||+++++.+...      ..+
T Consensus         2 y~~~~~lg~g~~g~v~~~-~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~   73 (255)
T cd08219           2 YNVLRVVGEGSFGRALLV-QHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD------GHL   73 (255)
T ss_pred             ceEEEEeeccCCeEEEEE-EEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC------CEE
Confidence            667889999999999964 567789999999886432 233455677899999999999999999988654      467


Q ss_pred             EEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         146 YMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       146 ~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      |++++++ +++|.+.+..   ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||+++.....
T Consensus        74 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  153 (255)
T cd08219          74 YIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP  153 (255)
T ss_pred             EEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence            8999888 6788887753   35899999999999999999999999999999999999999999999999987643211


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      ..                                                          ......|++.|+|||++.+.
T Consensus       154 ~~----------------------------------------------------------~~~~~~~~~~~~aPE~~~~~  175 (255)
T cd08219         154 GA----------------------------------------------------------YACTYVGTPYYVPPEIWENM  175 (255)
T ss_pred             cc----------------------------------------------------------ccccccCCccccCHHHHccC
Confidence            00                                                          00122466778888887776


Q ss_pred             cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHH
Q psy8260         302 MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQ  381 (427)
Q Consensus       302 ~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e  381 (427)
                      .+..++|+|++|++++.+.++..+|................  .     .......+.++.+||.+||+.||.+|||+.+
T Consensus       176 ~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~--~-----~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~  248 (255)
T cd08219         176 PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGS--Y-----KPLPSHYSYELRSLIKQMFKRNPRSRPSATT  248 (255)
T ss_pred             CcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCC--C-----CCCCcccCHHHHHHHHHHHhCCcccCCCHHH
Confidence            67778899999999988866655554322111111111110  0     0112346788999999999999999999999


Q ss_pred             HhcC
Q psy8260         382 ALAH  385 (427)
Q Consensus       382 ~L~H  385 (427)
                      +++-
T Consensus       249 il~~  252 (255)
T cd08219         249 ILSR  252 (255)
T ss_pred             Hhhc
Confidence            9863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8e-35  Score=279.96  Aligned_cols=261  Identities=19%  Similarity=0.221  Sum_probs=183.4

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeC-------------cCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCce
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDS-------------VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVI  127 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~-------------~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv  127 (427)
                      +...+|.+.+.||+|+||.||.+....             .+...||+|.+... ........+.+|++++++++||||+
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~   80 (295)
T cd05097           2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNII   80 (295)
T ss_pred             CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcC
Confidence            345678999999999999999654321             12245899988653 2334455678999999999999999


Q ss_pred             eeeeeeecCccccCCceEEEEeccC-CCCHHHHHhhC-------------CCCHHHHHHHHHHHHHHHHHHHhcCceecc
Q psy8260         128 GLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQ-------------KLSDDHVQFLVYQILRGLKYIHSAGIIHRD  193 (427)
Q Consensus       128 ~l~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~-------------~l~~~~~~~~~~qi~~aL~yLH~~~iiHrD  193 (427)
                      ++++++...      ...++++|++ +++|.+++...             .+++..+..++.|++.||.|||++|++|||
T Consensus        81 ~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~d  154 (295)
T cd05097          81 RLLGVCVSD------DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRD  154 (295)
T ss_pred             eEEEEEcCC------CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccc
Confidence            999998643      3568888877 68998887532             267788889999999999999999999999


Q ss_pred             CCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhcc
Q psy8260         194 LKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDF  273 (427)
Q Consensus       194 LKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~  273 (427)
                      |||+||+++.++.+||+|||+++........                                                 
T Consensus       155 lkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-------------------------------------------------  185 (295)
T cd05097         155 LATRNCLVGNHYTIKIADFGMSRNLYSGDYY-------------------------------------------------  185 (295)
T ss_pred             cChhhEEEcCCCcEEecccccccccccCcce-------------------------------------------------
Confidence            9999999999999999999998643211000                                                 


Q ss_pred             CCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHh--CCCCHHHHhhcCcHHHHHHHhcCCCCCcccHH
Q psy8260         274 GLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEML--GTPPAEFMAKISSDSARKYINSLPLLTKKDFR  351 (427)
Q Consensus       274 g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~l--g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (427)
                             .......+++.|+|||++.+..+..++|+||+|++++.+  +.+..+|.......................+.
T Consensus       186 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (295)
T cd05097         186 -------RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYL  258 (295)
T ss_pred             -------eccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccC
Confidence                   000112346678888888777777888999999999877  33443333211111111110000000000001


Q ss_pred             hhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy8260         352 QVFKGANPQAIDLLSLMLELDSEKRITAEQALA  384 (427)
Q Consensus       352 ~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~  384 (427)
                      ...+..++.+.|||.+||+.||.+|||++++++
T Consensus       259 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         259 SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            112235688999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-35  Score=277.53  Aligned_cols=255  Identities=18%  Similarity=0.353  Sum_probs=188.4

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCC---CCCceeeeeeeecCccccCC
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN---HENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~---HpnIv~l~~~~~~~~~~~~~  142 (427)
                      |++.+.+|.|+||.||.+. +..+++.||+|.+.... .......+.+|+.+++.++   |||++++++++...      
T Consensus         3 y~~~~~l~~g~~g~v~~~~-~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~------   74 (277)
T cd06917           3 YQRLELIGRGAYGAVYRGK-HVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG------   74 (277)
T ss_pred             hhhhhheeccCCceEEEEE-EcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC------
Confidence            5667889999999999754 56789999999886532 2333456778999999886   99999999987543      


Q ss_pred             ceEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      ...+++++++ +++|.++++.+.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++......
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          75 PRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             CEEEEEEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            4578888877 779999988888999999999999999999999999999999999999999999999999988643221


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh-
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN-  300 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~-  300 (427)
                      ..                                                          ......|+..|+|||++.+ 
T Consensus       155 ~~----------------------------------------------------------~~~~~~~~~~y~aPE~~~~~  176 (277)
T cd06917         155 SS----------------------------------------------------------KRSTFVGTPYWMAPEVITEG  176 (277)
T ss_pred             cc----------------------------------------------------------ccccccCCcceeCHHHhccC
Confidence            10                                                          0011235566777776643 


Q ss_pred             ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHH
Q psy8260         301 WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAE  380 (427)
Q Consensus       301 ~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~  380 (427)
                      ..+...+|+|++|++++.+.++..+|.......    ............+.  ....++++.+||.+||+.||++|||+.
T Consensus       177 ~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~----~~~~~~~~~~~~~~--~~~~~~~~~~~i~~~l~~~p~~R~~~~  250 (277)
T cd06917         177 KYYDTKADIWSLGITIYEMATGNPPYSDVDAFR----AMMLIPKSKPPRLE--DNGYSKLLREFVAACLDEEPKERLSAE  250 (277)
T ss_pred             CccccchhHHHHHHHHHHHHhCCCCCCCCChhh----hhhccccCCCCCCC--cccCCHHHHHHHHHHcCCCcccCcCHH
Confidence            234567899999999987755555543221111    11111000000000  112578899999999999999999999


Q ss_pred             HHhcCCCCCCCC
Q psy8260         381 QALAHPYLSQYS  392 (427)
Q Consensus       381 e~L~Hp~f~~~~  392 (427)
                      |+++||||++..
T Consensus       251 ~il~~~~~~~~~  262 (277)
T cd06917         251 ELLKSKWIKAHS  262 (277)
T ss_pred             HHhhChHhhccc
Confidence            999999997654

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-34  Score=272.99  Aligned_cols=258  Identities=20%  Similarity=0.337  Sum_probs=191.5

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcC---CCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcccc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPF---QSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  140 (427)
                      ..|.+++.||+|+||.||. +.+..+|..||+|.+....   ........+.+|++++++++||||+++++.+....   
T Consensus         2 ~~~~~~~~lg~g~~g~v~~-~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~---   77 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYL-CYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE---   77 (264)
T ss_pred             CceeeeeeEccCCCeEEEE-EEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC---
Confidence            3578899999999999996 4567789999999875321   12234456778999999999999999999875431   


Q ss_pred             CCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCC
Q psy8260         141 DFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT  218 (427)
Q Consensus       141 ~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~  218 (427)
                       ...+++++|++ +++|.+.+.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++..
T Consensus        78 -~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  156 (264)
T cd06653          78 -EKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRI  156 (264)
T ss_pred             -CCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence             23567888877 6789888764 56899999999999999999999999999999999999999999999999998753


Q ss_pred             CCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         219 ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       219 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                      ......         .                                              .......|+..|+|||++
T Consensus       157 ~~~~~~---------~----------------------------------------------~~~~~~~~~~~y~aPE~~  181 (264)
T cd06653         157 QTICMS---------G----------------------------------------------TGIKSVTGTPYWMSPEVI  181 (264)
T ss_pred             cccccc---------C----------------------------------------------ccccccCCcccccCHhhh
Confidence            211000         0                                              001123467778888888


Q ss_pred             hhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC
Q psy8260         299 LNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT  378 (427)
Q Consensus       299 ~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t  378 (427)
                      .+......+|+|++|++++.+-++..+|..........+.. ..+..     .......++++.|||.+||+ +|.+|||
T Consensus       182 ~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~-----~~~p~~~~~~~~~~i~~~l~-~~~~r~~  254 (264)
T cd06653         182 SGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA-TQPTK-----PMLPDGVSDACRDFLKQIFV-EEKRRPT  254 (264)
T ss_pred             cCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH-cCCCC-----CCCCcccCHHHHHHHHHHhc-CcccCcc
Confidence            77667778899999999988865555553221111111111 11110     11234578899999999999 5799999


Q ss_pred             HHHHhcCCCC
Q psy8260         379 AEQALAHPYL  388 (427)
Q Consensus       379 a~e~L~Hp~f  388 (427)
                      +.++++|||.
T Consensus       255 ~~~~~~~~~~  264 (264)
T cd06653         255 AEFLLRHPFV  264 (264)
T ss_pred             HHHHhcCCCC
Confidence            9999999994

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=5.3e-35  Score=277.92  Aligned_cols=271  Identities=25%  Similarity=0.366  Sum_probs=197.1

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCC-CCCceeeeeeeecCccccCC
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMN-HENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .|.+.+.||.|+||.||.+ .+..+|+.||+|++..... .......+.+|+.++++++ ||||+++++++...      
T Consensus         2 ~y~~~~~lg~g~~~~vy~~-~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~------   74 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLA-KEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE------   74 (280)
T ss_pred             CceEeeeecCCCceEEEEE-EEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC------
Confidence            4778889999999999965 4566899999998865322 2233456778999999998 99999999887543      


Q ss_pred             ceEEEEeccC-CCCHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILRTQ-KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~~~-~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      ...+++++++ +++|.+++... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          75 ENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             ceEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            4678999988 88999888664 799999999999999999999999999999999999999999999999999875543


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      ..........|+.+.                                      ..............|+..|+|||++..
T Consensus       155 ~~~~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~~~~~~~~~~~Pe~~~~  196 (280)
T cd05581         155 NSSPESNKGDATNID--------------------------------------SQIEKNRRRFASFVGTAEYVSPELLNE  196 (280)
T ss_pred             ccccccCCCCCcccc--------------------------------------ccccccccccccccCCccccCHHHhCC
Confidence            221110000111000                                      000000011234467889999999887


Q ss_pred             ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH-
Q psy8260         301 WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA-  379 (427)
Q Consensus       301 ~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta-  379 (427)
                      ......+|+|++|++++.+-++..++.................        ......++.+.+||.+||+.||.+|||+ 
T Consensus       197 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~R~~~~  268 (280)
T cd05581         197 KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY--------SFPPNFPPDAKDLIEKLLVLDPQDRLGVN  268 (280)
T ss_pred             CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC--------CCCCccCHHHHHHHHHHhcCCHhhCCCcc
Confidence            7777788999999998777555444432211111111111100        1123457889999999999999999999 


Q ss_pred             ---HHHhcCCCC
Q psy8260         380 ---EQALAHPYL  388 (427)
Q Consensus       380 ---~e~L~Hp~f  388 (427)
                         +|+|+||||
T Consensus       269 ~~~~~ll~~~~~  280 (280)
T cd05581         269 EGYDELKAHPFF  280 (280)
T ss_pred             cCHHHHhcCCCC
Confidence               999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=8e-35  Score=277.66  Aligned_cols=254  Identities=37%  Similarity=0.590  Sum_probs=181.7

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCC-CCCceeeeeeeecCccccCCce
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN-HENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      |.+.+.||.|+||.||.+ ....+++.||||++...... .......+|+..+++++ ||||+++++++...      ..
T Consensus         1 y~~~~~ig~g~~g~v~~~-~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~------~~   72 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLA-RNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFREN------DE   72 (283)
T ss_pred             CeeheeeccCCceEEEEE-EECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcC------Cc
Confidence            457788999999999975 45667899999998654332 22334567999999999 99999999987653      46


Q ss_pred             EEEEeccCCCCHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         145 VYMVTHLMGADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       145 ~~lv~e~~g~~L~~~l~~~---~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      .++++++++++|.+.+...   .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus        73 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~  152 (283)
T cd07830          73 LYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR  152 (283)
T ss_pred             EEEEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence            7899999999998877543   6899999999999999999999999999999999999999999999999998654321


Q ss_pred             --cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         222 --MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       222 --~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                        .+...++.                                                             .|+|||++.
T Consensus       153 ~~~~~~~~~~-------------------------------------------------------------~~~aPE~~~  171 (283)
T cd07830         153 PPYTDYVSTR-------------------------------------------------------------WYRAPEILL  171 (283)
T ss_pred             CCcCCCCCcc-------------------------------------------------------------cccCceeee
Confidence              12233444                                                             455555442


Q ss_pred             h-ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHh----------------------cCCCCCcccHHhhcCC
Q psy8260         300 N-WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYIN----------------------SLPLLTKKDFRQVFKG  356 (427)
Q Consensus       300 ~-~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~  356 (427)
                      + ..+..++|+||+|++++.+.++..+|......+...+...                      ..+..........+..
T Consensus       172 ~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (283)
T cd07830         172 RSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPN  251 (283)
T ss_pred             cCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHccc
Confidence            2 2244567888888887766444333321111111111100                      0011111122333444


Q ss_pred             CChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q psy8260         357 ANPQAIDLLSLMLELDSEKRITAEQALAHPYL  388 (427)
Q Consensus       357 ~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f  388 (427)
                      .++++++||.+||+.||.+|||++|++.||||
T Consensus       252 ~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         252 ASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             CCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            57889999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0983|consensus

Probab=100.00  E-value=1.2e-35  Score=267.17  Aligned_cols=256  Identities=21%  Similarity=0.320  Sum_probs=194.2

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCC-CCCceeeeeeeecCccccCCce
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN-HENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      .++...+|.|+-|.|++ +..+++|...|||.+.+.. +....++++..+.++.+.+ .|.||+.+++|..+      ..
T Consensus        94 l~~l~dlGsGtcG~V~k-~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n------~d  165 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWK-MRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN------TD  165 (391)
T ss_pred             hhhHHhhcCCCccceEE-EEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC------ch
Confidence            44556899999999995 5567899999999997653 4556677888888776654 79999999999865      34


Q ss_pred             EEEEeccCCCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         145 VYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       145 ~~lv~e~~g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~-~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      +.+.||+|+..+..+++.  +.++|..+-.+...++.||.||.. +||||||+||+|||+|+.|++|+||||++..+...
T Consensus       166 V~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS  245 (391)
T KOG0983|consen  166 VFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS  245 (391)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc
Confidence            678899998888887764  679999999999999999999975 58999999999999999999999999998765432


Q ss_pred             --cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         222 --MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       222 --~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                        .+...|-+.|||||-|.-.                                                          .
T Consensus       246 kAhtrsAGC~~YMaPERidp~----------------------------------------------------------~  267 (391)
T KOG0983|consen  246 KAHTRSAGCAAYMAPERIDPP----------------------------------------------------------D  267 (391)
T ss_pred             cccccccCCccccCccccCCC----------------------------------------------------------C
Confidence              2334555666666654210                                                          0


Q ss_pred             hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCc-HHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC
Q psy8260         300 NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISS-DSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT  378 (427)
Q Consensus       300 ~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t  378 (427)
                      +..|+-.+|+||||+.+++|.++..|+...... +...+.++..|...+     .-.+.|+++.+|+..||++|+.+||.
T Consensus       268 ~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~-----~~~gFSp~F~~fv~~CL~kd~r~RP~  342 (391)
T KOG0983|consen  268 KPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLP-----GHMGFSPDFQSFVKDCLTKDHRKRPK  342 (391)
T ss_pred             CCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCC-----cccCcCHHHHHHHHHHhhcCcccCcc
Confidence            112445679999999999998888777543222 223344444332111     11236999999999999999999999


Q ss_pred             HHHHhcCCCCCCCC
Q psy8260         379 AEQALAHPYLSQYS  392 (427)
Q Consensus       379 a~e~L~Hp~f~~~~  392 (427)
                      -.++|+|||+..+.
T Consensus       343 Y~~Ll~h~Fi~~ye  356 (391)
T KOG0983|consen  343 YNKLLEHPFIKRYE  356 (391)
T ss_pred             hHHHhcCcceeecc
Confidence            99999999998764

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-34  Score=273.30  Aligned_cols=253  Identities=21%  Similarity=0.289  Sum_probs=186.8

Q ss_pred             CcceeeccccCcccccEEEEeEEeC--cCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcccc
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDS--VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  140 (427)
                      .++|++.+.||+|+||.||++....  .+...||||.+.... .......+.+|+.+++.++||||+++++++...    
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----   77 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS----   77 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC----
Confidence            4568899999999999999876643  245689999886543 344455678999999999999999999987643    


Q ss_pred             CCceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCC
Q psy8260         141 DFKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP  217 (427)
Q Consensus       141 ~~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~  217 (427)
                        ...+++++++ +++|.+++..  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        78 --~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~  155 (266)
T cd05033          78 --RPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRR  155 (266)
T ss_pred             --CceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhc
Confidence              3468888877 6799998854  3689999999999999999999999999999999999999999999999999875


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      ........                                                        ......+++.|+|||.
T Consensus       156 ~~~~~~~~--------------------------------------------------------~~~~~~~~~~y~~Pe~  179 (266)
T cd05033         156 LEDSEATY--------------------------------------------------------TTKGGKIPIRWTAPEA  179 (266)
T ss_pred             ccccccce--------------------------------------------------------eccCCCCCccccChhh
Confidence            43111000                                                        0001123566888888


Q ss_pred             hhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCC
Q psy8260         298 MLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKR  376 (427)
Q Consensus       298 l~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R  376 (427)
                      +.+..+...+|+|++|++++.+.+ +..++.......... ........      ......++.+.+|+.+||+.||++|
T Consensus       180 ~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~-~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~R  252 (266)
T cd05033         180 IAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIK-AVEDGYRL------PPPMDCPSALYQLMLDCWQKDRNER  252 (266)
T ss_pred             hccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHH-HHHcCCCC------CCCCCCCHHHHHHHHHHcCCCcccC
Confidence            777667778899999999887533 333333221111111 11111000      0113457889999999999999999


Q ss_pred             CCHHHHhcC
Q psy8260         377 ITAEQALAH  385 (427)
Q Consensus       377 ~ta~e~L~H  385 (427)
                      ||++|++++
T Consensus       253 p~~~ei~~~  261 (266)
T cd05033         253 PTFSQIVST  261 (266)
T ss_pred             cCHHHHHHH
Confidence            999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=7.1e-35  Score=286.67  Aligned_cols=256  Identities=20%  Similarity=0.316  Sum_probs=185.3

Q ss_pred             cccCcceeeccccCcccccEEEEeEE----eCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeeee
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSAL----DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFH  134 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~  134 (427)
                      ++..++|.+.+.||+|+||.||.+..    +..+++.||||.+.... .......+.+|+.+|.++ +||||+++++++.
T Consensus         3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (343)
T cd05103           3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACT   81 (343)
T ss_pred             ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence            55667899999999999999997653    34578899999986432 233345678999999999 6899999998764


Q ss_pred             cCccccCCceEEEEeccC-CCCHHHHHhhC--------------------------------------------------
Q psy8260         135 SNTCLADFKNVYMVTHLM-GADLNNILRTQ--------------------------------------------------  163 (427)
Q Consensus       135 ~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~--------------------------------------------------  163 (427)
                      ..     ...+++++||+ +++|.+++...                                                  
T Consensus        82 ~~-----~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (343)
T cd05103          82 KP-----GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEK  156 (343)
T ss_pred             cC-----CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCC
Confidence            32     23578888888 78998877531                                                  


Q ss_pred             ------------------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccc
Q psy8260         164 ------------------KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGY  225 (427)
Q Consensus       164 ------------------~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  225 (427)
                                        .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......  
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~--  234 (343)
T cd05103         157 SLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD--  234 (343)
T ss_pred             ccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcc--
Confidence                              256777888999999999999999999999999999999999999999999864321100  


Q ss_pred             cccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCC
Q psy8260         226 VATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYN  305 (427)
Q Consensus       226 ~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~  305 (427)
                                ..                                            ......+++.|+|||++.+..+..
T Consensus       235 ----------~~--------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~  260 (343)
T cd05103         235 ----------YV--------------------------------------------RKGDARLPLKWMAPETIFDRVYTI  260 (343)
T ss_pred             ----------hh--------------------------------------------hcCCCCCCcceECcHHhcCCCCCc
Confidence                      00                                            000112456688888887777778


Q ss_pred             CCCHHHHHHHHHHh---CCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q psy8260         306 QTDIHQLNLIMEML---GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQA  382 (427)
Q Consensus       306 ~~d~~slg~i~~~l---g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~  382 (427)
                      ++|+|++|++++.+   |..|.+  ..................      ......++++.+++.+||+.||++|||+.|+
T Consensus       261 ~~Di~slG~~l~el~~~g~~p~~--~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~cl~~~p~~Rps~~ei  332 (343)
T cd05103         261 QSDVWSFGVLLWEIFSLGASPYP--GVKIDEEFCRRLKEGTRM------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL  332 (343)
T ss_pred             hhhHHHHHHHHHHHHHCCCCCCC--CccccHHHHHHHhccCCC------CCCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            88999999998765   444432  111111111111111111      0112357789999999999999999999999


Q ss_pred             hcC
Q psy8260         383 LAH  385 (427)
Q Consensus       383 L~H  385 (427)
                      ++|
T Consensus       333 l~~  335 (343)
T cd05103         333 VEH  335 (343)
T ss_pred             HHH
Confidence            987

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=7.2e-35  Score=309.53  Aligned_cols=270  Identities=24%  Similarity=0.306  Sum_probs=192.0

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      ++|.+.+.||+|+||.||. +.+..+|+.||||++..... .....+++.+|+++++.++||||+++++++...      
T Consensus         2 grYeIi~~LGkGgfG~VYl-A~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~------   74 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYL-AYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG------   74 (932)
T ss_pred             CCeEEEEEEecCCCEEEEE-EEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC------
Confidence            5688999999999999996 56778899999999865432 233456688999999999999999999987643      


Q ss_pred             ceEEEEeccC-CCCHHHHHhh------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEE
Q psy8260         143 KNVYMVTHLM-GADLNNILRT------------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKI  209 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~~------------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl  209 (427)
                      ...|++|+++ |++|.+++..            ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus        75 ~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKL  154 (932)
T PRK13184         75 DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVI  154 (932)
T ss_pred             CEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEE
Confidence            4578889887 7899888753            12455677889999999999999999999999999999999999999


Q ss_pred             eeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccc
Q psy8260         210 LDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT  289 (427)
Q Consensus       210 ~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt  289 (427)
                      +|||+++........ ..+.....+.                  ..+                     .........+||
T Consensus       155 iDFGLAk~i~~~~~~-~~~l~~~~~~------------------s~~---------------------s~~t~~g~~vGT  194 (932)
T PRK13184        155 LDWGAAIFKKLEEED-LLDIDVDERN------------------ICY---------------------SSMTIPGKIVGT  194 (932)
T ss_pred             EecCcceeccccccc-cccccccccc------------------ccc---------------------cccccCCCCCCC
Confidence            999999754221100 0000000000                  000                     000011234699


Q ss_pred             ccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhc
Q psy8260         290 RWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLML  369 (427)
Q Consensus       290 ~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL  369 (427)
                      +.|+|||++.+..+..++|+||+|++++.|.++..||...........  ...  ...... ..+..+++.+.+++.+||
T Consensus       195 ~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~--~~i--~~P~~~-~p~~~iP~~L~~LI~rcL  269 (932)
T PRK13184        195 PDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYR--DVI--LSPIEV-APYREIPPFLSQIAMKAL  269 (932)
T ss_pred             CCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhh--hhc--cChhhc-cccccCCHHHHHHHHHHc
Confidence            999999999988888889999999999888766666543221111100  000  000000 112356788999999999


Q ss_pred             CCCCCCCCCHHHHhcC
Q psy8260         370 ELDSEKRITAEQALAH  385 (427)
Q Consensus       370 ~~dP~~R~ta~e~L~H  385 (427)
                      +.||++|++..+.+.+
T Consensus       270 ~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        270 AVDPAERYSSVQELKQ  285 (932)
T ss_pred             cCChhhCcCHHHHHHH
Confidence            9999999987666544

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.5e-34  Score=271.18  Aligned_cols=244  Identities=22%  Similarity=0.290  Sum_probs=177.9

Q ss_pred             cccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEEEe
Q psy8260          70 PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT  149 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~lv~  149 (427)
                      +.||+|+||.||.+ .+..+|+.||+|.+... ........+.+|+++++.++||||+++++++...      ...++++
T Consensus         1 ~~lg~g~~g~vy~~-~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~   72 (252)
T cd05084           1 ERIGRGNFGEVFSG-RLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK------QPIYIVM   72 (252)
T ss_pred             CccCcccCccEEEE-EEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC------CCeEEEE
Confidence            36899999999974 45668899999987643 2334456678999999999999999999987653      3578888


Q ss_pred             ccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCccccc
Q psy8260         150 HLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV  226 (427)
Q Consensus       150 e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  226 (427)
                      |++ +++|.+++..  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......... 
T Consensus        73 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~-  151 (252)
T cd05084          73 ELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS-  151 (252)
T ss_pred             eeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccc-
Confidence            877 7799988854  358999999999999999999999999999999999999999999999999986432110000 


Q ss_pred             ccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCCC
Q psy8260         227 ATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQ  306 (427)
Q Consensus       227 gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~  306 (427)
                                                                             ......++..|+|||.+.+..+...
T Consensus       152 -------------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~  176 (252)
T cd05084         152 -------------------------------------------------------TGGMKQIPVKWTAPEALNYGRYSSE  176 (252)
T ss_pred             -------------------------------------------------------cCCCCCCceeecCchhhcCCCCChH
Confidence                                                                   0000112356888888877667777


Q ss_pred             CCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy8260         307 TDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALA  384 (427)
Q Consensus       307 ~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~  384 (427)
                      +|+||+|++++.+-+ +..++.... ..............      ......+.++.+||.+||+.||++|||++|+++
T Consensus       177 ~Dv~slG~il~e~~~~~~~p~~~~~-~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         177 SDVWSFGILLWEAFSLGAVPYANLS-NQQTREAIEQGVRL------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             HHHHHHHHHHHHHHhCCCCCccccC-HHHHHHHHHcCCCC------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            899999999976532 333332211 11111121111100      112245788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.6e-34  Score=279.04  Aligned_cols=256  Identities=23%  Similarity=0.311  Sum_probs=187.8

Q ss_pred             cccCcceeeccccCcccccEEEEeEE----eCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeeee
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSAL----DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFH  134 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~  134 (427)
                      .+...+|.+.+.||+|+||.||.+..    ...++..||||.+.... .....+.+.+|+.+++++ +||||+++++++.
T Consensus        31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  109 (302)
T cd05055          31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACT  109 (302)
T ss_pred             cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence            45667899999999999999997653    23456789999886542 233445678999999999 8999999999876


Q ss_pred             cCccccCCceEEEEeccC-CCCHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEe
Q psy8260         135 SNTCLADFKNVYMVTHLM-GADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKIL  210 (427)
Q Consensus       135 ~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~---~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~  210 (427)
                      ..      ...|+++|++ +++|.++++..   .+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+
T Consensus       110 ~~------~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~  183 (302)
T cd05055         110 IG------GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKIC  183 (302)
T ss_pred             cC------CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEEC
Confidence            53      3578888887 68999888643   28999999999999999999999999999999999999999999999


Q ss_pred             eCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccc
Q psy8260         211 DFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATR  290 (427)
Q Consensus       211 DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~  290 (427)
                      |||+++.........                                                        ......+++
T Consensus       184 dfg~~~~~~~~~~~~--------------------------------------------------------~~~~~~~~~  207 (302)
T cd05055         184 DFGLARDIMNDSNYV--------------------------------------------------------VKGNARLPV  207 (302)
T ss_pred             CCcccccccCCCcee--------------------------------------------------------ecCCCCccc
Confidence            999986432211000                                                        000123466


Q ss_pred             cccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhc
Q psy8260         291 WYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLML  369 (427)
Q Consensus       291 ~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL  369 (427)
                      .|+|||++.+..+...+|+||+|++++.+.+ +..++..........+........      ......++++.+||.+||
T Consensus       208 ~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl  281 (302)
T cd05055         208 KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM------AQPEHAPAEIYDIMKTCW  281 (302)
T ss_pred             ccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC------CCCCCCCHHHHHHHHHHc
Confidence            7888888877777778899999999977532 222332211111121221111000      011245789999999999


Q ss_pred             CCCCCCCCCHHHHhc
Q psy8260         370 ELDSEKRITAEQALA  384 (427)
Q Consensus       370 ~~dP~~R~ta~e~L~  384 (427)
                      ..||++|||+.|+++
T Consensus       282 ~~~p~~Rpt~~ell~  296 (302)
T cd05055         282 DADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCCchhCcCHHHHHH
Confidence            999999999999985

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.5e-35  Score=282.46  Aligned_cols=257  Identities=21%  Similarity=0.353  Sum_probs=192.2

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      +.|.+.+.+|.|+||.||.+ .+..++..||+|.+....  ....+.+.+|+.+++.++||||+++++.+...      .
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~-~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~------~   89 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTA-IDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLVG------D   89 (293)
T ss_pred             hhceeeeEecCCCCeEEEEE-EEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeeeC------C
Confidence            56788899999999999965 566678999999885432  22345578999999999999999999987643      4


Q ss_pred             eEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCc
Q psy8260         144 NVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM  222 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~  222 (427)
                      ..|++++++ +++|.+++....+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~  169 (293)
T cd06647          90 ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (293)
T ss_pred             cEEEEEecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence            578888887 7899999988789999999999999999999999999999999999999999999999999875322110


Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhcc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM  302 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~  302 (427)
                      .                                                          ......|++.|+|||++....
T Consensus       170 ~----------------------------------------------------------~~~~~~~~~~y~~PE~~~~~~  191 (293)
T cd06647         170 S----------------------------------------------------------KRSTMVGTPYWMAPEVVTRKA  191 (293)
T ss_pred             c----------------------------------------------------------ccccccCChhhcCchhhccCC
Confidence            0                                                          001123566677777766555


Q ss_pred             CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q psy8260         303 HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQA  382 (427)
Q Consensus       303 ~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~  382 (427)
                      +...+|+|++|++++.+.++..+|..........    .........+ .....+++..+|||.+||..||.+|||++|+
T Consensus       192 ~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~----~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~i  266 (293)
T cd06647         192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY----LIATNGTPEL-QNPEKLSAIFRDFLNRCLEMDVEKRGSAKEL  266 (293)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee----ehhcCCCCCC-CCccccCHHHHHHHHHHccCChhhCcCHHHH
Confidence            6667899999999988866655553221111000    0000000000 1122356789999999999999999999999


Q ss_pred             hcCCCCCCCC
Q psy8260         383 LAHPYLSQYS  392 (427)
Q Consensus       383 L~Hp~f~~~~  392 (427)
                      ++||||....
T Consensus       267 l~h~~~~~~~  276 (293)
T cd06647         267 LQHPFLKIAK  276 (293)
T ss_pred             hcCHHHhcCc
Confidence            9999997653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.5e-34  Score=272.36  Aligned_cols=255  Identities=27%  Similarity=0.389  Sum_probs=192.7

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCce
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      .|++.+.||.|++|.||++ .+..+++.||||++...... .....+.+|+..+..++|+||+++++++...      ..
T Consensus         2 ~~~~~~~i~~g~~~~v~~~-~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~   73 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKV-RHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKE------GE   73 (264)
T ss_pred             cceeeeeeeecCCeEEEEE-EEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccC------Ce
Confidence            4678899999999999965 55568999999998654322 4456688999999999999999999987654      45


Q ss_pred             EEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         145 VYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       145 ~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~-~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      .+++++++ +++|.+++.. ..+++..+..++.|++.||.|||+ +|++||||+|+||+++.++.++|+|||++......
T Consensus        74 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~  153 (264)
T cd06623          74 ISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT  153 (264)
T ss_pred             EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence            78888887 5899998865 678999999999999999999999 99999999999999999999999999988644321


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      ...                                                          .....++..|+|||++...
T Consensus       154 ~~~----------------------------------------------------------~~~~~~~~~y~~pE~~~~~  175 (264)
T cd06623         154 LDQ----------------------------------------------------------CNTFVGTVTYMSPERIQGE  175 (264)
T ss_pred             CCc----------------------------------------------------------ccceeecccccCHhhhCCC
Confidence            100                                                          0112355667777776666


Q ss_pred             cCCCCCCHHHHHHHHHHhCCCCHHHHhhc--CcHHHHHHHhcCCCCCcccHHhhcCC-CChhHHHHHHHhcCCCCCCCCC
Q psy8260         302 MHYNQTDIHQLNLIMEMLGTPPAEFMAKI--SSDSARKYINSLPLLTKKDFRQVFKG-ANPQAIDLLSLMLELDSEKRIT  378 (427)
Q Consensus       302 ~~~~~~d~~slg~i~~~lg~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~dLi~~mL~~dP~~R~t  378 (427)
                      .+...+|+|++|++++.+.++..++....  ......+........      ..... .+..+.+||.+||..||++|||
T Consensus       176 ~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~R~~  249 (264)
T cd06623         176 SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPP------SLPAEEFSPEFRDFISACLQKDPKKRPS  249 (264)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCC------CCCcccCCHHHHHHHHHHccCChhhCCC
Confidence            56677899999999988866554443221  111111111111100      11122 5788999999999999999999


Q ss_pred             HHHHhcCCCCCCC
Q psy8260         379 AEQALAHPYLSQY  391 (427)
Q Consensus       379 a~e~L~Hp~f~~~  391 (427)
                      ++|+++||||+..
T Consensus       250 ~~~ll~~~~~~~~  262 (264)
T cd06623         250 AAELLQHPFIKKA  262 (264)
T ss_pred             HHHHHhCHHHHhc
Confidence            9999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2e-34  Score=280.31  Aligned_cols=257  Identities=21%  Similarity=0.297  Sum_probs=188.1

Q ss_pred             cCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcccc
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  140 (427)
                      .+..|...+.||+|+||.||++ .+..+|..||+|++..... .......+.+|+++++.++|||++++++++...    
T Consensus        23 ~~~~f~~~~~lg~G~~~~v~~~-~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----   97 (317)
T cd06635          23 PEKLFTDLREIGHGSFGAVYFA-RDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE----   97 (317)
T ss_pred             chhhhhhhheeccCCCeEEEEE-EEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC----
Confidence            3445777889999999999965 4566889999999864322 233445678999999999999999999987653    


Q ss_pred             CCceEEEEeccCCCCHHHHHh--hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCC
Q psy8260         141 DFKNVYMVTHLMGADLNNILR--TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT  218 (427)
Q Consensus       141 ~~~~~~lv~e~~g~~L~~~l~--~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~  218 (427)
                        ...+++++++.++|.+++.  ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus        98 --~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~  175 (317)
T cd06635          98 --HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIA  175 (317)
T ss_pred             --CeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCcccc
Confidence              3578999999888877764  356899999999999999999999999999999999999999999999999987643


Q ss_pred             CCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         219 ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       219 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                      .. .....++..|+|||++...                                                          
T Consensus       176 ~~-~~~~~~~~~y~aPE~~~~~----------------------------------------------------------  196 (317)
T cd06635         176 SP-ANSFVGTPYWMAPEVILAM----------------------------------------------------------  196 (317)
T ss_pred             CC-cccccCCccccChhhhhcC----------------------------------------------------------
Confidence            21 1222344445555543210                                                          


Q ss_pred             hhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcC-CCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC
Q psy8260         299 LNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSL-PLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI  377 (427)
Q Consensus       299 ~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~  377 (427)
                      .......++|+|++|++++.+.++..+|................ +...       ....++.+++||.+||+.||.+||
T Consensus       197 ~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rp  269 (317)
T cd06635         197 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ-------SNEWSDYFRNFVDSCLQKIPQDRP  269 (317)
T ss_pred             CCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCC-------CccccHHHHHHHHHHccCCcccCc
Confidence            11124456799999999988855555443322112222221111 1110       123567899999999999999999


Q ss_pred             CHHHHhcCCCCCCC
Q psy8260         378 TAEQALAHPYLSQY  391 (427)
Q Consensus       378 ta~e~L~Hp~f~~~  391 (427)
                      |++|+++|||+...
T Consensus       270 t~~~il~~~~~~~~  283 (317)
T cd06635         270 TSEELLKHMFVLRE  283 (317)
T ss_pred             CHHHHHhChhhhcc
Confidence            99999999999653

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.1e-34  Score=276.99  Aligned_cols=253  Identities=18%  Similarity=0.213  Sum_probs=183.4

Q ss_pred             CcceeeccccCcccccEEEEeEEeC----cCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDS----VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      ...|.+.+.||+|+||.||.+....    .+++.||||++.... .......+.+|+.++..++||||+++++++...  
T Consensus         4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--   80 (283)
T cd05091           4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE--   80 (283)
T ss_pred             HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--
Confidence            3457788999999999999876432    346789999987442 333445677899999999999999999987654  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhh-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeE
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRT-----------------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA  200 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~-----------------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NIL  200 (427)
                          ...+++++++ +++|..++..                 ..+++..+..++.|++.||.|||++||+||||||+|||
T Consensus        81 ----~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil  156 (283)
T cd05091          81 ----QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVL  156 (283)
T ss_pred             ----CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheE
Confidence                3467777776 6788887742                 24788889999999999999999999999999999999


Q ss_pred             EcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCc
Q psy8260         201 VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTE  280 (427)
Q Consensus       201 l~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~  280 (427)
                      +++++.+||+|||+++........                                                        
T Consensus       157 ~~~~~~~kl~Dfg~~~~~~~~~~~--------------------------------------------------------  180 (283)
T cd05091         157 VFDKLNVKISDLGLFREVYAADYY--------------------------------------------------------  180 (283)
T ss_pred             ecCCCceEecccccccccccchhe--------------------------------------------------------
Confidence            999999999999998753211000                                                        


Q ss_pred             cccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCCh
Q psy8260         281 NEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANP  359 (427)
Q Consensus       281 ~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  359 (427)
                      .......+++.|+|||++.+..+...+|+||+|++++.+.+ +..++......+.... .......      ......+.
T Consensus       181 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-i~~~~~~------~~~~~~~~  253 (283)
T cd05091         181 KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM-IRNRQVL------PCPDDCPA  253 (283)
T ss_pred             eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HHcCCcC------CCCCCCCH
Confidence            00011234667888888876667778899999999987644 3333322211111111 1111110      11234577


Q ss_pred             hHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         360 QAIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       360 ~~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                      +..+|+.+||+.||.+|||++|+++.
T Consensus       254 ~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         254 WVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            88999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.7e-34  Score=272.96  Aligned_cols=252  Identities=21%  Similarity=0.291  Sum_probs=185.6

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcC-CCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPF-QSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      +.|.+.+.+|.|+||.||.+ .+..+++.||||.+.... ........+.+|+++++.++||||+++++++...      
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~-~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------   74 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRA-TCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED------   74 (267)
T ss_pred             cceeeeeeeccCCCeeEEEE-EEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC------
Confidence            46788999999999999964 466689999999875432 2334445677899999999999999999987643      


Q ss_pred             ceEEEEeccC-CCCHHHHHh-----hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILR-----TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~-----~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                      ...+++++++ +++|.+++.     ...+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.
T Consensus        75 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~  154 (267)
T cd08228          75 NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR  154 (267)
T ss_pred             CeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccce
Confidence            4578888888 578887764     2347899999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         217 PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       217 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      .......                                                          ......|++.|+|||
T Consensus       155 ~~~~~~~----------------------------------------------------------~~~~~~~~~~~~aPE  176 (267)
T cd08228         155 FFSSKTT----------------------------------------------------------AAHSLVGTPYYMSPE  176 (267)
T ss_pred             eccchhH----------------------------------------------------------HHhcCCCCccccChh
Confidence            4322100                                                          001123566777888


Q ss_pred             HhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCc-HHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCC
Q psy8260         297 IMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISS-DSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEK  375 (427)
Q Consensus       297 vl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~  375 (427)
                      ++.+......+|+|++|++++.+-++..++...... .......... ..+..    .....+.++.+||.+||+.||.+
T Consensus       177 ~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~----~~~~~~~~~~~li~~cl~~~p~~  251 (267)
T cd08228         177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQC-DYPPL----PTEHYSEKLRELVSMCIYPDPDQ  251 (267)
T ss_pred             hhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcC-CCCCC----ChhhcCHHHHHHHHHHCCCCccc
Confidence            776666667789999999998886555444322111 1111111111 11110    01235678999999999999999


Q ss_pred             CCCHHHHhcC
Q psy8260         376 RITAEQALAH  385 (427)
Q Consensus       376 R~ta~e~L~H  385 (427)
                      |||+.++++.
T Consensus       252 Rp~~~~vl~~  261 (267)
T cd08228         252 RPDIGYVHQI  261 (267)
T ss_pred             CcCHHHHHHH
Confidence            9999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=6.4e-35  Score=274.67  Aligned_cols=257  Identities=29%  Similarity=0.422  Sum_probs=189.2

Q ss_pred             cCcccccEEEEeEEeCcCCcEEEEEEccCcCCC-HHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEEEec
Q psy8260          72 LSKESFDLIFSSALDSVSGVKVAIKKIARPFQS-AVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH  150 (427)
Q Consensus        72 lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~lv~e  150 (427)
                      +|.|+||.||.+ .+..+|+.||+|.+...... ......+.+|+++++.++||||+++++.+...      ...|++++
T Consensus         1 lg~g~~~~vy~~-~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~------~~~~lv~e   73 (265)
T cd05579           1 ISKGAYGRVFLA-KKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGK------KNLYLVME   73 (265)
T ss_pred             CCCCCceEEEEE-EECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecC------cEEEEEEe
Confidence            589999999965 45668999999988654221 23345677899999999999999998877543      46788888


Q ss_pred             cC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCccccccc
Q psy8260         151 LM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT  228 (427)
Q Consensus       151 ~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt  228 (427)
                      ++ +++|.+++.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++...........  
T Consensus        74 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~--  151 (265)
T cd05579          74 YLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL--  151 (265)
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc--
Confidence            88 6799988865 5689999999999999999999999999999999999999999999999998764321110000  


Q ss_pred             ccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCCCCC
Q psy8260         229 RWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD  308 (427)
Q Consensus       229 ~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d  308 (427)
                          .++                                            ........+++.|+|||++........+|
T Consensus       152 ----~~~--------------------------------------------~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D  183 (265)
T cd05579         152 ----NDD--------------------------------------------EKEDKRIVGTPDYIAPEVILGQGHSKTVD  183 (265)
T ss_pred             ----ccc--------------------------------------------cccccCcccCccccCHHHhcCCCCCcchh
Confidence                000                                            00112234677899999987777777889


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH---HHHhcC
Q psy8260         309 IHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA---EQALAH  385 (427)
Q Consensus       309 ~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta---~e~L~H  385 (427)
                      +|++|++++.+.++..+|..................     +... ...++++.+||.+||+.||++|||+   .|+|+|
T Consensus       184 v~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~-~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~  257 (265)
T cd05579         184 WWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIE-----WPED-VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH  257 (265)
T ss_pred             hHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcC-----CCcc-ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence            999999998886655554332211111111111111     1111 1247899999999999999999999   999999


Q ss_pred             CCCCCC
Q psy8260         386 PYLSQY  391 (427)
Q Consensus       386 p~f~~~  391 (427)
                      |||+..
T Consensus       258 ~~~~~~  263 (265)
T cd05579         258 PFFKGI  263 (265)
T ss_pred             ccccCC
Confidence            999864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.8e-34  Score=272.10  Aligned_cols=250  Identities=22%  Similarity=0.291  Sum_probs=185.7

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      ++....|.+.+.+|.|+||.||.+..  .++..||+|.+....   ...+.+.+|+.+++.++|+||+++++.+...   
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---   73 (261)
T cd05072           2 EIPRESIKLVKKLGAGQFGEVWMGYY--NNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKE---   73 (261)
T ss_pred             cCchHHeEEeeecCCcCCceEEEEEe--cCCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCC---
Confidence            45567899999999999999997653  356789999876432   2345678999999999999999999887543   


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                         ...+++++++ +++|.+++..   ..+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++
T Consensus        74 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~  150 (261)
T cd05072          74 ---EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLA  150 (261)
T ss_pred             ---CCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccc
Confidence               4568888887 7899988754   45788899999999999999999999999999999999999999999999998


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      +........                                                         ...+..++..|+||
T Consensus       151 ~~~~~~~~~---------------------------------------------------------~~~~~~~~~~y~aP  173 (261)
T cd05072         151 RVIEDNEYT---------------------------------------------------------AREGAKFPIKWTAP  173 (261)
T ss_pred             eecCCCcee---------------------------------------------------------ccCCCccceecCCH
Confidence            754321100                                                         00112245668888


Q ss_pred             HHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCC
Q psy8260         296 EIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       296 Evl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~  374 (427)
                      |++.+..+...+|+||+|++++.+.+ +..+|............. .....      ......+.++.+||.+||..||+
T Consensus       174 E~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~------~~~~~~~~~~~~li~~~l~~~p~  246 (261)
T cd05072         174 EAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ-RGYRM------PRMENCPDELYDIMKTCWKEKAE  246 (261)
T ss_pred             HHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHH-cCCCC------CCCCCCCHHHHHHHHHHccCCcc
Confidence            88776666677899999999987754 444443221111111111 11111      11234678899999999999999


Q ss_pred             CCCCHHHHhc
Q psy8260         375 KRITAEQALA  384 (427)
Q Consensus       375 ~R~ta~e~L~  384 (427)
                      +|||++++++
T Consensus       247 ~Rp~~~~i~~  256 (261)
T cd05072         247 ERPTFDYLQS  256 (261)
T ss_pred             cCcCHHHHHH
Confidence            9999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-34  Score=273.30  Aligned_cols=255  Identities=20%  Similarity=0.299  Sum_probs=187.8

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeC----cCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeec
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDS----VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHS  135 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~  135 (427)
                      ++...+|.+.+.||.|+||.||.+....    .++..||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (277)
T cd05032           2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVST   80 (277)
T ss_pred             ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence            4566788999999999999999765532    345789999986432 33344567799999999999999999999765


Q ss_pred             CccccCCceEEEEeccC-CCCHHHHHhhC-----------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcC
Q psy8260         136 NTCLADFKNVYMVTHLM-GADLNNILRTQ-----------KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE  203 (427)
Q Consensus       136 ~~~~~~~~~~~lv~e~~-g~~L~~~l~~~-----------~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~  203 (427)
                      .      ...++++|++ +++|.+++...           .+++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus        81 ~------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~  154 (277)
T cd05032          81 G------QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAE  154 (277)
T ss_pred             C------CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcC
Confidence            3      4578888887 68999887532           2577888999999999999999999999999999999999


Q ss_pred             CCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccc
Q psy8260         204 DCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEM  283 (427)
Q Consensus       204 ~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~  283 (427)
                      ++.+||+|||+++........                   .                                     ..
T Consensus       155 ~~~~kl~dfg~~~~~~~~~~~-------------------~-------------------------------------~~  178 (277)
T cd05032         155 DLTVKIGDFGMTRDIYETDYY-------------------R-------------------------------------KG  178 (277)
T ss_pred             CCCEEECCcccchhhccCccc-------------------c-------------------------------------cC
Confidence            999999999998643221000                   0                                     00


Q ss_pred             ccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHH
Q psy8260         284 TGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAI  362 (427)
Q Consensus       284 ~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  362 (427)
                      ....+|..|+|||++.+..+..++|+|++|++++.+.+ +..++.... .....+........      ......+.++.
T Consensus       179 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-~~~~~~~~~~~~~~------~~~~~~~~~~~  251 (277)
T cd05032         179 GKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS-NEEVLKFVIDGGHL------DLPENCPDKLL  251 (277)
T ss_pred             CCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC-HHHHHHHHhcCCCC------CCCCCCCHHHH
Confidence            11234667888888877667778899999999987754 333333221 12222222211111      11233578899


Q ss_pred             HHHHHhcCCCCCCCCCHHHHhc
Q psy8260         363 DLLSLMLELDSEKRITAEQALA  384 (427)
Q Consensus       363 dLi~~mL~~dP~~R~ta~e~L~  384 (427)
                      +||.+||+.||++|||+.|+++
T Consensus       252 ~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         252 ELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             HHHHHHcCCChhhCCCHHHHHH
Confidence            9999999999999999999985

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-34  Score=268.20  Aligned_cols=251  Identities=25%  Similarity=0.440  Sum_probs=191.1

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceE
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV  145 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~  145 (427)
                      |.+.+.||.|++|.||.+ .+..+++.||+|.+............+.+|++++++++|||++++++++...      ...
T Consensus         2 y~~~~~l~~g~~~~v~~~-~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~~   74 (254)
T cd06627           2 YQLGDLIGRGAFGVVYKG-LNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS------DSL   74 (254)
T ss_pred             ceeeeEEcccCCeEEEEE-EEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC------CEE
Confidence            667889999999999964 4567889999999876554445566788999999999999999999987653      457


Q ss_pred             EEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcc
Q psy8260         146 YMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT  223 (427)
Q Consensus       146 ~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~  223 (427)
                      +++++++ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++........
T Consensus        75 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          75 YIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            8888887 6789888754 5789999999999999999999999999999999999999999999999999865432111


Q ss_pred             cccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccC
Q psy8260         224 GYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH  303 (427)
Q Consensus       224 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~  303 (427)
                      .                                                          .....|+..|+|||.+.+...
T Consensus       155 ~----------------------------------------------------------~~~~~~~~~y~~pe~~~~~~~  176 (254)
T cd06627         155 D----------------------------------------------------------DASVVGTPYWMAPEVIEMSGA  176 (254)
T ss_pred             c----------------------------------------------------------ccccccchhhcCHhhhcCCCC
Confidence            0                                                          011235667778877766656


Q ss_pred             CCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q psy8260         304 YNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQAL  383 (427)
Q Consensus       304 ~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L  383 (427)
                      ...+|+|++|++++.+-++..++..........+...  .     ........+++++.+||.+||..||++|||+.|++
T Consensus       177 ~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~-----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l  249 (254)
T cd06627         177 STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ--D-----DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLL  249 (254)
T ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc--c-----CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHh
Confidence            6678999999998777554444432211111111110  0     01112235678999999999999999999999999


Q ss_pred             cCCCC
Q psy8260         384 AHPYL  388 (427)
Q Consensus       384 ~Hp~f  388 (427)
                      +||||
T Consensus       250 ~~~~~  254 (254)
T cd06627         250 KHPWI  254 (254)
T ss_pred             cCCCC
Confidence            99997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2e-34  Score=280.04  Aligned_cols=254  Identities=18%  Similarity=0.229  Sum_probs=183.1

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeC---cCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCc
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDS---VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNT  137 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~---~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~  137 (427)
                      +...+|.+.+.||+|+||.||++....   ..+..||||.+... ......+.+.+|+.+++.++||||+++++++... 
T Consensus         4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-   81 (316)
T cd05108           4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   81 (316)
T ss_pred             cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence            345668889999999999999876432   12335999988643 3344456678999999999999999999987542 


Q ss_pred             cccCCceEEEEecc-CCCCHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCC
Q psy8260         138 CLADFKNVYMVTHL-MGADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL  214 (427)
Q Consensus       138 ~~~~~~~~~lv~e~-~g~~L~~~l~~~--~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGl  214 (427)
                            ..++++++ .+++|.+++...  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus        82 ------~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~  155 (316)
T cd05108          82 ------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGL  155 (316)
T ss_pred             ------CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccc
Confidence                  23445554 588998888653  588889999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccc
Q psy8260         215 ARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRA  294 (427)
Q Consensus       215 a~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~A  294 (427)
                      ++.........                                                        ...+..++..|+|
T Consensus       156 a~~~~~~~~~~--------------------------------------------------------~~~~~~~~~~y~a  179 (316)
T cd05108         156 AKLLGADEKEY--------------------------------------------------------HAEGGKVPIKWMA  179 (316)
T ss_pred             cccccCCCcce--------------------------------------------------------eccCCccceeecC
Confidence            87543211000                                                        0011234567888


Q ss_pred             hHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCC
Q psy8260         295 PEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDS  373 (427)
Q Consensus       295 PEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP  373 (427)
                      ||++.+..+..++|+||+|++++.+.+ +..++... ...............+      .....+.++.++|.+||+.||
T Consensus       180 pE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p  252 (316)
T cd05108         180 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLP------QPPICTIDVYMIMVKCWMIDA  252 (316)
T ss_pred             hHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHhCCCCCC------CCCCCCHHHHHHHHHHccCCh
Confidence            888877778888999999999987532 33333221 1111112221111111      112356788999999999999


Q ss_pred             CCCCCHHHHhcC
Q psy8260         374 EKRITAEQALAH  385 (427)
Q Consensus       374 ~~R~ta~e~L~H  385 (427)
                      .+|||+.+++.+
T Consensus       253 ~~Rps~~~l~~~  264 (316)
T cd05108         253 DSRPKFRELIIE  264 (316)
T ss_pred             hhCcCHHHHHHH
Confidence            999999999987

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.7e-34  Score=277.98  Aligned_cols=250  Identities=20%  Similarity=0.315  Sum_probs=185.5

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCce
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      |.....+|+|+||.||.+ .+..+|+.||+|++..... .......+.+|+++++.++|||++++++++...      ..
T Consensus        23 ~~~~~~lg~g~~g~v~~~-~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~   95 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFA-TNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE------HT   95 (313)
T ss_pred             hhcceeeccCCCeEEEEE-EECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC------CE
Confidence            445567999999999975 5667899999999864322 233345677899999999999999999988653      45


Q ss_pred             EEEEeccCCCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCc
Q psy8260         145 VYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM  222 (427)
Q Consensus       145 ~~lv~e~~g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~  222 (427)
                      .|++++++.+++.+++..  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..... .
T Consensus        96 ~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-~  174 (313)
T cd06633          96 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-A  174 (313)
T ss_pred             EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-C
Confidence            789999998888877743  4689999999999999999999999999999999999999999999999998753211 1


Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh---
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML---  299 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~---  299 (427)
                      ....|+                                                             ..|+|||++.   
T Consensus       175 ~~~~~~-------------------------------------------------------------~~y~aPE~~~~~~  193 (313)
T cd06633         175 NSFVGT-------------------------------------------------------------PYWMAPEVILAMD  193 (313)
T ss_pred             CCcccc-------------------------------------------------------------ccccChhhccccC
Confidence            122344                                                             4455555542   


Q ss_pred             hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhc-CCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC
Q psy8260         300 NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINS-LPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT  378 (427)
Q Consensus       300 ~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t  378 (427)
                      ...+...+|+||+|++++.+.++..|+..........+.... .+..       .....+..+++||.+||++||.+|||
T Consensus       194 ~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~P~~Rp~  266 (313)
T cd06633         194 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL-------QSNEWTDSFRGFVDYCLQKIPQERPA  266 (313)
T ss_pred             CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-------CccccCHHHHHHHHHHccCChhhCcC
Confidence            122445679999999998886665555433211222211111 1111       11234677999999999999999999


Q ss_pred             HHHHhcCCCCCCC
Q psy8260         379 AEQALAHPYLSQY  391 (427)
Q Consensus       379 a~e~L~Hp~f~~~  391 (427)
                      ++++++||||...
T Consensus       267 ~~~~l~~~~~~~~  279 (313)
T cd06633         267 SAELLRHDFVRRD  279 (313)
T ss_pred             HHHHhcCcccCCC
Confidence            9999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.6e-34  Score=270.40  Aligned_cols=246  Identities=22%  Similarity=0.278  Sum_probs=182.0

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      ..|++.+.||+|+||.||.+..  .++..+|+|.+.....   ....+.+|+.+++.++||||+++++++...      .
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~--~~~~~~a~K~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~   72 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKW--RAQIKVAIKAINEGAM---SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ------K   72 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEe--ccCceEEEEecccCCc---cHHHHHHHHHHHHHCCCCCceeEEEEEccC------C
Confidence            4578889999999999997654  3456899998764322   234577899999999999999999987543      4


Q ss_pred             eEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      ..+++++++ +++|.+++..  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus        73 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05114          73 PLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD  152 (256)
T ss_pred             CEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCC
Confidence            578888888 6899988864  3589999999999999999999999999999999999999999999999998864321


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      ....                                                         ...+..++..|+|||++.+
T Consensus       153 ~~~~---------------------------------------------------------~~~~~~~~~~y~aPE~~~~  175 (256)
T cd05114         153 DEYT---------------------------------------------------------SSSGAKFPVKWSPPEVFNF  175 (256)
T ss_pred             Ccee---------------------------------------------------------ccCCCCCchhhCChhhccc
Confidence            1000                                                         0011224556888888877


Q ss_pred             ccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH
Q psy8260         301 WMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA  379 (427)
Q Consensus       301 ~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta  379 (427)
                      ..+..++|+||+|++++.+-+ +..+|......+............       .....++++.+||.+|++.||.+|||+
T Consensus       176 ~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~-------~~~~~~~~~~~li~~c~~~~p~~Rps~  248 (256)
T cd05114         176 SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLY-------RPKLASMTVYEVMYSCWHEKPEGRPTF  248 (256)
T ss_pred             CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC-------CCCCCCHHHHHHHHHHccCCcccCcCH
Confidence            667778899999999987744 333443222112222221111100       112346789999999999999999999


Q ss_pred             HHHhc
Q psy8260         380 EQALA  384 (427)
Q Consensus       380 ~e~L~  384 (427)
                      +|+++
T Consensus       249 ~~l~~  253 (256)
T cd05114         249 AELLR  253 (256)
T ss_pred             HHHHH
Confidence            99985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.3e-34  Score=276.19  Aligned_cols=258  Identities=22%  Similarity=0.304  Sum_probs=188.4

Q ss_pred             cccccCcceeeccccCcccccEEEEeEEeC----cCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeee
Q psy8260          58 YSEICRGVIDIGPTLSKESFDLIFSSALDS----VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDV  132 (427)
Q Consensus        58 ~~~~~~~~~~~~~~lg~g~fg~v~~~~~~~----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~  132 (427)
                      ..++..+.|++.+.||+|+||.||++....    .....||+|.+.... .......+.+|+.+++++ +|+||++++++
T Consensus         6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   84 (293)
T cd05053           6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGV   84 (293)
T ss_pred             ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            356777889999999999999999865432    234679999886542 334445678999999999 89999999998


Q ss_pred             eecCccccCCceEEEEeccC-CCCHHHHHhh-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccC
Q psy8260         133 FHSNTCLADFKNVYMVTHLM-GADLNNILRT-----------------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDL  194 (427)
Q Consensus       133 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~-----------------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDL  194 (427)
                      +...      ..++++++++ +++|..+++.                 ..+++..+..++.|++.||+|||++||+||||
T Consensus        85 ~~~~------~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dl  158 (293)
T cd05053          85 CTQE------GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDL  158 (293)
T ss_pred             EcCC------CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCcccccc
Confidence            7643      3468888876 7899988753                 34788899999999999999999999999999


Q ss_pred             CCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccC
Q psy8260         195 KPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFG  274 (427)
Q Consensus       195 Kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g  274 (427)
                      ||+|||++.++.+||+|||+++.........                                                 
T Consensus       159 kp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~-------------------------------------------------  189 (293)
T cd05053         159 AARNVLVTEDHVMKIADFGLARDIHHIDYYR-------------------------------------------------  189 (293)
T ss_pred             ceeeEEEcCCCeEEeCcccccccccccccee-------------------------------------------------
Confidence            9999999999999999999987543211000                                                 


Q ss_pred             CCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhh
Q psy8260         275 LARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQV  353 (427)
Q Consensus       275 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (427)
                             ......+++.|+|||++.+..+..++|+||+|++++.+-+ +..++..... ....+........      ..
T Consensus       190 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~~~~~~~~~~~------~~  255 (293)
T cd05053         190 -------KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-EELFKLLKEGYRM------EK  255 (293)
T ss_pred             -------ccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH-HHHHHHHHcCCcC------CC
Confidence                   0001123456888888877777788899999999976532 3333322211 1111111111110      11


Q ss_pred             cCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         354 FKGANPQAIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       354 ~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                      ....+.++.+||.+||..||.+|||++|++++
T Consensus       256 ~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         256 PQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             CCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            12457789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.9e-34  Score=269.44  Aligned_cols=245  Identities=18%  Similarity=0.269  Sum_probs=181.1

Q ss_pred             ccCcccccEEEEeEE-eCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEEEe
Q psy8260          71 TLSKESFDLIFSSAL-DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT  149 (427)
Q Consensus        71 ~lg~g~fg~v~~~~~-~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~lv~  149 (427)
                      .||+|+||.||.+.. ...++..||+|++..........+.+.+|+.+++.++||||+++++++..       ...++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------~~~~lv~   74 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-------ESWMLVM   74 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-------CCcEEEE
Confidence            589999999998754 34578899999987554445556678899999999999999999988643       2457788


Q ss_pred             ccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccc
Q psy8260         150 HLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVA  227 (427)
Q Consensus       150 e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~g  227 (427)
                      +++ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.......... 
T Consensus        75 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~-  153 (257)
T cd05116          75 ELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK-  153 (257)
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee-
Confidence            877 5789888854 5689999999999999999999999999999999999999999999999999875432211000 


Q ss_pred             cccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCCCC
Q psy8260         228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT  307 (427)
Q Consensus       228 t~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~  307 (427)
                                                                            ......+++.|+|||++.+..+...+
T Consensus       154 ------------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~  179 (257)
T cd05116         154 ------------------------------------------------------AKTHGKWPVKWYAPECMNYYKFSSKS  179 (257)
T ss_pred             ------------------------------------------------------ecCCCCCCccccCHhHhccCCcCchh
Confidence                                                                  00011235678888887766667788


Q ss_pred             CHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy8260         308 DIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALA  384 (427)
Q Consensus       308 d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~  384 (427)
                      |+||+|++++.+-+ +..+|......... ..+......      ......++++.|||.+||+.||++|||++++.+
T Consensus       180 Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~i~~~~~~------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         180 DVWSFGVLMWEAFSYGQKPYKGMKGNEVT-QMIESGERM------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             HHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHCCCCC------CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence            99999999987643 43344322111111 122211111      122356889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3e-34  Score=277.20  Aligned_cols=257  Identities=22%  Similarity=0.298  Sum_probs=187.4

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEe------CcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeee
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALD------SVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLD  131 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~------~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~  131 (427)
                      +++....|.+++.||+|+||.||.+...      ..++..||+|.+... ........+.+|+.+++.+ +||||+++++
T Consensus        10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   88 (304)
T cd05101          10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLG   88 (304)
T ss_pred             ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchheeE
Confidence            4667788999999999999999976531      234568999988643 2234456678999999999 8999999999


Q ss_pred             eeecCccccCCceEEEEeccC-CCCHHHHHhhC-----------------CCCHHHHHHHHHHHHHHHHHHHhcCceecc
Q psy8260         132 VFHSNTCLADFKNVYMVTHLM-GADLNNILRTQ-----------------KLSDDHVQFLVYQILRGLKYIHSAGIIHRD  193 (427)
Q Consensus       132 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~-----------------~l~~~~~~~~~~qi~~aL~yLH~~~iiHrD  193 (427)
                      ++...      ...|++++++ +++|.+++...                 .++...+..++.|++.||.|||++||+|||
T Consensus        89 ~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~d  162 (304)
T cd05101          89 ACTQD------GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRD  162 (304)
T ss_pred             EEecC------CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence            87653      4578888887 67999888542                 367788899999999999999999999999


Q ss_pred             CCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhcc
Q psy8260         194 LKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDF  273 (427)
Q Consensus       194 LKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~  273 (427)
                      |||+|||++.++.+||+|||+++.........                                                
T Consensus       163 lkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~------------------------------------------------  194 (304)
T cd05101         163 LAARNVLVTENNVMKIADFGLARDVNNIDYYK------------------------------------------------  194 (304)
T ss_pred             cccceEEEcCCCcEEECCCccceecccccccc------------------------------------------------
Confidence            99999999999999999999987542211000                                                


Q ss_pred             CCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHh
Q psy8260         274 GLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQ  352 (427)
Q Consensus       274 g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (427)
                              ......+++.|+|||++.+..+..++|+||+|++++.+-+ +..++.... .....+........      .
T Consensus       195 --------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-~~~~~~~~~~~~~~------~  259 (304)
T cd05101         195 --------KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKLLKEGHRM------D  259 (304)
T ss_pred             --------cccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-HHHHHHHHHcCCcC------C
Confidence                    0011234567888888877777778899999999877633 222232111 11111111111110      0


Q ss_pred             hcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         353 VFKGANPQAIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       353 ~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                      .....+.++++||.+||..+|.+|||+.|+++.
T Consensus       260 ~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         260 KPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            123457889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-34  Score=271.35  Aligned_cols=250  Identities=22%  Similarity=0.279  Sum_probs=185.9

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      ++.+..|.+.+.||+|++|.||++..  .+++.||+|.+.....   ..+.+.+|+.++++++||||+++++++...   
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---   73 (261)
T cd05068           2 EIDRTSIQLLRKLGAGQFGEVWEGLW--NNTTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTLE---   73 (261)
T ss_pred             ccchhheeeEEEecccCCccEEEEEe--cCCeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEecC---
Confidence            56677899999999999999997654  3457899999865322   235577899999999999999999987643   


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~~---~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                         ...+++++++ +++|.+++...   .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        74 ---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~  150 (261)
T cd05068          74 ---EPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLA  150 (261)
T ss_pred             ---CCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceE
Confidence               4578889888 88999988643   5899999999999999999999999999999999999999999999999998


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      +........                                                         ...+..++..|+||
T Consensus       151 ~~~~~~~~~---------------------------------------------------------~~~~~~~~~~y~aP  173 (261)
T cd05068         151 RVIKEDIYE---------------------------------------------------------AREGAKFPIKWTAP  173 (261)
T ss_pred             EEccCCccc---------------------------------------------------------ccCCCcCceeccCc
Confidence            654311000                                                         00111234568888


Q ss_pred             HHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCC
Q psy8260         296 EIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       296 Evl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~  374 (427)
                      |++.+..+..++|+||+|++++.+-+ +..+|.... ..............      ......+..+.++|.+||+.||.
T Consensus       174 E~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~P~  246 (261)
T cd05068         174 EAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT-NAEVLQQVDQGYRM------PCPPGCPKELYDIMLDCWKEDPD  246 (261)
T ss_pred             cccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHHcCCCC------CCCCcCCHHHHHHHHHHhhcCcc
Confidence            88777667778899999999987644 333332211 11111111111100      01134578899999999999999


Q ss_pred             CCCCHHHHhc
Q psy8260         375 KRITAEQALA  384 (427)
Q Consensus       375 ~R~ta~e~L~  384 (427)
                      +|||++++++
T Consensus       247 ~Rp~~~~l~~  256 (261)
T cd05068         247 DRPTFETLQW  256 (261)
T ss_pred             cCCCHHHHHH
Confidence            9999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3.6e-34  Score=270.74  Aligned_cols=249  Identities=23%  Similarity=0.322  Sum_probs=183.3

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      ++..+.|.+.+.||+|+||.||.+.. ..+ ..||+|++......   ...+.+|+++++.++||||+++++++..    
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~v~~~~~-~~~-~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~----   72 (262)
T cd05071           2 EIPRESLRLEVKLGQGCFGEVWMGTW-NGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE----   72 (262)
T ss_pred             CCChHHeeEeeecCCCCCCcEEEEEe-cCC-ceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECC----
Confidence            45667899999999999999997644 333 46999998753322   2457789999999999999999987643    


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                         ...+++++++ +++|.+++..   ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||++
T Consensus        73 ---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~  149 (262)
T cd05071          73 ---EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA  149 (262)
T ss_pred             ---CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCce
Confidence               2357888887 6799988864   34789999999999999999999999999999999999999999999999998


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      +........                                                         ...+..++..|+||
T Consensus       150 ~~~~~~~~~---------------------------------------------------------~~~~~~~~~~y~~P  172 (262)
T cd05071         150 RLIEDNEYT---------------------------------------------------------ARQGAKFPIKWTAP  172 (262)
T ss_pred             eeccccccc---------------------------------------------------------cccCCcccceecCH
Confidence            643221100                                                         00012245668888


Q ss_pred             HHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCC
Q psy8260         296 EIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       296 Evl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~  374 (427)
                      |++.+..+...+|+||+|++++.+.+ +..+|................+.       ......+..+.+||.+||+.||+
T Consensus       173 E~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~  245 (262)
T cd05071         173 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-------PCPPECPESLHDLMCQCWRKEPE  245 (262)
T ss_pred             hHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC-------CCccccCHHHHHHHHHHccCCcc
Confidence            88777667778899999999987754 33333222111111111111110       01124577899999999999999


Q ss_pred             CCCCHHHHhc
Q psy8260         375 KRITAEQALA  384 (427)
Q Consensus       375 ~R~ta~e~L~  384 (427)
                      +|||++++++
T Consensus       246 ~Rp~~~~~~~  255 (262)
T cd05071         246 ERPTFEYLQA  255 (262)
T ss_pred             cCCCHHHHHH
Confidence            9999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4.8e-34  Score=268.90  Aligned_cols=247  Identities=21%  Similarity=0.287  Sum_probs=182.6

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      ..|.+.+.+|+|+||.||.+..  ..+..||||.+.....   ....+.+|+.++++++||||+++++++...      .
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~--~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~   72 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKW--RGQYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ------R   72 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEe--cCCCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEccC------C
Confidence            4678889999999999997643  2345699998864322   234578899999999999999999987543      3


Q ss_pred             eEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      .+++++|++ +++|.+++..  ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++....
T Consensus        73 ~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05113          73 PIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD  152 (256)
T ss_pred             CcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCC
Confidence            468888887 6789988864  3589999999999999999999999999999999999999999999999998764321


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      ....                                                         ...+..++..|+|||++.+
T Consensus       153 ~~~~---------------------------------------------------------~~~~~~~~~~y~~pe~~~~  175 (256)
T cd05113         153 DEYT---------------------------------------------------------SSVGSKFPVRWSPPEVLLY  175 (256)
T ss_pred             Ccee---------------------------------------------------------ecCCCccChhhCCHHHHhc
Confidence            1000                                                         0012235567888888877


Q ss_pred             ccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH
Q psy8260         301 WMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA  379 (427)
Q Consensus       301 ~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta  379 (427)
                      ..+..++|+||+|++++.+-+ +..+|...................       .....++.+++++.+||+.||.+|||+
T Consensus       176 ~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~li~~cl~~~p~~Rp~~  248 (256)
T cd05113         176 SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLY-------RPHLASEKVYAIMYSCWHEKAEERPTF  248 (256)
T ss_pred             CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCC-------CCCCCCHHHHHHHHHHcCCCcccCCCH
Confidence            677778899999999987644 433332211111111121111110       112357889999999999999999999


Q ss_pred             HHHhcC
Q psy8260         380 EQALAH  385 (427)
Q Consensus       380 ~e~L~H  385 (427)
                      .+++++
T Consensus       249 ~~ll~~  254 (256)
T cd05113         249 QQLLSS  254 (256)
T ss_pred             HHHHHh
Confidence            999875

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=5.1e-34  Score=273.84  Aligned_cols=252  Identities=20%  Similarity=0.278  Sum_probs=185.1

Q ss_pred             CcceeeccccCcccccEEEEeEEe----CcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALD----SVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~----~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      .+.|.+.+.||+|+||.||.+...    ..++..||+|.+...  .....+.+.+|++++++++||||+++++++...  
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--   79 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGDG--   79 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC--
Confidence            456888899999999999976542    245677999988543  233345677999999999999999999987643  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhhC-----------------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeE
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRTQ-----------------KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA  200 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~~-----------------~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NIL  200 (427)
                          ...+++++++ +++|.+++...                 .+++..+..++.|++.||.|||++||+||||||+|||
T Consensus        80 ----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil  155 (291)
T cd05094          80 ----DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCL  155 (291)
T ss_pred             ----CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEE
Confidence                3468888887 78999988542                 3788999999999999999999999999999999999


Q ss_pred             EcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCc
Q psy8260         201 VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTE  280 (427)
Q Consensus       201 l~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~  280 (427)
                      ++.++.+||+|||+++.........                                                       
T Consensus       156 ~~~~~~~~l~dfg~a~~~~~~~~~~-------------------------------------------------------  180 (291)
T cd05094         156 VGANLLVKIGDFGMSRDVYSTDYYR-------------------------------------------------------  180 (291)
T ss_pred             EccCCcEEECCCCcccccCCCceee-------------------------------------------------------
Confidence            9999999999999986432110000                                                       


Q ss_pred             cccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCCh
Q psy8260         281 NEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANP  359 (427)
Q Consensus       281 ~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  359 (427)
                       ......+++.|+|||++.+..+..++|+||+|++++.|-+ +..+|.......... .... ....     ......+.
T Consensus       181 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~-~~~~-~~~~-----~~~~~~~~  252 (291)
T cd05094         181 -VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE-CITQ-GRVL-----ERPRVCPK  252 (291)
T ss_pred             -cCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHhC-CCCC-----CCCccCCH
Confidence             0011235677888888877777778999999999987654 444443221111111 1111 1110     11223567


Q ss_pred             hHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         360 QAIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       360 ~~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                      ++.+||.+||+.||.+|||++++++.
T Consensus       253 ~~~~li~~~l~~~P~~Rpt~~~v~~~  278 (291)
T cd05094         253 EVYDIMLGCWQREPQQRLNIKEIYKI  278 (291)
T ss_pred             HHHHHHHHHcccChhhCcCHHHHHHH
Confidence            89999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.4e-34  Score=275.71  Aligned_cols=260  Identities=21%  Similarity=0.316  Sum_probs=186.6

Q ss_pred             eeeccccCcccccEEEEeEEe--CcCCcEEEEEEccCcCC--CHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCcccc
Q psy8260          66 IDIGPTLSKESFDLIFSSALD--SVSGVKVAIKKIARPFQ--SAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~--~~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~  140 (427)
                      |.+.+.||.|+||.||.+...  ..+|..||+|++.....  .....+.+.+|+++++++ +|+||+++++.|..+    
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~----   77 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD----   77 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC----
Confidence            567889999999999975432  24789999999864322  122335567899999999 689999999887653    


Q ss_pred             CCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCC
Q psy8260         141 DFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT  218 (427)
Q Consensus       141 ~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~  218 (427)
                        ..+|++++++ +++|.+.+.. ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++..
T Consensus        78 --~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  155 (290)
T cd05613          78 --TKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  155 (290)
T ss_pred             --CeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence              4578888888 6788887754 56899999999999999999999999999999999999999999999999998653


Q ss_pred             CCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         219 ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       219 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                      ......                                                         ......|+..|+|||++
T Consensus       156 ~~~~~~---------------------------------------------------------~~~~~~~~~~y~aPE~~  178 (290)
T cd05613         156 HEDEVE---------------------------------------------------------RAYSFCGTIEYMAPDIV  178 (290)
T ss_pred             cccccc---------------------------------------------------------ccccccCCcccCChhhc
Confidence            221000                                                         00112355566666665


Q ss_pred             hhc--cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCC
Q psy8260         299 LNW--MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKR  376 (427)
Q Consensus       299 ~~~--~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R  376 (427)
                      ...  .+....|+|++|++++.+.++..++.................... .   ......++.+.+||.+||+.||++|
T Consensus       179 ~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~---~~~~~~~~~~~~ll~~~l~~~p~~R  254 (290)
T cd05613         179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-P---PYPQEMSALAKDIIQRLLMKDPKKR  254 (290)
T ss_pred             cCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC-C---CCCccCCHHHHHHHHHHhcCCHHHh
Confidence            432  244567999999999888666555432111111111111110000 0   1123467889999999999999999


Q ss_pred             C-----CHHHHhcCCCCCCCC
Q psy8260         377 I-----TAEQALAHPYLSQYS  392 (427)
Q Consensus       377 ~-----ta~e~L~Hp~f~~~~  392 (427)
                      +     +++++++||||....
T Consensus       255 ~~~~~~~~~~l~~~~~~~~~~  275 (290)
T cd05613         255 LGCGPSDADEIKKHPFFQKIN  275 (290)
T ss_pred             cCCCCCCHHHHHcCcccccCC
Confidence            7     899999999998764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=3.4e-34  Score=268.73  Aligned_cols=249  Identities=22%  Similarity=0.319  Sum_probs=188.9

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceE
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV  145 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~  145 (427)
                      |++.+.+|.|+||.||.+ .+..+++.+|+|.+............+.+|+++++.++|+||+++++++...      ...
T Consensus         2 y~~~~~i~~g~~~~v~~~-~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~~   74 (256)
T cd08530           2 FKVLKKLGKGSYGSVYKV-KRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG------NKL   74 (256)
T ss_pred             ceEeeeecCCCceeEEEE-EECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC------CEE
Confidence            667788999999999965 4667899999999876544445556677999999999999999999887643      457


Q ss_pred             EEEeccC-CCCHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         146 YMVTHLM-GADLNNILRT-----QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       146 ~lv~e~~-g~~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                      |++++++ +++|.+++..     ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....
T Consensus        75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~  154 (256)
T cd08530          75 CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLK  154 (256)
T ss_pred             EEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhc
Confidence            8888887 7799888754     468999999999999999999999999999999999999999999999999886432


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      ....                                                            ....|++.|+|||.+.
T Consensus       155 ~~~~------------------------------------------------------------~~~~~~~~~~~Pe~~~  174 (256)
T cd08530         155 KNMA------------------------------------------------------------KTQIGTPHYMAPEVWK  174 (256)
T ss_pred             cCCc------------------------------------------------------------ccccCCccccCHHHHC
Confidence            2100                                                            0123556677777776


Q ss_pred             hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH
Q psy8260         300 NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA  379 (427)
Q Consensus       300 ~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta  379 (427)
                      +..+...+|+|++|++++.+.++..+|..... ........ .....     ......+.+++++|.+||+.||.+|||+
T Consensus       175 ~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-~~~~~~~~-~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~  247 (256)
T cd08530         175 GRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-QDLRYKVQ-RGKYP-----PIPPIYSQDLQNFIRSMLQVKPKLRPNC  247 (256)
T ss_pred             CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHh-cCCCC-----CCchhhCHHHHHHHHHHcCCCcccCCCH
Confidence            66666678999999999877555544432211 11111111 11111     1112457889999999999999999999


Q ss_pred             HHHhcCCCC
Q psy8260         380 EQALAHPYL  388 (427)
Q Consensus       380 ~e~L~Hp~f  388 (427)
                      .|+++||++
T Consensus       248 ~~~l~~p~~  256 (256)
T cd08530         248 DKILASPAV  256 (256)
T ss_pred             HHHhcCCCC
Confidence            999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.8e-34  Score=275.61  Aligned_cols=248  Identities=18%  Similarity=0.252  Sum_probs=180.2

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCC--cEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCcccc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSG--VKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g--~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~  140 (427)
                      +.|.+.+.||+|+||.||.+.. ..++  ..+|+|.+... ......+.+.+|+++++++ +||||+++++++...    
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~----   75 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMI-KKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENR----   75 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEe-cCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC----
Confidence            3578889999999999997654 3344  35788887632 2334456678999999999 799999999987643    


Q ss_pred             CCceEEEEeccC-CCCHHHHHhhC-----------------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEc
Q psy8260         141 DFKNVYMVTHLM-GADLNNILRTQ-----------------KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN  202 (427)
Q Consensus       141 ~~~~~~lv~e~~-g~~L~~~l~~~-----------------~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~  202 (427)
                        ...|++++++ +++|.+++...                 .+++..+..++.|++.||+|||++||+||||||+|||++
T Consensus        76 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~  153 (297)
T cd05089          76 --GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG  153 (297)
T ss_pred             --CcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEEC
Confidence              3467888877 68999888542                 378889999999999999999999999999999999999


Q ss_pred             CCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccc
Q psy8260         203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENE  282 (427)
Q Consensus       203 ~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~  282 (427)
                      .++.+||+|||++..........                                                         
T Consensus       154 ~~~~~kl~dfg~~~~~~~~~~~~---------------------------------------------------------  176 (297)
T cd05089         154 ENLASKIADFGLSRGEEVYVKKT---------------------------------------------------------  176 (297)
T ss_pred             CCCeEEECCcCCCccccceeccC---------------------------------------------------------
Confidence            99999999999875321100000                                                         


Q ss_pred             cccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhH
Q psy8260         283 MTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQA  361 (427)
Q Consensus       283 ~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  361 (427)
                        ....+..|+|||++.+..+..++|+||+|++++.|-+ +..+|..........+......       .......++++
T Consensus       177 --~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~  247 (297)
T cd05089         177 --MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR-------MEKPRNCDDEV  247 (297)
T ss_pred             --CCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC-------CCCCCCCCHHH
Confidence              0012345788887776667778899999999987743 4444432221111111111100       01123467899


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         362 IDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       362 ~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                      .+||.+||+.||.+|||++|+++.
T Consensus       248 ~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         248 YELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=5.5e-34  Score=271.56  Aligned_cols=255  Identities=19%  Similarity=0.287  Sum_probs=185.2

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCc----CCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecC
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSV----SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSN  136 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~----~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~  136 (427)
                      +....|.+.+.||+|+||.||.+.....    +++.||+|.+... ........+.+|+.+++.++|+||+++++++...
T Consensus         3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (277)
T cd05036           3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES-CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER   81 (277)
T ss_pred             CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            3446688899999999999997655321    6788999987543 2233345678999999999999999999987543


Q ss_pred             ccccCCceEEEEeccC-CCCHHHHHhhC--------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCC--
Q psy8260         137 TCLADFKNVYMVTHLM-GADLNNILRTQ--------KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC--  205 (427)
Q Consensus       137 ~~~~~~~~~~lv~e~~-g~~L~~~l~~~--------~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~--  205 (427)
                            ...+++++++ +++|.+++...        .+++..+..++.||+.||.|||+++++||||||+|||++.++  
T Consensus        82 ------~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~  155 (277)
T cd05036          82 ------LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPG  155 (277)
T ss_pred             ------CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCC
Confidence                  3457888877 78999988643        478899999999999999999999999999999999998654  


Q ss_pred             -CEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccc
Q psy8260         206 -ELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMT  284 (427)
Q Consensus       206 -~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~  284 (427)
                       .+||+|||+++.........                                                        ...
T Consensus       156 ~~~kl~dfg~~~~~~~~~~~~--------------------------------------------------------~~~  179 (277)
T cd05036         156 RVAKIADFGMARDIYRASYYR--------------------------------------------------------KGG  179 (277)
T ss_pred             cceEeccCccccccCCcccee--------------------------------------------------------cCC
Confidence             59999999987542110000                                                        000


Q ss_pred             cccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHH
Q psy8260         285 GYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAID  363 (427)
Q Consensus       285 ~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d  363 (427)
                      ....++.|+|||++.+..+..++|+||+|++++.+.+ +..+|..... ....+........      ......++++.+
T Consensus       180 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~-~~~~~~~~~~~~~------~~~~~~~~~~~~  252 (277)
T cd05036         180 RAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-QEVMEFVTGGGRL------DPPKGCPGPVYR  252 (277)
T ss_pred             CCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHcCCcC------CCCCCCCHHHHH
Confidence            1122456888998877778888999999999987543 3333332211 1111222111111      112345788999


Q ss_pred             HHHHhcCCCCCCCCCHHHHhcC
Q psy8260         364 LLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       364 Li~~mL~~dP~~R~ta~e~L~H  385 (427)
                      +|.+||+.||++|||+.++++|
T Consensus       253 ~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         253 IMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             HHHHHcCCCcccCcCHHHHHHH
Confidence            9999999999999999999987

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=4.7e-34  Score=276.56  Aligned_cols=257  Identities=22%  Similarity=0.299  Sum_probs=188.3

Q ss_pred             cCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcC-CCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcccc
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPF-QSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  140 (427)
                      ....|...+.+|.|+||.||.+. +..++..||+|.+.... .......++.+|+++++.++|+|++++++++...    
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~-~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----   87 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFAR-DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE----   87 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEE-EcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC----
Confidence            34456777889999999999754 56688999999886432 2333445677899999999999999999987653    


Q ss_pred             CCceEEEEeccCCCCHHHHHh--hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCC
Q psy8260         141 DFKNVYMVTHLMGADLNNILR--TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT  218 (427)
Q Consensus       141 ~~~~~~lv~e~~g~~L~~~l~--~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~  218 (427)
                        ...+++++++.+++.+++.  ...+++..+..++.|++.||.|||+++++||||||+|||++.++.+||+|||++...
T Consensus        88 --~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  165 (308)
T cd06634          88 --HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM  165 (308)
T ss_pred             --CeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceee
Confidence              4578999998888877664  345899999999999999999999999999999999999999999999999987643


Q ss_pred             CCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         219 ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       219 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                      ... ....++                                                             +.|+|||++
T Consensus       166 ~~~-~~~~~~-------------------------------------------------------------~~y~aPE~~  183 (308)
T cd06634         166 APA-NXFVGT-------------------------------------------------------------PYWMAPEVI  183 (308)
T ss_pred             cCc-ccccCC-------------------------------------------------------------ccccCHHHH
Confidence            221 122334                                                             445555554


Q ss_pred             hh---ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhc-CCCCCcccHHhhcCCCChhHHHHHHHhcCCCCC
Q psy8260         299 LN---WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINS-LPLLTKKDFRQVFKGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       299 ~~---~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~  374 (427)
                      .+   .....++|+||+|++++.+-++..++............... .+...       ....+..+.+||.+||+.||.
T Consensus       184 ~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~cl~~~P~  256 (308)
T cd06634         184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ-------SGHWSEYFRNFVDSCLQKIPQ  256 (308)
T ss_pred             hhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcC-------cccccHHHHHHHHHHhhCCcc
Confidence            31   22445679999999998885555444322111111111111 11110       124577899999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCC
Q psy8260         375 KRITAEQALAHPYLSQYSDP  394 (427)
Q Consensus       375 ~R~ta~e~L~Hp~f~~~~~~  394 (427)
                      +|||++++++|||+.....+
T Consensus       257 ~Rp~~~~ll~~~~~~~~~~~  276 (308)
T cd06634         257 DRPTSEVLLKHRFVLRERPP  276 (308)
T ss_pred             cCCCHHHHhhCccccccCCh
Confidence            99999999999999875443

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.7e-34  Score=273.50  Aligned_cols=256  Identities=20%  Similarity=0.232  Sum_probs=183.9

Q ss_pred             eeccccCcccccEEEEeEE---eCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          67 DIGPTLSKESFDLIFSSAL---DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        67 ~~~~~lg~g~fg~v~~~~~---~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      .+.+.||+|+||.||....   ...++..||+|.+.... .......+.+|+++++.++||||+++++++...    ...
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----~~~   81 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ----GGK   81 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC----CCc
Confidence            6778999999999986543   34578899999886542 233455677999999999999999999886532    123


Q ss_pred             eEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCc
Q psy8260         144 NVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM  222 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~  222 (427)
                      .++++++++ +++|.+++....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  161 (283)
T cd05080          82 GLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH  161 (283)
T ss_pred             eEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence            578888877 6899999888889999999999999999999999999999999999999999999999999987543211


Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhcc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM  302 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~  302 (427)
                      ...      .                                                 ......++..|+|||++.+..
T Consensus       162 ~~~------~-------------------------------------------------~~~~~~~~~~~~~PE~~~~~~  186 (283)
T cd05080         162 EYY------R-------------------------------------------------VREDGDSPVFWYAVECLKENK  186 (283)
T ss_pred             hhh------c-------------------------------------------------cCCCCCCCceeeCHhHhcccC
Confidence            000      0                                                 000112455688888887777


Q ss_pred             CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhc-CCCCCcccH---------HhhcCCCChhHHHHHHHhcCCC
Q psy8260         303 HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINS-LPLLTKKDF---------RQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       303 ~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---------~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                      +..++|+||+|++++.|.++..|+.....  ........ ........+         .......+.++.+|+.+||+.|
T Consensus       187 ~~~~~Di~slG~~l~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  264 (283)
T cd05080         187 FSYASDVWSFGVTLYELLTHCDSKQSPPK--KFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETE  264 (283)
T ss_pred             CCcccccHHHHHHHHHHHhCCCCCCCCcc--hhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccC
Confidence            77788999999999888554333211100  00000000 000000000         0012335678999999999999


Q ss_pred             CCCCCCHHHHhc
Q psy8260         373 SEKRITAEQALA  384 (427)
Q Consensus       373 P~~R~ta~e~L~  384 (427)
                      |++|||++++++
T Consensus       265 p~~Rps~~~i~~  276 (283)
T cd05080         265 AKFRPTFRSLIP  276 (283)
T ss_pred             hhhCCCHHHHHH
Confidence            999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.9e-34  Score=276.86  Aligned_cols=257  Identities=22%  Similarity=0.294  Sum_probs=187.3

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEeC------cCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeee
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALDS------VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLD  131 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~~------~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~  131 (427)
                      +++..+.|.+++.||+|+||.||.+....      .++..||+|.+... ........+.+|+.+++.+ +||||+++++
T Consensus        13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~   91 (307)
T cd05098          13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLG   91 (307)
T ss_pred             ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC-CChHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence            35666789999999999999999764321      23467999988653 2334456678899999999 7999999999


Q ss_pred             eeecCccccCCceEEEEeccC-CCCHHHHHhhC-----------------CCCHHHHHHHHHHHHHHHHHHHhcCceecc
Q psy8260         132 VFHSNTCLADFKNVYMVTHLM-GADLNNILRTQ-----------------KLSDDHVQFLVYQILRGLKYIHSAGIIHRD  193 (427)
Q Consensus       132 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~-----------------~l~~~~~~~~~~qi~~aL~yLH~~~iiHrD  193 (427)
                      ++...      ...|++++++ +++|.+++...                 .+++..+..++.|++.||+|||++|++|||
T Consensus        92 ~~~~~------~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~d  165 (307)
T cd05098          92 ACTQD------GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRD  165 (307)
T ss_pred             EEecC------CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCccccc
Confidence            87653      3578888888 67999888642                 378888999999999999999999999999


Q ss_pred             CCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhcc
Q psy8260         194 LKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDF  273 (427)
Q Consensus       194 LKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~  273 (427)
                      |||+|||++.++.+||+|||+++.........                                                
T Consensus       166 lkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~------------------------------------------------  197 (307)
T cd05098         166 LAARNVLVTEDNVMKIADFGLARDIHHIDYYK------------------------------------------------  197 (307)
T ss_pred             ccHHheEEcCCCcEEECCCcccccccccchhh------------------------------------------------
Confidence            99999999999999999999886432110000                                                


Q ss_pred             CCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHh
Q psy8260         274 GLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQ  352 (427)
Q Consensus       274 g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (427)
                              ......+++.|+|||++.+..+...+|+||+|++++.|.+ +..++... ...............      .
T Consensus       198 --------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~------~  262 (307)
T cd05098         198 --------KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKEGHRM------D  262 (307)
T ss_pred             --------ccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC-CHHHHHHHHHcCCCC------C
Confidence                    0001123467888888877777778899999999987743 32233221 111222222111110      1


Q ss_pred             hcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         353 VFKGANPQAIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       353 ~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                      .....+.++.+||.+||..||.+|||+.|++++
T Consensus       263 ~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         263 KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            123457899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.9e-34  Score=267.84  Aligned_cols=257  Identities=26%  Similarity=0.372  Sum_probs=193.1

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceE
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV  145 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~  145 (427)
                      |.+.+.+|+|++|.||.+ .+..+++.|++|++............+.+|+.++++++||||+++++.+....    ....
T Consensus         2 ~~~~~~i~~g~~~~v~~~-~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~   76 (260)
T cd06606           2 WTRGELLGRGSFGSVYLA-LDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE----KNTL   76 (260)
T ss_pred             ceeeeEeeecCceEEEEE-EECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC----CCeE
Confidence            566788999999999965 45568999999998765444455667789999999999999999998876531    1457


Q ss_pred             EEEeccC-CCCHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcc
Q psy8260         146 YMVTHLM-GADLNNILRTQ-KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT  223 (427)
Q Consensus       146 ~lv~e~~-g~~L~~~l~~~-~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~  223 (427)
                      +++++++ +++|.+++... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||.+........
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          77 NIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence            8888888 78999988654 789999999999999999999999999999999999999999999999998764432210


Q ss_pred             cccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccC
Q psy8260         224 GYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH  303 (427)
Q Consensus       224 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~  303 (427)
                      .                                                        .......++..|+|||.+.....
T Consensus       157 ~--------------------------------------------------------~~~~~~~~~~~y~~pE~~~~~~~  180 (260)
T cd06606         157 G--------------------------------------------------------EGTGSVRGTPYWMAPEVIRGEEY  180 (260)
T ss_pred             c--------------------------------------------------------ccccCCCCCccccCHhhhcCCCC
Confidence            0                                                        00112245667778887766666


Q ss_pred             CCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q psy8260         304 YNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQAL  383 (427)
Q Consensus       304 ~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L  383 (427)
                      ..++|+|++|++++.+.++..+|.....  ..........   ...........++++.+||.+||+.||.+|||+.|++
T Consensus       181 ~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~---~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll  255 (260)
T cd06606         181 GRAADIWSLGCTVIEMATGKPPWSELGN--PMAALYKIGS---SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELL  255 (260)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHhccc---cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHh
Confidence            7778999999999877555444432211  1111111000   0111122334578999999999999999999999999


Q ss_pred             cCCCC
Q psy8260         384 AHPYL  388 (427)
Q Consensus       384 ~Hp~f  388 (427)
                      +||||
T Consensus       256 ~~~~~  260 (260)
T cd06606         256 QHPFL  260 (260)
T ss_pred             hCCCC
Confidence            99997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=4.6e-34  Score=274.80  Aligned_cols=257  Identities=19%  Similarity=0.234  Sum_probs=181.2

Q ss_pred             cCcceeeccccCcccccEEEEeEE---------------eCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCc
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSAL---------------DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENV  126 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~---------------~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnI  126 (427)
                      ..++|.+.+.||+|+||.||.+..               ...++..||+|.+... ........+.+|+++++.++|+||
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i   81 (296)
T cd05095           3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNI   81 (296)
T ss_pred             ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCc
Confidence            456789999999999999996531               1223457999988643 233445667899999999999999


Q ss_pred             eeeeeeeecCccccCCceEEEEeccC-CCCHHHHHhhC------------CCCHHHHHHHHHHHHHHHHHHHhcCceecc
Q psy8260         127 IGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQ------------KLSDDHVQFLVYQILRGLKYIHSAGIIHRD  193 (427)
Q Consensus       127 v~l~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~------------~l~~~~~~~~~~qi~~aL~yLH~~~iiHrD  193 (427)
                      +++++++...      ...+++++++ +++|.+++...            .+++..+..++.|++.||+|||++|++|||
T Consensus        82 ~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~d  155 (296)
T cd05095          82 IRLLAVCITS------DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRD  155 (296)
T ss_pred             ceEEEEEecC------CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeeccc
Confidence            9999988654      3468888877 68999887542            256778999999999999999999999999


Q ss_pred             CCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhcc
Q psy8260         194 LKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDF  273 (427)
Q Consensus       194 LKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~  273 (427)
                      |||+|||++.++.+||+|||+++.........                                                
T Consensus       156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~------------------------------------------------  187 (296)
T cd05095         156 LATRNCLVGKNYTIKIADFGMSRNLYSGDYYR------------------------------------------------  187 (296)
T ss_pred             CChheEEEcCCCCEEeccCcccccccCCccee------------------------------------------------
Confidence            99999999999999999999986432210000                                                


Q ss_pred             CCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC--CCHHHHhhcCcHHHHH---HHhcCCCCCcc
Q psy8260         274 GLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT--PPAEFMAKISSDSARK---YINSLPLLTKK  348 (427)
Q Consensus       274 g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~--~~~~~~~~~~~~~~~~---~~~~~~~~~~~  348 (427)
                              ......+++.|+|||+..+..+..++|+||+|++++.+-+  +..++......+....   +......  . 
T Consensus       188 --------~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~--~-  256 (296)
T cd05095         188 --------IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGR--Q-  256 (296)
T ss_pred             --------ccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccc--c-
Confidence                    0001123566888888776667778899999999987632  3333322111111111   1100000  0 


Q ss_pred             cHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy8260         349 DFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALA  384 (427)
Q Consensus       349 ~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~  384 (427)
                      .........++.+.+||.+||+.||.+|||+.|+++
T Consensus       257 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         257 VYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             ccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            000111234678899999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3.1e-34  Score=271.23  Aligned_cols=251  Identities=22%  Similarity=0.308  Sum_probs=183.9

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      +.|.+.+.||.|+||.||.+ .+..+|..||||.+..... .......+.+|+.+++.++||||+++++++...      
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~-~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~------   74 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRA-TCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED------   74 (267)
T ss_pred             chhhhhhhhcccCCeEEEEE-eecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC------
Confidence            35778899999999999965 4566899999998764322 233445677999999999999999999887643      


Q ss_pred             ceEEEEeccC-CCCHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILRT-----QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                      ...+++++++ +++|.++++.     ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.
T Consensus        75 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~  154 (267)
T cd08229          75 NELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR  154 (267)
T ss_pred             CeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhh
Confidence            4577888877 6789887752     458999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         217 PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       217 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      .......                                                          ...+..|++.|+|||
T Consensus       155 ~~~~~~~----------------------------------------------------------~~~~~~~~~~~~ape  176 (267)
T cd08229         155 FFSSKTT----------------------------------------------------------AAHSLVGTPYYMSPE  176 (267)
T ss_pred             ccccCCc----------------------------------------------------------ccccccCCcCccCHH
Confidence            4322110                                                          001223566777777


Q ss_pred             HhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCc-HHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCC
Q psy8260         297 IMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISS-DSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEK  375 (427)
Q Consensus       297 vl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~  375 (427)
                      ++.+..+...+|+||+|++++.+.++..||...... ....+..... .....    .....++++.+||.+||+.||.+
T Consensus       177 ~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~----~~~~~~~~~~~li~~~l~~~p~~  251 (267)
T cd08229         177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-DYPPL----PSDHYSEELRQLVNMCINPDPEK  251 (267)
T ss_pred             HhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC-CCCCC----CcccccHHHHHHHHHhcCCCccc
Confidence            776666666789999999998886655555322111 0111111100 00000    11235778999999999999999


Q ss_pred             CCCHHHHhc
Q psy8260         376 RITAEQALA  384 (427)
Q Consensus       376 R~ta~e~L~  384 (427)
                      |||+.++++
T Consensus       252 Rpt~~~i~~  260 (267)
T cd08229         252 RPDITYVYD  260 (267)
T ss_pred             CCCHHHHHH
Confidence            999997764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.8e-34  Score=269.17  Aligned_cols=249  Identities=23%  Similarity=0.294  Sum_probs=183.0

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      ++...+|.+.+.+|+|+||.||.+..  ..+..||+|.+......   ...+.+|+.++++++|+||+++++++..    
T Consensus         2 ~~~~~~~~~~~~ig~g~~~~v~~~~~--~~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~----   72 (260)
T cd05070           2 EIPRESLQLIKKLGNGQFGEVWMGTW--NGNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSE----   72 (260)
T ss_pred             CCchHHhhhhheeccccCceEEEEEe--cCCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECC----
Confidence            45566788999999999999997643  35677999988654332   2457799999999999999999987642    


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                         ...|++++++ +++|.+++..   ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        73 ---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~  149 (260)
T cd05070          73 ---EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLA  149 (260)
T ss_pred             ---CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceee
Confidence               2357888877 6799988864   34899999999999999999999999999999999999999999999999998


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      .........                                                         ...+..++..|+||
T Consensus       150 ~~~~~~~~~---------------------------------------------------------~~~~~~~~~~y~aP  172 (260)
T cd05070         150 RLIEDNEYT---------------------------------------------------------ARQGAKFPIKWTAP  172 (260)
T ss_pred             eeccCcccc---------------------------------------------------------cccCCCCCccccCh
Confidence            643211000                                                         00111244568888


Q ss_pred             HHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCC
Q psy8260         296 EIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       296 Evl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~  374 (427)
                      |++.+..+...+|+||+|++++.+.+ +..+|......+...... .....      ......+.++.+||.+||+.||.
T Consensus       173 E~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~------~~~~~~~~~~~~li~~~l~~~p~  245 (260)
T cd05070         173 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYRM------PCPQDCPISLHELMLQCWKKDPE  245 (260)
T ss_pred             HHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCC------CCCCcCCHHHHHHHHHHcccCcc
Confidence            88776667778899999999987744 333343221111122111 11111      11234678899999999999999


Q ss_pred             CCCCHHHHhc
Q psy8260         375 KRITAEQALA  384 (427)
Q Consensus       375 ~R~ta~e~L~  384 (427)
                      +|||++++.+
T Consensus       246 ~Rpt~~~l~~  255 (260)
T cd05070         246 ERPTFEYLQS  255 (260)
T ss_pred             cCcCHHHHHH
Confidence            9999999863

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=4.1e-34  Score=275.17  Aligned_cols=260  Identities=21%  Similarity=0.327  Sum_probs=187.2

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCcc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTC  138 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~  138 (427)
                      .+..+.|++.+.+|.|+||.||.+ .+..+++.||||.+..... ........+|+.++.+. +||||+++++++...  
T Consensus        11 ~~~~~~~~~~~~lg~g~~~~v~~~-~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--   86 (296)
T cd06618          11 PADLNDLENLGEIGSGTCGQVYKM-RFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFITD--   86 (296)
T ss_pred             cCCcchheeeeEeeccCCeEEEEE-EECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeeecC--
Confidence            344567888999999999999965 4556799999999865432 22344566777766666 599999999987653  


Q ss_pred             ccCCceEEEEeccCCCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         139 LADFKNVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       139 ~~~~~~~~lv~e~~g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~-~~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                          ...|++++++++++.++...  ..+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++
T Consensus        87 ----~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~  162 (296)
T cd06618          87 ----SDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGIS  162 (296)
T ss_pred             ----CeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccc
Confidence                46899999998888877654  468999999999999999999997 59999999999999999999999999998


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      .........                                                           ....+++.|+||
T Consensus       163 ~~~~~~~~~-----------------------------------------------------------~~~~~~~~y~aP  183 (296)
T cd06618         163 GRLVDSKAK-----------------------------------------------------------TRSAGCAAYMAP  183 (296)
T ss_pred             hhccCCCcc-----------------------------------------------------------cCCCCCccccCH
Confidence            643221100                                                           011234455555


Q ss_pred             HHhhhcc----CCCCCCHHHHHHHHHHhCCCCHHHHhhcCc-HHHHHHHhcC-CCCCcccHHhhcCCCChhHHHHHHHhc
Q psy8260         296 EIMLNWM----HYNQTDIHQLNLIMEMLGTPPAEFMAKISS-DSARKYINSL-PLLTKKDFRQVFKGANPQAIDLLSLML  369 (427)
Q Consensus       296 Evl~~~~----~~~~~d~~slg~i~~~lg~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dLi~~mL  369 (427)
                      |++.+..    +..++|+||+|++++.+-++..+|...... +......... +...      .....++++.+||.+||
T Consensus       184 E~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l  257 (296)
T cd06618         184 ERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLP------PNEGFSPDFCSFVDLCL  257 (296)
T ss_pred             hhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCC------CCCCCCHHHHHHHHHHc
Confidence            5554332    455789999999998886655555321111 1111111111 1111      01135778999999999


Q ss_pred             CCCCCCCCCHHHHhcCCCCCCCC
Q psy8260         370 ELDSEKRITAEQALAHPYLSQYS  392 (427)
Q Consensus       370 ~~dP~~R~ta~e~L~Hp~f~~~~  392 (427)
                      ..||.+|||++++++||||....
T Consensus       258 ~~~p~~Rp~~~~il~~~~~~~~~  280 (296)
T cd06618         258 TKDHRKRPKYRELLQHPFIRRYE  280 (296)
T ss_pred             cCChhhCCCHHHHhcChhhhccc
Confidence            99999999999999999998653

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=9.6e-34  Score=264.11  Aligned_cols=248  Identities=27%  Similarity=0.452  Sum_probs=184.9

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceE
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV  145 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~  145 (427)
                      |.+.+.+|.|++|.||.+ .+..++..||+|++.....  .....+.+|+.+++.++|+||+++++++...      ...
T Consensus         2 y~~~~~l~~g~~~~v~~~-~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~~   72 (253)
T cd05122           2 FEILEKIGKGGFGEVYKA-RHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKK------DEL   72 (253)
T ss_pred             ceeeeeeccCCceEEEEE-EECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC------CeE
Confidence            567788999999999965 4556889999999865432  3456678999999999999999999988654      356


Q ss_pred             EEEeccC-CCCHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCc
Q psy8260         146 YMVTHLM-GADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM  222 (427)
Q Consensus       146 ~lv~e~~-g~~L~~~l~~~--~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~  222 (427)
                      +++++++ +++|.+++...  .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+.......
T Consensus        73 ~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  152 (253)
T cd05122          73 WIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK  152 (253)
T ss_pred             EEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence            7888887 58999988664  78999999999999999999999999999999999999999999999999886543221


Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhcc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM  302 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~  302 (427)
                      .                                                           .....|+..|+|||++.+..
T Consensus       153 ~-----------------------------------------------------------~~~~~~~~~~~~PE~~~~~~  173 (253)
T cd05122         153 A-----------------------------------------------------------RNTMVGTPYWMAPEVINGKP  173 (253)
T ss_pred             c-----------------------------------------------------------ccceecCCcccCHHHHcCCC
Confidence            0                                                           00123455566666665555


Q ss_pred             CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhc-CCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHH
Q psy8260         303 HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINS-LPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQ  381 (427)
Q Consensus       303 ~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e  381 (427)
                      ...++|+|++|++++.+.++..++............... .+....      ....+.++.++|.+||+.||++|||+.|
T Consensus       174 ~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~i~~~l~~~p~~R~t~~~  247 (253)
T cd05122         174 YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRN------PEKWSDEFKDFLKKCLQKNPEKRPTAEQ  247 (253)
T ss_pred             CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCc------ccccCHHHHHHHHHHccCChhhCCCHHH
Confidence            556789999999998776555444322111111111110 011100      0113678999999999999999999999


Q ss_pred             HhcCCC
Q psy8260         382 ALAHPY  387 (427)
Q Consensus       382 ~L~Hp~  387 (427)
                      +|+|||
T Consensus       248 ~l~~~~  253 (253)
T cd05122         248 LLKHPF  253 (253)
T ss_pred             HhcCCC
Confidence            999999

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1e-33  Score=268.56  Aligned_cols=257  Identities=19%  Similarity=0.221  Sum_probs=182.7

Q ss_pred             eeeccccCcccccEEEEeEEe--CcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          66 IDIGPTLSKESFDLIFSSALD--SVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~--~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      |.+.+.||+|+||.||.+...  ..+++.||||.+..........+++.+|+++++.++||||+++++++..........
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            456789999999999987653  346789999998765555556677889999999999999999999875432111112


Q ss_pred             eEEEEeccC-CCCHHHHHhh-------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRT-------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~-------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                      ..+++++++ +++|..++..       ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~  160 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS  160 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence            235666665 7888876532       14788899999999999999999999999999999999999999999999998


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      +.........                                                        ......+++.|++|
T Consensus       161 ~~~~~~~~~~--------------------------------------------------------~~~~~~~~~~~~~p  184 (273)
T cd05074         161 KKIYSGDYYR--------------------------------------------------------QGCASKLPVKWLAL  184 (273)
T ss_pred             ccccCCccee--------------------------------------------------------cCCCccCchhhcCH
Confidence            7532211000                                                        00011234568888


Q ss_pred             HHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCC
Q psy8260         296 EIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       296 Evl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~  374 (427)
                      |.+.+..+...+|+||+|++++.+-+ +..++... ................      .....++.+.+++.+||..||+
T Consensus       185 e~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~-~~~~~~~~~~~~~~~~------~~~~~~~~~~~l~~~~l~~~p~  257 (273)
T cd05074         185 ESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV-ENSEIYNYLIKGNRLK------QPPDCLEDVYELMCQCWSPEPK  257 (273)
T ss_pred             hHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC-CHHHHHHHHHcCCcCC------CCCCCCHHHHHHHHHHcCCChh
Confidence            88877777778899999999987633 22223211 1111222221111100      1123567899999999999999


Q ss_pred             CCCCHHHHhcC
Q psy8260         375 KRITAEQALAH  385 (427)
Q Consensus       375 ~R~ta~e~L~H  385 (427)
                      +|||+.|++++
T Consensus       258 ~Rps~~~~~~~  268 (273)
T cd05074         258 CRPSFQHLRDQ  268 (273)
T ss_pred             hCcCHHHHHHH
Confidence            99999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=8e-34  Score=266.52  Aligned_cols=246  Identities=24%  Similarity=0.349  Sum_probs=183.2

Q ss_pred             cccCcccccEEEEeEEeC--cCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEE
Q psy8260          70 PTLSKESFDLIFSSALDS--VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYM  147 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~l  147 (427)
                      +.||+|+||.||.+....  .++..||+|.+....... ....+.+|+++++.++|+||+++++++...      ..+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------~~~~l   73 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEE------EPLYL   73 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCC------CceEE
Confidence            368999999999765432  237899999987654333 456778999999999999999999987652      45789


Q ss_pred             EeccC-CCCHHHHHhh----------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         148 VTHLM-GADLNNILRT----------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       148 v~e~~-g~~L~~~l~~----------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                      +++++ +++|.+++..          ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||.++
T Consensus        74 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~  153 (262)
T cd00192          74 VLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSR  153 (262)
T ss_pred             EEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccc
Confidence            99988 8999998865          468999999999999999999999999999999999999999999999999987


Q ss_pred             CCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         217 PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       217 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      ........                                                        .......+++.|+|||
T Consensus       154 ~~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~aPE  177 (262)
T cd00192         154 DVYDDDYY--------------------------------------------------------RKKTGGKLPIRWMAPE  177 (262)
T ss_pred             cccccccc--------------------------------------------------------ccccCCCcCccccCHH
Confidence            54321100                                                        0011234567788888


Q ss_pred             HhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCC
Q psy8260         297 IMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEK  375 (427)
Q Consensus       297 vl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~  375 (427)
                      ++....+...+|+||+|++++.+.+ +..+|.... .............      .......++++.++|.+||+.||.+
T Consensus       178 ~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~  250 (262)
T cd00192         178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS-NEEVLEYLRKGYR------LPKPEYCPDELYELMLSCWQLDPED  250 (262)
T ss_pred             HhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHHcCCC------CCCCccCChHHHHHHHHHccCCccc
Confidence            8776667778899999999987633 233332221 1111111111100      0112345789999999999999999


Q ss_pred             CCCHHHHhcC
Q psy8260         376 RITAEQALAH  385 (427)
Q Consensus       376 R~ta~e~L~H  385 (427)
                      |||++|+++|
T Consensus       251 Rps~~~l~~~  260 (262)
T cd00192         251 RPTFSELVER  260 (262)
T ss_pred             CcCHHHHHHh
Confidence            9999999976

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.3e-33  Score=267.39  Aligned_cols=253  Identities=22%  Similarity=0.291  Sum_probs=186.4

Q ss_pred             CcceeeccccCcccccEEEEeEEeCc--CCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcccc
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSV--SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~--~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  140 (427)
                      .++|++.+.||+|+||.||.+.....  .+..||+|.+.... .......+.+|+.++++++||||+++++++...    
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----   77 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS----   77 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC----
Confidence            35688899999999999998754322  33479999886543 334456778999999999999999999988643    


Q ss_pred             CCceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCC
Q psy8260         141 DFKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP  217 (427)
Q Consensus       141 ~~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~  217 (427)
                        ...|+++|++ +++|.+++..  ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++.
T Consensus        78 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~  155 (267)
T cd05066          78 --KPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV  155 (267)
T ss_pred             --CccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence              3578888888 6799998865  3589999999999999999999999999999999999999999999999999875


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      .........                                                       ...+..+++.|+|||+
T Consensus       156 ~~~~~~~~~-------------------------------------------------------~~~~~~~~~~y~~pe~  180 (267)
T cd05066         156 LEDDPEAAY-------------------------------------------------------TTRGGKIPIRWTAPEA  180 (267)
T ss_pred             cccccceee-------------------------------------------------------ecCCCccceeecCHhH
Confidence            432110000                                                       0011123567889998


Q ss_pred             hhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCC
Q psy8260         298 MLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKR  376 (427)
Q Consensus       298 l~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R  376 (427)
                      +.+..+..++|+|++|++++.+.+ +..+|......+...... .....      ......++.+.+|+.+||+.||.+|
T Consensus       181 ~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-~~~~~------~~~~~~~~~~~~li~~~l~~~p~~R  253 (267)
T cd05066         181 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE-EGYRL------PAPMDCPAALHQLMLDCWQKDRNER  253 (267)
T ss_pred             hccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHh-CCCcC------CCCCCCCHHHHHHHHHHcccCchhC
Confidence            887777788899999999987433 444443322122111111 11000      1123457789999999999999999


Q ss_pred             CCHHHHhc
Q psy8260         377 ITAEQALA  384 (427)
Q Consensus       377 ~ta~e~L~  384 (427)
                      ||+.++++
T Consensus       254 p~~~~i~~  261 (267)
T cd05066         254 PKFEQIVS  261 (267)
T ss_pred             CCHHHHHH
Confidence            99999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-33  Score=266.24  Aligned_cols=245  Identities=18%  Similarity=0.217  Sum_probs=179.8

Q ss_pred             cccCcccccEEEEeEEeCcC--CcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEE
Q psy8260          70 PTLSKESFDLIFSSALDSVS--GVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYM  147 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~~--g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~l  147 (427)
                      +.||+|+||.||++.....+  +..||+|.+...... ...+.+.+|+++++.++|||||++++++..       ...++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------~~~~~   72 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG-------EPLML   72 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-------CceEE
Confidence            46899999999987654433  378999998754332 345567899999999999999999988643       24678


Q ss_pred             EeccC-CCCHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccc
Q psy8260         148 VTHLM-GADLNNILRTQ-KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGY  225 (427)
Q Consensus       148 v~e~~-g~~L~~~l~~~-~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  225 (427)
                      +++++ +++|.+++... .+++..+..++.|++.||+|||+++++||||||+|||++.++.+||+|||+++.........
T Consensus        73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          73 VMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            88876 67999988654 59999999999999999999999999999999999999999999999999986432211000


Q ss_pred             cccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCC
Q psy8260         226 VATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYN  305 (427)
Q Consensus       226 ~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~  305 (427)
                      .                                                       ...+..++..|+|||++.+..+..
T Consensus       153 ~-------------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~  177 (257)
T cd05060         153 R-------------------------------------------------------ATTAGRWPLKWYAPECINYGKFSS  177 (257)
T ss_pred             c-------------------------------------------------------cccCccccccccCHHHhcCCCCCc
Confidence            0                                                       001112455788888887777777


Q ss_pred             CCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy8260         306 QTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALA  384 (427)
Q Consensus       306 ~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~  384 (427)
                      .+|+||+|++++.+.+ +..+|.... .....+........      ......++.++|+|.+||..||.+|||+.++++
T Consensus       178 ~~Di~slG~~l~~~~~~g~~p~~~~~-~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         178 KSDVWSYGVTLWEAFSYGAKPYGEMK-GAEVIAMLESGERL------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             cchHHHHHHHHHHHHcCCCCCcccCC-HHHHHHHHHcCCcC------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            8999999999876643 333343221 11222222211111      122346788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=9.9e-34  Score=274.96  Aligned_cols=256  Identities=23%  Similarity=0.299  Sum_probs=185.4

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEe------CcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeee
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALD------SVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLD  131 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~------~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~  131 (427)
                      +.+..++|.+++.||+|+||.||.+...      ...+..||+|.+... ........+.+|+++++.+ +||||+++++
T Consensus         7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~   85 (314)
T cd05099           7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN-ATDKDLADLISEMELMKLIGKHKNIINLLG   85 (314)
T ss_pred             ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC-CChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence            3566688999999999999999976431      123567999988643 2344456678999999999 6999999999


Q ss_pred             eeecCccccCCceEEEEeccC-CCCHHHHHhh-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecc
Q psy8260         132 VFHSNTCLADFKNVYMVTHLM-GADLNNILRT-----------------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRD  193 (427)
Q Consensus       132 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~-----------------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrD  193 (427)
                      ++...      ..+|++++++ +++|.+++..                 ..+++..+..++.|++.||.|||++||+|||
T Consensus        86 ~~~~~------~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~d  159 (314)
T cd05099          86 VCTQE------GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRD  159 (314)
T ss_pred             EEccC------CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence            87543      3578888887 6899988853                 2378888999999999999999999999999


Q ss_pred             CCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhcc
Q psy8260         194 LKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDF  273 (427)
Q Consensus       194 LKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~  273 (427)
                      |||+|||++.++.+||+|||+++.........                                                
T Consensus       160 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~------------------------------------------------  191 (314)
T cd05099         160 LAARNVLVTEDNVMKIADFGLARGVHDIDYYK------------------------------------------------  191 (314)
T ss_pred             ccceeEEEcCCCcEEEcccccccccccccccc------------------------------------------------
Confidence            99999999999999999999987542210000                                                


Q ss_pred             CCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHh
Q psy8260         274 GLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQ  352 (427)
Q Consensus       274 g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (427)
                              ......+++.|+|||++.+..+...+|+||+|++++.+.+ +..+|.... ..............      .
T Consensus       192 --------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~-~~~~~~~~~~~~~~------~  256 (314)
T cd05099         192 --------KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP-VEELFKLLREGHRM------D  256 (314)
T ss_pred             --------ccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCCCC------C
Confidence                    0001123456888888877777778899999999877643 223332211 11122221111100      1


Q ss_pred             hcCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy8260         353 VFKGANPQAIDLLSLMLELDSEKRITAEQALA  384 (427)
Q Consensus       353 ~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~  384 (427)
                      .....+.++++||.+||..||++|||+.|+++
T Consensus       257 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         257 KPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            12345678999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.8e-34  Score=267.25  Aligned_cols=247  Identities=21%  Similarity=0.277  Sum_probs=182.1

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      .++.+.+.+|+|+||.||.+..  .++..+|+|.+......   ...+.+|+++++.++||||+++++++...      .
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~--~~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~   72 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKW--RGKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQ------R   72 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEe--cCCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCC------C
Confidence            3577889999999999997643  35678999988643322   23567899999999999999999887543      3


Q ss_pred             eEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      ..|+++|++ +++|.+++..  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++...+
T Consensus        73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~  152 (256)
T cd05059          73 PIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD  152 (256)
T ss_pred             ceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccc
Confidence            578888887 7889988854  3589999999999999999999999999999999999999999999999999864322


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      ....                                                         ...+..++..|+|||++.+
T Consensus       153 ~~~~---------------------------------------------------------~~~~~~~~~~y~~Pe~~~~  175 (256)
T cd05059         153 DQYT---------------------------------------------------------SSQGTKFPVKWAPPEVFDY  175 (256)
T ss_pred             cccc---------------------------------------------------------ccCCCCCCccccCHHHhcc
Confidence            1100                                                         0001123456888888777


Q ss_pred             ccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH
Q psy8260         301 WMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA  379 (427)
Q Consensus       301 ~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta  379 (427)
                      ..+..++|+||+|++++.+-+ +..+|......+.......... .      ......++++.+++.+||..||++|||+
T Consensus       176 ~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~------~~~~~~~~~~~~li~~cl~~~p~~Rpt~  248 (256)
T cd05059         176 SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR-L------YRPKLAPTEVYTIMYSCWHEKPEDRPAF  248 (256)
T ss_pred             CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc-C------CCCCCCCHHHHHHHHHHhcCChhhCcCH
Confidence            667778899999999987644 3333322111111111111111 0      1123467899999999999999999999


Q ss_pred             HHHhcC
Q psy8260         380 EQALAH  385 (427)
Q Consensus       380 ~e~L~H  385 (427)
                      +|+++.
T Consensus       249 ~~~l~~  254 (256)
T cd05059         249 KKLLSQ  254 (256)
T ss_pred             HHHHHH
Confidence            999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=6.5e-34  Score=278.72  Aligned_cols=259  Identities=22%  Similarity=0.303  Sum_probs=188.2

Q ss_pred             ccccccCcceeeccccCcccccEEEEeEEeC------cCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceee
Q psy8260          57 PYSEICRGVIDIGPTLSKESFDLIFSSALDS------VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGL  129 (427)
Q Consensus        57 ~~~~~~~~~~~~~~~lg~g~fg~v~~~~~~~------~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l  129 (427)
                      |.+++....|.+++.||+|+||.||.+....      ..+..||+|.+... ........+.+|+++++++ +||||+++
T Consensus         5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~   83 (334)
T cd05100           5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINL   83 (334)
T ss_pred             cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence            5678888889999999999999999764321      12347999987643 2344456788999999999 89999999


Q ss_pred             eeeeecCccccCCceEEEEeccC-CCCHHHHHhhC-----------------CCCHHHHHHHHHHHHHHHHHHHhcCcee
Q psy8260         130 LDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQ-----------------KLSDDHVQFLVYQILRGLKYIHSAGIIH  191 (427)
Q Consensus       130 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~-----------------~l~~~~~~~~~~qi~~aL~yLH~~~iiH  191 (427)
                      ++++...      ..++++++++ +++|.+++...                 .++...+..++.|++.||.|||++||+|
T Consensus        84 ~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH  157 (334)
T cd05100          84 LGACTQD------GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIH  157 (334)
T ss_pred             eEEEccC------CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            9987543      3567888877 67999887532                 3677888889999999999999999999


Q ss_pred             ccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhh
Q psy8260         192 RDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKIL  271 (427)
Q Consensus       192 rDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~  271 (427)
                      |||||+|||++.++.+||+|||+++.........                                              
T Consensus       158 ~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~----------------------------------------------  191 (334)
T cd05100         158 RDLAARNVLVTEDNVMKIADFGLARDVHNIDYYK----------------------------------------------  191 (334)
T ss_pred             cccccceEEEcCCCcEEECCcccceecccccccc----------------------------------------------
Confidence            9999999999999999999999987432210000                                              


Q ss_pred             ccCCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccH
Q psy8260         272 DFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDF  350 (427)
Q Consensus       272 d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (427)
                                ......++..|+|||++.+..+...+|+|++|++++.|-+ +..+|.... .....+........     
T Consensus       192 ----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-~~~~~~~~~~~~~~-----  255 (334)
T cd05100         192 ----------KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-VEELFKLLKEGHRM-----  255 (334)
T ss_pred             ----------cccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHHcCCCC-----
Confidence                      0001123456888888877777788899999999877633 222332211 11111111111100     


Q ss_pred             HhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         351 RQVFKGANPQAIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       351 ~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                       ......+.++.+||.+||+.||.+|||+.|++++
T Consensus       256 -~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         256 -DKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             -CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence             1123457789999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=8.9e-34  Score=270.63  Aligned_cols=250  Identities=19%  Similarity=0.268  Sum_probs=183.3

Q ss_pred             cceeeccccCcccccEEEEeEE----eCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSAL----DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      .++.+...||+|+||.||.+..    +..++..||+|.+...  .......+.+|+++++.++|+||+++++++...   
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---   79 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG---   79 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC---
Confidence            4567788999999999997643    3346778999987643  334456688999999999999999999987653   


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhhC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEc
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRTQ----------------KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN  202 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~~----------------~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~  202 (427)
                         ...+++++++ +++|.+++...                .+++..+..++.|++.||.|||++|++||||||+|||++
T Consensus        80 ---~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~  156 (280)
T cd05092          80 ---RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG  156 (280)
T ss_pred             ---CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc
Confidence               3467888877 78999887642                378899999999999999999999999999999999999


Q ss_pred             CCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccc
Q psy8260         203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENE  282 (427)
Q Consensus       203 ~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~  282 (427)
                      +++.+||+|||+++........                   .                                     .
T Consensus       157 ~~~~~kL~dfg~~~~~~~~~~~-------------------~-------------------------------------~  180 (280)
T cd05092         157 QGLVVKIGDFGMSRDIYSTDYY-------------------R-------------------------------------V  180 (280)
T ss_pred             CCCCEEECCCCceeEcCCCcee-------------------e-------------------------------------c
Confidence            9999999999998643211000                   0                                     0


Q ss_pred             cccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhH
Q psy8260         283 MTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQA  361 (427)
Q Consensus       283 ~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  361 (427)
                      .....+++.|+|||++.+..+..++|+||+|++++.+-+ +..+|......+.........+.       ......++.+
T Consensus       181 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~  253 (280)
T cd05092         181 GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGREL-------ERPRTCPPEV  253 (280)
T ss_pred             CCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCccC-------CCCCCCCHHH
Confidence            011224567888888877777778899999999887643 33333222111111111111111       1123467889


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhc
Q psy8260         362 IDLLSLMLELDSEKRITAEQALA  384 (427)
Q Consensus       362 ~dLi~~mL~~dP~~R~ta~e~L~  384 (427)
                      .+||.+||+.||.+|||++|+++
T Consensus       254 ~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         254 YAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HHHHHHHccCChhhCCCHHHHHH
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.3e-33  Score=266.22  Aligned_cols=245  Identities=18%  Similarity=0.246  Sum_probs=178.3

Q ss_pred             ccCcccccEEEEeEEe-CcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEEEe
Q psy8260          71 TLSKESFDLIFSSALD-SVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT  149 (427)
Q Consensus        71 ~lg~g~fg~v~~~~~~-~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~lv~  149 (427)
                      .||+|+||.||.+... ..++..||+|.+... ......+.+.+|+.++++++||||+++++++..       ...++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-------~~~~lv~   73 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE-NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-------EALMLVM   73 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccc-cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-------CCeEEEE
Confidence            3899999999987654 335667999988654 233444567899999999999999999998643       2467888


Q ss_pred             ccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCccccc
Q psy8260         150 HLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV  226 (427)
Q Consensus       150 e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  226 (427)
                      |++ +++|.+++..  ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++..........
T Consensus        74 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  153 (257)
T cd05115          74 EMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK  153 (257)
T ss_pred             EeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence            877 7899988853  4689999999999999999999999999999999999999999999999999864322110000


Q ss_pred             ccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCCC
Q psy8260         227 ATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQ  306 (427)
Q Consensus       227 gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~  306 (427)
                                                                             ......+++.|+|||++....+..+
T Consensus       154 -------------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~  178 (257)
T cd05115         154 -------------------------------------------------------ARSAGKWPLKWYAPECINFRKFSSR  178 (257)
T ss_pred             -------------------------------------------------------ccCCCCCCcccCCHHHHccCCCCch
Confidence                                                                   0011123567888888877667778


Q ss_pred             CCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         307 TDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       307 ~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                      +|+||+|++++.+-+ +..||..... .............      ......++++.+||.+|++.||++||+++++.+.
T Consensus       179 ~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~~~~~~~~~------~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~  251 (257)
T cd05115         179 SDVWSYGITMWEAFSYGQKPYKKMKG-PEVMSFIEQGKRL------DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEER  251 (257)
T ss_pred             hhHHHHHHHHHHHhcCCCCCcCcCCH-HHHHHHHHCCCCC------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            899999999886532 4444432211 1111111111100      1123457899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=5.3e-34  Score=268.74  Aligned_cols=249  Identities=21%  Similarity=0.280  Sum_probs=187.0

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcccc
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  140 (427)
                      .....|.+.+.||.|+||.||.+.. .. ++.||+|.+....  ......+.+|+++++.++||||+++++++...    
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~-~~-~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----   74 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLW-KN-RVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVG----   74 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEe-cC-CCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecC----
Confidence            4456788999999999999997554 33 8899999986532  22345577899999999999999999987654    


Q ss_pred             CCceEEEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         141 DFKNVYMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       141 ~~~~~~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                        ...+++++++ +++|.+++..   ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus        75 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~  152 (261)
T cd05148          75 --EPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLAR  152 (261)
T ss_pred             --CCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchh
Confidence              3568888887 6799998864   358999999999999999999999999999999999999999999999999886


Q ss_pred             CCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         217 PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       217 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      .......                                                          ...+..+++.|+|||
T Consensus       153 ~~~~~~~----------------------------------------------------------~~~~~~~~~~~~~PE  174 (261)
T cd05148         153 LIKEDVY----------------------------------------------------------LSSDKKIPYKWTAPE  174 (261)
T ss_pred             hcCCccc----------------------------------------------------------cccCCCCceEecCHH
Confidence            4322100                                                          000122456788888


Q ss_pred             HhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCC
Q psy8260         297 IMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEK  375 (427)
Q Consensus       297 vl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~  375 (427)
                      ++....+..++|+|++|++++.+.+ +..+|......+.......... .      ......++.+.++|.+||+.||.+
T Consensus       175 ~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~------~~~~~~~~~~~~~i~~~l~~~p~~  247 (261)
T cd05148         175 AASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR-M------PCPAKCPQEIYKIMLECWAAEPED  247 (261)
T ss_pred             HHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCc-C------CCCCCCCHHHHHHHHHHcCCCchh
Confidence            8877667778899999999988754 4444432221222222211110 0      112346788999999999999999


Q ss_pred             CCCHHHHhc
Q psy8260         376 RITAEQALA  384 (427)
Q Consensus       376 R~ta~e~L~  384 (427)
                      |||++++++
T Consensus       248 Rpt~~~l~~  256 (261)
T cd05148         248 RPSFKALRE  256 (261)
T ss_pred             CcCHHHHHH
Confidence            999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=5.9e-34  Score=272.51  Aligned_cols=255  Identities=24%  Similarity=0.432  Sum_probs=192.0

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      ...|.+.+.+|.|+||.||.+. +..++..||+|++.....   ....+.+|+++++.++|+||+++++.+...      
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~-~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------   87 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKAT-DRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVG------   87 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEE-EccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC------
Confidence            3457778899999999999754 556789999999865322   445677999999999999999999988654      


Q ss_pred             ceEEEEeccC-CCCHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~~~--~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                      ...|++++++ +++|.+++...  .+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++....
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  167 (286)
T cd06614          88 DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT  167 (286)
T ss_pred             CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence            4578888888 58999998765  79999999999999999999999999999999999999999999999999865322


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      ....                                                          ......+++.|+|||++.
T Consensus       168 ~~~~----------------------------------------------------------~~~~~~~~~~y~~PE~~~  189 (286)
T cd06614         168 KEKS----------------------------------------------------------KRNSVVGTPYWMAPEVIK  189 (286)
T ss_pred             cchh----------------------------------------------------------hhccccCCcccCCHhHhc
Confidence            1100                                                          001123566788888877


Q ss_pred             hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH
Q psy8260         300 NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA  379 (427)
Q Consensus       300 ~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta  379 (427)
                      +..+..++|+|++|++++.+-++..++........... ...... ..  . ......+.++++||.+||+.||.+|||+
T Consensus       190 ~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~-~~~~~~-~~--~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~  264 (286)
T cd06614         190 RKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFL-ITTKGI-PP--L-KNPEKWSPEFKDFLNKCLVKDPEKRPSA  264 (286)
T ss_pred             CCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhcCC-CC--C-cchhhCCHHHHHHHHHHhccChhhCcCH
Confidence            76677788999999999888555444432211111111 111110 00  0 0112357789999999999999999999


Q ss_pred             HHHhcCCCCCC
Q psy8260         380 EQALAHPYLSQ  390 (427)
Q Consensus       380 ~e~L~Hp~f~~  390 (427)
                      .|+++||||.+
T Consensus       265 ~~il~~~~~~~  275 (286)
T cd06614         265 EELLQHPFLKK  275 (286)
T ss_pred             HHHhhChHhhc
Confidence            99999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=9.3e-34  Score=267.24  Aligned_cols=249  Identities=23%  Similarity=0.307  Sum_probs=184.5

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      ++....|.+.+.||.|+||.||++..  .+++.||+|.+......   ...+.+|+.+++.++||||+++++++..    
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~--~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~----   72 (260)
T cd05067           2 EVPRETLKLVKKLGAGQFGEVWMGYY--NGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVTQ----   72 (260)
T ss_pred             ccchHHceeeeeeccCccceEEeeec--CCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEcc----
Confidence            56677899999999999999998653  45788999988654332   3467789999999999999999988643    


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                         ...+++++++ +++|.+++..   ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++
T Consensus        73 ---~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~  149 (260)
T cd05067          73 ---EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLA  149 (260)
T ss_pred             ---CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcce
Confidence               2467888877 7899888753   35889999999999999999999999999999999999999999999999988


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      .........                                                         ...+..++..|+||
T Consensus       150 ~~~~~~~~~---------------------------------------------------------~~~~~~~~~~y~~p  172 (260)
T cd05067         150 RLIEDNEYT---------------------------------------------------------AREGAKFPIKWTAP  172 (260)
T ss_pred             eecCCCCcc---------------------------------------------------------cccCCcccccccCH
Confidence            643211000                                                         00112345668888


Q ss_pred             HHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCC
Q psy8260         296 EIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       296 Evl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~  374 (427)
                      |++....+..++|+||+|++++.+.+ +..+|.......... ........      ......+.++.+||.+||..||+
T Consensus       173 e~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~  245 (260)
T cd05067         173 EAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ-NLERGYRM------PRPDNCPEELYELMRLCWKEKPE  245 (260)
T ss_pred             HHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHH-HHHcCCCC------CCCCCCCHHHHHHHHHHccCChh
Confidence            88776667778899999999876644 444443222111111 11111110      11234567899999999999999


Q ss_pred             CCCCHHHHhc
Q psy8260         375 KRITAEQALA  384 (427)
Q Consensus       375 ~R~ta~e~L~  384 (427)
                      +|||++++++
T Consensus       246 ~Rp~~~~l~~  255 (260)
T cd05067         246 ERPTFEYLRS  255 (260)
T ss_pred             hCCCHHHHHH
Confidence            9999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=6.6e-34  Score=284.84  Aligned_cols=258  Identities=22%  Similarity=0.275  Sum_probs=186.4

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEe----CcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCC-CCCceeeeeee
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALD----SVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN-HENVIGLLDVF  133 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~----~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~  133 (427)
                      +++....+.+++.||+|+||.||.+...    ..++..||||++.... .....+.+.+|+.+|..+. |||||++++++
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~  110 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGAC  110 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence            4666778889999999999999976542    3456789999997543 2333456789999999997 99999999987


Q ss_pred             ecCccccCCceEEEEeccC-CCCHHHHHhhC-------------------------------------------------
Q psy8260         134 HSNTCLADFKNVYMVTHLM-GADLNNILRTQ-------------------------------------------------  163 (427)
Q Consensus       134 ~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~-------------------------------------------------  163 (427)
                      ...      ..+++++|++ +++|.++++..                                                 
T Consensus       111 ~~~------~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  184 (401)
T cd05107         111 TKG------GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKD  184 (401)
T ss_pred             ccC------CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCc
Confidence            653      3578899887 78998887532                                                 


Q ss_pred             --------------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhcCceecc
Q psy8260         164 --------------------------------------------------KLSDDHVQFLVYQILRGLKYIHSAGIIHRD  193 (427)
Q Consensus       164 --------------------------------------------------~l~~~~~~~~~~qi~~aL~yLH~~~iiHrD  193 (427)
                                                                        .+++..+..++.|++.||.|||+++|+|||
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrd  264 (401)
T cd05107         185 ESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRD  264 (401)
T ss_pred             cccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCccc
Confidence                                                              246667788999999999999999999999


Q ss_pred             CCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhcc
Q psy8260         194 LKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDF  273 (427)
Q Consensus       194 LKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~  273 (427)
                      |||+|||++.++.+||+|||+++.........                                                
T Consensus       265 lkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~------------------------------------------------  296 (401)
T cd05107         265 LAARNVLICEGKLVKICDFGLARDIMRDSNYI------------------------------------------------  296 (401)
T ss_pred             CCcceEEEeCCCEEEEEecCcceecccccccc------------------------------------------------
Confidence            99999999999999999999986432110000                                                


Q ss_pred             CCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHh
Q psy8260         274 GLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQ  352 (427)
Q Consensus       274 g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (427)
                              ......+++.|+|||++.+..+...+|+||+|++++.+.+ +..|+......+............      .
T Consensus       297 --------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~------~  362 (401)
T cd05107         297 --------SKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRM------A  362 (401)
T ss_pred             --------cCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCC------C
Confidence                    0011235677888888877667777899999999876532 222222111111111111111000      1


Q ss_pred             hcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         353 VFKGANPQAIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       353 ~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                      .....++++.+||.+|++.||.+|||++|+++.
T Consensus       363 ~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         363 KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            123467899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=7.2e-34  Score=274.62  Aligned_cols=249  Identities=20%  Similarity=0.272  Sum_probs=180.8

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCc--EEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCccc
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGV--KVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~--~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~  139 (427)
                      -+.|.+.+.||+|+||.||.+.. ..+|.  .+|+|.+... ........+.+|+.++.++ +||||+++++++...   
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~-~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~---   80 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARI-KKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR---   80 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEE-ccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC---
Confidence            45688889999999999997654 44554  4678776532 2334455677899999999 899999999987643   


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhhC-----------------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEE
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRTQ-----------------KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV  201 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~~-----------------~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl  201 (427)
                         ...|++++++ +++|.++++..                 .+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus        81 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili  157 (303)
T cd05088          81 ---GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV  157 (303)
T ss_pred             ---CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEe
Confidence               3578888887 78999888532                 47888999999999999999999999999999999999


Q ss_pred             cCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcc
Q psy8260         202 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTEN  281 (427)
Q Consensus       202 ~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~  281 (427)
                      +.++.+||+|||+++........                                                         
T Consensus       158 ~~~~~~kl~dfg~~~~~~~~~~~---------------------------------------------------------  180 (303)
T cd05088         158 GENYVAKIADFGLSRGQEVYVKK---------------------------------------------------------  180 (303)
T ss_pred             cCCCcEEeCccccCcccchhhhc---------------------------------------------------------
Confidence            99999999999987532110000                                                         


Q ss_pred             ccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChh
Q psy8260         282 EMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQ  360 (427)
Q Consensus       282 ~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  360 (427)
                        ....++..|+|||++.+..+...+|+||+|++++.+.+ +..+|......+... ........      ......+++
T Consensus       181 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-~~~~~~~~------~~~~~~~~~  251 (303)
T cd05088         181 --TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE-KLPQGYRL------EKPLNCDDE  251 (303)
T ss_pred             --ccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHH-HHhcCCcC------CCCCCCCHH
Confidence              00112456888887777667778899999999987743 333343221111111 11110000      111235788


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         361 AIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       361 ~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                      +.+||.+||+.||.+|||+++++++
T Consensus       252 ~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         252 VYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.6e-33  Score=265.99  Aligned_cols=251  Identities=24%  Similarity=0.337  Sum_probs=184.9

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcC-CCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPF-QSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      +.|++.+.||.|+||.||.+ .+..+|+.||+|.+.... ........+.+|++++++++|+||+++++.+...      
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~-~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~------   74 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKA-ICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN------   74 (267)
T ss_pred             CceeeeeeeccCCceEEEEE-EEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC------
Confidence            46888999999999999965 455789999999886432 2233456678999999999999999999988653      


Q ss_pred             ceEEEEeccC-CCCHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILRT-----QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                      ...+++++++ +++|..++..     ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~  154 (267)
T cd08224          75 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGR  154 (267)
T ss_pred             CeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceee
Confidence            4578888887 6799888753     348899999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         217 PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       217 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      .......                                                          ......|++.|+|||
T Consensus       155 ~~~~~~~----------------------------------------------------------~~~~~~~~~~y~apE  176 (267)
T cd08224         155 FFSSKTT----------------------------------------------------------AAHSLVGTPYYMSPE  176 (267)
T ss_pred             eccCCCc----------------------------------------------------------ccceecCCccccCHH
Confidence            4322100                                                          001223566788888


Q ss_pred             HhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCc-HHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCC
Q psy8260         297 IMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISS-DSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEK  375 (427)
Q Consensus       297 vl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~  375 (427)
                      ++.+..+...+|+|++|++++.+-++..++...... ......... .......    ....+.+..++|.+||..||++
T Consensus       177 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~----~~~~~~~~~~~i~~cl~~~p~~  251 (267)
T cd08224         177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK-CDYPPLP----ADHYSEELRDLVSRCINPDPEK  251 (267)
T ss_pred             HhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc-CCCCCCC----hhhcCHHHHHHHHHHcCCCccc
Confidence            777666777889999999998775444444221110 001011100 0000000    1145678999999999999999


Q ss_pred             CCCHHHHhc
Q psy8260         376 RITAEQALA  384 (427)
Q Consensus       376 R~ta~e~L~  384 (427)
                      |||+.++++
T Consensus       252 Rp~~~~il~  260 (267)
T cd08224         252 RPDISYVLQ  260 (267)
T ss_pred             CCCHHHHHH
Confidence            999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG0696|consensus

Probab=100.00  E-value=1.5e-35  Score=279.26  Aligned_cols=262  Identities=21%  Similarity=0.262  Sum_probs=201.9

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH-HHHHHHHHHHHHHhcC-CCCCceeeeeeeecCc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA-VHAKRTYRELRMLKHM-NHENVIGLLDVFHSNT  137 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~  137 (427)
                      -+...+|.+..+||+|+||.|..+. .+.|.+.+|||++++...-+ .+.+-...|-++|... +-|.+++|+.+|++. 
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLae-rkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm-  422 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAE-RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM-  422 (683)
T ss_pred             ceeecccceEEEeccCccceeeeec-ccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh-
Confidence            3445678899999999999999654 45577899999987653221 1233345677777766 457889998777654 


Q ss_pred             cccCCceEEEEeccC-CCCHHH-HHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         138 CLADFKNVYMVTHLM-GADLNN-ILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       138 ~~~~~~~~~lv~e~~-g~~L~~-~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                           +.+|+||||+ ||+|-. +.+-++|.|..+..|+.+|+-||-|||++|||.||||.+|||+|.+|++||+|||++
T Consensus       423 -----DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmc  497 (683)
T KOG0696|consen  423 -----DRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMC  497 (683)
T ss_pred             -----hheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccc
Confidence                 5689999998 778754 445588999999999999999999999999999999999999999999999999998


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      +.---.                                                          .....++||||.|+||
T Consensus       498 KEni~~----------------------------------------------------------~~TTkTFCGTPdYiAP  519 (683)
T KOG0696|consen  498 KENIFD----------------------------------------------------------GVTTKTFCGTPDYIAP  519 (683)
T ss_pred             cccccC----------------------------------------------------------CcceeeecCCCccccc
Confidence            731100                                                          0023467899999999


Q ss_pred             HHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCC
Q psy8260         296 EIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEK  375 (427)
Q Consensus       296 Evl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~  375 (427)
                      |++...+|...+|||+.|+++|+|..+.+||..+...+....+...+..        +.+..|.+|.++...+|...|.+
T Consensus       520 EIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvs--------yPKslSkEAv~ickg~ltK~P~k  591 (683)
T KOG0696|consen  520 EIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVS--------YPKSLSKEAVAICKGLLTKHPGK  591 (683)
T ss_pred             ceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCc--------CcccccHHHHHHHHHHhhcCCcc
Confidence            9998888999999999999999886666666655433333333322222        23467899999999999999999


Q ss_pred             CCCH-----HHHhcCCCCCCCCCC
Q psy8260         376 RITA-----EQALAHPYLSQYSDP  394 (427)
Q Consensus       376 R~ta-----~e~L~Hp~f~~~~~~  394 (427)
                      |+.+     +++-.||||+.+...
T Consensus       592 RLGcg~~ge~di~~H~FFR~iDWe  615 (683)
T KOG0696|consen  592 RLGCGPEGERDIREHPFFRRIDWE  615 (683)
T ss_pred             ccCCCCccccchhhCcchhhccHH
Confidence            9854     689999999976543

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.9e-33  Score=267.98  Aligned_cols=251  Identities=21%  Similarity=0.241  Sum_probs=181.4

Q ss_pred             cCcceeeccccCcccccEEEEeEEeCcCCc----EEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCc
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSALDSVSGV----KVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNT  137 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~----~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~  137 (427)
                      ....|++.+.||.|+||.||++... .+|.    .||+|.+... ........+.+|+.+++.++||||+++++++... 
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-   81 (279)
T cd05109           5 KETELKKVKVLGSGAFGTVYKGIWI-PDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-   81 (279)
T ss_pred             chhheeeeeecCCCCCceEEEEEEe-cCCCccceEEEEEEecCC-CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-
Confidence            3456888899999999999976543 2333    5899988643 2334456678999999999999999999886532 


Q ss_pred             cccCCceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCC
Q psy8260         138 CLADFKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL  214 (427)
Q Consensus       138 ~~~~~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGl  214 (427)
                            ..+++++++ +++|.++++.  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        82 ------~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~  155 (279)
T cd05109          82 ------TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGL  155 (279)
T ss_pred             ------CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCc
Confidence                  245566655 7899888864  3589999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccc
Q psy8260         215 ARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRA  294 (427)
Q Consensus       215 a~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~A  294 (427)
                      ++.........                                                        ...+..+++.|+|
T Consensus       156 ~~~~~~~~~~~--------------------------------------------------------~~~~~~~~~~y~~  179 (279)
T cd05109         156 ARLLDIDETEY--------------------------------------------------------HADGGKVPIKWMA  179 (279)
T ss_pred             eeeccccccee--------------------------------------------------------ecCCCccchhhCC
Confidence            87543211000                                                        0011224566888


Q ss_pred             hHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCC
Q psy8260         295 PEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDS  373 (427)
Q Consensus       295 PEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP  373 (427)
                      ||++.+..+..++|+||+|++++.+.+ +..++... ........+......      ......++++.++|.+||+.||
T Consensus       180 PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~dp  252 (279)
T cd05109         180 LESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI-PAREIPDLLEKGERL------PQPPICTIDVYMIMVKCWMIDS  252 (279)
T ss_pred             HHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHCCCcC------CCCccCCHHHHHHHHHHcCCCh
Confidence            888777667778899999999987533 33333211 111122222211111      1123457889999999999999


Q ss_pred             CCCCCHHHHhc
Q psy8260         374 EKRITAEQALA  384 (427)
Q Consensus       374 ~~R~ta~e~L~  384 (427)
                      ++|||+.++++
T Consensus       253 ~~Rp~~~~l~~  263 (279)
T cd05109         253 ECRPRFRELVD  263 (279)
T ss_pred             hhCcCHHHHHH
Confidence            99999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.1e-34  Score=273.40  Aligned_cols=255  Identities=19%  Similarity=0.279  Sum_probs=185.9

Q ss_pred             ceeeccccCcccccEEEEeEEe---CcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccC
Q psy8260          65 VIDIGPTLSKESFDLIFSSALD---SVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~---~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      .|.+.+.||+|+||.||.+..+   ..++..||+|.+... ........+.+|+++++.++||||+++++++...    .
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~   79 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-SGGNHIADLKKEIEILRNLYHENIVKYKGICTED----G   79 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC----C
Confidence            3567789999999999977643   457889999998643 2344456688999999999999999999987543    1


Q ss_pred             CceEEEEeccC-CCCHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCC
Q psy8260         142 FKNVYMVTHLM-GADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT  218 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l~~~--~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~  218 (427)
                      ....++++|++ |++|.+++...  .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++..
T Consensus        80 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          80 GNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             CCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence            24578888888 78999988543  4899999999999999999999999999999999999999999999999998754


Q ss_pred             CCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         219 ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       219 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                      .......      .                                                 ......|+..|+|||++
T Consensus       160 ~~~~~~~------~-------------------------------------------------~~~~~~~~~~y~apE~~  184 (284)
T cd05079         160 ETDKEYY------T-------------------------------------------------VKDDLDSPVFWYAPECL  184 (284)
T ss_pred             ccCccce------e-------------------------------------------------ecCCCCCCccccCHHHh
Confidence            2211000      0                                                 00122356678888888


Q ss_pred             hhccCCCCCCHHHHHHHHHHhCCCCHHHH-------hhc----Cc---HHHHHHHhcCCCCCcccHHhhcCCCChhHHHH
Q psy8260         299 LNWMHYNQTDIHQLNLIMEMLGTPPAEFM-------AKI----SS---DSARKYINSLPLLTKKDFRQVFKGANPQAIDL  364 (427)
Q Consensus       299 ~~~~~~~~~d~~slg~i~~~lg~~~~~~~-------~~~----~~---~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL  364 (427)
                      .+..+...+|+||+|++++.+.+...+..       ...    ..   ....+......      ........++++.+|
T Consensus       185 ~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l  258 (284)
T cd05079         185 IQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGK------RLPRPPNCPEEVYQL  258 (284)
T ss_pred             ccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCc------cCCCCCCCCHHHHHH
Confidence            77777778899999999987754221110       000    00   00000000000      011234567899999


Q ss_pred             HHHhcCCCCCCCCCHHHHhcC
Q psy8260         365 LSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       365 i~~mL~~dP~~R~ta~e~L~H  385 (427)
                      |.+||+.||.+|||+++++++
T Consensus       259 i~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         259 MRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             HHHHccCCcccCcCHHHHHHH
Confidence            999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.3e-33  Score=270.32  Aligned_cols=254  Identities=20%  Similarity=0.241  Sum_probs=184.6

Q ss_pred             ccCcceeeccccCcccccEEEEeEEe----CcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecC
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALD----SVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSN  136 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~----~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~  136 (427)
                      +..++|++.+.||.|+||.||.+...    ..++..||+|.+.... .......+.+|+.++++++||||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~   80 (288)
T cd05050           2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG   80 (288)
T ss_pred             CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            34567889999999999999976542    2467899999886432 334445677899999999999999999987643


Q ss_pred             ccccCCceEEEEeccC-CCCHHHHHhhC-----------------------CCCHHHHHHHHHHHHHHHHHHHhcCceec
Q psy8260         137 TCLADFKNVYMVTHLM-GADLNNILRTQ-----------------------KLSDDHVQFLVYQILRGLKYIHSAGIIHR  192 (427)
Q Consensus       137 ~~~~~~~~~~lv~e~~-g~~L~~~l~~~-----------------------~l~~~~~~~~~~qi~~aL~yLH~~~iiHr  192 (427)
                            ...++++|++ +++|.+++...                       .+++..+..++.|++.||.|||+++++||
T Consensus        81 ------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~  154 (288)
T cd05050          81 ------KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHR  154 (288)
T ss_pred             ------CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence                  3568888887 67999888532                       36778889999999999999999999999


Q ss_pred             cCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhc
Q psy8260         193 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILD  272 (427)
Q Consensus       193 DLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d  272 (427)
                      ||||+||+++.++.+||+|||+++.......       +.                                        
T Consensus       155 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-------~~----------------------------------------  187 (288)
T cd05050         155 DLATRNCLVGENMVVKIADFGLSRNIYSADY-------YK----------------------------------------  187 (288)
T ss_pred             cccHhheEecCCCceEECccccceecccCcc-------cc----------------------------------------
Confidence            9999999999999999999998764321100       00                                        


Q ss_pred             cCCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHH
Q psy8260         273 FGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFR  351 (427)
Q Consensus       273 ~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (427)
                               ......+++.|+|||++.+..+..++|+||+|++++.+-+ +..+|......+......... ..      
T Consensus       188 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~-~~------  251 (288)
T cd05050         188 ---------ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGN-VL------  251 (288)
T ss_pred             ---------ccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-CC------
Confidence                     0001123456889998887777888999999999877743 332332211111111111111 00      


Q ss_pred             hhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy8260         352 QVFKGANPQAIDLLSLMLELDSEKRITAEQALA  384 (427)
Q Consensus       352 ~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~  384 (427)
                      ......++++.+||.+||+.||.+|||++|+++
T Consensus       252 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         252 SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            111245688999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG2345|consensus

Probab=100.00  E-value=4.3e-35  Score=260.31  Aligned_cols=260  Identities=21%  Similarity=0.247  Sum_probs=184.6

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      -++..+|.+.+.+|+|||.-|+.. .+..++..+|+|++.-.  +....+..++|++..++++||||++++++...... 
T Consensus        17 ~In~~Ryri~~~LgeGGfsfv~LV-~~~s~~~~YAlKkI~c~--~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~-   92 (302)
T KOG2345|consen   17 IINNKRYRIQRLLGEGGFSFVDLV-KGLSTGHLYALKKILCH--SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK-   92 (302)
T ss_pred             EEcCceEEEeeeecCCCceeeeee-cccCcccchhhheeecc--chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc-
Confidence            355678999999999999999964 46788999999999654  34566778999999999999999999887432211 


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhcC--ceeccCCCCCeEEcCCCCEEEee
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRT-----QKLSDDHVQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILD  211 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~yLH~~~--iiHrDLKp~NILl~~~~~~kl~D  211 (427)
                      +.....|+++.+. .|+|.+.++.     ..+++.++..++.+|++||++||+..  ..||||||.|||+.+.+.++|.|
T Consensus        93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D  172 (302)
T KOG2345|consen   93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMD  172 (302)
T ss_pred             cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEe
Confidence            1234577777655 6788776642     35899999999999999999999998  99999999999999999999999


Q ss_pred             CCCCCCCCCCc------------ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCC
Q psy8260         212 FGLARPTENEM------------TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPT  279 (427)
Q Consensus       212 FGla~~~~~~~------------~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~  279 (427)
                      ||.+....-..            ..-..|..|+|||++.-                +                       
T Consensus       173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~v----------------k-----------------------  213 (302)
T KOG2345|consen  173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNV----------------K-----------------------  213 (302)
T ss_pred             ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheec----------------c-----------------------
Confidence            99987543211            11233445555555321                0                       


Q ss_pred             ccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCCh
Q psy8260         280 ENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANP  359 (427)
Q Consensus       280 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  359 (427)
                                         .+.....++|+||||+.+|.+-.+..||.....+...-.+.-..+..   .+.+. ...|.
T Consensus       214 -------------------~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~---s~P~~-~~yse  270 (302)
T KOG2345|consen  214 -------------------SHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQI---SIPNS-SRYSE  270 (302)
T ss_pred             -------------------cCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeecccc---ccCCC-CCccH
Confidence                               01224567899999999987755444443322111000000001110   11111 12678


Q ss_pred             hHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         360 QAIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       360 ~~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                      ....||+.||+.||.+|||+.+++.+
T Consensus       271 ~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  271 ALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             HHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            88999999999999999999999875

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.5e-33  Score=265.96  Aligned_cols=249  Identities=24%  Similarity=0.327  Sum_probs=181.8

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      ++..+.+.+...||+|+||.||.+.. . .+..||+|.+.....   ..+.+.+|+++++.++|||++++++++..    
T Consensus         2 ~~~~~~~~~~~~ig~g~~~~v~~~~~-~-~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----   72 (260)
T cd05069           2 EIPRESLRLDVKLGQGCFGEVWMGTW-N-GTTKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVSE----   72 (260)
T ss_pred             cCChHHeeeeeeecCcCCCeEEEEEE-c-CCceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEcC----
Confidence            45567788999999999999997643 2 334699998764322   23457789999999999999999988643    


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~~---~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                         ...+++|+++ +++|.+++...   .+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||++
T Consensus        73 ---~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~  149 (260)
T cd05069          73 ---EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLA  149 (260)
T ss_pred             ---CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccc
Confidence               2357888877 57999888642   3788999999999999999999999999999999999999999999999998


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      +........                                                         ...+..++..|+||
T Consensus       150 ~~~~~~~~~---------------------------------------------------------~~~~~~~~~~y~~P  172 (260)
T cd05069         150 RLIEDNEYT---------------------------------------------------------ARQGAKFPIKWTAP  172 (260)
T ss_pred             eEccCCccc---------------------------------------------------------ccCCCccchhhCCH
Confidence            643211000                                                         00111245668888


Q ss_pred             HHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCC
Q psy8260         296 EIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       296 Evl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~  374 (427)
                      |++.+......+|+||+|++++.+-+ +..++............. .....      ......+..+.+||.+||..||.
T Consensus       173 e~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~------~~~~~~~~~~~~li~~~l~~~p~  245 (260)
T cd05069         173 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYRM------PCPQGCPESLHELMKLCWKKDPD  245 (260)
T ss_pred             HHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCC------CCCcccCHHHHHHHHHHccCCcc
Confidence            88777667777899999999987754 444443322111111111 11111      11234578899999999999999


Q ss_pred             CCCCHHHHhc
Q psy8260         375 KRITAEQALA  384 (427)
Q Consensus       375 ~R~ta~e~L~  384 (427)
                      +|||++++++
T Consensus       246 ~Rp~~~~i~~  255 (260)
T cd05069         246 ERPTFEYIQS  255 (260)
T ss_pred             cCcCHHHHHH
Confidence            9999999874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.6e-33  Score=267.11  Aligned_cols=255  Identities=20%  Similarity=0.249  Sum_probs=186.6

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeC---cCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCc
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDS---VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNT  137 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~---~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~  137 (427)
                      +....|.+.+.||+|+||.||++....   .++..||+|.+... ........+.+|+.+++.++||||+++++++... 
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-   80 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-   80 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-
Confidence            345678899999999999999877654   23688999987643 3445566678999999999999999999976432 


Q ss_pred             cccCCceEEEEeccC-CCCHHHHHhh---------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCE
Q psy8260         138 CLADFKNVYMVTHLM-GADLNNILRT---------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL  207 (427)
Q Consensus       138 ~~~~~~~~~lv~e~~-g~~L~~~l~~---------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~  207 (427)
                          ....+++++++ +++|..++..         ..+++..+..++.|++.||.|||+++++||||||+||+++.++.+
T Consensus        81 ----~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~  156 (280)
T cd05043          81 ----GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQV  156 (280)
T ss_pred             ----CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcE
Confidence                13457777776 6899888754         348899999999999999999999999999999999999999999


Q ss_pred             EEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccc
Q psy8260         208 KILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV  287 (427)
Q Consensus       208 kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~  287 (427)
                      ||+|||+++.........                                                        ......
T Consensus       157 kl~d~g~~~~~~~~~~~~--------------------------------------------------------~~~~~~  180 (280)
T cd05043         157 KITDNALSRDLFPMDYHC--------------------------------------------------------LGDNEN  180 (280)
T ss_pred             EECCCCCcccccCCceEE--------------------------------------------------------eCCCCC
Confidence            999999987532211000                                                        000112


Q ss_pred             ccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHH
Q psy8260         288 ATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLS  366 (427)
Q Consensus       288 gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~  366 (427)
                      ++..|+|||++.+..+..++|+||+|++++.+-+ +..||.... ...............      .....++++.+++.
T Consensus       181 ~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-~~~~~~~~~~~~~~~------~~~~~~~~~~~li~  253 (280)
T cd05043         181 RPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID-PFEMAAYLKDGYRLA------QPINCPDELFAVMA  253 (280)
T ss_pred             cchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC-HHHHHHHHHcCCCCC------CCCcCCHHHHHHHH
Confidence            4566888888877777778899999999877644 444443221 112222221111110      11234678999999


Q ss_pred             HhcCCCCCCCCCHHHHhc
Q psy8260         367 LMLELDSEKRITAEQALA  384 (427)
Q Consensus       367 ~mL~~dP~~R~ta~e~L~  384 (427)
                      +|++.||++|||+.|+++
T Consensus       254 ~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         254 CCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             HHcCCChhhCCCHHHHHH
Confidence            999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-33  Score=265.46  Aligned_cols=243  Identities=21%  Similarity=0.317  Sum_probs=179.8

Q ss_pred             cCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccC
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      ....|++.+.+|.|+||.||.+..   .|+.||||.+.....   ..+++.+|+.+++.++|+||+++++++...     
T Consensus         4 ~~~~~~~~~~ig~g~~g~v~~~~~---~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----   72 (256)
T cd05039           4 NSKELKLGATIGKGEFGDVMLGDY---RGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQG-----   72 (256)
T ss_pred             ChhhccceeeeecCCCceEEEEEe---cCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCC-----
Confidence            345678889999999999997653   478999999865422   456688999999999999999999987642     


Q ss_pred             CceEEEEeccC-CCCHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCC
Q psy8260         142 FKNVYMVTHLM-GADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP  217 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l~~~---~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~  217 (427)
                       ...+++++++ +++|.++++..   .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.
T Consensus        73 -~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~  151 (256)
T cd05039          73 -NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKE  151 (256)
T ss_pred             -CCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccc
Confidence             4578888888 57999988653   589999999999999999999999999999999999999999999999999875


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      .........                                                             ++..|+|||+
T Consensus       152 ~~~~~~~~~-------------------------------------------------------------~~~~~~ape~  170 (256)
T cd05039         152 ASQGQDSGK-------------------------------------------------------------LPVKWTAPEA  170 (256)
T ss_pred             cccccccCC-------------------------------------------------------------CcccccCchh
Confidence            422211111                                                             2234666666


Q ss_pred             hhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCC
Q psy8260         298 MLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKR  376 (427)
Q Consensus       298 l~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R  376 (427)
                      +....+...+|+||+|++++.+-+ +..+|... ...............      ......++++.|||.+||..||++|
T Consensus       171 ~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~R  243 (256)
T cd05039         171 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPHVEKGYRM------EAPEGCPPEVYKVMKDCWELDPAKR  243 (256)
T ss_pred             hcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhcCCCC------CCccCCCHHHHHHHHHHhccChhhC
Confidence            655555667899999999865522 22223221 111111111111100      1123457899999999999999999


Q ss_pred             CCHHHHhc
Q psy8260         377 ITAEQALA  384 (427)
Q Consensus       377 ~ta~e~L~  384 (427)
                      ||++|+++
T Consensus       244 p~~~~l~~  251 (256)
T cd05039         244 PTFKQLRE  251 (256)
T ss_pred             cCHHHHHH
Confidence            99999985

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2e-33  Score=268.38  Aligned_cols=254  Identities=21%  Similarity=0.300  Sum_probs=183.5

Q ss_pred             cceeeccccCcccccEEEEeEE---eCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcccc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSAL---DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~---~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  140 (427)
                      ..+.+.+.||+|+||.||.+..   +..++..||||++...  .....+.+.+|+++++.++||||+++++++...    
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----   77 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA----   77 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC----
Confidence            3577889999999999998764   4567899999998643  334456678999999999999999999876432    


Q ss_pred             CCceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCC
Q psy8260         141 DFKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP  217 (427)
Q Consensus       141 ~~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~  217 (427)
                      +...++++++++ +++|.+++..  ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.
T Consensus        78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          78 GRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             CCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccc
Confidence            223578889887 7899998864  3589999999999999999999999999999999999999999999999999875


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      .........                                                       ......++..|+|||+
T Consensus       158 ~~~~~~~~~-------------------------------------------------------~~~~~~~~~~y~aPE~  182 (284)
T cd05081         158 LPQDKEYYK-------------------------------------------------------VREPGESPIFWYAPES  182 (284)
T ss_pred             ccCCCccee-------------------------------------------------------ecCCCCCceEeeCHHH
Confidence            432111000                                                       0000113345888888


Q ss_pred             hhhccCCCCCCHHHHHHHHHHhCCCCHH-------HHhhcCcH-----H---HHHHHhcCCCCCcccHHhhcCCCChhHH
Q psy8260         298 MLNWMHYNQTDIHQLNLIMEMLGTPPAE-------FMAKISSD-----S---ARKYINSLPLLTKKDFRQVFKGANPQAI  362 (427)
Q Consensus       298 l~~~~~~~~~d~~slg~i~~~lg~~~~~-------~~~~~~~~-----~---~~~~~~~~~~~~~~~~~~~~~~~s~~~~  362 (427)
                      +.+..+...+|+||+|++++.+.+...+       +.......     .   ..........      .......++++.
T Consensus       183 ~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~  256 (284)
T cd05081         183 LTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGR------LPAPPGCPAEIY  256 (284)
T ss_pred             hccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCc------CCCCCCCCHHHH
Confidence            8776677788999999999877543211       11100000     0   0000000000      011234567899


Q ss_pred             HHHHHhcCCCCCCCCCHHHHhc
Q psy8260         363 DLLSLMLELDSEKRITAEQALA  384 (427)
Q Consensus       363 dLi~~mL~~dP~~R~ta~e~L~  384 (427)
                      +||.+||..||++|||++|+++
T Consensus       257 ~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         257 AIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HHHHHHccCChhhCCCHHHHHH
Confidence            9999999999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.2e-33  Score=272.03  Aligned_cols=267  Identities=15%  Similarity=0.174  Sum_probs=182.1

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEeCcC---CcEEEEEEccCcCCCHHH---------HHHHHHHHHHHhcCCCCCc
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALDSVS---GVKVAIKKIARPFQSAVH---------AKRTYRELRMLKHMNHENV  126 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~---g~~vAvK~i~~~~~~~~~---------~~~~~~Ei~~l~~l~HpnI  126 (427)
                      .++....|.+.+.||+|+||.||++.. ..+   +..+|+|+..........         ......+...+..++|+||
T Consensus         7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~-~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i   85 (294)
T PHA02882          7 IDITGKEWKIDKLIGCGGFGCVYETQC-ASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGI   85 (294)
T ss_pred             eccCCCceEEeeEEecCCCceEEEEEE-cCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCC
Confidence            355567899999999999999997654 334   556777754322111100         0112234455677899999


Q ss_pred             eeeeeeeecCccccCCceEEEEeccCCCCHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCC
Q psy8260         127 IGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQ-KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC  205 (427)
Q Consensus       127 v~l~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~l~~~-~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~  205 (427)
                      +++++......+.  ....+++++....++.+++... ..++..+..++.|++.||+|||+++|+||||||+|||++.++
T Consensus        86 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         86 PKYYGCGSFKRCR--MYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN  163 (294)
T ss_pred             CcEEEeeeEecCC--ceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC
Confidence            9999875443221  1234667777766777666543 478888999999999999999999999999999999999999


Q ss_pred             CEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccc
Q psy8260         206 ELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTG  285 (427)
Q Consensus       206 ~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~  285 (427)
                      .+||+|||+|+........    ..|.                                               ......
T Consensus       164 ~~~l~DFGla~~~~~~~~~----~~~~-----------------------------------------------~~~~~~  192 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKH----IEYS-----------------------------------------------KEQKDL  192 (294)
T ss_pred             cEEEEEcCCceeeccCCcc----cccc-----------------------------------------------cccccc
Confidence            9999999998754321100    0000                                               001122


Q ss_pred             ccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHH-----HHHhcCCCCCcccHHhhcCCCChh
Q psy8260         286 YVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSAR-----KYINSLPLLTKKDFRQVFKGANPQ  360 (427)
Q Consensus       286 ~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~s~~  360 (427)
                      ..||+.|+|||+..+..+..++|+||+|++++.+.++..||..........     .+......   .  +......+++
T Consensus       193 ~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~---~--~~~~~~~~~~  267 (294)
T PHA02882        193 HRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHE---G--KIKIKNANKF  267 (294)
T ss_pred             cCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhh---h--hhccCCCCHH
Confidence            358999999999988888888999999999988876666664331111110     11111100   0  0012344678


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHhc
Q psy8260         361 AIDLLSLMLELDSEKRITAEQALA  384 (427)
Q Consensus       361 ~~dLi~~mL~~dP~~R~ta~e~L~  384 (427)
                      +.|+++.|+..||.+||+.+++++
T Consensus       268 ~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        268 IYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHHHHHHhCCCCCCCCHHHHHH
Confidence            999999999999999999999875

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.3e-33  Score=265.54  Aligned_cols=243  Identities=21%  Similarity=0.297  Sum_probs=177.9

Q ss_pred             cCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccC
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      ....|.+.+.+|+|+||.||.+..   .|..||+|.+...    ...+.+.+|+.+++.++|+|++++++++...     
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~---~~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----   71 (256)
T cd05082           4 NMKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE-----   71 (256)
T ss_pred             cHHhCeeeeeecccCCCeEEEEEE---cCCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcC-----
Confidence            345678889999999999997643   4788999988542    1234577999999999999999999875432     


Q ss_pred             CceEEEEeccC-CCCHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCC
Q psy8260         142 FKNVYMVTHLM-GADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP  217 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l~~~---~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~  217 (427)
                      ....|++++++ +++|.++++..   .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.
T Consensus        72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~  151 (256)
T cd05082          72 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKE  151 (256)
T ss_pred             CCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCcccee
Confidence            23578889888 67999888643   378899999999999999999999999999999999999999999999998864


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      ........                                                             .++..|+|||+
T Consensus       152 ~~~~~~~~-------------------------------------------------------------~~~~~y~aPE~  170 (256)
T cd05082         152 ASSTQDTG-------------------------------------------------------------KLPVKWTAPEA  170 (256)
T ss_pred             ccccCCCC-------------------------------------------------------------ccceeecCHHH
Confidence            32211111                                                             12345777777


Q ss_pred             hhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCC
Q psy8260         298 MLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKR  376 (427)
Q Consensus       298 l~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R  376 (427)
                      +.+..+...+|+|++|++++.+-+ +..++......... .......  .    ....+..++.+.++|.+||+.||++|
T Consensus       171 ~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~-~~~~~~~--~----~~~~~~~~~~~~~li~~~l~~~p~~R  243 (256)
T cd05082         171 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-PRVEKGY--K----MDAPDGCPPVVYDVMKQCWHLDAATR  243 (256)
T ss_pred             HccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHhcCC--C----CCCCCCCCHHHHHHHHHHhcCChhhC
Confidence            666666677899999999876632 32233211111111 1111100  0    01223567889999999999999999


Q ss_pred             CCHHHHhc
Q psy8260         377 ITAEQALA  384 (427)
Q Consensus       377 ~ta~e~L~  384 (427)
                      ||+.++++
T Consensus       244 pt~~~l~~  251 (256)
T cd05082         244 PSFLQLRE  251 (256)
T ss_pred             cCHHHHHH
Confidence            99999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=4.2e-34  Score=266.36  Aligned_cols=227  Identities=21%  Similarity=0.282  Sum_probs=168.3

Q ss_pred             ccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEEEeccC-C
Q psy8260          75 ESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-G  153 (427)
Q Consensus        75 g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-g  153 (427)
                      |.||.||. +.+..+|+.||+|++....       ...+|...+....||||+++++++...      ...++++|++ +
T Consensus         4 g~~~~v~~-~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~------~~~~lv~e~~~~   69 (237)
T cd05576           4 GVIDKVLL-VMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSE------DSVFLVLQHAEG   69 (237)
T ss_pred             cccceEEE-EEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecC------CeEEEEEecCCC
Confidence            78899985 6788899999999986532       123455555566899999999987643      4578888887 6


Q ss_pred             CCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCccccccccccc
Q psy8260         154 ADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR  232 (427)
Q Consensus       154 ~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~  232 (427)
                      ++|.+.+.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++++|||++........+..+     
T Consensus        70 ~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~-----  144 (237)
T cd05576          70 GKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAV-----  144 (237)
T ss_pred             CCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCc-----
Confidence            789887644 56999999999999999999999999999999999999999999999999987544332222223     


Q ss_pred             chhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCCCCCHHHH
Q psy8260         233 APEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQL  312 (427)
Q Consensus       233 aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~sl  312 (427)
                                                                              +..|+|||.+.+..+..++|+||+
T Consensus       145 --------------------------------------------------------~~~y~aPE~~~~~~~~~~~Dvwsl  168 (237)
T cd05576         145 --------------------------------------------------------ENMYCAPEVGGISEETEACDWWSL  168 (237)
T ss_pred             --------------------------------------------------------CccccCCcccCCCCCCchhhHHHH
Confidence                                                                    344555655544445667899999


Q ss_pred             HHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH-----HHHhcCCC
Q psy8260         313 NLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA-----EQALAHPY  387 (427)
Q Consensus       313 g~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta-----~e~L~Hp~  387 (427)
                      |++++.+-++..++.....  .    .....   .   .......++++++||.+||+.||++|+|+     +|+++|||
T Consensus       169 G~il~el~~g~~~~~~~~~--~----~~~~~---~---~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~  236 (237)
T cd05576         169 GAILFELLTGKTLVECHPS--G----INTHT---T---LNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPF  236 (237)
T ss_pred             HHHHHHHHHCcchhhcCch--h----ccccc---c---cCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCC
Confidence            9999877555443321110  0    00000   0   01123468899999999999999999996     99999999


Q ss_pred             C
Q psy8260         388 L  388 (427)
Q Consensus       388 f  388 (427)
                      |
T Consensus       237 ~  237 (237)
T cd05576         237 F  237 (237)
T ss_pred             C
Confidence            8

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=8.4e-34  Score=271.70  Aligned_cols=257  Identities=22%  Similarity=0.334  Sum_probs=186.3

Q ss_pred             eeeccccCcccccEEEEeEE--eCcCCcEEEEEEccCcCCC--HHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCcccc
Q psy8260          66 IDIGPTLSKESFDLIFSSAL--DSVSGVKVAIKKIARPFQS--AVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~--~~~~g~~vAvK~i~~~~~~--~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~  140 (427)
                      |.+.+.||+|+||.||.+..  +..++..||||.+.+....  ......+.+|+.++.++ +||||+++++.+...    
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~----   77 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD----   77 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC----
Confidence            56778999999999997543  2457789999988643221  22334567899999999 699999999887643    


Q ss_pred             CCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCC
Q psy8260         141 DFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT  218 (427)
Q Consensus       141 ~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~  218 (427)
                        ...|++++++ +++|.+.+.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++..
T Consensus        78 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~  155 (288)
T cd05583          78 --TKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (288)
T ss_pred             --CEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence              4578899888 6788887754 56899999999999999999999999999999999999999999999999998643


Q ss_pred             CCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         219 ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       219 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                      ......                                                         ......|++.|+|||++
T Consensus       156 ~~~~~~---------------------------------------------------------~~~~~~~~~~y~aPE~~  178 (288)
T cd05583         156 LAEEEE---------------------------------------------------------RAYSFCGTIEYMAPEVI  178 (288)
T ss_pred             cccccc---------------------------------------------------------ccccccCCccccCHHHh
Confidence            221100                                                         00112355667777766


Q ss_pred             hhcc--CCCCCCHHHHHHHHHHhCCCCHHHHhhcCc----HHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         299 LNWM--HYNQTDIHQLNLIMEMLGTPPAEFMAKISS----DSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       299 ~~~~--~~~~~d~~slg~i~~~lg~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                      .+..  ...++|+|++|++++.+-++..++......    ..........+        ......++++.+||.+||+.|
T Consensus       179 ~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~~  250 (288)
T cd05583         179 RGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP--------PFPKTMSAEARDFIQKLLEKD  250 (288)
T ss_pred             cCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC--------CCCcccCHHHHHHHHHHhcCC
Confidence            5443  455679999999998876655444321111    11111111111        112345788999999999999


Q ss_pred             CCCCCC---HHHHhcCCCCCCCCC
Q psy8260         373 SEKRIT---AEQALAHPYLSQYSD  393 (427)
Q Consensus       373 P~~R~t---a~e~L~Hp~f~~~~~  393 (427)
                      |++|||   +.++|+||||+....
T Consensus       251 p~~R~t~~~~~~~l~~~~~~~~~~  274 (288)
T cd05583         251 PKKRLGANGADEIKNHPFFQGIDW  274 (288)
T ss_pred             HhhccCcchHHHHhcCcccccCCH
Confidence            999998   567799999987644

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG4721|consensus

Probab=100.00  E-value=3.3e-35  Score=286.33  Aligned_cols=243  Identities=21%  Similarity=0.248  Sum_probs=185.8

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      ++....+.-..-||.|+-|.||.+.++   ++.||||+++.-         -..+|+.|++|+||||+.+.+++....  
T Consensus       120 eiPFe~IsELeWlGSGaQGAVF~Grl~---netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqsP--  185 (904)
T KOG4721|consen  120 EIPFEEISELEWLGSGAQGAVFLGRLH---NETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQSP--  185 (904)
T ss_pred             cCCHHHhhhhhhhccCcccceeeeecc---CceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCCc--
Confidence            333333334466999999999988764   568999988521         125889999999999999999976554  


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCC
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP  217 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~  217 (427)
                          .++|+|||| .|-|..+|+. +.+.......|..+|+.||.|||.+.|||||||.-||||..+..|||+|||.++.
T Consensus       186 ----cyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e  261 (904)
T KOG4721|consen  186 ----CYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKE  261 (904)
T ss_pred             ----eeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHh
Confidence                468999998 6899999976 4688899999999999999999999999999999999999999999999998764


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      .....                                                           -...++||..||||||
T Consensus       262 ~~~~S-----------------------------------------------------------TkMSFaGTVaWMAPEv  282 (904)
T KOG4721|consen  262 LSDKS-----------------------------------------------------------TKMSFAGTVAWMAPEV  282 (904)
T ss_pred             hhhhh-----------------------------------------------------------hhhhhhhhHhhhCHHH
Confidence            32211                                                           1235789999999999


Q ss_pred             hhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCC-CChhHHHHHHHhcCCCCCCC
Q psy8260         298 MLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKG-ANPQAIDLLSLMLELDSEKR  376 (427)
Q Consensus       298 l~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~dLi~~mL~~dP~~R  376 (427)
                      |++.+...++||||+|+++.+|.|...|+.+-.........-       ...+.-..+. ...-++=||++|++-.|..|
T Consensus       283 IrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVG-------sNsL~LpvPstcP~GfklL~Kqcw~sKpRNR  355 (904)
T KOG4721|consen  283 IRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVG-------SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNR  355 (904)
T ss_pred             hhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEecc-------CCcccccCcccCchHHHHHHHHHHhcCCCCC
Confidence            999999999999999999999988776664332211110000       0000001112 23346678999999999999


Q ss_pred             CCHHHHhcCC
Q psy8260         377 ITAEQALAHP  386 (427)
Q Consensus       377 ~ta~e~L~Hp  386 (427)
                      |+..|+|.|=
T Consensus       356 PSFrqil~Hl  365 (904)
T KOG4721|consen  356 PSFRQILLHL  365 (904)
T ss_pred             ccHHHHHHHH
Confidence            9999999993

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.7e-33  Score=266.25  Aligned_cols=237  Identities=14%  Similarity=0.187  Sum_probs=166.4

Q ss_pred             cccCcccccEEEEeEEeCc-----------CCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          70 PTLSKESFDLIFSSALDSV-----------SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~-----------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      +.||+|+||.||++.....           ....||+|.+...  .......+.+|+.+++.++||||+++++++...  
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~--   76 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRD--   76 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--
Confidence            3689999999998875422           2346899987543  222334567899999999999999999987643  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCC-------EE
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE-------LK  208 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~-------~k  208 (427)
                          ...+++++++ +++|..++..  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.       +|
T Consensus        77 ----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~  152 (262)
T cd05077          77 ----VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIK  152 (262)
T ss_pred             ----CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeE
Confidence                3457888887 5778777753  45899999999999999999999999999999999999986654       89


Q ss_pred             EeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccc
Q psy8260         209 ILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVA  288 (427)
Q Consensus       209 l~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~g  288 (427)
                      ++|||++...... ....                                                             |
T Consensus       153 l~d~g~~~~~~~~-~~~~-------------------------------------------------------------~  170 (262)
T cd05077         153 LSDPGIPITVLSR-QECV-------------------------------------------------------------E  170 (262)
T ss_pred             eCCCCCCccccCc-cccc-------------------------------------------------------------c
Confidence            9999987543211 1122                                                             3


Q ss_pred             cccccchHHhh-hccCCCCCCHHHHHHHHHHhC-CCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHH
Q psy8260         289 TRWYRAPEIML-NWMHYNQTDIHQLNLIMEMLG-TPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLS  366 (427)
Q Consensus       289 t~~Y~APEvl~-~~~~~~~~d~~slg~i~~~lg-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~  366 (427)
                      +..|+|||++. +..+...+|+||+|++++.+. .+..++..... .....+......        .....++++.+||.
T Consensus       171 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~~~~~~~~~~~--------~~~~~~~~~~~li~  241 (262)
T cd05077         171 RIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL-AEKERFYEGQCM--------LVTPSCKELADLMT  241 (262)
T ss_pred             cccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHhcCcc--------CCCCChHHHHHHHH
Confidence            44555666554 233555679999999998763 22333322111 111111111110        11223567899999


Q ss_pred             HhcCCCCCCCCCHHHHhcC
Q psy8260         367 LMLELDSEKRITAEQALAH  385 (427)
Q Consensus       367 ~mL~~dP~~R~ta~e~L~H  385 (427)
                      +||+.||.+|||..|++++
T Consensus       242 ~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         242 HCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             HHcCCChhhCcCHHHHHHh
Confidence            9999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG1187|consensus

Probab=100.00  E-value=4e-34  Score=280.85  Aligned_cols=259  Identities=22%  Similarity=0.298  Sum_probs=179.2

Q ss_pred             CccccccC--cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeee
Q psy8260          56 QPYSEICR--GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVF  133 (427)
Q Consensus        56 ~~~~~~~~--~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~  133 (427)
                      +.|.++..  +.|.-.+.||+|+||.||++.++.  |+.||||++.......  ..++.+|+.++.+++|||+|+|++++
T Consensus        65 fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~--~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   65 FSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD--GTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             eeHHHHHHHHhCCchhcceecCCCeEEEEEEECC--CCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            44555544  456666899999999999988854  4899999886543322  34589999999999999999999986


Q ss_pred             ecCccccCCceEEEEeccC-CCCHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhcC---ceeccCCCCCeEEcCCCC
Q psy8260         134 HSNTCLADFKNVYMVTHLM-GADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCE  206 (427)
Q Consensus       134 ~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~---~l~~~~~~~~~~qi~~aL~yLH~~~---iiHrDLKp~NILl~~~~~  206 (427)
                      ...     ....++|.||+ +|+|.+.+...   .++|....+|+.++++||+|||...   ||||||||+|||+|++..
T Consensus       141 ~e~-----~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~  215 (361)
T KOG1187|consen  141 LEG-----GEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN  215 (361)
T ss_pred             ecC-----CceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC
Confidence            532     22467788877 68999988653   6899999999999999999999753   999999999999999999


Q ss_pred             EEEeeCCCCCCCCC-CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccc
Q psy8260         207 LKILDFGLARPTEN-EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTG  285 (427)
Q Consensus       207 ~kl~DFGla~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~  285 (427)
                      +||+|||+|+.... .....                                                           .
T Consensus       216 aKlsDFGLa~~~~~~~~~~~-----------------------------------------------------------~  236 (361)
T KOG1187|consen  216 AKLSDFGLAKLGPEGDTSVS-----------------------------------------------------------T  236 (361)
T ss_pred             EEccCccCcccCCcccccee-----------------------------------------------------------e
Confidence            99999999965432 11100                                                           0


Q ss_pred             c-cccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhc--CcHHHHHH----HhcC--CCCCcccHHhhcCC
Q psy8260         286 Y-VATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKI--SSDSARKY----INSL--PLLTKKDFRQVFKG  356 (427)
Q Consensus       286 ~-~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~--~~~~~~~~----~~~~--~~~~~~~~~~~~~~  356 (427)
                      . .||.+|+|||.+.......++|++|+|+++.++.++..+.....  .......+    +...  ..+.+..+..  ..
T Consensus       237 ~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~--~~  314 (361)
T KOG1187|consen  237 TVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKE--GE  314 (361)
T ss_pred             ecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccC--CC
Confidence            1 46666666666655557778899999998866544443222111  01111111    1110  0000000000  01


Q ss_pred             CC-----hhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy8260         357 AN-----PQAIDLLSLMLELDSEKRITAEQALA  384 (427)
Q Consensus       357 ~s-----~~~~dLi~~mL~~dP~~R~ta~e~L~  384 (427)
                      ..     ..+..+..+|++.+|.+||++.|+++
T Consensus       315 ~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  315 YPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             CChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            11     12557888999999999999999753

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-33  Score=264.52  Aligned_cols=244  Identities=28%  Similarity=0.431  Sum_probs=183.6

Q ss_pred             cCcccccEEEEeEEeCcCCcEEEEEEccCcCCC-HHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEEEec
Q psy8260          72 LSKESFDLIFSSALDSVSGVKVAIKKIARPFQS-AVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH  150 (427)
Q Consensus        72 lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~lv~e  150 (427)
                      ||.|+||.||.+. +..+++.||+|.+...... ......+.+|+.+++.++||||+++++.+..+      ...|++++
T Consensus         1 lg~G~~~~v~~~~-~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~~v~e   73 (250)
T cd05123           1 LGKGSFGKVLLVR-KKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTE------EKLYLVLE   73 (250)
T ss_pred             CCCCCceEEEEEE-ECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecC------CeeEEEEe
Confidence            6899999999754 5567899999988654322 22445677899999999999999999887643      46789998


Q ss_pred             cC-CCCHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCccccccc
Q psy8260         151 LM-GADLNNILRTQ-KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT  228 (427)
Q Consensus       151 ~~-g~~L~~~l~~~-~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt  228 (427)
                      ++ +++|.+++... .+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++........     
T Consensus        74 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-----  148 (250)
T cd05123          74 YAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-----  148 (250)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC-----
Confidence            88 88999888654 689999999999999999999999999999999999999999999999998864322100     


Q ss_pred             ccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCCCCC
Q psy8260         229 RWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD  308 (427)
Q Consensus       229 ~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d  308 (427)
                                                                           ......++..|+|||.+.+......+|
T Consensus       149 -----------------------------------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~D  175 (250)
T cd05123         149 -----------------------------------------------------RTNTFCGTPEYLAPEVLLGKGYGKAVD  175 (250)
T ss_pred             -----------------------------------------------------cccCCcCCccccChHHhCCCCCCchhh
Confidence                                                                 001123555667777666555666789


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH---HHHhcC
Q psy8260         309 IHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA---EQALAH  385 (427)
Q Consensus       309 ~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta---~e~L~H  385 (427)
                      +|++|++++.+.++..+|.................        ......+.+..+||.+||..||.+|||+   +++++|
T Consensus       176 ~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~  247 (250)
T cd05123         176 WWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPL--------RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH  247 (250)
T ss_pred             HHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC--------CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence            99999998877666655532211111111111000        1122347789999999999999999999   999999


Q ss_pred             CCC
Q psy8260         386 PYL  388 (427)
Q Consensus       386 p~f  388 (427)
                      |||
T Consensus       248 ~~f  250 (250)
T cd05123         248 PFF  250 (250)
T ss_pred             CCC
Confidence            998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.6e-33  Score=266.24  Aligned_cols=254  Identities=20%  Similarity=0.257  Sum_probs=183.4

Q ss_pred             cCcceeeccccCcccccEEEEeEEeC----cCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCc
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSALDS----VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNT  137 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~~~----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~  137 (427)
                      +...|.+...+|.|+||.||.+....    .+.+.||+|.+.... .......+.+|++++++++||||+++++++... 
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-   80 (275)
T cd05046           3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA-   80 (275)
T ss_pred             ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC-
Confidence            34567788899999999999776432    245679999875432 223456688999999999999999999987543 


Q ss_pred             cccCCceEEEEeccC-CCCHHHHHhhC----------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCC
Q psy8260         138 CLADFKNVYMVTHLM-GADLNNILRTQ----------KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE  206 (427)
Q Consensus       138 ~~~~~~~~~lv~e~~-g~~L~~~l~~~----------~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~  206 (427)
                           ...+++++++ +++|.+++...          .+++..+..++.|++.||.|||+++|+||||||+|||++.++.
T Consensus        81 -----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~  155 (275)
T cd05046          81 -----EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE  155 (275)
T ss_pred             -----CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCc
Confidence                 3468888888 68999988642          4899999999999999999999999999999999999999999


Q ss_pred             EEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccc
Q psy8260         207 LKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGY  286 (427)
Q Consensus       207 ~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~  286 (427)
                      ++++|||+++.......                                                         ......
T Consensus       156 ~~l~~~~~~~~~~~~~~---------------------------------------------------------~~~~~~  178 (275)
T cd05046         156 VKVSLLSLSKDVYNSEY---------------------------------------------------------YKLRNA  178 (275)
T ss_pred             EEEcccccccccCcccc---------------------------------------------------------cccCCc
Confidence            99999998763221100                                                         001122


Q ss_pred             cccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHH
Q psy8260         287 VATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLL  365 (427)
Q Consensus       287 ~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi  365 (427)
                      .+++.|+|||.+.+......+|+||+|++++.+-+ +..+|....................      .....++.+.++|
T Consensus       179 ~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~~i  252 (275)
T cd05046         179 LIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP------VPEGCPSRLYKLM  252 (275)
T ss_pred             eeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCC------CCCCCCHHHHHHH
Confidence            34566888888776666677899999999876533 3333322111111111110010010      1234567899999


Q ss_pred             HHhcCCCCCCCCCHHHHhcC
Q psy8260         366 SLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       366 ~~mL~~dP~~R~ta~e~L~H  385 (427)
                      .+||+.||.+|||+.|++++
T Consensus       253 ~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         253 TRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             HHHcCCCcccCCCHHHHHHH
Confidence            99999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.7e-33  Score=268.16  Aligned_cols=236  Identities=14%  Similarity=0.151  Sum_probs=166.8

Q ss_pred             ccCcccccEEEEeEEeC-----------------------cCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCce
Q psy8260          71 TLSKESFDLIFSSALDS-----------------------VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVI  127 (427)
Q Consensus        71 ~lg~g~fg~v~~~~~~~-----------------------~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv  127 (427)
                      .||+|+||.||.+....                       .....||+|.+...  .......+.+|+.+++.++||||+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv   79 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA   79 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence            68999999999886532                       12246899988542  222345577899999999999999


Q ss_pred             eeeeeeecCccccCCceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCC
Q psy8260         128 GLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED  204 (427)
Q Consensus       128 ~l~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~  204 (427)
                      ++++++...      ...+++|||+ +++|..+++.  +.+++..+..++.|++.||+|||++||+||||||+|||++..
T Consensus        80 ~~~~~~~~~------~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~  153 (274)
T cd05076          80 FVHGVCVRG------SENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARL  153 (274)
T ss_pred             eEEEEEEeC------CceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEecc
Confidence            999987643      3467888888 6788888754  468999999999999999999999999999999999999754


Q ss_pred             C-------CEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCC
Q psy8260         205 C-------ELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLAR  277 (427)
Q Consensus       205 ~-------~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~  277 (427)
                      +       .+|++|||++...... ...                                                    
T Consensus       154 ~~~~~~~~~~kl~d~g~~~~~~~~-~~~----------------------------------------------------  180 (274)
T cd05076         154 GLAEGTSPFIKLSDPGVSFTALSR-EER----------------------------------------------------  180 (274)
T ss_pred             CcccCccceeeecCCccccccccc-ccc----------------------------------------------------
Confidence            3       4899999987532111 111                                                    


Q ss_pred             CCccccccccccccccchHHhhh-ccCCCCCCHHHHHHHHHHh-CCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcC
Q psy8260         278 PTENEMTGYVATRWYRAPEIMLN-WMHYNQTDIHQLNLIMEML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFK  355 (427)
Q Consensus       278 ~~~~~~~~~~gt~~Y~APEvl~~-~~~~~~~d~~slg~i~~~l-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (427)
                               .++..|+|||++.+ ..+..++|+||+|++++.+ .++..++..... .....+.......        ..
T Consensus       181 ---------~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~~~~~~~~~~~--------~~  242 (274)
T cd05076         181 ---------VERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP-SEKERFYEKKHRL--------PE  242 (274)
T ss_pred             ---------ccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh-HHHHHHHHhccCC--------CC
Confidence                     23445666665543 2355677999999988765 233333332211 1111121111111        12


Q ss_pred             CCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         356 GANPQAIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       356 ~~s~~~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                      ..++++.+||.+||+.||++|||++|++++
T Consensus       243 ~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         243 PSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             CCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            245789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3.6e-33  Score=266.39  Aligned_cols=251  Identities=17%  Similarity=0.188  Sum_probs=178.7

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCc----EEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGV----KVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~----~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      .+.|++.+.||+|+||.||.+.. ..+|.    +||+|.+... .......++..|+.++++++||||+++++++..   
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~-~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~---   80 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIW-IPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG---   80 (279)
T ss_pred             HhhceeccccCccCCcceEEEEE-cCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC---
Confidence            45678889999999999997654 33443    5788877532 223334566788889999999999999998642   


Q ss_pred             ccCCceEEEEecc-CCCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         139 LADFKNVYMVTHL-MGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       139 ~~~~~~~~lv~e~-~g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                          ...++++++ .+++|.+++..  ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++
T Consensus        81 ----~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~  156 (279)
T cd05111          81 ----ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVA  156 (279)
T ss_pred             ----CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccc
Confidence                123455555 57899998854  46899999999999999999999999999999999999999999999999998


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      +.........                                                        ......++..|+||
T Consensus       157 ~~~~~~~~~~--------------------------------------------------------~~~~~~~~~~y~~p  180 (279)
T cd05111         157 DLLYPDDKKY--------------------------------------------------------FYSEHKTPIKWMAL  180 (279)
T ss_pred             eeccCCCccc--------------------------------------------------------ccCCCCCcccccCH
Confidence            6432110000                                                        00112355678888


Q ss_pred             HHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCC
Q psy8260         296 EIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       296 Evl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~  374 (427)
                      |++.+..+..++|+||+|++++.+.+ +..++... ......+..........      ....+.+..+++.+|+..||+
T Consensus       181 E~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~-~~~~~~~~~~~~~~~~~------~~~~~~~~~~li~~c~~~~p~  253 (279)
T cd05111         181 ESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM-RPHEVPDLLEKGERLAQ------PQICTIDVYMVMVKCWMIDEN  253 (279)
T ss_pred             HHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHCCCcCCC------CCCCCHHHHHHHHHHcCCCcc
Confidence            88877677778899999999987743 43333221 11112222221111110      122456788999999999999


Q ss_pred             CCCCHHHHhcC
Q psy8260         375 KRITAEQALAH  385 (427)
Q Consensus       375 ~R~ta~e~L~H  385 (427)
                      +|||++|+++.
T Consensus       254 ~Rps~~el~~~  264 (279)
T cd05111         254 VRPTFKELANE  264 (279)
T ss_pred             cCcCHHHHHHH
Confidence            99999999763

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=8.9e-34  Score=267.21  Aligned_cols=251  Identities=22%  Similarity=0.320  Sum_probs=180.0

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCc---CCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccC
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP---FQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~---~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      +|.+.+.||+|+||.||.+. +..++..+++|.++..   ........++.+|+.+++.++||||+++++++...     
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----   74 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVK-DKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER-----   74 (260)
T ss_pred             CceeeeeecCCCCceEEEEE-ecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC-----
Confidence            36778899999999999754 4455666666655432   11222334566899999999999999999887543     


Q ss_pred             CceEEEEeccC-CCCHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         142 FKNVYMVTHLM-GADLNNILRT-----QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                       ...+++++++ +++|..++..     ..+++..+..++.|++.||.|||++|++|+||||+||+++. +.+||+|||++
T Consensus        75 -~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~  152 (260)
T cd08222          75 -DAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVS  152 (260)
T ss_pred             -CceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCce
Confidence             3567888877 6788877642     46899999999999999999999999999999999999975 56999999987


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      +.......                                                          ......|++.|+||
T Consensus       153 ~~~~~~~~----------------------------------------------------------~~~~~~~~~~~~~p  174 (260)
T cd08222         153 RLLMGSCD----------------------------------------------------------LATTFTGTPYYMSP  174 (260)
T ss_pred             eecCCCcc----------------------------------------------------------cccCCCCCcCccCH
Confidence            64321100                                                          00112356677888


Q ss_pred             HHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCC
Q psy8260         296 EIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEK  375 (427)
Q Consensus       296 Evl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~  375 (427)
                      |.+.+..+..++|+|++|++++.+-++..++..........+......       .......++++.|||.+||+.||++
T Consensus       175 e~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~  247 (260)
T cd08222         175 EALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPT-------PSLPETYSRQLNSIMQSMLNKDPSL  247 (260)
T ss_pred             HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCC-------CCCcchhcHHHHHHHHHHhcCChhh
Confidence            877666666778999999999877555444432211111111111100       0112345789999999999999999


Q ss_pred             CCCHHHHhcCCCC
Q psy8260         376 RITAEQALAHPYL  388 (427)
Q Consensus       376 R~ta~e~L~Hp~f  388 (427)
                      ||+++|+++||||
T Consensus       248 Rp~~~~il~~~~~  260 (260)
T cd08222         248 RPSAAEILRNPFI  260 (260)
T ss_pred             CcCHHHHhhCCCC
Confidence            9999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-33  Score=263.14  Aligned_cols=250  Identities=23%  Similarity=0.317  Sum_probs=185.4

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      ++....|.+.+.||.|+||.||++.. . .++.||||.+.....   ....+.+|+.++++++||||+++++++...   
T Consensus         2 ~~~~~~~~i~~~ig~g~~~~v~~~~~-~-~~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---   73 (261)
T cd05034           2 EIPRESLKLERKLGAGQFGEVWMGTW-N-GTTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSEE---   73 (261)
T ss_pred             ccchhheeeeeeeccCcceEEEEEEE-c-CCceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeecC---
Confidence            56678899999999999999997653 3 457899998865332   234577899999999999999999987643   


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                         ...+++++++ +++|.+++..   ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++
T Consensus        74 ---~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~  150 (261)
T cd05034          74 ---EPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLA  150 (261)
T ss_pred             ---CceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccc
Confidence               3468888877 6799988864   35899999999999999999999999999999999999999999999999988


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      +........                                                         ...+..++..|+||
T Consensus       151 ~~~~~~~~~---------------------------------------------------------~~~~~~~~~~y~~P  173 (261)
T cd05034         151 RLIEDDEYT---------------------------------------------------------AREGAKFPIKWTAP  173 (261)
T ss_pred             eeccchhhh---------------------------------------------------------hhhccCCCccccCH
Confidence            643221000                                                         00011234568888


Q ss_pred             HHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCC
Q psy8260         296 EIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       296 Evl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~  374 (427)
                      |.+.+......+|+||+|++++.+-+ +..+|..........+.......       ......++++.+++.+||+.||.
T Consensus       174 E~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~~p~  246 (261)
T cd05034         174 EAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM-------PRPPNCPEELYDLMLQCWDKDPE  246 (261)
T ss_pred             HHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------CCCCCCCHHHHHHHHHHcccCcc
Confidence            88877667777899999999877654 44444322111112222111110       11123467899999999999999


Q ss_pred             CCCCHHHHhc
Q psy8260         375 KRITAEQALA  384 (427)
Q Consensus       375 ~R~ta~e~L~  384 (427)
                      +|||++++.+
T Consensus       247 ~Rp~~~~l~~  256 (261)
T cd05034         247 ERPTFEYLQS  256 (261)
T ss_pred             cCCCHHHHHH
Confidence            9999999864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.7e-33  Score=267.61  Aligned_cols=249  Identities=20%  Similarity=0.283  Sum_probs=179.6

Q ss_pred             eeeccccCcccccEEEEeEEeC----cCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccC
Q psy8260          66 IDIGPTLSKESFDLIFSSALDS----VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      |.+.+.||+|+||.||++....    .....||+|.+... .......++.+|+.+++.++||||+++++.+...     
T Consensus         2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----   75 (290)
T cd05045           2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN-ASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD-----   75 (290)
T ss_pred             ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCC-CCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC-----
Confidence            5677899999999999875432    23356889887643 2344456788999999999999999999987643     


Q ss_pred             CceEEEEeccC-CCCHHHHHhh-------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCC
Q psy8260         142 FKNVYMVTHLM-GADLNNILRT-------------------------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLK  195 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l~~-------------------------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLK  195 (427)
                       ...+++++++ +++|.+++..                         ..+++..+..++.|++.||.|||++||+|||||
T Consensus        76 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dik  154 (290)
T cd05045          76 -GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLA  154 (290)
T ss_pred             -CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhh
Confidence             3457777777 6889887753                         236788889999999999999999999999999


Q ss_pred             CCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCC
Q psy8260         196 PSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGL  275 (427)
Q Consensus       196 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~  275 (427)
                      |+|||+++++.+||+|||+++........                   .                               
T Consensus       155 p~nill~~~~~~kl~dfg~~~~~~~~~~~-------------------~-------------------------------  184 (290)
T cd05045         155 ARNVLVAEGRKMKISDFGLSRDVYEEDSY-------------------V-------------------------------  184 (290)
T ss_pred             hheEEEcCCCcEEeccccccccccCccch-------------------h-------------------------------
Confidence            99999999999999999998643221100                   0                               


Q ss_pred             CCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhc
Q psy8260         276 ARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVF  354 (427)
Q Consensus       276 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (427)
                            ......++..|+|||++.+..+...+|+||+|++++.|.+ +..+|.... ..............      ...
T Consensus       185 ------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-~~~~~~~~~~~~~~------~~~  251 (290)
T cd05045         185 ------KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA-PERLFNLLKTGYRM------ERP  251 (290)
T ss_pred             ------cccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHhCCCCC------CCC
Confidence                  0001123556888888777667778899999999877654 443342221 11111222111000      012


Q ss_pred             CCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy8260         355 KGANPQAIDLLSLMLELDSEKRITAEQALA  384 (427)
Q Consensus       355 ~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~  384 (427)
                      ...+.++.+||.+||+.||.+|||++|+++
T Consensus       252 ~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         252 ENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             CCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            346788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.8e-33  Score=264.37  Aligned_cols=248  Identities=21%  Similarity=0.247  Sum_probs=168.2

Q ss_pred             cccCcccccEEEEeEEe-CcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEEE
Q psy8260          70 PTLSKESFDLIFSSALD-SVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV  148 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~-~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~lv  148 (427)
                      +.||+|+||.||.+... ......+|+|.+... ........+.+|+.+++.++||||+++++.+...      ...|++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~------~~~~lv   73 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES------IPYLLV   73 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC------CceEEE
Confidence            35899999999987543 335567999987543 2333445677999999999999999999987643      457889


Q ss_pred             eccC-CCCHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         149 THLM-GADLNNILRTQ------KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       149 ~e~~-g~~L~~~l~~~------~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      +|++ +++|.+++...      ..++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  153 (269)
T cd05042          74 LEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPE  153 (269)
T ss_pred             EEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccc
Confidence            9888 68999988643      2457778899999999999999999999999999999999999999999998643211


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh-
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN-  300 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~-  300 (427)
                      ....                                                        ......+++.|+|||++.. 
T Consensus       154 ~~~~--------------------------------------------------------~~~~~~~~~~y~aPE~~~~~  177 (269)
T cd05042         154 DYYI--------------------------------------------------------TKDCHAVPLRWLAPELVEIR  177 (269)
T ss_pred             hhee--------------------------------------------------------ccCCCCCcccccCHHHHhhc
Confidence            0000                                                        0001122344555555432 


Q ss_pred             ------ccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCC-CCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         301 ------WMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLP-LLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       301 ------~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                            ..+..++|+||+|++++.+-+ +..+|......+...+...... .....   ......++...+++..|+ .|
T Consensus       178 ~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~-~d  253 (269)
T cd05042         178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKP---QLDLKYSDRWYEVMQFCW-LD  253 (269)
T ss_pred             cccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCC---cccccCCHHHHHHHHHHh-cC
Confidence                  123456799999999877643 3333322111112222221111 11111   122345778889998888 59


Q ss_pred             CCCCCCHHHHhc
Q psy8260         373 SEKRITAEQALA  384 (427)
Q Consensus       373 P~~R~ta~e~L~  384 (427)
                      |++|||++|+++
T Consensus       254 p~~Rpt~~~v~~  265 (269)
T cd05042         254 PETRPTAEEVHE  265 (269)
T ss_pred             cccccCHHHHHH
Confidence            999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.9e-33  Score=265.36  Aligned_cols=253  Identities=21%  Similarity=0.288  Sum_probs=183.6

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCc--CCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSV--SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~--~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      +....+.+.+.+|.|+||.||.+.....  +...||||...... .....+.+.+|+.+++.++||||+++++++..   
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~---   78 (270)
T cd05056           3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE---   78 (270)
T ss_pred             echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC---
Confidence            4456688899999999999998765332  24568999875432 24455678899999999999999999998754   


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~~--~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                          ...|++++++ +++|.+++...  .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++
T Consensus        79 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~  154 (270)
T cd05056          79 ----NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLS  154 (270)
T ss_pred             ----CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCcee
Confidence                2356777777 78999988653  4899999999999999999999999999999999999999999999999988


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      +....... +                                                        ......+++.|+||
T Consensus       155 ~~~~~~~~-~--------------------------------------------------------~~~~~~~~~~y~aP  177 (270)
T cd05056         155 RYLEDESY-Y--------------------------------------------------------KASKGKLPIKWMAP  177 (270)
T ss_pred             eecccccc-e--------------------------------------------------------ecCCCCccccccCh
Confidence            64322100 0                                                        00011234568888


Q ss_pred             HHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCC
Q psy8260         296 EIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       296 Evl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~  374 (427)
                      |++....+...+|+||+|++++.+.+ +..+|................ ..      ......++++.+||.+||..||.
T Consensus       178 E~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~~------~~~~~~~~~~~~li~~~l~~~P~  250 (270)
T cd05056         178 ESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE-RL------PMPPNCPPTLYSLMTKCWAYDPS  250 (270)
T ss_pred             hhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-cC------CCCCCCCHHHHHHHHHHcCCChh
Confidence            88776667778899999999876432 333332221111111111111 01      12245678999999999999999


Q ss_pred             CCCCHHHHhcC
Q psy8260         375 KRITAEQALAH  385 (427)
Q Consensus       375 ~R~ta~e~L~H  385 (427)
                      +|||+.+++..
T Consensus       251 ~Rpt~~~~~~~  261 (270)
T cd05056         251 KRPRFTELKAQ  261 (270)
T ss_pred             hCcCHHHHHHH
Confidence            99999998864

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=6.1e-33  Score=262.69  Aligned_cols=255  Identities=22%  Similarity=0.300  Sum_probs=184.4

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCc--CCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSV--SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~--~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      +....|+..+.+|+|+||.||++.....  ....||+|.+.... .......+.+|++++++++||||+++.+++...  
T Consensus         2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--   78 (268)
T cd05063           2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF--   78 (268)
T ss_pred             CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC--
Confidence            3445678889999999999997665322  22479999886432 334456678999999999999999999987643  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                          ...|+++|++ +++|.+++..  ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++
T Consensus        79 ----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~  154 (268)
T cd05063          79 ----KPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLS  154 (268)
T ss_pred             ----CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccc
Confidence                4578888877 6789888864  45899999999999999999999999999999999999999999999999988


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      ...........                                                       .......++.|+||
T Consensus       155 ~~~~~~~~~~~-------------------------------------------------------~~~~~~~~~~y~~P  179 (268)
T cd05063         155 RVLEDDPEGTY-------------------------------------------------------TTSGGKIPIRWTAP  179 (268)
T ss_pred             eecccccccce-------------------------------------------------------eccCCCcCceecCH
Confidence            64322110000                                                       00011124568888


Q ss_pred             HHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCC
Q psy8260         296 EIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       296 Evl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~  374 (427)
                      |++.+..+..++|+||+|++++.+.+ +..||......+ ....+......+      .....+.++.+||.+||+.||.
T Consensus       180 E~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-~~~~i~~~~~~~------~~~~~~~~~~~li~~c~~~~p~  252 (268)
T cd05063         180 EAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-VMKAINDGFRLP------APMDCPSAVYQLMLQCWQQDRA  252 (268)
T ss_pred             HHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhcCCCCC------CCCCCCHHHHHHHHHHcCCCcc
Confidence            88877667778899999999987533 444443322111 111111111000      1123567889999999999999


Q ss_pred             CCCCHHHHhc
Q psy8260         375 KRITAEQALA  384 (427)
Q Consensus       375 ~R~ta~e~L~  384 (427)
                      +||+++++++
T Consensus       253 ~Rp~~~~i~~  262 (268)
T cd05063         253 RRPRFVDIVN  262 (268)
T ss_pred             cCcCHHHHHH
Confidence            9999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=4.5e-33  Score=261.24  Aligned_cols=247  Identities=24%  Similarity=0.354  Sum_probs=181.0

Q ss_pred             eeccccCcccccEEEEeEEeCc---CCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          67 DIGPTLSKESFDLIFSSALDSV---SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        67 ~~~~~lg~g~fg~v~~~~~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      .+.+.+|.|+||.||.+.....   ++..||+|.+.... .......+.+|+.+++.++|+||+++++++...      .
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~   74 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE------E   74 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC------C
Confidence            4678899999999997655432   24889999986543 222456778999999999999999999987653      3


Q ss_pred             eEEEEeccC-CCCHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRTQK---LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~~~---l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                      ..+++++++ +++|.+++....   +++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++...
T Consensus        75 ~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~  154 (258)
T smart00219       75 PLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY  154 (258)
T ss_pred             eeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecc
Confidence            578888877 789998886432   8999999999999999999999999999999999999999999999999986443


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      .....                                                         ......+++.|+|||.+.
T Consensus       155 ~~~~~---------------------------------------------------------~~~~~~~~~~y~~Pe~~~  177 (258)
T smart00219      155 DDDYY---------------------------------------------------------KKKGGKLPIRWMAPESLK  177 (258)
T ss_pred             ccccc---------------------------------------------------------ccccCCCcccccChHHhc
Confidence            22000                                                         000112566788888887


Q ss_pred             hccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC
Q psy8260         300 NWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT  378 (427)
Q Consensus       300 ~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t  378 (427)
                      +..+..++|+|++|++++.+.+ +..++............. .....      ......+.++.++|.+||..||.+|||
T Consensus       178 ~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~------~~~~~~~~~~~~~i~~~l~~~p~~Rpt  250 (258)
T smart00219      178 DGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLK-KGYRL------PKPENCPPEIYKLMLQCWAEDPEDRPT  250 (258)
T ss_pred             cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCC------CCCCcCCHHHHHHHHHHCcCChhhCcC
Confidence            6667778899999999876633 222332211111111111 11110      111236788999999999999999999


Q ss_pred             HHHHhc
Q psy8260         379 AEQALA  384 (427)
Q Consensus       379 a~e~L~  384 (427)
                      +.|+++
T Consensus       251 ~~~ll~  256 (258)
T smart00219      251 FSELVE  256 (258)
T ss_pred             HHHHHh
Confidence            999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=6.6e-33  Score=262.76  Aligned_cols=256  Identities=20%  Similarity=0.270  Sum_probs=184.8

Q ss_pred             CcceeeccccCcccccEEEEeEEeCc--CCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcccc
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSV--SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~--~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  140 (427)
                      .+.+++.+.||+|+||.||++.....  ++..||||.+.... .......+.+|+.+++.++||||+++++++...    
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~----   77 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS----   77 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC----
Confidence            35678899999999999997654322  23479999886542 344556788999999999999999999987643    


Q ss_pred             CCceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCC
Q psy8260         141 DFKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP  217 (427)
Q Consensus       141 ~~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~  217 (427)
                        ...++++|++ +++|.++++.  +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.
T Consensus        78 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~  155 (269)
T cd05065          78 --RPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRF  155 (269)
T ss_pred             --CceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccc
Confidence              3568888887 6789988864  4589999999999999999999999999999999999999999999999998864


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      .......    ..+.                                                 ...+...+..|+|||+
T Consensus       156 ~~~~~~~----~~~~-------------------------------------------------~~~~~~~~~~y~~PE~  182 (269)
T cd05065         156 LEDDTSD----PTYT-------------------------------------------------SSLGGKIPIRWTAPEA  182 (269)
T ss_pred             cccCccc----cccc-------------------------------------------------cccCCCcceeecCHhH
Confidence            3221100    0000                                                 0001112456889998


Q ss_pred             hhhccCCCCCCHHHHHHHHHHhC-CCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCC
Q psy8260         298 MLNWMHYNQTDIHQLNLIMEMLG-TPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKR  376 (427)
Q Consensus       298 l~~~~~~~~~d~~slg~i~~~lg-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R  376 (427)
                      +.+..+...+|+||+|++++.+. .+..+|....... ..+........+      .....++.+.+++.+||+.||.+|
T Consensus       183 ~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~-~~~~i~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~R  255 (269)
T cd05065         183 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-VINAIEQDYRLP------PPMDCPTALHQLMLDCWQKDRNAR  255 (269)
T ss_pred             hccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH-HHHHHHcCCcCC------CcccCCHHHHHHHHHHcCCChhhC
Confidence            88777777889999999987643 2434443322111 111111110000      112456788999999999999999


Q ss_pred             CCHHHHhcC
Q psy8260         377 ITAEQALAH  385 (427)
Q Consensus       377 ~ta~e~L~H  385 (427)
                      ||++++++.
T Consensus       256 p~~~~i~~~  264 (269)
T cd05065         256 PKFGQIVST  264 (269)
T ss_pred             cCHHHHHHH
Confidence            999999863

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG0587|consensus

Probab=100.00  E-value=4.6e-34  Score=291.03  Aligned_cols=265  Identities=20%  Similarity=0.370  Sum_probs=201.9

Q ss_pred             cCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCcccc
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~  140 (427)
                      ..+.|+|-.++|+|.+|.||+ +.++++|+.+|||++.....   ..+.+..|.++|+.+ .|||++.++++|..... .
T Consensus        17 p~d~~ei~evig~Gtygkv~k-~k~~~~~~~aa~kI~~~~~d---~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~-~   91 (953)
T KOG0587|consen   17 PADIFEIIEVIGNGTYGKVYK-GRHVKTGQLAAIKIMDPTED---EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP-G   91 (953)
T ss_pred             CCCccEEEEEEeeccceeEEE-EeeeecCceeeeEeecCCcc---ccHHHHHHHHHHHhccCCCCcceEEEEEEEecC-C
Confidence            456788899999999999995 67888999999998764322   223455688888876 79999999999864333 2


Q ss_pred             CCceEEEEeccC-CCCHHHHHh---hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         141 DFKNVYMVTHLM-GADLNNILR---TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       141 ~~~~~~lv~e~~-g~~L~~~l~---~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                      ..+.+++|||+| ||+..++++   ..++.|..+..|++.++.||.+||.+.+||||+|-.|||++.++.|||+|||++.
T Consensus        92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSa  171 (953)
T KOG0587|consen   92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSA  171 (953)
T ss_pred             CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeee
Confidence            345789999999 578887775   4679999999999999999999999999999999999999999999999999987


Q ss_pred             CCCC---CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccccc
Q psy8260         217 PTEN---EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR  293 (427)
Q Consensus       217 ~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~  293 (427)
                      ....   ...+.+||++|||||++.....++.                                                
T Consensus       172 QldsT~grRnT~iGtP~WMAPEViac~e~~d~------------------------------------------------  203 (953)
T KOG0587|consen  172 QLDSTVGRRNTFIGTPYWMAPEVIACDESPDA------------------------------------------------  203 (953)
T ss_pred             eeecccccccCcCCCcccccceeeecccCCCC------------------------------------------------
Confidence            6543   3456788888888888754221111                                                


Q ss_pred             chHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCC
Q psy8260         294 APEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDS  373 (427)
Q Consensus       294 APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP  373 (427)
                              .|...+|+||||++.-+||-+++|+.+--.   .+..+ ..|.-++..+ ..+...+.++.|||+.||..|-
T Consensus       204 --------tyd~R~D~WsLGITaIEladG~PPl~DmHP---mraLF-~IpRNPPPkL-krp~kWs~~FndFIs~cL~Kd~  270 (953)
T KOG0587|consen  204 --------TYDYRSDLWSLGITAIEMAEGAPPLCDMHP---MRALF-LIPRNPPPKL-KRPKKWSKKFNDFISTCLVKDY  270 (953)
T ss_pred             --------CcccccchhhccceeehhcCCCCCccCcch---hhhhc-cCCCCCCccc-cchhhHHHHHHHHHHHHHhhcc
Confidence                    144457999999999999888877654321   12111 1221111111 1123447788999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCCC
Q psy8260         374 EKRITAEQALAHPYLSQYS  392 (427)
Q Consensus       374 ~~R~ta~e~L~Hp~f~~~~  392 (427)
                      .+||+..++|+|||+.+..
T Consensus       271 e~RP~~~~ll~hpFi~e~~  289 (953)
T KOG0587|consen  271 EQRPSTEELLKHPFITEQP  289 (953)
T ss_pred             ccCcchhhhccCCcccccc
Confidence            9999999999999998543

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=7.2e-33  Score=261.19  Aligned_cols=249  Identities=20%  Similarity=0.248  Sum_probs=175.0

Q ss_pred             cccCcccccEEEEeEEeC--cCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEE
Q psy8260          70 PTLSKESFDLIFSSALDS--VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYM  147 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~l  147 (427)
                      +.||+|+||.||++....  ..+..||||.+... ........+.+|+.+++.++||||+++++++...     ....++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~~l   74 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS-----EGSPLV   74 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC-----CCCcEE
Confidence            368999999999876432  24567999987532 2334456678999999999999999999875432     133567


Q ss_pred             EeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCccc
Q psy8260         148 VTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTG  224 (427)
Q Consensus       148 v~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~  224 (427)
                      +++++ +++|.+++..  ...++..+..++.|++.||.|||+++++||||||+|||++.++.+||+|||+++........
T Consensus        75 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          75 VLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            77776 7899998864  34677788889999999999999999999999999999999999999999998643221100


Q ss_pred             ccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCC
Q psy8260         225 YVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHY  304 (427)
Q Consensus       225 ~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~  304 (427)
                              .+                                              ....+..++..|+|||++.+..+.
T Consensus       155 --------~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~  180 (262)
T cd05058         155 --------SV----------------------------------------------HNHTGAKLPVKWMALESLQTQKFT  180 (262)
T ss_pred             --------ee----------------------------------------------cccccCcCCccccChhHhccCccc
Confidence                    00                                              000112345678888888776677


Q ss_pred             CCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q psy8260         305 NQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQAL  383 (427)
Q Consensus       305 ~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L  383 (427)
                      .++|+||+|++++.+.+ +..++... ................      .....++.+.+++.+||+.||++|||+.|++
T Consensus       181 ~~~Di~slG~~l~el~~~~~~~~~~~-~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il  253 (262)
T cd05058         181 TKSDVWSFGVLLWELMTRGAPPYPDV-DSFDITVYLLQGRRLL------QPEYCPDPLYEVMLSCWHPKPEMRPTFSELV  253 (262)
T ss_pred             hHHHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHhcCCCCC------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence            78899999999987733 22222211 1111111111110000      0123467899999999999999999999998


Q ss_pred             cC
Q psy8260         384 AH  385 (427)
Q Consensus       384 ~H  385 (427)
                      +.
T Consensus       254 ~~  255 (262)
T cd05058         254 SR  255 (262)
T ss_pred             HH
Confidence            64

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=6.6e-33  Score=261.53  Aligned_cols=250  Identities=21%  Similarity=0.276  Sum_probs=184.5

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      +++..+.+.+.+.+|+|+||.||.+..  ..+..||+|.+...   ......+.+|+++++.++|+||+++++.+..   
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~--~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---   72 (260)
T cd05073           1 WEIPRESLKLEKKLGAGQFGEVWMATY--NKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK---   72 (260)
T ss_pred             CcccccceeEEeEecCccceEEEEEEe--cCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC---
Confidence            366778899999999999999997653  34567999987643   2334567889999999999999999988754   


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL  214 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGl  214 (427)
                          ...+++++++ +++|.+++..   ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||+
T Consensus        73 ----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~  148 (260)
T cd05073          73 ----EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGL  148 (260)
T ss_pred             ----CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcc
Confidence                2468888887 6799988864   2478888999999999999999999999999999999999999999999998


Q ss_pred             CCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccc
Q psy8260         215 ARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRA  294 (427)
Q Consensus       215 a~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~A  294 (427)
                      +.........                                                         ...+..++..|+|
T Consensus       149 ~~~~~~~~~~---------------------------------------------------------~~~~~~~~~~y~~  171 (260)
T cd05073         149 ARVIEDNEYT---------------------------------------------------------AREGAKFPIKWTA  171 (260)
T ss_pred             eeeccCCCcc---------------------------------------------------------cccCCcccccccC
Confidence            8643211000                                                         0011224566888


Q ss_pred             hHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCC
Q psy8260         295 PEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDS  373 (427)
Q Consensus       295 PEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP  373 (427)
                      ||++....+...+|+|++|++++.+-+ +..+|.......... ........      ......+.++.+++.+||+.||
T Consensus       172 PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~-~~~~~~~~------~~~~~~~~~~~~~i~~~l~~~p  244 (260)
T cd05073         172 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR-ALERGYRM------PRPENCPEELYNIMMRCWKNRP  244 (260)
T ss_pred             HhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHH-HHhCCCCC------CCcccCCHHHHHHHHHHcccCc
Confidence            888876666777899999999876654 444443221111111 11111111      1123467889999999999999


Q ss_pred             CCCCCHHHHhc
Q psy8260         374 EKRITAEQALA  384 (427)
Q Consensus       374 ~~R~ta~e~L~  384 (427)
                      ++|||+.++++
T Consensus       245 ~~Rp~~~~l~~  255 (260)
T cd05073         245 EERPTFEYIQS  255 (260)
T ss_pred             ccCcCHHHHHH
Confidence            99999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=7.7e-33  Score=260.22  Aligned_cols=246  Identities=22%  Similarity=0.239  Sum_probs=180.2

Q ss_pred             cccCcccccEEEEeEEeCcCC--cEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEE
Q psy8260          70 PTLSKESFDLIFSSALDSVSG--VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYM  147 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~~g--~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~l  147 (427)
                      +.||.|++|.||++......+  ..||||.+...... ...+.+.+|++++++++||||+++++++..       ...++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------~~~~~   72 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-------HPLMM   72 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-------CeEEE
Confidence            368999999999876644344  36999998765432 455678899999999999999999998754       34688


Q ss_pred             EeccC-CCCHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcc
Q psy8260         148 VTHLM-GADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT  223 (427)
Q Consensus       148 v~e~~-g~~L~~~l~~~---~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~  223 (427)
                      ++|++ +++|.+.+...   .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.......
T Consensus        73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (257)
T cd05040          73 VTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED  152 (257)
T ss_pred             EEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccc
Confidence            88887 78999888653   488999999999999999999999999999999999999999999999999875432110


Q ss_pred             cccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccC
Q psy8260         224 GYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH  303 (427)
Q Consensus       224 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~  303 (427)
                      .      |            .                                     ......++..|+|||++.+..+
T Consensus       153 ~------~------------~-------------------------------------~~~~~~~~~~y~~pE~~~~~~~  177 (257)
T cd05040         153 H------Y------------V-------------------------------------MEEHLKVPFAWCAPESLRTRTF  177 (257)
T ss_pred             c------e------------e-------------------------------------cccCCCCCceecCHHHhcccCc
Confidence            0      0            0                                     0001235667889998877777


Q ss_pred             CCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q psy8260         304 YNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQA  382 (427)
Q Consensus       304 ~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~  382 (427)
                      ...+|+||+|++++.+-+ +..++......+.............      .....+.++.+|+.+||+.||++|||++|+
T Consensus       178 ~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~  251 (257)
T cd05040         178 SHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLE------RPEACPQDIYNVMLQCWAHNPADRPTFAAL  251 (257)
T ss_pred             CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCC------CCccCCHHHHHHHHHHCCCCcccCCCHHHH
Confidence            788999999999987733 3333321111111111111111110      112356789999999999999999999998


Q ss_pred             hc
Q psy8260         383 LA  384 (427)
Q Consensus       383 L~  384 (427)
                      ++
T Consensus       252 ~~  253 (257)
T cd05040         252 RE  253 (257)
T ss_pred             HH
Confidence            75

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.6e-33  Score=265.49  Aligned_cols=237  Identities=12%  Similarity=0.170  Sum_probs=168.4

Q ss_pred             cccCcccccEEEEeEEeC------cCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          70 PTLSKESFDLIFSSALDS------VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~------~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      +.||.|+||.||++....      .....||+|.+...  .....+.+.+|+.+++.++||||+++++++...      .
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~------~   72 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG------D   72 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC------C
Confidence            368999999999765432      12345888877532  223345677899999999999999999998653      3


Q ss_pred             eEEEEeccC-CCCHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCC--------EEEeeC
Q psy8260         144 NVYMVTHLM-GADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE--------LKILDF  212 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~~--~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~--------~kl~DF  212 (427)
                      ..++++|++ +++|..+++..  .+++..+..++.||+.||.|||++||+||||||+|||++.++.        +|++||
T Consensus        73 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~  152 (258)
T cd05078          73 ESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP  152 (258)
T ss_pred             CcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccc
Confidence            467888888 67999988653  4899999999999999999999999999999999999987654        688898


Q ss_pred             CCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccc
Q psy8260         213 GLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWY  292 (427)
Q Consensus       213 Gla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y  292 (427)
                      |++...... ..                                                             ..+++.|
T Consensus       153 g~~~~~~~~-~~-------------------------------------------------------------~~~~~~y  170 (258)
T cd05078         153 GISITVLPK-EI-------------------------------------------------------------LLERIPW  170 (258)
T ss_pred             ccccccCCc-hh-------------------------------------------------------------ccccCCc
Confidence            876532211 11                                                             1244556


Q ss_pred             cchHHhhhc-cCCCCCCHHHHHHHHHHhCCCC-HHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcC
Q psy8260         293 RAPEIMLNW-MHYNQTDIHQLNLIMEMLGTPP-AEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLE  370 (427)
Q Consensus       293 ~APEvl~~~-~~~~~~d~~slg~i~~~lg~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~  370 (427)
                      +|||++.+. .+...+|+||+|++++.+.++. .++.. ...............        .....++++.+||.+||+
T Consensus       171 ~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~-~~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~  241 (258)
T cd05078         171 VPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA-LDSQKKLQFYEDRHQ--------LPAPKWTELANLINQCMD  241 (258)
T ss_pred             cCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh-ccHHHHHHHHHcccc--------CCCCCcHHHHHHHHHHhc
Confidence            666666542 3455689999999998775542 22221 111111111111111        112345788999999999


Q ss_pred             CCCCCCCCHHHHhcC
Q psy8260         371 LDSEKRITAEQALAH  385 (427)
Q Consensus       371 ~dP~~R~ta~e~L~H  385 (427)
                      .||++|||++++++.
T Consensus       242 ~~p~~Rps~~~il~~  256 (258)
T cd05078         242 YEPDFRPSFRAIIRD  256 (258)
T ss_pred             cChhhCCCHHHHHHh
Confidence            999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.3e-33  Score=266.60  Aligned_cols=248  Identities=21%  Similarity=0.341  Sum_probs=179.3

Q ss_pred             eeccccCcccccEEEEeEEe---CcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          67 DIGPTLSKESFDLIFSSALD---SVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        67 ~~~~~lg~g~fg~v~~~~~~---~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      .+.+.||.|.||.||.+.+.   ...+..||||.+.. .......+.+.+|++.+++++||||+++++++...      .
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~------~   74 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN------E   74 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS------S
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeeccccccccccccccccccccccc------c
Confidence            45678999999999988876   23467899999854 33445577889999999999999999999998632      3


Q ss_pred             eEEEEeccC-CCCHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~~---~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                      ..++++|++ +++|.+++...   .+++.....++.||+.||.|||+++++|+||+++|||++.++.+||+|||+++...
T Consensus        75 ~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~  154 (259)
T PF07714_consen   75 PLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPIS  154 (259)
T ss_dssp             SEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            477888887 58999988765   69999999999999999999999999999999999999999999999999986441


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      .....                                                        .......+...|+|||++.
T Consensus       155 ~~~~~--------------------------------------------------------~~~~~~~~~~~~~aPE~~~  178 (259)
T PF07714_consen  155 EKSKY--------------------------------------------------------KNDSSQQLPLRYLAPEVLK  178 (259)
T ss_dssp             TSSSE--------------------------------------------------------EESTTSESGGGGS-HHHHH
T ss_pred             ccccc--------------------------------------------------------ccccccccccccccccccc
Confidence            11000                                                        0011123456788888888


Q ss_pred             hccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC
Q psy8260         300 NWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT  378 (427)
Q Consensus       300 ~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t  378 (427)
                      +..+..++|+||+|++++++-+ +..++......+...+. .....      .......+....++|.+|+..||.+|||
T Consensus       179 ~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~------~~~~~~~~~~~~~li~~C~~~~p~~RPs  251 (259)
T PF07714_consen  179 DGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQR------LPIPDNCPKDIYSLIQQCWSHDPEKRPS  251 (259)
T ss_dssp             HSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEE------TTSBTTSBHHHHHHHHHHT-SSGGGS--
T ss_pred             cccccccccccccccccccccccccccccccccccccccc-ccccc------ceeccchhHHHHHHHHHHcCCChhhCcC
Confidence            7777778899999999877755 44444332211212222 11111      0112345778899999999999999999


Q ss_pred             HHHHhc
Q psy8260         379 AEQALA  384 (427)
Q Consensus       379 a~e~L~  384 (427)
                      ++++++
T Consensus       252 ~~~i~~  257 (259)
T PF07714_consen  252 FQEILQ  257 (259)
T ss_dssp             HHHHHH
T ss_pred             HHHHHh
Confidence            999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=6.2e-33  Score=260.68  Aligned_cols=247  Identities=20%  Similarity=0.279  Sum_probs=180.8

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      ..+.+.+.+|.|+||.||++...  .+..+|+|.+......   ...+.+|++++++++||||+++++++...      .
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~--~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~   72 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL--EKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTER------S   72 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe--CCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccC------C
Confidence            45778899999999999976542  4678999988654332   23577899999999999999999987543      3


Q ss_pred             eEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      ..+++++++ +++|.+++..  ..+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|||+++....
T Consensus        73 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  152 (256)
T cd05112          73 PICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD  152 (256)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeeccc
Confidence            567888877 6789888864  3589999999999999999999999999999999999999999999999998764321


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      ....                                                         ...+..++..|+|||++.+
T Consensus       153 ~~~~---------------------------------------------------------~~~~~~~~~~~~aPe~~~~  175 (256)
T cd05112         153 DQYT---------------------------------------------------------SSTGTKFPVKWSSPEVFSF  175 (256)
T ss_pred             Cccc---------------------------------------------------------ccCCCccchhhcCHhHhcc
Confidence            1000                                                         0012234567888888776


Q ss_pred             ccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH
Q psy8260         301 WMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA  379 (427)
Q Consensus       301 ~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta  379 (427)
                      ..+...+|+||+|++++.+-+ +..+|...................       .....+..+.+|+.+||+.||++|||+
T Consensus       176 ~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~l~~~~l~~~p~~Rp~~  248 (256)
T cd05112         176 SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLY-------KPRLASQSVYELMQHCWKERPEDRPSF  248 (256)
T ss_pred             CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCC-------CCCCCCHHHHHHHHHHcccChhhCCCH
Confidence            667777899999999877643 333443221111111111100000       012246789999999999999999999


Q ss_pred             HHHhcC
Q psy8260         380 EQALAH  385 (427)
Q Consensus       380 ~e~L~H  385 (427)
                      +|++++
T Consensus       249 ~~~l~~  254 (256)
T cd05112         249 SLLLHQ  254 (256)
T ss_pred             HHHHHh
Confidence            999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.2e-32  Score=257.87  Aligned_cols=242  Identities=21%  Similarity=0.302  Sum_probs=177.2

Q ss_pred             ccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEEEec
Q psy8260          71 TLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH  150 (427)
Q Consensus        71 ~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~lv~e  150 (427)
                      .||.|+||.||.+..  .++..||+|.+.... .......+.+|+++++.++||||+++++++...      ...++++|
T Consensus         2 ~ig~g~~g~vy~~~~--~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e   72 (250)
T cd05085           2 LLGKGNFGEVFKGTL--KDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQR------QPIYIVME   72 (250)
T ss_pred             ccCCCCCceEEEEEe--cCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC------CccEEEEE
Confidence            689999999998753  367899999886543 333445678999999999999999999987643      34688888


Q ss_pred             cC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccc
Q psy8260         151 LM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVA  227 (427)
Q Consensus       151 ~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~g  227 (427)
                      ++ +++|.+++..  ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.........  
T Consensus        73 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~--  150 (250)
T cd05085          73 LVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS--  150 (250)
T ss_pred             CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccccc--
Confidence            77 7899888754  357899999999999999999999999999999999999999999999999886422110000  


Q ss_pred             cccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCCCC
Q psy8260         228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT  307 (427)
Q Consensus       228 t~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~  307 (427)
                                                                             .....+++.|+|||++.+..+..++
T Consensus       151 -------------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~  175 (250)
T cd05085         151 -------------------------------------------------------SGLKQIPIKWTAPEALNYGRYSSES  175 (250)
T ss_pred             -------------------------------------------------------CCCCCCcccccCHHHhccCCCCchh
Confidence                                                                   0001234568888887766667778


Q ss_pred             CHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         308 DIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       308 d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                      |+||+|++++.+.+ +..||...... ............      ......++++.+|+.+||..||.+|||+.|+++.
T Consensus       176 Di~slG~ll~~~~~~g~~p~~~~~~~-~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  247 (250)
T cd05085         176 DVWSYGILLWETFSLGVCPYPGMTNQ-QAREQVEKGYRM------SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKE  247 (250)
T ss_pred             HHHHHHHHHHHHhcCCCCCCCCCCHH-HHHHHHHcCCCC------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            99999999887643 33334222111 111111111110      1123467899999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-32  Score=257.92  Aligned_cols=243  Identities=21%  Similarity=0.295  Sum_probs=177.8

Q ss_pred             cccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEEEe
Q psy8260          70 PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT  149 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~lv~  149 (427)
                      +.||.|+||.||.+.. .. ++.||+|.+..... ......+.+|++++++++||||+++++++...      ...++++
T Consensus         1 ~~lg~g~~g~v~~~~~-~~-~~~v~~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~~~~v~   71 (251)
T cd05041           1 EKIGKGNFGDVYKGVL-KG-NTEVAVKTCRSTLP-PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQK------QPIYIVM   71 (251)
T ss_pred             CccccCCCceEEEEEE-eC-CCcEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecC------CCeEEEE
Confidence            3689999999997654 44 89999998865433 23456678999999999999999999987654      3567888


Q ss_pred             ccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCccccc
Q psy8260         150 HLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV  226 (427)
Q Consensus       150 e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  226 (427)
                      +++ +++|.+++..  ..+++..+..++.|++.||.|||+++++||||||+|||++.++.+||+|||+++......... 
T Consensus        72 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-  150 (251)
T cd05041          72 ELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV-  150 (251)
T ss_pred             EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCccee-
Confidence            877 7889888854  357888999999999999999999999999999999999999999999999986432111000 


Q ss_pred             ccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCCC
Q psy8260         227 ATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQ  306 (427)
Q Consensus       227 gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~  306 (427)
                                                                             ......++..|+|||++.+..+...
T Consensus       151 -------------------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~  175 (251)
T cd05041         151 -------------------------------------------------------SDGLKQIPIKWTAPEALNYGRYTSE  175 (251)
T ss_pred             -------------------------------------------------------ccccCcceeccCChHhhccCCCCcc
Confidence                                                                   0001123456888888776667778


Q ss_pred             CCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy8260         307 TDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALA  384 (427)
Q Consensus       307 ~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~  384 (427)
                      +|+||+|++++.+-+ +..+|..... ..............      .....+.+..|||.+||+.||.+|||++|+++
T Consensus       176 ~Di~slG~i~~~l~t~~~~p~~~~~~-~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         176 SDVWSYGILLWETFSLGDTPYPGMSN-QQTRERIESGYRMP------APQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             hhHHHHHHHHHHHHhccCCCCccCCH-HHHHHHHhcCCCCC------CCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            899999999987654 3333322111 11111111111110      12345778999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-32  Score=260.68  Aligned_cols=251  Identities=21%  Similarity=0.259  Sum_probs=182.5

Q ss_pred             cCcceeeccccCcccccEEEEeEEeCcCC----cEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCc
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSALDSVSG----VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNT  137 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~~~~~g----~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~  137 (427)
                      ..+.|.+.+.||+|+||.||++... .+|    ..||+|.+.... .......+.+|+.+++.++||||+++++++..  
T Consensus         5 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--   80 (279)
T cd05057           5 KETELEKIKVLGSGAFGTVYKGVWI-PEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS--   80 (279)
T ss_pred             CHHHcEEcceecCCCCccEEEEEEe-cCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--
Confidence            3467888999999999999976643 233    368999876542 34445667899999999999999999998754  


Q ss_pred             cccCCceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCC
Q psy8260         138 CLADFKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL  214 (427)
Q Consensus       138 ~~~~~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGl  214 (427)
                           ...+++++++ +++|.+.+..  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus        81 -----~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~  155 (279)
T cd05057          81 -----SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGL  155 (279)
T ss_pred             -----CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcc
Confidence                 2467777776 7899988865  3589999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccc
Q psy8260         215 ARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRA  294 (427)
Q Consensus       215 a~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~A  294 (427)
                      ++.........                                                        ...+..++..|+|
T Consensus       156 ~~~~~~~~~~~--------------------------------------------------------~~~~~~~~~~y~~  179 (279)
T cd05057         156 AKLLDVDEKEY--------------------------------------------------------HAEGGKVPIKWMA  179 (279)
T ss_pred             cccccCcccce--------------------------------------------------------ecCCCcccccccC
Confidence            87543211000                                                        0001123456888


Q ss_pred             hHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCC
Q psy8260         295 PEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDS  373 (427)
Q Consensus       295 PEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP  373 (427)
                      ||.+....+...+|+|++|++++.+-+ +..+|.... ..............      ......+.++.++|.+||..||
T Consensus       180 PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~p  252 (279)
T cd05057         180 LESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP-AVEIPDLLEKGERL------PQPPICTIDVYMVLVKCWMIDA  252 (279)
T ss_pred             HHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC-HHHHHHHHhCCCCC------CCCCCCCHHHHHHHHHHcCCCh
Confidence            888876667778899999999877543 333332221 11111111111111      1112356788999999999999


Q ss_pred             CCCCCHHHHhc
Q psy8260         374 EKRITAEQALA  384 (427)
Q Consensus       374 ~~R~ta~e~L~  384 (427)
                      .+|||+.++++
T Consensus       253 ~~Rp~~~~l~~  263 (279)
T cd05057         253 ESRPTFKELIN  263 (279)
T ss_pred             hhCCCHHHHHH
Confidence            99999999864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-32  Score=260.27  Aligned_cols=240  Identities=21%  Similarity=0.284  Sum_probs=173.8

Q ss_pred             ccCcccccEEEEeEEeCcCCc--EEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCccccCCceEEE
Q psy8260          71 TLSKESFDLIFSSALDSVSGV--KVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLADFKNVYM  147 (427)
Q Consensus        71 ~lg~g~fg~v~~~~~~~~~g~--~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~~~~~~~l  147 (427)
                      .||+|+||.||.+.. ..++.  .+|+|.+... ........+.+|+++++++ +||||+++++++...      ...|+
T Consensus         2 ~lg~g~~g~v~~~~~-~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~------~~~~l   73 (270)
T cd05047           2 VIGEGNFGQVLKARI-KKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR------GYLYL   73 (270)
T ss_pred             cCCCCCCceEEEEEE-cCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC------CCceE
Confidence            589999999997654 34554  5788887632 2334445677899999999 899999999988653      34688


Q ss_pred             EeccC-CCCHHHHHhhC-----------------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEE
Q psy8260         148 VTHLM-GADLNNILRTQ-----------------KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKI  209 (427)
Q Consensus       148 v~e~~-g~~L~~~l~~~-----------------~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl  209 (427)
                      +++++ +++|.+++...                 .+++..+..++.|++.||+|||++|++||||||+|||++.++.+||
T Consensus        74 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl  153 (270)
T cd05047          74 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI  153 (270)
T ss_pred             EEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEE
Confidence            88877 78999888542                 3788899999999999999999999999999999999999999999


Q ss_pred             eeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccc
Q psy8260         210 LDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT  289 (427)
Q Consensus       210 ~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt  289 (427)
                      +|||+++........                                                           .....+
T Consensus       154 ~dfgl~~~~~~~~~~-----------------------------------------------------------~~~~~~  174 (270)
T cd05047         154 ADFGLSRGQEVYVKK-----------------------------------------------------------TMGRLP  174 (270)
T ss_pred             CCCCCccccchhhhc-----------------------------------------------------------cCCCCc
Confidence            999987521100000                                                           001124


Q ss_pred             ccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHh
Q psy8260         290 RWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLM  368 (427)
Q Consensus       290 ~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~m  368 (427)
                      ..|+|||++....+..++|+||+|++++.+.+ +..+|............. .....      ......+.++.+||.+|
T Consensus       175 ~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~------~~~~~~~~~~~~li~~~  247 (270)
T cd05047         175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRL------EKPLNCDDEVYDLMRQC  247 (270)
T ss_pred             cccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHh-CCCCC------CCCCcCCHHHHHHHHHH
Confidence            56888888877667778899999999877743 444443221111111111 10000      11223577899999999


Q ss_pred             cCCCCCCCCCHHHHhc
Q psy8260         369 LELDSEKRITAEQALA  384 (427)
Q Consensus       369 L~~dP~~R~ta~e~L~  384 (427)
                      |..||.+|||++|+++
T Consensus       248 l~~~p~~Rps~~~il~  263 (270)
T cd05047         248 WREKPYERPSFAQILV  263 (270)
T ss_pred             cccChhhCCCHHHHHH
Confidence            9999999999999975

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.9e-32  Score=259.68  Aligned_cols=248  Identities=17%  Similarity=0.193  Sum_probs=168.0

Q ss_pred             cccCcccccEEEEeEEe-CcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEEE
Q psy8260          70 PTLSKESFDLIFSSALD-SVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV  148 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~-~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~lv  148 (427)
                      +.||+|+||.||.+... ..++..+|+|.+.... .......+.+|+.++++++||||+++++++...      ..++++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~lv   73 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA-SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV------TPYLLV   73 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC------CCcEEE
Confidence            35899999999987653 4567789999886543 233344677899999999999999999987543      346888


Q ss_pred             eccC-CCCHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         149 THLM-GADLNNILRTQ------KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       149 ~e~~-g~~L~~~l~~~------~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      +|++ +++|.+++...      ..++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus        74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~  153 (269)
T cd05087          74 MEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE  153 (269)
T ss_pred             EECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCc
Confidence            8887 68999888532      3466778889999999999999999999999999999999999999999998643221


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      ....                                                        ......|++.|+|||++.+.
T Consensus       154 ~~~~--------------------------------------------------------~~~~~~~~~~y~aPE~~~~~  177 (269)
T cd05087         154 DYYV--------------------------------------------------------TPDQLWVPLRWIAPELVDEV  177 (269)
T ss_pred             ceee--------------------------------------------------------cCCCcCCcccccCHhHhccc
Confidence            1000                                                        00011234445555554321


Q ss_pred             -------cCCCCCCHHHHHHHHHHhC-CCCHHHHhhcCcHHHHHHHhc-CCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         302 -------MHYNQTDIHQLNLIMEMLG-TPPAEFMAKISSDSARKYINS-LPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       302 -------~~~~~~d~~slg~i~~~lg-~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                             .+..++|+||+|++++.+. .+..||......+........ .......   ......++...+++.+|+ .|
T Consensus       178 ~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~~c~-~~  253 (269)
T cd05087         178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKP---RLKLPLSDRWYEVMQFCW-LQ  253 (269)
T ss_pred             cccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCC---ccCCCCChHHHHHHHHHh-cC
Confidence                   1345679999999887653 233333221111111111111 1111110   111235678899999998 69


Q ss_pred             CCCCCCHHHHhc
Q psy8260         373 SEKRITAEQALA  384 (427)
Q Consensus       373 P~~R~ta~e~L~  384 (427)
                      |.+|||++|++.
T Consensus       254 P~~Rpt~~~l~~  265 (269)
T cd05087         254 PEQRPSAEEVHL  265 (269)
T ss_pred             cccCCCHHHHHH
Confidence            999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.6e-33  Score=282.91  Aligned_cols=288  Identities=20%  Similarity=0.266  Sum_probs=181.9

Q ss_pred             ccCcceeeccccCcccccEEEEeEE---------------eCcCCcEEEEEEccCcCCCHH------------HHHHHHH
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSAL---------------DSVSGVKVAIKKIARPFQSAV------------HAKRTYR  113 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~---------------~~~~g~~vAvK~i~~~~~~~~------------~~~~~~~  113 (427)
                      ...+.|.+.+.||+|+||.||++..               +...++.||||++........            ..+....
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            3567899999999999999998753               123457899999864321110            0112234


Q ss_pred             HHHHHhcCCCCCc-----eeeeeeeecCc--cccCCceEEEEeccC-CCCHHHHHhhC----------------------
Q psy8260         114 ELRMLKHMNHENV-----IGLLDVFHSNT--CLADFKNVYMVTHLM-GADLNNILRTQ----------------------  163 (427)
Q Consensus       114 Ei~~l~~l~HpnI-----v~l~~~~~~~~--~~~~~~~~~lv~e~~-g~~L~~~l~~~----------------------  163 (427)
                      |+.++.+++|.|+     +++++++....  ........++|++|+ +++|.+++...                      
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            7777777777654     56666654321  011124578888888 67888776531                      


Q ss_pred             ---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC--ccc--ccccccccchhh
Q psy8260         164 ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE--MTG--YVATRWYRAPEI  236 (427)
Q Consensus       164 ---~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~--~~~--~~gt~~y~aPE~  236 (427)
                         .+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.....  ...  ..+|+.|+|||+
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~  381 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE  381 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence               2345678889999999999999999999999999999999999999999999754321  112  234789999999


Q ss_pred             hhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHH
Q psy8260         237 MLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIM  316 (427)
Q Consensus       237 l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~  316 (427)
                      +.....+...       +.+                               .+....+|... ........|+||+|+++
T Consensus       382 l~~~~~~~~~-------~~~-------------------------------~~~~~l~~~~~-~yg~~~~~DvwSlGvil  422 (507)
T PLN03224        382 LVMPQSCPRA-------PAP-------------------------------AMAALLSPFAW-LYGRPDLFDSYTAGVLL  422 (507)
T ss_pred             hcCCCCCCcc-------chh-------------------------------hhhhhhhhhHH-hcCCCCccchhhHHHHH
Confidence            8642111100       000                               00001111111 01122346999999999


Q ss_pred             HHhCCCCH-HHHh------hcC--cHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCC---CCCCCHHHHhc
Q psy8260         317 EMLGTPPA-EFMA------KIS--SDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDS---EKRITAEQALA  384 (427)
Q Consensus       317 ~~lg~~~~-~~~~------~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP---~~R~ta~e~L~  384 (427)
                      +.|.++.. ++..      ...  ......+.....  ....+ ..++..++.++|||.+||+.||   .+|+|++|+|+
T Consensus       423 ~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~--~~~~~-~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        423 MQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG--QKYDF-SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             HHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc--cCCCc-ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            88866532 2211      000  000001100000  01111 1355678999999999999876   68999999999


Q ss_pred             CCCCCC
Q psy8260         385 HPYLSQ  390 (427)
Q Consensus       385 Hp~f~~  390 (427)
                      ||||..
T Consensus       500 Hp~f~~  505 (507)
T PLN03224        500 HRFFLP  505 (507)
T ss_pred             CCCcCC
Confidence            999964

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.1e-32  Score=258.96  Aligned_cols=240  Identities=23%  Similarity=0.342  Sum_probs=177.0

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      ...|.+.+.+|+|+||.||.+.   .+++.||+|.+....    ....+.+|+.+++.++||||+++++++...      
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~---~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------   71 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGE---YTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN------   71 (254)
T ss_pred             HHHceeeeeeccCCCCceEecc---cCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC------
Confidence            3568899999999999999653   478889999885421    234577899999999999999999987542      


Q ss_pred             ceEEEEeccC-CCCHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT  218 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~~~---~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~  218 (427)
                       ..+++++++ +++|.+++...   .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus        72 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~  150 (254)
T cd05083          72 -GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVG  150 (254)
T ss_pred             -CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceec
Confidence             357888877 68999988642   4789999999999999999999999999999999999999999999999988642


Q ss_pred             CCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         219 ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       219 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                      .......                                                             ..+..|+|||++
T Consensus       151 ~~~~~~~-------------------------------------------------------------~~~~~y~~pe~~  169 (254)
T cd05083         151 SMGVDNS-------------------------------------------------------------KLPVKWTAPEAL  169 (254)
T ss_pred             cccCCCC-------------------------------------------------------------CCCceecCHHHh
Confidence            2111111                                                             123457777776


Q ss_pred             hhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC
Q psy8260         299 LNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI  377 (427)
Q Consensus       299 ~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~  377 (427)
                      .+..+..++|+||+|++++.+.+ +..+|.... ..............      ......++++.+||.+||+.||.+||
T Consensus       170 ~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp  242 (254)
T cd05083         170 KHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS-LKEVKECVEKGYRM------EPPEGCPADVYVLMTSCWETEPKKRP  242 (254)
T ss_pred             ccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC-HHHHHHHHhCCCCC------CCCCcCCHHHHHHHHHHcCCChhhCc
Confidence            66566677899999999877632 233332211 11111111111100      01234678899999999999999999


Q ss_pred             CHHHHhc
Q psy8260         378 TAEQALA  384 (427)
Q Consensus       378 ta~e~L~  384 (427)
                      |++++++
T Consensus       243 ~~~~l~~  249 (254)
T cd05083         243 SFHKLRE  249 (254)
T ss_pred             CHHHHHH
Confidence            9999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG4250|consensus

Probab=100.00  E-value=7.4e-34  Score=284.50  Aligned_cols=253  Identities=24%  Similarity=0.328  Sum_probs=181.6

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      +.|...+.||+|+||.||.+ .++.||+.||||..+... .....++..+|+++|++++|||||+++++=++....-...
T Consensus        13 y~W~~~e~LG~Ga~g~V~rg-rnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~   90 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRG-RNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR   90 (732)
T ss_pred             cceeehhhhcCCccceeeee-cccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence            45677789999999999964 578899999999887543 3344566789999999999999999998854432111123


Q ss_pred             eEEEEeccC-CCCHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEc--CCC--CEEEeeCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRT----QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN--EDC--ELKILDFGL  214 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~----~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~--~~~--~~kl~DFGl  214 (427)
                      .-.++|||| ||+|...++.    .++++.+...+...++.||.|||++||+||||||.||++-  .+|  .-||+|||.
T Consensus        91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            345666666 8999999964    4799999999999999999999999999999999999973  334  479999999


Q ss_pred             CCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccc
Q psy8260         215 ARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRA  294 (427)
Q Consensus       215 a~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~A  294 (427)
                      ||...+..                                                           ...+..||+.|.+
T Consensus       171 Arel~d~s-----------------------------------------------------------~~~S~vGT~~YLh  191 (732)
T KOG4250|consen  171 ARELDDNS-----------------------------------------------------------LFTSLVGTEEYLH  191 (732)
T ss_pred             cccCCCCC-----------------------------------------------------------eeeeecCchhhcC
Confidence            98654431                                                           2334567777777


Q ss_pred             hHHhhh-ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcH----HHHHHHhcCCCC----------CcccHHhhcC---C
Q psy8260         295 PEIMLN-WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSD----SARKYINSLPLL----------TKKDFRQVFK---G  356 (427)
Q Consensus       295 PEvl~~-~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~----~~~~~~~~~~~~----------~~~~~~~~~~---~  356 (427)
                      ||+... ..+...+|.||+|+++|.+.|+..||...-...    .....+...+..          .+..|+..++   .
T Consensus       192 Pel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~  271 (732)
T KOG4250|consen  192 PELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNH  271 (732)
T ss_pred             hHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCccc
Confidence            777763 455566799999999999999988886543221    111111111110          0111222221   1


Q ss_pred             CCh----hHHHHHHHhcCCCCCCCC
Q psy8260         357 ANP----QAIDLLSLMLELDSEKRI  377 (427)
Q Consensus       357 ~s~----~~~dLi~~mL~~dP~~R~  377 (427)
                      .++    ..-..|..||..||.+|.
T Consensus       272 Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  272 LSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             ccHHHHhhhhHHHHHHHhhhHHHhC
Confidence            222    334788899999999999

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.3e-32  Score=258.75  Aligned_cols=233  Identities=18%  Similarity=0.195  Sum_probs=165.8

Q ss_pred             cccCcccccEEEEeEEeCcCC----------cEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          70 PTLSKESFDLIFSSALDSVSG----------VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~~g----------~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      +.||+|+||.||++.... ++          ..||+|.+....   .....+.+|+.+++.++||||+++++++..    
T Consensus         1 ~~lg~G~~~~v~~~~~~~-~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----   72 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRV-QSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR----   72 (259)
T ss_pred             CcccccccceEEEEEEec-cCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec----
Confidence            368999999999766543 33          457888765332   114667899999999999999999998654    


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCC-------CEEE
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC-------ELKI  209 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~~--~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~-------~~kl  209 (427)
                         ...+++++++ +++|.+++...  .+++..+..++.|++.||+|||++||+||||||+|||++.++       .+||
T Consensus        73 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl  149 (259)
T cd05037          73 ---DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKL  149 (259)
T ss_pred             ---CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEe
Confidence               2347788877 78999888643  589999999999999999999999999999999999999877       7999


Q ss_pred             eeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccc
Q psy8260         210 LDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT  289 (427)
Q Consensus       210 ~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt  289 (427)
                      +|||+++.... .....                                                             ++
T Consensus       150 ~Dfg~a~~~~~-~~~~~-------------------------------------------------------------~~  167 (259)
T cd05037         150 SDPGIPITVLS-REERV-------------------------------------------------------------ER  167 (259)
T ss_pred             CCCCccccccc-ccccc-------------------------------------------------------------cC
Confidence            99999875322 11112                                                             23


Q ss_pred             ccccchHHhhhc--cCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHH
Q psy8260         290 RWYRAPEIMLNW--MHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLS  366 (427)
Q Consensus       290 ~~Y~APEvl~~~--~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~  366 (427)
                      ..|+|||++.+.  .+..++|+||+|++++.+.+ +..++...........+ ......        ......++.+||.
T Consensus       168 ~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~-~~~~~~--------~~~~~~~~~~li~  238 (259)
T cd05037         168 IPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY-QDQHRL--------PMPDCAELANLIN  238 (259)
T ss_pred             CCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHH-hcCCCC--------CCCCchHHHHHHH
Confidence            345555555443  35566799999999877643 23333222111111111 111100        0112368899999


Q ss_pred             HhcCCCCCCCCCHHHHhc
Q psy8260         367 LMLELDSEKRITAEQALA  384 (427)
Q Consensus       367 ~mL~~dP~~R~ta~e~L~  384 (427)
                      +||..||.+|||+.|+++
T Consensus       239 ~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         239 QCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             HHhccChhhCCCHHHHHH
Confidence            999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0695|consensus

Probab=100.00  E-value=6.8e-34  Score=262.04  Aligned_cols=266  Identities=19%  Similarity=0.299  Sum_probs=194.6

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC-HHHHHHHHHHHHHHhc-CCCCCceeeeeeeecCc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS-AVHAKRTYRELRMLKH-MNHENVIGLLDVFHSNT  137 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~-l~HpnIv~l~~~~~~~~  137 (427)
                      .+...+|++..+||+|++..|+. +...+|.+.+|+|++++.-.+ .+...=...|-.+..+ -+||.+|.|+.+|+++.
T Consensus       246 ~l~l~df~ll~vigrgsyakvl~-~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes  324 (593)
T KOG0695|consen  246 GLGLQDFDLLRVIGRGSYAKVLL-VRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES  324 (593)
T ss_pred             ccccccceeeeeecCcchhhhhh-eehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence            45567899999999999999985 445678999999998765322 2222223344444444 38999999998887653


Q ss_pred             cccCCceEEEEeccC-CCCHHH-HHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         138 CLADFKNVYMVTHLM-GADLNN-ILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       138 ~~~~~~~~~lv~e~~-g~~L~~-~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                            .+++|.||. ||+|-- ..+..++++++++.+...|+.||.|||++|||.||||.+|+|+|..|.+||.|+|++
T Consensus       325 ------rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmc  398 (593)
T KOG0695|consen  325 ------RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMC  398 (593)
T ss_pred             ------eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchh
Confidence                  345555554 788754 445578999999999999999999999999999999999999999999999999988


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      +..-...                                                          ....++||||.|.||
T Consensus       399 ke~l~~g----------------------------------------------------------d~tstfcgtpnyiap  420 (593)
T KOG0695|consen  399 KEGLGPG----------------------------------------------------------DTTSTFCGTPNYIAP  420 (593)
T ss_pred             hcCCCCC----------------------------------------------------------cccccccCCCcccch
Confidence            6321100                                                          123467899999999


Q ss_pred             HHhhhccCCCCCCHHHHHHHHHHhCCCCHHHH--h-hcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         296 EIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFM--A-KISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       296 Evl~~~~~~~~~d~~slg~i~~~lg~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                      |++++..|...+|||+||+++++|-.+..||.  . .+.......|+........   -.+.+..|-.|-..|+..|.+|
T Consensus       421 eilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq---iriprslsvkas~vlkgflnkd  497 (593)
T KOG0695|consen  421 EILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ---IRIPRSLSVKASHVLKGFLNKD  497 (593)
T ss_pred             hhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc---ccccceeehhhHHHHHHhhcCC
Confidence            99999999999999999999877744444442  2 1122223333322111100   1234567888999999999999


Q ss_pred             CCCCC------CHHHHhcCCCCCCCCC
Q psy8260         373 SEKRI------TAEQALAHPYLSQYSD  393 (427)
Q Consensus       373 P~~R~------ta~e~L~Hp~f~~~~~  393 (427)
                      |+.|+      ...++..||||+....
T Consensus       498 p~erlgc~~~~g~~dik~h~ffr~idw  524 (593)
T KOG0695|consen  498 PKERLGCRPQTGFSDIKSHAFFRSIDW  524 (593)
T ss_pred             cHHhcCCCcccchhhhhcchhhhhCCH
Confidence            99997      4689999999986544

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=4.1e-32  Score=262.31  Aligned_cols=251  Identities=20%  Similarity=0.240  Sum_probs=179.8

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCc----EEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGV----KVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~----~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      ...|+..+.||.|+||.||.+.. ..+|.    .||+|.+.... .......+.+|+.+++.++||||+++++++...  
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--   81 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIW-VPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP--   81 (303)
T ss_pred             hhhceeccccccCCCccEEEEEE-ecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC--
Confidence            45677888999999999997543 33443    57999876432 233344577999999999999999999987542  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~~--~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                           ..+++++++ +++|.+++...  .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        82 -----~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~  156 (303)
T cd05110          82 -----TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLA  156 (303)
T ss_pred             -----CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccc
Confidence                 234566655 68898887643  5889999999999999999999999999999999999999999999999998


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      +.........                                                        ...+..++..|+||
T Consensus       157 ~~~~~~~~~~--------------------------------------------------------~~~~~~~~~~y~~P  180 (303)
T cd05110         157 RLLEGDEKEY--------------------------------------------------------NADGGKMPIKWMAL  180 (303)
T ss_pred             ccccCccccc--------------------------------------------------------ccCCCccccccCCH
Confidence            7532211000                                                        00112345678888


Q ss_pred             HHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCC
Q psy8260         296 EIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       296 Evl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~  374 (427)
                      |++.+..+..++|+||+|++++.+.+ +..++... ................      .....+.++.++|.+|+..||+
T Consensus       181 E~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~c~~~~p~  253 (303)
T cd05110         181 ECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLP------QPPICTIDVYMVMVKCWMIDAD  253 (303)
T ss_pred             HHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHCCCCCC------CCCCCCHHHHHHHHHHcCCChh
Confidence            88877777778899999998877532 22333211 1112222222211111      1123567899999999999999


Q ss_pred             CCCCHHHHhcC
Q psy8260         375 KRITAEQALAH  385 (427)
Q Consensus       375 ~R~ta~e~L~H  385 (427)
                      +|||++++++.
T Consensus       254 ~Rp~~~~l~~~  264 (303)
T cd05110         254 SRPKFKELAAE  264 (303)
T ss_pred             hCcCHHHHHHH
Confidence            99999998775

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG1026|consensus

Probab=100.00  E-value=4.9e-33  Score=284.58  Aligned_cols=254  Identities=23%  Similarity=0.342  Sum_probs=191.4

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEeC----cCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeee
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALDS----VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFH  134 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~~----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~  134 (427)
                      .++.+..+.+.+.||+|.||.||.+....    ...+.||||.++.. .+....++|.||+++|..++|||||+|+++..
T Consensus       481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~  559 (774)
T KOG1026|consen  481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRLLGVCR  559 (774)
T ss_pred             eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence            46778888899999999999999876532    34467999998754 44556778999999999999999999999975


Q ss_pred             cCccccCCceEEEEeccC-CCCHHHHHhh-----------CC----CCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCC
Q psy8260         135 SNTCLADFKNVYMVTHLM-GADLNNILRT-----------QK----LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSN  198 (427)
Q Consensus       135 ~~~~~~~~~~~~lv~e~~-g~~L~~~l~~-----------~~----l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~N  198 (427)
                      .+      +.+||++||+ .|||.++|+.           ..    ++..+...++.||+.||.||-++.+|||||..+|
T Consensus       560 ~~------~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRN  633 (774)
T KOG1026|consen  560 EG------DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRN  633 (774)
T ss_pred             cC------CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhh
Confidence            43      5689999998 6999999863           12    7788899999999999999999999999999999


Q ss_pred             eEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCC
Q psy8260         199 IAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARP  278 (427)
Q Consensus       199 ILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~  278 (427)
                      +||+++..|||+||||+|...+..       +|+.            .+                               
T Consensus       634 CLVge~l~VKIsDfGLsRdiYssD-------YYk~------------~~-------------------------------  663 (774)
T KOG1026|consen  634 CLVGENLVVKISDFGLSRDIYSSD-------YYKV------------RG-------------------------------  663 (774)
T ss_pred             ceeccceEEEecccccchhhhhhh-------hhcc------------cC-------------------------------
Confidence            999999999999999998543321       1110            00                               


Q ss_pred             CccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHh-CCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCC
Q psy8260         279 TENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGA  357 (427)
Q Consensus       279 ~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~l-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (427)
                            ...--+.||+||-|+...+..++|+||.|+++.+. -.+.-|+. ....+..-.+++.-..+      +..+.-
T Consensus       664 ------~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~-glSn~EVIe~i~~g~lL------~~Pe~C  730 (774)
T KOG1026|consen  664 ------NTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYY-GLSNQEVIECIRAGQLL------SCPENC  730 (774)
T ss_pred             ------CceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccc-ccchHHHHHHHHcCCcc------cCCCCC
Confidence                  00113568888888888899999999999988444 22322222 22223333333221111      122445


Q ss_pred             ChhHHHHHHHhcCCCCCCCCCHHHH
Q psy8260         358 NPQAIDLLSLMLELDSEKRITAEQA  382 (427)
Q Consensus       358 s~~~~dLi~~mL~~dP~~R~ta~e~  382 (427)
                      .++..+|+..|-+.+|++|||..|+
T Consensus       731 P~~vY~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  731 PTEVYSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             CHHHHHHHHHHhhcCcccCCCHHHH
Confidence            6788999999999999999999986

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.4e-32  Score=258.67  Aligned_cols=245  Identities=23%  Similarity=0.299  Sum_probs=174.7

Q ss_pred             cccCcccccEEEEeEEeC-----cCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCce
Q psy8260          70 PTLSKESFDLIFSSALDS-----VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      +.+|+|+||.||.+....     ..++.||||.+.... .......+.+|+++++.++||||+++++++...      ..
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~   73 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN------EP   73 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC------CC
Confidence            368999999999765421     233689999875432 223445678999999999999999999987543      34


Q ss_pred             EEEEeccC-CCCHHHHHhh--------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCC-----CEEEe
Q psy8260         145 VYMVTHLM-GADLNNILRT--------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC-----ELKIL  210 (427)
Q Consensus       145 ~~lv~e~~-g~~L~~~l~~--------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~-----~~kl~  210 (427)
                      .+++++++ +++|.+++..        ..+++..+..++.|++.||.|||+++++|+||||+||+++.++     .+||+
T Consensus        74 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~  153 (269)
T cd05044          74 QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIG  153 (269)
T ss_pred             eEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEEC
Confidence            68888876 7899988753        2377888999999999999999999999999999999999877     89999


Q ss_pred             eCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccc
Q psy8260         211 DFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATR  290 (427)
Q Consensus       211 DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~  290 (427)
                      |||+++........        .                                                ......++.
T Consensus       154 dfg~~~~~~~~~~~--------~------------------------------------------------~~~~~~~~~  177 (269)
T cd05044         154 DFGLARDIYKSDYY--------R------------------------------------------------KEGEGLLPV  177 (269)
T ss_pred             Cccccccccccccc--------c------------------------------------------------cCcccCCCc
Confidence            99998643211000        0                                                000112456


Q ss_pred             cccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhc
Q psy8260         291 WYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLML  369 (427)
Q Consensus       291 ~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL  369 (427)
                      .|+|||++.+..+..++|+||+|++++.+.+ +..+|.... ..............      ......++++.+||.+||
T Consensus       178 ~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~-~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l  250 (269)
T cd05044         178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN-NQEVLQHVTAGGRL------QKPENCPDKIYQLMTNCW  250 (269)
T ss_pred             cccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC-HHHHHHHHhcCCcc------CCcccchHHHHHHHHHHc
Confidence            7888888877777778899999999987533 322332211 11111111111111      112345788999999999


Q ss_pred             CCCCCCCCCHHHHhc
Q psy8260         370 ELDSEKRITAEQALA  384 (427)
Q Consensus       370 ~~dP~~R~ta~e~L~  384 (427)
                      +.||.+|||++++++
T Consensus       251 ~~~p~~Rp~~~~i~~  265 (269)
T cd05044         251 AQDPSERPTFDRIQE  265 (269)
T ss_pred             CCCcccCCCHHHHHH
Confidence            999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5.7e-32  Score=256.52  Aligned_cols=249  Identities=17%  Similarity=0.201  Sum_probs=167.6

Q ss_pred             ccCcccccEEEEeEEeC-cCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEEEe
Q psy8260          71 TLSKESFDLIFSSALDS-VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT  149 (427)
Q Consensus        71 ~lg~g~fg~v~~~~~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~lv~  149 (427)
                      .||+|+||.||++.... .....+++|.+... ........+.+|+.+++.++||||+++++.+...      ...|+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~------~~~~lv~   74 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN-ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA------IPYLLVF   74 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCC-CChHHHHHHHHHHHHHhccCCcchhheEEEecCC------CccEEEE
Confidence            58999999999875432 23445677776543 2233456788999999999999999999987643      3578899


Q ss_pred             ccC-CCCHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC---
Q psy8260         150 HLM-GADLNNILRTQ-----KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN---  220 (427)
Q Consensus       150 e~~-g~~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~---  220 (427)
                      |++ +++|.+++...     .+++..+..++.||+.||+|||+++++||||||+|||++.++.+||+|||++.....   
T Consensus        75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~  154 (268)
T cd05086          75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY  154 (268)
T ss_pred             ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchh
Confidence            888 67999888642     356677888999999999999999999999999999999999999999999764221   


Q ss_pred             --CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         221 --EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       221 --~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                        ......++..|+|||++.+...                                          +.            
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~------------------------------------------~~------------  180 (268)
T cd05086         155 IETEDDKCVPLRWLAPELVGEFHG------------------------------------------GL------------  180 (268)
T ss_pred             hhcccCCcCcccccCchhcccccC------------------------------------------cc------------
Confidence              1122345555666665431000                                          00            


Q ss_pred             hhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcC-CCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCC
Q psy8260         299 LNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSL-PLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKR  376 (427)
Q Consensus       299 ~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R  376 (427)
                      ....+..++|+||+|++++.|-+ +..++..........+..... .....   .......++...++|..|+ .||.+|
T Consensus       181 ~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~~c~-~~P~~R  256 (268)
T cd05086         181 ITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFK---PQLELPYSERWYEVLQFCW-LSPEKR  256 (268)
T ss_pred             ccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCC---CccCCCCcHHHHHHHHHHh-hCcccC
Confidence            00113456799999999877632 222332111111122221111 11111   1112346788899999998 689999


Q ss_pred             CCHHHHhc
Q psy8260         377 ITAEQALA  384 (427)
Q Consensus       377 ~ta~e~L~  384 (427)
                      ||++|+++
T Consensus       257 p~~~~i~~  264 (268)
T cd05086         257 ATAEEVHR  264 (268)
T ss_pred             CCHHHHHH
Confidence            99999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.8e-32  Score=261.28  Aligned_cols=255  Identities=20%  Similarity=0.269  Sum_probs=183.5

Q ss_pred             cceeeccccCcccccEEEEeEEe---CcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcccc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALD---SVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~---~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  140 (427)
                      ..+.+.+.||+|+||.||.+..+   ..++..||||.+...... .....+.+|+++++.++||||+++++++...    
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~----   78 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKP----   78 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecC----
Confidence            34667789999999999987754   346889999998754332 3456688999999999999999999887542    


Q ss_pred             CCceEEEEeccC-CCCHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCC
Q psy8260         141 DFKNVYMVTHLM-GADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP  217 (427)
Q Consensus       141 ~~~~~~lv~e~~-g~~L~~~l~~~~--l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~  217 (427)
                      .....+++++++ +++|.+++....  +++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++..
T Consensus        79 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          79 GGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             CCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            124578888887 789999887644  89999999999999999999999999999999999999999999999999875


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      .......+..                                                       .....++..|+|||.
T Consensus       159 ~~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~~Pe~  183 (284)
T cd05038         159 LPEDKDYYYV-------------------------------------------------------KEPGESPIFWYAPEC  183 (284)
T ss_pred             cccCCcceec-------------------------------------------------------cCCCCCcccccCcHH
Confidence            4322110000                                                       001123345777777


Q ss_pred             hhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcH--------------HHHHHHhcCCCCCcccHHhhcCCCChhHHH
Q psy8260         298 MLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSD--------------SARKYINSLPLLTKKDFRQVFKGANPQAID  363 (427)
Q Consensus       298 l~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d  363 (427)
                      +.+..+...+|+||+|++++.+-++..++.......              .............      .....+.++.+
T Consensus       184 ~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~  257 (284)
T cd05038         184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLP------RPPSCPDEVYD  257 (284)
T ss_pred             HccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCcCC------CCccCCHHHHH
Confidence            766666667899999999988865443332111000              0000111100000      01234568899


Q ss_pred             HHHHhcCCCCCCCCCHHHHhc
Q psy8260         364 LLSLMLELDSEKRITAEQALA  384 (427)
Q Consensus       364 Li~~mL~~dP~~R~ta~e~L~  384 (427)
                      |+.+||+.||.+|||+.|+++
T Consensus       258 li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         258 LMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHHHHhccChhhCCCHHHHHH
Confidence            999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG1027|consensus

Probab=100.00  E-value=1.3e-33  Score=286.53  Aligned_cols=246  Identities=25%  Similarity=0.337  Sum_probs=174.0

Q ss_pred             ccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCccccCCceEEE
Q psy8260          69 GPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLADFKNVYM  147 (427)
Q Consensus        69 ~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~~~~~~~l  147 (427)
                      .+.+|.|+-|+|++...  -.|+.||||++...     ......|||..|+.- +|||||++++.-.      +....||
T Consensus       514 ~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~------d~qF~YI  580 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGV--YEGREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQ------DRQFLYI  580 (903)
T ss_pred             HHHcccCCCCcEEEEEe--eCCceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeecc------CCceEEE
Confidence            45788998877664332  35789999988542     234567999999887 7999999987633      3367899


Q ss_pred             EeccCCCCHHHHHhhCC-----CCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcC---C--CCEEEeeCCCCCC
Q psy8260         148 VTHLMGADLNNILRTQK-----LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE---D--CELKILDFGLARP  217 (427)
Q Consensus       148 v~e~~g~~L~~~l~~~~-----l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~---~--~~~kl~DFGla~~  217 (427)
                      ..|+|..+|.++++...     ........++.|++.||++||+.+||||||||.||||+.   +  ..++|+|||+++.
T Consensus       581 alELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk  660 (903)
T KOG1027|consen  581 ALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK  660 (903)
T ss_pred             EehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence            99999999999997631     111334677889999999999999999999999999975   2  4789999999986


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      .....+.+                                                       ....+..||-+|+|||+
T Consensus       661 l~~~~sS~-------------------------------------------------------~r~s~~sGt~GW~APE~  685 (903)
T KOG1027|consen  661 LAGGKSSF-------------------------------------------------------SRLSGGSGTSGWQAPEQ  685 (903)
T ss_pred             cCCCcchh-------------------------------------------------------hcccCCCCcccccCHHH
Confidence            54322110                                                       01334567888888888


Q ss_pred             hhhccCCCCCCHHHHHHHHHHh-CCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCC
Q psy8260         298 MLNWMHYNQTDIHQLNLIMEML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKR  376 (427)
Q Consensus       298 l~~~~~~~~~d~~slg~i~~~l-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R  376 (427)
                      ++...-...+|++++||+++.. -.+.-||-+....+  -+++.....     +...-...+.+|.|||.+||.+||.+|
T Consensus       686 L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~-----L~~L~~~~d~eA~dLI~~ml~~dP~~R  758 (903)
T KOG1027|consen  686 LREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYT-----LVHLEPLPDCEAKDLISRMLNPDPQLR  758 (903)
T ss_pred             HhccccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccc-----eeeeccCchHHHHHHHHHhcCCCcccC
Confidence            8776666678999999998544 33344553322111  111111111     111111112289999999999999999


Q ss_pred             CCHHHHhcCCCCC
Q psy8260         377 ITAEQALAHPYLS  389 (427)
Q Consensus       377 ~ta~e~L~Hp~f~  389 (427)
                      |||.++|+||+|=
T Consensus       759 Psa~~VL~HPlFW  771 (903)
T KOG1027|consen  759 PSATDVLNHPLFW  771 (903)
T ss_pred             CCHHHHhCCCccC
Confidence            9999999999993

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=9.1e-32  Score=254.78  Aligned_cols=249  Identities=24%  Similarity=0.360  Sum_probs=182.2

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcC--------CCHHHHHHHHHHHHHHhc-CCCCCceeeeeeeecC
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPF--------QSAVHAKRTYRELRMLKH-MNHENVIGLLDVFHSN  136 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~--------~~~~~~~~~~~Ei~~l~~-l~HpnIv~l~~~~~~~  136 (427)
                      |.+.+.||+|+||.||.+.....+++.+|+|.+....        .......++.+|+.++.+ ++||||+++++++...
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   81 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN   81 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence            5677899999999999877655578899999875321        122334556789988865 7999999999987643


Q ss_pred             ccccCCceEEEEeccC-CCCHHHHHh-----hCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCCeEEcCCCCEEE
Q psy8260         137 TCLADFKNVYMVTHLM-GADLNNILR-----TQKLSDDHVQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNEDCELKI  209 (427)
Q Consensus       137 ~~~~~~~~~~lv~e~~-g~~L~~~l~-----~~~l~~~~~~~~~~qi~~aL~yLH~-~~iiHrDLKp~NILl~~~~~~kl  209 (427)
                            ...++++|++ +++|.+++.     ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||
T Consensus        82 ------~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l  155 (269)
T cd08528          82 ------DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTI  155 (269)
T ss_pred             ------CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEE
Confidence                  4578888887 678887763     2458999999999999999999996 78999999999999999999999


Q ss_pred             eeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccc
Q psy8260         210 LDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT  289 (427)
Q Consensus       210 ~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt  289 (427)
                      +|||++.......                                                           ......|+
T Consensus       156 ~dfg~~~~~~~~~-----------------------------------------------------------~~~~~~~~  176 (269)
T cd08528         156 TDFGLAKQKQPES-----------------------------------------------------------KLTSVVGT  176 (269)
T ss_pred             ecccceeeccccc-----------------------------------------------------------ccccccCc
Confidence            9999986432210                                                           00122356


Q ss_pred             ccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhc
Q psy8260         290 RWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLML  369 (427)
Q Consensus       290 ~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL  369 (427)
                      ..|+|||++.+..+..++|+||+|++++.+.++..+|..............  .....    ......++++.+||.+||
T Consensus       177 ~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~----~~~~~~~~~l~~li~~cl  250 (269)
T cd08528         177 ILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVE--AVYEP----LPEGMYSEDVTDVITSCL  250 (269)
T ss_pred             ccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhh--ccCCc----CCcccCCHHHHHHHHHHC
Confidence            678888877766666778999999999888666555533211111111111  11100    011245789999999999


Q ss_pred             CCCCCCCCCHHHHhcC
Q psy8260         370 ELDSEKRITAEQALAH  385 (427)
Q Consensus       370 ~~dP~~R~ta~e~L~H  385 (427)
                      +.||.+|||+.|+..+
T Consensus       251 ~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         251 TPDAEARPDIIQVSAM  266 (269)
T ss_pred             CCCCccCCCHHHHHHH
Confidence            9999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG1151|consensus

Probab=100.00  E-value=1.6e-33  Score=267.71  Aligned_cols=267  Identities=25%  Similarity=0.340  Sum_probs=191.9

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHH-----HHHHHHHHHHHHhcCCCCCceeeeeeeecCc
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAV-----HAKRTYRELRMLKHMNHENVIGLLDVFHSNT  137 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~-----~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~  137 (427)
                      ..+|-+...||+|+|+.|| .++|....+.||||+-........     -.+-..||.+|.+.|+||.||++|++|.-+.
T Consensus       462 n~RYLlLhLLGrGGFSEVy-KAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt  540 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVY-KAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT  540 (775)
T ss_pred             HHHHHHHHHhccccHHHHH-HhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence            3556677899999999999 578888889999997644332221     1234568999999999999999999996432


Q ss_pred             cccCCceEEEEeccC-CCCHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhc--CceeccCCCCCeEEcC---CCCEEEe
Q psy8260         138 CLADFKNVYMVTHLM-GADLNNILRTQ-KLSDDHVQFLVYQILRGLKYIHSA--GIIHRDLKPSNIAVNE---DCELKIL  210 (427)
Q Consensus       138 ~~~~~~~~~lv~e~~-g~~L~~~l~~~-~l~~~~~~~~~~qi~~aL~yLH~~--~iiHrDLKp~NILl~~---~~~~kl~  210 (427)
                           ..++-|.||| |.+|.-+++.. -+++.+++.|+-||+.||.||...  .|||-||||.|||+..   .|.+||.
T Consensus       541 -----dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKIT  615 (775)
T KOG1151|consen  541 -----DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKIT  615 (775)
T ss_pred             -----ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEee
Confidence                 4577888888 77898888754 589999999999999999999866  5999999999999853   4789999


Q ss_pred             eCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccc
Q psy8260         211 DFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATR  290 (427)
Q Consensus       211 DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~  290 (427)
                      ||||++.+..+....+                                              .|     .....-..||.
T Consensus       616 DFGLSKIMdddSy~~v----------------------------------------------dG-----meLTSQgAGTY  644 (775)
T KOG1151|consen  616 DFGLSKIMDDDSYNSV----------------------------------------------DG-----MELTSQGAGTY  644 (775)
T ss_pred             ecchhhhccCCccCcc----------------------------------------------cc-----eeeecccCcee
Confidence            9999997755321100                                              00     00112234555


Q ss_pred             cccchHHhh-hc---cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCC--CCcccHHhhcCCCChhHHHH
Q psy8260         291 WYRAPEIML-NW---MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPL--LTKKDFRQVFKGANPQAIDL  364 (427)
Q Consensus       291 ~Y~APEvl~-~~---~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~s~~~~dL  364 (427)
                      ||+.||++. +.   ....++|+||+|+|+|-+..+..||-......   +++..+..  .....|.. -+.++++|++|
T Consensus       645 WYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ---dILqeNTIlkAtEVqFP~-KPvVsseAkaF  720 (775)
T KOG1151|consen  645 WYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ---DILQENTILKATEVQFPP-KPVVSSEAKAF  720 (775)
T ss_pred             eecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH---HHHhhhchhcceeccCCC-CCccCHHHHHH
Confidence            555555432 11   23457799999999998877777774332222   22221111  11111111 13579999999


Q ss_pred             HHHhcCCCCCCCCCHHHHhcCCCCCC
Q psy8260         365 LSLMLELDSEKRITAEQALAHPYLSQ  390 (427)
Q Consensus       365 i~~mL~~dP~~R~ta~e~L~Hp~f~~  390 (427)
                      |++||.+--..|+.+.|+-.||||..
T Consensus       721 IRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  721 IRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             HHHHHHhhhhhhhhHHHHccCccccc
Confidence            99999999999999999999999975

>KOG1095|consensus

Probab=99.98  E-value=1.3e-31  Score=283.29  Aligned_cols=252  Identities=21%  Similarity=0.338  Sum_probs=188.8

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCc----EEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeec
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGV----KVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHS  135 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~----~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~  135 (427)
                      ++....+++.+.||+|+||.||.+.+....|.    .||||.+.+. .+......+++|..+|++++|||||+++++.-.
T Consensus       688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~  766 (1025)
T KOG1095|consen  688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD  766 (1025)
T ss_pred             cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence            45677889999999999999999988766664    5999998764 456667789999999999999999999998533


Q ss_pred             CccccCCceEEEEeccC-CCCHHHHHhhC--------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCC
Q psy8260         136 NTCLADFKNVYMVTHLM-GADLNNILRTQ--------KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE  206 (427)
Q Consensus       136 ~~~~~~~~~~~lv~e~~-g~~L~~~l~~~--------~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~  206 (427)
                            ....+|++||| ||||..++++.        .++..+...++.||++|++||+++++|||||..+|+||+....
T Consensus       767 ------~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~  840 (1025)
T KOG1095|consen  767 ------SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRV  840 (1025)
T ss_pred             ------CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCc
Confidence                  23456777776 89999999764        4888999999999999999999999999999999999999999


Q ss_pred             EEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccc
Q psy8260         207 LKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGY  286 (427)
Q Consensus       207 ~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~  286 (427)
                      |||+|||+||......                   .|...                                      +.
T Consensus       841 VKIaDFGlArDiy~~~-------------------yyr~~--------------------------------------~~  863 (1025)
T KOG1095|consen  841 VKIADFGLARDIYDKD-------------------YYRKH--------------------------------------GE  863 (1025)
T ss_pred             EEEcccchhHhhhhch-------------------heecc--------------------------------------Cc
Confidence            9999999998432211                   01100                                      00


Q ss_pred             -cccccccchHHhhhccCCCCCCHHHHHHHHHHh---CCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHH
Q psy8260         287 -VATRWYRAPEIMLNWMHYNQTDIHQLNLIMEML---GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAI  362 (427)
Q Consensus       287 -~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~l---g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  362 (427)
                       .--.-|||||.+....+..++|+||+|+++.++   |..|.+-..  ..+....+...- .+..      .........
T Consensus       864 a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~--n~~v~~~~~~gg-RL~~------P~~CP~~ly  934 (1025)
T KOG1095|consen  864 AMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS--NFEVLLDVLEGG-RLDP------PSYCPEKLY  934 (1025)
T ss_pred             cccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc--hHHHHHHHHhCC-ccCC------CCCCChHHH
Confidence             011357888888877788899999999987544   555543221  111111122211 1111      112334567


Q ss_pred             HHHHHhcCCCCCCCCCHHHHhc
Q psy8260         363 DLLSLMLELDSEKRITAEQALA  384 (427)
Q Consensus       363 dLi~~mL~~dP~~R~ta~e~L~  384 (427)
                      +++.+|.+-||++||+...+++
T Consensus       935 ~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  935 QLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             HHHHHHccCChhhCccHHHHHh
Confidence            9999999999999999999886

>KOG1167|consensus

Probab=99.97  E-value=2.7e-32  Score=259.11  Aligned_cols=300  Identities=25%  Similarity=0.336  Sum_probs=192.7

Q ss_pred             cceeeccccCcccccEEEEeEEeCc--CCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCcccc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSV--SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~--~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~  140 (427)
                      ..|.+.+.+|.|.|++||.+..-..  .++.||+|.+....    +..+..+|+++|..+ .+.||+++.+++..+    
T Consensus        36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn----  107 (418)
T KOG1167|consen   36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS----SPSRILNELEMLYRLGGSDNIIKLNGCFRNN----  107 (418)
T ss_pred             hhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc----CchHHHHHHHHHHHhccchhhhcchhhhccC----
Confidence            4577889999999999996543322  67889999986532    235578999999988 689999999888654    


Q ss_pred             CCceEEEEeccCC-CCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcC-CCCEEEeeCCCCCCC
Q psy8260         141 DFKNVYMVTHLMG-ADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE-DCELKILDFGLARPT  218 (427)
Q Consensus       141 ~~~~~~lv~e~~g-~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~-~~~~kl~DFGla~~~  218 (427)
                        +.+.+++++.+ ....+++.  .++...++.+++.++.||.++|.+|||||||||+|+|.+. .+.-.|+|||+|...
T Consensus       108 --d~v~ivlp~~~H~~f~~l~~--~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~  183 (418)
T KOG1167|consen  108 --DQVAIVLPYFEHDRFRDLYR--SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY  183 (418)
T ss_pred             --CeeEEEecccCccCHHHHHh--cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHH
Confidence              46788888885 46667665  4678889999999999999999999999999999999984 578899999999732


Q ss_pred             CCCcccccccccccchhhhh-cccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         219 ENEMTGYVATRWYRAPEIML-NWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       219 ~~~~~~~~gt~~y~aPE~l~-~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      ..... .-.+..|+.|-.-. ....+....+..   .-.+.|...         +.  ......+...+.||++|+||||
T Consensus       184 d~~~~-~~~s~~~~~~~~~~~~g~~~~~~~~~~---~~~p~g~~~---------~~--~~~r~~~~anrAGT~GfRaPEv  248 (418)
T KOG1167|consen  184 DGYQQ-TEHSRSYSGRHATPAMGKDVHCQSVAT---ASKPAGYYR---------RC--NDGRPSERANRAGTPGFRAPEV  248 (418)
T ss_pred             Hhhhh-hhhhhhhhcccCCccccCccccccccc---ccCCCCcee---------cc--CCCccceecccCCCCCCCchHH
Confidence            11100 00111222220000 000000000000   000111110         00  1122345667899999999999


Q ss_pred             hhhccCCC-CCCHHHHHHHHHHhCCCCHHHHhhcC-------------cHHHHHHHhcCCC---CC--------------
Q psy8260         298 MLNWMHYN-QTDIHQLNLIMEMLGTPPAEFMAKIS-------------SDSARKYINSLPL---LT--------------  346 (427)
Q Consensus       298 l~~~~~~~-~~d~~slg~i~~~lg~~~~~~~~~~~-------------~~~~~~~~~~~~~---~~--------------  346 (427)
                      +.+.+... ..|+||.|+|+..+.+...||.....             ....++.......   +.              
T Consensus       249 L~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f  328 (418)
T KOG1167|consen  249 LFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNF  328 (418)
T ss_pred             HhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhch
Confidence            98766544 55999999998666555555532211             1111111000000   00              


Q ss_pred             -----------cc--cHHhhc-CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q psy8260         347 -----------KK--DFRQVF-KGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQ  390 (427)
Q Consensus       347 -----------~~--~~~~~~-~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~  390 (427)
                                 ..  .....+ ...+..+.||+.+||+.||.+|+||+++|+||||..
T Consensus       329 ~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~  386 (418)
T KOG1167|consen  329 ETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE  386 (418)
T ss_pred             hccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence                       00  000011 123458899999999999999999999999999984

>KOG1006|consensus

Probab=99.97  E-value=8.4e-33  Score=247.90  Aligned_cols=258  Identities=19%  Similarity=0.287  Sum_probs=183.4

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhc-CCCCCceeeeeeeecCccccCCce
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKH-MNHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~-l~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      ..-...||.|.||+|.+ -.++.+|+..|||+|.... .....++++.|....++ -+.||||++|+....+      ..
T Consensus        66 Lqdlg~iG~G~fG~V~K-M~hk~sg~~mAVKrIr~~n-~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E------Gd  137 (361)
T KOG1006|consen   66 LQDLGEIGNGAFGTVNK-MLHKPSGKLMAVKRIRSNN-IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE------GD  137 (361)
T ss_pred             HHHHHHhcCCcchhhhh-hhcCccCcEEEEEEeeecc-chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC------Cc
Confidence            33345799999999995 5678899999999997543 34556778888876554 4789999999874332      23


Q ss_pred             EEEEeccCCCCHHHHHh------hCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCCeEEcCCCCEEEeeCCCCCC
Q psy8260         145 VYMVTHLMGADLNNILR------TQKLSDDHVQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNEDCELKILDFGLARP  217 (427)
Q Consensus       145 ~~lv~e~~g~~L~~~l~------~~~l~~~~~~~~~~qi~~aL~yLH~-~~iiHrDLKp~NILl~~~~~~kl~DFGla~~  217 (427)
                      .++.||+|..+|..+.+      ...++|..+-.+....+.||+||.. ..|||||+||+|||++..|.+||||||++..
T Consensus       138 cWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGq  217 (361)
T KOG1006|consen  138 CWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQ  217 (361)
T ss_pred             eeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHh
Confidence            57899999888776543      3569999888888889999999975 5899999999999999999999999999865


Q ss_pred             CCCC--cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         218 TENE--MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       218 ~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      ..+.  .+.-.|-+.|||||-|...                                                       
T Consensus       218 Lv~SiAkT~daGCrpYmAPERi~p~-------------------------------------------------------  242 (361)
T KOG1006|consen  218 LVDSIAKTVDAGCRPYMAPERIDPS-------------------------------------------------------  242 (361)
T ss_pred             HHHHHHhhhccCCccccChhccCCc-------------------------------------------------------
Confidence            4432  1222344445555544210                                                       


Q ss_pred             HHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHh--hcCcHHHHHHHhc-CCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         296 EIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMA--KISSDSARKYINS-LPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       296 Evl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                          ...+.-.+|+||||+.+++..++.+|+..  ....+.. ..... .|.+.   +...--..|..+++||.-||.+|
T Consensus       243 ----~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~-~Vv~gdpp~l~---~~~~~~~~s~~~~~fintCl~Kd  314 (361)
T KOG1006|consen  243 ----DKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLC-QVVIGDPPILL---FDKECVHYSFSMVRFINTCLIKD  314 (361)
T ss_pred             ----cCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHH-HHHcCCCCeec---CcccccccCHHHHHHHHHHhhcc
Confidence                11245567999999999888777766532  2111111 11111 11111   11111236889999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCCCCC
Q psy8260         373 SEKRITAEQALAHPYLSQYSDP  394 (427)
Q Consensus       373 P~~R~ta~e~L~Hp~f~~~~~~  394 (427)
                      -+.||+-.+++++||++.+...
T Consensus       315 ~~~Rpky~~Lk~~~fyr~y~~~  336 (361)
T KOG1006|consen  315 RSDRPKYDDLKKFPFYRMYAVE  336 (361)
T ss_pred             cccCcchhhhhcCchhhhhhhc
Confidence            9999999999999999876543

>KOG1094|consensus

Probab=99.97  E-value=1.3e-30  Score=255.29  Aligned_cols=262  Identities=21%  Similarity=0.292  Sum_probs=186.4

Q ss_pred             CccccccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeec
Q psy8260          56 QPYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHS  135 (427)
Q Consensus        56 ~~~~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~  135 (427)
                      .+-.++++....+++.||+|.||.|..+..+.  +.+||||.++.. ........+.+||++|.+|+|||||.|++++..
T Consensus       530 ~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg--~lkVAVK~Lr~~-a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~  606 (807)
T KOG1094|consen  530 PALVEFPRSRLRFKEKIGEGQFGEVHLCEVEG--PLKVAVKILRPD-ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ  606 (807)
T ss_pred             cchhhcchhheehhhhhcCcccceeEEEEecC--ceEEEEeecCcc-cchhHHHHHHHHHHHHhccCCCCeeEEEeeeec
Confidence            34457788889999999999999999776543  689999998653 233345778899999999999999999999654


Q ss_pred             CccccCCceEEEEeccC-CCCHHHHHhhCCC---CHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEee
Q psy8260         136 NTCLADFKNVYMVTHLM-GADLNNILRTQKL---SDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILD  211 (427)
Q Consensus       136 ~~~~~~~~~~~lv~e~~-g~~L~~~l~~~~l---~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~D  211 (427)
                      +      +.+++++||+ .|+|.+++.....   .......++.||+.||+||.+.++|||||.+.|||++.++++||+|
T Consensus       607 D------ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiad  680 (807)
T KOG1094|consen  607 D------DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIAD  680 (807)
T ss_pred             C------CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecC
Confidence            3      4567888888 7999999876532   3344566999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccc
Q psy8260         212 FGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRW  291 (427)
Q Consensus       212 FGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~  291 (427)
                      ||++|......       .|++                                                 .-..+-.+.
T Consensus       681 fgmsR~lysg~-------yy~v-------------------------------------------------qgr~vlpiR  704 (807)
T KOG1094|consen  681 FGMSRNLYSGD-------YYRV-------------------------------------------------QGRAVLPIR  704 (807)
T ss_pred             cccccccccCC-------ceee-------------------------------------------------ecceeeeee
Confidence            99998543211       0100                                                 001123456


Q ss_pred             ccchHHhhhccCCCCCCHHHHHHHHHHh----CCCCHH-HHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHH
Q psy8260         292 YRAPEIMLNWMHYNQTDIHQLNLIMEML----GTPPAE-FMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLS  366 (427)
Q Consensus       292 Y~APEvl~~~~~~~~~d~~slg~i~~~l----g~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~  366 (427)
                      |||||.|....+.+++|+|++|+.++++    -..|.. ..++.--+....+   .+....................|+.
T Consensus       705 wmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~---~~~~~~~~~l~~P~~cp~~lyelml  781 (807)
T KOG1094|consen  705 WMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEF---FRDQGRQVVLSRPPACPQGLYELML  781 (807)
T ss_pred             ehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhh---cCCCCcceeccCCCcCcHHHHHHHH
Confidence            8888887777788899999999876544    223321 1111000111111   1111111112222334567789999


Q ss_pred             HhcCCCCCCCCCHHHHhcC
Q psy8260         367 LMLELDSEKRITAEQALAH  385 (427)
Q Consensus       367 ~mL~~dP~~R~ta~e~L~H  385 (427)
                      +|..+|.++|||.+++-.|
T Consensus       782 ~Cw~~es~~RPsFe~lh~~  800 (807)
T KOG1094|consen  782 RCWRRESEQRPSFEQLHLF  800 (807)
T ss_pred             HHhchhhhcCCCHHHHHHH
Confidence            9999999999999998543

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=9.5e-30  Score=235.35  Aligned_cols=242  Identities=37%  Similarity=0.530  Sum_probs=177.0

Q ss_pred             cccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEEEeccCCC-
Q psy8260          76 SFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGA-  154 (427)
Q Consensus        76 ~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~lv~e~~g~-  154 (427)
                      +||.||.+. ...+|+.||+|++........ ...+.+|++.++.++|+||+++++.+...      ...++++++.++ 
T Consensus         1 ~~g~v~~~~-~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~------~~~~l~~e~~~~~   72 (244)
T smart00220        1 SFGKVYLAR-DKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDE------DKLYLVMEYCDGG   72 (244)
T ss_pred             CceEEEEEE-ECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeC------CEEEEEEeCCCCC
Confidence            478888654 455789999999865432221 46678999999999999999999887543      457888888854 


Q ss_pred             CHHHHHhhCC-CCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccc
Q psy8260         155 DLNNILRTQK-LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRA  233 (427)
Q Consensus       155 ~L~~~l~~~~-l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~a  233 (427)
                      +|..++.... +++..+..++.|++.|+.|||+.+++|+||+|+||+++.++.++|+|||.+.......           
T Consensus        73 ~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-----------  141 (244)
T smart00220       73 DLFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-----------  141 (244)
T ss_pred             CHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-----------
Confidence            9999886654 8999999999999999999999999999999999999999999999999886433210           


Q ss_pred             hhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCCCCCHHHHH
Q psy8260         234 PEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN  313 (427)
Q Consensus       234 PE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg  313 (427)
                                                                      ......++..|++||.+....+..++|+|++|
T Consensus       142 ------------------------------------------------~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG  173 (244)
T smart00220      142 ------------------------------------------------LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLG  173 (244)
T ss_pred             ------------------------------------------------ccccccCCcCCCCHHHHccCCCCchhhHHHHH
Confidence                                                            00112355667777776655566678999999


Q ss_pred             HHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q psy8260         314 LIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYL  388 (427)
Q Consensus       314 ~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f  388 (427)
                      ++++.+.++..++...................    ........+.++.+++.+||..||++|||+.|+++||||
T Consensus       174 ~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      174 VILYELLTGKPPFPGDDQLLELFKKIGKPKPP----FPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             HHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC----CccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence            99877766554443311112221221111110    001111156789999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=4.5e-31  Score=286.38  Aligned_cols=221  Identities=16%  Similarity=0.198  Sum_probs=161.2

Q ss_pred             cCCC-CCceeeeeeeecCcccc-CCceEEEEeccCCCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCC
Q psy8260         120 HMNH-ENVIGLLDVFHSNTCLA-DFKNVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLK  195 (427)
Q Consensus       120 ~l~H-pnIv~l~~~~~~~~~~~-~~~~~~lv~e~~g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLK  195 (427)
                      .++| +||+.++++|....... ....++.++|+++++|.++++.  ..+++.++..+++||+.||+|||++||||||||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK  107 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR  107 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence            3455 58888888874332111 1235677788889999999964  359999999999999999999999999999999


Q ss_pred             CCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCC
Q psy8260         196 PSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGL  275 (427)
Q Consensus       196 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~  275 (427)
                      |+||||+..+.+|++|||++.....                                          ..++.+|++|||+
T Consensus       108 P~NiLl~~~~~~k~~d~~~~~~~~~------------------------------------------~~~~~~ki~DfG~  145 (793)
T PLN00181        108 PSCFVMSSFNHVSFIESASCSDSGS------------------------------------------DEDATTKSREIGS  145 (793)
T ss_pred             chhEEEcccCcEEEeeccccCcccc------------------------------------------cccCccccccccc
Confidence            9999999999999999998763211                                          1123567788887


Q ss_pred             CCCCcc-------------------ccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHH
Q psy8260         276 ARPTEN-------------------EMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSAR  336 (427)
Q Consensus       276 ~~~~~~-------------------~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~  336 (427)
                      ++....                   .....+||++|||||++.+..+..++|+||+|+++++|.++..++.....  ...
T Consensus       146 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~  223 (793)
T PLN00181        146 SRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMS  223 (793)
T ss_pred             ccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHH
Confidence            753211                   01124689999999999988888899999999999998766554432110  111


Q ss_pred             HHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q psy8260         337 KYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~  391 (427)
                      .....  ..+.     ......+++.+++.+||+.||.+|||+.|+|+||||.+.
T Consensus       224 ~~~~~--~~~~-----~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~  271 (793)
T PLN00181        224 SLRHR--VLPP-----QILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP  271 (793)
T ss_pred             HHHHh--hcCh-----hhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence            11000  0011     011225677899999999999999999999999999764

>KOG4257|consensus

Probab=99.97  E-value=2e-30  Score=255.36  Aligned_cols=249  Identities=22%  Similarity=0.360  Sum_probs=183.7

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCc-CCc--EEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecC
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSV-SGV--KVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSN  136 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~-~g~--~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~  136 (427)
                      ++.+..+.+++.||.|.||.||.|.+... .|.  .||||.-+... .....+.++.|.-+|++++|||||+|++++.. 
T Consensus       385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~e-  462 (974)
T KOG4257|consen  385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-  462 (974)
T ss_pred             eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-
Confidence            56677788889999999999999987543 343  48889776543 34457889999999999999999999999764 


Q ss_pred             ccccCCceEEEEeccC-CCCHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCC
Q psy8260         137 TCLADFKNVYMVTHLM-GADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG  213 (427)
Q Consensus       137 ~~~~~~~~~~lv~e~~-g~~L~~~l~~~--~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFG  213 (427)
                            ..++++||++ -|.|..+++.+  .++......|+.||+.||.|||+.++|||||..+|||+.....|||+|||
T Consensus       463 ------~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFG  536 (974)
T KOG4257|consen  463 ------QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFG  536 (974)
T ss_pred             ------cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccc
Confidence                  3578999988 58999999754  47888888999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccccc
Q psy8260         214 LARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR  293 (427)
Q Consensus       214 la~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~  293 (427)
                      |+|-.+.+..       |.|            +                                     .+ .-.+-||
T Consensus       537 LSR~~ed~~y-------Yka------------S-------------------------------------~~-kLPIKWm  559 (974)
T KOG4257|consen  537 LSRYLEDDAY-------YKA------------S-------------------------------------RG-KLPIKWM  559 (974)
T ss_pred             hhhhccccch-------hhc------------c-------------------------------------cc-ccceeec
Confidence            9986554311       110            0                                     00 0124588


Q ss_pred             chHHhhhccCCCCCCHHHHHHHH-HHh--CCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcC
Q psy8260         294 APEIMLNWMHYNQTDIHQLNLIM-EML--GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLE  370 (427)
Q Consensus       294 APEvl~~~~~~~~~d~~slg~i~-~~l--g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~  370 (427)
                      |||-+....+...+|+|.+|+.+ .+|  |..|+.....  ++-.       ..+....-....+...|.+..|.++|-.
T Consensus       560 aPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN--sDVI-------~~iEnGeRlP~P~nCPp~LYslmskcWa  630 (974)
T KOG4257|consen  560 APESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN--SDVI-------GHIENGERLPCPPNCPPALYSLMSKCWA  630 (974)
T ss_pred             CccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc--cceE-------EEecCCCCCCCCCCCChHHHHHHHHHhc
Confidence            88888877788889999999655 444  5544322211  1100       0000000001223456778899999999


Q ss_pred             CCCCCCCCHHHH
Q psy8260         371 LDSEKRITAEQA  382 (427)
Q Consensus       371 ~dP~~R~ta~e~  382 (427)
                      +||.+||+..|+
T Consensus       631 yeP~kRPrftei  642 (974)
T KOG4257|consen  631 YEPSKRPRFTEI  642 (974)
T ss_pred             cCcccCCcHHHH
Confidence            999999987654

>KOG0576|consensus

Probab=99.97  E-value=1.3e-31  Score=265.75  Aligned_cols=259  Identities=22%  Similarity=0.342  Sum_probs=189.7

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      +.+|++..++|.|.+|.||+ +.|..++...|||.++......  ..-...|+-+++..+|||||.+++-|-..      
T Consensus        14 ~ddyellqrvgsgTygdvyK-aRd~~s~elaavkvVkLep~dd--~~~iqqei~~~~dc~h~nivay~gsylr~------   84 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYK-ARDKRSGELAAVKVVKLEPGDD--FSGIQQEIGMLRDCRHPNIVAYFGSYLRR------   84 (829)
T ss_pred             ccchhheeeecCCcccchhh-hcccccCchhhheeeeccCCcc--ccccccceeeeecCCCcChHHHHhhhhhh------
Confidence            45688889999999999995 7788999999999997653332  33456799999999999999999876433      


Q ss_pred             ceEEEEeccC-CCCHHHHHh-hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~-~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      ..+.+.|||| ||+|+++.. .+.+++.++..+++..+.||+|||++|-+|||||-.|||+++.|.+|++|||.+.....
T Consensus        85 dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita  164 (829)
T KOG0576|consen   85 DKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA  164 (829)
T ss_pred             cCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh
Confidence            3578999999 568888765 36799999999999999999999999999999999999999999999999998754321


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh--
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM--  298 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl--  298 (427)
                      .                                                          -.....+.|||+||||||-  
T Consensus       165 t----------------------------------------------------------i~KrksfiGtpywmapEvaav  186 (829)
T KOG0576|consen  165 T----------------------------------------------------------IAKRKSFIGTPYWMAPEVAAV  186 (829)
T ss_pred             h----------------------------------------------------------hhhhhcccCCccccchhHHHH
Confidence            1                                                          0123445666666666653  


Q ss_pred             -hhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC
Q psy8260         299 -LNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI  377 (427)
Q Consensus       299 -~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~  377 (427)
                       +...|...+|+|++|+..-++|....|..+........-..++.+  .+..+++. ...++.+-+|++.+|..+|+|||
T Consensus       187 erkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~--qpp~lkDk-~kws~~fh~fvK~altknpKkRp  263 (829)
T KOG0576|consen  187 ERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGF--QPPTLKDK-TKWSEFFHNFVKGALTKNPKKRP  263 (829)
T ss_pred             HhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCC--CCCcccCC-ccchHHHHHHHHHHhcCCCccCC
Confidence             223466678999999777677654444332211111111111111  11111110 12356778999999999999999


Q ss_pred             CHHHHhcCCCCCCC
Q psy8260         378 TAEQALAHPYLSQY  391 (427)
Q Consensus       378 ta~e~L~Hp~f~~~  391 (427)
                      |++.+|+|||+++.
T Consensus       264 taeklL~h~fvs~~  277 (829)
T KOG0576|consen  264 TAEKLLQHPFVSQT  277 (829)
T ss_pred             Chhhheeceeeccc
Confidence            99999999999854

>KOG4278|consensus

Probab=99.97  E-value=4e-30  Score=252.93  Aligned_cols=252  Identities=19%  Similarity=0.314  Sum_probs=185.5

Q ss_pred             ccccccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecC
Q psy8260          57 PYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSN  136 (427)
Q Consensus        57 ~~~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~  136 (427)
                      .-||+.+.++.+...||.|+||.||.+.+.+. .--||||.++.   +....+.|++|+.+|+.++|||+|+|++++..+
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKky-slTvAVKtLKE---DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~E  335 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKY-SLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE  335 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeecc-ceeeehhhhhh---cchhHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence            45788899999999999999999999998764 34689998864   345677899999999999999999999996543


Q ss_pred             ccccCCceEEEEeccC-CCCHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeC
Q psy8260         137 TCLADFKNVYMVTHLM-GADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDF  212 (427)
Q Consensus       137 ~~~~~~~~~~lv~e~~-g~~L~~~l~~~---~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DF  212 (427)
                            ..+||+.||| .|+|.++|+..   .++.-....++.||..||.||..+++|||||...|+|+.++..|||+||
T Consensus       336 ------pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADF  409 (1157)
T KOG4278|consen  336 ------PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADF  409 (1157)
T ss_pred             ------CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeecc
Confidence                  4578888877 78999999753   3566666778889999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCc-ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccc
Q psy8260         213 GLARPTENEM-TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRW  291 (427)
Q Consensus       213 Gla~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~  291 (427)
                      ||+|.+..+. +...|..+                                                          .+-
T Consensus       410 GLsRlMtgDTYTAHAGAKF----------------------------------------------------------PIK  431 (1157)
T KOG4278|consen  410 GLSRLMTGDTYTAHAGAKF----------------------------------------------------------PIK  431 (1157)
T ss_pred             chhhhhcCCceecccCccC----------------------------------------------------------ccc
Confidence            9999875542 32333221                                                          123


Q ss_pred             ccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcC
Q psy8260         292 YRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLE  370 (427)
Q Consensus       292 Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~  370 (427)
                      |.|||-+-...+.-++|+|++|+++.+..+ +..|+. .+........+..--..      +...+..+....|++.|.+
T Consensus       432 WTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYP-GidlSqVY~LLEkgyRM------~~PeGCPpkVYeLMraCW~  504 (1157)
T KOG4278|consen  432 WTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYP-GIDLSQVYGLLEKGYRM------DGPEGCPPKVYELMRACWN  504 (1157)
T ss_pred             ccCcccccccccccchhhHHHHHHHHHHHhcCCCCCC-CccHHHHHHHHhccccc------cCCCCCCHHHHHHHHHHhc
Confidence            455555544446667899999988865522 222221 11111122222111111      1124566788999999999


Q ss_pred             CCCCCCCCHHHHh
Q psy8260         371 LDSEKRITAEQAL  383 (427)
Q Consensus       371 ~dP~~R~ta~e~L  383 (427)
                      ++|+.||+.+|+-
T Consensus       505 WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  505 WSPSDRPSFAEIH  517 (1157)
T ss_pred             CCcccCccHHHHH
Confidence            9999999988763

>KOG0196|consensus

Probab=99.96  E-value=4e-30  Score=259.11  Aligned_cols=258  Identities=22%  Similarity=0.320  Sum_probs=194.7

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEeCc--CCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecC
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALDSV--SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSN  136 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~--~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~  136 (427)
                      .|+.-..+.|.++||.|.||.|+.+.+...  ....||||.++.. ..+.+...|+.|+.||-+++||||++|-++....
T Consensus       624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks  702 (996)
T KOG0196|consen  624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS  702 (996)
T ss_pred             hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence            366677789999999999999999987643  3456999999754 4566778899999999999999999999998643


Q ss_pred             ccccCCceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCC
Q psy8260         137 TCLADFKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG  213 (427)
Q Consensus       137 ~~~~~~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFG  213 (427)
                            ..+.|+.||| +|.|+.+|+.  +.|+..++.-+.+.|+.||+||-++|.|||||...|||++.+..+|++|||
T Consensus       703 ------~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFG  776 (996)
T KOG0196|consen  703 ------KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFG  776 (996)
T ss_pred             ------ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEecccc
Confidence                  4678888888 7999999975  468888999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccccc
Q psy8260         214 LARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR  293 (427)
Q Consensus       214 la~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~  293 (427)
                      |+|..+++......|                 .+                                     |++ -..|.
T Consensus       777 LSRvledd~~~~ytt-----------------~G-------------------------------------GKI-PiRWT  801 (996)
T KOG0196|consen  777 LSRVLEDDPEAAYTT-----------------LG-------------------------------------GKI-PIRWT  801 (996)
T ss_pred             ceeecccCCCccccc-----------------cC-------------------------------------Ccc-ceeec
Confidence            999776543111111                 00                                     111 24577


Q ss_pred             chHHhhhccCCCCCCHHHHHHHH-HHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         294 APEIMLNWMHYNQTDIHQLNLIM-EMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       294 APEvl~~~~~~~~~d~~slg~i~-~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                      |||.|....+...+|+||.|+++ ..|-.+..|+|+-...+-.+ -+..--.++.      ...-...+..|+..|-++|
T Consensus       802 APEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIk-aIe~gyRLPp------PmDCP~aL~qLMldCWqkd  874 (996)
T KOG0196|consen  802 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIK-AIEQGYRLPP------PMDCPAALYQLMLDCWQKD  874 (996)
T ss_pred             ChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHH-HHHhccCCCC------CCCCcHHHHHHHHHHHHHH
Confidence            88888777788888999999876 55666666666543222221 1111111111      0112234568899999999


Q ss_pred             CCCCCCHHHHhcC
Q psy8260         373 SEKRITAEQALAH  385 (427)
Q Consensus       373 P~~R~ta~e~L~H  385 (427)
                      -.+||+..|++++
T Consensus       875 R~~RP~F~qiV~~  887 (996)
T KOG0196|consen  875 RNRRPKFAQIVST  887 (996)
T ss_pred             hhcCCCHHHHHHH
Confidence            9999999998875

>KOG3653|consensus

Probab=99.96  E-value=9.3e-29  Score=237.56  Aligned_cols=252  Identities=23%  Similarity=0.365  Sum_probs=172.4

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHh--cCCCCCceeeeeeeecCccccCC
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLK--HMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~--~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      ...+...+|+|.||.||++.++   ++.||||++..     .+.+.+..|-+|.+  .++|+||+++++.-..  +..+.
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~---~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr--~t~~~  280 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD---NRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKR--GTADR  280 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc---CceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhcc--CCccc
Confidence            3456688999999999987764   58999998842     33445666655554  5799999999987443  22334


Q ss_pred             ceEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHh---------cCceeccCCCCCeEEcCCCCEEEeeC
Q psy8260         143 KNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHS---------AGIIHRDLKPSNIAVNEDCELKILDF  212 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~---------~~iiHrDLKp~NILl~~~~~~kl~DF  212 (427)
                      ..+.+|++|. .|+|.++|+...+++....+++..+++||+|||+         ..|+|||||..|||+.+|+.+.|+||
T Consensus       281 ~eywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF  360 (534)
T KOG3653|consen  281 MEYWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF  360 (534)
T ss_pred             cceeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence            5677888876 7999999999999999999999999999999995         35999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccc
Q psy8260         213 GLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWY  292 (427)
Q Consensus       213 Gla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y  292 (427)
                      |||........                                                        .....+.+||..|
T Consensus       361 GLAl~~~p~~~--------------------------------------------------------~~d~~~qVGT~RY  384 (534)
T KOG3653|consen  361 GLALRLEPGKP--------------------------------------------------------QGDTHGQVGTRRY  384 (534)
T ss_pred             ceeEEecCCCC--------------------------------------------------------Ccchhhhhhhhhh
Confidence            99975432100                                                        0012234555555


Q ss_pred             cchHHhhhccCC------CCCCHHHHHHHHHHhCC--------CCH----HHHhhcCc----HHHHHH---HhcCCCCCc
Q psy8260         293 RAPEIMLNWMHY------NQTDIHQLNLIMEMLGT--------PPA----EFMAKISS----DSARKY---INSLPLLTK  347 (427)
Q Consensus       293 ~APEvl~~~~~~------~~~d~~slg~i~~~lg~--------~~~----~~~~~~~~----~~~~~~---~~~~~~~~~  347 (427)
                      |||||+.+..-+      ...|++++|+++.++.+        ++.    +|-.++..    +..+..   .+..|.++ 
T Consensus       385 MAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p-  463 (534)
T KOG3653|consen  385 MAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIP-  463 (534)
T ss_pred             cCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCCh-
Confidence            555555543332      34599999999876621        111    22222221    111111   11223222 


Q ss_pred             ccHHhhcCC--CChhHHHHHHHhcCCCCCCCCCHHHH------hcCCC
Q psy8260         348 KDFRQVFKG--ANPQAIDLLSLMLELDSEKRITAEQA------LAHPY  387 (427)
Q Consensus       348 ~~~~~~~~~--~s~~~~dLi~~mL~~dP~~R~ta~e~------L~Hp~  387 (427)
                          +.|..  .-..+++.|..|-..||+.|+||.-+      |.|+|
T Consensus       464 ----~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  464 ----DAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             ----hhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence                22222  12356799999999999999999654      56766

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.96  E-value=1.6e-28  Score=272.56  Aligned_cols=240  Identities=19%  Similarity=0.269  Sum_probs=169.3

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceE
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV  145 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~  145 (427)
                      +...+.+|+|+||.||++ ....+|+.||||++......      ..+|++++++++|||||++++++...      ...
T Consensus       692 ~~~~~~ig~G~~g~Vy~~-~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~------~~~  758 (968)
T PLN00113        692 LKEENVISRGKKGASYKG-KSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSE------KGA  758 (968)
T ss_pred             CCcccEEccCCCeeEEEE-EECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcC------CCC
Confidence            455678999999999975 45568899999988643211      12468899999999999999998654      346


Q ss_pred             EEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHH---hcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         146 YMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       146 ~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH---~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      |++|||+ +++|.++++  .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++..++. ||.+......
T Consensus       759 ~lv~Ey~~~g~L~~~l~--~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~  835 (968)
T PLN00113        759 YLIHEYIEGKNLSEVLR--NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD  835 (968)
T ss_pred             EEEEeCCCCCcHHHHHh--cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC
Confidence            8888888 789999986  4889999999999999999999   6799999999999999988888775 5544321100


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                       .                                                             ...||+.|+|||++.+.
T Consensus       836 -~-------------------------------------------------------------~~~~t~~y~aPE~~~~~  853 (968)
T PLN00113        836 -T-------------------------------------------------------------KCFISSAYVAPETRETK  853 (968)
T ss_pred             -C-------------------------------------------------------------CccccccccCcccccCC
Confidence             0                                                             11356677777777666


Q ss_pred             cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCc-HHHHHHHhc-----------CCCCCcccHHhhcCCCChhHHHHHHHhc
Q psy8260         302 MHYNQTDIHQLNLIMEMLGTPPAEFMAKISS-DSARKYINS-----------LPLLTKKDFRQVFKGANPQAIDLLSLML  369 (427)
Q Consensus       302 ~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~-~~~~~~~~~-----------~~~~~~~~~~~~~~~~s~~~~dLi~~mL  369 (427)
                      .+..++|+||+|++++++-++..|+...... .....+...           .+..... . ........++.+++.+|+
T Consensus       854 ~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~l~~~Cl  931 (968)
T PLN00113        854 DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD-V-SVNQNEIVEVMNLALHCT  931 (968)
T ss_pred             CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC-C-CccHHHHHHHHHHHHhhC
Confidence            6777889999999998886655544221110 111111110           0000000 0 000001135679999999


Q ss_pred             CCCCCCCCCHHHHhcC
Q psy8260         370 ELDSEKRITAEQALAH  385 (427)
Q Consensus       370 ~~dP~~R~ta~e~L~H  385 (427)
                      +.||++|||++|+++.
T Consensus       932 ~~~P~~RPt~~evl~~  947 (968)
T PLN00113        932 ATDPTARPCANDVLKT  947 (968)
T ss_pred             cCCchhCcCHHHHHHH
Confidence            9999999999999876

>KOG0199|consensus

Probab=99.96  E-value=1.1e-28  Score=245.89  Aligned_cols=259  Identities=21%  Similarity=0.213  Sum_probs=193.3

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCc--EEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGV--KVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNT  137 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~--~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~  137 (427)
                      .|..+.+.+.+.||.|.||.|..+.++..+|+  .||||.+....... ....|++|+.+|.+|+|||+++||+++-+  
T Consensus       106 lIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~--  182 (1039)
T KOG0199|consen  106 LIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD--  182 (1039)
T ss_pred             eccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc--
Confidence            35566778889999999999999999887664  58999997654433 56789999999999999999999999764  


Q ss_pred             cccCCceEEEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCC
Q psy8260         138 CLADFKNVYMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG  213 (427)
Q Consensus       138 ~~~~~~~~~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFG  213 (427)
                           ..+.||+|++ .|+|.+.|+.   ..|.......|+.||+.||.||.++++|||||...|+|+-....|||||||
T Consensus       183 -----qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFG  257 (1039)
T KOG0199|consen  183 -----QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFG  257 (1039)
T ss_pred             -----chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeeccc
Confidence                 3467899988 6888877765   347888899999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccccc
Q psy8260         214 LARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR  293 (427)
Q Consensus       214 la~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~  293 (427)
                      |.|.+......|+     |+|-                                                  +.--.-|-
T Consensus       258 LmRaLg~ned~Yv-----m~p~--------------------------------------------------rkvPfAWC  282 (1039)
T KOG0199|consen  258 LMRALGENEDMYV-----MAPQ--------------------------------------------------RKVPFAWC  282 (1039)
T ss_pred             ceeccCCCCcceE-----ecCC--------------------------------------------------CcCccccc
Confidence            9997665433221     1110                                                  00112367


Q ss_pred             chHHhhhccCCCCCCHHHHHHHHHHhC-CCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         294 APEIMLNWMHYNQTDIHQLNLIMEMLG-TPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       294 APEvl~~~~~~~~~d~~slg~i~~~lg-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                      |||.|+...+..++|+|+.|+.+.+|- .+..+|.......... .+.....++      ..+..+.+..+++.+|-..+
T Consensus       283 aPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~-~iD~~erLp------RPk~csedIY~imk~cWah~  355 (1039)
T KOG0199|consen  283 APESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILK-NIDAGERLP------RPKYCSEDIYQIMKNCWAHN  355 (1039)
T ss_pred             CHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHH-hccccccCC------CCCCChHHHHHHHHHhccCC
Confidence            888888888888999999999876654 3444443322222222 111111111      12345677889999999999


Q ss_pred             CCCCCCHHHHhcCCCC
Q psy8260         373 SEKRITAEQALAHPYL  388 (427)
Q Consensus       373 P~~R~ta~e~L~Hp~f  388 (427)
                      |++|+|...+.+.-+.
T Consensus       356 paDRptFsair~~~~l  371 (1039)
T KOG0199|consen  356 PADRPTFSAIREDLVL  371 (1039)
T ss_pred             ccccccHHHHHHhHHH
Confidence            9999999887644433

>KOG0984|consensus

Probab=99.96  E-value=1.1e-28  Score=214.05  Aligned_cols=170  Identities=24%  Similarity=0.399  Sum_probs=130.9

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhc-CCCCCceeeeeeeecCcc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKH-MNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~-l~HpnIv~l~~~~~~~~~  138 (427)
                      ++..........||+|++|.|- ...+..+|+..|+|.+.... ..+..++.++|+.+.++ ...|.+|.+|+.+...  
T Consensus        42 eV~ad~L~~i~elGrGayG~ve-kmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re--  117 (282)
T KOG0984|consen   42 EVPADDLVGIEELGRGAYGVVE-KMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE--  117 (282)
T ss_pred             ccchhhhhhhhhhcCCccchhh-heeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc--
Confidence            3444445556789999998765 45567899999999997543 34555677889987655 4789999999875432  


Q ss_pred             ccCCceEEEEeccCCCCHHHHHh-----hCCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCCeEEcCCCCEEEeeC
Q psy8260         139 LADFKNVYMVTHLMGADLNNILR-----TQKLSDDHVQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDCELKILDF  212 (427)
Q Consensus       139 ~~~~~~~~lv~e~~g~~L~~~l~-----~~~l~~~~~~~~~~qi~~aL~yLH~~-~iiHrDLKp~NILl~~~~~~kl~DF  212 (427)
                          ..+.+.||.+..+|..+.+     ++.++|..+-+++..|+.||.|||++ .|||||+||+||||+.+|.||+|||
T Consensus       118 ----gdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDF  193 (282)
T KOG0984|consen  118 ----GDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDF  193 (282)
T ss_pred             ----ccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccc
Confidence                4588999999988887653     35699999999999999999999976 8999999999999999999999999


Q ss_pred             CCCCCCCCCc--ccccccccccchhhh
Q psy8260         213 GLARPTENEM--TGYVATRWYRAPEIM  237 (427)
Q Consensus       213 Gla~~~~~~~--~~~~gt~~y~aPE~l  237 (427)
                      |++....+..  +.-.|-..|||||.+
T Consensus       194 GIsG~L~dSiAkt~daGCkpYmaPEri  220 (282)
T KOG0984|consen  194 GISGYLVDSIAKTMDAGCKPYMAPERI  220 (282)
T ss_pred             ccceeehhhhHHHHhcCCCccCChhhc
Confidence            9987554432  112344455555554

>KOG1152|consensus

Probab=99.96  E-value=9.4e-29  Score=242.02  Aligned_cols=189  Identities=25%  Similarity=0.428  Sum_probs=150.7

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHH------HHHHHHHHHHHHhcCC---CCCceeeeeeeec
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAV------HAKRTYRELRMLKHMN---HENVIGLLDVFHS  135 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~------~~~~~~~Ei~~l~~l~---HpnIv~l~~~~~~  135 (427)
                      .|...+.+|.|+||.|..+ .++.....|+||.|.+...-..      ..-..--||+||..++   |+||++++++|+.
T Consensus       562 ~yttlq~lG~GAyGkV~la-i~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  562 DYTTLQPLGEGAYGKVNLA-IHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             cceeeeeccccccceEEEe-eecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            4777889999999999964 5556688999999876432110      0111335999999997   9999999999976


Q ss_pred             CccccCCceEEEEeccCC--CCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeC
Q psy8260         136 NTCLADFKNVYMVTHLMG--ADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDF  212 (427)
Q Consensus       136 ~~~~~~~~~~~lv~e~~g--~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DF  212 (427)
                      +      +++|++++..|  -||.+++.. ..++|.+++.+++||+.|+++||++||||||||-||+.++.+|-+||+||
T Consensus       641 d------d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  641 D------DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             C------CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeec
Confidence            4      57899999874  588998875 56999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccc
Q psy8260         213 GLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWY  292 (427)
Q Consensus       213 Gla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y  292 (427)
                      |.|....                          ++                                  ....++||..|
T Consensus       715 gsaa~~k--------------------------sg----------------------------------pfd~f~gtv~~  734 (772)
T KOG1152|consen  715 GSAAYTK--------------------------SG----------------------------------PFDVFVGTVDY  734 (772)
T ss_pred             cchhhhc--------------------------CC----------------------------------Ccceeeeeccc
Confidence            9864221                          11                                  23456788888


Q ss_pred             cchHHhhhccCCCC-CCHHHHHHHHHHhC
Q psy8260         293 RAPEIMLNWMHYNQ-TDIHQLNLIMEMLG  320 (427)
Q Consensus       293 ~APEvl~~~~~~~~-~d~~slg~i~~~lg  320 (427)
                      .|||++.+..|-.+ .|||+||+++|..-
T Consensus       735 aapevl~g~~y~gk~qdiwalgillytiv  763 (772)
T KOG1152|consen  735 AAPEVLGGEKYLGKPQDIWALGILLYTIV  763 (772)
T ss_pred             cchhhhCCCccCCCcchhhhhhheeeEEE
Confidence            88888887776654 49999999887553

>KOG0200|consensus

Probab=99.95  E-value=3.8e-27  Score=247.15  Aligned_cols=256  Identities=24%  Similarity=0.373  Sum_probs=187.1

Q ss_pred             cccccCcceeeccccCcccccEEEEeEEeCcC------CcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeee
Q psy8260          58 YSEICRGVIDIGPTLSKESFDLIFSSALDSVS------GVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLL  130 (427)
Q Consensus        58 ~~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~------g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~  130 (427)
                      .+++.+....+++.+|.|.||.|+++......      ...||||.++..... .+.+.+..|+++|+.+ .|+||+.++
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll  368 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL  368 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence            46777777788899999999999988754222      457999988765443 5667788999999998 599999999


Q ss_pred             eeeecCccccCCceEEEEeccC-CCCHHHHHhhCC-----------------CCHHHHHHHHHHHHHHHHHHHhcCceec
Q psy8260         131 DVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQK-----------------LSDDHVQFLVYQILRGLKYIHSAGIIHR  192 (427)
Q Consensus       131 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~~-----------------l~~~~~~~~~~qi~~aL~yLH~~~iiHr  192 (427)
                      ++...      ...++++.|++ .|+|.++++..+                 ++..+...++.||+.|++||++.++|||
T Consensus       369 G~~t~------~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHR  442 (609)
T KOG0200|consen  369 GACTQ------DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHR  442 (609)
T ss_pred             eeecc------CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccch
Confidence            98654      24466666666 799999998766                 8889999999999999999999999999


Q ss_pred             cCCCCCeEEcCCCCEEEeeCCCCCCCCCCcc-cccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhh
Q psy8260         193 DLKPSNIAVNEDCELKILDFGLARPTENEMT-GYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKIL  271 (427)
Q Consensus       193 DLKp~NILl~~~~~~kl~DFGla~~~~~~~~-~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~  271 (427)
                      ||..+|||+..+..+||+|||+||....... ...++.                                          
T Consensus       443 DLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~------------------------------------------  480 (609)
T KOG0200|consen  443 DLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSA------------------------------------------  480 (609)
T ss_pred             hhhhhhEEecCCCEEEEccccceeccCCCCceEecCCC------------------------------------------
Confidence            9999999999999999999999985332210 000000                                          


Q ss_pred             ccCCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHh---CCCCHHHHhhcCcHHHHHHHhcCCCCCcc
Q psy8260         272 DFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEML---GTPPAEFMAKISSDSARKYINSLPLLTKK  348 (427)
Q Consensus       272 d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~l---g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (427)
                                   ++ --..|||||.+....+..++|+||.|+.++++   |..|.+-+.  .......+++.--..   
T Consensus       481 -------------~~-LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~--~~~~l~~~l~~G~r~---  541 (609)
T KOG0200|consen  481 -------------GT-LPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP--PTEELLEFLKEGNRM---  541 (609)
T ss_pred             -------------Cc-cceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC--cHHHHHHHHhcCCCC---
Confidence                         00 01237788877777788889999999987654   544443211  011222222211111   


Q ss_pred             cHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy8260         349 DFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALA  384 (427)
Q Consensus       349 ~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~  384 (427)
                         ......+++..++++.|-..||++||+..|+.+
T Consensus       542 ---~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  542 ---EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             ---CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence               011234788999999999999999999988753

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=3e-26  Score=206.46  Aligned_cols=210  Identities=36%  Similarity=0.598  Sum_probs=166.8

Q ss_pred             cCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEEEecc
Q psy8260          72 LSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHL  151 (427)
Q Consensus        72 lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~lv~e~  151 (427)
                      ||.|++|.||++.. ..+|+.+++|+........ ....+.+|++.++.++|++|+++++++...      ...++++++
T Consensus         1 l~~g~~~~v~~~~~-~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~------~~~~~~~e~   72 (215)
T cd00180           1 LGEGGFGTVYLARD-KKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDE------NHLYLVMEY   72 (215)
T ss_pred             CCcCCceEEEEEEe-cCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecC------CeEEEEEec
Confidence            68999999997554 4478999999987543221 345678999999999999999999987653      457888888


Q ss_pred             CC-CCHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcC-CCCEEEeeCCCCCCCCCCcccccc
Q psy8260         152 MG-ADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE-DCELKILDFGLARPTENEMTGYVA  227 (427)
Q Consensus       152 ~g-~~L~~~l~~~--~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~g  227 (427)
                      ++ ++|.+++...  .++...+..++.+++.+|.|||++|++|+||+|.||+++. ++.++|+|||.+........    
T Consensus        73 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~----  148 (215)
T cd00180          73 CEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS----  148 (215)
T ss_pred             CCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc----
Confidence            85 8999998765  6899999999999999999999999999999999999998 89999999998864432210    


Q ss_pred             cccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc-cCCCC
Q psy8260         228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW-MHYNQ  306 (427)
Q Consensus       228 t~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~-~~~~~  306 (427)
                                                                            ......++..|++||++... .....
T Consensus       149 ------------------------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~  174 (215)
T cd00180         149 ------------------------------------------------------LLKTIVGTPAYMAPEVLLGKGYYSEK  174 (215)
T ss_pred             ------------------------------------------------------hhhcccCCCCccChhHhcccCCCCch
Confidence                                                                  00011234456666665544 45566


Q ss_pred             CCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCC
Q psy8260         307 TDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHP  386 (427)
Q Consensus       307 ~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp  386 (427)
                      .|+|++|++++.+                                       ....++|.+||+.||++|+|++++++|+
T Consensus       175 ~D~~~lg~~~~~l---------------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         175 SDIWSLGVILYEL---------------------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             hhhHHHHHHHHHH---------------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence            7999999998776                                       3457999999999999999999999986

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG2052|consensus

Probab=99.95  E-value=1.4e-27  Score=227.91  Aligned_cols=166  Identities=25%  Similarity=0.430  Sum_probs=131.4

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHh--cCCCCCceeeeeeeecCccccC
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLK--HMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~--~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      ..+.+.+.+|+|.||.|+.|.+   .|..||||++..     .+....+||.+|.+  .|+|+||+.+++.-..+.  ..
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~w---rGe~VAVKiF~s-----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~--gs  280 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRW---RGEDVAVKIFSS-----RDERSWFRETEIYQTVMLRHENILGFIAADNKDN--GS  280 (513)
T ss_pred             heeEEEEEecCccccceeeccc---cCCceEEEEecc-----cchhhhhhHHHHHHHHHhccchhhhhhhccccCC--Cc
Confidence            4567889999999999998877   478999998853     22345777777765  469999999987633221  11


Q ss_pred             CceEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhc--------CceeccCCCCCeEEcCCCCEEEeeC
Q psy8260         142 FKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSA--------GIIHRDLKPSNIAVNEDCELKILDF  212 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~--------~iiHrDLKp~NILl~~~~~~kl~DF  212 (427)
                      -..++++.+|. .|+|+++|....++...+.+++..+++||++||-.        .|.|||||..|||+..++.+.|+|+
T Consensus       281 ~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL  360 (513)
T KOG2052|consen  281 WTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  360 (513)
T ss_pred             eEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence            24588999887 79999999999999999999999999999999942        4999999999999999999999999


Q ss_pred             CCCCCCCCC-------cccccccccccchhhhhc
Q psy8260         213 GLARPTENE-------MTGYVATRWYRAPEIMLN  239 (427)
Q Consensus       213 Gla~~~~~~-------~~~~~gt~~y~aPE~l~~  239 (427)
                      |||....+.       .+..+||..|||||+|.+
T Consensus       361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLde  394 (513)
T KOG2052|consen  361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDE  394 (513)
T ss_pred             eeeEEecccCCcccCCCCCccceeeccChHHhhh
Confidence            999654322       234567777777777654

>KOG1345|consensus

Probab=99.94  E-value=1.2e-27  Score=215.44  Aligned_cols=260  Identities=22%  Similarity=0.297  Sum_probs=190.5

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeee-eecCccccC
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDV-FHSNTCLAD  141 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~-~~~~~~~~~  141 (427)
                      ..|+|.+.+|+|.||.+-. +-++.+.+.+++|.+.++.   ...+.+.||...--.| .|.||+.-|++ |++      
T Consensus        24 d~y~I~k~lgeG~FgkIlL-~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt------   93 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILL-AEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQT------   93 (378)
T ss_pred             hhhhHHHHhcccceeeEEe-eeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhc------
Confidence            5688999999999999985 5677889999999987643   3456688898766666 58899998876 333      


Q ss_pred             CceEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEc--CCCCEEEeeCCCCCCC
Q psy8260         142 FKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN--EDCELKILDFGLARPT  218 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~--~~~~~kl~DFGla~~~  218 (427)
                      .+.+++++|++ -|+|.+-+...++.|.-.+.++.|+++|+.|||++++||||||.+||||-  +..++||||||+++..
T Consensus        94 ~d~YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen   94 SDAYVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV  173 (378)
T ss_pred             CceEEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence            24566788887 68999888778899999999999999999999999999999999999984  3458999999998765


Q ss_pred             CCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         219 ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       219 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                      +......--+..|.|||+.....                     .+                                  
T Consensus       174 g~tV~~~~~~~~y~~pe~~~~~~---------------------ne----------------------------------  198 (378)
T KOG1345|consen  174 GTTVKYLEYVNNYHAPELCDTVV---------------------NE----------------------------------  198 (378)
T ss_pred             CceehhhhhhcccCCcHHHhhcc---------------------cc----------------------------------
Confidence            54333333345577888754210                     00                                  


Q ss_pred             hhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcC-cHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCC-
Q psy8260         299 LNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKIS-SDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKR-  376 (427)
Q Consensus       299 ~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R-  376 (427)
                       .....+.+|+|++|+|++.+.++.+|+-.... ......+......... ...+.|+..|+.|..+.++-|..+|++| 
T Consensus       199 -~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~-~~P~~F~~fs~~a~r~Fkk~lt~~~~drc  276 (378)
T KOG1345|consen  199 -KLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP-ALPKKFNPFSEKALRLFKKSLTPRFKDRC  276 (378)
T ss_pred             -ceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc-cCchhhcccCHHHHHHHHHhcCCcccccc
Confidence             00133456999999999888777777653321 1222223222221111 2345577789999999999999999999 


Q ss_pred             --CCHHHHhcCCCCCC
Q psy8260         377 --ITAEQALAHPYLSQ  390 (427)
Q Consensus       377 --~ta~e~L~Hp~f~~  390 (427)
                        .++......-|...
T Consensus       277 ki~~~kk~rk~~w~E~  292 (378)
T KOG1345|consen  277 KIWTAKKMRKCLWKEK  292 (378)
T ss_pred             hhHHHHHHHHHHHHHh
Confidence              77788888888753

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=2.2e-25  Score=217.86  Aligned_cols=161  Identities=22%  Similarity=0.286  Sum_probs=124.0

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC---CHHHHHHHHHHHHHHhcCCCCCcee-eeeeeecCcc
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ---SAVHAKRTYRELRMLKHMNHENVIG-LLDVFHSNTC  138 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~-l~~~~~~~~~  138 (427)
                      .+.|.+++.||+|+||.||++.....+++.||||++.....   .......+.+|+++|++++|+||+. ++++      
T Consensus        17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~------   90 (365)
T PRK09188         17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT------   90 (365)
T ss_pred             cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc------
Confidence            45689999999999999997655545788899998753211   2334456789999999999999985 4432      


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccC-CCCCeEEcCCCCEEEeeCCCCC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDL-KPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDL-Kp~NILl~~~~~~kl~DFGla~  216 (427)
                          ...|++||++ |++|.. ..  ...   ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+|+
T Consensus        91 ----~~~~LVmE~~~G~~L~~-~~--~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~  160 (365)
T PRK09188         91 ----GKDGLVRGWTEGVPLHL-AR--PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLAS  160 (365)
T ss_pred             ----CCcEEEEEccCCCCHHH-hC--ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence                2368999988 667763 21  111   1467889999999999999999999 9999999999999999999998


Q ss_pred             CCCCC-----------cccccccccccchhhhhc
Q psy8260         217 PTENE-----------MTGYVATRWYRAPEIMLN  239 (427)
Q Consensus       217 ~~~~~-----------~~~~~gt~~y~aPE~l~~  239 (427)
                      .....           .++..++..|+|||.+..
T Consensus       161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            54332           234567888999999864

>KOG0590|consensus

Probab=99.93  E-value=1.3e-26  Score=240.61  Aligned_cols=264  Identities=25%  Similarity=0.281  Sum_probs=180.7

Q ss_pred             eccccCcccccEEEEeEEeCcCCcEEEEEEccC---cCCCHHH-HHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          68 IGPTLSKESFDLIFSSALDSVSGVKVAIKKIAR---PFQSAVH-AKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        68 ~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~---~~~~~~~-~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      .+..+|.|++|.|+. +.........+.|....   ....... ...+..|..+-..+.|||++..+..+...      .
T Consensus       322 ~~~~~g~ga~g~~~~-~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~------~  394 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRI-AKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI------D  394 (601)
T ss_pred             ccceeeecccCceEE-EEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc------c
Confidence            456788899886653 33444444444443321   1112222 22255678788889999998777665432      2


Q ss_pred             eEEEEeccCCCCHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCc
Q psy8260         144 NVYMVTHLMGADLNNILRTQ-KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM  222 (427)
Q Consensus       144 ~~~lv~e~~g~~L~~~l~~~-~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~  222 (427)
                      ..+-.||++.+||..++... .+...++..+++|++.|++|||+.||.||||||+|+++..+|.+||+|||.+.......
T Consensus       395 ~~~~~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  395 GILQSMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             cchhhhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            23344888866999888765 79999999999999999999999999999999999999999999999999875322110


Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhcc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM  302 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~  302 (427)
                      .                                  .                    ......+.+|+-.|+|||++.+..
T Consensus       475 e----------------------------------~--------------------~~~~~~g~~gS~pY~apE~~~~~~  500 (601)
T KOG0590|consen  475 E----------------------------------K--------------------NIHESSGIVGSDPYLAPEVLTGKE  500 (601)
T ss_pred             c----------------------------------h--------------------hhhhhcCcccCCcCcCcccccccc
Confidence            0                                  0                    001345667888888888887777


Q ss_pred             CCCC-CCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHh-cCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHH
Q psy8260         303 HYNQ-TDIHQLNLIMEMLGTPPAEFMAKISSDSARKYIN-SLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAE  380 (427)
Q Consensus       303 ~~~~-~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~  380 (427)
                      |... .|+|+.|+|+..|-++..+|......+....... ............++..+....+.+|.+||++||.+|+|++
T Consensus       501 ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~  580 (601)
T KOG0590|consen  501 YDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIE  580 (601)
T ss_pred             cCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHH
Confidence            7764 4999999988777666666543322221101110 0111111223345555677889999999999999999999


Q ss_pred             HHhcCCCCCCCC
Q psy8260         381 QALAHPYLSQYS  392 (427)
Q Consensus       381 e~L~Hp~f~~~~  392 (427)
                      ++++.+||+...
T Consensus       581 ~i~~d~W~~~i~  592 (601)
T KOG0590|consen  581 QILNDEWIRSIE  592 (601)
T ss_pred             HHhhChHhhhcc
Confidence            999999998764

>KOG1025|consensus

Probab=99.93  E-value=1.9e-25  Score=226.32  Aligned_cols=247  Identities=21%  Similarity=0.280  Sum_probs=182.0

Q ss_pred             eeeccccCcccccEEEEeEEeCc---CCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSV---SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      ..-.++||.|+||.||+|.+-.+   -..+||||++.. +........++.|+-+|.+++|||+++|+++....      
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~-~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s------  770 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIE-FTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS------  770 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeec-cCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc------
Confidence            34567999999999999988544   124689998754 34555567788999999999999999999986542      


Q ss_pred             ceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                       .+-+++.++ .|.|.++++.  .++.......|..||++||.|||.++++||||..+|||+.....+||.|||+|+...
T Consensus       771 -~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~  849 (1177)
T KOG1025|consen  771 -TLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA  849 (1177)
T ss_pred             -hHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence             244566665 7899998865  468888999999999999999999999999999999999999999999999998654


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      .....      |.||+                                                  ..-.+-|||-|.++
T Consensus       850 ~d~~e------y~~~~--------------------------------------------------gK~pikwmale~i~  873 (1177)
T KOG1025|consen  850 PDEKE------YSAPG--------------------------------------------------GKVPIKWMALESIR  873 (1177)
T ss_pred             ccccc------ccccc--------------------------------------------------cccCcHHHHHHHhh
Confidence            43221      11211                                                  01235688899999


Q ss_pred             hccCCCCCCHHHHHHHHHHh-CCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC
Q psy8260         300 NWMHYNQTDIHQLNLIMEML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT  378 (427)
Q Consensus       300 ~~~~~~~~d~~slg~i~~~l-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t  378 (427)
                      ...+..++|+|+.|+.+.++ .++..|.. .+..++..+.++.-..+..      .+.-+-+..-++.+|+-.|+..||+
T Consensus       874 ~~~~thqSDVWsfGVtiWElmTFGa~Py~-gi~~~eI~dlle~geRLsq------PpiCtiDVy~~mvkCwmid~~~rp~  946 (1177)
T KOG1025|consen  874 IRKYTHQSDVWSFGVTIWELMTFGAKPYD-GIPAEEIPDLLEKGERLSQ------PPICTIDVYMVMVKCWMIDADSRPT  946 (1177)
T ss_pred             ccCCCchhhhhhhhhhHHHHHhcCCCccC-CCCHHHhhHHHhccccCCC------CCCccHHHHHHHHHHhccCcccCcc
Confidence            98999999999999877554 33333332 2333333333332111111      1234567778999999999999999


Q ss_pred             HHHHh
Q psy8260         379 AEQAL  383 (427)
Q Consensus       379 a~e~L  383 (427)
                      ++++-
T Consensus       947 fkel~  951 (1177)
T KOG1025|consen  947 FKELA  951 (1177)
T ss_pred             HHHHH
Confidence            98864

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.91  E-value=9.8e-25  Score=193.51  Aligned_cols=164  Identities=21%  Similarity=0.249  Sum_probs=117.1

Q ss_pred             CCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccc
Q psy8260         154 ADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWY  231 (427)
Q Consensus       154 ~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y  231 (427)
                      |+|.++++.  ..+++..+..++.|++.||.|||+++      ||+|||++.++.+|+  ||+++......         
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---------   63 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ---------   63 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc---------
Confidence            578888864  45999999999999999999999998      999999999999999  99876432110         


Q ss_pred             cchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCCCCCHHH
Q psy8260         232 RAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ  311 (427)
Q Consensus       232 ~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~s  311 (427)
                                                                            ..||+.|||||++.+..+..++|+||
T Consensus        64 ------------------------------------------------------~~g~~~y~aPE~~~~~~~~~~~DiwS   89 (176)
T smart00750       64 ------------------------------------------------------SRVDPYFMAPEVIQGQSYTEKADIYS   89 (176)
T ss_pred             ------------------------------------------------------CCCcccccChHHhcCCCCcchhhHHH
Confidence                                                                  13567777777777767777889999


Q ss_pred             HHHHHHHhCCCCHHHHhhcC-cHHHHHHHhcCCCCCcccHHhhcCCCCh--hHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q psy8260         312 LNLIMEMLGTPPAEFMAKIS-SDSARKYINSLPLLTKKDFRQVFKGANP--QAIDLLSLMLELDSEKRITAEQALAHPYL  388 (427)
Q Consensus       312 lg~i~~~lg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f  388 (427)
                      +|++++.+.++..+|..... .................. .......+.  ++++||.+||..||.+|||+.|+++|+|+
T Consensus        90 lG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~  168 (176)
T smart00750       90 LGITLYEALDYELPYNEERELSAILEILLNGMPADDPRD-RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA  168 (176)
T ss_pred             HHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccc-cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence            99999988766655543221 112222221111110000 000111222  68999999999999999999999999997


Q ss_pred             C
Q psy8260         389 S  389 (427)
Q Consensus       389 ~  389 (427)
                      .
T Consensus       169 ~  169 (176)
T smart00750      169 L  169 (176)
T ss_pred             H
Confidence            5

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.90  E-value=1.1e-22  Score=186.26  Aligned_cols=197  Identities=33%  Similarity=0.542  Sum_probs=150.0

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceE
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV  145 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~  145 (427)
                      |.++..+|.|++|.||.+. ...+++.+|+|.+...... .....+.+|++.++.++|+|++++++.+...      ...
T Consensus         1 ~~~~~~i~~g~~~~v~~~~-~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~------~~~   72 (225)
T smart00221        1 YELGKKLGEGAFGKVYLAR-DKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDP------EPL   72 (225)
T ss_pred             CceeeEeecCCCeEEEEEE-EcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecC------Cce
Confidence            3567889999999999754 4557889999998754332 2455677899999999999999999887543      356


Q ss_pred             EEEeccC-CCCHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCc
Q psy8260         146 YMVTHLM-GADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM  222 (427)
Q Consensus       146 ~lv~e~~-g~~L~~~l~~~~--l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~  222 (427)
                      +++++++ +++|.+++....  +++..+..++.|++.++.|||+++++|+||+|+||+++.++.++|+|||++.......
T Consensus        73 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~  152 (225)
T smart00221       73 YLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL  152 (225)
T ss_pred             EEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence            7888877 459999886643  8999999999999999999999999999999999999999999999999886543221


Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh-hhc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM-LNW  301 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl-~~~  301 (427)
                      ..                                                         ......++..|++||++ ...
T Consensus       153 ~~---------------------------------------------------------~~~~~~~~~~~~~pe~~~~~~  175 (225)
T smart00221      153 AA---------------------------------------------------------LLKTVKGTPFYLAPEVLLGGK  175 (225)
T ss_pred             cc---------------------------------------------------------cccceeccCCcCCHhHhcCCC
Confidence            00                                                         00112344556666665 333


Q ss_pred             cCCCCCCHHHHHHHHHHhCCCCHHHH
Q psy8260         302 MHYNQTDIHQLNLIMEMLGTPPAEFM  327 (427)
Q Consensus       302 ~~~~~~d~~slg~i~~~lg~~~~~~~  327 (427)
                      .+...+|+|++|++++.+.++..+|.
T Consensus       176 ~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      176 GYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             CCCchhhHHHHHHHHHHHHHCCCCcc
Confidence            34457799999999887766666663

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.88  E-value=3e-21  Score=184.79  Aligned_cols=265  Identities=29%  Similarity=0.440  Sum_probs=180.9

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHH-HHHHHHHHHHHHhcCCCC-CceeeeeeeecCccccCCc
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAV-HAKRTYRELRMLKHMNHE-NVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~-~~~~~~~Ei~~l~~l~Hp-nIv~l~~~~~~~~~~~~~~  143 (427)
                      |.+...+|.|+|+.||.+...    ..+|+|.+........ ....+.+|+.++..+.|+ ||+.+.+.+...      .
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~----~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~------~   71 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR----KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDE------G   71 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec----cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecC------C
Confidence            456778999999877765433    7899999876544433 466788999999999988 799999998443      2


Q ss_pred             eEEEEeccC-CCCHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCC-CEEEeeCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRTQ----KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC-ELKILDFGLARP  217 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~~----~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~-~~kl~DFGla~~  217 (427)
                      ..+++++++ ++++.+++...    .+++..+..++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||+++.
T Consensus        72 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~  151 (384)
T COG0515          72 SLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKL  151 (384)
T ss_pred             EEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCccee
Confidence            357777776 67888777654    689999999999999999999999999999999999999888 799999999873


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      ...........                                                    .......||..|+|||+
T Consensus       152 ~~~~~~~~~~~----------------------------------------------------~~~~~~~~t~~~~~pe~  179 (384)
T COG0515         152 LPDPGSTSSIP----------------------------------------------------ALPSTSVGTPGYMAPEV  179 (384)
T ss_pred             cCCCCcccccc----------------------------------------------------ccccccccccccCCHHH
Confidence            32211000000                                                    01234457777777777


Q ss_pred             hhh---ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcC---cHHHHHHHhcCCCC--CcccHHhhcCCCChhHHHHHHHhc
Q psy8260         298 MLN---WMHYNQTDIHQLNLIMEMLGTPPAEFMAKIS---SDSARKYINSLPLL--TKKDFRQVFKGANPQAIDLLSLML  369 (427)
Q Consensus       298 l~~---~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~---~~~~~~~~~~~~~~--~~~~~~~~~~~~s~~~~dLi~~mL  369 (427)
                      +.+   .......|+|++|++++.+..+..++.....   ..............  ...............+.+++.+++
T Consensus       180 ~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (384)
T COG0515         180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLL  259 (384)
T ss_pred             hcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHH
Confidence            766   3455567999999777655443333322221   11111222111110  000000000111247889999999


Q ss_pred             CCCCCCCCCHHHHhcCCCCCCCC
Q psy8260         370 ELDSEKRITAEQALAHPYLSQYS  392 (427)
Q Consensus       370 ~~dP~~R~ta~e~L~Hp~f~~~~  392 (427)
                      ..+|..|.+..+...++|.....
T Consensus       260 ~~~~~~r~~~~~~~~~~~~~~~~  282 (384)
T COG0515         260 AKDPKNRLSSSSDLSHDLLAHLK  282 (384)
T ss_pred             hcCchhcCCHHHHhhchHhhCcc
Confidence            99999999999999998776543

>KOG1024|consensus

Probab=99.88  E-value=3.2e-22  Score=188.50  Aligned_cols=254  Identities=17%  Similarity=0.259  Sum_probs=179.8

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCc----CCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeec
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSV----SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHS  135 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~----~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~  135 (427)
                      .+.+.++.+...+.+|.||.||++.+...    +.+.|-+|.++. ..++.+...++.|...+..+.|||+..+.++...
T Consensus       280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~-~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie  358 (563)
T KOG1024|consen  280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ-HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE  358 (563)
T ss_pred             hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh-cccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence            45566788889999999999999966432    235577887754 3456677778899999999999999999988543


Q ss_pred             CccccCCceEEEEeccCC-CCHHHHHhh---------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCC
Q psy8260         136 NTCLADFKNVYMVTHLMG-ADLNNILRT---------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC  205 (427)
Q Consensus       136 ~~~~~~~~~~~lv~e~~g-~~L~~~l~~---------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~  205 (427)
                           +....++...+.| |+|..++.-         +.++..+...++.|++.|++|||++||||.||..+|++||+..
T Consensus       359 -----~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  359 -----DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQL  433 (563)
T ss_pred             -----ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhe
Confidence                 2233455555554 789988861         2366677888999999999999999999999999999999999


Q ss_pred             CEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccc
Q psy8260         206 ELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTG  285 (427)
Q Consensus       206 ~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~  285 (427)
                      .+||+|=.++|..........|-.                                                        
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDn--------------------------------------------------------  457 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDN--------------------------------------------------------  457 (563)
T ss_pred             eEEeccchhccccCcccccccCCC--------------------------------------------------------
Confidence            999999888875432110000000                                                        


Q ss_pred             ccccccccchHHhhhccCCCCCCHHHHHHHHHHh---CCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHH
Q psy8260         286 YVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEML---GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAI  362 (427)
Q Consensus       286 ~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~l---g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  362 (427)
                      .--..-||+||-+.+..+..++|+|++|+.+.+|   |..|.   .+++..+...++..--.+     .+- -+..++.-
T Consensus       458 EnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Py---aeIDPfEm~~ylkdGyRl-----aQP-~NCPDeLf  528 (563)
T KOG1024|consen  458 ENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPY---AEIDPFEMEHYLKDGYRL-----AQP-FNCPDELF  528 (563)
T ss_pred             CCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCc---cccCHHHHHHHHhcccee-----cCC-CCCcHHHH
Confidence            0012458899988888888999999999988655   33331   122223333343321111     111 12345677


Q ss_pred             HHHHHhcCCCCCCCCCHHHHhc
Q psy8260         363 DLLSLMLELDSEKRITAEQALA  384 (427)
Q Consensus       363 dLi~~mL~~dP~~R~ta~e~L~  384 (427)
                      ..+..|-..+|++||+.+|+..
T Consensus       529 ~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  529 TVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             HHHHHHHhcCcccCCCHHHHHH
Confidence            8899999999999999999764

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.87  E-value=5e-22  Score=178.60  Aligned_cols=139  Identities=18%  Similarity=0.255  Sum_probs=104.3

Q ss_pred             ccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHH------------------------HHHHHHHHHHHhcCCCC
Q psy8260          69 GPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVH------------------------AKRTYRELRMLKHMNHE  124 (427)
Q Consensus        69 ~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~------------------------~~~~~~Ei~~l~~l~Hp  124 (427)
                      ...||.|+||.||.+.. . +|+.||||++.........                        .....+|++++.++.++
T Consensus         2 ~~~ig~G~~~~Vy~a~~-~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05147           2 NGCISTGKEANVYHATT-A-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA   79 (190)
T ss_pred             CCccccccceEEEEEEC-C-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHC
Confidence            36799999999997644 4 8999999998654211100                        11224599999999888


Q ss_pred             CceeeeeeeecCccccCCceEEEEeccCCC-CHHHH-HhhCCCCHHHHHHHHHHHHHHHHHH-HhcCceeccCCCCCeEE
Q psy8260         125 NVIGLLDVFHSNTCLADFKNVYMVTHLMGA-DLNNI-LRTQKLSDDHVQFLVYQILRGLKYI-HSAGIIHRDLKPSNIAV  201 (427)
Q Consensus       125 nIv~l~~~~~~~~~~~~~~~~~lv~e~~g~-~L~~~-l~~~~l~~~~~~~~~~qi~~aL~yL-H~~~iiHrDLKp~NILl  201 (427)
                      ++.....+..        ...+++||++++ ++... +....+++..+..++.|++.+|.|+ |+.||+||||||+|||+
T Consensus        80 ~v~~p~~~~~--------~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli  151 (190)
T cd05147          80 GIPCPEPILL--------KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLY  151 (190)
T ss_pred             CCCCCcEEEe--------cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE
Confidence            7643332211        123789998854 44433 4556799999999999999999999 79999999999999999


Q ss_pred             cCCCCEEEeeCCCCCCC
Q psy8260         202 NEDCELKILDFGLARPT  218 (427)
Q Consensus       202 ~~~~~~kl~DFGla~~~  218 (427)
                      + ++.++|+|||+|...
T Consensus       152 ~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         152 H-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             E-CCcEEEEEccccccC
Confidence            8 478999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0603|consensus

Probab=99.87  E-value=3.4e-23  Score=206.47  Aligned_cols=239  Identities=21%  Similarity=0.323  Sum_probs=176.4

Q ss_pred             ccCcccccEEEEeE--EeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCC-CCCceeeeeeeecCccccCCceEEE
Q psy8260          71 TLSKESFDLIFSSA--LDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN-HENVIGLLDVFHSNTCLADFKNVYM  147 (427)
Q Consensus        71 ~lg~g~fg~v~~~~--~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~~~~~~~l  147 (427)
                      ++|.|.||.|+...  -....|..+|+|+..+.............|-.++..++ ||.+|++...|+.+      ...++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~------~kl~l   74 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTD------GKLYL   74 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccc------cchhH
Confidence            36889999888432  23456778999988765332222223345777788886 99999999888765      34567


Q ss_pred             EeccC-CCCHHHHHh-hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccc
Q psy8260         148 VTHLM-GADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGY  225 (427)
Q Consensus       148 v~e~~-g~~L~~~l~-~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  225 (427)
                      +.++. |++|...+. ...+.+...+.+...++.|++++|+.+|+|||+|++||+++.+|.+|+.|||+++..-....  
T Consensus        75 ~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--  152 (612)
T KOG0603|consen   75 ILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--  152 (612)
T ss_pred             hhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence            77766 667766554 45678888889999999999999999999999999999999999999999999874322111  


Q ss_pred             cccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCC
Q psy8260         226 VATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYN  305 (427)
Q Consensus       226 ~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~  305 (427)
                                                                                  .|||..||||||+.  .+..
T Consensus       153 ------------------------------------------------------------~cgt~eymApEI~~--gh~~  170 (612)
T KOG0603|consen  153 ------------------------------------------------------------ACGTYEYRAPEIIN--GHLS  170 (612)
T ss_pred             ------------------------------------------------------------cccchhhhhhHhhh--ccCC
Confidence                                                                        15666666666666  3566


Q ss_pred             CCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH-----H
Q psy8260         306 QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA-----E  380 (427)
Q Consensus       306 ~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta-----~  380 (427)
                      ..|+|++|.+++.|.++..+|..    +..+.+.......        .+..+.+|++++..|+..+|.+|.-+     .
T Consensus       171 a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~--------p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~  238 (612)
T KOG0603|consen  171 AADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEM--------PRELSAEARSLFRQLFKRNPENRLGAGPDGVD  238 (612)
T ss_pred             cccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCC--------chhhhHHHHHHHHHHHhhCHHHHhccCcchhH
Confidence            67999999999999888877755    2222222211111        23467899999999999999999854     8


Q ss_pred             HHhcCCCCCCC
Q psy8260         381 QALAHPYLSQY  391 (427)
Q Consensus       381 e~L~Hp~f~~~  391 (427)
                      |+++|+||...
T Consensus       239 eik~h~f~~~i  249 (612)
T KOG0603|consen  239 EIKQHEFFQSI  249 (612)
T ss_pred             HHhccchheee
Confidence            99999999864

>KOG1165|consensus

Probab=99.87  E-value=3.9e-21  Score=177.97  Aligned_cols=204  Identities=22%  Similarity=0.363  Sum_probs=148.8

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCccc
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~  139 (427)
                      +..-.|.+|+.||+|+||..+.+ .+.-+++.||||.=.+ .....+..   -|.+..+.| .-++|.+.|.+-.   | 
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G-~Nl~nne~VAIKfEPr-kS~APQLr---dEYr~YKlL~g~~GIP~vYYFGq---e-   95 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLG-KNLYNNEPVAIKFEPR-KSEAPQLR---DEYRTYKLLGGTEGIPQVYYFGQ---E-   95 (449)
T ss_pred             EecccceeccccccCcceeeecc-cccccCceEEEEeccc-cCCcchHH---HHHHHHHHHcCCCCCCceeeecc---c-
Confidence            44556899999999999999975 4667899999995432 22333333   344444444 4578888775422   1 


Q ss_pred             cCCceEEEEeccCCCCHHHHHh--hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCC-----CCEEEeeC
Q psy8260         140 ADFKNVYMVTHLMGADLNNILR--TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED-----CELKILDF  212 (427)
Q Consensus       140 ~~~~~~~lv~e~~g~~L~~~l~--~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~-----~~~kl~DF  212 (427)
                        ..+-.+|++++|.+|.++..  ..+|+...+..++.|++.-++|+|++.+|.|||||+|+||+..     ..+.|+||
T Consensus        96 --G~~NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDF  173 (449)
T KOG1165|consen   96 --GKYNILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDF  173 (449)
T ss_pred             --cchhhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEec
Confidence              13346899999999998864  5679999999999999999999999999999999999999743     46899999


Q ss_pred             CCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccc
Q psy8260         213 GLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWY  292 (427)
Q Consensus       213 Gla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y  292 (427)
                      |+|+.             |+.|+.-.. ..|.                                     ......||-.|
T Consensus       174 GmAK~-------------YrDp~TkqH-IPYr-------------------------------------E~KSLsGTARY  202 (449)
T KOG1165|consen  174 GMAKE-------------YRDPKTKQH-IPYR-------------------------------------EHKSLSGTARY  202 (449)
T ss_pred             cchhh-------------hcCcccccc-Cccc-------------------------------------cccccccceee
Confidence            99974             455543211 1111                                     23345688888


Q ss_pred             cchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHH
Q psy8260         293 RAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEF  326 (427)
Q Consensus       293 ~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~  326 (427)
                      |+.-.-++..-....|+.+||-++..+..+..||
T Consensus       203 MSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPW  236 (449)
T KOG1165|consen  203 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW  236 (449)
T ss_pred             eEeeccccchhhhhhhHHHhhhhhhhhccCCCcc
Confidence            8887777777777789999997765554455554

>KOG1164|consensus

Probab=99.86  E-value=1.3e-20  Score=183.71  Aligned_cols=260  Identities=23%  Similarity=0.291  Sum_probs=170.5

Q ss_pred             ceeeccccCcccccEEEEeEEeCcC-CcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCC----CCceeeeeeeecCccc
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVS-GVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNH----ENVIGLLDVFHSNTCL  139 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~-g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~H----pnIv~l~~~~~~~~~~  139 (427)
                      .|.+.+.||+|+||.||.+. +..+ ...+|+|.........  ...+..|+.++..+..    +++..+++....    
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~-~~~~~~~~~a~K~e~~~~~~~--~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~----   91 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVS-DKSEKNKEYAKKLEKKELGSK--PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRS----   91 (322)
T ss_pred             ceEEeeeccccCCceEEEEE-ecCCCCeeEEEEEEEecccCC--CccchhHHHHHHHHhhhcCCCCCCEEEEeccC----
Confidence            78999999999999999754 4333 4678888765432111  1135568888887763    578888877631    


Q ss_pred             cCCceEEEEeccCCCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCC-----CCEEEee
Q psy8260         140 ADFKNVYMVTHLMGADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED-----CELKILD  211 (427)
Q Consensus       140 ~~~~~~~lv~e~~g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~-----~~~kl~D  211 (427)
                       ....-|+||.+.|.+|.++.+.   +.++...+..++.|++.+|++||+.|+|||||||+|++++..     ..+.|.|
T Consensus        92 -~~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llD  170 (322)
T KOG1164|consen   92 -TEDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLD  170 (322)
T ss_pred             -CCceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEe
Confidence             1235689999999999998753   569999999999999999999999999999999999999854     4699999


Q ss_pred             CCCCCCCC--CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccc
Q psy8260         212 FGLARPTE--NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT  289 (427)
Q Consensus       212 FGla~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt  289 (427)
                      ||+|+...  ......     .+.|                                             ......+.||
T Consensus       171 fGlar~~~~~~~~~~~-----~~~~---------------------------------------------r~~~~~~rGT  200 (322)
T KOG1164|consen  171 FGLARRFKYVGDSGGN-----LRPP---------------------------------------------RPQKGLFRGT  200 (322)
T ss_pred             cCCCccccccCCCCcc-----cccC---------------------------------------------CCCccCCCCc
Confidence            99998322  111000     0000                                             0012345689


Q ss_pred             ccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhc
Q psy8260         290 RWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLML  369 (427)
Q Consensus       290 ~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL  369 (427)
                      ..|.++.+-.+.......|+||+..++..+..+..|+..........++..........   ........+..++...+-
T Consensus       201 ~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  277 (322)
T KOG1164|consen  201 LRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTD---RFGDLKPEEFAKILEYID  277 (322)
T ss_pred             cccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccc---cccCCChHHHHHHHHHhh
Confidence            99999999888888899999999877655544433332111111111111100000000   011112345556666666


Q ss_pred             CCCCCCCCCHHHHhcC
Q psy8260         370 ELDSEKRITAEQALAH  385 (427)
Q Consensus       370 ~~dP~~R~ta~e~L~H  385 (427)
                      ..+...+|.-..+.+.
T Consensus       278 ~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  278 SLDYEDKPDYEKLAEL  293 (322)
T ss_pred             ccCCcCCCCHHHHHHH
Confidence            6788888877766555

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.86  E-value=3.4e-21  Score=173.43  Aligned_cols=141  Identities=20%  Similarity=0.248  Sum_probs=108.0

Q ss_pred             ccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC----------------------HH--HHHHHHHHHHHHhcCCCC
Q psy8260          69 GPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS----------------------AV--HAKRTYRELRMLKHMNHE  124 (427)
Q Consensus        69 ~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~----------------------~~--~~~~~~~Ei~~l~~l~Hp  124 (427)
                      ...||.|+||.||.+.. . +|+.||||++......                      ..  ......+|.+.+.++.|+
T Consensus         2 ~~~ig~G~~~~Vy~a~~-~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           2 NGCISTGKEANVYHART-G-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CceeecCCCcEEEEEEc-C-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            46799999999997654 3 8999999998754211                      00  012235799999999999


Q ss_pred             CceeeeeeeecCccccCCceEEEEeccCCCC-H-HHHHhhCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCCeEE
Q psy8260         125 NVIGLLDVFHSNTCLADFKNVYMVTHLMGAD-L-NNILRTQKLSDDHVQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAV  201 (427)
Q Consensus       125 nIv~l~~~~~~~~~~~~~~~~~lv~e~~g~~-L-~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~-~~iiHrDLKp~NILl  201 (427)
                      +|.....+...        ..|++||++++. + ...+....+++..+..++.|++.+|.++|+ +||+||||||+|||+
T Consensus        80 ~i~~p~~~~~~--------~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll  151 (190)
T cd05145          80 GVPVPEPILLK--------KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILY  151 (190)
T ss_pred             CCCCceEEEec--------CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEE
Confidence            87544433221        137899998543 3 344556678889999999999999999999 999999999999999


Q ss_pred             cCCCCEEEeeCCCCCCCCC
Q psy8260         202 NEDCELKILDFGLARPTEN  220 (427)
Q Consensus       202 ~~~~~~kl~DFGla~~~~~  220 (427)
                      + ++.++|+|||+++....
T Consensus       152 ~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         152 H-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             E-CCCEEEEEcccceecCC
Confidence            9 88999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1163|consensus

Probab=99.86  E-value=6.9e-21  Score=169.30  Aligned_cols=149  Identities=23%  Similarity=0.376  Sum_probs=117.0

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCC-CCceeeeeeeecCcc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNH-ENVIGLLDVFHSNTC  138 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~l~~~~~~~~~  138 (427)
                      .+..+.|.+.+.||.|+||-+|. +....+|..||||.=......    -+...|..+.+.|+| ..|..+..++...  
T Consensus        11 ~iv~gky~lvrkiGsGSFGdIy~-~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~--   83 (341)
T KOG1163|consen   11 LIVGGKYKLVRKIGSGSFGDIYL-GISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTEK--   83 (341)
T ss_pred             heeccceEEEEeecCCchhheee-eeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhcccc--
Confidence            45678899999999999999996 467789999999964322111    235568888887766 3455544443322  


Q ss_pred             ccCCceEEEEeccCCCCHHHHHh--hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcC---CCCEEEeeCC
Q psy8260         139 LADFKNVYMVTHLMGADLNNILR--TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE---DCELKILDFG  213 (427)
Q Consensus       139 ~~~~~~~~lv~e~~g~~L~~~l~--~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~---~~~~kl~DFG  213 (427)
                          .+-.+||++.|.+|.++..  ...|+...+..++.|++.-++|+|.+++|||||||+|+|++-   ...+-++|||
T Consensus        84 ----~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFG  159 (341)
T KOG1163|consen   84 ----DYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFG  159 (341)
T ss_pred             ----ccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEecc
Confidence                3347899999999998874  467999999999999999999999999999999999999864   3578999999


Q ss_pred             CCCCCC
Q psy8260         214 LARPTE  219 (427)
Q Consensus       214 la~~~~  219 (427)
                      +|+...
T Consensus       160 LaKky~  165 (341)
T KOG1163|consen  160 LAKKYR  165 (341)
T ss_pred             chhhhc
Confidence            998543

>PRK10345 hypothetical protein; Provisional

Probab=99.85  E-value=9.9e-21  Score=172.05  Aligned_cols=135  Identities=18%  Similarity=0.258  Sum_probs=104.9

Q ss_pred             cccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-----CCCCceeeeeeeecCccccCCce
Q psy8260          70 PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-----NHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-----~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      ..||+|+|+.||.   +..++.+ +||++.....  ...+.+.+|+.+++.+     +||||++++++++++..   ...
T Consensus         8 ~~LG~G~~~~Vy~---hp~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g---~g~   78 (210)
T PRK10345          8 SPLGTGRHRKCYA---HPEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG---TGY   78 (210)
T ss_pred             ceecCCCceEEEE---CCCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC---CeE
Confidence            6799999999993   5566666 6998865322  2345678999999999     67999999999987521   123


Q ss_pred             EE-EEeccCC---CCHHHHHhhCCCCHHHHHHHHHHHHHHH-HHHHhcCceeccCCCCCeEEcC----CCCEEEeeCCCC
Q psy8260         145 VY-MVTHLMG---ADLNNILRTQKLSDDHVQFLVYQILRGL-KYIHSAGIIHRDLKPSNIAVNE----DCELKILDFGLA  215 (427)
Q Consensus       145 ~~-lv~e~~g---~~L~~~l~~~~l~~~~~~~~~~qi~~aL-~yLH~~~iiHrDLKp~NILl~~----~~~~kl~DFGla  215 (427)
                      ++ +++++.|   ++|.++++...+++.  ..++.|++.++ +|||+++|+||||||+|||++.    +..++|+||+.+
T Consensus        79 v~~~I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         79 VYDVIADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEEEEecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            34 6788865   799999987777766  35678888888 9999999999999999999974    237999995444

>KOG0606|consensus

Probab=99.85  E-value=1.2e-21  Score=204.44  Aligned_cols=238  Identities=20%  Similarity=0.289  Sum_probs=160.2

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      ...|+..+.+..|++|.||. ..++.+.+++|+ ++++...       +.|-  ++.....|.+|               
T Consensus        82 e~df~~IklisngAygavyl-vrh~~trqrfa~-kiNkq~l-------ilRn--ilt~a~npfvv---------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYL-VRHKETRQRFAM-KINKQNL-------ILRN--ILTFAGNPFVV---------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceee-eeccccccchhh-cccccch-------hhhc--cccccCCccee---------------
Confidence            45677788999999999996 557788899999 4543211       1111  22223333333               


Q ss_pred             ceEEEEeccCCCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         143 KNVYMVTHLMGADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       143 ~~~~lv~e~~g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                                 ||-..+++. +.++.        +.+.+++|||+-||+|||+||+|.||..-|.+|+.|||+++...-.
T Consensus       136 -----------gDc~tllk~~g~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms  196 (1205)
T KOG0606|consen  136 -----------GDCATLLKNIGPLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS  196 (1205)
T ss_pred             -----------chhhhhcccCCCCcc--------hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence                       222233332 23443        2378999999999999999999999999999999999998743221


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      .++    .                                +.+ +.++. |     ..+..-.+.+|||.|+||||+...
T Consensus       197 ~at----n--------------------------------l~e-g~I~k-~-----t~Ef~dKqvcgTPeyiaPeVilrq  233 (1205)
T KOG0606|consen  197 LAT----N--------------------------------LKE-GHIEK-D-----THEFQDKQVCGTPEYIAPEVILRQ  233 (1205)
T ss_pred             ccc----h--------------------------------hhh-cchHH-H-----HHHhhhccccCCccccChhhhhhh
Confidence            111    0                                000 00000 0     001122456899999999999998


Q ss_pred             cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC---C
Q psy8260         302 MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI---T  378 (427)
Q Consensus       302 ~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~---t  378 (427)
                      .|+..+|||++|+|+|++..+-.+|.....++....++.....++.     .-....+|++|+|.+||+.+|..|.   .
T Consensus       234 gygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE-----~dea~p~Ea~dli~~LL~qnp~~Rlgt~g  308 (1205)
T KOG0606|consen  234 GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE-----EDEALPPEAQDLIEQLLRQNPLCRLGTGG  308 (1205)
T ss_pred             ccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc-----cCcCCCHHHHHHHHHHHHhChHhhcccch
Confidence            9999999999999999887766666655433333333333222322     2345689999999999999999997   5


Q ss_pred             HHHHhcCCCCCCCCC
Q psy8260         379 AEQALAHPYLSQYSD  393 (427)
Q Consensus       379 a~e~L~Hp~f~~~~~  393 (427)
                      +-++.+|+||..+..
T Consensus       309 a~evk~h~ff~~LDw  323 (1205)
T KOG0606|consen  309 ALEVKQHGFFQLLDW  323 (1205)
T ss_pred             hhhhhhccceeeccc
Confidence            778899999986543

>KOG4158|consensus

Probab=99.80  E-value=2.7e-19  Score=169.35  Aligned_cols=201  Identities=21%  Similarity=0.308  Sum_probs=135.5

Q ss_pred             CCCCceeeeeeeecCc---------------------cccCCceEEEEeccCCCCHHHHHhhCCCCHHHHHHHHHHHHHH
Q psy8260         122 NHENVIGLLDVFHSNT---------------------CLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRG  180 (427)
Q Consensus       122 ~HpnIv~l~~~~~~~~---------------------~~~~~~~~~lv~e~~g~~L~~~l~~~~l~~~~~~~~~~qi~~a  180 (427)
                      +|||||++..+|.+.-                     .......+|++|.-...+|..++..+..+....+.++.|+++|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~~s~r~~~~~laQlLEa  353 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRHRSYRTGRVILAQLLEA  353 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCCCchHHHHHHHHHHHHH
Confidence            6999999998875421                     1123456899999989999999998888888888899999999


Q ss_pred             HHHHHhcCceeccCCCCCeEEc--CCC--CEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCC
Q psy8260         181 LKYIHSAGIIHRDLKPSNIAVN--EDC--ELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLK  256 (427)
Q Consensus       181 L~yLH~~~iiHrDLKp~NILl~--~~~--~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~  256 (427)
                      +.|||++||.|||||.+|||+.  +++  .+.|+|||.+-...+..-                       -++|.     
T Consensus       354 v~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGl-----------------------qlpy~-----  405 (598)
T KOG4158|consen  354 VTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGL-----------------------QLPYE-----  405 (598)
T ss_pred             HHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeecccccc-----------------------ccccc-----
Confidence            9999999999999999999983  443  578999997643221100                       00000     


Q ss_pred             cccccccccchhhhhccCCCCCCccccccccccccccchHHhhhcc------CCCCCCHHHHHHHHHHhCCCCHHHHhhc
Q psy8260         257 PSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM------HYNQTDIHQLNLIMEMLGTPPAEFMAKI  330 (427)
Q Consensus       257 ~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~------~~~~~d~~slg~i~~~lg~~~~~~~~~~  330 (427)
                                              .......|.-.-|||||..-.+      -+.+.|.|+.|.+.|+.-....||...-
T Consensus       406 ------------------------S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG  461 (598)
T KOG4158|consen  406 ------------------------SDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG  461 (598)
T ss_pred             ------------------------cccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc
Confidence                                    0001112333345555554322      2456799999999877755556665411


Q ss_pred             C-cHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHH
Q psy8260         331 S-SDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQ  381 (427)
Q Consensus       331 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e  381 (427)
                      . .-+.+.       +....+......+.|.+++|+..+|+.||+||++++=
T Consensus       462 em~L~~r~-------Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~i  506 (598)
T KOG4158|consen  462 EMLLDTRT-------YQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNI  506 (598)
T ss_pred             hheechhh-------hhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccH
Confidence            0 001111       2222333344567899999999999999999998654

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.79  E-value=1e-18  Score=159.69  Aligned_cols=148  Identities=18%  Similarity=0.211  Sum_probs=112.3

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHH-HHH------HHHHHHHHhcCCCCCceeeeee
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVH-AKR------TYRELRMLKHMNHENVIGLLDV  132 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~-~~~------~~~Ei~~l~~l~HpnIv~l~~~  132 (427)
                      .+..+.|.+.+.+|.|+||.||. + +. ++..+|||.+......... ...      +.+|++.+.++.||+|....++
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l-~-~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~  103 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSL-I-DT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF  103 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEE-E-ec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence            44568899999999999999996 3 33 4778999998654433322 222      4689999999999999999888


Q ss_pred             eecCcc--ccCCceEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEE
Q psy8260         133 FHSNTC--LADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKI  209 (427)
Q Consensus       133 ~~~~~~--~~~~~~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl  209 (427)
                      +.....  .......+++||++ |.+|.++.   .+++.    ...+++.+|..||+.|++|||+||+||+++.+| ++|
T Consensus       104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~---~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~l  175 (232)
T PRK10359        104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMP---EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRI  175 (232)
T ss_pred             eeecccccccccCCeEEEEEEECCccHHHhh---hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEE
Confidence            653211  11123578899988 55787763   23332    456999999999999999999999999999888 999


Q ss_pred             eeCCCCCCC
Q psy8260         210 LDFGLARPT  218 (427)
Q Consensus       210 ~DFGla~~~  218 (427)
                      +|||..+..
T Consensus       176 iDfg~~~~~  184 (232)
T PRK10359        176 IDLSGKRCT  184 (232)
T ss_pred             EECCCcccc
Confidence            999987654

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=2e-18  Score=154.74  Aligned_cols=133  Identities=21%  Similarity=0.195  Sum_probs=101.0

Q ss_pred             eeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC--HHHHHHHHHHHHHHhcCC-CCCceeeeeeeecCccccCCc
Q psy8260          67 DIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS--AVHAKRTYRELRMLKHMN-HENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        67 ~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      .+...|+.|+||.|+..   ...+.+++.+.+......  ......+.+|+++|++++ |++|++++++.          
T Consensus         5 ~~~~~l~~~~f~~v~~~---~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~----------   71 (218)
T PRK12274          5 AVNEPLKSDTFGRILLV---RGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD----------   71 (218)
T ss_pred             ccceeecCCCcceEEEe---ecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc----------
Confidence            45678999999999943   237888888777543221  112234678999999995 58899998761          


Q ss_pred             eEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccC-CCCCeEEcCCCCEEEeeCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDL-KPSNIAVNEDCELKILDFGLARPT  218 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDL-Kp~NILl~~~~~~kl~DFGla~~~  218 (427)
                      ..+++|++. |.+|.+....     . ...++.|++.+|.++|++||+|||| ||+|||++.++.++|+|||+|...
T Consensus        72 ~~~lvmeyI~G~~L~~~~~~-----~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~  142 (218)
T PRK12274         72 GRHLDRSYLAGAAMYQRPPR-----G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRG  142 (218)
T ss_pred             CEEEEEeeecCccHHhhhhh-----h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceec
Confidence            257888886 6677654321     1 1347789999999999999999999 799999999999999999999743

>smart00090 RIO RIO-like kinase

Probab=99.77  E-value=1.3e-18  Score=161.80  Aligned_cols=147  Identities=18%  Similarity=0.201  Sum_probs=107.5

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC--------------------HH--HHHHHHHHHHHHhcCC
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS--------------------AV--HAKRTYRELRMLKHMN  122 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~--------------------~~--~~~~~~~Ei~~l~~l~  122 (427)
                      .|.+.+.||+|+||.||.+..+..+|+.||||++......                    ..  ....+.+|+.++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            4678899999999999976435678999999988643210                    00  1123468999999997


Q ss_pred             CCCceeeeeeeecCccccCCceEEEEeccCCC-CHHHHH-hhCCCCHHHHHHHHHHHHHHHHHHHhcC-ceeccCCCCCe
Q psy8260         123 HENVIGLLDVFHSNTCLADFKNVYMVTHLMGA-DLNNIL-RTQKLSDDHVQFLVYQILRGLKYIHSAG-IIHRDLKPSNI  199 (427)
Q Consensus       123 HpnIv~l~~~~~~~~~~~~~~~~~lv~e~~g~-~L~~~l-~~~~l~~~~~~~~~~qi~~aL~yLH~~~-iiHrDLKp~NI  199 (427)
                      +.+ +....++...       ..+++||++++ +|.... ....+....+..++.|++.+|.+||++| |+||||||+||
T Consensus       109 ~~~-i~~p~~~~~~-------~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NI  180 (237)
T smart00090      109 EAG-VPVPKPIAWR-------RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNI  180 (237)
T ss_pred             hcC-CCCCeeeEec-------CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhE
Confidence            633 2222232211       23788888855 554433 3445666677889999999999999999 99999999999


Q ss_pred             EEcCCCCEEEeeCCCCCCCCC
Q psy8260         200 AVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       200 Ll~~~~~~kl~DFGla~~~~~  220 (427)
                      +++ ++.++|+|||.|.....
T Consensus       181 li~-~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      181 LVH-DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             EEE-CCCEEEEEChhhhccCC
Confidence            999 88999999999875443

>KOG1240|consensus

Probab=99.77  E-value=5.6e-19  Score=184.90  Aligned_cols=252  Identities=21%  Similarity=0.267  Sum_probs=169.7

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcC--CCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPF--QSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .++..+.||.+.|-.|.++ .++ .|. |+||+.-+..  .+-....+.++|++ ...++|||.+.+..+-...      
T Consensus        24 e~~~~~~LGstRFlKv~r~-k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~------   93 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARA-KDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTD------   93 (1431)
T ss_pred             ceeeecccCchhhhhhhhc-cCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhh------
Confidence            5677889999999988853 332 454 8899875532  22333455567777 6677999999887554332      


Q ss_pred             ceEEEEeccCCCCHHHHHhhCC-CCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC--
Q psy8260         143 KNVYMVTHLMGADLNNILRTQK-LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE--  219 (427)
Q Consensus       143 ~~~~lv~e~~g~~L~~~l~~~~-l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~--  219 (427)
                      ...|||-.|...+|++-+..++ +...+-+.|+.|++.||.-||..||.|+|||.|||||+.=+.+.|+||..-+...  
T Consensus        94 kAAylvRqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP  173 (1431)
T KOG1240|consen   94 KAAYLVRQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLP  173 (1431)
T ss_pred             HHHHHHHHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCC
Confidence            3467888888889998887766 5667788899999999999999999999999999999999999999998766432  


Q ss_pred             --CC--cc----cccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccc
Q psy8260         220 --NE--MT----GYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRW  291 (427)
Q Consensus       220 --~~--~~----~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~  291 (427)
                        +.  .+    +...-.+|.|||-+.....+...                                         +...
T Consensus       174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~-----------------------------------------~q~~  212 (1431)
T KOG1240|consen  174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSV-----------------------------------------GQDA  212 (1431)
T ss_pred             CCCcccceEEEecCCceeeecChHhhhcccccccc-----------------------------------------CCcc
Confidence              11  11    11223358888876542111000                                         0000


Q ss_pred             ccchHHhhhccCCCCCCHHHHHHHHHHh---CCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHh
Q psy8260         292 YRAPEIMLNWMHYNQTDIHQLNLIMEML---GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLM  368 (427)
Q Consensus       292 Y~APEvl~~~~~~~~~d~~slg~i~~~l---g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~m  368 (427)
                      .         .+.+.-||+|+||++.+|   |.|++....      ...|...........+.+   -.++..+.||..|
T Consensus       213 ~---------~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~aYr~~~~~~~e~~Le~---Ied~~~Rnlil~M  274 (1431)
T KOG1240|consen  213 P---------LLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LLAYRSGNADDPEQLLEK---IEDVSLRNLILSM  274 (1431)
T ss_pred             c---------ccChhhhhhhhhHHHHHHHhcCCCcccHHH------HHhHhccCccCHHHHHHh---CcCccHHHHHHHH
Confidence            0         033345999999988666   666665432      112222111111111111   2356789999999


Q ss_pred             cCCCCCCCCCHHHHhcC
Q psy8260         369 LELDSEKRITAEQALAH  385 (427)
Q Consensus       369 L~~dP~~R~ta~e~L~H  385 (427)
                      +++||++|++|++.|+-
T Consensus       275 i~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  275 IQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HccCchhccCHHHHHHh
Confidence            99999999999999976

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.75  E-value=1.3e-18  Score=163.63  Aligned_cols=245  Identities=18%  Similarity=0.192  Sum_probs=136.4

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH-HHHHHHHHHHHHHhcCCC----------CCceeeeeeee
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA-VHAKRTYRELRMLKHMNH----------ENVIGLLDVFH  134 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~l~H----------pnIv~l~~~~~  134 (427)
                      +..++.||.|+++.||. +.+..||+.+|||+........ ...+++.+|.-....+.+          -.++--++...
T Consensus        14 l~~~~~i~~g~~~~v~~-v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFE-VTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEETTEEEEE-EEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEccccccCCceEEEE-EEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            45678999999999994 6788999999999875443222 234555555544433322          11222222211


Q ss_pred             ---------cCcc--ccCCceEEEEeccCCCCHHHHHhh----CCC--CH-HHH-HHHHHHHHHHHHHHHhcCceeccCC
Q psy8260         135 ---------SNTC--LADFKNVYMVTHLMGADLNNILRT----QKL--SD-DHV-QFLVYQILRGLKYIHSAGIIHRDLK  195 (427)
Q Consensus       135 ---------~~~~--~~~~~~~~lv~e~~g~~L~~~l~~----~~l--~~-~~~-~~~~~qi~~aL~yLH~~~iiHrDLK  195 (427)
                               ....  .....+.++.+.-+.++|..++..    ...  .. ..+ ..+..|+++.+++||+.||+|+|||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~  172 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK  172 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence                     1000  000114466777778888877542    222  11 222 3345799999999999999999999


Q ss_pred             CCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCC
Q psy8260         196 PSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGL  275 (427)
Q Consensus       196 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~  275 (427)
                      |+|++++.+|.+.|+||+..............+..|.+||.......|..                              
T Consensus       173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~------------------------------  222 (288)
T PF14531_consen  173 PENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQ------------------------------  222 (288)
T ss_dssp             GGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHH------------------------------
T ss_pred             eeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCc------------------------------
Confidence            99999999999999999876654443332344566778886532111100                              


Q ss_pred             CCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcC
Q psy8260         276 ARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFK  355 (427)
Q Consensus       276 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (427)
                                             ....+....|.|+||+++|.+-+...||.......        .   ....|...- 
T Consensus       223 -----------------------~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~--------~---~~~~f~~C~-  267 (288)
T PF14531_consen  223 -----------------------NNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEA--------D---PEWDFSRCR-  267 (288)
T ss_dssp             -----------------------SEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGS--------T---SGGGGTTSS-
T ss_pred             -----------------------ccceeeeccCHHHHHHHHHHHHHccCCCCCCCccc--------c---ccccchhcC-
Confidence                                   00113345699999999987754444442111000        0   000222222 


Q ss_pred             CCChhHHHHHHHhcCCCCCCC
Q psy8260         356 GANPQAIDLLSLMLELDSEKR  376 (427)
Q Consensus       356 ~~s~~~~dLi~~mL~~dP~~R  376 (427)
                      .+....++||.+||++||.+|
T Consensus       268 ~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  268 DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             ---HHHHHHHHHHT-SSGGGS
T ss_pred             CcCHHHHHHHHHHccCCcccC
Confidence            456788999999999999988

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.74  E-value=1.4e-17  Score=150.85  Aligned_cols=138  Identities=22%  Similarity=0.243  Sum_probs=102.2

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH--------------------HHHHHHHHHHHHHhcCCCCC
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA--------------------VHAKRTYRELRMLKHMNHEN  125 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~--------------------~~~~~~~~Ei~~l~~l~Hpn  125 (427)
                      +.+.+.||.|+||.||.+..  .+|+.||||++.......                    .......+|+.++..+.|++
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALD--PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             hhcCCccccCcceEEEEEEc--CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            66778999999999997654  379999999865432110                    01123567899999998875


Q ss_pred             --ceeeeeeeecCccccCCceEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEc
Q psy8260         126 --VIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN  202 (427)
Q Consensus       126 --Iv~l~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~  202 (427)
                        +...++.          ...+++|+++ |++|..+...     .....++.+++.++.++|+.||+||||||+||+++
T Consensus        95 i~v~~~~~~----------~~~~lv~e~~~g~~L~~~~~~-----~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~  159 (198)
T cd05144          95 FPVPKPIDW----------NRHAVVMEYIDGVELYRVRVL-----EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVD  159 (198)
T ss_pred             CCCCceeec----------CCceEEEEEeCCcchhhcccc-----ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEc
Confidence              3333321          2347788877 5677654321     34567888999999999999999999999999999


Q ss_pred             CCCCEEEeeCCCCCCCCC
Q psy8260         203 EDCELKILDFGLARPTEN  220 (427)
Q Consensus       203 ~~~~~kl~DFGla~~~~~  220 (427)
                      .++.++|+|||++.....
T Consensus       160 ~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         160 DDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCCcEEEEECCccccCCC
Confidence            999999999999865443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.73  E-value=5.5e-17  Score=148.19  Aligned_cols=135  Identities=26%  Similarity=0.339  Sum_probs=104.6

Q ss_pred             cccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC-H-----HHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          70 PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS-A-----VHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~-~-----~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      +.||+|++|.||.+..   .|..|+||+....... .     ....++.+|+.++..+.|+||.....++...      .
T Consensus         2 ~~l~~G~~~~vy~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~------~   72 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF---LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP------E   72 (211)
T ss_pred             cccccCceEEEEEEee---CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC------C
Confidence            4689999999997654   6788999976532211 1     1224567899999999999887665554322      2


Q ss_pred             eEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP  217 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~  217 (427)
                      ..+++|+++ |++|.+++....  . ....++.+++.+|.++|+.|++|||++|+|||++ ++.++|+|||+++.
T Consensus        73 ~~~lv~e~~~G~~L~~~~~~~~--~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         73 NFIIVMEYIEGEPLKDLINSNG--M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CCEEEEEEeCCcCHHHHHHhcc--H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            457788877 778988876432  2 7778899999999999999999999999999999 78999999999864

>KOG0590|consensus

Probab=99.72  E-value=3.6e-19  Score=185.17  Aligned_cols=263  Identities=22%  Similarity=0.293  Sum_probs=186.9

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCC-CCCceeeeeeeecCccccCC
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN-HENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~~~  142 (427)
                      ..+.+.+.+|+|+|+.|........+...+|+|.+...............|..+-..+. |.|++.+++.....      
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~------   93 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSP------   93 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCC------
Confidence            34556677999999999866555566778899988765433444445556887777776 99999999876543      


Q ss_pred             ceEEEEeccC-CCCHHHHH-hhC--CCCHHHHHHHHHHHHHHHHHHH-hcCceeccCCCCCeEEcCCC-CEEEeeCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNIL-RTQ--KLSDDHVQFLVYQILRGLKYIH-SAGIIHRDLKPSNIAVNEDC-ELKILDFGLAR  216 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l-~~~--~l~~~~~~~~~~qi~~aL~yLH-~~~iiHrDLKp~NILl~~~~-~~kl~DFGla~  216 (427)
                      ...++..++. |+++...+ ...  ..+...+..++.|+..|+.|+| ..++.|||+||+|.+++..+ .+|++|||+|.
T Consensus        94 ~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At  173 (601)
T KOG0590|consen   94 RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLAT  173 (601)
T ss_pred             cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhc
Confidence            3456777776 67777666 332  5778889999999999999999 99999999999999999999 99999999986


Q ss_pred             CCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccc-cccccch
Q psy8260         217 PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVA-TRWYRAP  295 (427)
Q Consensus       217 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~g-t~~Y~AP  295 (427)
                      .......                                                       ........+| ++.|+||
T Consensus       174 ~~~~~~g-------------------------------------------------------~~~~~~~~~g~s~~y~a~  198 (601)
T KOG0590|consen  174 AYRNKNG-------------------------------------------------------AERSLKDRCGSSPPYGAP  198 (601)
T ss_pred             cccccCC-------------------------------------------------------cceeeecccCCCCCCCCc
Confidence            4432100                                                       0012223455 7778888


Q ss_pred             HHhhhccCCC-CCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCC
Q psy8260         296 EIMLNWMHYN-QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       296 Evl~~~~~~~-~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~  374 (427)
                      |+..+..+.. ..|+|++|+++..+.++..++.........  +... ...........|...+..+.+++.++|..+|.
T Consensus       199 E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~  275 (601)
T KOG0590|consen  199 EHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR--YSSW-KSNKGRFTQLPWNSISDQAHDLLHKILKENPS  275 (601)
T ss_pred             ccccchhhcCCCcccccccccccccccCCCCcccccccccc--ceee-cccccccccCccccCChhhhhcccccccCCch
Confidence            8776644433 459999999887776666554332222111  1000 00000111234567889999999999999999


Q ss_pred             CCCCHHHHhcCCCCCC
Q psy8260         375 KRITAEQALAHPYLSQ  390 (427)
Q Consensus       375 ~R~ta~e~L~Hp~f~~  390 (427)
                      .|.+.+++-.+||+..
T Consensus       276 ~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  276 NRLSIEELKLDNWLSS  291 (601)
T ss_pred             hccccccccccccccc
Confidence            9999999999999987

>KOG1033|consensus

Probab=99.72  E-value=3.9e-18  Score=167.52  Aligned_cols=215  Identities=29%  Similarity=0.367  Sum_probs=147.2

Q ss_pred             HHHHHHHHHHhcCCCCCceeeeee------eecCccccCCceEEEEeccC-CCCHHHHHhhC----CCCHHHHHHHHHHH
Q psy8260         109 KRTYRELRMLKHMNHENVIGLLDV------FHSNTCLADFKNVYMVTHLM-GADLNNILRTQ----KLSDDHVQFLVYQI  177 (427)
Q Consensus       109 ~~~~~Ei~~l~~l~HpnIv~l~~~------~~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~----~l~~~~~~~~~~qi  177 (427)
                      ...++++-.+....|-|..-+.+.      ....+......++|+.|.+| ..+|.++++..    ..+...+..++.|+
T Consensus       289 ~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~  368 (516)
T KOG1033|consen  289 KYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQI  368 (516)
T ss_pred             hhhhhhhhheeccccCCcccccCCCCchhhhccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhh
Confidence            445567776666666555544441      11112222233578899988 57899998643    35667888999999


Q ss_pred             HHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCc
Q psy8260         178 LRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP  257 (427)
Q Consensus       178 ~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~  257 (427)
                      +.|++|   ++.||||+||.||....+..+||.|||+........+.        +                        
T Consensus       369 ~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~--------~------------------------  413 (516)
T KOG1033|consen  369 APAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETV--------A------------------------  413 (516)
T ss_pred             ccchhh---ccchhhhccccccccccchhhhhhhhhheeecccCCcc--------c------------------------
Confidence            999999   99999999999999998899999999987543221110        0                        


Q ss_pred             ccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCC-CHHHHhhcCcHHHH
Q psy8260         258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTP-PAEFMAKISSDSAR  336 (427)
Q Consensus       258 ~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~-~~~~~~~~~~~~~~  336 (427)
                                          ......+...||.+||+||-|.+..|..++||++||+|+++|... ..++...       
T Consensus       414 --------------------~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~-------  466 (516)
T KOG1033|consen  414 --------------------PAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI-------  466 (516)
T ss_pred             --------------------chhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH-------
Confidence                                001134566899999999999999999999999999999877541 1111110       


Q ss_pred             HHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q psy8260         337 KYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYL  388 (427)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f  388 (427)
                      +...   ......+.+.+..-.|+..+|+.+||...|.+||++.+.--|+|.
T Consensus       467 ~t~~---d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  467 ATLT---DIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             Hhhh---hhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            0000   011111222233345788899999999999999988888888775

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.70  E-value=9.8e-17  Score=145.22  Aligned_cols=131  Identities=27%  Similarity=0.374  Sum_probs=98.0

Q ss_pred             ccCcccccEEEEeEEeCcCCcEEEEEEccCcC-CCH-----HHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCce
Q psy8260          71 TLSKESFDLIFSSALDSVSGVKVAIKKIARPF-QSA-----VHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        71 ~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~-~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      .||+|+||.||.+.   .+|..|++|...... ...     ....++.+|+++++.+.|+++....-++...      ..
T Consensus         1 ~ig~G~~~~vy~~~---~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~------~~   71 (199)
T TIGR03724         1 LIAKGAEAIIYLGD---FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP------DN   71 (199)
T ss_pred             CCCCCceEEEEEee---cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC------CC
Confidence            37999999999876   367889999854321 111     1234567899999999888654333222211      23


Q ss_pred             EEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCC
Q psy8260         145 VYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP  217 (427)
Q Consensus       145 ~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~  217 (427)
                      .+++|+++ |++|.+++.....      .++.|++.+|.+||+.|++|||+||+||+++ ++.++++|||+++.
T Consensus        72 ~~lv~e~~~g~~l~~~~~~~~~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        72 KTIVMEYIEGKPLKDVIEEGND------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CEEEEEEECCccHHHHHhhcHH------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            57788877 7788887654321      6889999999999999999999999999999 88999999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.69  E-value=1.7e-16  Score=164.98  Aligned_cols=135  Identities=25%  Similarity=0.313  Sum_probs=101.0

Q ss_pred             eeccccCcccccEEEEeEEeCcCCcEEEEEEcc-CcCCC-----HHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcccc
Q psy8260          67 DIGPTLSKESFDLIFSSALDSVSGVKVAIKKIA-RPFQS-----AVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        67 ~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~-~~~~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  140 (427)
                      ...+.||+|+||.||++..   .+..+++|+.. +....     ....+++.+|+++++.++|+|++....+....    
T Consensus       336 ~~~~~iG~G~~g~Vy~~~~---~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~----  408 (535)
T PRK09605        336 IPDHLIGKGAEADIKKGEY---LGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP----  408 (535)
T ss_pred             CccceeccCCcEEEEEEee---cCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC----
Confidence            4568899999999998654   23344444322 11111     12234577999999999999998766554322    


Q ss_pred             CCceEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCC
Q psy8260         141 DFKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT  218 (427)
Q Consensus       141 ~~~~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~  218 (427)
                        ...+++||++ |++|.+++.       ....++.|++.+|.|||+.|++||||||+|||+ .++.++|+|||+++..
T Consensus       409 --~~~~lv~E~~~g~~L~~~l~-------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        409 --EEKTIVMEYIGGKDLKDVLE-------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             --CCCEEEEEecCCCcHHHHHH-------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence              2356788877 778988775       356788999999999999999999999999999 5789999999998753

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.69  E-value=1.8e-16  Score=141.98  Aligned_cols=137  Identities=26%  Similarity=0.334  Sum_probs=92.6

Q ss_pred             ccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHH----------------------HHHHHHHHhcCCCCC-
Q psy8260          69 GPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKR----------------------TYRELRMLKHMNHEN-  125 (427)
Q Consensus        69 ~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~----------------------~~~Ei~~l~~l~Hpn-  125 (427)
                      ++.||+|+||.||.+. +. +|+.||||++............                      ...|...+..+.+.. 
T Consensus         2 ~~~lg~G~~g~Vy~a~-~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   79 (187)
T cd05119           2 GGPIGTGKEADVYLAL-DG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV   79 (187)
T ss_pred             CcccccccceeEEEEE-CC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence            5679999999999764 33 7999999987643222111111                      124555555554432 


Q ss_pred             -ceeeeeeeecCccccCCceEEEEeccCCC-CHH-HHHhhCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCCeEE
Q psy8260         126 -VIGLLDVFHSNTCLADFKNVYMVTHLMGA-DLN-NILRTQKLSDDHVQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAV  201 (427)
Q Consensus       126 -Iv~l~~~~~~~~~~~~~~~~~lv~e~~g~-~L~-~~l~~~~l~~~~~~~~~~qi~~aL~yLH~-~~iiHrDLKp~NILl  201 (427)
                       +.+.++.          ...+++++++++ .+. ..+...... ..+..++.|++.++.++|+ .||+||||||+||++
T Consensus        80 ~~~~~~~~----------~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili  148 (187)
T cd05119          80 PVPKPIDL----------NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILV  148 (187)
T ss_pred             CCCceEec----------CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEE
Confidence             3333322          124788888754 221 112111111 6678899999999999999 999999999999999


Q ss_pred             cCCCCEEEeeCCCCCCCC
Q psy8260         202 NEDCELKILDFGLARPTE  219 (427)
Q Consensus       202 ~~~~~~kl~DFGla~~~~  219 (427)
                      + ++.++|+|||.+....
T Consensus       149 ~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         149 D-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             E-CCcEEEEECccccccc
Confidence            9 8999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.68  E-value=6e-16  Score=144.13  Aligned_cols=139  Identities=19%  Similarity=0.303  Sum_probs=100.1

Q ss_pred             cccC-cccccEEEEeEEeCcCCcEEEEEEccCcCC-----------CHHHHHHHHHHHHHHhcCCCCCc--eeeeeeeec
Q psy8260          70 PTLS-KESFDLIFSSALDSVSGVKVAIKKIARPFQ-----------SAVHAKRTYRELRMLKHMNHENV--IGLLDVFHS  135 (427)
Q Consensus        70 ~~lg-~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-----------~~~~~~~~~~Ei~~l~~l~HpnI--v~l~~~~~~  135 (427)
                      ..+| .|+.|+|+....   .+..+|||...+...           ......++.+|++++..++|++|  +..+++...
T Consensus        37 ~~lg~~~g~gtv~~v~~---~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT---PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             ceeecCCCCccEEEEEe---CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            4565 677777775433   377899997753211           11233457789999999998875  666665432


Q ss_pred             CccccCCceEEEEeccC-C-CCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCC
Q psy8260         136 NTCLADFKNVYMVTHLM-G-ADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG  213 (427)
Q Consensus       136 ~~~~~~~~~~~lv~e~~-g-~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFG  213 (427)
                      ....  ....+++++++ | .+|.+++....+++..    +.|++.+|.+||++||+||||||+|||++.++.++|+|||
T Consensus       114 ~~~~--~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg  187 (239)
T PRK01723        114 RHGL--FYRADILIERIEGARDLVALLQEAPLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFD  187 (239)
T ss_pred             ecCc--ceeeeEEEEecCCCCCHHHHHhcCCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECC
Confidence            2111  11234777766 4 5898888776666653    5689999999999999999999999999988899999999


Q ss_pred             CCCC
Q psy8260         214 LARP  217 (427)
Q Consensus       214 la~~  217 (427)
                      .++.
T Consensus       188 ~~~~  191 (239)
T PRK01723        188 RGEL  191 (239)
T ss_pred             Cccc
Confidence            8864

>KOG1166|consensus

Probab=99.62  E-value=2.4e-15  Score=160.25  Aligned_cols=196  Identities=18%  Similarity=0.248  Sum_probs=134.2

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCC---CCCceeeeeeeec
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN---HENVIGLLDVFHS  135 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~---HpnIv~l~~~~~~  135 (427)
                      .++....|.|...+|+|+||.||.++-+.  |+.||+|+=+.+...+.     +-=.+++.+|+   -+-|..+...+..
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~--~~~~alK~e~P~~~WEf-----YI~~q~~~RLk~~~~~~~~~~~~a~~~  765 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSN--GKLVALKVEKPPNPWEF-----YICLQVMERLKPQMLPSIMHISSAHVF  765 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCC--CcEEEEEeecCCCceee-----eehHHHHHhhchhhhcchHHHHHHHcc
Confidence            35666789999999999999999877654  99999997655433221     11112233333   0122222222111


Q ss_pred             CccccCCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcC-------CCC
Q psy8260         136 NTCLADFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE-------DCE  206 (427)
Q Consensus       136 ~~~~~~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~-------~~~  206 (427)
                      .      ..-+++++|. -|+|.+++.. +.+++..+..+..|++.-++.||..+|||+||||+|+||..       .-.
T Consensus       766 ~------~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~  839 (974)
T KOG1166|consen  766 Q------NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKG  839 (974)
T ss_pred             C------CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccc
Confidence            1      2235666666 5888888864 46899999999999999999999999999999999999842       346


Q ss_pred             EEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccc
Q psy8260         207 LKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGY  286 (427)
Q Consensus       207 ~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~  286 (427)
                      ++|+|||.+-.+.--..   |                                                     ....+.
T Consensus       840 l~lIDfG~siDm~lfp~---~-----------------------------------------------------~~F~~~  863 (974)
T KOG1166|consen  840 LYLIDFGRSIDMKLFPD---G-----------------------------------------------------TKFKAV  863 (974)
T ss_pred             eEEEecccceeeeEcCC---C-----------------------------------------------------cEEeee
Confidence            89999997743210000   0                                                     023344


Q ss_pred             cccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCC
Q psy8260         287 VATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPP  323 (427)
Q Consensus       287 ~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~  323 (427)
                      ++|-.+--+|+..+.++....|.+-++.+++.|.++.
T Consensus       864 ~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  864 WHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             eccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence            5566666778888888888999999998888776554

>KOG0195|consensus

Probab=99.57  E-value=8.7e-15  Score=132.67  Aligned_cols=246  Identities=17%  Similarity=0.224  Sum_probs=160.8

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      ..+.-+..++.-.|.+..-|..+++.+.   |..+++|++..........+.+..|.-.|+-+.||||+.+++.....  
T Consensus       185 ~gid~~~lnl~tkl~e~hsgelwrgrwq---gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp--  259 (448)
T KOG0195|consen  185 TGIDVSSLNLITKLAESHSGELWRGRWQ---GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP--  259 (448)
T ss_pred             cCcchhhhhhhhhhccCCCccccccccc---CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC--
Confidence            3344444455556666666888877663   44566777654433444445677788889999999999999876443  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHHhcC-ce-eccCCCCCeEEcCCCCEEEeeC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRTQK---LSDDHVQFLVYQILRGLKYIHSAG-II-HRDLKPSNIAVNEDCELKILDF  212 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~~~---l~~~~~~~~~~qi~~aL~yLH~~~-ii-HrDLKp~NILl~~~~~~kl~DF  212 (427)
                          .++.++..|+ -++|+.++..+.   .+..++.+++.++++|+.|||+.. +| ---|....++||++...+|+- 
T Consensus       260 ----pnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarism-  334 (448)
T KOG0195|consen  260 ----PNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISM-  334 (448)
T ss_pred             ----CCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheec-
Confidence                4556666665 689999997653   677889999999999999999874 33 335788889999887766541 


Q ss_pred             CCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccc
Q psy8260         213 GLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWY  292 (427)
Q Consensus       213 Gla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y  292 (427)
                      +-+++.. ...                                                             |+.-.|.|
T Consensus       335 ad~kfsf-qe~-------------------------------------------------------------gr~y~paw  352 (448)
T KOG0195|consen  335 ADTKFSF-QEV-------------------------------------------------------------GRAYSPAW  352 (448)
T ss_pred             ccceeee-ecc-------------------------------------------------------------ccccCccc
Confidence            1011100 011                                                             22233444


Q ss_pred             cchHHhhhccCC---CCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhc
Q psy8260         293 RAPEIMLNWMHY---NQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLML  369 (427)
Q Consensus       293 ~APEvl~~~~~~---~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL  369 (427)
                      |+||.+...+-.   ..+|+||+++++.+|.+...||.+-..-+...+..-.  .+    -..+.+++++..-.|++-|+
T Consensus       353 mspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkiale--gl----rv~ippgis~hm~klm~icm  426 (448)
T KOG0195|consen  353 MSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALE--GL----RVHIPPGISRHMNKLMNICM  426 (448)
T ss_pred             CCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhc--cc----cccCCCCccHHHHHHHHHHh
Confidence            444444433222   2469999999999999888777543222332222110  00    11345678999999999999


Q ss_pred             CCCCCCCCCHHHH
Q psy8260         370 ELDSEKRITAEQA  382 (427)
Q Consensus       370 ~~dP~~R~ta~e~  382 (427)
                      .-||.|||..+++
T Consensus       427 nedpgkrpkfdmi  439 (448)
T KOG0195|consen  427 NEDPGKRPKFDMI  439 (448)
T ss_pred             cCCCCcCCCccee
Confidence            9999999987664

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.54  E-value=6.7e-14  Score=119.61  Aligned_cols=130  Identities=20%  Similarity=0.234  Sum_probs=100.4

Q ss_pred             ccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCC--CCceeeeeeeecCccccCCceEE
Q psy8260          69 GPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNH--ENVIGLLDVFHSNTCLADFKNVY  146 (427)
Q Consensus        69 ~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~H--pnIv~l~~~~~~~~~~~~~~~~~  146 (427)
                      .+.+|.|.++.||....+   +..++||.......    ...+.+|+.+++.++|  .++.+++.++...      ...+
T Consensus         3 ~~~i~~g~~~~v~~~~~~---~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~------~~~~   69 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTK---DEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESD------GWSY   69 (155)
T ss_pred             ceecccccccceEEEEec---CCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC------CccE
Confidence            467899999999976543   36899998865432    3456789999999976  4888888776432      3467


Q ss_pred             EEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhc---CceeccCCCCCeEEcCCCCEEEeeCCCCCC
Q psy8260         147 MVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARP  217 (427)
Q Consensus       147 lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~---~iiHrDLKp~NILl~~~~~~kl~DFGla~~  217 (427)
                      ++++++ |..+..+      +......++.+++.+|.++|..   +++|+|+||+||+++..+.++++|||.++.
T Consensus        70 ~v~e~~~g~~~~~~------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          70 LLMEWIEGETLDEV------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             EEEEecCCeecccC------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            788777 4444432      4556677889999999999985   799999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601|consensus

Probab=99.53  E-value=1.2e-14  Score=145.64  Aligned_cols=264  Identities=23%  Similarity=0.234  Sum_probs=180.8

Q ss_pred             ccCcceeeccccCc--ccccEEEEeEE-eCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecC
Q psy8260          61 ICRGVIDIGPTLSK--ESFDLIFSSAL-DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSN  136 (427)
Q Consensus        61 ~~~~~~~~~~~lg~--g~fg~v~~~~~-~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~  136 (427)
                      .....+.+...+|.  |++|.+|.+.. ...++..+|+|+-+...........-.+|+...+.+ .|+|.++.+..+.+.
T Consensus       111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~  190 (524)
T KOG0601|consen  111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS  190 (524)
T ss_pred             hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC
Confidence            33455667788999  99999996543 367889999998665555555555567888877777 599999977666543


Q ss_pred             ccccCCceEEEEeccCCCCHHHHHhh--CCCCHHHHHHHHHHHHH----HHHHHHhcCceeccCCCCCeEEcCC-CCEEE
Q psy8260         137 TCLADFKNVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILR----GLKYIHSAGIIHRDLKPSNIAVNED-CELKI  209 (427)
Q Consensus       137 ~~~~~~~~~~lv~e~~g~~L~~~l~~--~~l~~~~~~~~~~qi~~----aL~yLH~~~iiHrDLKp~NILl~~~-~~~kl  209 (427)
                            ...|+.+|+++.+|..+...  .-+++..+...+.+...    ||.++|+.+++|-|+||.||++..+ ..+++
T Consensus       191 ------~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~  264 (524)
T KOG0601|consen  191 ------GILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKL  264 (524)
T ss_pred             ------CcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeec
Confidence                  56799999999999887754  23788888888888888    9999999999999999999999988 89999


Q ss_pred             eeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccc
Q psy8260         210 LDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT  289 (427)
Q Consensus       210 ~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt  289 (427)
                      .|||+...+....-..+                                                    . .....-.|.
T Consensus       265 ~df~~v~~i~~~~~~~~----------------------------------------------------~-~~~~r~~~~  291 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSV----------------------------------------------------F-KVSKRPEGD  291 (524)
T ss_pred             CCcceeEEccCCccccc----------------------------------------------------e-eeeecCCCC
Confidence            99998765443210000                                                    0 000111345


Q ss_pred             ccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhc
Q psy8260         290 RWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLML  369 (427)
Q Consensus       290 ~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL  369 (427)
                      .-|++||++.+. +....|+.++|.++-.-+.............    |. .+...  ..-.++..+.+......+.+|+
T Consensus       292 ~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~----W~-~~r~~--~ip~e~~~~~s~~l~~~~~~~~  363 (524)
T KOG0601|consen  292 CIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSS----WS-QLRQG--YIPLEFCEGGSSSLRSVTSQML  363 (524)
T ss_pred             ceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCC----cc-ccccc--cCchhhhcCcchhhhhHHHHhc
Confidence            567777777653 4445688999877644333322111110000    00 00000  0111233445555666999999


Q ss_pred             CCCCCCCCCHHHHhcCCCCCCC
Q psy8260         370 ELDSEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       370 ~~dP~~R~ta~e~L~Hp~f~~~  391 (427)
                      +.||..|++++.+++|+++...
T Consensus       364 d~~~~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  364 DEDPRLRLTAQILTALNVIHSK  385 (524)
T ss_pred             CcchhhhhHHHHHhccccccch
Confidence            9999999999999999999743

>KOG1023|consensus

Probab=99.45  E-value=4.1e-13  Score=134.42  Aligned_cols=207  Identities=21%  Similarity=0.241  Sum_probs=134.4

Q ss_pred             HhcCCCCCceeeeeeeecCccccCCceEEEEeccC-CCCHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhcCc-eecc
Q psy8260         118 LKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGI-IHRD  193 (427)
Q Consensus       118 l~~l~HpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~--~l~~~~~~~~~~qi~~aL~yLH~~~i-iHrD  193 (427)
                      |+.+.|.|+.++++.....      ..++++-++| .|+|.+.+...  .++..-...++++|+.||.|+|+..| .|+-
T Consensus         1 l~~l~h~n~~~f~g~~~~~------~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~   74 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDG------PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGA   74 (484)
T ss_pred             CcccchhhhhhheeeEecC------CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeee
Confidence            4678999999999986543      4567777777 68999998764  45555566788999999999998876 9999


Q ss_pred             CCCCCeEEcCCCCEEEeeCCCCCCCCC-----CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchh
Q psy8260         194 LKPSNIAVNEDCELKILDFGLARPTEN-----EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCEL  268 (427)
Q Consensus       194 LKp~NILl~~~~~~kl~DFGla~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  268 (427)
                      |+..|+++|....+||+|||+......     ......-..-|.|||++.+.......                      
T Consensus        75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~----------------------  132 (484)
T KOG1023|consen   75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLE----------------------  132 (484)
T ss_pred             eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhccccccccc----------------------
Confidence            999999999999999999999765432     01111122235556655431100000                      


Q ss_pred             hhhccCCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHH---HHHHHhcCCCC
Q psy8260         269 KILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDS---ARKYINSLPLL  345 (427)
Q Consensus       269 ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~---~~~~~~~~~~~  345 (427)
                                                      .......|++|+|+|++++.+...+|........   .-..+......
T Consensus       133 --------------------------------~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~  180 (484)
T KOG1023|consen  133 --------------------------------SALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSN  180 (484)
T ss_pred             --------------------------------ccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCC
Confidence                                            0022346999999999888666555543222211   11112220110


Q ss_pred             CcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy8260         346 TKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALA  384 (427)
Q Consensus       346 ~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~  384 (427)
                      ...+.-.......++...++.+|-.-+|..||+++++-.
T Consensus       181 ~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  181 PFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             CcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            011100111134557899999999999999999999753

>KOG0606|consensus

Probab=99.38  E-value=2e-13  Score=143.68  Aligned_cols=286  Identities=20%  Similarity=0.185  Sum_probs=180.3

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC-HHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS-AVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      ..+.+.+-+..+.|+.++- +....+|-..++|.......- ....+...++-.++-...||-++....-|      ...
T Consensus       804 d~~~i~~p~qS~sp~ss~p-~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~------~~r  876 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFP-ASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF------PCR  876 (1205)
T ss_pred             ccceecccccCCCCccccc-CCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC------CCC
Confidence            3456666888999988884 334445545555543321110 00111122222232233445555443221      123


Q ss_pred             ceEEEEeccC-CCCHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILRTQ-KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~~~-~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      ...++++++. +++|...++.. ..+.+-++.+...+..+++|||+..++|||+||.|+|+..++..++.|||+.....-
T Consensus       877 sP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~  956 (1205)
T KOG0606|consen  877 SPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL  956 (1205)
T ss_pred             CCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccc
Confidence            5678888887 67888888764 477777888888999999999999999999999999999999999999995543211


Q ss_pred             --Ccccc-----cccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccccc
Q psy8260         221 --EMTGY-----VATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR  293 (427)
Q Consensus       221 --~~~~~-----~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~  293 (427)
                        ..+..     .|+..-.++-.                                ...++...  ....-....||+.|.
T Consensus       957 ~~p~~~~sg~~~~~~~~~~~~~~--------------------------------~~~~l~~~--~~~~~~~~~~t~~~l 1002 (1205)
T KOG0606|consen  957 IPPTTDLSGPSSSGTPRRLSRSE--------------------------------RRPQLSAD--EARRKHAVVGTPDYL 1002 (1205)
T ss_pred             ccCcCCcccccccCccccccccc--------------------------------cccccccc--hhhccccccCCCccc
Confidence              11111     11111110000                                00000000  000123457899999


Q ss_pred             chHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCC
Q psy8260         294 APEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDS  373 (427)
Q Consensus       294 APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP  373 (427)
                      |||.+.+...+...|+|+.|.++....++..+|.+...+...+...+..     ..|.......++++++++.++|..+|
T Consensus      1003 aPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~-----~~~p~g~~~~s~~aq~~~~~ll~~~~ 1077 (1205)
T KOG0606|consen 1003 APEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRD-----IPWPEGPEEGSYEAQDLINRLLTEEP 1077 (1205)
T ss_pred             CCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCC-----CCCCCCccccChhhhhhhhhhhccCc
Confidence            9999999999999999999999877766666665443333333222221     22333334568999999999999999


Q ss_pred             CCCCCHH---HHhcCCCCCCCCCCC
Q psy8260         374 EKRITAE---QALAHPYLSQYSDPN  395 (427)
Q Consensus       374 ~~R~ta~---e~L~Hp~f~~~~~~~  395 (427)
                      .+|.++.   +.-.||||+......
T Consensus      1078 ~qr~~a~~~~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1078 TQRLGAKGAAEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred             hhccCcccccccccCCccCCCCccc
Confidence            9999988   899999999765543

>KOG0660|consensus

Probab=99.36  E-value=6.8e-13  Score=125.10  Aligned_cols=120  Identities=35%  Similarity=0.508  Sum_probs=86.9

Q ss_pred             eeeccCCcccccccccchhhhhccCCCCCC-----ccccccccccccccchHHhhhcc-CCCCCCHHHHHHHHHHhCCCC
Q psy8260         250 FYFQDLKPSNIAVNEDCELKILDFGLARPT-----ENEMTGYVATRWYRAPEIMLNWM-HYNQTDIHQLNLIMEMLGTPP  323 (427)
Q Consensus       250 ~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~-----~~~~~~~~gt~~Y~APEvl~~~~-~~~~~d~~slg~i~~~lg~~~  323 (427)
                      -.++|++++|..+.++|.+||+|||+|+..     ...+++.+.|.||+|||++.... |....|+||.|||+.+|.++.
T Consensus       146 ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gk  225 (359)
T KOG0660|consen  146 VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGK  225 (359)
T ss_pred             ccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCC
Confidence            467899999999999999999999999977     45678999999999999987665 445569999999998886666


Q ss_pred             HHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         324 AEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                      ..|.....-+.........+......+..   -.|+.|+..|+++=+..
T Consensus       226 plFpG~d~v~Ql~lI~~~lGtP~~e~l~~---i~s~~ar~yi~slp~~p  271 (359)
T KOG0660|consen  226 PLFPGKDYVHQLQLILELLGTPSEEDLQK---IRSEKARPYIKSLPQIP  271 (359)
T ss_pred             CCCCCCchHHHHHHHHHhcCCCCHHHHHH---hccHHHHHHHHhCCCCC
Confidence            65654433233333333344333322222   24677888888876553

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.36  E-value=4.3e-12  Score=128.33  Aligned_cols=141  Identities=22%  Similarity=0.328  Sum_probs=92.7

Q ss_pred             cccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHH--------------------------------H------HHH
Q psy8260          70 PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVH--------------------------------A------KRT  111 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~--------------------------------~------~~~  111 (427)
                      +.+|.|++|.||++.+  .+|+.||||+..........                                .      -.+
T Consensus       123 ~plasaSigQVh~A~l--~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       123 KPLAAASIAQVHRARL--VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             cceeeeehhheEEEEe--cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            5799999999998765  47999999987543110000                                0      012


Q ss_pred             HHHHHHHhcC----CCCCceeeeeeeecCccccCCceEEEEeccC-CCCHHHHHhhC--CCCHHHHHHHHHHHHH-HHHH
Q psy8260         112 YRELRMLKHM----NHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQ--KLSDDHVQFLVYQILR-GLKY  183 (427)
Q Consensus       112 ~~Ei~~l~~l----~HpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~--~l~~~~~~~~~~qi~~-aL~y  183 (427)
                      .+|++.+.++    +|.+-+..-.++.. .|    ..-+++||++ |.+|.++....  ..+   ...++.+++. .+..
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~-~~----~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~q  272 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWD-RT----SERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQ  272 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehh-hc----CCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHH
Confidence            3455544444    34344444444422 11    2347888888 66777665422  222   2345555555 4678


Q ss_pred             HHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         184 IHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       184 LH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      +|..|++|+|+||.||+++.++.++++|||++.....
T Consensus       273 l~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       273 VLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            8999999999999999999999999999999876543

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.26  E-value=5.1e-11  Score=106.71  Aligned_cols=139  Identities=19%  Similarity=0.254  Sum_probs=95.3

Q ss_pred             cccCcccccEEEEeEEeCc-----CCcEEEEEEccCcC----------------------CCHHHH--HHHHHHHHHHhc
Q psy8260          70 PTLSKESFDLIFSSALDSV-----SGVKVAIKKIARPF----------------------QSAVHA--KRTYRELRMLKH  120 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~-----~g~~vAvK~i~~~~----------------------~~~~~~--~~~~~Ei~~l~~  120 (427)
                      ..+|.|.=+.||.+.-...     .+..+|||+.....                      .+....  .-..+|.+.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            4577777788887653221     35789999754210                      011111  113489999998


Q ss_pred             CCC--CCceeeeeeeecCccccCCceEEEEeccCCCC-H-HHHHhhCCCCHHHHHHHHHHHHHHHHHH-HhcCceeccCC
Q psy8260         121 MNH--ENVIGLLDVFHSNTCLADFKNVYMVTHLMGAD-L-NNILRTQKLSDDHVQFLVYQILRGLKYI-HSAGIIHRDLK  195 (427)
Q Consensus       121 l~H--pnIv~l~~~~~~~~~~~~~~~~~lv~e~~g~~-L-~~~l~~~~l~~~~~~~~~~qi~~aL~yL-H~~~iiHrDLK  195 (427)
                      +..  -++.+.+++.          .-+++||+.+++ + ...++...+++.....+..|++.+|..| |+.||||+||+
T Consensus        83 l~~~Gv~vP~pi~~~----------~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs  152 (197)
T cd05146          83 MQKAGIPCPEVVVLK----------KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLS  152 (197)
T ss_pred             HHHcCCCCCeEEEec----------CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            853  4566666541          237889988653 2 2234444566667778889999999999 89999999999


Q ss_pred             CCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         196 PSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       196 p~NILl~~~~~~kl~DFGla~~~~  219 (427)
                      +.|||++ ++.+.|+|||.+....
T Consensus       153 ~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         153 EYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             HHHEEEE-CCcEEEEECCCceeCC
Confidence            9999997 4689999999886543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.26  E-value=5.9e-12  Score=129.08  Aligned_cols=142  Identities=24%  Similarity=0.404  Sum_probs=90.2

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC---------------------------H-----HHHHH--
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS---------------------------A-----VHAKR--  110 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~---------------------------~-----~~~~~--  110 (427)
                      .|+. ..+|.|++|.|+.+.+ ..+|+.||||++.+....                           .     ...+.  
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l-~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARL-KDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEE-CCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            3555 6899999999997654 446999999998643100                           0     00111  


Q ss_pred             ----HHHHHHHHhcC----CCCCceeeeeeeecCccccCCceEEEEeccC-CCCHHHH--HhhCC-----CCHHHHHHHH
Q psy8260         111 ----TYRELRMLKHM----NHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNI--LRTQK-----LSDDHVQFLV  174 (427)
Q Consensus       111 ----~~~Ei~~l~~l----~HpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~--l~~~~-----l~~~~~~~~~  174 (427)
                          +.+|+..+.++    .+.+.+.+-.+|.. .|    ..-+++||++ |+.+.++  +...+     +.+..+..++
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d-~s----t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~  273 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWD-YC----SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFF  273 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecc-cC----CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHH
Confidence                22344333333    24444444444432 12    2357888888 6677664  33333     4444455555


Q ss_pred             HHHHHHHHHHHhcCceeccCCCCCeEEcCCC----CEEEeeCCCCCCCCC
Q psy8260         175 YQILRGLKYIHSAGIIHRDLKPSNIAVNEDC----ELKILDFGLARPTEN  220 (427)
Q Consensus       175 ~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~----~~kl~DFGla~~~~~  220 (427)
                      .|++       ..|++|+|+||.||+++.++    .++++|||++.....
T Consensus       274 ~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        274 TQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            6654       58999999999999999887    999999999876543

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.24  E-value=3.1e-11  Score=106.02  Aligned_cols=126  Identities=18%  Similarity=0.164  Sum_probs=86.5

Q ss_pred             cccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCce-eeeeeeecCccccCCceEEEE
Q psy8260          70 PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVI-GLLDVFHSNTCLADFKNVYMV  148 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv-~l~~~~~~~~~~~~~~~~~lv  148 (427)
                      +.++.|.++.||....   .|..|++|.......   ......+|+.+++.+.+.+++ +++.+...        ..+++
T Consensus         4 ~~l~~G~~~~vy~~~~---~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~--------~~~lv   69 (170)
T cd05151           4 SPLKGGMTNKNYRVEV---ANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDPE--------TGVLI   69 (170)
T ss_pred             eecCCcccCceEEEEE---CCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeCC--------CCeEE
Confidence            3567888899996543   377899998654321   112346788888888665544 44443211        13577


Q ss_pred             eccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCc-----eeccCCCCCeEEcCCCCEEEeeCCCCCC
Q psy8260         149 THLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGI-----IHRDLKPSNIAVNEDCELKILDFGLARP  217 (427)
Q Consensus       149 ~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~i-----iHrDLKp~NILl~~~~~~kl~DFGla~~  217 (427)
                      |+++ |..+...       .......+.+++.+|..||+.++     +|+|++|.||+++ ++.++++|||.+..
T Consensus        70 ~e~i~G~~l~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          70 TEFIEGSELLTE-------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             EEecCCCccccc-------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            7777 4454432       11123456799999999999885     9999999999999 67899999998763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601|consensus

Probab=99.14  E-value=2.9e-11  Score=121.47  Aligned_cols=149  Identities=22%  Similarity=0.258  Sum_probs=114.3

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCccccC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~~  141 (427)
                      .++|.....||.+.|+.|+....+..++..+|+|.+.+..........-+.|+.+...+ .|.+++.++..|...     
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~-----  338 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL-----  338 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc-----
Confidence            46678888999999999997776667889999998876544444444445677766665 588888877655432     


Q ss_pred             CceEEEEeccC-CCCHHHH-HhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCC-CCEEEeeCCCCCC
Q psy8260         142 FKNVYMVTHLM-GADLNNI-LRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARP  217 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~-l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~-~~~kl~DFGla~~  217 (427)
                       +..|+-.|++ ++++..- .-...+.+...+....|++.|+.++|++.++|+|+||+||++..+ +..++.|||....
T Consensus       339 -r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  339 -RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             -ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccc
Confidence             4567888888 5544322 223568888899999999999999999999999999999999876 7889999997753

>KOG0593|consensus

Probab=99.11  E-value=2.3e-11  Score=112.29  Aligned_cols=78  Identities=35%  Similarity=0.561  Sum_probs=67.5

Q ss_pred             cceeeccCCcccccccccchhhhhccCCCCCC---ccccccccccccccchHHhhh-ccCCCCCCHHHHHHHHHHhCCCC
Q psy8260         248 VPFYFQDLKPSNIAVNEDCELKILDFGLARPT---ENEMTGYVATRWYRAPEIMLN-WMHYNQTDIHQLNLIMEMLGTPP  323 (427)
Q Consensus       248 ~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~---~~~~~~~~gt~~Y~APEvl~~-~~~~~~~d~~slg~i~~~lg~~~  323 (427)
                      ..+.++|+++.|+++...+.+|++|||+|+..   ....+..++|.||+|||.+.+ ..|+..+|+|++||++.+|.++.
T Consensus       120 ~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~  199 (396)
T KOG0593|consen  120 NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGE  199 (396)
T ss_pred             cCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCC
Confidence            35889999999999999999999999999854   346778999999999999988 56777889999999998887665


Q ss_pred             HH
Q psy8260         324 AE  325 (427)
Q Consensus       324 ~~  325 (427)
                      +-
T Consensus       200 pL  201 (396)
T KOG0593|consen  200 PL  201 (396)
T ss_pred             cC
Confidence            43

>KOG0661|consensus

Probab=99.03  E-value=1.7e-10  Score=112.46  Aligned_cols=95  Identities=37%  Similarity=0.543  Sum_probs=70.9

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCCcc--ccccccccccccchHHhhhcc-CCCCCCHHHHHHHHHHhCCCCHH
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPTEN--EMTGYVATRWYRAPEIMLNWM-HYNQTDIHQLNLIMEMLGTPPAE  325 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~--~~~~~~gt~~Y~APEvl~~~~-~~~~~d~~slg~i~~~lg~~~~~  325 (427)
                      .|+++|+++.|+++.....+||+|||+|+....  .++..+.|.||+||||++... |..+.|+|++|||++++-+..+-
T Consensus       130 GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPL  209 (538)
T KOG0661|consen  130 GFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPL  209 (538)
T ss_pred             CcccccCChhheEecccceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhccc
Confidence            588999999999999888999999999997543  567899999999999987655 44567999999999887544433


Q ss_pred             HHhhcCcHHHHHHHhcCC
Q psy8260         326 FMAKISSDSARKYINSLP  343 (427)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~  343 (427)
                      |.....-+...+....+.
T Consensus       210 FPG~sE~Dqi~KIc~VLG  227 (538)
T KOG0661|consen  210 FPGASEIDQIYKICEVLG  227 (538)
T ss_pred             CCCCcHHHHHHHHHHHhC
Confidence            433322233444444333

>KOG0659|consensus

Probab=99.02  E-value=1.5e-10  Score=105.14  Aligned_cols=70  Identities=40%  Similarity=0.592  Sum_probs=57.9

Q ss_pred             eeccCCcccccccccchhhhhccCCCCCC---ccccccccccccccchHHhhhc-cCCCCCCHHHHHHHHHHhC
Q psy8260         251 YFQDLKPSNIAVNEDCELKILDFGLARPT---ENEMTGYVATRWYRAPEIMLNW-MHYNQTDIHQLNLIMEMLG  320 (427)
Q Consensus       251 ~~~d~~~~~~~~~~~~~~ki~d~g~~~~~---~~~~~~~~gt~~Y~APEvl~~~-~~~~~~d~~slg~i~~~lg  320 (427)
                      -++|+++.|.++..++.+|++|||+++..   .......+.|.||+|||.+.+. .|..++|+||.|||+.+|.
T Consensus       123 lHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELl  196 (318)
T KOG0659|consen  123 LHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELL  196 (318)
T ss_pred             hcccCCccceEEcCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHH
Confidence            45699999999999999999999999853   3334445789999999998765 4667889999999997663

>KOG0667|consensus

Probab=99.02  E-value=1e-10  Score=118.20  Aligned_cols=80  Identities=30%  Similarity=0.493  Sum_probs=69.9

Q ss_pred             CcceeeccCCcccccccc--cchhhhhccCCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCH
Q psy8260         247 GVPFYFQDLKPSNIAVNE--DCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPA  324 (427)
Q Consensus       247 ~~~~~~~d~~~~~~~~~~--~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~  324 (427)
                      ....+++|+++.|+++..  .+.+|++|||.++.........+.+..|+|||||++.+|..+.||||||||+.+|-++-+
T Consensus       307 ~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~P  386 (586)
T KOG0667|consen  307 ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEP  386 (586)
T ss_pred             hCCeeeccCChhheeeccCCcCceeEEecccccccCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCcc
Confidence            345789999999999765  567899999999988777779999999999999999999999999999999998866644


Q ss_pred             HH
Q psy8260         325 EF  326 (427)
Q Consensus       325 ~~  326 (427)
                      -|
T Consensus       387 Lf  388 (586)
T KOG0667|consen  387 LF  388 (586)
T ss_pred             cc
Confidence            34

>KOG0594|consensus

Probab=99.00  E-value=1.8e-10  Score=108.93  Aligned_cols=93  Identities=33%  Similarity=0.450  Sum_probs=71.3

Q ss_pred             eeeccCCcccccccccchhhhhccCCCCCC---ccccccccccccccchHHhhhc-cCCCCCCHHHHHHHHHHhCCCCHH
Q psy8260         250 FYFQDLKPSNIAVNEDCELKILDFGLARPT---ENEMTGYVATRWYRAPEIMLNW-MHYNQTDIHQLNLIMEMLGTPPAE  325 (427)
Q Consensus       250 ~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~---~~~~~~~~gt~~Y~APEvl~~~-~~~~~~d~~slg~i~~~lg~~~~~  325 (427)
                      ..++|+++-|++++..+.+|++|||+++..   ....+..++|.||+|||++.+. .|....|+||+|||+.+|-+...-
T Consensus       141 IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~L  220 (323)
T KOG0594|consen  141 ILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPL  220 (323)
T ss_pred             eecccCCcceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCC
Confidence            467899999999999999999999999853   2346678999999999999887 566678999999999888666555


Q ss_pred             HHhhcCcHHHHHHHhcC
Q psy8260         326 FMAKISSDSARKYINSL  342 (427)
Q Consensus       326 ~~~~~~~~~~~~~~~~~  342 (427)
                      |......+......+..
T Consensus       221 FpG~se~~ql~~If~~l  237 (323)
T KOG0594|consen  221 FPGDSEIDQLFRIFRLL  237 (323)
T ss_pred             CCCCcHHHHHHHHHHHc
Confidence            54433333333444333

>KOG0663|consensus

Probab=99.00  E-value=1.8e-10  Score=107.71  Aligned_cols=74  Identities=38%  Similarity=0.522  Sum_probs=62.7

Q ss_pred             eeeccCCcccccccccchhhhhccCCCCCCccc---cccccccccccchHHhhhcc-CCCCCCHHHHHHHHHHhCCCC
Q psy8260         250 FYFQDLKPSNIAVNEDCELKILDFGLARPTENE---MTGYVATRWYRAPEIMLNWM-HYNQTDIHQLNLIMEMLGTPP  323 (427)
Q Consensus       250 ~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~---~~~~~gt~~Y~APEvl~~~~-~~~~~d~~slg~i~~~lg~~~  323 (427)
                      +.++|++++|.++...|.+||+|||+|+.....   ++..+.|.||+|||.+++.. |....|+||+|||+.+|....
T Consensus       198 ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~k  275 (419)
T KOG0663|consen  198 ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQK  275 (419)
T ss_pred             eEecccchhheeeccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcC
Confidence            567899999999999999999999999975444   67788999999999998765 556679999999997764443

>KOG1266|consensus

Probab=98.98  E-value=6e-10  Score=104.17  Aligned_cols=93  Identities=25%  Similarity=0.368  Sum_probs=73.1

Q ss_pred             HHhcCCCCCceeeeeeeecCccccCCceEEEEeccC-CCCHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhc--C
Q psy8260         117 MLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRT-----QKLSDDHVQFLVYQILRGLKYIHSA--G  188 (427)
Q Consensus       117 ~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~yLH~~--~  188 (427)
                      -|-++.|-|||+++.++.+.. .++...+.+..+|+ .+.+.++|++     ..+.....++|+.||+.||.|||+.  -
T Consensus       120 nllqlvHsnlvkfH~yw~d~K-~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKK-YEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccc-cccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence            345668999999999886543 23344455555555 7899988864     3478888899999999999999987  4


Q ss_pred             ceeccCCCCCeEEcCCCCEEEe
Q psy8260         189 IIHRDLKPSNIAVNEDCELKIL  210 (427)
Q Consensus       189 iiHrDLKp~NILl~~~~~~kl~  210 (427)
                      |+|..+...-|++..+|-+|+.
T Consensus       199 iihgnlTc~tifiq~ngLIkig  220 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIG  220 (458)
T ss_pred             cccCCcchhheeecCCceEEec
Confidence            9999999999999999888864

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.94  E-value=1.6e-08  Score=88.22  Aligned_cols=129  Identities=26%  Similarity=0.392  Sum_probs=85.4

Q ss_pred             cCcccccEEEEeEEeCcCCcEEEEEE-ccCcCCCH-----HHHHHHHHHHHHHhcCCC--CCceeeeeeeecCccccCCc
Q psy8260          72 LSKESFDLIFSSALDSVSGVKVAIKK-IARPFQSA-----VHAKRTYRELRMLKHMNH--ENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        72 lg~g~fg~v~~~~~~~~~g~~vAvK~-i~~~~~~~-----~~~~~~~~Ei~~l~~l~H--pnIv~l~~~~~~~~~~~~~~  143 (427)
                      +.+|+=..++..-+   -|..+.+|. +.+....+     ....+..+|++++.++.-  -|+..++++..        .
T Consensus         4 i~~GAEa~i~~~~~---~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~--------~   72 (204)
T COG3642           4 IKQGAEAIIYLTDF---LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDP--------D   72 (204)
T ss_pred             hhCCcceeEEeeec---cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcC--------C
Confidence            45566566664322   244566663 33332222     123557789999988754  34555565532        3


Q ss_pred             eEEEEeccCCC-CHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCC
Q psy8260         144 NVYMVTHLMGA-DLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT  218 (427)
Q Consensus       144 ~~~lv~e~~g~-~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~  218 (427)
                      ...++|++.+| .|.+.+...  .    ..+++.|-.-+.-||..||+|+||.++||++..++ +.++||||+...
T Consensus        73 ~~~I~me~I~G~~lkd~l~~~--~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          73 NGLIVMEYIEGELLKDALEEA--R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             CCEEEEEEeCChhHHHHHHhc--c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            45688888855 566677654  1    34566777777889999999999999999998654 999999998743

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.93  E-value=1.8e-08  Score=95.11  Aligned_cols=127  Identities=16%  Similarity=0.206  Sum_probs=84.2

Q ss_pred             CCcEEEEEEccCcCCCH---------HHHHHHHHHHHHHhcCCCCCc--eeeeeeeecCccccCCceEEEEeccCCC--C
Q psy8260          89 SGVKVAIKKIARPFQSA---------VHAKRTYRELRMLKHMNHENV--IGLLDVFHSNTCLADFKNVYMVTHLMGA--D  155 (427)
Q Consensus        89 ~g~~vAvK~i~~~~~~~---------~~~~~~~~Ei~~l~~l~HpnI--v~l~~~~~~~~~~~~~~~~~lv~e~~g~--~  155 (427)
                      .|+.|.||.........         .-...+.+|.+.+..|..-+|  ...+.+...... ......++++++.++  +
T Consensus        44 ~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~-~~~~~s~LVte~l~~~~s  122 (268)
T PRK15123         44 AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSN-PATRTSFIITEDLAPTIS  122 (268)
T ss_pred             CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCC-CccceeEEEEeeCCCCcc
Confidence            46678888653321100         001135678887777643332  333444322111 111345678887754  6


Q ss_pred             HHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcC-------CCCEEEeeCCCCC
Q psy8260         156 LNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE-------DCELKILDFGLAR  216 (427)
Q Consensus       156 L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~-------~~~~kl~DFGla~  216 (427)
                      |.+++..   ...+......++.+++..+.-||+.||+|+||+++|||++.       +..+.++||+.++
T Consensus       123 L~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        123 LEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             HHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            8888752   34566777889999999999999999999999999999975       4689999999875

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.91  E-value=1e-08  Score=93.88  Aligned_cols=142  Identities=20%  Similarity=0.279  Sum_probs=94.2

Q ss_pred             cccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCC--CCceeeeeeeecCccccCCceEEE
Q psy8260          70 PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNH--ENVIGLLDVFHSNTCLADFKNVYM  147 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~H--pnIv~l~~~~~~~~~~~~~~~~~l  147 (427)
                      ..++.|..+.+|+....  .|..+++|........ .......+|+++++.+.+  .++.+++.+.....   .....++
T Consensus         4 ~~l~~G~~n~~~~v~~~--~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~---~~~~~~~   77 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG--GGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS---VLGTPFY   77 (223)
T ss_pred             eecCCCccceEEEEEec--CCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC---ccCCceE
Confidence            35788999999976542  3688999987543221 123456789999998866  34566666543221   0123467


Q ss_pred             EeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q psy8260         148 VTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHS----------------------------------------  186 (427)
Q Consensus       148 v~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~----------------------------------------  186 (427)
                      +++++ |.++...+....+++.....++.+++.+|..||+                                        
T Consensus        78 v~e~i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (223)
T cd05154          78 VMERVDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM  157 (223)
T ss_pred             EEEEeCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence            78777 4455443321345666666667777777777763                                        


Q ss_pred             ----------------cCceeccCCCCCeEEcC--CCCEEEeeCCCCCC
Q psy8260         187 ----------------AGIIHRDLKPSNIAVNE--DCELKILDFGLARP  217 (427)
Q Consensus       187 ----------------~~iiHrDLKp~NILl~~--~~~~kl~DFGla~~  217 (427)
                                      ..++|+|+.|.||+++.  ++.+.|+||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                            24699999999999998  66789999998763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0600|consensus

Probab=98.90  E-value=6.5e-10  Score=109.14  Aligned_cols=74  Identities=35%  Similarity=0.481  Sum_probs=62.4

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCC----ccccccccccccccchHHhhhcc-CCCCCCHHHHHHHHHHhCCC
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPT----ENEMTGYVATRWYRAPEIMLNWM-HYNQTDIHQLNLIMEMLGTP  322 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~----~~~~~~~~gt~~Y~APEvl~~~~-~~~~~d~~slg~i~~~lg~~  322 (427)
                      ..-++|++++|++++.++.+||+|||+|+..    ...++.++-|.||+|||.|++.. |..++|+||.|||+.+|-.+
T Consensus       238 gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~g  316 (560)
T KOG0600|consen  238 GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLG  316 (560)
T ss_pred             CeeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcC
Confidence            3567899999999999999999999999832    23578899999999999998865 55677999999999777443

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.89  E-value=9.3e-09  Score=91.77  Aligned_cols=99  Identities=29%  Similarity=0.386  Sum_probs=65.8

Q ss_pred             HHHHHHHHHHhcCCCC--CceeeeeeeecCccccCCceEEEEeccCC--CCHHHHHhhCCCCHHHHHHHHHHHHHHHHH-
Q psy8260         109 KRTYRELRMLKHMNHE--NVIGLLDVFHSNTCLADFKNVYMVTHLMG--ADLNNILRTQKLSDDHVQFLVYQILRGLKY-  183 (427)
Q Consensus       109 ~~~~~Ei~~l~~l~Hp--nIv~l~~~~~~~~~~~~~~~~~lv~e~~g--~~L~~~l~~~~l~~~~~~~~~~qi~~aL~y-  183 (427)
                      ....+|.+.|.++..-  ++.+.+++-          .-+++||+.+  |.....+....++......++.+++..+.. 
T Consensus        53 ~~~~~E~~~L~~l~~~Gv~vP~p~~~~----------~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~  122 (188)
T PF01163_consen   53 EWAKKEFRNLKRLYEAGVPVPKPYDYN----------RNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKM  122 (188)
T ss_dssp             HHHHHHHHHHHHCCCTT-SS--EEEEE----------TTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHCCccCCcEEEEe----------CCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHH
Confidence            3456899999999765  566666552          1268888886  533333333333345566777888886665 


Q ss_pred             HHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCC
Q psy8260         184 IHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT  218 (427)
Q Consensus       184 LH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~  218 (427)
                      +|+.||+|+||.+.|||++++ .+.|+|||.+...
T Consensus       123 ~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~  156 (188)
T PF01163_consen  123 LHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDS  156 (188)
T ss_dssp             HHCTTEEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred             HHhcCceecCCChhhEEeecc-eEEEEecCcceec
Confidence            579999999999999999977 9999999987543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PTZ00284 protein kinase; Provisional

Probab=98.77  E-value=5.5e-09  Score=107.23  Aligned_cols=79  Identities=29%  Similarity=0.390  Sum_probs=66.7

Q ss_pred             ceeeccCCcccccccccc----------------hhhhhccCCCCCCccccccccccccccchHHhhhccCCCCCCHHHH
Q psy8260         249 PFYFQDLKPSNIAVNEDC----------------ELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQL  312 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~----------------~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~sl  312 (427)
                      ...++|+++.|+++..++                .+|++|||.+..........+||+.|+|||++.+..+..++|+||+
T Consensus       252 gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSl  331 (467)
T PTZ00284        252 HLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSM  331 (467)
T ss_pred             CeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHH
Confidence            577889999999997654                5899999988765555567889999999999999888888999999


Q ss_pred             HHHHHHhCCCCHHHH
Q psy8260         313 NLIMEMLGTPPAEFM  327 (427)
Q Consensus       313 g~i~~~lg~~~~~~~  327 (427)
                      |+++++|.++..+|.
T Consensus       332 Gvil~elltG~~pf~  346 (467)
T PTZ00284        332 GCIIYELYTGKLLYD  346 (467)
T ss_pred             HHHHHHHHhCCCCCC
Confidence            999998877666664

>KOG1243|consensus

Probab=98.75  E-value=7.7e-08  Score=98.17  Aligned_cols=121  Identities=23%  Similarity=0.394  Sum_probs=95.1

Q ss_pred             eCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEEEeccCCCCHHHHHhhCCC
Q psy8260          86 DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKL  165 (427)
Q Consensus        86 ~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~l~~~~l  165 (427)
                      .+.++.+|.|........  .......+-++-|+.++||||+++++.+...      ...|+++|-+. -|..+++.  +
T Consensus        33 ~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~------~~~ylvTErV~-Pl~~~lk~--l  101 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEE------GTLYLVTERVR-PLETVLKE--L  101 (690)
T ss_pred             eeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhccc------CceEEEeeccc-cHHHHHHH--h
Confidence            346788899988765433  4445567888999999999999999887654      46799999764 24444433  2


Q ss_pred             CHHHHHHHHHHHHHHHHHHH-hcCceeccCCCCCeEEcCCCCEEEeeCCCCCC
Q psy8260         166 SDDHVQFLVYQILRGLKYIH-SAGIIHRDLKPSNIAVNEDCELKILDFGLARP  217 (427)
Q Consensus       166 ~~~~~~~~~~qi~~aL~yLH-~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~  217 (427)
                      ....+..-+.||+.||.||| +.+++|.+|.-..|+++..|+.||++|-++..
T Consensus       102 ~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~  154 (690)
T KOG1243|consen  102 GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSK  154 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEec
Confidence            36667777899999999997 67899999999999999999999999987653

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.74  E-value=1.6e-07  Score=85.59  Aligned_cols=128  Identities=24%  Similarity=0.365  Sum_probs=84.8

Q ss_pred             cCCcEEEEEEccCcCCCH-----HHHHHHHHHHHHHhcCCCC--CceeeeeeeecCccccCCceEEEEeccC-C-CCHHH
Q psy8260          88 VSGVKVAIKKIARPFQSA-----VHAKRTYRELRMLKHMNHE--NVIGLLDVFHSNTCLADFKNVYMVTHLM-G-ADLNN  158 (427)
Q Consensus        88 ~~g~~vAvK~i~~~~~~~-----~~~~~~~~Ei~~l~~l~Hp--nIv~l~~~~~~~~~~~~~~~~~lv~e~~-g-~~L~~  158 (427)
                      ..++.+-+|.........     ....+..+|...+..|..-  .+.+.+++........  ...+++++.. + .+|.+
T Consensus        30 ~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~--~~s~lite~l~~~~~L~~  107 (206)
T PF06293_consen   30 LVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGG--YRSYLITEALPGAQDLRD  107 (206)
T ss_pred             ccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCc--eeEEEEEEeCCCcccHHH
Confidence            345566666543221111     1233466777777666432  2344444443321111  3346666665 4 37888


Q ss_pred             HHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCC---CEEEeeCCCCCC
Q psy8260         159 ILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC---ELKILDFGLARP  217 (427)
Q Consensus       159 ~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~---~~kl~DFGla~~  217 (427)
                      ++.. ...+......++.+++..+.-||++||+|+|+++.|||++.++   .+.++||+.++.
T Consensus       108 ~~~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  108 LLQQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            8865 3366777888999999999999999999999999999999876   899999997764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG3087|consensus

Probab=98.73  E-value=1.5e-07  Score=81.93  Aligned_cols=137  Identities=20%  Similarity=0.284  Sum_probs=87.8

Q ss_pred             ccCcccccEEEEeEEeCcCCcEEEEEEcc-CcCCC-----HHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCce
Q psy8260          71 TLSKESFDLIFSSALDSVSGVKVAIKKIA-RPFQS-----AVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        71 ~lg~g~fg~v~~~~~~~~~g~~vAvK~i~-~~~~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      .+-+|+=+.|+.+.   ..|+.+.||.-. +....     .....+..+|++.|.++.--.|..-.=+|.+.      ..
T Consensus        14 likQGAEArv~~~~---~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~------~~   84 (229)
T KOG3087|consen   14 LIKQGAEARVPRGS---FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT------YG   84 (229)
T ss_pred             eeeccceeeEeeec---cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec------CC
Confidence            34455555565433   467888888532 21111     22345678899999887543332211112111      22


Q ss_pred             EEEEeccCCC--CHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCC---CEEEeeCCCCC
Q psy8260         145 VYMVTHLMGA--DLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC---ELKILDFGLAR  216 (427)
Q Consensus       145 ~~lv~e~~g~--~L~~~l~~~---~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~---~~kl~DFGla~  216 (427)
                      -.++||+..|  ++.+++...   .........++++|-+.+.-||.++|||+||..+||++..++   .+.++|||++.
T Consensus        85 ~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   85 GQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             CeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence            3577888765  677766532   222333367889999999999999999999999999997654   35899999975

>KOG0666|consensus

Probab=98.72  E-value=3.4e-09  Score=98.45  Aligned_cols=76  Identities=42%  Similarity=0.636  Sum_probs=61.9

Q ss_pred             eeccCCccccccccc----chhhhhccCCCCCCccc------cccccccccccchHHhhhccCCCCC-CHHHHHHHHHHh
Q psy8260         251 YFQDLKPSNIAVNED----CELKILDFGLARPTENE------MTGYVATRWYRAPEIMLNWMHYNQT-DIHQLNLIMEML  319 (427)
Q Consensus       251 ~~~d~~~~~~~~~~~----~~~ki~d~g~~~~~~~~------~~~~~gt~~Y~APEvl~~~~~~~~~-d~~slg~i~~~l  319 (427)
                      .++|++++|+++..+    |.+||+|+|+++...+.      ....+.|.||+|||.+++...+++. |+|++|||+.+|
T Consensus       154 lHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaEl  233 (438)
T KOG0666|consen  154 LHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAEL  233 (438)
T ss_pred             eeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHH
Confidence            456999999998887    89999999999864433      2356779999999999998877765 999999999887


Q ss_pred             CCCCHHH
Q psy8260         320 GTPPAEF  326 (427)
Q Consensus       320 g~~~~~~  326 (427)
                      .+..+-|
T Consensus       234 Ltl~PlF  240 (438)
T KOG0666|consen  234 LTLEPLF  240 (438)
T ss_pred             HccCccc
Confidence            6655444

>KOG0665|consensus

Probab=98.72  E-value=5.7e-09  Score=97.31  Aligned_cols=79  Identities=49%  Similarity=0.696  Sum_probs=67.4

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCCc--cccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHH
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPTE--NEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEF  326 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~--~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~  326 (427)
                      ...++|+++.|+++..+|.+|++|||.++...  .+.+..+.|..|+||||+.+..+...+||||+|||+-.|..+..-|
T Consensus       138 ~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf  217 (369)
T KOG0665|consen  138 GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLF  217 (369)
T ss_pred             ceeecccCcccceecchhheeeccchhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEe
Confidence            35677999999999999999999999998543  3567899999999999999999888889999999998886665444


Q ss_pred             H
Q psy8260         327 M  327 (427)
Q Consensus       327 ~  327 (427)
                      .
T Consensus       218 ~  218 (369)
T KOG0665|consen  218 P  218 (369)
T ss_pred             c
Confidence            3

>KOG0664|consensus

Probab=98.70  E-value=4.1e-09  Score=96.21  Aligned_cols=73  Identities=41%  Similarity=0.662  Sum_probs=59.5

Q ss_pred             eeeccCCcccccccccchhhhhccCCCCCCc----cccccccccccccchHHhhhccCCC-CCCHHHHHHHHHHhCCC
Q psy8260         250 FYFQDLKPSNIAVNEDCELKILDFGLARPTE----NEMTGYVATRWYRAPEIMLNWMHYN-QTDIHQLNLIMEMLGTP  322 (427)
Q Consensus       250 ~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~----~~~~~~~gt~~Y~APEvl~~~~~~~-~~d~~slg~i~~~lg~~  322 (427)
                      .-++|++++|.+++.+|.+||+|||+++..+    ..++-.+.|.+|+|||++.+...+. ..|+||.|+|+.+|...
T Consensus       177 ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgR  254 (449)
T KOG0664|consen  177 ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQR  254 (449)
T ss_pred             hhhccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhh
Confidence            3456999999999999999999999998643    2345567899999999999877655 55999999999666433

>PRK09902 hypothetical protein; Provisional

Probab=98.68  E-value=3.1e-07  Score=82.69  Aligned_cols=142  Identities=16%  Similarity=0.203  Sum_probs=95.8

Q ss_pred             cccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC----HHHHHHHHHHHHHHhcCCCCC--ceeeeeeeecCccccCCc
Q psy8260          70 PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS----AVHAKRTYRELRMLKHMNHEN--VIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~----~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~~~~~~~~~~~~~~  143 (427)
                      ..-|+||-++|+.-.+   .|..+=+|+-......    +.-...+.+|...|..|..-+  +.+.. ++. ........
T Consensus        24 pN~~rgG~SgV~r~~~---~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~-~~k~~~~~   98 (216)
T PRK09902         24 PNYRRNGMSGVQCVER---NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGE-AVKIEGEW   98 (216)
T ss_pred             CCcCCCCcceEEEEEe---CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eee-eeccCCce
Confidence            3456788888986443   3446888876421110    112345778998888875433  33333 221 11111123


Q ss_pred             eEEEEeccCC--CCHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCC--EEEeeCCCCC
Q psy8260         144 NVYMVTHLMG--ADLNNILRTQK---LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE--LKILDFGLAR  216 (427)
Q Consensus       144 ~~~lv~e~~g--~~L~~~l~~~~---l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~--~kl~DFGla~  216 (427)
                      ..++|++-.+  .+|.+++....   .+......+..+++..+.-||+.|+.|+|+-+.|||++.++.  ++++||--++
T Consensus        99 rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902         99 RALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            4567777555  58988886644   466666789999999999999999999999999999986666  9999998665

>KOG3741|consensus

Probab=98.63  E-value=6.7e-07  Score=88.91  Aligned_cols=135  Identities=19%  Similarity=0.289  Sum_probs=98.5

Q ss_pred             ccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEEEeccC--CC
Q psy8260          77 FDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GA  154 (427)
Q Consensus        77 fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~lv~e~~--g~  154 (427)
                      |...-+++....+|..|.+|++.....  ....+...-++..+++.|+|||++.++|.+.. + ....+++|..|.  .+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~--~~~nk~t~lve~wkkl~h~NvV~frevf~t~t-F-~D~SlvlvYDYyP~s~  363 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRD--QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT-F-GDLSLVLVYDYYPSSP  363 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccc--cCcccchHHHHHHHHhccCceeehhhhhhhhc-c-CcceEEEEEecCCCCc
Confidence            544444678888999999999943211  11122334567789999999999999998432 2 224566666665  34


Q ss_pred             CHHHHH-h---------------hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         155 DLNNIL-R---------------TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       155 ~L~~~l-~---------------~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                      +|.++. .               ..+.+|..+..|+.|+..||.++|+.|+.-+-|.|.+||++.+.+++|+--|..
T Consensus       364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~  440 (655)
T KOG3741|consen  364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIM  440 (655)
T ss_pred             hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccce
Confidence            666543 1               124678899999999999999999999999999999999998888888766654

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=98.62  E-value=1.4e-08  Score=99.76  Aligned_cols=78  Identities=62%  Similarity=0.936  Sum_probs=66.1

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh-ccCCCCCCHHHHHHHHHHhCCCCHHH
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN-WMHYNQTDIHQLNLIMEMLGTPPAEF  326 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~-~~~~~~~d~~slg~i~~~lg~~~~~~  326 (427)
                      ...++|+++.|+++..++.+|++|||++........+.+||+.|+|||++.+ ..+..++|+||+|++++.+.++..+|
T Consensus       138 ~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf  216 (343)
T cd07878         138 GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF  216 (343)
T ss_pred             CeecccCChhhEEECCCCCEEEcCCccceecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCC
Confidence            4678899999999999999999999999877666677889999999999876 44666789999999998875555444

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0658|consensus

Probab=98.61  E-value=2e-08  Score=95.41  Aligned_cols=80  Identities=31%  Similarity=0.477  Sum_probs=61.6

Q ss_pred             ceeeccCCccccccccc-chhhhhccCCCCCC--ccccccccccccccchHHhhhcc-CCCCCCHHHHHHHHHHhCCCCH
Q psy8260         249 PFYFQDLKPSNIAVNED-CELKILDFGLARPT--ENEMTGYVATRWYRAPEIMLNWM-HYNQTDIHQLNLIMEMLGTPPA  324 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~-~~~ki~d~g~~~~~--~~~~~~~~gt~~Y~APEvl~~~~-~~~~~d~~slg~i~~~lg~~~~  324 (427)
                      ...++|++|.|++++.+ +.+||+|||.|+..  ...-.+..-|.+|+|||.+.+.. |....|+||.||++.+|..+..
T Consensus       145 ~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~p  224 (364)
T KOG0658|consen  145 GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQP  224 (364)
T ss_pred             CcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCc
Confidence            45678999999998876 88899999999853  22335666799999999998765 5556699999999987755544


Q ss_pred             HHHh
Q psy8260         325 EFMA  328 (427)
Q Consensus       325 ~~~~  328 (427)
                      -|..
T Consensus       225 lFpG  228 (364)
T KOG0658|consen  225 LFPG  228 (364)
T ss_pred             ccCC
Confidence            4443

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=98.59  E-value=5.2e-08  Score=95.19  Aligned_cols=31  Identities=58%  Similarity=0.979  Sum_probs=27.6

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCC
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPT  279 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~  279 (427)
                      ...++|+++.|+++..++.+|++|||++...
T Consensus       123 ~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859         123 NVFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            4678899999999999999999999998643

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG2137|consensus

Probab=98.52  E-value=7.8e-08  Score=98.47  Aligned_cols=164  Identities=17%  Similarity=0.249  Sum_probs=101.7

Q ss_pred             HHHHHHHHHHhc-CceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeecc
Q psy8260         176 QILRGLKYIHSA-GIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQD  254 (427)
Q Consensus       176 qi~~aL~yLH~~-~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d  254 (427)
                      +++.||.|+|.. ++||+.|.|++|.++.++..||+.|+.+........       |=       +             +
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~-------~p-------~-------------~  159 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTE-------YP-------F-------------S  159 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCc-------cc-------c-------------c
Confidence            455999999964 899999999999999999999999997754322111       00       0             1


Q ss_pred             CCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHH
Q psy8260         255 LKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDS  334 (427)
Q Consensus       255 ~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~  334 (427)
                      .|..+..                      .-..-...|.|||++.+.......|++|+|+.++..-....+.........
T Consensus       160 ~yd~~lp----------------------~~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~  217 (700)
T KOG2137|consen  160 EYDPPLP----------------------LLLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL  217 (700)
T ss_pred             cCCCCCC----------------------hhhccCcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcc
Confidence            1111100                      001123568888888876666677999999766443211111111111111


Q ss_pred             HHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q psy8260         335 ARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~  391 (427)
                      ....-.........   .+-..+.++.++=|.++|..|+..|+++.+++.-|||++.
T Consensus       218 ~~~~~~~~~~~~~~---~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~  271 (700)
T KOG2137|consen  218 SYSFSRNLLNAGAF---GYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDP  271 (700)
T ss_pred             hhhhhhcccccccc---cccccCcHHHHHHHHHHhcCCcccCcchhhhhcccccCCc
Confidence            11111111111100   1114567899999999999999999999999999999864

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.48  E-value=1.3e-06  Score=80.84  Aligned_cols=135  Identities=24%  Similarity=0.293  Sum_probs=93.3

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCc------------------CCC--HHHHHHHHHHHHHHhcCCCC-
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP------------------FQS--AVHAKRTYRELRMLKHMNHE-  124 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~------------------~~~--~~~~~~~~~Ei~~l~~l~Hp-  124 (427)
                      ..++..||.|.=+.||.+. + ..|.++|||.-...                  ..+  ........+|.++|.+|... 
T Consensus        93 e~iG~~IGvGKEsdVY~~~-~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G  170 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAI-D-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG  170 (304)
T ss_pred             HhhccccccCccceEEEEE-C-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence            4688999999999999654 3 36899999964211                  011  12334567899999998654 


Q ss_pred             -CceeeeeeeecCccccCCceEEEEeccCCC-CHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEc
Q psy8260         125 -NVIGLLDVFHSNTCLADFKNVYMVTHLMGA-DLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN  202 (427)
Q Consensus       125 -nIv~l~~~~~~~~~~~~~~~~~lv~e~~g~-~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~  202 (427)
                       .|.+.+++          +...++|++..| .|...    +++......++..|+.-+.-.-..||||+|+.+=||+++
T Consensus       171 ~~VP~P~~~----------nRHaVvMe~ieG~eL~~~----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~  236 (304)
T COG0478         171 VKVPKPIAW----------NRHAVVMEYIEGVELYRL----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVT  236 (304)
T ss_pred             CCCCCcccc----------ccceeeeehcccceeecc----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEe
Confidence             66666655          335688888854 33322    223444444555566555555589999999999999999


Q ss_pred             CCCCEEEeeCCCCC
Q psy8260         203 EDCELKILDFGLAR  216 (427)
Q Consensus       203 ~~~~~kl~DFGla~  216 (427)
                      ++|.+.++||--+.
T Consensus       237 ~dg~~~vIDwPQ~v  250 (304)
T COG0478         237 EDGDIVVIDWPQAV  250 (304)
T ss_pred             cCCCEEEEeCcccc
Confidence            99999999996543

>KOG0671|consensus

Probab=98.38  E-value=3.5e-08  Score=94.11  Aligned_cols=62  Identities=31%  Similarity=0.451  Sum_probs=54.1

Q ss_pred             cchhhhhccCCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHH
Q psy8260         265 DCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEF  326 (427)
Q Consensus       265 ~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~  326 (427)
                      +..+++.|||.|.-........+.|..|+||||+++-.+...+|+||+|||+.+|-++..-|
T Consensus       248 s~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LF  309 (415)
T KOG0671|consen  248 STAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLF  309 (415)
T ss_pred             CcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceec
Confidence            56789999999987766678889999999999999999999999999999998886665544

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=98.38  E-value=4.1e-07  Score=90.46  Aligned_cols=80  Identities=41%  Similarity=0.594  Sum_probs=63.8

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCCc----cccccccccccccchHHhhhcc-CCCCCCHHHHHHHHHHhCCCC
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPTE----NEMTGYVATRWYRAPEIMLNWM-HYNQTDIHQLNLIMEMLGTPP  323 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~----~~~~~~~gt~~Y~APEvl~~~~-~~~~~d~~slg~i~~~lg~~~  323 (427)
                      ...++|+++.|+++..++.+|++|||++....    .......+|+.|+|||++.+.. +..++|+||+|++++.|.++.
T Consensus       123 ~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~  202 (372)
T cd07853         123 GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR  202 (372)
T ss_pred             CeeCCCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCC
Confidence            46788999999999999999999999986432    1234457899999999998754 566779999999998887666


Q ss_pred             HHHHh
Q psy8260         324 AEFMA  328 (427)
Q Consensus       324 ~~~~~  328 (427)
                      .+|..
T Consensus       203 ~pf~~  207 (372)
T cd07853         203 ILFQA  207 (372)
T ss_pred             CCCCC
Confidence            65543

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0669|consensus

Probab=98.30  E-value=4.7e-07  Score=82.12  Aligned_cols=78  Identities=33%  Similarity=0.473  Sum_probs=63.2

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCC-------ccccccccccccccchHHhhhcc-CCCCCCHHHHHHHHHHhC
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPT-------ENEMTGYVATRWYRAPEIMLNWM-HYNQTDIHQLNLIMEMLG  320 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~-------~~~~~~~~gt~~Y~APEvl~~~~-~~~~~d~~slg~i~~~lg  320 (427)
                      .+.++|+++.|+++..++.+|++|||+++..       ....+.++.|.||+.||.+.+.. +....|+|..|||+..|-
T Consensus       144 kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMw  223 (376)
T KOG0669|consen  144 KILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMW  223 (376)
T ss_pred             hHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHH
Confidence            4567799999999999999999999999642       22345678899999999988754 556679999999998887


Q ss_pred             CCCHHH
Q psy8260         321 TPPAEF  326 (427)
Q Consensus       321 ~~~~~~  326 (427)
                      +...-+
T Consensus       224 trspim  229 (376)
T KOG0669|consen  224 TRSPIM  229 (376)
T ss_pred             ccCccc
Confidence            765433

>KOG0670|consensus

Probab=98.29  E-value=9.7e-08  Score=94.36  Aligned_cols=81  Identities=38%  Similarity=0.498  Sum_probs=67.5

Q ss_pred             ceeeccCCcccccccccc-hhhhhccCCCCC-CccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHH
Q psy8260         249 PFYFQDLKPSNIAVNEDC-ELKILDFGLARP-TENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEF  326 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~-~~ki~d~g~~~~-~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~  326 (427)
                      ...++|+++.|+++.+.- .+|+||||.|.. .++.++.+..+..|+|||+|++.+|..+.|+||.||.+|+|=++..-|
T Consensus       556 ~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlF  635 (752)
T KOG0670|consen  556 GVLHADIKPDNILVNESKNILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILF  635 (752)
T ss_pred             CeeecccCccceEeccCcceeeeccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceec
Confidence            456779999999999864 459999999975 455677778889999999999999999999999999999986666555


Q ss_pred             Hhh
Q psy8260         327 MAK  329 (427)
Q Consensus       327 ~~~  329 (427)
                      ...
T Consensus       636 pG~  638 (752)
T KOG0670|consen  636 PGR  638 (752)
T ss_pred             CCC
Confidence            443

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=98.26  E-value=6.7e-07  Score=87.98  Aligned_cols=51  Identities=82%  Similarity=1.329  Sum_probs=44.1

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      ...++|+.+.|+++..++.++++|||++...........||+.|+|||++.
T Consensus       140 ~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~  190 (345)
T cd07877         140 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIML  190 (345)
T ss_pred             CeeecCCChHHEEEcCCCCEEEecccccccccccccccccCCCccCHHHHh
Confidence            467889999999999999999999999987665556678899999999863

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=98.25  E-value=4.5e-07  Score=87.59  Aligned_cols=50  Identities=44%  Similarity=0.802  Sum_probs=40.8

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCCcc---ccccccccccccchHHh
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPTEN---EMTGYVATRWYRAPEIM  298 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~---~~~~~~gt~~Y~APEvl  298 (427)
                      ...++|+++.|+++..++.+|++|||.+.....   ......+|+.|+|||++
T Consensus       124 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~  176 (309)
T cd07872         124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL  176 (309)
T ss_pred             CeecCCCCHHHEEECCCCCEEECccccceecCCCccccccccccccccCCHHH
Confidence            467889999999999999999999999865322   23346789999999985

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=98.17  E-value=7.6e-07  Score=87.46  Aligned_cols=78  Identities=58%  Similarity=0.957  Sum_probs=64.6

Q ss_pred             eeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc-cCCCCCCHHHHHHHHHHhCCCCHHHH
Q psy8260         250 FYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW-MHYNQTDIHQLNLIMEMLGTPPAEFM  327 (427)
Q Consensus       250 ~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~-~~~~~~d~~slg~i~~~lg~~~~~~~  327 (427)
                      ..++|+.+.|+++..++.++++|||++........+..+|+.|+|||++.+. .+..++|+||+|++++.|-++..+|.
T Consensus       138 i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~  216 (342)
T cd07879         138 IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK  216 (342)
T ss_pred             cccCCCCHHHEEECCCCCEEEeeCCCCcCCCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCC
Confidence            5678999999999999999999999998765555667889999999998763 45667899999999988866555553

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=98.15  E-value=2.7e-06  Score=83.62  Aligned_cols=79  Identities=66%  Similarity=0.991  Sum_probs=64.9

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc-cCCCCCCHHHHHHHHHHhCCCCHHHH
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW-MHYNQTDIHQLNLIMEMLGTPPAEFM  327 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~-~~~~~~d~~slg~i~~~lg~~~~~~~  327 (427)
                      ...++|+++.|+++..++.++++|||.+...........+|+.|+|||++.+. .+..++|+||+|++++.+.++..+|.
T Consensus       138 gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~  217 (343)
T cd07851         138 GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP  217 (343)
T ss_pred             CeecCCCCHHHeEECCCCCEEEccccccccccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence            46778999999999999999999999998765556667889999999998753 45567899999999988866655553

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0662|consensus

Probab=98.08  E-value=1e-06  Score=76.04  Aligned_cols=91  Identities=34%  Similarity=0.553  Sum_probs=66.9

Q ss_pred             ccccchhhhhcccccCCCCcce------eeccCCcccccccccchhhhhccCCCCCCcc---ccccccccccccchHHhh
Q psy8260         229 RWYRAPEIMLNWMHYNQTGVPF------YFQDLKPSNIAVNEDCELKILDFGLARPTEN---EMTGYVATRWYRAPEIML  299 (427)
Q Consensus       229 ~~y~aPE~l~~~~~~~~~~~~~------~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~---~~~~~~gt~~Y~APEvl~  299 (427)
                      ..|+.||+......---.+..+      -++|+++-|.++..+++.|++|||+++.-.-   -....+.|.||+.|.|+.
T Consensus        95 ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysaevvtlwyrppdvlf  174 (292)
T KOG0662|consen   95 NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLF  174 (292)
T ss_pred             CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceee
Confidence            3578888755422111111111      3458999999999999999999999985322   245678899999999998


Q ss_pred             hccCCCCC-CHHHHHHHHHHh
Q psy8260         300 NWMHYNQT-DIHQLNLIMEML  319 (427)
Q Consensus       300 ~~~~~~~~-d~~slg~i~~~l  319 (427)
                      +...+..+ |+||.|+|+.++
T Consensus       175 gakly~tsidmwsagcifael  195 (292)
T KOG0662|consen  175 GAKLYSTSIDMWSAGCIFAEL  195 (292)
T ss_pred             eeehhccchHhhhcchHHHHH
Confidence            87766655 999999999877

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=98.03  E-value=4e-06  Score=82.43  Aligned_cols=50  Identities=74%  Similarity=1.275  Sum_probs=43.6

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                      .+.++|+.+.|+++..++.++++|||.+........+..+++.|+|||++
T Consensus       138 gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~  187 (343)
T cd07880         138 GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRWYRAPEVI  187 (343)
T ss_pred             CeecCCCCHHHEEEcCCCCEEEeecccccccccCccccccCCcccCHHHH
Confidence            46788999999999999999999999998766555667889999999986

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=98.02  E-value=5.7e-06  Score=80.88  Aligned_cols=80  Identities=45%  Similarity=0.671  Sum_probs=62.9

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCCcc-------ccccccccccccchHHhhh-ccCCCCCCHHHHHHHHHHhC
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPTEN-------EMTGYVATRWYRAPEIMLN-WMHYNQTDIHQLNLIMEMLG  320 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~-------~~~~~~gt~~Y~APEvl~~-~~~~~~~d~~slg~i~~~lg  320 (427)
                      ...++|+.+.|+.+..++.+|++|||.+.....       ...+..|+.+|+|||++.+ ..+..++|+|++|++++.+.
T Consensus       127 ~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~  206 (334)
T cd07855         127 NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML  206 (334)
T ss_pred             CeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHH
Confidence            367789999999999999999999999864321       1134578999999999865 34667789999999998886


Q ss_pred             CCCHHHHh
Q psy8260         321 TPPAEFMA  328 (427)
Q Consensus       321 ~~~~~~~~  328 (427)
                      ++..+|..
T Consensus       207 ~g~~pf~~  214 (334)
T cd07855         207 GRRQLFPG  214 (334)
T ss_pred             cCCCccCC
Confidence            66666643

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=98.01  E-value=3.3e-06  Score=82.61  Aligned_cols=31  Identities=55%  Similarity=0.932  Sum_probs=27.1

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCC
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPT  279 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~  279 (427)
                      ...++|+.+.|+.+..++.+|++|||++...
T Consensus       126 ~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  156 (336)
T cd07849         126 NVLHRDLKPSNLLLNTNCDLKICDFGLARIA  156 (336)
T ss_pred             CeeccCCCHHHEEECCCCCEEECcccceeec
Confidence            4677899999999999999999999988643

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=97.97  E-value=3.3e-06  Score=82.24  Aligned_cols=31  Identities=61%  Similarity=0.962  Sum_probs=27.3

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCC
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPT  279 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~  279 (427)
                      ...++|+.+.|+++..++.++++|||.+...
T Consensus       123 gi~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834         123 NVIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             CeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            3678899999999999999999999988654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=97.94  E-value=5.3e-06  Score=81.06  Aligned_cols=31  Identities=61%  Similarity=0.948  Sum_probs=27.1

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCC
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPT  279 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~  279 (427)
                      ...++|+++.|+++..++.+|++|||.+...
T Consensus       125 givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857         125 NVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             CcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            3577899999999999999999999988643

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=97.92  E-value=6.4e-06  Score=80.67  Aligned_cols=50  Identities=60%  Similarity=1.059  Sum_probs=40.4

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCCcc---ccccccccccccchHHh
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPTEN---EMTGYVATRWYRAPEIM  298 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~---~~~~~~gt~~Y~APEvl  298 (427)
                      .+.++|+.+.|+++..++.+|++|||++.....   ......+|..|+|||++
T Consensus       128 ~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~  180 (337)
T cd07858         128 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELL  180 (337)
T ss_pred             CEecCCCCHHHEEEcCCCCEEECcCccccccCCCcccccccccccCccChHHH
Confidence            467789999999999999999999999875432   22345789999999984

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=97.92  E-value=5e-06  Score=78.94  Aligned_cols=46  Identities=52%  Similarity=0.806  Sum_probs=33.4

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCCccc----cccccccccccc
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPTENE----MTGYVATRWYRA  294 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~----~~~~~gt~~Y~A  294 (427)
                      ...++|+.+.|+.+..++.++++|||.+......    .....|+..|+|
T Consensus       119 ~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~a  168 (286)
T cd07832         119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRA  168 (286)
T ss_pred             CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccccC
Confidence            3678899999999999999999999988754322    223445555543

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG1290|consensus

Probab=97.90  E-value=4.6e-06  Score=82.20  Aligned_cols=91  Identities=31%  Similarity=0.391  Sum_probs=62.6

Q ss_pred             CCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccc
Q psy8260         204 DCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEM  283 (427)
Q Consensus       204 ~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~  283 (427)
                      +..|||+|||-|+-.....|.-+.|+.|+|||+|+|.....       ..|+||..|+.-|                 ..
T Consensus       390 di~vKIaDlGNACW~~khFT~DIQTRQYRapEVllGsgY~~-------~ADiWS~AC~~FE-----------------La  445 (590)
T KOG1290|consen  390 DIRVKIADLGNACWVHKHFTEDIQTRQYRAPEVLLGSGYST-------SADIWSTACMAFE-----------------LA  445 (590)
T ss_pred             ceeEEEeeccchhhhhhhhchhhhhhhccCcceeecCCCCC-------chhHHHHHHHHHH-----------------hh
Confidence            45799999999998887888889999999999999864333       2399999998765                 11


Q ss_pred             ccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHH
Q psy8260         284 TGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEF  326 (427)
Q Consensus       284 ~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~  326 (427)
                      +|..   .| .|-  .+  -....|-..++.|+.+||.-|..+
T Consensus       446 TGDy---LF-ePh--sG--~~Y~rDEDHiA~i~ELLG~iPr~i  480 (590)
T KOG1290|consen  446 TGDY---LF-EPH--SG--ENYSRDEDHIALIMELLGKIPRKI  480 (590)
T ss_pred             cCce---ee-cCC--CC--CCCCccHHHHHHHHHHHhhccHHH
Confidence            1111   00 000  00  011236778999999998877655

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=97.88  E-value=6.9e-06  Score=80.39  Aligned_cols=31  Identities=55%  Similarity=0.921  Sum_probs=27.4

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCC
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPT  279 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~  279 (427)
                      .+.++|+.+.|+.+..++.+|++|||.+...
T Consensus       127 ~i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852         127 NVIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             CeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence            4677899999999999999999999988654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=97.84  E-value=4.9e-06  Score=81.29  Aligned_cols=50  Identities=66%  Similarity=1.101  Sum_probs=42.5

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                      ...++|+.+.|+++..++.++++|||.+........+..+++.|+|||++
T Consensus       128 ~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~y~aPE~~  177 (328)
T cd07856         128 GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRYYRAPEIM  177 (328)
T ss_pred             CcccCCCCHHHEeECCCCCEEeCccccccccCCCcCCCcccccccCceee
Confidence            35678999999999999999999999998665555567789999999975

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.82  E-value=0.00052  Score=61.85  Aligned_cols=131  Identities=20%  Similarity=0.334  Sum_probs=82.1

Q ss_pred             cccCcccccEEEEeEEeCcCCcEEEEEEccCcC--------------CCHHHHHHHHHHHHHHhcCC------CCCceee
Q psy8260          70 PTLSKESFDLIFSSALDSVSGVKVAIKKIARPF--------------QSAVHAKRTYRELRMLKHMN------HENVIGL  129 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~--------------~~~~~~~~~~~Ei~~l~~l~------HpnIv~l  129 (427)
                      ..+|.|+.=.||.   +. ......||++....              .......+..+|+.....+.      +..|.++
T Consensus         7 ~~i~~G~~R~cy~---HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    7 DLIAQGGERDCYQ---HP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             cccccCCCceEEE---CC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            4678888766663   22 22345677765433              01112344556665555444      7789999


Q ss_pred             eeeeecCccccCCceEEEEeccC----C---CCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEc
Q psy8260         130 LDVFHSNTCLADFKNVYMVTHLM----G---ADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN  202 (427)
Q Consensus       130 ~~~~~~~~~~~~~~~~~lv~e~~----g---~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~  202 (427)
                      +++.+++..      .-+|+|..    |   .+|.++++.+.+++ ....   .+-.-.+||-+.+|+.+||+|.||++.
T Consensus        83 ~G~veT~~G------~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   83 YGFVETNLG------LGLVVELIRDADGNISPTLEDYLKEGGLTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQ  152 (199)
T ss_pred             eEEEecCCc------eEEEEEEEECCCCCcCccHHHHHHcCCccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEE
Confidence            999887532      23444432    2   36888888777777 3322   333445688899999999999999996


Q ss_pred             CC--C--CEEEee-CCC
Q psy8260         203 ED--C--ELKILD-FGL  214 (427)
Q Consensus       203 ~~--~--~~kl~D-FGl  214 (427)
                      ..  +  .+.|+| ||-
T Consensus       153 ~~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  153 RRDSGEFRLVLIDGLGE  169 (199)
T ss_pred             ecCCCceEEEEEeCCCC
Confidence            32  2  588998 553

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.81  E-value=0.00024  Score=65.34  Aligned_cols=137  Identities=22%  Similarity=0.220  Sum_probs=89.4

Q ss_pred             ccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC--------------------HHHHH-H-HHHHHHHHhcCC--CCCc
Q psy8260          71 TLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS--------------------AVHAK-R-TYRELRMLKHMN--HENV  126 (427)
Q Consensus        71 ~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~--------------------~~~~~-~-~~~Ei~~l~~l~--HpnI  126 (427)
                      .|+.|.=..||.+..  .++..||||+.......                    ..... . ..+|..-|+++.  +-.+
T Consensus        55 ~istGKEA~Vy~a~~--~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv  132 (268)
T COG1718          55 CISTGKEANVYLAET--GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV  132 (268)
T ss_pred             eecCCcceEEEeecc--CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence            566666677886542  46789999986532111                    11110 1 235777777663  3344


Q ss_pred             eeeeeeeecCccccCCceEEEEeccCCCCHH--HHHhhCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCCeEEcC
Q psy8260         127 IGLLDVFHSNTCLADFKNVYMVTHLMGADLN--NILRTQKLSDDHVQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNE  203 (427)
Q Consensus       127 v~l~~~~~~~~~~~~~~~~~lv~e~~g~~L~--~~l~~~~l~~~~~~~~~~qi~~aL~yLH~-~~iiHrDLKp~NILl~~  203 (427)
                      .+-+.++          .-.++||+.|....  -.|+.-.+...++..+..+++..+.-|-. .++||.||..=|||+. 
T Consensus       133 P~Pi~~~----------~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-  201 (268)
T COG1718         133 PEPIAFR----------NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-  201 (268)
T ss_pred             CCceeec----------CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-
Confidence            4444442          23688999875511  11222334444688888899999988865 8999999999999999 


Q ss_pred             CCCEEEeeCCCCCCCCC
Q psy8260         204 DCELKILDFGLARPTEN  220 (427)
Q Consensus       204 ~~~~kl~DFGla~~~~~  220 (427)
                      ++.+.|+|||-|.....
T Consensus       202 ~~~p~iID~~QaV~~~h  218 (268)
T COG1718         202 DGEPYIIDVSQAVTIDH  218 (268)
T ss_pred             CCeEEEEECccccccCC
Confidence            88999999998865543

>KOG0577|consensus

Probab=97.80  E-value=5.4e-06  Score=83.43  Aligned_cols=51  Identities=31%  Similarity=0.501  Sum_probs=43.7

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      ..++.|++++|+++.+.+.||++|||.+... ....+++|||+|||||||+-
T Consensus       146 ~~IHRDiKAGNILLse~g~VKLaDFGSAsi~-~PAnsFvGTPywMAPEVILA  196 (948)
T KOG0577|consen  146 NRIHRDIKAGNILLSEPGLVKLADFGSASIM-APANSFVGTPYWMAPEVILA  196 (948)
T ss_pred             hHHhhhccccceEecCCCeeeeccccchhhc-CchhcccCCccccchhHhee
Confidence            3567899999999999999999999988542 34568999999999999865

>KOG1035|consensus

Probab=97.80  E-value=0.00015  Score=78.84  Aligned_cols=202  Identities=23%  Similarity=0.290  Sum_probs=114.6

Q ss_pred             HHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHh
Q psy8260         109 KRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHS  186 (427)
Q Consensus       109 ~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~  186 (427)
                      .....|+..+.+..|+|++.++.|--..-+..  -.+.+..+++ ..++...+.. +..+...++.+..++.+||.|+|+
T Consensus       227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g--~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRG--IVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHHHHhhccccccceeEEeehhhcch--HHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH
Confidence            33456778888999999999887743221110  0122233444 4455555543 567888999999999999999999


Q ss_pred             cCceeccCCCC---CeEEcCCCCEEEe--eCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCccccc
Q psy8260         187 AGIIHRDLKPS---NIAVNEDCELKIL--DFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIA  261 (427)
Q Consensus       187 ~~iiHrDLKp~---NILl~~~~~~kl~--DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~  261 (427)
                      ....|.=|-.+   +--.+..+.+.++  ||+..+........                                     
T Consensus       305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~-------------------------------------  347 (1351)
T KOG1035|consen  305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS-------------------------------------  347 (1351)
T ss_pred             hccceeEEecccccccccCccceeecchhhhcccccCCCcccc-------------------------------------
Confidence            86555444333   2223334445555  66655433221110                                     


Q ss_pred             ccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCCC--CCHHHHHHHHHHh--CCCCHHHHhhcCcHHHHH
Q psy8260         262 VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQ--TDIHQLNLIMEML--GTPPAEFMAKISSDSARK  337 (427)
Q Consensus       262 ~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~--~d~~slg~i~~~l--g~~~~~~~~~~~~~~~~~  337 (427)
                                            ....-+..+.|+|.........+  .|+|++|...--+  |........         
T Consensus       348 ----------------------~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~---------  396 (1351)
T KOG1035|consen  348 ----------------------FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSA---------  396 (1351)
T ss_pred             ----------------------hhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCccccccc---------
Confidence                                  00011122334443332222222  4999998665322  222211100         


Q ss_pred             HHhcCCCCCcccHHhhcCCCCh-hHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q psy8260         338 YINSLPLLTKKDFRQVFKGANP-QAIDLLSLMLELDSEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~s~-~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~  391 (427)
                                 ....+....+. +..|++.+|+.-|+++|+++.+++.|||.+..
T Consensus       397 -----------~~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~  440 (1351)
T KOG1035|consen  397 -----------VPVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP  440 (1351)
T ss_pred             -----------chhhhhccccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence                       00111112222 67799999999999999999999999999743

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=97.77  E-value=0.00023  Score=73.16  Aligned_cols=142  Identities=20%  Similarity=0.327  Sum_probs=83.9

Q ss_pred             cccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC---------------------------HH-H----HH------HH
Q psy8260          70 PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS---------------------------AV-H----AK------RT  111 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~---------------------------~~-~----~~------~~  111 (427)
                      ..++.++-|.||.+.+.  +|+.||||+....-..                           .. .    .+      ..
T Consensus       131 ~PiAsASIaQVH~A~L~--sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy  208 (517)
T COG0661         131 EPIASASIAQVHRAVLK--SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDY  208 (517)
T ss_pred             CchhhhhHhhheeEEec--CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCH
Confidence            46778888999988874  4999999986532100                           00 0    01      12


Q ss_pred             HHHHHHHhcC----CCCCceeeeeeeecCccccCCceEEEEeccC-CCCHHHH--HhhCCCCHHHHHHHHHHHHHHHHHH
Q psy8260         112 YRELRMLKHM----NHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNI--LRTQKLSDDHVQFLVYQILRGLKYI  184 (427)
Q Consensus       112 ~~Ei~~l~~l----~HpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~--l~~~~l~~~~~~~~~~qi~~aL~yL  184 (427)
                      .+|...+.++    ++..=+.+-.+|.. .|    ..-.++||+. |-.+.++  ++..+++.+.+.....++  -+.-+
T Consensus       209 ~~EA~n~~~~~~nf~~~~~v~VP~V~we-~t----~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~  281 (517)
T COG0661         209 RREAANAERFRENFKDDPDVYVPKVYWE-YT----TRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQL  281 (517)
T ss_pred             HHHHHHHHHHHHHcCCCCCeEeceeehh-cc----CCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHH
Confidence            2355444433    22222233333321 11    2236778877 5456555  445566643332222111  12223


Q ss_pred             HhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         185 HSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       185 H~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      -..|+.|.|..|.||+++.+|.+.+.|||+......
T Consensus       282 ~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         282 LRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HhcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            348999999999999999999999999999876554

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.63  E-value=0.00094  Score=60.71  Aligned_cols=66  Identities=27%  Similarity=0.521  Sum_probs=48.7

Q ss_pred             eEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP  217 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~  217 (427)
                      ..++++|+. |..|.+...   +++.    +...+..++.-+|+.|+.|+|..|.|++++.+ .++++||+..+.
T Consensus       117 ~~~ll~EYIeG~~l~d~~~---i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~~~k~~  183 (229)
T PF06176_consen  117 SYVLLMEYIEGVELNDIED---IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDTQGKRM  183 (229)
T ss_pred             EEEEEEEEecCeecccchh---cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEECccccc
Confidence            456788888 545554321   3332    34567788999999999999999999999855 499999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG0599|consensus

Probab=97.62  E-value=1.2e-05  Score=73.89  Aligned_cols=52  Identities=33%  Similarity=0.504  Sum_probs=44.7

Q ss_pred             eeeccCCcccccccccchhhhhccCCCCCC--ccccccccccccccchHHhhhc
Q psy8260         250 FYFQDLKPSNIAVNEDCELKILDFGLARPT--ENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       250 ~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~--~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      .-+.|+++.|++++++..+|++|||+++..  ...+...||||+|+|||++.=.
T Consensus       144 IVHRDLKpENILlddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~  197 (411)
T KOG0599|consen  144 IVHRDLKPENILLDDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCS  197 (411)
T ss_pred             hhhcccChhheeeccccceEEeccceeeccCCchhHHHhcCCCcccChhheeee
Confidence            446799999999999999999999999864  3456789999999999998643

>KOG0576|consensus

Probab=97.58  E-value=1.4e-05  Score=81.54  Aligned_cols=150  Identities=17%  Similarity=0.207  Sum_probs=90.7

Q ss_pred             cccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCC-ceeeeeeeecCccccCCceEEEE
Q psy8260          70 PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHEN-VIGLLDVFHSNTCLADFKNVYMV  148 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~Hpn-Iv~l~~~~~~~~~~~~~~~~~lv  148 (427)
                      ..+++++.+.++++ ....+...+ .+.+...       ....-++++|.+++||| .+..++-+..      .....+.
T Consensus       248 h~fvK~altknpKk-RptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~------E~~~~i~  312 (829)
T KOG0576|consen  248 HNFVKGALTKNPKK-RPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDG------EDYLWIP  312 (829)
T ss_pred             HHHHHHHhcCCCcc-CCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCc------ccccchh
Confidence            45678888888853 233333333 5544321       22334888999999999 4444433222      2345677


Q ss_pred             eccCCCC--HHHHH--hhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC--c
Q psy8260         149 THLMGAD--LNNIL--RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE--M  222 (427)
Q Consensus       149 ~e~~g~~--L~~~l--~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~--~  222 (427)
                      ++++++.  -....  ..-.+.+-......+.-.++++|+|+.--+|||    |||..+ +..|..|||........  .
T Consensus       313 ~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~  387 (829)
T KOG0576|consen  313 MRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKP  387 (829)
T ss_pred             hhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccccc
Confidence            7777533  11100  011233333444566678899999998779999    877654 68899999988766544  3


Q ss_pred             ccccccccccchhhhhc
Q psy8260         223 TGYVATRWYRAPEIMLN  239 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~  239 (427)
                      ++..+|+.++|||++.+
T Consensus       388 ~t~~~~~~~~~pev~~~  404 (829)
T KOG0576|consen  388 RTAIGTPEPLAPEVIQE  404 (829)
T ss_pred             ccCCCCCCCCCchhhcc
Confidence            44566677777776544

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.50  E-value=0.00048  Score=61.62  Aligned_cols=95  Identities=21%  Similarity=0.241  Sum_probs=71.6

Q ss_pred             HHHHHHhcCCC-CCceeeeeeeecCccccCCceEEEEeccCCCCHHH----HHhhCCCCHHHHHHHHHHHHHHHHHHHh-
Q psy8260         113 RELRMLKHMNH-ENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNN----ILRTQKLSDDHVQFLVYQILRGLKYIHS-  186 (427)
Q Consensus       113 ~Ei~~l~~l~H-pnIv~l~~~~~~~~~~~~~~~~~lv~e~~g~~L~~----~l~~~~l~~~~~~~~~~qi~~aL~yLH~-  186 (427)
                      .|.-+|+.+++ +++.+++|..         +.+|++++...+.+..    +.+-...++....+++.|++..+.+++. 
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~C---------G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~   78 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSC---------GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHG   78 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeEC---------CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC
Confidence            58888888876 6899999874         2356555544344421    1111235888999999999999999987 


Q ss_pred             --cCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         187 --AGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       187 --~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                        ..+.-.|++|+|+-+++++.+|++|...+.
T Consensus        79 ~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~  110 (188)
T PF12260_consen   79 PLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVF  110 (188)
T ss_pred             CCCcEEEeecchHHeEEeCCCcEEEEechhcc
Confidence              357789999999999999999999987654

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG0984|consensus

Probab=97.48  E-value=3.2e-05  Score=68.57  Aligned_cols=80  Identities=25%  Similarity=0.301  Sum_probs=63.8

Q ss_pred             CcceeeccCCcccccccccchhhhhccCCCCCCcc-cccc-ccccccccchHHhhhc----cCCCCCCHHHHHHHHHHhC
Q psy8260         247 GVPFYFQDLKPSNIAVNEDCELKILDFGLARPTEN-EMTG-YVATRWYRAPEIMLNW----MHYNQTDIHQLNLIMEMLG  320 (427)
Q Consensus       247 ~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~-~~~~-~~gt~~Y~APEvl~~~----~~~~~~d~~slg~i~~~lg  320 (427)
                      ....+++|++++|++++.++++|++|||.+.-... ...+ ..|...|||||.+...    .|.-++|+||||+.+.+|.
T Consensus       167 kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA  246 (282)
T KOG0984|consen  167 KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMA  246 (282)
T ss_pred             HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhh
Confidence            34567889999999999999999999999986533 3344 6889999999998643    4555789999999988886


Q ss_pred             CCCHHH
Q psy8260         321 TPPAEF  326 (427)
Q Consensus       321 ~~~~~~  326 (427)
                      +...|+
T Consensus       247 ~lr~PY  252 (282)
T KOG0984|consen  247 ILRFPY  252 (282)
T ss_pred             hccccc
Confidence            665544

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.45  E-value=0.00078  Score=61.65  Aligned_cols=137  Identities=24%  Similarity=0.305  Sum_probs=69.7

Q ss_pred             cccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCC--ceeeeeeeecCccccCCceEEE
Q psy8260          70 PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHEN--VIGLLDVFHSNTCLADFKNVYM  147 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~~~~~~~~~~~~~~~~~l  147 (427)
                      +.++.|..+.||....+   +..+++|.....    .......+|..+++.+....  +.+++.......   .....++
T Consensus         3 ~~l~~G~~n~~~~v~~~---~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~---~~~~~~~   72 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTD---DGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDE---FNGFPYL   72 (239)
T ss_dssp             EEEEESSSSEEEEEEET---TSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETE---ETSEEEE
T ss_pred             ccCCCCCeeeEEEEEEC---CcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccc---ccccceE
Confidence            35677888889965432   248999986432    33455668888887775433  445554322111   1123566


Q ss_pred             EeccC-CCCHHH----------------HHh---hC-----CCCHHH---H---HHH---------------HHHHHH-H
Q psy8260         148 VTHLM-GADLNN----------------ILR---TQ-----KLSDDH---V---QFL---------------VYQILR-G  180 (427)
Q Consensus       148 v~e~~-g~~L~~----------------~l~---~~-----~l~~~~---~---~~~---------------~~qi~~-a  180 (427)
                      ++++. |..+..                .+.   ..     .+....   .   ...               ...+.. .
T Consensus        73 ~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (239)
T PF01636_consen   73 LMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERL  152 (239)
T ss_dssp             EEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHH
T ss_pred             EEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHH
Confidence            77766 444444                111   11     111000   0   000               001122 2


Q ss_pred             HHHHH-------hcCceeccCCCCCeEEc-CCCCEEEeeCCCCC
Q psy8260         181 LKYIH-------SAGIIHRDLKPSNIAVN-EDCELKILDFGLAR  216 (427)
Q Consensus       181 L~yLH-------~~~iiHrDLKp~NILl~-~~~~~kl~DFGla~  216 (427)
                      +..++       ...++|+|+.|.|||++ .++.+.|+||+.+.
T Consensus       153 ~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  153 LQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            33333       24599999999999999 66667899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.43  E-value=0.0045  Score=55.63  Aligned_cols=133  Identities=23%  Similarity=0.250  Sum_probs=83.8

Q ss_pred             cceeeccccCcccc-cEEEEeEEeCcCCcEEEEEEccC---cC-------CC--H-------HHHHHHHHHHHHHhcC--
Q psy8260          64 GVIDIGPTLSKESF-DLIFSSALDSVSGVKVAIKKIAR---PF-------QS--A-------VHAKRTYRELRMLKHM--  121 (427)
Q Consensus        64 ~~~~~~~~lg~g~f-g~v~~~~~~~~~g~~vAvK~i~~---~~-------~~--~-------~~~~~~~~Ei~~l~~l--  121 (427)
                      ..+++.+.||.|.- |.||+...   .|+.+|+|....   ..       ..  .       ....-+..|.+...+|  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I---~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke  113 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI---DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE  113 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE---CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence            67888999999999 99997654   577999998211   00       00  0       1122355677655544  


Q ss_pred             -CCCCc--eeeeeeeecCc--cc----------cCCceEEEEeccCCCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHh
Q psy8260         122 -NHENV--IGLLDVFHSNT--CL----------ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHS  186 (427)
Q Consensus       122 -~HpnI--v~l~~~~~~~~--~~----------~~~~~~~lv~e~~g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~  186 (427)
                       ++.++  |+.++|+.-..  -.          ......-||.++....-       .+...    -+.++.+-|..+|.
T Consensus       114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------~~~~~----~~~~~~~dl~~~~k  182 (207)
T PF13095_consen  114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------PLQIR----DIPQMLRDLKILHK  182 (207)
T ss_pred             ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------ccchh----HHHHHHHHHHHHHH
Confidence             55666  88888863210  00          01122345555442111       12222    34577888899999


Q ss_pred             cCceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         187 AGIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       187 ~~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                      .||+-+|+|+.|..     .-||+|||.+
T Consensus       183 ~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  183 LGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             CCeeeccCcccccc-----CCEEEecccC
Confidence            99999999999986     3489999964

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.43  E-value=0.0021  Score=59.34  Aligned_cols=28  Identities=18%  Similarity=0.235  Sum_probs=25.2

Q ss_pred             CceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         188 GIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       188 ~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                      .++|+|+.|.||+++.++ +.|+||+.+.
T Consensus       154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            478999999999999888 9999999765

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	427
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-107
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-107
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-107
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-107
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-107
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-107
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-107
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-107
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-107
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-107
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-107
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-107
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-107
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-107
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-107
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-107
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-107
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-107
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-106
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-106
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-106
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-106
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-106
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-106
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-106
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-106
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-106
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-106
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-106
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-106
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-106
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-106
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-106
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-106
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-106
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-106
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-106
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-106
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-106
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-106
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-106
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-106
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-106
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-106
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-106
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-106
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-106
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-105
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-105
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-105
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-105
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-105
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-105
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-105
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-105
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-105
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-105
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-104
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-104
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-100
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-99
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-99
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-87
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-80
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-80
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-62
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-61
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-61
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-60
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-60
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-60
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-60
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-60
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-60
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-60
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		5e-60
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		5e-60
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		5e-60
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		5e-60
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		5e-60
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		5e-60
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		9e-60
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-59
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-59
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-59
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-59
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-59
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-59
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-58
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-58
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-58
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-57
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		5e-57
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-56
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		4e-56
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-56
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-54
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		5e-54
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-54
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-54
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-53
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-53
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-53
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-53
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-53
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-53
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-53
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-53
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-53
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-53
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-53
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-53
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-53
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-53
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		7e-53
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		7e-53
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-53
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		9e-53
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-52
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-52
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-52
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-52
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-52
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-51
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-48
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-47
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		3e-39
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-37
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-36
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		4e-36
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		5e-36
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		6e-35
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		5e-32
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-26
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-26
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-26
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-26
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-25
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-25
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-25
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-25
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-25
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-25
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-25
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-25
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-25
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-25
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-25
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-25
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-25
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-25
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-25
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-25
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-25
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-25
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-25
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-25
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-25
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-25
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-25
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-25
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-25
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-25
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-25
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		6e-25
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-25
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		7e-25
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		9e-25
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-24
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-24
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-23
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-22
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-20
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-19
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-19
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-19
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		5e-19
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-19
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-06
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		7e-19
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		7e-19
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		7e-19
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		8e-19
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		9e-19
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		9e-19
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		9e-19
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-18
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-18
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-18
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-18
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-18
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-18
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-18
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-18
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-18
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-18
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		5e-18
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		6e-18
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		6e-18
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		7e-18
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-18
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		7e-18
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		7e-18
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		7e-18
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		8e-18
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		8e-18
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		9e-18
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-17
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-07
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-17
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-08
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-17
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-17
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-17
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-07
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-17
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-17
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-17
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-07
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-17
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-07
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-17
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-07
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-17
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-07
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		7e-17
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-08
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-15
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-15
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-15
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-04
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-15
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		6e-06
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-15
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-15
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		6e-06
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-15
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-06
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-15
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-04
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		6e-15
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		6e-15
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-14
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-14
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		5e-04
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-14
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-04
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-14
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-04
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-14
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-04
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-14
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-04
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-14
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-14
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-14
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-04
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-14
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		6e-04
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-14
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		6e-04
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		5e-14
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-05
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		6e-14
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		6e-05
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		7e-14
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		9e-05
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-05
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-13
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-13
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-13
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-13
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-13
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-13
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-04
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-13
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		7e-04
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-13
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-04
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-13
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-13
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-13
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-13
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-13
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		5e-13
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		5e-13
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		6e-13
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		6e-13
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		7e-13
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-05
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		8e-13
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		8e-13
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		8e-13
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		9e-13
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-12
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-04
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-12
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-04
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		6e-06
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-12
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-04
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-12
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-12
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-04
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-12
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-12
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-12
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-04
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-12
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-05
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-12
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-04
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-12
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-12
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-04
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-12
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-04
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-12
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		5e-04
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-12
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-04
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-12
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-04
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-12
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-04
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-12
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		5e-04
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-12
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		5e-04
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-12
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-04
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-12
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		5e-04
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-12
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		5e-04
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-12
4ae6_A	343	Structure And Function Of The Human Sperm-specific		5e-04
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-12
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		5e-04
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-12
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-04
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-12
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		6e-04
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-12
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		5e-04
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-12
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-04
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-12
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-04
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-12
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		5e-04
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-12
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-04
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-12
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-12
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-04
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-12
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		6e-04
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-05
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-12
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		6e-04
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		4e-12
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-12
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		4e-12
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		4e-12
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		4e-12
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		4e-12
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		4e-12
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-05
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-05
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		4e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-12
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		4e-12
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		4e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-05
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		4e-12
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-12
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-04
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		4e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		4e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-05
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-12
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-04
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-12
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		4e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		5e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-05
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		5e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-05
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		5e-12
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		8e-04
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-12
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-04
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		5e-12
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		5e-12
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		5e-12
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-12
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-12
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		6e-12
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		6e-12
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		6e-12
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		6e-12
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		6e-12
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		6e-12
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-04
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		6e-12
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		6e-12
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		6e-12
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-04
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		7e-12
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		7e-12
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		7e-12
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		7e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		7e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-05
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		7e-12
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		7e-12
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		7e-12
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		7e-12
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-12
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		8e-12
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		8e-12
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		8e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		9e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		9e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		6e-04
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		9e-12
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		9e-12
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-04
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-11
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-04
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-11
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-04
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-11
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-04
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-11
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		5e-04
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-11
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-04
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-11
4ae9_A	343	Structure And Function Of The Human Sperm-specific		5e-04
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-11
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-04
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-11
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-04
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-11
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		6e-04
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-11
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-11
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-11
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-11
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-11
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-04
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-11
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		7e-06
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-11
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-11
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-11
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-11
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-11
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-11
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-11
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-11
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-11
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-11
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-11
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-11
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-11
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		6e-06
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-11
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		7e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		4e-11
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-11
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		8e-06
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-11
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		4e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-06
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-06
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-11
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-05
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		6e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-05
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-11
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-11
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		6e-11
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-11
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-11
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-11
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		7e-11
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		7e-11
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		7e-11
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		5e-06
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		7e-11
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		7e-11
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		7e-11
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		7e-11
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		7e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		7e-11
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		8e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		8e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-05
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		8e-11
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		8e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		9e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-07
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		9e-11
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-07
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		9e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-10
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-10
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		6e-07
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-10
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-10
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-06
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		8e-07
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		7e-07
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-07
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		8e-07
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-07
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-10
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-05
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		8e-07
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-07
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		8e-07
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		8e-07
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		8e-07
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-10
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		2e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		8e-07
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		8e-07
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		2e-10
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		2e-10
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-10
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		2e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		9e-07
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-10
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		2e-10
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		2e-10
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-10
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		2e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		8e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-10
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-10
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-10
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-10
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-10
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-10
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-10
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-10
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-10
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-10
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-10
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-10
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-10
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-06
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-10
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-10
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-05
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-10
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-10
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-10
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-10
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		4e-10
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		5e-10
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		7e-05
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		5e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		9e-07
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		5e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-06
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-10
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		6e-10
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		6e-10
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-10
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-10
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		6e-10
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-10
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		6e-10
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		6e-10
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		7e-10
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		7e-10
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		7e-10
4fie_A	423	Full-Length Human Pak4 Length = 423		7e-10
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		7e-10
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		7e-10
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		8e-10
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		8e-10
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		8e-10
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		9e-10
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		9e-10
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		9e-10
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		9e-10
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		9e-10
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		9e-10
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		9e-10
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		9e-10
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		9e-10
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		9e-10
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		9e-10
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		9e-10
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		9e-10
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-09
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-09
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-09
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-09
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-09
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-09
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-09
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-09
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-09
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-09
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-09
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-09
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-09
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-09
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-09
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-09
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-09
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-09
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-09
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-09
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-09
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-09
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-09
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-09
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-09
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-09
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-09
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-09
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-09
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-09
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-09
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-05
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-05
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-05
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-06
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-09
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-05
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-09
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-09
3soa_A	444	Full-Length Human Camkii Length = 444		3e-09
3soa_A	444	Full-Length Human Camkii Length = 444		2e-04
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-09
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		5e-04
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		7e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		6e-06
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-09
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		5e-04
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-09
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-09
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		4e-09
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-09
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-04
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-04
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-04
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-04
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-04
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-09
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-09
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		5e-09
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-09
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-09
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-04
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		5e-09
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-09
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		7e-04
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		5e-09
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-09
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		5e-09
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		5e-09
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-04
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		6e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		6e-09
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		6e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		6e-09
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		6e-09
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		7e-09
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		7e-09
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		7e-09
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		8e-09
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		8e-09
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		8e-09
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		8e-09
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		8e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		8e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-04
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		8e-09
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		8e-09
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		8e-09
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		8e-09
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		9e-09
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		9e-09
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		9e-09
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		9e-09
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		9e-09
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		9e-09
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-08
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-08
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-08
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-08
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-08
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-08
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-08
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-08
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-08
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-08
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-08
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-08
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-08
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-08
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-08
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-08
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-04
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-08
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-08
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-08
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-08
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-08
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-08
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-08
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		5e-04
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-08
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		9e-04
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-08
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-08
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-08
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-08
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-08
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-08
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-08
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-08
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		4e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		5e-08
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-08
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		5e-08
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-08
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		5e-08
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		6e-08
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-08
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		6e-08
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-08
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		6e-08
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-08
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		6e-08
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		7e-08
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		7e-08
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		7e-08
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		7e-08
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		7e-08
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		7e-08
4h58_A	275	Braf In Complex With Compound 3 Length = 275		7e-08
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		7e-08
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		8e-08
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		8e-08
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		8e-08
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		8e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		8e-08
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		8e-08
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		8e-08
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		8e-08
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		8e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		8e-08
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		8e-08
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		8e-08
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		9e-08
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		9e-08
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		9e-08
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-08
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		9e-08
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		1e-07
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-07
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-07
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-07
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-07
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-07
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-07
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-07
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-07
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-07
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-07
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-07
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-07
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-07
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-07
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-07
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-07
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-07
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-07
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-07
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-07
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-07
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-07
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-07
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-07
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		1e-07
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-07
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		2e-07
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-07
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		2e-07
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-07
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-07
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-07
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-07
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-07
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-07
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-07
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-07
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		3e-07
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-07
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		3e-07
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-07
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-07
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-07
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-07
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		3e-07
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-07
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-07
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-07
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		3e-07
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		3e-07
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-07
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-07
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-07
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-07
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-07
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-07
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-07
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-04
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-07
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-07
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-07
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-07
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-07
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-07
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-07
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-04
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-07
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-07
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-07
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		4e-07
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-07
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-07
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-07
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-07
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-07
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-04
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-07
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-07
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-07
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-07
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-07
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		4e-07
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-07
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-07
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-07
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		4e-07
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-07
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-07
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		4e-07
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-07
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-07
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		4e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-07
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-07
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-07
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-07
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		5e-07
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-07
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		5e-07
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-07
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		5e-07
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		5e-07
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		6e-07
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		8e-04
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		6e-07
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-07
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-07
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		7e-07
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		7e-07
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		7e-07
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		7e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		7e-07
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		7e-07
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		7e-07
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		8e-07
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		8e-07
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		9e-07
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		9e-07
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-06
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-06
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-06
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		1e-06
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-06
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-06
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-06
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-06
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-06
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-06
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-06
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-06
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-06
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-06
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-06
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-06
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-06
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-06
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-06
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-06
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-06
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		3e-06
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-06
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-06
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		4e-06
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-06
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-06
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-06
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-06
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-06
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-06
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-06
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		5e-06
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		5e-06
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		5e-06
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		5e-06
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-06
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-06
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-06
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		5e-06
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		5e-06
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		5e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		5e-06
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-06
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		6e-06
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		6e-06
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		6e-06
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		6e-06
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-06
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		8e-06
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		8e-06
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		8e-06
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		8e-06
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		9e-06
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		9e-06
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		9e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		9e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		9e-06
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		9e-06
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-04
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-05
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-05
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-05
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-05
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-05
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-05
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-05
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		9e-04
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-05
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-05
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-05
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-05
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-05
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-05
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-05
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-05
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-05
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-05
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-05
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		2e-05
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-05
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-05
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-05
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-05
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-05
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-05
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-05
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		2e-05
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-05
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-05
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-05
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-05
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-05
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-05
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-05
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-05
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-05
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-05
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-05
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-05
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-05
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-05
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-05
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		3e-05
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-05
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-05
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-05
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-05
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-05
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-05
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-05
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-05
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-05
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-05
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-05
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-05
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-05
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-05
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-05
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-05
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-05
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		5e-05
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		5e-05
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-05
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-05
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		6e-05
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		6e-05
4fl3_A	635	Structural And Biophysical Characterization Of The		6e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		6e-05
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		6e-05
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		6e-05
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		7e-05
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		7e-05
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		7e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		7e-05
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		7e-05
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		7e-05
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		7e-05
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		7e-05
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-05
4fl2_A	636	Structural And Biophysical Characterization Of The		7e-05
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		7e-05
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		7e-05
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		7e-05
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		7e-05
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		8e-05
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		8e-05
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		8e-05
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-05
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		8e-05
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		8e-05
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		8e-05
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		8e-05
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		8e-05
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		8e-05
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		9e-05

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  384 bits (986), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 195/337 (57%), Positives = 232/337 (68%), Gaps = 39/337 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 52  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 111
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 112 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 171
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 172 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 215
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 216 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 253
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 254 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 313
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWK 418
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK
Sbjct: 314 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWK 350

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  384 bits (986), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 195/337 (57%), Positives = 232/337 (68%), Gaps = 39/337 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 52  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 111
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 112 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 171
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 172 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 215
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 216 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 253
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 254 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 313
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWK 418
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK
Sbjct: 314 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWK 350

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  384 bits (986), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 195/338 (57%), Positives = 232/338 (68%), Gaps = 39/338 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 45  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 104
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 105 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 164
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 165 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 208
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 209 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 246
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 247 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 306
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 307 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 344

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  384 bits (986), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 195/338 (57%), Positives = 232/338 (68%), Gaps = 39/338 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 39  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 98
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 99  NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 158
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 159 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 202
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 203 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 240
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 241 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 300
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 301 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 338

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  384 bits (986), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 195/338 (57%), Positives = 232/338 (68%), Gaps = 39/338 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 47  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 107 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 166
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 167 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 210
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 211 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 248
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 249 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 308
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 309 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 346

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  384 bits (985), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 195/338 (57%), Positives = 232/338 (68%), Gaps = 39/338 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 42  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 101
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 102 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 161
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 162 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 205
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 206 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 243
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 244 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 303
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 304 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 341

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  384 bits (985), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 195/338 (57%), Positives = 232/338 (68%), Gaps = 39/338 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 100 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 159
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 160 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 203
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 204 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 242 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 302 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 339

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  384 bits (985), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 195/338 (57%), Positives = 232/338 (68%), Gaps = 39/338 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 100 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 159
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 160 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 203
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 204 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 242 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 302 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 339

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  384 bits (985), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 195/338 (57%), Positives = 232/338 (68%), Gaps = 39/338 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 45  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 104
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 105 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 164
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 165 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 208
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 209 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 246
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 247 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 306
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 307 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 344

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  384 bits (985), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 195/338 (57%), Positives = 232/338 (68%), Gaps = 39/338 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 100 NDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 159
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 160 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 203
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 204 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 242 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 302 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 339

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  384 bits (985), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 195/337 (57%), Positives = 232/337 (68%), Gaps = 39/337 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 51  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 110
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 111 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 170
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 171 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 214
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 215 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 252
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 253 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 312
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWK 418
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK
Sbjct: 313 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWK 349

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  384 bits (985), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 195/338 (57%), Positives = 232/338 (68%), Gaps = 39/338 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 42  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 101
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 102 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 161
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 162 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 205
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 206 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 243
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 244 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 303
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 304 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 341

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  384 bits (985), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 195/337 (57%), Positives = 232/337 (68%), Gaps = 39/337 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 63  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 122
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 123 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 182
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 183 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 226
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 227 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 264
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 265 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 324
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWK 418
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK
Sbjct: 325 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWK 361

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  384 bits (985), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 195/338 (57%), Positives = 232/338 (68%), Gaps = 39/338 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 42  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 101
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 102 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 161
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 162 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 205
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 206 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 243
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 244 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 303
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 304 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 341

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  384 bits (985), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 195/338 (57%), Positives = 232/338 (68%), Gaps = 39/338 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 46  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 105
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 106 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 165
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 166 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 209
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 210 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 247
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 248 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 307
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 308 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 345

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  383 bits (984), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 195/339 (57%), Positives = 232/339 (68%), Gaps = 39/339 (11%)
Query: 82  SSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD 141
            +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +
Sbjct: 39  CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 98
Query: 142 FKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           F +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AV
Sbjct: 99  FNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 202 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIA 261
           NEDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT               
Sbjct: 159 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT--------------- 203
Query: 262 VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLG 320
                 + I   G                     E++     +  TD I QL LI+ ++G
Sbjct: 204 ------VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVG 240
Query: 321 TPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAE 380
           TP AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA 
Sbjct: 241 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 300
Query: 381 QALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           QALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 301 QALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 339

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  383 bits (984), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 195/337 (57%), Positives = 232/337 (68%), Gaps = 39/337 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 59  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 118
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 119 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 178
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 179 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 222
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 223 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 260
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 261 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 320
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWK 418
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK
Sbjct: 321 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWK 357

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  383 bits (984), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 195/337 (57%), Positives = 232/337 (68%), Gaps = 39/337 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 60  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 119
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 120 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 179
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 180 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 223
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 224 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 261
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 262 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 321
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWK 418
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK
Sbjct: 322 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWK 358

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  383 bits (984), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 195/339 (57%), Positives = 232/339 (68%), Gaps = 39/339 (11%)
Query: 82  SSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD 141
            +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +
Sbjct: 35  CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 94
Query: 142 FKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           F +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AV
Sbjct: 95  FNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 154
Query: 202 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIA 261
           NEDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT               
Sbjct: 155 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT--------------- 199
Query: 262 VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLG 320
                 + I   G                     E++     +  TD I QL LI+ ++G
Sbjct: 200 ------VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVG 236
Query: 321 TPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAE 380
           TP AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA 
Sbjct: 237 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296
Query: 381 QALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           QALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 297 QALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 335

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  383 bits (983), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 195/338 (57%), Positives = 231/338 (68%), Gaps = 39/338 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 47  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 107 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 166
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T +EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 167 EDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 210
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 211 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 248
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 249 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 308
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 309 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 346

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  383 bits (983), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 195/339 (57%), Positives = 232/339 (68%), Gaps = 39/339 (11%)
Query: 82  SSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD 141
            +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +
Sbjct: 36  CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 95
Query: 142 FKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           F +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AV
Sbjct: 96  FNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 155
Query: 202 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIA 261
           NEDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT               
Sbjct: 156 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT--------------- 200
Query: 262 VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLG 320
                 + I   G                     E++     +  TD I QL LI+ ++G
Sbjct: 201 ------VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVG 237
Query: 321 TPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAE 380
           TP AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA 
Sbjct: 238 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 297
Query: 381 QALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           QALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 298 QALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 336

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  383 bits (983), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 195/338 (57%), Positives = 232/338 (68%), Gaps = 39/338 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 46  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 105
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 106 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 165
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 166 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 209
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 210 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 247
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 248 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 307
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 308 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 345

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  383 bits (983), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 194/337 (57%), Positives = 231/337 (68%), Gaps = 39/337 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           S+ D  SG+K+A+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF   T L +F
Sbjct: 69  SSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPATSLEEF 128
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 129 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 188
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYN T                
Sbjct: 189 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNMT---------------- 232
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I+QL  IM + GT
Sbjct: 233 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHINQLQQIMRLTGT 270
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           PPA  ++++ S  AR YINSLP + K++F  VF GANP A+            KRITA +
Sbjct: 271 PPASVISRMPSHEARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASE 330
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWK 418
           ALAHPY SQY DP+DEP S PYDQSFE   L +++WK
Sbjct: 331 ALAHPYFSQYHDPDDEPESEPYDQSFESRQLEIEEWK 367

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  383 bits (983), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 195/339 (57%), Positives = 232/339 (68%), Gaps = 39/339 (11%)
Query: 82  SSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD 141
            +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +
Sbjct: 36  CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 95
Query: 142 FKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           F +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AV
Sbjct: 96  FNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 155
Query: 202 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIA 261
           NEDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT               
Sbjct: 156 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT--------------- 200
Query: 262 VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLG 320
                 + I   G                     E++     +  TD I QL LI+ ++G
Sbjct: 201 ------VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVG 237
Query: 321 TPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAE 380
           TP AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA 
Sbjct: 238 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 297
Query: 381 QALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           QALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 298 QALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 336

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  383 bits (983), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 195/339 (57%), Positives = 232/339 (68%), Gaps = 39/339 (11%)
Query: 82  SSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD 141
            +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +
Sbjct: 37  CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 96
Query: 142 FKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           F +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AV
Sbjct: 97  FNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 156
Query: 202 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIA 261
           NEDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT               
Sbjct: 157 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT--------------- 201
Query: 262 VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLG 320
                 + I   G                     E++     +  TD I QL LI+ ++G
Sbjct: 202 ------VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVG 238
Query: 321 TPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAE 380
           TP AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA 
Sbjct: 239 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 298
Query: 381 QALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           QALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 299 QALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 337

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  382 bits (982), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 194/337 (57%), Positives = 232/337 (68%), Gaps = 39/337 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK+++PFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 52  AAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 111
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 112 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 171
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 172 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 215
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 216 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 253
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 254 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 313
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWK 418
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK
Sbjct: 314 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWK 350

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  382 bits (982), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 194/338 (57%), Positives = 232/338 (68%), Gaps = 39/338 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 100 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 159
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILD+GLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 160 EDCELKILDYGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 203
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 204 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 242 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 302 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 339

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  382 bits (982), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 194/338 (57%), Positives = 232/338 (68%), Gaps = 39/338 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 100 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 159
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 160 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 203
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 204 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 242 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + P+DQSFE  DL +D+WK 
Sbjct: 302 ALAHAYFAQYHDPDDEPVADPFDQSFESRDLLIDEWKS 339

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  382 bits (981), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 194/338 (57%), Positives = 231/338 (68%), Gaps = 39/338 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 63  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 122
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 123 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 182
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EM GYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 183 EDCELKILDFGLARHTDDEMXGYVATRWYRAPEIMLNWMHYNQT---------------- 226
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 227 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 264
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 265 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 324
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 325 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 362

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  382 bits (981), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 195/338 (57%), Positives = 231/338 (68%), Gaps = 39/338 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G +VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 40  AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 100 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 159
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 160 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 203
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 204 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 242 PGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 302 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 339

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  382 bits (981), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 195/338 (57%), Positives = 231/338 (68%), Gaps = 39/338 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G +VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 50  AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 109
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 110 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 169
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 170 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 213
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 214 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 251
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 252 PGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 311
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 312 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 349

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  382 bits (980), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 195/337 (57%), Positives = 231/337 (68%), Gaps = 39/337 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G +VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 60  AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 119
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 120 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 179
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 180 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 223
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 224 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 261
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 262 PGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 321
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWK 418
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK
Sbjct: 322 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWK 358

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  382 bits (980), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 195/337 (57%), Positives = 231/337 (68%), Gaps = 39/337 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G +VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 59  AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 118
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 119 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 178
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 179 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 222
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 223 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 260
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 261 PGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 320
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWK 418
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK
Sbjct: 321 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWK 357

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  381 bits (979), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 195/338 (57%), Positives = 231/338 (68%), Gaps = 39/338 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G +VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 46  AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 105
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 106 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 165
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 166 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 209
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 210 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 247
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 248 PGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 307
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 308 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 345

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  381 bits (979), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 195/339 (57%), Positives = 231/339 (68%), Gaps = 39/339 (11%)
Query: 82  SSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD 141
            +A D+ +G +VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +
Sbjct: 35  CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 94
Query: 142 FKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           F +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AV
Sbjct: 95  FNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 154
Query: 202 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIA 261
           NEDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT               
Sbjct: 155 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT--------------- 199
Query: 262 VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLG 320
                 + I   G                     E++     +  TD I QL LI+ ++G
Sbjct: 200 ------VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVG 236
Query: 321 TPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAE 380
           TP AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA 
Sbjct: 237 TPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296
Query: 381 QALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           QALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 297 QALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 335

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  381 bits (978), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 194/338 (57%), Positives = 231/338 (68%), Gaps = 39/338 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 100 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 159
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 160 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 203
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 204 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 242 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + P DQSFE  DL +D+WK 
Sbjct: 302 ALAHAYFAQYHDPDDEPVADPTDQSFESRDLLIDEWKS 339

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  381 bits (978), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 194/338 (57%), Positives = 231/338 (68%), Gaps = 39/338 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 100 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 159
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKIL FGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 160 EDCELKILGFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 203
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 204 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 242 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 302 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 339

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  381 bits (978), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 194/338 (57%), Positives = 231/338 (68%), Gaps = 39/338 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 100 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 159
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 160 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 203
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 204 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 242 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + P DQSFE  DL +D+WK 
Sbjct: 302 ALAHAYFAQYHDPDDEPVADPRDQSFESRDLLIDEWKS 339

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  381 bits (978), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 194/338 (57%), Positives = 231/338 (68%), Gaps = 39/338 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 100 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 159
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 160 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 203
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 204 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 242 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + P DQSFE  DL +D+WK 
Sbjct: 302 ALAHAYFAQYHDPDDEPVADPQDQSFESRDLLIDEWKS 339

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  380 bits (977), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 194/338 (57%), Positives = 230/338 (68%), Gaps = 39/338 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 47  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 107 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 166
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T +EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 167 EDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 210
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 211 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 248
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 249 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 308
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + PYDQS E  DL +D+WK 
Sbjct: 309 ALAHAYFAQYHDPDDEPVADPYDQSLESRDLLIDEWKS 346

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  380 bits (977), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 194/338 (57%), Positives = 231/338 (68%), Gaps = 39/338 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 100 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 159
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILD GLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 160 EDCELKILDAGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 203
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 204 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 242 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 302 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 339

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  380 bits (977), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 194/339 (57%), Positives = 231/339 (68%), Gaps = 39/339 (11%)
Query: 82  SSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD 141
            +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +
Sbjct: 39  CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 98
Query: 142 FKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           F +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AV
Sbjct: 99  FNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 202 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIA 261
           NEDCELKILDFGLAR T++EMTG VATRWYRAPEIMLNWMHYNQT               
Sbjct: 159 NEDCELKILDFGLARHTDDEMTGXVATRWYRAPEIMLNWMHYNQT--------------- 203
Query: 262 VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLG 320
                 + I   G                     E++     +  TD I QL LI+ ++G
Sbjct: 204 ------VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVG 240
Query: 321 TPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAE 380
           TP AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA 
Sbjct: 241 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 300
Query: 381 QALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           QALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 301 QALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 339

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  380 bits (976), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 194/338 (57%), Positives = 231/338 (68%), Gaps = 39/338 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 100 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 159
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILD GLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 160 EDCELKILDGGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 203
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 204 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 242 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 302 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 339

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  380 bits (976), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 194/338 (57%), Positives = 231/338 (68%), Gaps = 39/338 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 100 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 159
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILD GLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 160 EDCELKILDRGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 203
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 204 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 242 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 302 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 339

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  380 bits (976), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 194/338 (57%), Positives = 231/338 (68%), Gaps = 39/338 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 46  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 105
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 106 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 165
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           ED ELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 166 EDSELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 209
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 210 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 247
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 248 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 307
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 308 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 345

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  380 bits (975), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 194/338 (57%), Positives = 231/338 (68%), Gaps = 39/338 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 42  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 101
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 102 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 161
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           ED ELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 162 EDSELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 205
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 206 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 243
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 244 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 303
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 304 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 341

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  380 bits (975), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 194/338 (57%), Positives = 230/338 (68%), Gaps = 39/338 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 47  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 107 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 166
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T +EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 167 EDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 210
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 211 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 248
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 249 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 308
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + PYDQS E  DL +D+WK 
Sbjct: 309 ALAHAYFAQYHDPDDEPVADPYDQSSESRDLLIDEWKS 346

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  379 bits (974), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 194/338 (57%), Positives = 231/338 (68%), Gaps = 39/338 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 100 NDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 159
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           ED ELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 160 EDXELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 203
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 204 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 242 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 302 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 339

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  379 bits (974), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 194/338 (57%), Positives = 231/338 (68%), Gaps = 39/338 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 45  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 104
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 105 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 164
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           ED ELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 165 EDXELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 208
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 209 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 246
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 247 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 306
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 307 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 344

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  379 bits (974), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 194/338 (57%), Positives = 231/338 (68%), Gaps = 39/338 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 45  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 104
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 105 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 164
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           ED ELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 165 EDXELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 208
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 209 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 246
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 247 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 306
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 307 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 344

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  379 bits (974), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 194/337 (57%), Positives = 231/337 (68%), Gaps = 39/337 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 51  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 110
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 111 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 170
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           ED ELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 171 EDXELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 214
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 215 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 252
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 253 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 312
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWK 418
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK
Sbjct: 313 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWK 349

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  379 bits (973), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 194/339 (57%), Positives = 230/339 (67%), Gaps = 39/339 (11%)
Query: 82  SSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD 141
            +A D+ +G +VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +
Sbjct: 35  CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 94
Query: 142 FKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           F +VY+VTHLMGADLNNI++  KL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AV
Sbjct: 95  FNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 154
Query: 202 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIA 261
           NEDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQT               
Sbjct: 155 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT--------------- 199
Query: 262 VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLG 320
                 + I   G                     E++     +  TD I QL LI+ ++G
Sbjct: 200 ------VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVG 236
Query: 321 TPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAE 380
           TP AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA 
Sbjct: 237 TPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296
Query: 381 QALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           QALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 297 QALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 335

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  379 bits (973), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 194/338 (57%), Positives = 231/338 (68%), Gaps = 39/338 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 100 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 159
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EMTGYVATRWYRAPEIMLN MHYNQT                
Sbjct: 160 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNAMHYNQT---------------- 203
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 204 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 242 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 302 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 339

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  379 bits (972), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 193/338 (57%), Positives = 230/338 (68%), Gaps = 39/338 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G +VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 40  AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 100 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 159
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EM G+VATRWYRAPEIMLNWMHYNQT                
Sbjct: 160 EDCELKILDFGLARHTDDEMAGFVATRWYRAPEIMLNWMHYNQT---------------- 203
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 204 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 242 PGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 302 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 339

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  379 bits (972), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 193/338 (57%), Positives = 230/338 (68%), Gaps = 39/338 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G +VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 40  AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 100 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 159
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EM G+VATRWYRAPEIMLNWMHYNQT                
Sbjct: 160 EDCELKILDFGLARHTDDEMAGFVATRWYRAPEIMLNWMHYNQT---------------- 203
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 204 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 242 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 302 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 339

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  379 bits (972), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 193/339 (56%), Positives = 230/339 (67%), Gaps = 39/339 (11%)
Query: 82  SSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD 141
            +A D+ +G +VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +
Sbjct: 35  CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 94
Query: 142 FKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           F +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AV
Sbjct: 95  FNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 154
Query: 202 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIA 261
           NEDCELKILDFGLAR T++EM G+VATRWYRAPEIMLNWMHYNQT               
Sbjct: 155 NEDCELKILDFGLARHTDDEMAGFVATRWYRAPEIMLNWMHYNQT--------------- 199
Query: 262 VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLG 320
                 + I   G                     E++     +  TD I QL LI+ ++G
Sbjct: 200 ------VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVG 236
Query: 321 TPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAE 380
           TP AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA 
Sbjct: 237 TPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296
Query: 381 QALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           QALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 297 QALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 335

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  378 bits (971), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 194/338 (57%), Positives = 230/338 (68%), Gaps = 39/338 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G +VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 40  AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 100 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 159
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDF LAR T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 160 EDCELKILDFYLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 203
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 204 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 242 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK 
Sbjct: 302 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKS 339

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  377 bits (967), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 193/337 (57%), Positives = 229/337 (67%), Gaps = 39/337 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G +VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 60  AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 119
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 120 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 179
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR T++EM G VATRWYRAPEIMLNWMHYNQT                
Sbjct: 180 EDCELKILDFGLARHTDDEMXGXVATRWYRAPEIMLNWMHYNQT---------------- 223
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 224 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 261
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 262 PGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 321
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWK 418
           ALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK
Sbjct: 322 ALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWK 358

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  376 bits (966), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 192/338 (56%), Positives = 230/338 (68%), Gaps = 39/338 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +VY+VTHLMGADLNNI+++QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVN
Sbjct: 100 NDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 159
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           ED ELKILDFGL R T++EMTGYVATRWYRAPEIMLNWMHYNQT                
Sbjct: 160 EDSELKILDFGLCRHTDDEMTGYVATRWYRAPEIMLNWMHYNQT---------------- 203
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  TD I QL LI+ ++GT
Sbjct: 204 -----VDIWSVGCI-----------------MAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P AE + KISS+SAR YI SL  + K +F  VF GANP A+            KRITA Q
Sbjct: 242 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKG 419
           ALAH Y +QY DP+DEP + PYDQS E  DL +D+WK 
Sbjct: 302 ALAHAYFAQYHDPDDEPVADPYDQSLESRDLLIDEWKS 339

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  361 bits (926), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 186/336 (55%), Positives = 225/336 (66%), Gaps = 37/336 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           SA D+    KVA+KK++RPFQS +HA+RTYRELR+LKH+ HENVIGLLDVF   T + DF
Sbjct: 38  SAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDF 97
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
             VY+VT LMGADLNNI++ Q LSD+HVQFLVYQ+LRGLKYIHSAGIIHRDLKPSN+AVN
Sbjct: 98  SEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVN 157
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCEL+ILDFGLAR  + EMTGYVATRWYRAPEIMLNWMHYNQT       D+      +
Sbjct: 158 EDCELRILDFGLARQADEEMTGYVATRWYRAPEIMLNWMHYNQT------VDIWSVGCIM 211
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTP 322
            E  + K L  G         + Y                      I QL  IME++GTP
Sbjct: 212 AELLQGKALFPG---------SDY----------------------IDQLKRIMEVVGTP 240
Query: 323 PAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQA 382
             E +AKISS+ AR YI SLP + +KD   +F+GANP AI            +R++A +A
Sbjct: 241 SPEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEA 300
Query: 383 LAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWK 418
           LAH Y SQY DP DEP + PYD+S E  +  +++WK
Sbjct: 301 LAHAYFSQYHDPEDEPEAEPYDESVEAKERTLEEWK 336

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  358 bits (920), Expect = 2e-99,   Method: Compositional matrix adjust.
 Identities = 185/336 (55%), Positives = 225/336 (66%), Gaps = 37/336 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           SA D+    KVA+KK++RPFQS +HA+RTYRELR+LKH+ HENVIGLLDVF   T + DF
Sbjct: 46  SAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDF 105
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
             VY+VT LMGADLNNI+++Q LSD+HVQFLVYQ+LRGLKYIHSAGIIHRDLKPSN+AVN
Sbjct: 106 SEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVN 165
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           ED EL+ILDFGLAR  + EMTGYVATRWYRAPEIMLNWMHYNQT       D+      +
Sbjct: 166 EDSELRILDFGLARQADEEMTGYVATRWYRAPEIMLNWMHYNQT------VDIWSVGCIM 219
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTP 322
            E  + K L  G         + Y                      I QL  IME++GTP
Sbjct: 220 AELLQGKALFPG---------SDY----------------------IDQLKRIMEVVGTP 248
Query: 323 PAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQA 382
             E +AKISS+ AR YI SLP + +KD   +F+GANP AI            +R++A +A
Sbjct: 249 SPEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEA 308
Query: 383 LAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWK 418
           LAH Y SQY DP DEP + PYD+S E  +  +++WK
Sbjct: 309 LAHAYFSQYHDPEDEPEAEPYDESVEAKERTLEEWK 344

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  358 bits (918), Expect = 4e-99,   Method: Compositional matrix adjust.
 Identities = 185/336 (55%), Positives = 224/336 (66%), Gaps = 37/336 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           SA D+    KVA+KK++RPFQS +HA+RTYRELR+LKH+ HENVIGLLDVF   T + DF
Sbjct: 46  SAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDF 105
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
             VY+VT LMGADLNNI++ Q LSD+HVQFLVYQ+LRGLKYIHSAGIIHRDLKPSN+AVN
Sbjct: 106 SEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVN 165
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           ED EL+ILDFGLAR  + EMTGYVATRWYRAPEIMLNWMHYNQT       D+      +
Sbjct: 166 EDSELRILDFGLARQADEEMTGYVATRWYRAPEIMLNWMHYNQT------VDIWSVGCIM 219
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTP 322
            E  + K L  G         + Y                      I QL  IME++GTP
Sbjct: 220 AELLQGKALFPG---------SDY----------------------IDQLKRIMEVVGTP 248
Query: 323 PAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQA 382
             E +AKISS+ AR YI SLP + +KD   +F+GANP AI            +R++A +A
Sbjct: 249 SPEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEA 308
Query: 383 LAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWK 418
           LAH Y SQY DP DEP + PYD+S E  +  +++WK
Sbjct: 309 LAHAYFSQYHDPEDEPEAEPYDESVEAKERTLEEWK 344

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  318 bits (816), Expect = 3e-87,   Method: Compositional matrix adjust.
 Identities = 160/337 (47%), Positives = 206/337 (61%), Gaps = 39/337 (11%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           SA+D  +G KVAIKK+ RPFQS + AKR YRELR+LKHM HENVIGLLDVF  +  L DF
Sbjct: 43  SAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            + Y+V   MG DL  +++ +KL +D +QFLVYQ+L+GL+YIH+AGIIHRDLKP N+AVN
Sbjct: 103 TDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN 162
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR  ++EM G V TRWYRAPE++LNWM Y QT                
Sbjct: 163 EDCELKILDFGLARQADSEMXGXVVTRWYRAPEVILNWMRYTQT---------------- 206
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +  +D + QL  IM++ GT
Sbjct: 207 -----VDIWSVGCI-----------------MAEMITGKTLFKGSDHLDQLKEIMKVTGT 244
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           PPAEF+ ++ SD A+ Y+  LP L KKDF  +   A+P A+            +R+TA +
Sbjct: 245 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 304
Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWK 418
           ALAHPY     D  DEP    YD SF+D+D  +D+WK
Sbjct: 305 ALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWK 341

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  296 bits (759), Expect = 1e-80,   Method: Compositional matrix adjust.
 Identities = 157/338 (46%), Positives = 203/338 (60%), Gaps = 41/338 (12%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           SA+D  SG KVAIKK++RPFQS + AKR YREL +LKHM HENVIGLLDVF   + L +F
Sbjct: 42  SAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            + Y+V   M  DL  I+   K S++ +Q+LVYQ+L+GLKYIHSAG++HRDLKP N+AVN
Sbjct: 102 YDFYLVMPFMQTDLQKIMGL-KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN 160
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR  + EMTGYV TRWYRAPE++L+WMHYNQT                
Sbjct: 161 EDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQT---------------- 204
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +   D + QL  I+++ G 
Sbjct: 205 -----VDIWSVGCI-----------------MAEMLTGKTLFKGKDYLDQLTQILKVTGV 242
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P  EF+ K++  +A+ YI SLP   +KDF Q+F  A+PQA             KR+TA Q
Sbjct: 243 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQ 302
Query: 382 ALAHPYLSQYSDPNDEPTS-PPYDQSFEDMDLPVDQWK 418
           AL HP+   + DP +E  +  P+D S E   L VD+WK
Sbjct: 303 ALTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEWK 340

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  295 bits (756), Expect = 2e-80,   Method: Compositional matrix adjust.
 Identities = 156/338 (46%), Positives = 203/338 (60%), Gaps = 41/338 (12%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           SA+D  SG KVAIKK++RPFQS + AKR YREL +LKHM HENVIGLLDVF   + L +F
Sbjct: 60  SAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            + Y+V   M  DL  I+  +  S++ +Q+LVYQ+L+GLKYIHSAG++HRDLKP N+AVN
Sbjct: 120 YDFYLVMPFMQTDLQKIMGME-FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN 178
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           EDCELKILDFGLAR  + EMTGYV TRWYRAPE++L+WMHYNQT                
Sbjct: 179 EDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQT---------------- 222
Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIMEMLGT 321
                + I   G                     E++     +   D + QL  I+++ G 
Sbjct: 223 -----VDIWSVGCI-----------------MAEMLTGKTLFKGKDYLDQLTQILKVTGV 260
Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQ 381
           P  EF+ K++  +A+ YI SLP   +KDF Q+F  A+PQA             KR+TA Q
Sbjct: 261 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQ 320
Query: 382 ALAHPYLSQYSDPNDEPTS-PPYDQSFEDMDLPVDQWK 418
           AL HP+   + DP +E  +  P+D S E   L VD+WK
Sbjct: 321 ALTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEWK 358

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  235 bits (600), Expect = 3e-62,   Method: Compositional matrix adjust.
 Identities = 150/372 (40%), Positives = 209/372 (56%), Gaps = 52/372 (13%)
Query: 60  EICRG-VIDIGPTLSKESFDL-----IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYR 113
           E+ RG V D+GP  +  S+       +  SA D+V+ V+VAIKKI+ PF+   + +RT R
Sbjct: 32  EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLR 90
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL 173
           E+++L    HEN+IG+ D+  + T +   K+VY+VTHLMGADL  +L+TQ LS+DH+ + 
Sbjct: 91  EIKILLRFRHENIIGINDIIRAPT-IEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYF 149
Query: 174 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE------MTGYVA 227
           +YQILRGLKYIHSA ++HRDLKPSN+ +N   +LKI DFGLAR  + +      +T YVA
Sbjct: 150 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV 287
           TRWYRAPEIMLN   Y ++                     + I   G            +
Sbjct: 210 TRWYRAPEIMLNSKGYTKS---------------------IDIWSVGCI----------L 238
Query: 288 ATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTK 347
           A      P  +    HY    + QLN I+ +LG+P  E +  I +  AR Y+ SLP   K
Sbjct: 239 AEMLSNRP--IFPGKHY----LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNK 292
Query: 348 KDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTS-PPYDQS 406
             + ++F  A+ +A+            KRI  EQALAHPYL QY DP+DEP +  P+   
Sbjct: 293 VPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFD 352
Query: 407 FEDMDLPVDQWK 418
            E  DLP ++ K
Sbjct: 353 MELDDLPKEKLK 364

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  234 bits (596), Expect = 1e-61,   Method: Compositional matrix adjust.
 Identities = 136/348 (39%), Positives = 195/348 (56%), Gaps = 46/348 (13%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           + SSA   ++G +VAIKKI   F    +AKRT REL++LKH  H+N+I + D+       
Sbjct: 69  VVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPY 128
Query: 140 ADFKNVYMVTHLMGADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSN 198
            +FK+VY+V  LM +DL+ I+ + Q L+ +HV++ +YQ+LRGLKY+HSA +IHRDLKPSN
Sbjct: 129 GEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSN 188
Query: 199 IAVNEDCELKILDFGLAR-----PTENE--MTGYVATRWYRAPEIMLNWMHYNQTGVPFY 251
           + VNE+CELKI DFG+AR     P E++  MT YVATRWYRAPE+ML+   Y Q      
Sbjct: 189 LLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQA----- 243
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
                           + +   G        + G +  R    P          +  +HQ
Sbjct: 244 ----------------IDLWSVGC-------IFGEMLARRQLFP---------GKNYVHQ 271
Query: 312 LNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXX 371
           L LIM +LGTP    +  + ++  R YI SLP      +  V+ GA+ QA+         
Sbjct: 272 LQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRF 331
Query: 372 XXXKRITAEQALAHPYLSQYSDPNDEP-TSPPYDQSFEDMDLPVDQWK 418
               RI+A  AL HP+L++Y DP+DEP  +PP+D +F+   L  ++ K
Sbjct: 332 EPSARISAAAALRHPFLAKYHDPDDEPDCAPPFDFAFDREALTRERIK 379

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  233 bits (594), Expect = 1e-61,   Method: Compositional matrix adjust.
 Identities = 134/338 (39%), Positives = 191/338 (56%), Gaps = 46/338 (13%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           + SSA   ++G +VAIKKI   F    +AKRT REL++LKH  H+N+I + D+       
Sbjct: 70  VVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPY 129
Query: 140 ADFKNVYMVTHLMGADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSN 198
            +FK+VY+V  LM +DL+ I+ + Q L+ +HV++ +YQ+LRGLKY+HSA +IHRDLKPSN
Sbjct: 130 GEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSN 189
Query: 199 IAVNEDCELKILDFGLAR-----PTENE--MTGYVATRWYRAPEIMLNWMHYNQTGVPFY 251
           + VNE+CELKI DFG+AR     P E++  MT YVATRWYRAPE+ML+   Y Q      
Sbjct: 190 LLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQA----- 244
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
                           + +   G        + G +  R    P          +  +HQ
Sbjct: 245 ----------------IDLWSVGC-------IFGEMLARRQLFP---------GKNYVHQ 272
Query: 312 LNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXX 371
           L LIM +LGTP    +  + ++  R YI SLP      +  V+ GA+ QA+         
Sbjct: 273 LQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRF 332
Query: 372 XXXKRITAEQALAHPYLSQYSDPNDEP-TSPPYDQSFE 408
               RI+A  AL HP+L++Y DP+DEP  +PP+D +F+
Sbjct: 333 EPSARISAAAALRHPFLAKYHDPDDEPDCAPPFDFAFD 370

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  229 bits (584), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 147/372 (39%), Positives = 206/372 (55%), Gaps = 52/372 (13%)
Query: 60  EICRG-VIDIGPTLSKESFDL-----IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYR 113
           E+ RG V D+GP  +  S+       +  SA D+V+ V+VAIKKI+ PF+   + +RT R
Sbjct: 12  EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLR 70
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL 173
           E+++L    HEN+IG+ D+  + T +   K+VY+V  LM  DL  +L+TQ LS+DH+ + 
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 129
Query: 174 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE------MTGYVA 227
           +YQILRGLKYIHSA ++HRDLKPSN+ +N  C+LKI DFGLAR  + +      +T YVA
Sbjct: 130 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV 287
           TRWYRAPEIMLN   Y ++                     + I   G            +
Sbjct: 190 TRWYRAPEIMLNSKGYTKS---------------------IDIWSVGCI----------L 218
Query: 288 ATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTK 347
           A      P  +    HY    + QLN I+ +LG+P  E +  I +  AR Y+ SLP   K
Sbjct: 219 AEMLSNRP--IFPGKHY----LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNK 272
Query: 348 KDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTS-PPYDQS 406
             + ++F  A+ +A+            KRI  EQALAHPYL QY DP+DEP +  P+   
Sbjct: 273 VPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFD 332
Query: 407 FEDMDLPVDQWK 418
            E  DLP ++ K
Sbjct: 333 MELDDLPKEKLK 344

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  229 bits (584), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 147/372 (39%), Positives = 207/372 (55%), Gaps = 52/372 (13%)
Query: 60  EICRG-VIDIGPTLSKESFDL-----IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYR 113
           E+ RG V D+GP  +  S+       +  SA D+V+ V+VAIKKI+ PF+   + +RT R
Sbjct: 14  EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLR 72
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL 173
           E+++L    HEN+IG+ D+  + T +   K+VY+V  LM  DL  +L+TQ LS+DH+ + 
Sbjct: 73  EIKILLAFRHENIIGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 131
Query: 174 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE------MTGYVA 227
           +YQILRGLKYIHSA ++HRDLKPSN+ +N  C+LKI DFGLAR  + +      +T YVA
Sbjct: 132 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV 287
           TRWYRAPEIMLN   Y ++                     + I   G            +
Sbjct: 192 TRWYRAPEIMLNSKGYTKS---------------------IDIWSVGCI----------L 220
Query: 288 ATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTK 347
           A      P  +    HY    + QLN I+ +LG+P  E +  I +  AR Y+ SLP   K
Sbjct: 221 AEMLSNRP--IFPGKHY----LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNK 274
Query: 348 KDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTS-PPYDQS 406
             + ++F  A+ +A+            KRI  EQALAHPYL+QY DP+DEP +  P+   
Sbjct: 275 VPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDPSDEPIAEAPFKFD 334
Query: 407 FEDMDLPVDQWK 418
            E  DLP ++ K
Sbjct: 335 MELDDLPKEKLK 346

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  229 bits (584), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 147/372 (39%), Positives = 206/372 (55%), Gaps = 52/372 (13%)
Query: 60  EICRG-VIDIGPTLSKESFDL-----IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYR 113
           E+ RG V D+GP  +  S+       +  SA D+V+ V+VAIKKI+ PF+   + +RT R
Sbjct: 20  EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLR 78
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL 173
           E+++L    HEN+IG+ D+  + T +   K+VY+V  LM  DL  +L+TQ LS+DH+ + 
Sbjct: 79  EIKILLRFRHENIIGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 137
Query: 174 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE------MTGYVA 227
           +YQILRGLKYIHSA ++HRDLKPSN+ +N  C+LKI DFGLAR  + +      +T YVA
Sbjct: 138 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 197
Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV 287
           TRWYRAPEIMLN   Y ++                     + I   G            +
Sbjct: 198 TRWYRAPEIMLNSKGYTKS---------------------IDIWSVGCI----------L 226
Query: 288 ATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTK 347
           A      P  +    HY    + QLN I+ +LG+P  E +  I +  AR Y+ SLP   K
Sbjct: 227 AEMLSNRP--IFPGKHY----LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNK 280
Query: 348 KDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTS-PPYDQS 406
             + ++F  A+ +A+            KRI  EQALAHPYL QY DP+DEP +  P+   
Sbjct: 281 VPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFD 340
Query: 407 FEDMDLPVDQWK 418
            E  DLP ++ K
Sbjct: 341 MELDDLPKEKLK 352

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  229 bits (584), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 147/372 (39%), Positives = 206/372 (55%), Gaps = 52/372 (13%)
Query: 60  EICRG-VIDIGPTLSKESFDL-----IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYR 113
           E+ RG V D+GP  +  S+       +  SA D+V+ V+VAIKKI+ PF+   + +RT R
Sbjct: 12  EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLR 70
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL 173
           E+++L    HEN+IG+ D+  + T +   K+VY+V  LM  DL  +L+TQ LS+DH+ + 
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 129
Query: 174 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE------MTGYVA 227
           +YQILRGLKYIHSA ++HRDLKPSN+ +N  C+LKI DFGLAR  + +      +T YVA
Sbjct: 130 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV 287
           TRWYRAPEIMLN   Y ++                     + I   G            +
Sbjct: 190 TRWYRAPEIMLNSKGYTKS---------------------IDIWSVGCI----------L 218
Query: 288 ATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTK 347
           A      P  +    HY    + QLN I+ +LG+P  E +  I +  AR Y+ SLP   K
Sbjct: 219 AEMLSNRP--IFPGKHY----LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNK 272
Query: 348 KDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTS-PPYDQS 406
             + ++F  A+ +A+            KRI  EQALAHPYL QY DP+DEP +  P+   
Sbjct: 273 VPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFD 332
Query: 407 FEDMDLPVDQWK 418
            E  DLP ++ K
Sbjct: 333 MELDDLPKEKLK 344

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  229 bits (584), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 147/372 (39%), Positives = 206/372 (55%), Gaps = 52/372 (13%)
Query: 60  EICRG-VIDIGPTLSKESFDL-----IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYR 113
           E+ RG V D+GP  +  S+       +  SA D+V+ V+VAIKKI+ PF+   + +RT R
Sbjct: 14  EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLR 72
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL 173
           E+++L    HEN+IG+ D+  + T +   K+VY+V  LM  DL  +L+TQ LS+DH+ + 
Sbjct: 73  EIKILLRFRHENIIGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 131
Query: 174 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE------MTGYVA 227
           +YQILRGLKYIHSA ++HRDLKPSN+ +N  C+LKI DFGLAR  + +      +T YVA
Sbjct: 132 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV 287
           TRWYRAPEIMLN   Y ++                     + I   G            +
Sbjct: 192 TRWYRAPEIMLNSKGYTKS---------------------IDIWSVGCI----------L 220
Query: 288 ATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTK 347
           A      P  +    HY    + QLN I+ +LG+P  E +  I +  AR Y+ SLP   K
Sbjct: 221 AEMLSNRP--IFPGKHY----LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNK 274
Query: 348 KDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTS-PPYDQS 406
             + ++F  A+ +A+            KRI  EQALAHPYL QY DP+DEP +  P+   
Sbjct: 275 VPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFD 334
Query: 407 FEDMDLPVDQWK 418
            E  DLP ++ K
Sbjct: 335 MELDDLPKEKLK 346

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  229 bits (583), Expect = 3e-60,   Method: Compositional matrix adjust.
 Identities = 147/372 (39%), Positives = 206/372 (55%), Gaps = 52/372 (13%)
Query: 60  EICRG-VIDIGPTLSKESFDL-----IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYR 113
           E+ RG V D+GP  +  S+       +  SA D+V+ V+VAIKKI+ PF+   + +RT R
Sbjct: 32  EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLR 90
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL 173
           E+++L    HEN+IG+ D+  + T +   K+VY+V  LM  DL  +L+TQ LS+DH+ + 
Sbjct: 91  EIKILLRFRHENIIGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 149
Query: 174 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE------MTGYVA 227
           +YQILRGLKYIHSA ++HRDLKPSN+ +N  C+LKI DFGLAR  + +      +T YVA
Sbjct: 150 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV 287
           TRWYRAPEIMLN   Y ++                     + I   G            +
Sbjct: 210 TRWYRAPEIMLNSKGYTKS---------------------IDIWSVGCI----------L 238
Query: 288 ATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTK 347
           A      P  +    HY    + QLN I+ +LG+P  E +  I +  AR Y+ SLP   K
Sbjct: 239 AEMLSNRP--IFPGKHY----LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNK 292
Query: 348 KDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTS-PPYDQS 406
             + ++F  A+ +A+            KRI  EQALAHPYL QY DP+DEP +  P+   
Sbjct: 293 VPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFD 352
Query: 407 FEDMDLPVDQWK 418
            E  DLP ++ K
Sbjct: 353 MELDDLPKEKLK 364

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  228 bits (582), Expect = 4e-60,   Method: Compositional matrix adjust.
 Identities = 146/372 (39%), Positives = 208/372 (55%), Gaps = 52/372 (13%)
Query: 60  EICRGV-IDIGPTLSK-----ESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYR 113
           E+ +G   D+GP  ++     E    + SSA D V   +VAIKKI+ PF+   + +RT R
Sbjct: 32  EMVKGQPFDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKIS-PFEHQTYCQRTLR 90
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL 173
           E+++L    HENVIG+ D+  ++T L   ++VY+V  LM  DL  +L++Q+LS+DH+ + 
Sbjct: 91  EIQILLRFRHENVIGIRDILRAST-LEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYF 149
Query: 174 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT--ENEMTGY----VA 227
           +YQILRGLKYIHSA ++HRDLKPSN+ +N  C+LKI DFGLAR    E++ TG+    VA
Sbjct: 150 LYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVA 209
Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV 287
           TRWYRAPEIMLN   Y ++                     + I   G            +
Sbjct: 210 TRWYRAPEIMLNSKGYTKS---------------------IDIWSVGCI----------L 238
Query: 288 ATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTK 347
           A      P  +    HY    + QLN I+ +LG+P  E +  I +  AR Y+ SLP  TK
Sbjct: 239 AEMLSNRP--IFPGKHY----LDQLNHILGILGSPSQEDLNCIINMKARNYLQSLPSKTK 292
Query: 348 KDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTS-PPYDQS 406
             + ++F  ++ +A+            KRIT E+ALAHPYL QY DP DEP +  P+  +
Sbjct: 293 VAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYLEQYYDPTDEPVAEEPFTFA 352
Query: 407 FEDMDLPVDQWK 418
            E  DLP ++ K
Sbjct: 353 MELDDLPKERLK 364

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  228 bits (581), Expect = 5e-60,   Method: Compositional matrix adjust.
 Identities = 146/372 (39%), Positives = 206/372 (55%), Gaps = 52/372 (13%)
Query: 60  EICRG-VIDIGPTLSKESFDL-----IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYR 113
           E+ RG V D+GP  +  S+       +  SA D+++ V+VAIKKI+ PF+   + +RT R
Sbjct: 17  EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLR 75
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL 173
           E+++L    HEN+IG+ D+  + T +   K+VY+V  LM  DL  +L+TQ LS+DH+ + 
Sbjct: 76  EIKILLRFRHENIIGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 134
Query: 174 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE------MTGYVA 227
           +YQILRGLKYIHSA ++HRDLKPSN+ +N  C+LKI DFGLAR  + +      +T YVA
Sbjct: 135 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 194
Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV 287
           TRWYRAPEIMLN   Y ++                     + I   G            +
Sbjct: 195 TRWYRAPEIMLNSKGYTKS---------------------IDIWSVGCI----------L 223
Query: 288 ATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTK 347
           A      P  +    HY    + QLN I+ +LG+P  E +  I +  AR Y+ SLP   K
Sbjct: 224 AEMLSNRP--IFPGKHY----LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNK 277
Query: 348 KDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTS-PPYDQS 406
             + ++F  A+ +A+            KRI  EQALAHPYL QY DP+DEP +  P+   
Sbjct: 278 VPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFD 337
Query: 407 FEDMDLPVDQWK 418
            E  DLP ++ K
Sbjct: 338 MELDDLPKEKLK 349

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  228 bits (581), Expect = 5e-60,   Method: Compositional matrix adjust.
 Identities = 146/372 (39%), Positives = 206/372 (55%), Gaps = 52/372 (13%)
Query: 60  EICRG-VIDIGPTLSKESFDL-----IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYR 113
           E+ RG V D+GP  +  S+       +  SA D+++ V+VAIKKI+ PF+   + +RT R
Sbjct: 18  EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLR 76
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL 173
           E+++L    HEN+IG+ D+  + T +   K+VY+V  LM  DL  +L+TQ LS+DH+ + 
Sbjct: 77  EIKILLRFRHENIIGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 135
Query: 174 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE------MTGYVA 227
           +YQILRGLKYIHSA ++HRDLKPSN+ +N  C+LKI DFGLAR  + +      +T YVA
Sbjct: 136 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 195
Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV 287
           TRWYRAPEIMLN   Y ++                     + I   G            +
Sbjct: 196 TRWYRAPEIMLNSKGYTKS---------------------IDIWSVGCI----------L 224
Query: 288 ATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTK 347
           A      P  +    HY    + QLN I+ +LG+P  E +  I +  AR Y+ SLP   K
Sbjct: 225 AEMLSNRP--IFPGKHY----LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNK 278
Query: 348 KDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTS-PPYDQS 406
             + ++F  A+ +A+            KRI  EQALAHPYL QY DP+DEP +  P+   
Sbjct: 279 VPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFD 338
Query: 407 FEDMDLPVDQWK 418
            E  DLP ++ K
Sbjct: 339 MELDDLPKEKLK 350

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  228 bits (581), Expect = 5e-60,   Method: Compositional matrix adjust.
 Identities = 146/372 (39%), Positives = 206/372 (55%), Gaps = 52/372 (13%)
Query: 60  EICRG-VIDIGPTLSKESFDL-----IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYR 113
           E+ RG V D+GP  +  S+       +  SA D+++ V+VAIKKI+ PF+   + +RT R
Sbjct: 9   EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLR 67
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL 173
           E+++L    HEN+IG+ D+  + T +   K+VY+V  LM  DL  +L+TQ LS+DH+ + 
Sbjct: 68  EIKILLRFRHENIIGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 126
Query: 174 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE------MTGYVA 227
           +YQILRGLKYIHSA ++HRDLKPSN+ +N  C+LKI DFGLAR  + +      +T YVA
Sbjct: 127 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 186
Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV 287
           TRWYRAPEIMLN   Y ++                     + I   G            +
Sbjct: 187 TRWYRAPEIMLNSKGYTKS---------------------IDIWSVGCI----------L 215
Query: 288 ATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTK 347
           A      P  +    HY    + QLN I+ +LG+P  E +  I +  AR Y+ SLP   K
Sbjct: 216 AEMLSNRP--IFPGKHY----LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNK 269
Query: 348 KDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTS-PPYDQS 406
             + ++F  A+ +A+            KRI  EQALAHPYL QY DP+DEP +  P+   
Sbjct: 270 VPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFD 329
Query: 407 FEDMDLPVDQWK 418
            E  DLP ++ K
Sbjct: 330 MELDDLPKEKLK 341

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  228 bits (581), Expect = 5e-60,   Method: Compositional matrix adjust.
 Identities = 146/372 (39%), Positives = 206/372 (55%), Gaps = 52/372 (13%)
Query: 60  EICRG-VIDIGPTLSKESFDL-----IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYR 113
           E+ RG V D+GP  +  S+       +  SA D+++ V+VAIKKI+ PF+   + +RT R
Sbjct: 16  EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLR 74
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL 173
           E+++L    HEN+IG+ D+  + T +   K+VY+V  LM  DL  +L+TQ LS+DH+ + 
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 133
Query: 174 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE------MTGYVA 227
           +YQILRGLKYIHSA ++HRDLKPSN+ +N  C+LKI DFGLAR  + +      +T YVA
Sbjct: 134 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV 287
           TRWYRAPEIMLN   Y ++                     + I   G            +
Sbjct: 194 TRWYRAPEIMLNSKGYTKS---------------------IDIWSVGCI----------L 222
Query: 288 ATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTK 347
           A      P  +    HY    + QLN I+ +LG+P  E +  I +  AR Y+ SLP   K
Sbjct: 223 AEMLSNRP--IFPGKHY----LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNK 276
Query: 348 KDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTS-PPYDQS 406
             + ++F  A+ +A+            KRI  EQALAHPYL QY DP+DEP +  P+   
Sbjct: 277 VPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFD 336
Query: 407 FEDMDLPVDQWK 418
            E  DLP ++ K
Sbjct: 337 MELDDLPKEKLK 348

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  228 bits (581), Expect = 5e-60,   Method: Compositional matrix adjust.
 Identities = 146/372 (39%), Positives = 206/372 (55%), Gaps = 52/372 (13%)
Query: 60  EICRG-VIDIGPTLSKESFDL-----IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYR 113
           E+ RG V D+GP  +  S+       +  SA D+++ V+VAIKKI+ PF+   + +RT R
Sbjct: 10  EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLR 68
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL 173
           E+++L    HEN+IG+ D+  + T +   K+VY+V  LM  DL  +L+TQ LS+DH+ + 
Sbjct: 69  EIKILLRFRHENIIGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 127
Query: 174 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE------MTGYVA 227
           +YQILRGLKYIHSA ++HRDLKPSN+ +N  C+LKI DFGLAR  + +      +T YVA
Sbjct: 128 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV 287
           TRWYRAPEIMLN   Y ++                     + I   G            +
Sbjct: 188 TRWYRAPEIMLNSKGYTKS---------------------IDIWSVGCI----------L 216
Query: 288 ATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTK 347
           A      P  +    HY    + QLN I+ +LG+P  E +  I +  AR Y+ SLP   K
Sbjct: 217 AEMLSNRP--IFPGKHY----LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNK 270
Query: 348 KDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTS-PPYDQS 406
             + ++F  A+ +A+            KRI  EQALAHPYL QY DP+DEP +  P+   
Sbjct: 271 VPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFD 330
Query: 407 FEDMDLPVDQWK 418
            E  DLP ++ K
Sbjct: 331 MELDDLPKEKLK 342

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  228 bits (581), Expect = 5e-60,   Method: Compositional matrix adjust.
 Identities = 146/372 (39%), Positives = 206/372 (55%), Gaps = 52/372 (13%)
Query: 60  EICRG-VIDIGPTLSKESFDL-----IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYR 113
           E+ RG V D+GP  +  S+       +  SA D+++ V+VAIKKI+ PF+   + +RT R
Sbjct: 10  EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLR 68
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL 173
           E+++L    HEN+IG+ D+  + T +   K+VY+V  LM  DL  +L+TQ LS+DH+ + 
Sbjct: 69  EIKILLRFRHENIIGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 127
Query: 174 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE------MTGYVA 227
           +YQILRGLKYIHSA ++HRDLKPSN+ +N  C+LKI DFGLAR  + +      +T YVA
Sbjct: 128 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV 287
           TRWYRAPEIMLN   Y ++                     + I   G            +
Sbjct: 188 TRWYRAPEIMLNSKGYTKS---------------------IDIWSVGCI----------L 216
Query: 288 ATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTK 347
           A      P  +    HY    + QLN I+ +LG+P  E +  I +  AR Y+ SLP   K
Sbjct: 217 AEMLSNRP--IFPGKHY----LDQLNHILGILGSPEQEDLNCIINLKARNYLLSLPHKNK 270
Query: 348 KDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTS-PPYDQS 406
             + ++F  A+ +A+            KRI  EQALAHPYL QY DP+DEP +  P+   
Sbjct: 271 VPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFD 330
Query: 407 FEDMDLPVDQWK 418
            E  DLP ++ K
Sbjct: 331 MELDDLPKEKLK 342

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  227 bits (579), Expect = 9e-60,   Method: Compositional matrix adjust.
 Identities = 145/372 (38%), Positives = 206/372 (55%), Gaps = 52/372 (13%)
Query: 60  EICRG-VIDIGPTLSKESFDL-----IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYR 113
           E+ RG V D+GP  +  S+       +  SA D+++ V+VAI+KI+ PF+   + +RT R
Sbjct: 16  EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKIS-PFEHQTYCQRTLR 74
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL 173
           E+++L    HEN+IG+ D+  + T +   K+VY+V  LM  DL  +L+TQ LS+DH+ + 
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 133
Query: 174 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE------MTGYVA 227
           +YQILRGLKYIHSA ++HRDLKPSN+ +N  C+LKI DFGLAR  + +      +T YVA
Sbjct: 134 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV 287
           TRWYRAPEIMLN   Y ++                     + I   G            +
Sbjct: 194 TRWYRAPEIMLNSKGYTKS---------------------IDIWSVGCI----------L 222
Query: 288 ATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTK 347
           A      P  +    HY    + QLN I+ +LG+P  E +  I +  AR Y+ SLP   K
Sbjct: 223 AEMLSNRP--IFPGKHY----LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNK 276
Query: 348 KDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTS-PPYDQS 406
             + ++F  A+ +A+            KRI  EQALAHPYL QY DP+DEP +  P+   
Sbjct: 277 VPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFD 336
Query: 407 FEDMDLPVDQWK 418
            E  DLP ++ K
Sbjct: 337 MELDDLPKEKLK 348

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  226 bits (577), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 145/372 (38%), Positives = 205/372 (55%), Gaps = 52/372 (13%)
Query: 60  EICRG-VIDIGPTLSKESFDL-----IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYR 113
           E+ RG V D+GP  +  S+       +  SA D+++ V+VAIKKI+ PF+   + +RT R
Sbjct: 16  EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLR 74
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL 173
           E+++L    HEN+IG+ D+  + T +   K+VY+V  LM  DL  +L+ Q LS+DH+ + 
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYF 133
Query: 174 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE------MTGYVA 227
           +YQILRGLKYIHSA ++HRDLKPSN+ +N  C+LKI DFGLAR  + +      +T YVA
Sbjct: 134 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV 287
           TRWYRAPEIMLN   Y ++                     + I   G            +
Sbjct: 194 TRWYRAPEIMLNSKGYTKS---------------------IDIWSVGCI----------L 222
Query: 288 ATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTK 347
           A      P  +    HY    + QLN I+ +LG+P  E +  I +  AR Y+ SLP   K
Sbjct: 223 AEMLSNRP--IFPGKHY----LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNK 276
Query: 348 KDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTS-PPYDQS 406
             + ++F  A+ +A+            KRI  EQALAHPYL QY DP+DEP +  P+   
Sbjct: 277 VPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFD 336
Query: 407 FEDMDLPVDQWK 418
            E  DLP ++ K
Sbjct: 337 MELDDLPKEKLK 348

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  225 bits (574), Expect = 3e-59,   Method: Compositional matrix adjust.
 Identities = 146/372 (39%), Positives = 207/372 (55%), Gaps = 52/372 (13%)
Query: 60  EICRG-VIDIGPTLSKESFDL-----IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYR 113
           E+ RG V D+GP  +  S+       +  SA D+++ V+VAIKKI+ PF+   + +RT R
Sbjct: 16  EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLR 74
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL 173
           E+++L    HEN+IG+ D+  + T +   K+VY+V  LM  DL  +L+TQ LS+DH+ + 
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 133
Query: 174 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT--ENEMTGY----VA 227
           +YQILRGLKYIHSA ++HRDLKPSN+ +N  C+LKI DFGLAR    +++ TG+    VA
Sbjct: 134 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 193
Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV 287
           TRWYRAPEIMLN   Y ++                     + I   G            +
Sbjct: 194 TRWYRAPEIMLNSKGYTKS---------------------IDIWSVGCI----------L 222
Query: 288 ATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTK 347
           A      P  +    HY    + QLN I+ +LG+P  E +  I +  AR Y+ SLP   K
Sbjct: 223 AEMLSNRP--IFPGKHY----LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNK 276
Query: 348 KDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTS-PPYDQS 406
             + ++F  A+ +A+            KRI  EQALAHPYL QY DP+DEP +  P+   
Sbjct: 277 VPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFD 336
Query: 407 FEDMDLPVDQWK 418
            E  DLP ++ K
Sbjct: 337 MELDDLPKEKLK 348

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  225 bits (574), Expect = 3e-59,   Method: Compositional matrix adjust.
 Identities = 146/372 (39%), Positives = 207/372 (55%), Gaps = 52/372 (13%)
Query: 60  EICRG-VIDIGPTLSKESFDL-----IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYR 113
           E+ RG V D+GP  +  S+       +  SA D+++ V+VAIKKI+ PF+   + +RT R
Sbjct: 17  EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLR 75
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL 173
           E+++L    HEN+IG+ D+  + T +   K+VY+V  LM  DL  +L+TQ LS+DH+ + 
Sbjct: 76  EIKILLRFRHENIIGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 134
Query: 174 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT--ENEMTGY----VA 227
           +YQILRGLKYIHSA ++HRDLKPSN+ +N  C+LKI DFGLAR    +++ TG+    VA
Sbjct: 135 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 194
Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV 287
           TRWYRAPEIMLN   Y ++                     + I   G            +
Sbjct: 195 TRWYRAPEIMLNSKGYTKS---------------------IDIWSVGCI----------L 223
Query: 288 ATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTK 347
           A      P  +    HY    + QLN I+ +LG+P  E +  I +  AR Y+ SLP   K
Sbjct: 224 AEMLSNRP--IFPGKHY----LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNK 277
Query: 348 KDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTS-PPYDQS 406
             + ++F  A+ +A+            KRI  EQALAHPYL QY DP+DEP +  P+   
Sbjct: 278 VPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFD 337
Query: 407 FEDMDLPVDQWK 418
            E  DLP ++ K
Sbjct: 338 MELDDLPKEKLK 349

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  225 bits (573), Expect = 4e-59,   Method: Compositional matrix adjust.
 Identities = 146/372 (39%), Positives = 205/372 (55%), Gaps = 52/372 (13%)
Query: 60  EICRG-VIDIGPTLSKESFDL-----IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYR 113
           E+ RG V D+GP  +  S+       +  SA D+V+ V+VAIKKI+ PF+   + +RT R
Sbjct: 12  EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLR 70
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL 173
           E+++L    HEN+IG+ D+  + T +   K+VY+V  LM  DL  +L+TQ LS+DH+ + 
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 129
Query: 174 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE------MTGYVA 227
           +YQILRGLKYIHSA ++HRDLKPSN+ +N   +LKI DFGLAR  + +      +T YVA
Sbjct: 130 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV 287
           TRWYRAPEIMLN   Y ++                     + I   G            +
Sbjct: 190 TRWYRAPEIMLNSKGYTKS---------------------IDIWSVGCI----------L 218
Query: 288 ATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTK 347
           A      P  +    HY    + QLN I+ +LG+P  E +  I +  AR Y+ SLP   K
Sbjct: 219 AEMLSNRP--IFPGKHY----LDQLNHILGILGSPSQEDLNXIINLKARNYLLSLPHKNK 272
Query: 348 KDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTS-PPYDQS 406
             + ++F  A+ +A+            KRI  EQALAHPYL QY DP+DEP +  P+   
Sbjct: 273 VPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFD 332
Query: 407 FEDMDLPVDQWK 418
            E  DLP ++ K
Sbjct: 333 MELDDLPKEKLK 344

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  225 bits (573), Expect = 5e-59,   Method: Compositional matrix adjust.
 Identities = 146/372 (39%), Positives = 205/372 (55%), Gaps = 52/372 (13%)
Query: 60  EICRG-VIDIGPTLSKESFDL-----IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYR 113
           E+ RG V D+GP  +  S+       +  SA D+V+ V+VAIKKI+ PF+   + +RT R
Sbjct: 12  EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLR 70
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL 173
           E+++L    HEN+IG+ D+  + T +   K+VY+V  LM  DL  +L+TQ LS+DH+ + 
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 129
Query: 174 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE------MTGYVA 227
           +YQILRGLKYIHSA ++HRDLKPSN+ +N   +LKI DFGLAR  + +      +T YVA
Sbjct: 130 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVA 189
Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV 287
           TRWYRAPEIMLN   Y ++                     + I   G            +
Sbjct: 190 TRWYRAPEIMLNSKGYTKS---------------------IDIWSVGCI----------L 218
Query: 288 ATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTK 347
           A      P  +    HY    + QLN I+ +LG+P  E +  I +  AR Y+ SLP   K
Sbjct: 219 AEMLSNRP--IFPGKHY----LDQLNHILGILGSPSQEDLNXIINLKARNYLLSLPHKNK 272
Query: 348 KDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTS-PPYDQS 406
             + ++F  A+ +A+            KRI  EQALAHPYL QY DP+DEP +  P+   
Sbjct: 273 VPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFD 332
Query: 407 FEDMDLPVDQWK 418
            E  DLP ++ K
Sbjct: 333 MELDDLPKEKLK 344

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  224 bits (572), Expect = 5e-59,   Method: Compositional matrix adjust.
 Identities = 146/372 (39%), Positives = 205/372 (55%), Gaps = 52/372 (13%)
Query: 60  EICRG-VIDIGPTLSKESFDL-----IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYR 113
           E+ RG V D+GP  +  S+       +  SA D+V+ V+VAIKKI+ PF+   + +RT R
Sbjct: 12  EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLR 70
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL 173
           E+++L    HEN+IG+ D+  + T +   K+VY+V  LM  DL  +L+TQ LS+DH+ + 
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 129
Query: 174 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE------MTGYVA 227
           +YQILRGLKYIHSA ++HRDLKPSN+ +N   +LKI DFGLAR  + +      +T YVA
Sbjct: 130 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV 287
           TRWYRAPEIMLN   Y ++                     + I   G            +
Sbjct: 190 TRWYRAPEIMLNSKGYTKS---------------------IDIWSVGCI----------L 218
Query: 288 ATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTK 347
           A      P  +    HY    + QLN I+ +LG+P  E +  I +  AR Y+ SLP   K
Sbjct: 219 AEMLSNRP--IFPGKHY----LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNK 272
Query: 348 KDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTS-PPYDQS 406
             + ++F  A+ +A+            KRI  EQALAHPYL QY DP+DEP +  P+   
Sbjct: 273 VPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFD 332
Query: 407 FEDMDLPVDQWK 418
            E  DLP ++ K
Sbjct: 333 MELDDLPKEKLK 344

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  223 bits (569), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 145/372 (38%), Positives = 205/372 (55%), Gaps = 52/372 (13%)
Query: 60  EICRG-VIDIGPTLSKESFDL-----IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYR 113
           E+ RG V D+GP  +  S+       +  SA D+++ V+VAIKKI+ PF+   + +RT R
Sbjct: 16  EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLR 74
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL 173
           E+++L    HEN+IG+ D+  + T +   K+VY+V  LM  DL  +L+TQ LS+DH+ + 
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 133
Query: 174 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE------MTGYVA 227
           +YQILRGLKYIHSA ++HRDLKPSN+ +N   +LKI DFGLAR  + +      +T YVA
Sbjct: 134 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV 287
           TRWYRAPEIMLN   Y ++                     + I   G            +
Sbjct: 194 TRWYRAPEIMLNSKGYTKS---------------------IDIWSVGCI----------L 222
Query: 288 ATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTK 347
           A      P  +    HY    + QLN I+ +LG+P  E +  I +  AR Y+ SLP   K
Sbjct: 223 AEMLSNRP--IFPGKHY----LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNK 276
Query: 348 KDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTS-PPYDQS 406
             + ++F  A+ +A+            KRI  EQALAHPYL QY DP+DEP +  P+   
Sbjct: 277 VPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFD 336
Query: 407 FEDMDLPVDQWK 418
            E  DLP ++ K
Sbjct: 337 MELDDLPKEKLK 348

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  223 bits (567), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 145/372 (38%), Positives = 205/372 (55%), Gaps = 52/372 (13%)
Query: 60  EICRG-VIDIGPTLSKESFDL-----IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYR 113
           E+ RG V D+GP  +  S+       +  SA D+++ V+VAIKKI+ PF+   + +RT R
Sbjct: 16  EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYXQRTLR 74
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL 173
           E+++L    HEN+IG+ D+  + T +   K+VY+V  LM  DL  +L+TQ LS+DH+ + 
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 133
Query: 174 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE------MTGYVA 227
           +YQILRGLKYIHSA ++HRDLKPSN+ +N   +LKI DFGLAR  + +      +T YVA
Sbjct: 134 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV 287
           TRWYRAPEIMLN   Y ++                     + I   G            +
Sbjct: 194 TRWYRAPEIMLNSKGYTKS---------------------IDIWSVGCI----------L 222
Query: 288 ATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTK 347
           A      P  +    HY    + QLN I+ +LG+P  E +  I +  AR Y+ SLP   K
Sbjct: 223 AEMLSNRP--IFPGKHY----LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNK 276
Query: 348 KDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTS-PPYDQS 406
             + ++F  A+ +A+            KRI  EQALAHPYL QY DP+DEP +  P+   
Sbjct: 277 VPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFD 336
Query: 407 FEDMDLPVDQWK 418
            E  DLP ++ K
Sbjct: 337 MELDDLPKEKLK 348

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  222 bits (565), Expect = 3e-58,   Method: Compositional matrix adjust.
 Identities = 145/372 (38%), Positives = 205/372 (55%), Gaps = 52/372 (13%)
Query: 60  EICRG-VIDIGPTLSKESFDL-----IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYR 113
           E+ RG V D+GP  +  S+       +  SA D+V+ V+VAIKKI+ PF+   + +RT R
Sbjct: 14  EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLR 72
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL 173
           E+++L    HEN+IG+ D+  + T +   K+VY+V  LM  DL  +L+TQ LS+DH+ + 
Sbjct: 73  EIKILLAFRHENIIGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 131
Query: 174 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE------MTGYVA 227
           +YQILRGLKYIHSA ++HRDLKPSN+ +N   +LKI DFGLAR  + +      +T YVA
Sbjct: 132 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV 287
           TRWYRAPEIMLN   Y ++                     + I   G            +
Sbjct: 192 TRWYRAPEIMLNSKGYTKS---------------------IDIWSVGCI----------L 220
Query: 288 ATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTK 347
           A      P  +    HY    + QLN I+ +LG+P  E +    +  AR Y+ SLP   K
Sbjct: 221 AEMLSNRP--IFPGKHY----LDQLNHILGILGSPSQEDLNCGINLKARNYLLSLPHKNK 274
Query: 348 KDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTS-PPYDQS 406
             + ++F  A+ +A+            KRI  EQALAHPYL+QY DP+DEP +  P+   
Sbjct: 275 VPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDPSDEPIAEAPFKFD 334
Query: 407 FEDMDLPVDQWK 418
            E  DLP ++ K
Sbjct: 335 MELDDLPKEKLK 346

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  218 bits (556), Expect = 4e-57,   Method: Compositional matrix adjust.
 Identities = 131/346 (37%), Positives = 182/346 (52%), Gaps = 53/346 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +  SA    +G  VAIKKI  PF   + A RT RE+++LKH  HEN+I + ++   ++  
Sbjct: 26  VVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDS-F 83
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F  VY++  LM  DL+ ++ TQ LSDDH+Q+ +YQ LR +K +H + +IHRDLKPSN+
Sbjct: 84  ENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNL 143
Query: 200 AVNEDCELKILDFGLAR-----------PT--ENEMTGYVATRWYRAPEIMLNWMHYNQT 246
            +N +C+LK+ DFGLAR           PT  ++ MT YVATRWYRAPE+ML    Y++ 
Sbjct: 144 LINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRA 203
Query: 247 GVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQ 306
              +               C   + +  L RP           R YR             
Sbjct: 204 MDVW--------------SCGCILAELFLRRPI-------FPGRDYR------------- 229
Query: 307 TDIHQLNLIMEMLGTPPAEF-MAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXX 365
              HQL LI  ++GTP ++  +  I S  AR+YI SLP+       ++F   NP+ I   
Sbjct: 230 ---HQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLL 286
Query: 366 XXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTSPPYDQSFEDMD 411
                    KRITA++AL HPYL  Y DPNDEP   P   SF + D
Sbjct: 287 QRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEFD 332

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  218 bits (555), Expect = 5e-57,   Method: Compositional matrix adjust.
 Identities = 133/356 (37%), Positives = 189/356 (53%), Gaps = 58/356 (16%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I  +A D+V G+ VA+KK++RPFQ+  HAKR YREL +LK +NH+N+I LL+VF     L
Sbjct: 39  IVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTL 98
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F++VY+V  LM A+L  ++  + L  + + +L+YQ+L G+K++HSAGIIHRDLKPSNI
Sbjct: 99  EEFQDVYLVMELMDANLCQVIHME-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 157
Query: 200 AVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            V  DC LKILDFGLAR   T   MT YV TR+YRAPE+                     
Sbjct: 158 VVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEV--------------------- 196
Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIM 316
                       IL  G A   +    G +        E++   + +  TD I Q N ++
Sbjct: 197 ------------ILGMGYAANVDIWSVGCIMG------ELVKGCVIFQGTDHIDQWNKVI 238
Query: 317 EMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF------------KGANPQAIXX 364
           E LGTP AEFMA +   + R Y+ + P      F ++F            K    QA   
Sbjct: 239 EQLGTPSAEFMAALQP-TVRNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDL 297
Query: 365 XXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTSPP--YDQSFEDMDLPVDQWK 418
                     KRI+ ++AL HPY++ + DP +    PP  YD   E+ +  +++WK
Sbjct: 298 LSKMLVIDPDKRISVDEALRHPYITVWYDPAEAEAPPPQIYDAQLEEREHAIEEWK 353

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  217 bits (552), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 134/356 (37%), Positives = 192/356 (53%), Gaps = 58/356 (16%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I  +A D+V G+ VA+KK++RPFQ+  HAKR YREL +LK +NH+N+I LL+VF     L
Sbjct: 37  IVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTL 96
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F++VY+V  LM A+L  ++  + L  + + +L+YQ+L G+K++HSAGIIHRDLKPSNI
Sbjct: 97  EEFQDVYLVMELMDANLCQVIHME-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 155
Query: 200 AVNEDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L  M Y +            
Sbjct: 156 VVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEVILG-MGYKEN----------- 203
Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIM 316
                     + I   G        + G          E++   + +  TD I Q N ++
Sbjct: 204 ----------VDIWSVGC-------IMG----------ELVKGSVIFQGTDHIDQWNKVI 236
Query: 317 EMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF------------KGANPQAIXX 364
           E LGTP AEFMA +   + R Y+ + P      F ++F            K    QA   
Sbjct: 237 EQLGTPSAEFMAALQP-TVRNYVENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDL 295
Query: 365 XXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTSPP--YDQSFEDMDLPVDQWK 418
                     KRI+ ++AL HPY++ + DP +    PP  YD   E+ +  +++WK
Sbjct: 296 LSKMLVIDPDKRISVDEALRHPYITVWYDPAEAEAPPPQIYDAQLEEREHAIEEWK 351

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  215 bits (548), Expect = 4e-56,   Method: Compositional matrix adjust.
 Identities = 130/346 (37%), Positives = 181/346 (52%), Gaps = 53/346 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +  SA    +G  VAIKKI  PF   + A RT RE+++LKH  HEN+I + ++   ++  
Sbjct: 26  VVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDS-F 83
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F  VY++  LM  DL+ ++ TQ LSDDH+Q+ +YQ LR +K +H + +IHRDLKPSN+
Sbjct: 84  ENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNL 143
Query: 200 AVNEDCELKILDFGLAR-----------PT--ENEMTGYVATRWYRAPEIMLNWMHYNQT 246
            +N +C+LK+ DFGLAR           PT  ++ MT  VATRWYRAPE+ML    Y++ 
Sbjct: 144 LINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRA 203
Query: 247 GVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQ 306
              +               C   + +  L RP           R YR             
Sbjct: 204 MDVW--------------SCGCILAELFLRRPI-------FPGRDYR------------- 229
Query: 307 TDIHQLNLIMEMLGTPPAEF-MAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXX 365
              HQL LI  ++GTP ++  +  I S  AR+YI SLP+       ++F   NP+ I   
Sbjct: 230 ---HQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLL 286
Query: 366 XXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTSPPYDQSFEDMD 411
                    KRITA++AL HPYL  Y DPNDEP   P   SF + D
Sbjct: 287 QRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEFD 332

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  215 bits (547), Expect = 4e-56,   Method: Compositional matrix adjust.
 Identities = 129/346 (37%), Positives = 181/346 (52%), Gaps = 53/346 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +  SA    +G  VAIKKI  PF   + A RT RE+++LKH  HEN+I + ++   ++  
Sbjct: 26  VVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDS-F 83
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F  VY++  LM  DL+ ++ TQ LSDDH+Q+ +YQ LR +K +H + +IHRDLKPSN+
Sbjct: 84  ENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNL 143
Query: 200 AVNEDCELKILDFGLAR-----------PT--ENEMTGYVATRWYRAPEIMLNWMHYNQT 246
            +N +C+LK+ DFGLAR           PT  ++ M  +VATRWYRAPE+ML    Y++ 
Sbjct: 144 LINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRA 203
Query: 247 GVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQ 306
              +               C   + +  L RP           R YR             
Sbjct: 204 MDVW--------------SCGCILAELFLRRPI-------FPGRDYR------------- 229
Query: 307 TDIHQLNLIMEMLGTPPAEF-MAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXX 365
              HQL LI  ++GTP ++  +  I S  AR+YI SLP+       ++F   NP+ I   
Sbjct: 230 ---HQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLL 286
Query: 366 XXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTSPPYDQSFEDMD 411
                    KRITA++AL HPYL  Y DPNDEP   P   SF + D
Sbjct: 287 QRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEFD 332

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  208 bits (530), Expect = 4e-54,   Method: Compositional matrix adjust.
 Identities = 133/355 (37%), Positives = 190/355 (53%), Gaps = 56/355 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I  +A D++    VAIKK++RPFQ+  HAKR YREL ++K +NH+N+IGLL+VF     L
Sbjct: 44  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 103
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F++VY+V  LM A+L  +++ + L  + + +L+YQ+L G+K++HSAGIIHRDLKPSNI
Sbjct: 104 EEFQDVYIVMELMDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 162
Query: 200 AVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L  M Y +        DL  
Sbjct: 163 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKEN------VDLWS 215
Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIME 317
               + E    KIL  G               R Y                I Q N ++E
Sbjct: 216 VGCIMGEMVCHKILFPG---------------RDY----------------IDQWNKVIE 244
Query: 318 MLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF------------KGANPQAIXXX 365
            LGTP  EFM K+   + R Y+ + P      F ++F            K    QA    
Sbjct: 245 QLGTPCPEFMKKLQP-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL 303
Query: 366 XXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTSPPY--DQSFEDMDLPVDQWK 418
                    KRI+ ++AL HPY++ + DP++    PP   D+  ++ +  +++WK
Sbjct: 304 SKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWK 358

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  208 bits (529), Expect = 5e-54,   Method: Compositional matrix adjust.
 Identities = 133/355 (37%), Positives = 190/355 (53%), Gaps = 56/355 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I  +A D++    VAIKK++RPFQ+  HAKR YREL ++K +NH+N+IGLL+VF     L
Sbjct: 33  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 92
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F++VY+V  LM A+L  +++ + L  + + +L+YQ+L G+K++HSAGIIHRDLKPSNI
Sbjct: 93  EEFQDVYIVMELMDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 151
Query: 200 AVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L  M Y +        DL  
Sbjct: 152 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKEN------VDLWS 204
Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIME 317
               + E    KIL  G               R Y                I Q N ++E
Sbjct: 205 VGCIMGEMVCHKILFPG---------------RDY----------------IDQWNKVIE 233
Query: 318 MLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF------------KGANPQAIXXX 365
            LGTP  EFM K+   + R Y+ + P      F ++F            K    QA    
Sbjct: 234 QLGTPCPEFMKKLQP-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL 292
Query: 366 XXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTSPPY--DQSFEDMDLPVDQWK 418
                    KRI+ ++AL HPY++ + DP++    PP   D+  ++ +  +++WK
Sbjct: 293 SKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWK 347

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  208 bits (529), Expect = 5e-54,   Method: Compositional matrix adjust.
 Identities = 130/356 (36%), Positives = 193/356 (54%), Gaps = 58/356 (16%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I  +A D++    VAIKK++RPFQ+  HAKR YREL ++K +NH+N+IGLL+VF     L
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F++VY+V  LM A+L+ +++ + L  + + +L+YQ+L G+K++HSAGIIHRDLKPSNI
Sbjct: 99  EEFQDVYIVMELMDANLSQVIQME-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 157
Query: 200 AVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L  M Y +            
Sbjct: 158 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKEN----------- 205
Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIM 316
                     + I   G        + G          E++   + +  TD I Q N ++
Sbjct: 206 ----------VDIWSVGC-------IMG----------EMIKGGVLFPGTDHIDQWNKVI 238
Query: 317 EMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF------------KGANPQAIXX 364
           E LGTP  EFM K+   + R Y+ + P      F ++F            K    QA   
Sbjct: 239 EQLGTPSPEFMKKLQP-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDL 297
Query: 365 XXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTSPPY--DQSFEDMDLPVDQWK 418
                     KRI+ ++AL HPY++ + DP++    PP   D+  ++ +  +++WK
Sbjct: 298 LSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWK 353

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  207 bits (527), Expect = 9e-54,   Method: Compositional matrix adjust.
 Identities = 130/356 (36%), Positives = 192/356 (53%), Gaps = 58/356 (16%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I  +A D++    VAIKK++RPFQ+  HAKR YREL ++K +NH+N+IGLL+VF     L
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F++VY+V  LM A+L  +++ + L  + + +L+YQ+L G+K++HSAGIIHRDLKPSNI
Sbjct: 99  EEFQDVYIVMELMDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 157
Query: 200 AVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L  M Y +            
Sbjct: 158 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKEN----------- 205
Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIM 316
                     + I   G        + G          E++   + +  TD I Q N ++
Sbjct: 206 ----------VDIWSVGC-------IMG----------EMIKGGVLFPGTDHIDQWNKVI 238
Query: 317 EMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF------------KGANPQAIXX 364
           E LGTP  EFM K+   + R Y+ + P      F ++F            K    QA   
Sbjct: 239 EQLGTPSPEFMKKLQP-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDL 297
Query: 365 XXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTSPPY--DQSFEDMDLPVDQWK 418
                     KRI+ ++AL HPY++ + DP++    PP   D+  ++ +  +++WK
Sbjct: 298 LSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWK 353

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  207 bits (526), Expect = 1e-53,   Method: Compositional matrix adjust.
 Identities = 130/356 (36%), Positives = 192/356 (53%), Gaps = 58/356 (16%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I  +A D++    VAIKK++RPFQ+  HAKR YREL ++K +NH+N+IGLL+VF     L
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F++VY+V  LM A+L  +++ + L  + + +L+YQ+L G+K++HSAGIIHRDLKPSNI
Sbjct: 99  EEFQDVYIVMELMDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 157
Query: 200 AVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L  M Y +            
Sbjct: 158 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKEN----------- 205
Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIM 316
                     + I   G        + G          E++   + +  TD I Q N ++
Sbjct: 206 ----------VDIWSVGC-------IMG----------EMIKGGVLFPGTDHIDQWNKVI 238
Query: 317 EMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF------------KGANPQAIXX 364
           E LGTP  EFM K+   + R Y+ + P      F ++F            K    QA   
Sbjct: 239 EQLGTPCPEFMKKLQP-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDL 297
Query: 365 XXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTSPPY--DQSFEDMDLPVDQWK 418
                     KRI+ ++AL HPY++ + DP++    PP   D+  ++ +  +++WK
Sbjct: 298 LSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWK 353

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  207 bits (526), Expect = 1e-53,   Method: Compositional matrix adjust.
 Identities = 130/356 (36%), Positives = 192/356 (53%), Gaps = 58/356 (16%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I  +A D++    VAIKK++RPFQ+  HAKR YREL ++K +NH+N+IGLL+VF     L
Sbjct: 40  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 99
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F++VY+V  LM A+L  +++ + L  + + +L+YQ+L G+K++HSAGIIHRDLKPSNI
Sbjct: 100 EEFQDVYIVMELMDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 158
Query: 200 AVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L  M Y +            
Sbjct: 159 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKEN----------- 206
Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIM 316
                     + I   G        + G          E++   + +  TD I Q N ++
Sbjct: 207 ----------VDIWSVGC-------IMG----------EMIKGGVLFPGTDHIDQWNKVI 239
Query: 317 EMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF------------KGANPQAIXX 364
           E LGTP  EFM K+   + R Y+ + P      F ++F            K    QA   
Sbjct: 240 EQLGTPCPEFMKKLQP-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDL 298
Query: 365 XXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTSPPY--DQSFEDMDLPVDQWK 418
                     KRI+ ++AL HPY++ + DP++    PP   D+  ++ +  +++WK
Sbjct: 299 LSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWK 354

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  206 bits (524), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 133/355 (37%), Positives = 188/355 (52%), Gaps = 56/355 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I  +A D+V    VAIKK++RPFQ+  HAKR YREL ++K +NH+N+I LL+VF     L
Sbjct: 39  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 98
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F++VY+V  LM A+L  +++ + L  + + +L+YQ+L G+K++HSAGIIHRDLKPSNI
Sbjct: 99  EEFQDVYLVMELMDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 157
Query: 200 AVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L  M Y +        D+  
Sbjct: 158 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKEN------VDIWS 210
Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIME 317
               + E    KIL  G               R Y                I Q N ++E
Sbjct: 211 VGCIMGEMVRHKILFPG---------------RDY----------------IDQWNKVIE 239
Query: 318 MLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF------------KGANPQAIXXX 365
            LGTP  EFM K+   + R Y+ + P      F ++F            K    QA    
Sbjct: 240 QLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 298
Query: 366 XXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTSPP--YDQSFEDMDLPVDQWK 418
                    KRI+ + AL HPY++ + DP +    PP  YD+  ++ +  +++WK
Sbjct: 299 SKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWK 353

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  206 bits (524), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 133/355 (37%), Positives = 188/355 (52%), Gaps = 56/355 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I  +A D+V    VAIKK++RPFQ+  HAKR YREL ++K +NH+N+I LL+VF     L
Sbjct: 40  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 99
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F++VY+V  LM A+L  +++ + L  + + +L+YQ+L G+K++HSAGIIHRDLKPSNI
Sbjct: 100 EEFQDVYLVMELMDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 158
Query: 200 AVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L  M Y +        D+  
Sbjct: 159 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKEN------VDIWS 211
Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIME 317
               + E    KIL  G               R Y                I Q N ++E
Sbjct: 212 VGCIMGEMVRHKILFPG---------------RDY----------------IDQWNKVIE 240
Query: 318 MLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF------------KGANPQAIXXX 365
            LGTP  EFM K+   + R Y+ + P      F ++F            K    QA    
Sbjct: 241 QLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 299
Query: 366 XXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTSPP--YDQSFEDMDLPVDQWK 418
                    KRI+ + AL HPY++ + DP +    PP  YD+  ++ +  +++WK
Sbjct: 300 SKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWK 354

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  206 bits (524), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 133/355 (37%), Positives = 188/355 (52%), Gaps = 56/355 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I  +A D+V    VAIKK++RPFQ+  HAKR YREL ++K +NH+N+I LL+VF     L
Sbjct: 40  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 99
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F++VY+V  LM A+L  +++ + L  + + +L+YQ+L G+K++HSAGIIHRDLKPSNI
Sbjct: 100 EEFQDVYLVMELMDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 158
Query: 200 AVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L  M Y +        D+  
Sbjct: 159 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKEN------VDIWS 211
Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIME 317
               + E    KIL  G               R Y                I Q N ++E
Sbjct: 212 VGCIMGEMVRHKILFPG---------------RDY----------------IDQWNKVIE 240
Query: 318 MLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF------------KGANPQAIXXX 365
            LGTP  EFM K+   + R Y+ + P      F ++F            K    QA    
Sbjct: 241 QLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 299
Query: 366 XXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTSPP--YDQSFEDMDLPVDQWK 418
                    KRI+ + AL HPY++ + DP +    PP  YD+  ++ +  +++WK
Sbjct: 300 SKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWK 354

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  206 bits (523), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 133/355 (37%), Positives = 188/355 (52%), Gaps = 56/355 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I  +A D+V    VAIKK++RPFQ+  HAKR YREL ++K +NH+N+I LL+VF     L
Sbjct: 77  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 136
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F++VY+V  LM A+L  +++ + L  + + +L+YQ+L G+K++HSAGIIHRDLKPSNI
Sbjct: 137 EEFQDVYLVMELMDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 195
Query: 200 AVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L  M Y +        D+  
Sbjct: 196 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKEN------VDIWS 248
Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIME 317
               + E    KIL  G               R Y                I Q N ++E
Sbjct: 249 VGCIMGEMVRHKILFPG---------------RDY----------------IDQWNKVIE 277
Query: 318 MLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF------------KGANPQAIXXX 365
            LGTP  EFM K+   + R Y+ + P      F ++F            K    QA    
Sbjct: 278 QLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 336
Query: 366 XXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTSPP--YDQSFEDMDLPVDQWK 418
                    KRI+ + AL HPY++ + DP +    PP  YD+  ++ +  +++WK
Sbjct: 337 SKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWK 391

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  206 bits (523), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 133/355 (37%), Positives = 188/355 (52%), Gaps = 56/355 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I  +A D+V    VAIKK++RPFQ+  HAKR YREL ++K +NH+N+I LL+VF     L
Sbjct: 32  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 91
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F++VY+V  LM A+L  +++ + L  + + +L+YQ+L G+K++HSAGIIHRDLKPSNI
Sbjct: 92  EEFQDVYLVMELMDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 150
Query: 200 AVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L  M Y +        D+  
Sbjct: 151 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKEN------VDIWS 203
Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIME 317
               + E    KIL  G               R Y                I Q N ++E
Sbjct: 204 VGCIMGEMVRHKILFPG---------------RDY----------------IDQWNKVIE 232
Query: 318 MLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF------------KGANPQAIXXX 365
            LGTP  EFM K+   + R Y+ + P      F ++F            K    QA    
Sbjct: 233 QLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 291
Query: 366 XXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTSPP--YDQSFEDMDLPVDQWK 418
                    KRI+ + AL HPY++ + DP +    PP  YD+  ++ +  +++WK
Sbjct: 292 SKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWK 346

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  206 bits (523), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 133/355 (37%), Positives = 188/355 (52%), Gaps = 56/355 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I  +A D+V    VAIKK++RPFQ+  HAKR YREL ++K +NH+N+I LL+VF     L
Sbjct: 33  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 92
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F++VY+V  LM A+L  +++ + L  + + +L+YQ+L G+K++HSAGIIHRDLKPSNI
Sbjct: 93  EEFQDVYLVMELMDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 151
Query: 200 AVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L  M Y +        D+  
Sbjct: 152 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKEN------VDIWS 204
Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIME 317
               + E    KIL  G               R Y                I Q N ++E
Sbjct: 205 VGCIMGEMVRHKILFPG---------------RDY----------------IDQWNKVIE 233
Query: 318 MLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF------------KGANPQAIXXX 365
            LGTP  EFM K+   + R Y+ + P      F ++F            K    QA    
Sbjct: 234 QLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 292
Query: 366 XXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTSPP--YDQSFEDMDLPVDQWK 418
                    KRI+ + AL HPY++ + DP +    PP  YD+  ++ +  +++WK
Sbjct: 293 SKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWK 347

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  206 bits (523), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 133/355 (37%), Positives = 188/355 (52%), Gaps = 56/355 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I  +A D+V    VAIKK++RPFQ+  HAKR YREL ++K +NH+N+I LL+VF     L
Sbjct: 39  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 98
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F++VY+V  LM A+L  +++ + L  + + +L+YQ+L G+K++HSAGIIHRDLKPSNI
Sbjct: 99  EEFQDVYLVMELMDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 157
Query: 200 AVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L  M Y +        D+  
Sbjct: 158 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKEN------VDIWS 210
Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIME 317
               + E    KIL  G               R Y                I Q N ++E
Sbjct: 211 VGCIMGEMVRHKILFPG---------------RDY----------------IDQWNKVIE 239
Query: 318 MLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF------------KGANPQAIXXX 365
            LGTP  EFM K+   + R Y+ + P      F ++F            K    QA    
Sbjct: 240 QLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 298
Query: 366 XXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTSPP--YDQSFEDMDLPVDQWK 418
                    KRI+ + AL HPY++ + DP +    PP  YD+  ++ +  +++WK
Sbjct: 299 SKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWK 353

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  206 bits (523), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 133/355 (37%), Positives = 188/355 (52%), Gaps = 56/355 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I  +A D+V    VAIKK++RPFQ+  HAKR YREL ++K +NH+N+I LL+VF     L
Sbjct: 38  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 97
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F++VY+V  LM A+L  +++ + L  + + +L+YQ+L G+K++HSAGIIHRDLKPSNI
Sbjct: 98  EEFQDVYLVMELMDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 156
Query: 200 AVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L  M Y +        D+  
Sbjct: 157 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKEN------VDIWS 209
Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIME 317
               + E    KIL  G               R Y                I Q N ++E
Sbjct: 210 VGCIMGEMVRHKILFPG---------------RDY----------------IDQWNKVIE 238
Query: 318 MLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF------------KGANPQAIXXX 365
            LGTP  EFM K+   + R Y+ + P      F ++F            K    QA    
Sbjct: 239 QLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 297
Query: 366 XXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTSPP--YDQSFEDMDLPVDQWK 418
                    KRI+ + AL HPY++ + DP +    PP  YD+  ++ +  +++WK
Sbjct: 298 SKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWK 352

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  206 bits (523), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 133/355 (37%), Positives = 188/355 (52%), Gaps = 56/355 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I  +A D+V    VAIKK++RPFQ+  HAKR YREL ++K +NH+N+I LL+VF     L
Sbjct: 33  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 92
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F++VY+V  LM A+L  +++ + L  + + +L+YQ+L G+K++HSAGIIHRDLKPSNI
Sbjct: 93  EEFQDVYLVMELMDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 151
Query: 200 AVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L  M Y +        D+  
Sbjct: 152 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKEN------VDIWS 204
Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIME 317
               + E    KIL  G               R Y                I Q N ++E
Sbjct: 205 VGCIMGEMVRHKILFPG---------------RDY----------------IDQWNKVIE 233
Query: 318 MLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF------------KGANPQAIXXX 365
            LGTP  EFM K+   + R Y+ + P      F ++F            K    QA    
Sbjct: 234 QLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 292
Query: 366 XXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTSPP--YDQSFEDMDLPVDQWK 418
                    KRI+ + AL HPY++ + DP +    PP  YD+  ++ +  +++WK
Sbjct: 293 SKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWK 347

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  206 bits (523), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 133/355 (37%), Positives = 188/355 (52%), Gaps = 56/355 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I  +A D+V    VAIKK++RPFQ+  HAKR YREL ++K +NH+N+I LL+VF     L
Sbjct: 77  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 136
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F++VY+V  LM A+L  +++ + L  + + +L+YQ+L G+K++HSAGIIHRDLKPSNI
Sbjct: 137 EEFQDVYLVMELMDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 195
Query: 200 AVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            V  DC LKILDFGLAR   T   MT YV TR+YRAPE++L  M Y +        D+  
Sbjct: 196 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKEN------VDIWS 248
Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIME 317
               + E    KIL  G               R Y                I Q N ++E
Sbjct: 249 VGCIMGEMVRHKILFPG---------------RDY----------------IDQWNKVIE 277
Query: 318 MLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF------------KGANPQAIXXX 365
            LGTP  EFM K+   + R Y+ + P      F ++F            K    QA    
Sbjct: 278 QLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 336
Query: 366 XXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTSPP--YDQSFEDMDLPVDQWK 418
                    KRI+ + AL HPY++ + DP +    PP  YD+  ++ +  +++WK
Sbjct: 337 SKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWK 391

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  205 bits (522), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 127/355 (35%), Positives = 191/355 (53%), Gaps = 56/355 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I  +A D++    VAIKK++RPFQ+  HAKR YREL ++K +NH+N+IGLL+VF     L
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSL 98
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F++VY+V  LM A+L+ +++ + L  + + +L+YQ+L G+K++HSAGIIHRDLKPSNI
Sbjct: 99  EEFQDVYIVMELMDANLSQVIQME-LDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNI 157
Query: 200 AVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            V  D  LKILDFGLAR   T   MT YV TR+YRAPE++L  M Y +        D+  
Sbjct: 158 VVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKEN------VDIWS 210
Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIME 317
             + + E     ++  G+  P  +                           I Q N ++E
Sbjct: 211 VGVIMGE-----MIKGGVLFPGTDH--------------------------IDQWNKVIE 239
Query: 318 MLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF------------KGANPQAIXXX 365
            LGTP  EFM K+   + R Y+ + P      F ++F            K    QA    
Sbjct: 240 QLGTPSPEFMKKLQP-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL 298
Query: 366 XXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTSPPY--DQSFEDMDLPVDQWK 418
                    KRI+ ++AL HPY++ + DP++    PP   D+  ++ +  +++WK
Sbjct: 299 SKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWK 353

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  205 bits (521), Expect = 5e-53,   Method: Compositional matrix adjust.
 Identities = 127/355 (35%), Positives = 191/355 (53%), Gaps = 56/355 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I  +A D++    VAIKK++RPFQ+  HAKR YREL ++K +NH+N+IGLL+VF     L
Sbjct: 39  IVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSL 98
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F++VY+V  LM A+L+ +++ + L  + + +L+YQ+L G+K++HSAGIIHRDLKPSNI
Sbjct: 99  EEFQDVYIVMELMDANLSQVIQME-LDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNI 157
Query: 200 AVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            V  D  LKILDFGLAR   T   MT YV TR+YRAPE++L  M Y +        D+  
Sbjct: 158 VVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKEN------VDIWS 210
Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIME 317
             + + E     ++  G+  P  +                           I Q N ++E
Sbjct: 211 VGVIMGE-----MIKGGVLFPGTDH--------------------------IDQWNKVIE 239
Query: 318 MLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF------------KGANPQAIXXX 365
            LGTP  EFM K+   + R Y+ + P      F ++F            K    QA    
Sbjct: 240 QLGTPSPEFMKKLQP-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL 298
Query: 366 XXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTSPPY--DQSFEDMDLPVDQWK 418
                    KRI+ ++AL HPY++ + DP++    PP   D+  ++ +  +++WK
Sbjct: 299 SKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWK 353

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  204 bits (520), Expect = 7e-53,   Method: Compositional matrix adjust.
 Identities = 129/356 (36%), Positives = 192/356 (53%), Gaps = 58/356 (16%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I  +A D++    VAIKK++RPFQ+  HAKR YREL ++K +NH+N+IGLL+VF     L
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F++VY+V  LM A+L+ +++ + L  + + +L+YQ+L G+K++HSAGIIHRDLKPSNI
Sbjct: 99  EEFQDVYIVMELMDANLSQVIQME-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 157
Query: 200 AVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            V  D  LKILDFGLAR   T   MT YV TR+YRAPE++L  M Y +            
Sbjct: 158 VVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKEN----------- 205
Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIM 316
                     + I   G        + G          E++   + +  TD I Q N ++
Sbjct: 206 ----------VDIWSVGC-------IMG----------EMIKGGVLFPGTDHIDQWNKVI 238
Query: 317 EMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF------------KGANPQAIXX 364
           E LGTP  EFM K+   + R Y+ + P      F ++F            K    QA   
Sbjct: 239 EQLGTPSPEFMKKLQP-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDL 297
Query: 365 XXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTSPPY--DQSFEDMDLPVDQWK 418
                     KRI+ ++AL HPY++ + DP++    PP   D+  ++ +  +++WK
Sbjct: 298 LSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWK 353

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  204 bits (519), Expect = 7e-53,   Method: Compositional matrix adjust.
 Identities = 129/356 (36%), Positives = 192/356 (53%), Gaps = 58/356 (16%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I  +A D++    VAIKK++RPFQ+  HAKR YREL ++K +NH+N+IGLL+VF     L
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSL 98
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F++VY+V  LM A+L+ +++ + L  + + +L+YQ+L G+K++HSAGIIHRDLKPSNI
Sbjct: 99  EEFQDVYIVMELMDANLSQVIQME-LDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNI 157
Query: 200 AVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            V  D  LKILDFGLAR   T   MT YV TR+YRAPE++L  M Y +            
Sbjct: 158 VVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKEN----------- 205
Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIM 316
                     + I   G        + G          E++   + +  TD I Q N ++
Sbjct: 206 ----------VDIWSVGC-------IMG----------EMIKGGVLFPGTDHIDQWNKVI 238
Query: 317 EMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF------------KGANPQAIXX 364
           E LGTP  EFM K+   + R Y+ + P      F ++F            K    QA   
Sbjct: 239 EQLGTPSPEFMKKLQP-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDL 297
Query: 365 XXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTSPPY--DQSFEDMDLPVDQWK 418
                     KRI+ ++AL HPY++ + DP++    PP   D+  ++ +  +++WK
Sbjct: 298 LSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWK 353

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  204 bits (519), Expect = 7e-53,   Method: Compositional matrix adjust.
 Identities = 129/356 (36%), Positives = 192/356 (53%), Gaps = 58/356 (16%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I  +A D++    VAIKK++RPFQ+  HAKR YREL ++K +NH+N+IGLL+VF     L
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSL 98
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F++VY+V  LM A+L+ +++ + L  + + +L+YQ+L G+K++HSAGIIHRDLKPSNI
Sbjct: 99  EEFQDVYIVMELMDANLSQVIQME-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 157
Query: 200 AVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            V  D  LKILDFGLAR   T   MT YV TR+YRAPE++L  M Y +            
Sbjct: 158 VVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKEN----------- 205
Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIM 316
                     + I   G        + G          E++   + +  TD I Q N ++
Sbjct: 206 ----------VDIWSVGC-------IMG----------EMIKGGVLFPGTDHIDQWNKVI 238
Query: 317 EMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF------------KGANPQAIXX 364
           E LGTP  EFM K+   + R Y+ + P      F ++F            K    QA   
Sbjct: 239 EQLGTPSPEFMKKLQP-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDL 297
Query: 365 XXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTSPPY--DQSFEDMDLPVDQWK 418
                     KRI+ ++AL HPY++ + DP++    PP   D+  ++ +  +++WK
Sbjct: 298 LSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWK 353

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  204 bits (519), Expect = 9e-53,   Method: Compositional matrix adjust.
 Identities = 128/356 (35%), Positives = 191/356 (53%), Gaps = 58/356 (16%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I  +A D++    VAIKK++RPFQ+  HAKR YREL ++K +NH+N+IGLL+VF     L
Sbjct: 41  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 100
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F++VY+V  LM A+L  +++ + L  + + +L+YQ+L G+K++HSAGIIHRDLKPSNI
Sbjct: 101 EEFQDVYIVMELMDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 159
Query: 200 AVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            V  DC LKILDFGLAR   T   M  +V TR+YRAPE++L  M Y +            
Sbjct: 160 VVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILG-MGYKEN----------- 207
Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIM 316
                     + I   G        + G          E++   + +  TD I Q N ++
Sbjct: 208 ----------VDIWSVGC-------IMG----------EMIKGGVLFPGTDHIDQWNKVI 240
Query: 317 EMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF------------KGANPQAIXX 364
           E LGTP  EFM K+   + R Y+ + P      F ++F            K    QA   
Sbjct: 241 EQLGTPCPEFMKKLQP-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDL 299
Query: 365 XXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTSPPY--DQSFEDMDLPVDQWK 418
                     KRI+ ++AL HPY++ + DP++    PP   D+  ++ +  +++WK
Sbjct: 300 LSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWK 355

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  202 bits (515), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 132/355 (37%), Positives = 187/355 (52%), Gaps = 56/355 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I  +A D+V    VAIKK++RPFQ+  HAKR YREL ++K +NH+N+I LL+VF     L
Sbjct: 39  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTL 98
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F++VY+V  LM A+L  +++ + L  + + +L+YQ+L G+K++HSAGIIHRDLKPSNI
Sbjct: 99  EEFQDVYLVMELMDANLXQVIQME-LDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNI 157
Query: 200 AVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            V  D  LKILDFGLAR   T   MT YV TR+YRAPE++L  M Y +        D+  
Sbjct: 158 VVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKEN------VDIWS 210
Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIME 317
               + E    KIL  G               R Y                I Q N ++E
Sbjct: 211 VGCIMGEMVRHKILFPG---------------RDY----------------IDQWNKVIE 239
Query: 318 MLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF------------KGANPQAIXXX 365
            LGTP  EFM K+   + R Y+ + P      F ++F            K    QA    
Sbjct: 240 QLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 298
Query: 366 XXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTSPP--YDQSFEDMDLPVDQWK 418
                    KRI+ + AL HPY++ + DP +    PP  YD+  ++ +  +++WK
Sbjct: 299 SKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWK 353

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  202 bits (515), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 131/355 (36%), Positives = 188/355 (52%), Gaps = 56/355 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I  +A D++    VAIKK++RPFQ+  HAKR YREL ++K +NH+N+IGLL+VF     L
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F++VY+V  LM A+L  +++ + L  + + +L+YQ+L G+K++HSAGIIHRDLKPSNI
Sbjct: 99  EEFQDVYIVMELMDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 157
Query: 200 AVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            V  DC LKILDFGLAR   T   M   V TR+YRAPE++L  M Y +        DL  
Sbjct: 158 VVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILG-MGYKEN------VDLWS 210
Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIME 317
               + E    KIL  G               R Y                I Q N ++E
Sbjct: 211 VGCIMGEMVCHKILFPG---------------RDY----------------IDQWNKVIE 239
Query: 318 MLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF------------KGANPQAIXXX 365
            LGTP  EFM K+   + R Y+ + P      F ++F            K    QA    
Sbjct: 240 QLGTPCPEFMKKLQP-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL 298
Query: 366 XXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTSPPY--DQSFEDMDLPVDQWK 418
                    KRI+ ++AL HPY++ + DP++    PP   D+  ++ +  +++WK
Sbjct: 299 SKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWK 353

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  202 bits (514), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 128/356 (35%), Positives = 190/356 (53%), Gaps = 58/356 (16%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I  +A D++    VAIKK++RPFQ+  HAKR YREL ++K +NH+N+IGLL+VF     L
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F++VY+V  LM A+L  +++ + L  + + +L+YQ+L G+K++HSAGIIHRDLKPSNI
Sbjct: 99  EEFQDVYIVMELMDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 157
Query: 200 AVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            V  DC LKILDFGLAR   T   MT  V TR+YRAPE++L  M Y +            
Sbjct: 158 VVKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILG-MGYKEN----------- 205
Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD-IHQLNLIM 316
                     + I   G        + G          E++   + +  TD I Q N ++
Sbjct: 206 ----------VDIWSVGC-------IMG----------EMIKGGVLFPGTDHIDQWNKVI 238
Query: 317 EMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGA------------NPQAIXX 364
           E LGTP  EFM K+   + R Y+ + P      F ++F                 QA   
Sbjct: 239 EQLGTPCPEFMKKLQP-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNALKASQARDL 297
Query: 365 XXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTSPPY--DQSFEDMDLPVDQWK 418
                     KRI+ ++AL HPY++ + DP++    PP   D+  ++ +  +++WK
Sbjct: 298 LSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWK 353

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  202 bits (514), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 132/355 (37%), Positives = 187/355 (52%), Gaps = 56/355 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I  +A D+V    VAIKK++RPFQ+  HAKR YREL ++K +NH+N+I LL+VF     L
Sbjct: 39  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 98
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F++VY+V  LM A+L  +++ + L  + + +L+YQ+L G+K++HSAGIIHRDLKPSNI
Sbjct: 99  EEFQDVYLVMELMDANLXQVIQME-LDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNI 157
Query: 200 AVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            V  D  LKILDFGLAR   T   MT YV TR+YRAPE++L  M Y +        D+  
Sbjct: 158 VVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKEN------VDIWS 210
Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIME 317
               + E    KIL  G               R Y                I Q N ++E
Sbjct: 211 VGCIMGEMVRHKILFPG---------------RDY----------------IDQWNKVIE 239
Query: 318 MLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF------------KGANPQAIXXX 365
            LGTP  EFM K+   + R Y+ + P      F ++F            K    QA    
Sbjct: 240 QLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 298
Query: 366 XXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTSPP--YDQSFEDMDLPVDQWK 418
                    KRI+ + AL HPY++ + DP +    PP  YD+  ++ +  +++WK
Sbjct: 299 SKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWK 353

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  202 bits (513), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 132/355 (37%), Positives = 187/355 (52%), Gaps = 56/355 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I  +A D+V    VAIKK++RPFQ+  HAKR YREL ++K +NH+N+I LL+VF     L
Sbjct: 32  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 91
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F++VY+V  LM A+L  +++ + L  + + +L+YQ+L G+K++HSAGIIHRDLKPSNI
Sbjct: 92  EEFQDVYLVMELMDANLXQVIQME-LDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNI 150
Query: 200 AVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            V  D  LKILDFGLAR   T   MT YV TR+YRAPE++L  M Y +        D+  
Sbjct: 151 VVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKEN------VDIWS 203
Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIME 317
               + E    KIL  G               R Y                I Q N ++E
Sbjct: 204 VGCIMGEMVRHKILFPG---------------RDY----------------IDQWNKVIE 232
Query: 318 MLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF------------KGANPQAIXXX 365
            LGTP  EFM K+   + R Y+ + P      F ++F            K    QA    
Sbjct: 233 QLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 291
Query: 366 XXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTSPP--YDQSFEDMDLPVDQWK 418
                    KRI+ + AL HPY++ + DP +    PP  YD+  ++ +  +++WK
Sbjct: 292 SKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWK 346

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  199 bits (506), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 129/355 (36%), Positives = 187/355 (52%), Gaps = 56/355 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I  +A D++    VAIKK++RPFQ+  HAKR YREL ++K +NH+N+IGLL+VF     L
Sbjct: 39  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F++VY+V  LM A+L  +++ + L  + + +L+YQ+L G+K++HSAGIIHRDLKPSNI
Sbjct: 99  EEFQDVYIVMELMDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 157
Query: 200 AVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            V  DC LKILDFGLAR   T   M   V TR+YRAPE++L  M Y +        D+  
Sbjct: 158 VVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILG-MGYKEN------VDIWS 210
Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIME 317
               + E    KIL  G               R Y                I Q N ++E
Sbjct: 211 VGCIMGEMVCHKILFPG---------------RDY----------------IDQWNKVIE 239
Query: 318 MLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF------------KGANPQAIXXX 365
            LGTP   FM K+   + R Y+ + P      F ++F            K    QA    
Sbjct: 240 QLGTPCPAFMKKLQP-TVRNYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL 298
Query: 366 XXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTSPPY--DQSFEDMDLPVDQWK 418
                    KRI+ ++AL HPY++ + DP++    PP   D+  ++ +  +++WK
Sbjct: 299 SKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWK 353

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  189 bits (481), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 126/329 (38%), Positives = 173/329 (52%), Gaps = 54/329 (16%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I  +A D+V    VAIKK++RPFQ+  HAKR YREL ++K +NH+N+I LL+VF     L
Sbjct: 39  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTL 98
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F++VY+V  LM A+L  +++ + L  + + +L+YQ+L G+K++HSAGIIHRDLKPSNI
Sbjct: 99  EEFQDVYLVMELMDANLXQVIQME-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 157
Query: 200 AVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            V  D  LKILDFGLAR   T   MT YV TR+YRAPE++L  M Y +        D+  
Sbjct: 158 VVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKEN------VDIWS 210
Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIME 317
               + E    KIL  G               R Y                I Q N ++E
Sbjct: 211 VGCIMGEMVRHKILFPG---------------RDY----------------IDQWNKVIE 239
Query: 318 MLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF------------KGANPQAIXXX 365
            LGTP  EFM K+   + R Y+ + P      F ++F            K    QA    
Sbjct: 240 QLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 298
Query: 366 XXXXXXXXXKRITAEQALAHPYLSQYSDP 394
                    KRI+ + AL HPY++ + DP
Sbjct: 299 SKMLVIDPAKRISVDDALQHPYINVWYDP 327

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  185 bits (470), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 124/324 (38%), Positives = 170/324 (52%), Gaps = 54/324 (16%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I  +A D+V    VAIKK++RPFQ+  HAKR YREL ++K +NH+N+I LL+VF     L
Sbjct: 39  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTL 98
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F++VY+V  LM A+L  +++ + L  + + +L+YQ+L G+K++HSAGIIHRDLKPSNI
Sbjct: 99  EEFQDVYLVMELMDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 157
Query: 200 AVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            V  D  LKILDFGLAR   T   MT YV TR+YRAPE++L  M Y +        D+  
Sbjct: 158 VVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKEN------VDIWS 210
Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIME 317
               + E    KIL  G               R Y                I Q N ++E
Sbjct: 211 VGCIMGEMVRHKILFPG---------------RDY----------------IDQWNKVIE 239
Query: 318 MLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF------------KGANPQAIXXX 365
            LGTP  EFM K+   + R Y+ + P      F ++F            K    QA    
Sbjct: 240 QLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 298
Query: 366 XXXXXXXXXKRITAEQALAHPYLS 389
                    KRI+ + AL HPY++
Sbjct: 299 SKMLVIDPAKRISVDDALQHPYIN 322

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  159 bits (402), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 109/374 (29%), Positives = 174/374 (46%), Gaps = 58/374 (15%)
Query: 82  SSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD 141
             A D +    VAIKKI R F+  +  KR  RE+ +L  +NH++V+ +LD+      +  
Sbjct: 70  CEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKD-VEK 128
Query: 142 FKNVYMVTHLMGADLNNILRTQ-KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
           F  +Y+V  +  +D   + RT   L++ H++ L+Y +L G+KY+HSAGI+HRDLKP+N  
Sbjct: 129 FDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCL 188
Query: 201 VNEDCELKILDFGLAR---------------PTENEM---------------TGYVATRW 230
           VN+DC +K+ DFGLAR               P E++M               TG+V TRW
Sbjct: 189 VNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRW 248
Query: 231 YRAPEIMLNWMHYNQT------GVPFY-FQDLKPSNIAVNEDCELKILDFGLARPTENEM 283
           YRAPE++L   +Y +       G  F    ++   N+A + D             + ++ 
Sbjct: 249 YRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQK 308
Query: 284 TGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLP 343
            G              ++  + + +  QLN+I  +LGTP  E +  +  + A++YI   P
Sbjct: 309 AGN-------------DFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFP 355
Query: 344 LLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTSPPY 403
                D  + F  ++  AI            KRIT  + LAHP+  +      E  +   
Sbjct: 356 KREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNAT-- 413
Query: 404 DQSFEDMDLPVDQW 417
               E + LP + W
Sbjct: 414 ----EKVRLPFNDW 423

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 108/368 (29%), Positives = 171/368 (46%), Gaps = 55/368 (14%)
Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
           A D  +   VAIKK+ R F+  +  KR  RE+ +L  +  + +I L D+      L  F 
Sbjct: 47  AYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLHDLIIPEDLLK-FD 105
Query: 144 NVYMVTHLMGADLNNILRTQK-LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +Y+V  +  +DL  + +T   L++ HV+ ++Y +L G K+IH +GIIHRDLKP+N  +N
Sbjct: 106 ELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKFIHESGIIHRDLKPANCLLN 165
Query: 203 EDCELKILDFGLARPT----------------------------ENEMTGYVATRWYRAP 234
           +DC +KI DFGLAR                              + ++T +V TRWYRAP
Sbjct: 166 QDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAP 225
Query: 235 EIMLNWMHYNQT----GVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATR 290
           E++L   +Y  +         F +L            L ++   +  PT N    +  + 
Sbjct: 226 ELILLQENYTNSIDIWSTGCIFAEL------------LNMMKSHINNPT-NRFPLFPGSS 272
Query: 291 WY-RAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKD 349
            +  +P+     +H  +++  QLN+I  ++GTPP E +  I+     KYI   P     D
Sbjct: 273 CFPLSPDHNSKKVH-EKSNRDQLNIIFNVIGTPPEEDLKCITKQEVIKYIKLFPTRDGID 331
Query: 350 FRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTSPPYDQSFED 409
             + +   + + I            KRIT ++AL+HPYL      N E      + S E 
Sbjct: 332 LSKKYSSISKEGIDLLESMLRFNAQKRITIDKALSHPYLKDVRKENLE------NFSTEK 385
Query: 410 MDLPVDQW 417
           + LP D W
Sbjct: 386 IILPFDDW 393

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 109/369 (29%), Positives = 181/369 (49%), Gaps = 83/369 (22%)
Query: 72  LSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN-HENVIGLL 130
           L K ++ +++ S +D  +G  VA+KKI   FQ++  A+RT+RE+ +L  ++ HEN++ LL
Sbjct: 17  LGKGAYGIVWKS-IDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLL 75
Query: 131 DVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGII 190
           +V  ++    + ++VY+V   M  DL+ ++R   L   H Q++VYQ+++ +KY+HS G++
Sbjct: 76  NVLRAD----NDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLL 131
Query: 191 HRDLKPSNIAVNEDCELKILDFGLARP------------------TEN------EMTGYV 226
           HRD+KPSNI +N +C +K+ DFGL+R                   TEN       +T YV
Sbjct: 132 HRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYV 191
Query: 227 ATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGY 286
           ATRWYRAPEI+L    Y + G+  +           +  C L  +  G  +P        
Sbjct: 192 ATRWYRAPEILLGSTKYTK-GIDMW-----------SLGCILGEILCG--KP-------- 229
Query: 287 VATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLP--- 343
                          +    + ++QL  I+ ++  P  E +  I S  A+  I SL    
Sbjct: 230 ---------------IFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKV 274
Query: 344 LLTKKDFRQVF-------------KGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQ 390
            + + + R +F                N +A+            KRI+A  AL HP++S 
Sbjct: 275 EIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSI 334
Query: 391 YSDPNDEPT 399
           + +PN+EP 
Sbjct: 335 FHNPNEEPN 343

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  149 bits (375), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 105/328 (32%), Positives = 156/328 (47%), Gaps = 53/328 (16%)
Query: 83  SALDSVSGVKVAIKKI---------ARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVF 133
           + +DS  G+ VAIK++               +   KR  RE+R+L H +H N++GL D+F
Sbjct: 40  AGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98
Query: 134 HSNTCLADFKNVYMVTHLMGADLNNILRTQKL--SDDHVQFLVYQILRGLKYIHSAGIIH 191
                 A  K +Y+VT LM  DL  ++  Q++  S  H+Q+ +Y IL GL  +H AG++H
Sbjct: 99  VHFEEPAMHK-LYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVH 157
Query: 192 RDLKPSNIAVNEDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVP 249
           RDL P NI + ++ ++ I DF LAR    +   T YV  RWYRAPE+++ +  +      
Sbjct: 158 RDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFT----- 212
Query: 250 FYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDI 309
                              K++D   A        G V    +    +      YN    
Sbjct: 213 -------------------KLVDMWSA--------GCVMAEMFNRKALFRGSTFYN---- 241
Query: 310 HQLNLIMEMLGTPPAEFMAKISSDSARKYI-NSLPLLTKKDFRQVFKGANPQAIXXXXXX 368
            QLN I+E++GTP  E +   SS SAR Y+ NSL  +  + +  V   A+P A+      
Sbjct: 242 -QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKM 300
Query: 369 XXXXXXKRITAEQALAHPYLSQYSDPND 396
                 +RI+ EQAL HPY     DP D
Sbjct: 301 LEFNPQRRISTEQALRHPYFESLFDPLD 328

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  148 bits (374), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 105/329 (31%), Positives = 156/329 (47%), Gaps = 53/329 (16%)
Query: 82  SSALDSVSGVKVAIKKI---------ARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDV 132
            + +DS  G+ VAIK++               +   KR  RE+R+L H +H N++GL D+
Sbjct: 39  CAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97
Query: 133 FHSNTCLADFKNVYMVTHLMGADLNNILRTQKL--SDDHVQFLVYQILRGLKYIHSAGII 190
           F      A  K +Y+VT LM  DL  ++  Q++  S  H+Q+ +Y IL GL  +H AG++
Sbjct: 98  FVHFEEPAMHK-LYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVV 156
Query: 191 HRDLKPSNIAVNEDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIMLNWMHYNQTGV 248
           HRDL P NI + ++ ++ I DF LAR    +   T YV  RWYRAPE+++ +  +     
Sbjct: 157 HRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFT---- 212
Query: 249 PFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD 308
                               K++D   A        G V    +    +      YN   
Sbjct: 213 --------------------KLVDMWSA--------GCVMAEMFNRKALFRGSTFYN--- 241
Query: 309 IHQLNLIMEMLGTPPAEFMAKISSDSARKYI-NSLPLLTKKDFRQVFKGANPQAIXXXXX 367
             QLN I+E++GTP  E +   SS SAR Y+ NSL  +  + +  V   A+P A+     
Sbjct: 242 --QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAK 299
Query: 368 XXXXXXXKRITAEQALAHPYLSQYSDPND 396
                  +RI+ EQAL HPY     DP D
Sbjct: 300 MLEFNPQRRISTEQALRHPYFESLFDPLD 328

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  145 bits (365), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 106/365 (29%), Positives = 171/365 (46%), Gaps = 52/365 (14%)
Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
           A D  +   VAIKK+ R F+  +  KR  RE+ +L  +  + +I L D+   +  L  F 
Sbjct: 45  AYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK-FD 103
Query: 144 NVYMVTHLMGADLNNILRTQK-LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +Y+V  +  +DL  + +T   L+++H++ ++Y +L G  +IH +GIIHRDLKP+N  +N
Sbjct: 104 ELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLN 163
Query: 203 EDCELKILDFGLARPT-------------ENE------------MTGYVATRWYRAPEIM 237
           +DC +K+ DFGLAR               ENE            +T +V TRWYRAPE++
Sbjct: 164 QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELI 223
Query: 238 LNWMHYNQT----GVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWY- 292
           L   +Y ++         F +L            L +L   +  PT N    +  +  + 
Sbjct: 224 LLQENYTKSIDIWSTGCIFAEL------------LNMLQSHINDPT-NRFPLFPGSSCFP 270
Query: 293 RAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQ 352
            +P+     +H  +++  QLN+I  ++GTP  + +  I+     KYI   P     + +Q
Sbjct: 271 LSPDRNSKKVH-EKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQ 329
Query: 353 VFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTSPPYDQSFEDMDL 412
            +   +   I            KRIT +QAL HPYL        E      + S + + L
Sbjct: 330 KYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLE------NFSTKKIIL 383
Query: 413 PVDQW 417
           P D W
Sbjct: 384 PFDDW 388

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 101/343 (29%), Positives = 167/343 (48%), Gaps = 72/343 (20%)
Query: 79  LIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC 138
           L+FS A+D+    +VAIKKI      +V  K   RE+++++ ++H+N++ + ++   +  
Sbjct: 26  LVFS-AVDNDCDKRVAIKKIVLTDPQSV--KHALREIKIIRRLDHDNIVKVFEILGPSGS 82
Query: 139 --------LADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGII 190
                   L +  +VY+V   M  DL N+L    L ++H +  +YQ+LRGLKYIHSA ++
Sbjct: 83  QLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVL 142
Query: 191 HRDLKPSNIAVN-EDCELKILDFGLARPTE------NEMTGYVATRWYRAPEIMLNWMHY 243
           HRDLKP+N+ +N ED  LKI DFGLAR  +        ++  + T+WYR+P ++L+  +Y
Sbjct: 143 HRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNY 202
Query: 244 NQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEM-TGYVATRWYRAPEIMLNWM 302
                                    K +D   A     EM TG   T +  A E      
Sbjct: 203 T------------------------KAIDMWAAGCIFAEMLTG--KTLFAGAHE------ 230
Query: 303 HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKD-------FRQVFK 355
                 + Q+ LI+E +          +  +  ++ ++ +P+  + D         Q+  
Sbjct: 231 ------LEQMQLILESIPV--------VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLP 276
Query: 356 GANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEP 398
           G + +A+             R+TAE+AL+HPY+S YS P DEP
Sbjct: 277 GISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMDEP 319

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 88/321 (27%), Positives = 139/321 (43%), Gaps = 51/321 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +   A + ++G  VA+KKI    ++        RE+ +LK +NH N++ LLDV H+   L
Sbjct: 20  VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 79
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL---VYQILRGLKYIHSAGIIHRDLKP 196
                 Y+V   +  DL + +    L+   +  +   ++Q+L+GL + HS  ++HRDLKP
Sbjct: 80  ------YLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 133
Query: 197 SNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQ 253
            N+ +N +  +K+ DFGLAR     +  Y   V T WYRAPEI+L   +Y+         
Sbjct: 134 QNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA------- 186
Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
                         + I   G        +   + TR    P           ++I QL 
Sbjct: 187 --------------VDIWSLGC-------IFAEMVTRRALFP---------GDSEIDQLF 216
Query: 314 LIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXX 373
            I   LGTP       ++  S   Y  S P   ++DF +V    +               
Sbjct: 217 RIFRTLGTPDEVVWPGVT--SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 274
Query: 374 XKRITAEQALAHPYLSQYSDP 394
            KRI+A+ ALAHP+    + P
Sbjct: 275 NKRISAKAALAHPFFQDVTKP 295

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 88/321 (27%), Positives = 139/321 (43%), Gaps = 51/321 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +   A + ++G  VA+KKI    ++        RE+ +LK +NH N++ LLDV H+   L
Sbjct: 21  VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 80
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL---VYQILRGLKYIHSAGIIHRDLKP 196
                 Y+V   +  DL + +    L+   +  +   ++Q+L+GL + HS  ++HRDLKP
Sbjct: 81  ------YLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 134
Query: 197 SNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQ 253
            N+ +N +  +K+ DFGLAR     +  Y   V T WYRAPEI+L   +Y+         
Sbjct: 135 QNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA------- 187
Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
                         + I   G        +   + TR    P           ++I QL 
Sbjct: 188 --------------VDIWSLGC-------IFAEMVTRRALFP---------GDSEIDQLF 217
Query: 314 LIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXX 373
            I   LGTP       ++  S   Y  S P   ++DF +V    +               
Sbjct: 218 RIFRTLGTPDEVVWPGVT--SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 275
Query: 374 XKRITAEQALAHPYLSQYSDP 394
            KRI+A+ ALAHP+    + P
Sbjct: 276 NKRISAKAALAHPFFQDVTKP 296

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 88/321 (27%), Positives = 138/321 (42%), Gaps = 51/321 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +   A + ++G  VA+KKI    ++        RE+ +LK +NH N++ LLDV H+   L
Sbjct: 21  VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 80
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL---VYQILRGLKYIHSAGIIHRDLKP 196
                 Y+V   +  DL   +    L+   +  +   ++Q+L+GL + HS  ++HRDLKP
Sbjct: 81  ------YLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 134
Query: 197 SNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQ 253
            N+ +N +  +K+ DFGLAR     +  Y   V T WYRAPEI+L   +Y+         
Sbjct: 135 ENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA------- 187
Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
                         + I   G        +   + TR    P           ++I QL 
Sbjct: 188 --------------VDIWSLGC-------IFAEMVTRRALFP---------GDSEIDQLF 217
Query: 314 LIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXX 373
            I   LGTP       ++  S   Y  S P   ++DF +V    +               
Sbjct: 218 RIFRTLGTPDEVVWPGVT--SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 275
Query: 374 XKRITAEQALAHPYLSQYSDP 394
            KRI+A+ ALAHP+    + P
Sbjct: 276 NKRISAKAALAHPFFQDVTKP 296

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  114 bits (286), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 88/321 (27%), Positives = 138/321 (42%), Gaps = 51/321 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +   A + ++G  VA+KKI    ++        RE+ +LK +NH N++ LLDV H+   L
Sbjct: 19  VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 78
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL---VYQILRGLKYIHSAGIIHRDLKP 196
                 Y+V   +  DL   +    L+   +  +   ++Q+L+GL + HS  ++HRDLKP
Sbjct: 79  ------YLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 132
Query: 197 SNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQ 253
            N+ +N +  +K+ DFGLAR     +  Y   V T WYRAPEI+L   +Y+         
Sbjct: 133 ENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA------- 185
Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
                         + I   G        +   + TR    P           ++I QL 
Sbjct: 186 --------------VDIWSLGC-------IFAEMVTRRALFP---------GDSEIDQLF 215
Query: 314 LIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXX 373
            I   LGTP       ++  S   Y  S P   ++DF +V    +               
Sbjct: 216 RIFRTLGTPDEVVWPGVT--SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 273
Query: 374 XKRITAEQALAHPYLSQYSDP 394
            KRI+A+ ALAHP+    + P
Sbjct: 274 NKRISAKAALAHPFFQDVTKP 294

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 88/321 (27%), Positives = 139/321 (43%), Gaps = 51/321 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +   A + ++G  VA+KKI    ++        RE+ +LK +NH N++ LLDV H+   L
Sbjct: 18  VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 77
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL---VYQILRGLKYIHSAGIIHRDLKP 196
                 Y+V   +  DL + +    L+   +  +   ++Q+L+GL + HS  ++HRDLKP
Sbjct: 78  ------YLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 131
Query: 197 SNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQ 253
            N+ +N +  +K+ DFGLAR     +  Y   V T WYRAPEI+L   +Y+         
Sbjct: 132 ENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA------- 184
Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
                         + I   G        +   + TR    P           ++I QL 
Sbjct: 185 --------------VDIWSLGC-------IFAEMVTRRALFP---------GDSEIDQLF 214
Query: 314 LIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXX 373
            I   LGTP       ++  S   Y  S P   ++DF +V    +               
Sbjct: 215 RIFRTLGTPDEVVWPGVT--SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 272
Query: 374 XKRITAEQALAHPYLSQYSDP 394
            KRI+A+ ALAHP+    + P
Sbjct: 273 NKRISAKAALAHPFFQDVTKP 293

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 88/321 (27%), Positives = 138/321 (42%), Gaps = 51/321 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +   A + ++G  VA+KKI    ++        RE+ +LK +NH N++ LLDV H+   L
Sbjct: 20  VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 79
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL---VYQILRGLKYIHSAGIIHRDLKP 196
                 Y+V   +  DL   +    L+   +  +   ++Q+L+GL + HS  ++HRDLKP
Sbjct: 80  ------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 133
Query: 197 SNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQ 253
            N+ +N +  +K+ DFGLAR     +  Y   V T WYRAPEI+L   +Y+         
Sbjct: 134 ENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA------- 186
Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
                         + I   G        +   + TR    P           ++I QL 
Sbjct: 187 --------------VDIWSLGC-------IFAEMVTRRALFP---------GDSEIDQLF 216
Query: 314 LIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXX 373
            I   LGTP       ++  S   Y  S P   ++DF +V    +               
Sbjct: 217 RIFRTLGTPDEVVWPGVT--SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 274
Query: 374 XKRITAEQALAHPYLSQYSDP 394
            KRI+A+ ALAHP+    + P
Sbjct: 275 NKRISAKAALAHPFFQDVTKP 295

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 88/321 (27%), Positives = 138/321 (42%), Gaps = 51/321 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +   A + ++G  VA+KKI    ++        RE+ +LK +NH N++ LLDV H+   L
Sbjct: 20  VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 79
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL---VYQILRGLKYIHSAGIIHRDLKP 196
                 Y+V   +  DL   +    L+   +  +   ++Q+L+GL + HS  ++HRDLKP
Sbjct: 80  ------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 133
Query: 197 SNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQ 253
            N+ +N +  +K+ DFGLAR     +  Y   V T WYRAPEI+L   +Y+         
Sbjct: 134 QNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA------- 186
Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
                         + I   G        +   + TR    P           ++I QL 
Sbjct: 187 --------------VDIWSLGC-------IFAEMVTRRALFP---------GDSEIDQLF 216
Query: 314 LIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXX 373
            I   LGTP       ++  S   Y  S P   ++DF +V    +               
Sbjct: 217 RIFRTLGTPDEVVWPGVT--SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 274
Query: 374 XKRITAEQALAHPYLSQYSDP 394
            KRI+A+ ALAHP+    + P
Sbjct: 275 NKRISAKAALAHPFFQDVTKP 295

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 88/321 (27%), Positives = 138/321 (42%), Gaps = 51/321 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +   A + ++G  VA+KKI    ++        RE+ +LK +NH N++ LLDV H+   L
Sbjct: 22  VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 81
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL---VYQILRGLKYIHSAGIIHRDLKP 196
                 Y+V   +  DL   +    L+   +  +   ++Q+L+GL + HS  ++HRDLKP
Sbjct: 82  ------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 135
Query: 197 SNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQ 253
            N+ +N +  +K+ DFGLAR     +  Y   V T WYRAPEI+L   +Y+         
Sbjct: 136 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA------- 188
Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
                         + I   G        +   + TR    P           ++I QL 
Sbjct: 189 --------------VDIWSLGC-------IFAEMVTRRALFP---------GDSEIDQLF 218
Query: 314 LIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXX 373
            I   LGTP       ++  S   Y  S P   ++DF +V    +               
Sbjct: 219 RIFRTLGTPDEVVWPGVT--SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 276
Query: 374 XKRITAEQALAHPYLSQYSDP 394
            KRI+A+ ALAHP+    + P
Sbjct: 277 NKRISAKAALAHPFFQDVTKP 297

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 88/321 (27%), Positives = 138/321 (42%), Gaps = 51/321 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +   A + ++G  VA+KKI    ++        RE+ +LK +NH N++ LLDV H+   L
Sbjct: 21  VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 80
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL---VYQILRGLKYIHSAGIIHRDLKP 196
                 Y+V   +  DL   +    L+   +  +   ++Q+L+GL + HS  ++HRDLKP
Sbjct: 81  ------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 134
Query: 197 SNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQ 253
            N+ +N +  +K+ DFGLAR     +  Y   V T WYRAPEI+L   +Y+         
Sbjct: 135 QNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA------- 187
Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
                         + I   G        +   + TR    P           ++I QL 
Sbjct: 188 --------------VDIWSLGC-------IFAEMVTRRALFP---------GDSEIDQLF 217
Query: 314 LIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXX 373
            I   LGTP       ++  S   Y  S P   ++DF +V    +               
Sbjct: 218 RIFRTLGTPDEVVWPGVT--SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 275
Query: 374 XKRITAEQALAHPYLSQYSDP 394
            KRI+A+ ALAHP+    + P
Sbjct: 276 NKRISAKAALAHPFFQDVTKP 296

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 88/321 (27%), Positives = 138/321 (42%), Gaps = 51/321 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +   A + ++G  VA+KKI    ++        RE+ +LK +NH N++ LLDV H+   L
Sbjct: 20  VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 79
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL---VYQILRGLKYIHSAGIIHRDLKP 196
                 Y+V   +  DL   +    L+   +  +   ++Q+L+GL + HS  ++HRDLKP
Sbjct: 80  ------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 133
Query: 197 SNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQ 253
            N+ +N +  +K+ DFGLAR     +  Y   V T WYRAPEI+L   +Y+         
Sbjct: 134 QNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA------- 186
Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
                         + I   G        +   + TR    P           ++I QL 
Sbjct: 187 --------------VDIWSLGC-------IFAEMVTRRALFP---------GDSEIDQLF 216
Query: 314 LIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXX 373
            I   LGTP       ++  S   Y  S P   ++DF +V    +               
Sbjct: 217 RIFRTLGTPDEVVWPGVT--SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 274
Query: 374 XKRITAEQALAHPYLSQYSDP 394
            KRI+A+ ALAHP+    + P
Sbjct: 275 NKRISAKAALAHPFFQDVTKP 295

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 88/321 (27%), Positives = 138/321 (42%), Gaps = 51/321 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +   A + ++G  VA+KKI    ++        RE+ +LK +NH N++ LLDV H+   L
Sbjct: 25  VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 84
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL---VYQILRGLKYIHSAGIIHRDLKP 196
                 Y+V   +  DL   +    L+   +  +   ++Q+L+GL + HS  ++HRDLKP
Sbjct: 85  ------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 138
Query: 197 SNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQ 253
            N+ +N +  +K+ DFGLAR     +  Y   V T WYRAPEI+L   +Y+         
Sbjct: 139 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA------- 191
Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
                         + I   G        +   + TR    P           ++I QL 
Sbjct: 192 --------------VDIWSLGC-------IFAEMVTRRALFP---------GDSEIDQLF 221
Query: 314 LIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXX 373
            I   LGTP       ++  S   Y  S P   ++DF +V    +               
Sbjct: 222 RIFRTLGTPDEVVWPGVT--SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 279
Query: 374 XKRITAEQALAHPYLSQYSDP 394
            KRI+A+ ALAHP+    + P
Sbjct: 280 NKRISAKAALAHPFFQDVTKP 300

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 88/321 (27%), Positives = 138/321 (42%), Gaps = 51/321 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +   A + ++G  VA+KKI    ++        RE+ +LK +NH N++ LLDV H+   L
Sbjct: 19  VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 78
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL---VYQILRGLKYIHSAGIIHRDLKP 196
                 Y+V   +  DL   +    L+   +  +   ++Q+L+GL + HS  ++HRDLKP
Sbjct: 79  ------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 132
Query: 197 SNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQ 253
            N+ +N +  +K+ DFGLAR     +  Y   V T WYRAPEI+L   +Y+         
Sbjct: 133 ENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA------- 185
Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
                         + I   G        +   + TR    P           ++I QL 
Sbjct: 186 --------------VDIWSLGC-------IFAEMVTRRALFP---------GDSEIDQLF 215
Query: 314 LIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXX 373
            I   LGTP       ++  S   Y  S P   ++DF +V    +               
Sbjct: 216 RIFRTLGTPDEVVWPGVT--SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 273
Query: 374 XKRITAEQALAHPYLSQYSDP 394
            KRI+A+ ALAHP+    + P
Sbjct: 274 NKRISAKAALAHPFFQDVTKP 294

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 88/321 (27%), Positives = 138/321 (42%), Gaps = 51/321 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +   A + ++G  VA+KKI    ++        RE+ +LK +NH N++ LLDV H+   L
Sbjct: 18  VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 77
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL---VYQILRGLKYIHSAGIIHRDLKP 196
                 Y+V   +  DL   +    L+   +  +   ++Q+L+GL + HS  ++HRDLKP
Sbjct: 78  ------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHRVLHRDLKP 131
Query: 197 SNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQ 253
            N+ +N +  +K+ DFGLAR     +  Y   V T WYRAPEI+L   +Y+         
Sbjct: 132 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA------- 184
Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
                         + I   G        +   + TR    P           ++I QL 
Sbjct: 185 --------------VDIWSLGC-------IFAEMVTRRALFP---------GDSEIDQLF 214
Query: 314 LIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXX 373
            I   LGTP       ++  S   Y  S P   ++DF +V    +               
Sbjct: 215 RIFRTLGTPDEVVWPGVT--SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 272
Query: 374 XKRITAEQALAHPYLSQYSDP 394
            KRI+A+ ALAHP+    + P
Sbjct: 273 NKRISAKAALAHPFFQDVTKP 293

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 88/321 (27%), Positives = 138/321 (42%), Gaps = 51/321 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +   A + ++G  VA+KKI    ++        RE+ +LK +NH N++ LLDV H+   L
Sbjct: 22  VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 81
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL---VYQILRGLKYIHSAGIIHRDLKP 196
                 Y+V   +  DL   +    L+   +  +   ++Q+L+GL + HS  ++HRDLKP
Sbjct: 82  ------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 135
Query: 197 SNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQ 253
            N+ +N +  +K+ DFGLAR     +  Y   V T WYRAPEI+L   +Y+         
Sbjct: 136 QNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA------- 188
Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
                         + I   G        +   + TR    P           ++I QL 
Sbjct: 189 --------------VDIWSLGC-------IFAEMVTRRALFP---------GDSEIDQLF 218
Query: 314 LIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXX 373
            I   LGTP       ++  S   Y  S P   ++DF +V    +               
Sbjct: 219 RIFRTLGTPDEVVWPGVT--SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 276
Query: 374 XKRITAEQALAHPYLSQYSDP 394
            KRI+A+ ALAHP+    + P
Sbjct: 277 NKRISAKAALAHPFFQDVTKP 297

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 88/321 (27%), Positives = 138/321 (42%), Gaps = 51/321 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +   A + ++G  VA+KKI    ++        RE+ +LK +NH N++ LLDV H+   L
Sbjct: 21  VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 80
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL---VYQILRGLKYIHSAGIIHRDLKP 196
                 Y+V   +  DL   +    L+   +  +   ++Q+L+GL + HS  ++HRDLKP
Sbjct: 81  ------YLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 134
Query: 197 SNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQ 253
            N+ +N +  +K+ DFGLAR     +  Y   V T WYRAPEI+L   +Y+         
Sbjct: 135 QNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA------- 187
Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
                         + I   G        +   + TR    P           ++I QL 
Sbjct: 188 --------------VDIWSLGC-------IFAEMVTRRALFP---------GDSEIDQLF 217
Query: 314 LIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXX 373
            I   LGTP       ++  S   Y  S P   ++DF +V    +               
Sbjct: 218 RIFRTLGTPDEVVWPGVT--SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 275
Query: 374 XKRITAEQALAHPYLSQYSDP 394
            KRI+A+ ALAHP+    + P
Sbjct: 276 NKRISAKAALAHPFFQDVTKP 296

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 88/321 (27%), Positives = 138/321 (42%), Gaps = 51/321 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +   A + ++G  VA+KKI    ++        RE+ +LK +NH N++ LLDV H+   L
Sbjct: 18  VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 77
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL---VYQILRGLKYIHSAGIIHRDLKP 196
                 Y+V   +  DL   +    L+   +  +   ++Q+L+GL + HS  ++HRDLKP
Sbjct: 78  ------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 131
Query: 197 SNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQ 253
            N+ +N +  +K+ DFGLAR     +  Y   V T WYRAPEI+L   +Y+         
Sbjct: 132 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA------- 184
Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
                         + I   G        +   + TR    P           ++I QL 
Sbjct: 185 --------------VDIWSLGC-------IFAEMVTRRALFP---------GDSEIDQLF 214
Query: 314 LIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXX 373
            I   LGTP       ++  S   Y  S P   ++DF +V    +               
Sbjct: 215 RIFRTLGTPDEVVWPGVT--SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 272
Query: 374 XKRITAEQALAHPYLSQYSDP 394
            KRI+A+ ALAHP+    + P
Sbjct: 273 NKRISAKAALAHPFFQDVTKP 293

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 88/321 (27%), Positives = 138/321 (42%), Gaps = 51/321 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +   A + ++G  VA+KKI    ++        RE+ +LK +NH N++ LLDV H+   L
Sbjct: 17  VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 76
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL---VYQILRGLKYIHSAGIIHRDLKP 196
                 Y+V   +  DL   +    L+   +  +   ++Q+L+GL + HS  ++HRDLKP
Sbjct: 77  ------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 130
Query: 197 SNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQ 253
            N+ +N +  +K+ DFGLAR     +  Y   V T WYRAPEI+L   +Y+         
Sbjct: 131 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA------- 183
Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
                         + I   G        +   + TR    P           ++I QL 
Sbjct: 184 --------------VDIWSLGC-------IFAEMVTRRALFP---------GDSEIDQLF 213
Query: 314 LIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXX 373
            I   LGTP       ++  S   Y  S P   ++DF +V    +               
Sbjct: 214 RIFRTLGTPDEVVWPGVT--SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 271
Query: 374 XKRITAEQALAHPYLSQYSDP 394
            KRI+A+ ALAHP+    + P
Sbjct: 272 NKRISAKAALAHPFFQDVTKP 292

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 88/321 (27%), Positives = 138/321 (42%), Gaps = 51/321 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +   A + ++G  VA+KKI    ++        RE+ +LK +NH N++ LLDV H+   L
Sbjct: 21  VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 80
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL---VYQILRGLKYIHSAGIIHRDLKP 196
                 Y+V   +  DL   +    L+   +  +   ++Q+L+GL + HS  ++HRDLKP
Sbjct: 81  ------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 134
Query: 197 SNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQ 253
            N+ +N +  +K+ DFGLAR     +  Y   V T WYRAPEI+L   +Y+         
Sbjct: 135 QNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA------- 187
Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
                         + I   G        +   + TR    P           ++I QL 
Sbjct: 188 --------------VDIWSLGC-------IFAEMVTRRALFP---------GDSEIDQLF 217
Query: 314 LIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXX 373
            I   LGTP       ++  S   Y  S P   ++DF +V    +               
Sbjct: 218 RIFRTLGTPDEVVWPGVT--SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 275
Query: 374 XKRITAEQALAHPYLSQYSDP 394
            KRI+A+ ALAHP+    + P
Sbjct: 276 NKRISAKAALAHPFFQDVTKP 296

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 88/321 (27%), Positives = 138/321 (42%), Gaps = 51/321 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +   A + ++G  VA+KKI    ++        RE+ +LK +NH N++ LLDV H+   L
Sbjct: 25  VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 84
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL---VYQILRGLKYIHSAGIIHRDLKP 196
                 Y+V   +  DL   +    L+   +  +   ++Q+L+GL + HS  ++HRDLKP
Sbjct: 85  ------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 138
Query: 197 SNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQ 253
            N+ +N +  +K+ DFGLAR     +  Y   V T WYRAPEI+L   +Y+         
Sbjct: 139 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTA------- 191
Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
                         + I   G        +   + TR    P           ++I QL 
Sbjct: 192 --------------VDIWSLGC-------IFAEMVTRRALFP---------GDSEIDQLF 221
Query: 314 LIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXX 373
            I   LGTP       ++  S   Y  S P   ++DF +V    +               
Sbjct: 222 RIFRTLGTPDEVVWPGVT--SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 279
Query: 374 XKRITAEQALAHPYLSQYSDP 394
            KRI+A+ ALAHP+    + P
Sbjct: 280 NKRISAKAALAHPFFQDVTKP 300

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 88/321 (27%), Positives = 138/321 (42%), Gaps = 51/321 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +   A + ++G  VA+KKI    ++        RE+ +LK +NH N++ LLDV H+   L
Sbjct: 18  VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 77
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL---VYQILRGLKYIHSAGIIHRDLKP 196
                 Y+V   +  DL   +    L+   +  +   ++Q+L+GL + HS  ++HRDLKP
Sbjct: 78  ------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 131
Query: 197 SNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQ 253
            N+ +N +  +K+ DFGLAR     +  Y   V T WYRAPEI+L   +Y+         
Sbjct: 132 QNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA------- 184
Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
                         + I   G        +   + TR    P           ++I QL 
Sbjct: 185 --------------VDIWSLGC-------IFAEMVTRRALFP---------GDSEIDQLF 214
Query: 314 LIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXX 373
            I   LGTP       ++  S   Y  S P   ++DF +V    +               
Sbjct: 215 RIFRTLGTPDEVVWPGVT--SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 272
Query: 374 XKRITAEQALAHPYLSQYSDP 394
            KRI+A+ ALAHP+    + P
Sbjct: 273 NKRISAKAALAHPFFQDVTKP 293

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 88/321 (27%), Positives = 138/321 (42%), Gaps = 51/321 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +   A + ++G  VA+KKI    ++        RE+ +LK +NH N++ LLDV H+   L
Sbjct: 17  VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 76
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL---VYQILRGLKYIHSAGIIHRDLKP 196
                 Y+V   +  DL   +    L+   +  +   ++Q+L+GL + HS  ++HRDLKP
Sbjct: 77  ------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 130
Query: 197 SNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQ 253
            N+ +N +  +K+ DFGLAR     +  Y   V T WYRAPEI+L   +Y+         
Sbjct: 131 QNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA------- 183
Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
                         + I   G        +   + TR    P           ++I QL 
Sbjct: 184 --------------VDIWSLGC-------IFAEMVTRRALFP---------GDSEIDQLF 213
Query: 314 LIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXX 373
            I   LGTP       ++  S   Y  S P   ++DF +V    +               
Sbjct: 214 RIFRTLGTPDEVVWPGVT--SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 271
Query: 374 XKRITAEQALAHPYLSQYSDP 394
            KRI+A+ ALAHP+    + P
Sbjct: 272 NKRISAKAALAHPFFQDVTKP 292

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 88/321 (27%), Positives = 138/321 (42%), Gaps = 51/321 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +   A + ++G  VA+KKI    ++        RE+ +LK +NH N++ LLDV H+   L
Sbjct: 19  VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 78
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL---VYQILRGLKYIHSAGIIHRDLKP 196
                 Y+V   +  DL   +    L+   +  +   ++Q+L+GL + HS  ++HRDLKP
Sbjct: 79  ------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 132
Query: 197 SNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQ 253
            N+ +N +  +K+ DFGLAR     +  Y   V T WYRAPEI+L   +Y+         
Sbjct: 133 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA------- 185
Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
                         + I   G        +   + TR    P           ++I QL 
Sbjct: 186 --------------VDIWSLGC-------IFAEMVTRRALFP---------GDSEIDQLF 215
Query: 314 LIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXX 373
            I   LGTP       ++  S   Y  S P   ++DF +V    +               
Sbjct: 216 RIFRTLGTPDEVVWPGVT--SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 273
Query: 374 XKRITAEQALAHPYLSQYSDP 394
            KRI+A+ ALAHP+    + P
Sbjct: 274 NKRISAKAALAHPFFQDVTKP 294

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 88/321 (27%), Positives = 138/321 (42%), Gaps = 51/321 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +   A + ++G  VA+KKI    ++        RE+ +LK +NH N++ LLDV H+   L
Sbjct: 18  VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 77
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL---VYQILRGLKYIHSAGIIHRDLKP 196
                 Y+V   +  DL   +    L+   +  +   ++Q+L+GL + HS  ++HRDLKP
Sbjct: 78  ------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 131
Query: 197 SNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQ 253
            N+ +N +  +K+ DFGLAR     +  Y   V T WYRAPEI+L   +Y+         
Sbjct: 132 QNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA------- 184
Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
                         + I   G        +   + TR    P           ++I QL 
Sbjct: 185 --------------VDIWSLGC-------IFAEMVTRRALFP---------GDSEIDQLF 214
Query: 314 LIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXX 373
            I   LGTP       ++  S   Y  S P   ++DF +V    +               
Sbjct: 215 RIFRTLGTPDEVVWPGVT--SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 272
Query: 374 XKRITAEQALAHPYLSQYSDP 394
            KRI+A+ ALAHP+    + P
Sbjct: 273 NKRISAKAALAHPFFQDVTKP 293

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 88/321 (27%), Positives = 138/321 (42%), Gaps = 51/321 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +   A + ++G  VA+KKI    ++        RE+ +LK +NH N++ LLDV H+   L
Sbjct: 18  VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 77
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL---VYQILRGLKYIHSAGIIHRDLKP 196
                 Y+V   +  DL   +    L+   +  +   ++Q+L+GL + HS  ++HRDLKP
Sbjct: 78  ------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 131
Query: 197 SNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQ 253
            N+ +N +  +K+ DFGLAR     +  Y   V T WYRAPEI+L   +Y+         
Sbjct: 132 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA------- 184
Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
                         + I   G        +   + TR    P           ++I QL 
Sbjct: 185 --------------VDIWSLGC-------IFAEMVTRRALFP---------GDSEIDQLF 214
Query: 314 LIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXX 373
            I   LGTP       ++  S   Y  S P   ++DF +V    +               
Sbjct: 215 RIFRTLGTPDEVVWPGVT--SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 272
Query: 374 XKRITAEQALAHPYLSQYSDP 394
            KRI+A+ ALAHP+    + P
Sbjct: 273 NKRISAKAALAHPFFQDVTKP 293

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 88/321 (27%), Positives = 138/321 (42%), Gaps = 51/321 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +   A + ++G  VA+KKI    ++        RE+ +LK +NH N++ LLDV H+   L
Sbjct: 17  VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 76
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL---VYQILRGLKYIHSAGIIHRDLKP 196
                 Y+V   +  DL   +    L+   +  +   ++Q+L+GL + HS  ++HRDLKP
Sbjct: 77  ------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 130
Query: 197 SNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQ 253
            N+ +N +  +K+ DFGLAR     +  Y   V T WYRAPEI+L   +Y+         
Sbjct: 131 QNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA------- 183
Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
                         + I   G        +   + TR    P           ++I QL 
Sbjct: 184 --------------VDIWSLGC-------IFAEMVTRRALFP---------GDSEIDQLF 213
Query: 314 LIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXX 373
            I   LGTP       ++  S   Y  S P   ++DF +V    +               
Sbjct: 214 RIFRTLGTPDEVVWPGVT--SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 271
Query: 374 XKRITAEQALAHPYLSQYSDP 394
            KRI+A+ ALAHP+    + P
Sbjct: 272 NKRISAKAALAHPFFQDVTKP 292

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 88/321 (27%), Positives = 138/321 (42%), Gaps = 51/321 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +   A + ++G  VA+KKI    ++        RE+ +LK +NH N++ LLDV H+   L
Sbjct: 18  VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 77
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL---VYQILRGLKYIHSAGIIHRDLKP 196
                 Y+V   +  DL   +    L+   +  +   ++Q+L+GL + HS  ++HRDLKP
Sbjct: 78  ------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 131
Query: 197 SNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQ 253
            N+ +N +  +K+ DFGLAR     +  Y   V T WYRAPEI+L   +Y+         
Sbjct: 132 QNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA------- 184
Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
                         + I   G        +   + TR    P           ++I QL 
Sbjct: 185 --------------VDIWSLGC-------IFAEMVTRRALFP---------GDSEIDQLF 214
Query: 314 LIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXX 373
            I   LGTP       ++  S   Y  S P   ++DF +V    +               
Sbjct: 215 RIFRTLGTPDEVVWPGVT--SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 272
Query: 374 XKRITAEQALAHPYLSQYSDP 394
            KRI+A+ ALAHP+    + P
Sbjct: 273 NKRISAKAALAHPFFQDVTKP 293

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 88/321 (27%), Positives = 138/321 (42%), Gaps = 51/321 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +   A + ++G  VA+KKI    ++        RE+ +LK +NH N++ LLDV H+   L
Sbjct: 17  VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 76
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL---VYQILRGLKYIHSAGIIHRDLKP 196
                 Y+V   +  DL   +    L+   +  +   ++Q+L+GL + HS  ++HRDLKP
Sbjct: 77  ------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 130
Query: 197 SNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQ 253
            N+ +N +  +K+ DFGLAR     +  Y   V T WYRAPEI+L   +Y+         
Sbjct: 131 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA------- 183
Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
                         + I   G        +   + TR    P           ++I QL 
Sbjct: 184 --------------VDIWSLGC-------IFAEMVTRRALFP---------GDSEIDQLF 213
Query: 314 LIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXX 373
            I   LGTP       ++  S   Y  S P   ++DF +V    +               
Sbjct: 214 RIFRTLGTPDEVVWPGVT--SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 271
Query: 374 XKRITAEQALAHPYLSQYSDP 394
            KRI+A+ ALAHP+    + P
Sbjct: 272 NKRISAKAALAHPFFQDVTKP 292

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 88/321 (27%), Positives = 138/321 (42%), Gaps = 51/321 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +   A + ++G  VA+KKI    ++        RE+ +LK +NH N++ LLDV H+   L
Sbjct: 19  VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 78
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL---VYQILRGLKYIHSAGIIHRDLKP 196
                 Y+V   +  DL   +    L+   +  +   ++Q+L+GL + HS  ++HRDLKP
Sbjct: 79  ------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 132
Query: 197 SNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQ 253
            N+ +N +  +K+ DFGLAR     +  Y   V T WYRAPEI+L   +Y+         
Sbjct: 133 QNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA------- 185
Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
                         + I   G        +   + TR    P           ++I QL 
Sbjct: 186 --------------VDIWSLGC-------IFAEMVTRRALFP---------GDSEIDQLF 215
Query: 314 LIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXX 373
            I   LGTP       ++  S   Y  S P   ++DF +V    +               
Sbjct: 216 RIFRTLGTPDEVVWPGVT--SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 273
Query: 374 XKRITAEQALAHPYLSQYSDP 394
            KRI+A+ ALAHP+    + P
Sbjct: 274 NKRISAKAALAHPFFQDVTKP 294

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 88/321 (27%), Positives = 138/321 (42%), Gaps = 51/321 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +   A + ++G  VA+KKI    ++        RE+ +LK +NH N++ LLDV H+   L
Sbjct: 19  VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 78
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL---VYQILRGLKYIHSAGIIHRDLKP 196
                 Y+V   +  DL   +    L+   +  +   ++Q+L+GL + HS  ++HRDLKP
Sbjct: 79  ------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 132
Query: 197 SNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQ 253
            N+ +N +  +K+ DFGLAR     +  Y   V T WYRAPEI+L   +Y+         
Sbjct: 133 QNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA------- 185
Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
                         + I   G        +   + TR    P           ++I QL 
Sbjct: 186 --------------VDIWSLGC-------IFAEMVTRRALFP---------GDSEIDQLF 215
Query: 314 LIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXX 373
            I   LGTP       ++  S   Y  S P   ++DF +V    +               
Sbjct: 216 RIFRTLGTPDEVVWPGVT--SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 273
Query: 374 XKRITAEQALAHPYLSQYSDP 394
            KRI+A+ ALAHP+    + P
Sbjct: 274 NKRISAKAALAHPFFQDVTKP 294

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 88/321 (27%), Positives = 138/321 (42%), Gaps = 51/321 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +   A + ++G  VA+KKI    ++        RE+ +LK +NH N++ LLDV H+   L
Sbjct: 18  VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 77
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL---VYQILRGLKYIHSAGIIHRDLKP 196
                 Y+V   +  DL   +    L+   +  +   ++Q+L+GL + HS  ++HRDLKP
Sbjct: 78  ------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 131
Query: 197 SNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQ 253
            N+ +N +  +K+ DFGLAR     +  Y   V T WYRAPEI+L   +Y+         
Sbjct: 132 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTA------- 184
Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
                         + I   G        +   + TR    P           ++I QL 
Sbjct: 185 --------------VDIWSLGC-------IFAEMVTRRALFP---------GDSEIDQLF 214
Query: 314 LIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXX 373
            I   LGTP       ++  S   Y  S P   ++DF +V    +               
Sbjct: 215 RIFRTLGTPDEVVWPGVT--SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 272
Query: 374 XKRITAEQALAHPYLSQYSDP 394
            KRI+A+ ALAHP+    + P
Sbjct: 273 NKRISAKAALAHPFFQDVTKP 293

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 88/321 (27%), Positives = 138/321 (42%), Gaps = 51/321 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +   A + ++G  VA+KKI    ++        RE+ +LK +NH N++ LLDV H+   L
Sbjct: 21  VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 80
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL---VYQILRGLKYIHSAGIIHRDLKP 196
                 Y+V   +  DL   +    L+   +  +   ++Q+L+GL + HS  ++HRDLKP
Sbjct: 81  ------YLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 134
Query: 197 SNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQ 253
            N+ +N +  +K+ DFGLAR     +  Y   V T WYRAPEI+L   +Y+         
Sbjct: 135 QNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA------- 187
Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
                         + I   G        +   + TR    P           ++I QL 
Sbjct: 188 --------------VDIWSLGC-------IFAEMVTRRALFP---------GDSEIDQLF 217
Query: 314 LIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXX 373
            I   LGTP       ++  S   Y  S P   ++DF +V    +               
Sbjct: 218 RIFRTLGTPDEVVWPGVT--SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 275
Query: 374 XKRITAEQALAHPYLSQYSDP 394
            KRI+A+ ALAHP+    + P
Sbjct: 276 NKRISAKAALAHPFFQDVTKP 296

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 88/321 (27%), Positives = 138/321 (42%), Gaps = 51/321 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +   A + ++G  VA+KKI    ++        RE+ +LK +NH N++ LLDV H+   L
Sbjct: 17  VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 76
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL---VYQILRGLKYIHSAGIIHRDLKP 196
                 Y+V   +  DL   +    L+   +  +   ++Q+L+GL + HS  ++HRDLKP
Sbjct: 77  ------YLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 130
Query: 197 SNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQ 253
            N+ +N +  +K+ DFGLAR     +  Y   V T WYRAPEI+L   +Y+         
Sbjct: 131 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA------- 183
Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
                         + I   G        +   + TR    P           ++I QL 
Sbjct: 184 --------------VDIWSLGC-------IFAEMVTRRALFP---------GDSEIDQLF 213
Query: 314 LIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXX 373
            I   LGTP       ++  S   Y  S P   ++DF +V    +               
Sbjct: 214 RIFRTLGTPDEVVWPGVT--SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 271
Query: 374 XKRITAEQALAHPYLSQYSDP 394
            KRI+A+ ALAHP+    + P
Sbjct: 272 NKRISAKAALAHPFFQDVTKP 292

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 87/321 (27%), Positives = 137/321 (42%), Gaps = 51/321 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +   A + ++G  VA+ KI    ++        RE+ +LK +NH N++ LLDV H+   L
Sbjct: 18  VVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 77
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL---VYQILRGLKYIHSAGIIHRDLKP 196
                 Y+V   +  DL   +    L+   +  +   ++Q+L+GL + HS  ++HRDLKP
Sbjct: 78  ------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 131
Query: 197 SNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQ 253
            N+ +N +  +K+ DFGLAR     +  Y   V T WYRAPEI+L   +Y+         
Sbjct: 132 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA------- 184
Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
                         + I   G        +   + TR    P           ++I QL 
Sbjct: 185 --------------VDIWSLGC-------IFAEMVTRRALFP---------GDSEIDQLF 214
Query: 314 LIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXX 373
            I   LGTP       ++  S   Y  S P   ++DF +V    +               
Sbjct: 215 RIFRTLGTPDEVVWPGVT--SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 272
Query: 374 XKRITAEQALAHPYLSQYSDP 394
            KRI+A+ ALAHP+    + P
Sbjct: 273 NKRISAKAALAHPFFQDVTKP 293

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 87/321 (27%), Positives = 137/321 (42%), Gaps = 51/321 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +   A + ++G  VA+ KI    ++        RE+ +LK +NH N++ LLDV H+   L
Sbjct: 17  VVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 76
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL---VYQILRGLKYIHSAGIIHRDLKP 196
                 Y+V   +  DL   +    L+   +  +   ++Q+L+GL + HS  ++HRDLKP
Sbjct: 77  ------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 130
Query: 197 SNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQ 253
            N+ +N +  +K+ DFGLAR     +  Y   V T WYRAPEI+L   +Y+         
Sbjct: 131 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA------- 183
Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
                         + I   G        +   + TR    P           ++I QL 
Sbjct: 184 --------------VDIWSLGC-------IFAEMVTRRALFP---------GDSEIDQLF 213
Query: 314 LIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXX 373
            I   LGTP       ++  S   Y  S P   ++DF +V    +               
Sbjct: 214 RIFRTLGTPDEVVWPGVT--SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 271
Query: 374 XKRITAEQALAHPYLSQYSDP 394
            KRI+A+ ALAHP+    + P
Sbjct: 272 NKRISAKAALAHPFFQDVTKP 292

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 87/315 (27%), Positives = 136/315 (43%), Gaps = 51/315 (16%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +   A + ++G  VA+KKI    ++        RE+ +LK +NH N++ LLDV H+   L
Sbjct: 18  VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 77
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL---VYQILRGLKYIHSAGIIHRDLKP 196
                 Y+V   +  DL   +    L+   +  +   ++Q+L+GL + HS  ++HRDLKP
Sbjct: 78  ------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 131
Query: 197 SNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQ 253
            N+ +N +  +K+ DFGLAR     +  Y   V T WYRAPEI+L   +Y+         
Sbjct: 132 QNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA------- 184
Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
                         + I   G        +   + TR    P           ++I QL 
Sbjct: 185 --------------VDIWSLGC-------IFAEMVTRRALFP---------GDSEIDQLF 214
Query: 314 LIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXX 373
            I   LGTP       ++  S   Y  S P   ++DF +V    +               
Sbjct: 215 RIFRTLGTPDEVVWPGVT--SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 272
Query: 374 XKRITAEQALAHPYL 388
            KRI+A+ ALAHP+ 
Sbjct: 273 NKRISAKAALAHPFF 287

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 89/314 (28%), Positives = 131/314 (41%), Gaps = 50/314 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +   A DS  G  VA+K+I    +         RE+ +LK ++H N++ L+DV HS  CL
Sbjct: 36  VVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL 94
Query: 140 ADFKNVYMVTHLMGADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPS 197
                  +V   M  DL  +L   K  L D  ++  +YQ+LRG+ + H   I+HRDLKP 
Sbjct: 95  T------LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQ 148
Query: 198 NIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQD 254
           N+ +N D  LK+ DFGLAR     +  Y   V T WYRAP++++    Y+ +       D
Sbjct: 149 NLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTS------VD 202
Query: 255 LKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNL 314
           +        E    K L  G+                               TD  QL  
Sbjct: 203 IWSIGCIFAEMITGKPLFPGV-------------------------------TDDDQLPK 231
Query: 315 IMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXX 374
           I  +LGTP      ++      K   +  +  KK +  +  G   + I            
Sbjct: 232 IFSILGTPNPREWPQVQELPLWKQ-RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPN 290
Query: 375 KRITAEQALAHPYL 388
           KRI+A  A+ HPY 
Sbjct: 291 KRISARDAMNHPYF 304

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 89/314 (28%), Positives = 131/314 (41%), Gaps = 50/314 (15%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +   A DS  G  VA+K+I    +         RE+ +LK ++H N++ L+DV HS  CL
Sbjct: 36  VVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL 94
Query: 140 ADFKNVYMVTHLMGADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPS 197
                  +V   M  DL  +L   K  L D  ++  +YQ+LRG+ + H   I+HRDLKP 
Sbjct: 95  T------LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQ 148
Query: 198 NIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQD 254
           N+ +N D  LK+ DFGLAR     +  Y   V T WYRAP++++    Y+ +       D
Sbjct: 149 NLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTS------VD 202
Query: 255 LKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNL 314
           +        E    K L  G+                               TD  QL  
Sbjct: 203 IWSIGCIFAEMITGKPLFPGV-------------------------------TDDDQLPK 231
Query: 315 IMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXX 374
           I  +LGTP      ++      K   +  +  KK +  +  G   + I            
Sbjct: 232 IFSILGTPNPREWPQVQELPLWKQ-RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPN 290
Query: 375 KRITAEQALAHPYL 388
           KRI+A  A+ HPY 
Sbjct: 291 KRISARDAMNHPYF 304

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 96/332 (28%), Positives = 140/332 (42%), Gaps = 55/332 (16%)
Query: 72  LSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVH---AKRTYRELRMLKHMNHENVIG 128
           L +  F  ++  A D  +   VAIKKI    +S       +   RE+++L+ ++H N+IG
Sbjct: 18  LGEGQFATVYK-ARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 129 LLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKL--SDDHVQFLVYQILRGLKYIHS 186
           LLD F   +      N+ +V   M  DL  I++   L  +  H++  +   L+GL+Y+H 
Sbjct: 77  LLDAFGHKS------NISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 130
Query: 187 AGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHY 243
             I+HRDLKP+N+ ++E+  LK+ DFGLA+   +    Y   V TRWYRAPE++     Y
Sbjct: 131 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMY 190
Query: 244 NQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH 303
              GV  +         AV   C L                   A    R P +      
Sbjct: 191 G-VGVDMW---------AVG--CIL-------------------AELLLRVPFLP----- 214
Query: 304 YNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIX 363
              +D+ QL  I E LGTP  E    + S        S P +       +F  A    + 
Sbjct: 215 -GDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIP---LHHIFSAAGDDLLD 270
Query: 364 XXXXXXXXXXXKRITAEQALAHPYLSQYSDPN 395
                       RITA QAL   Y S    P 
Sbjct: 271 LIQGLFLFNPCARITATQALKMKYFSNRPGPT 302

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 78/323 (24%), Positives = 141/323 (43%), Gaps = 61/323 (18%)
Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
            L+  +GV VA+K++    +    +    RE+ ++K + HEN++ L DV H+   L    
Sbjct: 24  GLNKTTGVYVALKEVKLDSEEGTPST-AIREISLMKELKHENIVRLYDVIHTENKLT--- 79
Query: 144 NVYMVTHLMGADLNNILRTQKLSD-------DHVQFLVYQILRGLKYIHSAGIIHRDLKP 196
              +V   M  DL   + ++ + +       + V++  +Q+L+GL + H   I+HRDLKP
Sbjct: 80  ---LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKP 136
Query: 197 SNIAVNEDCELKILDFGLARPTE---NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQ 253
            N+ +N+  +LK+ DFGLAR      N  +  V T WYRAP++++    Y+ T +  +  
Sbjct: 137 QNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYS-TSIDIW-- 193
Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
                       C   + +    +P                       +     D  QL 
Sbjct: 194 -----------SCGCILAEMITGKP-----------------------LFPGTNDEEQLK 219
Query: 314 LIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXX 373
           LI +++GTP       ++     KY  ++     +D RQV +    + +           
Sbjct: 220 LIFDIMGTPNESLWPSVT--KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGL 277
Query: 374 XK-----RITAEQALAHPYLSQY 391
            +     R++A+QAL HP+ ++Y
Sbjct: 278 LQLNPDMRLSAKQALHHPWFAEY 300

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 87/319 (27%), Positives = 132/319 (41%), Gaps = 73/319 (22%)
Query: 93  VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM 152
           VA+K++              RE+ +LK + H+N++ L DV HS+      K + +V    
Sbjct: 30  VALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD------KKLTLVFEFC 83
Query: 153 GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKIL 210
             DL     +    L  + V+  ++Q+L+GL + HS  ++HRDLKP N+ +N + ELK+ 
Sbjct: 84  DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLA 143
Query: 211 DFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCE 267
           DFGLAR     +  Y   V T WYR P+++     Y+ T +  +      + +A      
Sbjct: 144 DFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS-TSIDMWSAGCIFAELA------ 196
Query: 268 LKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAE-- 325
                   ARP                          N  D  QL  I  +LGTP  E  
Sbjct: 197 ------NAARPL----------------------FPGNDVD-DQLKRIFRLLGTPTEEQW 227
Query: 326 -FMAKISS-------DSARKYINSLPLL--TKKDFRQVFKGANPQAIXXXXXXXXXXXXK 375
             M K+          +    +N +P L  T +D  Q     NP               +
Sbjct: 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNP--------------VQ 273
Query: 376 RITAEQALAHPYLSQYSDP 394
           RI+AE+AL HPY S +  P
Sbjct: 274 RISAEEALQHPYFSDFCPP 292

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 86/319 (26%), Positives = 131/319 (41%), Gaps = 73/319 (22%)
Query: 93  VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM 152
           VA+K++              RE+ +LK + H+N++ L DV HS+      K + +V    
Sbjct: 30  VALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD------KKLTLVFEFC 83
Query: 153 GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKIL 210
             DL     +    L  + V+  ++Q+L+GL + HS  ++HRDLKP N+ +N + ELK+ 
Sbjct: 84  DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLA 143
Query: 211 DFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCE 267
           +FGLAR     +  Y   V T WYR P+++     Y+ +       D+  +     E   
Sbjct: 144 NFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS------IDMWSAGCIFAE--- 194
Query: 268 LKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAE-- 325
                  LA        G                   N  D  QL  I  +LGTP  E  
Sbjct: 195 -------LANAGRPLFPG-------------------NDVD-DQLKRIFRLLGTPTEEQW 227
Query: 326 -FMAKISS-------DSARKYINSLPLL--TKKDFRQVFKGANPQAIXXXXXXXXXXXXK 375
             M K+          +    +N +P L  T +D  Q     NP               +
Sbjct: 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNP--------------VQ 273
Query: 376 RITAEQALAHPYLSQYSDP 394
           RI+AE+AL HPY S +  P
Sbjct: 274 RISAEEALQHPYFSDFCPP 292

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 87/334 (26%), Positives = 147/334 (44%), Gaps = 66/334 (19%)
Query: 76  SFDLIFSSALDSVSGVKVAIKKI--ARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVF 133
           SF +++ + L   SG  VAIKK+   + F++        REL++++ ++H N++ L   F
Sbjct: 32  SFGVVYQAKLCD-SGELVAIKKVLQGKAFKN--------RELQIMRKLDHCNIVRLRYFF 82
Query: 134 HSNTCLADFKNVYMVTHLMGADLNNILR-----TQKLSDDHVQFLVYQILRGLKYIHSAG 188
           +S+    D   + +V   +   +  + R      Q L   +V+  +YQ+ R L YIHS G
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 189 IIHRDLKPSNIAVNEDCE-LKILDFG----LARPTENEMTGYVATRWYRAPEIMLNWMHY 243
           I HRD+KP N+ ++ D   LK+ DFG    L R   N    Y+ +R+YRAPE++     Y
Sbjct: 143 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRYYRAPELIFGATDY 200
Query: 244 NQTGVPFYFQDLKPSNIAV-NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM 302
                         S+I V +  C L  L  G                           +
Sbjct: 201 T-------------SSIDVWSAGCVLAELLLG-------------------------QPI 222
Query: 303 HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGAN-PQA 361
               + + QL  I+++LGTP  E + +++ +       + P +    + +VF+    P+A
Sbjct: 223 FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE---FAFPQIKAHPWTKVFRPRTPPEA 279
Query: 362 IXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPN 395
           I             R+T  +A AH +  +  DPN
Sbjct: 280 IALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 81/306 (26%), Positives = 125/306 (40%), Gaps = 50/306 (16%)
Query: 90  GVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT 149
           G   A+KKI    +       T RE+ +LK + H N++ L DV H+       K + +V 
Sbjct: 26  GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK------KRLVLVF 79
Query: 150 HLMGADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
             +  DL  +L   +  L     +  + Q+L G+ Y H   ++HRDLKP N+ +N + EL
Sbjct: 80  EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGEL 139
Query: 208 KILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE 264
           KI DFGLAR     +  Y   V T WYRAP++++    Y+ T                  
Sbjct: 140 KIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTT------------------ 181
Query: 265 DCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPA 324
                 +D         EM          AP      +    ++  QL  I  +LGTP +
Sbjct: 182 ------IDIWSVGCIFAEMVN-------GAP------LFPGVSEADQLMRIFRILGTPNS 222
Query: 325 EFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALA 384
           +    ++     KY  +  +     +    KG +   I            +RITA+QAL 
Sbjct: 223 KNWPNVT--ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
Query: 385 HPYLSQ 390
           H Y  +
Sbjct: 281 HAYFKE 286

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 87/334 (26%), Positives = 146/334 (43%), Gaps = 66/334 (19%)
Query: 76  SFDLIFSSALDSVSGVKVAIKKI--ARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVF 133
           SF +++ + L   SG  VAIKK+   + F++        REL++++ ++H N++ L   F
Sbjct: 32  SFGVVYQAKLCD-SGELVAIKKVLQGKAFKN--------RELQIMRKLDHCNIVRLRYFF 82
Query: 134 HSNTCLADFKNVYMVTHLMGADLNNILR-----TQKLSDDHVQFLVYQILRGLKYIHSAG 188
           +S+    D   + +V   +   +  + R      Q L   +V+  +YQ+ R L YIHS G
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 189 IIHRDLKPSNIAVNEDCE-LKILDFG----LARPTENEMTGYVATRWYRAPEIMLNWMHY 243
           I HRD+KP N+ ++ D   LK+ DFG    L R   N    Y+ +R+YRAPE++     Y
Sbjct: 143 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRYYRAPELIFGATDY 200
Query: 244 NQTGVPFYFQDLKPSNIAV-NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM 302
                         S+I V +  C L  L  G                           +
Sbjct: 201 T-------------SSIDVWSAGCVLAELLLG-------------------------QPI 222
Query: 303 HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGAN-PQA 361
               + + QL  I+++LGTP  E + +++ +         P +    + +VF+    P+A
Sbjct: 223 FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE---FKFPQIKAHPWTKVFRPRTPPEA 279
Query: 362 IXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPN 395
           I             R+T  +A AH +  +  DPN
Sbjct: 280 IALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 60/165 (36%), Positives = 86/165 (52%), Gaps = 15/165 (9%)
Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           +G  VAIKK        +  K   RE+++LK + HEN++ LL+V          K  Y+V
Sbjct: 49  TGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK------KRWYLV 102
Query: 149 ----THLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED 204
                H +  DL   L    L    VQ  ++QI+ G+ + HS  IIHRD+KP NI V++ 
Sbjct: 103 FEFVDHTILDDLE--LFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS 160
Query: 205 CELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQT 246
             +K+ DFG AR        Y   VATRWYRAPE+++  + Y + 
Sbjct: 161 GVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKA 205

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/76 (38%), Positives = 43/76 (56%), Gaps = 5/76 (6%)
Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQ-TD 308
           +D+KP NI V++   +K+ DFG AR        Y   VATRWYRAPE+++  + Y +  D
Sbjct: 148 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVD 207
Query: 309 IHQLN-LIMEMLGTPP 323
           +  +  L+ EM    P
Sbjct: 208 VWAIGCLVTEMFMGEP 223

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 88/333 (26%), Positives = 145/333 (43%), Gaps = 64/333 (19%)
Query: 76  SFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKR-TYRELRMLKHMNHENVIGLLDVFH 134
           SF +++ + L   SG  VAIKK+       +  KR   REL++++ ++H N++ L   F+
Sbjct: 32  SFGVVYQAKLCD-SGELVAIKKV-------LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 135 SNTCLADFKNVYMVTHLMGADLNNILR-----TQKLSDDHVQFLVYQILRGLKYIHSAGI 189
           S+    D   + +V   +   +  + R      Q L   +V+  +YQ+ R L YIHS GI
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 143
Query: 190 IHRDLKPSNIAVNEDCE-LKILDFG----LARPTENEMTGYVATRWYRAPEIMLNWMHYN 244
            HRD+KP N+ ++ D   LK+ DFG    L R   N    Y+ +R+YRAPE++     Y 
Sbjct: 144 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRYYRAPELIFGATDYT 201
Query: 245 QTGVPFYFQDLKPSNIAV-NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH 303
                        S+I V +  C L  L  G                           + 
Sbjct: 202 -------------SSIDVWSAGCVLAELLLG-------------------------QPIF 223
Query: 304 YNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGAN-PQAI 362
              + + QL  I+++LGTP  E + +++ +         P +    + +VF+    P+AI
Sbjct: 224 PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE---FKFPQIKAHPWTKVFRPRTPPEAI 280
Query: 363 XXXXXXXXXXXXKRITAEQALAHPYLSQYSDPN 395
                        R+T  +A AH +  +  DPN
Sbjct: 281 ALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 93  VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM 152
           VA+K+I    +         RE+ +LK + H N++ L D+ H+       K++ +V   +
Sbjct: 30  VALKEIRLEHEEGAPCT-AIREVSLLKDLKHANIVTLHDIIHTE------KSLTLVFEYL 82
Query: 153 GADLNNILR--TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKIL 210
             DL   L      ++  +V+  ++Q+LRGL Y H   ++HRDLKP N+ +NE  ELK+ 
Sbjct: 83  DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLA 142
Query: 211 DFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQT----GVPFYFQDL---KPSNI 260
           DFGLAR        Y   V T WYR P+I+L    Y+      GV   F ++   +P   
Sbjct: 143 DFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFP 202
Query: 261 AVNEDCELKILDFGLARPTENEMTGYVATRWYRA 294
               + +L  +   L  PTE    G ++   ++ 
Sbjct: 203 GSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 64/163 (39%), Gaps = 28/163 (17%)
Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYN-QTD 308
           +DLKP N+ +NE  ELK+ DFGLAR        Y   V T WYR P+I+L    Y+ Q D
Sbjct: 124 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQID 183
Query: 309 I-----------------------HQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLL 345
           +                        QL+ I  +LGTP  E    I S+   K  N  P  
Sbjct: 184 MWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYN-YPKY 242
Query: 346 TKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYL 388
             +         +                 RI+AE A+ HP+ 
Sbjct: 243 RAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF 285

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 83/162 (51%), Gaps = 11/162 (6%)
Query: 90  GVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT 149
           G   A+KKI    +       T RE+ +LK + H N++ L DV H+       K + +V 
Sbjct: 26  GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK------KRLVLVF 79
Query: 150 HLMGADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
             +  DL  +L   +  L     +  + Q+L G+ Y H   ++HRDLKP N+ +N + EL
Sbjct: 80  EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGEL 139
Query: 208 KILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQT 246
           KI DFGLAR     +  Y   V T WYRAP++++    Y+ T
Sbjct: 140 KIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTT 181

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 70/165 (42%), Gaps = 29/165 (17%)
Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQT-- 307
           +DLKP N+ +N + ELKI DFGLAR     +  Y   V T WYRAP++++    Y+ T  
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTID 183
Query: 308 ----------------------DIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLL 345
                                 +  QL  I  +LGTP ++    ++     KY  +  + 
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT--ELPKYDPNFTVY 241
Query: 346 TKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQ 390
               +    KG +   I            +RITA+QAL H Y  +
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 87/338 (25%), Positives = 148/338 (43%), Gaps = 66/338 (19%)
Query: 72  LSKESFDLIFSSALDSVSGVKVAIKKI--ARPFQSAVHAKRTYRELRMLKHMNHENVIGL 129
           +   SF +++ + L   SG  VAIKK+   + F++        REL++++ ++H N++ L
Sbjct: 28  IGNGSFGVVYQAKLCD-SGELVAIKKVLQGKAFKN--------RELQIMRKLDHCNIVRL 78
Query: 130 LDVFHSNTCLADFKNVYMVTHLMGADLNNILR-----TQKLSDDHVQFLVYQILRGLKYI 184
              F+S+    D   + +V   + A +  + R      Q L   +V+  +YQ+ R L YI
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 185 HSAGIIHRDLKPSNIAVNEDCE-LKILDFG----LARPTENEMTGYVATRWYRAPEIMLN 239
           HS GI HRD+KP N+ ++ D   LK+ DFG    L R   N     + +R+YRAPE++  
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRYYRAPELIFG 196
Query: 240 WMHYNQTGVPFYFQDLKPSNIAV-NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM 298
              Y              S+I V +  C L  L  G                        
Sbjct: 197 ATDYT-------------SSIDVWSAGCVLAELLLG------------------------ 219
Query: 299 LNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGAN 358
              +    + + QL  I+++LGTP  E + +++ +       + P +    + +VF+   
Sbjct: 220 -QPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE---FAFPQIKAHPWTKVFRPRT 275
Query: 359 -PQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPN 395
            P+AI             R+T  +A AH +  +  DPN
Sbjct: 276 PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 90/363 (24%), Positives = 150/363 (41%), Gaps = 90/363 (24%)
Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVI 127
           +G TL   SF ++     D  SG + A+KK+ +        +   REL ++K ++H N+I
Sbjct: 11  LGKTLGTGSFGIV-CEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDHVNII 63
Query: 128 GLLDVF------------------------------HSNTCLADFKNVYM--VTHLMGAD 155
            L+D F                              H +  +   +N Y+  +   +   
Sbjct: 64  KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDT 123
Query: 156 LNNILRT-----QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN-EDCELKI 209
           L+ +L++     + +  + +   +YQ+ R + +IHS GI HRD+KP N+ VN +D  LK+
Sbjct: 124 LHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKL 183
Query: 210 LDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDC 266
            DFG A+   P+E  +   + +R+YRAPE+ML    Y             PS    +  C
Sbjct: 184 CDFGSAKKLIPSEPSV-AXICSRFYRAPELMLGATEYT------------PSIDLWSIGC 230
Query: 267 ELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEF 326
               L  G  +P                       +   +T I QL  I++++GTP  E 
Sbjct: 231 VFGELILG--KP-----------------------LFSGETSIDQLVRIIQIMGTPTKEQ 265
Query: 327 MAKISSDSARKYINSLPLLTKKDFRQVFKGANPQ-AIXXXXXXXXXXXXKRITAEQALAH 385
           M +++           P L  KD+R++     P  AI             RI   +A+AH
Sbjct: 266 MIRMNPHYTEV---RFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAH 322
Query: 386 PYL 388
           P+ 
Sbjct: 323 PFF 325

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 88/333 (26%), Positives = 145/333 (43%), Gaps = 64/333 (19%)
Query: 76  SFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKR-TYRELRMLKHMNHENVIGLLDVFH 134
           SF +++ + L   SG  VAIKK+       +  KR   REL++++ ++H N++ L   F+
Sbjct: 45  SFGVVYQAKLCD-SGELVAIKKV-------LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 96
Query: 135 SNTCLADFKNVYMVTHLMGADLNNILR-----TQKLSDDHVQFLVYQILRGLKYIHSAGI 189
           S+    D   + +V   +   +  + R      Q L   +V+  +YQ+ R L YIHS GI
Sbjct: 97  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 156
Query: 190 IHRDLKPSNIAVNEDCE-LKILDFG----LARPTENEMTGYVATRWYRAPEIMLNWMHYN 244
            HRD+KP N+ ++ D   LK+ DFG    L R   N    Y+ +R+YRAPE++     Y 
Sbjct: 157 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRYYRAPELIFGATDYT 214
Query: 245 QTGVPFYFQDLKPSNIAV-NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH 303
                        S+I V +  C L  L  G                           + 
Sbjct: 215 -------------SSIDVWSAGCVLAELLLG-------------------------QPIF 236
Query: 304 YNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGAN-PQAI 362
              + + QL  I+++LGTP  E + +++ +         P +    + +VF+    P+AI
Sbjct: 237 PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE---FKFPQIKAHPWTKVFRPRTPPEAI 293
Query: 363 XXXXXXXXXXXXKRITAEQALAHPYLSQYSDPN 395
                        R+T  +A AH +  +  DPN
Sbjct: 294 ALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 326

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 88/337 (26%), Positives = 146/337 (43%), Gaps = 64/337 (18%)
Query: 72  LSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKR-TYRELRMLKHMNHENVIGLL 130
           +   SF +++ + L   SG  VAIKK+       +  KR   REL++++ ++H N++ L 
Sbjct: 64  IGNGSFGVVYQAKLCD-SGELVAIKKV-------LQDKRFKNRELQIMRKLDHCNIVRLR 115
Query: 131 DVFHSNTCLADFKNVYMVTHLMGADLNNILR-----TQKLSDDHVQFLVYQILRGLKYIH 185
             F+S+    D   + +V   +   +  + R      Q L   +V+  +YQ+ R L YIH
Sbjct: 116 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 175
Query: 186 SAGIIHRDLKPSNIAVNEDCE-LKILDFG----LARPTENEMTGYVATRWYRAPEIMLNW 240
           S GI HRD+KP N+ ++ D   LK+ DFG    L R   N    Y+ +R+YRAPE++   
Sbjct: 176 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRYYRAPELIFGA 233
Query: 241 MHYNQTGVPFYFQDLKPSNIAV-NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML 299
             Y              S+I V +  C L  L  G                         
Sbjct: 234 TDYT-------------SSIDVWSAGCVLAELLLG------------------------- 255
Query: 300 NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGAN- 358
             +    + + QL  I+++LGTP  E + +++ +         P +    + +VF+    
Sbjct: 256 QPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE---FKFPQIKAHPWTKVFRPRTP 312
Query: 359 PQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPN 395
           P+AI             R+T  +A AH +  +  DPN
Sbjct: 313 PEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 349

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 88/337 (26%), Positives = 146/337 (43%), Gaps = 64/337 (18%)
Query: 72  LSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKR-TYRELRMLKHMNHENVIGLL 130
           +   SF +++ + L   SG  VAIKK+       +  KR   REL++++ ++H N++ L 
Sbjct: 107 IGNGSFGVVYQAKLCD-SGELVAIKKV-------LQDKRFKNRELQIMRKLDHCNIVRLR 158
Query: 131 DVFHSNTCLADFKNVYMVTHLMGADLNNILR-----TQKLSDDHVQFLVYQILRGLKYIH 185
             F+S+    D   + +V   +   +  + R      Q L   +V+  +YQ+ R L YIH
Sbjct: 159 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 218
Query: 186 SAGIIHRDLKPSNIAVNEDCE-LKILDFG----LARPTENEMTGYVATRWYRAPEIMLNW 240
           S GI HRD+KP N+ ++ D   LK+ DFG    L R   N    Y+ +R+YRAPE++   
Sbjct: 219 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRYYRAPELIFGA 276
Query: 241 MHYNQTGVPFYFQDLKPSNIAV-NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML 299
             Y              S+I V +  C L  L  G                         
Sbjct: 277 TDYT-------------SSIDVWSAGCVLAELLLG------------------------- 298
Query: 300 NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGAN- 358
             +    + + QL  I+++LGTP  E + +++ +         P +    + +VF+    
Sbjct: 299 QPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE---FKFPQIKAHPWTKVFRPRTP 355
Query: 359 PQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPN 395
           P+AI             R+T  +A AH +  +  DPN
Sbjct: 356 PEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 392

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 83/162 (51%), Gaps = 11/162 (6%)
Query: 90  GVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT 149
           G   A+KKI    +       T RE+ +LK + H N++ L DV H+       K + +V 
Sbjct: 26  GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK------KRLVLVF 79
Query: 150 HLMGADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
             +  DL  +L   +  L     +  + Q+L G+ Y H   ++HRDLKP N+ +N + EL
Sbjct: 80  EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGEL 139
Query: 208 KILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQT 246
           KI DFGLAR     +  Y   + T WYRAP++++    Y+ T
Sbjct: 140 KIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 70/165 (42%), Gaps = 29/165 (17%)
Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQT-- 307
           +DLKP N+ +N + ELKI DFGLAR     +  Y   + T WYRAP++++    Y+ T  
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTID 183
Query: 308 ----------------------DIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLL 345
                                 +  QL  I  +LGTP ++    ++     KY  +  + 
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT--ELPKYDPNFTVY 241
Query: 346 TKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQ 390
               +    KG +   I            +RITA+QAL H Y  +
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 88/337 (26%), Positives = 146/337 (43%), Gaps = 64/337 (18%)
Query: 72  LSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKR-TYRELRMLKHMNHENVIGLL 130
           +   SF +++ + L   SG  VAIKK+       +  KR   REL++++ ++H N++ L 
Sbjct: 66  IGNGSFGVVYQAKLCD-SGELVAIKKV-------LQDKRFKNRELQIMRKLDHCNIVRLR 117
Query: 131 DVFHSNTCLADFKNVYMVTHLMGADLNNILR-----TQKLSDDHVQFLVYQILRGLKYIH 185
             F+S+    D   + +V   +   +  + R      Q L   +V+  +YQ+ R L YIH
Sbjct: 118 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 177
Query: 186 SAGIIHRDLKPSNIAVNEDCE-LKILDFG----LARPTENEMTGYVATRWYRAPEIMLNW 240
           S GI HRD+KP N+ ++ D   LK+ DFG    L R   N    Y+ +R+YRAPE++   
Sbjct: 178 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRYYRAPELIFGA 235
Query: 241 MHYNQTGVPFYFQDLKPSNIAV-NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML 299
             Y              S+I V +  C L  L  G                         
Sbjct: 236 TDYT-------------SSIDVWSAGCVLAELLLG------------------------- 257
Query: 300 NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGAN- 358
             +    + + QL  I+++LGTP  E + +++ +         P +    + +VF+    
Sbjct: 258 QPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE---FKFPQIKAHPWTKVFRPRTP 314
Query: 359 PQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPN 395
           P+AI             R+T  +A AH +  +  DPN
Sbjct: 315 PEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 351

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 88/333 (26%), Positives = 145/333 (43%), Gaps = 64/333 (19%)
Query: 76  SFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKR-TYRELRMLKHMNHENVIGLLDVFH 134
           SF +++ + L   SG  VAIKK+       +  KR   REL++++ ++H N++ L   F+
Sbjct: 66  SFGVVYQAKLCD-SGELVAIKKV-------LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 117
Query: 135 SNTCLADFKNVYMVTHLMGADLNNILR-----TQKLSDDHVQFLVYQILRGLKYIHSAGI 189
           S+    D   + +V   +   +  + R      Q L   +V+  +YQ+ R L YIHS GI
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 177
Query: 190 IHRDLKPSNIAVNEDCE-LKILDFG----LARPTENEMTGYVATRWYRAPEIMLNWMHYN 244
            HRD+KP N+ ++ D   LK+ DFG    L R   N    Y+ +R+YRAPE++     Y 
Sbjct: 178 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRYYRAPELIFGATDYT 235
Query: 245 QTGVPFYFQDLKPSNIAV-NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH 303
                        S+I V +  C L  L  G                           + 
Sbjct: 236 -------------SSIDVWSAGCVLAELLLG-------------------------QPIF 257
Query: 304 YNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGAN-PQAI 362
              + + QL  I+++LGTP  E + +++ +         P +    + +VF+    P+AI
Sbjct: 258 PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE---FKFPQIKAHPWTKVFRPRTPPEAI 314
Query: 363 XXXXXXXXXXXXKRITAEQALAHPYLSQYSDPN 395
                        R+T  +A AH +  +  DPN
Sbjct: 315 ALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 347

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 88/333 (26%), Positives = 145/333 (43%), Gaps = 64/333 (19%)
Query: 76  SFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKR-TYRELRMLKHMNHENVIGLLDVFH 134
           SF +++ + L   SG  VAIKK+       +  KR   REL++++ ++H N++ L   F+
Sbjct: 60  SFGVVYQAKLCD-SGELVAIKKV-------LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 111
Query: 135 SNTCLADFKNVYMVTHLMGADLNNILR-----TQKLSDDHVQFLVYQILRGLKYIHSAGI 189
           S+    D   + +V   +   +  + R      Q L   +V+  +YQ+ R L YIHS GI
Sbjct: 112 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 171
Query: 190 IHRDLKPSNIAVNEDCE-LKILDFG----LARPTENEMTGYVATRWYRAPEIMLNWMHYN 244
            HRD+KP N+ ++ D   LK+ DFG    L R   N    Y+ +R+YRAPE++     Y 
Sbjct: 172 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRYYRAPELIFGATDYT 229
Query: 245 QTGVPFYFQDLKPSNIAV-NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH 303
                        S+I V +  C L  L  G                           + 
Sbjct: 230 -------------SSIDVWSAGCVLAELLLG-------------------------QPIF 251
Query: 304 YNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGAN-PQAI 362
              + + QL  I+++LGTP  E + +++ +         P +    + +VF+    P+AI
Sbjct: 252 PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE---FKFPQIKAHPWTKVFRPRTPPEAI 308
Query: 363 XXXXXXXXXXXXKRITAEQALAHPYLSQYSDPN 395
                        R+T  +A AH +  +  DPN
Sbjct: 309 ALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 341

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 88/337 (26%), Positives = 146/337 (43%), Gaps = 64/337 (18%)
Query: 72  LSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKR-TYRELRMLKHMNHENVIGLL 130
           +   SF +++ + L   SG  VAIKK+       +  KR   REL++++ ++H N++ L 
Sbjct: 33  IGNGSFGVVYQAKLCD-SGELVAIKKV-------LQDKRFKNRELQIMRKLDHCNIVRLR 84
Query: 131 DVFHSNTCLADFKNVYMVTHLMGADLNNILR-----TQKLSDDHVQFLVYQILRGLKYIH 185
             F+S+    D   + +V   +   +  + R      Q L   +V+  +YQ+ R L YIH
Sbjct: 85  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 144
Query: 186 SAGIIHRDLKPSNIAVNEDCE-LKILDFG----LARPTENEMTGYVATRWYRAPEIMLNW 240
           S GI HRD+KP N+ ++ D   LK+ DFG    L R   N    Y+ +R+YRAPE++   
Sbjct: 145 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRYYRAPELIFGA 202
Query: 241 MHYNQTGVPFYFQDLKPSNIAV-NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML 299
             Y              S+I V +  C L  L  G                         
Sbjct: 203 TDYT-------------SSIDVWSAGCVLAELLLG------------------------- 224
Query: 300 NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGAN- 358
             +    + + QL  I+++LGTP  E + +++ +         P +    + +VF+    
Sbjct: 225 QPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE---FKFPQIKAHPWTKVFRPRTP 281
Query: 359 PQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPN 395
           P+AI             R+T  +A AH +  +  DPN
Sbjct: 282 PEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 318

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 92/340 (27%), Positives = 147/340 (43%), Gaps = 62/340 (18%)
Query: 72  LSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLD 131
           + + +F  +F  A    +G KVA+KK+    +         RE+++L+ + HENV+ L++
Sbjct: 26  IGQGTFGEVFK-ARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 132 VFHS-----NTCLADFKNVY-MVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIH 185
           +  +     N C A    V+    H +   L+N+L    LS+  ++ ++  +L GL YIH
Sbjct: 85  ICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVMQMLLNGLYYIH 142
Query: 186 SAGIIHRDLKPSNIAVNEDCELKILDFGLARP-------TENEMTGYVATRWYRAPEIML 238
              I+HRD+K +N+ +  D  LK+ DFGLAR          N     V T WYR PE++L
Sbjct: 143 RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLL 202
Query: 239 NWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM 298
               Y   G P                     +D   A     EM       W R+P + 
Sbjct: 203 GERDY---GPP---------------------IDLWGAGCIMAEM-------WTRSPIMQ 231
Query: 299 LNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLT--KKDFRQVFKG 356
            N      T+ HQL LI ++ G+   E    +  D+   Y   L L+   K+  +   K 
Sbjct: 232 GN------TEQHQLALISQLCGSITPEVWPNV--DNYELY-EKLELVKGQKRKVKDRLKA 282
Query: 357 --ANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDP 394
              +P A+            +RI ++ AL H +   +SDP
Sbjct: 283 YVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF--WSDP 320

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 87/333 (26%), Positives = 144/333 (43%), Gaps = 64/333 (19%)
Query: 76  SFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKR-TYRELRMLKHMNHENVIGLLDVFH 134
           SF +++ + L   SG  VAIKK+       +  KR   REL++++ ++H N++ L   F+
Sbjct: 32  SFGVVYQAKLCD-SGELVAIKKV-------LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 135 SNTCLADFKNVYMVTHLMGADLNNILR-----TQKLSDDHVQFLVYQILRGLKYIHSAGI 189
           S+    D   + +V   +   +  + R      Q L   +V+  +YQ+ R L YIHS GI
Sbjct: 84  SSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 143
Query: 190 IHRDLKPSNIAVNEDCE-LKILDFG----LARPTENEMTGYVATRWYRAPEIMLNWMHYN 244
            HRD+KP N+ ++ D   LK+ DFG    L R   N     + +R+YRAPE++     Y 
Sbjct: 144 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRYYRAPELIFGATDYT 201
Query: 245 QTGVPFYFQDLKPSNIAV-NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH 303
                        S+I V +  C L  L  G                           + 
Sbjct: 202 -------------SSIDVWSAGCVLAELLLG-------------------------QPIF 223
Query: 304 YNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGAN-PQAI 362
              + + QL  I+++LGTP  E + +++ +         P +    + +VF+    P+AI
Sbjct: 224 PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE---FKFPQIKAHPWTKVFRPRTPPEAI 280
Query: 363 XXXXXXXXXXXXKRITAEQALAHPYLSQYSDPN 395
                        R+T  +A AH +  +  DPN
Sbjct: 281 ALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 91/340 (26%), Positives = 146/340 (42%), Gaps = 62/340 (18%)
Query: 72  LSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLD 131
           + + +F  +F  A    +G KVA+KK+    +         RE+++L+ + HENV+ L++
Sbjct: 26  IGQGTFGEVFK-ARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 132 VFHS-----NTCLADFKNVY-MVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIH 185
           +  +     N C      V+    H +   L+N+L    LS+  ++ ++  +L GL YIH
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVMQMLLNGLYYIH 142
Query: 186 SAGIIHRDLKPSNIAVNEDCELKILDFGLARP-------TENEMTGYVATRWYRAPEIML 238
              I+HRD+K +N+ +  D  LK+ DFGLAR          N     V T WYR PE++L
Sbjct: 143 RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLL 202
Query: 239 NWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM 298
               Y   G P                     +D   A     EM       W R+P + 
Sbjct: 203 GERDY---GPP---------------------IDLWGAGCIMAEM-------WTRSPIMQ 231
Query: 299 LNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLT--KKDFRQVFKG 356
            N      T+ HQL LI ++ G+   E    +  D+   Y   L L+   K+  +   K 
Sbjct: 232 GN------TEQHQLALISQLCGSITPEVWPNV--DNYELY-EKLELVKGQKRKVKDRLKA 282
Query: 357 --ANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDP 394
              +P A+            +RI ++ AL H +   +SDP
Sbjct: 283 YVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF--WSDP 320

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 91/340 (26%), Positives = 146/340 (42%), Gaps = 62/340 (18%)
Query: 72  LSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLD 131
           + + +F  +F  A    +G KVA+KK+    +         RE+++L+ + HENV+ L++
Sbjct: 26  IGQGTFGEVFK-ARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 132 VFHS-----NTCLADFKNVY-MVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIH 185
           +  +     N C      V+    H +   L+N+L    LS+  ++ ++  +L GL YIH
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVMQMLLNGLYYIH 142
Query: 186 SAGIIHRDLKPSNIAVNEDCELKILDFGLARP-------TENEMTGYVATRWYRAPEIML 238
              I+HRD+K +N+ +  D  LK+ DFGLAR          N     V T WYR PE++L
Sbjct: 143 RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLL 202
Query: 239 NWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM 298
               Y   G P                     +D   A     EM       W R+P + 
Sbjct: 203 GERDY---GPP---------------------IDLWGAGCIMAEM-------WTRSPIMQ 231
Query: 299 LNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLT--KKDFRQVFKG 356
            N      T+ HQL LI ++ G+   E    +  D+   Y   L L+   K+  +   K 
Sbjct: 232 GN------TEQHQLALISQLCGSITPEVWPNV--DNYELY-EKLELVKGQKRKVKDRLKA 282
Query: 357 --ANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDP 394
              +P A+            +RI ++ AL H +   +SDP
Sbjct: 283 YVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF--WSDP 320

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 91/340 (26%), Positives = 146/340 (42%), Gaps = 62/340 (18%)
Query: 72  LSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLD 131
           + + +F  +F  A    +G KVA+KK+    +         RE+++L+ + HENV+ L++
Sbjct: 25  IGQGTFGEVFK-ARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 132 VFHS-----NTCLADFKNVY-MVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIH 185
           +  +     N C      V+    H +   L+N+L    LS+  ++ ++  +L GL YIH
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVMQMLLNGLYYIH 141
Query: 186 SAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE-------NEMTGYVATRWYRAPEIML 238
              I+HRD+K +N+ +  D  LK+ DFGLAR          N     V T WYR PE++L
Sbjct: 142 RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLL 201
Query: 239 NWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM 298
               Y   G P                     +D   A     EM       W R+P + 
Sbjct: 202 GERDY---GPP---------------------IDLWGAGCIMAEM-------WTRSPIMQ 230
Query: 299 LNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLT--KKDFRQVFKG 356
            N      T+ HQL LI ++ G+   E    +  D+   Y   L L+   K+  +   K 
Sbjct: 231 GN------TEQHQLALISQLCGSITPEVWPNV--DNYELY-EKLELVKGQKRKVKDRLKA 281
Query: 357 --ANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDP 394
              +P A+            +RI ++ AL H +   +SDP
Sbjct: 282 YVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF--WSDP 319

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 87/333 (26%), Positives = 144/333 (43%), Gaps = 64/333 (19%)
Query: 76  SFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKR-TYRELRMLKHMNHENVIGLLDVFH 134
           SF +++ + L   SG  VAIKK+       +  KR   REL++++ ++H N++ L   F+
Sbjct: 36  SFGVVYQAKLCD-SGELVAIKKV-------LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 87
Query: 135 SNTCLADFKNVYMVTHLMGADLNNILR-----TQKLSDDHVQFLVYQILRGLKYIHSAGI 189
           S+    D   + +V   +   +  + R      Q L   +V+  +YQ+ R L YIHS GI
Sbjct: 88  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 147
Query: 190 IHRDLKPSNIAVNEDCE-LKILDFG----LARPTENEMTGYVATRWYRAPEIMLNWMHYN 244
            HRD+KP N+ ++ D   LK+ DFG    L R   N     + +R+YRAPE++     Y 
Sbjct: 148 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRYYRAPELIFGATDYT 205
Query: 245 QTGVPFYFQDLKPSNIAV-NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH 303
                        S+I V +  C L  L  G                           + 
Sbjct: 206 -------------SSIDVWSAGCVLAELLLG-------------------------QPIF 227
Query: 304 YNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGAN-PQAI 362
              + + QL  I+++LGTP  E + +++ +         P +    + +VF+    P+AI
Sbjct: 228 PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE---FKFPQIKAHPWTKVFRPRTPPEAI 284
Query: 363 XXXXXXXXXXXXKRITAEQALAHPYLSQYSDPN 395
                        R+T  +A AH +  +  DPN
Sbjct: 285 ALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 317

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 87/333 (26%), Positives = 144/333 (43%), Gaps = 64/333 (19%)
Query: 76  SFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKR-TYRELRMLKHMNHENVIGLLDVFH 134
           SF +++ + L   SG  VAIKK+       +  KR   REL++++ ++H N++ L   F+
Sbjct: 32  SFGVVYQAKLCD-SGELVAIKKV-------LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 135 SNTCLADFKNVYMVTHLMGADLNNILR-----TQKLSDDHVQFLVYQILRGLKYIHSAGI 189
           S+    D   + +V   +   +  + R      Q L   +V+  +YQ+ R L YIHS GI
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 143
Query: 190 IHRDLKPSNIAVNEDCE-LKILDFG----LARPTENEMTGYVATRWYRAPEIMLNWMHYN 244
            HRD+KP N+ ++ D   LK+ DFG    L R   N     + +R+YRAPE++     Y 
Sbjct: 144 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRYYRAPELIFGATDYT 201
Query: 245 QTGVPFYFQDLKPSNIAV-NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH 303
                        S+I V +  C L  L  G                           + 
Sbjct: 202 -------------SSIDVWSAGCVLAELLLG-------------------------QPIF 223
Query: 304 YNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGAN-PQAI 362
              + + QL  I+++LGTP  E + +++ +         P +    + +VF+    P+AI
Sbjct: 224 PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE---FKFPQIKAHPWTKVFRPRTPPEAI 280
Query: 363 XXXXXXXXXXXXKRITAEQALAHPYLSQYSDPN 395
                        R+T  +A AH +  +  DPN
Sbjct: 281 ALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 87/333 (26%), Positives = 144/333 (43%), Gaps = 64/333 (19%)
Query: 76  SFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKR-TYRELRMLKHMNHENVIGLLDVFH 134
           SF +++ + L   SG  VAIKK+       +  KR   REL++++ ++H N++ L   F+
Sbjct: 33  SFGVVYQAKLCD-SGELVAIKKV-------LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 84
Query: 135 SNTCLADFKNVYMVTHLMGADLNNILR-----TQKLSDDHVQFLVYQILRGLKYIHSAGI 189
           S+    D   + +V   +   +  + R      Q L   +V+  +YQ+ R L YIHS GI
Sbjct: 85  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 144
Query: 190 IHRDLKPSNIAVNEDCE-LKILDFG----LARPTENEMTGYVATRWYRAPEIMLNWMHYN 244
            HRD+KP N+ ++ D   LK+ DFG    L R   N     + +R+YRAPE++     Y 
Sbjct: 145 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRYYRAPELIFGATDYT 202
Query: 245 QTGVPFYFQDLKPSNIAV-NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH 303
                        S+I V +  C L  L  G                           + 
Sbjct: 203 -------------SSIDVWSAGCVLAELLLG-------------------------QPIF 224
Query: 304 YNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGAN-PQAI 362
              + + QL  I+++LGTP  E + +++ +         P +    + +VF+    P+AI
Sbjct: 225 PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE---FKFPQIKAHPWTKVFRPRTPPEAI 281
Query: 363 XXXXXXXXXXXXKRITAEQALAHPYLSQYSDPN 395
                        R+T  +A AH +  +  DPN
Sbjct: 282 ALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 314

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 87/333 (26%), Positives = 144/333 (43%), Gaps = 64/333 (19%)
Query: 76  SFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKR-TYRELRMLKHMNHENVIGLLDVFH 134
           SF +++ + L   SG  VAIKK+       +  KR   REL++++ ++H N++ L   F+
Sbjct: 32  SFGVVYQAKLCD-SGELVAIKKV-------LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 135 SNTCLADFKNVYMVTHLMGADLNNILR-----TQKLSDDHVQFLVYQILRGLKYIHSAGI 189
           S+    D   + +V   +   +  + R      Q L   +V+  +YQ+ R L YIHS GI
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 143
Query: 190 IHRDLKPSNIAVNEDCE-LKILDFG----LARPTENEMTGYVATRWYRAPEIMLNWMHYN 244
            HRD+KP N+ ++ D   LK+ DFG    L R   N     + +R+YRAPE++     Y 
Sbjct: 144 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRYYRAPELIFGATDYT 201
Query: 245 QTGVPFYFQDLKPSNIAV-NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH 303
                        S+I V +  C L  L  G                           + 
Sbjct: 202 -------------SSIDVWSAGCVLAELLLG-------------------------QPIF 223
Query: 304 YNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGAN-PQAI 362
              + + QL  I+++LGTP  E + +++ +         P +    + +VF+    P+AI
Sbjct: 224 PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE---FKFPQIKAHPWTKVFRPRTPPEAI 280
Query: 363 XXXXXXXXXXXXKRITAEQALAHPYLSQYSDPN 395
                        R+T  +A AH +  +  DPN
Sbjct: 281 ALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 85/317 (26%), Positives = 131/317 (41%), Gaps = 55/317 (17%)
Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
           A+D+V+   VAIK+I    +         RE+ +LK + H N+I L  V H N       
Sbjct: 53  AIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN------H 106
Query: 144 NVYMVTHLMGADLNNIL-RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSN--IA 200
            ++++      DL   + +   +S   ++  +YQ++ G+ + HS   +HRDLKP N  ++
Sbjct: 107 RLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLS 166
Query: 201 VNEDCE---LKILDFGLARPTE---NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQD 254
           V++  E   LKI DFGLAR       + T  + T WYR PEI+L   HY+ T V  +   
Sbjct: 167 VSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYS-TSVDIW--- 222
Query: 255 LKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNL 314
                                           +A  W  A  +M   +    ++I QL  
Sbjct: 223 -------------------------------SIACIW--AEMLMKTPLFPGDSEIDQLFK 249
Query: 315 IMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXX- 373
           I E+LG P       +++    K   S P    K  ++V                     
Sbjct: 250 IFEVLGLPDDTTWPGVTALPDWK--QSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDP 307
Query: 374 XKRITAEQALAHPYLSQ 390
            KRI+A+ AL HPY S 
Sbjct: 308 VKRISAKNALEHPYFSH 324

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 87/333 (26%), Positives = 144/333 (43%), Gaps = 64/333 (19%)
Query: 76  SFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKR-TYRELRMLKHMNHENVIGLLDVFH 134
           SF +++ + L   SG  VAIKK+       +  KR   REL++++ ++H N++ L   F+
Sbjct: 44  SFGVVYQAKLCD-SGELVAIKKV-------LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 95
Query: 135 SNTCLADFKNVYMVTHLMGADLNNILR-----TQKLSDDHVQFLVYQILRGLKYIHSAGI 189
           S+    D   + +V   +   +  + R      Q L   +V+  +YQ+ R L YIHS GI
Sbjct: 96  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 155
Query: 190 IHRDLKPSNIAVNEDCE-LKILDFG----LARPTENEMTGYVATRWYRAPEIMLNWMHYN 244
            HRD+KP N+ ++ D   LK+ DFG    L R   N     + +R+YRAPE++     Y 
Sbjct: 156 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRYYRAPELIFGATDYT 213
Query: 245 QTGVPFYFQDLKPSNIAV-NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH 303
                        S+I V +  C L  L  G                           + 
Sbjct: 214 -------------SSIDVWSAGCVLAELLLG-------------------------QPIF 235
Query: 304 YNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGAN-PQAI 362
              + + QL  I+++LGTP  E + +++ +         P +    + +VF+    P+AI
Sbjct: 236 PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE---FKFPQIKAHPWTKVFRPRTPPEAI 292
Query: 363 XXXXXXXXXXXXKRITAEQALAHPYLSQYSDPN 395
                        R+T  +A AH +  +  DPN
Sbjct: 293 ALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 325

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 87/333 (26%), Positives = 144/333 (43%), Gaps = 64/333 (19%)
Query: 76  SFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKR-TYRELRMLKHMNHENVIGLLDVFH 134
           SF +++ + L   SG  VAIKK+       +  KR   REL++++ ++H N++ L   F+
Sbjct: 51  SFGVVYQAKLCD-SGELVAIKKV-------LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 102
Query: 135 SNTCLADFKNVYMVTHLMGADLNNILR-----TQKLSDDHVQFLVYQILRGLKYIHSAGI 189
           S+    D   + +V   +   +  + R      Q L   +V+  +YQ+ R L YIHS GI
Sbjct: 103 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 162
Query: 190 IHRDLKPSNIAVNEDCE-LKILDFG----LARPTENEMTGYVATRWYRAPEIMLNWMHYN 244
            HRD+KP N+ ++ D   LK+ DFG    L R   N     + +R+YRAPE++     Y 
Sbjct: 163 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRYYRAPELIFGATDYT 220
Query: 245 QTGVPFYFQDLKPSNIAV-NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH 303
                        S+I V +  C L  L  G                           + 
Sbjct: 221 -------------SSIDVWSAGCVLAELLLG-------------------------QPIF 242
Query: 304 YNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGAN-PQAI 362
              + + QL  I+++LGTP  E + +++ +         P +    + +VF+    P+AI
Sbjct: 243 PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE---FKFPQIKAHPWTKVFRPRTPPEAI 299
Query: 363 XXXXXXXXXXXXKRITAEQALAHPYLSQYSDPN 395
                        R+T  +A AH +  +  DPN
Sbjct: 300 ALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 332

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 87/333 (26%), Positives = 144/333 (43%), Gaps = 64/333 (19%)
Query: 76  SFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKR-TYRELRMLKHMNHENVIGLLDVFH 134
           SF +++ + L   SG  VAIKK+       +  KR   REL++++ ++H N++ L   F+
Sbjct: 66  SFGVVYQAKLCD-SGELVAIKKV-------LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 117
Query: 135 SNTCLADFKNVYMVTHLMGADLNNILR-----TQKLSDDHVQFLVYQILRGLKYIHSAGI 189
           S+    D   + +V   +   +  + R      Q L   +V+  +YQ+ R L YIHS GI
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 177
Query: 190 IHRDLKPSNIAVNEDCE-LKILDFG----LARPTENEMTGYVATRWYRAPEIMLNWMHYN 244
            HRD+KP N+ ++ D   LK+ DFG    L R   N     + +R+YRAPE++     Y 
Sbjct: 178 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRYYRAPELIFGATDYT 235
Query: 245 QTGVPFYFQDLKPSNIAV-NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH 303
                        S+I V +  C L  L  G                           + 
Sbjct: 236 -------------SSIDVWSAGCVLAELLLG-------------------------QPIF 257
Query: 304 YNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGAN-PQAI 362
              + + QL  I+++LGTP  E + +++ +         P +    + +VF+    P+AI
Sbjct: 258 PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE---FKFPQIKAHPWTKVFRPRTPPEAI 314
Query: 363 XXXXXXXXXXXXKRITAEQALAHPYLSQYSDPN 395
                        R+T  +A AH +  +  DPN
Sbjct: 315 ALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 347

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 87/333 (26%), Positives = 144/333 (43%), Gaps = 64/333 (19%)
Query: 76  SFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKR-TYRELRMLKHMNHENVIGLLDVFH 134
           SF +++ + L   SG  VAIKK+       +  KR   REL++++ ++H N++ L   F+
Sbjct: 44  SFGVVYQAKLCD-SGELVAIKKV-------LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 95
Query: 135 SNTCLADFKNVYMVTHLMGADLNNILR-----TQKLSDDHVQFLVYQILRGLKYIHSAGI 189
           S+    D   + +V   +   +  + R      Q L   +V+  +YQ+ R L YIHS GI
Sbjct: 96  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 155
Query: 190 IHRDLKPSNIAVNEDCE-LKILDFG----LARPTENEMTGYVATRWYRAPEIMLNWMHYN 244
            HRD+KP N+ ++ D   LK+ DFG    L R   N     + +R+YRAPE++     Y 
Sbjct: 156 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRYYRAPELIFGATDYT 213
Query: 245 QTGVPFYFQDLKPSNIAV-NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH 303
                        S+I V +  C L  L  G                           + 
Sbjct: 214 -------------SSIDVWSAGCVLAELLLG-------------------------QPIF 235
Query: 304 YNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGAN-PQAI 362
              + + QL  I+++LGTP  E + +++ +         P +    + +VF+    P+AI
Sbjct: 236 PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE---FKFPQIKAHPWTKVFRPRTPPEAI 292
Query: 363 XXXXXXXXXXXXKRITAEQALAHPYLSQYSDPN 395
                        R+T  +A AH +  +  DPN
Sbjct: 293 ALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 325

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 87/333 (26%), Positives = 144/333 (43%), Gaps = 64/333 (19%)
Query: 76  SFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKR-TYRELRMLKHMNHENVIGLLDVFH 134
           SF +++ + L   SG  VAIKK+       +  KR   REL++++ ++H N++ L   F+
Sbjct: 40  SFGVVYQAKLCD-SGELVAIKKV-------LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 91
Query: 135 SNTCLADFKNVYMVTHLMGADLNNILR-----TQKLSDDHVQFLVYQILRGLKYIHSAGI 189
           S+    D   + +V   +   +  + R      Q L   +V+  +YQ+ R L YIHS GI
Sbjct: 92  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 151
Query: 190 IHRDLKPSNIAVNEDCE-LKILDFG----LARPTENEMTGYVATRWYRAPEIMLNWMHYN 244
            HRD+KP N+ ++ D   LK+ DFG    L R   N     + +R+YRAPE++     Y 
Sbjct: 152 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRYYRAPELIFGATDYT 209
Query: 245 QTGVPFYFQDLKPSNIAV-NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH 303
                        S+I V +  C L  L  G                           + 
Sbjct: 210 -------------SSIDVWSAGCVLAELLLG-------------------------QPIF 231
Query: 304 YNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGAN-PQAI 362
              + + QL  I+++LGTP  E + +++ +         P +    + +VF+    P+AI
Sbjct: 232 PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE---FKFPQIKAHPWTKVFRPRTPPEAI 288
Query: 363 XXXXXXXXXXXXKRITAEQALAHPYLSQYSDPN 395
                        R+T  +A AH +  +  DPN
Sbjct: 289 ALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 321

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 91/178 (51%), Gaps = 12/178 (6%)
Query: 72  LSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLD 131
           + + S+ ++F    +  +G  VAIKK        V  K   RE+RMLK + H N++ LL+
Sbjct: 11  IGEGSYGVVFKCR-NRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 132 VFHSNTCLADFKNVYMVTHLMGAD-LNNILRTQKLSDDH-VQFLVYQILRGLKYIHSAGI 189
           VF         + +++V        L+ + R Q+   +H V+ + +Q L+ + + H    
Sbjct: 70  VFRRK------RRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNC 123
Query: 190 IHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYN 244
           IHRD+KP NI + +   +K+ DFG AR        Y   VATRWYR+PE+++    Y 
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYG 181

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 70/174 (40%), Gaps = 33/174 (18%)
Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHY----- 304
           +D+KP NI + +   +K+ DFG AR        Y   VATRWYR+PE+++    Y     
Sbjct: 126 RDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVD 185
Query: 305 -------------------NQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLL 345
                               ++D+ QL LI + LG          S++   +Y + + + 
Sbjct: 186 VWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN---QYFSGVKIP 242
Query: 346 TKKDFRQV---FKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPND 396
             +D   +   F   +  A+            +R+T EQ L HPY     +  D
Sbjct: 243 DPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIED 296

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/164 (36%), Positives = 84/164 (51%), Gaps = 9/164 (5%)
Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRE---LRMLKHMNHENVIGLLDVFHSNTCLA 140
           A D  SG  VA+K +  P         T RE   LR L+   H NV+ L+DV  ++    
Sbjct: 23  ARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDR 82
Query: 141 DFKNVYMVTHLMGADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPS 197
           + K   +  H+   DL   L       L  + ++ L+ Q LRGL ++H+  I+HRDLKP 
Sbjct: 83  EIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPE 141
Query: 198 NIAVNEDCELKILDFGLARPTENEMTGY--VATRWYRAPEIMLN 239
           NI V     +K+ DFGLAR    +M  +  V T WYRAPE++L 
Sbjct: 142 NILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVLLQ 185

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 72/175 (41%), Gaps = 27/175 (15%)
Query: 238 LNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGY--VATRWYRAP 295
           L+++H N        +DLKP NI V     +K+ DFGLAR    +M  +  V T WYRAP
Sbjct: 125 LDFLHANC----IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAP 180
Query: 296 EIMLNWMHYNQTDIHQLNLIM-EMLGTPPAEFMAKISSDSARKYINSLPLLTKKDF---- 350
           E++L   +    D+  +  I  EM    P  F     +D   K  + + L  + D+    
Sbjct: 181 EVLLQSTYATPVDMWSVGCIFAEMFRRKPL-FCGNSEADQLGKIFDLIGLPPEDDWPRDV 239
Query: 351 ---RQVFKGANPQAIXXXXXXXXXXXX------------KRITAEQALAHPYLSQ 390
              R  F    P+ +                        KRI+A +AL H YL +
Sbjct: 240 SLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 294

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 92/355 (25%), Positives = 153/355 (43%), Gaps = 64/355 (18%)
Query: 76  SFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKR-TYRELRMLKHMNHENVIGLLDVFH 134
           SF ++F + L  V   +VAIKK+       +  KR   REL++++ + H NV+ L   F+
Sbjct: 52  SFGVVFQAKL--VESDEVAIKKV-------LQDKRFKNRELQIMRIVKHPNVVDLKAFFY 102
Query: 135 SNTCLAD--FKNV---YMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGI 189
           SN    D  F N+   Y+   +  A  +     Q +    ++  +YQ+LR L YIHS GI
Sbjct: 103 SNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGI 162
Query: 190 IHRDLKPSNIAVNEDCE-LKILDFGLAR--PTENEMTGYVATRWYRAPEIMLNWMHYNQT 246
            HRD+KP N+ ++     LK++DFG A+           + +R+YRAPE++    +Y   
Sbjct: 163 CHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRAPELIFGATNYT-- 220
Query: 247 GVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQ 306
                      +NI +                     TG V     +        +   +
Sbjct: 221 -----------TNIDIWS-------------------TGCVMAELMQG-----QPLFPGE 245
Query: 307 TDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGAN-PQAIXXX 365
           + I QL  I+++LGTP  E   +I + +     +  P +    F +VF+    P AI   
Sbjct: 246 SGIDQLVEIIKVLGTPSRE---QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLI 302
Query: 366 XXXXXXXXXKRITAEQALAHPYLSQYSD-----PNDEPTSPPYDQSFEDMDLPVD 415
                     R+TA +AL HP+  +        PN     P ++ + E++ +  D
Sbjct: 303 SRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELSVRPD 357

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/319 (25%), Positives = 129/319 (40%), Gaps = 73/319 (22%)
Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN---HENVIGLLDVFHSNTCLADFKNV 145
            G  VA+K++            T RE+ +L+H+    H NV+ L DV   +    + K  
Sbjct: 36  GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 95
Query: 146 YMVTHLMGADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +  H +  DL   L       +  + ++ +++Q+LRGL ++HS  ++HRDLKP NI V 
Sbjct: 96  LVFEH-VDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT 154
Query: 203 EDCELKILDFGLARPTENEM--TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNI 260
              ++K+ DFGLAR    +M  T  V T WYRAPE++L   +                  
Sbjct: 155 SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSY------------------ 196
Query: 261 AVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLG 320
                          A P +    G +    +R   +         +D+ QL  I++++G
Sbjct: 197 ---------------ATPVDLWSVGCIFAEMFRRKPLF-----RGSSDVDQLGKILDVIG 236
Query: 321 TP-----------PAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXX 369
            P           P +     S+    K++  +  L K    +     NP          
Sbjct: 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLT-FNP---------- 285
Query: 370 XXXXXKRITAEQALAHPYL 388
                KRI+A  AL+HPY 
Sbjct: 286 ----AKRISAYSALSHPYF 300

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 98/191 (51%), Gaps = 22/191 (11%)
Query: 54  FNQPYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYR 113
           F + Y+ +C         L K SF  +     D ++  + A+K I +            R
Sbjct: 20  FAERYNIVC--------MLGKGSFGEVLKCK-DRITQQEYAVKVINKASAKNKDTSTILR 70
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHL-MGADL-NNILRTQKLSDDHVQ 171
           E+ +LK ++H N++ L ++      L D  + Y+V  L  G +L + I++ ++ S+    
Sbjct: 71  EVELLKKLDHPNIMKLFEI------LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA 124
Query: 172 FLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILDFGLARPTEN--EMTGYV 226
            ++ Q+  G+ Y+H   I+HRDLKP NI +    +DC++KI+DFGL+   +   +M   +
Sbjct: 125 RIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI 184
Query: 227 ATRWYRAPEIM 237
            T +Y APE++
Sbjct: 185 GTAYYIAPEVL 195

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 71/152 (46%), Gaps = 24/152 (15%)
Query: 253 QDLKPSNIAVN---EDCELKILDFGLARPTEN--EMTGYVATRWYRAPEIMLNWMHYNQT 307
           +DLKP NI +    +DC++KI+DFGL+   +   +M   + T +Y APE+ L   +  + 
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV-LRGTYDEKC 203
Query: 308 DIHQLNLIMEML--GTPPAEFMAKISSDSAR-----KYINSLPLLTKKDFRQVFKGANPQ 360
           D+    +I+ +L  GTPP  F  K   D  +     KY   LP          ++  +  
Sbjct: 204 DVWSAGVILYILLSGTPP--FYGKNEYDILKRVETGKYAFDLP---------QWRTISDD 252
Query: 361 AIXXXXXXXXXXXXKRITAEQALAHPYLSQYS 392
           A              RITA Q L HP++ +YS
Sbjct: 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/319 (25%), Positives = 129/319 (40%), Gaps = 73/319 (22%)
Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN---HENVIGLLDVFHSNTCLADFKNV 145
            G  VA+K++            T RE+ +L+H+    H NV+ L DV   +    + K  
Sbjct: 36  GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 95
Query: 146 YMVTHLMGADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +  H +  DL   L       +  + ++ +++Q+LRGL ++HS  ++HRDLKP NI V 
Sbjct: 96  LVFEH-VDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT 154
Query: 203 EDCELKILDFGLARPTENEM--TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNI 260
              ++K+ DFGLAR    +M  T  V T WYRAPE++L   +                  
Sbjct: 155 SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSY------------------ 196
Query: 261 AVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLG 320
                          A P +    G +    +R   +         +D+ QL  I++++G
Sbjct: 197 ---------------ATPVDLWSVGCIFAEMFRRKPLF-----RGSSDVDQLGKILDVIG 236
Query: 321 TP-----------PAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXX 369
            P           P +     S+    K++  +  L K    +     NP          
Sbjct: 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLT-FNP---------- 285
Query: 370 XXXXXKRITAEQALAHPYL 388
                KRI+A  AL+HPY 
Sbjct: 286 ----AKRISAYSALSHPYF 300

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/319 (25%), Positives = 129/319 (40%), Gaps = 73/319 (22%)
Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN---HENVIGLLDVFHSNTCLADFKNV 145
            G  VA+K++            T RE+ +L+H+    H NV+ L DV   +    + K  
Sbjct: 36  GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 95
Query: 146 YMVTHLMGADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +  H +  DL   L       +  + ++ +++Q+LRGL ++HS  ++HRDLKP NI V 
Sbjct: 96  LVFEH-VDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT 154
Query: 203 EDCELKILDFGLARPTENEM--TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNI 260
              ++K+ DFGLAR    +M  T  V T WYRAPE++L   +                  
Sbjct: 155 SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSY------------------ 196
Query: 261 AVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLG 320
                          A P +    G +    +R   +         +D+ QL  I++++G
Sbjct: 197 ---------------ATPVDLWSVGCIFAEMFRRKPLF-----RGSSDVDQLGKILDVIG 236
Query: 321 TP-----------PAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXX 369
            P           P +     S+    K++  +  L K    +     NP          
Sbjct: 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLT-FNP---------- 285
Query: 370 XXXXXKRITAEQALAHPYL 388
                KRI+A  AL+HPY 
Sbjct: 286 ----AKRISAYSALSHPYF 300

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/164 (36%), Positives = 83/164 (50%), Gaps = 9/164 (5%)
Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRE---LRMLKHMNHENVIGLLDVFHSNTCLA 140
           A D  SG  VA+K +  P         T RE   LR L+   H NV+ L+DV  ++    
Sbjct: 23  ARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDR 82
Query: 141 DFKNVYMVTHLMGADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPS 197
           + K   +  H+   DL   L       L  + ++ L+ Q LRGL ++H+  I+HRDLKP 
Sbjct: 83  EIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPE 141
Query: 198 NIAVNEDCELKILDFGLARPTENEM--TGYVATRWYRAPEIMLN 239
           NI V     +K+ DFGLAR    +M     V T WYRAPE++L 
Sbjct: 142 NILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEVLLQ 185

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 71/175 (40%), Gaps = 27/175 (15%)
Query: 238 LNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEM--TGYVATRWYRAP 295
           L+++H N        +DLKP NI V     +K+ DFGLAR    +M     V T WYRAP
Sbjct: 125 LDFLHANC----IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAP 180
Query: 296 EIMLNWMHYNQTDIHQLNLIM-EMLGTPPAEFMAKISSDSARKYINSLPLLTKKDF---- 350
           E++L   +    D+  +  I  EM    P  F     +D   K  + + L  + D+    
Sbjct: 181 EVLLQSTYATPVDMWSVGCIFAEMFRRKPL-FCGNSEADQLGKIFDLIGLPPEDDWPRDV 239
Query: 351 ---RQVFKGANPQAIXXXXXXXXXXXX------------KRITAEQALAHPYLSQ 390
              R  F    P+ +                        KRI+A +AL H YL +
Sbjct: 240 SLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 294

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/164 (36%), Positives = 83/164 (50%), Gaps = 9/164 (5%)
Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRE---LRMLKHMNHENVIGLLDVFHSNTCLA 140
           A D  SG  VA+K +  P         T RE   LR L+   H NV+ L+DV  ++    
Sbjct: 23  ARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDR 82
Query: 141 DFKNVYMVTHLMGADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPS 197
           + K   +  H+   DL   L       L  + ++ L+ Q LRGL ++H+  I+HRDLKP 
Sbjct: 83  EIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPE 141
Query: 198 NIAVNEDCELKILDFGLARPTENEMT--GYVATRWYRAPEIMLN 239
           NI V     +K+ DFGLAR    +M     V T WYRAPE++L 
Sbjct: 142 NILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVLLQ 185

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 71/175 (40%), Gaps = 27/175 (15%)
Query: 238 LNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMT--GYVATRWYRAP 295
           L+++H N        +DLKP NI V     +K+ DFGLAR    +M     V T WYRAP
Sbjct: 125 LDFLHANC----IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAP 180
Query: 296 EIMLNWMHYNQTDIHQLNLIM-EMLGTPPAEFMAKISSDSARKYINSLPLLTKKDF---- 350
           E++L   +    D+  +  I  EM    P  F     +D   K  + + L  + D+    
Sbjct: 181 EVLLQSTYATPVDMWSVGCIFAEMFRRKPL-FCGNSEADQLGKIFDLIGLPPEDDWPRDV 239
Query: 351 ---RQVFKGANPQAIXXXXXXXXXXXX------------KRITAEQALAHPYLSQ 390
              R  F    P+ +                        KRI+A +AL H YL +
Sbjct: 240 SLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 294

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 98/191 (51%), Gaps = 22/191 (11%)
Query: 54  FNQPYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYR 113
           F + Y+ +C         L K SF  +     D ++  + A+K I +            R
Sbjct: 20  FAERYNIVC--------MLGKGSFGEVLKCK-DRITQQEYAVKVINKASAKNKDTSTILR 70
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHL-MGADL-NNILRTQKLSDDHVQ 171
           E+ +LK ++H N++ L ++      L D  + Y+V  L  G +L + I++ ++ S+    
Sbjct: 71  EVELLKKLDHPNIMKLFEI------LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA 124
Query: 172 FLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILDFGLARPTEN--EMTGYV 226
            ++ Q+  G+ Y+H   I+HRDLKP NI +    +DC++KI+DFGL+   +   +M   +
Sbjct: 125 RIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI 184
Query: 227 ATRWYRAPEIM 237
            T +Y APE++
Sbjct: 185 GTAYYIAPEVL 195

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 71/152 (46%), Gaps = 24/152 (15%)
Query: 253 QDLKPSNIAVN---EDCELKILDFGLARPTEN--EMTGYVATRWYRAPEIMLNWMHYNQT 307
           +DLKP NI +    +DC++KI+DFGL+   +   +M   + T +Y APE+ L   +  + 
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV-LRGTYDEKC 203
Query: 308 DIHQLNLIMEML--GTPPAEFMAKISSDSAR-----KYINSLPLLTKKDFRQVFKGANPQ 360
           D+    +I+ +L  GTPP  F  K   D  +     KY   LP          ++  +  
Sbjct: 204 DVWSAGVILYILLSGTPP--FYGKNEYDILKRVETGKYAFDLPQ---------WRTISDD 252
Query: 361 AIXXXXXXXXXXXXKRITAEQALAHPYLSQYS 392
           A              RITA Q L HP++ +YS
Sbjct: 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 98/191 (51%), Gaps = 22/191 (11%)
Query: 54  FNQPYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYR 113
           F + Y+ +C         L K SF  +     D ++  + A+K I +            R
Sbjct: 20  FAERYNIVC--------MLGKGSFGEVLKCK-DRITQQEYAVKVINKASAKNKDTSTILR 70
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHL-MGADL-NNILRTQKLSDDHVQ 171
           E+ +LK ++H N++ L ++      L D  + Y+V  L  G +L + I++ ++ S+    
Sbjct: 71  EVELLKKLDHPNIMKLFEI------LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA 124
Query: 172 FLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILDFGLARPTEN--EMTGYV 226
            ++ Q+  G+ Y+H   I+HRDLKP NI +    +DC++KI+DFGL+   +   +M   +
Sbjct: 125 RIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI 184
Query: 227 ATRWYRAPEIM 237
            T +Y APE++
Sbjct: 185 GTAYYIAPEVL 195

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 71/152 (46%), Gaps = 24/152 (15%)
Query: 253 QDLKPSNIAVN---EDCELKILDFGLARPTEN--EMTGYVATRWYRAPEIMLNWMHYNQT 307
           +DLKP NI +    +DC++KI+DFGL+   +   +M   + T +Y APE+ L   +  + 
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV-LRGTYDEKC 203
Query: 308 DIHQLNLIMEML--GTPPAEFMAKISSDSAR-----KYINSLPLLTKKDFRQVFKGANPQ 360
           D+    +I+ +L  GTPP  F  K   D  +     KY   LP          ++  +  
Sbjct: 204 DVWSAGVILYILLSGTPP--FYGKNEYDILKRVETGKYAFDLPQ---------WRTISDD 252
Query: 361 AIXXXXXXXXXXXXKRITAEQALAHPYLSQYS 392
           A              RITA Q L HP++ +YS
Sbjct: 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 61/167 (36%), Positives = 84/167 (50%), Gaps = 12/167 (7%)
Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAK---RTYRE---LRMLKHMNHENVIGLLDVFHSNT 137
           A D  SG  VA+K +  P            T RE   LR L+   H NV+ L+DV  ++ 
Sbjct: 28  ARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87
Query: 138 CLADFKNVYMVTHLMGADLNNILRTQK---LSDDHVQFLVYQILRGLKYIHSAGIIHRDL 194
              + K   +  H+   DL   L       L  + ++ L+ Q LRGL ++H+  I+HRDL
Sbjct: 88  TDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDL 146
Query: 195 KPSNIAVNEDCELKILDFGLARPTENEM--TGYVATRWYRAPEIMLN 239
           KP NI V     +K+ DFGLAR    +M  T  V T WYRAPE++L 
Sbjct: 147 KPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQ 193

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 72/175 (41%), Gaps = 27/175 (15%)
Query: 238 LNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEM--TGYVATRWYRAP 295
           L+++H N        +DLKP NI V     +K+ DFGLAR    +M  T  V T WYRAP
Sbjct: 133 LDFLHANC----IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAP 188
Query: 296 EIMLNWMHYNQTDIHQLNLIM-EMLGTPPAEFMAKISSDSARKYINSLPLLTKKDF---- 350
           E++L   +    D+  +  I  EM    P  F     +D   K  + + L  + D+    
Sbjct: 189 EVLLQSTYATPVDMWSVGCIFAEMFRRKPL-FCGNSEADQLGKIFDLIGLPPEDDWPRDV 247
Query: 351 ---RQVFKGANPQAIXXXXXXXXXXXX------------KRITAEQALAHPYLSQ 390
              R  F    P+ +                        KRI+A +AL H YL +
Sbjct: 248 SLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 86/159 (54%), Gaps = 13/159 (8%)
Query: 86  DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV 145
           D V+ V+ AIK I +   S     +   E+ +LK ++H N++ L D F       D +N 
Sbjct: 58  DKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE------DKRNY 111
Query: 146 YMVTHL-MGADL-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI---A 200
           Y+V     G +L + I+   K ++     ++ Q+L G+ Y+H   I+HRDLKP N+   +
Sbjct: 112 YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLES 171
Query: 201 VNEDCELKILDFGLARPTENE--MTGYVATRWYRAPEIM 237
             +D  +KI+DFGL+   EN+  M   + T +Y APE++
Sbjct: 172 KEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL 210

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 98/223 (43%), Gaps = 39/223 (17%)
Query: 207 LKILDFGLARPTENEMTGYVATRWYRAPEI---MLNWMHYNQ-----------TGVPFYF 252
           +K+ DF      E++   Y+    Y+  E+   +++ M +N+           +GV +  
Sbjct: 99  MKLYDF-----FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLH 153
Query: 253 Q------DLKPSNIAVN---EDCELKILDFGLARPTENE--MTGYVATRWYRAPEIMLNW 301
           +      DLKP N+ +    +D  +KI+DFGL+   EN+  M   + T +Y APE+ L  
Sbjct: 154 KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEV-LRK 212
Query: 302 MHYNQTDIHQLNLIMEML--GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANP 359
            +  + D+  + +I+ +L  G PP  F  +   +  RK           +++ V +GA  
Sbjct: 213 KYDEKCDVWSIGVILFILLAGYPP--FGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKD 270
Query: 360 QAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPTSPP 402
                          +RI+A+QAL HP++ +     +     P
Sbjct: 271 ----LIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELP 309

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/132 (38%), Positives = 77/132 (58%), Gaps = 19/132 (14%)
Query: 117 MLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDDHVQFLV 174
           +L++  H N+I L DV+       D K+VY+VT LM  G  L+ ILR +  S+    F++
Sbjct: 74  LLRYGQHPNIITLKDVYD------DGKHVYLVTELMRGGELLDKILRQKFFSEREASFVL 127
Query: 175 YQILRGLKYIHSAGIIHRDLKPSNI-----AVNEDCELKILDFGLARPTENEMTGYVATR 229
           + I + ++Y+HS G++HRDLKPSNI     + N +C L+I DFG A+    E  G + T 
Sbjct: 128 HTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPEC-LRICDFGFAKQLRAE-NGLLMTP 185
Query: 230 WYR----APEIM 237
            Y     APE++
Sbjct: 186 CYTANFVAPEVL 197

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 89/173 (51%), Gaps = 11/173 (6%)
Query: 71  TLSKESFDLIFSSALDSVSGVKVAIKKIA-RPFQSAVHAKRTYRELRMLKHMNHENVIGL 129
            L K SF  +     D ++G + A+K I+ R  +     +   RE+++LK ++H N++ L
Sbjct: 39  VLGKGSFGEVILCK-DKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 97
Query: 130 LDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGI 189
            + F           VY    L     + I+  ++ S+     ++ Q+L G+ Y+H   I
Sbjct: 98  YEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGITYMHKNKI 153
Query: 190 IHRDLKPSNIAV---NEDCELKILDFGLARPTE--NEMTGYVATRWYRAPEIM 237
           +HRDLKP N+ +   ++D  ++I+DFGL+   E   +M   + T +Y APE++
Sbjct: 154 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL 206

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 77/179 (43%), Gaps = 30/179 (16%)
Query: 227 ATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV---NEDCELKILDFGLARPTE--N 281
           A R  R     + +MH N+       +DLKP N+ +   ++D  ++I+DFGL+   E   
Sbjct: 134 AARIIRQVLSGITYMHKNK----IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 189
Query: 282 EMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEML--GTPP------AEFMAKISSD 333
           +M   + T +Y APE+ L+  +  + D+    +I+ +L  G PP       + + K+   
Sbjct: 190 KMKDKIGTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKG 248
Query: 334 SARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYS 392
              KY   LP          +K  +  A              RI+A  AL H ++  Y+
Sbjct: 249 ---KYTFELPQ---------WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 295

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 89/172 (51%), Gaps = 11/172 (6%)
Query: 72  LSKESFDLIFSSALDSVSGVKVAIKKIA-RPFQSAVHAKRTYRELRMLKHMNHENVIGLL 130
           L K SF  +     D ++G + A+K I+ R  +     +   RE+++LK ++H N++ L 
Sbjct: 57  LGKGSFGEVILCK-DKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 115
Query: 131 DVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGII 190
           + F           VY    L     + I+  ++ S+     ++ Q+L G+ Y+H   I+
Sbjct: 116 EFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIV 171
Query: 191 HRDLKPSNI---AVNEDCELKILDFGLARPTE--NEMTGYVATRWYRAPEIM 237
           HRDLKP N+   + ++D  ++I+DFGL+   E   +M   + T +Y APE++
Sbjct: 172 HRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL 223

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 88/210 (41%), Gaps = 34/210 (16%)
Query: 227 ATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNI---AVNEDCELKILDFGLARPTE--N 281
           A R  R     + +MH N+       +DLKP N+   + ++D  ++I+DFGL+   E   
Sbjct: 151 AARIIRQVLSGITYMHKNK----IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 206
Query: 282 EMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEML--GTPP------AEFMAKISSD 333
           +M   + T +Y APE+ L+  +  + D+    +I+ +L  G PP       + + K+   
Sbjct: 207 KMKDKIGTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKG 265
Query: 334 SARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSD 393
              KY   LP          +K  +  A              RI+A  AL H ++  Y+ 
Sbjct: 266 ---KYTFELPQ---------WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 313
Query: 394 PNDEPTSPPYDQSFEDMDLPVDQWKGTYSL 423
                  P  D +     L + Q++GT  L
Sbjct: 314 EQISVDVPSLDNAI----LNIRQFQGTQKL 339

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/132 (38%), Positives = 77/132 (58%), Gaps = 19/132 (14%)
Query: 117 MLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDDHVQFLV 174
           +L++  H N+I L DV+       D K+VY+VT LM  G  L+ ILR +  S+    F++
Sbjct: 74  LLRYGQHPNIITLKDVYD------DGKHVYLVTELMRGGELLDKILRQKFFSEREASFVL 127
Query: 175 YQILRGLKYIHSAGIIHRDLKPSNI-----AVNEDCELKILDFGLARPTENEMTGYVATR 229
           + I + ++Y+HS G++HRDLKPSNI     + N +C L+I DFG A+    E  G + T 
Sbjct: 128 HTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPEC-LRICDFGFAKQLRAE-NGLLMTP 185
Query: 230 WYR----APEIM 237
            Y     APE++
Sbjct: 186 CYTANFVAPEVL 197

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 89/172 (51%), Gaps = 11/172 (6%)
Query: 72  LSKESFDLIFSSALDSVSGVKVAIKKIA-RPFQSAVHAKRTYRELRMLKHMNHENVIGLL 130
           L K SF  +     D ++G + A+K I+ R  +     +   RE+++LK ++H N++ L 
Sbjct: 58  LGKGSFGEVILCK-DKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 116
Query: 131 DVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGII 190
           + F           VY    L     + I+  ++ S+     ++ Q+L G+ Y+H   I+
Sbjct: 117 EFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIV 172
Query: 191 HRDLKPSNI---AVNEDCELKILDFGLARPTE--NEMTGYVATRWYRAPEIM 237
           HRDLKP N+   + ++D  ++I+DFGL+   E   +M   + T +Y APE++
Sbjct: 173 HRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL 224

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 88/210 (41%), Gaps = 34/210 (16%)
Query: 227 ATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNI---AVNEDCELKILDFGLARPTE--N 281
           A R  R     + +MH N+       +DLKP N+   + ++D  ++I+DFGL+   E   
Sbjct: 152 AARIIRQVLSGITYMHKNK----IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 207
Query: 282 EMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEML--GTPP------AEFMAKISSD 333
           +M   + T +Y APE+ L+  +  + D+    +I+ +L  G PP       + + K+   
Sbjct: 208 KMKDKIGTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKG 266
Query: 334 SARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSD 393
              KY   LP          +K  +  A              RI+A  AL H ++  Y+ 
Sbjct: 267 ---KYTFELPQ---------WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 314
Query: 394 PNDEPTSPPYDQSFEDMDLPVDQWKGTYSL 423
                  P  D +     L + Q++GT  L
Sbjct: 315 EQISVDVPSLDNAI----LNIRQFQGTQKL 340

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 89/173 (51%), Gaps = 11/173 (6%)
Query: 71  TLSKESFDLIFSSALDSVSGVKVAIKKIA-RPFQSAVHAKRTYRELRMLKHMNHENVIGL 129
            L K SF  +     D ++G + A+K I+ R  +     +   RE+++LK ++H N++ L
Sbjct: 33  VLGKGSFGEVILCK-DKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 130 LDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGI 189
            + F           VY    L     + I+  ++ S+     ++ Q+L G+ Y+H   I
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGITYMHKNKI 147
Query: 190 IHRDLKPSNIAV---NEDCELKILDFGLARPTE--NEMTGYVATRWYRAPEIM 237
           +HRDLKP N+ +   ++D  ++I+DFGL+   E   +M   + T +Y APE++
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL 200

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 88/210 (41%), Gaps = 34/210 (16%)
Query: 227 ATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV---NEDCELKILDFGLARPTE--N 281
           A R  R     + +MH N+       +DLKP N+ +   ++D  ++I+DFGL+   E   
Sbjct: 128 AARIIRQVLSGITYMHKNK----IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183
Query: 282 EMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEML--GTPP------AEFMAKISSD 333
           +M   + T +Y APE+ L+  +  + D+    +I+ +L  G PP       + + K+   
Sbjct: 184 KMKDKIGTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKG 242
Query: 334 SARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSD 393
              KY   LP          +K  +  A              RI+A  AL H ++  Y+ 
Sbjct: 243 ---KYTFELPQ---------WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290
Query: 394 PNDEPTSPPYDQSFEDMDLPVDQWKGTYSL 423
                  P  D +     L + Q++GT  L
Sbjct: 291 EQISVDVPSLDNAI----LNIRQFQGTQKL 316

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/154 (35%), Positives = 83/154 (53%), Gaps = 24/154 (15%)
Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDH--- 169
           RE+ +L+ + H NVI L  VF S+   AD + V+++      DL +I++  + S  +   
Sbjct: 67  REIALLRELKHPNVISLQKVFLSH---AD-RKVWLLFDYAEHDLWHIIKFHRASKANKKP 122
Query: 170 -------VQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV----NEDCELKILDFGLARPT 218
                  V+ L+YQIL G+ Y+H+  ++HRDLKP+NI V     E   +KI D G AR  
Sbjct: 123 VQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182
Query: 219 EN------EMTGYVATRWYRAPEIMLNWMHYNQT 246
            +      ++   V T WYRAPE++L   HY + 
Sbjct: 183 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKA 216

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 50/99 (50%), Gaps = 13/99 (13%)
Query: 237 MLNWMHYNQTGVPFYFQDLKPSNIAV----NEDCELKILDFGLARPTEN------EMTGY 286
           +L+ +HY       + +DLKP+NI V     E   +KI D G AR   +      ++   
Sbjct: 137 ILDGIHYLHANWVLH-RDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195
Query: 287 VATRWYRAPEIMLNWMHYNQT-DIHQLNLIM-EMLGTPP 323
           V T WYRAPE++L   HY +  DI  +  I  E+L + P
Sbjct: 196 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 234

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 95/178 (53%), Gaps = 22/178 (12%)
Query: 71  TLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLL 130
            L K ++ ++++   D  + V++AIK+I  P + + +++  + E+ + KH+ H+N++  L
Sbjct: 29  VLGKGTYGIVYA-GRDLSNQVRIAIKEI--PERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 131 DVFHSNTCLADFKNVYMVTHLMGADLNNILRTQ----KLSDDHVQFLVYQILRGLKYIHS 186
             F  N     F  ++M   + G  L+ +LR++    K ++  + F   QIL GLKY+H 
Sbjct: 86  GSFSENG----FIKIFM-EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD 140
Query: 187 AGIIHRDLKPSNIAVNE-DCELKILDFGLAR------PTENEMTGYVATRWYRAPEIM 237
             I+HRD+K  N+ +N     LKI DFG ++      P     TG   T  Y APEI+
Sbjct: 141 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTG---TLQYMAPEII 195

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 95/178 (53%), Gaps = 22/178 (12%)
Query: 71  TLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLL 130
            L K ++ ++++   D  + V++AIK+I  P + + +++  + E+ + KH+ H+N++  L
Sbjct: 15  VLGKGTYGIVYAGR-DLSNQVRIAIKEI--PERDSRYSQPLHEEIALHKHLKHKNIVQYL 71
Query: 131 DVFHSNTCLADFKNVYMVTHLMGADLNNILRTQ----KLSDDHVQFLVYQILRGLKYIHS 186
             F  N     F  ++M   + G  L+ +LR++    K ++  + F   QIL GLKY+H 
Sbjct: 72  GSFSENG----FIKIFM-EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD 126
Query: 187 AGIIHRDLKPSNIAVNE-DCELKILDFGLAR------PTENEMTGYVATRWYRAPEIM 237
             I+HRD+K  N+ +N     LKI DFG ++      P     TG   T  Y APEI+
Sbjct: 127 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTG---TLQYMAPEII 181

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 42/131 (32%), Positives = 78/131 (59%), Gaps = 8/131 (6%)
Query: 109 KRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSD 167
           ++ Y+E+ +LK ++H NV+ L++V        +  ++YMV  L+    +  +   + LS+
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDD----PNEDHLYMVFELVNQGPVMEVPTLKPLSE 136
Query: 168 DHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA---RPTENEMTG 224
           D  +F    +++G++Y+H   IIHRD+KPSN+ V ED  +KI DFG++   + ++  ++ 
Sbjct: 137 DQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSN 196
Query: 225 YVATRWYRAPE 235
            V T  + APE
Sbjct: 197 TVGTPAFMAPE 207

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 89/169 (52%), Gaps = 20/169 (11%)
Query: 84  ALDSVSGVKVAIKKIA-RPF-----QSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNT 137
           A +  +  KVAIK I+ R F     + A  A     E+ +LK +NH  +I + + F    
Sbjct: 28  AFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF---- 83
Query: 138 CLADFKNVYMVTHLM--GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLK 195
              D ++ Y+V  LM  G   + ++  ++L +   +   YQ+L  ++Y+H  GIIHRDLK
Sbjct: 84  ---DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLK 140
Query: 196 PSNIAVN---EDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIMLN 239
           P N+ ++   EDC +KI DFG ++     + M     T  Y APE++++
Sbjct: 141 PENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVS 189

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 81/168 (48%), Gaps = 25/168 (14%)
Query: 235 EIMLNWMHYNQTGVPFYFQDLKPSNIAVN---EDCELKILDFGLAR--PTENEMTGYVAT 289
           +++L   + ++ G+    +DLKP N+ ++   EDC +KI DFG ++     + M     T
Sbjct: 121 QMLLAVQYLHENGI--IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 178
Query: 290 RWYRAPEIMLN--WMHYNQT-DIHQLNLIMEML--GTPP-AEFMAKISSD---SARKYIN 340
             Y APE++++     YN+  D   L +I+ +   G PP +E   ++S     ++ KY N
Sbjct: 179 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY-N 237
Query: 341 SLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYL 388
            +P        +V+   + +A+             R T E+AL HP+L
Sbjct: 238 FIP--------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 277

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 89/169 (52%), Gaps = 20/169 (11%)
Query: 84  ALDSVSGVKVAIKKIA-RPF-----QSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNT 137
           A +  +  KVAIK I+ R F     + A  A     E+ +LK +NH  +I + + F    
Sbjct: 29  AFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF---- 84
Query: 138 CLADFKNVYMVTHLM--GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLK 195
              D ++ Y+V  LM  G   + ++  ++L +   +   YQ+L  ++Y+H  GIIHRDLK
Sbjct: 85  ---DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLK 141
Query: 196 PSNIAVN---EDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIMLN 239
           P N+ ++   EDC +KI DFG ++     + M     T  Y APE++++
Sbjct: 142 PENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVS 190

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 81/168 (48%), Gaps = 25/168 (14%)
Query: 235 EIMLNWMHYNQTGVPFYFQDLKPSNIAVN---EDCELKILDFGLAR--PTENEMTGYVAT 289
           +++L   + ++ G+    +DLKP N+ ++   EDC +KI DFG ++     + M     T
Sbjct: 122 QMLLAVQYLHENGI--IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 179
Query: 290 RWYRAPEIMLN--WMHYNQT-DIHQLNLIMEML--GTPP-AEFMAKISSD---SARKYIN 340
             Y APE++++     YN+  D   L +I+ +   G PP +E   ++S     ++ KY N
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY-N 238
Query: 341 SLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYL 388
            +P        +V+   + +A+             R T E+AL HP+L
Sbjct: 239 FIP--------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 89/169 (52%), Gaps = 20/169 (11%)
Query: 84  ALDSVSGVKVAIKKIA-RPF-----QSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNT 137
           A +  +  KVAIK I+ R F     + A  A     E+ +LK +NH  +I + + F    
Sbjct: 29  AFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF---- 84
Query: 138 CLADFKNVYMVTHLM--GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLK 195
              D ++ Y+V  LM  G   + ++  ++L +   +   YQ+L  ++Y+H  GIIHRDLK
Sbjct: 85  ---DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLK 141
Query: 196 PSNIAVN---EDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIMLN 239
           P N+ ++   EDC +KI DFG ++     + M     T  Y APE++++
Sbjct: 142 PENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVS 190

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 81/168 (48%), Gaps = 25/168 (14%)
Query: 235 EIMLNWMHYNQTGVPFYFQDLKPSNIAVN---EDCELKILDFGLAR--PTENEMTGYVAT 289
           +++L   + ++ G+    +DLKP N+ ++   EDC +KI DFG ++     + M     T
Sbjct: 122 QMLLAVQYLHENGI--IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 179
Query: 290 RWYRAPEIMLN--WMHYNQT-DIHQLNLIMEML--GTPP-AEFMAKISSD---SARKYIN 340
             Y APE++++     YN+  D   L +I+ +   G PP +E   ++S     ++ KY N
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY-N 238
Query: 341 SLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYL 388
            +P        +V+   + +A+             R T E+AL HP+L
Sbjct: 239 FIP--------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 89/169 (52%), Gaps = 20/169 (11%)
Query: 84  ALDSVSGVKVAIKKIA-RPF-----QSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNT 137
           A +  +  KVAIK I+ R F     + A  A     E+ +LK +NH  +I + + F    
Sbjct: 29  AFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF---- 84
Query: 138 CLADFKNVYMVTHLM--GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLK 195
              D ++ Y+V  LM  G   + ++  ++L +   +   YQ+L  ++Y+H  GIIHRDLK
Sbjct: 85  ---DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLK 141
Query: 196 PSNIAVN---EDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIMLN 239
           P N+ ++   EDC +KI DFG ++     + M     T  Y APE++++
Sbjct: 142 PENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVS 190

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 81/168 (48%), Gaps = 25/168 (14%)
Query: 235 EIMLNWMHYNQTGVPFYFQDLKPSNIAVN---EDCELKILDFGLAR--PTENEMTGYVAT 289
           +++L   + ++ G+    +DLKP N+ ++   EDC +KI DFG ++     + M     T
Sbjct: 122 QMLLAVQYLHENGI--IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 179
Query: 290 RWYRAPEIMLN--WMHYNQT-DIHQLNLIMEML--GTPP-AEFMAKISSD---SARKYIN 340
             Y APE++++     YN+  D   L +I+ +   G PP +E   ++S     ++ KY N
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY-N 238
Query: 341 SLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYL 388
            +P        +V+   + +A+             R T E+AL HP+L
Sbjct: 239 FIP--------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 89/169 (52%), Gaps = 20/169 (11%)
Query: 84  ALDSVSGVKVAIKKIA-RPF-----QSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNT 137
           A +  +  KVAIK I+ R F     + A  A     E+ +LK +NH  +I + + F    
Sbjct: 35  AFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF---- 90
Query: 138 CLADFKNVYMVTHLM--GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLK 195
              D ++ Y+V  LM  G   + ++  ++L +   +   YQ+L  ++Y+H  GIIHRDLK
Sbjct: 91  ---DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLK 147
Query: 196 PSNIAVN---EDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIMLN 239
           P N+ ++   EDC +KI DFG ++     + M     T  Y APE++++
Sbjct: 148 PENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVS 196

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 81/168 (48%), Gaps = 25/168 (14%)
Query: 235 EIMLNWMHYNQTGVPFYFQDLKPSNIAVN---EDCELKILDFGLAR--PTENEMTGYVAT 289
           +++L   + ++ G+    +DLKP N+ ++   EDC +KI DFG ++     + M     T
Sbjct: 128 QMLLAVQYLHENGI--IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 185
Query: 290 RWYRAPEIMLN--WMHYNQT-DIHQLNLIMEML--GTPP-AEFMAKISSD---SARKYIN 340
             Y APE++++     YN+  D   L +I+ +   G PP +E   ++S     ++ KY N
Sbjct: 186 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY-N 244
Query: 341 SLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYL 388
            +P        +V+   + +A+             R T E+AL HP+L
Sbjct: 245 FIP--------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 284

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 91/179 (50%), Gaps = 22/179 (12%)
Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           SG++  IK I +  +S V  ++   E+ +LK ++H N+I + +VF       D+ N+Y+V
Sbjct: 46  SGLERVIKTINKD-RSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE------DYHNMYIV 98
Query: 149 --THLMGADLNNIL----RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
             T   G  L  I+    R + LS+ +V  L+ Q++  L Y HS  ++H+DLKP NI   
Sbjct: 99  METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQ 158
Query: 203 ED---CELKILDFGLAR--PTENEMTGYVATRWYRAPEIMLNWMHYN----QTGVPFYF 252
           +      +KI+DFGLA    ++   T    T  Y APE+    + +       GV  YF
Sbjct: 159 DTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYF 217

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 72/130 (55%), Gaps = 12/130 (9%)
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDDHVQ 171
           E+ +LK + HEN++ L D++ S T      + Y+V  L+  G   + IL     ++    
Sbjct: 56  EIAVLKKIKHENIVTLEDIYESTT------HYYLVMQLVSGGELFDRILERGVYTEKDAS 109
Query: 172 FLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILDFGLARPTENE-MTGYVA 227
            ++ Q+L  +KY+H  GI+HRDLKP N+      E+ ++ I DFGL++  +N  M+    
Sbjct: 110 LVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACG 169
Query: 228 TRWYRAPEIM 237
           T  Y APE++
Sbjct: 170 TPGYVAPEVL 179

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 86/172 (50%), Gaps = 11/172 (6%)
Query: 72  LSKESFDLIFSSALDSVSGVKVAIKKIA-RPFQSAVHAKRTYRELRMLKHMNHENVIGLL 130
           L K SF  +     D ++G + A+K I+ R  +     +   RE+++LK ++H N+  L 
Sbjct: 34  LGKGSFGEVILCK-DKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLY 92
Query: 131 DVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGII 190
           + F           VY    L     + I+  ++ S+     ++ Q+L G+ Y H   I+
Sbjct: 93  EFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGITYXHKNKIV 148
Query: 191 HRDLKPSNI---AVNEDCELKILDFGLARPTE--NEMTGYVATRWYRAPEIM 237
           HRDLKP N+   + ++D  ++I+DFGL+   E   +    + T +Y APE++
Sbjct: 149 HRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVL 200

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 87/210 (41%), Gaps = 34/210 (16%)
Query: 227 ATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNI---AVNEDCELKILDFGLARPTE--N 281
           A R  R     + + H N+       +DLKP N+   + ++D  ++I+DFGL+   E   
Sbjct: 128 AARIIRQVLSGITYXHKNK----IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183
Query: 282 EMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEML--GTPP------AEFMAKISSD 333
           +    + T +Y APE+ L+  +  + D+    +I+ +L  G PP       + + K+   
Sbjct: 184 KXKDKIGTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKG 242
Query: 334 SARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSD 393
              KY   LP          +K  +  A              RI+A  AL H ++  Y+ 
Sbjct: 243 ---KYTFELPQ---------WKKVSESAKDLIRKXLTYVPSXRISARDALDHEWIQTYTK 290
Query: 394 PNDEPTSPPYDQSFEDMDLPVDQWKGTYSL 423
                  P  D +     L + Q++GT  L
Sbjct: 291 EQISVDVPSLDNAI----LNIRQFQGTQKL 316

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 89/169 (52%), Gaps = 20/169 (11%)
Query: 84  ALDSVSGVKVAIKKIA-RPF-----QSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNT 137
           A +  +  KVAI+ I+ R F     + A  A     E+ +LK +NH  +I + + F    
Sbjct: 154 AFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF---- 209
Query: 138 CLADFKNVYMVTHLM--GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLK 195
              D ++ Y+V  LM  G   + ++  ++L +   +   YQ+L  ++Y+H  GIIHRDLK
Sbjct: 210 ---DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLK 266
Query: 196 PSNIAVN---EDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIMLN 239
           P N+ ++   EDC +KI DFG ++     + M     T  Y APE++++
Sbjct: 267 PENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVS 315

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 81/168 (48%), Gaps = 25/168 (14%)
Query: 235 EIMLNWMHYNQTGVPFYFQDLKPSNIAVN---EDCELKILDFGLAR--PTENEMTGYVAT 289
           +++L   + ++ G+    +DLKP N+ ++   EDC +KI DFG ++     + M     T
Sbjct: 247 QMLLAVQYLHENGI--IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 304
Query: 290 RWYRAPEIMLN--WMHYNQT-DIHQLNLIMEML--GTPP-AEFMAKISSD---SARKYIN 340
             Y APE++++     YN+  D   L +I+ +   G PP +E   ++S     ++ KY N
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY-N 363
Query: 341 SLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYL 388
            +P        +V+   + +A+             R T E+AL HP+L
Sbjct: 364 FIP--------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 403

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 89/169 (52%), Gaps = 20/169 (11%)
Query: 84  ALDSVSGVKVAIKKIA-RPF-----QSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNT 137
           A +  +  KVAI+ I+ R F     + A  A     E+ +LK +NH  +I + + F    
Sbjct: 168 AFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF---- 223
Query: 138 CLADFKNVYMVTHLM--GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLK 195
              D ++ Y+V  LM  G   + ++  ++L +   +   YQ+L  ++Y+H  GIIHRDLK
Sbjct: 224 ---DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLK 280
Query: 196 PSNIAVN---EDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIMLN 239
           P N+ ++   EDC +KI DFG ++     + M     T  Y APE++++
Sbjct: 281 PENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVS 329

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 81/168 (48%), Gaps = 25/168 (14%)
Query: 235 EIMLNWMHYNQTGVPFYFQDLKPSNIAVN---EDCELKILDFGLAR--PTENEMTGYVAT 289
           +++L   + ++ G+    +DLKP N+ ++   EDC +KI DFG ++     + M     T
Sbjct: 261 QMLLAVQYLHENGI--IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 318
Query: 290 RWYRAPEIMLN--WMHYNQ-TDIHQLNLIMEML--GTPP-AEFMAKISSD---SARKYIN 340
             Y APE++++     YN+  D   L +I+ +   G PP +E   ++S     ++ KY N
Sbjct: 319 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY-N 377
Query: 341 SLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYL 388
            +P        +V+   + +A+             R T E+AL HP+L
Sbjct: 378 FIP--------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 417

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 85/160 (53%), Gaps = 14/160 (8%)
Query: 86  DSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN 144
           D ++G + AIK I +    +  ++     E+ +LK ++H N++ L + F       D +N
Sbjct: 42  DKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFE------DKRN 95
Query: 145 VYMVTHLM--GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV- 201
            Y+V  +   G   + I+  QK S+     ++ Q+L G  Y+H   I+HRDLKP N+ + 
Sbjct: 96  YYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLE 155
Query: 202 --NEDCELKILDFGLARPTE--NEMTGYVATRWYRAPEIM 237
             + D  +KI+DFGL+   E   +M   + T +Y APE++
Sbjct: 156 SKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL 195

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 70/147 (47%), Gaps = 14/147 (9%)
Query: 253 QDLKPSNIAV---NEDCELKILDFGLARPTE--NEMTGYVATRWYRAPEIMLNWMHYNQT 307
           +DLKP N+ +   + D  +KI+DFGL+   E   +M   + T +Y APE+ L   +  + 
Sbjct: 145 RDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEV-LRKKYDEKC 203
Query: 308 DIHQLNLIMEML--GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXX 365
           D+    +I+ +L  G PP  F  +   +  ++           D+ QV    + +A    
Sbjct: 204 DVWSCGVILYILLCGYPP--FGGQTDQEILKRVEKGKFSFDPPDWTQV----SDEAKQLV 257
Query: 366 XXXXXXXXXKRITAEQALAHPYLSQYS 392
                    KRI+AE+AL HP++ ++ 
Sbjct: 258 KLMLTYEPSKRISAEEALNHPWIVKFC 284

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 87/160 (54%), Gaps = 14/160 (8%)
Query: 86  DSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN 144
           D ++G + AIK I +    +  ++     E+ +LK ++H N++ L + F       D +N
Sbjct: 25  DKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFE------DKRN 78
Query: 145 VYMVTHLM-GADL-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV- 201
            Y+V  +  G +L + I+  QK S+     ++ Q+L G  Y+H   I+HRDLKP N+ + 
Sbjct: 79  YYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLE 138
Query: 202 --NEDCELKILDFGLARPTE--NEMTGYVATRWYRAPEIM 237
             + D  +KI+DFGL+   E   +M   + T +Y APE++
Sbjct: 139 SKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL 178

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 70/146 (47%), Gaps = 14/146 (9%)
Query: 253 QDLKPSNIAV---NEDCELKILDFGLARPTE--NEMTGYVATRWYRAPEIMLNWMHYNQT 307
           +DLKP N+ +   + D  +KI+DFGL+   E   +M   + T +Y APE+ L   +  + 
Sbjct: 128 RDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEV-LRKKYDEKC 186
Query: 308 DIHQLNLIMEML--GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXX 365
           D+    +I+ +L  G PP  F  +   +  ++           D+ QV    + +A    
Sbjct: 187 DVWSCGVILYILLCGYPP--FGGQTDQEILKRVEKGKFSFDPPDWTQV----SDEAKQLV 240
Query: 366 XXXXXXXXXKRITAEQALAHPYLSQY 391
                    KRI+AE+AL HP++ ++
Sbjct: 241 KLMLTYEPSKRISAEEALNHPWIVKF 266

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 84/159 (52%), Gaps = 13/159 (8%)
Query: 84  ALDSVSGVKVAIKKI-ARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           A D++  +KVAIK I   P +     KR  RE+     ++H+N++ ++DV   + C    
Sbjct: 30  AEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY--- 86
Query: 143 KNVYMV-THLMGADLNNILRTQK-LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
              Y+V  ++ G  L+  + +   LS D       QIL G+K+ H   I+HRD+KP NI 
Sbjct: 87  ---YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNIL 143
Query: 201 VNEDCELKILDFGLARP-TENEMTG---YVATRWYRAPE 235
           ++ +  LKI DFG+A+  +E  +T     + T  Y +PE
Sbjct: 144 IDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 83/166 (50%), Gaps = 22/166 (13%)
Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVP------FYFQDLK 256
           +DC   ++++ +  PT +E   Y+ +    + +  +N+ +    G+          +D+K
Sbjct: 83  DDCYYLVMEY-IEGPTLSE---YIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIK 138
Query: 257 PSNIAVNEDCELKILDFGLARP-TENEMTG---YVATRWYRAPEIMLNWMHYNQTDIHQL 312
           P NI ++ +  LKI DFG+A+  +E  +T     + T  Y +PE          TDI+ +
Sbjct: 139 PQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSI 198
Query: 313 NLIM-EML-GTPPAEFMAKISSDSARKYI-NSLPLLT---KKDFRQ 352
            +++ EML G PP  F  + +   A K+I +S+P +T   +KD  Q
Sbjct: 199 GIVLYEMLVGEPP--FNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ 242

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 86/159 (54%), Gaps = 10/159 (6%)
Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           SG+ +A K I    + A+   +  REL++L   N   ++G    F+S+  ++       +
Sbjct: 40  SGLIMARKLIHLEIKPAIR-NQIIRELQVLHECNSPYIVGFYGAFYSDGEIS-----ICM 93
Query: 149 THLMGADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDCE 206
            H+ G  L+ +L+  +++ ++ +  +   +LRGL Y+     I+HRD+KPSNI VN   E
Sbjct: 94  EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE 153
Query: 207 LKILDFGLARPTENEMT-GYVATRWYRAPEIMLNWMHYN 244
           +K+ DFG++    + M   +V TR Y APE  L   HY+
Sbjct: 154 IKLCDFGVSGQLIDSMANSFVGTRSYMAPE-RLQGTHYS 191

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/64 (43%), Positives = 39/64 (60%), Gaps = 3/64 (4%)
Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEMT-GYVATRWYRAPEIMLNWMHYN-QTDIH 310
           +D+KPSNI VN   E+K+ DFG++    + M   +V TR Y APE  L   HY+ Q+DI 
Sbjct: 139 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMAPE-RLQGTHYSVQSDIW 197
Query: 311 QLNL 314
            + L
Sbjct: 198 SMGL 201

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 93/183 (50%), Gaps = 19/183 (10%)
Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKI----ARPFQSAVHAKRTYRELRMLKHMN 122
           DIG  L    F ++     +  +G++ A K I    +R  +  V  +   RE+ +L+ + 
Sbjct: 15  DIGEELGSGQFAIV-KKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 123 HENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNIL-RTQKLSDDHVQFLVYQILRG 180
           H NVI L DV+ + T      +V ++  L+ G +L + L + + LS++     + QIL G
Sbjct: 74  HHNVITLHDVYENRT------DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 181 LKYIHSAGIIHRDLKPSNIAVNEDC----ELKILDFGLARPTEN--EMTGYVATRWYRAP 234
           + Y+H+  I H DLKP NI + +       +K++DFGLA   E+  E      T  + AP
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
Query: 235 EIM 237
           EI+
Sbjct: 188 EIV 190

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 93/183 (50%), Gaps = 19/183 (10%)
Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKI----ARPFQSAVHAKRTYRELRMLKHMN 122
           DIG  L    F ++     +  +G++ A K I    +R  +  V  +   RE+ +L+ + 
Sbjct: 15  DIGEELGSGQFAIV-KKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 123 HENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNIL-RTQKLSDDHVQFLVYQILRG 180
           H NVI L DV+ + T      +V ++  L+ G +L + L + + LS++     + QIL G
Sbjct: 74  HHNVITLHDVYENRT------DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 181 LKYIHSAGIIHRDLKPSNIAVNEDC----ELKILDFGLARPTEN--EMTGYVATRWYRAP 234
           + Y+H+  I H DLKP NI + +       +K++DFGLA   E+  E      T  + AP
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
Query: 235 EIM 237
           EI+
Sbjct: 188 EIV 190

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 93/183 (50%), Gaps = 19/183 (10%)
Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKI----ARPFQSAVHAKRTYRELRMLKHMN 122
           DIG  L    F ++     +  +G++ A K I    +R  +  V  +   RE+ +L+ + 
Sbjct: 15  DIGEELGSGQFAIV-KKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 123 HENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNIL-RTQKLSDDHVQFLVYQILRG 180
           H NVI L DV+ + T      +V ++  L+ G +L + L + + LS++     + QIL G
Sbjct: 74  HHNVITLHDVYENRT------DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 181 LKYIHSAGIIHRDLKPSNIAVNEDC----ELKILDFGLARPTEN--EMTGYVATRWYRAP 234
           + Y+H+  I H DLKP NI + +       +K++DFGLA   E+  E      T  + AP
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
Query: 235 EIM 237
           EI+
Sbjct: 188 EIV 190

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 93/183 (50%), Gaps = 19/183 (10%)
Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKI----ARPFQSAVHAKRTYRELRMLKHMN 122
           DIG  L    F ++     +  +G++ A K I    +R  +  V  +   RE+ +L+ + 
Sbjct: 15  DIGEELGSGQFAIV-KKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 123 HENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNIL-RTQKLSDDHVQFLVYQILRG 180
           H NVI L DV+ + T      +V ++  L+ G +L + L + + LS++     + QIL G
Sbjct: 74  HHNVITLHDVYENRT------DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 181 LKYIHSAGIIHRDLKPSNIAVNEDC----ELKILDFGLARPTEN--EMTGYVATRWYRAP 234
           + Y+H+  I H DLKP NI + +       +K++DFGLA   E+  E      T  + AP
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
Query: 235 EIM 237
           EI+
Sbjct: 188 EIV 190

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 93/183 (50%), Gaps = 19/183 (10%)
Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKI----ARPFQSAVHAKRTYRELRMLKHMN 122
           DIG  L    F ++     +  +G++ A K I    +R  +  V  +   RE+ +L+ + 
Sbjct: 15  DIGEELGSGQFAIV-KKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 123 HENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNIL-RTQKLSDDHVQFLVYQILRG 180
           H NVI L DV+ + T      +V ++  L+ G +L + L + + LS++     + QIL G
Sbjct: 74  HHNVITLHDVYENRT------DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 181 LKYIHSAGIIHRDLKPSNIAVNEDC----ELKILDFGLARPTEN--EMTGYVATRWYRAP 234
           + Y+H+  I H DLKP NI + +       +K++DFGLA   E+  E      T  + AP
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
Query: 235 EIM 237
           EI+
Sbjct: 188 EIV 190

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 72/131 (54%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADL-NNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV   M G D+ +++ R  + S+ 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYMPGGDMFSHLRRIGRFSEP 141
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +K+ DFG A+  +        T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGT 201
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 202 PEYLAPEIILS 212

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/74 (35%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +K+ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 164 YRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 224 LGVLIYEMAAGYPP 237

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 100/180 (55%), Gaps = 17/180 (9%)
Query: 72  LSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLL 130
           L +  +  +F  A++  +  KV +K I +P    V   +  RE+++L+++    N+I L 
Sbjct: 45  LGRGKYSEVFE-AINITNNEKVVVK-ILKP----VKKNKIKREIKILENLRGGPNIITLA 98
Query: 131 DVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGII 190
           D+              +  H+   D   + +T  L+D  ++F +Y+IL+ L Y HS GI+
Sbjct: 99  DIVKDPVSRTP---ALVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIM 153
Query: 191 HRDLKPSNIAVN-EDCELKILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHYNQT 246
           HRD+KP N+ ++ E  +L+++D+GLA    P + E    VA+R+++ PE+++++  Y+ +
Sbjct: 154 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYS 212

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 37/171 (21%), Positives = 79/171 (46%), Gaps = 36/171 (21%)
Query: 253 QDLKPSNIAVN-EDCELKILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHYNQT- 307
           +D+KP N+ ++ E  +L+++D+GLA    P + E    VA+R+++ PE+++++  Y+ + 
Sbjct: 155 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSL 213
Query: 308 ------------------------DIHQLNLIMEMLGTPPA-EFMAKISSDSARKYINSL 342
                                   +  QL  I ++LGT    +++ K + +   ++ + L
Sbjct: 214 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDIL 273
Query: 343 PLLTKKDFRQVFKGAN-----PQAIXXXXXXXXXXXXKRITAEQALAHPYL 388
              ++K + +     N     P+A+             R+TA +A+ HPY 
Sbjct: 274 GRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 72/131 (54%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADL-NNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV   M G D+ +++ R  + S+ 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYMPGGDMFSHLRRIGRFSEP 141
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +K+ DFG A+  +        T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGT 201
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 202 PEYLAPEIILS 212

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/74 (35%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +K+ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 164 YRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 224 LGVLIYEMAAGYPP 237

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 96/188 (51%), Gaps = 19/188 (10%)
Query: 59  SEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTY--RELR 116
           +E  R + D    L   +F  +   A D  +   VAIK IA+    A+  K      E+ 
Sbjct: 13  AEDIRDIYDFRDVLGTGAFSEVIL-AEDKRTQKLVAIKCIAK---EALEGKEGSMENEIA 68
Query: 117 MLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDDHVQFLV 174
           +L  + H N++ L D++ S        ++Y++  L+  G   + I+     ++     L+
Sbjct: 69  VLHKIKHPNIVALDDIYESGG------HLYLIMQLVSGGELFDRIVEKGFYTERDASRLI 122
Query: 175 YQILRGLKYIHSAGIIHRDLKPSNI---AVNEDCELKILDFGLARPTE--NEMTGYVATR 229
           +Q+L  +KY+H  GI+HRDLKP N+   +++ED ++ I DFGL++  +  + ++    T 
Sbjct: 123 FQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTP 182
Query: 230 WYRAPEIM 237
            Y APE++
Sbjct: 183 GYVAPEVL 190

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/133 (34%), Positives = 72/133 (54%), Gaps = 13/133 (9%)
Query: 112 YRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADL-NNILRTQKLSDDH 169
           Y E+ +LK ++H N+I L DVF       D K  Y+VT    G +L   I+   K  +  
Sbjct: 94  YNEISLLKSLDHPNIIKLFDVFE------DKKYFYLVTEFYEGGELFEQIINRHKFDECD 147
Query: 170 VQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILDFGLAR--PTENEMTG 224
              ++ QIL G+ Y+H   I+HRD+KP NI +   N    +KI+DFGL+     + ++  
Sbjct: 148 AANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD 207
Query: 225 YVATRWYRAPEIM 237
            + T +Y APE++
Sbjct: 208 RLGTAYYIAPEVL 220

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 96/188 (51%), Gaps = 19/188 (10%)
Query: 59  SEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTY--RELR 116
           +E  R + D    L   +F  +   A D  +   VAIK IA+    A+  K      E+ 
Sbjct: 13  AEDIRDIYDFRDVLGTGAFSEVIL-AEDKRTQKLVAIKCIAK---KALEGKEGSMENEIA 68
Query: 117 MLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDDHVQFLV 174
           +L  + H N++ L D++ S        ++Y++  L+  G   + I+     ++     L+
Sbjct: 69  VLHKIKHPNIVALDDIYESGG------HLYLIMQLVSGGELFDRIVEKGFYTERDASRLI 122
Query: 175 YQILRGLKYIHSAGIIHRDLKPSNI---AVNEDCELKILDFGLARPTE--NEMTGYVATR 229
           +Q+L  +KY+H  GI+HRDLKP N+   +++ED ++ I DFGL++  +  + ++    T 
Sbjct: 123 FQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTP 182
Query: 230 WYRAPEIM 237
            Y APE++
Sbjct: 183 GYVAPEVL 190

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 96/188 (51%), Gaps = 19/188 (10%)
Query: 59  SEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTY--RELR 116
           +E  R + D    L   +F  +   A D  +   VAIK IA+    A+  K      E+ 
Sbjct: 13  AEDIRDIYDFRDVLGTGAFSEVIL-AEDKRTQKLVAIKCIAK---EALEGKEGSMENEIA 68
Query: 117 MLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDDHVQFLV 174
           +L  + H N++ L D++ S        ++Y++  L+  G   + I+     ++     L+
Sbjct: 69  VLHKIKHPNIVALDDIYESGG------HLYLIMQLVSGGELFDRIVEKGFYTERDASRLI 122
Query: 175 YQILRGLKYIHSAGIIHRDLKPSNI---AVNEDCELKILDFGLARPTE--NEMTGYVATR 229
           +Q+L  +KY+H  GI+HRDLKP N+   +++ED ++ I DFGL++  +  + ++    T 
Sbjct: 123 FQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTP 182
Query: 230 WYRAPEIM 237
            Y APE++
Sbjct: 183 GYVAPEVL 190

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 94/180 (52%), Gaps = 18/180 (10%)
Query: 68  IGP-----TLSKESFDLIFSSALDSVSGVKVAIKKIARPF--QSAVHAKRTYRELRMLKH 120
           IGP     TL + SF  +   A    +  KVA+K I+R    +S +H  R  RE+  LK 
Sbjct: 8   IGPYIIRETLGEGSFGKV-KLATHYKTQQKVALKFISRQLLKKSDMHM-RVEREISYLKL 65
Query: 121 MNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADL-NNILRTQKLSDDHVQFLVYQILR 179
           + H ++I L DV  + T      ++ MV    G +L + I+  +++++D  +    QI+ 
Sbjct: 66  LRHPHIIKLYDVITTPT------DIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIIC 119
Query: 180 GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIM 237
            ++Y H   I+HRDLKP N+ ++++  +KI DFGL+      N +     +  Y APE++
Sbjct: 120 AIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVI 179

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 96/188 (51%), Gaps = 19/188 (10%)
Query: 59  SEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTY--RELR 116
           +E  R + D    L   +F  +   A D  +   VAIK IA+    A+  K      E+ 
Sbjct: 13  AEDIRDIYDFRDVLGTGAFSEVIL-AEDKRTQKLVAIKCIAK---EALEGKEGSMENEIA 68
Query: 117 MLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDDHVQFLV 174
           +L  + H N++ L D++ S        ++Y++  L+  G   + I+     ++     L+
Sbjct: 69  VLHKIKHPNIVALDDIYESGG------HLYLIMQLVSGGELFDRIVEKGFYTERDASRLI 122
Query: 175 YQILRGLKYIHSAGIIHRDLKPSNI---AVNEDCELKILDFGLARPTE--NEMTGYVATR 229
           +Q+L  +KY+H  GI+HRDLKP N+   +++ED ++ I DFGL++  +  + ++    T 
Sbjct: 123 FQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTP 182
Query: 230 WYRAPEIM 237
            Y APE++
Sbjct: 183 GYVAPEVL 190

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 94/184 (51%), Gaps = 18/184 (9%)
Query: 68  IGPTLSKESFDLIFSSALDSV-SGVKVAIKKI-ARPFQSAVHAKRTYRELRMLKHMNHEN 125
           +G  L K SF  ++ +  +S+ +G++VAIK I  +    A   +R   E+++   + H +
Sbjct: 15  VGNLLGKGSFAGVYRA--ESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 126 VIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNIL--RTQKLSDDHVQFLVYQILRGLK 182
           ++ L + F       D   VY+V  +    ++N  L  R +  S++  +  ++QI+ G+ 
Sbjct: 73  ILELYNYF------EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 183 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR----PTENEMTGYVATRWYRAPEIML 238
           Y+HS GI+HRDL  SN+ +  +  +KI DFGLA     P E   T    T  Y +PEI  
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIAT 185
Query: 239 NWMH 242
              H
Sbjct: 186 RSAH 189

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 46/131 (35%), Positives = 73/131 (55%), Gaps = 17/131 (12%)
Query: 117 MLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDDHVQFLV 174
           +L++  H N+I L DV+       D K VY+VT LM  G  L+ ILR +  S+     ++
Sbjct: 69  LLRYGQHPNIITLKDVYD------DGKYVYVVTELMKGGELLDKILRQKFFSEREASAVL 122
Query: 175 YQILRGLKYIHSAGIIHRDLKPSNIAVNEDC----ELKILDFGLARPTENEMTGYVATRW 230
           + I + ++Y+H+ G++HRDLKPSNI   ++      ++I DFG A+    E  G + T  
Sbjct: 123 FTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE-NGLLMTPC 181
Query: 231 YR----APEIM 237
           Y     APE++
Sbjct: 182 YTANFVAPEVL 192

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 93/183 (50%), Gaps = 19/183 (10%)
Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKI----ARPFQSAVHAKRTYRELRMLKHMN 122
           DIG  L    F ++     +  +G++ A K I    +R  +  V  +   RE+ +L+ + 
Sbjct: 15  DIGEELGSGQFAIV-KKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 123 HENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNIL-RTQKLSDDHVQFLVYQILRG 180
           H N+I L DV+ + T      +V ++  L+ G +L + L + + LS++     + QIL G
Sbjct: 74  HPNIITLHDVYENRT------DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 181 LKYIHSAGIIHRDLKPSNIAVNEDC----ELKILDFGLARPTEN--EMTGYVATRWYRAP 234
           + Y+H+  I H DLKP NI + +       +K++DFGLA   E+  E      T  + AP
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
Query: 235 EIM 237
           EI+
Sbjct: 188 EIV 190

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 42/131 (32%), Positives = 70/131 (53%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV      G   +++ R  + S+ 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYAPGGEMFSHLRRIGRFSEP 141
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +K+ DFGLA+  +        T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLCGT 201
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 202 PEYLAPEIILS 212

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 27/74 (36%), Positives = 40/74 (54%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +K+ DFGLA+  +        T  Y APEI+L+  +    D   
Sbjct: 164 YRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 224 LGVLIYEMAAGYPP 237

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 88/178 (49%), Gaps = 11/178 (6%)
Query: 64  GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAK-RTYRELRMLKHMN 122
           G   I  TL + SF  +   A  + +G KVA+K I +   +    + R  RE+  L+ + 
Sbjct: 4   GNYQIVKTLGEGSFGKV-KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 62
Query: 123 HENVIGLLDVFHSNTCLADFKNVYMVTHLMGADL-NNILRTQKLSDDHVQFLVYQILRGL 181
           H ++I L DV  S         + MV    G +L + I++  K+S+   +    QI+  +
Sbjct: 63  HPHIIKLYDVIKSKD------EIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAV 116
Query: 182 KYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIM 237
           +Y H   I+HRDLKP N+ ++E   +KI DFGL+      N +     +  Y APE++
Sbjct: 117 EYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVI 174

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 88/178 (49%), Gaps = 11/178 (6%)
Query: 64  GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAK-RTYRELRMLKHMN 122
           G   I  TL + SF  +   A  + +G KVA+K I +   +    + R  RE+  L+ + 
Sbjct: 13  GNYQIVKTLGEGSFGKV-KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 71
Query: 123 HENVIGLLDVFHSNTCLADFKNVYMVTHLMGADL-NNILRTQKLSDDHVQFLVYQILRGL 181
           H ++I L DV  S         + MV    G +L + I++  K+S+   +    QI+  +
Sbjct: 72  HPHIIKLYDVIKSKD------EIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAV 125
Query: 182 KYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIM 237
           +Y H   I+HRDLKP N+ ++E   +KI DFGL+      N +     +  Y APE++
Sbjct: 126 EYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVI 183

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 88/178 (49%), Gaps = 11/178 (6%)
Query: 64  GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAK-RTYRELRMLKHMN 122
           G   I  TL + SF  +   A  + +G KVA+K I +   +    + R  RE+  L+ + 
Sbjct: 8   GNYQIVKTLGEGSFGKV-KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 66
Query: 123 HENVIGLLDVFHSNTCLADFKNVYMVTHLMGADL-NNILRTQKLSDDHVQFLVYQILRGL 181
           H ++I L DV  S         + MV    G +L + I++  K+S+   +    QI+  +
Sbjct: 67  HPHIIKLYDVIKSKD------EIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAV 120
Query: 182 KYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIM 237
           +Y H   I+HRDLKP N+ ++E   +KI DFGL+      N +     +  Y APE++
Sbjct: 121 EYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVI 178

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 88/178 (49%), Gaps = 11/178 (6%)
Query: 64  GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAK-RTYRELRMLKHMN 122
           G   I  TL + SF  +   A  + +G KVA+K I +   +    + R  RE+  L+ + 
Sbjct: 14  GNYQIVKTLGEGSFGKV-KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 72
Query: 123 HENVIGLLDVFHSNTCLADFKNVYMVTHLMGADL-NNILRTQKLSDDHVQFLVYQILRGL 181
           H ++I L DV  S         + MV    G +L + I++  K+S+   +    QI+  +
Sbjct: 73  HPHIIKLYDVIKSKD------EIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAV 126
Query: 182 KYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIM 237
           +Y H   I+HRDLKP N+ ++E   +KI DFGL+      N +     +  Y APE++
Sbjct: 127 EYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVI 184

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 81/156 (51%), Gaps = 13/156 (8%)
Query: 89  SGVKVAIKKIARPFQSAVHAKR---TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV 145
           SG   A+K + +  Q  V  K+   T  E R+L+ +N   ++ L   F  N+      N+
Sbjct: 52  SGNHYAMKILDK--QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS------NL 103
Query: 146 YMVTHLM--GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE 203
           YMV   +  G   +++ R  + S+ H +F   QI+   +Y+HS  +I+RDLKP N+ ++E
Sbjct: 104 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDE 163
Query: 204 DCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN 239
              +++ DFG A+  +        T  Y APEI+L+
Sbjct: 164 QGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILS 199

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/74 (35%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ ++E   +++ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 151 YRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 210
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 211 LGVLIYEMAAGYPP 224

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 70/131 (53%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV   +  G   +++ R  + S+ 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYVPGGEMFSHLRRIGRFSEP 141
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +K+ DFG A+  +        T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGT 201
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 202 PEYLAPEIILS 212

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/74 (35%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +K+ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 164 YRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 224 LGVLIYEMAAGYPP 237

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 85/159 (53%), Gaps = 10/159 (6%)
Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           SG+ +A K I    + A+   +  REL++L   N   ++G    F+S+  ++       +
Sbjct: 33  SGLVMARKLIHLEIKPAIR-NQIIRELQVLHECNSPYIVGFYGAFYSDGEIS-----ICM 86
Query: 149 THLMGADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDCE 206
            H+ G  L+ +L+   ++ +  +  +   +++GL Y+     I+HRD+KPSNI VN   E
Sbjct: 87  EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE 146
Query: 207 LKILDFGLARPTENEMTG-YVATRWYRAPEIMLNWMHYN 244
           +K+ DFG++    +EM   +V TR Y +PE  L   HY+
Sbjct: 147 IKLCDFGVSGQLIDEMANEFVGTRSYMSPE-RLQGTHYS 184

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/80 (42%), Positives = 49/80 (61%), Gaps = 5/80 (6%)
Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEMTG-YVATRWYRAPEIMLNWMHYN-QTDIH 310
           +D+KPSNI VN   E+K+ DFG++    +EM   +V TR Y +PE  L   HY+ Q+DI 
Sbjct: 132 RDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTRSYMSPE-RLQGTHYSVQSDIW 190
Query: 311 QLNL-IMEM-LGTPPAEFMA 328
            + L ++EM +G  P   MA
Sbjct: 191 SMGLSLVEMAVGRYPRPPMA 210

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 69/131 (52%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV      G   +++ R  + S+ 
Sbjct: 89  TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYAPGGEMFSHLRRIGRFSEP 142
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +K+ DFG A+  +        T
Sbjct: 143 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGT 202
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 203 PEYLAPEIILS 213

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/74 (35%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +K+ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 165 YRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 224
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 225 LGVLIYEMAAGYPP 238

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 80/154 (51%), Gaps = 10/154 (6%)
Query: 88  VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYM 147
           ++G +VA+K I +   ++   ++ +RE+R++K +NH N++ L +V  +       K +Y+
Sbjct: 37  LTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETE------KTLYL 90
Query: 148 VTHLM--GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
           V      G   + ++   ++ +   +    QI+  ++Y H   I+HRDLK  N+ ++ D 
Sbjct: 91  VMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADM 150
Query: 206 ELKILDFGLARPTE--NEMTGYVATRWYRAPEIM 237
            +KI DFG +      N++  +     Y APE+ 
Sbjct: 151 NIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELF 184

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 69/131 (52%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV      G   +++ R  + S+ 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYAPGGEMFSHLRRIGRFSEP 141
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +K+ DFG A+  +        T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGT 201
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 202 PEYLAPEIILS 212

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/74 (35%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +K+ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 164 YRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 224 LGVLIYEMAAGYPP 237

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 81/154 (52%), Gaps = 10/154 (6%)
Query: 88  VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYM 147
           ++G +VA+K I +   ++   ++ +RE+R++K +NH N++ L +V  +       K +Y+
Sbjct: 37  LTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETE------KTLYL 90
Query: 148 VTHLM--GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
           V      G   + ++   ++ +   +    QI+  ++Y H   I+HRDLK  N+ ++ D 
Sbjct: 91  VMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADM 150
Query: 206 ELKILDFGLARPTE--NEMTGYVATRWYRAPEIM 237
            +KI DFG +      N++  +  +  Y APE+ 
Sbjct: 151 NIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELF 184

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 81/154 (52%), Gaps = 10/154 (6%)
Query: 88  VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYM 147
           ++G +VA+K I +   ++   ++ +RE+R++K +NH N++ L +V  +       K +Y+
Sbjct: 37  LTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETE------KTLYL 90
Query: 148 VTHLM--GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
           V      G   + ++   ++ +   +    QI+  ++Y H   I+HRDLK  N+ ++ D 
Sbjct: 91  VMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADM 150
Query: 206 ELKILDFGLARPTE--NEMTGYVATRWYRAPEIM 237
            +KI DFG +      N++  +  +  Y APE+ 
Sbjct: 151 NIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELF 184

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 70/131 (53%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV      G   +++ R  + S+ 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYAPGGEMFSHLRRIGRFSEP 141
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +++ DFGLA+  +        T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLCGT 201
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 202 PEYLAPEIILS 212

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/74 (35%), Positives = 40/74 (54%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +++ DFGLA+  +        T  Y APEI+L+  +    D   
Sbjct: 164 YRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 224 LGVLIYEMAAGYPP 237

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/131 (34%), Positives = 72/131 (54%), Gaps = 17/131 (12%)
Query: 117 MLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDDHVQFLV 174
           +L++  H N+I L DV+       D K VY+VT L   G  L+ ILR +  S+     ++
Sbjct: 69  LLRYGQHPNIITLKDVYD------DGKYVYVVTELXKGGELLDKILRQKFFSEREASAVL 122
Query: 175 YQILRGLKYIHSAGIIHRDLKPSNIAVNEDC----ELKILDFGLARPTENEMTGYVATRW 230
           + I + ++Y+H+ G++HRDLKPSNI   ++      ++I DFG A+    E  G + T  
Sbjct: 123 FTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE-NGLLXTPC 181
Query: 231 YR----APEIM 237
           Y     APE++
Sbjct: 182 YTANFVAPEVL 192

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 87/171 (50%), Gaps = 11/171 (6%)
Query: 71  TLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLL 130
           T+ K +F  +   A   ++G +VA+K I +   +    ++ +RE+R++K +NH N++ L 
Sbjct: 22  TIGKGNFAKV-KLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 131 DVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAG 188
           +V  +       K +Y+V      G   + ++   ++ +   +    QI+  ++Y H   
Sbjct: 81  EVIETE------KTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKY 134
Query: 189 IIHRDLKPSNIAVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIM 237
           I+HRDLK  N+ ++ D  +KI DFG +      N++  +  +  Y APE+ 
Sbjct: 135 IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELF 185

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 84/159 (52%), Gaps = 10/159 (6%)
Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           SG+ +A K I    + A+   +  REL++L   N   ++G    F+S+  ++       +
Sbjct: 92  SGLVMARKLIHLEIKPAIR-NQIIRELQVLHECNSPYIVGFYGAFYSDGEIS-----ICM 145
Query: 149 THLMGADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDCE 206
            H+ G  L+ +L+   ++ +  +  +   +++GL Y+     I+HRD+KPSNI VN   E
Sbjct: 146 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE 205
Query: 207 LKILDFGLARPTENEMT-GYVATRWYRAPEIMLNWMHYN 244
           +K+ DFG++    + M   +V TR Y +PE  L   HY+
Sbjct: 206 IKLCDFGVSGQLIDSMANSFVGTRSYMSPE-RLQGTHYS 243

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/69 (42%), Positives = 43/69 (62%), Gaps = 4/69 (5%)
Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEMT-GYVATRWYRAPEIMLNWMHYN-QTDIH 310
           +D+KPSNI VN   E+K+ DFG++    + M   +V TR Y +PE  L   HY+ Q+DI 
Sbjct: 191 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE-RLQGTHYSVQSDIW 249
Query: 311 QLNL-IMEM 318
            + L ++EM
Sbjct: 250 SMGLSLVEM 258

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 70/131 (53%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV   +  G   +++ R  + S+ 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +++ DFG A+  +        T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 201
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 202 PEYLAPEIILS 212

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 51/98 (52%), Gaps = 5/98 (5%)
Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV 287
            R+Y A +I+L + + +   +   ++DLKP N+ +++   +++ DFG A+  +       
Sbjct: 143 ARFY-AAQIVLTFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC 199
Query: 288 ATRWYRAPEIMLNWMHYNQTDIHQLN-LIMEM-LGTPP 323
            T  Y APEI+L+  +    D   L  LI EM  G PP
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 70/131 (53%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV   +  G   +++ R  + S+ 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +++ DFG A+  +        T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 201
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 202 PEYLAPEIILS 212

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 70/131 (53%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV   +  G   +++ R  + S+ 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +++ DFG A+  +        T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLAGT 201
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 202 PEYLAPEIILS 212

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +++ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLAGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 224 LGVLIYEMAAGYPP 237

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 70/131 (53%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV   +  G   +++ R  + S+ 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +++ DFG A+  +        T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 201
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 202 PEYLAPEIILS 212

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +++ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 224 LGVLIYEMAAGYPP 237

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 70/131 (53%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV   +  G   +++ R  + S+ 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEYSFKDNS------NLYMVMEYVPGGEMFSHLRRIGRFSEP 141
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +++ DFG A+  +        T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 201
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 202 PEYLAPEIILS 212

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +++ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 224 LGVLIYEMAAGYPP 237

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 70/131 (53%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV   +  G   +++ R  + S+ 
Sbjct: 89  TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYVPGGEMFSHLRRIGRFSEP 142
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +++ DFG A+  +        T
Sbjct: 143 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 202
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 203 PEYLAPEIILS 213

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +++ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 224
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 225 LGVLIYEMAAGYPP 238

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 70/131 (53%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV   +  G   +++ R  + S+ 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +++ DFG A+  +        T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 201
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 202 PEYLAPEIILS 212

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +++ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 224 LGVLIYEMAAGYPP 237

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 70/131 (53%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV   +  G   +++ R  + S+ 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +++ DFG A+  +        T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 201
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 202 PEYLAPEIILS 212

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +++ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 224 LGVLIYEMAAGYPP 237

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 70/131 (53%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV   +  G   +++ R  + S+ 
Sbjct: 89  TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYVPGGEMFSHLRRIGRFSEP 142
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +++ DFG A+  +        T
Sbjct: 143 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 202
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 203 PEYLAPEIILS 213

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +++ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 224
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 225 LGVLIYEMAAGYPP 238

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 70/131 (53%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV   +  G   +++ R  + S+ 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +++ DFG A+  +        T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 201
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 202 PEYLAPEIILS 212

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +++ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 224 LGVLIYEMAAGYPP 237

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 70/131 (53%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV   +  G   +++ R  + S+ 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEYSFKDNS------NLYMVMEYVPGGEMFSHLRRIGRFSEP 141
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +++ DFG A+  +        T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 201
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 202 PEYLAPEIILS 212

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +++ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 224 LGVLIYEMAAGYPP 237

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 70/131 (53%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV   +  G   +++ R  + S+ 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEYSFKDNS------NLYMVMEYVPGGEMFSHLRRIGRFSEP 141
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +++ DFG A+  +        T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 201
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 202 PEYLAPEIILS 212

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +++ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 224 LGVLIYEMAAGYPP 237

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 70/131 (53%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV   +  G   +++ R  + S+ 
Sbjct: 89  TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYVAGGEMFSHLRRIGRFSEP 142
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +++ DFG A+  +        T
Sbjct: 143 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 202
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 203 PEYLAPEIILS 213

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +++ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 224
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 225 LGVLIYEMAAGYPP 238

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 70/131 (53%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV   +  G   +++ R  + S+ 
Sbjct: 81  TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYVPGGEMFSHLRRIGRFSEP 134
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +++ DFG A+  +        T
Sbjct: 135 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 194
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 195 PEYLAPEIILS 205

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +++ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 157 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 216
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 217 LGVLIYEMAAGYPP 230

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 70/131 (53%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV   +  G   +++ R  + S+ 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYVPGGEMFSHLRRIGRFSEP 141
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +++ DFG A+  +        T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 201
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 202 PEYLAPEIILS 212

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +++ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 224 LGVLIYEMAAGYPP 237

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 70/131 (53%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV   +  G   +++ R  + S+ 
Sbjct: 89  TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYVPGGEMFSHLRRIGRFSEP 142
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +++ DFG A+  +        T
Sbjct: 143 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 202
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 203 PEYLAPEIILS 213

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +++ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 224
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 225 LGVLIYEMAAGYPP 238

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 70/131 (53%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV   +  G   +++ R  + S+ 
Sbjct: 74  TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYVPGGEMFSHLRRIGRFSEP 127
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +++ DFG A+  +        T
Sbjct: 128 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGT 187
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 188 PEYLAPEIILS 198

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +++ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 150 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWA 209
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 210 LGVLIYEMAAGYPP 223

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 70/131 (53%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV   +  G   +++ R  + S+ 
Sbjct: 109 TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYVPGGEMFSHLRRIGRFSEP 162
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +++ DFG A+  +        T
Sbjct: 163 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 222
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 223 PEYLAPEIILS 233

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +++ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 185 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 244
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 245 LGVLIYEMAAGYPP 258

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 70/131 (53%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV   +  G   +++ R  + S+ 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYVPGGEMFSHLRRIGRFSEP 141
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +++ DFG A+  +        T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 201
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 202 PEYLAPEIILS 212

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +++ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 224 LGVLIYEMAAGYPP 237

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 70/131 (53%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV   +  G   +++ R  + S+ 
Sbjct: 89  TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYVPGGEMFSHLRRIGRFSEP 142
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +++ DFG A+  +        T
Sbjct: 143 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGT 202
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 203 PEYLAPEIILS 213

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +++ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWA 224
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 225 LGVLIYEMAAGYPP 238

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 70/131 (53%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV   +  G   +++ R  + S+ 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +++ DFG A+  +        T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 201
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 202 PEYLAPEIILS 212

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +++ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 224 LGVLIYEMAAGYPP 237

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 70/131 (53%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV   +  G   +++ R  + S+ 
Sbjct: 89  TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYVPGGEMFSHLRRIGRFSEP 142
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +++ DFG A+  +        T
Sbjct: 143 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 202
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 203 PEYLAPEIILS 213

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +++ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 224
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 225 LGVLIYEMAAGYPP 238

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 95/189 (50%), Gaps = 21/189 (11%)
Query: 59  SEICRGVIDIGPTLSKESFD---LIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYREL 115
           +E  + + +   TL   +F    L    A   +  VK   KK  +  +S++       E+
Sbjct: 17  AEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIE-----NEI 71
Query: 116 RMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADL-NNILRTQKLSDDHVQFL 173
            +L+ + HEN++ L D++ S        ++Y+V  L+ G +L + I+     ++     L
Sbjct: 72  AVLRKIKHENIVALEDIYESPN------HLYLVMQLVSGGELFDRIVEKGFYTEKDASTL 125
Query: 174 VYQILRGLKYIHSAGIIHRDLKPSNI---AVNEDCELKILDFGLAR--PTENEMTGYVAT 228
           + Q+L  + Y+H  GI+HRDLKP N+   + +E+ ++ I DFGL++     + M+    T
Sbjct: 126 IRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGT 185
Query: 229 RWYRAPEIM 237
             Y APE++
Sbjct: 186 PGYVAPEVL 194

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 70/131 (53%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV   +  G   +++ R  + S+ 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYVPGGEMFSHLRRIGRFSEP 141
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +++ DFG A+  +        T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 201
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 202 PEYLAPEIILS 212

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +++ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 224 LGVLIYEMAAGYPP 237

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 70/131 (53%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV   +  G   +++ R  + S+ 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +++ DFG A+  +        T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLXGT 201
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 202 PEYLAPEIILS 212

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +++ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLXGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 224 LGVLIYEMAAGYPP 237

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 84/159 (52%), Gaps = 10/159 (6%)
Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           SG+ +A K I    + A+   +  REL++L   N   ++G    F+S+  ++       +
Sbjct: 30  SGLVMARKLIHLEIKPAIR-NQIIRELQVLHECNSPYIVGFYGAFYSDGEIS-----ICM 83
Query: 149 THLMGADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDCE 206
            H+ G  L+ +L+   ++ +  +  +   +++GL Y+     I+HRD+KPSNI VN   E
Sbjct: 84  EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE 143
Query: 207 LKILDFGLARPTENEMT-GYVATRWYRAPEIMLNWMHYN 244
           +K+ DFG++    + M   +V TR Y +PE  L   HY+
Sbjct: 144 IKLCDFGVSGQLIDSMANSFVGTRSYMSPE-RLQGTHYS 181

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/69 (42%), Positives = 43/69 (62%), Gaps = 4/69 (5%)
Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEMT-GYVATRWYRAPEIMLNWMHYN-QTDIH 310
           +D+KPSNI VN   E+K+ DFG++    + M   +V TR Y +PE  L   HY+ Q+DI 
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE-RLQGTHYSVQSDIW 187
Query: 311 QLNL-IMEM 318
            + L ++EM
Sbjct: 188 SMGLSLVEM 196

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 70/131 (53%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV   +  G   +++ R  + S+ 
Sbjct: 109 TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYVAGGEMFSHLRRIGRFSEP 162
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +++ DFG A+  +        T
Sbjct: 163 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLCGT 222
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 223 PEYLAPEIILS 233

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 51/98 (52%), Gaps = 5/98 (5%)
Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV 287
            R+Y A +I+L + + +   +   ++DLKP N+ +++   +++ DFG A+  +       
Sbjct: 164 ARFY-AAQIVLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLC 220
Query: 288 ATRWYRAPEIMLNWMHYNQTDIHQLN-LIMEM-LGTPP 323
            T  Y APEI+L+  +    D   L  LI EM  G PP
Sbjct: 221 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 112/248 (45%), Gaps = 47/248 (18%)
Query: 150 HLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN-EDCELK 208
           H+   D   + +T  L+D  ++F +Y+IL+ L Y HS GI+HRD+KP N+ ++ E  +L+
Sbjct: 115 HVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLR 172
Query: 209 ILDFGLARPTE--NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDC 266
           ++D+GLA       E    VA+R+++ PE+++++  Y                     D 
Sbjct: 173 LIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMY---------------------DY 211
Query: 267 ELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPP-AE 325
            L +   G            +A+  +R         +Y+     QL  I ++LGT    +
Sbjct: 212 SLDMWSLGCM----------LASMIFRKEPFFHGHDNYD-----QLVRIAKVLGTEDLYD 256
Query: 326 FMAKISSDSARKYINSLPLLTKKDFRQVFKGAN-----PQAIXXXXXXXXXXXXKRITAE 380
           ++ K + +   ++ + L   ++K + +     N     P+A+             R+TA 
Sbjct: 257 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 316
Query: 381 QALAHPYL 388
           +A+ HPY 
Sbjct: 317 EAMEHPYF 324

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 81/154 (52%), Gaps = 10/154 (6%)
Query: 88  VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYM 147
           ++G +VA++ I +   ++   ++ +RE+R++K +NH N++ L +V  +       K +Y+
Sbjct: 37  LTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETE------KTLYL 90
Query: 148 VTHLM--GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
           V      G   + ++   ++ +   +    QI+  ++Y H   I+HRDLK  N+ ++ D 
Sbjct: 91  VMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADM 150
Query: 206 ELKILDFGLARPTE--NEMTGYVATRWYRAPEIM 237
            +KI DFG +      N++  +  +  Y APE+ 
Sbjct: 151 NIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELF 184

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 112/248 (45%), Gaps = 47/248 (18%)
Query: 150 HLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN-EDCELK 208
           H+   D   + +T  L+D  ++F +Y+IL+ L Y HS GI+HRD+KP N+ ++ E  +L+
Sbjct: 115 HVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLR 172
Query: 209 ILDFGLARPTE--NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDC 266
           ++D+GLA       E    VA+R+++ PE+++++  Y                     D 
Sbjct: 173 LIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMY---------------------DY 211
Query: 267 ELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPP-AE 325
            L +   G            +A+  +R         +Y+     QL  I ++LGT    +
Sbjct: 212 SLDMWSLGCM----------LASMIFRKEPFFHGHDNYD-----QLVRIAKVLGTEDLYD 256
Query: 326 FMAKISSDSARKYINSLPLLTKKDFRQVFKGAN-----PQAIXXXXXXXXXXXXKRITAE 380
           ++ K + +   ++ + L   ++K + +     N     P+A+             R+TA 
Sbjct: 257 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 316
Query: 381 QALAHPYL 388
           +A+ HPY 
Sbjct: 317 EAMEHPYF 324

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 112/248 (45%), Gaps = 47/248 (18%)
Query: 150 HLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN-EDCELK 208
           H+   D   + +T  L+D  ++F +Y+IL+ L Y HS GI+HRD+KP N+ ++ E  +L+
Sbjct: 115 HVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLR 172
Query: 209 ILDFGLARPTE--NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDC 266
           ++D+GLA       E    VA+R+++ PE+++++  Y                     D 
Sbjct: 173 LIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMY---------------------DY 211
Query: 267 ELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPP-AE 325
            L +   G            +A+  +R         +Y+     QL  I ++LGT    +
Sbjct: 212 SLDMWSLGCM----------LASMIFRKEPFFHGHDNYD-----QLVRIAKVLGTEDLYD 256
Query: 326 FMAKISSDSARKYINSLPLLTKKDFRQVFKGAN-----PQAIXXXXXXXXXXXXKRITAE 380
           ++ K + +   ++ + L   ++K + +     N     P+A+             R+TA 
Sbjct: 257 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 316
Query: 381 QALAHPYL 388
           +A+ HPY 
Sbjct: 317 EAMEHPYF 324

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 112/248 (45%), Gaps = 47/248 (18%)
Query: 150 HLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN-EDCELK 208
           H+   D   + +T  L+D  ++F +Y+IL+ L Y HS GI+HRD+KP N+ ++ E  +L+
Sbjct: 115 HVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLR 172
Query: 209 ILDFGLARPTE--NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDC 266
           ++D+GLA       E    VA+R+++ PE+++++  Y                     D 
Sbjct: 173 LIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMY---------------------DY 211
Query: 267 ELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPP-AE 325
            L +   G            +A+  +R         +Y+     QL  I ++LGT    +
Sbjct: 212 SLDMWSLGCM----------LASMIFRKEPFFHGHDNYD-----QLVRIAKVLGTEDLYD 256
Query: 326 FMAKISSDSARKYINSLPLLTKKDFRQVFKGAN-----PQAIXXXXXXXXXXXXKRITAE 380
           ++ K + +   ++ + L   ++K + +     N     P+A+             R+TA 
Sbjct: 257 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 316
Query: 381 QALAHPYL 388
           +A+ HPY 
Sbjct: 317 EAMEHPYF 324

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 114/249 (45%), Gaps = 49/249 (19%)
Query: 150 HLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN-EDCELK 208
           H+   D   + +T  L+D  ++F +Y+IL+ L Y HS GI+HRD+KP N+ ++ E  +L+
Sbjct: 114 HVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLR 171
Query: 209 ILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNED 265
           ++D+GLA    P + E    VA+R+++ PE+++++  Y                     D
Sbjct: 172 LIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLVDYQMY---------------------D 209
Query: 266 CELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPP-A 324
             L +   G            +A+  +R         +Y+     QL  I ++LGT    
Sbjct: 210 YSLDMWSLGCM----------LASMIFRKEPFFHGHDNYD-----QLVRIAKVLGTEDLY 254
Query: 325 EFMAKISSDSARKYINSLPLLTKKDFRQVFKGAN-----PQAIXXXXXXXXXXXXKRITA 379
           +++ K + +   ++ + L   ++K + +     N     P+A+             R+TA
Sbjct: 255 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 314
Query: 380 EQALAHPYL 388
            +A+ HPY 
Sbjct: 315 REAMEHPYF 323

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 114/249 (45%), Gaps = 49/249 (19%)
Query: 150 HLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN-EDCELK 208
           H+   D   + +T  L+D  ++F +Y+IL+ L Y HS GI+HRD+KP N+ ++ E  +L+
Sbjct: 115 HVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLR 172
Query: 209 ILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNED 265
           ++D+GLA    P + E    VA+R+++ PE+++++  Y                     D
Sbjct: 173 LIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLVDYQMY---------------------D 210
Query: 266 CELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPP-A 324
             L +   G            +A+  +R         +Y+     QL  I ++LGT    
Sbjct: 211 YSLDMWSLGCM----------LASMIFRKEPFFHGHDNYD-----QLVRIAKVLGTEDLY 255
Query: 325 EFMAKISSDSARKYINSLPLLTKKDFRQVFKGAN-----PQAIXXXXXXXXXXXXKRITA 379
           +++ K + +   ++ + L   ++K + +     N     P+A+             R+TA
Sbjct: 256 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 315
Query: 380 EQALAHPYL 388
            +A+ HPY 
Sbjct: 316 REAMEHPYF 324

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 81/154 (52%), Gaps = 10/154 (6%)
Query: 88  VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYM 147
           ++G +VA++ I +   ++   ++ +RE+R++K +NH N++ L +V  +       K +Y+
Sbjct: 37  LTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETE------KTLYL 90
Query: 148 VTHLM--GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
           V      G   + ++   ++ +   +    QI+  ++Y H   I+HRDLK  N+ ++ D 
Sbjct: 91  VMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADM 150
Query: 206 ELKILDFGLARPTE--NEMTGYVATRWYRAPEIM 237
            +KI DFG +      N++  +  +  Y APE+ 
Sbjct: 151 NIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELF 184

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 84/159 (52%), Gaps = 10/159 (6%)
Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           SG+ +A K I    + A+   +  REL++L   N   ++G    F+S+  ++       +
Sbjct: 30  SGLVMARKLIHLEIKPAIR-NQIIRELQVLHECNSPYIVGFYGAFYSDGEIS-----ICM 83
Query: 149 THLMGADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDCE 206
            H+ G  L+ +L+   ++ +  +  +   +++GL Y+     I+HRD+KPSNI VN   E
Sbjct: 84  EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE 143
Query: 207 LKILDFGLARPTENEMT-GYVATRWYRAPEIMLNWMHYN 244
           +K+ DFG++    + M   +V TR Y +PE  L   HY+
Sbjct: 144 IKLCDFGVSGQLIDSMANSFVGTRSYMSPE-RLQGTHYS 181

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/69 (42%), Positives = 43/69 (62%), Gaps = 4/69 (5%)
Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEMT-GYVATRWYRAPEIMLNWMHYN-QTDIH 310
           +D+KPSNI VN   E+K+ DFG++    + M   +V TR Y +PE  L   HY+ Q+DI 
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE-RLQGTHYSVQSDIW 187
Query: 311 QLNL-IMEM 318
            + L ++EM
Sbjct: 188 SMGLSLVEM 196

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 84/159 (52%), Gaps = 10/159 (6%)
Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           SG+ +A K I    + A+   +  REL++L   N   ++G    F+S+  ++       +
Sbjct: 57  SGLVMARKLIHLEIKPAIR-NQIIRELQVLHECNSPYIVGFYGAFYSDGEIS-----ICM 110
Query: 149 THLMGADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDCE 206
            H+ G  L+ +L+   ++ +  +  +   +++GL Y+     I+HRD+KPSNI VN   E
Sbjct: 111 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE 170
Query: 207 LKILDFGLARPTENEMT-GYVATRWYRAPEIMLNWMHYN 244
           +K+ DFG++    + M   +V TR Y +PE  L   HY+
Sbjct: 171 IKLCDFGVSGQLIDSMANSFVGTRSYMSPE-RLQGTHYS 208

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/69 (42%), Positives = 43/69 (62%), Gaps = 4/69 (5%)
Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEMT-GYVATRWYRAPEIMLNWMHYN-QTDIH 310
           +D+KPSNI VN   E+K+ DFG++    + M   +V TR Y +PE  L   HY+ Q+DI 
Sbjct: 156 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE-RLQGTHYSVQSDIW 214
Query: 311 QLNL-IMEM 318
            + L ++EM
Sbjct: 215 SMGLSLVEM 223

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 112/248 (45%), Gaps = 47/248 (18%)
Query: 150 HLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN-EDCELK 208
           H+   D   + +T  L+D  ++F +Y+IL+ L Y HS GI+HRD+KP N+ ++ E  +L+
Sbjct: 114 HVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLR 171
Query: 209 ILDFGLARPTE--NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDC 266
           ++D+GLA       E    VA+R+++ PE+++++  Y                     D 
Sbjct: 172 LIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMY---------------------DY 210
Query: 267 ELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPP-AE 325
            L +   G            +A+  +R         +Y+     QL  I ++LGT    +
Sbjct: 211 SLDMWSLGCM----------LASMIFRKEPFFHGHDNYD-----QLVRIAKVLGTEDLYD 255
Query: 326 FMAKISSDSARKYINSLPLLTKKDFRQVFKGAN-----PQAIXXXXXXXXXXXXKRITAE 380
           ++ K + +   ++ + L   ++K + +     N     P+A+             R+TA 
Sbjct: 256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 315
Query: 381 QALAHPYL 388
           +A+ HPY 
Sbjct: 316 EAMEHPYF 323

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 13/166 (7%)
Query: 90  GVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT 149
           G +  IK+I     S+   + + RE+ +L +M H N++   + F  N  L      Y+V 
Sbjct: 49  GRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSL------YIVM 102
Query: 150 -HLMGADLNNILRTQK---LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
            +  G DL   +  QK     +D +     QI   LK++H   I+HRD+K  NI + +D 
Sbjct: 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG 162
Query: 206 ELKILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHYNQTGV 248
            +++ DFG+AR    T       + T +Y +PEI  N  + N++ +
Sbjct: 163 TVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDI 208

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 112/248 (45%), Gaps = 47/248 (18%)
Query: 150 HLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN-EDCELK 208
           H+   D   + +T  L+D  ++F +Y+IL+ L Y HS GI+HRD+KP N+ ++ E  +L+
Sbjct: 113 HVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLR 170
Query: 209 ILDFGLARPTE--NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDC 266
           ++D+GLA       E    VA+R+++ PE+++++  Y                     D 
Sbjct: 171 LIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMY---------------------DY 209
Query: 267 ELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPP-AE 325
            L +   G            +A+  +R         +Y+     QL  I ++LGT    +
Sbjct: 210 SLDMWSLGCM----------LASMIFRKEPFFHGHDNYD-----QLVRIAKVLGTEDLYD 254
Query: 326 FMAKISSDSARKYINSLPLLTKKDFRQVFKGAN-----PQAIXXXXXXXXXXXXKRITAE 380
           ++ K + +   ++ + L   ++K + +     N     P+A+             R+TA 
Sbjct: 255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 314
Query: 381 QALAHPYL 388
           +A+ HPY 
Sbjct: 315 EAMEHPYF 322

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 114/249 (45%), Gaps = 49/249 (19%)
Query: 150 HLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN-EDCELK 208
           H+   D   + +T  L+D  ++F +Y+IL+ L Y HS GI+HRD+KP N+ ++ E  +L+
Sbjct: 115 HVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLR 172
Query: 209 ILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNED 265
           ++D+GLA    P + E    VA+R+++ PE+++++  Y                     D
Sbjct: 173 LIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLVDYQMY---------------------D 210
Query: 266 CELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPP-A 324
             L +   G            +A+  +R         +Y+     QL  I ++LGT    
Sbjct: 211 YSLDMWSLGCM----------LASMIFRKEPFFHGHDNYD-----QLVRIAKVLGTEDLY 255
Query: 325 EFMAKISSDSARKYINSLPLLTKKDFRQVFKGAN-----PQAIXXXXXXXXXXXXKRITA 379
           +++ K + +   ++ + L   ++K + +     N     P+A+             R+TA
Sbjct: 256 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 315
Query: 380 EQALAHPYL 388
            +A+ HPY 
Sbjct: 316 REAMEHPYF 324

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 84/159 (52%), Gaps = 10/159 (6%)
Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           SG+ +A K I    + A+   +  REL++L   N   ++G    F+S+  ++       +
Sbjct: 30  SGLVMARKLIHLEIKPAIR-NQIIRELQVLHECNSPYIVGFYGAFYSDGEIS-----ICM 83
Query: 149 THLMGADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDCE 206
            H+ G  L+ +L+   ++ +  +  +   +++GL Y+     I+HRD+KPSNI VN   E
Sbjct: 84  EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE 143
Query: 207 LKILDFGLARPTENEMT-GYVATRWYRAPEIMLNWMHYN 244
           +K+ DFG++    + M   +V TR Y +PE  L   HY+
Sbjct: 144 IKLCDFGVSGQLIDSMANSFVGTRSYMSPE-RLQGTHYS 181

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/69 (42%), Positives = 43/69 (62%), Gaps = 4/69 (5%)
Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEMT-GYVATRWYRAPEIMLNWMHYN-QTDIH 310
           +D+KPSNI VN   E+K+ DFG++    + M   +V TR Y +PE  L   HY+ Q+DI 
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE-RLQGTHYSVQSDIW 187
Query: 311 QLNL-IMEM 318
            + L ++EM
Sbjct: 188 SMGLSLVEM 196

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 112/248 (45%), Gaps = 47/248 (18%)
Query: 150 HLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN-EDCELK 208
           H+   D   + +T  L+D  ++F +Y+IL+ L Y HS GI+HRD+KP N+ ++ E  +L+
Sbjct: 115 HVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLR 172
Query: 209 ILDFGLARPTE--NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDC 266
           ++D+GLA       E    VA+R+++ PE+++++  Y                     D 
Sbjct: 173 LIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMY---------------------DY 211
Query: 267 ELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPP-AE 325
            L +   G            +A+  +R         +Y+     QL  I ++LGT    +
Sbjct: 212 SLDMWSLGCM----------LASMIFRKEPFFHGHDNYD-----QLVRIAKVLGTEDLYD 256
Query: 326 FMAKISSDSARKYINSLPLLTKKDFRQVFKGAN-----PQAIXXXXXXXXXXXXKRITAE 380
           ++ K + +   ++ + L   ++K + +     N     P+A+             R+TA 
Sbjct: 257 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 316
Query: 381 QALAHPYL 388
           +A+ HPY 
Sbjct: 317 EAMEHPYF 324

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 69/131 (52%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV      G   +++ R  + S+ 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYAPGGEMFSHLRRIGRFSEP 141
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +++ DFG A+  +        T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLCGT 201
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 202 PEYLAPEIILS 212

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +++ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 164 YRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 224 LGVLIYEMAAGYPP 237

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/261 (23%), Positives = 117/261 (44%), Gaps = 49/261 (18%)
Query: 150 HLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN-EDCELK 208
           H+   D   + +T  L+D  ++F +Y+IL+ L Y HS GI+HRD+KP N+ ++ E  +L+
Sbjct: 115 HVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLR 172
Query: 209 ILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNED 265
           ++D+GLA    P + E    VA+R+++ PE+++++  Y                     D
Sbjct: 173 LIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLVDYQMY---------------------D 210
Query: 266 CELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPA- 324
             L +   G            +A+  +R         +Y+     QL  I ++LGT    
Sbjct: 211 YSLDMWSLGCM----------LASMIFRKEPFFHGHDNYD-----QLVRIAKVLGTEDLY 255
Query: 325 EFMAKISSDSARKYINSLPLLTKKDFRQVFKGAN-----PQAIXXXXXXXXXXXXKRITA 379
           +++ K + +   ++ + L   ++K + +     N     P+A+             R+TA
Sbjct: 256 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 315
Query: 380 EQALAHPYLSQYSDPNDEPTS 400
            +A+ HPY         +P +
Sbjct: 316 REAMEHPYFYPVVKEQSQPCA 336

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 79/153 (51%), Gaps = 9/153 (5%)
Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           SG   A+K + +         RT  E  +L  +NH  V+ L   F +   L       ++
Sbjct: 55  SGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKLHYAFQTEGKL-----YLIL 109
Query: 149 THLMGADLNNILRTQKL-SDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
             L G DL   L  + + +++ V+F + ++  GL ++HS GII+RDLKP NI ++E+  +
Sbjct: 110 DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHSLGIIYRDLKPENILLDEEGHI 169
Query: 208 KILDFGLARPT---ENEMTGYVATRWYRAPEIM 237
           K+ DFGL++     E +   +  T  Y APE++
Sbjct: 170 KLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVV 202

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 57/111 (51%), Gaps = 14/111 (12%)
Query: 218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLAR 277
           TE ++  Y+A       E+ L   H +  G+   ++DLKP NI ++E+  +K+ DFGL++
Sbjct: 128 TEEDVKFYLA-------ELALGLDHLHSLGI--IYRDLKPENILLDEEGHIKLTDFGLSK 178
Query: 278 PT---ENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIM-EML-GTPP 323
                E +   +  T  Y APE++    H +  D     ++M EML G+ P
Sbjct: 179 EAIDHEKKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLP 229

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 68/131 (51%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   +  L   F  N+      N+YMV      G   +++ R  + S+ 
Sbjct: 89  TLNEKRILQAVNFPFLTKLEFSFKDNS------NLYMVMEYAPGGEMFSHLRRIGRFSEP 142
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +K+ DFG A+  +        T
Sbjct: 143 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGT 202
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 203 PEYLAPEIILS 213

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/74 (35%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +K+ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 165 YRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 224
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 225 LGVLIYEMAAGYPP 238

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 90/183 (49%), Gaps = 19/183 (10%)
Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKI----ARPFQSAVHAKRTYRELRMLKHMN 122
           D G  L    F ++     +  +G++ A K I     +  +  V  +   RE+ +LK + 
Sbjct: 14  DTGEELGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 123 HENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNIL-RTQKLSDDHVQFLVYQILRG 180
           H NVI L +V+ + T      +V ++  L+ G +L + L   + L+++     + QIL G
Sbjct: 73  HPNVITLHEVYENKT------DVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 181 LKYIHSAGIIHRDLKPSNIAVNE----DCELKILDFGLARPTE--NEMTGYVATRWYRAP 234
           + Y+HS  I H DLKP NI + +       +KI+DFGLA   +  NE      T  + AP
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 235 EIM 237
           EI+
Sbjct: 187 EIV 189

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 114/249 (45%), Gaps = 49/249 (19%)
Query: 150 HLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN-EDCELK 208
           H+   D   + +T  L+D  ++F +Y+IL+ L Y HS GI+HRD+KP N+ ++ E  +L+
Sbjct: 120 HVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLR 177
Query: 209 ILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNED 265
           ++D+GLA    P + E    VA+R+++ PE+++++  Y                     D
Sbjct: 178 LIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLVDYQMY---------------------D 215
Query: 266 CELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPP-A 324
             L +   G            +A+  +R         +Y+     QL  I ++LGT    
Sbjct: 216 YSLDMWSLGCM----------LASMIFRKEPFFHGHDNYD-----QLVRIAKVLGTEDLY 260
Query: 325 EFMAKISSDSARKYINSLPLLTKKDFRQVFKGAN-----PQAIXXXXXXXXXXXXKRITA 379
           +++ K + +   ++ + L   ++K + +     N     P+A+             R+TA
Sbjct: 261 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 320
Query: 380 EQALAHPYL 388
            +A+ HPY 
Sbjct: 321 REAMEHPYF 329

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 84/159 (52%), Gaps = 10/159 (6%)
Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           SG+ +A K I    + A+   +  REL++L   N   ++G    F+S+  ++       +
Sbjct: 30  SGLVMARKLIHLEIKPAIR-NQIIRELQVLHECNSPYIVGFYGAFYSDGEIS-----ICM 83
Query: 149 THLMGADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDCE 206
            H+ G  L+ +L+   ++ +  +  +   +++GL Y+     I+HRD+KPSNI VN   E
Sbjct: 84  EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE 143
Query: 207 LKILDFGLARPTENEMT-GYVATRWYRAPEIMLNWMHYN 244
           +K+ DFG++    + M   +V TR Y +PE  L   HY+
Sbjct: 144 IKLCDFGVSGQLIDSMANSFVGTRSYMSPE-RLQGTHYS 181

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/69 (42%), Positives = 43/69 (62%), Gaps = 4/69 (5%)
Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEMT-GYVATRWYRAPEIMLNWMHYN-QTDIH 310
           +D+KPSNI VN   E+K+ DFG++    + M   +V TR Y +PE  L   HY+ Q+DI 
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE-RLQGTHYSVQSDIW 187
Query: 311 QLNL-IMEM 318
            + L ++EM
Sbjct: 188 SMGLSLVEM 196

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 84/159 (52%), Gaps = 10/159 (6%)
Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           SG+ +A K I    + A+   +  REL++L   N   ++G    F+S+  ++       +
Sbjct: 30  SGLVMARKLIHLEIKPAIR-NQIIRELQVLHECNSPYIVGFYGAFYSDGEIS-----ICM 83
Query: 149 THLMGADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDCE 206
            H+ G  L+ +L+   ++ +  +  +   +++GL Y+     I+HRD+KPSNI VN   E
Sbjct: 84  EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE 143
Query: 207 LKILDFGLARPTENEMT-GYVATRWYRAPEIMLNWMHYN 244
           +K+ DFG++    + M   +V TR Y +PE  L   HY+
Sbjct: 144 IKLCDFGVSGQLIDSMANSFVGTRSYMSPE-RLQGTHYS 181

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/69 (42%), Positives = 43/69 (62%), Gaps = 4/69 (5%)
Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEMT-GYVATRWYRAPEIMLNWMHYN-QTDIH 310
           +D+KPSNI VN   E+K+ DFG++    + M   +V TR Y +PE  L   HY+ Q+DI 
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE-RLQGTHYSVQSDIW 187
Query: 311 QLNL-IMEM 318
            + L ++EM
Sbjct: 188 SMGLSLVEM 196

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 70/131 (53%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV   +  G   +++ R  + S+ 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +++ DFG A+  +        T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLCGT 201
Query: 229 RWYRAPEIMLN 239
             Y APEI+++
Sbjct: 202 PEYLAPEIIIS 212

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 5/98 (5%)
Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV 287
            R+Y A +I+L + + +   +   ++DLKP N+ +++   +++ DFG A+  +       
Sbjct: 143 ARFY-AAQIVLTFEYLH--SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLC 199
Query: 288 ATRWYRAPEIMLNWMHYNQTDIHQLN-LIMEM-LGTPP 323
            T  Y APEI+++  +    D   L  LI EM  G PP
Sbjct: 200 GTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 68/131 (51%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   +  L   F  N+      N+YMV      G   +++ R  + S+ 
Sbjct: 89  TLNEKRILQAVNFPFLTKLEFSFKDNS------NLYMVMEYAPGGEMFSHLRRIGRFSEP 142
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +K+ DFG A+  +        T
Sbjct: 143 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGT 202
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 203 PEYLAPEIILS 213

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/74 (35%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +K+ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 165 YRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 224
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 225 LGVLIYEMAAGYPP 238

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 114/249 (45%), Gaps = 49/249 (19%)
Query: 150 HLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN-EDCELK 208
           H+   D   + +T  L+D  ++F +Y+IL+ L Y HS GI+HRD+KP N+ ++ E  +L+
Sbjct: 115 HVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVLIDHEHRKLR 172
Query: 209 ILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNED 265
           ++D+GLA    P + E    VA+R+++ PE+++++  Y                     D
Sbjct: 173 LIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLVDYQMY---------------------D 210
Query: 266 CELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPA- 324
             L +   G            +A+  +R         +Y+     QL  I ++LGT    
Sbjct: 211 YSLDMWSLGCM----------LASMIFRKEPFFHGHDNYD-----QLVRIAKVLGTEDLY 255
Query: 325 EFMAKISSDSARKYINSLPLLTKKDFRQVFKGAN-----PQAIXXXXXXXXXXXXKRITA 379
           +++ K + +   ++ + L   ++K + +     N     P+A+             R+TA
Sbjct: 256 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 315
Query: 380 EQALAHPYL 388
            +A+ HPY 
Sbjct: 316 REAMEHPYF 324

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 113/249 (45%), Gaps = 49/249 (19%)
Query: 150 HLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN-EDCELK 208
           H+   D   +   Q L+D  ++F +Y+IL+ L Y HS GI+HRD+KP N+ ++ E  +L+
Sbjct: 115 HVNNTDFKQL--RQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLR 172
Query: 209 ILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNED 265
           ++D+GLA    P + E    VA+R+++ PE+++++  Y                     D
Sbjct: 173 LIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLVDYQMY---------------------D 210
Query: 266 CELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPP-A 324
             L +   G            +A+  +R         +Y+     QL  I ++LGT    
Sbjct: 211 YSLDMWSLGCM----------LASMIFRKEPFFHGHDNYD-----QLVRIAKVLGTEDLY 255
Query: 325 EFMAKISSDSARKYINSLPLLTKKDFRQVFKGAN-----PQAIXXXXXXXXXXXXKRITA 379
           +++ K + +   ++ + L   ++K + +     N     P+A+             R+TA
Sbjct: 256 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 315
Query: 380 EQALAHPYL 388
            +A+ HPY 
Sbjct: 316 REAMEHPYF 324

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 76/143 (53%), Gaps = 14/143 (9%)
Query: 103 QSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNIL- 160
           +  V  +   RE+ +L+ + H N+I L D+F + T      +V ++  L+ G +L + L 
Sbjct: 54  RRGVSREEIEREVNILREIRHPNIITLHDIFENKT------DVVLILELVSGGELFDFLA 107
Query: 161 RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE----DCELKILDFGLAR 216
             + L++D     + QIL G+ Y+HS  I H DLKP NI + +    +  +K++DFG+A 
Sbjct: 108 EKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 167
Query: 217 PTE--NEMTGYVATRWYRAPEIM 237
             E  NE      T  + APEI+
Sbjct: 168 KIEAGNEFKNIFGTPEFVAPEIV 190

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 90/183 (49%), Gaps = 19/183 (10%)
Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKI----ARPFQSAVHAKRTYRELRMLKHMN 122
           D G  L    F ++     +  +G++ A K I     +  +  V  +   RE+ +LK + 
Sbjct: 13  DTGEELGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 123 HENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNIL-RTQKLSDDHVQFLVYQILRG 180
           H NVI L +V+ + T      +V ++  L+ G +L + L   + L+++     + QIL G
Sbjct: 72  HPNVITLHEVYENKT------DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 125
Query: 181 LKYIHSAGIIHRDLKPSNIAVNE----DCELKILDFGLARPTE--NEMTGYVATRWYRAP 234
           + Y+HS  I H DLKP NI + +       +KI+DFGLA   +  NE      T  + AP
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 185
Query: 235 EIM 237
           EI+
Sbjct: 186 EIV 188

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 90/183 (49%), Gaps = 19/183 (10%)
Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKI----ARPFQSAVHAKRTYRELRMLKHMN 122
           D G  L    F ++     +  +G++ A K I     +  +  V  +   RE+ +LK + 
Sbjct: 14  DTGEELGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 123 HENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNIL-RTQKLSDDHVQFLVYQILRG 180
           H NVI L +V+ + T      +V ++  L+ G +L + L   + L+++     + QIL G
Sbjct: 73  HPNVITLHEVYENKT------DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 181 LKYIHSAGIIHRDLKPSNIAVNE----DCELKILDFGLARPTE--NEMTGYVATRWYRAP 234
           + Y+HS  I H DLKP NI + +       +KI+DFGLA   +  NE      T  + AP
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 235 EIM 237
           EI+
Sbjct: 187 EIV 189

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 90/183 (49%), Gaps = 19/183 (10%)
Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKI----ARPFQSAVHAKRTYRELRMLKHMN 122
           D G  L    F ++     +  +G++ A K I     +  +  V  +   RE+ +LK + 
Sbjct: 13  DTGEELGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 123 HENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNIL-RTQKLSDDHVQFLVYQILRG 180
           H NVI L +V+ + T      +V ++  L+ G +L + L   + L+++     + QIL G
Sbjct: 72  HPNVITLHEVYENKT------DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 125
Query: 181 LKYIHSAGIIHRDLKPSNIAVNE----DCELKILDFGLARPTE--NEMTGYVATRWYRAP 234
           + Y+HS  I H DLKP NI + +       +KI+DFGLA   +  NE      T  + AP
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 185
Query: 235 EIM 237
           EI+
Sbjct: 186 EIV 188

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 111/248 (44%), Gaps = 47/248 (18%)
Query: 163 QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN-EDCELKILDFGLAR---PT 218
           Q L+D  ++F +Y++L+ L Y HS GI+HRD+KP N+ ++ +  +L+++D+GLA    P 
Sbjct: 127 QILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPA 186
Query: 219 ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARP 278
           + E    VA+R+++ PE+++++  Y                     D  L +   G    
Sbjct: 187 Q-EYNVRVASRYFKGPELLVDYQMY---------------------DYSLDMWSLGC--- 221
Query: 279 TENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPA-EFMAKISSDSARK 337
               M   +  R  R P        + Q +  QL  I ++LGT     ++ K   D    
Sbjct: 222 ----MLASMIFR--REP------FFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPH 269
Query: 338 YINSLPLLTKKDFRQVFKGAN-----PQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYS 392
           + + L   ++K +       N     P+A+            +R+TA++A+ HPY     
Sbjct: 270 FNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYFYPVV 329
Query: 393 DPNDEPTS 400
               +P++
Sbjct: 330 KEQSQPSA 337

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 76/143 (53%), Gaps = 14/143 (9%)
Query: 103 QSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNIL- 160
           +  V  +   RE+ +L+ + H N+I L D+F + T      +V ++  L+ G +L + L 
Sbjct: 68  RRGVSREEIEREVNILREIRHPNIITLHDIFENKT------DVVLILELVSGGELFDFLA 121
Query: 161 RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE----DCELKILDFGLAR 216
             + L++D     + QIL G+ Y+HS  I H DLKP NI + +    +  +K++DFG+A 
Sbjct: 122 EKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 181
Query: 217 PTE--NEMTGYVATRWYRAPEIM 237
             E  NE      T  + APEI+
Sbjct: 182 KIEAGNEFKNIFGTPEFVAPEIV 204

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 90/183 (49%), Gaps = 19/183 (10%)
Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKI----ARPFQSAVHAKRTYRELRMLKHMN 122
           D G  L    F ++     +  +G++ A K I     +  +  V  +   RE+ +LK + 
Sbjct: 14  DTGEELGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 123 HENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNIL-RTQKLSDDHVQFLVYQILRG 180
           H NVI L +V+ + T      +V ++  L+ G +L + L   + L+++     + QIL G
Sbjct: 73  HPNVITLHEVYENKT------DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 181 LKYIHSAGIIHRDLKPSNIAVNE----DCELKILDFGLARPTE--NEMTGYVATRWYRAP 234
           + Y+HS  I H DLKP NI + +       +KI+DFGLA   +  NE      T  + AP
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 235 EIM 237
           EI+
Sbjct: 187 EIV 189

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 90/183 (49%), Gaps = 19/183 (10%)
Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKI----ARPFQSAVHAKRTYRELRMLKHMN 122
           D G  L    F ++     +  +G++ A K I     +  +  V  +   RE+ +LK + 
Sbjct: 14  DTGEELGSGKFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 123 HENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNIL-RTQKLSDDHVQFLVYQILRG 180
           H NVI L +V+ + T      +V ++  L+ G +L + L   + L+++     + QIL G
Sbjct: 73  HPNVITLHEVYENKT------DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 181 LKYIHSAGIIHRDLKPSNIAVNE----DCELKILDFGLARPTE--NEMTGYVATRWYRAP 234
           + Y+HS  I H DLKP NI + +       +KI+DFGLA   +  NE      T  + AP
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 235 EIM 237
           EI+
Sbjct: 187 EIV 189

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 70/131 (53%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV   +  G   +++ R  + ++ 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYVAGGEMFSHLRRIGRFAEP 141
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +++ DFG A+  +        T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 201
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 202 PEYLAPEIILS 212

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +++ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 224 LGVLIYEMAAGYPP 237

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 87/168 (51%), Gaps = 18/168 (10%)
Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYM- 147
           +G+ VAIKK+    Q      R  + ++ L  ++H N++ L   F++     D +++Y+ 
Sbjct: 47  TGMSVAIKKV---IQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYT-LGERDRRDIYLN 102
Query: 148 -----VTHLMGADLNNILRTQKLSDD-HVQFLVYQILRGLKYIH--SAGIIHRDLKPSNI 199
                V   +     N  R Q       ++  ++Q++R +  +H  S  + HRD+KP N+
Sbjct: 103 VVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNV 162
Query: 200 AVNE-DCELKILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHY 243
            VNE D  LK+ DFG A+   P+E  +  Y+ +R+YRAPE++    HY
Sbjct: 163 LVNEADGTLKLCDFGSAKKLSPSEPNV-AYICSRYYRAPELIFGNQHY 209

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 73/171 (42%), Gaps = 30/171 (17%)
Query: 253 QDLKPSNIAVNE-DCELKILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHY-NQT 307
           +D+KP N+ VNE D  LK+ DFG A+   P+E  +  Y+ +R+YRAPE++    HY    
Sbjct: 155 RDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV-AYICSRYYRAPELIFGNQHYTTAV 213
Query: 308 DI-----------------------HQLNLIMEMLGTPPAEFMAKIS-SDSARKYINSLP 343
           DI                        QL+ I+ +LG P  E + K++ S +     NS  
Sbjct: 214 DIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKG 273
Query: 344 LLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDP 394
           +     F         +A             +R+   +AL HPY  +  DP
Sbjct: 274 IPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDP 324

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 76/143 (53%), Gaps = 14/143 (9%)
Query: 103 QSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNIL- 160
           +  V  +   RE+ +L+ + H N+I L D+F + T      +V ++  L+ G +L + L 
Sbjct: 47  RRGVSREEIEREVNILREIRHPNIITLHDIFENKT------DVVLILELVSGGELFDFLA 100
Query: 161 RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE----DCELKILDFGLAR 216
             + L++D     + QIL G+ Y+HS  I H DLKP NI + +    +  +K++DFG+A 
Sbjct: 101 EKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160
Query: 217 PTE--NEMTGYVATRWYRAPEIM 237
             E  NE      T  + APEI+
Sbjct: 161 KIEAGNEFKNIFGTPEFVAPEIV 183

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 68/131 (51%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV      G   +++ R  +  + 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYAPGGEMFSHLRRIGRFXEP 141
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +K+ DFG A+  +        T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGT 201
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 202 PEYLAPEIILS 212

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/74 (35%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +K+ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 164 YRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 224 LGVLIYEMAAGYPP 237

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 90/183 (49%), Gaps = 19/183 (10%)
Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKI----ARPFQSAVHAKRTYRELRMLKHMN 122
           D G  L    F ++     +  +G++ A K I     +  +  V  +   RE+ +LK + 
Sbjct: 14  DTGEELGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 123 HENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNIL-RTQKLSDDHVQFLVYQILRG 180
           H NVI L +V+ + T      +V ++  L+ G +L + L   + L+++     + QIL G
Sbjct: 73  HPNVITLHEVYENKT------DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 181 LKYIHSAGIIHRDLKPSNIAVNE----DCELKILDFGLARPTE--NEMTGYVATRWYRAP 234
           + Y+HS  I H DLKP NI + +       +KI+DFGLA   +  NE      T  + AP
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 235 EIM 237
           EI+
Sbjct: 187 EIV 189

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 90/183 (49%), Gaps = 19/183 (10%)
Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKI----ARPFQSAVHAKRTYRELRMLKHMN 122
           D G  L    F ++     +  +G++ A K I     +  +  V  +   RE+ +LK + 
Sbjct: 14  DTGEELGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 123 HENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNIL-RTQKLSDDHVQFLVYQILRG 180
           H NVI L +V+ + T      +V ++  L+ G +L + L   + L+++     + QIL G
Sbjct: 73  HPNVITLHEVYENKT------DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 181 LKYIHSAGIIHRDLKPSNIAVNE----DCELKILDFGLARPTE--NEMTGYVATRWYRAP 234
           + Y+HS  I H DLKP NI + +       +KI+DFGLA   +  NE      T  + AP
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 235 EIM 237
           EI+
Sbjct: 187 EIV 189

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 90/183 (49%), Gaps = 19/183 (10%)
Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKI----ARPFQSAVHAKRTYRELRMLKHMN 122
           D G  L    F ++     +  +G++ A K I     +  +  V  +   RE+ +LK + 
Sbjct: 14  DTGEELGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 123 HENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNIL-RTQKLSDDHVQFLVYQILRG 180
           H NVI L +V+ + T      +V ++  L+ G +L + L   + L+++     + QIL G
Sbjct: 73  HPNVITLHEVYENKT------DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 181 LKYIHSAGIIHRDLKPSNIAVNE----DCELKILDFGLARPTE--NEMTGYVATRWYRAP 234
           + Y+HS  I H DLKP NI + +       +KI+DFGLA   +  NE      T  + AP
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAP 186
Query: 235 EIM 237
           EI+
Sbjct: 187 EIV 189

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 90/183 (49%), Gaps = 19/183 (10%)
Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKI----ARPFQSAVHAKRTYRELRMLKHMN 122
           D G  L    F ++     +  +G++ A K I     +  +  V  +   RE+ +LK + 
Sbjct: 14  DTGEELGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 123 HENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNIL-RTQKLSDDHVQFLVYQILRG 180
           H NVI L +V+ + T      +V ++  L+ G +L + L   + L+++     + QIL G
Sbjct: 73  HPNVITLHEVYENKT------DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 181 LKYIHSAGIIHRDLKPSNIAVNE----DCELKILDFGLARPTE--NEMTGYVATRWYRAP 234
           + Y+HS  I H DLKP NI + +       +KI+DFGLA   +  NE      T  + AP
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 235 EIM 237
           EI+
Sbjct: 187 EIV 189

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 84/159 (52%), Gaps = 10/159 (6%)
Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           SG+ +A K I    + A+   +  REL++L   N   ++G    F+S+  ++       +
Sbjct: 49  SGLVMARKLIHLEIKPAIR-NQIIRELQVLHECNSPYIVGFYGAFYSDGEIS-----ICM 102
Query: 149 THLMGADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDCE 206
            H+ G  L+ +L+   ++ +  +  +   +++GL Y+     I+HRD+KPSNI VN   E
Sbjct: 103 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE 162
Query: 207 LKILDFGLARPTENEMT-GYVATRWYRAPEIMLNWMHYN 244
           +K+ DFG++    + M   +V TR Y +PE  L   HY+
Sbjct: 163 IKLCDFGVSGQLIDSMANSFVGTRSYMSPE-RLQGTHYS 200

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/69 (42%), Positives = 43/69 (62%), Gaps = 4/69 (5%)
Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEMT-GYVATRWYRAPEIMLNWMHYN-QTDIH 310
           +D+KPSNI VN   E+K+ DFG++    + M   +V TR Y +PE  L   HY+ Q+DI 
Sbjct: 148 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE-RLQGTHYSVQSDIW 206
Query: 311 QLNL-IMEM 318
            + L ++EM
Sbjct: 207 SMGLSLVEM 215

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 90/183 (49%), Gaps = 19/183 (10%)
Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKI----ARPFQSAVHAKRTYRELRMLKHMN 122
           D G  L    F ++     +  +G++ A K I     +  +  V  +   RE+ +LK + 
Sbjct: 14  DTGEELGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 123 HENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNIL-RTQKLSDDHVQFLVYQILRG 180
           H NVI L +V+ + T      +V ++  L+ G +L + L   + L+++     + QIL G
Sbjct: 73  HPNVITLHEVYENKT------DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 181 LKYIHSAGIIHRDLKPSNIAVNE----DCELKILDFGLARPTE--NEMTGYVATRWYRAP 234
           + Y+HS  I H DLKP NI + +       +KI+DFGLA   +  NE      T  + AP
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 235 EIM 237
           EI+
Sbjct: 187 EIV 189

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 82/154 (53%), Gaps = 10/154 (6%)
Query: 88  VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYM 147
           ++G +VA+K I +   ++   ++ +RE+R++K +NH N++ L +V  +       K +Y+
Sbjct: 30  LTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETE------KTLYL 83
Query: 148 VT-HLMGADLNNILRTQK-LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
           V  +  G ++ + L     + +   +    QI+  ++Y H   I+HRDLK  N+ ++ D 
Sbjct: 84  VMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADM 143
Query: 206 ELKILDFGLARPTE--NEMTGYVATRWYRAPEIM 237
            +KI DFG +      N++  +  +  Y APE+ 
Sbjct: 144 NIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELF 177

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 88  VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYM 147
           ++G +VAIK I +   +    ++ +RE+R++K +NH N++ L +V  +       K +Y+
Sbjct: 38  LTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETE------KTLYL 91
Query: 148 VTHLM--GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
           +      G   + ++   ++ +   +    QI+  ++Y H   I+HRDLK  N+ ++ D 
Sbjct: 92  IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADM 151
Query: 206 ELKILDFGLARP--TENEMTGYVATRWYRAPEIM 237
            +KI DFG +       ++  +     Y APE+ 
Sbjct: 152 NIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELF 185

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 90/183 (49%), Gaps = 19/183 (10%)
Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKI----ARPFQSAVHAKRTYRELRMLKHMN 122
           D G  L    F ++     +  +G++ A K I     +  +  V  +   RE+ +LK + 
Sbjct: 14  DTGEELGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 123 HENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNIL-RTQKLSDDHVQFLVYQILRG 180
           H NVI L +V+ + T      +V ++  L+ G +L + L   + L+++     + QIL G
Sbjct: 73  HPNVITLHEVYENKT------DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 181 LKYIHSAGIIHRDLKPSNIAVNE----DCELKILDFGLARPTE--NEMTGYVATRWYRAP 234
           + Y+HS  I H DLKP NI + +       +KI+DFGLA   +  NE      T  + AP
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 235 EIM 237
           EI+
Sbjct: 187 EIV 189

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 88  VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYM 147
           ++G +VA+K I +   ++   ++ +RE+R+ K +NH N++ L +V  +       K +Y+
Sbjct: 37  LTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEVIETE------KTLYL 90
Query: 148 VTHLM--GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
           V      G   + ++   +  +   +    QI+  ++Y H   I+HRDLK  N+ ++ D 
Sbjct: 91  VXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADX 150
Query: 206 ELKILDFGLARPTE--NEMTGYVATRWYRAPEIM 237
            +KI DFG +      N++  +     Y APE+ 
Sbjct: 151 NIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELF 184

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 88/168 (52%), Gaps = 20/168 (11%)
Query: 92  KVAIKKIARPFQSAVHAKR----TYRELRMLKHM-NHENVIGLLDVFHSNTCLADFKNVY 146
           K   KK  + F   + +KR    T +E+  LK    H N++ L +VFH      D  + +
Sbjct: 29  KCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFH------DQLHTF 82
Query: 147 MVTHLM--GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV--- 201
           +V  L+  G     I + +  S+    +++ +++  + ++H  G++HRDLKP N+     
Sbjct: 83  LVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDE 142
Query: 202 NEDCELKILDFGLAR--PTENE-MTGYVATRWYRAPEIMLNWMHYNQT 246
           N++ E+KI+DFG AR  P +N+ +     T  Y APE +LN   Y+++
Sbjct: 143 NDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE-LLNQNGYDES 189

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 90/183 (49%), Gaps = 19/183 (10%)
Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKI----ARPFQSAVHAKRTYRELRMLKHMN 122
           D G  L    F ++     +  +G++ A K I     +  +  V  +   RE+ +LK + 
Sbjct: 14  DTGEELGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 123 HENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNIL-RTQKLSDDHVQFLVYQILRG 180
           H NVI L +V+ + T      +V ++  L+ G +L + L   + L+++     + QIL G
Sbjct: 73  HPNVITLHEVYENKT------DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 181 LKYIHSAGIIHRDLKPSNIAVNE----DCELKILDFGLARPTE--NEMTGYVATRWYRAP 234
           + Y+HS  I H DLKP NI + +       +KI+DFGLA   +  NE      T  + AP
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 235 EIM 237
           EI+
Sbjct: 187 EIV 189

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 90/183 (49%), Gaps = 19/183 (10%)
Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKI----ARPFQSAVHAKRTYRELRMLKHMN 122
           D G  L    F ++     +  +G++ A K I     +  +  V  +   RE+ +LK + 
Sbjct: 14  DTGEELGSGVFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 123 HENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNIL-RTQKLSDDHVQFLVYQILRG 180
           H NVI L +V+ + T      +V ++  L+ G +L + L   + L+++     + QIL G
Sbjct: 73  HPNVITLHEVYENKT------DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 181 LKYIHSAGIIHRDLKPSNIAVNE----DCELKILDFGLARPTE--NEMTGYVATRWYRAP 234
           + Y+HS  I H DLKP NI + +       +KI+DFGLA   +  NE      T  + AP
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 235 EIM 237
           EI+
Sbjct: 187 EIV 189

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 79/153 (51%), Gaps = 10/153 (6%)
Query: 88  VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYM 147
           ++G +VAIK I +   +    ++ +RE+R++K +NH N++ L +V  +       K +Y+
Sbjct: 35  LTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETE------KTLYL 88
Query: 148 VTHLM--GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
           +      G   + ++   ++ +   +    QI+  ++Y H   I+HRDLK  N+ ++ D 
Sbjct: 89  IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADM 148
Query: 206 ELKILDFGLARP--TENEMTGYVATRWYRAPEI 236
            +KI DFG +       ++  +  +  Y APE+
Sbjct: 149 NIKIADFGFSNEFTVGGKLDTFCGSPPYAAPEL 181

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 84/161 (52%), Gaps = 10/161 (6%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I   A +  +G +VA+KK+    +     +  + E+ +++  +H+NV+ +    +S+  +
Sbjct: 60  IVCIATEKHTGKQVAVKKMD--LRKQQRRELLFNEVVIMRDYHHDNVVDM----YSSYLV 113
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            D   V M   L G  L +I+   +++++ +  +   +LR L Y+H+ G+IHRD+K  +I
Sbjct: 114 GDELWVVM-EFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSI 172
Query: 200 AVNEDCELKILDFGLARPTENEM---TGYVATRWYRAPEIM 237
            +  D  +K+ DFG       E+      V T ++ APE++
Sbjct: 173 LLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVI 213

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 73/165 (44%), Gaps = 20/165 (12%)
Query: 238 LNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEM---TGYVATRWYRA 294
           L+++H NQ  +    +D+K  +I +  D  +K+ DFG       E+      V T ++ A
Sbjct: 154 LSYLH-NQGVI---HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMA 209
Query: 295 PEIMLNWMHYNQTDIHQLN-LIMEML-GTPPAEFMAKISSDSARKYINSLPLLTKK--DF 350
           PE++    +  + DI  L  +++EM+ G PP  +  +    + R+  +SLP   K     
Sbjct: 210 PEVISRLPYGTEVDIWSLGIMVIEMIDGEPP--YFNEPPLQAMRRIRDSLPPRVKDLHKV 267
Query: 351 RQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPN 395
             V +G                  +R TA++ L HP+L     P+
Sbjct: 268 SSVLRG-------FLDLMLVREPSQRATAQELLGHPFLKLAGPPS 305

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 107/236 (45%), Gaps = 47/236 (19%)
Query: 163 QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN-EDCELKILDFGLAR---PT 218
           Q L+D  ++F +Y++L+ L Y HS GI+HRD+KP N+ ++ +  +L+++D+GLA    P 
Sbjct: 132 QILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPA 191
Query: 219 ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARP 278
           + E    VA+R+++ PE+++++  Y                     D  L +   G    
Sbjct: 192 Q-EYNVRVASRYFKGPELLVDYQMY---------------------DYSLDMWSLGCM-- 227
Query: 279 TENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPA-EFMAKISSDSARK 337
                   +A+  +R          + Q +  QL  I ++LGT     ++ K   D    
Sbjct: 228 --------LASMIFRREPFF-----HGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPH 274
Query: 338 YINSLPLLTKKDFRQVFKGAN-----PQAIXXXXXXXXXXXXKRITAEQALAHPYL 388
           + + L   ++K +       N     P+A+            +R+TA++A+ HPY 
Sbjct: 275 FNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 330

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 80/156 (51%), Gaps = 13/156 (8%)
Query: 89  SGVKVAIKKIARPFQSAVHAKR---TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV 145
           SG   A+K + +  Q  V  K+   T  E R+L+ +N   ++ L   F  N+      N+
Sbjct: 65  SGNHYAMKILDK--QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS------NL 116
Query: 146 YMVTHLM--GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE 203
           YMV   +  G   +++ R  +  + H +F   QI+   +Y+HS  +I+RDLKP N+ +++
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ 176
Query: 204 DCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN 239
              +++ DFG A+  +        T  Y APEI+L+
Sbjct: 177 QGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILS 212

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 51/98 (52%), Gaps = 5/98 (5%)
Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV 287
            R+Y A +I+L + + +   +   ++DLKP N+ +++   +++ DFG A+  +       
Sbjct: 143 ARFY-AAQIVLTFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC 199
Query: 288 ATRWYRAPEIMLNWMHYNQTDIHQLN-LIMEM-LGTPP 323
            T  Y APEI+L+  +    D   L  LI EM  G PP
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 69/131 (52%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV   +  G   +++ R  +  + 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYVAGGEMFSHLRRIGRFXEP 141
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +++ DFG A+  +        T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 201
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 202 PEYLAPEIILS 212

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +++ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 224 LGVLIYEMAAGYPP 237

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 68/131 (51%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+ + +N   ++ L   F  N+      N+YMV      G   +++ R  + S+ 
Sbjct: 89  TLNEKRIQQAVNFPFLVKLEFSFKDNS------NLYMVLEYAPGGEMFSHLRRIGRFSEP 142
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +K+ DFG A+  +        T
Sbjct: 143 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGT 202
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 203 PEYLAPEIILS 213

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/74 (35%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +K+ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 165 YRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 224
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 225 LGVLIYEMAAGYPP 238

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 80/156 (51%), Gaps = 13/156 (8%)
Query: 89  SGVKVAIKKIARPFQSAVHAKR---TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV 145
           SG   A+K + +  Q  V  K+   T  E R+L+ +N   ++ L   F  N+      N+
Sbjct: 60  SGNHYAMKILDK--QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS------NL 111
Query: 146 YMVTHLM--GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE 203
           YMV   +  G   +++ R  +  + H +F   QI+   +Y+HS  +I+RDLKP N+ +++
Sbjct: 112 YMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ 171
Query: 204 DCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN 239
              +++ DFG A+  +        T  Y APEI+L+
Sbjct: 172 QGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILS 207

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +++ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 159 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 218
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 219 LGVLIYEMAAGYPP 232

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 69/131 (52%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV   +  G   +++ R  +  + 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYVAGGEMFSHLRRIGRFXEP 141
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +++ DFG A+  +        T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 201
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 202 PEYLAPEIILS 212

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +++ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 224 LGVLIYEMAAGYPP 237

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 69/131 (52%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV   +  G   +++ R  +  + 
Sbjct: 109 TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYVAGGEMFSHLRRIGRFXEP 162
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +++ DFG A+  +        T
Sbjct: 163 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 222
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 223 PEYLAPEIILS 233

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 51/98 (52%), Gaps = 5/98 (5%)
Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV 287
            R+Y A +I+L + + +   +   ++DLKP N+ +++   +++ DFG A+  +       
Sbjct: 164 ARFY-AAQIVLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC 220
Query: 288 ATRWYRAPEIMLNWMHYNQTDIHQLN-LIMEM-LGTPP 323
            T  Y APEI+L+  +    D   L  LI EM  G PP
Sbjct: 221 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 69/131 (52%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV   +  G   +++ R  +  + 
Sbjct: 81  TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYVPGGEMFSHLRRIGRFXEP 134
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +++ DFG A+  +        T
Sbjct: 135 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 194
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 195 PEYLAPEIILS 205

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +++ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 157 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 216
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 217 LGVLIYEMAAGYPP 230

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 69/131 (52%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV   +  G   +++ R  +  + 
Sbjct: 89  TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYVPGGEMFSHLRRIGRFXEP 142
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +++ DFG A+  +        T
Sbjct: 143 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 202
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 203 PEYLAPEIILS 213

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +++ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 224
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 225 LGVLIYEMAAGYPP 238

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 69/131 (52%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV   +  G   +++ R  +  + 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYVPGGEMFSHLRRIGRFXEP 141
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +++ DFG A+  +        T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 201
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 202 PEYLAPEIILS 212

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +++ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 224 LGVLIYEMAAGYPP 237

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 69/131 (52%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV   +  G   +++ R  +  + 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYVPGGEMFSHLRRIGRFXEP 141
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +++ DFG A+  +        T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 201
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 202 PEYLAPEIILS 212

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +++ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 224 LGVLIYEMAAGYPP 237

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 85/178 (47%), Gaps = 14/178 (7%)
Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENV 126
           D+   L K +F ++    +   +G++ A K I     SA   ++  RE R+ + + H N+
Sbjct: 9   DVKEELGKGAFSVV-RRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67
Query: 127 IGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDDHVQFLVYQILRGLKYI 184
           + L D     +    F   Y+V  L+  G    +I+  +  S+      + QIL  + Y 
Sbjct: 68  VRLHDSIQEES----FH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 185 HSAGIIHRDLKPSNIAVNEDCE---LKILDFGLARPTENEMT--GYVATRWYRAPEIM 237
           HS GI+HR+LKP N+ +    +   +K+ DFGLA    +     G+  T  Y +PE++
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 179

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 69/131 (52%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV   +  G   +++ R  + S+ 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +++ DFG A+  +        T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 201
Query: 229 RWYRAPEIMLN 239
             Y AP I+L+
Sbjct: 202 PEYLAPAIILS 212

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 87/178 (48%), Gaps = 14/178 (7%)
Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENV 126
           D+   L K +F ++    +   +G++ A K I     SA   ++  RE R+ + + H N+
Sbjct: 32  DVKEELGKGAFSVV-RRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 90
Query: 127 IGLLDVFHSNTCLADFKNVYMVTHLM-GADL-NNILRTQKLSDDHVQFLVYQILRGLKYI 184
           + L D     +    F   Y+V  L+ G +L  +I+  +  S+      + QIL  + Y 
Sbjct: 91  VRLHDSIQEES----FH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 144
Query: 185 HSAGIIHRDLKPSNIAVNEDCE---LKILDFGLARPTENEMT--GYVATRWYRAPEIM 237
           HS GI+HR+LKP N+ +    +   +K+ DFGLA    +     G+  T  Y +PE++
Sbjct: 145 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 202

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 85/178 (47%), Gaps = 14/178 (7%)
Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENV 126
           D+   L K +F ++    +   +G++ A K I     SA   ++  RE R+ + + H N+
Sbjct: 9   DVKEELGKGAFSVV-RRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67
Query: 127 IGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDDHVQFLVYQILRGLKYI 184
           + L D     +    F   Y+V  L+  G    +I+  +  S+      + QIL  + Y 
Sbjct: 68  VRLHDSIQEES----FH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 185 HSAGIIHRDLKPSNIAVNEDCE---LKILDFGLARPTENEMT--GYVATRWYRAPEIM 237
           HS GI+HR+LKP N+ +    +   +K+ DFGLA    +     G+  T  Y +PE++
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 179

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 85/178 (47%), Gaps = 14/178 (7%)
Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENV 126
           D+   L K +F ++    +   +G++ A K I     SA   ++  RE R+ + + H N+
Sbjct: 8   DVKEELGKGAFSVV-RRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 66
Query: 127 IGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDDHVQFLVYQILRGLKYI 184
           + L D     +    F   Y+V  L+  G    +I+  +  S+      + QIL  + Y 
Sbjct: 67  VRLHDSIQEES----FH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 120
Query: 185 HSAGIIHRDLKPSNIAVNEDCE---LKILDFGLARPTENEMT--GYVATRWYRAPEIM 237
           HS GI+HR+LKP N+ +    +   +K+ DFGLA    +     G+  T  Y +PE++
Sbjct: 121 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 178

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 67/131 (51%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   +  L   F  N+      N+YMV      G   +++ R  +  + 
Sbjct: 89  TLNEKRILQAVNFPFLTKLEFSFKDNS------NLYMVMEYAPGGEMFSHLRRIGRFXEP 142
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +K+ DFG A+  +        T
Sbjct: 143 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGT 202
Query: 229 RWYRAPEIMLN 239
             Y APEI+L+
Sbjct: 203 PEYLAPEIILS 213

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/74 (35%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           ++DLKP N+ +++   +K+ DFG A+  +        T  Y APEI+L+  +    D   
Sbjct: 165 YRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 224
Query: 312 LN-LIMEM-LGTPP 323
           L  LI EM  G PP
Sbjct: 225 LGVLIYEMAAGYPP 238

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 71/145 (48%), Gaps = 13/145 (8%)
Query: 100 RPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLN 157
           +  +  V  K    E+ +L  ++H N+I L ++F + T       + +V  L+  G   +
Sbjct: 84  KVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPT------EISLVLELVTGGELFD 137
Query: 158 NILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE---DCELKILDFGL 214
            I+     S+      V QIL  + Y+H  GI+HRDLKP N+       D  LKI DFGL
Sbjct: 138 RIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGL 197
Query: 215 ARPTENE--MTGYVATRWYRAPEIM 237
           ++  E++  M     T  Y APEI+
Sbjct: 198 SKIVEHQVLMKTVCGTPGYCAPEIL 222

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 76  SFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHS 135
           S ++     L   +G  VA+KK+    +   H +   RE+ +LK + H+N++    V +S
Sbjct: 56  SVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVKYKGVCYS 113
Query: 136 NTCLADFKNVYMV-THLMGADLNNILRTQKLSDDHVQFLVY--QILRGLKYIHSAGIIHR 192
               A  +N+ ++  +L    L + L+  K   DH++ L Y  QI +G++Y+ +   IHR
Sbjct: 114 ----AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHR 169
Query: 193 DLKPSNIAVNEDCELKILDFGLAR--PTENEMT-----GYVATRWYRAPE 235
           DL   NI V  +  +KI DFGL +  P + E       G     WY APE
Sbjct: 170 DLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APE 218

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 72/132 (54%), Gaps = 9/132 (6%)
Query: 110 RTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKL-SDD 168
           RT  E  +L  +NH  ++ L   F +   L       ++  L G DL   L  + + +++
Sbjct: 72  RTKMERDILVEVNHPFIVKLHYAFQTEGKL-----YLILDFLRGGDLFTRLSKEVMFTEE 126
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT---ENEMTGY 225
            V+F + ++   L ++HS GII+RDLKP NI ++E+  +K+ DFGL++ +   E +   +
Sbjct: 127 DVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 186
Query: 226 VATRWYRAPEIM 237
             T  Y APE++
Sbjct: 187 CGTVEYMAPEVV 198

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 35/111 (31%), Positives = 57/111 (51%), Gaps = 14/111 (12%)
Query: 218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLAR 277
           TE ++  Y+A       E+ L   H +  G+   ++DLKP NI ++E+  +K+ DFGL++
Sbjct: 124 TEEDVKFYLA-------ELALALDHLHSLGI--IYRDLKPENILLDEEGHIKLTDFGLSK 174
Query: 278 PT---ENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIM-EML-GTPP 323
            +   E +   +  T  Y APE++    H    D     ++M EML GT P
Sbjct: 175 ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 76  SFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHS 135
           S ++     L   +G  VA+KK+    +   H +   RE+ +LK + H+N++    V +S
Sbjct: 25  SVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVKYKGVCYS 82
Query: 136 NTCLADFKNVYMV-THLMGADLNNILRTQKLSDDHVQFLVY--QILRGLKYIHSAGIIHR 192
               A  +N+ ++  +L    L + L+  K   DH++ L Y  QI +G++Y+ +   IHR
Sbjct: 83  ----AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHR 138
Query: 193 DLKPSNIAVNEDCELKILDFGLAR--PTENEMT-----GYVATRWYRAPE 235
           DL   NI V  +  +KI DFGL +  P + E       G     WY APE
Sbjct: 139 DLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APE 187

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 76  SFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHS 135
           S ++     L   +G  VA+KK+    +   H +   RE+ +LK + H+N++    V +S
Sbjct: 28  SVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVKYKGVCYS 85
Query: 136 NTCLADFKNVYMV-THLMGADLNNILRTQKLSDDHVQFLVY--QILRGLKYIHSAGIIHR 192
               A  +N+ ++  +L    L + L+  K   DH++ L Y  QI +G++Y+ +   IHR
Sbjct: 86  ----AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHR 141
Query: 193 DLKPSNIAVNEDCELKILDFGLAR--PTENEMT-----GYVATRWYRAPE 235
           DL   NI V  +  +KI DFGL +  P + E       G     WY APE
Sbjct: 142 DLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APE 190

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 101/198 (51%), Gaps = 17/198 (8%)
Query: 46  PSRRLHDHFNQPYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA 105
           P R+L        ++    V D+   L + S+  ++  A+   +G  VAIK++  P +S 
Sbjct: 11  PRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYK-AIHKETGQIVAIKQV--PVESD 67
Query: 106 VHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGA-DLNNI--LRT 162
           +  +   +E+ +++  +  +V+     +  NT      ++++V    GA  +++I  LR 
Sbjct: 68  L--QEIIKEISIMQQCDSPHVVKYYGSYFKNT------DLWIVMEYCGAGSVSDIIRLRN 119
Query: 163 QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM 222
           + L++D +  ++   L+GL+Y+H    IHRD+K  NI +N +   K+ DFG+A    + M
Sbjct: 120 KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXM 179
Query: 223 TG---YVATRWYRAPEIM 237
                 + T ++ APE++
Sbjct: 180 AKRNXVIGTPFWMAPEVI 197

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 76  SFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHS 135
           S ++     L   +G  VA+KK+    +   H +   RE+ +LK + H+N++    V +S
Sbjct: 29  SVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVKYKGVCYS 86
Query: 136 NTCLADFKNVYMV-THLMGADLNNILRTQKLSDDHVQFLVY--QILRGLKYIHSAGIIHR 192
               A  +N+ ++  +L    L + L+  K   DH++ L Y  QI +G++Y+ +   IHR
Sbjct: 87  ----AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHR 142
Query: 193 DLKPSNIAVNEDCELKILDFGLAR--PTENEMT-----GYVATRWYRAPE 235
           DL   NI V  +  +KI DFGL +  P + E       G     WY APE
Sbjct: 143 DLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APE 191

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 76  SFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHS 135
           S ++     L   +G  VA+KK+    +   H +   RE+ +LK + H+N++    V +S
Sbjct: 24  SVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVKYKGVCYS 81
Query: 136 NTCLADFKNVYMV-THLMGADLNNILRTQKLSDDHVQFLVY--QILRGLKYIHSAGIIHR 192
               A  +N+ ++  +L    L + L+  K   DH++ L Y  QI +G++Y+ +   IHR
Sbjct: 82  ----AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHR 137
Query: 193 DLKPSNIAVNEDCELKILDFGLAR--PTENEMT-----GYVATRWYRAPE 235
           DL   NI V  +  +KI DFGL +  P + E       G     WY APE
Sbjct: 138 DLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APE 186

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 85/183 (46%), Gaps = 15/183 (8%)
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHE 124
            DIG  L K  F  ++  A +  S   +A+K + +   + A    +  RE+ +  H+ H 
Sbjct: 14  FDIGRPLGKGKFGNVYL-ARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 125 NVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRT-QKLS---DDHVQFLVYQILRG 180
           N++ L   FH  T       VY++  L  A L  + R  QKLS   +      + ++   
Sbjct: 73  NILRLYGYFHDAT------RVYLI--LEYAPLGTVYRELQKLSRFDEQRTATYITELANA 124
Query: 181 LKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-RPTENEMTGYVATRWYRAPEIMLN 239
           L Y HS  +IHRD+KP N+ +  + ELKI DFG +     +  T    T  Y  PE++  
Sbjct: 125 LSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEG 184
Query: 240 WMH 242
            MH
Sbjct: 185 RMH 187

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 76  SFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHS 135
           S ++     L   +G  VA+KK+    +   H +   RE+ +LK + H+N++    V +S
Sbjct: 23  SVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVKYKGVCYS 80
Query: 136 NTCLADFKNVYMV-THLMGADLNNILRTQKLSDDHVQFLVY--QILRGLKYIHSAGIIHR 192
               A  +N+ ++  +L    L + L+  K   DH++ L Y  QI +G++Y+ +   IHR
Sbjct: 81  ----AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHR 136
Query: 193 DLKPSNIAVNEDCELKILDFGLAR--PTENEMT-----GYVATRWYRAPE 235
           DL   NI V  +  +KI DFGL +  P + E       G     WY APE
Sbjct: 137 DLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APE 185

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 76  SFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHS 135
           S ++     L   +G  VA+KK+    +   H +   RE+ +LK + H+N++    V +S
Sbjct: 32  SVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVKYKGVCYS 89
Query: 136 NTCLADFKNVYMV-THLMGADLNNILRTQKLSDDHVQFLVY--QILRGLKYIHSAGIIHR 192
               A  +N+ ++  +L    L + L+  K   DH++ L Y  QI +G++Y+ +   IHR
Sbjct: 90  ----AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHR 145
Query: 193 DLKPSNIAVNEDCELKILDFGLAR--PTENEMT-----GYVATRWYRAPE 235
           DL   NI V  +  +KI DFGL +  P + E       G     WY APE
Sbjct: 146 DLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APE 194

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 76  SFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHS 135
           S ++     L   +G  VA+KK+    +   H +   RE+ +LK + H+N++    V +S
Sbjct: 25  SVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVKYKGVCYS 82
Query: 136 NTCLADFKNVYMV-THLMGADLNNILRTQKLSDDHVQFLVY--QILRGLKYIHSAGIIHR 192
               A  +N+ ++  +L    L + L+  K   DH++ L Y  QI +G++Y+ +   IHR
Sbjct: 83  ----AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHR 138
Query: 193 DLKPSNIAVNEDCELKILDFGLAR--PTENEMT-----GYVATRWYRAPE 235
           DL   NI V  +  +KI DFGL +  P + E       G     WY APE
Sbjct: 139 DLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APE 187

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 69/131 (52%), Gaps = 8/131 (6%)
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDD 168
           T  E R+L+ +N   ++ L   F  N+      N+YMV   +  G   +++ R  + S+ 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNS------NLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +++ DFG A+  +        T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 201
Query: 229 RWYRAPEIMLN 239
               APEI+L+
Sbjct: 202 PEALAPEIILS 212

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 76  SFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHS 135
           S ++     L   +G  VA+KK+    +   H +   RE+ +LK + H+N++    V +S
Sbjct: 30  SVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVKYKGVCYS 87
Query: 136 NTCLADFKNVYMV-THLMGADLNNILRTQKLSDDHVQFLVY--QILRGLKYIHSAGIIHR 192
               A  +N+ ++  +L    L + L+  K   DH++ L Y  QI +G++Y+ +   IHR
Sbjct: 88  ----AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHR 143
Query: 193 DLKPSNIAVNEDCELKILDFGLAR--PTENEMT-----GYVATRWYRAPE 235
           DL   NI V  +  +KI DFGL +  P + E       G     WY APE
Sbjct: 144 DLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APE 192

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 76  SFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHS 135
           S ++     L   +G  VA+KK+    +   H +   RE+ +LK + H+N++    V +S
Sbjct: 31  SVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVKYKGVCYS 88
Query: 136 NTCLADFKNVYMV-THLMGADLNNILRTQKLSDDHVQFLVY--QILRGLKYIHSAGIIHR 192
               A  +N+ ++  +L    L + L+  K   DH++ L Y  QI +G++Y+ +   IHR
Sbjct: 89  ----AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHR 144
Query: 193 DLKPSNIAVNEDCELKILDFGLAR--PTENEMT-----GYVATRWYRAPE 235
           DL   NI V  +  +KI DFGL +  P + E       G     WY APE
Sbjct: 145 DLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APE 193

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 76  SFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHS 135
           S ++     L   +G  VA+KK+    +   H +   RE+ +LK + H+N++    V +S
Sbjct: 43  SVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVKYKGVCYS 100
Query: 136 NTCLADFKNVYMV-THLMGADLNNILRTQKLSDDHVQFLVY--QILRGLKYIHSAGIIHR 192
               A  +N+ ++  +L    L + L+  K   DH++ L Y  QI +G++Y+ +   IHR
Sbjct: 101 ----AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHR 156
Query: 193 DLKPSNIAVNEDCELKILDFGLAR--PTENEMT-----GYVATRWYRAPE 235
           DL   NI V  +  +KI DFGL +  P + E       G     WY APE
Sbjct: 157 DLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APE 205

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 76  SFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHS 135
           S ++     L   +G  VA+KK+    +   H +   RE+ +LK + H+N++    V +S
Sbjct: 25  SVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVKYKGVCYS 82
Query: 136 NTCLADFKNVYMV-THLMGADLNNILRTQKLSDDHVQFLVY--QILRGLKYIHSAGIIHR 192
               A  +N+ ++  +L    L + L+  K   DH++ L Y  QI +G++Y+ +   IHR
Sbjct: 83  ----AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHR 138
Query: 193 DLKPSNIAVNEDCELKILDFGLAR--PTENEM-----TGYVATRWYRAPE 235
           DL   NI V  +  +KI DFGL +  P + E       G     WY APE
Sbjct: 139 DLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY-APE 187

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 76  SFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHS 135
           S ++     L   +G  VA+KK+    +   H +   RE+ +LK + H+N++    V +S
Sbjct: 43  SVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVKYKGVCYS 100
Query: 136 NTCLADFKNVYMV-THLMGADLNNILRTQKLSDDHVQFLVY--QILRGLKYIHSAGIIHR 192
               A  +N+ ++  +L    L + L+  K   DH++ L Y  QI +G++Y+ +   IHR
Sbjct: 101 ----AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHR 156
Query: 193 DLKPSNIAVNEDCELKILDFGLAR--PTENEMT-----GYVATRWYRAPE 235
           DL   NI V  +  +KI DFGL +  P + E       G     WY APE
Sbjct: 157 DLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APE 205

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 72/132 (54%), Gaps = 9/132 (6%)
Query: 110 RTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKL-SDD 168
           RT  E  +L  +NH  ++ L   F +   L       ++  L G DL   L  + + +++
Sbjct: 73  RTKMERDILVEVNHPFIVKLHYAFQTEGKL-----YLILDFLRGGDLFTRLSKEVMFTEE 127
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT---ENEMTGY 225
            V+F + ++   L ++HS GII+RDLKP NI ++E+  +K+ DFGL++ +   E +   +
Sbjct: 128 DVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 187
Query: 226 VATRWYRAPEIM 237
             T  Y APE++
Sbjct: 188 CGTVEYMAPEVV 199

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/111 (31%), Positives = 57/111 (51%), Gaps = 14/111 (12%)
Query: 218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLAR 277
           TE ++  Y+A       E+ L   H +  G+   ++DLKP NI ++E+  +K+ DFGL++
Sbjct: 125 TEEDVKFYLA-------ELALALDHLHSLGI--IYRDLKPENILLDEEGHIKLTDFGLSK 175
Query: 278 PT---ENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIM-EML-GTPP 323
            +   E +   +  T  Y APE++    H    D     ++M EML GT P
Sbjct: 176 ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 82/170 (48%), Gaps = 17/170 (10%)
Query: 76  SFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHS 135
           S ++     L   +G  VA+KK+    +   H +   RE+ +LK + H+N++    V +S
Sbjct: 28  SVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVKYKGVCYS 85
Query: 136 NTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDDHVQFLVY--QILRGLKYIHSAGIIHR 192
               A  +N+ ++   +    L   L+  K   DH++ L Y  QI +G++Y+ +   IHR
Sbjct: 86  ----AGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHR 141
Query: 193 DLKPSNIAVNEDCELKILDFGLAR--PTENEMT-----GYVATRWYRAPE 235
           DL   NI V  +  +KI DFGL +  P + E       G     WY APE
Sbjct: 142 DLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APE 190

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 80/181 (44%), Gaps = 11/181 (6%)
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHE 124
            +IG  L K  F  ++  A +  S   +A+K + +   + A    +  RE+ +  H+ H 
Sbjct: 36  FEIGRPLGKGKFGNVYL-AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 94
Query: 125 NVIGLLDVFHSNTCLADFKNVYMVTHL--MGADLNNILRTQKLSDDHVQFLVYQILRGLK 182
           N++ L   FH      D   VY++     +G     + +  K  +      + ++   L 
Sbjct: 95  NILRLYGYFH------DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 183 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-RPTENEMTGYVATRWYRAPEIMLNWM 241
           Y HS  +IHRD+KP N+ +    ELKI DFG +     +  T    T  Y  PE++   M
Sbjct: 149 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM 208
Query: 242 H 242
           H
Sbjct: 209 H 209

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 72/132 (54%), Gaps = 9/132 (6%)
Query: 110 RTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKL-SDD 168
           RT  E  +L  +NH  ++ L   F +   L       ++  L G DL   L  + + +++
Sbjct: 72  RTKMERDILVEVNHPFIVKLHYAFQTEGKL-----YLILDFLRGGDLFTRLSKEVMFTEE 126
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT---ENEMTGY 225
            V+F + ++   L ++HS GII+RDLKP NI ++E+  +K+ DFGL++ +   E +   +
Sbjct: 127 DVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 186
Query: 226 VATRWYRAPEIM 237
             T  Y APE++
Sbjct: 187 CGTVEYMAPEVV 198

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 35/111 (31%), Positives = 57/111 (51%), Gaps = 14/111 (12%)
Query: 218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLAR 277
           TE ++  Y+A       E+ L   H +  G+   ++DLKP NI ++E+  +K+ DFGL++
Sbjct: 124 TEEDVKFYLA-------ELALALDHLHSLGI--IYRDLKPENILLDEEGHIKLTDFGLSK 174
Query: 278 PT---ENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIM-EML-GTPP 323
            +   E +   +  T  Y APE++    H    D     ++M EML GT P
Sbjct: 175 ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 81/162 (50%), Gaps = 17/162 (10%)
Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
           A+   + ++ A KKI + F   V   R  +E+ ++K ++H N+I L + F  NT      
Sbjct: 28  AVQKGTRIRRAAKKIPKYFVEDVD--RFKQEIEIMKSLDHPNIIRLYETFEDNT------ 79
Query: 144 NVYMVTHLM--GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSN--- 198
           ++Y+V  L   G     ++  +   +     ++  +L  + Y H   + HRDLKP N   
Sbjct: 80  DIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLF 139
Query: 199 IAVNEDCELKILDFGLA---RPTENEMTGYVATRWYRAPEIM 237
           +  + D  LK++DFGLA   +P +  M   V T +Y +P+++
Sbjct: 140 LTDSPDSPLKLIDFGLAARFKPGKM-MRTKVGTPYYVSPQVL 180

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 68/138 (49%), Gaps = 7/138 (5%)
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL 173
           E+ + + + H++V+G    F  N    DF  V +      + L    R + L++   ++ 
Sbjct: 71  EISIHRSLAHQHVVGFHGFFEDN----DFVFVVLELCRRRSLLELHKRRKALTEPEARYY 126
Query: 174 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE---NEMTGYVATRW 230
           + QI+ G +Y+H   +IHRDLK  N+ +NED E+KI DFGLA   E           T  
Sbjct: 127 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPN 186
Query: 231 YRAPEIMLNWMHYNQTGV 248
           Y APE++    H  +  V
Sbjct: 187 YIAPEVLSKKGHSFEVDV 204

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 49/104 (47%), Gaps = 10/104 (9%)
Query: 228 TRWY-RAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTE---NEM 283
            R+Y R   +   ++H N+       +DLK  N+ +NED E+KI DFGLA   E      
Sbjct: 123 ARYYLRQIVLGCQYLHRNRV----IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 178
Query: 284 TGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEML--GTPPAE 325
                T  Y APE++    H  + D+  +  IM  L  G PP E
Sbjct: 179 KTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 222

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 81/162 (50%), Gaps = 17/162 (10%)
Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
           A+   + ++ A KKI + F   V   R  +E+ ++K ++H N+I L + F  NT      
Sbjct: 45  AVQKGTRIRRAAKKIPKYFVEDVD--RFKQEIEIMKSLDHPNIIRLYETFEDNT------ 96
Query: 144 NVYMVTHLM--GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSN--- 198
           ++Y+V  L   G     ++  +   +     ++  +L  + Y H   + HRDLKP N   
Sbjct: 97  DIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLF 156
Query: 199 IAVNEDCELKILDFGLA---RPTENEMTGYVATRWYRAPEIM 237
           +  + D  LK++DFGLA   +P +  M   V T +Y +P+++
Sbjct: 157 LTDSPDSPLKLIDFGLAARFKPGKM-MRTKVGTPYYVSPQVL 197

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 65/129 (50%), Gaps = 7/129 (5%)
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNIL-RTQKLSDDHVQF 172
           E+ +L  + H N+I +LD+F +      F  + M  H  G DL   + R  +L +    +
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQ----GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY 134
Query: 173 LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGY--VATRW 230
           +  Q++  + Y+    IIHRD+K  NI + ED  +K++DFG A   E     Y    T  
Sbjct: 135 IFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIE 194
Query: 231 YRAPEIMLN 239
           Y APE+++ 
Sbjct: 195 YCAPEVLMG 203

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 68/138 (49%), Gaps = 7/138 (5%)
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL 173
           E+ + + + H++V+G    F  N    DF  V +      + L    R + L++   ++ 
Sbjct: 67  EISIHRSLAHQHVVGFHGFFEDN----DFVFVVLELCRRRSLLELHKRRKALTEPEARYY 122
Query: 174 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE---NEMTGYVATRW 230
           + QI+ G +Y+H   +IHRDLK  N+ +NED E+KI DFGLA   E           T  
Sbjct: 123 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPN 182
Query: 231 YRAPEIMLNWMHYNQTGV 248
           Y APE++    H  +  V
Sbjct: 183 YIAPEVLSKKGHSFEVDV 200

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 49/104 (47%), Gaps = 10/104 (9%)
Query: 228 TRWY-RAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTE---NEM 283
            R+Y R   +   ++H N+       +DLK  N+ +NED E+KI DFGLA   E      
Sbjct: 119 ARYYLRQIVLGCQYLHRNRV----IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 174
Query: 284 TGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEML--GTPPAE 325
                T  Y APE++    H  + D+  +  IM  L  G PP E
Sbjct: 175 KTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 68/138 (49%), Gaps = 7/138 (5%)
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL 173
           E+ + + + H++V+G    F  N    DF  V +      + L    R + L++   ++ 
Sbjct: 67  EISIHRSLAHQHVVGFHGFFEDN----DFVFVVLELCRRRSLLELHKRRKALTEPEARYY 122
Query: 174 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE---NEMTGYVATRW 230
           + QI+ G +Y+H   +IHRDLK  N+ +NED E+KI DFGLA   E           T  
Sbjct: 123 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPN 182
Query: 231 YRAPEIMLNWMHYNQTGV 248
           Y APE++    H  +  V
Sbjct: 183 YIAPEVLSKKGHSFEVDV 200

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 49/104 (47%), Gaps = 10/104 (9%)
Query: 228 TRWY-RAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTE---NEM 283
            R+Y R   +   ++H N+       +DLK  N+ +NED E+KI DFGLA   E      
Sbjct: 119 ARYYLRQIVLGCQYLHRNRV----IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 174
Query: 284 TGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEML--GTPPAE 325
                T  Y APE++    H  + D+  +  IM  L  G PP E
Sbjct: 175 KTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 84/172 (48%), Gaps = 14/172 (8%)
Query: 71  TLSKESFD---LIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVI 127
           TL   SF    LI S        +KV  K+I    +   H   T  E  ML  + H  +I
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEH---TNDERLMLSIVTHPFII 69
Query: 128 GLLDVFHSNTCLADFKNVYMVT-HLMGADLNNILR-TQKLSDDHVQFLVYQILRGLKYIH 185
            +   F       D + ++M+  ++ G +L ++LR +Q+  +   +F   ++   L+Y+H
Sbjct: 70  RMWGTFQ------DAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 123
Query: 186 SAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM 237
           S  II+RDLKP NI ++++  +KI DFG A+   +       T  Y APE++
Sbjct: 124 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLCGTPDYIAPEVV 175

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 80/181 (44%), Gaps = 11/181 (6%)
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHE 124
            +IG  L K  F  ++  A +  S   +A+K + +   + A    +  RE+ +  H+ H 
Sbjct: 10  FEIGRPLGKGKFGNVYL-AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 125 NVIGLLDVFHSNTCLADFKNVYMVTHL--MGADLNNILRTQKLSDDHVQFLVYQILRGLK 182
           N++ L   FH  T       VY++     +G     + +  K  +      + ++   L 
Sbjct: 69  NILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 183 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-RPTENEMTGYVATRWYRAPEIMLNWM 241
           Y HS  +IHRD+KP N+ +    ELKI DFG +     +  T    T  Y  PE++   M
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM 182
Query: 242 H 242
           H
Sbjct: 183 H 183

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 71/140 (50%), Gaps = 11/140 (7%)
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL 173
           E+ + + + H++V+G    F  N    DF  V +      + L    R + L++   ++ 
Sbjct: 91  EISIHRSLAHQHVVGFHGFFEDN----DFVFVVLELCRRRSLLELHKRRKALTEPEARYY 146
Query: 174 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTG-----YVAT 228
           + QI+ G +Y+H   +IHRDLK  N+ +NED E+KI DFGLA  T+ E  G        T
Sbjct: 147 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA--TKVEYDGERKKVLCGT 204
Query: 229 RWYRAPEIMLNWMHYNQTGV 248
             Y APE++    H  +  V
Sbjct: 205 PNYIAPEVLSKKGHSFEVDV 224

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 52/106 (49%), Gaps = 14/106 (13%)
Query: 228 TRWY-RAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTG- 285
            R+Y R   +   ++H N+       +DLK  N+ +NED E+KI DFGLA  T+ E  G 
Sbjct: 143 ARYYLRQIVLGCQYLHRNRV----IHRDLKLGNLFLNEDLEVKIGDFGLA--TKVEYDGE 196
Query: 286 ----YVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEML--GTPPAE 325
                  T  Y APE++    H  + D+  +  IM  L  G PP E
Sbjct: 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 242

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 80/181 (44%), Gaps = 11/181 (6%)
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHE 124
            +IG  L K  F  ++  A +  S   +A+K + +   + A    +  RE+ +  H+ H 
Sbjct: 10  FEIGRPLGKGKFGNVYL-AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 125 NVIGLLDVFHSNTCLADFKNVYMVTHL--MGADLNNILRTQKLSDDHVQFLVYQILRGLK 182
           N++ L   FH  T       VY++     +G     + +  K  +      + ++   L 
Sbjct: 69  NILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 183 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-RPTENEMTGYVATRWYRAPEIMLNWM 241
           Y HS  +IHRD+KP N+ +    ELKI DFG +     +  T    T  Y  PE++   M
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELCGTLDYLPPEMIEGRM 182
Query: 242 H 242
           H
Sbjct: 183 H 183

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 71/140 (50%), Gaps = 11/140 (7%)
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL 173
           E+ + + + H++V+G    F  N    DF  V +      + L    R + L++   ++ 
Sbjct: 89  EISIHRSLAHQHVVGFHGFFEDN----DFVFVVLELCRRRSLLELHKRRKALTEPEARYY 144
Query: 174 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTG-----YVAT 228
           + QI+ G +Y+H   +IHRDLK  N+ +NED E+KI DFGLA  T+ E  G        T
Sbjct: 145 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA--TKVEYDGERKKVLCGT 202
Query: 229 RWYRAPEIMLNWMHYNQTGV 248
             Y APE++    H  +  V
Sbjct: 203 PNYIAPEVLSKKGHSFEVDV 222

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 52/106 (49%), Gaps = 14/106 (13%)
Query: 228 TRWY-RAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTG- 285
            R+Y R   +   ++H N+       +DLK  N+ +NED E+KI DFGLA  T+ E  G 
Sbjct: 141 ARYYLRQIVLGCQYLHRNRV----IHRDLKLGNLFLNEDLEVKIGDFGLA--TKVEYDGE 194
Query: 286 ----YVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEML--GTPPAE 325
                  T  Y APE++    H  + D+  +  IM  L  G PP E
Sbjct: 195 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 240

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 82/158 (51%), Gaps = 10/158 (6%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A+D  +G +VAI+++    Q     +    E+ +++   + N++  LD +     + D 
Sbjct: 38  TAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLDSY----LVGDE 91
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
             V M  +L G  L +++    + +  +  +  + L+ L+++HS  +IHRD+K  NI + 
Sbjct: 92  LWVVM-EYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 150
Query: 203 EDCELKILDFGLA---RPTENEMTGYVATRWYRAPEIM 237
            D  +K+ DFG      P +++ +  V T ++ APE++
Sbjct: 151 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 80/181 (44%), Gaps = 11/181 (6%)
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHE 124
            +IG  L K  F  ++  A +  S   +A+K + +   + A    +  RE+ +  H+ H 
Sbjct: 15  FEIGRPLGKGKFGNVYL-AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 73
Query: 125 NVIGLLDVFHSNTCLADFKNVYMVTHL--MGADLNNILRTQKLSDDHVQFLVYQILRGLK 182
           N++ L   FH  T       VY++     +G     + +  K  +      + ++   L 
Sbjct: 74  NILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 183 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-RPTENEMTGYVATRWYRAPEIMLNWM 241
           Y HS  +IHRD+KP N+ +    ELKI DFG +     +  T    T  Y  PE++   M
Sbjct: 128 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRM 187
Query: 242 H 242
           H
Sbjct: 188 H 188

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 80/181 (44%), Gaps = 11/181 (6%)
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHE 124
            +IG  L K  F  ++  A +  S   +A+K + +   + A    +  RE+ +  H+ H 
Sbjct: 27  FEIGRPLGKGKFGNVYL-AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 85
Query: 125 NVIGLLDVFHSNTCLADFKNVYMVTHL--MGADLNNILRTQKLSDDHVQFLVYQILRGLK 182
           N++ L   FH      D   VY++     +G     + +  K  +      + ++   L 
Sbjct: 86  NILRLYGYFH------DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 139
Query: 183 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-RPTENEMTGYVATRWYRAPEIMLNWM 241
           Y HS  +IHRD+KP N+ +    ELKI DFG +     +  T    T  Y  PE++   M
Sbjct: 140 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM 199
Query: 242 H 242
           H
Sbjct: 200 H 200

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 80/181 (44%), Gaps = 11/181 (6%)
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHE 124
            +IG  L K  F  ++  A +  S   +A+K + +   + A    +  RE+ +  H+ H 
Sbjct: 11  FEIGRPLGKGKFGNVYL-AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 69
Query: 125 NVIGLLDVFHSNTCLADFKNVYMVTHL--MGADLNNILRTQKLSDDHVQFLVYQILRGLK 182
           N++ L   FH  T       VY++     +G     + +  K  +      + ++   L 
Sbjct: 70  NILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 183 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-RPTENEMTGYVATRWYRAPEIMLNWM 241
           Y HS  +IHRD+KP N+ +    ELKI DFG +     +  T    T  Y  PE++   M
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRM 183
Query: 242 H 242
           H
Sbjct: 184 H 184

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 80/181 (44%), Gaps = 11/181 (6%)
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHE 124
            +IG  L K  F  ++  A +  S   +A+K + +   + A    +  RE+ +  H+ H 
Sbjct: 10  FEIGRPLGKGKFGNVYL-AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 125 NVIGLLDVFHSNTCLADFKNVYMVTHL--MGADLNNILRTQKLSDDHVQFLVYQILRGLK 182
           N++ L   FH  T       VY++     +G     + +  K  +      + ++   L 
Sbjct: 69  NILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 183 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-RPTENEMTGYVATRWYRAPEIMLNWM 241
           Y HS  +IHRD+KP N+ +    ELKI DFG +     +  T    T  Y  PE++   M
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRM 182
Query: 242 H 242
           H
Sbjct: 183 H 183

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 80/181 (44%), Gaps = 11/181 (6%)
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHE 124
            +IG  L K  F  ++  A +  S   +A+K + +   + A    +  RE+ +  H+ H 
Sbjct: 15  FEIGRPLGKGKFGNVYL-AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 73
Query: 125 NVIGLLDVFHSNTCLADFKNVYMVTHL--MGADLNNILRTQKLSDDHVQFLVYQILRGLK 182
           N++ L   FH  T       VY++     +G     + +  K  +      + ++   L 
Sbjct: 74  NILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 183 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-RPTENEMTGYVATRWYRAPEIMLNWM 241
           Y HS  +IHRD+KP N+ +    ELKI DFG +     +  T    T  Y  PE++   M
Sbjct: 128 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM 187
Query: 242 H 242
           H
Sbjct: 188 H 188

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 80/181 (44%), Gaps = 11/181 (6%)
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHE 124
            +IG  L K  F  ++  A +  S   +A+K + +   + A    +  RE+ +  H+ H 
Sbjct: 10  FEIGRPLGKGKFGNVYL-AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 125 NVIGLLDVFHSNTCLADFKNVYMVTHL--MGADLNNILRTQKLSDDHVQFLVYQILRGLK 182
           N++ L   FH  T       VY++     +G     + +  K  +      + ++   L 
Sbjct: 69  NILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 183 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-RPTENEMTGYVATRWYRAPEIMLNWM 241
           Y HS  +IHRD+KP N+ +    ELKI DFG +     +  T    T  Y  PE++   M
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLCGTLDYLPPEMIEGRM 182
Query: 242 H 242
           H
Sbjct: 183 H 183

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 80/181 (44%), Gaps = 11/181 (6%)
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHE 124
            +IG  L K  F  ++  A +  S   +A+K + +   + A    +  RE+ +  H+ H 
Sbjct: 14  FEIGRPLGKGKFGNVYL-AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 125 NVIGLLDVFHSNTCLADFKNVYMVTHL--MGADLNNILRTQKLSDDHVQFLVYQILRGLK 182
           N++ L   FH  T       VY++     +G     + +  K  +      + ++   L 
Sbjct: 73  NILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 126
Query: 183 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-RPTENEMTGYVATRWYRAPEIMLNWM 241
           Y HS  +IHRD+KP N+ +    ELKI DFG +     +  T    T  Y  PE++   M
Sbjct: 127 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM 186
Query: 242 H 242
           H
Sbjct: 187 H 187

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 62/130 (47%), Gaps = 9/130 (6%)
Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQF 172
           RE  ++  ++H   + L   F  +  L  F   Y      G  L  I +     +   +F
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLY-FGLSYAKN---GCLLKYIRKIGSFDETCTRF 136
Query: 173 LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR-----PTENEMTGYVA 227
              +I+  L+Y+H  GIIHRDLKP NI +NED  ++I DFG A+       +     +V 
Sbjct: 137 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 196
Query: 228 TRWYRAPEIM 237
           T  Y +PE++
Sbjct: 197 TAQYVSPELL 206

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 60/132 (45%), Gaps = 23/132 (17%)
Query: 210 LDFGLARPTENEMTGYV---------ATRWYRAPEIM--LNWMHYNQTGVPFYFQDLKPS 258
           L FGL+      +  Y+          TR+Y A EI+  L ++H    G     +DLKP 
Sbjct: 107 LYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTA-EIVSALEYLH----GKGIIHRDLKPE 161
Query: 259 NIAVNEDCELKILDFGLAR-----PTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
           NI +NED  ++I DFG A+       +     +V T  Y +PE++        +D+  L 
Sbjct: 162 NILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSASKSSDLWALG 221
Query: 314 LIMEML--GTPP 323
            I+  L  G PP
Sbjct: 222 CIIYQLVAGLPP 233

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 82/158 (51%), Gaps = 10/158 (6%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A+D  +G +VAI+++    Q     +    E+ +++   + N++  LD +     + D 
Sbjct: 38  TAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLDSY----LVGDE 91
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
             V M  +L G  L +++    + +  +  +  + L+ L+++HS  +IHRD+K  NI + 
Sbjct: 92  LWVVM-EYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 150
Query: 203 EDCELKILDFGLA---RPTENEMTGYVATRWYRAPEIM 237
            D  +K+ DFG      P +++ +  V T ++ APE++
Sbjct: 151 MDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVV 188

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 80/181 (44%), Gaps = 11/181 (6%)
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHE 124
            +IG  L K  F  ++  A +  S   +A+K + +   + A    +  RE+ +  H+ H 
Sbjct: 13  FEIGRPLGKGKFGNVYL-AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 71
Query: 125 NVIGLLDVFHSNTCLADFKNVYMVTHL--MGADLNNILRTQKLSDDHVQFLVYQILRGLK 182
           N++ L   FH  T       VY++     +G     + +  K  +      + ++   L 
Sbjct: 72  NILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 183 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-RPTENEMTGYVATRWYRAPEIMLNWM 241
           Y HS  +IHRD+KP N+ +    ELKI DFG +     +  T    T  Y  PE++   M
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM 185
Query: 242 H 242
           H
Sbjct: 186 H 186

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 80/181 (44%), Gaps = 11/181 (6%)
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHE 124
            +IG  L K  F  ++  A +  S   +A+K + +   + A    +  RE+ +  H+ H 
Sbjct: 9   FEIGRPLGKGKFGNVYL-AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 67
Query: 125 NVIGLLDVFHSNTCLADFKNVYMVTHL--MGADLNNILRTQKLSDDHVQFLVYQILRGLK 182
           N++ L   FH  T       VY++     +G     + +  K  +      + ++   L 
Sbjct: 68  NILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 121
Query: 183 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-RPTENEMTGYVATRWYRAPEIMLNWM 241
           Y HS  +IHRD+KP N+ +    ELKI DFG +     +  T    T  Y  PE++   M
Sbjct: 122 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM 181
Query: 242 H 242
           H
Sbjct: 182 H 182

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 80/181 (44%), Gaps = 11/181 (6%)
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHE 124
            +IG  L K  F  ++  A +  S   +A+K + +   + A    +  RE+ +  H+ H 
Sbjct: 10  FEIGRPLGKGKFGNVYL-AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 125 NVIGLLDVFHSNTCLADFKNVYMVTHL--MGADLNNILRTQKLSDDHVQFLVYQILRGLK 182
           N++ L   FH  T       VY++     +G     + +  K  +      + ++   L 
Sbjct: 69  NILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 183 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-RPTENEMTGYVATRWYRAPEIMLNWM 241
           Y HS  +IHRD+KP N+ +    ELKI DFG +     +  T    T  Y  PE++   M
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRM 182
Query: 242 H 242
           H
Sbjct: 183 H 183

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 82/158 (51%), Gaps = 10/158 (6%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A+D  +G +VAI+++    Q     +    E+ +++   + N++  LD +     + D 
Sbjct: 39  TAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLDSY----LVGDE 92
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
             V M  +L G  L +++    + +  +  +  + L+ L+++HS  +IHRD+K  NI + 
Sbjct: 93  LWVVM-EYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 151
Query: 203 EDCELKILDFGLA---RPTENEMTGYVATRWYRAPEIM 237
            D  +K+ DFG      P +++ +  V T ++ APE++
Sbjct: 152 MDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVV 189

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 82/158 (51%), Gaps = 10/158 (6%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A+D  +G +VAI+++    Q     +    E+ +++   + N++  LD +     + D 
Sbjct: 38  TAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLDSY----LVGDE 91
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
             V M  +L G  L +++    + +  +  +  + L+ L+++HS  +IHRD+K  NI + 
Sbjct: 92  LWVVM-EYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 150
Query: 203 EDCELKILDFGLA---RPTENEMTGYVATRWYRAPEIM 237
            D  +K+ DFG      P +++ +  V T ++ APE++
Sbjct: 151 MDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVV 188

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 68/138 (49%), Gaps = 7/138 (5%)
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL 173
           E+ + + + H++V+G    F  N    DF  V +      + L    R + L++   ++ 
Sbjct: 65  EISIHRSLAHQHVVGFHGFFEDN----DFVFVVLELCRRRSLLELHKRRKALTEPEARYY 120
Query: 174 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE---NEMTGYVATRW 230
           + QI+ G +Y+H   +IHRDLK  N+ +NED E+KI DFGLA   E           T  
Sbjct: 121 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN 180
Query: 231 YRAPEIMLNWMHYNQTGV 248
           Y APE++    H  +  V
Sbjct: 181 YIAPEVLSKKGHSFEVDV 198

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 49/104 (47%), Gaps = 10/104 (9%)
Query: 228 TRWY-RAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTE---NEM 283
            R+Y R   +   ++H N+       +DLK  N+ +NED E+KI DFGLA   E      
Sbjct: 117 ARYYLRQIVLGCQYLHRNRV----IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 172
Query: 284 TGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEML--GTPPAE 325
                T  Y APE++    H  + D+  +  IM  L  G PP E
Sbjct: 173 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 86/184 (46%), Gaps = 17/184 (9%)
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHE 124
            DIG  L K  F  ++  A +  S   +A+K + +   + A    +  RE+ +  H+ H 
Sbjct: 14  FDIGRPLGKGKFGNVYL-ARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 125 NVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRT-QKLS---DDHVQFLVYQILRG 180
           N++ L   FH  T       VY++  L  A L  + R  QKLS   +      + ++   
Sbjct: 73  NILRLYGYFHDAT------RVYLI--LEYAPLGTVYRELQKLSRFDEQRTATYITELANA 124
Query: 181 LKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA--RPTENEMTGYVATRWYRAPEIML 238
           L Y HS  +IHRD+KP N+ +  + ELKI DFG +   P+    T    T  Y  PE++ 
Sbjct: 125 LSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDT-LCGTLDYLPPEMIE 183
Query: 239 NWMH 242
             MH
Sbjct: 184 GRMH 187

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 80/181 (44%), Gaps = 11/181 (6%)
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHE 124
            +IG  L K  F  ++  A +  S   +A+K + +   + A    +  RE+ +  H+ H 
Sbjct: 13  FEIGRPLGKGKFGNVYL-AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 71
Query: 125 NVIGLLDVFHSNTCLADFKNVYMVTHL--MGADLNNILRTQKLSDDHVQFLVYQILRGLK 182
           N++ L   FH  T       VY++     +G     + +  K  +      + ++   L 
Sbjct: 72  NILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 183 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-RPTENEMTGYVATRWYRAPEIMLNWM 241
           Y HS  +IHRD+KP N+ +    ELKI DFG +     +  T    T  Y  PE++   M
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM 185
Query: 242 H 242
           H
Sbjct: 186 H 186

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 62/130 (47%), Gaps = 9/130 (6%)
Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQF 172
           RE  ++  ++H   + L   F  +  L  F   Y      G  L  I +     +   +F
Sbjct: 79  RERDVMSRLDHPFFVKLYFTFQDDEKLY-FGLSYAKN---GELLKYIRKIGSFDETCTRF 134
Query: 173 LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR-----PTENEMTGYVA 227
              +I+  L+Y+H  GIIHRDLKP NI +NED  ++I DFG A+       +     +V 
Sbjct: 135 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVG 194
Query: 228 TRWYRAPEIM 237
           T  Y +PE++
Sbjct: 195 TAQYVSPELL 204

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 61/132 (46%), Gaps = 23/132 (17%)
Query: 210 LDFGLARPTENEMTGYV---------ATRWYRAPEIM--LNWMHYNQTGVPFYFQDLKPS 258
           L FGL+     E+  Y+          TR+Y A EI+  L ++H    G     +DLKP 
Sbjct: 105 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH----GKGIIHRDLKPE 159
Query: 259 NIAVNEDCELKILDFGLAR-----PTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
           NI +NED  ++I DFG A+       +     +V T  Y +PE++        +D+  L 
Sbjct: 160 NILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSACKSSDLWALG 219
Query: 314 LIMEML--GTPP 323
            I+  L  G PP
Sbjct: 220 CIIYQLVAGLPP 231

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 80/181 (44%), Gaps = 11/181 (6%)
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHE 124
            +IG  L K  F  ++  A +  S   +A+K + +   + A    +  RE+ +  H+ H 
Sbjct: 10  FEIGRPLGKGKFGNVYL-AREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 125 NVIGLLDVFHSNTCLADFKNVYMVTHL--MGADLNNILRTQKLSDDHVQFLVYQILRGLK 182
           N++ L   FH +T       VY++     +G     + +  K  +      + ++   L 
Sbjct: 69  NILRLYGYFHDST------RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 183 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-RPTENEMTGYVATRWYRAPEIMLNWM 241
           Y HS  +IHRD+KP N+ +    ELKI DFG +     +       T  Y  PE++   M
Sbjct: 123 YCHSKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMIEGRM 182
Query: 242 H 242
           H
Sbjct: 183 H 183

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 80/181 (44%), Gaps = 11/181 (6%)
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHE 124
            +IG  L K  F  ++  A +  S   +A+K + +   + A    +  RE+ +  H+ H 
Sbjct: 11  FEIGRPLGKGKFGNVYL-AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 69
Query: 125 NVIGLLDVFHSNTCLADFKNVYMVTHL--MGADLNNILRTQKLSDDHVQFLVYQILRGLK 182
           N++ L   FH      D   VY++     +G     + +  K  +      + ++   L 
Sbjct: 70  NILRLYGYFH------DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 183 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-RPTENEMTGYVATRWYRAPEIMLNWM 241
           Y HS  +IHRD+KP N+ +    ELKI DFG +     +  T    T  Y  PE++   M
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLSGTLDYLPPEMIEGRM 183
Query: 242 H 242
           H
Sbjct: 184 H 184

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 62/130 (47%), Gaps = 9/130 (6%)
Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQF 172
           RE  ++  ++H   + L   F  +  L  F   Y      G  L  I +     +   +F
Sbjct: 82  RERDVMSRLDHPFFVKLYFTFQDDEKLY-FGLSYAKN---GELLKYIRKIGSFDETCTRF 137
Query: 173 LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR-----PTENEMTGYVA 227
              +I+  L+Y+H  GIIHRDLKP NI +NED  ++I DFG A+       +     +V 
Sbjct: 138 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 197
Query: 228 TRWYRAPEIM 237
           T  Y +PE++
Sbjct: 198 TAQYVSPELL 207

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 61/132 (46%), Gaps = 23/132 (17%)
Query: 210 LDFGLARPTENEMTGYV---------ATRWYRAPEIM--LNWMHYNQTGVPFYFQDLKPS 258
           L FGL+     E+  Y+          TR+Y A EI+  L ++H    G     +DLKP 
Sbjct: 108 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH----GKGIIHRDLKPE 162
Query: 259 NIAVNEDCELKILDFGLAR-----PTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
           NI +NED  ++I DFG A+       +     +V T  Y +PE++        +D+  L 
Sbjct: 163 NILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALG 222
Query: 314 LIMEML--GTPP 323
            I+  L  G PP
Sbjct: 223 CIIYQLVAGLPP 234

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDDHV 170
           RE  ++  ++H   + L        C  D + +Y        G  L  I +     +   
Sbjct: 86  RERDVMSRLDHPFFVKLY------FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT 139
Query: 171 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR-----PTENEMTGY 225
           +F   +I+  L+Y+H  GIIHRDLKP NI +NED  ++I DFG A+       +     +
Sbjct: 140 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 199
Query: 226 VATRWYRAPEIM 237
           V T  Y +PE++
Sbjct: 200 VGTAQYVSPELL 211

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 61/132 (46%), Gaps = 23/132 (17%)
Query: 210 LDFGLARPTENEMTGYV---------ATRWYRAPEIM--LNWMHYNQTGVPFYFQDLKPS 258
           L FGL+     E+  Y+          TR+Y A EI+  L ++H    G     +DLKP 
Sbjct: 112 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH----GKGIIHRDLKPE 166
Query: 259 NIAVNEDCELKILDFGLAR-----PTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
           NI +NED  ++I DFG A+       +     +V T  Y +PE++        +D+  L 
Sbjct: 167 NILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALG 226
Query: 314 LIMEML--GTPP 323
            I+  L  G PP
Sbjct: 227 CIIYQLVAGLPP 238

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 51/102 (50%), Gaps = 23/102 (22%)
Query: 173 LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR---------------- 216
           L  QIL  L YIHS GIIHRDLKP NI ++E   +KI DFGLA+                
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 217 -PTENEMTGYVATRWYRAPEIMLNWMHYNQT------GVPFY 251
             + + +T  + T  Y A E++    HYN+       G+ F+
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFF 222

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 47/90 (52%), Gaps = 17/90 (18%)
Query: 173 LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR---------------- 216
           L  QIL  L YIHS GIIHRDLKP NI ++E   +KI DFGLA+                
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 217 -PTENEMTGYVATRWYRAPEIMLNWMHYNQ 245
             + + +T  + T  Y A E++    HYN+
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNE 210

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 91/184 (49%), Gaps = 23/184 (12%)
Query: 71  TLSKESFDLIFSSALDSVSGVK-VAIKKIARPFQSAVHAKRTYRE------LRMLKHM-- 121
           +L  + FDL+      S + V  V +KK  R +   V  K    +      ++  KH+  
Sbjct: 48  SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFE 107
Query: 122 ---NHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLN-NILRTQKLSDDHVQFLVYQI 177
              NH  ++GL   F + + L      +++ ++ G DL  ++ R +KL ++H +F   +I
Sbjct: 108 QASNHPFLVGLHSCFQTESRL-----FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI 162
Query: 178 LRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA----RPTENEMTGYVATRWYRA 233
              L Y+H  GII+RDLK  N+ ++ +  +K+ D+G+     RP +   T +  T  Y A
Sbjct: 163 SLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIA 221
Query: 234 PEIM 237
           PEI+
Sbjct: 222 PEIL 225

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 83/170 (48%), Gaps = 17/170 (10%)
Query: 76  SFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHS 135
           S ++     L   +G  VA+KK+    +   H +   RE+ +LK + H+N++    V +S
Sbjct: 28  SVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVKYKGVCYS 85
Query: 136 NTCLADFKNVYMV-THLMGADLNNILRTQKLSDDHVQFLVY--QILRGLKYIHSAGIIHR 192
               A  +N+ ++  +L    L + L+      DH++ L Y  QI +G++Y+ +   IHR
Sbjct: 86  ----AGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTKRYIHR 141
Query: 193 DLKPSNIAVNEDCELKILDFGLAR--PTENEMT-----GYVATRWYRAPE 235
           DL   NI V  +  +KI DFGL +  P + E       G     WY APE
Sbjct: 142 DLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APE 190

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 48/90 (53%), Gaps = 5/90 (5%)
Query: 153 GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDF 212
           G  L  I +     +   +F   +I+  L+Y+H  GIIHRDLKP NI +NED  ++I DF
Sbjct: 114 GELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDF 173
Query: 213 GLAR-----PTENEMTGYVATRWYRAPEIM 237
           G A+       +     +V T  Y +PE++
Sbjct: 174 GTAKVLSPESKQARANSFVGTAQYVSPELL 203

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 59/131 (45%), Gaps = 21/131 (16%)
Query: 210 LDFGLARPTENEMTGYV---------ATRWYRAPEI-MLNWMHYNQTGVPFYFQDLKPSN 259
           L FGL+     E+  Y+          TR+Y A  +  L ++H    G     +DLKP N
Sbjct: 104 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH----GKGIIHRDLKPEN 159
Query: 260 IAVNEDCELKILDFGLAR-----PTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNL 314
           I +NED  ++I DFG A+       +     +V T  Y +PE++        +D+  L  
Sbjct: 160 ILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGC 219
Query: 315 IMEML--GTPP 323
           I+  L  G PP
Sbjct: 220 IIYQLVAGLPP 230

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 79/181 (43%), Gaps = 11/181 (6%)
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHE 124
            +IG  L K  F  ++  A +  S   +A+K + +   + A    +  RE+ +  H+ H 
Sbjct: 13  FEIGRPLGKGKFGNVYL-AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 71
Query: 125 NVIGLLDVFHSNTCLADFKNVYMVTHL--MGADLNNILRTQKLSDDHVQFLVYQILRGLK 182
           N++ L   FH  T       VY++     +G     + +  K  +      + ++   L 
Sbjct: 72  NILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 183 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-RPTENEMTGYVATRWYRAPEIMLNWM 241
           Y HS  +IHRD+KP N+ +    ELKI DFG +     +       T  Y  PE++   M
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMIEGRM 185
Query: 242 H 242
           H
Sbjct: 186 H 186

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 75/132 (56%), Gaps = 14/132 (10%)
Query: 121 MNHENVIGLLDVF---HSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQI 177
           M   N++ LLD+    HS T    F+      ++   D   +  T  L+D  +++ +Y++
Sbjct: 83  MGGPNIVKLLDIVRDQHSKTPSLIFE------YVNNTDFKVLYPT--LTDYDIRYYIYEL 134
Query: 178 LRGLKYIHSAGIIHRDLKPSNIAVNEDC-ELKILDFGLARPTE--NEMTGYVATRWYRAP 234
           L+ L Y HS GI+HRD+KP N+ ++ +  +L+++D+GLA       E    VA+R+++ P
Sbjct: 135 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 194
Query: 235 EIMLNWMHYNQT 246
           E++++   Y+ +
Sbjct: 195 ELLVDLQDYDYS 206

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 79/181 (43%), Gaps = 11/181 (6%)
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHE 124
            +IG  L K  F  ++  A +  S   +A+K + +   + A    +  RE+ +  H+ H 
Sbjct: 10  FEIGRPLGKGKFGNVYL-AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 125 NVIGLLDVFHSNTCLADFKNVYMVTHL--MGADLNNILRTQKLSDDHVQFLVYQILRGLK 182
           N++ L   FH  T       VY++     +G     + +  K  +      + ++   L 
Sbjct: 69  NILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 183 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-RPTENEMTGYVATRWYRAPEIMLNWM 241
           Y HS  +IHRD+KP N+ +    ELKI DFG +     +       T  Y  PE++   M
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMIEGRM 182
Query: 242 H 242
           H
Sbjct: 183 H 183

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 62/130 (47%), Gaps = 9/130 (6%)
Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQF 172
           RE  ++  ++H   + L   F  +  L  F   Y      G  L  I +     +   +F
Sbjct: 59  RERDVMSRLDHPFFVKLYFTFQDDEKLY-FGLSYAKN---GELLKYIRKIGSFDETCTRF 114
Query: 173 LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR-----PTENEMTGYVA 227
              +I+  L+Y+H  GIIHRDLKP NI +NED  ++I DFG A+       +     +V 
Sbjct: 115 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 174
Query: 228 TRWYRAPEIM 237
           T  Y +PE++
Sbjct: 175 TAQYVSPELL 184

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 61/132 (46%), Gaps = 23/132 (17%)
Query: 210 LDFGLARPTENEMTGYV---------ATRWYRAPEIM--LNWMHYNQTGVPFYFQDLKPS 258
           L FGL+     E+  Y+          TR+Y A EI+  L ++H    G     +DLKP 
Sbjct: 85  LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH----GKGIIHRDLKPE 139
Query: 259 NIAVNEDCELKILDFGLAR-----PTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
           NI +NED  ++I DFG A+       +     +V T  Y +PE++        +D+  L 
Sbjct: 140 NILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALG 199
Query: 314 LIMEML--GTPP 323
            I+  L  G PP
Sbjct: 200 CIIYQLVAGLPP 211

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 62/130 (47%), Gaps = 9/130 (6%)
Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQF 172
           RE  ++  ++H   + L   F  +  L  F   Y      G  L  I +     +   +F
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLY-FGLSYAKN---GELLKYIRKIGSFDETCTRF 136
Query: 173 LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR-----PTENEMTGYVA 227
              +I+  L+Y+H  GIIHRDLKP NI +NED  ++I DFG A+       +     +V 
Sbjct: 137 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 228 TRWYRAPEIM 237
           T  Y +PE++
Sbjct: 197 TAQYVSPELL 206

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 61/132 (46%), Gaps = 23/132 (17%)
Query: 210 LDFGLARPTENEMTGYV---------ATRWYRAPEIM--LNWMHYNQTGVPFYFQDLKPS 258
           L FGL+     E+  Y+          TR+Y A EI+  L ++H    G     +DLKP 
Sbjct: 107 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH----GKGIIHRDLKPE 161
Query: 259 NIAVNEDCELKILDFGLAR-----PTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
           NI +NED  ++I DFG A+       +     +V T  Y +PE++        +D+  L 
Sbjct: 162 NILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALG 221
Query: 314 LIMEML--GTPP 323
            I+  L  G PP
Sbjct: 222 CIIYQLVAGLPP 233

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 79/181 (43%), Gaps = 11/181 (6%)
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHE 124
            +IG  L K  F  ++  A +  S   +A+K + +   + A    +  RE+ +  H+ H 
Sbjct: 15  FEIGRPLGKGKFGNVYL-AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 73
Query: 125 NVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDDHVQFLVYQILRGLK 182
           N++ L   FH  T       VY++      G     + +  K  +      + ++   L 
Sbjct: 74  NILRLYGYFHDAT------RVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALS 127
Query: 183 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-RPTENEMTGYVATRWYRAPEIMLNWM 241
           Y HS  +IHRD+KP N+ +    ELKI DFG +     +  T    T  Y  PE++   M
Sbjct: 128 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM 187
Query: 242 H 242
           H
Sbjct: 188 H 188

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 62/130 (47%), Gaps = 9/130 (6%)
Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQF 172
           RE  ++  ++H   + L   F  +  L  F   Y      G  L  I +     +   +F
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLY-FGLSYAKN---GELLKYIRKIGSFDETCTRF 136
Query: 173 LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR-----PTENEMTGYVA 227
              +I+  L+Y+H  GIIHRDLKP NI +NED  ++I DFG A+       +     +V 
Sbjct: 137 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 228 TRWYRAPEIM 237
           T  Y +PE++
Sbjct: 197 TAQYVSPELL 206

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 61/132 (46%), Gaps = 23/132 (17%)
Query: 210 LDFGLARPTENEMTGYV---------ATRWYRAPEIM--LNWMHYNQTGVPFYFQDLKPS 258
           L FGL+     E+  Y+          TR+Y A EI+  L ++H    G     +DLKP 
Sbjct: 107 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH----GKGIIHRDLKPE 161
Query: 259 NIAVNEDCELKILDFGLAR-----PTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
           NI +NED  ++I DFG A+       +     +V T  Y +PE++        +D+  L 
Sbjct: 162 NILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAXKSSDLWALG 221
Query: 314 LIMEML--GTPP 323
            I+  L  G PP
Sbjct: 222 CIIYQLVAGLPP 233

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 62/130 (47%), Gaps = 9/130 (6%)
Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQF 172
           RE  ++  ++H   + L   F  +  L  F   Y      G  L  I +     +   +F
Sbjct: 79  RERDVMSRLDHPFFVKLYFTFQDDEKLY-FGLSYAKN---GELLKYIRKIGSFDETCTRF 134
Query: 173 LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR-----PTENEMTGYVA 227
              +I+  L+Y+H  GIIHRDLKP NI +NED  ++I DFG A+       +     +V 
Sbjct: 135 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 228 TRWYRAPEIM 237
           T  Y +PE++
Sbjct: 195 TAQYVSPELL 204

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 61/132 (46%), Gaps = 23/132 (17%)
Query: 210 LDFGLARPTENEMTGYV---------ATRWYRAPEIM--LNWMHYNQTGVPFYFQDLKPS 258
           L FGL+     E+  Y+          TR+Y A EI+  L ++H    G     +DLKP 
Sbjct: 105 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH----GKGIIHRDLKPE 159
Query: 259 NIAVNEDCELKILDFGLAR-----PTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
           NI +NED  ++I DFG A+       +     +V T  Y +PE++        +D+  L 
Sbjct: 160 NILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALG 219
Query: 314 LIMEML--GTPP 323
            I+  L  G PP
Sbjct: 220 CIIYQLVAGLPP 231

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 62/130 (47%), Gaps = 9/130 (6%)
Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQF 172
           RE  ++  ++H   + L   F  +  L  F   Y      G  L  I +     +   +F
Sbjct: 82  RERDVMSRLDHPFFVKLYFTFQDDEKLY-FGLSYAKN---GELLKYIRKIGSFDETCTRF 137
Query: 173 LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR-----PTENEMTGYVA 227
              +I+  L+Y+H  GIIHRDLKP NI +NED  ++I DFG A+       +     +V 
Sbjct: 138 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 197
Query: 228 TRWYRAPEIM 237
           T  Y +PE++
Sbjct: 198 TAQYVSPELL 207

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 61/132 (46%), Gaps = 23/132 (17%)
Query: 210 LDFGLARPTENEMTGYV---------ATRWYRAPEIM--LNWMHYNQTGVPFYFQDLKPS 258
           L FGL+     E+  Y+          TR+Y A EI+  L ++H    G     +DLKP 
Sbjct: 108 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH----GKGIIHRDLKPE 162
Query: 259 NIAVNEDCELKILDFGLAR-----PTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
           NI +NED  ++I DFG A+       +     +V T  Y +PE++        +D+  L 
Sbjct: 163 NILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALG 222
Query: 314 LIMEML--GTPP 323
            I+  L  G PP
Sbjct: 223 CIIYQLVAGLPP 234

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 62/130 (47%), Gaps = 9/130 (6%)
Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQF 172
           RE  ++  ++H   + L   F  +  L  F   Y      G  L  I +     +   +F
Sbjct: 58  RERDVMSRLDHPFFVKLYFTFQDDEKLY-FGLSYAKN---GELLKYIRKIGSFDETCTRF 113
Query: 173 LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR-----PTENEMTGYVA 227
              +I+  L+Y+H  GIIHRDLKP NI +NED  ++I DFG A+       +     +V 
Sbjct: 114 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 173
Query: 228 TRWYRAPEIM 237
           T  Y +PE++
Sbjct: 174 TAQYVSPELL 183

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 61/132 (46%), Gaps = 23/132 (17%)
Query: 210 LDFGLARPTENEMTGYV---------ATRWYRAPEIM--LNWMHYNQTGVPFYFQDLKPS 258
           L FGL+     E+  Y+          TR+Y A EI+  L ++H    G     +DLKP 
Sbjct: 84  LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH----GKGIIHRDLKPE 138
Query: 259 NIAVNEDCELKILDFGLAR-----PTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
           NI +NED  ++I DFG A+       +     +V T  Y +PE++        +D+  L 
Sbjct: 139 NILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALG 198
Query: 314 LIMEML--GTPP 323
            I+  L  G PP
Sbjct: 199 CIIYQLVAGLPP 210

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 62/130 (47%), Gaps = 9/130 (6%)
Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQF 172
           RE  ++  ++H   + L   F  +  L  F   Y      G  L  I +     +   +F
Sbjct: 79  RERDVMSRLDHPFFVKLYFTFQDDEKLY-FGLSYAKN---GELLKYIRKIGSFDETCTRF 134
Query: 173 LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR-----PTENEMTGYVA 227
              +I+  L+Y+H  GIIHRDLKP NI +NED  ++I DFG A+       +     +V 
Sbjct: 135 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 228 TRWYRAPEIM 237
           T  Y +PE++
Sbjct: 195 TAQYVSPELL 204

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 61/132 (46%), Gaps = 23/132 (17%)
Query: 210 LDFGLARPTENEMTGYV---------ATRWYRAPEIM--LNWMHYNQTGVPFYFQDLKPS 258
           L FGL+     E+  Y+          TR+Y A EI+  L ++H    G     +DLKP 
Sbjct: 105 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH----GKGIIHRDLKPE 159
Query: 259 NIAVNEDCELKILDFGLAR-----PTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
           NI +NED  ++I DFG A+       +     +V T  Y +PE++        +D+  L 
Sbjct: 160 NILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALG 219
Query: 314 LIMEML--GTPP 323
            I+  L  G PP
Sbjct: 220 CIIYQLVAGLPP 231

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 85/174 (48%), Gaps = 15/174 (8%)
Query: 72  LSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLD 131
           L K +F ++    +  ++G + A K I     SA   ++  RE R+ + + H N++ L D
Sbjct: 30  LGKGAFSVV-RRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 88
Query: 132 VFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGI 189
                  +++  + Y++  L+  G    +I+  +  S+      + QIL  + + H  G+
Sbjct: 89  ------SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGV 142
Query: 190 IHRDLKPSNIAVN---EDCELKILDFGLARPTENEMT---GYVATRWYRAPEIM 237
           +HRDLKP N+ +    +   +K+ DFGLA   E E     G+  T  Y +PE++
Sbjct: 143 VHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL 196

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 73/177 (41%), Gaps = 38/177 (21%)
Query: 235 EIMLNWMHYNQTGVPFYFQDLKPSNIAVN---EDCELKILDFGLARPTENEMT---GYVA 288
           +I+   +H +Q GV    +DLKP N+ +    +   +K+ DFGLA   E E     G+  
Sbjct: 129 QILEAVLHCHQMGV--VHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAG 186
Query: 289 TRWYRAPEIMLNWMHYNQTDIHQLNLIMEML--GTPPAEFMAKISSDSARKYINSLPLLT 346
           T  Y +PE++    +    D+    +I+ +L  G PP         D  R Y        
Sbjct: 187 TPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPF-----WDEDQHRLY-------- 233
Query: 347 KKDFRQVFKGA-----------NPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYS 392
               +Q+  GA            P+A             KRITA +AL HP++S  S
Sbjct: 234 ----QQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRS 286

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 62/130 (47%), Gaps = 9/130 (6%)
Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQF 172
           RE  ++  ++H   + L   F  +  L  F   Y      G  L  I +     +   +F
Sbjct: 84  RERDVMSRLDHPFFVKLYFTFQDDEKLY-FGLSYAKN---GELLKYIRKIGSFDETCTRF 139
Query: 173 LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR-----PTENEMTGYVA 227
              +I+  L+Y+H  GIIHRDLKP NI +NED  ++I DFG A+       +     +V 
Sbjct: 140 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 199
Query: 228 TRWYRAPEIM 237
           T  Y +PE++
Sbjct: 200 TAQYVSPELL 209

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 61/132 (46%), Gaps = 23/132 (17%)
Query: 210 LDFGLARPTENEMTGYV---------ATRWYRAPEIM--LNWMHYNQTGVPFYFQDLKPS 258
           L FGL+     E+  Y+          TR+Y A EI+  L ++H    G     +DLKP 
Sbjct: 110 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH----GKGIIHRDLKPE 164
Query: 259 NIAVNEDCELKILDFGLAR-----PTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
           NI +NED  ++I DFG A+       +     +V T  Y +PE++        +D+  L 
Sbjct: 165 NILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALG 224
Query: 314 LIMEML--GTPP 323
            I+  L  G PP
Sbjct: 225 CIIYQLVAGLPP 236

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 62/130 (47%), Gaps = 9/130 (6%)
Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQF 172
           RE  ++  ++H   + L   F  +  L  F   Y      G  L  I +     +   +F
Sbjct: 79  RERDVMSRLDHPFFVKLYFTFQDDEKLY-FGLSYAKN---GELLKYIRKIGSFDETCTRF 134
Query: 173 LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR-----PTENEMTGYVA 227
              +I+  L+Y+H  GIIHRDLKP NI +NED  ++I DFG A+       +     +V 
Sbjct: 135 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 228 TRWYRAPEIM 237
           T  Y +PE++
Sbjct: 195 TAQYVSPELL 204

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 61/132 (46%), Gaps = 23/132 (17%)
Query: 210 LDFGLARPTENEMTGYV---------ATRWYRAPEIM--LNWMHYNQTGVPFYFQDLKPS 258
           L FGL+     E+  Y+          TR+Y A EI+  L ++H    G     +DLKP 
Sbjct: 105 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH----GKGIIHRDLKPE 159
Query: 259 NIAVNEDCELKILDFGLAR-----PTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
           NI +NED  ++I DFG A+       +     +V T  Y +PE++        +D+  L 
Sbjct: 160 NILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALG 219
Query: 314 LIMEML--GTPP 323
            I+  L  G PP
Sbjct: 220 CIIYQLVAGLPP 231

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 62/130 (47%), Gaps = 9/130 (6%)
Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQF 172
           RE  ++  ++H   + L   F  +  L  F   Y      G  L  I +     +   +F
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLY-FGLSYAKN---GELLKYIRKIGSFDETCTRF 136
Query: 173 LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR-----PTENEMTGYVA 227
              +I+  L+Y+H  GIIHRDLKP NI +NED  ++I DFG A+       +     +V 
Sbjct: 137 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 228 TRWYRAPEIM 237
           T  Y +PE++
Sbjct: 197 TAQYVSPELL 206

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 61/132 (46%), Gaps = 23/132 (17%)
Query: 210 LDFGLARPTENEMTGYV---------ATRWYRAPEIM--LNWMHYNQTGVPFYFQDLKPS 258
           L FGL+     E+  Y+          TR+Y A EI+  L ++H    G     +DLKP 
Sbjct: 107 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH----GKGIIHRDLKPE 161
Query: 259 NIAVNEDCELKILDFGLAR-----PTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
           NI +NED  ++I DFG A+       +     +V T  Y +PE++        +D+  L 
Sbjct: 162 NILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALG 221
Query: 314 LIMEML--GTPP 323
            I+  L  G PP
Sbjct: 222 CIIYQLVAGLPP 233

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 62/130 (47%), Gaps = 9/130 (6%)
Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQF 172
           RE  ++  ++H   + L   F  +  L  F   Y      G  L  I +     +   +F
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLY-FGLSYAKN---GELLKYIRKIGSFDETCTRF 136
Query: 173 LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR-----PTENEMTGYVA 227
              +I+  L+Y+H  GIIHRDLKP NI +NED  ++I DFG A+       +     +V 
Sbjct: 137 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 228 TRWYRAPEIM 237
           T  Y +PE++
Sbjct: 197 TAQYVSPELL 206

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 61/132 (46%), Gaps = 23/132 (17%)
Query: 210 LDFGLARPTENEMTGYV---------ATRWYRAPEIM--LNWMHYNQTGVPFYFQDLKPS 258
           L FGL+     E+  Y+          TR+Y A EI+  L ++H    G     +DLKP 
Sbjct: 107 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH----GKGIIHRDLKPE 161
Query: 259 NIAVNEDCELKILDFGLAR-----PTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
           NI +NED  ++I DFG A+       +     +V T  Y +PE++        +D+  L 
Sbjct: 162 NILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALG 221
Query: 314 LIMEML--GTPP 323
            I+  L  G PP
Sbjct: 222 CIIYQLVAGLPP 233

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 62/130 (47%), Gaps = 9/130 (6%)
Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQF 172
           RE  ++  ++H   + L   F  +  L  F   Y      G  L  I +     +   +F
Sbjct: 56  RERDVMSRLDHPFFVKLYFTFQDDEKLY-FGLSYAKN---GELLKYIRKIGSFDETCTRF 111
Query: 173 LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR-----PTENEMTGYVA 227
              +I+  L+Y+H  GIIHRDLKP NI +NED  ++I DFG A+       +     +V 
Sbjct: 112 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 171
Query: 228 TRWYRAPEIM 237
           T  Y +PE++
Sbjct: 172 TAQYVSPELL 181

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 61/132 (46%), Gaps = 23/132 (17%)
Query: 210 LDFGLARPTENEMTGYV---------ATRWYRAPEIM--LNWMHYNQTGVPFYFQDLKPS 258
           L FGL+     E+  Y+          TR+Y A EI+  L ++H    G     +DLKP 
Sbjct: 82  LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH----GKGIIHRDLKPE 136
Query: 259 NIAVNEDCELKILDFGLAR-----PTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
           NI +NED  ++I DFG A+       +     +V T  Y +PE++        +D+  L 
Sbjct: 137 NILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALG 196
Query: 314 LIMEML--GTPP 323
            I+  L  G PP
Sbjct: 197 CIIYQLVAGLPP 208

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 73/133 (54%), Gaps = 10/133 (7%)
Query: 108 AKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLN-NILRTQKL 165
            +  ++EL++++ + H  ++ L   F       D ++++MV  L+ G DL  ++ +    
Sbjct: 59  VRNVFKELQIMQGLEHPFLVNLWYSFQ------DEEDMFMVVDLLLGGDLRYHLQQNVHF 112
Query: 166 SDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR--PTENEMT 223
            ++ V+  + +++  L Y+ +  IIHRD+KP NI ++E   + I DF +A   P E ++T
Sbjct: 113 KEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQIT 172
Query: 224 GYVATRWYRAPEI 236
               T+ Y APE+
Sbjct: 173 TMAGTKPYMAPEM 185

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/128 (29%), Positives = 74/128 (57%), Gaps = 14/128 (10%)
Query: 125 NVIGLLDVF---HSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGL 181
           N++ LLD+    HS T    F+      ++   D   +  T  L+D  +++ +Y++L+ L
Sbjct: 89  NIVKLLDIVRDQHSKTPSLIFE------YVNNTDFKVLYPT--LTDYDIRYYIYELLKAL 140
Query: 182 KYIHSAGIIHRDLKPSNIAVNEDC-ELKILDFGLARPTE--NEMTGYVATRWYRAPEIML 238
            Y HS GI+HRD+KP N+ ++ +  +L+++D+GLA       E    VA+R+++ PE+++
Sbjct: 141 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 200
Query: 239 NWMHYNQT 246
           +   Y+ +
Sbjct: 201 DLQDYDYS 208

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 62/130 (47%), Gaps = 9/130 (6%)
Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQF 172
           RE  ++  ++H   + L   F  +  L  F   Y      G  L  I +     +   +F
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLY-FGLSYAKN---GELLKYIRKIGSFDETCTRF 136
Query: 173 LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR-----PTENEMTGYVA 227
              +I+  L+Y+H  GIIHRDLKP NI +NED  ++I DFG A+       +     +V 
Sbjct: 137 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 228 TRWYRAPEIM 237
           T  Y +PE++
Sbjct: 197 TAQYVSPELL 206

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 61/132 (46%), Gaps = 23/132 (17%)
Query: 210 LDFGLARPTENEMTGYV---------ATRWYRAPEIM--LNWMHYNQTGVPFYFQDLKPS 258
           L FGL+     E+  Y+          TR+Y A EI+  L ++H    G     +DLKP 
Sbjct: 107 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH----GKGIIHRDLKPE 161
Query: 259 NIAVNEDCELKILDFGLAR-----PTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
           NI +NED  ++I DFG A+       +     +V T  Y +PE++        +D+  L 
Sbjct: 162 NILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALG 221
Query: 314 LIMEML--GTPP 323
            I+  L  G PP
Sbjct: 222 CIIYQLVAGLPP 233

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 76  SFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHS 135
           S ++     L   +G  VA+KK+    +   H +   RE+ +LK + H+N++    V +S
Sbjct: 26  SVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVKYKGVCYS 83
Query: 136 NTCLADFKNVYMV-THLMGADLNNILRTQKLSDDHVQFLVY--QILRGLKYIHSAGIIHR 192
               A  +N+ ++  +L    L + L+  K   DH++ L Y  QI +G++Y+ +   IHR
Sbjct: 84  ----AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHR 139
Query: 193 DLKPSNIAVNEDCELKILDFGLAR--PTENEM-----TGYVATRWYRAPE 235
           +L   NI V  +  +KI DFGL +  P + E       G     WY APE
Sbjct: 140 NLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY-APE 188

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 62/130 (47%), Gaps = 9/130 (6%)
Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQF 172
           RE  ++  ++H   + L   F  +  L  F   Y      G  L  I +     +   +F
Sbjct: 57  RERDVMSRLDHPFFVKLYFTFQDDEKLY-FGLSYAKN---GELLKYIRKIGSFDETCTRF 112
Query: 173 LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR-----PTENEMTGYVA 227
              +I+  L+Y+H  GIIHRDLKP NI +NED  ++I DFG A+       +     +V 
Sbjct: 113 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 172
Query: 228 TRWYRAPEIM 237
           T  Y +PE++
Sbjct: 173 TAQYVSPELL 182

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 61/132 (46%), Gaps = 23/132 (17%)
Query: 210 LDFGLARPTENEMTGYV---------ATRWYRAPEIM--LNWMHYNQTGVPFYFQDLKPS 258
           L FGL+     E+  Y+          TR+Y A EI+  L ++H    G     +DLKP 
Sbjct: 83  LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH----GKGIIHRDLKPE 137
Query: 259 NIAVNEDCELKILDFGLAR-----PTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
           NI +NED  ++I DFG A+       +     +V T  Y +PE++        +D+  L 
Sbjct: 138 NILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALG 197
Query: 314 LIMEML--GTPP 323
            I+  L  G PP
Sbjct: 198 CIIYQLVAGLPP 209

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/128 (29%), Positives = 74/128 (57%), Gaps = 14/128 (10%)
Query: 125 NVIGLLDVF---HSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGL 181
           N++ LLD+    HS T    F+      ++   D   +  T  L+D  +++ +Y++L+ L
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFE------YVNNTDFKVLYPT--LTDYDIRYYIYELLKAL 139
Query: 182 KYIHSAGIIHRDLKPSNIAVNEDC-ELKILDFGLARPTE--NEMTGYVATRWYRAPEIML 238
            Y HS GI+HRD+KP N+ ++ +  +L+++D+GLA       E    VA+R+++ PE+++
Sbjct: 140 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 199
Query: 239 NWMHYNQT 246
           +   Y+ +
Sbjct: 200 DLQDYDYS 207

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/128 (29%), Positives = 74/128 (57%), Gaps = 14/128 (10%)
Query: 125 NVIGLLDVF---HSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGL 181
           N++ LLD+    HS T    F+      ++   D   +  T  L+D  +++ +Y++L+ L
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFE------YVNNTDFKVLYPT--LTDYDIRYYIYELLKAL 138
Query: 182 KYIHSAGIIHRDLKPSNIAVNEDC-ELKILDFGLARPTE--NEMTGYVATRWYRAPEIML 238
            Y HS GI+HRD+KP N+ ++ +  +L+++D+GLA       E    VA+R+++ PE+++
Sbjct: 139 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 239 NWMHYNQT 246
           +   Y+ +
Sbjct: 199 DLQDYDYS 206

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/128 (29%), Positives = 74/128 (57%), Gaps = 14/128 (10%)
Query: 125 NVIGLLDVF---HSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGL 181
           N++ LLD+    HS T    F+      ++   D   +  T  L+D  +++ +Y++L+ L
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFE------YVNNTDFKVLYPT--LTDYDIRYYIYELLKAL 138
Query: 182 KYIHSAGIIHRDLKPSNIAVNEDC-ELKILDFGLARPTE--NEMTGYVATRWYRAPEIML 238
            Y HS GI+HRD+KP N+ ++ +  +L+++D+GLA       E    VA+R+++ PE+++
Sbjct: 139 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 239 NWMHYNQT 246
           +   Y+ +
Sbjct: 199 DLQDYDYS 206

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/128 (29%), Positives = 74/128 (57%), Gaps = 14/128 (10%)
Query: 125 NVIGLLDVF---HSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGL 181
           N++ LLD+    HS T    F+      ++   D   +  T  L+D  +++ +Y++L+ L
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFE------YVNNTDFKVLYPT--LTDYDIRYYIYELLKAL 138
Query: 182 KYIHSAGIIHRDLKPSNIAVNEDC-ELKILDFGLARPTE--NEMTGYVATRWYRAPEIML 238
            Y HS GI+HRD+KP N+ ++ +  +L+++D+GLA       E    VA+R+++ PE+++
Sbjct: 139 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 239 NWMHYNQT 246
           +   Y+ +
Sbjct: 199 DLQDYDYS 206

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 48/90 (53%), Gaps = 5/90 (5%)
Query: 153 GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDF 212
           G  L  I +     +   +F   +I+  L+Y+H  GIIHRDLKP NI +NED  ++I DF
Sbjct: 114 GELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDF 173
Query: 213 GLAR-----PTENEMTGYVATRWYRAPEIM 237
           G A+       +     +V T  Y +PE++
Sbjct: 174 GTAKVLSPESKQARANXFVGTAQYVSPELL 203

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 59/131 (45%), Gaps = 21/131 (16%)
Query: 210 LDFGLARPTENEMTGYV---------ATRWYRAPEI-MLNWMHYNQTGVPFYFQDLKPSN 259
           L FGL+     E+  Y+          TR+Y A  +  L ++H    G     +DLKP N
Sbjct: 104 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH----GKGIIHRDLKPEN 159
Query: 260 IAVNEDCELKILDFGLAR-----PTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNL 314
           I +NED  ++I DFG A+       +     +V T  Y +PE++        +D+  L  
Sbjct: 160 ILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGC 219
Query: 315 IMEML--GTPP 323
           I+  L  G PP
Sbjct: 220 IIYQLVAGLPP 230

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/128 (29%), Positives = 74/128 (57%), Gaps = 14/128 (10%)
Query: 125 NVIGLLDVF---HSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGL 181
           N++ LLD+    HS T    F+      ++   D   +  T  L+D  +++ +Y++L+ L
Sbjct: 108 NIVKLLDIVRDQHSKTPSLIFE------YVNNTDFKVLYPT--LTDYDIRYYIYELLKAL 159
Query: 182 KYIHSAGIIHRDLKPSNIAVNEDC-ELKILDFGLARPTE--NEMTGYVATRWYRAPEIML 238
            Y HS GI+HRD+KP N+ ++ +  +L+++D+GLA       E    VA+R+++ PE+++
Sbjct: 160 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 219
Query: 239 NWMHYNQT 246
           +   Y+ +
Sbjct: 220 DLQDYDYS 227

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/128 (29%), Positives = 74/128 (57%), Gaps = 14/128 (10%)
Query: 125 NVIGLLDVF---HSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGL 181
           N++ LLD+    HS T    F+      ++   D   +  T  L+D  +++ +Y++L+ L
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFE------YVNNTDFKVLYPT--LTDYDIRYYIYELLKAL 138
Query: 182 KYIHSAGIIHRDLKPSNIAVNEDC-ELKILDFGLARPTE--NEMTGYVATRWYRAPEIML 238
            Y HS GI+HRD+KP N+ ++ +  +L+++D+GLA       E    VA+R+++ PE+++
Sbjct: 139 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 239 NWMHYNQT 246
           +   Y+ +
Sbjct: 199 DLQDYDYS 206

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/128 (29%), Positives = 74/128 (57%), Gaps = 14/128 (10%)
Query: 125 NVIGLLDVF---HSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGL 181
           N++ LLD+    HS T    F+      ++   D   +  T  L+D  +++ +Y++L+ L
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFE------YVNNTDFKVLYPT--LTDYDIRYYIYELLKAL 138
Query: 182 KYIHSAGIIHRDLKPSNIAVNEDC-ELKILDFGLARPTE--NEMTGYVATRWYRAPEIML 238
            Y HS GI+HRD+KP N+ ++ +  +L+++D+GLA       E    VA+R+++ PE+++
Sbjct: 139 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 239 NWMHYNQT 246
           +   Y+ +
Sbjct: 199 DLQDYDYS 206

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/133 (27%), Positives = 69/133 (51%), Gaps = 8/133 (6%)
Query: 113 RELRMLK-HMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGA----DLNNILRTQKLSD 167
           +E+ MLK + +H N+      F           +++V    GA    DL    +   L +
Sbjct: 69  QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE 128
Query: 168 DHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP---TENEMTG 224
           + + ++  +ILRGL ++H   +IHRD+K  N+ + E+ E+K++DFG++     T      
Sbjct: 129 EWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT 188
Query: 225 YVATRWYRAPEIM 237
           ++ T ++ APE++
Sbjct: 189 FIGTPYWMAPEVI 201

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/128 (29%), Positives = 74/128 (57%), Gaps = 14/128 (10%)
Query: 125 NVIGLLDVF---HSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGL 181
           N++ LLD+    HS T    F+      ++   D   +  T  L+D  +++ +Y++L+ L
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFE------YVNNTDFKVLYPT--LTDYDIRYYIYELLKAL 139
Query: 182 KYIHSAGIIHRDLKPSNIAVNEDC-ELKILDFGLARPTE--NEMTGYVATRWYRAPEIML 238
            Y HS GI+HRD+KP N+ ++ +  +L+++D+GLA       E    VA+R+++ PE+++
Sbjct: 140 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 199
Query: 239 NWMHYNQT 246
           +   Y+ +
Sbjct: 200 DLQDYDYS 207

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 48/90 (53%), Gaps = 5/90 (5%)
Query: 153 GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDF 212
           G  L  I +     +   +F   +I+  L+Y+H  GIIHRDLKP NI +NED  ++I DF
Sbjct: 99  GELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDF 158
Query: 213 GLAR-----PTENEMTGYVATRWYRAPEIM 237
           G A+       +     +V T  Y +PE++
Sbjct: 159 GTAKVLSPESKQARANXFVGTAQYVSPELL 188

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 59/131 (45%), Gaps = 21/131 (16%)
Query: 210 LDFGLARPTENEMTGYV---------ATRWYRAPEI-MLNWMHYNQTGVPFYFQDLKPSN 259
           L FGL+     E+  Y+          TR+Y A  +  L ++H    G     +DLKP N
Sbjct: 89  LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH----GKGIIHRDLKPEN 144
Query: 260 IAVNEDCELKILDFGLAR-----PTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNL 314
           I +NED  ++I DFG A+       +     +V T  Y +PE++        +D+  L  
Sbjct: 145 ILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGC 204
Query: 315 IMEML--GTPP 323
           I+  L  G PP
Sbjct: 205 IIYQLVAGLPP 215

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 91/184 (49%), Gaps = 23/184 (12%)
Query: 71  TLSKESFDLIFSSALDSVSGVK-VAIKKIARPFQSAVHAKRTYRE------LRMLKHM-- 121
           +L  + FDL+      S + V  V +KK  R +   V  K    +      ++  KH+  
Sbjct: 1   SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE 60
Query: 122 ---NHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLN-NILRTQKLSDDHVQFLVYQI 177
              NH  ++GL   F + + L      +++ ++ G DL  ++ R +KL ++H +F   +I
Sbjct: 61  QASNHPFLVGLHSCFQTESRL-----FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI 115
Query: 178 LRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA----RPTENEMTGYVATRWYRA 233
              L Y+H  GII+RDLK  N+ ++ +  +K+ D+G+     RP +   + +  T  Y A
Sbjct: 116 SLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TSXFCGTPNYIA 174
Query: 234 PEIM 237
           PEI+
Sbjct: 175 PEIL 178

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 91/184 (49%), Gaps = 23/184 (12%)
Query: 71  TLSKESFDLIFSSALDSVSGVK-VAIKKIARPFQSAVHAKRTYRE------LRMLKHM-- 121
           +L  + FDL+      S + V  V +KK  R +   V  K    +      ++  KH+  
Sbjct: 16  SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE 75
Query: 122 ---NHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLN-NILRTQKLSDDHVQFLVYQI 177
              NH  ++GL   F + + L      +++ ++ G DL  ++ R +KL ++H +F   +I
Sbjct: 76  QASNHPFLVGLHSCFQTESRL-----FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI 130
Query: 178 LRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA----RPTENEMTGYVATRWYRA 233
              L Y+H  GII+RDLK  N+ ++ +  +K+ D+G+     RP +   + +  T  Y A
Sbjct: 131 SLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TSXFCGTPNYIA 189
Query: 234 PEIM 237
           PEI+
Sbjct: 190 PEIL 193

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 79/181 (43%), Gaps = 11/181 (6%)
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHE 124
            +IG  L K  F  ++  A +  S   +A+K + +   + A    +  RE+ +  H+ H 
Sbjct: 36  FEIGRPLGKGKFGNVYL-AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 94
Query: 125 NVIGLLDVFHSNTCLADFKNVYMVTHL--MGADLNNILRTQKLSDDHVQFLVYQILRGLK 182
           N++ L   FH      D   VY++     +G     + +  K  +      + ++   L 
Sbjct: 95  NILRLYGYFH------DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 183 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-RPTENEMTGYVATRWYRAPEIMLNWM 241
           Y HS  +IHRD+KP N+ +    ELKI DFG +     +       T  Y  PE++   M
Sbjct: 149 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTLDYLPPEMIEGRM 208
Query: 242 H 242
           H
Sbjct: 209 H 209

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 81/182 (44%), Gaps = 13/182 (7%)
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHE 124
            +IG  L K  F  ++  A +  S   +A+K + +   + A    +  RE+ +  H+ H 
Sbjct: 11  FEIGRPLGKGKFGNVYL-AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 69
Query: 125 NVIGLLDVFHSNTCLADFKNVYMVTHL--MGADLNNILRTQKLSDDHVQFLVYQILRGLK 182
           N++ L   FH  T       VY++     +G     + +  K  +      + ++   L 
Sbjct: 70  NILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 183 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA--RPTENEMTGYVATRWYRAPEIMLNW 240
           Y HS  +IHRD+KP N+ +    ELKI DFG +   P+    T    T  Y  PE++   
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDT-LCGTLDYLPPEMIEGR 182
Query: 241 MH 242
           MH
Sbjct: 183 MH 184

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 80/181 (44%), Gaps = 11/181 (6%)
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHE 124
            +IG  L K  F  ++  A +  S   +A+K + +   + A    +  RE+ +  H+ H 
Sbjct: 12  FEIGRPLGKGKFGNVYL-AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 70
Query: 125 NVIGLLDVFHSNTCLADFKNVYMVTHL--MGADLNNILRTQKLSDDHVQFLVYQILRGLK 182
           N++ L   FH      D   VY++     +G     + +  K  +      + ++   L 
Sbjct: 71  NILRLYGYFH------DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 183 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-RPTENEMTGYVATRWYRAPEIMLNWM 241
           Y HS  +IHRD+KP N+ +    ELKI +FG +     +  T    T  Y  PE++   M
Sbjct: 125 YCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM 184
Query: 242 H 242
           H
Sbjct: 185 H 185

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 66/130 (50%), Gaps = 10/130 (7%)
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRT--QKLSDDHVQ 171
           E+ +L   +H N++ LLD F+    L       ++    G  ++ ++    + L++  +Q
Sbjct: 84  EIDILASCDHPNIVKLLDAFYYENNLW-----ILIEFCAGGAVDAVMLELERPLTESQIQ 138
Query: 172 FLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP---TENEMTGYVAT 228
            +  Q L  L Y+H   IIHRDLK  NI    D ++K+ DFG++     T      ++ T
Sbjct: 139 VVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGT 198
Query: 229 RWYRAPEIML 238
            ++ APE+++
Sbjct: 199 PYWMAPEVVM 208

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 80/181 (44%), Gaps = 11/181 (6%)
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHE 124
            +IG  L K  F  ++  A +  S   +A+K + +   + A    +  RE+ +  H+ H 
Sbjct: 13  FEIGRPLGKGKFGNVYL-AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 71
Query: 125 NVIGLLDVFHSNTCLADFKNVYMVTHL--MGADLNNILRTQKLSDDHVQFLVYQILRGLK 182
           N++ L   FH  T       VY++     +G     + +  K  +      + ++   L 
Sbjct: 72  NILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 183 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-RPTENEMTGYVATRWYRAPEIMLNWM 241
           Y HS  +IHRD+KP N+ +    ELKI +FG +     +  T    T  Y  PE++   M
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM 185
Query: 242 H 242
           H
Sbjct: 186 H 186

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 79/181 (43%), Gaps = 11/181 (6%)
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHE 124
            +IG  L K  F  ++  A +  S   +A+K + +   + A    +  RE+ +  H+ H 
Sbjct: 12  FEIGRPLGKGKFGNVYL-AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 70
Query: 125 NVIGLLDVFHSNTCLADFKNVYMVTHL--MGADLNNILRTQKLSDDHVQFLVYQILRGLK 182
           N++ L   FH  T       VY++     +G     + +  K  +      + ++   L 
Sbjct: 71  NILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 183 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-RPTENEMTGYVATRWYRAPEIMLNWM 241
           Y HS  +IHRD+KP N+ +    ELKI DFG +     +       T  Y  PE++   M
Sbjct: 125 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMIEGRM 184
Query: 242 H 242
           H
Sbjct: 185 H 185

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/130 (26%), Positives = 66/130 (50%), Gaps = 10/130 (7%)
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRT--QKLSDDHVQ 171
           E+ +L   +H N++ LLD F+    L       ++    G  ++ ++    + L++  +Q
Sbjct: 84  EIDILASCDHPNIVKLLDAFYYENNLW-----ILIEFCAGGAVDAVMLELERPLTESQIQ 138
Query: 172 FLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT---GYVAT 228
            +  Q L  L Y+H   IIHRDLK  NI    D ++K+ DFG++      +     ++ T
Sbjct: 139 VVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGT 198
Query: 229 RWYRAPEIML 238
            ++ APE+++
Sbjct: 199 PYWMAPEVVM 208

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 79/181 (43%), Gaps = 11/181 (6%)
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHE 124
            +IG  L K  F  ++  A +  S   +A+K + +   + A    +  RE+ +  H+ H 
Sbjct: 10  FEIGRPLGKGKFGNVYL-AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 125 NVIGLLDVFHSNTCLADFKNVYMVTHL--MGADLNNILRTQKLSDDHVQFLVYQILRGLK 182
           N++ L   FH  T       VY++     +G     + +  K  +      + ++   L 
Sbjct: 69  NILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 183 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-RPTENEMTGYVATRWYRAPEIMLNWM 241
           Y HS  +IHRD+KP N+ +    ELKI DFG +     +       T  Y  PE++   M
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMIEGRM 182
Query: 242 H 242
           H
Sbjct: 183 H 183

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/158 (24%), Positives = 82/158 (51%), Gaps = 10/158 (6%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           +A+D  +G +VAI+++    Q     +    E+ +++   + N++  LD +     + D 
Sbjct: 39  TAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLDSY----LVGDE 92
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
             V M  +L G  L +++    + +  +  +  + L+ L+++HS  +IHR++K  NI + 
Sbjct: 93  LWVVM-EYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRNIKSDNILLG 151
Query: 203 EDCELKILDFGLA---RPTENEMTGYVATRWYRAPEIM 237
            D  +K+ DFG      P +++ +  V T ++ APE++
Sbjct: 152 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 189

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 79/181 (43%), Gaps = 11/181 (6%)
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHE 124
            +IG  L K  F  ++  A +  S   +A+K + +   + A    +  RE+ +  H+ H 
Sbjct: 13  FEIGRPLGKGKFGNVYL-AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 71
Query: 125 NVIGLLDVFHSNTCLADFKNVYMVTHL--MGADLNNILRTQKLSDDHVQFLVYQILRGLK 182
           N++ L   FH  T       VY++     +G     + +  K  +      + ++   L 
Sbjct: 72  NILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 183 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-RPTENEMTGYVATRWYRAPEIMLNWM 241
           Y HS  +IHRD+KP N+ +    ELKI DFG +     +       T  Y  PE++   M
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTLDYLPPEMIEGRM 185
Query: 242 H 242
           H
Sbjct: 186 H 186

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 79/181 (43%), Gaps = 11/181 (6%)
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHE 124
            +IG  L K  F  ++  A +      +A+K + +   + A    +  RE+ +  H+ H 
Sbjct: 7   FEIGRPLGKGKFGNVYL-AREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 65
Query: 125 NVIGLLDVFHSNTCLADFKNVYMVTHL--MGADLNNILRTQKLSDDHVQFLVYQILRGLK 182
           N++ L   FH  T       VY++     +G     + +  K  +      + ++   L 
Sbjct: 66  NILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 119
Query: 183 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-RPTENEMTGYVATRWYRAPEIMLNWM 241
           Y HS  +IHRD+KP N+ +    ELKI DFG +     +  T    T  Y  PE++   M
Sbjct: 120 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM 179
Query: 242 H 242
           H
Sbjct: 180 H 180

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 83/174 (47%), Gaps = 15/174 (8%)
Query: 72  LSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLD 131
           + K +F ++    +   +G + A K I     SA   ++  RE R+ + + H N++ L  
Sbjct: 12  IGKGAFSVV-RRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRL-- 68
Query: 132 VFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGI 189
             H +     F   Y+V  L+  G    +I+  +  S+      + QIL  + + H  G+
Sbjct: 69  --HDSISEEGFH--YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGV 124
Query: 190 IHRDLKPSNIAVNEDCE---LKILDFGLARPTENEMT---GYVATRWYRAPEIM 237
           +HRDLKP N+ +   C+   +K+ DFGLA   + +     G+  T  Y +PE++
Sbjct: 125 VHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 70/166 (42%), Gaps = 16/166 (9%)
Query: 235 EIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCE---LKILDFGLARPTENEMT---GYVA 288
           +I+   +H +Q GV    +DLKP N+ +   C+   +K+ DFGLA   + +     G+  
Sbjct: 111 QILEAVLHCHQMGV--VHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAG 168
Query: 289 TRWYRAPEIMLNWMHYNQTDIHQLNLIMEML--GTPPAEFMAKISSDSARKYINSLPLLT 346
           T  Y +PE++    +    DI    +I+ +L  G PP         +   K    +    
Sbjct: 169 TPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPP------FWDEDQHKLYQQIKAGA 222
Query: 347 KKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYS 392
                  +    P+A             KRITA +AL HP++ Q S
Sbjct: 223 YDFPSPEWDTVTPEAKNLINQMLTINPAKRITAHEALKHPWVCQRS 268

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 72  LSKESFDLIFSSALDSVSGVK-VAIKKIARPFQSAVHAKRTYRE------LRMLKHM--- 121
           L  + FDL+      S + V  V +KK  R +   V  K    +      ++  KH+   
Sbjct: 6   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 122 --NHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLN-NILRTQKLSDDHVQFLVYQIL 178
             NH  ++GL   F + + L      +++ ++ G DL  ++ R +KL ++H +F   +I 
Sbjct: 66  ASNHPFLVGLHSCFQTESRL-----FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 120
Query: 179 RGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA----RPTENEMTGYVATRWYRAP 234
             L Y+H  GII+RDLK  N+ ++ +  +K+ D+G+     RP +   + +  T  Y AP
Sbjct: 121 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TSXFCGTPNYIAP 179
Query: 235 EIM 237
           EI+
Sbjct: 180 EIL 182

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 82/174 (47%), Gaps = 15/174 (8%)
Query: 72  LSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLD 131
           L K +F ++    +      + A K I     SA   ++  RE R+ + + H N++ L  
Sbjct: 39  LGKGAFSVV-RRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRL-- 95
Query: 132 VFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGI 189
             H +     F   Y+V  L+  G    +I+  +  S+      ++QIL  + +IH   I
Sbjct: 96  --HDSISEEGFH--YLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQHDI 151
Query: 190 IHRDLKPSNIAVNEDCE---LKILDFGLARPTENEMT---GYVATRWYRAPEIM 237
           +HRDLKP N+ +   C+   +K+ DFGLA   + E     G+  T  Y +PE++
Sbjct: 152 VHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVL 205

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 62/148 (41%), Gaps = 14/148 (9%)
Query: 253 QDLKPSNIAVNEDCE---LKILDFGLARPTENEMT---GYVATRWYRAPEIMLNWMHYNQ 306
           +DLKP N+ +   C+   +K+ DFGLA   + E     G+  T  Y +PE++    +   
Sbjct: 154 RDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDPYGKP 213
Query: 307 TDIHQLNLIMEML--GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXX 364
            DI    +I+ +L  G PP         +   K    +           +    P+A   
Sbjct: 214 VDIWACGVILYILLVGYPP------FWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNL 267
Query: 365 XXXXXXXXXXKRITAEQALAHPYLSQYS 392
                     KRITA+QAL HP++ Q S
Sbjct: 268 INQMLTINPAKRITADQALKHPWVCQRS 295

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 87/175 (49%), Gaps = 12/175 (6%)
Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIKKIAR-PFQSAVHAKRTYRELRMLKHMNHENV 126
           +G TL   +F  +       ++G KVA+K + R   +S     +  RE++ LK   H ++
Sbjct: 20  LGDTLGVGTFGKV-KVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHI 78
Query: 127 IGLLDVFHSNTCLADFKNVYMV-THLMGADL-NNILRTQKLSDDHVQFLVYQILRGLKYI 184
           I L  V  + +      +++MV  ++ G +L + I +  +L +   + L  QIL G+ Y 
Sbjct: 79  IKLYQVISTPS------DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYC 132
Query: 185 HSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE--MTGYVATRWYRAPEIM 237
           H   ++HRDLKP N+ ++     KI DFGL+    +   +     +  Y APE++
Sbjct: 133 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVI 187

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 61/105 (58%), Gaps = 3/105 (2%)
Query: 136 NTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLK 195
            + L D K   ++ +L G    ++L    L +  +  ++ +IL+GL Y+HS   IHRD+K
Sbjct: 87  GSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 146
Query: 196 PSNIAVNEDCELKILDFGLA---RPTENEMTGYVATRWYRAPEIM 237
            +N+ ++E  E+K+ DFG+A     T+ +   +V T ++ APE++
Sbjct: 147 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI 191

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 79/181 (43%), Gaps = 11/181 (6%)
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHE 124
            +IG  L K  F  ++  A +  S   +A+K + +   + A    +  RE+ +  H+ H 
Sbjct: 13  FEIGRPLGKGKFGNVYL-AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 71
Query: 125 NVIGLLDVFHSNTCLADFKNVYMVTHL--MGADLNNILRTQKLSDDHVQFLVYQILRGLK 182
           N++ L   FH  T       VY++     +G     + +  K  +      + ++   L 
Sbjct: 72  NILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 183 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-RPTENEMTGYVATRWYRAPEIMLNWM 241
           Y HS  +IHRD+KP N+ +    ELKI DFG +     +       T  Y  PE++   M
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMIEGRM 185
Query: 242 H 242
           H
Sbjct: 186 H 186

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 47/90 (52%), Gaps = 17/90 (18%)
Query: 173 LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR---------------- 216
           L  QIL  L YIHS GIIHR+LKP NI ++E   +KI DFGLA+                
Sbjct: 121 LFRQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 217 -PTENEMTGYVATRWYRAPEIMLNWMHYNQ 245
             + + +T  + T  Y A E++    HYN+
Sbjct: 181 PGSSDNLTSAIGTAXYVATEVLDGTGHYNE 210

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 60/102 (58%), Gaps = 3/102 (2%)
Query: 139 LADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSN 198
           L D K   ++ +L G    ++L    L +  +  ++ +IL+GL Y+HS   IHRD+K +N
Sbjct: 95  LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAAN 154
Query: 199 IAVNEDCELKILDFGLA---RPTENEMTGYVATRWYRAPEIM 237
           + ++E  E+K+ DFG+A     T+ +   +V T ++ APE++
Sbjct: 155 VLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 196

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 61/105 (58%), Gaps = 3/105 (2%)
Query: 136 NTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLK 195
            + L D K   ++ +L G    ++L    L +  +  ++ +IL+GL Y+HS   IHRD+K
Sbjct: 72  GSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 131
Query: 196 PSNIAVNEDCELKILDFGLA---RPTENEMTGYVATRWYRAPEIM 237
            +N+ ++E  E+K+ DFG+A     T+ +   +V T ++ APE++
Sbjct: 132 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI 176

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 61/105 (58%), Gaps = 3/105 (2%)
Query: 136 NTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLK 195
            + L D K   ++ +L G    ++L    L +  +  ++ +IL+GL Y+HS   IHRD+K
Sbjct: 72  GSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 131
Query: 196 PSNIAVNEDCELKILDFGLA---RPTENEMTGYVATRWYRAPEIM 237
            +N+ ++E  E+K+ DFG+A     T+ +   +V T ++ APE++
Sbjct: 132 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 176

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 35/130 (26%), Positives = 66/130 (50%), Gaps = 10/130 (7%)
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRT--QKLSDDHVQ 171
           E+ +L   +H N++ LLD F+    L       ++    G  ++ ++    + L++  +Q
Sbjct: 84  EIDILASCDHPNIVKLLDAFYYENNLW-----ILIEFCAGGAVDAVMLELERPLTESQIQ 138
Query: 172 FLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT---GYVAT 228
            +  Q L  L Y+H   IIHRDLK  NI    D ++K+ DFG++      +     ++ T
Sbjct: 139 VVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGT 198
Query: 229 RWYRAPEIML 238
            ++ APE+++
Sbjct: 199 PYWMAPEVVM 208

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 84/160 (52%), Gaps = 17/160 (10%)
Query: 86  DSVSGVKVAIKKI-ARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN 144
           ++ +G+K+A K I  R  +     K    E+ ++  ++H N+I L D F S   +     
Sbjct: 110 ETATGLKLAAKIIKTRGMKDKEEVKN---EISVMNQLDHANLIQLYDAFESKNDI----- 161
Query: 145 VYMVTHLMGADLNN--ILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI-AV 201
           V ++ ++ G +L +  I  +  L++      + QI  G++++H   I+H DLKP NI  V
Sbjct: 162 VLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCV 221
Query: 202 NEDC-ELKILDFGLAR---PTENEMTGYVATRWYRAPEIM 237
           N D  ++KI+DFGLAR   P E     +  T  + APE++
Sbjct: 222 NRDAKQIKIIDFGLARRYKPREKLKVNF-GTPEFLAPEVV 260

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 71/144 (49%), Gaps = 12/144 (8%)
Query: 254 DLKPSNI-AVNEDC-ELKILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHYNQTD 308
           DLKP NI  VN D  ++KI+DFGLAR   P E     +  T  + APE++        TD
Sbjct: 212 DLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF-GTPEFLAPEVVNYDFVSFPTD 270
Query: 309 IHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFR-QVFKGANPQAIXXXXX 367
           +  + +I  ML +  + F+     D+  + +N++ L  + D   + F+  + +A      
Sbjct: 271 MWSVGVIAYMLLSGLSPFLG----DNDAETLNNI-LACRWDLEDEEFQDISEEAKEFISK 325
Query: 368 XXXXXXXKRITAEQALAHPYLSQY 391
                   RI+A +AL HP+LS +
Sbjct: 326 LLIKEKSWRISASEALKHPWLSDH 349

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 80/180 (44%), Gaps = 22/180 (12%)
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHEN 125
           I++   + + +F ++  +   +     VAIK+I    +S    K    ELR L  +NH N
Sbjct: 11  IEVEEVVGRGAFGVVCKAKWRAKD---VAIKQI----ESESERKAFIVELRQLSRVNHPN 63
Query: 126 VIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQK----LSDDHVQFLVYQILRGL 181
           ++ L     +  CL       ++ +  G  L N+L   +     +  H      Q  +G+
Sbjct: 64  IVKLYGACLNPVCL-------VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 116
Query: 182 KYIHS---AGIIHRDLKPSNIA-VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM 237
            Y+HS     +IHRDLKP N+  V     LKI DFG A   +  MT    +  + APE+ 
Sbjct: 117 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVF 176

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 84/180 (46%), Gaps = 13/180 (7%)
Query: 71  TLSKESFDLIFS--SALDSVSGVKVAIK--KIARPFQSAVHAKRTYRELRMLKHMNHENV 126
            L K  +  +F       + +G   A+K  K A   ++A     T  E  +L+ + H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 127 IGLLDVFHSNTCLADFKNVYMVTHLMGADL-NNILRTQKLSDDHVQFLVYQILRGLKYIH 185
           + L+  F +   L       ++ +L G +L   + R     +D   F + +I   L ++H
Sbjct: 84  VDLIYAFQTGGKL-----YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH 138
Query: 186 SAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT---GYVATRWYRAPEIMLNWMH 242
             GII+RDLKP NI +N    +K+ DFGL + + ++ T    +  T  Y APEI++   H
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMRSGH 198

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 40/128 (31%), Positives = 62/128 (48%), Gaps = 9/128 (7%)
Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMT--- 284
           T  +   EI +   H +Q G+   ++DLKP NI +N    +K+ DFGL + + ++ T   
Sbjct: 122 TACFYLAEISMALGHLHQKGI--IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH 179
Query: 285 GYVATRWYRAPEIMLNWMHYNQTDIHQLNLIM-EML-GTPP--AEFMAKISSDSARKYIN 340
            +  T  Y APEI++   H    D   L  +M +ML G PP   E   K      +  +N
Sbjct: 180 XFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN 239
Query: 341 SLPLLTKK 348
             P LT++
Sbjct: 240 LPPYLTQE 247

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 84/180 (46%), Gaps = 13/180 (7%)
Query: 71  TLSKESFDLIFS--SALDSVSGVKVAIK--KIARPFQSAVHAKRTYRELRMLKHMNHENV 126
            L K  +  +F       + +G   A+K  K A   ++A     T  E  +L+ + H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 127 IGLLDVFHSNTCLADFKNVYMVTHLMGADL-NNILRTQKLSDDHVQFLVYQILRGLKYIH 185
           + L+  F +   L       ++ +L G +L   + R     +D   F + +I   L ++H
Sbjct: 84  VDLIYAFQTGGKL-----YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH 138
Query: 186 SAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT---GYVATRWYRAPEIMLNWMH 242
             GII+RDLKP NI +N    +K+ DFGL + + ++ T    +  T  Y APEI++   H
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGH 198

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/128 (31%), Positives = 62/128 (48%), Gaps = 9/128 (7%)
Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMT--- 284
           T  +   EI +   H +Q G+   ++DLKP NI +N    +K+ DFGL + + ++ T   
Sbjct: 122 TACFYLAEISMALGHLHQKGI--IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH 179
Query: 285 GYVATRWYRAPEIMLNWMHYNQTDIHQLNLIM-EML-GTPP--AEFMAKISSDSARKYIN 340
            +  T  Y APEI++   H    D   L  +M +ML G PP   E   K      +  +N
Sbjct: 180 TFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN 239
Query: 341 SLPLLTKK 348
             P LT++
Sbjct: 240 LPPYLTQE 247

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 110/250 (44%), Gaps = 40/250 (16%)
Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLA--DFKNVY 146
           +G +VAIK+  +   S  + +R   E++++K +NH NV+   +V      LA  D   + 
Sbjct: 38  TGEQVAIKQCRQEL-SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLA 96
Query: 147 MVTHLMGADL----NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
           M  +  G DL    N       L +  ++ L+  I   L+Y+H   IIHRDLKP NI + 
Sbjct: 97  M-EYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQ 155
Query: 203 EDCEL---KILDFGLARPTENE--MTGYVATRWYRAPEIM--------LNWMHYNQ---- 245
              +    KI+D G A+  +     T +V T  Y APE++        +++  +      
Sbjct: 156 PGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFE 215
Query: 246 --TGVPFYFQDLKP------------SNIAVNEDCELKILDFGLARPTENEMTGYVATRW 291
             TG   +  + +P             +I V +D    +  F    PT N ++G +A + 
Sbjct: 216 CITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAV-KFSSVLPTPNHLSGILAGKL 274
Query: 292 YRAPEIMLNW 301
            R  + ML W
Sbjct: 275 ERWLQCMLMW 284

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 110/250 (44%), Gaps = 40/250 (16%)
Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLA--DFKNVY 146
           +G +VAIK+  +   S  + +R   E++++K +NH NV+   +V      LA  D   + 
Sbjct: 39  TGEQVAIKQCRQEL-SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLA 97
Query: 147 MVTHLMGADL----NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
           M  +  G DL    N       L +  ++ L+  I   L+Y+H   IIHRDLKP NI + 
Sbjct: 98  M-EYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQ 156
Query: 203 EDCEL---KILDFGLARPTENE--MTGYVATRWYRAPEIM--------LNWMHYNQ---- 245
              +    KI+D G A+  +     T +V T  Y APE++        +++  +      
Sbjct: 157 PGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFE 216
Query: 246 --TGVPFYFQDLKP------------SNIAVNEDCELKILDFGLARPTENEMTGYVATRW 291
             TG   +  + +P             +I V +D    +  F    PT N ++G +A + 
Sbjct: 217 CITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAV-KFSSVLPTPNHLSGILAGKL 275
Query: 292 YRAPEIMLNW 301
            R  + ML W
Sbjct: 276 ERWLQCMLMW 285

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/200 (23%), Positives = 94/200 (47%), Gaps = 16/200 (8%)
Query: 46  PSRRLHDHFNQPYSEIC-----RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIAR 100
           P R  H+ F      +      R  +D    + + S  ++  + + S SG  VA+KK+  
Sbjct: 6   PQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRS-SGKLVAVKKMD- 63
Query: 101 PFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNIL 160
             +     +  + E+ +++   HENV+ +      N+ L   +   ++  L G  L +I+
Sbjct: 64  -LRKQQRRELLFNEVVIMRDYQHENVVEMY-----NSYLVGDELWVVMEFLEGGALTDIV 117
Query: 161 RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN 220
              +++++ +  +   +L+ L  +H+ G+IHRD+K  +I +  D  +K+ DFG       
Sbjct: 118 THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 177
Query: 221 EM---TGYVATRWYRAPEIM 237
           E+      V T ++ APE++
Sbjct: 178 EVPRRKXLVGTPYWMAPELI 197

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 80/180 (44%), Gaps = 22/180 (12%)
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHEN 125
           I++   + + +F ++  +   +     VAIK+I    +S    K    ELR L  +NH N
Sbjct: 10  IEVEEVVGRGAFGVVCKAKWRAKD---VAIKQI----ESESERKAFIVELRQLSRVNHPN 62
Query: 126 VIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQK----LSDDHVQFLVYQILRGL 181
           ++ L     +  CL       ++ +  G  L N+L   +     +  H      Q  +G+
Sbjct: 63  IVKLYGACLNPVCL-------VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 182 KYIHS---AGIIHRDLKPSNIA-VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM 237
            Y+HS     +IHRDLKP N+  V     LKI DFG A   +  MT    +  + APE+ 
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVF 175

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 78/181 (43%), Gaps = 11/181 (6%)
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHE 124
            +IG  L K  F  ++  A +  S   +A+K + +   + A    +  RE+ +  H+ H 
Sbjct: 15  FEIGRPLGKGKFGNVYL-AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 73
Query: 125 NVIGLLDVFHSNTCLADFKNVYMVTHL--MGADLNNILRTQKLSDDHVQFLVYQILRGLK 182
           N++ L   FH  T       VY++     +G     + +  K  +      + ++   L 
Sbjct: 74  NILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 183 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-RPTENEMTGYVATRWYRAPEIMLNWM 241
           Y HS  +IHRD+KP N+ +    ELKI DFG +     +  T    T  Y  PE +    
Sbjct: 128 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEXIEGRX 187
Query: 242 H 242
           H
Sbjct: 188 H 188

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/200 (23%), Positives = 94/200 (47%), Gaps = 16/200 (8%)
Query: 46  PSRRLHDHFNQPYSEIC-----RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIAR 100
           P R  H+ F      +      R  +D    + + S  ++  + + S SG  VA+KK+  
Sbjct: 8   PQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRS-SGKLVAVKKMD- 65
Query: 101 PFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNIL 160
             +     +  + E+ +++   HENV+ +      N+ L   +   ++  L G  L +I+
Sbjct: 66  -LRKQQRRELLFNEVVIMRDYQHENVVEMY-----NSYLVGDELWVVMEFLEGGALTDIV 119
Query: 161 RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN 220
              +++++ +  +   +L+ L  +H+ G+IHRD+K  +I +  D  +K+ DFG       
Sbjct: 120 THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 179
Query: 221 EM---TGYVATRWYRAPEIM 237
           E+      V T ++ APE++
Sbjct: 180 EVPRRKXLVGTPYWMAPELI 199

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 18/177 (10%)
Query: 75  ESFDLIFSSALDSVSGVKVAIKKIARPFQSA--VHAKRTY-------RELRMLKHMNHEN 125
           E +DL+ +    +   V++A+ ++     +   V  KR         +E+ + K +NHEN
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHEN 65
Query: 126 VIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIH 185
           V+     F+ +    + + +++     G   + I     + +   Q   +Q++ G+ Y+H
Sbjct: 66  VVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 186 SAGIIHRDLKPSNIAVNEDCELKILDFGLA-----RPTENEMTGYVATRWYRAPEIM 237
             GI HRD+KP N+ ++E   LKI DFGLA        E  +     T  Y APE++
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 18/177 (10%)
Query: 75  ESFDLIFSSALDSVSGVKVAIKKIARPFQSA--VHAKRTY-------RELRMLKHMNHEN 125
           E +DL+ +    +   V++A+ ++     +   V  KR         +E+ + K +NHEN
Sbjct: 6   EDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 126 VIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIH 185
           V+     F+ +    + + +++     G   + I     + +   Q   +Q++ G+ Y+H
Sbjct: 66  VVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 186 SAGIIHRDLKPSNIAVNEDCELKILDFGLA-----RPTENEMTGYVATRWYRAPEIM 237
             GI HRD+KP N+ ++E   LKI DFGLA        E  +     T  Y APE++
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 66/138 (47%), Gaps = 19/138 (13%)
Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQF 172
           +E ++   + H N+I L  V     CL +     ++    G  LN +L  +++  D +  
Sbjct: 55  QEAKLFAMLKHPNIIALRGV-----CLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVN 109
Query: 173 LVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCE--------LKILDFGLARP--TE 219
              QI RG+ Y+H      IIHRDLK SNI + +  E        LKI DFGLAR     
Sbjct: 110 WAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT 169
Query: 220 NEMTGYVATRWYRAPEIM 237
            +M+   A  W  APE++
Sbjct: 170 TKMSAAGAYAWM-APEVI 186

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/200 (23%), Positives = 94/200 (47%), Gaps = 16/200 (8%)
Query: 46  PSRRLHDHFNQPYSEIC-----RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIAR 100
           P R  H+ F      +      R  +D    + + S  ++  + + S SG  VA+KK+  
Sbjct: 51  PQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRS-SGKLVAVKKMD- 108
Query: 101 PFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNIL 160
             +     +  + E+ +++   HENV+ +      N+ L   +   ++  L G  L +I+
Sbjct: 109 -LRKQQRRELLFNEVVIMRDYQHENVVEMY-----NSYLVGDELWVVMEFLEGGALTDIV 162
Query: 161 RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN 220
              +++++ +  +   +L+ L  +H+ G+IHRD+K  +I +  D  +K+ DFG       
Sbjct: 163 THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 222
Query: 221 EM---TGYVATRWYRAPEIM 237
           E+      V T ++ APE++
Sbjct: 223 EVPRRKXLVGTPYWMAPELI 242

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 88/186 (47%), Gaps = 19/186 (10%)
Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVI 127
           +G  + + +F  +FS  L + + + VA+K         + AK   +E R+LK  +H N++
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTL-VAVKSCRETLPPDLKAK-FLQEARILKQYSHPNIV 175
Query: 128 GLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQ--KLSDDHVQFLVYQILRGLKYI 184
            L+ V          + +Y+V  L+ G D    LRT+  +L    +  +V     G++Y+
Sbjct: 176 RLIGVCTQK------QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL 229
Query: 185 HSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTG------YVATRWYRAPEIML 238
            S   IHRDL   N  V E   LKI DFG++R   + +         V  +W  APE  L
Sbjct: 230 ESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWT-APE-AL 287
Query: 239 NWMHYN 244
           N+  Y+
Sbjct: 288 NYGRYS 293

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 18/177 (10%)
Query: 75  ESFDLIFSSALDSVSGVKVAIKKIARPFQSA--VHAKRTY-------RELRMLKHMNHEN 125
           E +DL+ +    +   V++A+ ++     +   V  KR         +E+ + K +NHEN
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHEN 66
Query: 126 VIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIH 185
           V+     F+ +    + + +++     G   + I     + +   Q   +Q++ G+ Y+H
Sbjct: 67  VVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 186 SAGIIHRDLKPSNIAVNEDCELKILDFGLA-----RPTENEMTGYVATRWYRAPEIM 237
             GI HRD+KP N+ ++E   LKI DFGLA        E  +     T  Y APE++
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 179

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 77/152 (50%), Gaps = 10/152 (6%)
Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           SG  VA+KK+    +     +  + E+ +++   HENV+ +      N+ L   +   ++
Sbjct: 175 SGKLVAVKKMD--LRKQQRRELLFNEVVIMRDYQHENVVEMY-----NSYLVGDELWVVM 227
Query: 149 THLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELK 208
             L G  L +I+   +++++ +  +   +L+ L  +H+ G+IHRD+K  +I +  D  +K
Sbjct: 228 EFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVK 287
Query: 209 ILDFGLARPTENEM---TGYVATRWYRAPEIM 237
           + DFG       E+      V T ++ APE++
Sbjct: 288 LSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI 319

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 18/177 (10%)
Query: 75  ESFDLIFSSALDSVSGVKVAIKKIARPFQSA--VHAKRTY-------RELRMLKHMNHEN 125
           E +DL+ +    +   V++A+ ++     +   V  KR         +E+ + K +NHEN
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHEN 65
Query: 126 VIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIH 185
           V+     F+ +    + + +++     G   + I     + +   Q   +Q++ G+ Y+H
Sbjct: 66  VVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 186 SAGIIHRDLKPSNIAVNEDCELKILDFGLA-----RPTENEMTGYVATRWYRAPEIM 237
             GI HRD+KP N+ ++E   LKI DFGLA        E  +     T  Y APE++
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 18/177 (10%)
Query: 75  ESFDLIFSSALDSVSGVKVAIKKIARPFQSA--VHAKRTY-------RELRMLKHMNHEN 125
           E +DL+ +    +   V++A+ ++     +   V  KR         +E+ + K +NHEN
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 126 VIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIH 185
           V+     F+ +    + + +++     G   + I     + +   Q   +Q++ G+ Y+H
Sbjct: 66  VVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 186 SAGIIHRDLKPSNIAVNEDCELKILDFGLA-----RPTENEMTGYVATRWYRAPEIM 237
             GI HRD+KP N+ ++E   LKI DFGLA        E  +     T  Y APE++
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 77/152 (50%), Gaps = 10/152 (6%)
Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           SG  VA+KK+    +     +  + E+ +++   HENV+ +      N+ L   +   ++
Sbjct: 44  SGKLVAVKKMD--LRKQQRRELLFNEVVIMRDYQHENVVEMY-----NSYLVGDELWVVM 96
Query: 149 THLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELK 208
             L G  L +I+   +++++ +  +   +L+ L  +H+ G+IHRD+K  +I +  D  +K
Sbjct: 97  EFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVK 156
Query: 209 ILDFGLARPTENEM---TGYVATRWYRAPEIM 237
           + DFG       E+      V T ++ APE++
Sbjct: 157 LSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI 188

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 18/177 (10%)
Query: 75  ESFDLIFSSALDSVSGVKVAIKKIARPFQSA--VHAKRTY-------RELRMLKHMNHEN 125
           E +DL+ +    +   V++A+ ++     +   V  KR         +E+ + K +NHEN
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 126 VIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIH 185
           V+     F+ +    + + +++     G   + I     + +   Q   +Q++ G+ Y+H
Sbjct: 67  VVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 186 SAGIIHRDLKPSNIAVNEDCELKILDFGLA-----RPTENEMTGYVATRWYRAPEIM 237
             GI HRD+KP N+ ++E   LKI DFGLA        E  +     T  Y APE++
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 77/152 (50%), Gaps = 10/152 (6%)
Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           SG  VA+KK+    +     +  + E+ +++   HENV+ +      N+ L   +   ++
Sbjct: 48  SGKLVAVKKMD--LRKQQRRELLFNEVVIMRDYQHENVVEMY-----NSYLVGDELWVVM 100
Query: 149 THLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELK 208
             L G  L +I+   +++++ +  +   +L+ L  +H+ G+IHRD+K  +I +  D  +K
Sbjct: 101 EFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVK 160
Query: 209 ILDFGLARPTENEM---TGYVATRWYRAPEIM 237
           + DFG       E+      V T ++ APE++
Sbjct: 161 LSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI 192

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 18/177 (10%)
Query: 75  ESFDLIFSSALDSVSGVKVAIKKIARPFQSA--VHAKRTY-------RELRMLKHMNHEN 125
           E +DL+ +    +   V++A+ ++     +   V  KR         +E+ + K +NHEN
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 126 VIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIH 185
           V+     F+ +    + + +++     G   + I     + +   Q   +Q++ G+ Y+H
Sbjct: 67  VVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 186 SAGIIHRDLKPSNIAVNEDCELKILDFGLA-----RPTENEMTGYVATRWYRAPEIM 237
             GI HRD+KP N+ ++E   LKI DFGLA        E  +     T  Y APE++
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 18/177 (10%)
Query: 75  ESFDLIFSSALDSVSGVKVAIKKIARPFQSA--VHAKRTY-------RELRMLKHMNHEN 125
           E +DL+ +    +   V++A+ ++     +   V  KR         +E+ + K +NHEN
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 126 VIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIH 185
           V+     F+ +    + + +++     G   + I     + +   Q   +Q++ G+ Y+H
Sbjct: 67  VVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 186 SAGIIHRDLKPSNIAVNEDCELKILDFGLA-----RPTENEMTGYVATRWYRAPEIM 237
             GI HRD+KP N+ ++E   LKI DFGLA        E  +     T  Y APE++
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 18/177 (10%)
Query: 75  ESFDLIFSSALDSVSGVKVAIKKIARPFQSA--VHAKRTY-------RELRMLKHMNHEN 125
           E +DL+ +    +   V++A+ ++     +   V  KR         +E+ + K +NHEN
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 126 VIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIH 185
           V+     F+ +    + + +++     G   + I     + +   Q   +Q++ G+ Y+H
Sbjct: 67  VVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 186 SAGIIHRDLKPSNIAVNEDCELKILDFGLA-----RPTENEMTGYVATRWYRAPEIM 237
             GI HRD+KP N+ ++E   LKI DFGLA        E  +     T  Y APE++
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 18/177 (10%)
Query: 75  ESFDLIFSSALDSVSGVKVAIKKIARPFQSA--VHAKRTY-------RELRMLKHMNHEN 125
           E +DL+ +    +   V++A+ ++     +   V  KR         +E+ + K +NHEN
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 126 VIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIH 185
           V+     F+ +    + + +++     G   + I     + +   Q   +Q++ G+ Y+H
Sbjct: 66  VVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 186 SAGIIHRDLKPSNIAVNEDCELKILDFGLA-----RPTENEMTGYVATRWYRAPEIM 237
             GI HRD+KP N+ ++E   LKI DFGLA        E  +     T  Y APE++
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 86  DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV 145
           D ++   VA+K I R    A   +   RE+   + + H N++   +V  + T LA     
Sbjct: 41  DKLTKELVAVKYIER---GAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA----- 92
Query: 146 YMVTHLMGADL-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED 204
            ++ +  G +L   I    + S+D  +F   Q+L G+ Y HS  I HRDLK  N  ++  
Sbjct: 93  IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGS 152
Query: 205 --CELKILDFGLARPT--ENEMTGYVATRWYRAPEIML 238
               LKI DFG ++ +   ++    V T  Y APE++L
Sbjct: 153 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 190

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 78/181 (43%), Gaps = 11/181 (6%)
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHE 124
            +IG  L K  F  ++  A +  S   +A+K + +   + A    +  RE+ +  H+ H 
Sbjct: 15  FEIGRPLGKGKFGNVYL-AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 73
Query: 125 NVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDDHVQFLVYQILRGLK 182
           N++ L   FH  T       VY++      G     + +  K  +      + ++   L 
Sbjct: 74  NILRLYGYFHDAT------RVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALS 127
Query: 183 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-RPTENEMTGYVATRWYRAPEIMLNWM 241
           Y HS  +IHRD+KP N+ +    ELKI DFG +     +       T  Y  PE++   M
Sbjct: 128 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLXGTLDYLPPEMIEGRM 187
Query: 242 H 242
           H
Sbjct: 188 H 188

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 18/177 (10%)
Query: 75  ESFDLIFSSALDSVSGVKVAIKKIARPFQSA--VHAKRTY-------RELRMLKHMNHEN 125
           E +DL+ +    +   V++A+ ++     +   V  KR         +E+ + K +NHEN
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 126 VIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIH 185
           V+     F+ +    + + +++     G   + I     + +   Q   +Q++ G+ Y+H
Sbjct: 66  VVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 186 SAGIIHRDLKPSNIAVNEDCELKILDFGLA-----RPTENEMTGYVATRWYRAPEIM 237
             GI HRD+KP N+ ++E   LKI DFGLA        E  +     T  Y APE++
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 18/177 (10%)
Query: 75  ESFDLIFSSALDSVSGVKVAIKKIARPFQSA--VHAKRTY-------RELRMLKHMNHEN 125
           E +DL+ +    +   V++A+ ++     +   V  KR         +E+ + K +NHEN
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 126 VIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIH 185
           V+     F+ +    + + +++     G   + I     + +   Q   +Q++ G+ Y+H
Sbjct: 66  VVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 186 SAGIIHRDLKPSNIAVNEDCELKILDFGLA-----RPTENEMTGYVATRWYRAPEIM 237
             GI HRD+KP N+ ++E   LKI DFGLA        E  +     T  Y APE++
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 87/194 (44%), Gaps = 34/194 (17%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLK 119
           EI R  + +   L +  F  ++    +  +  +VAIK + +P    +  +   +E +++K
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTT--RVAIKTL-KP--GTMSPEAFLQEAQVMK 68
Query: 120 HMNHENVIGLLDV-----------FHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDD 168
            + HE ++ L  V           + S  CL DF         +  ++   LR  +L D 
Sbjct: 69  KLRHEKLVQLYAVVSEEPIYIVTEYMSKGCLLDF---------LKGEMGKYLRLPQLVD- 118
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE-NEMTGYVA 227
               +  QI  G+ Y+     +HRDL+ +NI V E+   K+ DFGLAR  E NE T    
Sbjct: 119 ----MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 228 TRW---YRAPEIML 238
            ++   + APE  L
Sbjct: 175 AKFPIKWTAPEAAL 188

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 91/204 (44%), Gaps = 45/204 (22%)
Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHEN- 125
           +I  TL + +F  +         G  VA+K I +       A R+  E+++L+H+N  + 
Sbjct: 17  EIVDTLGEGAFGKVVECIDHKAGGRHVAVK-IVKNVDRYCEAARS--EIQVLEHLNTTDP 73
Query: 126 -----VIGLLDVF--HSNTCLADFKNVYMVTHLMGADLNNILRTQKL---SDDHVQFLVY 175
                 + +L+ F  H + C+        V  L+G    + ++         DH++ + Y
Sbjct: 74  NSTFRCVQMLEWFEHHGHICI--------VFELLGLSTYDFIKENGFLPFRLDHIRKMAY 125
Query: 176 QILRGLKYIHSAGIIHRDLKPSNI---------------------AVNEDCELKILDFGL 214
           QI + + ++HS  + H DLKP NI                      +N D  +K++DFG 
Sbjct: 126 QICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD--IKVVDFGS 183
Query: 215 ARPTENEMTGYVATRWYRAPEIML 238
           A   +   +  V+TR YRAPE++L
Sbjct: 184 ATYDDEHHSTLVSTRHYRAPEVIL 207

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 74/159 (46%), Gaps = 30/159 (18%)
Query: 114 ELRMLKHMN-HENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQK-------- 164
           E+ M+K +  H+N+I LL       C  D     +V +    +L   LR ++        
Sbjct: 136 EMEMMKMIGKHKNIINLL-----GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 190
Query: 165 ----LSDDHVQF-----LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 215
               + ++ + F       YQ+ RG++Y+ S   IHRDL   N+ V E+  +KI DFGLA
Sbjct: 191 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 250
Query: 216 RPTEN------EMTGYVATRWYRAPEIMLNWMHYNQTGV 248
           R   N         G +  +W  APE + + ++ +Q+ V
Sbjct: 251 RDINNIDYYKKTTNGRLPVKWM-APEALFDRVYTHQSDV 288

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 18/177 (10%)
Query: 75  ESFDLIFSSALDSVSGVKVAIKKIARPFQSA--VHAKRTY-------RELRMLKHMNHEN 125
           E +DL+ +    +   V++A+ ++     +   V  KR         +E+ + K +NHEN
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 126 VIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIH 185
           V+     F+ +    + + +++     G   + I     + +   Q   +Q++ G+ Y+H
Sbjct: 65  VVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 186 SAGIIHRDLKPSNIAVNEDCELKILDFGLA-----RPTENEMTGYVATRWYRAPEIM 237
             GI HRD+KP N+ ++E   LKI DFGLA        E  +     T  Y APE++
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 87/194 (44%), Gaps = 34/194 (17%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLK 119
           EI R  + +   L +  F  ++    +  +  +VAIK + +P    +  +   +E +++K
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTT--RVAIKTL-KP--GTMSPEAFLQEAQVMK 68
Query: 120 HMNHENVIGLLDV-----------FHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDD 168
            + HE ++ L  V           + S  CL DF         +  ++   LR  +L D 
Sbjct: 69  KLRHEKLVQLYAVVSEEPIYIVMEYMSKGCLLDF---------LKGEMGKYLRLPQLVD- 118
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE-NEMTGYVA 227
               +  QI  G+ Y+     +HRDL+ +NI V E+   K+ DFGLAR  E NE T    
Sbjct: 119 ----MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 228 TRW---YRAPEIML 238
            ++   + APE  L
Sbjct: 175 AKFPIKWTAPEAAL 188

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 18/177 (10%)
Query: 75  ESFDLIFSSALDSVSGVKVAIKKIARPFQSA--VHAKRTY-------RELRMLKHMNHEN 125
           E +DL+ +    +   V++A+ ++     +   V  KR         +E+ + K +NHEN
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 126 VIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIH 185
           V+     F+ +    + + +++     G   + I     + +   Q   +Q++ G+ Y+H
Sbjct: 67  VVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 186 SAGIIHRDLKPSNIAVNEDCELKILDFGLA-----RPTENEMTGYVATRWYRAPEIM 237
             GI HRD+KP N+ ++E   LKI DFGLA        E  +     T  Y APE++
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 72/159 (45%), Gaps = 30/159 (18%)
Query: 114 ELRMLKHMN-HENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRT---------- 162
           E+ M+K +  H+N+I LL       C  D     +V +    +L   L+           
Sbjct: 83  EMEMMKMIGKHKNIINLL-----GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSF 137
Query: 163 -------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 215
                  ++LS   +    YQ+ RG++Y+ S   IHRDL   N+ V ED  +KI DFGLA
Sbjct: 138 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 197
Query: 216 R------PTENEMTGYVATRWYRAPEIMLNWMHYNQTGV 248
           R        +    G +  +W  APE + + ++ +Q+ V
Sbjct: 198 RDIHHIDXXKKTTNGRLPVKWM-APEALFDRIYTHQSDV 235

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 86/186 (46%), Gaps = 19/186 (10%)
Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVI 127
           +G  + + +F  +FS  L +     VA+K         + AK   +E R+LK  +H N++
Sbjct: 118 LGEQIGRGNFGEVFSGRLRA-DNTLVAVKSCRETLPPDLKAK-FLQEARILKQYSHPNIV 175
Query: 128 GLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQ--KLSDDHVQFLVYQILRGLKYI 184
            L+ V          + +Y+V  L+ G D    LRT+  +L    +  +V     G++Y+
Sbjct: 176 RLIGVCTQK------QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL 229
Query: 185 HSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTG------YVATRWYRAPEIML 238
            S   IHRDL   N  V E   LKI DFG++R   + +         V  +W  APE  L
Sbjct: 230 ESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKW-TAPE-AL 287
Query: 239 NWMHYN 244
           N+  Y+
Sbjct: 288 NYGRYS 293

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 18/177 (10%)
Query: 75  ESFDLIFSSALDSVSGVKVAIKKIARPFQSA--VHAKRTY-------RELRMLKHMNHEN 125
           E +DL+ +    +   V++A+ ++     +   V  KR         +E+ + K +NHEN
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 126 VIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIH 185
           V+     F+ +    + + +++     G   + I     + +   Q   +Q++ G+ Y+H
Sbjct: 67  VVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 186 SAGIIHRDLKPSNIAVNEDCELKILDFGLA-----RPTENEMTGYVATRWYRAPEIM 237
             GI HRD+KP N+ ++E   LKI DFGLA        E  +     T  Y APE++
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 75/159 (47%), Gaps = 30/159 (18%)
Query: 114 ELRMLKHMN-HENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQK-------- 164
           E+ M+K +  H+N+I LL       C  D     +V +    +L   LR ++        
Sbjct: 90  EMEMMKMIGKHKNIINLL-----GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 165 ----LSDDHVQF-----LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 215
               + ++ + F       YQ+ RG++Y+ S   IHRDL   N+ V E+  +KI DFGLA
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
Query: 216 RPT------ENEMTGYVATRWYRAPEIMLNWMHYNQTGV 248
           R        +N   G +  +W  APE + + ++ +Q+ V
Sbjct: 205 RDINNIDYYKNTTNGRLPVKWM-APEALFDRVYTHQSDV 242

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 18/177 (10%)
Query: 75  ESFDLIFSSALDSVSGVKVAIKKIARPFQSA--VHAKRTY-------RELRMLKHMNHEN 125
           E +DL+ +    +   V++A+ ++     +   V  KR         +E+ + K +NHEN
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 126 VIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIH 185
           V+     F+ +    + + +++     G   + I     + +   Q   +Q++ G+ Y+H
Sbjct: 66  VVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 186 SAGIIHRDLKPSNIAVNEDCELKILDFGLA-----RPTENEMTGYVATRWYRAPEIM 237
             GI HRD+KP N+ ++E   LKI DFGLA        E  +     T  Y APE++
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 72/159 (45%), Gaps = 30/159 (18%)
Query: 114 ELRMLKHMN-HENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRT---------- 162
           E+ M+K +  H+N+I LL       C  D     +V +    +L   L+           
Sbjct: 75  EMEMMKMIGKHKNIINLL-----GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 129
Query: 163 -------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 215
                  ++LS   +    YQ+ RG++Y+ S   IHRDL   N+ V ED  +KI DFGLA
Sbjct: 130 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 189
Query: 216 RPT------ENEMTGYVATRWYRAPEIMLNWMHYNQTGV 248
           R        +    G +  +W  APE + + ++ +Q+ V
Sbjct: 190 RDIHHIDYYKKTTNGRLPVKWM-APEALFDRIYTHQSDV 227

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 74/159 (46%), Gaps = 30/159 (18%)
Query: 114 ELRMLKHMN-HENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQK-------- 164
           E+ M+K +  H+N+I LL       C  D     +V +    +L   LR ++        
Sbjct: 90  EMEMMKMIGKHKNIINLL-----GACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSY 144
Query: 165 ----LSDDHVQF-----LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 215
               + ++ + F       YQ+ RG++Y+ S   IHRDL   N+ V E+  +KI DFGLA
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
Query: 216 RPTEN------EMTGYVATRWYRAPEIMLNWMHYNQTGV 248
           R   N         G +  +W  APE + + ++ +Q+ V
Sbjct: 205 RDINNIDYYKKTTNGRLPVKWM-APEALFDRVYTHQSDV 242

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 18/177 (10%)
Query: 75  ESFDLIFSSALDSVSGVKVAIKKIARPFQSA--VHAKRTY-------RELRMLKHMNHEN 125
           E +DL+ +    +   V++A+ ++     +   V  KR         +E+ + K +NHEN
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 126 VIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIH 185
           V+     F+ +    + + +++     G   + I     + +   Q   +Q++ G+ Y+H
Sbjct: 66  VVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 186 SAGIIHRDLKPSNIAVNEDCELKILDFGLA-----RPTENEMTGYVATRWYRAPEIM 237
             GI HRD+KP N+ ++E   LKI DFGLA        E  +     T  Y APE++
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 72/159 (45%), Gaps = 30/159 (18%)
Query: 114 ELRMLKHMN-HENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRT---------- 162
           E+ M+K +  H+N+I LL       C  D     +V +    +L   L+           
Sbjct: 76  EMEMMKMIGKHKNIINLL-----GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 130
Query: 163 -------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 215
                  ++LS   +    YQ+ RG++Y+ S   IHRDL   N+ V ED  +KI DFGLA
Sbjct: 131 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 190
Query: 216 RPT------ENEMTGYVATRWYRAPEIMLNWMHYNQTGV 248
           R        +    G +  +W  APE + + ++ +Q+ V
Sbjct: 191 RDIHHIDYYKKTTNGRLPVKWM-APEALFDRIYTHQSDV 228

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 57/94 (60%), Gaps = 3/94 (3%)
Query: 147 MVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE 206
           ++ +L G    ++LR     +  +  ++ +IL+GL Y+HS   IHRD+K +N+ ++E  +
Sbjct: 99  IMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGD 158
Query: 207 LKILDFGLA---RPTENEMTGYVATRWYRAPEIM 237
           +K+ DFG+A     T+ +   +V T ++ APE++
Sbjct: 159 VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 192

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 95/222 (42%), Gaps = 37/222 (16%)
Query: 57  PYSEICRGVIDIGPTLSKESFDLIFSSALDSV------SGVKVAIKKIARPFQSAVHAKR 110
           P  E  R  + +G  L + +F  +  +    +        V VA+K + +   +      
Sbjct: 28  PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSD 86
Query: 111 TYRELRMLKHMN-HENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQK----- 164
              E+ M+K +  H+N+I LL       C  D     +V +    +L   LR ++     
Sbjct: 87  LVSEMEMMKMIGKHKNIINLL-----GACTQDGPLYVIVEYASKGNLREYLRARRPPGME 141
Query: 165 -------LSDDHVQF-----LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDF 212
                  + ++ + F       YQ+ RG++Y+ S   IHRDL   N+ V E+  +KI DF
Sbjct: 142 XSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 201
Query: 213 GLARPTEN------EMTGYVATRWYRAPEIMLNWMHYNQTGV 248
           GLAR   N         G +  +W  APE + + ++ +Q+ V
Sbjct: 202 GLARDINNIDXXKKTTNGRLPVKWM-APEALFDRVYTHQSDV 242

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 72/159 (45%), Gaps = 30/159 (18%)
Query: 114 ELRMLKHMN-HENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRT---------- 162
           E+ M+K +  H+N+I LL       C  D     +V +    +L   L+           
Sbjct: 83  EMEMMKMIGKHKNIINLL-----GACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSY 137
Query: 163 -------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 215
                  ++LS   +    YQ+ RG++Y+ S   IHRDL   N+ V ED  +KI DFGLA
Sbjct: 138 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 197
Query: 216 RPT------ENEMTGYVATRWYRAPEIMLNWMHYNQTGV 248
           R        +    G +  +W  APE + + ++ +Q+ V
Sbjct: 198 RDIHHIDYYKKTTNGRLPVKWM-APEALFDRIYTHQSDV 235

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 58/105 (55%), Gaps = 5/105 (4%)
Query: 146 YMVTHLMGADL-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED 204
           +++ +L G DL  +I    K       F   +I+ GL+++HS GI++RDLK  NI +++D
Sbjct: 95  FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD 154
Query: 205 CELKILDFGLARPT---ENEMTGYVATRWYRAPEIMLNWMHYNQT 246
             +KI DFG+ +     + +   +  T  Y APEI+L    YN +
Sbjct: 155 GHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLG-QKYNHS 198

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 72/159 (45%), Gaps = 30/159 (18%)
Query: 114 ELRMLKHMN-HENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRT---------- 162
           E+ M+K +  H+N+I LL       C  D     +V +    +L   L+           
Sbjct: 83  EMEMMKMIGKHKNIINLL-----GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 137
Query: 163 -------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 215
                  ++LS   +    YQ+ RG++Y+ S   IHRDL   N+ V ED  +KI DFGLA
Sbjct: 138 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 197
Query: 216 RPT------ENEMTGYVATRWYRAPEIMLNWMHYNQTGV 248
           R        +    G +  +W  APE + + ++ +Q+ V
Sbjct: 198 RDIHHIDYYKKTTNGRLPVKWM-APEALFDRIYTHQSDV 235

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 18/177 (10%)
Query: 75  ESFDLIFSSALDSVSGVKVAIKKIARPFQSA--VHAKRTY-------RELRMLKHMNHEN 125
           E +DL+ +    +   V++A+ ++     +   V  KR         +E+ + K +NHEN
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 126 VIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIH 185
           V+     F+ +    + + +++     G   + I     + +   Q   +Q++ G+ Y+H
Sbjct: 66  VVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 186 SAGIIHRDLKPSNIAVNEDCELKILDFGLA-----RPTENEMTGYVATRWYRAPEIM 237
             GI HRD+KP N+ ++E   LKI DFGLA        E  +     T  Y APE++
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 36/218 (16%)
Query: 35  RLWTVYPASKLPSRRL-HDHFNQPYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKV 93
           RL TV P SK  ++ L  D +     EI R  + +   L +  F  ++    +  +  +V
Sbjct: 242 RLTTVCPTSKPQTQGLAKDAW-----EIPRESLRLEVKLGQGCFGEVWMGTWNGTT--RV 294
Query: 94  AIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG 153
           AIK + +P    +  +   +E +++K + HE ++ L  V          + +Y+VT  M 
Sbjct: 295 AIKTL-KP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-------EPIYIVTEYMS 344
Query: 154 ---------ADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED 204
                     +    LR  +L D     +  QI  G+ Y+     +HRDL+ +NI V E+
Sbjct: 345 KGSLLDFLKGETGKYLRLPQLVD-----MAAQIASGMAYVERMNYVHRDLRAANILVGEN 399
Query: 205 CELKILDFGLARPTE-NEMTGYVATRW---YRAPEIML 238
              K+ DFGLAR  E NE T     ++   + APE  L
Sbjct: 400 LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 437

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 72/159 (45%), Gaps = 30/159 (18%)
Query: 114 ELRMLKHMN-HENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRT---------- 162
           E+ M+K +  H+N+I LL       C  D     +V +    +L   L+           
Sbjct: 72  EMEMMKMIGKHKNIINLL-----GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 126
Query: 163 -------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 215
                  ++LS   +    YQ+ RG++Y+ S   IHRDL   N+ V ED  +KI DFGLA
Sbjct: 127 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 186
Query: 216 RPT------ENEMTGYVATRWYRAPEIMLNWMHYNQTGV 248
           R        +    G +  +W  APE + + ++ +Q+ V
Sbjct: 187 RDIHHIDYYKKTTNGRLPVKWM-APEALFDRIYTHQSDV 224

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 18/177 (10%)
Query: 75  ESFDLIFSSALDSVSGVKVAIKKIARPFQSA--VHAKRTY-------RELRMLKHMNHEN 125
           E +DL+ +    +   V++A+ ++     +   V  KR         +E+ + K +NHEN
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 126 VIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIH 185
           V+     F+ +    + + +++     G   + I     + +   Q   +Q++ G+ Y+H
Sbjct: 66  VVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 186 SAGIIHRDLKPSNIAVNEDCELKILDFGLA-----RPTENEMTGYVATRWYRAPEIM 237
             GI HRD+KP N+ ++E   LKI DFGLA        E  +     T  Y APE++
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 59/94 (62%), Gaps = 3/94 (3%)
Query: 147 MVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE 206
           ++ +L G    ++L+   L + ++  ++ +IL+GL Y+HS   IHRD+K +N+ ++E  +
Sbjct: 95  IMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD 154
Query: 207 LKILDFGLA---RPTENEMTGYVATRWYRAPEIM 237
           +K+ DFG+A     T+ +   +V T ++ APE++
Sbjct: 155 VKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI 188

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 95/222 (42%), Gaps = 37/222 (16%)
Query: 57  PYSEICRGVIDIGPTLSKESFDLIFSSALDSV------SGVKVAIKKIARPFQSAVHAKR 110
           P  E  R  + +G  L + +F  +  +    +        V VA+K + +   +      
Sbjct: 28  PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSD 86
Query: 111 TYRELRMLKHMN-HENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQK----- 164
              E+ M+K +  H+N+I LL       C  D     +V +    +L   LR ++     
Sbjct: 87  LVSEMEMMKMIGKHKNIINLL-----GACTQDGPLYVIVEYASKGNLREYLRARRPPGME 141
Query: 165 -------LSDDHVQF-----LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDF 212
                  + ++ + F       YQ+ RG++Y+ S   IHRDL   N+ V E+  +KI DF
Sbjct: 142 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 201
Query: 213 GLARPTEN------EMTGYVATRWYRAPEIMLNWMHYNQTGV 248
           GLAR   N         G +  +W  APE + + ++ +Q+ V
Sbjct: 202 GLARDINNIDXXKKTTNGRLPVKWM-APEALFDRVYTHQSDV 242

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 72/159 (45%), Gaps = 30/159 (18%)
Query: 114 ELRMLKHMN-HENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRT---------- 162
           E+ M+K +  H+N+I LL       C  D     +V +    +L   L+           
Sbjct: 68  EMEMMKMIGKHKNIINLL-----GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCY 122
Query: 163 -------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 215
                  ++LS   +    YQ+ RG++Y+ S   IHRDL   N+ V ED  +KI DFGLA
Sbjct: 123 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 182
Query: 216 RPT------ENEMTGYVATRWYRAPEIMLNWMHYNQTGV 248
           R        +    G +  +W  APE + + ++ +Q+ V
Sbjct: 183 RDIHHIDYYKKTTNGRLPVKWM-APEALFDRIYTHQSDV 220

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 58/105 (55%), Gaps = 5/105 (4%)
Query: 146 YMVTHLMGADL-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED 204
           +++ +L G DL  +I    K       F   +I+ GL+++HS GI++RDLK  NI +++D
Sbjct: 96  FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD 155
Query: 205 CELKILDFGLARPT---ENEMTGYVATRWYRAPEIMLNWMHYNQT 246
             +KI DFG+ +     + +   +  T  Y APEI+L    YN +
Sbjct: 156 GHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLG-QKYNHS 199

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 72/159 (45%), Gaps = 30/159 (18%)
Query: 114 ELRMLKHMN-HENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRT---------- 162
           E+ M+K +  H+N+I LL       C  D     +V +    +L   L+           
Sbjct: 83  EMEMMKMIGKHKNIINLL-----GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCY 137
Query: 163 -------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 215
                  ++LS   +    YQ+ RG++Y+ S   IHRDL   N+ V ED  +KI DFGLA
Sbjct: 138 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 197
Query: 216 RPT------ENEMTGYVATRWYRAPEIMLNWMHYNQTGV 248
           R        +    G +  +W  APE + + ++ +Q+ V
Sbjct: 198 RDIHHIDYYKKTTNGRLPVKWM-APEALFDRIYTHQSDV 235

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 74/159 (46%), Gaps = 30/159 (18%)
Query: 114 ELRMLKHMN-HENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQK-------- 164
           E+ M+K +  H+N+I LL       C  D     +V +    +L   LR ++        
Sbjct: 79  EMEMMKMIGKHKNIINLL-----GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 133
Query: 165 ----LSDDHVQF-----LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 215
               + ++ + F       YQ+ RG++Y+ S   IHRDL   N+ V E+  +KI DFGLA
Sbjct: 134 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 193
Query: 216 RPTEN------EMTGYVATRWYRAPEIMLNWMHYNQTGV 248
           R   N         G +  +W  APE + + ++ +Q+ V
Sbjct: 194 RDINNIDYYKKTTNGRLPVKWM-APEALFDRVYTHQSDV 231

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 97/217 (44%), Gaps = 34/217 (15%)
Query: 35  RLWTVYPASKLPSRRLHDHFNQPYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVA 94
           RL TV P SK  ++ L     +   EI R  + +   L +  F  ++    +  +  +VA
Sbjct: 159 RLTTVCPTSKPQTQGLA----KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTT--RVA 212
Query: 95  IKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG- 153
           IK + +P    +  +   +E +++K + HE ++ L  V          + +Y+VT  M  
Sbjct: 213 IKTL-KP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-------EPIYIVTEYMSK 262
Query: 154 --------ADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
                    +    LR  +L D     +  QI  G+ Y+     +HRDL+ +NI V E+ 
Sbjct: 263 GSLLDFLKGETGKYLRLPQLVD-----MAAQIASGMAYVERMNYVHRDLRAANILVGENL 317
Query: 206 ELKILDFGLARPTE-NEMTGYVATRW---YRAPEIML 238
             K+ DFGLAR  E NE T     ++   + APE  L
Sbjct: 318 VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 354

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 73/157 (46%), Gaps = 11/157 (7%)
Query: 86  DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV 145
           D  S   VA+K I R  + A + KR     R L+H    N++   +V  + T LA    +
Sbjct: 40  DKQSNELVAVKYIERGEKIAANVKREIINHRSLRH---PNIVRFKEVILTPTHLA----I 92
Query: 146 YMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED- 204
            M     G     I    + S+D  +F   Q++ G+ Y H+  + HRDLK  N  ++   
Sbjct: 93  VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 152
Query: 205 -CELKILDFGLARPT--ENEMTGYVATRWYRAPEIML 238
              LKI DFG ++ +   ++    V T  Y APE++L
Sbjct: 153 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 189

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 18/177 (10%)
Query: 75  ESFDLIFSSALDSVSGVKVAIKKIARPFQSA--VHAKRTY-------RELRMLKHMNHEN 125
           E +DL+ +    +   V++A+ ++     +   V  KR         +E+ + K +NHEN
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 126 VIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIH 185
           V+     F+ +    + + +++     G   + I     + +   Q   +Q++ G+ Y+H
Sbjct: 66  VVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 186 SAGIIHRDLKPSNIAVNEDCELKILDFGLA-----RPTENEMTGYVATRWYRAPEIM 237
             GI HRD+KP N+ ++E   LKI DFGLA        E  +     T  Y APE++
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 97/217 (44%), Gaps = 34/217 (15%)
Query: 35  RLWTVYPASKLPSRRLHDHFNQPYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVA 94
           RL TV P SK  ++ L     +   EI R  + +   L +  F  ++    +  +  +VA
Sbjct: 159 RLTTVCPTSKPQTQGLA----KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTT--RVA 212
Query: 95  IKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG- 153
           IK + +P    +  +   +E +++K + HE ++ L  V          + +Y+VT  M  
Sbjct: 213 IKTL-KP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-------EPIYIVTEYMSK 262
Query: 154 --------ADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
                    +    LR  +L D     +  QI  G+ Y+     +HRDL+ +NI V E+ 
Sbjct: 263 GSLLDFLKGETGKYLRLPQLVD-----MAAQIASGMAYVERMNYVHRDLRAANILVGENL 317
Query: 206 ELKILDFGLARPTE-NEMTGYVATRW---YRAPEIML 238
             K+ DFGLAR  E NE T     ++   + APE  L
Sbjct: 318 VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 354

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 74/159 (46%), Gaps = 30/159 (18%)
Query: 114 ELRMLKHMN-HENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQK-------- 164
           E+ M+K +  H+N+I LL       C  D     +V +    +L   LR ++        
Sbjct: 77  EMEMMKMIGKHKNIINLL-----GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 131
Query: 165 ----LSDDHVQF-----LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 215
               + ++ + F       YQ+ RG++Y+ S   IHRDL   N+ V E+  +KI DFGLA
Sbjct: 132 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLA 191
Query: 216 RPTEN------EMTGYVATRWYRAPEIMLNWMHYNQTGV 248
           R   N         G +  +W  APE + + ++ +Q+ V
Sbjct: 192 RDINNIDYYKKTTNGRLPVKWM-APEALFDRVYTHQSDV 229

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 74/159 (46%), Gaps = 30/159 (18%)
Query: 114 ELRMLKHMN-HENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQK-------- 164
           E+ M+K +  H+N+I LL       C  D     +V +    +L   LR ++        
Sbjct: 82  EMEMMKMIGKHKNIINLL-----GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 136
Query: 165 ----LSDDHVQF-----LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 215
               + ++ + F       YQ+ RG++Y+ S   IHRDL   N+ V E+  +KI DFGLA
Sbjct: 137 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 196
Query: 216 RPTEN------EMTGYVATRWYRAPEIMLNWMHYNQTGV 248
           R   N         G +  +W  APE + + ++ +Q+ V
Sbjct: 197 RDINNIDYYKKTTNGRLPVKWM-APEALFDRVYTHQSDV 234

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 74/159 (46%), Gaps = 30/159 (18%)
Query: 114 ELRMLKHMN-HENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQK-------- 164
           E+ M+K +  H+N+I LL       C  D     +V +    +L   LR ++        
Sbjct: 90  EMEMMKMIGKHKNIINLL-----GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 165 ----LSDDHVQF-----LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 215
               + ++ + F       YQ+ RG++Y+ S   IHRDL   N+ V E+  +KI DFGLA
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
Query: 216 RPTEN------EMTGYVATRWYRAPEIMLNWMHYNQTGV 248
           R   N         G +  +W  APE + + ++ +Q+ V
Sbjct: 205 RDINNIDYYKKTTNGRLPVKWM-APEALFDRVYTHQSDV 242

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 100/218 (45%), Gaps = 20/218 (9%)
Query: 38  TVYPASKLPSRRLHDHFNQPYSE---ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVA 94
           ++ P  +LP       F Q Y     I RGV  +       +    F+  +  V+  +++
Sbjct: 76  SMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLS 135
Query: 95  IKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLADFKNVYMVTHLM- 152
                 P Q     + T RE  +L+ +  H ++I L+D + S++ +      ++V  LM 
Sbjct: 136 ------PEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM------FLVFDLMR 183
Query: 153 -GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILD 211
            G   + +     LS+   + ++  +L  + ++H+  I+HRDLKP NI ++++ ++++ D
Sbjct: 184 KGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSD 243
Query: 212 FGLARPTE--NEMTGYVATRWYRAPEIMLNWMHYNQTG 247
           FG +   E   ++     T  Y APEI+   M     G
Sbjct: 244 FGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPG 281

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 74/159 (46%), Gaps = 30/159 (18%)
Query: 114 ELRMLKHMN-HENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQK-------- 164
           E+ M+K +  H+N+I LL       C  D     +V +    +L   LR ++        
Sbjct: 90  EMEMMKMIGKHKNIINLL-----GACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSY 144
Query: 165 ----LSDDHVQF-----LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 215
               + ++ + F       YQ+ RG++Y+ S   IHRDL   N+ V E+  +KI DFGLA
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
Query: 216 RPTEN------EMTGYVATRWYRAPEIMLNWMHYNQTGV 248
           R   N         G +  +W  APE + + ++ +Q+ V
Sbjct: 205 RDINNIDYYKKTTNGRLPVKWM-APEALFDRVYTHQSDV 242

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 72/159 (45%), Gaps = 30/159 (18%)
Query: 114 ELRMLKHMN-HENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRT---------- 162
           E+ M+K +  H+N+I LL       C  D     +V +    +L   L+           
Sbjct: 124 EMEMMKMIGKHKNIINLL-----GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 178
Query: 163 -------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 215
                  ++LS   +    YQ+ RG++Y+ S   IHRDL   N+ V ED  +KI DFGLA
Sbjct: 179 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 238
Query: 216 RPT------ENEMTGYVATRWYRAPEIMLNWMHYNQTGV 248
           R        +    G +  +W  APE + + ++ +Q+ V
Sbjct: 239 RDIHHIDYYKKTTNGRLPVKWM-APEALFDRIYTHQSDV 276

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRT---QKLSDDH 169
           +E+++L+ + H+NVI L+DV ++     + + +YMV       +  +L +   ++     
Sbjct: 55  KEIQLLRRLRHKNVIQLVDVLYNE----EKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQ 110
Query: 170 VQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 215
                 Q++ GL+Y+HS GI+H+D+KP N+ +     LKI   G+A
Sbjct: 111 AHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVA 156

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 74/159 (46%), Gaps = 30/159 (18%)
Query: 114 ELRMLKHMN-HENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQK-------- 164
           E+ M+K +  H+N+I LL       C  D     +V +    +L   LR ++        
Sbjct: 90  EMEMMKMIGKHKNIITLL-----GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 165 ----LSDDHVQF-----LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 215
               + ++ + F       YQ+ RG++Y+ S   IHRDL   N+ V E+  +KI DFGLA
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
Query: 216 RPTEN------EMTGYVATRWYRAPEIMLNWMHYNQTGV 248
           R   N         G +  +W  APE + + ++ +Q+ V
Sbjct: 205 RDINNIDYYKKTTNGRLPVKWM-APEALFDRVYTHQSDV 242

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 71/134 (52%), Gaps = 11/134 (8%)
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL 173
           E+ + K +++ +V+G    F  +    DF  V +      + L    R + +++   ++ 
Sbjct: 92  EIAIHKSLDNPHVVGFHGFFEDD----DFVYVVLEICRRRSLLELHKRRKAVTEPEARYF 147
Query: 174 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTG-----YVAT 228
           + Q ++G++Y+H+  +IHRDLK  N+ +N+D ++KI DFGLA  T+ E  G        T
Sbjct: 148 MRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLA--TKIEFDGERKKTLCGT 205
Query: 229 RWYRAPEIMLNWMH 242
             Y APE++    H
Sbjct: 206 PNYIAPEVLCKKGH 219

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 48/95 (50%), Gaps = 13/95 (13%)
Query: 238 LNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTG-----YVATRWY 292
           + ++H N+       +DLK  N+ +N+D ++KI DFGLA  T+ E  G        T  Y
Sbjct: 155 VQYLHNNRV----IHRDLKLGNLFLNDDMDVKIGDFGLA--TKIEFDGERKKTLCGTPNY 208
Query: 293 RAPEIMLNWMHYNQTDIHQLNLIMEML--GTPPAE 325
            APE++    H  + DI  L  I+  L  G PP E
Sbjct: 209 IAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 71/134 (52%), Gaps = 11/134 (8%)
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL 173
           E+ + K +++ +V+G    F  +    DF  V +      + L    R + +++   ++ 
Sbjct: 92  EIAIHKSLDNPHVVGFHGFFEDD----DFVYVVLEICRRRSLLELHKRRKAVTEPEARYF 147
Query: 174 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTG-----YVAT 228
           + Q ++G++Y+H+  +IHRDLK  N+ +N+D ++KI DFGLA  T+ E  G        T
Sbjct: 148 MRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLA--TKIEFDGERKKXLCGT 205
Query: 229 RWYRAPEIMLNWMH 242
             Y APE++    H
Sbjct: 206 PNYIAPEVLCKKGH 219

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 48/95 (50%), Gaps = 13/95 (13%)
Query: 238 LNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTG-----YVATRWY 292
           + ++H N+       +DLK  N+ +N+D ++KI DFGLA  T+ E  G        T  Y
Sbjct: 155 VQYLHNNRV----IHRDLKLGNLFLNDDMDVKIGDFGLA--TKIEFDGERKKXLCGTPNY 208
Query: 293 RAPEIMLNWMHYNQTDIHQLNLIMEML--GTPPAE 325
            APE++    H  + DI  L  I+  L  G PP E
Sbjct: 209 IAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 71/134 (52%), Gaps = 11/134 (8%)
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL 173
           E+ + K +++ +V+G    F  +    DF  V +      + L    R + +++   ++ 
Sbjct: 92  EIAIHKSLDNPHVVGFHGFFEDD----DFVYVVLEICRRRSLLELHKRRKAVTEPEARYF 147
Query: 174 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTG-----YVAT 228
           + Q ++G++Y+H+  +IHRDLK  N+ +N+D ++KI DFGLA  T+ E  G        T
Sbjct: 148 MRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLA--TKIEFDGERKKDLCGT 205
Query: 229 RWYRAPEIMLNWMH 242
             Y APE++    H
Sbjct: 206 PNYIAPEVLCKKGH 219

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 48/95 (50%), Gaps = 13/95 (13%)
Query: 238 LNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTG-----YVATRWY 292
           + ++H N+       +DLK  N+ +N+D ++KI DFGLA  T+ E  G        T  Y
Sbjct: 155 VQYLHNNRV----IHRDLKLGNLFLNDDMDVKIGDFGLA--TKIEFDGERKKDLCGTPNY 208
Query: 293 RAPEIMLNWMHYNQTDIHQLNLIMEML--GTPPAE 325
            APE++    H  + DI  L  I+  L  G PP E
Sbjct: 209 IAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 74/143 (51%), Gaps = 13/143 (9%)
Query: 111 TYRELRMLKHMN-HENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSD 167
           T +E+ +L+ ++ H N+I L D + +NT        ++V  LM  G   + +     LS+
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFF------FLVFDLMKKGELFDYLTEKVTLSE 123
Query: 168 DHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA---RPTENEMTG 224
              + ++  +L  +  +H   I+HRDLKP NI +++D  +K+ DFG +    P E ++  
Sbjct: 124 KETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLRS 182
Query: 225 YVATRWYRAPEIMLNWMHYNQTG 247
              T  Y APEI+   M+ N  G
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPG 205

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 69/158 (43%), Gaps = 34/158 (21%)
Query: 253 QDLKPSNIAVNEDCELKILDFGLA---RPTENEMTGYVATRWYRAPEIMLNWMHYN---- 305
           +DLKP NI +++D  +K+ DFG +    P E ++     T  Y APEI+   M+ N    
Sbjct: 148 RDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLRSVCGTPSYLAPEIIECSMNDNHPGY 206
Query: 306 --QTDIHQLNLIMEML--GTPP---AEFMAKISSDSARKYINSLPLL-----TKKDFRQV 353
             + D+    +IM  L  G+PP    + M  +    +  Y    P       T KD    
Sbjct: 207 GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSR 266
Query: 354 FKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQY 391
           F    PQ              KR TAE+ALAHP+  QY
Sbjct: 267 FLVVQPQ--------------KRYTAEEALAHPFFQQY 290

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 35  RLWTVYPASKLPSRRLHDHFNQPYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVA 94
           RL TV P SK  ++ L     +   EI R  + +   L +  F  ++    +  +  +VA
Sbjct: 159 RLTTVCPTSKPQTQGLA----KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTT--RVA 212
Query: 95  IKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC--LADFKNVYMVTHLM 152
           IK + +P    +  +   +E +++K + HE ++ L  V        + ++ +   +   +
Sbjct: 213 IKTL-KP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVGEYMSKGSLLDFL 269
Query: 153 GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDF 212
             +    LR  +L D     +  QI  G+ Y+     +HRDL+ +NI V E+   K+ DF
Sbjct: 270 KGETGKYLRLPQLVD-----MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADF 324
Query: 213 GLARPTE-NEMTGYVATRW---YRAPEIML 238
           GLAR  E NE T     ++   + APE  L
Sbjct: 325 GLARLIEDNEYTARQGAKFPIKWTAPEAAL 354

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 83/174 (47%), Gaps = 15/174 (8%)
Query: 72  LSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLD 131
           L K +F ++    +   +G + A K I     SA   ++  RE R+ + + H N++ L  
Sbjct: 12  LGKGAFSVV-RRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRL-- 68
Query: 132 VFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGI 189
             H +     F   Y+V  L+  G    +I+  +  S+      + QIL  + + H  GI
Sbjct: 69  --HDSISEEGFH--YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGI 124
Query: 190 IHRDLKPSNIAV---NEDCELKILDFGLARPTENEMT---GYVATRWYRAPEIM 237
           +HRDLKP N+ +   ++   +K+ DFGLA   + +     G+  T  Y +PE++
Sbjct: 125 VHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 71/134 (52%), Gaps = 11/134 (8%)
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFL 173
           E+ + K +++ +V+G    F  +    DF  V +      + L    R + +++   ++ 
Sbjct: 76  EIAIHKSLDNPHVVGFHGFFEDD----DFVYVVLEICRRRSLLELHKRRKAVTEPEARYF 131
Query: 174 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTG-----YVAT 228
           + Q ++G++Y+H+  +IHRDLK  N+ +N+D ++KI DFGLA  T+ E  G        T
Sbjct: 132 MRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLA--TKIEFDGERKKDLCGT 189
Query: 229 RWYRAPEIMLNWMH 242
             Y APE++    H
Sbjct: 190 PNYIAPEVLCKKGH 203

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 48/95 (50%), Gaps = 13/95 (13%)
Query: 238 LNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTG-----YVATRWY 292
           + ++H N+       +DLK  N+ +N+D ++KI DFGLA  T+ E  G        T  Y
Sbjct: 139 VQYLHNNRV----IHRDLKLGNLFLNDDMDVKIGDFGLA--TKIEFDGERKKDLCGTPNY 192
Query: 293 RAPEIMLNWMHYNQTDIHQLNLIMEML--GTPPAE 325
            APE++    H  + DI  L  I+  L  G PP E
Sbjct: 193 IAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 227

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 74/159 (46%), Gaps = 30/159 (18%)
Query: 114 ELRMLKHMN-HENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQK-------- 164
           E+ M+K +  H+N+I LL       C  D     +V +    +L   LR ++        
Sbjct: 90  EMEMMKMIGKHKNIIHLL-----GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 165 ----LSDDHVQF-----LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 215
               + ++ + F       YQ+ RG++Y+ S   IHRDL   N+ V E+  +KI DFGLA
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
Query: 216 RPTEN------EMTGYVATRWYRAPEIMLNWMHYNQTGV 248
           R   N         G +  +W  APE + + ++ +Q+ V
Sbjct: 205 RDINNIDYYKKTTNGRLPVKWM-APEALFDRVYTHQSDV 242

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 83/174 (47%), Gaps = 15/174 (8%)
Query: 72  LSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLD 131
           L K +F ++    +   +G + A K I     SA   ++  RE R+ + + H N++ L  
Sbjct: 12  LGKGAFSVV-RRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRL-- 68
Query: 132 VFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGI 189
             H +     F   Y+V  L+  G    +I+  +  S+      + QIL  + + H  GI
Sbjct: 69  --HDSISEEGFH--YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGI 124
Query: 190 IHRDLKPSNIAV---NEDCELKILDFGLARPTENEMT---GYVATRWYRAPEIM 237
           +HRDLKP N+ +   ++   +K+ DFGLA   + +     G+  T  Y +PE++
Sbjct: 125 VHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 74/159 (46%), Gaps = 30/159 (18%)
Query: 114 ELRMLKHMN-HENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQK-------- 164
           E+ M+K +  H+N+I LL       C  D     +V +    +L   LR ++        
Sbjct: 90  EMEMMKMIGKHKNIINLL-----GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 165 ----LSDDHVQF-----LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 215
               + ++ + F       YQ+ RG++Y+ S   IHRDL   N+ V E+  ++I DFGLA
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLA 204
Query: 216 RPTEN------EMTGYVATRWYRAPEIMLNWMHYNQTGV 248
           R   N         G +  +W  APE + + ++ +Q+ V
Sbjct: 205 RDINNIDYYKKTTNGRLPVKWM-APEALFDRVYTHQSDV 242

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 84/174 (48%), Gaps = 15/174 (8%)
Query: 72  LSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLD 131
           L K +F ++    +  ++G + A   I     SA   ++  RE R+ + + H N++ L D
Sbjct: 19  LGKGAFSVV-RRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 132 VFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGI 189
                  +++  + Y++  L+  G    +I+  +  S+      + QIL  + + H  G+
Sbjct: 78  ------SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGV 131
Query: 190 IHRDLKPSNIAVN---EDCELKILDFGLARPTENEMT---GYVATRWYRAPEIM 237
           +HR+LKP N+ +    +   +K+ DFGLA   E E     G+  T  Y +PE++
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL 185

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 73/177 (41%), Gaps = 38/177 (21%)
Query: 235 EIMLNWMHYNQTGVPFYFQDLKPSNIAVN---EDCELKILDFGLARPTENEMT---GYVA 288
           +I+   +H +Q GV    ++LKP N+ +    +   +K+ DFGLA   E E     G+  
Sbjct: 118 QILEAVLHCHQMGV--VHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAG 175
Query: 289 TRWYRAPEIMLNWMHYNQTDIHQLNLIMEML--GTPPAEFMAKISSDSARKYINSLPLLT 346
           T  Y +PE++    +    D+    +I+ +L  G PP         D  R Y        
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPF-----WDEDQHRLY-------- 222
Query: 347 KKDFRQVFKGA-----------NPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYS 392
               +Q+  GA            P+A             KRITA +AL HP++S  S
Sbjct: 223 ----QQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRS 275

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/133 (25%), Positives = 64/133 (48%), Gaps = 8/133 (6%)
Query: 110 RTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQK-LSDD 168
           R  RE +    +NH  ++ + D   + T       + M  ++ G  L +I+ T+  ++  
Sbjct: 58  RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVM-EYVDGVTLRDIVHTEGPMTPK 116
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN------EM 222
               ++    + L + H  GIIHRD+KP+NI ++    +K++DFG+AR   +      + 
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 223 TGYVATRWYRAPE 235
              + T  Y +PE
Sbjct: 177 AAVIGTAQYLSPE 189

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/114 (27%), Positives = 52/114 (45%), Gaps = 12/114 (10%)
Query: 218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLAR 277
           TE  MT   A          LN+ H N        +D+KP+NI ++    +K++DFG+AR
Sbjct: 109 TEGPMTPKRAIEVIADACQALNFSHQNG----IIHRDVKPANIMISATNAVKVMDFGIAR 164
Query: 278 PTEN------EMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIM-EML-GTPP 323
              +      +    + T  Y +PE         ++D++ L  ++ E+L G PP
Sbjct: 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 89/194 (45%), Gaps = 17/194 (8%)
Query: 51  HDHFNQPYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKR 110
           HDH    Y        ++   + K SF  +   A D      VA+K +    +   H ++
Sbjct: 92  HDHVAYRY--------EVLKVIGKGSFGQVVK-AYDHKVHQHVALKMVRN--EKRFH-RQ 139
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRT---QKLSD 167
              E+R+L+H+  ++    ++V H         ++ M   L+  +L  +++    Q  S 
Sbjct: 140 AAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSL 199
Query: 168 DHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE--LKILDFGLARPTENEMTGY 225
             V+   + IL+ L  +H   IIH DLKP NI + +     +K++DFG +      +   
Sbjct: 200 PLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTX 259
Query: 226 VATRWYRAPEIMLN 239
           + +R+YRAPE++L 
Sbjct: 260 IQSRFYRAPEVILG 273

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 74/143 (51%), Gaps = 13/143 (9%)
Query: 111 TYRELRMLKHMN-HENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSD 167
           T +E+ +L+ ++ H N+I L D + +NT        ++V  LM  G   + +     LS+
Sbjct: 57  TLKEVDILRKVSGHPNIIQLKDTYETNTFF------FLVFDLMKKGELFDYLTEKVTLSE 110
Query: 168 DHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA---RPTENEMTG 224
              + ++  +L  +  +H   I+HRDLKP NI +++D  +K+ DFG +    P E ++  
Sbjct: 111 KETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLRE 169
Query: 225 YVATRWYRAPEIMLNWMHYNQTG 247
              T  Y APEI+   M+ N  G
Sbjct: 170 VCGTPSYLAPEIIECSMNDNHPG 192

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 69/158 (43%), Gaps = 34/158 (21%)
Query: 253 QDLKPSNIAVNEDCELKILDFGLA---RPTENEMTGYVATRWYRAPEIMLNWMHYN---- 305
           +DLKP NI +++D  +K+ DFG +    P E ++     T  Y APEI+   M+ N    
Sbjct: 135 RDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGY 193
Query: 306 --QTDIHQLNLIMEML--GTPP---AEFMAKISSDSARKYINSLPLL-----TKKDFRQV 353
             + D+    +IM  L  G+PP    + M  +    +  Y    P       T KD    
Sbjct: 194 GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSR 253
Query: 354 FKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQY 391
           F    PQ              KR TAE+ALAHP+  QY
Sbjct: 254 FLVVQPQ--------------KRYTAEEALAHPFFQQY 277

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 74/143 (51%), Gaps = 13/143 (9%)
Query: 111 TYRELRMLKHMN-HENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSD 167
           T +E+ +L+ ++ H N+I L D + +NT        ++V  LM  G   + +     LS+
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFF------FLVFDLMKKGELFDYLTEKVTLSE 123
Query: 168 DHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA---RPTENEMTG 224
              + ++  +L  +  +H   I+HRDLKP NI +++D  +K+ DFG +    P E ++  
Sbjct: 124 KETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLRE 182
Query: 225 YVATRWYRAPEIMLNWMHYNQTG 247
              T  Y APEI+   M+ N  G
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPG 205

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 69/158 (43%), Gaps = 34/158 (21%)
Query: 253 QDLKPSNIAVNEDCELKILDFGLA---RPTENEMTGYVATRWYRAPEIMLNWMHYN---- 305
           +DLKP NI +++D  +K+ DFG +    P E ++     T  Y APEI+   M+ N    
Sbjct: 148 RDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGY 206
Query: 306 --QTDIHQLNLIMEML--GTPP---AEFMAKISSDSARKYINSLPLL-----TKKDFRQV 353
             + D+    +IM  L  G+PP    + M  +    +  Y    P       T KD    
Sbjct: 207 GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSR 266
Query: 354 FKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQY 391
           F    PQ              KR TAE+ALAHP+  QY
Sbjct: 267 FLVVQPQ--------------KRYTAEEALAHPFFQQY 290

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/133 (25%), Positives = 64/133 (48%), Gaps = 8/133 (6%)
Query: 110 RTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQK-LSDD 168
           R  RE +    +NH  ++ + D   + T       + M  ++ G  L +I+ T+  ++  
Sbjct: 58  RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVM-EYVDGVTLRDIVHTEGPMTPK 116
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN------EM 222
               ++    + L + H  GIIHRD+KP+NI ++    +K++DFG+AR   +      + 
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 223 TGYVATRWYRAPE 235
              + T  Y +PE
Sbjct: 177 AAVIGTAQYLSPE 189

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/114 (27%), Positives = 52/114 (45%), Gaps = 12/114 (10%)
Query: 218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLAR 277
           TE  MT   A          LN+ H N        +D+KP+NI ++    +K++DFG+AR
Sbjct: 109 TEGPMTPKRAIEVIADACQALNFSHQNG----IIHRDVKPANIMISATNAVKVMDFGIAR 164
Query: 278 PTEN------EMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIM-EML-GTPP 323
              +      +    + T  Y +PE         ++D++ L  ++ E+L G PP
Sbjct: 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 86/192 (44%), Gaps = 30/192 (15%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLK 119
           EI R  + +   L +  F  ++    +  +  +VAIK + +P    +  +   +E +++K
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTT--RVAIKTL-KP--GTMSPEAFLQEAQVMK 68
Query: 120 HMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG---------ADLNNILRTQKLSDDHV 170
            + HE ++ L  V            +Y+VT  M           ++   LR  +L D   
Sbjct: 69  KLRHEKLVQLYAVVSEEP-------IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD--- 118
Query: 171 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE-NEMTGYVATR 229
             +  QI  G+ Y+     +HRDL+ +NI V E+   K+ DFGLAR  E NE T     +
Sbjct: 119 --MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 176
Query: 230 W---YRAPEIML 238
           +   + APE  L
Sbjct: 177 FPIKWTAPEAAL 188

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 86/192 (44%), Gaps = 30/192 (15%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLK 119
           EI R  + +   L +  F  ++    +  +  +VAIK + +P    +  +   +E +++K
Sbjct: 3   EIPRESLRLEVKLGQGCFGEVWMGTWNGTT--RVAIKTL-KP--GTMSPEAFLQEAQVMK 57
Query: 120 HMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG---------ADLNNILRTQKLSDDHV 170
            + HE ++ L  V            +Y+VT  M           ++   LR  +L D   
Sbjct: 58  KLRHEKLVQLYAVVSEEP-------IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD--- 107
Query: 171 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE-NEMTGYVATR 229
             +  QI  G+ Y+     +HRDL+ +NI V E+   K+ DFGLAR  E NE T     +
Sbjct: 108 --MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 165
Query: 230 W---YRAPEIML 238
           +   + APE  L
Sbjct: 166 FPIKWTAPEAAL 177

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 89/194 (45%), Gaps = 17/194 (8%)
Query: 51  HDHFNQPYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKR 110
           HDH    Y        ++   + K SF  +   A D      VA+K +    +   H ++
Sbjct: 92  HDHVAYRY--------EVLKVIGKGSFGQVVK-AYDHKVHQHVALKMVRN--EKRFH-RQ 139
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKL---SD 167
              E+R+L+H+  ++    ++V H         ++ M   L+  +L  +++  K    S 
Sbjct: 140 AAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSL 199
Query: 168 DHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE--LKILDFGLARPTENEMTGY 225
             V+   + IL+ L  +H   IIH DLKP NI + +     +K++DFG +      +   
Sbjct: 200 PLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTX 259
Query: 226 VATRWYRAPEIMLN 239
           + +R+YRAPE++L 
Sbjct: 260 IQSRFYRAPEVILG 273

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 34/133 (25%), Positives = 64/133 (48%), Gaps = 8/133 (6%)
Query: 110 RTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQK-LSDD 168
           R  RE +    +NH  ++ + D   + T       + M  ++ G  L +I+ T+  ++  
Sbjct: 58  RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVM-EYVDGVTLRDIVHTEGPMTPK 116
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN------EM 222
               ++    + L + H  GIIHRD+KP+NI ++    +K++DFG+AR   +      + 
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 223 TGYVATRWYRAPE 235
              + T  Y +PE
Sbjct: 177 AAVIGTAQYLSPE 189

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/114 (27%), Positives = 52/114 (45%), Gaps = 12/114 (10%)
Query: 218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLAR 277
           TE  MT   A          LN+ H N        +D+KP+NI ++    +K++DFG+AR
Sbjct: 109 TEGPMTPKRAIEVIADACQALNFSHQNG----IIHRDVKPANIMISATNAVKVMDFGIAR 164
Query: 278 PTEN------EMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIM-EML-GTPP 323
              +      +    + T  Y +PE         ++D++ L  ++ E+L G PP
Sbjct: 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 86/192 (44%), Gaps = 30/192 (15%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLK 119
           EI R  + +   L +  F  ++    +  +  +VAIK + +P    +  +   +E +++K
Sbjct: 5   EIPRESLRLEVKLGQGCFGEVWMGTWNGTT--RVAIKTL-KP--GTMSPEAFLQEAQVMK 59
Query: 120 HMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG---------ADLNNILRTQKLSDDHV 170
            + HE ++ L  V            +Y+VT  M           ++   LR  +L D   
Sbjct: 60  KLRHEKLVQLYAVVSEEP-------IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD--- 109
Query: 171 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE-NEMTGYVATR 229
             +  QI  G+ Y+     +HRDL+ +NI V E+   K+ DFGLAR  E NE T     +
Sbjct: 110 --MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 167
Query: 230 W---YRAPEIML 238
           +   + APE  L
Sbjct: 168 FPIKWTAPEAAL 179

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/177 (23%), Positives = 80/177 (45%), Gaps = 13/177 (7%)
Query: 71  TLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLL 130
            L +  F  +F+  + +   +    K   +  +     +    E ++L  ++   ++ L 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 131 DVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQ-----FLVYQILRGLKYIH 185
             F + T L       ++T + G D+   +      +   Q     F   QI+ GL+++H
Sbjct: 252 YAFETKTDL-----CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 186 SAGIIHRDLKPSNIAVNEDCELKILDFGLA---RPTENEMTGYVATRWYRAPEIMLN 239
              II+RDLKP N+ +++D  ++I D GLA   +  + +  GY  T  + APE++L 
Sbjct: 307 QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG 363

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/91 (27%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 235 EIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLA---RPTENEMTGYVATRW 291
           +I+    H +Q  +   ++DLKP N+ +++D  ++I D GLA   +  + +  GY  T  
Sbjct: 297 QIVSGLEHLHQRNI--IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 292 YRAPEIMLNWMHYNQTDIHQLNLIM-EMLGT 321
           + APE++L   +    D   L + + EM+  
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAA 385

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 67/134 (50%), Gaps = 13/134 (9%)
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQ-- 171
           E ++L  ++   ++ L   F + T L       ++T + G D+   +      +   Q  
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDL-----CLVMTIMNGGDIRYHIYNVDEDNPGFQEP 289
Query: 172 ---FLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA---RPTENEMTGY 225
              F   QI+ GL+++H   II+RDLKP N+ +++D  ++I D GLA   +  + +  GY
Sbjct: 290 RAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY 349
Query: 226 VATRWYRAPEIMLN 239
             T  + APE++L 
Sbjct: 350 AGTPGFMAPELLLG 363

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/91 (27%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 235 EIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLA---RPTENEMTGYVATRW 291
           +I+    H +Q  +   ++DLKP N+ +++D  ++I D GLA   +  + +  GY  T  
Sbjct: 297 QIVSGLEHLHQRNI--IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 292 YRAPEIMLNWMHYNQTDIHQLNLIM-EMLGT 321
           + APE++L   +    D   L + + EM+  
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAA 385

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 66/134 (49%), Gaps = 13/134 (9%)
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADL-----NNILRTQKLSDD 168
           E ++L  ++   ++ L   F + T L       ++T + G D+     N         + 
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDL-----CLVMTIMNGGDIRYHIYNVDEDNPGFQEP 289
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA---RPTENEMTGY 225
              F   QI+ GL+++H   II+RDLKP N+ +++D  ++I D GLA   +  + +  GY
Sbjct: 290 RAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY 349
Query: 226 VATRWYRAPEIMLN 239
             T  + APE++L 
Sbjct: 350 AGTPGFMAPELLLG 363

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/91 (27%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 235 EIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLA---RPTENEMTGYVATRW 291
           +I+    H +Q  +   ++DLKP N+ +++D  ++I D GLA   +  + +  GY  T  
Sbjct: 297 QIVSGLEHLHQRNI--IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 292 YRAPEIMLNWMHYNQTDIHQLNLIM-EMLGT 321
           + APE++L   +    D   L + + EM+  
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAA 385

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 67/134 (50%), Gaps = 13/134 (9%)
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQ-- 171
           E ++L  ++   ++ L   F + T L       ++T + G D+   +      +   Q  
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDL-----CLVMTIMNGGDIRYHIYNVDEDNPGFQEP 289
Query: 172 ---FLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA---RPTENEMTGY 225
              F   QI+ GL+++H   II+RDLKP N+ +++D  ++I D GLA   +  + +  GY
Sbjct: 290 RAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY 349
Query: 226 VATRWYRAPEIMLN 239
             T  + APE++L 
Sbjct: 350 AGTPGFMAPELLLG 363

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/91 (27%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 235 EIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLA---RPTENEMTGYVATRW 291
           +I+    H +Q  +   ++DLKP N+ +++D  ++I D GLA   +  + +  GY  T  
Sbjct: 297 QIVSGLEHLHQRNI--IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 292 YRAPEIMLNWMHYNQTDIHQLNLIM-EMLGT 321
           + APE++L   +    D   L + + EM+  
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAA 385

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 82/177 (46%), Gaps = 18/177 (10%)
Query: 75  ESFDLIFSSALDSVSGVKVAIKKIARPFQSA--VHAKRTY-------RELRMLKHMNHEN 125
           E +DL+ +    +   V++A+ ++     +   V  KR         +E+ +   +NHEN
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHEN 66
Query: 126 VIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIH 185
           V+     F+ +    + + +++     G   + I     + +   Q   +Q++ G+ Y+H
Sbjct: 67  VVK----FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 186 SAGIIHRDLKPSNIAVNEDCELKILDFGLA-----RPTENEMTGYVATRWYRAPEIM 237
             GI HRD+KP N+ ++E   LKI DFGLA        E  +     T  Y APE++
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 85/185 (45%), Gaps = 16/185 (8%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLK 119
           EI R  + +   L +  F  ++    +  +  +VAIK + +P    +  +   +E +++K
Sbjct: 11  EIPRESLRLEVKLGQGCFGEVWMGTWNGTT--RVAIKTL-KP--GTMSPEAFLQEAQVMK 65
Query: 120 HMNHENVIGLLDVFHSNTC--LADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQI 177
            + HE ++ L  V        + ++ N   +   +  +    LR  +L D     +  QI
Sbjct: 66  KLRHEKLVQLYAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVD-----MSAQI 120
Query: 178 LRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE-NEMTGYVATRW---YRA 233
             G+ Y+     +HRDL+ +NI V E+   K+ DFGLAR  E NE T     ++   + A
Sbjct: 121 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTA 180
Query: 234 PEIML 238
           PE  L
Sbjct: 181 PEAAL 185

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 86/192 (44%), Gaps = 30/192 (15%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLK 119
           EI R  + +   L +  F  ++    +  +  +VAIK + +P    +  +   +E +++K
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTT--RVAIKTL-KP--GTMSPEAFLQEAQVMK 68
Query: 120 HMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG---------ADLNNILRTQKLSDDHV 170
            + HE ++ L  V            +Y+VT  M           ++   LR  +L D   
Sbjct: 69  KIRHEKLVQLYAVVSEEP-------IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD--- 118
Query: 171 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE-NEMTGYVATR 229
             +  QI  G+ Y+     +HRDL+ +NI V E+   K+ DFGLAR  E NE T     +
Sbjct: 119 --MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 176
Query: 230 W---YRAPEIML 238
           +   + APE  L
Sbjct: 177 FPIKWTAPEAAL 188

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 34/217 (15%)
Query: 35  RLWTVYPASKLPSRRLHDHFNQPYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVA 94
           RL  V P SK  ++ L     +   EI R  + +   L +  F  ++    +  +  +VA
Sbjct: 160 RLTNVCPTSKPQTQGLA----KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTT--RVA 213
Query: 95  IKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG- 153
           IK + +P   +  A    +E +++K + HE ++ L  V          + +Y+VT  M  
Sbjct: 214 IKTL-KPGNMSPEA--FLQEAQVMKKLRHEKLVQLYAVVSE-------EPIYIVTEYMSK 263
Query: 154 --------ADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
                    ++   LR  +L D     +  QI  G+ Y+     +HRDL+ +NI V E+ 
Sbjct: 264 GSLLDFLKGEMGKYLRLPQLVD-----MAAQIASGMAYVERMNYVHRDLRAANILVGENL 318
Query: 206 ELKILDFGLARPTE-NEMTGYVATRW---YRAPEIML 238
             K+ DFGL R  E NE T     ++   + APE  L
Sbjct: 319 VCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAAL 355

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/133 (25%), Positives = 64/133 (48%), Gaps = 8/133 (6%)
Query: 110 RTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQK-LSDD 168
           R  RE +    +NH  ++ + D   + T       + M  ++ G  L +I+ T+  ++  
Sbjct: 58  RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVM-EYVDGVTLRDIVHTEGPMTPK 116
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN------EM 222
               ++    + L + H  GIIHRD+KP+NI ++    +K++DFG+AR   +      + 
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQT 176
Query: 223 TGYVATRWYRAPE 235
              + T  Y +PE
Sbjct: 177 AAVIGTAQYLSPE 189

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 31/114 (27%), Positives = 52/114 (45%), Gaps = 12/114 (10%)
Query: 218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLAR 277
           TE  MT   A          LN+ H N        +D+KP+NI ++    +K++DFG+AR
Sbjct: 109 TEGPMTPKRAIEVIADACQALNFSHQNG----IIHRDVKPANILISATNAVKVVDFGIAR 164
Query: 278 PTEN------EMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIM-EML-GTPP 323
              +      +    + T  Y +PE         ++D++ L  ++ E+L G PP
Sbjct: 165 AIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 36/136 (26%), Positives = 69/136 (50%), Gaps = 5/136 (3%)
Query: 109 KRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKL--- 165
           ++   E+R+L+H+  ++    ++V H         ++ M   L+  +L  +++  K    
Sbjct: 138 RQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGF 197
Query: 166 SDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE--LKILDFGLARPTENEMT 223
           S   V+   + IL+ L  +H   IIH DLKP NI + +     +K++DFG +      + 
Sbjct: 198 SLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY 257
Query: 224 GYVATRWYRAPEIMLN 239
             + +R+YRAPE++L 
Sbjct: 258 XXIQSRFYRAPEVILG 273

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/172 (22%), Positives = 83/172 (48%), Gaps = 10/172 (5%)
Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I   A +  SG +VA+K +    +     +  + E+ +++   H NV+ +   +     L
Sbjct: 60  IVCLAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY-----L 112
Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
              +   ++  L G  L +I+   +L+++ +  +   +L+ L Y+H+ G+IHRD+K  +I
Sbjct: 113 VGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSI 172
Query: 200 AVNEDCELKILDFGLARPTENEM---TGYVATRWYRAPEIMLNWMHYNQTGV 248
            +  D  +K+ DFG       ++      V T ++ APE++   ++  +  +
Sbjct: 173 LLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEVDI 224

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 70/157 (44%), Gaps = 30/157 (19%)
Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEM---TGYVATRWYRAPEIMLNWMHYNQTDI 309
           +D+K  +I +  D  +K+ DFG       ++      V T ++ APE++   ++  + DI
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEVDI 224
Query: 310 HQLN-LIMEML-GTPP------AEFMAKISSDSARKYINS---LPLLTKKDFRQVFKGAN 358
             L  +++EM+ G PP       + M ++      K  NS    P+L  +DF +     +
Sbjct: 225 WSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVL--RDFLERMLVRD 282
Query: 359 PQAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPN 395
           PQ              +R TA++ L HP+L Q   P 
Sbjct: 283 PQ--------------ERATAQELLDHPFLLQTGLPE 305

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 85/185 (45%), Gaps = 16/185 (8%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLK 119
           EI R  + +   L +  F  ++    +  +  +VAIK + +P    +  +   +E +++K
Sbjct: 11  EIPRESLRLEVKLGQGCFGEVWMGTWNGTT--RVAIKTL-KP--GTMSPEAFLQEAQVMK 65
Query: 120 HMNHENVIGLLDVFHSNTC--LADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQI 177
            + HE ++ L  V        + ++ N   +   +  +    LR  +L D     +  QI
Sbjct: 66  KLRHEKLVQLYAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVD-----MSAQI 120
Query: 178 LRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE-NEMTGYVATRW---YRA 233
             G+ Y+     +HRDL+ +NI V E+   K+ DFGLAR  E NE T     ++   + A
Sbjct: 121 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 180
Query: 234 PEIML 238
           PE  L
Sbjct: 181 PEAAL 185

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 86/185 (46%), Gaps = 16/185 (8%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLK 119
           EI R  + +   L +  F  ++    +  +  +VAIK + +P    +  +   +E +++K
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTT--RVAIKTL-KP--GTMSPEAFLQEAQVMK 68
Query: 120 HMNHENVIGLLDVFHSNTC--LADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQI 177
            + HE ++ L  V        + ++ +   +   +  ++   LR  +L D     +  QI
Sbjct: 69  KLRHEKLVQLYAVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVD-----MAAQI 123
Query: 178 LRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE-NEMTGYVATRW---YRA 233
             G+ Y+     +HRDL+ +NI V E+   K+ DFGLAR  E NE T     ++   + A
Sbjct: 124 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 183
Query: 234 PEIML 238
           PE  L
Sbjct: 184 PEAAL 188

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 82/174 (47%), Gaps = 17/174 (9%)
Query: 108 AKRTY-RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRT---Q 163
            +RT+ +E+++++ + H NV+  + V + +  L      ++  ++ G  L  I+++   Q
Sbjct: 50  TQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN-----FITEYIKGGTLRGIIKSMDSQ 104
Query: 164 KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT 223
                 V F    I  G+ Y+HS  IIHRDL   N  V E+  + + DFGLAR   +E T
Sbjct: 105 YPWSQRVSF-AKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163
Query: 224 GYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNI-AVNEDCELKILDFGLA 276
                R  + P+       Y   G P++   + P  I   + D ++ +  FG+ 
Sbjct: 164 QPEGLRSLKKPD---RKKRYTVVGNPYW---MAPEMINGRSYDEKVDVFSFGIV 211

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/133 (25%), Positives = 64/133 (48%), Gaps = 8/133 (6%)
Query: 110 RTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQK-LSDD 168
           R  RE +    +NH  ++ + D   + T       + M  ++ G  L +I+ T+  ++  
Sbjct: 75  RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVM-EYVDGVTLRDIVHTEGPMTPK 133
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN------EM 222
               ++    + L + H  GIIHRD+KP+NI ++    +K++DFG+AR   +      + 
Sbjct: 134 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 193
Query: 223 TGYVATRWYRAPE 235
              + T  Y +PE
Sbjct: 194 AAVIGTAQYLSPE 206

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 31/114 (27%), Positives = 52/114 (45%), Gaps = 12/114 (10%)
Query: 218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLAR 277
           TE  MT   A          LN+ H N        +D+KP+NI ++    +K++DFG+AR
Sbjct: 126 TEGPMTPKRAIEVIADACQALNFSHQNG----IIHRDVKPANIMISATNAVKVMDFGIAR 181
Query: 278 PTEN------EMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIM-EML-GTPP 323
              +      +    + T  Y +PE         ++D++ L  ++ E+L G PP
Sbjct: 182 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 235

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 89/210 (42%), Gaps = 37/210 (17%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIK---KIARPFQSAVHAKRTYRELR 116
           E  R  ++ G  L   +F  + ++    +S   V+I+   K+ +    +   +    EL+
Sbjct: 41  EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100
Query: 117 MLKHM-NHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRT--QKLSDDHVQF- 172
           M+  + +HEN++ LL       C        +  +    DL N LR+  +K S+D +++ 
Sbjct: 101 MMTQLGSHENIVNLL-----GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYE 155
Query: 173 ---------------------LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILD 211
                                  YQ+ +G++++     +HRDL   N+ V     +KI D
Sbjct: 156 NQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICD 215
Query: 212 FGLARPTENEMTGYVATRWYRAPEIMLNWM 241
           FGLAR   ++ + YV     R P   + WM
Sbjct: 216 FGLARDIMSD-SNYVVRGNARLP---VKWM 241

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 87/207 (42%), Gaps = 18/207 (8%)
Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN--VY 146
           +G +VA+K + +P     H     +E+ +L+++ HEN+     V +   C  D  N    
Sbjct: 49  TGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENI-----VKYKGICTEDGGNGIKL 102
Query: 147 MVTHLMGADLNNILRTQKLSDDHVQFLVY--QILRGLKYIHSAGIIHRDLKPSNIAVNED 204
           ++  L    L   L   K   +  Q L Y  QI +G+ Y+ S   +HRDL   N+ V  +
Sbjct: 103 IMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE 162
Query: 205 CELKILDFGLARPTENEMTGYVATR-------WYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            ++KI DFGL +  E +               WY APE ++    Y  + V  +   L  
Sbjct: 163 HQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLMQSKFYIASDVWSFGVTLHE 221
Query: 258 SNIAVNEDCELKILDFGLARPTENEMT 284
                + D     L   +  PT  +MT
Sbjct: 222 LLTYCDSDSSPMALFLKMIGPTHGQMT 248

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 45/204 (22%)
Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHEN- 125
           +I  TL + +F  +         G  VA+K I +       A R+  E+++L+H+N  + 
Sbjct: 17  EIVDTLGEGAFGKVVECIDHKAGGRHVAVK-IVKNVDRYCEAARS--EIQVLEHLNTTDP 73
Query: 126 -----VIGLLDVF--HSNTCLADFKNVYMVTHLMGADLNNILRTQKL---SDDHVQFLVY 175
                 + +L+ F  H + C+        V  L+G    + ++         DH++ + Y
Sbjct: 74  NSTFRCVQMLEWFEHHGHICI--------VFELLGLSTYDFIKENGFLPFRLDHIRKMAY 125
Query: 176 QILRGLKYIHSAGIIHRDLKPSNI---------------------AVNEDCELKILDFGL 214
           QI + + ++HS  + H DLKP NI                      +N D  +K++DFG 
Sbjct: 126 QICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD--IKVVDFGS 183
Query: 215 ARPTENEMTGYVATRWYRAPEIML 238
           A   +   +  V  R YRAPE++L
Sbjct: 184 ATYDDEHHSTLVXXRHYRAPEVIL 207

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 87/207 (42%), Gaps = 18/207 (8%)
Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN--VY 146
           +G +VA+K + +P     H     +E+ +L+++ HEN+     V +   C  D  N    
Sbjct: 37  TGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENI-----VKYKGICTEDGGNGIKL 90
Query: 147 MVTHLMGADLNNILRTQKLSDDHVQFLVY--QILRGLKYIHSAGIIHRDLKPSNIAVNED 204
           ++  L    L   L   K   +  Q L Y  QI +G+ Y+ S   +HRDL   N+ V  +
Sbjct: 91  IMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE 150
Query: 205 CELKILDFGLARPTENEMTGYVATR-------WYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            ++KI DFGL +  E +               WY APE ++    Y  + V  +   L  
Sbjct: 151 HQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLMQSKFYIASDVWSFGVTLHE 209
Query: 258 SNIAVNEDCELKILDFGLARPTENEMT 284
                + D     L   +  PT  +MT
Sbjct: 210 LLTYCDSDSSPMALFLKMIGPTHGQMT 236

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 72/149 (48%), Gaps = 10/149 (6%)
Query: 93  VAIKKIARPF-QSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHL 151
           VAIKK++    QS    +   +E+R L+ + H N I          C       ++V   
Sbjct: 82  VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI------QYRGCYLREHTAWLVMEY 135
Query: 152 MGADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKI 209
                +++L   K  L +  +  + +  L+GL Y+HS  +IHRD+K  NI ++E   +K+
Sbjct: 136 CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKL 195
Query: 210 LDFGLARPTENEMTGYVATRWYRAPEIML 238
            DFG A         +V T ++ APE++L
Sbjct: 196 GDFGSAS-IMAPANXFVGTPYWMAPEVIL 223

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 85/192 (44%), Gaps = 30/192 (15%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLK 119
           EI R  + +   L +  F  ++    +  +  +VAIK + +P    +  +   +E +++K
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTT--RVAIKTL-KP--GTMSPEAFLQEAQVMK 68
Query: 120 HMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG---------ADLNNILRTQKLSDDHV 170
            + HE ++ L  V            +Y+VT  M           ++   LR  +L D   
Sbjct: 69  KLRHEKLVQLYAVVSEEP-------IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD--- 118
Query: 171 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE-NEMTGYVATR 229
             +  QI  G+ Y+     +HRDL  +NI V E+   K+ DFGLAR  E NE T     +
Sbjct: 119 --MAAQIASGMAYVERMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 176
Query: 230 W---YRAPEIML 238
           +   + APE  L
Sbjct: 177 FPIKWTAPEAAL 188

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 86/171 (50%), Gaps = 25/171 (14%)
Query: 92  KVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHL 151
           KVAIK+I    +         +E++ +   +H N++     ++++  + D   +++V  L
Sbjct: 37  KVAIKRINLE-KCQTSMDELLKEIQAMSQCHHPNIVS----YYTSFVVKD--ELWLVMKL 89
Query: 152 M-GADLNNILR---------TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           + G  + +I++         +  L +  +  ++ ++L GL+Y+H  G IHRD+K  NI +
Sbjct: 90  LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL 149
Query: 202 NEDCELKILDFGLAR--PTENEMT------GYVATRWYRAPEIMLNWMHYN 244
            ED  ++I DFG++    T  ++T       +V T  + APE+M     Y+
Sbjct: 150 GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYD 200

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 86/171 (50%), Gaps = 25/171 (14%)
Query: 92  KVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHL 151
           KVAIK+I    +         +E++ +   +H N++     ++++  + D   +++V  L
Sbjct: 42  KVAIKRINLE-KCQTSMDELLKEIQAMSQCHHPNIVS----YYTSFVVKD--ELWLVMKL 94
Query: 152 M-GADLNNILR---------TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           + G  + +I++         +  L +  +  ++ ++L GL+Y+H  G IHRD+K  NI +
Sbjct: 95  LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL 154
Query: 202 NEDCELKILDFGLAR--PTENEMT------GYVATRWYRAPEIMLNWMHYN 244
            ED  ++I DFG++    T  ++T       +V T  + APE+M     Y+
Sbjct: 155 GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYD 205

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 75/155 (48%), Gaps = 18/155 (11%)
Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
            KVA+K +    Q ++       E  ++K + H+ ++ L  V          + +Y++T 
Sbjct: 46  TKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-------EPIYIITE 95
Query: 151 LM-GADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE 206
            M    L + L+T    KL+ + +  +  QI  G+ +I     IHRDL+ +NI V++   
Sbjct: 96  YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS 155
Query: 207 LKILDFGLARPTE-NEMTGYVATRW---YRAPEIM 237
            KI DFGLAR  E NE T     ++   + APE +
Sbjct: 156 CKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI 190

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 75/155 (48%), Gaps = 18/155 (11%)
Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
            KVA+K +    Q ++       E  ++K + H+ ++ L  V          + +Y++T 
Sbjct: 44  TKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-------EPIYIITE 93
Query: 151 LM-GADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE 206
            M    L + L+T    KL+ + +  +  QI  G+ +I     IHRDL+ +NI V++   
Sbjct: 94  YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS 153
Query: 207 LKILDFGLARPTE-NEMTGYVATRW---YRAPEIM 237
            KI DFGLAR  E NE T     ++   + APE +
Sbjct: 154 CKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI 188

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 86/185 (46%), Gaps = 16/185 (8%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLK 119
           EI R  + +   L +  F  ++    +  +  +VAIK + +P    +  +   +E +++K
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTT--RVAIKTL-KP--GTMSPEAFLQEAQVMK 68
Query: 120 HMNHENVIGLLDVFHSNTC--LADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQI 177
            + HE ++ L  V        + ++ +   +   +  ++   LR  +L D     +  QI
Sbjct: 69  KLRHEKLVQLYAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVD-----MAAQI 123
Query: 178 LRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE-NEMTGYVATRW---YRA 233
             G+ Y+     +HRDL+ +NI V E+   K+ DFGLAR  E NE T     ++   + A
Sbjct: 124 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTA 183
Query: 234 PEIML 238
           PE  L
Sbjct: 184 PEAAL 188

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 85/192 (44%), Gaps = 30/192 (15%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLK 119
           EI R  + +   L +  F  ++    +  +  +VAIK + +P    +  +   +E +++K
Sbjct: 7   EIPRESLRLEVKLGQGCFGEVWMGTWNGTT--RVAIKTL-KP--GTMSPEAFLQEAQVMK 61
Query: 120 HMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG---------ADLNNILRTQKLSDDHV 170
            + HE ++ L  V            +Y+VT  M           +    LR  +L D   
Sbjct: 62  KLRHEKLVQLYAVVSEEP-------IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD--- 111
Query: 171 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE-NEMTGYVATR 229
             +  QI  G+ Y+     +HRDL+ +NI V E+   K+ DFGLAR  E NE T     +
Sbjct: 112 --MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 169
Query: 230 W---YRAPEIML 238
           +   + APE  L
Sbjct: 170 FPIKWTAPEAAL 181

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 75/155 (48%), Gaps = 18/155 (11%)
Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
            KVA+K +    Q ++       E  ++K + H+ ++ L  V          + +Y++T 
Sbjct: 47  TKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-------EPIYIITE 96
Query: 151 LM-GADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE 206
            M    L + L+T    KL+ + +  +  QI  G+ +I     IHRDL+ +NI V++   
Sbjct: 97  YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS 156
Query: 207 LKILDFGLARPTE-NEMTGYVATRW---YRAPEIM 237
            KI DFGLAR  E NE T     ++   + APE +
Sbjct: 157 CKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI 191

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 80/201 (39%), Gaps = 30/201 (14%)
Query: 63  RGVIDIGP--TLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKH 120
           R + D  P   L +  F ++F  A + V     AIK+I  P +     K   RE++ L  
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFE-AKNKVDDCNYAIKRIRLPNRELAREK-VMREVKALAK 59
Query: 121 MNHENVIGLLDVFHSNTCLADFK----NVYMVTHLMGAD-------LNNILRTQKLSDDH 169
           + H  ++   + +         +     VY+   +           +N     ++     
Sbjct: 60  LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119
Query: 170 VQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR------------- 216
              +  QI   ++++HS G++HRDLKPSNI    D  +K+ DFGL               
Sbjct: 120 CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 217 --PTENEMTGYVATRWYRAPE 235
             P     TG V T+ Y +PE
Sbjct: 180 PMPAYARHTGQVGTKLYMSPE 200

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 51/111 (45%), Gaps = 15/111 (13%)
Query: 253 QDLKPSNIAVNEDCELKILDFGLAR---------------PTENEMTGYVATRWYRAPEI 297
           +DLKPSNI    D  +K+ DFGL                 P     TG V T+ Y +PE 
Sbjct: 142 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQ 201
Query: 298 MLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKK 348
           +    + ++ DI  L LI+  L  P +  M ++ + +  + +   PL T+K
Sbjct: 202 IHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQK 252

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 93/195 (47%), Gaps = 27/195 (13%)
Query: 79  LIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC 138
           L+   A      +K+  K++        H   T  E R+L++  H  +  L   F ++  
Sbjct: 28  LVREKATGRYYAMKILRKEVIIAKDEVAH---TVTESRVLQNTRHPFLTALKYAFQTHDR 84
Query: 139 LADFKNVYMVTHLMGADLN-NILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPS 197
           L      +++ +  G +L  ++ R +  +++  +F   +I+  L+Y+HS  +++RD+K  
Sbjct: 85  LC-----FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLE 139
Query: 198 NIAVNEDCELKILDFGLARPTENE---MTGYVATRWYRAPEIM--------LNW------ 240
           N+ +++D  +KI DFGL +   ++   M  +  T  Y APE++        ++W      
Sbjct: 140 NLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVV 199
Query: 241 MHYNQTG-VPFYFQD 254
           M+    G +PFY QD
Sbjct: 200 MYEMMCGRLPFYNQD 214

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 93/195 (47%), Gaps = 27/195 (13%)
Query: 79  LIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC 138
           L+   A      +K+  K++        H   T  E R+L++  H  +  L   F ++  
Sbjct: 23  LVREKATGRYYAMKILRKEVIIAKDEVAH---TVTESRVLQNTRHPFLTALKYAFQTHDR 79
Query: 139 LADFKNVYMVTHLMGADLN-NILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPS 197
           L      +++ +  G +L  ++ R +  +++  +F   +I+  L+Y+HS  +++RD+K  
Sbjct: 80  LC-----FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLE 134
Query: 198 NIAVNEDCELKILDFGLARPTENE---MTGYVATRWYRAPEIM--------LNW------ 240
           N+ +++D  +KI DFGL +   ++   M  +  T  Y APE++        ++W      
Sbjct: 135 NLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVV 194
Query: 241 MHYNQTG-VPFYFQD 254
           M+    G +PFY QD
Sbjct: 195 MYEMMCGRLPFYNQD 209

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 93/195 (47%), Gaps = 27/195 (13%)
Query: 79  LIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC 138
           L+   A      +K+  K++        H   T  E R+L++  H  +  L   F ++  
Sbjct: 23  LVREKATGRYYAMKILRKEVIIAKDEVAH---TVTESRVLQNTRHPFLTALKYAFQTHDR 79
Query: 139 LADFKNVYMVTHLMGADLN-NILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPS 197
           L      +++ +  G +L  ++ R +  +++  +F   +I+  L+Y+HS  +++RD+K  
Sbjct: 80  LC-----FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLE 134
Query: 198 NIAVNEDCELKILDFGLARPTENE---MTGYVATRWYRAPEIM--------LNW------ 240
           N+ +++D  +KI DFGL +   ++   M  +  T  Y APE++        ++W      
Sbjct: 135 NLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVV 194
Query: 241 MHYNQTG-VPFYFQD 254
           M+    G +PFY QD
Sbjct: 195 MYEMMCGRLPFYNQD 209

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 93/195 (47%), Gaps = 27/195 (13%)
Query: 79  LIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC 138
           L+   A      +K+  K++        H   T  E R+L++  H  +  L   F ++  
Sbjct: 23  LVREKATGRYYAMKILRKEVIIAKDEVAH---TVTESRVLQNTRHPFLTALKYAFQTHDR 79
Query: 139 LADFKNVYMVTHLMGADLN-NILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPS 197
           L      +++ +  G +L  ++ R +  +++  +F   +I+  L+Y+HS  +++RD+K  
Sbjct: 80  LC-----FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLE 134
Query: 198 NIAVNEDCELKILDFGLARPTENE---MTGYVATRWYRAPEIM--------LNW------ 240
           N+ +++D  +KI DFGL +   ++   M  +  T  Y APE++        ++W      
Sbjct: 135 NLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVV 194
Query: 241 MHYNQTG-VPFYFQD 254
           M+    G +PFY QD
Sbjct: 195 MYEMMCGRLPFYNQD 209

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 86/185 (46%), Gaps = 16/185 (8%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLK 119
           EI R  + +   L +  F  ++    +  +  +VAIK + +P    +  +   +E +++K
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTT--RVAIKTL-KP--GTMSPEAFLQEAQVMK 68
Query: 120 HMNHENVIGLLDVFHSNTC--LADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQI 177
            + HE ++ L  V        + ++ +   +   +  ++   LR  +L D     +  QI
Sbjct: 69  KLRHEKLVQLYAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVD-----MAAQI 123
Query: 178 LRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE-NEMTGYVATRW---YRA 233
             G+ Y+     +HRDL+ +NI V E+   K+ DFGLAR  E NE T     ++   + A
Sbjct: 124 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 183
Query: 234 PEIML 238
           PE  L
Sbjct: 184 PEAAL 188

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 93/195 (47%), Gaps = 27/195 (13%)
Query: 79  LIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC 138
           L+   A      +K+  K++        H   T  E R+L++  H  +  L   F ++  
Sbjct: 26  LVREKATGRYYAMKILRKEVIIAKDEVAH---TVTESRVLQNTRHPFLTALKYAFQTHDR 82
Query: 139 LADFKNVYMVTHLMGADLN-NILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPS 197
           L      +++ +  G +L  ++ R +  +++  +F   +I+  L+Y+HS  +++RD+K  
Sbjct: 83  LC-----FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLE 137
Query: 198 NIAVNEDCELKILDFGLARPTENE---MTGYVATRWYRAPEIM--------LNW------ 240
           N+ +++D  +KI DFGL +   ++   M  +  T  Y APE++        ++W      
Sbjct: 138 NLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVV 197
Query: 241 MHYNQTG-VPFYFQD 254
           M+    G +PFY QD
Sbjct: 198 MYEMMCGRLPFYNQD 212

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 97/205 (47%), Gaps = 30/205 (14%)
Query: 72  LSKESFD---LIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIG 128
           L K +F    L+   A      +K+  K++        H   T  E R+L++  H  +  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAH---TVTESRVLQNTRHPFLTA 69
Query: 129 LLDVFHSNTCLADFKNVYMVTHLMGADLN-NILRTQKLSDDHVQFLVYQILRGLKYIHSA 187
           L   F ++  L      +++ +  G +L  ++ R +  +++  +F   +I+  L+Y+HS 
Sbjct: 70  LKYAFQTHDRLC-----FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 188 GIIHRDLKPSNIAVNEDCELKILDFGLARPTENE---MTGYVATRWYRAPEIM------- 237
            +++RD+K  N+ +++D  +KI DFGL +   ++   M  +  T  Y APE++       
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 184
Query: 238 -LNW------MHYNQTG-VPFYFQD 254
            ++W      M+    G +PFY QD
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQD 209

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 87/187 (46%), Gaps = 19/187 (10%)
Query: 57  PYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELR 116
           P  EI R  I +   L    F  ++    ++ +  KVA+K + +P   +V A     E  
Sbjct: 5   PAWEIPRESIKLVKKLGAGQFGEVWMGYYNNST--KVAVKTL-KPGTMSVQA--FLEEAN 59
Query: 117 MLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDDHVQFLV- 174
           ++K + H+ ++ L  V          + +Y++T  M    L + L++ +     +  L+ 
Sbjct: 60  LMKTLQHDKLVRLYAVVTKE------EPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLID 113
Query: 175 --YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE-NEMTGYVATRW- 230
              QI  G+ YI     IHRDL+ +N+ V+E    KI DFGLAR  E NE T     ++ 
Sbjct: 114 FSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP 173
Query: 231 --YRAPE 235
             + APE
Sbjct: 174 IKWTAPE 180

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 75/155 (48%), Gaps = 18/155 (11%)
Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
            KVA+K +    Q ++       E  ++K + H+ ++ L  V          + +Y++T 
Sbjct: 38  TKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-------EPIYIITE 87
Query: 151 LM-GADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE 206
            M    L + L+T    KL+ + +  +  QI  G+ +I     IHRDL+ +NI V++   
Sbjct: 88  YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS 147
Query: 207 LKILDFGLARPTE-NEMTGYVATRW---YRAPEIM 237
            KI DFGLAR  E NE T     ++   + APE +
Sbjct: 148 CKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI 182

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 72/149 (48%), Gaps = 10/149 (6%)
Query: 93  VAIKKIARPF-QSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHL 151
           VAIKK++    QS    +   +E+R L+ + H N I          C       ++V   
Sbjct: 43  VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI------QYRGCYLREHTAWLVMEY 96
Query: 152 MGADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKI 209
                +++L   K  L +  +  + +  L+GL Y+HS  +IHRD+K  NI ++E   +K+
Sbjct: 97  CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKL 156
Query: 210 LDFGLARPTENEMTGYVATRWYRAPEIML 238
            DFG A         +V T ++ APE++L
Sbjct: 157 GDFGSA-SIMAPANXFVGTPYWMAPEVIL 184

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 93/195 (47%), Gaps = 27/195 (13%)
Query: 79  LIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC 138
           L+   A      +K+  K++        H   T  E R+L++  H  +  L   F ++  
Sbjct: 23  LVREKATGRYYAMKILRKEVIIAKDEVAH---TVTESRVLQNTRHPFLTALKYAFQTHDR 79
Query: 139 LADFKNVYMVTHLMGADLN-NILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPS 197
           L      +++ +  G +L  ++ R +  +++  +F   +I+  L+Y+HS  +++RD+K  
Sbjct: 80  LC-----FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLE 134
Query: 198 NIAVNEDCELKILDFGLARPTENE---MTGYVATRWYRAPEIM--------LNW------ 240
           N+ +++D  +KI DFGL +   ++   M  +  T  Y APE++        ++W      
Sbjct: 135 NLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVV 194
Query: 241 MHYNQTG-VPFYFQD 254
           M+    G +PFY QD
Sbjct: 195 MYEMMCGRLPFYNQD 209

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 75/154 (48%), Gaps = 18/154 (11%)
Query: 92  KVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHL 151
           KVA+K +    Q ++       E  ++K + H+ ++ L  V          + +Y++T  
Sbjct: 40  KVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-------EPIYIITEY 89
Query: 152 M-GADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
           M    L + L+T    KL+ + +  +  QI  G+ +I     IHRDL+ +NI V++    
Sbjct: 90  MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSC 149
Query: 208 KILDFGLARPTE-NEMTGYVATRW---YRAPEIM 237
           KI DFGLAR  E NE T     ++   + APE +
Sbjct: 150 KIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI 183

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 75/155 (48%), Gaps = 18/155 (11%)
Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
            KVA+K +    Q ++       E  ++K + H+ ++ L  V          + +Y++T 
Sbjct: 40  TKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-------EPIYIITE 89
Query: 151 LM-GADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE 206
            M    L + L+T    KL+ + +  +  QI  G+ +I     IHRDL+ +NI V++   
Sbjct: 90  YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS 149
Query: 207 LKILDFGLARPTE-NEMTGYVATRW---YRAPEIM 237
            KI DFGLAR  E NE T     ++   + APE +
Sbjct: 150 CKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI 184

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/130 (25%), Positives = 69/130 (53%), Gaps = 10/130 (7%)
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRT--QKLSDDHVQ 171
           E+ +L   +H  ++ LL  ++      D K   M+    G  ++ I+    + L++  +Q
Sbjct: 58  EIEILATCDHPYIVKLLGAYYH-----DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ 112
Query: 172 FLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR---PTENEMTGYVAT 228
            +  Q+L  L ++HS  IIHRDLK  N+ +  + ++++ DFG++     T  +   ++ T
Sbjct: 113 VVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGT 172
Query: 229 RWYRAPEIML 238
            ++ APE+++
Sbjct: 173 PYWMAPEVVM 182

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 85/185 (45%), Gaps = 16/185 (8%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLK 119
           EI R  + +   L +  F  ++    +  +  +VAIK + +P    +  +   +E +++K
Sbjct: 4   EIPRESLRLEVKLGQGCFGEVWMGTWNGTT--RVAIKTL-KP--GTMSPEAFLQEAQVMK 58
Query: 120 HMNHENVIGLLDVFHSN--TCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQI 177
            + HE ++ L  V        + ++ +   +   +  +    LR  +L D     +  QI
Sbjct: 59  KLRHEKLVQLYAVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVD-----MAAQI 113
Query: 178 LRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE-NEMTGYVATRW---YRA 233
             G+ Y+     +HRDL+ +NI V E+   K+ DFGLAR  E NE T     ++   + A
Sbjct: 114 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTA 173
Query: 234 PEIML 238
           PE  L
Sbjct: 174 PEAAL 178

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 75/155 (48%), Gaps = 18/155 (11%)
Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
            KVA+K +    Q ++       E  ++K + H+ ++ L  V          + +Y++T 
Sbjct: 48  TKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-------EPIYIITE 97
Query: 151 LM-GADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE 206
            M    L + L+T    KL+ + +  +  QI  G+ +I     IHRDL+ +NI V++   
Sbjct: 98  YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS 157
Query: 207 LKILDFGLARPTE-NEMTGYVATRW---YRAPEIM 237
            KI DFGLAR  E NE T     ++   + APE +
Sbjct: 158 CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 192

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 75/154 (48%), Gaps = 18/154 (11%)
Query: 92  KVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHL 151
           KVA+K +    Q ++       E  ++K + H+ ++ L  V          + +Y++T  
Sbjct: 39  KVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-------EPIYIITEY 88
Query: 152 M-GADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
           M    L + L+T    KL+ + +  +  QI  G+ +I     IHRDL+ +NI V++    
Sbjct: 89  MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSC 148
Query: 208 KILDFGLARPTE-NEMTGYVATRW---YRAPEIM 237
           KI DFGLAR  E NE T     ++   + APE +
Sbjct: 149 KIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI 182

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 75/155 (48%), Gaps = 18/155 (11%)
Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
            KVA+K +    Q ++       E  ++K + H+ ++ L  V          + +Y++T 
Sbjct: 43  TKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-------EPIYIITE 92
Query: 151 LM-GADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE 206
            M    L + L+T    KL+ + +  +  QI  G+ +I     IHRDL+ +NI V++   
Sbjct: 93  YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS 152
Query: 207 LKILDFGLARPTE-NEMTGYVATRW---YRAPEIM 237
            KI DFGLAR  E NE T     ++   + APE +
Sbjct: 153 CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 187

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 91/202 (45%), Gaps = 24/202 (11%)
Query: 52  DHFNQPYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRT 111
           D+F   Y +I + +   G  +  E +D++      +   V++   K ++     V+A + 
Sbjct: 54  DNFLNRYEKIVKKIR--GLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQ----KVYAMKL 107
Query: 112 YRELRMLKHMN------HENVIGLLD---VFHSNTCLADFKNVYMVTHLM-GADLNNILR 161
             +  M+K  +        +++   +   V        D K +YMV   M G DL N++ 
Sbjct: 108 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMS 167
Query: 162 TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE 221
              + +   +F   +++  L  IHS G+IHRD+KP N+ +++   LK+ DFG     +  
Sbjct: 168 NYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE- 226
Query: 222 MTGY------VATRWYRAPEIM 237
            TG       V T  Y +PE++
Sbjct: 227 -TGMVHCDTAVGTPDYISPEVL 247

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 75/155 (48%), Gaps = 18/155 (11%)
Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
            KVA+K +    Q ++       E  ++K + H+ ++ L  V          + +Y++T 
Sbjct: 44  TKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-------EPIYIITE 93
Query: 151 LM-GADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE 206
            M    L + L+T    KL+ + +  +  QI  G+ +I     IHRDL+ +NI V++   
Sbjct: 94  YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS 153
Query: 207 LKILDFGLARPTE-NEMTGYVATRW---YRAPEIM 237
            KI DFGLAR  E NE T     ++   + APE +
Sbjct: 154 CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 188

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/130 (25%), Positives = 69/130 (53%), Gaps = 10/130 (7%)
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRT--QKLSDDHVQ 171
           E+ +L   +H  ++ LL  ++      D K   M+    G  ++ I+    + L++  +Q
Sbjct: 66  EIEILATCDHPYIVKLLGAYYH-----DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ 120
Query: 172 FLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR---PTENEMTGYVAT 228
            +  Q+L  L ++HS  IIHRDLK  N+ +  + ++++ DFG++     T  +   ++ T
Sbjct: 121 VVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGT 180
Query: 229 RWYRAPEIML 238
            ++ APE+++
Sbjct: 181 PYWMAPEVVM 190

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 75/154 (48%), Gaps = 18/154 (11%)
Query: 92  KVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHL 151
           KVA+K +    Q ++       E  ++K + H+ ++ L  V          + +Y++T  
Sbjct: 39  KVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-------EPIYIITEY 88
Query: 152 M-GADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
           M    L + L+T    KL+ + +  +  QI  G+ +I     IHRDL+ +NI V++    
Sbjct: 89  MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSC 148
Query: 208 KILDFGLARPTE-NEMTGYVATRW---YRAPEIM 237
           KI DFGLAR  E NE T     ++   + APE +
Sbjct: 149 KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 90/224 (40%), Gaps = 29/224 (12%)
Query: 37  WTVYPASKLPSRRLHDHFNQPYSE---ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKV 93
           W +  + +  S    D    PY+E     R  +  G TL   +F  +  +    +     
Sbjct: 8   WKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDA 67
Query: 94  AIKKIARPFQSAVHAKRT---YRELRMLKHMN-HENVIGLLDVFHSNTCLADFKNVYMVT 149
            +K   +  +S  HA        EL+++ H+  HEN++ LL       C      + +  
Sbjct: 68  VLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLL-----GACTHGGPVLVITE 122
Query: 150 HLMGADLNNILRTQKLSD------------DHVQFLVYQILRGLKYIHSAGIIHRDLKPS 197
           +    DL N LR +  +D            D + F   Q+ +G+ ++ S   IHRD+   
Sbjct: 123 YCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF-SSQVAQGMAFLASKNCIHRDVAAR 181
Query: 198 NIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM 241
           N+ +      KI DFGLAR   N+ + Y+     R P   + WM
Sbjct: 182 NVLLTNGHVAKIGDFGLARDIMND-SNYIVKGNARLP---VKWM 221

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 72/157 (45%), Gaps = 11/157 (7%)
Query: 86  DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV 145
           D  S   VA+K I R  +   + KR     R L+H    N++   +V  + T LA    +
Sbjct: 39  DKQSNELVAVKYIERGEKIDENVKREIINHRSLRH---PNIVRFKEVILTPTHLA----I 91
Query: 146 YMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED- 204
            M     G     I    + S+D  +F   Q++ G+ Y H+  + HRDLK  N  ++   
Sbjct: 92  VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 151
Query: 205 -CELKILDFGLARPT--ENEMTGYVATRWYRAPEIML 238
              LKI DFG ++ +   ++    V T  Y APE++L
Sbjct: 152 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 188

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 86/175 (49%), Gaps = 12/175 (6%)
Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIKKIAR-PFQSAVHAKRTYRELRMLKHMNHENV 126
           +G TL   +F  +       ++G KVA+K + R   +S     +  RE++ LK   H ++
Sbjct: 15  LGDTLGVGTFGKV-KIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHI 73
Query: 127 IGLLDVFHSNTCLADFKNVYMVT-HLMGADL-NNILRTQKLSDDHVQFLVYQILRGLKYI 184
           I L  V  + T   DF   +MV  ++ G +L + I +  ++ +   + L  QIL  + Y 
Sbjct: 74  IKLYQVISTPT---DF---FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYC 127
Query: 185 HSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE--MTGYVATRWYRAPEIM 237
           H   ++HRDLKP N+ ++     KI DFGL+    +   +     +  Y APE++
Sbjct: 128 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVI 182

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 74/152 (48%), Gaps = 18/152 (11%)
Query: 92  KVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHL 151
           KVA+K +    Q ++       E  ++K + H+ ++ L  V          + +Y++T  
Sbjct: 34  KVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-------EPIYIITEY 83
Query: 152 M-GADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
           M    L + L+T    KL+ + +  +  QI  G+ +I     IHRDL+ +NI V++    
Sbjct: 84  MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSC 143
Query: 208 KILDFGLARPTE-NEMTGYVATRW---YRAPE 235
           KI DFGLAR  E NE T     ++   + APE
Sbjct: 144 KIADFGLARLIEDNEYTAREGAKFPIKWTAPE 175

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 86/175 (49%), Gaps = 12/175 (6%)
Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIKKIAR-PFQSAVHAKRTYRELRMLKHMNHENV 126
           +G TL   +F  +       ++G KVA+K + R   +S     +  RE++ LK   H ++
Sbjct: 15  LGDTLGVGTFGKV-KIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHI 73
Query: 127 IGLLDVFHSNTCLADFKNVYMVT-HLMGADL-NNILRTQKLSDDHVQFLVYQILRGLKYI 184
           I L  V  + T   DF   +MV  ++ G +L + I +  ++ +   + L  QIL  + Y 
Sbjct: 74  IKLYQVISTPT---DF---FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYC 127
Query: 185 HSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE--MTGYVATRWYRAPEIM 237
           H   ++HRDLKP N+ ++     KI DFGL+    +   +     +  Y APE++
Sbjct: 128 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVI 182

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 90/224 (40%), Gaps = 29/224 (12%)
Query: 37  WTVYPASKLPSRRLHDHFNQPYSE---ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKV 93
           W +  + +  S    D    PY+E     R  +  G TL   +F  +  +    +     
Sbjct: 16  WKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDA 75
Query: 94  AIKKIARPFQSAVHAKRT---YRELRMLKHMN-HENVIGLLDVFHSNTCLADFKNVYMVT 149
            +K   +  +S  HA        EL+++ H+  HEN++ LL       C      + +  
Sbjct: 76  VLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLL-----GACTHGGPVLVITE 130
Query: 150 HLMGADLNNILRTQKLSD------------DHVQFLVYQILRGLKYIHSAGIIHRDLKPS 197
           +    DL N LR +  +D            D + F   Q+ +G+ ++ S   IHRD+   
Sbjct: 131 YCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF-SSQVAQGMAFLASKNCIHRDVAAR 189
Query: 198 NIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM 241
           N+ +      KI DFGLAR   N+ + Y+     R P   + WM
Sbjct: 190 NVLLTNGHVAKIGDFGLARDIMND-SNYIVKGNARLP---VKWM 229

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 79/148 (53%), Gaps = 23/148 (15%)
Query: 114 ELRMLKHMNHENVIGLLD--VFHSNTCLADFKNVYMV-THLMGADLNNIL-----RTQKL 165
           E+ +L+ + H N++   D  +  +NT L      Y+V  +  G DL +++       Q L
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTL------YIVMEYCEGGDLASVITKGTKERQYL 108
Query: 166 SDDHVQFLVYQILRGLKYIH--SAG---IIHRDLKPSNIAVNEDCELKILDFGLARPTEN 220
            ++ V  ++ Q+   LK  H  S G   ++HRDLKP+N+ ++    +K+ DFGLAR   +
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 168
Query: 221 EMT---GYVATRWYRAPEIMLNWMHYNQ 245
           + +    +V T +Y +PE M N M YN+
Sbjct: 169 DTSFAKAFVGTPYYMSPEQM-NRMSYNE 195

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 50/97 (51%), Gaps = 13/97 (13%)
Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEMT---GYVATRWYRAPEIMLNWMHYNQ-TD 308
           +DLKP+N+ ++    +K+ DFGLAR   ++ +    +V T +Y +PE M N M YN+ +D
Sbjct: 140 RDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM-NRMSYNEKSD 198
Query: 309 IHQLNLIMEMLGT--PP------AEFMAKISSDSARK 337
           I  L  ++  L    PP       E   KI     R+
Sbjct: 199 IWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR 235

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 100/237 (42%), Gaps = 43/237 (18%)
Query: 46  PSRRLHDHFNQPYSEICRGVIDIGPTLSKESFDLIFSSA----LDSVSGVKVAIKKIARP 101
           P++  +DH      E  R  +  G TL   +F  +  +     + S + + VA+K + +P
Sbjct: 25  PTQLPYDH----KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KP 79
Query: 102 FQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNIL 160
                  +    EL++L ++ NH N++ LL       C      + +  +    DL N L
Sbjct: 80  SAHLTEREALMSELKVLSYLGNHMNIVNLL-----GACTIGGPTLVITEYCCYGDLLNFL 134
Query: 161 RTQKLS-------------------DDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           R ++ S                    + +    YQ+ +G+ ++ S   IHRDL   NI +
Sbjct: 135 RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 194
Query: 202 NEDCELKILDFGLARPTENEMTGYVA-------TRWYRAPEIMLNWMHYNQTGVPFY 251
                 KI DFGLAR  +N+ + YV         +W  APE + N ++  ++ V  Y
Sbjct: 195 THGRITKICDFGLARDIKND-SNYVVKGNARLPVKWM-APESIFNCVYTFESDVWSY 249

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 99/234 (42%), Gaps = 43/234 (18%)
Query: 46  PSRRLHDHFNQPYSEICRGVIDIGPTLSKESFDLIFSSA----LDSVSGVKVAIKKIARP 101
           P++  +DH      E  R  +  G TL   +F  +  +     + S + + VA+K + +P
Sbjct: 32  PTQLPYDH----KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KP 86
Query: 102 FQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNIL 160
                  +    EL++L ++ NH N++ LL       C      + +  +    DL N L
Sbjct: 87  SAHLTEREALMSELKVLSYLGNHMNIVNLL-----GACTIGGPTLVITEYCCYGDLLNFL 141
Query: 161 RTQKLS-------------------DDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           R ++ S                    + +    YQ+ +G+ ++ S   IHRDL   NI +
Sbjct: 142 RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 201
Query: 202 NEDCELKILDFGLARPTENEMTGYVA-------TRWYRAPEIMLNWMHYNQTGV 248
                 KI DFGLAR  +N+ + YV         +W  APE + N ++  ++ V
Sbjct: 202 THGRITKICDFGLARDIKND-SNYVVKGNARLPVKW-MAPESIFNCVYTFESDV 253

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 102/237 (43%), Gaps = 31/237 (13%)
Query: 10  GLELLETGRLLSRTLTDGTLSRS----IVRLWTVYPASKLPSRRLHDHFNQPYSEICRGV 65
           G ++ E G+++      GT+S +    +  +W  Y     P    HDH    Y       
Sbjct: 112 GYDVDEQGKIVR---GKGTVSSNYDNYVFDIWKQYYPQ--PVEIKHDHVLDHY------- 159
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHEN 125
            DI   L   +F ++     +  +G   A K +  P +S     R  +E++ +  + H  
Sbjct: 160 -DIHEELGTGAFGVVHR-VTERATGNNFAAKFVMTPHESDKETVR--KEIQTMSVLRHPT 215
Query: 126 VIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQ--KLSDDHVQFLVYQILRGLKY 183
           ++ L D F       D + V +   + G +L   +  +  K+S+D     + Q+ +GL +
Sbjct: 216 LVNLHDAFED-----DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCH 270
Query: 184 IHSAGIIHRDLKPSNI--AVNEDCELKILDFGLARPTENEMTGYV--ATRWYRAPEI 236
           +H    +H DLKP NI        ELK++DFGL    + + +  V   T  + APE+
Sbjct: 271 MHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 327

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 52/105 (49%), Gaps = 5/105 (4%)
Query: 138 CLADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKP 196
              D + +YMV   M G DL N++    + +   +F   +++  L  IHS G IHRD+KP
Sbjct: 142 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKP 201
Query: 197 SNIAVNEDCELKILDFGLARPTENE----MTGYVATRWYRAPEIM 237
            N+ +++   LK+ DFG       E        V T  Y +PE++
Sbjct: 202 DNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 246

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 102/237 (43%), Gaps = 31/237 (13%)
Query: 10  GLELLETGRLLSRTLTDGTLSRS----IVRLWTVYPASKLPSRRLHDHFNQPYSEICRGV 65
           G ++ E G+++      GT+S +    +  +W  Y     P    HDH    Y       
Sbjct: 6   GYDVDEQGKIVR---GKGTVSSNYDNYVFDIWKQYYPQ--PVEIKHDHVLDHY------- 53
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHEN 125
            DI   L   +F ++     +  +G   A K +  P +S     R  +E++ +  + H  
Sbjct: 54  -DIHEELGTGAFGVVHR-VTERATGNNFAAKFVMTPHESDKETVR--KEIQTMSVLRHPT 109
Query: 126 VIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQ--KLSDDHVQFLVYQILRGLKY 183
           ++ L D F  +  +     V +   + G +L   +  +  K+S+D     + Q+ +GL +
Sbjct: 110 LVNLHDAFEDDNEM-----VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCH 164
Query: 184 IHSAGIIHRDLKPSNI--AVNEDCELKILDFGLARPTENEMTGYV--ATRWYRAPEI 236
           +H    +H DLKP NI        ELK++DFGL    + + +  V   T  + APE+
Sbjct: 165 MHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 221

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 66/134 (49%), Gaps = 14/134 (10%)
Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
            KVA+K +    Q ++       E  ++K + H+ ++ L  V          + +Y++T 
Sbjct: 38  TKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-------EPIYIITE 87
Query: 151 LM-GADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE 206
            M    L + L+T    KL+ + +  +  QI  G+ +I     IHRDL+ +NI V++   
Sbjct: 88  YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS 147
Query: 207 LKILDFGLARPTEN 220
            KI DFGLAR  E+
Sbjct: 148 CKIADFGLARLIED 161

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 52/105 (49%), Gaps = 5/105 (4%)
Query: 138 CLADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKP 196
              D + +YMV   M G DL N++    + +   +F   +++  L  IHS G IHRD+KP
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKP 196
Query: 197 SNIAVNEDCELKILDFGLARPTENE----MTGYVATRWYRAPEIM 237
            N+ +++   LK+ DFG       E        V T  Y +PE++
Sbjct: 197 DNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 241

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 52/105 (49%), Gaps = 5/105 (4%)
Query: 138 CLADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKP 196
              D + +YMV   M G DL N++    + +   +F   +++  L  IHS G IHRD+KP
Sbjct: 142 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKP 201
Query: 197 SNIAVNEDCELKILDFGLARPTENE----MTGYVATRWYRAPEIM 237
            N+ +++   LK+ DFG       E        V T  Y +PE++
Sbjct: 202 DNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 246

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 94/223 (42%), Gaps = 39/223 (17%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSA----LDSVSGVKVAIKKIARPFQSAVHAKRTYREL 115
           E  R  +  G TL   +F  +  +     + S + + VA+K + +P       +    EL
Sbjct: 19  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALMSEL 77
Query: 116 RMLKHM-NHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLS-------- 166
           ++L ++ NH N++ LL       C      + +  +    DL N LR ++ S        
Sbjct: 78  KVLSYLGNHMNIVNLL-----GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132
Query: 167 -----------DDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 215
                       + +    YQ+ +G+ ++ S   IHRDL   NI +      KI DFGLA
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
Query: 216 RPTENEMTGYVA-------TRWYRAPEIMLNWMHYNQTGVPFY 251
           R  +N+ + YV         +W  APE + N ++  ++ V  Y
Sbjct: 193 RDIKND-SNYVVKGNARLPVKW-MAPESIFNCVYTFESDVWSY 233

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/133 (24%), Positives = 63/133 (47%), Gaps = 8/133 (6%)
Query: 110 RTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQK-LSDD 168
           R  RE +    +NH  ++ +     + T       + M  ++ G  L +I+ T+  ++  
Sbjct: 58  RFRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVM-EYVDGVTLRDIVHTEGPMTPK 116
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN------EM 222
               ++    + L + H  GIIHRD+KP+NI ++    +K++DFG+AR   +      + 
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 223 TGYVATRWYRAPE 235
              + T  Y +PE
Sbjct: 177 AAVIGTAQYLSPE 189

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/114 (27%), Positives = 52/114 (45%), Gaps = 12/114 (10%)
Query: 218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLAR 277
           TE  MT   A          LN+ H N        +D+KP+NI ++    +K++DFG+AR
Sbjct: 109 TEGPMTPKRAIEVIADACQALNFSHQNG----IIHRDVKPANIMISATNAVKVMDFGIAR 164
Query: 278 PTEN------EMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIM-EML-GTPP 323
              +      +    + T  Y +PE         ++D++ L  ++ E+L G PP
Sbjct: 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 79/148 (53%), Gaps = 23/148 (15%)
Query: 114 ELRMLKHMNHENVIGLLD--VFHSNTCLADFKNVYMV-THLMGADLNNIL-----RTQKL 165
           E+ +L+ + H N++   D  +  +NT L      Y+V  +  G DL +++       Q L
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTL------YIVMEYCEGGDLASVITKGTKERQYL 108
Query: 166 SDDHVQFLVYQILRGLKYIH--SAG---IIHRDLKPSNIAVNEDCELKILDFGLARPTEN 220
            ++ V  ++ Q+   LK  H  S G   ++HRDLKP+N+ ++    +K+ DFGLAR   +
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 168
Query: 221 EMT---GYVATRWYRAPEIMLNWMHYNQ 245
           + +    +V T +Y +PE M N M YN+
Sbjct: 169 DTSFAKTFVGTPYYMSPEQM-NRMSYNE 195

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 50/97 (51%), Gaps = 13/97 (13%)
Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEMT---GYVATRWYRAPEIMLNWMHYNQ-TD 308
           +DLKP+N+ ++    +K+ DFGLAR   ++ +    +V T +Y +PE M N M YN+ +D
Sbjct: 140 RDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM-NRMSYNEKSD 198
Query: 309 IHQLNLIMEMLGT--PP------AEFMAKISSDSARK 337
           I  L  ++  L    PP       E   KI     R+
Sbjct: 199 IWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR 235

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 100/237 (42%), Gaps = 43/237 (18%)
Query: 46  PSRRLHDHFNQPYSEICRGVIDIGPTLSKESFDLIFSSA----LDSVSGVKVAIKKIARP 101
           P++  +DH      E  R  +  G TL   +F  +  +     + S + + VA+K + +P
Sbjct: 27  PTQLPYDH----KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KP 81
Query: 102 FQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNIL 160
                  +    EL++L ++ NH N++ LL       C      + +  +    DL N L
Sbjct: 82  SAHLTEREALMSELKVLSYLGNHMNIVNLL-----GACTIGGPTLVITEYCCYGDLLNFL 136
Query: 161 RTQKLS-------------------DDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           R ++ S                    + +    YQ+ +G+ ++ S   IHRDL   NI +
Sbjct: 137 RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 196
Query: 202 NEDCELKILDFGLARPTENEMTGYVA-------TRWYRAPEIMLNWMHYNQTGVPFY 251
                 KI DFGLAR  +N+ + YV         +W  APE + N ++  ++ V  Y
Sbjct: 197 THGRITKICDFGLARDIKND-SNYVVKGNARLPVKW-MAPESIFNCVYTFESDVWSY 251

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 78/148 (52%), Gaps = 23/148 (15%)
Query: 114 ELRMLKHMNHENVIGLLD--VFHSNTCLADFKNVYMV-THLMGADLNNIL-----RTQKL 165
           E+ +L+ + H N++   D  +  +NT L      Y+V  +  G DL +++       Q L
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTL------YIVMEYCEGGDLASVITKGTKERQYL 108
Query: 166 SDDHVQFLVYQILRGLKYIH--SAG---IIHRDLKPSNIAVNEDCELKILDFGLAR---P 217
            ++ V  ++ Q+   LK  H  S G   ++HRDLKP+N+ ++    +K+ DFGLAR    
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 168
Query: 218 TENEMTGYVATRWYRAPEIMLNWMHYNQ 245
            E+    +V T +Y +PE M N M YN+
Sbjct: 169 DEDFAKEFVGTPYYMSPEQM-NRMSYNE 195

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 88/222 (39%), Gaps = 21/222 (9%)
Query: 37  WTVYPASKLPSRRLHDHFNQPYSE---ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKV 93
           W +  + +  S    D    PY+E     R  +  G TL   +F  +  +    +     
Sbjct: 16  WKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDA 75
Query: 94  AIKKIARPFQSAVHAKRT---YRELRMLKHMN-HENVIGLLD---------VFHSNTCLA 140
            +K   +  +S  HA        EL+++ H+  HEN++ LL          V     C  
Sbjct: 76  VLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG 135
Query: 141 DFKN-VYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
           D  N +   + ++  D    +    LS   +     Q+ +G+ ++ S   IHRD+   N+
Sbjct: 136 DLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNV 195
Query: 200 AVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM 241
            +      KI DFGLAR   N+ + Y+     R P   + WM
Sbjct: 196 LLTNGHVAKIGDFGLARDIMND-SNYIVKGNARLP---VKWM 233

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/229 (23%), Positives = 89/229 (38%), Gaps = 33/229 (14%)
Query: 37  WTVYPASKLPSRRLHDHFNQPYSE---ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKV 93
           W +  + +  S    D    PY+E     R  +  G TL   +F  +  +    +     
Sbjct: 16  WKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDA 75
Query: 94  AIKKIARPFQSAVHAKRT---YRELRMLKHMN-HENVIGLLDVFHSNTCLADFKNVYMVT 149
            +K   +  +S  HA        EL+++ H+  HEN++ LL       C      + +  
Sbjct: 76  VLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLL-----GACTHGGPVLVITE 130
Query: 150 HLMGADLNNILRTQK-----------------LSDDHVQFLVYQILRGLKYIHSAGIIHR 192
           +    DL N LR ++                 LS   +     Q+ +G+ ++ S   IHR
Sbjct: 131 YCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHR 190
Query: 193 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM 241
           D+   N+ +      KI DFGLAR   N+ + Y+     R P   + WM
Sbjct: 191 DVAARNVLLTNGHVAKIGDFGLARDIMND-SNYIVKGNARLP---VKWM 235

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 76/175 (43%), Gaps = 14/175 (8%)
Query: 66  IDIGPTLSKESFDLIFSSALD--SVSGVKVAIKKIARPFQSAVHAKRTY-RELRMLKHMN 122
           I I   +    F  + S  L   S   + VAIK +   +      +R +  E  ++   +
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE--KQRRDFLGEASIMGQFD 104
Query: 123 HENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQF--LVYQILR 179
           H N+I L  V   +      K V +VT  M    L++ LR        +Q   ++  I  
Sbjct: 105 HPNIIRLEGVVTKS------KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 180 GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP 234
           G+KY+   G +HRDL   NI +N +   K+ DFGLAR  E++      TR  + P
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIP 213

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 94/223 (42%), Gaps = 39/223 (17%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSA----LDSVSGVKVAIKKIARPFQSAVHAKRTYREL 115
           E  R  +  G TL   +F  +  +     + S + + VA+K + +P       +    EL
Sbjct: 42  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALMSEL 100
Query: 116 RMLKHM-NHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLS-------- 166
           ++L ++ NH N++ LL       C      + +  +    DL N LR ++ S        
Sbjct: 101 KVLSYLGNHMNIVNLL-----GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 155
Query: 167 -----------DDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 215
                       + +    YQ+ +G+ ++ S   IHRDL   NI +      KI DFGLA
Sbjct: 156 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 215
Query: 216 RPTENEMTGYVA-------TRWYRAPEIMLNWMHYNQTGVPFY 251
           R  +N+ + YV         +W  APE + N ++  ++ V  Y
Sbjct: 216 RHIKND-SNYVVKGNARLPVKW-MAPESIFNCVYTFESDVWSY 256

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/128 (31%), Positives = 65/128 (50%), Gaps = 13/128 (10%)
Query: 121 MNHENVIGLLD----VFHSNTCLADFKNVYMV-THLMGADL-NNILRTQKLSDDHVQFLV 174
           M  + V+ LLD    +   ++C      +Y V  ++ G DL  +I +  K  +    F  
Sbjct: 67  MVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYA 126
Query: 175 YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTG-----YVATR 229
            +I  GL ++H  GII+RDLK  N+ ++ +  +KI DFG+ +  E+ M G     +  T 
Sbjct: 127 AEISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMMDGVTTREFCGTP 184
Query: 230 WYRAPEIM 237
            Y APEI+
Sbjct: 185 DYIAPEII 192

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 75/176 (42%), Gaps = 27/176 (15%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-----FQSAVHAKRTYRE 114
           EI  G I +G  +   SF  ++         VK+       P     F++ V   R  R 
Sbjct: 4   EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 63
Query: 115 LRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLV 174
           + +L  M +     L  V    T   +  ++Y   H++      I    KL D     + 
Sbjct: 64  VNILLFMGYSTAPQLAIV----TQWCEGSSLYHHLHIIETKFEMI----KLID-----IA 110
Query: 175 YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRW 230
            Q  +G+ Y+H+  IIHRDLK +NI ++ED  +KI DFGLA          V +RW
Sbjct: 111 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT---------VKSRW 157

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 91/196 (46%), Gaps = 28/196 (14%)
Query: 79  LIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC 138
           L+   A      +K+  K++        H   T  E R+L++  H  +  L   F ++  
Sbjct: 28  LVKEKATGRYYAMKILKKEVIVAKDEVAH---TLTENRVLQNSRHPFLTALKYSFQTHDR 84
Query: 139 LADFKNVYMVTHLMGADLN-NILRTQKLSDDHVQFLVYQILRGLKYIHS-AGIIHRDLKP 196
           L      +++ +  G +L  ++ R +  S+D  +F   +I+  L Y+HS   +++RDLK 
Sbjct: 85  LC-----FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKL 139
Query: 197 SNIAVNEDCELKILDFGLARPTENE---MTGYVATRWYRAPEIM--------LNW----- 240
            N+ +++D  +KI DFGL +    +   M  +  T  Y APE++        ++W     
Sbjct: 140 ENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 199
Query: 241 -MHYNQTG-VPFYFQD 254
            M+    G +PFY QD
Sbjct: 200 VMYEMMCGRLPFYNQD 215

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 70/150 (46%), Gaps = 11/150 (7%)
Query: 93  VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM 152
           VA+K I R  +   + KR     R L+H    N++   +V  + T LA    + M     
Sbjct: 47  VAVKYIERGEKIDENVKREIINHRSLRH---PNIVRFKEVILTPTHLA----IVMEYASG 99
Query: 153 GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED--CELKIL 210
           G     I    + S+D  +F   Q++ G+ Y H+  + HRDLK  N  ++      LKI 
Sbjct: 100 GELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQVAHRDLKLENTLLDGSPAPRLKIA 159
Query: 211 DFGLARPT--ENEMTGYVATRWYRAPEIML 238
           DFG ++ +   ++    V T  Y APE++L
Sbjct: 160 DFGYSKASVLHSQPKSAVGTPAYIAPEVLL 189

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 87/186 (46%), Gaps = 19/186 (10%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLK 119
           EI R  I +   L    F  ++    ++ +  KVA+K + +P   +V A     E  ++K
Sbjct: 9   EIPRESIKLVKRLGAGQFGEVWMGYYNNST--KVAVKTL-KPGTMSVQA--FLEEANLMK 63
Query: 120 HMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDDHVQFLV---Y 175
            + H+ ++ L  V          + +Y++T  M    L + L++ +     +  L+    
Sbjct: 64  TLQHDKLVRLYAVVTRE------EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA 117
Query: 176 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE-NEMTGYVATRW---Y 231
           QI  G+ YI     IHRDL+ +N+ V+E    KI DFGLAR  E NE T     ++   +
Sbjct: 118 QIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW 177
Query: 232 RAPEIM 237
            APE +
Sbjct: 178 TAPEAI 183

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 91/196 (46%), Gaps = 28/196 (14%)
Query: 79  LIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC 138
           L+   A      +K+  K++        H   T  E R+L++  H  +  L   F ++  
Sbjct: 27  LVKEKATGRYYAMKILKKEVIVAKDEVAH---TLTENRVLQNSRHPFLTALKYSFQTHDR 83
Query: 139 LADFKNVYMVTHLMGADLN-NILRTQKLSDDHVQFLVYQILRGLKYIHS-AGIIHRDLKP 196
           L      +++ +  G +L  ++ R +  S+D  +F   +I+  L Y+HS   +++RDLK 
Sbjct: 84  LC-----FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKL 138
Query: 197 SNIAVNEDCELKILDFGLARPTENE---MTGYVATRWYRAPEIM--------LNW----- 240
            N+ +++D  +KI DFGL +    +   M  +  T  Y APE++        ++W     
Sbjct: 139 ENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 198
Query: 241 -MHYNQTG-VPFYFQD 254
            M+    G +PFY QD
Sbjct: 199 VMYEMMCGRLPFYNQD 214

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 91/196 (46%), Gaps = 28/196 (14%)
Query: 79  LIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC 138
           L+   A      +K+  K++        H   T  E R+L++  H  +  L   F ++  
Sbjct: 169 LVKEKATGRYYAMKILKKEVIVAKDEVAH---TLTENRVLQNSRHPFLTALKYSFQTHDR 225
Query: 139 LADFKNVYMVTHLMGADLN-NILRTQKLSDDHVQFLVYQILRGLKYIHS-AGIIHRDLKP 196
           L      +++ +  G +L  ++ R +  S+D  +F   +I+  L Y+HS   +++RDLK 
Sbjct: 226 LC-----FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKL 280
Query: 197 SNIAVNEDCELKILDFGLARPTENE---MTGYVATRWYRAPEIM--------LNW----- 240
            N+ +++D  +KI DFGL +    +   M  +  T  Y APE++        ++W     
Sbjct: 281 ENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 340
Query: 241 -MHYNQTG-VPFYFQD 254
            M+    G +PFY QD
Sbjct: 341 VMYEMMCGRLPFYNQD 356

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 91/196 (46%), Gaps = 28/196 (14%)
Query: 79  LIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC 138
           L+   A      +K+  K++        H   T  E R+L++  H  +  L   F ++  
Sbjct: 26  LVKEKATGRYYAMKILKKEVIVAKDEVAH---TLTENRVLQNSRHPFLTALKYSFQTHDR 82
Query: 139 LADFKNVYMVTHLMGADLN-NILRTQKLSDDHVQFLVYQILRGLKYIHS-AGIIHRDLKP 196
           L      +++ +  G +L  ++ R +  S+D  +F   +I+  L Y+HS   +++RDLK 
Sbjct: 83  LC-----FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKL 137
Query: 197 SNIAVNEDCELKILDFGLARPTENE---MTGYVATRWYRAPEIM--------LNW----- 240
            N+ +++D  +KI DFGL +    +   M  +  T  Y APE++        ++W     
Sbjct: 138 ENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 197
Query: 241 -MHYNQTG-VPFYFQD 254
            M+    G +PFY QD
Sbjct: 198 VMYEMMCGRLPFYNQD 213

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 95/206 (46%), Gaps = 31/206 (15%)
Query: 72  LSKESFD---LIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIG 128
           L K +F    L+   A      +K+  K++        H   T  E R+L++  H  +  
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAH---TLTENRVLQNSRHPFLTA 212
Query: 129 LLDVFHSNTCLADFKNVYMVTHLMGADLN-NILRTQKLSDDHVQFLVYQILRGLKYIHS- 186
           L   F ++  L      +++ +  G +L  ++ R +  S+D  +F   +I+  L Y+HS 
Sbjct: 213 LKYSFQTHDRLC-----FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 267
Query: 187 AGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE---MTGYVATRWYRAPEIM------ 237
             +++RDLK  N+ +++D  +KI DFGL +    +   M  +  T  Y APE++      
Sbjct: 268 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYG 327
Query: 238 --LNW------MHYNQTG-VPFYFQD 254
             ++W      M+    G +PFY QD
Sbjct: 328 RAVDWWGLGVVMYEMMCGRLPFYNQD 353

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 72/161 (44%), Gaps = 18/161 (11%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-----FQSAVHAKRTYRE 114
           EI  G I +G  +   SF  ++         VK+       P     F++ V   R  R 
Sbjct: 20  EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 79
Query: 115 LRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLV 174
           + +L  M +     L  V    T   +  ++Y   HL  ++       +KL D     + 
Sbjct: 80  VNILLFMGYSTAPQLAIV----TQWCEGSSLYH--HLHASETK--FEMKKLID-----IA 126
Query: 175 YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 215
            Q  RG+ Y+H+  IIHRDLK +NI ++ED  +KI DFGLA
Sbjct: 127 RQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA 167

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 79/172 (45%), Gaps = 18/172 (10%)
Query: 71  TLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLL 130
           T+ K  F  +    L    G KVA+K I    ++   A+    E  ++  + H N++ LL
Sbjct: 200 TIGKGEFGDVM---LGDYRGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLL 252
Query: 131 DVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQK---LSDDHVQFLVYQILRGLKYIHS 186
            V      + +   +Y+VT  M    L + LR++    L  D +      +   ++Y+  
Sbjct: 253 GVI-----VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 187 AGIIHRDLKPSNIAVNEDCELKILDFGLAR-PTENEMTGYVATRWYRAPEIM 237
              +HRDL   N+ V+ED   K+ DFGL +  +  + TG +  +W  APE +
Sbjct: 308 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKW-TAPEAL 358

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 76/175 (43%), Gaps = 14/175 (8%)
Query: 66  IDIGPTLSKESFDLIFSSALD--SVSGVKVAIKKIARPFQSAVHAKRTY-RELRMLKHMN 122
           I I   +    F  + S  L   S   + VAIK +   +      +R +  E  ++   +
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE--KQRRDFLGEASIMGQFD 104
Query: 123 HENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQF--LVYQILR 179
           H N+I L  V   +      K V +VT  M    L++ LR        +Q   ++  I  
Sbjct: 105 HPNIIRLEGVVTKS------KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 180 GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP 234
           G+KY+   G +HRDL   NI +N +   K+ DFGL+R  E++      TR  + P
Sbjct: 159 GMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 75/154 (48%), Gaps = 18/154 (11%)
Query: 92  KVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHL 151
           KVA+K +    Q ++       E  ++K + H+ ++ L  V          + +Y++T  
Sbjct: 35  KVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-------EPIYIITEY 84
Query: 152 M-GADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
           M    L + L+T    KL+ + +  +  QI  G+ +I     IHR+L+ +NI V++    
Sbjct: 85  MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRNLRAANILVSDTLSC 144
Query: 208 KILDFGLARPTE-NEMTGYVATRW---YRAPEIM 237
           KI DFGLAR  E NE T     ++   + APE +
Sbjct: 145 KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 178

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 79/172 (45%), Gaps = 18/172 (10%)
Query: 71  TLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLL 130
           T+ K  F  +    L    G KVA+K I    ++   A+    E  ++  + H N++ LL
Sbjct: 19  TIGKGEFGDVM---LGDYRGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLL 71
Query: 131 DVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQK---LSDDHVQFLVYQILRGLKYIHS 186
            V      + +   +Y+VT  M    L + LR++    L  D +      +   ++Y+  
Sbjct: 72  GVI-----VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 126
Query: 187 AGIIHRDLKPSNIAVNEDCELKILDFGLAR-PTENEMTGYVATRWYRAPEIM 237
              +HRDL   N+ V+ED   K+ DFGL +  +  + TG +  +W  APE +
Sbjct: 127 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKW-TAPEAL 177

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 76/175 (43%), Gaps = 14/175 (8%)
Query: 66  IDIGPTLSKESFDLIFSSALD--SVSGVKVAIKKIARPFQSAVHAKRTY-RELRMLKHMN 122
           I I   +    F  + S  L   S   + VAIK +   +      +R +  E  ++   +
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE--KQRRDFLGEASIMGQFD 104
Query: 123 HENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQF--LVYQILR 179
           H N+I L  V   +      K V +VT  M    L++ LR        +Q   ++  I  
Sbjct: 105 HPNIIRLEGVVTKS------KPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 180 GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP 234
           G+KY+   G +HRDL   NI +N +   K+ DFGL+R  E++      TR  + P
Sbjct: 159 GMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 71/154 (46%), Gaps = 16/154 (10%)
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAK----RTYRELRMLKHM 121
            DIG  L K  F  ++  A +  +   +A+K +   F+S +  +    +  RE+ +  H+
Sbjct: 17  FDIGRPLGKGKFGNVYL-AREKQNKFIMALKVL---FKSQLEKEGVEHQLRREIEIQSHL 72
Query: 122 NHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDDHVQFLVYQILR 179
            H N++ + + FH      D K +Y++      G     + +  +  +      + ++  
Sbjct: 73  RHPNILRMYNYFH------DRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELAD 126
Query: 180 GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG 213
            L Y H   +IHRD+KP N+ +    ELKI DFG
Sbjct: 127 ALHYCHERKVIHRDIKPENLLMGYKGELKIADFG 160

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 84/178 (47%), Gaps = 17/178 (9%)
Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIKKIA-RPFQSAVHAKRTYRELRMLKHMNHENV 126
           I   + +  F  ++ +A   + GV VA+KK+       A       +E+ +LK +NH NV
Sbjct: 36  IEKKIGRGQFSEVYRAAC-LLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNV 94
Query: 127 IGLLDVFHSNTCLADFKNVYMVTHLMGA-DLNNILRTQK-----LSDDHVQFLVYQILRG 180
           I     F  +        + +V  L  A DL+ +++  K     + +  V     Q+   
Sbjct: 95  IKYYASFIEDN------ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 181 LKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTG---YVATRWYRAPE 235
           L+++HS  ++HRD+KP+N+ +     +K+ D GL R   ++ T     V T +Y +PE
Sbjct: 149 LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 206

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 79/172 (45%), Gaps = 18/172 (10%)
Query: 71  TLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLL 130
           T+ K  F  +    L    G KVA+K I    ++   A+    E  ++  + H N++ LL
Sbjct: 28  TIGKGEFGDVM---LGDYRGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLL 80
Query: 131 DVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQK---LSDDHVQFLVYQILRGLKYIHS 186
            V      + +   +Y+VT  M    L + LR++    L  D +      +   ++Y+  
Sbjct: 81  GVI-----VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135
Query: 187 AGIIHRDLKPSNIAVNEDCELKILDFGLAR-PTENEMTGYVATRWYRAPEIM 237
              +HRDL   N+ V+ED   K+ DFGL +  +  + TG +  +W  APE +
Sbjct: 136 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKW-TAPEAL 186

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 76/175 (43%), Gaps = 14/175 (8%)
Query: 66  IDIGPTLSKESFDLIFSSALD--SVSGVKVAIKKIARPFQSAVHAKRTY-RELRMLKHMN 122
           I I   +    F  + S  L   S   + VAIK +   +      +R +  E  ++   +
Sbjct: 18  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE--KQRRDFLGEASIMGQFD 75
Query: 123 HENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQF--LVYQILR 179
           H N+I L  V   +      K V +VT  M    L++ LR        +Q   ++  I  
Sbjct: 76  HPNIIRLEGVVTKS------KPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 129
Query: 180 GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP 234
           G+KY+   G +HRDL   NI +N +   K+ DFGL+R  E++      TR  + P
Sbjct: 130 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 184

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 76/175 (43%), Gaps = 14/175 (8%)
Query: 66  IDIGPTLSKESFDLIFSSALD--SVSGVKVAIKKIARPFQSAVHAKRTY-RELRMLKHMN 122
           I I   +    F  + S  L   S   + VAIK +   +      +R +  E  ++   +
Sbjct: 18  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE--KQRRDFLGEASIMGQFD 75
Query: 123 HENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQF--LVYQILR 179
           H N+I L  V   +      K V +VT  M    L++ LR        +Q   ++  I  
Sbjct: 76  HPNIIRLEGVVTKS------KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 129
Query: 180 GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP 234
           G+KY+   G +HRDL   NI +N +   K+ DFGL+R  E++      TR  + P
Sbjct: 130 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 184

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 75/176 (42%), Gaps = 27/176 (15%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-----FQSAVHAKRTYRE 114
           EI  G I +G  +   SF  ++         VK+       P     F++ V   R  R 
Sbjct: 9   EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 68
Query: 115 LRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLV 174
           + +L  M +     L  V    T   +  ++Y   H++      I    KL D     + 
Sbjct: 69  VNILLFMGYSTKPQLAIV----TQWCEGSSLYHHLHIIETKFEMI----KLID-----IA 115
Query: 175 YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRW 230
            Q  +G+ Y+H+  IIHRDLK +NI ++ED  +KI DFGLA          V +RW
Sbjct: 116 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT---------VKSRW 162

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 68/130 (52%), Gaps = 11/130 (8%)
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQ--KLSDDHVQ 171
           E+ ++  ++H  +I L D F        ++ V ++  L G +L + +  +  K+S+  V 
Sbjct: 98  EISIMNQLHHPKLINLHDAFEDK-----YEMVLILEFLSGGELFDRIAAEDYKMSEAEVI 152
Query: 172 FLVYQILRGLKYIHSAGIIHRDLKPSNI--AVNEDCELKILDFGLA-RPTENEMTGY-VA 227
             + Q   GLK++H   I+H D+KP NI     +   +KI+DFGLA +   +E+     A
Sbjct: 153 NYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA 212
Query: 228 TRWYRAPEIM 237
           T  + APEI+
Sbjct: 213 TAEFAAPEIV 222

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 75/176 (42%), Gaps = 27/176 (15%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-----FQSAVHAKRTYRE 114
           EI  G I +G  +   SF  ++         VK+       P     F++ V   R  R 
Sbjct: 6   EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 65
Query: 115 LRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLV 174
           + +L  M +     L  V    T   +  ++Y   H++      I    KL D     + 
Sbjct: 66  VNILLFMGYSTKPQLAIV----TQWCEGSSLYHHLHIIETKFEMI----KLID-----IA 112
Query: 175 YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRW 230
            Q  +G+ Y+H+  IIHRDLK +NI ++ED  +KI DFGLA          V +RW
Sbjct: 113 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT---------VKSRW 159

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 76/175 (43%), Gaps = 14/175 (8%)
Query: 66  IDIGPTLSKESFDLIFSSALD--SVSGVKVAIKKIARPFQSAVHAKRTY-RELRMLKHMN 122
           I I   +    F  + S  L   S   + VAIK +   +      +R +  E  ++   +
Sbjct: 35  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE--KQRRDFLGEASIMGQFD 92
Query: 123 HENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQF--LVYQILR 179
           H N+I L  V   +      K V +VT  M    L++ LR        +Q   ++  I  
Sbjct: 93  HPNIIRLEGVVTKS------KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 146
Query: 180 GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP 234
           G+KY+   G +HRDL   NI +N +   K+ DFGL+R  E++      TR  + P
Sbjct: 147 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 201

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 76/175 (43%), Gaps = 14/175 (8%)
Query: 66  IDIGPTLSKESFDLIFSSALD--SVSGVKVAIKKIARPFQSAVHAKRTY-RELRMLKHMN 122
           I I   +    F  + S  L   S   + VAIK +   +      +R +  E  ++   +
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE--KQRRDFLGEASIMGQFD 104
Query: 123 HENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQF--LVYQILR 179
           H N+I L  V   +      K V +VT  M    L++ LR        +Q   ++  I  
Sbjct: 105 HPNIIRLEGVVTKS------KPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 180 GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP 234
           G+KY+   G +HRDL   NI +N +   K+ DFGL+R  E++      TR  + P
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 75/176 (42%), Gaps = 27/176 (15%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-----FQSAVHAKRTYRE 114
           EI  G I +G  +   SF  ++         VK+       P     F++ V   R  R 
Sbjct: 4   EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 63
Query: 115 LRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLV 174
           + +L  M +     L  V    T   +  ++Y   H++      I    KL D     + 
Sbjct: 64  VNILLFMGYSTKPQLAIV----TQWCEGSSLYHHLHIIETKFEMI----KLID-----IA 110
Query: 175 YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRW 230
            Q  +G+ Y+H+  IIHRDLK +NI ++ED  +KI DFGLA          V +RW
Sbjct: 111 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT---------VKSRW 157

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 76/175 (43%), Gaps = 14/175 (8%)
Query: 66  IDIGPTLSKESFDLIFSSALD--SVSGVKVAIKKIARPFQSAVHAKRTY-RELRMLKHMN 122
           I I   +    F  + S  L   S   + VAIK +   +      +R +  E  ++   +
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE--KQRRDFLGEASIMGQFD 104
Query: 123 HENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQF--LVYQILR 179
           H N+I L  V   +      K V +VT  M    L++ LR        +Q   ++  I  
Sbjct: 105 HPNIIRLEGVVTKS------KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 180 GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP 234
           G+KY+   G +HRDL   NI +N +   K+ DFGL+R  E++      TR  + P
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 75/176 (42%), Gaps = 27/176 (15%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-----FQSAVHAKRTYRE 114
           EI  G I +G  +   SF  ++         VK+       P     F++ V   R  R 
Sbjct: 9   EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 68
Query: 115 LRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLV 174
           + +L  M +     L  V    T   +  ++Y   H++      I    KL D     + 
Sbjct: 69  VNILLFMGYSTKPQLAIV----TQWCEGSSLYHHLHIIETKFEMI----KLID-----IA 115
Query: 175 YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRW 230
            Q  +G+ Y+H+  IIHRDLK +NI ++ED  +KI DFGLA          V +RW
Sbjct: 116 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT---------VKSRW 162

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 76/175 (43%), Gaps = 14/175 (8%)
Query: 66  IDIGPTLSKESFDLIFSSALD--SVSGVKVAIKKIARPFQSAVHAKRTY-RELRMLKHMN 122
           I I   +    F  + S  L   S   + VAIK +   +      +R +  E  ++   +
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE--KQRRDFLGEASIMGQFD 104
Query: 123 HENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQF--LVYQILR 179
           H N+I L  V   +      K V +VT  M    L++ LR        +Q   ++  I  
Sbjct: 105 HPNIIRLEGVVTKS------KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 180 GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP 234
           G+KY+   G +HRDL   NI +N +   K+ DFGL+R  E++      TR  + P
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 76/175 (43%), Gaps = 14/175 (8%)
Query: 66  IDIGPTLSKESFDLIFSSALD--SVSGVKVAIKKIARPFQSAVHAKRTY-RELRMLKHMN 122
           I I   +    F  + S  L   S   + VAIK +   +      +R +  E  ++   +
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE--KQRRDFLGEASIMGQFD 104
Query: 123 HENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQF--LVYQILR 179
           H N+I L  V   +      K V +VT  M    L++ LR        +Q   ++  I  
Sbjct: 105 HPNIIRLEGVVTKS------KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 180 GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP 234
           G+KY+   G +HRDL   NI +N +   K+ DFGL+R  E++      TR  + P
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 76/175 (43%), Gaps = 14/175 (8%)
Query: 66  IDIGPTLSKESFDLIFSSALD--SVSGVKVAIKKIARPFQSAVHAKRTY-RELRMLKHMN 122
           I I   +    F  + S  L   S   + VAIK +   +      +R +  E  ++   +
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE--KQRRDFLGEASIMGQFD 104
Query: 123 HENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQF--LVYQILR 179
           H N+I L  V   +      K V +VT  M    L++ LR        +Q   ++  I  
Sbjct: 105 HPNIIRLEGVVTKS------KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 180 GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP 234
           G+KY+   G +HRDL   NI +N +   K+ DFGL+R  E++      TR  + P
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 57/109 (52%), Gaps = 9/109 (8%)
Query: 136 NTCLADFKNVYMV-THLMGADL-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRD 193
           ++C      +Y V  ++ G DL  +I +  +  + H  F   +I  GL ++ S GII+RD
Sbjct: 408 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRD 467
Query: 194 LKPSNIAVNEDCELKILDFGLARPTENEMTG-----YVATRWYRAPEIM 237
           LK  N+ ++ +  +KI DFG+ +  EN   G     +  T  Y APEI+
Sbjct: 468 LKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPEII 514

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 66/125 (52%), Gaps = 9/125 (7%)
Query: 117 MLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADL-NNILRTQKLSDDHVQFLVY 175
           +LK++ H  ++GL    H +   AD K  +++ ++ G +L  ++ R +   +   +F   
Sbjct: 92  LLKNVKHPFLVGL----HFSFQTAD-KLYFVLDYINGGELFYHLQRERCFLEPRARFYAA 146
Query: 176 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT---ENEMTGYVATRWYR 232
           +I   L Y+HS  I++RDLKP NI ++    + + DFGL +      +  + +  T  Y 
Sbjct: 147 EIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYL 206
Query: 233 APEIM 237
           APE++
Sbjct: 207 APEVL 211

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 76/176 (43%), Gaps = 27/176 (15%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-----FQSAVHAKRTYRE 114
           EI  G I +G  +   SF  ++         VK+       P     F++ V   R  R 
Sbjct: 8   EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 67
Query: 115 LRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLV 174
           + +L  M +     L  V    T   +  ++Y   HL  ++       +KL D     + 
Sbjct: 68  VNILLFMGYSTKPQLAIV----TQWCEGSSLYH--HLHASETK--FEMKKLID-----IA 114
Query: 175 YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRW 230
            Q  RG+ Y+H+  IIHRDLK +NI ++ED  +KI DFGLA          V +RW
Sbjct: 115 RQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA---------TVKSRW 161

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 76/175 (43%), Gaps = 14/175 (8%)
Query: 66  IDIGPTLSKESFDLIFSSALD--SVSGVKVAIKKIARPFQSAVHAKRTY-RELRMLKHMN 122
           I I   +    F  + S  L   S   + VAIK +   +      +R +  E  ++   +
Sbjct: 45  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE--KQRRDFLGEASIMGQFD 102
Query: 123 HENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQF--LVYQILR 179
           H N+I L  V   +      K V +VT  M    L++ LR        +Q   ++  I  
Sbjct: 103 HPNIIRLEGVVTKS------KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 156
Query: 180 GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP 234
           G+KY+   G +HRDL   NI +N +   K+ DFGL+R  E++      TR  + P
Sbjct: 157 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 211

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 79/172 (45%), Gaps = 18/172 (10%)
Query: 71  TLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLL 130
           T+ K  F  +    L    G KVA+K I    ++   A+    E  ++  + H N++ LL
Sbjct: 13  TIGKGEFGDVM---LGDYRGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLL 65
Query: 131 DVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQK---LSDDHVQFLVYQILRGLKYIHS 186
            V      + +   +Y+VT  M    L + LR++    L  D +      +   ++Y+  
Sbjct: 66  GVI-----VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 120
Query: 187 AGIIHRDLKPSNIAVNEDCELKILDFGLAR-PTENEMTGYVATRWYRAPEIM 237
              +HRDL   N+ V+ED   K+ DFGL +  +  + TG +  +W  APE +
Sbjct: 121 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKW-TAPEAL 171

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 71/161 (44%), Gaps = 18/161 (11%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-----FQSAVHAKRTYRE 114
           EI  G I +G  +   SF  ++         VK+       P     F++ V   R  R 
Sbjct: 4   EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 63
Query: 115 LRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLV 174
           + +L  M +     L  V    T   +  ++Y   H++      I    KL D     + 
Sbjct: 64  VNILLFMGYSTKPQLAIV----TQWCEGSSLYHHLHIIETKFEMI----KLID-----IA 110
Query: 175 YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 215
            Q  +G+ Y+H+  IIHRDLK +NI ++ED  +KI DFGLA
Sbjct: 111 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA 151

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 57/109 (52%), Gaps = 9/109 (8%)
Query: 136 NTCLADFKNVYMV-THLMGADL-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRD 193
           ++C      +Y V  ++ G DL  +I +  +  + H  F   +I  GL ++ S GII+RD
Sbjct: 87  HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRD 146
Query: 194 LKPSNIAVNEDCELKILDFGLARPTENEMTG-----YVATRWYRAPEIM 237
           LK  N+ ++ +  +KI DFG+ +  EN   G     +  T  Y APEI+
Sbjct: 147 LKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPEII 193

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 75/175 (42%), Gaps = 14/175 (8%)
Query: 66  IDIGPTLSKESFDLIFSSALD--SVSGVKVAIKKIARPFQSAVHAKRTY-RELRMLKHMN 122
           I I   +    F  + S  L   S   + VAIK +   +      +R +  E  ++   +
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE--KQRRDFLGEASIMGQFD 104
Query: 123 HENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQF--LVYQILR 179
           H N+I L  V   +      K V +VT  M    L++ LR        +Q   ++  I  
Sbjct: 105 HPNIIRLEGVVTKS------KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 180 GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP 234
           G+KY+   G +HRDL   NI +N +   K+ DFGL R  E++      TR  + P
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIP 213

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 71/161 (44%), Gaps = 18/161 (11%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-----FQSAVHAKRTYRE 114
           EI  G I +G  +   SF  ++         VK+       P     F++ V   R  R 
Sbjct: 24  EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 83
Query: 115 LRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLV 174
           + +L  M +     L  V    T   +  ++Y   H++      I    KL D     + 
Sbjct: 84  VNILLFMGYSTKPQLAIV----TQWCEGSSLYHHLHIIETKFEMI----KLID-----IA 130
Query: 175 YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 215
            Q  +G+ Y+H+  IIHRDLK +NI ++ED  +KI DFGLA
Sbjct: 131 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA 171

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 75/176 (42%), Gaps = 27/176 (15%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-----FQSAVHAKRTYRE 114
           EI  G I +G  +   SF  ++         VK+       P     F++ V   R  R 
Sbjct: 32  EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 91
Query: 115 LRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLV 174
           + +L  M +     L  V    T   +  ++Y   H++      I    KL D     + 
Sbjct: 92  VNILLFMGYSTKPQLAIV----TQWCEGSSLYHHLHIIETKFEMI----KLID-----IA 138
Query: 175 YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRW 230
            Q  +G+ Y+H+  IIHRDLK +NI ++ED  +KI DFGLA          V +RW
Sbjct: 139 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA---------TVKSRW 185

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 71/161 (44%), Gaps = 18/161 (11%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-----FQSAVHAKRTYRE 114
           EI  G I +G  +   SF  ++         VK+       P     F++ V   R  R 
Sbjct: 32  EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 91
Query: 115 LRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLV 174
           + +L  M +     L  V    T   +  ++Y   H++      I    KL D     + 
Sbjct: 92  VNILLFMGYSTKPQLAIV----TQWCEGSSLYHHLHIIETKFEMI----KLID-----IA 138
Query: 175 YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 215
            Q  +G+ Y+H+  IIHRDLK +NI ++ED  +KI DFGLA
Sbjct: 139 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA 179

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 75/176 (42%), Gaps = 27/176 (15%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-----FQSAVHAKRTYRE 114
           EI  G I +G  +   SF  ++         VK+       P     F++ V   R  R 
Sbjct: 31  EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 90
Query: 115 LRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLV 174
           + +L  M +     L  V    T   +  ++Y   H++      I    KL D     + 
Sbjct: 91  VNILLFMGYSTKPQLAIV----TQWCEGSSLYHHLHIIETKFEMI----KLID-----IA 137
Query: 175 YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRW 230
            Q  +G+ Y+H+  IIHRDLK +NI ++ED  +KI DFGLA          V +RW
Sbjct: 138 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA---------TVKSRW 184

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 72/161 (44%), Gaps = 18/161 (11%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-----FQSAVHAKRTYRE 114
           EI  G I +G  +   SF  ++         VK+       P     F++ V   R  R 
Sbjct: 20  EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 79
Query: 115 LRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLV 174
           + +L  M +     L  V    T   +  ++Y   HL  ++       +KL D     + 
Sbjct: 80  VNILLFMGYSTKPQLAIV----TQWCEGSSLYH--HLHASETK--FEMKKLID-----IA 126
Query: 175 YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 215
            Q  RG+ Y+H+  IIHRDLK +NI ++ED  +KI DFGLA
Sbjct: 127 RQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA 167

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 88/204 (43%), Gaps = 31/204 (15%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSS---ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELR 116
           E  R  + +G  L + +F  +  +    +D  +  +    K+ +   +    +    EL+
Sbjct: 14  EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 73
Query: 117 MLKHMNHE-NVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQK---------- 164
           +L H+ H  NV+ LL       C      + ++T      +L+  LR+++          
Sbjct: 74  ILIHIGHHLNVVNLL-----GACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAP 128
Query: 165 -------LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP 217
                  L+ +H+    +Q+ +G++++ S   IHRDL   NI ++E   +KI DFGLAR 
Sbjct: 129 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 188
Query: 218 TENEMTGYVATRWYRAPEIMLNWM 241
              +   YV     R P   L WM
Sbjct: 189 IYKD-PDYVRKGDARLP---LKWM 208

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 11/157 (7%)
Query: 86  DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV 145
           D  S   VA+K I R  +   + KR     R L+H    N++   +V  + T LA    +
Sbjct: 40  DKQSNELVAVKYIERGEKIDENVKREIINHRSLRH---PNIVRFKEVILTPTHLA----I 92
Query: 146 YMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED- 204
            M     G     I    + S+D  +F   Q++ G+ Y H+  + HRDLK  N  ++   
Sbjct: 93  VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 152
Query: 205 -CELKILDFGLARPT--ENEMTGYVATRWYRAPEIML 238
              LKI  FG ++ +   ++    V T  Y APE++L
Sbjct: 153 APRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 189

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 35/199 (17%)
Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHEN- 125
           +I  TL + +F  +         G +VA+K I +  +    A R   E+ +L+ +N ++ 
Sbjct: 36  EIVSTLGEGTFGRVVQCVDHRRGGARVALK-IIKNVEKYKEAARL--EINVLEKINEKDP 92
Query: 126 -----VIGLLDVF--HSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQIL 178
                 + + D F  H + C++ F+ + + T     D NN L         V+ + +Q+ 
Sbjct: 93  DNKNLCVQMFDWFDYHGHMCIS-FELLGLSTFDFLKD-NNYL---PYPIHQVRHMAFQLC 147
Query: 179 RGLKYIHSAGIIHRDLKPSNIA-VNEDCEL------------------KILDFGLARPTE 219
           + +K++H   + H DLKP NI  VN D EL                  +++DFG A    
Sbjct: 148 QAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSATFDH 207
Query: 220 NEMTGYVATRWYRAPEIML 238
              +  V+TR YRAPE++L
Sbjct: 208 EHHSTIVSTRHYRAPEVIL 226

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/77 (42%), Positives = 44/77 (57%), Gaps = 2/77 (2%)
Query: 161 RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN 220
           R +KL       L  QI +G+ YIHS  +IHRDLKPSNI + +  ++KI DFGL    +N
Sbjct: 129 RGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKN 188
Query: 221 E--MTGYVATRWYRAPE 235
           +   T    T  Y +PE
Sbjct: 189 DGKRTRSKGTLRYMSPE 205

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 88/204 (43%), Gaps = 31/204 (15%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSS---ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELR 116
           E  R  + +G  L + +F  +  +    +D  +  +    K+ +   +    +    EL+
Sbjct: 14  EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 73
Query: 117 MLKHMNHE-NVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQK---------- 164
           +L H+ H  NV+ LL       C      + ++T      +L+  LR+++          
Sbjct: 74  ILIHIGHHLNVVNLL-----GACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAP 128
Query: 165 -------LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP 217
                  L+ +H+    +Q+ +G++++ S   IHRDL   NI ++E   +KI DFGLAR 
Sbjct: 129 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 188
Query: 218 TENEMTGYVATRWYRAPEIMLNWM 241
              +   YV     R P   L WM
Sbjct: 189 IYKD-PDYVRKGDARLP---LKWM 208

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/179 (23%), Positives = 80/179 (44%), Gaps = 27/179 (15%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSS---ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELR 116
           E  R  + +G  L + +F  +  +    +D  +  +    K+ +   +    +    EL+
Sbjct: 14  EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 73
Query: 117 MLKHMNHE-NVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQK---------- 164
           +L H+ H  NV+ LL       C      + ++T      +L+  LR+++          
Sbjct: 74  ILIHIGHHLNVVNLL-----GACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAP 128
Query: 165 -------LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
                  L+ +H+    +Q+ +G++++ S   IHRDL   NI ++E   +KI DFGLAR
Sbjct: 129 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 88/200 (44%), Gaps = 27/200 (13%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSS---ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELR 116
           E  R  +++G  L + +F  +  +    +D  +  +    K+ +   +    +    EL+
Sbjct: 23  EFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELK 82
Query: 117 MLKHMNHE-NVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQK---------- 164
           +L H+ H  NV+ LL       C      + ++       +L+  LR+++          
Sbjct: 83  ILIHIGHHLNVVNLL-----GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLY 137
Query: 165 ---LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE 221
              L+ +H+    +Q+ +G++++ S   IHRDL   NI ++E   +KI DFGLAR    +
Sbjct: 138 KDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKD 197
Query: 222 MTGYVATRWYRAPEIMLNWM 241
              YV     R P   L WM
Sbjct: 198 -PDYVRKGDARLP---LKWM 213

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 88/183 (48%), Gaps = 17/183 (9%)
Query: 76  SFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTY-RELRMLKHMNHENVIGLLDVFH 134
           S +L     L   +G  VA+K++     S    +R + RE+++LK ++ + ++    V +
Sbjct: 22  SVELCRYDPLGDNTGALVAVKQLQ---HSGPDQQRDFQREIQILKALHSDFIVKYRGVSY 78
Query: 135 SNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVY--QILRGLKYIHSAGIIHR 192
                 + + V  + +L    L + L+  +   D  + L+Y  QI +G++Y+ S   +HR
Sbjct: 79  GPG-RPELRLV--MEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHR 135
Query: 193 DLKPSNIAVNEDCELKILDFGLAR--PTENEMT-----GYVATRWYRAPEIMLNWMHYNQ 245
           DL   NI V  +  +KI DFGLA+  P + +       G     WY APE + + +   Q
Sbjct: 136 DLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWY-APESLSDNIFSRQ 194
Query: 246 TGV 248
           + V
Sbjct: 195 SDV 197

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 11/157 (7%)
Query: 86  DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV 145
           D  S   VA+K I R  +   + KR     R L+H    N++   +V  + T LA    +
Sbjct: 40  DKQSNELVAVKYIERGEKIDENVKREIINHRSLRH---PNIVRFKEVILTPTHLA----I 92
Query: 146 YMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED- 204
            M     G     I    + S+D  +F   Q++ G+ Y H+  + HRDLK  N  ++   
Sbjct: 93  VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 152
Query: 205 -CELKILDFGLARPT--ENEMTGYVATRWYRAPEIML 238
              LKI  FG ++ +   ++    V T  Y APE++L
Sbjct: 153 APRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLL 189

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 88/200 (44%), Gaps = 27/200 (13%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSS---ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELR 116
           E  R  +++G  L + +F  +  +    +D  +  +    K+ +   +    +    EL+
Sbjct: 23  EFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELK 82
Query: 117 MLKHMNHE-NVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQK---------- 164
           +L H+ H  NV+ LL       C      + ++       +L+  LR+++          
Sbjct: 83  ILIHIGHHLNVVNLL-----GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLY 137
Query: 165 ---LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE 221
              L+ +H+    +Q+ +G++++ S   IHRDL   NI ++E   +KI DFGLAR    +
Sbjct: 138 KDFLTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKD 197
Query: 222 MTGYVATRWYRAPEIMLNWM 241
              YV     R P   L WM
Sbjct: 198 -PDYVRKGDARLP---LKWM 213

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 65  VIDIGPTLSKESFDLIFSSALDSVSGVKV--AIKKIARPFQSAVHAKRTYRELRMLKHMN 122
           ++     + +  F  ++   L    G K+  A+K + R         +   E  ++K  +
Sbjct: 23  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFS 81
Query: 123 HENVIGLLDVFHSNTCL-ADFKNVYMVTHLMGADLNNILRTQKLS---DDHVQFLVYQIL 178
           H NV+ LL +     CL ++   + ++ ++   DL N +R +  +    D + F + Q+ 
Sbjct: 82  HPNVLSLLGI-----CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVA 135
Query: 179 RGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           +G+KY+ S   +HRDL   N  ++E   +K+ DFGLAR
Sbjct: 136 KGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 173

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 65  VIDIGPTLSKESFDLIFSSALDSVSGVKV--AIKKIARPFQSAVHAKRTYRELRMLKHMN 122
           ++     + +  F  ++   L    G K+  A+K + R         +   E  ++K  +
Sbjct: 26  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFS 84
Query: 123 HENVIGLLDVFHSNTCL-ADFKNVYMVTHLMGADLNNILRTQKLS---DDHVQFLVYQIL 178
           H NV+ LL +     CL ++   + ++ ++   DL N +R +  +    D + F + Q+ 
Sbjct: 85  HPNVLSLLGI-----CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVA 138
Query: 179 RGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           +G+KY+ S   +HRDL   N  ++E   +K+ DFGLAR
Sbjct: 139 KGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 87/222 (39%), Gaps = 21/222 (9%)
Query: 37  WTVYPASKLPSRRLHDHFNQPYSE---ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKV 93
           W +  + +  S    D    PY+E     R  +  G TL   +F  +  +    +     
Sbjct: 16  WKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDA 75
Query: 94  AIKKIARPFQSAVHAKRT---YRELRMLKHMN-HENVIGLLD---------VFHSNTCLA 140
            +K   +  +S  HA        EL+++ H+  HEN++ LL          V     C  
Sbjct: 76  VLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG 135
Query: 141 DFKN-VYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
           D  N +   + ++  D    +     S   +     Q+ +G+ ++ S   IHRD+   N+
Sbjct: 136 DLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNV 195
Query: 200 AVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM 241
            +      KI DFGLAR   N+ + Y+     R P   + WM
Sbjct: 196 LLTNGHVAKIGDFGLARDIMND-SNYIVKGNARLP---VKWM 233

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 65  VIDIGPTLSKESFDLIFSSALDSVSGVKV--AIKKIARPFQSAVHAKRTYRELRMLKHMN 122
           ++     + +  F  ++   L    G K+  A+K + R         +   E  ++K  +
Sbjct: 49  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFS 107
Query: 123 HENVIGLLDVFHSNTCL-ADFKNVYMVTHLMGADLNNILRTQKLS---DDHVQFLVYQIL 178
           H NV+ LL +     CL ++   + ++ ++   DL N +R +  +    D + F + Q+ 
Sbjct: 108 HPNVLSLLGI-----CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVA 161
Query: 179 RGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           +G+KY+ S   +HRDL   N  ++E   +K+ DFGLAR
Sbjct: 162 KGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 199

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 85/184 (46%), Gaps = 20/184 (10%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLK 119
           EI R  + +   L    F  ++ +  +  +  KVA+K + +P   +V A     E  ++K
Sbjct: 11  EIPRESLKLEKKLGAGQFGEVWMATYNKHT--KVAVKTM-KPGSMSVEA--FLAEANVMK 65
Query: 120 HMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDDHVQFLV---Y 175
            + H+ ++ L  V            +Y++T  M    L + L++ + S   +  L+    
Sbjct: 66  TLQHDKLVKLHAVVTKEP-------IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 118
Query: 176 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE-NEMTGYVATRW---Y 231
           QI  G+ +I     IHRDL+ +NI V+     KI DFGLAR  E NE T     ++   +
Sbjct: 119 QIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW 178
Query: 232 RAPE 235
            APE
Sbjct: 179 TAPE 182

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 65  VIDIGPTLSKESFDLIFSSALDSVSGVKV--AIKKIARPFQSAVHAKRTYRELRMLKHMN 122
           ++     + +  F  ++   L    G K+  A+K + R         +   E  ++K  +
Sbjct: 30  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFS 88
Query: 123 HENVIGLLDVFHSNTCL-ADFKNVYMVTHLMGADLNNILRTQKLS---DDHVQFLVYQIL 178
           H NV+ LL +     CL ++   + ++ ++   DL N +R +  +    D + F + Q+ 
Sbjct: 89  HPNVLSLLGI-----CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVA 142
Query: 179 RGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           +G+KY+ S   +HRDL   N  ++E   +K+ DFGLAR
Sbjct: 143 KGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 88/184 (47%), Gaps = 19/184 (10%)
Query: 76  SFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTY-RELRMLKHMNHENVIGLLDVFH 134
           S +L     L   +G  VA+K++     S    +R + RE+++LK ++ + ++    V +
Sbjct: 26  SVELCRYDPLGDNTGALVAVKQLQ---HSGPDQQRDFQREIQILKALHSDFIVKYRGVSY 82
Query: 135 SNTCLADFKNVYMV-THLMGADLNNILRTQKLSDDHVQFLVY--QILRGLKYIHSAGIIH 191
                   +++ +V  +L    L + L+  +   D  + L+Y  QI +G++Y+ S   +H
Sbjct: 83  G----PGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVH 138
Query: 192 RDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATR-------WYRAPEIMLNWMHYN 244
           RDL   NI V  +  +KI DFGLA+    +   YV          WY APE + + +   
Sbjct: 139 RDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY-APESLSDNIFSR 197
Query: 245 QTGV 248
           Q+ V
Sbjct: 198 QSDV 201

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 61/104 (58%), Gaps = 2/104 (1%)
Query: 146 YMVTHLMGADLNNILRTQKL-SDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED 204
           +++  + G DL+  L    + S+  ++F   +I+ GL+++H+  +++RDLKP+NI ++E 
Sbjct: 268 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH 327
Query: 205 CELKILDFGLARP-TENEMTGYVATRWYRAPEIMLNWMHYNQTG 247
             ++I D GLA   ++ +    V T  Y APE++   + Y+ + 
Sbjct: 328 GHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSA 371

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 65  VIDIGPTLSKESFDLIFSSALDSVSGVKV--AIKKIARPFQSAVHAKRTYRELRMLKHMN 122
           ++     + +  F  ++   L    G K+  A+K + R         +   E  ++K  +
Sbjct: 50  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFS 108
Query: 123 HENVIGLLDVFHSNTCL-ADFKNVYMVTHLMGADLNNILRTQKLS---DDHVQFLVYQIL 178
           H NV+ LL +     CL ++   + ++ ++   DL N +R +  +    D + F + Q+ 
Sbjct: 109 HPNVLSLLGI-----CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVA 162
Query: 179 RGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           +G+KY+ S   +HRDL   N  ++E   +K+ DFGLAR
Sbjct: 163 KGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 200

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 61/104 (58%), Gaps = 2/104 (1%)
Query: 146 YMVTHLMGADLNNILRTQKL-SDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED 204
           +++  + G DL+  L    + S+  ++F   +I+ GL+++H+  +++RDLKP+NI ++E 
Sbjct: 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH 328
Query: 205 CELKILDFGLARP-TENEMTGYVATRWYRAPEIMLNWMHYNQTG 247
             ++I D GLA   ++ +    V T  Y APE++   + Y+ + 
Sbjct: 329 GHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSA 372

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 65  VIDIGPTLSKESFDLIFSSALDSVSGVKV--AIKKIARPFQSAVHAKRTYRELRMLKHMN 122
           ++     + +  F  ++   L    G K+  A+K + R         +   E  ++K  +
Sbjct: 31  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFS 89
Query: 123 HENVIGLLDVFHSNTCL-ADFKNVYMVTHLMGADLNNILRTQKLS---DDHVQFLVYQIL 178
           H NV+ LL +     CL ++   + ++ ++   DL N +R +  +    D + F + Q+ 
Sbjct: 90  HPNVLSLLGI-----CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVA 143
Query: 179 RGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           +G+KY+ S   +HRDL   N  ++E   +K+ DFGLAR
Sbjct: 144 KGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 65  VIDIGPTLSKESFDLIFSSALDSVSGVKV--AIKKIARPFQSAVHAKRTYRELRMLKHMN 122
           ++     + +  F  ++   L    G K+  A+K + R         +   E  ++K  +
Sbjct: 31  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFS 89
Query: 123 HENVIGLLDVFHSNTCL-ADFKNVYMVTHLMGADLNNILRTQKLS---DDHVQFLVYQIL 178
           H NV+ LL +     CL ++   + ++ ++   DL N +R +  +    D + F + Q+ 
Sbjct: 90  HPNVLSLLGI-----CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVA 143
Query: 179 RGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           +G+KY+ S   +HRDL   N  ++E   +K+ DFGLAR
Sbjct: 144 KGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 65  VIDIGPTLSKESFDLIFSSALDSVSGVKV--AIKKIARPFQSAVHAKRTYRELRMLKHMN 122
           ++     + +  F  ++   L    G K+  A+K + R         +   E  ++K  +
Sbjct: 29  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFS 87
Query: 123 HENVIGLLDVFHSNTCL-ADFKNVYMVTHLMGADLNNILRTQKLS---DDHVQFLVYQIL 178
           H NV+ LL +     CL ++   + ++ ++   DL N +R +  +    D + F + Q+ 
Sbjct: 88  HPNVLSLLGI-----CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVA 141
Query: 179 RGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           +G+KY+ S   +HRDL   N  ++E   +K+ DFGLAR
Sbjct: 142 KGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 179

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 61/104 (58%), Gaps = 2/104 (1%)
Query: 146 YMVTHLMGADLNNILRTQKL-SDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED 204
           +++  + G DL+  L    + S+  ++F   +I+ GL+++H+  +++RDLKP+NI ++E 
Sbjct: 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH 328
Query: 205 CELKILDFGLARP-TENEMTGYVATRWYRAPEIMLNWMHYNQTG 247
             ++I D GLA   ++ +    V T  Y APE++   + Y+ + 
Sbjct: 329 GHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSA 372

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 61/104 (58%), Gaps = 2/104 (1%)
Query: 146 YMVTHLMGADLNNILRTQKL-SDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED 204
           +++  + G DL+  L    + S+  ++F   +I+ GL+++H+  +++RDLKP+NI ++E 
Sbjct: 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH 328
Query: 205 CELKILDFGLARP-TENEMTGYVATRWYRAPEIMLNWMHYNQTG 247
             ++I D GLA   ++ +    V T  Y APE++   + Y+ + 
Sbjct: 329 GHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSA 372

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 65  VIDIGPTLSKESFDLIFSSALDSVSGVKV--AIKKIARPFQSAVHAKRTYRELRMLKHMN 122
           ++     + +  F  ++   L    G K+  A+K + R         +   E  ++K  +
Sbjct: 28  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFS 86
Query: 123 HENVIGLLDVFHSNTCL-ADFKNVYMVTHLMGADLNNILRTQKLS---DDHVQFLVYQIL 178
           H NV+ LL +     CL ++   + ++ ++   DL N +R +  +    D + F + Q+ 
Sbjct: 87  HPNVLSLLGI-----CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVA 140
Query: 179 RGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           +G+KY+ S   +HRDL   N  ++E   +K+ DFGLAR
Sbjct: 141 KGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 80/175 (45%), Gaps = 32/175 (18%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRML-KHMNHENVIGLLDVFHSNTCLAD 141
            A+   +G + A+K I +  Q+     R +RE+  L +   ++N++ L++ F  +T    
Sbjct: 31  GAVSLQNGKEYAVKIIEK--QAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDT---- 84
Query: 142 FKNVYMVTHLM--GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
               Y+V   +  G+ L +I + +  ++     +V  +   L ++H+ GI HRDLKP NI
Sbjct: 85  --RFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENI 142
Query: 200 AVNEDCE-------LKILDFGLARP----------TENEMTGYVATRWYRAPEIM 237
                CE       +KI DF L             T  E+T    +  Y APE++
Sbjct: 143 L----CESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVV 193

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 88/184 (47%), Gaps = 19/184 (10%)
Query: 76  SFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTY-RELRMLKHMNHENVIGLLDVFH 134
           S +L     L   +G  VA+K++     S    +R + RE+++LK ++ + ++    V +
Sbjct: 25  SVELCRYDPLGDNTGALVAVKQLQ---HSGPDQQRDFQREIQILKALHSDFIVKYRGVSY 81
Query: 135 SNTCLADFKNVYMV-THLMGADLNNILRTQKLSDDHVQFLVY--QILRGLKYIHSAGIIH 191
                   +++ +V  +L    L + L+  +   D  + L+Y  QI +G++Y+ S   +H
Sbjct: 82  G----PGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVH 137
Query: 192 RDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATR-------WYRAPEIMLNWMHYN 244
           RDL   NI V  +  +KI DFGLA+    +   YV          WY APE + + +   
Sbjct: 138 RDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY-APESLSDNIFSR 196
Query: 245 QTGV 248
           Q+ V
Sbjct: 197 QSDV 200

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 65  VIDIGPTLSKESFDLIFSSALDSVSGVKV--AIKKIARPFQSAVHAKRTYRELRMLKHMN 122
           ++     + +  F  ++   L    G K+  A+K + R         +   E  ++K  +
Sbjct: 30  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFS 88
Query: 123 HENVIGLLDVFHSNTCL-ADFKNVYMVTHLMGADLNNILRTQKLS---DDHVQFLVYQIL 178
           H NV+ LL +     CL ++   + ++ ++   DL N +R +  +    D + F + Q+ 
Sbjct: 89  HPNVLSLLGI-----CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVA 142
Query: 179 RGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           +G+KY+ S   +HRDL   N  ++E   +K+ DFGLAR
Sbjct: 143 KGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 90/187 (48%), Gaps = 18/187 (9%)
Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP----FQSAVHAKRTYRELRMLKHMNH 123
           +GP L    F  ++S    S   + VAIK + +     +    +  R   E+ +LK ++ 
Sbjct: 12  VGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 70
Query: 124 --ENVIGLLDVFHS-NTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRG 180
               VI LLD F   ++ +   + +  V  L     + I     L ++  +   +Q+L  
Sbjct: 71  GFSGVIRLLDWFERPDSFVLILERMEPVQDL----FDFITERGALQEELARSFFWQVLEA 126
Query: 181 LKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARPTENEM-TGYVATRWYRAPEIML 238
           +++ H+ G++HRD+K  NI ++ +  ELK++DFG     ++ + T +  TR Y  PE   
Sbjct: 127 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE--- 183
Query: 239 NWMHYNQ 245
            W+ Y++
Sbjct: 184 -WIRYHR 189

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 88/184 (47%), Gaps = 19/184 (10%)
Query: 76  SFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTY-RELRMLKHMNHENVIGLLDVFH 134
           S +L     L   +G  VA+K++     S    +R + RE+++LK ++ + ++    V +
Sbjct: 38  SVELCRYDPLGDNTGALVAVKQLQ---HSGPDQQRDFQREIQILKALHSDFIVKYRGVSY 94
Query: 135 SNTCLADFKNVYMV-THLMGADLNNILRTQKLSDDHVQFLVY--QILRGLKYIHSAGIIH 191
                   +++ +V  +L    L + L+  +   D  + L+Y  QI +G++Y+ S   +H
Sbjct: 95  G----PGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVH 150
Query: 192 RDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATR-------WYRAPEIMLNWMHYN 244
           RDL   NI V  +  +KI DFGLA+    +   YV          WY APE + + +   
Sbjct: 151 RDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY-APESLSDNIFSR 209
Query: 245 QTGV 248
           Q+ V
Sbjct: 210 QSDV 213

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 78/351 (22%), Positives = 123/351 (35%), Gaps = 93/351 (26%)
Query: 83  SALDSVSG-VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDV-----FHSN 136
             LD   G  +VA+K I    +    A+     L+ +K  + EN    + +     FH +
Sbjct: 37  ECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96
Query: 137 TCLADFKNVYMVTHLMGADLNNILRTQKLSD---DHVQFLVYQILRGLKYIHSAGIIHRD 193
            C+A          L+G +    L+          HV+ + YQ+   L+++H   + H D
Sbjct: 97  MCIA--------FELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTD 148
Query: 194 LKPSNIAV-----------NEDCE--------LKILDFGLARPTENEMTGYVATRWYRAP 234
           LKP NI             ++ CE        +++ DFG A       T  VATR YR P
Sbjct: 149 LKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPP 208
Query: 235 EIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRA 294
           E+                                 IL+ G A+P +    G +   +YR 
Sbjct: 209 EV---------------------------------ILELGWAQPCDVWSIGCILFEYYRG 235
Query: 295 PEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLL---TKKDFR 351
               L   H N+     L ++ ++LG  P+     I     +KY     L+      D R
Sbjct: 236 --FTLFQTHENRE---HLVMMEKILGPIPSHM---IHRTRKQKYFYKGGLVWDENSSDGR 287
Query: 352 QVFKGANP-------------QAIXXXXXXXXXXXXKRITAEQALAHPYLS 389
            V +   P             Q              +RIT  +AL HP+ +
Sbjct: 288 YVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFA 338

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 74/155 (47%), Gaps = 18/155 (11%)
Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
            KVA+K + +P   +V A     E  ++K + H+ ++ L  V            +Y++T 
Sbjct: 213 TKVAVKTM-KPGSMSVEA--FLAEANVMKTLQHDKLVKLHAVVTKEP-------IYIITE 262
Query: 151 LMG-ADLNNILRTQKLSDDHVQFLV---YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE 206
            M    L + L++ + S   +  L+    QI  G+ +I     IHRDL+ +NI V+    
Sbjct: 263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV 322
Query: 207 LKILDFGLARPTE-NEMTGYVATRW---YRAPEIM 237
            KI DFGLAR  E NE T     ++   + APE +
Sbjct: 323 CKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 357

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 76/183 (41%), Gaps = 36/183 (19%)
Query: 84  ALDSVSG-VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDV-----FHSNT 137
            LD   G  +VA+K I    +    A+     L+ +K  + EN    + +     FH + 
Sbjct: 70  CLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 129
Query: 138 CLADFKNVYMVTHLMGADLNNILRTQKLSD---DHVQFLVYQILRGLKYIHSAGIIHRDL 194
           C+A          L+G +    L+          HV+ + YQ+   L+++H   + H DL
Sbjct: 130 CIA--------FELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDL 181
Query: 195 KPSNIAV-----------NEDCE--------LKILDFGLARPTENEMTGYVATRWYRAPE 235
           KP NI             ++ CE        +++ DFG A       T  VATR YR PE
Sbjct: 182 KPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPE 241
Query: 236 IML 238
           ++L
Sbjct: 242 VIL 244

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/178 (23%), Positives = 80/178 (44%), Gaps = 26/178 (14%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSS---ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELR 116
           E  R  +++G  L + +F  +  +    +D  +  +    K+ +   +    +    EL+
Sbjct: 24  EFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 83
Query: 117 MLKHMNHE-NVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQK---------- 164
           +L H+ H  NV+ LL       C      + ++       +L+  LR+++          
Sbjct: 84  ILIHIGHHLNVVNLL-----GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPE 138
Query: 165 ------LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
                 L+ +H+    +Q+ +G++++ S   IHRDL   NI ++E   +KI DFGLAR
Sbjct: 139 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 78/351 (22%), Positives = 123/351 (35%), Gaps = 93/351 (26%)
Query: 83  SALDSVSG-VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDV-----FHSN 136
             LD   G  +VA+K I    +    A+     L+ +K  + EN    + +     FH +
Sbjct: 46  ECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 105
Query: 137 TCLADFKNVYMVTHLMGADLNNILRTQKLSD---DHVQFLVYQILRGLKYIHSAGIIHRD 193
            C+A          L+G +    L+          HV+ + YQ+   L+++H   + H D
Sbjct: 106 MCIA--------FELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTD 157
Query: 194 LKPSNIAV-----------NEDCE--------LKILDFGLARPTENEMTGYVATRWYRAP 234
           LKP NI             ++ CE        +++ DFG A       T  VATR YR P
Sbjct: 158 LKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPP 217
Query: 235 EIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRA 294
           E+                                 IL+ G A+P +    G +   +YR 
Sbjct: 218 EV---------------------------------ILELGWAQPCDVWSIGCILFEYYRG 244
Query: 295 PEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLL---TKKDFR 351
               L   H N+     L ++ ++LG  P+     I     +KY     L+      D R
Sbjct: 245 --FTLFQTHENRE---HLVMMEKILGPIPSHM---IHRTRKQKYFYKGGLVWDENSSDGR 296
Query: 352 QVFKGANP-------------QAIXXXXXXXXXXXXKRITAEQALAHPYLS 389
            V +   P             Q              +RIT  +AL HP+ +
Sbjct: 297 YVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFA 347

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/103 (27%), Positives = 49/103 (47%), Gaps = 8/103 (7%)
Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDDHV 170
           RE+ +  H+ H N++ + + FH      D K +Y++      G     + +  +  +   
Sbjct: 63  REIEIQSHLRHPNILRMYNYFH------DRKRIYLMLEFAPRGELYKELQKHGRFDEQRS 116
Query: 171 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG 213
              + ++   L Y H   +IHRD+KP N+ +    ELKI DFG
Sbjct: 117 ATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFG 159

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 83/186 (44%), Gaps = 19/186 (10%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVS--GVKVAIKKIARPFQSAVHAKRTYRELRM 117
           EI R  I++G  + +  F  +      S     + VAIK        +V  K     L M
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 118 LKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDDHVQFLVY- 175
            +  +H +++ L+ V   N        V+++  L    +L + L+ +K S D    ++Y 
Sbjct: 66  -RQFDHPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKFSLDLASLILYA 117
Query: 176 -QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT-----GYVATR 229
            Q+   L Y+ S   +HRD+   N+ V+ +  +K+ DFGL+R  E+        G +  +
Sbjct: 118 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIK 177
Query: 230 WYRAPE 235
           W  APE
Sbjct: 178 WM-APE 182

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 84/180 (46%), Gaps = 40/180 (22%)
Query: 87  SVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN-HENVIGLLDVFHSNTCLADFKNV 145
           S  G  VA+K++   F           E+++L   + H NVI     ++ +     F  +
Sbjct: 36  SFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIR----YYCSETTDRF--L 84
Query: 146 YMVTHLMGADLNNILRTQKLSDDHVQF--------LVYQILRGLKYIHSAGIIHRDLKPS 197
           Y+   L   +L +++ ++ +SD++++         L+ QI  G+ ++HS  IIHRDLKP 
Sbjct: 85  YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQ 144
Query: 198 NIAVN-------------EDCELKILDFGLARPTENEMTGY-------VATRWYRAPEIM 237
           NI V+             E+  + I DFGL +  ++  + +         T  +RAPE++
Sbjct: 145 NILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELL 204

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 89/187 (47%), Gaps = 18/187 (9%)
Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP----FQSAVHAKRTYRELRMLKHMNH 123
           +GP L    F  ++S    S   + VAIK + +     +    +  R   E+ +LK ++ 
Sbjct: 13  VGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 71
Query: 124 --ENVIGLLDVFHS-NTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRG 180
               VI LLD F   ++ +   +    V  L     + I     L ++  +   +Q+L  
Sbjct: 72  GFSGVIRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARSFFWQVLEA 127
Query: 181 LKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARPTENEM-TGYVATRWYRAPEIML 238
           +++ H+ G++HRD+K  NI ++ +  ELK++DFG     ++ + T +  TR Y  PE   
Sbjct: 128 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE--- 184
Query: 239 NWMHYNQ 245
            W+ Y++
Sbjct: 185 -WIRYHR 190

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 77/172 (44%), Gaps = 21/172 (12%)
Query: 77  FDLIFSSALDSVSG---VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVF 133
           F  ++   L + SG   V VAIK +   +           E  ++   +H N+I L  V 
Sbjct: 57  FGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQFSHHNIIRLEGV- 114
Query: 134 HSNTCLADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQF--LVYQILRGLKYIHSAGII 190
                ++ +K + ++T  M    L+  LR +      +Q   ++  I  G+KY+ +   +
Sbjct: 115 -----ISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYV 169
Query: 191 HRDLKPSNIAVNEDCELKILDFGLARPTENE-------MTGYVATRWYRAPE 235
           HRDL   NI VN +   K+ DFGL+R  E++         G +  RW  APE
Sbjct: 170 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW-TAPE 220

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 87/204 (42%), Gaps = 31/204 (15%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSS---ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELR 116
           E  R  + +G  L + +F  +  +    +D  +  +    K+ +   +    +    EL+
Sbjct: 25  EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 84
Query: 117 MLKHMNHE-NVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQK---------- 164
           +L H+ H  NV+ LL       C      + ++       +L+  LR+++          
Sbjct: 85  ILIHIGHHLNVVNLL-----GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAP 139
Query: 165 -------LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP 217
                  L+ +H+    +Q+ +G++++ S   IHRDL   NI ++E   +KI DFGLAR 
Sbjct: 140 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 199
Query: 218 TENEMTGYVATRWYRAPEIMLNWM 241
              +   YV     R P   L WM
Sbjct: 200 IYKD-PDYVRKGDARLP---LKWM 219

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 78/182 (42%), Gaps = 23/182 (12%)
Query: 58  YSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRM 117
           Y EI    + +   +   SF  ++         V V I K+  P      A R   E+ +
Sbjct: 30  YWEIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRN--EVAV 85
Query: 118 LKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQFL--V 174
           L+   H N++  +     +       N+ +VT    G+ L   L  Q+      Q +   
Sbjct: 86  LRKTRHVNILLFMGYMTKD-------NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIA 138
Query: 175 YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP 234
            Q  +G+ Y+H+  IIHRD+K +NI ++E   +KI DFGLA          V +RW  + 
Sbjct: 139 RQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLAT---------VKSRWSGSQ 189
Query: 235 EI 236
           ++
Sbjct: 190 QV 191

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 87/204 (42%), Gaps = 31/204 (15%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSS---ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELR 116
           E  R  + +G  L + +F  +  +    +D  +  +    K+ +   +    +    EL+
Sbjct: 60  EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 119
Query: 117 MLKHMNHE-NVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQK---------- 164
           +L H+ H  NV+ LL       C      + ++       +L+  LR+++          
Sbjct: 120 ILIHIGHHLNVVNLL-----GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 174
Query: 165 -------LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP 217
                  L+ +H+    +Q+ +G++++ S   IHRDL   NI ++E   +KI DFGLAR 
Sbjct: 175 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 234
Query: 218 TENEMTGYVATRWYRAPEIMLNWM 241
              +   YV     R P   L WM
Sbjct: 235 IYKD-PDYVRKGDARLP---LKWM 254

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 89/187 (47%), Gaps = 18/187 (9%)
Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP----FQSAVHAKRTYRELRMLKHMNH 123
           +GP L    F  ++S    S   + VAIK + +     +    +  R   E+ +LK ++ 
Sbjct: 35  VGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 93
Query: 124 --ENVIGLLDVFHS-NTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRG 180
               VI LLD F   ++ +   +    V  L     + I     L ++  +   +Q+L  
Sbjct: 94  GFSGVIRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARSFFWQVLEA 149
Query: 181 LKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARPTENEM-TGYVATRWYRAPEIML 238
           +++ H+ G++HRD+K  NI ++ +  ELK++DFG     ++ + T +  TR Y  PE   
Sbjct: 150 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE--- 206
Query: 239 NWMHYNQ 245
            W+ Y++
Sbjct: 207 -WIRYHR 212

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 89/187 (47%), Gaps = 18/187 (9%)
Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP----FQSAVHAKRTYRELRMLKHMNH 123
           +GP L    F  ++S    S   + VAIK + +     +    +  R   E+ +LK ++ 
Sbjct: 28  VGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 86
Query: 124 --ENVIGLLDVFHS-NTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRG 180
               VI LLD F   ++ +   +    V  L     + I     L ++  +   +Q+L  
Sbjct: 87  GFSGVIRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARSFFWQVLEA 142
Query: 181 LKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARPTENEM-TGYVATRWYRAPEIML 238
           +++ H+ G++HRD+K  NI ++ +  ELK++DFG     ++ + T +  TR Y  PE   
Sbjct: 143 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE--- 199
Query: 239 NWMHYNQ 245
            W+ Y++
Sbjct: 200 -WIRYHR 205

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 89/187 (47%), Gaps = 18/187 (9%)
Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP----FQSAVHAKRTYRELRMLKHMNH 123
           +GP L    F  ++S    S   + VAIK + +     +    +  R   E+ +LK ++ 
Sbjct: 47  VGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 105
Query: 124 --ENVIGLLDVFHS-NTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRG 180
               VI LLD F   ++ +   +    V  L     + I     L ++  +   +Q+L  
Sbjct: 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARSFFWQVLEA 161
Query: 181 LKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARPTENEM-TGYVATRWYRAPEIML 238
           +++ H+ G++HRD+K  NI ++ +  ELK++DFG     ++ + T +  TR Y  PE   
Sbjct: 162 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE--- 218
Query: 239 NWMHYNQ 245
            W+ Y++
Sbjct: 219 -WIRYHR 224

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 89/187 (47%), Gaps = 18/187 (9%)
Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP----FQSAVHAKRTYRELRMLKHMNH 123
           +GP L    F  ++S    S   + VAIK + +     +    +  R   E+ +LK ++ 
Sbjct: 13  VGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 71
Query: 124 --ENVIGLLDVFHS-NTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRG 180
               VI LLD F   ++ +   +    V  L     + I     L ++  +   +Q+L  
Sbjct: 72  GFSGVIRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARSFFWQVLEA 127
Query: 181 LKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARPTENEM-TGYVATRWYRAPEIML 238
           +++ H+ G++HRD+K  NI ++ +  ELK++DFG     ++ + T +  TR Y  PE   
Sbjct: 128 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE--- 184
Query: 239 NWMHYNQ 245
            W+ Y++
Sbjct: 185 -WIRYHR 190

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 89/187 (47%), Gaps = 18/187 (9%)
Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP----FQSAVHAKRTYRELRMLKHMNH 123
           +GP L    F  ++S    S   + VAIK + +     +    +  R   E+ +LK ++ 
Sbjct: 28  VGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 86
Query: 124 --ENVIGLLDVFHS-NTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRG 180
               VI LLD F   ++ +   +    V  L     + I     L ++  +   +Q+L  
Sbjct: 87  GFSGVIRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARSFFWQVLEA 142
Query: 181 LKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARPTENEM-TGYVATRWYRAPEIML 238
           +++ H+ G++HRD+K  NI ++ +  ELK++DFG     ++ + T +  TR Y  PE   
Sbjct: 143 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE--- 199
Query: 239 NWMHYNQ 245
            W+ Y++
Sbjct: 200 -WIRYHR 205

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 89/187 (47%), Gaps = 18/187 (9%)
Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP----FQSAVHAKRTYRELRMLKHMNH 123
           +GP L    F  ++S    S   + VAIK + +     +    +  R   E+ +LK ++ 
Sbjct: 13  VGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 71
Query: 124 --ENVIGLLDVFHS-NTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRG 180
               VI LLD F   ++ +   +    V  L     + I     L ++  +   +Q+L  
Sbjct: 72  GFSGVIRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARSFFWQVLEA 127
Query: 181 LKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARPTENEM-TGYVATRWYRAPEIML 238
           +++ H+ G++HRD+K  NI ++ +  ELK++DFG     ++ + T +  TR Y  PE   
Sbjct: 128 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE--- 184
Query: 239 NWMHYNQ 245
            W+ Y++
Sbjct: 185 -WIRYHR 190

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 89/187 (47%), Gaps = 18/187 (9%)
Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP----FQSAVHAKRTYRELRMLKHMNH 123
           +GP L    F  ++S    S   + VAIK + +     +    +  R   E+ +LK ++ 
Sbjct: 27  VGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 85
Query: 124 --ENVIGLLDVFHS-NTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRG 180
               VI LLD F   ++ +   +    V  L     + I     L ++  +   +Q+L  
Sbjct: 86  GFSGVIRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARSFFWQVLEA 141
Query: 181 LKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARPTENEM-TGYVATRWYRAPEIML 238
           +++ H+ G++HRD+K  NI ++ +  ELK++DFG     ++ + T +  TR Y  PE   
Sbjct: 142 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE--- 198
Query: 239 NWMHYNQ 245
            W+ Y++
Sbjct: 199 -WIRYHR 204

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 87/177 (49%), Gaps = 26/177 (14%)
Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHEN-----------VIGLLDV 132
           A D V+   VA+K I R     V+ +    E+++L+ +N  +           ++ LLD 
Sbjct: 38  AKDMVNNTHVAMK-IVR--GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD- 93
Query: 133 FHSNTCLADFKNVYMVTHLMGADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHS-AG 188
            H N    +  +V MV  ++G +L  +++    + +   +V+ +  Q+L GL Y+H   G
Sbjct: 94  -HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG 152
Query: 189 IIHRDLKPSNIAVN------EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN 239
           IIH D+KP N+ +          ++KI D G A   +   T  + TR YR+PE++L 
Sbjct: 153 IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLG 209

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 89/187 (47%), Gaps = 18/187 (9%)
Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP----FQSAVHAKRTYRELRMLKHMNH 123
           +GP L    F  ++S    S   + VAIK + +     +    +  R   E+ +LK ++ 
Sbjct: 41  VGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 99
Query: 124 --ENVIGLLDVFHS-NTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRG 180
               VI LLD F   ++ +   +    V  L     + I     L ++  +   +Q+L  
Sbjct: 100 GFSGVIRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARSFFWQVLEA 155
Query: 181 LKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARPTENEM-TGYVATRWYRAPEIML 238
           +++ H+ G++HRD+K  NI ++ +  ELK++DFG     ++ + T +  TR Y  PE   
Sbjct: 156 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE--- 212
Query: 239 NWMHYNQ 245
            W+ Y++
Sbjct: 213 -WIRYHR 218

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/177 (23%), Positives = 79/177 (44%), Gaps = 25/177 (14%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSS---ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELR 116
           E  R  + +G  L + +F  +  +    +D  +  +    K+ +   +    +    EL+
Sbjct: 25  EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELK 84
Query: 117 MLKHMNHE-NVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQK---------- 164
           +L H+ H  NV+ LL       C      + ++       +L+  LR+++          
Sbjct: 85  ILIHIGHHLNVVNLL-----GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPED 139
Query: 165 -----LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
                L+ +H+    +Q+ +G++++ S   IHRDL   NI ++E   +KI DFGLAR
Sbjct: 140 LYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 89/187 (47%), Gaps = 18/187 (9%)
Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP----FQSAVHAKRTYRELRMLKHMNH 123
           +GP L    F  ++S    S   + VAIK + +     +    +  R   E+ +LK ++ 
Sbjct: 40  VGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 98
Query: 124 --ENVIGLLDVFHS-NTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRG 180
               VI LLD F   ++ +   +    V  L     + I     L ++  +   +Q+L  
Sbjct: 99  GFSGVIRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARSFFWQVLEA 154
Query: 181 LKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARPTENEM-TGYVATRWYRAPEIML 238
           +++ H+ G++HRD+K  NI ++ +  ELK++DFG     ++ + T +  TR Y  PE   
Sbjct: 155 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE--- 211
Query: 239 NWMHYNQ 245
            W+ Y++
Sbjct: 212 -WIRYHR 217

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 87/177 (49%), Gaps = 26/177 (14%)
Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHEN-----------VIGLLDV 132
           A D V+   VA+K I R     V+ +    E+++L+ +N  +           ++ LLD 
Sbjct: 38  AKDMVNNTHVAMK-IVR--GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD- 93
Query: 133 FHSNTCLADFKNVYMVTHLMGADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHS-AG 188
            H N    +  +V MV  ++G +L  +++    + +   +V+ +  Q+L GL Y+H   G
Sbjct: 94  -HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG 152
Query: 189 IIHRDLKPSNIAVN------EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN 239
           IIH D+KP N+ +          ++KI D G A   +   T  + TR YR+PE++L 
Sbjct: 153 IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLG 209

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 89/187 (47%), Gaps = 18/187 (9%)
Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP----FQSAVHAKRTYRELRMLKHMNH 123
           +GP L    F  ++S    S   + VAIK + +     +    +  R   E+ +LK ++ 
Sbjct: 28  VGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 86
Query: 124 --ENVIGLLDVFHS-NTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRG 180
               VI LLD F   ++ +   +    V  L     + I     L ++  +   +Q+L  
Sbjct: 87  GFSGVIRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARSFFWQVLEA 142
Query: 181 LKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARPTENEM-TGYVATRWYRAPEIML 238
           +++ H+ G++HRD+K  NI ++ +  ELK++DFG     ++ + T +  TR Y  PE   
Sbjct: 143 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE--- 199
Query: 239 NWMHYNQ 245
            W+ Y++
Sbjct: 200 -WIRYHR 205

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 72/153 (47%), Gaps = 11/153 (7%)
Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           ++ AIK ++R        +   RE  +++ +NH NV+ L+ +      L      YM   
Sbjct: 50  IQCAIKSLSR-ITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCH- 107
Query: 151 LMGADLNNILRTQKLS---DDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
               DL   +R+ + +    D + F + Q+ RG++Y+     +HRDL   N  ++E   +
Sbjct: 108 ---GDLLQFIRSPQRNPTVKDLISFGL-QVARGMEYLAEQKFVHRDLAARNCMLDESFTV 163
Query: 208 KILDFGLARPTENEMTGYVATRWYRAPEIMLNW 240
           K+ DFGLAR   +    Y + + +R   + + W
Sbjct: 164 KVADFGLARDILDR--EYYSVQQHRHARLPVKW 194

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 90/180 (50%), Gaps = 19/180 (10%)
Query: 69  GPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTY-RELRMLKHMNHENV 126
           G  + +  F +++   +++ +   VA+KK+A     +    K+ + +E++++    HEN+
Sbjct: 36  GNKMGEGGFGVVYKGYVNNTT---VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL 92
Query: 127 IGLLDVFHSNT---CLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQ-ILRGLK 182
           + LL  F S+    CL     VYM    +   L+ +  T  LS  H++  + Q    G+ 
Sbjct: 93  VELLG-FSSDGDDLCLV---YVYMPNGSLLDRLSCLDGTPPLSW-HMRCKIAQGAANGIN 147
Query: 183 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN-----EMTGYVATRWYRAPEIM 237
           ++H    IHRD+K +NI ++E    KI DFGLAR +E        +  V T  Y APE +
Sbjct: 148 FLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEAL 207

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 89/187 (47%), Gaps = 18/187 (9%)
Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP----FQSAVHAKRTYRELRMLKHMNH 123
           +GP L    F  ++S    S   + VAIK + +     +    +  R   E+ +LK ++ 
Sbjct: 27  VGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 85
Query: 124 --ENVIGLLDVFHS-NTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRG 180
               VI LLD F   ++ +   +    V  L     + I     L ++  +   +Q+L  
Sbjct: 86  GFSGVIRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARSFFWQVLEA 141
Query: 181 LKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARPTENEM-TGYVATRWYRAPEIML 238
           +++ H+ G++HRD+K  NI ++ +  ELK++DFG     ++ + T +  TR Y  PE   
Sbjct: 142 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE--- 198
Query: 239 NWMHYNQ 245
            W+ Y++
Sbjct: 199 -WIRYHR 204

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 89/187 (47%), Gaps = 18/187 (9%)
Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP----FQSAVHAKRTYRELRMLKHMNH 123
           +GP L    F  ++S    S   + VAIK + +     +    +  R   E+ +LK ++ 
Sbjct: 12  VGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 70
Query: 124 --ENVIGLLDVFHS-NTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRG 180
               VI LLD F   ++ +   +    V  L     + I     L ++  +   +Q+L  
Sbjct: 71  GFSGVIRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARSFFWQVLEA 126
Query: 181 LKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARPTENEM-TGYVATRWYRAPEIML 238
           +++ H+ G++HRD+K  NI ++ +  ELK++DFG     ++ + T +  TR Y  PE   
Sbjct: 127 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE--- 183
Query: 239 NWMHYNQ 245
            W+ Y++
Sbjct: 184 -WIRYHR 189

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 89/187 (47%), Gaps = 18/187 (9%)
Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP----FQSAVHAKRTYRELRMLKHMNH 123
           +GP L    F  ++S    S   + VAIK + +     +    +  R   E+ +LK ++ 
Sbjct: 40  VGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 98
Query: 124 --ENVIGLLDVFHS-NTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRG 180
               VI LLD F   ++ +   +    V  L     + I     L ++  +   +Q+L  
Sbjct: 99  GFSGVIRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARSFFWQVLEA 154
Query: 181 LKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARPTENEM-TGYVATRWYRAPEIML 238
           +++ H+ G++HRD+K  NI ++ +  ELK++DFG     ++ + T +  TR Y  PE   
Sbjct: 155 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE--- 211
Query: 239 NWMHYNQ 245
            W+ Y++
Sbjct: 212 -WIRYHR 217

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 81/216 (37%), Gaps = 37/216 (17%)
Query: 54  FNQPYSEICRGVIDIGPTLSKESFDLIFSSA---LDSVSGVKVAIKKIARPFQSAVHAKR 110
              P  E  R  + +G TL +  F  +  +    L   +G      K+ +   S    + 
Sbjct: 13  LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD 72
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQK------ 164
              E  +LK +NH +VI L        C  D   + +V +     L   LR  +      
Sbjct: 73  LLSEFNVLKQVNHPHVIKLY-----GACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 165 -------------------LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
                              L+   +    +QI +G++Y+    ++HRDL   NI V E  
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGR 187
Query: 206 ELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM 241
           ++KI DFGL+R    E   YV     R P   + WM
Sbjct: 188 KMKISDFGLSRDVYEE-DSYVKRSQGRIP---VKWM 219

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 65  VIDIGPTLSKESFDLIFSSALDSVSGVKV--AIKKIARPFQSAVHAKRTYRELRMLKHMN 122
           ++     + +  F  ++   L    G K+  A+K + R         +   E  ++K  +
Sbjct: 90  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFS 148
Query: 123 HENVIGLLDVFHSNTCL-ADFKNVYMVTHLMGADLNNILRTQKLS---DDHVQFLVYQIL 178
           H NV+ LL +     CL ++   + ++ ++   DL N +R +  +    D + F + Q+ 
Sbjct: 149 HPNVLSLLGI-----CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVA 202
Query: 179 RGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           +G+K++ S   +HRDL   N  ++E   +K+ DFGLAR
Sbjct: 203 KGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 89/187 (47%), Gaps = 18/187 (9%)
Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP----FQSAVHAKRTYRELRMLKHMNH 123
           +GP L    F  ++S    S   + VAIK + +     +    +  R   E+ +LK ++ 
Sbjct: 40  VGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 98
Query: 124 --ENVIGLLDVFHS-NTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRG 180
               VI LLD F   ++ +   +    V  L     + I     L ++  +   +Q+L  
Sbjct: 99  GFSGVIRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARSFFWQVLEA 154
Query: 181 LKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARPTENEM-TGYVATRWYRAPEIML 238
           +++ H+ G++HRD+K  NI ++ +  ELK++DFG     ++ + T +  TR Y  PE   
Sbjct: 155 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE--- 211
Query: 239 NWMHYNQ 245
            W+ Y++
Sbjct: 212 -WIRYHR 217

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/80 (37%), Positives = 49/80 (61%), Gaps = 5/80 (6%)
Query: 163 QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED---CELKILDFGLARPTE 219
           + +S++ V  L+ QIL G+ Y+H   I+H DLKP NI ++      ++KI+DFG++R   
Sbjct: 126 EMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185
Query: 220 N--EMTGYVATRWYRAPEIM 237
           +  E+   + T  Y APEI+
Sbjct: 186 HACELREIMGTPEYLAPEIL 205

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/147 (27%), Positives = 67/147 (45%), Gaps = 9/147 (6%)
Query: 254 DLKPSNIAVNED---CELKILDFGLARPTEN--EMTGYVATRWYRAPEIMLNWMHYNQTD 308
           DLKP NI ++      ++KI+DFG++R   +  E+   + T  Y APEI+        TD
Sbjct: 156 DLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATD 215
Query: 309 IHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXX 368
           +  + +I  ML T  + F+ +   D+   Y+N +  +      + F   +  A       
Sbjct: 216 MWNIGIIAYMLLTHTSPFVGE---DNQETYLN-ISQVNVDYSEETFSSVSQLATDFIQSL 271
Query: 369 XXXXXXKRITAEQALAHPYLSQYSDPN 395
                 KR TAE  L+H +L Q+   N
Sbjct: 272 LVKNPEKRPTAEICLSHSWLQQWDFEN 298

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 89/187 (47%), Gaps = 18/187 (9%)
Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP----FQSAVHAKRTYRELRMLKHMNH 123
           +GP L    F  ++S    S   + VAIK + +     +    +  R   E+ +LK ++ 
Sbjct: 41  VGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 99
Query: 124 --ENVIGLLDVFHS-NTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRG 180
               VI LLD F   ++ +   +    V  L     + I     L ++  +   +Q+L  
Sbjct: 100 GFSGVIRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARSFFWQVLEA 155
Query: 181 LKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARPTENEM-TGYVATRWYRAPEIML 238
           +++ H+ G++HRD+K  NI ++ +  ELK++DFG     ++ + T +  TR Y  PE   
Sbjct: 156 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE--- 212
Query: 239 NWMHYNQ 245
            W+ Y++
Sbjct: 213 -WIRYHR 218

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 87/204 (42%), Gaps = 31/204 (15%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSS---ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELR 116
           E  R  + +G  L + +F  +  +    +D  +  +    K+ +   +    +    EL+
Sbjct: 23  EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 82
Query: 117 MLKHMNHE-NVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQK---------- 164
           +L H+ H  NV+ LL       C      + ++       +L+  LR+++          
Sbjct: 83  ILIHIGHHLNVVNLL-----GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 137
Query: 165 -------LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP 217
                  L+ +H+    +Q+ +G++++ S   IHRDL   NI ++E   +KI DFGLAR 
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 197
Query: 218 TENEMTGYVATRWYRAPEIMLNWM 241
              +   YV     R P   L WM
Sbjct: 198 IYKD-PDYVRKGDARLP---LKWM 217

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 89/187 (47%), Gaps = 18/187 (9%)
Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP----FQSAVHAKRTYRELRMLKHMNH 123
           +GP L    F  ++S    S   + VAIK + +     +    +  R   E+ +LK ++ 
Sbjct: 41  VGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 99
Query: 124 --ENVIGLLDVFHS-NTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRG 180
               VI LLD F   ++ +   +    V  L     + I     L ++  +   +Q+L  
Sbjct: 100 GFSGVIRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARSFFWQVLEA 155
Query: 181 LKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARPTENEM-TGYVATRWYRAPEIML 238
           +++ H+ G++HRD+K  NI ++ +  ELK++DFG     ++ + T +  TR Y  PE   
Sbjct: 156 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE--- 212
Query: 239 NWMHYNQ 245
            W+ Y++
Sbjct: 213 -WIRYHR 218

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 89/187 (47%), Gaps = 18/187 (9%)
Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP----FQSAVHAKRTYRELRMLKHMNH 123
           +GP L    F  ++S    S   + VAIK + +     +    +  R   E+ +LK ++ 
Sbjct: 40  VGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 98
Query: 124 --ENVIGLLDVFHS-NTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRG 180
               VI LLD F   ++ +   +    V  L     + I     L ++  +   +Q+L  
Sbjct: 99  GFSGVIRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARSFFWQVLEA 154
Query: 181 LKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARPTENEM-TGYVATRWYRAPEIML 238
           +++ H+ G++HRD+K  NI ++ +  ELK++DFG     ++ + T +  TR Y  PE   
Sbjct: 155 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE--- 211
Query: 239 NWMHYNQ 245
            W+ Y++
Sbjct: 212 -WIRYHR 217

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 91/188 (48%), Gaps = 22/188 (11%)
Query: 65  VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKI-ARPFQSA--VHAKRTYRELRMLKHM 121
           V ++   + K +F ++    ++  +G + A+K +    F S+  +  +   RE  +   +
Sbjct: 25  VYELCEVIGKGAFSVV-RRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 122 NHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLN-NILRTQK----LSDDHVQFLVY 175
            H +++ LL+ + S+  L      YMV   M GADL   I++        S+      + 
Sbjct: 84  KHPHIVELLETYSSDGML------YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR 137
Query: 176 QILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILDFGLA-RPTENEMT--GYVATR 229
           QIL  L+Y H   IIHRD+KP N+ +        +K+ DFG+A +  E+ +   G V T 
Sbjct: 138 QILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTP 197
Query: 230 WYRAPEIM 237
            + APE++
Sbjct: 198 HFMAPEVV 205

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 83/186 (44%), Gaps = 19/186 (10%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVS--GVKVAIKKIARPFQSAVHAKRTYRELRM 117
           EI R  I++G  + +  F  +      S     + VAIK        +V  K     L M
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 445
Query: 118 LKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDDHVQFLVY- 175
            +  +H +++ L+ V   N        V+++  L    +L + L+ +K S D    ++Y 
Sbjct: 446 -RQFDHPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKFSLDLASLILYA 497
Query: 176 -QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM-----TGYVATR 229
            Q+   L Y+ S   +HRD+   N+ V+ +  +K+ DFGL+R  E+        G +  +
Sbjct: 498 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 557
Query: 230 WYRAPE 235
           W  APE
Sbjct: 558 WM-APE 562

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 65  VIDIGPTLSKESFDLIFSSALDSVSGVKV--AIKKIARPFQSAVHAKRTYRELRMLKHMN 122
           ++     + +  F  ++   L    G K+  A+K + R         +   E  ++K  +
Sbjct: 31  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFS 89
Query: 123 HENVIGLLDVFHSNTCL-ADFKNVYMVTHLMGADLNNILRTQKLS---DDHVQFLVYQIL 178
           H NV+ LL +     CL ++   + ++ ++   DL N +R +  +    D + F + Q+ 
Sbjct: 90  HPNVLSLLGI-----CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVA 143
Query: 179 RGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           +G+K++ S   +HRDL   N  ++E   +K+ DFGLAR
Sbjct: 144 KGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 89/187 (47%), Gaps = 18/187 (9%)
Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP----FQSAVHAKRTYRELRMLKHMNH 123
           +GP L    F  ++S    S   + VAIK + +     +    +  R   E+ +LK ++ 
Sbjct: 55  VGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 113
Query: 124 --ENVIGLLDVFHS-NTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRG 180
               VI LLD F   ++ +   +    V  L     + I     L ++  +   +Q+L  
Sbjct: 114 GFSGVIRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARSFFWQVLEA 169
Query: 181 LKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARPTENEM-TGYVATRWYRAPEIML 238
           +++ H+ G++HRD+K  NI ++ +  ELK++DFG     ++ + T +  TR Y  PE   
Sbjct: 170 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE--- 226
Query: 239 NWMHYNQ 245
            W+ Y++
Sbjct: 227 -WIRYHR 232

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 62/131 (47%), Gaps = 10/131 (7%)
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLN---NILRTQKLSDDHV 170
           E ++L+ +N   V+ L   + +   L       ++T + G DL      +      +   
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALC-----LVLTLMNGGDLKFHIYHMGQAGFPEARA 288
Query: 171 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA--RPTENEMTGYVAT 228
            F   +I  GL+ +H   I++RDLKP NI +++   ++I D GLA   P    + G V T
Sbjct: 289 VFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGT 348
Query: 229 RWYRAPEIMLN 239
             Y APE++ N
Sbjct: 349 VGYMAPEVVKN 359

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 48/97 (49%), Gaps = 5/97 (5%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLA--RPTENEMTGYVATRWYRAPEIMLNWMHYNQTDI 309
           ++DLKP NI +++   ++I D GLA   P    + G V T  Y APE++ N  +    D 
Sbjct: 309 YRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDW 368
Query: 310 HQLN-LIMEMLG--TPPAEFMAKISSDSARKYINSLP 343
             L  L+ EM+   +P  +   KI  +   + +  +P
Sbjct: 369 WALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP 405

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 83/186 (44%), Gaps = 19/186 (10%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVS--GVKVAIKKIARPFQSAVHAKRTYRELRM 117
           EI R  I++G  + +  F  +      S     + VAIK        +V  K     L M
Sbjct: 34  EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 93
Query: 118 LKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDDHVQFLVY- 175
            +  +H +++ L+ V   N        V+++  L    +L + L+ +K S D    ++Y 
Sbjct: 94  -RQFDHPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKYSLDLASLILYA 145
Query: 176 -QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM-----TGYVATR 229
            Q+   L Y+ S   +HRD+   N+ V+ +  +K+ DFGL+R  E+        G +  +
Sbjct: 146 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 205
Query: 230 WYRAPE 235
           W  APE
Sbjct: 206 WM-APE 210

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 89/187 (47%), Gaps = 18/187 (9%)
Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP----FQSAVHAKRTYRELRMLKHMNH 123
           +GP L    F  ++S    S   + VAIK + +     +    +  R   E+ +LK ++ 
Sbjct: 55  VGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 113
Query: 124 --ENVIGLLDVFHS-NTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRG 180
               VI LLD F   ++ +   +    V  L     + I     L ++  +   +Q+L  
Sbjct: 114 GFSGVIRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARSFFWQVLEA 169
Query: 181 LKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARPTENEM-TGYVATRWYRAPEIML 238
           +++ H+ G++HRD+K  NI ++ +  ELK++DFG     ++ + T +  TR Y  PE   
Sbjct: 170 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE--- 226
Query: 239 NWMHYNQ 245
            W+ Y++
Sbjct: 227 -WIRYHR 232

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 88/229 (38%), Gaps = 40/229 (17%)
Query: 54  FNQPYSEICRGVIDIGPTLSKESFDLIFSSA---LDSVSGVKVAIKKIARPFQSAVHAKR 110
              P  E  R  + +G TL +  F  +  +    L   +G      K+ +   S    + 
Sbjct: 13  LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD 72
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQK------ 164
              E  +LK +NH +VI L        C  D   + +V +     L   LR  +      
Sbjct: 73  LLSEFNVLKQVNHPHVIKLY-----GACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 165 -------------------LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
                              L+   +    +QI +G++Y+    ++HRDL   NI V E  
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGR 187
Query: 206 ELKILDFGLARPTENEMT------GYVATRWYRAPEIMLNWMHYNQTGV 248
           ++KI DFGL+R    E +      G +  +W  A E + + ++  Q+ V
Sbjct: 188 KMKISDFGLSRDVYEEDSXVKRSQGRIPVKWM-AIESLFDHIYTTQSDV 235

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 89/187 (47%), Gaps = 18/187 (9%)
Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP----FQSAVHAKRTYRELRMLKHMNH 123
           +GP L    F  ++S    S   + VAIK + +     +    +  R   E+ +LK ++ 
Sbjct: 60  VGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 118
Query: 124 --ENVIGLLDVFHS-NTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRG 180
               VI LLD F   ++ +   +    V  L     + I     L ++  +   +Q+L  
Sbjct: 119 GFSGVIRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARSFFWQVLEA 174
Query: 181 LKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARPTENEM-TGYVATRWYRAPEIML 238
           +++ H+ G++HRD+K  NI ++ +  ELK++DFG     ++ + T +  TR Y  PE   
Sbjct: 175 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE--- 231
Query: 239 NWMHYNQ 245
            W+ Y++
Sbjct: 232 -WIRYHR 237

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 89/187 (47%), Gaps = 18/187 (9%)
Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP----FQSAVHAKRTYRELRMLKHMNH 123
           +GP L    F  ++S    S   + VAIK + +     +    +  R   E+ +LK ++ 
Sbjct: 41  VGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 99
Query: 124 --ENVIGLLDVFHS-NTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRG 180
               VI LLD F   ++ +   +    V  L     + I     L ++  +   +Q+L  
Sbjct: 100 GFSGVIRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARSFFWQVLEA 155
Query: 181 LKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARPTENEM-TGYVATRWYRAPEIML 238
           +++ H+ G++HRD+K  NI ++ +  ELK++DFG     ++ + T +  TR Y  PE   
Sbjct: 156 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE--- 212
Query: 239 NWMHYNQ 245
            W+ Y++
Sbjct: 213 -WIRYHR 218

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 83/186 (44%), Gaps = 19/186 (10%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVS--GVKVAIKKIARPFQSAVHAKRTYRELRM 117
           EI R  I++G  + +  F  +      S     + VAIK        +V  K     L M
Sbjct: 11  EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 70
Query: 118 LKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDDHVQFLVY- 175
            +  +H +++ L+ V   N        V+++  L    +L + L+ +K S D    ++Y 
Sbjct: 71  -RQFDHPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKYSLDLASLILYA 122
Query: 176 -QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM-----TGYVATR 229
            Q+   L Y+ S   +HRD+   N+ V+ +  +K+ DFGL+R  E+        G +  +
Sbjct: 123 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 182
Query: 230 WYRAPE 235
           W  APE
Sbjct: 183 WM-APE 187

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 65  VIDIGPTLSKESFDLIFSSALDSVSGVKV--AIKKIARPFQSAVHAKRTYRELRMLKHMN 122
           ++     + +  F  ++   L    G K+  A+K + R         +   E  ++K  +
Sbjct: 36  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFS 94
Query: 123 HENVIGLLDVFHSNTCL-ADFKNVYMVTHLMGADLNNILRTQKLS---DDHVQFLVYQIL 178
           H NV+ LL +     CL ++   + ++ ++   DL N +R +  +    D + F + Q+ 
Sbjct: 95  HPNVLSLLGI-----CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVA 148
Query: 179 RGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           +G+K++ S   +HRDL   N  ++E   +K+ DFGLAR
Sbjct: 149 KGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 186

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/179 (22%), Positives = 79/179 (44%), Gaps = 27/179 (15%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSS---ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELR 116
           E  R  + +G  L + +F  +  +    +D  +  +    K+ +   +    +    EL+
Sbjct: 23  EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 82
Query: 117 MLKHMNHE-NVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQK---------- 164
           +L H+ H  NV+ LL       C      + ++       +L+  LR+++          
Sbjct: 83  ILIHIGHHLNVVNLL-----GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 137
Query: 165 -------LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
                  L+ +H+    +Q+ +G++++ S   IHRDL   NI ++E   +KI DFGLAR
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 62/131 (47%), Gaps = 10/131 (7%)
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLN---NILRTQKLSDDHV 170
           E ++L+ +N   V+ L   + +   L       ++T + G DL      +      +   
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALC-----LVLTLMNGGDLKFHIYHMGQAGFPEARA 288
Query: 171 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA--RPTENEMTGYVAT 228
            F   +I  GL+ +H   I++RDLKP NI +++   ++I D GLA   P    + G V T
Sbjct: 289 VFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGT 348
Query: 229 RWYRAPEIMLN 239
             Y APE++ N
Sbjct: 349 VGYMAPEVVKN 359

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 48/97 (49%), Gaps = 5/97 (5%)
Query: 252 FQDLKPSNIAVNEDCELKILDFGLA--RPTENEMTGYVATRWYRAPEIMLNWMHYNQTDI 309
           ++DLKP NI +++   ++I D GLA   P    + G V T  Y APE++ N  +    D 
Sbjct: 309 YRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDW 368
Query: 310 HQLN-LIMEMLG--TPPAEFMAKISSDSARKYINSLP 343
             L  L+ EM+   +P  +   KI  +   + +  +P
Sbjct: 369 WALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP 405

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 83/186 (44%), Gaps = 19/186 (10%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVS--GVKVAIKKIARPFQSAVHAKRTYRELRM 117
           EI R  I++G  + +  F  +      S     + VAIK        +V  K     L M
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 118 LKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDDHVQFLVY- 175
            +  +H +++ L+ V   N        V+++  L    +L + L+ +K S D    ++Y 
Sbjct: 66  -RQFDHPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKYSLDLASLILYA 117
Query: 176 -QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM-----TGYVATR 229
            Q+   L Y+ S   +HRD+   N+ V+ +  +K+ DFGL+R  E+        G +  +
Sbjct: 118 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 230 WYRAPE 235
           W  APE
Sbjct: 178 WM-APE 182

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/179 (22%), Positives = 79/179 (44%), Gaps = 27/179 (15%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSS---ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELR 116
           E  R  + +G  L + +F  +  +    +D  +  +    K+ +   +    +    EL+
Sbjct: 14  EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 73
Query: 117 MLKHMNHE-NVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQK---------- 164
           +L H+ H  NV+ LL       C      + ++       +L+  LR+++          
Sbjct: 74  ILIHIGHHLNVVNLL-----GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 128
Query: 165 -------LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
                  L+ +H+    +Q+ +G++++ S   IHRDL   NI ++E   +KI DFGLAR
Sbjct: 129 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 83/186 (44%), Gaps = 19/186 (10%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVS--GVKVAIKKIARPFQSAVHAKRTYRELRM 117
           EI R  I++G  + +  F  +      S     + VAIK        +V  K     L M
Sbjct: 8   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 67
Query: 118 LKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDDHVQFLVY- 175
            +  +H +++ L+ V   N        V+++  L    +L + L+ +K S D    ++Y 
Sbjct: 68  -RQFDHPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKYSLDLASLILYA 119
Query: 176 -QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM-----TGYVATR 229
            Q+   L Y+ S   +HRD+   N+ V+ +  +K+ DFGL+R  E+        G +  +
Sbjct: 120 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 179
Query: 230 WYRAPE 235
           W  APE
Sbjct: 180 WM-APE 184

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 83/186 (44%), Gaps = 19/186 (10%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVS--GVKVAIKKIARPFQSAVHAKRTYRELRM 117
           EI R  I++G  + +  F  +      S     + VAIK        +V  K     L M
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 118 LKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDDHVQFLVY- 175
            +  +H +++ L+ V   N        V+++  L    +L + L+ +K S D    ++Y 
Sbjct: 66  -RQFDHPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKYSLDLASLILYA 117
Query: 176 -QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM-----TGYVATR 229
            Q+   L Y+ S   +HRD+   N+ V+ +  +K+ DFGL+R  E+        G +  +
Sbjct: 118 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 230 WYRAPE 235
           W  APE
Sbjct: 178 WM-APE 182

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 83/186 (44%), Gaps = 19/186 (10%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVS--GVKVAIKKIARPFQSAVHAKRTYRELRM 117
           EI R  I++G  + +  F  +      S     + VAIK        +V  K     L M
Sbjct: 3   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 62
Query: 118 LKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDDHVQFLVY- 175
            +  +H +++ L+ V   N        V+++  L    +L + L+ +K S D    ++Y 
Sbjct: 63  -RQFDHPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKYSLDLASLILYA 114
Query: 176 -QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM-----TGYVATR 229
            Q+   L Y+ S   +HRD+   N+ V+ +  +K+ DFGL+R  E+        G +  +
Sbjct: 115 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 174
Query: 230 WYRAPE 235
           W  APE
Sbjct: 175 WM-APE 179

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/179 (22%), Positives = 79/179 (44%), Gaps = 27/179 (15%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSS---ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELR 116
           E  R  + +G  L + +F  +  +    +D  +  +    K+ +   +    +    EL+
Sbjct: 23  EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 82
Query: 117 MLKHMNHE-NVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQK---------- 164
           +L H+ H  NV+ LL       C      + ++       +L+  LR+++          
Sbjct: 83  ILIHIGHHLNVVNLL-----GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 137
Query: 165 -------LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
                  L+ +H+    +Q+ +G++++ S   IHRDL   NI ++E   +KI DFGLAR
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 83/186 (44%), Gaps = 19/186 (10%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVS--GVKVAIKKIARPFQSAVHAKRTYRELRM 117
           EI R  I++G  + +  F  +      S     + VAIK        +V  K     L M
Sbjct: 9   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 68
Query: 118 LKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDDHVQFLVY- 175
            +  +H +++ L+ V   N        V+++  L    +L + L+ +K S D    ++Y 
Sbjct: 69  -RQFDHPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKYSLDLASLILYA 120
Query: 176 -QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM-----TGYVATR 229
            Q+   L Y+ S   +HRD+   N+ V+ +  +K+ DFGL+R  E+        G +  +
Sbjct: 121 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 180
Query: 230 WYRAPE 235
           W  APE
Sbjct: 181 WM-APE 185

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 65  VIDIGPTLSKESFDLIFSSALDSVSGVKV--AIKKIARPFQSAVHAKRTYRELRMLKHMN 122
           ++     + +  F  ++   L    G K+  A+K + R         +   E  ++K  +
Sbjct: 32  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFS 90
Query: 123 HENVIGLLDVFHSNTCL-ADFKNVYMVTHLMGADLNNILRTQKLS---DDHVQFLVYQIL 178
           H NV+ LL +     CL ++   + ++ ++   DL N +R +  +    D + F + Q+ 
Sbjct: 91  HPNVLSLLGI-----CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVA 144
Query: 179 RGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           +G+K++ S   +HRDL   N  ++E   +K+ DFGLAR
Sbjct: 145 KGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 182

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 59/132 (44%), Gaps = 6/132 (4%)
Query: 109 KRTYRELRMLKHMNHENVIGLLD---VFHSNTCLADFKNVYMVTHLM-GADLNNILRTQK 164
           K  Y E +    +   +++G  D   + H    +   K V +VT  M    L+  L+   
Sbjct: 59  KVGYTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKND 118
Query: 165 LSDDHVQF--LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM 222
                +Q   ++  I  G+KY+   G +HRDL   NI +N +   K+ DFGL+R  E++ 
Sbjct: 119 GQFTVIQLVGMLRGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP 178
Query: 223 TGYVATRWYRAP 234
                TR  + P
Sbjct: 179 EAAYTTRGGKIP 190

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 89/187 (47%), Gaps = 18/187 (9%)
Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP----FQSAVHAKRTYRELRMLKHMNH 123
           +GP L    F  ++S    S   + VAIK + +     +    +  R   E+ +LK ++ 
Sbjct: 8   VGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 124 --ENVIGLLDVFHS-NTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRG 180
               VI LLD F   ++ +   +    V  L     + I     L ++  +   +Q+L  
Sbjct: 67  GFSGVIRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARSFFWQVLEA 122
Query: 181 LKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARPTENEM-TGYVATRWYRAPEIML 238
           +++ H+ G++HRD+K  NI ++ +  ELK++DFG     ++ + T +  TR Y  PE   
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE--- 179
Query: 239 NWMHYNQ 245
            W+ Y++
Sbjct: 180 -WIRYHR 185

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 75/153 (49%), Gaps = 16/153 (10%)
Query: 92  KVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHL 151
           KVAIK I    + A+  +    E  ++  ++H  ++ L  V     CL     + +VT  
Sbjct: 34  KVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV-----CLEQ-APICLVTEF 84
Query: 152 MG-ADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELK 208
           M    L++ LRTQ+   + + +  +   +  G+ Y+  A +IHRDL   N  V E+  +K
Sbjct: 85  MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIK 144
Query: 209 ILDFGLARPT-ENEMTGYVATRW---YRAPEIM 237
           + DFG+ R   +++ T    T++   + +PE+ 
Sbjct: 145 VSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 177

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 65  VIDIGPTLSKESFDLIFSSALDSVSGVKV--AIKKIARPFQSAVHAKRTYRELRMLKHMN 122
           ++     + +  F  ++   L    G K+  A+K + R         +   E  ++K  +
Sbjct: 29  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFS 87
Query: 123 HENVIGLLDVFHSNTCL-ADFKNVYMVTHLMGADLNNILRTQKLS---DDHVQFLVYQIL 178
           H NV+ LL +     CL ++   + ++ ++   DL N +R +  +    D + F + Q+ 
Sbjct: 88  HPNVLSLLGI-----CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVA 141
Query: 179 RGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           +G+K++ S   +HRDL   N  ++E   +K+ DFGLAR
Sbjct: 142 KGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 179

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 89/187 (47%), Gaps = 18/187 (9%)
Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP----FQSAVHAKRTYRELRMLKHMNH 123
           +GP L    F  ++S    S   + VAIK + +     +    +  R   E+ +LK ++ 
Sbjct: 11  VGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 69
Query: 124 --ENVIGLLDVFHS-NTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRG 180
               VI LLD F   ++ +   +    V  L     + I     L ++  +   +Q+L  
Sbjct: 70  GFSGVIRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARSFFWQVLEA 125
Query: 181 LKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARPTENEM-TGYVATRWYRAPEIML 238
           +++ H+ G++HRD+K  NI ++ +  ELK++DFG     ++ + T +  TR Y  PE   
Sbjct: 126 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE--- 182
Query: 239 NWMHYNQ 245
            W+ Y++
Sbjct: 183 -WIRYHR 188

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 65  VIDIGPTLSKESFDLIFSSALDSVSGVKV--AIKKIARPFQSAVHAKRTYRELRMLKHMN 122
           ++     + +  F  ++   L    G K+  A+K + R         +   E  ++K  +
Sbjct: 32  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFS 90
Query: 123 HENVIGLLDVFHSNTCL-ADFKNVYMVTHLMGADLNNILRTQKLS---DDHVQFLVYQIL 178
           H NV+ LL +     CL ++   + ++ ++   DL N +R +  +    D + F + Q+ 
Sbjct: 91  HPNVLSLLGI-----CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVA 144
Query: 179 RGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           +G+K++ S   +HRDL   N  ++E   +K+ DFGLAR
Sbjct: 145 KGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 182

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 67/138 (48%), Gaps = 21/138 (15%)
Query: 90  GVKVAIKKIARPFQSAVHAKRT---YRELRMLKHMNHENVIGLLDVFHSNTCLA------ 140
           G  VA+K +    +   HA+R     RE+ ++K + H N++  +        L+      
Sbjct: 60  GSDVAVKIL---MEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYL 116
Query: 141 DFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAG--IIHRDLKPSN 198
              ++Y + H  GA        ++L +     + Y + +G+ Y+H+    I+HRDLK  N
Sbjct: 117 SRGSLYRLLHKSGA-------REQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPN 169
Query: 199 IAVNEDCELKILDFGLAR 216
           + V++   +K+ DFGL+R
Sbjct: 170 LLVDKKYTVKVCDFGLSR 187

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 89/187 (47%), Gaps = 18/187 (9%)
Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP----FQSAVHAKRTYRELRMLKHMNH 123
           +GP L    F  ++S    S   + VAIK + +     +    +  R   E+ +LK ++ 
Sbjct: 8   VGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 124 --ENVIGLLDVFHS-NTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRG 180
               VI LLD F   ++ +   +    V  L     + I     L ++  +   +Q+L  
Sbjct: 67  GFSGVIRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARSFFWQVLEA 122
Query: 181 LKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARPTENEM-TGYVATRWYRAPEIML 238
           +++ H+ G++HRD+K  NI ++ +  ELK++DFG     ++ + T +  TR Y  PE   
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE--- 179
Query: 239 NWMHYNQ 245
            W+ Y++
Sbjct: 180 -WIRYHR 185

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 71/340 (20%), Positives = 125/340 (36%), Gaps = 83/340 (24%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           + ++ ++  + A+K I +  Q      R +RE+ ML         G  +V        + 
Sbjct: 31  TCINLITSQEYAVKIIEK--QPGHIRSRVFREVEMLYQCQ-----GHRNVLELIEFFEEE 83
Query: 143 KNVYMVTHLM--GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
              Y+V   M  G+ L++I + +  ++     +V  +   L ++H+ GI HRDLKP NI 
Sbjct: 84  DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENIL 143
Query: 201 V---NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
               N+   +KI DFGL                                           
Sbjct: 144 CEHPNQVSPVKICDFGLG------------------------------------------ 161
Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW-----MHYNQTDIHQL 312
           S I +N DC        ++ P   E+     +  Y APE++  +     ++  + D+  L
Sbjct: 162 SGIKLNGDCS------PISTP---ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSL 212
Query: 313 NLIMEML--GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGA-----------NP 359
            +I+ +L  G PP  F+ +  SD       + P      F  + +G            + 
Sbjct: 213 GVILYILLSGYPP--FVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISC 270
Query: 360 QAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPT 399
            A             +R++A Q L HP++   +  N  PT
Sbjct: 271 AAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPT 310

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 65  VIDIGPTLSKESFDLIFSSALDSVSGVKV--AIKKIARPFQSAVHAKRTYRELRMLKHMN 122
           ++     + +  F  ++   L    G K+  A+K + R         +   E  ++K  +
Sbjct: 31  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFS 89
Query: 123 HENVIGLLDVFHSNTCL-ADFKNVYMVTHLMGADLNNILRTQKLS---DDHVQFLVYQIL 178
           H NV+ LL +     CL ++   + ++ ++   DL N +R +  +    D + F + Q+ 
Sbjct: 90  HPNVLSLLGI-----CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVA 143
Query: 179 RGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           +G+K++ S   +HRDL   N  ++E   +K+ DFGLAR
Sbjct: 144 KGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 88/229 (38%), Gaps = 40/229 (17%)
Query: 54  FNQPYSEICRGVIDIGPTLSKESFDLIFSSA---LDSVSGVKVAIKKIARPFQSAVHAKR 110
              P  E  R  + +G TL +  F  +  +    L   +G      K+ +   S    + 
Sbjct: 13  LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD 72
Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQK------ 164
              E  +LK +NH +VI L        C  D   + +V +     L   LR  +      
Sbjct: 73  LLSEFNVLKQVNHPHVIKLY-----GACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 165 -------------------LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
                              L+   +    +QI +G++Y+    ++HRDL   NI V E  
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGR 187
Query: 206 ELKILDFGLARPTENEMT------GYVATRWYRAPEIMLNWMHYNQTGV 248
           ++KI DFGL+R    E +      G +  +W  A E + + ++  Q+ V
Sbjct: 188 KMKISDFGLSRDVYEEDSXVKRSQGRIPVKWM-AIESLFDHIYTTQSDV 235

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 89/180 (49%), Gaps = 19/180 (10%)
Query: 69  GPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTY-RELRMLKHMNHENV 126
           G  + +  F +++   +++ +   VA+KK+A     +    K+ + +E++++    HEN+
Sbjct: 30  GNKMGEGGFGVVYKGYVNNTT---VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL 86
Query: 127 IGLLDVFHSNT---CLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQ-ILRGLK 182
           + LL  F S+    CL     VYM    +   L+ +  T  LS  H++  + Q    G+ 
Sbjct: 87  VELLG-FSSDGDDLCLV---YVYMPNGSLLDRLSCLDGTPPLSW-HMRCKIAQGAANGIN 141
Query: 183 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN-----EMTGYVATRWYRAPEIM 237
           ++H    IHRD+K +NI ++E    KI DFGLAR +E           V T  Y APE +
Sbjct: 142 FLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEAL 201

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 89/180 (49%), Gaps = 19/180 (10%)
Query: 69  GPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTY-RELRMLKHMNHENV 126
           G  + +  F +++   +++ +   VA+KK+A     +    K+ + +E++++    HEN+
Sbjct: 36  GNKMGEGGFGVVYKGYVNNTT---VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL 92
Query: 127 IGLLDVFHSNT---CLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQ-ILRGLK 182
           + LL  F S+    CL     VYM    +   L+ +  T  LS  H++  + Q    G+ 
Sbjct: 93  VELLG-FSSDGDDLCLV---YVYMPNGSLLDRLSCLDGTPPLSW-HMRCKIAQGAANGIN 147
Query: 183 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN-----EMTGYVATRWYRAPEIM 237
           ++H    IHRD+K +NI ++E    KI DFGLAR +E           V T  Y APE +
Sbjct: 148 FLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEAL 207

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 72/152 (47%), Gaps = 14/152 (9%)
Query: 92  KVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHL 151
           KVAIK I    + A+  +    E  ++  ++H  ++ L  V     CL       +   +
Sbjct: 33  KVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV-----CLEQAPICLVFEFM 84
Query: 152 MGADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKI 209
               L++ LRTQ+   + + +  +   +  G+ Y+  A +IHRDL   N  V E+  +K+
Sbjct: 85  EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDLAARNCLVGENQVIKV 144
Query: 210 LDFGLARPT-ENEMTGYVATRW---YRAPEIM 237
            DFG+ R   +++ T    T++   + +PE+ 
Sbjct: 145 SDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 176

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 107/240 (44%), Gaps = 40/240 (16%)
Query: 88  VSGVKVAIKKIARPFQSAVHAKRT-YRELRMLKHM--------NHENVIGLLDVFHSNTC 138
           + G K    K+ +   SA H   T   E+R+LK +        N E V+ LLD F  +  
Sbjct: 43  IQGKKFVAMKVVK---SAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG- 98
Query: 139 LADFKNVYMVTHLMGADL-NNILRT--QKLSDDHVQFLVYQILRGLKYIHS-AGIIHRDL 194
             +  ++ MV  ++G  L   I+++  Q L    V+ ++ Q+L+GL Y+H+   IIH D+
Sbjct: 99  -VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDI 157
Query: 195 KPSNI--AVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVP 249
           KP NI  +VNE    ++     A  TE + +G      +    AP    N          
Sbjct: 158 KPENILLSVNEQYIRRLA----AEATEWQRSGAPPPSGSAVSTAPATAGN---------- 203
Query: 250 FYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDI 309
           F    L+P N    E  ++KI D G A       T  + TR YR+ E+++   +    DI
Sbjct: 204 FLVNPLEPKNA---EKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADI 260

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 84/187 (44%), Gaps = 21/187 (11%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVS--GVKVAIKKIARPFQSAVHAKRTYRELRM 117
           EI R  I++G  + +  F  +      S     + VAIK        +V  K     L M
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 118 LKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDDHVQFLVY- 175
            +  +H +++ L+ V   N        V+++  L    +L + L+ +K S D    ++Y 
Sbjct: 66  -RQFDHPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKFSLDLASLILYA 117
Query: 176 -QILRGLKYIHSAGIIHRDLKPSNIAVNE-DCELKILDFGLARPTENEM-----TGYVAT 228
            Q+   L Y+ S   +HRD+   N+ V+  DC +K+ DFGL+R  E+        G +  
Sbjct: 118 YQLSTALAYLESKRFVHRDIAARNVLVSATDC-VKLGDFGLSRYMEDSTYYKASKGKLPI 176
Query: 229 RWYRAPE 235
           +W  APE
Sbjct: 177 KWM-APE 182

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 107/240 (44%), Gaps = 40/240 (16%)
Query: 88  VSGVKVAIKKIARPFQSAVHAKRT-YRELRMLKHM--------NHENVIGLLDVFHSNTC 138
           + G K    K+ +   SA H   T   E+R+LK +        N E V+ LLD F  +  
Sbjct: 59  IQGKKFVAMKVVK---SAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG- 114
Query: 139 LADFKNVYMVTHLMGADL-NNILRT--QKLSDDHVQFLVYQILRGLKYIHS-AGIIHRDL 194
             +  ++ MV  ++G  L   I+++  Q L    V+ ++ Q+L+GL Y+H+   IIH D+
Sbjct: 115 -VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDI 173
Query: 195 KPSNI--AVNEDCELKILDFGLARPTENEMTGY---VATRWYRAPEIMLNWMHYNQTGVP 249
           KP NI  +VNE    ++     A  TE + +G      +    AP    N          
Sbjct: 174 KPENILLSVNEQYIRRLA----AEATEWQRSGAPPPSGSAVSTAPATAGN---------- 219
Query: 250 FYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDI 309
           F    L+P N    E  ++KI D G A       T  + TR YR+ E+++   +    DI
Sbjct: 220 FLVNPLEPKNA---EKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADI 276

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 89/187 (47%), Gaps = 18/187 (9%)
Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP----FQSAVHAKRTYRELRMLKHMNH 123
           +GP L    F  ++S    S   + VAIK + +     +    +  R   E+ +LK ++ 
Sbjct: 8   VGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 124 --ENVIGLLDVFHS-NTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRG 180
               VI LLD F   ++ +   +    V  L     + I     L ++  +   +Q+L  
Sbjct: 67  GFSGVIRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARSFFWQVLEA 122
Query: 181 LKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARPTENEM-TGYVATRWYRAPEIML 238
           +++ H+ G++HRD+K  NI ++ +  ELK++DFG     ++ + T +  TR Y  PE   
Sbjct: 123 VRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE--- 179
Query: 239 NWMHYNQ 245
            W+ Y++
Sbjct: 180 -WIRYHR 185

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 77/175 (44%), Gaps = 45/175 (25%)
Query: 108 AKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-----------GADL 156
            +R   E+R++K ++H N+  L +V+     +     +    HL+           G   
Sbjct: 72  VERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCA 131
Query: 157 NNILRTQ-------------------KLSDDHVQF------LVYQILRGLKYIHSAGIIH 191
            ++++TQ                   + S D VQ       ++ QI   L Y+H+ GI H
Sbjct: 132 MDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICH 191
Query: 192 RDLKPSN--IAVNEDCELKILDFGLARP----TENE---MTGYVATRWYRAPEIM 237
           RD+KP N   + N+  E+K++DFGL++        E   MT    T ++ APE++
Sbjct: 192 RDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVL 246

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 36/152 (23%), Positives = 68/152 (44%), Gaps = 15/152 (9%)
Query: 253 QDLKPSNI--AVNEDCELKILDFGLARP----TENE---MTGYVATRWYRAPEIM--LNW 301
           +D+KP N   + N+  E+K++DFGL++        E   MT    T ++ APE++   N 
Sbjct: 192 RDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE 251
Query: 302 MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQA 361
            +  + D     +++ +L      F     +D+  + +N        ++  +    +P A
Sbjct: 252 SYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVL----SPLA 307
Query: 362 IXXXXXXXXXXXXKRITAEQALAHPYLSQYSD 393
                        +R  A +AL HP++SQ+SD
Sbjct: 308 RDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 83/207 (40%), Gaps = 30/207 (14%)
Query: 46  PSRRLHDHFNQPYSEICRGVIDIGPTLSKESFDLIFSSALD--SVSGVKVAIKKIARPFQ 103
           P+R +H    Q   E+    I I   +    F  + S  L       V VAIK +     
Sbjct: 29  PNRAVH----QFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTL----- 79
Query: 104 SAVHAKRTYRELRMLKHMNHENVIGLLD---VFHSNTCLADFKNVYMVTHLM-GADLNNI 159
                K  Y E +    +   +++G  D   V H    +   K V +V   M    L+  
Sbjct: 80  -----KVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAF 134
Query: 160 LRTQKLSDDHVQF--LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP 217
           LR        +Q   ++  I  G++Y+   G +HRDL   NI VN +   K+ DFGL+R 
Sbjct: 135 LRKHDGQFTVIQLVGMLRGIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRV 194
Query: 218 TENE-------MTGYVATRWYRAPEIM 237
            E++         G +  RW  APE +
Sbjct: 195 IEDDPEAVYTTTGGKIPVRW-TAPEAI 220

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 72/152 (47%), Gaps = 14/152 (9%)
Query: 92  KVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHL 151
           KVAIK I    + A+  +    E  ++  ++H  ++ L  V     CL       +   +
Sbjct: 33  KVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV-----CLEQAPICLVFEFM 84
Query: 152 MGADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKI 209
               L++ LRTQ+   + + +  +   +  G+ Y+  A +IHRDL   N  V E+  +K+
Sbjct: 85  EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKV 144
Query: 210 LDFGLARPT-ENEMTGYVATRW---YRAPEIM 237
            DFG+ R   +++ T    T++   + +PE+ 
Sbjct: 145 SDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 176

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 84/187 (44%), Gaps = 21/187 (11%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVS--GVKVAIKKIARPFQSAVHAKRTYRELRM 117
           EI R  I++G  + +  F  +      S     + VAIK        +V  K     L M
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 445
Query: 118 LKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDDHVQFLVY- 175
            +  +H +++ L+ V   N        V+++  L    +L + L+ +K S D    ++Y 
Sbjct: 446 -RQFDHPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKFSLDLASLILYA 497
Query: 176 -QILRGLKYIHSAGIIHRDLKPSNIAVNE-DCELKILDFGLARPTENEM-----TGYVAT 228
            Q+   L Y+ S   +HRD+   N+ V+  DC +K+ DFGL+R  E+        G +  
Sbjct: 498 YQLSTALAYLESKRFVHRDIAARNVLVSATDC-VKLGDFGLSRYMEDSTYYKASKGKLPI 556
Query: 229 RWYRAPE 235
           +W  APE
Sbjct: 557 KWM-APE 562

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 72/152 (47%), Gaps = 14/152 (9%)
Query: 92  KVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHL 151
           KVAIK I    + A+  +    E  ++  ++H  ++ L  V     CL       +   +
Sbjct: 36  KVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV-----CLEQAPICLVFEFM 87
Query: 152 MGADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKI 209
               L++ LRTQ+   + + +  +   +  G+ Y+  A +IHRDL   N  V E+  +K+
Sbjct: 88  EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKV 147
Query: 210 LDFGLARPT-ENEMTGYVATRW---YRAPEIM 237
            DFG+ R   +++ T    T++   + +PE+ 
Sbjct: 148 SDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 179

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 82/187 (43%), Gaps = 20/187 (10%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLK 119
           EI R  + +   L    F  ++    +     KVAIK + +P    +  +    E +++K
Sbjct: 5   EIPRESLQLIKRLGNGQFGEVWMGTWNG--NTKVAIKTL-KP--GTMSPESFLEEAQIMK 59
Query: 120 HMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILR---TQKLSDDHVQFLVY 175
            + H+ ++ L  V            +Y+VT  M    L + L+    + L   ++  +  
Sbjct: 60  KLKHDKLVQLYAVVSEEP-------IYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAA 112
Query: 176 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE-NEMTGYVATRW---Y 231
           Q+  G+ YI     IHRDL+ +NI V      KI DFGLAR  E NE T     ++   +
Sbjct: 113 QVAAGMAYIERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKW 172
Query: 232 RAPEIML 238
            APE  L
Sbjct: 173 TAPEAAL 179

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 83/180 (46%), Gaps = 40/180 (22%)
Query: 87  SVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN-HENVIGLLDVFHSNTCLADFKNV 145
           S  G  VA+K++   F           E+++L   + H NVI     ++ +     F  +
Sbjct: 36  SFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIR----YYCSETTDRF--L 84
Query: 146 YMVTHLMGADLNNILRTQKLSDDHVQF--------LVYQILRGLKYIHSAGIIHRDLKPS 197
           Y+   L   +L +++ ++ +SD++++         L+ QI  G+ ++HS  IIHRDLKP 
Sbjct: 85  YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQ 144
Query: 198 NIAVN-------------EDCELKILDFGLARPTENEMTGY-------VATRWYRAPEIM 237
           NI V+             E+  + I DFGL +  ++    +         T  +RAPE++
Sbjct: 145 NILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELL 204

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 72/152 (47%), Gaps = 14/152 (9%)
Query: 92  KVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHL 151
           KVAIK I    + A+  +    E  ++  ++H  ++ L  V     CL       +   +
Sbjct: 31  KVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV-----CLEQAPICLVFEFM 82
Query: 152 MGADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKI 209
               L++ LRTQ+   + + +  +   +  G+ Y+  A +IHRDL   N  V E+  +K+
Sbjct: 83  EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKV 142
Query: 210 LDFGLARPT-ENEMTGYVATRW---YRAPEIM 237
            DFG+ R   +++ T    T++   + +PE+ 
Sbjct: 143 SDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 81/190 (42%), Gaps = 22/190 (11%)
Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIKKIAR-------PFQSAVHAKRTYREL-RMLK 119
           +GP L K  F  +F+        ++VAIK I R       P   +V        L ++  
Sbjct: 35  LGPLLGKGGFGTVFAGH-RLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGA 93
Query: 120 HMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADL-NNILRTQKLSDDHVQFLVYQIL 178
              H  VI LLD F +         + +   L   DL + I     L +   +    Q++
Sbjct: 94  GGGHPGVIRLLDWFETQEGFM----LVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVV 149
Query: 179 RGLKYIHSAGIIHRDLKPSNIAVN--EDCELKILDFGLARPTENE-MTGYVATRWYRAPE 235
             +++ HS G++HRD+K  NI ++    C  K++DFG      +E  T +  TR Y  PE
Sbjct: 150 AAIQHCHSRGVVHRDIKDENILIDLRRGCA-KLIDFGSGALLHDEPYTDFDGTRVYSPPE 208
Query: 236 IMLNWMHYNQ 245
               W+  +Q
Sbjct: 209 ----WISRHQ 214

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 71/151 (47%), Gaps = 12/151 (7%)
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHEN 125
           ++IG  + K  F  ++          +VAI+ I     +    K   RE+   +   HEN
Sbjct: 35  LEIGELIGKGRFGQVYHGRWHG----EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHEN 90
Query: 126 VIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDD--HVQFLVYQILRGLKY 183
           V     V     C++      + +   G  L +++R  K+  D    + +  +I++G+ Y
Sbjct: 91  V-----VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGY 145
Query: 184 IHSAGIIHRDLKPSNIAVNEDCELKILDFGL 214
           +H+ GI+H+DLK  N+   ++ ++ I DFGL
Sbjct: 146 LHAKGILHKDLKSKNV-FYDNGKVVITDFGL 175

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 60/121 (49%), Gaps = 28/121 (23%)
Query: 145 VYMVTHLMGADLNNILRTQKLSDDHVQF--------LVYQILRGLKYIHSAGIIHRDLKP 196
           +Y+   L   +L +++ ++ +SD++++         L+ QI  G+ ++HS  IIHRDLKP
Sbjct: 102 LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKP 161
Query: 197 SNIAVN-------------EDCELKILDFGLARPTENEMTGY-------VATRWYRAPEI 236
            NI V+             E+  + I DFGL +  ++    +         T  +RAPE+
Sbjct: 162 QNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPEL 221
Query: 237 M 237
           +
Sbjct: 222 L 222

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 60/121 (49%), Gaps = 28/121 (23%)
Query: 145 VYMVTHLMGADLNNILRTQKLSDDHVQF--------LVYQILRGLKYIHSAGIIHRDLKP 196
           +Y+   L   +L +++ ++ +SD++++         L+ QI  G+ ++HS  IIHRDLKP
Sbjct: 102 LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKP 161
Query: 197 SNIAVN-------------EDCELKILDFGLARPTENEMTGY-------VATRWYRAPEI 236
            NI V+             E+  + I DFGL +  ++    +         T  +RAPE+
Sbjct: 162 QNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPEL 221
Query: 237 M 237
           +
Sbjct: 222 L 222

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 118/290 (40%), Gaps = 63/290 (21%)
Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENV 126
           +I   + K SF  +   A D V    VAIK I           +   E+R+L+ MN  + 
Sbjct: 38  EIDSLIGKGSFGQVVK-AYDRVEQEWVAIKIIK---NKKAFLNQAQIEVRLLELMNKHDT 93
Query: 127 IGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRT---QKLSDDHVQFLVYQILRGLKY 183
                + H         ++ +V  ++  +L ++LR    + +S +  +    Q+   L +
Sbjct: 94  EMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 153
Query: 184 IHSA--GIIHRDLKPSNIAVN--EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN 239
           + +    IIH DLKP NI +   +   +KI+DFG +      +   + +R+YR+PE++L 
Sbjct: 154 LATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQXIQSRFYRSPEVLL- 212
Query: 240 WMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML 299
                  G+P+              D  + +   G                       +L
Sbjct: 213 -------GMPY--------------DLAIDMWSLG----------------------CIL 229
Query: 300 NWMHYNQ------TDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLP 343
             MH  +       ++ Q+N I+E+LG PPA  + +  +  ARK+   LP
Sbjct: 230 VEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQ--APKARKFFEKLP 277

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 118/290 (40%), Gaps = 63/290 (21%)
Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENV 126
           +I   + K SF  +   A D V    VAIK I           +   E+R+L+ MN  + 
Sbjct: 57  EIDSLIGKGSFGQVVK-AYDRVEQEWVAIKIIK---NKKAFLNQAQIEVRLLELMNKHDT 112
Query: 127 IGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRT---QKLSDDHVQFLVYQILRGLKY 183
                + H         ++ +V  ++  +L ++LR    + +S +  +    Q+   L +
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172
Query: 184 IHSA--GIIHRDLKPSNIAVN--EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN 239
           + +    IIH DLKP NI +   +   +KI+DFG +      +   + +R+YR+PE++L 
Sbjct: 173 LATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQXIQSRFYRSPEVLL- 231
Query: 240 WMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML 299
                  G+P+              D  + +   G                       +L
Sbjct: 232 -------GMPY--------------DLAIDMWSLG----------------------CIL 248
Query: 300 NWMHYNQ------TDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLP 343
             MH  +       ++ Q+N I+E+LG PPA  + +  +  ARK+   LP
Sbjct: 249 VEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQ--APKARKFFEKLP 296

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 60/133 (45%), Gaps = 26/133 (19%)
Query: 109 KRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF--------------KNVYMVTHLMGA 154
           ++  RE++ L  ++H N++      H N C   F              K   +   +   
Sbjct: 49  EKAEREVKALAKLDHVNIV------HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFC 102
Query: 155 DLNNI------LRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELK 208
           D   +       R +KL       L  QI +G+ YIHS  +I+RDLKPSNI + +  ++K
Sbjct: 103 DKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK 162
Query: 209 ILDFGLARPTENE 221
           I DFGL    +N+
Sbjct: 163 IGDFGLVTSLKND 175

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 70/156 (44%), Gaps = 22/156 (14%)
Query: 93  VAIKKIARPFQSAVHAKRTY-RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHL 151
           VAIK +   +      +R +  E  ++   +H NVI L  V   +T       V ++T  
Sbjct: 64  VAIKTLKSGYTE--KQRRDFLSEASIMGQFDHPNVIHLEGVVTKST------PVMIITEF 115
Query: 152 M-GADLNNILRTQKLSDDHVQF--LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELK 208
           M    L++ LR        +Q   ++  I  G+KY+     +HRDL   NI VN +   K
Sbjct: 116 MENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCK 175
Query: 209 ILDFGLARPTENE---------MTGYVATRWYRAPE 235
           + DFGL+R  E++         + G +  RW  APE
Sbjct: 176 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRW-TAPE 210

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 16/161 (9%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLK 119
           EI R  + +   L    F  ++ +  +  +  KVA+K + +P   +V A     E  ++K
Sbjct: 178 EIPRESLKLEKKLGAGQFGEVWMATYNKHT--KVAVKTM-KPGSMSVEA--FLAEANVMK 232
Query: 120 HMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDDHVQFLV---Y 175
            + H+ ++ L  V            +Y++T  M    L + L++ + S   +  L+    
Sbjct: 233 TLQHDKLVKLHAVVTKEP-------IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 285
Query: 176 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           QI  G+ +I     IHRDL+ +NI V+     KI DFGLAR
Sbjct: 286 QIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR 326

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 85/184 (46%), Gaps = 18/184 (9%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLK 119
           E+ R  I +   L    F  ++       S + VA+K +    +  +  +   +E  ++K
Sbjct: 7   EMERTDITMKHKLGGGQFGEVYEGVWKKYS-LTVAVKTLK---EDTMEVEEFLKEAAVMK 62
Query: 120 HMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRT---QKLSDDHVQFLVY 175
            + H N++ LL V     C  +    Y++T  M   +L + LR    Q++S   + ++  
Sbjct: 63  EIKHPNLVQLLGV-----CTRE-PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 116
Query: 176 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR-PTENEMTGYVATRW---Y 231
           QI   ++Y+     IHRDL   N  V E+  +K+ DFGL+R  T +  T +   ++   +
Sbjct: 117 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKW 176
Query: 232 RAPE 235
            APE
Sbjct: 177 TAPE 180

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 118/290 (40%), Gaps = 63/290 (21%)
Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENV 126
           +I   + K SF  +   A D V    VAIK I           +   E+R+L+ MN  + 
Sbjct: 57  EIDSLIGKGSFGQVVK-AYDRVEQEWVAIKIIK---NKKAFLNQAQIEVRLLELMNKHDT 112
Query: 127 IGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRT---QKLSDDHVQFLVYQILRGLKY 183
                + H         ++ +V  ++  +L ++LR    + +S +  +    Q+   L +
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172
Query: 184 IHSA--GIIHRDLKPSNIAVN--EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN 239
           + +    IIH DLKP NI +   +   +KI+DFG +      +   + +R+YR+PE++L 
Sbjct: 173 LATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQRIYQXIQSRFYRSPEVLL- 231
Query: 240 WMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML 299
                  G+P+              D  + +   G                       +L
Sbjct: 232 -------GMPY--------------DLAIDMWSLG----------------------CIL 248
Query: 300 NWMHYNQ------TDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLP 343
             MH  +       ++ Q+N I+E+LG PPA  + +  +  ARK+   LP
Sbjct: 249 VEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQ--APKARKFFEKLP 296

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/138 (25%), Positives = 67/138 (48%), Gaps = 21/138 (15%)
Query: 90  GVKVAIKKIARPFQSAVHAKRT---YRELRMLKHMNHENVIGLLDVFHSNTCLA------ 140
           G  VA+K +    +   HA+R     RE+ ++K + H N++  +        L+      
Sbjct: 60  GSDVAVKIL---MEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYL 116
Query: 141 DFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAG--IIHRDLKPSN 198
              ++Y + H  GA        ++L +     + Y + +G+ Y+H+    I+HR+LK  N
Sbjct: 117 SRGSLYRLLHKSGA-------REQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPN 169
Query: 199 IAVNEDCELKILDFGLAR 216
           + V++   +K+ DFGL+R
Sbjct: 170 LLVDKKYTVKVCDFGLSR 187

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 63/140 (45%), Gaps = 21/140 (15%)
Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           + VA+K +     +A   K  +RE  +L ++ HE+++    V     C+     + +  +
Sbjct: 44  ILVAVKTLKDASDNA--RKDFHREAELLTNLQHEHIVKFYGV-----CVEGDPLIMVFEY 96
Query: 151 LMGADLNNILRTQ--------------KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKP 196
           +   DLN  LR                +L+   +  +  QI  G+ Y+ S   +HRDL  
Sbjct: 97  MKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLAT 156
Query: 197 SNIAVNEDCELKILDFGLAR 216
            N  V E+  +KI DFG++R
Sbjct: 157 RNCLVGENLLVKIGDFGMSR 176

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 71/160 (44%), Gaps = 12/160 (7%)
Query: 68  IGPTLSKESFDLIFSSALDSVSG--VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHEN 125
           +G  L K  F  +  + L    G  VKVA+K +     ++   +   RE   +K  +H +
Sbjct: 27  LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 126 VIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDDH--------VQFLVYQ 176
           V  L+ V   +          ++   M   DL+  L   ++ ++         V+F+V  
Sbjct: 87  VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV-D 145
Query: 177 ILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           I  G++Y+ S   IHRDL   N  + ED  + + DFGL+R
Sbjct: 146 IACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 88/231 (38%), Gaps = 30/231 (12%)
Query: 37  WTVYPASKLPSRRLHDHFNQPYSE---ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKV 93
           W +  + +  S    D    PY+E     R  +  G TL   +F  +  +    +     
Sbjct: 1   WKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDA 60
Query: 94  AIKKIARPFQSAVHAKRT---YRELRMLKHMN-HENVIGLLD---------VFHSNTCLA 140
            +K   +  +S  HA        EL+++ H+  HEN++ LL          V     C  
Sbjct: 61  VLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG 120
Query: 141 DFKNVY--MVTHLMGADLNNILRTQKLSDDHVQFL--------VYQILRGLKYIHSAGII 190
           D  N        ++G  L      + L  +  + L          Q+ +G+ ++ S   I
Sbjct: 121 DLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCI 180
Query: 191 HRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM 241
           HRD+   N+ +      KI DFGLAR   N+ + Y+     R P   + WM
Sbjct: 181 HRDVAARNVLLTNGHVAKIGDFGLARDIMND-SNYIVKGNARLP---VKWM 227

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 74/151 (49%), Gaps = 17/151 (11%)
Query: 93  VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM 152
           VA+K +    +  +  +   +E  ++K + H N++ LL V     C  +    Y++T  M
Sbjct: 39  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV-----CTRE-PPFYIITEFM 89
Query: 153 G-ADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELK 208
              +L + LR    Q++S   + ++  QI   ++Y+     IHRDL   N  V E+  +K
Sbjct: 90  TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVK 149
Query: 209 ILDFGLAR-PTENEMTGYVATRW---YRAPE 235
           + DFGL+R  T +  T +   ++   + APE
Sbjct: 150 VADFGLSRLMTGDTFTAHAGAKFPIKWTAPE 180

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 146 YMVTHLMGADLN-NILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED 204
           +++  + G DL  +I ++++  +   +F   +I+  L ++H  GII+RDLK  N+ ++ +
Sbjct: 101 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHE 160
Query: 205 CELKILDFGLARPTENEMTG-----YVATRWYRAPEIM 237
              K+ DFG+ +  E    G     +  T  Y APEI+
Sbjct: 161 GHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPEIL 196

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 81/176 (46%), Gaps = 13/176 (7%)
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHEN 125
           I+IG    + SF  ++   LD+ + V+VA  ++     +    +R   E   LK + H N
Sbjct: 32  IEIG----RGSFKTVYK-GLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPN 86
Query: 126 VIGLLDVFHSNTCLADFKNVYMVTHL-MGADLNNILRTQKLSDDHV-QFLVYQILRGLKY 183
           ++   D + S   +   K + +VT L     L   L+  K+    V +    QIL+GL++
Sbjct: 87  IVRFYDSWEST--VKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQF 144
Query: 184 IHSAG--IIHRDLKPSNIAVNE-DCELKILDFGLARPTENEMT-GYVATRWYRAPE 235
           +H+    IIHRDLK  NI +      +KI D GLA           + T  + APE
Sbjct: 145 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFXAPE 200

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/124 (26%), Positives = 65/124 (52%), Gaps = 16/124 (12%)
Query: 125 NVIGLLDVF----HSNTCLADFKNVYMVTHLMGADLNNILRT---QKLSDDHVQFLVYQI 177
           +++ +LDV+    H   CL     + ++  + G +L + ++    Q  ++     ++  I
Sbjct: 83  HIVCILDVYENMHHGKRCL-----LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDI 137
Query: 178 LRGLKYIHSAGIIHRDLKPSNI---AVNEDCELKILDFGLARP-TENEMTGYVATRWYRA 233
              ++++HS  I HRD+KP N+   +  +D  LK+ DFG A+  T+N +     T +Y A
Sbjct: 138 GTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVA 197
Query: 234 PEIM 237
           PE++
Sbjct: 198 PEVL 201

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/124 (26%), Positives = 65/124 (52%), Gaps = 16/124 (12%)
Query: 125 NVIGLLDVF----HSNTCLADFKNVYMVTHLMGADLNNILRT---QKLSDDHVQFLVYQI 177
           +++ +LDV+    H   CL     + ++  + G +L + ++    Q  ++     ++  I
Sbjct: 64  HIVCILDVYENMHHGKRCL-----LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDI 118
Query: 178 LRGLKYIHSAGIIHRDLKPSNI---AVNEDCELKILDFGLARP-TENEMTGYVATRWYRA 233
              ++++HS  I HRD+KP N+   +  +D  LK+ DFG A+  T+N +     T +Y A
Sbjct: 119 GTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVA 178
Query: 234 PEIM 237
           PE++
Sbjct: 179 PEVL 182

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/128 (28%), Positives = 64/128 (50%), Gaps = 13/128 (10%)
Query: 93  VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM 152
           VA+K +    +  +  +   +E  ++K + H N++ LL V     C  +    Y++T  M
Sbjct: 46  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV-----CTRE-PPFYIITEFM 96
Query: 153 G-ADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELK 208
              +L + LR    Q++S   + ++  QI   ++Y+     IHRDL   N  V E+  +K
Sbjct: 97  TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVK 156
Query: 209 ILDFGLAR 216
           + DFGL+R
Sbjct: 157 VADFGLSR 164

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/152 (24%), Positives = 71/152 (46%), Gaps = 14/152 (9%)
Query: 92  KVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHL 151
           KVAIK I    + ++       E  ++  ++H  ++ L  V     CL       +   +
Sbjct: 53  KVAIKTIK---EGSMSEDDFIEEAEVMMKLSHPKLVQLYGV-----CLEQAPICLVFEFM 104
Query: 152 MGADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKI 209
               L++ LRTQ+   + + +  +   +  G+ Y+  A +IHRDL   N  V E+  +K+
Sbjct: 105 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKV 164
Query: 210 LDFGLARPT-ENEMTGYVATRW---YRAPEIM 237
            DFG+ R   +++ T    T++   + +PE+ 
Sbjct: 165 SDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 196

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 74/162 (45%), Gaps = 23/162 (14%)
Query: 93  VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT--H 150
           VA+K    P Q     +  Y E+  L  M HEN++  +      T +    +++++T  H
Sbjct: 50  VAVKIF--PIQDKQSWQNEY-EVYSLPGMKHENILQFIGAEKRGTSVD--VDLWLITAFH 104
Query: 151 LMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHS----------AGIIHRDLKPSNIA 200
             G+ L++ L+   +S + +  +   + RGL Y+H             I HRD+K  N+ 
Sbjct: 105 EKGS-LSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVL 163
Query: 201 VNEDCELKILDFGLARPTE-----NEMTGYVATRWYRAPEIM 237
           +  +    I DFGLA   E      +  G V TR Y APE++
Sbjct: 164 LKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVL 205

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/128 (28%), Positives = 64/128 (50%), Gaps = 13/128 (10%)
Query: 93  VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM 152
           VA+K +    +  +  +   +E  ++K + H N++ LL V     C  +    Y++T  M
Sbjct: 41  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV-----CTRE-PPFYIITEFM 91
Query: 153 G-ADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELK 208
              +L + LR    Q++S   + ++  QI   ++Y+     IHRDL   N  V E+  +K
Sbjct: 92  TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVK 151
Query: 209 ILDFGLAR 216
           + DFGL+R
Sbjct: 152 VADFGLSR 159

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 76/182 (41%), Gaps = 16/182 (8%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSG---VKVAIKKIARPFQSAVHAKRTY-REL 115
           EI    I I   +    F  + S  L  V G   + VAIK +   +      +R +  E 
Sbjct: 25  EIDASCIKIEKVIGVGEFGEVCSGRL-KVPGKREICVAIKTLKAGYTD--KQRRDFLSEA 81
Query: 116 RMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQF-- 172
            ++   +H N+I      H    +   K V ++T  M    L+  LR        +Q   
Sbjct: 82  SIMGQFDHPNII------HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVG 135
Query: 173 LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR 232
           ++  I  G+KY+     +HRDL   NI VN +   K+ DFG++R  E++      TR  +
Sbjct: 136 MLRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGK 195
Query: 233 AP 234
            P
Sbjct: 196 IP 197

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/128 (28%), Positives = 64/128 (50%), Gaps = 13/128 (10%)
Query: 93  VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM 152
           VA+K +    +  +  +   +E  ++K + H N++ LL V     C  +    Y++T  M
Sbjct: 41  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV-----CTRE-PPFYIITEFM 91
Query: 153 G-ADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELK 208
              +L + LR    Q++S   + ++  QI   ++Y+     IHRDL   N  V E+  +K
Sbjct: 92  TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVK 151
Query: 209 ILDFGLAR 216
           + DFGL+R
Sbjct: 152 VADFGLSR 159

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 63/129 (48%), Gaps = 6/129 (4%)
Query: 90  GVKVAIKK-IARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF-KNVYM 147
           G KVA+K+      Q     +     L   +H +  ++IG  D  +    +  + +N  +
Sbjct: 63  GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 148 VTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
             HL G+DL     T  +S +    +     RGL Y+H+  IIHRD+K  NI ++E+   
Sbjct: 123 KRHLYGSDLP----TMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVP 178
Query: 208 KILDFGLAR 216
           KI DFG+++
Sbjct: 179 KITDFGISK 187

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 63/129 (48%), Gaps = 6/129 (4%)
Query: 90  GVKVAIKK-IARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF-KNVYM 147
           G KVA+K+      Q     +     L   +H +  ++IG  D  +    +  + +N  +
Sbjct: 63  GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 148 VTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
             HL G+DL     T  +S +    +     RGL Y+H+  IIHRD+K  NI ++E+   
Sbjct: 123 KRHLYGSDLP----TMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVP 178
Query: 208 KILDFGLAR 216
           KI DFG+++
Sbjct: 179 KITDFGISK 187

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/75 (38%), Positives = 39/75 (52%), Gaps = 15/75 (20%)
Query: 176 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT---ENEMT--------- 223
           QI   ++++HS G++HRDLKPSNI    D  +K+ DFGL       E E T         
Sbjct: 172 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 231
Query: 224 ---GYVATRWYRAPE 235
              G V T+ Y +PE
Sbjct: 232 THXGQVGTKLYMSPE 246

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 67/145 (46%), Gaps = 26/145 (17%)
Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-----GADLNNILRTQK--- 164
           RE  M +  NH N++ L+       CL +    +    L+     G   N I R +    
Sbjct: 75  READMHRLFNHPNILRLV-----AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGN 129
Query: 165 -LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT 223
            L++D + +L+  I RGL+ IH+ G  HRDLKP+NI + ++ +  ++D G        + 
Sbjct: 130 FLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVE 189
Query: 224 G---------YVATRW---YRAPEI 236
           G         + A R    YRAPE+
Sbjct: 190 GSRQALTLQDWAAQRCTISYRAPEL 214

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 76/147 (51%), Gaps = 11/147 (7%)
Query: 97  KIARPFQSAVHAKRTYRELRMLKHMNHEN-VIGLLDVFHSNTCLADFKNVYMVTHLMGAD 155
           K A   Q A   + T  E ++L+H+     ++ L   F + T L       ++ ++ G +
Sbjct: 91  KKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH-----LILDYINGGE 145
Query: 156 L-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL 214
           L  ++ + ++ ++  VQ  V +I+  L+++H  GII+RD+K  NI ++ +  + + DFGL
Sbjct: 146 LFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL 205
Query: 215 ARPTENEMT----GYVATRWYRAPEIM 237
           ++    + T     +  T  Y AP+I+
Sbjct: 206 SKEFVADETERAYDFCGTIEYMAPDIV 232

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 73/161 (45%), Gaps = 14/161 (8%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLK 119
           E+ R  I +   L    +  ++       S + VA+K +    +  +  +   +E  ++K
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEGVWKKYS-LTVAVKTLK---EDTMEVEEFLKEAAVMK 69
Query: 120 HMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDDHVQFLVY--- 175
            + H N++ LL V     C  +    Y++T  M   +L + LR     + +   L+Y   
Sbjct: 70  EIKHPNLVQLLGV-----CTRE-PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 176 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           QI   ++Y+     IHRDL   N  V E+  +K+ DFGL+R
Sbjct: 124 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 164

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/128 (28%), Positives = 62/128 (48%), Gaps = 13/128 (10%)
Query: 93  VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM 152
           VA+K +    +  +  +   +E  ++K + H N++ LL V     C  +    Y++T  M
Sbjct: 42  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV-----CTRE-PPFYIITEFM 92
Query: 153 G-ADLNNILRTQKLSDDHVQFLVY---QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELK 208
              +L + LR     + +   L+Y   QI   ++Y+     IHRDL   N  V E+  +K
Sbjct: 93  TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVK 152
Query: 209 ILDFGLAR 216
           + DFGL+R
Sbjct: 153 VADFGLSR 160

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 70/340 (20%), Positives = 124/340 (36%), Gaps = 83/340 (24%)
Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           + ++ ++  + A+K I +  Q      R +RE+ ML         G  +V        + 
Sbjct: 31  TCINLITSQEYAVKIIEK--QPGHIRSRVFREVEMLYQCQ-----GHRNVLELIEFFEEE 83
Query: 143 KNVYMVTHLM--GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
              Y+V   M  G+ L++I + +  ++     +V  +   L ++H+ GI HRDLKP NI 
Sbjct: 84  DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENIL 143
Query: 201 V---NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
               N+   +KI DF L                                           
Sbjct: 144 CEHPNQVSPVKICDFDLG------------------------------------------ 161
Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW-----MHYNQTDIHQL 312
           S I +N DC        ++ P   E+     +  Y APE++  +     ++  + D+  L
Sbjct: 162 SGIKLNGDCS------PISTP---ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSL 212
Query: 313 NLIMEML--GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGA-----------NP 359
            +I+ +L  G PP  F+ +  SD       + P      F  + +G            + 
Sbjct: 213 GVILYILLSGYPP--FVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISC 270
Query: 360 QAIXXXXXXXXXXXXKRITAEQALAHPYLSQYSDPNDEPT 399
            A             +R++A Q L HP++   +  N  PT
Sbjct: 271 AAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPT 310

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 73/161 (45%), Gaps = 14/161 (8%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLK 119
           E+ R  I +   L    +  ++       S + VA+K +    +  +  +   +E  ++K
Sbjct: 13  EMERTDITMKHKLGGGQYGEVYEGVWKKYS-LTVAVKTLK---EDTMEVEEFLKEAAVMK 68
Query: 120 HMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDDHVQFLVY--- 175
            + H N++ LL V     C  +    Y++T  M   +L + LR     + +   L+Y   
Sbjct: 69  EIKHPNLVQLLGV-----CTRE-PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 122
Query: 176 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           QI   ++Y+     IHRDL   N  V E+  +K+ DFGL+R
Sbjct: 123 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 163

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 76/182 (41%), Gaps = 16/182 (8%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSG---VKVAIKKIARPFQSAVHAKRTY-REL 115
           EI    I I   +    F  + S  L  V G   + VAIK +   +      +R +  E 
Sbjct: 4   EIDASCIKIEKVIGVGEFGEVCSGRL-KVPGKREICVAIKTLKAGYTD--KQRRDFLSEA 60
Query: 116 RMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQF-- 172
            ++   +H N+I      H    +   K V ++T  M    L+  LR        +Q   
Sbjct: 61  SIMGQFDHPNII------HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVG 114
Query: 173 LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR 232
           ++  I  G+KY+     +HRDL   NI VN +   K+ DFG++R  E++      TR  +
Sbjct: 115 MLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGK 174
Query: 233 AP 234
            P
Sbjct: 175 IP 176

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 73/161 (45%), Gaps = 14/161 (8%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLK 119
           E+ R  I +   L    +  ++       S + VA+K +    +  +  +   +E  ++K
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEGVWKKYS-LTVAVKTLK---EDTMEVEEFLKEAAVMK 69
Query: 120 HMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDDHVQFLVY--- 175
            + H N++ LL V     C  +    Y++T  M   +L + LR     + +   L+Y   
Sbjct: 70  EIKHPNLVQLLGV-----CTRE-PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 176 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           QI   ++Y+     IHRDL   N  V E+  +K+ DFGL+R
Sbjct: 124 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 164

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/128 (28%), Positives = 62/128 (48%), Gaps = 13/128 (10%)
Query: 93  VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM 152
           VA+K +    +  +  +   +E  ++K + H N++ LL V     C  +    Y++T  M
Sbjct: 43  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV-----CTRE-PPFYIITEFM 93
Query: 153 G-ADLNNILRTQKLSDDHVQFLVY---QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELK 208
              +L + LR     + +   L+Y   QI   ++Y+     IHRDL   N  V E+  +K
Sbjct: 94  TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVK 153
Query: 209 ILDFGLAR 216
           + DFGL+R
Sbjct: 154 VADFGLSR 161

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 76/182 (41%), Gaps = 16/182 (8%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSG---VKVAIKKIARPFQSAVHAKRTY-REL 115
           EI    I I   +    F  + S  L  V G   + VAIK +   +      +R +  E 
Sbjct: 10  EIDASCIKIEKVIGVGEFGEVCSGRL-KVPGKREICVAIKTLKAGYTD--KQRRDFLSEA 66
Query: 116 RMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQF-- 172
            ++   +H N+I      H    +   K V ++T  M    L+  LR        +Q   
Sbjct: 67  SIMGQFDHPNII------HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVG 120
Query: 173 LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR 232
           ++  I  G+KY+     +HRDL   NI VN +   K+ DFG++R  E++      TR  +
Sbjct: 121 MLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGK 180
Query: 233 AP 234
            P
Sbjct: 181 IP 182

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 73/161 (45%), Gaps = 14/161 (8%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLK 119
           E+ R  I +   L    +  ++       S + VA+K +    +  +  +   +E  ++K
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYS-LTVAVKTLK---EDTMEVEEFLKEAAVMK 64
Query: 120 HMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDDHVQFLVY--- 175
            + H N++ LL V     C  +    Y++T  M   +L + LR     + +   L+Y   
Sbjct: 65  EIKHPNLVQLLGV-----CTRE-PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 118
Query: 176 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           QI   ++Y+     IHRDL   N  V E+  +K+ DFGL+R
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 159

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/128 (28%), Positives = 62/128 (48%), Gaps = 13/128 (10%)
Query: 93  VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM 152
           VA+K +    +  +  +   +E  ++K + H N++ LL V     C  +    Y++T  M
Sbjct: 46  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV-----CTRE-PPFYIITEFM 96
Query: 153 G-ADLNNILRTQKLSDDHVQFLVY---QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELK 208
              +L + LR     + +   L+Y   QI   ++Y+     IHRDL   N  V E+  +K
Sbjct: 97  TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVK 156
Query: 209 ILDFGLAR 216
           + DFGL+R
Sbjct: 157 VADFGLSR 164

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 75/160 (46%), Gaps = 14/160 (8%)
Query: 88  VSGVKVAIKKIARPFQ-SAVHAKRTY-RELRMLKHMNHENVIGLLDVFHSNT---CLADF 142
           V+   VA+KK+A     +    K+ + +E+++     HEN++ LL  F S+    CL   
Sbjct: 43  VNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLG-FSSDGDDLCLV-- 99
Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
             VY     +   L+ +  T  LS      +      G+ ++H    IHRD+K +NI ++
Sbjct: 100 -YVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHHIHRDIKSANILLD 158
Query: 203 EDCELKILDFGLARPTEN-----EMTGYVATRWYRAPEIM 237
           E    KI DFGLAR +E        +  V T  Y APE +
Sbjct: 159 EAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEAL 198

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 72/165 (43%), Gaps = 34/165 (20%)
Query: 91  VKVAIKKIARPFQSAVHAKRTYR----ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVY 146
           V VAIK +      A + +R  R    E  ++   +H N+I L  V  +   LA     Y
Sbjct: 78  VPVAIKAL-----KAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV-TRGRLAMIVTEY 131
Query: 147 MVTHLMGADLNNILRTQKLSDDHVQFLVYQIL-------RGLKYIHSAGIIHRDLKPSNI 199
           M        L+  LRT        QF + Q++        G++Y+   G +HRDL   N+
Sbjct: 132 MEN----GSLDTFLRTHD-----GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNV 182
Query: 200 AVNEDCELKILDFGLARPTENE-------MTGYVATRWYRAPEIM 237
            V+ +   K+ DFGL+R  E++         G +  RW  APE +
Sbjct: 183 LVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWT-APEAI 226

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 55/100 (55%), Gaps = 8/100 (8%)
Query: 144 NVYMVTHLMGADLNN-----ILRTQKLSDDHVQFLVYQILRGLKYIHSA-GIIHRDLKPS 197
           +V++   LM   L+      I + Q + +D +  +   I++ L+++HS   +IHRD+KPS
Sbjct: 124 DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPS 183
Query: 198 NIAVNEDCELKILDFGLARPTENEMTGYV--ATRWYRAPE 235
           N+ +N   ++K+ DFG++    + +   +    + Y APE
Sbjct: 184 NVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPE 223

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 73/161 (45%), Gaps = 14/161 (8%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLK 119
           E+ R  I +   L    +  ++       S + VA+K +    +  +  +   +E  ++K
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYS-LTVAVKTLK---EDTMEVEEFLKEAAVMK 64
Query: 120 HMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDDHVQFLVY--- 175
            + H N++ LL V     C  +    Y++T  M   +L + LR     + +   L+Y   
Sbjct: 65  EIKHPNLVQLLGV-----CTRE-PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 118
Query: 176 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           QI   ++Y+     IHRDL   N  V E+  +K+ DFGL+R
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 159

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 73/161 (45%), Gaps = 14/161 (8%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLK 119
           E+ R  I +   L    +  ++       S + VA+K +    +  +  +   +E  ++K
Sbjct: 22  EMERTDITMKHKLGGGQYGEVYEGVWKKYS-LTVAVKTLK---EDTMEVEEFLKEAAVMK 77
Query: 120 HMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDDHVQFLVY--- 175
            + H N++ LL V     C  +    Y++T  M   +L + LR     + +   L+Y   
Sbjct: 78  EIKHPNLVQLLGV-----CTRE-PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 131
Query: 176 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           QI   ++Y+     IHRDL   N  V E+  +K+ DFGL+R
Sbjct: 132 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 172

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 72/165 (43%), Gaps = 34/165 (20%)
Query: 91  VKVAIKKIARPFQSAVHAKRTYR----ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVY 146
           V VAIK +      A + +R  R    E  ++   +H N+I L  V  +   LA     Y
Sbjct: 78  VPVAIKAL-----KAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV-TRGRLAMIVTEY 131
Query: 147 MVTHLMGADLNNILRTQKLSDDHVQFLVYQIL-------RGLKYIHSAGIIHRDLKPSNI 199
           M        L+  LRT        QF + Q++        G++Y+   G +HRDL   N+
Sbjct: 132 MEN----GSLDTFLRTHD-----GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNV 182
Query: 200 AVNEDCELKILDFGLARPTENE-------MTGYVATRWYRAPEIM 237
            V+ +   K+ DFGL+R  E++         G +  RW  APE +
Sbjct: 183 LVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT-APEAI 226

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 84/197 (42%), Gaps = 47/197 (23%)
Query: 58  YSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRM 117
           + E+CRG +   P   KES                VAIK +   + +    +    E  +
Sbjct: 29  FGEVCRGRLK-APG-KKESC---------------VAIKTLKGGY-TERQRREFLSEASI 70
Query: 118 LKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQ 176
           +    H N+I L  V  ++        V ++T  M    L++ LR   L+D   QF V Q
Sbjct: 71  MGQFEHPNIIRLEGVVTNSM------PVMILTEFMENGALDSFLR---LNDG--QFTVIQ 119
Query: 177 -------ILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR--------PTE-N 220
                  I  G++Y+     +HRDL   NI VN +   K+ DFGL+R        PTE +
Sbjct: 120 LVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETS 179
Query: 221 EMTGYVATRWYRAPEIM 237
            + G +  RW  APE +
Sbjct: 180 SLGGKIPIRWT-APEAI 195

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 72/150 (48%), Gaps = 15/150 (10%)
Query: 93  VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM 152
           VA+K +    +  +  +   +E  ++K + H N++ LL V     C  +     ++  + 
Sbjct: 39  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV-----CTREPPFYIIIEFMT 90
Query: 153 GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKI 209
             +L + LR    Q++S   + ++  QI   ++Y+     IHRDL   N  V E+  +K+
Sbjct: 91  YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKV 150
Query: 210 LDFGLAR-PTENEMTGYVATRW---YRAPE 235
            DFGL+R  T +  T +   ++   + APE
Sbjct: 151 ADFGLSRLMTGDTXTAHAGAKFPIKWTAPE 180

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 85/185 (45%), Gaps = 19/185 (10%)
Query: 66  IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAK----RTYRELRMLKHM 121
            +IG  L K  F  ++  A +  S   VA+K +   F+S +  +    +  RE+ +  H+
Sbjct: 25  FEIGRPLGKGKFGNVYL-AREKKSHFIVALKVL---FKSQIEKEGVEHQLRREIEIQAHL 80
Query: 122 NHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQKLSDDHVQFLVYQILR 179
           +H N++ L + F+      D + +Y++      G     + ++    +     ++ ++  
Sbjct: 81  HHPNILRLYNYFY------DRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELAD 134
Query: 180 GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG--LARPTENEMTGYVATRWYRAPEIM 237
            L Y H   +IHRD+KP N+ +    ELKI DFG  +  P+    T    T  Y  PE++
Sbjct: 135 ALMYCHGKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKT-MCGTLDYLPPEMI 193
Query: 238 LNWMH 242
              MH
Sbjct: 194 EGRMH 198

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/128 (28%), Positives = 62/128 (48%), Gaps = 13/128 (10%)
Query: 93  VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM 152
           VA+K +    +  +  +   +E  ++K + H N++ LL V     C  +    Y++T  M
Sbjct: 43  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV-----CTRE-PPFYIITEFM 93
Query: 153 G-ADLNNILRTQKLSDDHVQFLVY---QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELK 208
              +L + LR     + +   L+Y   QI   ++Y+     IHRDL   N  V E+  +K
Sbjct: 94  TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVK 153
Query: 209 ILDFGLAR 216
           + DFGL+R
Sbjct: 154 VADFGLSR 161

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 62/127 (48%), Gaps = 11/127 (8%)
Query: 93  VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM 152
           VA+K +    +  +  +   +E  ++K + H N++ LL V     C  +     ++  + 
Sbjct: 41  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV-----CTREPPFYIIIEFMT 92
Query: 153 GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKI 209
             +L + LR    Q++S   + ++  QI   ++Y+     IHRDL   N  V E+  +K+
Sbjct: 93  YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKV 152
Query: 210 LDFGLAR 216
            DFGL+R
Sbjct: 153 ADFGLSR 159

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 56/100 (56%), Gaps = 8/100 (8%)
Query: 144 NVYMVTHLMGADLNN-----ILRTQKLSDDHVQFLVYQILRGLKYIHSA-GIIHRDLKPS 197
           +V++   LM   L+      I + Q + +D +  +   I++ L+++HS   +IHRD+KPS
Sbjct: 80  DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPS 139
Query: 198 NIAVNEDCELKILDFGLARPTENEMTGYV--ATRWYRAPE 235
           N+ +N   ++K+ DFG++    +++   +    + Y APE
Sbjct: 140 NVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPE 179

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 73/161 (45%), Gaps = 14/161 (8%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLK 119
           E+ R  I +   L    +  ++       S + VA+K +    +  +  +   +E  ++K
Sbjct: 11  EMERTDITMKHKLGGGQYGEVYEGVWKKYS-LTVAVKTLK---EDTMEVEEFLKEAAVMK 66
Query: 120 HMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDDHVQFLVY--- 175
            + H N++ LL V     C  +    Y++T  M   +L + LR     + +   L+Y   
Sbjct: 67  EIKHPNLVQLLGV-----CTRE-PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 120
Query: 176 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           QI   ++Y+     IHRDL   N  V E+  +K+ DFGL+R
Sbjct: 121 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 161

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 62/127 (48%), Gaps = 11/127 (8%)
Query: 93  VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM 152
           VA+K +    +  +  +   +E  ++K + H N++ LL V     C  +     ++  + 
Sbjct: 41  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV-----CTREPPFYIIIEFMT 92
Query: 153 GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKI 209
             +L + LR    Q++S   + ++  QI   ++Y+     IHRDL   N  V E+  +K+
Sbjct: 93  YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKV 152
Query: 210 LDFGLAR 216
            DFGL+R
Sbjct: 153 ADFGLSR 159

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 2/92 (2%)
Query: 146 YMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
           Y+V   +G       + QKL        + +IL  L Y+HS G+++ DLKP NI + E+ 
Sbjct: 160 YIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE- 218
Query: 206 ELKILDFGLARPTENEMTGYVATRWYRAPEIM 237
           +LK++D G A    N       T  ++APEI+
Sbjct: 219 QLKLIDLG-AVSRINSFGYLYGTPGFQAPEIV 249

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 74/166 (44%), Gaps = 11/166 (6%)
Query: 61  ICRGVIDIGPTLSKESFDLIFSSALDSVSG--VKVAIKKIARPFQSAVHAKRTYRELRML 118
           I R ++ +G  L +  F  +    L    G  +KVA+K +     S    +    E   +
Sbjct: 31  IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACM 90
Query: 119 KHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDD--HV------ 170
           K  +H NVI LL V    +     K + ++  +   DL+  L   +L     H+      
Sbjct: 91  KDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLL 150
Query: 171 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           +F+V  I  G++Y+ +   +HRDL   N  + +D  + + DFGL++
Sbjct: 151 KFMV-DIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 93  VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT-HL 151
           VA+K I    + ++     ++E + +  ++H  ++    V     C  ++  +Y+VT ++
Sbjct: 35  VAVKMIK---EGSMSEDEFFQEAQTMMKLSHPKLVKFYGV-----CSKEYP-IYIVTEYI 85
Query: 152 MGADLNNILRTQKLSDDHVQFL--VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKI 209
               L N LR+     +  Q L   Y +  G+ ++ S   IHRDL   N  V+ D  +K+
Sbjct: 86  SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKV 145
Query: 210 LDFGLARPT-ENEMTGYVATRW---YRAPEIM 237
            DFG+ R   +++    V T++   + APE+ 
Sbjct: 146 SDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVF 177

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 75/161 (46%), Gaps = 14/161 (8%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLK 119
           E+ R  I +   L    +  ++       S + VA+K +    +  +  +   +E  ++K
Sbjct: 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYS-LTVAVKTLK---EDTMEVEEFLKEAAVMK 271
Query: 120 HMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRT---QKLSDDHVQFLVY 175
            + H N++ LL V     C  +    Y++T  M   +L + LR    Q++S   + ++  
Sbjct: 272 EIKHPNLVQLLGV-----CTRE-PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 325
Query: 176 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           QI   ++Y+     IHR+L   N  V E+  +K+ DFGL+R
Sbjct: 326 QISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSR 366

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 25/83 (30%), Positives = 49/83 (59%), Gaps = 6/83 (7%)
Query: 165 LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARPTENEM- 222
           L ++  +   +Q+L  +++ H+ G++HRD+K  NI ++ +  ELK++DFG     ++ + 
Sbjct: 154 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 213
Query: 223 TGYVATRWYRAPEIMLNWMHYNQ 245
           T +  TR Y  PE    W+ Y++
Sbjct: 214 TDFDGTRVYSPPE----WIRYHR 232

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 76/162 (46%), Gaps = 17/162 (10%)
Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIK-KIARPFQSAVHAKRTYRELRMLKHMNHENV 126
           +G  +   SF  I+  A +  SG +VAIK +  +     +H      E +  K M  +  
Sbjct: 13  LGRKIGSGSFGDIYLGA-NIASGEEVAIKLECVKTKHPQLHI-----ESKFYKMM--QGG 64
Query: 127 IGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILR--TQKLSDDHVQFLVYQILRGLKYI 184
           +G+  +     C A+     MV  L+G  L ++    ++K S   V  L  Q++  ++YI
Sbjct: 65  VGIPSI---KWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 121
Query: 185 HSAGIIHRDLKPSNIAVN---EDCELKILDFGLARPTENEMT 223
           HS   IHRD+KP N  +    +   + I+DFGLA+   +  T
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 60/127 (47%), Gaps = 11/127 (8%)
Query: 93  VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM 152
           VA+K +    +  +  +   +E  ++K + H N++ LL V     C  +     ++  + 
Sbjct: 46  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV-----CTREPPFYIIIEFMT 97
Query: 153 GADLNNILRTQKLSDDHVQFLVY---QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKI 209
             +L + LR     + +   L+Y   QI   ++Y+     IHRDL   N  V E+  +K+
Sbjct: 98  YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKV 157
Query: 210 LDFGLAR 216
            DFGL+R
Sbjct: 158 ADFGLSR 164

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 69/156 (44%), Gaps = 22/156 (14%)
Query: 93  VAIKKIARPFQSAVHAKRTY-RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHL 151
           VAIK +   +      +R +  E  ++   +H NVI L  V   +T       V ++T  
Sbjct: 38  VAIKTLKSGYTE--KQRRDFLSEASIMGQFDHPNVIHLEGVVTKST------PVMIITEF 89
Query: 152 M-GADLNNILRTQKLSDDHVQF--LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELK 208
           M    L++ LR        +Q   ++  I  G+KY+     +HR L   NI VN +   K
Sbjct: 90  MENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRALAARNILVNSNLVCK 149
Query: 209 ILDFGLARPTENE---------MTGYVATRWYRAPE 235
           + DFGL+R  E++         + G +  RW  APE
Sbjct: 150 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRW-TAPE 184

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 74/153 (48%), Gaps = 16/153 (10%)
Query: 93  VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM 152
           VAIK I    + ++       E +++ +++HE ++ L  V     C    + ++++T  M
Sbjct: 51  VAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGV-----CTKQ-RPIFIITEYM 101
Query: 153 G-ADLNNILRTQKLSDDHVQFL--VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKI 209
               L N LR  +      Q L     +   ++Y+ S   +HRDL   N  VN+   +K+
Sbjct: 102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKV 161
Query: 210 LDFGLARPT-ENEMTGYVATRW---YRAPEIML 238
            DFGL+R   ++E T  V +++   +  PE+++
Sbjct: 162 SDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 194

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 31/117 (26%), Positives = 56/117 (47%), Gaps = 11/117 (9%)
Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILR----TQKLSDD 168
           RE  +LK +NH+N++ L  +    T       V ++       L  +L        L + 
Sbjct: 56  REFEVLKKLNHKNIVKLFAIEEETTTR---HKVLIMEFCPCGSLYTVLEEPSNAYGLPES 112
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNI--AVNEDCE--LKILDFGLARPTENE 221
               ++  ++ G+ ++   GI+HR++KP NI   + ED +   K+ DFG AR  E++
Sbjct: 113 EFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD 169

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 73/170 (42%), Gaps = 18/170 (10%)
Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYM- 147
           +G  VA+K + +      H     +E+ +L+ + HE++I          C  D     + 
Sbjct: 59  TGEMVAVKAL-KADAGPQHRSGWKQEIDILRTLYHEHII------KYKGCCEDAGAASLQ 111
Query: 148 --VTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
             + ++    L + L    +    +     QI  G+ Y+H+   IHRDL   N+ ++ D 
Sbjct: 112 LVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDR 171
Query: 206 ELKILDFGLAR--PTENEM-----TGYVATRWYRAPEIMLNWMHYNQTGV 248
            +KI DFGLA+  P  +E       G     WY APE +  +  Y  + V
Sbjct: 172 LVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWY-APECLKEYKFYYASDV 220

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 54/109 (49%), Gaps = 7/109 (6%)
Query: 145 VYMVTHLMGADLNNILRTQKLSDDHVQFLVYQ-ILRGLKYIHSAGIIHRDLKPSNIAVNE 203
           +YMV      DLN+ L+ +K  D   +   ++ +L  +  IH  GI+H DLKP+N  +  
Sbjct: 131 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 189
Query: 204 DCELKILDFGLARPTENEMTGY-----VATRWYRAPEIMLNWMHYNQTG 247
           D  LK++DFG+A   + + T       V T  Y  PE + +     + G
Sbjct: 190 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENG 238

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 54/109 (49%), Gaps = 7/109 (6%)
Query: 145 VYMVTHLMGADLNNILRTQKLSDDHVQFLVYQ-ILRGLKYIHSAGIIHRDLKPSNIAVNE 203
           +YMV      DLN+ L+ +K  D   +   ++ +L  +  IH  GI+H DLKP+N  +  
Sbjct: 131 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 189
Query: 204 DCELKILDFGLARPTENEMTGY-----VATRWYRAPEIMLNWMHYNQTG 247
           D  LK++DFG+A   + + T       V T  Y  PE + +     + G
Sbjct: 190 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENG 238

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 65/131 (49%), Gaps = 13/131 (9%)
Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQ--KLSDDHV 170
           +E+ +L    H N++ L + F S   L     V +   + G D+   + T   +L++  +
Sbjct: 50  KEISILNIARHRNILHLHESFESMEEL-----VMIFEFISGLDIFERINTSAFELNEREI 104
Query: 171 QFLVYQILRGLKYIHSAGIIHRDLKPSNI--AVNEDCELKILDFGLAR---PTENEMTGY 225
              V+Q+   L+++HS  I H D++P NI         +KI++FG AR   P +N    +
Sbjct: 105 VSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF 164
Query: 226 VATRWYRAPEI 236
            A  +Y APE+
Sbjct: 165 TAPEYY-APEV 174

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 83/177 (46%), Gaps = 19/177 (10%)
Query: 219 ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNI--AVNEDCELKILDFGLA 276
           E E+  YV    ++  E  L ++H +  G   +F D++P NI         +KI++FG A
Sbjct: 101 EREIVSYV----HQVCE-ALQFLHSHNIG---HF-DIRPENIIYQTRRSSTIKIIEFGQA 151
Query: 277 R---PTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSD 333
           R   P +N    + A  +Y APE+  + +    TD+  L  ++ +L +    F+A+ +  
Sbjct: 152 RQLKPGDNFRLLFTAPEYY-APEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ 210
Query: 334 SARKYINSLPLLTKKDFRQVFKGANPQAIXXXXXXXXXXXXKRITAEQALAHPYLSQ 390
                +N+     ++ F+++    + +A+             R+TA +AL HP+L Q
Sbjct: 211 IIENIMNAEYTFDEEAFKEI----SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 60/127 (47%), Gaps = 11/127 (8%)
Query: 93  VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM 152
           VA+K +    +  +  +   +E  ++K + H N++ LL V     C  +     ++  + 
Sbjct: 42  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV-----CTREPPFYIIIEFMT 93
Query: 153 GADLNNILRTQKLSDDHVQFLVY---QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKI 209
             +L + LR     + +   L+Y   QI   ++Y+     IHRDL   N  V E+  +K+
Sbjct: 94  YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKV 153
Query: 210 LDFGLAR 216
            DFGL+R
Sbjct: 154 ADFGLSR 160

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/117 (26%), Positives = 56/117 (47%), Gaps = 11/117 (9%)
Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILR----TQKLSDD 168
           RE  +LK +NH+N++ L  +    T       V ++       L  +L        L + 
Sbjct: 56  REFEVLKKLNHKNIVKLFAIEEETTTR---HKVLIMEFCPCGSLYTVLEEPSNAYGLPES 112
Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNI--AVNEDCE--LKILDFGLARPTENE 221
               ++  ++ G+ ++   GI+HR++KP NI   + ED +   K+ DFG AR  E++
Sbjct: 113 EFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD 169

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 74/153 (48%), Gaps = 16/153 (10%)
Query: 93  VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM 152
           VAIK I    + ++       E +++ +++HE ++ L  V     C    + ++++T  M
Sbjct: 42  VAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGV-----CTKQ-RPIFIITEYM 92
Query: 153 G-ADLNNILRTQKLSDDHVQFL--VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKI 209
               L N LR  +      Q L     +   ++Y+ S   +HRDL   N  VN+   +K+
Sbjct: 93  ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKV 152
Query: 210 LDFGLARPT-ENEMTGYVATRW---YRAPEIML 238
            DFGL+R   ++E T  V +++   +  PE+++
Sbjct: 153 SDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 185

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/153 (24%), Positives = 73/153 (47%), Gaps = 16/153 (10%)
Query: 93  VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM 152
           VAIK I    + ++       E +++ +++HE ++ L  V          + ++++T  M
Sbjct: 35  VAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ------RPIFIITEYM 85
Query: 153 G-ADLNNILRTQKLSDDHVQFL--VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKI 209
               L N LR  +      Q L     +   ++Y+ S   +HRDL   N  VN+   +K+
Sbjct: 86  ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKV 145
Query: 210 LDFGLARPT-ENEMTGYVATRW---YRAPEIML 238
            DFGL+R   ++E T  V +++   +  PE+++
Sbjct: 146 SDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 178

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 61/128 (47%), Gaps = 13/128 (10%)
Query: 93  VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM 152
           VA+K +    +  +  +   +E  ++K + H N++ LL V     C  +    Y+VT  M
Sbjct: 60  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV-----CTLE-PPFYIVTEYM 110
Query: 153 G-ADLNNILRTQKLSDDHVQFLVY---QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELK 208
              +L + LR     +     L+Y   QI   ++Y+     IHRDL   N  V E+  +K
Sbjct: 111 PYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVK 170
Query: 209 ILDFGLAR 216
           + DFGL+R
Sbjct: 171 VADFGLSR 178

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/153 (24%), Positives = 73/153 (47%), Gaps = 16/153 (10%)
Query: 93  VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM 152
           VAIK I    + ++       E +++ +++HE ++ L  V          + ++++T  M
Sbjct: 51  VAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ------RPIFIITEYM 101
Query: 153 G-ADLNNILRTQKLSDDHVQFL--VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKI 209
               L N LR  +      Q L     +   ++Y+ S   +HRDL   N  VN+   +K+
Sbjct: 102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKV 161
Query: 210 LDFGLARPT-ENEMTGYVATRW---YRAPEIML 238
            DFGL+R   ++E T  V +++   +  PE+++
Sbjct: 162 SDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLM 194

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 73/159 (45%), Gaps = 13/159 (8%)
Query: 84  ALDSVSGVKVAIKKIARPFQS-AVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           A D+V    VA+K  +    S  V   R  RE R    +   +V+ + D    +  L   
Sbjct: 53  AEDTVRERIVALKLXSETLSSDPVFRTRXQREARTAGRLQEPHVVPIHDFGEIDGQL--- 109
Query: 143 KNVYMVTHLM-GADLNNILRTQK-LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
              Y+   L+ G DL   LR Q  L+      +V QI   L   H+AG  HRD+KP NI 
Sbjct: 110 ---YVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENIL 166
Query: 201 VNEDCELKILDFGLARPTENE----MTGYVATRWYRAPE 235
           V+ D    ++DFG+A  T +E    +   V T +Y APE
Sbjct: 167 VSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPE 205

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 25/77 (32%), Positives = 40/77 (51%), Gaps = 6/77 (7%)
Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENE----MTGYVATRWYRAPEIMLNWMHYNQTD 308
           +D+KP NI V+ D    ++DFG+A  T +E    +   V T +Y APE         + D
Sbjct: 158 RDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRAD 217
Query: 309 IHQLNLIME--MLGTPP 323
           I+ L  ++   + G+PP
Sbjct: 218 IYALTCVLYECLTGSPP 234

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 7/97 (7%)
Query: 145 VYMVTHLMGADLNNILRTQKLSDDHVQFLVYQ-ILRGLKYIHSAGIIHRDLKPSNIAVNE 203
           +YMV      DLN+ L+ +K  D   +   ++ +L  +  IH  GI+H DLKP+N  +  
Sbjct: 87  IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 145
Query: 204 DCELKILDFGLARPTENEMTGY-----VATRWYRAPE 235
           D  LK++DFG+A   + + T       V T  Y  PE
Sbjct: 146 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 182

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 7/97 (7%)
Query: 145 VYMVTHLMGADLNNILRTQKLSDDHVQFLVYQ-ILRGLKYIHSAGIIHRDLKPSNIAVNE 203
           +YMV      DLN+ L+ +K  D   +   ++ +L  +  IH  GI+H DLKP+N  +  
Sbjct: 84  IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 142
Query: 204 DCELKILDFGLARPTENEMTGY-----VATRWYRAPE 235
           D  LK++DFG+A   + + T       V T  Y  PE
Sbjct: 143 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 7/97 (7%)
Query: 145 VYMVTHLMGADLNNILRTQKLSDDHVQFLVYQ-ILRGLKYIHSAGIIHRDLKPSNIAVNE 203
           +YMV      DLN+ L+ +K  D   +   ++ +L  +  IH  GI+H DLKP+N  +  
Sbjct: 103 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 161
Query: 204 DCELKILDFGLARPTENEMTGY-----VATRWYRAPE 235
           D  LK++DFG+A   + + T       V T  Y  PE
Sbjct: 162 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 198

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/153 (24%), Positives = 73/153 (47%), Gaps = 16/153 (10%)
Query: 93  VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM 152
           VAIK I    + ++       E +++ +++HE ++ L  V          + ++++T  M
Sbjct: 31  VAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ------RPIFIITEYM 81
Query: 153 G-ADLNNILRTQKLSDDHVQFL--VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKI 209
               L N LR  +      Q L     +   ++Y+ S   +HRDL   N  VN+   +K+
Sbjct: 82  ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKV 141
Query: 210 LDFGLARPT-ENEMTGYVATRW---YRAPEIML 238
            DFGL+R   ++E T  V +++   +  PE+++
Sbjct: 142 SDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 174

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/83 (34%), Positives = 46/83 (55%), Gaps = 2/83 (2%)
Query: 145 VYMVTHLMGADLNNILRTQKLSDDHVQFLVYQ-ILRGLKYIHSAGIIHRDLKPSNIAVNE 203
           +YMV      DLN+ L+ +K  D   +   ++ +L  +  IH  GI+H DLKP+N  +  
Sbjct: 131 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 189
Query: 204 DCELKILDFGLARPTENEMTGYV 226
           D  LK++DFG+A   + + T  V
Sbjct: 190 DGMLKLIDFGIANQMQPDTTSVV 212

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 74/153 (48%), Gaps = 16/153 (10%)
Query: 93  VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM 152
           VAIK I    + ++       E +++ +++HE ++ L  V     C    + ++++T  M
Sbjct: 36  VAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGV-----CTKQ-RPIFIITEYM 86
Query: 153 G-ADLNNILRTQKLSDDHVQFL--VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKI 209
               L N LR  +      Q L     +   ++Y+ S   +HRDL   N  VN+   +K+
Sbjct: 87  ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKV 146
Query: 210 LDFGLARPT-ENEMTGYVATRW---YRAPEIML 238
            DFGL+R   ++E T  V +++   +  PE+++
Sbjct: 147 SDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 179

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 7/97 (7%)
Query: 145 VYMVTHLMGADLNNILRTQKLSDDHVQFLVYQ-ILRGLKYIHSAGIIHRDLKPSNIAVNE 203
           +YMV      DLN+ L+ +K  D   +   ++ +L  +  IH  GI+H DLKP+N  +  
Sbjct: 83  IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 141
Query: 204 DCELKILDFGLARPTENEMTGY-----VATRWYRAPE 235
           D  LK++DFG+A   + + T       V T  Y  PE
Sbjct: 142 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 178

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 70/167 (41%), Gaps = 30/167 (17%)
Query: 72  LSKESFDLIFSSALDSVSGVK----VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVI 127
           L + +F  +F +   ++S  K    VA+K +  P  +A   K   RE  +L ++ HE+++
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA--RKDFQREAELLTNLQHEHIV 80
Query: 128 GLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQ-----------------KLSDDH 169
               V        D   + MV   M   DLN  LR                   +L    
Sbjct: 81  KFYGV------CGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 170 VQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           +  +  QI  G+ Y+ S   +HRDL   N  V  +  +KI DFG++R
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 73/161 (45%), Gaps = 14/161 (8%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLK 119
           E+ R  I +   L    +  ++       S + VA+K +    +  +  +   +E  ++K
Sbjct: 255 EMERTDITMKHKLGGGQYGEVYEGVWKKYS-LTVAVKTLK---EDTMEVEEFLKEAAVMK 310
Query: 120 HMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDDHVQFLVY--- 175
            + H N++ LL V     C  +    Y++T  M   +L + LR     + +   L+Y   
Sbjct: 311 EIKHPNLVQLLGV-----CTRE-PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 364
Query: 176 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           QI   ++Y+     IHR+L   N  V E+  +K+ DFGL+R
Sbjct: 365 QISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSR 405

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 26/80 (32%), Positives = 43/80 (53%), Gaps = 5/80 (6%)
Query: 163 QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI---AVNEDCELKILDFGLARPT- 218
           Q  ++     ++  I   ++Y+HS  I HRD+KP N+   +   +  LK+ DFG A+ T 
Sbjct: 118 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 177
Query: 219 -ENEMTGYVATRWYRAPEIM 237
             N +T    T +Y APE++
Sbjct: 178 SHNSLTTPCYTPYYVAPEVL 197

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 80/175 (45%), Gaps = 27/175 (15%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSG----VKVAIKKIARPFQSAVHAKRT--YR 113
           E+ R  I +   L + SF +++      V       +VAIK +    ++A   +R     
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLN 77
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQK--LSDDHV 170
           E  ++K  N  +V+ LL V      ++  +   ++  LM   DL + LR+ +  ++++ V
Sbjct: 78  EASVMKEFNCHHVVRLLGV------VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPV 131
Query: 171 QF---------LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
                      +  +I  G+ Y+++   +HRDL   N  V ED  +KI DFG+ R
Sbjct: 132 LAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 26/80 (32%), Positives = 43/80 (53%), Gaps = 5/80 (6%)
Query: 163 QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI---AVNEDCELKILDFGLARPT- 218
           Q  ++     ++  I   ++Y+HS  I HRD+KP N+   +   +  LK+ DFG A+ T 
Sbjct: 117 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 176
Query: 219 -ENEMTGYVATRWYRAPEIM 237
             N +T    T +Y APE++
Sbjct: 177 SHNSLTTPCYTPYYVAPEVL 196

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 70/154 (45%), Gaps = 15/154 (9%)
Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           + VAIK + R   S    K    E  ++  +    V  LL +  ++T       V +VT 
Sbjct: 47  IPVAIK-VLRENTSPKANKEILDEAYVMAGVGSPYVSRLLGICLTST-------VQLVTQ 98
Query: 151 LM--GADLNNILRTQ-KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
           LM  G  L+++   + +L    +     QI +G+ Y+    ++HRDL   N+ V     +
Sbjct: 99  LMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDVRLVHRDLAARNVLVKSPNHV 158
Query: 208 KILDFGLARPTENEMTGYVATRWYRAPEIMLNWM 241
           KI DFGLAR  + + T Y A       ++ + WM
Sbjct: 159 KITDFGLARLLDIDETEYHAD----GGKVPIKWM 188

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 76/162 (46%), Gaps = 17/162 (10%)
Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIK-KIARPFQSAVHAKRTYRELRMLKHMNHENV 126
           +G  +   SF  I+    D  +G +VAIK +  +     +H      E ++ K M  +  
Sbjct: 13  LGRKIGSGSFGDIYLGT-DIAAGEEVAIKLECVKTKHPQLHI-----ESKIYKMM--QGG 64
Query: 127 IGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILR--TQKLSDDHVQFLVYQILRGLKYI 184
           +G+  +     C A+     MV  L+G  L ++    ++K S   V  L  Q++  ++YI
Sbjct: 65  VGIPTI---RWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 121
Query: 185 HSAGIIHRDLKPSNIAVN---EDCELKILDFGLARPTENEMT 223
           HS   IHRD+KP N  +    +   + I+DFGLA+   +  T
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 26/80 (32%), Positives = 43/80 (53%), Gaps = 5/80 (6%)
Query: 163 QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI---AVNEDCELKILDFGLARPT- 218
           Q  ++     ++  I   ++Y+HS  I HRD+KP N+   +   +  LK+ DFG A+ T 
Sbjct: 116 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 175
Query: 219 -ENEMTGYVATRWYRAPEIM 237
             N +T    T +Y APE++
Sbjct: 176 SHNSLTTPCYTPYYVAPEVL 195

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 77/175 (44%), Gaps = 27/175 (15%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSG----VKVAIKKIARPFQSAVHAKRT--YR 113
           E+ R  I +   L + SF +++      V       +VAIK +    ++A   +R     
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLN 77
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDDHVQF 172
           E  ++K  N  +V+ LL V      ++  +   ++  LM   DL + LR+ +   ++   
Sbjct: 78  EASVMKEFNCHHVVRLLGV------VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 131
Query: 173 LV-----------YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           L             +I  G+ Y+++   +HRDL   N  V ED  +KI DFG+ R
Sbjct: 132 LAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 26/80 (32%), Positives = 43/80 (53%), Gaps = 5/80 (6%)
Query: 163 QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI---AVNEDCELKILDFGLARPT- 218
           Q  ++     ++  I   ++Y+HS  I HRD+KP N+   +   +  LK+ DFG A+ T 
Sbjct: 126 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 185
Query: 219 -ENEMTGYVATRWYRAPEIM 237
             N +T    T +Y APE++
Sbjct: 186 SHNSLTTPCYTPYYVAPEVL 205

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 26/80 (32%), Positives = 43/80 (53%), Gaps = 5/80 (6%)
Query: 163 QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI---AVNEDCELKILDFGLARPT- 218
           Q  ++     ++  I   ++Y+HS  I HRD+KP N+   +   +  LK+ DFG A+ T 
Sbjct: 156 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215
Query: 219 -ENEMTGYVATRWYRAPEIM 237
             N +T    T +Y APE++
Sbjct: 216 SHNSLTTPCYTPYYVAPEVL 235

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 26/80 (32%), Positives = 43/80 (53%), Gaps = 5/80 (6%)
Query: 163 QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI---AVNEDCELKILDFGLARPT- 218
           Q  ++     ++  I   ++Y+HS  I HRD+KP N+   +   +  LK+ DFG A+ T 
Sbjct: 110 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 169
Query: 219 -ENEMTGYVATRWYRAPEIM 237
             N +T    T +Y APE++
Sbjct: 170 SHNSLTTPCYTPYYVAPEVL 189

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 26/80 (32%), Positives = 43/80 (53%), Gaps = 5/80 (6%)
Query: 163 QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI---AVNEDCELKILDFGLARPT- 218
           Q  ++     ++  I   ++Y+HS  I HRD+KP N+   +   +  LK+ DFG A+ T 
Sbjct: 162 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 221
Query: 219 -ENEMTGYVATRWYRAPEIM 237
             N +T    T +Y APE++
Sbjct: 222 SHNSLTTPCYTPYYVAPEVL 241

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 26/80 (32%), Positives = 43/80 (53%), Gaps = 5/80 (6%)
Query: 163 QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI---AVNEDCELKILDFGLARPT- 218
           Q  ++     ++  I   ++Y+HS  I HRD+KP N+   +   +  LK+ DFG A+ T 
Sbjct: 111 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 170
Query: 219 -ENEMTGYVATRWYRAPEIM 237
             N +T    T +Y APE++
Sbjct: 171 SHNSLTTPCYTPYYVAPEVL 190

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 76/162 (46%), Gaps = 17/162 (10%)
Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIK-KIARPFQSAVHAKRTYRELRMLKHMNHENV 126
           +G  +   SF  I+    D  +G +VAIK +  +     +H      E ++ K M  +  
Sbjct: 11  LGRKIGSGSFGDIYLGT-DIAAGEEVAIKLECVKTKHPQLHI-----ESKIYKMM--QGG 62
Query: 127 IGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILR--TQKLSDDHVQFLVYQILRGLKYI 184
           +G+  +     C A+     MV  L+G  L ++    ++K S   V  L  Q++  ++YI
Sbjct: 63  VGIPTI---RWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 185 HSAGIIHRDLKPSNIAVN---EDCELKILDFGLARPTENEMT 223
           HS   IHRD+KP N  +    +   + I+DFGLA+   +  T
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 26/80 (32%), Positives = 43/80 (53%), Gaps = 5/80 (6%)
Query: 163 QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI---AVNEDCELKILDFGLARPT- 218
           Q  ++     ++  I   ++Y+HS  I HRD+KP N+   +   +  LK+ DFG A+ T 
Sbjct: 112 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 171
Query: 219 -ENEMTGYVATRWYRAPEIM 237
             N +T    T +Y APE++
Sbjct: 172 SHNSLTTPCYTPYYVAPEVL 191

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 26/80 (32%), Positives = 43/80 (53%), Gaps = 5/80 (6%)
Query: 163 QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI---AVNEDCELKILDFGLARPT- 218
           Q  ++     ++  I   ++Y+HS  I HRD+KP N+   +   +  LK+ DFG A+ T 
Sbjct: 112 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 171
Query: 219 -ENEMTGYVATRWYRAPEIM 237
             N +T    T +Y APE++
Sbjct: 172 SHNSLTTPCYTPYYVAPEVL 191

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 20/42 (47%), Positives = 30/42 (71%)
Query: 175 YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           +Q+ RG++++ S   IHRDL   NI ++E+  +KI DFGLAR
Sbjct: 206 FQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLAR 247

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 77/175 (44%), Gaps = 27/175 (15%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSG----VKVAIKKIARPFQSAVHAKRT--YR 113
           E+ R  I +   L + SF +++      V       +VAIK +    ++A   +R     
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLN 64
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDDHVQF 172
           E  ++K  N  +V+ LL V      ++  +   ++  LM   DL + LR+ +   ++   
Sbjct: 65  EASVMKEFNCHHVVRLLGV------VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 118
Query: 173 LV-----------YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           L             +I  G+ Y+++   +HRDL   N  V ED  +KI DFG+ R
Sbjct: 119 LAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTR 173

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 80/175 (45%), Gaps = 27/175 (15%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSG----VKVAIKKIARPFQSAVHAKRT--YR 113
           E+ R  I +   L + SF +++      V       +VAIK +    ++A   +R     
Sbjct: 11  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLN 67
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQK--LSDDHV 170
           E  ++K  N  +V+ LL V      ++  +   ++  LM   DL + LR+ +  ++++ V
Sbjct: 68  EASVMKEFNCHHVVRLLGV------VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPV 121
Query: 171 QF---------LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
                      +  +I  G+ Y+++   +HRDL   N  V ED  +KI DFG+ R
Sbjct: 122 LAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 176

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 101/229 (44%), Gaps = 28/229 (12%)
Query: 28  TLSRSIVRLWTVYPASKLPSRRLHDHF---NQPYSEICRGVIDIGPTLSKESFDLIFSSA 84
           TL   +V L+T    S L   +    F    +P++++ + +      L +E F++I    
Sbjct: 45  TLLDVLVCLYTECSHSALRRDKYVAEFLEWAKPFTQLVKEM-----QLHREDFEII--KV 97
Query: 85  LDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC------ 138
           +   +  +VA+ K+       ++A +   +  MLK           DV  +  C      
Sbjct: 98  IGRGAFGEVAVVKMKNT--ERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITAL 155
Query: 139 ---LADFKNVYMVT-HLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHR 192
                D  ++Y+V  + +G DL  +L     KL +D  +F + +++  +  IH    +HR
Sbjct: 156 HYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHR 215
Query: 193 DLKPSNIAVNEDCELKILDFGLARPTENEMTGY----VATRWYRAPEIM 237
           D+KP N+ ++ +  +++ DFG      ++ T      V T  Y +PEI+
Sbjct: 216 DIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEIL 264

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 26/80 (32%), Positives = 43/80 (53%), Gaps = 5/80 (6%)
Query: 163 QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI---AVNEDCELKILDFGLARPT- 218
           Q  ++     ++  I   ++Y+HS  I HRD+KP N+   +   +  LK+ DFG A+ T 
Sbjct: 110 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 169
Query: 219 -ENEMTGYVATRWYRAPEIM 237
             N +T    T +Y APE++
Sbjct: 170 SHNSLTEPCYTPYYVAPEVL 189

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 101/229 (44%), Gaps = 28/229 (12%)
Query: 28  TLSRSIVRLWTVYPASKLPSRRLHDHF---NQPYSEICRGVIDIGPTLSKESFDLIFSSA 84
           TL   +V L+T    S L   +    F    +P++++ + +      L +E F++I    
Sbjct: 29  TLLDVLVCLYTECSHSALRRDKYVAEFLEWAKPFTQLVKEM-----QLHREDFEII--KV 81
Query: 85  LDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC------ 138
           +   +  +VA+ K+       ++A +   +  MLK           DV  +  C      
Sbjct: 82  IGRGAFGEVAVVKMKNT--ERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITAL 139
Query: 139 ---LADFKNVYMVT-HLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHR 192
                D  ++Y+V  + +G DL  +L     KL +D  +F + +++  +  IH    +HR
Sbjct: 140 HYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHR 199
Query: 193 DLKPSNIAVNEDCELKILDFGLARPTENEMTGY----VATRWYRAPEIM 237
           D+KP N+ ++ +  +++ DFG      ++ T      V T  Y +PEI+
Sbjct: 200 DIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEIL 248

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 75/170 (44%), Gaps = 18/170 (10%)
Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD--FKNVY 146
           +G  VA+K + +      H     +E+ +L+ + HE++I          C  D   K++ 
Sbjct: 42  TGEMVAVKAL-KADCGPQHRSGWKQEIDILRTLYHEHIIKY------KGCCEDQGEKSLQ 94
Query: 147 MVTHLMG-ADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
           +V   +    L + L    +    +     QI  G+ Y+HS   IHR+L   N+ ++ D 
Sbjct: 95  LVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHSQHYIHRNLAARNVLLDNDR 154
Query: 206 ELKILDFGLAR--PTENEM-----TGYVATRWYRAPEIMLNWMHYNQTGV 248
            +KI DFGLA+  P  +E       G     WY APE +  +  Y  + V
Sbjct: 155 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKEYKFYYASDV 203

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 83/197 (42%), Gaps = 47/197 (23%)
Query: 58  YSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRM 117
           + E+CRG +   P   KES                VAIK +   + +    +    E  +
Sbjct: 27  FGEVCRGRLK-APG-KKESC---------------VAIKTLKGGY-TERQRREFLSEASI 68
Query: 118 LKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQ 176
           +    H N+I L  V  ++        V ++T  M    L++ LR   L+D   QF V Q
Sbjct: 69  MGQFEHPNIIRLEGVVTNSM------PVMILTEFMENGALDSFLR---LNDG--QFTVIQ 117
Query: 177 -------ILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR--------PT-EN 220
                  I  G++Y+     +HRDL   NI VN +   K+ DFGL+R        PT  +
Sbjct: 118 LVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTS 177
Query: 221 EMTGYVATRWYRAPEIM 237
            + G +  RW  APE +
Sbjct: 178 SLGGKIPIRWT-APEAI 193

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 77/175 (44%), Gaps = 27/175 (15%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSG----VKVAIKKIARPFQSAVHAKRT--YR 113
           E+ R  I +   L + SF +++      V       +VAIK +    ++A   +R     
Sbjct: 14  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLN 70
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDDHVQF 172
           E  ++K  N  +V+ LL V      ++  +   ++  LM   DL + LR+ +   ++   
Sbjct: 71  EASVMKEFNCHHVVRLLGV------VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 124
Query: 173 LV-----------YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           L             +I  G+ Y+++   +HRDL   N  V ED  +KI DFG+ R
Sbjct: 125 LAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 77/175 (44%), Gaps = 27/175 (15%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSG----VKVAIKKIARPFQSAVHAKRT--YR 113
           E+ R  I +   L + SF +++      V       +VAIK +    ++A   +R     
Sbjct: 12  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLN 68
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDDHVQF 172
           E  ++K  N  +V+ LL V      ++  +   ++  LM   DL + LR+ +   ++   
Sbjct: 69  EASVMKEFNCHHVVRLLGV------VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 122
Query: 173 LV-----------YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           L             +I  G+ Y+++   +HRDL   N  V ED  +KI DFG+ R
Sbjct: 123 LAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 177

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 77/175 (44%), Gaps = 27/175 (15%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSG----VKVAIKKIARPFQSAVHAKRT--YR 113
           E+ R  I +   L + SF +++      V       +VAIK +    ++A   +R     
Sbjct: 15  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLN 71
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDDHVQF 172
           E  ++K  N  +V+ LL V      ++  +   ++  LM   DL + LR+ +   ++   
Sbjct: 72  EASVMKEFNCHHVVRLLGV------VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 125
Query: 173 LV-----------YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           L             +I  G+ Y+++   +HRDL   N  V ED  +KI DFG+ R
Sbjct: 126 LAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 180

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 77/175 (44%), Gaps = 27/175 (15%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSG----VKVAIKKIARPFQSAVHAKRT--YR 113
           E+ R  I +   L + SF +++      V       +VAIK +    ++A   +R     
Sbjct: 14  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLN 70
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDDHVQF 172
           E  ++K  N  +V+ LL V      ++  +   ++  LM   DL + LR+ +   ++   
Sbjct: 71  EASVMKEFNCHHVVRLLGV------VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 124
Query: 173 LV-----------YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           L             +I  G+ Y+++   +HRDL   N  V ED  +KI DFG+ R
Sbjct: 125 LAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 77/175 (44%), Gaps = 27/175 (15%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSG----VKVAIKKIARPFQSAVHAKRT--YR 113
           E+ R  I +   L + SF +++      V       +VAIK +    ++A   +R     
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLN 64
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDDHVQF 172
           E  ++K  N  +V+ LL V      ++  +   ++  LM   DL + LR+ +   ++   
Sbjct: 65  EASVMKEFNCHHVVRLLGV------VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 118
Query: 173 LV-----------YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           L             +I  G+ Y+++   +HRDL   N  V ED  +KI DFG+ R
Sbjct: 119 LAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 173

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/122 (27%), Positives = 63/122 (51%), Gaps = 11/122 (9%)
Query: 125 NVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRG 180
           +++ ++DV+ +    A  K + +V   + G +L + ++    Q  ++     +   I   
Sbjct: 116 HIVRIVDVYEN--LYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEA 173
Query: 181 LKYIHSAGIIHRDLKPSNI---AVNEDCELKILDFGLARPT--ENEMTGYVATRWYRAPE 235
           ++Y+HS  I HRD+KP N+   +   +  LK+ DFG A+ T   N +T    T +Y APE
Sbjct: 174 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 233
Query: 236 IM 237
           ++
Sbjct: 234 VL 235

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/131 (25%), Positives = 67/131 (51%), Gaps = 11/131 (8%)
Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRM-LKHMNHENVIGLLDVFHSNTCLADFKNVYM 147
           +G  +A+K++ R        KR   +L + LK  +   ++     F +NT      +V++
Sbjct: 49  TGHVIAVKQMRRSGNKE-ENKRILMDLDVVLKSHDCPYIVQCFGTFITNT------DVFI 101
Query: 148 VTHLMGADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNED 204
              LMG     + +  +  + +  +  +   I++ L Y+    G+IHRD+KPSNI ++E 
Sbjct: 102 AMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER 161
Query: 205 CELKILDFGLA 215
            ++K+ DFG++
Sbjct: 162 GQIKLCDFGIS 172

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 57/116 (49%), Gaps = 9/116 (7%)
Query: 107 HAKRTYRELRMLK-HMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKL 165
           H  R   EL+ L      +NV+G+   F  N  +     V  + +L      +IL +  L
Sbjct: 62  HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV-----VIAMPYLEHESFLDILNS--L 114
Query: 166 SDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC-ELKILDFGLARPTEN 220
           S   V+  +  + + LK IH  GI+HRD+KPSN   N    +  ++DFGLA+ T +
Sbjct: 115 SFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 77/175 (44%), Gaps = 27/175 (15%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSG----VKVAIKKIARPFQSAVHAKRT--YR 113
           E+ R  I +   L + SF +++      V       +VAIK +    ++A   +R     
Sbjct: 15  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLN 71
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDDHVQF 172
           E  ++K  N  +V+ LL V      ++  +   ++  LM   DL + LR+ +   ++   
Sbjct: 72  EASVMKEFNCHHVVRLLGV------VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 125
Query: 173 LV-----------YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           L             +I  G+ Y+++   +HRDL   N  V ED  +KI DFG+ R
Sbjct: 126 LAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 180

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 77/175 (44%), Gaps = 27/175 (15%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSG----VKVAIKKIARPFQSAVHAKRT--YR 113
           E+ R  I +   L + SF +++      V       +VAIK +    ++A   +R     
Sbjct: 6   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLN 62
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDDHVQF 172
           E  ++K  N  +V+ LL V      ++  +   ++  LM   DL + LR+ +   ++   
Sbjct: 63  EASVMKEFNCHHVVRLLGV------VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 116
Query: 173 LV-----------YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           L             +I  G+ Y+++   +HRDL   N  V ED  +KI DFG+ R
Sbjct: 117 LAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 171

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 73/173 (42%), Gaps = 21/173 (12%)
Query: 72  LSKESFDLIFSSALDSVSG--VKVAIKKIARPFQSAVHAKRTY-RELRMLKHMNHENVIG 128
           L   SF ++     D+ SG  V VA+K +     S   A   + RE+  +  ++H N+I 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 129 LLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLV-------YQILRGL 181
           L  V  +         + MVT L  A L ++L   +L      FL+        Q+  G+
Sbjct: 80  LYGVVLTPP-------MKMVTEL--APLGSLL--DRLRKHQGHFLLGTLSRYAVQVAEGM 128
Query: 182 KYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP 234
            Y+ S   IHRDL   N+ +     +KI DFGL R        YV     + P
Sbjct: 129 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 181

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 73/173 (42%), Gaps = 21/173 (12%)
Query: 72  LSKESFDLIFSSALDSVSG--VKVAIKKIARPFQSAVHAKRTY-RELRMLKHMNHENVIG 128
           L   SF ++     D+ SG  V VA+K +     S   A   + RE+  +  ++H N+I 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 129 LLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLV-------YQILRGL 181
           L  V  +         + MVT L  A L ++L   +L      FL+        Q+  G+
Sbjct: 86  LYGVVLTPP-------MKMVTEL--APLGSLL--DRLRKHQGHFLLGTLSRYAVQVAEGM 134
Query: 182 KYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP 234
            Y+ S   IHRDL   N+ +     +KI DFGL R        YV     + P
Sbjct: 135 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 187

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 77/175 (44%), Gaps = 27/175 (15%)
Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSG----VKVAIKKIARPFQSAVHAKRT--YR 113
           E+ R  I +   L + SF +++      V       +VAIK +    ++A   +R     
Sbjct: 43  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLN 99
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDDHVQF 172
           E  ++K  N  +V+ LL V      ++  +   ++  LM   DL + LR+ +   ++   
Sbjct: 100 EASVMKEFNCHHVVRLLGV------VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 153
Query: 173 LV-----------YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           L             +I  G+ Y+++   +HRDL   N  V ED  +KI DFG+ R
Sbjct: 154 LAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 208

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 73/173 (42%), Gaps = 21/173 (12%)
Query: 72  LSKESFDLIFSSALDSVSG--VKVAIKKIARPFQSAVHAKRTY-RELRMLKHMNHENVIG 128
           L   SF ++     D+ SG  V VA+K +     S   A   + RE+  +  ++H N+I 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 129 LLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLV-------YQILRGL 181
           L  V  +         + MVT L  A L ++L   +L      FL+        Q+  G+
Sbjct: 76  LYGVVLTPP-------MKMVTEL--APLGSLL--DRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 182 KYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP 234
            Y+ S   IHRDL   N+ +     +KI DFGL R        YV     + P
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 66/137 (48%), Gaps = 18/137 (13%)
Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLN-NILRTQKL----S 166
           RE  +   + H +++ LL+ + S+  L      YMV   M GADL   I++        S
Sbjct: 77  REASICHMLKHPHIVELLETYSSDGML------YMVFEFMDGADLCFEIVKRADAGFVYS 130
Query: 167 DDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILDFGLA-RPTENEM 222
           +      + QIL  L+Y H   IIHRD+KP  + +        +K+  FG+A +  E+ +
Sbjct: 131 EAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL 190
Query: 223 T--GYVATRWYRAPEIM 237
              G V T  + APE++
Sbjct: 191 VAGGRVGTPHFMAPEVV 207

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/77 (36%), Positives = 42/77 (54%), Gaps = 4/77 (5%)
Query: 165 LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTG 224
           L+ +H+    +Q+ +G++++ S   IHRDL   NI ++E   +KI DFGLAR    +   
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD-PD 253
Query: 225 YVATRWYRAPEIMLNWM 241
           YV     R P   L WM
Sbjct: 254 YVRKGDARLP---LKWM 267

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/77 (36%), Positives = 42/77 (54%), Gaps = 4/77 (5%)
Query: 165 LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTG 224
           L+ +H+    +Q+ +G++++ S   IHRDL   NI ++E   +KI DFGLAR    +   
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD-PD 248
Query: 225 YVATRWYRAPEIMLNWM 241
           YV     R P   L WM
Sbjct: 249 YVRKGDARLP---LKWM 262

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/77 (36%), Positives = 42/77 (54%), Gaps = 4/77 (5%)
Query: 165 LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTG 224
           L+ +H+    +Q+ +G++++ S   IHRDL   NI ++E   +KI DFGLAR    +   
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD-PD 246
Query: 225 YVATRWYRAPEIMLNWM 241
           YV     R P   L WM
Sbjct: 247 YVRKGDARLP---LKWM 260

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 43/81 (53%), Gaps = 2/81 (2%)
Query: 170 VQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNEDCELKILDFGLAR-PTENEMTGYVA 227
           ++ ++  +L    YIH+   I HRD+KPSNI ++++  +K+ DFG +    + ++ G   
Sbjct: 153 IKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRG 212
Query: 228 TRWYRAPEIMLNWMHYNQTGV 248
           T  +  PE   N   YN   V
Sbjct: 213 TYEFMPPEFFSNESSYNGAKV 233

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/77 (36%), Positives = 42/77 (54%), Gaps = 4/77 (5%)
Query: 165 LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTG 224
           L+ +H+    +Q+ +G++++ S   IHRDL   NI ++E   +KI DFGLAR    +   
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD-PD 255
Query: 225 YVATRWYRAPEIMLNWM 241
           YV     R P   L WM
Sbjct: 256 YVRKGDARLP---LKWM 269

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 73/173 (42%), Gaps = 21/173 (12%)
Query: 72  LSKESFDLIFSSALDSVSG--VKVAIKKIARPFQSAVHAKRTY-RELRMLKHMNHENVIG 128
           L   SF ++     D+ SG  V VA+K +     S   A   + RE+  +  ++H N+I 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 129 LLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLV-------YQILRGL 181
           L  V  +         + MVT L  A L ++L   +L      FL+        Q+  G+
Sbjct: 80  LYGVVLTPP-------MKMVTEL--APLGSLL--DRLRKHQGHFLLGTLSRYAVQVAEGM 128
Query: 182 KYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP 234
            Y+ S   IHRDL   N+ +     +KI DFGL R        YV     + P
Sbjct: 129 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 181

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 73/173 (42%), Gaps = 21/173 (12%)
Query: 72  LSKESFDLIFSSALDSVSG--VKVAIKKIARPFQSAVHAKRTY-RELRMLKHMNHENVIG 128
           L   SF ++     D+ SG  V VA+K +     S   A   + RE+  +  ++H N+I 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 129 LLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLV-------YQILRGL 181
           L  V  +         + MVT L  A L ++L   +L      FL+        Q+  G+
Sbjct: 76  LYGVVLTPP-------MKMVTEL--APLGSLL--DRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 182 KYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP 234
            Y+ S   IHRDL   N+ +     +KI DFGL R        YV     + P
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 66/137 (48%), Gaps = 18/137 (13%)
Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLN-NILRTQK----LS 166
           RE  +   + H +++ LL+ + S+  L      YMV   M GADL   I++        S
Sbjct: 75  REASICHMLKHPHIVELLETYSSDGML------YMVFEFMDGADLCFEIVKRADAGFVYS 128
Query: 167 DDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILDFGLA-RPTENEM 222
           +      + QIL  L+Y H   IIHRD+KP  + +        +K+  FG+A +  E+ +
Sbjct: 129 EAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL 188
Query: 223 T--GYVATRWYRAPEIM 237
              G V T  + APE++
Sbjct: 189 VAGGRVGTPHFMAPEVV 205

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/69 (36%), Positives = 33/69 (47%), Gaps = 3/69 (4%)
Query: 165 LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE---NE 221
           LS   +      + RG+ Y+     IHRDL   NI V E+   KI DFGL+R  E    +
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 198
Query: 222 MTGYVATRW 230
             G +  RW
Sbjct: 199 TMGRLPVRW 207

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 25/69 (36%), Positives = 33/69 (47%), Gaps = 3/69 (4%)
Query: 165 LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE---NE 221
           LS   +      + RG+ Y+     IHRDL   NI V E+   KI DFGL+R  E    +
Sbjct: 129 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 188
Query: 222 MTGYVATRW 230
             G +  RW
Sbjct: 189 TMGRLPVRW 197

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/100 (27%), Positives = 54/100 (54%), Gaps = 8/100 (8%)
Query: 144 NVYMVTHLMGADLNN-----ILRTQKLSDDHVQFLVYQILRGLKYIHSA-GIIHRDLKPS 197
           +V++   L    L+      I + Q + +D +  +   I++ L+++HS   +IHRD+KPS
Sbjct: 107 DVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPS 166
Query: 198 NIAVNEDCELKILDFGLARPTENEMTGYV--ATRWYRAPE 235
           N+ +N   ++K  DFG++    +++   +    + Y APE
Sbjct: 167 NVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPE 206

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 54/106 (50%), Gaps = 11/106 (10%)
Query: 144 NVYMVTHLMGADLNNILRTQK-LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
           N++M   L G  L  +++ Q  L +D   + + Q L GL+Y+HS  I+H D+K  N+ ++
Sbjct: 161 NIFMEL-LEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLS 219
Query: 203 ED-CELKILDFGLARPTENEMTG-------YV-ATRWYRAPEIMLN 239
            D     + DFG A   + +  G       Y+  T  + APE++L 
Sbjct: 220 SDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLG 265

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 27/72 (37%), Positives = 42/72 (58%), Gaps = 2/72 (2%)
Query: 145 VYMVTHLMGADLNNILRTQKLSDDHVQFLVYQ-ILRGLKYIHSAGIIHRDLKPSNIAVNE 203
           +YMV      DLN+ L+ +K  D   +   ++ +L  +  IH  GI+H DLKP+N  +  
Sbjct: 103 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 161
Query: 204 DCELKILDFGLA 215
           D  LK++DFG+A
Sbjct: 162 DGMLKLIDFGIA 173

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 54/106 (50%), Gaps = 11/106 (10%)
Query: 144 NVYMVTHLMGADLNNILRTQK-LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
           N++M   L G  L  +++ Q  L +D   + + Q L GL+Y+HS  I+H D+K  N+ ++
Sbjct: 142 NIFMEL-LEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLS 200
Query: 203 ED-CELKILDFGLARPTENEMTG-------YV-ATRWYRAPEIMLN 239
            D     + DFG A   + +  G       Y+  T  + APE++L 
Sbjct: 201 SDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLG 246

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 75/170 (44%), Gaps = 18/170 (10%)
Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD--FKNVY 146
           +G  VA+K + +      H     +E+ +L+ + HE++I          C  D   K++ 
Sbjct: 42  TGEMVAVKAL-KADCGPQHRSGWKQEIDILRTLYHEHIIKY------KGCCEDQGEKSLQ 94
Query: 147 MVTHLMG-ADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
           +V   +    L + L    +    +     QI  G+ Y+H+   IHR+L   N+ ++ D 
Sbjct: 95  LVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRNLAARNVLLDNDR 154
Query: 206 ELKILDFGLAR--PTENEM-----TGYVATRWYRAPEIMLNWMHYNQTGV 248
            +KI DFGLA+  P  +E       G     WY APE +  +  Y  + V
Sbjct: 155 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKEYKFYYASDV 203

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 9/90 (10%)
Query: 156 LNNILRTQK-LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL 214
           LN  L+  + + D ++  LV+Q+  G+KY+  +  +HRDL   N+ +      KI DFGL
Sbjct: 98  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 157
Query: 215 ARPTENEMTGYVA-------TRWYRAPEIM 237
           ++    +   Y A        +WY APE +
Sbjct: 158 SKALRADENXYKAQTHGKWPVKWY-APECI 186

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 81/170 (47%), Gaps = 18/170 (10%)
Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           + VAIK++ R   S    K    E  ++  +++ +V  LL +  ++T       V ++T 
Sbjct: 45  IPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-------VQLITQ 96
Query: 151 LMG-ADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
           LM    L + +R  K  +   ++     QI +G+ Y+    ++HRDL   N+ V     +
Sbjct: 97  LMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHV 156
Query: 208 KILDFGLAR---PTENEM---TGYVATRWYRAPEIMLNWMHYNQTGVPFY 251
           KI DFGLA+     E E     G V  +W  A E +L+ ++ +Q+ V  Y
Sbjct: 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWM-ALESILHRIYTHQSDVWSY 205

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 69/155 (44%), Gaps = 21/155 (13%)
Query: 72  LSKESFDLIFSSALDSVSG--VKVAIKKIARPFQSAVHAKRTY-RELRMLKHMNHENVIG 128
           L   SF ++     D+ SG  V VA+K +     S   A   + RE+  +  ++H N+I 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 129 LLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLV-------YQILRGL 181
           L  V  +         + MVT L  A L ++L   +L      FL+        Q+  G+
Sbjct: 86  LYGVVLTPP-------MKMVTEL--APLGSLL--DRLRKHQGHFLLGTLSRYAVQVAEGM 134
Query: 182 KYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
            Y+ S   IHRDL   N+ +     +KI DFGL R
Sbjct: 135 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR 169

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 65/144 (45%), Gaps = 23/144 (15%)
Query: 121 MNHENVIGLLDVFHSNTCLADFKNVYMVT--HLMGADLNNILRTQKLSDDHVQFLVYQIL 178
           M HEN++G +      T    +  +Y++T  H  G+ L + L++  L    +  L Y  +
Sbjct: 88  MRHENILGFIAADIKGT--GSWTQLYLITDYHENGS-LYDYLKSTTLDAKSMLKLAYSSV 144
Query: 179 RGLKYIHSA--------GIIHRDLKPSNIAVNEDCELKILDFGLAR---PTENEM----T 223
            GL ++H+          I HRDLK  NI V ++    I D GLA       NE+     
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPN 204
Query: 224 GYVATRWYRAPEIM---LNWMHYN 244
             V T+ Y  PE++   LN  H+ 
Sbjct: 205 TRVGTKRYMPPEVLDESLNRNHFQ 228

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 55/117 (47%), Gaps = 10/117 (8%)
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQ-KLSDDHV 170
           E  ++  M+H +++ LL V  S T       + +VT LM  G  L  +   +  +    +
Sbjct: 90  EALIMASMDHPHLVRLLGVCLSPT-------IQLVTQLMPHGCLLEYVHEHKDNIGSQLL 142
Query: 171 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVA 227
                QI +G+ Y+    ++HRDL   N+ V     +KI DFGLAR  E +   Y A
Sbjct: 143 LNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA 199

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 9/90 (10%)
Query: 156 LNNILRTQK-LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL 214
           LN  L+  + + D ++  LV+Q+  G+KY+  +  +HRDL   N+ +      KI DFGL
Sbjct: 456 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 515
Query: 215 A---RPTEN----EMTGYVATRWYRAPEIM 237
           +   R  EN    +  G    +WY APE +
Sbjct: 516 SKALRADENYYKAQTHGKWPVKWY-APECI 544

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 83/194 (42%), Gaps = 33/194 (17%)
Query: 71  TLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN-HENVIGL 129
            L++  F  ++  A D  SG + A+K++    +    A    +E+  +K ++ H N++  
Sbjct: 35  VLAEGGFAFVYE-AQDVGSGREYALKRLLSNEEEKNRA--IIQEVCFMKKLSGHPNIVQF 91
Query: 130 LDVF-----HSNTCLADFKNVYMVTHLMGADLNNILRTQK----LSDDHVQFLVYQILRG 180
                     S+T  A+F    ++T L    L   L+  +    LS D V  + YQ  R 
Sbjct: 92  CSAASIGKEESDTGQAEF---LLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 181 LKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLA---------------RPTENEMT 223
           ++++H     IIHRDLK  N+ ++    +K+ DFG A               R    E  
Sbjct: 149 VQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 224 GYVATRWYRAPEIM 237
               T  YR PEI+
Sbjct: 209 TRNTTPMYRTPEII 222

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 81/170 (47%), Gaps = 18/170 (10%)
Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           + VAIK++ R   S    K    E  ++  +++ +V  LL +  ++T       V ++T 
Sbjct: 70  IPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-------VQLITQ 121
Query: 151 LMG-ADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
           LM    L + +R  K  +   ++     QI +G+ Y+    ++HRDL   N+ V     +
Sbjct: 122 LMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHV 181
Query: 208 KILDFGLAR---PTENEM---TGYVATRWYRAPEIMLNWMHYNQTGVPFY 251
           KI DFGLA+     E E     G V  +W  A E +L+ ++ +Q+ V  Y
Sbjct: 182 KITDFGLAKLLGAEEKEYHAEGGKVPIKWM-ALESILHRIYTHQSDVWSY 230

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 81/170 (47%), Gaps = 18/170 (10%)
Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           + VAIK++ R   S    K    E  ++  +++ +V  LL +  ++T       V ++T 
Sbjct: 48  IPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-------VQLITQ 99
Query: 151 LMG-ADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
           LM    L + +R  K  +   ++     QI +G+ Y+    ++HRDL   N+ V     +
Sbjct: 100 LMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHV 159
Query: 208 KILDFGLAR---PTENEM---TGYVATRWYRAPEIMLNWMHYNQTGVPFY 251
           KI DFGLA+     E E     G V  +W  A E +L+ ++ +Q+ V  Y
Sbjct: 160 KITDFGLAKLLGAEEKEYHAEGGKVPIKWM-ALESILHRIYTHQSDVWSY 208

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 69/155 (44%), Gaps = 21/155 (13%)
Query: 72  LSKESFDLIFSSALDSVSG--VKVAIKKIARPFQSAVHAKRTY-RELRMLKHMNHENVIG 128
           L   SF ++     D+ SG  V VA+K +     S   A   + RE+  +  ++H N+I 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 129 LLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLV-------YQILRGL 181
           L  V  +         + MVT L  A L ++L   +L      FL+        Q+  G+
Sbjct: 76  LYGVVLTPP-------MKMVTEL--APLGSLL--DRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 182 KYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
            Y+ S   IHRDL   N+ +     +KI DFGL R
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR 159

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 81/170 (47%), Gaps = 18/170 (10%)
Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           + VAIK++ R   S    K    E  ++  +++ +V  LL +  ++T       V ++T 
Sbjct: 48  IPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-------VQLITQ 99
Query: 151 LMG-ADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
           LM    L + +R  K  +   ++     QI +G+ Y+    ++HRDL   N+ V     +
Sbjct: 100 LMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHV 159
Query: 208 KILDFGLAR---PTENEM---TGYVATRWYRAPEIMLNWMHYNQTGVPFY 251
           KI DFGLA+     E E     G V  +W  A E +L+ ++ +Q+ V  Y
Sbjct: 160 KITDFGLAKLLGAEEKEYHAEGGKVPIKWM-ALESILHRIYTHQSDVWSY 208

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 81/170 (47%), Gaps = 18/170 (10%)
Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           + VAIK++ R   S    K    E  ++  +++ +V  LL +  ++T       V ++T 
Sbjct: 47  IPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-------VQLITQ 98
Query: 151 LMG-ADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
           LM    L + +R  K  +   ++     QI +G+ Y+    ++HRDL   N+ V     +
Sbjct: 99  LMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHV 158
Query: 208 KILDFGLAR---PTENEM---TGYVATRWYRAPEIMLNWMHYNQTGVPFY 251
           KI DFGLA+     E E     G V  +W  A E +L+ ++ +Q+ V  Y
Sbjct: 159 KITDFGLAKLLGAEEKEYHAEGGKVPIKWM-ALESILHRIYTHQSDVWSY 207

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 57/148 (38%), Gaps = 9/148 (6%)
Query: 94  AIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMG 153
           A+K+   PF+      R   E+      +HE V              +   +Y+ T L G
Sbjct: 86  AVKRSMSPFRGPKDRARKLAEVG-----SHEKVGQHPCCVRLEQAWEEGGILYLQTELCG 140
Query: 154 ADLNNILRTQKLSDDHVQFLVY--QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILD 211
             L         S    Q   Y    L  L ++HS G++H D+KP+NI +      K+ D
Sbjct: 141 PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGD 200
Query: 212 FGLARPTENEMTGYV--ATRWYRAPEIM 237
           FGL         G V      Y APE++
Sbjct: 201 FGLLVELGTAGAGEVQEGDPRYMAPELL 228

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 81/170 (47%), Gaps = 18/170 (10%)
Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           + VAIK++ R   S    K    E  ++  +++ +V  LL +  ++T       V ++T 
Sbjct: 52  IPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-------VQLITQ 103
Query: 151 LMG-ADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
           LM    L + +R  K  +   ++     QI +G+ Y+    ++HRDL   N+ V     +
Sbjct: 104 LMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHV 163
Query: 208 KILDFGLAR---PTENEM---TGYVATRWYRAPEIMLNWMHYNQTGVPFY 251
           KI DFGLA+     E E     G V  +W  A E +L+ ++ +Q+ V  Y
Sbjct: 164 KITDFGLAKLLGAEEKEYHAEGGKVPIKWM-ALESILHRIYTHQSDVWSY 212

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 81/170 (47%), Gaps = 18/170 (10%)
Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           + VAIK++ R   S    K    E  ++  +++ +V  LL +  ++T       V ++T 
Sbjct: 45  IPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-------VQLITQ 96
Query: 151 LMG-ADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
           LM    L + +R  K  +   ++     QI +G+ Y+    ++HRDL   N+ V     +
Sbjct: 97  LMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHV 156
Query: 208 KILDFGLAR---PTENEM---TGYVATRWYRAPEIMLNWMHYNQTGVPFY 251
           KI DFGLA+     E E     G V  +W  A E +L+ ++ +Q+ V  Y
Sbjct: 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWM-ALESILHRIYTHQSDVWSY 205

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 81/170 (47%), Gaps = 18/170 (10%)
Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           + VAIK++ R   S    K    E  ++  +++ +V  LL +  ++T       V ++T 
Sbjct: 48  IPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-------VQLITQ 99
Query: 151 LMG-ADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
           LM    L + +R  K  +   ++     QI +G+ Y+    ++HRDL   N+ V     +
Sbjct: 100 LMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHV 159
Query: 208 KILDFGLAR---PTENEM---TGYVATRWYRAPEIMLNWMHYNQTGVPFY 251
           KI DFGLA+     E E     G V  +W  A E +L+ ++ +Q+ V  Y
Sbjct: 160 KITDFGLAKLLGAEEKEYHAEGGKVPIKWM-ALESILHRIYTHQSDVWSY 208

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 81/170 (47%), Gaps = 18/170 (10%)
Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           + VAIK++ R   S    K    E  ++  +++ +V  LL +  ++T       V ++T 
Sbjct: 55  IPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-------VQLITQ 106
Query: 151 LMG-ADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
           LM    L + +R  K  +   ++     QI +G+ Y+    ++HRDL   N+ V     +
Sbjct: 107 LMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHV 166
Query: 208 KILDFGLAR---PTENEM---TGYVATRWYRAPEIMLNWMHYNQTGVPFY 251
           KI DFGLA+     E E     G V  +W  A E +L+ ++ +Q+ V  Y
Sbjct: 167 KITDFGLAKLLGAEEKEYHAEGGKVPIKWM-ALESILHRIYTHQSDVWSY 215

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 81/170 (47%), Gaps = 18/170 (10%)
Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           + VAIK++ R   S    K    E  ++  +++ +V  LL +  ++T       V ++T 
Sbjct: 45  IPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-------VQLITQ 96
Query: 151 LMG-ADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
           LM    L + +R  K  +   ++     QI +G+ Y+    ++HRDL   N+ V     +
Sbjct: 97  LMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHV 156
Query: 208 KILDFGLAR---PTENEM---TGYVATRWYRAPEIMLNWMHYNQTGVPFY 251
           KI DFGLA+     E E     G V  +W  A E +L+ ++ +Q+ V  Y
Sbjct: 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWM-ALESILHRIYTHQSDVWSY 205

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 9/90 (10%)
Query: 156 LNNILRTQK-LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL 214
           LN  L+  + + D ++  LV+Q+  G+KY+  +  +HRDL   N+ +      KI DFGL
Sbjct: 457 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 516
Query: 215 A---RPTEN----EMTGYVATRWYRAPEIM 237
           +   R  EN    +  G    +WY APE +
Sbjct: 517 SKALRADENYYKAQTHGKWPVKWY-APECI 545

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 81/170 (47%), Gaps = 18/170 (10%)
Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           + VAIK++ R   S    K    E  ++  +++ +V  LL +  ++T       V ++T 
Sbjct: 52  IPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-------VQLITQ 103
Query: 151 LMG-ADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
           LM    L + +R  K  +   ++     QI +G+ Y+    ++HRDL   N+ V     +
Sbjct: 104 LMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHV 163
Query: 208 KILDFGLAR---PTENEM---TGYVATRWYRAPEIMLNWMHYNQTGVPFY 251
           KI DFGLA+     E E     G V  +W  A E +L+ ++ +Q+ V  Y
Sbjct: 164 KITDFGLAKLLGAEEKEYHAEGGKVPIKWM-ALESILHRIYTHQSDVWSY 212

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 55/117 (47%), Gaps = 10/117 (8%)
Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM--GADLNNILRTQ-KLSDDHV 170
           E  ++  M+H +++ LL V  S T       + +VT LM  G  L  +   +  +    +
Sbjct: 67  EALIMASMDHPHLVRLLGVCLSPT-------IQLVTQLMPHGCLLEYVHEHKDNIGSQLL 119
Query: 171 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVA 227
                QI +G+ Y+    ++HRDL   N+ V     +KI DFGLAR  E +   Y A
Sbjct: 120 LNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA 176

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 81/170 (47%), Gaps = 18/170 (10%)
Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           + VAIK++ R   S    K    E  ++  +++ +V  LL +  ++T       V ++T 
Sbjct: 51  IPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-------VQLITQ 102
Query: 151 LMG-ADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
           LM    L + +R  K  +   ++     QI +G+ Y+    ++HRDL   N+ V     +
Sbjct: 103 LMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHV 162
Query: 208 KILDFGLAR---PTENEM---TGYVATRWYRAPEIMLNWMHYNQTGVPFY 251
           KI DFGLA+     E E     G V  +W  A E +L+ ++ +Q+ V  Y
Sbjct: 163 KITDFGLAKLLGAEEKEYHAEGGKVPIKWM-ALESILHRIYTHQSDVWSY 211

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 102/248 (41%), Gaps = 31/248 (12%)
Query: 103 QSAVHAKRT-YRELRMLKHM--------NHENVIGLLDVFHSNTCLADFKNVYMVTHLMG 153
           +SA H   T   E+++LK +        N + V+ L+D F  +    +  +V MV  ++G
Sbjct: 65  KSAQHYTETALDEIKLLKCVRESDPSDPNKDMVVQLIDDFKISG--MNGIHVCMVFEVLG 122
Query: 154 ADL-NNILRT--QKLSDDHVQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNEDCELKI 209
             L   I+++  Q L    V+ ++ Q+L+GL Y+HS   IIH D+KP NI       L  
Sbjct: 123 HHLLKWIIKSNYQGLPVRCVKSIIRQVLQGLDYLHSKCKIIHTDIKPENI-------LMC 175
Query: 210 LDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT-GVPFYFQDLKPSNIAVNEDCEL 268
           +D    R    E     AT W +A     +    +           L P N    +   +
Sbjct: 176 VDDAYVRRMAAE-----ATEWQKAGAPPPSGSAVSTAPAADLLVNPLDPRNA---DKIRV 227
Query: 269 KILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMA 328
           KI D G A       T  + TR YR+ E+++   +    DI     +   L T    F  
Sbjct: 228 KIADLGNACWVHKHFTEDIQTRQYRSIEVLIGAGYSTPADIWSTACMAFELATGDYLFEP 287
Query: 329 KISSDSAR 336
               D +R
Sbjct: 288 HSGEDYSR 295

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 9/90 (10%)
Query: 156 LNNILRTQK-LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL 214
           LN  L+  + + D ++  LV+Q+  G+KY+  +  +HRDL   N+ +      KI DFGL
Sbjct: 114 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 173
Query: 215 A---RPTEN----EMTGYVATRWYRAPEIM 237
           +   R  EN    +  G    +WY APE +
Sbjct: 174 SKALRADENYYKAQTHGKWPVKWY-APECI 202

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 9/90 (10%)
Query: 156 LNNILRTQK-LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL 214
           LN  L+  + + D ++  LV+Q+  G+KY+  +  +HRDL   N+ +      KI DFGL
Sbjct: 114 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 173
Query: 215 A---RPTEN----EMTGYVATRWYRAPEIM 237
           +   R  EN    +  G    +WY APE +
Sbjct: 174 SKALRADENYYKAQTHGKWPVKWY-APECI 202

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 75/157 (47%), Gaps = 19/157 (12%)
Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           + VAIK + +  + A   +   RE +++  +++  ++ L+ V  +   +       +V  
Sbjct: 38  IDVAIKVLKQGTEKA-DTEEMMREAQIMHQLDNPYIVRLIGVCQAEALM-------LVME 89
Query: 151 LMGAD-LNNIL--RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
           + G   L+  L  + +++   +V  L++Q+  G+KY+     +HRDL   N+ +      
Sbjct: 90  MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYA 149
Query: 208 KILDFGLARPTENEMTGYVAT-------RWYRAPEIM 237
           KI DFGL++    + + Y A        +WY APE +
Sbjct: 150 KISDFGLSKALGADDSYYTARSAGKWPLKWY-APECI 185

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 9/90 (10%)
Query: 156 LNNILRTQK-LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL 214
           LN  L+  + + D ++  LV+Q+  G+KY+  +  +HRDL   N+ +      KI DFGL
Sbjct: 98  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 157
Query: 215 A---RPTEN----EMTGYVATRWYRAPEIM 237
           +   R  EN    +  G    +WY APE +
Sbjct: 158 SKALRADENYYKAQTHGKWPVKWY-APECI 186

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 72/153 (47%), Gaps = 16/153 (10%)
Query: 93  VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM 152
           VAIK I    + ++       E +++ +++HE ++ L  V          + ++++T  M
Sbjct: 36  VAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ------RPIFIITEYM 86
Query: 153 G-ADLNNILRTQKLSDDHVQFL--VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKI 209
               L N LR  +      Q L     +   ++Y+ S   +HRDL   N  VN+   +K+
Sbjct: 87  ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKV 146
Query: 210 LDFGLARPT-ENEMTGYVATRW---YRAPEIML 238
            DFGL+R   ++E T    +++   +  PE+++
Sbjct: 147 SDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLM 179

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 9/90 (10%)
Query: 156 LNNILRTQK-LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL 214
           LN  L+  + + D ++  LV+Q+  G+KY+  +  +HRDL   N+ +      KI DFGL
Sbjct: 112 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 171
Query: 215 A---RPTEN----EMTGYVATRWYRAPEIM 237
           +   R  EN    +  G    +WY APE +
Sbjct: 172 SKALRADENYYKAQTHGKWPVKWY-APECI 200

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 81/170 (47%), Gaps = 18/170 (10%)
Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           + VAIK++ R   S    K    E  ++  +++ +V  LL +  ++T       V ++T 
Sbjct: 39  IPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-------VQLITQ 90
Query: 151 LMG-ADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
           LM    L + +R  K  +   ++     QI +G+ Y+    ++HRDL   N+ V     +
Sbjct: 91  LMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHV 150
Query: 208 KILDFGLAR---PTENEM---TGYVATRWYRAPEIMLNWMHYNQTGVPFY 251
           KI DFGLA+     E E     G V  +W  A E +L+ ++ +Q+ V  Y
Sbjct: 151 KITDFGLAKLLGAEEKEYHAEGGKVPIKWM-ALESILHRIYTHQSDVWSY 199

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 9/90 (10%)
Query: 156 LNNILRTQK-LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL 214
           LN  L+  + + D ++  LV+Q+  G+KY+  +  +HRDL   N+ +      KI DFGL
Sbjct: 94  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 153
Query: 215 ARPTENEMTGYVA-------TRWYRAPEIM 237
           ++    +   Y A        +WY APE +
Sbjct: 154 SKALRADENYYKAQTHGKWPVKWY-APECI 182

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 69/154 (44%), Gaps = 21/154 (13%)
Query: 110 RTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT--HLMGADLNNILRTQKLSD 167
           ++ RE+     M HEN++  +      + L     ++++T  H  G+ L + L+   ++ 
Sbjct: 55  QSEREIFSTPGMKHENLLQFIAAEKRGSNLE--VELWLITAFHDKGS-LTDYLKGNIITW 111
Query: 168 DHVQFLVYQILRGLKYIHS-----------AGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
           + +  +   + RGL Y+H              I HRD K  N+ +  D    + DFGLA 
Sbjct: 112 NELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAV 171
Query: 217 PTE-----NEMTGYVATRWYRAPEIMLNWMHYNQ 245
             E      +  G V TR Y APE++   +++ +
Sbjct: 172 RFEPGKPPGDTHGQVGTRRYMAPEVLEGAINFQR 205

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 9/90 (10%)
Query: 156 LNNILRTQK-LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL 214
           LN  L+  + + D ++  LV+Q+  G+KY+  +  +HRDL   N+ +      KI DFGL
Sbjct: 104 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 163
Query: 215 ARPTENEMTGYVA-------TRWYRAPEIM 237
           ++    +   Y A        +WY APE +
Sbjct: 164 SKALRADENYYKAQTHGKWPVKWY-APECI 192

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 9/90 (10%)
Query: 156 LNNILRTQK-LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL 214
           LN  L+  + + D ++  LV+Q+  G+KY+  +  +HRDL   N+ +      KI DFGL
Sbjct: 92  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 151
Query: 215 ARPTENEMTGYVA-------TRWYRAPEIM 237
           ++    +   Y A        +WY APE +
Sbjct: 152 SKALRADENYYKAQTHGKWPVKWY-APECI 180
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	427
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-153
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-150
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-144
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-143
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-107
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-94
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-107
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	6e-94
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-105
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	7e-92
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-102
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-90
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-98
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-79
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	9e-98
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-76
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	9e-97
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-89
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-96
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-78
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	7e-78
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	8e-75
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-56
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-72
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-60
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-71
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	6e-56
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-67
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	9e-56
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	6e-59
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-54
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-53
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-46
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	7e-50
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-41
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-47
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-43
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-37
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-42
3o0g_A	292	Cell division protein kinase 5; kinase activator c	5e-35
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-42
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-37
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-41
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-36
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-41
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	7e-36
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-41
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-37
3niz_A	311	Rhodanese family protein; structural genomics, str	6e-41
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-35
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-40
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	7e-37
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-39
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-39
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-39
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	7e-39
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-37
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	8e-39
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	8e-39
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	7e-38
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	9e-38
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-37
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-37
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	6e-37
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-36
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-35
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	6e-35
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	7e-35
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	8e-35
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-34
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-34
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	9e-34
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-15
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-33
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	7e-33
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	7e-33
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-32
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-32
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-32
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-15
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	8e-32
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-31
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-16
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-31
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-31
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	9e-19
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-31
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-30
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-14
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-30
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-15
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-30
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-30
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-30
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-16
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-30
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-30
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-16
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-30
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-17
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-30
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-15
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-29
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	6e-15
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-29
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-17
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-29
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-15
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-29
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-13
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	5e-29
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-13
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	7e-29
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	8e-29
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-13
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-28
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-28
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-12
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-28
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	7e-13
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-27
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-27
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	7e-16
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-27
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-27
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	8e-09
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-27
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-18
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-27
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	5e-14
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	8e-27
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-17
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-26
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-26
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	6e-07
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-26
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-10
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-26
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-17
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-26
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-07
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	6e-26
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-17
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-25
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-15
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-25
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-17
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-25
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-16
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-25
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-07
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-25
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-06
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-25
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-11
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-25
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	9e-05
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-25
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-16
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-25
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-15
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-25
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-16
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	7e-25
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-08
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	7e-25
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	6e-17
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-25
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-11
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-24
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	8e-10
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-24
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-24
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-05
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-24
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-10
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-24
3q4u_A	301	Activin receptor type-1; structural genomics conso	6e-24
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-07
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	6e-24
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	6e-08
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	7e-24
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	7e-10
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	9e-24
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	7e-10
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-23
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-23
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-07
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-23
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-05
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-23
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-23
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-07
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	6e-23
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-09
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	7e-23
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	7e-08
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	8e-23
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-22
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	5e-08
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-22
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-22
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-04
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-22
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	7e-22
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-08
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-21
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	7e-09
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-21
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-11
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-21
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	8e-04
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-21
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-04
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-21
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-21
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-06
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-21
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-04
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	5e-21
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	9e-08
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-21
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-09
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	7e-21
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	6e-07
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	8e-21
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-09
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	9e-21
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	8e-08
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-20
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-05
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-20
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-20
3an0_A	340	Dual specificity mitogen-activated protein kinase;	7e-10
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-20
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	6e-04
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-20
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-20
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-07
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-20
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	7e-20
3ork_A	311	Serine/threonine protein kinase; structural genomi	9e-20
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-05
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-19
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-06
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-19
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-19
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-04
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-19
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-19
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-04
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-19
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-05
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-19
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	7e-07
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-19
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	8e-04
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-19
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-04
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-19
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-19
2dyl_A	318	Dual specificity mitogen-activated protein kinase	4e-09
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-19
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	5e-07
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	8e-19
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	8e-07
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	9e-19
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-06
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-18
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-06
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-18
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-18
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-18
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-18
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	7e-07
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-18
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-18
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-18
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-07
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	4e-18
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-18
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	6e-18
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-18
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	8e-18
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-17
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-17
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-17
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-17
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-17
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-17
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-17
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-17
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-17
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-17
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	7e-17
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	7e-17
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-09
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-16
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-04
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-16
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-16
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-06
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-15
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-15
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-15
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-15
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-15
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-15
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	8e-15
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	8e-15
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-14
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-14
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-04
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-14
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-06
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-14
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-14
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-14
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-14
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-04
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-14
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-14
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	5e-14
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	8e-14
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	9e-14
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-04
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-13
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-04
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-13
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-13
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-13
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-13
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-13
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	7e-13
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	9e-13
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-04
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-12
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-04
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-12
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	8e-04
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-12
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	7e-05
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-12
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-12
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	6e-05
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-12
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	6e-04
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-12
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	8e-04
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-12
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-12
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-12
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-12
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	7e-06
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-12
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-12
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	5e-12
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	7e-12
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-09
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	7e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-05
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	3e-05

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  436 bits (1123), Expect = e-153
 Identities = 127/366 (34%), Positives = 178/366 (48%), Gaps = 80/366 (21%)

Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           SA    +G  VAIKKI  PF   + A RT RE+++LKH  HEN+I + ++   ++   +F
Sbjct: 29  SATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDS-FENF 86

Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
             VY++  LM  DL+ ++ TQ LSDDH+Q+ +YQ LR +K +H + +IHRDLKPSN+ +N
Sbjct: 87  NEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN 146

Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
            +C+LK+ DFGLAR  +                                           
Sbjct: 147 SNCDLKVCDFGLARIIDESAA--------------------------------------- 167

Query: 263 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT-DI------------ 309
                    D       ++ M  +VATRWYRAPE+ML    Y++  D+            
Sbjct: 168 ---------DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL 218

Query: 310 -----------HQLNLIMEMLGTPPAE-FMAKISSDSARKYINSLPLLTKKDFRQVFKGA 357
                      HQL LI  ++GTP ++  +  I S  AR+YI SLP+       ++F   
Sbjct: 219 RRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRV 278

Query: 358 NPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPP-----YDQSFEDMDL 412
           NP+ IDLL  ML  D  KRITA++AL HPYL  Y DPNDEP   P     ++       L
Sbjct: 279 NPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEAL 338

Query: 413 PVDQWK 418
                K
Sbjct: 339 TTKDLK 344

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  433 bits (1114), Expect = e-150
 Identities = 105/372 (28%), Positives = 171/372 (45%), Gaps = 54/372 (14%)

Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
            A D  +   VAIKK+ R F+  +  KR  RE+ +L  +  + +I L D+   +  L  F
Sbjct: 44  LAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDD-LLKF 102

Query: 143 KNVYMVTHLMGADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
             +Y+V  +  +DL  + +T   L+++H++ ++Y +L G  +IH +GIIHRDLKP+N  +
Sbjct: 103 DELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL 162

Query: 202 NEDCELKILDFGLARPTENE-------------------------MTGYVATRWYRAPEI 236
           N+DC +K+ DFGLAR   +E                         +T +V TRWYRAPE+
Sbjct: 163 NQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPEL 222

Query: 237 MLNWMHYNQTGVPFYFQDLKPSNIAVNED-----C---ELKILDFGLARPTENEMTGYVA 288
           +L   +Y +               ++  D     C   EL  +         N    +  
Sbjct: 223 ILLQENYTK---------------SI--DIWSTGCIFAELLNMLQSHINDPTNRFPLFPG 265

Query: 289 TRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKK 348
           +  +       +   + +++  QLN+I  ++GTP  + +  I+     KYI   P     
Sbjct: 266 SSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPI 325

Query: 349 DFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSP-PYDQSF 407
           + +Q +   +   I+LL  ML+ +  KRIT +QAL HPYL        E  S       F
Sbjct: 326 NLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPF 385

Query: 408 ED-MDLPVDQWK 418
           +D M L   Q +
Sbjct: 386 DDWMVLSETQLR 397

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  415 bits (1069), Expect = e-144
 Identities = 104/379 (27%), Positives = 171/379 (45%), Gaps = 84/379 (22%)

Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN-HENVIGLLDVFHSNTCLAD 141
            ++D  +G  VA+KKI   FQ++  A+RT+RE+ +L  ++ HEN++ LL+V  ++    +
Sbjct: 27  KSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD----N 82

Query: 142 FKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
            ++VY+V   M  DL+ ++R   L   H Q++VYQ+++ +KY+HS G++HRD+KPSNI +
Sbjct: 83  DRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL 142

Query: 202 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIA 261
           N +C +K+ DFGL+R                                             
Sbjct: 143 NAECHVKVADFGLSRS-------------------------------------FVNIRRV 165

Query: 262 VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT-DI----------- 309
            N        +       +  +T YVATRWYRAPEI+L    Y +  D+           
Sbjct: 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL 225

Query: 310 ------------HQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFK-- 355
                       +QL  I+ ++  P  E +  I S  A+  I SL    +          
Sbjct: 226 CGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIF 285

Query: 356 --------------GANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPT-S 400
                           N +A+DLL  +L+ +  KRI+A  AL HP++S + +PN+EP   
Sbjct: 286 TKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCD 345

Query: 401 PPYDQSFED-MDLPVDQWK 418
                   D +   +D ++
Sbjct: 346 HIITIPINDNVKHSIDDYR 364

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  414 bits (1066), Expect = e-143
 Identities = 110/380 (28%), Positives = 173/380 (45%), Gaps = 62/380 (16%)

Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
            A D +    VAIKKI R F+  +  KR  RE+ +L  +NH++V+ +LD+      +  F
Sbjct: 71  EAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKD-VEKF 129

Query: 143 KNVYMVTHLMGADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
             +Y+V  +  +D   + RT   L++ H++ L+Y +L G+KY+HSAGI+HRDLKP+N  V
Sbjct: 130 DELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV 189

Query: 202 NEDCELKILDFGLAR------------------------------PTENEMTGYVATRWY 231
           N+DC +K+ DFGLAR                                + ++TG+V TRWY
Sbjct: 190 NQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWY 249

Query: 232 RAPEIMLNWMHYNQTGVPFYFQD-----------LKPSNIAVNEDCELKILDFGLARPTE 280
           RAPE++L   +Y    +     D           L      V    +   L F       
Sbjct: 250 RAPELILLQENYT-EAI-----DVWSIGCIFAELLNMIKENVAYHADRGPL-F------- 295

Query: 281 NEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYIN 340
               G          +   ++  + + +  QLN+I  +LGTP  E +  +  + A++YI 
Sbjct: 296 ---PGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIR 352

Query: 341 SLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTS 400
             P     D  + F  ++  AI LL  ML  +  KRIT  + LAHP+  +      E  +
Sbjct: 353 IFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNA 412

Query: 401 P-PYDQSFED-MDLPVDQWK 418
                  F D M++   Q +
Sbjct: 413 TEKVRLPFNDWMNMDEPQLR 432

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  320 bits (821), Expect = e-107
 Identities = 130/167 (77%), Positives = 149/167 (89%)

Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
              +A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L
Sbjct: 44  SVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 103

Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+
Sbjct: 104 EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL 163

Query: 200 AVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT 246
           AVNEDCELKILDFGLAR T +EMTGYVATRWYRAPEIMLNWMHYNQT
Sbjct: 164 AVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQT 210

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  287 bits (736), Expect = 3e-94
 Identities = 118/189 (62%), Positives = 134/189 (70%), Gaps = 24/189 (12%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT-DI--- 309
           DLKPSN+AVNEDCELKILDFGLAR T +EMTGYVATRWYRAPEIMLNWMHYNQT DI   
Sbjct: 157 DLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 216

Query: 310 --------------------HQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKD 349
                                QL LI+ ++GTP AE + KISS+SAR YI SL  + K +
Sbjct: 217 GCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN 276

Query: 350 FRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPPYDQSFED 409
           F  VF GANP A+DLL  ML LDS+KRITA QALAH Y +QY DP+DEP + PYDQS E 
Sbjct: 277 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSLES 336

Query: 410 MDLPVDQWK 418
            DL +D+WK
Sbjct: 337 RDLLIDEWK 345

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  319 bits (820), Expect = e-107
 Identities = 111/165 (67%), Positives = 134/165 (81%)

Query: 82  SSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD 141
            SA+D  +G KVAIKK+ RPFQS + AKR YRELR+LKHM HENVIGLLDVF  +  L D
Sbjct: 42  CSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101

Query: 142 FKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           F + Y+V   MG DL  +++ +KL +D +QFLVYQ+L+GL+YIH+AGIIHRDLKP N+AV
Sbjct: 102 FTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV 161

Query: 202 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT 246
           NEDCELKILDFGLAR  ++EMTGYV TRWYRAPE++LNWM Y QT
Sbjct: 162 NEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQT 206

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  286 bits (734), Expect = 6e-94
 Identities = 99/189 (52%), Positives = 123/189 (65%), Gaps = 24/189 (12%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT-DI--- 309
           DLKP N+AVNEDCELKILDFGLAR  ++EMTGYV TRWYRAPE++LNWM Y QT DI   
Sbjct: 153 DLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSV 212

Query: 310 --------------------HQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKD 349
                                QL  IM++ GTPPAEF+ ++ SD A+ Y+  LP L KKD
Sbjct: 213 GCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKD 272

Query: 350 FRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPPYDQSFED 409
           F  +   A+P A++LL  ML LD+E+R+TA +ALAHPY     D  DEP    YD SF+D
Sbjct: 273 FASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDD 332

Query: 410 MDLPVDQWK 418
           +D  +D+WK
Sbjct: 333 VDRTLDEWK 341

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  314 bits (806), Expect = e-105
 Identities = 109/167 (65%), Positives = 132/167 (79%), Gaps = 1/167 (0%)

Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
              SA+D  SG KVAIKK++RPFQS + AKR YREL +LKHM HENVIGLLDVF   + L
Sbjct: 39  SVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL 98

Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F + Y+V   M  DL  I+   K S++ +Q+LVYQ+L+GLKYIHSAG++HRDLKP N+
Sbjct: 99  RNFYDFYLVMPFMQTDLQKIMG-LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNL 157

Query: 200 AVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT 246
           AVNEDCELKILDFGLAR  + EMTGYV TRWYRAPE++L+WMHYNQT
Sbjct: 158 AVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQT 204

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  280 bits (718), Expect = 7e-92
 Identities = 98/190 (51%), Positives = 122/190 (64%), Gaps = 25/190 (13%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT-DI--- 309
           DLKP N+AVNEDCELKILDFGLAR  + EMTGYV TRWYRAPE++L+WMHYNQT DI   
Sbjct: 151 DLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSV 210

Query: 310 --------------------HQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKD 349
                                QL  I+++ G P  EF+ K++  +A+ YI SLP   +KD
Sbjct: 211 GCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKD 270

Query: 350 FRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSP-PYDQSFE 408
           F Q+F  A+PQA DLL  MLELD +KR+TA QAL HP+   + DP +E  +  P+D S E
Sbjct: 271 FTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDDSLE 330

Query: 409 DMDLPVDQWK 418
              L VD+WK
Sbjct: 331 HEKLTVDEWK 340

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  306 bits (786), Expect = e-102
 Identities = 88/173 (50%), Positives = 122/173 (70%), Gaps = 8/173 (4%)

Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           +  SA D+++ V+VAIKKI  PF+   + +RT RE+++L    HEN+IG+ D+  + T +
Sbjct: 42  MVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT-I 99

Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
              K+VY+V  LM  DL  +L+TQ LS+DH+ + +YQILRGLKYIHSA ++HRDLKPSN+
Sbjct: 100 EQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNL 159

Query: 200 AVNEDCELKILDFGLARPTENE------MTGYVATRWYRAPEIMLNWMHYNQT 246
            +N  C+LKI DFGLAR  + +      +T YVATRWYRAPEIMLN   Y ++
Sbjct: 160 LLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 212

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  276 bits (708), Expect = 4e-90
 Identities = 85/196 (43%), Positives = 111/196 (56%), Gaps = 31/196 (15%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENE------MTGYVATRWYRAPEIMLNWMHYNQT 307
           DLKPSN+ +N  C+LKI DFGLAR  + +      +T YVATRWYRAPEIMLN   Y ++
Sbjct: 153 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 212

Query: 308 -DI-----------------------HQLNLIMEMLGTPPAEFMAKISSDSARKYINSLP 343
            DI                        QLN I+ +LG+P  E +  I +  AR Y+ SLP
Sbjct: 213 IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLP 272

Query: 344 LLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSP-P 402
              K  + ++F  A+ +A+DLL  ML  +  KRI  EQALAHPYL QY DP+DEP +  P
Sbjct: 273 HKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAP 332

Query: 403 YDQSFEDMDLPVDQWK 418
           +    E  DLP ++ K
Sbjct: 333 FKFDMELDDLPKEKLK 348

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  297 bits (763), Expect = 2e-98
 Identities = 87/169 (51%), Positives = 120/169 (71%), Gaps = 4/169 (2%)

Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I  +A D++    VAIKK++RPFQ+  HAKR YREL ++K +NH+N+IGLL+VF     L
Sbjct: 40  IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 99

Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F++VY+V  LM A+L  +++  +L  + + +L+YQ+L G+K++HSAGIIHRDLKPSNI
Sbjct: 100 EEFQDVYIVMELMDANLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 158

Query: 200 AVNEDCELKILDFGLARPTENE--MTGYVATRWYRAPEIMLNWMHYNQT 246
            V  DC LKILDFGLAR       MT YV TR+YRAPE++L    Y + 
Sbjct: 159 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKEN 206

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  248 bits (634), Expect = 5e-79
 Identities = 75/205 (36%), Positives = 103/205 (50%), Gaps = 42/205 (20%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENE--MTGYVATRWYRAPEIMLNWMHYNQT-DI- 309
           DLKPSNI V  DC LKILDFGLAR       MT YV TR+YRAPE++L    Y +  DI 
Sbjct: 152 DLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIW 210

Query: 310 ----------------------HQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTK 347
                                  Q N ++E LGTP  EFM K+     R Y+ + P    
Sbjct: 211 SVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT-VRTYVENRPKYAG 269

Query: 348 KDFRQVFKGA------------NPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPN 395
             F ++F                 QA DLLS ML +D+ KRI+ ++AL HPY++ + DP+
Sbjct: 270 YSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPS 329

Query: 396 DEPTSPP--YDQSFEDMDLPVDQWK 418
           +    PP   D+  ++ +  +++WK
Sbjct: 330 EAEAPPPKIPDKQLDEREHTIEEWK 354

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  294 bits (755), Expect = 9e-98
 Identities = 63/179 (35%), Positives = 104/179 (58%), Gaps = 17/179 (9%)

Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFH-------- 134
           SA+D+    +VAIKKI          K   RE+++++ ++H+N++ + ++          
Sbjct: 29  SAVDNDCDKRVAIKKIV--LTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86

Query: 135 SNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDL 194
               L +  +VY+V   M  DL N+L    L ++H +  +YQ+LRGLKYIHSA ++HRDL
Sbjct: 87  DVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDL 146

Query: 195 KPSNIAVN-EDCELKILDFGLARPTENE------MTGYVATRWYRAPEIMLNWMHYNQT 246
           KP+N+ +N ED  LKI DFGLAR  +        ++  + T+WYR+P ++L+  +Y + 
Sbjct: 147 KPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKA 205

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  238 bits (610), Expect = 5e-76
 Identities = 56/176 (31%), Positives = 86/176 (48%), Gaps = 32/176 (18%)

Query: 254 DLKPSNIAVN-EDCELKILDFGLARPTENE------MTGYVATRWYRAPEIMLNWMHYNQ 306
           DLKP+N+ +N ED  LKI DFGLAR  +        ++  + T+WYR+P ++L+  +Y +
Sbjct: 145 DLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTK 204

Query: 307 T-DI-----------------------HQLNLIMEMLGTPPAEFMAKISSDSARKYINSL 342
             D+                        Q+ LI+E +     E   ++ S     YI + 
Sbjct: 205 AIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLS-VIPVYIRND 263

Query: 343 PLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEP 398
                K   Q+  G + +A+D L  +L      R+TAE+AL+HPY+S YS P DEP
Sbjct: 264 MTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMDEP 319

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  293 bits (752), Expect = 9e-97
 Identities = 62/177 (35%), Positives = 98/177 (55%), Gaps = 15/177 (8%)

Query: 83  SALDSVSGVKVAIKKI---------ARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVF 133
           + +DS  G+ VAIK++               +   KR  RE+R+L H +H N++GL D+F
Sbjct: 40  AGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98

Query: 134 HSNTCLADFKNVYMVTHLMGADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIH 191
                      +Y+VT LM  DL  ++  Q+  +S  H+Q+ +Y IL GL  +H AG++H
Sbjct: 99  VHFE-EPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVH 157

Query: 192 RDLKPSNIAVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIMLNWMHYNQT 246
           RDL P NI + ++ ++ I DF LAR    +   T YV  RWYRAPE+++ +  + + 
Sbjct: 158 RDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKL 214

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  274 bits (702), Expect = 3e-89
 Identities = 63/192 (32%), Positives = 95/192 (49%), Gaps = 27/192 (14%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIMLNWMHYNQT-DI- 309
           DL P NI + ++ ++ I DF LAR    +   T YV  RWYRAPE+++ +  + +  D+ 
Sbjct: 159 DLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMW 218

Query: 310 ----------------------HQLNLIMEMLGTPPAEFMAKISSDSARKYI-NSLPLLT 346
                                 +QLN I+E++GTP  E +   SS SAR Y+ NSL  + 
Sbjct: 219 SAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVP 278

Query: 347 KKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPPYDQS 406
            + +  V   A+P A+DL++ MLE + ++RI+ EQAL HPY     DP D          
Sbjct: 279 ARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGLSERFH 338

Query: 407 FEDMDLPVDQWK 418
           F++    V    
Sbjct: 339 FDESVTDVYDMH 350

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  295 bits (758), Expect = 2e-96
 Identities = 87/169 (51%), Positives = 119/169 (70%), Gaps = 4/169 (2%)

Query: 80  IFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
           I  +A D+V    VAIKK++RPFQ+  HAKR YREL ++K +NH+N+I LL+VF     L
Sbjct: 77  IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 136

Query: 140 ADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            +F++VY+V  LM A+L  +++  +L  + + +L+YQ+L G+K++HSAGIIHRDLKPSNI
Sbjct: 137 EEFQDVYLVMELMDANLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI 195

Query: 200 AVNEDCELKILDFGLARPTENE--MTGYVATRWYRAPEIMLNWMHYNQT 246
            V  DC LKILDFGLAR       MT YV TR+YRAPE++L    Y + 
Sbjct: 196 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKEN 243

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  248 bits (636), Expect = 3e-78
 Identities = 76/205 (37%), Positives = 102/205 (49%), Gaps = 42/205 (20%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENE--MTGYVATRWYRAPEIMLNWMHYNQT-DI- 309
           DLKPSNI V  DC LKILDFGLAR       MT YV TR+YRAPE++L    Y +  DI 
Sbjct: 189 DLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIW 247

Query: 310 ----------------------HQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTK 347
                                  Q N ++E LGTP  EFM K+     R Y+ + P    
Sbjct: 248 SVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT-VRNYVENRPKYAG 306

Query: 348 KDFRQVFKGA------------NPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPN 395
             F ++F  +              QA DLLS ML +D  KRI+ + AL HPY++ + DP 
Sbjct: 307 LTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPA 366

Query: 396 DEPTSPP--YDQSFEDMDLPVDQWK 418
           +    PP  YD+  ++ +  +++WK
Sbjct: 367 EVEAPPPQIYDKQLDEREHTIEEWK 391

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  244 bits (626), Expect = 7e-78
 Identities = 73/375 (19%), Positives = 130/375 (34%), Gaps = 100/375 (26%)

Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
              +  +G+ VAIKK+    Q      R  + ++ L  ++H N++ L   F++     D 
Sbjct: 41  LGKEKSTGMSVAIKKV---IQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLG-ERDR 96

Query: 143 KNVY--MVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
           +++Y  +V   +                     +++  R   Y                 
Sbjct: 97  RDIYLNVVMEYVPDT------------------LHRCCR--NYYRRQVAP---------- 126

Query: 201 VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNI 260
                 +K+  F L R                     +  +H     V    +D+KP N+
Sbjct: 127 --PPILIKVFLFQLIR--------------------SIGCLHLPSVNV--CHRDIKPHNV 162

Query: 261 AVN-EDCELKILDFGLARPTE--NEMTGYVATRWYRAPEIMLNWMHYN------------ 305
            VN  D  LK+ DFG A+          Y+ +R+YRAPE++    HY             
Sbjct: 163 LVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIF 222

Query: 306 ------------QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQV 353
                            QL+ I+ +LG P  E + K++          L       +  V
Sbjct: 223 AEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVD---LYNSKGIPWSNV 279

Query: 354 FKG----ANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTS------PPY 403
           F         +A DLLS +L+   E+R+   +AL HPY  +  DP  +  +        +
Sbjct: 280 FSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLF 339

Query: 404 DQSFEDMDLPVDQWK 418
                ++++  +  K
Sbjct: 340 RFLPNEIEVMSEAQK 354

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  236 bits (603), Expect = 8e-75
 Identities = 47/168 (27%), Positives = 93/168 (55%), Gaps = 14/168 (8%)

Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLAD 141
            A++  +  KV +K + +P +     K+  RE+++L+++    N+I L D+         
Sbjct: 54  EAINITNNEKVVVKIL-KPVK----KKKIKREIKILENLRGGPNIITLADIVKDPV---S 105

Query: 142 FKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
                +  H+   D   +   Q L+D  ++F +Y+IL+ L Y HS GI+HRD+KP N+ +
Sbjct: 106 RTPALVFEHVNNTDFKQLY--QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI 163

Query: 202 N-EDCELKILDFGLARPTE--NEMTGYVATRWYRAPEIMLNWMHYNQT 246
           + E  +L+++D+GLA       E    VA+R+++ PE+++++  Y+ +
Sbjct: 164 DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYS 211

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  187 bits (477), Expect = 3e-56
 Identities = 40/175 (22%), Positives = 81/175 (46%), Gaps = 34/175 (19%)

Query: 254 DLKPSNIAVN-EDCELKILDFGLARPTE--NEMTGYVATRWYRAPEIMLNWMHYNQT--- 307
           D+KP N+ ++ E  +L+++D+GLA       E    VA+R+++ PE+++++  Y+ +   
Sbjct: 155 DVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDM 214

Query: 308 ----------------------DIHQLNLIMEMLGTPPAE-FMAKISSDSARKYINSLPL 344
                                 +  QL  I ++LGT     ++ K + +   ++ + L  
Sbjct: 215 WSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGR 274

Query: 345 LTKKDFRQVFKGAN-----PQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDP 394
            ++K + +     N     P+A+D L  +L  D + R+TA +A+ HPY       
Sbjct: 275 HSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 329

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  231 bits (590), Expect = 3e-72
 Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 46/203 (22%)

Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNT----- 137
              D  SG + A+KK+ +        +   REL ++K ++H N+I L+D F++       
Sbjct: 25  EVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78

Query: 138 ---------------------------CLADFKNVYMVTHLMGADLNNILRT-----QKL 165
                                        +  K + ++   +   L+ +L++     + +
Sbjct: 79  PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSI 138

Query: 166 SDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN-EDCELKILDFGLARPTE--NEM 222
             + +   +YQ+ R + +IHS GI HRD+KP N+ VN +D  LK+ DFG A+        
Sbjct: 139 PMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS 198

Query: 223 TGYVATRWYRAPEIMLNWMHYNQ 245
             Y+ +R+YRAPE+ML    Y  
Sbjct: 199 VAYICSRFYRAPELMLGATEYTP 221

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  200 bits (510), Expect = 2e-60
 Identities = 51/189 (26%), Positives = 84/189 (44%), Gaps = 32/189 (16%)

Query: 254 DLKPSNIAVN-EDCELKILDFGLARPTEN--EMTGYVATRWYRAPEIMLNWMHYNQT-DI 309
           D+KP N+ VN +D  LK+ DFG A+          Y+ +R+YRAPE+ML    Y  + D+
Sbjct: 166 DIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDL 225

Query: 310 -----------------------HQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLT 346
                                   QL  I++++GTP  E M +++           P L 
Sbjct: 226 WSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVR---FPTLK 282

Query: 347 KKDFRQVFKGANPQ-AIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPPYD- 404
            KD+R++     P  AIDLL  +L  + + RI   +A+AHP+     +  +       + 
Sbjct: 283 AKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNF 342

Query: 405 QSFEDMDLP 413
               + ++P
Sbjct: 343 PHGVNQNIP 351

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  229 bits (586), Expect = 3e-71
 Identities = 53/170 (31%), Positives = 86/170 (50%), Gaps = 14/170 (8%)

Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
            A    SG  VAIKK+ +        +   REL++++ ++H N++ L   F+S+    D 
Sbjct: 72  QAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125

Query: 143 KNVYMVTHLMGADLNNILR-----TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPS 197
             + +V   +   +  + R      Q L   +V+  +YQ+ R L YIHS GI HRD+KP 
Sbjct: 126 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQ 185

Query: 198 NIAVNEDC-ELKILDFGLARPTE--NEMTGYVATRWYRAPEIMLNWMHYN 244
           N+ ++ D   LK+ DFG A+          Y+ +R+YRAPE++     Y 
Sbjct: 186 NLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYT 235

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  189 bits (482), Expect = 6e-56
 Identities = 46/198 (23%), Positives = 83/198 (41%), Gaps = 36/198 (18%)

Query: 254 DLKPSNIAVNEDC-ELKILDFGLARPTE--NEMTGYVATRWYRAPEIMLNWMHYN----- 305
           D+KP N+ ++ D   LK+ DFG A+          Y+ +R+YRAPE++     Y      
Sbjct: 181 DIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDV 240

Query: 306 -------------------QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLT 346
                               + + QL  I+++LGTP  E + +++ +         P + 
Sbjct: 241 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF---KFPQIK 297

Query: 347 KKDFRQVF-KGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDE-----PTS 400
              + +VF     P+AI L S +LE     R+T  +A AH +  +  DPN +      T 
Sbjct: 298 AHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTP 357

Query: 401 PPYDQSFEDMDLPVDQWK 418
             ++ + +++        
Sbjct: 358 ALFNFTTQELSSNPPLAT 375

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  219 bits (559), Expect = 2e-67
 Identities = 52/170 (30%), Positives = 85/170 (50%), Gaps = 15/170 (8%)

Query: 83  SALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
            A    S  +VAIKK+ +        +   REL++++ + H NV+ L   F+SN    D 
Sbjct: 58  QAKLVESD-EVAIKKVLQ------DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE 110

Query: 143 KNVYMVTHLMGADLNNILR-----TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPS 197
             + +V   +   +    R      Q +    ++  +YQ+LR L YIHS GI HRD+KP 
Sbjct: 111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQ 170

Query: 198 NIAVNEDC-ELKILDFGLARPTE--NEMTGYVATRWYRAPEIMLNWMHYN 244
           N+ ++     LK++DFG A+          Y+ +R+YRAPE++    +Y 
Sbjct: 171 NLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYT 220

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  188 bits (479), Expect = 9e-56
 Identities = 49/198 (24%), Positives = 86/198 (43%), Gaps = 36/198 (18%)

Query: 254 DLKPSNIAVNEDC-ELKILDFGLARPTE--NEMTGYVATRWYRAPEIMLNWMHYN----- 305
           D+KP N+ ++     LK++DFG A+          Y+ +R+YRAPE++    +Y      
Sbjct: 166 DIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDI 225

Query: 306 -------------------QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLT 346
                              ++ I QL  I+++LGTP  E +  ++ +      +  P + 
Sbjct: 226 WSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPN---YMEHKFPQIR 282

Query: 347 KKDFRQVF-KGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDE-----PTS 400
              F +VF     P AIDL+S +LE     R+TA +AL HP+  +               
Sbjct: 283 PHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELP 342

Query: 401 PPYDQSFEDMDLPVDQWK 418
           P ++ + E++ +  D   
Sbjct: 343 PLFNWTKEELSVRPDLIS 360

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  195 bits (497), Expect = 6e-59
 Identities = 81/363 (22%), Positives = 134/363 (36%), Gaps = 106/363 (29%)

Query: 84  ALDSVSGVKVAIKKIAR--------PFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHS 135
           A    +G KVA+KK+          P  +A+      RE+++L+ + HENV+ L+++  +
Sbjct: 36  ARHRKTGQKVALKKV-LMENEKEGFPI-TAL------REIKILQLLKHENVVNLIEICRT 87

Query: 136 NT--CLADFKNVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIH 191
                     ++Y+V      DL  +L     K +   ++ ++  +L GL YIH   I+H
Sbjct: 88  KASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILH 147

Query: 192 RDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFY 251
           RD+K +N+ +  D  LK+ DFGLA             R +                    
Sbjct: 148 RDMKAANVLITRDGVLKLADFGLA-------------RAFSLA----------------- 177

Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYN------ 305
                                        N  T  V T WYR PE++L    Y       
Sbjct: 178 ------------------------KNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLW 213

Query: 306 ------------------QTDIHQLNLIMEMLGTPPAEFMAKISS-DSARKYINSLPLLT 346
                              T+ HQL LI ++ G+   E    + + +   K    L    
Sbjct: 214 GAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKL--ELVKGQ 271

Query: 347 KKDFRQVFK--GANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQY---SDPNDEPTSP 401
           K+  +   K    +P A+DL+  +L LD  +RI ++ AL H +       SD     ++ 
Sbjct: 272 KRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTH 331

Query: 402 PYD 404
              
Sbjct: 332 LTS 334

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  182 bits (463), Expect = 4e-54
 Identities = 89/345 (25%), Positives = 139/345 (40%), Gaps = 111/345 (32%)

Query: 84  ALDSVSGVKVAIKKIAR--------PFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHS 135
           A+D+V+   VAIK+I R        P  +A+      RE+ +LK + H N+I L  V H 
Sbjct: 53  AIDTVTNETVAIKRI-RLEHEEEGVPG-TAI------REVSLLKELQHRNIIELKSVIHH 104

Query: 136 NTCLADFKNVYMVTHLMGADLNNIL-RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDL 194
           N        ++++      DL   + +   +S   ++  +YQ++ G+ + HS   +HRDL
Sbjct: 105 N------HRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDL 158

Query: 195 KPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQD 254
           KP N                                     ++L+    ++T        
Sbjct: 159 KPQN-------------------------------------LLLSVSDASETP------- 174

Query: 255 LKPSNIAVNEDCELKILDFGLAR----PTENEMTGYVATRWYRAPEIMLNWMHYN----- 305
                        LKI DFGLAR    P   + T  + T WYR PEI+L   HY+     
Sbjct: 175 ------------VLKIGDFGLARAFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDI 221

Query: 306 -------------------QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLT 346
                               ++I QL  I E+LG P       +++     +  S P   
Sbjct: 222 WSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA--LPDWKQSFPKFR 279

Query: 347 KKDFRQVFKGA-NPQAIDLLSLMLELDSEKRITAEQALAHPYLSQ 390
            K  ++V     + + +DLL+ MLE+D  KRI+A+ AL HPY S 
Sbjct: 280 GKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH 324

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  179 bits (457), Expect = 2e-53
 Identities = 52/171 (30%), Positives = 85/171 (49%), Gaps = 14/171 (8%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
             +  +G  VAIKK        V  K   RE+RMLK + H N++ LL+VF         +
Sbjct: 22  CRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK------R 75

Query: 144 NVYMVTHLMGADLNNIL--RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
            +++V       + + L    + + +  V+ + +Q L+ + + H    IHRD+KP NI +
Sbjct: 76  RLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI 135

Query: 202 NEDCELKILDFGLAR----PTENEMTGYVATRWYRAPEIMLNWMHYNQTGV 248
            +   +K+ DFG AR    P++      VATRWYR+PE+++    Y    V
Sbjct: 136 TKHSVIKLCDFGFARLLTGPSDY-YDDEVATRWYRSPELLVGDTQYG-PPV 184

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  160 bits (407), Expect = 5e-46
 Identities = 45/178 (25%), Positives = 70/178 (39%), Gaps = 29/178 (16%)

Query: 254 DLKPSNIAVNEDCELKILDFGLAR----PTENEMTGYVATRWYRAPEIMLNWMHYN---- 305
           D+KP NI + +   +K+ DFG AR    P++      VATRWYR+PE+++    Y     
Sbjct: 127 DVKPENILITKHSVIKLCDFGFARLLTGPSDY-YDDEVATRWYRSPELLVGDTQYGPPVD 185

Query: 306 --------------------QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLL 345
                               ++D+ QL LI + LG          S++     +      
Sbjct: 186 VWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPE 245

Query: 346 TKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPPY 403
             +     F   +  A+ LL   L +D  +R+T EQ L HPY     +  D       
Sbjct: 246 DMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDLAKEHDK 303

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  170 bits (434), Expect = 7e-50
 Identities = 58/171 (33%), Positives = 86/171 (50%), Gaps = 14/171 (8%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
             +  +G  VAIKK        +  K   RE+++LK + HEN++ LL+V          K
Sbjct: 44  CRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK------K 97

Query: 144 NVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
             Y+V   +   + + L      L    VQ  ++QI+ G+ + HS  IIHRD+KP NI V
Sbjct: 98  RWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV 157

Query: 202 NEDCELKILDFGLAR----PTENEMTGYVATRWYRAPEIMLNWMHYNQTGV 248
           ++   +K+ DFG AR    P        VATRWYRAPE+++  + Y    V
Sbjct: 158 SQSGVVKLCDFGFARTLAAPG-EVYDDEVATRWYRAPELLVGDVKYG-KAV 206

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  148 bits (375), Expect = 3e-41
 Identities = 41/177 (23%), Positives = 64/177 (36%), Gaps = 29/177 (16%)

Query: 254 DLKPSNIAVNEDCELKILDFGLAR----PTENEMTGYVATRWYRAPEIMLNWMHYN---- 305
           D+KP NI V++   +K+ DFG AR    P        VATRWYRAPE+++  + Y     
Sbjct: 149 DIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYDDEVATRWYRAPELLVGDVKYGKAVD 207

Query: 306 --------------------QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLL 345
                                +DI QL  IM  LG          + +     +    + 
Sbjct: 208 VWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIK 267

Query: 346 TKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPP 402
            ++   + +   +   IDL    L +D +KR    + L H +               
Sbjct: 268 EREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERFSQELQ 324

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  166 bits (423), Expect = 1e-47
 Identities = 82/362 (22%), Positives = 134/362 (37%), Gaps = 94/362 (25%)

Query: 86  DSVSGVKVAIKKIAR---PFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           D       A+K+I        SA       RE+ +L+ + H NVI L  VF S+      
Sbjct: 44  DGKDDKDYALKQIEGTGIS-MSAC------REIALLRELKHPNVISLQKVFLSHAD---- 92

Query: 143 KNVYMVTHLMGADLNNILRT----------QKLSDDHVQFLVYQILRGLKYIHSAGIIHR 192
           + V+++      DL +I++            +L    V+ L+YQIL G+ Y+H+  ++HR
Sbjct: 93  RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHR 152

Query: 193 DLKPSNIAVNEDC----ELKILDFGLAR------PTENEMTGYVATRWYRAPEIMLNWMH 242
           DLKP+NI V  +      +KI D G AR          ++   V T WYRAPE++L   H
Sbjct: 153 DLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARH 212

Query: 243 YNQ---------------TGVPFYFQ---DLKPSNIAVNEDCELKILDFGLARPTENEMT 284
           Y +               T  P  F    +   ++   + D   +I +  +  P + +  
Sbjct: 213 YTKAIDIWAIGCIFAELLTSEPI-FHCRQEDIKTSNPYHHDQLDRIFNV-MGFPADKDWE 270

Query: 285 GYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPL 344
                  +    +M ++     T                                     
Sbjct: 271 DIKKMPEHS--TLMKDFRRNTYT-----------------------------------NC 293

Query: 345 LTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQY---SDPNDEPTSP 401
              K   +     + +A  LL  +L +D  KRIT+EQA+  PY  +    +         
Sbjct: 294 SLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQI 353

Query: 402 PY 403
           PY
Sbjct: 354 PY 355

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  153 bits (389), Expect = 4e-43
 Identities = 64/176 (36%), Positives = 94/176 (53%), Gaps = 21/176 (11%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKR-----TYRELRMLKHMNHENVIGLLDVFHSNTC 138
           A D  +   VAIKKI         AK        RE+++L+ ++H N+IGLLD F   + 
Sbjct: 29  ARDKNTNQIVAIKKI--KLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS- 85

Query: 139 LADFKNVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKP 196
                N+ +V   M  DL  I++     L+  H++  +   L+GL+Y+H   I+HRDLKP
Sbjct: 86  -----NISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKP 140

Query: 197 SNIAVNEDCELKILDFGLAR----PTENEMTGYVATRWYRAPEIMLNWMHYNQTGV 248
           +N+ ++E+  LK+ DFGLA+    P     T  V TRWYRAPE++     Y   GV
Sbjct: 141 NNLLLDENGVLKLADFGLAKSFGSPN-RAYTHQVVTRWYRAPELLFGARMYG-VGV 194

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  138 bits (350), Expect = 2e-37
 Identities = 53/186 (28%), Positives = 74/186 (39%), Gaps = 32/186 (17%)

Query: 254 DLKPSNIAVNEDCELKILDFGLAR----PTENEMTGYVATRWYRAPEIMLNWMHYN---- 305
           DLKP+N+ ++E+  LK+ DFGLA+    P     T  V TRWYRAPE++     Y     
Sbjct: 137 DLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVD 195

Query: 306 --------------------QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLL 345
                                +D+ QL  I E LGTP  E    + S     Y+ +    
Sbjct: 196 MWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS--LPDYV-TFKSF 252

Query: 346 TKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPPYDQ 405
                  +F  A    +DL+  +   +   RITA QAL   Y S    P      P  + 
Sbjct: 253 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPRPNC 312

Query: 406 SFEDMD 411
             E + 
Sbjct: 313 PVETLK 318

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  149 bits (380), Expect = 2e-42
 Identities = 56/179 (31%), Positives = 92/179 (51%), Gaps = 30/179 (16%)

Query: 84  ALDSVSGVKVAIKKIAR--------PFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHS 135
           A +  +   VA+K++ R        P  SA+      RE+ +LK + H+N++ L DV HS
Sbjct: 21  AKNRETHEIVALKRV-RLDDDDEGVPS-SAL------REICLLKELKHKNIVRLHDVLHS 72

Query: 136 NTCLADFKNVYMVTHLMGADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRD 193
           +      K + +V      DL     +    L  + V+  ++Q+L+GL + HS  ++HRD
Sbjct: 73  D------KKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRD 126

Query: 194 LKPSNIAVNEDCELKILDFGLAR----PTENEMTGYVATRWYRAPEIMLNWMHYNQTGV 248
           LKP N+ +N + ELK+ +FGLAR    P     +  V T WYR P+++     Y+ T +
Sbjct: 127 LKPQNLLINRNGELKLANFGLARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKLYS-TSI 183

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  130 bits (329), Expect = 5e-35
 Identities = 48/171 (28%), Positives = 69/171 (40%), Gaps = 34/171 (19%)

Query: 254 DLKPSNIAVNEDCELKILDFGLAR----PTENEMTGYVATRWYRAPEIMLNWMHYN---- 305
           DLKP N+ +N + ELK+ +FGLAR    P     +  V T WYR P+++     Y+    
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSID 184

Query: 306 ---------------------QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPL 344
                                     QL  I  +LGTP  E    ++           P+
Sbjct: 185 MWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK---LPDYKPYPM 241

Query: 345 LTKK-DFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDP 394
                    V    N    DLL  +L+ +  +RI+AE+AL HPY S +  P
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  148 bits (376), Expect = 2e-41
 Identities = 59/178 (33%), Positives = 92/178 (51%), Gaps = 29/178 (16%)

Query: 84  ALDSVSGVKVAIKKIAR-------PFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSN 136
               ++   VA+K+I R       P  +A+      RE+ +LK + H N++ L D+ H+ 
Sbjct: 21  GKSKLTDNLVALKEI-RLEHEEGAPC-TAI------REVSLLKDLKHANIVTLHDIIHTE 72

Query: 137 TCLADFKNVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDL 194
                 K++ +V   +  DL   L      ++  +V+  ++Q+LRGL Y H   ++HRDL
Sbjct: 73  ------KSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDL 126

Query: 195 KPSNIAVNEDCELKILDFGLAR----PTENEMTGYVATRWYRAPEIMLNWMHYNQTGV 248
           KP N+ +NE  ELK+ DFGLAR    PT       V T WYR P+I+L    Y+ T +
Sbjct: 127 KPQNLLINERGELKLADFGLARAKSIPT-KTYDNEVVTLWYRPPDILLGSTDYS-TQI 182

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  135 bits (342), Expect = 1e-36
 Identities = 55/183 (30%), Positives = 73/183 (39%), Gaps = 32/183 (17%)

Query: 254 DLKPSNIAVNEDCELKILDFGLAR----PTENEMTGYVATRWYRAPEIMLNWMHYN---- 305
           DLKP N+ +NE  ELK+ DFGLAR    PT       V T WYR P+I+L    Y+    
Sbjct: 125 DLKPQNLLINERGELKLADFGLARAKSIPT-KTYDNEVVTLWYRPPDILLGSTDYSTQID 183

Query: 306 --------------------QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLL 345
                                T   QL+ I  +LGTP  E    I S+   K  N  P  
Sbjct: 184 MWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYN-YPKY 242

Query: 346 TKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPPYDQ 405
             +         +    DLL+ +L+ +   RI+AE A+ HP+    S        P    
Sbjct: 243 RAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL--SLGERIHKLPDTTS 300

Query: 406 SFE 408
            F 
Sbjct: 301 IFA 303

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  147 bits (373), Expect = 4e-41
 Identities = 62/173 (35%), Positives = 86/173 (49%), Gaps = 26/173 (15%)

Query: 84  ALDSVSGVKVAIKKI----------ARPFQSAVHAKRTYRE---LRMLKHMNHENVIGLL 130
           A D  SG  VA+K +            P  S V      RE   LR L+   H NV+ L+
Sbjct: 28  ARDPHSGHFVALKSVRVPNGGGGGGGLPI-STV------REVALLRRLEAFEHPNVVRLM 80

Query: 131 DVFHSNTCLADFKNVYMVTHLMGADLNNILRTQK---LSDDHVQFLVYQILRGLKYIHSA 187
           DV  ++    + K V +V   +  DL   L       L  + ++ L+ Q LRGL ++H+ 
Sbjct: 81  DVCATSRTDREIK-VTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN 139

Query: 188 GIIHRDLKPSNIAVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIML 238
            I+HRDLKP NI V     +K+ DFGLAR    +  +T  V T WYRAPE++L
Sbjct: 140 CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLL 192

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  133 bits (336), Expect = 7e-36
 Identities = 49/173 (28%), Positives = 73/173 (42%), Gaps = 35/173 (20%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIMLN---------W- 301
           DLKP NI V     +K+ DFGLAR    +  +T  V T WYRAPE++L          W 
Sbjct: 145 DLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWS 204

Query: 302 -------MHYNQ------TDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKK 348
                  M   +      ++  QL  I +++G PP +   +  S    +   + P    +
Sbjct: 205 VGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVS--LPRG--AFPPRGPR 260

Query: 349 DFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSP 401
             + V          LL  ML  +  KRI+A +AL H YL      + +  +P
Sbjct: 261 PVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL------HKDEGNP 307

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  146 bits (371), Expect = 4e-41
 Identities = 56/174 (32%), Positives = 86/174 (49%), Gaps = 30/174 (17%)

Query: 89  SGVKVAIKKIAR--------PFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLA 140
            G   A+KKI R        P  + +      RE+ +LK + H N++ L DV H+     
Sbjct: 25  YGETFALKKI-RLEKEDEGIPS-TTI------REISILKELKHSNIVKLYDVIHTK---- 72

Query: 141 DFKNVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSN 198
             K + +V   +  DL  +L      L     +  + Q+L G+ Y H   ++HRDLKP N
Sbjct: 73  --KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQN 130

Query: 199 IAVNEDCELKILDFGLAR----PTENEMTGYVATRWYRAPEIMLNWMHYNQTGV 248
           + +N + ELKI DFGLAR    P   + T  + T WYRAP++++    Y+ T +
Sbjct: 131 LLINREGELKIADFGLARAFGIPV-RKYTHEIVTLWYRAPDVLMGSKKYS-TTI 182

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  136 bits (345), Expect = 3e-37
 Identities = 54/167 (32%), Positives = 80/167 (47%), Gaps = 31/167 (18%)

Query: 254 DLKPSNIAVNEDCELKILDFGLAR----PTENEMTGYVATRWYRAPEIMLNWMHYN---- 305
           DLKP N+ +N + ELKI DFGLAR    P   + T  + T WYRAP++++    Y+    
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPV-RKYTHEIVTLWYRAPDVLMGSKKYSTTID 183

Query: 306 --------------------QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLL 345
                                ++  QL  I  +LGTP ++    ++     KY  +  + 
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE--LPKYDPNFTVY 241

Query: 346 TKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYS 392
               +    KG +   IDLLS ML+LD  +RITA+QAL H Y  + +
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKENN 288

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  146 bits (371), Expect = 6e-41
 Identities = 63/173 (36%), Positives = 93/173 (53%), Gaps = 30/173 (17%)

Query: 90  GVKVAIKKIAR--------PFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD 141
           G  VA+K+I R        P  +A+      RE+ +LK ++H N++ L+DV HS      
Sbjct: 45  GRIVALKRI-RLDAEDEGIPS-TAI------REISLLKELHHPNIVSLIDVIHSE----- 91

Query: 142 FKNVYMVTHLMGADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
            + + +V   M  DL  +L   K  L D  ++  +YQ+LRG+ + H   I+HRDLKP N+
Sbjct: 92  -RCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNL 150

Query: 200 AVNEDCELKILDFGLAR----PTENEMTGYVATRWYRAPEIMLNWMHYNQTGV 248
            +N D  LK+ DFGLAR    P     T  V T WYRAP++++    Y+ T V
Sbjct: 151 LINSDGALKLADFGLARAFGIPV-RSYTHEVVTLWYRAPDVLMGSKKYS-TSV 201

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  132 bits (334), Expect = 1e-35
 Identities = 54/166 (32%), Positives = 71/166 (42%), Gaps = 30/166 (18%)

Query: 254 DLKPSNIAVNEDCELKILDFGLAR----PTENEMTGYVATRWYRAPEIMLNWMHYN---- 305
           DLKP N+ +N D  LK+ DFGLAR    P     T  V T WYRAP++++    Y+    
Sbjct: 144 DLKPQNLLINSDGALKLADFGLARAFGIPV-RSYTHEVVTLWYRAPDVLMGSKKYSTSVD 202

Query: 306 --------------------QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLL 345
                                TD  QL  I  +LGTP      ++      K      + 
Sbjct: 203 IWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRT-FQVF 261

Query: 346 TKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQY 391
            KK +  +  G   + IDLLS ML  D  KRI+A  A+ HPY    
Sbjct: 262 EKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  145 bits (369), Expect = 1e-40
 Identities = 57/183 (31%), Positives = 97/183 (53%), Gaps = 34/183 (18%)

Query: 84  ALDSVSGVKVAIKKIAR-------PFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSN 136
            L+  +GV VA+K++ +       P  +A+      RE+ ++K + HEN++ L DV H+ 
Sbjct: 24  GLNKTTGVYVALKEV-KLDSEEGTPS-TAI------REISLMKELKHENIVRLYDVIHTE 75

Query: 137 TCLADFKNVYMVTHLMGADLNNILRT-------QKLSDDHVQFLVYQILRGLKYIHSAGI 189
                   + +V   M  DL   + +       + L  + V++  +Q+L+GL + H   I
Sbjct: 76  ------NKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKI 129

Query: 190 IHRDLKPSNIAVNEDCELKILDFGLAR----PTENEMTGYVATRWYRAPEIMLNWMHYNQ 245
           +HRDLKP N+ +N+  +LK+ DFGLAR    P  N  +  V T WYRAP++++    Y+ 
Sbjct: 130 LHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV-NTFSSEVVTLWYRAPDVLMGSRTYS- 187

Query: 246 TGV 248
           T +
Sbjct: 188 TSI 190

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  136 bits (344), Expect = 7e-37
 Identities = 51/188 (27%), Positives = 84/188 (44%), Gaps = 36/188 (19%)

Query: 254 DLKPSNIAVNEDCELKILDFGLAR----PTENEMTGYVATRWYRAPEIMLNWMHYN---- 305
           DLKP N+ +N+  +LK+ DFGLAR    P  N  +  V T WYRAP++++    Y+    
Sbjct: 133 DLKPQNLLINKRGQLKLGDFGLARAFGIPV-NTFSSEVVTLWYRAPDVLMGSRTYSTSID 191

Query: 306 --------------------QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLL 345
                                 D  QL LI +++GTP       ++     KY  ++   
Sbjct: 192 IWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK--LPKYNPNIQQR 249

Query: 346 TKKDFRQVFKGA-----NPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTS 400
             +D RQV +       +   +D L  +L+L+ + R++A+QAL HP+ ++Y        S
Sbjct: 250 PPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHASMGGS 309

Query: 401 PPYDQSFE 408
             +     
Sbjct: 310 RSHHHHHH 317

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  145 bits (368), Expect = 2e-39
 Identities = 78/362 (21%), Positives = 135/362 (37%), Gaps = 95/362 (26%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHE------NVIGLLDVFHSNT 137
           A D      VA+K + R  +          E+R+L+H+  +      NVI +L+ F    
Sbjct: 116 AYDHKVHQHVALK-MVRNEKRFHRQAAE--EIRILEHLRKQDKDNTMNVIHMLENF---- 168

Query: 138 CLADFKN-VYMVTHLMGADLNNILRTQK---LSDDHVQFLVYQILRGLKYIHSAGIIHRD 193
               F+N + M   L+  +L  +++  K    S   V+   + IL+ L  +H   IIH D
Sbjct: 169 ---TFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCD 225

Query: 194 LKPSNIAVNE--DCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFY 251
           LKP NI + +     +K++DFG +      +  Y+ +R+YRAPE++L        G  + 
Sbjct: 226 LKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVIL--------GARY- 276

Query: 252 FQDLKPSNIAVNEDCELKILDFG--LARPTENEM-TGYVATRWYRAPEIMLNWMHYNQTD 308
                           + +   G  LA     E+ TGY               +   + +
Sbjct: 277 -------------GMPIDMWSLGCILA-----ELLTGYP--------------LLPGEDE 304

Query: 309 IHQLNLIMEMLGTPPAEFMAK---------------------------ISSDSARKYINS 341
             QL  ++E+LG P  + +                             + +    +    
Sbjct: 305 GDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKL 364

Query: 342 LPLLTKKDFRQVFKGANPQA-IDLLSLMLELDSEKRITAEQALAHPYLSQ-YSDPNDEPT 399
                 +++    KG +    +D L   LE D   R+T  QAL HP+L +    P     
Sbjct: 365 RGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKPPTGEK 424

Query: 400 SP 401
           + 
Sbjct: 425 TS 426

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  142 bits (359), Expect = 3e-39
 Identities = 60/334 (17%), Positives = 108/334 (32%), Gaps = 88/334 (26%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNH--ENVIGLLDVFHSNTCLADFKNVY 146
                AIK +               E+  L  +    + +I L D   ++      + +Y
Sbjct: 51  KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD------QYIY 104

Query: 147 MVTHLMGADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
           MV      DLN+ L+  + +     +     +L  +  IH  GI+H DLKP+N  + +  
Sbjct: 105 MVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM 164

Query: 206 ELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNED 265
            LK++DFG+A   + + T               + +  +Q G   Y              
Sbjct: 165 -LKLIDFGIANQMQPDTT---------------SVVKDSQVGTVNY-------------- 194

Query: 266 CELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNL----------- 314
                            M           PE + +     +    +  +           
Sbjct: 195 -----------------M----------PPEAIKDMSSSRENGKSKSKISPKSDVWSLGC 227

Query: 315 IM-EML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF-KGANPQAIDLLSLMLEL 371
           I+  M  G  P  F   I+  S    I         +    F         D+L   L+ 
Sbjct: 228 ILYYMTYGKTP--FQQIINQISKLHAI------IDPNHEIEFPDIPEKDLQDVLKCCLKR 279

Query: 372 DSEKRITAEQALAHPYLSQYSDPNDEPTSPPYDQ 405
           D ++RI+  + LAHPY+   + P ++      ++
Sbjct: 280 DPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEE 313

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  141 bits (358), Expect = 4e-39
 Identities = 68/323 (21%), Positives = 112/323 (34%), Gaps = 78/323 (24%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
           A +++     AIKKI     +         E+ +L  +NH+ V+     +          
Sbjct: 25  ARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81

Query: 144 N-------VYMVTHLM-GADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRD 193
                   +++         L +++ ++      D    L  QIL  L YIHS GIIHRD
Sbjct: 82  TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRD 141

Query: 194 LKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQ 253
           LKP NI ++E   +KI DFGLA+                                     
Sbjct: 142 LKPMNIFIDESRNVKIGDFGLAK------------------------------------- 164

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQ-TDIHQL 312
                   V+   ++  LD      + + +T  + T  Y A E++    HYN+  D++ L
Sbjct: 165 -------NVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSL 217

Query: 313 NLIM-EMLGTPP------AEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLL 365
            +I  EM+  P          + K+     R      P                    ++
Sbjct: 218 GIIFFEMI-YPFSTGMERVNILKKL-----RSVSIEFP-------PDFDDNKMKVEKKII 264

Query: 366 SLMLELDSEKRITAEQALAHPYL 388
            L+++ D  KR  A   L   +L
Sbjct: 265 RLLIDHDPNKRPGARTLLNSGWL 287

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  141 bits (358), Expect = 7e-39
 Identities = 55/162 (33%), Positives = 85/162 (52%), Gaps = 25/162 (15%)

Query: 93  VAIKKIAR--------PFQSAVHAKRTYRE---LRMLKHMNHENVIGLLDVFHSNTCLAD 141
           VA+K++ R        P  S +      RE   LR L+   H NV+ L DV   +    +
Sbjct: 40  VALKRV-RVQTGEEGMPL-STI------REVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 91

Query: 142 FKNVYMVTHLMGADLNNILRTQK---LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSN 198
            K + +V   +  DL   L       +  + ++ +++Q+LRGL ++HS  ++HRDLKP N
Sbjct: 92  TK-LTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQN 150

Query: 199 IAVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIML 238
           I V    ++K+ DFGLAR    +  +T  V T WYRAPE++L
Sbjct: 151 ILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 192

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  137 bits (348), Expect = 2e-37
 Identities = 50/182 (27%), Positives = 77/182 (42%), Gaps = 31/182 (17%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARP--TENEMTGYVATRWYRAPEIMLN---------W- 301
           DLKP NI V    ++K+ DFGLAR    +  +T  V T WYRAPE++L          W 
Sbjct: 145 DLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWS 204

Query: 302 -------MHYNQ------TDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKK 348
                  M   +      +D+ QL  I++++G P  E   +  +    +   +    + +
Sbjct: 205 VGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA--LPRQ--AFHSKSAQ 260

Query: 349 DFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQ--YSDPNDEPTSPPYDQS 406
              +     +    DLL   L  +  KRI+A  AL+HPY         N +   PP   +
Sbjct: 261 PIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKENLDSHLPPSQNT 320

Query: 407 FE 408
            E
Sbjct: 321 SE 322

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  140 bits (356), Expect = 8e-39
 Identities = 61/329 (18%), Positives = 108/329 (32%), Gaps = 69/329 (20%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
           A + V     AIK+I  P    +  ++  RE++ L  + H  ++   + +         +
Sbjct: 24  AKNKVDDCNYAIKRIRLP-NRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82

Query: 144 NVYMVTHL---M----GADLNNILRTQK----LSDDHVQFLVYQILRGLKYIHSAGIIHR 192
                 +L   M      +L + +  +             +  QI   ++++HS G++HR
Sbjct: 83  PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHR 142

Query: 193 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYF 252
           DLKPSNI    D  +K+ DFGL                                      
Sbjct: 143 DLKPSNIFFTMDDVVKVGDFGLVT------------------------------------ 166

Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQL 312
                   A+++D E +        P     TG V T+ Y +PE +    + ++ DI  L
Sbjct: 167 --------AMDQDEEEQ--TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSL 216

Query: 313 NLIM-EMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLEL 371
            LI+ E+L     +     +    R             F  +F    P    ++  ML  
Sbjct: 217 GLILFELLYPFSTQMERVRTLTDVRNLK----------FPPLFTQKYPCEYVMVQDMLSP 266

Query: 372 DSEKRITAEQALAHPYLSQYSDPNDEPTS 400
              +R  A   + +        P      
Sbjct: 267 SPMERPEAINIIENAVFEDLDFPGKTVLR 295

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  141 bits (358), Expect = 8e-39
 Identities = 60/334 (17%), Positives = 108/334 (32%), Gaps = 88/334 (26%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNH--ENVIGLLDVFHSNTCLADFKNVY 146
                AIK +               E+  L  +    + +I L D   ++      + +Y
Sbjct: 32  KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD------QYIY 85

Query: 147 MVTHLMGADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
           MV      DLN+ L+  + +     +     +L  +  IH  GI+H DLKP+N  + +  
Sbjct: 86  MVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM 145

Query: 206 ELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNED 265
            LK++DFG+A   + + T               + +  +Q G   Y              
Sbjct: 146 -LKLIDFGIANQMQPDTT---------------SVVKDSQVGTVNY-------------- 175

Query: 266 CELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNL----------- 314
                            M           PE + +     +    +  +           
Sbjct: 176 -----------------M----------PPEAIKDMSSSRENGKSKSKISPKSDVWSLGC 208

Query: 315 IM-EML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF-KGANPQAIDLLSLMLEL 371
           I+  M  G  P  F   I+  S    I         +    F         D+L   L+ 
Sbjct: 209 ILYYMTYGKTP--FQQIINQISKLHAI------IDPNHEIEFPDIPEKDLQDVLKCCLKR 260

Query: 372 DSEKRITAEQALAHPYLSQYSDPNDEPTSPPYDQ 405
           D ++RI+  + LAHPY+   + P ++      ++
Sbjct: 261 DPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEE 294

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  142 bits (360), Expect = 7e-38
 Identities = 77/352 (21%), Positives = 139/352 (39%), Gaps = 81/352 (23%)

Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKIA-RPFQSAVHAKRTYRELRMLKHMNHEN 125
                L K SF  +     D ++G + A+K I+ R  +     +   RE+++LK ++H N
Sbjct: 29  KGQRVLGKGSFGEVIL-CKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87

Query: 126 VIGLLDVFHSNTCLADFKNVYMVTHLM-GADL-NNILRTQKLSDDHVQFLVYQILRGLKY 183
           ++ L + F       D    Y+V  +  G +L + I+  ++ S+     ++ Q+L G+ Y
Sbjct: 88  IMKLYEFFE------DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITY 141

Query: 184 IHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHY 243
           +H   I+HRDLK                                      PE   N +  
Sbjct: 142 MHKNKIVHRDLK--------------------------------------PE---NLLLE 160

Query: 244 NQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENE--MTGYVATRWYRAPEIMLNW 301
           ++                 ++D  ++I+DFGL+   E    M   + T +Y APE++   
Sbjct: 161 SK-----------------SKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG- 202

Query: 302 MHYNQT-DIHQLNLIMEML--GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGAN 358
             Y++  D+    +I+ +L  G PP  F      D  +K            +++V    +
Sbjct: 203 -TYDEKCDVWSTGVILYILLSGCPP--FNGANEYDILKKVEKGKYTFELPQWKKV----S 255

Query: 359 PQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPPYDQSFEDM 410
             A DL+  ML      RI+A  AL H ++  Y+        P  D +  ++
Sbjct: 256 ESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNI 307

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  140 bits (354), Expect = 9e-38
 Identities = 61/334 (18%), Positives = 107/334 (32%), Gaps = 88/334 (26%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNH--ENVIGLLDVFHSNTCLADFKNVY 146
                AIK +               E+  L  +    + +I L D   ++      + +Y
Sbjct: 79  KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD------QYIY 132

Query: 147 MVTHLMGADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
           MV      DLN+ L+  + +     +     +L  +  IH  GI+H DLKP+N  + +  
Sbjct: 133 MVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM 192

Query: 206 ELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNED 265
            LK++DFG+A   + + T  V                 +Q G   Y              
Sbjct: 193 -LKLIDFGIANQMQPDTTSVVKD---------------SQVGAVNY-------------- 222

Query: 266 CELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNL----------- 314
                            M           PE + +     +    +  +           
Sbjct: 223 -----------------M----------PPEAIKDMSSSRENGKSKSKISPKSDVWSLGC 255

Query: 315 IM-EML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF-KGANPQAIDLLSLMLEL 371
           I+  M  G  P  F   I+  S    I         +    F         D+L   L+ 
Sbjct: 256 ILYYMTYGKTP--FQQIINQISKLHAI------IDPNHEIEFPDIPEKDLQDVLKCCLKR 307

Query: 372 DSEKRITAEQALAHPYLSQYSDPNDEPTSPPYDQ 405
           D ++RI+  + LAHPY+   + P ++      ++
Sbjct: 308 DPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEE 341

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  141 bits (357), Expect = 2e-37
 Identities = 81/347 (23%), Positives = 143/347 (41%), Gaps = 80/347 (23%)

Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENV 126
                L   ++  +     D V+ V+ AIK I +   S     +   E+ +LK ++H N+
Sbjct: 40  QRVKKLGSGAYGEVLL-CRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98

Query: 127 IGLLDVFHSNTCLADFKNVYMVTHLM-GADL-NNILRTQKLSDDHVQFLVYQILRGLKYI 184
           + L D F       D +N Y+V     G +L + I+   K ++     ++ Q+L G+ Y+
Sbjct: 99  MKLYDFFE------DKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYL 152

Query: 185 HSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYN 244
           H   I+HRDLK                                      PE   N +  +
Sbjct: 153 HKHNIVHRDLK--------------------------------------PE---NLLLES 171

Query: 245 QTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENE--MTGYVATRWYRAPEIMLNWM 302
           +                  +D  +KI+DFGL+   EN+  M   + T +Y APE++    
Sbjct: 172 K-----------------EKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK-- 212

Query: 303 HYNQT-DIHQLNLIMEML--GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANP 359
            Y++  D+  + +I+ +L  G PP  F  +   +  RK           +++ V    + 
Sbjct: 213 KYDEKCDVWSIGVILFILLAGYPP--FGGQTDQEILRKVEKGKYTFDSPEWKNV----SE 266

Query: 360 QAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPPYDQS 406
            A DL+  ML+ DS++RI+A+QAL HP++ +     +     P   +
Sbjct: 267 GAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLAN 313

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  140 bits (355), Expect = 3e-37
 Identities = 80/347 (23%), Positives = 140/347 (40%), Gaps = 80/347 (23%)

Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENV 126
           +I   L K SF  +     D ++  + A+K I +            RE+ +LK ++H N+
Sbjct: 25  NIVCMLGKGSFGEVLK-CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 127 IGLLDVFHSNTCLADFKNVYMVTHLM-GADL-NNILRTQKLSDDHVQFLVYQILRGLKYI 184
           + L ++        D  + Y+V  L  G +L + I++ ++ S+     ++ Q+  G+ Y+
Sbjct: 84  MKLFEILE------DSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137

Query: 185 HSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYN 244
           H   I+HRDLK                                      PE   N +  +
Sbjct: 138 HKHNIVHRDLK--------------------------------------PE---NILLES 156

Query: 245 QTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENE--MTGYVATRWYRAPEIMLNWM 302
           +                  +DC++KI+DFGL+   +    M   + T +Y APE++    
Sbjct: 157 K-----------------EKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-- 197

Query: 303 HYNQT-DIHQLNLIMEML--GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANP 359
            Y++  D+    +I+ +L  GTPP  F  K   D  ++            +R +    + 
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPP--FYGKNEYDILKRVETGKYAFDLPQWRTI----SD 251

Query: 360 QAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPPYDQS 406
            A DL+  ML      RITA Q L HP++ +YS      +  P  +S
Sbjct: 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLES 298

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  137 bits (346), Expect = 6e-37
 Identities = 56/358 (15%), Positives = 114/358 (31%), Gaps = 105/358 (29%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYR-----ELRMLKHMNHE-----NVIGLLDVF 133
                +    A+K + R         + Y      E  +LK + ++     N++     F
Sbjct: 54  CQHIDNKKYYAVK-VVR-------NIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF 105

Query: 134 HSNTCLADFKN-VYMVTHLMGADLNNILRTQK---LSDDHVQFLVYQILRGLKYIHSAGI 189
                   + + + ++   +G  L  I+          + ++    +IL+ L Y+    +
Sbjct: 106 -------MYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSL 158

Query: 190 IHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVP 249
            H DLKP NI +++    K L          ++  Y                        
Sbjct: 159 THTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS-------------------- 198

Query: 250 FYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQ--- 306
                             +K++DFG A    +     + TR YRAPE++LN + ++    
Sbjct: 199 ----------------TGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILN-LGWDVSSD 241

Query: 307 ---------------------TDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLL 345
                                  +  L ++  ++   P   + + +  +  KY+N   L 
Sbjct: 242 MWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELK 301

Query: 346 --------TKKDFRQVFKG-------ANPQAIDLLSLMLELDSEKRITAEQALAHPYL 388
                   +    + V K         +    D L  +L++D   R +  + L H +L
Sbjct: 302 LAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  135 bits (343), Expect = 2e-36
 Identities = 77/376 (20%), Positives = 133/376 (35%), Gaps = 121/376 (32%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYR-----ELRMLKHMN-----------HENVI 127
           A D V+   VA+K I R         + Y      E+++L+ +N             +++
Sbjct: 38  AKDMVNNTHVAMK-IVR-------GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHIL 89

Query: 128 GLLDVFHSNTCLADFKNVY-----MVTHLMGADLNNILRT---QKLSDDHVQFLVYQILR 179
            LLD F       + K        MV  ++G +L  +++    + +   +V+ +  Q+L 
Sbjct: 90  KLLDHF-------NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 142

Query: 180 GLKYIHS-AGIIHRDLKPSNIAVNE------DCELKILDFGLARPTENEMTGYVATRWYR 232
           GL Y+H   GIIH D+KP N+ +          ++KI D G A   +   T  + TR YR
Sbjct: 143 GLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 202

Query: 233 APEIMLNWMHYNQ---------------TGVPFYFQDLKPSNIAVNEDCELKILDFGLAR 277
           +PE++L    +                 TG    F+  +  +   ++D            
Sbjct: 203 SPEVLLG-APWGCGADIWSTACLIFELITGDFL-FEPDEGHSYTKDDD------------ 248

Query: 278 PTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAK-------I 330
                                +  +             +E+LG  P+  +          
Sbjct: 249 --------------------HIAQI-------------IELLGELPSYLLRNGKYTRTFF 275

Query: 331 SSDSARKYINSLPLLTKKD----FRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHP 386
           +S    + I+ L     +D      +  K    +  D LS ML+LD  KR  A   + HP
Sbjct: 276 NSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHP 335

Query: 387 YLSQYSDPNDEPTSPP 402
           +L        E    P
Sbjct: 336 WLKD--TLGMEEIRVP 349

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  136 bits (344), Expect = 1e-35
 Identities = 80/362 (22%), Positives = 137/362 (37%), Gaps = 91/362 (25%)

Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKIAR-----------PFQSAVHAKRTYREL 115
                L   ++  +     +     + AIK I +                   +  Y E+
Sbjct: 39  FKVRKLGSGAYGEVLL-CKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97

Query: 116 RMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADL-NNILRTQKLSDDHVQFL 173
            +LK ++H N+I L DVF       D K  Y+VT    G +L   I+   K  +     +
Sbjct: 98  SLLKSLDHPNIIKLFDVFE------DKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI 151

Query: 174 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRA 233
           + QIL G+ Y+H   I+HRD+K                                      
Sbjct: 152 MKQILSGICYLHKHNIVHRDIK-------------------------------------- 173

Query: 234 PEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLAR--PTENEMTGYVATRW 291
           PE   N +  N+                 N    +KI+DFGL+     + ++   + T +
Sbjct: 174 PE---NILLENK-----------------NSLLNIKIVDFGLSSFFSKDYKLRDRLGTAY 213

Query: 292 YRAPEIMLNWMHYNQT-DIHQLNLIMEML--GTPPAEFMAKISSDSARKYINSLPLLTKK 348
           Y APE++     YN+  D+    +IM +L  G PP  F  +   D  +K           
Sbjct: 214 YIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPP--FGGQNDQDIIKKVEKGKYYFDFN 269

Query: 349 DFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPPYDQSFE 408
           D++ +    + +A +L+ LML  D  KR TAE+AL   ++ +Y++  ++        +  
Sbjct: 270 DWKNI----SDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALS 325

Query: 409 DM 410
           +M
Sbjct: 326 NM 327

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  130 bits (328), Expect = 6e-35
 Identities = 78/334 (23%), Positives = 136/334 (40%), Gaps = 80/334 (23%)

Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENV 126
           +I   L K SF  +     D ++  + A+K I +            RE+ +LK ++H N+
Sbjct: 25  NIVCMLGKGSFGEVLK-CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 127 IGLLDVFHSNTCLADFKNVYMVTHLM-GADL-NNILRTQKLSDDHVQFLVYQILRGLKYI 184
           + L ++        D  + Y+V  L  G +L + I++ ++ S+     ++ Q+  G+ Y+
Sbjct: 84  MKLFEILE------DSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137

Query: 185 HSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYN 244
           H   I+HRDLK                                      PE   N +  +
Sbjct: 138 HKHNIVHRDLK--------------------------------------PE---NILLES 156

Query: 245 QTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENE--MTGYVATRWYRAPEIMLNWM 302
           +                  +DC++KI+DFGL+   +    M   + T +Y APE++    
Sbjct: 157 K-----------------EKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-- 197

Query: 303 HYNQT-DIHQLNLIMEML--GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANP 359
            Y++  D+    +I+ +L  GTPP  F  K   D  ++            +R +    + 
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPP--FYGKNEYDILKRVETGKYAFDLPQWRTI----SD 251

Query: 360 QAIDLLSLMLELDSEKRITAEQALAHPYLSQYSD 393
            A DL+  ML      RITA Q L HP++ +YS 
Sbjct: 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  131 bits (331), Expect = 7e-35
 Identities = 71/368 (19%), Positives = 129/368 (35%), Gaps = 119/368 (32%)

Query: 84  ALDSVSGVK-VAIKKIARPFQSAVHAKRTYR-----ELRMLKHMNHE------NVIGLLD 131
            +D  +G + VA+K I +           Y      E+++L+H+N          + +L+
Sbjct: 33  CIDHKAGGRHVAVK-IVK-------NVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLE 84

Query: 132 VFHSNTCLADFKN-VYMVTHLMGADLNNILRTQK---LSDDHVQFLVYQILRGLKYIHSA 187
            F       +    + +V  L+G    + ++         DH++ + YQI + + ++HS 
Sbjct: 85  WF-------EHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN 137

Query: 188 GIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTG 247
            + H DLKP                      EN               I+     Y +  
Sbjct: 138 KLTHTDLKP----------------------EN---------------ILFVQSDYTEAY 160

Query: 248 VPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQ- 306
            P         +     + ++K++DFG A   +   +  V+TR YRAPE++L  + ++Q 
Sbjct: 161 NPK-----IKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILA-LGWSQP 214

Query: 307 -----------------------TDIHQLNLIMEMLGTPPAEFMAKIS------------ 331
                                       L ++  +LG  P   + K              
Sbjct: 215 CDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDW 274

Query: 332 --SDSARKYINSLPLLTKKDFRQVFKGANP---QAIDLLSLMLELDSEKRITAEQALAHP 386
               SA +Y++       K  ++     +    +  DL+  MLE D  KRIT  +AL HP
Sbjct: 275 DEHSSAGRYVSR----ACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHP 330

Query: 387 YLSQYSDP 394
           +       
Sbjct: 331 FFDLLKKS 338

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  131 bits (331), Expect = 8e-35
 Identities = 74/379 (19%), Positives = 127/379 (33%), Gaps = 118/379 (31%)

Query: 84  ALDSVSG-VKVAIKKIARPFQSAVHAKRTYR-----ELRMLKHMNHE------NVIGLLD 131
            LD   G  +VA+K I R           YR     E+ +LK +  +        + + D
Sbjct: 38  CLDHARGKSQVALK-IIR-------NVGKYREAARLEINVLKKIKEKDKENKFLCVLMSD 89

Query: 132 VFHSNTCLADFKN-VYMVTHLMGADLNNILRTQK---LSDDHVQFLVYQILRGLKYIHSA 187
            F       +F   + +   L+G +    L+          HV+ + YQ+   L+++H  
Sbjct: 90  WF-------NFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN 142

Query: 188 GIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTG 247
            + H DLKP NI         + +   +   ++                           
Sbjct: 143 QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV-------------------------- 176

Query: 248 VPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQ- 306
                           ++  +++ DFG A       T  VATR YR PE++L  + + Q 
Sbjct: 177 ----------------KNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILE-LGWAQP 219

Query: 307 -----------------------TDIHQLNLIMEMLGTPPAEFMAK-------------- 329
                                   +   L ++ ++LG  P+  + +              
Sbjct: 220 CDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVW 279

Query: 330 --ISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPY 387
              SSD      N  PL   K +       + Q  DL+  MLE D  +RIT  +AL HP+
Sbjct: 280 DENSSDGRYVKENCKPL---KSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPF 336

Query: 388 LSQYSDPNDEPTSPPYDQS 406
            +  + P +       + S
Sbjct: 337 FAGLT-PEERSFHTSRNPS 354

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  131 bits (331), Expect = 1e-34
 Identities = 86/414 (20%), Positives = 148/414 (35%), Gaps = 148/414 (35%)

Query: 49  RLHDHFNQPYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHA 108
           +  + +   Y      +  +   + K SF  +   A D V    VAIK I +        
Sbjct: 47  KNGEKWMDRYE-----IDSL---IGKGSFGQVVK-AYDRVEQEWVAIK-IIK-------N 89

Query: 109 KRTYR-----ELRMLKHMNHE------NVIGLLDVFHSNTCLADFKN-VYMVTHLMGADL 156
           K+ +      E+R+L+ MN         ++ L   F        F+N + +V  ++  +L
Sbjct: 90  KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF-------MFRNHLCLVFEMLSYNL 142

Query: 157 NNILRTQK---LSDDHVQFLVYQILRGLKYIHS--AGIIHRDLKPSNIAV--NEDCELKI 209
            ++LR      +S +  +    Q+   L ++ +    IIH DLKP NI +   +   +KI
Sbjct: 143 YDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKI 202

Query: 210 LDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQ---------------TGVPFYFQD 254
           +DFG +      +  Y+ +R+YR+PE++L  M Y+                TG P +   
Sbjct: 203 VDFGSSCQLGQRIYQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLF--- 258

Query: 255 LKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNL 314
                                     NE+                           Q+N 
Sbjct: 259 -----------------------SGANEV--------------------------DQMNK 269

Query: 315 IMEMLGTPPAEFMAKISSDSARKYINSLP-----LLTKKDFRQVFKGANPQA-------- 361
           I+E+LG PPA  + +  +  ARK+   LP     L   KD ++ +K    +         
Sbjct: 270 IVEVLGIPPAHILDQ--APKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVE 327

Query: 362 ----------------------IDLLSLMLELDSEKRITAEQALAHPYLSQYSD 393
                                  DL+  ML+ D + RI    AL H +  + +D
Sbjct: 328 TGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  131 bits (330), Expect = 4e-34
 Identities = 74/357 (20%), Positives = 119/357 (33%), Gaps = 103/357 (28%)

Query: 86  DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLADFKN 144
            S  G  VA+K++   F           E+++L    +H NVI       ++      + 
Sbjct: 35  GSFQGRPVAVKRMLIDFCDIA-----LMEIKLLTESDDHPNVIRYYCSETTD------RF 83

Query: 145 VYMVTHLMGADLNNIL--------RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKP 196
           +Y+   L   +L +++          +   + +   L+ QI  G+ ++HS  IIHRDLKP
Sbjct: 84  LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKP 143

Query: 197 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLK 256
            NI V+                                                      
Sbjct: 144 QNILVSTS------------------------------------------------SRFT 155

Query: 257 PSNIAVNEDCELKILDFGLAR-------PTENEMTGYVATRWYRAPEIMLNWMHYNQT-- 307
                  E+  + I DFGL +            +     T  +RAPE++    +      
Sbjct: 156 ADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRR 215

Query: 308 -----DIHQLNLIM-EML--GTPPAEFMAKISSDSA-RKYINSLPLLTKKDFRQVFKGAN 358
                DI  +  +   +L  G  P  F  K S +S   + I SL  +     R +     
Sbjct: 216 LTRSIDIFSMGCVFYYILSKGKHP--FGDKYSRESNIIRGIFSLDEMKCLHDRSL----I 269

Query: 359 PQAIDLLSLMLELDSEKRITAEQALAHPY-------LSQYSDPND----EPTSPPYD 404
            +A DL+S M++ D  KR TA + L HP        L      +D    E   PP  
Sbjct: 270 AEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLLKVSDRLEIENRDPPSA 326

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  129 bits (327), Expect = 9e-34
 Identities = 61/242 (25%), Positives = 107/242 (44%), Gaps = 32/242 (13%)

Query: 17  GRLLSRTLTDG---TLSRSIVRLWTVYPASKLPSRRLHDHFNQPYSEICRGVIDIGPTLS 73
           G+   R L +     LS S  +++  +  +              Y         +  TL 
Sbjct: 93  GKGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEY--------IMSKTLG 144

Query: 74  KESFDLIFSSALDSVSGVKVAIKKIAR------PFQSAVHAKRTYRELRMLKHMNHENVI 127
             +   +   A +  +  KVAI+ I++        + A  A     E+ +LK +NH  +I
Sbjct: 145 SGACGEVKL-AFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII 203

Query: 128 GLLDVFHSNTCLADFKNVYMVTHLM-GADL-NNILRTQKLSDDHVQFLVYQILRGLKYIH 185
            + + F       D ++ Y+V  LM G +L + ++  ++L +   +   YQ+L  ++Y+H
Sbjct: 204 KIKNFF-------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH 256

Query: 186 SAGIIHRDLKPSNIAV---NEDCELKILDFGLARPTENE--MTGYVATRWYRAPEIMLNW 240
             GIIHRDLKP N+ +    EDC +KI DFG ++       M     T  Y APE++++ 
Sbjct: 257 ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSV 316

Query: 241 MH 242
             
Sbjct: 317 GT 318

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 44/164 (26%), Positives = 69/164 (42%), Gaps = 37/164 (22%)

Query: 254 DLKPSNIAV---NEDCELKILDFGLARPTENE--MTGYVATRWYRAPEIMLNWMH--YNQ 306
           DLKP N+ +    EDC +KI DFG ++       M     T  Y APE++++     YN+
Sbjct: 264 DLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNR 323

Query: 307 T-DIHQLNLIMEML--GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGA------ 357
             D   L +I+ +   G PP  F    S    +  +            Q+  G       
Sbjct: 324 AVDCWSLGVILFICLSGYPP--F----SEHRTQVSL----------KDQITSGKYNFIPE 367

Query: 358 -----NPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPND 396
                + +A+DL+  +L +D + R T E+AL HP+L        
Sbjct: 368 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRK 411

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  125 bits (316), Expect = 3e-33
 Identities = 75/329 (22%), Positives = 125/329 (37%), Gaps = 95/329 (28%)

Query: 89  SGVKVAIKKIA----RPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN 144
           +G + A K I        +  V  +   RE+ +L+ + H N+I L D+F + T      +
Sbjct: 29  TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT------D 82

Query: 145 VYMVTHLM-GADL-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
           V ++  L+ G +L + +   + L++D     + QIL G+ Y+HS  I H DLKP      
Sbjct: 83  VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKP------ 136

Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
                           EN               IML     ++                 
Sbjct: 137 ----------------EN---------------IML----LDKNV--------------- 146

Query: 263 NEDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIMLNWMHYN-QTDIHQLNLIMEML 319
             +  +K++DFG+A      NE      T  + APEI +N+     + D+  + +I  +L
Sbjct: 147 -PNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVITYIL 204

Query: 320 --GTPP------AEFMAKISSDSARKYINSLPLLTKKDF-RQVFKGANPQAIDLLSLMLE 370
             G  P       E +  IS   A  Y          DF  + F   +  A D +  +L 
Sbjct: 205 LSGASPFLGETKQETLTNIS---AVNY----------DFDEEYFSNTSELAKDFIRRLLV 251

Query: 371 LDSEKRITAEQALAHPYLSQYSDPNDEPT 399
            D ++R+T  Q+L H ++      N    
Sbjct: 252 KDPKRRMTIAQSLEHSWIKAIRRRNVRGE 280

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  125 bits (315), Expect = 7e-33
 Identities = 55/320 (17%), Positives = 95/320 (29%), Gaps = 60/320 (18%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
                +G   AIK                RE  +LK +NH+N++ L  +    T     +
Sbjct: 28  GRHKKTGDLFAIKVFNNI-SFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT----R 82

Query: 144 NVYMVTHLM-GADLNNIL----RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSN 198
           +  ++        L  +L        L +     ++  ++ G+ ++   GI+HR++KP N
Sbjct: 83  HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGN 142

Query: 199 I----AVNEDCELKILDFGLARPTENE--MTGYVATRWYRAPEIMLNWMHYNQTGVPFYF 252
           I      +     K+ DFG AR  E++        T  Y  P++                
Sbjct: 143 IMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY--------ERAVLRK 194

Query: 253 QDLKPSNIAVNED-----CELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT 307
              K     V  D                       TG +  R +  P      M+   T
Sbjct: 195 DHQKKYGATV--DLWSIGVTFYHA-----------ATGSLPFRPFEGPRRNKEVMYKIIT 241

Query: 308 -DIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLS 366
                    ++     P ++   +          SL    +     V             
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMP------VSCSLSRGLQVLLTPVLAN---------- 285

Query: 367 LMLELDSEKRITAEQALAHP 386
            +LE D EK    +Q  A  
Sbjct: 286 -ILEADQEKCWGFDQFFAET 304

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  124 bits (313), Expect = 7e-33
 Identities = 77/334 (23%), Positives = 128/334 (38%), Gaps = 84/334 (25%)

Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENV 126
                L   +F  +     +  SG++  IK I +  +S V  ++   E+ +LK ++H N+
Sbjct: 25  IFKRKLGSGAFGDVHL-VEERSSGLERVIKTINKD-RSQVPMEQIEAEIEVLKSLDHPNI 82

Query: 127 IGLLDVFHSNTCLADFKNVYMVTHLM-GADL-----NNILRTQKLSDDHVQFLVYQILRG 180
           I + +VF       D+ N+Y+V     G +L     +   R + LS+ +V  L+ Q++  
Sbjct: 83  IKIFEVF------EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA 136

Query: 181 LKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW 240
           L Y HS  ++H+DLK                                      PE   N 
Sbjct: 137 LAYFHSQHVVHKDLK--------------------------------------PE---NI 155

Query: 241 MHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIM 298
           +  +                  +    +KI+DFGLA    ++   T    T  Y APE+ 
Sbjct: 156 LFQDT-----------------SPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV- 197

Query: 299 LNWMHYNQTDIHQLNLIMEML--GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKG 356
                  + DI    ++M  L  G  P  F      +  +K         + ++    + 
Sbjct: 198 FKRDVTFKCDIWSAGVVMYFLLTGCLP--FTGTSLEEVQQKATYK-----EPNYAVECRP 250

Query: 357 ANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQ 390
             PQA+DLL  ML  D E+R +A Q L H +  Q
Sbjct: 251 LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  124 bits (312), Expect = 2e-32
 Identities = 61/329 (18%), Positives = 107/329 (32%), Gaps = 73/329 (22%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
                 G   A+K+I    Q      +  RE  M +  NH N++ L+             
Sbjct: 48  VEGLHDGHFYALKRILCHEQQDREEAQ--READMHRLFNHPNILRLVAYCLRER--GAKH 103

Query: 144 NVYMVTHLM-GADLNNILRTQK-----LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPS 197
             +++        L N +   K     L++D + +L+  I RGL+ IH+ G  HRDLKP+
Sbjct: 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPT 163

Query: 198 NIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
           NI + ++ +  ++D G        + G        + + +       Q            
Sbjct: 164 NILLGDEGQPVLMDLGSMNQACIHVEG--------SRQALTLQDWAAQRCTIS------- 208

Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHY---NQTDIHQLNL 314
                                             YRAPE+     H     +TD+  L  
Sbjct: 209 ----------------------------------YRAPELFSVQSHCVIDERTDVWSLGC 234

Query: 315 IM-EML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQ-VFKGANPQAIDLLSLMLEL 371
           ++  M+ G  P  +      D   +  +S+ L  +           +     LL+ M+ +
Sbjct: 235 VLYAMMFGEGP--Y------DMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTV 286

Query: 372 DSEKRITAEQALAHPYLSQYSDPNDEPTS 400
           D  +R      L+     Q   P    T 
Sbjct: 287 DPHQRPHIPLLLSQLEALQPPAPGQHTTQ 315

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  123 bits (310), Expect = 2e-32
 Identities = 52/322 (16%), Positives = 104/322 (32%), Gaps = 77/322 (23%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLADF 142
            +  + G   AIK+  +P   +V  +   RE+     +  H +V+     +  +  +   
Sbjct: 30  CVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM--- 86

Query: 143 KNVYMVTHLM-GADLNNILRTQK-----LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKP 196
               +      G  L + +           +  ++ L+ Q+ RGL+YIHS  ++H D+KP
Sbjct: 87  ---LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKP 143

Query: 197 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLK 256
           SNI ++                                             +P    +  
Sbjct: 144 SNIFISRT------------------------------------------SIPNAASEEG 161

Query: 257 PSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQ-TDIHQLNL- 314
             +   +     KI D G      +          + A E++     +    DI  L L 
Sbjct: 162 DEDDWASNKVMFKIGDLGHVTRISSPQV-EEGDSRFLANEVLQENYTHLPKADIFALALT 220

Query: 315 IMEMLGTPPA----EFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLE 370
           ++   G  P     +   +I                +    ++ +  + +  +LL +M+ 
Sbjct: 221 VVCAAGAEPLPRNGDQWHEI---------------RQGRLPRIPQVLSQEFTELLKVMIH 265

Query: 371 LDSEKRITAEQALAHPYLSQYS 392
            D E+R +A   + H  L   S
Sbjct: 266 PDPERRPSAMALVKHSVLLSAS 287

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  122 bits (309), Expect = 6e-32
 Identities = 52/169 (30%), Positives = 88/169 (52%), Gaps = 20/169 (11%)

Query: 84  ALDSVSGVKVAIKKIAR------PFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNT 137
           A +  +  KVAIK I++        + A  A     E+ +LK +NH  +I + + F +  
Sbjct: 29  AFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 86

Query: 138 CLADFKNVYMVTHLM-GADL-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLK 195
                ++ Y+V  LM G +L + ++  ++L +   +   YQ+L  ++Y+H  GIIHRDLK
Sbjct: 87  -----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLK 141

Query: 196 PSNI---AVNEDCELKILDFGLARPTENE--MTGYVATRWYRAPEIMLN 239
           P N+   +  EDC +KI DFG ++       M     T  Y APE++++
Sbjct: 142 PENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVS 190

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 44/164 (26%), Positives = 69/164 (42%), Gaps = 37/164 (22%)

Query: 254 DLKPSNI---AVNEDCELKILDFGLARPTENE--MTGYVATRWYRAPEIMLNWMH--YNQ 306
           DLKP N+   +  EDC +KI DFG ++       M     T  Y APE++++     YN+
Sbjct: 139 DLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNR 198

Query: 307 T-DIHQLNLIMEML--GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGA------ 357
             D   L +I+ +   G PP  F    S    +  +            Q+  G       
Sbjct: 199 AVDCWSLGVILFICLSGYPP--F----SEHRTQVSL----------KDQITSGKYNFIPE 242

Query: 358 -----NPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPND 396
                + +A+DL+  +L +D + R T E+AL HP+L        
Sbjct: 243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRK 286

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  122 bits (308), Expect = 8e-32
 Identities = 75/332 (22%), Positives = 130/332 (39%), Gaps = 95/332 (28%)

Query: 89  SGVKVAIKKIA----RPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN 144
           +G++ A K I     R  +  V  +   RE+ +L+ + H NVI L DV+ + T      +
Sbjct: 36  TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT------D 89

Query: 145 VYMVTHLM-GADL-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
           V ++  L+ G +L + + + + LS++     + QIL G+ Y+H+  I H DLKP      
Sbjct: 90  VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKP------ 143

Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
                           EN               IML     ++                 
Sbjct: 144 ----------------EN---------------IML----LDKNI--------------- 153

Query: 263 NEDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIMLNWMHYN-QTDIHQLNLIMEML 319
                +K++DFGLA       E      T  + APEI +N+     + D+  + +I  +L
Sbjct: 154 -PIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVITYIL 211

Query: 320 --GTPP------AEFMAKISSDSARKYINSLPLLTKKDF-RQVFKGANPQAIDLLSLMLE 370
             G  P       E +A I+   +  Y          DF  + F   +  A D +  +L 
Sbjct: 212 LSGASPFLGDTKQETLANIT---SVSY----------DFDEEFFSHTSELAKDFIRKLLV 258

Query: 371 LDSEKRITAEQALAHPYLSQYSDPNDEPTSPP 402
            ++ KR+T ++AL HP+++   +         
Sbjct: 259 KETRKRLTIQEALRHPWITPVDNQQAMVRRES 290

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  121 bits (305), Expect = 2e-31
 Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 16/185 (8%)

Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENV 126
                L   +F  +F      ++G   A+K I +    A        E+ +LK + HEN+
Sbjct: 12  IFMEVLGSGAFSEVFL-VKQRLTGKLFALKCIKK--SPAFRDSSLENEIAVLKKIKHENI 68

Query: 127 IGLLDVFHSNTCLADFKNVYMVTHLM-GADL-NNILRTQKLSDDHVQFLVYQILRGLKYI 184
           + L D++ S        + Y+V  L+ G +L + IL     ++     ++ Q+L  +KY+
Sbjct: 69  VTLEDIYEST------THYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYL 122

Query: 185 HSAGIIHRDLKPSNIAV---NEDCELKILDFGLARPTENE-MTGYVATRWYRAPEIMLNW 240
           H  GI+HRDLKP N+      E+ ++ I DFGL++  +N  M+    T  Y APE+ L  
Sbjct: 123 HENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEV-LAQ 181

Query: 241 MHYNQ 245
             Y++
Sbjct: 182 KPYSK 186

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 78.0 bits (193), Expect = 3e-16
 Identities = 41/156 (26%), Positives = 69/156 (44%), Gaps = 28/156 (17%)

Query: 254 DLKPSNIAV---NEDCELKILDFGLARPTENE-MTGYVATRWYRAPEIMLNWMHYNQT-D 308
           DLKP N+      E+ ++ I DFGL++  +N  M+    T  Y APE+ L    Y++  D
Sbjct: 131 DLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEV-LAQKPYSKAVD 189

Query: 309 IHQLNLIMEML--GTPP------AEFMAKISSDSARKYINSLPLLTKKDF-RQVFKGANP 359
              + +I  +L  G PP      ++   KI                  +F    +   + 
Sbjct: 190 CWSIGVITYILLCGYPPFYEETESKLFEKI-------------KEGYYEFESPFWDDISE 236

Query: 360 QAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPN 395
            A D +  +LE D  +R T E+AL+HP++   +  +
Sbjct: 237 SAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALH 272

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  122 bits (308), Expect = 2e-31
 Identities = 76/328 (23%), Positives = 131/328 (39%), Gaps = 95/328 (28%)

Query: 89  SGVKVAIKKIA----RPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN 144
           +G++ A K I     R  +  V  +   RE+ +L+ + H N+I L DV+ + T      +
Sbjct: 36  TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT------D 89

Query: 145 VYMVTHLM-GADL-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
           V ++  L+ G +L + + + + LS++     + QIL G+ Y+H+  I H DLKP      
Sbjct: 90  VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKP------ 143

Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
                           EN               IML     ++                 
Sbjct: 144 ----------------EN---------------IML----LDKNI--------------- 153

Query: 263 NEDCELKILDFGLARPTEN--EMTGYVATRWYRAPEIMLNWMHYN-QTDIHQLNLIMEML 319
                +K++DFGLA   E+  E      T  + APEI +N+     + D+  + +I  +L
Sbjct: 154 -PIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVITYIL 211

Query: 320 --GTPP------AEFMAKISSDSARKYINSLPLLTKKDF-RQVFKGANPQAIDLLSLMLE 370
             G  P       E +A I+   A  Y          DF  + F   +  A D +  +L 
Sbjct: 212 LSGASPFLGDTKQETLANIT---AVSY----------DFDEEFFSQTSELAKDFIRKLLV 258

Query: 371 LDSEKRITAEQALAHPYLSQYSDPNDEP 398
            ++ KR+T ++AL HP+++         
Sbjct: 259 KETRKRLTIQEALRHPWITPVDTQQAMV 286

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  120 bits (304), Expect = 2e-31
 Identities = 50/217 (23%), Positives = 94/217 (43%), Gaps = 27/217 (12%)

Query: 43  SKLPSRRLHDHFNQPYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPF 102
           + LP       F + Y        +    L +    ++    +   +  + A+K I    
Sbjct: 4   AALPGSHSTHGFYENY--------EPKEILGRGVSSVVRR-CIHKPTCKEYAVKIIDVTG 54

Query: 103 QSAVHAKR-------TYRELRMLKHMN-HENVIGLLDVFHSNTCLADFKNVYMVTHLM-G 153
             +  A+        T +E+ +L+ ++ H N+I L D + +NT        ++V  LM  
Sbjct: 55  GGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT------FFFLVFDLMKK 108

Query: 154 ADL-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDF 212
            +L + +     LS+   + ++  +L  +  +H   I+HRDLKP NI +++D  +K+ DF
Sbjct: 109 GELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDF 168

Query: 213 GLAR--PTENEMTGYVATRWYRAPEIMLNWMHYNQTG 247
           G +       ++     T  Y APEI+   M+ N  G
Sbjct: 169 GFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPG 205

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 85.4 bits (212), Expect = 9e-19
 Identities = 44/155 (28%), Positives = 68/155 (43%), Gaps = 16/155 (10%)

Query: 254 DLKPSNIAVNEDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIMLNWMHYNQT---- 307
           DLKP NI +++D  +K+ DFG +       ++     T  Y APEI+   M+ N      
Sbjct: 149 DLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGK 208

Query: 308 --DIHQLNLIMEML--GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAID 363
             D+    +IM  L  G+PP  F  +      R  ++        ++       +    D
Sbjct: 209 EVDMWSTGVIMYTLLAGSPP--FWHRKQMLMLRMIMSGNYQFGSPEWDDY----SDTVKD 262

Query: 364 LLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEP 398
           L+S  L +  +KR TAE+ALAHP+  QY       
Sbjct: 263 LVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVRH 297

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  125 bits (315), Expect = 3e-31
 Identities = 62/323 (19%), Positives = 100/323 (30%), Gaps = 68/323 (21%)

Query: 88  VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYM 147
            +G +VAIK+  +   S  + +R   E++++K +NH NV+   +V      LA      +
Sbjct: 37  DTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLL 95

Query: 148 VTHLM-GADLNNIL----RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI--- 199
                 G DL   L        L +  ++ L+  I   L+Y+H   IIHRDLKP NI   
Sbjct: 96  AMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQ 155

Query: 200 AVNEDCELKILDFGLARPTENE--MTGYVATRWYRAPEIMLNWMHYNQT------GVPFY 251
              +    KI+D G A+  +     T +V T  Y APE++     Y  T      G   +
Sbjct: 156 PGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAF 214

Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
                                          +TG+        P               Q
Sbjct: 215 ------------------EC-----------ITGF-------RP-------FLPNWQPVQ 231

Query: 312 LNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLEL 371
            +  +             ++       +   P         +      +    L  ML  
Sbjct: 232 WHGKVREKSNEHIVVYDDLTGAVKFSSVLPTP-------NHLSGILAGKLERWLQCMLMW 284

Query: 372 DSEKRITAEQALAHPYLSQYSDP 394
              +R T  Q             
Sbjct: 285 HQRQRGTDPQNPNVGCFQALDSI 307

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  119 bits (300), Expect = 1e-30
 Identities = 38/161 (23%), Positives = 59/161 (36%), Gaps = 11/161 (6%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLADF 142
                 G   A+K+   PF+      R   E+   + +  H   + L   +     L   
Sbjct: 76  VRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL--- 132

Query: 143 KNVYMVTHLMGADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
              Y+ T L G  L          L +  V   +   L  L ++HS G++H D+KP+NI 
Sbjct: 133 ---YLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIF 189

Query: 201 VNEDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIMLN 239
           +      K+ DFGL     T            Y APE++  
Sbjct: 190 LGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG 230

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 72.0 bits (177), Expect = 3e-14
 Identities = 37/142 (26%), Positives = 52/142 (36%), Gaps = 18/142 (12%)

Query: 254 DLKPSNIAVNEDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIMLNWMHYNQ-TDIH 310
           D+KP+NI +      K+ DFGL     T            Y APE++     Y    D+ 
Sbjct: 182 DVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVF 239

Query: 311 QLNLIM-EMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF-KGANPQAIDLLSLM 368
            L L + E+                          L +      F  G + +   +L +M
Sbjct: 240 SLGLTILEVACNMELPHGG-----------EGWQQLRQGYLPPEFTAGLSSELRSVLVMM 288

Query: 369 LELDSEKRITAEQALAHPYLSQ 390
           LE D + R TAE  LA P L Q
Sbjct: 289 LEPDPKLRATAEALLALPVLRQ 310

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  118 bits (298), Expect = 1e-30
 Identities = 47/163 (28%), Positives = 79/163 (48%), Gaps = 14/163 (8%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           +G++ A K I     SA   ++  RE R+ + + H N++ L D     +        Y+V
Sbjct: 30  TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES------FHYLV 83

Query: 149 THLM-GADL-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NE 203
             L+ G +L  +I+  +  S+      + QIL  + Y HS GI+HR+LKP N+ +    +
Sbjct: 84  FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAK 143

Query: 204 DCELKILDFGLARPTENE--MTGYVATRWYRAPEIMLNWMHYN 244
              +K+ DFGLA    +     G+  T  Y +PE+ L    Y+
Sbjct: 144 GAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV-LKKDPYS 185

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 75.3 bits (186), Expect = 2e-15
 Identities = 40/147 (27%), Positives = 67/147 (45%), Gaps = 15/147 (10%)

Query: 254 DLKPSNIAV---NEDCELKILDFGLARPTENE--MTGYVATRWYRAPEIMLNWMHYNQT- 307
           +LKP N+ +    +   +K+ DFGLA    +     G+  T  Y +PE+ L    Y++  
Sbjct: 130 NLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV-LKKDPYSKPV 188

Query: 308 DIHQLNLIMEML--GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLL 365
           DI    +I+ +L  G PP  F  +       +           ++  V     P+A  L+
Sbjct: 189 DIWACGVILYILLVGYPP--FWDEDQHRLYAQIKAGAYDYPSPEWDTV----TPEAKSLI 242

Query: 366 SLMLELDSEKRITAEQALAHPYLSQYS 392
             ML ++ +KRITA+QAL  P++    
Sbjct: 243 DSMLTVNPKKRITADQALKVPWICNRE 269

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  120 bits (302), Expect = 2e-30
 Identities = 82/368 (22%), Positives = 134/368 (36%), Gaps = 89/368 (24%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM--------NHENVIGLLDVFH- 134
           + D      VA+K + +   +  + +    E+R+LK +        N E V+ LLD F  
Sbjct: 56  SWDIQGKKFVAMK-VVK--SAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112

Query: 135 -----SNTCLADFKNVYMVTHLMGADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHS 186
                ++ C        MV  ++G  L   +     Q L    V+ ++ Q+L+GL Y+H+
Sbjct: 113 SGVNGTHIC--------MVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT 164

Query: 187 -AGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQ 245
              IIH D+KP NI       L + +  + R          +     +   +        
Sbjct: 165 KCRIIHTDIKPENIL------LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218

Query: 246 TGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYN 305
             +    +          E  ++KI D G A       T  + TR YR+ E+++    YN
Sbjct: 219 NFLVNPLEPKN------AEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIG-SGYN 271

Query: 306 Q-TDI-----------------------------HQLNLIMEMLGTPPAEFMAK------ 329
              DI                               + LI+E+LG  P + +        
Sbjct: 272 TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKE 331

Query: 330 -ISSDSARKYINSLP-------LLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQ 381
             +     K+I  L        L+ K ++ Q          D L  MLEL  EKR TA +
Sbjct: 332 FFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEA---AGFTDFLLPMLELIPEKRATAAE 388

Query: 382 ALAHPYLS 389
            L HP+L+
Sbjct: 389 CLRHPWLN 396

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  118 bits (298), Expect = 2e-30
 Identities = 78/341 (22%), Positives = 132/341 (38%), Gaps = 99/341 (29%)

Query: 89  SGVKVAIKKIA----RPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN 144
           +G++ A K I     +  +  V  +   RE+ +LK + H NVI L +V+ + T      +
Sbjct: 35  TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT------D 88

Query: 145 VYMVTHLM-GADL-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
           V ++  L+ G +L + +   + L+++     + QIL G+ Y+HS  I H DLK       
Sbjct: 89  VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLK------- 141

Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
                                          PE   N M  ++                 
Sbjct: 142 -------------------------------PE---NIMLLDRN---------------- 151

Query: 263 NEDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIMLNWMHYN-QTDIHQLNLIMEML 319
                +KI+DFGLA      NE      T  + APEI +N+     + D+  + +I  +L
Sbjct: 152 VPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVITYIL 210

Query: 320 --GTPP------AEFMAKISSDSARKYINSLPLLTKKDF-RQVFKGANPQAIDLLSLMLE 370
             G  P       E +A +S   A  Y          +F  + F   +  A D +  +L 
Sbjct: 211 LSGASPFLGDTKQETLANVS---AVNY----------EFEDEYFSNTSALAKDFIRRLLV 257

Query: 371 LDSEKRITAEQALAHPYLSQYSDPNDEPTSPPYDQSFEDMD 411
            D +KR+T + +L HP++     P D   +     S  +M+
Sbjct: 258 KDPKKRMTIQDSLQHPWIK----PKDTQQALSRKASAVNME 294

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  119 bits (300), Expect = 2e-30
 Identities = 49/218 (22%), Positives = 97/218 (44%), Gaps = 26/218 (11%)

Query: 41  PASKLPSRRLHDHFNQPYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIAR 100
           P  +LP       F Q Y        D    + +    ++    +   +G + A+K +  
Sbjct: 79  PEDELPDWAAAKEFYQKY--------DPKDVIGRGVSSVVRR-CVHRATGHEFAVKIMEV 129

Query: 101 ------PFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLADFKNVYMVTHLM- 152
                 P Q     + T RE  +L+ +  H ++I L+D + S++       +++V  LM 
Sbjct: 130 TAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS------FMFLVFDLMR 183

Query: 153 GADL-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILD 211
             +L + +     LS+   + ++  +L  + ++H+  I+HRDLKP NI ++++ ++++ D
Sbjct: 184 KGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSD 243

Query: 212 FGLAR--PTENEMTGYVATRWYRAPEIMLNWMHYNQTG 247
           FG +       ++     T  Y APEI+   M     G
Sbjct: 244 FGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPG 281

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 79.0 bits (195), Expect = 3e-16
 Identities = 40/158 (25%), Positives = 67/158 (42%), Gaps = 38/158 (24%)

Query: 254 DLKPSNIAVNEDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIMLNWMHYNQT---- 307
           DLKP NI ++++ ++++ DFG +       ++     T  Y APEI+   M         
Sbjct: 225 DLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGK 284

Query: 308 --DIHQLNLIMEML--GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGA------ 357
             D+    +I+  L  G+PP  F  +                     R + +G       
Sbjct: 285 EVDLWACGVILFTLLAGSPP--FWHR--RQI-------------LMLRMIMEGQYQFSSP 327

Query: 358 -----NPQAIDLLSLMLELDSEKRITAEQALAHPYLSQ 390
                +    DL+S +L++D E R+TAEQAL HP+  +
Sbjct: 328 EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  119 bits (301), Expect = 2e-30
 Identities = 56/310 (18%), Positives = 101/310 (32%), Gaps = 52/310 (16%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           +G   AIK                RE  +LK +NH+N++ L  +    T     ++  ++
Sbjct: 33  TGDLFAIKVFNNI-SFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT----RHKVLI 87

Query: 149 THLM-GADLNNIL----RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI---- 199
                   L  +L        L +     ++  ++ G+ ++   GI+HR++KP NI    
Sbjct: 88  MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVI 147

Query: 200 AVNEDCELKILDFGLARPTENE--MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
             +     K+ DFG AR  E++        T  Y  P++                   K 
Sbjct: 148 GEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY--------ERAVLRKDHQKK 199

Query: 258 SNIAVNEDC-ELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT-DIHQLNLI 315
               V  D   + +  +  A       TG +  R +  P      M+   T         
Sbjct: 200 YGATV--DLWSIGVTFYHAA-------TGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250

Query: 316 MEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEK 375
           ++     P ++   +          SL    +                +L+ +LE D EK
Sbjct: 251 VQKAENGPIDWSGDMP------VSCSLSRGLQVLLTP-----------VLANILEADQEK 293

Query: 376 RITAEQALAH 385
               +Q  A 
Sbjct: 294 CWGFDQFFAE 303

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  117 bits (295), Expect = 3e-30
 Identities = 43/178 (24%), Positives = 75/178 (42%), Gaps = 23/178 (12%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF- 142
           A   + G    IK++    + A       RE++ L  ++H N++     +       +  
Sbjct: 30  AKHRIDGKTYVIKRVKYNNEKAE------REVKALAKLDHVNIVHYNGCWDGFDYDPETS 83

Query: 143 ---------KNVYMVTHLM-GADLNNILRTQK---LSDDHVQFLVYQILRGLKYIHSAGI 189
                    K +++         L   +  ++   L       L  QI +G+ YIHS  +
Sbjct: 84  SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKL 143

Query: 190 IHRDLKPSNIAVNEDCELKILDFGLARPTEN--EMTGYVATRWYRAPEIMLNWMHYNQ 245
           I+RDLKPSNI + +  ++KI DFGL    +N  + T    T  Y +PE + +   Y +
Sbjct: 144 INRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISS-QDYGK 200

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 78.1 bits (193), Expect = 2e-16
 Identities = 37/151 (24%), Positives = 62/151 (41%), Gaps = 18/151 (11%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTEN--EMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
           DLKPSNI + +  ++KI DFGL    +N  + T    T  Y +PE + +  +  + D++ 
Sbjct: 147 DLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYA 206

Query: 312 LNLIM-EML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLML 369
           L LI+ E+L     A   +K               L       +F   + +   LL  +L
Sbjct: 207 LGLILAELLHVCDTAFETSKF-----------FTDLRDGIISDIF---DKKEKTLLQKLL 252

Query: 370 ELDSEKRITAEQALAHPYLSQYSDPNDEPTS 400
               E R    + L    + + S   +E  +
Sbjct: 253 SKKPEDRPNTSEILRTLTVWKKSPEKNERHT 283

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  116 bits (294), Expect = 3e-30
 Identities = 44/177 (24%), Positives = 82/177 (46%), Gaps = 16/177 (9%)

Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENV 126
            +  T+ + S+  +   A+   + ++ A KKI +         R  +E+ ++K ++H N+
Sbjct: 12  TLENTIGRGSWGEVKI-AVQKGTRIRRAAKKIPK--YFVEDVDRFKQEIEIMKSLDHPNI 68

Query: 127 IGLLDVFHSNTCLADFKNVYMVTHLM-GADL-NNILRTQKLSDDHVQFLVYQILRGLKYI 184
           I L + F       D  ++Y+V  L  G +L   ++  +   +     ++  +L  + Y 
Sbjct: 69  IRLYETF------EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYC 122

Query: 185 HSAGIIHRDLKPSNI---AVNEDCELKILDFGLAR--PTENEMTGYVATRWYRAPEI 236
           H   + HRDLKP N      + D  LK++DFGLA        M   V T +Y +P++
Sbjct: 123 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQV 179

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 80.7 bits (200), Expect = 2e-17
 Identities = 44/153 (28%), Positives = 67/153 (43%), Gaps = 16/153 (10%)

Query: 254 DLKPSNI---AVNEDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIMLNWMHYNQT- 307
           DLKP N      + D  LK++DFGLA        M   V T +Y +P+++     Y    
Sbjct: 131 DLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG--LYGPEC 188

Query: 308 DIHQLNLIMEML--GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLL 365
           D     ++M +L  G PP  F A   S+   K         +KD+  V    +PQA  L+
Sbjct: 189 DEWSAGVMMYVLLCGYPP--FSAPTDSEVMLKIREGTFTFPEKDWLNV----SPQAESLI 242

Query: 366 SLMLELDSEKRITAEQALAHPYLSQYSDPNDEP 398
             +L    ++RIT+ QAL H +  +    +   
Sbjct: 243 RRLLTKSPKQRITSLQALEHEWFEKQLSSSPRN 275

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  120 bits (302), Expect = 4e-30
 Identities = 45/179 (25%), Positives = 86/179 (48%), Gaps = 15/179 (8%)

Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENV 126
            +   L K +F ++    +  ++G + A   I     SA   ++  RE R+ + + H N+
Sbjct: 14  QLFEELGKGAFSVVRR-CVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72

Query: 127 IGLLDVFHSNTCLADFKNVYMVTHLM-GADL-NNILRTQKLSDDHVQFLVYQILRGLKYI 184
           + L D        ++  + Y++  L+ G +L  +I+  +  S+      + QIL  + + 
Sbjct: 73  VRLHDSI------SEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 126

Query: 185 HSAGIIHRDLKPSNI---AVNEDCELKILDFGLARPTENE---MTGYVATRWYRAPEIM 237
           H  G++HR+LKP N+   +  +   +K+ DFGLA   E E     G+  T  Y +PE++
Sbjct: 127 HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL 185

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 44/165 (26%), Positives = 72/165 (43%), Gaps = 38/165 (23%)

Query: 254 DLKPSNI---AVNEDCELKILDFGLARPTENE---MTGYVATRWYRAPEIMLNWMHYNQT 307
           +LKP N+   +  +   +K+ DFGLA   E E     G+  T  Y +PE++    +    
Sbjct: 135 NLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPV 194

Query: 308 DIHQLNLIMEML--GTPPAEFMAKISSDSARKYINSLPLLTKKD-FRQVFKGA------- 357
           D+    +I+ +L  G PP  F  +                 +   ++Q+  GA       
Sbjct: 195 DLWACGVILYILLVGYPP--FWDE----------------DQHRLYQQIKAGAYDFPSPE 236

Query: 358 ----NPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEP 398
                P+A DL++ ML ++  KRITA +AL HP++S  S      
Sbjct: 237 WDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCM 281

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  117 bits (294), Expect = 1e-29
 Identities = 49/178 (27%), Positives = 84/178 (47%), Gaps = 18/178 (10%)

Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENV 126
           ++   L + +  +++       +    A+K + +     V  K    E+ +L  ++H N+
Sbjct: 56  EVESELGRGATSIVYR-CKQKGTQKPYALKVLKK----TVDKKIVRTEIGVLLRLSHPNI 110

Query: 127 IGLLDVFHSNTCLADFKNVYMVTHLM-GADL-NNILRTQKLSDDHVQFLVYQILRGLKYI 184
           I L ++F +         + +V  L+ G +L + I+     S+      V QIL  + Y+
Sbjct: 111 IKLKEIFETP------TEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYL 164

Query: 185 HSAGIIHRDLKPSNIAV---NEDCELKILDFGLARPTENE--MTGYVATRWYRAPEIM 237
           H  GI+HRDLKP N+       D  LKI DFGL++  E++  M     T  Y APEI+
Sbjct: 165 HENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEIL 222

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 74.7 bits (184), Expect = 6e-15
 Identities = 42/166 (25%), Positives = 72/166 (43%), Gaps = 36/166 (21%)

Query: 254 DLKPSNIAV---NEDCELKILDFGLARPTENE--MTGYVATRWYRAPEIMLNWMHYNQTD 308
           DLKP N+       D  LKI DFGL++  E++  M     T  Y APEI+    +  + D
Sbjct: 173 DLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVD 232

Query: 309 IHQLNLIMEML--GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGA--------- 357
           +  + +I  +L  G  P  F      +   +++          FR++             
Sbjct: 233 MWSVGIITYILLCGFEP--F----YDERGDQFM----------FRRILNCEYYFISPWWD 276

Query: 358 --NPQAIDLLSLMLELDSEKRITAEQALAHPYLSQY--SDPNDEPT 399
             +  A DL+  ++ LD +KR+T  QAL HP+++    +  + +  
Sbjct: 277 EVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHMDTA 322

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  118 bits (297), Expect = 1e-29
 Identities = 47/189 (24%), Positives = 72/189 (38%), Gaps = 33/189 (17%)

Query: 86  DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN-HENVIGLLDVFHSNTCLADFKN 144
                  VA+K+I     S        RE+++L+  + H NVI             D + 
Sbjct: 44  GMFDNRDVAVKRILPECFSFAD-----REVQLLRESDEHPNVIRYFCTEK------DRQF 92

Query: 145 VYMVTHLMGADLNNIL--RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI--- 199
            Y+   L  A L   +  +           L+ Q   GL ++HS  I+HRDLKP NI   
Sbjct: 93  QYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILIS 152

Query: 200 --AVNEDCELKILDFGLAR------PTENEMTGYVATRWYRAPEIMLNWMHYNQT----- 246
               +   +  I DFGL +       + +  +G   T  + APE++      N T     
Sbjct: 153 MPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDI 212

Query: 247 ---GVPFYF 252
              G  FY+
Sbjct: 213 FSAGCVFYY 221

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 38/152 (25%), Positives = 62/152 (40%), Gaps = 24/152 (15%)

Query: 254 DLKPSNI-----AVNEDCELKILDFGLAR------PTENEMTGYVATRWYRAPEIMLNWM 302
           DLKP NI       +   +  I DFGL +       + +  +G   T  + APE++    
Sbjct: 143 DLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDC 202

Query: 303 HYNQT---DIHQLNLIM-EML--GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKG 356
             N T   DI     +   ++  G+ P  F       S ++  N L      D     K 
Sbjct: 203 KENPTYTVDIFSAGCVFYYVISEGSHP--F-----GKSLQRQANILLGACSLDCLHPEKH 255

Query: 357 ANPQAIDLLSLMLELDSEKRITAEQALAHPYL 388
            +  A +L+  M+ +D +KR +A+  L HP+ 
Sbjct: 256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  116 bits (293), Expect = 2e-29
 Identities = 49/177 (27%), Positives = 85/177 (48%), Gaps = 14/177 (7%)

Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENV 126
           D+   L K +F ++    +   +G++ A K I     SA   ++  RE R+ + + H N+
Sbjct: 32  DVKEELGKGAFSVVRR-CVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 90

Query: 127 IGLLDVFHSNTCLADFKNVYMVTHLM-GADL-NNILRTQKLSDDHVQFLVYQILRGLKYI 184
           + L D     +        Y+V  L+ G +L  +I+  +  S+      + QIL  + Y 
Sbjct: 91  VRLHDSIQEES------FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 144

Query: 185 HSAGIIHRDLKPSNIAV---NEDCELKILDFGLARPTENE--MTGYVATRWYRAPEI 236
           HS GI+HR+LKP N+ +    +   +K+ DFGLA    +     G+  T  Y +PE+
Sbjct: 145 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV 201

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 75.8 bits (187), Expect = 3e-15
 Identities = 40/153 (26%), Positives = 67/153 (43%), Gaps = 15/153 (9%)

Query: 254 DLKPSNIAV---NEDCELKILDFGLARPTENE--MTGYVATRWYRAPEIMLNWMHYNQ-T 307
           +LKP N+ +    +   +K+ DFGLA    +     G+  T  Y +PE+ L    Y++  
Sbjct: 153 NLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV-LKKDPYSKPV 211

Query: 308 DIHQLNLIMEML--GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLL 365
           DI    +I+ +L  G PP  F  +       +           ++  V     P+A  L+
Sbjct: 212 DIWACGVILYILLVGYPP--FWDEDQHRLYAQIKAGAYDYPSPEWDTV----TPEAKSLI 265

Query: 366 SLMLELDSEKRITAEQALAHPYLSQYSDPNDEP 398
             ML ++ +KRITA+QAL  P++          
Sbjct: 266 DSMLTVNPKKRITADQALKVPWICNRERVASAI 298

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  114 bits (287), Expect = 4e-29
 Identities = 47/168 (27%), Positives = 80/168 (47%), Gaps = 18/168 (10%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAK-RTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
             D+ +    A K + +      H + +   E+ + + + H++V+G    F  N      
Sbjct: 34  ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND----- 88

Query: 143 KNVYMVTHL-MGADLNNILRTQK-LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
             V++V  L     L  + + +K L++   ++ + QI+ G +Y+H   +IHRDLK  N+ 
Sbjct: 89  -FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLF 147

Query: 201 VNEDCELKILDFGLA----RPTENEMT--GYVATRWYRAPEIMLNWMH 242
           +NED E+KI DFGLA       E +    G   T  Y APE++    H
Sbjct: 148 LNEDLEVKIGDFGLATKVEYDGERKKVLCG---TPNYIAPEVLSKKGH 192

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 68.4 bits (168), Expect = 5e-13
 Identities = 44/158 (27%), Positives = 63/158 (39%), Gaps = 27/158 (17%)

Query: 254 DLKPSNIAVNEDCELKILDFGLA----RPTENEMT--GYVATRWYRAPEIMLNWMHYNQT 307
           DLK  N+ +NED E+KI DFGLA       E +    G   T  Y APE++    H  + 
Sbjct: 140 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCG---TPNYIAPEVLSKKGHSFEV 196

Query: 308 DIHQLNLIM-EML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFK---GANPQAI 362
           D+  +  IM  +L G PP  F               L     +  +  +      NP A 
Sbjct: 197 DVWSIGCIMYTLLVGKPP--FETS-----------CLKETYLRIKKNEYSIPKHINPVAA 243

Query: 363 DLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTS 400
            L+  ML+ D   R T  + L   + +    P   P +
Sbjct: 244 SLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPIT 281

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  115 bits (289), Expect = 5e-29
 Identities = 39/135 (28%), Positives = 69/135 (51%), Gaps = 9/135 (6%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAK-RTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
             D+ +    A K + +      H + +   E+ + + + H++V+G    F  N      
Sbjct: 60  ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND----- 114

Query: 143 KNVYMVTHL-MGADLNNILRTQK-LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
             V++V  L     L  + + +K L++   ++ + QI+ G +Y+H   +IHRDLK  N+ 
Sbjct: 115 -FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLF 173

Query: 201 VNEDCELKILDFGLA 215
           +NED E+KI DFGLA
Sbjct: 174 LNEDLEVKIGDFGLA 188

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 68.1 bits (167), Expect = 8e-13
 Identities = 45/162 (27%), Positives = 64/162 (39%), Gaps = 35/162 (21%)

Query: 254 DLKPSNIAVNEDCELKILDFGLA----RPTENEMT--GYVATRWYRAPEIMLNWMHYNQT 307
           DLK  N+ +NED E+KI DFGLA       E +    G   T  Y APE++    H  + 
Sbjct: 166 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCG---TPNYIAPEVLSKKGHSFEV 222

Query: 308 DIHQLNLIM-EML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGA-------N 358
           D+  +  IM  +L G PP  F               L       + ++ K         N
Sbjct: 223 DVWSIGCIMYTLLVGKPP--FETS-----------CLKET----YLRIKKNEYSIPKHIN 265

Query: 359 PQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTS 400
           P A  L+  ML+ D   R T  + L   + +    P   P +
Sbjct: 266 PVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPIT 307

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  114 bits (287), Expect = 7e-29
 Identities = 53/284 (18%), Positives = 94/284 (33%), Gaps = 70/284 (24%)

Query: 112 YRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQK----LS 166
             ++R +   + +N +G L        L      Y+   L    +L + +  +       
Sbjct: 109 SVKIRRMDPFSTKNTVGQLQPSSPKVYL------YIQMQLCRKENLKDWMNRRCSLEDRE 162

Query: 167 DDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV 226
                 +  QI   ++++HS G++HRDLKPSNI    D  +K+ DFGL    + +     
Sbjct: 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE---- 218

Query: 227 ATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGY 286
                                                     +        P     TG 
Sbjct: 219 ------------------------------------------EEQTVLTPMPAYATHTGQ 236

Query: 287 VATRWYRAPEIMLNWMHYNQ-TDIHQLNLIM-EMLGTPPAEFMAKISSDSARKYINSLPL 344
           V T+ Y +PE +    +Y+   DI  L LI+ E+L    +  M +         +  +  
Sbjct: 237 VGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFELL-YSFSTQMER---------VRIITD 285

Query: 345 LTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYL 388
           +    F  +F    PQ   ++  ML     +R  A   + +   
Sbjct: 286 VRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  113 bits (284), Expect = 8e-29
 Identities = 48/183 (26%), Positives = 80/183 (43%), Gaps = 17/183 (9%)

Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHEN 125
           +IG  L K  F  ++  A +  S   +A+K + +   + A    +  RE+ +  H+ H N
Sbjct: 12  EIGRPLGKGKFGNVYL-AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70

Query: 126 VIGLLDVFHSNTCLADFKNVYMVT-HLMGADLNNILR-TQKLSDDHVQFLVYQILRGLKY 183
           ++ L   FH  T       VY++  +     +   L+   K  +      + ++   L Y
Sbjct: 71  ILRLYGYFHDAT------RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 124

Query: 184 IHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT----GYVATRWYRAPEIMLN 239
            HS  +IHRD+KP N+ +    ELKI DFG +    +       G   T  Y  PE++  
Sbjct: 125 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCG---TLDYLPPEMIEG 181

Query: 240 WMH 242
            MH
Sbjct: 182 RMH 184

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 68.8 bits (169), Expect = 3e-13
 Identities = 40/150 (26%), Positives = 62/150 (41%), Gaps = 25/150 (16%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMT----GYVATRWYRAPEIMLNWMHYNQTDI 309
           D+KP N+ +    ELKI DFG +    +       G   T  Y  PE++   MH  + D+
Sbjct: 134 DIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCG---TLDYLPPEMIEGRMHDEKVDL 190

Query: 310 HQLNLIM-EML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFK---GANPQAIDL 364
             L ++  E L G PP  F A            +     K+  R  F         A DL
Sbjct: 191 WSLGVLCYEFLVGKPP--FEAN-----------TYQETYKRISRVEFTFPDFVTEGARDL 237

Query: 365 LSLMLELDSEKRITAEQALAHPYLSQYSDP 394
           +S +L+ +  +R    + L HP+++  S  
Sbjct: 238 ISRLLKHNPSQRPMLREVLEHPWITANSSK 267

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  115 bits (288), Expect = 1e-28
 Identities = 24/183 (13%), Positives = 42/183 (22%), Gaps = 29/183 (15%)

Query: 84  ALDSVSGVKVAIKKI-ARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLA-- 140
             D       A+K        S    +R +        +  E+     D           
Sbjct: 81  VRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140

Query: 141 ------------------DFKNVYMVTHLMGADLNNILRTQK--------LSDDHVQFLV 174
                                N  ++      DL  +  T               +  L 
Sbjct: 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILT 200

Query: 175 YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP 234
            Q++R    + S G++H    P N+ +  D  L + D                   Y   
Sbjct: 201 AQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPR 260

Query: 235 EIM 237
           E +
Sbjct: 261 EFL 263

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  112 bits (282), Expect = 2e-28
 Identities = 45/153 (29%), Positives = 80/153 (52%), Gaps = 11/153 (7%)

Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKIAR-PFQSAVHAKRTYRELRMLKHMNHEN 125
            +G  L K SF  ++  A    +G++VAIK I +     A   +R   E+++   + H +
Sbjct: 14  KVGNLLGKGSFAGVYR-AESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72

Query: 126 VIGLLDVFHSNTCLADFKNVYMVT-HLMGADLNNILRTQ--KLSDDHVQFLVYQILRGLK 182
           ++ L + F  +        VY+V       ++N  L+ +    S++  +  ++QI+ G+ 
Sbjct: 73  ILELYNYFEDSN------YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126

Query: 183 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 215
           Y+HS GI+HRDL  SN+ +  +  +KI DFGLA
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA 159

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 66.8 bits (164), Expect = 1e-12
 Identities = 39/152 (25%), Positives = 63/152 (41%), Gaps = 27/152 (17%)

Query: 254 DLKPSNIAVNEDCELKILDFGLA----RPTENEMT--GYVATRWYRAPEIMLNWMHYNQT 307
           DL  SN+ +  +  +KI DFGLA     P E   T  G   T  Y +PEI     H  ++
Sbjct: 137 DLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCG---TPNYISPEIATRSAHGLES 193

Query: 308 DIHQLNLIM-EML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFK---GANPQAI 362
           D+  L  +   +L G PP  F              ++     K     ++     + +A 
Sbjct: 194 DVWSLGCMFYTLLIGRPP--FDTD-----------TVKNTLNKVVLADYEMPSFLSIEAK 240

Query: 363 DLLSLMLELDSEKRITAEQALAHPYLSQYSDP 394
           DL+  +L  +   R++    L HP++S+ S  
Sbjct: 241 DLIHQLLRRNPADRLSLSSVLDHPFMSRNSST 272

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  113 bits (284), Expect = 3e-28
 Identities = 48/169 (28%), Positives = 79/169 (46%), Gaps = 14/169 (8%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
              +  G +  IK+I     S+   + + RE+ +L +M H N++   + F  N  L    
Sbjct: 43  VKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSL---- 98

Query: 144 NVYMVTHLM-GADLNNILRTQK---LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
             Y+V     G DL   +  QK     +D +     QI   LK++H   I+HRD+K  NI
Sbjct: 99  --YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNI 156

Query: 200 AVNEDCELKILDFGLARPTENEM---TGYVATRWYRAPEIMLNWMHYNQ 245
            + +D  +++ DFG+AR   + +      + T +Y +PEI  N   YN 
Sbjct: 157 FLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN-KPYNN 204

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 68.2 bits (167), Expect = 7e-13
 Identities = 34/163 (20%), Positives = 63/163 (38%), Gaps = 24/163 (14%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEM---TGYVATRWYRAPEIMLNWMHYNQ-TDI 309
           D+K  NI + +D  +++ DFG+AR   + +      + T +Y +PEI  N   YN  +DI
Sbjct: 150 DIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN-KPYNNKSDI 208

Query: 310 HQLNLIM-EML-GTPPAEFMAKISSDSARKYINSLPLLTKK----DFRQVFKGANPQAID 363
             L  ++ E+        F A            S+  L  K     F  V    +     
Sbjct: 209 WALGCVLYELCTLKHA--FEAG-----------SMKNLVLKIISGSFPPVSLHYSYDLRS 255

Query: 364 LLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPPYDQS 406
           L+S + + +   R +    L   ++++  +    P     +  
Sbjct: 256 LVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFC 298

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  111 bits (279), Expect = 1e-27
 Identities = 67/332 (20%), Positives = 133/332 (40%), Gaps = 53/332 (15%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAK---RTYRELRMLKHMNHENVIGLLDVFHSNTCLA 140
           A+++ +    AIK + +     ++ K   R   E+R++K ++H N+  L +V+       
Sbjct: 45  AIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE------ 98

Query: 141 DFKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
           D + + +V  L  G  L                L    +          +     +    
Sbjct: 99  DEQYICLVMELCHGGHL----------------LDKLNVFIDDSTGKCAMDVVKTQICPC 142

Query: 200 AVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM--LNWMHYNQTGVPFYFQDLKP 257
               +  +     G     +      + +   R  +I   L+++H    G+    +D+KP
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMR--QIFSALHYLHNQ--GI--CHRDIKP 196

Query: 258 SNI--AVNEDCELKILDFGLAR-------PTENEMTGYVATRWYRAPEIMLNWMH-YN-Q 306
            N   + N+  E+K++DFGL++            MT    T ++ APE++      Y  +
Sbjct: 197 ENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256

Query: 307 TDIHQLNLIM-EML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDL 364
            D     +++  +L G  P  F     +D+  + +N        ++  +    +P A DL
Sbjct: 257 CDAWSAGVLLHLLLMGAVP--FPGVNDADTISQVLNKKLCFENPNYNVL----SPLARDL 310

Query: 365 LSLMLELDSEKRITAEQALAHPYLSQYSDPND 396
           LS +L  + ++R  A +AL HP++SQ+SD   
Sbjct: 311 LSNLLNRNVDERFDAMRALQHPWISQFSDKIY 342

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  110 bits (278), Expect = 2e-27
 Identities = 42/172 (24%), Positives = 73/172 (42%), Gaps = 22/172 (12%)

Query: 89  SGVKVAIKKIAR---PFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV 145
           +G + A+K +          +  +   RE  +   + H +++ LL+ +      +    +
Sbjct: 48  TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETY------SSDGML 101

Query: 146 YMVTHLM-GADL-NNILR----TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
           YMV   M GADL   I++        S+      + QIL  L+Y H   IIHRD+KP  +
Sbjct: 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCV 161

Query: 200 ---AVNEDCELKILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHYNQ 245
              +      +K+  FG+A     +     G V T  + APE+ +    Y +
Sbjct: 162 LLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV-VKREPYGK 212

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 77.3 bits (191), Expect = 7e-16
 Identities = 36/160 (22%), Positives = 61/160 (38%), Gaps = 29/160 (18%)

Query: 254 DLKPSNI---AVNEDCELKILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHYNQ- 306
           D+KP  +   +      +K+  FG+A     +     G V T  + APE+ +    Y + 
Sbjct: 155 DVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV-VKREPYGKP 213

Query: 307 TDIHQLNLIMEML--GTPP-----AEFMAKISSDSARKYINSLPLLTKKDF-RQVFKGAN 358
            D+    +I+ +L  G  P           I             +  K     + +   +
Sbjct: 214 VDVWGCGVILFILLSGCLPFYGTKERLFEGI-------------IKGKYKMNPRQWSHIS 260

Query: 359 PQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEP 398
             A DL+  ML LD  +RIT  +AL HP+L +      + 
Sbjct: 261 ESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKI 300

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  110 bits (277), Expect = 2e-27
 Identities = 53/316 (16%), Positives = 102/316 (32%), Gaps = 88/316 (27%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
             D  +G + A+KK+    +          EL     ++   ++ L         +    
Sbjct: 77  MKDKQTGFQCAVKKV--RLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWV---- 125

Query: 144 NVYMVTHLMGADLNNILRTQ-KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
           N++M   L G  L  +++    L +D   + + Q L GL+Y+H+  I+H D+K  N+ ++
Sbjct: 126 NIFM-ELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS 184

Query: 203 ED-CELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIA 261
            D     + DFG A                                              
Sbjct: 185 SDGSRAALCDFGHAL--------------------------------------------- 199

Query: 262 VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN-LIMEML- 319
                 L+    G +  T + + G   T  + APE+++      + DI     +++ ML 
Sbjct: 200 -----CLQPDGLGKSLLTGDYIPG---TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLN 251

Query: 320 GTPP-AEF-----MAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDS 373
           G  P  ++       KI+S+         P+              P     +   L  + 
Sbjct: 252 GCHPWTQYFRGPLCLKIASEPP-------PIREIPP------SCAPLTAQAIQEGLRKEP 298

Query: 374 EKRITAEQALAHPYLS 389
             R +A +       +
Sbjct: 299 VHRASAMELRRKVGKA 314

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  109 bits (275), Expect = 2e-27
 Identities = 49/165 (29%), Positives = 71/165 (43%), Gaps = 22/165 (13%)

Query: 90  GVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT 149
              VAIK+I    +     K    ELR L  +NH N++ L        CL     V +V 
Sbjct: 31  AKDVAIKQIESESER----KAFIVELRQLSRVNHPNIVKLYGA-----CL---NPVCLVM 78

Query: 150 HLM-GADLNNILRTQK----LSDDHVQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAV 201
               G  L N+L   +     +  H      Q  +G+ Y+HS     +IHRDLKP N+ +
Sbjct: 79  EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLL 138

Query: 202 NEDCE-LKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQ 245
                 LKI DFG A   +  MT    +  + APE+     +Y++
Sbjct: 139 VAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEG-SNYSE 182

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 55.8 bits (135), Expect = 8e-09
 Identities = 19/70 (27%), Positives = 33/70 (47%), Gaps = 3/70 (4%)

Query: 238 LNWMHYNQTGVPFYFQDLKPSNIAVNEDCE-LKILDFGLARPTENEMTGYVATRWYRAPE 296
           + ++H +        +DLKP N+ +      LKI DFG A   +  MT    +  + APE
Sbjct: 115 VAYLH-SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPE 173

Query: 297 IMLNWMHYNQ 306
           +     +Y++
Sbjct: 174 VFEG-SNYSE 182

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  109 bits (275), Expect = 3e-27
 Identities = 47/171 (27%), Positives = 86/171 (50%), Gaps = 21/171 (12%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLADF 142
            +   S    A+K I++  ++        +E+  LK    H N++ L +VFH      D 
Sbjct: 30  CVHKKSNQAFAVKIISKRMEANTQ-----KEITALKLCEGHPNIVKLHEVFH------DQ 78

Query: 143 KNVYMVTHLM-GADL-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI- 199
            + ++V  L+ G +L   I + +  S+    +++ +++  + ++H  G++HRDLKP N+ 
Sbjct: 79  LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLL 138

Query: 200 --AVNEDCELKILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHYNQ 245
               N++ E+KI+DFG AR   P    +     T  Y APE+ LN   Y++
Sbjct: 139 FTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPEL-LNQNGYDE 188

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 83.5 bits (207), Expect = 5e-18
 Identities = 45/189 (23%), Positives = 76/189 (40%), Gaps = 32/189 (16%)

Query: 254 DLKPSNI---AVNEDCELKILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHYNQT 307
           DLKP N+     N++ E+KI+DFG AR   P    +     T  Y APE+ LN   Y+++
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPEL-LNQNGYDES 189

Query: 308 -DIHQLNLIMEML--GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGA------- 357
            D+  L +I+  +  G  P  F +   S +             +  +++ KG        
Sbjct: 190 CDLWSLGVILYTMLSGQVP--FQSHDRSLTCTS--------AVEIMKKIKKGDFSFEGEA 239

Query: 358 ----NPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLP 413
               + +A DL+  +L +D  KR+       + +L   S  +  P   P         + 
Sbjct: 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAV- 298

Query: 414 VDQWKGTYS 422
               K T+ 
Sbjct: 299 HTCVKATFH 307

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  108 bits (272), Expect = 4e-27
 Identities = 42/183 (22%), Positives = 77/183 (42%), Gaps = 17/183 (9%)

Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHEN 125
           DIG  L K  F  ++  A +  +   +A+K + +   +      +  RE+ +  H+ H N
Sbjct: 17  DIGRPLGKGKFGNVYL-AREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75

Query: 126 VIGLLDVFHSNTCLADFKNVYMVT-HLMGADLNNIL-RTQKLSDDHVQFLVYQILRGLKY 183
           ++ + + FH          +Y++       +L   L +  +  +      + ++   L Y
Sbjct: 76  ILRMYNYFHDRK------RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHY 129

Query: 184 IHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT----GYVATRWYRAPEIMLN 239
            H   +IHRD+KP N+ +    ELKI DFG +    +       G   T  Y  PE++  
Sbjct: 130 CHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCG---TLDYLPPEMIEG 186

Query: 240 WMH 242
             H
Sbjct: 187 KTH 189

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 71.1 bits (175), Expect = 5e-14
 Identities = 35/161 (21%), Positives = 59/161 (36%), Gaps = 25/161 (15%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMT----GYVATRWYRAPEIMLNWMHYNQTDI 309
           D+KP N+ +    ELKI DFG +    +       G   T  Y  PE++    H  + D+
Sbjct: 139 DIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCG---TLDYLPPEMIEGKTHDEKVDL 195

Query: 310 HQLNLIM-EML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFK---GANPQAIDL 364
               ++  E L G PP  F +            S     ++      K     +  + DL
Sbjct: 196 WCAGVLCYEFLVGMPP--FDSP-----------SHTETHRRIVNVDLKFPPFLSDGSKDL 242

Query: 365 LSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPPYDQ 405
           +S +L     +R+  +  + HP++   S     P       
Sbjct: 243 ISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQSTQS 283

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  108 bits (273), Expect = 8e-27
 Identities = 38/166 (22%), Positives = 76/166 (45%), Gaps = 19/166 (11%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKH-MNHENVIGLLDVFHSNTCLADFKNVYM 147
           +G K A+K +         + +  +E+          +++ +LDV+ +       + + +
Sbjct: 53  TGQKCALKLLYD-------SPKARQEVDHHWQASGGPHIVCILDVYENMH--HGKRCLLI 103

Query: 148 VTHLM-GADL-NNILR--TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI---A 200
           +   M G +L + I     Q  ++     ++  I   ++++HS  I HRD+KP N+   +
Sbjct: 104 IMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTS 163

Query: 201 VNEDCELKILDFGLARPTEN-EMTGYVATRWYRAPEIMLNWMHYNQ 245
             +D  LK+ DFG A+ T    +     T +Y APE+ L    Y++
Sbjct: 164 KEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEV-LGPEKYDK 208

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 82.4 bits (204), Expect = 1e-17
 Identities = 43/163 (26%), Positives = 74/163 (45%), Gaps = 32/163 (19%)

Query: 254 DLKPSNI---AVNEDCELKILDFGLARPTEN-EMTGYVATRWYRAPEIMLNWMHYNQT-D 308
           D+KP N+   +  +D  LK+ DFG A+ T    +     T +Y APE+ L    Y+++ D
Sbjct: 153 DVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEV-LGPEKYDKSCD 211

Query: 309 IHQLNLIMEML--GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGA--------- 357
           +  L +IM +L  G PP  F     S++ +     +        R++  G          
Sbjct: 212 MWSLGVIMYILLCGFPP--F----YSNTGQAISPGM-------KRRIRLGQYGFPNPEWS 258

Query: 358 --NPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEP 398
             +  A  L+ L+L+ D  +R+T  Q + HP+++Q       P
Sbjct: 259 EVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTP 301

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  106 bits (268), Expect = 1e-26
 Identities = 42/171 (24%), Positives = 77/171 (45%), Gaps = 19/171 (11%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
            G  +  K++     +    +    E+ +L+ + H N++   D     T       +Y+V
Sbjct: 30  DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT----NTTLYIV 85

Query: 149 T-HLMGADLNNILRTQK-----LSDDHVQFLVYQILRGLKYIHSAG-----IIHRDLKPS 197
             +  G DL +++         L ++ V  ++ Q+   LK  H        ++HRDLKP+
Sbjct: 86  MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPA 145

Query: 198 NIAVNEDCELKILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHYNQ 245
           N+ ++    +K+ DFGLAR      +    +V T +Y +PE M   M YN+
Sbjct: 146 NVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR-MSYNE 195

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  106 bits (267), Expect = 2e-26
 Identities = 40/156 (25%), Positives = 69/156 (44%), Gaps = 15/156 (9%)

Query: 92  KVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHL 151
            VA+K +     +    +    E+ +L+   H N++  +         A    + +VT  
Sbjct: 48  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-----STAP--QLAIVTQW 100

Query: 152 M-GADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELK 208
             G+ L + L     K     +  +  Q  RG+ Y+H+  IIHRDLK +NI ++ED  +K
Sbjct: 101 CEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVK 160

Query: 209 ILDFGLAR-----PTENEMTGYVATRWYRAPEIMLN 239
           I DFGLA         ++      +  + APE++  
Sbjct: 161 IGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 49.6 bits (119), Expect = 6e-07
 Identities = 17/52 (32%), Positives = 27/52 (51%), Gaps = 5/52 (9%)

Query: 254 DLKPSNIAVNEDCELKILDFGLAR-----PTENEMTGYVATRWYRAPEIMLN 300
           DLK +NI ++ED  +KI DFGLA         ++      +  + APE++  
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  107 bits (268), Expect = 2e-26
 Identities = 47/172 (27%), Positives = 80/172 (46%), Gaps = 17/172 (9%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKR-TYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           A   + GV VA+KK+         A+    +E+ +LK +NH NVI     F  +  L   
Sbjct: 51  AACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL--- 107

Query: 143 KNVYMVTHLM-GADLNNILRTQK-----LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKP 196
               +V  L    DL+ +++  K     + +  V     Q+   L+++HS  ++HRD+KP
Sbjct: 108 ---NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKP 164

Query: 197 SNIAVNEDCELKILDFGLARPTENEMTG---YVATRWYRAPEIMLNWMHYNQ 245
           +N+ +     +K+ D GL R   ++ T     V T +Y +PE +     YN 
Sbjct: 165 ANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNF 215

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 34/145 (23%), Positives = 56/145 (38%), Gaps = 21/145 (14%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTG---YVATRWYRAPEIMLNWMHYNQ-TDI 309
           D+KP+N+ +     +K+ D GL R   ++ T     V T +Y +PE +     YN  +DI
Sbjct: 161 DIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDI 219

Query: 310 HQLN-LIMEML-GTPPAEFMAKISSDSARKYINSLPLLTK---KDFRQVFKGA-NPQAID 363
             L  L+ EM     P  F            +N   L  K    D+  +     + +   
Sbjct: 220 WSLGCLLYEMAALQSP--FYG--------DKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 269

Query: 364 LLSLMLELDSEKRITAEQALAHPYL 388
           L+++ +  D EKR            
Sbjct: 270 LVNMCINPDPEKRPDVTYVYDVAKR 294

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  106 bits (268), Expect = 3e-26
 Identities = 43/165 (26%), Positives = 73/165 (44%), Gaps = 26/165 (15%)

Query: 89  SGVKVAIKKIARPFQSAVHAK-RTYRELRMLKH-MNHENVIGLLDVFHSNTCLADFKNVY 146
           +  + A+K I +      H + R +RE+ ML     H NV+ L++ F       +    Y
Sbjct: 37  TSQEYAVKIIEK---QPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE------EEDRFY 87

Query: 147 MVTHLM-GADL-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI---AV 201
           +V   M G  + ++I + +  ++     +V  +   L ++H+ GI HRDLKP NI     
Sbjct: 88  LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHP 147

Query: 202 NEDCELKILDFGLAR----------PTENEMTGYVATRWYRAPEI 236
           N+   +KI DF L             +  E+     +  Y APE+
Sbjct: 148 NQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 80.4 bits (199), Expect = 5e-17
 Identities = 45/177 (25%), Positives = 73/177 (41%), Gaps = 33/177 (18%)

Query: 254 DLKPSNI---AVNEDCELKILDFGLAR----------PTENEMTGYVATRWYRAPEIMLN 300
           DLKP NI     N+   +KI DF L             +  E+     +  Y APE++  
Sbjct: 136 DLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEA 195

Query: 301 WMHYNQT-----DIHQLNLIMEML--GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQV 353
           +           D+  L +I+ +L  G PP  F+ +  SD       + P      F  +
Sbjct: 196 FSEEASIYDKRCDLWSLGVILYILLSGYPP--FVGRCGSDCGWDRGEACPACQNMLFESI 253

Query: 354 FKGA-----------NPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPT 399
            +G            +  A DL+S +L  D+++R++A Q L HP++   +  N  PT
Sbjct: 254 QEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPT 310

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  106 bits (266), Expect = 4e-26
 Identities = 39/166 (23%), Positives = 73/166 (43%), Gaps = 17/166 (10%)

Query: 90  GVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT 149
           G  VA+K +      A       RE+ ++K + H N++  +             N+ +VT
Sbjct: 60  GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA-----VT-QPPNLSIVT 113

Query: 150 HLM-GADLNNILRTQ----KLSDDHVQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVN 202
             +    L  +L       +L +     + Y + +G+ Y+H+    I+HR+LK  N+ V+
Sbjct: 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD 173

Query: 203 EDCELKILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHYNQ 245
           +   +K+ DFGL+R    T         T  + APE++ +    N+
Sbjct: 174 KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD-EPSNE 218

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 16/56 (28%), Positives = 28/56 (50%), Gaps = 4/56 (7%)

Query: 254 DLKPSNIAVNEDCELKILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHYNQ 306
           +LK  N+ V++   +K+ DFGL+R    T         T  + APE++ +    N+
Sbjct: 164 NLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD-EPSNE 218

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  107 bits (269), Expect = 6e-26
 Identities = 40/163 (24%), Positives = 69/163 (42%), Gaps = 16/163 (9%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           +G     K I       +       E+ ++  ++H  +I L D F           + ++
Sbjct: 75  TGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK------YEMVLI 126

Query: 149 THLM-GADL-NNIL-RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI--AVNE 203
              + G +L + I     K+S+  V   + Q   GLK++H   I+H D+KP NI     +
Sbjct: 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKK 186

Query: 204 DCELKILDFGLAR--PTENEMTGYVATRWYRAPEIMLNWMHYN 244
              +KI+DFGLA     +  +    AT  + APEI ++     
Sbjct: 187 ASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI-VDREPVG 228

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 82.8 bits (205), Expect = 1e-17
 Identities = 38/162 (23%), Positives = 64/162 (39%), Gaps = 28/162 (17%)

Query: 254 DLKPSNI--AVNEDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIMLNWMHYN-QTD 308
           D+KP NI     +   +KI+DFGLA     +  +    AT  + APEI ++       TD
Sbjct: 174 DIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI-VDREPVGFYTD 232

Query: 309 IHQLNLIMEML--GTPP------AEFMAKISSDSARKYINSLPLLTKKDF-RQVFKGANP 359
           +  + ++  +L  G  P       E +  +       +          +F    F   +P
Sbjct: 233 MWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC---DW----------EFDEDAFSSVSP 279

Query: 360 QAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSP 401
           +A D +  +L+ +  KR+T   AL HP+L             
Sbjct: 280 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPS 321

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  105 bits (265), Expect = 1e-25
 Identities = 49/167 (29%), Positives = 83/167 (49%), Gaps = 23/167 (13%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLADFKNVYM 147
           + ++ A+K I +        +    E+ +L     H N+I L DV+       D K VY+
Sbjct: 46  TNMEFAVKIIDK------SKRDPTEEIEILLRYGQHPNIITLKDVYD------DGKYVYV 93

Query: 148 VTHLM-GADL-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
           VT LM G +L + ILR +  S+     +++ I + ++Y+H+ G++HRDLKPSNI   ++ 
Sbjct: 94  VTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDES 153

Query: 206 E----LKILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHYNQ 245
                ++I DFG A+        +     T  + APE+ L    Y+ 
Sbjct: 154 GNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEV-LERQGYDA 199

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 74.6 bits (184), Expect = 5e-15
 Identities = 39/166 (23%), Positives = 62/166 (37%), Gaps = 36/166 (21%)

Query: 254 DLKPSNIAVNEDCE----LKILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHYNQ 306
           DLKPSNI   ++      ++I DFG A+        +     T  + APE+ L    Y+ 
Sbjct: 141 DLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEV-LERQGYDA 199

Query: 307 T-DIHQLNLIMEML--GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGA------ 357
             DI  L +++  +  G  P  F            I            ++  G       
Sbjct: 200 ACDIWSLGVLLYTMLTGYTP--FANGPDDTPEE--I----------LARIGSGKFSLSGG 245

Query: 358 -----NPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEP 398
                +  A DL+S ML +D  +R+TA   L HP++  +       
Sbjct: 246 YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQ 291

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  105 bits (264), Expect = 1e-25
 Identities = 43/166 (25%), Positives = 80/166 (48%), Gaps = 17/166 (10%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNH-ENVIGLLDVFHSNTCLADFKNVYM 147
           +G + A K + +  +          E+ +L+       VI L +V+ + +       + +
Sbjct: 53  TGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS------EIIL 106

Query: 148 VTHLM-GADL-NNIL--RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI---A 200
           +     G ++ +  L    + +S++ V  L+ QIL G+ Y+H   I+H DLKP NI   +
Sbjct: 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSS 166

Query: 201 VNEDCELKILDFGLARPTEN--EMTGYVATRWYRAPEIMLNWMHYN 244
           +    ++KI+DFG++R   +  E+   + T  Y APEI LN+    
Sbjct: 167 IYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEI-LNYDPIT 211

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 82.3 bits (204), Expect = 1e-17
 Identities = 47/164 (28%), Positives = 70/164 (42%), Gaps = 29/164 (17%)

Query: 254 DLKPSNI---AVNEDCELKILDFGLARPTEN--EMTGYVATRWYRAPEIMLNWMHYNQ-T 307
           DLKP NI   ++    ++KI+DFG++R   +  E+   + T  Y APEI LN+      T
Sbjct: 156 DLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEI-LNYDPITTAT 214

Query: 308 DIHQLNLIMEML--GTPP------AEFMAKISSDSARKYINSLPLLTKKDF-RQVFKGAN 358
           D+  + +I  ML   T P       E    IS                 D+  + F   +
Sbjct: 215 DMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS---QVNV----------DYSEETFSSVS 261

Query: 359 PQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPP 402
             A D +  +L  + EKR TAE  L+H +L Q+   N       
Sbjct: 262 QLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEET 305

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  105 bits (264), Expect = 1e-25
 Identities = 36/156 (23%), Positives = 63/156 (40%), Gaps = 18/156 (11%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           S      K +              +E+ +L    H N++ L + F S         + M+
Sbjct: 29  SKKTYMAKFVKV---KGTDQVLVKKEISILNIARHRNILHLHESFESME------ELVMI 79

Query: 149 THLM-GADL-NNIL-RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI--AVNE 203
              + G D+   I     +L++  +   V+Q+   L+++HS  I H D++P NI      
Sbjct: 80  FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRR 139

Query: 204 DCELKILDFGLAR---PTENEMTGYVATRWYRAPEI 236
              +KI++FG AR   P +           Y APE+
Sbjct: 140 SSTIKIIEFGQARQLKPGD-NFRLLFTAPEYYAPEV 174

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 78.8 bits (195), Expect = 2e-16
 Identities = 38/158 (24%), Positives = 65/158 (41%), Gaps = 30/158 (18%)

Query: 254 DLKPSNI--AVNEDCELKILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHYN-QT 307
           D++P NI         +KI++FG AR   P +           Y APE+       +  T
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEYYAPEV-HQHDVVSTAT 184

Query: 308 DIHQLNLIMEML--GTPP------AEFMAKISSDSARKYINSLPLLTKKDF-RQVFKGAN 358
           D+  L  ++ +L  G  P       + +  I      +Y           F  + FK  +
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETNQQIIENIM---NAEY----------TFDEEAFKEIS 231

Query: 359 PQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPND 396
            +A+D +  +L  + + R+TA +AL HP+L Q  +   
Sbjct: 232 IEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVS 269

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  104 bits (261), Expect = 1e-25
 Identities = 36/163 (22%), Positives = 67/163 (41%), Gaps = 23/163 (14%)

Query: 90  GVKVAIKKIARPFQSAVHAKRT-----YRELRMLKHMNHENVIGLLDVFHSNTCLADFKN 144
              VAIK +                   RE+ ++ ++NH N++ L  +            
Sbjct: 44  KSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL-----MH---NP 95

Query: 145 VYMVTHLM-GADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAG--IIHRDLKPSNI 199
             MV   +   DL + L  +   +       L+  I  G++Y+ +    I+HRDL+  NI
Sbjct: 96  PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNI 155

Query: 200 AVNEDCE-----LKILDFGLARPTENEMTGYVATRWYRAPEIM 237
            +    E      K+ DFGL++ + + ++G +    + APE +
Sbjct: 156 FLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETI 198

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 51.5 bits (124), Expect = 2e-07
 Identities = 14/50 (28%), Positives = 26/50 (52%), Gaps = 5/50 (10%)

Query: 254 DLKPSNIAVNEDCE-----LKILDFGLARPTENEMTGYVATRWYRAPEIM 298
           DL+  NI +    E      K+ DFGL++ + + ++G +    + APE +
Sbjct: 149 DLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETI 198

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  103 bits (260), Expect = 2e-25
 Identities = 48/165 (29%), Positives = 72/165 (43%), Gaps = 21/165 (12%)

Query: 90  GVKVAIKKIARPFQS--AVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYM 147
           G +VA+K          +   +   +E ++   + H N+I L  V     CL +  N+ +
Sbjct: 30  GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGV-----CLKE-PNLCL 83

Query: 148 VTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNE 203
           V     G  LN +L  +++  D +     QI RG+ Y+H      IIHRDLK SNI + +
Sbjct: 84  VMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQ 143

Query: 204 DCE--------LKILDFGLARP-TENEMTGYVATRWYRAPEIMLN 239
             E        LKI DFGLAR               + APE++  
Sbjct: 144 KVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRA 188

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 47.3 bits (113), Expect = 3e-06
 Identities = 27/85 (31%), Positives = 39/85 (45%), Gaps = 18/85 (21%)

Query: 234 PEIMLNW-------MHY--NQTGVPFYFQDLKPSNIAVNEDCE--------LKILDFGLA 276
           P+I++NW       M+Y  ++  VP   +DLK SNI + +  E        LKI DFGLA
Sbjct: 104 PDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163

Query: 277 RP-TENEMTGYVATRWYRAPEIMLN 300
           R               + APE++  
Sbjct: 164 REWHRTTKMSAAGAYAWMAPEVIRA 188

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  105 bits (263), Expect = 2e-25
 Identities = 44/164 (26%), Positives = 73/164 (44%), Gaps = 17/164 (10%)

Query: 84  ALDSVSGVKVAIKKIAR------PFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNT 137
           A+D     +V +K I +       +       +   E+ +L  + H N+I +LD+F +  
Sbjct: 43  AVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102

Query: 138 CLADFKNVYMVT--HLMGADL-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDL 194
                    +V   H  G DL   I R  +L +    ++  Q++  + Y+    IIHRD+
Sbjct: 103 ------FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDI 156

Query: 195 KPSNIAVNEDCELKILDFGLARPTENE--MTGYVATRWYRAPEI 236
           K  NI + ED  +K++DFG A   E       +  T  Y APE+
Sbjct: 157 KDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEV 200

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 63.2 bits (154), Expect = 3e-11
 Identities = 32/172 (18%), Positives = 66/172 (38%), Gaps = 37/172 (21%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENE--MTGYVATRWYRAPEIMLNWMHYN--QTDI 309
           D+K  NI + ED  +K++DFG A   E       +  T  Y APE+++    Y   + ++
Sbjct: 155 DIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMG-NPYRGPELEM 213

Query: 310 HQLNLIMEML--GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGA-------NPQ 360
             L + +  L     P                         +  +  + A       + +
Sbjct: 214 WSLGVTLYTLVFEENPFC-----------------------ELEETVEAAIHPPYLVSKE 250

Query: 361 AIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPPYDQSFEDMDL 412
            + L+S +L+   E+R T E+ +  P+++Q  +  D      +  +  +  +
Sbjct: 251 LMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGV 302

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  104 bits (261), Expect = 2e-25
 Identities = 43/182 (23%), Positives = 81/182 (44%), Gaps = 25/182 (13%)

Query: 92  KVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHL 151
           +VAI+ I     +    K   RE+   +   HENV+  +       C++   ++ ++T L
Sbjct: 57  EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA-----CMSP-PHLAIITSL 110

Query: 152 M-GADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELK 208
             G  L +++R  K  L  +  + +  +I++G+ Y+H+ GI+H+DLK  N+  +    + 
Sbjct: 111 CKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGK-VV 169

Query: 209 ILDFGLAR--------PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNI 260
           I DFGL            E+++        + APEI+       +   P   +D  P + 
Sbjct: 170 ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII-------RQLSPDTEEDKLPFSK 222

Query: 261 AV 262
             
Sbjct: 223 HS 224

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 43.1 bits (102), Expect = 9e-05
 Identities = 14/53 (26%), Positives = 22/53 (41%), Gaps = 9/53 (16%)

Query: 254 DLKPSNIAVNEDCELKILDFGLAR--------PTENEMTGYVATRWYRAPEIM 298
           DLK  N+  +    + I DFGL            E+++        + APEI+
Sbjct: 155 DLKSKNVFYDNGK-VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  107 bits (268), Expect = 3e-25
 Identities = 37/163 (22%), Positives = 65/163 (39%), Gaps = 16/163 (9%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           +G   A K +          +   +E++ +  + H  ++ L D F  +        + M+
Sbjct: 181 TGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN------EMVMI 232

Query: 149 THLM-GADL--NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI--AVNE 203
              M G +L         K+S+D     + Q+ +GL ++H    +H DLKP NI      
Sbjct: 233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKR 292

Query: 204 DCELKILDFGLARPTEN--EMTGYVATRWYRAPEIMLNWMHYN 244
             ELK++DFGL    +    +     T  + APE+        
Sbjct: 293 SNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV-AEGKPVG 334

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 79.9 bits (197), Expect = 3e-16
 Identities = 37/156 (23%), Positives = 60/156 (38%), Gaps = 28/156 (17%)

Query: 254 DLKPSNI--AVNEDCELKILDFGLARPTEN--EMTGYVATRWYRAPEIMLNWMHYN-QTD 308
           DLKP NI        ELK++DFGL    +    +     T  + APE+          TD
Sbjct: 280 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV-AEGKPVGYYTD 338

Query: 309 IHQLNLIMEML--GTPP------AEFMAKISSDSARKYINSLPLLTKKDF-RQVFKGANP 359
           +  + ++  +L  G  P       E +  +    +  +          +     F G + 
Sbjct: 339 MWSVGVLSYILLSGLSPFGGENDDETLRNVK---SCDW----------NMDDSAFSGISE 385

Query: 360 QAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPN 395
              D +  +L  D   R+T  QAL HP+L+  + P 
Sbjct: 386 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 421

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  104 bits (261), Expect = 4e-25
 Identities = 33/186 (17%), Positives = 65/186 (34%), Gaps = 39/186 (20%)

Query: 89  SGVKVAIKKIAR---------------PFQSAVHAKRTYRELRMLKHMNHENVIGLLDVF 133
                A+KK  +                            EL+++  + +E  +    + 
Sbjct: 53  DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGII 112

Query: 134 HSNTCLADFKNVYMVT----------HLMGADLNNILRTQKLSDDHVQFLVYQILRGLKY 183
            +         VY++                 + +   T  +    ++ ++  +L    Y
Sbjct: 113 TNY------DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSY 166

Query: 184 IHSA-GIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT----GYVATRWYRAPEIML 238
           IH+   I HRD+KPSNI ++++  +K+ DFG +    ++      G   T  +  PE   
Sbjct: 167 IHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRG---TYEFMPPEFFS 223

Query: 239 NWMHYN 244
           N   YN
Sbjct: 224 NESSYN 229

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 75.5 bits (186), Expect = 3e-15
 Identities = 43/167 (25%), Positives = 68/167 (40%), Gaps = 25/167 (14%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMT----GYVATRWYRAPEIMLNWMHYN--QT 307
           D+KPSNI ++++  +K+ DFG +    ++      G   T  +  PE   N   YN  + 
Sbjct: 177 DVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRG---TYEFMPPEFFSNESSYNGAKV 233

Query: 308 DIHQLNLIM-EML-GTPPAEFMAKISSDSARKYINS----LPLLTKKDFRQVFKGAN--- 358
           DI  L + +  M     P  F  KIS       I +     PL        +    +   
Sbjct: 234 DIWSLGICLYVMFYNVVP--FSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCS 291

Query: 359 -----PQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTS 400
                 + ID L L L  +  +RIT+E AL H +L+  +  +    S
Sbjct: 292 NNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLREFS 338

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  104 bits (261), Expect = 5e-25
 Identities = 42/155 (27%), Positives = 77/155 (49%), Gaps = 15/155 (9%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           +G+K+A K I    +     +    E+ ++  ++H N+I L D F S        ++ +V
Sbjct: 113 TGLKLAAKIIKT--RGMKDKEEVKNEISVMNQLDHANLIQLYDAFESK------NDIVLV 164

Query: 149 THLM-GADL-NNIL-RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI--AVNE 203
              + G +L + I+  +  L++      + QI  G++++H   I+H DLKP NI     +
Sbjct: 165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRD 224

Query: 204 DCELKILDFGLAR--PTENEMTGYVATRWYRAPEI 236
             ++KI+DFGLAR      ++     T  + APE+
Sbjct: 225 AKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEV 259

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 45/172 (26%), Positives = 78/172 (45%), Gaps = 28/172 (16%)

Query: 254 DLKPSNI--AVNEDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIMLNWMHYN-QTD 308
           DLKP NI     +  ++KI+DFGLAR      ++     T  + APE+ +N+   +  TD
Sbjct: 212 DLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEV-VNYDFVSFPTD 270

Query: 309 IHQLNLIMEML--GTPP------AEFMAKISSDSARKYINSLPLLTKKDF-RQVFKGANP 359
           +  + +I  ML  G  P      AE +  I    A ++          D   + F+  + 
Sbjct: 271 MWSVGVIAYMLLSGLSPFLGDNDAETLNNIL---ACRW----------DLEDEEFQDISE 317

Query: 360 QAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPPYDQSFEDMD 411
           +A + +S +L  +   RI+A +AL HP+LS +   +        ++  +  D
Sbjct: 318 EAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKKKNRGSDAQD 369

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  102 bits (256), Expect = 7e-25
 Identities = 47/159 (29%), Positives = 75/159 (47%), Gaps = 8/159 (5%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
            LD+ + V+VA  ++     +    +R   E  MLK + H N++   D + S       K
Sbjct: 45  GLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV--KGKK 102

Query: 144 NVYMVTHLM-GADLNNIL-RTQKLSDDHVQFLVYQILRGLKYIHSAG--IIHRDLKPSNI 199
            + +VT LM    L   L R + +    ++    QIL+GL+++H+    IIHRDLK  NI
Sbjct: 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNI 162

Query: 200 AVN-EDCELKILDFGLAR-PTENEMTGYVATRWYRAPEI 236
            +      +KI D GLA     +     + T  + APE+
Sbjct: 163 FITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEM 201

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 53.1 bits (128), Expect = 5e-08
 Identities = 27/151 (17%), Positives = 58/151 (38%), Gaps = 28/151 (18%)

Query: 254 DLKPSNIAVN-EDCELKILDFGLAR-PTENEMTGYVATRWYRAPEIMLNWMHYNQ-TDIH 310
           DLK  NI +      +KI D GLA     +     + T  + APE+      Y++  D++
Sbjct: 156 DLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE--KYDESVDVY 213

Query: 311 QLN-LIMEML-GTPP-------AEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQA 361
                ++EM     P       A+   +++S       + +              A P+ 
Sbjct: 214 AFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV--------------AIPEV 259

Query: 362 IDLLSLMLELDSEKRITAEQALAHPYLSQYS 392
            +++   +  + ++R + +  L H +  + +
Sbjct: 260 KEIIEGCIRQNKDERYSIKDLLNHAFFQEET 290

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  104 bits (261), Expect = 7e-25
 Identities = 40/167 (23%), Positives = 76/167 (45%), Gaps = 20/167 (11%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLADFKNVYM 147
           +  K A+K +           +  RE+ +        +++ ++DV+      A  K + +
Sbjct: 86  TQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYE--NLYAGRKCLLI 136

Query: 148 VTHLM-GADL-NNILR--TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI---A 200
           V   + G +L + I     Q  ++     ++  I   ++Y+HS  I HRD+KP N+   +
Sbjct: 137 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTS 196

Query: 201 VNEDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIMLNWMHYNQ 245
              +  LK+ DFG A+   + N +T    T +Y APE+ L    Y++
Sbjct: 197 KRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV-LGPEKYDK 242

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 81.3 bits (201), Expect = 6e-17
 Identities = 37/164 (22%), Positives = 70/164 (42%), Gaps = 33/164 (20%)

Query: 254 DLKPSNI---AVNEDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIMLNWMHYNQT- 307
           D+KP N+   +   +  LK+ DFG A+   + N +T    T +Y APE+ L    Y+++ 
Sbjct: 186 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV-LGPEKYDKSC 244

Query: 308 DIHQLNLIMEML--GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGA-------- 357
           D+  L +IM +L  G PP  F +      +                ++  G         
Sbjct: 245 DMWSLGVIMYILLCGYPP--FYSNHGLAISPGM-----------KTRIRMGQYEFPNPEW 291

Query: 358 ---NPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEP 398
              + +   L+  +L+ +  +R+T  + + HP++ Q +     P
Sbjct: 292 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 335

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  102 bits (257), Expect = 7e-25
 Identities = 38/171 (22%), Positives = 76/171 (44%), Gaps = 14/171 (8%)

Query: 84  ALDSVSGVKVAIKKIARP--FQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD 141
            LDS +  + A+K + +    +         +E+++L+ + H+NVI L+DV ++      
Sbjct: 24  VLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEK--- 80

Query: 142 FKNVYMVTHLM---GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSN 198
            + +YMV         ++ + +  ++           Q++ GL+Y+HS GI+H+D+KP N
Sbjct: 81  -QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGN 139

Query: 199 IAVNEDCELKILDFGLARPTENEMTGYVATRW-----YRAPEIMLNWMHYN 244
           + +     LKI   G+A                    ++ PEI      ++
Sbjct: 140 LLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFS 190

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 64.2 bits (157), Expect = 1e-11
 Identities = 33/168 (19%), Positives = 56/168 (33%), Gaps = 25/168 (14%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRW-----YRAPEIMLNWMHYN--Q 306
           D+KP N+ +     LKI   G+A                    ++ PEI      ++  +
Sbjct: 134 DIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFK 193

Query: 307 TDIHQLNLIMEML--GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFK---GANPQA 361
            DI    + +  +  G  P E               ++  L +   +  +       P  
Sbjct: 194 VDIWSAGVTLYNITTGLYPFE-------GD------NIYKLFENIGKGSYAIPGDCGPPL 240

Query: 362 IDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPPYDQSFED 409
            DLL  MLE +  KR +  Q   H +  +   P + P   P     +D
Sbjct: 241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKD 288

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  102 bits (257), Expect = 1e-24
 Identities = 51/209 (24%), Positives = 88/209 (42%), Gaps = 20/209 (9%)

Query: 41  PASKLPSRRLHDHFNQPYS--EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKI 98
            +   P   LH     P    E       +GP L    F  ++S  +     + VAIK +
Sbjct: 18  GSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYS-GIRVSDNLPVAIKHV 76

Query: 99  AR----PFQSAVHAKRTYRELRMLKHMNHE--NVIGLLDVFHSNTCLADFKNVYMVT-HL 151
            +     +    +  R   E+ +LK ++     VI LLD F          +  ++    
Sbjct: 77  EKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD------SFVLILERP 130

Query: 152 MGA-DL-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED-CELK 208
               DL + I     L ++  +   +Q+L  +++ H+ G++HRD+K  NI ++ +  ELK
Sbjct: 131 EPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK 190

Query: 209 ILDFGL-ARPTENEMTGYVATRWYRAPEI 236
           ++DFG  A   +   T +  TR Y  PE 
Sbjct: 191 LIDFGSGALLKDTVYTDFDGTRVYSPPEW 219

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 58.9 bits (143), Expect = 8e-10
 Identities = 33/157 (21%), Positives = 60/157 (38%), Gaps = 23/157 (14%)

Query: 254 DLKPSNIAVNED-CELKILDFGL-ARPTENEMTGYVATRWYRAPEIMLNWMHYN--QTDI 309
           D+K  NI ++ +  ELK++DFG  A   +   T +  TR Y  PE  + +  Y+     +
Sbjct: 174 DIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE-WIRYHRYHGRSAAV 232

Query: 310 HQLNLIM-EML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSL 367
             L +++ +M+ G  P E   +I                        +  + +   L+  
Sbjct: 233 WSLGILLYDMVCGDIPFEHDEEIIRGQVF-----FR-----------QRVSSECQHLIRW 276

Query: 368 MLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPPYD 404
            L L    R T E+   HP++     P +      + 
Sbjct: 277 CLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHS 313

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  101 bits (255), Expect = 1e-24
 Identities = 75/330 (22%), Positives = 119/330 (36%), Gaps = 99/330 (30%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
             D  + V++AIK+I  P + + +++  + E+ + KH+ H+N++  L  F  N  +    
Sbjct: 41  GRDLSNQVRIAIKEI--PERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFI---- 94

Query: 144 NVYM--VTHLMGADLNNILRTQ----KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPS 197
            ++M  V    G  L+ +LR++    K ++  + F   QIL GLKY+H   I+HRD+K  
Sbjct: 95  KIFMEQVP---GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGD 151

Query: 198 NIAVN-EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLK 256
           N+ +N     LKI DFG ++                             TG   Y     
Sbjct: 152 NVLINTYSGVLKISDFGTSKRLAGINP-----------------CTETFTGTLQY----- 189

Query: 257 PSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE-IMLNWMHYNQ-TDIHQLN- 313
                                     M          APE I      Y +  DI  L  
Sbjct: 190 --------------------------M----------APEIIDKGPRGYGKAADIWSLGC 213

Query: 314 LIMEML-GTPP----AEFMA---KISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLL 365
            I+EM  G PP     E  A   K+                 K   ++ +  + +A   +
Sbjct: 214 TIIEMATGKPPFYELGEPQAAMFKVG--------------MFKVHPEIPESMSAEAKAFI 259

Query: 366 SLMLELDSEKRITAEQALAHPYLSQYSDPN 395
               E D +KR  A   L   +L   S   
Sbjct: 260 LKCFEPDPDKRACANDLLVDEFLKVSSKKK 289

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  101 bits (253), Expect = 4e-24
 Identities = 40/160 (25%), Positives = 79/160 (49%), Gaps = 10/160 (6%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
           A   ++G +VAIK I +   +    ++ +RE+R++K +NH N++ L +V  +        
Sbjct: 34  ARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK------ 87

Query: 144 NVYMVT-HLMGADL-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
            +Y++  +  G ++ + ++   ++ +   +    QI+  ++Y H   I+HRDLK  N+ +
Sbjct: 88  TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL 147

Query: 202 NEDCELKILDFGL-ARPTENEM-TGYVATRWYRAPEIMLN 239
           + D  +KI DFG     T       +     Y APE+   
Sbjct: 148 DADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQG 187

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 61.5 bits (150), Expect = 1e-10
 Identities = 41/171 (23%), Positives = 64/171 (37%), Gaps = 28/171 (16%)

Query: 254 DLKPSNIAVNEDCELKILDFGL-ARPTENEM-TGYVATRWYRAPEIMLNWMHYN--QTDI 309
           DLK  N+ ++ D  +KI DFG     T       +     Y APE +     Y+  + D+
Sbjct: 139 DLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPE-LFQGKKYDGPEVDV 197

Query: 310 HQLNLIMEML--GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF---KGANPQAIDL 364
             L +I+  L  G+ P  F  +           +L  L ++  R  +      +    +L
Sbjct: 198 WSLGVILYTLVSGSLP--FDGQ-----------NLKELRERVLRGKYRIPFYMSTDCENL 244

Query: 365 LSLMLELDSEKRITAEQALAHP-----YLSQYSDPNDEPTSPPYDQSFEDM 410
           L   L L+  KR T EQ +        +      P  EP     DQ   D+
Sbjct: 245 LKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDI 295

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  101 bits (253), Expect = 4e-24
 Identities = 42/171 (24%), Positives = 69/171 (40%), Gaps = 21/171 (12%)

Query: 90  GVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT 149
           G KVA+K     F +   +     E+     M HEN++G +           +  +Y++T
Sbjct: 60  GEKVAVKVF---FTTEEASWFRETEIYQTVLMRHENILGFIAA--DIKGTGSWTQLYLIT 114

Query: 150 HLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSA--------GIIHRDLKPSNIA 200
                  L + L++  L    +  L Y  + GL ++H+          I HRDLK  NI 
Sbjct: 115 DYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNIL 174

Query: 201 VNEDCELKILDFGLAR-------PTENEMTGYVATRWYRAPEIMLNWMHYN 244
           V ++    I D GLA          +      V T+ Y  PE++   ++ N
Sbjct: 175 VKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRN 225

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  100 bits (250), Expect = 6e-24
 Identities = 43/165 (26%), Positives = 66/165 (40%), Gaps = 23/165 (13%)

Query: 90  GVKVAIKKI-ARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           G  VA+K   +R  +S         EL     + HEN++G +      T       ++++
Sbjct: 31  GENVAVKIFSSRDEKSWFRET----ELYNTVMLRHENILGFIAS--DMTSRHSSTQLWLI 84

Query: 149 THLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSA--------GIIHRDLKPSNI 199
           TH      L + L+   L       +V  I  GL ++H           I HRDLK  NI
Sbjct: 85  THYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNI 144

Query: 200 AVNEDCELKILDFGLAR-------PTENEMTGYVATRWYRAPEIM 237
            V ++ +  I D GLA          +      V T+ Y APE++
Sbjct: 145 LVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 21/80 (26%), Positives = 34/80 (42%), Gaps = 14/80 (17%)

Query: 254 DLKPSNIAVNEDCELKILDFGLAR-------PTENEMTGYVATRWYRAPEIM-----LNW 301
           DLK  NI V ++ +  I D GLA          +      V T+ Y APE++     ++ 
Sbjct: 138 DLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDC 197

Query: 302 MHYN-QTDIHQLNLIM-EML 319
                + DI    L++ E+ 
Sbjct: 198 FDSYKRVDIWAFGLVLWEVA 217

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  100 bits (250), Expect = 7e-24
 Identities = 48/183 (26%), Positives = 77/183 (42%), Gaps = 20/183 (10%)

Query: 67  DIGPTLSKESFDLIFSSALDSVSGVKVAIKKIAR----PFQSAVHAKRTYRELRMLKHMN 122
            +GP L K  F  +F+        ++VAIK I R     +     +     E+ +L  + 
Sbjct: 34  RLGPLLGKGGFGTVFA-GHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92

Query: 123 ----HENVIGLLDVFHSNTCLADFKNVYMVT--HLMGADL-NNILRTQKLSDDHVQFLVY 175
               H  VI LLD F +           +V    L   DL + I     L +   +    
Sbjct: 93  AGGGHPGVIRLLDWFETQE------GFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFG 146

Query: 176 QILRGLKYIHSAGIIHRDLKPSNIAVN-EDCELKILDFGL-ARPTENEMTGYVATRWYRA 233
           Q++  +++ HS G++HRD+K  NI ++      K++DFG  A   +   T +  TR Y  
Sbjct: 147 QVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSP 206

Query: 234 PEI 236
           PE 
Sbjct: 207 PEW 209

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 58.9 bits (143), Expect = 7e-10
 Identities = 31/168 (18%), Positives = 58/168 (34%), Gaps = 26/168 (15%)

Query: 254 DLKPSNIAVN-EDCELKILDFGL-ARPTENEMTGYVATRWYRAPEIMLNWMHYN--QTDI 309
           D+K  NI ++      K++DFG  A   +   T +  TR Y  PE  ++   Y+     +
Sbjct: 164 DIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPE-WISRHQYHALPATV 222

Query: 310 HQLNLIMEML--GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSL 367
             L +++  +  G  P E   +I      +     P              +P    L+  
Sbjct: 223 WSLGILLYDMVCGDIPFERDQEILE---AEL--HFP-----------AHVSPDCCALIRR 266

Query: 368 MLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVD 415
            L      R + E+ L  P++     P ++    P       +   + 
Sbjct: 267 CLAPKPSSRPSLEEILLDPWMQT---PAEDVPLNPSKGGPAPLAWSLL 311

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 99.6 bits (249), Expect = 9e-24
 Identities = 47/181 (25%), Positives = 84/181 (46%), Gaps = 32/181 (17%)

Query: 84  ALDSVSGVKVAIK-----KIARPFQSAVHAK-------------------RTYRELRMLK 119
           A +       A+K     K+ R                            + Y+E+ +LK
Sbjct: 32  AYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91

Query: 120 HMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQIL 178
            ++H NV+ L++V           ++YMV  L+    +  +   + LS+D  +F    ++
Sbjct: 92  KLDHPNVVKLVEVLDDPNE----DHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLI 147

Query: 179 RGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA---RPTENEMTGYVATRWYRAPE 235
           +G++Y+H   IIHRD+KPSN+ V ED  +KI DFG++   + ++  ++  V T  + APE
Sbjct: 148 KGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPE 207

Query: 236 I 236
            
Sbjct: 208 S 208

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 58.8 bits (143), Expect = 7e-10
 Identities = 35/146 (23%), Positives = 60/146 (41%), Gaps = 26/146 (17%)

Query: 254 DLKPSNIAVNEDCELKILDFGLA---RPTENEMTGYVATRWYRAPEIMLNWMH-YN--QT 307
           D+KPSN+ V ED  +KI DFG++   + ++  ++  V T  + APE +      ++    
Sbjct: 162 DIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKAL 221

Query: 308 DIHQLNLIMEML--GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFK-----GANPQ 360
           D+  + + +     G  P  FM              +  L  K   Q  +          
Sbjct: 222 DVWAMGVTLYCFVFGQCP--FMD-----------ERIMCLHSKIKSQALEFPDQPDIAED 268

Query: 361 AIDLLSLMLELDSEKRITAEQALAHP 386
             DL++ ML+ + E RI   +   HP
Sbjct: 269 LKDLITRMLDKNPESRIVVPEIKLHP 294

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 98.8 bits (247), Expect = 1e-23
 Identities = 28/157 (17%), Positives = 58/157 (36%), Gaps = 14/157 (8%)

Query: 90  GVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLA-DFKNVYMV 148
           G  + +K +     S   ++    E   L+  +H NV+ +L       C +    +  ++
Sbjct: 33  GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA-----CQSPPAPHPTLI 87

Query: 149 THLM-GADLNNILRTQK---LSDDHVQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVN 202
           TH M    L N+L       +           + RG+ ++H+    I    L   ++ ++
Sbjct: 88  THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID 147

Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN 239
           ED   +I    +      +  G +    + APE +  
Sbjct: 148 EDMTARISMADVKF--SFQSPGRMYAPAWVAPEALQK 182

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 98.9 bits (247), Expect = 2e-23
 Identities = 43/177 (24%), Positives = 76/177 (42%), Gaps = 29/177 (16%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           +G  + +K++ R  +         +E+++++ + H NV+  + V        D K +  +
Sbjct: 34  TGEVMVMKELIRFDEETQRTFL--KEVKVMRCLEHPNVLKFIGV-----LYKD-KRLNFI 85

Query: 149 THLM-GADLNNILRTQKLSDDHVQFL--VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
           T  + G  L  I+++        Q +     I  G+ Y+HS  IIHRDL   N  V E+ 
Sbjct: 86  TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENK 145

Query: 206 ELKILDFGLAR-----------------PTENEMTGYVATRWYRAPEIMLNWMHYNQ 245
            + + DFGLAR                 P   +    V   ++ APE M+N   Y++
Sbjct: 146 NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE-MINGRSYDE 201

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 19/70 (27%), Positives = 28/70 (40%), Gaps = 18/70 (25%)

Query: 254 DLKPSNIAVNEDCELKILDFGLAR-----------------PTENEMTGYVATRWYRAPE 296
           DL   N  V E+  + + DFGLAR                 P   +    V   ++ APE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192

Query: 297 IMLNWMHYNQ 306
            M+N   Y++
Sbjct: 193 -MINGRSYDE 201

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =   99 bits (249), Expect = 2e-23
 Identities = 64/333 (19%), Positives = 113/333 (33%), Gaps = 66/333 (19%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
                SG+ +A K I    + A+   +  REL++L   N   ++G    F+S+       
Sbjct: 52  VSHKPSGLVMARKLIHLEIKPAIR-NQIIRELQVLHECNSPYIVGFYGAFYSDGE----- 105

Query: 144 NVYMVTHLMGAD-LNNILRTQK-LSDDHVQFLVYQILRGLKYIHSAG-IIHRDLKPSNIA 200
            + +    M    L+ +L+    + +  +  +   +++GL Y+     I+HRD+KPSNI 
Sbjct: 106 -ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNIL 164

Query: 201 VNEDCELKILDFGLARPTENEMTG-YVATRWYRAPEIMLNWMHYNQ-------------- 245
           VN   E+K+ DFG++    + M   +V TR Y +PE  L   HY+               
Sbjct: 165 VNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPER-LQGTHYSVQSDIWSMGLSLVEM 223

Query: 246 -TGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHY 304
             G                 D +   L FG     +   T        R           
Sbjct: 224 AVGRYPIPP----------PDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRP 273

Query: 305 NQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDL 364
                  L+ I+                          P L    F   F+       D 
Sbjct: 274 PMAIFELLDYIVN----------------------EPPPKLPSGVFSLEFQ-------DF 304

Query: 365 LSLMLELDSEKRITAEQALAHPYLSQYSDPNDE 397
           ++  L  +  +R   +Q + H ++ +      +
Sbjct: 305 VNKCLIKNPAERADLKQLMVHAFIKRSDAEEVD 337

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 98.3 bits (245), Expect = 5e-23
 Identities = 39/173 (22%), Positives = 69/173 (39%), Gaps = 23/173 (13%)

Query: 90  GVKVAIKKI-ARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           G +VA+K   +R  +S         E+     + HEN++G +     N     +  +++V
Sbjct: 65  GEEVAVKIFSSREERSWFREA----EIYQTVMLRHENILGFIAA--DNKDNGTWTQLWLV 118

Query: 149 THLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSA--------GIIHRDLKPSNI 199
           +       L + L    ++ + +  L      GL ++H           I HRDLK  NI
Sbjct: 119 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 178

Query: 200 AVNEDCELKILDFGLAR-------PTENEMTGYVATRWYRAPEIMLNWMHYNQ 245
            V ++    I D GLA          +      V T+ Y APE++ + ++   
Sbjct: 179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH 231

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 21/80 (26%), Positives = 35/80 (43%), Gaps = 14/80 (17%)

Query: 254 DLKPSNIAVNEDCELKILDFGLAR-------PTENEMTGYVATRWYRAPEIMLN------ 300
           DLK  NI V ++    I D GLA          +      V T+ Y APE++ +      
Sbjct: 172 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH 231

Query: 301 WMHYNQTDIHQLNLIM-EML 319
           +  + + DI+ + L+  E+ 
Sbjct: 232 FESFKRADIYAMGLVFWEIA 251

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 97.7 bits (244), Expect = 6e-23
 Identities = 50/161 (31%), Positives = 83/161 (51%), Gaps = 18/161 (11%)

Query: 84  ALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           A    +  KVA+K I+R   + +    R  RE+  LK + H ++I L DV  + T     
Sbjct: 28  ATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT----- 82

Query: 143 KNVYMVTHLMGADL-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
            ++ MV    G +L + I+  +++++D  +    QI+  ++Y H   I+HRDLKP N+ +
Sbjct: 83  -DIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL 141

Query: 202 NEDCELKILDFGLARPTENEMT-GYVATRW-----YRAPEI 236
           +++  +KI DFGL+    N MT G           Y APE+
Sbjct: 142 DDNLNVKIADFGLS----NIMTDGNFLKTSCGSPNYAAPEV 178

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 57.3 bits (139), Expect = 3e-09
 Identities = 44/169 (26%), Positives = 70/169 (41%), Gaps = 35/169 (20%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMT-GYVATRW-----YRAPEIMLNWMHYN-- 305
           DLKP N+ ++++  +KI DFGL+    N MT G           Y APE ++N   Y   
Sbjct: 133 DLKPENLLLDDNLNVKIADFGLS----NIMTDGNFLKTSCGSPNYAAPE-VINGKLYAGP 187

Query: 306 QTDIHQLNLIMEML--GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF---KGANPQ 360
           + D+    +++ ++  G  P +       D        +P L KK    V+      +P 
Sbjct: 188 EVDVWSCGIVLYVMLVGRLPFD-------DE------FIPNLFKKVNSCVYVMPDFLSPG 234

Query: 361 AIDLLSLMLELDSEKRITAEQALAHP----YLSQYSDPNDEPTSPPYDQ 405
           A  L+  M+  D  +RIT ++    P     L  Y  P +E      D 
Sbjct: 235 AQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADS 283

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 96.5 bits (241), Expect = 7e-23
 Identities = 47/162 (29%), Positives = 80/162 (49%), Gaps = 19/162 (11%)

Query: 84  ALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
               ++G KVA+K + R   +S     +  RE++ LK   H ++I L  V  + T     
Sbjct: 30  GEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT----- 84

Query: 143 KNVYMVT-HLMGADL-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
            + +MV  ++ G +L + I +  ++ +   + L  QIL  + Y H   ++HRDLKP N+ 
Sbjct: 85  -DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVL 143

Query: 201 VNEDCELKILDFGLARPTENEMT--GYVATR----WYRAPEI 236
           ++     KI DFGL+    N M+   ++ T      Y APE+
Sbjct: 144 LDAHMNAKIADFGLS----NMMSDGEFLRTSCGSPNYAAPEV 181

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 52.6 bits (127), Expect = 7e-08
 Identities = 43/162 (26%), Positives = 65/162 (40%), Gaps = 39/162 (24%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMT--GYVATR----WYRAPEIMLNWMHYN-- 305
           DLKP N+ ++     KI DFGL+    N M+   ++ T      Y APE +++   Y   
Sbjct: 136 DLKPENVLLDAHMNAKIADFGLS----NMMSDGEFLRTSCGSPNYAAPE-VISGRLYAGP 190

Query: 306 QTDIHQLNLIMEML--GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGA------ 357
           + DI    +I+  L  GT P +       D        +P L    F+++  G       
Sbjct: 191 EVDIWSCGVILYALLCGTLPFD-------DE------HVPTL----FKKIRGGVFYIPEY 233

Query: 358 -NPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEP 398
            N     LL  ML++D  KR T +    H +  Q       P
Sbjct: 234 LNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYLFP 275

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 98.1 bits (244), Expect = 8e-23
 Identities = 30/182 (16%), Positives = 54/182 (29%), Gaps = 32/182 (17%)

Query: 86  DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV 145
           D+ +  K  +K          +     + +  LK       +                  
Sbjct: 91  DAKNKQKFVLKVQKPANPWEFYIGT--QLMERLKPSMQHMFMKFYSAHLFQNGS------ 142

Query: 146 YMVTHLM-GADLNNILRTQK------LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSN 198
            +V  L     L N +   K      +    V     ++L  ++ +H   IIH D+KP N
Sbjct: 143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDN 202

Query: 199 IAVNEDCE-----------LKILDFGLAR-----PTENEMTGYVATRWYRAPEIMLNWMH 242
             +                L ++D G +      P     T    T  ++  E ML+   
Sbjct: 203 FILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVE-MLSNKP 261

Query: 243 YN 244
           +N
Sbjct: 262 WN 263

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 95.3 bits (238), Expect = 2e-22
 Identities = 42/160 (26%), Positives = 72/160 (45%), Gaps = 14/160 (8%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
           A++ V+   VA+K +    ++    +   +E+ + K +NHENV+                
Sbjct: 26  AVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHENVVKFYGHRREGN------ 78

Query: 144 NVYMVT-HLMGADL-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
             Y+   +  G +L + I     + +   Q   +Q++ G+ Y+H  GI HRD+KP N+ +
Sbjct: 79  IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL 138

Query: 202 NEDCELKILDFGL-ARPTENEMTGYVATR----WYRAPEI 236
           +E   LKI DFGL      N     +        Y APE+
Sbjct: 139 DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 53.0 bits (128), Expect = 5e-08
 Identities = 31/146 (21%), Positives = 54/146 (36%), Gaps = 25/146 (17%)

Query: 254 DLKPSNIAVNEDCELKILDFGL-ARPTENEMTGYVATR----WYRAPEIMLNWMHYN--Q 306
           D+KP N+ ++E   LKI DFGL      N     +        Y APE +L    ++   
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE-LLKRREFHAEP 188

Query: 307 TDIHQLNLIM-EML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF----KGANPQ 360
            D+    +++  ML G  P +           +  +S    +    ++ +    K  +  
Sbjct: 189 VDVWSCGIVLTAMLAGELPWD-----------QPSDSCQEYSDWKEKKTYLNPWKKIDSA 237

Query: 361 AIDLLSLMLELDSEKRITAEQALAHP 386
            + LL  +L  +   RIT        
Sbjct: 238 PLALLHKILVENPSARITIPDIKKDR 263

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 96.6 bits (240), Expect = 3e-22
 Identities = 30/216 (13%), Positives = 64/216 (29%), Gaps = 40/216 (18%)

Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIK--------------------KIARPFQSAVH 107
            G  L +E        A D  +G    +                        R  +   +
Sbjct: 77  RGTVLGQEDPYAYLE-ATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 135

Query: 108 AKRTYRELR------MLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNIL- 160
            K+    LR      ++K    + +I +         L    + + +   M ++L     
Sbjct: 136 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVL----SRFFLYPRMQSNLQTFGE 191

Query: 161 -------RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG 213
                    + L       L  Q++R L  +H  G++H  L+P +I +++   + +  F 
Sbjct: 192 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFE 251

Query: 214 LARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVP 249
                +        +R +  PE+       +     
Sbjct: 252 HLVR-DGARVVSSVSRGFEPPELEARRATISYHRDR 286

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 95.5 bits (238), Expect = 3e-22
 Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 18/157 (11%)

Query: 90  GVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD-FKNVYMV 148
           G +VA+K + +P     H     +E+ +L+++ HEN++    +     C  D    + ++
Sbjct: 50  GEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENIVKYKGI-----CTEDGGNGIKLI 103

Query: 149 THLM-GADLNNILRTQKLSDDHVQFLVY--QILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
              +    L   L   K   +  Q L Y  QI +G+ Y+ S   +HRDL   N+ V  + 
Sbjct: 104 MEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH 163

Query: 206 ELKILDFGLARPTENEMTGYVAT-------RWYRAPE 235
           ++KI DFGL +  E +   Y           WY APE
Sbjct: 164 QVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY-APE 199

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 17/50 (34%), Positives = 23/50 (46%), Gaps = 8/50 (16%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT-------RWYRAPE 296
           DL   N+ V  + ++KI DFGL +  E +   Y           WY APE
Sbjct: 151 DLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY-APE 199

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 96.1 bits (239), Expect = 6e-22
 Identities = 52/344 (15%), Positives = 109/344 (31%), Gaps = 73/344 (21%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
           A    +G  V +++I     S         EL + K  NH N++     F ++  L    
Sbjct: 46  ARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL---- 101

Query: 144 NVYMVTHLMGA----DLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
             ++VT  M      DL        +++  + +++  +L+ L YIH  G +HR +K S+I
Sbjct: 102 --WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHI 159

Query: 200 AVNEDCELKILDFGLA---------RPTENEMTGY-VATRWYRAPEIMLNWMH-YNQ--- 245
            ++ D ++ +               +   ++   Y V    + +PE++   +  Y+    
Sbjct: 160 LISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSD 219

Query: 246 ------------TGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR 293
                        G   +  D+             ++L   L +                
Sbjct: 220 IYSVGITACELANGHVPFK-DMPA----------TQML---LEKLNGT------------ 253

Query: 294 APEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQV 353
            P +    +  +     +L +             +  +S       +S      + F   
Sbjct: 254 VPCL----LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPH 309

Query: 354 FKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDE 397
           F          +   L+ + + R +A   L H +  Q      E
Sbjct: 310 FH-------HFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASE 346

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 94.8 bits (236), Expect = 7e-22
 Identities = 42/190 (22%), Positives = 74/190 (38%), Gaps = 27/190 (14%)

Query: 71  TLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGL 129
            L++  F  ++  A D  SG + A+K++          +   +E+  +K +  H N++  
Sbjct: 35  VLAEGGFAFVYE-AQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQF 91

Query: 130 LDVFHSNTCLADFKN--VYMVTHLMG----ADLNNILRTQKLSDDHVQFLVYQILRGLKY 183
                     +D       ++T L        L  +     LS D V  + YQ  R +++
Sbjct: 92  CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQH 151

Query: 184 IHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRW----------- 230
           +H     IIHRDLK  N+ ++    +K+ DFG A    +      + +            
Sbjct: 152 MHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211

Query: 231 ----YRAPEI 236
               YR PEI
Sbjct: 212 TTPMYRTPEI 221

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 53.6 bits (129), Expect = 4e-08
 Identities = 34/191 (17%), Positives = 67/191 (35%), Gaps = 36/191 (18%)

Query: 238 LNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRW------ 291
           +  MH  +   P   +DLK  N+ ++    +K+ DFG A    +      + +       
Sbjct: 149 VQHMHRQKP--PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206

Query: 292 ---------YRAPEIMLNWMHY---NQTDIHQLNLIM-EML-GTPPAEFMAKISSDSARK 337
                    YR PEI+  + ++    + DI  L  I+  +     P E       D A+ 
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE-------DGAKL 259

Query: 338 YINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSD--PN 395
            I +          Q           L+  ML+++ E+R++  + +        +     
Sbjct: 260 RIVNGKYSIPPHDTQ-----YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNP 314

Query: 396 DEPTSPPYDQS 406
             P +   +Q+
Sbjct: 315 KSPITELLEQN 325

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 94.3 bits (235), Expect = 1e-21
 Identities = 42/160 (26%), Positives = 72/160 (45%), Gaps = 14/160 (8%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
           A++ V+   VA+K +    ++    +   +E+ + K +NHENV+                
Sbjct: 26  AVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHENVVKFYGHRREGN------ 78

Query: 144 NVYMVT-HLMGADL-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
             Y+   +  G +L + I     + +   Q   +Q++ G+ Y+H  GI HRD+KP N+ +
Sbjct: 79  IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL 138

Query: 202 NEDCELKILDFGL-ARPTENEMTGYVATR----WYRAPEI 236
           +E   LKI DFGL      N     +        Y APE+
Sbjct: 139 DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 55.8 bits (135), Expect = 7e-09
 Identities = 34/173 (19%), Positives = 57/173 (32%), Gaps = 26/173 (15%)

Query: 254 DLKPSNIAVNEDCELKILDFGL-ARPTENEMTGYVATR----WYRAPEIMLNWMHYN--Q 306
           D+KP N+ ++E   LKI DFGL      N     +        Y APE +L    ++   
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE-LLKRREFHAEP 188

Query: 307 TDIHQLNLIM-EML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF----KGANPQ 360
            D+    +++  ML G  P +           +  +S    +    ++ +    K  +  
Sbjct: 189 VDVWSCGIVLTAMLAGELPWD-----------QPSDSCQEYSDWKEKKTYLNPWKKIDSA 237

Query: 361 AIDLLSLMLELDSEKRITAEQALAHP-YLSQYSDPNDEPTSPPYDQSFEDMDL 412
            + LL  +L  +   RIT         Y          P       S      
Sbjct: 238 PLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGF 290

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 93.1 bits (232), Expect = 1e-21
 Identities = 31/135 (22%), Positives = 59/135 (43%), Gaps = 17/135 (12%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLADFKNVYM 147
           +  K A+K +           +  RE+ +        +++ ++DV+      A  K + +
Sbjct: 42  TQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYE--NLYAGRKCLLI 92

Query: 148 VTHLM-GADL-NNILR--TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV-- 201
           V   + G +L + I     Q  ++     ++  I   ++Y+HS  I HRD+KP N+    
Sbjct: 93  VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTS 152

Query: 202 -NEDCELKILDFGLA 215
              +  LK+ DFG A
Sbjct: 153 KRPNAILKLTDFGFA 167

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 64.2 bits (157), Expect = 1e-11
 Identities = 30/162 (18%), Positives = 57/162 (35%), Gaps = 50/162 (30%)

Query: 254 DLKPSNIAV---NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQT-DI 309
           D+KP N+       +  LK+ DFG A                   E       Y+++ D+
Sbjct: 142 DVKPENLLYTSKRPNAILKLTDFGFA------------------KETTGE--KYDKSCDM 181

Query: 310 HQLNLIMEML--GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGA---------- 357
             L +IM +L  G PP  F +      +                ++  G           
Sbjct: 182 WSLGVIMYILLCGYPP--FYSNHGLAISPGM-----------KTRIRMGQYEFPNPEWSE 228

Query: 358 -NPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEP 398
            + +   L+  +L+ +  +R+T  + + HP++ Q +     P
Sbjct: 229 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 270

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 93.6 bits (233), Expect = 2e-21
 Identities = 40/156 (25%), Positives = 66/156 (42%), Gaps = 16/156 (10%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL-ADFKNVYM 147
           +G  VA+K + +      H     +E+ +L+ + HE++I          C  A   ++ +
Sbjct: 59  TGEMVAVKAL-KADAGPQHRSGWKQEIDILRTLYHEHIIKYKGC-----CEDAGAASLQL 112

Query: 148 VTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE 206
           V   +    L + L    +    +     QI  G+ Y+H+   IHRDL   N+ ++ D  
Sbjct: 113 VMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL 172

Query: 207 LKILDFGLARPTENEMTGYVAT-------RWYRAPE 235
           +KI DFGLA+        Y           WY APE
Sbjct: 173 VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APE 207

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 40.4 bits (95), Expect = 8e-04
 Identities = 17/50 (34%), Positives = 22/50 (44%), Gaps = 8/50 (16%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT-------RWYRAPE 296
           DL   N+ ++ D  +KI DFGLA+        Y           WY APE
Sbjct: 159 DLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APE 207

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 92.7 bits (231), Expect = 2e-21
 Identities = 45/165 (27%), Positives = 75/165 (45%), Gaps = 33/165 (20%)

Query: 89  SGVKVAIKKI-------ARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD 141
           +G  VA+KK+        R F+         RE+ +LK + H+N++    V     C + 
Sbjct: 38  TGEVVAVKKLQHSTEEHLRDFE---------REIEILKSLQHDNIVKYKGV-----CYSA 83

Query: 142 FKN-VYMVTHLM-GADLNNILRTQKLSDDHVQFLVY--QILRGLKYIHSAGIIHRDLKPS 197
            +  + ++   +    L + L+  K   DH++ L Y  QI +G++Y+ +   IHRDL   
Sbjct: 84  GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATR 143

Query: 198 NIAVNEDCELKILDFGLARPTENEMTGYVAT-------RWYRAPE 235
           NI V  +  +KI DFGL +    +   +           WY APE
Sbjct: 144 NILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY-APE 187

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 41.5 bits (98), Expect = 3e-04
 Identities = 16/50 (32%), Positives = 21/50 (42%), Gaps = 8/50 (16%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT-------RWYRAPE 296
           DL   NI V  +  +KI DFGL +    +   +           WY APE
Sbjct: 139 DLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY-APE 187

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 93.4 bits (232), Expect = 2e-21
 Identities = 45/264 (17%), Positives = 74/264 (28%), Gaps = 41/264 (15%)

Query: 90  GVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT 149
              VA+K       +        + +  +  M H+N+   +      T         +V 
Sbjct: 36  ERPVAVKVF---SFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR-MEYLLVM 91

Query: 150 HLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSA---------GIIHRDLKPSNI 199
                  L   L            L + + RGL Y+H+           I HRDL   N+
Sbjct: 92  EYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNV 151

Query: 200 AVNEDCELKILDFGLAR-----------PTENEMTGYVATRWYRAPEIMLNWMHYNQTGV 248
            V  D    I DFGL+              +N     V T  Y APE++   ++      
Sbjct: 152 LVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXES 211

Query: 249 PFYFQDL---------------KPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR 293
                D+                        + ++         PT  +M   V+    R
Sbjct: 212 ALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQR 271

Query: 294 APEIMLNWMHYNQTDIHQLNLIME 317
            P+    W   +         I +
Sbjct: 272 -PKFPEAWKENSLAVRSLKETIED 294

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 91.9 bits (229), Expect = 4e-21
 Identities = 54/165 (32%), Positives = 83/165 (50%), Gaps = 25/165 (15%)

Query: 84  ALDSVSGVKVAIKKIARPFQS-AVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           A D++  +KVAIK I  P +      KR  RE+     ++H+N++ ++DV   + C    
Sbjct: 30  AEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDC---- 85

Query: 143 KNVYMVTHLM----GADLNNILRTQ-KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPS 197
              Y+V   M    G  L+  + +   LS D       QIL G+K+ H   I+HRD+KP 
Sbjct: 86  --YYLV---MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQ 140

Query: 198 NIAVNEDCELKILDFGLARP-TENEMT------GYVATRWYRAPE 235
           NI ++ +  LKI DFG+A+  +E  +T      G V    Y +PE
Sbjct: 141 NILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQ---YFSPE 182

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 47.6 bits (114), Expect = 3e-06
 Identities = 28/79 (35%), Positives = 42/79 (53%), Gaps = 12/79 (15%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARP-TENEMT------GYVATRWYRAPEIMLNWMHYNQ 306
           D+KP NI ++ +  LKI DFG+A+  +E  +T      G V    Y +PE          
Sbjct: 136 DIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQ---YFSPEQAKGEATDEC 192

Query: 307 TDIHQLNLIM-EML-GTPP 323
           TDI+ + +++ EML G PP
Sbjct: 193 TDIYSIGIVLYEMLVGEPP 211

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 92.4 bits (230), Expect = 4e-21
 Identities = 46/164 (28%), Positives = 74/164 (45%), Gaps = 33/164 (20%)

Query: 90  GVKVAIKKI-------ARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           G  VA+KK+        R F+         RE+ +LK + H+N++    V     C +  
Sbjct: 70  GEVVAVKKLQHSTEEHLRDFE---------REIEILKSLQHDNIVKYKGV-----CYSAG 115

Query: 143 KN-VYMVTHLM-GADLNNILRTQKLSDDHVQFLVY--QILRGLKYIHSAGIIHRDLKPSN 198
           +  + ++   +    L + L+  K   DH++ L Y  QI +G++Y+ +   IHRDL   N
Sbjct: 116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRN 175

Query: 199 IAVNEDCELKILDFGLARPTENEMTGYVAT-------RWYRAPE 235
           I V  +  +KI DFGL +    +   Y           WY APE
Sbjct: 176 ILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY-APE 218

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 17/50 (34%), Positives = 21/50 (42%), Gaps = 8/50 (16%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT-------RWYRAPE 296
           DL   NI V  +  +KI DFGL +    +   Y           WY APE
Sbjct: 170 DLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY-APE 218

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 92.0 bits (229), Expect = 5e-21
 Identities = 36/157 (22%), Positives = 78/157 (49%), Gaps = 12/157 (7%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
           A+D  +G +VAI+++    Q     +    E+ +++   + N++  LD +     L    
Sbjct: 39  AMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL---- 92

Query: 144 NVYMVTHLMGA-DLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
             ++V   +    L +++    + +  +  +  + L+ L+++HS  +IHRD+K  NI + 
Sbjct: 93  --WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 150

Query: 203 EDCELKILDFGLA---RPTENEMTGYVATRWYRAPEI 236
            D  +K+ DFG      P +++ +  V T ++ APE+
Sbjct: 151 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 52.3 bits (126), Expect = 9e-08
 Identities = 43/146 (29%), Positives = 68/146 (46%), Gaps = 20/146 (13%)

Query: 254 DLKPSNIAVNEDCELKILDFGLA---RPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIH 310
           D+K  NI +  D  +K+ DFG      P +++ +  V T ++ APE++    +  + DI 
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200

Query: 311 QLNLIM--EML-GTPPAEFMAKISSDSARKYI--NSLPLLTKKD-FRQVFKGANPQAIDL 364
            L  IM  EM+ G PP       +   A   I  N  P L   +    +F+       D 
Sbjct: 201 SLG-IMAIEMIEGEPP---YLNENPLRALYLIATNGTPELQNPEKLSAIFR-------DF 249

Query: 365 LSLMLELDSEKRITAEQALAHPYLSQ 390
           L+  LE+D EKR +A++ L H +L  
Sbjct: 250 LNRCLEMDVEKRGSAKELLQHQFLKI 275

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 91.5 bits (228), Expect = 6e-21
 Identities = 36/161 (22%), Positives = 69/161 (42%), Gaps = 16/161 (9%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLADF 142
                SG  +A+K+I     S    KR   +L +     +    +               
Sbjct: 26  MRHVPSGQIMAVKRIRATVNSQEQ-KRLLMDLDISMRTVDCPFTVTFYGALFREGD---- 80

Query: 143 KNVYMVTHLMGADLNNIL-----RTQKLSDDHVQFLVYQILRGLKYIHSAG-IIHRDLKP 196
             V++   LM   L+        + Q + +D +  +   I++ L+++HS   +IHRD+KP
Sbjct: 81  --VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKP 138

Query: 197 SNIAVNEDCELKILDFGLARPTENEMTG--YVATRWYRAPE 235
           SN+ +N   ++K+ DFG++    +++        + Y APE
Sbjct: 139 SNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPE 179

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 57.6 bits (140), Expect = 1e-09
 Identities = 35/157 (22%), Positives = 70/157 (44%), Gaps = 29/157 (18%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTG--YVATRWYRAPE-IM--LNWMHYN-QT 307
           D+KPSN+ +N   ++K+ DFG++    +++        + Y APE I   LN   Y+ ++
Sbjct: 135 DVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKS 194

Query: 308 DIHQLNL-IMEM-LGTPP-------AEFMAKISSDSARKYINSLPLLTKKDFRQVFKGAN 358
           DI  L + ++E+ +   P        + + ++  + +       P L    F   F    
Sbjct: 195 DIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS-------PQLPADKFSAEFV--- 244

Query: 359 PQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPN 395
               D  S  L+ +S++R T  + + HP+ + +    
Sbjct: 245 ----DFTSQCLKKNSKERPTYPELMQHPFFTLHESKG 277

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 91.7 bits (228), Expect = 7e-21
 Identities = 40/164 (24%), Positives = 74/164 (45%), Gaps = 17/164 (10%)

Query: 84  ALDSVSGVKVAIKKI---ARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCL 139
                +G   AIK +       +         +E+ MLK   +H N+      F      
Sbjct: 43  GRHVKTGQLAAIKVMDVTGDEEEEIK------QEINMLKKYSHHRNIATYYGAFIKKNPP 96

Query: 140 ADFKNVYMVTHLMGA----DLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLK 195
                +++V    GA    DL    +   L ++ + ++  +ILRGL ++H   +IHRD+K
Sbjct: 97  GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIK 156

Query: 196 PSNIAVNEDCELKILDFGLAR---PTENEMTGYVATRWYRAPEI 236
             N+ + E+ E+K++DFG++     T      ++ T ++ APE+
Sbjct: 157 GQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 200

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 50.1 bits (120), Expect = 6e-07
 Identities = 35/154 (22%), Positives = 68/154 (44%), Gaps = 22/154 (14%)

Query: 254 DLKPSNIAVNEDCELKILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMH----YNQ 306
           D+K  N+ + E+ E+K++DFG++     T      ++ T ++ APE++    +    Y+ 
Sbjct: 154 DIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDF 213

Query: 307 -TDIHQLNL-IMEML-GTPPAEFMAKISSDSARKYI--NSLPLLTKKDFRQVFKGANPQA 361
            +D+  L +  +EM  G PP   +  +    A   I  N  P L  K + + F+      
Sbjct: 214 KSDLWSLGITAIEMAEGAPP---LCDMHPMRALFLIPRNPAPRLKSKKWSKKFQ------ 264

Query: 362 IDLLSLMLELDSEKRITAEQALAHPYLSQYSDPN 395
              +   L  +  +R   EQ + HP++    +  
Sbjct: 265 -SFIESCLVKNHSQRPATEQLMKHPFIRDQPNER 297

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 93.3 bits (232), Expect = 8e-21
 Identities = 48/163 (29%), Positives = 82/163 (50%), Gaps = 21/163 (12%)

Query: 84  ALDSVSGVKVAIKKIARP-FQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
               ++G KVA+K + R   +S     +  RE++ LK   H ++I L  V  + +     
Sbjct: 35  GKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS----- 89

Query: 143 KNVYMVT-HLMGADL-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
            +++MV  ++ G +L + I +  +L +   + L  QIL G+ Y H   ++HRDLKP N+ 
Sbjct: 90  -DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVL 148

Query: 201 VNEDCELKILDFGLARPTENEMT--GYVATRW-----YRAPEI 236
           ++     KI DFGL+    N M+   ++ T       Y APE+
Sbjct: 149 LDAHMNAKIADFGLS----NMMSDGEFLRT-SCGSPNYAAPEV 186

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 49/172 (28%), Positives = 72/172 (41%), Gaps = 33/172 (19%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMT--GYVATRW-----YRAPEIMLNWMHYN- 305
           DLKP N+ ++     KI DFGL+    N M+   ++ T       Y APE +++   Y  
Sbjct: 141 DLKPENVLLDAHMNAKIADFGLS----NMMSDGEFLRT-SCGSPNYAAPE-VISGRLYAG 194

Query: 306 -QTDIHQLNLIMEML--GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF---KGANP 359
            + DI    +I+  L  GT P +       D        +P L KK    +F   +  NP
Sbjct: 195 PEVDIWSSGVILYALLCGTLPFD-------DD------HVPTLFKKICDGIFYTPQYLNP 241

Query: 360 QAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPPYDQSFEDMD 411
             I LL  ML++D  KR T +    H +  Q       P  P Y  +  D +
Sbjct: 242 SVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDE 293

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 91.7 bits (228), Expect = 9e-21
 Identities = 35/157 (22%), Positives = 75/157 (47%), Gaps = 12/157 (7%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
           A +  SG +VA+K +    +     +  + E+ +++   H NV+ +   +     L    
Sbjct: 64  AREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL---- 117

Query: 144 NVYMVTHLMGA-DLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
             +++   +    L +I+   +L+++ +  +   +L+ L Y+H+ G+IHRD+K  +I + 
Sbjct: 118 --WVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLT 175

Query: 203 EDCELKILDFGLA---RPTENEMTGYVATRWYRAPEI 236
            D  +K+ DFG          +    V T ++ APE+
Sbjct: 176 LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEV 212

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 52.8 bits (127), Expect = 8e-08
 Identities = 43/150 (28%), Positives = 65/150 (43%), Gaps = 20/150 (13%)

Query: 254 DLKPSNIAVNEDCELKILDFGLA---RPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIH 310
           D+K  +I +  D  +K+ DFG          +    V T ++ APE++   ++  + DI 
Sbjct: 166 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIW 225

Query: 311 QLNLIM--EML-GTPPAEFMAKISSDSARKYI--NSLPLLTKKD-FRQVFKGANPQAIDL 364
            L  IM  EM+ G PP       S   A K +  +  P L        V +       D 
Sbjct: 226 SLG-IMVIEMVDGEPP---YFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLR-------DF 274

Query: 365 LSLMLELDSEKRITAEQALAHPYLSQYSDP 394
           L  ML  D ++R TA++ L HP+L Q   P
Sbjct: 275 LERMLVRDPQERATAQELLDHPFLLQTGLP 304

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 93.8 bits (233), Expect = 1e-20
 Identities = 45/159 (28%), Positives = 70/159 (44%), Gaps = 15/159 (9%)

Query: 84  ALD-SVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           ALD +V+G  V +K        A        E + L  + H +++ + +         D 
Sbjct: 99  ALDRNVNGRPVVLK-GLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD- 156

Query: 143 KNVYMVTHLM----GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSN 198
              Y+V   M    G  L      QKL        + +IL  L Y+HS G+++ DLKP N
Sbjct: 157 PVGYIV---MEYVGGQSLKRSKG-QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPEN 212

Query: 199 IAVNEDCELKILDFGLARPTENEMTGYVA-TRWYRAPEI 236
           I + E+ +LK++D G          GY+  T  ++APEI
Sbjct: 213 IMLTEE-QLKLIDLGAVSRI--NSFGYLYGTPGFQAPEI 248

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 44.8 bits (106), Expect = 4e-05
 Identities = 22/73 (30%), Positives = 35/73 (47%), Gaps = 7/73 (9%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVA-TRWYRAPEIMLNWMHYNQTDIHQL 312
           DLKP NI + E+ +LK++D G          GY+  T  ++APEI+        TDI+ +
Sbjct: 207 DLKPENIMLTEE-QLKLIDLGAVSRI--NSFGYLYGTPGFQAPEIVRT-GPTVATDIYTV 262

Query: 313 NLIM-EML-GTPP 323
              +  +    P 
Sbjct: 263 GRTLAALTLDLPT 275

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 90.9 bits (226), Expect = 1e-20
 Identities = 47/245 (19%), Positives = 91/245 (37%), Gaps = 45/245 (18%)

Query: 90  GVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLL--DVFHSNTCLADFKNVYM 147
              VA+K           + +   E+  L  M HEN++  +  +   ++       ++++
Sbjct: 47  NEYVAVKIF---PIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD----VDLWL 99

Query: 148 VTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSA----------GIIHRDLKP 196
           +T       L++ L+   +S + +  +   + RGL Y+H             I HRD+K 
Sbjct: 100 ITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKS 159

Query: 197 SNIAVNEDCELKILDFGLAR-----PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFY 251
            N+ +  +    I DFGLA       +  +  G V TR Y APE++   +++ +      
Sbjct: 160 KNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRD----A 215

Query: 252 FQ--D-------------LKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE 296
           F   D                +     ++  L   +     P+  +M   V  +  R P 
Sbjct: 216 FLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKR-PV 274

Query: 297 IMLNW 301
           +   W
Sbjct: 275 LRDYW 279

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 90.5 bits (225), Expect = 2e-20
 Identities = 43/159 (27%), Positives = 75/159 (47%), Gaps = 21/159 (13%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTY-RELRMLKHMNHENVIGLLDVFHSNTCLADFKN-VY 146
           +G  VA+K++     S    +R + RE+++LK ++ + ++    V          +  + 
Sbjct: 51  TGALVAVKQLQ---HSGPDQQRDFQREIQILKALHSDFIVKYRGV-----SYGPGRQSLR 102

Query: 147 MVTHLM-GADLNNILRTQKLSDDHVQFLVY--QILRGLKYIHSAGIIHRDLKPSNIAVNE 203
           +V   +    L + L+  +   D  + L+Y  QI +G++Y+ S   +HRDL   NI V  
Sbjct: 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVES 162

Query: 204 DCELKILDFGLARPTENEMTGYVAT-------RWYRAPE 235
           +  +KI DFGLA+    +   YV          WY APE
Sbjct: 163 EAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY-APE 200

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 40.8 bits (96), Expect = 6e-04
 Identities = 19/50 (38%), Positives = 23/50 (46%), Gaps = 8/50 (16%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT-------RWYRAPE 296
           DL   NI V  +  +KI DFGLA+    +   YV          WY APE
Sbjct: 152 DLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY-APE 200

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 91.7 bits (227), Expect = 2e-20
 Identities = 25/184 (13%), Positives = 53/184 (28%), Gaps = 31/184 (16%)

Query: 84  ALDSVSGVKVAIK--------------------KIARPFQSAVHAKRTYRELRMLKHMNH 123
           A D  +G    +                        R  +   + K+    LR +   + 
Sbjct: 97  ATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156

Query: 124 ENVIGLLDVFHSNTCLADF--KNVYMVTHLMGADLNNILRT--------QKLSDDHVQFL 173
                   +        D    + + +   M ++L              + L       L
Sbjct: 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQL 216

Query: 174 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRA 233
             Q++R L  +H  G++H  L+P +I +++   + +  F      +         R +  
Sbjct: 217 TLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR-DGASAVSPIGRGFAP 275

Query: 234 PEIM 237
           PE  
Sbjct: 276 PETT 279

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 90.9 bits (226), Expect = 2e-20
 Identities = 44/160 (27%), Positives = 71/160 (44%), Gaps = 17/160 (10%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
             D ++   VA+K I R    A   +   RE+   + + H N++   +V  + T      
Sbjct: 39  MRDKLTKELVAVKYIER---GAAIDENVQREIINHRSLRHPNIVRFKEVILTPT------ 89

Query: 144 NVYMVT-HLMGADL-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           ++ ++  +  G +L   I    + S+D  +F   Q+L G+ Y HS  I HRDLK  N  +
Sbjct: 90  HLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLL 149

Query: 202 --NEDCELKILDFGL-ARPTENEM--TGYVATRWYRAPEI 236
             +    LKI DFG       +    +  V T  Y APE+
Sbjct: 150 DGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEV 188

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 50.4 bits (121), Expect = 5e-07
 Identities = 36/181 (19%), Positives = 63/181 (34%), Gaps = 34/181 (18%)

Query: 254 DLKPSNIAV--NEDCELKILDFGL-ARPTENEM--TGYVATRWYRAPEIMLNWMHYN--Q 306
           DLK  N  +  +    LKI DFG       +    +  V T  Y APE +L    Y+   
Sbjct: 141 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPE-VLLRQEYDGKI 198

Query: 307 TDIHQLNLIMEML--GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGA------- 357
            D+    + + ++  G  P E       D         P   +K  +++           
Sbjct: 199 ADVWSCGVTLYVMLVGAYPFE-------DP------EEPRDYRKTIQRILSVKYSIPDDI 245

Query: 358 --NPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVD 415
             +P+   L+S +   D   RI+  +   H +    + P D          F++ + P+ 
Sbjct: 246 RISPECCHLISRIFVADPATRISIPEIKTHSWF-LKNLPADLMNESNTGSQFQEPEQPMQ 304

Query: 416 Q 416
            
Sbjct: 305 S 305

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 90.9 bits (226), Expect = 4e-20
 Identities = 46/202 (22%), Positives = 82/202 (40%), Gaps = 18/202 (8%)

Query: 39  VYPASKLPSRRLHDHFNQPYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKI 98
           + P     +    D F +    +    + +  T+ K  F  +         G KVA+K I
Sbjct: 168 IKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCI 224

Query: 99  ARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLN 157
                +   A+    E  ++  + H N++ LL V      + +   +Y+VT  M    L 
Sbjct: 225 K----NDATAQAFLAEASVMTQLRHSNLVQLLGV-----IVEEKGGLYIVTEYMAKGSLV 275

Query: 158 NILRTQKLSDDHVQFLV---YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL 214
           + LR++  S      L+     +   ++Y+     +HRDL   N+ V+ED   K+ DFGL
Sbjct: 276 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 335

Query: 215 ARPTENEMTGY-VATRWYRAPE 235
            +   +      +  +W  APE
Sbjct: 336 TKEASSTQDTGKLPVKWT-APE 356

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 88.8 bits (221), Expect = 7e-20
 Identities = 44/154 (28%), Positives = 68/154 (44%), Gaps = 18/154 (11%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           + VAIK++ R   S    K    E  ++  +++ +V  LL +     CL     V ++T 
Sbjct: 45  IPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCRLLGI-----CLTS--TVQLITQ 96

Query: 151 LM-GADLNNILRTQKLSDDHVQFL--VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
           LM    L + +R  K +      L    QI +G+ Y+    ++HRDL   N+ V     +
Sbjct: 97  LMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHV 156

Query: 208 KILDFGLARPTENEMTGYVAT------RWYRAPE 235
           KI DFGLA+    E   Y A       +W  A E
Sbjct: 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWM-ALE 189

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 88.5 bits (220), Expect = 9e-20
 Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 23/167 (13%)

Query: 84  ALDSVSGVKVAIKKIARPFQS-AVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           A D      VA+K +            R  RE +    +NH  ++ + D   + T     
Sbjct: 31  ARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90

Query: 143 KNVYMVTHLM----GADLNNILRTQ-KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPS 197
              Y+V   M    G  L +I+ T+  ++      ++    + L + H  GIIHRD+KP+
Sbjct: 91  --PYIV---MEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPA 145

Query: 198 NIAVNEDCELKILDFGLAR---PTENEMT------GYVATRWYRAPE 235
           NI ++    +K++DFG+AR    + N +T      G      Y +PE
Sbjct: 146 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ---YLSPE 189

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 44.9 bits (107), Expect = 3e-05
 Identities = 24/81 (29%), Positives = 42/81 (51%), Gaps = 14/81 (17%)

Query: 254 DLKPSNIAVNEDCELKILDFGLAR---PTENEMT------GYVATRWYRAPEIMLNWMHY 304
           D+KP+NI ++    +K++DFG+AR    + N +T      G      Y +PE        
Sbjct: 141 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ---YLSPEQARGDSVD 197

Query: 305 NQTDIHQLNLIM-EML-GTPP 323
            ++D++ L  ++ E+L G PP
Sbjct: 198 ARSDVYSLGCVLYEVLTGEPP 218

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 41/159 (25%), Positives = 79/159 (49%), Gaps = 13/159 (8%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTY-RELRMLKHMNHENVIGLLDVFHSNTCLADF 142
            +D+ +   VAIK I    + A        +E+ +L   +   V      +  +T L   
Sbjct: 41  GIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL--- 95

Query: 143 KNVYMVTHLMGA-DLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
              +++   +G     ++L    L +  +  ++ +IL+GL Y+HS   IHRD+K +N+ +
Sbjct: 96  ---WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL 152

Query: 202 NEDCELKILDFGLA---RPTENEMTGYVATRWYRAPEIM 237
           +E  E+K+ DFG+A     T+ +   +V T ++ APE++
Sbjct: 153 SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 191

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 34/150 (22%), Positives = 72/150 (48%), Gaps = 18/150 (12%)

Query: 254 DLKPSNIAVNEDCELKILDFGLA---RPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIH 310
           D+K +N+ ++E  E+K+ DFG+A     T+ +   +V T ++ APE++    + ++ DI 
Sbjct: 144 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIW 203

Query: 311 QLNL-IMEML-GTPPAEFMAKISSDSARKYI--NSLPLLTKKDFRQVFKGANPQAIDLLS 366
            L +  +E+  G PP    +++        I  N+ P L + ++ +  K       + + 
Sbjct: 204 SLGITAIELARGEPP---HSELHPMKVLFLIPKNNPPTL-EGNYSKPLK-------EFVE 252

Query: 367 LMLELDSEKRITAEQALAHPYLSQYSDPND 396
             L  +   R TA++ L H ++ + +    
Sbjct: 253 ACLNKEPSFRPTAKELLKHKFILRNAKKTS 282

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 30/162 (18%), Positives = 63/162 (38%), Gaps = 17/162 (10%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLADF 142
            +   SG  +A+K+I          K+   +L ++    +   ++               
Sbjct: 41  MVHKPSGQIMAVKRIRSTVDEKEQ-KQLLMDLDVVMRSSDCPYIVQFYGALFREGD---- 95

Query: 143 KNVYMVTHLMGADLNNILRT------QKLSDDHVQFLVYQILRGLKYIHSAG-IIHRDLK 195
              ++   LM    +   +         + ++ +  +    ++ L ++     IIHRD+K
Sbjct: 96  --CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIK 153

Query: 196 PSNIAVNEDCELKILDFGLARPTENEM--TGYVATRWYRAPE 235
           PSNI ++    +K+ DFG++    + +  T     R Y APE
Sbjct: 154 PSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 195

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 41/155 (26%), Positives = 67/155 (43%), Gaps = 18/155 (11%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           V VAIK + +   +    +    E  ++   +H N+I L  V          +   +VT 
Sbjct: 78  VPVAIKAL-KAGYTERQRRDFLSEASIMGQFDHPNIIRLEGV-----VTRG-RLAMIVTE 130

Query: 151 LM-GADLNNILRTQKLSDDHVQFL--VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
            M    L+  LRT       +Q +  +  +  G++Y+   G +HRDL   N+ V+ +   
Sbjct: 131 YMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVC 190

Query: 208 KILDFGLARPTENEMTGYVAT-------RWYRAPE 235
           K+ DFGL+R  E++      T       RW  APE
Sbjct: 191 KVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT-APE 224

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 40.7 bits (96), Expect = 5e-04
 Identities = 17/50 (34%), Positives = 24/50 (48%), Gaps = 8/50 (16%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT-------RWYRAPE 296
           DL   N+ V+ +   K+ DFGL+R  E++      T       RW  APE
Sbjct: 176 DLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT-APE 224

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 86.5 bits (215), Expect = 2e-19
 Identities = 42/151 (27%), Positives = 71/151 (47%), Gaps = 15/151 (9%)

Query: 90  GVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT 149
           G KVA+K I    ++   A+    E  ++  + H N++ LL V      + +   +Y+VT
Sbjct: 44  GNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLGV-----IVEEKGGLYIVT 94

Query: 150 HLM-GADLNNILRTQKLSDDHVQFLV---YQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
             M    L + LR++  S      L+     +   ++Y+     +HRDL   N+ V+ED 
Sbjct: 95  EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN 154

Query: 206 ELKILDFGLARPT-ENEMTGYVATRWYRAPE 235
             K+ DFGL +     + TG +  +W  APE
Sbjct: 155 VAKVSDFGLTKEASSTQDTGKLPVKWT-APE 184

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 86.5 bits (215), Expect = 3e-19
 Identities = 35/154 (22%), Positives = 69/154 (44%), Gaps = 17/154 (11%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
             VA+K +               E  +++ +++  ++ ++ +     C A+  +  +V  
Sbjct: 45  KTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI-----CEAE--SWMLVME 97

Query: 151 LM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELK 208
           +     LN  L+  + + D ++  LV+Q+  G+KY+  +  +HRDL   N+ +      K
Sbjct: 98  MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAK 157

Query: 209 ILDFGLARPTENEMTGYVAT-------RWYRAPE 235
           I DFGL++    +   Y A        +WY APE
Sbjct: 158 ISDFGLSKALRADENYYKAQTHGKWPVKWY-APE 190

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 16/50 (32%), Positives = 22/50 (44%), Gaps = 8/50 (16%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT-------RWYRAPE 296
           DL   N+ +      KI DFGL++    +   Y A        +WY APE
Sbjct: 142 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APE 190

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 86.6 bits (215), Expect = 3e-19
 Identities = 36/161 (22%), Positives = 78/161 (48%), Gaps = 14/161 (8%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
           A +  +G   A K I    +S    +    E+ +L   +H  ++ LL  ++ +  L    
Sbjct: 38  AKNKETGALAAAKVI--ETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKL---- 91

Query: 144 NVYMVTHLMGA-DLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
             +++        ++ I+      L++  +Q +  Q+L  L ++HS  IIHRDLK  N+ 
Sbjct: 92  --WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVL 149

Query: 201 VNEDCELKILDFGLA---RPTENEMTGYVATRWYRAPEIML 238
           +  + ++++ DFG++     T  +   ++ T ++ APE+++
Sbjct: 150 MTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM 190

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 36/156 (23%), Positives = 67/156 (42%), Gaps = 25/156 (16%)

Query: 254 DLKPSNIAVNEDCELKILDFGLA---RPTENEMTGYVATRWYRAPEIMLNWM----HYNQ 306
           DLK  N+ +  + ++++ DFG++     T  +   ++ T ++ APE+++        Y+ 
Sbjct: 142 DLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDY 201

Query: 307 -TDIHQLNLIM--EML-GTPPAEFMAKISSDSARKYI--NSLPLLTKKD-FRQVFKGANP 359
             DI  L  I   EM    PP     +++       I  +  P L     +   F+    
Sbjct: 202 KADIWSLG-ITLIEMAQIEPP---HHELNPMRVLLKIAKSDPPTLLTPSKWSVEFR---- 253

Query: 360 QAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPN 395
              D L + L+ + E R +A Q L HP++S  +   
Sbjct: 254 ---DFLKIALDKNPETRPSAAQLLEHPFVSSITSNK 286

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 87.5 bits (217), Expect = 3e-19
 Identities = 41/156 (26%), Positives = 73/156 (46%), Gaps = 10/156 (6%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTY-RELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           A D  +   VAIKK++   + +    +   +E+R L+ + H N I     +         
Sbjct: 73  ARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA--- 129

Query: 143 KNVYMVTHLMGADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
              ++V        +++L   K  L +  +  + +  L+GL Y+HS  +IHRD+K  NI 
Sbjct: 130 ---WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNIL 186

Query: 201 VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI 236
           ++E   +K+ DFG A         +V T ++ APE+
Sbjct: 187 LSEPGLVKLGDFGSA-SIMAPANSFVGTPYWMAPEV 221

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 50.1 bits (120), Expect = 7e-07
 Identities = 36/145 (24%), Positives = 65/145 (44%), Gaps = 20/145 (13%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW--MHYNQ-TDIH 310
           D+K  NI ++E   +K+ DFG A         +V T ++ APE++L      Y+   D+ 
Sbjct: 179 DVKAGNILLSEPGLVKLGDFGSA-SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVW 237

Query: 311 QLNLIM--EML-GTPPAEFMAKISSDSARKYI--NSLPLLTKKDFRQVFKGANPQAIDLL 365
            L  I   E+    PP   +  +++ SA  +I  N  P L    + + F+       + +
Sbjct: 238 SLG-ITCIELAERKPP---LFNMNAMSALYHIAQNESPALQSGHWSEYFR-------NFV 286

Query: 366 SLMLELDSEKRITAEQALAHPYLSQ 390
              L+   + R T+E  L H ++ +
Sbjct: 287 DSCLQKIPQDRPTSEVLLKHRFVLR 311

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 86.1 bits (214), Expect = 4e-19
 Identities = 45/156 (28%), Positives = 62/156 (39%), Gaps = 19/156 (12%)

Query: 91  VKVAIKKIARPFQSAVHAKRTY-RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT 149
           V VA+K +     S   A   + RE+  +  ++H N+I L  V      L     + MVT
Sbjct: 47  VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGV-----VLTP--PMKMVT 99

Query: 150 HLM-GADLNNILRTQKLSDDHVQFLVY--QILRGLKYIHSAGIIHRDLKPSNIAVNEDCE 206
            L     L + LR  +          Y  Q+  G+ Y+ S   IHRDL   N+ +     
Sbjct: 100 ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL 159

Query: 207 LKILDFGLARPTENEMTGYVAT-------RWYRAPE 235
           +KI DFGL R        YV          W  APE
Sbjct: 160 VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC-APE 194

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 40.3 bits (95), Expect = 8e-04
 Identities = 16/50 (32%), Positives = 19/50 (38%), Gaps = 8/50 (16%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT-------RWYRAPE 296
           DL   N+ +     +KI DFGL R        YV          W  APE
Sbjct: 146 DLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC-APE 194

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 85.8 bits (213), Expect = 5e-19
 Identities = 36/155 (23%), Positives = 67/155 (43%), Gaps = 19/155 (12%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           + VAIK + +        +   RE +++  +++  ++ L+ V     C A+   + +V  
Sbjct: 38  IDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV-----CQAE--ALMLVME 89

Query: 151 LM-GADLNNILRTQKLSDDHVQFLVY--QILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
           +  G  L+  L  ++             Q+  G+KY+     +HRDL   N+ +      
Sbjct: 90  MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYA 149

Query: 208 KILDFGLARPTENEMTGYVAT-------RWYRAPE 235
           KI DFGL++    + + Y A        +WY APE
Sbjct: 150 KISDFGLSKALGADDSYYTARSAGKWPLKWY-APE 183

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 40.7 bits (96), Expect = 5e-04
 Identities = 16/50 (32%), Positives = 23/50 (46%), Gaps = 8/50 (16%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT-------RWYRAPE 296
           DL   N+ +      KI DFGL++    + + Y A        +WY APE
Sbjct: 135 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY-APE 183

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 88.3 bits (219), Expect = 5e-19
 Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 23/157 (14%)

Query: 90  GVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT 149
            + VA+K +    +  +  +   +E  ++K + H N++ LL V     C  +    Y++T
Sbjct: 245 SLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV-----CTRE-PPFYIIT 295

Query: 150 HLM-GADLNNILRTQKLSDDHVQFLV---YQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
             M   +L + LR     +     L+    QI   ++Y+     IHR+L   N  V E+ 
Sbjct: 296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENH 355

Query: 206 ELKILDFGLARPTENEMTGYVAT-------RWYRAPE 235
            +K+ DFGL+R    +   Y A        +W  APE
Sbjct: 356 LVKVADFGLSRLMTGDT--YTAHAGAKFPIKWT-APE 389

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 86.3 bits (214), Expect = 5e-19
 Identities = 37/158 (23%), Positives = 71/158 (44%), Gaps = 13/158 (8%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRML-KHMNHENVIGLLDVFHSNTCLADF 142
                +G  +A+K++ R      + KR   +L ++ K  +   ++     F +NT     
Sbjct: 44  MRFRKTGHVIAVKQMRRSGNKEEN-KRILMDLDVVLKSHDCPYIVQCFGTFITNTD---- 98

Query: 143 KNVYMVTHLMGA--DLNNILRTQKLSDDHVQFLVYQILRGLKYIHSA-GIIHRDLKPSNI 199
             V++   LMG   +         + +  +  +   I++ L Y+    G+IHRD+KPSNI
Sbjct: 99  --VFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI 156

Query: 200 AVNEDCELKILDFGLARPTENEM--TGYVATRWYRAPE 235
            ++E  ++K+ DFG++    ++           Y APE
Sbjct: 157 LLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPE 194

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 56.6 bits (137), Expect = 4e-09
 Identities = 34/159 (21%), Positives = 59/159 (37%), Gaps = 31/159 (19%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEM--TGYVATRWYRAPEIMLNWMHYNQT---- 307
           D+KPSNI ++E  ++K+ DFG++    ++           Y APE +             
Sbjct: 150 DVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIR 209

Query: 308 -DIHQLNL-IMEM-LGTPP-------AEFMAKISSDSARKYINSLPLLTKKD-FRQVFKG 356
            D+  L + ++E+  G  P        E + K+  +         PLL     F   F+ 
Sbjct: 210 ADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP-------PLLPGHMGFSGDFQ- 261

Query: 357 ANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPN 395
                   +   L  D  KR    + L H ++ +Y    
Sbjct: 262 ------SFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLE 294

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 87.0 bits (216), Expect = 6e-19
 Identities = 38/133 (28%), Positives = 72/133 (54%), Gaps = 10/133 (7%)

Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNIL-RTQKLSDD 168
            ++EL++++ + H  ++ L   F       D ++++MV  L+ G DL   L +     ++
Sbjct: 62  VFKELQIMQGLEHPFLVNLWYSFQ------DEEDMFMVVDLLLGGDLRYHLQQNVHFKEE 115

Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR--PTENEMTGYV 226
            V+  + +++  L Y+ +  IIHRD+KP NI ++E   + I DF +A   P E ++T   
Sbjct: 116 TVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA 175

Query: 227 ATRWYRAPEIMLN 239
            T+ Y APE+  +
Sbjct: 176 GTKPYMAPEMFSS 188

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 50.4 bits (121), Expect = 5e-07
 Identities = 35/144 (24%), Positives = 62/144 (43%), Gaps = 15/144 (10%)

Query: 254 DLKPSNIAVNEDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIMLNWMH--YNQT-D 308
           D+KP NI ++E   + I DF +A   P E ++T    T+ Y APE+  +     Y+   D
Sbjct: 140 DMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVD 199

Query: 309 IHQLNLIM-EML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLS 366
              L +   E+L G  P  +  + S+ S           T   +   +   + + + LL 
Sbjct: 200 WWSLGVTAYELLRGRRP--YHIRSSTSSKEIVHTFET--TVVTYPSAW---SQEMVSLLK 252

Query: 367 LMLELDSEKRI-TAEQALAHPYLS 389
            +LE + ++R          PY++
Sbjct: 253 KLLEPNPDQRFSQLSDVQNFPYMN 276

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 85.9 bits (213), Expect = 8e-19
 Identities = 43/160 (26%), Positives = 82/160 (51%), Gaps = 18/160 (11%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
           A+   +G  VAIK++  P +S +  +   +E+ +++  +  +V+     +  NT L    
Sbjct: 48  AIHKETGQIVAIKQV--PVESDL--QEIIKEISIMQQCDSPHVVKYYGSYFKNTDL---- 99

Query: 144 NVYMVTHLMGA----DLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
             ++V    GA    D+  + R + L++D +  ++   L+GL+Y+H    IHRD+K  NI
Sbjct: 100 --WIVMEYCGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNI 156

Query: 200 AVNEDCELKILDFGLA---RPTENEMTGYVATRWYRAPEI 236
            +N +   K+ DFG+A     T  +    + T ++ APE+
Sbjct: 157 LLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEV 196

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 49.7 bits (119), Expect = 8e-07
 Identities = 42/146 (28%), Positives = 60/146 (41%), Gaps = 20/146 (13%)

Query: 254 DLKPSNIAVNEDCELKILDFGLA---RPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIH 310
           D+K  NI +N +   K+ DFG+A     T  +    + T ++ APE++    +    DI 
Sbjct: 150 DIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIW 209

Query: 311 QLNLIM--EML-GTPPAEFMAKISSDSARKYI--NSLPLLTKKD-FRQVFKGANPQAIDL 364
            L  I   EM  G PP    A I    A   I  N  P   K + +   F        D 
Sbjct: 210 SLG-ITAIEMAEGKPP---YADIHPMRAIFMIPTNPPPTFRKPELWSDNFT-------DF 258

Query: 365 LSLMLELDSEKRITAEQALAHPYLSQ 390
           +   L    E+R TA Q L HP++  
Sbjct: 259 VKQCLVKSPEQRATATQLLQHPFVRS 284

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 86.2 bits (214), Expect = 9e-19
 Identities = 40/131 (30%), Positives = 69/131 (52%), Gaps = 8/131 (6%)

Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILR-TQKLSDD 168
           T  E R+L+ +N   ++ L   F       D  N+YMV   + G ++ + LR   + S+ 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFK------DNSNLYMVMEYVAGGEMFSHLRRIGRFSEP 141

Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
           H +F   QI+   +Y+HS  +I+RDLKP N+ +++   +++ DFG A+  +        T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGT 201

Query: 229 RWYRAPEIMLN 239
               APEI+L+
Sbjct: 202 PEALAPEIILS 212

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 48.1 bits (115), Expect = 2e-06
 Identities = 37/128 (28%), Positives = 55/128 (42%), Gaps = 16/128 (12%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
           DLKP N+ +++   +++ DFG A+  +        T    APEI+L+  +    D   L 
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALG 225

Query: 314 -LIMEML-GTPPAEFMAKISSDSARKY--INSLPLLTKKDFRQVFKGANPQAIDLLSLML 369
            LI EM  G PP  F A       + Y  I S  +     F       +    DLL  +L
Sbjct: 226 VLIYEMAAGYPP--FFAD---QPIQIYEKIVSGKVRFPSHF-------SSDLKDLLRNLL 273

Query: 370 ELDSEKRI 377
           ++D  KR 
Sbjct: 274 QVDLTKRF 281

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 85.0 bits (211), Expect = 1e-18
 Identities = 52/159 (32%), Positives = 76/159 (47%), Gaps = 13/159 (8%)

Query: 84  ALDSVSGVKVAIKKIARPFQS-AVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           A D+V    VA+K ++    S  V   R  RE R    +   +V+ + D    +  L   
Sbjct: 53  AEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL--- 109

Query: 143 KNVYMVTHLM-GADLNNILRTQ-KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
              Y+   L+ G DL  +LR Q  L+      +V QI   L   H+AG  HRD+KP NI 
Sbjct: 110 ---YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENIL 166

Query: 201 VNEDCELKILDFGLAR-PTENEMTG---YVATRWYRAPE 235
           V+ D    ++DFG+A   T+ ++T     V T +Y APE
Sbjct: 167 VSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPE 205

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 47.6 bits (114), Expect = 3e-06
 Identities = 27/76 (35%), Positives = 41/76 (53%), Gaps = 6/76 (7%)

Query: 254 DLKPSNIAVNEDCELKILDFGLAR-PTENEMTG---YVATRWYRAPEIMLNWMHYNQTDI 309
           D+KP NI V+ D    ++DFG+A   T+ ++T     V T +Y APE         + DI
Sbjct: 159 DVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADI 218

Query: 310 HQLNLIM-EML-GTPP 323
           + L  ++ E L G+PP
Sbjct: 219 YALTCVLYECLTGSPP 234

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 46/154 (29%), Positives = 67/154 (43%), Gaps = 17/154 (11%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
             VA+K   R         +  +E R+LK  +H N++ L+ V     C    + +Y+V  
Sbjct: 140 TLVAVKSC-RETLPPDLKAKFLQEARILKQYSHPNIVRLIGV-----CTQK-QPIYIVME 192

Query: 151 LM-GADLNNILRTQKLSDDHVQFL--VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
           L+ G D    LRT+         L  V     G++Y+ S   IHRDL   N  V E   L
Sbjct: 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVL 252

Query: 208 KILDFGLARPTENEM------TGYVATRWYRAPE 235
           KI DFG++R   + +         V  +W  APE
Sbjct: 253 KISDFGMSREEADGVYAASGGLRQVPVKWT-APE 285

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 84.7 bits (210), Expect = 2e-18
 Identities = 43/155 (27%), Positives = 67/155 (43%), Gaps = 18/155 (11%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           V VAIK + +   +         E  ++   +H N+I L  V          K + ++T 
Sbjct: 74  VPVAIKTL-KAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGV-----ISKY-KPMMIITE 126

Query: 151 LM-GADLNNILRTQKLSDDHVQFL--VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
            M    L+  LR +      +Q +  +  I  G+KY+ +   +HRDL   NI VN +   
Sbjct: 127 YMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVC 186

Query: 208 KILDFGLARPTENEMTGYVAT-------RWYRAPE 235
           K+ DFGL+R  E++      T       RW  APE
Sbjct: 187 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWT-APE 220

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 83.4 bits (207), Expect = 3e-18
 Identities = 38/155 (24%), Positives = 71/155 (45%), Gaps = 21/155 (13%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           + VAIK   +   S    ++  +E   ++  +H +++ L+ V        +   V+++  
Sbjct: 44  LAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV-----ITEN--PVWIIME 95

Query: 151 LM-GADLNNILRTQKLSDDHVQFL--VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
           L    +L + L+ +K S D    +   YQ+   L Y+ S   +HRD+   N+ V+ +  +
Sbjct: 96  LCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCV 155

Query: 208 KILDFGLARPTENEMTGYVAT-------RWYRAPE 235
           K+ DFGL+R  E+    Y          +W  APE
Sbjct: 156 KLGDFGLSRYMEDS--TYYKASKGKLPIKWM-APE 187

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 83.9 bits (208), Expect = 3e-18
 Identities = 42/180 (23%), Positives = 73/180 (40%), Gaps = 25/180 (13%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTY-RELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           A  +    KVAIK+I    +    +     +E++ +   +H N++     F     L   
Sbjct: 34  AYCAPKKEKVAIKRI--NLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW-- 89

Query: 143 KNVYM-------VTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDL 194
             + M       V  ++         ++  L +  +  ++ ++L GL+Y+H  G IHRD+
Sbjct: 90  --LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDV 147

Query: 195 KPSNIAVNEDCELKILDFGL-ARPTENEMTGYVATR--------WYRAPEIMLNWMHYNQ 245
           K  NI + ED  ++I DFG+ A             R        W  APE+M     Y+ 
Sbjct: 148 KAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM-APEVMEQVRGYDF 206

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 49.6 bits (119), Expect = 7e-07
 Identities = 37/162 (22%), Positives = 60/162 (37%), Gaps = 29/162 (17%)

Query: 254 DLKPSNIAVNEDCELKILDFGL-ARPTENEMTGYVATR--------WYRAPEIMLNWMHY 304
           D+K  NI + ED  ++I DFG+ A             R        W  APE+M     Y
Sbjct: 146 DVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM-APEVMEQVRGY 204

Query: 305 NQ-TDIHQLNL-IMEML-GTPP--------AEFMAKISSDSARKYINSLPLLTKKDFRQV 353
           +   DI    +  +E+  G  P           +  + +D              K + + 
Sbjct: 205 DFKADIWSFGITAIELATGAAPYHKYPPMKVLML-TLQNDPPSLETGVQDKEMLKKYGKS 263

Query: 354 FKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPN 395
           F+        ++SL L+ D EKR TA + L H +  +  +  
Sbjct: 264 FR-------KMISLCLQKDPEKRPTAAELLRHKFFQKAKNKE 298

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 85.1 bits (211), Expect = 3e-18
 Identities = 43/155 (27%), Positives = 67/155 (43%), Gaps = 18/155 (11%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           + VAIK + +   +    +    E  ++   +H N+I L  V          K V +VT 
Sbjct: 74  ISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGV-----VTKS-KPVMIVTE 126

Query: 151 LM-GADLNNILRTQKLSDDHVQFL--VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
            M    L++ LR        +Q +  +  I  G+KY+   G +HRDL   NI +N +   
Sbjct: 127 YMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVC 186

Query: 208 KILDFGLARPTENEMTGYVAT-------RWYRAPE 235
           K+ DFGL R  E++      T       RW  +PE
Sbjct: 187 KVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT-SPE 220

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 85.1 bits (211), Expect = 3e-18
 Identities = 36/138 (26%), Positives = 62/138 (44%), Gaps = 15/138 (10%)

Query: 109 KRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT-HLMGADLNNILRTQKLSD 167
              + E  ++   N   V+ L   F  +  L      YMV  ++ G DL N++    + +
Sbjct: 114 AFFWEERDIMAFANSPWVVQLFYAFQDDRYL------YMVMEYMPGGDLVNLMSNYDVPE 167

Query: 168 DHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVA 227
              +F   +++  L  IHS G IHRD+KP N+ +++   LK+ DFG     +    G V 
Sbjct: 168 KWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM--KMNKEGMVR 225

Query: 228 TRW------YRAPEIMLN 239
                    Y +PE++ +
Sbjct: 226 CDTAVGTPDYISPEVLKS 243

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 83.4 bits (207), Expect = 4e-18
 Identities = 36/140 (25%), Positives = 59/140 (42%), Gaps = 17/140 (12%)

Query: 109 KRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT-HLMGADLNNIL-RTQKLS 166
               RE  ++  ++H   + L   F  +  L      Y    +    +L   + +     
Sbjct: 75  PYVTRERDVMSRLDHPFFVKLYFTFQDDEKL------YFGLSYAKNGELLKYIRKIGSFD 128

Query: 167 DDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV 226
           +   +F   +I+  L+Y+H  GIIHRDLKP NI +NED  ++I DFG A+          
Sbjct: 129 ETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAK--VLSPESKQ 186

Query: 227 ATRW-------YRAPEIMLN 239
           A          Y +PE++  
Sbjct: 187 ARANSFVGTAQYVSPELLTE 206

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 50.3 bits (121), Expect = 5e-07
 Identities = 39/139 (28%), Positives = 61/139 (43%), Gaps = 25/139 (17%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRW-------YRAPEIMLNWMHYNQ 306
           DLKP NI +NED  ++I DFG A+          A          Y +PE++        
Sbjct: 155 DLKPENILLNEDMHIQITDFGTAK--VLSPESKQARANSFVGTAQYVSPELLTEKSACKS 212

Query: 307 TDIHQL-NLIMEML-GTPPAEFMAKISSDSARKY--INSLPLLTKKDFRQVFKGANPQAI 362
           +D+  L  +I +++ G PP  F A    +    +  I  L     + F        P+A 
Sbjct: 213 SDLWALGCIIYQLVAGLPP--FRAG---NEYLIFQKIIKLEYDFPEKF-------FPKAR 260

Query: 363 DLLSLMLELDSEKRITAEQ 381
           DL+  +L LD+ KR+  E+
Sbjct: 261 DLVEKLLVLDATKRLGCEE 279

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 83.1 bits (206), Expect = 4e-18
 Identities = 41/156 (26%), Positives = 69/156 (44%), Gaps = 23/156 (14%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           + VA+K +    +  +  +   +E  ++K + H N++ LL V     C  +    Y++T 
Sbjct: 39  LTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV-----CTRE-PPFYIITE 89

Query: 151 LM-GADLNNILRTQKLSDDHVQFLV---YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE 206
            M   +L + LR     +     L+    QI   ++Y+     IHRDL   N  V E+  
Sbjct: 90  FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL 149

Query: 207 LKILDFGLARPTENEMTGYVAT-------RWYRAPE 235
           +K+ DFGL+R    +   Y A        +W  APE
Sbjct: 150 VKVADFGLSRLMTGDT--YTAHAGAKFPIKWT-APE 182

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 85.3 bits (211), Expect = 4e-18
 Identities = 44/154 (28%), Positives = 71/154 (46%), Gaps = 20/154 (12%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
            +VAIK +       +  +   +E +++K + HE ++ L  V        +   +Y+VT 
Sbjct: 292 TRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-----VSEE--PIYIVTE 341

Query: 151 LM-GADLNNILRTQKLSDDHVQFLV---YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE 206
            M    L + L+ +      +  LV    QI  G+ Y+     +HRDL+ +NI V E+  
Sbjct: 342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV 401

Query: 207 LKILDFGLAR-PTENEMT----GYVATRWYRAPE 235
            K+ DFGLAR   +NE T         +W  APE
Sbjct: 402 CKVADFGLARLIEDNEYTARQGAKFPIKWT-APE 434

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 85.4 bits (211), Expect = 6e-18
 Identities = 35/155 (22%), Positives = 69/155 (44%), Gaps = 19/155 (12%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           + VAIK + +        +   RE +++  +++  ++ L+ V     C A+   + +V  
Sbjct: 364 IDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV-----CQAE--ALMLVME 415

Query: 151 LM-GADLNNILRTQKLSDDHVQFL--VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
           +  G  L+  L  ++           ++Q+  G+KY+     +HR+L   N+ +      
Sbjct: 416 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYA 475

Query: 208 KILDFGLARPTENEMTGYVAT-------RWYRAPE 235
           KI DFGL++    + + Y A        +WY APE
Sbjct: 476 KISDFGLSKALGADDSYYTARSAGKWPLKWY-APE 509

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 83.1 bits (206), Expect = 7e-18
 Identities = 44/154 (28%), Positives = 68/154 (44%), Gaps = 18/154 (11%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           + VAIK++ R   S    K    E  ++  +++ +V  LL +     CL     V ++T 
Sbjct: 45  IPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCRLLGI-----CLTS--TVQLITQ 96

Query: 151 LM-GADLNNILRTQKLSDDHVQFL--VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
           LM    L + +R  K +      L    QI +G+ Y+    ++HRDL   N+ V     +
Sbjct: 97  LMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHV 156

Query: 208 KILDFGLARPTENEMTGYVAT------RWYRAPE 235
           KI DFGLA+    E   Y A       +W  A E
Sbjct: 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWM-ALE 189

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 84.0 bits (208), Expect = 8e-18
 Identities = 43/156 (27%), Positives = 71/156 (45%), Gaps = 24/156 (15%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
            KVA+K +      ++  +    E  ++K + H+ ++ L  V        +   +Y++T 
Sbjct: 213 TKVAVKTMK---PGSMSVEAFLAEANVMKTLQHDKLVKLHAV-----VTKE--PIYIITE 262

Query: 151 LM-GADLNNILRTQKLSDDHVQFLV---YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE 206
            M    L + L++ + S   +  L+    QI  G+ +I     IHRDL+ +NI V+    
Sbjct: 263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV 322

Query: 207 LKILDFGLARPTENEMTGYVAT-------RWYRAPE 235
            KI DFGLAR  E+    Y A        +W  APE
Sbjct: 323 CKIADFGLARVIEDNE--YTAREGAKFPIKWT-APE 355

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 84.0 bits (208), Expect = 1e-17
 Identities = 44/156 (28%), Positives = 71/156 (45%), Gaps = 24/156 (15%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
            +VAIK +       +  +   +E +++K + HE ++ L  V        +   +Y+VT 
Sbjct: 209 TRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-----VSEE--PIYIVTE 258

Query: 151 LM-GADLNNILRTQKLSDDHVQFLV---YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE 206
            M    L + L+ +      +  LV    QI  G+ Y+     +HRDL+ +NI V E+  
Sbjct: 259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV 318

Query: 207 LKILDFGLARPTENEMTGYVAT-------RWYRAPE 235
            K+ DFGLAR  E+    Y A        +W  APE
Sbjct: 319 CKVADFGLARLIEDNE--YTARQGAKFPIKWT-APE 351

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 81.5 bits (202), Expect = 1e-17
 Identities = 42/155 (27%), Positives = 70/155 (45%), Gaps = 22/155 (14%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
            KVAIK I    + A+  +    E  ++  ++H  ++ L  V     CL     + +VT 
Sbjct: 33  DKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV-----CLEQ-APICLVTE 83

Query: 151 LM-GADLNNILRTQKLSDDHVQFL--VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
            M    L++ LRTQ+        L     +  G+ Y+  A +IHRDL   N  V E+  +
Sbjct: 84  FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVI 143

Query: 208 KILDFGLARPTENEMTGYVAT-------RWYRAPE 235
           K+ DFG+ R   ++   Y ++       +W  +PE
Sbjct: 144 KVSDFGMTRFVLDDQ--YTSSTGTKFPVKWA-SPE 175

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 81.9 bits (203), Expect = 1e-17
 Identities = 35/155 (22%), Positives = 72/155 (46%), Gaps = 21/155 (13%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           + VA+K   +   +  + ++   E  ++K+++H +++ L+ +        +    +++  
Sbjct: 41  INVAVKTC-KKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGI-----IEEE--PTWIIME 92

Query: 151 LM-GADLNNILRTQKLSDDHVQFLVY--QILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
           L    +L + L   K S   +  ++Y  QI + + Y+ S   +HRD+   NI V     +
Sbjct: 93  LYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECV 152

Query: 208 KILDFGLARPTENEMTGYVAT-------RWYRAPE 235
           K+ DFGL+R  E+E   Y          +W  +PE
Sbjct: 153 KLGDFGLSRYIEDE--DYYKASVTRLPIKWM-SPE 184

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 81.5 bits (202), Expect = 1e-17
 Identities = 39/155 (25%), Positives = 70/155 (45%), Gaps = 22/155 (14%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
             VA+K I    + ++     ++E + +  ++H  ++    V     C  +   +Y+VT 
Sbjct: 33  YDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPKLVKFYGV-----CSKE-YPIYIVTE 83

Query: 151 LM-GADLNNILRTQKLSDDHVQFL--VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
            +    L N LR+     +  Q L   Y +  G+ ++ S   IHRDL   N  V+ D  +
Sbjct: 84  YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCV 143

Query: 208 KILDFGLARPTENEMTGYVAT-------RWYRAPE 235
           K+ DFG+ R   ++   YV++       +W  APE
Sbjct: 144 KVSDFGMTRYVLDDQ--YVSSVGTKFPVKWS-APE 175

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 29/154 (18%), Positives = 64/154 (41%), Gaps = 18/154 (11%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           + V IK I          +     +  +  ++H +++ LL +     C     ++ +VT 
Sbjct: 43  IPVCIKVI-EDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGL-----CPGS--SLQLVTQ 94

Query: 151 LM-GADLNNILRTQKLSDDHVQFL--VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
            +    L + +R  + +      L    QI +G+ Y+   G++HR+L   N+ +    ++
Sbjct: 95  YLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQV 154

Query: 208 KILDFGLARPTENEMTGYVAT------RWYRAPE 235
           ++ DFG+A     +    + +      +W  A E
Sbjct: 155 QVADFGVADLLPPDDKQLLYSEAKTPIKWM-ALE 187

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 81.7 bits (202), Expect = 3e-17
 Identities = 41/189 (21%), Positives = 74/189 (39%), Gaps = 20/189 (10%)

Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSG--VKVAIKKIARPFQSAVHAKRTYRELRM 117
                ++     + +  F  ++   L    G  +  A+K +           +   E  +
Sbjct: 85  GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGII 143

Query: 118 LKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQFL--V 174
           +K  +H NV+ LL +     CL    +  +V   M   DL N +R +  +      +   
Sbjct: 144 MKDFSHPNVLSLLGI-----CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 198

Query: 175 YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP-TENEMTGYVAT----- 228
            Q+ +G+K++ S   +HRDL   N  ++E   +K+ DFGLAR   + E            
Sbjct: 199 LQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 258

Query: 229 --RWYRAPE 235
             +W  A E
Sbjct: 259 PVKWM-ALE 266

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 80.3 bits (199), Expect = 3e-17
 Identities = 44/156 (28%), Positives = 70/156 (44%), Gaps = 24/156 (15%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
            KVA+K +    Q ++       E  ++K + H+ ++ L  V        +   +Y++T 
Sbjct: 38  TKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-----VTQE--PIYIITE 87

Query: 151 LM-GADLNNILRTQKLSDDHVQFLV---YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE 206
            M    L + L+T       +  L+    QI  G+ +I     IHRDL+ +NI V++   
Sbjct: 88  YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS 147

Query: 207 LKILDFGLARPTENEMTGYVAT-------RWYRAPE 235
            KI DFGLAR  E+    Y A        +W  APE
Sbjct: 148 CKIADFGLARLIEDNE--YTAREGAKFPIKWT-APE 180

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 80.3 bits (199), Expect = 4e-17
 Identities = 39/155 (25%), Positives = 69/155 (44%), Gaps = 22/155 (14%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
             VAIK I    + ++       E +++ +++HE ++ L  V     C    + ++++T 
Sbjct: 49  YDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGV-----CTKQ-RPIFIITE 99

Query: 151 LM-GADLNNILRTQKLSDDHVQFL--VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
            M    L N LR  +      Q L     +   ++Y+ S   +HRDL   N  VN+   +
Sbjct: 100 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVV 159

Query: 208 KILDFGLARPTENEMTGYVAT-------RWYRAPE 235
           K+ DFGL+R   ++   Y ++       RW   PE
Sbjct: 160 KVSDFGLSRYVLDDE--YTSSVGSKFPVRWS-PPE 191

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 80.4 bits (199), Expect = 4e-17
 Identities = 38/162 (23%), Positives = 68/162 (41%), Gaps = 11/162 (6%)

Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSG--VKVAIKKIARPFQSAVHAKRTYRELRM 117
                ++     + +  F  ++   L    G  +  A+K +           +   E  +
Sbjct: 21  GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGII 79

Query: 118 LKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQFL--V 174
           +K  +H NV+ LL +     CL    +  +V   M   DL N +R +  +      +   
Sbjct: 80  MKDFSHPNVLSLLGI-----CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 134

Query: 175 YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
            Q+ +G+KY+ S   +HRDL   N  ++E   +K+ DFGLAR
Sbjct: 135 LQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 82.2 bits (203), Expect = 6e-17
 Identities = 38/153 (24%), Positives = 72/153 (47%), Gaps = 17/153 (11%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           + VAIK   +   S    ++  +E   ++  +H +++ L+ V        +   V+++  
Sbjct: 419 MAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV-----ITEN--PVWIIME 470

Query: 151 LM-GADLNNILRTQKLSDDHVQFL--VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
           L    +L + L+ +K S D    +   YQ+   L Y+ S   +HRD+   N+ V+ +  +
Sbjct: 471 LCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCV 530

Query: 208 KILDFGLARPTENE-----MTGYVATRWYRAPE 235
           K+ DFGL+R  E+        G +  +W  APE
Sbjct: 531 KLGDFGLSRYMEDSTYYKASKGKLPIKWM-APE 562

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 80.1 bits (198), Expect = 7e-17
 Identities = 44/193 (22%), Positives = 74/193 (38%), Gaps = 19/193 (9%)

Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSG--VKVAIKKIARPFQSAVHAKRTYRELRM 117
            I      +G  L K  F  +  + L    G  VKVA+K +     ++   +   RE   
Sbjct: 19  LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAAC 78

Query: 118 LKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLV-- 174
           +K  +H +V  L+ V   +          ++   M   DL+  L   ++ ++     +  
Sbjct: 79  MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQT 138

Query: 175 -----YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT- 228
                  I  G++Y+ S   IHRDL   N  + ED  + + DFGL+R   +    Y    
Sbjct: 139 LVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY-YRQGC 197

Query: 229 ------RWYRAPE 235
                 +W  A E
Sbjct: 198 ASKLPVKWL-ALE 209

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 81.9 bits (202), Expect = 7e-17
 Identities = 36/139 (25%), Positives = 71/139 (51%), Gaps = 12/139 (8%)

Query: 114 ELRMLKHMNHEN---VIGLLDVFHSNTCLADFKNVYMVTHLM-GADL-NNILRTQKLSDD 168
           E  ML  ++  +   ++ +   FH+         +  +  LM G DL  ++ +    S+ 
Sbjct: 239 ERIMLSLVSTGDCPFIVCMSYAFHTPD------KLSFILDLMNGGDLHYHLSQHGVFSEA 292

Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT-GYVA 227
            ++F   +I+ GL+++H+  +++RDLKP+NI ++E   ++I D GLA     +     V 
Sbjct: 293 DMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG 352

Query: 228 TRWYRAPEIMLNWMHYNQT 246
           T  Y APE++   + Y+ +
Sbjct: 353 THGYMAPEVLQKGVAYDSS 371

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 45/169 (26%), Positives = 79/169 (46%), Gaps = 19/169 (11%)

Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMT-GY 286
            R+Y A EI+L   H +   V   ++DLKP+NI ++E   ++I D GLA     +     
Sbjct: 294 MRFYAA-EIILGLEHMHNRFV--VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 350

Query: 287 VATRWYRAPEIMLNWMHYNQT-DIHQLN-LIMEML-GTPPAEFMAKISSDSARKYINSLP 343
           V T  Y APE++   + Y+ + D   L  ++ ++L G  P  F    + D  +  I+ + 
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP--FRQHKTKD--KHEIDRMT 406

Query: 344 LLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI-----TAEQALAHPY 387
           L    +    F   +P+   LL  +L+ D  +R+      A++    P+
Sbjct: 407 LTMAVELPDSF---SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 452

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 78.3 bits (194), Expect = 3e-16
 Identities = 38/131 (29%), Positives = 66/131 (50%), Gaps = 8/131 (6%)

Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILR-TQKLSDD 168
           T  E  ML  + H  +I +   F     +      +M+   + G +L ++LR +Q+  + 
Sbjct: 53  TNDERLMLSIVTHPFIIRMWGTFQDAQQI------FMIMDYIEGGELFSLLRKSQRFPNP 106

Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT 228
             +F   ++   L+Y+HS  II+RDLKP NI ++++  +KI DFG A+   +       T
Sbjct: 107 VAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGT 166

Query: 229 RWYRAPEIMLN 239
             Y APE++  
Sbjct: 167 PDYIAPEVVST 177

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 42.9 bits (102), Expect = 1e-04
 Identities = 41/147 (27%), Positives = 60/147 (40%), Gaps = 29/147 (19%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTD----- 308
           DLKP NI ++++  +KI DFG A+   +       T  Y APE++    +    D     
Sbjct: 131 DLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFG 190

Query: 309 IHQLNLIMEML-GTPPAEFMAKISSDSARKY--INSLPLLTKKDFRQVFKGANPQAIDLL 365
           I    LI EML G  P  F      ++ + Y  I +  L     F       N    DLL
Sbjct: 191 I----LIYEMLAGYTP--FYDS---NTMKTYEKILNAELRFPPFF-------NEDVKDLL 234

Query: 366 SLMLELDSEKRI-----TAEQALAHPY 387
           S ++  D  +R+       E    HP+
Sbjct: 235 SRLITRDLSQRLGNLQNGTEDVKNHPW 261

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 78.1 bits (193), Expect = 3e-16
 Identities = 32/129 (24%), Positives = 60/129 (46%), Gaps = 9/129 (6%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           ++ AIK +          +   RE  +++ +NH NV+ L+ +      L      +++  
Sbjct: 50  IQCAIKSL-SRITEMQQVEAFLREGLLMRGLNHPNVLALIGI-----MLPPEGLPHVLLP 103

Query: 151 LM-GADLNNILRTQKLSDDHVQFL--VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCEL 207
            M   DL   +R+ + +      +    Q+ RG++Y+     +HRDL   N  ++E   +
Sbjct: 104 YMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTV 163

Query: 208 KILDFGLAR 216
           K+ DFGLAR
Sbjct: 164 KVADFGLAR 172

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 79.1 bits (195), Expect = 5e-16
 Identities = 39/135 (28%), Positives = 64/135 (47%), Gaps = 15/135 (11%)

Query: 114 ELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADL-----NNILRTQKLSD 167
           E ++L  ++   ++ L   F + T L       +V  +M G D+     N         +
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDL------CLVMTIMNGGDIRYHIYNVDEDNPGFQE 288

Query: 168 DHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR--PTENEMT-G 224
               F   QI+ GL+++H   II+RDLKP N+ +++D  ++I D GLA         T G
Sbjct: 289 PRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG 348

Query: 225 YVATRWYRAPEIMLN 239
           Y  T  + APE++L 
Sbjct: 349 YAGTPGFMAPELLLG 363

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 47.9 bits (114), Expect = 4e-06
 Identities = 43/173 (24%), Positives = 74/173 (42%), Gaps = 25/173 (14%)

Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLAR--PTENEMT- 284
             +Y A +I+    H +Q  +  Y +DLKP N+ +++D  ++I D GLA         T 
Sbjct: 291 AIFYTA-QIVSGLEHLHQRNI-IY-RDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK 347

Query: 285 GYVATRWYRAPEIMLNWMHYNQTDIHQLN-LIMEML-GTPPAEFMA---KISSDSARKYI 339
           GY  T  + APE++L   +    D   L   + EM+    P  F A   K+ +   ++ +
Sbjct: 348 GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP--FRARGEKVENKELKQRV 405

Query: 340 NSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI-----TAEQALAHPY 387
               +     F       +P + D    +L+ D EKR+     + +    HP 
Sbjct: 406 LEQAVTYPDKF-------SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 37/164 (22%), Positives = 62/164 (37%), Gaps = 26/164 (15%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD----FKNVY 146
           +KVA+K +     S    +    E   +K  +H NVI LL V     C+           
Sbjct: 63  LKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV-----CIEMSSQGIPKPM 117

Query: 147 MVTHLM-GADLNNILRTQKLSDDHVQFLV-------YQILRGLKYIHSAGIIHRDLKPSN 198
           ++   M   DL+  L   +L        +         I  G++Y+ +   +HRDL   N
Sbjct: 118 VILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARN 177

Query: 199 IAVNEDCELKILDFGLARPTENEMTGYVAT-------RWYRAPE 235
             + +D  + + DFGL++   +    Y          +W  A E
Sbjct: 178 CMLRDDMTVCVADFGLSKKIYSGDY-YRQGRIAKMPVKWI-AIE 219

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 75.2 bits (185), Expect = 2e-15
 Identities = 24/137 (17%), Positives = 44/137 (32%), Gaps = 9/137 (6%)

Query: 84  ALDSVSGVKVAIKKIARPF-QSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           ALD+    +VA+  +           + T      L  ++   V  +LDV H+       
Sbjct: 50  ALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAG---- 105

Query: 143 KNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
               +V   + G  L  +  T   S       +  +       H AG+      PS + V
Sbjct: 106 --GLVVAEWIRGGSLQEVADTS-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRV 162

Query: 202 NEDCELKILDFGLARPT 218
           + D ++ +         
Sbjct: 163 SIDGDVVLAYPATMPDA 179

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 75.4 bits (186), Expect = 3e-15
 Identities = 46/173 (26%), Positives = 71/173 (41%), Gaps = 37/173 (21%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLADFKNVYMVT 149
           + VA+K + +P       +    EL++L ++ NH N++ LL       C        ++T
Sbjct: 54  MTVAVKML-KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA-----CTIG-GPTLVIT 106

Query: 150 HLM-GADLNNILRTQKLSDDHVQFLV-------------------YQILRGLKYIHSAGI 189
                 DL N LR ++ S    +                      YQ+ +G+ ++ S   
Sbjct: 107 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC 166

Query: 190 IHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT-------RWYRAPE 235
           IHRDL   NI +      KI DFGLAR  +N+   YV         +W  APE
Sbjct: 167 IHRDLAARNILLTHGRITKICDFGLARDIKNDSN-YVVKGNARLPVKWM-APE 217

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 23/165 (13%), Positives = 61/165 (36%), Gaps = 22/165 (13%)

Query: 91  VKVAIKKIARPFQSAVHAKRTY-RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT 149
            +V +K +    ++  +   ++     M+  ++H++++    V     C+       +V 
Sbjct: 41  TEVLLKVLD---KAHRNYSESFFEAASMMSKLSHKHLVLNYGV-----CV-CGDENILVQ 91

Query: 150 HLM-GADLNNILRTQKLSDDHVQFL--VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE 206
             +    L+  L+  K   + +  L    Q+   + ++    +IH ++   NI +  + +
Sbjct: 92  EFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREED 151

Query: 207 L--------KILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHY 243
                    K+ D G++     +        W   PE + N  + 
Sbjct: 152 RKTGNPPFIKLSDPGISITVLPKDILQERIPWV-PPECIENPKNL 195

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 74.6 bits (184), Expect = 5e-15
 Identities = 41/171 (23%), Positives = 72/171 (42%), Gaps = 34/171 (19%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLADFKNVYMVT 149
             VA+K + +   +    +    EL++L H+ +H NV+ LL       C      + ++ 
Sbjct: 58  RTVAVKML-KEGATHSEHRALMSELKILIHIGHHLNVVNLLGA-----CTKPGGPLMVIV 111

Query: 150 HLM-GADLNNILRTQKLSDDHVQFLV-----------------YQILRGLKYIHSAGIIH 191
                 +L+  LR+++      +                    +Q+ +G++++ S   IH
Sbjct: 112 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIH 171

Query: 192 RDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT-------RWYRAPE 235
           RDL   NI ++E   +KI DFGLAR    +   YV         +W  APE
Sbjct: 172 RDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWM-APE 220

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 74.6 bits (184), Expect = 5e-15
 Identities = 36/143 (25%), Positives = 58/143 (40%), Gaps = 19/143 (13%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
            +VAIK +     S         E  ++K  N  +V+ LL V          +   ++  
Sbjct: 56  TRVAIKTV-NEAASMRERIEFLNEASVMKEFNCHHVVRLLGV-----VSQG-QPTLVIME 108

Query: 151 LM-GADLNNILRTQKLSDDHVQFLV-----------YQILRGLKYIHSAGIIHRDLKPSN 198
           LM   DL + LR+ + +  +   L             +I  G+ Y+++   +HRDL   N
Sbjct: 109 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARN 168

Query: 199 IAVNEDCELKILDFGLARPTENE 221
             V ED  +KI DFG+ R     
Sbjct: 169 CMVAEDFTVKIGDFGMTRDIYET 191

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 73.4 bits (181), Expect = 8e-15
 Identities = 33/122 (27%), Positives = 50/122 (40%), Gaps = 24/122 (19%)

Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILR---------- 161
           RE  +L ++ HE+++    V     C      + MV   M   DLN  LR          
Sbjct: 66  REAELLTNLQHEHIVKFYGV-----CGDG-DPLIMVFEYMKHGDLNKFLRAHGPDAMILV 119

Query: 162 -------TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL 214
                    +L    +  +  QI  G+ Y+ S   +HRDL   N  V  +  +KI DFG+
Sbjct: 120 DGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGM 179

Query: 215 AR 216
           +R
Sbjct: 180 SR 181

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 73.9 bits (182), Expect = 8e-15
 Identities = 44/171 (25%), Positives = 67/171 (39%), Gaps = 38/171 (22%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLADFKNVYMVT 149
           +  AIK++ + + S    +    EL +L  + +H N+I LL       C      +Y+  
Sbjct: 53  MDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGA-----CEHR-GYLYLAI 105

Query: 150 HLM-GADLNNILRTQKLSDDHVQFLV-----------------YQILRGLKYIHSAGIIH 191
                 +L + LR  ++ +    F +                   + RG+ Y+     IH
Sbjct: 106 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIH 165

Query: 192 RDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT-------RWYRAPE 235
           RDL   NI V E+   KI DFGL+R  E     YV         RW  A E
Sbjct: 166 RDLAARNILVGENYVAKIADFGLSRGQEV----YVKKTMGRLPVRWM-AIE 211

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 73.0 bits (180), Expect = 1e-14
 Identities = 37/148 (25%), Positives = 55/148 (37%), Gaps = 33/148 (22%)

Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQKLSDDH-- 169
            E  +   + H NV+ LL V        D + + M+       DL+  L  +    D   
Sbjct: 61  HEAMLRARLQHPNVVCLLGV-----VTKD-QPLSMIFSYCSHGDLHEFLVMRSPHSDVGS 114

Query: 170 -------------VQFL--VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL 214
                          F+  V QI  G++Y+ S  ++H+DL   N+ V +   +KI D GL
Sbjct: 115 TDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGL 174

Query: 215 ARPTENEMTGYVAT-------RWYRAPE 235
            R        Y          RW  APE
Sbjct: 175 FREVYAADY-YKLLGNSLLPIRWM-APE 200

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 73.8 bits (182), Expect = 1e-14
 Identities = 43/165 (26%), Positives = 77/165 (46%), Gaps = 28/165 (16%)

Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT-HLMGADL-NNILRTQKLSDD 168
           T  E R+L++  H  +  L   F ++  L        V  +  G +L  ++ R +  +++
Sbjct: 52  TVTESRVLQNTRHPFLTALKYAFQTHDRL------CFVMEYANGGELFFHLSRERVFTEE 105

Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP--TENEMTG-Y 225
             +F   +I+  L+Y+HS  +++RD+K  N+ +++D  +KI DFGL +   ++      +
Sbjct: 106 RARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 165

Query: 226 VATRWYRAPEIMLNWMHYNQT------GV----------PFYFQD 254
             T  Y APE+ L    Y +       GV          PFY QD
Sbjct: 166 CGTPEYLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 41.1 bits (97), Expect = 4e-04
 Identities = 42/177 (23%), Positives = 76/177 (42%), Gaps = 37/177 (20%)

Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARP--TENEMTG 285
            R+Y A EI+    + +   V  Y +D+K  N+ +++D  +KI DFGL +   ++     
Sbjct: 107 ARFYGA-EIVSALEYLHSRDV-VY-RDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 163

Query: 286 -YVATRWYRAPEIMLNWMHYNQT-DIHQLN-LIMEML-GTPP------AEFMAKISSDSA 335
            +  T  Y APE+ L    Y +  D   L  ++ EM+ G  P            I  +  
Sbjct: 164 TFCGTPEYLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI 222

Query: 336 RKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI-----TAEQALAHPY 387
           R +  +L                P+A  LL+ +L+ D ++R+      A++ + H +
Sbjct: 223 R-FPRTLS---------------PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 39/135 (28%), Positives = 62/135 (45%), Gaps = 12/135 (8%)

Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLN---NILRTQKLS 166
              E ++L+ +N   V+ L   + +   L       +V  LM G DL      +      
Sbjct: 231 ALNEKQILEKVNSRFVVSLAYAYETKDAL------CLVLTLMNGGDLKFHIYHMGQAGFP 284

Query: 167 DDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP-TENEMT-G 224
           +    F   +I  GL+ +H   I++RDLKP NI +++   ++I D GLA    E +   G
Sbjct: 285 EARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 344

Query: 225 YVATRWYRAPEIMLN 239
            V T  Y APE++ N
Sbjct: 345 RVGTVGYMAPEVVKN 359

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 47/169 (27%), Positives = 76/169 (44%), Gaps = 18/169 (10%)

Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARP-TENEMT-G 285
             +Y A EI       ++  +  Y +DLKP NI +++   ++I D GLA    E +   G
Sbjct: 288 AVFYAA-EICCGLEDLHRERI-VY-RDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 344

Query: 286 YVATRWYRAPEIMLNWMHYNQTDIHQLN-LIMEML-GTPPAEFMAKISSDSARKYINSLP 343
            V T  Y APE++ N  +    D   L  L+ EM+ G  P  F  +      R+ +  L 
Sbjct: 345 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP--FQQR-KKKIKREEVERLV 401

Query: 344 LLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI-----TAEQALAHPY 387
               +++ + F   +PQA  L S +L  D  +R+     +A +   HP 
Sbjct: 402 KEVPEEYSERF---SPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL 447

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 30/121 (24%), Positives = 49/121 (40%), Gaps = 23/121 (19%)

Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRT--------- 162
           RE  +L  + H++++    V     C    + + MV   M   DLN  LR+         
Sbjct: 92  REAELLTMLQHQHIVRFFGV-----CTEG-RPLLMVFEYMRHGDLNRFLRSHGPDAKLLA 145

Query: 163 -------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 215
                    L    +  +  Q+  G+ Y+     +HRDL   N  V +   +KI DFG++
Sbjct: 146 GGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205

Query: 216 R 216
           R
Sbjct: 206 R 206

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 43/169 (25%), Positives = 69/169 (40%), Gaps = 33/169 (19%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLADFKNVYMVT 149
           +KVA+K + +    A   +    EL+++ H+  HEN++ LL       C      V ++T
Sbjct: 77  LKVAVKML-KSTAHADEKEALMSELKIMSHLGQHENIVNLLGA-----CTHG-GPVLVIT 129

Query: 150 HLM-GADLNNILRTQKLSDDHVQFLV---------------YQILRGLKYIHSAGIIHRD 193
                 DL N LR +    +                      Q+ +G+ ++ S   IHRD
Sbjct: 130 EYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRD 189

Query: 194 LKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT-------RWYRAPE 235
           +   N+ +      KI DFGLAR   N+   Y+         +W  APE
Sbjct: 190 VAARNVLLTNGHVAKIGDFGLARDIMNDSN-YIVKGNARLPVKWM-APE 236

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 72.7 bits (179), Expect = 3e-14
 Identities = 47/171 (27%), Positives = 72/171 (42%), Gaps = 35/171 (20%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLADFKNVYMVT 149
           V VA+K + +   +         E+ M+K +  H+N+I LL       C  D   +Y++ 
Sbjct: 68  VTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA-----CTQD-GPLYVIV 120

Query: 150 HLM-GADLNNILRTQKLSDDHVQFLV-----------------YQILRGLKYIHSAGIIH 191
                 +L   LR ++       + +                 YQ+ RG++Y+ S   IH
Sbjct: 121 EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIH 180

Query: 192 RDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT-------RWYRAPE 235
           RDL   N+ V E+  +KI DFGLAR   N    Y  T       +W  APE
Sbjct: 181 RDLAARNVLVTENNVMKIADFGLARDINNIDY-YKKTTNGRLPVKWM-APE 229

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 73.3 bits (180), Expect = 3e-14
 Identities = 31/138 (22%), Positives = 63/138 (45%), Gaps = 17/138 (12%)

Query: 110 RTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT-HLMGADLNNILR--TQKLS 166
               E  +L + + + +  L   F       D  N+Y+V  + +G DL  +L     +L 
Sbjct: 120 CFREERDVLVNGDSKWITTLHYAFQ------DDNNLYLVMDYYVGGDLLTLLSKFEDRLP 173

Query: 167 DDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV 226
           ++  +F + +++  +  +H    +HRD+KP NI ++ +  +++ DFG     +    G V
Sbjct: 174 EEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCL--KLMEDGTV 231

Query: 227 ATRW------YRAPEIML 238
            +        Y +PEI+ 
Sbjct: 232 QSSVAVGTPDYISPEILQ 249

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 41.7 bits (98), Expect = 4e-04
 Identities = 35/149 (23%), Positives = 55/149 (36%), Gaps = 24/149 (16%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRW------YRAPEIMLNWMH---- 303
           D+KP NI ++ +  +++ DFG     +    G V +        Y +PEI+         
Sbjct: 200 DIKPDNILMDMNGHIRLADFGSCL--KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGR 257

Query: 304 YNQT-DIHQLNLIM-EML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQ 360
           Y    D   L + M EML G  P  F A+        Y   +    +  F       +  
Sbjct: 258 YGPECDWWSLGVCMYEMLYGETP--FYAE---SLVETYGKIMNHKERFQFPTQVTDVSEN 312

Query: 361 AIDLLSLMLELDSEKRIT---AEQALAHP 386
           A DL+  ++    E R+     E    HP
Sbjct: 313 AKDLIRRLIC-SREHRLGQNGIEDFKKHP 340

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 72.4 bits (178), Expect = 4e-14
 Identities = 47/171 (27%), Positives = 72/171 (42%), Gaps = 35/171 (20%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLADFKNVYMVT 149
           V VA+K + +   +         E+ M+K +  H+N+I LL       C  D   +Y++ 
Sbjct: 114 VTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA-----CTQD-GPLYVIV 166

Query: 150 HLM-GADLNNILRTQKLSDDHVQFLV-----------------YQILRGLKYIHSAGIIH 191
                 +L   LR ++       + +                 YQ+ RG++Y+ S   IH
Sbjct: 167 EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIH 226

Query: 192 RDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT-------RWYRAPE 235
           RDL   N+ V E+  +KI DFGLAR   N    Y  T       +W  APE
Sbjct: 227 RDLAARNVLVTENNVMKIADFGLARDINNIDY-YKKTTNGRLPVKWM-APE 275

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 72.4 bits (178), Expect = 4e-14
 Identities = 55/228 (24%), Positives = 88/228 (38%), Gaps = 41/228 (17%)

Query: 40  YPASKLPSRRLHDHFNQPYSEICRGVIDIGPTLSKESF------DLIFSSALDSVSGVKV 93
           Y    L     ++    P  E+ R  + +G  L + +F      + I           KV
Sbjct: 45  YFQGMLAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKV 104

Query: 94  AIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLADFKNVYMVTHLM 152
           A+K + +   +         E+ M+K +  H+N+I LL       C  D   +Y++    
Sbjct: 105 AVKML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA-----CTQD-GPLYVIVEYA 157

Query: 153 -GADLNNILRTQKLSDDHVQFLV-----------------YQILRGLKYIHSAGIIHRDL 194
              +L   L+ ++       +                   YQ+ RG++Y+ S   IHRDL
Sbjct: 158 SKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDL 217

Query: 195 KPSNIAVNEDCELKILDFGLARPTENEMTGYVAT-------RWYRAPE 235
              N+ V ED  +KI DFGLAR   +    Y  T       +W  APE
Sbjct: 218 AARNVLVTEDNVMKIADFGLARDIHHIDY-YKKTTNGRLPVKWM-APE 263

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 71.5 bits (176), Expect = 5e-14
 Identities = 42/178 (23%), Positives = 65/178 (36%), Gaps = 42/178 (23%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
             VA+K + +   S    +    E  +LK +NH +VI L        C  D   + ++  
Sbjct: 54  TTVAVKML-KENASPSELRDLLSEFNVLKQVNHPHVIKLYGA-----CSQD-GPLLLIVE 106

Query: 151 LM-GADLNNILRTQKLSDDHVQFLV-------------------------YQILRGLKYI 184
                 L   LR  +                                   +QI +G++Y+
Sbjct: 107 YAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL 166

Query: 185 HSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT-------RWYRAPE 235
               ++HRDL   NI V E  ++KI DFGL+R    E + YV         +W  A E
Sbjct: 167 AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS-YVKRSQGRIPVKWM-AIE 222

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 71.2 bits (175), Expect = 8e-14
 Identities = 41/178 (23%), Positives = 73/178 (41%), Gaps = 42/178 (23%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLADFKNVYMVT 149
           ++VA+K + +    +   +    EL+M+  + +HEN++ LL       C      +Y++ 
Sbjct: 76  IQVAVKML-KEKADSSEREALMSELKMMTQLGSHENIVNLLGA-----CTLS-GPIYLIF 128

Query: 150 HLM-GADLNNILRTQKLSDDHVQFLV------------------------YQILRGLKYI 184
                 DL N LR+++      +                           YQ+ +G++++
Sbjct: 129 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL 188

Query: 185 HSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT-------RWYRAPE 235
                +HRDL   N+ V     +KI DFGLAR   ++   YV         +W  APE
Sbjct: 189 EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN-YVVRGNARLPVKWM-APE 244

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 71.7 bits (176), Expect = 9e-14
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 29/166 (17%)

Query: 111 TYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT-HLMGADL-NNILRTQKLSDD 168
           T  E R+L++  H  +  L   F ++  L        V  +  G +L  ++ R +  S+D
Sbjct: 195 TLTENRVLQNSRHPFLTALKYSFQTHDRL------CFVMEYANGGELFFHLSRERVFSED 248

Query: 169 HVQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDCELKILDFGLARP--TENEMTG- 224
             +F   +I+  L Y+HS   +++RDLK  N+ +++D  +KI DFGL +    +      
Sbjct: 249 RARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 308

Query: 225 YVATRWYRAPEIMLNWMHYNQT------GV----------PFYFQD 254
           +  T  Y APE+ L    Y +       GV          PFY QD
Sbjct: 309 FCGTPEYLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 41/177 (23%), Positives = 77/177 (43%), Gaps = 36/177 (20%)

Query: 228 TRWYRAPEIMLNWMH-YNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARP--TENEMT 284
            R+Y A EI+    + +++  V   ++DLK  N+ +++D  +KI DFGL +    +    
Sbjct: 250 ARFYGA-EIVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM 306

Query: 285 G-YVATRWYRAPEIMLNWMHYNQTDIHQLN-LIMEML-GTPP------AEFMAKISSDSA 335
             +  T  Y APE++ +  +    D   L  ++ EM+ G  P       +    I  +  
Sbjct: 307 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI 366

Query: 336 RKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI-----TAEQALAHPY 387
           R      P           +   P+A  LLS +L+ D ++R+      A++ + H +
Sbjct: 367 R-----FP-----------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 71.3 bits (175), Expect = 1e-13
 Identities = 31/142 (21%), Positives = 58/142 (40%), Gaps = 17/142 (11%)

Query: 107 HAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILR--TQ 163
                  E  +L + +   +  L   F     L      Y+V     G DL  +L    +
Sbjct: 104 EVSCFREERDVLVNGDRRWITQLHFAFQDENYL------YLVMEYYVGGDLLTLLSKFGE 157

Query: 164 KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT 223
           ++  +  +F + +I+  +  +H  G +HRD+KP NI ++    +++ DFG     +    
Sbjct: 158 RIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSC--LKLRAD 215

Query: 224 GYVATRW------YRAPEIMLN 239
           G V +        Y +PEI+  
Sbjct: 216 GTVRSLVAVGTPDYLSPEILQA 237

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 39/178 (21%), Positives = 65/178 (36%), Gaps = 29/178 (16%)

Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV 287
            R+Y A EI++     ++ G  +  +D+KP NI ++    +++ DFG     +    G V
Sbjct: 164 ARFYLA-EIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSC--LKLRADGTV 218

Query: 288 ATRW------YRAPEIMLNWMHYNQTDIHQLN--------LIMEML-GTPPAEFMAKISS 332
            +        Y +PEI+        T  +              EM  G  P  F A    
Sbjct: 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP--FYAD--- 273

Query: 333 DSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT---AEQALAHPY 387
            +A  Y   +          V +G   +A D +  +L    E R+    A     HP+
Sbjct: 274 STAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPF 330

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 70.5 bits (173), Expect = 1e-13
 Identities = 44/207 (21%), Positives = 74/207 (35%), Gaps = 35/207 (16%)

Query: 38  TVYPASKLPSRRLHDHFNQPYS------------EICRGVIDIGPTLSKESFDLIFSSAL 85
             Y  SKL +  +   +N  Y             E+ R  I +   L   +F  ++   +
Sbjct: 33  PEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQV 92

Query: 86  DSVSG----VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD 141
             +      ++VA+K +     S         E  ++   NH+N++  + V      L  
Sbjct: 93  SGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIVRCIGV-----SLQS 146

Query: 142 FKNVYMVTHLM-GADLNNILRTQKLSDDHVQFL--------VYQILRGLKYIHSAGIIHR 192
               +++  LM G DL + LR  +        L           I  G +Y+     IHR
Sbjct: 147 -LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHR 205

Query: 193 DLKPSNIAVNEDCE---LKILDFGLAR 216
           D+   N  +         KI DFG+AR
Sbjct: 206 DIAARNCLLTCPGPGRVAKIGDFGMAR 232

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 31/165 (18%), Positives = 58/165 (35%), Gaps = 20/165 (12%)

Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVI 127
           +G  +    F LI+  A  +    K A   +    +   +    + EL+  + +  ++ I
Sbjct: 41  LGKKIGSGGFGLIYL-AFPTNKPEKDARHVV--KVEYQEN-GPLFSELKFYQRVAKKDCI 96

Query: 128 GLLDVFHSNTCLA-------------DFKNVYMVTHLMGADLNNILRT-QKLSDDHVQFL 173
                      L                   +MV   +G DL  I           V  L
Sbjct: 97  KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQL 156

Query: 174 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKI--LDFGLAR 216
             ++L  L+YIH    +H D+K +N+ +      ++   D+GL+ 
Sbjct: 157 GIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 69.6 bits (171), Expect = 2e-13
 Identities = 33/143 (23%), Positives = 53/143 (37%), Gaps = 19/143 (13%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
           ++VA+K +     S         E  ++   NH+N++  + V      L      +++  
Sbjct: 61  LQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIVRCIGV-----SL-QSLPRFILME 113

Query: 151 LM-GADLNNILRTQKLSDDHVQFL--------VYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           LM G DL + LR  +        L           I  G +Y+     IHRD+   N  +
Sbjct: 114 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLL 173

Query: 202 NEDCE---LKILDFGLARPTENE 221
                    KI DFG+AR     
Sbjct: 174 TCPGPGRVAKIGDFGMARDIYRA 196

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 35/158 (22%), Positives = 64/158 (40%), Gaps = 21/158 (13%)

Query: 68  IGPTLSKESFDLIFSSALDSVSGVKVAIK--KIARPFQSAVHAKRTYRELRMLKHMNHEN 125
           +G  +   +F  +     +  +   VAIK   +           R Y++L         +
Sbjct: 13  VGKKIGCGNFGELRL-GKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG--------S 63

Query: 126 VIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQ--KLSDDHVQFLVYQILRGLKY 183
             G+  V++   C    K   MV  L+G  L ++        S   V  +  Q++  ++Y
Sbjct: 64  GDGIPQVYYFGPC---GKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEY 120

Query: 184 IHSAGIIHRDLKPSNIAV-----NEDCELKILDFGLAR 216
           +HS  +I+RD+KP N  +          + I+DF LA+
Sbjct: 121 VHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 69.3 bits (170), Expect = 3e-13
 Identities = 36/152 (23%), Positives = 56/152 (36%), Gaps = 33/152 (21%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTH 150
             VA+K + +   SA       RE  ++   ++ N++ LL V     C    K + ++  
Sbjct: 78  TMVAVKML-KEEASADMQADFQREAALMAEFDNPNIVKLLGV-----CAVG-KPMCLLFE 130

Query: 151 LM-GADLNNILRTQKLSDDHVQFLV-------------------------YQILRGLKYI 184
            M   DLN  LR+                                      Q+  G+ Y+
Sbjct: 131 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL 190

Query: 185 HSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 216
                +HRDL   N  V E+  +KI DFGL+R
Sbjct: 191 SERKFVHRDLATRNCLVGENMVVKIADFGLSR 222

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 67.8 bits (166), Expect = 7e-13
 Identities = 39/156 (25%), Positives = 64/156 (41%), Gaps = 19/156 (12%)

Query: 76  SFDLIFSSALDSVSGVKVAIK--KIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVF 133
           SF  I+    D  +G +VAIK   +           + Y+ ++          +G+  + 
Sbjct: 21  SFGDIYL-GTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ--------GGVGIPTIR 71

Query: 134 HSNTCLADFKNVYMVTHLMGADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIH 191
                        MV  L+G  L ++      K S   V  L  Q++  ++YIHS   IH
Sbjct: 72  WCGAE---GDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIH 128

Query: 192 RDLKPSNIAV---NEDCELKILDFGLARPTENEMTG 224
           RD+KP N  +    +   + I+DFGLA+   +  T 
Sbjct: 129 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 68.9 bits (168), Expect = 9e-13
 Identities = 40/134 (29%), Positives = 65/134 (48%), Gaps = 28/134 (20%)

Query: 145 VYMVT-HLMGADL-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
           +Y V  ++ G DL  +I +  +  + H  F   +I  GL ++ S GII+RDLK  N+ ++
Sbjct: 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD 476

Query: 203 EDCELKILDFGLARPTENEMTGYVATRW------YRAPEIMLNWMHYNQT------GV-- 248
            +  +KI DFG+ +  EN +   V T+       Y APEI + +  Y ++      GV  
Sbjct: 477 SEGHIKIADFGMCK--EN-IWDGVTTKTFCGTPDYIAPEI-IAYQPYGKSVDWWAFGVLL 532

Query: 249 --------PFYFQD 254
                   PF  +D
Sbjct: 533 YEMLAGQAPFEGED 546

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 40/180 (22%), Positives = 67/180 (37%), Gaps = 43/180 (23%)

Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV 287
             +Y A EI +        G+  Y +DLK  N+ ++ +  +KI DFG+ +  EN +   V
Sbjct: 444 AVFYAA-EIAIGLFFLQSKGI-IY-RDLKLDNVMLDSEGHIKIADFGMCK--EN-IWDGV 497

Query: 288 ATRW------YRAPEIMLNWMHYNQT-DIHQLN-LIMEML-GTPP------AEFMAKISS 332
            T+       Y APEI + +  Y ++ D      L+ EML G  P       E    I  
Sbjct: 498 TTKTFCGTPDYIAPEI-IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 556

Query: 333 DSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI-----TAEQALAHPY 387
            +   Y  S+                 +A+ +   ++     KR+            H +
Sbjct: 557 HNVA-YPKSMS---------------KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 600

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 67.6 bits (166), Expect = 1e-12
 Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 28/166 (16%)

Query: 110 RTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT-HLMGADL-NNILRTQKLSD 167
           RT  E  +L  +NH  ++ L   F +   L      Y++   L G DL   + +    ++
Sbjct: 72  RTKMERDILVEVNHPFIVKLHYAFQTEGKL------YLILDFLRGGDLFTRLSKEVMFTE 125

Query: 168 DHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP--TENEMTG- 224
           + V+F + ++   L ++HS GII+RDLKP NI ++E+  +K+ DFGL++      +    
Sbjct: 126 EDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 185

Query: 225 YVATRWYRAPEIMLNWMHYNQT------GV----------PFYFQD 254
           +  T  Y APE+ +N   + Q+      GV          PF  +D
Sbjct: 186 FCGTVEYMAPEV-VNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 41.4 bits (98), Expect = 4e-04
 Identities = 45/177 (25%), Positives = 75/177 (42%), Gaps = 37/177 (20%)

Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARP--TENEMTG 285
            ++Y A E+ L   H +  G+  Y +DLKP NI ++E+  +K+ DFGL++      +   
Sbjct: 128 VKFYLA-ELALALDHLHSLGI-IY-RDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY 184

Query: 286 -YVATRWYRAPEIMLNWMHYNQT-DIHQL-NLIMEML-GTPP------AEFMAKISSDSA 335
            +  T  Y APE+ +N   + Q+ D      L+ EML GT P       E M  I     
Sbjct: 185 SFCGTVEYMAPEV-VNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA-- 241

Query: 336 RKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI-----TAEQALAHPY 387
                   L   +         +P+A  LL ++ + +   R+       E+   H +
Sbjct: 242 -------KLGMPQFL-------SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 39/142 (27%), Positives = 64/142 (45%), Gaps = 22/142 (15%)

Query: 145 VYMVTHLM-GADL-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
           ++ V   + G DL  ++ R +KL ++H +F   +I   L Y+H  GII+RDLK  N+ ++
Sbjct: 85  LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD 144

Query: 203 EDCELKILDFGLARP--TENEMTG-YVATRWYRAPEIMLNWMHYNQT------GV----- 248
            +  +K+ D+G+ +      + T  +  T  Y APEI L    Y  +      GV     
Sbjct: 145 SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI-LRGEDYGFSVDWWALGVLMFEM 203

Query: 249 -----PFYFQDLKPSNIAVNED 265
                PF       +     ED
Sbjct: 204 MAGRSPFDIVGSSDNPDQNTED 225

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 40.3 bits (95), Expect = 8e-04
 Identities = 41/166 (24%), Positives = 70/166 (42%), Gaps = 33/166 (19%)

Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARP--TENEMTG 285
            R+Y A EI L   + ++ G+  Y +DLK  N+ ++ +  +K+ D+G+ +      + T 
Sbjct: 112 ARFYSA-EISLALNYLHERGI-IY-RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 168

Query: 286 -YVATRWYRAPEIMLNWMHYNQT-DIHQLN-LIMEML-GTPPAEFMAKISSDSARKYINS 341
            +  T  Y APEI L    Y  + D   L  L+ EM+ G  P  F    SSD+       
Sbjct: 169 TFCGTPNYIAPEI-LRGEDYGFSVDWWALGVLMFEMMAGRSP--FDIVGSSDNPD----- 220

Query: 342 LPLLTKKDFRQVF-----------KGANPQAIDLLSLMLELDSEKR 376
                +     +F           +  + +A  +L   L  D ++R
Sbjct: 221 -----QNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 261

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 66.8 bits (164), Expect = 2e-12
 Identities = 24/64 (37%), Positives = 35/64 (54%), Gaps = 5/64 (7%)

Query: 179 RGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRW-----YRA 233
            G+ ++H    IHRD+K +NI ++E    KI DFGLAR +E      + +R      Y A
Sbjct: 144 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMA 203

Query: 234 PEIM 237
           PE +
Sbjct: 204 PEAL 207

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 43.7 bits (104), Expect = 7e-05
 Identities = 19/50 (38%), Positives = 27/50 (54%), Gaps = 5/50 (10%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRW-----YRAPEIM 298
           D+K +NI ++E    KI DFGLAR +E      + +R      Y APE +
Sbjct: 158 DIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL 207

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 35/158 (22%), Positives = 66/158 (41%), Gaps = 21/158 (13%)

Query: 76  SFDLIFSSALDSVSGVKVAIK--KIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVF 133
           SF +IF    + ++  +VAIK               RTY+ L            G+ +V+
Sbjct: 22  SFGVIFE-GTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLA--------GCTGIPNVY 72

Query: 134 HSNTCLADFKNVYMVTHLMGADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIH 191
           +      +  +  +V  L+G  L ++L     K S   V     Q+L  ++ IH   +++
Sbjct: 73  Y---FGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 129

Query: 192 RDLKPSNIAV-----NEDCELKILDFGLARPTENEMTG 224
           RD+KP N  +          + ++DFG+ +   + +T 
Sbjct: 130 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 167

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 43/131 (32%), Positives = 64/131 (48%), Gaps = 22/131 (16%)

Query: 145 VYMVT-HLMGADL-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
           ++ V  +L G DL  +I    K       F   +I+ GL+++HS GI++RDLK  NI ++
Sbjct: 93  LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD 152

Query: 203 EDCELKILDFGLARP--TENEMTG-YVATRWYRAPEIMLNWMHYNQT------GV----- 248
           +D  +KI DFG+ +     +  T  +  T  Y APEI L    YN +      GV     
Sbjct: 153 KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI-LLGQKYNHSVDWWSFGVLLYEM 211

Query: 249 -----PFYFQD 254
                PF+ QD
Sbjct: 212 LIGQSPFHGQD 222

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 43.7 bits (104), Expect = 6e-05
 Identities = 48/173 (27%), Positives = 70/173 (40%), Gaps = 33/173 (19%)

Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARP--TENEMTG 285
             +Y A EI+L     +  G+  Y +DLK  NI +++D  +KI DFG+ +     +  T 
Sbjct: 120 ATFYAA-EIILGLQFLHSKGI-VY-RDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN 176

Query: 286 -YVATRWYRAPEIMLNWMHYNQT-DIHQLN-LIMEML-GTPP------AEFMAKISSDSA 335
            +  T  Y APEI L    YN + D      L+ EML G  P       E    I  D+ 
Sbjct: 177 TFCGTPDYIAPEI-LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP 235

Query: 336 RKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQAL-AHPY 387
                  P           +    +A DLL  +   + EKR+     +  HP 
Sbjct: 236 F-----YP-----------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPL 272

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 35/131 (26%), Positives = 60/131 (45%), Gaps = 22/131 (16%)

Query: 145 VYMVT-HLMGADL-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
           ++ V   + G DL  +I ++++  +   +F   +I+  L ++H  GII+RDLK  N+ ++
Sbjct: 99  LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLD 158

Query: 203 EDCELKILDFGLARP--TENEMTG-YVATRWYRAPEIMLNWMHYNQT------GV----- 248
            +   K+ DFG+ +        T  +  T  Y APEI L  M Y         GV     
Sbjct: 159 HEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEI-LQEMLYGPAVDWWAMGVLLYEM 217

Query: 249 -----PFYFQD 254
                PF  ++
Sbjct: 218 LCGHAPFEAEN 228

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 40.7 bits (96), Expect = 6e-04
 Identities = 44/178 (24%), Positives = 67/178 (37%), Gaps = 38/178 (21%)

Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARP--TENEMTG 285
            R+Y A EI+   M  +  G+  Y +DLK  N+ ++ +   K+ DFG+ +        T 
Sbjct: 126 ARFYAA-EIISALMFLHDKGI-IY-RDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTA 182

Query: 286 -YVATRWYRAPEIMLNWMHYNQT-DIHQLN-LIMEML-GTPP------AEFMAKISSDSA 335
            +  T  Y APEI L  M Y    D   +  L+ EML G  P       +    I +D  
Sbjct: 183 TFCGTPDYIAPEI-LQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV 241

Query: 336 RKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI-----TAEQAL-AHPY 387
             Y   L                  A  +L   +  +   R+       E A+  HP+
Sbjct: 242 V-YPTWLH---------------EDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPF 283

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 66.4 bits (163), Expect = 2e-12
 Identities = 50/185 (27%), Positives = 84/185 (45%), Gaps = 30/185 (16%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT- 149
           +KV +KK A   ++A     T  E  +L+ + H  ++ L+  F +         +Y++  
Sbjct: 50  MKV-LKK-AMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG------KLYLILE 101

Query: 150 HLMGADL-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELK 208
           +L G +L   + R     +D   F + +I   L ++H  GII+RDLKP NI +N    +K
Sbjct: 102 YLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVK 161

Query: 209 ILDFGLARP--TENEMTG-YVATRWYRAPEIMLNWMHYNQT------GV----------P 249
           + DFGL +    +  +T  +  T  Y APEI L    +N+       G           P
Sbjct: 162 LTDFGLCKESIHDGTVTHTFCGTIEYMAPEI-LMRSGHNRAVDWWSLGALMYDMLTGAPP 220

Query: 250 FYFQD 254
           F  ++
Sbjct: 221 FTGEN 225

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 40.2 bits (95), Expect = 8e-04
 Identities = 51/177 (28%), Positives = 77/177 (43%), Gaps = 37/177 (20%)

Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARP--TENEMTG 285
             +Y A EI +   H +Q G+  Y +DLKP NI +N    +K+ DFGL +    +  +T 
Sbjct: 123 ACFYLA-EISMALGHLHQKGI-IY-RDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH 179

Query: 286 -YVATRWYRAPEIMLNWMHYNQT-DIHQLN-LIMEML-GTPP------AEFMAKISSDSA 335
            +  T  Y APEI L    +N+  D   L  L+ +ML G PP       + + KI     
Sbjct: 180 TFCGTIEYMAPEI-LMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL 238

Query: 336 RKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI-----TAEQALAHPY 387
                 LP                +A DLL  +L+ ++  R+      A +  AHP+
Sbjct: 239 N-----LP-----------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 66.5 bits (163), Expect = 3e-12
 Identities = 38/131 (29%), Positives = 63/131 (48%), Gaps = 22/131 (16%)

Query: 145 VYMVT-HLMGADL-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
           +Y V  ++ G DL  +I +  +  + H  F   +I  GL ++ S GII+RDLK  N+ ++
Sbjct: 96  LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD 155

Query: 203 EDCELKILDFGLARP--TENEMTG-YVATRWYRAPEIMLNWMHYNQT------GV----- 248
            +  +KI DFG+ +    +   T  +  T  Y APEI + +  Y ++      GV     
Sbjct: 156 SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEI-IAYQPYGKSVDWWAFGVLLYEM 214

Query: 249 -----PFYFQD 254
                PF  +D
Sbjct: 215 LAGQAPFEGED 225

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 66.9 bits (164), Expect = 3e-12
 Identities = 37/131 (28%), Positives = 62/131 (47%), Gaps = 22/131 (16%)

Query: 145 VYMVT-HLMGADL-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
           +Y V  ++ G +L  ++ R +   +   +F   +I   L Y+HS  I++RDLKP NI ++
Sbjct: 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD 173

Query: 203 EDCELKILDFGLARP--TENEMTG-YVATRWYRAPEIMLNWMHYNQT------GV----- 248
               + + DFGL +     N  T  +  T  Y APE+ L+   Y++T      G      
Sbjct: 174 SQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEV-LHKQPYDRTVDWWCLGAVLYEM 232

Query: 249 -----PFYFQD 254
                PFY ++
Sbjct: 233 LYGLPPFYSRN 243

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 66.7 bits (163), Expect = 3e-12
 Identities = 23/166 (13%), Positives = 64/166 (38%), Gaps = 19/166 (11%)

Query: 68  IGPTLSKESFDLIF-------SSALDSVSGVKVAIK---KIARPFQSAVHAKRTYR--EL 115
           +    ++++  +++        +        K ++K   K  R F      +R  +  ++
Sbjct: 46  LKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQV 105

Query: 116 RMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRT---QKLSDDHVQF 172
              K +    ++ +            ++  ++V   +G  L + L       LS+  V  
Sbjct: 106 NKWKKLYSTPLLAIPTCMGFGVHQDKYR--FLVLPSLGRSLQSALDVSPKHVLSERSVLQ 163

Query: 173 LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKI--LDFGLAR 216
           +  ++L  L+++H    +H ++   NI V+ + + ++    +G A 
Sbjct: 164 VACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 66.5 bits (163), Expect = 3e-12
 Identities = 29/77 (37%), Positives = 41/77 (53%), Gaps = 16/77 (20%)

Query: 179 RGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRW----- 230
           RGL Y+H      IIHRD+K +NI ++E+ E  + DFGLA+  + + T +V T       
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIG 200

Query: 231 YRAPEIMLNWMHYNQTG 247
           + APE       Y  TG
Sbjct: 201 HIAPE-------YLSTG 210

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 46.8 bits (112), Expect = 7e-06
 Identities = 17/48 (35%), Positives = 28/48 (58%), Gaps = 6/48 (12%)

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRW-----YRAPE 296
           D+K +NI ++E+ E  + DFGLA+  + + T +V T       + APE
Sbjct: 159 DVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPE 205

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 66.2 bits (162), Expect = 4e-12
 Identities = 39/142 (27%), Positives = 64/142 (45%), Gaps = 22/142 (15%)

Query: 145 VYMVTHLM-GADL-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
           ++ V   + G DL  ++ R +KL ++H +F   +I   L Y+H  GII+RDLK  N+ ++
Sbjct: 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD 187

Query: 203 EDCELKILDFGLARP--TENEMTG-YVATRWYRAPEIMLNWMHYNQT------GV----- 248
            +  +K+ D+G+ +      + T  +  T  Y APEI L    Y  +      GV     
Sbjct: 188 SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI-LRGEDYGFSVDWWALGVLMFEM 246

Query: 249 -----PFYFQDLKPSNIAVNED 265
                PF       +     ED
Sbjct: 247 MAGRSPFDIVGSSDNPDQNTED 268

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 65.9 bits (161), Expect = 5e-12
 Identities = 34/170 (20%), Positives = 58/170 (34%), Gaps = 27/170 (15%)

Query: 68  IGPTLSKESFDLIF----SSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNH 123
           +G  + +  F  I+    +S+    S     +K               + EL+  +    
Sbjct: 39  VGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSD------NGPLFTELKFYQRAAK 92

Query: 124 ENVIGLLDVFHSNTCLA-------------DFKNVYMVTHLMGADLNNILRTQ--KLSDD 168
              I           L                   +M+    G+DL  I      + S  
Sbjct: 93  PEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRK 152

Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKI--LDFGLAR 216
            V  L  +IL  L+YIH    +H D+K SN+ +N     ++  +D+GLA 
Sbjct: 153 TVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 65.3 bits (160), Expect = 5e-12
 Identities = 23/62 (37%), Positives = 35/62 (56%), Gaps = 5/62 (8%)

Query: 179 RGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRW-----YRA 233
           RGL Y+H+  IIHRD+K  NI ++E+   KI DFG+++        +++T       Y  
Sbjct: 150 RGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYID 209

Query: 234 PE 235
           PE
Sbjct: 210 PE 211

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 65.4 bits (160), Expect = 7e-12
 Identities = 27/101 (26%), Positives = 58/101 (57%), Gaps = 6/101 (5%)

Query: 144 NVYMVT-HLMGADL-NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
            ++++  ++ G +L  ++ + ++ ++  VQ  V +I+  L+++H  GII+RD+K  NI +
Sbjct: 133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL 192

Query: 202 NEDCELKILDFGLAR---PTENEMTG-YVATRWYRAPEIML 238
           + +  + + DFGL++     E E    +  T  Y AP+I+ 
Sbjct: 193 DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 233

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 40.7 bits (96), Expect = 6e-04
 Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 17/157 (10%)

Query: 228 TRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLAR---PTENEMT 284
            + Y   EI+L   H ++ G+  Y +D+K  NI ++ +  + + DFGL++     E E  
Sbjct: 161 VQIYVG-EIVLALEHLHKLGI-IY-RDIKLENILLDSNGHVVLTDFGLSKEFVADETERA 217

Query: 285 G-YVATRWYRAPEIMLNWMH-YNQT-DIHQL-NLIMEML-GTPPAEFMAKISSDSARKYI 339
             +  T  Y AP+I+      +++  D   L  L+ E+L G  P  F      +S  +  
Sbjct: 218 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTVDGEKNSQAEIS 275

Query: 340 NSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKR 376
             + L ++  + Q     +  A DL+  +L  D +KR
Sbjct: 276 RRI-LKSEPPYPQEM---SALAKDLIQRLLMKDPKKR 308

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 37/156 (23%), Positives = 67/156 (42%), Gaps = 19/156 (12%)

Query: 76  SFDLIFSSALDSVSGVKVAIK--KIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVF 133
           SF  I+    +  +  +VAIK   +       ++  + YR L+           G+ +V 
Sbjct: 19  SFGEIYL-GTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQ--------GGTGIPNVR 69

Query: 134 HSNTCLADFKNVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIH 191
                        +V  L+G  L ++     +KLS   V  L  Q++  ++++HS   +H
Sbjct: 70  WFGVE---GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126

Query: 192 RDLKPSNIAV---NEDCELKILDFGLARPTENEMTG 224
           RD+KP N  +       ++ I+DFGLA+   +  T 
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 26/67 (38%), Positives = 37/67 (55%), Gaps = 4/67 (5%)

Query: 175 YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP 234
           +Q+ +G++++ S   IHRDL   NI ++E   +KI DFGLAR    +   YV     R P
Sbjct: 200 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLP 258

Query: 235 EIMLNWM 241
              L WM
Sbjct: 259 ---LKWM 262

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 56.9 bits (137), Expect = 4e-09
 Identities = 46/202 (22%), Positives = 76/202 (37%), Gaps = 23/202 (11%)

Query: 112 YRELRMLKHM-NHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQKLSDDH 169
             EL++L H+ +H NV+ LL       C      + ++       +L+  LR+++     
Sbjct: 73  MSELKILIHIGHHLNVVNLLGA-----CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 127

Query: 170 VQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP---TENEMTGYV 226
            +    +  +G  Y+   G I  DLK    ++          F   +     E E     
Sbjct: 128 YKTKGARFRQGKDYV---GAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPED 184

Query: 227 ATRWYRAPEIMLNWMHYNQTGVPFYFQ------DLKPSNIAVNEDCELKILDFGLARPTE 280
             + +   E ++ +      G+ F         DL   NI ++E   +KI DFGLAR   
Sbjct: 185 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 244

Query: 281 NEMTGYVATRWYRAPEIMLNWM 302
            +   YV     R P   L WM
Sbjct: 245 KDPD-YVRKGDARLP---LKWM 262

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 56.0 bits (134), Expect = 7e-09
 Identities = 44/258 (17%), Positives = 76/258 (29%), Gaps = 58/258 (22%)

Query: 90  GVKVAIKKIARPFQSAVHAK---------------RTYRELRMLKHMNHENVIGLLDVFH 134
              VAIK IA      V+                 +    L        E  IGL  V  
Sbjct: 43  HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHC 102

Query: 135 ----------------------SNTCLADFKN--VYMVTHLM--GADLNNILRTQKLSDD 168
                                 +N     FK+  +++V      G DL  + RT+  S  
Sbjct: 103 VQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQM-RTKLSSLA 161

Query: 169 HVQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGY-V 226
             + +++Q+   L    ++    HRDL   N+ + +    K+      + +     G  V
Sbjct: 162 TAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQV 221

Query: 227 ATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGY 286
           +   Y    +  +        V F    +       + D +  I    + +   N    Y
Sbjct: 222 SIIDYTLSRLERD------GIVVFCDVSMDEDLFTGDGDYQFDIYRL-MKKENNNRWGEY 274

Query: 287 VATRWYRAPEIMLNWMHY 304
                   P   + W+HY
Sbjct: 275 -------HPYSNVLWLHY 285

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 45.6 bits (107), Expect = 3e-05
 Identities = 60/416 (14%), Positives = 125/416 (30%), Gaps = 96/416 (23%)

Query: 49  RLHDHFNQP------YSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPF 102
            +     QP      Y E  R  +        + F     S L     ++ A+ ++ RP 
Sbjct: 97  PIKTEQRQPSMMTRMYIE-QRDRLYNDN----QVFAKYNVSRLQPYLKLRQALLEL-RPA 150

Query: 103 QS-AVH----------AKRTYRELRMLKHMNHENV--IGLLDVFHSNTCLADFKNVYMVT 149
           ++  +           A       ++   M+   +  + L +     T L   + +    
Sbjct: 151 KNVLIDGVLGSGKTWVALDVCLSYKVQCKMDF-KIFWLNLKNCNSPETVLEMLQKLLYQI 209

Query: 150 HLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI--AVNEDCEL 207
                  ++     KL    +Q  + ++L+   Y +   ++  +++ +    A N  C  
Sbjct: 210 DPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL-LVLLNVQNAKAWNAFNLSC-- 266

Query: 208 KIL----DFGLARPTENEMTGYVATRWYRAP-------EIMLNWMHYNQTGVPFYFQDLK 256
           KIL       +        T +++   +           ++L ++           QDL 
Sbjct: 267 KILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCR-------PQDLP 319

Query: 257 PSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIM 316
              +  N     ++         +   T                W ++   +  +L  I+
Sbjct: 320 REVLTTNP---RRLSIIA-ESIRDGLAT----------------WDNWKHVNCDKLTTII 359

Query: 317 EM----LGTPPAE----------FM--AKISSD------SARKYINSLPLLTK-KDFRQV 353
           E     L   PAE          F   A I +             + + ++ K   +  V
Sbjct: 360 ESSLNVL--EPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLV 417

Query: 354 FKGANPQAIDLLSLMLEL--DSEKRITAEQALAHPYLSQYSDPNDEPTSPPYDQSF 407
            K      I + S+ LEL    E      +++   Y    +  +D+   P  DQ F
Sbjct: 418 EKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYF 473

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 25/114 (21%), Positives = 48/114 (42%), Gaps = 18/114 (15%)

Query: 108 AKRTYRELRMLKHMNHENVIG--LLDVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKL 165
             RT RE R L  +    +    + DV   N  +       M++++ G    +++     
Sbjct: 383 KSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI-------MMSYINGKLAKDVI----- 430

Query: 166 SDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE 219
             +    + Y+I   +  +H   +IH DL  SN   ++D  +  +DFGL + + 
Sbjct: 431 --EDNLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDKDLYI--IDFGLGKISN 480

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	427
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.83
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.68
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.15
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.11
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.98
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	98.88
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.88
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	98.86
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	98.85
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	98.77
3rp9_A	458	Mitogen-activated protein kinase; structural genom	98.75
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	98.75
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	98.65
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	98.62
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	98.58
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	98.58
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	98.52
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	98.51
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	98.49
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.36
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	98.34
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.32
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.14
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	97.76
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	97.68
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.59
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.58
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.54
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.45
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	97.07
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	97.07
3ats_A	357	Putative uncharacterized protein; hypothetical pro	96.97
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	96.88
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	96.84
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	96.75
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	96.74
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	96.66
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	96.66
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	96.62
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	96.62
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	96.6
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	96.51
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	96.42
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	96.39
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	96.37
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	96.36
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	96.31
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	96.3
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	96.24
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	96.23
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	96.2
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	96.16
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.15
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	96.14
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	96.14
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	95.97
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	95.86
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	95.86
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	95.74
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	95.59
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	95.24
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	95.11
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	95.06
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	94.94
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	94.93
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	94.72
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	94.71
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	94.71
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	94.64
3niz_A	311	Rhodanese family protein; structural genomics, str	94.48
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	94.26
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	94.15
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	93.59
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	93.33
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	93.2
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	93.11
3o0g_A	292	Cell division protein kinase 5; kinase activator c	92.9
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	92.89
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	92.82
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	92.81
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	92.76
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	92.36
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	92.05
4aoj_A	329	High affinity nerve growth factor receptor; transf	92.04
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	91.84
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	91.23
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	90.28
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	90.26
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	90.18
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	90.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	89.98
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	89.75
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	89.66
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	89.59
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	89.27
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	89.17
3ork_A	311	Serine/threonine protein kinase; structural genomi	89.1
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	88.92
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	88.71
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	88.67
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	88.61
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	88.47
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	88.38
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	88.29
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	88.17
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	87.92
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	87.9
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	87.88
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	87.74
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	87.64
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	87.58
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	87.53
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	87.5
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	87.37
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	87.3
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	87.1
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	87.05
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	86.86
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	86.85
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	86.63
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	86.37
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	86.09
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	85.71
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	85.66
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	85.48
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	85.41
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	84.97
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	84.91
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	84.86
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	84.69
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	84.67
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	84.6
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	84.33
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	84.18
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	84.02
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	83.96
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	83.94
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	83.8
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	83.74
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	83.58
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	83.27
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	83.01
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	82.61
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	82.18
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	82.02
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	82.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	81.92
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	81.91
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	81.84
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	81.83
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	81.61
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	81.51
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	81.33
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	81.05
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	80.63
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	80.55
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	80.36
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	80.05
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	80.01

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.3e-61  Score=478.85  Aligned_cols=322  Identities=43%  Similarity=0.735  Sum_probs=263.6

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      ++|++.+.||+|+||.||+ +.+..+|+.||||++.+........+++.+|+++|+.++|||||++++++.......+..
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~-a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSS-ARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEE-EEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCeEEEEEEecccCeEEEE-EEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            5699999999999999995 678889999999999876666667778899999999999999999999987665555667


Q ss_pred             eEEEEeccCCCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC--
Q psy8260         144 NVYMVTHLMGADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN--  220 (427)
Q Consensus       144 ~~~lv~e~~g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~--  220 (427)
                      .+|+||||++|+|.+++.. +.+++..++.+++||+.||+|||++|||||||||+|||++.++.+||+|||+|+....  
T Consensus       133 ~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~  212 (398)
T 4b99_A          133 SVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP  212 (398)
T ss_dssp             CEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC----
T ss_pred             EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCc
Confidence            8999999999999998864 5799999999999999999999999999999999999999999999999999986532  


Q ss_pred             -----CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         221 -----EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       221 -----~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                           ..++.+||++|||||++.+...|+...      |+||.||++.+                 +.+|.         
T Consensus       213 ~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~------DiWSlG~il~e-----------------ll~G~---------  260 (398)
T 4b99_A          213 AEHQYFMTEYVATRWYRAPELMLSLHEYTQAI------DLWSVGCIFGE-----------------MLARR---------  260 (398)
T ss_dssp             ---CCCCCSSCCCCTTCCHHHHTTCSCCCTHH------HHHHHHHHHHH-----------------HHHTS---------
T ss_pred             cccccccccceeChHhcCHHHhcCCCCCCChh------heehhHHHHHH-----------------HHHCC---------
Confidence                 234578888888888887755555443      88888887766                 33332         


Q ss_pred             HHhhhccCCCC-CCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCC
Q psy8260         296 EIMLNWMHYNQ-TDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       296 Evl~~~~~~~~-~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~  374 (427)
                            .+|.+ .+..++..|+..+|+++...+..........+....+......+...++..|++++|||.+||++||+
T Consensus       261 ------~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~  334 (398)
T 4b99_A          261 ------QLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPS  334 (398)
T ss_dssp             ------CSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTT
T ss_pred             ------CCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChh
Confidence                  24433 35667777888888887766655544455556666777777788888999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCCCCCCC-CCCCCcccccCCCCHHHHHHHHhhh
Q psy8260         375 KRITAEQALAHPYLSQYSDPNDEPT-SPPYDQSFEDMDLPVDQWKGTYSLE  424 (427)
Q Consensus       375 ~R~ta~e~L~Hp~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  424 (427)
                      +|+||+|+|+||||++...|..+|. .++++.+++....+.++++..+..|
T Consensus       335 ~R~ta~e~L~Hp~f~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~k~~i~~e  385 (398)
T 4b99_A          335 ARISAAAALRHPFLAKYHDPDDEPDCAPPFDFAFDREALTRERIKEAIVAE  385 (398)
T ss_dssp             TSCCHHHHTTSGGGTTTCCGGGSCCCSSCCCCHHHHSCCCHHHHHHHHHHH
T ss_pred             HCcCHHHHhcCHhhCcCCCCccccCCCCCCCCccchhhcCHHHHHHHHHHH
Confidence            9999999999999999988877765 4778888888889999998876554

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.1e-58  Score=449.03  Aligned_cols=259  Identities=22%  Similarity=0.404  Sum_probs=210.0

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      ...|++.+.||+|+||.||+ +.+..+|+.||||++......  ..+.+.+|+++|+.++|||||+++++|...      
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~-a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~------  143 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCI-ATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVG------  143 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEE-EEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEET------
T ss_pred             hHhcEEeEEeecCcCeEEEE-EEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEEC------
Confidence            35688999999999999996 567889999999999654322  234577999999999999999999999764      


Q ss_pred             ceEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      ..+||||||+ ||+|.+++..+++++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus       144 ~~~~ivmEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  223 (346)
T 4fih_A          144 DELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  223 (346)
T ss_dssp             TEEEEEECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred             CEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence            4689999999 789999999889999999999999999999999999999999999999999999999999999754321


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      ..                                                          ...+.+||+.|||||++.+.
T Consensus       224 ~~----------------------------------------------------------~~~~~~GTp~YmAPEvl~~~  245 (346)
T 4fih_A          224 VP----------------------------------------------------------RRKSLVGTPYWMAPELISRL  245 (346)
T ss_dssp             SC----------------------------------------------------------CBCCCCSCGGGCCHHHHTTC
T ss_pred             CC----------------------------------------------------------cccccccCcCcCCHHHHCCC
Confidence            10                                                          12345788888888888887


Q ss_pred             cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHH
Q psy8260         302 MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQ  381 (427)
Q Consensus       302 ~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e  381 (427)
                      .|..++||||+|+++++|.++..||......+.........+.. .    ..+..+|++++|||.+||++||++|+|++|
T Consensus       246 ~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~-~----~~~~~~s~~~~dli~~~L~~dP~~R~ta~e  320 (346)
T 4fih_A          246 PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR-L----KNLHKVSPSLKGFLDRLLVRDPAQRATAAE  320 (346)
T ss_dssp             CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC-C----SCGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC-C----CccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            88888999999999999976666665443222333332222111 1    123457999999999999999999999999


Q ss_pred             HhcCCCCCCCCC
Q psy8260         382 ALAHPYLSQYSD  393 (427)
Q Consensus       382 ~L~Hp~f~~~~~  393 (427)
                      +|+||||++...
T Consensus       321 ~l~Hp~~~~~~~  332 (346)
T 4fih_A          321 LLKHPFLAKAGP  332 (346)
T ss_dssp             HTTCGGGGGCCC
T ss_pred             HhcCHhhcCCCC
Confidence            999999987543

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2e-58  Score=442.88  Aligned_cols=260  Identities=26%  Similarity=0.373  Sum_probs=210.9

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC-HHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS-AVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .+|++.+.||+|+||.||. +.+..+|+.||||++.+.... ....+.+.+|+++|++++|||||+++++|++.      
T Consensus        32 ~dy~i~~~lG~G~fg~V~~-a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------  104 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVL-ARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD------  104 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEE-EEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS------
T ss_pred             cccEEEEEEecccCeEEEE-EEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC------
Confidence            5699999999999999995 668889999999999653211 11245678999999999999999999999764      


Q ss_pred             ceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      ..+|++|||+ ||+|.++++. +.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus       105 ~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~  184 (311)
T 4aw0_A          105 EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  184 (311)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             CEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence            5689999999 7899998864 6799999999999999999999999999999999999999999999999999975432


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      ...                                                        .....+.+||+.|||||++.+
T Consensus       185 ~~~--------------------------------------------------------~~~~~~~~GTp~YmAPEvl~~  208 (311)
T 4aw0_A          185 ESK--------------------------------------------------------QARANSFVGTAQYVSPELLTE  208 (311)
T ss_dssp             TTT--------------------------------------------------------CCCBCCCCSCGGGCCHHHHHH
T ss_pred             CCC--------------------------------------------------------cccccCcccCcccCCHHHHcC
Confidence            110                                                        002235678999999999988


Q ss_pred             ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHH
Q psy8260         301 WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAE  380 (427)
Q Consensus       301 ~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~  380 (427)
                      ..+..++|+||+|+++|+|.++..||..........+..+....+        ...+|++++|||.+||++||++|+|++
T Consensus       209 ~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~--------p~~~s~~~~dli~~lL~~dp~~R~t~~  280 (311)
T 4aw0_A          209 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDF--------PEKFFPKARDLVEKLLVLDATKRLGCE  280 (311)
T ss_dssp             SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC--------CTTCCHHHHHHHHHHSCSSGGGSTTSG
T ss_pred             CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--------CcccCHHHHHHHHHHccCCHhHCcChH
Confidence            888888999999999999977776775443333333443333222        245799999999999999999999999


Q ss_pred             H------HhcCCCCCCCCCC
Q psy8260         381 Q------ALAHPYLSQYSDP  394 (427)
Q Consensus       381 e------~L~Hp~f~~~~~~  394 (427)
                      |      +++||||++....
T Consensus       281 e~~~~~~i~~Hp~F~~idw~  300 (311)
T 4aw0_A          281 EMEGYGPLKAHPFFESVTWE  300 (311)
T ss_dssp             GGTCHHHHHTSGGGTTCCCT
T ss_pred             HHcCCHHHHCCCCcCCCCHH
Confidence            8      5899999876443

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2e-57  Score=429.82  Aligned_cols=253  Identities=26%  Similarity=0.371  Sum_probs=193.2

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH-HHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA-VHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      ++|++.+.||+|+||.||. +.+..+|+.||||++.+..... ....++.+|+++|+.++|||||+++++|...      
T Consensus        13 g~Y~i~~~lG~G~fg~V~~-~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~------   85 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKL-AYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK------   85 (275)
T ss_dssp             -CCEEEEEEEC---CCEEE-EECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS------
T ss_pred             eCeEEEEEEecCcCeEEEE-EEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC------
Confidence            5789999999999999995 6678899999999997653322 2345678999999999999999999999764      


Q ss_pred             ceEEEEeccCCCCHHHHHh-hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         143 KNVYMVTHLMGADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       143 ~~~~lv~e~~g~~L~~~l~-~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      ..+|++|||++|+|.+.+. .+.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus        86 ~~~~ivmEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           86 DEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             SEEEEEEECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             CEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            4689999999999988775 467999999999999999999999999999999999999999999999999999743221


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      .                                                           ...+.+||+.|||||++.+.
T Consensus       166 ~-----------------------------------------------------------~~~~~~GT~~Y~APE~~~~~  186 (275)
T 3hyh_A          166 N-----------------------------------------------------------FLKTSCGSPNYAAPEVISGK  186 (275)
T ss_dssp             --------------------------------------------------------------------CTTSCHHHHSSS
T ss_pred             C-----------------------------------------------------------ccCCeeECcccCChhhhcCC
Confidence            0                                                           11234678888888887776


Q ss_pred             cCC-CCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHH
Q psy8260         302 MHY-NQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAE  380 (427)
Q Consensus       302 ~~~-~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~  380 (427)
                      .+. .++|+||+|+++++|.++..||................+.+        ...+|++++|||.+||++||++|+|++
T Consensus       187 ~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~--------p~~~s~~~~~li~~~L~~dP~~R~s~~  258 (275)
T 3hyh_A          187 LYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTL--------PKFLSPGAAGLIKRMLIVNPLNRISIH  258 (275)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC--------CTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             CCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC--------CCCCCHHHHHHHHHHccCChhHCcCHH
Confidence            665 46799999999999977666665432222223332222221        245799999999999999999999999


Q ss_pred             HHhcCCCCCC
Q psy8260         381 QALAHPYLSQ  390 (427)
Q Consensus       381 e~L~Hp~f~~  390 (427)
                      |+|+||||+.
T Consensus       259 eil~hpw~k~  268 (275)
T 3hyh_A          259 EIMQDDWFKV  268 (275)
T ss_dssp             HHHHCHHHHT
T ss_pred             HHHcCccccc
Confidence            9999999964

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.4e-57  Score=450.22  Aligned_cols=258  Identities=22%  Similarity=0.405  Sum_probs=210.4

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      +..|++.+.||+|+||.||. +.+..+|+.||||++......  ..+.+.+|+.+|+.++|||||+++++|...      
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~-a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~------  220 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCI-ATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVG------  220 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEE-EEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEET------
T ss_pred             hHhcEeeeEeccCcCcEEEE-EEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEEC------
Confidence            45689999999999999995 667889999999999754322  234577999999999999999999999764      


Q ss_pred             ceEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      ..+||||||+ ||+|.++++.+++++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.....
T Consensus       221 ~~~~iVmEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~  300 (423)
T 4fie_A          221 DELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  300 (423)
T ss_dssp             TEEEEEEECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred             CEEEEEEeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence            4689999999 789999999899999999999999999999999999999999999999999999999999999754321


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      .                                                          ....+.+||++|||||++.+.
T Consensus       301 ~----------------------------------------------------------~~~~~~~GTp~YmAPEvl~~~  322 (423)
T 4fie_A          301 V----------------------------------------------------------PRRKSLVGTPYWMAPELISRL  322 (423)
T ss_dssp             C----------------------------------------------------------CCBCCCEECTTTCCHHHHTTC
T ss_pred             C----------------------------------------------------------ccccccccCcCcCCHHHHCCC
Confidence            1                                                          022345788888888888888


Q ss_pred             cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHH
Q psy8260         302 MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQ  381 (427)
Q Consensus       302 ~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e  381 (427)
                      .|..++||||+|+++++|.++..||................+.. .    ..+..+|++++|||.+||++||++|+|++|
T Consensus       323 ~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~-~----~~~~~~s~~~~dli~~~L~~dP~~R~ta~e  397 (423)
T 4fie_A          323 PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR-L----KNLHKVSPSLKGFLDRLLVRDPAQRATAAE  397 (423)
T ss_dssp             CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-C----SCTTSSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC-C----cccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            88888999999999999977666665443222333332222111 1    123567999999999999999999999999


Q ss_pred             HhcCCCCCCCC
Q psy8260         382 ALAHPYLSQYS  392 (427)
Q Consensus       382 ~L~Hp~f~~~~  392 (427)
                      +|+||||++..
T Consensus       398 ll~Hp~~~~~~  408 (423)
T 4fie_A          398 LLKHPFLAKAG  408 (423)
T ss_dssp             HTTCGGGGGCC
T ss_pred             HhcCHHhcCCC
Confidence            99999998754

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.3e-57  Score=444.05  Aligned_cols=255  Identities=24%  Similarity=0.309  Sum_probs=204.1

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      .+|.+.+.||+|+||.||+ +.+..+|+.||||++.+........+++.+|+++|++++|||||+++++|...      .
T Consensus        24 e~Y~~~~~lG~G~fg~V~~-a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~------~   96 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAIL-VKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEEN------G   96 (350)
T ss_dssp             CCEEEEEEC------CEEE-EEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET------T
T ss_pred             cceEEeEEEecCCCeEEEE-EEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC------C
Confidence            4689999999999999996 56788999999999987766667777889999999999999999999998754      5


Q ss_pred             eEEEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                      .+|+||||+ ||+|.+++..   ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+...
T Consensus        97 ~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  176 (350)
T 4b9d_A           97 SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN  176 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeec
Confidence            689999999 7899998854   247999999999999999999999999999999999999999999999999997543


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      ...                                                          ....+.+||+.|||||++.
T Consensus       177 ~~~----------------------------------------------------------~~~~~~~GT~~YmAPE~l~  198 (350)
T 4b9d_A          177 STV----------------------------------------------------------ELARACIGTPYYLSPEICE  198 (350)
T ss_dssp             HHH----------------------------------------------------------HHHHHHHSCCTTCCHHHHT
T ss_pred             CCc----------------------------------------------------------ccccccCCCccccCHHHHC
Confidence            210                                                          0122446888888888888


Q ss_pred             hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH
Q psy8260         300 NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA  379 (427)
Q Consensus       300 ~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta  379 (427)
                      +..+..++|+||+|+++|+|.++..||......+...+......       ......+|++++|||.+||++||++|||+
T Consensus       199 ~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-------~~~~~~~s~~~~~li~~~L~~dP~~R~s~  271 (350)
T 4b9d_A          199 NKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF-------PPVSLHYSYDLRSLVSQLFKRNPRDRPSV  271 (350)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-------CCCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-------CCCCccCCHHHHHHHHHHccCChhHCcCH
Confidence            87788888999999999999776666654332233333332211       11234578999999999999999999999


Q ss_pred             HHHhcCCCCCC
Q psy8260         380 EQALAHPYLSQ  390 (427)
Q Consensus       380 ~e~L~Hp~f~~  390 (427)
                      +|+|+||||++
T Consensus       272 ~e~l~hp~~~~  282 (350)
T 4b9d_A          272 NSILEKGFIAK  282 (350)
T ss_dssp             HHHHTSHHHHT
T ss_pred             HHHhcCHHhhc
Confidence            99999999975

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.6e-56  Score=424.57  Aligned_cols=255  Identities=23%  Similarity=0.335  Sum_probs=201.1

Q ss_pred             eeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEE
Q psy8260          67 DIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVY  146 (427)
Q Consensus        67 ~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~  146 (427)
                      .+...||+|+||.||+ +.+..+++.||||++..........+++.+|+++|++++|||||+++++|....  .....+|
T Consensus        29 ~~~~~iG~G~fg~Vy~-a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~--~~~~~~~  105 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYK-GLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV--KGKKCIV  105 (290)
T ss_dssp             EEEEEEEECSSEEEEE-EEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE--TTEEEEE
T ss_pred             EeeeEEecCcCcEEEE-EEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc--CCCcEEE
Confidence            6778899999999996 567889999999999776666666778899999999999999999999986421  1224689


Q ss_pred             EEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcC--ceeccCCCCCeEEcC-CCCEEEeeCCCCCCCCCC
Q psy8260         147 MVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNE-DCELKILDFGLARPTENE  221 (427)
Q Consensus       147 lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~--iiHrDLKp~NILl~~-~~~~kl~DFGla~~~~~~  221 (427)
                      ++|||+ ||+|.++++. +.+++..++.++.||+.||+|||++|  ||||||||+|||++. ++.+||+|||+|+.....
T Consensus       106 lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~  185 (290)
T 3fpq_A          106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  185 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence            999998 7899998864 67999999999999999999999998  999999999999974 799999999998642211


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                                                                                  ...+.+||+.|||||++.+ 
T Consensus       186 ------------------------------------------------------------~~~~~~GTp~YmAPE~~~~-  204 (290)
T 3fpq_A          186 ------------------------------------------------------------FAKAVIGTPEFMAPEMYEE-  204 (290)
T ss_dssp             ------------------------------------------------------------SBEESCSSCCCCCGGGGGT-
T ss_pred             ------------------------------------------------------------ccCCcccCccccCHHHcCC-
Confidence                                                                        1123457777777777654 


Q ss_pred             cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHH
Q psy8260         302 MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQ  381 (427)
Q Consensus       302 ~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e  381 (427)
                      .+..++|+||+|+++++|.++..||.................  .+   .......+++++|||.+||+.||++|||++|
T Consensus       205 ~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~--~~---~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e  279 (290)
T 3fpq_A          205 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV--KP---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKD  279 (290)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC--CC---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCC--CC---CCCCccCCHHHHHHHHHHccCChhHCcCHHH
Confidence            467778999999999999777666654322222222221111  11   1233457899999999999999999999999


Q ss_pred             HhcCCCCCC
Q psy8260         382 ALAHPYLSQ  390 (427)
Q Consensus       382 ~L~Hp~f~~  390 (427)
                      +|+||||++
T Consensus       280 ~l~Hp~~~~  288 (290)
T 3fpq_A          280 LLNHAFFQE  288 (290)
T ss_dssp             HHTSGGGC-
T ss_pred             HhcCccccC
Confidence            999999975

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.6e-57  Score=433.78  Aligned_cols=258  Identities=23%  Similarity=0.354  Sum_probs=201.6

Q ss_pred             cCcceeeccccCcccccEEEEeEE--eCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSAL--DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~--~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      ...+|++.+.||+|+||.||.+..  +..+++.||||++.+.........++.+|+++|++++|||||+++++|...   
T Consensus        22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~---   98 (304)
T 3ubd_A           22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTE---   98 (304)
T ss_dssp             CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEET---
T ss_pred             CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC---
Confidence            346799999999999999997543  245789999999875432222233567899999999999999999999754   


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCC
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP  217 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~  217 (427)
                         ..+|++|||+ ||+|.++++. +.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.
T Consensus        99 ---~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~  175 (304)
T 3ubd_A           99 ---GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE  175 (304)
T ss_dssp             ---TEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred             ---CEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence               5689999999 7899988854 6799999999999999999999999999999999999999999999999999874


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      .....                                                          ....+.+||+.|||||+
T Consensus       176 ~~~~~----------------------------------------------------------~~~~~~~GT~~YmAPE~  197 (304)
T 3ubd_A          176 SIDHE----------------------------------------------------------KKAYSFCGTVEYMAPEV  197 (304)
T ss_dssp             ---------------------------------------------------------------CCCCSCCCCGGGCCHHH
T ss_pred             ccCCC----------------------------------------------------------ccccccccCcccCCHHH
Confidence            32110                                                          01234578888888888


Q ss_pred             hhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC
Q psy8260         298 MLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI  377 (427)
Q Consensus       298 l~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~  377 (427)
                      +.+..+..++|+||+|+++++|.++..||......+...+..+..+..        ...+|++++|||.+||++||++|+
T Consensus       198 ~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~--------p~~~s~~~~~li~~~L~~dP~~R~  269 (304)
T 3ubd_A          198 VNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM--------PQFLSPEAQSLLRMLFKRNPANRL  269 (304)
T ss_dssp             HHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------CTTSCHHHHHHHHHHTCSSGGGST
T ss_pred             hccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC--------CCcCCHHHHHHHHHHcccCHHHCC
Confidence            888888888999999999999977766675443333333333332222        245799999999999999999999


Q ss_pred             C-----HHHHhcCCCCCCC
Q psy8260         378 T-----AEQALAHPYLSQY  391 (427)
Q Consensus       378 t-----a~e~L~Hp~f~~~  391 (427)
                      |     ++|+++||||+..
T Consensus       270 ta~~~~~~eil~Hp~f~~i  288 (304)
T 3ubd_A          270 GAGPDGVEEIKRHSFFSTI  288 (304)
T ss_dssp             TCSTTTHHHHHTSGGGTTC
T ss_pred             CCCcCCHHHHHcCccccCC
Confidence            8     5899999999875

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.8e-55  Score=425.76  Aligned_cols=260  Identities=20%  Similarity=0.286  Sum_probs=208.2

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      ..|.+.+.||+|+||.||+ +.+..+|+.||||++.....       ..+|+.+|+.++|||||+++++|...      .
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~-a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~------~  123 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHR-MKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREG------P  123 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEE-EEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEET------T
T ss_pred             hheEeCcEeccCCCeEEEE-EEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEEC------C
Confidence            5688889999999999996 56788999999999975422       24799999999999999999998754      4


Q ss_pred             eEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCC-CEEEeeCCCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC-ELKILDFGLARPTEN  220 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~-~~kl~DFGla~~~~~  220 (427)
                      .+|+||||+ ||+|.++++. +.+++..++.++.||+.||+|||++|||||||||+|||++.+| .+||+|||+|+....
T Consensus       124 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~  203 (336)
T 4g3f_A          124 WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQP  203 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred             EEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence            689999999 7899998864 6799999999999999999999999999999999999999887 699999999975432


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      .....                    .                                 .......+||+.|||||++.+
T Consensus       204 ~~~~~--------------------~---------------------------------~~~~~~~~GT~~YmAPE~~~~  230 (336)
T 4g3f_A          204 DGLGK--------------------S---------------------------------LLTGDYIPGTETHMAPEVVMG  230 (336)
T ss_dssp             ---------------------------------------------------------------CCCCCCGGGCCHHHHTT
T ss_pred             CCccc--------------------c---------------------------------eecCCccccCccccCHHHHCC
Confidence            11000                    0                                 001123579999999999999


Q ss_pred             ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHH
Q psy8260         301 WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAE  380 (427)
Q Consensus       301 ~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~  380 (427)
                      ..+..++|+||+|+++++|.++..||..........+.....+     .+..+++.++++++|||.+||++||++|||++
T Consensus       231 ~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-----~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~  305 (336)
T 4g3f_A          231 KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPP-----PIREIPPSCAPLTAQAIQEGLRKEPVHRASAM  305 (336)
T ss_dssp             CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCC-----GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCC-----CchhcCccCCHHHHHHHHHHccCCHhHCcCHH
Confidence            8888889999999999998666666655444333444333221     22345567899999999999999999999999


Q ss_pred             HH-------------hcCCCCCCCCCCC
Q psy8260         381 QA-------------LAHPYLSQYSDPN  395 (427)
Q Consensus       381 e~-------------L~Hp~f~~~~~~~  395 (427)
                      |+             |+|||+.++..|.
T Consensus       306 el~~~l~~~l~~~~~l~hPw~~~~~~Pr  333 (336)
T 4g3f_A          306 ELRRKVGKALQEVGGLKSPWKGEYKEPR  333 (336)
T ss_dssp             HHHHHHHHHHHHTTSSCSCSSSSCCCCC
T ss_pred             HHHHHHHHHHhhhhhccCCCcCCCCCCC
Confidence            97             6899999877664

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=9.7e-55  Score=417.56  Aligned_cols=275  Identities=22%  Similarity=0.344  Sum_probs=194.7

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc----
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL----  139 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~----  139 (427)
                      ++|++.+.||+|+||.||. +.+..+|+.||||++.... .....+++.+|+++|++++|||||+++++|......    
T Consensus         5 ~dy~~~~~lG~G~fg~V~~-a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~   82 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFE-AKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ   82 (299)
T ss_dssp             HHEEEEEEEEECC--EEEE-EEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred             hhCEEeeEEecCCCeEEEE-EEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence            3588899999999999995 5678899999999986543 444556788999999999999999999998654321    


Q ss_pred             --cCCceEEEEeccC-CCCHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeC
Q psy8260         140 --ADFKNVYMVTHLM-GADLNNILRTQK----LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDF  212 (427)
Q Consensus       140 --~~~~~~~lv~e~~-g~~L~~~l~~~~----l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DF  212 (427)
                        .....+|++|||+ |++|.++++...    .++..+..++.||+.||+|||++|||||||||+|||++.++.+||+||
T Consensus        83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF  162 (299)
T 4g31_A           83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF  162 (299)
T ss_dssp             ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence              1223579999999 789999987542    455678899999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccc
Q psy8260         213 GLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWY  292 (427)
Q Consensus       213 Gla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y  292 (427)
                      |+|+...........    ..|                                          ........+.+||+.|
T Consensus       163 Gla~~~~~~~~~~~~----~~~------------------------------------------~~~~~~~~~~~GT~~Y  196 (299)
T 4g31_A          163 GLVTAMDQDEEEQTV----LTP------------------------------------------MPAYARHTGQVGTKLY  196 (299)
T ss_dssp             CCC------------------------------------------------------------------------CCCTT
T ss_pred             ccceecCCCcccccc----ccc------------------------------------------cccccccCCcccCccc
Confidence            999865432110000    000                                          0000133567899999


Q ss_pred             cchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         293 RAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       293 ~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                      ||||++.+..+..++|+||+|+++++|.+|........  ...... .. ...     ...+...++++++||.+||+.|
T Consensus       197 mAPE~~~~~~y~~~~DiwSlGvilyell~Pf~~~~~~~--~~~~~~-~~-~~~-----p~~~~~~~~~~~~li~~~L~~d  267 (299)
T 4g31_A          197 MSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERV--RTLTDV-RN-LKF-----PPLFTQKYPCEYVMVQDMLSPS  267 (299)
T ss_dssp             SCHHHHTTCCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHH-HT-TCC-----CHHHHHHCHHHHHHHHHHTCSS
T ss_pred             cCHHHHcCCCCCCHHHHHHHHHHHHHHccCCCCccHHH--HHHHHH-hc-CCC-----CCCCcccCHHHHHHHHHHcCCC
Confidence            99999999889889999999999998876432111100  011111 11 111     1223345788999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCCCCCC
Q psy8260         373 SEKRITAEQALAHPYLSQYSDPN  395 (427)
Q Consensus       373 P~~R~ta~e~L~Hp~f~~~~~~~  395 (427)
                      |++|||++|+|+||||++...|.
T Consensus       268 P~~Rps~~eil~h~~~~~~~~p~  290 (299)
T 4g31_A          268 PMERPEAINIIENAVFEDLDFPG  290 (299)
T ss_dssp             GGGSCCHHHHHTSGGGCCC----
T ss_pred             hhHCcCHHHHhcCHhhCCCCCCC
Confidence            99999999999999998765443

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-53  Score=417.90  Aligned_cols=324  Identities=53%  Similarity=0.918  Sum_probs=266.2

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .+.|.+.+.||+|+||.||. +.+..+|+.||||++..........+++.+|+++|+.++||||+++++++.......+.
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~-a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCS-AVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             BSSEEEEEEC------CEEE-EEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cceEEEeEEeeecCCeEEEE-EEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            46789999999999999995 56778999999999977666666677889999999999999999999999766544445


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCc
Q psy8260         143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM  222 (427)
Q Consensus       143 ~~~~lv~e~~g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~  222 (427)
                      ..+|+++++++++|.++++...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       103 ~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  182 (367)
T 1cm8_A          103 TDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM  182 (367)
T ss_dssp             CCCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSSC
T ss_pred             ceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccccc
Confidence            66899999999999999988899999999999999999999999999999999999999999999999999999877777


Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhcc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM  302 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~  302 (427)
                      +..++|++|+|||++.+...|+...      |+|+.||++.+                 +.+|.               .
T Consensus       183 ~~~~~t~~y~aPE~~~~~~~~~~~~------DiwslG~il~e-----------------ll~g~---------------~  224 (367)
T 1cm8_A          183 TGYVVTRWYRAPEVILNWMRYTQTV------DIWSVGCIMAE-----------------MITGK---------------T  224 (367)
T ss_dssp             CSSCSCGGGCCTHHHHTTTCCCTTH------HHHHHHHHHHH-----------------HHHSS---------------C
T ss_pred             CcCcCCCCcCCHHHHhCCCCCChhh------hHHHHHHHHHH-----------------HHhCC---------------C
Confidence            7889999999999998765565544      99999998766                 22222               2


Q ss_pred             CCCCC-CHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHH
Q psy8260         303 HYNQT-DIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQ  381 (427)
Q Consensus       303 ~~~~~-d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e  381 (427)
                      .+.+. +..++..|+..+|+++.++...........+....+......+...+...+++++|||.+||++||.+|+|++|
T Consensus       225 pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e  304 (367)
T 1cm8_A          225 LFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE  304 (367)
T ss_dssp             SSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             CCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHH
Confidence            34433 56678888899999999998888888788888888887778888888899999999999999999999999999


Q ss_pred             HhcCCCCCCCCCCCCCCCCCCCCcccccCCCCHHHHHHHHhhhc
Q psy8260         382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKGTYSLES  425 (427)
Q Consensus       382 ~L~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (427)
                      +|+||||.....+..++...+++.++++.....++|+..+..|.
T Consensus       305 ~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (367)
T 1cm8_A          305 ALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEV  348 (367)
T ss_dssp             HHHSGGGTTTC------CCCCCCCC-----CCHHHHHHHHHHHH
T ss_pred             HhcChHHHhhcCCccCCCCCCCCCChhhhcCCHHHHHHHHHHHH
Confidence            99999999998888888888899999999999999998877664

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.3e-53  Score=418.48  Aligned_cols=287  Identities=25%  Similarity=0.374  Sum_probs=198.3

Q ss_pred             CcceeeccccCcccccEEEEeEEe--CcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCccc
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALD--SVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~--~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~  139 (427)
                      .+.|++.+.||+|+||.||++...  ..+++.||||++.+...    ..++.+|+++|+.+ +|||||+++++|...   
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~---   92 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----PIRIAAELQCLTVAGGQDNVMGVKYCFRKN---   92 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBCCCSEEEEET---
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----HHHHHHHHHHHHHhcCCCCCceEEEEEEEC---
Confidence            356999999999999999976533  35688999999865422    34577899999988 699999999998754   


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCC-CCEEEeeCCCCCC
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARP  217 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~-~~~kl~DFGla~~  217 (427)
                         .++|++|||+ |++|.++++  .+++.+++.+++||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+.
T Consensus        93 ---~~~~lvmE~~~g~~L~~~~~--~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           93 ---DHVVIAMPYLEHESFLDILN--SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG  167 (361)
T ss_dssp             ---TEEEEEEECCCCCCHHHHHT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             ---CEEEEEEeCCCcccHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence               5689999998 689999884  69999999999999999999999999999999999999876 7999999999986


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      .........   .+...+....                         .+....+.  ..........+.+||++|||||+
T Consensus       168 ~~~~~~~~~---~~~~~~~~~~-------------------------~~~~~~~~--~~~~~~~~~~~~~GT~~Y~APE~  217 (361)
T 4f9c_A          168 THDTKIELL---KFVQSEAQQE-------------------------RCSQNKCS--ICLSRRQQVAPRAGTPGFRAPEV  217 (361)
T ss_dssp             CTTCSCGGG---GGC-----------------------------------------------------CCCCGGGCCHHH
T ss_pred             cCCcccccc---cccccccccc-------------------------cccccccc--ccccccccccccccCccccCHHH
Confidence            543211100   0000000000                         00000000  00011224567899999999999


Q ss_pred             hhhcc-CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHH-HH----------------------------------HHHh-
Q psy8260         298 MLNWM-HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDS-AR----------------------------------KYIN-  340 (427)
Q Consensus       298 l~~~~-~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~-~~----------------------------------~~~~-  340 (427)
                      +.+.. +..++|+||+|+|+++|.++..||........ ..                                  +... 
T Consensus       218 l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~  297 (361)
T 4f9c_A          218 LTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCER  297 (361)
T ss_dssp             HTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHH
T ss_pred             HcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHh
Confidence            98765 55667999999999988666555532211100 00                                  0000 


Q ss_pred             ------cCCCC-----CcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q psy8260         341 ------SLPLL-----TKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       341 ------~~~~~-----~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~  391 (427)
                            ..+..     ........+..+|++|+|||++||++||++|+||+|+|+||||+++
T Consensus       298 ~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          298 LRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             HC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             hccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence                  00000     0001112356689999999999999999999999999999999875

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.9e-52  Score=413.85  Aligned_cols=323  Identities=63%  Similarity=0.994  Sum_probs=259.4

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      +.|.+.+.||+|+||.||. +.+..+|+.||||++..........+++.+|+++|+.++||||+++++++..........
T Consensus        29 ~~y~~~~~lG~G~~g~V~~-a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCA-AFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             TTEEEEEECC----CCEEE-EEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEeeEEeecCCeEEEE-EEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            6789999999999999996 567789999999999876666667778889999999999999999999987654444456


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcc
Q psy8260         144 NVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT  223 (427)
Q Consensus       144 ~~~lv~e~~g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~  223 (427)
                      .+|+++++++++|.++++.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......+
T Consensus       108 ~~~lv~e~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~  187 (367)
T 2fst_X          108 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT  187 (367)
T ss_dssp             CCEEEEECCCEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC------------
T ss_pred             eEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccccCC
Confidence            78999999999999999888899999999999999999999999999999999999999999999999999988776677


Q ss_pred             cccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccC
Q psy8260         224 GYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH  303 (427)
Q Consensus       224 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~  303 (427)
                      ..+||++|+|||++.+...|+...      |+|+.||++.+                 +.+|.               ..
T Consensus       188 ~~~~t~~y~aPE~~~~~~~~~~~~------DiwslG~il~e-----------------ll~g~---------------~p  229 (367)
T 2fst_X          188 GYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAE-----------------LLTGR---------------TL  229 (367)
T ss_dssp             ---CCCTTCCHHHHTTCCSCCTTH------HHHHHHHHHHH-----------------HHHSS---------------CS
T ss_pred             CcCcCcCccChHHHcCCcCCCchh------hHHHHHHHHHH-----------------HHhCC---------------CC
Confidence            789999999999998755565544      99999998766                 22222               23


Q ss_pred             CCC-CCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q psy8260         304 YNQ-TDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQA  382 (427)
Q Consensus       304 ~~~-~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~  382 (427)
                      +.+ .+..++..|+..+|+++.++...+.....+.+....+......+...+...+++++|||.+||++||.+|||++|+
T Consensus       230 f~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~  309 (367)
T 2fst_X          230 FPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA  309 (367)
T ss_dssp             CCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             CCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHH
Confidence            433 3567788899999999999988888887888887777777778888889999999999999999999999999999


Q ss_pred             hcCCCCCCCCCCCCCCCCCCCCcccccCCCCHHHHHHHHhhhc
Q psy8260         383 LAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKGTYSLES  425 (427)
Q Consensus       383 L~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (427)
                      |+||||.+...|..++...++++++++.+...++|+..++.|.
T Consensus       310 L~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~  352 (367)
T 2fst_X          310 LAHAYFAQYHDPDDEPVADPYDQSLESRDLLIDEWKSLTYDEV  352 (367)
T ss_dssp             HTSGGGTTTCCGGGCCCCCCCCGGGSSCCCCHHHHHHHHHHHH
T ss_pred             hcChhhhhccCCCCCCCCCCCCcchhhccCCHHHHHHHHHHHH
Confidence            9999999999988888888899999999999999998877664

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.1e-51  Score=416.74  Aligned_cols=346  Identities=32%  Similarity=0.551  Sum_probs=253.1

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .++|.+.+.||+|+||.||. +.+..+|+.||||++.+........+++.+|+++|+.++|||||++++++.... ....
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~-~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~  129 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCE-AYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKD-VEKF  129 (458)
T ss_dssp             CTTEEECCC-------CEEE-EEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC-TTTC
T ss_pred             CCCeEEeeEeeecCCeEEEE-EEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCC-cccC
Confidence            36799999999999999995 567789999999999876666677788899999999999999999999985432 2334


Q ss_pred             ceEEEEeccCCCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC-
Q psy8260         143 KNVYMVTHLMGADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN-  220 (427)
Q Consensus       143 ~~~~lv~e~~g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~-  220 (427)
                      ..+|+++|+++++|.++++. ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.... 
T Consensus       130 ~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  209 (458)
T 3rp9_A          130 DELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP  209 (458)
T ss_dssp             CCEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred             ceEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence            57899999999999998876 4599999999999999999999999999999999999999999999999999986531 


Q ss_pred             -----------------------------CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhh
Q psy8260         221 -----------------------------EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKIL  271 (427)
Q Consensus       221 -----------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~  271 (427)
                                                   ..++++||++|+|||++.....|+...      |+|+.||++.+-...   
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~------DiwSlG~il~elltg---  280 (458)
T 3rp9_A          210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI------DVWSIGCIFAELLNM---  280 (458)
T ss_dssp             TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHH------HHHHHHHHHHHHHTT---
T ss_pred             cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHh------HHHHHHHHHHHHHHh---
Confidence                                         235578999999999987666666544      999999998872110   


Q ss_pred             ccCCCCCCccccccccccccccc-------hHH-hhh-ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcC
Q psy8260         272 DFGLARPTENEMTGYVATRWYRA-------PEI-MLN-WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSL  342 (427)
Q Consensus       272 d~g~~~~~~~~~~~~~gt~~Y~A-------PEv-l~~-~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~  342 (427)
                         .....   .....|.+.|-.       +.. ..+ ..+....+..++..|+.++|+++.+.+..........+....
T Consensus       281 ---~~~~~---~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~  354 (458)
T 3rp9_A          281 ---IKENV---AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIF  354 (458)
T ss_dssp             ---STTTC---SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTS
T ss_pred             ---ccccc---cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhc
Confidence               00000   000001111100       000 000 001111246788899999999999988888777778888777


Q ss_pred             CCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCCC-CCCCccc-ccCCCCHHHHHHH
Q psy8260         343 PLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTS-PPYDQSF-EDMDLPVDQWKGT  420 (427)
Q Consensus       343 ~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~  420 (427)
                      +......+...++..+++++|||.+||++||.+|+|++|+|+||||+++..+..++.. .+....+ +..+++.+++...
T Consensus       355 ~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~  434 (458)
T 3rp9_A          355 PKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFNDWMNMDEPQLRYA  434 (458)
T ss_dssp             CCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCCCCSSCTTSCCCHHHHHHH
T ss_pred             CCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCCCCCccccccCCHHHHHHH
Confidence            7777777888888999999999999999999999999999999999998776655433 2222233 2357888888888


Q ss_pred             Hhhhc
Q psy8260         421 YSLES  425 (427)
Q Consensus       421 ~~~~~  425 (427)
                      +..|.
T Consensus       435 ~~~e~  439 (458)
T 3rp9_A          435 FVKEI  439 (458)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            76654

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.5e-50  Score=408.72  Aligned_cols=345  Identities=30%  Similarity=0.524  Sum_probs=263.7

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .+.|.+.+.||+|+||.||. +.+..+|+.||||++..........+++.+|+++|+.++||||+++++++..... ...
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~-a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~  102 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYL-AYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDL-LKF  102 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEE-EEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT-TTC
T ss_pred             cCCEEEEEEEeecCCEEEEE-EEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCC-CcC
Confidence            46799999999999999995 5677899999999998766666777888999999999999999999999865421 223


Q ss_pred             ceEEEEeccCCCCHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC-
Q psy8260         143 KNVYMVTHLMGADLNNILRTQ-KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN-  220 (427)
Q Consensus       143 ~~~~lv~e~~g~~L~~~l~~~-~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~-  220 (427)
                      ..+|+++|+++++|.++++.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.... 
T Consensus       103 ~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  182 (432)
T 3n9x_A          103 DELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE  182 (432)
T ss_dssp             CCEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred             CeEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence            568999999999999998764 599999999999999999999999999999999999999999999999999985432 


Q ss_pred             ------------------------CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCC
Q psy8260         221 ------------------------EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLA  276 (427)
Q Consensus       221 ------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~  276 (427)
                                              ..+.++||++|+|||++.....|+.+.      |+|+.||++.+-..      |..
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~------DiwSlG~il~ell~------g~~  250 (432)
T 3n9x_A          183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI------DIWSTGCIFAELLN------MLQ  250 (432)
T ss_dssp             ----------------------------CCCCCTTCCHHHHTTCSCCCTHH------HHHHHHHHHHHHHT------TCT
T ss_pred             ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCccc------ccchHHHHHHHHHh------ccc
Confidence                                    135678999999999987766666544      99999999877211      000


Q ss_pred             CCCccccccccccccccc-------hHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCccc
Q psy8260         277 RPTENEMTGYVATRWYRA-------PEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKD  349 (427)
Q Consensus       277 ~~~~~~~~~~~gt~~Y~A-------PEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (427)
                      ......   ..|.|.|.+       |... ........+..++..|+..+|+|+.+............+....+......
T Consensus       251 p~~~~~---~~~~p~f~g~~~~~~~~~~~-~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (432)
T 3n9x_A          251 SHINDP---TNRFPLFPGSSCFPLSPDRN-SKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPIN  326 (432)
T ss_dssp             TTCSSG---GGCCCSCCCSCSCC-----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCC
T ss_pred             cccccc---ccccccCCCccccccCcccc-cccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCC
Confidence            000000   001111100       0000 00000011367888999999999999888888877888887777777777


Q ss_pred             HHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCCC-CCCCccccc-CCCCHHHHHHHHhhhc
Q psy8260         350 FRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTS-PPYDQSFED-MDLPVDQWKGTYSLES  425 (427)
Q Consensus       350 ~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~  425 (427)
                      +...++..+++++|||.+||++||++|||++|+|+||||++...+..++.. .++...+++ ..++.++++..+..|.
T Consensus       327 ~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~  404 (432)
T 3n9x_A          327 LKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFDDWMVLSETQLRYIFLKEV  404 (432)
T ss_dssp             HHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCCCCSSCTTCCCCHHHHHHHHHHHH
T ss_pred             HHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCCCCChhhcccCCHHHHHHHHHHHH
Confidence            888889999999999999999999999999999999999998887766543 233334443 5788888888777664

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.2e-51  Score=429.46  Aligned_cols=261  Identities=23%  Similarity=0.377  Sum_probs=210.6

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      ++|++.+.||+|+||.||+ +.++.+|+.||||++...  .....+.+.+|+++|+.++|||||+++++|...      .
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~-~~~~~tg~~~AiK~i~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------~  227 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHR-VTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD------N  227 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEE-EEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS------S
T ss_pred             cccEEEEEEeeccCeEEEE-EEECCCCCEEEEEEEecc--chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC------C
Confidence            5689999999999999995 678889999999998654  344456678999999999999999999999764      5


Q ss_pred             eEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCC--CCEEEeeCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED--CELKILDFGLARPT  218 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~--~~~kl~DFGla~~~  218 (427)
                      .+|++|||+ ||+|.+++..  +.+++..++.+++||+.||+|||++||+||||||+|||++.+  +.+||+|||+|+..
T Consensus       228 ~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~  307 (573)
T 3uto_A          228 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  307 (573)
T ss_dssp             EEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred             EEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence            689999998 7899998853  469999999999999999999999999999999999999854  89999999999754


Q ss_pred             CCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         219 ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       219 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                      ....                                                           .....+||+.|||||++
T Consensus       308 ~~~~-----------------------------------------------------------~~~~~~GT~~y~APEv~  328 (573)
T 3uto_A          308 DPKQ-----------------------------------------------------------SVKVTTGTAEFAAPEVA  328 (573)
T ss_dssp             CTTS-----------------------------------------------------------EEEEECSSGGGCCHHHH
T ss_pred             cCCC-----------------------------------------------------------ceeeeEECccccCHHHh
Confidence            3211                                                           12234688888888888


Q ss_pred             hhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC
Q psy8260         299 LNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT  378 (427)
Q Consensus       299 ~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t  378 (427)
                      .+..+...+|+||+|+++++|.++..||......+...+.......+..    ..+..+|++++|||.+||++||.+|+|
T Consensus       329 ~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~s~~~~dli~~~L~~dp~~R~t  404 (573)
T 3uto_A          329 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD----SAFSGISEDGKDFIRKLLLADPNTRMT  404 (573)
T ss_dssp             TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCS----GGGTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred             CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCc----ccccCCCHHHHHHHHHHccCChhHCcC
Confidence            8877877889999999999886666666543333333333332222222    345678999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCCCCC
Q psy8260         379 AEQALAHPYLSQYSDPND  396 (427)
Q Consensus       379 a~e~L~Hp~f~~~~~~~~  396 (427)
                      ++|+|+||||+....|..
T Consensus       405 ~~e~l~Hpw~~~~~~~~~  422 (573)
T 3uto_A          405 IHQALEHPWLTPGNAPGR  422 (573)
T ss_dssp             HHHHHHSTTTSCCCCTTT
T ss_pred             HHHHhcCcCcCCCCCCCc
Confidence            999999999997665543

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.2e-51  Score=393.28  Aligned_cols=261  Identities=21%  Similarity=0.267  Sum_probs=198.0

Q ss_pred             cccccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCc
Q psy8260          58 YSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNT  137 (427)
Q Consensus        58 ~~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~  137 (427)
                      +||+....+.+++.||+|+||.||++.+.    ..||||+++.........+.+.+|+.+|++++|||||++++++..  
T Consensus        30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~----~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~--  103 (307)
T 3omv_A           30 YWEIEASEVMLSTRIGSGSFGTVYKGKWH----GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK--  103 (307)
T ss_dssp             CCBCCTTSCCEEEECCCCSSSEEEEEESS----SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--
T ss_pred             CcEEcHHHeEEeeEEeeCCCcEEEEEEEC----CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC--
Confidence            46888889999999999999999987543    359999997665666677788999999999999999999998643  


Q ss_pred             cccCCceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCC
Q psy8260         138 CLADFKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL  214 (427)
Q Consensus       138 ~~~~~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGl  214 (427)
                           ..+|+||||+ ||+|.+++..  ..+++..+..++.||+.||+|||+++||||||||+|||+++++.+||+|||+
T Consensus       104 -----~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGl  178 (307)
T 3omv_A          104 -----DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGL  178 (307)
T ss_dssp             -----SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSS
T ss_pred             -----CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccC
Confidence                 3478999998 7899999864  4699999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccc
Q psy8260         215 ARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRA  294 (427)
Q Consensus       215 a~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~A  294 (427)
                      |+........                                                        ....+.+||+.|||
T Consensus       179 a~~~~~~~~~--------------------------------------------------------~~~~~~~GT~~ymA  202 (307)
T 3omv_A          179 ATVKSRWSGS--------------------------------------------------------QQVEQPTGSVLWMA  202 (307)
T ss_dssp             CBC--------------------------------------------------------------------CCCCTTSCC
T ss_pred             ceecccCCcc--------------------------------------------------------eeecccccCCCccC
Confidence            9754321100                                                        01123457777777


Q ss_pred             hHHhhhc---cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCC
Q psy8260         295 PEIMLNW---MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLEL  371 (427)
Q Consensus       295 PEvl~~~---~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~  371 (427)
                      ||++.+.   .+..++|+||+|+++++|.++..||..................  ...........++++.+||.+||+.
T Consensus       203 PE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~--~p~~~~~~~~~~~~l~~li~~cl~~  280 (307)
T 3omv_A          203 PEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYA--SPDLSKLYKNCPKAMKRLVADCVKK  280 (307)
T ss_dssp             HHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCC--CCCSTTSCTTSCHHHHHHHHHHTCS
T ss_pred             HHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC--CCCcccccccchHHHHHHHHHHcCC
Confidence            7777543   3556789999999999987666666543222222222221111  1112233456788999999999999


Q ss_pred             CCCCCCCHHHH------hcCCC
Q psy8260         372 DSEKRITAEQA------LAHPY  387 (427)
Q Consensus       372 dP~~R~ta~e~------L~Hp~  387 (427)
                      ||++|||+.|+      |+||+
T Consensus       281 dP~~RPs~~ei~~~Le~l~~~l  302 (307)
T 3omv_A          281 VKEERPLFPQILSSIELLQHSL  302 (307)
T ss_dssp             SSTTSCCHHHHHHHHHHHHTTC
T ss_pred             CHhHCcCHHHHHHHHHHHhccC
Confidence            99999999986      56665

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=7.9e-51  Score=423.06  Aligned_cols=257  Identities=21%  Similarity=0.315  Sum_probs=202.8

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcC----CCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecC
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPF----QSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSN  136 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~----~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~  136 (427)
                      +..++|++.+.||+|+||.||. +.+..+|+.||||++.+..    ..........+++.+++.++|||||+++++|++.
T Consensus       186 ~slddf~i~k~LG~G~fG~V~l-a~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~  264 (689)
T 3v5w_A          186 LTMNDFSVHRIIGRGGFGEVYG-CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP  264 (689)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEE-EEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred             CchHHeEEEEEEecccCeEEEE-EEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence            3456799999999999999995 6678899999999986432    1222233334567788899999999999999765


Q ss_pred             ccccCCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCC
Q psy8260         137 TCLADFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL  214 (427)
Q Consensus       137 ~~~~~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGl  214 (427)
                            ..+|+||||+ ||+|..++.. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+
T Consensus       265 ------~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGl  338 (689)
T 3v5w_A          265 ------DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGL  338 (689)
T ss_dssp             ------SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             ------CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccce
Confidence                  5689999998 7899998854 6799999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccc
Q psy8260         215 ARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRA  294 (427)
Q Consensus       215 a~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~A  294 (427)
                      |+.....                                                            ...+.+||+.|||
T Consensus       339 A~~~~~~------------------------------------------------------------~~~t~~GTp~YmA  358 (689)
T 3v5w_A          339 ACDFSKK------------------------------------------------------------KPHASVGTHGYMA  358 (689)
T ss_dssp             CEECSSC------------------------------------------------------------CCCSCCSCGGGCC
T ss_pred             eeecCCC------------------------------------------------------------CCCCccCCcCccC
Confidence            9743221                                                            1123467888888


Q ss_pred             hHHhhh-ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHH---HHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcC
Q psy8260         295 PEIMLN-WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDS---ARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLE  370 (427)
Q Consensus       295 PEvl~~-~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~  370 (427)
                      ||++.+ ..|...+||||+|+++|+|.++..||........   ..........        ++..+|++++|||.+||+
T Consensus       359 PEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~--------~p~~~S~~a~dLI~~lL~  430 (689)
T 3v5w_A          359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE--------LPDSFSPELRSLLEGLLQ  430 (689)
T ss_dssp             HHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCC--------CCTTSCHHHHHHHHHHTC
T ss_pred             HHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCC--------CCccCCHHHHHHHHHHcc
Confidence            888753 4577788999999999999776666754332221   1112211111        234579999999999999


Q ss_pred             CCCCCCCC-----HHHHhcCCCCCCCC
Q psy8260         371 LDSEKRIT-----AEQALAHPYLSQYS  392 (427)
Q Consensus       371 ~dP~~R~t-----a~e~L~Hp~f~~~~  392 (427)
                      +||.+|++     ++|+++||||+.+.
T Consensus       431 ~dP~~Rl~~~~~ga~ei~~HpfF~~id  457 (689)
T 3v5w_A          431 RDVNRRLGCLGRGAQEVKESPFFRSLD  457 (689)
T ss_dssp             SCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred             CCHhHCCCCCCCCHHHHhcCccccCCC
Confidence            99999998     89999999998753

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.1e-50  Score=409.88  Aligned_cols=321  Identities=40%  Similarity=0.703  Sum_probs=243.5

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .++|.+.+.||+|+||.||. +.+..+|+.||||++.+........+++.+|+.+|+.++|||||+++++|.......+.
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~-a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCA-AYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEE-EEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             cCCeEEEEEeecCCCeEEEE-EEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            36689999999999999995 66788999999999987666667777889999999999999999999999776555556


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC-
Q psy8260         143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE-  221 (427)
Q Consensus       143 ~~~~lv~e~~g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~-  221 (427)
                      ..+|++||+++++|.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..... 
T Consensus       140 ~~~~lv~E~~~~~l~~~~~~-~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  218 (464)
T 3ttj_A          140 QDVYLVMELMDANLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF  218 (464)
T ss_dssp             CEEEEEEECCSEEHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----CC
T ss_pred             CeEEEEEeCCCCCHHHHHhh-cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc
Confidence            78899999998888887754 5999999999999999999999999999999999999999999999999999865442 


Q ss_pred             -cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         222 -MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       222 -~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                       .+..+||++|+|||++.+. .|+..      .|+|+.||++.+                 +..|.              
T Consensus       219 ~~~~~~gt~~y~aPE~~~~~-~~~~~------~DiwSlG~il~e-----------------ll~g~--------------  260 (464)
T 3ttj_A          219 MMTPYVVTRYYRAPEVILGM-GYKEN------VDIWSVGCIMGE-----------------MVRHK--------------  260 (464)
T ss_dssp             CC----CCCTTCCHHHHTTC-CCCTT------HHHHHHHHHHHH-----------------HHHSS--------------
T ss_pred             ccCCCcccccccCHHHHcCC-CCCHH------HHHHHHHHHHHH-----------------HHhCC--------------
Confidence             4567889999999998763 34433      388888888765                 22222              


Q ss_pred             ccCCCCC-CHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCC------------ChhHHHHHHH
Q psy8260         301 WMHYNQT-DIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGA------------NPQAIDLLSL  367 (427)
Q Consensus       301 ~~~~~~~-d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------s~~~~dLi~~  367 (427)
                       ..+.+. ...++..|+..+|++..+++.... .....+....+......+...++..            +++++|||.+
T Consensus       261 -~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~  338 (464)
T 3ttj_A          261 -ILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK  338 (464)
T ss_dssp             -CSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC-HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHH
T ss_pred             -CCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc-hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHH
Confidence             234433 456777888888998888877654 4455566666655555555544332            6789999999


Q ss_pred             hcCCCCCCCCCHHHHhcCCCCCCCCCCCCC--CCCCCCCcccccCCCCHHHHHHHHhhhc
Q psy8260         368 MLELDSEKRITAEQALAHPYLSQYSDPNDE--PTSPPYDQSFEDMDLPVDQWKGTYSLES  425 (427)
Q Consensus       368 mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (427)
                      ||++||++|+|++|+|+||||..+..|.+.  +.+..++...++....+++|+..+..|.
T Consensus       339 mL~~dP~~R~ta~e~L~Hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~  398 (464)
T 3ttj_A          339 MLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEV  398 (464)
T ss_dssp             HSCSSTTTSCCHHHHHTSTTTGGGCCHHHHSCCC-----------CCCHHHHHHHHHHHH
T ss_pred             HcCCChhhCCCHHHHhcChhhhhccCcccccCCCCccCCcchhhccCCHHHHHHHHHHHH
Confidence            999999999999999999999987776543  3334467777888899999998876654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2e-50  Score=387.19  Aligned_cols=260  Identities=21%  Similarity=0.273  Sum_probs=199.3

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEe----CcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeee
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALD----SVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFH  134 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~----~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~  134 (427)
                      .++.+.++.+.+.||+|+||.||++...    ..+++.||||++...  .....+++.+|+++|++++|||||++++++.
T Consensus         8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~   85 (299)
T 4asz_A            8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCV   85 (299)
T ss_dssp             CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence            3566788999999999999999987653    346889999999653  4555677889999999999999999999986


Q ss_pred             cCccccCCceEEEEeccC-CCCHHHHHhh--------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCe
Q psy8260         135 SNTCLADFKNVYMVTHLM-GADLNNILRT--------------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI  199 (427)
Q Consensus       135 ~~~~~~~~~~~~lv~e~~-g~~L~~~l~~--------------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NI  199 (427)
                      ..      ..+|+||||+ +|+|.++++.              ..+++..+..++.||+.||.|||+++||||||||+||
T Consensus        86 ~~------~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NI  159 (299)
T 4asz_A           86 EG------DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNC  159 (299)
T ss_dssp             SS------SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             eC------CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhE
Confidence            53      4689999998 7899999864              2589999999999999999999999999999999999


Q ss_pred             EEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCC
Q psy8260         200 AVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPT  279 (427)
Q Consensus       200 Ll~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~  279 (427)
                      |++.++.+||+|||+|+........                                                       
T Consensus       160 Ll~~~~~~Ki~DFGla~~~~~~~~~-------------------------------------------------------  184 (299)
T 4asz_A          160 LVGENLLVKIGDFGMSRDVYSTDYY-------------------------------------------------------  184 (299)
T ss_dssp             EECGGGCEEECCCSCHHHHTGGGCE-------------------------------------------------------
T ss_pred             EECCCCcEEECCcccceecCCCCce-------------------------------------------------------
Confidence            9999999999999998743211000                                                       


Q ss_pred             ccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCC
Q psy8260         280 ENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGAN  358 (427)
Q Consensus       280 ~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  358 (427)
                       .......||+.|||||++.+..+..++|+||+|+++++|.+ +..||......+.......... .      ......+
T Consensus       185 -~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~-~------~~p~~~~  256 (299)
T 4asz_A          185 -RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV-L------QRPRTCP  256 (299)
T ss_dssp             -EETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCC-C------CCCTTCC
T ss_pred             -eecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-C------CCCccch
Confidence             01123458899999999988888888999999999987754 4445543322222222222111 1      1124568


Q ss_pred             hhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q psy8260         359 PQAIDLLSLMLELDSEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       359 ~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~  391 (427)
                      +++.+||.+||+.||++|||++|+  |+|+++.
T Consensus       257 ~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~  287 (299)
T 4asz_A          257 QEVYELMLGCWQREPHMRKNIKGI--HTLLQNL  287 (299)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHH
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHH--HHHHHHH
Confidence            899999999999999999999999  4566543

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.8e-50  Score=400.06  Aligned_cols=321  Identities=33%  Similarity=0.582  Sum_probs=209.9

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCC-CCCceeeeeeeecCccccC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN-HENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~~  141 (427)
                      .++|.+.+.||+|+||.||. +.+..+|+.||||++...........+..+|+.+|+.+. ||||+++++++...    +
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~-~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----~   82 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWK-SIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD----N   82 (388)
T ss_dssp             HTTEEEEEC-------CEEE-EEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT----T
T ss_pred             cCceEEEEEeeeCCCeEEEE-EEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC----C
Confidence            35689999999999999995 567889999999999776666777788899999999997 99999999998653    2


Q ss_pred             CceEEEEeccCCCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         142 FKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       142 ~~~~~lv~e~~g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      ...+|++|++++++|..+++.+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus        83 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  162 (388)
T 3oz6_A           83 DRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI  162 (388)
T ss_dssp             SSCEEEEEECCSEEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred             CCEEEEEecccCcCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence            24689999999999999999889999999999999999999999999999999999999999999999999999754321


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh-
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN-  300 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~-  300 (427)
                      .......+. ...+...   ......                                 ......+||++|+|||++.+ 
T Consensus       163 ~~~~~~~~~-~~~~~~~---~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~  205 (388)
T 3oz6_A          163 RRVTNNIPL-SINENTE---NFDDDQ---------------------------------PILTDYVATRWYRAPEILLGS  205 (388)
T ss_dssp             CCCCCCGGG-CCC---------------------------------------------------CCCGGGGCCHHHHTTC
T ss_pred             ccccccccc-ccccccc---cccccc---------------------------------ccccCCcccCCcCCHHHhcCC
Confidence            100000000 0000000   000000                                 01223456666666666654 


Q ss_pred             ccCCCCCCHHHHHHHHHHhCC-----------------------CCHHHHhhcCcHHHHHHHhcC---CCCCccc-----
Q psy8260         301 WMHYNQTDIHQLNLIMEMLGT-----------------------PPAEFMAKISSDSARKYINSL---PLLTKKD-----  349 (427)
Q Consensus       301 ~~~~~~~d~~slg~i~~~lg~-----------------------~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-----  349 (427)
                      ..+..++|+||+|++++.|.+                       |+.+............+....   .......     
T Consensus       206 ~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (388)
T 3oz6_A          206 TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIF  285 (388)
T ss_dssp             CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCH
T ss_pred             CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhC
Confidence            334445566666666655533                       332222221111111111100   0000000     


Q ss_pred             --HHh------hcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCCC-CCCCcccc-cCCCCHHHHHH
Q psy8260         350 --FRQ------VFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTS-PPYDQSFE-DMDLPVDQWKG  419 (427)
Q Consensus       350 --~~~------~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~  419 (427)
                        +..      .....+++++|||.+||++||++|+|++|+|+||||+.+..+..++.. ..++.+++ +...+.++|+.
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (388)
T 3oz6_A          286 TKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDYRN  365 (388)
T ss_dssp             HHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTCCGGGCCCCSSCCCCC------CCHHHHHH
T ss_pred             cchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhcCCccCCCCCCCCCCCccccccCCHHHHHH
Confidence              000      012578999999999999999999999999999999998888776654 34555554 46788899988


Q ss_pred             HHhhhc
Q psy8260         420 TYSLES  425 (427)
Q Consensus       420 ~~~~~~  425 (427)
                      .++.|.
T Consensus       366 ~~~~~~  371 (388)
T 3oz6_A          366 LVYSEI  371 (388)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            766553

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=7.8e-50  Score=388.19  Aligned_cols=255  Identities=19%  Similarity=0.262  Sum_probs=192.7

Q ss_pred             cccCcceeeccccCcccccEEEEeEEe----CcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeec
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALD----SVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHS  135 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~----~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~  135 (427)
                      ++.+.++.+.+.||+|+||.||++.+.    ..+++.||||++...  .....+++.+|+++|++++|||||++++++..
T Consensus        37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~  114 (329)
T 4aoj_A           37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTE  114 (329)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            456678889999999999999988653    357899999999653  45556778899999999999999999999865


Q ss_pred             CccccCCceEEEEeccC-CCCHHHHHhh----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCC
Q psy8260         136 NTCLADFKNVYMVTHLM-GADLNNILRT----------------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSN  198 (427)
Q Consensus       136 ~~~~~~~~~~~lv~e~~-g~~L~~~l~~----------------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~N  198 (427)
                      .      ..+|+||||+ +|+|.++++.                ..+++..+..++.||+.||.|||+++||||||||+|
T Consensus       115 ~------~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~N  188 (329)
T 4aoj_A          115 G------RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRN  188 (329)
T ss_dssp             S------SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             C------CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhh
Confidence            3      4689999998 7899998864                248999999999999999999999999999999999


Q ss_pred             eEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCC
Q psy8260         199 IAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARP  278 (427)
Q Consensus       199 ILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~  278 (427)
                      ||++.++.+||+|||+|+........                                                      
T Consensus       189 ILl~~~~~~Ki~DFGla~~~~~~~~~------------------------------------------------------  214 (329)
T 4aoj_A          189 CLVGQGLVVKIGDFGMSRDIYSTDYY------------------------------------------------------  214 (329)
T ss_dssp             EEEETTTEEEECCCC-----------------------------------------------------------------
T ss_pred             EEECCCCcEEEcccccceeccCCCcc------------------------------------------------------
Confidence            99999999999999999854321100                                                      


Q ss_pred             CccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCC
Q psy8260         279 TENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGA  357 (427)
Q Consensus       279 ~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (427)
                        ......+||+.|||||++.+..+..++|+||+|++++++.+ +..||......+...........       ......
T Consensus       215 --~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~-------~~p~~~  285 (329)
T 4aoj_A          215 --RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGREL-------ERPRAC  285 (329)
T ss_dssp             -------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCCC-------CCCTTC
T ss_pred             --eecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC-------CCcccc
Confidence              01123468888999999888888888999999999987754 44445332212222222221111       112457


Q ss_pred             ChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         358 NPQAIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       358 s~~~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                      ++++.+||.+||+.||++|||++|++++
T Consensus       286 ~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          286 PPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             CHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             cHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            8899999999999999999999999865

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=8.6e-50  Score=391.09  Aligned_cols=259  Identities=19%  Similarity=0.270  Sum_probs=202.3

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEeC----cCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCC-CCceeeeeee
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALDS----VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNH-ENVIGLLDVF  133 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~~----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~l~~~~  133 (427)
                      ||+.+.+|.+++.||+|+||.||++....    .+++.||||++... ......+.+.+|+++|++++| ||||++++++
T Consensus        59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~-~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~  137 (353)
T 4ase_A           59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGAC  137 (353)
T ss_dssp             HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cChHHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence            58899999999999999999999876532    34578999998754 344456678899999999966 8999999987


Q ss_pred             ecCccccCCceEEEEeccC-CCCHHHHHhh-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCC
Q psy8260         134 HSNTCLADFKNVYMVTHLM-GADLNNILRT-----------------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLK  195 (427)
Q Consensus       134 ~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~-----------------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLK  195 (427)
                      ...     ...+|+||||+ +|+|.++++.                 ..+++..+..++.||+.||.|||+++|||||||
T Consensus       138 ~~~-----~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK  212 (353)
T 4ase_A          138 TKP-----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLA  212 (353)
T ss_dssp             CCT-----TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             Eec-----CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccC
Confidence            532     24578999998 7899999864                 237899999999999999999999999999999


Q ss_pred             CCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCC
Q psy8260         196 PSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGL  275 (427)
Q Consensus       196 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~  275 (427)
                      |+|||++.++.+||+|||+|+........                                                   
T Consensus       213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~---------------------------------------------------  241 (353)
T 4ase_A          213 ARNILLSEKNVVKICDFGLARDIYKDPDY---------------------------------------------------  241 (353)
T ss_dssp             GGGEEECGGGCEEECCCGGGSCTTTCTTS---------------------------------------------------
T ss_pred             ccceeeCCCCCEEECcchhhhhcccCCCc---------------------------------------------------
Confidence            99999999999999999999854322110                                                   


Q ss_pred             CCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhc
Q psy8260         276 ARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVF  354 (427)
Q Consensus       276 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (427)
                           ....+.+||+.|||||++.+..+..++|+||+|++++++.+ +..||..........+.+.......      ..
T Consensus       242 -----~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~------~p  310 (353)
T 4ase_A          242 -----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR------AP  310 (353)
T ss_dssp             -----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC------CC
T ss_pred             -----eeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCC------CC
Confidence                 01123468888999999988888888999999999988754 4555543322233333332211111      12


Q ss_pred             CCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         355 KGANPQAIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       355 ~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                      ...++++.+||.+||+.||++|||+.|+++|
T Consensus       311 ~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          311 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            3468899999999999999999999999988

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=9.2e-50  Score=384.18  Aligned_cols=259  Identities=19%  Similarity=0.229  Sum_probs=198.4

Q ss_pred             ccccccCcceeeccccCcccccEEEEeEE----eCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeee
Q psy8260          57 PYSEICRGVIDIGPTLSKESFDLIFSSAL----DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDV  132 (427)
Q Consensus        57 ~~~~~~~~~~~~~~~lg~g~fg~v~~~~~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~  132 (427)
                      ...++....+.+.+.||+|+||.||++.+    +..+++.||||++.... .....+++.+|+.+|++++|||||+++++
T Consensus        19 ~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~   97 (308)
T 4gt4_A           19 KLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGV   97 (308)
T ss_dssp             CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceE
Confidence            34577788899999999999999999876    34578899999996543 23334678899999999999999999999


Q ss_pred             eecCccccCCceEEEEeccC-CCCHHHHHhh-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccC
Q psy8260         133 FHSNTCLADFKNVYMVTHLM-GADLNNILRT-----------------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDL  194 (427)
Q Consensus       133 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~-----------------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDL  194 (427)
                      +...      ..+++||||+ +|+|.+++..                 ..+++..+..++.||+.||.|||+++||||||
T Consensus        98 ~~~~------~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDL  171 (308)
T 4gt4_A           98 VTKD------QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDL  171 (308)
T ss_dssp             ECSS------SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             EEEC------CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCc
Confidence            7643      4578999998 7899999853                 24899999999999999999999999999999


Q ss_pred             CCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccC
Q psy8260         195 KPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFG  274 (427)
Q Consensus       195 Kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g  274 (427)
                      ||+|||+++++.+||+|||+|+........                                                  
T Consensus       172 K~~NILl~~~~~~Ki~DFGlar~~~~~~~~--------------------------------------------------  201 (308)
T 4gt4_A          172 ATRNVLVYDKLNVKISDLGLFREVYAADYY--------------------------------------------------  201 (308)
T ss_dssp             SGGGEEECGGGCEEECCSCCBCGGGGGGCB--------------------------------------------------
T ss_pred             cccceEECCCCCEEECCcccceeccCCCce--------------------------------------------------
Confidence            999999999999999999999743211000                                                  


Q ss_pred             CCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhh
Q psy8260         275 LARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQV  353 (427)
Q Consensus       275 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (427)
                            ....+.+||+.|||||++.+..+..++|+||+|++++++.+ +..||......+... .+......      ..
T Consensus       202 ------~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~-~i~~~~~~------~~  268 (308)
T 4gt4_A          202 ------KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE-MIRNRQVL------PC  268 (308)
T ss_dssp             ------CSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH-HHHTTCCC------CC
T ss_pred             ------eEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHcCCCC------CC
Confidence                  01223468899999999988888888999999999987644 444443322122222 22221111      11


Q ss_pred             cCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         354 FKGANPQAIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       354 ~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                      ....++++.+|+.+|++.||++|||++|++++
T Consensus       269 p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          269 PDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            24567899999999999999999999999876

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=9.5e-48  Score=380.61  Aligned_cols=322  Identities=51%  Similarity=0.879  Sum_probs=253.1

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      +.|.+.+.||+|+||.||. +.+..+|+.||||++...........++.+|+.+++.++||||+++++++..........
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~-~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCS-AIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEE-EEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             ccEEEEeEEecCCCeEEEE-EEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            5788999999999999996 567789999999999876666666778889999999999999999999997654443344


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcc
Q psy8260         144 NVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT  223 (427)
Q Consensus       144 ~~~lv~e~~g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~  223 (427)
                      .+|+++++++++|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus       121 ~~~lv~e~~~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~  199 (371)
T 4exu_A          121 DFYLVMPFMQTDLQKIMG-MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT  199 (371)
T ss_dssp             CCEEEEECCCEEHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC--------
T ss_pred             eEEEEEccccccHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccCcC
Confidence            569999999999988774 4599999999999999999999999999999999999999999999999999987766666


Q ss_pred             cccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccC
Q psy8260         224 GYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH  303 (427)
Q Consensus       224 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~  303 (427)
                      ..+||++|+|||++.+...++..      .|+|+.||++.+                 +.+|.               .+
T Consensus       200 ~~~~t~~y~aPE~~~~~~~~~~~------~DiwslG~il~e-----------------l~~g~---------------~p  241 (371)
T 4exu_A          200 GYVVTRWYRAPEVILSWMHYNQT------VDIWSVGCIMAE-----------------MLTGK---------------TL  241 (371)
T ss_dssp             CTTCCCTTSCHHHHSCCSCCCTT------HHHHHHHHHHHH-----------------HHHSS---------------CS
T ss_pred             CcccCccccCHHHhcCCCCCCcH------HhHHHHHHHHHH-----------------HHhCC---------------CC
Confidence            77888889999888764444433      377777776654                 22221               12


Q ss_pred             CCC-CCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q psy8260         304 YNQ-TDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQA  382 (427)
Q Consensus       304 ~~~-~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~  382 (427)
                      +.+ .....+..++..+|.++.++...........+....+......+...+...++++++||.+||++||.+|||++|+
T Consensus       242 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  321 (371)
T 4exu_A          242 FKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQA  321 (371)
T ss_dssp             CCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred             CCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHH
Confidence            222 2344556666777777777776666555556666666666677778888899999999999999999999999999


Q ss_pred             hcCCCCCCCCCCCCCC-CCCCCCcccccCCCCHHHHHHHHhhhc
Q psy8260         383 LAHPYLSQYSDPNDEP-TSPPYDQSFEDMDLPVDQWKGTYSLES  425 (427)
Q Consensus       383 L~Hp~f~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (427)
                      |+||||+....|..+. ...+++.+.+.....+++|+..+..|.
T Consensus       322 l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (371)
T 4exu_A          322 LTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEWKQHIYKEI  365 (371)
T ss_dssp             HTSGGGTTTCCGGGCCCCSSCCCCTTSSCCCCHHHHHHHHHHHH
T ss_pred             hcCcccccCCCcccccccccCcCcchhhcccchHHHHHHHHHHH
Confidence            9999999887765543 346777788888899999999887764

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.3e-47  Score=374.94  Aligned_cols=322  Identities=52%  Similarity=0.879  Sum_probs=244.5

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      +.|.+.+.||+|+||.||. +.+..+|+.||||++..........+++.+|+.+++.++||||+++++++..........
T Consensus        24 ~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCS-AIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEE-EEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             ceEEEeeeEecCCCeEEEE-EEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            5688999999999999996 567789999999999776666666677889999999999999999999987654433344


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcc
Q psy8260         144 NVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT  223 (427)
Q Consensus       144 ~~~lv~e~~g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~  223 (427)
                      .+|+++++++++|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus       103 ~~~lv~e~~~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  181 (353)
T 3coi_A          103 DFYLVMPFMQTDLQKIMG-LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT  181 (353)
T ss_dssp             CCEEEEECCSEEGGGTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC------
T ss_pred             eEEEEeccccCCHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCCcc
Confidence            579999999989888775 3599999999999999999999999999999999999999999999999999987665556


Q ss_pred             cccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccC
Q psy8260         224 GYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH  303 (427)
Q Consensus       224 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~  303 (427)
                      ...+|+.|+|||++.+...++..      .|+|+.||++.+                 +.+|.               ..
T Consensus       182 ~~~~t~~y~aPE~~~~~~~~~~~------~Di~slG~il~e-----------------l~~g~---------------~p  223 (353)
T 3coi_A          182 GYVVTRWYRAPEVILSWMHYNQT------VDIWSVGCIMAE-----------------MLTGK---------------TL  223 (353)
T ss_dssp             --CCSBCCSCHHHHSCCSCCCTT------HHHHHHHHHHHH-----------------HHHSS---------------CS
T ss_pred             ccccCcCcCCHHHHhCcCCCCch------hhHHHHHHHHHH-----------------HHhCC---------------CC
Confidence            66788888888887654333333      266766666544                 11111               12


Q ss_pred             CCCC-CHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q psy8260         304 YNQT-DIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQA  382 (427)
Q Consensus       304 ~~~~-d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~  382 (427)
                      +.+. ....+..++..+|.++.++...........+....+......+...+...++++.+||.+||+.||.+|||++|+
T Consensus       224 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~  303 (353)
T 3coi_A          224 FKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQA  303 (353)
T ss_dssp             SBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred             CCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHH
Confidence            2222 233445555666666666666655555555555555444445556667789999999999999999999999999


Q ss_pred             hcCCCCCCCCCCCCCCC-CCCCCcccccCCCCHHHHHHHHhhhc
Q psy8260         383 LAHPYLSQYSDPNDEPT-SPPYDQSFEDMDLPVDQWKGTYSLES  425 (427)
Q Consensus       383 L~Hp~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (427)
                      |+||||.....|..++. ..+++.+.+.-..++++|+..+..|.
T Consensus       304 l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (353)
T 3coi_A          304 LTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEWKQHIYKEI  347 (353)
T ss_dssp             HTSGGGTTTCCGGGCCCCSSCCCCTTTTCCCCHHHHHHHHHHHH
T ss_pred             hcCcchhhccCccccccCCCCCccchhhccCCHHHHHHHHHHHH
Confidence            99999998877655433 45788888888999999998887664

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=5.7e-47  Score=373.91  Aligned_cols=321  Identities=43%  Similarity=0.709  Sum_probs=234.2

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      +.|.+.+.||+|+||.||. +.+..+++.||||++... ........+.+|+++++.++||||+++++++.... .....
T Consensus        27 ~~y~~~~~lG~G~~g~V~~-~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~  103 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCS-AYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT-IEQMK  103 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEE-EEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS-TTTCC
T ss_pred             ccEEEEEEeecCCCeEEEE-EEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCC-ccccc
Confidence            5799999999999999995 567788999999998643 34455567889999999999999999999986542 12335


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC--
Q psy8260         144 NVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE--  221 (427)
Q Consensus       144 ~~~lv~e~~g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~--  221 (427)
                      .+|+++++++++|.++++.+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....  
T Consensus       104 ~~~iv~e~~~~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  183 (364)
T 3qyz_A          104 DVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD  183 (364)
T ss_dssp             CEEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred             eEEEEEcccCcCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCC
Confidence            689999999999999999889999999999999999999999999999999999999999999999999999754322  


Q ss_pred             ----cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         222 ----MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       222 ----~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                          ....+||++|+|||++.+...++..      .|+|+.||++.+                 +.++.           
T Consensus       184 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~------~DiwslG~il~e-----------------ll~g~-----------  229 (364)
T 3qyz_A          184 HTGFLTEYVATRWYRAPEIMLNSKGYTKS------IDIWSVGCILAE-----------------MLSNR-----------  229 (364)
T ss_dssp             BCCTTCCCCSCGGGCCHHHHHTBCSCSTH------HHHHHHHHHHHH-----------------HHHSS-----------
T ss_pred             ccccccccccccCCCCCHHhcCCCCCCcc------hhHHHHHHHHHH-----------------HHHCC-----------
Confidence                1234566666666665543323222      255555554433                 11111           


Q ss_pred             hhhccCCC-CCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCC
Q psy8260         298 MLNWMHYN-QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKR  376 (427)
Q Consensus       298 l~~~~~~~-~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R  376 (427)
                          ..+. ..+...+..++..+|.++.+............+....+......+...+...+++++|||.+||++||.+|
T Consensus       230 ----~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  305 (364)
T 3qyz_A          230 ----PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKR  305 (364)
T ss_dssp             ----CSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTS
T ss_pred             ----CCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhC
Confidence                1111 12333444444555555554444443333444444555555556777788899999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCCCCCCCC-CCCCcccccCCCCHHHHHHHHhhhc
Q psy8260         377 ITAEQALAHPYLSQYSDPNDEPTS-PPYDQSFEDMDLPVDQWKGTYSLES  425 (427)
Q Consensus       377 ~ta~e~L~Hp~f~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  425 (427)
                      ||++|+|+||||++...+..++.. .++..+.+..+.+.++++..+..|.
T Consensus       306 ~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~  355 (364)
T 3qyz_A          306 IEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEET  355 (364)
T ss_dssp             CCHHHHHTSGGGTTTCCGGGSCCCSSCCCCC-----CCHHHHHHHHHHHT
T ss_pred             CCHHHHhcCcchhhccCcccccCCCCcCCcccccccCCHHHHHHHHHHHH
Confidence            999999999999998776655443 5666666777788888888876654

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=7.1e-47  Score=368.27  Aligned_cols=258  Identities=23%  Similarity=0.361  Sum_probs=205.1

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .+.|.+.+.||+|+||.||. +.+..+|+.||||++..........+++.+|+++|+.++||||+++++++...      
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~-a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------   86 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKL-ARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETE------   86 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEE-EEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS------
T ss_pred             cCCEEEEEEEeeCCCEEEEE-EEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC------
Confidence            46799999999999999995 56778999999999987666666777888999999999999999999998654      


Q ss_pred             ceEEEEeccC-CCCHHHHHh-hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~-~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      ..+|+++|++ +++|.+++. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  166 (328)
T 3fe3_A           87 KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV  166 (328)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred             CEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence            4689999998 789988774 46899999999999999999999999999999999999999999999999999864321


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      ..                                                           .....+||+.|+|||++.+
T Consensus       167 ~~-----------------------------------------------------------~~~~~~gt~~y~aPE~~~~  187 (328)
T 3fe3_A          167 GG-----------------------------------------------------------KLDAFCGAPPYAAPELFQG  187 (328)
T ss_dssp             SC-----------------------------------------------------------GGGTTSSSGGGCCHHHHHT
T ss_pred             CC-----------------------------------------------------------ccccccCCcceeCcccccC
Confidence            10                                                           1123356777777777766


Q ss_pred             ccCC-CCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH
Q psy8260         301 WMHY-NQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA  379 (427)
Q Consensus       301 ~~~~-~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta  379 (427)
                      ..+. .++|+||+|++++.|.++..||...................        ....++++.+||.+||+.||.+|||+
T Consensus       188 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~--------p~~~s~~~~~li~~~L~~dP~~R~t~  259 (328)
T 3fe3_A          188 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI--------PFYMSTDCENLLKRFLVLNPIKRGTL  259 (328)
T ss_dssp             CCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------CTTSCHHHHHHHHHHCCSSTTTSCCH
T ss_pred             CCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--------CCCCCHHHHHHHHHHCCCChhHCcCH
Confidence            6554 45799999999988865555554332222222222222211        12468999999999999999999999


Q ss_pred             HHHhcCCCCCCCCCC
Q psy8260         380 EQALAHPYLSQYSDP  394 (427)
Q Consensus       380 ~e~L~Hp~f~~~~~~  394 (427)
                      +|+|+||||.....+
T Consensus       260 ~eil~h~~~~~~~~~  274 (328)
T 3fe3_A          260 EQIMKDRWINAGHEE  274 (328)
T ss_dssp             HHHTTCTTTTTTCTT
T ss_pred             HHHhcCHhhcCCCcc
Confidence            999999999876443

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.8e-47  Score=376.29  Aligned_cols=301  Identities=40%  Similarity=0.684  Sum_probs=216.2

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .+.|.+.+.||+|+||.||. +.+..+|+.||||++..........+.+.+|+.+++.++||||+++++++.........
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCA-AYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEE-EEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             hhheeEeeeeEecCCEEEEE-EEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            35789999999999999996 56778899999999976655666677788999999999999999999999766544455


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCc
Q psy8260         143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM  222 (427)
Q Consensus       143 ~~~~lv~e~~g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~  222 (427)
                      ..+|++||+++++|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       103 ~~~~lv~e~~~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~  181 (371)
T 2xrw_A          103 QDVYIVMELMDANLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF  181 (371)
T ss_dssp             CEEEEEEECCSEEHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC--------
T ss_pred             cceEEEEEcCCCCHHHHHh-hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccccc
Confidence            6789999999989988886 569999999999999999999999999999999999999999999999999987543210


Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhcc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM  302 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~  302 (427)
                                                                                 .....+||+.|+|||++.+..
T Consensus       182 -----------------------------------------------------------~~~~~~gt~~y~aPE~~~~~~  202 (371)
T 2xrw_A          182 -----------------------------------------------------------MMTPYVVTRYYRAPEVILGMG  202 (371)
T ss_dssp             -------------------------------------------------------------------CTTCCHHHHTTCC
T ss_pred             -----------------------------------------------------------ccCCceecCCccCHHHhcCCC
Confidence                                                                       011223555566666555555


Q ss_pred             CCCCCCHHHHHHHHHHhCCCCHHH-----------------------HhhcCcHHHHHHHhcCCCCCcccHHhhcCC---
Q psy8260         303 HYNQTDIHQLNLIMEMLGTPPAEF-----------------------MAKISSDSARKYINSLPLLTKKDFRQVFKG---  356 (427)
Q Consensus       303 ~~~~~d~~slg~i~~~lg~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  356 (427)
                      +..++|+||+|++++.|.++..+|                       ..... .....+....+......+...++.   
T Consensus       203 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (371)
T 2xrw_A          203 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLF  281 (371)
T ss_dssp             CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC-HHHHHHHHSSCCCCCCCHHHHSCGGGS
T ss_pred             CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh-hHHHHHHhhCccccccchhhhcccccC
Confidence            555667777777766553333222                       22211 122222223333332233222221   


Q ss_pred             ---------CChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCCC--CCCCcccccCCCCHHHHHHHHhhhc
Q psy8260         357 ---------ANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTS--PPYDQSFEDMDLPVDQWKGTYSLES  425 (427)
Q Consensus       357 ---------~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  425 (427)
                               .+++++|||.+||++||++|||++|+|+||||+.+..|......  ...+...++....+++|+..+..+.
T Consensus       282 ~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (371)
T 2xrw_A          282 PADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEV  361 (371)
T ss_dssp             CCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHHHTCCCCCCCTTTTCCCCCCHHHHHHHHHHHH
T ss_pred             cccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccccCCCCCCCCChhhccccCcHHHHHHHHHHHH
Confidence                     15689999999999999999999999999999987665432222  2234455677889999999887664

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.7e-46  Score=362.70  Aligned_cols=266  Identities=31%  Similarity=0.517  Sum_probs=194.1

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      +...+.|.+.+.||+|+||.||.+. + .+|+.||||++............+.+|+++++.++||||+++++++...   
T Consensus        17 q~l~~~y~~~~~lG~G~~g~V~~~~-~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---   91 (311)
T 3niz_A           17 QGLMEKYQKLEKVGEGTYGVVYKAK-D-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE---   91 (311)
T ss_dssp             ECSSCEEEEEEEEEECSSCEEEEEE-E-TTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS---
T ss_pred             cchHhhhHhhhhccCCCCeEEEEEE-E-CCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC---
Confidence            4455789999999999999999764 4 3589999999875443333456678999999999999999999998654   


Q ss_pred             cCCceEEEEeccCCCCHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCC
Q psy8260         140 ADFKNVYMVTHLMGADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP  217 (427)
Q Consensus       140 ~~~~~~~lv~e~~g~~L~~~l~~~--~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~  217 (427)
                         ..++++||++.++|.+.+...  .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        92 ---~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  168 (311)
T 3niz_A           92 ---RCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARA  168 (311)
T ss_dssp             ---SCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             ---CEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCcee
Confidence               467999999988998887653  499999999999999999999999999999999999999999999999999875


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      ......                                                          ......||+.|+|||+
T Consensus       169 ~~~~~~----------------------------------------------------------~~~~~~~t~~y~aPE~  190 (311)
T 3niz_A          169 FGIPVR----------------------------------------------------------SYTHEVVTLWYRAPDV  190 (311)
T ss_dssp             TTSCCC-------------------------------------------------------------CCCCCCTTCCHHH
T ss_pred             cCCCcc----------------------------------------------------------cccCCcccCCcCCHHH
Confidence            432110                                                          0111234555555555


Q ss_pred             hhh-ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHh----------------------cCCCCCcccHHhhc
Q psy8260         298 MLN-WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYIN----------------------SLPLLTKKDFRQVF  354 (427)
Q Consensus       298 l~~-~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~  354 (427)
                      +.+ ..+..++|+||+|++++.|.++..+|......+.......                      .........+....
T Consensus       191 ~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (311)
T 3niz_A          191 LMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSII  270 (311)
T ss_dssp             HTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHS
T ss_pred             hcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhC
Confidence            543 2244456777777777666443333322211111111111                      11122333455666


Q ss_pred             CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q psy8260         355 KGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       355 ~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~  391 (427)
                      +..+++++|||.+||++||++|||++|+|+||||++.
T Consensus       271 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  307 (311)
T 3niz_A          271 PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL  307 (311)
T ss_dssp             TTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred             cccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence            7789999999999999999999999999999999875

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.5e-46  Score=359.20  Aligned_cols=265  Identities=27%  Similarity=0.459  Sum_probs=198.4

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      .+|.+.+.||+|+||.||. +.+..+|+.||||++............+.+|+.++++++||||+++++++...      .
T Consensus         2 ~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~   74 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFK-AKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD------K   74 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEE-EEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET------T
T ss_pred             CCceeeeEecCCCCeEEEE-EEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC------C
Confidence            3588899999999999996 56778899999999976555555556788999999999999999999998654      4


Q ss_pred             eEEEEeccCCCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         144 NVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       144 ~~~lv~e~~g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      .+++++|++++++.+.+..  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        75 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  154 (292)
T 3o0g_A           75 KLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             EEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred             EEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence            6899999998888776643  57999999999999999999999999999999999999999999999999998643221


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      ..                                                          ......||+.|+|||++.+.
T Consensus       155 ~~----------------------------------------------------------~~~~~~~t~~y~aPE~~~~~  176 (292)
T 3o0g_A          155 VR----------------------------------------------------------CYSAEVVTLWYRPPDVLFGA  176 (292)
T ss_dssp             CS----------------------------------------------------------CCCSCCSCGGGCCHHHHTTC
T ss_pred             cc----------------------------------------------------------cccCCccccCCcChHHHcCC
Confidence            10                                                          11123466677777776654


Q ss_pred             c-CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcH-HHHHHHhcCCCCC---------------------cccHHhhcCCCC
Q psy8260         302 M-HYNQTDIHQLNLIMEMLGTPPAEFMAKISSD-SARKYINSLPLLT---------------------KKDFRQVFKGAN  358 (427)
Q Consensus       302 ~-~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~-~~~~~~~~~~~~~---------------------~~~~~~~~~~~s  358 (427)
                      . +..++|+||+|++++.|.++..++....... .............                     ........+..+
T Consensus       177 ~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (292)
T 3o0g_A          177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLN  256 (292)
T ss_dssp             SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCC
T ss_pred             CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccC
Confidence            4 4556799999999888765443332221111 1111111000000                     011122334578


Q ss_pred             hhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q psy8260         359 PQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSD  393 (427)
Q Consensus       359 ~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  393 (427)
                      ++++|||.+||+.||++|||++|+|+||||++...
T Consensus       257 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~p  291 (292)
T 3o0g_A          257 ATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC--
T ss_pred             hHHHHHHHHHhccChhhCCCHHHHhcCcccccCCC
Confidence            99999999999999999999999999999998643

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=5.6e-46  Score=366.55  Aligned_cols=259  Identities=27%  Similarity=0.440  Sum_probs=204.4

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH----HHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA----VHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      .+.|.+++.||+|+||.||. +.+..+|+.||||++.......    ...+.+.+|+.+|+.++||||++++++|...  
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~-~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--   87 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKK-CREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR--   87 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEE-EEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--
T ss_pred             hhceEEeeEEeeCcCEEEEE-EEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC--
Confidence            45689999999999999996 5677899999999987543221    1235678999999999999999999998754  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCC----CEEEeeC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC----ELKILDF  212 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~----~~kl~DF  212 (427)
                          ..+|+++|++ |++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++    .+||+||
T Consensus        88 ----~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           88 ----TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             ----SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             ----CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence                4679999998 7899998864 5699999999999999999999999999999999999998776    7999999


Q ss_pred             CCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccc
Q psy8260         213 GLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWY  292 (427)
Q Consensus       213 Gla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y  292 (427)
                      |+++......                                                           .....+||+.|
T Consensus       164 G~a~~~~~~~-----------------------------------------------------------~~~~~~gt~~y  184 (361)
T 2yab_A          164 GLAHEIEDGV-----------------------------------------------------------EFKNIFGTPEF  184 (361)
T ss_dssp             SSCEECCTTC-----------------------------------------------------------CCCCCCSCGGG
T ss_pred             CCceEcCCCC-----------------------------------------------------------ccccCCCCccE
Confidence            9986432210                                                           11234578888


Q ss_pred             cchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         293 RAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       293 ~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                      +|||++.+..+...+|+||+|++++.|.++..||..................+    ....+..++++++|||.+||+.|
T Consensus       185 ~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~s~~~~~li~~~L~~d  260 (361)
T 2yab_A          185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF----DEEFFSQTSELAKDFIRKLLVKE  260 (361)
T ss_dssp             CCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC----CHHHHTTSCHHHHHHHHHHSCSS
T ss_pred             ECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC----CchhccCCCHHHHHHHHHHCCCC
Confidence            88888877777778899999999988866655564432222222222222211    12455678999999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCC
Q psy8260         373 SEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       373 P~~R~ta~e~L~Hp~f~~~  391 (427)
                      |.+|||++|+|+||||...
T Consensus       261 P~~R~t~~e~l~hp~~~~~  279 (361)
T 2yab_A          261 TRKRLTIQEALRHPWITPV  279 (361)
T ss_dssp             TTTSCCHHHHHTSTTTSCS
T ss_pred             hhHCcCHHHHhcCcCcCCC
Confidence            9999999999999999854

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=8.2e-47  Score=363.57  Aligned_cols=256  Identities=19%  Similarity=0.259  Sum_probs=176.0

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCce
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      ++.+.+.||+|+||.||++.+   +|+.||||++...   ........+|+..+.+++|||||++++++.....  ....
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~---~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~--~~~~   75 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNG--TWTQ   75 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEE---TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS--SSEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE---CCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCC--CceE
Confidence            467889999999999998754   5899999998643   1222223456777778999999999999865321  1235


Q ss_pred             EEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhc--------CceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         145 VYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSA--------GIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       145 ~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~--------~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                      +|+||||+ +|+|.++++...++++.+..++.|++.||.|||++        +||||||||+|||++.++.+||+|||+|
T Consensus        76 ~~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           76 LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            79999999 78999999999999999999999999999999987        9999999999999999999999999999


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      +.........                                                      .....+.+||+.||||
T Consensus       156 ~~~~~~~~~~------------------------------------------------------~~~~~~~~GT~~ymAP  181 (303)
T 3hmm_A          156 VRHDSATDTI------------------------------------------------------DIAPNHRVGTKRYMAP  181 (303)
T ss_dssp             EEEETTTTEE------------------------------------------------------SCC-----CCGGGCCH
T ss_pred             ccccCCCCce------------------------------------------------------eeecccccccccccCH
Confidence            7543211000                                                      0011123466666666


Q ss_pred             HHhhhcc------CCCCCCHHHHHHHHHHhCCCCHHH----------HhhcC----cHHHHHHHhc---CCCCCcccHHh
Q psy8260         296 EIMLNWM------HYNQTDIHQLNLIMEMLGTPPAEF----------MAKIS----SDSARKYINS---LPLLTKKDFRQ  352 (427)
Q Consensus       296 Evl~~~~------~~~~~d~~slg~i~~~lg~~~~~~----------~~~~~----~~~~~~~~~~---~~~~~~~~~~~  352 (427)
                      |++.+..      ++.++|+||+|+++++|.++..++          .....    .....+....   .|..+... . 
T Consensus       182 E~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~-~-  259 (303)
T 3hmm_A          182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW-Q-  259 (303)
T ss_dssp             HHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG-G-
T ss_pred             HHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccc-c-
Confidence            6665431      334679999999998885432211          11000    0111111111   11111100 0 


Q ss_pred             hcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         353 VFKGANPQAIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       353 ~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                       .....+.+.+|+.+||+.||++|||+.|++++
T Consensus       260 -~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          260 -SCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             -SSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             -chHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence             00112457899999999999999999999864

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=373.14  Aligned_cols=259  Identities=25%  Similarity=0.370  Sum_probs=204.1

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .+.|.+.+.||+|+||.||. +.+..+|+.||+|++..........+.+.+|+.+|+.++|||||++++++...      
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~-~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------   82 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRR-CVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEE------   82 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEE-EEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS------
T ss_pred             cCCeEEEEEeccCCCeEEEE-EEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC------
Confidence            35688999999999999995 56788999999999977655555667788999999999999999999998654      


Q ss_pred             ceEEEEeccC-CCCHHHHHh-hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEc---CCCCEEEeeCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN---EDCELKILDFGLARP  217 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~-~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~---~~~~~kl~DFGla~~  217 (427)
                      ...|++||++ |++|.+.+. ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.
T Consensus        83 ~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           83 GHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             SEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             CEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            4679999998 679987765 46799999999999999999999999999999999999998   467899999999865


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      ......                                                          ...+.+||+.|+|||+
T Consensus       163 ~~~~~~----------------------------------------------------------~~~~~~gt~~Y~APE~  184 (444)
T 3soa_A          163 VEGEQQ----------------------------------------------------------AWFGFAGTPGYLSPEV  184 (444)
T ss_dssp             CCTTCC----------------------------------------------------------BCCCSCSCGGGCCHHH
T ss_pred             ecCCCc----------------------------------------------------------eeecccCCcccCCHHH
Confidence            432110                                                          1123467888888888


Q ss_pred             hhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC
Q psy8260         298 MLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI  377 (427)
Q Consensus       298 l~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~  377 (427)
                      +.+..+..++|+||+|++++.|.++..||...................+.    ..+..+++++++||.+||+.||.+||
T Consensus       185 l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~s~~~~~li~~~L~~dP~~Rp  260 (444)
T 3soa_A          185 LRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS----PEWDTVTPEAKDLINKMLTINPSKRI  260 (444)
T ss_dssp             HTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT----TTTTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred             hcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCc----cccccCCHHHHHHHHHHcCCChhHCC
Confidence            87777888889999999998886655555443222222233222222221    23456799999999999999999999


Q ss_pred             CHHHHhcCCCCCC
Q psy8260         378 TAEQALAHPYLSQ  390 (427)
Q Consensus       378 ta~e~L~Hp~f~~  390 (427)
                      |++|+|+||||..
T Consensus       261 ta~e~L~hp~~~~  273 (444)
T 3soa_A          261 TAAEALKHPWISH  273 (444)
T ss_dssp             CHHHHHHSCTTHH
T ss_pred             CHHHHhcCccccC
Confidence            9999999999975

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=354.76  Aligned_cols=271  Identities=29%  Similarity=0.435  Sum_probs=196.8

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC---HHHHHHHHHHHHHHhcC---CCCCceeeeeee
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS---AVHAKRTYRELRMLKHM---NHENVIGLLDVF  133 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~~~Ei~~l~~l---~HpnIv~l~~~~  133 (427)
                      .+..++|.+.+.||+|+||.||. +.+..+|+.||||++......   ........+|+.+++.+   +||||+++++++
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~   83 (308)
T 3g33_A            5 SMATSRYEPVAEIGVGAYGTVYK-ARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC   83 (308)
T ss_dssp             -----CCEEEEEECCSSSCCEEE-EECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred             cccccceEEEEEEecCCCeEEEE-EEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence            34567899999999999999996 567789999999998643211   11122345666666655   599999999998


Q ss_pred             ecCccccCCceEEEEeccCCCCHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEe
Q psy8260         134 HSNTCLADFKNVYMVTHLMGADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKIL  210 (427)
Q Consensus       134 ~~~~~~~~~~~~~lv~e~~g~~L~~~l~~~---~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~  210 (427)
                      ..... .....+++++++++++|.+++...   .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+
T Consensus        84 ~~~~~-~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           84 ATSRT-DREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             EECCS-SSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred             eccCC-CCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEe
Confidence            65321 112357899999999999988754   38999999999999999999999999999999999999999999999


Q ss_pred             eCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccc
Q psy8260         211 DFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATR  290 (427)
Q Consensus       211 DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~  290 (427)
                      |||+++......                                                           ......||+
T Consensus       163 Dfg~a~~~~~~~-----------------------------------------------------------~~~~~~gt~  183 (308)
T 3g33_A          163 DFGLARIYSYQM-----------------------------------------------------------ALTPVVVTL  183 (308)
T ss_dssp             SCSCTTTSTTCC-----------------------------------------------------------CSGGGGCCC
T ss_pred             eCccccccCCCc-----------------------------------------------------------ccCCccccc
Confidence            999987543211                                                           111234677


Q ss_pred             cccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcC-------------------CCCCcccHH
Q psy8260         291 WYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSL-------------------PLLTKKDFR  351 (427)
Q Consensus       291 ~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~  351 (427)
                      .|+|||++.+..+..++|+||+|++++.|.++..+|..........+.....                   +........
T Consensus       184 ~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (308)
T 3g33_A          184 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQ  263 (308)
T ss_dssp             SSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHH
T ss_pred             cccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHH
Confidence            7777777776667777899999999988877666654322222222221110                   111122334


Q ss_pred             hhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q psy8260         352 QVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       352 ~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~  391 (427)
                      ...+..++++.+||.+||++||++|||++|+|+||||.+.
T Consensus       264 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          264 SVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             HHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             HhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence            4556788999999999999999999999999999999864

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.3e-45  Score=357.77  Aligned_cols=256  Identities=21%  Similarity=0.310  Sum_probs=200.5

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      .+.|++.+.||+|+||.||. +.+..+|+.||||++.+... .......+.+|+.+|+.++||||++++++|...     
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~-~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-----   77 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVIL-VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----   77 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEE-EEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-----
T ss_pred             hHHeEEEEEEecCCCeEEEE-EEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC-----
Confidence            46789999999999999996 55778999999999864311 111234577899999999999999999998754     


Q ss_pred             CceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         142 FKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                       ..+|++||++ |++|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        78 -~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  156 (337)
T 1o6l_A           78 -DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             -SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             -CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence             4689999998 6799887754 679999999999999999999999999999999999999999999999999987422


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      ....                                                          .....+||+.|+|||++.
T Consensus       157 ~~~~----------------------------------------------------------~~~~~~gt~~y~aPE~~~  178 (337)
T 1o6l_A          157 SDGA----------------------------------------------------------TMKTFCGTPEYLAPEVLE  178 (337)
T ss_dssp             CTTC----------------------------------------------------------CBCCCEECGGGCCGGGGS
T ss_pred             cCCC----------------------------------------------------------cccccccChhhCChhhhc
Confidence            1100                                                          112346778888888877


Q ss_pred             hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC--
Q psy8260         300 NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI--  377 (427)
Q Consensus       300 ~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~--  377 (427)
                      +..+...+|+||+|++++.|.++..||..................+        ....++++++||.+||+.||.+|+  
T Consensus       179 ~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~--------p~~~s~~~~~li~~lL~~dP~~R~g~  250 (337)
T 1o6l_A          179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF--------PRTLSPEAKSLLAGLLKKDPKQRLGG  250 (337)
T ss_dssp             SSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------CTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             CCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC--------CCCCCHHHHHHHHHHhhcCHHHhcCC
Confidence            7777788899999999988865555554332222222222222211        235789999999999999999999  


Q ss_pred             ---CHHHHhcCCCCCCC
Q psy8260         378 ---TAEQALAHPYLSQY  391 (427)
Q Consensus       378 ---ta~e~L~Hp~f~~~  391 (427)
                         |++|+++||||...
T Consensus       251 ~~~~~~ei~~h~~f~~~  267 (337)
T 1o6l_A          251 GPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             STTTHHHHHTSGGGTTC
T ss_pred             CCCCHHHHHcCCCcCCC
Confidence               99999999999864

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3.3e-45  Score=351.35  Aligned_cols=256  Identities=21%  Similarity=0.349  Sum_probs=202.1

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .+.|.+.+.||+|+||.||. +.+..+|+.||||++.......  .+.+.+|+.+++.++||||++++++|...      
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------   89 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYT-AMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVG------   89 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEE-EEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEET------
T ss_pred             hhceeeeeeeccCCCeEEEE-EEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEEC------
Confidence            35688899999999999996 5677899999999986543222  34577999999999999999999998654      


Q ss_pred             ceEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      ..+|++||++ +++|.+++....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        90 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (297)
T 3fxz_A           90 DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (297)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             CEEEEEEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence            4578999988 889999998889999999999999999999999999999999999999999999999999998643221


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      ..                                                          ......||+.|+|||++.+.
T Consensus       170 ~~----------------------------------------------------------~~~~~~gt~~y~aPE~~~~~  191 (297)
T 3fxz_A          170 QS----------------------------------------------------------KRSTMVGTPYWMAPEVVTRK  191 (297)
T ss_dssp             TC----------------------------------------------------------CBCCCCSCGGGCCHHHHHCS
T ss_pred             cc----------------------------------------------------------ccCCccCCcCccChhhhcCC
Confidence            00                                                          11234578888888888777


Q ss_pred             cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHh-cCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHH
Q psy8260         302 MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYIN-SLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAE  380 (427)
Q Consensus       302 ~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~  380 (427)
                      .+..++|+||+|++++.|.++..||.............. ..+...      .....++++.+||.+||+.||.+|||++
T Consensus       192 ~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~  265 (297)
T 3fxz_A          192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ------NPEKLSAIFRDFLNRCLEMDVEKRGSAK  265 (297)
T ss_dssp             CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCS------CGGGSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC------CccccCHHHHHHHHHHccCChhHCcCHH
Confidence            787888999999999888666555543321111111111 111111      1234688999999999999999999999


Q ss_pred             HHhcCCCCCCC
Q psy8260         381 QALAHPYLSQY  391 (427)
Q Consensus       381 e~L~Hp~f~~~  391 (427)
                      |+|+||||+..
T Consensus       266 ell~h~~~~~~  276 (297)
T 3fxz_A          266 ELLQHQFLKIA  276 (297)
T ss_dssp             HHTTCGGGGGC
T ss_pred             HHhhChhhccc
Confidence            99999999864

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=6.5e-46  Score=359.50  Aligned_cols=268  Identities=28%  Similarity=0.498  Sum_probs=180.7

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      +.|.+.+.||+|+||.||. +.+..+|+.||||++..... ......+.+|+.+++.++||||+++++++...      .
T Consensus         5 ~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~   76 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYK-GLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTE------N   76 (317)
T ss_dssp             --------------CEEEE-EECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCT------T
T ss_pred             cceeEeeEECCCCCEEEEE-EEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEEC------C
Confidence            4688889999999999996 56778899999999865432 22234577899999999999999999998653      4


Q ss_pred             eEEEEeccCCCCHHHHHhh-------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         144 NVYMVTHLMGADLNNILRT-------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       144 ~~~lv~e~~g~~L~~~l~~-------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                      .+|+++|++.++|.+++..       ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        77 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~  156 (317)
T 2pmi_A           77 KLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR  156 (317)
T ss_dssp             EEEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCE
T ss_pred             eEEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccce
Confidence            6899999998899988753       358999999999999999999999999999999999999999999999999986


Q ss_pred             CCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         217 PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       217 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      .......                                                          ......||+.|+|||
T Consensus       157 ~~~~~~~----------------------------------------------------------~~~~~~~t~~y~aPE  178 (317)
T 2pmi_A          157 AFGIPVN----------------------------------------------------------TFSSEVVTLWYRAPD  178 (317)
T ss_dssp             ETTSCCC----------------------------------------------------------CCCCCCSCCTTCCHH
T ss_pred             ecCCCcc----------------------------------------------------------cCCCCcccccccCch
Confidence            5322110                                                          011224566666666


Q ss_pred             Hhhhc-cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhc--------------CCC-------CCcccHHh--
Q psy8260         297 IMLNW-MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINS--------------LPL-------LTKKDFRQ--  352 (427)
Q Consensus       297 vl~~~-~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~--------------~~~-------~~~~~~~~--  352 (427)
                      ++.+. .+..++|+||+|++++.|.++..+|...............              .+.       .....+.+  
T Consensus       179 ~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (317)
T 2pmi_A          179 VLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVL  258 (317)
T ss_dssp             HHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHH
T ss_pred             HhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhh
Confidence            66542 3455668888888887764444333222111111111110              000       00011111  


Q ss_pred             ---hcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCC
Q psy8260         353 ---VFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDE  397 (427)
Q Consensus       353 ---~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~  397 (427)
                         .....+++++|||.+||+.||++|||++|+|+||||++...+..+
T Consensus       259 ~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~  306 (317)
T 2pmi_A          259 QPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHASM  306 (317)
T ss_dssp             GGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC----
T ss_pred             cccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhhc
Confidence               123578899999999999999999999999999999987665443

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.9e-45  Score=361.76  Aligned_cols=259  Identities=21%  Similarity=0.314  Sum_probs=199.4

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNT  137 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~  137 (427)
                      .+..+.|++.+.||+|+||.||. +.+..+|+.||||++.+... .........+|.++++.+ +||||++++++|... 
T Consensus        19 ~~~~~~y~~~~~lG~G~fg~V~~-~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~-   96 (353)
T 3txo_A           19 RLGIDNFEFIRVLGKGSFGKVML-ARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP-   96 (353)
T ss_dssp             ----CCEEEEEEEEEETTEEEEE-EEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-
T ss_pred             CCchhheEEEEEEeeCCCEEEEE-EEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC-
Confidence            34457799999999999999996 55677899999999865321 112234567899999988 799999999998754 


Q ss_pred             cccCCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         138 CLADFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       138 ~~~~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                           ..+|++||++ |++|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|
T Consensus        97 -----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a  171 (353)
T 3txo_A           97 -----DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC  171 (353)
T ss_dssp             -----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             -----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccce
Confidence                 4689999988 6799888754 67999999999999999999999999999999999999999999999999998


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      +......                                                          ......+||+.|+||
T Consensus       172 ~~~~~~~----------------------------------------------------------~~~~~~~gt~~y~aP  193 (353)
T 3txo_A          172 KEGICNG----------------------------------------------------------VTTATFCGTPDYIAP  193 (353)
T ss_dssp             BCSCC-------------------------------------------------------------------CCGGGCCH
T ss_pred             eecccCC----------------------------------------------------------ccccccCCCcCeECh
Confidence            6422110                                                          011234688888888


Q ss_pred             HHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCC
Q psy8260         296 EIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEK  375 (427)
Q Consensus       296 Evl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~  375 (427)
                      |++.+..+..++|+||+|++++.|.++..||......+...+.......+        ....++++++||.+||++||.+
T Consensus       194 E~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~--------p~~~~~~~~~li~~lL~~dP~~  265 (353)
T 3txo_A          194 EILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY--------PTWLHEDATGILKSFMTKNPTM  265 (353)
T ss_dssp             HHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------CTTSCHHHHHHHHHHTCSSGGG
T ss_pred             hhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--------CCCCCHHHHHHHHHHhhhCHHH
Confidence            88888778888899999999988865555554332222333333322222        1346899999999999999999


Q ss_pred             CCCH------HHHhcCCCCCCC
Q psy8260         376 RITA------EQALAHPYLSQY  391 (427)
Q Consensus       376 R~ta------~e~L~Hp~f~~~  391 (427)
                      |+|+      +|+++||||++.
T Consensus       266 R~~~~~~~~~~~il~hp~f~~~  287 (353)
T 3txo_A          266 RLGSLTQGGEHAILRHPFFKEI  287 (353)
T ss_dssp             STTSGGGTCTHHHHTSGGGTTC
T ss_pred             ccCCcccCCHHHHhhCCcccCC
Confidence            9999      899999999875

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.8e-44  Score=352.36  Aligned_cols=312  Identities=38%  Similarity=0.645  Sum_probs=228.3

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .+.|.+.+.||+|+||.||. +.+..+|+.||||++... ........+.+|+++++.++||||+++++++.... ....
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~   86 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCS-ATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDS-FENF   86 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEE-EEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC-STTC
T ss_pred             ccceEEeeEEcCCCCeEEEE-EEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccc-cCcc
Confidence            46789999999999999996 456778999999998643 34455567789999999999999999999876432 2334


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCc
Q psy8260         143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM  222 (427)
Q Consensus       143 ~~~~lv~e~~g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~  222 (427)
                      ...|+++++++++|.+++..+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        87 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  166 (353)
T 2b9h_A           87 NEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA  166 (353)
T ss_dssp             CCEEEEECCCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             ceEEEEEeccCccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence            57899999999999999988899999999999999999999999999999999999999999999999999997543221


Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh-c
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN-W  301 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~-~  301 (427)
                      .......              ...                                  ......+||+.|+|||++.+ .
T Consensus       167 ~~~~~~~--------------~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~  198 (353)
T 2b9h_A          167 ADNSEPT--------------GQQ----------------------------------SGMVEFVATRWYRAPEVMLTSA  198 (353)
T ss_dssp             -------------------------------------------------------------CCCCCCGGGCCHHHHHSCC
T ss_pred             ccccCcc--------------ccc----------------------------------cchhhccccccccCCeeeccCC
Confidence            1000000              000                                  01123457777777777654 3


Q ss_pred             cCCCCCCHHHHHHHHHHhCCCCHHHHhhc------------------------CcHHHHHHHhcCCCCCcccHHhhcCCC
Q psy8260         302 MHYNQTDIHQLNLIMEMLGTPPAEFMAKI------------------------SSDSARKYINSLPLLTKKDFRQVFKGA  357 (427)
Q Consensus       302 ~~~~~~d~~slg~i~~~lg~~~~~~~~~~------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (427)
                      .+..++|+||+|++++.|.++..+|....                        .......+....+......+...+...
T Consensus       199 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (353)
T 2b9h_A          199 KYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRV  278 (353)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTS
T ss_pred             CccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccC
Confidence            44556688888888876643333332111                        111122233334444444556667788


Q ss_pred             ChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCC-----CcccccCCCCHHHHHHHHhhhc
Q psy8260         358 NPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPPY-----DQSFEDMDLPVDQWKGTYSLES  425 (427)
Q Consensus       358 s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~  425 (427)
                      ++++.+||.+||+.||++|||++|+|+||||+....+...+...+.     +.+.........+|+..+..|.
T Consensus       279 ~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (353)
T 2b9h_A          279 NPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEI  351 (353)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSCCCCCCCGGGGGGGCCSSCCCHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcccccccCCCCcceeeecchhhcCCHHHHHHHHHHHh
Confidence            9999999999999999999999999999999988777655443333     3344556677788888877664

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=7.5e-46  Score=353.82  Aligned_cols=261  Identities=30%  Similarity=0.489  Sum_probs=192.9

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      ++|.+.+.||+|+||.||.+. + .+|+.||||++............+.+|+++++.++||||+++++++...      .
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~-~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~   73 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQ-N-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK------K   73 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEE-E-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS------S
T ss_pred             ccchhhhhcccCCCEEEEEEE-c-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC------C
Confidence            357889999999999999764 4 5789999999865433332335677999999999999999999998754      4


Q ss_pred             eEEEEeccCCCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         144 NVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       144 ~~~lv~e~~g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      .+|+++|++.++|.+++..  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        74 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  153 (288)
T 1ob3_A           74 RLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (288)
T ss_dssp             CEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             eEEEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence            6899999998899988864  56999999999999999999999999999999999999999999999999987532211


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      ..                                                          ......||+.|+|||++.+.
T Consensus       154 ~~----------------------------------------------------------~~~~~~~t~~y~aPE~~~~~  175 (288)
T 1ob3_A          154 VR----------------------------------------------------------KYTHEIVTLWYRAPDVLMGS  175 (288)
T ss_dssp             ------------------------------------------------------------------CCCTTCCHHHHTTC
T ss_pred             cc----------------------------------------------------------ccccccccccccCchheeCC
Confidence            00                                                          01123456666777766543


Q ss_pred             -cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhc---------------------CCCCCcccHHhhcCCCCh
Q psy8260         302 -MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINS---------------------LPLLTKKDFRQVFKGANP  359 (427)
Q Consensus       302 -~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~s~  359 (427)
                       .+..++|+||+|++++.|.++..+|......+........                     ........+......+++
T Consensus       176 ~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (288)
T 1ob3_A          176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDE  255 (288)
T ss_dssp             CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCH
T ss_pred             CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCH
Confidence             2455679999999887774444434221111111111110                     011112223444567899


Q ss_pred             hHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q psy8260         360 QAIDLLSLMLELDSEKRITAEQALAHPYLSQ  390 (427)
Q Consensus       360 ~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~  390 (427)
                      +++|||.+||+.||++|||++|+|+||||++
T Consensus       256 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          256 SGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence            9999999999999999999999999999975

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.1e-45  Score=361.49  Aligned_cols=258  Identities=26%  Similarity=0.392  Sum_probs=204.1

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .+.|.+.+.||+|+||.||. +.+..+|+.||||++..........+.+.+|+.+++.++||||+++++++...      
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~-~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~------  100 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRR-CVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE------  100 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEE-EEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS------
T ss_pred             ccCeEEeeEEecCCCeEEEE-EEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC------
Confidence            46789999999999999996 55778999999999977655666667788999999999999999999998754      


Q ss_pred             ceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCC---CCEEEeeCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED---CELKILDFGLARP  217 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~---~~~kl~DFGla~~  217 (427)
                      ...|+++|++ |++|.+.+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+   +.+||+|||+++.
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          101 SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             SEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             CEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            4678999988 6799887754 568999999999999999999999999999999999999864   4699999999864


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      .....                                                           ...+.+||+.|+|||+
T Consensus       181 ~~~~~-----------------------------------------------------------~~~~~~gt~~y~aPE~  201 (362)
T 2bdw_A          181 VNDSE-----------------------------------------------------------AWHGFAGTPGYLSPEV  201 (362)
T ss_dssp             CTTCC-----------------------------------------------------------SCCCSCSCTTTCCHHH
T ss_pred             ecCCc-----------------------------------------------------------ccccCCCCccccCHHH
Confidence            33210                                                           1123457788888888


Q ss_pred             hhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC
Q psy8260         298 MLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI  377 (427)
Q Consensus       298 l~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~  377 (427)
                      +.+..+..++|+||+|++++.|.++..||...................+.    ..+..+++++++||.+||+.||.+||
T Consensus       202 ~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dP~~R~  277 (362)
T 2bdw_A          202 LKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS----PEWDTVTPEAKSLIDSMLTVNPKKRI  277 (362)
T ss_dssp             HTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----TGGGGSCHHHHHHHHHHSCSSGGGSC
T ss_pred             HccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc----ccccCCCHHHHHHHHHHcCCChhhCc
Confidence            87777777889999999998886665555433222222222222222222    23456789999999999999999999


Q ss_pred             CHHHHhcCCCCCC
Q psy8260         378 TAEQALAHPYLSQ  390 (427)
Q Consensus       378 ta~e~L~Hp~f~~  390 (427)
                      |++|+|+||||..
T Consensus       278 t~~e~l~hp~~~~  290 (362)
T 2bdw_A          278 TADQALKVPWICN  290 (362)
T ss_dssp             CHHHHTTSHHHHT
T ss_pred             CHHHHhcCcccCC
Confidence            9999999999975

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.9e-45  Score=364.85  Aligned_cols=276  Identities=17%  Similarity=0.217  Sum_probs=202.6

Q ss_pred             cCcceeeccccCcc--cccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          62 CRGVIDIGPTLSKE--SFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        62 ~~~~~~~~~~lg~g--~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      ..++|.+.+.||+|  +||.||. +.+..+|+.||||++..........+.+.+|+.+++.++|||||+++++|...   
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---   98 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNL-ARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD---   98 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEE-EEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---
T ss_pred             CCCcEEEEecccCCcCCceEEEE-EEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC---
Confidence            35789999999999  9999996 55677899999999977655666667788999999999999999999998754   


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                         ..+|+++|++ +++|.+++..   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        99 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~  175 (389)
T 3gni_B           99 ---NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN  175 (389)
T ss_dssp             ---TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred             ---CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccc
Confidence               4678999988 6899998865   56999999999999999999999999999999999999999999999999987


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      ...........                                                   .........+||+.|+||
T Consensus       176 ~~~~~~~~~~~---------------------------------------------------~~~~~~~~~~gt~~y~aP  204 (389)
T 3gni_B          176 LSMISHGQRQR---------------------------------------------------VVHDFPKYSVKVLPWLSP  204 (389)
T ss_dssp             EECEETTEECS---------------------------------------------------CBCCCCTTCTTTGGGSCH
T ss_pred             eeecccccccc---------------------------------------------------ccccccccccccccccCH
Confidence            53221100000                                                   000011234678889999


Q ss_pred             HHhhh--ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhc-CC-----------------------------
Q psy8260         296 EIMLN--WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINS-LP-----------------------------  343 (427)
Q Consensus       296 Evl~~--~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~-~~-----------------------------  343 (427)
                      |++.+  ..+..++|+||+|++++.|.++..+|............... .+                             
T Consensus       205 E~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (389)
T 3gni_B          205 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDS  284 (389)
T ss_dssp             HHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------------------------------
T ss_pred             HHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccc
Confidence            98876  45677789999999998885555455332211111111000 00                             


Q ss_pred             --------CCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q psy8260         344 --------LLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPN  395 (427)
Q Consensus       344 --------~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~  395 (427)
                              .............++++++|||.+||++||++|||++|+|+||||++...+.
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~~~  344 (389)
T 3gni_B          285 LTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRA  344 (389)
T ss_dssp             ---------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC---C
T ss_pred             cccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhhcc
Confidence                    0000001123455789999999999999999999999999999999876543

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.4e-44  Score=360.32  Aligned_cols=258  Identities=20%  Similarity=0.314  Sum_probs=199.1

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH-HHHHHHHHHHHHHhcC-CCCCceeeeeeeecCcc
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA-VHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTC  138 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~  138 (427)
                      +...+|++.+.||+|+||.||. +.+..+++.||||++.+..... .....+.+|..++.++ +|||||+++++|...  
T Consensus        49 ~~~~~y~~~~~LG~G~fG~V~~-~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~--  125 (396)
T 4dc2_A           49 LGLQDFDLLRVIGRGSYAKVLL-VRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--  125 (396)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEE-EEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS--
T ss_pred             CChhHcEEEEEEeeCCCeEEEE-EEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC--
Confidence            4456799999999999999996 5567789999999987653322 2334567899999876 899999999998754  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                          ..+|++||++ |++|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+
T Consensus       126 ----~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~  201 (396)
T 4dc2_A          126 ----SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK  201 (396)
T ss_dssp             ----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             ----CEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceee
Confidence                4689999988 6799887754 679999999999999999999999999999999999999999999999999987


Q ss_pred             CCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         217 PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       217 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      ......                                                          ......+||+.|+|||
T Consensus       202 ~~~~~~----------------------------------------------------------~~~~~~~gt~~Y~aPE  223 (396)
T 4dc2_A          202 EGLRPG----------------------------------------------------------DTTSTFCGTPNYIAPE  223 (396)
T ss_dssp             CCCCTT----------------------------------------------------------CCBCCCCBCGGGCCHH
T ss_pred             ecccCC----------------------------------------------------------CccccccCCcccCCch
Confidence            421110                                                          0122446788888888


Q ss_pred             HhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcC--------cH-HHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHH
Q psy8260         297 IMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKIS--------SD-SARKYINSLPLLTKKDFRQVFKGANPQAIDLLSL  367 (427)
Q Consensus       297 vl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~--------~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~  367 (427)
                      ++.+..+...+|+||+|++++.|.++..||.....        .. ...........        ....++++++|||.+
T Consensus       224 ~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~--------~p~~~s~~~~~li~~  295 (396)
T 4dc2_A          224 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--------IPRSLSVKAASVLKS  295 (396)
T ss_dssp             HHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC--------CCTTSCHHHHHHHHH
T ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC--------CCCcCCHHHHHHHHH
Confidence            88877788888999999999887555444531110        01 11111111111        123578999999999


Q ss_pred             hcCCCCCCCCCH------HHHhcCCCCCCC
Q psy8260         368 MLELDSEKRITA------EQALAHPYLSQY  391 (427)
Q Consensus       368 mL~~dP~~R~ta------~e~L~Hp~f~~~  391 (427)
                      ||+.||.+|+|+      +|+++||||+..
T Consensus       296 lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i  325 (396)
T 4dc2_A          296 FLNKDPKERLGCHPQTGFADIQGHPFFRNV  325 (396)
T ss_dssp             HTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred             HhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence            999999999995      899999999865

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-45  Score=354.29  Aligned_cols=257  Identities=23%  Similarity=0.358  Sum_probs=203.0

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .+.|.+.+.||+|+||.||. +.+..+|+.||+|.+...   ......+.+|+.+|+.++||||+++++++...      
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~-~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------   73 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHR-CVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESM------   73 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEE-EEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEET------
T ss_pred             hhceEeeeEEecCCCeEEEE-EEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecC------
Confidence            35788999999999999996 567789999999998643   23445677999999999999999999998653      


Q ss_pred             ceEEEEeccC-CCCHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcC--CCCEEEeeCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE--DCELKILDFGLARP  217 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~~~--~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~--~~~~kl~DFGla~~  217 (427)
                      ..+|+++|++ |++|.+.+...  .+++..+..++.|++.||.|||++||+||||||+|||++.  ++.+||+|||+++.
T Consensus        74 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~  153 (321)
T 1tki_A           74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ  153 (321)
T ss_dssp             TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred             CEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence            4689999998 67999988653  5999999999999999999999999999999999999987  78999999999864


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      .....                                                           ......||+.|+|||+
T Consensus       154 ~~~~~-----------------------------------------------------------~~~~~~gt~~y~aPE~  174 (321)
T 1tki_A          154 LKPGD-----------------------------------------------------------NFRLLFTAPEYYAPEV  174 (321)
T ss_dssp             CCTTC-----------------------------------------------------------EEEEEESCGGGSCHHH
T ss_pred             CCCCC-----------------------------------------------------------ccccccCChhhcCcHH
Confidence            32210                                                           1112346777777777


Q ss_pred             hhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC
Q psy8260         298 MLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI  377 (427)
Q Consensus       298 l~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~  377 (427)
                      +.+..+..++|+||+|++++.|.++..||....................    ...++.+++++++||.+||+.||.+||
T Consensus       175 ~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~s~~~~~li~~~L~~dp~~Rp  250 (321)
T 1tki_A          175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD----EEAFKEISIEAMDFVDRLLVKERKSRM  250 (321)
T ss_dssp             HTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----HHHHTTSCHHHHHHHHTTSCSSGGGSC
T ss_pred             hcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCC----hhhhccCCHHHHHHHHHHcCCChhHCc
Confidence            7766666778999999999888666555644332223333333222222    234567899999999999999999999


Q ss_pred             CHHHHhcCCCCCCCC
Q psy8260         378 TAEQALAHPYLSQYS  392 (427)
Q Consensus       378 ta~e~L~Hp~f~~~~  392 (427)
                      |++|+|+||||.+..
T Consensus       251 t~~e~l~hp~~~~~~  265 (321)
T 1tki_A          251 TASEALQHPWLKQKI  265 (321)
T ss_dssp             CHHHHHHSHHHHSCG
T ss_pred             CHHHHhcChhhccCc
Confidence            999999999998653

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.2e-45  Score=356.83  Aligned_cols=266  Identities=26%  Similarity=0.449  Sum_probs=186.8

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      +.|.+.+.||+|+||.||. +.+..+|+.||||++..... ......+.+|+++++.++||||+++++++...      .
T Consensus         2 ~~y~~~~~lG~G~~g~V~~-~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~   73 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYK-GKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTE------K   73 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEE-EEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECS------S
T ss_pred             CceEEEEEEcCCCCEEEEE-EEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeC------C
Confidence            3588899999999999996 55677899999999864321 11112345799999999999999999998654      4


Q ss_pred             eEEEEeccCCCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         144 NVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       144 ~~~lv~e~~g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      ..+++||+++++|.+++..  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        74 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  153 (324)
T 3mtl_A           74 SLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP  153 (324)
T ss_dssp             CEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred             EEEEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence            5799999999999988764  35899999999999999999999999999999999999999999999999998643321


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh-
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN-  300 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~-  300 (427)
                      ..                                                          ......||+.|+|||++.+ 
T Consensus       154 ~~----------------------------------------------------------~~~~~~~t~~y~aPE~~~~~  175 (324)
T 3mtl_A          154 TK----------------------------------------------------------TYDNEVVTLWYRPPDILLGS  175 (324)
T ss_dssp             -------------------------------------------------------------------CGGGCCHHHHTTC
T ss_pred             cc----------------------------------------------------------ccccccCcccccChhhhcCC
Confidence            10                                                          0112234555555555543 


Q ss_pred             ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHh----------------------cCCCCCcccHHhhcCCCC
Q psy8260         301 WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYIN----------------------SLPLLTKKDFRQVFKGAN  358 (427)
Q Consensus       301 ~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~s  358 (427)
                      ..+..++|+||+|++++.|.++..+|......+.......                      ..+.............++
T Consensus       176 ~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (324)
T 3mtl_A          176 TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLD  255 (324)
T ss_dssp             CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSC
T ss_pred             CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCC
Confidence            2234455777777766655333333321111111111110                      112222223344556789


Q ss_pred             hhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q psy8260         359 PQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPN  395 (427)
Q Consensus       359 ~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~  395 (427)
                      ++++|||.+||++||.+|||++|+|+||||.+.....
T Consensus       256 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  292 (324)
T 3mtl_A          256 SDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERI  292 (324)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTT
T ss_pred             HHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccccc
Confidence            9999999999999999999999999999998765443

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1e-45  Score=370.30  Aligned_cols=262  Identities=19%  Similarity=0.264  Sum_probs=200.5

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH-HHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA-VHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      .+..+.|.+.+.||+|+||.||. +.+..+|+.||||++.+..... .....+.+|+.+++.++|||||+++++|...  
T Consensus        65 ~~~~~~y~~~~~LG~G~fG~V~~-~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--  141 (410)
T 3v8s_A           65 RMKAEDYEVVKVIGRGAFGEVQL-VRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD--  141 (410)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEE-EEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS--
T ss_pred             ccCccccEEEEEEEcCCCEEEEE-EEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--
Confidence            34557899999999999999996 5567789999999986421100 0112366899999999999999999998754  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP  217 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~  217 (427)
                          ..+|++||++ |++|.++++...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus       142 ----~~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~  217 (410)
T 3v8s_A          142 ----RYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  217 (410)
T ss_dssp             ----SEEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             ----CEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence                4689999999 88999999888999999999999999999999999999999999999999999999999999875


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      ......                                                         ....+.+||+.|+|||+
T Consensus       218 ~~~~~~---------------------------------------------------------~~~~~~~gt~~Y~APE~  240 (410)
T 3v8s_A          218 MNKEGM---------------------------------------------------------VRCDTAVGTPDYISPEV  240 (410)
T ss_dssp             CCTTSE---------------------------------------------------------EECCSCCSCGGGCCHHH
T ss_pred             eccCCc---------------------------------------------------------ccccCCcCCccccCHHH
Confidence            432110                                                         01113356667777776


Q ss_pred             hhhcc----CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcC--CCCCcccHHhhcCCCChhHHHHHHHhcCC
Q psy8260         298 MLNWM----HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSL--PLLTKKDFRQVFKGANPQAIDLLSLMLEL  371 (427)
Q Consensus       298 l~~~~----~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~s~~~~dLi~~mL~~  371 (427)
                      +.+..    +..++|+||+|++++.|.++..||..........+.....  ..++      ....++++++|||.+||+.
T Consensus       241 l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p------~~~~~s~~~~~li~~lL~~  314 (410)
T 3v8s_A          241 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP------DDNDISKEAKNLICAFLTD  314 (410)
T ss_dssp             HHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC------TTCCCCHHHHHHHHHHSSC
T ss_pred             hhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCC------CcccccHHHHHHHHHHccC
Confidence            66543    4556799999999998866665664332222222322210  1111      1235789999999999999


Q ss_pred             CCCC--CCCHHHHhcCCCCCCC
Q psy8260         372 DSEK--RITAEQALAHPYLSQY  391 (427)
Q Consensus       372 dP~~--R~ta~e~L~Hp~f~~~  391 (427)
                      +|.+  |+|++|+++||||+..
T Consensus       315 ~~~rlgR~~~~ei~~Hp~f~~~  336 (410)
T 3v8s_A          315 REVRLGRNGVEEIKRHLFFKND  336 (410)
T ss_dssp             GGGCTTSSCHHHHHTSGGGCCS
T ss_pred             hhhhCCCCCHHHHhcCccccCC
Confidence            9998  9999999999999865

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=8.3e-45  Score=352.16  Aligned_cols=253  Identities=24%  Similarity=0.341  Sum_probs=200.0

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH-HHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA-VHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      .+.|.+.+.||+|+||.||. +.+..+|+.||||++.+..... ...+.+.+|+.+++.++||||++++++|...     
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~-~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-----   78 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHL-IRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-----   78 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEE-EEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS-----
T ss_pred             hHHcEEEEEEeeCCCEEEEE-EEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC-----
Confidence            46789999999999999996 5567789999999986432111 1234567899999999999999999998754     


Q ss_pred             CceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         142 FKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                       ..+|++||++ |++|.++++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        79 -~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~  157 (318)
T 1fot_A           79 -QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP  157 (318)
T ss_dssp             -SEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             -CEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecC
Confidence             4689999998 6799998865 579999999999999999999999999999999999999999999999999986433


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      ....                                                             ..+||+.|+|||++.
T Consensus       158 ~~~~-------------------------------------------------------------~~~gt~~y~aPE~~~  176 (318)
T 1fot_A          158 DVTY-------------------------------------------------------------TLCGTPDYIAPEVVS  176 (318)
T ss_dssp             SCBC-------------------------------------------------------------CCCSCTTTCCHHHHT
T ss_pred             Cccc-------------------------------------------------------------cccCCccccCHhHhc
Confidence            2211                                                             234677777777777


Q ss_pred             hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC--
Q psy8260         300 NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI--  377 (427)
Q Consensus       300 ~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~--  377 (427)
                      +..+..++|+||+|++++.|.++..||..........+.......+        ....++++++||.+||+.||++|+  
T Consensus       177 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~--------p~~~~~~~~~li~~lL~~dp~~R~~~  248 (318)
T 1fot_A          177 TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF--------PPFFNEDVKDLLSRLITRDLSQRLGN  248 (318)
T ss_dssp             TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCC--------CTTSCHHHHHHHHHHTCSCTTTCTTS
T ss_pred             CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--------CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            6667778899999999988866655554332222233333322221        234689999999999999999999  


Q ss_pred             ---CHHHHhcCCCCCCC
Q psy8260         378 ---TAEQALAHPYLSQY  391 (427)
Q Consensus       378 ---ta~e~L~Hp~f~~~  391 (427)
                         |++|+++||||++.
T Consensus       249 ~~~~~~~i~~hp~f~~~  265 (318)
T 1fot_A          249 LQNGTEDVKNHPWFKEV  265 (318)
T ss_dssp             STTTTHHHHTSGGGSSC
T ss_pred             cCCCHHHHhcCccccCC
Confidence               99999999999865

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.5e-44  Score=350.92  Aligned_cols=258  Identities=20%  Similarity=0.310  Sum_probs=200.8

Q ss_pred             cCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCccc
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~  139 (427)
                      ..+.|.+.+.||+|+||.||. +.+..+|+.||||++.+... .......+.+|+.+++++ +||||++++++|...   
T Consensus         7 ~~~~y~~~~~lG~G~fg~V~~-~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~---   82 (345)
T 3a8x_A            7 GLQDFDLLRVIGRGSYAKVLL-VRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE---   82 (345)
T ss_dssp             CGGGEEEEEEEEECSSEEEEE-EEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS---
T ss_pred             chhheEEEEEEEecCCeEEEE-EEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC---
Confidence            346789999999999999996 45677899999999976543 344456677999999987 899999999998754   


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCC
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP  217 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~  217 (427)
                         ..+|++||++ |++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        83 ---~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~  159 (345)
T 3a8x_A           83 ---SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  159 (345)
T ss_dssp             ---SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred             ---CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecccccc
Confidence               4689999998 7799888754 6799999999999999999999999999999999999999999999999999864


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      .....                                                          ......+||+.|+|||+
T Consensus       160 ~~~~~----------------------------------------------------------~~~~~~~gt~~y~aPE~  181 (345)
T 3a8x_A          160 GLRPG----------------------------------------------------------DTTSTFCGTPNYIAPEI  181 (345)
T ss_dssp             SCCTT----------------------------------------------------------CCBCCCCSCGGGCCHHH
T ss_pred             ccCCC----------------------------------------------------------CcccccCCCccccCccc
Confidence            21110                                                          01123467888888888


Q ss_pred             hhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhc--------CcH-HHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHh
Q psy8260         298 MLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKI--------SSD-SARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLM  368 (427)
Q Consensus       298 l~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~--------~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~m  368 (427)
                      +.+..+...+|+||+|++++.|.++..||....        ... ...........        .....++++++||.+|
T Consensus       182 ~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~--------~p~~~s~~~~~li~~l  253 (345)
T 3a8x_A          182 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--------IPRSLSVKAASVLKSF  253 (345)
T ss_dssp             HTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC--------CCTTSCHHHHHHHHHH
T ss_pred             cCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC--------CCCCCCHHHHHHHHHH
Confidence            877777778899999999988755554553210        001 11111111111        1235789999999999


Q ss_pred             cCCCCCCCCCH------HHHhcCCCCCCCC
Q psy8260         369 LELDSEKRITA------EQALAHPYLSQYS  392 (427)
Q Consensus       369 L~~dP~~R~ta------~e~L~Hp~f~~~~  392 (427)
                      |+.||.+|+|+      +|+++||||....
T Consensus       254 L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~  283 (345)
T 3a8x_A          254 LNKDPKERLGCHPQTGFADIQGHPFFRNVD  283 (345)
T ss_dssp             TCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred             hcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence            99999999995      8999999998653

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1e-45  Score=373.11  Aligned_cols=267  Identities=19%  Similarity=0.242  Sum_probs=200.3

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH-HHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA-VHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      .+..++|++.+.||+|+||.||.+ .+..+++.||||++.+..... .....+.+|+.++..++||||++++++|...  
T Consensus        70 ~~~~~~y~~~~~LG~G~fG~V~~~-~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~--  146 (437)
T 4aw2_A           70 RLHREDFEILKVIGRGAFGEVAVV-KLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD--  146 (437)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEE-EETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS--
T ss_pred             cCChhheEEEEEEEeCCCEEEEEE-EEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC--
Confidence            455678999999999999999964 566789999999986421100 0112267899999999999999999998754  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                          ..+|++||++ |++|.+++..  ..+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|
T Consensus       147 ----~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla  222 (437)
T 4aw2_A          147 ----NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSC  222 (437)
T ss_dssp             ----SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             ----CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence                4689999988 8899999875  57999999999999999999999999999999999999999999999999998


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      +........                                                         .....+||+.|+||
T Consensus       223 ~~~~~~~~~---------------------------------------------------------~~~~~~GT~~Y~AP  245 (437)
T 4aw2_A          223 LKLMEDGTV---------------------------------------------------------QSSVAVGTPDYISP  245 (437)
T ss_dssp             EECCTTSCE---------------------------------------------------------ECCSCCSCGGGCCH
T ss_pred             hhcccCCCc---------------------------------------------------------ccccccCCcCeeCh
Confidence            643221100                                                         01123566666666


Q ss_pred             HHhh-----hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcC
Q psy8260         296 EIML-----NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLE  370 (427)
Q Consensus       296 Evl~-----~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~  370 (427)
                      |++.     ...+..++|+||+|+++++|.++..||......+...+.......   ..+...+..++++++|||++||+
T Consensus       246 E~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---~~~p~~~~~~s~~~~dLi~~lL~  322 (437)
T 4aw2_A          246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER---FQFPTQVTDVSENAKDLIRRLIC  322 (437)
T ss_dssp             HHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH---CCCCSSCCCSCHHHHHHHHTTSS
T ss_pred             HHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc---ccCCcccccCCHHHHHHHHHHhc
Confidence            6665     234566789999999998886666556433222222222211000   00111224579999999999999


Q ss_pred             CCCCC--CCCHHHHhcCCCCCCCCC
Q psy8260         371 LDSEK--RITAEQALAHPYLSQYSD  393 (427)
Q Consensus       371 ~dP~~--R~ta~e~L~Hp~f~~~~~  393 (427)
                      .+|++  |++++|+++||||+....
T Consensus       323 ~~~~r~~r~~~~eil~Hpff~~i~w  347 (437)
T 4aw2_A          323 SREHRLGQNGIEDFKKHPFFSGIDW  347 (437)
T ss_dssp             CGGGCTTTTTTHHHHTSGGGTTCCT
T ss_pred             ccccccCCCCHHHHhCCCccCCCCH
Confidence            99998  999999999999987643

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.4e-44  Score=363.82  Aligned_cols=286  Identities=29%  Similarity=0.468  Sum_probs=196.8

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      ...|.+.+.||+|+||.||. +.+..+|+.||||++.....      ...+|+++|+.++|||||+++++|.......+.
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~-~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~  125 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQ-AKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE  125 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEE-EEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred             cceEEeeeEEeeCCCEEEEE-EEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence            45689999999999999996 45667899999999864321      123799999999999999999998643322233


Q ss_pred             ceEEEEeccCCCCHHHHHh-----hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCC-CCEEEeeCCCCC
Q psy8260         143 KNVYMVTHLMGADLNNILR-----TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLAR  216 (427)
Q Consensus       143 ~~~~lv~e~~g~~L~~~l~-----~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~-~~~kl~DFGla~  216 (427)
                      ..++++++++.+++.+++.     ...+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus       126 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          126 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            4577999999888877654     3579999999999999999999999999999999999999965 678999999997


Q ss_pred             CCCC--CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccc
Q psy8260         217 PTEN--EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRA  294 (427)
Q Consensus       217 ~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~A  294 (427)
                      ....  ....++||++|+|||++.+...|+..      .|+|+.||++.+                 +.+|.        
T Consensus       206 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~------~DiwSlG~il~e-----------------ll~G~--------  254 (420)
T 1j1b_A          206 QLVRGEPNVSYICSRYYRAPELIFGATDYTSS------IDVWSAGCVLAE-----------------LLLGQ--------  254 (420)
T ss_dssp             ECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTH------HHHHHHHHHHHH-----------------HHHSS--------
T ss_pred             hcccCCCceeeeeCCCcCCHHHHcCCCCCCch------hhhHHHHHHHHH-----------------HHhCC--------
Confidence            5432  23345666667777766543233222      255555544433                 22221        


Q ss_pred             hHHhhhccCCCC-CCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhc-CCCChhHHHHHHHhcCCC
Q psy8260         295 PEIMLNWMHYNQ-TDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF-KGANPQAIDLLSLMLELD  372 (427)
Q Consensus       295 PEvl~~~~~~~~-~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dLi~~mL~~d  372 (427)
                             ..+.+ .+..++..++..+|++..+.+....... .  ....+......|...+ ...+++++|||.+||++|
T Consensus       255 -------~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~-~--~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~d  324 (420)
T 1j1b_A          255 -------PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY-T--EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT  324 (420)
T ss_dssp             -------CSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCC-C--CCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSS
T ss_pred             -------CCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh-h--hhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCC
Confidence                   12222 2333444444445554443322111000 0  0011222333444443 356899999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCCCCCCC
Q psy8260         373 SEKRITAEQALAHPYLSQYSDPND  396 (427)
Q Consensus       373 P~~R~ta~e~L~Hp~f~~~~~~~~  396 (427)
                      |.+|+|++|+|+||||.+...+..
T Consensus       325 P~~R~t~~e~l~hp~f~~~~~~~~  348 (420)
T 1j1b_A          325 PTARLTPLEACAHSFFDELRDPNV  348 (420)
T ss_dssp             GGGSCCHHHHHTSGGGGGGGCTTC
T ss_pred             hhHCCCHHHHhCCHhhcccccccc
Confidence            999999999999999988766543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.8e-44  Score=350.93  Aligned_cols=259  Identities=26%  Similarity=0.410  Sum_probs=201.3

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH----HHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA----VHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      .+.|.+.+.||+|+||.||. +.+..+|+.||||++.......    ...+.+.+|+.+|+.++||||+++++++...  
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~-~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--   86 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKK-CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK--   86 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEE-EEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--
T ss_pred             ccceEeceEEeeCCCeEEEE-EEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--
Confidence            35689999999999999996 5677889999999986543221    1245678999999999999999999998653  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCC----CEEEeeC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC----ELKILDF  212 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~----~~kl~DF  212 (427)
                          ..+|+++|++ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++    .+||+||
T Consensus        87 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           87 ----TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             ----SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             ----CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence                4678999988 7899998864 5699999999999999999999999999999999999998877    8999999


Q ss_pred             CCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccc
Q psy8260         213 GLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWY  292 (427)
Q Consensus       213 Gla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y  292 (427)
                      |+++......                                                           ......||+.|
T Consensus       163 g~a~~~~~~~-----------------------------------------------------------~~~~~~gt~~y  183 (326)
T 2y0a_A          163 GLAHKIDFGN-----------------------------------------------------------EFKNIFGTPEF  183 (326)
T ss_dssp             TTCEECCTTS-----------------------------------------------------------CCCCCCSCTTT
T ss_pred             CCCeECCCCC-----------------------------------------------------------ccccccCCcCc
Confidence            9986432110                                                           01123477778


Q ss_pred             cchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         293 RAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       293 ~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                      +|||++.+..+..++|+||+|++++.|.++..||...................    ....+...++++++||.+||+.|
T Consensus       184 ~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~L~~d  259 (326)
T 2y0a_A          184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF----EDEYFSNTSALAKDFIRRLLVKD  259 (326)
T ss_dssp             CCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCC----CHHHHTTSCHHHHHHHHHHSCSS
T ss_pred             CCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCc----CccccccCCHHHHHHHHHHccCC
Confidence            88887776667777899999999988866555554322222222222222211    12345678999999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCC
Q psy8260         373 SEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       373 P~~R~ta~e~L~Hp~f~~~  391 (427)
                      |.+|||++|+|+||||...
T Consensus       260 P~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          260 PKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             GGGSCCHHHHHHSTTTSCC
T ss_pred             hhhCCCHHHHhcCCCccCC
Confidence            9999999999999999754

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.9e-45  Score=358.31  Aligned_cols=259  Identities=23%  Similarity=0.326  Sum_probs=200.9

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC-HHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCcc
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS-AVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTC  138 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~  138 (427)
                      +..+.|.+.+.||+|+||.||. +.+..+|+.||||++.+.... ........+|..++..+ +||||++++++|...  
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~-~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~--   90 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFL-AEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--   90 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEE-EEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--
T ss_pred             CChHHeEEEEEEeeCCCeEEEE-EEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC--
Confidence            4457799999999999999996 556778999999998653110 11234567899988876 999999999998754  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                          ..+|++||++ |++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        91 ----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~  166 (345)
T 1xjd_A           91 ----ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK  166 (345)
T ss_dssp             ----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             ----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence                4689999998 7899988864 679999999999999999999999999999999999999999999999999986


Q ss_pred             CCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         217 PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       217 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      ......                                                          ......+||+.|+|||
T Consensus       167 ~~~~~~----------------------------------------------------------~~~~~~~gt~~y~aPE  188 (345)
T 1xjd_A          167 ENMLGD----------------------------------------------------------AKTNTFCGTPDYIAPE  188 (345)
T ss_dssp             CCCCTT----------------------------------------------------------CCBCCCCSCGGGCCHH
T ss_pred             hcccCC----------------------------------------------------------CcccCCCCCcccCChh
Confidence            421110                                                          0112346788888888


Q ss_pred             HhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCC
Q psy8260         297 IMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKR  376 (427)
Q Consensus       297 vl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R  376 (427)
                      ++.+..+...+|+||+|++++.|.++..||................+.+        ....++++++||.+||+.||++|
T Consensus       189 ~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~--------p~~~s~~~~~li~~lL~~dp~~R  260 (345)
T 1xjd_A          189 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY--------PRWLEKEAKDLLVKLFVREPEKR  260 (345)
T ss_dssp             HHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------CTTSCHHHHHHHHHHSCSSGGGS
T ss_pred             hhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCC--------CcccCHHHHHHHHHHhcCCHhHc
Confidence            8877777778899999999988865555554332222222332222222        13478999999999999999999


Q ss_pred             CCHH-HHhcCCCCCCCC
Q psy8260         377 ITAE-QALAHPYLSQYS  392 (427)
Q Consensus       377 ~ta~-e~L~Hp~f~~~~  392 (427)
                      +|+. |+++||||+...
T Consensus       261 ~~~~~~i~~hp~f~~~~  277 (345)
T 1xjd_A          261 LGVRGDIRQHPLFREIN  277 (345)
T ss_dssp             BTTBSCGGGSGGGTTCC
T ss_pred             CCChHHHHcCccccCCC
Confidence            9998 999999998753

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.6e-44  Score=360.45  Aligned_cols=287  Identities=30%  Similarity=0.484  Sum_probs=205.4

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcccc
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  140 (427)
                      .....|.+.+.||+|+||.||.+. +..++ .||+|++.....      ...+|+++|+.++||||++++++|.......
T Consensus        37 ~~~~~Y~~~~~lG~G~~g~V~~a~-~~~~~-~~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  108 (394)
T 4e7w_A           37 QREIAYTNCKVIGNGSFGVVFQAK-LVESD-EVAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKK  108 (394)
T ss_dssp             EEEEEEEEEEEEEEETTEEEEEEE-ETTTE-EEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSS
T ss_pred             cccceEEEeEEEeeCCCeEEEEEE-ECCCC-eEEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCC
Confidence            345679999999999999999754 44444 489998754321      1237999999999999999999986544333


Q ss_pred             CCceEEEEeccCCCCHHHHHh-----hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEc-CCCCEEEeeCCC
Q psy8260         141 DFKNVYMVTHLMGADLNNILR-----TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN-EDCELKILDFGL  214 (427)
Q Consensus       141 ~~~~~~lv~e~~g~~L~~~l~-----~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~-~~~~~kl~DFGl  214 (427)
                      +...+++++|++.+++.+.+.     ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus       109 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~  188 (394)
T 4e7w_A          109 DEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGS  188 (394)
T ss_dssp             SCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             CceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence            445578999999887766543     45799999999999999999999999999999999999999 789999999999


Q ss_pred             CCCCCC--CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccc
Q psy8260         215 ARPTEN--EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWY  292 (427)
Q Consensus       215 a~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y  292 (427)
                      |+....  ....++||++|+|||++.+...|+..      .|+|+.||++.+                 +.+|.      
T Consensus       189 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~------~DiwSlG~il~e-----------------ll~g~------  239 (394)
T 4e7w_A          189 AKILIAGEPNVSYICSRYYRAPELIFGATNYTTN------IDIWSTGCVMAE-----------------LMQGQ------  239 (394)
T ss_dssp             CEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTH------HHHHHHHHHHHH-----------------HHHSS------
T ss_pred             cccccCCCCCcccccCcCccCHHHHcCCCCCCcH------HHHHHHHHHHHH-----------------HHhCC------
Confidence            975432  33456778888888877654444433      266666666544                 22221      


Q ss_pred             cchHHhhhccCCC-CCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcC-CCChhHHHHHHHhcC
Q psy8260         293 RAPEIMLNWMHYN-QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFK-GANPQAIDLLSLMLE  370 (427)
Q Consensus       293 ~APEvl~~~~~~~-~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~dLi~~mL~  370 (427)
                               ..+. ..+..++..++..+|+++.+.+.......   .....+......+...+. ..+++++|||.+||+
T Consensus       240 ---------~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  307 (394)
T 4e7w_A          240 ---------PLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNY---MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLE  307 (394)
T ss_dssp             ---------CSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGG---SSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred             ---------CCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh---hhhccccccCCcHHHhccccCCHHHHHHHHHHhC
Confidence                     1222 23445566666666666655433221100   001123333444555444 488999999999999


Q ss_pred             CCCCCCCCHHHHhcCCCCCCCCCCCC
Q psy8260         371 LDSEKRITAEQALAHPYLSQYSDPND  396 (427)
Q Consensus       371 ~dP~~R~ta~e~L~Hp~f~~~~~~~~  396 (427)
                      +||.+|||++|+|+||||++...+..
T Consensus       308 ~dP~~R~t~~e~l~hp~f~~~~~~~~  333 (394)
T 4e7w_A          308 YTPSARLTAIEALCHPFFDELRTGEA  333 (394)
T ss_dssp             SSGGGSCCHHHHHTSGGGSTTTSSCC
T ss_pred             CChhhCCCHHHHhcChhhhhhccccc
Confidence            99999999999999999998766543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4.1e-45  Score=355.68  Aligned_cols=265  Identities=30%  Similarity=0.463  Sum_probs=188.4

Q ss_pred             cCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccC
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      ..++|.+.+.||+|+||.||. +.+..+|+.||||++............+.+|+.+++.++||||+++++++...     
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----  105 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYK-AIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN-----  105 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEE-EEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET-----
T ss_pred             chhhEEEEEEEEecCCeEEEE-EEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC-----
Confidence            346799999999999999996 56778999999999976544444455677999999999999999999998754     


Q ss_pred             CceEEEEeccCCCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEc-----CCCCEEEeeCCCC
Q psy8260         142 FKNVYMVTHLMGADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN-----EDCELKILDFGLA  215 (427)
Q Consensus       142 ~~~~~lv~e~~g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~-----~~~~~kl~DFGla  215 (427)
                       ..+|+++|+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++     .++.+||+|||++
T Consensus       106 -~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          106 -HRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             -TEEEEEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             -CEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence             46899999999999998865 4699999999999999999999999999999999999994     4556999999988


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      +.......                                                          ......||+.|+||
T Consensus       185 ~~~~~~~~----------------------------------------------------------~~~~~~~t~~y~aP  206 (329)
T 3gbz_A          185 RAFGIPIR----------------------------------------------------------QFTHEIITLWYRPP  206 (329)
T ss_dssp             HHHC---------------------------------------------------------------------CCTTCCH
T ss_pred             cccCCccc----------------------------------------------------------ccCCCcCCccccCH
Confidence            64321100                                                          11123456666666


Q ss_pred             HHhhhcc-CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhc---------------------CCCCCcccHHh-
Q psy8260         296 EIMLNWM-HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINS---------------------LPLLTKKDFRQ-  352 (427)
Q Consensus       296 Evl~~~~-~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~-  352 (427)
                      |++.+.. +..++|+||+|++++.|.++..+|......+........                     .+......+.. 
T Consensus       207 E~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (329)
T 3gbz_A          207 EILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRV  286 (329)
T ss_dssp             HHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHH
T ss_pred             HHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhh
Confidence            6665533 455678999998887774444434222111111111111                     11111111222 


Q ss_pred             hcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q psy8260         353 VFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       353 ~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~  391 (427)
                      .....+++++|||.+||++||.+|||++|+|+||||++.
T Consensus       287 ~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  325 (329)
T 3gbz_A          287 LGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN  325 (329)
T ss_dssp             HGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred             cccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence            122368999999999999999999999999999999875

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.4e-45  Score=358.52  Aligned_cols=255  Identities=24%  Similarity=0.346  Sum_probs=193.8

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH-HHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA-VHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      .+.|.+.+.||+|+||.||. +.+..+|+.||||++.+..... .....+.+|+.+++.++||||+++++++...     
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~-a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----   81 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKL-ATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP-----   81 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEE-EEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS-----
T ss_pred             cCCEEEEEEEecCCCeEEEE-EEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----
Confidence            46799999999999999996 5677899999999986431111 1124577999999999999999999998754     


Q ss_pred             CceEEEEeccCCCCHHHHH-hhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         142 FKNVYMVTHLMGADLNNIL-RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       142 ~~~~~lv~e~~g~~L~~~l-~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                       ..+++++|+++++|.+.+ ..+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        82 -~~~~lv~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           82 -TDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             -SEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             -CEEEEEEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence             468999999998888766 457799999999999999999999999999999999999999999999999999875432


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      ..                                                           .....+||+.|+|||++.+
T Consensus       161 ~~-----------------------------------------------------------~~~~~~gt~~y~aPE~~~~  181 (336)
T 3h4j_B          161 GN-----------------------------------------------------------FLKTSCGSPNYAAPEVING  181 (336)
T ss_dssp             SB-----------------------------------------------------------TTCCCTTSTTTSCGGGSCC
T ss_pred             Cc-----------------------------------------------------------ccccccCCcCcCCHHHHcC
Confidence            11                                                           0112245566666666555


Q ss_pred             ccC-CCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH
Q psy8260         301 WMH-YNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA  379 (427)
Q Consensus       301 ~~~-~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta  379 (427)
                      ..+ ..++|+||+|++++.|.++..||.........    ....    ..........++++.+||.+||+.||.+|||+
T Consensus       182 ~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----~~i~----~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~  253 (336)
T 3h4j_B          182 KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----KKVN----SCVYVMPDFLSPGAQSLIRRMIVADPMQRITI  253 (336)
T ss_dssp             SGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----CCCC----SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCH
T ss_pred             CCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----HHHH----cCCCCCcccCCHHHHHHHHHHcCCChhHCcCH
Confidence            444 34579999999998876555555432211100    0000    00011224578999999999999999999999


Q ss_pred             HHHhcCCCCCCC
Q psy8260         380 EQALAHPYLSQY  391 (427)
Q Consensus       380 ~e~L~Hp~f~~~  391 (427)
                      +|+++||||+..
T Consensus       254 ~eil~hp~~~~~  265 (336)
T 3h4j_B          254 QEIRRDPWFNVN  265 (336)
T ss_dssp             HHHTTCHHHHTT
T ss_pred             HHHHhChhhccC
Confidence            999999999753

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.6e-44  Score=354.23  Aligned_cols=277  Identities=26%  Similarity=0.399  Sum_probs=198.7

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc--ccC
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC--LAD  141 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~--~~~  141 (427)
                      +.|.+.+.||+|+||.||. +.+..+|+.||||++............+.+|+.+++.++||||+++++++.....  ...
T Consensus        17 ~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFK-ARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEE-EEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             cceeEEEEEecCCCcEEEE-EEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            6799999999999999996 5577899999999986554433334567799999999999999999999865321  111


Q ss_pred             CceEEEEeccCCCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         142 FKNVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       142 ~~~~~lv~e~~g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                      ...+|+++|+++++|...+..  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        96 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~  175 (351)
T 3mi9_A           96 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS  175 (351)
T ss_dssp             -CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccc
Confidence            346899999998888887754  469999999999999999999999999999999999999999999999999987433


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      .....                                                      .........||+.|+|||++.
T Consensus       176 ~~~~~------------------------------------------------------~~~~~~~~~gt~~y~aPE~~~  201 (351)
T 3mi9_A          176 LAKNS------------------------------------------------------QPNRYTNRVVTLWYRPPELLL  201 (351)
T ss_dssp             CCSSS------------------------------------------------------SCCCCCSSCSCGGGCCHHHHT
T ss_pred             ccccc------------------------------------------------------cccccCCcccccCccCchhhc
Confidence            21100                                                      000122345777888888776


Q ss_pred             hc-cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCccc----------------------HHhhc--
Q psy8260         300 NW-MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKD----------------------FRQVF--  354 (427)
Q Consensus       300 ~~-~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~--  354 (427)
                      +. .+..++|+||+|++++.|.++..+|.......................                      ....+  
T Consensus       202 ~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (351)
T 3mi9_A          202 GERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKA  281 (351)
T ss_dssp             TCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHH
T ss_pred             CCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhh
Confidence            53 355667999999998877444443332211111111111000000000                      00000  


Q ss_pred             CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q psy8260         355 KGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPN  395 (427)
Q Consensus       355 ~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~  395 (427)
                      ...+++++|||.+||++||++|||++|+|+||||.....|.
T Consensus       282 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  322 (351)
T 3mi9_A          282 YVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS  322 (351)
T ss_dssp             HHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCC
T ss_pred             ccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcc
Confidence            01378899999999999999999999999999998765554

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.9e-45  Score=364.14  Aligned_cols=267  Identities=20%  Similarity=0.251  Sum_probs=197.6

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH-HHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA-VHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      .+..+.|++.+.||+|+||.||. +.+..+|+.||||++.+..... .....+.+|..++..++||||++++++|...  
T Consensus        57 ~~~~~~f~~~~~lG~G~fG~V~~-~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~--  133 (412)
T 2vd5_A           57 RLQRDDFEILKVIGRGAFSEVAV-VKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE--  133 (412)
T ss_dssp             SCCGGGEEEEEEEEECSSCEEEE-EEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS--
T ss_pred             cCChhhEEEEEEEeeCCCeEEEE-EEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC--
Confidence            45567899999999999999996 4567799999999986421111 1122366899999999999999999998754  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                          ..+|++||++ |++|.+++..  ..+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||++
T Consensus       134 ----~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla  209 (412)
T 2vd5_A          134 ----NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSC  209 (412)
T ss_dssp             ----SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             ----CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhh
Confidence                4689999998 8899998865  47999999999999999999999999999999999999999999999999998


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      +........                                                         .....+||+.|+||
T Consensus       210 ~~~~~~~~~---------------------------------------------------------~~~~~~Gt~~Y~AP  232 (412)
T 2vd5_A          210 LKLRADGTV---------------------------------------------------------RSLVAVGTPDYLSP  232 (412)
T ss_dssp             EECCTTSCE---------------------------------------------------------ECSSCCSCGGGCCH
T ss_pred             eeccCCCcc---------------------------------------------------------ccceeccccCcCCH
Confidence            754321100                                                         01123456666666


Q ss_pred             HHhhh-------ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHh
Q psy8260         296 EIMLN-------WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLM  368 (427)
Q Consensus       296 Evl~~-------~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~m  368 (427)
                      |++..       ..+..++|+||+|+++++|.++..||..........+........   .+......++++++|||.+|
T Consensus       233 E~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~---~~p~~~~~~s~~~~dli~~l  309 (412)
T 2vd5_A          233 EILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL---SLPLVDEGVPEEARDFIQRL  309 (412)
T ss_dssp             HHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC---CCC----CCCHHHHHHHHTT
T ss_pred             HHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCc---CCCccccCCCHHHHHHHHHH
Confidence            66552       235667799999999988866665664432222222222110000   01112246799999999999


Q ss_pred             cCCCCCCCC---CHHHHhcCCCCCCCCCC
Q psy8260         369 LELDSEKRI---TAEQALAHPYLSQYSDP  394 (427)
Q Consensus       369 L~~dP~~R~---ta~e~L~Hp~f~~~~~~  394 (427)
                      |+ ||.+|+   |++|+++||||+.....
T Consensus       310 L~-~p~~Rlgr~~~~ei~~Hpff~~i~w~  337 (412)
T 2vd5_A          310 LC-PPETRLGRGGAGDFRTHPFFFGLDWD  337 (412)
T ss_dssp             SS-CGGGCTTTTTHHHHHTSGGGTTCCST
T ss_pred             cC-ChhhcCCCCCHHHHhcCCCcCCCCHH
Confidence            99 999985   99999999999876443

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-44  Score=360.04  Aligned_cols=284  Identities=31%  Similarity=0.550  Sum_probs=205.3

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc-
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL-  139 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~-  139 (427)
                      ...+.|.+.+.||+|+||.||. +.+..+|+.||||++.....      ...+|+++|+.++|||||+++++|...... 
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~-a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   76 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCE-VFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE   76 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEE-EEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred             cccceEEEEEEEEeccCEEEEE-EEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence            3456799999999999999996 56778999999998864321      123799999999999999999998543210 


Q ss_pred             -------------------------------cCCceEEEEeccCCCCHHHHHh-----hCCCCHHHHHHHHHHHHHHHHH
Q psy8260         140 -------------------------------ADFKNVYMVTHLMGADLNNILR-----TQKLSDDHVQFLVYQILRGLKY  183 (427)
Q Consensus       140 -------------------------------~~~~~~~lv~e~~g~~L~~~l~-----~~~l~~~~~~~~~~qi~~aL~y  183 (427)
                                                     .+...++++||+++++|.+.+.     ...+++..+..++.||+.||.|
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             ---------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                           2234588999999888887764     2579999999999999999999


Q ss_pred             HHhcCceeccCCCCCeEEc-CCCCEEEeeCCCCCCCCC--CcccccccccccchhhhhcccccCCCCcceeeccCCcccc
Q psy8260         184 IHSAGIIHRDLKPSNIAVN-EDCELKILDFGLARPTEN--EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNI  260 (427)
Q Consensus       184 LH~~~iiHrDLKp~NILl~-~~~~~kl~DFGla~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~  260 (427)
                      ||++||+||||||+|||++ .++.+||+|||+|+....  ......||+.|+|||++.+...|+..      .|+|+.||
T Consensus       157 LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~------~DiwslG~  230 (383)
T 3eb0_A          157 IHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPS------IDLWSIGC  230 (383)
T ss_dssp             HHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTH------HHHHHHHH
T ss_pred             HHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcc------hhhhhHHH
Confidence            9999999999999999998 688999999999975432  34456778888888887764444433      37777776


Q ss_pred             cccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCC-CCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHH
Q psy8260         261 AVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYN-QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYI  339 (427)
Q Consensus       261 ~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~-~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~  339 (427)
                      ++.+                 +.+|.               ..+. ..+..++..++..+|+++.+.+........   .
T Consensus       231 il~e-----------------ll~g~---------------~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~---~  275 (383)
T 3eb0_A          231 VFGE-----------------LILGK---------------PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYT---E  275 (383)
T ss_dssp             HHHH-----------------HHHSS---------------CSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC-----
T ss_pred             HHHH-----------------HHhCC---------------CCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccc---c
Confidence            6654                 22221               1222 234556666667777776654433211100   0


Q ss_pred             hcCCCCCcccHHhhc-CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q psy8260         340 NSLPLLTKKDFRQVF-KGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYS  392 (427)
Q Consensus       340 ~~~~~~~~~~~~~~~-~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~  392 (427)
                      ...+......+...+ ...+++++|||.+||++||.+|+|++|+|+||||+++.
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  329 (383)
T 3eb0_A          276 VRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLR  329 (383)
T ss_dssp             CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHHH
T ss_pred             ccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHHH
Confidence            012333344455544 34789999999999999999999999999999998643

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.8e-45  Score=347.96  Aligned_cols=259  Identities=23%  Similarity=0.368  Sum_probs=189.0

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH------------------------HHHHHHHHHHHHH
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA------------------------VHAKRTYRELRML  118 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~------------------------~~~~~~~~Ei~~l  118 (427)
                      .+.|.+.+.||+|+||.||. +.+..+|+.||||++.......                        ...+.+.+|+++|
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~-a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   90 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKL-AYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL   90 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEE-EEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEE-EEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence            46789999999999999996 5677889999999986542111                        1134577999999


Q ss_pred             hcCCCCCceeeeeeeecCccccCCceEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCC
Q psy8260         119 KHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPS  197 (427)
Q Consensus       119 ~~l~HpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~  197 (427)
                      +.++||||+++++++...    ....+|++||++ +++|.+++....+++..+..++.|++.||.|||++||+||||||+
T Consensus        91 ~~l~h~~iv~~~~~~~~~----~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~  166 (298)
T 2zv2_A           91 KKLDHPNVVKLVEVLDDP----NEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS  166 (298)
T ss_dssp             HTCCCTTBCCEEEEEECS----SSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred             HhCCCCCCCeEEEEEEcC----CCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence            999999999999998652    124689999998 678887776778999999999999999999999999999999999


Q ss_pred             CeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCC
Q psy8260         198 NIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLAR  277 (427)
Q Consensus       198 NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~  277 (427)
                      |||++.++.+||+|||+++.......                                                      
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~~~~------------------------------------------------------  192 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKGSDA------------------------------------------------------  192 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSSC------------------------------------------------------
T ss_pred             HEEECCCCCEEEecCCCccccccccc------------------------------------------------------
Confidence            99999999999999999875432110                                                      


Q ss_pred             CCccccccccccccccchHHhhhcc---CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhc
Q psy8260         278 PTENEMTGYVATRWYRAPEIMLNWM---HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF  354 (427)
Q Consensus       278 ~~~~~~~~~~gt~~Y~APEvl~~~~---~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (427)
                          ......||+.|+|||++.+..   ...++|+||+|++++.|.++..||...................+      ..
T Consensus       193 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------~~  262 (298)
T 2zv2_A          193 ----LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFP------DQ  262 (298)
T ss_dssp             ----EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC------SS
T ss_pred             ----cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCCC------Cc
Confidence                011223555555555554332   13346999999999887555555533211111111111111111      12


Q ss_pred             CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q psy8260         355 KGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQ  390 (427)
Q Consensus       355 ~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~  390 (427)
                      ..+++++.+||.+||+.||.+|||++|+|+||||++
T Consensus       263 ~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          263 PDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             cccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence            357889999999999999999999999999999853

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.9e-44  Score=354.52  Aligned_cols=258  Identities=19%  Similarity=0.250  Sum_probs=200.8

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCcc
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTC  138 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~  138 (427)
                      +..+.|.+.+.||+|+||.||. +.+..+|+.||||++.+... .....+...+|..+|..+ +||||++++++|...  
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~-~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--   93 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVML-SERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--   93 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEE-EEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS--
T ss_pred             CchHHcEEEEEEeeCCCEEEEE-EEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC--
Confidence            4457799999999999999996 45667899999999865321 011234567899999988 899999999998754  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                          ..+|++||++ |++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        94 ----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~  169 (353)
T 2i0e_A           94 ----DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK  169 (353)
T ss_dssp             ----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             ----CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence                4689999998 7899988864 679999999999999999999999999999999999999999999999999987


Q ss_pred             CCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         217 PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       217 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      ......                                                          ......+||+.|+|||
T Consensus       170 ~~~~~~----------------------------------------------------------~~~~~~~gt~~y~aPE  191 (353)
T 2i0e_A          170 ENIWDG----------------------------------------------------------VTTKTFCGTPDYIAPE  191 (353)
T ss_dssp             CCCCTT----------------------------------------------------------CCBCCCCSCGGGCCHH
T ss_pred             ccccCC----------------------------------------------------------cccccccCCccccChh
Confidence            421110                                                          0112346788888888


Q ss_pred             HhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCC
Q psy8260         297 IMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKR  376 (427)
Q Consensus       297 vl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R  376 (427)
                      ++.+..+...+|+||+|++++.|.++..||..........+.......+        ....++++++||.+||+.||.+|
T Consensus       192 ~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~--------p~~~s~~~~~li~~lL~~dP~~R  263 (353)
T 2i0e_A          192 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY--------PKSMSKEAVAICKGLMTKHPGKR  263 (353)
T ss_dssp             HHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------CTTSCHHHHHHHHHHTCSCTTSC
T ss_pred             hhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCC--------CCCCCHHHHHHHHHHhhcCHHHc
Confidence            8877777778899999999988865555554332222233333322222        23578999999999999999999


Q ss_pred             C-----CHHHHhcCCCCCCC
Q psy8260         377 I-----TAEQALAHPYLSQY  391 (427)
Q Consensus       377 ~-----ta~e~L~Hp~f~~~  391 (427)
                      +     +++|+++||||+..
T Consensus       264 ~~~~~~~~~~i~~h~~f~~~  283 (353)
T 2i0e_A          264 LGCGPEGERDIKEHAFFRYI  283 (353)
T ss_dssp             TTCSTTHHHHHHTSGGGTTC
T ss_pred             CCCCCCCHHHHhcCccccCC
Confidence            9     47999999999865

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.1e-43  Score=347.67  Aligned_cols=323  Identities=33%  Similarity=0.582  Sum_probs=214.8

Q ss_pred             cCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC---------CHHHHHHHHHHHHHHhcCCCCCceeeeee
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ---------SAVHAKRTYRELRMLKHMNHENVIGLLDV  132 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~---------~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~  132 (427)
                      ..+.|.+.+.||+|+||.||.+. +. +|+.||||++.....         .....+.+.+|+++++.++||||++++++
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~-~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   97 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGV-DS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI   97 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEE-CT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             hccceEEeEEeccCCCEEEEEEE-CC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence            34678999999999999999654 43 499999998864322         22334678899999999999999999999


Q ss_pred             eecCccccCCceEEEEeccCCCCHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEe
Q psy8260         133 FHSNTCLADFKNVYMVTHLMGADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKIL  210 (427)
Q Consensus       133 ~~~~~~~~~~~~~~lv~e~~g~~L~~~l~~~--~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~  210 (427)
                      +..... .....+|+++++++++|.+.+...  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus        98 ~~~~~~-~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~  176 (362)
T 3pg1_A           98 FVHFEE-PAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC  176 (362)
T ss_dssp             EEECCT-TTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             EEeccC-CCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEE
Confidence            854321 223468999999999998887654  59999999999999999999999999999999999999999999999


Q ss_pred             eCCCCCCCCC--CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccc
Q psy8260         211 DFGLARPTEN--EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVA  288 (427)
Q Consensus       211 DFGla~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~g  288 (427)
                      |||+++....  ......||++|+|||++.+...++..      .|+|+.||++.+                 +.++   
T Consensus       177 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~------~DiwslG~il~~-----------------l~~g---  230 (362)
T 3pg1_A          177 DFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKL------VDMWSAGCVMAE-----------------MFNR---  230 (362)
T ss_dssp             CTTC---------------CGGGCCHHHHTTCTTCCTH------HHHHHHHHHHHH-----------------HHHS---
T ss_pred             ecCcccccccccccceecccceecCcHHhcCCCCCCcH------hHHHhHHHHHHH-----------------HHhC---
Confidence            9999974332  22334556666666665432222211      244444443322                 1111   


Q ss_pred             cccccchHHhhhccCCCCC-CHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHh-cCCCCCcccHHhhcCCCChhHHHHHH
Q psy8260         289 TRWYRAPEIMLNWMHYNQT-DIHQLNLIMEMLGTPPAEFMAKISSDSARKYIN-SLPLLTKKDFRQVFKGANPQAIDLLS  366 (427)
Q Consensus       289 t~~Y~APEvl~~~~~~~~~-d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~dLi~  366 (427)
                                  ...+.+. +...+..+...+|.++.+............+.. .........+.......++++.+||.
T Consensus       231 ------------~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  298 (362)
T 3pg1_A          231 ------------KALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIA  298 (362)
T ss_dssp             ------------SCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHH
T ss_pred             ------------CCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHH
Confidence                        0111111 222233333334444433332222222222222 22333444566677788999999999


Q ss_pred             HhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCcccccCCCCHHHHHHHHhhhc
Q psy8260         367 LMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKGTYSLES  425 (427)
Q Consensus       367 ~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (427)
                      +||++||.+|||++|+|+||||+....|.+......-...++....++..+...+..|.
T Consensus       299 ~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~  357 (362)
T 3pg1_A          299 KMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGLSERFHFDESVTDVYDMHKIFTAEV  357 (362)
T ss_dssp             HHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGTTTCCCCCCCCTTCCCHHHHHHHHHHHH
T ss_pred             HHhcCChhhCCCHHHHHcCchhhhccCccccccccccccChhhhhhhHHHHHHHHHHHH
Confidence            99999999999999999999999987775544333333345567777888887776654

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.6e-44  Score=343.60  Aligned_cols=266  Identities=27%  Similarity=0.424  Sum_probs=193.9

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      ++|.+.+.||+|+||.||. +.+..+|+.||||++..........+.+.+|++++++++||||+++++++...      .
T Consensus         3 ~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~   75 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFK-CRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK------R   75 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEE-EEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET------T
T ss_pred             ccceEeeEEeecCCeEEEE-EEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC------C
Confidence            4688899999999999996 55677899999999876655555566778999999999999999999998653      4


Q ss_pred             eEEEEeccCC-CCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         144 NVYMVTHLMG-ADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       144 ~~~lv~e~~g-~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      ..+++++++. ++|..++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           76 RLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             EEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             eEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence            6789999885 567777653 56999999999999999999999999999999999999999999999999998643221


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh-
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN-  300 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~-  300 (427)
                      ..                                                          ......||+.|+|||++.+ 
T Consensus       156 ~~----------------------------------------------------------~~~~~~~~~~y~aPE~~~~~  177 (311)
T 4agu_A          156 SD----------------------------------------------------------YYDDEVATRWYRSPELLVGD  177 (311)
T ss_dssp             --------------------------------------------------------------------GGGCCHHHHHTC
T ss_pred             cc----------------------------------------------------------ccCCCcCCccccChHHHhcC
Confidence            10                                                          0112346666777777655 


Q ss_pred             ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhc----------------------CCC-CCcccHHhhcCCC
Q psy8260         301 WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINS----------------------LPL-LTKKDFRQVFKGA  357 (427)
Q Consensus       301 ~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~----------------------~~~-~~~~~~~~~~~~~  357 (427)
                      ..+..++|+||+|++++.+.++..+|......+........                      .+. .........++.+
T Consensus       178 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (311)
T 4agu_A          178 TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNI  257 (311)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTC
T ss_pred             CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccc
Confidence            33455679999999987774443333221111111110000                      000 0111233345678


Q ss_pred             ChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q psy8260         358 NPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDP  394 (427)
Q Consensus       358 s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  394 (427)
                      ++++.+||.+||+.||.+|||++|+|+||||++....
T Consensus       258 ~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  294 (311)
T 4agu_A          258 SYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI  294 (311)
T ss_dssp             CHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred             cHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence            8999999999999999999999999999999987554

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=9.5e-45  Score=356.46  Aligned_cols=260  Identities=25%  Similarity=0.350  Sum_probs=198.8

Q ss_pred             cCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcC---CCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPF---QSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      ..+.|.+.+.||+|+||.||. +.+..+|+.||||++....   ......+.+.+|+.+++.++||||+++++++...  
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--   98 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRR-CINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD--   98 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEE-EEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET--
T ss_pred             cccceEEeeEEeeCCCEEEEE-EEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--
Confidence            346789999999999999996 5677899999999885321   1111245678999999999999999999998653  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCC---CEEE
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRT-----QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC---ELKI  209 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~---~~kl  209 (427)
                          ..+|++||++ |++|.+.+..     ..+++..+..++.||+.||.|||++||+||||||+|||++.++   .+||
T Consensus        99 ----~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl  174 (351)
T 3c0i_A           99 ----GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKL  174 (351)
T ss_dssp             ----TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEE
T ss_pred             ----CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEE
Confidence                4689999998 6899776642     2489999999999999999999999999999999999998655   4999


Q ss_pred             eeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccc
Q psy8260         210 LDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT  289 (427)
Q Consensus       210 ~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt  289 (427)
                      +|||+++.......                                                          .....+||
T Consensus       175 ~Dfg~a~~~~~~~~----------------------------------------------------------~~~~~~gt  196 (351)
T 3c0i_A          175 GGFGVAIQLGESGL----------------------------------------------------------VAGGRVGT  196 (351)
T ss_dssp             CCCTTCEECCTTSC----------------------------------------------------------BCCCCCSC
T ss_pred             ecCcceeEecCCCe----------------------------------------------------------eecCCcCC
Confidence            99999864322100                                                          11234578


Q ss_pred             ccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhc
Q psy8260         290 RWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLML  369 (427)
Q Consensus       290 ~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL  369 (427)
                      +.|+|||++.+..+..++|+||+|++++.|.++..||.... ...............    ...+..+++++++||.+||
T Consensus       197 ~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~----~~~~~~~s~~~~~li~~~L  271 (351)
T 3c0i_A          197 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMN----PRQWSHISESAKDLVRRML  271 (351)
T ss_dssp             GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCC----HHHHTTSCHHHHHHHHHHT
T ss_pred             cCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCC----ccccccCCHHHHHHHHHHC
Confidence            88888888877777778899999999988866555553321 111222222221111    2334678999999999999


Q ss_pred             CCCCCCCCCHHHHhcCCCCCCC
Q psy8260         370 ELDSEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       370 ~~dP~~R~ta~e~L~Hp~f~~~  391 (427)
                      +.||++|||++|+|+||||.+.
T Consensus       272 ~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          272 MLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             CSSTTTSCCHHHHHTSHHHHTH
T ss_pred             CCChhHCcCHHHHhcChhhcCC
Confidence            9999999999999999999753

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=7.1e-44  Score=350.17  Aligned_cols=254  Identities=24%  Similarity=0.331  Sum_probs=200.0

Q ss_pred             cCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC-HHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcccc
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS-AVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  140 (427)
                      ..+.|++.+.||+|+||.||. +.+..+|+.||||++.+.... ....+.+.+|+++|+.++||||++++++|...    
T Consensus        39 ~~~~y~~~~~lG~G~~g~V~~-~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----  113 (350)
T 1rdq_E           39 QLDQFDRIKTLGTGSFGRVML-VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN----  113 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEE-EEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS----
T ss_pred             CHHHCEEEEEeecCcCcEEEE-EEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC----
Confidence            346799999999999999996 456778999999998643211 11235577899999999999999999998754    


Q ss_pred             CCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCC
Q psy8260         141 DFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT  218 (427)
Q Consensus       141 ~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~  218 (427)
                        ..+|++||++ |++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       114 --~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~  191 (350)
T 1rdq_E          114 --SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV  191 (350)
T ss_dssp             --SEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             --CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceec
Confidence              4689999998 7899988864 67999999999999999999999999999999999999999999999999998754


Q ss_pred             CCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         219 ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       219 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                      .....                                                             ..+||+.|+|||++
T Consensus       192 ~~~~~-------------------------------------------------------------~~~gt~~y~aPE~~  210 (350)
T 1rdq_E          192 KGRTW-------------------------------------------------------------TLCGTPEALAPEII  210 (350)
T ss_dssp             SSCBC-------------------------------------------------------------CCEECGGGCCHHHH
T ss_pred             cCCcc-------------------------------------------------------------cccCCccccCHHHh
Confidence            32222                                                             23466777777777


Q ss_pred             hhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC
Q psy8260         299 LNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT  378 (427)
Q Consensus       299 ~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t  378 (427)
                      .+..+...+|+||+|++++.|.++..||..........+.......+        ....++++.+||.+||+.||.+|++
T Consensus       211 ~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~--------p~~~~~~~~~li~~lL~~dp~~R~~  282 (350)
T 1rdq_E          211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--------PSHFSSDLKDLLRNLLQVDLTKRFG  282 (350)
T ss_dssp             TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------CTTCCHHHHHHHHHHSCSCTTTCTT
T ss_pred             cCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCC--------CCCCCHHHHHHHHHHhhcCHHhccC
Confidence            66667777899999999988865555554332222222333222211        2356899999999999999999998


Q ss_pred             -----HHHHhcCCCCCCC
Q psy8260         379 -----AEQALAHPYLSQY  391 (427)
Q Consensus       379 -----a~e~L~Hp~f~~~  391 (427)
                           ++|+++||||...
T Consensus       283 ~~~~~~~ei~~h~~f~~~  300 (350)
T 1rdq_E          283 NLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             SSTTTTHHHHTSGGGTTC
T ss_pred             CccCCHHHHHhCcCcCCC
Confidence                 9999999999864

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=4.3e-44  Score=353.21  Aligned_cols=256  Identities=21%  Similarity=0.299  Sum_probs=188.8

Q ss_pred             cCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccC
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      ..++|.+.+.||+|+||.||. +.+..+|+.||||++......   ...+.+|+.+++.++||||+++++++...     
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~-~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----   88 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARL-MRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKEVILTP-----   88 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEE-EEETTTCCEEEEEEEESSTTS---CHHHHHHHHHHHHCCCTTBCCEEEEEECS-----
T ss_pred             CCCcEEEEEEeccCCCEEEEE-EEECCCCcEEEEEEEecCccc---cHHHHHHHHHHHhCCCCCCCcEEEEEeeC-----
Confidence            346799999999999999995 567789999999998754322   24467899999999999999999998754     


Q ss_pred             CceEEEEeccC-CCCHHHHHh-hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCC--EEEeeCCCCCC
Q psy8260         142 FKNVYMVTHLM-GADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE--LKILDFGLARP  217 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l~-~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~--~kl~DFGla~~  217 (427)
                       ..+|+++|++ +++|.+++. .+.+++..+..++.|++.||.|||++||+||||||+|||++.++.  +||+|||+++.
T Consensus        89 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~  167 (361)
T 3uc3_A           89 -THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS  167 (361)
T ss_dssp             -SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred             -CEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence             4678999998 789988875 467999999999999999999999999999999999999987665  99999999863


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      .....                                                           .....+||+.|+|||+
T Consensus       168 ~~~~~-----------------------------------------------------------~~~~~~gt~~y~aPE~  188 (361)
T 3uc3_A          168 SVLHS-----------------------------------------------------------QPKSTVGTPAYIAPEV  188 (361)
T ss_dssp             ------------------------------------------------------------------------CTTSCHHH
T ss_pred             ccccC-----------------------------------------------------------CCCCCcCCCCcCChhh
Confidence            21110                                                           0112346677777777


Q ss_pred             hhhccCCCC-CCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHH----HhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         298 MLNWMHYNQ-TDIHQLNLIMEMLGTPPAEFMAKISSDSARKY----INSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       298 l~~~~~~~~-~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                      +.+..+... +|+||+|++++.|.++..||..........+.    .......+      .....++++++||.+||+.|
T Consensus       189 ~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~s~~~~~li~~~L~~d  262 (361)
T 3uc3_A          189 LLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIP------DDIRISPECCHLISRIFVAD  262 (361)
T ss_dssp             HHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCC------TTSCCCHHHHHHHHHHSCSC
T ss_pred             hcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCC------CcCCCCHHHHHHHHHHccCC
Confidence            666555544 69999999998875554444332211111111    11111111      11246899999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCCC
Q psy8260         373 SEKRITAEQALAHPYLSQYS  392 (427)
Q Consensus       373 P~~R~ta~e~L~Hp~f~~~~  392 (427)
                      |.+|||++|+++||||.+..
T Consensus       263 P~~Rps~~ell~hp~f~~~~  282 (361)
T 3uc3_A          263 PATRISIPEIKTHSWFLKNL  282 (361)
T ss_dssp             TTTSCCHHHHHTSHHHHTTC
T ss_pred             hhHCcCHHHHHhCcchhcCC
Confidence            99999999999999997653

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-44  Score=350.70  Aligned_cols=268  Identities=29%  Similarity=0.460  Sum_probs=191.5

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHH---HHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAV---HAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      .+.|.+.+.||+|+||.||. +.+..+|+.||||++........   ....+.+|+.+++.++||||+++++++...   
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---   84 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYK-ARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK---   84 (346)
T ss_dssp             ----CEEEEEEEETTEEEEE-EECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT---
T ss_pred             hcccEEEeEEeecCCEEEEE-EEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC---
Confidence            35688999999999999996 55677899999999865322211   123567999999999999999999998643   


Q ss_pred             cCCceEEEEeccCCCCHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCC
Q psy8260         140 ADFKNVYMVTHLMGADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP  217 (427)
Q Consensus       140 ~~~~~~~lv~e~~g~~L~~~l~~~--~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~  217 (427)
                         ...++++++++++|..++...  .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        85 ---~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           85 ---SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             ---TCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             ---CceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence               457899999988999888654  489999999999999999999999999999999999999999999999999875


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      ......                                                          .....+||+.|+|||+
T Consensus       162 ~~~~~~----------------------------------------------------------~~~~~~~t~~y~aPE~  183 (346)
T 1ua2_A          162 FGSPNR----------------------------------------------------------AYTHQVVTRWYRAPEL  183 (346)
T ss_dssp             TTSCCC----------------------------------------------------------CCCCSCCCCTTCCHHH
T ss_pred             ccCCcc----------------------------------------------------------cCCcccccccccCchH
Confidence            432110                                                          0112245566666666


Q ss_pred             hhhcc-CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhc--C------------------CCCCcccHHhhcCC
Q psy8260         298 MLNWM-HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINS--L------------------PLLTKKDFRQVFKG  356 (427)
Q Consensus       298 l~~~~-~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~--~------------------~~~~~~~~~~~~~~  356 (427)
                      +.+.. +..++|+||+|++++.|.++..+|...............  .                  ...+...+...+..
T Consensus       184 ~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (346)
T 1ua2_A          184 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSA  263 (346)
T ss_dssp             HTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTT
T ss_pred             hhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhcc
Confidence            54432 344568899988887664433333221111111111111  0                  01112234455677


Q ss_pred             CChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q psy8260         357 ANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPN  395 (427)
Q Consensus       357 ~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~  395 (427)
                      .+++++|||.+||+.||.+|||++|+|+||||.+...|.
T Consensus       264 ~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~  302 (346)
T 1ua2_A          264 AGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT  302 (346)
T ss_dssp             CCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred             CCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCC
Confidence            889999999999999999999999999999998765554

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=5e-44  Score=346.73  Aligned_cols=271  Identities=22%  Similarity=0.337  Sum_probs=198.0

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc-----
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC-----  138 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~-----  138 (427)
                      +.|++.+.||+|+||.||+ +.+..+|+.||||++.... .....+.+.+|+++|++++|||||+++++|.....     
T Consensus         6 ~~y~~~~~lG~G~~g~V~~-a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFE-AKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEE-EEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hcCceeeEecCCCCeEEEE-EEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            5688999999999999996 4567789999999986543 33345678899999999999999999998754311     


Q ss_pred             ----------------------------------------------ccCCceEEEEeccC-CCCHHHHHhhC----CCCH
Q psy8260         139 ----------------------------------------------LADFKNVYMVTHLM-GADLNNILRTQ----KLSD  167 (427)
Q Consensus       139 ----------------------------------------------~~~~~~~~lv~e~~-g~~L~~~l~~~----~l~~  167 (427)
                                                                    ......++++||++ +++|.+++...    ..++
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                          01112478999988 67999998753    2566


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCC
Q psy8260         168 DHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTG  247 (427)
Q Consensus       168 ~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~  247 (427)
                      ..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...........    ..|.            
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~----~~~~------------  227 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV----LTPM------------  227 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------------------
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccc----cccc------------
Confidence            678899999999999999999999999999999999999999999999755432110000    0000            


Q ss_pred             cceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHH
Q psy8260         248 VPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFM  327 (427)
Q Consensus       248 ~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~  327 (427)
                                                    .......+..||+.|+|||++.+..+..++|+||+|++++.|.++..++.
T Consensus       228 ------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~  277 (332)
T 3qd2_B          228 ------------------------------PAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM  277 (332)
T ss_dssp             ----------------------------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred             ------------------------------cccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence                                          00012335679999999999998888888899999999988866554432


Q ss_pred             hhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q psy8260         328 AKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~  391 (427)
                      ...  ...... .. ...     ...+...++++.+||.+||+.||.+|||++|+|+||||+++
T Consensus       278 ~~~--~~~~~~-~~-~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          278 ERV--RIITDV-RN-LKF-----PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             HHH--HHHHHH-HT-TCC-----CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             HHH--HHHHHh-hc-cCC-----CcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence            211  011111 11 111     11223346888999999999999999999999999999863

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=4.9e-44  Score=345.37  Aligned_cols=254  Identities=23%  Similarity=0.285  Sum_probs=194.0

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCccc
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~  139 (427)
                      +..+.|.+.+.||+|+||.||+ +.+..+|+.||||++...........+..+|+..+..+ +||||+++++++...   
T Consensus        54 ~~~~~y~~~~~LG~G~~g~Vy~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~---  129 (311)
T 3p1a_A           54 FFQQSFQRLSRLGHGSYGEVFK-VRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG---  129 (311)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEE-EEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---
T ss_pred             hhhhheeeeheeccCCCeEEEE-EEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC---
Confidence            3346799999999999999996 45677899999999876655666666667777666655 999999999998643   


Q ss_pred             cCCceEEEEeccCCCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCC
Q psy8260         140 ADFKNVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP  217 (427)
Q Consensus       140 ~~~~~~~lv~e~~g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~  217 (427)
                         ..+|+++|+++++|.+.+..  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       130 ---~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~  206 (311)
T 3p1a_A          130 ---GILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE  206 (311)
T ss_dssp             ---TEEEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred             ---CEEEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeee
Confidence               56899999999999887754  4599999999999999999999999999999999999999999999999999864


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      .....                                                           ......||+.|+|||+
T Consensus       207 ~~~~~-----------------------------------------------------------~~~~~~gt~~y~aPE~  227 (311)
T 3p1a_A          207 LGTAG-----------------------------------------------------------AGEVQEGDPRYMAPEL  227 (311)
T ss_dssp             CC-----------------------------------------------------------------CCCCCGGGCCGGG
T ss_pred             cccCC-----------------------------------------------------------CCcccCCCccccCHhH
Confidence            32210                                                           0112246777777777


Q ss_pred             hhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC
Q psy8260         298 MLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI  377 (427)
Q Consensus       298 l~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~  377 (427)
                      +.+ .+..++|+||+|++++.+.++..++...   ...... .. ...    ........++++.+||.+||+.||++||
T Consensus       228 ~~~-~~~~~~DiwslG~il~el~~g~~~~~~~---~~~~~~-~~-~~~----~~~~~~~~~~~l~~li~~~L~~dP~~Rp  297 (311)
T 3p1a_A          228 LQG-SYGTAADVFSLGLTILEVACNMELPHGG---EGWQQL-RQ-GYL----PPEFTAGLSSELRSVLVMMLEPDPKLRA  297 (311)
T ss_dssp             GGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH---HHHHHH-TT-TCC----CHHHHTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred             hcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc---cHHHHH-hc-cCC----CcccccCCCHHHHHHHHHHcCCChhhCc
Confidence            665 4666779999999987774432111111   111111 11 111    1233456789999999999999999999


Q ss_pred             CHHHHhcCCCCCC
Q psy8260         378 TAEQALAHPYLSQ  390 (427)
Q Consensus       378 ta~e~L~Hp~f~~  390 (427)
                      |++|+|+||||++
T Consensus       298 t~~ell~hp~~~~  310 (311)
T 3p1a_A          298 TAEALLALPVLRQ  310 (311)
T ss_dssp             CHHHHHTSGGGSC
T ss_pred             CHHHHHhCccccC
Confidence            9999999999975

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=4.9e-44  Score=347.39  Aligned_cols=259  Identities=21%  Similarity=0.300  Sum_probs=195.4

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      +.|.+.+.||+|+||.||. +.+..+++.||||++..... ....+.+.+|+.+++.++||||+++++++...      .
T Consensus         7 ~~y~i~~~lG~G~~g~V~~-~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~   78 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREG------N   78 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEE-EEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECS------S
T ss_pred             hhceeeeEEecCCCEEEEE-EEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecC------C
Confidence            5789999999999999996 56677899999999864322 22235577999999999999999999998654      4


Q ss_pred             eEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      ..|+++|++ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           79 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             eEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence            678999988 6799888765 46999999999999999999999999999999999999999999999999998643211


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      ...                                                        ......+||+.|+|||++.+.
T Consensus       159 ~~~--------------------------------------------------------~~~~~~~gt~~y~aPE~~~~~  182 (323)
T 3tki_A          159 NRE--------------------------------------------------------RLLNKMCGTLPYVAPELLKRR  182 (323)
T ss_dssp             TEE--------------------------------------------------------CCBCSCCSCGGGSCHHHHHCS
T ss_pred             Ccc--------------------------------------------------------cccCCCccCcCccCcHHhccC
Confidence            000                                                        011234577778888877665


Q ss_pred             cC-CCCCCHHHHHHHHHHhCCCCHHHHhhcCc-HHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH
Q psy8260         302 MH-YNQTDIHQLNLIMEMLGTPPAEFMAKISS-DSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA  379 (427)
Q Consensus       302 ~~-~~~~d~~slg~i~~~lg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta  379 (427)
                      .+ ..++|+||+|++++.|.++..+|...... .....+.......      ..+..+++++++||.+||+.||.+|||+
T Consensus       183 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~L~~dP~~R~t~  256 (323)
T 3tki_A          183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL------NPWKKIDSAPLALLHKILVENPSARITI  256 (323)
T ss_dssp             SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTS------TTGGGSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccC------CccccCCHHHHHHHHHHccCChhhCcCH
Confidence            54 34579999999998886555555332221 1122221111111      1134578999999999999999999999


Q ss_pred             HHHhcCCCCCCCC
Q psy8260         380 EQALAHPYLSQYS  392 (427)
Q Consensus       380 ~e~L~Hp~f~~~~  392 (427)
                      +|+++||||.+..
T Consensus       257 ~eil~h~~~~~~~  269 (323)
T 3tki_A          257 PDIKKDRWYNKPL  269 (323)
T ss_dssp             HHHTTCTTTTCCC
T ss_pred             HHHhhChhhcccc
Confidence            9999999998653

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=9.8e-44  Score=349.74  Aligned_cols=262  Identities=19%  Similarity=0.285  Sum_probs=192.1

Q ss_pred             ccccccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCC-----CCCceeeee
Q psy8260          57 PYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN-----HENVIGLLD  131 (427)
Q Consensus        57 ~~~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~-----HpnIv~l~~  131 (427)
                      .-..+..+.|.+.+.||+|+||.||. +.+..+++.||||++..   .........+|+.+++.+.     ||||+++++
T Consensus        28 ~~g~~~~~~y~~~~~lG~G~~g~V~~-~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~  103 (360)
T 3llt_A           28 KKGMLLNNAFLVIRKMGDGTFGRVLL-CQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHG  103 (360)
T ss_dssp             CTTCEETTTEEEEEEEEECSSEEEEE-EEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred             ecceEecCEEEEEEEEcccCCeEEEE-EEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence            33456678899999999999999996 45677899999999863   2344556678999999886     999999999


Q ss_pred             eeecCccccCCceEEEEeccCCCCHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcC-----
Q psy8260         132 VFHSNTCLADFKNVYMVTHLMGADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE-----  203 (427)
Q Consensus       132 ~~~~~~~~~~~~~~~lv~e~~g~~L~~~l~~~---~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~-----  203 (427)
                      ++...      ...++++++++++|.+++...   .+++..+..++.||+.||.|||++||+||||||+|||++.     
T Consensus       104 ~~~~~------~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~  177 (360)
T 3llt_A          104 KFMYY------DHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEK  177 (360)
T ss_dssp             EEEET------TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCE
T ss_pred             eeeEC------CeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccc
Confidence            98653      468999999999999988754   4999999999999999999999999999999999999975     


Q ss_pred             --------------------CCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCccccccc
Q psy8260         204 --------------------DCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVN  263 (427)
Q Consensus       204 --------------------~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~  263 (427)
                                          ++.+||+|||+|+........                                       
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~---------------------------------------  218 (360)
T 3llt_A          178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGS---------------------------------------  218 (360)
T ss_dssp             EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCCS---------------------------------------
T ss_pred             cccchhcccccccccccccCCCCEEEEeccCceecCCCCcC---------------------------------------
Confidence                                778999999988643332222                                       


Q ss_pred             ccchhhhhccCCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCC
Q psy8260         264 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLP  343 (427)
Q Consensus       264 ~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~  343 (427)
                                            ..||+.|+|||++.+..+..++|+||+|++++.|.++..+|......+..........
T Consensus       219 ----------------------~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  276 (360)
T 3llt_A          219 ----------------------IINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQ  276 (360)
T ss_dssp             ----------------------CCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTC
T ss_pred             ----------------------ccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcC
Confidence                                  2456666666666666666677888888888777444443322111111111111010


Q ss_pred             CCCcccH--------------------------------------HhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         344 LLTKKDF--------------------------------------RQVFKGANPQAIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       344 ~~~~~~~--------------------------------------~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                      ..+...+                                      .......++++.+||.+||++||++|||++|+|+|
T Consensus       277 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          277 PIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             CCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             CCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            0000000                                      00011235778899999999999999999999999


Q ss_pred             CCCC
Q psy8260         386 PYLS  389 (427)
Q Consensus       386 p~f~  389 (427)
                      |||+
T Consensus       357 p~f~  360 (360)
T 3llt_A          357 KFLE  360 (360)
T ss_dssp             GGGC
T ss_pred             cccC
Confidence            9995

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=8.3e-44  Score=346.33  Aligned_cols=260  Identities=25%  Similarity=0.367  Sum_probs=194.3

Q ss_pred             cccCcceeeccccCcccccEEEEeEEe--CcCCcEEEEEEccCcCC--CHHHHHHHHHHHHHHhcCCCCCceeeeeeeec
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALD--SVSGVKVAIKKIARPFQ--SAVHAKRTYRELRMLKHMNHENVIGLLDVFHS  135 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~--~~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~  135 (427)
                      .+..+.|.+.+.||+|+||.||.+...  ..+|+.||||++.+...  .......+.+|+.+|+.++||||+++++++..
T Consensus        13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   92 (327)
T 3a62_A           13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT   92 (327)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence            455678999999999999999975432  36899999999875432  12234456789999999999999999999875


Q ss_pred             CccccCCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCC
Q psy8260         136 NTCLADFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG  213 (427)
Q Consensus       136 ~~~~~~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFG  213 (427)
                      .      ..+|++||++ |++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        93 ~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  166 (327)
T 3a62_A           93 G------GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFG  166 (327)
T ss_dssp             S------SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCS
T ss_pred             C------CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCC
Confidence            4      4678999988 6899888764 679999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccccc
Q psy8260         214 LARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR  293 (427)
Q Consensus       214 la~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~  293 (427)
                      +++.......                                                          .....+||+.|+
T Consensus       167 ~~~~~~~~~~----------------------------------------------------------~~~~~~gt~~y~  188 (327)
T 3a62_A          167 LCKESIHDGT----------------------------------------------------------VTHTFCGTIEYM  188 (327)
T ss_dssp             CC--------------------------------------------------------------------CTTSSCCTTS
T ss_pred             cccccccCCc----------------------------------------------------------cccccCCCcCcc
Confidence            9864221100                                                          112335777888


Q ss_pred             chHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCC
Q psy8260         294 APEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDS  373 (427)
Q Consensus       294 APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP  373 (427)
                      |||++.+..+..++|+||+|++++.|.++..+|..........+........        ....++++++||.+||+.||
T Consensus       189 aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~--------p~~~~~~~~~li~~~L~~dp  260 (327)
T 3a62_A          189 APEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL--------PPYLTQEARDLLKKLLKRNA  260 (327)
T ss_dssp             CHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC--------CTTSCHHHHHHHHHHSCSCG
T ss_pred             CHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC--------CCCCCHHHHHHHHHHHhcCH
Confidence            8888777667777899999999988865555554332222222333222211        23468899999999999999


Q ss_pred             CCCC-----CHHHHhcCCCCCCC
Q psy8260         374 EKRI-----TAEQALAHPYLSQY  391 (427)
Q Consensus       374 ~~R~-----ta~e~L~Hp~f~~~  391 (427)
                      .+|+     |++|+++||||+..
T Consensus       261 ~~R~~~~~~~~~e~l~hp~f~~~  283 (327)
T 3a62_A          261 ASRLGAGPGDAGEVQAHPFFRHI  283 (327)
T ss_dssp             GGSTTSSTTTHHHHHHSGGGSSC
T ss_pred             hhccCCCCCCHHHHHcCCcccCC
Confidence            9999     89999999999865

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.4e-44  Score=363.71  Aligned_cols=261  Identities=22%  Similarity=0.311  Sum_probs=195.5

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCc
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNT  137 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~  137 (427)
                      ..+..+.|.+.+.||+|+||.||. +.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++... 
T Consensus       143 ~~~~~~~y~~~~~lG~G~~g~V~~-~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-  220 (446)
T 4ejn_A          143 HRVTMNEFEYLKLLGKGTFGKVIL-VKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-  220 (446)
T ss_dssp             -CCCGGGEEEEEEEEEETTEEEEE-EEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET-
T ss_pred             cCCChHHcEEeEEEeeCcCEEEEE-EEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC-
Confidence            345567899999999999999995 56778999999999864321 222345567899999999999999999998654 


Q ss_pred             cccCCceEEEEeccC-CCCHHHHHh-hCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCCeEEcCCCCEEEeeCCC
Q psy8260         138 CLADFKNVYMVTHLM-GADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNEDCELKILDFGL  214 (427)
Q Consensus       138 ~~~~~~~~~lv~e~~-g~~L~~~l~-~~~l~~~~~~~~~~qi~~aL~yLH~-~~iiHrDLKp~NILl~~~~~~kl~DFGl  214 (427)
                           ..+|++||++ +++|..++. ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+
T Consensus       221 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~  295 (446)
T 4ejn_A          221 -----DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGL  295 (446)
T ss_dssp             -----TEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCC
T ss_pred             -----CEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCC
Confidence                 4679999998 679988775 4679999999999999999999998 9999999999999999999999999999


Q ss_pred             CCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccc
Q psy8260         215 ARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRA  294 (427)
Q Consensus       215 a~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~A  294 (427)
                      |+.......                                                          .....+||+.|+|
T Consensus       296 a~~~~~~~~----------------------------------------------------------~~~~~~gt~~y~a  317 (446)
T 4ejn_A          296 CKEGIKDGA----------------------------------------------------------TMKTFCGTPEYLA  317 (446)
T ss_dssp             CCTTCC---------------------------------------------------------------CCSSSCGGGCC
T ss_pred             ceeccCCCc----------------------------------------------------------ccccccCCccccC
Confidence            874221100                                                          1123467888888


Q ss_pred             hHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCC
Q psy8260         295 PEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       295 PEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~  374 (427)
                      ||++.+..+..++|+||+|++++.|.++..||...................        ....++++.+||.+||++||.
T Consensus       318 PE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~--------p~~~~~~~~~li~~~L~~dP~  389 (446)
T 4ejn_A          318 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF--------PRTLGPEAKSLLSGLLKKDPK  389 (446)
T ss_dssp             HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------CTTSCHHHHHHHHHHTCSSTT
T ss_pred             HhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC--------CccCCHHHHHHHHHHcccCHH
Confidence            888877778788899999999988866555554332222222222222211        235789999999999999999


Q ss_pred             CCC-----CHHHHhcCCCCCCCC
Q psy8260         375 KRI-----TAEQALAHPYLSQYS  392 (427)
Q Consensus       375 ~R~-----ta~e~L~Hp~f~~~~  392 (427)
                      +|+     |++|+|+||||....
T Consensus       390 ~R~~~~~~t~~ell~hp~f~~~~  412 (446)
T 4ejn_A          390 QRLGGGSEDAKEIMQHRFFAGIV  412 (446)
T ss_dssp             TSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             HhCCCCCCCHHHHHhCccccCCC
Confidence            999     999999999998753

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=8.3e-44  Score=343.43  Aligned_cols=278  Identities=34%  Similarity=0.586  Sum_probs=199.7

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCc-----
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNT-----  137 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-----  137 (427)
                      .++|.+.+.||+|+||.||. +.+..+|+.||||++...  .....+.+.+|+++++.++||||+++++++....     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   86 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFS-AVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD   86 (320)
T ss_dssp             TTTEEEEEECC-----CEEE-EEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred             CCceeEEEEeccCCCeEEEE-EEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence            46789999999999999996 456778999999988643  4455677889999999999999999999975421     


Q ss_pred             ---cccCCceEEEEeccCCCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEc-CCCCEEEeeCC
Q psy8260         138 ---CLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN-EDCELKILDFG  213 (427)
Q Consensus       138 ---~~~~~~~~~lv~e~~g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~-~~~~~kl~DFG  213 (427)
                         +..+....|+++++++++|.++++.+.+++..+..++.|++.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus        87 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg  166 (320)
T 2i6l_A           87 DVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFG  166 (320)
T ss_dssp             ----CCSCSEEEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred             ccccccccCceeEEeeccCCCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCc
Confidence               12334678999999999999999888899999999999999999999999999999999999997 56799999999


Q ss_pred             CCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccccc
Q psy8260         214 LARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR  293 (427)
Q Consensus       214 la~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~  293 (427)
                      +++........                                                       ........||+.|+
T Consensus       167 ~~~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~~y~  191 (320)
T 2i6l_A          167 LARIMDPHYSH-------------------------------------------------------KGHLSEGLVTKWYR  191 (320)
T ss_dssp             TCBCC---------------------------------------------------------------CCCGGGSCCTTC
T ss_pred             cccccCCCccc-------------------------------------------------------cccccccccccccc
Confidence            98754321100                                                       00111234567777


Q ss_pred             chHHhhh-ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCC----------------------CCcccH
Q psy8260         294 APEIMLN-WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPL----------------------LTKKDF  350 (427)
Q Consensus       294 APEvl~~-~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~  350 (427)
                      |||++.+ ..+..++|+||+|++++.+.++..+|................+.                      .....+
T Consensus       192 aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (320)
T 2i6l_A          192 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPL  271 (320)
T ss_dssp             CHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCH
T ss_pred             CcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCCh
Confidence            7777654 34555679999999998775554444322111111112111111                      122233


Q ss_pred             HhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCC
Q psy8260         351 RQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEP  398 (427)
Q Consensus       351 ~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~  398 (427)
                      ....+.+++++++||.+||+.||.+|||++|+|+||||+....|..+|
T Consensus       272 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~~~~  319 (320)
T 2i6l_A          272 TQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMDEP  319 (320)
T ss_dssp             HHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-----
T ss_pred             hHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCccCCC
Confidence            445567899999999999999999999999999999999877766554

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.7e-44  Score=355.31  Aligned_cols=257  Identities=20%  Similarity=0.358  Sum_probs=196.2

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      .+..+.|.+.+.||+|+||.||. +.+..+|+.||||++.+... .......+.+|+++|+.++|||||+++++|...  
T Consensus        11 ~v~~~~y~i~~~LG~G~fG~V~~-~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--   87 (384)
T 4fr4_A           11 DVNFDHFEILRAIGKGSFGKVCI-VQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE--   87 (384)
T ss_dssp             CCCGGGEEEEEEEECCTTCCEEE-EEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--
T ss_pred             CCChHHeEEEEEEeeCCCeEEEE-EEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--
Confidence            55567899999999999999996 56778899999999864321 111235677999999999999999999998754  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                          ..+|++++++ |++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        88 ----~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~  163 (384)
T 4fr4_A           88 ----EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA  163 (384)
T ss_dssp             ----SEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             ----CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceee
Confidence                4678999988 7899988865 469999999999999999999999999999999999999999999999999987


Q ss_pred             CCCC--CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccc
Q psy8260         217 PTEN--EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRA  294 (427)
Q Consensus       217 ~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~A  294 (427)
                      ....  .....+                                                             ||+.|+|
T Consensus       164 ~~~~~~~~~~~~-------------------------------------------------------------gt~~Y~a  182 (384)
T 4fr4_A          164 MLPRETQITTMA-------------------------------------------------------------GTKPYMA  182 (384)
T ss_dssp             ECCTTCCBCCCC-------------------------------------------------------------SCGGGCC
T ss_pred             eccCCCceeccC-------------------------------------------------------------CCccccC
Confidence            5432  122334                                                             5555555


Q ss_pred             hHHhhh---ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCc--HHH-HHHHhcCCCCCcccHHhhcCCCChhHHHHHHHh
Q psy8260         295 PEIMLN---WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISS--DSA-RKYINSLPLLTKKDFRQVFKGANPQAIDLLSLM  368 (427)
Q Consensus       295 PEvl~~---~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~m  368 (427)
                      ||++..   ..+...+|+||+|++++.|.++..||......  ... .........        .....++++.+||.+|
T Consensus       183 PE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--------~p~~~s~~~~~li~~l  254 (384)
T 4fr4_A          183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVT--------YPSAWSQEMVSLLKKL  254 (384)
T ss_dssp             GGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCC--------CCTTSCHHHHHHHHHH
T ss_pred             CeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccC--------CCCcCCHHHHHHHHHH
Confidence            555532   22556779999999998885555555322111  111 111111111        1234689999999999


Q ss_pred             cCCCCCCCCC-HHHHhcCCCCCCCC
Q psy8260         369 LELDSEKRIT-AEQALAHPYLSQYS  392 (427)
Q Consensus       369 L~~dP~~R~t-a~e~L~Hp~f~~~~  392 (427)
                      |+.||.+|++ ++++++||||....
T Consensus       255 L~~dP~~R~s~~~~l~~hp~f~~~~  279 (384)
T 4fr4_A          255 LEPNPDQRFSQLSDVQNFPYMNDIN  279 (384)
T ss_dssp             SCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred             hcCCHhHhcccHHHHHcChhhhcCC
Confidence            9999999998 99999999998653

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-43  Score=351.99  Aligned_cols=256  Identities=24%  Similarity=0.366  Sum_probs=199.4

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      +.|.+.+.||+|+||.||. +.+..+|+.||+|++...  .......+.+|+.+|+.++||||++++++|...      .
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~-~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~------~  121 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHR-CVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK------Y  121 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEE-EEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS------S
T ss_pred             cceEEEEEEecCCCEEEEE-EEECCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC------C
Confidence            5689999999999999996 567788999999998653  234445678999999999999999999998653      4


Q ss_pred             eEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcC--CCCEEEeeCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE--DCELKILDFGLARPT  218 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~--~~~~kl~DFGla~~~  218 (427)
                      .++++||++ +++|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.  ++.+||+|||+++..
T Consensus       122 ~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~  201 (387)
T 1kob_A          122 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL  201 (387)
T ss_dssp             EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             EEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceec
Confidence            678999988 7899988864  36899999999999999999999999999999999999974  478999999998643


Q ss_pred             CCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         219 ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       219 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                      ....                                                           .....+||+.|+|||++
T Consensus       202 ~~~~-----------------------------------------------------------~~~~~~gt~~y~aPE~~  222 (387)
T 1kob_A          202 NPDE-----------------------------------------------------------IVKVTTATAEFAAPEIV  222 (387)
T ss_dssp             CTTS-----------------------------------------------------------CEEEECSSGGGCCHHHH
T ss_pred             CCCc-----------------------------------------------------------ceeeeccCCCccCchhc
Confidence            2210                                                           01123467778888877


Q ss_pred             hhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC
Q psy8260         299 LNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT  378 (427)
Q Consensus       299 ~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t  378 (427)
                      .+..+...+|+||+|++++.|.++..||.....................    ..+..+++++++||.+||+.||.+|||
T Consensus       223 ~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~s~~~~~li~~~L~~dP~~Rpt  298 (387)
T 1kob_A          223 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE----DAFSSVSPEAKDFIKNLLQKEPRKRLT  298 (387)
T ss_dssp             TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS----STTTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred             cCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----cccccCCHHHHHHHHHHcCCChhHCcC
Confidence            7766777789999999998886655555432211222222222111111    234567899999999999999999999


Q ss_pred             HHHHhcCCCCCCC
Q psy8260         379 AEQALAHPYLSQY  391 (427)
Q Consensus       379 a~e~L~Hp~f~~~  391 (427)
                      ++|+|+||||...
T Consensus       299 ~~ell~hp~~~~~  311 (387)
T 1kob_A          299 VHDALEHPWLKGD  311 (387)
T ss_dssp             HHHHHTSTTTSSC
T ss_pred             HHHHhhCccccCC
Confidence            9999999999864

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.7e-43  Score=341.88  Aligned_cols=256  Identities=22%  Similarity=0.415  Sum_probs=198.3

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCce
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      .++..+.||+|+||.||.+ .+..+|+.||||++......  ..+.+.+|+.+++.++||||+++++++...      ..
T Consensus        46 ~~~~~~~lg~G~~g~V~~a-~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~  116 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLA-REKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLVG------EE  116 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEE-EETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCCCTTBCCEEEEEEET------TE
T ss_pred             hhhccEEeccCCCeEEEEE-EECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCcceEEEEEEEC------CE
Confidence            4667779999999999964 56678999999998654322  235577999999999999999999998653      45


Q ss_pred             EEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcc
Q psy8260         145 VYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT  223 (427)
Q Consensus       145 ~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~  223 (427)
                      .|++||++ +++|.+++....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus       117 ~~lv~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  196 (321)
T 2c30_A          117 LWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP  196 (321)
T ss_dssp             EEEEECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred             EEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc
Confidence            78999988 78999999888899999999999999999999999999999999999999999999999999864322110


Q ss_pred             cccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccC
Q psy8260         224 GYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH  303 (427)
Q Consensus       224 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~  303 (427)
                                                                                ......||+.|+|||++.+..+
T Consensus       197 ----------------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~  218 (321)
T 2c30_A          197 ----------------------------------------------------------KRKSLVGTPYWMAPEVISRSLY  218 (321)
T ss_dssp             ----------------------------------------------------------CBCCCCSCGGGCCHHHHTTCCB
T ss_pred             ----------------------------------------------------------ccccccCCccccCHhhhcCCCC
Confidence                                                                      0112357777888888777667


Q ss_pred             CCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q psy8260         304 YNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQAL  383 (427)
Q Consensus       304 ~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L  383 (427)
                      ..++|+||+|++++.|.++..+|................+...     ......++++.+||.+||+.||++|||++|++
T Consensus       219 ~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell  293 (321)
T 2c30_A          219 ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL-----KNSHKVSPVLRDFLERMLVRDPQERATAQELL  293 (321)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC-----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCc-----CccccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence            7788999999999888655555543221122222221111100     01234688999999999999999999999999


Q ss_pred             cCCCCCCCC
Q psy8260         384 AHPYLSQYS  392 (427)
Q Consensus       384 ~Hp~f~~~~  392 (427)
                      +||||.+..
T Consensus       294 ~hp~~~~~~  302 (321)
T 2c30_A          294 DHPFLLQTG  302 (321)
T ss_dssp             TSGGGGGCC
T ss_pred             cChhhccCC
Confidence            999998654

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5.4e-44  Score=364.22  Aligned_cols=258  Identities=26%  Similarity=0.375  Sum_probs=199.5

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH-HHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA-VHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      .+..+.|.+++.||+|+||.||. +.+..+|+.||||++....... .....+.+|+.+|+.++||||+++++++...  
T Consensus        12 ~~~~~~Y~l~~~LG~G~fg~V~~-a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--   88 (476)
T 2y94_A           12 RVKIGHYILGDTLGVGTFGKVKV-GKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP--   88 (476)
T ss_dssp             CCEETTEEEEEEEECCSSSCEEE-EEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS--
T ss_pred             CceecCEEEEEEEeeCCCeEEEE-EEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--
Confidence            34457899999999999999996 4567799999999986432111 1234577999999999999999999998754  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                          ..+|+++|++ |++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        89 ----~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~  164 (476)
T 2y94_A           89 ----SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSN  164 (476)
T ss_dssp             ----SEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             ----CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchh
Confidence                4689999998 7899998864 569999999999999999999999999999999999999999999999999986


Q ss_pred             CCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         217 PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       217 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      ......                                                           .....+||+.|+|||
T Consensus       165 ~~~~~~-----------------------------------------------------------~~~~~~gt~~y~aPE  185 (476)
T 2y94_A          165 MMSDGE-----------------------------------------------------------FLRTSCGSPNYAAPE  185 (476)
T ss_dssp             ECCTTC-----------------------------------------------------------CBCCCCSCSTTCCHH
T ss_pred             hccccc-----------------------------------------------------------cccccCCCcCeEChh
Confidence            432210                                                           111234666777777


Q ss_pred             HhhhccCC-CCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCC
Q psy8260         297 IMLNWMHY-NQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEK  375 (427)
Q Consensus       297 vl~~~~~~-~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~  375 (427)
                      ++.+..+. .++|+||+|++++.|.++..+|..........+........        ....++++++||.+||+.||.+
T Consensus       186 ~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--------p~~~s~~~~~Li~~~L~~dP~~  257 (476)
T 2y94_A          186 VISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYT--------PQYLNPSVISLLKHMLQVDPMK  257 (476)
T ss_dssp             HHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCC--------CTTCCHHHHHHHHHHTCSSTTT
T ss_pred             hccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCC--------CccCCHHHHHHHHHHcCCCchh
Confidence            76665443 45799999999988866555554433223333332222111        1346889999999999999999


Q ss_pred             CCCHHHHhcCCCCCCC
Q psy8260         376 RITAEQALAHPYLSQY  391 (427)
Q Consensus       376 R~ta~e~L~Hp~f~~~  391 (427)
                      |||++|+++||||.+.
T Consensus       258 Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          258 RATIKDIREHEWFKQD  273 (476)
T ss_dssp             SCCHHHHHTCHHHHTT
T ss_pred             CcCHHHHHhCHHhhhc
Confidence            9999999999999864

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=355.20  Aligned_cols=295  Identities=29%  Similarity=0.456  Sum_probs=183.4

Q ss_pred             cceee-ccccCcccccEEEEeEE-eCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccC
Q psy8260          64 GVIDI-GPTLSKESFDLIFSSAL-DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        64 ~~~~~-~~~lg~g~fg~v~~~~~-~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      +.|.+ ++.||+|+||.||.+.. +..+++.||||++......    ..+.+|+.+|+.++|||||+++++|...    .
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~----~   91 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSH----A   91 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEET----T
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecC----C
Confidence            44555 67899999999997654 3357899999999754332    3467899999999999999999998542    2


Q ss_pred             CceEEEEeccCCCCHHHHHhh----------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEE----cCCCCE
Q psy8260         142 FKNVYMVTHLMGADLNNILRT----------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV----NEDCEL  207 (427)
Q Consensus       142 ~~~~~lv~e~~g~~L~~~l~~----------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl----~~~~~~  207 (427)
                      ...+|+++++++++|.+++..          ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+
T Consensus        92 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~  171 (405)
T 3rgf_A           92 DRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV  171 (405)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred             CCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcE
Confidence            256899999999999887742          139999999999999999999999999999999999999    677899


Q ss_pred             EEeeCCCCCCCCCC------cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcc
Q psy8260         208 KILDFGLARPTENE------MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTEN  281 (427)
Q Consensus       208 kl~DFGla~~~~~~------~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~  281 (427)
                      ||+|||+|+.....      ....+||++|+|||++.+...|+..      .|+|+.||++.+                 
T Consensus       172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~------~DiwSlG~il~e-----------------  228 (405)
T 3rgf_A          172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKA------IDIWAIGCIFAE-----------------  228 (405)
T ss_dssp             EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHH------HHHHHHHHHHHH-----------------
T ss_pred             EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccch------hhhHHHHHHHHH-----------------
Confidence            99999999865421      2334566666666666543333322      255665555544                 


Q ss_pred             ccccccccccccc-hHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcH-HHHHHHhcCC--CCCccc----HHhh
Q psy8260         282 EMTGYVATRWYRA-PEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSD-SARKYINSLP--LLTKKD----FRQV  353 (427)
Q Consensus       282 ~~~~~~gt~~Y~A-PEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~----~~~~  353 (427)
                      +.+|..   .|-+ .+-+   .........++..|+..+|.++...+...... ..........  ......    ....
T Consensus       229 ll~g~~---pf~~~~~~~---~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (405)
T 3rgf_A          229 LLTSEP---IFHCRQEDI---KTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKH  302 (405)
T ss_dssp             HHHSSC---TTCCCC---------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTT
T ss_pred             HHhCCC---CCCCccccc---cccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhc
Confidence            111110   0000 0000   00011123445555555555554433222110 0000000000  000000    1111


Q ss_pred             cCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q psy8260         354 FKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPN  395 (427)
Q Consensus       354 ~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~  395 (427)
                      ....+++++|||.+||++||.+|||++|+|+||||.+...|.
T Consensus       303 ~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~~~  344 (405)
T 3rgf_A          303 KVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPT  344 (405)
T ss_dssp             TCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSCCC
T ss_pred             CCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCCCc
Confidence            123478999999999999999999999999999998765554

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.3e-43  Score=351.03  Aligned_cols=258  Identities=22%  Similarity=0.299  Sum_probs=195.0

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC-HHHHHHHHHHHHH-HhcCCCCCceeeeeeeecCcc
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS-AVHAKRTYRELRM-LKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~-l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      +..++|++.+.||+|+||.||. +.+..+++.||||++.+.... ......+.+|..+ ++.++|||||+++++|...  
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~-~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~--  111 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLL-ARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA--  111 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEE-EEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS--
T ss_pred             CChhheEEEEEEeeCCCeEEEE-EEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC--
Confidence            4457899999999999999996 556778999999998765332 2234456677776 5678999999999998754  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                          ..+|++||++ |++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus       112 ----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~  187 (373)
T 2r5t_A          112 ----DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK  187 (373)
T ss_dssp             ----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCG
T ss_pred             ----CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccc
Confidence                4689999998 6799888764 679999999999999999999999999999999999999999999999999986


Q ss_pred             CCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         217 PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       217 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      ......                                                          ......+||+.|+|||
T Consensus       188 ~~~~~~----------------------------------------------------------~~~~~~~gt~~y~aPE  209 (373)
T 2r5t_A          188 ENIEHN----------------------------------------------------------STTSTFCGTPEYLAPE  209 (373)
T ss_dssp             GGBCCC----------------------------------------------------------CCCCSBSCCCCCCCHH
T ss_pred             ccccCC----------------------------------------------------------CccccccCCccccCHH
Confidence            321100                                                          0112346788888888


Q ss_pred             HhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCC
Q psy8260         297 IMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKR  376 (427)
Q Consensus       297 vl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R  376 (427)
                      ++.+..+...+|+||+|++++.|.++..+|..........+.......        ....+++++++||.+||+.||.+|
T Consensus       210 ~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~--------~~~~~~~~~~~li~~lL~~dp~~R  281 (373)
T 2r5t_A          210 VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ--------LKPNITNSARHLLEGLLQKDRTKR  281 (373)
T ss_dssp             HHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCC--------CCSSSCHHHHHHHHHHTCSSGGGS
T ss_pred             HhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccC--------CCCCCCHHHHHHHHHHcccCHHhC
Confidence            887777777889999999998886665566443322333333322211        123578999999999999999999


Q ss_pred             CCH----HHHhcCCCCCCC
Q psy8260         377 ITA----EQALAHPYLSQY  391 (427)
Q Consensus       377 ~ta----~e~L~Hp~f~~~  391 (427)
                      +++    +|+++||||+..
T Consensus       282 ~~~~~~~~~i~~h~~f~~~  300 (373)
T 2r5t_A          282 LGAKDDFMEIKSHVFFSLI  300 (373)
T ss_dssp             TTTTTTHHHHHTSGGGTTC
T ss_pred             CCCCCCHHHHhCCccccCC
Confidence            997    699999999865

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=4.3e-43  Score=338.69  Aligned_cols=268  Identities=22%  Similarity=0.352  Sum_probs=192.3

Q ss_pred             Ccceee-ccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCcccc
Q psy8260          63 RGVIDI-GPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        63 ~~~~~~-~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~  140 (427)
                      .+.|.+ ++.||+|+||.||. +.+..+|+.||||++.....  .....+.+|+.++.++ +||||+++++++...    
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~-~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~----   83 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQT-CINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEEE----   83 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEE-EECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET----
T ss_pred             ceeEEecCceecCCceEEEEE-EEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC----
Confidence            345677 47899999999996 56778899999999865432  2245678999999884 799999999998653    


Q ss_pred             CCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCC---EEEeeCCCC
Q psy8260         141 DFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE---LKILDFGLA  215 (427)
Q Consensus       141 ~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~---~kl~DFGla  215 (427)
                        ..+|+++|++ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.   +||+|||++
T Consensus        84 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~  161 (316)
T 2ac3_A           84 --DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLG  161 (316)
T ss_dssp             --TEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred             --CEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence              4689999988 6899988854 67999999999999999999999999999999999999987765   999999998


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      +..........    .                                               ........+||+.|+||
T Consensus       162 ~~~~~~~~~~~----~-----------------------------------------------~~~~~~~~~gt~~y~aP  190 (316)
T 2ac3_A          162 SGIKLNGDCSP----I-----------------------------------------------STPELLTPCGSAEYMAP  190 (316)
T ss_dssp             C----------------------------------------------------------------------CCSGGGCCH
T ss_pred             cccccCCcccc----c-----------------------------------------------cccccccccCCcCccCh
Confidence            75321100000    0                                               00011234578888888


Q ss_pred             HHhhh-----ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCc---------------HHHHHHHhcCCCCCcccHHhhcC
Q psy8260         296 EIMLN-----WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISS---------------DSARKYINSLPLLTKKDFRQVFK  355 (427)
Q Consensus       296 Evl~~-----~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~  355 (427)
                      |++.+     ..+..++|+||+|++++.|.++..+|......               .............+    ...+.
T Consensus       191 E~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~----~~~~~  266 (316)
T 2ac3_A          191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFP----DKDWA  266 (316)
T ss_dssp             HHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCC----HHHHT
T ss_pred             HHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccC----chhcc
Confidence            88764     44667889999999998885555444322110               01111111111111    12345


Q ss_pred             CCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q psy8260         356 GANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDP  394 (427)
Q Consensus       356 ~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  394 (427)
                      .+++++++||.+||+.||.+|||++|+|+||||.+...+
T Consensus       267 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~  305 (316)
T 2ac3_A          267 HISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPE  305 (316)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-----
T ss_pred             cCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCc
Confidence            678999999999999999999999999999999876433

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=4.5e-43  Score=333.22  Aligned_cols=261  Identities=26%  Similarity=0.388  Sum_probs=202.6

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .+.|.+.+.||.|+||.||. +.+..+|+.||+|++..........+.+.+|+.++++++||||+++++++...      
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------   77 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRR-CVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE------   77 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEE-EEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS------
T ss_pred             hhhhhhhhhhcCcCCeEEEE-EEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC------
Confidence            46789999999999999996 56777899999999976666666677788999999999999999999998654      


Q ss_pred             ceEEEEeccC-CCCHHHHH-hhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCC---EEEeeCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNIL-RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE---LKILDFGLARP  217 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l-~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~---~kl~DFGla~~  217 (427)
                      ...+++++++ +++|.+.+ ....+++..+..++.|++.||.|||++||+||||||+|||++.++.   +||+|||++..
T Consensus        78 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~  157 (284)
T 3kk8_A           78 SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  157 (284)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence            4578899988 67887665 4567999999999999999999999999999999999999986554   99999999854


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      .....                                                           ......||+.|+|||+
T Consensus       158 ~~~~~-----------------------------------------------------------~~~~~~~~~~y~aPE~  178 (284)
T 3kk8_A          158 VNDSE-----------------------------------------------------------AWHGFAGTPGYLSPEV  178 (284)
T ss_dssp             CCSSC-----------------------------------------------------------BCCCSCSCGGGCCHHH
T ss_pred             cccCc-----------------------------------------------------------cccCCCCCcCCcCchh
Confidence            32210                                                           1112357777888888


Q ss_pred             hhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC
Q psy8260         298 MLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI  377 (427)
Q Consensus       298 l~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~  377 (427)
                      +.+..+..++|+||+|++++.+.++..+|...................+.    ..+...++++.+||.+||+.||.+||
T Consensus       179 ~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rp  254 (284)
T 3kk8_A          179 LKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS----PEWDTVTPEAKSLIDSMLTVNPKKRI  254 (284)
T ss_dssp             HTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----TTTTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred             hcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCc----hhhcccCHHHHHHHHHHcccChhhCC
Confidence            77777777889999999998875555555433222222222222211111    12346789999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCC
Q psy8260         378 TAEQALAHPYLSQYSD  393 (427)
Q Consensus       378 ta~e~L~Hp~f~~~~~  393 (427)
                      |++|+|+||||.+...
T Consensus       255 s~~~~l~h~~~~~~~~  270 (284)
T 3kk8_A          255 TADQALKVPWICNRER  270 (284)
T ss_dssp             CHHHHTTSHHHHSCCC
T ss_pred             CHHHHhcCccccCChh
Confidence            9999999999987543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=6.2e-44  Score=365.64  Aligned_cols=260  Identities=27%  Similarity=0.496  Sum_probs=197.5

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .+.|.+.+.||+|+||.||. +.+..+|+.||||++.+..........+.+|+.+|++++|||||++++++...      
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------   93 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLK-CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS------   93 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEE-EEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS------
T ss_pred             hcceEEeEEEeecCCEEEEE-EEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC------
Confidence            46789999999999999996 56778999999999864322222345678999999999999999999998654      


Q ss_pred             ceEEEEeccC-CCCHHHHH-hhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEc---CCCCEEEeeCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNIL-RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN---EDCELKILDFGLARP  217 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l-~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~---~~~~~kl~DFGla~~  217 (427)
                      ..+|++++++ +++|.+.+ ....+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.
T Consensus        94 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A           94 SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            4678999988 67887766 457899999999999999999999999999999999999995   456899999999875


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      .....                                                           .....+||+.|+|||+
T Consensus       174 ~~~~~-----------------------------------------------------------~~~~~~gt~~y~aPE~  194 (486)
T 3mwu_A          174 FQQNT-----------------------------------------------------------KMKDRIGTAYYIAPEV  194 (486)
T ss_dssp             BCCC---------------------------------------------------------------CCTTGGGGCCGGG
T ss_pred             CCCCC-----------------------------------------------------------ccCCCcCCCCCCCHHH
Confidence            32211                                                           1112346677777777


Q ss_pred             hhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC
Q psy8260         298 MLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI  377 (427)
Q Consensus       298 l~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~  377 (427)
                      +.+. +..++|+||+|++++.|.++..||.....................    ..+..+++++++||.+||+.||.+||
T Consensus       195 ~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~s~~~~~li~~~L~~dp~~R~  269 (486)
T 3mwu_A          195 LRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL----PQWRTISDDAKDLIRKMLTFHPSLRI  269 (486)
T ss_dssp             GGSC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCS----GGGGGSCHHHHHHHHHHTCSSTTTSC
T ss_pred             hCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----cccCCCCHHHHHHHHHHcCCChhhCc
Confidence            6542 555679999999998885555555433222222222222222211    22456799999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCC
Q psy8260         378 TAEQALAHPYLSQYSD  393 (427)
Q Consensus       378 ta~e~L~Hp~f~~~~~  393 (427)
                      |+.|+|+||||.+...
T Consensus       270 t~~~~l~hp~~~~~~~  285 (486)
T 3mwu_A          270 TATQCLEHPWIQKYSS  285 (486)
T ss_dssp             CHHHHHHCHHHHHTCC
T ss_pred             CHHHHhcCHhhccCcc
Confidence            9999999999987543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.9e-43  Score=344.58  Aligned_cols=270  Identities=22%  Similarity=0.301  Sum_probs=194.8

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCC--CCceeeeeeeecCc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNH--ENVIGLLDVFHSNT  137 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~H--pnIv~l~~~~~~~~  137 (427)
                      ++....|.+.+.||+|+||.||.+. + .+++.||||++............+.+|+.+|+.++|  |||+++++++... 
T Consensus         5 ~~~~~~y~i~~~lG~G~~g~Vy~~~-~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~-   81 (343)
T 3dbq_A            5 SVKGRIYSILKQIGSGGSSKVFQVL-N-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-   81 (343)
T ss_dssp             ESSSCEEEEEEEESCCSSEEEEEEE-C-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-
T ss_pred             eeecCEEEEEEEEecCCCeEEEEEE-e-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC-
Confidence            4456779999999999999999754 3 468999999997665566666778899999999987  9999999998654 


Q ss_pred             cccCCceEEEEeccCCCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         138 CLADFKNVYMVTHLMGADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       138 ~~~~~~~~~lv~e~~g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                           ..+|++||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++
T Consensus        82 -----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~  155 (343)
T 3dbq_A           82 -----QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN  155 (343)
T ss_dssp             -----SEEEEEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred             -----CEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeeccccc
Confidence                 46899999889999998865 5699999999999999999999999999999999999997 5789999999998


Q ss_pred             CCCCCc-----ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccc
Q psy8260         217 PTENEM-----TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRW  291 (427)
Q Consensus       217 ~~~~~~-----~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~  291 (427)
                      ......     ...+||+.|+|||++.+.......                                      +      
T Consensus       156 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--------------------------------------~------  191 (343)
T 3dbq_A          156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN--------------------------------------G------  191 (343)
T ss_dssp             CC------------CCCCSSCCHHHHHHCC--------------------------------------------------
T ss_pred             ccCcccccccCCCCcCCcCcCCHHHHhhccccccc--------------------------------------c------
Confidence            653321     233455666666655431000000                                      0      


Q ss_pred             ccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcH-HHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcC
Q psy8260         292 YRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSD-SARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLE  370 (427)
Q Consensus       292 Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~  370 (427)
                            .....+..++|+||+|++++.|.++..||....... ............      ......++++.+||.+||+
T Consensus       192 ------~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~L~  259 (343)
T 3dbq_A          192 ------KSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI------EFPDIPEKDLQDVLKCCLK  259 (343)
T ss_dssp             -----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC------CCCCCSCHHHHHHHHHHTC
T ss_pred             ------ccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCccc------CCcccCCHHHHHHHHHHcC
Confidence                  000224456799999999988865555553322111 111111111100      1122346789999999999


Q ss_pred             CCCCCCCCHHHHhcCCCCCCCCCC
Q psy8260         371 LDSEKRITAEQALAHPYLSQYSDP  394 (427)
Q Consensus       371 ~dP~~R~ta~e~L~Hp~f~~~~~~  394 (427)
                      .||.+|||++|+|+||||+....|
T Consensus       260 ~dp~~Rpt~~e~l~hp~~~~~~~~  283 (343)
T 3dbq_A          260 RDPKQRISIPELLAHPYVQIQTHP  283 (343)
T ss_dssp             SSTTTSCCHHHHHTSHHHHSCCC-
T ss_pred             CChhHCCCHHHHHhCccccccCCc
Confidence            999999999999999999865444

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=7.5e-43  Score=352.13  Aligned_cols=279  Identities=28%  Similarity=0.457  Sum_probs=203.6

Q ss_pred             cCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC------CCCCceeeeeeeec
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM------NHENVIGLLDVFHS  135 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l------~HpnIv~l~~~~~~  135 (427)
                      ...+|.+.+.||+|+||.||+ +.+..+++.||||++...   ......+.+|+++++.+      +|+||+++++++..
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~-a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~  170 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVK-AYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF  170 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEE-EEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred             ccCcEEEEEEcccCccEEEEE-EEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence            346799999999999999996 567788999999998642   33445566788777765      67899999999865


Q ss_pred             CccccCCceEEEEeccCCCCHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCC--EEEe
Q psy8260         136 NTCLADFKNVYMVTHLMGADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE--LKIL  210 (427)
Q Consensus       136 ~~~~~~~~~~~lv~e~~g~~L~~~l~~~---~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~--~kl~  210 (427)
                      .      ..+++++|+++++|.+++...   .+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+
T Consensus       171 ~------~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~  244 (429)
T 3kvw_A          171 R------NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVI  244 (429)
T ss_dssp             T------TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEEC
T ss_pred             C------CeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEe
Confidence            3      468999999999999988653   4899999999999999999999999999999999999999887  9999


Q ss_pred             eCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccc
Q psy8260         211 DFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATR  290 (427)
Q Consensus       211 DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~  290 (427)
                      |||+|+.........+||+.|+|||++.+.. |+.      ..|+|+.||++.+                 +.+|.    
T Consensus       245 DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~------~~DiwSlG~il~e-----------------lltG~----  296 (429)
T 3kvw_A          245 DFGSSCYEHQRVYTYIQSRFYRAPEVILGAR-YGM------PIDMWSLGCILAE-----------------LLTGY----  296 (429)
T ss_dssp             CCTTCEETTCCCCSSCSCGGGCCHHHHHTBC-CCT------HHHHHHHHHHHHH-----------------HHHSS----
T ss_pred             ecccceecCCcccccCCCCCccChHHHhCCC-CCc------hHHHHhHHHHHHH-----------------HHhCC----
Confidence            9999987666666677888888888876532 222      2377777776654                 22221    


Q ss_pred             cccchHHhhhccCCCC-CCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcC--CC-----------------------
Q psy8260         291 WYRAPEIMLNWMHYNQ-TDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSL--PL-----------------------  344 (427)
Q Consensus       291 ~Y~APEvl~~~~~~~~-~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~--~~-----------------------  344 (427)
                                 ..+.+ .+...+..++..+|.++.++......  ...+....  +.                       
T Consensus       297 -----------~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (429)
T 3kvw_A          297 -----------PLLPGEDEGDQLACMIELLGMPSQKLLDASKR--AKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGK  363 (429)
T ss_dssp             -----------CSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTT--HHHHBCTTSCBTTSCEECCCC--CEECCEECTTCC
T ss_pred             -----------CCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhh--hhhccCCCCCcccccccccccccccccccccchhh
Confidence                       12222 34455666667777777666543321  11111110  00                       


Q ss_pred             ----CCcccHHhhc-CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q psy8260         345 ----LTKKDFRQVF-KGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       345 ----~~~~~~~~~~-~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~  391 (427)
                          .....+...+ ...+++++|||.+||++||++|||++|+|+||||++.
T Consensus       364 ~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~  415 (429)
T 3kvw_A          364 LRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRR  415 (429)
T ss_dssp             EECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC--
T ss_pred             ccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccC
Confidence                0011222222 2347889999999999999999999999999999874

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=9.9e-44  Score=348.04  Aligned_cols=255  Identities=25%  Similarity=0.407  Sum_probs=193.5

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCccccC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~~  141 (427)
                      .+.|.+.+.||+|+||.||. +.+..+|+.||||++.+....      ..+|++++.++ +||||++++++|...     
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~-~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~-----   88 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKR-CIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDG-----   88 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEE-EEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECS-----
T ss_pred             cccEEEEEEEeeCCCEEEEE-EEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcC-----
Confidence            45689999999999999996 567789999999998754322      34688888877 899999999998754     


Q ss_pred             CceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCC----CCEEEeeCCCC
Q psy8260         142 FKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED----CELKILDFGLA  215 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~----~~~kl~DFGla  215 (427)
                       ..+|++||++ |++|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||+..+    +.+||+|||++
T Consensus        89 -~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a  167 (342)
T 2qr7_A           89 -KYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFA  167 (342)
T ss_dssp             -SEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred             -CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence             4689999998 6799887754 569999999999999999999999999999999999998532    35999999998


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      +.......                                                          .....+||+.|+||
T Consensus       168 ~~~~~~~~----------------------------------------------------------~~~~~~gt~~y~aP  189 (342)
T 2qr7_A          168 KQLRAENG----------------------------------------------------------LLMTPCYTANFVAP  189 (342)
T ss_dssp             EECBCTTC----------------------------------------------------------CBCCSSCCSSCCCH
T ss_pred             ccCcCCCC----------------------------------------------------------ceeccCCCccccCH
Confidence            64322100                                                          11233577778888


Q ss_pred             HHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcC--cH-HHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         296 EIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKIS--SD-SARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       296 Evl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                      |++.+..+...+|+||+|++++.|.++..||.....  .. .............    ...+..+++++++||.+||+.|
T Consensus       190 E~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~----~~~~~~~s~~~~~li~~~L~~d  265 (342)
T 2qr7_A          190 EVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLS----GGYWNSVSDTAKDLVSKMLHVD  265 (342)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCC----STTTTTSCHHHHHHHHHHTCSS
T ss_pred             HHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccC----ccccccCCHHHHHHHHHHCCCC
Confidence            887776666778999999999888555555542211  11 1111211111111    1234568999999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCCC
Q psy8260         373 SEKRITAEQALAHPYLSQYS  392 (427)
Q Consensus       373 P~~R~ta~e~L~Hp~f~~~~  392 (427)
                      |++|||++|+|+||||.++.
T Consensus       266 P~~R~t~~~il~hp~~~~~~  285 (342)
T 2qr7_A          266 PHQRLTAALVLRHPWIVHWD  285 (342)
T ss_dssp             TTTSCCHHHHTTSHHHHTGG
T ss_pred             hhHCcCHHHHhcCCeecCcc
Confidence            99999999999999997653

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1e-43  Score=345.46  Aligned_cols=251  Identities=24%  Similarity=0.407  Sum_probs=177.3

Q ss_pred             ccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCC-CCCceeeeeeeecCccccCCceEEE
Q psy8260          69 GPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN-HENVIGLLDVFHSNTCLADFKNVYM  147 (427)
Q Consensus        69 ~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~~~~~~~l  147 (427)
                      ++.||+|+||.||. +.+..+|+.||||++...     ......+|+.+++.+. ||||+++++++...      ...|+
T Consensus        16 ~~~lG~G~~g~V~~-~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~------~~~~l   83 (325)
T 3kn6_A           16 DKPLGEGSFSICRK-CVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQ------LHTFL   83 (325)
T ss_dssp             SCCSEEETTEEEEE-EEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS------SEEEE
T ss_pred             CCccccCCCeEEEE-EEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC------CEEEE
Confidence            37899999999996 567788999999998643     2345678999999997 99999999998754      46789


Q ss_pred             EeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCC---CEEEeeCCCCCCCCCCc
Q psy8260         148 VTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC---ELKILDFGLARPTENEM  222 (427)
Q Consensus       148 v~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~---~~kl~DFGla~~~~~~~  222 (427)
                      ++|++ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++   .+||+|||+++......
T Consensus        84 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~  163 (325)
T 3kn6_A           84 VMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN  163 (325)
T ss_dssp             EECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred             EEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence            99998 6799988865 5699999999999999999999999999999999999997655   89999999986432110


Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhcc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM  302 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~  302 (427)
                      .                                                          .....+||+.|+|||++.+..
T Consensus       164 ~----------------------------------------------------------~~~~~~~t~~y~aPE~~~~~~  185 (325)
T 3kn6_A          164 Q----------------------------------------------------------PLKTPCFTLHYAAPELLNQNG  185 (325)
T ss_dssp             ------------------------------------------------------------------------------CC
T ss_pred             C----------------------------------------------------------cccccCCCcCccCHHHhcCCC
Confidence            0                                                          112334677777777777666


Q ss_pred             CCCCCCHHHHHHHHHHhCCCCHHHHhhcCc-------HHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCC
Q psy8260         303 HYNQTDIHQLNLIMEMLGTPPAEFMAKISS-------DSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEK  375 (427)
Q Consensus       303 ~~~~~d~~slg~i~~~lg~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~  375 (427)
                      +..++|+||+|++++.|.++..||......       ..............    ...+..+++++++||.+||+.||.+
T Consensus       186 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~----~~~~~~~s~~~~~li~~~L~~dP~~  261 (325)
T 3kn6_A          186 YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE----GEAWKNVSQEAKDLIQGLLTVDPNK  261 (325)
T ss_dssp             CCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC----SHHHHTSCHHHHHHHHHHHCCCTTT
T ss_pred             CCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC----cccccCCCHHHHHHHHHHCCCChhH
Confidence            777789999999998875554444322110       11111111111111    1234567999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCC
Q psy8260         376 RITAEQALAHPYLSQYSD  393 (427)
Q Consensus       376 R~ta~e~L~Hp~f~~~~~  393 (427)
                      |||++|+++||||.+...
T Consensus       262 Rpt~~ell~h~w~~~~~~  279 (325)
T 3kn6_A          262 RLKMSGLRYNEWLQDGSQ  279 (325)
T ss_dssp             CCCTTTSTTCGGGCTTCC
T ss_pred             CCCHHHHhcChhhccCcc
Confidence            999999999999987543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.3e-43  Score=349.45  Aligned_cols=251  Identities=25%  Similarity=0.393  Sum_probs=189.9

Q ss_pred             ccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEEE
Q psy8260          69 GPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV  148 (427)
Q Consensus        69 ~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~lv  148 (427)
                      .+.||+|+||.||. +.+..+|+.||||++...  .....+.+.+|+++|++++||||+++++++...      ..++++
T Consensus        94 ~~~lG~G~~g~Vy~-a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~~~~lv  164 (373)
T 2x4f_A           94 TEILGGGRFGQVHK-CEETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLDHANLIQLYDAFESK------NDIVLV  164 (373)
T ss_dssp             EEECC-----CEEE-EEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS------SEEEEE
T ss_pred             ceEEecCcCEEEEE-EEEcCCCcEEEEEEEccc--ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC------CEEEEE
Confidence            56899999999996 456778999999998653  234456788999999999999999999998754      467899


Q ss_pred             eccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEE--cCCCCEEEeeCCCCCCCCCCcc
Q psy8260         149 THLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV--NEDCELKILDFGLARPTENEMT  223 (427)
Q Consensus       149 ~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl--~~~~~~kl~DFGla~~~~~~~~  223 (427)
                      +|++ +++|.+.+..  ..+++..+..++.||+.||.|||++||+||||||+|||+  +.++.+||+|||+++...... 
T Consensus       165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-  243 (373)
T 2x4f_A          165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-  243 (373)
T ss_dssp             EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-
T ss_pred             EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-
Confidence            9988 6788887754  359999999999999999999999999999999999999  567899999999986432210 


Q ss_pred             cccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccC
Q psy8260         224 GYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH  303 (427)
Q Consensus       224 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~  303 (427)
                                                                                .....+||+.|+|||++.+..+
T Consensus       244 ----------------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~  265 (373)
T 2x4f_A          244 ----------------------------------------------------------KLKVNFGTPEFLAPEVVNYDFV  265 (373)
T ss_dssp             ----------------------------------------------------------BCCCCCSSCTTCCHHHHTTCBC
T ss_pred             ----------------------------------------------------------ccccccCCCcEeChhhccCCCC
Confidence                                                                      0112246777777777766666


Q ss_pred             CCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q psy8260         304 YNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQAL  383 (427)
Q Consensus       304 ~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L  383 (427)
                      ..++|+||+|++++.|.++..+|.....................    ..+..+++++++||.+||+.||.+|||++|+|
T Consensus       266 ~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l  341 (373)
T 2x4f_A          266 SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED----EEFQDISEEAKEFISKLLIKEKSWRISASEAL  341 (373)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCS----GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred             CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCh----hhhccCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence            66789999999998886665555433222223333332222221    23456799999999999999999999999999


Q ss_pred             cCCCCCCC
Q psy8260         384 AHPYLSQY  391 (427)
Q Consensus       384 ~Hp~f~~~  391 (427)
                      +||||.+.
T Consensus       342 ~hp~~~~~  349 (373)
T 2x4f_A          342 KHPWLSDH  349 (373)
T ss_dssp             HSHHHHCH
T ss_pred             cCcCcCCC
Confidence            99999864

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=7.5e-43  Score=342.70  Aligned_cols=257  Identities=26%  Similarity=0.403  Sum_probs=188.4

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcccc
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  140 (427)
                      ...+.|.+.+.||+|+||.||. +.+..+++.||||++....    ..+.+.+|+.+|++++||||+++++++...    
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~-~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----  120 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYR-CKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETP----  120 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEE-EEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECS----
T ss_pred             cccCcEEEeeEEeeCCCEEEEE-EEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecC----
Confidence            3456799999999999999996 4566789999999986532    234567899999999999999999998654    


Q ss_pred             CCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcC---CCCEEEeeCCCC
Q psy8260         141 DFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE---DCELKILDFGLA  215 (427)
Q Consensus       141 ~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~---~~~~kl~DFGla  215 (427)
                        ...++++|++ +++|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+|||++.   ++.+||+|||++
T Consensus       121 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a  198 (349)
T 2w4o_A          121 --TEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLS  198 (349)
T ss_dssp             --SEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred             --CeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccc
Confidence              4678999988 6899888865 45899999999999999999999999999999999999975   789999999998


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      +......                                                           ......||+.|+||
T Consensus       199 ~~~~~~~-----------------------------------------------------------~~~~~~gt~~y~aP  219 (349)
T 2w4o_A          199 KIVEHQV-----------------------------------------------------------LMKTVCGTPGYCAP  219 (349)
T ss_dssp             -------------------------------------------------------------------------CGGGSCH
T ss_pred             cccCccc-----------------------------------------------------------ccccccCCCCccCH
Confidence            6432210                                                           01123577788888


Q ss_pred             HHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcH-HHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCC
Q psy8260         296 EIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSD-SARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       296 Evl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~  374 (427)
                      |++.+..+..++|+||+|++++.|.++..+|....... ............    ....+..+++++++||.+||+.||+
T Consensus       220 E~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~~~~~li~~~L~~dP~  295 (349)
T 2w4o_A          220 EILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYF----ISPWWDEVSLNAKDLVRKLIVLDPK  295 (349)
T ss_dssp             HHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCC----CTTTTTTSCHHHHHHHHTTSCSSGG
T ss_pred             HHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCcc----CCchhhhCCHHHHHHHHHHccCChh
Confidence            88777777778899999999988866555554332222 122222211111    1123456789999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCC
Q psy8260         375 KRITAEQALAHPYLSQY  391 (427)
Q Consensus       375 ~R~ta~e~L~Hp~f~~~  391 (427)
                      +|||++|+|+||||.+.
T Consensus       296 ~Rpt~~e~l~hp~~~~~  312 (349)
T 2w4o_A          296 KRLTTFQALQHPWVTGK  312 (349)
T ss_dssp             GSCCHHHHHHSTTTTST
T ss_pred             hCcCHHHHhcCcccCCC
Confidence            99999999999999864

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.1e-43  Score=361.20  Aligned_cols=258  Identities=28%  Similarity=0.477  Sum_probs=193.9

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .+.|.+.+.||+|+||.||. +.+..++..||||++.+..........+.+|+.+++.++|||||+++++|...      
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~-~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------  108 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLL-CRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK------  108 (494)
T ss_dssp             HHHEEEEEEEECC---EEEE-EEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS------
T ss_pred             hcCeEEeeEEecCCCEEEEE-EEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC------
Confidence            35689999999999999996 56778999999999876543333345678999999999999999999998754      


Q ss_pred             ceEEEEeccC-CCCHHHHH-hhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcC---CCCEEEeeCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNIL-RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE---DCELKILDFGLARP  217 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l-~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~---~~~~kl~DFGla~~  217 (427)
                      ..+|+++|++ +++|.+.+ +...+++..+..++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++.
T Consensus       109 ~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          109 RNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            4678999988 67887765 4567999999999999999999999999999999999999975   45699999999864


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      .....                                                           .....+||+.|+|||+
T Consensus       189 ~~~~~-----------------------------------------------------------~~~~~~gt~~y~aPE~  209 (494)
T 3lij_A          189 FENQK-----------------------------------------------------------KMKERLGTAYYIAPEV  209 (494)
T ss_dssp             CBTTB-----------------------------------------------------------CBCCCCSCTTTCCHHH
T ss_pred             CCCCc-----------------------------------------------------------cccccCCCcCeeCHHH
Confidence            32210                                                           1122356777777777


Q ss_pred             hhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC
Q psy8260         298 MLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI  377 (427)
Q Consensus       298 l~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~  377 (427)
                      +.+ .+..++|+||+|++++.|.++..||.....................    ..+..+++++++||.+||++||.+||
T Consensus       210 l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~s~~~~~li~~~L~~dp~~R~  284 (494)
T 3lij_A          210 LRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDS----PEWKNVSEGAKDLIKQMLQFDSQRRI  284 (494)
T ss_dssp             HTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCS----GGGTTSCHHHHHHHHHHTCSSTTTSC
T ss_pred             Hcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----hhcccCCHHHHHHHHHHCCCChhhCc
Confidence            653 3666789999999998885555555433222222333222222222    23467899999999999999999999


Q ss_pred             CHHHHhcCCCCCCC
Q psy8260         378 TAEQALAHPYLSQY  391 (427)
Q Consensus       378 ta~e~L~Hp~f~~~  391 (427)
                      |++|+|+||||.+.
T Consensus       285 s~~e~l~hp~~~~~  298 (494)
T 3lij_A          285 SAQQALEHPWIKEM  298 (494)
T ss_dssp             CHHHHHTCHHHHHH
T ss_pred             cHHHHhcCcccccC
Confidence            99999999999764

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=6.5e-43  Score=338.75  Aligned_cols=259  Identities=27%  Similarity=0.444  Sum_probs=201.3

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH----HHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA----VHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      .+.|.+.+.||+|+||.||. +.+..+|+.||||++.......    ...+.+.+|+.+++.++||||+++++++...  
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--   87 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKK-CREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR--   87 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEE-EEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--
T ss_pred             hccEEEeeEeeecCCEEEEE-EEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC--
Confidence            46789999999999999996 5567789999999986543221    1245678999999999999999999998654  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCC----CEEEeeC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC----ELKILDF  212 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~----~~kl~DF  212 (427)
                          ...++++|++ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++    .+||+||
T Consensus        88 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           88 ----TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             ----SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             ----CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence                4678999998 7899998865 4689999999999999999999999999999999999999887    7999999


Q ss_pred             CCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccc
Q psy8260         213 GLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWY  292 (427)
Q Consensus       213 Gla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y  292 (427)
                      |+++......                                                           ......||+.|
T Consensus       164 g~~~~~~~~~-----------------------------------------------------------~~~~~~gt~~y  184 (321)
T 2a2a_A          164 GLAHEIEDGV-----------------------------------------------------------EFKNIFGTPEF  184 (321)
T ss_dssp             TTCEECCTTC-----------------------------------------------------------CCCCCCSCGGG
T ss_pred             ccceecCccc-----------------------------------------------------------cccccCCCCCc
Confidence            9986432210                                                           01123467778


Q ss_pred             cchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         293 RAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       293 ~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                      +|||++.+..+..++|+||+|++++.|.++..+|...................    ....+...++++.+||.+||+.|
T Consensus       185 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~~~~~li~~~l~~d  260 (321)
T 2a2a_A          185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF----DEEFFSHTSELAKDFIRKLLVKE  260 (321)
T ss_dssp             CCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC----CHHHHTTCCHHHHHHHHTTSCSS
T ss_pred             cCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccccc----ChhhhcccCHHHHHHHHHHcCCC
Confidence            88888777667777899999999988866555553322122222222111111    12345678899999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCC
Q psy8260         373 SEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       373 P~~R~ta~e~L~Hp~f~~~  391 (427)
                      |.+|||++|+|+||||...
T Consensus       261 p~~Rps~~e~l~hp~~~~~  279 (321)
T 2a2a_A          261 TRKRLTIQEALRHPWITPV  279 (321)
T ss_dssp             TTTSCCHHHHHHSTTTSCS
T ss_pred             hhhCcCHHHHhcCccccCC
Confidence            9999999999999999764

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=8.3e-44  Score=364.42  Aligned_cols=263  Identities=26%  Similarity=0.441  Sum_probs=201.9

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC-HHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS-AVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      ....+.|.+.+.||+|+||.||. +.+..+|+.||||++...... ......+.+|+.++++++|||||++++++...  
T Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--   98 (484)
T 3nyv_A           22 AIFSDRYKGQRVLGKGSFGEVIL-CKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDK--   98 (484)
T ss_dssp             CCHHHHEEEEEEEEEETTEEEEE-EEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--
T ss_pred             CcccCceEEeeEEecCCCEEEEE-EEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--
Confidence            34456799999999999999996 567789999999998654322 22345678999999999999999999998754  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHh-hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEE---cCCCCEEEeeCC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILDFG  213 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~-~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl---~~~~~~kl~DFG  213 (427)
                          ..+|++++++ +++|.+.+. ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||
T Consensus        99 ----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  174 (484)
T 3nyv_A           99 ----GYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFG  174 (484)
T ss_dssp             ----SEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTT
T ss_pred             ----CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeee
Confidence                4678999987 788987765 4679999999999999999999999999999999999999   467899999999


Q ss_pred             CCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccccc
Q psy8260         214 LARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR  293 (427)
Q Consensus       214 la~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~  293 (427)
                      +++......                                                           .....+||+.|+
T Consensus       175 ~a~~~~~~~-----------------------------------------------------------~~~~~~gt~~y~  195 (484)
T 3nyv_A          175 LSTHFEASK-----------------------------------------------------------KMKDKIGTAYYI  195 (484)
T ss_dssp             HHHHBCCCC-----------------------------------------------------------SHHHHTTGGGTC
T ss_pred             eeEEccccc-----------------------------------------------------------ccccCCCCcccc
Confidence            875332110                                                           112235777788


Q ss_pred             chHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCC
Q psy8260         294 APEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDS  373 (427)
Q Consensus       294 APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP  373 (427)
                      |||++.+ .+..++|+||+|++++.|.++..||.....................    ..+..+++++++||.+||++||
T Consensus       196 aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~s~~~~~li~~~L~~dp  270 (484)
T 3nyv_A          196 APEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFEL----PQWKKVSESAKDLIRKMLTYVP  270 (484)
T ss_dssp             CHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS----GGGGGSCHHHHHHHHHHTCSSG
T ss_pred             CceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC----cccccCCHHHHHHHHHHCCCCh
Confidence            8887765 4666789999999998886555555433222222233222222221    2235679999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCCCC
Q psy8260         374 EKRITAEQALAHPYLSQYSD  393 (427)
Q Consensus       374 ~~R~ta~e~L~Hp~f~~~~~  393 (427)
                      .+|||++|+|+||||.....
T Consensus       271 ~~R~s~~e~l~h~~~~~~~~  290 (484)
T 3nyv_A          271 SMRISARDALDHEWIQTYTK  290 (484)
T ss_dssp             GGSCCHHHHHTSHHHHHHTC
T ss_pred             hHCcCHHHHhhChhhccccc
Confidence            99999999999999987544

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=8.6e-44  Score=368.47  Aligned_cols=258  Identities=23%  Similarity=0.333  Sum_probs=201.4

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC-HHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS-AVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      +..+.|.+.+.||+|+||.||. +.+..+|+.||||++.+.... ......+.+|+++|+.++|||||+++++|...   
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~-a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~---  256 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCA-CQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK---  256 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEE-EEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS---
T ss_pred             ccccceEEEEEEeeCCCEEEEE-EEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC---
Confidence            5567799999999999999996 456779999999998643111 11234467899999999999999999998754   


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~~---~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                         ..+|++||++ |++|..++...   .+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||++
T Consensus       257 ---~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla  333 (576)
T 2acx_A          257 ---DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA  333 (576)
T ss_dssp             ---SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ---CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccc
Confidence               4689999998 78999888653   3999999999999999999999999999999999999999999999999998


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      +......                                                           ...+.+||+.|+||
T Consensus       334 ~~~~~~~-----------------------------------------------------------~~~~~~GT~~Y~AP  354 (576)
T 2acx_A          334 VHVPEGQ-----------------------------------------------------------TIKGRVGTVGYMAP  354 (576)
T ss_dssp             EECCTTC-----------------------------------------------------------CEECCCSCGGGCCH
T ss_pred             eecccCc-----------------------------------------------------------cccccCCCccccCH
Confidence            6432110                                                           11234678888888


Q ss_pred             HHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCc---HHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         296 EIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISS---DSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       296 Evl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                      |++.+..+...+|+||+|++++.|.++..||......   ..........+.       .....++++++|||.+||+.|
T Consensus       355 Evl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~-------~~p~~~s~~~~dLI~~lL~~d  427 (576)
T 2acx_A          355 EVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE-------EYSERFSPQARSLCSQLLCKD  427 (576)
T ss_dssp             HHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC-------CCCTTSCHHHHHHHHHHTCSS
T ss_pred             HHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc-------cCCccCCHHHHHHHHHhccCC
Confidence            8887777777889999999998886655555432211   112222211111       112457899999999999999


Q ss_pred             CCCCC-----CHHHHhcCCCCCCC
Q psy8260         373 SEKRI-----TAEQALAHPYLSQY  391 (427)
Q Consensus       373 P~~R~-----ta~e~L~Hp~f~~~  391 (427)
                      |.+|+     |++|+++||||+..
T Consensus       428 P~~R~g~~~~sa~eil~HpfF~~i  451 (576)
T 2acx_A          428 PAERLGCRGGSAREVKEHPLFKKL  451 (576)
T ss_dssp             GGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred             HHHcCCCCCCCHHHHHhChhhccC
Confidence            99999     89999999999875

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=4.8e-43  Score=360.64  Aligned_cols=261  Identities=27%  Similarity=0.425  Sum_probs=197.3

Q ss_pred             cCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH-----------HHHHHHHHHHHHHhcCCCCCceeee
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA-----------VHAKRTYRELRMLKHMNHENVIGLL  130 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~-----------~~~~~~~~Ei~~l~~l~HpnIv~l~  130 (427)
                      ..+.|.+.+.||+|+||.||. +.+..+++.||||++.......           ...+.+.+|+.+|+.++||||++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~-~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  112 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLL-CKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF  112 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEE-EEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             cccceEEEeEecccCCeEEEE-EEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            346799999999999999996 5677899999999987543221           1235678999999999999999999


Q ss_pred             eeeecCccccCCceEEEEeccC-CCCHHHHHh-hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCC---
Q psy8260         131 DVFHSNTCLADFKNVYMVTHLM-GADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC---  205 (427)
Q Consensus       131 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~l~-~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~---  205 (427)
                      +++...      ..+|+++|++ |++|.+.+. ...+++..+..++.||+.||.|||++||+||||||+|||++.++   
T Consensus       113 ~~~~~~------~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~  186 (504)
T 3q5i_A          113 DVFEDK------KYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLL  186 (504)
T ss_dssp             EEEECS------SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCS
T ss_pred             EEEEcC------CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCc
Confidence            998754      4688999998 678877664 56799999999999999999999999999999999999998765   


Q ss_pred             CEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccc
Q psy8260         206 ELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTG  285 (427)
Q Consensus       206 ~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~  285 (427)
                      .+||+|||+++......                                                           ....
T Consensus       187 ~~kl~Dfg~a~~~~~~~-----------------------------------------------------------~~~~  207 (504)
T 3q5i_A          187 NIKIVDFGLSSFFSKDY-----------------------------------------------------------KLRD  207 (504)
T ss_dssp             SEEECCCTTCEECCTTS-----------------------------------------------------------CBCC
T ss_pred             cEEEEECCCCEEcCCCC-----------------------------------------------------------cccc
Confidence            69999999986432210                                                           1122


Q ss_pred             ccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHH
Q psy8260         286 YVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLL  365 (427)
Q Consensus       286 ~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi  365 (427)
                      .+||+.|+|||++.+ .+..++|+||+|++++.|.++..||....................    ...+..+++++++||
T Consensus       208 ~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~s~~~~~li  282 (504)
T 3q5i_A          208 RLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD----FNDWKNISDEAKELI  282 (504)
T ss_dssp             CCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----HHHHTTSCHHHHHHH
T ss_pred             ccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----ccccCCCCHHHHHHH
Confidence            346777777777654 366677999999999888555555543322222222222222221    234567899999999


Q ss_pred             HHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q psy8260         366 SLMLELDSEKRITAEQALAHPYLSQYSD  393 (427)
Q Consensus       366 ~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  393 (427)
                      .+||++||.+|||++|+|+||||++...
T Consensus       283 ~~~L~~dp~~R~t~~e~l~h~~~~~~~~  310 (504)
T 3q5i_A          283 KLMLTYDYNKRCTAEEALNSRWIKKYAN  310 (504)
T ss_dssp             HHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred             HHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence            9999999999999999999999987543

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=9.4e-43  Score=347.12  Aligned_cols=270  Identities=21%  Similarity=0.303  Sum_probs=192.8

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCC--CCCceeeeeeeecCc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN--HENVIGLLDVFHSNT  137 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~--HpnIv~l~~~~~~~~  137 (427)
                      .+....|.+.+.||+|+||.||.+. +. +++.||||++............+.+|+.+|+.++  ||||+++++++... 
T Consensus        52 ~~~~~~y~~~~~LG~G~fg~Vy~~~-~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~-  128 (390)
T 2zmd_A           52 SVKGRIYSILKQIGSGGSSKVFQVL-NE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-  128 (390)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEE-CT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-
T ss_pred             cccCCceEEEEEEccCCCeEEEEEE-cC-CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC-
Confidence            3445569999999999999999754 43 4899999999766556666777889999999996  59999999987654 


Q ss_pred             cccCCceEEEEeccCCCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         138 CLADFKNVYMVTHLMGADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       138 ~~~~~~~~~lv~e~~g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                           ..+|++||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++
T Consensus       129 -----~~~~lv~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~  202 (390)
T 2zmd_A          129 -----QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN  202 (390)
T ss_dssp             -----SEEEEEEECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSC
T ss_pred             -----CEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccc
Confidence                 45899999888999998865 5689999999999999999999999999999999999996 5899999999998


Q ss_pred             CCCCC-----cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccc
Q psy8260         217 PTENE-----MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRW  291 (427)
Q Consensus       217 ~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~  291 (427)
                      .....     ....+||+.|+|||++.+.......                                      +.     
T Consensus       203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--------------------------------------~~-----  239 (390)
T 2zmd_A          203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSREN--------------------------------------GK-----  239 (390)
T ss_dssp             CC---------CCSCCCGGGCCHHHHHCC---------------------------------------------------
T ss_pred             cccCCCccccCCCCCcCCCccChHHhhhccccccc--------------------------------------cc-----
Confidence            65332     1223455555555554321000000                                      00     


Q ss_pred             ccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCc-HHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcC
Q psy8260         292 YRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISS-DSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLE  370 (427)
Q Consensus       292 Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~  370 (427)
                             ....+..++|+||+|++++.|.++..||...... .............      ......++++++||.+||+
T Consensus       240 -------~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~L~  306 (390)
T 2zmd_A          240 -------SKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI------EFPDIPEKDLQDVLKCCLK  306 (390)
T ss_dssp             -----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC------CCCCCSCHHHHHHHHHHTC
T ss_pred             -------cccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccC------CCCccchHHHHHHHHHHcc
Confidence                   0012445679999999998886555555432211 1111121111111      0112346789999999999


Q ss_pred             CCCCCCCCHHHHhcCCCCCCCCCC
Q psy8260         371 LDSEKRITAEQALAHPYLSQYSDP  394 (427)
Q Consensus       371 ~dP~~R~ta~e~L~Hp~f~~~~~~  394 (427)
                      .||.+|||++|+|+||||.....|
T Consensus       307 ~dP~~Rps~~ell~hp~~~~~~~~  330 (390)
T 2zmd_A          307 RDPKQRISIPELLAHPYVQIQTHP  330 (390)
T ss_dssp             SSTTTSCCHHHHHTSHHHHSCC--
T ss_pred             cChhhCCCHHHHhhCcCccccCcc
Confidence            999999999999999999865443

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4.6e-43  Score=372.04  Aligned_cols=259  Identities=19%  Similarity=0.251  Sum_probs=202.3

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCcc
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTC  138 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~  138 (427)
                      +..++|++.+.||+|+||.||. +.+..+++.||||++.+... .....+...+|..+|..+ +||||++++++|...  
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~-~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~--  414 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVML-SERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--  414 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEE-EEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS--
T ss_pred             ccccceEEEEEEccCCCEEEEE-EEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC--
Confidence            4456799999999999999996 45677899999999864311 111234567899999987 799999999998654  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                          ..+|++|||+ |++|..++.. +.+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+
T Consensus       415 ----~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~  490 (674)
T 3pfq_A          415 ----DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK  490 (674)
T ss_dssp             ----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred             ----CEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceee
Confidence                4689999998 7899988865 679999999999999999999999999999999999999999999999999986


Q ss_pred             CCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         217 PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       217 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      ......                                                          ......+||+.|+|||
T Consensus       491 ~~~~~~----------------------------------------------------------~~~~~~~GT~~Y~APE  512 (674)
T 3pfq_A          491 ENIWDG----------------------------------------------------------VTTKTFCGTPDYIAPE  512 (674)
T ss_dssp             ECCCTT----------------------------------------------------------CCBCCCCSCSSSCCHH
T ss_pred             ccccCC----------------------------------------------------------cccccccCCCcccCHh
Confidence            321110                                                          0112346788888888


Q ss_pred             HhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCC
Q psy8260         297 IMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKR  376 (427)
Q Consensus       297 vl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R  376 (427)
                      ++.+..+...+|+||+|+++++|.++..||......+...........+        ...++++++|||.+||++||.+|
T Consensus       513 ~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~--------p~~~s~~~~~li~~lL~~dP~~R  584 (674)
T 3pfq_A          513 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY--------PKSMSKEAVAICKGLMTKHPGKR  584 (674)
T ss_dssp             HHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCC--------CTTSCHHHHHHHHHHSCSSSTTC
T ss_pred             hhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCC--------CccCCHHHHHHHHHHccCCHHHC
Confidence            8877778888899999999998866665564433223333333322222        23578999999999999999999


Q ss_pred             CCH-----HHHhcCCCCCCCC
Q psy8260         377 ITA-----EQALAHPYLSQYS  392 (427)
Q Consensus       377 ~ta-----~e~L~Hp~f~~~~  392 (427)
                      +++     +|+++||||+...
T Consensus       585 ~~~~~~~~~ei~~h~ff~~i~  605 (674)
T 3pfq_A          585 LGCGPEGERDIKEHAFFRYID  605 (674)
T ss_dssp             TTCSTTHHHHHHSSGGGSSCC
T ss_pred             CCCCCCcHHHHhcCccccCCC
Confidence            997     9999999998653

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.2e-43  Score=354.71  Aligned_cols=255  Identities=20%  Similarity=0.310  Sum_probs=187.9

Q ss_pred             cceeec-cccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHH-hcCCCCCceeeeeeeecCccccC
Q psy8260          64 GVIDIG-PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRML-KHMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        64 ~~~~~~-~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l-~~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      +.|.+. +.||.|+||.||. +.+..+|+.||||++...       ....+|+.++ +..+||||++++++|...  ..+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~-~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~--~~~  130 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQ-IFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENL--YAG  130 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEE-EEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE--ETT
T ss_pred             ccceeccceeeeccCeEEEE-EEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeec--ccC
Confidence            345555 7899999999996 567789999999998532       2356788877 456899999999998641  122


Q ss_pred             CceEEEEeccC-CCCHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcC---CCCEEEeeCCC
Q psy8260         142 FKNVYMVTHLM-GADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE---DCELKILDFGL  214 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l~~~---~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~---~~~~kl~DFGl  214 (427)
                      ...+|++||++ |++|.+++...   .+++..+..++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+
T Consensus       131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence            35689999998 67999998753   4999999999999999999999999999999999999987   78999999999


Q ss_pred             CCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccc
Q psy8260         215 ARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRA  294 (427)
Q Consensus       215 a~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~A  294 (427)
                      ++......                                                           .....+||+.|+|
T Consensus       211 a~~~~~~~-----------------------------------------------------------~~~~~~gt~~y~a  231 (400)
T 1nxk_A          211 AKETTSHN-----------------------------------------------------------SLTTPCYTPYYVA  231 (400)
T ss_dssp             CEECC----------------------------------------------------------------------CTTCC
T ss_pred             ccccCCCC-----------------------------------------------------------ccccCCCCCCccC
Confidence            86432110                                                           1123356777777


Q ss_pred             hHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCc----HHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcC
Q psy8260         295 PEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISS----DSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLE  370 (427)
Q Consensus       295 PEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~  370 (427)
                      ||++.+..+...+|+||+|++++.|.++..+|......    ...............    ..+..+++++++||.+||+
T Consensus       232 PE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~----~~~~~~s~~~~~li~~~L~  307 (400)
T 1nxk_A          232 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN----PEWSEVSEEVKMLIRNLLK  307 (400)
T ss_dssp             GGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT----TTTTTSCHHHHHHHHTTSC
T ss_pred             HhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC----cccccCCHHHHHHHHHHCC
Confidence            77776666777789999999998886555555332111    111122111111111    1235678999999999999


Q ss_pred             CCCCCCCCHHHHhcCCCCCCC
Q psy8260         371 LDSEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       371 ~dP~~R~ta~e~L~Hp~f~~~  391 (427)
                      .||.+|||++|+|+||||.+.
T Consensus       308 ~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          308 TEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             SSGGGSCCHHHHHHSHHHHTT
T ss_pred             CChhHCcCHHHHhcCccccCC
Confidence            999999999999999999764

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3e-42  Score=328.90  Aligned_cols=259  Identities=22%  Similarity=0.343  Sum_probs=197.9

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      ...|.+.+.||+|+||.||. +.+..+++.||+|++..........+.+.+|+.+++.++||||+++++++....  ...
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~-~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~  101 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYK-GLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV--KGK  101 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEE-EEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES--SSC
T ss_pred             ceeEEeeeeccCCCCeEEEE-eEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc--CCC
Confidence            34578889999999999996 467788999999998766666666777889999999999999999999886421  223


Q ss_pred             ceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcC--ceeccCCCCCeEEc-CCCCEEEeeCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVN-EDCELKILDFGLARP  217 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~--iiHrDLKp~NILl~-~~~~~kl~DFGla~~  217 (427)
                      ..++++++++ +++|.+++.. ..+++..+..++.|++.||.|||++|  |+||||||+|||++ .++.+||+|||++..
T Consensus       102 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             ceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            5688999998 7799998875 67999999999999999999999999  99999999999997 789999999998853


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      .....                                                            .....||+.|+|||+
T Consensus       182 ~~~~~------------------------------------------------------------~~~~~~t~~y~aPE~  201 (290)
T 1t4h_A          182 KRASF------------------------------------------------------------AKAVIGTPEFMAPEM  201 (290)
T ss_dssp             CCTTS------------------------------------------------------------BEESCSSCCCCCGGG
T ss_pred             ccccc------------------------------------------------------------cccccCCcCcCCHHH
Confidence            32211                                                            112235666667776


Q ss_pred             hhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC
Q psy8260         298 MLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI  377 (427)
Q Consensus       298 l~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~  377 (427)
                      +.+ .+..++|+||+|++++.+.++..||................  ...   .......++++.+||.+||+.||.+||
T Consensus       202 ~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rp  275 (290)
T 1t4h_A          202 YEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG--VKP---ASFDKVAIPEVKEIIEGCIRQNKDERY  275 (290)
T ss_dssp             GGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT--CCC---GGGGGCCCHHHHHHHHHHSCSSGGGSC
T ss_pred             Hhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhcc--CCc---cccCCCCCHHHHHHHHHHccCChhhCC
Confidence            553 25566799999999988865555554322222211111111  111   122345678999999999999999999


Q ss_pred             CHHHHhcCCCCCC
Q psy8260         378 TAEQALAHPYLSQ  390 (427)
Q Consensus       378 ta~e~L~Hp~f~~  390 (427)
                      |++|+|+||||++
T Consensus       276 s~~ell~h~~f~~  288 (290)
T 1t4h_A          276 SIKDLLNHAFFQE  288 (290)
T ss_dssp             CHHHHHTSGGGC-
T ss_pred             CHHHHhhCccccc
Confidence            9999999999975

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=5.5e-43  Score=340.71  Aligned_cols=263  Identities=27%  Similarity=0.411  Sum_probs=192.8

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .+.|.+.+.||+|+||.||. +.+..+|+.||||++..........+.+.+|+.+++.++||||+++++++...      
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------   96 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMK-CRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK------   96 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEE-EEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET------
T ss_pred             hhhheeeeEEeecCCEEEEE-EEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC------
Confidence            46799999999999999996 55777899999999876655566666778999999999999999999998653      


Q ss_pred             ceEEEEeccCC-CCHHHHHh-hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         143 KNVYMVTHLMG-ADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       143 ~~~~lv~e~~g-~~L~~~l~-~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      ...|++++++. ++|..+.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        97 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A           97 KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             TEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             CEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence            46789999985 45665544 45799999999999999999999999999999999999999999999999999875332


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      ...                                                          ......||+.|+|||++.+
T Consensus       177 ~~~----------------------------------------------------------~~~~~~~t~~y~aPE~~~~  198 (331)
T 4aaa_A          177 PGE----------------------------------------------------------VYDDEVATRWYRAPELLVG  198 (331)
T ss_dssp             -----------------------------------------------------------------CCCCCTTCCHHHHTT
T ss_pred             Ccc----------------------------------------------------------ccCCCcCCccccCcccccC
Confidence            110                                                          0112235666666666654


Q ss_pred             c-cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHH--------------hcC--------CC-CCcccHHhhcCC
Q psy8260         301 W-MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYI--------------NSL--------PL-LTKKDFRQVFKG  356 (427)
Q Consensus       301 ~-~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~--------------~~~--------~~-~~~~~~~~~~~~  356 (427)
                      . .+..++|+||+|++++.|.++..+|.............              ...        +. .........++.
T Consensus       199 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (331)
T 4aaa_A          199 DVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPK  278 (331)
T ss_dssp             CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTT
T ss_pred             CCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccc
Confidence            3 34556699999988877744443332211111111110              000        11 112223445567


Q ss_pred             CChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q psy8260         357 ANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQ  390 (427)
Q Consensus       357 ~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~  390 (427)
                      .++++.+||.+||+.||.+|||++|+|+||||+.
T Consensus       279 ~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~  312 (331)
T 4aaa_A          279 LSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM  312 (331)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred             hhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence            8999999999999999999999999999999975

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.8e-42  Score=330.08  Aligned_cols=255  Identities=29%  Similarity=0.422  Sum_probs=189.1

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .+.|.+.+.||+|+||.||. +.+..+|+.||+|++..... ....+.+.+|+++++.++||||+++++++...      
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------   92 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHL-VEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY------   92 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEE-EEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS------
T ss_pred             hhheeecceeccCCCeEEEE-EEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecC------
Confidence            36789999999999999996 55777899999999865432 22245678999999999999999999998653      


Q ss_pred             ceEEEEeccC-CCCHHHHHh-----hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEc---CCCCEEEeeCC
Q psy8260         143 KNVYMVTHLM-GADLNNILR-----TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN---EDCELKILDFG  213 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~-----~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~---~~~~~kl~DFG  213 (427)
                      ...++++|++ +++|.+.+.     ...+++..+..++.|++.||.|||++||+||||||+|||++   .++.+||+|||
T Consensus        93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg  172 (285)
T 3is5_A           93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFG  172 (285)
T ss_dssp             SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred             CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeee
Confidence            4678999988 678888763     25699999999999999999999999999999999999994   46789999999


Q ss_pred             CCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccccc
Q psy8260         214 LARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR  293 (427)
Q Consensus       214 la~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~  293 (427)
                      +++......                                                           ......||+.|+
T Consensus       173 ~a~~~~~~~-----------------------------------------------------------~~~~~~~t~~y~  193 (285)
T 3is5_A          173 LAELFKSDE-----------------------------------------------------------HSTNAAGTALYM  193 (285)
T ss_dssp             CCCC---------------------------------------------------------------------CTTGGGC
T ss_pred             cceecCCcc-----------------------------------------------------------cCcCcccccCcC
Confidence            987532211                                                           011224566677


Q ss_pred             chHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCC
Q psy8260         294 APEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDS  373 (427)
Q Consensus       294 APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP  373 (427)
                      |||++.+ .+..++|+||+|++++.|.++..+|................+...     ......++++.+||.+||+.||
T Consensus       194 aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dP  267 (285)
T 3is5_A          194 APEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA-----VECRPLTPQAVDLLKQMLTKDP  267 (285)
T ss_dssp             CHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-----C--CCCCHHHHHHHHHHTCSCT
T ss_pred             ChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccc-----cccCcCCHHHHHHHHHHccCCh
Confidence            7776643 345567999999999877555444432221111111111122111     1123468899999999999999


Q ss_pred             CCCCCHHHHhcCCCCCC
Q psy8260         374 EKRITAEQALAHPYLSQ  390 (427)
Q Consensus       374 ~~R~ta~e~L~Hp~f~~  390 (427)
                      .+|||++|+|+||||++
T Consensus       268 ~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          268 ERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             TTSCCHHHHHTSGGGGC
T ss_pred             hhCcCHHHHhcCHHhhc
Confidence            99999999999999975

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.7e-43  Score=353.32  Aligned_cols=259  Identities=28%  Similarity=0.426  Sum_probs=186.6

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC------CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ------SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSN  136 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~------~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~  136 (427)
                      .+.|.+.+.||+|+||.||. +.+..+++.||||++.+...      .......+.+|+.+|++++|||||++++++.. 
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~-a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-  211 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKL-AFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-  211 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEE-EEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred             hccEEEEeEEeeCCCeEEEE-EEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence            46789999999999999996 56778999999999865321      11122346799999999999999999999754 


Q ss_pred             ccccCCceEEEEeccC-CCCHHHHHh-hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCC---CCEEEee
Q psy8260         137 TCLADFKNVYMVTHLM-GADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED---CELKILD  211 (427)
Q Consensus       137 ~~~~~~~~~~lv~e~~-g~~L~~~l~-~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~---~~~kl~D  211 (427)
                            ...|++||++ +++|.+.+. ...+++..+..++.|++.||.|||++||+||||||+|||++.+   +.+||+|
T Consensus       212 ------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~D  285 (419)
T 3i6u_A          212 ------EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITD  285 (419)
T ss_dssp             ------SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred             ------CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEee
Confidence                  3468899988 778987765 4579999999999999999999999999999999999999754   4599999


Q ss_pred             CCCCCCCCCC--cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccc
Q psy8260         212 FGLARPTENE--MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT  289 (427)
Q Consensus       212 FGla~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt  289 (427)
                      ||+++.....  ....+||+.|+|||++.+.                                                 
T Consensus       286 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-------------------------------------------------  316 (419)
T 3i6u_A          286 FGHSKILGETSLMRTLCGTPTYLAPEVLVSV-------------------------------------------------  316 (419)
T ss_dssp             SSTTTSCC-----------CTTCCTTTTC---------------------------------------------------
T ss_pred             cccceecCCCccccccCCCCCccCceeeecC-------------------------------------------------
Confidence            9999865432  1233455555555543210                                                 


Q ss_pred             ccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhc
Q psy8260         290 RWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLML  369 (427)
Q Consensus       290 ~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL  369 (427)
                               ....+..++|+||+|++++.|.++..||.................   .......+..+++++++||.+||
T Consensus       317 ---------~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~~~~~li~~~L  384 (419)
T 3i6u_A          317 ---------GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK---YNFIPEVWAEVSEKALDLVKKLL  384 (419)
T ss_dssp             -----------CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTC---CCCCHHHHTTSCHHHHHHHHHHS
T ss_pred             ---------CCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCC---CCCCchhhcccCHHHHHHHHHHc
Confidence                     011233457999999999888555555543222212222221111   11123445678999999999999


Q ss_pred             CCCCCCCCCHHHHhcCCCCCC
Q psy8260         370 ELDSEKRITAEQALAHPYLSQ  390 (427)
Q Consensus       370 ~~dP~~R~ta~e~L~Hp~f~~  390 (427)
                      ++||.+|||++|+|+||||++
T Consensus       385 ~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          385 VVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             CSSTTTSCCHHHHHHSGGGCC
T ss_pred             cCChhHCcCHHHHhCCcccCC
Confidence            999999999999999999975

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.6e-42  Score=340.30  Aligned_cols=253  Identities=21%  Similarity=0.298  Sum_probs=193.8

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC-HHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS-AVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      ...|.+.+.||+|+||.||. +.+..+|+.||||++...... ....+.+.+|+++++.++||||+++++++...     
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~-a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----  126 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYF-ARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----  126 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEE-EEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----
T ss_pred             hhheeeeeEEccCCCEEEEE-EEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----
Confidence            45688899999999999996 456778999999998754333 33446678999999999999999999998653     


Q ss_pred             CceEEEEeccCCCCHHHHHh--hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         142 FKNVYMVTHLMGADLNNILR--TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       142 ~~~~~lv~e~~g~~L~~~l~--~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                       ...++++|++.++|.+++.  ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       127 -~~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  205 (348)
T 1u5q_A          127 -HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA  205 (348)
T ss_dssp             -TEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred             -CeEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence             4689999999888888774  3579999999999999999999999999999999999999999999999999987543


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      .. ...+|                                                             |+.|+|||++.
T Consensus       206 ~~-~~~~g-------------------------------------------------------------t~~y~aPE~~~  223 (348)
T 1u5q_A          206 PA-NSFVG-------------------------------------------------------------TPYWMAPEVIL  223 (348)
T ss_dssp             SB-CCCCS-------------------------------------------------------------CGGGCCHHHHH
T ss_pred             CC-CcccC-------------------------------------------------------------CcceeCHhhhc
Confidence            21 22344                                                             44455555443


Q ss_pred             ---hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhc-CCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCC
Q psy8260         300 ---NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINS-LPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEK  375 (427)
Q Consensus       300 ---~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~  375 (427)
                         ...+..++|+||+|++++.|.++..+|............... .+...       ....++++.+||.+||+.||.+
T Consensus       224 ~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dP~~  296 (348)
T 1u5q_A          224 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ-------SGHWSEYFRNFVDSCLQKIPQD  296 (348)
T ss_dssp             TTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCC-------CTTSCHHHHHHHHHHTCSSGGG
T ss_pred             cccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-------CCCCCHHHHHHHHHHcccChhh
Confidence               223555679999999998886555555332211222222221 11111       1346788999999999999999


Q ss_pred             CCCHHHHhcCCCCCCC
Q psy8260         376 RITAEQALAHPYLSQY  391 (427)
Q Consensus       376 R~ta~e~L~Hp~f~~~  391 (427)
                      |||++|+++||||...
T Consensus       297 Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          297 RPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             SCCHHHHTTCHHHHSC
T ss_pred             CcCHHHHhhChhhhcc
Confidence            9999999999999764

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=8.6e-43  Score=359.75  Aligned_cols=258  Identities=22%  Similarity=0.323  Sum_probs=200.1

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH-HHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA-VHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      +....|.+.+.||+|+||.||. +.+..+|+.||||++.+..... .....+.+|+++|+.++||||++++++|...   
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~-a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~---  257 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFA-CQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK---  257 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEE-EEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS---
T ss_pred             CChhheEEEEEEeeCCCeEEEE-EEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC---
Confidence            4457789999999999999996 4567789999999986432111 1234577899999999999999999998754   


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCC
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRT-----QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG  213 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFG  213 (427)
                         ..+|++||++ |++|..++..     ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||
T Consensus       258 ---~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFG  334 (543)
T 3c4z_A          258 ---TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLG  334 (543)
T ss_dssp             ---SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             ---CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecc
Confidence               4689999988 7899988864     259999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccccc
Q psy8260         214 LARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR  293 (427)
Q Consensus       214 la~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~  293 (427)
                      +++.......                                                          ...+.+||+.|+
T Consensus       335 la~~~~~~~~----------------------------------------------------------~~~~~~GT~~Y~  356 (543)
T 3c4z_A          335 LAVELKAGQT----------------------------------------------------------KTKGYAGTPGFM  356 (543)
T ss_dssp             TCEECCTTCC----------------------------------------------------------CBCCCCSCTTTS
T ss_pred             eeeeccCCCc----------------------------------------------------------ccccccCCcccc
Confidence            9864322100                                                          112346788888


Q ss_pred             chHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCc---H-HHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhc
Q psy8260         294 APEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISS---D-SARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLML  369 (427)
Q Consensus       294 APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL  369 (427)
                      |||++.+..+..++|+||+|++++.|.++..||......   . ...........        ....+++++++||.+||
T Consensus       357 APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~--------~p~~~s~~~~~li~~lL  428 (543)
T 3c4z_A          357 APELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVT--------YPDKFSPASKDFCEALL  428 (543)
T ss_dssp             CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCC--------CCTTSCHHHHHHHHHHS
T ss_pred             ChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccC--------CCcccCHHHHHHHHHhc
Confidence            888887777778889999999998886555555432211   1 11122221111        12457899999999999


Q ss_pred             CCCCCCCCC-----HHHHhcCCCCCCC
Q psy8260         370 ELDSEKRIT-----AEQALAHPYLSQY  391 (427)
Q Consensus       370 ~~dP~~R~t-----a~e~L~Hp~f~~~  391 (427)
                      +.||.+|++     ++|+++||||+..
T Consensus       429 ~~dP~~R~~~~~~~a~ei~~Hpff~~i  455 (543)
T 3c4z_A          429 QKDPEKRLGFRDGSCDGLRTHPLFRDI  455 (543)
T ss_dssp             CSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred             cCCHhHCCCCcccCHHHHHcCccccCC
Confidence            999999995     5899999999874

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.1e-42  Score=337.22  Aligned_cols=272  Identities=26%  Similarity=0.417  Sum_probs=197.1

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC---CCCCceeeeeeeecCccc
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM---NHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l---~HpnIv~l~~~~~~~~~~  139 (427)
                      .+.|.+.+.||+|+||.||.+.....+|+.||||++............+.+|+.+++.+   +||||+++++++.... .
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~-~   88 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR-T   88 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE-C
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc-c
Confidence            36789999999999999997654346789999998864332221122345676666655   8999999999976221 1


Q ss_pred             cCCceEEEEeccCCCCHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         140 ADFKNVYMVTHLMGADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       140 ~~~~~~~lv~e~~g~~L~~~l~~~---~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                      ......++++++++++|.+++...   .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        89 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~  168 (326)
T 1blx_A           89 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  168 (326)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             CCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence            123568999999989999988653   48999999999999999999999999999999999999999999999999986


Q ss_pred             CCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         217 PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       217 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      ......                                                           ......||+.|+|||
T Consensus       169 ~~~~~~-----------------------------------------------------------~~~~~~~~~~y~aPE  189 (326)
T 1blx_A          169 IYSFQM-----------------------------------------------------------ALTSVVVTLWYRAPE  189 (326)
T ss_dssp             CCCGGG-----------------------------------------------------------GGCCCCCCCTTCCHH
T ss_pred             cccCCC-----------------------------------------------------------CccccccccceeCHH
Confidence            532110                                                           011234677777777


Q ss_pred             HhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCC-------------------CCCcccHHhhcCCC
Q psy8260         297 IMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLP-------------------LLTKKDFRQVFKGA  357 (427)
Q Consensus       297 vl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~  357 (427)
                      ++.+..+..++|+||+|++++.+.++..+|.................                   .............+
T Consensus       190 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (326)
T 1blx_A          190 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDI  269 (326)
T ss_dssp             HHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSC
T ss_pred             HHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccC
Confidence            77766677778999999998777444444432211111111111100                   00111223345668


Q ss_pred             ChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q psy8260         358 NPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDP  394 (427)
Q Consensus       358 s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  394 (427)
                      ++++++||.+||+.||.+|||++|+|+||||.+....
T Consensus       270 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~  306 (326)
T 1blx_A          270 DELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC  306 (326)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence            8999999999999999999999999999999876543

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.2e-42  Score=341.58  Aligned_cols=270  Identities=24%  Similarity=0.384  Sum_probs=179.6

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc-ccC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC-LAD  141 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~-~~~  141 (427)
                      .+.|.+.+.||+|+||.||. +.+..+|+.||||++......   ..+..+|++.++.++||||++++++|..... ...
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~   97 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQL-GKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR   97 (360)
T ss_dssp             HTTEEEC----------CEE-EEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred             ccceEEEEEEecCCCeEEEE-EEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence            46799999999999999996 456778999999988543221   2345678888888999999999999864321 112


Q ss_pred             CceEEEEeccCCCCHHHHHh-----hCCCCHHHHHHHHHHHHHHHHHHH--hcCceeccCCCCCeEEcC-CCCEEEeeCC
Q psy8260         142 FKNVYMVTHLMGADLNNILR-----TQKLSDDHVQFLVYQILRGLKYIH--SAGIIHRDLKPSNIAVNE-DCELKILDFG  213 (427)
Q Consensus       142 ~~~~~lv~e~~g~~L~~~l~-----~~~l~~~~~~~~~~qi~~aL~yLH--~~~iiHrDLKp~NILl~~-~~~~kl~DFG  213 (427)
                      ...++++|++++++|...+.     ...+++..+..++.|++.||.|||  ++||+||||||+|||++. ++.+||+|||
T Consensus        98 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg  177 (360)
T 3e3p_A           98 DIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG  177 (360)
T ss_dssp             CEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred             ceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence            23478999999888766543     346899999999999999999999  999999999999999996 8999999999


Q ss_pred             CCCCCCCC--cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccc
Q psy8260         214 LARPTENE--MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRW  291 (427)
Q Consensus       214 la~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~  291 (427)
                      +++.....  .....                                                             ||+.
T Consensus       178 ~a~~~~~~~~~~~~~-------------------------------------------------------------gt~~  196 (360)
T 3e3p_A          178 SAKKLSPSEPNVAYI-------------------------------------------------------------CSRY  196 (360)
T ss_dssp             TCBCCCTTSCCCSTT-------------------------------------------------------------SCGG
T ss_pred             CceecCCCCCccccc-------------------------------------------------------------CCcc
Confidence            99754322  12233                                                             4555


Q ss_pred             ccchHHhhhcc-CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhc------------CC--------CCCcccH
Q psy8260         292 YRAPEIMLNWM-HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINS------------LP--------LLTKKDF  350 (427)
Q Consensus       292 Y~APEvl~~~~-~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~------------~~--------~~~~~~~  350 (427)
                      |+|||++.+.. +..++|+||+|++++.|.++..+|...............            .+        ......+
T Consensus       197 y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (360)
T 3e3p_A          197 YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPW  276 (360)
T ss_dssp             GCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCH
T ss_pred             eeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCc
Confidence            55555554332 344567777777776664443333221111111111110            00        0111123


Q ss_pred             HhhcCC----CChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCC
Q psy8260         351 RQVFKG----ANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDE  397 (427)
Q Consensus       351 ~~~~~~----~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~  397 (427)
                      ...+..    .+++++|||.+||++||.+|||++|+|+||||++...+...
T Consensus       277 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~  327 (360)
T 3e3p_A          277 SNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATK  327 (360)
T ss_dssp             HHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCC
T ss_pred             ccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCcccc
Confidence            333322    56789999999999999999999999999999987766543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.2e-42  Score=329.78  Aligned_cols=256  Identities=23%  Similarity=0.350  Sum_probs=194.5

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHH-HHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAV-HAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      ...+.|.+.+.||+|+||.||. +.+..+++.||||++........ ....+.+|+.+++.++||||+++++++...   
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---   81 (279)
T 3fdn_A            6 WALEDFEIGRPLGKGKFGNVYL-AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA---   81 (279)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEE-EEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS---
T ss_pred             eecccEEEeeEEecCCCeEEEE-EEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC---
Confidence            3457799999999999999996 55677899999999854321111 134577899999999999999999998654   


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCC
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP  217 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~  217 (427)
                         ...+++++++ +++|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        82 ---~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~  158 (279)
T 3fdn_A           82 ---TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH  158 (279)
T ss_dssp             ---SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESC
T ss_pred             ---CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEecccccc
Confidence               4578999988 5788887754 6799999999999999999999999999999999999999999999999998753


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      .....                                                            .....||+.|+|||+
T Consensus       159 ~~~~~------------------------------------------------------------~~~~~~~~~y~aPE~  178 (279)
T 3fdn_A          159 APSSR------------------------------------------------------------RTDLCGTLDYLPPEM  178 (279)
T ss_dssp             C--------------------------------------------------------------------CCCCTTCCHHH
T ss_pred             CCccc------------------------------------------------------------ccccCCCCCccCHhH
Confidence            32110                                                            112246677777777


Q ss_pred             hhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC
Q psy8260         298 MLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI  377 (427)
Q Consensus       298 l~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~  377 (427)
                      +.+..+...+|+||+|++++.+.++..+|..................        .....++++.+||.+||+.||.+||
T Consensus       179 ~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rp  250 (279)
T 3fdn_A          179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT--------FPDFVTEGARDLISRLLKHNPSQRP  250 (279)
T ss_dssp             HTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC--------CCTTSCHHHHHHHHHHCCSSGGGSC
T ss_pred             hccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCC--------CCCcCCHHHHHHHHHHhccChhhCC
Confidence            76666777789999999998775554444322211111122111111        1234678999999999999999999


Q ss_pred             CHHHHhcCCCCCCC
Q psy8260         378 TAEQALAHPYLSQY  391 (427)
Q Consensus       378 ta~e~L~Hp~f~~~  391 (427)
                      |++|+|+||||...
T Consensus       251 s~~e~l~h~~~~~~  264 (279)
T 3fdn_A          251 MLREVLEHPWITAN  264 (279)
T ss_dssp             CHHHHHHCHHHHHH
T ss_pred             CHHHHhhCccccCC
Confidence            99999999999864

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=5.6e-42  Score=332.87  Aligned_cols=259  Identities=25%  Similarity=0.487  Sum_probs=188.7

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCC-CCCceeeeeeeecCccccC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN-HENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~~  141 (427)
                      .+.|.+.+.||+|+||.||. +.+..+++.||||++....     .+.+.+|+.+++.++ ||||+++++++....    
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~----  104 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFE-AINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPV----  104 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEE-EEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTT----
T ss_pred             CCceEEEEEecccCCeEEEE-EEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCC----
Confidence            46799999999999999996 5577889999999986432     345779999999997 999999999987521    


Q ss_pred             CceEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCC-CEEEeeCCCCCCCC
Q psy8260         142 FKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC-ELKILDFGLARPTE  219 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~-~~kl~DFGla~~~~  219 (427)
                      ....+++++++ +++|.++++  .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus       105 ~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          105 SRTPALVFEHVNNTDFKQLYQ--TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             TCCEEEEEECCCCCCHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             CCceEEEEeccCchhHHHHHH--hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            24578888888 678888775  489999999999999999999999999999999999999776 89999999986432


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      ...                                                           ......||+.|+|||++.
T Consensus       183 ~~~-----------------------------------------------------------~~~~~~~~~~y~aPE~~~  203 (330)
T 3nsz_A          183 PGQ-----------------------------------------------------------EYNVRVASRYFKGPELLV  203 (330)
T ss_dssp             TTC-----------------------------------------------------------CCCSCCSCGGGCCHHHHT
T ss_pred             CCC-----------------------------------------------------------ccccccccccccChhhhc
Confidence            211                                                           011223556666666665


Q ss_pred             h-ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcC-------------cHHHHHHHhcCC------------CCCcccHHhh
Q psy8260         300 N-WMHYNQTDIHQLNLIMEMLGTPPAEFMAKIS-------------SDSARKYINSLP------------LLTKKDFRQV  353 (427)
Q Consensus       300 ~-~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~-------------~~~~~~~~~~~~------------~~~~~~~~~~  353 (427)
                      + ..+..++|+||+|++++.|.++..||.....             ......+.....            ......+...
T Consensus       204 ~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (330)
T 3nsz_A          204 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERF  283 (330)
T ss_dssp             TCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGG
T ss_pred             CCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhh
Confidence            4 3355567999999988877444433321110             001111111100            0011111111


Q ss_pred             -----cCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q psy8260         354 -----FKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYS  392 (427)
Q Consensus       354 -----~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~  392 (427)
                           ...+++++++||.+||++||.+|||++|+|+||||++..
T Consensus       284 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  327 (330)
T 3nsz_A          284 VHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  327 (330)
T ss_dssp             CCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             ccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence                 122689999999999999999999999999999998764

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.3e-42  Score=326.23  Aligned_cols=256  Identities=25%  Similarity=0.394  Sum_probs=196.6

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .+.|.+.+.||+|+||.||. +.+..++..||+|++.......  .+.+.+|+++++.++||||+++++++...      
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~~a~k~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------   78 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKI-AVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIRLYETFEDN------   78 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEE-EEETTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECS------
T ss_pred             hhhEEeeeEEeecCCEEEEE-EEeCCCCcEEEEEeehhhccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecC------
Confidence            35688999999999999996 4567789999999987543322  45677999999999999999999998653      


Q ss_pred             ceEEEEeccC-CCCHHHHHh-hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEE---cCCCCEEEeeCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILDFGLARP  217 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~-~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl---~~~~~~kl~DFGla~~  217 (427)
                      ...+++++++ +++|.+.+. ...+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~  158 (277)
T 3f3z_A           79 TDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR  158 (277)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             CeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence            4578999988 679987764 4679999999999999999999999999999999999999   7788999999999864


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      .....                                                           ......||+.|+|||+
T Consensus       159 ~~~~~-----------------------------------------------------------~~~~~~~t~~y~aPE~  179 (277)
T 3f3z_A          159 FKPGK-----------------------------------------------------------MMRTKVGTPYYVSPQV  179 (277)
T ss_dssp             CCTTS-----------------------------------------------------------CBCCCCSCTTTCCHHH
T ss_pred             ccCcc-----------------------------------------------------------chhccCCCCCccChHH
Confidence            32210                                                           1112346677777777


Q ss_pred             hhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC
Q psy8260         298 MLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI  377 (427)
Q Consensus       298 l~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~  377 (427)
                      +.+. +..++|+||+|++++.+.++..+|...................+    ...+...++++.+||.+||+.||.+||
T Consensus       180 ~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~R~  254 (277)
T 3f3z_A          180 LEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFP----EKDWLNVSPQAESLIRRLLTKSPKQRI  254 (277)
T ss_dssp             HTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----HHHHTTSCHHHHHHHHHHTCSSTTTSC
T ss_pred             hccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC----chhhhcCCHHHHHHHHHHccCChhhCc
Confidence            6554 56678999999999887555444433221222222222222222    223346789999999999999999999


Q ss_pred             CHHHHhcCCCCCCC
Q psy8260         378 TAEQALAHPYLSQY  391 (427)
Q Consensus       378 ta~e~L~Hp~f~~~  391 (427)
                      |+.|+|+||||++.
T Consensus       255 s~~~~l~h~~~~~~  268 (277)
T 3f3z_A          255 TSLQALEHEWFEKQ  268 (277)
T ss_dssp             CHHHHTTSHHHHHH
T ss_pred             CHHHHhcCHHHhcc
Confidence            99999999999764

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.8e-43  Score=343.18  Aligned_cols=266  Identities=25%  Similarity=0.404  Sum_probs=195.4

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcC---CCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPF---QSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      .+.|.+.+.||+|+||.||. +.+..+++.||||++....   ......+.+.+|+++++.++||||+++++++...   
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~-~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---  100 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRV-AIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE---  100 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEE-EEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS---
T ss_pred             hhheeecceeeecCCeEEEE-EEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC---
Confidence            46799999999999999996 4577889999999886431   1223456688999999999999999999998653   


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhh-----------------------------------------CCCCHHHHHHHHHHH
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRT-----------------------------------------QKLSDDHVQFLVYQI  177 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~-----------------------------------------~~l~~~~~~~~~~qi  177 (427)
                         ...++++|++ +++|.+++..                                         ..+++..+..++.||
T Consensus       101 ---~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi  177 (345)
T 3hko_A          101 ---QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI  177 (345)
T ss_dssp             ---SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred             ---CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence               4678999988 7899988741                                         123577888999999


Q ss_pred             HHHHHHHHhcCceeccCCCCCeEEcCCC--CEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccC
Q psy8260         178 LRGLKYIHSAGIIHRDLKPSNIAVNEDC--ELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDL  255 (427)
Q Consensus       178 ~~aL~yLH~~~iiHrDLKp~NILl~~~~--~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~  255 (427)
                      +.||.|||++||+||||||+|||++.++  .+||+|||+++.........                              
T Consensus       178 ~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~------------------------------  227 (345)
T 3hko_A          178 FSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE------------------------------  227 (345)
T ss_dssp             HHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC-------------------------------
T ss_pred             HHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccc------------------------------
Confidence            9999999999999999999999998766  89999999986432110000                              


Q ss_pred             CcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh--ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcH
Q psy8260         256 KPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN--WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSD  333 (427)
Q Consensus       256 ~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~--~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~  333 (427)
                                              ........||+.|+|||++.+  ..+..++|+||+|++++.|.++..||......+
T Consensus       228 ------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~  283 (345)
T 3hko_A          228 ------------------------YYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD  283 (345)
T ss_dssp             -------------------------------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             ------------------------cccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHH
Confidence                                    001123357777888887754  345567799999999988755555553322222


Q ss_pred             HHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q psy8260         334 SARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSD  393 (427)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  393 (427)
                      ..............    ..+...++++.+||.+||+.||.+|||++|+|+||||++...
T Consensus       284 ~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~  339 (345)
T 3hko_A          284 TISQVLNKKLCFEN----PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD  339 (345)
T ss_dssp             HHHHHHHCCCCTTS----GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred             HHHHHHhcccccCC----cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence            22333332222221    122347899999999999999999999999999999987643

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.1e-42  Score=327.12  Aligned_cols=250  Identities=20%  Similarity=0.316  Sum_probs=187.5

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCccccC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~~  141 (427)
                      .+.|.+.+.||+|+||.||. +.+..+++.||||++...........++.+|+..+..+ +||||+++++++...     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~-----   83 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFK-CVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED-----   83 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEE-EEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET-----
T ss_pred             cchhhhhhhhcCCCceEEEE-EEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----
Confidence            46789999999999999996 45677899999999976655555667788999999999 999999999998653     


Q ss_pred             CceEEEEeccC-CCCHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCC----------
Q psy8260         142 FKNVYMVTHLM-GADLNNILRT-----QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC----------  205 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~----------  205 (427)
                       ...++++|++ +++|.+++..     ..+++..+..++.||+.||.|||++||+||||||+|||++.++          
T Consensus        84 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~  162 (289)
T 1x8b_A           84 -DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGD  162 (289)
T ss_dssp             -TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------
T ss_pred             -CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccc
Confidence             4678999998 6799998864     5699999999999999999999999999999999999998544          


Q ss_pred             ---------CEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCC
Q psy8260         206 ---------ELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLA  276 (427)
Q Consensus       206 ---------~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~  276 (427)
                               .+||+|||+++......                                                      
T Consensus       163 ~~~~~~~~~~~kl~Dfg~~~~~~~~~------------------------------------------------------  188 (289)
T 1x8b_A          163 EDDWASNKVMFKIGDLGHVTRISSPQ------------------------------------------------------  188 (289)
T ss_dssp             -------CCCEEECCCTTCEETTCSC------------------------------------------------------
T ss_pred             cccccCCceEEEEcccccccccCCcc------------------------------------------------------
Confidence                     67888888765432211                                                      


Q ss_pred             CCCccccccccccccccchHHhhhc-cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcC
Q psy8260         277 RPTENEMTGYVATRWYRAPEIMLNW-MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFK  355 (427)
Q Consensus       277 ~~~~~~~~~~~gt~~Y~APEvl~~~-~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (427)
                              ...||+.|+|||++.+. .+..++|+||+|++++.+.++..++..   ............       .....
T Consensus       189 --------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~---~~~~~~~~~~~~-------~~~~~  250 (289)
T 1x8b_A          189 --------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN---GDQWHEIRQGRL-------PRIPQ  250 (289)
T ss_dssp             --------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS---SHHHHHHHTTCC-------CCCSS
T ss_pred             --------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc---hhHHHHHHcCCC-------CCCCc
Confidence                    12356666666666543 222467999999999877554432211   111112211110       11224


Q ss_pred             CCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q psy8260         356 GANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       356 ~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~  391 (427)
                      ..++++.+||.+||+.||.+|||++|+++||||.+.
T Consensus       251 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          251 VLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             CCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             ccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            578999999999999999999999999999999763

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.6e-42  Score=330.26  Aligned_cols=261  Identities=19%  Similarity=0.280  Sum_probs=182.2

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      ++..+.|.+.+.||+|+||.||. +.+..+|+.||||++..........+...++...++.++||||+++++++...   
T Consensus         3 ~i~~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~---   78 (290)
T 3fme_A            3 EVKADDLEPIMELGRGAYGVVEK-MRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE---   78 (290)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEE-EEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS---
T ss_pred             cccHHhhhhHHhcCCCCCeEEEE-EEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc---
Confidence            45667899999999999999996 56777899999999875433333333344555668889999999999998653   


Q ss_pred             cCCceEEEEeccCCCCHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCCeEEcCCCCEEEeeCC
Q psy8260         140 ADFKNVYMVTHLMGADLNNILRT-----QKLSDDHVQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDCELKILDFG  213 (427)
Q Consensus       140 ~~~~~~~lv~e~~g~~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~yLH~~-~iiHrDLKp~NILl~~~~~~kl~DFG  213 (427)
                         ...++++|+++++|.+++..     ..+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus        79 ---~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T 3fme_A           79 ---GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFG  155 (290)
T ss_dssp             ---SSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-
T ss_pred             ---CCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecC
Confidence               45799999998888776642     5799999999999999999999998 99999999999999999999999999


Q ss_pred             CCCCCCCCc--ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccc
Q psy8260         214 LARPTENEM--TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRW  291 (427)
Q Consensus       214 la~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~  291 (427)
                      +++......  ....||+.|+|||++...                                                   
T Consensus       156 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---------------------------------------------------  184 (290)
T 3fme_A          156 ISGYLVDDVAKDIDAGCKPYMAPERINPE---------------------------------------------------  184 (290)
T ss_dssp             --------------CCCCCCSCHHHHSCC---------------------------------------------------
T ss_pred             CcccccccccccccCCCccccChhhcChh---------------------------------------------------
Confidence            987543321  112344444444443110                                                   


Q ss_pred             ccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCc-HHHHHHHhc-CCCCCcccHHhhcCCCChhHHHHHHHhc
Q psy8260         292 YRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISS-DSARKYINS-LPLLTKKDFRQVFKGANPQAIDLLSLML  369 (427)
Q Consensus       292 Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~dLi~~mL  369 (427)
                            ..+..+..++|+||+|++++.+.++..||...... ......... .+...       ....++++.+||.+||
T Consensus       185 ------~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~l  251 (290)
T 3fme_A          185 ------LNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLP-------ADKFSAEFVDFTSQCL  251 (290)
T ss_dssp             ------TTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCC-------TTTSCHHHHHHHHHHT
T ss_pred             ------hcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcc-------cccCCHHHHHHHHHHh
Confidence                  01223444679999999998875554444321111 111111111 11111       1346889999999999


Q ss_pred             CCCCCCCCCHHHHhcCCCCCCC
Q psy8260         370 ELDSEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       370 ~~dP~~R~ta~e~L~Hp~f~~~  391 (427)
                      +.||.+|||++|+++||||+..
T Consensus       252 ~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          252 KKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             CSSGGGSCCHHHHTTSHHHHHH
T ss_pred             hcChhhCcCHHHHHhCcccccC
Confidence            9999999999999999999753

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.6e-42  Score=328.37  Aligned_cols=258  Identities=21%  Similarity=0.337  Sum_probs=197.9

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH-HHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA-VHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      .+..+.|.+.+.||+|+||.||. +.+..+++.||||++....... .....+.+|+++++.++||||+++++++...  
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~Vy~-~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--   86 (284)
T 2vgo_A           10 KFTIDDFDIGRPLGKGKFGNVYL-AREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR--   86 (284)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEE-EEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--
T ss_pred             chhhhhceeeheecCCCCeEEEE-EEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC--
Confidence            34457899999999999999996 4567789999999985421111 1134577899999999999999999998653  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                          ...|++++++ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus        87 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~  162 (284)
T 2vgo_A           87 ----KRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV  162 (284)
T ss_dssp             ----SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             ----CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccc
Confidence                4678999998 6799888754 679999999999999999999999999999999999999999999999999875


Q ss_pred             CCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         217 PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       217 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      ......                                                            .....||+.|+|||
T Consensus       163 ~~~~~~------------------------------------------------------------~~~~~~~~~y~aPE  182 (284)
T 2vgo_A          163 HAPSLR------------------------------------------------------------RRTMCGTLDYLPPE  182 (284)
T ss_dssp             ECSSSC------------------------------------------------------------BCCCCSCGGGCCHH
T ss_pred             cCcccc------------------------------------------------------------cccccCCCCcCCHH
Confidence            322110                                                            01234677777777


Q ss_pred             HhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCC
Q psy8260         297 IMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKR  376 (427)
Q Consensus       297 vl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R  376 (427)
                      ++.+..+...+|+||+|++++.+.++..+|..................        .....++++++||.+||+.||.+|
T Consensus       183 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~R  254 (284)
T 2vgo_A          183 MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK--------FPPFLSDGSKDLISKLLRYHPPQR  254 (284)
T ss_dssp             HHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC--------CCTTSCHHHHHHHHHHSCSSGGGS
T ss_pred             HhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccC--------CCCcCCHHHHHHHHHHhhcCHhhC
Confidence            777766777889999999998775555444322111222222211111        123468899999999999999999


Q ss_pred             CCHHHHhcCCCCCCCC
Q psy8260         377 ITAEQALAHPYLSQYS  392 (427)
Q Consensus       377 ~ta~e~L~Hp~f~~~~  392 (427)
                      ||++|+++||||....
T Consensus       255 ps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          255 LPLKGVMEHPWVKANS  270 (284)
T ss_dssp             CCHHHHHTCHHHHHHC
T ss_pred             CCHHHHhhCHHHHhhc
Confidence            9999999999998643

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=9.6e-43  Score=340.06  Aligned_cols=249  Identities=22%  Similarity=0.325  Sum_probs=191.7

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHH------HHHHHHHHHHHHhcCCCCCceeeeeeeecC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAV------HAKRTYRELRMLKHMNHENVIGLLDVFHSN  136 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~------~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~  136 (427)
                      .+.|.+.+.||+|+||.||. +.+..+|+.||||++........      ....+.+|+.+|+.++||||++++++|...
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~-a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWT-AVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEE-EEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             ccceEEEeEEEecCCEEEEE-EEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            35789999999999999996 56778899999999875432111      223456899999999999999999998654


Q ss_pred             ccccCCceEEEEeccC-CC-CHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCC
Q psy8260         137 TCLADFKNVYMVTHLM-GA-DLNNILRTQ-KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG  213 (427)
Q Consensus       137 ~~~~~~~~~~lv~e~~-g~-~L~~~l~~~-~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFG  213 (427)
                            ..++++++++ ++ +|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus       102 ------~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          102 ------GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             ------SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             ------CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecc
Confidence                  4678888876 44 899888654 69999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccccc
Q psy8260         214 LARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR  293 (427)
Q Consensus       214 la~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~  293 (427)
                      +++......                                                           .....+||+.|+
T Consensus       176 ~a~~~~~~~-----------------------------------------------------------~~~~~~gt~~y~  196 (335)
T 3dls_A          176 SAAYLERGK-----------------------------------------------------------LFYTFCGTIEYC  196 (335)
T ss_dssp             TCEECCTTC-----------------------------------------------------------CBCEECSCGGGC
T ss_pred             cceECCCCC-----------------------------------------------------------ceeccCCCcccc
Confidence            986432211                                                           111234667777


Q ss_pred             chHHhhhccC-CCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         294 APEIMLNWMH-YNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       294 APEvl~~~~~-~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                      |||++.+..+ ..++|+||+|++++.|.++..||.....      ......        .....+++++.+||.+||+.|
T Consensus       197 aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~--------~~~~~~~~~l~~li~~~L~~d  262 (335)
T 3dls_A          197 APEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAI--------HPPYLVSKELMSLVSGLLQPV  262 (335)
T ss_dssp             CHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCC--------CCSSCCCHHHHHHHHHHTCSS
T ss_pred             ChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhcc--------CCCcccCHHHHHHHHHHccCC
Confidence            7777666555 3456999999999887555444432110      000000        011246889999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCC
Q psy8260         373 SEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       373 P~~R~ta~e~L~Hp~f~~~  391 (427)
                      |.+|||++|+++||||.+.
T Consensus       263 P~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          263 PERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             GGGSCCHHHHHHCTTTTCC
T ss_pred             hhhCcCHHHHhcCccccCC
Confidence            9999999999999999864

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=7.9e-42  Score=333.33  Aligned_cols=263  Identities=25%  Similarity=0.339  Sum_probs=203.9

Q ss_pred             cCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcccc
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  140 (427)
                      ..+.|.+.+.||+|+||.||. +.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++...    
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~-~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----  113 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFE-ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN----  113 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEE-EEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS----
T ss_pred             cCCceEEEEEEeeCCCeEEEE-EEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC----
Confidence            456799999999999999996 56777899999999865432 344556678999999999999999999998654    


Q ss_pred             CCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCC
Q psy8260         141 DFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT  218 (427)
Q Consensus       141 ~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~  218 (427)
                        ..+|+++|++ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       114 --~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  191 (335)
T 2owb_A          114 --DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV  191 (335)
T ss_dssp             --SEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             --CeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence              4678999998 5799888764 67999999999999999999999999999999999999999999999999998643


Q ss_pred             CCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         219 ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       219 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                      .....                                                          ......||+.|+|||++
T Consensus       192 ~~~~~----------------------------------------------------------~~~~~~gt~~y~aPE~~  213 (335)
T 2owb_A          192 EYDGE----------------------------------------------------------RKKVLCGTPNYIAPEVL  213 (335)
T ss_dssp             CSTTC----------------------------------------------------------CBCCCCSCCSSCCHHHH
T ss_pred             ccCcc----------------------------------------------------------cccccCCCccccCHHHh
Confidence            21100                                                          01123467778888887


Q ss_pred             hhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC
Q psy8260         299 LNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT  378 (427)
Q Consensus       299 ~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t  378 (427)
                      .+..+..++|+||+|++++.|.++..+|..................        .....++++.+||.+||+.||.+|||
T Consensus       214 ~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~dp~~Rps  285 (335)
T 2owb_A          214 SKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS--------IPKHINPVAASLIQKMLQTDPTARPT  285 (335)
T ss_dssp             HTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC--------CCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred             ccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCC--------CCccCCHHHHHHHHHHccCChhHCcC
Confidence            7766777789999999998875555444322211122222211111        12346889999999999999999999


Q ss_pred             HHHHhcCCCCCCCCCCCCC
Q psy8260         379 AEQALAHPYLSQYSDPNDE  397 (427)
Q Consensus       379 a~e~L~Hp~f~~~~~~~~~  397 (427)
                      ++|+|+||||.....|...
T Consensus       286 ~~ell~~~~~~~~~~~~~~  304 (335)
T 2owb_A          286 INELLNDEFFTSGYIPARL  304 (335)
T ss_dssp             GGGGGGSHHHHTSCCCSCC
T ss_pred             HHHHhcCccccCCCccccC
Confidence            9999999999876555433

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.2e-41  Score=336.19  Aligned_cols=261  Identities=24%  Similarity=0.385  Sum_probs=193.1

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC--CH----HHHHHHHHHHHHHhcC-CCCCceeeeeeeecC
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ--SA----VHAKRTYRELRMLKHM-NHENVIGLLDVFHSN  136 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~--~~----~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~  136 (427)
                      +.|.+.+.||.|+||.||. +.+..+|+.||||++.....  ..    ...+.+.+|+.+++.+ +||||+++++++...
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~-a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  172 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRR-CVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS  172 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEE-EEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred             hhcccceEEecCCCEEEEE-EEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence            5688999999999999996 45667899999998865431  11    1234567899999998 899999999998653


Q ss_pred             ccccCCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCC
Q psy8260         137 TCLADFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL  214 (427)
Q Consensus       137 ~~~~~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGl  214 (427)
                            ...|++||++ |++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus       173 ------~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~  246 (365)
T 2y7j_A          173 ------SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGF  246 (365)
T ss_dssp             ------SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             ------CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCc
Confidence                  4678999998 6799988764 5799999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCC--cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccc
Q psy8260         215 ARPTENE--MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWY  292 (427)
Q Consensus       215 a~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y  292 (427)
                      +......  ....+||+.|+|||++.+....                                                 
T Consensus       247 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-------------------------------------------------  277 (365)
T 2y7j_A          247 SCHLEPGEKLRELCGTPGYLAPEILKCSMDE-------------------------------------------------  277 (365)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHTTCT-------------------------------------------------
T ss_pred             ccccCCCcccccCCCCCCccChhhccccccc-------------------------------------------------
Confidence            8654321  2233445555555544321000                                                 


Q ss_pred             cchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         293 RAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       293 ~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                            ....+..++|+||+|++++.|.++..+|....................    ...+...++++.+||.+||+.|
T Consensus       278 ------~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~~~~~li~~~L~~d  347 (365)
T 2y7j_A          278 ------THPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFS----SPEWDDRSSTVKDLISRLLQVD  347 (365)
T ss_dssp             ------TSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----HHHHSSSCHHHHHHHHHHSCSS
T ss_pred             ------cCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC----CcccccCCHHHHHHHHHHcCCC
Confidence                  011245567999999999888655555543221112222222211111    2234567899999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCC
Q psy8260         373 SEKRITAEQALAHPYLSQ  390 (427)
Q Consensus       373 P~~R~ta~e~L~Hp~f~~  390 (427)
                      |.+|||++|+|+||||++
T Consensus       348 P~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          348 PEARLTAEQALQHPFFER  365 (365)
T ss_dssp             TTTSCCHHHHHHSGGGCC
T ss_pred             hhHCcCHHHHhcCcccCC
Confidence            999999999999999963

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.4e-42  Score=337.58  Aligned_cols=263  Identities=24%  Similarity=0.363  Sum_probs=198.9

Q ss_pred             ccCcceeec-cccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCcc
Q psy8260          61 ICRGVIDIG-PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTC  138 (427)
Q Consensus        61 ~~~~~~~~~-~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~  138 (427)
                      ...+.|.+. +.||+|+||.||. +.+..+|+.||||++............+.+|+.+++.+ +||||+++++++...  
T Consensus        25 ~~~~~y~~~~~~lG~G~~g~V~~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~--  101 (327)
T 3lm5_A           25 NFNNFYILTSKELGRGKFAVVRQ-CISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT--  101 (327)
T ss_dssp             HHHHHEEEEEEEEEEETTEEEEE-EEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--
T ss_pred             hhhhEEeeccceeCCCCCeEEEE-EEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC--
Confidence            334566666 8899999999996 56778899999999876544443456678999999998 569999999998653  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcC---CCCEEEee
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE---DCELKILD  211 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~---~~~~kl~D  211 (427)
                          ..+|+++|++ +++|.+++..   ..+++..+..++.|++.||.|||++||+||||||+|||++.   ++.+||+|
T Consensus       102 ----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~D  177 (327)
T 3lm5_A          102 ----SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVD  177 (327)
T ss_dssp             ----SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred             ----CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEee
Confidence                4578999988 6789888743   56999999999999999999999999999999999999987   78999999


Q ss_pred             CCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccc
Q psy8260         212 FGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRW  291 (427)
Q Consensus       212 FGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~  291 (427)
                      ||+++......                                                           ......||+.
T Consensus       178 fg~a~~~~~~~-----------------------------------------------------------~~~~~~gt~~  198 (327)
T 3lm5_A          178 FGMSRKIGHAC-----------------------------------------------------------ELREIMGTPE  198 (327)
T ss_dssp             GGGCEEC--------------------------------------------------------------------CCCGG
T ss_pred             CccccccCCcc-----------------------------------------------------------ccccccCCcC
Confidence            99986432110                                                           0112357778


Q ss_pred             ccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCC
Q psy8260         292 YRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLEL  371 (427)
Q Consensus       292 Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~  371 (427)
                      |+|||++.+..+..++|+||+|++++.|.++..||....................    ...+...++++.+||.+||+.
T Consensus       199 y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~~~~~li~~~L~~  274 (327)
T 3lm5_A          199 YLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYS----EETFSSVSQLATDFIQSLLVK  274 (327)
T ss_dssp             GCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----TTTTTTSCHHHHHHHHHHSCS
T ss_pred             ccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccC----chhhcccCHHHHHHHHHHcCC
Confidence            8888887777777788999999999887555555533221122222222111111    123356789999999999999


Q ss_pred             CCCCCCCHHHHhcCCCCCCCCC
Q psy8260         372 DSEKRITAEQALAHPYLSQYSD  393 (427)
Q Consensus       372 dP~~R~ta~e~L~Hp~f~~~~~  393 (427)
                      ||.+|||++|+|+||||++...
T Consensus       275 dP~~Rpt~~~ll~h~~~~~~~~  296 (327)
T 3lm5_A          275 NPEKRPTAEICLSHSWLQQWDF  296 (327)
T ss_dssp             SGGGSCCHHHHTTCGGGCCCCT
T ss_pred             ChhhCcCHHHHhCCHhhccccc
Confidence            9999999999999999987643

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=8.9e-42  Score=326.25  Aligned_cols=263  Identities=25%  Similarity=0.339  Sum_probs=203.0

Q ss_pred             cCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcccc
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  140 (427)
                      ..+.|.+.+.||+|+||.||. +.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++...    
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~-~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----   87 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFE-ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN----   87 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEE-EEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS----
T ss_pred             cccceEEEEEEeecCCEEEEE-EEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC----
Confidence            346789999999999999996 55677899999999865432 344556678999999999999999999998653    


Q ss_pred             CCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCC
Q psy8260         141 DFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT  218 (427)
Q Consensus       141 ~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~  218 (427)
                        ...++++|++ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        88 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  165 (294)
T 2rku_A           88 --DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV  165 (294)
T ss_dssp             --SEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             --CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceec
Confidence              4578999988 5789887754 67999999999999999999999999999999999999999999999999998643


Q ss_pred             CCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         219 ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       219 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                      .....                                                          ......||+.|+|||++
T Consensus       166 ~~~~~----------------------------------------------------------~~~~~~~~~~y~aPE~~  187 (294)
T 2rku_A          166 EYDGE----------------------------------------------------------RKKVLCGTPNYIAPEVL  187 (294)
T ss_dssp             CSTTC----------------------------------------------------------CBCCCCSCCSSCCHHHH
T ss_pred             ccCcc----------------------------------------------------------ccccccCCCCcCCcchh
Confidence            21100                                                          01123467777888877


Q ss_pred             hhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC
Q psy8260         299 LNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT  378 (427)
Q Consensus       299 ~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t  378 (427)
                      .+..+..++|+|++|++++.|.++..+|......+...........        .....++++.+||.+||+.||++|||
T Consensus       188 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rps  259 (294)
T 2rku_A          188 SKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS--------IPKHINPVAASLIQKMLQTDPTARPT  259 (294)
T ss_dssp             TTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC--------CCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred             ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCC--------CccccCHHHHHHHHHHcccChhhCcC
Confidence            7666777789999999998775555444332211122222111111        12346889999999999999999999


Q ss_pred             HHHHhcCCCCCCCCCCCCC
Q psy8260         379 AEQALAHPYLSQYSDPNDE  397 (427)
Q Consensus       379 a~e~L~Hp~f~~~~~~~~~  397 (427)
                      ++|+++||||.....|...
T Consensus       260 ~~~ll~~~~~~~~~~~~~~  278 (294)
T 2rku_A          260 INELLNDEFFTSGYIPARL  278 (294)
T ss_dssp             GGGGGGSHHHHTSCCCSCC
T ss_pred             HHHHhhChheecCCcCCCC
Confidence            9999999999876655544

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.9e-41  Score=327.16  Aligned_cols=263  Identities=20%  Similarity=0.315  Sum_probs=195.7

Q ss_pred             CCccccccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeee
Q psy8260          55 NQPYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFH  134 (427)
Q Consensus        55 ~~~~~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~  134 (427)
                      .....++..+.|.+.+.||+|+||.||.+..   +|..||||++..........+.+.+|++++++++||||+++++++.
T Consensus        28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  104 (309)
T 3p86_A           28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW---HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT  104 (309)
T ss_dssp             ----CBCCGGGEEEEEEEEECSSEEEEEEEE---TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CcccccCChhHceeeeEeecCCCeEEEEEEE---CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            3344567778999999999999999997643   6889999999776656666777889999999999999999999986


Q ss_pred             cCccccCCceEEEEeccC-CCCHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHHhcC--ceeccCCCCCeEEcCCCCE
Q psy8260         135 SNTCLADFKNVYMVTHLM-GADLNNILRTQK----LSDDHVQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCEL  207 (427)
Q Consensus       135 ~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~~----l~~~~~~~~~~qi~~aL~yLH~~~--iiHrDLKp~NILl~~~~~~  207 (427)
                      ..      ..+++++|++ +++|.+++....    +++..+..++.|++.||.|||++|  |+||||||+|||++.++.+
T Consensus       105 ~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~  178 (309)
T 3p86_A          105 QP------PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTV  178 (309)
T ss_dssp             ST------TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCE
T ss_pred             EC------CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcE
Confidence            53      3578899988 679999987543    899999999999999999999999  9999999999999999999


Q ss_pred             EEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccc
Q psy8260         208 KILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV  287 (427)
Q Consensus       208 kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~  287 (427)
                      ||+|||+++.......                                                          ......
T Consensus       179 kL~Dfg~a~~~~~~~~----------------------------------------------------------~~~~~~  200 (309)
T 3p86_A          179 KVCDFGLSRLKASTFL----------------------------------------------------------SSKSAA  200 (309)
T ss_dssp             EECCCC--------------------------------------------------------------------------
T ss_pred             EECCCCCCcccccccc----------------------------------------------------------ccccCC
Confidence            9999999864321100                                                          111235


Q ss_pred             ccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHH
Q psy8260         288 ATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSL  367 (427)
Q Consensus       288 gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~  367 (427)
                      ||+.|+|||++.+..+..++|+||+|++++.+.++..||...................      ......++++.+||.+
T Consensus       201 gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~  274 (309)
T 3p86_A          201 GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL------EIPRNLNPQVAAIIEG  274 (309)
T ss_dssp             -CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC------CCCTTSCHHHHHHHHH
T ss_pred             CCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC------CCCccCCHHHHHHHHH
Confidence            7788888888877777778899999999988865555554322111111111111111      1224578899999999


Q ss_pred             hcCCCCCCCCCHHHHhc--CCCCCC
Q psy8260         368 MLELDSEKRITAEQALA--HPYLSQ  390 (427)
Q Consensus       368 mL~~dP~~R~ta~e~L~--Hp~f~~  390 (427)
                      ||+.||.+|||++|+++  ++++..
T Consensus       275 ~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          275 CWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             HccCChhhCcCHHHHHHHHHHHHHh
Confidence            99999999999999987  566654

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.7e-42  Score=327.03  Aligned_cols=255  Identities=25%  Similarity=0.416  Sum_probs=178.1

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH-HHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA-VHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      +.|.+.+.||+|+||.||. +.+..+|+.||||++....... ...+.+.+|+.+++.++||||+++++++...      
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------   83 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYR-AESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS------   83 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEE-EEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS------
T ss_pred             ccceeeeeecCCCceEEEE-EEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC------
Confidence            5689999999999999996 4566789999999985421111 1135577999999999999999999998653      


Q ss_pred             ceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                      ...|+++|++ +++|.+++..  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  163 (278)
T 3cok_A           84 NYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLK  163 (278)
T ss_dssp             SEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence            4678999988 6799998875  468999999999999999999999999999999999999999999999999986432


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      ....                                                          ......||+.|+|||++.
T Consensus       164 ~~~~----------------------------------------------------------~~~~~~~~~~y~aPE~~~  185 (278)
T 3cok_A          164 MPHE----------------------------------------------------------KHYTLCGTPNYISPEIAT  185 (278)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             CCCC----------------------------------------------------------cceeccCCCCcCCcchhc
Confidence            1100                                                          011234677777888777


Q ss_pred             hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH
Q psy8260         300 NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA  379 (427)
Q Consensus       300 ~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta  379 (427)
                      +..+..++|+||+|++++.+.++..+|.............    . ...   ......++++.+||.+||+.||.+|||+
T Consensus       186 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~-~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~  257 (278)
T 3cok_A          186 RSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV----L-ADY---EMPSFLSIEAKDLIHQLLRRNPADRLSL  257 (278)
T ss_dssp             ------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC----S-SCC---CCCTTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             CCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh----h-ccc---CCccccCHHHHHHHHHHcccCHhhCCCH
Confidence            6667778899999999987755544443222111111110    0 000   1123468899999999999999999999


Q ss_pred             HHHhcCCCCCCC
Q psy8260         380 EQALAHPYLSQY  391 (427)
Q Consensus       380 ~e~L~Hp~f~~~  391 (427)
                      +|+++||||.+.
T Consensus       258 ~~~l~h~~~~~~  269 (278)
T 3cok_A          258 SSVLDHPFMSRN  269 (278)
T ss_dssp             HHHTTSTTTC--
T ss_pred             HHHhcCccccCC
Confidence            999999999864

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=327.07  Aligned_cols=265  Identities=22%  Similarity=0.325  Sum_probs=195.1

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC--CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccC
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ--SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      +.|.+.+.||+|+||.||. +.+..+++.||||++.....  .......+.+|+++++.++||||+++++++...    +
T Consensus         5 ~~y~i~~~lg~G~~g~V~~-~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----~   79 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKE-VLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE----E   79 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEE-EEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-----
T ss_pred             cceeEeeEEecCCCeEEEE-EEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC----C
Confidence            5688999999999999996 56778999999999864321  112345678999999999999999999997532    2


Q ss_pred             CceEEEEeccCCCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCC
Q psy8260         142 FKNVYMVTHLMGADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT  218 (427)
Q Consensus       142 ~~~~~lv~e~~g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~  218 (427)
                      ....|+++|++.+.|.+++..   ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        80 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           80 KQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             --CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            246899999997777777653   56999999999999999999999999999999999999999999999999998643


Q ss_pred             CCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         219 ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       219 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                      ......                                                        .......||+.|+|||++
T Consensus       160 ~~~~~~--------------------------------------------------------~~~~~~~~~~~y~aPE~~  183 (305)
T 2wtk_C          160 HPFAAD--------------------------------------------------------DTCRTSQGSPAFQPPEIA  183 (305)
T ss_dssp             CTTCSS--------------------------------------------------------CEECCCCSCGGGCCHHHH
T ss_pred             Cccccc--------------------------------------------------------cccccCCCCCCCcChhhc
Confidence            211000                                                        011123466777777776


Q ss_pred             hhccC--CCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCC
Q psy8260         299 LNWMH--YNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKR  376 (427)
Q Consensus       299 ~~~~~--~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R  376 (427)
                      .+...  ..++|+||+|++++.|.++..+|..................        .....++++.+||.+||+.||.+|
T Consensus       184 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~R  255 (305)
T 2wtk_C          184 NGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA--------IPGDCGPPLSDLLKGMLEYEPAKR  255 (305)
T ss_dssp             TCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC--------CCSSSCHHHHHHHHHHTCSSTTTS
T ss_pred             cCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCC--------CCCccCHHHHHHHHHHccCChhhC
Confidence            54322  34579999999998885555444322111111111111111        123467899999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCCCCC
Q psy8260         377 ITAEQALAHPYLSQYSDPNDE  397 (427)
Q Consensus       377 ~ta~e~L~Hp~f~~~~~~~~~  397 (427)
                      ||++|+++||||.+...+...
T Consensus       256 ps~~~ll~~~~~~~~~~~~~~  276 (305)
T 2wtk_C          256 FSIRQIRQHSWFRKKHPPAEA  276 (305)
T ss_dssp             CCHHHHHHSHHHHSCCCC-CC
T ss_pred             CCHHHHhcCcccccCCCCcCC
Confidence            999999999999876555433

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=5.1e-42  Score=333.30  Aligned_cols=263  Identities=25%  Similarity=0.418  Sum_probs=187.0

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCC------ceeeeeee
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHEN------VIGLLDVF  133 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~Hpn------Iv~l~~~~  133 (427)
                      ++..++|.+.+.||+|+||.||.+.....+|+.||||++..   .......+.+|+++++.++|+|      |+++++++
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~   86 (339)
T 1z57_A           10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN---VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF   86 (339)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred             CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec---CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence            44567899999999999999997654466899999999864   2344566778999988887654      99999988


Q ss_pred             ecCccccCCceEEEEeccCCCCHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcC-------
Q psy8260         134 HSNTCLADFKNVYMVTHLMGADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE-------  203 (427)
Q Consensus       134 ~~~~~~~~~~~~~lv~e~~g~~L~~~l~~~---~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~-------  203 (427)
                      ...      ..+++++|+++++|.+++...   .+++..+..++.|++.||.|||++||+||||||+|||++.       
T Consensus        87 ~~~------~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~  160 (339)
T 1z57_A           87 EHH------GHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAY  160 (339)
T ss_dssp             EET------TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEE
T ss_pred             ccC------CcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEecccccccc
Confidence            654      468999999999999988654   5899999999999999999999999999999999999987       


Q ss_pred             ------------CCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhh
Q psy8260         204 ------------DCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKIL  271 (427)
Q Consensus       204 ------------~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~  271 (427)
                                  ++.+||+|||+++.........                                              
T Consensus       161 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~----------------------------------------------  194 (339)
T 1z57_A          161 NPKIKRDERTLINPDIKVVDFGSATYDDEHHSTL----------------------------------------------  194 (339)
T ss_dssp             C----CEEEEESCCCEEECCCSSCEETTSCCCSS----------------------------------------------
T ss_pred             CCccccccccccCCCceEeeCcccccCccccccc----------------------------------------------
Confidence                        6679999999886433332223                                              


Q ss_pred             ccCCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcc---
Q psy8260         272 DFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKK---  348 (427)
Q Consensus       272 d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  348 (427)
                                     .||+.|+|||++.+..+..++|+||+|++++.+.++..+|......+............+..   
T Consensus       195 ---------------~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~  259 (339)
T 1z57_A          195 ---------------VSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQ  259 (339)
T ss_dssp             ---------------CSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHH
T ss_pred             ---------------cCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Confidence                           35555666666555555666788888888766533332232111111000000000000000   


Q ss_pred             ------------------------------cHHhh---cCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q psy8260         349 ------------------------------DFRQV---FKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYS  392 (427)
Q Consensus       349 ------------------------------~~~~~---~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~  392 (427)
                                                    .....   ....++++.+||.+||+.||.+|||++|+|+||||....
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  336 (339)
T 1z57_A          260 KTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLK  336 (339)
T ss_dssp             HCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGGG
T ss_pred             hccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHHh
Confidence                                          00000   011246788999999999999999999999999998653

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=9.2e-42  Score=327.87  Aligned_cols=256  Identities=27%  Similarity=0.437  Sum_probs=194.3

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .+.|.+.+.||+|+||.||. +.+..+|+.||||++....  ......+.+|+.+++.++||||+++++++...      
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------   78 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFL-VKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYEST------   78 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEE-EEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECS------
T ss_pred             hccceeeeeccCCCCceEEE-EEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhcccC------
Confidence            45788999999999999996 4567789999999987532  22334577999999999999999999998653      


Q ss_pred             ceEEEEeccC-CCCHHHHHh-hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEE---cCCCCEEEeeCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILDFGLARP  217 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~-~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl---~~~~~~kl~DFGla~~  217 (427)
                      ...|+++|++ +++|.+.+. .+.+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||+++.
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~  158 (304)
T 2jam_A           79 THYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM  158 (304)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred             CEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence            4678999988 679988764 4679999999999999999999999999999999999999   6788999999999864


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      .....                                                            .....||+.|+|||+
T Consensus       159 ~~~~~------------------------------------------------------------~~~~~~~~~y~aPE~  178 (304)
T 2jam_A          159 EQNGI------------------------------------------------------------MSTACGTPGYVAPEV  178 (304)
T ss_dssp             CCCBT------------------------------------------------------------THHHHSCCCBCCTTT
T ss_pred             cCCCc------------------------------------------------------------cccccCCCCccChHH
Confidence            32211                                                            011235666666666


Q ss_pred             hhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC
Q psy8260         298 MLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI  377 (427)
Q Consensus       298 l~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~  377 (427)
                      +.+..+..++|+||+|++++.|.++..+|....................    ...+..+++++.+||.+||+.||.+||
T Consensus       179 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rp  254 (304)
T 2jam_A          179 LAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFE----SPFWDDISESAKDFICHLLEKDPNERY  254 (304)
T ss_dssp             BSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCC----TTTTTTSCHHHHHHHHHHHCSSTTTSC
T ss_pred             hccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC----ccccccCCHHHHHHHHHHcCCChhHCc
Confidence            6555566678999999999888665555543322222222222221111    122356789999999999999999999


Q ss_pred             CHHHHhcCCCCCCC
Q psy8260         378 TAEQALAHPYLSQY  391 (427)
Q Consensus       378 ta~e~L~Hp~f~~~  391 (427)
                      |++|+|+||||...
T Consensus       255 s~~~~l~h~~~~~~  268 (304)
T 2jam_A          255 TCEKALSHPWIDGN  268 (304)
T ss_dssp             CHHHHHTSHHHHSS
T ss_pred             CHHHHhcCccccCC
Confidence            99999999999764

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.1e-41  Score=338.39  Aligned_cols=282  Identities=28%  Similarity=0.444  Sum_probs=189.4

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCC-CC-----Cceeeeeee
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN-HE-----NVIGLLDVF  133 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~-Hp-----nIv~l~~~~  133 (427)
                      +...+.|.+.+.||+|+||.||+ +.+..+|+.||||++...   ........+|+++++.++ |+     +|+++++++
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~-~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~  125 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVK-AYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF  125 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEE-EEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred             CEeeeeEEEEEEEeecCCEEEEE-EEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence            33457899999999999999996 567788999999998642   334455678888888775 44     489999887


Q ss_pred             ecCccccCCceEEEEeccCCCCHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHH--hcCceeccCCCCCeEEc--CCCC
Q psy8260         134 HSNTCLADFKNVYMVTHLMGADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIH--SAGIIHRDLKPSNIAVN--EDCE  206 (427)
Q Consensus       134 ~~~~~~~~~~~~~lv~e~~g~~L~~~l~~~---~l~~~~~~~~~~qi~~aL~yLH--~~~iiHrDLKp~NILl~--~~~~  206 (427)
                      ...      ..+|+++|+++++|.+++...   .+++..++.++.|++.||.|||  +.||+||||||+|||++  .++.
T Consensus       126 ~~~------~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~  199 (382)
T 2vx3_A          126 MFR------NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSA  199 (382)
T ss_dssp             EET------TEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCC
T ss_pred             ccC------CceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCc
Confidence            653      468999999999999988653   5899999999999999999999  57999999999999995  4778


Q ss_pred             EEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccc
Q psy8260         207 LKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGY  286 (427)
Q Consensus       207 ~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~  286 (427)
                      +||+|||+++.........+||+.|+|||++.+.. |+      ...|+|+.||++.+                 +.+|.
T Consensus       200 ~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~-~~------~~~DiwSlG~il~e-----------------lltg~  255 (382)
T 2vx3_A          200 IKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMP-YD------LAIDMWSLGCILVE-----------------MHTGE  255 (382)
T ss_dssp             EEECCCTTCEETTCCCCSSCSCGGGCCHHHHTTCC-CC------THHHHHHHHHHHHH-----------------HHHSS
T ss_pred             EEEEeccCceecccccccccCCccccChHHHcCCC-CC------cHHHHHHHHHHHHH-----------------HHhCC
Confidence            99999999986655555556666677776665421 21      12255555554433                 11111


Q ss_pred             cccccccchHHhhhccCCCC-CCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCC-----------------cc
Q psy8260         287 VATRWYRAPEIMLNWMHYNQ-TDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLT-----------------KK  348 (427)
Q Consensus       287 ~gt~~Y~APEvl~~~~~~~~-~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~  348 (427)
                                     ..+.+ .+...+..++..+|.++........  ..+.+....+...                 ..
T Consensus       256 ---------------~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (382)
T 2vx3_A          256 ---------------PLFSGANEVDQMNKIVEVLGIPPAHILDQAP--KARKFFEKLPDGTWNLKKTKDGKREYKPPGTR  318 (382)
T ss_dssp             ---------------CSSCCSSHHHHHHHHHHHHCSCCHHHHTTCT--THHHHEEECTTSCEEECCCCTTCCCSCCTTCS
T ss_pred             ---------------CCCCCCCHHHHHHHHHHHhCCCCHHHHHhhH--HHHHHHHhccccccccccccccccccCCcchh
Confidence                           12221 2233344444445555444333211  1111211111100                 00


Q ss_pred             cHHhhcCC------------------CChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q psy8260         349 DFRQVFKG------------------ANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYS  392 (427)
Q Consensus       349 ~~~~~~~~------------------~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~  392 (427)
                      .+...+..                  .+++++|||.+||++||++|||++|+|+||||++..
T Consensus       319 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          319 KLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             CHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC--
T ss_pred             hHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccCC
Confidence            01111100                  014789999999999999999999999999998753

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.7e-42  Score=328.82  Aligned_cols=272  Identities=23%  Similarity=0.340  Sum_probs=180.4

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      .+..+.|.+.+.||+|+||.||. +.+..+++.||||++.... .......+.+|+.+++.++||||+++++++...   
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---   85 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQA-AYCAPKKEKVAIKRINLEK-CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK---   85 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEE-EEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESS---
T ss_pred             ccchhhhhhhheeccccceEEEE-EEECCCCcEEEEEEEEhhh-cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec---
Confidence            55677899999999999999996 4566789999999886432 123345677999999999999999999998654   


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhh---------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEE
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRT---------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKI  209 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~---------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl  209 (427)
                         ...+++++++ +++|.+++..         ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||
T Consensus        86 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl  162 (303)
T 2vwi_A           86 ---DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQI  162 (303)
T ss_dssp             ---SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEE
T ss_pred             ---CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEE
Confidence               3578899988 7899988752         45899999999999999999999999999999999999999999999


Q ss_pred             eeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccc
Q psy8260         210 LDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT  289 (427)
Q Consensus       210 ~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt  289 (427)
                      +|||+++.........                                                     .........||
T Consensus       163 ~dfg~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~  189 (303)
T 2vwi_A          163 ADFGVSAFLATGGDIT-----------------------------------------------------RNKVRKTFVGT  189 (303)
T ss_dssp             CCCHHHHHCC--------------------------------------------------------------------CC
T ss_pred             EeccchheeccCCCcc-----------------------------------------------------chhhhcccCCC
Confidence            9999875332110000                                                     00011234578


Q ss_pred             ccccchHHhhh-ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCC-CCCc-ccHHhhcCCCChhHHHHHH
Q psy8260         290 RWYRAPEIMLN-WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLP-LLTK-KDFRQVFKGANPQAIDLLS  366 (427)
Q Consensus       290 ~~Y~APEvl~~-~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~s~~~~dLi~  366 (427)
                      +.|+|||++.+ ..+..++|+||+|++++.|.++..+|................+ .... ..........++++.+||.
T Consensus       190 ~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  269 (303)
T 2vwi_A          190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMIS  269 (303)
T ss_dssp             CTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHH
T ss_pred             ccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHH
Confidence            88888888865 4466678999999999887555555543222222222222111 1111 1112234567889999999


Q ss_pred             HhcCCCCCCCCCHHHHhcCCCCCCCC
Q psy8260         367 LMLELDSEKRITAEQALAHPYLSQYS  392 (427)
Q Consensus       367 ~mL~~dP~~R~ta~e~L~Hp~f~~~~  392 (427)
                      +||+.||.+|||++|+++||||.+..
T Consensus       270 ~~l~~dp~~Rps~~~ll~h~~~~~~~  295 (303)
T 2vwi_A          270 LCLQKDPEKRPTAAELLRHKFFQKAK  295 (303)
T ss_dssp             HHCCSSGGGSCCHHHHHTSTTC----
T ss_pred             HHccCChhhCcCHHHHhhChhhhcCC
Confidence            99999999999999999999998754

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=5.4e-43  Score=347.13  Aligned_cols=265  Identities=16%  Similarity=0.162  Sum_probs=185.6

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcC-CCHHHHHHHHHHH---HHHhcCCCCCceeee-------e
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPF-QSAVHAKRTYREL---RMLKHMNHENVIGLL-------D  131 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~~~Ei---~~l~~l~HpnIv~l~-------~  131 (427)
                      .+.|.+.+.||+|+||.||. +.+..+|+.||||++.... ......+.+.+|+   ++|+.++|||||+++       +
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~-a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLE-ATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEE-EEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CceEEEcceeecCCCEEEEE-EEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            46789999999999999996 4566789999999986432 2233456678999   556666899999998       4


Q ss_pred             eeecCcc------ccCC-----ceEEEEeccCCCCHHHHHhh-CCCCH-------HHHHHHHHHHHHHHHHHHhcCceec
Q psy8260         132 VFHSNTC------LADF-----KNVYMVTHLMGADLNNILRT-QKLSD-------DHVQFLVYQILRGLKYIHSAGIIHR  192 (427)
Q Consensus       132 ~~~~~~~------~~~~-----~~~~lv~e~~g~~L~~~l~~-~~l~~-------~~~~~~~~qi~~aL~yLH~~~iiHr  192 (427)
                      ++.....      ..+.     ...|++||+++|+|.+++.. +.+++       ..+..++.||+.||.|||++||+||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  230 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  230 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            4443211      0000     13789999999999998864 23444       7777899999999999999999999


Q ss_pred             cCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhc
Q psy8260         193 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILD  272 (427)
Q Consensus       193 DLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d  272 (427)
                      ||||+|||++.++.+||+|||+|+.........+| +.|+|||++.+...-                             
T Consensus       231 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~-----------------------------  280 (377)
T 3byv_A          231 YLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATI-----------------------------  280 (377)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTST-----------------------------
T ss_pred             CCCHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccc-----------------------------
Confidence            99999999999999999999999754443334444 555555555431000                             


Q ss_pred             cCCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHh
Q psy8260         273 FGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQ  352 (427)
Q Consensus       273 ~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (427)
                               ...+..            ...+..++|+||+|++++.|.++..||........            ......
T Consensus       281 ---------~~~~~~------------~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~------------~~~~~~  327 (377)
T 3byv_A          281 ---------SYHRDR------------RTLMTFSFDAWALGLVIYWIWCADLPITKDAALGG------------SEWIFR  327 (377)
T ss_dssp             ---------HHHHCC------------EEECCHHHHHHHHHHHHHHHHHSSCCC------CC------------SGGGGS
T ss_pred             ---------cccccc------------cccCChhhhHHHHHHHHHHHHHCCCCCcccccccc------------hhhhhh
Confidence                     000000            00355667999999999887555444432211000            001111


Q ss_pred             hcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q psy8260         353 VFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       353 ~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~  391 (427)
                      ....+++++.+||.+||+.||.+|||++|+|+||||++.
T Consensus       328 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~  366 (377)
T 3byv_A          328 SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  366 (377)
T ss_dssp             SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred             hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence            224678999999999999999999999999999999754

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.7e-42  Score=343.01  Aligned_cols=302  Identities=26%  Similarity=0.309  Sum_probs=191.2

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCC--------CCCceeeee
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN--------HENVIGLLD  131 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~--------HpnIv~l~~  131 (427)
                      ++..++|.+.+.||+|+||.||. +.+..+|+.||||++..   .....+.+.+|+++++.++        |+||+++++
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~  108 (397)
T 1wak_A           33 DLFNGRYHVIRKLGWGHFSTVWL-SWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD  108 (397)
T ss_dssp             CEETTTEEEEEEEEECSSEEEEE-EEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred             hhcCCeEEEEEEeeecCCeeEEE-EEecCCCeEEEEEEEec---CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence            44567899999999999999996 56778899999999864   3444566789999998885        788999999


Q ss_pred             eeecCccccCCceEEEEeccCCCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCCeEEcCCCCE
Q psy8260         132 VFHSNTCLADFKNVYMVTHLMGADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDCEL  207 (427)
Q Consensus       132 ~~~~~~~~~~~~~~~lv~e~~g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~-~iiHrDLKp~NILl~~~~~~  207 (427)
                      +|....  .....++++|++++++|.+.+..   ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++..
T Consensus       109 ~~~~~~--~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~  186 (397)
T 1wak_A          109 DFKISG--VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQY  186 (397)
T ss_dssp             EEEEEE--TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHH
T ss_pred             ceeecC--CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchh
Confidence            986321  12256899999998888776643   3599999999999999999999998 99999999999999877521


Q ss_pred             EEeeCCCC---------CCCCCC--cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCC
Q psy8260         208 KILDFGLA---------RPTENE--MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLA  276 (427)
Q Consensus       208 kl~DFGla---------~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~  276 (427)
                      ...+++.+         ......  ............|.....      .                 ....+|++|||.+
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~-----------------~~~~~kl~DfG~a  243 (397)
T 1wak_A          187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKN------A-----------------EKLKVKIADLGNA  243 (397)
T ss_dssp             HHHHHHHHC---------------------CCTTSCCTTSGGG------G-----------------GGCCEEECCGGGC
T ss_pred             hhhhhhhhHHHhhcCCCCCCCCccccCCccccccccccccccc------c-----------------cccceEecccccc
Confidence            11111000         000000  000000000000000000      0                 1124455566655


Q ss_pred             CCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCc------HHHHHHHhcCCCCCc---
Q psy8260         277 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISS------DSARKYINSLPLLTK---  347 (427)
Q Consensus       277 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~------~~~~~~~~~~~~~~~---  347 (427)
                      ...........||+.|+|||++.+..+..++|+||+|++++.|.++..+|......      .............+.   
T Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~  323 (397)
T 1wak_A          244 CWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI  323 (397)
T ss_dssp             EETTBCSCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHH
T ss_pred             ccccccCccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHh
Confidence            54433444556777777777777766777778888888887764444433211100      000000000000000   


Q ss_pred             ------------------------ccH----Hhh---cCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q psy8260         348 ------------------------KDF----RQV---FKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQ  390 (427)
Q Consensus       348 ------------------------~~~----~~~---~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~  390 (427)
                                              ...    ...   ....++++++||.+||++||++|||++|+|+||||++
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          324 VAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             HHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             hcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                                    000    000   0112457889999999999999999999999999963

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.2e-41  Score=323.23  Aligned_cols=260  Identities=25%  Similarity=0.408  Sum_probs=198.8

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH----HHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA----VHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      .+.|.+.+.||+|+||.||. +.+..+|+.||||++.......    ...+.+.+|+.++++++||||+++++++...  
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--   80 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRK-CRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK--   80 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEE-EEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--
T ss_pred             hhhhhhHHhhcccCceEEEE-EEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC--
Confidence            35688999999999999996 5567789999999986543221    1245678999999999999999999998653  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCC----CEEEeeC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC----ELKILDF  212 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~----~~kl~DF  212 (427)
                          ...+++++++ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++    .+||+||
T Consensus        81 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~df  156 (283)
T 3bhy_A           81 ----TDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDF  156 (283)
T ss_dssp             ----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             ----CeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEec
Confidence                4578999988 7899998854 6799999999999999999999999999999999999998776    8999999


Q ss_pred             CCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccc
Q psy8260         213 GLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWY  292 (427)
Q Consensus       213 Gla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y  292 (427)
                      |+++......                                                           ......||+.|
T Consensus       157 g~~~~~~~~~-----------------------------------------------------------~~~~~~~~~~y  177 (283)
T 3bhy_A          157 GIAHKIEAGN-----------------------------------------------------------EFKNIFGTPEF  177 (283)
T ss_dssp             TTCEECC-------------------------------------------------------------------CCCGGG
T ss_pred             ccceeccCCC-----------------------------------------------------------cccccCCCcCc
Confidence            9986432110                                                           01122467778


Q ss_pred             cchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         293 RAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       293 ~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                      +|||++.+..+..++|+||+|++++.+.++..+|...................    ....+...++++.+||.+||+.|
T Consensus       178 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~d  253 (283)
T 3bhy_A          178 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDF----DEEYFSNTSELAKDFIRRLLVKD  253 (283)
T ss_dssp             CCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC----CHHHHTTCCHHHHHHHHTTSCSS
T ss_pred             cCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCC----cchhcccCCHHHHHHHHHHccCC
Confidence            88888777667777899999999987755555554322122222222111111    12345677899999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCCC
Q psy8260         373 SEKRITAEQALAHPYLSQYS  392 (427)
Q Consensus       373 P~~R~ta~e~L~Hp~f~~~~  392 (427)
                      |.+|||++|+|+||||+...
T Consensus       254 p~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          254 PKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             GGGSCCHHHHHHCHHHHHHH
T ss_pred             HhHCcCHHHHHhCHHHHHHH
Confidence            99999999999999998653

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.1e-41  Score=330.01  Aligned_cols=258  Identities=28%  Similarity=0.421  Sum_probs=189.3

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC------HHHHHHHHHHHHHHhcCCCCCceeeeeeeecC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS------AVHAKRTYRELRMLKHMNHENVIGLLDVFHSN  136 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~------~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~  136 (427)
                      .+.|.+.+.||+|+||.||. +.+..+|+.||||++......      ......+.+|+++|+.++||||+++++++...
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKL-AFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEE-EEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhceeEeeEEecCCCEEEEE-EEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            46789999999999999996 567778999999998653211      11223467899999999999999999998643


Q ss_pred             ccccCCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCC---EEEee
Q psy8260         137 TCLADFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE---LKILD  211 (427)
Q Consensus       137 ~~~~~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~---~kl~D  211 (427)
                             ..|++++++ +++|.+.+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|
T Consensus        88 -------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           88 -------DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             -------SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             -------ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEcc
Confidence                   368889888 6789887754 57999999999999999999999999999999999999987654   99999


Q ss_pred             CCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccc
Q psy8260         212 FGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRW  291 (427)
Q Consensus       212 FGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~  291 (427)
                      ||+++.......                                                           .....||+.
T Consensus       161 fg~~~~~~~~~~-----------------------------------------------------------~~~~~gt~~  181 (322)
T 2ycf_A          161 FGHSKILGETSL-----------------------------------------------------------MRTLCGTPT  181 (322)
T ss_dssp             CTTCEECCCCHH-----------------------------------------------------------HHHHHSCCT
T ss_pred             Cccceecccccc-----------------------------------------------------------cccccCCcC
Confidence            999865432110                                                           011235555


Q ss_pred             ccchHHhh---hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHh-cCCCCCcccHHhhcCCCChhHHHHHHH
Q psy8260         292 YRAPEIML---NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYIN-SLPLLTKKDFRQVFKGANPQAIDLLSL  367 (427)
Q Consensus       292 Y~APEvl~---~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~dLi~~  367 (427)
                      |+|||++.   ...+..++|+||+|++++.|.++..+|.............. .....    ....+...++++.+||.+
T Consensus       182 y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~  257 (322)
T 2ycf_A          182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF----IPEVWAEVSEKALDLVKK  257 (322)
T ss_dssp             TCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCC----CHHHHTTSCHHHHHHHHH
T ss_pred             ccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcccc----CchhhhhcCHHHHHHHHH
Confidence            66666553   22345567999999999887555545533222211111111 11111    223456678999999999


Q ss_pred             hcCCCCCCCCCHHHHhcCCCCCCC
Q psy8260         368 MLELDSEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       368 mL~~dP~~R~ta~e~L~Hp~f~~~  391 (427)
                      ||+.||.+|||++|+|+||||.+.
T Consensus       258 ~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          258 LLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             HSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             HcccCHhhCCCHHHHhhCcCcCCH
Confidence            999999999999999999999753

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.5e-41  Score=321.06  Aligned_cols=259  Identities=21%  Similarity=0.300  Sum_probs=195.3

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      +.|.+.+.||+|+||.||. +.+..+|+.||||++..... ....+.+.+|+.+++.++||||+++++++...      .
T Consensus         7 ~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~   78 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREG------N   78 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEE-EEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET------T
T ss_pred             cceEEEEEeecCCCcEEEE-EEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC------C
Confidence            5688999999999999996 45677899999999864332 23345678999999999999999999998643      4


Q ss_pred             eEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      ..|+++|++ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           79 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             EEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence            578999988 5699888764 46999999999999999999999999999999999999999999999999998643211


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      ...                                                        .......||+.|+|||++.+.
T Consensus       159 ~~~--------------------------------------------------------~~~~~~~~~~~y~aPE~~~~~  182 (276)
T 2yex_A          159 NRE--------------------------------------------------------RLLNKMCGTLPYVAPELLKRR  182 (276)
T ss_dssp             TEE--------------------------------------------------------CCBCCCCSCGGGCCGGGGTCS
T ss_pred             cch--------------------------------------------------------hcccCCccccCccChHHHhcC
Confidence            000                                                        011123466777777776654


Q ss_pred             cC-CCCCCHHHHHHHHHHhCCCCHHHHhhcCc-HHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH
Q psy8260         302 MH-YNQTDIHQLNLIMEMLGTPPAEFMAKISS-DSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA  379 (427)
Q Consensus       302 ~~-~~~~d~~slg~i~~~lg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta  379 (427)
                      .+ ..++|+||+|++++.+.++..+|...... .....+.......      ..+...++++.+||.+||+.||.+|||+
T Consensus       183 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~  256 (276)
T 2yex_A          183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL------NPWKKIDSAPLALLHKILVENPSARITI  256 (276)
T ss_dssp             SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTS------TTGGGSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccccc------CchhhcCHHHHHHHHHHCCCCchhCCCH
Confidence            44 33579999999998875555444332211 1122222111111      1124578899999999999999999999


Q ss_pred             HHHhcCCCCCCCC
Q psy8260         380 EQALAHPYLSQYS  392 (427)
Q Consensus       380 ~e~L~Hp~f~~~~  392 (427)
                      +|+++||||++..
T Consensus       257 ~~il~~~~~~~~~  269 (276)
T 2yex_A          257 PDIKKDRWYNKPL  269 (276)
T ss_dssp             HHHTTCTTTTCCC
T ss_pred             HHHhcCccccChh
Confidence            9999999998653

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2e-41  Score=328.08  Aligned_cols=268  Identities=20%  Similarity=0.218  Sum_probs=183.0

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCC---cEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecC
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSG---VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSN  136 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g---~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~  136 (427)
                      .+..+.|.+.+.||+|+||.||.+. +..++   ..||||++..........+.+.+|+++++.++||||+++++++...
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   97 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQ-LKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS   97 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEE-C-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred             ccChhHeEEeceecccCCeEEEEEE-EcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence            4566789999999999999999764 33344   3899999876544455567788999999999999999999998765


Q ss_pred             ccccCCceEEEEeccC-CCCHHHHHhhC-------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEE
Q psy8260         137 TCLADFKNVYMVTHLM-GADLNNILRTQ-------KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELK  208 (427)
Q Consensus       137 ~~~~~~~~~~lv~e~~-g~~L~~~l~~~-------~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~k  208 (427)
                      .........+++++++ +++|.+++...       .+++..+..++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus        98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A           98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEE
T ss_pred             ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEE
Confidence            4332223447888877 67999887532       589999999999999999999999999999999999999999999


Q ss_pred             EeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccc
Q psy8260         209 ILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVA  288 (427)
Q Consensus       209 l~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~g  288 (427)
                      |+|||+++........                                                        .......+
T Consensus       178 l~Dfg~a~~~~~~~~~--------------------------------------------------------~~~~~~~~  201 (323)
T 3qup_A          178 VADFGLSRKIYSGDYY--------------------------------------------------------RQGCASKL  201 (323)
T ss_dssp             ECCCCC-------------------------------------------------------------------------C
T ss_pred             Eeeccccccccccccc--------------------------------------------------------cccccccC
Confidence            9999998753221100                                                        00112346


Q ss_pred             cccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHH
Q psy8260         289 TRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSL  367 (427)
Q Consensus       289 t~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~  367 (427)
                      |+.|+|||++.+..+..++|+||+|++++.|.+ +..+|..................       ......++++.+||.+
T Consensus       202 ~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~  274 (323)
T 3qup_A          202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRL-------KQPPECMEEVYDLMYQ  274 (323)
T ss_dssp             CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-------CCCTTCCHHHHHHHHH
T ss_pred             cccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCC-------CCCCccCHHHHHHHHH
Confidence            778889998888777778899999999987644 44445433222222222221111       1123567899999999


Q ss_pred             hcCCCCCCCCC-------HHHHhcCCCCCCC
Q psy8260         368 MLELDSEKRIT-------AEQALAHPYLSQY  391 (427)
Q Consensus       368 mL~~dP~~R~t-------a~e~L~Hp~f~~~  391 (427)
                      ||+.||.+|||       ++++++|||+...
T Consensus       275 ~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~  305 (323)
T 3qup_A          275 CWSADPKQRPSFTCLRMELENILGHLSVLST  305 (323)
T ss_dssp             TTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred             HccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence            99999999999       7889999999753

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=329.77  Aligned_cols=267  Identities=20%  Similarity=0.275  Sum_probs=189.8

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcccc
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  140 (427)
                      ...+.|.+.+.||+|+||.||. +.+..+|+.||||++..... ....+.+.+|+++++.++||||+++++++....   
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---   80 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFR-GRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---   80 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEE-EEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---
T ss_pred             CCCCCEEEEEEecCCCCeEEEE-EEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCC---
Confidence            3457899999999999999996 55677899999999864321 122455679999999999999999999986532   


Q ss_pred             CCceEEEEeccC-CCCHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEE----cCCCCEEEee
Q psy8260         141 DFKNVYMVTHLM-GADLNNILRTQ----KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV----NEDCELKILD  211 (427)
Q Consensus       141 ~~~~~~lv~e~~-g~~L~~~l~~~----~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl----~~~~~~kl~D  211 (427)
                       ....+++||++ +++|.+++...    .+++..+..++.|++.||.|||++||+||||||+|||+    +.++.+||+|
T Consensus        81 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (319)
T 4euu_A           81 -TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (319)
T ss_dssp             -TCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECC
T ss_pred             -CceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEcc
Confidence             23678999988 68999998642    39999999999999999999999999999999999999    7778899999


Q ss_pred             CCCCCCCCCC--cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccc
Q psy8260         212 FGLARPTENE--MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT  289 (427)
Q Consensus       212 FGla~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt  289 (427)
                      ||+++.....  .....||+.|+|||++........                                            
T Consensus       160 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--------------------------------------------  195 (319)
T 4euu_A          160 FGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKD--------------------------------------------  195 (319)
T ss_dssp             CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCC--------------------------------------------
T ss_pred             CCCceecCCCCceeecccCCCccCHHHhhhcccccc--------------------------------------------
Confidence            9999754322  223345555555555432100000                                            


Q ss_pred             ccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhh----cCcHHHHHHHhcCCCCCc----------ccHH----
Q psy8260         290 RWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAK----ISSDSARKYINSLPLLTK----------KDFR----  351 (427)
Q Consensus       290 ~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~----~~~~~~~~~~~~~~~~~~----------~~~~----  351 (427)
                               .+..+..++|+||+|++++.|.++..||...    .......+.....+....          ..|.    
T Consensus       196 ---------~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  266 (319)
T 4euu_A          196 ---------HQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMP  266 (319)
T ss_dssp             ---------CCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCC
T ss_pred             ---------ccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCC
Confidence                     0223556789999999998885555444321    111222223322221100          0000    


Q ss_pred             ---hhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCC
Q psy8260         352 ---QVFKGANPQAIDLLSLMLELDSEKRITAEQALAHP  386 (427)
Q Consensus       352 ---~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp  386 (427)
                         ......++.+.+||.+||++||++|+|++|+|+||
T Consensus       267 ~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          267 VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             cccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence               01112345788999999999999999999999997

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.8e-41  Score=331.75  Aligned_cols=260  Identities=19%  Similarity=0.291  Sum_probs=200.1

Q ss_pred             cccccCcceeeccccCcccccEEEEeEE----eCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeee
Q psy8260          58 YSEICRGVIDIGPTLSKESFDLIFSSAL----DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDV  132 (427)
Q Consensus        58 ~~~~~~~~~~~~~~lg~g~fg~v~~~~~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~  132 (427)
                      .+++..+.|.+.+.||+|+||.||.+..    +..+++.||||++... ......+.+.+|+++++++ +|||||+++++
T Consensus        16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~   94 (359)
T 3vhe_A           16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGA   94 (359)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeeee
Confidence            4577889999999999999999997653    4567899999999654 3444556788999999999 88999999999


Q ss_pred             eecCccccCCceEEEEeccC-CCCHHHHHhhCC-----------------------------------------------
Q psy8260         133 FHSNTCLADFKNVYMVTHLM-GADLNNILRTQK-----------------------------------------------  164 (427)
Q Consensus       133 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~~-----------------------------------------------  164 (427)
                      +....     ..+++++|++ +++|.+++....                                               
T Consensus        95 ~~~~~-----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (359)
T 3vhe_A           95 CTKPG-----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE  169 (359)
T ss_dssp             ECSTT-----SCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred             eecCC-----CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence            76432     3468888888 679999886432                                               


Q ss_pred             --------------------CCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCccc
Q psy8260         165 --------------------LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTG  224 (427)
Q Consensus       165 --------------------l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~  224 (427)
                                          +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  249 (359)
T 3vhe_A          170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY  249 (359)
T ss_dssp             --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred             ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence                                889999999999999999999999999999999999999999999999998754221100


Q ss_pred             ccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCC
Q psy8260         225 YVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHY  304 (427)
Q Consensus       225 ~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~  304 (427)
                                                                              .......||+.|+|||++.+..+.
T Consensus       250 --------------------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~  273 (359)
T 3vhe_A          250 --------------------------------------------------------VRKGDARLPLKWMAPETIFDRVYT  273 (359)
T ss_dssp             --------------------------------------------------------EEC--CEECGGGCCHHHHHHCCCC
T ss_pred             --------------------------------------------------------hhccccCCCceeEChhhhcCCCCC
Confidence                                                                    011233578888888888877777


Q ss_pred             CCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHh
Q psy8260         305 NQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQAL  383 (427)
Q Consensus       305 ~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L  383 (427)
                      .++|+||+|++++.|.+ +..+|...................      ......++++.+||.+||+.||.+|||++|++
T Consensus       274 ~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell  347 (359)
T 3vhe_A          274 IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV  347 (359)
T ss_dssp             HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             chhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence            78899999999988865 555554333223222222221111      11234688999999999999999999999999


Q ss_pred             cC
Q psy8260         384 AH  385 (427)
Q Consensus       384 ~H  385 (427)
                      +|
T Consensus       348 ~~  349 (359)
T 3vhe_A          348 EH  349 (359)
T ss_dssp             HH
T ss_pred             HH
Confidence            87

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=7.7e-41  Score=331.00  Aligned_cols=257  Identities=21%  Similarity=0.297  Sum_probs=195.5

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEe------CcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeee
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALD------SVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLD  131 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~------~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~  131 (427)
                      +++..+.|.+++.||+|+||.||.+...      ..++..||||++... ......+.+.+|+.+|+.+ +||||+++++
T Consensus        76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  154 (370)
T 2psq_A           76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLG  154 (370)
T ss_dssp             TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred             ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence            4566788999999999999999987542      245678999998654 3445566788999999999 8999999999


Q ss_pred             eeecCccccCCceEEEEeccC-CCCHHHHHhhC-----------------CCCHHHHHHHHHHHHHHHHHHHhcCceecc
Q psy8260         132 VFHSNTCLADFKNVYMVTHLM-GADLNNILRTQ-----------------KLSDDHVQFLVYQILRGLKYIHSAGIIHRD  193 (427)
Q Consensus       132 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~-----------------~l~~~~~~~~~~qi~~aL~yLH~~~iiHrD  193 (427)
                      ++...      ..+|+++|++ +++|.++++..                 .+++..+..++.||+.||.|||++||+|||
T Consensus       155 ~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrD  228 (370)
T 2psq_A          155 ACTQD------GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRD  228 (370)
T ss_dssp             EECSS------SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             EEccC------CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence            98653      3578888888 67999988653                 378999999999999999999999999999


Q ss_pred             CCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhcc
Q psy8260         194 LKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDF  273 (427)
Q Consensus       194 LKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~  273 (427)
                      |||+|||++.++.+||+|||+++........                                                 
T Consensus       229 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-------------------------------------------------  259 (370)
T 2psq_A          229 LAARNVLVTENNVMKIADFGLARDINNIDYY-------------------------------------------------  259 (370)
T ss_dssp             CCGGGEEECTTCCEEECCCSSCEETTCCCTT-------------------------------------------------
T ss_pred             cchhhEEECCCCCEEEccccCCcccCcccce-------------------------------------------------
Confidence            9999999999999999999998743221000                                                 


Q ss_pred             CCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHh
Q psy8260         274 GLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQ  352 (427)
Q Consensus       274 g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (427)
                             .......||+.|+|||++.+..+..++|+||+|++++.|.+ +..+|................. .      .
T Consensus       260 -------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~-~------~  325 (370)
T 2psq_A          260 -------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR-M------D  325 (370)
T ss_dssp             -------CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC-C------C
T ss_pred             -------ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC-C------C
Confidence                   01112346788888888887777778899999999987644 4444433222222222211111 0      1


Q ss_pred             hcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         353 VFKGANPQAIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       353 ~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                      .....++++.+||.+||+.||.+|||++|++++
T Consensus       326 ~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          326 KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            123467899999999999999999999999875

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=5.9e-41  Score=323.12  Aligned_cols=266  Identities=21%  Similarity=0.325  Sum_probs=198.3

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      .+..+.|.+++.||+|+||.||. +.+..+|+.||+|++..  ......+.+.+|+++++.++||||+++++++...   
T Consensus         6 ~~~~~~~~~~~~lG~G~~g~V~~-~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---   79 (310)
T 3s95_A            6 IFRPSDLIHGEVLGKGCFGQAIK-VTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD---   79 (310)
T ss_dssp             EECGGGEEEEEEEECCSSEEEEE-EEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET---
T ss_pred             eeChhHeeccceecCCCCEEEEE-EEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC---
Confidence            45567899999999999999996 55677899999998854  3455667788999999999999999999998653   


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                         ...++++|++ +++|.++++.  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        80 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  156 (310)
T 3s95_A           80 ---KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLAR  156 (310)
T ss_dssp             ---TEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCE
T ss_pred             ---CeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccce
Confidence               4578899988 7799999875  569999999999999999999999999999999999999999999999999997


Q ss_pred             CCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         217 PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       217 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      ..........+......                                            .........+||+.|+|||
T Consensus       157 ~~~~~~~~~~~~~~~~~--------------------------------------------~~~~~~~~~~gt~~y~aPE  192 (310)
T 3s95_A          157 LMVDEKTQPEGLRSLKK--------------------------------------------PDRKKRYTVVGNPYWMAPE  192 (310)
T ss_dssp             ECC----------------------------------------------------------------CCCCSCGGGCCHH
T ss_pred             ecccccccccccccccc--------------------------------------------cccccccccCCCcceeCHH
Confidence            54432211111000000                                            0011223567999999999


Q ss_pred             HhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcH-----HHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCC
Q psy8260         297 IMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSD-----SARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLEL  371 (427)
Q Consensus       297 vl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~  371 (427)
                      ++.+..+..++|+||+|++++.+.++..++.......     .......          .......++++.+||.+||+.
T Consensus       193 ~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~  262 (310)
T 3s95_A          193 MINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD----------RYCPPNCPPSFFPITVRCCDL  262 (310)
T ss_dssp             HHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH----------HTCCTTCCTTHHHHHHHHTCS
T ss_pred             HhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc----------ccCCCCCCHHHHHHHHHHccC
Confidence            9998888888999999999987743332222111000     0000000          011245678999999999999


Q ss_pred             CCCCCCCHHHHhcCCCCCC
Q psy8260         372 DSEKRITAEQALAHPYLSQ  390 (427)
Q Consensus       372 dP~~R~ta~e~L~Hp~f~~  390 (427)
                      ||++|||++|+++  |+..
T Consensus       263 dP~~Rps~~~l~~--~L~~  279 (310)
T 3s95_A          263 DPEKRPSFVKLEH--WLET  279 (310)
T ss_dssp             SGGGSCCHHHHHH--HHHH
T ss_pred             ChhhCcCHHHHHH--HHHH
Confidence            9999999999987  4543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=8.2e-42  Score=329.57  Aligned_cols=267  Identities=19%  Similarity=0.267  Sum_probs=199.9

Q ss_pred             cCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcccc
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  140 (427)
                      ..+.|.+.+.||+|+||.||. +.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++.....  
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~--   86 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHL-ARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP--   86 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEE-EEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET--
T ss_pred             ecCcEEEEEEEccCCCEEEEE-EEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC--
Confidence            346799999999999999996 56778899999999876433 33445667899999999999999999999865321  


Q ss_pred             CCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCC
Q psy8260         141 DFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT  218 (427)
Q Consensus       141 ~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~  218 (427)
                      .....|++||++ |++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        87 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           87 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             TEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             CCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence            113458999998 6899998864 67999999999999999999999999999999999999999999999999998754


Q ss_pred             CCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         219 ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       219 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                      .......                                                       .......||+.|+|||++
T Consensus       167 ~~~~~~~-------------------------------------------------------~~~~~~~gt~~y~aPE~~  191 (311)
T 3ork_A          167 ADSGNSV-------------------------------------------------------TQTAAVIGTAQYLSPEQA  191 (311)
T ss_dssp             ----------------------------------------------------------------------CCTTCCHHHH
T ss_pred             ccccccc-------------------------------------------------------ccccccCcCcccCCHHHh
Confidence            3211000                                                       011234578888888888


Q ss_pred             hhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC
Q psy8260         299 LNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT  378 (427)
Q Consensus       299 ~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t  378 (427)
                      .+..+..++|+||+|++++.|.++..+|................+.    .........++++.+||.+||+.||.+||+
T Consensus       192 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~dP~~R~~  267 (311)
T 3ork_A          192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI----PPSARHEGLSADLDAVVLKALAKNPENRYQ  267 (311)
T ss_dssp             HTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC----CHHHHSTTCCHHHHHHHHHHTCSSGGGSCS
T ss_pred             cCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC----CcccccCCCCHHHHHHHHHHHhcCHhhChh
Confidence            8777777889999999998886555555332211222222222211    122344568999999999999999999999


Q ss_pred             HHHHhcCCCCCC
Q psy8260         379 AEQALAHPYLSQ  390 (427)
Q Consensus       379 a~e~L~Hp~f~~  390 (427)
                      +.+++.|+|+..
T Consensus       268 ~~~~l~~~l~~~  279 (311)
T 3ork_A          268 TAAEMRADLVRV  279 (311)
T ss_dssp             SHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHH
Confidence            999999999974

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.7e-41  Score=321.47  Aligned_cols=264  Identities=25%  Similarity=0.336  Sum_probs=193.7

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC---C----HHHHHHHHHHHHHHhcCC-CCCceeeeeeee
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ---S----AVHAKRTYRELRMLKHMN-HENVIGLLDVFH  134 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~---~----~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~  134 (427)
                      .+.|.+.+.||+|+||.||. +.+..+|+.||||++.....   .    ....+.+.+|+++++++. ||||+++++++.
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRR-CIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEE-EEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhccceeeeecCCCceEEEE-EEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            36788999999999999996 55677899999999865321   1    122455779999999995 999999999986


Q ss_pred             cCccccCCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeC
Q psy8260         135 SNTCLADFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDF  212 (427)
Q Consensus       135 ~~~~~~~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DF  212 (427)
                      ..      ...+++++++ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+||
T Consensus        95 ~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           95 TN------TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             CS------SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             cC------CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecc
Confidence            53      4678999988 5799998864 57999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCC--cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccc
Q psy8260         213 GLARPTENE--MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATR  290 (427)
Q Consensus       213 Gla~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~  290 (427)
                      |+++.....  .....||+.|+|||++.+....                                               
T Consensus       169 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-----------------------------------------------  201 (298)
T 1phk_A          169 GFSCQLDPGEKLREVCGTPSYLAPEIIECSMND-----------------------------------------------  201 (298)
T ss_dssp             TTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCT-----------------------------------------------
T ss_pred             cchhhcCCCcccccccCCccccCHHHhcccccc-----------------------------------------------
Confidence            998654321  1223344444444444321000                                               


Q ss_pred             cccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcC
Q psy8260         291 WYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLE  370 (427)
Q Consensus       291 ~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~  370 (427)
                              ....+..++|+||+|++++.|.++..+|.....................    ..+...++++.+||.+||+
T Consensus       202 --------~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~  269 (298)
T 1phk_A          202 --------NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS----PEWDDYSDTVKDLVSRFLV  269 (298)
T ss_dssp             --------TSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----TTGGGSCHHHHHHHHHHCC
T ss_pred             --------ccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc----ccccccCHHHHHHHHHHcc
Confidence                    0112445679999999998885555444332211222222222221111    1234568899999999999


Q ss_pred             CCCCCCCCHHHHhcCCCCCCCC
Q psy8260         371 LDSEKRITAEQALAHPYLSQYS  392 (427)
Q Consensus       371 ~dP~~R~ta~e~L~Hp~f~~~~  392 (427)
                      .||.+|||++|+|+||||.+..
T Consensus       270 ~dp~~Rps~~~ll~h~~~~~~~  291 (298)
T 1phk_A          270 VQPQKRYTAEEALAHPFFQQYV  291 (298)
T ss_dssp             SSGGGSCCHHHHTTSGGGCTTC
T ss_pred             CCcccCCCHHHHHhChHhhhcc
Confidence            9999999999999999998754

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=7.6e-42  Score=336.40  Aligned_cols=264  Identities=21%  Similarity=0.320  Sum_probs=195.9

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      ++..+.|.+.+.||+|+||.||. +.+..+|+.||+|++... ......+.+.+|+.+++.++||||+++++++...   
T Consensus        29 ~~~~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~va~K~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---  103 (360)
T 3eqc_A           29 ELKDDDFEKISELGAGNGGVVFK-VSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD---  103 (360)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEE-EEETTTCCEEEEEEEECC-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET---
T ss_pred             ccccccceeeeeecCCCCeEEEE-EEECCCCcEEEEEEeccc-cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC---
Confidence            56678899999999999999996 456778999999998754 3455566788999999999999999999998653   


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~-~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                         ...+++|+++ +++|.+++.. ..+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++
T Consensus       104 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  180 (360)
T 3eqc_A          104 ---GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG  180 (360)
T ss_dssp             ---TEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred             ---CEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCc
Confidence               4678999998 6799998865 5799999999999999999999996 99999999999999999999999999875


Q ss_pred             CCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         217 PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       217 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      .....                                                            ......||+.|+|||
T Consensus       181 ~~~~~------------------------------------------------------------~~~~~~gt~~y~aPE  200 (360)
T 3eqc_A          181 QLIDS------------------------------------------------------------MANSFVGTRSYMSPE  200 (360)
T ss_dssp             HHHHH------------------------------------------------------------C----CCCCTTCCHH
T ss_pred             ccccc------------------------------------------------------------cccCCCCCCCeECHH
Confidence            32110                                                            011234677777777


Q ss_pred             HhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHh---------------------------cCCCCCccc
Q psy8260         297 IMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYIN---------------------------SLPLLTKKD  349 (427)
Q Consensus       297 vl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~  349 (427)
                      ++.+..+..++|+||+|++++.|.++..||....... ......                           ..+......
T Consensus       201 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (360)
T 3eqc_A          201 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE-LELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFE  279 (360)
T ss_dssp             HHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHH-HHHHHC------------------------------CCCHHH
T ss_pred             HHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchh
Confidence            7766666667799999999887744443332111000 000000                           000000000


Q ss_pred             -HH---------hhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q psy8260         350 -FR---------QVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYS  392 (427)
Q Consensus       350 -~~---------~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~  392 (427)
                       ..         ......++++.+||.+||++||.+|||++|+|+||||++..
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  332 (360)
T 3eqc_A          280 LLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  332 (360)
T ss_dssp             HHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             hhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence             00         00123578999999999999999999999999999998643

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.6e-42  Score=341.38  Aligned_cols=264  Identities=14%  Similarity=0.068  Sum_probs=176.6

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH-HHHHHHHHH---HHHHhcCCCCCceeee-------ee
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA-VHAKRTYRE---LRMLKHMNHENVIGLL-------DV  132 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~E---i~~l~~l~HpnIv~l~-------~~  132 (427)
                      ..|.+.+.||+|+||.||. +.+..+|+.||||++....... ...+.+.+|   +++|+. +||||++++       ++
T Consensus        62 ~~y~~~~~lG~G~~g~V~~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFL-VRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEE-EEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred             eeeeeeeeccCCCCEEEEE-EEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence            3488999999999999996 5567789999999998755433 334455567   456666 799988865       33


Q ss_pred             eecCccc-----------cCCceEEEEeccCCCCHHHHHhh--CCCCHHHH------HHHHHHHHHHHHHHHhcCceecc
Q psy8260         133 FHSNTCL-----------ADFKNVYMVTHLMGADLNNILRT--QKLSDDHV------QFLVYQILRGLKYIHSAGIIHRD  193 (427)
Q Consensus       133 ~~~~~~~-----------~~~~~~~lv~e~~g~~L~~~l~~--~~l~~~~~------~~~~~qi~~aL~yLH~~~iiHrD  193 (427)
                      +......           .....+|++||+++++|.+++..  ..+++...      ..++.||+.||+|||++||+|||
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD  219 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH  219 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence            3322110           00145899999999999999864  23444444      56679999999999999999999


Q ss_pred             CCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhcc
Q psy8260         194 LKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDF  273 (427)
Q Consensus       194 LKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~  273 (427)
                      |||+|||++.++.+||+|||+|+..........                                               
T Consensus       220 ikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~-----------------------------------------------  252 (371)
T 3q60_A          220 FTPDNLFIMPDGRLMLGDVSALWKVGTRGPASS-----------------------------------------------  252 (371)
T ss_dssp             CSGGGEEECTTSCEEECCGGGEEETTCEEEGGG-----------------------------------------------
T ss_pred             CCHHHEEECCCCCEEEEecceeeecCCCccCcc-----------------------------------------------
Confidence            999999999999999999999875433221222                                               


Q ss_pred             CCCCCCccccccccccccccchHHhhh--ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhc--CCCCCccc
Q psy8260         274 GLARPTENEMTGYVATRWYRAPEIMLN--WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINS--LPLLTKKD  349 (427)
Q Consensus       274 g~~~~~~~~~~~~~gt~~Y~APEvl~~--~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  349 (427)
                                    ||+.|+|||++.+  ..+..++|+||+|++++.|.++..||........ ..+...  ........
T Consensus       253 --------------~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~  317 (371)
T 3q60_A          253 --------------VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK-GSWKRPSLRVPGTDSL  317 (371)
T ss_dssp             --------------SCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCT-TCCCBCCTTSCCCCSC
T ss_pred             --------------CCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccc-cchhhhhhhhcccccc
Confidence                          3455666666654  4466678999999999888555555543311100 000000  00000000


Q ss_pred             HHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q psy8260         350 FRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       350 ~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~  391 (427)
                      ....+..+++++.+||.+||+.||++|||++|+|+||||++.
T Consensus       318 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  359 (371)
T 3q60_A          318 AFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL  359 (371)
T ss_dssp             CCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred             chhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence            111234678999999999999999999999999999999764

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.8e-41  Score=330.38  Aligned_cols=262  Identities=24%  Similarity=0.369  Sum_probs=183.6

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCC-cEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCC------ceeeeee
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSG-VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHEN------VIGLLDV  132 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g-~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~Hpn------Iv~l~~~  132 (427)
                      +...+.|.+.+.||+|+||.||.+. +..++ +.||||++..   .......+.+|+.+++.++|+|      ++.++++
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~   90 (355)
T 2eu9_A           15 DWLQERYEIVGNLGEGTFGKVVECL-DHARGKSQVALKIIRN---VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDW   90 (355)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEE-ETTTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred             ceecccEEEEEEeeccCCeEEEEEE-ecCCCceEEEEEEEcc---cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence            4456789999999999999999654 44455 7899999864   2344556778999999887766      8888888


Q ss_pred             eecCccccCCceEEEEeccCCCCHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEE--------
Q psy8260         133 FHSNTCLADFKNVYMVTHLMGADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV--------  201 (427)
Q Consensus       133 ~~~~~~~~~~~~~~lv~e~~g~~L~~~l~~~---~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl--------  201 (427)
                      +...      ...++++|++++++.+.+...   .+++..+..++.||+.||.|||++||+||||||+|||+        
T Consensus        91 ~~~~------~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~  164 (355)
T 2eu9_A           91 FNFH------GHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETL  164 (355)
T ss_dssp             EEET------TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEE
T ss_pred             eeeC------CeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccc
Confidence            7643      468999999988888777543   59999999999999999999999999999999999999        


Q ss_pred             -----------cCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhh
Q psy8260         202 -----------NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKI  270 (427)
Q Consensus       202 -----------~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki  270 (427)
                                 +.++.+||+|||+++..........                                            
T Consensus       165 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~--------------------------------------------  200 (355)
T 2eu9_A          165 YNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIV--------------------------------------------  200 (355)
T ss_dssp             ECCC-CCCEEEESCCCEEECCCTTCEETTSCCCSSC--------------------------------------------
T ss_pred             ccccccccccccCCCcEEEeecCccccccccccCCc--------------------------------------------
Confidence                       5678899999998865433333333                                            


Q ss_pred             hccCCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcc--
Q psy8260         271 LDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKK--  348 (427)
Q Consensus       271 ~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  348 (427)
                                       ||+.|+|||++.+..+..++|+||+|++++.|.++..+|...................+..  
T Consensus       201 -----------------gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~  263 (355)
T 2eu9_A          201 -----------------ATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMI  263 (355)
T ss_dssp             -----------------SCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             -----------------CCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHh
Confidence                             4555555555555555556688888877766644333332111111000000000000000  


Q ss_pred             -------------------------------cHHhh---cCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q psy8260         349 -------------------------------DFRQV---FKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYS  392 (427)
Q Consensus       349 -------------------------------~~~~~---~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~  392 (427)
                                                     .+...   ....++++.+||.+||+.||++|||++|+|+||||.+..
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  341 (355)
T 2eu9_A          264 HRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT  341 (355)
T ss_dssp             HHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCC
T ss_pred             hhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCC
Confidence                                           00000   001135788999999999999999999999999998763

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=6e-41  Score=321.86  Aligned_cols=256  Identities=20%  Similarity=0.312  Sum_probs=198.8

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      ...|.+.+.||+|+||.||. +.+..+++.||||++..... ....+.+.+|+.+++.++||||+++++++...      
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------   92 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFK-GIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD------   92 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEE-EEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEET------
T ss_pred             HHHHHHhhhhcccCCeEEEE-EEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC------
Confidence            45688999999999999996 45677899999999865432 22345678999999999999999999988653      


Q ss_pred             ceEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      ...|++++++ +++|.+++..+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        93 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  172 (303)
T 3a7i_A           93 TKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  172 (303)
T ss_dssp             TEEEEEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred             CeEEEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence            4578999988 579999998888999999999999999999999999999999999999999999999999998643221


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      ..                                                          ......||+.|+|||++.+.
T Consensus       173 ~~----------------------------------------------------------~~~~~~~~~~y~aPE~~~~~  194 (303)
T 3a7i_A          173 QI----------------------------------------------------------KRNTFVGTPFWMAPEVIKQS  194 (303)
T ss_dssp             BC----------------------------------------------------------CBCCCCSCGGGCCHHHHTTC
T ss_pred             cc----------------------------------------------------------ccCccCCCcCccCHHHHhcC
Confidence            00                                                          01123567778888887776


Q ss_pred             cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHH
Q psy8260         302 MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQ  381 (427)
Q Consensus       302 ~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e  381 (427)
                      .+..++|+||+|++++.+.++..+|................+.       ......++++.+||.+||+.||.+|||++|
T Consensus       195 ~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  267 (303)
T 3a7i_A          195 AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPP-------TLEGNYSKPLKEFVEACLNKEPSFRPTAKE  267 (303)
T ss_dssp             CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-------CCCSSCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             CCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCC-------CCccccCHHHHHHHHHHcCCChhhCcCHHH
Confidence            6777789999999998875554444322111111111111110       112356889999999999999999999999


Q ss_pred             HhcCCCCCCC
Q psy8260         382 ALAHPYLSQY  391 (427)
Q Consensus       382 ~L~Hp~f~~~  391 (427)
                      +++||||...
T Consensus       268 ll~~~~~~~~  277 (303)
T 3a7i_A          268 LLKHKFILRN  277 (303)
T ss_dssp             HTTCHHHHHH
T ss_pred             HhhChhhhcC
Confidence            9999999753

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.2e-41  Score=324.51  Aligned_cols=260  Identities=18%  Similarity=0.328  Sum_probs=190.3

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCccc
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~  139 (427)
                      ...+.|.+.+.||.|+||.||.+ .+..+|+.||||++......   ...+.+|+.+++.+ +||||+++++++......
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   96 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKG-RHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   96 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEE-EETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred             CCCCcEEEEEEeccCCCEEEEEE-EECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence            34678999999999999999964 56678999999998654322   34577899999998 899999999998754322


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                      .....+|+++|++ +++|.+++..   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  176 (326)
T 2x7f_A           97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS  176 (326)
T ss_dssp             CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred             cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence            2235689999998 5699998865   46999999999999999999999999999999999999999999999999998


Q ss_pred             CCCCCC---cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccc
Q psy8260         216 RPTENE---MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWY  292 (427)
Q Consensus       216 ~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y  292 (427)
                      ......   .....                                                             ||+.|
T Consensus       177 ~~~~~~~~~~~~~~-------------------------------------------------------------~~~~y  195 (326)
T 2x7f_A          177 AQLDRTVGRRNTFI-------------------------------------------------------------GTPYW  195 (326)
T ss_dssp             C--------------------------------------------------------------------------CCGGG
T ss_pred             eecCcCcccccccc-------------------------------------------------------------CCccc
Confidence            754321   11223                                                             45555


Q ss_pred             cchHHhh-----hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHH
Q psy8260         293 RAPEIML-----NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSL  367 (427)
Q Consensus       293 ~APEvl~-----~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~  367 (427)
                      +|||++.     +..+..++|+||+|++++.|.++..+|.............. .+...     ......++++.+||.+
T Consensus       196 ~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~-----~~~~~~~~~l~~li~~  269 (326)
T 2x7f_A          196 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR-NPAPR-----LKSKKWSKKFQSFIES  269 (326)
T ss_dssp             CCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-SCCCC-----CSCSCSCHHHHHHHHH
T ss_pred             cChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc-Ccccc-----CCccccCHHHHHHHHH
Confidence            5555543     23355677999999999888555555533211111111111 11100     0123467899999999


Q ss_pred             hcCCCCCCCCCHHHHhcCCCCCCC
Q psy8260         368 MLELDSEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       368 mL~~dP~~R~ta~e~L~Hp~f~~~  391 (427)
                      ||..||.+|||++|+++||||.+.
T Consensus       270 ~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          270 CLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             HCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             HhccChhhCCCHHHHhhChHHhhC
Confidence            999999999999999999999864

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=320.46  Aligned_cols=258  Identities=21%  Similarity=0.357  Sum_probs=191.9

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      ......|++.+.||.|+||.||.+ .+..+|+.||||.+.....    ...+.+|+.+++.++||||+++++++...   
T Consensus        25 ~~~~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---   96 (314)
T 3com_A           25 KQPEEVFDVLEKLGEGSYGSVYKA-IHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKN---   96 (314)
T ss_dssp             -----CEEEEEECC----CEEEEE-EETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEET---
T ss_pred             hcchhhhhhheeeccCCCeEEEEE-EECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeC---
Confidence            344567899999999999999964 5677899999999865432    24577899999999999999999998653   


Q ss_pred             cCCceEEEEeccC-CCCHHHHHh--hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILR--TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~--~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                         ...|++++++ +++|.+++.  ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++
T Consensus        97 ---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  173 (314)
T 3com_A           97 ---TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAG  173 (314)
T ss_dssp             ---TEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             ---CEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccch
Confidence               4578999988 569999885  4679999999999999999999999999999999999999999999999999986


Q ss_pred             CCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         217 PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       217 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      .......                                                          ......||+.|+|||
T Consensus       174 ~~~~~~~----------------------------------------------------------~~~~~~~~~~y~aPE  195 (314)
T 3com_A          174 QLTDTMA----------------------------------------------------------KRNTVIGTPFWMAPE  195 (314)
T ss_dssp             ECBTTBS----------------------------------------------------------CBCCCCSCGGGCCHH
T ss_pred             hhhhhcc----------------------------------------------------------ccCccCCCCCccChh
Confidence            4322100                                                          011234677788888


Q ss_pred             HhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCC-CCCcccHHhhcCCCChhHHHHHHHhcCCCCCC
Q psy8260         297 IMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLP-LLTKKDFRQVFKGANPQAIDLLSLMLELDSEK  375 (427)
Q Consensus       297 vl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~  375 (427)
                      ++.+..+..++|+||+|++++.|.++..+|................+ ...      .....++++.+||.+||+.||.+
T Consensus       196 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~  269 (314)
T 3com_A          196 VIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFR------KPELWSDNFTDFVKQCLVKSPEQ  269 (314)
T ss_dssp             HHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS------SGGGSCHHHHHHHHHHTCSCTTT
T ss_pred             hcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccC------CcccCCHHHHHHHHHHccCChhh
Confidence            87776677788999999999887555555533211111111111111 111      11235789999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCC
Q psy8260         376 RITAEQALAHPYLSQYS  392 (427)
Q Consensus       376 R~ta~e~L~Hp~f~~~~  392 (427)
                      |||++|+++||||....
T Consensus       270 Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          270 RATATQLLQHPFVRSAK  286 (314)
T ss_dssp             SCCHHHHTTSHHHHTCC
T ss_pred             CcCHHHHHhCHHHhcCC
Confidence            99999999999998653

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.3e-40  Score=318.72  Aligned_cols=265  Identities=25%  Similarity=0.322  Sum_probs=199.2

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      .+..++|.+.+.||+|+||.||. +.+..+++.||||++..... .....+.+.+|+.+++.++||||+++++++...  
T Consensus         7 ~~~~~~y~i~~~lg~G~~g~V~~-~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--   83 (294)
T 4eqm_A            7 KIINERYKIVDKLGGGGMSTVYL-AEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED--   83 (294)
T ss_dssp             SCEETTEEEEEEEEEETTEEEEE-EEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS--
T ss_pred             hHhhccEEEEEEEccCCCEEEEE-EEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC--
Confidence            34457799999999999999996 56778899999999865433 344556788999999999999999999998654  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                          ...|++||++ |++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        84 ----~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~  159 (294)
T 4eqm_A           84 ----DCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAK  159 (294)
T ss_dssp             ----SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSST
T ss_pred             ----CeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcc
Confidence                4678999988 6799998864 569999999999999999999999999999999999999999999999999987


Q ss_pred             CCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         217 PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       217 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      ........                                                         ......||+.|+|||
T Consensus       160 ~~~~~~~~---------------------------------------------------------~~~~~~gt~~y~aPE  182 (294)
T 4eqm_A          160 ALSETSLT---------------------------------------------------------QTNHVLGTVQYFSPE  182 (294)
T ss_dssp             TC----------------------------------------------------------------------CCSSCCHH
T ss_pred             cccccccc---------------------------------------------------------ccCccccCccccCHh
Confidence            54321100                                                         111235788888888


Q ss_pred             HhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCC
Q psy8260         297 IMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKR  376 (427)
Q Consensus       297 vl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R  376 (427)
                      ++.+..+...+|+||+|++++.|.++..||..........+.....   ...........+++.+.++|.+||+.||.+|
T Consensus       183 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R  259 (294)
T 4eqm_A          183 QAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDS---VPNVTTDVRKDIPQSLSNVILRATEKDKANR  259 (294)
T ss_dssp             HHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSC---CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGS
T ss_pred             HhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcc---CCCcchhcccCCCHHHHHHHHHHhcCCHhHc
Confidence            8887777778899999999988865555553322111111111111   1111223445678999999999999999999


Q ss_pred             CCHHHHhcCCCCCCC
Q psy8260         377 ITAEQALAHPYLSQY  391 (427)
Q Consensus       377 ~ta~e~L~Hp~f~~~  391 (427)
                      ++..+.+.+.|..-.
T Consensus       260 ~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          260 YKTIQEMKDDLSSVL  274 (294)
T ss_dssp             CSSHHHHHHHHHTSS
T ss_pred             cccHHHHHHHHHHHH
Confidence            977777777776543

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.9e-41  Score=334.52  Aligned_cols=268  Identities=27%  Similarity=0.344  Sum_probs=186.7

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCC-----------CCCcee
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN-----------HENVIG  128 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~-----------HpnIv~  128 (427)
                      .+..+.|.+.+.||+|+||.||. +.+..+|+.||||++..   .......+.+|+.++++++           ||||++
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~   90 (373)
T 1q8y_A           15 PYKDARYILVRKLGWGHFSTVWL-AKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK   90 (373)
T ss_dssp             EETTTTEEEEEEEEECSSEEEEE-EEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred             cccCCeEEEEEeeeecCCeEEEE-EEecCCCcEEEEEEecC---CccchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence            34567899999999999999996 56778899999999864   3344556778999988876           899999


Q ss_pred             eeeeeecCccccCCceEEEEeccCCCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCCeEEc--
Q psy8260         129 LLDVFHSNTCLADFKNVYMVTHLMGADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVN--  202 (427)
Q Consensus       129 l~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~-~iiHrDLKp~NILl~--  202 (427)
                      +++++....  .....+++++++++++|.+++..   ..+++..+..++.||+.||.|||++ ||+||||||+|||++  
T Consensus        91 ~~~~~~~~~--~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~  168 (373)
T 1q8y_A           91 LLDHFNHKG--PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV  168 (373)
T ss_dssp             CCEEEEEEE--TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred             HHHHhhccC--CCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEecc
Confidence            999986432  12236889999999999998864   4599999999999999999999998 999999999999995  


Q ss_pred             ----CCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCC
Q psy8260         203 ----EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARP  278 (427)
Q Consensus       203 ----~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~  278 (427)
                          ..+.+||+|||+++......+...|                                                   
T Consensus       169 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~---------------------------------------------------  197 (373)
T 1q8y_A          169 DSPENLIQIKIADLGNACWYDEHYTNSIQ---------------------------------------------------  197 (373)
T ss_dssp             ETTTTEEEEEECCCTTCEETTBCCCSCCS---------------------------------------------------
T ss_pred             CCCcCcceEEEcccccccccCCCCCCCCC---------------------------------------------------
Confidence                3448999999998755443333344                                                   


Q ss_pred             CccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCc------HHHHHHHhcCCCC-------
Q psy8260         279 TENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISS------DSARKYINSLPLL-------  345 (427)
Q Consensus       279 ~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~------~~~~~~~~~~~~~-------  345 (427)
                                |+.|+|||++.+..+..++|+||+|++++.|.++..+|......      .............       
T Consensus       198 ----------t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~  267 (373)
T 1q8y_A          198 ----------TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRN  267 (373)
T ss_dssp             ----------CGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             ----------CccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhc
Confidence                      44555555554444555567777776666553333323211100      0000000000000       


Q ss_pred             --------------------CcccHHh-------hcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q psy8260         346 --------------------TKKDFRQ-------VFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDP  394 (427)
Q Consensus       346 --------------------~~~~~~~-------~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  394 (427)
                                          .......       .....++++.+||.+||+.||.+|||++|+|+||||.+....
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  343 (373)
T 1q8y_A          268 GKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGM  343 (373)
T ss_dssp             CTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTTC
T ss_pred             cchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcccCc
Confidence                                0000000       001235678999999999999999999999999999986544

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.7e-41  Score=320.14  Aligned_cols=260  Identities=22%  Similarity=0.315  Sum_probs=197.2

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      +.|.+.+.||+|+||.||. +.+..+|+.||+|++..........+.+.+|+.+++.++||||+++++++...    ...
T Consensus         6 ~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~~   80 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQK-IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR----TNT   80 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEE-EEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG----GGT
T ss_pred             hheeeehhccCCCCcEEEE-EEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC----CCc
Confidence            5788999999999999996 45677899999999976655566667788999999999999999999987432    124


Q ss_pred             eEEEEeccC-CCCHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhcC-----ceeccCCCCCeEEcCCCCEEEeeC
Q psy8260         144 NVYMVTHLM-GADLNNILRT-----QKLSDDHVQFLVYQILRGLKYIHSAG-----IIHRDLKPSNIAVNEDCELKILDF  212 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~yLH~~~-----iiHrDLKp~NILl~~~~~~kl~DF  212 (427)
                      .+|+++|++ +++|.+++..     ..+++..+..++.|++.||.|||++|     |+||||||+|||++.++.+||+||
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df  160 (279)
T 2w5a_A           81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF  160 (279)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred             eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence            688999998 6799998854     24999999999999999999999999     999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccc
Q psy8260         213 GLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWY  292 (427)
Q Consensus       213 Gla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y  292 (427)
                      |+++.......                                                          ......||+.|
T Consensus       161 g~~~~~~~~~~----------------------------------------------------------~~~~~~~~~~y  182 (279)
T 2w5a_A          161 GLARILNHDTS----------------------------------------------------------FAKTFVGTPYY  182 (279)
T ss_dssp             CHHHHC---CH----------------------------------------------------------HHHHHHSCCTT
T ss_pred             chheeeccccc----------------------------------------------------------cccccCCCccc
Confidence            98754321100                                                          01123467777


Q ss_pred             cchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         293 RAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       293 ~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                      +|||++.+..+...+|+||+|++++.+.++..+|.................       .......++++.+||.+||+.|
T Consensus       183 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~-------~~~~~~~~~~l~~li~~~l~~~  255 (279)
T 2w5a_A          183 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF-------RRIPYRYSDELNEIITRMLNLK  255 (279)
T ss_dssp             CCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-------CCCCTTSCHHHHHHHHHHTCSS
T ss_pred             cChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc-------ccCCcccCHHHHHHHHHHcCCC
Confidence            777777766666678999999999877554444432211111112211111       0112346889999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCCCC
Q psy8260         373 SEKRITAEQALAHPYLSQYSD  393 (427)
Q Consensus       373 P~~R~ta~e~L~Hp~f~~~~~  393 (427)
                      |.+|||++|+++|||+.+...
T Consensus       256 p~~Rps~~~ll~~~~~~~~~~  276 (279)
T 2w5a_A          256 DYHRPSVEEILENPLILEHHH  276 (279)
T ss_dssp             GGGSCCHHHHHTSTTCCGGGS
T ss_pred             cccCCCHHHHHhChhhhhhcc
Confidence            999999999999999986443

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.4e-42  Score=335.62  Aligned_cols=261  Identities=22%  Similarity=0.326  Sum_probs=193.8

Q ss_pred             cccCcceeeccccCcccccEEEEeEEe--CcCCcEEEEEEccCcCC--CHHHHHHHHHHHHHHhcC-CCCCceeeeeeee
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALD--SVSGVKVAIKKIARPFQ--SAVHAKRTYRELRMLKHM-NHENVIGLLDVFH  134 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~--~~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~  134 (427)
                      .+..+.|.+.+.||+|+||.||.+...  ..+|+.||||++.....  .......+.+|+++|+.+ +||||+++++++.
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  129 (355)
T 1vzo_A           50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ  129 (355)
T ss_dssp             CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred             cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence            344578999999999999999976542  35899999999864321  111223456799999999 7999999999886


Q ss_pred             cCccccCCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeC
Q psy8260         135 SNTCLADFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDF  212 (427)
Q Consensus       135 ~~~~~~~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DF  212 (427)
                      ..      ..+|++||++ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus       130 ~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Df  203 (355)
T 1vzo_A          130 TE------TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDF  203 (355)
T ss_dssp             ET------TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCS
T ss_pred             eC------ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeC
Confidence            53      4678999998 6799988754 67999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccc
Q psy8260         213 GLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWY  292 (427)
Q Consensus       213 Gla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y  292 (427)
                      |+++........                                                         .....+||+.|
T Consensus       204 G~a~~~~~~~~~---------------------------------------------------------~~~~~~gt~~y  226 (355)
T 1vzo_A          204 GLSKEFVADETE---------------------------------------------------------RAYDFCGTIEY  226 (355)
T ss_dssp             SEEEECCGGGGG---------------------------------------------------------GGCGGGSCCTT
T ss_pred             CCCeecccCCCC---------------------------------------------------------cccCcccCcCc
Confidence            998643211000                                                         11123567777


Q ss_pred             cchHHhhhc--cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcH----HHHHHHhcCCCCCcccHHhhcCCCChhHHHHHH
Q psy8260         293 RAPEIMLNW--MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSD----SARKYINSLPLLTKKDFRQVFKGANPQAIDLLS  366 (427)
Q Consensus       293 ~APEvl~~~--~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~  366 (427)
                      +|||++.+.  .+..++|+||+|++++.|.++..+|.......    .........+.        .....++.+++||.
T Consensus       227 ~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~li~  298 (355)
T 1vzo_A          227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--------YPQEMSALAKDLIQ  298 (355)
T ss_dssp             CCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC--------CCTTSCHHHHHHHH
T ss_pred             cChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCC--------CCcccCHHHHHHHH
Confidence            777777642  24556799999999988855555553221111    11111111221        12346889999999


Q ss_pred             HhcCCCCCCCC-----CHHHHhcCCCCCCC
Q psy8260         367 LMLELDSEKRI-----TAEQALAHPYLSQY  391 (427)
Q Consensus       367 ~mL~~dP~~R~-----ta~e~L~Hp~f~~~  391 (427)
                      +||+.||.+||     |++|+++||||.+.
T Consensus       299 ~~L~~dP~~R~~~~~~s~~ell~h~~f~~~  328 (355)
T 1vzo_A          299 RLLMKDPKKRLGCGPRDADEIKEHLFFQKI  328 (355)
T ss_dssp             HHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             HHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence            99999999999     99999999999875

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.4e-41  Score=321.27  Aligned_cols=259  Identities=27%  Similarity=0.484  Sum_probs=195.5

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .+.|.+.+.||+|+||.||. +.+..+++.||||++............+.+|++++++++||||+++++++...      
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~-~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------   93 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLK-CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS------   93 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEE-EEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS------
T ss_pred             hhcceeeEEEcCCCCEEEEE-EEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCC------
Confidence            46789999999999999996 45667899999999865443333456678999999999999999999998653      


Q ss_pred             ceEEEEeccC-CCCHHHHHh-hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCC---CCEEEeeCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED---CELKILDFGLARP  217 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~-~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~---~~~kl~DFGla~~  217 (427)
                      ...|++++++ +++|.+.+. ...+++..+..++.|++.||.|||++||+||||||+||+++.+   +.+||+|||+++.
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~  173 (287)
T 2wei_A           94 SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (287)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred             CeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence            4678999987 678877664 5679999999999999999999999999999999999999754   4799999998864


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      .....                                                           ......||+.|+|||+
T Consensus       174 ~~~~~-----------------------------------------------------------~~~~~~~~~~y~aPE~  194 (287)
T 2wei_A          174 FQQNT-----------------------------------------------------------KMKDRIGTAYYIAPEV  194 (287)
T ss_dssp             BCCCS-----------------------------------------------------------SCSCHHHHHTTCCHHH
T ss_pred             ecCCC-----------------------------------------------------------ccccccCcccccChHH
Confidence            32210                                                           0112246677777777


Q ss_pred             hhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC
Q psy8260         298 MLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI  377 (427)
Q Consensus       298 l~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~  377 (427)
                      +.+. +..++|+||+|++++.|.++..+|.....................    ..+..+++++.+||.+||+.||.+||
T Consensus       195 ~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rp  269 (287)
T 2wei_A          195 LRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL----PQWRTISDDAKDLIRKMLTFHPSLRI  269 (287)
T ss_dssp             HTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS----GGGTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred             hcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc----hhhhhcCHHHHHHHHHHcccChhhCc
Confidence            6653 556679999999998775554444332211122222221111111    12356789999999999999999999


Q ss_pred             CHHHHhcCCCCCCCC
Q psy8260         378 TAEQALAHPYLSQYS  392 (427)
Q Consensus       378 ta~e~L~Hp~f~~~~  392 (427)
                      |++|+|+||||.+..
T Consensus       270 s~~ell~hp~~~~~~  284 (287)
T 2wei_A          270 TATQCLEHPWIQKYS  284 (287)
T ss_dssp             CHHHHHHSHHHHHHC
T ss_pred             CHHHHhcCHHHhccc
Confidence            999999999998653

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.8e-40  Score=317.33  Aligned_cols=273  Identities=23%  Similarity=0.310  Sum_probs=193.7

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc-----
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC-----  138 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~-----  138 (427)
                      +.|.+.+.||+|+||.||. +.+..+|+.||||++..   .......+.+|+.+++.++||||+++++++.....     
T Consensus         6 ~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVK-ARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM   81 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEE-EEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred             ccchhhheeccCCcEEEEE-EEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence            5688999999999999996 55677899999999854   23445678899999999999999999998754311     


Q ss_pred             --ccCCceEEEEeccC-CCCHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCC
Q psy8260         139 --LADFKNVYMVTHLM-GADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG  213 (427)
Q Consensus       139 --~~~~~~~~lv~e~~-g~~L~~~l~~~--~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFG  213 (427)
                        .......|+++|++ +++|.+++...  .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg  161 (303)
T 1zy4_A           82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG  161 (303)
T ss_dssp             ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence              12235688999998 67999998753  47888999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccccc
Q psy8260         214 LARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR  293 (427)
Q Consensus       214 la~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~  293 (427)
                      +++............ ....|                                           ..........||+.|+
T Consensus       162 ~~~~~~~~~~~~~~~-~~~~~-------------------------------------------~~~~~~~~~~~~~~y~  197 (303)
T 1zy4_A          162 LAKNVHRSLDILKLD-SQNLP-------------------------------------------GSSDNLTSAIGTAMYV  197 (303)
T ss_dssp             CCSCTTC---------------------------------------------------------------------CTTS
T ss_pred             chhhcccccchhccc-ccccc-------------------------------------------ccccccccCCCccccc
Confidence            997654321100000 00000                                           0001223456899999


Q ss_pred             chHHhhhc-cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         294 APEIMLNW-MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       294 APEvl~~~-~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                      |||++.+. .+..++|+||+|++++.|.+|.......  ..............+.    ......++.+++||.+||+.|
T Consensus       198 aPE~~~~~~~~~~~~Di~slG~il~~l~~p~~~~~~~--~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~d  271 (303)
T 1zy4_A          198 ATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMER--VNILKKLRSVSIEFPP----DFDDNKMKVEKKIIRLLIDHD  271 (303)
T ss_dssp             CHHHHTSCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHSTTCCCCT----TCCTTTSHHHHHHHHHHTCSS
T ss_pred             CcccccCCCCCcchhhHHHHHHHHHHHHhccCCchhH--HHHHHhccccccccCc----cccccchHHHHHHHHHHHhcC
Confidence            99998765 4566779999999998887754322111  0111111111111111    122345678999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCC
Q psy8260         373 SEKRITAEQALAHPYLSQ  390 (427)
Q Consensus       373 P~~R~ta~e~L~Hp~f~~  390 (427)
                      |.+|||++|+++||||..
T Consensus       272 p~~Rps~~~ll~h~~~~~  289 (303)
T 1zy4_A          272 PNKRPGARTLLNSGWLPV  289 (303)
T ss_dssp             GGGSCCHHHHHHSSCSCC
T ss_pred             cccCcCHHHHhCCCCcCC
Confidence            999999999999999975

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.1e-40  Score=321.58  Aligned_cols=276  Identities=21%  Similarity=0.283  Sum_probs=194.5

Q ss_pred             CCCccccccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCC--CCCceeeee
Q psy8260          54 FNQPYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN--HENVIGLLD  131 (427)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~--HpnIv~l~~  131 (427)
                      +..+...+....|.+.+.||+|+||.||.+. + .+++.||||++............+.+|+.+++.++  ||||+++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~-~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~   95 (313)
T 3cek_A           18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVL-N-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD   95 (313)
T ss_dssp             --CCEEEETTEEEEEEEEEECCSSEEEEEEE-C-TTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred             CCeeeeeeccceEEEEEEecCCCCEEEEEEE-c-CCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence            3444456677889999999999999999754 4 35899999999766556666777889999999997  599999999


Q ss_pred             eeecCccccCCceEEEEeccCCCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEe
Q psy8260         132 VFHSNTCLADFKNVYMVTHLMGADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKIL  210 (427)
Q Consensus       132 ~~~~~~~~~~~~~~~lv~e~~g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~  210 (427)
                      ++...      ...|+++|+.+++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||+++ +.+||+
T Consensus        96 ~~~~~------~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~  168 (313)
T 3cek_A           96 YEITD------QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLI  168 (313)
T ss_dssp             EEECS------SEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEEC
T ss_pred             EeecC------CEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEe
Confidence            88654      45889999889999998865 56899999999999999999999999999999999999964 899999


Q ss_pred             eCCCCCCCCCCc-----ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccc
Q psy8260         211 DFGLARPTENEM-----TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTG  285 (427)
Q Consensus       211 DFGla~~~~~~~-----~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~  285 (427)
                      |||+++......     ....||+.|+|||++.+.......                                      +
T Consensus       169 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--------------------------------------~  210 (313)
T 3cek_A          169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN--------------------------------------G  210 (313)
T ss_dssp             CCSSSCC--------------CCGGGCCHHHHTTCC--------------------------------------------
T ss_pred             eccccccccCccccccccCCCCCCCcCCHHHHhhccccccc--------------------------------------c
Confidence            999997643321     123455555555554321000000                                      0


Q ss_pred             ccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcH-HHHHHHhcCCCCCcccHHhhcCCCChhHHHH
Q psy8260         286 YVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSD-SARKYINSLPLLTKKDFRQVFKGANPQAIDL  364 (427)
Q Consensus       286 ~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL  364 (427)
                      .            ....+..++|+||+|++++.|.++..+|....... ............      ......++++.+|
T Consensus       211 ~------------~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~l  272 (313)
T 3cek_A          211 K------------SKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI------EFPDIPEKDLQDV  272 (313)
T ss_dssp             ----------------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC------CCCCCSCHHHHHH
T ss_pred             c------------ccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccccc------CCcccchHHHHHH
Confidence            0            00124446799999999988865555553322111 111111111100      1123346789999


Q ss_pred             HHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q psy8260         365 LSLMLELDSEKRITAEQALAHPYLSQYSDP  394 (427)
Q Consensus       365 i~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  394 (427)
                      |.+||+.||.+|||++|+|+||||.....|
T Consensus       273 i~~~l~~dp~~Rps~~ell~h~~~~~~~~~  302 (313)
T 3cek_A          273 LKCCLKRDPKQRISIPELLAHPYVQIQTHP  302 (313)
T ss_dssp             HHHHTCSSTTTSCCHHHHHTSHHHHCC---
T ss_pred             HHHHccCCcccCcCHHHHhcCccccCCCCc
Confidence            999999999999999999999999865443

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.7e-41  Score=322.09  Aligned_cols=259  Identities=21%  Similarity=0.354  Sum_probs=189.4

Q ss_pred             cCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccC
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      ..+.|.+.+.||+|+||.||.+ .+..+|+.||+|++....  ......+.+|+.+++.++||||+++++++...     
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~-~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----   88 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKA-KNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHD-----   88 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEE-EETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-----
T ss_pred             CccceeecceeccCCCeEEEEE-EEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC-----
Confidence            4567899999999999999964 566789999999986532  22345678999999999999999999998653     


Q ss_pred             CceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCC
Q psy8260         142 FKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT  218 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~  218 (427)
                       ...+++++++ +++|..++..  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        89 -~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  167 (302)
T 2j7t_A           89 -GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN  167 (302)
T ss_dssp             --CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred             -CeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence             4578899988 6789887753  67999999999999999999999999999999999999999999999999976421


Q ss_pred             CCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         219 ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       219 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                      .....                                                          ......||+.|+|||++
T Consensus       168 ~~~~~----------------------------------------------------------~~~~~~~~~~y~aPE~~  189 (302)
T 2j7t_A          168 LKTLQ----------------------------------------------------------KRDSFIGTPYWMAPEVV  189 (302)
T ss_dssp             HHHHH----------------------------------------------------------C-----CCGGGCCHHHH
T ss_pred             ccccc----------------------------------------------------------ccccccCChhhcCCeee
Confidence            10000                                                          01122456666666665


Q ss_pred             h-----hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCC
Q psy8260         299 L-----NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDS  373 (427)
Q Consensus       299 ~-----~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP  373 (427)
                      .     +..+..++|+||+|++++.|.++..++................+...     ......++++.+||.+||+.||
T Consensus       190 ~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dp  264 (302)
T 2j7t_A          190 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL-----LTPSKWSVEFRDFLKIALDKNP  264 (302)
T ss_dssp             HHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-----SSGGGSCHHHHHHHHHHSCSCT
T ss_pred             ccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc-----CCccccCHHHHHHHHHHcccCh
Confidence            3     23345567999999999887555444432221112222222111100     0112357889999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCCC
Q psy8260         374 EKRITAEQALAHPYLSQYS  392 (427)
Q Consensus       374 ~~R~ta~e~L~Hp~f~~~~  392 (427)
                      .+|||++|+++||||....
T Consensus       265 ~~Rps~~~ll~h~~~~~~~  283 (302)
T 2j7t_A          265 ETRPSAAQLLEHPFVSSIT  283 (302)
T ss_dssp             TTSCCHHHHTTSTTTTTCC
T ss_pred             hhCCCHHHHhcChHHhhhc
Confidence            9999999999999998754

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3e-41  Score=333.60  Aligned_cols=261  Identities=19%  Similarity=0.247  Sum_probs=196.2

Q ss_pred             ccccCcceeeccccCcccccEEEEeEE----eCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeee
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSAL----DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFH  134 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~  134 (427)
                      .++....|.+.+.||+|+||.||.+..    +..+++.||||++... ........+.+|+.+++.++|||||++++++.
T Consensus        66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  144 (367)
T 3l9p_A           66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSL  144 (367)
T ss_dssp             CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            467778899999999999999998764    3457889999998643 34555567889999999999999999999986


Q ss_pred             cCccccCCceEEEEeccC-CCCHHHHHhh--------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCC
Q psy8260         135 SNTCLADFKNVYMVTHLM-GADLNNILRT--------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC  205 (427)
Q Consensus       135 ~~~~~~~~~~~~lv~e~~-g~~L~~~l~~--------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~  205 (427)
                      ..      ...|++||++ +++|.++++.        ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus       145 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~  218 (367)
T 3l9p_A          145 QS------LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG  218 (367)
T ss_dssp             SS------SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS
T ss_pred             cC------CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCC
Confidence            53      3468889988 7899998864        2489999999999999999999999999999999999998554


Q ss_pred             ---CEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccc
Q psy8260         206 ---ELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENE  282 (427)
Q Consensus       206 ---~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~  282 (427)
                         .+||+|||+++.......                   +                                     ..
T Consensus       219 ~~~~~kL~DFG~a~~~~~~~~-------------------~-------------------------------------~~  242 (367)
T 3l9p_A          219 PGRVAKIGDFGMARDIYRAGY-------------------Y-------------------------------------RK  242 (367)
T ss_dssp             TTCCEEECCCHHHHHHHHHSS-------------------C-------------------------------------TT
T ss_pred             CCceEEECCCccccccccccc-------------------c-------------------------------------cc
Confidence               599999998753211000                   0                                     01


Q ss_pred             cccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhH
Q psy8260         283 MTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQA  361 (427)
Q Consensus       283 ~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  361 (427)
                      .....||+.|+|||++.+..+..++|+||+|++++.|.+ +..+|....... ...........      ......++++
T Consensus       243 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~-~~~~i~~~~~~------~~~~~~~~~l  315 (367)
T 3l9p_A          243 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-VLEFVTSGGRM------DPPKNCPGPV  315 (367)
T ss_dssp             CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHHHHHTTCCC------CCCTTCCHHH
T ss_pred             CCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCCCC------CCCccCCHHH
Confidence            112356788888888887777778899999999987744 444443322111 21222111111      1123467889


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q psy8260         362 IDLLSLMLELDSEKRITAEQALAHPYLS  389 (427)
Q Consensus       362 ~dLi~~mL~~dP~~R~ta~e~L~Hp~f~  389 (427)
                      .+||.+||+.||.+|||++|+++|.++.
T Consensus       316 ~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          316 YRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            9999999999999999999999998875

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.7e-41  Score=318.67  Aligned_cols=258  Identities=24%  Similarity=0.333  Sum_probs=189.2

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC-HHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS-AVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      .+..+.|.+.+.||+|+||.||.+ .+..+|+.||||++...... ......+.+|+.+++.++||||+++++++...  
T Consensus         7 ~~~~~~y~i~~~lg~G~~g~V~~~-~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--   83 (276)
T 2h6d_A            7 RVKIGHYVLGDTLGVGTFGKVKIG-EHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP--   83 (276)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEE-EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--
T ss_pred             cceeccEEEEeeecCCCCeEEEEE-EECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC--
Confidence            344577999999999999999964 56678999999998643111 11234577999999999999999999998653  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                          ...|++++++ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        84 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~  159 (276)
T 2h6d_A           84 ----TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSN  159 (276)
T ss_dssp             ----SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGG
T ss_pred             ----CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeeccccc
Confidence                4678999988 6799988854 679999999999999999999999999999999999999999999999999886


Q ss_pred             CCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         217 PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       217 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      ......                                                           ......||+.|+|||
T Consensus       160 ~~~~~~-----------------------------------------------------------~~~~~~~~~~y~aPE  180 (276)
T 2h6d_A          160 MMSDGE-----------------------------------------------------------FLRTSCGSPNYAAPE  180 (276)
T ss_dssp             CCCC------------------------------------------------------------------------CCTG
T ss_pred             ccCCCc-----------------------------------------------------------ceecccCCccccCHH
Confidence            543211                                                           001123566666666


Q ss_pred             HhhhccCC-CCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCC
Q psy8260         297 IMLNWMHY-NQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEK  375 (427)
Q Consensus       297 vl~~~~~~-~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~  375 (427)
                      ++.+..+. .++|+||+|++++.+.++..+|...................        ....++++.+||.+||+.||.+
T Consensus       181 ~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~~~l~~li~~~l~~~p~~  252 (276)
T 2h6d_A          181 VISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYI--------PEYLNRSVATLLMHMLQVDPLK  252 (276)
T ss_dssp             GGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------CTTSCHHHHHHHHHHTCSSGGG
T ss_pred             HHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccC--------chhcCHHHHHHHHHHccCChhh
Confidence            66554432 45799999999987755544443221111112221111111        1345788999999999999999


Q ss_pred             CCCHHHHhcCCCCCCC
Q psy8260         376 RITAEQALAHPYLSQY  391 (427)
Q Consensus       376 R~ta~e~L~Hp~f~~~  391 (427)
                      |||++|+++||||.+.
T Consensus       253 Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          253 RATIKDIREHEWFKQD  268 (276)
T ss_dssp             SCCHHHHHHSHHHHTT
T ss_pred             CCCHHHHHhChhhccC
Confidence            9999999999999764

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.9e-40  Score=327.19  Aligned_cols=259  Identities=22%  Similarity=0.301  Sum_probs=198.0

Q ss_pred             ccccccCcceeeccccCcccccEEEEeEEeC------cCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceee
Q psy8260          57 PYSEICRGVIDIGPTLSKESFDLIFSSALDS------VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGL  129 (427)
Q Consensus        57 ~~~~~~~~~~~~~~~lg~g~fg~v~~~~~~~------~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l  129 (427)
                      +.+++..+.|.+++.||+|+||.||.+....      .++..||||++... .......++.+|+++++.+ +|||||++
T Consensus        62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~  140 (382)
T 3tt0_A           62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINL  140 (382)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhh
Confidence            4457888999999999999999999765421      34468999998754 3455567788999999999 99999999


Q ss_pred             eeeeecCccccCCceEEEEeccC-CCCHHHHHhhC-----------------CCCHHHHHHHHHHHHHHHHHHHhcCcee
Q psy8260         130 LDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQ-----------------KLSDDHVQFLVYQILRGLKYIHSAGIIH  191 (427)
Q Consensus       130 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~-----------------~l~~~~~~~~~~qi~~aL~yLH~~~iiH  191 (427)
                      ++++...      ..+++++|++ +++|.+++...                 .+++..+..++.||+.||.|||++||+|
T Consensus       141 ~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH  214 (382)
T 3tt0_A          141 LGACTQD------GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIH  214 (382)
T ss_dssp             EEEECSS------SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             eeeeccC------CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEec
Confidence            9998654      3568899988 67999998753                 3899999999999999999999999999


Q ss_pred             ccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhh
Q psy8260         192 RDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKIL  271 (427)
Q Consensus       192 rDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~  271 (427)
                      |||||+|||++.++.+||+|||+++........                                               
T Consensus       215 ~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~-----------------------------------------------  247 (382)
T 3tt0_A          215 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYY-----------------------------------------------  247 (382)
T ss_dssp             SCCCGGGEEECTTCCEEECSCSCCCCSSCCCTT-----------------------------------------------
T ss_pred             CCCCcceEEEcCCCcEEEcccCccccccccccc-----------------------------------------------
Confidence            999999999999999999999998754321100                                               


Q ss_pred             ccCCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccH
Q psy8260         272 DFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDF  350 (427)
Q Consensus       272 d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (427)
                               .......||+.|+|||++.+..+..++|+||+|++++.|.+ +..+|.... ..............     
T Consensus       248 ---------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~-~~~~~~~~~~~~~~-----  312 (382)
T 3tt0_A          248 ---------KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKLLKEGHRM-----  312 (382)
T ss_dssp             ---------CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHHHHHHHTTCCC-----
T ss_pred             ---------ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCCCC-----
Confidence                     01112346778888888887777778899999999987644 444443221 11222222211111     


Q ss_pred             HhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         351 RQVFKGANPQAIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       351 ~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                       ......++++.+||.+||+.||.+|||++|+++|
T Consensus       313 -~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          313 -DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             -CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             1123568899999999999999999999999987

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.6e-40  Score=312.02  Aligned_cols=251  Identities=19%  Similarity=0.256  Sum_probs=193.1

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      .+....|.+.+.||+|+||.||.+.. . +++.||||++.......   +.+.+|++++++++||||+++++++...   
T Consensus         6 ~i~~~~y~~~~~lg~G~~g~V~~~~~-~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~---   77 (269)
T 4hcu_A            6 VIDPSELTFVQEIGSGQFGLVHLGYW-L-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQ---   77 (269)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEE-T-TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSS---
T ss_pred             EeChhhceeeheecCCCccEEEEEEe-c-CCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecC---
Confidence            55667899999999999999997654 2 57789999997654333   4578999999999999999999998653   


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                         ...+++++++ +++|.+++..  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        78 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  154 (269)
T 4hcu_A           78 ---APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR  154 (269)
T ss_dssp             ---SSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGG
T ss_pred             ---CceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccc
Confidence               4578999988 6799999865  348999999999999999999999999999999999999999999999999886


Q ss_pred             CCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         217 PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       217 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      .......                                                         ....+..||+.|+|||
T Consensus       155 ~~~~~~~---------------------------------------------------------~~~~~~~~~~~y~aPE  177 (269)
T 4hcu_A          155 FVLDDQY---------------------------------------------------------TSSTGTKFPVKWASPE  177 (269)
T ss_dssp             GBCCHHH---------------------------------------------------------HSTTSTTCCGGGCCHH
T ss_pred             ccccccc---------------------------------------------------------ccccCcccccccCCHH
Confidence            4322100                                                         0112334677888888


Q ss_pred             HhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCC
Q psy8260         297 IMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEK  375 (427)
Q Consensus       297 vl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~  375 (427)
                      ++.+..+..++|+||+|++++.+.+ +..+|...................       .....++++.+||.+||+.||.+
T Consensus       178 ~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~  250 (269)
T 4hcu_A          178 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-------KPRLASTHVYQIMNHCWRERPED  250 (269)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-------CCTTSCHHHHHHHHHHTCSSGGG
T ss_pred             HhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCC-------CCCcCCHHHHHHHHHHccCCccc
Confidence            8887777778899999999987744 444443322222222222111111       11345789999999999999999


Q ss_pred             CCCHHHHhcC
Q psy8260         376 RITAEQALAH  385 (427)
Q Consensus       376 R~ta~e~L~H  385 (427)
                      |||++|+++|
T Consensus       251 Rps~~~ll~~  260 (269)
T 4hcu_A          251 RPAFSRLLRQ  260 (269)
T ss_dssp             SCCHHHHHHH
T ss_pred             CcCHHHHHHH
Confidence            9999999986

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.6e-40  Score=319.65  Aligned_cols=258  Identities=21%  Similarity=0.255  Sum_probs=194.8

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEeC--cCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecC
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALDS--VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSN  136 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~  136 (427)
                      .++..+.|.+.+.||+|+||.||.+....  ..+..||||++... ......+.+.+|+.+++.++||||+++++++...
T Consensus        44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  122 (325)
T 3kul_A           44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG  122 (325)
T ss_dssp             CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred             cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            36677889999999999999999765432  23456999998754 3455566788999999999999999999998643


Q ss_pred             ccccCCceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCC
Q psy8260         137 TCLADFKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG  213 (427)
Q Consensus       137 ~~~~~~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFG  213 (427)
                            ...|++||++ +++|.++++.  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus       123 ------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  196 (325)
T 3kul_A          123 ------RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFG  196 (325)
T ss_dssp             ------GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCS
T ss_pred             ------CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCC
Confidence                  4578999988 7799999864  469999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccccc
Q psy8260         214 LARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR  293 (427)
Q Consensus       214 la~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~  293 (427)
                      +++.........                                                       ....+..+|+.|+
T Consensus       197 ~a~~~~~~~~~~-------------------------------------------------------~~~~~~~~t~~y~  221 (325)
T 3kul_A          197 LSRVLEDDPDAA-------------------------------------------------------YTTTGGKIPIRWT  221 (325)
T ss_dssp             SCEECC----CC-------------------------------------------------------EECC---CCGGGS
T ss_pred             cccccccCccce-------------------------------------------------------eeccCCCCccccc
Confidence            987543211000                                                       0112334677899


Q ss_pred             chHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         294 APEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       294 APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                      |||++.+..+..++|+||+|++++.+.+ +..+|................ ...      .....++++.+||.+||+.|
T Consensus       222 aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-~~~------~~~~~~~~l~~li~~~l~~d  294 (325)
T 3kul_A          222 APEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY-RLP------APMGCPHALHQLMLDCWHKD  294 (325)
T ss_dssp             CHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC-CCC------CCTTCCHHHHHHHHHHTCSS
T ss_pred             CHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC-CCC------CCCCcCHHHHHHHHHHccCC
Confidence            9998887777778899999999987644 555554332222222221111 111      12356889999999999999


Q ss_pred             CCCCCCHHHHhcC
Q psy8260         373 SEKRITAEQALAH  385 (427)
Q Consensus       373 P~~R~ta~e~L~H  385 (427)
                      |.+|||++|+++.
T Consensus       295 p~~Rps~~eil~~  307 (325)
T 3kul_A          295 RAQRPRFSQIVSV  307 (325)
T ss_dssp             GGGSCCHHHHHHH
T ss_pred             hhhCcCHHHHHHH
Confidence            9999999998864

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=5.5e-40  Score=313.41  Aligned_cols=248  Identities=26%  Similarity=0.394  Sum_probs=185.2

Q ss_pred             ccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEEE
Q psy8260          69 GPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV  148 (427)
Q Consensus        69 ~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~lv  148 (427)
                      ...||+|+||.||. +.+..+++.||||.+....  ....+.+.+|+.+++.++||||+++++++...      ...+++
T Consensus        27 ~~~lg~G~~g~Vy~-~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv   97 (295)
T 2clq_A           27 RVVLGKGTYGIVYA-GRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN------GFIKIF   97 (295)
T ss_dssp             BCEEEECSSSEEEE-EEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEET------TEEEEE
T ss_pred             cEEEeecCcEEEEE-EEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC------CcEEEE
Confidence            35899999999996 4567789999999986542  23345678999999999999999999998653      457889


Q ss_pred             eccC-CCCHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcC-CCCEEEeeCCCCCCCCCCc
Q psy8260         149 THLM-GADLNNILRTQ----KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE-DCELKILDFGLARPTENEM  222 (427)
Q Consensus       149 ~e~~-g~~L~~~l~~~----~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~-~~~~kl~DFGla~~~~~~~  222 (427)
                      ++++ +++|.+++...    .+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+++......
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A           98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN  177 (295)
T ss_dssp             EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred             EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence            9988 78999988653    4678899999999999999999999999999999999987 8999999999986432210


Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhcc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM  302 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~  302 (427)
                      .                                                          ......||+.|+|||++.+..
T Consensus       178 ~----------------------------------------------------------~~~~~~~~~~y~aPE~~~~~~  199 (295)
T 2clq_A          178 P----------------------------------------------------------CTETFTGTLQYMAPEIIDKGP  199 (295)
T ss_dssp             -------------------------------------------------------------CCCCCCGGGCCHHHHHHGG
T ss_pred             C----------------------------------------------------------cccccCCCccccChhhhcCCC
Confidence            0                                                          011224666777777765432


Q ss_pred             --CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHH-HHH-H-hcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC
Q psy8260         303 --HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSA-RKY-I-NSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI  377 (427)
Q Consensus       303 --~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~-~~~-~-~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~  377 (427)
                        +...+|+||+|++++.|.++..+|......... ... . ...+        ......++++.+||.+||+.||.+||
T Consensus       200 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rp  271 (295)
T 2clq_A          200 RGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP--------EIPESMSAEAKAFILKCFEPDPDKRA  271 (295)
T ss_dssp             GGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCC--------CCCTTSCHHHHHHHHHTTCSSTTTSC
T ss_pred             CCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccc--------cccccCCHHHHHHHHHHccCChhhCC
Confidence              455679999999998775555555432211111 110 0 0111        12245688999999999999999999


Q ss_pred             CHHHHhcCCCCCCC
Q psy8260         378 TAEQALAHPYLSQY  391 (427)
Q Consensus       378 ta~e~L~Hp~f~~~  391 (427)
                      |++|+|+||||...
T Consensus       272 s~~~ll~~~~~~~~  285 (295)
T 2clq_A          272 CANDLLVDEFLKVS  285 (295)
T ss_dssp             CHHHHHTSGGGCC-
T ss_pred             CHHHHhcChhhhhc
Confidence            99999999999864

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4.4e-41  Score=328.32  Aligned_cols=262  Identities=20%  Similarity=0.301  Sum_probs=172.1

Q ss_pred             cCcceeec-cccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcccc
Q psy8260          62 CRGVIDIG-PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        62 ~~~~~~~~-~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  140 (427)
                      ..+.|.+. +.||+|+||.||. +.+..+|+.||||++...   .....   .....++.++||||+++++++....  .
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~-~~~~~~~~~vavK~~~~~---~~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~--~   96 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLE-CFHRRTGQKCALKLLYDS---PKARQ---EVDHHWQASGGPHIVCILDVYENMH--H   96 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEE-EEETTTCCEEEEEEEESS---HHHHH---HHHHHHHHTTSTTBCCEEEEEEEEE--T
T ss_pred             ccceeEecceeeeeCCCeEEEE-EEECCCCCEEEEEEecCc---HHHHH---HHHHHHHhcCCCChHHHHHHHhhcc--C
Confidence            34668884 5699999999995 567788999999998642   22111   2223456779999999999986421  1


Q ss_pred             CCceEEEEeccC-CCCHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcC---CCCEEEeeCC
Q psy8260         141 DFKNVYMVTHLM-GADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE---DCELKILDFG  213 (427)
Q Consensus       141 ~~~~~~lv~e~~-g~~L~~~l~~~---~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~---~~~~kl~DFG  213 (427)
                      ....+++++|++ +++|.+++...   .+++..+..++.|++.||.|||++||+||||||+|||++.   ++.+||+|||
T Consensus        97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A           97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence            224578999998 67999998754   5999999999999999999999999999999999999976   4569999999


Q ss_pred             CCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccccc
Q psy8260         214 LARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR  293 (427)
Q Consensus       214 la~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~  293 (427)
                      +++......                                                            .....||+.|+
T Consensus       177 ~~~~~~~~~------------------------------------------------------------~~~~~~t~~y~  196 (336)
T 3fhr_A          177 FAKETTQNA------------------------------------------------------------LQTPCYTPYYV  196 (336)
T ss_dssp             TCEEC---------------------------------------------------------------------------
T ss_pred             cceeccccc------------------------------------------------------------cccCCCCcCcc
Confidence            986432211                                                            11223566666


Q ss_pred             chHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCC
Q psy8260         294 APEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDS  373 (427)
Q Consensus       294 APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP  373 (427)
                      |||++.+..+..++|+||+|++++.|.++..+|...........................+..+++++++||.+||+.||
T Consensus       197 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  276 (336)
T 3fhr_A          197 APEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDP  276 (336)
T ss_dssp             -------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHHHHHHHHHHSCSSG
T ss_pred             ChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCCh
Confidence            66666555555677999999999877554444432221111000000000000000112234678999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCCC
Q psy8260         374 EKRITAEQALAHPYLSQYS  392 (427)
Q Consensus       374 ~~R~ta~e~L~Hp~f~~~~  392 (427)
                      .+|||++|+|+||||.+..
T Consensus       277 ~~Rpt~~ell~hp~~~~~~  295 (336)
T 3fhr_A          277 TERLTITQFMNHPWINQSM  295 (336)
T ss_dssp             GGSCCHHHHHHSHHHHTGG
T ss_pred             hHCcCHHHHhcCccccccc
Confidence            9999999999999998743

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.6e-41  Score=337.20  Aligned_cols=258  Identities=22%  Similarity=0.266  Sum_probs=181.2

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCcc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTC  138 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~  138 (427)
                      .+....|.+.+.||+|+||.||+..  ..+|+.||||++.....     ....+|+++|+.+ +|||||++++++...  
T Consensus        20 ~i~~~~y~~~~~LG~G~~G~V~~~~--~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~--   90 (432)
T 3p23_A           20 IVGKISFCPKDVLGHGAEGTIVYRG--MFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDR--   90 (432)
T ss_dssp             EETTEEEEEEEEEEECGGGCEEEEE--ESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEET--
T ss_pred             EEccEEEecCCeeecCcCEEEEEEE--EeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecC--
Confidence            4555678999999999999987543  35789999999865322     1245799999999 899999999987643  


Q ss_pred             ccCCceEEEEeccCCCCHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcC-----CCCEEEee
Q psy8260         139 LADFKNVYMVTHLMGADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE-----DCELKILD  211 (427)
Q Consensus       139 ~~~~~~~~lv~e~~g~~L~~~l~~~~--l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~-----~~~~kl~D  211 (427)
                          ...|+++|+++++|.+++....  +++..+..++.||+.||.|||++||+||||||+|||++.     ...+||+|
T Consensus        91 ----~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~D  166 (432)
T 3p23_A           91 ----QFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISD  166 (432)
T ss_dssp             ----TEEEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECC
T ss_pred             ----CEEEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEec
Confidence                4679999999999999987643  555567889999999999999999999999999999953     23688999


Q ss_pred             CCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccc
Q psy8260         212 FGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRW  291 (427)
Q Consensus       212 FGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~  291 (427)
                      ||+|+.........                                                       ....+.+||+.
T Consensus       167 FG~a~~~~~~~~~~-------------------------------------------------------~~~~~~~gt~~  191 (432)
T 3p23_A          167 FGLCKKLAVGRHSF-------------------------------------------------------SRRSGVPGTEG  191 (432)
T ss_dssp             TTEEECC-------------------------------------------------------------------CCSCTT
T ss_pred             ccceeeccCCCcce-------------------------------------------------------eeccccCCCcC
Confidence            99987543211000                                                       01122346666


Q ss_pred             ccchHHhhh---ccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHH
Q psy8260         292 YRAPEIMLN---WMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSL  367 (427)
Q Consensus       292 Y~APEvl~~---~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~  367 (427)
                      |+|||++.+   ..+..++|+||+|++++.+.+ +..+|..... ....... ........   ......++.+++||.+
T Consensus       192 y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-~~~~~~~-~~~~~~~~---~~~~~~~~~~~~li~~  266 (432)
T 3p23_A          192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-RQANILL-GACSLDCL---HPEKHEDVIARELIEK  266 (432)
T ss_dssp             SCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-HHHHHHT-TCCCCTTS---CTTCHHHHHHHHHHHH
T ss_pred             ccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-HHHHHHh-ccCCcccc---CccccccHHHHHHHHH
Confidence            666666652   234446799999999987755 5555532221 1111111 11111000   0011124568999999


Q ss_pred             hcCCCCCCCCCHHHHhcCCCCCC
Q psy8260         368 MLELDSEKRITAEQALAHPYLSQ  390 (427)
Q Consensus       368 mL~~dP~~R~ta~e~L~Hp~f~~  390 (427)
                      ||+.||.+|||++|+++||||..
T Consensus       267 ~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          267 MIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             HSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             HHhCCHhhCCCHHHHHhCccccC
Confidence            99999999999999999999975

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1e-40  Score=323.90  Aligned_cols=263  Identities=17%  Similarity=0.293  Sum_probs=181.9

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHH-HHhcCCCCCceeeeeeeecCc
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELR-MLKHMNHENVIGLLDVFHSNT  137 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~-~l~~l~HpnIv~l~~~~~~~~  137 (427)
                      +.+..+.|.+.+.||+|+||.||. +.+..+|+.||||++.... ......+..+|+. +++.++||||+++++++... 
T Consensus        17 ~~~~~~~y~~~~~lg~G~~g~Vy~-~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~-   93 (327)
T 3aln_A           17 WDFTAEDLKDLGEIGRGAYGSVNK-MVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE-   93 (327)
T ss_dssp             ECCCSCSEEC-CEEEECSSEEEEE-EEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS-
T ss_pred             cccCHHHhhehheeccCCCEEEEE-EEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC-
Confidence            356668899999999999999996 4567789999999987543 3344455666666 77888999999999998654 


Q ss_pred             cccCCceEEEEeccCCCCHHHHHh------hCCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCCeEEcCCCCEEEe
Q psy8260         138 CLADFKNVYMVTHLMGADLNNILR------TQKLSDDHVQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDCELKIL  210 (427)
Q Consensus       138 ~~~~~~~~~lv~e~~g~~L~~~l~------~~~l~~~~~~~~~~qi~~aL~yLH~~-~iiHrDLKp~NILl~~~~~~kl~  210 (427)
                           ...++++|++.++|.+++.      ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+
T Consensus        94 -----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~  168 (327)
T 3aln_A           94 -----GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLC  168 (327)
T ss_dssp             -----SEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEEC
T ss_pred             -----CceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEc
Confidence                 4679999999888888775      45799999999999999999999999 99999999999999999999999


Q ss_pred             eCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccc
Q psy8260         211 DFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATR  290 (427)
Q Consensus       211 DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~  290 (427)
                      |||+++........                                                           ....||+
T Consensus       169 Dfg~~~~~~~~~~~-----------------------------------------------------------~~~~gt~  189 (327)
T 3aln_A          169 DFGISGQLVDSIAK-----------------------------------------------------------TRDAGCR  189 (327)
T ss_dssp             CCSSSCC-------------------------------------------------------------------------
T ss_pred             cCCCceeccccccc-----------------------------------------------------------ccCCCCc
Confidence            99998754322110                                                           0113455


Q ss_pred             cccchHHh----hhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccH-HhhcCCCChhHHHHH
Q psy8260         291 WYRAPEIM----LNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDF-RQVFKGANPQAIDLL  365 (427)
Q Consensus       291 ~Y~APEvl----~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dLi  365 (427)
                      .|+|||++    .+..+..++|+||+|++++.|.++..+|.....   ...............+ .......++++.+||
T Consensus       190 ~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  266 (327)
T 3aln_A          190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS---VFDQLTQVVKGDPPQLSNSEEREFSPSFINFV  266 (327)
T ss_dssp             ----------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------CCCCCSCCCCCCCCSSCCCCHHHHHHH
T ss_pred             cccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcch---HHHHHHHHhcCCCCCCCCcccccCCHHHHHHH
Confidence            55555555    223355567999999999877554444422110   0001111100000000 112235788999999


Q ss_pred             HHhcCCCCCCCCCHHHHhcCCCCCCC
Q psy8260         366 SLMLELDSEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       366 ~~mL~~dP~~R~ta~e~L~Hp~f~~~  391 (427)
                      .+||+.||.+|||++|+++||||...
T Consensus       267 ~~~l~~dp~~Rps~~ell~hp~~~~~  292 (327)
T 3aln_A          267 NLCLTKDESKRPKYKELLKHPFILMY  292 (327)
T ss_dssp             HHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             HHHhhCChhhCcCHHHHHhChHHHHh
Confidence            99999999999999999999999754

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=6.9e-40  Score=315.53  Aligned_cols=260  Identities=20%  Similarity=0.262  Sum_probs=198.2

Q ss_pred             CccccccCcceeeccccCcccccEEEEeEEe----CcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeee
Q psy8260          56 QPYSEICRGVIDIGPTLSKESFDLIFSSALD----SVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLD  131 (427)
Q Consensus        56 ~~~~~~~~~~~~~~~~lg~g~fg~v~~~~~~----~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~  131 (427)
                      .+-+++....|.+.+.||+|+||.||.+...    ..+++.||||++... ......+.+.+|+++++.++||||+++++
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~   93 (314)
T 2ivs_A           15 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYG   93 (314)
T ss_dssp             CTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             CcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEE
Confidence            3445677888999999999999999976542    345689999998653 34555677889999999999999999999


Q ss_pred             eeecCccccCCceEEEEeccC-CCCHHHHHhhC-------------------------CCCHHHHHHHHHHHHHHHHHHH
Q psy8260         132 VFHSNTCLADFKNVYMVTHLM-GADLNNILRTQ-------------------------KLSDDHVQFLVYQILRGLKYIH  185 (427)
Q Consensus       132 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~-------------------------~l~~~~~~~~~~qi~~aL~yLH  185 (427)
                      ++...      ...+++++++ +++|.+++...                         .+++..+..++.||+.||.|||
T Consensus        94 ~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH  167 (314)
T 2ivs_A           94 ACSQD------GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA  167 (314)
T ss_dssp             EECSS------SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH
T ss_pred             EEecC------CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH
Confidence            98653      3578888888 68999988642                         2789999999999999999999


Q ss_pred             hcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCccccccccc
Q psy8260         186 SAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNED  265 (427)
Q Consensus       186 ~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~  265 (427)
                      ++||+||||||+|||++.++.+||+|||+++.........                                        
T Consensus       168 ~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~----------------------------------------  207 (314)
T 2ivs_A          168 EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV----------------------------------------  207 (314)
T ss_dssp             HTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEE----------------------------------------
T ss_pred             HCCCcccccchheEEEcCCCCEEEccccccccccccccce----------------------------------------
Confidence            9999999999999999999999999999986432211000                                        


Q ss_pred             chhhhhccCCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCC
Q psy8260         266 CELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPL  344 (427)
Q Consensus       266 ~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~  344 (427)
                                      ......+|+.|+|||++.+..+..++|+||+|++++.|.+ +..+|.......... .......
T Consensus       208 ----------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~-~~~~~~~  270 (314)
T 2ivs_A          208 ----------------KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFN-LLKTGHR  270 (314)
T ss_dssp             ----------------CSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-HHHTTCC
T ss_pred             ----------------eccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HhhcCCc
Confidence                            0112346778888888887777778899999999987755 444443322222222 2211111


Q ss_pred             CCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         345 LTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       345 ~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                      .      ......++++.+||.+||+.||.+|||++|+++|
T Consensus       271 ~------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          271 M------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             C------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             C------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            1      1124578899999999999999999999999875

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=5.6e-40  Score=316.01  Aligned_cols=258  Identities=23%  Similarity=0.286  Sum_probs=198.6

Q ss_pred             ccccCcceeeccccCcccccEEEEeEE----eCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeee
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSAL----DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVF  133 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~  133 (427)
                      +++..+.|.+.+.||+|+||.||.+..    +..+++.||||++... ......+.+.+|+.+++++ +||||+++++++
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   96 (313)
T 1t46_A           18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGAC   96 (313)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc-hhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence            467778999999999999999998764    4567889999998754 3344556788999999999 999999999998


Q ss_pred             ecCccccCCceEEEEeccC-CCCHHHHHhhC-------------------CCCHHHHHHHHHHHHHHHHHHHhcCceecc
Q psy8260         134 HSNTCLADFKNVYMVTHLM-GADLNNILRTQ-------------------KLSDDHVQFLVYQILRGLKYIHSAGIIHRD  193 (427)
Q Consensus       134 ~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~-------------------~l~~~~~~~~~~qi~~aL~yLH~~~iiHrD  193 (427)
                      ...      ...++++|++ +++|.+++...                   .+++..+..++.|++.||.|||++||+|||
T Consensus        97 ~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~d  170 (313)
T 1t46_A           97 TIG------GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRD  170 (313)
T ss_dssp             CSS------SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             ecC------CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence            654      3568888888 67999988653                   389999999999999999999999999999


Q ss_pred             CCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhcc
Q psy8260         194 LKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDF  273 (427)
Q Consensus       194 LKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~  273 (427)
                      |||+|||++.++.+||+|||+++........                                                 
T Consensus       171 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-------------------------------------------------  201 (313)
T 1t46_A          171 LAARNILLTHGRITKICDFGLARDIKNDSNY-------------------------------------------------  201 (313)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCTTSCTTS-------------------------------------------------
T ss_pred             CccceEEEcCCCCEEEccccccccccccccc-------------------------------------------------
Confidence            9999999999999999999998754322100                                                 


Q ss_pred             CCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHh
Q psy8260         274 GLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQ  352 (427)
Q Consensus       274 g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (427)
                             .......||+.|+|||++.+..+..++|+||+|++++.|.+ +..+|....................      
T Consensus       202 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~------  268 (313)
T 1t46_A          202 -------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML------  268 (313)
T ss_dssp             -------EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCC------
T ss_pred             -------eeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCC------
Confidence                   01112346788888888887777778899999999987744 4444433322222222222211110      


Q ss_pred             hcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         353 VFKGANPQAIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       353 ~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                      .....++++.+||.+||+.||.+|||++|++++
T Consensus       269 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          269 SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            113467899999999999999999999999875

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=7.5e-40  Score=308.52  Aligned_cols=251  Identities=21%  Similarity=0.280  Sum_probs=193.5

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      ++..+.|.+.+.||+|+||.||.+..  .++..||||++.......   ..+.+|++++++++||||+++++++...   
T Consensus         4 ~l~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~---   75 (268)
T 3sxs_A            4 ELKREEITLLKELGSGQFGVVKLGKW--KGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKE---   75 (268)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEE--TTTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred             EechhheeeeeeeccCCCceEEEEEe--cCceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccC---
Confidence            56678899999999999999997643  357789999987544332   4577999999999999999999998643   


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                         ...+++++++ +++|.+++..  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        76 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~  152 (268)
T 3sxs_A           76 ---YPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTR  152 (268)
T ss_dssp             ---SSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEE
T ss_pred             ---CceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccce
Confidence               4578999988 7889998864  359999999999999999999999999999999999999999999999999986


Q ss_pred             CCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         217 PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       217 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      .......                                                         ....+..+|+.|+|||
T Consensus       153 ~~~~~~~---------------------------------------------------------~~~~~~~~~~~y~aPE  175 (268)
T 3sxs_A          153 YVLDDQY---------------------------------------------------------VSSVGTKFPVKWSAPE  175 (268)
T ss_dssp             ECCTTCE---------------------------------------------------------EECCSCCCCGGGCCHH
T ss_pred             ecchhhh---------------------------------------------------------hcccCCCcCcccCCHH
Confidence            4322110                                                         0112334677889999


Q ss_pred             HhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCC
Q psy8260         297 IMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEK  375 (427)
Q Consensus       297 vl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~  375 (427)
                      ++.+..+..++|+||+|++++.+.+ +..||....................       ....++++.+||.+||+.||.+
T Consensus       176 ~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~  248 (268)
T 3sxs_A          176 VFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR-------PHLASDTIYQIMYSCWHELPEK  248 (268)
T ss_dssp             HHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC-------CTTSCHHHHHHHHHTTCSSGGG
T ss_pred             HHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCC-------CCcChHHHHHHHHHHcCCChhh
Confidence            8888778888999999999987754 4444432221222222221111111       1235788999999999999999


Q ss_pred             CCCHHHHhcC
Q psy8260         376 RITAEQALAH  385 (427)
Q Consensus       376 R~ta~e~L~H  385 (427)
                      |||++|+++|
T Consensus       249 Rps~~~ll~~  258 (268)
T 3sxs_A          249 RPTFQQLLSS  258 (268)
T ss_dssp             SCCHHHHHHH
T ss_pred             CcCHHHHHHH
Confidence            9999999987

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=7.2e-40  Score=311.11  Aligned_cols=252  Identities=20%  Similarity=0.283  Sum_probs=191.9

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      +++...+|.+.+.||+|+||.||.+..  .++..||||++.......   +.+.+|+++++.++||||+++++++...  
T Consensus        19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~--   91 (283)
T 3gen_A           19 WEIDPKDLTFLKELGTGQFGVVKYGKW--RGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQ--   91 (283)
T ss_dssp             TBCCGGGEEEEEECC---CEEEEEEEE--TTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSS--
T ss_pred             ccCCHHHHHhHhhcCCCCCceEEEEEE--cCCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecC--
Confidence            467778899999999999999997643  367789999997654333   4577999999999999999999998643  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                          ...+++++++ +++|.+++..  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        92 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~  167 (283)
T 3gen_A           92 ----RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS  167 (283)
T ss_dssp             ----SSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGG
T ss_pred             ----CCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccc
Confidence                4578999988 7899998865  57999999999999999999999999999999999999999999999999988


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      +.......                                                         ....+..+|+.|+||
T Consensus       168 ~~~~~~~~---------------------------------------------------------~~~~~~~~~~~y~aP  190 (283)
T 3gen_A          168 RYVLDDEY---------------------------------------------------------TSSVGSKFPVRWSPP  190 (283)
T ss_dssp             GGBCCHHH---------------------------------------------------------HSTTSTTSCGGGCCH
T ss_pred             cccccccc---------------------------------------------------------ccccCCccCcccCCH
Confidence            64322100                                                         011223467788899


Q ss_pred             HHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCC
Q psy8260         296 EIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       296 Evl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~  374 (427)
                      |++.+..+..++|+||+|++++.+.+ +..+|....................       ....++++.+||.+||+.||.
T Consensus       191 E~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~  263 (283)
T 3gen_A          191 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR-------PHLASEKVYTIMYSCWHEKAD  263 (283)
T ss_dssp             HHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC-------CTTCCHHHHHHHHHTTCSSGG
T ss_pred             HHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC-------CCcCCHHHHHHHHHHccCChh
Confidence            98887777778899999999987754 4444433222222222222111111       134578899999999999999


Q ss_pred             CCCCHHHHhcC
Q psy8260         375 KRITAEQALAH  385 (427)
Q Consensus       375 ~R~ta~e~L~H  385 (427)
                      +|||++|+++|
T Consensus       264 ~Rps~~~ll~~  274 (283)
T 3gen_A          264 ERPTFKILLSN  274 (283)
T ss_dssp             GSCCHHHHHHH
T ss_pred             HCcCHHHHHHH
Confidence            99999999986

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=7.2e-40  Score=311.10  Aligned_cols=255  Identities=20%  Similarity=0.274  Sum_probs=185.4

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEeC--cCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecC
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALDS--VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSN  136 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~  136 (427)
                      .++..+.|.+.+.||+|+||.||.+....  .++..||||++... ......+.+.+|+.+++.++||||+++++++.. 
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-   87 (281)
T 1mp8_A           10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-   87 (281)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred             eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-
Confidence            36677889999999999999999765432  34668999988653 344556678899999999999999999998743 


Q ss_pred             ccccCCceEEEEeccC-CCCHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCC
Q psy8260         137 TCLADFKNVYMVTHLM-GADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG  213 (427)
Q Consensus       137 ~~~~~~~~~~lv~e~~-g~~L~~~l~~~--~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFG  213 (427)
                            ...|++++++ +++|.+++...  .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        88 ------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  161 (281)
T 1mp8_A           88 ------NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG  161 (281)
T ss_dssp             ------SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--
T ss_pred             ------CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccc
Confidence                  2467888888 57999988753  58999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccccc
Q psy8260         214 LARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR  293 (427)
Q Consensus       214 la~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~  293 (427)
                      +++........                                                         ......+|+.|+
T Consensus       162 ~~~~~~~~~~~---------------------------------------------------------~~~~~~~~~~y~  184 (281)
T 1mp8_A          162 LSRYMEDSTYY---------------------------------------------------------KASKGKLPIKWM  184 (281)
T ss_dssp             --------------------------------------------------------------------------CCGGGC
T ss_pred             cccccCccccc---------------------------------------------------------ccccCCCccccc
Confidence            98754321100                                                         001123567888


Q ss_pred             chHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         294 APEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       294 APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                      |||++.+..+..++|+||+|++++.+.+ +..||......+.......... .      ......++++.+||.+||+.|
T Consensus       185 aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~-~------~~~~~~~~~l~~li~~~l~~~  257 (281)
T 1mp8_A          185 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER-L------PMPPNCPPTLYSLMTKCWAYD  257 (281)
T ss_dssp             CHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-C------CCCTTCCHHHHHHHHHHTCSS
T ss_pred             ChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC-C------CCCCCCCHHHHHHHHHHccCC
Confidence            8888877777777899999999876532 4444433222222222221111 0      122457889999999999999


Q ss_pred             CCCCCCHHHHhcC
Q psy8260         373 SEKRITAEQALAH  385 (427)
Q Consensus       373 P~~R~ta~e~L~H  385 (427)
                      |.+|||++|++++
T Consensus       258 p~~Rps~~~l~~~  270 (281)
T 1mp8_A          258 PSRRPRFTELKAQ  270 (281)
T ss_dssp             GGGSCCHHHHHHH
T ss_pred             hhhCcCHHHHHHH
Confidence            9999999999864

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.2e-40  Score=336.45  Aligned_cols=258  Identities=25%  Similarity=0.356  Sum_probs=176.5

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCccccC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~~  141 (427)
                      .+.+.+.+.||+|+||.||.+  ...+|+.||||++....     .....+|+.+|+.+ +|||||++++++...     
T Consensus        14 ~~~~~~~~~LG~G~~g~V~~~--~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-----   81 (434)
T 2rio_A           14 KNLVVSEKILGYGSSGTVVFQ--GSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTD-----   81 (434)
T ss_dssp             SSCEEEEEEEEECSTTCEEEE--EESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECS-----
T ss_pred             hheeeccCeEeeCCCeEEEEE--EEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecC-----
Confidence            445667789999999999864  34579999999886432     23467899999876 899999999987653     


Q ss_pred             CceEEEEeccCCCCHHHHHhhCCCC--------HHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCC---------
Q psy8260         142 FKNVYMVTHLMGADLNNILRTQKLS--------DDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED---------  204 (427)
Q Consensus       142 ~~~~~lv~e~~g~~L~~~l~~~~l~--------~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~---------  204 (427)
                       ..+|+++|+++++|.+++......        +..+..++.||+.||.|||++||+||||||+|||++.+         
T Consensus        82 -~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~  160 (434)
T 2rio_A           82 -RFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQT  160 (434)
T ss_dssp             -SEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTT
T ss_pred             -CeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccccc
Confidence             468999999999999999764322        22346799999999999999999999999999999754         


Q ss_pred             ----CCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCc
Q psy8260         205 ----CELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTE  280 (427)
Q Consensus       205 ----~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~  280 (427)
                          +.+||+|||+++..........                                                      
T Consensus       161 ~~~~~~~kL~DFG~a~~~~~~~~~~~------------------------------------------------------  186 (434)
T 2rio_A          161 GAENLRILISDFGLCKKLDSGQSSFR------------------------------------------------------  186 (434)
T ss_dssp             CCCSCEEEECCCTTCEECCC------------------------------------------------------------
T ss_pred             CCCceEEEEcccccceecCCCCccce------------------------------------------------------
Confidence                4899999999975432210000                                                      


Q ss_pred             cccccccccccccchHHhhh-------ccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHh
Q psy8260         281 NEMTGYVATRWYRAPEIMLN-------WMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQ  352 (427)
Q Consensus       281 ~~~~~~~gt~~Y~APEvl~~-------~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (427)
                      ......+||+.|+|||++.+       ..+..++|+||+|++++.+.+ +..||.......  ............... .
T Consensus       187 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~~~-~  263 (434)
T 2rio_A          187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKC-L  263 (434)
T ss_dssp             --------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCCTT-C
T ss_pred             eeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccccc-c
Confidence            00112235555555555543       235556799999999987654 555553322111  122222111111000 0


Q ss_pred             hcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q psy8260         353 VFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQ  390 (427)
Q Consensus       353 ~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~  390 (427)
                      .....++++++||.+||+.||.+|||+.|+++||||..
T Consensus       264 ~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          264 HDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             CCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             ccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            00123578999999999999999999999999999963

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=6.9e-40  Score=317.03  Aligned_cols=259  Identities=19%  Similarity=0.293  Sum_probs=196.6

Q ss_pred             ccccccCcceeeccccCcccccEEEEeEEe----CcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeee
Q psy8260          57 PYSEICRGVIDIGPTLSKESFDLIFSSALD----SVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDV  132 (427)
Q Consensus        57 ~~~~~~~~~~~~~~~lg~g~fg~v~~~~~~----~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~  132 (427)
                      ..+++..+.|.+.+.||+|+||.||.+...    ..+++.||||.+... ........+.+|+.+++.++||||++++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   96 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGV   96 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence            345777889999999999999999976543    256789999998753 344455678899999999999999999999


Q ss_pred             eecCccccCCceEEEEeccC-CCCHHHHHhh-----------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeE
Q psy8260         133 FHSNTCLADFKNVYMVTHLM-GADLNNILRT-----------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA  200 (427)
Q Consensus       133 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~-----------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NIL  200 (427)
                      +...      ...+++++++ +++|.+++..           ..+++..+..++.|++.||.|||++||+||||||+|||
T Consensus        97 ~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIl  170 (322)
T 1p4o_A           97 VSQG------QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM  170 (322)
T ss_dssp             ECSS------SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEE
T ss_pred             EccC------CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEE
Confidence            8653      3568888888 6799998854           35789999999999999999999999999999999999


Q ss_pred             EcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCc
Q psy8260         201 VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTE  280 (427)
Q Consensus       201 l~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~  280 (427)
                      ++.++.+||+|||+++........                                                        
T Consensus       171 i~~~~~~kl~Dfg~~~~~~~~~~~--------------------------------------------------------  194 (322)
T 1p4o_A          171 VAEDFTVKIGDFGMTRDIYETDYY--------------------------------------------------------  194 (322)
T ss_dssp             ECTTCCEEECCTTCCCGGGGGGCE--------------------------------------------------------
T ss_pred             EcCCCeEEECcCcccccccccccc--------------------------------------------------------
Confidence            999999999999998643211000                                                        


Q ss_pred             cccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCCh
Q psy8260         281 NEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANP  359 (427)
Q Consensus       281 ~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  359 (427)
                      .......||+.|+|||++.+..+..++|+||+|++++.+.+ +..+|.... ..............      ......++
T Consensus       195 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-~~~~~~~~~~~~~~------~~~~~~~~  267 (322)
T 1p4o_A          195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-NEQVLRFVMEGGLL------DKPDNCPD  267 (322)
T ss_dssp             EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-HHHHHHHHHTTCCC------CCCTTCCH
T ss_pred             ccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC-HHHHHHHHHcCCcC------CCCCCCCH
Confidence            01112346788999998887777778899999999987744 333343221 11111111111110      11235678


Q ss_pred             hHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         360 QAIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       360 ~~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                      ++.+||.+||+.||.+|||++|+++|
T Consensus       268 ~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          268 MLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            99999999999999999999999987

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.6e-40  Score=320.25  Aligned_cols=259  Identities=20%  Similarity=0.270  Sum_probs=197.1

Q ss_pred             ccccCcceeeccccCcccccEEEEeEE----eCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeee
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSAL----DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVF  133 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~  133 (427)
                      +++....|.+.+.||+|+||.||.+..    ...+++.||||++.... .....+.+.+|+.+++++ +||||+++++++
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  118 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGAC  118 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            467788999999999999999997764    23467789999986432 233446678999999999 999999999998


Q ss_pred             ecCccccCCceEEEEeccC-CCCHHHHHhhC------------------------CCCHHHHHHHHHHHHHHHHHHHhcC
Q psy8260         134 HSNTCLADFKNVYMVTHLM-GADLNNILRTQ------------------------KLSDDHVQFLVYQILRGLKYIHSAG  188 (427)
Q Consensus       134 ~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~------------------------~l~~~~~~~~~~qi~~aL~yLH~~~  188 (427)
                      ...      ...+++||++ +++|.+++...                        .+++..+..++.||+.||.|||++|
T Consensus       119 ~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  192 (344)
T 1rjb_A          119 TLS------GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS  192 (344)
T ss_dssp             CSS------SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eeC------CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            653      3578899988 77999988653                        2789999999999999999999999


Q ss_pred             ceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchh
Q psy8260         189 IIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCEL  268 (427)
Q Consensus       189 iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  268 (427)
                      |+||||||+|||++.++.+||+|||+++........                                            
T Consensus       193 ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~--------------------------------------------  228 (344)
T 1rjb_A          193 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY--------------------------------------------  228 (344)
T ss_dssp             EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTS--------------------------------------------
T ss_pred             cccCCCChhhEEEcCCCcEEeCCCccCcccccCccc--------------------------------------------
Confidence            999999999999999999999999998643221100                                            


Q ss_pred             hhhccCCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCc
Q psy8260         269 KILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTK  347 (427)
Q Consensus       269 ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (427)
                                  .......||+.|+|||++.+..+..++|+||+|++++.|.+ +..||.................... 
T Consensus       229 ------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~-  295 (344)
T 1rjb_A          229 ------------VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMD-  295 (344)
T ss_dssp             ------------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCC-
T ss_pred             ------------eeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCC-
Confidence                        01123356788899998887777778899999999988865 5555544333333333322211110 


Q ss_pred             ccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCC
Q psy8260         348 KDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHP  386 (427)
Q Consensus       348 ~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp  386 (427)
                           .....++++.+||.+||+.||.+|||++|+++|-
T Consensus       296 -----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          296 -----QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             -----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence                 1234678999999999999999999999999873

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.6e-40  Score=320.85  Aligned_cols=260  Identities=20%  Similarity=0.285  Sum_probs=185.6

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      ..+..+.|.+.+.||+|+||.||.+..   .++.||||++...   ........+|+.+++.++|||||++++++.....
T Consensus        19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   92 (322)
T 3soc_A           19 LYFQSMPLQLLEVKARGRFGCVWKAQL---LNEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS   92 (322)
T ss_dssp             EEETTEEEEEEEEEECSTTCEEEEEEE---TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred             cccchhhchhhheecccCceEEEEEEE---CCCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCC
Confidence            456678899999999999999997653   3789999998643   2334455679999999999999999999875321


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhc----------CceeccCCCCCeEEcCCCCE
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSA----------GIIHRDLKPSNIAVNEDCEL  207 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~----------~iiHrDLKp~NILl~~~~~~  207 (427)
                        ....+++++|++ +++|.++++...+++..+..++.|++.||.|||++          ||+||||||+|||++.++.+
T Consensus        93 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~  170 (322)
T 3soc_A           93 --VDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA  170 (322)
T ss_dssp             --SSEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCE
T ss_pred             --CCceEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeE
Confidence              124578999988 67999999988999999999999999999999999          99999999999999999999


Q ss_pred             EEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccc
Q psy8260         208 KILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV  287 (427)
Q Consensus       208 kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~  287 (427)
                      ||+|||+++........                                                        ....+..
T Consensus       171 kL~DFg~a~~~~~~~~~--------------------------------------------------------~~~~~~~  194 (322)
T 3soc_A          171 CIADFGLALKFEAGKSA--------------------------------------------------------GDTHGQV  194 (322)
T ss_dssp             EECCCTTCEEECTTSCC--------------------------------------------------------CCCTTCC
T ss_pred             EEccCCcccccccccCc--------------------------------------------------------cccccCc
Confidence            99999998643221100                                                        0011234


Q ss_pred             ccccccchHHhhhc-----cCCCCCCHHHHHHHHHHhCCCCHHHHhhcC--------------c-HHHHHHHhcCCCCCc
Q psy8260         288 ATRWYRAPEIMLNW-----MHYNQTDIHQLNLIMEMLGTPPAEFMAKIS--------------S-DSARKYINSLPLLTK  347 (427)
Q Consensus       288 gt~~Y~APEvl~~~-----~~~~~~d~~slg~i~~~lg~~~~~~~~~~~--------------~-~~~~~~~~~~~~~~~  347 (427)
                      ||+.|+|||++.+.     .+..++|+||+|++++.|.++..+|.....              . ...........  ..
T Consensus       195 gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  272 (322)
T 3soc_A          195 GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKK--KR  272 (322)
T ss_dssp             CCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSC--CC
T ss_pred             cCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhccc--CC
Confidence            55566666665542     223356999999999988665444422110              0 01111110000  00


Q ss_pred             ccHHhhcC--CCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy8260         348 KDFRQVFK--GANPQAIDLLSLMLELDSEKRITAEQALA  384 (427)
Q Consensus       348 ~~~~~~~~--~~s~~~~dLi~~mL~~dP~~R~ta~e~L~  384 (427)
                      ......+.  ..++++.+||.+||+.||++|||++|+++
T Consensus       273 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          273 PVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             CCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            00111111  11345899999999999999999999986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=5.5e-41  Score=328.30  Aligned_cols=261  Identities=23%  Similarity=0.291  Sum_probs=190.4

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH---------------HHHHHHHHHHHHHhcCCCCC
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA---------------VHAKRTYRELRMLKHMNHEN  125 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~---------------~~~~~~~~Ei~~l~~l~Hpn  125 (427)
                      ...+.|.+.+.||.|+||.||.+..   +|+.||||++.......               .....+.+|+.+++.++|||
T Consensus        28 ~~~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~  104 (348)
T 2pml_X           28 KYINDYRIIRTLNQGKFNKIILCEK---DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY  104 (348)
T ss_dssp             EEETTEEEEEEEECCSSCCEEEEEE---TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTT
T ss_pred             cccCceEEEEEEcCCCCeEEEEEEc---CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCC
Confidence            3456899999999999999997654   89999999986431110               01156789999999999999


Q ss_pred             ceeeeeeeecCccccCCceEEEEeccC-CCCHHHH------Hh---hCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccC
Q psy8260         126 VIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNI------LR---TQKLSDDHVQFLVYQILRGLKYIHS-AGIIHRDL  194 (427)
Q Consensus       126 Iv~l~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~------l~---~~~l~~~~~~~~~~qi~~aL~yLH~-~~iiHrDL  194 (427)
                      |+++++++...      ...|+++|++ +++|.++      +.   ...+++..+..++.|++.||.|||+ +||+||||
T Consensus       105 i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl  178 (348)
T 2pml_X          105 CLTCEGIITNY------DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDV  178 (348)
T ss_dssp             BCCCSEEEESS------SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCC
T ss_pred             cceEEEEEeeC------CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCC
Confidence            99999998654      4678999998 5699887      54   3569999999999999999999999 99999999


Q ss_pred             CCCCeEEcCCCCEEEeeCCCCCCCCCC-cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhcc
Q psy8260         195 KPSNIAVNEDCELKILDFGLARPTENE-MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDF  273 (427)
Q Consensus       195 Kp~NILl~~~~~~kl~DFGla~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~  273 (427)
                      ||+|||++.++.+||+|||+++..... .....                                               
T Consensus       179 ~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~-----------------------------------------------  211 (348)
T 2pml_X          179 KPSNILMDKNGRVKLSDFGESEYMVDKKIKGSR-----------------------------------------------  211 (348)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECBTTEECSSC-----------------------------------------------
T ss_pred             ChHhEEEcCCCcEEEeccccccccccccccCCC-----------------------------------------------
Confidence            999999999999999999998653221 12223                                               


Q ss_pred             CCCCCCccccccccccccccchHHhhhc-cCCC-CCCHHHHHHHHHHhCCCCHHHHhhcCcHHH-HHHHhcCCCCCc---
Q psy8260         274 GLARPTENEMTGYVATRWYRAPEIMLNW-MHYN-QTDIHQLNLIMEMLGTPPAEFMAKISSDSA-RKYINSLPLLTK---  347 (427)
Q Consensus       274 g~~~~~~~~~~~~~gt~~Y~APEvl~~~-~~~~-~~d~~slg~i~~~lg~~~~~~~~~~~~~~~-~~~~~~~~~~~~---  347 (427)
                                    ||+.|+|||++.+. .+.. ++|+||+|++++.|.++..+|......... ..........+.   
T Consensus       212 --------------~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~  277 (348)
T 2pml_X          212 --------------GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRN  277 (348)
T ss_dssp             --------------SCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSS
T ss_pred             --------------CCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccchh
Confidence                          45555555555443 2333 579999999998875555555433221222 222111111110   


Q ss_pred             --------ccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q psy8260         348 --------KDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       348 --------~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~  391 (427)
                              ..........++++.+||.+||+.||.+|||++|+++||||.+.
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~  329 (348)
T 2pml_X          278 HFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT  329 (348)
T ss_dssp             SSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             hhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence                    00111124578999999999999999999999999999999864

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=4.1e-40  Score=313.55  Aligned_cols=259  Identities=13%  Similarity=0.187  Sum_probs=190.6

Q ss_pred             cccccCcceeeccccCcccccEEEEeEEeCcCC-------cEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeee
Q psy8260          58 YSEICRGVIDIGPTLSKESFDLIFSSALDSVSG-------VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLL  130 (427)
Q Consensus        58 ~~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g-------~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~  130 (427)
                      |.++..++|.+.+.||+|+||.||.+. +..++       ..||+|++....  ....+.+.+|+.+++.++||||++++
T Consensus         2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~   78 (289)
T 4fvq_A            2 FHKIRNEDLIFNESLGQGTFTKIFKGV-RREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNY   78 (289)
T ss_dssp             CCBCCGGGEEEEEEEEEETTEEEEEEE-EEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEE
T ss_pred             eEEechhHeeeeeeeccCCCceEEEEE-Eecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEE
Confidence            346677889999999999999999764 44444       579999986532  23345678999999999999999999


Q ss_pred             eeeecCccccCCceEEEEeccC-CCCHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCC-
Q psy8260         131 DVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE-  206 (427)
Q Consensus       131 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~~--l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~-  206 (427)
                      +++...      ...++++|++ +++|.+++....  +++..+..++.||+.||.|||++||+||||||+|||++.++. 
T Consensus        79 ~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~  152 (289)
T 4fvq_A           79 GVCVCG------DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDR  152 (289)
T ss_dssp             EEECCT------TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBG
T ss_pred             EEEEeC------CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcc
Confidence            998653      3468889888 689999987643  999999999999999999999999999999999999998876 


Q ss_pred             -------EEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCC
Q psy8260         207 -------LKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPT  279 (427)
Q Consensus       207 -------~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~  279 (427)
                             +||+|||+++..... ...                                                      
T Consensus       153 ~~~~~~~~kl~Dfg~~~~~~~~-~~~------------------------------------------------------  177 (289)
T 4fvq_A          153 KTGNPPFIKLSDPGISITVLPK-DIL------------------------------------------------------  177 (289)
T ss_dssp             GGTBCCEEEECCCCSCTTTSCH-HHH------------------------------------------------------
T ss_pred             cccccceeeeccCcccccccCc-ccc------------------------------------------------------
Confidence                   999999998643221 111                                                      


Q ss_pred             ccccccccccccccchHHhhh-ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCC
Q psy8260         280 ENEMTGYVATRWYRAPEIMLN-WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGAN  358 (427)
Q Consensus       280 ~~~~~~~~gt~~Y~APEvl~~-~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  358 (427)
                             .||+.|+|||++.+ ..+..++|+||+|++++.|.++..++...................        ....+
T Consensus       178 -------~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~  242 (289)
T 4fvq_A          178 -------QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQL--------PAPKA  242 (289)
T ss_dssp             -------HHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC--------CCCSS
T ss_pred             -------CCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCC--------CCCCC
Confidence                   24555666666654 345556799999999988755322222222222222222222111        23357


Q ss_pred             hhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCC
Q psy8260         359 PQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDE  397 (427)
Q Consensus       359 ~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~  397 (427)
                      +++.+||.+||+.||.+|||++|+++|  +.++.+|...
T Consensus       243 ~~l~~li~~~l~~dp~~Rps~~~ll~~--l~~l~~p~~~  279 (289)
T 4fvq_A          243 AELANLINNCMDYEPDHRPSFRAIIRD--LNSLFTPDLV  279 (289)
T ss_dssp             CTTHHHHHHHSCSSGGGSCCHHHHHHH--HHTCC-----
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHHH--HHHhcCCCCC
Confidence            789999999999999999999999998  7777666543

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.5e-39  Score=313.76  Aligned_cols=264  Identities=19%  Similarity=0.255  Sum_probs=179.1

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      ....+.|.+.+.||.|+||.||. +.+..+|+.||||++..........+.+..+..+++.++||||+++++++...   
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~---   96 (318)
T 2dyl_A           21 QAEINDLENLGEMGSGTCGQVWK-MRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN---   96 (318)
T ss_dssp             ECCGGGEEEEEEC------CEEE-EEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS---
T ss_pred             hhhhccccccceeeecCCeeEEE-EEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC---
Confidence            44457789999999999999996 45667899999999876533333333334455678889999999999998654   


Q ss_pred             cCCceEEEEeccCCCCHHHHHh--hCCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         140 ADFKNVYMVTHLMGADLNNILR--TQKLSDDHVQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       140 ~~~~~~~lv~e~~g~~L~~~l~--~~~l~~~~~~~~~~qi~~aL~yLH~~-~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                         ...|+++|++++.+..+..  ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++
T Consensus        97 ---~~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  173 (318)
T 2dyl_A           97 ---TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISG  173 (318)
T ss_dssp             ---SEEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred             ---CcEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCch
Confidence               4689999999877777665  36799999999999999999999995 99999999999999999999999999986


Q ss_pred             CCCCC--cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccc
Q psy8260         217 PTENE--MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRA  294 (427)
Q Consensus       217 ~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~A  294 (427)
                      .....  .....||+.|+|||++.+...                                                    
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~----------------------------------------------------  201 (318)
T 2dyl_A          174 RLVDDKAKDRSAGCAAYMAPERIDPPDP----------------------------------------------------  201 (318)
T ss_dssp             -------------CCTTCCHHHHC--------------------------------------------------------
T ss_pred             hccCCccccccCCCccccChhhcccccc----------------------------------------------------
Confidence            54321  112234444444444321000                                                    


Q ss_pred             hHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCc-HHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCC
Q psy8260         295 PEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISS-DSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDS  373 (427)
Q Consensus       295 PEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP  373 (427)
                          ....+..++|+||+|++++.|.++..+|...... ..........+....     .....++++.+||.+||+.||
T Consensus       202 ----~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dp  272 (318)
T 2dyl_A          202 ----TKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLP-----GHMGFSGDFQSFVKDCLTKDH  272 (318)
T ss_dssp             --------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCC-----SSSCCCHHHHHHHHHHTCSCT
T ss_pred             ----cccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCC-----ccCCCCHHHHHHHHHHccCCh
Confidence                1223455679999999998886555555332111 111222222111110     113468899999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCC
Q psy8260         374 EKRITAEQALAHPYLSQY  391 (427)
Q Consensus       374 ~~R~ta~e~L~Hp~f~~~  391 (427)
                      .+|||++|+++||||.+.
T Consensus       273 ~~Rps~~~ll~h~~~~~~  290 (318)
T 2dyl_A          273 RKRPKYNKLLEHSFIKRY  290 (318)
T ss_dssp             TTSCCHHHHTTSHHHHHH
T ss_pred             hHCcCHHHHhhCHHHHhc
Confidence            999999999999999754

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.4e-40  Score=320.92  Aligned_cols=257  Identities=18%  Similarity=0.202  Sum_probs=191.8

Q ss_pred             cCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCcccc
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~  140 (427)
                      ..+.|.+.+.||+|+||.||. +.+..+|+.||||++......    ..+.+|+.+++.+ +||||+++++++...    
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~----   77 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRL-GKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCG----   77 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEE-EEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEET----
T ss_pred             EcCCeEEEEEeeccCCceEEE-EEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecC----
Confidence            456799999999999999996 456788999999988643221    2467899999999 999999999988653    


Q ss_pred             CCceEEEEeccCCCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCC-----EEEeeCC
Q psy8260         141 DFKNVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE-----LKILDFG  213 (427)
Q Consensus       141 ~~~~~~lv~e~~g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~-----~kl~DFG  213 (427)
                        ...+++|++++++|.+++..  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.     +||+|||
T Consensus        78 --~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg  155 (330)
T 2izr_A           78 --KYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFA  155 (330)
T ss_dssp             --TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred             --CccEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence              46789999999999999874  67999999999999999999999999999999999999998876     9999999


Q ss_pred             CCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccccc
Q psy8260         214 LARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR  293 (427)
Q Consensus       214 la~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~  293 (427)
                      +++..........  .                                                 .........||+.|+
T Consensus       156 ~a~~~~~~~~~~~--~-------------------------------------------------~~~~~~~~~gt~~y~  184 (330)
T 2izr_A          156 LAKEYIDPETKKH--I-------------------------------------------------PYREHKSLTGTARYM  184 (330)
T ss_dssp             TCEESBCTTTCCB--C-------------------------------------------------CCCCCCCCCSCTTTC
T ss_pred             cceeeecCCCCcc--c-------------------------------------------------cccccCCcCCCcccc
Confidence            9975432211000  0                                                 000123456899999


Q ss_pred             chHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHH---HHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcC
Q psy8260         294 APEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSA---RKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLE  370 (427)
Q Consensus       294 APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~  370 (427)
                      |||++.+..+..++|+||+|++++.|.++..||.........   .+.........   . .......|++.+||.+||+
T Consensus       185 aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~---~-~~~~~~~p~~~~li~~~l~  260 (330)
T 2izr_A          185 SINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP---I-EVLCENFPEMATYLRYVRR  260 (330)
T ss_dssp             CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC---H-HHHTTTCHHHHHHHHHHHH
T ss_pred             ChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC---H-HHHhccChHHHHHHHHHHh
Confidence            999998877777889999999998885555555432211111   11111000000   1 1112234599999999999


Q ss_pred             CCCCCCCCHHHHhc
Q psy8260         371 LDSEKRITAEQALA  384 (427)
Q Consensus       371 ~dP~~R~ta~e~L~  384 (427)
                      .||.+|||++++++
T Consensus       261 ~~p~~RP~~~~l~~  274 (330)
T 2izr_A          261 LDFFEKPDYDYLRK  274 (330)
T ss_dssp             CCTTCCCCHHHHHH
T ss_pred             CCCCCCCCHHHHHH
Confidence            99999999998865

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=9.3e-40  Score=318.74  Aligned_cols=256  Identities=19%  Similarity=0.211  Sum_probs=195.9

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeC----cCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeec
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDS----VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHS  135 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~  135 (427)
                      ++..+.|.+.+.||+|+||.||.+....    .+++.||||++... ......+.+.+|+.+++.++||||+++++++..
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            5667889999999999999999876543    46689999998754 344455678899999999999999999999865


Q ss_pred             CccccCCceEEEEeccC-CCCHHHHHhh-------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCc
Q psy8260         136 NTCLADFKNVYMVTHLM-GADLNNILRT-------------------------QKLSDDHVQFLVYQILRGLKYIHSAGI  189 (427)
Q Consensus       136 ~~~~~~~~~~~lv~e~~-g~~L~~~l~~-------------------------~~l~~~~~~~~~~qi~~aL~yLH~~~i  189 (427)
                      .      ...|+++|++ +++|.+++..                         ..+++..+..++.||+.||.|||++||
T Consensus       122 ~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~i  195 (343)
T 1luf_A          122 G------KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF  195 (343)
T ss_dssp             S------SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             C------CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            3      4578899988 6799998865                         468999999999999999999999999


Q ss_pred             eeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhh
Q psy8260         190 IHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELK  269 (427)
Q Consensus       190 iHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~k  269 (427)
                      +||||||+|||++.++.+||+|||+++........                                             
T Consensus       196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~---------------------------------------------  230 (343)
T 1luf_A          196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY---------------------------------------------  230 (343)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB---------------------------------------------
T ss_pred             ecCCCCcceEEECCCCeEEEeecCCCcccccCccc---------------------------------------------
Confidence            99999999999999999999999987532211000                                             


Q ss_pred             hhccCCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcc
Q psy8260         270 ILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKK  348 (427)
Q Consensus       270 i~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (427)
                                 .......||+.|+|||++.+..+..++|+||+|++++.|.+ +..+|..................    
T Consensus       231 -----------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~----  295 (343)
T 1luf_A          231 -----------KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL----  295 (343)
T ss_dssp             -----------C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC----
T ss_pred             -----------cccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcC----
Confidence                       01112357888999998887777778899999999987755 54444332211222211111110    


Q ss_pred             cHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         349 DFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       349 ~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                         ......++++.+||.+||+.||.+|||++|++++
T Consensus       296 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          296 ---ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence               1123567899999999999999999999999875

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=7e-40  Score=324.87  Aligned_cols=257  Identities=20%  Similarity=0.277  Sum_probs=194.5

Q ss_pred             ccccccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecC
Q psy8260          57 PYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSN  136 (427)
Q Consensus        57 ~~~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~  136 (427)
                      .-+++....|.+.+.||+|+||.||.+. +..+++.||||.+... ........+.+|+++|+.++|||||++++++...
T Consensus       107 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~-~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  184 (377)
T 3cbl_A          107 DKWVLNHEDLVLGEQIGRGNFGEVFSGR-LRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK  184 (377)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEE-ETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             cccEEchHHeEEeeEeccCCCCeEEEEE-EecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC
Confidence            3457778899999999999999999754 5568999999998643 3344455678999999999999999999998643


Q ss_pred             ccccCCceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCC
Q psy8260         137 TCLADFKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG  213 (427)
Q Consensus       137 ~~~~~~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFG  213 (427)
                            ..+|++||++ +++|.++++.  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||
T Consensus       185 ------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG  258 (377)
T 3cbl_A          185 ------QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFG  258 (377)
T ss_dssp             ------SSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGG
T ss_pred             ------CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCC
Confidence                  3578999988 7899998864  359999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccccc
Q psy8260         214 LARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR  293 (427)
Q Consensus       214 la~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~  293 (427)
                      +++.........                                                        ......+++.|+
T Consensus       259 ~s~~~~~~~~~~--------------------------------------------------------~~~~~~~~~~y~  282 (377)
T 3cbl_A          259 MSREEADGVYAA--------------------------------------------------------SGGLRQVPVKWT  282 (377)
T ss_dssp             GCEECTTSEEEC--------------------------------------------------------CSSCCEEEGGGS
T ss_pred             CceecCCCceee--------------------------------------------------------cCCCCCCCcCcC
Confidence            986432211000                                                        001123567788


Q ss_pred             chHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         294 APEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       294 APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                      |||++.+..+..++|+||+|++++++.+ +..||... ...............+      .....++++.+||.+||+.|
T Consensus       283 aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~-~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~d  355 (377)
T 3cbl_A          283 APEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL-SNQQTREFVEKGGRLP------CPELCPDAVFRLMEQCWAYE  355 (377)
T ss_dssp             CHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS-CHHHHHHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSS
T ss_pred             CHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCCC------CCCCCCHHHHHHHHHHcCCC
Confidence            8888877777778899999999987643 33333222 1122222222211111      12345788999999999999


Q ss_pred             CCCCCCHHHHhc
Q psy8260         373 SEKRITAEQALA  384 (427)
Q Consensus       373 P~~R~ta~e~L~  384 (427)
                      |.+|||++|+++
T Consensus       356 P~~Rps~~~i~~  367 (377)
T 3cbl_A          356 PGQRPSFSTIYQ  367 (377)
T ss_dssp             GGGSCCHHHHHH
T ss_pred             chhCcCHHHHHH
Confidence            999999999875

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=9.5e-40  Score=312.24  Aligned_cols=264  Identities=17%  Similarity=0.231  Sum_probs=196.4

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCcc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTC  138 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~  138 (427)
                      .+..+.|.+.+.||+|+||.||. +.+..+|+.||||++.....    ...+.+|+.+++.+ +|+||+++++++...  
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--   78 (298)
T 1csn_A            6 NVVGVHYKVGRRIGEGSFGVIFE-GTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEG--   78 (298)
T ss_dssp             CEETTTEEEEEEEEECSSCEEEE-EEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEET--
T ss_pred             cccccceEEEEEEeecCCEEEEE-EEECCCCcEEEEEEeccCCc----cHHHHHHHHHHHHHhcCCCCCeEEeecCCC--
Confidence            44567899999999999999996 45677899999998864322    22466899999999 899999999987543  


Q ss_pred             ccCCceEEEEeccCCCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCC-----EEEee
Q psy8260         139 LADFKNVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE-----LKILD  211 (427)
Q Consensus       139 ~~~~~~~~lv~e~~g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~-----~kl~D  211 (427)
                          ...++++++++++|.+++..  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.     +||+|
T Consensus        79 ----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~D  154 (298)
T 1csn_A           79 ----LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVD  154 (298)
T ss_dssp             ----TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred             ----ceeEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEE
Confidence                46789999999999999874  45999999999999999999999999999999999999987765     99999


Q ss_pred             CCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccc
Q psy8260         212 FGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRW  291 (427)
Q Consensus       212 FGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~  291 (427)
                      ||+++..........  .                                                 .........||+.
T Consensus       155 fg~~~~~~~~~~~~~--~-------------------------------------------------~~~~~~~~~gt~~  183 (298)
T 1csn_A          155 FGMVKFYRDPVTKQH--I-------------------------------------------------PYREKKNLSGTAR  183 (298)
T ss_dssp             CTTCEESBCTTTCCB--C-------------------------------------------------CCCCCCCCCSCTT
T ss_pred             Ccccccccccccccc--c-------------------------------------------------cccCccCCCCCcc
Confidence            999875432211000  0                                                 0001234568899


Q ss_pred             ccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCC
Q psy8260         292 YRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLEL  371 (427)
Q Consensus       292 Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~  371 (427)
                      |+|||++.+..+..++|+||+|++++.|.++..||...........+...................++++.+||.+||+.
T Consensus       184 y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  263 (298)
T 1csn_A          184 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNL  263 (298)
T ss_dssp             TCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHC
T ss_pred             cCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcC
Confidence            99999988877777889999999998875555555332111111111000000001112334456789999999999999


Q ss_pred             CCCCCCCHHHHhcC
Q psy8260         372 DSEKRITAEQALAH  385 (427)
Q Consensus       372 dP~~R~ta~e~L~H  385 (427)
                      ||.+|||++|+++.
T Consensus       264 dp~~RP~~~~l~~~  277 (298)
T 1csn_A          264 AFDATPDYDYLQGL  277 (298)
T ss_dssp             CTTCCCCHHHHHHH
T ss_pred             CcccCCCHHHHHHH
Confidence            99999999998765

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.3e-39  Score=314.00  Aligned_cols=259  Identities=19%  Similarity=0.295  Sum_probs=197.1

Q ss_pred             ccccCcceeeccccCcccccEEEEeEE----eCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeee
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSAL----DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVF  133 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~  133 (427)
                      +++..+.|.+.+.||+|+||.||.+..    +..+++.||||++... ......+.+.+|+.+++++ +||||+++++++
T Consensus        22 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  100 (316)
T 2xir_A           22 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGAC  100 (316)
T ss_dssp             HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             eecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC-CCcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence            356678899999999999999998654    3467889999998754 3344556788999999999 789999999997


Q ss_pred             ecCccccCCceEEEEeccC-CCCHHHHHhhCC-----------------CCHHHHHHHHHHHHHHHHHHHhcCceeccCC
Q psy8260         134 HSNTCLADFKNVYMVTHLM-GADLNNILRTQK-----------------LSDDHVQFLVYQILRGLKYIHSAGIIHRDLK  195 (427)
Q Consensus       134 ~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~~-----------------l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLK  195 (427)
                      ....     ..++++++++ +++|.+++....                 +++..+..++.|++.||.|||++||+|||||
T Consensus       101 ~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dik  175 (316)
T 2xir_A          101 TKPG-----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLA  175 (316)
T ss_dssp             CCTT-----SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             ecCC-----CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCc
Confidence            6432     3478888888 679999987543                 7899999999999999999999999999999


Q ss_pred             CCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCC
Q psy8260         196 PSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGL  275 (427)
Q Consensus       196 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~  275 (427)
                      |+|||++.++.+||+|||+++........                                                   
T Consensus       176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---------------------------------------------------  204 (316)
T 2xir_A          176 ARNILLSEKNVVKICDFGLARDIYKDPDY---------------------------------------------------  204 (316)
T ss_dssp             GGGEEECGGGCEEECCCGGGSCTTTCTTS---------------------------------------------------
T ss_pred             cceEEECCCCCEEECCCccccccccCccc---------------------------------------------------
Confidence            99999999999999999998754321100                                                   


Q ss_pred             CCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhc
Q psy8260         276 ARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVF  354 (427)
Q Consensus       276 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (427)
                           .......||+.|+|||++.+..+..++|+||+|++++.|.+ +..+|...................      ...
T Consensus       205 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~------~~~  273 (316)
T 2xir_A          205 -----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM------RAP  273 (316)
T ss_dssp             -----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCC------CCC
T ss_pred             -----eeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccC------CCC
Confidence                 01122356788888888887777778899999999987654 444443322222222222211111      112


Q ss_pred             CCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         355 KGANPQAIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       355 ~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                      ...++++.+||.+||+.||.+|||++|+++|
T Consensus       274 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          274 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3468899999999999999999999999987

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3e-40  Score=320.09  Aligned_cols=254  Identities=23%  Similarity=0.377  Sum_probs=192.1

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH----HHHHHHHHHHHHHhcCC--CCCceeeeeee
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA----VHAKRTYRELRMLKHMN--HENVIGLLDVF  133 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~----~~~~~~~~Ei~~l~~l~--HpnIv~l~~~~  133 (427)
                      +...+.|.+.+.||+|+||.||. +.+..+|+.||||++.......    .....+.+|+.+++.++  ||||+++++++
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~  117 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYS-GIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF  117 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEE-EEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEE-EEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence            44567899999999999999996 4567789999999986542211    11233557999999986  59999999998


Q ss_pred             ecCccccCCceEEEEeccCC--CCHHHHHh-hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEc-CCCCEEE
Q psy8260         134 HSNTCLADFKNVYMVTHLMG--ADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN-EDCELKI  209 (427)
Q Consensus       134 ~~~~~~~~~~~~~lv~e~~g--~~L~~~l~-~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~-~~~~~kl  209 (427)
                      ...      ...+++++++.  ++|.+++. ...+++..+..++.|++.||.|||++||+||||||+|||++ .++.+||
T Consensus       118 ~~~------~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL  191 (320)
T 3a99_A          118 ERP------DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKL  191 (320)
T ss_dssp             ECS------SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEE
T ss_pred             ecC------CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEE
Confidence            754      45778888774  78998875 46799999999999999999999999999999999999999 7889999


Q ss_pred             eeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccc
Q psy8260         210 LDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT  289 (427)
Q Consensus       210 ~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt  289 (427)
                      +|||+++......                                                            .....||
T Consensus       192 ~Dfg~~~~~~~~~------------------------------------------------------------~~~~~gt  211 (320)
T 3a99_A          192 IDFGSGALLKDTV------------------------------------------------------------YTDFDGT  211 (320)
T ss_dssp             CCCTTCEECCSSC------------------------------------------------------------BCCCCSC
T ss_pred             eeCcccccccccc------------------------------------------------------------ccCCCCC
Confidence            9999986433211                                                            1122356


Q ss_pred             ccccchHHhhhccCC-CCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHh
Q psy8260         290 RWYRAPEIMLNWMHY-NQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLM  368 (427)
Q Consensus       290 ~~Y~APEvl~~~~~~-~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~m  368 (427)
                      +.|+|||++.+..+. ..+|+||+|++++.|.++..+|...      .........        .....++++.+||.+|
T Consensus       212 ~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~------~~~~~~~~~--------~~~~~~~~~~~li~~~  277 (320)
T 3a99_A          212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVF--------FRQRVSSECQHLIRWC  277 (320)
T ss_dssp             GGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCC--------CSSCCCHHHHHHHHHH
T ss_pred             ccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh------hhhhccccc--------ccccCCHHHHHHHHHH
Confidence            667777766655443 3569999999998875554444221      111111111        1135688999999999


Q ss_pred             cCCCCCCCCCHHHHhcCCCCCCCCCC
Q psy8260         369 LELDSEKRITAEQALAHPYLSQYSDP  394 (427)
Q Consensus       369 L~~dP~~R~ta~e~L~Hp~f~~~~~~  394 (427)
                      |+.||.+|||++|+++||||.+...+
T Consensus       278 l~~dp~~Rps~~~ll~hp~~~~~~~~  303 (320)
T 3a99_A          278 LALRPSDRPTFEEIQNHPWMQDVLLP  303 (320)
T ss_dssp             TCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred             ccCChhhCcCHHHHhcCHhhcCccCc
Confidence            99999999999999999999876544

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.7e-39  Score=310.48  Aligned_cols=258  Identities=19%  Similarity=0.254  Sum_probs=191.3

Q ss_pred             cccCcceeeccccCcccccEEEEeEE---eCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecC
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSAL---DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSN  136 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~---~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~  136 (427)
                      ++..+.|.+.+.||+|+||.||.+..   +..+|+.||||++...  .....+.+.+|+++++.++||||+++++++...
T Consensus         6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   83 (295)
T 3ugc_A            6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA   83 (295)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred             cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            55678899999999999999998764   5678999999998643  455566788999999999999999999987542


Q ss_pred             ccccCCceEEEEeccC-CCCHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCC
Q psy8260         137 TCLADFKNVYMVTHLM-GADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG  213 (427)
Q Consensus       137 ~~~~~~~~~~lv~e~~-g~~L~~~l~~~--~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFG  213 (427)
                          +...++++++++ +++|.+++...  .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        84 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg  159 (295)
T 3ugc_A           84 ----GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG  159 (295)
T ss_dssp             ----HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             ----CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCc
Confidence                123478899988 78999998754  49999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccccc
Q psy8260         214 LARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR  293 (427)
Q Consensus       214 la~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~  293 (427)
                      +++.........                                                       .......||+.|+
T Consensus       160 ~~~~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~y~  184 (295)
T 3ugc_A          160 LTKVLPQDKEFF-------------------------------------------------------KVKEPGESPIFWY  184 (295)
T ss_dssp             SCC--------------------------------------------------------------------CTTCGGGGC
T ss_pred             ccccccCCccee-------------------------------------------------------eeccCCCCcccee
Confidence            987543211000                                                       0011234677889


Q ss_pred             chHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHH-------hhcCc----H----HHHHHHhcCCCCCcccHHhhcCCCC
Q psy8260         294 APEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFM-------AKISS----D----SARKYINSLPLLTKKDFRQVFKGAN  358 (427)
Q Consensus       294 APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~-------~~~~~----~----~~~~~~~~~~~~~~~~~~~~~~~~s  358 (427)
                      |||++.+..+..++|+||+|++++.+.++..++.       .....    .    ............      ......+
T Consensus       185 aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~  258 (295)
T 3ugc_A          185 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL------PRPDGCP  258 (295)
T ss_dssp             CHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCC------CCCTTCC
T ss_pred             CcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcC------CCCcCcC
Confidence            9998888777778899999999987744322211       00000    0    000001111100      1123567


Q ss_pred             hhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy8260         359 PQAIDLLSLMLELDSEKRITAEQALA  384 (427)
Q Consensus       359 ~~~~dLi~~mL~~dP~~R~ta~e~L~  384 (427)
                      +++.+||.+||+.||.+|||++|+++
T Consensus       259 ~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          259 DEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            89999999999999999999999975

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.3e-39  Score=307.26  Aligned_cols=251  Identities=24%  Similarity=0.297  Sum_probs=183.9

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH--HHHHHHHHHHHHHhcCCCCCceeeeeeeecCc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA--VHAKRTYRELRMLKHMNHENVIGLLDVFHSNT  137 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~  137 (427)
                      ++..+.|.+.+.||+|+||.||.+..   +|..||||++.......  ...+.+.+|+++++.++||||+++++++... 
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-   78 (271)
T 3dtc_A            3 EIDFAELTLEEIIGIGGFGKVYRAFW---IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE-   78 (271)
T ss_dssp             BCCTTSEEEEEEEEEETTEEEEEEEE---TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC-
T ss_pred             ccchhheeeeeeeccCCCeEEEEEEE---cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC-
Confidence            44567899999999999999997653   48899999986543221  2235677999999999999999999998654 


Q ss_pred             cccCCceEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcC---ceeccCCCCCeEEcC--------CC
Q psy8260         138 CLADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNE--------DC  205 (427)
Q Consensus       138 ~~~~~~~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~---iiHrDLKp~NILl~~--------~~  205 (427)
                           ...+++++++ +++|.++++.+.+++..+..++.|++.||.|||++|   |+||||||+|||++.        ++
T Consensus        79 -----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~  153 (271)
T 3dtc_A           79 -----PNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNK  153 (271)
T ss_dssp             -------CEEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSC
T ss_pred             -----CceEEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCc
Confidence                 3568899988 789999998889999999999999999999999999   999999999999986        67


Q ss_pred             CEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccc
Q psy8260         206 ELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTG  285 (427)
Q Consensus       206 ~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~  285 (427)
                      .+||+|||+++......                                                            ...
T Consensus       154 ~~kl~Dfg~~~~~~~~~------------------------------------------------------------~~~  173 (271)
T 3dtc_A          154 ILKITDFGLAREWHRTT------------------------------------------------------------KMS  173 (271)
T ss_dssp             CEEECCCCC-----------------------------------------------------------------------
T ss_pred             ceEEccCCccccccccc------------------------------------------------------------ccC
Confidence            89999999986432210                                                            012


Q ss_pred             ccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHH
Q psy8260         286 YVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLL  365 (427)
Q Consensus       286 ~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi  365 (427)
                      ..||+.|+|||++.+..+..++|+||+|++++.+.++..||...................      ......++++.+||
T Consensus       174 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li  247 (271)
T 3dtc_A          174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL------PIPSTCPEPFAKLM  247 (271)
T ss_dssp             --CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCC------CCCTTCCHHHHHHH
T ss_pred             CCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCC------CCCcccCHHHHHHH
Confidence            246777888887777667777899999999988765555554322111111111111111      11235678999999


Q ss_pred             HHhcCCCCCCCCCHHHHhcC
Q psy8260         366 SLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       366 ~~mL~~dP~~R~ta~e~L~H  385 (427)
                      .+||+.||.+|||++|+++|
T Consensus       248 ~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          248 EDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhcCCcccCcCHHHHHHH
Confidence            99999999999999999875

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=8.3e-42  Score=333.08  Aligned_cols=256  Identities=18%  Similarity=0.148  Sum_probs=172.5

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC------CHHHHHHHHHHHHHHhcCC---------CCC
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ------SAVHAKRTYRELRMLKHMN---------HEN  125 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~------~~~~~~~~~~Ei~~l~~l~---------Hpn  125 (427)
                      +..+.|.+.+.||+|+||.||.+..   +|+.||||++.....      .....+.+.+|+.+|+.++         |||
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~n   93 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIA---DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEG   93 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEE---TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCC
T ss_pred             cccccchheeeecccCceEEEEEEe---CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCc
Confidence            3456789999999999999997643   689999999875432      1122355678888888775         777


Q ss_pred             ceeeeeeeecCcc------------------------ccCCceEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHH
Q psy8260         126 VIGLLDVFHSNTC------------------------LADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRG  180 (427)
Q Consensus       126 Iv~l~~~~~~~~~------------------------~~~~~~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~a  180 (427)
                      ||++.+++.....                        ..+...+|++||++ +|++.+.+..+.+++..++.++.||+.|
T Consensus        94 iv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           94 FIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             BCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHH
T ss_pred             hhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHH
Confidence            7777766421100                        01246789999997 5644444455779999999999999999


Q ss_pred             HHHHH-hcCceeccCCCCCeEEcCCC--------------------CEEEeeCCCCCCCCCCcccccccccccchhhhhc
Q psy8260         181 LKYIH-SAGIIHRDLKPSNIAVNEDC--------------------ELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  239 (427)
Q Consensus       181 L~yLH-~~~iiHrDLKp~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~  239 (427)
                      |.||| ++||+||||||+|||++.++                    .+||+|||+|+.....  ..+             
T Consensus       174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--~~~-------------  238 (336)
T 2vuw_A          174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--IVV-------------  238 (336)
T ss_dssp             HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--EEE-------------
T ss_pred             HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--cEE-------------
Confidence            99999 99999999999999999877                    8999999988743221  123             


Q ss_pred             ccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHH-HHH
Q psy8260         240 WMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLI-MEM  318 (427)
Q Consensus       240 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i-~~~  318 (427)
                                                                      ||+.|+|||++.+.. ..++|+||++.. .+.
T Consensus       239 ------------------------------------------------gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~  269 (336)
T 2vuw_A          239 ------------------------------------------------FCDVSMDEDLFTGDG-DYQFDIYRLMKKENNN  269 (336)
T ss_dssp             ------------------------------------------------CCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTT
T ss_pred             ------------------------------------------------EeecccChhhhcCCC-ccceehhhhhCCCCcc
Confidence                                                            455555555554433 335699998655 444


Q ss_pred             hCCCCHHHHhhcC-cHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHh-cCCCCC
Q psy8260         319 LGTPPAEFMAKIS-SDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQAL-AHPYLS  389 (427)
Q Consensus       319 lg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L-~Hp~f~  389 (427)
                      +-.+..+|..... .......... ...........+..++++++|||.+||++|     ||+|+| +||||+
T Consensus       270 ~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          270 RWGEYHPYSNVLWLHYLTDKMLKQ-MTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             CTTSCCTHHHHHHHHHHHHHHHHT-CCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             cccccCCCcchhhhhHHHHhhhhh-hccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence            4333333322110 0111111111 111111122233456889999999999988     999999 999995

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.6e-39  Score=306.11  Aligned_cols=255  Identities=17%  Similarity=0.223  Sum_probs=191.8

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEeCc--CCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecC
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALDSV--SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSN  136 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~--~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~  136 (427)
                      ..+..+.|.+.+.||+|+||.||.+.....  ++..||||.+... ......+.+.+|+.+++.++||||+++++++...
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   85 (281)
T 3cc6_A            7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE   85 (281)
T ss_dssp             CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT-SCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS
T ss_pred             ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc-cCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC
Confidence            456678899999999999999998765433  4557999998754 2445567788999999999999999999997542


Q ss_pred             ccccCCceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCC
Q psy8260         137 TCLADFKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG  213 (427)
Q Consensus       137 ~~~~~~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFG  213 (427)
                             ..|++++++ +++|.+++..  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        86 -------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  158 (281)
T 3cc6_A           86 -------PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFG  158 (281)
T ss_dssp             -------SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCC
T ss_pred             -------CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccC
Confidence                   346777777 6899998864  459999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccccc
Q psy8260         214 LARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR  293 (427)
Q Consensus       214 la~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~  293 (427)
                      +++........                                                         ......+|+.|+
T Consensus       159 ~~~~~~~~~~~---------------------------------------------------------~~~~~~~~~~y~  181 (281)
T 3cc6_A          159 LSRYIEDEDYY---------------------------------------------------------KASVTRLPIKWM  181 (281)
T ss_dssp             GGGCC------------------------------------------------------------------CCCCCGGGC
T ss_pred             CCccccccccc---------------------------------------------------------ccccCCCCccee
Confidence            98643221100                                                         011224577888


Q ss_pred             chHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         294 APEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       294 APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                      |||++.+..+..++|+||+|++++.+.+ +..||................. ..      .....++++.+||.+||+.|
T Consensus       182 aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~-~~------~~~~~~~~l~~li~~~l~~~  254 (281)
T 3cc6_A          182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR-LP------KPDLCPPVLYTLMTRCWDYD  254 (281)
T ss_dssp             CHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCC-CC------CCTTCCHHHHHHHHHHTCSS
T ss_pred             CchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCC-CC------CCCCCCHHHHHHHHHHccCC
Confidence            8888877777777899999999987654 4444432222222222211111 11      12346789999999999999


Q ss_pred             CCCCCCHHHHhcC
Q psy8260         373 SEKRITAEQALAH  385 (427)
Q Consensus       373 P~~R~ta~e~L~H  385 (427)
                      |.+|||++|+++|
T Consensus       255 p~~Rps~~ell~~  267 (281)
T 3cc6_A          255 PSDRPRFTELVCS  267 (281)
T ss_dssp             GGGSCCHHHHHHH
T ss_pred             chhCcCHHHHHHH
Confidence            9999999999875

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.3e-39  Score=311.66  Aligned_cols=260  Identities=21%  Similarity=0.293  Sum_probs=181.6

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhc--CCCCCceeeeeeeecCcc
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKH--MNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~--l~HpnIv~l~~~~~~~~~  138 (427)
                      ...+.|.+.+.||+|+||.||.+..   +|+.||||++...     ......+|.+++..  ++||||+++++++.... 
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-   75 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW---QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSR-   75 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE---TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE---CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeecccc-
Confidence            3456789999999999999997653   6889999998542     12334556666555  89999999999865321 


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHH--------hcCceeccCCCCCeEEcCCCCEEE
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIH--------SAGIIHRDLKPSNIAVNEDCELKI  209 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH--------~~~iiHrDLKp~NILl~~~~~~kl  209 (427)
                       .....+++++|++ +++|.++++...+++..+..++.|++.||.|||        ++||+||||||+|||++.++.+||
T Consensus        76 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl  154 (301)
T 3q4u_A           76 -HSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI  154 (301)
T ss_dssp             -TTEEEEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred             -CCCceeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence             1234678999988 679999998889999999999999999999999        999999999999999999999999


Q ss_pred             eeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccc
Q psy8260         210 LDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT  289 (427)
Q Consensus       210 ~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt  289 (427)
                      +|||+++.........                                                      ........||
T Consensus       155 ~Dfg~a~~~~~~~~~~------------------------------------------------------~~~~~~~~gt  180 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQL------------------------------------------------------DVGNNPRVGT  180 (301)
T ss_dssp             CCCTTCEEEETTTTEE------------------------------------------------------ECCCCCCCCC
T ss_pred             eeCCCeeecccccccc------------------------------------------------------cccccccccc
Confidence            9999986432211000                                                      0001123466


Q ss_pred             ccccchHHhhhcc------CCCCCCHHHHHHHHHHhCCC----------CHHHHhhcCc----HHHHHHHhcCCCCCccc
Q psy8260         290 RWYRAPEIMLNWM------HYNQTDIHQLNLIMEMLGTP----------PAEFMAKISS----DSARKYINSLPLLTKKD  349 (427)
Q Consensus       290 ~~Y~APEvl~~~~------~~~~~d~~slg~i~~~lg~~----------~~~~~~~~~~----~~~~~~~~~~~~~~~~~  349 (427)
                      +.|+|||++.+..      +..++|+||+|++++.|.++          ..||......    ....+............
T Consensus       181 ~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (301)
T 3q4u_A          181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIP  260 (301)
T ss_dssp             GGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCC
T ss_pred             cceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCC
Confidence            6666666665542      23457999999999888655          3344322111    11111111111111100


Q ss_pred             HHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy8260         350 FRQVFKGANPQAIDLLSLMLELDSEKRITAEQALA  384 (427)
Q Consensus       350 ~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~  384 (427)
                      ........++++.+||.+||+.||.+|||++|+++
T Consensus       261 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          261 NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            00111223567899999999999999999999986

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.7e-39  Score=306.82  Aligned_cols=253  Identities=19%  Similarity=0.280  Sum_probs=195.3

Q ss_pred             cccccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCc
Q psy8260          58 YSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNT  137 (427)
Q Consensus        58 ~~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~  137 (427)
                      .+++....|.+.+.||+|+||.||.+ .+..+++.||||.+....   ...+.+.+|+.+++.++||||+++++++... 
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~-~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-   81 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-   81 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEE-EEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             cccccccceeEEeecCCCCceeEEEe-EecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccC-
Confidence            35677888999999999999999964 566789999999986532   2346678999999999999999999998653 


Q ss_pred             cccCCceEEEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCC
Q psy8260         138 CLADFKNVYMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG  213 (427)
Q Consensus       138 ~~~~~~~~~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFG  213 (427)
                           ..++++++++ +++|.+++..   ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||
T Consensus        82 -----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg  156 (288)
T 3kfa_A           82 -----PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG  156 (288)
T ss_dssp             -----SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             -----CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCc
Confidence                 4578899988 5899998864   348999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccccc
Q psy8260         214 LARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR  293 (427)
Q Consensus       214 la~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~  293 (427)
                      +++........                                                         ...+..+|+.|+
T Consensus       157 ~~~~~~~~~~~---------------------------------------------------------~~~~~~~~~~y~  179 (288)
T 3kfa_A          157 LSRLMTGDTYT---------------------------------------------------------AHAGAKFPIKWT  179 (288)
T ss_dssp             GGGTSCSSSSE---------------------------------------------------------EETTEEECGGGC
T ss_pred             cceeccCCccc---------------------------------------------------------cccCCccccCcC
Confidence            98654321100                                                         112334677888


Q ss_pred             chHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         294 APEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       294 APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                      |||++.+..+..++|+||+|++++.|.+ +..+|.......... ........      ......++++.+||.+||+.|
T Consensus       180 aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~-~~~~~~~~------~~~~~~~~~l~~li~~~l~~d  252 (288)
T 3kfa_A          180 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYRM------ERPEGCPEKVYELMRACWQWN  252 (288)
T ss_dssp             CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-HHHTTCCC------CCCTTCCHHHHHHHHHHTCSS
T ss_pred             ChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHhccCCC------CCCCCCCHHHHHHHHHHhCCC
Confidence            8888887777778899999999987754 443443222222222 12111111      112356889999999999999


Q ss_pred             CCCCCCHHHHhc
Q psy8260         373 SEKRITAEQALA  384 (427)
Q Consensus       373 P~~R~ta~e~L~  384 (427)
                      |.+|||++|+++
T Consensus       253 p~~Rps~~~~~~  264 (288)
T 3kfa_A          253 PSDRPSFAEIHQ  264 (288)
T ss_dssp             GGGSCCHHHHHH
T ss_pred             hhhCcCHHHHHH
Confidence            999999999976

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.4e-39  Score=319.32  Aligned_cols=272  Identities=15%  Similarity=0.150  Sum_probs=193.4

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCc----CCcEEEEEEccCcCCCHHHH---------HHHHHHHHHHhcCCCCCc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSV----SGVKVAIKKIARPFQSAVHA---------KRTYRELRMLKHMNHENV  126 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~----~g~~vAvK~i~~~~~~~~~~---------~~~~~Ei~~l~~l~HpnI  126 (427)
                      ++..+.|.+.+.||+|+||.||.+.....    .++.||||++..........         ....+|+..++.++||||
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i  110 (364)
T 3op5_A           31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV  110 (364)
T ss_dssp             CTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred             ccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence            34566899999999999999998654332    36889999986532111110         123456677888999999


Q ss_pred             eeeeeeeecCccccCCceEEEEeccCCCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEc--
Q psy8260         127 IGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN--  202 (427)
Q Consensus       127 v~l~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~--  202 (427)
                      +++++++....  ......|++||++|++|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++  
T Consensus       111 v~~~~~~~~~~--~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          111 PKYWGSGLHDK--NGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK  188 (364)
T ss_dssp             CCEEEEEEEEE--TTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESS
T ss_pred             CeEEeeeeecc--CCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecC
Confidence            99999976431  11245789999999999999865  4699999999999999999999999999999999999999  


Q ss_pred             CCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccc
Q psy8260         203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENE  282 (427)
Q Consensus       203 ~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~  282 (427)
                      .++.+||+|||+++..........                                                   .....
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~---------------------------------------------------~~~~~  217 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKA---------------------------------------------------YAADP  217 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCC---------------------------------------------------SSCCS
T ss_pred             CCCeEEEEECCcceecccCCcccc---------------------------------------------------cccCc
Confidence            889999999999975432110000                                                   00001


Q ss_pred             cccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhc-CCCCCcccHHhhc--CCCCh
Q psy8260         283 MTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINS-LPLLTKKDFRQVF--KGANP  359 (427)
Q Consensus       283 ~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~s~  359 (427)
                      ....+||+.|+|||++.+..+..++|+||+|++++.|.++..||............... ............+  ...++
T Consensus       218 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (364)
T 3op5_A          218 KRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPG  297 (364)
T ss_dssp             SCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCH
T ss_pred             ccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHH
Confidence            23456899999999998887877889999999998886666566543222221111100 0000000011111  45688


Q ss_pred             hHHHHHHHhcCCCCCCCCCHHHHhc
Q psy8260         360 QAIDLLSLMLELDSEKRITAEQALA  384 (427)
Q Consensus       360 ~~~dLi~~mL~~dP~~R~ta~e~L~  384 (427)
                      ++.+||..||..||.+|||++++++
T Consensus       298 ~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          298 EIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            9999999999999999999999876

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.7e-39  Score=309.94  Aligned_cols=258  Identities=23%  Similarity=0.312  Sum_probs=185.3

Q ss_pred             cccccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCc
Q psy8260          58 YSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNT  137 (427)
Q Consensus        58 ~~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~  137 (427)
                      -.++..+.|.+.+.||+|+||.||.+..    ...||||++..........+.+.+|+.+++.++||||++++++...  
T Consensus        18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--   91 (289)
T 3og7_A           18 DWEIPDGQITVGQRIGSGSFGTVYKGKW----HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--   91 (289)
T ss_dssp             CCBCCTTSCEEEEEEEECSSEEEEEEES----SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--
T ss_pred             CCccCccceeeeeEecCCCCeEEEEEEE----cCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC--
Confidence            3588889999999999999999997643    2359999997766666677788899999999999999999986532  


Q ss_pred             cccCCceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCC
Q psy8260         138 CLADFKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL  214 (427)
Q Consensus       138 ~~~~~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGl  214 (427)
                           ...+++++++ +++|.+++..  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        92 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~  166 (289)
T 3og7_A           92 -----PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGL  166 (289)
T ss_dssp             -----SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-
T ss_pred             -----CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEcccee
Confidence                 3467888877 6899988853  4699999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccc
Q psy8260         215 ARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRA  294 (427)
Q Consensus       215 a~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~A  294 (427)
                      ++........                                                        .......||+.|+|
T Consensus       167 ~~~~~~~~~~--------------------------------------------------------~~~~~~~gt~~y~a  190 (289)
T 3og7_A          167 ATEKSRWSGS--------------------------------------------------------HQFEQLSGSILWMA  190 (289)
T ss_dssp             -------------------------------------------------------------------------CCCTTCC
T ss_pred             cccccccccc--------------------------------------------------------ccccccCCCccccC
Confidence            8643221000                                                        01112346666777


Q ss_pred             hHHhh---hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCC
Q psy8260         295 PEIML---NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLEL  371 (427)
Q Consensus       295 PEvl~---~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~  371 (427)
                      ||++.   +..+..++|+||+|++++.+.++..+|..................  ...+.......++++.+||.+||+.
T Consensus       191 PE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~  268 (289)
T 3og7_A          191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL--SPDLSKVRSNCPKRMKRLMAECLKK  268 (289)
T ss_dssp             HHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSC--CCCTTSSCTTSCHHHHHHHHHHTCS
T ss_pred             chhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhccccc--CcchhhccccCCHHHHHHHHHHccC
Confidence            77664   333445679999999998876555555432222222222221111  1111222345678999999999999


Q ss_pred             CCCCCCCHHHHhc
Q psy8260         372 DSEKRITAEQALA  384 (427)
Q Consensus       372 dP~~R~ta~e~L~  384 (427)
                      ||.+|||++|+++
T Consensus       269 ~p~~Rps~~ell~  281 (289)
T 3og7_A          269 KRDERPSFPRILA  281 (289)
T ss_dssp             SGGGSCCHHHHHH
T ss_pred             ChhhCCCHHHHHH
Confidence            9999999999986

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=5.5e-39  Score=312.85  Aligned_cols=259  Identities=22%  Similarity=0.303  Sum_probs=194.7

Q ss_pred             ccccccCcceeeccccCcccccEEEEeEEe------CcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceee
Q psy8260          57 PYSEICRGVIDIGPTLSKESFDLIFSSALD------SVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGL  129 (427)
Q Consensus        57 ~~~~~~~~~~~~~~~lg~g~fg~v~~~~~~------~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l  129 (427)
                      +.+++..+.|.+.+.||+|+||.||.+...      ..+++.||||++... ........+.+|+.+++.+ +||||+++
T Consensus        28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~  106 (334)
T 2pvf_A           28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINL  106 (334)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC-CcHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence            445777889999999999999999976542      246789999998754 3445566788999999999 99999999


Q ss_pred             eeeeecCccccCCceEEEEeccC-CCCHHHHHhhC-----------------CCCHHHHHHHHHHHHHHHHHHHhcCcee
Q psy8260         130 LDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQ-----------------KLSDDHVQFLVYQILRGLKYIHSAGIIH  191 (427)
Q Consensus       130 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~-----------------~l~~~~~~~~~~qi~~aL~yLH~~~iiH  191 (427)
                      ++++...      ..+|++++++ +++|.+++...                 .+++..+..++.||+.||.|||++||+|
T Consensus       107 ~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH  180 (334)
T 2pvf_A          107 LGACTQD------GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIH  180 (334)
T ss_dssp             EEEECSS------SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             EEEEccC------CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence            9998653      3578889888 67999998653                 3889999999999999999999999999


Q ss_pred             ccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhh
Q psy8260         192 RDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKIL  271 (427)
Q Consensus       192 rDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~  271 (427)
                      |||||+|||++.++.+||+|||+++........                                               
T Consensus       181 ~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-----------------------------------------------  213 (334)
T 2pvf_A          181 RDLAARNVLVTENNVMKIADFGLARDINNIDYY-----------------------------------------------  213 (334)
T ss_dssp             SCCSGGGEEECTTCCEEECCCTTCEECTTTSSE-----------------------------------------------
T ss_pred             CCCccceEEEcCCCCEEEccccccccccccccc-----------------------------------------------
Confidence            999999999999999999999998643221100                                               


Q ss_pred             ccCCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccH
Q psy8260         272 DFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDF  350 (427)
Q Consensus       272 d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (427)
                               .......+|+.|+|||++.+..+..++|+||+|++++.|.+ +..+|................. .     
T Consensus       214 ---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~-~-----  278 (334)
T 2pvf_A          214 ---------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR-M-----  278 (334)
T ss_dssp             ---------ECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC-C-----
T ss_pred             ---------cccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCC-C-----
Confidence                     00112246778888888887777778899999999987644 4444432211111111111111 0     


Q ss_pred             HhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         351 RQVFKGANPQAIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       351 ~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                       ......++++.+||.+||+.||.+|||++|++++
T Consensus       279 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          279 -DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence             1123467899999999999999999999999876

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=5.4e-39  Score=329.69  Aligned_cols=254  Identities=19%  Similarity=0.272  Sum_probs=195.7

Q ss_pred             ccccccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecC
Q psy8260          57 PYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSN  136 (427)
Q Consensus        57 ~~~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~  136 (427)
                      ..+++....|.+.+.||+|+||.||.+. +..+++.||||.+......   .+.+.+|+.+|++++|||||++++++...
T Consensus       213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~  288 (495)
T 1opk_A          213 DKWEMERTDITMKHKLGGGQYGEVYEGV-WKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTRE  288 (495)
T ss_dssp             SCCBCCGGGEEEEEESGGGTTSSEEEEE-EGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cccccCHHHceeeeEecCCCCeEEEEEE-EcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            3457778889999999999999999754 4567899999998754332   45688999999999999999999998643


Q ss_pred             ccccCCceEEEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeC
Q psy8260         137 TCLADFKNVYMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDF  212 (427)
Q Consensus       137 ~~~~~~~~~~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DF  212 (427)
                            ..+|++||++ +++|.++++.   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus       289 ------~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DF  362 (495)
T 1opk_A          289 ------PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADF  362 (495)
T ss_dssp             ------SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCT
T ss_pred             ------CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeec
Confidence                  4578999988 6899999864   45899999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccc
Q psy8260         213 GLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWY  292 (427)
Q Consensus       213 Gla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y  292 (427)
                      |+++........                                                         ...+..+|+.|
T Consensus       363 G~a~~~~~~~~~---------------------------------------------------------~~~~~~~~~~y  385 (495)
T 1opk_A          363 GLSRLMTGDTYT---------------------------------------------------------AHAGAKFPIKW  385 (495)
T ss_dssp             TCEECCTTCCEE---------------------------------------------------------CCTTCCCCGGG
T ss_pred             ccceeccCCcee---------------------------------------------------------ecCCCcCCcce
Confidence            998754321100                                                         11123456788


Q ss_pred             cchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCC
Q psy8260         293 RAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLEL  371 (427)
Q Consensus       293 ~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~  371 (427)
                      +|||++.+..+..++|+||+|++++.|.+ +..+|....... ....+......      ......++++.+||.+||+.
T Consensus       386 ~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~  458 (495)
T 1opk_A          386 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKDYRM------ERPEGCPEKVYELMRACWQW  458 (495)
T ss_dssp             CCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-HHHHHHTTCCC------CCCTTCCHHHHHHHHHHTCS
T ss_pred             eCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCCCC------CCCCCCCHHHHHHHHHHcCc
Confidence            88888887777778899999999987744 333343222122 22222211111      11235678999999999999


Q ss_pred             CCCCCCCHHHHhc
Q psy8260         372 DSEKRITAEQALA  384 (427)
Q Consensus       372 dP~~R~ta~e~L~  384 (427)
                      ||.+|||++|+++
T Consensus       459 dP~~RPs~~el~~  471 (495)
T 1opk_A          459 NPSDRPSFAEIHQ  471 (495)
T ss_dssp             SGGGSCCHHHHHH
T ss_pred             ChhHCcCHHHHHH
Confidence            9999999999986

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=7.6e-39  Score=308.63  Aligned_cols=263  Identities=17%  Similarity=0.203  Sum_probs=189.9

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEeC--cCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecC
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALDS--VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSN  136 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~  136 (427)
                      ..+..+.|.+++.||+|+||.||.+....  .+++.||||++..........+.+.+|+.++++++||||+++++++...
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            35567889999999999999999875543  3567899999976655666667788999999999999999999998654


Q ss_pred             ccccCCceEEEEeccC-CCCHHHHHhh-------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEE
Q psy8260         137 TCLADFKNVYMVTHLM-GADLNNILRT-------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELK  208 (427)
Q Consensus       137 ~~~~~~~~~~lv~e~~-g~~L~~~l~~-------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~k  208 (427)
                      ... .....+++++++ +++|.+++..       ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus       109 ~~~-~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~k  187 (313)
T 3brb_A          109 SSQ-GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVC  187 (313)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEE
T ss_pred             ccc-CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEE
Confidence            221 112457888887 6799998732       4589999999999999999999999999999999999999999999


Q ss_pred             EeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccc
Q psy8260         209 ILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVA  288 (427)
Q Consensus       209 l~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~g  288 (427)
                      |+|||+++.........                                                        ......+
T Consensus       188 l~Dfg~~~~~~~~~~~~--------------------------------------------------------~~~~~~~  211 (313)
T 3brb_A          188 VADFGLSKKIYSGDYYR--------------------------------------------------------QGRIAKM  211 (313)
T ss_dssp             ECSCSCC------------------------------------------------------------------------C
T ss_pred             EeecCcceecccccccC--------------------------------------------------------cccccCC
Confidence            99999987532211000                                                        0011235


Q ss_pred             cccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHH
Q psy8260         289 TRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSL  367 (427)
Q Consensus       289 t~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~  367 (427)
                      ++.|+|||++.+..+..++|+||+|++++.|.+ +..+|..................       ......++++.+||.+
T Consensus       212 ~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~  284 (313)
T 3brb_A          212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL-------KQPEDCLDELYEIMYS  284 (313)
T ss_dssp             CGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC-------CCBTTCCHHHHHHHHH
T ss_pred             CccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCC-------CCCccccHHHHHHHHH
Confidence            778888888887777778899999999987755 44444332222222222221111       1124567899999999


Q ss_pred             hcCCCCCCCCCHHHHhcC
Q psy8260         368 MLELDSEKRITAEQALAH  385 (427)
Q Consensus       368 mL~~dP~~R~ta~e~L~H  385 (427)
                      ||+.||.+|||++|+++|
T Consensus       285 ~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          285 CWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             TTCSSGGGSCCHHHHHHH
T ss_pred             HcCCChhhCcCHHHHHHH
Confidence            999999999999999875

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=7e-39  Score=304.91  Aligned_cols=252  Identities=21%  Similarity=0.266  Sum_probs=186.6

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHH--H---HHHHHHHHHHhcCCCCCceeeeeeee
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVH--A---KRTYRELRMLKHMNHENVIGLLDVFH  134 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~--~---~~~~~Ei~~l~~l~HpnIv~l~~~~~  134 (427)
                      .+..+.|.+.+.||+|+||.||. +.+..+++.||||++.........  .   +.+.+|+.++++++||||+++++++.
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   93 (287)
T 4f0f_A           15 TLADNEIEYEKQIGKGGFGLVHK-GRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH   93 (287)
T ss_dssp             BCCSTTEEEEEECCCCSSSCEEE-EEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred             hhhhccceehhccccCCceeEEE-EEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence            45567899999999999999996 456678999999998654322211  1   56789999999999999999999985


Q ss_pred             cCccccCCceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcC--ceeccCCCCCeEEcCCCC---
Q psy8260         135 SNTCLADFKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCE---  206 (427)
Q Consensus       135 ~~~~~~~~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~--iiHrDLKp~NILl~~~~~---  206 (427)
                      ..        .+++++++ +++|.+.+..  ..+++..+..++.|++.||.|||++|  |+||||||+|||++.++.   
T Consensus        94 ~~--------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~  165 (287)
T 4f0f_A           94 NP--------PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAP  165 (287)
T ss_dssp             TT--------TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCS
T ss_pred             CC--------CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCc
Confidence            43        25788877 6899887743  46999999999999999999999999  999999999999987776   


Q ss_pred             --EEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccc
Q psy8260         207 --LKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMT  284 (427)
Q Consensus       207 --~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~  284 (427)
                        +||+|||+++..........||+.|+|||++.+                                             
T Consensus       166 ~~~kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~---------------------------------------------  200 (287)
T 4f0f_A          166 VCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGA---------------------------------------------  200 (287)
T ss_dssp             CCEEECCCTTCBCCSSCEECCCCCCTTSCGGGSSC---------------------------------------------
T ss_pred             eeEEeCCCCccccccccccccCCCccccCchhhcc---------------------------------------------
Confidence              999999999765544444556666666665421                                             


Q ss_pred             cccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHH-HHHHhcCCCCCcccHHhhcCCCChhHHH
Q psy8260         285 GYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSA-RKYINSLPLLTKKDFRQVFKGANPQAID  363 (427)
Q Consensus       285 ~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~d  363 (427)
                                    ....+..++|+||+|++++.|.++..+|......... ...........     ......++++.+
T Consensus       201 --------------~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~  261 (287)
T 4f0f_A          201 --------------EEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP-----TIPEDCPPRLRN  261 (287)
T ss_dssp             --------------SSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCC-----CCCTTSCHHHHH
T ss_pred             --------------CCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCC-----CCCcccCHHHHH
Confidence                          1112344579999999998886555555433222211 11111111100     122456889999


Q ss_pred             HHHHhcCCCCCCCCCHHHHhc
Q psy8260         364 LLSLMLELDSEKRITAEQALA  384 (427)
Q Consensus       364 Li~~mL~~dP~~R~ta~e~L~  384 (427)
                      ||.+||+.||.+|||++|+++
T Consensus       262 li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          262 VIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcCChhhCcCHHHHHH
Confidence            999999999999999999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-39  Score=313.54  Aligned_cols=251  Identities=22%  Similarity=0.338  Sum_probs=182.4

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH----HHHHHHHHHHHHHhcC----CCCCceeeee
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA----VHAKRTYRELRMLKHM----NHENVIGLLD  131 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~----~~~~~~~~Ei~~l~~l----~HpnIv~l~~  131 (427)
                      +...+.|.+.+.||+|+||.||. +.+..+|+.||||++.......    .....+.+|+.+++++    +||||+++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFA-GHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEE-EECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEE-EEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            44567899999999999999996 5567789999999986543222    1222345799999888    8999999999


Q ss_pred             eeecCccccCCceEEEEecc-C-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEc-CCCCE
Q psy8260         132 VFHSNTCLADFKNVYMVTHL-M-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN-EDCEL  207 (427)
Q Consensus       132 ~~~~~~~~~~~~~~~lv~e~-~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~-~~~~~  207 (427)
                      ++...      ...++++++ + +++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++ .++.+
T Consensus       106 ~~~~~------~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~  179 (312)
T 2iwi_A          106 WFETQ------EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCA  179 (312)
T ss_dssp             EC-----------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEE
T ss_pred             EEecC------CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeE
Confidence            98653      345667765 3 7899988864 5699999999999999999999999999999999999999 78999


Q ss_pred             EEeeCCCCCCCCCC-cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccc
Q psy8260         208 KILDFGLARPTENE-MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGY  286 (427)
Q Consensus       208 kl~DFGla~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~  286 (427)
                      ||+|||+++..... ..                                                             ..
T Consensus       180 kl~dfg~~~~~~~~~~~-------------------------------------------------------------~~  198 (312)
T 2iwi_A          180 KLIDFGSGALLHDEPYT-------------------------------------------------------------DF  198 (312)
T ss_dssp             EECCCSSCEECCSSCBC-------------------------------------------------------------CC
T ss_pred             EEEEcchhhhcccCccc-------------------------------------------------------------cc
Confidence            99999998643321 11                                                             22


Q ss_pred             cccccccchHHhhhccCCC-CCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHH
Q psy8260         287 VATRWYRAPEIMLNWMHYN-QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLL  365 (427)
Q Consensus       287 ~gt~~Y~APEvl~~~~~~~-~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi  365 (427)
                      .||+.|+|||++.+..+.. ++|+||+|++++.+.++..+|...      .........        .....++++.+||
T Consensus       199 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~~~~~~~--------~~~~~~~~~~~li  264 (312)
T 2iwi_A          199 DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAELH--------FPAHVSPDCCALI  264 (312)
T ss_dssp             CSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHTCCC--------CCTTSCHHHHHHH
T ss_pred             CCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh------HHHhhhccC--------CcccCCHHHHHHH
Confidence            3566666666665544443 579999999998775554444211      111111111        1234688999999


Q ss_pred             HHhcCCCCCCCCCHHHHhcCCCCCCCC
Q psy8260         366 SLMLELDSEKRITAEQALAHPYLSQYS  392 (427)
Q Consensus       366 ~~mL~~dP~~R~ta~e~L~Hp~f~~~~  392 (427)
                      .+||+.||++|||++|+++||||....
T Consensus       265 ~~~l~~~p~~Rps~~e~l~~~~~~~~~  291 (312)
T 2iwi_A          265 RRCLAPKPSSRPSLEEILLDPWMQTPA  291 (312)
T ss_dssp             HHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred             HHHccCChhhCcCHHHHhcChhhcCch
Confidence            999999999999999999999998643

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.8e-39  Score=319.19  Aligned_cols=257  Identities=21%  Similarity=0.290  Sum_probs=185.4

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEe--CcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecC
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALD--SVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSN  136 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~--~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~  136 (427)
                      .++....|.+.+.||+|+||.||.+...  ..++..||||++... ......+.+.+|+.+|++++||||+++++++...
T Consensus        40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  118 (373)
T 2qol_A           40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS  118 (373)
T ss_dssp             CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence            3566678999999999999999976543  246788999998654 2455566788999999999999999999998643


Q ss_pred             ccccCCceEEEEeccC-CCCHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCC
Q psy8260         137 TCLADFKNVYMVTHLM-GADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG  213 (427)
Q Consensus       137 ~~~~~~~~~~lv~e~~-g~~L~~~l~~~--~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFG  213 (427)
                            ..+++++|++ +++|.++++..  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus       119 ------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  192 (373)
T 2qol_A          119 ------KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFG  192 (373)
T ss_dssp             ------SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred             ------CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCc
Confidence                  4578999988 78999998753  59999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccccc
Q psy8260         214 LARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR  293 (427)
Q Consensus       214 la~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~  293 (427)
                      +++..........                                                       ...+..+|+.|+
T Consensus       193 ~a~~~~~~~~~~~-------------------------------------------------------~~~~~~~~~~y~  217 (373)
T 2qol_A          193 LGRVLEDDPEAAY-------------------------------------------------------TTRGGKIPIRWT  217 (373)
T ss_dssp             ----------------------------------------------------------------------------CTTS
T ss_pred             cccccccCCccce-------------------------------------------------------eccCCCcCCCcc
Confidence            9875432110000                                                       011223577889


Q ss_pred             chHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         294 APEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       294 APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                      |||++.+..+..++|+||+|++++.+.+ +..||................ ..      ......++++.+||.+||+.|
T Consensus       218 aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~-~~------~~~~~~~~~l~~li~~cl~~d  290 (373)
T 2qol_A          218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY-RL------PPPMDCPAALYQLMLDCWQKD  290 (373)
T ss_dssp             CHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE-EC------CCCTTCBHHHHHHHHHHTCSS
T ss_pred             ChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CC------CCCccccHHHHHHHHHHhCcC
Confidence            9998888777778899999999987533 444454322111111111110 00      011245678999999999999


Q ss_pred             CCCCCCHHHHhc
Q psy8260         373 SEKRITAEQALA  384 (427)
Q Consensus       373 P~~R~ta~e~L~  384 (427)
                      |.+|||++|+++
T Consensus       291 p~~RPs~~~i~~  302 (373)
T 2qol_A          291 RNNRPKFEQIVS  302 (373)
T ss_dssp             GGGSCCHHHHHH
T ss_pred             hhhCcCHHHHHH
Confidence            999999999865

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.6e-39  Score=302.01  Aligned_cols=251  Identities=20%  Similarity=0.267  Sum_probs=192.5

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      .+....|.+.+.||+|+||.||.+..  .+++.||+|++.......   +.+.+|+++++.++||||+++++++...   
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~---   75 (267)
T 3t9t_A            4 VIDPSELTFVQEIGSGQFGLVHLGYW--LNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQ---   75 (267)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEE--TTTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSS---
T ss_pred             EEchhheeeeeEecCCCceeEEEEEe--cCCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccC---
Confidence            45667899999999999999997654  267889999997654332   4578999999999999999999998653   


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                         ...+++++++ +++|.+++..  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++
T Consensus        76 ---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~  152 (267)
T 3t9t_A           76 ---APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR  152 (267)
T ss_dssp             ---SSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGG
T ss_pred             ---CCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccc
Confidence               3578899988 6799998875  358999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         217 PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       217 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      .......                                                         ....+..||+.|+|||
T Consensus       153 ~~~~~~~---------------------------------------------------------~~~~~~~~~~~y~aPE  175 (267)
T 3t9t_A          153 FVLDDQY---------------------------------------------------------TSSTGTKFPVKWASPE  175 (267)
T ss_dssp             GBCCHHH---------------------------------------------------------HSTTSTTCCGGGCCHH
T ss_pred             ccccccc---------------------------------------------------------cccccccccccccChh
Confidence            4321100                                                         0111234677888999


Q ss_pred             HhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCC
Q psy8260         297 IMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEK  375 (427)
Q Consensus       297 vl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~  375 (427)
                      ++.+..+..++|+||+|++++.|.+ +..+|...................       .....++++.+||.+||+.||.+
T Consensus       176 ~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~  248 (267)
T 3t9t_A          176 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-------KPRLASTHVYQIMNHCWRERPED  248 (267)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-------CCTTSCHHHHHHHHHHTCSSGGG
T ss_pred             hhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCC-------CCccCcHHHHHHHHHHccCChhh
Confidence            8887777777899999999987755 444443322122222222111111       11245788999999999999999


Q ss_pred             CCCHHHHhcC
Q psy8260         376 RITAEQALAH  385 (427)
Q Consensus       376 R~ta~e~L~H  385 (427)
                      |||++|++++
T Consensus       249 Rps~~~ll~~  258 (267)
T 3t9t_A          249 RPAFSRLLRQ  258 (267)
T ss_dssp             SCCHHHHHHH
T ss_pred             CcCHHHHHHH
Confidence            9999999875

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=5.9e-39  Score=302.09  Aligned_cols=249  Identities=16%  Similarity=0.209  Sum_probs=189.1

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      ++..+.|.+.+.||+|+||.||.+..   +|..||||++..........+.+.+|+.++++++||||+++++++....  
T Consensus         6 ~i~~~~y~~~~~lg~G~~g~V~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--   80 (271)
T 3kmu_A            6 GIDFKQLNFLTKLNENHSGELWKGRW---QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP--   80 (271)
T ss_dssp             CCCGGGCEEEEEEEEETTEEEEEEEE---TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT--
T ss_pred             CCCHHHhHHHHHhcCCCcceEEEEEE---CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC--
Confidence            45567899999999999999997654   3889999999876656666777889999999999999999999986531  


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhcC--ceeccCCCCCeEEcCCCCEEEeeCC
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFG  213 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~~---~l~~~~~~~~~~qi~~aL~yLH~~~--iiHrDLKp~NILl~~~~~~kl~DFG  213 (427)
                        ....+++++++ +++|.+++...   .+++..+..++.|++.||.|||++|  |+||||||+|||++.++.++|+|||
T Consensus        81 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~  158 (271)
T 3kmu_A           81 --APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMAD  158 (271)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGG
T ss_pred             --CCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecc
Confidence              24568888888 67999999764   3899999999999999999999999  9999999999999999999999988


Q ss_pred             CCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccccc
Q psy8260         214 LARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR  293 (427)
Q Consensus       214 la~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~  293 (427)
                      ++.....  ...                                                             .||+.|+
T Consensus       159 ~~~~~~~--~~~-------------------------------------------------------------~~t~~y~  175 (271)
T 3kmu_A          159 VKFSFQS--PGR-------------------------------------------------------------MYAPAWV  175 (271)
T ss_dssp             SCCTTSC--TTC-------------------------------------------------------------BSCGGGS
T ss_pred             ceeeecc--cCc-------------------------------------------------------------cCCcccc
Confidence            7643211  112                                                             3455555


Q ss_pred             chHHhhhccCCC---CCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcC
Q psy8260         294 APEIMLNWMHYN---QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLE  370 (427)
Q Consensus       294 APEvl~~~~~~~---~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~  370 (427)
                      |||++.+.....   ++|+||+|++++.+.++..||...................      ......++++.+||.+||+
T Consensus       176 aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~  249 (271)
T 3kmu_A          176 APEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP------TIPPGISPHVSKLMKICMN  249 (271)
T ss_dssp             CHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC------CCCTTCCHHHHHHHHHHTC
T ss_pred             ChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC------CCCCCCCHHHHHHHHHHcC
Confidence            555555443333   4799999999988855555554322112212222111110      1224578899999999999


Q ss_pred             CCCCCCCCHHHHhc
Q psy8260         371 LDSEKRITAEQALA  384 (427)
Q Consensus       371 ~dP~~R~ta~e~L~  384 (427)
                      .||.+|||++|+++
T Consensus       250 ~~p~~Rps~~~il~  263 (271)
T 3kmu_A          250 EDPAKRPKFDMIVP  263 (271)
T ss_dssp             SSGGGSCCHHHHHH
T ss_pred             CChhhCcCHHHHHH
Confidence            99999999999986

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.5e-39  Score=314.54  Aligned_cols=255  Identities=18%  Similarity=0.193  Sum_probs=184.3

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCc----EEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeec
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGV----KVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHS  135 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~----~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~  135 (427)
                      .+..+.|.+.+.||+|+||.||++. +..+|+    +||+|.+... ......+.+.+|+.++++++||||+++++++..
T Consensus        11 ~l~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   88 (327)
T 3poz_A           11 ILKETEFKKIKVLGSGAFGTVYKGL-WIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLT   88 (327)
T ss_dssp             ECCGGGEEEEEEEEEETTEEEEEEE-ECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred             hcCHHHcccceEEeeCCCeEEEEEE-EcCCCceEEEEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence            3456789999999999999999754 444554    4688877543 223334668899999999999999999999865


Q ss_pred             CccccCCceEEEEeccCCCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCC
Q psy8260         136 NTCLADFKNVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG  213 (427)
Q Consensus       136 ~~~~~~~~~~~lv~e~~g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFG  213 (427)
                      .      ...++++++.+++|.+++..  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        89 ~------~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg  162 (327)
T 3poz_A           89 S------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG  162 (327)
T ss_dssp             S------SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTT
T ss_pred             C------CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCc
Confidence            3      23345555558899998865  469999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccccc
Q psy8260         214 LARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR  293 (427)
Q Consensus       214 la~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~  293 (427)
                      +++........                                                        ....+..||+.|+
T Consensus       163 ~a~~~~~~~~~--------------------------------------------------------~~~~~~~~t~~y~  186 (327)
T 3poz_A          163 LAKLLGAEEKE--------------------------------------------------------YHAEGGKVPIKWM  186 (327)
T ss_dssp             HHHHHTTTCC---------------------------------------------------------------CCCGGGS
T ss_pred             ceeEccCCccc--------------------------------------------------------ccccCCCcccccc
Confidence            98643211100                                                        0112234678899


Q ss_pred             chHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         294 APEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       294 APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                      |||++.+..+..++|+||+|++++.+.+ +..+|...... .............      .....++++.+||.+||+.|
T Consensus       187 aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~  259 (327)
T 3poz_A          187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EISSILEKGERLP------QPPICTIDVYMIMVKCWMID  259 (327)
T ss_dssp             CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHHHHHTTCCCC------CCTTBCHHHHHHHHHHTCSC
T ss_pred             ChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH-HHHHHHHcCCCCC------CCccCCHHHHHHHHHHcCCC
Confidence            9998888778888899999999987655 55555432222 2222222211111      12345788999999999999


Q ss_pred             CCCCCCHHHHhcC
Q psy8260         373 SEKRITAEQALAH  385 (427)
Q Consensus       373 P~~R~ta~e~L~H  385 (427)
                      |.+|||++|+++|
T Consensus       260 p~~Rps~~ell~~  272 (327)
T 3poz_A          260 ADSRPKFRELIIE  272 (327)
T ss_dssp             GGGSCCHHHHHHH
T ss_pred             hhhCCCHHHHHHH
Confidence            9999999999876

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=6.7e-39  Score=325.56  Aligned_cols=252  Identities=21%  Similarity=0.272  Sum_probs=193.2

Q ss_pred             ccccccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecC
Q psy8260          57 PYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSN  136 (427)
Q Consensus        57 ~~~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~  136 (427)
                      ..+++....|.+.+.||+|+||.||.+...  ++..||||++.....   ..+.+.+|+++|+.++|||||++++++.. 
T Consensus       181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-  254 (454)
T 1qcf_A          181 DAWEIPRESLKLEKKLGAGQFGEVWMATYN--KHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVTK-  254 (454)
T ss_dssp             TCSBCCGGGEEEEEEEECCSSEEEEEEEET--TTEEEEEEEECTTSB---CHHHHHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred             cceeechHHeEEEEEcccCCceEEEEEEEC--CccEEEEEEecCCCc---cHHHHHHHHHHHhhCCCCCEeeEEEEEeC-
Confidence            446788889999999999999999987653  477899999875432   24568899999999999999999998753 


Q ss_pred             ccccCCceEEEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeC
Q psy8260         137 TCLADFKNVYMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDF  212 (427)
Q Consensus       137 ~~~~~~~~~~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DF  212 (427)
                            ..+|++||++ +++|.++++.   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus       255 ------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DF  328 (454)
T 1qcf_A          255 ------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADF  328 (454)
T ss_dssp             ------SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECST
T ss_pred             ------CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeC
Confidence                  3468899988 7899999864   36899999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccc
Q psy8260         213 GLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWY  292 (427)
Q Consensus       213 Gla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y  292 (427)
                      |+++........                                                         ...+..+|+.|
T Consensus       329 G~a~~~~~~~~~---------------------------------------------------------~~~~~~~~~~y  351 (454)
T 1qcf_A          329 GLARVIEDNEYT---------------------------------------------------------AREGAKFPIKW  351 (454)
T ss_dssp             TGGGGBCCHHHH---------------------------------------------------------TTCSSSSCGGG
T ss_pred             CCceEcCCCcee---------------------------------------------------------ccCCCcccccc
Confidence            998753221000                                                         01123457788


Q ss_pred             cchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCC
Q psy8260         293 RAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLEL  371 (427)
Q Consensus       293 ~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~  371 (427)
                      +|||++....+..++|+||+|++++.+.+ +..||......+......... ..+      .....++++.+||.+||+.
T Consensus       352 ~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~-~~~------~~~~~~~~l~~li~~cl~~  424 (454)
T 1qcf_A          352 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY-RMP------RPENCPEELYNIMMRCWKN  424 (454)
T ss_dssp             SCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC-CCC------CCTTSCHHHHHHHHHHTCS
T ss_pred             cCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCC------CCCCCCHHHHHHHHHHccC
Confidence            88888887777778899999999987654 444443221111222221111 111      1234678999999999999


Q ss_pred             CCCCCCCHHHHhc
Q psy8260         372 DSEKRITAEQALA  384 (427)
Q Consensus       372 dP~~R~ta~e~L~  384 (427)
                      ||.+|||++++++
T Consensus       425 dp~~RPt~~~i~~  437 (454)
T 1qcf_A          425 RPEERPTFEYIQS  437 (454)
T ss_dssp             SGGGSCCHHHHHH
T ss_pred             ChhHCcCHHHHHH
Confidence            9999999999875

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-38  Score=302.89  Aligned_cols=258  Identities=17%  Similarity=0.226  Sum_probs=194.2

Q ss_pred             cccCcceeecc-ccCcccccEEEEeEE-eCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCc
Q psy8260          60 EICRGVIDIGP-TLSKESFDLIFSSAL-DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNT  137 (427)
Q Consensus        60 ~~~~~~~~~~~-~lg~g~fg~v~~~~~-~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~  137 (427)
                      .+..+.+.+.. .||+|+||.||.+.. ...+++.||||++... ......+.+.+|+++++.++||||+++++++..  
T Consensus         5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--   81 (287)
T 1u59_A            5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--   81 (287)
T ss_dssp             BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred             cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC--
Confidence            34456677766 999999999998754 3457889999998754 345556778899999999999999999999843  


Q ss_pred             cccCCceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCC
Q psy8260         138 CLADFKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL  214 (427)
Q Consensus       138 ~~~~~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGl  214 (427)
                           ...+++++++ +++|.+++..  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        82 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~  156 (287)
T 1u59_A           82 -----EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGL  156 (287)
T ss_dssp             -----SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred             -----CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccc
Confidence                 2478888888 6799998853  4599999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccc
Q psy8260         215 ARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRA  294 (427)
Q Consensus       215 a~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~A  294 (427)
                      ++.........                                                       .......||+.|+|
T Consensus       157 ~~~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~y~a  181 (287)
T 1u59_A          157 SKALGADDSYY-------------------------------------------------------TARSAGKWPLKWYA  181 (287)
T ss_dssp             CEECTTCSCEE-------------------------------------------------------CCCCSSCCCGGGCC
T ss_pred             eeeeccCccee-------------------------------------------------------eccccccccccccC
Confidence            87543211000                                                       00112346788888


Q ss_pred             hHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCC
Q psy8260         295 PEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDS  373 (427)
Q Consensus       295 PEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP  373 (427)
                      ||++.+..+..++|+||+|++++.+.+ +..+|......... ..+......      ......++++.+||.+||+.||
T Consensus       182 PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-~~i~~~~~~------~~~~~~~~~l~~li~~~l~~~p  254 (287)
T 1u59_A          182 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-AFIEQGKRM------ECPPECPPELYALMSDCWIYKW  254 (287)
T ss_dssp             HHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH-HHHHTTCCC------CCCTTCCHHHHHHHHHTTCSSG
T ss_pred             HHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH-HHHhcCCcC------CCCCCcCHHHHHHHHHHcCCCh
Confidence            888887777778899999999987654 55555433222222 222211110      1124578899999999999999


Q ss_pred             CCCCCHHHHhcCCC
Q psy8260         374 EKRITAEQALAHPY  387 (427)
Q Consensus       374 ~~R~ta~e~L~Hp~  387 (427)
                      .+|||++|+++|.+
T Consensus       255 ~~Rps~~~l~~~l~  268 (287)
T 1u59_A          255 EDRPDFLTVEQRMR  268 (287)
T ss_dssp             GGSCCHHHHHHHHH
T ss_pred             hhCcCHHHHHHHHH
Confidence            99999999998843

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.9e-39  Score=314.97  Aligned_cols=254  Identities=15%  Similarity=0.139  Sum_probs=186.2

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcE----EEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeec
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVK----VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHS  135 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~----vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~  135 (427)
                      .+....|.+.+.||+|+||.||++. +..+|+.    ||+|.+..... ......+.+|+.+++.++||||+++++++..
T Consensus         9 ~~~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   86 (325)
T 3kex_A            9 IFKETELRKLKVLGSGVFGTVHKGV-WIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG   86 (325)
T ss_dssp             BCCTTTEEEEEEEECCSSCEEEEEE-ECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEECB
T ss_pred             hcCHhHceeeeeeeecCCceEEEEE-EcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence            3456779999999999999999754 4445554    78887753321 1122345689999999999999999998753


Q ss_pred             CccccCCceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeC
Q psy8260         136 NTCLADFKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDF  212 (427)
Q Consensus       136 ~~~~~~~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DF  212 (427)
                             ...+++++++ +++|.+++..  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus        87 -------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Df  159 (325)
T 3kex_A           87 -------SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADF  159 (325)
T ss_dssp             -------SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSC
T ss_pred             -------CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCC
Confidence                   2356677666 7899988865  36899999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccc
Q psy8260         213 GLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWY  292 (427)
Q Consensus       213 Gla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y  292 (427)
                      |+++........                                                        .......||+.|
T Consensus       160 g~a~~~~~~~~~--------------------------------------------------------~~~~~~~~~~~y  183 (325)
T 3kex_A          160 GVADLLPPDDKQ--------------------------------------------------------LLYSEAKTPIKW  183 (325)
T ss_dssp             SGGGGSCCCTTC--------------------------------------------------------CC-----CCTTT
T ss_pred             CcccccCccccc--------------------------------------------------------ccccCCCCcccc
Confidence            998754321100                                                        011223467788


Q ss_pred             cchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCC
Q psy8260         293 RAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLEL  371 (427)
Q Consensus       293 ~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~  371 (427)
                      +|||++.+..+..++|+||+|++++.+.+ +..+|............ .......      .....++++.+||.+||+.
T Consensus       184 ~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~------~~~~~~~~~~~li~~~l~~  256 (325)
T 3kex_A          184 MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL-EKGERLA------QPQICTIDVYMVMVKCWMI  256 (325)
T ss_dssp             SCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH-HTTCBCC------CCTTBCTTTTHHHHHHTCS
T ss_pred             cChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH-HcCCCCC------CCCcCcHHHHHHHHHHcCC
Confidence            88888887777778899999999987655 55555443322222222 2111110      1123577889999999999


Q ss_pred             CCCCCCCHHHHhcC
Q psy8260         372 DSEKRITAEQALAH  385 (427)
Q Consensus       372 dP~~R~ta~e~L~H  385 (427)
                      ||.+|||++|+++|
T Consensus       257 dp~~Rps~~el~~~  270 (325)
T 3kex_A          257 DENIRPTFKELANE  270 (325)
T ss_dssp             CTTTSCCHHHHHHH
T ss_pred             ChhhCcCHHHHHHH
Confidence            99999999999987

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.2e-39  Score=314.64  Aligned_cols=261  Identities=18%  Similarity=0.234  Sum_probs=192.5

Q ss_pred             ccccCcceeeccccCcccccEEEEeEE----eCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeee
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSAL----DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFH  134 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~  134 (427)
                      .++..+.|.+.+.||+|+||.||.+..    +..+++.||||++... .......++.+|+.+++.++||||+++++++.
T Consensus        25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  103 (327)
T 2yfx_A           25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSL  103 (327)
T ss_dssp             CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence            356678899999999999999997653    4567889999998643 34455667889999999999999999999986


Q ss_pred             cCccccCCceEEEEeccC-CCCHHHHHhhC--------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcC--
Q psy8260         135 SNTCLADFKNVYMVTHLM-GADLNNILRTQ--------KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE--  203 (427)
Q Consensus       135 ~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~--------~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~--  203 (427)
                      ..      ...|++++++ +++|.+++...        .+++..+..++.|++.||.|||++||+||||||+|||++.  
T Consensus       104 ~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~  177 (327)
T 2yfx_A          104 QS------LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG  177 (327)
T ss_dssp             SS------SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS
T ss_pred             CC------CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCC
Confidence            53      3468899988 78999998753        3899999999999999999999999999999999999984  


Q ss_pred             -CCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccc
Q psy8260         204 -DCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENE  282 (427)
Q Consensus       204 -~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~  282 (427)
                       +..+||+|||+++........                                                        ..
T Consensus       178 ~~~~~kl~Dfg~~~~~~~~~~~--------------------------------------------------------~~  201 (327)
T 2yfx_A          178 PGRVAKIGDFGMARDIYRASYY--------------------------------------------------------RK  201 (327)
T ss_dssp             TTCCEEECCCHHHHHHHC--------------------------------------------------------------
T ss_pred             CcceEEECcccccccccccccc--------------------------------------------------------cc
Confidence             456999999987532110000                                                        00


Q ss_pred             cccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhH
Q psy8260         283 MTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQA  361 (427)
Q Consensus       283 ~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  361 (427)
                      .....||+.|+|||++.+..+..++|+||+|++++.|.+ +..+|..... .............      ......++++
T Consensus       202 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-~~~~~~~~~~~~~------~~~~~~~~~l  274 (327)
T 2yfx_A          202 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTSGGRM------DPPKNCPGPV  274 (327)
T ss_dssp             CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHHHHHHHTTCCC------CCCTTCCHHH
T ss_pred             CCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH-HHHHHHHhcCCCC------CCCCCCCHHH
Confidence            112346788888888877777778899999999987654 4334432211 1111111111111      1123567899


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q psy8260         362 IDLLSLMLELDSEKRITAEQALAHPYLS  389 (427)
Q Consensus       362 ~dLi~~mL~~dP~~R~ta~e~L~Hp~f~  389 (427)
                      .+||.+||+.||.+|||++|+++|.|+.
T Consensus       275 ~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          275 YRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            9999999999999999999999999875

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-38  Score=302.98  Aligned_cols=256  Identities=18%  Similarity=0.235  Sum_probs=189.4

Q ss_pred             cceeeccccCcccccEEEEeEEe--CcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccC
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALD--SVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~--~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      ..|.+++.||+|+||.||.+...  ..++..||+|.+... ......+.+.+|+.+++.++||||+++++++....    
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----   95 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE----   95 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC----
Confidence            35677899999999999976542  234457999998653 34455677889999999999999999999986432    


Q ss_pred             CceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCC
Q psy8260         142 FKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT  218 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~  218 (427)
                       ...+++++++ +++|.+++..  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        96 -~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  174 (298)
T 3pls_A           96 -GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDI  174 (298)
T ss_dssp             -SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred             -CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence             2335666665 8899999875  56899999999999999999999999999999999999999999999999998754


Q ss_pred             CCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         219 ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       219 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                      .......                                                      ........||+.|+|||++
T Consensus       175 ~~~~~~~------------------------------------------------------~~~~~~~~~~~~y~aPE~~  200 (298)
T 3pls_A          175 LDREYYS------------------------------------------------------VQQHRHARLPVKWTALESL  200 (298)
T ss_dssp             TTGGGGC------------------------------------------------------SCCSSCTTCGGGGSCHHHH
T ss_pred             cCCcccc------------------------------------------------------cccCcCCCCCccccChhhh
Confidence            3211000                                                      0011233578889999998


Q ss_pred             hhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC
Q psy8260         299 LNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT  378 (427)
Q Consensus       299 ~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t  378 (427)
                      .+..+..++|+||+|++++.|.++..++....................      .....++++.+||.+||+.||.+|||
T Consensus       201 ~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rps  274 (298)
T 3pls_A          201 QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLP------QPEYCPDSLYQVMQQCWEADPAVRPT  274 (298)
T ss_dssp             TTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             ccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCC------CCccchHHHHHHHHHHccCChhhCcC
Confidence            887777788999999999877442222222222222222222211111      12346789999999999999999999


Q ss_pred             HHHHhcC
Q psy8260         379 AEQALAH  385 (427)
Q Consensus       379 a~e~L~H  385 (427)
                      ++|+++.
T Consensus       275 ~~~ll~~  281 (298)
T 3pls_A          275 FRVLVGE  281 (298)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9998763

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.8e-39  Score=313.05  Aligned_cols=259  Identities=19%  Similarity=0.252  Sum_probs=190.0

Q ss_pred             cCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccC
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      ..+.|++.+.||+|+||.||.+..  .+|+.||||++.....  ...+.+.+|+.+++.++||||+++++++...     
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----  107 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVL--RDGAKVALKRRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFCDER-----  107 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEEC--TTCCEEEEEECCSCCS--SHHHHHHHHHHGGGSCCCTTBCCEEEECCCT-----
T ss_pred             HHhccCccceeecCCCeeEEEEEE--CCCCEEEEEEecccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-----
Confidence            456789999999999999997653  4689999998865432  3355678999999999999999999997643     


Q ss_pred             CceEEEEeccC-CCCHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         142 FKNVYMVTHLM-GADLNNILRTQ-----KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                       ...+++++++ +++|.+++...     .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus       108 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  186 (321)
T 2qkw_B          108 -NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGIS  186 (321)
T ss_dssp             -TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred             -CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccc
Confidence             4568888888 67999887543     4899999999999999999999999999999999999999999999999998


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      +........                                                        .......||+.|+||
T Consensus       187 ~~~~~~~~~--------------------------------------------------------~~~~~~~gt~~y~aP  210 (321)
T 2qkw_B          187 KKGTELDQT--------------------------------------------------------HLSTVVKGTLGYIDP  210 (321)
T ss_dssp             EECSSSSCC--------------------------------------------------------CCBCCCEEETTTCCH
T ss_pred             ccccccccc--------------------------------------------------------ccccccCCCccccCH
Confidence            643211000                                                        011233578888888


Q ss_pred             HHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHH--HHHH---HhcCC---CCCcccH-HhhcCCCChhHHHHHH
Q psy8260         296 EIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDS--ARKY---INSLP---LLTKKDF-RQVFKGANPQAIDLLS  366 (427)
Q Consensus       296 Evl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~--~~~~---~~~~~---~~~~~~~-~~~~~~~s~~~~dLi~  366 (427)
                      |++.+..+..++|+||+|++++.|.++..+|........  ...+   .....   ....... .......++++.+||.
T Consensus       211 E~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  290 (321)
T 2qkw_B          211 EYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAV  290 (321)
T ss_dssp             HHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHH
T ss_pred             HHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHH
Confidence            888877788888999999999887555544432211100  0000   00000   0000000 0011112457889999


Q ss_pred             HhcCCCCCCCCCHHHHhcCC
Q psy8260         367 LMLELDSEKRITAEQALAHP  386 (427)
Q Consensus       367 ~mL~~dP~~R~ta~e~L~Hp  386 (427)
                      +||+.||++|||++|+++|-
T Consensus       291 ~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          291 KCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             HHTCSSGGGSCCHHHHHHHH
T ss_pred             HHcCCCcccCcCHHHHHHHH
Confidence            99999999999999999873

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1e-38  Score=310.46  Aligned_cols=257  Identities=22%  Similarity=0.276  Sum_probs=195.1

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEeCcCC-----cEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeee
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALDSVSG-----VKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDV  132 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g-----~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~  132 (427)
                      .++..+.|.+.+.||+|+||.||.+.. ..++     +.||||.+... ......+.+.+|+.+++.+ +||||++++++
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  118 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATA-FGLGKEDAVLKVAVKMLKST-AHADEKEALMSELKIMSHLGQHENIVNLLGA  118 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEE-TTCSSSCCCCEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEe-cCCCcccchhHHHHHhcccc-cChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            466778899999999999999997653 3333     58999998654 2344556788999999999 89999999999


Q ss_pred             eecCccccCCceEEEEeccC-CCCHHHHHhh---------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCC
Q psy8260         133 FHSNTCLADFKNVYMVTHLM-GADLNNILRT---------------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKP  196 (427)
Q Consensus       133 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~---------------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp  196 (427)
                      +...      ..+|++++++ +++|.+++..               ..+++..+..++.|++.||.|||++||+||||||
T Consensus       119 ~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp  192 (333)
T 2i1m_A          119 CTHG------GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAA  192 (333)
T ss_dssp             ECSS------SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred             EecC------CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCccc
Confidence            8653      3578899988 6799988753               3579999999999999999999999999999999


Q ss_pred             CCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCC
Q psy8260         197 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLA  276 (427)
Q Consensus       197 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~  276 (427)
                      +|||++.++.+||+|||+++........                                                    
T Consensus       193 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~----------------------------------------------------  220 (333)
T 2i1m_A          193 RNVLLTNGHVAKIGDFGLARDIMNDSNY----------------------------------------------------  220 (333)
T ss_dssp             GGCEEEGGGEEEBCCCGGGCCGGGCTTS----------------------------------------------------
T ss_pred             ceEEECCCCeEEECccccccccccccce----------------------------------------------------
Confidence            9999999999999999998643221100                                                    


Q ss_pred             CCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcC
Q psy8260         277 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFK  355 (427)
Q Consensus       277 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (427)
                          .......||+.|+|||++.+..+..++|+||+|++++.|.+ +..+|....................      ...
T Consensus       221 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~------~~~  290 (333)
T 2i1m_A          221 ----IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMA------QPA  290 (333)
T ss_dssp             ----EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCC------CCT
T ss_pred             ----eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCC------CCC
Confidence                01112346788899998887777778899999999988765 4444543332333222222211110      112


Q ss_pred             CCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         356 GANPQAIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       356 ~~s~~~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                      ..++++.+||.+||+.||.+|||++|++++
T Consensus       291 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          291 FAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            357889999999999999999999999874

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.4e-38  Score=302.84  Aligned_cols=254  Identities=19%  Similarity=0.244  Sum_probs=188.4

Q ss_pred             cceeeccccCcccccEEEEeEEeC--cCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccC
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDS--VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      ..|.+.+.||+|+||.||.+....  .++..||+|.+... ......+.+.+|+.++++++||||+++++++...     
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----   98 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-----   98 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS-----
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC-----
Confidence            458899999999999999876432  23456899988653 3445567788999999999999999999985432     


Q ss_pred             CceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCC
Q psy8260         142 FKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT  218 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~  218 (427)
                      ....+++++++ +++|.++++.  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        99 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A           99 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccc
Confidence            23567888888 6699999864  45899999999999999999999999999999999999999999999999998754


Q ss_pred             CCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         219 ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       219 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                      .......                                                      .....+..||+.|+|||++
T Consensus       179 ~~~~~~~------------------------------------------------------~~~~~~~~~~~~y~aPE~~  204 (298)
T 3f66_A          179 YDKEYYS------------------------------------------------------VHNKTGAKLPVKWMALESL  204 (298)
T ss_dssp             SCGGGCB------------------------------------------------------C-----CCBCGGGSCHHHH
T ss_pred             cccchhc------------------------------------------------------cccccCCCCCccccChHHh
Confidence            3211000                                                      0012234578889999999


Q ss_pred             hhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC
Q psy8260         299 LNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI  377 (427)
Q Consensus       299 ~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~  377 (427)
                      .+..+..++|+||+|++++.+.+ ...++....................       ....++++.+||.+||+.||.+||
T Consensus       205 ~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rp  277 (298)
T 3f66_A          205 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ-------PEYCPDPLYEVMLKCWHPKAEMRP  277 (298)
T ss_dssp             HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCC-------CTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred             cCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCC-------CccCCHHHHHHHHHHcCCChhhCc
Confidence            88777778899999999987744 2223332222222222222111111       134578899999999999999999


Q ss_pred             CHHHHhc
Q psy8260         378 TAEQALA  384 (427)
Q Consensus       378 ta~e~L~  384 (427)
                      |++|+++
T Consensus       278 s~~ell~  284 (298)
T 3f66_A          278 SFSELVS  284 (298)
T ss_dssp             CHHHHHH
T ss_pred             CHHHHHH
Confidence            9999886

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.6e-38  Score=308.58  Aligned_cols=258  Identities=18%  Similarity=0.245  Sum_probs=195.3

Q ss_pred             ccCcceeeccccCcccccEEEEeEE---eCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCc
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSAL---DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNT  137 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~---~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~  137 (427)
                      +....|.+.+.||+|+||.||.+..   +..+++.||||++...  .....+.+.+|+++++.++||||+++++++... 
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-   96 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGP-   96 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC-
Confidence            3457899999999999999997664   5678999999998653  445556788999999999999999999987642 


Q ss_pred             cccCCceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCC
Q psy8260         138 CLADFKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL  214 (427)
Q Consensus       138 ~~~~~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGl  214 (427)
                         +...+|+++|++ +++|.+++..  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        97 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  173 (327)
T 3lxl_A           97 ---GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGL  173 (327)
T ss_dssp             ---SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred             ---CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccc
Confidence               235688999988 7899998864  4599999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccc
Q psy8260         215 ARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRA  294 (427)
Q Consensus       215 a~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~A  294 (427)
                      ++.........                                                       .......||+.|+|
T Consensus       174 ~~~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~y~a  198 (327)
T 3lxl_A          174 AKLLPLDKDYY-------------------------------------------------------VVREPGQSPIFWYA  198 (327)
T ss_dssp             CEECCTTCSEE-------------------------------------------------------ECSSCCCSCGGGSC
T ss_pred             ceecccCCccc-------------------------------------------------------eeeccCCccccccC
Confidence            87543211000                                                       01112347778888


Q ss_pred             hHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCc--------------HHHHHHHhcCCCCCcccHHhhcCCCChh
Q psy8260         295 PEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISS--------------DSARKYINSLPLLTKKDFRQVFKGANPQ  360 (427)
Q Consensus       295 PEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~s~~  360 (427)
                      ||++.+..+..++|+||+|++++.+.++..++......              .............      ......+++
T Consensus       199 PE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~  272 (327)
T 3lxl_A          199 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRL------PAPPACPAE  272 (327)
T ss_dssp             HHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCC------CCCTTCCHH
T ss_pred             HHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCC------CCCCcccHH
Confidence            88888777777889999999998886654444321100              0000000000000      112356889


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         361 AIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       361 ~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                      +.+||.+||+.||.+|||++|+++|
T Consensus       273 l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          273 VHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999544

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=7.5e-39  Score=313.51  Aligned_cols=271  Identities=14%  Similarity=0.126  Sum_probs=191.4

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCc---CCcEEEEEEccCcCCCHHH---------HHHHHHHHHHHhcCCCCCce
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSV---SGVKVAIKKIARPFQSAVH---------AKRTYRELRMLKHMNHENVI  127 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~---~g~~vAvK~i~~~~~~~~~---------~~~~~~Ei~~l~~l~HpnIv  127 (427)
                      ++..+.|.+.+.||+|+||.||.+. +..   ++..||||++.........         ...+.+|+..++.++||||+
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~  111 (345)
T 2v62_A           33 DMEGNQWVLGKKIGSGGFGLIYLAF-PTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIP  111 (345)
T ss_dssp             CTTSCEEEEEEEC------CEEEEE-ESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred             cccCceEEEEeeEeecCCeEEEEEE-ecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcc
Confidence            4456789999999999999999754 443   7889999998654221111         12355788999999999999


Q ss_pred             eeeeeeecCccccCCceEEEEeccCCCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCC-
Q psy8260         128 GLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC-  205 (427)
Q Consensus       128 ~l~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~-  205 (427)
                      ++++++....  ......|++||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ 
T Consensus       112 ~~~~~~~~~~--~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~  189 (345)
T 2v62_A          112 LFYGSGLTEF--KGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNP  189 (345)
T ss_dssp             CEEEEEEEES--SSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSST
T ss_pred             eeeccccccc--CCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCC
Confidence            9999986521  22357899999999999998864 3799999999999999999999999999999999999998877 


Q ss_pred             -CEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccc
Q psy8260         206 -ELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMT  284 (427)
Q Consensus       206 -~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~  284 (427)
                       .+||+|||+++........   ..                                                .......
T Consensus       190 ~~~kL~Dfg~a~~~~~~~~~---~~------------------------------------------------~~~~~~~  218 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPNGNH---KQ------------------------------------------------YQENPRK  218 (345)
T ss_dssp             TSEEECCCTTCEESSGGGCC---CC------------------------------------------------CCCCGGG
T ss_pred             CcEEEEeCCCceeccccccc---cc------------------------------------------------chhcccc
Confidence             9999999999754321100   00                                                0000123


Q ss_pred             cccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHH-HHhc-CCCCCcccHHhhcC--CCChh
Q psy8260         285 GYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARK-YINS-LPLLTKKDFRQVFK--GANPQ  360 (427)
Q Consensus       285 ~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~--~~s~~  360 (427)
                      ...||+.|+|||++.+..+..++|+||+|++++.|.++..||........... .... .+.. .........  ..+++
T Consensus       219 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  297 (345)
T 2v62_A          219 GHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDEL-PQSVLKWAPSGSSCCE  297 (345)
T ss_dssp             CSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTT-THHHHHHSCTTSCCHH
T ss_pred             ccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccc-cHHHHhhccccccHHH
Confidence            45689999999999887777788999999999887555555543222211111 1100 0111 111112222  67889


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         361 AIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       361 ~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                      +.+||.+||+.||.+|||++|+++.
T Consensus       298 l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          298 IAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             HHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHHHHHHHhhcCcccCCCHHHHHHH
Confidence            9999999999999999999999875

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.9e-38  Score=302.91  Aligned_cols=256  Identities=17%  Similarity=0.241  Sum_probs=190.6

Q ss_pred             cccCcceeecc-ccCcccccEEEEeEE-eCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCc
Q psy8260          60 EICRGVIDIGP-TLSKESFDLIFSSAL-DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNT  137 (427)
Q Consensus        60 ~~~~~~~~~~~-~lg~g~fg~v~~~~~-~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~  137 (427)
                      .+....|.+.+ .||+|+||.||.+.. +..+++.||||++..........+.+.+|+++++.++||||+++++++..  
T Consensus        12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--   89 (291)
T 1xbb_A           12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA--   89 (291)
T ss_dssp             BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES--
T ss_pred             eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC--
Confidence            45567788888 999999999997653 45678899999987654444446678899999999999999999999743  


Q ss_pred             cccCCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         138 CLADFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       138 ~~~~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                           ...+++++++ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        90 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~  164 (291)
T 1xbb_A           90 -----ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS  164 (291)
T ss_dssp             -----SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             -----CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcc
Confidence                 3468888888 6899998875 45999999999999999999999999999999999999999999999999998


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      +.........                                                       .......||+.|+||
T Consensus       165 ~~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~y~aP  189 (291)
T 1xbb_A          165 KALRADENYY-------------------------------------------------------KAQTHGKWPVKWYAP  189 (291)
T ss_dssp             EECCTTCSEE-------------------------------------------------------EC----CCCGGGCCH
T ss_pred             eeeccCCCcc-------------------------------------------------------cccccCCCCceeeCh
Confidence            6432211000                                                       001122356788888


Q ss_pred             HHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCC
Q psy8260         296 EIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       296 Evl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~  374 (427)
                      |++.+..+..++|+||+|++++.|.+ +..+|..... .............      ......++++.+||.+||+.||.
T Consensus       190 E~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~dp~  262 (291)
T 1xbb_A          190 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-SEVTAMLEKGERM------GCPAGCPREMYDLMNLCWTYDVE  262 (291)
T ss_dssp             HHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHHTTCCC------CCCTTCCHHHHHHHHHHTCSSTT
T ss_pred             HHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHHcCCCC------CCCCCCCHHHHHHHHHHcCCChh
Confidence            88877777777899999999987654 4444433221 1111122111110      11235688999999999999999


Q ss_pred             CCCCHHHHhc
Q psy8260         375 KRITAEQALA  384 (427)
Q Consensus       375 ~R~ta~e~L~  384 (427)
                      +|||++|+++
T Consensus       263 ~Rps~~~l~~  272 (291)
T 1xbb_A          263 NRPGFAAVEL  272 (291)
T ss_dssp             TSCCHHHHHH
T ss_pred             hCcCHHHHHH
Confidence            9999999875

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.8e-39  Score=307.57  Aligned_cols=258  Identities=21%  Similarity=0.264  Sum_probs=189.3

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .+.|.+.+.||+|+||.||. +.+..+++.||||++.....    ...+.+|+.+++.++|+|++..+..+..     ..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~-----~~   77 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYL-GTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGA-----EG   77 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEE-EEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEE-----ET
T ss_pred             CCceEEeeeecCCCCeEEEE-EEEcCCCceEEEEeeccccc----chHHHHHHHHHHHhcCCCCCCeeeeecC-----CC
Confidence            46789999999999999996 55777899999998654322    2346789999999999988877766532     22


Q ss_pred             ceEEEEeccCCCCHHHHHh--hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEE---cCCCCEEEeeCCCCCC
Q psy8260         143 KNVYMVTHLMGADLNNILR--TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILDFGLARP  217 (427)
Q Consensus       143 ~~~~lv~e~~g~~L~~~l~--~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl---~~~~~~kl~DFGla~~  217 (427)
                      ...++++++++++|.+++.  ...+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||+++.
T Consensus        78 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~  157 (296)
T 4hgt_A           78 DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             TEEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             CceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence            5678999999999999987  4579999999999999999999999999999999999999   7889999999999875


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      ........ .. .|                                                 .......||+.|+|||+
T Consensus       158 ~~~~~~~~-~~-~~-------------------------------------------------~~~~~~~gt~~y~aPE~  186 (296)
T 4hgt_A          158 YRDARTHQ-HI-PY-------------------------------------------------RENKNLTGTARYASINT  186 (296)
T ss_dssp             CBCTTTCC-BC-CC-------------------------------------------------CCSCCCCSCGGGCCHHH
T ss_pred             ccCcccCc-cC-CC-------------------------------------------------CcccccCCCccccchHH
Confidence            43221100 00 00                                                 01223468899999999


Q ss_pred             hhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCc---HHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCC
Q psy8260         298 MLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISS---DSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       298 l~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~  374 (427)
                      +.+..+..++|+||+|++++.+.++..||......   ..........   ............++++.+||.+||+.||+
T Consensus       187 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~~p~  263 (296)
T 4hgt_A          187 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK---MSTPIEVLCKGYPSEFATYLNFCRSLRFD  263 (296)
T ss_dssp             HTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH---HHSCHHHHTTTSCHHHHHHHHHHHTSCTT
T ss_pred             hcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc---ccchhhhhhccCCHHHHHHHHHHHhcCCC
Confidence            98877777889999999998885555555321111   1111111000   00112233356789999999999999999


Q ss_pred             CCCCHHHHhc
Q psy8260         375 KRITAEQALA  384 (427)
Q Consensus       375 ~R~ta~e~L~  384 (427)
                      +|||++|+++
T Consensus       264 ~Rpt~~~l~~  273 (296)
T 4hgt_A          264 DKPDYSYLRQ  273 (296)
T ss_dssp             CCCCHHHHHH
T ss_pred             CCCCHHHHHH
Confidence            9999999986

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.3e-38  Score=300.08  Aligned_cols=251  Identities=22%  Similarity=0.303  Sum_probs=191.0

Q ss_pred             cccccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCc
Q psy8260          58 YSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNT  137 (427)
Q Consensus        58 ~~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~  137 (427)
                      .+++....|.+.+.||+|+||.||.+..  .++..||||++......   .+.+.+|+++++.++||||+++++++..  
T Consensus         7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~--   79 (279)
T 1qpc_A            7 EWEVPRETLKLVERLGAGQFGEVWMGYY--NGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ--   79 (279)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEE--TTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             hcccCHHhhhheeeecCCCCeEEEEEEE--cCCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC--
Confidence            3577788999999999999999997653  35778999998754332   3567799999999999999999998753  


Q ss_pred             cccCCceEEEEeccC-CCCHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCC
Q psy8260         138 CLADFKNVYMVTHLM-GADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG  213 (427)
Q Consensus       138 ~~~~~~~~~lv~e~~-g~~L~~~l~~~---~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFG  213 (427)
                           ...+++++++ +++|.+++...   .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        80 -----~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg  154 (279)
T 1qpc_A           80 -----EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFG  154 (279)
T ss_dssp             -----SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             -----CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCc
Confidence                 2367888887 78999988642   69999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccccc
Q psy8260         214 LARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR  293 (427)
Q Consensus       214 la~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~  293 (427)
                      +++........                                                         ...+..+|+.|+
T Consensus       155 ~~~~~~~~~~~---------------------------------------------------------~~~~~~~~~~y~  177 (279)
T 1qpc_A          155 LARLIEDNEYT---------------------------------------------------------AREGAKFPIKWT  177 (279)
T ss_dssp             TCEECSSSCEE---------------------------------------------------------CCTTCCCCTTTS
T ss_pred             ccccccCcccc---------------------------------------------------------cccCCCCccCcc
Confidence            98644321100                                                         011234567788


Q ss_pred             chHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         294 APEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       294 APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                      |||++.+..+..++|+||+|++++.|.+ +..+|..................       ......++++.+||.+||..|
T Consensus       178 aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~  250 (279)
T 1qpc_A          178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM-------VRPDNCPEELYQLMRLCWKER  250 (279)
T ss_dssp             CHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-------CCCTTCCHHHHHHHHHHTCSS
T ss_pred             ChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCC-------CCcccccHHHHHHHHHHhccC
Confidence            8888877667777899999999987654 44444322111122222111111       012356789999999999999


Q ss_pred             CCCCCCHHHHhc
Q psy8260         373 SEKRITAEQALA  384 (427)
Q Consensus       373 P~~R~ta~e~L~  384 (427)
                      |.+|||++++++
T Consensus       251 p~~Rps~~~l~~  262 (279)
T 1qpc_A          251 PEDRPTFDYLRS  262 (279)
T ss_dssp             GGGSCCHHHHHH
T ss_pred             hhhCCCHHHHHH
Confidence            999999999876

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1e-38  Score=309.99  Aligned_cols=254  Identities=21%  Similarity=0.285  Sum_probs=188.5

Q ss_pred             cccccCcceeeccccCcccccEEEEeEEeCcCCcEE--EEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeeee
Q psy8260          58 YSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKV--AIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFH  134 (427)
Q Consensus        58 ~~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~v--AvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~  134 (427)
                      |..+..+.|.+.+.||+|+||.||.+. +..+|..+  |||.+... ......+.+.+|+++++++ +||||+++++++.
T Consensus        19 ~p~~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~   96 (327)
T 1fvr_A           19 YPVLDWNDIKFQDVIGEGNFGQVLKAR-IKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACE   96 (327)
T ss_dssp             SSBCCGGGCEEEEEEECGGGCEEEEEE-EEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred             cccccHHHccceeeeecCCCceEEEEE-EccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceeee
Confidence            344556789999999999999999754 55667654  99988643 2333445678999999999 9999999999986


Q ss_pred             cCccccCCceEEEEeccC-CCCHHHHHhhC-----------------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCC
Q psy8260         135 SNTCLADFKNVYMVTHLM-GADLNNILRTQ-----------------KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKP  196 (427)
Q Consensus       135 ~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~-----------------~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp  196 (427)
                      ..      ..+|+++|++ +++|.+++...                 .+++..+..++.|++.||.|||++||+||||||
T Consensus        97 ~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp  170 (327)
T 1fvr_A           97 HR------GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAA  170 (327)
T ss_dssp             ET------TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred             eC------CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCcc
Confidence            53      4678999998 77999988653                 589999999999999999999999999999999


Q ss_pred             CCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCC
Q psy8260         197 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLA  276 (427)
Q Consensus       197 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~  276 (427)
                      +|||++.++.+||+|||+++......                                                      
T Consensus       171 ~NIl~~~~~~~kL~Dfg~~~~~~~~~------------------------------------------------------  196 (327)
T 1fvr_A          171 RNILVGENYVAKIADFGLSRGQEVYV------------------------------------------------------  196 (327)
T ss_dssp             GGEEECGGGCEEECCTTCEESSCEEC------------------------------------------------------
T ss_pred             ceEEEcCCCeEEEcccCcCccccccc------------------------------------------------------
Confidence            99999999999999999986321110                                                      


Q ss_pred             CCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcC
Q psy8260         277 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFK  355 (427)
Q Consensus       277 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (427)
                           ......+|+.|+|||++.+..+..++|+||+|++++.|.+ +..+|................. .      ....
T Consensus       197 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~-~------~~~~  264 (327)
T 1fvr_A          197 -----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR-L------EKPL  264 (327)
T ss_dssp             -----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC-C------CCCT
T ss_pred             -----cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCC-C------CCCC
Confidence                 0011235667888888777667777899999999987754 5444433221111111111110 0      1123


Q ss_pred             CCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         356 GANPQAIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       356 ~~s~~~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                      ..++++.+||.+||+.||.+|||++|+++|
T Consensus       265 ~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          265 NCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             TBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            467899999999999999999999999986

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.9e-38  Score=321.88  Aligned_cols=246  Identities=21%  Similarity=0.302  Sum_probs=187.8

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      +++....|.+.+.||+|+||.||.+..   .|+.||||++....    ..+.+.+|+++|++++|||||++++++...  
T Consensus       188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~---~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--  258 (450)
T 1k9a_A          188 WALNMKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE--  258 (450)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEE---TTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECT--
T ss_pred             cccChHHeEEEeeecCcCCeeEEEEEe---cCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcC--
Confidence            467778899999999999999997654   47899999987543    235678999999999999999999986542  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL  214 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~~---~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGl  214 (427)
                         ...+|+++|++ +++|.++++..   .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus       259 ---~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~  335 (450)
T 1k9a_A          259 ---KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL  335 (450)
T ss_dssp             ---TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             ---CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCC
Confidence               23578999988 67999988652   379999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccc
Q psy8260         215 ARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRA  294 (427)
Q Consensus       215 a~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~A  294 (427)
                      ++........                                                             ..+|+.|+|
T Consensus       336 a~~~~~~~~~-------------------------------------------------------------~~~~~~y~a  354 (450)
T 1k9a_A          336 TKEASSTQDT-------------------------------------------------------------GKLPVKWTA  354 (450)
T ss_dssp             CEECC-------------------------------------------------------------------CCCTTTSC
T ss_pred             cccccccccC-------------------------------------------------------------CCCCcceeC
Confidence            8643211111                                                             124566777


Q ss_pred             hHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCC
Q psy8260         295 PEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDS  373 (427)
Q Consensus       295 PEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP  373 (427)
                      ||++.+..+..++|+||+|++++.+.+ +..||......+.......... .      ......++++.+||.+||+.||
T Consensus       355 PE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-~------~~p~~~~~~l~~li~~cl~~dp  427 (450)
T 1k9a_A          355 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-M------DAPDGCPPAVYDVMKNCWHLDA  427 (450)
T ss_dssp             HHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC-C------CCCTTCCHHHHHHHHHHTCSSG
T ss_pred             HHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-C------CCCCcCCHHHHHHHHHHcCCCh
Confidence            777766667777899999999987744 4444433222222222221111 1      1123568899999999999999


Q ss_pred             CCCCCHHHHhc
Q psy8260         374 EKRITAEQALA  384 (427)
Q Consensus       374 ~~R~ta~e~L~  384 (427)
                      .+|||++|+++
T Consensus       428 ~~Rpt~~~l~~  438 (450)
T 1k9a_A          428 ATRPTFLQLRE  438 (450)
T ss_dssp             GGSCCHHHHHH
T ss_pred             hHCcCHHHHHH
Confidence            99999999874

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2e-38  Score=303.80  Aligned_cols=259  Identities=17%  Similarity=0.279  Sum_probs=190.5

Q ss_pred             cccCcceeeccccCcccccEEEEeEE---eCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecC
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSAL---DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSN  136 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~---~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~  136 (427)
                      .+....|.+.+.||+|+||.||.+.+   +..+++.||||++.... .......+.+|+++++.++||||+++++++...
T Consensus        17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (302)
T 4e5w_A           17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTED   95 (302)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred             hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence            34456689999999999999997664   56789999999986532 222345678999999999999999999998653


Q ss_pred             ccccCCceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCC
Q psy8260         137 TCLADFKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG  213 (427)
Q Consensus       137 ~~~~~~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFG  213 (427)
                      .    ...++++++++ +++|.+++..  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        96 ~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg  171 (302)
T 4e5w_A           96 G----GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG  171 (302)
T ss_dssp             ------CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred             C----CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccc
Confidence            2    24578899988 6799998843  469999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccccc
Q psy8260         214 LARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR  293 (427)
Q Consensus       214 la~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~  293 (427)
                      +++.........                                                       .......||+.|+
T Consensus       172 ~~~~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~y~  196 (302)
T 4e5w_A          172 LTKAIETDKEYY-------------------------------------------------------TVKDDRDSPVFWY  196 (302)
T ss_dssp             TCEECCTTCCEE-------------------------------------------------------ECCCCTTCCGGGC
T ss_pred             ccccccCCCcce-------------------------------------------------------eccCCCCCCcccc
Confidence            987543221000                                                       0112335777888


Q ss_pred             chHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhc-----------CcHHHHHH---HhcCCCCCcccHHhhcCCCCh
Q psy8260         294 APEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKI-----------SSDSARKY---INSLPLLTKKDFRQVFKGANP  359 (427)
Q Consensus       294 APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~-----------~~~~~~~~---~~~~~~~~~~~~~~~~~~~s~  359 (427)
                      |||++.+..+..++|+||+|++++.+.++..++....           ........   .......      ......++
T Consensus       197 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~  270 (302)
T 4e5w_A          197 APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRL------PCPPNCPD  270 (302)
T ss_dssp             CHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCC------CCCTTCCH
T ss_pred             CCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCC------CCCCCCCH
Confidence            8888877777777899999999988865443321110           00000000   1000000      11235688


Q ss_pred             hHHHHHHHhcCCCCCCCCCHHHHhc
Q psy8260         360 QAIDLLSLMLELDSEKRITAEQALA  384 (427)
Q Consensus       360 ~~~dLi~~mL~~dP~~R~ta~e~L~  384 (427)
                      ++.+||.+||+.||.+|||++|+++
T Consensus       271 ~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          271 EVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            9999999999999999999999985

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=6.1e-39  Score=311.07  Aligned_cols=265  Identities=21%  Similarity=0.220  Sum_probs=189.8

Q ss_pred             cccccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCc
Q psy8260          58 YSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNT  137 (427)
Q Consensus        58 ~~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~  137 (427)
                      ..++..+.|.+.+.||+|+||.||.+.  ..+|+.||||++..... ......+.+|+.+++.++||||+++++++... 
T Consensus        24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-   99 (326)
T 3uim_A           24 ELQVASDNFSNKNILGRGGFGKVYKGR--LADGTLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-   99 (326)
T ss_dssp             HHHTTTTSSCSTTEEECCSSSEEEEEC--CSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS-
T ss_pred             HHHHHhhccccceeEecCCCcEEEEEE--ecCCCEEEEEEeccccC-chHHHHHHHHHHHHHhccCCCccceEEEEecC-
Confidence            345567789999999999999999764  34689999999865321 11123577999999999999999999998653 


Q ss_pred             cccCCceEEEEeccC-CCCHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHhc---CceeccCCCCCeEEcCCCCEE
Q psy8260         138 CLADFKNVYMVTHLM-GADLNNILRTQ-----KLSDDHVQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELK  208 (427)
Q Consensus       138 ~~~~~~~~~lv~e~~-g~~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~yLH~~---~iiHrDLKp~NILl~~~~~~k  208 (427)
                           ...+++++++ +++|.+++...     .+++..+..++.|++.||.|||++   ||+||||||+|||++.++.+|
T Consensus       100 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A          100 -----TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             -----SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             -----CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence                 3467888888 67999998653     389999999999999999999999   999999999999999999999


Q ss_pred             EeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccc
Q psy8260         209 ILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVA  288 (427)
Q Consensus       209 l~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~g  288 (427)
                      |+|||+++........                                                         ......|
T Consensus       175 l~Dfg~~~~~~~~~~~---------------------------------------------------------~~~~~~g  197 (326)
T 3uim_A          175 VGDFGLAKLMDYKDTH---------------------------------------------------------VTTAVRG  197 (326)
T ss_dssp             ECCCSSCEECCSSSSC---------------------------------------------------------EECCCCS
T ss_pred             eccCccccccCccccc---------------------------------------------------------ccccccC
Confidence            9999998643221100                                                         1122347


Q ss_pred             cccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHH--hhc--CcHHHHHHHhcCCC------CCcccH-HhhcCCC
Q psy8260         289 TRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFM--AKI--SSDSARKYINSLPL------LTKKDF-RQVFKGA  357 (427)
Q Consensus       289 t~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~--~~~--~~~~~~~~~~~~~~------~~~~~~-~~~~~~~  357 (427)
                      |+.|+|||++.+..+..++|+||+|++++.|.++..+|.  ...  .......+......      ...... .......
T Consensus       198 t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (326)
T 3uim_A          198 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEE  277 (326)
T ss_dssp             CGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHH
T ss_pred             CcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHH
Confidence            788888888877777778899999999987744443332  110  00111111111000      000000 0000112


Q ss_pred             ChhHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q psy8260         358 NPQAIDLLSLMLELDSEKRITAEQALAHPYL  388 (427)
Q Consensus       358 s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f  388 (427)
                      ++++.+||.+||+.||.+|||++|+++|-.-
T Consensus       278 ~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          278 VEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             HHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            3678999999999999999999999998653

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1e-38  Score=308.89  Aligned_cols=254  Identities=19%  Similarity=0.254  Sum_probs=192.2

Q ss_pred             ceeeccccCcccccEEEEeEE---eCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccC
Q psy8260          65 VIDIGPTLSKESFDLIFSSAL---DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~---~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      .|.+.+.||+|+||.||.+.+   +..+|+.||||++... ......+.+.+|+++++.++||||+++++++...    .
T Consensus        32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~  106 (318)
T 3lxp_A           32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA----G  106 (318)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET----T
T ss_pred             HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC----C
Confidence            358999999999999987654   4558899999998754 3455567788999999999999999999998653    1


Q ss_pred             CceEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         142 FKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      ...++++++++ +++|.+++....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  186 (318)
T 3lxp_A          107 AASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  186 (318)
T ss_dssp             TTEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred             CceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence            24678999988 67999999888899999999999999999999999999999999999999999999999999865432


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      .....                                                       .......||+.|+|||++.+
T Consensus       187 ~~~~~-------------------------------------------------------~~~~~~~~~~~y~aPE~~~~  211 (318)
T 3lxp_A          187 GHEYY-------------------------------------------------------RVREDGDSPVFWYAPECLKE  211 (318)
T ss_dssp             TCSEE-------------------------------------------------------EC---CCCCGGGCCHHHHHH
T ss_pred             ccccc-------------------------------------------------------ccccCCCCCceeeChHHhcC
Confidence            11000                                                       01112346778888888887


Q ss_pred             ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcC---------cH-----HHHHHHhcCCCCCcccHHhhcCCCChhHHHHHH
Q psy8260         301 WMHYNQTDIHQLNLIMEMLGTPPAEFMAKIS---------SD-----SARKYINSLPLLTKKDFRQVFKGANPQAIDLLS  366 (427)
Q Consensus       301 ~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~---------~~-----~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~  366 (427)
                      ..+..++|+||+|++++.|.++..+|.....         ..     ............      ......++++.+||.
T Consensus       212 ~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~  285 (318)
T 3lxp_A          212 YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERL------PRPDKCPAEVYHLMK  285 (318)
T ss_dssp             CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCC------CCCTTCCHHHHHHHH
T ss_pred             CCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCC------CCCccccHHHHHHHH
Confidence            7777778999999999888665444432110         00     000111111000      112356889999999


Q ss_pred             HhcCCCCCCCCCHHHHhc
Q psy8260         367 LMLELDSEKRITAEQALA  384 (427)
Q Consensus       367 ~mL~~dP~~R~ta~e~L~  384 (427)
                      +||+.||.+|||++|+++
T Consensus       286 ~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          286 NCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHcCCCcccCcCHHHHHH
Confidence            999999999999999985

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.1e-38  Score=309.89  Aligned_cols=271  Identities=22%  Similarity=0.295  Sum_probs=183.7

Q ss_pred             cccccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCC-CCCceeeeeeeecC
Q psy8260          58 YSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN-HENVIGLLDVFHSN  136 (427)
Q Consensus        58 ~~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~  136 (427)
                      ..++...+|.+.+.||+|+||.||. +.+..+|+.||||++...  .......+.+|+.+++++. ||||+++++++...
T Consensus        22 ~~~~~~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~   98 (337)
T 3ll6_A           22 TVELGELRLRVRRVLAEGGFAFVYE-AQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG   98 (337)
T ss_dssp             EEEETTEEEEEEEEEECCSSEEEEE-EEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred             eeeccCceEEEEEEEccCCceEEEE-EEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence            3466677899999999999999996 456778999999988543  3455567789999999995 99999999988432


Q ss_pred             c--cccCCceEEEEeccCCCCHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhcC--ceeccCCCCCeEEcCCCCEE
Q psy8260         137 T--CLADFKNVYMVTHLMGADLNNILRT----QKLSDDHVQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELK  208 (427)
Q Consensus       137 ~--~~~~~~~~~lv~e~~g~~L~~~l~~----~~l~~~~~~~~~~qi~~aL~yLH~~~--iiHrDLKp~NILl~~~~~~k  208 (427)
                      .  .......+++++++++++|.+++..    ..+++..+..++.||+.||.|||++|  |+||||||+|||++.++.+|
T Consensus        99 ~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~k  178 (337)
T 3ll6_A           99 KEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIK  178 (337)
T ss_dssp             TTTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEE
T ss_pred             ccccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEE
Confidence            1  1123456899999999999887753    46999999999999999999999999  99999999999999999999


Q ss_pred             EeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccc
Q psy8260         209 ILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVA  288 (427)
Q Consensus       209 l~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~g  288 (427)
                      |+|||+++...........     +..                                         ...........|
T Consensus       179 l~Dfg~~~~~~~~~~~~~~-----~~~-----------------------------------------~~~~~~~~~~~~  212 (337)
T 3ll6_A          179 LCDFGSATTISHYPDYSWS-----AQR-----------------------------------------RALVEEEITRNT  212 (337)
T ss_dssp             BCCCTTCBCCSSCC------------------------------------------------------------------
T ss_pred             EecCccceeccccCccccc-----ccc-----------------------------------------cccchhhccccC
Confidence            9999999765432110000     000                                         000001224468


Q ss_pred             cccccchHHh---hhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHH
Q psy8260         289 TRWYRAPEIM---LNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLL  365 (427)
Q Consensus       289 t~~Y~APEvl---~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi  365 (427)
                      |+.|+|||++   .+..+..++|+||+|++++.|.++..+|.......    ........      ......++++.+||
T Consensus       213 t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~------~~~~~~~~~~~~li  282 (337)
T 3ll6_A          213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR----IVNGKYSI------PPHDTQYTVFHSLI  282 (337)
T ss_dssp             -----------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------------CCC------CTTCCSSGGGHHHH
T ss_pred             CCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH----hhcCcccC------CcccccchHHHHHH
Confidence            8889999988   34445557799999999988755444443221111    11111100      01234567889999


Q ss_pred             HHhcCCCCCCCCCHHHHhcCCC
Q psy8260         366 SLMLELDSEKRITAEQALAHPY  387 (427)
Q Consensus       366 ~~mL~~dP~~R~ta~e~L~Hp~  387 (427)
                      .+||+.||.+|||++|+++|-+
T Consensus       283 ~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          283 RAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             HHHSCSSGGGSCCHHHHHHHHH
T ss_pred             HHHccCChhhCcCHHHHHHHHH
Confidence            9999999999999999999843

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-38  Score=309.40  Aligned_cols=254  Identities=18%  Similarity=0.203  Sum_probs=183.9

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcE----EEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecC
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVK----VAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSN  136 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~----vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~  136 (427)
                      +..+.|.+.+.||+|+||.||.+. +..+++.    ||+|.+.... .....+.+.+|+.+++.++||||+++++++...
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   89 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGL-WIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEE-ECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEE-EcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence            446789999999999999999754 4455554    5777765332 223345678999999999999999999998653


Q ss_pred             ccccCCceEEEEeccCCCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCC
Q psy8260         137 TCLADFKNVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL  214 (427)
Q Consensus       137 ~~~~~~~~~~lv~e~~g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGl  214 (427)
                            ...++++++.+++|.+++..  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        90 ------~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~  163 (327)
T 3lzb_A           90 ------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL  163 (327)
T ss_dssp             ------SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC
T ss_pred             ------CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcc
Confidence                  23344445558899998864  4699999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccc
Q psy8260         215 ARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRA  294 (427)
Q Consensus       215 a~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~A  294 (427)
                      ++........                                                        ....+..||+.|+|
T Consensus       164 a~~~~~~~~~--------------------------------------------------------~~~~~~~~t~~y~a  187 (327)
T 3lzb_A          164 AKLLGAEEKE--------------------------------------------------------YHAEGGKVPIKWMA  187 (327)
T ss_dssp             ------------------------------------------------------------------------CCCGGGSC
T ss_pred             eeEccCcccc--------------------------------------------------------ccccCCCccccccC
Confidence            8754321100                                                        01122346788999


Q ss_pred             hHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCC
Q psy8260         295 PEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDS  373 (427)
Q Consensus       295 PEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP  373 (427)
                      ||++.+..+..++|+||+|++++.|.+ +..+|....... ............      .....++++.+||.+||+.||
T Consensus       188 PE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp  260 (327)
T 3lzb_A          188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLP------QPPICTIDVYMIMRKCWMIDA  260 (327)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-HHHHHHTTCCCC------CCTTBCHHHHHHHHHHTCSSG
T ss_pred             HHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-HHHHHHcCCCCC------CCccCCHHHHHHHHHHcCCCh
Confidence            998888778778899999999987655 555554332222 222222211111      123467899999999999999


Q ss_pred             CCCCCHHHHhcC
Q psy8260         374 EKRITAEQALAH  385 (427)
Q Consensus       374 ~~R~ta~e~L~H  385 (427)
                      .+|||++|+++.
T Consensus       261 ~~Rps~~ell~~  272 (327)
T 3lzb_A          261 DSRPKFRELIIE  272 (327)
T ss_dssp             GGSCCHHHHHHH
T ss_pred             hHCcCHHHHHHH
Confidence            999999999863

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-38  Score=306.01  Aligned_cols=258  Identities=20%  Similarity=0.274  Sum_probs=189.9

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEeCcC---CcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeec
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALDSVS---GVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHS  135 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~---g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~  135 (427)
                      .++....|.+.+.||+|+||.||.+......   +..||||.+... ........+.+|+.+++.++||||+++++++..
T Consensus        39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  117 (333)
T 1mqb_A           39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK  117 (333)
T ss_dssp             CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence            3667788999999999999999987654332   356999998654 344555678899999999999999999999864


Q ss_pred             CccccCCceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeC
Q psy8260         136 NTCLADFKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDF  212 (427)
Q Consensus       136 ~~~~~~~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DF  212 (427)
                      .      ...++++|++ +++|.+++..  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus       118 ~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Df  191 (333)
T 1mqb_A          118 Y------KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDF  191 (333)
T ss_dssp             S------SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             C------CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCC
Confidence            3      4578999988 6699998865  46999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccc
Q psy8260         213 GLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWY  292 (427)
Q Consensus       213 Gla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y  292 (427)
                      |+++.........                                                       ....+..+|+.|
T Consensus       192 g~~~~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~y  216 (333)
T 1mqb_A          192 GLSRVLEDDPEAT-------------------------------------------------------YTTSGGKIPIRW  216 (333)
T ss_dssp             CC------------------------------------------------------------------------CCCGGG
T ss_pred             Ccchhhccccccc-------------------------------------------------------cccCCCCccccc
Confidence            9987543211000                                                       001123467788


Q ss_pred             cchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCC
Q psy8260         293 RAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLEL  371 (427)
Q Consensus       293 ~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~  371 (427)
                      +|||++.+..+..++|+||+|++++.+.+ +..+|............... ....      .....++++.+||.+||+.
T Consensus       217 ~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~-~~~~------~~~~~~~~l~~li~~~l~~  289 (333)
T 1mqb_A          217 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-FRLP------TPMDCPSAIYQLMMQCWQQ  289 (333)
T ss_dssp             SCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCCC------CCTTCBHHHHHHHHHHTCS
T ss_pred             cCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCC-CcCC------CcccCCHHHHHHHHHHcCC
Confidence            89998887777777899999999987644 44444332211122222111 1111      1234678899999999999


Q ss_pred             CCCCCCCHHHHhcC
Q psy8260         372 DSEKRITAEQALAH  385 (427)
Q Consensus       372 dP~~R~ta~e~L~H  385 (427)
                      ||.+|||++|++++
T Consensus       290 ~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          290 ERARRPKFADIVSI  303 (333)
T ss_dssp             STTTSCCHHHHHHH
T ss_pred             ChhhCcCHHHHHHH
Confidence            99999999998875

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=9.6e-39  Score=304.95  Aligned_cols=259  Identities=20%  Similarity=0.256  Sum_probs=192.3

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .+.|.+.+.||+|+||.||. +.+..+|+.||||++......    ..+.+|+.+++.++|+|++..+..+..     ..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~-----~~   77 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYL-GTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGA-----EG   77 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEE-EEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEE-----ET
T ss_pred             ccEEEEEEEEccCCCeEEEE-EEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccC-----CC
Confidence            46789999999999999996 456778999999988654322    246789999999999987777665532     22


Q ss_pred             ceEEEEeccCCCCHHHHHh--hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEE---cCCCCEEEeeCCCCCC
Q psy8260         143 KNVYMVTHLMGADLNNILR--TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILDFGLARP  217 (427)
Q Consensus       143 ~~~~lv~e~~g~~L~~~l~--~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl---~~~~~~kl~DFGla~~  217 (427)
                      ...++++|+++++|.+++.  ...+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||+++.
T Consensus        78 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  157 (296)
T 3uzp_A           78 DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             CceEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence            5678999999999999986  4579999999999999999999999999999999999999   4788999999999875


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      ........  ...|                                                 .......||+.|+|||+
T Consensus       158 ~~~~~~~~--~~~~-------------------------------------------------~~~~~~~gt~~y~aPE~  186 (296)
T 3uzp_A          158 YRDARTHQ--HIPY-------------------------------------------------RENKNLTGTARYASINT  186 (296)
T ss_dssp             CBCTTTCC--BCCC-------------------------------------------------CCSCCCCSCTTTCCHHH
T ss_pred             cccccccc--cccc-------------------------------------------------ccccccccccccCChhh
Confidence            43221100  0000                                                 01223468899999999


Q ss_pred             hhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcC---cHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCC
Q psy8260         298 MLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKIS---SDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       298 l~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~  374 (427)
                      +.+..+..++|+||+|++++.|.++..||.....   ............   ...........++++.+||.+||+.||.
T Consensus       187 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~  263 (296)
T 3uzp_A          187 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM---STPIEVLCKGYPSEFATYLNFCRSLRFD  263 (296)
T ss_dssp             HTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH---HSCHHHHTTTSCHHHHHHHHHHHTSCTT
T ss_pred             hcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc---CCchHHHHhhCCHHHHHHHHHHHhcCcC
Confidence            9887777788999999999888555555532111   111111111000   0111223356789999999999999999


Q ss_pred             CCCCHHHHhcC
Q psy8260         375 KRITAEQALAH  385 (427)
Q Consensus       375 ~R~ta~e~L~H  385 (427)
                      +|||++|+++.
T Consensus       264 ~Rps~~~l~~~  274 (296)
T 3uzp_A          264 DKPDYSYLRQL  274 (296)
T ss_dssp             CCCCHHHHHHH
T ss_pred             cCCCHHHHHHH
Confidence            99999998764

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=6.9e-38  Score=301.52  Aligned_cols=254  Identities=22%  Similarity=0.298  Sum_probs=182.3

Q ss_pred             cCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcC-CCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcccc
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPF-QSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  140 (427)
                      ..+.|.+.+.||+|+||.||.+ .+..+|+.||||++.... ........+.+|+.+++.++||||+++++++...    
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----  104 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRA-ACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED----  104 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEE-EETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET----
T ss_pred             cccceEEEEeecCCCCceEEEE-EEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----
Confidence            3467999999999999999964 566789999999987532 3445566788999999999999999999998653    


Q ss_pred             CCceEEEEeccC-CCCHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCC
Q psy8260         141 DFKNVYMVTHLM-GADLNNILRT-----QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL  214 (427)
Q Consensus       141 ~~~~~~lv~e~~-g~~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGl  214 (427)
                        ...+++++++ +++|.+++..     ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus       105 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~  182 (310)
T 2wqm_A          105 --NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL  182 (310)
T ss_dssp             --TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--
T ss_pred             --CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccc
Confidence              4578899988 5699988753     4589999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccc
Q psy8260         215 ARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRA  294 (427)
Q Consensus       215 a~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~A  294 (427)
                      ++.......                                                          ......||+.|+|
T Consensus       183 ~~~~~~~~~----------------------------------------------------------~~~~~~~~~~y~a  204 (310)
T 2wqm_A          183 GRFFSSKTT----------------------------------------------------------AAHSLVGTPYYMS  204 (310)
T ss_dssp             --------------------------------------------------------------------------CCSSCC
T ss_pred             eeeecCCCc----------------------------------------------------------cccccCCCeeEeC
Confidence            864322110                                                          0112346777777


Q ss_pred             hHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcH-HHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCC
Q psy8260         295 PEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSD-SARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDS  373 (427)
Q Consensus       295 PEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP  373 (427)
                      ||++.+..+..++|+||+|++++.|.++..+|....... ......... .....    .....++++.+||.+||+.||
T Consensus       205 PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~----~~~~~~~~l~~li~~~l~~dp  279 (310)
T 2wqm_A          205 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-DYPPL----PSDHYSEELRQLVNMCINPDP  279 (310)
T ss_dssp             HHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT-CSCCC----CTTTSCHHHHHHHHHHTCSSG
T ss_pred             hHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc-cCCCC----cccccCHHHHHHHHHHcCCCh
Confidence            777776666667899999999988755554443221111 111111111 11110    013468899999999999999


Q ss_pred             CCCCCHHHHhcC
Q psy8260         374 EKRITAEQALAH  385 (427)
Q Consensus       374 ~~R~ta~e~L~H  385 (427)
                      .+|||++|++++
T Consensus       280 ~~Rps~~~il~~  291 (310)
T 2wqm_A          280 EKRPDVTYVYDV  291 (310)
T ss_dssp             GGSCCHHHHHHH
T ss_pred             hhCCCHHHHHHH
Confidence            999999999875

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=310.02  Aligned_cols=273  Identities=19%  Similarity=0.209  Sum_probs=185.1

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      .+..+.|.+.+.||+|+||.||.+..   +++.||||++....   .......+|+..+..++||||+++++.+.... .
T Consensus         9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~   81 (336)
T 3g2f_A            9 SLDLDNLKLLELIGRGRYGAVYKGSL---DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVT-A   81 (336)
T ss_dssp             CCCTTSEEEEEEEEECSSEEEEEEEE---TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-T
T ss_pred             CcChHHhheeeecccCCCeEEEEEEE---CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccc-c
Confidence            44567899999999999999997643   68999999986432   11112234444455689999999998654321 1


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhc---------CceeccCCCCCeEEcCCCCEEE
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSA---------GIIHRDLKPSNIAVNEDCELKI  209 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~---------~iiHrDLKp~NILl~~~~~~kl  209 (427)
                      .....++++||++ +++|.++++....++..+..++.||+.||.|||++         ||+||||||+|||++.++.+||
T Consensus        82 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL  161 (336)
T 3g2f_A           82 DGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI  161 (336)
T ss_dssp             TSCEEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred             CCCceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence            2334678999998 78999999888889999999999999999999999         9999999999999999999999


Q ss_pred             eeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccc
Q psy8260         210 LDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT  289 (427)
Q Consensus       210 ~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt  289 (427)
                      +|||+++..........+.                                                  .........||
T Consensus       162 ~DFG~a~~~~~~~~~~~~~--------------------------------------------------~~~~~~~~~gt  191 (336)
T 3g2f_A          162 SDFGLSMRLTGNRLVRPGE--------------------------------------------------EDNAAISEVGT  191 (336)
T ss_dssp             CCCTTCEECSSSSCC-----------------------------------------------------------CCTTSC
T ss_pred             eeccceeecccccccCccc--------------------------------------------------cccccccCCCc
Confidence            9999997543221000000                                                  00011234567


Q ss_pred             ccccchHHhhh-------ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcH-----------------HHHHHHhcCCCC
Q psy8260         290 RWYRAPEIMLN-------WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSD-----------------SARKYINSLPLL  345 (427)
Q Consensus       290 ~~Y~APEvl~~-------~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~-----------------~~~~~~~~~~~~  345 (427)
                      +.|+|||++.+       ..+..++|+||+|++++.|.++..++.......                 ........ ...
T Consensus       192 ~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  270 (336)
T 3g2f_A          192 IRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSR-EKQ  270 (336)
T ss_dssp             GGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTT-SCC
T ss_pred             cceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcc-ccc
Confidence            77777777665       233446799999999988866544432211100                 00000000 000


Q ss_pred             CcccHHhhcC---CCChhHHHHHHHhcCCCCCCCCCHHHH------hcCCCCCCC
Q psy8260         346 TKKDFRQVFK---GANPQAIDLLSLMLELDSEKRITAEQA------LAHPYLSQY  391 (427)
Q Consensus       346 ~~~~~~~~~~---~~s~~~~dLi~~mL~~dP~~R~ta~e~------L~Hp~f~~~  391 (427)
                       ...+...+.   ..++++.+||.+||+.||++|||++|+      +.++|-++.
T Consensus       271 -~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~  324 (336)
T 3g2f_A          271 -RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK  324 (336)
T ss_dssp             -CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred             -CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence             000111111   123479999999999999999999999      668887653

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3.5e-38  Score=320.07  Aligned_cols=258  Identities=23%  Similarity=0.319  Sum_probs=192.7

Q ss_pred             ccccccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecC
Q psy8260          57 PYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSN  136 (427)
Q Consensus        57 ~~~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~  136 (427)
                      ..+++....|.+.+.||+|+||.||.+...  .+..||||++......   .+.+.+|+++|++++||||+++++++.. 
T Consensus       177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-  250 (452)
T 1fmk_A          177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-  250 (452)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSCEEEEEEET--TTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             cccccChhHceeeeeecCCCCeEEEEEEEC--CCceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-
Confidence            346788889999999999999999987653  3567999998754333   3467899999999999999999998753 


Q ss_pred             ccccCCceEEEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeC
Q psy8260         137 TCLADFKNVYMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDF  212 (427)
Q Consensus       137 ~~~~~~~~~~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DF  212 (427)
                            ..+|++||++ +++|.++++.   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus       251 ------~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~Df  324 (452)
T 1fmk_A          251 ------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADF  324 (452)
T ss_dssp             ------SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             ------CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCC
Confidence                  3468899988 6799999853   45999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccc
Q psy8260         213 GLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWY  292 (427)
Q Consensus       213 Gla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y  292 (427)
                      |+++........                                                         ...+..+|+.|
T Consensus       325 G~a~~~~~~~~~---------------------------------------------------------~~~~~~~~~~y  347 (452)
T 1fmk_A          325 GLARLIEDNEYT---------------------------------------------------------ARQGAKFPIKW  347 (452)
T ss_dssp             CTTC-----------------------------------------------------------------------CCGGG
T ss_pred             ccceecCCCcee---------------------------------------------------------cccCCcccccc
Confidence            998754221000                                                         01123457788


Q ss_pred             cchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCC
Q psy8260         293 RAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLEL  371 (427)
Q Consensus       293 ~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~  371 (427)
                      +|||++.+..+..++|+||+|++++.+.+ +..||......+......... ..+      .....++++.+||.+||+.
T Consensus       348 ~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~-~~~------~~~~~~~~l~~li~~cl~~  420 (452)
T 1fmk_A          348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RMP------CPPECPESLHDLMCQCWRK  420 (452)
T ss_dssp             SCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CCC------CCTTSCHHHHHHHHHHTCS
T ss_pred             cCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCC------CCCCCCHHHHHHHHHHccC
Confidence            88888887777778899999999987755 444443221112222221111 110      1234678899999999999


Q ss_pred             CCCCCCCHHHHhc--CCCCCC
Q psy8260         372 DSEKRITAEQALA--HPYLSQ  390 (427)
Q Consensus       372 dP~~R~ta~e~L~--Hp~f~~  390 (427)
                      ||++|||++++++  ..++..
T Consensus       421 dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          421 EPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             SGGGSCCHHHHHHHHHTTTSC
T ss_pred             ChhhCcCHHHHHHHHHHHhcc
Confidence            9999999999986  355543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.8e-38  Score=302.98  Aligned_cols=253  Identities=25%  Similarity=0.289  Sum_probs=185.1

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      .+.|.+.+.||+|+||.||. +.+..+++.||||++..... .....+.+.+|+.+++.++||||+++++++...     
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~-~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----  106 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYE-AEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID-----  106 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEE-EEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----
T ss_pred             eccEEEEEEEcCCCCeeEEE-EEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC-----
Confidence            46799999999999999996 45677899999999875433 333456678999999999999999999998653     


Q ss_pred             CceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         142 FKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                       ...|+++|++ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       107 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          107 -GQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             -TEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             -CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence             4678999988 5799998865 569999999999999999999999999999999999999999999999999986432


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      .....                                                         ......||+.|+|||++.
T Consensus       186 ~~~~~---------------------------------------------------------~~~~~~~~~~y~aPE~~~  208 (309)
T 2h34_A          186 DEKLT---------------------------------------------------------QLGNTVGTLYYMAPERFS  208 (309)
T ss_dssp             --------------------------------------------------------------------CCGGGCCGGGTC
T ss_pred             ccccc---------------------------------------------------------cccccCCCcCccCHHHHc
Confidence            21000                                                         111234677778888777


Q ss_pred             hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC-C
Q psy8260         300 NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI-T  378 (427)
Q Consensus       300 ~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~-t  378 (427)
                      +..+..++|+||+|++++.+.++..+|...... ...........    ........+++++.+||.+||+.||.+|| |
T Consensus       209 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s  283 (309)
T 2h34_A          209 ESHATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAIP----RPSTVRPGIPVAFDAVIARGMAKNPEDRYVT  283 (309)
T ss_dssp             C----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSCCC----CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSS
T ss_pred             CCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccCCC----CccccCCCCCHHHHHHHHHhccCCHHHHHHh
Confidence            666777889999999998875554444322111 11111211111    11233456788999999999999999999 7


Q ss_pred             HHHHhc
Q psy8260         379 AEQALA  384 (427)
Q Consensus       379 a~e~L~  384 (427)
                      ++++++
T Consensus       284 ~~~l~~  289 (309)
T 2h34_A          284 CGDLSA  289 (309)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            888764

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.1e-39  Score=322.25  Aligned_cols=266  Identities=20%  Similarity=0.269  Sum_probs=185.0

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcccc
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  140 (427)
                      ...+.|.+.+.||+|+||.||. +.+..+|+.||||++..... ....+.+.+|++++++++||||+++++++....   
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~-~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---   80 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFR-GRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---   80 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEE-EEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---
T ss_pred             CCCCceEEEEEEEcCCCeEEEE-EEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC---
Confidence            3457899999999999999996 55677899999999864321 122455679999999999999999999986532   


Q ss_pred             CCceEEEEeccC-CCCHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEE----cCCCCEEEee
Q psy8260         141 DFKNVYMVTHLM-GADLNNILRTQ----KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV----NEDCELKILD  211 (427)
Q Consensus       141 ~~~~~~lv~e~~-g~~L~~~l~~~----~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl----~~~~~~kl~D  211 (427)
                       ....+++||++ +++|.++++..    .+++..+..++.|++.||.|||++||+||||||+|||+    +.++.+||+|
T Consensus        81 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (396)
T 4eut_A           81 -TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (396)
T ss_dssp             -TCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECC
T ss_pred             -CCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEec
Confidence             23578999988 78999988642    39999999999999999999999999999999999999    6777899999


Q ss_pred             CCCCCCCCCC--cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccc
Q psy8260         212 FGLARPTENE--MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT  289 (427)
Q Consensus       212 FGla~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt  289 (427)
                      ||+++.....  .....||+.|+|||++.+.....                                         .   
T Consensus       160 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-----------------------------------------~---  195 (396)
T 4eut_A          160 FGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRK-----------------------------------------D---  195 (396)
T ss_dssp             GGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC-------------------------------------------C---
T ss_pred             CCCceEccCCCccccccCCccccCHHHhhcccccc-----------------------------------------c---
Confidence            9998754322  22234455555555443200000                                         0   


Q ss_pred             ccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhc----CcHHHHHHHhcCCCCCc----------ccHHh---
Q psy8260         290 RWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKI----SSDSARKYINSLPLLTK----------KDFRQ---  352 (427)
Q Consensus       290 ~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~----~~~~~~~~~~~~~~~~~----------~~~~~---  352 (427)
                               ....+..++|+||+|++++.|.++..||....    ......+.....+....          ..|..   
T Consensus       196 ---------~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  266 (396)
T 4eut_A          196 ---------HQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMP  266 (396)
T ss_dssp             ---------HHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCC
T ss_pred             ---------cccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCC
Confidence                     00223445799999999988855555553211    11222223322221100          00100   


Q ss_pred             ----hcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         353 ----VFKGANPQAIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       353 ----~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                          .....++.+.+||.+||+.||++|+|++|++++
T Consensus       267 ~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          267 VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             cccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence                011234578899999999999999999998543

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.7e-38  Score=301.37  Aligned_cols=250  Identities=24%  Similarity=0.300  Sum_probs=182.5

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcccc
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  140 (427)
                      +..+.|++.+.||+|+||.||.+..   .++.||||++...    ...+.+.+|++++++++||||+++++++..     
T Consensus         5 i~~~~~~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----   72 (307)
T 2eva_A            5 IDYKEIEVEEVVGRGAFGVVCKAKW---RAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN-----   72 (307)
T ss_dssp             CCGGGEEEEEEEECCSSSEEEEEEE---TTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT-----
T ss_pred             CCHhHeeeeeEeecCCCceEEEEEE---CCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-----
Confidence            4456789999999999999997653   4789999998642    234567899999999999999999998652     


Q ss_pred             CCceEEEEeccC-CCCHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHh---cCceeccCCCCCeEEcCCCC-EEEee
Q psy8260         141 DFKNVYMVTHLM-GADLNNILRTQ----KLSDDHVQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCE-LKILD  211 (427)
Q Consensus       141 ~~~~~~lv~e~~-g~~L~~~l~~~----~l~~~~~~~~~~qi~~aL~yLH~---~~iiHrDLKp~NILl~~~~~-~kl~D  211 (427)
                         ..++++|++ +++|.+++...    .+++..+..++.|++.||.|||+   +||+||||||+|||++.++. +||+|
T Consensus        73 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~D  149 (307)
T 2eva_A           73 ---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICD  149 (307)
T ss_dssp             ---TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECC
T ss_pred             ---CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcc
Confidence               257888888 78999998753    37889999999999999999999   89999999999999998876 79999


Q ss_pred             CCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccc
Q psy8260         212 FGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRW  291 (427)
Q Consensus       212 FGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~  291 (427)
                      ||+++.........                                                             .||+.
T Consensus       150 fg~~~~~~~~~~~~-------------------------------------------------------------~gt~~  168 (307)
T 2eva_A          150 FGTACDIQTHMTNN-------------------------------------------------------------KGSAA  168 (307)
T ss_dssp             CCC-------------------------------------------------------------------------CCTT
T ss_pred             cccccccccccccC-------------------------------------------------------------CCCCc
Confidence            99986433222222                                                             35666


Q ss_pred             ccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCC
Q psy8260         292 YRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLEL  371 (427)
Q Consensus       292 Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~  371 (427)
                      |+|||++.+..+..++|+||+|++++.|.++..+|...................     .......++++.+||.+||+.
T Consensus       169 y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~  243 (307)
T 2eva_A          169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR-----PPLIKNLPKPIESLMTRCWSK  243 (307)
T ss_dssp             SSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC-----CCCBTTCCHHHHHHHHHHTCS
T ss_pred             eEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC-----CCcccccCHHHHHHHHHHhcC
Confidence            677776666566677899999999988855555553221111110000001100     012345688999999999999


Q ss_pred             CCCCCCCHHHHhc-----CCCCCCC
Q psy8260         372 DSEKRITAEQALA-----HPYLSQY  391 (427)
Q Consensus       372 dP~~R~ta~e~L~-----Hp~f~~~  391 (427)
                      ||.+|||++|+++     ..++...
T Consensus       244 dp~~Rps~~ell~~L~~~~~~~~~~  268 (307)
T 2eva_A          244 DPSQRPSMEEIVKIMTHLMRYFPGA  268 (307)
T ss_dssp             SGGGSCCHHHHHHHHHHHGGGCCCT
T ss_pred             ChhhCcCHHHHHHHHHHHHHhccCC
Confidence            9999999999987     4555443

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-38  Score=313.41  Aligned_cols=255  Identities=18%  Similarity=0.245  Sum_probs=182.9

Q ss_pred             cceeeccccCcccccEEEEeEEeCcC--CcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccC
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVS--GVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~--g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      ..|.+.+.||+|+||.||++.....+  +..||||.+... ......+++.+|+.++++++||||+++++++...     
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----  162 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-----  162 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC-----
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC-----
Confidence            45778899999999999987654333  356899988653 3344567788999999999999999999985432     


Q ss_pred             CceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCC
Q psy8260         142 FKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT  218 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~  218 (427)
                      ....|+++|++ +++|.++++.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~  242 (373)
T 3c1x_A          163 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM  242 (373)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             CCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccc
Confidence            13467888887 6799999875  35889999999999999999999999999999999999999999999999998754


Q ss_pred             CCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         219 ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       219 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                      .......                                                      .....+..+|+.|+|||++
T Consensus       243 ~~~~~~~------------------------------------------------------~~~~~~~~~~~~y~aPE~~  268 (373)
T 3c1x_A          243 YDKEFDS------------------------------------------------------VHNKTGAKLPVKWMALESL  268 (373)
T ss_dssp             ---------------------------------------------------------------------CCGGGSCHHHH
T ss_pred             ccccccc------------------------------------------------------ccccCCCCCcccccChHHh
Confidence            2211000                                                      0011234577889999998


Q ss_pred             hhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC
Q psy8260         299 LNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI  377 (427)
Q Consensus       299 ~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~  377 (427)
                      .+..+..++|+||+|++++.+.+ +..+|......+............       .....++++.+||.+||+.||.+||
T Consensus       269 ~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~-------~p~~~~~~l~~li~~cl~~dp~~RP  341 (373)
T 3c1x_A          269 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL-------QPEYCPDPLYEVMLKCWHPKAEMRP  341 (373)
T ss_dssp             HHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCC-------CCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred             cCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCC-------CCCCCCHHHHHHHHHHcCCChhhCc
Confidence            88778888899999999987744 333333222222222222111111       1134678899999999999999999


Q ss_pred             CHHHHhcC
Q psy8260         378 TAEQALAH  385 (427)
Q Consensus       378 ta~e~L~H  385 (427)
                      |++|++++
T Consensus       342 s~~ell~~  349 (373)
T 3c1x_A          342 SFSELVSR  349 (373)
T ss_dssp             CHHHHHHH
T ss_pred             CHHHHHHH
Confidence            99999875

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-38  Score=306.41  Aligned_cols=261  Identities=22%  Similarity=0.298  Sum_probs=182.0

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhc--CCCCCceeeeeeeecCcc
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKH--MNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~--l~HpnIv~l~~~~~~~~~  138 (427)
                      ...+.|.+.+.||+|+||.||.+..   +|+.||||++....     .....+|.+++..  ++||||+++++++.....
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~  105 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKW---RGEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTG  105 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEE---TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred             ccccceEEEeEeecCCCeEEEEEEE---CCceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence            3446789999999999999997653   48999999985321     2234455555555  499999999998764321


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhc--------CceeccCCCCCeEEcCCCCEEE
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSA--------GIIHRDLKPSNIAVNEDCELKI  209 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~--------~iiHrDLKp~NILl~~~~~~kl  209 (427)
                        ....+|+++|++ +++|.++++...+++..+..++.|++.||.|||++        ||+||||||+|||++.++.+||
T Consensus       106 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl  183 (337)
T 3mdy_A          106 --SWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI  183 (337)
T ss_dssp             --GGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred             --CCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence              124688999998 67999999988999999999999999999999998        9999999999999999999999


Q ss_pred             eeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccc
Q psy8260         210 LDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVAT  289 (427)
Q Consensus       210 ~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt  289 (427)
                      +|||+++.........                                                      ........||
T Consensus       184 ~Dfg~a~~~~~~~~~~------------------------------------------------------~~~~~~~~gt  209 (337)
T 3mdy_A          184 ADLGLAVKFISDTNEV------------------------------------------------------DIPPNTRVGT  209 (337)
T ss_dssp             CCCTTCEECC---------------------------------------------------------------CCSSCSC
T ss_pred             EeCCCceeeccccccc------------------------------------------------------cCCCCCCccC
Confidence            9999986433211000                                                      0001123567


Q ss_pred             ccccchHHhhhccCCCC------CCHHHHHHHHHHhCCC----------CHHHHhhcCc----HHHHHHHhcCCCCCccc
Q psy8260         290 RWYRAPEIMLNWMHYNQ------TDIHQLNLIMEMLGTP----------PAEFMAKISS----DSARKYINSLPLLTKKD  349 (427)
Q Consensus       290 ~~Y~APEvl~~~~~~~~------~d~~slg~i~~~lg~~----------~~~~~~~~~~----~~~~~~~~~~~~~~~~~  349 (427)
                      +.|+|||++.+......      +|+||+|++++.|.++          ..+|......    .................
T Consensus       210 ~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (337)
T 3mdy_A          210 KRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFP  289 (337)
T ss_dssp             GGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCC
T ss_pred             cceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCcccc
Confidence            77777777766555554      7999999999888655          3333221111    11111111110000000


Q ss_pred             HHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         350 FRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       350 ~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                      ........++++.+||.+||+.||.+|||++|+++|
T Consensus       290 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          290 NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            000011235678999999999999999999999986

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.4e-38  Score=300.21  Aligned_cols=250  Identities=22%  Similarity=0.258  Sum_probs=190.9

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc----
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC----  138 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~----  138 (427)
                      .+.|.+.+.||+|+||.||.+ .+..+|+.||||++....      ..+.+|+++++.++||||+++++++.....    
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~-~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKA-KHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET   82 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEE-EETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred             ccccceeeeeccCCceEEEEE-EEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence            456889999999999999964 566789999999986532      245689999999999999999998753110    


Q ss_pred             ------ccCCceEEEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEE
Q psy8260         139 ------LADFKNVYMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELK  208 (427)
Q Consensus       139 ------~~~~~~~~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~k  208 (427)
                            ......+|+++|++ +++|.+++..   ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k  162 (284)
T 2a19_B           83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK  162 (284)
T ss_dssp             ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred             ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEE
Confidence                  01234578999998 5699998853   4699999999999999999999999999999999999999999999


Q ss_pred             EeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccc
Q psy8260         209 ILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVA  288 (427)
Q Consensus       209 l~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~g  288 (427)
                      |+|||+++......                                                           ......|
T Consensus       163 l~Dfg~~~~~~~~~-----------------------------------------------------------~~~~~~~  183 (284)
T 2a19_B          163 IGDFGLVTSLKNDG-----------------------------------------------------------KRTRSKG  183 (284)
T ss_dssp             ECCCTTCEESSCCS-----------------------------------------------------------CCCCCCS
T ss_pred             ECcchhheeccccc-----------------------------------------------------------cccccCC
Confidence            99999986432210                                                           0112246


Q ss_pred             cccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHh
Q psy8260         289 TRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLM  368 (427)
Q Consensus       289 t~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~m  368 (427)
                      |+.|+|||++.+..+..++|+||+|++++.|.++..++....  .......  ...        .....++++.+||.+|
T Consensus       184 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~--~~~--------~~~~~~~~~~~li~~~  251 (284)
T 2a19_B          184 TLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLR--DGI--------ISDIFDKKEKTLLQKL  251 (284)
T ss_dssp             CCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHH--TTC--------CCTTSCHHHHHHHHHH
T ss_pred             cccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhh--ccc--------ccccCCHHHHHHHHHH
Confidence            777778887777667777899999999988755544333211  1111111  111        1134678899999999


Q ss_pred             cCCCCCCCCCHHHHhcCCCCCC
Q psy8260         369 LELDSEKRITAEQALAHPYLSQ  390 (427)
Q Consensus       369 L~~dP~~R~ta~e~L~Hp~f~~  390 (427)
                      |+.||.+|||+.|+++|.+.-.
T Consensus       252 l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          252 LSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHHT
T ss_pred             ccCChhhCcCHHHHHHHHHHHh
Confidence            9999999999999999988754

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=8.8e-39  Score=313.79  Aligned_cols=263  Identities=13%  Similarity=0.139  Sum_probs=188.5

Q ss_pred             CcceeeccccCcccccEEEEeEEeCc-------CCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeec
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSV-------SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHS  135 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~-------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~  135 (427)
                      .+.|.+.+.||+|+||.||.+.....       .++.||||.+...       ..+.+|++++++++||||+++++.+..
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~  113 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS  113 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence            57899999999999999997654322       4889999998643       246789999999999999984332211


Q ss_pred             C----------ccccCCceEEEEeccCCCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEc
Q psy8260         136 N----------TCLADFKNVYMVTHLMGADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN  202 (427)
Q Consensus       136 ~----------~~~~~~~~~~lv~e~~g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~  202 (427)
                      .          .+.......|++||+++++|.+++..   ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus       114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~  193 (352)
T 2jii_A          114 TPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD  193 (352)
T ss_dssp             CTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE
T ss_pred             CCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc
Confidence            0          01112356899999999999999875   5699999999999999999999999999999999999999


Q ss_pred             CCC--CEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCc
Q psy8260         203 EDC--ELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTE  280 (427)
Q Consensus       203 ~~~--~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~  280 (427)
                      .++  .+||+|||+++...........                                                   ..
T Consensus       194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~---------------------------------------------------~~  222 (352)
T 2jii_A          194 PEDQSQVTLAGYGFAFRYCPSGKHVAY---------------------------------------------------VE  222 (352)
T ss_dssp             TTEEEEEEECCGGGCBCSSGGGCCCCC---------------------------------------------------CT
T ss_pred             CCCCceEEEecCcceeeccCCCccccc---------------------------------------------------cc
Confidence            988  9999999999754322110000                                                   00


Q ss_pred             cccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCc-HHHHHH----HhcCCCCCcccHHhhcC
Q psy8260         281 NEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISS-DSARKY----INSLPLLTKKDFRQVFK  355 (427)
Q Consensus       281 ~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~  355 (427)
                      .......||+.|+|||++.+..+..++|+||+|++++.|.++..+|...... ......    .........  ....+.
T Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  300 (352)
T 2jii_A          223 GSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVG--PCGHWI  300 (352)
T ss_dssp             TSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEEC--TTSCEE
T ss_pred             cccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhh--hccccC
Confidence            0122346889999999998877777889999999998875555555443211 111111    111111100  011123


Q ss_pred             CCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         356 GANPQAIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       356 ~~s~~~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                      .+++++.+||.+||+.||.+|||++|+++.
T Consensus       301 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  330 (352)
T 2jii_A          301 RPSETLQKYLKVVMALTYEEKPPYAMLRNN  330 (352)
T ss_dssp             CCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             CCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence            568999999999999999999999998764

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=6.6e-38  Score=302.43  Aligned_cols=270  Identities=20%  Similarity=0.262  Sum_probs=192.8

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      ..+..+.|.+.+.||+|+||.||. +.+..+|+.||||++...  .....+.+.+|+.+++.++||||+++++++.... 
T Consensus        24 ~~i~~~~y~~~~~lg~G~~g~V~~-~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   99 (317)
T 2buj_A           24 VIIDNKHYLFIQKLGEGGFSYVDL-VEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRER-   99 (317)
T ss_dssp             EEETTEEEEEEEEEEC--CEEEEE-EEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-
T ss_pred             EEECCeEEEEEEEecCCCCeEEEE-EEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-
Confidence            356678899999999999999996 556778999999988542  4455667889999999999999999999986321 


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRT-----QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDF  212 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DF  212 (427)
                       ......+++++++ +++|.+++..     ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus       100 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~df  178 (317)
T 2buj_A          100 -GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDL  178 (317)
T ss_dssp             -TTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred             -CCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEec
Confidence             1224678888888 6699988754     56999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccc
Q psy8260         213 GLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWY  292 (427)
Q Consensus       213 Gla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y  292 (427)
                      |+++..........        ...                               ..          .......||+.|
T Consensus       179 g~~~~~~~~~~~~~--------~~~-------------------------------~~----------~~~~~~~gt~~y  209 (317)
T 2buj_A          179 GSMNQACIHVEGSR--------QAL-------------------------------TL----------QDWAAQRCTISY  209 (317)
T ss_dssp             SSCEESCEEEESHH--------HHH-------------------------------HH----------HHHHHHHSCGGG
T ss_pred             Ccchhccccccccc--------ccc-------------------------------cc----------cccccccCCccc
Confidence            98864321100000        000                               00          011223467778


Q ss_pred             cchHHhhhcc---CCCCCCHHHHHHHHHHhCCCCHHHHh--hcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHH
Q psy8260         293 RAPEIMLNWM---HYNQTDIHQLNLIMEMLGTPPAEFMA--KISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSL  367 (427)
Q Consensus       293 ~APEvl~~~~---~~~~~d~~slg~i~~~lg~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~  367 (427)
                      +|||++.+..   +..++|+||+|++++.|.++..+|..  ........ ........+      .....++++.+||.+
T Consensus       210 ~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-~~~~~~~~~------~~~~~~~~l~~li~~  282 (317)
T 2buj_A          210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL-AVQNQLSIP------QSPRHSSALWQLLNS  282 (317)
T ss_dssp             CCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH-HHHCC--CC------CCTTSCHHHHHHHHH
T ss_pred             CCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH-HhhccCCCC------ccccCCHHHHHHHHH
Confidence            8888775432   45677999999999877444433322  11111111 111111110      123468899999999


Q ss_pred             hcCCCCCCCCCHHHHhcCCCCCCC
Q psy8260         368 MLELDSEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       368 mL~~dP~~R~ta~e~L~Hp~f~~~  391 (427)
                      ||+.||.+|||++|+++|  +...
T Consensus       283 ~l~~dp~~Rps~~~ll~~--L~~~  304 (317)
T 2buj_A          283 MMTVDPHQRPHIPLLLSQ--LEAL  304 (317)
T ss_dssp             HTCSSGGGSCCHHHHHHH--HHHT
T ss_pred             HhhcChhhCCCHHHHHHH--hhhc
Confidence            999999999999999997  4444

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.9e-38  Score=300.02  Aligned_cols=258  Identities=21%  Similarity=0.199  Sum_probs=184.6

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCc--EEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecC
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGV--KVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSN  136 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~--~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~  136 (427)
                      .+....|.+.+.||+|+||.||.+.....++.  .||||++..... .....+.+.+|+++++.++||||+++++++...
T Consensus        14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   93 (291)
T 1u46_A           14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP   93 (291)
T ss_dssp             ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence            44567899999999999999998776554444  689998865432 234456788999999999999999999998653


Q ss_pred             ccccCCceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCC
Q psy8260         137 TCLADFKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG  213 (427)
Q Consensus       137 ~~~~~~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFG  213 (427)
                             ..+++++++ +++|.+++..  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        94 -------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg  166 (291)
T 1u46_A           94 -------PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFG  166 (291)
T ss_dssp             -------SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             -------CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccc
Confidence                   256777776 6899988864  459999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccccc
Q psy8260         214 LARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR  293 (427)
Q Consensus       214 la~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~  293 (427)
                      +++.........                                                       .......+|+.|+
T Consensus       167 ~~~~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~y~  191 (291)
T 1u46_A          167 LMRALPQNDDHY-------------------------------------------------------VMQEHRKVPFAWC  191 (291)
T ss_dssp             TCEECCC-CCEE-------------------------------------------------------EC-----CCGGGC
T ss_pred             ccccccccccch-------------------------------------------------------hhhccCCCCceee
Confidence            986543211000                                                       0011234677788


Q ss_pred             chHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         294 APEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       294 APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                      |||++.+..+..++|+||+|++++.+.+ +..+|....................      .....++++.+||.+||+.|
T Consensus       192 aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~~  265 (291)
T 1u46_A          192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP------RPEDCPQDIYNVMVQCWAHK  265 (291)
T ss_dssp             CHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC------CCTTCCHHHHHHHHHHTCSS
T ss_pred             CchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCC------CCcCcCHHHHHHHHHHccCC
Confidence            8888877767777899999999987755 5555543222222222222111111      12356889999999999999


Q ss_pred             CCCCCCHHHHhcC
Q psy8260         373 SEKRITAEQALAH  385 (427)
Q Consensus       373 P~~R~ta~e~L~H  385 (427)
                      |.+|||++|++++
T Consensus       266 p~~Rps~~~l~~~  278 (291)
T 1u46_A          266 PEDRPTFVALRDF  278 (291)
T ss_dssp             GGGSCCHHHHHHH
T ss_pred             cccCcCHHHHHHH
Confidence            9999999999974

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=5.8e-38  Score=297.35  Aligned_cols=246  Identities=20%  Similarity=0.296  Sum_probs=181.6

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      +.+..+.|.+.+.||+|+||.||.+..   +|+.||||++....    ..+.+.+|+.+++.++||||+++++++...  
T Consensus        16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--   86 (278)
T 1byg_A           16 WALNMKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE--   86 (278)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEE---TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred             ccCChhhceEEeEEecCCCceEEEEEE---cCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--
Confidence            456678899999999999999997643   48899999986532    345678999999999999999999986432  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL  214 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~~---~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGl  214 (427)
                         ....|++++++ +++|.+++...   .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus        87 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~  163 (278)
T 1byg_A           87 ---KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL  163 (278)
T ss_dssp             -----CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred             ---CCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccc
Confidence               23578999988 56999988653   389999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccc
Q psy8260         215 ARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRA  294 (427)
Q Consensus       215 a~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~A  294 (427)
                      ++.........                                                             .+|+.|+|
T Consensus       164 ~~~~~~~~~~~-------------------------------------------------------------~~~~~y~a  182 (278)
T 1byg_A          164 TKEASSTQDTG-------------------------------------------------------------KLPVKWTA  182 (278)
T ss_dssp             -------------------------------------------------------------------------CCTTTSC
T ss_pred             cccccccccCC-------------------------------------------------------------CccccccC
Confidence            86432221111                                                             24566777


Q ss_pred             hHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCC
Q psy8260         295 PEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDS  373 (427)
Q Consensus       295 PEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP  373 (427)
                      ||++.+..+..++|+||+|++++.+.+ +..+|................. .      ......++++.+||.+||+.||
T Consensus       183 PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~-~------~~~~~~~~~l~~li~~~l~~~p  255 (278)
T 1byg_A          183 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-M------DAPDGCPPAVYEVMKNCWHLDA  255 (278)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC-C------CCCTTCCHHHHHHHHHHTCSSG
T ss_pred             HHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC-C------CCcccCCHHHHHHHHHHhcCCh
Confidence            777766666667899999999987744 4444433222222222111110 0      1124568899999999999999


Q ss_pred             CCCCCHHHHhc
Q psy8260         374 EKRITAEQALA  384 (427)
Q Consensus       374 ~~R~ta~e~L~  384 (427)
                      .+|||++|+++
T Consensus       256 ~~Rps~~~l~~  266 (278)
T 1byg_A          256 AMRPSFLQLRE  266 (278)
T ss_dssp             GGSCCHHHHHH
T ss_pred             hhCCCHHHHHH
Confidence            99999999875

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=5.9e-39  Score=335.93  Aligned_cols=267  Identities=24%  Similarity=0.276  Sum_probs=191.3

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      +.|.+.+.||.|+||.||. +.+..+|+.||||++... ......+.+.+|+++++.++||||+++++++..........
T Consensus        14 grY~i~~~LG~G~fG~Vyl-a~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLR-WIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCC-CCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred             CCeEEEEEEeeCCCeEEEE-EEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence            6799999999999999995 556778999999988654 34555677889999999999999999999976533333345


Q ss_pred             eEEEEeccC-CCCHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCC---EEEeeCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRTQ----KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE---LKILDFGLA  215 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~~----~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~---~kl~DFGla  215 (427)
                      ..|++++++ |++|.+++...    .+++..+..++.|++.||.|||++||+||||||+|||++.++.   +||+|||++
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a  171 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA  171 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred             eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence            678899988 78999998752    5899999999999999999999999999999999999997664   999999998


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      +......                                                           ......||+.|+||
T Consensus       172 ~~~~~~~-----------------------------------------------------------~~~~~~gt~~Y~AP  192 (676)
T 3qa8_A          172 KELDQGE-----------------------------------------------------------LCTEFVGTLQYLAP  192 (676)
T ss_dssp             CBTTSCC-----------------------------------------------------------CCCCCCSCCTTCSS
T ss_pred             ccccccc-----------------------------------------------------------ccccccCCcccCCh
Confidence            7543211                                                           01123456666777


Q ss_pred             HHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhc---------CcHHHHHHHhcCCCCCcccH-------HhhcCCCCh
Q psy8260         296 EIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKI---------SSDSARKYINSLPLLTKKDF-------RQVFKGANP  359 (427)
Q Consensus       296 Evl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~-------~~~~~~~s~  359 (427)
                      |++.+..+...+|+||+|++++.+.++..||....         ...................+       ......+++
T Consensus       193 E~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~  272 (676)
T 3qa8_A          193 ELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAG  272 (676)
T ss_dssp             CSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHH
T ss_pred             HHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhH
Confidence            76666667777899999999988866655553210         00000000000000000000       111223467


Q ss_pred             hHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q psy8260         360 QAIDLLSLMLELDSEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       360 ~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~  391 (427)
                      ++.+||.+||++||.+|||++|+|+||||..+
T Consensus       273 ~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l  304 (676)
T 3qa8_A          273 KLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL  304 (676)
T ss_dssp             HHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred             HHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence            89999999999999999999999999999754

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=4.9e-38  Score=331.33  Aligned_cols=253  Identities=17%  Similarity=0.253  Sum_probs=188.2

Q ss_pred             Ccceeec-cccCcccccEEEEeEE-eCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcccc
Q psy8260          63 RGVIDIG-PTLSKESFDLIFSSAL-DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        63 ~~~~~~~-~~lg~g~fg~v~~~~~-~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~  140 (427)
                      ...+.+. +.||+|+||.||++.. +..+++.||||++..........+.+.+|+++|++++|||||++++++..     
T Consensus       367 ~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----  441 (635)
T 4fl3_A          367 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-----  441 (635)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-----
T ss_pred             chhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----
Confidence            3334443 4799999999998754 34567899999997654444456678899999999999999999998754     


Q ss_pred             CCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCC
Q psy8260         141 DFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT  218 (427)
Q Consensus       141 ~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~  218 (427)
                        ...+++||++ +++|.+++.. ..+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+++..
T Consensus       442 --~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~  519 (635)
T 4fl3_A          442 --ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL  519 (635)
T ss_dssp             --SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHT
T ss_pred             --CCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCcccc
Confidence              2467888888 7899998865 46999999999999999999999999999999999999999999999999998643


Q ss_pred             CCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         219 ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       219 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                      .......                                                       .......||+.|+|||++
T Consensus       520 ~~~~~~~-------------------------------------------------------~~~~~~~~t~~y~APE~~  544 (635)
T 4fl3_A          520 RADENYY-------------------------------------------------------KAQTHGKWPVKWYAPECI  544 (635)
T ss_dssp             TC--------------------------------------------------------------------CGGGSCHHHH
T ss_pred             ccCcccc-------------------------------------------------------ccccCCCCceeeeChhhh
Confidence            2211000                                                       011123467889999998


Q ss_pred             hhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC
Q psy8260         299 LNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI  377 (427)
Q Consensus       299 ~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~  377 (427)
                      .+..+..++|+||+|+++++|.+ +..||....... ....+......      ......++++.+||.+||+.||.+||
T Consensus       545 ~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-~~~~i~~~~~~------~~p~~~~~~l~~li~~cl~~dP~~RP  617 (635)
T 4fl3_A          545 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERM------GCPAGCPREMYDLMNLCWTYDVENRP  617 (635)
T ss_dssp             HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHHHHTTCCC------CCCTTCCHHHHHHHHHHTCSSTTTSC
T ss_pred             cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCCCC------CCCCCCCHHHHHHHHHHcCCCHhHCc
Confidence            88778888899999999987654 555553322112 21222111111      11235688999999999999999999


Q ss_pred             CHHHHhc
Q psy8260         378 TAEQALA  384 (427)
Q Consensus       378 ta~e~L~  384 (427)
                      |++++++
T Consensus       618 s~~~l~~  624 (635)
T 4fl3_A          618 GFAAVEL  624 (635)
T ss_dssp             CHHHHHH
T ss_pred             CHHHHHH
Confidence            9999875

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=8.9e-38  Score=323.53  Aligned_cols=257  Identities=23%  Similarity=0.319  Sum_probs=196.4

Q ss_pred             ccccccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecC
Q psy8260          57 PYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSN  136 (427)
Q Consensus        57 ~~~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~  136 (427)
                      ..+++....|.+.+.||+|+||.||.+...  .+..||||++......   .+.+.+|+++|++++|||||++++++.. 
T Consensus       260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-  333 (535)
T 2h8h_A          260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-  333 (535)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSEEEEEEEET--TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             cceecchhhhhhheecccCCCeEEEEEEEC--CCceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence            346788889999999999999999987653  3567999999754332   3567899999999999999999998753 


Q ss_pred             ccccCCceEEEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeC
Q psy8260         137 TCLADFKNVYMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDF  212 (427)
Q Consensus       137 ~~~~~~~~~~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DF  212 (427)
                            ..+|++||++ +++|.++++.   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus       334 ------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DF  407 (535)
T 2h8h_A          334 ------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADF  407 (535)
T ss_dssp             ------SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCT
T ss_pred             ------ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEccc
Confidence                  3468999988 6799999863   45999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccc
Q psy8260         213 GLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWY  292 (427)
Q Consensus       213 Gla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y  292 (427)
                      |+++........                                                         ...+..+|+.|
T Consensus       408 G~a~~~~~~~~~---------------------------------------------------------~~~~~~~~~~y  430 (535)
T 2h8h_A          408 GLARLIEDNEYT---------------------------------------------------------ARQGAKFPIKW  430 (535)
T ss_dssp             TSTTTCCCHHHH---------------------------------------------------------TTCSTTSCGGG
T ss_pred             ccceecCCCcee---------------------------------------------------------cccCCcCcccc
Confidence            998754321000                                                         01123456778


Q ss_pred             cchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCC
Q psy8260         293 RAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLEL  371 (427)
Q Consensus       293 ~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~  371 (427)
                      +|||++.+..+..++|+||+|+++++|.+ +..+|......+......... ...      .....++++.+||.+||+.
T Consensus       431 ~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~-~~~------~~~~~~~~l~~li~~cl~~  503 (535)
T 2h8h_A          431 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RMP------CPPECPESLHDLMCQCWRK  503 (535)
T ss_dssp             SCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC-CCC------CCTTCCHHHHHHHHHHTCS
T ss_pred             cCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCC------CCCCCCHHHHHHHHHHcCC
Confidence            88888887777778899999999988866 554553322112222221111 110      1234678899999999999


Q ss_pred             CCCCCCCHHHHhcC--CCCC
Q psy8260         372 DSEKRITAEQALAH--PYLS  389 (427)
Q Consensus       372 dP~~R~ta~e~L~H--p~f~  389 (427)
                      ||++|||++++++.  .+|.
T Consensus       504 dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          504 EPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             SGGGSCCHHHHHHHHHTSSC
T ss_pred             ChhHCcCHHHHHHHHHHHhh
Confidence            99999999999864  5554

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.6e-38  Score=303.35  Aligned_cols=239  Identities=19%  Similarity=0.304  Sum_probs=175.7

Q ss_pred             cceeec-cccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHH-hcCCCCCceeeeeeeecCccccC
Q psy8260          64 GVIDIG-PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRML-KHMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        64 ~~~~~~-~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l-~~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      +.|.+. +.||+|+||.||. +.+..+|+.||||++...       ....+|+.++ +.++||||+++++++...  ...
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~-~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~--~~~   86 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQ-IFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENL--YAG   86 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEE-EEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE--ETT
T ss_pred             cchhhcCcccccCCCeEEEE-EEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhh--cCC
Confidence            446665 7899999999996 567788999999998542       2356788887 667999999999998641  112


Q ss_pred             CceEEEEeccC-CCCHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcC---CCCEEEeeCCC
Q psy8260         142 FKNVYMVTHLM-GADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE---DCELKILDFGL  214 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l~~~---~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~---~~~~kl~DFGl  214 (427)
                      ...++++++++ +++|.+++...   .+++..+..++.|++.||.|||++||+||||||+|||++.   ++.+||+|||+
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~  166 (299)
T 3m2w_A           87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF  166 (299)
T ss_dssp             EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence            35688999998 67999988754   5999999999999999999999999999999999999997   78999999998


Q ss_pred             CCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccc
Q psy8260         215 ARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRA  294 (427)
Q Consensus       215 a~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~A  294 (427)
                      ++.....                                                                         
T Consensus       167 a~~~~~~-------------------------------------------------------------------------  173 (299)
T 3m2w_A          167 AKETTGE-------------------------------------------------------------------------  173 (299)
T ss_dssp             CEECTTC-------------------------------------------------------------------------
T ss_pred             ccccccc-------------------------------------------------------------------------
Confidence            7532110                                                                         


Q ss_pred             hHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCC
Q psy8260         295 PEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       295 PEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~  374 (427)
                             .+..++|+||+|++++.|.++..+|...........................+..+++++.+||.+||+.||.
T Consensus       174 -------~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  246 (299)
T 3m2w_A          174 -------KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT  246 (299)
T ss_dssp             -------GGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTT
T ss_pred             -------cCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChh
Confidence                   0233469999999998875554444322111000000000000001111223456899999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCC
Q psy8260         375 KRITAEQALAHPYLSQYS  392 (427)
Q Consensus       375 ~R~ta~e~L~Hp~f~~~~  392 (427)
                      +|||++|+|+||||.+..
T Consensus       247 ~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          247 QRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             TSCCHHHHHTSHHHHTGG
T ss_pred             hCCCHHHHhcChhhcccc
Confidence            999999999999998654

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3e-37  Score=324.30  Aligned_cols=259  Identities=18%  Similarity=0.247  Sum_probs=190.1

Q ss_pred             ccCcceeecc-ccCcccccEEEEeEEe-CcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          61 ICRGVIDIGP-TLSKESFDLIFSSALD-SVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        61 ~~~~~~~~~~-~lg~g~fg~v~~~~~~-~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      +....+.+.+ .||+|+||.||.+... ..++..||||++.... .....+.+.+|+++|++++|||||++++++..   
T Consensus       332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---  407 (613)
T 2ozo_A          332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---  407 (613)
T ss_dssp             CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES---
T ss_pred             ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc---
Confidence            3444555555 7999999999987654 3456789999997542 22345678899999999999999999999864   


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                          ..+|++||++ +++|.+++..  ..+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||++
T Consensus       408 ----~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla  483 (613)
T 2ozo_A          408 ----EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLS  483 (613)
T ss_dssp             ----SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTT
T ss_pred             ----CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCc
Confidence                2478889888 7899998854  45999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      +.........                                                       .......+|+.|+||
T Consensus       484 ~~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~y~AP  508 (613)
T 2ozo_A          484 KALGADDSYY-------------------------------------------------------TARSAGKWPLKWYAP  508 (613)
T ss_dssp             TTCC---------------------------------------------------------------------CCTTSCH
T ss_pred             ccccCCCcee-------------------------------------------------------eeccCCCCccceeCH
Confidence            7543211000                                                       001112356788999


Q ss_pred             HHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCC
Q psy8260         296 EIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       296 Evl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~  374 (427)
                      |++.+..+..++|+||+|+++++|.+ +..||......+... .+......      ......++++.+||.+||+.||.
T Consensus       509 E~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~-~i~~~~~~------~~p~~~~~~l~~li~~cl~~dP~  581 (613)
T 2ozo_A          509 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA-FIEQGKRM------ECPPECPPELYALMSDCWIYKWE  581 (613)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHH-HHHTTCCC------CCCTTCCHHHHHHHHHTTCSSTT
T ss_pred             hhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH-HHHcCCCC------CCCCcCCHHHHHHHHHHcCCChh
Confidence            98887777788899999999987654 555554332222222 22211111      11234678999999999999999


Q ss_pred             CCCCHHHH---hcCCCCC
Q psy8260         375 KRITAEQA---LAHPYLS  389 (427)
Q Consensus       375 ~R~ta~e~---L~Hp~f~  389 (427)
                      +|||++++   |++.|+.
T Consensus       582 ~RPs~~~l~~~L~~~~~~  599 (613)
T 2ozo_A          582 DRPDFLTVEQRMRACYYS  599 (613)
T ss_dssp             TSCCHHHHHHHHHHHHHH
T ss_pred             HCcCHHHHHHHHHHHHHH
Confidence            99999997   4555553

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.2e-37  Score=317.81  Aligned_cols=262  Identities=18%  Similarity=0.251  Sum_probs=190.3

Q ss_pred             cCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccC
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      ..+.|.+.+.||+|+||.||. +.+..+|+.||||++......    .++.+|+++++.++|++++..+.++..     .
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~-a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~-----~   74 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYL-GTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGV-----E   74 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEE-EEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEE-----E
T ss_pred             cCCcEEEEEEEeeCCCEEEEE-EEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEe-----e
Confidence            356799999999999999996 456778999999987643322    236789999999988655554444432     2


Q ss_pred             CceEEEEeccCCCCHHHHHh--hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEE---cCCCCEEEeeCCCCC
Q psy8260         142 FKNVYMVTHLMGADLNNILR--TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILDFGLAR  216 (427)
Q Consensus       142 ~~~~~lv~e~~g~~L~~~l~--~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl---~~~~~~kl~DFGla~  216 (427)
                      ....+++|++++++|.+++.  ...+++..+..++.||+.||.|||++|||||||||+|||+   +.++.+||+|||+++
T Consensus        75 ~~~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~  154 (483)
T 3sv0_A           75 GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (483)
T ss_dssp             TTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             CCEEEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence            24678999999999999987  4679999999999999999999999999999999999999   578999999999997


Q ss_pred             CCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         217 PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       217 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      .........  ...|                                                 .......||+.|+|||
T Consensus       155 ~~~~~~~~~--~~~~-------------------------------------------------~~~~~~~gt~~Y~aPE  183 (483)
T 3sv0_A          155 KYRDTSTHQ--HIPY-------------------------------------------------RENKNLTGTARYASVN  183 (483)
T ss_dssp             ECBCTTTCC--BCCC-------------------------------------------------CCCCCCCSCTTTCCHH
T ss_pred             eccCCcccc--cccc-------------------------------------------------ccccccCCCccccCHH
Confidence            543221100  0000                                                 0122456889999999


Q ss_pred             HhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCC
Q psy8260         297 IMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKR  376 (427)
Q Consensus       297 vl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R  376 (427)
                      ++.+..+..++|+||+|++++.|.++..+|...........+...................++++.+||.+||+.||.+|
T Consensus       184 ~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~R  263 (483)
T 3sv0_A          184 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDK  263 (483)
T ss_dssp             HHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCC
T ss_pred             HhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhC
Confidence            99888787788999999999888655555533221111111110000000111223446678999999999999999999


Q ss_pred             CCHHHHhc
Q psy8260         377 ITAEQALA  384 (427)
Q Consensus       377 ~ta~e~L~  384 (427)
                      |+++++++
T Consensus       264 Ps~~el~~  271 (483)
T 3sv0_A          264 PDYSYLKR  271 (483)
T ss_dssp             CCHHHHHH
T ss_pred             cCHHHHHH
Confidence            99987643

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.9e-37  Score=297.85  Aligned_cols=254  Identities=20%  Similarity=0.252  Sum_probs=180.8

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcC--CCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPF--QSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      +..++.||+|+||.||.+..   +++.||||++....  ......+.+.+|+.+++.++||||+++++++...      .
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~  103 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV---NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDG------D  103 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES---SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSS------S
T ss_pred             cccCCccccCCCeEEEEEEE---CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecC------C
Confidence            33458899999999997643   68899999986532  2233456678999999999999999999998653      3


Q ss_pred             eEEEEeccC-CCCHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRT----QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT  218 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~----~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~  218 (427)
                      ..+++++++ +++|.+++..    ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  183 (307)
T 2nru_A          104 DLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARAS  183 (307)
T ss_dssp             SCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             ceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccc
Confidence            568888887 7899988852    45899999999999999999999999999999999999999999999999998643


Q ss_pred             CCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         219 ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       219 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                      ......                                                        .......||+.|+|||++
T Consensus       184 ~~~~~~--------------------------------------------------------~~~~~~~g~~~y~aPE~~  207 (307)
T 2nru_A          184 EKFAQT--------------------------------------------------------VMTSRIVGTTAYMAPEAL  207 (307)
T ss_dssp             CSCSSC--------------------------------------------------------EECSSCCSCGGGCCHHHH
T ss_pred             cccccc--------------------------------------------------------ccccccCCCcCcCChHHh
Confidence            221100                                                        011123577788888877


Q ss_pred             hhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcH----HHHHHHhcCCCCC---cccHHhhcCCCChhHHHHHHHhcCC
Q psy8260         299 LNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSD----SARKYINSLPLLT---KKDFRQVFKGANPQAIDLLSLMLEL  371 (427)
Q Consensus       299 ~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~----~~~~~~~~~~~~~---~~~~~~~~~~~s~~~~dLi~~mL~~  371 (427)
                      .+. +..++|+||+|++++.|.++..+|.......    .............   ...........++.+.+||.+||+.
T Consensus       208 ~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  286 (307)
T 2nru_A          208 RGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHE  286 (307)
T ss_dssp             TTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCS
T ss_pred             cCC-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCC
Confidence            653 5567799999999988755444443221111    1111100000000   0000000011235688999999999


Q ss_pred             CCCCCCCHHHHhcC
Q psy8260         372 DSEKRITAEQALAH  385 (427)
Q Consensus       372 dP~~R~ta~e~L~H  385 (427)
                      ||.+|||++|+++|
T Consensus       287 ~p~~Rps~~~l~~~  300 (307)
T 2nru_A          287 KKNKRPDIKKVQQL  300 (307)
T ss_dssp             STTTSCCHHHHHHH
T ss_pred             CcccCcCHHHHHHH
Confidence            99999999999875

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=7.5e-39  Score=321.33  Aligned_cols=263  Identities=16%  Similarity=0.144  Sum_probs=182.4

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCC-CCceee---------eee
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNH-ENVIGL---------LDV  132 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~H-pnIv~l---------~~~  132 (427)
                      ..+.+++.||+|+||.||+ +.+..+|+.||||++..... .....+.+.+|+.+++.++| +|....         .+.
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~-a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLE-ATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEE-EEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             eeEEEecccccCCCEEEEE-EEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            4577889999999999996 56778899999998873322 22234567899999999987 322111         111


Q ss_pred             eec-----------CccccCCceEEEEeccCCCCHHHHHh--------hCCCCHHHHHHHHHHHHHHHHHHHhcCceecc
Q psy8260         133 FHS-----------NTCLADFKNVYMVTHLMGADLNNILR--------TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRD  193 (427)
Q Consensus       133 ~~~-----------~~~~~~~~~~~lv~e~~g~~L~~~l~--------~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrD  193 (427)
                      ...           .........+++++++++++|.++++        ...+++..+..++.||+.||+|||++||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD  236 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY  236 (413)
T ss_dssp             EECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             cccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence            100           00001123578888999999998884        23477788888999999999999999999999


Q ss_pred             CCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhcc
Q psy8260         194 LKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDF  273 (427)
Q Consensus       194 LKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~  273 (427)
                      |||+|||++.++.+||+|||+++.........+| +.|+|||++.+....                              
T Consensus       237 iKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~------------------------------  285 (413)
T 3dzo_A          237 LRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLP------------------------------  285 (413)
T ss_dssp             CCGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTST------------------------------
T ss_pred             cccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccc------------------------------
Confidence            9999999999999999999998866555555566 777777776431000                              


Q ss_pred             CCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhh
Q psy8260         274 GLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQV  353 (427)
Q Consensus       274 g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (427)
                                .+..           .+..+..++|+||+|++++.|.++..||.........           .. ....
T Consensus       286 ----------~~~~-----------~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~-----------~~-~~~~  332 (413)
T 3dzo_A          286 ----------FGQH-----------HPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS-----------EW-IFRS  332 (413)
T ss_dssp             ----------TGGG-----------CCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCS-----------GG-GGSS
T ss_pred             ----------cccc-----------cCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhH-----------HH-HHhh
Confidence                      0000           1112445679999999998885554444322111000           00 0011


Q ss_pred             cCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q psy8260         354 FKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       354 ~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~  391 (427)
                      ...+++++.+||.+||+.||.+|||+.|+++||||.+.
T Consensus       333 ~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~  370 (413)
T 3dzo_A          333 CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  370 (413)
T ss_dssp             CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence            23568899999999999999999999999999999754

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=5.2e-37  Score=324.66  Aligned_cols=255  Identities=20%  Similarity=0.274  Sum_probs=191.3

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEeC--cCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecC
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALDS--VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSN  136 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~  136 (427)
                      .++..+.|.+++.||+|+||.||.+....  ..+..||||++... ......+.+.+|+.+|+.++||||+++++++.. 
T Consensus       385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-  462 (656)
T 2j0j_A          385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-  462 (656)
T ss_dssp             TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-
Confidence            35667889999999999999999876532  34678999988653 344555678899999999999999999998743 


Q ss_pred             ccccCCceEEEEeccC-CCCHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCC
Q psy8260         137 TCLADFKNVYMVTHLM-GADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG  213 (427)
Q Consensus       137 ~~~~~~~~~~lv~e~~-g~~L~~~l~~~--~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFG  213 (427)
                            ...|++||++ +++|.++++..  .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus       463 ------~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG  536 (656)
T 2j0j_A          463 ------NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG  536 (656)
T ss_dssp             ------SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             ------CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecC
Confidence                  2468888888 68999998754  58999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccccc
Q psy8260         214 LARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR  293 (427)
Q Consensus       214 la~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~  293 (427)
                      +++........                                                         ......||+.|+
T Consensus       537 ~a~~~~~~~~~---------------------------------------------------------~~~~~~~t~~y~  559 (656)
T 2j0j_A          537 LSRYMEDSTYY---------------------------------------------------------KASKGKLPIKWM  559 (656)
T ss_dssp             CCCSCCC-------------------------------------------------------------------CCGGGC
T ss_pred             CCeecCCCcce---------------------------------------------------------eccCCCCCccee
Confidence            99754321100                                                         001224577888


Q ss_pred             chHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         294 APEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       294 APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                      |||++.+..+..++|+||+|++++.+.+ +..||......+...........       ......++++.+||.+||+.|
T Consensus       560 aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~-------~~~~~~~~~l~~li~~~l~~d  632 (656)
T 2j0j_A          560 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL-------PMPPNCPPTLYSLMTKCWAYD  632 (656)
T ss_dssp             CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC-------CCCTTCCHHHHHHHHHHTCSS
T ss_pred             CHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC-------CCCccccHHHHHHHHHHcCCC
Confidence            8888887777778899999999876532 33344322211222222211111       112356789999999999999


Q ss_pred             CCCCCCHHHHhcC
Q psy8260         373 SEKRITAEQALAH  385 (427)
Q Consensus       373 P~~R~ta~e~L~H  385 (427)
                      |.+|||++|++++
T Consensus       633 P~~RPs~~el~~~  645 (656)
T 2j0j_A          633 PSRRPRFTELKAQ  645 (656)
T ss_dssp             GGGSCCHHHHHHH
T ss_pred             hhHCcCHHHHHHH
Confidence            9999999999853

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=5.4e-38  Score=303.14  Aligned_cols=264  Identities=22%  Similarity=0.311  Sum_probs=184.1

Q ss_pred             ccccccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecC
Q psy8260          57 PYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSN  136 (427)
Q Consensus        57 ~~~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~  136 (427)
                      ..+++..+.|.+.+.||+|+||.||.+...    ..||+|++..........+.+.+|+.+++.++||||+++++++...
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~----~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  101 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWH----GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP  101 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEES----SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEc----CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence            345677788999999999999999976542    2499999875433333334466899999999999999999998754


Q ss_pred             ccccCCceEEEEeccC-CCCHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCC
Q psy8260         137 TCLADFKNVYMVTHLM-GADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG  213 (427)
Q Consensus       137 ~~~~~~~~~~lv~e~~-g~~L~~~l~~~--~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFG  213 (427)
                            ..++++++++ +++|.+++...  .+++..+..++.|++.||.|||++||+||||||+|||++ ++.+||+|||
T Consensus       102 ------~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg  174 (319)
T 2y4i_B          102 ------PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFG  174 (319)
T ss_dssp             ------SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCS
T ss_pred             ------CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecC
Confidence                  3578999988 68999998754  489999999999999999999999999999999999998 6799999999


Q ss_pred             CCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccccc
Q psy8260         214 LARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR  293 (427)
Q Consensus       214 la~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~  293 (427)
                      +++.........                                                     .........||+.|+
T Consensus       175 ~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~g~~~y~  201 (319)
T 2y4i_B          175 LFSISGVLQAGR-----------------------------------------------------REDKLRIQNGWLCHL  201 (319)
T ss_dssp             CCC---------------------------------------------------------------CCSCBCCSGGGGTS
T ss_pred             Cccccccccccc-----------------------------------------------------cccccccCCCccccc
Confidence            986432110000                                                     000111223455555


Q ss_pred             chHHhhhc---------cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcC-CCCCcccHHhhcCCCChhHHH
Q psy8260         294 APEIMLNW---------MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSL-PLLTKKDFRQVFKGANPQAID  363 (427)
Q Consensus       294 APEvl~~~---------~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~d  363 (427)
                      |||++.+.         .+..++|+||+|++++.+.++..+|................ +...       ....++++.+
T Consensus       202 aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~  274 (319)
T 2y4i_B          202 APEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLS-------QIGMGKEISD  274 (319)
T ss_dssp             CHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCC-------CSSCCTTHHH
T ss_pred             ChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCC-------cCCCCHHHHH
Confidence            55555431         23445799999999988865555543322111111111111 1110       1246788999


Q ss_pred             HHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q psy8260         364 LLSLMLELDSEKRITAEQALAHPYLSQYSD  393 (427)
Q Consensus       364 Li~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  393 (427)
                      ||.+||..||.+|||++|+++.  +.....
T Consensus       275 li~~~l~~~p~~Rpt~~~l~~~--l~~l~~  302 (319)
T 2y4i_B          275 ILLFCWAFEQEERPTFTKLMDM--LEKLPK  302 (319)
T ss_dssp             HHHHHHCSSTTTSCCHHHHHHH--HTTC--
T ss_pred             HHHHHhcCChhhCcCHHHHHHH--HHHHHH
Confidence            9999999999999999999975  555443

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.1e-37  Score=296.94  Aligned_cols=258  Identities=19%  Similarity=0.259  Sum_probs=191.2

Q ss_pred             cccCcceeeccccCcccccEEEEeEE---eCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecC
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSAL---DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSN  136 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~---~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~  136 (427)
                      .+..+.|.+.+.||+|+||.||.+..   +..+|+.||||++...  .....+.+.+|+++++.++||||+++++++...
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  114 (326)
T 2w1i_A           37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA  114 (326)
T ss_dssp             CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred             ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence            44567799999999999999997664   4668999999998653  344556788999999999999999999987543


Q ss_pred             ccccCCceEEEEeccC-CCCHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCC
Q psy8260         137 TCLADFKNVYMVTHLM-GADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG  213 (427)
Q Consensus       137 ~~~~~~~~~~lv~e~~-g~~L~~~l~~~--~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFG  213 (427)
                      .    ...++++++++ +++|.+++...  .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus       115 ~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg  190 (326)
T 2w1i_A          115 G----RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG  190 (326)
T ss_dssp             -------CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             C----CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCc
Confidence            1    23578899988 67999998753  48999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccccc
Q psy8260         214 LARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR  293 (427)
Q Consensus       214 la~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~  293 (427)
                      +++.........                                                       .......+|+.|+
T Consensus       191 ~~~~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~y~  215 (326)
T 2w1i_A          191 LTKVLPQDKEYY-------------------------------------------------------KVKEPGESPIFWY  215 (326)
T ss_dssp             TCEECCSSCSEE-------------------------------------------------------ECSSCCSCCGGGC
T ss_pred             chhhcccccccc-------------------------------------------------------ccccCCCCceeEE
Confidence            987543221000                                                       0011224667788


Q ss_pred             chHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhh-------cCc----HH----HHHHHhcCCCCCcccHHhhcCCCC
Q psy8260         294 APEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAK-------ISS----DS----ARKYINSLPLLTKKDFRQVFKGAN  358 (427)
Q Consensus       294 APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~-------~~~----~~----~~~~~~~~~~~~~~~~~~~~~~~s  358 (427)
                      |||++.+..+..++|+||+|++++.|.++..++...       ...    ..    ...........      ......+
T Consensus       216 aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~  289 (326)
T 2w1i_A          216 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL------PRPDGCP  289 (326)
T ss_dssp             CHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCC------CCCTTCC
T ss_pred             CchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCC------CCCCccc
Confidence            888887776777789999999998775543322110       000    00    00111111100      1123567


Q ss_pred             hhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy8260         359 PQAIDLLSLMLELDSEKRITAEQALA  384 (427)
Q Consensus       359 ~~~~dLi~~mL~~dP~~R~ta~e~L~  384 (427)
                      +++.+||.+||+.||.+|||++|+++
T Consensus       290 ~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          290 DEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            89999999999999999999999875

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1e-37  Score=307.62  Aligned_cols=249  Identities=13%  Similarity=0.167  Sum_probs=184.3

Q ss_pred             ccccCcceeeccccCcccccEEEEeE----EeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCC---CCCceeeee
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSA----LDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN---HENVIGLLD  131 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~----~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~---HpnIv~l~~  131 (427)
                      .++....|.+.+.||+|+||.||.+.    .+..+++.||||++....     ...+.+|+++++.++   |+||+++++
T Consensus        60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~  134 (365)
T 3e7e_A           60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYS  134 (365)
T ss_dssp             EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred             EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence            35667889999999999999999764    356789999999986532     234567777777776   999999999


Q ss_pred             eeecCccccCCceEEEEeccC-CCCHHHHHh------hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcC-
Q psy8260         132 VFHSNTCLADFKNVYMVTHLM-GADLNNILR------TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE-  203 (427)
Q Consensus       132 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~l~------~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~-  203 (427)
                      ++...      ...|++||++ +++|.+++.      ...+++..+..++.||+.||+|||++|||||||||+|||++. 
T Consensus       135 ~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~  208 (365)
T 3e7e_A          135 AHLFQ------NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNG  208 (365)
T ss_dssp             EEECS------SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGG
T ss_pred             eeecC------CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEeccc
Confidence            98654      4578999988 789999885      356999999999999999999999999999999999999988 


Q ss_pred             ----------CCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhcc
Q psy8260         204 ----------DCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDF  273 (427)
Q Consensus       204 ----------~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~  273 (427)
                                ++.+||+|||+|+.......                                                  
T Consensus       209 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~--------------------------------------------------  238 (365)
T 3e7e_A          209 FLEQDDEDDLSAGLALIDLGQSIDMKLFPK--------------------------------------------------  238 (365)
T ss_dssp             GTCC------CTTEEECCCTTCEEGGGSCT--------------------------------------------------
T ss_pred             ccCccccccccCCEEEeeCchhhhhhccCC--------------------------------------------------
Confidence                      89999999999864221000                                                  


Q ss_pred             CCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhh
Q psy8260         274 GLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQV  353 (427)
Q Consensus       274 g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (427)
                            .......+||+.|+|||++.+..+..++|+||+|++++.|.++..+|........     .......     ..
T Consensus       239 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-----~~~~~~~-----~~  302 (365)
T 3e7e_A          239 ------GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC-----KPEGLFR-----RL  302 (365)
T ss_dssp             ------TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-----EECSCCT-----TC
T ss_pred             ------CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-----eechhcc-----cc
Confidence                  0022345688888888888887788888999999999888665555543221100     0000010     00


Q ss_pred             cCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCC
Q psy8260         354 FKGANPQAIDLLSLMLELDSEKRITAEQALAHP  386 (427)
Q Consensus       354 ~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp  386 (427)
                        ..++...+++.+||..||.+|++..+.+.+.
T Consensus       303 --~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~  333 (365)
T 3e7e_A          303 --PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK  333 (365)
T ss_dssp             --SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred             --CcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence              1245678999999999999997665555443

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=5e-37  Score=299.29  Aligned_cols=258  Identities=20%  Similarity=0.316  Sum_probs=182.2

Q ss_pred             cCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhc--CCCCCceeeeeeeecCccc
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKH--MNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~--l~HpnIv~l~~~~~~~~~~  139 (427)
                      ..+.|.+.+.||+|+||.||.+..   +|+.||||++...     ....+.+|++++..  ++||||+++++++..... 
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~-  110 (342)
T 1b6c_B           40 IARTIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNG-  110 (342)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEE---TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS-
T ss_pred             ccccEEEEeeecCCCCcEEEEEEE---cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC-
Confidence            346789999999999999997654   5899999998542     23456688888877  799999999999865421 


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHH--------hcCceeccCCCCCeEEcCCCCEEEe
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIH--------SAGIIHRDLKPSNIAVNEDCELKIL  210 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH--------~~~iiHrDLKp~NILl~~~~~~kl~  210 (427)
                       ....++++++++ +++|.+++....+++..+..++.|++.||.|||        ++||+||||||+|||++.++.+||+
T Consensus       111 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~  189 (342)
T 1b6c_B          111 -TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  189 (342)
T ss_dssp             -SCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEEC
T ss_pred             -ccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEE
Confidence             113678999988 569999998889999999999999999999999        8999999999999999999999999


Q ss_pred             eCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccc
Q psy8260         211 DFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATR  290 (427)
Q Consensus       211 DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~  290 (427)
                      |||+++.........                                                      ........||+
T Consensus       190 Dfg~~~~~~~~~~~~------------------------------------------------------~~~~~~~~gt~  215 (342)
T 1b6c_B          190 DLGLAVRHDSATDTI------------------------------------------------------DIAPNHRVGTK  215 (342)
T ss_dssp             CCTTCEEEETTTTEE------------------------------------------------------EECCCSCCCCG
T ss_pred             ECCCceecccccccc------------------------------------------------------ccccccCCcCc
Confidence            999986432211000                                                      00011224556


Q ss_pred             cccchHHhhhcc------CCCCCCHHHHHHHHHHhCCC----------CHHHHhhcCc----HHHHHHHhcCCCCCcccH
Q psy8260         291 WYRAPEIMLNWM------HYNQTDIHQLNLIMEMLGTP----------PAEFMAKISS----DSARKYINSLPLLTKKDF  350 (427)
Q Consensus       291 ~Y~APEvl~~~~------~~~~~d~~slg~i~~~lg~~----------~~~~~~~~~~----~~~~~~~~~~~~~~~~~~  350 (427)
                      .|+|||++.+..      +..++|+||+|++++.|.++          ..||......    ........... ... ..
T Consensus       216 ~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~-~~  293 (342)
T 1b6c_B          216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK-LRP-NI  293 (342)
T ss_dssp             GGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC-CCC-CC
T ss_pred             ccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHH-hCC-CC
Confidence            666666655432      12357999999999888655          3344332111    11111111110 000 00


Q ss_pred             Hhhc--CCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         351 RQVF--KGANPQAIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       351 ~~~~--~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                      ...+  ....+.+.+||.+||+.||++|||++|+++|
T Consensus       294 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          294 PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             CGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            0111  1123568899999999999999999999976

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.9e-37  Score=326.89  Aligned_cols=249  Identities=20%  Similarity=0.293  Sum_probs=185.6

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      ++..+.|.+.+.||+|+||.||.+.....+|+.||||++... ........+.+|++++++++|||||++++++......
T Consensus        76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  154 (681)
T 2pzi_A           76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH  154 (681)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred             CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence            455688999999999999999976554457999999988653 3445556678999999999999999999998754321


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCC
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT  218 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~  218 (427)
                       .....|+|||++ |++|.+++.. .+++..+..++.||+.||.|||++|||||||||+|||++.+ .+||+|||+++..
T Consensus       155 -~~~~~~lv~E~~~g~~L~~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          155 -GDPVGYIVMEYVGGQSLKRSKGQ-KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             -SCEEEEEEEECCCCEECC----C-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             -CCceeEEEEEeCCCCcHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence             112368999998 6788887654 79999999999999999999999999999999999999975 8999999998643


Q ss_pred             CCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         219 ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       219 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                      ... +..                                                             .||+.|+|||++
T Consensus       232 ~~~-~~~-------------------------------------------------------------~gt~~y~aPE~~  249 (681)
T 2pzi_A          232 NSF-GYL-------------------------------------------------------------YGTPGFQAPEIV  249 (681)
T ss_dssp             TCC-SCC-------------------------------------------------------------CCCTTTSCTTHH
T ss_pred             ccC-Ccc-------------------------------------------------------------CCCccccCHHHH
Confidence            321 222                                                             355566666665


Q ss_pred             hhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC
Q psy8260         299 LNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT  378 (427)
Q Consensus       299 ~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t  378 (427)
                      .+. ...++|+||+|++++.|.++..++......        ..+  .....    ...++.+.+||.+||+.||.+|+|
T Consensus       250 ~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------~~~--~~~~~----~~~~~~l~~li~~~l~~dP~~R~~  314 (681)
T 2pzi_A          250 RTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD--------GLP--EDDPV----LKTYDSYGRLLRRAIDPDPRQRFT  314 (681)
T ss_dssp             HHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS--------SCC--TTCHH----HHHCHHHHHHHHHHTCSSGGGSCS
T ss_pred             cCC-CCCceehhhhHHHHHHHHhCCCCCcccccc--------ccc--ccccc----cccCHHHHHHHhhhccCChhhCCC
Confidence            443 244579999999998876554433322110        111  00011    113578899999999999999999


Q ss_pred             HHHHhcCCCCC
Q psy8260         379 AEQALAHPYLS  389 (427)
Q Consensus       379 a~e~L~Hp~f~  389 (427)
                      +.+.+.|+|+.
T Consensus       315 ~~~~l~~~l~~  325 (681)
T 2pzi_A          315 TAEEMSAQLTG  325 (681)
T ss_dssp             SHHHHHHHHHH
T ss_pred             HHHHHHHHHHH
Confidence            99999999885

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.4e-34  Score=276.16  Aligned_cols=230  Identities=15%  Similarity=0.058  Sum_probs=176.7

Q ss_pred             ccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC-HHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          61 ICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS-AVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        61 ~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      +..++|.+.+.||+|+||.||. +.+..+|+.||||++...... ....+.+.+|+.+++.++||||+++++++...   
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~-a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~---  103 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQ-ALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR---  103 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEE-EEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET---
T ss_pred             EecCcEEEEEEEcccCCeEEEE-EEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC---
Confidence            5567899999999999999996 567778999999999765433 44556788999999999999999999998654   


Q ss_pred             cCCceEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCC
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPT  218 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~  218 (427)
                         ...|++||++ |++|.++++.+ .....+..++.|++.||.|||++||+||||||+|||++.++.+||+++|.    
T Consensus       104 ---~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~----  175 (286)
T 3uqc_A          104 ---AGGLVVAEWIRGGSLQEVADTS-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT----  175 (286)
T ss_dssp             ---TEEEEEEECCCEEEHHHHHTTC-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC----
T ss_pred             ---CcEEEEEEecCCCCHHHHHhcC-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc----
Confidence               4579999998 68999999755 46667888999999999999999999999999999999999999986542    


Q ss_pred             CCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         219 ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       219 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                                   ++|                                                                
T Consensus       176 -------------~~~----------------------------------------------------------------  178 (286)
T 3uqc_A          176 -------------MPD----------------------------------------------------------------  178 (286)
T ss_dssp             -------------CTT----------------------------------------------------------------
T ss_pred             -------------cCC----------------------------------------------------------------
Confidence                         111                                                                


Q ss_pred             hhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC
Q psy8260         299 LNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT  378 (427)
Q Consensus       299 ~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t  378 (427)
                          +..++|+||+|++++.|.++..+|.......... ...................+++++.+||.+||+.||.+| |
T Consensus       179 ----~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s  252 (286)
T 3uqc_A          179 ----ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA-PAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-S  252 (286)
T ss_dssp             ----CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE-ECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-C
T ss_pred             ----CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH-HHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-C
Confidence                2234699999999988866655554322110000 000000111222344556789999999999999999999 9


Q ss_pred             HHHHhcC
Q psy8260         379 AEQALAH  385 (427)
Q Consensus       379 a~e~L~H  385 (427)
                      ++|+++.
T Consensus       253 ~~el~~~  259 (286)
T 3uqc_A          253 ASTLLNL  259 (286)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9999874

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=1.5e-32  Score=285.75  Aligned_cols=158  Identities=16%  Similarity=0.199  Sum_probs=115.8

Q ss_pred             ccCcccccEEEEeEEeCcCCcEEEEEEccCcCC--------CHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecCccccC
Q psy8260          71 TLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ--------SAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        71 ~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~--------~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~~  141 (427)
                      ..+.|++|... ++.....|+.||+|++.+...        .....+++.+|+++|+++ +|+||++++++++.+     
T Consensus       241 ~~~~~~~~~h~-~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~-----  314 (569)
T 4azs_A          241 QPYAGAGLAHK-RSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA-----  314 (569)
T ss_dssp             C-C---------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS-----
T ss_pred             ccccCCccccc-ccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC-----
Confidence            44555555444 445556899999999865321        123445688999999999 799999999998754     


Q ss_pred             CceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         142 FKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                       ..+||||||+ |++|.++++. +.+++.   .|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+...
T Consensus       315 -~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~  390 (569)
T 4azs_A          315 -QSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTP  390 (569)
T ss_dssp             -SEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred             -CEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence             5789999999 7899999875 456654   588999999999999999999999999999999999999999998654


Q ss_pred             CC---cccccccccccchhhhh
Q psy8260         220 NE---MTGYVATRWYRAPEIML  238 (427)
Q Consensus       220 ~~---~~~~~gt~~y~aPE~l~  238 (427)
                      ..   .++.+||+.|||||++.
T Consensus       391 ~~~~~~~t~vGTp~YmAPE~l~  412 (569)
T 4azs_A          391 QDCSWPTNLVQSFFVFVNELFA  412 (569)
T ss_dssp             ---CCSHHHHHHHHHHHHHHC-
T ss_pred             CCCccccCceechhhccHHHhC
Confidence            32   22344555555555543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=1e-25  Score=232.96  Aligned_cols=151  Identities=23%  Similarity=0.267  Sum_probs=116.2

Q ss_pred             ccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC-H-----HHHHHHHHHHHHHhcCCCCCce--eeeeeeecCcccc
Q psy8260          69 GPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS-A-----VHAKRTYRELRMLKHMNHENVI--GLLDVFHSNTCLA  140 (427)
Q Consensus        69 ~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~-~-----~~~~~~~~Ei~~l~~l~HpnIv--~l~~~~~~~~~~~  140 (427)
                      .+.||+|+||.||++   ...++.+|+|+....... .     ...+++.+|+++|++++||||+  .++++..      
T Consensus       341 ~~~LG~G~fg~Vy~~---~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~------  411 (540)
T 3en9_A          341 EHLIGKGAEADIKRD---SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL------  411 (540)
T ss_dssp             -------CCEEEEEE---ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET------
T ss_pred             CCEEeeCCCEEEEEE---EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC------
Confidence            468999999999976   346789999986443221 1     1234578999999999999999  5554421      


Q ss_pred             CCceEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         141 DFKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       141 ~~~~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                        ...|++||++ |++|.+++..       +..++.|++.||.|||++||+||||||+|||++.  .+||+|||+|+...
T Consensus       412 --~~~~lVmE~~~ggsL~~~l~~-------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~  480 (540)
T 3en9_A          412 --DNKRIMMSYINGKLAKDVIED-------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISN  480 (540)
T ss_dssp             --TTTEEEEECCCSEEHHHHSTT-------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred             --CccEEEEECCCCCCHHHHHHH-------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence              2358999988 6899998865       5679999999999999999999999999999998  99999999998765


Q ss_pred             CC----------cccccccccccchhhhhc
Q psy8260         220 NE----------MTGYVATRWYRAPEIMLN  239 (427)
Q Consensus       220 ~~----------~~~~~gt~~y~aPE~l~~  239 (427)
                      ..          ....+||+.|||||++.+
T Consensus       481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~  510 (540)
T 3en9_A          481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWER  510 (540)
T ss_dssp             CHHHHHHHHHHHHHHHHHHCGGGHHHHHHH
T ss_pred             CccccccchhhhhhhhcCCCCcCCHHHHHH
Confidence            42          135689999999999875

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=6.4e-24  Score=201.78  Aligned_cols=145  Identities=18%  Similarity=0.208  Sum_probs=113.1

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH----------------HHHHHHHHHHHHHhcCCCCCceee
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA----------------VHAKRTYRELRMLKHMNHENVIGL  129 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~----------------~~~~~~~~Ei~~l~~l~HpnIv~l  129 (427)
                      +.+++.||+|+||.||.+..  .+|+.||||.+.......                .....+.+|+.+|+.++  | +++
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~--~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v  166 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS--EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV  166 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE--TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred             EEecCEeccCCCceEEEEEe--CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence            45669999999999997654  789999999986432111                23456789999999999  4 555


Q ss_pred             eeeeecCccccCCceEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEE
Q psy8260         130 LDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELK  208 (427)
Q Consensus       130 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~k  208 (427)
                      ++++..       ...|++||++ |++|.+ +.     ......++.|++.||.|||++||+||||||+|||++ ++.+|
T Consensus       167 ~~~~~~-------~~~~lvmE~~~g~~L~~-l~-----~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vk  232 (282)
T 1zar_A          167 PKVYAW-------EGNAVLMELIDAKELYR-VR-----VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIW  232 (282)
T ss_dssp             CCEEEE-------ETTEEEEECCCCEEGGG-CC-----CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEE
T ss_pred             CeEEec-------cceEEEEEecCCCcHHH-cc-----hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEE
Confidence            555432       2358899988 678887 32     133557999999999999999999999999999999 99999


Q ss_pred             EeeCCCCCCCCCCcccccccccccchhhhhc
Q psy8260         209 ILDFGLARPTENEMTGYVATRWYRAPEIMLN  239 (427)
Q Consensus       209 l~DFGla~~~~~~~~~~~gt~~y~aPE~l~~  239 (427)
                      |+|||+|+          .+..|+|||++..
T Consensus       233 l~DFG~a~----------~~~~~~a~e~l~r  253 (282)
T 1zar_A          233 IIDFPQSV----------EVGEEGWREILER  253 (282)
T ss_dssp             ECCCTTCE----------ETTSTTHHHHHHH
T ss_pred             EEECCCCe----------ECCCCCHHHHHHH
Confidence            99999985          3456799999864

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.83  E-value=9.3e-21  Score=177.57  Aligned_cols=138  Identities=19%  Similarity=0.233  Sum_probs=104.0

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcE--EEEEEccCcCCC----------------------HHHHHHHHHHHHHHhcC
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVK--VAIKKIARPFQS----------------------AVHAKRTYRELRMLKHM  121 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~--vAvK~i~~~~~~----------------------~~~~~~~~~Ei~~l~~l  121 (427)
                      +.+.+.||.|+||.||.+. +..+|+.  ||||++......                      ......+.+|+.+|..+
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~-~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYAD-GVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEE-EEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEE-EcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            5788999999999999754 4457888  999986543111                      01123567899999999


Q ss_pred             CCCCc--eeeeeeeecCccccCCceEEEEeccCCC------CHHHHHhhCCCCHHHHHHHHHHHHHHHHHHH-hcCceec
Q psy8260         122 NHENV--IGLLDVFHSNTCLADFKNVYMVTHLMGA------DLNNILRTQKLSDDHVQFLVYQILRGLKYIH-SAGIIHR  192 (427)
Q Consensus       122 ~HpnI--v~l~~~~~~~~~~~~~~~~~lv~e~~g~------~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH-~~~iiHr  192 (427)
                      .|+||  ...++.          ...+++||++++      .|.+....  .++..+..++.|++.||.||| ++||+||
T Consensus       128 ~~~~i~~p~~~~~----------~~~~lVmE~~g~~g~~~~~L~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~givHr  195 (258)
T 1zth_A          128 KEAGVSVPQPYTY----------MKNVLLMEFIGEDELPAPTLVELGRE--LKELDVEGIFNDVVENVKRLYQEAELVHA  195 (258)
T ss_dssp             HHTTCCCCCEEEE----------ETTEEEEECCEETTEECCBHHHHGGG--GGGSCHHHHHHHHHHHHHHHHHTSCEECS
T ss_pred             HhCCCCCCeEEEc----------CCCEEEEEecCCCCCccccHHHHhhc--cChHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence            88864  333322          235789999853      66665432  235567889999999999999 9999999


Q ss_pred             cCCCCCeEEcCCCCEEEeeCCCCCCC
Q psy8260         193 DLKPSNIAVNEDCELKILDFGLARPT  218 (427)
Q Consensus       193 DLKp~NILl~~~~~~kl~DFGla~~~  218 (427)
                      ||||+|||++.  .++|+|||+|...
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999998  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.68  E-value=4.8e-18  Score=166.56  Aligned_cols=136  Identities=18%  Similarity=0.174  Sum_probs=94.5

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC---------------CHHH-----HHHHHHHHHHHhcCCCC
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ---------------SAVH-----AKRTYRELRMLKHMNHE  124 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~---------------~~~~-----~~~~~~Ei~~l~~l~Hp  124 (427)
                      .|.++..||.|+||.||.+. + .+|+.||||++.....               ....     .....+|...|.++.+.
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~-d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~  173 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVA-D-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE  173 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEE-C-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             EEEecCEeeeCCceEEEEEE-C-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence            47899999999999999754 3 4699999998643210               0111     11123577777777554


Q ss_pred             Cce--eeeeeeecCccccCCceEEEEeccCC-CCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEE
Q psy8260         125 NVI--GLLDVFHSNTCLADFKNVYMVTHLMG-ADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV  201 (427)
Q Consensus       125 nIv--~l~~~~~~~~~~~~~~~~~lv~e~~g-~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl  201 (427)
                      ++.  ..++.          ...+++||+++ ..|.++.     ....+..++.|++.+|.|||++|||||||||.|||+
T Consensus       174 gv~vp~p~~~----------~~~~LVME~i~G~~L~~l~-----~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl  238 (397)
T 4gyi_A          174 GFPVPEPIAQ----------SRHTIVMSLVDALPMRQVS-----SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILI  238 (397)
T ss_dssp             TCSCCCEEEE----------ETTEEEEECCSCEEGGGCC-----CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE
T ss_pred             CCCCCeeeec----------cCceEEEEecCCccHhhhc-----ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEE
Confidence            432  22221          12368899884 4665432     223456788999999999999999999999999999


Q ss_pred             cCCC----------CEEEeeCCCCCC
Q psy8260         202 NEDC----------ELKILDFGLARP  217 (427)
Q Consensus       202 ~~~~----------~~kl~DFGla~~  217 (427)
                      ++++          .+.|+||+-+..
T Consensus       239 ~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          239 REEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             EEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             eCCCCcccccccccceEEEEeCCccc
Confidence            8776          389999997653

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.15  E-value=6.5e-12  Score=124.49  Aligned_cols=81  Identities=47%  Similarity=0.711  Sum_probs=66.2

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCC-------ccccccccccccccchHHhhhccC-CCCCCHHHHHHHHHHhC
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPT-------ENEMTGYVATRWYRAPEIMLNWMH-YNQTDIHQLNLIMEMLG  320 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~-------~~~~~~~~gt~~Y~APEvl~~~~~-~~~~d~~slg~i~~~lg  320 (427)
                      ...++|+++.|++++.++.+|++|||+++..       .....+.+||++|||||++.+..+ ..++|+||+|+|+++|.
T Consensus       178 ~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell  257 (398)
T 4b99_A          178 QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEML  257 (398)
T ss_dssp             TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred             cCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHH
Confidence            3578899999999999999999999999743       223457899999999999988654 56679999999999886


Q ss_pred             CCCHHHHhh
Q psy8260         321 TPPAEFMAK  329 (427)
Q Consensus       321 ~~~~~~~~~  329 (427)
                      ++..+|...
T Consensus       258 ~G~~pF~g~  266 (398)
T 4b99_A          258 ARRQLFPGK  266 (398)
T ss_dssp             HTSCSSCCS
T ss_pred             HCCCCCCCC
Confidence            666566443

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.11  E-value=2.2e-10  Score=106.58  Aligned_cols=136  Identities=14%  Similarity=0.112  Sum_probs=97.4

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCC-CCCceeeeeeeecCccccCCce
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN-HENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      +.+....+.|+.+.||...   ..|..+++|.........  ...+.+|+.+|+.+. |.++.+++++....      ..
T Consensus        16 ~~~~~~~~g~s~~~v~~~~---~~~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~------~~   84 (263)
T 3tm0_A           16 YRCVKDTEGMSPAKVYKLV---GENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHD------GW   84 (263)
T ss_dssp             SEEEECCSCCSSSEEEEEE---CSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEET------TE
T ss_pred             ceeEeeccCCCCCeEEEEE---CCCCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEecC------Cc
Confidence            5666777888888898643   236799999875421111  124678999998874 66777888776532      35


Q ss_pred             EEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q psy8260         145 VYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHS-------------------------------------  186 (427)
Q Consensus       145 ~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~-------------------------------------  186 (427)
                      .|++|++. |.+|.+...    +......++.+++.+|..||+                                     
T Consensus        85 ~~lv~e~i~G~~l~~~~~----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T 3tm0_A           85 SNLLMSEADGVLCSEEYE----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEEEEECCSSEEHHHHCC----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred             eEEEEEecCCeehhhccC----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence            67888887 557765421    222334678899999999998                                     


Q ss_pred             ----------------------cCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         187 ----------------------AGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       187 ----------------------~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                                            ..++|+|++|.|||++.++.+.|+||+.+.
T Consensus       161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                  458999999999999876667899999764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.98  E-value=7.7e-10  Score=102.26  Aligned_cols=130  Identities=17%  Similarity=0.133  Sum_probs=86.9

Q ss_pred             eeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCC--ceeeeeeeecCccccCCce
Q psy8260          67 DIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHEN--VIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        67 ~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~~~~~~~~~~~~~~~  144 (427)
                      .+....+.|..+.||..  ...+|..+++|......     ...+.+|+.+++.+.+.+  +.+++++....      ..
T Consensus        23 ~~~~~~~gg~~~~v~~~--~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~------~~   89 (264)
T 1nd4_A           23 DWAQQTIGCSDAAVFRL--SAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEA------GR   89 (264)
T ss_dssp             EEEECSCTTSSCEEEEE--ECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS------SC
T ss_pred             ceEecccCCCCceEEEE--ecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCC------CC
Confidence            34333345556888854  33567889999865431     123567888888885544  45577765432      34


Q ss_pred             EEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q psy8260         145 VYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAG-----------------------------------  188 (427)
Q Consensus       145 ~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~-----------------------------------  188 (427)
                      .+++|+++ |..+.  .  ...+   ...++.+++..|..||+..                                   
T Consensus        90 ~~~v~e~i~G~~l~--~--~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (264)
T 1nd4_A           90 DWLLLGEVPGQDLL--S--SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH  162 (264)
T ss_dssp             EEEEEECCSSEETT--T--SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred             CEEEEEecCCcccC--c--CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence            67888887 55563  1  1122   2246677888888888643                                   


Q ss_pred             -----------------------ceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         189 -----------------------IIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       189 -----------------------iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                                             ++|+|++|.|||++.++.++|+|||.+.
T Consensus       163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                   9999999999999877677899999864

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=98.88  E-value=6.5e-10  Score=108.94  Aligned_cols=79  Identities=56%  Similarity=0.879  Sum_probs=67.3

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh-ccCCCCCCHHHHHHHHHHhCCCCHHHH
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN-WMHYNQTDIHQLNLIMEMLGTPPAEFM  327 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~-~~~~~~~d~~slg~i~~~lg~~~~~~~  327 (427)
                      ...++|+++.|+++..++.+|++|||+++.......+.+||++|+|||++.+ ..+..++|+||+|++++.|.++..+|.
T Consensus       148 ~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~  227 (367)
T 1cm8_A          148 GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK  227 (367)
T ss_dssp             TEECCCCCGGGEEECTTCCEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CccccCcCHHHEEEcCCCCEEEEeeecccccccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCC
Confidence            4678899999999999999999999999876666778899999999999987 556777899999999988855554443

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.88  E-value=5.3e-09  Score=101.96  Aligned_cols=140  Identities=14%  Similarity=0.221  Sum_probs=94.6

Q ss_pred             cccCcccccEEEEeEEeCcCCcEEEEEEcc--CcCCCHHHHHHHHHHHHHHhcCC--CCCceeeeeeeecCccccCCceE
Q psy8260          70 PTLSKESFDLIFSSALDSVSGVKVAIKKIA--RPFQSAVHAKRTYRELRMLKHMN--HENVIGLLDVFHSNTCLADFKNV  145 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~--~~~~~~~~~~~~~~Ei~~l~~l~--HpnIv~l~~~~~~~~~~~~~~~~  145 (427)
                      ..++.|.++.||....   .+..+++|+..  ... .......+.+|+.+++.+.  +.++.+++.+......   ....
T Consensus        44 ~~l~~G~sn~~y~v~~---~~~~~vlr~~~~p~~~-~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~---~g~~  116 (359)
T 3dxp_A           44 EQFKGGQSNPTFKLVT---PGQTYVMRAKPGPKSK-LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESV---IGRA  116 (359)
T ss_dssp             EECCC-CCSCEEEEEC---SSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTT---TSSC
T ss_pred             EEcCCcccceEEEEEE---CCceEEEEeCCCCCCC-CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCc---cCCe
Confidence            4678899999996432   34688898765  221 1112345678999998886  4557777777544321   1335


Q ss_pred             EEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q psy8260         146 YMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHS--------------------------------------  186 (427)
Q Consensus       146 ~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~--------------------------------------  186 (427)
                      |++|+++ |..+.+.. ...++......++.+++..|..||+                                      
T Consensus       117 ~~vme~v~G~~l~~~~-~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          117 FYIMEFVSGRVLWDQS-LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             EEEEECCCCBCCCCTT-CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EEEEEecCCeecCCCc-cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            7778877 44453211 1246788888899999999999997                                      


Q ss_pred             --------------------cCceeccCCCCCeEEcCCCC--EEEeeCCCCCC
Q psy8260         187 --------------------AGIIHRDLKPSNIAVNEDCE--LKILDFGLARP  217 (427)
Q Consensus       187 --------------------~~iiHrDLKp~NILl~~~~~--~kl~DFGla~~  217 (427)
                                          .+++|+|++|.|||++.++.  +.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                35899999999999987653  69999998753

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=98.86  E-value=4.1e-10  Score=111.05  Aligned_cols=31  Identities=45%  Similarity=0.884  Sum_probs=27.8

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCC
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPT  279 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~  279 (427)
                      ...++|+++.|+++..++.+|++|||+++..
T Consensus       129 ~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A          129 GLLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             TEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             CEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence            4678899999999999999999999999643

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=98.85  E-value=6.7e-10  Score=108.88  Aligned_cols=79  Identities=63%  Similarity=0.913  Sum_probs=54.4

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh-ccCCCCCCHHHHHHHHHHhCCCCHHHH
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN-WMHYNQTDIHQLNLIMEMLGTPPAEFM  327 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~-~~~~~~~d~~slg~i~~~lg~~~~~~~  327 (427)
                      ...++|+++.|+++..++.+|++|||+++.......+.+||++|+|||++.+ ..+..++|+||+|++++.|.++..+|.
T Consensus       152 givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~  231 (367)
T 2fst_X          152 DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP  231 (367)
T ss_dssp             TCCCCCCCGGGEEECTTCCEEECC---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CeeeCCCCHhhEEECCCCCEEEeeccccccccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            3578899999999999999999999999877666677899999999999987 456667899999999988755544443

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=98.77  E-value=1.2e-09  Score=110.48  Aligned_cols=79  Identities=47%  Similarity=0.687  Sum_probs=61.4

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCCcc--ccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHH
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPTEN--EMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEF  326 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~--~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~  326 (427)
                      ...++|+++.|+++..++.+|++|||+++....  .....+||++|+|||++.+..+..++|+||+|++++.|.++..+|
T Consensus       184 ~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF  263 (464)
T 3ttj_A          184 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF  263 (464)
T ss_dssp             TCCCCCCCGGGEEECTTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             CcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCC
Confidence            467889999999999999999999999976433  345689999999999999988888899999999998885555445


Q ss_pred             H
Q psy8260         327 M  327 (427)
Q Consensus       327 ~  327 (427)
                      .
T Consensus       264 ~  264 (464)
T 3ttj_A          264 P  264 (464)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=98.75  E-value=2.3e-09  Score=108.08  Aligned_cols=73  Identities=42%  Similarity=0.739  Sum_probs=56.6

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCCc------------------------------cccccccccccccchHHh
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPTE------------------------------NEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~------------------------------~~~~~~~gt~~Y~APEvl  298 (427)
                      ...++|+++.|+++..++.+|++|||+++...                              ....+.+||++|+|||++
T Consensus       176 ~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~  255 (458)
T 3rp9_A          176 GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELI  255 (458)
T ss_dssp             TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHH
T ss_pred             CcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHh
Confidence            46788999999999999999999999997532                              134567899999999987


Q ss_pred             h-hccCCCCCCHHHHHHHHHHhCC
Q psy8260         299 L-NWMHYNQTDIHQLNLIMEMLGT  321 (427)
Q Consensus       299 ~-~~~~~~~~d~~slg~i~~~lg~  321 (427)
                      . +..+..++|+||+|+++++|.+
T Consensus       256 ~~~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          256 LLQENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             TTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             hCCCCCCcHhHHHHHHHHHHHHHH
Confidence            5 4456777899999999988754

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=98.75  E-value=1.5e-09  Score=108.68  Aligned_cols=78  Identities=29%  Similarity=0.445  Sum_probs=67.3

Q ss_pred             ceeeccCCcccccccccch--hhhhccCCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHH
Q psy8260         249 PFYFQDLKPSNIAVNEDCE--LKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEF  326 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~--~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~  326 (427)
                      ...++|+++.|+++..++.  +|++|||+++.........+||+.|+|||++.+..+..++|+||+|++++.|.++..+|
T Consensus       220 ~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf  299 (429)
T 3kvw_A          220 RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLL  299 (429)
T ss_dssp             TEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CeecCCCCHHHeEEccCCCcceEEeecccceecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCC
Confidence            4678899999999999887  99999999987666667789999999999999988888899999999998875554444

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=98.65  E-value=5.3e-09  Score=104.73  Aligned_cols=73  Identities=41%  Similarity=0.679  Sum_probs=58.0

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCCcc-------------------------ccccccccccccchHHhh-hcc
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPTEN-------------------------EMTGYVATRWYRAPEIML-NWM  302 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~-------------------------~~~~~~gt~~Y~APEvl~-~~~  302 (427)
                      ...++|+++.|+++..++.+|++|||+++....                         .....+||++|+|||++. ...
T Consensus       149 givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~  228 (432)
T 3n9x_A          149 GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQEN  228 (432)
T ss_dssp             TEECCCCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSC
T ss_pred             CCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCC
Confidence            467889999999999999999999999975321                         246789999999999974 445


Q ss_pred             CCCCCCHHHHHHHHHHhCC
Q psy8260         303 HYNQTDIHQLNLIMEMLGT  321 (427)
Q Consensus       303 ~~~~~d~~slg~i~~~lg~  321 (427)
                      +..++|+||+|++++.|.+
T Consensus       229 ~~~~~DiwSlG~il~ell~  247 (432)
T 3n9x_A          229 YTKSIDIWSTGCIFAELLN  247 (432)
T ss_dssp             CCTHHHHHHHHHHHHHHHT
T ss_pred             CCcccccchHHHHHHHHHh
Confidence            6667799999999987754

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=98.62  E-value=6e-09  Score=102.07  Aligned_cols=79  Identities=54%  Similarity=0.857  Sum_probs=61.3

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh-ccCCCCCCHHHHHHHHHHhCCCCHHHH
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN-WMHYNQTDIHQLNLIMEMLGTPPAEFM  327 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~-~~~~~~~d~~slg~i~~~lg~~~~~~~  327 (427)
                      ...++|+++.|+++..++.+|++|||.+........+..||+.|+|||++.+ ..+..++|+||+|++++.|.++..+|.
T Consensus       164 ~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~  243 (371)
T 4exu_A          164 GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK  243 (371)
T ss_dssp             TCCCSCCCGGGEEECTTCCEEECSTTCC--------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CCcCCCcCHHHeEECCCCCEEEEecCcccccccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCC
Confidence            4677899999999999999999999999877666778899999999999987 556777899999999988755555553

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=98.58  E-value=8.2e-09  Score=102.04  Aligned_cols=79  Identities=28%  Similarity=0.473  Sum_probs=63.5

Q ss_pred             ceeeccCCccccccc-ccchhhhhccCCCCCC--ccccccccccccccchHHhhhcc-CCCCCCHHHHHHHHHHhCCCCH
Q psy8260         249 PFYFQDLKPSNIAVN-EDCELKILDFGLARPT--ENEMTGYVATRWYRAPEIMLNWM-HYNQTDIHQLNLIMEMLGTPPA  324 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~-~~~~~ki~d~g~~~~~--~~~~~~~~gt~~Y~APEvl~~~~-~~~~~d~~slg~i~~~lg~~~~  324 (427)
                      ...++|+++.|+++. .++.+|++|||+++..  ........||+.|+|||++.+.. +..++|+||+|++++.|.++..
T Consensus       161 ~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~  240 (394)
T 4e7w_A          161 GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQP  240 (394)
T ss_dssp             TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence            467889999999998 7899999999999643  23345678999999999997654 6667799999999988855554


Q ss_pred             HHH
Q psy8260         325 EFM  327 (427)
Q Consensus       325 ~~~  327 (427)
                      +|.
T Consensus       241 pf~  243 (394)
T 4e7w_A          241 LFP  243 (394)
T ss_dssp             SSC
T ss_pred             CCC
Confidence            453

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=98.58  E-value=1e-08  Score=99.46  Aligned_cols=79  Identities=54%  Similarity=0.857  Sum_probs=60.9

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh-ccCCCCCCHHHHHHHHHHhCCCCHHHH
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN-WMHYNQTDIHQLNLIMEMLGTPPAEFM  327 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~-~~~~~~~d~~slg~i~~~lg~~~~~~~  327 (427)
                      ...++|+++.|+++..++.+|++|||.+........+..||+.|+|||++.+ ..+..++|+||+|++++.|.++..+|.
T Consensus       146 ~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~  225 (353)
T 3coi_A          146 GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK  225 (353)
T ss_dssp             TCCCSSCCGGGEEECTTCCEEECSTTCTTC--------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSB
T ss_pred             CcccCCCCHHHEeECCCCcEEEeecccccCCCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            4678899999999999999999999999876666677889999999999987 456667799999999988855554453

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=98.52  E-value=2e-08  Score=97.68  Aligned_cols=125  Identities=26%  Similarity=0.367  Sum_probs=73.9

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCCc--cccccccccccccchHHhhh-ccCCCCCCHHHHHHHHHHhCCCCHH
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPTE--NEMTGYVATRWYRAPEIMLN-WMHYNQTDIHQLNLIMEMLGTPPAE  325 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~--~~~~~~~gt~~Y~APEvl~~-~~~~~~~d~~slg~i~~~lg~~~~~  325 (427)
                      ...++|+++.|+++..++.+|++|||.+....  .......||+.|+|||++.+ ..+..++|+||+|++++.+.++..+
T Consensus       154 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p  233 (362)
T 3pg1_A          154 GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKAL  233 (362)
T ss_dssp             TCCCCCCCGGGEEECTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCEecCCChHHEEEcCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCC
Confidence            46788999999999999999999999997432  23345789999999999987 4566677999999999887555444


Q ss_pred             HHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCC
Q psy8260         326 FMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKR  376 (427)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R  376 (427)
                      |....................   ........++...+++...+...|..+
T Consensus       234 f~~~~~~~~~~~i~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (362)
T 3pg1_A          234 FRGSTFYNQLNKIVEVVGTPK---IEDVVMFSSPSARDYLRNSLSNVPARA  281 (362)
T ss_dssp             CCCSSHHHHHHHHHHHHCCCC---HHHHHHTSCHHHHHHTTTCCCCCCCCC
T ss_pred             CCCCCHHHHHHHHHHHcCCCC---hHHhhhccchhhhHHHHhhcccCChhh
Confidence            433221122222221111111   111222345666777777766655543

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=98.51  E-value=2.3e-08  Score=97.50  Aligned_cols=79  Identities=47%  Similarity=0.719  Sum_probs=62.8

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCCcc------ccccccccccccchHHhhhcc-CCCCCCHHHHHHHHHHhCC
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPTEN------EMTGYVATRWYRAPEIMLNWM-HYNQTDIHQLNLIMEMLGT  321 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~------~~~~~~gt~~Y~APEvl~~~~-~~~~~d~~slg~i~~~lg~  321 (427)
                      ...++|+++.|+++..++.+|++|||.+.....      .....+||+.|+|||++.+.. +..++|+||+|++++.|.+
T Consensus       148 ~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~  227 (364)
T 3qyz_A          148 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS  227 (364)
T ss_dssp             TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHH
T ss_pred             CeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHH
Confidence            467889999999999999999999999974322      134568999999999976544 5667799999999988755


Q ss_pred             CCHHHH
Q psy8260         322 PPAEFM  327 (427)
Q Consensus       322 ~~~~~~  327 (427)
                      +..+|.
T Consensus       228 g~~pf~  233 (364)
T 3qyz_A          228 NRPIFP  233 (364)
T ss_dssp             SSCSSC
T ss_pred             CCCCCC
Confidence            554453

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=98.49  E-value=2.7e-08  Score=97.81  Aligned_cols=79  Identities=32%  Similarity=0.515  Sum_probs=63.3

Q ss_pred             ceeeccCCccccccc-ccchhhhhccCCCCCC--ccccccccccccccchHHhhhcc-CCCCCCHHHHHHHHHHhCCCCH
Q psy8260         249 PFYFQDLKPSNIAVN-EDCELKILDFGLARPT--ENEMTGYVATRWYRAPEIMLNWM-HYNQTDIHQLNLIMEMLGTPPA  324 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~-~~~~~ki~d~g~~~~~--~~~~~~~~gt~~Y~APEvl~~~~-~~~~~d~~slg~i~~~lg~~~~  324 (427)
                      ...++|+++.|+++. .++.+|++|||.+...  ........||+.|+|||++.+.. +..++|+||+|++++.|.++..
T Consensus       161 gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~  240 (383)
T 3eb0_A          161 GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP  240 (383)
T ss_dssp             TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCC
Confidence            477889999999997 6889999999999743  33445678999999999998755 6667799999999987755544


Q ss_pred             HHH
Q psy8260         325 EFM  327 (427)
Q Consensus       325 ~~~  327 (427)
                      +|.
T Consensus       241 pf~  243 (383)
T 3eb0_A          241 LFS  243 (383)
T ss_dssp             SSC
T ss_pred             CCC
Confidence            443

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.36  E-value=7.6e-07  Score=84.50  Aligned_cols=133  Identities=16%  Similarity=0.204  Sum_probs=87.5

Q ss_pred             ccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCC-CCC--ceeeeeeeecCccccCCceEEE
Q psy8260          71 TLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN-HEN--VIGLLDVFHSNTCLADFKNVYM  147 (427)
Q Consensus        71 ~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~-Hpn--Iv~l~~~~~~~~~~~~~~~~~l  147 (427)
                      .++.|....||..      +..+++|+-..    ......+.+|+++|+.+. +..  +.+.+......   ......|+
T Consensus        27 ~~~~G~~n~v~~v------~~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~---~~~~~~~~   93 (304)
T 3sg8_A           27 ISGEGNDCIAYEI------NRDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPS---ETYQMSFA   93 (304)
T ss_dssp             EEEECSSEEEEES------TTSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCC---SSCSCSCE
T ss_pred             ecCCCCcceEEEE------CCEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCC---CCCCcceE
Confidence            4778888888853      14688887532    234456778999998873 333  33333332111   11123366


Q ss_pred             EeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q psy8260         148 VTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHS----------------------------------------  186 (427)
Q Consensus       148 v~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~----------------------------------------  186 (427)
                      +|++. |..+..... ..++..+...++.|++..|..||+                                        
T Consensus        94 vm~~i~G~~l~~~~~-~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           94 GFTKIKGVPLTPLLL-NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             EEECCCCEECCHHHH-HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             EEcccCCeECCcccc-ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            67776 555553222 346777778888888888888885                                        


Q ss_pred             ------------------cCceeccCCCCCeEEcC--CCCEEEeeCCCCCC
Q psy8260         187 ------------------AGIIHRDLKPSNIAVNE--DCELKILDFGLARP  217 (427)
Q Consensus       187 ------------------~~iiHrDLKp~NILl~~--~~~~kl~DFGla~~  217 (427)
                                        ..++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~  223 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI  223 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence                              13799999999999997  56789999998753

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=98.34  E-value=5.9e-08  Score=93.84  Aligned_cols=31  Identities=52%  Similarity=0.919  Sum_probs=27.7

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCC
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPT  279 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~  279 (427)
                      ...++|+++.|+++..++.+|++|||.+...
T Consensus       132 ~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (353)
T 2b9h_A          132 NVIHRDLKPSNLLINSNCDLKVCDFGLARII  162 (353)
T ss_dssp             TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence            4678899999999999999999999998643

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.14  E-value=1.7e-05  Score=75.35  Aligned_cols=130  Identities=19%  Similarity=0.167  Sum_probs=79.4

Q ss_pred             ccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCC---CceeeeeeeecCccccCCceEEE
Q psy8260          71 TLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHE---NVIGLLDVFHSNTCLADFKNVYM  147 (427)
Q Consensus        71 ~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~Hp---nIv~l~~~~~~~~~~~~~~~~~l  147 (427)
                      .++.|....||..      |..+++|+-.    .......+.+|.++|+.+.+.   .+.+.+.+...     .....++
T Consensus        26 ~l~~G~~n~v~~v------g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-----~~g~~~~   90 (306)
T 3tdw_A           26 SLGEGFRNYAILV------NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-----SDGNPFV   90 (306)
T ss_dssp             EEEECSSEEEEEE------TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-----TTSCEEE
T ss_pred             ecCCCcceeEEEE------CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-----CCCceEE
Confidence            3567777778753      5678888742    233445677999999998653   23444444321     1133467


Q ss_pred             EeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------------
Q psy8260         148 VTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSA---------------------------------------  187 (427)
Q Consensus       148 v~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~---------------------------------------  187 (427)
                      +|++. |..+.... -..++......++.|+...|..||+.                                       
T Consensus        91 v~e~i~G~~l~~~~-~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~  169 (306)
T 3tdw_A           91 GYRKVQGQILGEDG-MAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR  169 (306)
T ss_dssp             EEECCCSEECHHHH-HTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred             EEeccCCeECchhh-hhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence            77776 54554421 12234444444555555555554431                                       


Q ss_pred             ---------------------CceeccCCCCCeEEcC---CCC-EEEeeCCCCC
Q psy8260         188 ---------------------GIIHRDLKPSNIAVNE---DCE-LKILDFGLAR  216 (427)
Q Consensus       188 ---------------------~iiHrDLKp~NILl~~---~~~-~kl~DFGla~  216 (427)
                                           .++|+|++|.|||++.   ++. +.|+||+.+.
T Consensus       170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~  223 (306)
T 3tdw_A          170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA  223 (306)
T ss_dssp             HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred             HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence                                 3599999999999987   355 5899999775

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=97.76  E-value=0.00027  Score=65.27  Aligned_cols=123  Identities=15%  Similarity=0.206  Sum_probs=73.2

Q ss_pred             EEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCC-CCceeeeeeeecCccccCCceEEEEeccC-CCCH
Q psy8260          79 LIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNH-ENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADL  156 (427)
Q Consensus        79 ~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~l~~~~~~~~~~~~~~~~~lv~e~~-g~~L  156 (427)
                      .||. ......+..+.+|+-..     .....+.+|...|+.+.. --+.+++.+....      ...+++|++. |..+
T Consensus        40 ~v~r-l~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~------~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           40 TIYR-LYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP------DDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEEE-EECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET------TEEEEEEECCCSEEH
T ss_pred             eEEE-EEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC------CeEEEEEEeeCCccc
Confidence            4663 33444567788997532     223456789988887742 2244555554322      3457777777 5455


Q ss_pred             HHHHhhCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------------
Q psy8260         157 NNILRTQKLSDDHVQFLVYQILRGLKYIHS--------------------------------------------------  186 (427)
Q Consensus       157 ~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~--------------------------------------------------  186 (427)
                      .+.....   ......+..++...|.-||+                                                  
T Consensus       108 ~~~~~~~---~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  184 (272)
T 4gkh_A          108 FQVLEEY---PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMH  184 (272)
T ss_dssp             HHHHHHC---GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHH
T ss_pred             cccccCC---HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHH
Confidence            5443221   11122233344444444442                                                  


Q ss_pred             --------cCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         187 --------AGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       187 --------~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                              ..++|+|+.|.|||++.++.+-|+||+.+.
T Consensus       185 ~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          185 KLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             TTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                    127999999999999987777899999764

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=97.68  E-value=4e-06  Score=81.76  Aligned_cols=65  Identities=20%  Similarity=0.306  Sum_probs=45.1

Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      .++.+||++|||||++.+...|+.+.      |+||.||++.+                 +.+|..              
T Consensus       203 ~~~~~GT~~Y~APE~l~~~~~y~~~~------DiWSlG~il~e-----------------ll~G~~--------------  245 (361)
T 4f9c_A          203 VAPRAGTPGFRAPEVLTKCPNQTTAI------DMWSAGVIFLS-----------------LLSGRY--------------  245 (361)
T ss_dssp             ---CCCCGGGCCHHHHTTCSCCCTHH------HHHHHHHHHHH-----------------HHHTCS--------------
T ss_pred             ccccccCccccCHHHHcCCCCCCCcc------chhhhHHHHHH-----------------HHHCCC--------------
Confidence            45678999999999998866666554      99999999877                 443332              


Q ss_pred             cCCCC-CCHHHHHHHHHHhCCCC
Q psy8260         302 MHYNQ-TDIHQLNLIMEMLGTPP  323 (427)
Q Consensus       302 ~~~~~-~d~~slg~i~~~lg~~~  323 (427)
                      +++.+ .+..++..|+..+|+++
T Consensus       246 Pf~~~~~~~~~l~~I~~~~G~~~  268 (361)
T 4f9c_A          246 PFYKASDDLTALAQIMTIRGSRE  268 (361)
T ss_dssp             SSSCCSSHHHHHHHHHHHHCHHH
T ss_pred             CCCCCCCHHHHHHHHHHhcCCcc
Confidence            13333 36778888888887643

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.58  E-value=0.00074  Score=64.30  Aligned_cols=30  Identities=17%  Similarity=0.371  Sum_probs=27.2

Q ss_pred             cCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         187 AGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       187 ~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                      .+++|+|+++.|||++.++.+.|+||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            579999999999999888899999999764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.54  E-value=0.00027  Score=69.37  Aligned_cols=30  Identities=33%  Similarity=0.466  Sum_probs=25.6

Q ss_pred             hcCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         186 SAGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       186 ~~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                      ...++|+|+.|.|||++.+ .++|+||..+.
T Consensus       226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~  255 (397)
T 2olc_A          226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAF  255 (397)
T ss_dssp             CCEEECSCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             CCceeeCCCCcCcEEEeCC-CeEEEeCcccc
Confidence            3579999999999999865 48999998765

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=97.07  E-value=5.3e-05  Score=77.84  Aligned_cols=63  Identities=22%  Similarity=0.252  Sum_probs=50.8

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCCccc----------cccccccccccchHHhhh--ccCCCCCCHHHHH
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPTENE----------MTGYVATRWYRAPEIMLN--WMHYNQTDIHQLN  313 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~----------~~~~~gt~~Y~APEvl~~--~~~~~~~d~~slg  313 (427)
                      ...++|+++.|+++..  .+|++|||+++.....          ....+||+.|||||++..  ..|....|+|+..
T Consensus       451 gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~v  525 (540)
T 3en9_A          451 DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEII  525 (540)
T ss_dssp             TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHH
T ss_pred             cCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHH
Confidence            4678899999999998  9999999999865431          246789999999999986  4455567888755

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=97.07  E-value=0.00017  Score=69.79  Aligned_cols=29  Identities=31%  Similarity=0.770  Sum_probs=26.5

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCC
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLAR  277 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~  277 (427)
                      ...++|+++.|+++..++.+|++|||+++
T Consensus       161 ~ivHrDlkp~NIll~~~g~~kL~DFg~a~  189 (350)
T 1rdq_E          161 DLIYRDLKPENLLIDQQGYIQVTDFGFAK  189 (350)
T ss_dssp             TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CcccccCccceEEECCCCCEEEcccccce
Confidence            46788999999999999999999999885

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=96.97  E-value=0.0014  Score=63.08  Aligned_cols=30  Identities=13%  Similarity=0.269  Sum_probs=25.7

Q ss_pred             cCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         187 AGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       187 ~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                      ..++|+|+.|.|||++++..+.|+||+.+.
T Consensus       222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~  251 (357)
T 3ats_A          222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVA  251 (357)
T ss_dssp             CEEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred             ceEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence            469999999999999965567999999775

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=96.88  E-value=0.00065  Score=65.44  Aligned_cols=72  Identities=18%  Similarity=0.226  Sum_probs=46.9

Q ss_pred             HHHHHHHh----cCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeecc
Q psy8260         179 RGLKYIHS----AGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQD  254 (427)
Q Consensus       179 ~aL~yLH~----~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d  254 (427)
                      .....+|.    .+|+=.  +-.+|-|.+-|-.+..+-.     ....++.+||++|||||++.+ ..|+..      .|
T Consensus       187 H~~~IiHRDlKp~NILl~--~~g~vKl~DFGla~~~~~~-----~~~~~~~~GTp~YmAPEvl~~-~~y~~~------~D  252 (346)
T 4fih_A          187 HAQGVIHRDIKSDSILLT--HDGRVKLSDFGFCAQVSKE-----VPRRKSLVGTPYWMAPELISR-LPYGPE------VD  252 (346)
T ss_dssp             HHTTEECCCCSGGGEEEC--TTCCEEECCCTTCEECCSS-----SCCBCCCCSCGGGCCHHHHTT-CCBCTH------HH
T ss_pred             HHCCcccccCCHHHEEEC--CCCCEEEecCcCceecCCC-----CCcccccccCcCcCCHHHHCC-CCCCcH------HH
Confidence            34456773    344421  1245667777777655432     223456799999999999865 345543      49


Q ss_pred             CCcccccccc
Q psy8260         255 LKPSNIAVNE  264 (427)
Q Consensus       255 ~~~~~~~~~~  264 (427)
                      +||.||++.+
T Consensus       253 iWSlGvilye  262 (346)
T 4fih_A          253 IWSLGIMVIE  262 (346)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHH
Confidence            9999999877

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=96.84  E-value=0.00025  Score=68.83  Aligned_cols=29  Identities=17%  Similarity=0.218  Sum_probs=26.7

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCC
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLAR  277 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~  277 (427)
                      .+.++|+++.|+++..++.+|++|||+++
T Consensus       214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~  242 (371)
T 3q60_A          214 GLVHGHFTPDNLFIMPDGRLMLGDVSALW  242 (371)
T ss_dssp             TEEETTCSGGGEEECTTSCEEECCGGGEE
T ss_pred             CCccCcCCHHHEEECCCCCEEEEecceee
Confidence            47889999999999999999999999875

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=96.75  E-value=0.00036  Score=66.22  Aligned_cols=58  Identities=17%  Similarity=0.211  Sum_probs=40.9

Q ss_pred             CCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         197 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       197 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      .+|-|.+-|..+..+-+-   ......+.+||+.|||||++.+. .|+.      ..|+||.||++.+
T Consensus       169 g~vKl~DFGla~~~~~~~---~~~~~~~~~GTp~YmAPEvl~~~-~y~~------~~DiWSlGvilye  226 (311)
T 4aw0_A          169 MHIQITDFGTAKVLSPES---KQARANSFVGTAQYVSPELLTEK-SACK------SSDLWALGCIIYQ  226 (311)
T ss_dssp             SCEEECCCTTCEECCTTT---TCCCBCCCCSCGGGCCHHHHHHS-CBCH------HHHHHHHHHHHHH
T ss_pred             CCEEEEEcCCceecCCCC---CcccccCcccCcccCCHHHHcCC-CCCc------HHHHHHHHHHHHH
Confidence            457777778887764321   12234567999999999999863 3443      3499999999877

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=96.74  E-value=0.00048  Score=67.15  Aligned_cols=80  Identities=29%  Similarity=0.473  Sum_probs=67.8

Q ss_pred             cceeeccCCccccccc--ccchhhhhccCCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHH
Q psy8260         248 VPFYFQDLKPSNIAVN--EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAE  325 (427)
Q Consensus       248 ~~~~~~d~~~~~~~~~--~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~  325 (427)
                      ....++|+++.|+++.  .++.+|++|||+++.........+||+.|+|||++.+..+..++|+||+|++++.|.++..+
T Consensus       178 ~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p  257 (382)
T 2vx3_A          178 LSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPL  257 (382)
T ss_dssp             TCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCEEcCCCCcccEEEecCCCCcEEEEeccCceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            4578899999999994  47789999999998766666778999999999999998888888999999999888665555


Q ss_pred             HH
Q psy8260         326 FM  327 (427)
Q Consensus       326 ~~  327 (427)
                      |.
T Consensus       258 f~  259 (382)
T 2vx3_A          258 FS  259 (382)
T ss_dssp             SC
T ss_pred             CC
Confidence            54

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=96.66  E-value=0.00021  Score=66.67  Aligned_cols=56  Identities=14%  Similarity=0.102  Sum_probs=30.3

Q ss_pred             CCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         197 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       197 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      .++-|.+-|..+..+-+-..     . +.+||+.|||||++.+...++..      .|+||.||++.+
T Consensus       149 ~~vkl~DFGla~~~~~~~~~-----~-~~~GT~~Y~APE~~~~~~y~~~~------~DiwSlGvily~  204 (275)
T 3hyh_A          149 LNVKIADFGLSNIMTDGNFL-----K-TSCGSPNYAAPEVISGKLYAGPE------VDVWSCGVILYV  204 (275)
T ss_dssp             CCEEECCSSCC---------------------CTTSCHHHHSSSSCCCTH------HHHHHHHHHHHH
T ss_pred             CCEEEeecCCCeecCCCCcc-----C-CeeECcccCChhhhcCCCCCCCh------hhhHHHHHHHHH
Confidence            35666666655544321111     1 24899999999999875444333      499999999876

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=96.66  E-value=0.00045  Score=68.22  Aligned_cols=52  Identities=13%  Similarity=0.206  Sum_probs=45.5

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      .+.++|+++.|+++..++.+|++|||+++.........+| +.|+|||++...
T Consensus       231 ~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~  282 (413)
T 3dzo_A          231 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAER  282 (413)
T ss_dssp             TEECSCCCGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHH
T ss_pred             CcccCCcccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhcc
Confidence            4678899999999999999999999999876666677888 999999998654

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=96.62  E-value=0.0011  Score=65.69  Aligned_cols=72  Identities=18%  Similarity=0.243  Sum_probs=47.1

Q ss_pred             HHHHHHHh----cCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeecc
Q psy8260         179 RGLKYIHS----AGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQD  254 (427)
Q Consensus       179 ~aL~yLH~----~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d  254 (427)
                      .....+|.    .+|+=.  +-.+|-|.+-|-++..+-..     ...++.+||++|||||++.+ ..|+..      .|
T Consensus       264 H~~~IiHRDiKp~NILl~--~~g~vKl~DFGla~~~~~~~-----~~~~~~~GTp~YmAPEvl~~-~~y~~~------~D  329 (423)
T 4fie_A          264 HAQGVIHRDIKSDSILLT--HDGRVKLSDFGFCAQVSKEV-----PRRKSLVGTPYWMAPELISR-LPYGPE------VD  329 (423)
T ss_dssp             HHTTEECCCCSTTTEEEC--TTCCEEECCCTTCEECCSSC-----CCBCCCEECTTTCCHHHHTT-CCBCTH------HH
T ss_pred             HHCCeecccCCHHHEEEc--CCCCEEEecCccceECCCCC-----ccccccccCcCcCCHHHHCC-CCCCcH------HH
Confidence            34456773    355431  12356677777776554322     23456799999999999875 345543      49


Q ss_pred             CCcccccccc
Q psy8260         255 LKPSNIAVNE  264 (427)
Q Consensus       255 ~~~~~~~~~~  264 (427)
                      +||.||++.+
T Consensus       330 iWSlGvilye  339 (423)
T 4fie_A          330 IWSLGIMVIE  339 (423)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHH
Confidence            9999999877

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=96.62  E-value=0.00074  Score=66.34  Aligned_cols=78  Identities=37%  Similarity=0.513  Sum_probs=57.7

Q ss_pred             ceeeccCCcccccc----cccchhhhhccCCCCCCc------cccccccccccccchHHhhhcc-CCCCCCHHHHHHHHH
Q psy8260         249 PFYFQDLKPSNIAV----NEDCELKILDFGLARPTE------NEMTGYVATRWYRAPEIMLNWM-HYNQTDIHQLNLIME  317 (427)
Q Consensus       249 ~~~~~d~~~~~~~~----~~~~~~ki~d~g~~~~~~------~~~~~~~gt~~Y~APEvl~~~~-~~~~~d~~slg~i~~  317 (427)
                      ...++|+++.|+++    ..++.+|++|||+++...      ......+||++|+|||++.+.. +..++|+||+|++++
T Consensus       148 ~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~  227 (405)
T 3rgf_A          148 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFA  227 (405)
T ss_dssp             TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHH
T ss_pred             CEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHH
Confidence            36788999999999    677899999999997543      2334678999999999998754 566779999999998


Q ss_pred             HhCCCCHHH
Q psy8260         318 MLGTPPAEF  326 (427)
Q Consensus       318 ~lg~~~~~~  326 (427)
                      .|.++..+|
T Consensus       228 ell~g~~pf  236 (405)
T 3rgf_A          228 ELLTSEPIF  236 (405)
T ss_dssp             HHHHSSCTT
T ss_pred             HHHhCCCCC
Confidence            885555555

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=96.60  E-value=0.00069  Score=65.22  Aligned_cols=29  Identities=38%  Similarity=0.726  Sum_probs=25.1

Q ss_pred             ceeeccCCcccccccc-------------------------cchhhhhccCCCC
Q psy8260         249 PFYFQDLKPSNIAVNE-------------------------DCELKILDFGLAR  277 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~-------------------------~~~~ki~d~g~~~  277 (427)
                      ...++|+++.|+++..                         ++.+|++|||++.
T Consensus       157 ~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~  210 (360)
T 3llt_A          157 SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCAT  210 (360)
T ss_dssp             TEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCE
T ss_pred             CeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCce
Confidence            4678899999999965                         7889999999885

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=96.51  E-value=0.00041  Score=65.70  Aligned_cols=71  Identities=20%  Similarity=0.124  Sum_probs=43.1

Q ss_pred             HHHHHHh----cCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccC
Q psy8260         180 GLKYIHS----AGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDL  255 (427)
Q Consensus       180 aL~yLH~----~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~  255 (427)
                      ....+|.    .+|+-.  +-.+|-|.+-|..+...-+     .....+.+||+.|||||++.+ ..|+..      .|+
T Consensus       144 ~~~IiHRDlKp~NILl~--~~g~vKl~DFGla~~~~~~-----~~~~~~~~GT~~YmAPE~~~~-~~y~~~------~Di  209 (304)
T 3ubd_A          144 SLGIIYRDLKPENILLD--EEGHIKLTDFGLSKESIDH-----EKKAYSFCGTVEYMAPEVVNR-RGHTQS------ADW  209 (304)
T ss_dssp             HTTCCCSSCCGGGEEEC--TTSCEEEESSEEEEC----------CCCCSCCCCGGGCCHHHHHT-SCCCTH------HHH
T ss_pred             HCCCcCCCCCHHHeEEc--CCCCEEecccccceeccCC-----CccccccccCcccCCHHHhcc-CCCCCC------Ccc
Confidence            3456673    345432  1235666666666532211     223456799999999999976 344433      499


Q ss_pred             Ccccccccc
Q psy8260         256 KPSNIAVNE  264 (427)
Q Consensus       256 ~~~~~~~~~  264 (427)
                      ||.||++.+
T Consensus       210 wSlGvilye  218 (304)
T 3ubd_A          210 WSFGVLMFE  218 (304)
T ss_dssp             HHHHHHHHH
T ss_pred             cchHHHHHH
Confidence            999999877

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=96.42  E-value=0.00089  Score=65.08  Aligned_cols=19  Identities=26%  Similarity=0.459  Sum_probs=15.9

Q ss_pred             ceeeccCCcccccccccch
Q psy8260         249 PFYFQDLKPSNIAVNEDCE  267 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~  267 (427)
                      ...++|+++.|+++..++.
T Consensus       167 givHrDikp~NIll~~~~~  185 (397)
T 1wak_A          167 RIIHTDIKPENILLSVNEQ  185 (397)
T ss_dssp             CEECCCCSGGGEEECCCHH
T ss_pred             CEecCCCCHHHeeEeccch
Confidence            5788999999999987653

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=96.39  E-value=0.001  Score=62.54  Aligned_cols=32  Identities=22%  Similarity=0.387  Sum_probs=25.8

Q ss_pred             ccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         225 YVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       225 ~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      .+||+.|||||++.+  .|+..      .|+||.||++.+
T Consensus       190 ~~GTp~YmAPE~~~~--~y~~~------~DiwSlGvilye  221 (290)
T 3fpq_A          190 VIGTPEFMAPEMYEE--KYDES------VDVYAFGMCMLE  221 (290)
T ss_dssp             SCSSCCCCCGGGGGT--CCCTH------HHHHHHHHHHHH
T ss_pred             cccCccccCHHHcCC--CCCcH------HHHHHHHHHHHH
Confidence            479999999999864  35543      499999999877

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=96.37  E-value=0.0011  Score=63.25  Aligned_cols=29  Identities=34%  Similarity=0.608  Sum_probs=25.3

Q ss_pred             ceeeccCCcccccc-------------------cccchhhhhccCCCC
Q psy8260         249 PFYFQDLKPSNIAV-------------------NEDCELKILDFGLAR  277 (427)
Q Consensus       249 ~~~~~d~~~~~~~~-------------------~~~~~~ki~d~g~~~  277 (427)
                      .+.++|+++.|+++                   ..++.+|++|||.+.
T Consensus       143 ~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~  190 (355)
T 2eu9_A          143 QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT  190 (355)
T ss_dssp             TEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCE
T ss_pred             CcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccc
Confidence            57888999999998                   567889999999885

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=96.36  E-value=0.0012  Score=62.49  Aligned_cols=29  Identities=38%  Similarity=0.649  Sum_probs=24.8

Q ss_pred             ceeeccCCcccccccc-------------------cchhhhhccCCCC
Q psy8260         249 PFYFQDLKPSNIAVNE-------------------DCELKILDFGLAR  277 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~-------------------~~~~ki~d~g~~~  277 (427)
                      ...++|+++.|+++..                   ++.+|++|||.+.
T Consensus       138 ~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~  185 (339)
T 1z57_A          138 KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSAT  185 (339)
T ss_dssp             TEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCE
T ss_pred             CCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccc
Confidence            4678899999999877                   5679999999875

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=96.31  E-value=0.0012  Score=63.55  Aligned_cols=30  Identities=30%  Similarity=0.413  Sum_probs=24.8

Q ss_pred             ceeeccCCccccccc------ccchhhhhccCCCCC
Q psy8260         249 PFYFQDLKPSNIAVN------EDCELKILDFGLARP  278 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~------~~~~~ki~d~g~~~~  278 (427)
                      ...++|+++.|+++.      ..+.+|++|||++..
T Consensus       152 ~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~  187 (373)
T 1q8y_A          152 GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW  187 (373)
T ss_dssp             CEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEE
T ss_pred             CEEecCCChHHeEEeccCCCcCcceEEEcccccccc
Confidence            477889999999994      445799999998854

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=96.30  E-value=0.0014  Score=60.79  Aligned_cols=49  Identities=31%  Similarity=0.527  Sum_probs=42.7

Q ss_pred             ceeeccCCcccccccccch-----hhhhccCCCCCCccccccccccccccchHH
Q psy8260         249 PFYFQDLKPSNIAVNEDCE-----LKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~-----~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      ++.++|+++.|+++..++.     +|++|||.+...........||+.|+|||+
T Consensus       144 ~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~  197 (287)
T 4f0f_A          144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPET  197 (287)
T ss_dssp             CCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSSCEECCCCCCTTSCGGG
T ss_pred             CeecCCCCcceEEEeccCCCCceeEEeCCCCccccccccccccCCCccccCchh
Confidence            4788999999999987776     999999999876666677889999999996

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=96.24  E-value=0.0004  Score=65.60  Aligned_cols=36  Identities=28%  Similarity=0.421  Sum_probs=25.6

Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      .++.+||+.|||||++.+ ..|+.+      .|+||.||++.+
T Consensus       187 ~~~~~GT~~YmAPE~~~~-~~y~~~------~DiwSlGvilye  222 (299)
T 4g31_A          187 HTGQVGTKLYMSPEQIHG-NSYSHK------VDIFSLGLILFE  222 (299)
T ss_dssp             -----CCCTTSCHHHHTT-CCCCTH------HHHHHHHHHHHH
T ss_pred             cCCcccCccccCHHHHcC-CCCCCH------HHHHHHHHHHHH
Confidence            456789999999999976 345543      499999999877

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=96.23  E-value=0.00075  Score=64.76  Aligned_cols=58  Identities=17%  Similarity=0.066  Sum_probs=35.7

Q ss_pred             eEEcCCCCEEEee-CCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         199 IAVNEDCELKILD-FGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       199 ILl~~~~~~kl~D-FGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      |-|.+-|..+..+ -+..+.. ......+||+.|||||++.+ ..|+..      .|+||.||++.+
T Consensus       190 vKl~DFGla~~~~~~~~~~~~-~~~~~~~GT~~YmAPE~~~~-~~y~~~------~DiwSlGvilye  248 (336)
T 4g3f_A          190 AALCDFGHALCLQPDGLGKSL-LTGDYIPGTETHMAPEVVMG-KPCDAK------VDIWSSCCMMLH  248 (336)
T ss_dssp             EEECCCTTCEEC-------------CCCCCCGGGCCHHHHTT-CCCCTH------HHHHHHHHHHHH
T ss_pred             EEEeeCCCCeEccCCCcccce-ecCCccccCccccCHHHHCC-CCCCcH------HHHHHHHHHHHH
Confidence            6676677666553 2322211 12234689999999999986 345443      499999999877

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=96.20  E-value=0.0014  Score=61.67  Aligned_cols=30  Identities=40%  Similarity=0.568  Sum_probs=24.2

Q ss_pred             cceeeccCCcccccccccch-hhhhccCCCC
Q psy8260         248 VPFYFQDLKPSNIAVNEDCE-LKILDFGLAR  277 (427)
Q Consensus       248 ~~~~~~d~~~~~~~~~~~~~-~ki~d~g~~~  277 (427)
                      ....++|+++.|+++..++. +|++|||.+.
T Consensus       124 ~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~  154 (307)
T 2eva_A          124 KALIHRDLKPPNLLLVAGGTVLKICDFGTAC  154 (307)
T ss_dssp             SCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred             CCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence            35678899999999988776 7999999875

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=96.16  E-value=0.00045  Score=66.66  Aligned_cols=56  Identities=20%  Similarity=0.271  Sum_probs=39.2

Q ss_pred             CCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         197 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       197 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      .+|-|.+-|..+..+-+     ....++.+||+.|||||++.+ ..|+.      ..|+||.||++.+
T Consensus       162 g~vKl~DFGla~~~~~~-----~~~~~~~~GT~~YmAPE~l~~-~~y~~------~~DiwSlGvilye  217 (350)
T 4b9d_A          162 GTVQLGDFGIARVLNST-----VELARACIGTPYYLSPEICEN-KPYNN------KSDIWALGCVLYE  217 (350)
T ss_dssp             CCEEECSTTEESCCCHH-----HHHHHHHHSCCTTCCHHHHTT-CCCCH------HHHHHHHHHHHHH
T ss_pred             CCEEEcccccceeecCC-----cccccccCCCccccCHHHHCC-CCCCc------HHHHHHHHHHHHH
Confidence            35667777776654422     122356789999999999976 34443      3499999999877

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.15  E-value=0.021  Score=53.42  Aligned_cols=28  Identities=18%  Similarity=0.189  Sum_probs=24.1

Q ss_pred             CceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         188 GIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       188 ~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                      .++|+|+.|.||+ ..++.+.|+||..+.
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~  201 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSG  201 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence            4899999999999 556778999998775

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=96.14  E-value=0.00043  Score=72.30  Aligned_cols=55  Identities=15%  Similarity=0.148  Sum_probs=39.0

Q ss_pred             CCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         197 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       197 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      .+|-|.+-|-.+..+-+.+.       +.+||+.|||||++.+...|+.+.      |+||.||++.+
T Consensus       329 G~vKL~DFGlA~~~~~~~~~-------t~~GTp~YmAPEvl~~~~~y~~~v------DiWSLGvilYE  383 (689)
T 3v5w_A          329 GHVRISDLGLACDFSKKKPH-------ASVGTHGYMAPEVLQKGVAYDSSA------DWFSLGCMLFK  383 (689)
T ss_dssp             SCEEECCCTTCEECSSCCCC-------SCCSCGGGCCHHHHSTTCCCCTHH------HHHHHHHHHHH
T ss_pred             CCEEecccceeeecCCCCCC-------CccCCcCccCHHHHhCCCCCCcHH------HHHHHHHHHHH
Confidence            35667666766654333222       248999999999997655666554      99999999887

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=96.14  E-value=0.0014  Score=64.76  Aligned_cols=43  Identities=23%  Similarity=0.413  Sum_probs=33.8

Q ss_pred             cccccccccchHHhhhc-cCCCCCCHHHHHHHHHHhCCCCHHHH
Q psy8260         285 GYVATRWYRAPEIMLNW-MHYNQTDIHQLNLIMEMLGTPPAEFM  327 (427)
Q Consensus       285 ~~~gt~~Y~APEvl~~~-~~~~~~d~~slg~i~~~lg~~~~~~~  327 (427)
                      ..+||++|+|||++.+. .+..++|+||+|+++++|.++..+|.
T Consensus       215 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~  258 (420)
T 1j1b_A          215 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP  258 (420)
T ss_dssp             SCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             eeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence            35689999999999765 56667799999999988855554453

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=95.97  E-value=0.002  Score=64.28  Aligned_cols=29  Identities=41%  Similarity=0.667  Sum_probs=26.6

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCC
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLAR  277 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~  277 (427)
                      .+.++|+++.|+++..++.+|++|||+++
T Consensus       309 ~ivHrDlkp~Nill~~~~~~kl~DfG~a~  337 (450)
T 1k9a_A          309 NFVHRDLAARNVLVSEDNVAKVSDFGLTK  337 (450)
T ss_dssp             TEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             CeeCCCCCHhhEEECCCCCEEEeeCCCcc
Confidence            47888999999999999999999999875

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=95.86  E-value=0.0025  Score=58.72  Aligned_cols=29  Identities=41%  Similarity=0.667  Sum_probs=24.8

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCC
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLAR  277 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~  277 (427)
                      ...++|+++.|+.+..++.+|++|||.+.
T Consensus       137 ~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~  165 (278)
T 1byg_A          137 NFVHRDLAARNVLVSEDNVAKVSDFGLTK  165 (278)
T ss_dssp             TCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred             CccccCCCcceEEEeCCCcEEEeeccccc
Confidence            36788999999999999999999999875

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=95.86  E-value=0.0033  Score=58.31  Aligned_cols=31  Identities=45%  Similarity=0.677  Sum_probs=27.4

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCC
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPT  279 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~  279 (427)
                      ...++|+++.|+++..++.+|++|||.+...
T Consensus       136 ~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  166 (303)
T 1zy4_A          136 GIIHRDLKPMNIFIDESRNVKIGDFGLAKNV  166 (303)
T ss_dssp             TCCCSCCCGGGEEECTTSCEEECCCCCCSCT
T ss_pred             CeecccCCHHhEEEcCCCCEEEeeCcchhhc
Confidence            4677899999999999999999999998754

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=95.74  E-value=0.18  Score=47.41  Aligned_cols=28  Identities=29%  Similarity=0.273  Sum_probs=24.6

Q ss_pred             cCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         187 AGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       187 ~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                      ..++|+|+++.|||++ + .+.|+||+.+.
T Consensus       195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             CEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             eeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence            4589999999999999 4 89999998765

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=95.59  E-value=0.0027  Score=63.11  Aligned_cols=31  Identities=35%  Similarity=0.558  Sum_probs=23.8

Q ss_pred             ceeeccCCcccccccc-----cchhhhhccCCCCCC
Q psy8260         249 PFYFQDLKPSNIAVNE-----DCELKILDFGLARPT  279 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~-----~~~~ki~d~g~~~~~  279 (427)
                      ...++|+++.|+++..     ...+|++|||+++..
T Consensus       138 ~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A          138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             cCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            3678899999999943     345679999988643

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=95.24  E-value=0.0034  Score=64.72  Aligned_cols=73  Identities=14%  Similarity=0.104  Sum_probs=45.5

Q ss_pred             HHHHHHHh----cCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeecc
Q psy8260         179 RGLKYIHS----AGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQD  254 (427)
Q Consensus       179 ~aL~yLH~----~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d  254 (427)
                      .....+|.    .+|+-.+=...+|-|.+-|..+..+-+-..     . ..+||++|||||++.+. .|+.      ..|
T Consensus       272 H~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~-----~-~~~GT~~y~APEv~~~~-~y~~------~~D  338 (573)
T 3uto_A          272 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV-----K-VTTGTAEFAAPEVAEGK-PVGY------YTD  338 (573)
T ss_dssp             HHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEE-----E-EECSSGGGCCHHHHTTC-CBCH------HHH
T ss_pred             HHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCce-----e-eeEECccccCHHHhCCC-CCCc------HHH
Confidence            34556774    355443223345666666766665533211     1 24799999999999863 3443      349


Q ss_pred             CCcccccccc
Q psy8260         255 LKPSNIAVNE  264 (427)
Q Consensus       255 ~~~~~~~~~~  264 (427)
                      +||.||++.+
T Consensus       339 iWSlGvilye  348 (573)
T 3uto_A          339 MWSVGVLSYI  348 (573)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHH
Confidence            9999999876

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=95.11  E-value=0.11  Score=48.05  Aligned_cols=53  Identities=9%  Similarity=0.034  Sum_probs=34.6

Q ss_pred             eeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCC
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN  122 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~  122 (427)
                      +.-...+|.|..+.||+..+  .+|+.|.+|+-.......  ...+.+|+..|+.+.
T Consensus        17 v~~v~~~g~G~~~~vyrv~l--~DG~~~~vK~~~~~~~~~--~~~~~~Ea~~L~~L~   69 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVEL--ADGTPLFVKALPDDAPAL--DGLFRAEALGLDWLG   69 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEE--TTSCEEEEEECCTTCCCC--TTHHHHHHHHHHHHT
T ss_pred             eEEEEecCCCCCeEEEEEEE--CCCCEEEEEEeCCCCcch--hhHHHHHHHHHHHHH
Confidence            33346788899999996543  578999999764322111  123557888887774

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=95.06  E-value=0.0064  Score=64.02  Aligned_cols=29  Identities=38%  Similarity=0.760  Sum_probs=25.1

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCC
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARP  278 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~  278 (427)
                      .+.++|+++.|+++..+ .+|++|||++..
T Consensus       202 giiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          202 GLVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             TEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             CCeecccChHHeEEeCC-cEEEEecccchh
Confidence            47788999999999886 899999998853

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=94.94  E-value=0.16  Score=47.89  Aligned_cols=69  Identities=14%  Similarity=0.080  Sum_probs=43.8

Q ss_pred             cccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCC---CCCceeeeeeeecCccccCCceEE
Q psy8260          70 PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN---HENVIGLLDVFHSNTCLADFKNVY  146 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~---HpnIv~l~~~~~~~~~~~~~~~~~  146 (427)
                      ..++.|....+|...  . ++..+++|.-...     ....+.+|...|+.+.   ...+.+.+.+....      ...+
T Consensus        42 ~~l~gG~~n~~y~v~--~-~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~------g~~~  107 (312)
T 3jr1_A           42 EKLYSGEMNEIWLIN--D-EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ------GHSF  107 (312)
T ss_dssp             EEECCSSSSEEEEEE--S-SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS------SEEE
T ss_pred             EEeCCccceeeeEEE--E-CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC------CceE
Confidence            457888889999643  2 4678889976432     1344667888887763   24566666654321      3467


Q ss_pred             EEeccC
Q psy8260         147 MVTHLM  152 (427)
Q Consensus       147 lv~e~~  152 (427)
                      ++|++.
T Consensus       108 lvme~l  113 (312)
T 3jr1_A          108 LLLEAL  113 (312)
T ss_dssp             EEEECC
T ss_pred             EEEEec
Confidence            777776

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=94.93  E-value=0.0041  Score=58.85  Aligned_cols=72  Identities=15%  Similarity=0.182  Sum_probs=40.5

Q ss_pred             HHHHHh----cCc-eeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhccc--ccCCCCcceeec
Q psy8260         181 LKYIHS----AGI-IHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM--HYNQTGVPFYFQ  253 (427)
Q Consensus       181 L~yLH~----~~i-iHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~~~~~~~~  253 (427)
                      -..+|.    .+| +..|.   ++-|.+-|-.++.+-...   ....+..+||+.|||||++.+..  .|+.      .+
T Consensus       151 ~~IiHRDlKp~NILl~~~~---~~Ki~DFGla~~~~~~~~---~~~~~~~~GT~~ymAPE~l~~~~~~~y~~------ks  218 (307)
T 3omv_A          151 KNIIHRDMKSNNIFLHEGL---TVKIGDFGLATVKSRWSG---SQQVEQPTGSVLWMAPEVIRMQDNNPFSF------QS  218 (307)
T ss_dssp             TTCBCSCCCSSSEEEETTE---EEEECCCSSCBC---------------CCCCTTSCCHHHHHCCSSCCCCH------HH
T ss_pred             CCccCCccCHHHEEECCCC---cEEEeeccCceecccCCc---ceeecccccCCCccCHHHhhccCCCCCCc------HH
Confidence            456783    354 43332   455666676655432211   12345578999999999997532  2333      45


Q ss_pred             cCCcccccccc
Q psy8260         254 DLKPSNIAVNE  264 (427)
Q Consensus       254 d~~~~~~~~~~  264 (427)
                      |+||.||++.+
T Consensus       219 DVwS~Gvvl~E  229 (307)
T 3omv_A          219 DVYSYGIVLYE  229 (307)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HhHhHHHHHHH
Confidence            99999999877

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=94.72  E-value=0.0061  Score=57.48  Aligned_cols=56  Identities=20%  Similarity=0.399  Sum_probs=36.1

Q ss_pred             CeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         198 NIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       198 NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ++-|.+-|..+..+-.     .......+||+.|+|||++.+...++..      .|+|+.||++.+
T Consensus       146 ~~kl~Dfg~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~------~DiwslG~il~e  201 (317)
T 2pmi_A          146 QLKLGDFGLARAFGIP-----VNTFSSEVVTLWYRAPDVLMGSRTYSTS------IDIWSCGCILAE  201 (317)
T ss_dssp             CEEECCCSSCEETTSC-----CCCCCCCCSCCTTCCHHHHTTCCCCCTH------HHHHHHHHHHHH
T ss_pred             CEEECcCccceecCCC-----cccCCCCcccccccCchHhhCCCCCCcH------HHHHHHHHHHHH
Confidence            4555555555543322     1223445789999999999765444433      499999998766

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=94.71  E-value=0.024  Score=55.86  Aligned_cols=32  Identities=22%  Similarity=0.421  Sum_probs=27.8

Q ss_pred             HhcCceeccCCCCCeEEcCCCCEEEeeCCCCCC
Q psy8260         185 HSAGIIHRDLKPSNIAVNEDCELKILDFGLARP  217 (427)
Q Consensus       185 H~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~  217 (427)
                      +...++|+|++|.|||++.++ ++|+||+.+..
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            456799999999999998776 99999998753

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=94.71  E-value=0.0037  Score=58.93  Aligned_cols=65  Identities=15%  Similarity=0.098  Sum_probs=37.3

Q ss_pred             CeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         198 NIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       198 NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ++-|.+-|-.+..+-+... ........+||++|||||++.+..... ........|+||.||++.|
T Consensus       146 ~~Ki~DFGla~~~~~~~~~-~~~~~~~~~GT~~ymAPE~l~~~~~~~-~~~~~~k~DVwS~Gvvl~E  210 (303)
T 3hmm_A          146 TCCIADLGLAVRHDSATDT-IDIAPNHRVGTKRYMAPEVLDDSINMK-HFESFKRADIYAMGLVFWE  210 (303)
T ss_dssp             CEEECCCTTCEEEETTTTE-ESCC-----CCGGGCCHHHHTTCSCTT-CHHHHHHHHHHHHHHHHHH
T ss_pred             CEEEEeCCCCccccCCCCc-eeeecccccccccccCHHHhccccccc-CCccChhHhhhhHHHHHHH
Confidence            4557777777766643221 112234568999999999997642111 0011234599999999887

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=94.64  E-value=0.016  Score=55.33  Aligned_cols=60  Identities=23%  Similarity=0.354  Sum_probs=39.9

Q ss_pred             CeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         198 NIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       198 NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ++-|.+-|..+..+..... ........+||+.|+|||++.+...++..      .|+|+.||++.+
T Consensus       162 ~~kl~Dfg~a~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~------~DiwslG~il~e  221 (351)
T 3mi9_A          162 VLKLADFGLARAFSLAKNS-QPNRYTNRVVTLWYRPPELLLGERDYGPP------IDLWGAGCIMAE  221 (351)
T ss_dssp             CEEECCCTTCEECCCCSSS-SCCCCCSSCSCGGGCCHHHHTTCCSCCTH------HHHHHHHHHHHH
T ss_pred             CEEEccchhcccccccccc-cccccCCcccccCccCchhhcCCCCCCcH------hHHHHHHHHHHH
Confidence            5666666666665533221 12234556899999999999775555443      499999998766

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=94.48  E-value=0.0086  Score=56.34  Aligned_cols=56  Identities=20%  Similarity=0.365  Sum_probs=36.7

Q ss_pred             CeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         198 NIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       198 NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ++.|.+-|..+..+...     ...+..+||+.|+|||++.+...++..      .|+|+.||++.+
T Consensus       157 ~~kl~Dfg~a~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~------~DiwslG~il~~  212 (311)
T 3niz_A          157 ALKLADFGLARAFGIPV-----RSYTHEVVTLWYRAPDVLMGSKKYSTS------VDIWSIGCIFAE  212 (311)
T ss_dssp             CEEECCCTTCEETTSCC-----C---CCCCCCTTCCHHHHTTCCSCCTH------HHHHHHHHHHHH
T ss_pred             CEEEccCcCceecCCCc-----ccccCCcccCCcCCHHHhcCCCCCCch------HHhHHHHHHHHH
Confidence            56666666666544222     223445789999999999875555443      499999998766

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=94.26  E-value=0.0075  Score=57.06  Aligned_cols=36  Identities=31%  Similarity=0.515  Sum_probs=24.7

Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ...+||++|+|||++.+...++..      .|+|+.||++.+
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~------~DiwslG~il~~  193 (324)
T 3mtl_A          158 DNEVVTLWYRPPDILLGSTDYSTQ------IDMWGVGCIFYE  193 (324)
T ss_dssp             -----CGGGCCHHHHTTCCCCCTH------HHHHHHHHHHHH
T ss_pred             ccccCcccccChhhhcCCCCCCcH------HHHHHHHHHHHH
Confidence            445789999999999875555443      499999998766

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=94.15  E-value=0.014  Score=55.87  Aligned_cols=60  Identities=30%  Similarity=0.498  Sum_probs=38.6

Q ss_pred             ccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCC-CCCH
Q psy8260         231 YRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYN-QTDI  309 (427)
Q Consensus       231 y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~-~~d~  309 (427)
                      |+|||++.+...++..      .|+|+.||++.+                 +.++.               ..+. ..+.
T Consensus       197 y~aPE~~~~~~~~~~~------~Di~slG~il~e-----------------ll~g~---------------~pf~~~~~~  238 (360)
T 3e3p_A          197 YRAPELIFGNQHYTTA------VDIWSVGCIFAE-----------------MMLGE---------------PIFRGDNSA  238 (360)
T ss_dssp             GCCHHHHTTCSSCCTH------HHHHHHHHHHHH-----------------HHHSS---------------CSSCCSSHH
T ss_pred             eeCHHHHcCCCCCCcH------HHHHHHHHHHHH-----------------HHhCC---------------CCcCCCChH
Confidence            9999999765544443      499999998766                 22222               1233 2344


Q ss_pred             HHHHHHHHHhCCCCHHHHh
Q psy8260         310 HQLNLIMEMLGTPPAEFMA  328 (427)
Q Consensus       310 ~slg~i~~~lg~~~~~~~~  328 (427)
                      ..+..++..++.++.+.+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~  257 (360)
T 3e3p_A          239 GQLHEIVRVLGCPSREVLR  257 (360)
T ss_dssp             HHHHHHHHHHCCCCHHHHH
T ss_pred             HHHHHHHHHcCCCCHHHHH
Confidence            5566777778888776654

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=93.59  E-value=0.013  Score=54.33  Aligned_cols=35  Identities=26%  Similarity=0.512  Sum_probs=25.1

Q ss_pred             cccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         224 GYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       224 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ...||+.|+|||++.+...++.      ..|+|+.||++.+
T Consensus       159 ~~~~t~~y~aPE~~~~~~~~~~------~~DiwslG~il~~  193 (288)
T 1ob3_A          159 HEIVTLWYRAPDVLMGSKKYST------TIDIWSVGCIFAE  193 (288)
T ss_dssp             ---CCCTTCCHHHHTTCCSCCT------HHHHHHHHHHHHH
T ss_pred             cccccccccCchheeCCCCCCc------HHHHHHHHHHHHH
Confidence            3467999999999976544443      3499999998766

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=93.33  E-value=0.029  Score=52.34  Aligned_cols=33  Identities=36%  Similarity=0.578  Sum_probs=25.3

Q ss_pred             ccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         225 YVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       225 ~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      .+||+.|+|||++.+.. ++.      ..|+|+.||++.+
T Consensus       179 ~~gt~~y~aPE~~~~~~-~~~------~~DiwslG~il~~  211 (308)
T 3g33_A          179 VVVTLWYRAPEVLLQST-YAT------PVDMWSVGCIFAE  211 (308)
T ss_dssp             GGCCCSSCCHHHHHTSC-CCS------THHHHHHHHHHHH
T ss_pred             ccccccccCchHHcCCC-CCc------hHHHHHHHHHHHH
Confidence            36899999999997633 333      3499999998866

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=93.20  E-value=0.016  Score=54.96  Aligned_cols=36  Identities=36%  Similarity=0.567  Sum_probs=24.8

Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ...+||+.|+|||++.+...++..      .|+|+.||++.+
T Consensus       195 ~~~~~t~~y~aPE~~~~~~~~~~~------~DiwslG~il~e  230 (329)
T 3gbz_A          195 THEIITLWYRPPEILLGSRHYSTS------VDIWSIACIWAE  230 (329)
T ss_dssp             -----CCTTCCHHHHTTCCCCCTH------HHHHHHHHHHHH
T ss_pred             CCCcCCccccCHHHhcCCCCCCcH------HHHHHHHHHHHH
Confidence            345789999999999875555543      499999998766

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=93.11  E-value=0.016  Score=55.38  Aligned_cols=36  Identities=36%  Similarity=0.544  Sum_probs=27.4

Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      +..+||++|+|||++.+...++.      ..|+|+.||++.+
T Consensus       170 ~~~~~t~~y~aPE~~~~~~~~~~------~~DiwslG~il~e  205 (346)
T 1ua2_A          170 THQVVTRWYRAPELLFGARMYGV------GVDMWAVGCILAE  205 (346)
T ss_dssp             CCSCCCCTTCCHHHHTTCSCCCH------HHHHHHHHHHHHH
T ss_pred             CcccccccccCchHhhCCCCCCc------hhhhHhHHHHHHH
Confidence            45678999999999976444443      3499999998766

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=92.90  E-value=0.023  Score=52.59  Aligned_cols=56  Identities=16%  Similarity=0.329  Sum_probs=36.7

Q ss_pred             CeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         198 NIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       198 NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ++.|.+-|..+..+...     .......||+.|+|||++.+...++..      .|+|+.||++.+
T Consensus       139 ~~kl~Dfg~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~------~DiwslG~il~~  194 (292)
T 3o0g_A          139 ELKLANFGLARAFGIPV-----RCYSAEVVTLWYRPPDVLFGAKLYSTS------IDMWSAGCIFAE  194 (292)
T ss_dssp             CEEECCCTTCEECCSCC-----SCCCSCCSCGGGCCHHHHTTCSCCCTH------HHHHHHHHHHHH
T ss_pred             CEEEeecccceecCCcc-----ccccCCccccCCcChHHHcCCCCcCch------HHHHHHHHHHHH
Confidence            45555555555443221     223455789999999999875544443      499999998766

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=92.89  E-value=0.045  Score=51.47  Aligned_cols=30  Identities=37%  Similarity=0.438  Sum_probs=25.9

Q ss_pred             cCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         187 AGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       187 ~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                      .+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus       187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            469999999999999887666899999764

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=92.82  E-value=0.041  Score=51.10  Aligned_cols=41  Identities=22%  Similarity=0.172  Sum_probs=35.3

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      .+.++|+++.|+++. ++.+|++|||++.          .+..|+|||++..
T Consensus       213 giiHrDlkp~NILl~-~~~vkl~DFG~a~----------~~~~~~a~e~l~r  253 (282)
T 1zar_A          213 GIVHGDLSQYNVLVS-EEGIWIIDFPQSV----------EVGEEGWREILER  253 (282)
T ss_dssp             TEECSCCSTTSEEEE-TTEEEECCCTTCE----------ETTSTTHHHHHHH
T ss_pred             CCEeCCCCHHHEEEE-CCcEEEEECCCCe----------ECCCCCHHHHHHH
Confidence            478889999999999 9999999999884          4566899999864

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=92.81  E-value=0.0085  Score=57.81  Aligned_cols=57  Identities=12%  Similarity=0.041  Sum_probs=36.1

Q ss_pred             CeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         198 NIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       198 NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ++=|.+-|-.+...-.   ......+..+||+.|||||++.+. .|+.      .+|+||.||++.|
T Consensus       223 ~vKi~DFGlar~~~~~---~~~~~~~~~~gt~~ymAPE~l~~~-~y~~------ksDVwS~Gv~l~E  279 (353)
T 4ase_A          223 VVKICDFGLARDIYKD---PDYVRKGDARLPLKWMAPETIFDR-VYTI------QSDVWSFGVLLWE  279 (353)
T ss_dssp             CEEECCCGGGSCTTTC---TTSEEETTEEECGGGCCHHHHHHC-CCCH------HHHHHHHHHHHHH
T ss_pred             CEEECcchhhhhcccC---CCceeeccccccccccCHHHHhcC-CCCC------cccEeehHHHHHH
Confidence            4556665655433211   111123456899999999999863 3443      3499999999876

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=92.76  E-value=0.01  Score=56.15  Aligned_cols=72  Identities=11%  Similarity=0.149  Sum_probs=43.3

Q ss_pred             HHHHHHh----cCc-eeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeecc
Q psy8260         180 GLKYIHS----AGI-IHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQD  254 (427)
Q Consensus       180 aL~yLH~----~~i-iHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d  254 (427)
                      ....+|.    .+| +..|.   ++-|.+-|-.+...-+   ......+..+||+.|||||++.+. .|+.      .+|
T Consensus       163 ~~~iiHRDLK~~NILl~~~~---~~Ki~DFGlar~~~~~---~~~~~~~~~~gt~~ymAPE~l~~~-~~s~------ksD  229 (308)
T 4gt4_A          163 SHHVVHKDLATRNVLVYDKL---NVKISDLGLFREVYAA---DYYKLLGNSLLPIRWMAPEAIMYG-KFSI------DSD  229 (308)
T ss_dssp             HTTCCCSCCSGGGEEECGGG---CEEECCSCCBCGGGGG---GCBCSSSSSCBCGGGCCHHHHHHC-CCCH------HHH
T ss_pred             hCCCCCCCccccceEECCCC---CEEECCcccceeccCC---CceeEecccccCCcccCHHHHhCC-CCCc------cch
Confidence            3455773    344 43332   4556666655533211   111223456899999999999864 3443      349


Q ss_pred             CCcccccccc
Q psy8260         255 LKPSNIAVNE  264 (427)
Q Consensus       255 ~~~~~~~~~~  264 (427)
                      +||.||++.|
T Consensus       230 VwSfGvvl~E  239 (308)
T 4gt4_A          230 IWSYGVVLWE  239 (308)
T ss_dssp             HHHHHHHHHH
T ss_pred             hhhHHHHHHH
Confidence            9999999876

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=92.36  E-value=0.022  Score=54.14  Aligned_cols=34  Identities=15%  Similarity=0.106  Sum_probs=26.0

Q ss_pred             ccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         225 YVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       225 ~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      .+||++|+|||++.+...++      ...|+|+.||++.+
T Consensus       173 ~~gt~~y~aPE~~~~~~~~~------~~~DiwslG~il~e  206 (328)
T 3fe3_A          173 FCGAPPYAAPELFQGKKYDG------PEVDVWSLGVILYT  206 (328)
T ss_dssp             TSSSGGGCCHHHHHTCCCCS------HHHHHHHHHHHHHH
T ss_pred             ccCCcceeCcccccCCCcCC------chhhhhhhHHHHHH
Confidence            36899999999998744332      23599999998866

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=92.05  E-value=0.012  Score=55.30  Aligned_cols=34  Identities=12%  Similarity=0.167  Sum_probs=26.6

Q ss_pred             cccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         224 GYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       224 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ...||+.|||||++.+. .|+.      .+|+||.||++.|
T Consensus       189 ~~~gt~~ymAPE~~~~~-~~~~------k~DVwS~Gvvl~E  222 (299)
T 4asz_A          189 HTMLPIRWMPPESIMYR-KFTT------ESDVWSLGVVLWE  222 (299)
T ss_dssp             TEEECGGGCCHHHHHHC-CCCH------HHHHHHHHHHHHH
T ss_pred             ceecChhhcCHHHHcCC-CCCc------hhhHHHHHHHHHH
Confidence            35789999999999863 3443      3499999999876

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=92.04  E-value=0.014  Score=55.78  Aligned_cols=72  Identities=11%  Similarity=0.091  Sum_probs=38.1

Q ss_pred             HHHHHHh----cCc-eeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeecc
Q psy8260         180 GLKYIHS----AGI-IHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQD  254 (427)
Q Consensus       180 aL~yLH~----~~i-iHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d  254 (427)
                      ....+|.    .+| +..|   .++-|.+-|-.+..+-+-   .....+..+||+.|||||++.+. .|+.      .+|
T Consensus       176 ~~~iiHRDLKp~NILl~~~---~~~Ki~DFGla~~~~~~~---~~~~~~~~~gt~~ymAPE~~~~~-~~~~------~sD  242 (329)
T 4aoj_A          176 GLHFVHRDLATRNCLVGQG---LVVKIGDFGMSRDIYSTD---YYRVGGRTMLPIRWMPPESILYR-KFTT------ESD  242 (329)
T ss_dssp             HTTCCCSCCCGGGEEEETT---TEEEECCCC-------------------CCCCGGGCCHHHHTTC-CCCH------HHH
T ss_pred             cCCeecccccHhhEEECCC---CcEEEcccccceeccCCC---cceecCcccccccccChhhhcCC-CCCc------ccc
Confidence            3456783    344 3332   345577777666543221   11122446899999999998763 3433      349


Q ss_pred             CCcccccccc
Q psy8260         255 LKPSNIAVNE  264 (427)
Q Consensus       255 ~~~~~~~~~~  264 (427)
                      +||.||++.|
T Consensus       243 vwS~Gvvl~E  252 (329)
T 4aoj_A          243 VWSFGVVLWE  252 (329)
T ss_dssp             HHHHHHHHHH
T ss_pred             ccchHHHHHH
Confidence            9999999876

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=91.84  E-value=0.081  Score=50.05  Aligned_cols=31  Identities=23%  Similarity=0.435  Sum_probs=26.8

Q ss_pred             hcCceeccCCCCCeEEcCC----CCEEEeeCCCCC
Q psy8260         186 SAGIIHRDLKPSNIAVNED----CELKILDFGLAR  216 (427)
Q Consensus       186 ~~~iiHrDLKp~NILl~~~----~~~kl~DFGla~  216 (427)
                      ...++|+|+.+.|||++.+    +.+.|+||+.+.
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~  216 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK  216 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence            3469999999999999874    689999999875

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=91.23  E-value=1.4  Score=39.11  Aligned_cols=57  Identities=23%  Similarity=0.289  Sum_probs=41.1

Q ss_pred             CHHHHHh--hCCCCHHHHHHHHHHHHHHHHHHH-hcCceeccCCCCCeEEcCCCCEEEee
Q psy8260         155 DLNNILR--TQKLSDDHVQFLVYQILRGLKYIH-SAGIIHRDLKPSNIAVNEDCELKILD  211 (427)
Q Consensus       155 ~L~~~l~--~~~l~~~~~~~~~~qi~~aL~yLH-~~~iiHrDLKp~NILl~~~~~~kl~D  211 (427)
                      +|.++|+  +.+++|+++..++.|.+.+|.-+- .+.-..+=+-|..|++..+|.|...+
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~   93 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP   93 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc
Confidence            6888885  578999999999999999987662 11111222345788888888887664

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=90.28  E-value=0.05  Score=52.42  Aligned_cols=33  Identities=39%  Similarity=0.702  Sum_probs=22.7

Q ss_pred             ccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         225 YVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       225 ~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      .+||+.|+|||++.+. .|+.      ..|+|+.||++.+
T Consensus       186 ~~gt~~y~aPE~~~~~-~~~~------~~DiwslG~il~e  218 (371)
T 2xrw_A          186 YVVTRYYRAPEVILGM-GYKE------NVDIWSVGCIMGE  218 (371)
T ss_dssp             ----CTTCCHHHHTTC-CCCT------THHHHHHHHHHHH
T ss_pred             ceecCCccCHHHhcCC-CCCc------hHhHHHHHHHHHH
Confidence            3689999999999763 3333      3499999998876

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=90.26  E-value=0.081  Score=49.86  Aligned_cols=36  Identities=39%  Similarity=0.635  Sum_probs=26.2

Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ....||++|+|||++.+...++.      ..|+|+.||++.+
T Consensus       182 ~~~~~t~~y~aPE~~~~~~~~~~------~~Di~slG~il~~  217 (331)
T 4aaa_A          182 DDEVATRWYRAPELLVGDVKYGK------AVDVWAIGCLVTE  217 (331)
T ss_dssp             --CCCCCTTCCHHHHTTCTTCCT------HHHHHHHHHHHHH
T ss_pred             CCCcCCccccCcccccCCCCcch------HHHHHHHHHHHHH
Confidence            34578999999999976444443      3499999998766

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=90.00  E-value=0.036  Score=53.23  Aligned_cols=58  Identities=16%  Similarity=0.064  Sum_probs=38.1

Q ss_pred             CCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         197 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       197 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      .++-|.+-|..+.....   ......+..+||+.|+|||++.+.. |+.      ..|+|+.||++.+
T Consensus       220 ~~~kl~DFG~a~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~-~~~------~~DiwslG~il~e  277 (365)
T 3e7e_A          220 AGLALIDLGQSIDMKLF---PKGTIFTAKCETSGFQCVEMLSNKP-WNY------QIDYFGVAATVYC  277 (365)
T ss_dssp             TTEEECCCTTCEEGGGS---CTTEEECCSSCTTSCCCHHHHTTCC-BST------HHHHHHHHHHHHH
T ss_pred             CCEEEeeCchhhhhhcc---CCCceeeeecCCCCCCChHHhcCCC-CCc------cccHHHHHHHHHH
Confidence            45666666666554321   1122335568999999999997643 443      4499999999877

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=89.75  E-value=0.044  Score=52.64  Aligned_cols=55  Identities=18%  Similarity=0.098  Sum_probs=31.6

Q ss_pred             CeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         198 NIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       198 NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ++-|.+-|.++....     ........+||+.|+|||++.+. .|+.      ..|+|+.||++.+
T Consensus       162 ~ikL~DFG~a~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~-~~~~------~~DiwslG~il~e  216 (353)
T 3txo_A          162 HCKLADFGMCKEGIC-----NGVTTATFCGTPDYIAPEILQEM-LYGP------AVDWWAMGVLLYE  216 (353)
T ss_dssp             CEEECCCTTCBCSCC--------------CCGGGCCHHHHHHH-HCTT------HHHHHHHHHHHHH
T ss_pred             CEEEccccceeeccc-----CCccccccCCCcCeEChhhcCCC-CcCC------ccCCCcchHHHHH
Confidence            465655554442211     12234556899999999998763 3443      3499999999876

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=89.66  E-value=0.074  Score=52.50  Aligned_cols=66  Identities=17%  Similarity=0.081  Sum_probs=36.0

Q ss_pred             CeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         198 NIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       198 NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ++.|.+-|..+..+.+-... .......+||+.|+|||++.+..............|+|+.||++.+
T Consensus       166 ~~kL~DFG~a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~e  231 (434)
T 2rio_A          166 RILISDFGLCKKLDSGQSSF-RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYY  231 (434)
T ss_dssp             EEEECCCTTCEECCC---------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHH
T ss_pred             EEEEcccccceecCCCCccc-eeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHH
Confidence            56677777777665543221 1123456899999999999763322222223345699999999876

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=89.59  E-value=0.047  Score=52.84  Aligned_cols=61  Identities=15%  Similarity=0.186  Sum_probs=39.7

Q ss_pred             CeEEcC-CCCEEEeeCCCCCCCCC-Ccccccccccccchhhhhcc-cccCCCCcceeeccCCcccccccc
Q psy8260         198 NIAVNE-DCELKILDFGLARPTEN-EMTGYVATRWYRAPEIMLNW-MHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       198 NILl~~-~~~~kl~DFGla~~~~~-~~~~~~gt~~y~aPE~l~~~-~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ++.+.+ .....+.+.|....... .....+||+.|+|||++.+. ..|+.      ..|+|+.||++.+
T Consensus       166 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~------~~DiwslG~il~e  229 (389)
T 3gni_B          166 KVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDA------KSDIYSVGITACE  229 (389)
T ss_dssp             CEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCT------HHHHHHHHHHHHH
T ss_pred             CEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCc------HhHHHHHHHHHHH
Confidence            444443 34566677775543322 23445899999999999763 23433      3499999999876

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=89.27  E-value=0.094  Score=48.73  Aligned_cols=36  Identities=33%  Similarity=0.589  Sum_probs=23.5

Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ...+||++|+|||++.+...++..      .|+|+.|+++.+
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~------~Di~slG~il~~  195 (311)
T 4agu_A          160 DDEVATRWYRSPELLVGDTQYGPP------VDVWAIGCVFAE  195 (311)
T ss_dssp             ------GGGCCHHHHHTCSCCCTH------HHHHHHHHHHHH
T ss_pred             CCCcCCccccChHHHhcCCCCCcc------hhhHHHHHHHHH
Confidence            345789999999999865544443      499999988766

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=89.17  E-value=0.05  Score=53.18  Aligned_cols=56  Identities=20%  Similarity=0.136  Sum_probs=37.1

Q ss_pred             CCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         197 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       197 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      .++-|.+-|.++...     .........+||+.|+|||++.+. .|+.      ..|+|+.||++.+
T Consensus       190 g~ikL~DFGla~~~~-----~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~------~~DiwslGvllye  245 (396)
T 4dc2_A          190 GHIKLTDYGMCKEGL-----RPGDTTSTFCGTPNYIAPEILRGE-DYGF------SVDWWALGVLMFE  245 (396)
T ss_dssp             SCEEECCCTTCBCCC-----CTTCCBCCCCBCGGGCCHHHHTTC-CBCT------HHHHHHHHHHHHH
T ss_pred             CCEEEeecceeeecc-----cCCCccccccCCcccCCchhhcCC-CCCh------HHHHHHHHHHHHH
Confidence            356666666555311     112334567899999999999763 3333      3499999999877

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=89.10  E-value=0.19  Score=46.78  Aligned_cols=35  Identities=17%  Similarity=0.125  Sum_probs=23.1

Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ...+||+.|+|||++.+. .++      ...|+|+.|+++.+
T Consensus       177 ~~~~gt~~y~aPE~~~~~-~~~------~~~Di~slG~~l~~  211 (311)
T 3ork_A          177 AAVIGTAQYLSPEQARGD-SVD------ARSDVYSLGCVLYE  211 (311)
T ss_dssp             -----CCTTCCHHHHHTC-CCC------HHHHHHHHHHHHHH
T ss_pred             cccCcCcccCCHHHhcCC-CCC------chHhHHHHHHHHHH
Confidence            345789999999998763 222      24599999998766

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=88.92  E-value=0.14  Score=49.16  Aligned_cols=54  Identities=15%  Similarity=0.048  Sum_probs=35.0

Q ss_pred             CeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         198 NIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       198 NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ++-|.+-|..+..+-+...  .    ..+||+.|+|||++.+. .|+.      ..|+|+.||++.+
T Consensus       157 ~vkl~DFG~a~~~~~~~~~--~----~~~gt~~y~aPE~~~~~-~~~~------~~DiwslGvil~~  210 (361)
T 2yab_A          157 HIKLIDFGLAHEIEDGVEF--K----NIFGTPEFVAPEIVNYE-PLGL------EADMWSIGVITYI  210 (361)
T ss_dssp             CEEECCCSSCEECCTTCCC--C----CCCSCGGGCCHHHHTTC-CCCT------HHHHHHHHHHHHH
T ss_pred             CEEEEecCCceEcCCCCcc--c----cCCCCccEECchHHcCC-CCCc------cccHHHHHHHHHH
Confidence            5666666666555433211  1    13689999999998752 2332      3499999998765

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=88.71  E-value=0.38  Score=46.05  Aligned_cols=28  Identities=32%  Similarity=0.655  Sum_probs=23.9

Q ss_pred             CceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         188 GIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       188 ~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                      +++|+|+.+.|||++.++ +.|+||..+.
T Consensus       213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~  240 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC-LRLIDFEYSG  240 (369)
T ss_dssp             EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred             EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence            589999999999998654 8999998775

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=88.67  E-value=0.29  Score=46.52  Aligned_cols=30  Identities=20%  Similarity=0.366  Sum_probs=26.6

Q ss_pred             cCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         187 AGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       187 ~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                      ..++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~  235 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM  235 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence            369999999999999988889999998664

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=88.61  E-value=0.046  Score=54.26  Aligned_cols=75  Identities=21%  Similarity=0.192  Sum_probs=44.1

Q ss_pred             HHHHHHHHh----cCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhc----ccccCCCCcc
Q psy8260         178 LRGLKYIHS----AGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN----WMHYNQTGVP  249 (427)
Q Consensus       178 ~~aL~yLH~----~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~~~~  249 (427)
                      +....++|.    .+|+= | +-.++-|.+-|..+...-.    .....+..+||++|+|||++..    ...|+.    
T Consensus       191 LH~~giiHrDLKp~NILl-~-~~g~vkL~DFGla~~~~~~----~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~----  260 (437)
T 4aw2_A          191 VHQLHYVHRDIKPDNILM-D-MNGHIRLADFGSCLKLMED----GTVQSSVAVGTPDYISPEILQAMEGGKGRYGP----  260 (437)
T ss_dssp             HHHTTEECCCCSGGGEEE-C-TTSCEEECCCTTCEECCTT----SCEECCSCCSCGGGCCHHHHHHHHTSCCEECT----
T ss_pred             HHhCCeEecccCHHHeeE-c-CCCCEEEcchhhhhhcccC----CCcccccccCCcCeeChHHHhhcccCCCCCCC----
Confidence            344556773    24432 1 1235666666655543221    1122345689999999999973    223433    


Q ss_pred             eeeccCCcccccccc
Q psy8260         250 FYFQDLKPSNIAVNE  264 (427)
Q Consensus       250 ~~~~d~~~~~~~~~~  264 (427)
                        ..|+|+.||++.+
T Consensus       261 --~~DvwSlGvil~e  273 (437)
T 4aw2_A          261 --ECDWWSLGVCMYE  273 (437)
T ss_dssp             --HHHHHHHHHHHHH
T ss_pred             --cCeeHHHHHHHHH
Confidence              3499999999876

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=88.47  E-value=0.054  Score=54.17  Aligned_cols=62  Identities=6%  Similarity=-0.042  Sum_probs=16.2

Q ss_pred             eccccCcccccEEEEeEEeCcCCcEEEE------EEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeee
Q psy8260          68 IGPTLSKESFDLIFSSALDSVSGVKVAI------KKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVF  133 (427)
Q Consensus        68 ~~~~lg~g~fg~v~~~~~~~~~g~~vAv------K~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~  133 (427)
                      +.+.+|   ||.|+++.+.. ...+|||      |..............+.+|..+++.++|||+++.+.+-
T Consensus       146 l~~~lG---fG~v~~g~~~~-~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~  213 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYK-KHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK  213 (463)
T ss_dssp             STTTSS---BCCC----------CCBGGGC-----------------------------------CBCCCEE
T ss_pred             ccccCC---chhhhcccccc-cCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence            345555   99999887753 2457888      66543333333345677899999999999999998764

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=88.38  E-value=0.087  Score=50.52  Aligned_cols=36  Identities=25%  Similarity=0.272  Sum_probs=27.5

Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ....+||+.|+|||++.+. .|+.      ..|+|+.||++.+
T Consensus       178 ~~~~~gt~~y~aPE~~~~~-~~~~------~~DiwslG~il~e  213 (353)
T 2i0e_A          178 TKTFCGTPDYIAPEIIAYQ-PYGK------SVDWWAFGVLLYE  213 (353)
T ss_dssp             BCCCCSCGGGCCHHHHTTC-CBST------HHHHHHHHHHHHH
T ss_pred             cccccCCccccChhhhcCC-CcCC------cccccchHHHHHH
Confidence            3456899999999998753 2333      3499999999876

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=88.29  E-value=0.065  Score=52.15  Aligned_cols=28  Identities=25%  Similarity=0.308  Sum_probs=20.5

Q ss_pred             ccchhhhhccc--ccCCCCcceeeccCCcccccccc
Q psy8260         231 YRAPEIMLNWM--HYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       231 y~aPE~l~~~~--~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      |+|||++.+..  .|+.      ..|+|+.||++.+
T Consensus       180 Y~aPE~~~~~~~~~~~~------~~DiwSlG~il~e  209 (384)
T 4fr4_A          180 YMAPEMFSSRKGAGYSF------AVDWWSLGVTAYE  209 (384)
T ss_dssp             GCCGGGTCCCSSCCBCT------THHHHHHHHHHHH
T ss_pred             ccCCeeeccCCCCCCCc------cceeechHHHHHH
Confidence            89999987521  2333      3499999999876

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=88.17  E-value=0.091  Score=49.81  Aligned_cols=34  Identities=15%  Similarity=0.161  Sum_probs=25.7

Q ss_pred             ccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         225 YVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       225 ~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      .+||+.|+|||++.+...++      ...|+|+.||++.+
T Consensus       189 ~~gt~~y~aPE~~~~~~~~~------~~~DiwslG~il~e  222 (335)
T 3dls_A          189 FCGTIEYCAPEVLMGNPYRG------PELEMWSLGVTLYT  222 (335)
T ss_dssp             ECSCGGGCCHHHHTTCCBCS------HHHHHHHHHHHHHH
T ss_pred             cCCCccccChhhhcCCCCCC------CcccchhHHHHHHH
Confidence            46899999999997643323      23499999998866

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=87.92  E-value=0.052  Score=53.34  Aligned_cols=61  Identities=13%  Similarity=-0.043  Sum_probs=38.0

Q ss_pred             CCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         197 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       197 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      .++-|.+-|.++..+-.-    .....+.+||+.|+|||++.+....   .......|+|+.||++.+
T Consensus       205 g~ikL~DFG~a~~~~~~~----~~~~~~~~gt~~Y~APE~l~~~~~~---~~~~~~~DiwSlGvilye  265 (410)
T 3v8s_A          205 GHLKLADFGTCMKMNKEG----MVRCDTAVGTPDYISPEVLKSQGGD---GYYGRECDWWSVGVFLYE  265 (410)
T ss_dssp             SCEEECCCTTCEECCTTS----EEECCSCCSCGGGCCHHHHHTTTTT---CEEETHHHHHHHHHHHHH
T ss_pred             CCEEEeccceeEeeccCC----cccccCCcCCccccCHHHhhccCCC---cCCCCcceEecchHHHHH
Confidence            356676666666543221    1123456899999999999763210   011234599999999876

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=87.90  E-value=0.077  Score=50.51  Aligned_cols=36  Identities=25%  Similarity=0.350  Sum_probs=27.5

Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ....+||+.|+|||++.+. .|+.      ..|+|+.||++.+
T Consensus       162 ~~~~~gt~~y~aPE~~~~~-~~~~------~~DiwslG~il~e  197 (337)
T 1o6l_A          162 MKTFCGTPEYLAPEVLEDN-DYGR------AVDWWGLGVVMYE  197 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSS-CBCT------THHHHHHHHHHHH
T ss_pred             ccccccChhhCChhhhcCC-CCCc------hhhcccchhHHHH
Confidence            3557899999999998753 3333      3499999998876

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=87.88  E-value=0.21  Score=46.32  Aligned_cols=55  Identities=16%  Similarity=0.164  Sum_probs=35.8

Q ss_pred             CeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         198 NIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       198 NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ++.|.+-|..+..+-..     ......+||+.|+|||++.+. .|+.      ..|+|+.||++.+
T Consensus       154 ~~kl~Dfg~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~-~~~~------~~DiwslG~il~e  208 (297)
T 3fxz_A          154 SVKLTDFGFCAQITPEQ-----SKRSTMVGTPYWMAPEVVTRK-AYGP------KVDIWSLGIMAIE  208 (297)
T ss_dssp             CEEECCCTTCEECCSTT-----CCBCCCCSCGGGCCHHHHHCS-CBCT------HHHHHHHHHHHHH
T ss_pred             CEEEeeCCCceecCCcc-----cccCCccCCcCccChhhhcCC-CCCc------HHHHHHHHHHHHH
Confidence            46565555554443221     223456899999999998763 2332      4599999998866

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=87.74  E-value=0.07  Score=50.94  Aligned_cols=36  Identities=25%  Similarity=0.260  Sum_probs=27.7

Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ....+||+.|+|||++.+. .|+.      ..|+|+.||++.+
T Consensus       167 ~~~~~gt~~y~aPE~~~~~-~~~~------~~DiwslG~il~e  202 (345)
T 3a8x_A          167 TSTFCGTPNYIAPEILRGE-DYGF------SVDWWALGVLMFE  202 (345)
T ss_dssp             BCCCCSCGGGCCHHHHTTC-CBCT------HHHHHHHHHHHHH
T ss_pred             ccccCCCccccCccccCCC-CCCh------HHhHHHHHHHHHH
Confidence            3556899999999999763 2332      3499999999877

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=87.64  E-value=0.22  Score=47.43  Aligned_cols=54  Identities=17%  Similarity=0.056  Sum_probs=34.3

Q ss_pred             eEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         199 IAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       199 ILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      +-+.+-|..+..+-.     .......+||+.|+|||++.+. .|+      ...|+|+.||++.+
T Consensus       172 vkl~Dfg~a~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~-~~~------~~~DiwslG~il~~  225 (351)
T 3c0i_A          172 VKLGGFGVAIQLGES-----GLVAGGRVGTPHFMAPEVVKRE-PYG------KPVDVWGCGVILFI  225 (351)
T ss_dssp             EEECCCTTCEECCTT-----SCBCCCCCSCGGGCCHHHHTTC-CBC------THHHHHHHHHHHHH
T ss_pred             EEEecCcceeEecCC-----CeeecCCcCCcCccCHHHHcCC-CCC------chHhhHHHHHHHHH
Confidence            555555554433211     1123455899999999998753 233      34599999998866

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=87.58  E-value=0.053  Score=51.68  Aligned_cols=33  Identities=18%  Similarity=0.150  Sum_probs=25.4

Q ss_pred             cccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         226 VATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       226 ~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      +||+.|+|||++.+...++      ...|+|+.||++.+
T Consensus       168 ~gt~~y~aPE~~~~~~~~~------~~~DiwslG~il~~  200 (336)
T 3h4j_B          168 CGSPNYAAPEVINGKLYAG------PEVDVWSCGIVLYV  200 (336)
T ss_dssp             TTSTTTSCGGGSCCSGGGC------HHHHHHHHHHHHHH
T ss_pred             cCCcCcCCHHHHcCCCCCC------CccchhHHHHHHHH
Confidence            6899999999987643322      23599999999876

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=87.53  E-value=0.11  Score=54.50  Aligned_cols=71  Identities=17%  Similarity=0.154  Sum_probs=45.5

Q ss_pred             HHHHHHHh----cCce-eccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeec
Q psy8260         179 RGLKYIHS----AGII-HRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQ  253 (427)
Q Consensus       179 ~aL~yLH~----~~ii-HrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~  253 (427)
                      .....+|.    .+|+ ..|   .++-|.+-|..+.....     .......+||+.|+|||++.+. .|+.      ..
T Consensus       459 H~~gIiHrDLKp~NILl~~~---g~ikL~DFGla~~~~~~-----~~~~~~~~GT~~Y~APE~l~~~-~~~~------~~  523 (674)
T 3pfq_A          459 QSKGIIYRDLKLDNVMLDSE---GHIKIADFGMCKENIWD-----GVTTKTFCGTPDYIAPEIIAYQ-PYGK------SV  523 (674)
T ss_dssp             HHTSEECCCCCSTTEEECSS---SCEEECCCTTCEECCCT-----TCCBCCCCSCSSSCCHHHHTCC-CBST------HH
T ss_pred             HhCCeEeccCChhhEEEcCC---CcEEEeecceeeccccC-----CcccccccCCCcccCHhhhcCC-CCCc------cc
Confidence            34456773    3443 332   35777777776654322     1234567899999999999753 3443      34


Q ss_pred             cCCcccccccc
Q psy8260         254 DLKPSNIAVNE  264 (427)
Q Consensus       254 d~~~~~~~~~~  264 (427)
                      |+|+.|+++.+
T Consensus       524 DvwSlGvilye  534 (674)
T 3pfq_A          524 DWWAFGVLLYE  534 (674)
T ss_dssp             HHHHHHHHHHH
T ss_pred             eEechHHHHHH
Confidence            99999999877

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=87.50  E-value=0.12  Score=51.12  Aligned_cols=36  Identities=25%  Similarity=0.350  Sum_probs=27.1

Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ....+||+.|+|||++.+. .|+.      ..|+|+.||++.+
T Consensus       306 ~~~~~gt~~y~aPE~~~~~-~~~~------~~DiwslG~il~e  341 (446)
T 4ejn_A          306 MKTFCGTPEYLAPEVLEDN-DYGR------AVDWWGLGVVMYE  341 (446)
T ss_dssp             -CCSSSCGGGCCHHHHHTS-CCCT------HHHHHHHHHHHHH
T ss_pred             cccccCCccccCHhhcCCC-CCCC------ccchhhhHHHHHH
Confidence            3457899999999998753 3333      3499999998876

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=87.37  E-value=0.076  Score=50.77  Aligned_cols=55  Identities=25%  Similarity=0.257  Sum_probs=36.4

Q ss_pred             CeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         198 NIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       198 NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ++-|.+-|..+....+-     ......+||+.|+|||++.+. .|+.      ..|+|+.||++.+
T Consensus       156 ~vkL~DFG~a~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~-~~~~------~~DiwslG~il~e  210 (345)
T 1xjd_A          156 HIKIADFGMCKENMLGD-----AKTNTFCGTPDYIAPEILLGQ-KYNH------SVDWWSFGVLLYE  210 (345)
T ss_dssp             CEEECCCTTCBCCCCTT-----CCBCCCCSCGGGCCHHHHTTC-CBCT------HHHHHHHHHHHHH
T ss_pred             CEEEeEChhhhhcccCC-----CcccCCCCCcccCChhhhcCC-CCCC------hhhhHHHHHHHHH
Confidence            56666555555333222     224567899999999999763 2332      3499999998876

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=87.30  E-value=0.069  Score=52.46  Aligned_cols=80  Identities=20%  Similarity=0.044  Sum_probs=44.7

Q ss_pred             HHHHHHHh----cCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeecc
Q psy8260         179 RGLKYIHS----AGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQD  254 (427)
Q Consensus       179 ~aL~yLH~----~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d  254 (427)
                      ....++|.    .+|+-.  +-.++-|.+-|..+..+-.-    .......+||+.|+|||++.+..............|
T Consensus       179 H~~giiHrDLKp~NILld--~~g~vkL~DFGla~~~~~~~----~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~D  252 (412)
T 2vd5_A          179 HRLGYVHRDIKPDNILLD--RCGHIRLADFGSCLKLRADG----TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECD  252 (412)
T ss_dssp             HHTTEECCCCSGGGEEEC--TTSCEEECCCTTCEECCTTS----CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHH
T ss_pred             HHCCeeecccCHHHeeec--CCCCEEEeechhheeccCCC----ccccceeccccCcCCHHHHhhcccCcCCCCCChHHh
Confidence            34456673    244431  12356676666665543221    112345689999999999974211000111123349


Q ss_pred             CCcccccccc
Q psy8260         255 LKPSNIAVNE  264 (427)
Q Consensus       255 ~~~~~~~~~~  264 (427)
                      +|+.||++.+
T Consensus       253 iwSlGvilye  262 (412)
T 2vd5_A          253 WWALGVFAYE  262 (412)
T ss_dssp             HHHHHHHHHH
T ss_pred             hhHHhHHHHH
Confidence            9999999876

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=87.10  E-value=0.18  Score=51.67  Aligned_cols=76  Identities=18%  Similarity=0.187  Sum_probs=47.8

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCCc---cccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHH
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPTE---NEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAE  325 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~---~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~  325 (427)
                      ...++|+++.|++++.++.+|++|||+++...   ....+.+||+.|||||++.+. ...++|+|++|++.+.+-.+..+
T Consensus       359 GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          359 GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             TCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence            46789999999999999999999999987543   234578999999999999875 45568999999887666444333

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=87.05  E-value=0.087  Score=50.97  Aligned_cols=36  Identities=22%  Similarity=0.277  Sum_probs=27.7

Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ....+||+.|+|||++.+. .|+.      ..|+|+.||++.+
T Consensus       196 ~~~~~gt~~y~aPE~~~~~-~~~~------~~DiwslG~il~e  231 (373)
T 2r5t_A          196 TSTFCGTPEYLAPEVLHKQ-PYDR------TVDWWCLGAVLYE  231 (373)
T ss_dssp             CCSBSCCCCCCCHHHHTTC-CCCT------HHHHHHHHHHHHH
T ss_pred             cccccCCccccCHHHhCCC-CCCc------hhhhHHHHHHHHH
Confidence            4567899999999998753 3333      3499999999876

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=86.86  E-value=0.091  Score=49.52  Aligned_cols=31  Identities=32%  Similarity=0.364  Sum_probs=23.6

Q ss_pred             ccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         227 ATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       227 gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ||+.|+|||++.+. .|+..      .|+|+.||++.+
T Consensus       165 gt~~y~aPE~~~~~-~~~~~------~DiwslG~il~e  195 (318)
T 1fot_A          165 GTPDYIAPEVVSTK-PYNKS------IDWWSFGILIYE  195 (318)
T ss_dssp             SCTTTCCHHHHTTC-CBCTT------HHHHHHHHHHHH
T ss_pred             CCccccCHhHhcCC-CCCcc------cchhhhHHHHHH
Confidence            47889999998753 34333      499999998876

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=86.85  E-value=0.18  Score=49.97  Aligned_cols=59  Identities=17%  Similarity=0.187  Sum_probs=37.0

Q ss_pred             CCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         194 LKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       194 LKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      .+...+.|.+-|..+..+-     ........+||+.|+|||++.+. .|+.      ..|+|+.||++.+
T Consensus       147 ~~~~~vkL~DFG~a~~~~~-----~~~~~~~~~gt~~Y~APE~l~~~-~~~~------~~DIwSlGvilye  205 (444)
T 3soa_A          147 LKGAAVKLADFGLAIEVEG-----EQQAWFGFAGTPGYLSPEVLRKD-PYGK------PVDLWACGVILYI  205 (444)
T ss_dssp             STTCCEEECCCSSCBCCCT-----TCCBCCCSCSCGGGCCHHHHTTC-CBCT------HHHHHHHHHHHHH
T ss_pred             CCCCcEEEccCceeEEecC-----CCceeecccCCcccCCHHHhcCC-CCCC------ccccHHHHHHHHH
Confidence            3445566655554433321     12223456899999999998753 3333      3499999998766

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=86.63  E-value=0.047  Score=51.46  Aligned_cols=42  Identities=19%  Similarity=0.151  Sum_probs=28.1

Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ...+||+.|+|||++.+..............|+|+.||++.+
T Consensus       186 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~e  227 (336)
T 3g2f_A          186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWE  227 (336)
T ss_dssp             CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHH
T ss_pred             ccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHH
Confidence            456899999999999763221111112234599999999876

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=86.37  E-value=0.067  Score=51.99  Aligned_cols=12  Identities=8%  Similarity=-0.061  Sum_probs=10.4

Q ss_pred             ccCCcccccccc
Q psy8260         253 QDLKPSNIAVNE  264 (427)
Q Consensus       253 ~d~~~~~~~~~~  264 (427)
                      .|+|+.||++.+
T Consensus       248 ~DiwSlGvil~e  259 (390)
T 2zmd_A          248 SDVWSLGCILYY  259 (390)
T ss_dssp             HHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHH
Confidence            499999999876

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=86.09  E-value=0.092  Score=53.58  Aligned_cols=56  Identities=23%  Similarity=0.322  Sum_probs=38.5

Q ss_pred             CCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         197 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       197 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      .++-|.+-|..+..+-+.     ......+||+.|+|||++.+. .|+.      ..|+|+.||++.+
T Consensus       326 g~vkL~DFGla~~~~~~~-----~~~~~~~GT~~Y~APE~l~~~-~~~~------~~DiwSlGvilye  381 (543)
T 3c4z_A          326 GNVRISDLGLAVELKAGQ-----TKTKGYAGTPGFMAPELLLGE-EYDF------SVDYFALGVTLYE  381 (543)
T ss_dssp             SCEEECCCTTCEECCTTC-----CCBCCCCSCTTTSCHHHHTTC-CBCT------HHHHHHHHHHHHH
T ss_pred             CCEEEeecceeeeccCCC-----cccccccCCccccChhhhcCC-CCCh------HHhcCcchHHHHH
Confidence            356676666666554332     223556899999999999763 3333      3499999999877

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=85.71  E-value=0.57  Score=46.57  Aligned_cols=59  Identities=10%  Similarity=0.070  Sum_probs=31.1

Q ss_pred             ccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCc-eeeeeee
Q psy8260          71 TLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENV-IGLLDVF  133 (427)
Q Consensus        71 ~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnI-v~l~~~~  133 (427)
                      .|+.|--..+|+.... ..+..+.+|+........   ....+|..+++.+...++ .++++.+
T Consensus       115 ~lsgG~tN~~y~v~~~-~~~~~~vLRi~g~~~~~~---idR~~E~~vl~~L~~~gl~P~ll~~~  174 (458)
T 2qg7_A          115 IINGGITNILIKVKDM-SKQAKYLIRLYGPKTDEI---INREREKKISCILYNKNIAKKIYVFF  174 (458)
T ss_dssp             EECC--CEEEEEEEET-TTTEEEEEEEECC-CCSC---SCHHHHHHHHHHHTTSSSBCCEEEEE
T ss_pred             EcCCCeEeEEEEEEEC-CCCceEEEEECCCChhhh---cCHHHHHHHHHHHHhcCCCCCEEEEe
Confidence            4555655777764432 234778888753321110   012478888888765554 4566554

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=85.66  E-value=0.069  Score=50.34  Aligned_cols=58  Identities=14%  Similarity=0.141  Sum_probs=38.0

Q ss_pred             CeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         198 NIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       198 NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ++.|.+-|..+..+.+-..   ......+||+.|+|||++.+...++      ...|+|+.||++.+
T Consensus       143 ~~kl~Dfg~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~------~~~DiwslG~il~~  200 (323)
T 3tki_A          143 NLKISDFGLATVFRYNNRE---RLLNKMCGTLPYVAPELLKRREFHA------EPVDVWSCGIVLTA  200 (323)
T ss_dssp             CEEECCCTTCEECEETTEE---CCBCSCCSCGGGSCHHHHHCSSBCH------HHHHHHHHHHHHHH
T ss_pred             CEEEEEeeccceeccCCcc---cccCCCccCcCccCcHHhccCCCCC------CcccHHHHHHHHHH
Confidence            5666666666655433211   2234568999999999997643322      23599999998866

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=85.48  E-value=0.064  Score=51.54  Aligned_cols=33  Identities=24%  Similarity=0.270  Sum_probs=22.6

Q ss_pred             cccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         226 VATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       226 ~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      +||++|+|||++.+...+.      ...|+|+.||++.+
T Consensus       178 ~gt~~y~aPE~~~~~~~~~------~~~DiwslG~il~e  210 (361)
T 3uc3_A          178 VGTPAYIAPEVLLRQEYDG------KIADVWSCGVTLYV  210 (361)
T ss_dssp             ---CTTSCHHHHHCSSCCH------HHHHHHHHHHHHHH
T ss_pred             cCCCCcCChhhhcCCCCCC------CeeeeehhHHHHHH
Confidence            6899999999997643322      12499999998876

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=85.41  E-value=0.24  Score=49.46  Aligned_cols=31  Identities=23%  Similarity=0.432  Sum_probs=24.5

Q ss_pred             cccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         226 VATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       226 ~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      +||+.|+|||++.+.  |+.      ..|+|+.||++.+
T Consensus       184 ~gt~~y~aPE~~~~~--~~~------~~DiwslG~il~~  214 (486)
T 3mwu_A          184 IGTAYYIAPEVLRGT--YDE------KCDVWSAGVILYI  214 (486)
T ss_dssp             TTGGGGCCGGGGGSC--CCH------HHHHHHHHHHHHH
T ss_pred             cCCCCCCCHHHhCCC--CCc------hhhHHHHHHHHHH
Confidence            689999999998752  333      4599999998766

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=84.97  E-value=0.26  Score=49.18  Aligned_cols=31  Identities=23%  Similarity=0.474  Sum_probs=24.7

Q ss_pred             cccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         226 VATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       226 ~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      +||+.|+|||++.+  .|+.      ..|+|+.||++.+
T Consensus       189 ~gt~~y~aPE~~~~--~~~~------~~DiwslG~il~~  219 (484)
T 3nyv_A          189 IGTAYYIAPEVLHG--TYDE------KCDVWSTGVILYI  219 (484)
T ss_dssp             TTGGGTCCHHHHHT--CCCT------HHHHHHHHHHHHH
T ss_pred             CCCccccCceeecC--CCCC------cceeHHHHHHHHH
Confidence            68999999999875  3443      3599999998866

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=84.91  E-value=0.43  Score=44.32  Aligned_cols=35  Identities=29%  Similarity=0.343  Sum_probs=22.5

Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ....||+.|+|||++.+. .++      ...|+|+.|+++.+
T Consensus       193 ~~~~~~~~y~aPE~~~~~-~~~------~~~Di~slG~il~~  227 (309)
T 2h34_A          193 GNTVGTLYYMAPERFSES-HAT------YRADIYALTCVLYE  227 (309)
T ss_dssp             ----CCGGGCCGGGTCC-----------CCCHHHHHHHHHHH
T ss_pred             cccCCCcCccCHHHHcCC-CCC------chHhHHHHHHHHHH
Confidence            345789999999998653 222      24599999988766

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=84.86  E-value=0.29  Score=48.98  Aligned_cols=52  Identities=15%  Similarity=0.214  Sum_probs=33.0

Q ss_pred             eEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         199 IAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       199 ILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      +-|.+-|..+..+-+-  ...    ..+||+.|+|||++.+  .|+.      ..|+|+.||++.+
T Consensus       178 ~kl~DfG~a~~~~~~~--~~~----~~~gt~~y~aPE~l~~--~~~~------~~DiwslG~il~~  229 (494)
T 3lij_A          178 IKIVDFGLSAVFENQK--KMK----ERLGTAYYIAPEVLRK--KYDE------KCDVWSIGVILFI  229 (494)
T ss_dssp             EEECCCTTCEECBTTB--CBC----CCCSCTTTCCHHHHTT--CBCT------HHHHHHHHHHHHH
T ss_pred             EEEEECCCCeECCCCc--ccc----ccCCCcCeeCHHHHcc--cCCC------chhHHHHHHHHHH
Confidence            5565556555543221  111    1368999999999863  3433      3599999998866

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=84.69  E-value=0.25  Score=45.70  Aligned_cols=36  Identities=25%  Similarity=0.529  Sum_probs=27.0

Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ....+|++|+|||++.+...++.      ..|+|+.|+++.+
T Consensus       182 ~~~~~~~~y~aPE~~~~~~~~~~------~~Di~slG~il~e  217 (320)
T 2i6l_A          182 SEGLVTKWYRSPRLLLSPNNYTK------AIDMWAAGCIFAE  217 (320)
T ss_dssp             CGGGSCCTTCCHHHHHCTTCCCH------HHHHHHHHHHHHH
T ss_pred             ccccccccccCcHHhcCcccCCc------hhhhHhHHHHHHH
Confidence            34578999999999876444443      3499999998766

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=84.67  E-value=0.11  Score=49.80  Aligned_cols=33  Identities=18%  Similarity=0.297  Sum_probs=25.2

Q ss_pred             ccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         225 YVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       225 ~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      .+||+.|+|||++.+. .|+.      ..|+|+.||++.+
T Consensus       190 ~~gt~~y~aPE~~~~~-~~~~------~~DiwslG~il~~  222 (362)
T 2bdw_A          190 FAGTPGYLSPEVLKKD-PYSK------PVDIWACGVILYI  222 (362)
T ss_dssp             SCSCTTTCCHHHHTTC-CCCT------HHHHHHHHHHHHH
T ss_pred             CCCCccccCHHHHccC-CCCc------hhhHHHHHHHHHH
Confidence            3689999999998753 2332      3499999998866

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=84.60  E-value=0.1  Score=52.24  Aligned_cols=55  Identities=15%  Similarity=0.100  Sum_probs=34.6

Q ss_pred             CeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         198 NIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       198 NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ++-|.+-|..+..+-+-..  .    ..+||+.|+|||++.+...++      ...|+|+.||++.+
T Consensus       154 ~vkL~DFG~a~~~~~~~~~--~----~~~gt~~y~aPE~~~~~~~~~------~~~DiwSlGvil~e  208 (476)
T 2y94_A          154 NAKIADFGLSNMMSDGEFL--R----TSCGSPNYAAPEVISGRLYAG------PEVDIWSSGVILYA  208 (476)
T ss_dssp             CEEECCCSSCEECCTTCCB--C----CCCSCSTTCCHHHHTTCCBCS------HHHHHHHHHHHHHH
T ss_pred             CeEEEeccchhhccccccc--c----ccCCCcCeEChhhccCCCCCC------CcceehhhHHHHHH
Confidence            4555555555544332111  1    136899999999998643322      23599999999876

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=84.33  E-value=0.24  Score=46.20  Aligned_cols=32  Identities=41%  Similarity=0.592  Sum_probs=24.1

Q ss_pred             cccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         226 VATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       226 ~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      .||..|+|||++.+.. ++      ...|+|+.|+++.+
T Consensus       180 ~~~~~y~aPE~~~~~~-~~------~~~Di~slG~il~~  211 (326)
T 1blx_A          180 VVTLWYRAPEVLLQSS-YA------TPVDLWSVGCIFAE  211 (326)
T ss_dssp             CCCCTTCCHHHHTTCC-CC------THHHHHHHHHHHHH
T ss_pred             ccccceeCHHHHhcCC-CC------cchhHHHHHHHHHH
Confidence            6789999999987532 22      24599999988765

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=84.02  E-value=0.12  Score=48.18  Aligned_cols=53  Identities=21%  Similarity=0.170  Sum_probs=31.9

Q ss_pred             CeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         198 NIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       198 NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ++-|.+-|.++..+-....  .    ...||+.|+|||++.+  .++.      ..|+|+.||++.+
T Consensus       195 ~~kl~DFG~a~~~~~~~~~--~----~~~gt~~y~aPE~~~~--~~~~------~~DiwslG~il~e  247 (311)
T 3p1a_A          195 RCKLGDFGLLVELGTAGAG--E----VQEGDPRYMAPELLQG--SYGT------AADVFSLGLTILE  247 (311)
T ss_dssp             CEEECCCTTCEECC------------CCCCCGGGCCGGGGGT--CCST------HHHHHHHHHHHHH
T ss_pred             CEEEccceeeeecccCCCC--c----ccCCCccccCHhHhcC--CCCc------hhhHHHHHHHHHH
Confidence            4666655655444322111  1    1258999999999875  2333      4599999998765

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=83.96  E-value=0.37  Score=47.48  Aligned_cols=59  Identities=14%  Similarity=0.244  Sum_probs=33.8

Q ss_pred             ccCcccccEEEEeEEeC------cCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCc-eeeeeee
Q psy8260          71 TLSKESFDLIFSSALDS------VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENV-IGLLDVF  133 (427)
Q Consensus        71 ~lg~g~fg~v~~~~~~~------~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnI-v~l~~~~  133 (427)
                      .++.|.-..+|+.....      .++..+.+|+.... ..   ...+.+|..+++.+...++ .++++.+
T Consensus        80 ~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~---~~~li~E~~~l~~L~~~g~~P~l~~~~  145 (429)
T 1nw1_A           80 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET---ESHLVAESVIFTLLSERHLGPKLYGIF  145 (429)
T ss_dssp             EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC---HHHHHHHHHHHHHHHHTTSSSCEEEEE
T ss_pred             EeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEe
Confidence            46666667888654431      12578889876332 11   1234478888877743333 4556554

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=83.94  E-value=0.6  Score=43.75  Aligned_cols=55  Identities=18%  Similarity=0.107  Sum_probs=36.9

Q ss_pred             CCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         197 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       197 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      .++.|.+-|..+..+.+-...      ..+||+.|+|||++.+. .++      ...|+|+.||++.+
T Consensus       155 ~~~kl~Dfg~a~~~~~~~~~~------~~~gt~~y~aPE~~~~~-~~~------~~~DiwslG~il~~  209 (326)
T 2y0a_A          155 PRIKIIDFGLAHKIDFGNEFK------NIFGTPEFVAPEIVNYE-PLG------LEADMWSIGVITYI  209 (326)
T ss_dssp             CCEEECCCTTCEECCTTSCCC------CCCSCTTTCCHHHHTTC-CCC------THHHHHHHHHHHHH
T ss_pred             CCEEEEECCCCeECCCCCccc------cccCCcCcCCceeecCC-CCC------cHHHHHHHHHHHHH
Confidence            356777777777766553211      13689999999998652 233      23599999998766

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=83.80  E-value=0.12  Score=48.46  Aligned_cols=41  Identities=20%  Similarity=0.283  Sum_probs=27.7

Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ...+||+.|+|||++.+..... ........|+|+.||++.+
T Consensus       204 ~~~~gt~~y~aPE~~~~~~~~~-~~~~~~~~DiwslG~il~e  244 (337)
T 3mdy_A          204 NTRVGTKRYMPPEVLDESLNRN-HFQSYIMADMYSFGLILWE  244 (337)
T ss_dssp             CSSCSCGGGCCHHHHTTCCCTT-CTHHHHHHHHHHHHHHHHH
T ss_pred             CCCccCcceeChhhcccccCCc-cccCccccchHHHHHHHHH
Confidence            3458999999999997643222 1111123599999999877

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=83.74  E-value=0.095  Score=49.72  Aligned_cols=12  Identities=8%  Similarity=-0.061  Sum_probs=10.3

Q ss_pred             ccCCcccccccc
Q psy8260         253 QDLKPSNIAVNE  264 (427)
Q Consensus       253 ~d~~~~~~~~~~  264 (427)
                      .|+|+.||++.+
T Consensus       201 ~DiwslG~il~e  212 (343)
T 3dbq_A          201 SDVWSLGCILYY  212 (343)
T ss_dssp             HHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHH
Confidence            499999998876

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=83.58  E-value=0.11  Score=50.61  Aligned_cols=72  Identities=13%  Similarity=0.087  Sum_probs=37.8

Q ss_pred             HHHHHHh----cCceecc-CCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeecc
Q psy8260         180 GLKYIHS----AGIIHRD-LKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQD  254 (427)
Q Consensus       180 aL~yLH~----~~iiHrD-LKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d  254 (427)
                      ....+|.    .+|+=.+ -.-.++-|.+-|..+..+-.-.  .   . ..+||+.|+|||++.+. .|+.      ..|
T Consensus       179 ~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~--~---~-~~~gt~~y~aPE~~~~~-~~~~------~~D  245 (400)
T 1nxk_A          179 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--L---T-TPCYTPYYVAPEVLGPE-KYDK------SCD  245 (400)
T ss_dssp             HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------------CTTCCGGGSCCC-CSSS------HHH
T ss_pred             HCCccccCcCcceEEEecCCCCccEEEEecccccccCCCCc--c---c-cCCCCCCccCHhhcCCC-CCCC------ccc
Confidence            3456673    3454322 1123466666666655432111  1   1 24789999999998642 3333      349


Q ss_pred             CCcccccccc
Q psy8260         255 LKPSNIAVNE  264 (427)
Q Consensus       255 ~~~~~~~~~~  264 (427)
                      +|+.||++.+
T Consensus       246 iwslG~il~e  255 (400)
T 1nxk_A          246 MWSLGVIMYI  255 (400)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHH
Confidence            9999999876

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=83.27  E-value=0.14  Score=48.01  Aligned_cols=55  Identities=15%  Similarity=0.288  Sum_probs=36.4

Q ss_pred             CeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         198 NIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       198 NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ++.|.+-|..+..+-+-...      ...||+.|+|||++.+...++..      .|+|+.||++.+
T Consensus       169 ~~kl~Dfg~a~~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~------~DiwslG~il~~  223 (330)
T 3nsz_A          169 KLRLIDWGLAEFYHPGQEYN------VRVASRYFKGPELLVDYQMYDYS------LDMWSLGCMLAS  223 (330)
T ss_dssp             EEEECCCTTCEECCTTCCCC------SCCSCGGGCCHHHHTTCCCCCTH------HHHHHHHHHHHH
T ss_pred             EEEEEeCCCceEcCCCCccc------cccccccccChhhhcCCCcCCch------hhHHHHHHHHHH
Confidence            46666666666554332211      12678999999999765555433      499999998766

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=83.01  E-value=0.35  Score=46.54  Aligned_cols=71  Identities=11%  Similarity=0.031  Sum_probs=41.4

Q ss_pred             HHHHHh----cCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCC
Q psy8260         181 LKYIHS----AGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLK  256 (427)
Q Consensus       181 L~yLH~----~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~  256 (427)
                      ...+|.    .+|+-.+=...++-|.+-|..+..+-+-..     . ..+||+.|+|||++.+. .++      ...|+|
T Consensus       206 ~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~-----~-~~~gt~~y~aPE~~~~~-~~~------~~~Diw  272 (373)
T 2x4f_A          206 MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL-----K-VNFGTPEFLAPEVVNYD-FVS------FPTDMW  272 (373)
T ss_dssp             TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC-----C-CCCSSCTTCCHHHHTTC-BCC------HHHHHH
T ss_pred             CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc-----c-cccCCCcEeChhhccCC-CCC------cHHhHH
Confidence            345663    355432222345666666666654322111     1 12689999999998642 222      345999


Q ss_pred             cccccccc
Q psy8260         257 PSNIAVNE  264 (427)
Q Consensus       257 ~~~~~~~~  264 (427)
                      +.||++.+
T Consensus       273 slG~il~e  280 (373)
T 2x4f_A          273 SVGVIAYM  280 (373)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            99998866

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=82.61  E-value=0.15  Score=48.63  Aligned_cols=28  Identities=29%  Similarity=0.323  Sum_probs=20.2

Q ss_pred             ccchhhhhc--ccccCCCCcceeeccCCcccccccc
Q psy8260         231 YRAPEIMLN--WMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       231 y~aPE~l~~--~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      |+|||++.+  ...++      ...|+|+.||++.+
T Consensus       216 y~aPE~~~~~~~~~~~------~~~DiwslG~il~e  245 (348)
T 1u5q_A          216 WMAPEVILAMDEGQYD------GKVDVWSLGITCIE  245 (348)
T ss_dssp             GCCHHHHHTTSSCCBC------THHHHHHHHHHHHH
T ss_pred             eeCHhhhccccCCCCC------cHHHHHHHHHHHHH
Confidence            899999864  22233      24599999998876

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=82.18  E-value=0.15  Score=47.92  Aligned_cols=59  Identities=14%  Similarity=-0.074  Sum_probs=36.2

Q ss_pred             eEEcCCCCEEEeeCCCCC--CCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         199 IAVNEDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       199 ILl~~~~~~kl~DFGla~--~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      +.|.+-|..+...-....  .........+||+.|+|||++.+.. ++      ...|+|+.||++.+
T Consensus       149 ~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~------~~~Di~slG~il~e  209 (330)
T 2izr_A          149 IHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKE-QS------RRDDLEALGHMFMY  209 (330)
T ss_dssp             EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CC------HHHHHHHHHHHHHH
T ss_pred             EEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCC-CC------chhHHHHHHHHHHH
Confidence            556555655543322111  1112234578999999999987632 22      34599999998866

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=82.02  E-value=0.16  Score=47.46  Aligned_cols=60  Identities=22%  Similarity=0.219  Sum_probs=35.6

Q ss_pred             CeEEcCCCCEEEeeCCCCCCC-------CCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         198 NIAVNEDCELKILDFGLARPT-------ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       198 NILl~~~~~~kl~DFGla~~~-------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      .+.|.+-|.++..+-......       .......+||+.|+|||++.+. .++      ...|+|+.||++.+
T Consensus       202 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~------~~~Di~slG~il~e  268 (332)
T 3qd2_B          202 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGN-NYS------HKVDIFSLGLILFE  268 (332)
T ss_dssp             CEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCC-CCC------THHHHHHHHHHHHH
T ss_pred             CEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCC-CCc------chhhHHHHHHHHHH
Confidence            566666666655543321110       1223456899999999998763 233      24499999998876

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=82.00  E-value=0.19  Score=46.65  Aligned_cols=81  Identities=12%  Similarity=-0.013  Sum_probs=40.4

Q ss_pred             HHHHHh----cCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCC--CCcceeecc
Q psy8260         181 LKYIHS----AGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQ--TGVPFYFQD  254 (427)
Q Consensus       181 L~yLH~----~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~--~~~~~~~~d  254 (427)
                      ..++|.    .+|+-.   -.++.+.+-|..+..+...............||+.|+|||++.+......  ........|
T Consensus       149 ~~i~H~dlkp~NIl~~---~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~D  225 (319)
T 2y4i_B          149 KGILHKDLKSKNVFYD---NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSD  225 (319)
T ss_dssp             TTCCCCCCCSTTEEEC-----CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHH
T ss_pred             CCccccCCChhhEEEe---CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhh
Confidence            345663    355543   24666665555444432222222223344578999999999975321110  111223459


Q ss_pred             CCcccccccc
Q psy8260         255 LKPSNIAVNE  264 (427)
Q Consensus       255 ~~~~~~~~~~  264 (427)
                      +|+.|+++.+
T Consensus       226 i~slG~il~e  235 (319)
T 2y4i_B          226 VFALGTIWYE  235 (319)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHH
Confidence            9999988766

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=81.92  E-value=0.54  Score=47.13  Aligned_cols=70  Identities=17%  Similarity=0.220  Sum_probs=41.6

Q ss_pred             HHHHHh----cCcee-ccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccC
Q psy8260         181 LKYIHS----AGIIH-RDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDL  255 (427)
Q Consensus       181 L~yLH~----~~iiH-rDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~  255 (427)
                      ...+|.    .+|+- .+=...++-|.+-|..+..+-+...  .    ..+||+.|+|||++.+  .|+.      ..|+
T Consensus       165 ~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~--~----~~~gt~~y~aPE~~~~--~~~~------~~Di  230 (504)
T 3q5i_A          165 HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL--R----DRLGTAYYIAPEVLKK--KYNE------KCDV  230 (504)
T ss_dssp             TTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCB--C----CCCSCTTTCCHHHHTT--CBCT------HHHH
T ss_pred             CCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCcc--c----cccCCcCCCCHHHhcc--CCCc------hHHH
Confidence            345663    34443 2222235777666666655432111  1    1368999999999864  2433      4599


Q ss_pred             Ccccccccc
Q psy8260         256 KPSNIAVNE  264 (427)
Q Consensus       256 ~~~~~~~~~  264 (427)
                      |+.||++.+
T Consensus       231 wslG~il~~  239 (504)
T 3q5i_A          231 WSCGVIMYI  239 (504)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHHH
Confidence            999998766

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=81.91  E-value=0.16  Score=47.97  Aligned_cols=60  Identities=17%  Similarity=0.047  Sum_probs=33.3

Q ss_pred             CeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcc-cccCCCCcceeeccCCcccccccc
Q psy8260         198 NIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW-MHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       198 NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      .+.|.+-|..+...-.-. ..........||+.|+|||++.+. ..++.      ..|+|+.||++.+
T Consensus       208 ~~kl~Dfg~a~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~------~~DiwslG~il~e  268 (345)
T 3hko_A          208 EIKLVDFGLSKEFYKLNN-GEYYGMTTKAGTPYFVAPEVLNTTNESYGP------KCDAWSAGVLLHL  268 (345)
T ss_dssp             CEEECCCTTCEEGGGTTC-C--------CCCGGGCCHHHHTCSSSCCCT------HHHHHHHHHHHHH
T ss_pred             eEEEeeccccccccccCc-cccccccccCCCccccCchhhccCCCCCCc------HHHHHHHHHHHHH
Confidence            466665565554422110 011123456799999999999652 23332      4599999998765

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=81.84  E-value=0.19  Score=46.91  Aligned_cols=12  Identities=17%  Similarity=0.155  Sum_probs=10.2

Q ss_pred             ccCCcccccccc
Q psy8260         253 QDLKPSNIAVNE  264 (427)
Q Consensus       253 ~d~~~~~~~~~~  264 (427)
                      .|+|+.||++.+
T Consensus       204 ~DiwslG~il~e  215 (319)
T 4euu_A          204 VDLWSIGVTFYH  215 (319)
T ss_dssp             HHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHH
Confidence            399999998876

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=81.61  E-value=0.17  Score=48.32  Aligned_cols=58  Identities=14%  Similarity=0.054  Sum_probs=36.4

Q ss_pred             CCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhccc-ccCCCCcceeeccCCcccccccc
Q psy8260         197 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM-HYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       197 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      .++.|.+-|..+...-.    ........+||+.|+|||++.+.. .++      ...|+|+.||++.+
T Consensus       196 ~~~kl~DfG~a~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~------~~~DvwslG~il~e  254 (355)
T 1vzo_A          196 GHVVLTDFGLSKEFVAD----ETERAYDFCGTIEYMAPDIVRGGDSGHD------KAVDWWSLGVLMYE  254 (355)
T ss_dssp             SCEEESCSSEEEECCGG----GGGGGCGGGSCCTTCCHHHHTTCC---C------THHHHHHHHHHHHH
T ss_pred             CcEEEeeCCCCeecccC----CCCcccCcccCcCccChhhhcCCCCCCC------chhhHHHHHHHHHH
Confidence            35667666665543211    112234568999999999997521 222      23599999998876

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=81.51  E-value=0.68  Score=44.81  Aligned_cols=29  Identities=24%  Similarity=0.416  Sum_probs=26.0

Q ss_pred             CceeccCCCCCeEEcCC----CCEEEeeCCCCC
Q psy8260         188 GIIHRDLKPSNIAVNED----CELKILDFGLAR  216 (427)
Q Consensus       188 ~iiHrDLKp~NILl~~~----~~~kl~DFGla~  216 (427)
                      .++|+|+.+.|||++.+    +.+.|+||..|.
T Consensus       221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             EEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             EEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            58999999999999876    789999999875

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=81.33  E-value=0.16  Score=48.61  Aligned_cols=77  Identities=8%  Similarity=-0.014  Sum_probs=44.8

Q ss_pred             HHHHHh----cCceeccCCCCCeEEcCCCCEEEeeCC-CCCCC-CCCcccccccccccchhhhhcccccCCCCcceeecc
Q psy8260         181 LKYIHS----AGIIHRDLKPSNIAVNEDCELKILDFG-LARPT-ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQD  254 (427)
Q Consensus       181 L~yLH~----~~iiHrDLKp~NILl~~~~~~kl~DFG-la~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d  254 (427)
                      ..++|.    .+|+-..=...++.|.+-|..+..+-. ..... .......+||+.|+|||++.+.. ++      ...|
T Consensus       171 ~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~------~~~D  243 (364)
T 3op5_A          171 HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PS------RRGD  243 (364)
T ss_dssp             TTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CC------HHHH
T ss_pred             CCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CC------chhh
Confidence            345663    244433112345666666666554322 11111 12234567999999999987632 32      3459


Q ss_pred             CCcccccccc
Q psy8260         255 LKPSNIAVNE  264 (427)
Q Consensus       255 ~~~~~~~~~~  264 (427)
                      +|+.||++.+
T Consensus       244 i~slG~~l~e  253 (364)
T 3op5_A          244 LEILGYCMIQ  253 (364)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHH
Confidence            9999998876

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=81.05  E-value=0.18  Score=46.77  Aligned_cols=34  Identities=24%  Similarity=0.329  Sum_probs=26.3

Q ss_pred             cccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         224 GYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       224 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ..+||+.|+|||++.+. .++      ...|+|+.|+++.+
T Consensus       181 ~~~gt~~y~aPE~~~~~-~~~------~~~Di~slG~~l~e  214 (310)
T 3s95_A          181 TVVGNPYWMAPEMINGR-SYD------EKVDVFSFGIVLCE  214 (310)
T ss_dssp             CCCSCGGGCCHHHHTTC-CCC------THHHHHHHHHHHHH
T ss_pred             ccCCCcceeCHHHhcCC-CCC------cHHHHHHHHHHHHH
Confidence            56899999999998752 233      24599999998876

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=80.63  E-value=0.17  Score=51.92  Aligned_cols=54  Identities=22%  Similarity=0.124  Sum_probs=35.9

Q ss_pred             CeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         198 NIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       198 NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ++-|.+-|..+..+-+-..     .+ .+||+.|+|||++.+. .|+.      ..|+|+.||++.+
T Consensus       324 ~vKL~DFGla~~~~~~~~~-----~~-~~GT~~Y~APEvl~~~-~~~~------~~DiwSLGvilye  377 (576)
T 2acx_A          324 HIRISDLGLAVHVPEGQTI-----KG-RVGTVGYMAPEVVKNE-RYTF------SPDWWALGCLLYE  377 (576)
T ss_dssp             CEEECCCTTCEECCTTCCE-----EC-CCSCGGGCCHHHHTTC-EESS------HHHHHHHHHHHHH
T ss_pred             CeEEEecccceecccCccc-----cc-cCCCccccCHHHHcCC-CCCc------cchHHHHHHHHHH
Confidence            5667666666655433211     11 3799999999999763 2333      3499999999876

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=80.55  E-value=0.15  Score=47.48  Aligned_cols=36  Identities=19%  Similarity=0.212  Sum_probs=25.2

Q ss_pred             ccccccccccchhhhhcc----cccCCCCcceeeccCCcccccccc
Q psy8260         223 TGYVATRWYRAPEIMLNW----MHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~----~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ...+||+.|+|||++.+.    ..++.      ..|+|+.||++.+
T Consensus       179 ~~~~gt~~y~aPE~~~~~~~~~~~~~~------~~DiwslG~il~~  218 (316)
T 2ac3_A          179 LTPCGSAEYMAPEVVEAFSEEASIYDK------RCDLWSLGVILYI  218 (316)
T ss_dssp             ---CCSGGGCCHHHHHHTSHHHHHHTT------THHHHHHHHHHHH
T ss_pred             ccccCCcCccChHHhhcccccccCCCc------ccccHhHHHHHHH
Confidence            345799999999999752    22333      3499999999876

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=80.36  E-value=0.21  Score=47.00  Aligned_cols=35  Identities=23%  Similarity=0.182  Sum_probs=26.4

Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ...+||+.|+|||++.+.. ++      ...|+|+.||++.+
T Consensus       179 ~~~~gt~~y~aPE~~~~~~-~~------~~~DiwslG~il~e  213 (327)
T 3a62_A          179 HTFCGTIEYMAPEILMRSG-HN------RAVDWWSLGALMYD  213 (327)
T ss_dssp             CTTSSCCTTSCHHHHTTSC-CC------THHHHHHHHHHHHH
T ss_pred             cccCCCcCccCHhhCcCCC-CC------CcccchhHHHHHHH
Confidence            4568999999999987532 22      24599999998766

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=80.05  E-value=0.57  Score=43.87  Aligned_cols=55  Identities=20%  Similarity=0.056  Sum_probs=33.7

Q ss_pred             CCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         197 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       197 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      .++.+.+-|..+..+-+-..     . ...||+.|+|||++.+.. ++      ...|+|+.||++.+
T Consensus       141 ~~~kl~Dfg~a~~~~~~~~~-----~-~~~gt~~y~aPE~~~~~~-~~------~~~DiwslG~il~~  195 (321)
T 1tki_A          141 STIKIIEFGQARQLKPGDNF-----R-LLFTAPEYYAPEVHQHDV-VS------TATDMWSLGTLVYV  195 (321)
T ss_dssp             CCEEECCCTTCEECCTTCEE-----E-EEESCGGGSCHHHHTTCE-EC------HHHHHHHHHHHHHH
T ss_pred             CCEEEEECCCCeECCCCCcc-----c-cccCChhhcCcHHhcCCC-CC------chhhHHHHHHHHHH
Confidence            34555555555544332111     1 136789999999987532 22      34599999998766

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=80.01  E-value=0.86  Score=43.49  Aligned_cols=12  Identities=17%  Similarity=0.152  Sum_probs=9.9

Q ss_pred             ccCCcccccccc
Q psy8260         253 QDLKPSNIAVNE  264 (427)
Q Consensus       253 ~d~~~~~~~~~~  264 (427)
                      .|+|+.||++.+
T Consensus       286 ~Di~slG~il~e  297 (365)
T 2y7j_A          286 VDLWACGVILFT  297 (365)
T ss_dssp             HHHHHHHHHHHH
T ss_pred             hhHHhHHHHHHH
Confidence            399999998766

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	427
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	8e-78
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-77
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	7e-69
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-58
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-50
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-50
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-49
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-46
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-45
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	6e-45
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	7e-44
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	9e-44
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-41
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-40
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-39
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	7e-39
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-36
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-22
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-36
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-36
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	5e-36
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-22
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	6e-36
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-23
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	7e-36
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-35
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-33
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-32
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-32
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	6e-32
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	6e-32
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-32
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-31
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	8e-31
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-19
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-30
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-30
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	7e-30
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-29
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-28
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	7e-20
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-28
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-27
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-27
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-27
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-27
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-27
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-18
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	7e-27
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-26
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	6e-18
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	6e-26
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-16
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-25
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-12
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-25
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-14
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-24
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	6e-16
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-24
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-14
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-24
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	7e-13
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-24
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	7e-24
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	9e-19
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	8e-24
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	8e-24
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-13
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-23
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-23
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-15
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-22
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-21
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-14
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-21
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-20
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-12
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-20
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	8e-20
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-15

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  243 bits (620), Expect = 8e-78
 Identities = 199/340 (58%), Positives = 234/340 (68%), Gaps = 47/340 (13%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
           A D+ +G++VA+KK++RPFQS +HAKRTYRELR+LKHM HENVIGLLDVF     L +F 
Sbjct: 37  AFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96

Query: 144 NVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE 203
           +VY+VTHLMGADLNNI++ QKL+DDHVQFL+YQILRGLKYIHSA IIHRDLKPSN+AVNE
Sbjct: 97  DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 156

Query: 204 DCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVN 263
           DCELKILDFGLAR T++EMTGYVATRWYRAPEIMLNWMHYNQ                  
Sbjct: 157 DCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ------------------ 198

Query: 264 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH-----YNQTDIHQLNLIMEM 318
                                       +    IM   +           I QL LI+ +
Sbjct: 199 ------------------------TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 234

Query: 319 LGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT 378
           +GTP AE + KISS+SAR YI SL  + K +F  VF GANP A+DLL  ML LDS+KRIT
Sbjct: 235 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 294

Query: 379 AEQALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWK 418
           A QALAH Y +QY DP+DEP + PYDQSFE  DL +D+WK
Sbjct: 295 AAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWK 334

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  241 bits (616), Expect = 3e-77
 Identities = 166/335 (49%), Positives = 215/335 (64%), Gaps = 37/335 (11%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
           A+D  +G KVAIKK+ RPFQS + AKR YRELR+LKHM HENVIGLLDVF  +  L DF 
Sbjct: 37  AVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96

Query: 144 NVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE 203
           + Y+V   MG DL  +++ +KL +D +QFLVYQ+L+GL+YIH+AGIIHRDLKP N+AVNE
Sbjct: 97  DFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE 156

Query: 204 DCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVN 263
           DCELKILDFGLAR  ++EMTGYV TRWYRAPE++LNWM Y Q             +I   
Sbjct: 157 DCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQ-----------TVDI--- 202

Query: 264 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPP 323
               +  +   +       +TG                +      + QL  IM++ GTPP
Sbjct: 203 --WSVGCIMAEM-------ITGKT--------------LFKGSDHLDQLKEIMKVTGTPP 239

Query: 324 AEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQAL 383
           AEF+ ++ SD A+ Y+  LP L KKDF  +   A+P A++LL  ML LD+E+R+TA +AL
Sbjct: 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 299

Query: 384 AHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWK 418
           AHPY     D  DEP    YD SF+D+D  +D+WK
Sbjct: 300 AHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWK 334

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  220 bits (560), Expect = 7e-69
 Identities = 142/342 (41%), Positives = 195/342 (57%), Gaps = 46/342 (13%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
           A D+V+ V+VAIKKI  PF+   + +RT RE+++L    HEN+IG+ D+  + T     K
Sbjct: 27  AYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE-QMK 84

Query: 144 NVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE 203
           +VY+VTHLMGADL  +L+TQ LS+DH+ + +YQILRGLKYIHSA ++HRDLKPSN+ +N 
Sbjct: 85  DVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 144

Query: 204 DCELKILDFGLAR------PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
            C+LKI DFGLAR           +T YVATRWYRAPEIMLN   Y ++   +       
Sbjct: 145 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIW------- 197

Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIME 317
                                      G +         +    +   +  + QLN I+ 
Sbjct: 198 -------------------------SVGCILAEM-----LSNRPIFPGKHYLDQLNHILG 227

Query: 318 MLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI 377
           +LG+P  E +  I +  AR Y+ SLP   K  + ++F  A+ +A+DLL  ML  +  KRI
Sbjct: 228 ILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 287

Query: 378 TAEQALAHPYLSQYSDPNDEPTSP-PYDQSFEDMDLPVDQWK 418
             EQALAHPYL QY DP+DEP +  P+    E  DLP ++ K
Sbjct: 288 EVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLK 329

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 1e-58
 Identities = 134/351 (38%), Positives = 190/351 (54%), Gaps = 56/351 (15%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
           A D+V    VAIKK++RPFQ+  HAKR YREL ++K +NH+N+I LL+VF     L +F+
Sbjct: 36  AYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95

Query: 144 NVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE 203
           +VY+V  LM A+L  +++  +L  + + +L+YQ+L G+K++HSAGIIHRDLKPSNI V  
Sbjct: 96  DVYLVMELMDANLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 154

Query: 204 DCELKILDFGLAR--PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIA 261
           DC LKILDFGLAR   T   MT YV TR+YRAPE++L   +           D+      
Sbjct: 155 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV-------DIWSVGCI 207

Query: 262 VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT 321
           + E    KIL                                  +  I Q N ++E LGT
Sbjct: 208 MGEMVRHKIL-------------------------------FPGRDYIDQWNKVIEQLGT 236

Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVF------------KGANPQAIDLLSLML 369
           P  EFM K+   + R Y+ + P      F ++F            K    QA DLLS ML
Sbjct: 237 PCPEFMKKL-QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 295

Query: 370 ELDSEKRITAEQALAHPYLSQYSDPNDEPTSPP--YDQSFEDMDLPVDQWK 418
            +D  KRI+ + AL HPY++ + DP +    PP  YD+  ++ +  +++WK
Sbjct: 296 VIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWK 346

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 3e-50
 Identities = 78/325 (24%), Positives = 134/325 (41%), Gaps = 49/325 (15%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC--LAD 141
           A    +G KVA+KK+    +         RE+++L+ + HENV+ L+++  +        
Sbjct: 29  ARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88

Query: 142 FKNVYMVTHLMGADL--NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI 199
             ++Y+V      DL         K +   ++ ++  +L GL YIH   I+HRD+K +N+
Sbjct: 89  KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANV 148

Query: 200 AVNEDCELKILDFGLAR-------PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYF 252
            +  D  LK+ DFGLAR          N  T  V T WYR PE++L    Y         
Sbjct: 149 LITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYG-------- 200

Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQL 312
               P ++            +G         T                 +    T+ HQL
Sbjct: 201 ---PPIDL------------WGAGCIMAEMWTRSP--------------IMQGNTEQHQL 231

Query: 313 NLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFK-GANPQAIDLLSLMLEL 371
            LI ++ G+   E    + +    + +  +    +K   ++     +P A+DL+  +L L
Sbjct: 232 ALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL 291

Query: 372 DSEKRITAEQALAHPYLSQYSDPND 396
           D  +RI ++ AL H +      P+D
Sbjct: 292 DPAQRIDSDDALNHDFFWSDPMPSD 316

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 5e-50
 Identities = 81/337 (24%), Positives = 143/337 (42%), Gaps = 55/337 (16%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
           A    SG  VAIKK+ +        +   REL++++ ++H N++ L   F+S+    D  
Sbjct: 39  AKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92

Query: 144 NVYMVTHLMGADLNNILRT-----QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSN 198
            + +V   +   +  + R      Q L   +V+  +YQ+ R L YIHS GI HRD+KP N
Sbjct: 93  YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQN 152

Query: 199 IAVNEDCE-LKILDFGLARPTENE--MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDL 255
           + ++ D   LK+ DFG A+          Y+ +R+YRAPE++     Y            
Sbjct: 153 LLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYT----------- 201

Query: 256 KPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLI 315
              ++          +   L       + G                +    + + QL  I
Sbjct: 202 SSIDV-----WSAGCVLAEL-------LLGQP--------------IFPGDSGVDQLVEI 235

Query: 316 MEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFK-GANPQAIDLLSLMLELDSE 374
           +++LGTP  E + +++ +         P +    + +VF+    P+AI L S +LE    
Sbjct: 236 IKVLGTPTREQIREMNPNYTEFK---FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 292

Query: 375 KRITAEQALAHPYLSQYSDPNDEPTSPPYDQSFEDMD 411
            R+T  +A AH +  +  DPN +  +     +  +  
Sbjct: 293 ARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFT 329

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 3e-49
 Identities = 92/326 (28%), Positives = 133/326 (40%), Gaps = 54/326 (16%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVH---AKRTYRELRMLKHMNHENVIGLLDVFHSNTCLA 140
           A D  +   VAIKKI    +S       +   RE+++L+ ++H N+IGLLD F       
Sbjct: 17  ARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK---- 72

Query: 141 DFKNVYMVTHLMGADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSN 198
              N+ +V   M  DL  I++     L+  H++  +   L+GL+Y+H   I+HRDLKP+N
Sbjct: 73  --SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNN 130

Query: 199 IAVNEDCELKILDFGLARPTENE---MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDL 255
           + ++E+  LK+ DFGLA+   +     T  V TRWYRAPE++     Y      +     
Sbjct: 131 LLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVG-- 188

Query: 256 KPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLI 315
                     C L  L      P                            +D+ QL  I
Sbjct: 189 ----------CILAELLLR--VP-----------------------FLPGDSDLDQLTRI 213

Query: 316 MEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEK 375
            E LGTP  E    + S        S P         +F  A    +DL+  +   +   
Sbjct: 214 FETLGTPTEEQWPDMCSLPDYVTFKSFP---GIPLHHIFSAAGDDLLDLIQGLFLFNPCA 270

Query: 376 RITAEQALAHPYLSQYSDPNDEPTSP 401
           RITA QAL   Y S    P      P
Sbjct: 271 RITATQALKMKYFSNRPGPTPGCQLP 296

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (407), Expect = 1e-46
 Identities = 59/318 (18%), Positives = 115/318 (36%), Gaps = 48/318 (15%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
                SG+ +A K I    + A+   +  REL++L   N   ++G    F+S+       
Sbjct: 25  VSHKPSGLVMARKLIHLEIKPAIR-NQIIRELQVLHECNSPYIVGFYGAFYSD------G 77

Query: 144 NVYMVTHLM-GADLNNIL-RTQKLSDDHVQFLVYQILRGLKYIHSA-GIIHRDLKPSNIA 200
            + +    M G  L+ +L +  ++ +  +  +   +++GL Y+     I+HRD+KPSNI 
Sbjct: 78  EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNIL 137

Query: 201 VNEDCELKILDFGLARPTENEMTG-YVATRWYRAPEIMLNWMHYNQT-----GVPFYFQD 254
           VN   E+K+ DFG++    + M   +V TR Y +PE +    +  Q+     G+      
Sbjct: 138 VNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLV--- 194

Query: 255 LKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNL 314
                       E+                G             L  M   Q +      
Sbjct: 195 ------------EM--------------AVGRYP--IPPPDAKELELMFGCQVEGDAAET 226

Query: 315 IMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGA-NPQAIDLLSLMLELDS 373
                          + S         L  +  +   ++  G  + +  D ++  L  + 
Sbjct: 227 PPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNP 286

Query: 374 EKRITAEQALAHPYLSQY 391
            +R   +Q + H ++ + 
Sbjct: 287 AERADLKQLMVHAFIKRS 304

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 1e-45
 Identities = 91/317 (28%), Positives = 138/317 (43%), Gaps = 51/317 (16%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
           A + ++G  VA+KKI    ++        RE+ +LK +NH N++ LLDV H+   L    
Sbjct: 21  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL---- 76

Query: 144 NVYMVTHLMGADLNNILR---TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
             Y+V   +  DL   +       +    ++  ++Q+L+GL + HS  ++HRDLKP N+ 
Sbjct: 77  --YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL 134

Query: 201 VNEDCELKILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKP 257
           +N +  +K+ DFGLAR         T  V T WYRAPEI+L   +Y+     +       
Sbjct: 135 INTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSL----- 189

Query: 258 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIME 317
                   C    +                     RA            ++I QL  I  
Sbjct: 190 -------GCIFAEMVTR------------------RAL-------FPGDSEIDQLFRIFR 217

Query: 318 MLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI 377
            LGTP       ++  S   Y  S P   ++DF +V    +     LLS ML  D  KRI
Sbjct: 218 TLGTPDEVVWPGVT--SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI 275

Query: 378 TAEQALAHPYLSQYSDP 394
           +A+ ALAHP+    + P
Sbjct: 276 SAKAALAHPFFQDVTKP 292

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  155 bits (392), Expect = 6e-45
 Identities = 84/307 (27%), Positives = 133/307 (43%), Gaps = 50/307 (16%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
            G   A+KKI    +       T RE+ +LK + H N++ L DV H        K + +V
Sbjct: 25  YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH------TKKRLVLV 78

Query: 149 THLMGADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE 206
              +  DL  +L   +  L     +  + Q+L G+ Y H   ++HRDLKP N+ +N + E
Sbjct: 79  FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE 138

Query: 207 LKILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVN 263
           LKI DFGLAR       + T  + T WYRAP++++    Y+              +I   
Sbjct: 139 LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS-----------TTIDI--- 184

Query: 264 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPP 323
               +  +   +       + G                +    ++  QL  I  +LGTP 
Sbjct: 185 --WSVGCIFAEM-------VNGT--------------PLFPGVSEADQLMRIFRILGTPN 221

Query: 324 AEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQAL 383
           ++    ++     KY  +  +     +    KG +   IDLLS ML+LD  +RITA+QAL
Sbjct: 222 SKNWPNVT--ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279

Query: 384 AHPYLSQ 390
            H Y  +
Sbjct: 280 EHAYFKE 286

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 7e-44
 Identities = 76/314 (24%), Positives = 121/314 (38%), Gaps = 45/314 (14%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
           A +  +   VA+K++              RE+ +LK + H+N++ L DV HS+       
Sbjct: 21  AKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK----L 76

Query: 144 NVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE 203
            +                   L  + V+  ++Q+L+GL + HS  ++HRDLKP N+ +N 
Sbjct: 77  TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINR 136

Query: 204 DCELKILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNI 260
           + ELK+ +FGLAR         +  V T WYR P+++     Y+ +       D+  +  
Sbjct: 137 NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS------IDMWSAGC 190

Query: 261 AVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLG 320
              E        F                                     QL  I  +LG
Sbjct: 191 IFAELANAGRPLF------------------------------PGNDVDDQLKRIFRLLG 220

Query: 321 TPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAE 380
           TP  E    ++     K     P         V    N    DLL  +L+ +  +RI+AE
Sbjct: 221 TPTEEQWPSMTKLPDYKPYPMYP--ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAE 278

Query: 381 QALAHPYLSQYSDP 394
           +AL HPY S +  P
Sbjct: 279 EALQHPYFSDFCPP 292

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  154 bits (390), Expect = 9e-44
 Identities = 64/344 (18%), Positives = 111/344 (32%), Gaps = 82/344 (23%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
             +  +G   A K +  P +S    +   +E++ +  + H  ++ L D F  +       
Sbjct: 45  VTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHPTLVNLHDAFEDD------N 96

Query: 144 NVYMVTHLM-GADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
            + M+   M G +L   +  +  K+S+D     + Q+ +GL ++H    +H DLKP NI 
Sbjct: 97  EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIM 156

Query: 201 VN--EDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLK 256
                  ELK++DFGL      +  +     T  + APE+         T +        
Sbjct: 157 FTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVG---- 212

Query: 257 PSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIM 316
                        IL  G                   +P          + D   L  + 
Sbjct: 213 ---------VLSYILLSG------------------LSP-------FGGENDDETLRNVK 238

Query: 317 EMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKR 376
                      + IS                               D +  +L  D   R
Sbjct: 239 SCDWNMDDSAFSGIS---------------------------EDGKDFIRKLLLADPNTR 271

Query: 377 ITAEQALAHPYLSQYSDPNDEPTSPP--YDQSFEDMDLPVDQWK 418
           +T  QAL HP+L+  + P  +   P   Y +  + +    D W 
Sbjct: 272 MTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWP 315

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  146 bits (370), Expect = 3e-41
 Identities = 72/315 (22%), Positives = 144/315 (45%), Gaps = 58/315 (18%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN-HENVIGLLDVFHSNTCLADF 142
           A++  +  KV +K +       V  K+  RE+++L+++    N+I L D+          
Sbjct: 54  AINITNNEKVVVKIL-----KPVKKKKIKREIKILENLRGGPNIITLADIVKDPVS---- 104

Query: 143 KNVYMVT-HLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           +   +V  H+   D   +   Q L+D  ++F +Y+IL+ L Y HS GI+HRD+KP N+ +
Sbjct: 105 RTPALVFEHVNNTDFKQLY--QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI 162

Query: 202 -NEDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPS 258
            +E  +L+++D+GLA       E    VA+R+++ PE+++++  Y+              
Sbjct: 163 DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD-----------YSL 211

Query: 259 NIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEM 318
           ++       L  +   +       +                    +   +  QL  I ++
Sbjct: 212 DM-----WSLGCMLASM-------IFRK-------------EPFFHGHDNYDQLVRIAKV 246

Query: 319 LGTP-PAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGAN-----PQAIDLLSLMLELD 372
           LGT    +++ K + +   ++ + L   ++K + +     N     P+A+D L  +L  D
Sbjct: 247 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD 306

Query: 373 SEKRITAEQALAHPY 387
            + R+TA +A+ HPY
Sbjct: 307 HQSRLTAREAMEHPY 321

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 1e-40
 Identities = 73/308 (23%), Positives = 128/308 (41%), Gaps = 51/308 (16%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM---NHENVIGLLDVFHSNTCLADFKNV 145
            G  VA+K++            T RE+ +L+H+    H NV+ L DV   +    + K  
Sbjct: 32  GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 91

Query: 146 YMVTHLMGADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE 203
            +  H+       + +  +  +  + ++ +++Q+LRGL ++HS  ++HRDLKP NI V  
Sbjct: 92  LVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS 151

Query: 204 DCELKILDFGLAR--PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIA 261
             ++K+ DFGLAR    +  +T  V T WYRAPE++L   +                   
Sbjct: 152 SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSY------------------- 192

Query: 262 VNEDCELKILDFGLARPTENEM-TGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLG 320
                 + +   G       EM                   +    +D+ QL  I++++G
Sbjct: 193 ---ATPVDLWSVGC---IFAEMFRRKP--------------LFRGSSDVDQLGKILDVIG 232

Query: 321 TPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAE 380
            P  E   +  +   + +       + +   +     +    DLL   L  +  KRI+A 
Sbjct: 233 LPGEEDWPRDVALPRQAF----HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 288

Query: 381 QALAHPYL 388
            AL+HPY 
Sbjct: 289 SALSHPYF 296

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 2e-39
 Identities = 63/326 (19%), Positives = 125/326 (38%), Gaps = 91/326 (27%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
           A+D  +G +VAI+++    Q     +    E+ +++   + N++  LD +          
Sbjct: 39  AMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNYLDSYL------VGD 90

Query: 144 NVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +++V   + G  L +++    + +  +  +  + L+ L+++HS  +IHRD+K  NI + 
Sbjct: 91  ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 150

Query: 203 EDCELKILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHYNQT------GVPFYFQ 253
            D  +K+ DFG      P +++ +  V T ++ APE ++    Y         G+     
Sbjct: 151 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVTRKAYGPKVDIWSLGIMAI-- 207

Query: 254 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLN 313
                        E+              + G         P       + N+  +  L 
Sbjct: 208 -------------EM--------------IEG-------EPP-------YLNENPLRALY 226

Query: 314 LIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDS 373
           LI    GTP  +   K+S+                              D L+  L++D 
Sbjct: 227 LIA-TNGTPELQNPEKLSAI---------------------------FRDFLNRCLDMDV 258

Query: 374 EKRITAEQALAHPYLSQYSDPNDEPT 399
           EKR +A++ L H +L + + P    T
Sbjct: 259 EKRGSAKELLQHQFL-KIAKPLSSLT 283

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  141 bits (356), Expect = 7e-39
 Identities = 66/348 (18%), Positives = 121/348 (34%), Gaps = 91/348 (26%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
            ++  +G     K I  P+   +       E+ ++  ++H  +I L D F          
Sbjct: 48  CVEKATGRVFVAKFINTPYP--LDKYTVKNEISIMNQLHHPKLINLHDAFEDK------Y 99

Query: 144 NVYMVTHLM-GADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI- 199
            + ++   + G +L + +  +  K+S+  V   + Q   GLK++H   I+H D+KP NI 
Sbjct: 100 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIM 159

Query: 200 -AVNEDCELKILDFGLARPTENE--MTGYVATRWYRAPEIMLNWMHYNQT-----GVPFY 251
               +   +KI+DFGLA     +  +    AT  + APEI+        T     GV  Y
Sbjct: 160 CETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGY 219

Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
                           L              ++G        +P          + D+  
Sbjct: 220 ---------------VL--------------LSG-------LSP-------FAGEDDLET 236

Query: 312 LNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLEL 371
           L  +         +  + +S                           P+A D +  +L+ 
Sbjct: 237 LQNVKRCDWEFDEDAFSSVS---------------------------PEAKDFIKNLLQK 269

Query: 372 DSEKRITAEQALAHPYLSQ-YSDPNDEPTSPPYDQSFEDMDLPVDQWK 418
           +  KR+T   AL HP+L   +S+      S  Y++  + +      W 
Sbjct: 270 EPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWP 317

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 2e-36
 Identities = 42/168 (25%), Positives = 80/168 (47%), Gaps = 14/168 (8%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
           A +  + V  A K I    +S    +    E+ +L   +H N++ LLD F+         
Sbjct: 31  AQNKETSVLAAAKVIDT--KSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE------N 82

Query: 144 NVYMVTHLM-GADLNNIL--RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
           N++++     G  ++ ++    + L++  +Q +  Q L  L Y+H   IIHRDLK  NI 
Sbjct: 83  NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNIL 142

Query: 201 VNEDCELKILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHYNQ 245
              D ++K+ DFG++     T      ++ T ++ APE+++     ++
Sbjct: 143 FTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 190

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.7 bits (235), Expect = 2e-22
 Identities = 35/150 (23%), Positives = 59/150 (39%), Gaps = 17/150 (11%)

Query: 254 DLKPSNIAVNEDCELKILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHYNQ---- 306
           DLK  NI    D ++K+ DFG++     T      ++ T ++ APE+++     ++    
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDY 194

Query: 307 -TDIHQLNLIM-EML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAID 363
             D+  L + + EM    PP             K   S P              +    D
Sbjct: 195 KADVWSLGITLIEMAEIEPP--HHELNPMRVLLKIAKSEP-----PTLAQPSRWSSNFKD 247

Query: 364 LLSLMLELDSEKRITAEQALAHPYLSQYSD 393
            L   LE + + R T  Q L HP+++  S+
Sbjct: 248 FLKKCLEKNVDARWTTSQLLQHPFVTVDSN 277

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  132 bits (332), Expect = 3e-36
 Identities = 69/321 (21%), Positives = 122/321 (38%), Gaps = 79/321 (24%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAK-------RTYRELRMLKHMN-HENVIGLLDVFHS 135
            +   +  + A+K I      +  A+        T +E+ +L+ ++ H N+I L D + +
Sbjct: 22  CIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81

Query: 136 NTCLADFKNVYMVTHLM-GADLNNILRTQK-LSDDHVQFLVYQILRGLKYIHSAGIIHRD 193
           NT        ++V  LM   +L + L  +  LS+   + ++  +L  +  +H   I+HRD
Sbjct: 82  NTFF------FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRD 135

Query: 194 LKPSNIAVNEDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFY 251
           LKP NI +++D  +K+ DFG +       ++     T  Y APEI+   M+ N  G    
Sbjct: 136 LKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGY--- 192

Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEM-TGYVATRWYRAPEIMLNWMHYNQTDIH 310
                          E+ +   G+       +  G                  +++  + 
Sbjct: 193 -------------GKEVDMWSTGV---IMYTLLAGSPP--------------FWHRKQML 222

Query: 311 QLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLE 370
            L +IM       +      S                               DL+S  L 
Sbjct: 223 MLRMIMSGNYQFGSPEWDDYSDT---------------------------VKDLVSRFLV 255

Query: 371 LDSEKRITAEQALAHPYLSQY 391
           +  +KR TAE+ALAHP+  QY
Sbjct: 256 VQPQKRYTAEEALAHPFFQQY 276

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  132 bits (334), Expect = 3e-36
 Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 10/167 (5%)

Query: 84  ALDSVSGVKVAIKKI-ARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           A D  +   VAIKK+     QS    +   +E+R L+ + H N I     +         
Sbjct: 34  ARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE------ 87

Query: 143 KNVYMVTHLMGADL--NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
              ++V             +  + L +  +  + +  L+GL Y+HS  +IHRD+K  NI 
Sbjct: 88  HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNIL 147

Query: 201 VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTG 247
           ++E   +K+ DFG A         +V T ++ APE++L        G
Sbjct: 148 LSEPGLVKLGDFGSASIM-APANSFVGTPYWMAPEVILAMDEGQYDG 193

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 5e-36
 Identities = 43/169 (25%), Positives = 74/169 (43%), Gaps = 14/169 (8%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
           A++ V+   VA+K +    ++    +   +E+ + K +NHENV+                
Sbjct: 24  AVNRVTEEAVAVKIV-DMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ---- 78

Query: 144 NVYMVTHLM--GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
             Y+       G   + I     + +   Q   +Q++ G+ Y+H  GI HRD+KP N+ +
Sbjct: 79  --YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL 136

Query: 202 NEDCELKILDFGLAR-----PTENEMTGYVATRWYRAPEIMLNWMHYNQ 245
           +E   LKI DFGLA        E  +     T  Y APE++     + +
Sbjct: 137 DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 185

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.5 bits (232), Expect = 2e-22
 Identities = 38/161 (23%), Positives = 68/161 (42%), Gaps = 19/161 (11%)

Query: 238 LNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLAR-----PTENEMTGYVATRWY 292
           + ++H          +D+KP N+ ++E   LKI DFGLA        E  +     T  Y
Sbjct: 116 VVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 171

Query: 293 RAPEIMLNWMHYNQ-TDIHQLNLIM-EML-GTPPAEFMAKISSDSARKYINSLPLLTKKD 349
            APE++     + +  D+    +++  ML G  P +      SDS ++Y +      KK 
Sbjct: 172 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP----SDSCQEYSD---WKEKKT 224

Query: 350 FRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQ 390
           +   +K  +   + LL  +L  +   RIT        + ++
Sbjct: 225 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (329), Expect = 6e-36
 Identities = 41/163 (25%), Positives = 70/163 (42%), Gaps = 10/163 (6%)

Query: 84  ALDSVSGVKVAIKKIAR-PFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           A +  S   +A+K + +   + A    +  RE+ +  H+ H N++ L   FH  T +   
Sbjct: 25  AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV--- 81

Query: 143 KNVYMVTHLM-GADLNNIL-RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
              Y++        +   L +  K  +      + ++   L Y HS  +IHRD+KP N+ 
Sbjct: 82  ---YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLL 138

Query: 201 VNEDCELKILDFGLARPTENEMTG-YVATRWYRAPEIMLNWMH 242
           +    ELKI DFG +    +        T  Y  PE++   MH
Sbjct: 139 LGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMH 181

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.2 bits (239), Expect = 3e-23
 Identities = 48/246 (19%), Positives = 90/246 (36%), Gaps = 33/246 (13%)

Query: 159 ILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIH----RDLKPSNIAVNEDCELKILDFGL 214
           +L   +L    V+  + + +    ++    I+              + E   L  +   L
Sbjct: 38  VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL 97

Query: 215 ARP---TENEMTGYVATRWYRAPEIM--LNWMHYNQTGVPFYFQDLKPSNIAVNEDCELK 269
            +     E     Y+        E+   L++ H  +       +D+KP N+ +    ELK
Sbjct: 98  QKLSKFDEQRTATYIT-------ELANALSYCHSKR----VIHRDIKPENLLLGSAGELK 146

Query: 270 ILDFGLARPTENEMTG-YVATRWYRAPEIMLNWMHYNQTDIHQLNLIM-EML-GTPPAEF 326
           I DFG +    +        T  Y  PE++   MH  + D+  L ++  E L G PP  F
Sbjct: 147 IADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP--F 204

Query: 327 MAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAHP 386
            A    ++ ++                       A DL+S +L+ +  +R    + L HP
Sbjct: 205 EANTYQETYKRISRVEFTFPDF--------VTEGARDLISRLLKHNPSQRPMLREVLEHP 256

Query: 387 YLSQYS 392
           +++  S
Sbjct: 257 WITANS 262

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 7e-36
 Identities = 62/330 (18%), Positives = 112/330 (33%), Gaps = 91/330 (27%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
            +++ S      K +       V  K+   E+ +L    H N++ L + F S       +
Sbjct: 24  CVETSSKKTYMAKFVKVKGTDQVLVKK---EISILNIARHRNILHLHESFESM------E 74

Query: 144 NVYMVTHLM-GADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNI- 199
            + M+   + G D+   + T    L++  +   V+Q+   L+++HS  I H D++P NI 
Sbjct: 75  ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENII 134

Query: 200 -AVNEDCELKILDFGLARPTE--NEMTGYVATRWYRAPEIMLNWMHYNQT-----GVPFY 251
                   +KI++FG AR  +  +          Y APE+  + +    T     G   Y
Sbjct: 135 YQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVY 194

Query: 252 FQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQ 311
                           L              ++G         P          +T+   
Sbjct: 195 ---------------VL--------------LSG-------INP-------FLAETNQQI 211

Query: 312 LNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLEL 371
           +  IM    T   E   +IS                            +A+D +  +L  
Sbjct: 212 IENIMNAEYTFDEEAFKEIS---------------------------IEAMDFVDRLLVK 244

Query: 372 DSEKRITAEQALAHPYLSQYSDPNDEPTSP 401
           + + R+TA +AL HP+L Q  +        
Sbjct: 245 ERKSRMTASEALQHPWLKQKIERVSTKVIR 274

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  129 bits (326), Expect = 5e-35
 Identities = 72/335 (21%), Positives = 126/335 (37%), Gaps = 91/335 (27%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
           A D  +   VAIK IA+             E+ +L  + H N++ L D++ S        
Sbjct: 28  AEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESG------G 80

Query: 144 NVYMVTHLM-GADLNNILRTQK-LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           ++Y++  L+ G +L + +  +   ++     L++Q+L  +KY+H  GI+HRDLKP N+  
Sbjct: 81  HLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLY 140

Query: 202 ---NEDCELKILDFGLARPTENE--MTGYVATRWYRAPEIMLNWMHYNQT------GVPF 250
              +ED ++ I DFGL++  +    ++    T  Y AP  +L    Y++       GV  
Sbjct: 141 YSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP-EVLAQKPYSKAVDCWSIGVIA 199

Query: 251 YFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIH 310
           Y                               + GY                 Y++ D  
Sbjct: 200 YIL-----------------------------LCGYPP--------------FYDENDAK 216

Query: 311 QLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLE 370
               I++      + +   IS                             A D +  ++E
Sbjct: 217 LFEQILKAEYEFDSPYWDDIS---------------------------DSAKDFIRHLME 249

Query: 371 LDSEKRITAEQALAHPYLSQYSDPNDEPTSPPYDQ 405
            D EKR T EQAL HP+++  +  +        +Q
Sbjct: 250 KDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQ 284

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 1e-33
 Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 8/160 (5%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
            LD+ + V+VA  ++     +    +R   E  MLK + H N++   D +   + +   K
Sbjct: 28  GLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWE--STVKGKK 85

Query: 144 NVYMVTHLM-GADLNNIL-RTQKLSDDHVQFLVYQILRGLKYIHSAG--IIHRDLKPSNI 199
            + +VT LM    L   L R + +    ++    QIL+GL+++H+    IIHRDLK  NI
Sbjct: 86  CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNI 145

Query: 200 AVN-EDCELKILDFGLARPTENEMT-GYVATRWYRAPEIM 237
            +      +KI D GLA           + T  + APE+ 
Sbjct: 146 FITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMY 185

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 2e-32
 Identities = 43/175 (24%), Positives = 77/175 (44%), Gaps = 19/175 (10%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
                 G  +  K++     +    +    E+ +L+ + H N++   D     T      
Sbjct: 23  IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT----NT 78

Query: 144 NVYMVTHLM-GADLNNILR-----TQKLSDDHVQFLVYQILRGLKYIHSAG-----IIHR 192
            +Y+V     G DL +++       Q L ++ V  ++ Q+   LK  H        ++HR
Sbjct: 79  TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHR 138

Query: 193 DLKPSNIAVNEDCELKILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMHYN 244
           DLKP+N+ ++    +K+ DFGLAR      +    +V T +Y +PE  +N M YN
Sbjct: 139 DLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPE-QMNRMSYN 192

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  122 bits (308), Expect = 3e-32
 Identities = 62/335 (18%), Positives = 123/335 (36%), Gaps = 55/335 (16%)

Query: 84  ALDSVSGVKVAIKKI-ARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
                SG   A+K +  +        + T  E R+L+ +N   ++ L   F  N+ L   
Sbjct: 60  VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119

Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
                   +     +++ R  + S+ H +F   QI+   +Y+HS  +I+RDLKP N+ ++
Sbjct: 120 MEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175

Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAV 262
           +   +++ DFG A+  +        T    APEI+L+                K  N AV
Sbjct: 176 QQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILS----------------KGYNKAV 219

Query: 263 NEDCELKILDFGLARPTENEM-TGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT 321
                    D+        EM  GY                 +    I     I+     
Sbjct: 220 ---------DWWALGVLIYEMAAGYPP--------------FFADQPIQIYEKIVSGKVR 256

Query: 322 PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQ 381
            P+ F     S   +  + +   L + D  + F        D+ +      ++     ++
Sbjct: 257 FPSHF-----SSDLKDLLRN---LLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 308

Query: 382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQ 416
            +  P++ ++  P D      Y++  E++ + +++
Sbjct: 309 KVEAPFIPKFKGPGDTSNFDDYEE--EEIRVSINE 341

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  122 bits (307), Expect = 6e-32
 Identities = 56/318 (17%), Positives = 108/318 (33%), Gaps = 83/318 (26%)

Query: 84  ALDSVSGVKVAIKKI----ARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
              + +G   A+K +     +  Q    A      L ++   +   ++ +   FH+   L
Sbjct: 23  CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82

Query: 140 ADFKNVYMVTHLM-GADLNNILRTQKL-SDDHVQFLVYQILRGLKYIHSAGIIHRDLKPS 197
                   +  LM G DL+  L    + S+  ++F   +I+ GL+++H+  +++RDLKP+
Sbjct: 83  ------SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPA 136

Query: 198 NIAVNEDCELKILDFGLARPTENEMTGYVA-TRWYRAPEIMLNWMHYNQTGVPFYFQDLK 256
           NI ++E   ++I D GLA     +       T  Y APE++   + Y+ +   F      
Sbjct: 137 NILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSL---- 192

Query: 257 PSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIM 316
                                       G +        +++     + Q      + I 
Sbjct: 193 ----------------------------GCMLF------KLLRGHSPFRQHKTKDKHEID 218

Query: 317 EMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKR 376
            M  T   E     S                           P+   LL  +L+ D  +R
Sbjct: 219 RMTLTMAVELPDSFS---------------------------PELRSLLEGLLQRDVNRR 251

Query: 377 IT-----AEQALAHPYLS 389
           +      A++    P+  
Sbjct: 252 LGCLGRGAQEVKESPFFR 269

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 6e-32
 Identities = 68/341 (19%), Positives = 120/341 (35%), Gaps = 96/341 (28%)

Query: 84  ALDSVSGVKVAIKKIARPF----QSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL 139
             +  +G++ A K I +      +  V  +   RE+ +LK + H NVI L +V+ + T  
Sbjct: 29  CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT-- 86

Query: 140 ADFKNVYMVTHLM--GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPS 197
               +V ++  L+  G   + +   + L+++     + QIL G+ Y+HS  I H DLKP 
Sbjct: 87  ----DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPE 142

Query: 198 NIAVNED----CELKILDFGLARPTE--NEMTGYVATRWYRAPEIMLNWMHYNQT----- 246
           NI + +       +KI+DFGLA   +  NE      T  + APEI+       +      
Sbjct: 143 NIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSI 202

Query: 247 GVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQ 306
           GV  Y                               ++G                     
Sbjct: 203 GVITYIL-----------------------------LSGA--------------SPFLGD 219

Query: 307 TDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLS 366
           T    L  +  +      E+ +  S                             A D + 
Sbjct: 220 TKQETLANVSAVNYEFEDEYFSNTS---------------------------ALAKDFIR 252

Query: 367 LMLELDSEKRITAEQALAHPYLSQYSDP---NDEPTSPPYD 404
            +L  D +KR+T + +L HP++         +   + P ++
Sbjct: 253 RLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSHPQFE 293

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  122 bits (306), Expect = 7e-32
 Identities = 76/360 (21%), Positives = 131/360 (36%), Gaps = 66/360 (18%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSN------- 136
           A D V+   VA+K +       V+ +    E+++L+ +N  +      +  ++       
Sbjct: 32  AKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88

Query: 137 --TCLADFKNVYMVTHLMGA---DLNNILRTQKLSDDHVQFLVYQILRGLKYIH-SAGII 190
                 +  +V MV  ++G     L      + +   +V+ +  Q+L GL Y+H   GII
Sbjct: 89  FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGII 148

Query: 191 HRDLKPSNIAVNED------CELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYN 244
           H D+KP N+ +          ++KI D G A   +   T  + TR YR+PE++L      
Sbjct: 149 HTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGC 208

Query: 245 QTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHY 304
              +                 C +  L  G                 +   E      H 
Sbjct: 209 GADIWSTA-------------CLIFELITG--------------DFLFEPDE-----GHS 236

Query: 305 NQTDIHQLNLIMEMLGTPPAEFMAKI-------SSDSARKYINSLPLLTKKDF----RQV 353
              D   +  I+E+LG  P+  +          +S    + I+ L     +D      + 
Sbjct: 237 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKF 296

Query: 354 FKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLP 413
            K    +  D LS ML+LD  KR  A   + HP+L       +E   P  +      D+P
Sbjct: 297 SKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGM-EEIRVPDRELYGSGSDIP 355

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (298), Expect = 2e-31
 Identities = 45/189 (23%), Positives = 80/189 (42%), Gaps = 19/189 (10%)

Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLK 119
           EI  G I +G  +   SF  ++           VA+K +     +    +    E+ +L+
Sbjct: 4   EIPDGQITVGQRIGSGSFGTVYKGKWHG----DVAVKMLNVTAPTPQQLQAFKNEVGVLR 59

Query: 120 HMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQ--KLSDDHVQFLVYQ 176
              H N++  +    +         + +VT    G+ L + L     K     +  +  Q
Sbjct: 60  KTRHVNILLFMGYSTAP-------QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 112

Query: 177 ILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR-----PTENEMTGYVATRWY 231
             +G+ Y+H+  IIHRDLK +NI ++ED  +KI DFGLA         ++      +  +
Sbjct: 113 TAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 172

Query: 232 RAPEIMLNW 240
            APE++   
Sbjct: 173 MAPEVIRMQ 181

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 8e-31
 Identities = 43/164 (26%), Positives = 70/164 (42%), Gaps = 14/164 (8%)

Query: 84  ALDSVSGVKVAIKKI-ARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           A +  +  + AIK +  R            RE  ++  ++H   + L   F  +  L   
Sbjct: 27  ARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL--- 83

Query: 143 KNVYMVTHLM-GADLNNIL-RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
              Y         +L   + +     +   +F   +I+  L+Y+H  GIIHRDLKP NI 
Sbjct: 84  ---YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENIL 140

Query: 201 VNEDCELKILDFGLARPTENE-----MTGYVATRWYRAPEIMLN 239
           +NED  ++I DFG A+    E        +V T  Y +PE++  
Sbjct: 141 LNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.8 bits (212), Expect = 2e-19
 Identities = 49/179 (27%), Positives = 77/179 (43%), Gaps = 27/179 (15%)

Query: 238 LNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENE-----MTGYVATRWY 292
           L ++H          +DLKP NI +NED  ++I DFG A+    E        +V T  Y
Sbjct: 121 LEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 176

Query: 293 RAPEIMLNWMHYNQTDIHQLNLIM-EML-GTPPAEFMAKISSDSARKYINSLPLLTKKDF 350
            +PE++        +D+  L  I+ +++ G PP  F A       +K I       +K  
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPEK-- 232

Query: 351 RQVFKGANPQAIDLLSLMLELDSEKRITAEQA------LAHPYLSQYSDPNDEPTSPPY 403
                   P+A DL+  +L LD+ KR+  E+        AHP+    +  N    +PP 
Sbjct: 233 ------FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPK 285

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (290), Expect = 2e-30
 Identities = 39/154 (25%), Positives = 68/154 (44%), Gaps = 13/154 (8%)

Query: 90  GVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVT 149
           G KVA+K I    ++   A+    E  ++  + H N++ LL V      + +   +Y+VT
Sbjct: 30  GNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLGV-----IVEEKGGLYIVT 80

Query: 150 HLM-GADLNNILRTQK---LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
             M    L + LR++    L  D +      +   ++Y+     +HRDL   N+ V+ED 
Sbjct: 81  EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN 140

Query: 206 ELKILDFGLARPTENEMTGYVATRWYRAPEIMLN 239
             K+ DFGL +   +          + APE +  
Sbjct: 141 VAKVSDFGLTKEASSTQDTGKLPVKWTAPEALRE 174

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (290), Expect = 3e-30
 Identities = 48/316 (15%), Positives = 100/316 (31%), Gaps = 79/316 (25%)

Query: 86  DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV 145
                  VA+K +               E  +++ +++  ++ ++ +          ++ 
Sbjct: 30  MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-------AESW 82

Query: 146 YMVTHLM-GADLNNIL-RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE 203
            +V  +     LN  L + + + D ++  LV+Q+  G+KY+  +  +HRDL   N+ +  
Sbjct: 83  MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT 142

Query: 204 DCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVN 263
               KI DFGL++    +   Y A    + P   + W                       
Sbjct: 143 QHYAKISDFGLSKALRADENYYKAQTHGKWP---VKWY---------------------- 177

Query: 264 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIM-EML--G 320
                                         APE +  +   +++D+    ++M E    G
Sbjct: 178 ------------------------------APECINYYKFSSKSDVWSFGVLMWEAFSYG 207

Query: 321 TPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAE 380
             P  +     S+          +           G   +  DL++L    D E R    
Sbjct: 208 QKP--YRGMKGSEVTAMLEKGERM-------GCPAGCPREMYDLMNLCWTYDVENRPGFA 258

Query: 381 Q---ALAHPYLSQYSD 393
                L + Y    ++
Sbjct: 259 AVELRLRNYYYDVVNE 274

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 7e-30
 Identities = 54/311 (17%), Positives = 102/311 (32%), Gaps = 62/311 (19%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
            G +VA+K  +   + +   +    E+     + HEN++G +   + +     +  +++V
Sbjct: 25  RGEEVAVKIFSSREERSWFREA---EIYQTVMLRHENILGFIAADNKDN--GTWTQLWLV 79

Query: 149 THLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSA--------GIIHRDLKPSNI 199
           +       L + L    ++ + +  L      GL ++H           I HRDLK  NI
Sbjct: 80  SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 139

Query: 200 AVNEDCELKILDFGLARPTENE-------MTGYVATRWYRAPEIMLNWMHYNQTGVPFYF 252
            V ++    I D GLA   ++            V T+ Y APE++ + ++          
Sbjct: 140 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFES---- 195

Query: 253 QDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQL 312
                            I   GL                    EI          + +QL
Sbjct: 196 ------------FKRADIYAMGLV-----------------FWEIARRCSIGGIHEDYQL 226

Query: 313 NLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD 372
                +   P  E M K+  +  +K   ++P       R     A      ++      +
Sbjct: 227 PYYDLVPSDPSVEEMRKVVCE--QKLRPNIP------NRWQSCEALRVMAKIMRECWYAN 278

Query: 373 SEKRITAEQAL 383
              R+TA +  
Sbjct: 279 GAARLTALRIK 289

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  114 bits (287), Expect = 1e-29
 Identities = 55/329 (16%), Positives = 97/329 (29%), Gaps = 73/329 (22%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
             D  +G +VAIK      +      + + E ++ K M     I  +       C A+  
Sbjct: 26  GTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRW-----CGAEGD 76

Query: 144 NVYMVTHLMGADL--NNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
              MV  L+G  L       ++K S   V  L  Q++  ++YIHS   IHRD+KP N  +
Sbjct: 77  YNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLM 136

Query: 202 NE---DCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPS 258
                   + I+DFGLA+   +  T                 + Y +             
Sbjct: 137 GLGKKGNLVYIIDFGLAKKYRDARTH--------------QHIPYREN------------ 170

Query: 259 NIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEM 318
                                         T  Y +    L      + D+  L  ++  
Sbjct: 171 -------------------------KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMY 205

Query: 319 LGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT 378
                  +    ++   +KY              + KG   +    L+    L  + +  
Sbjct: 206 FNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPD 265

Query: 379 AE---QALAHPYLSQYSDPNDEPTSPPYD 404
                Q   + +  Q    +       +D
Sbjct: 266 YSYLRQLFRNLFHRQGFSYDY-----VFD 289

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 2e-28
 Identities = 37/169 (21%), Positives = 75/169 (44%), Gaps = 19/169 (11%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELR-MLKHMNHENVIGLLDVFHSNTCLADF 142
             +  +  K A+K +           +  RE+    +     +++ ++DV+      A  
Sbjct: 31  IFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYE--NLYAGR 81

Query: 143 KNVYMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSN 198
           K + +V   + G +L + ++    Q  ++     ++  I   ++Y+HS  I HRD+KP N
Sbjct: 82  KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPEN 141

Query: 199 IAVN---EDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIMLNWMH 242
           +       +  LK+ DFG A+   + N +T    T +Y APE++    +
Sbjct: 142 LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY 190

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.8 bits (217), Expect = 7e-20
 Identities = 34/172 (19%), Positives = 71/172 (41%), Gaps = 7/172 (4%)

Query: 254 DLKPSNIAVN---EDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIMLNWMHYNQTD 308
           D+KP N+       +  LK+ DFG A+   + N +T    T +Y APE++    +    D
Sbjct: 136 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 195

Query: 309 IHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLM 368
           +  L +IM +L      F +      +      + +   +     +   + +   L+  +
Sbjct: 196 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 255

Query: 369 LELDSEKRITAEQALAHPYLSQYSDPNDEP--TSPPYDQSFEDMDLPVDQWK 418
           L+ +  +R+T  + + HP++ Q +     P  TS    +  E  +   ++  
Sbjct: 256 LKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMT 307

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  110 bits (276), Expect = 3e-28
 Identities = 52/312 (16%), Positives = 96/312 (30%), Gaps = 76/312 (24%)

Query: 84  ALDSVSGVKVAIKKI-ARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
           A D      VA+K + A   +      R  RE +    +NH  ++ + D   + T     
Sbjct: 26  ARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85

Query: 143 KNVYMVTHLM-GADLNNILRTQK-LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
              Y+V   + G  L +I+ T+  ++      ++    + L + H  GIIHRD+KP+NI 
Sbjct: 86  --PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIM 143

Query: 201 VNEDCELKILDFGLARP------TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQD 254
           ++    +K++DFG+AR       +  +    + T  Y +PE         ++ V      
Sbjct: 144 ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLG-- 201

Query: 255 LKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNL 314
                      C L  +  G                    P           + +     
Sbjct: 202 -----------CVLYEVLTG------------------EPP-------FTGDSPVSVAYQ 225

Query: 315 IMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSE 374
            +     PP+     +S                                ++   L  + E
Sbjct: 226 HVREDPIPPSARHEGLS---------------------------ADLDAVVLKALAKNPE 258

Query: 375 KRITAEQALAHP 386
            R      +   
Sbjct: 259 NRYQTAAEMRAD 270

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (272), Expect = 1e-27
 Identities = 47/198 (23%), Positives = 83/198 (41%), Gaps = 21/198 (10%)

Query: 53  HFNQPYSEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTY 112
            +   + E+ R  + +   L    F  ++    +     KVA+K +    Q ++      
Sbjct: 3   WWEDEW-EVPRETLKLVERLGAGQFGEVWMGYYNG--HTKVAVKSLK---QGSMSPDAFL 56

Query: 113 RELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQ---KLSDD 168
            E  ++K + H+ ++ L  V            +Y++T  M    L + L+T    KL+ +
Sbjct: 57  AEANLMKQLQHQRLVRLYAVVTQE-------PIYIITEYMENGSLVDFLKTPSGIKLTIN 109

Query: 169 HVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE----MTG 224
            +  +  QI  G+ +I     IHRDL+ +NI V++    KI DFGLAR  E+       G
Sbjct: 110 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 169

Query: 225 YVATRWYRAPEIMLNWMH 242
                 + APE +     
Sbjct: 170 AKFPIKWTAPEAINYGTF 187

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 1e-27
 Identities = 44/224 (19%), Positives = 90/224 (40%), Gaps = 42/224 (18%)

Query: 60  EICRGVIDIGPTLSKESFDLIFS----SALDSVSGVKVAIKKIARPFQSAVHAKRTYREL 115
           E  R  ++ G  L   +F  + +        +   ++VA+K + +    +   +    EL
Sbjct: 33  EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADSSEREALMSEL 91

Query: 116 RMLKHM-NHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQK--------- 164
           +M+  + +HEN++ LL     +        +Y++       DL N LR+++         
Sbjct: 92  KMMTQLGSHENIVNLLGACTLS------GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIE 145

Query: 165 ---------------LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKI 209
                          L+ + +    YQ+ +G++++     +HRDL   N+ V     +KI
Sbjct: 146 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKI 205

Query: 210 LDFGLARPTENE-----MTGYVATRWYRAPEIMLNWMHYNQTGV 248
            DFGLAR   ++              + APE +   ++  ++ V
Sbjct: 206 CDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDV 249

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  108 bits (271), Expect = 2e-27
 Identities = 54/305 (17%), Positives = 95/305 (31%), Gaps = 71/305 (23%)

Query: 85  LDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN 144
           L     + VAIK + +   +    +    E  ++   +H NVI L  V   +T       
Sbjct: 49  LPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST------P 101

Query: 145 VYMVTHLM-GADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           V ++T  M    L++ LR    + +   +  ++  I  G+KY+     +HRDL   NI V
Sbjct: 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV 161

Query: 202 NEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIA 261
           N +   K+ DFGL+R  E++ +                                      
Sbjct: 162 NSNLVCKVSDFGLSRFLEDDTS-------------------------------------- 183

Query: 262 VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIM-EMLG 320
                           PT     G      + APE +      + +D+    ++M E++ 
Sbjct: 184 ---------------DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 228

Query: 321 TPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAE 380
                +    + D          L    D              L+    + D   R    
Sbjct: 229 YGERPYWDMTNQDVINAIEQDYRLPPPMDC-------PSALHQLMLDCWQKDRNHRPKFG 281

Query: 381 QALAH 385
           Q +  
Sbjct: 282 QIVNT 286

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 3e-27
 Identities = 49/211 (23%), Positives = 81/211 (38%), Gaps = 32/211 (15%)

Query: 60  EICRGVIDIGPTLSKESFDLIFS----SALDSVSGVKVAIKKIARPFQSAVHAKRTYREL 115
           E  R  +  G TL   +F  +        + S + + VA+K + +P       +    EL
Sbjct: 19  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALMSEL 77

Query: 116 RMLKHM-NHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQK--------- 164
           ++L ++ NH N++ LL                ++T      DL N LR ++         
Sbjct: 78  KVLSYLGNHMNIVNLLGACTIG------GPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 131

Query: 165 ----------LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL 214
                     L  + +    YQ+ +G+ ++ S   IHRDL   NI +      KI DFGL
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGL 191

Query: 215 ARPTENEMTGYVATRWYRAPEIMLNWMHYNQ 245
           AR  +N+    V        + M     +N 
Sbjct: 192 ARDIKNDSNYVVKGNARLPVKWMAPESIFNC 222

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  107 bits (269), Expect = 5e-27
 Identities = 37/155 (23%), Positives = 67/155 (43%), Gaps = 5/155 (3%)

Query: 84  ALDSVSGVKVAIKKI-ARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
                +G   A+K +           + T  E  ML  + H  +I +   F     +   
Sbjct: 23  IRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82

Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +      L     + + ++Q+  +   +F   ++   L+Y+HS  II+RDLKP NI ++
Sbjct: 83  MDYIEGGELF----SLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD 138

Query: 203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIM 237
           ++  +KI DFG A+   +       T  Y APE++
Sbjct: 139 KNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVV 173

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 82.1 bits (202), Expect = 5e-18
 Identities = 47/255 (18%), Positives = 85/255 (33%), Gaps = 23/255 (9%)

Query: 159 ILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIH-RDLKPSNIAVNEDCELKILDFGLARP 217
           +L+ + +               L  +    II           +    +        +  
Sbjct: 36  VLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL 95

Query: 218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLAR 277
            +++       ++Y A   +   + Y  +     ++DLKP NI ++++  +KI DFG A+
Sbjct: 96  RKSQRFPNPVAKFYAA--EVCLALEYLHS-KDIIYRDLKPENILLDKNGHIKITDFGFAK 152

Query: 278 PTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQL-NLIMEML-GTPPAEFMAKISSDSA 335
              +       T  Y APE++    +    D      LI EML G  P  F    +  + 
Sbjct: 153 YVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP--FYDSNTMKTY 210

Query: 336 RKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI-----TAEQALAHPYLSQ 390
            K +N+                N    DLLS ++  D  +R+       E    HP+  +
Sbjct: 211 EKILNAELRFPPF--------FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262

Query: 391 Y--SDPNDEPTSPPY 403
                        PY
Sbjct: 263 VVWEKLLSRNIETPY 277

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 7e-27
 Identities = 33/169 (19%), Positives = 71/169 (42%), Gaps = 17/169 (10%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
             + VAIK + +        +   RE +++  +++  ++ L+ V  +         + +V
Sbjct: 35  KQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-------ALMLV 86

Query: 149 THLM-GADLNNILRTQK--LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
             +  G  L+  L  ++  +   +V  L++Q+  G+KY+     +HRDL   N+ +    
Sbjct: 87  MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH 146

Query: 206 ELKILDFGLAR------PTENEMTGYVATRWYRAPEIMLNWMHYNQTGV 248
             KI DFGL++            +       + APE +      +++ V
Sbjct: 147 YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDV 195

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (264), Expect = 1e-26
 Identities = 38/170 (22%), Positives = 74/170 (43%), Gaps = 11/170 (6%)

Query: 84  ALDSVSGVKVAIKKI----ARPFQSAVHAKRTYRELRMLKHMN--HENVIGLLDVFHSNT 137
            +     + VAIK +       +    +  R   E+ +LK ++     VI LLD F    
Sbjct: 23  GIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82

Query: 138 CLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPS 197
                  +      +    + I     L ++  +   +Q+L  +++ H+ G++HRD+K  
Sbjct: 83  SFV---LILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDE 139

Query: 198 NIAVNED-CELKILDFGLARPTENE-MTGYVATRWYRAPEIMLNWMHYNQ 245
           NI ++ +  ELK++DFG     ++   T +  TR Y  PE +    ++ +
Sbjct: 140 NILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGR 189

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.3 bits (200), Expect = 6e-18
 Identities = 34/150 (22%), Positives = 62/150 (41%), Gaps = 21/150 (14%)

Query: 254 DLKPSNIAVNED-CELKILDFGLARPTENE-MTGYVATRWYRAPEIMLNWMHYNQ-TDIH 310
           D+K  NI ++ +  ELK++DFG     ++   T +  TR Y  PE +    ++ +   + 
Sbjct: 135 DIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVW 194

Query: 311 QLNLIM-EML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLM 368
            L +++ +M+ G  P E   +I                +  FRQ     + +   L+   
Sbjct: 195 SLGILLYDMVCGDIPFEHDEEIIRG-------------QVFFRQRV---SSECQHLIRWC 238

Query: 369 LELDSEKRITAEQALAHPYLSQYSDPNDEP 398
           L L    R T E+   HP++     P +  
Sbjct: 239 LALRPSDRPTFEEIQNHPWMQDVLLPQETA 268

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (261), Expect = 6e-26
 Identities = 43/165 (26%), Positives = 76/165 (46%), Gaps = 11/165 (6%)

Query: 84  ALDSVSGVKVAIKKIAR-PFQSAVHAKRTYRELRMLKH-MNHENVIGLLDVFHSNTCLAD 141
           A    +    AIK + +         + T  E R+L     H  +  +   F +   L  
Sbjct: 21  AEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL-- 78

Query: 142 FKNVYMVTHLMGADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
               +++ +L G DL   +++  K       F   +I+ GL+++HS GI++RDLK  NI 
Sbjct: 79  ---FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNIL 135

Query: 201 VNEDCELKILDFGLAR---PTENEMTGYVATRWYRAPEIMLNWMH 242
           +++D  +KI DFG+ +     + +   +  T  Y APEI+L   +
Sbjct: 136 LDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY 180

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.5 bits (190), Expect = 2e-16
 Identities = 37/175 (21%), Positives = 71/175 (40%), Gaps = 19/175 (10%)

Query: 237 MLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLAR---PTENEMTGYVATRWYR 293
           ++  + +  +     ++DLK  NI +++D  +KI DFG+ +     + +   +  T  Y 
Sbjct: 112 IILGLQFLHS-KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYI 170

Query: 294 APEIMLNWMHYNQTDIHQLNLIM-EML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFR 351
           APEI+L   + +  D     +++ EML G  P  F  +   +         P   +    
Sbjct: 171 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSP--FHGQDEEELFHSIRMDNPFYPR---- 224

Query: 352 QVFKGANPQAIDLLSLMLELDSEKRITAEQA-LAHPYLSQ--YSDPNDEPTSPPY 403
                   +A DLL  +   + EKR+        HP   +  + +   +   PP+
Sbjct: 225 ----WLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPF 275

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  103 bits (258), Expect = 1e-25
 Identities = 40/195 (20%), Positives = 77/195 (39%), Gaps = 14/195 (7%)

Query: 60  EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLK 119
           E+ R  I +   L    +  ++   +     + VA+K +       +  +   +E  ++K
Sbjct: 13  EMERTDITMKHKLGGGQYGEVYE-GVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMK 68

Query: 120 HMNHENVIGLLDVFHSNTCLADFKNVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQI 177
            + H N++ LL V            +       G  L+ +     Q++S   + ++  QI
Sbjct: 69  EIKHPNLVQLLGVCTREPPF----YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 124

Query: 178 LRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE----MTGYVATRWYRA 233
              ++Y+     IHRDL   N  V E+  +K+ DFGL+R    +      G      + A
Sbjct: 125 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 184

Query: 234 PEIMLNWMHYNQTGV 248
           PE +       ++ V
Sbjct: 185 PESLAYNKFSIKSDV 199

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 65.9 bits (160), Expect = 1e-12
 Identities = 35/249 (14%), Positives = 85/249 (34%), Gaps = 18/249 (7%)

Query: 142 FKNVYMVTHLMGADLNNILRTQKLSDDHVQFLV-YQILRGLKYIHSAGIIHRDLKPSNIA 200
           +  VY       +    +   ++ + +  +FL    +++ +K+ +   ++    +     
Sbjct: 30  YGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89

Query: 201 VN-EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSN 259
           +  E      L   L      E++  V           + ++        F  +DL   N
Sbjct: 90  IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK----NFIHRDLAARN 145

Query: 260 IAVNEDCELKILDFGLARPTENE----MTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLI 315
             V E+  +K+ DFGL+R    +      G      + APE +       ++D+    ++
Sbjct: 146 CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 205

Query: 316 MEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF-KGANPQAIDLLSLMLELDSE 374
           +  + T        I      + +       +KD+R    +G   +  +L+    + +  
Sbjct: 206 LWEIATYGMSPYPGIDLSQVYELL-------EKDYRMERPEGCPEKVYELMRACWQWNPS 258

Query: 375 KRITAEQAL 383
            R +  +  
Sbjct: 259 DRPSFAEIH 267

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (254), Expect = 2e-25
 Identities = 33/158 (20%), Positives = 66/158 (41%), Gaps = 16/158 (10%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
               VAIK I      ++       E +++ +++HE ++ L  V          + ++++
Sbjct: 27  GQYDVAIKMIKE---GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ------RPIFII 77

Query: 149 THLM-GADLNNIL--RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
           T  M    L N L     +     +  +   +   ++Y+ S   +HRDL   N  VN+  
Sbjct: 78  TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG 137

Query: 206 ELKILDFGLARPTENE----MTGYVATRWYRAPEIMLN 239
            +K+ DFGL+R   ++      G      +  PE+++ 
Sbjct: 138 VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.6 bits (175), Expect = 1e-14
 Identities = 36/250 (14%), Positives = 85/250 (34%), Gaps = 18/250 (7%)

Query: 142 FKNVYMVTHLMGADLN-NILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
           F  V         D+   +++   +S+D       +++  L +     +     K   I 
Sbjct: 17  FGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEA-KVMMNLSHEKLVQLYGVCTKQRPIF 75

Query: 201 VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNI 260
           +  +           R   +           +     + ++        F  +DL   N 
Sbjct: 76  IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK----QFLHRDLAARNC 131

Query: 261 AVNEDCELKILDFGLARPTENE----MTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIM 316
            VN+   +K+ DFGL+R   ++      G      +  PE+++     +++DI    ++M
Sbjct: 132 LVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLM 191

Query: 317 -EMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEK 375
            E+       +    +S++A      L L            A+ +   ++       +++
Sbjct: 192 WEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHL-------ASEKVYTIMYSCWHEKADE 244

Query: 376 RITAEQALAH 385
           R T +  L++
Sbjct: 245 RPTFKILLSN 254

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 1e-24
 Identities = 37/160 (23%), Positives = 73/160 (45%), Gaps = 8/160 (5%)

Query: 84  ALDSVSGVKVAIKKI-ARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF 142
             +  +G   A+K +      +      T  E R+L++  H  +  L   F ++  L   
Sbjct: 24  VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL--- 80

Query: 143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
               M     G    ++ R +  +++  +F   +I+  L+Y+HS  +++RD+K  N+ ++
Sbjct: 81  -CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD 139

Query: 203 EDCELKILDFGLAR---PTENEMTGYVATRWYRAPEIMLN 239
           +D  +KI DFGL +        M  +  T  Y APE++ +
Sbjct: 140 KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED 179

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.4 bits (187), Expect = 6e-16
 Identities = 38/178 (21%), Positives = 75/178 (42%), Gaps = 26/178 (14%)

Query: 238 LNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLAR---PTENEMTGYVATRWYRA 294
           L ++H         ++D+K  N+ +++D  +KI DFGL +        M  +  T  Y A
Sbjct: 118 LEYLHSR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 173

Query: 295 PEIMLNWMHYNQTDIHQLNLIM-EML-GTPPAEFMAKISSDSARKYINSLPLLTKKDFRQ 352
           PE++ +  +    D   L ++M EM+ G  P  F  +         +       +     
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHERLFELILMEEIRFPRT---- 227

Query: 353 VFKGANPQAIDLLSLMLELDSEKRI-----TAEQALAHPYLS--QYSDPNDEPTSPPY 403
                +P+A  LL+ +L+ D ++R+      A++ + H +     + D   +   PP+
Sbjct: 228 ----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPF 281

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 1e-24
 Identities = 33/159 (20%), Positives = 62/159 (38%), Gaps = 10/159 (6%)

Query: 86  DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV 145
                + VAIK++ R   S    K    E  ++  +++ +V  LL +  ++      + +
Sbjct: 34  GEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----TVQLI 88

Query: 146 YMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
             +                +   ++     QI +G+ Y+    ++HRDL   N+ V    
Sbjct: 89  TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ 148

Query: 206 ELKILDFGLAR-----PTENEMTGYVATRWYRAPEIMLN 239
            +KI DFGLA+       E    G      + A E +L+
Sbjct: 149 HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.6 bits (172), Expect = 4e-14
 Identities = 48/301 (15%), Positives = 96/301 (31%), Gaps = 38/301 (12%)

Query: 142 FKNVYMVTHLMGADLNNI------LRTQKLSDDHVQFLV-YQILRGLKYIHSAGIIHRDL 194
           F  VY    +   +   I      LR       + + L    ++  +   H   ++   L
Sbjct: 22  FGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL 81

Query: 195 KPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQD 254
             +   + +      L   +    +N +       W       +N++   +       +D
Sbjct: 82  TSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDRR----LVHRD 136

Query: 255 LKPSNIAVNEDCELKILDFGLAR-----PTENEMTGYVATRWYRAPEIMLNWMHYNQTDI 309
           L   N+ V     +KI DFGLA+       E    G      + A E +L+ ++ +Q+D+
Sbjct: 137 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDV 196

Query: 310 HQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLML 369
               + +  L T  ++    I +      +     L +                ++    
Sbjct: 197 WSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP------ICTIDVYMIMVKCW 250

Query: 370 ELDSEKRITAEQALAH---------PYLSQYSD---PNDEPTSPPYDQSF---EDMDLPV 414
            +D++ R    + +            YL    D       PT   + ++    EDMD  V
Sbjct: 251 MIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVV 310

Query: 415 D 415
           D
Sbjct: 311 D 311

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.8 bits (248), Expect = 2e-24
 Identities = 37/170 (21%), Positives = 58/170 (34%), Gaps = 16/170 (9%)

Query: 85  LDSVSGVKVAIKKI-ARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
             S   V VA+K +               RE+  +  ++H N+I L  V  +        
Sbjct: 31  APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP------- 83

Query: 144 NVYMVTHLM-GADLNNIL--RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
            + MVT L     L + L           +     Q+  G+ Y+ S   IHRDL   N+ 
Sbjct: 84  PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLL 143

Query: 201 VNEDCELKILDFGLAR-----PTENEMTGYVATRWYRAPEIMLNWMHYNQ 245
           +     +KI DFGL R          M  +    +       L    ++ 
Sbjct: 144 LATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSH 193

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 66.3 bits (161), Expect = 7e-13
 Identities = 33/217 (15%), Positives = 62/217 (28%), Gaps = 22/217 (10%)

Query: 176 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE 235
             +  L + +   +    L P    V E   L  L   L +  +        +R+     
Sbjct: 63  NAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVA 121

Query: 236 IMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLAR-----PTENEMTGYVATR 290
             + ++        F  +DL   N+ +     +KI DFGL R          M  +    
Sbjct: 122 EGMGYLESK----RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177

Query: 291 WYRAPEIMLNWMHYNQ-TDIHQLNLIM-EML--GTPPAEFMAKISSDSARKYINSLPLLT 346
           +       L    ++  +D     + + EM   G  P  ++    S    K       L 
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGSQILHKIDKEGERLP 235

Query: 347 KKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQAL 383
           + +             +++        E R T     
Sbjct: 236 RPE------DCPQDIYNVMVQCWAHKPEDRPTFVALR 266

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 99.9 bits (248), Expect = 3e-24
 Identities = 43/328 (13%), Positives = 92/328 (28%), Gaps = 69/328 (21%)

Query: 84  ALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK 143
             + ++  +VAIK   R    A   +  YR  ++L        +             +  
Sbjct: 24  GTNLLNNQQVAIKFEPR-RSDAPQLRDEYRTYKLLAGCTGIPNV--YYFGQ------EGL 74

Query: 144 NVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 201
           +  +V  L+G  L ++L    +K S   V     Q+L  ++ IH   +++RD+KP N  +
Sbjct: 75  HNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLI 134

Query: 202 NEDC-----ELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLK 256
                     + ++DFG+ +   + +T                                 
Sbjct: 135 GRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYR-------------------------- 168

Query: 257 PSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIM 316
                                    E      T  Y +    L      + D+  L  + 
Sbjct: 169 -------------------------EKKNLSGTARYMSINTHLGREQSRRDDLEALGHVF 203

Query: 317 EMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKR 376
                    +    ++ + +KY            R++  G   +    +     L  +  
Sbjct: 204 MYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263

Query: 377 ITAEQALAHPYLSQYSDPNDEPTSPPYD 404
              +        S+  +  +      +D
Sbjct: 264 PDYDYLQG--LFSKVLERLNTTEDENFD 289

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.6 bits (245), Expect = 7e-24
 Identities = 42/168 (25%), Positives = 70/168 (41%), Gaps = 18/168 (10%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
              +VAIK +       +  +   +E +++K + HE ++ L  V          + +Y+V
Sbjct: 40  GTTRVAIKTLKP---GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-------EEPIYIV 89

Query: 149 THLMG----ADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED 204
           T  M      D       + L    +  +  QI  G+ Y+     +HRDL+ +NI V E+
Sbjct: 90  TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN 149

Query: 205 CELKILDFGLARPTENE----MTGYVATRWYRAPEIMLNWMHYNQTGV 248
              K+ DFGLAR  E+       G      + APE  L      ++ V
Sbjct: 150 LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 197

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.6 bits (206), Expect = 9e-19
 Identities = 44/267 (16%), Positives = 89/267 (33%), Gaps = 21/267 (7%)

Query: 142 FKNVYMVTHLMGADLN-NILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
           F  V+M T      +    L+   +S +       Q+++ L++     +     +     
Sbjct: 30  FGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEA-QVMKKLRHEKLVQLYAVVSEEPIYI 88

Query: 201 VNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNI 260
           V E      L   L   T   +               + ++        +  +DL+ +NI
Sbjct: 89  VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANI 144

Query: 261 AVNEDCELKILDFGLARPTENE----MTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIM 316
            V E+   K+ DFGLAR  E+       G      + APE  L      ++D+    +++
Sbjct: 145 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 204

Query: 317 -EMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEK 375
            E+       +   ++ +   +      +    +             DL+      + E+
Sbjct: 205 TELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC-------PESLHDLMCQCWRKEPEE 257

Query: 376 RITAEQALA--HPYLSQYSDPNDEPTS 400
           R T E   A    Y +  ++P  +P  
Sbjct: 258 RPTFEYLQAFLEDYFTS-TEPQYQPGE 283

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.9 bits (243), Expect = 8e-24
 Identities = 43/199 (21%), Positives = 82/199 (41%), Gaps = 17/199 (8%)

Query: 60  EICRGVIDIGPTLSKESFDLIFSSAL--DSVSGVKVAIKKIARPFQSAVHAKRTYRELRM 117
           EI R  I++G  + +  F  +            + VAIK   +   S    ++  +E   
Sbjct: 3   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALT 61

Query: 118 LKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNIL--RTQKLSDDHVQFLV 174
           ++  +H +++ L+ V   N        V+++  L    +L + L  R   L    +    
Sbjct: 62  MRQFDHPHIVKLIGVITEN-------PVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 114

Query: 175 YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR----PTENEMTGYVATRW 230
           YQ+   L Y+ S   +HRD+   N+ V+ +  +K+ DFGL+R     T  + +       
Sbjct: 115 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 174

Query: 231 YRAPEIMLNWMHYNQTGVP 249
           + APE +      + + V 
Sbjct: 175 WMAPESINFRRFTSASDVW 193

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.8 bits (243), Expect = 8e-24
 Identities = 37/161 (22%), Positives = 68/161 (42%), Gaps = 16/161 (9%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV 148
           +  KVAIK I      A+  +    E  ++  ++H  ++ L  V            + +V
Sbjct: 28  NKDKVAIKTIRE---GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ------APICLV 78

Query: 149 THLM-GADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
              M    L++ LRTQ    + + +  +   +  G+ Y+  A +IHRDL   N  V E+ 
Sbjct: 79  FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ 138

Query: 206 ELKILDFGLARPTENEMT----GYVATRWYRAPEIMLNWMH 242
            +K+ DFG+ R   ++      G      + +PE+     +
Sbjct: 139 VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.4 bits (164), Expect = 2e-13
 Identities = 31/169 (18%), Positives = 62/169 (36%), Gaps = 22/169 (13%)

Query: 230 WYRAPEIMLNWMHYNQTGV------PFYFQDLKPSNIAVNEDCELKILDFGLARPTENEM 283
              A E +L        G+          +DL   N  V E+  +K+ DFG+ R   ++ 
Sbjct: 96  GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155

Query: 284 T----GYVATRWYRAPEIMLNWMHYNQTDIHQLNLIM-EML--GTPPAEFMAKISSDSAR 336
                G      + +PE+     + +++D+    ++M E+   G  P E     S+    
Sbjct: 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR---SNSEVV 212

Query: 337 KYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAH 385
           + I++   L K       + A+     +++   +   E R    + L  
Sbjct: 213 EDISTGFRLYKP------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.6 bits (242), Expect = 2e-23
 Identities = 41/167 (24%), Positives = 63/167 (37%), Gaps = 16/167 (9%)

Query: 91  VKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFH------------SNT 137
           +  AIK++ + + S    +    EL +L  + +H N+I LL                 + 
Sbjct: 38  MDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 96

Query: 138 CLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPS 197
            L DF     V     A          LS   +      + RG+ Y+     IHRDL   
Sbjct: 97  NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR 156

Query: 198 NIAVNEDCELKILDFGLAR--PTENEMTGYVATRWYRAPEIMLNWMH 242
           NI V E+   KI DFGL+R      + T       + A E +   ++
Sbjct: 157 NILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVY 203

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.4 bits (239), Expect = 3e-23
 Identities = 37/169 (21%), Positives = 65/169 (38%), Gaps = 10/169 (5%)

Query: 86  DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV 145
                V VAIK + +   +         E  ++   +H N+I L  V      +     +
Sbjct: 32  SGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI---I 87

Query: 146 YMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
                    D     +  + S   +  ++  I  G+KY+ +   +HRDL   NI VN + 
Sbjct: 88  TEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL 147

Query: 206 ELKILDFGLARPTENE------MTGYVATRWYRAPEIMLNWMHYNQTGV 248
             K+ DFGL+R  E++       +G      + APE +      + + V
Sbjct: 148 VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDV 196

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.9 bits (178), Expect = 5e-15
 Identities = 41/256 (16%), Positives = 79/256 (30%), Gaps = 23/256 (8%)

Query: 142 FKNVYMVTHLMGADLNN------ILRTQKLSDDHVQFLV-YQILRGLKYIHSAGIIHRDL 194
           F  VY       +           L+        V FL    I+    + +   +     
Sbjct: 20  FGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 79

Query: 195 KPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQD 254
           K   + +  +           R  + E +        R    +   M Y    + +  +D
Sbjct: 80  KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG---IAAGMKYLAN-MNYVHRD 135

Query: 255 LKPSNIAVNEDCELKILDFGLARPTENE------MTGYVATRWYRAPEIMLNWMHYNQTD 308
           L   NI VN +   K+ DFGL+R  E++       +G      + APE +      + +D
Sbjct: 136 LAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASD 195

Query: 309 IHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLM 368
           +    ++M  + T       ++S+    K IN    L                  L+   
Sbjct: 196 VWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPM------DCPSAIYQLMMQC 249

Query: 369 LELDSEKRITAEQALA 384
            + +  +R      ++
Sbjct: 250 WQQERARRPKFADIVS 265

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 94.9 bits (235), Expect = 1e-22
 Identities = 40/189 (21%), Positives = 65/189 (34%), Gaps = 38/189 (20%)

Query: 85  LDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN 144
           L       VA+K + +   SA       RE  ++   ++ N++ LL V          K 
Sbjct: 38  LPYEPFTMVAVKML-KEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG------KP 90

Query: 145 VYMVTHLM-GADLNNILRTQK-------------------------LSDDHVQFLVYQIL 178
           + ++   M   DLN  LR+                           LS      +  Q+ 
Sbjct: 91  MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVA 150

Query: 179 RGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE-----MTGYVATRWYRA 233
            G+ Y+     +HRDL   N  V E+  +KI DFGL+R   +               +  
Sbjct: 151 AGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMP 210

Query: 234 PEIMLNWMH 242
           PE +    +
Sbjct: 211 PESIFYNRY 219

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.1 bits (228), Expect = 1e-21
 Identities = 39/173 (22%), Positives = 70/173 (40%), Gaps = 16/173 (9%)

Query: 86  DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNV 145
           +    +  A+K +           +   E  ++K  +H NV+ LL +     CL    + 
Sbjct: 51  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI-----CLRSEGSP 104

Query: 146 YMVTHLM-GADLNNIL--RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 202
            +V   M   DL N +   T   +   +     Q+ +G+K++ S   +HRDL   N  ++
Sbjct: 105 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD 164

Query: 203 EDCELKILDFGLARP-------TENEMTGYVATRWYRAPEIMLNWMHYNQTGV 248
           E   +K+ DFGLAR        + +  TG      + A E +       ++ V
Sbjct: 165 EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDV 217

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.6 bits (172), Expect = 4e-14
 Identities = 34/242 (14%), Positives = 80/242 (33%), Gaps = 28/242 (11%)

Query: 176 QILRGLKYIHSAGIIHRDLKPSN--IAVNEDCELKILDFGLARPTENEMTGYVATRWYRA 233
            I++   + +   ++   L+     + V    +   L     R   +  T      +   
Sbjct: 80  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQ 138

Query: 234 PEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARP-------TENEMTGY 286
               + ++        F  +DL   N  ++E   +K+ DFGLAR        + +  TG 
Sbjct: 139 VAKGMKFLASK----KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 194

Query: 287 VATRWYRAPEIMLNWMHYNQTDIHQLNLIM-EML--GTPPAEFMAKISSDSARKYINSLP 343
                + A E +       ++D+    +++ E++  G PP  +    + D     +    
Sbjct: 195 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--YPDVNTFDITVYLLQGRR 252

Query: 344 LLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAH--PYLSQYSDPNDEPTSP 401
           LL  +              +++       +E R +  + ++      S +   +    + 
Sbjct: 253 LLQPEYC-------PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNA 305

Query: 402 PY 403
            Y
Sbjct: 306 TY 307

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.7 bits (224), Expect = 5e-21
 Identities = 45/224 (20%), Positives = 86/224 (38%), Gaps = 37/224 (16%)

Query: 60  EICRGVIDIGPTLSKESFDLIF----SSALDSVSGVKVAIKKIARPFQSAVHAKRTYREL 115
           E  R  + +G  L + +F  +          + +   VA+K + +   +    +    EL
Sbjct: 9   EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALMSEL 67

Query: 116 RMLKHMNHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQK---------- 164
           ++L H+ H   +    V     C      + ++       +L+  LR+++          
Sbjct: 68  KILIHIGHHLNV----VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 123

Query: 165 -------LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR- 216
                  L+ +H+    +Q+ +G++++ S   IHRDL   NI ++E   +KI DFGLAR 
Sbjct: 124 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 183

Query: 217 ----PTENEMTGYVATRWYRAPEIMLN-----WMHYNQTGVPFY 251
               P             + APE + +            GV  +
Sbjct: 184 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 227

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.9 bits (222), Expect = 1e-20
 Identities = 35/162 (21%), Positives = 73/162 (45%), Gaps = 7/162 (4%)

Query: 89  SGVKVAIKKI--ARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVY 146
           +G   A+K +  A   Q A   + T  E ++L+H+     +  L          + K   
Sbjct: 51  TGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA----FQTETKLHL 106

Query: 147 MVTHLMGADLNNILRTQ-KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 205
           ++ ++ G +L   L  + + ++  VQ  V +I+  L+++H  GII+RD+K  NI ++ + 
Sbjct: 107 ILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG 166

Query: 206 ELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTG 247
            + + DFGL++    + T            +  + +    +G
Sbjct: 167 HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSG 208

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.5 bits (156), Expect = 4e-12
 Identities = 31/182 (17%), Positives = 68/182 (37%), Gaps = 22/182 (12%)

Query: 237 MLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLA-----RPTENEMTGYVATRW 291
           ++  + +    +   ++D+K  NI ++ +  + + DFGL+       TE          +
Sbjct: 138 IVLALEHLHK-LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 196

Query: 292 YRAPEIMLNWMHYNQ-TDIHQLNLIM-EML-GTPPAEFMAKISSDSARKYINSLPLLTKK 348
                +      +++  D   L ++M E+L G  P  F      +S  +    +     K
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTVDGEKNSQAEISRRIL----K 250

Query: 349 DFRQVFKGANPQAIDLLSLMLELDSEKRI-----TAEQALAHPYLS--QYSDPNDEPTSP 401
                 +  +  A DL+  +L  D +KR+      A++   H +     + D   +    
Sbjct: 251 SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPA 310

Query: 402 PY 403
           P+
Sbjct: 311 PF 312

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.5 bits (221), Expect = 1e-20
 Identities = 40/204 (19%), Positives = 75/204 (36%), Gaps = 16/204 (7%)

Query: 60  EICRGVIDIGPTLSKESFDLIF----SSALDSVSGVKVAIKKIARPFQSAVHAKRTYREL 115
           E+ R  I +   L + SF +++       +      +VAIK +     S         E 
Sbjct: 16  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFLNEA 74

Query: 116 RMLKHMNHENVIGLLDVFHSNTCL------ADFKNVYMVTHLMGADLNNILRTQKLSDDH 169
            ++K  N  +V+ LL V                 ++      +   + N       S   
Sbjct: 75  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134

Query: 170 VQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR-----PTENEMTG 224
           +  +  +I  G+ Y+++   +HRDL   N  V ED  +KI DFG+ R         +   
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194

Query: 225 YVATRWYRAPEIMLNWMHYNQTGV 248
            +    + +PE + + +    + V
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDV 218

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.2 bits (215), Expect = 8e-20
 Identities = 49/211 (23%), Positives = 83/211 (39%), Gaps = 32/211 (15%)

Query: 60  EICRGVIDIGPTLSKESF------DLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYR 113
           E+ R  + +G  L + +F      + I           KVA+K + +   +         
Sbjct: 9   ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLIS 67

Query: 114 ELRMLKHM-NHENVIGLLDVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQK------- 164
           E+ M+K +  H+N+I LL     +  L      Y++       +L   L+ ++       
Sbjct: 68  EMEMMKMIGKHKNIINLLGACTQDGPL------YVIVEYASKGNLREYLQARRPPGLEYS 121

Query: 165 ----------LSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL 214
                     LS   +    YQ+ RG++Y+ S   IHRDL   N+ V ED  +KI DFGL
Sbjct: 122 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL 181

Query: 215 ARPTENEMTGYVATRWYRAPEIMLNWMHYNQ 245
           AR   +       T      + M     +++
Sbjct: 182 ARDIHHIDYYKKTTNGRLPVKWMAPEALFDR 212

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 72.5 bits (177), Expect = 2e-15
 Identities = 19/159 (11%), Positives = 44/159 (27%), Gaps = 23/159 (14%)

Query: 89  SGVKVAIKKIARPFQSAVHAKRTY--------RELRMLKHMNHENVIGLLDVFHSNTCLA 140
              +  +K       S    K                        +  L  +        
Sbjct: 23  KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY-- 80

Query: 141 DFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 200
            ++   ++  L+ A         ++  ++   ++  IL  +   +  GI+H DL   N+ 
Sbjct: 81  AWEGNAVLMELIDAK-----ELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVL 135

Query: 201 VNEDCELKILDFGLARPTENEMTGY-------VATRWYR 232
           V  +  + I+DF  +     E               ++ 
Sbjct: 136 V-SEEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFS 173

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	427
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.89
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	98.89
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	98.8
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	98.78
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	98.65
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	98.64
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	98.57
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	98.51
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	98.5
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.38
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	96.98
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	96.86
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	96.82
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	96.7
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	96.44
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	96.01
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	95.96
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	95.91
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	95.84
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	95.82
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	95.68
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	95.62
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	95.47
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	95.44
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	95.32
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	95.28
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	95.08
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	95.02
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	95.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	94.84
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	94.75
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	94.66
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	94.41
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	94.39
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	94.23
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	94.08
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	93.28
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	93.25
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	93.14
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	93.03
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	92.65
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	92.31
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	92.29
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	90.92
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	90.72
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	90.67
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	89.99
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	89.25
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	89.16
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	88.1
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	87.43
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	87.37
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	86.61
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	86.55
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	86.24
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	84.61
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	81.26
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	81.09

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-57  Score=440.08  Aligned_cols=325  Identities=53%  Similarity=0.917  Sum_probs=258.0

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      ..+|.+.+.||+|+||.||+ +.+..+|+.||||++.+........+++.+|+++|++++|||||+++++|.........
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~-~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCS-AVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             BSSEEEEEEC------CEEE-EEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             CCcEEEEEEEecCCCeEEEE-EEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            46789999999999999996 56788999999999987666666777889999999999999999999999877666566


Q ss_pred             ceEEEEeccCCCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCc
Q psy8260         143 KNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM  222 (427)
Q Consensus       143 ~~~~lv~e~~g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~  222 (427)
                      ..+|++||+++.+|..+.+...+++..++.++.||+.||+|||++|||||||||+|||++.++.+|++|||+|+......
T Consensus        96 ~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~  175 (346)
T d1cm8a_          96 TDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM  175 (346)
T ss_dssp             CCCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSSC
T ss_pred             ceEEEEEecccccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCcc
Confidence            67899999999999999988999999999999999999999999999999999999999999999999999999887777


Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhcc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM  302 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~  302 (427)
                      +..+||+.|+|||++.+...++.+.      |+||.||++.+                 +..|.               .
T Consensus       176 ~~~~~t~~y~aPE~~~~~~~~~~~~------DiwSlGvil~e-----------------ll~g~---------------~  217 (346)
T d1cm8a_         176 TGYVVTRWYRAPEVILNWMRYTQTV------DIWSVGCIMAE-----------------MITGK---------------T  217 (346)
T ss_dssp             CSSCSCGGGCCTHHHHTTTCCCTTH------HHHHHHHHHHH-----------------HHHSS---------------C
T ss_pred             ccccccccccCHHHHcCCCCCCccc------hhhcchHHHHH-----------------HHHCc---------------C
Confidence            7888999999999887655444443      78888777655                 22221               1


Q ss_pred             CCCC-CCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHH
Q psy8260         303 HYNQ-TDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQ  381 (427)
Q Consensus       303 ~~~~-~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e  381 (427)
                      ++.+ .+...+..+....+.++.++...........+....+......+...+...+++++|||.+||++||++||||+|
T Consensus       218 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e  297 (346)
T d1cm8a_         218 LFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE  297 (346)
T ss_dssp             SSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             CCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHH
Confidence            3332 344555666677788887777766666555666666767777777888889999999999999999999999999


Q ss_pred             HhcCCCCCCCCCCCCCCCCCCCCcccccCCCCHHHHHHHHhhhcc
Q psy8260         382 ALAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKGTYSLESL  426 (427)
Q Consensus       382 ~L~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  426 (427)
                      +|+||||+....+.++|..+.++.++++...+.++|+..+..|.+
T Consensus       298 iL~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~e~k~~~~~e~~  342 (346)
T d1cm8a_         298 ALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVL  342 (346)
T ss_dssp             HHHSGGGTTTC------CCCCCCCC-----CCHHHHHHHHHHHHH
T ss_pred             HhcChhhCcCCCccccccCCCCCCchhhhhcCHHHHHHHHHHHhh
Confidence            999999999888888888888999999999999999988887753

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-55  Score=425.57  Aligned_cols=323  Identities=63%  Similarity=1.004  Sum_probs=251.9

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      .+|++.+.||+|+||.||+ +.+..+|+.||||++.+...+....+++.+|+++|++++|||||+++++|......++..
T Consensus        18 ~rY~i~~~LG~G~fg~Vy~-a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          18 ERYQNLSPVGSGAYGSVCA-AFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             TTEEEEEECGGGTTSSEEE-EEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCeEEEEEEecCCCeEEEE-EEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            4688999999999999996 578889999999999877666777778889999999999999999999997665555566


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcc
Q psy8260         144 NVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT  223 (427)
Q Consensus       144 ~~~lv~e~~g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~  223 (427)
                      .+|+++++.|++|.+++..+++++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+|........
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~~~  176 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT  176 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGGGS
T ss_pred             eEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCcccc
Confidence            78889999999999999888999999999999999999999999999999999999999999999999999987666556


Q ss_pred             cccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccC
Q psy8260         224 GYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH  303 (427)
Q Consensus       224 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~  303 (427)
                      +..||+.|+|||++.+...++...      |+||.||++.+                 +.+|               ..+
T Consensus       177 ~~~g~~~y~apE~~~~~~~~~~~~------DiwSlGv~l~~-----------------ll~g---------------~~p  218 (348)
T d2gfsa1         177 GYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAE-----------------LLTG---------------RTL  218 (348)
T ss_dssp             SSCHHHHTSCHHHHTTCSCCCTTH------HHHHHHHHHHH-----------------HHHS---------------SCS
T ss_pred             cccccccccCchhhcCCccCCccc------chhhhhHHHHH-----------------HHhC---------------CCC
Confidence            666777777777765533333222      55555554433                 1111               112


Q ss_pred             CCCC-CHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHH
Q psy8260         304 YNQT-DIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQA  382 (427)
Q Consensus       304 ~~~~-d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~  382 (427)
                      +.+. +......|+...+.++.+............+...........+...+...+++++|||.+||++||.+|+||+|+
T Consensus       219 F~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~el  298 (348)
T d2gfsa1         219 FPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA  298 (348)
T ss_dssp             CCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             CCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHH
Confidence            2222 223333444444555554444444444444555555556666777888899999999999999999999999999


Q ss_pred             hcCCCCCCCCCCCCCCCCCCCCcccccCCCCHHHHHHHHhhhc
Q psy8260         383 LAHPYLSQYSDPNDEPTSPPYDQSFEDMDLPVDQWKGTYSLES  425 (427)
Q Consensus       383 L~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (427)
                      |+||||++...|..++...+++.++++.....++|+..+..|.
T Consensus       299 L~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~e~  341 (348)
T d2gfsa1         299 LAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEV  341 (348)
T ss_dssp             HTSGGGTTTCCTTSCCCCCCCCCGGGGCCCCHHHHHHHHHHHH
T ss_pred             hcCHhhCCCCCCccCCCCCCCCCcccchhcCHHHHHHHHHHHh
Confidence            9999999999999999999999999999999999998776653

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-55  Score=414.37  Aligned_cols=254  Identities=20%  Similarity=0.351  Sum_probs=204.9

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      .+|.+.+.||+|+||.||+ +.+..+|+.||||++.......  .+.+.+|+++|++++|||||+++++|...      .
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~-a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~------~   90 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYT-AMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVG------D   90 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEE-EEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEET------T
T ss_pred             cccEEEEEEecCcCcEEEE-EEECCCCCEEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeEeEEEEEC------C
Confidence            4578889999999999996 5678899999999986543322  35678999999999999999999998764      4


Q ss_pred             eEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCc
Q psy8260         144 NVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM  222 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~  222 (427)
                      .+|++|||+ |++|.+++..+.+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+......
T Consensus        91 ~~~ivmEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~  170 (293)
T d1yhwa1          91 ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (293)
T ss_dssp             EEEEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EEEEEEEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence            689999988 7899999988899999999999999999999999999999999999999999999999999987432210


Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhcc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM  302 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~  302 (427)
                      .                                                          .....+||+.|+|||++.+..
T Consensus       171 ~----------------------------------------------------------~~~~~~gt~~Y~aPE~~~~~~  192 (293)
T d1yhwa1         171 S----------------------------------------------------------KRSTMVGTPYWMAPEVVTRKA  192 (293)
T ss_dssp             C----------------------------------------------------------CBCCCCSCGGGCCHHHHSSSC
T ss_pred             c----------------------------------------------------------cccccccCCCccChhhhcCCC
Confidence            0                                                          122346888888888888877


Q ss_pred             CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhc-CCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHH
Q psy8260         303 HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINS-LPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQ  381 (427)
Q Consensus       303 ~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e  381 (427)
                      +..++|+||+|++++.|.++..||............... .+...      ....++++++|||.+||+.||.+|||++|
T Consensus       193 ~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~------~~~~~s~~~~~li~~~L~~dP~~R~s~~e  266 (293)
T d1yhwa1         193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ------NPEKLSAIFRDFLNRCLDMDVEKRGSAKE  266 (293)
T ss_dssp             BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCS------SGGGSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             CCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCC------CcccCCHHHHHHHHHHccCChhHCcCHHH
Confidence            888889999999999886666666543322222222222 12111      12457899999999999999999999999


Q ss_pred             HhcCCCCCC
Q psy8260         382 ALAHPYLSQ  390 (427)
Q Consensus       382 ~L~Hp~f~~  390 (427)
                      +|+||||+.
T Consensus       267 il~Hp~~~~  275 (293)
T d1yhwa1         267 LLQHQFLKI  275 (293)
T ss_dssp             HTTCGGGGG
T ss_pred             HhcCHhhCC
Confidence            999999964

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-55  Score=412.27  Aligned_cols=259  Identities=21%  Similarity=0.279  Sum_probs=199.2

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      ++|++.+.||+|+||.||. +.++.+|+.||||++..... ....+.+.+|+++|++++|||||++++++...      .
T Consensus         5 ~dy~~~~~lG~G~fg~V~~-~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~------~   76 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREG------N   76 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEE-EEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEET------T
T ss_pred             cceEEEEEEecCcCeEEEE-EEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccC------c
Confidence            4689999999999999995 56788999999999865422 22345678999999999999999999998754      4


Q ss_pred             eEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      .+|++|||+ |++|.+++.. ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus        77 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~  156 (271)
T d1nvra_          77 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN  156 (271)
T ss_dssp             EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             eeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence            689999998 6799988864 56999999999999999999999999999999999999999999999999999753211


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      ...                                                        ....+.+||+.|||||++.+.
T Consensus       157 ~~~--------------------------------------------------------~~~~~~~GT~~Y~APE~~~~~  180 (271)
T d1nvra_         157 NRE--------------------------------------------------------RLLNKMCGTLPYVAPELLKRR  180 (271)
T ss_dssp             TEE--------------------------------------------------------CCBCCCCSCGGGSCTHHHHCS
T ss_pred             Ccc--------------------------------------------------------ccccceeeCcCccCHhHhcCC
Confidence            000                                                        012344688888888888776


Q ss_pred             cCC-CCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHH
Q psy8260         302 MHY-NQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAE  380 (427)
Q Consensus       302 ~~~-~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~  380 (427)
                      .++ .++|+||+|+++++|.++..||...................     ...+..++++++|||.+||+.||++|||++
T Consensus       181 ~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~-----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~  255 (271)
T d1nvra_         181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-----LNPWKKIDSAPLALLHKILVENPSARITIP  255 (271)
T ss_dssp             SBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT-----STTGGGSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             CCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----CCccccCCHHHHHHHHHHcCCChhHCcCHH
Confidence            665 45799999999998866555553322221111111111111     122345789999999999999999999999


Q ss_pred             HHhcCCCCCCC
Q psy8260         381 QALAHPYLSQY  391 (427)
Q Consensus       381 e~L~Hp~f~~~  391 (427)
                      |+|+||||++.
T Consensus       256 eil~hpwf~~~  266 (271)
T d1nvra_         256 DIKKDRWYNKP  266 (271)
T ss_dssp             HHTTCTTTTCC
T ss_pred             HHhcCHhhCcC
Confidence            99999999753

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-55  Score=408.97  Aligned_cols=252  Identities=23%  Similarity=0.362  Sum_probs=202.3

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH-HHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA-VHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .+|++.+.||+|+||.||. +.+..+|+.||||++.+..... .....+.+|+++|+.++|||||++++++...      
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~-~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~------   78 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYL-AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA------   78 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEE-EEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS------
T ss_pred             hHeEEEEEEecCCCcEEEE-EEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC------
Confidence            5689999999999999996 5677899999999986432111 1234577999999999999999999998754      


Q ss_pred             ceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      ..+|++|||+ +|+|.+++.. ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus        79 ~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          79 TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             CEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC
Confidence            4689999998 6899988864 6799999999999999999999999999999999999999999999999999875322


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      .                                                            .....+||+.|||||++.+
T Consensus       159 ~------------------------------------------------------------~~~~~~Gt~~Y~APE~~~~  178 (263)
T d2j4za1         159 S------------------------------------------------------------RRTTLCGTLDYLPPEMIEG  178 (263)
T ss_dssp             C------------------------------------------------------------CCEETTEEGGGCCHHHHTT
T ss_pred             C------------------------------------------------------------cccccCCCCcccCHHHHcC
Confidence            1                                                            1112357888888888888


Q ss_pred             ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHH
Q psy8260         301 WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAE  380 (427)
Q Consensus       301 ~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~  380 (427)
                      ..+..++|+||+|+++++|.++..||..........+..+..+..        .+..+++++|||.+||++||++|||++
T Consensus       179 ~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~--------p~~~s~~~~~li~~~L~~dp~~R~t~~  250 (263)
T d2j4za1         179 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF--------PDFVTEGARDLISRLLKHNPSQRPMLR  250 (263)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC--------CTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC--------CccCCHHHHHHHHHHccCCHhHCcCHH
Confidence            778888899999999998866666664332222222222222211        235789999999999999999999999


Q ss_pred             HHhcCCCCCC
Q psy8260         381 QALAHPYLSQ  390 (427)
Q Consensus       381 e~L~Hp~f~~  390 (427)
                      |+|+||||+.
T Consensus       251 eil~hp~~~~  260 (263)
T d2j4za1         251 EVLEHPWITA  260 (263)
T ss_dssp             HHHTCHHHHH
T ss_pred             HHHcCcCcCC
Confidence            9999999964

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-53  Score=400.61  Aligned_cols=254  Identities=23%  Similarity=0.342  Sum_probs=198.6

Q ss_pred             eeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEE
Q psy8260          67 DIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVY  146 (427)
Q Consensus        67 ~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~  146 (427)
                      ++...||+|+||.||+ +.+..+++.||+|++..........+.+.+|+++|++++|||||+++++|....  .....+|
T Consensus        12 ~~~~~iG~G~fg~Vy~-~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~~~~~~   88 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYK-GLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV--KGKKCIV   88 (270)
T ss_dssp             EEEEEEEECSSEEEEE-EEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES--SSCEEEE
T ss_pred             EeeeEEecCcCcEEEE-EEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc--ccCCEEE
Confidence            5677899999999996 567789999999999776556666677889999999999999999999986421  2235689


Q ss_pred             EEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcC--ceeccCCCCCeEEc-CCCCEEEeeCCCCCCCCCC
Q psy8260         147 MVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVN-EDCELKILDFGLARPTENE  221 (427)
Q Consensus       147 lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~--iiHrDLKp~NILl~-~~~~~kl~DFGla~~~~~~  221 (427)
                      ++||++ +++|.+++.. ..+++..++.++.||+.||+|||+++  ||||||||+|||++ .++.+||+|||+|+.....
T Consensus        89 ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~  168 (270)
T d1t4ha_          89 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  168 (270)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             EEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence            999988 7899998854 67999999999999999999999998  99999999999996 5789999999998643221


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      .                                                            ..+.+||+.|||||++.+ 
T Consensus       169 ~------------------------------------------------------------~~~~~GT~~Y~aPE~~~~-  187 (270)
T d1t4ha_         169 F------------------------------------------------------------AKAVIGTPEFMAPEMYEE-  187 (270)
T ss_dssp             S------------------------------------------------------------BEESCSSCCCCCGGGGGT-
T ss_pred             c------------------------------------------------------------cCCcccCccccCHHHhCC-
Confidence            1                                                            112356777777776654 


Q ss_pred             cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHH
Q psy8260         302 MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQ  381 (427)
Q Consensus       302 ~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e  381 (427)
                      .+..++|+||+|+++++|.++..||..........+......  ..   .......+++++|||.+||+.||++|||++|
T Consensus       188 ~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~--~~---~~~~~~~~~~~~~li~~~l~~dp~~R~s~~e  262 (270)
T d1t4ha_         188 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV--KP---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKD  262 (270)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC--CC---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCC--CC---cccCccCCHHHHHHHHHHccCCHhHCcCHHH
Confidence            366778999999999998666666644322222222221111  11   1233457899999999999999999999999


Q ss_pred             HhcCCCCC
Q psy8260         382 ALAHPYLS  389 (427)
Q Consensus       382 ~L~Hp~f~  389 (427)
                      +|+||||+
T Consensus       263 ll~Hp~fk  270 (270)
T d1t4ha_         263 LLNHAFFQ  270 (270)
T ss_dssp             HHTSGGGC
T ss_pred             HhCCcccC
Confidence            99999995

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-54  Score=419.27  Aligned_cols=264  Identities=21%  Similarity=0.328  Sum_probs=199.7

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      |+..++|++.+.||+|+||.||+ +.+..+|+.||||++.... ......++.+|+.+|++++|||||+++++|...   
T Consensus         2 el~~d~y~~~~~iG~G~fg~V~~-~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~---   76 (322)
T d1s9ja_           2 ELKDDDFEKISELGAGNGGVVFK-VSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD---   76 (322)
T ss_dssp             CCCGGGEEEEEEEECCSSCCEEE-EEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS---
T ss_pred             CCCccCCEEEEEEecCCCeEEEE-EEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC---
Confidence            45567899999999999999996 5678899999999987543 333456788999999999999999999999764   


Q ss_pred             cCCceEEEEeccC-CCCHHHHHh-hCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~-~~~l~~~~~~~~~~qi~~aL~yLH~-~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                         ..+|+||||+ |++|.+++. .+.+++..++.++.|++.||.|||+ +|||||||||+|||++.++.+||+|||+|+
T Consensus        77 ---~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~  153 (322)
T d1s9ja_          77 ---GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG  153 (322)
T ss_dssp             ---SEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred             ---CEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCcc
Confidence               4689999988 679999885 4679999999999999999999997 599999999999999999999999999986


Q ss_pred             CCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         217 PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       217 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      .....                                                            ...+.+||++|||||
T Consensus       154 ~~~~~------------------------------------------------------------~~~~~~GT~~Y~APE  173 (322)
T d1s9ja_         154 QLIDS------------------------------------------------------------MANSFVGTRSYMSPE  173 (322)
T ss_dssp             HHHHH------------------------------------------------------------TC---CCSSCCCCHH
T ss_pred             ccCCC------------------------------------------------------------ccccccCCccccCch
Confidence            32110                                                            112346778888888


Q ss_pred             HhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHH--------------------------hcCCCCCccc-
Q psy8260         297 IMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYI--------------------------NSLPLLTKKD-  349 (427)
Q Consensus       297 vl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~-  349 (427)
                      ++.+..+..++|+||+|+++++|.++..||.............                          ...+...... 
T Consensus       174 vl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (322)
T d1s9ja_         174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFEL  253 (322)
T ss_dssp             HHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHH
T ss_pred             HHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHH
Confidence            8877778888899999999988855544443221111000000                          0000000000 


Q ss_pred             HHhh---------cCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q psy8260         350 FRQV---------FKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       350 ~~~~---------~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~  391 (427)
                      ....         ....|++++|||.+||++||.+||||+|+|+||||++.
T Consensus       254 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~  304 (322)
T d1s9ja_         254 LDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  304 (322)
T ss_dssp             HHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             HhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence            0000         01357899999999999999999999999999999753

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-53  Score=408.67  Aligned_cols=258  Identities=26%  Similarity=0.417  Sum_probs=192.7

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      +..|++.+.||+|+||.||+ +.+..+|+.||||++.+.... .....+.+|+.+|++++|||||+++++|...      
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~-~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------   79 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVIL-AEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESG------   79 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEE-EEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECS------
T ss_pred             ccceEEEEEEeeccCeEEEE-EEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC------
Confidence            56699999999999999996 567789999999999754322 2234567999999999999999999998754      


Q ss_pred             ceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEc---CCCCEEEeeCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN---EDCELKILDFGLARP  217 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~---~~~~~kl~DFGla~~  217 (427)
                      ..+|++|||+ |++|.+++.. +.+++..+..++.||+.||+|||++|||||||||+|||+.   .++.+||+|||+|+.
T Consensus        80 ~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~  159 (307)
T d1a06a_          80 GHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM  159 (307)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred             CEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEE
Confidence            5689999998 6899998864 5799999999999999999999999999999999999995   578999999999874


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      .....                                                           ...+.+||+.|||||+
T Consensus       160 ~~~~~-----------------------------------------------------------~~~~~~GT~~y~APE~  180 (307)
T d1a06a_         160 EDPGS-----------------------------------------------------------VLSTACGTPGYVAPEV  180 (307)
T ss_dssp             ------------------------------------------------------------------------CTTSCHHH
T ss_pred             ccCCC-----------------------------------------------------------eeeeeeeCccccCcHH
Confidence            32110                                                           1123467888888888


Q ss_pred             hhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC
Q psy8260         298 MLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI  377 (427)
Q Consensus       298 l~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~  377 (427)
                      +.+..+..++|+||+|++++.|.++..||....................    ...++.+|++++|||.+||++||++||
T Consensus       181 ~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~s~~~~~li~~~L~~dP~~R~  256 (307)
T d1a06a_         181 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD----SPYWDDISDSAKDFIRHLMEKDPEKRF  256 (307)
T ss_dssp             HTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCC----TTTTTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred             HcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCC----CccccCCCHHHHHHHHHHccCCHhHCc
Confidence            8887788888999999999988666666644322222233332222211    123456899999999999999999999


Q ss_pred             CHHHHhcCCCCCCC
Q psy8260         378 TAEQALAHPYLSQY  391 (427)
Q Consensus       378 ta~e~L~Hp~f~~~  391 (427)
                      |++|+|+||||++.
T Consensus       257 s~~eil~hp~~~~~  270 (307)
T d1a06a_         257 TCEQALQHPWIAGD  270 (307)
T ss_dssp             CHHHHHHSTTTTSS
T ss_pred             CHHHHhcCHhhCCC
Confidence            99999999999763

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.2e-53  Score=414.71  Aligned_cols=261  Identities=23%  Similarity=0.377  Sum_probs=207.6

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      ++|++.+.||+|+||.||+ +.+..+|+.||||++...  .....+.+.+|+++|++++|||||+++++|...      .
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~-~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~------~   96 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHR-VTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD------N   96 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEE-EEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET------T
T ss_pred             cCeEEEEEEecCcCeEEEE-EEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC------C
Confidence            4689999999999999996 667889999999999654  334456678999999999999999999998754      5


Q ss_pred             eEEEEeccC-CCCHHHHHh--hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcC--CCCEEEeeCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILR--TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE--DCELKILDFGLARPT  218 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~--~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~--~~~~kl~DFGla~~~  218 (427)
                      .+|++||++ ||+|.+++.  .+.+++..++.++.||+.||+|||++|||||||||+|||++.  ++.+||+|||+|+..
T Consensus        97 ~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~  176 (350)
T d1koaa2          97 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  176 (350)
T ss_dssp             EEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred             EEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence            689999998 789999884  346999999999999999999999999999999999999964  678999999998753


Q ss_pred             CCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         219 ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       219 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                      ....                                                           ...+..||+.|||||++
T Consensus       177 ~~~~-----------------------------------------------------------~~~~~~gT~~Y~aPEv~  197 (350)
T d1koaa2         177 DPKQ-----------------------------------------------------------SVKVTTGTAEFAAPEVA  197 (350)
T ss_dssp             CTTS-----------------------------------------------------------CEEEECSCTTTCCHHHH
T ss_pred             cccc-----------------------------------------------------------ccceecCcccccCHHHH
Confidence            3211                                                           11234578888888888


Q ss_pred             hhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC
Q psy8260         299 LNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT  378 (427)
Q Consensus       299 ~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t  378 (427)
                      .+..+..++|+||+|+++++|.++..||......+..............    ..+..++++++|||.+||++||++|||
T Consensus       198 ~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~s~~~~~li~~~L~~dP~~R~t  273 (350)
T d1koaa2         198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD----SAFSGISEDGKDFIRKLLLADPNTRMT  273 (350)
T ss_dssp             HTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC----GGGGGCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             cCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----ccccCCCHHHHHHHHHHccCChhHCcC
Confidence            7777777889999999999886665556433222333333333322222    233567999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCCCCC
Q psy8260         379 AEQALAHPYLSQYSDPND  396 (427)
Q Consensus       379 a~e~L~Hp~f~~~~~~~~  396 (427)
                      ++|+|+||||++...|..
T Consensus       274 ~~eil~hp~~~~~~~~~~  291 (350)
T d1koaa2         274 IHQALEHPWLTPGNAPGR  291 (350)
T ss_dssp             HHHHHHSTTTSCTTCCSC
T ss_pred             HHHHhcCcccCCCCCCCc
Confidence            999999999997655543

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-54  Score=409.67  Aligned_cols=258  Identities=26%  Similarity=0.381  Sum_probs=203.4

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .+|++++.||+|+||.||. +.+..+|+.||||++.+... .....+.+.+|+++|++++|||||+++++|...      
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~-a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------   80 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVL-ARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD------   80 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEE-EEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS------
T ss_pred             CCCEEEEEEeeCCCeEEEE-EEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC------
Confidence            4699999999999999995 56778999999999864321 111235578999999999999999999998754      


Q ss_pred             ceEEEEeccC-CCCHHHHHh-hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~-~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      ..+|++|||+ ||+|.+++. .+.+++..++.++.|++.||+|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus        81 ~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          81 EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             CEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceeccc
Confidence            4689999998 679988775 46799999999999999999999999999999999999999999999999999975432


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      ....                                                        ....+.+||+.|||||++.+
T Consensus       161 ~~~~--------------------------------------------------------~~~~~~~GT~~Y~APE~~~~  184 (288)
T d1uu3a_         161 ESKQ--------------------------------------------------------ARANSFVGTAQYVSPELLTE  184 (288)
T ss_dssp             -----------------------------------------------------------------CCCCGGGCCHHHHHT
T ss_pred             CCcc--------------------------------------------------------cccccccCCccccCceeecc
Confidence            1100                                                        01224468888889998888


Q ss_pred             ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHH
Q psy8260         301 WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAE  380 (427)
Q Consensus       301 ~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~  380 (427)
                      ..++.++|+||+|++++.|.++..||..........+.......+        ...++++++|||.+||+.||.+|+|++
T Consensus       185 ~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~--------p~~~s~~~~~li~~~L~~dP~~R~t~~  256 (288)
T d1uu3a_         185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF--------PEKFFPKARDLVEKLLVLDATKRLGCE  256 (288)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC--------CTTCCHHHHHHHHTTSCSSGGGSTTSG
T ss_pred             CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCC--------CccCCHHHHHHHHHHccCCHhHCcCHH
Confidence            888888899999999998866666665433222233333222221        235789999999999999999999999


Q ss_pred             H------HhcCCCCCCCC
Q psy8260         381 Q------ALAHPYLSQYS  392 (427)
Q Consensus       381 e------~L~Hp~f~~~~  392 (427)
                      |      +++||||+...
T Consensus       257 e~~~~~~i~~Hpff~~i~  274 (288)
T d1uu3a_         257 EMEGYGPLKAHPFFESVT  274 (288)
T ss_dssp             GGTCHHHHHTSGGGTTCC
T ss_pred             HHcCCHHHHcCCccCCCC
Confidence            8      58999998764

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-53  Score=410.38  Aligned_cols=256  Identities=21%  Similarity=0.307  Sum_probs=205.7

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC-HHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS-AVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      -++|++.+.||+|+||.||+ +.+..+|+.||||++.+.... ....+.+.+|+.+|+.++|||||+++++|...     
T Consensus         4 l~dy~~~~~lG~G~fg~V~~-~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----   77 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVIL-VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----   77 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEE-EEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-----
T ss_pred             hHhcEEEEEEecCcCeEEEE-EEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc-----
Confidence            35799999999999999995 568889999999998653211 11245678999999999999999999999764     


Q ss_pred             CceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         142 FKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                       ..+|++||++ ||+|..++.. +.+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+...
T Consensus        78 -~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~  156 (337)
T d1o6la_          78 -DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             -SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             -cccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccc
Confidence             4689999988 7899887764 679999999999999999999999999999999999999999999999999997532


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      ....                                                          .....+||+.|+|||++.
T Consensus       157 ~~~~----------------------------------------------------------~~~~~~GT~~Y~aPE~~~  178 (337)
T d1o6la_         157 SDGA----------------------------------------------------------TMKTFCGTPEYLAPEVLE  178 (337)
T ss_dssp             CTTC----------------------------------------------------------CBCCCEECGGGCCGGGGS
T ss_pred             cCCc----------------------------------------------------------ccccceeCHHHhhhhhcc
Confidence            2110                                                          122456888888888888


Q ss_pred             hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC--
Q psy8260         300 NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI--  377 (427)
Q Consensus       300 ~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~--  377 (427)
                      +..+..++|+||+|+++++|.++..||..........+.....+.+        +..+|++++|||++||++||++|+  
T Consensus       179 ~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~--------p~~~s~~~~dli~~~L~~dP~~R~~~  250 (337)
T d1o6la_         179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF--------PRTLSPEAKSLLAGLLKKDPKQRLGG  250 (337)
T ss_dssp             SSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------CTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             CCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCC--------CccCCHHHHHHHHhhccCCchhhccc
Confidence            8788888999999999998866655555433223333333322222        245799999999999999999999  


Q ss_pred             ---CHHHHhcCCCCCCC
Q psy8260         378 ---TAEQALAHPYLSQY  391 (427)
Q Consensus       378 ---ta~e~L~Hp~f~~~  391 (427)
                         |++|+++||||.+.
T Consensus       251 ~~~~~~eil~Hp~f~~i  267 (337)
T d1o6la_         251 GPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             STTTHHHHHTSGGGTTC
T ss_pred             ccccHHHHHcCcccccC
Confidence               49999999999864

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=406.22  Aligned_cols=252  Identities=23%  Similarity=0.368  Sum_probs=197.6

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      +.|++.+.||+|+||.||+ +.+..+|+.||||++....  ....+.+.+|+++|++++|||||+++++|...      .
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~-~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------~   82 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYK-AQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYE------N   82 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEE-EEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET------T
T ss_pred             cCeEEeEEEeeCCCcEEEE-EEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC------C
Confidence            4588999999999999996 5678899999999986542  23345678999999999999999999998754      4


Q ss_pred             eEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      .+|++|||+ +++|.+++..  +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus        83 ~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~  162 (288)
T d2jfla1          83 NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR  162 (288)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred             eEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence            689999998 7899988643  5699999999999999999999999999999999999999999999999999864322


Q ss_pred             C---cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         221 E---MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       221 ~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      .   ..+.+                                                             ||+.|||||+
T Consensus       163 ~~~~~~~~~-------------------------------------------------------------Gt~~y~APE~  181 (288)
T d2jfla1         163 TIQRRDSFI-------------------------------------------------------------GTPYWMAPEV  181 (288)
T ss_dssp             HHHHHTCCC-------------------------------------------------------------SCCTTCCHHH
T ss_pred             Ccccccccc-------------------------------------------------------------cccccCCHHH
Confidence            1   12234                                                             4555555555


Q ss_pred             hh-----hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         298 ML-----NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       298 l~-----~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                      +.     +..++.++|+||+|++++.|.++..||......+...+.....+...     ......+++++|||.+||++|
T Consensus       182 l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~-----~~~~~~s~~~~~li~~~L~~d  256 (288)
T d2jfla1         182 VMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL-----AQPSRWSSNFKDFLKKCLEKN  256 (288)
T ss_dssp             HTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC-----SSGGGSCHHHHHHHHHHSCSS
T ss_pred             HhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC-----CccccCCHHHHHHHHHHccCC
Confidence            42     22355677999999999988766666655443344444433322111     112357899999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCC
Q psy8260         373 SEKRITAEQALAHPYLSQ  390 (427)
Q Consensus       373 P~~R~ta~e~L~Hp~f~~  390 (427)
                      |++|||++|+|+||||+.
T Consensus       257 p~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         257 VDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             TTTSCCHHHHTTSGGGCC
T ss_pred             hhHCcCHHHHhcCcccCC
Confidence            999999999999999974

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-54  Score=402.91  Aligned_cols=255  Identities=22%  Similarity=0.326  Sum_probs=194.2

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      .+|++.+.||+|+||.||+ +.++.+|+.||||++..........+.+.+|+++|++++|||||++++++...    ...
T Consensus         4 edy~~~~~iG~G~fg~Vy~-~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~----~~~   78 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQK-IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR----TNT   78 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEE-EEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC--------
T ss_pred             hhCEEeEEEecCCCeEEEE-EEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC----CCC
Confidence            4688999999999999995 66788999999999987666666677788999999999999999999988542    124


Q ss_pred             eEEEEeccC-CCCHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhcC-----ceeccCCCCCeEEcCCCCEEEeeC
Q psy8260         144 NVYMVTHLM-GADLNNILRT-----QKLSDDHVQFLVYQILRGLKYIHSAG-----IIHRDLKPSNIAVNEDCELKILDF  212 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~yLH~~~-----iiHrDLKp~NILl~~~~~~kl~DF  212 (427)
                      .+|++|||+ +|+|.+++..     ..+++..+..++.||+.||+|||++|     ||||||||+|||++.++.+||+||
T Consensus        79 ~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DF  158 (269)
T d2java1          79 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF  158 (269)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCH
T ss_pred             EEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeec
Confidence            579999998 7899998742     56999999999999999999999976     999999999999999999999999


Q ss_pred             CCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccc
Q psy8260         213 GLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWY  292 (427)
Q Consensus       213 Gla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y  292 (427)
                      |+|+.......                                                          ...+.+||+.|
T Consensus       159 G~a~~~~~~~~----------------------------------------------------------~~~~~~gt~~Y  180 (269)
T d2java1         159 GLARILNHDTS----------------------------------------------------------FAKAFVGTPYY  180 (269)
T ss_dssp             HHHHHC---------------------------------------------------------------------CCCSC
T ss_pred             cceeecccCCC----------------------------------------------------------ccccCCCCccc
Confidence            99864322100                                                          11234678888


Q ss_pred             cchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         293 RAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       293 ~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                      ||||++.+..+..++|+||+|+++++|.++..||......+...+......       .......|+++++||.+||+.|
T Consensus       181 ~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~-------~~~~~~~s~~l~~li~~~L~~d  253 (269)
T d2java1         181 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF-------RRIPYRYSDELNEIITRMLNLK  253 (269)
T ss_dssp             CCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-------CCCCTTSCHHHHHHHHHHTCSS
T ss_pred             CCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-------CCCCcccCHHHHHHHHHHcCCC
Confidence            888888777777788999999999988655555543222222222222111       1122457899999999999999


Q ss_pred             CCCCCCHHHHhcCCCC
Q psy8260         373 SEKRITAEQALAHPYL  388 (427)
Q Consensus       373 P~~R~ta~e~L~Hp~f  388 (427)
                      |.+|||++|+|+|||+
T Consensus       254 p~~Rps~~ell~hp~i  269 (269)
T d2java1         254 DYHRPSVEEILENPLI  269 (269)
T ss_dssp             GGGSCCHHHHHTSTTC
T ss_pred             hhHCcCHHHHHhCCcC
Confidence            9999999999999996

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-52  Score=405.40  Aligned_cols=304  Identities=45%  Similarity=0.698  Sum_probs=221.4

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      .+|.+.+.||+|+||.||+ +.+..+|+.||||++.+.. .....+++.+|+++|++++|||||++++++..... ....
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~-~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~-~~~~   84 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCS-AYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI-EQMK   84 (345)
T ss_dssp             TTEEEEEECC---CCCEEE-EEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST-TTCC
T ss_pred             CCeEEEEEEeeccCeEEEE-EEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc-cccc
Confidence            4588999999999999996 5678899999999997533 44556678899999999999999999999865432 2334


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcc
Q psy8260         144 NVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMT  223 (427)
Q Consensus       144 ~~~lv~e~~g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~  223 (427)
                      .+|+++++++++|.+++..+++++..++.++.|++.||+|||++|||||||||+|||++.++.+||+|||+|+.......
T Consensus        85 ~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~  164 (345)
T d1pmea_          85 DVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD  164 (345)
T ss_dssp             CEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred             eEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence            67889999999999999988999999999999999999999999999999999999999999999999999975432110


Q ss_pred             cccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc-c
Q psy8260         224 GYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW-M  302 (427)
Q Consensus       224 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~-~  302 (427)
                      ..                                                       ......+||+.|+|||++... .
T Consensus       165 ~~-------------------------------------------------------~~~~~~~gt~~y~aPE~l~~~~~  189 (345)
T d1pmea_         165 HT-------------------------------------------------------GFLTEYVATRWYRAPEIMLNSKG  189 (345)
T ss_dssp             BC-------------------------------------------------------CTTCCCCSCGGGCCGGGTTTBCS
T ss_pred             cc-------------------------------------------------------eeeccccccceechHHHhhcCCC
Confidence            00                                                       011123466666666666433 3


Q ss_pred             CCCCCCHHHHHHHHHHhCCCCHHHHhhc-----------------------CcHHHHHHHhcCCCCCcccHHhhcCCCCh
Q psy8260         303 HYNQTDIHQLNLIMEMLGTPPAEFMAKI-----------------------SSDSARKYINSLPLLTKKDFRQVFKGANP  359 (427)
Q Consensus       303 ~~~~~d~~slg~i~~~lg~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  359 (427)
                      +..++|+||+|++++.|.++..+|....                       ............+......+...+..+|+
T Consensus       190 ~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  269 (345)
T d1pmea_         190 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADS  269 (345)
T ss_dssp             CSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCH
T ss_pred             CCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCH
Confidence            3445688888888877744433332111                       11111122223344445556777888999


Q ss_pred             hHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCCC-CCCCcccccCCCCHHHHHHHHhhhc
Q psy8260         360 QAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDPNDEPTS-PPYDQSFEDMDLPVDQWKGTYSLES  425 (427)
Q Consensus       360 ~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  425 (427)
                      +++|||.+||++||.+||||+|+|+||||++...|.+.+.. +++..+.+....+.++++..+..|.
T Consensus       270 ~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~e~  336 (345)
T d1pmea_         270 KALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEET  336 (345)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSSCC--------CCHHHHHHHHHHHS
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCccccCccCCChhhhhCCHHHHHHHHHHHH
Confidence            99999999999999999999999999999988887766553 4555566666778888877655543

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=399.86  Aligned_cols=259  Identities=26%  Similarity=0.409  Sum_probs=205.1

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC----HHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS----AVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      .+.|++++.||+|+||.||+ +.++.+|+.||||++.+....    ....+.+.+|+.+|++++|||||+++++|...  
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~-~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--   85 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKK-CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK--   85 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEE-EEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--
T ss_pred             ccCEEEeEEEecCCCeEEEE-EEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--
Confidence            35699999999999999995 567889999999998654321    12346678999999999999999999998764  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCC----CEEEeeC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC----ELKILDF  212 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~----~~kl~DF  212 (427)
                          ..+|++|||+ |++|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++    .+||+||
T Consensus        86 ----~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          86 ----TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             ----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             ----CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecch
Confidence                5689999998 7899998854 6799999999999999999999999999999999999998766    5999999


Q ss_pred             CCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccc
Q psy8260         213 GLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWY  292 (427)
Q Consensus       213 Gla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y  292 (427)
                      |+|+......                                                           ...+..||+.|
T Consensus       162 G~a~~~~~~~-----------------------------------------------------------~~~~~~~t~~y  182 (293)
T d1jksa_         162 GLAHKIDFGN-----------------------------------------------------------EFKNIFGTPEF  182 (293)
T ss_dssp             TTCEECTTSC-----------------------------------------------------------BCSCCCCCGGG
T ss_pred             hhhhhcCCCc-----------------------------------------------------------cccccCCCCcc
Confidence            9986432110                                                           11234577888


Q ss_pred             cchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         293 RAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       293 ~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                      +|||++.+..+..++|+||+|++++.|.++..||......+............    ....+...|++++|||++||+.|
T Consensus       183 ~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~s~~~~~li~~~L~~d  258 (293)
T d1jksa_         183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF----EDEYFSNTSALAKDFIRRLLVKD  258 (293)
T ss_dssp             CCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC----CHHHHTTSCHHHHHHHHTTSCSS
T ss_pred             cCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC----CchhcCCCCHHHHHHHHHHccCC
Confidence            88888887778888899999999998866666664432222222222222211    12345678999999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCC
Q psy8260         373 SEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       373 P~~R~ta~e~L~Hp~f~~~  391 (427)
                      |++|||++|+|+||||++.
T Consensus       259 P~~R~s~~eil~hp~~~~~  277 (293)
T d1jksa_         259 PKKRMTIQDSLQHPWIKPK  277 (293)
T ss_dssp             GGGSCCHHHHHHSTTTCC-
T ss_pred             hhHCcCHHHHhcCcccCCC
Confidence            9999999999999999864

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-52  Score=402.52  Aligned_cols=254  Identities=21%  Similarity=0.300  Sum_probs=195.7

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH-HHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA-VHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      ...|++.+.||+|+||.||+ +.+..+|+.||||++....... ...+.+.+|+++|++++|||||+++++|...     
T Consensus        14 ~~~y~~l~~lG~G~fg~Vy~-a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----   87 (309)
T d1u5ra_          14 EKLFSDLREIGHGSFGAVYF-ARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----   87 (309)
T ss_dssp             HHHEEEEEEEEECSSSEEEE-EEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----
T ss_pred             HHhcEeeEEEecCCCeEEEE-EEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC-----
Confidence            34588889999999999996 5677899999999987654433 3456688999999999999999999998754     


Q ss_pred             CceEEEEeccC-CCCHHHHH-hhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         142 FKNVYMVTHLM-GADLNNIL-RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l-~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                       ..+|++|||+ +++|..++ ..+.+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+...
T Consensus        88 -~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~  166 (309)
T d1u5ra_          88 -HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA  166 (309)
T ss_dssp             -TEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred             -CEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccC
Confidence             4689999998 55665544 34679999999999999999999999999999999999999999999999999997543


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      .. ...+                                                             ||+.|||||++.
T Consensus       167 ~~-~~~~-------------------------------------------------------------GT~~Y~APE~~~  184 (309)
T d1u5ra_         167 PA-NSFV-------------------------------------------------------------GTPYWMAPEVIL  184 (309)
T ss_dssp             SB-CCCC-------------------------------------------------------------SCGGGCCHHHHT
T ss_pred             CC-Cccc-------------------------------------------------------------cCccccCHHHHh
Confidence            22 2234                                                             455555555553


Q ss_pred             hc---cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhc-CCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCC
Q psy8260         300 NW---MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINS-LPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEK  375 (427)
Q Consensus       300 ~~---~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~  375 (427)
                      +.   .+..++|+||+|+++++|.++..||..........+.... .+...       ....+++++|||.+||++||.+
T Consensus       185 ~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~-------~~~~s~~~~~li~~~L~~dP~~  257 (309)
T d1u5ra_         185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ-------SGHWSEYFRNFVDSCLQKIPQD  257 (309)
T ss_dssp             TTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS-------CTTSCHHHHHHHHHHTCSSGGG
T ss_pred             ccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC-------CCCCCHHHHHHHHHHCcCChhH
Confidence            21   2556779999999999886665555443222222222222 11111       1346899999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCC
Q psy8260         376 RITAEQALAHPYLSQYS  392 (427)
Q Consensus       376 R~ta~e~L~Hp~f~~~~  392 (427)
                      |||++|+|+||||.+..
T Consensus       258 Rpt~~ell~Hp~~~~~~  274 (309)
T d1u5ra_         258 RPTSEVLLKHRFVLRER  274 (309)
T ss_dssp             SCCHHHHTTCHHHHSCC
T ss_pred             CcCHHHHHhCHHhcCCC
Confidence            99999999999997643

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.1e-52  Score=408.07  Aligned_cols=256  Identities=24%  Similarity=0.368  Sum_probs=204.6

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      +.|++.+.||+|+||.||+ +.+..+|+.||||++...  .......+.+|+.+|++++|||||+++++|...      .
T Consensus        29 d~Y~i~~~lG~G~fg~V~~-a~~~~~~~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~------~   99 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHR-CVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK------Y   99 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEE-EEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS------S
T ss_pred             cceEEEEEEecCCCeEEEE-EEECCCCCEEEEEEECCc--chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC------C
Confidence            4689999999999999996 567789999999998754  234456678999999999999999999998754      4


Q ss_pred             eEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEc--CCCCEEEeeCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN--EDCELKILDFGLARPT  218 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~--~~~~~kl~DFGla~~~  218 (427)
                      .+|++||++ |++|.+.+..  .++++..++.++.||+.||+|||++|||||||||+|||++  .++.+||+|||+|+..
T Consensus       100 ~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~  179 (352)
T d1koba_         100 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL  179 (352)
T ss_dssp             EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             EEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceec
Confidence            689999998 7899887643  3699999999999999999999999999999999999998  5789999999998754


Q ss_pred             CCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         219 ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       219 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                      ....                                                           ......||+.|+|||++
T Consensus       180 ~~~~-----------------------------------------------------------~~~~~~gt~~y~aPE~~  200 (352)
T d1koba_         180 NPDE-----------------------------------------------------------IVKVTTATAEFAAPEIV  200 (352)
T ss_dssp             CTTS-----------------------------------------------------------CEEEECSSGGGCCHHHH
T ss_pred             CCCC-----------------------------------------------------------ceeeccCcccccCHHHH
Confidence            3211                                                           11233577788888888


Q ss_pred             hhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC
Q psy8260         299 LNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT  378 (427)
Q Consensus       299 ~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t  378 (427)
                      .+..+..++|+||+|++++.|.++..||...................+.    ..+..++++++|||.+||++||.+|||
T Consensus       201 ~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~s~~~~~li~~~L~~dp~~R~s  276 (352)
T d1koba_         201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE----DAFSSVSPEAKDFIKNLLQKEPRKRLT  276 (352)
T ss_dssp             TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS----STTTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred             cCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----ccccCCCHHHHHHHHHHccCChhHCcC
Confidence            7777777889999999999886666666443222333333333222221    234568999999999999999999999


Q ss_pred             HHHHhcCCCCCCC
Q psy8260         379 AEQALAHPYLSQY  391 (427)
Q Consensus       379 a~e~L~Hp~f~~~  391 (427)
                      ++|+|+||||+..
T Consensus       277 ~~eil~Hp~~~~~  289 (352)
T d1koba_         277 VHDALEHPWLKGD  289 (352)
T ss_dssp             HHHHHTSTTTSSC
T ss_pred             HHHHhcCHhhCCC
Confidence            9999999999864

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-52  Score=400.83  Aligned_cols=280  Identities=32%  Similarity=0.505  Sum_probs=192.4

Q ss_pred             cccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHH---HHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEE
Q psy8260          70 PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAV---HAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVY  146 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~  146 (427)
                      +.||+|+||.||+ +.+..+|+.||||++........   ..+.+.+|+.+|++++|||||+++++|...      ..+|
T Consensus         4 ~~lG~G~fg~Vy~-~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~------~~~~   76 (299)
T d1ua2a_           4 DFLGEGQFATVYK-ARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK------SNIS   76 (299)
T ss_dssp             EEEEEETTEEEEE-EECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT------TCCE
T ss_pred             eEeccCcCeEEEE-EEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC------Ccee
Confidence            5799999999995 66788999999999865432221   124578999999999999999999998764      4579


Q ss_pred             EEeccCCCCHHHHHh--hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC---
Q psy8260         147 MVTHLMGADLNNILR--TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE---  221 (427)
Q Consensus       147 lv~e~~g~~L~~~l~--~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~---  221 (427)
                      ++||++.+.+...+.  ...+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....   
T Consensus        77 ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~  156 (299)
T d1ua2a_          77 LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA  156 (299)
T ss_dssp             EEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred             ehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence            999999665544443  346999999999999999999999999999999999999999999999999999765432   


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      ....+||++|+|||++.+...|+.+.      |+||.||++.+                 +.+|..              
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~------DiwSlGvil~e-----------------l~~g~~--------------  199 (299)
T d1ua2a_         157 YTHQVVTRWYRAPELLFGARMYGVGV------DMWAVGCILAE-----------------LLLRVP--------------  199 (299)
T ss_dssp             CCCSCCCCTTCCHHHHTTCSCCCHHH------HHHHHHHHHHH-----------------HHHSSC--------------
T ss_pred             ccceecChhhccHHHHccCCCCChhh------hhhhcchHHHH-----------------HHhCcC--------------
Confidence            23345666666666665433333222      55555554433                 111111              


Q ss_pred             cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHH
Q psy8260         302 MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQ  381 (427)
Q Consensus       302 ~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e  381 (427)
                      ++...++...+..|+..+|+++.+.+.......   ........+...+...+...+++++|||.+||++||++||||+|
T Consensus       200 pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e  276 (299)
T d1ua2a_         200 FLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP---DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQ  276 (299)
T ss_dssp             SSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST---TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred             CCCCCCHHHHHHHHHHhcCCCChhhccchhccc---hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            011122344444454445544433221111000   00011122334456677788999999999999999999999999


Q ss_pred             HhcCCCCCCCCCCCC
Q psy8260         382 ALAHPYLSQYSDPND  396 (427)
Q Consensus       382 ~L~Hp~f~~~~~~~~  396 (427)
                      +|+||||++.+.|..
T Consensus       277 ~L~Hp~f~~~p~p~~  291 (299)
T d1ua2a_         277 ALKMKYFSNRPGPTP  291 (299)
T ss_dssp             HHTSGGGTSSSCCCC
T ss_pred             HhCCHhhCCCCCCCC
Confidence            999999987655543

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.7e-52  Score=400.70  Aligned_cols=252  Identities=24%  Similarity=0.344  Sum_probs=202.5

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC-HHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS-AVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .+|++.+.||+|+||.||+ +.++.+|+.||||++.+.... ....+.+.+|+.+|+.++|||||+++++|...      
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~-a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~------   76 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHL-IRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA------   76 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEE-EEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS------
T ss_pred             hHeEEEEEEecCcCcEEEE-EEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC------
Confidence            4689999999999999995 567889999999998643211 11235677999999999999999999998754      


Q ss_pred             ceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      ..+|++||++ |++|..++.. ..+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus        77 ~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~  156 (316)
T d1fota_          77 QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  156 (316)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             CeeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc
Confidence            5689999998 6788887754 5689999999999999999999999999999999999999999999999999875433


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      ..+                                                             +.+||+.|||||++.+
T Consensus       157 ~~~-------------------------------------------------------------~~~Gt~~Y~APE~l~~  175 (316)
T d1fota_         157 VTY-------------------------------------------------------------TLCGTPDYIAPEVVST  175 (316)
T ss_dssp             CBC-------------------------------------------------------------CCCSCTTTCCHHHHTT
T ss_pred             ccc-------------------------------------------------------------cccCcccccCHHHHcC
Confidence            222                                                             2357777777777777


Q ss_pred             ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC---
Q psy8260         301 WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI---  377 (427)
Q Consensus       301 ~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~---  377 (427)
                      ..+..++|+||+|++++.|.++..||..........+........        ...++++++|||.+||++||.+|+   
T Consensus       176 ~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~--------p~~~s~~~~~li~~~L~~dp~~R~~~~  247 (316)
T d1fota_         176 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF--------PPFFNEDVKDLLSRLITRDLSQRLGNL  247 (316)
T ss_dssp             CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCC--------CTTSCHHHHHHHHHHTCSCTTTCTTSS
T ss_pred             CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC--------CCCCCHHHHHHHHHHhhhCHHhccccc
Confidence            777788899999999998877766665443223333333322221        235789999999999999999997   


Q ss_pred             --CHHHHhcCCCCCCC
Q psy8260         378 --TAEQALAHPYLSQY  391 (427)
Q Consensus       378 --ta~e~L~Hp~f~~~  391 (427)
                        |++|+|+||||++.
T Consensus       248 r~t~~~il~Hp~f~~i  263 (316)
T d1fota_         248 QNGTEDVKNHPWFKEV  263 (316)
T ss_dssp             TTTTHHHHTSGGGSSC
T ss_pred             hhhHHHHHcCcccccC
Confidence              99999999999875

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-52  Score=396.16  Aligned_cols=266  Identities=32%  Similarity=0.534  Sum_probs=199.4

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      .+|++.+.||+|+||.||. +.+..+|+.||||++...........++.+|+++|++++|||||+++++|...      .
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~-~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~------~   74 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYK-ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE------N   74 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEE-EEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET------T
T ss_pred             CCCEeccEEecCcCeEEEE-EEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccc------c
Confidence            3688899999999999995 66788999999999965443333356788999999999999999999999764      4


Q ss_pred             eEEEEeccCCCCHHHHHh---hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         144 NVYMVTHLMGADLNNILR---TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       144 ~~~lv~e~~g~~L~~~l~---~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      .+|++||++++.+...+.   ...+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus        75 ~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~  154 (298)
T d1gz8a_          75 KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV  154 (298)
T ss_dssp             EEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred             ceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccC
Confidence            689999999877666553   34699999999999999999999999999999999999999999999999998864321


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      ...                                                          ......||+.|+|||++..
T Consensus       155 ~~~----------------------------------------------------------~~~~~~gt~~y~apE~~~~  176 (298)
T d1gz8a_         155 PVR----------------------------------------------------------TYTHEVVTLWYRAPEILLG  176 (298)
T ss_dssp             CSB----------------------------------------------------------CTTCCBCCCTTCCHHHHTT
T ss_pred             Ccc----------------------------------------------------------cceeecccceeeehhhhcc
Confidence            110                                                          1122346666666666655


Q ss_pred             ccC-CCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHh---------------------cCCCCCcccHHhhcCCCC
Q psy8260         301 WMH-YNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYIN---------------------SLPLLTKKDFRQVFKGAN  358 (427)
Q Consensus       301 ~~~-~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~s  358 (427)
                      ..+ ..++|+||+|++++.|.++..||......+...+...                     ..+......+...+...|
T Consensus       177 ~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  256 (298)
T d1gz8a_         177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD  256 (298)
T ss_dssp             CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCC
T ss_pred             ccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCC
Confidence            544 3457999999998877555444432211111111110                     112223334555667889


Q ss_pred             hhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q psy8260         359 PQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDP  394 (427)
Q Consensus       359 ~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  394 (427)
                      ++++|||++||++||++|||++|+|+||||++...|
T Consensus       257 ~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         257 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence            999999999999999999999999999999987666

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-51  Score=402.49  Aligned_cols=252  Identities=25%  Similarity=0.340  Sum_probs=200.4

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      .+|++.+.||+|+||.||+ +.++.+|+.||||++.+... .....+.+.+|+++|+.++|||||+++++|...      
T Consensus        41 d~y~i~~~lG~G~fg~Vy~-a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~------  113 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVML-VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN------  113 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEE-EEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS------
T ss_pred             cCeEEEEEeecCcCcEEEE-EEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccc------
Confidence            5799999999999999996 66788999999999864321 112235678999999999999999999998754      


Q ss_pred             ceEEEEeccC-CCCHHHHHh-hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~-~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      ..+|++++++ |++|...+. .+.+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus       114 ~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             cccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence            4567888776 788887764 46899999999999999999999999999999999999999999999999999975433


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      ...                                                             +.+||+.|||||++.+
T Consensus       194 ~~~-------------------------------------------------------------~~~Gt~~Y~APE~~~~  212 (350)
T d1rdqe_         194 RTW-------------------------------------------------------------TLCGTPEALAPEIILS  212 (350)
T ss_dssp             CBC-------------------------------------------------------------CCEECGGGCCHHHHTT
T ss_pred             ccc-------------------------------------------------------------cccCccccCCHHHHcC
Confidence            222                                                             2356777777777777


Q ss_pred             ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCC---
Q psy8260         301 WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRI---  377 (427)
Q Consensus       301 ~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~---  377 (427)
                      ..+..++|+||+|++++.|.++..||..........+.....+..        ...+++++.|||++||++||.+|+   
T Consensus       213 ~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~--------p~~~s~~~~~li~~~L~~dP~kR~~~~  284 (350)
T d1rdqe_         213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--------PSHFSSDLKDLLRNLLQVDLTKRFGNL  284 (350)
T ss_dssp             CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------CTTCCHHHHHHHHHHSCSCTTTCTTSS
T ss_pred             CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCC--------CccCCHHHHHHHHHHhhhCHHhccccc
Confidence            777778899999999999876666664432222222232222221        245789999999999999999995   


Q ss_pred             --CHHHHhcCCCCCCC
Q psy8260         378 --TAEQALAHPYLSQY  391 (427)
Q Consensus       378 --ta~e~L~Hp~f~~~  391 (427)
                        |++|+|+||||+..
T Consensus       285 r~t~~ell~Hp~f~~~  300 (350)
T d1rdqe_         285 KNGVNDIKNHKWFATT  300 (350)
T ss_dssp             TTTTHHHHTSGGGTTC
T ss_pred             cccHHHHHcCccccCC
Confidence              99999999999864

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.2e-51  Score=386.95  Aligned_cols=262  Identities=25%  Similarity=0.344  Sum_probs=203.2

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH-------HHHHHHHHHHHHHhcCC-CCCceeeeeeeec
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA-------VHAKRTYRELRMLKHMN-HENVIGLLDVFHS  135 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~-------~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~  135 (427)
                      .+|++.+.||+|+||.||+ +.+..+|+.||||++.+.....       ...+++.+|+.+|++++ |||||+++++|..
T Consensus         3 ~~y~~~~~iG~G~~g~V~~-~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRR-CIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEE-EEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             ccCEEceEEecCcCeEEEE-EEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            4688999999999999996 5677899999999987543221       12345779999999997 9999999999975


Q ss_pred             CccccCCceEEEEeccC-CCCHHHHHh-hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCC
Q psy8260         136 NTCLADFKNVYMVTHLM-GADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG  213 (427)
Q Consensus       136 ~~~~~~~~~~~lv~e~~-g~~L~~~l~-~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFG  213 (427)
                      +      ..+|++|||+ |++|.++++ .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus        82 ~------~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          82 N------TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             S------SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             C------cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccch
Confidence            4      5789999999 789999885 4679999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCC--CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccc
Q psy8260         214 LARPTEN--EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRW  291 (427)
Q Consensus       214 la~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~  291 (427)
                      +|+....  ..+..+||+.|+|||++.+....                                                
T Consensus       156 ~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~------------------------------------------------  187 (277)
T d1phka_         156 FSCQLDPGEKLREVCGTPSYLAPEIIECSMND------------------------------------------------  187 (277)
T ss_dssp             TCEECCTTCCBCCCCSCGGGCCHHHHHHHHCT------------------------------------------------
T ss_pred             heeEccCCCceeeeeccCCCCCHHHhhccccc------------------------------------------------
Confidence            9975433  23334566666666665431000                                                


Q ss_pred             ccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCC
Q psy8260         292 YRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLEL  371 (427)
Q Consensus       292 Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~  371 (427)
                             ....+..++|+||+|++++.|.++..||.....................    ..+..+|++++|||.+||+.
T Consensus       188 -------~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~s~~~~~li~~~L~~  256 (277)
T d1phka_         188 -------NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS----PEWDDYSDTVKDLVSRFLVV  256 (277)
T ss_dssp             -------TSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----TTGGGSCHHHHHHHHHHCCS
T ss_pred             -------cCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCC----cccccCCHHHHHHHHHHccC
Confidence                   0012445679999999999987777777554333333333333322221    12346899999999999999


Q ss_pred             CCCCCCCHHHHhcCCCCCCC
Q psy8260         372 DSEKRITAEQALAHPYLSQY  391 (427)
Q Consensus       372 dP~~R~ta~e~L~Hp~f~~~  391 (427)
                      ||++|||++|+|+||||+++
T Consensus       257 ~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         257 QPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             SGGGSCCHHHHTTSGGGCTT
T ss_pred             ChhHCcCHHHHHcCHHHHHh
Confidence            99999999999999999874

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-51  Score=397.76  Aligned_cols=321  Identities=40%  Similarity=0.699  Sum_probs=225.9

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      .+|++.+.||+|+||.||+ +.+..+|+.||||++.+.........++.+|+.+|++++|||||+++++|......+...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~-~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCA-AYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             TTEEEEEECSCC--CEEEE-EEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             CCeEEEEEeecCcCeEEEE-EEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            4588999999999999996 568889999999999877666667778889999999999999999999998766656667


Q ss_pred             eEEEEeccCCCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC--C
Q psy8260         144 NVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN--E  221 (427)
Q Consensus       144 ~~~lv~e~~g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~--~  221 (427)
                      .+|++||++.+++.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+++....  .
T Consensus        96 ~~~iv~Ey~~~~l~~~~~-~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~  174 (355)
T d2b1pa1          96 DVYLVMELMDANLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM  174 (355)
T ss_dssp             EEEEEEECCSEEHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred             eeEEEEeccchHHHHhhh-cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccccc
Confidence            899999999888777664 5699999999999999999999999999999999999999999999999999875443  2


Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNW  301 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~  301 (427)
                      .+..++|+.|+|||++.+. .++..      .|+||.||++.+                 +..|.               
T Consensus       175 ~~~~~~t~~y~aPE~l~~~-~~~~~------~DiwSlG~~l~e-----------------ll~g~---------------  215 (355)
T d2b1pa1         175 MTPYVVTRYYRAPEVILGM-GYKEN------VDIWSVGCIMGE-----------------MVRHK---------------  215 (355)
T ss_dssp             ------CCTTCCHHHHTTC-CCCTT------HHHHHHHHHHHH-----------------HHHSS---------------
T ss_pred             cccccccccccChhhhcCC-CCCCC------cccccccchHHH-----------------HhhCC---------------
Confidence            3445667777777776552 23322      266666666544                 22221               


Q ss_pred             cCCC-CCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhc------------CCCChhHHHHHHHh
Q psy8260         302 MHYN-QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVF------------KGANPQAIDLLSLM  368 (427)
Q Consensus       302 ~~~~-~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~s~~~~dLi~~m  368 (427)
                      ..|. ..+..++..++..++.+..+++..... .........+......+...+            ...+++++|||++|
T Consensus       216 ~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~m  294 (355)
T d2b1pa1         216 ILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM  294 (355)
T ss_dssp             CSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH-HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh-hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHH
Confidence            1222 234455556666666666665554432 223333333333222222221            12467899999999


Q ss_pred             cCCCCCCCCCHHHHhcCCCCCCCCCCCCCCC--CCCCCcccccCCCCHHHHHHHHhhhcc
Q psy8260         369 LELDSEKRITAEQALAHPYLSQYSDPNDEPT--SPPYDQSFEDMDLPVDQWKGTYSLESL  426 (427)
Q Consensus       369 L~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  426 (427)
                      |++||++||||+|+|+||||+....|.....  +..++...++..++.++|+..+..|.+
T Consensus       295 L~~dP~~R~ta~elL~Hpw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (355)
T d2b1pa1         295 LVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVM  354 (355)
T ss_dssp             SCSSTTTSCCHHHHHTSTTTGGGCCHHHHTCCCC-------CCCCCCHHHHHHHHHHHHH
T ss_pred             CcCChhHCcCHHHHhcCcccCCCCCcccccCCCCCCCCcchhhhhcCHHHHHHHHHHHhc
Confidence            9999999999999999999998766544433  344566678889999999999887754

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-51  Score=395.97  Aligned_cols=255  Identities=23%  Similarity=0.365  Sum_probs=204.9

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      ++|.+.+.||+|+||.||+ +.+..+|+.||||++...   ......+.+|+++|+.++|||||+++++|...      .
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~-~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~------~   74 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHR-CVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESM------E   74 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEE-EEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEET------T
T ss_pred             cceEEEEEEecCCCeEEEE-EEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC------C
Confidence            5689999999999999995 678889999999999753   23344577999999999999999999998754      4


Q ss_pred             eEEEEeccC-CCCHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCC--CCEEEeeCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED--CELKILDFGLARPT  218 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~~--~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~--~~~kl~DFGla~~~  218 (427)
                      .+|++|||+ |++|.+++...  .+++.+++.++.||+.||+|||++||+||||||+|||++.+  ..+||+|||+++..
T Consensus        75 ~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~  154 (321)
T d1tkia_          75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence            689999998 67999988653  68999999999999999999999999999999999999854  58999999998643


Q ss_pred             CCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         219 ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       219 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                      ....                                                           ......||+.|+|||++
T Consensus       155 ~~~~-----------------------------------------------------------~~~~~~~t~~y~ape~~  175 (321)
T d1tkia_         155 KPGD-----------------------------------------------------------NFRLLFTAPEYYAPEVH  175 (321)
T ss_dssp             CTTC-----------------------------------------------------------EEEEEESCGGGSCHHHH
T ss_pred             ccCC-----------------------------------------------------------cccccccccccccchhc
Confidence            2210                                                           11223567778888887


Q ss_pred             hhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC
Q psy8260         299 LNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT  378 (427)
Q Consensus       299 ~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t  378 (427)
                      .+..+..++|+||+|++++.|.++..||..........+..+....++    ...++.+|++++|||.+||++||.+|||
T Consensus       176 ~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~s~~~~~li~~~L~~dp~~R~s  251 (321)
T d1tkia_         176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD----EEAFKEISIEAMDFVDRLLVKERKSRMT  251 (321)
T ss_dssp             TTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----HHHHTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred             cCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----hhhccCCCHHHHHHHHHHccCChhHCcC
Confidence            777777788999999999998777666654433333333333332222    2345678999999999999999999999


Q ss_pred             HHHHhcCCCCCCC
Q psy8260         379 AEQALAHPYLSQY  391 (427)
Q Consensus       379 a~e~L~Hp~f~~~  391 (427)
                      ++|+|+||||++.
T Consensus       252 ~~eil~hp~~~~~  264 (321)
T d1tkia_         252 ASEALQHPWLKQK  264 (321)
T ss_dssp             HHHHHHSHHHHSC
T ss_pred             HHHHhcCHhhccC
Confidence            9999999999753

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.3e-50  Score=397.07  Aligned_cols=256  Identities=20%  Similarity=0.299  Sum_probs=196.4

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC----CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ----SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~----~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~  139 (427)
                      ++|++.+.||+|+||.||+ +.+..+|+.||||++.+...    ......+..+|+++++.++|||||+++++|...   
T Consensus         4 ddy~i~~~lG~G~fg~Vy~-~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~---   79 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYG-CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP---   79 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEE-EEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS---
T ss_pred             HhCeeeeEEecCCCeEEEE-EEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC---
Confidence            5689999999999999995 66788999999999864321    122223334567888899999999999998764   


Q ss_pred             cCCceEEEEeccC-CCCHHHHHh-hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCC
Q psy8260         140 ADFKNVYMVTHLM-GADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARP  217 (427)
Q Consensus       140 ~~~~~~~lv~e~~-g~~L~~~l~-~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~  217 (427)
                         ..+|++|||+ |++|.+++. ...+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.
T Consensus        80 ---~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~  156 (364)
T d1omwa3          80 ---DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD  156 (364)
T ss_dssp             ---SEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred             ---CEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeee
Confidence               4689999998 789998875 46799999999999999999999999999999999999999999999999999874


Q ss_pred             CCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         218 TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       218 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      .....                                                            ....+||+.|+|||+
T Consensus       157 ~~~~~------------------------------------------------------------~~~~~GT~~y~APE~  176 (364)
T d1omwa3         157 FSKKK------------------------------------------------------------PHASVGTHGYMAPEV  176 (364)
T ss_dssp             CSSSC------------------------------------------------------------CCSCCSCGGGCCHHH
T ss_pred             cCCCc------------------------------------------------------------ccccccccccchhHH
Confidence            33211                                                            112346777777777


Q ss_pred             hhh-ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCC
Q psy8260         298 MLN-WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKR  376 (427)
Q Consensus       298 l~~-~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R  376 (427)
                      +.. ..+..++|+||+|+++++|.++..||.......... .........    ...+..++++++|||.+||++||++|
T Consensus       177 ~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~~~~----~~~~~~~s~~~~~li~~~L~~dP~~R  251 (364)
T d1omwa3         177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMA----VELPDSFSPELRSLLEGLLQRDVNRR  251 (364)
T ss_dssp             HSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSSSCC----CCCCSSSCHHHHHHHHHHTCSSTTTS
T ss_pred             hhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcccCC----CCCCCCCCHHHHHHHHHHcccCHHHh
Confidence            653 346667899999999999866666665433222111 111111110    11234679999999999999999999


Q ss_pred             CC-----HHHHhcCCCCCCC
Q psy8260         377 IT-----AEQALAHPYLSQY  391 (427)
Q Consensus       377 ~t-----a~e~L~Hp~f~~~  391 (427)
                      +|     |+|+++||||++.
T Consensus       252 ~t~~~~~a~eil~Hp~f~~i  271 (364)
T d1omwa3         252 LGCLGRGAQEVKESPFFRSL  271 (364)
T ss_dssp             TTTSSSTHHHHHTSGGGTTC
T ss_pred             CCCcccCHHHHHcCccccCC
Confidence            99     8999999999865

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-51  Score=391.10  Aligned_cols=269  Identities=27%  Similarity=0.437  Sum_probs=192.7

Q ss_pred             cceeeccccCcccccEEEEeEEeCc-CCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC---CCCCceeeeeeeecCccc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSV-SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM---NHENVIGLLDVFHSNTCL  139 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l---~HpnIv~l~~~~~~~~~~  139 (427)
                      .+|++.+.||+|+||.||++ .+.. +++.||||++..............+|+.+|+.+   +|||||+++++|.... .
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a-~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~-~   84 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKA-RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR-T   84 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEE-EETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE-C
T ss_pred             CCEEEEEEEecccCeEEEEE-EEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc-c
Confidence            57899999999999999964 5544 467899999865433322223455677766654   8999999999986421 1


Q ss_pred             cCCceEEEEeccCCCCHHHHH---hhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         140 ADFKNVYMVTHLMGADLNNIL---RTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       140 ~~~~~~~lv~e~~g~~L~~~l---~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                      .....+|+++|++.+.+..+.   ....+++..++.++.|++.||+|||++|||||||||+|||++.++.+||+|||+++
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~  164 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  164 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence            223568899999966544433   23569999999999999999999999999999999999999999999999999986


Q ss_pred             CCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         217 PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       217 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      ......                                                           .....+||+.|||||
T Consensus       165 ~~~~~~-----------------------------------------------------------~~~~~~gT~~Y~APE  185 (305)
T d1blxa_         165 IYSFQM-----------------------------------------------------------ALTSVVVTLWYRAPE  185 (305)
T ss_dssp             CCCGGG-----------------------------------------------------------GGCCCCCCCTTCCHH
T ss_pred             hhcccc-----------------------------------------------------------cCCCcccChhhcCcc
Confidence            432210                                                           112335677777777


Q ss_pred             HhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhc-------------------CCCCCcccHHhhcCCC
Q psy8260         297 IMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINS-------------------LPLLTKKDFRQVFKGA  357 (427)
Q Consensus       297 vl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~  357 (427)
                      ++.+..+..++|+||+|+++++|.++..||......+........                   ................
T Consensus       186 ~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (305)
T d1blxa_         186 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDI  265 (305)
T ss_dssp             HHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSC
T ss_pred             hhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccC
Confidence            776666777778888888887775554444322111111111110                   0111122233455678


Q ss_pred             ChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q psy8260         358 NPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSD  393 (427)
Q Consensus       358 s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  393 (427)
                      +++++|||.+||++||++||||+|+|+||||+++..
T Consensus       266 s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~  301 (305)
T d1blxa_         266 DELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  301 (305)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             CHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence            999999999999999999999999999999987643

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-51  Score=396.19  Aligned_cols=259  Identities=20%  Similarity=0.294  Sum_probs=194.3

Q ss_pred             cceeec-cccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhc-CCCCCceeeeeeeecCccccC
Q psy8260          64 GVIDIG-PTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKH-MNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        64 ~~~~~~-~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~-l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      +.|.+. +.||+|+||.||+ |.+..+|+.||||++...       ....+|+.++.+ .+|||||+++++|...  ...
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~-a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~--~~~   80 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQ-IFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENL--YAG   80 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEE-EEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE--ETT
T ss_pred             cCEEEeeEEeeeccCeEEEE-EEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeec--ccC
Confidence            467765 5699999999996 567789999999998642       346689988654 5899999999998642  122


Q ss_pred             CceEEEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcC---CCCEEEeeCCC
Q psy8260         142 FKNVYMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE---DCELKILDFGL  214 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~---~~~~kl~DFGl  214 (427)
                      ...+|++|||+ ||+|.+++..   ..+++.+++.++.||+.||+|||++||+||||||+|||++.   ++.+||+|||+
T Consensus        81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             CCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccce
Confidence            35689999999 6899999865   35999999999999999999999999999999999999985   46799999999


Q ss_pred             CCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccc
Q psy8260         215 ARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRA  294 (427)
Q Consensus       215 a~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~A  294 (427)
                      |+......                                                           .....+||+.|||
T Consensus       161 a~~~~~~~-----------------------------------------------------------~~~~~~gt~~y~a  181 (335)
T d2ozaa1         161 AKETTSHN-----------------------------------------------------------SLTTPCYTPYYVA  181 (335)
T ss_dssp             CEECCCCC-----------------------------------------------------------CCCCCSCCCSSCC
T ss_pred             eeeccCCC-----------------------------------------------------------ccccccCCcccCC
Confidence            87533211                                                           1112346777777


Q ss_pred             hHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCC
Q psy8260         295 PEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       295 PEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~  374 (427)
                      ||++.+..+..++|+||+|++++.|.++..||...........................+..+|++++|||++||++||+
T Consensus       182 PE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~  261 (335)
T d2ozaa1         182 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT  261 (335)
T ss_dssp             CCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTT
T ss_pred             cHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChh
Confidence            77776666777889999999999998888777554332222211111111110001112335799999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCC
Q psy8260         375 KRITAEQALAHPYLSQY  391 (427)
Q Consensus       375 ~R~ta~e~L~Hp~f~~~  391 (427)
                      +|||++|+|+||||.+.
T Consensus       262 ~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         262 QRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             TSCCHHHHHHSHHHHTT
T ss_pred             HCcCHHHHHcCHHhhCC
Confidence            99999999999999653

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-50  Score=391.22  Aligned_cols=255  Identities=24%  Similarity=0.336  Sum_probs=202.2

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHh-cCCCCCceeeeeeeecCccccC
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLK-HMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~-~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      .+|++.+.||+|+||.||+ +.+..+|+.||||++.+... .....+.+.+|+.++. .++|||||+++++|...     
T Consensus         2 ddy~i~~~iG~G~fg~Vy~-~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~-----   75 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFL-AEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK-----   75 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEE-EEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-----
T ss_pred             CCeEEeeEEecCCCcEEEE-EEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC-----
Confidence            3588999999999999996 56778999999999864321 1112345667777665 68999999999998764     


Q ss_pred             CceEEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         142 FKNVYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                       ..+|++|||+ +|+|.++++. ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+...
T Consensus        76 -~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~  154 (320)
T d1xjda_          76 -ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  154 (320)
T ss_dssp             -SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             -CceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcc
Confidence             4689999998 7899998854 679999999999999999999999999999999999999999999999999987432


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      ....                                                          .....+||+.|+|||++.
T Consensus       155 ~~~~----------------------------------------------------------~~~~~~gt~~y~aPE~~~  176 (320)
T d1xjda_         155 LGDA----------------------------------------------------------KTNTFCGTPDYIAPEILL  176 (320)
T ss_dssp             CTTC----------------------------------------------------------CBCCCCSCGGGCCHHHHT
T ss_pred             cccc----------------------------------------------------------cccccCCCCCcCCHHHHc
Confidence            2100                                                          112346888888999888


Q ss_pred             hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH
Q psy8260         300 NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA  379 (427)
Q Consensus       300 ~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta  379 (427)
                      +..+..++|+||+|++++.|.++..||..........+.....+..        .+.++++++|||++||++||++|||+
T Consensus       177 ~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~--------p~~~s~~~~dli~~~L~~dP~~R~s~  248 (320)
T d1xjda_         177 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY--------PRWLEKEAKDLLVKLFVREPEKRLGV  248 (320)
T ss_dssp             TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------CTTSCHHHHHHHHHHSCSSGGGSBTT
T ss_pred             CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--------CccCCHHHHHHHHHhcccCCCCCcCH
Confidence            8888888899999999998877666665433222233333333322        23578999999999999999999999


Q ss_pred             H-HHhcCCCCCCC
Q psy8260         380 E-QALAHPYLSQY  391 (427)
Q Consensus       380 ~-e~L~Hp~f~~~  391 (427)
                      + |+++||||++.
T Consensus       249 ~~~l~~hpff~~~  261 (320)
T d1xjda_         249 RGDIRQHPLFREI  261 (320)
T ss_dssp             BSCGGGSGGGTTC
T ss_pred             HHHHHhCchhccC
Confidence            6 89999999875

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=388.97  Aligned_cols=284  Identities=29%  Similarity=0.458  Sum_probs=198.6

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCce
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      .|...+.||+|+||.||+ +.+..+|+.||||++.+....      ..+|+++|++++|||||+++++|.......+..+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~-a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~   93 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQ-AKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY   93 (350)
T ss_dssp             EEEEEEEEEEETTEEEEE-EEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred             CcEeeeEEeeCcCeEEEE-EEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence            578889999999999995 567789999999999754321      2379999999999999999999875444344567


Q ss_pred             EEEEeccCCCCHHHHHh-----hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCC-CEEEeeCCCCCCC
Q psy8260         145 VYMVTHLMGADLNNILR-----TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC-ELKILDFGLARPT  218 (427)
Q Consensus       145 ~~lv~e~~g~~L~~~l~-----~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~-~~kl~DFGla~~~  218 (427)
                      +|++|||+++++...+.     ...+++..++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus        94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            89999999876655442     34699999999999999999999999999999999999999765 8999999999754


Q ss_pred             CC--CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         219 EN--EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       219 ~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      ..  ...+.+||+.|+|||++.+...|+...      |+||.||++.+                 +.+|.          
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~------DIwSlG~il~e-----------------l~~g~----------  220 (350)
T d1q5ka_         174 VRGEPNVSYICSRYYRAPELIFGATDYTSSI------DVWSAGCVLAE-----------------LLLGQ----------  220 (350)
T ss_dssp             CTTSCCCSCCSCTTSCCHHHHTTCSSCCTHH------HHHHHHHHHHH-----------------HHHTS----------
T ss_pred             cCCcccccccccccccChHHhhcccCCCcce------eecccceEEEe-----------------hhhCC----------
Confidence            32  234456677777777665543333322      55555555443                 11111          


Q ss_pred             HhhhccCCC-CCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHh-hcCCCChhHHHHHHHhcCCCCC
Q psy8260         297 IMLNWMHYN-QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQ-VFKGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       297 vl~~~~~~~-~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dLi~~mL~~dP~  374 (427)
                           .++. ..+..++..++..+|++..+.+........   ....+......+.. .....+++++|||.+||++||+
T Consensus       221 -----~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~  292 (350)
T d1q5ka_         221 -----PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT---EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT  292 (350)
T ss_dssp             -----CSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC------CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGG
T ss_pred             -----CCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchh---hccccccccCchhhhcccCCCHHHHHHHHHHccCChh
Confidence                 1221 223444555555555555544332211100   00111112222222 2345789999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCCCC
Q psy8260         375 KRITAEQALAHPYLSQYSDPND  396 (427)
Q Consensus       375 ~R~ta~e~L~Hp~f~~~~~~~~  396 (427)
                      +|+||+|+|+||||++...|..
T Consensus       293 ~R~ta~e~L~Hp~f~~~~~~~~  314 (350)
T d1q5ka_         293 ARLTPLEACAHSFFDELRDPNV  314 (350)
T ss_dssp             GSCCHHHHHTSGGGGGGGCTTC
T ss_pred             HCcCHHHHhcCHhhccccCCCC
Confidence            9999999999999998766543

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-50  Score=382.63  Aligned_cols=251  Identities=23%  Similarity=0.374  Sum_probs=193.1

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCH----HHHHHHHHHHHHHhcCC--CCCceeeeeeeecC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSA----VHAKRTYRELRMLKHMN--HENVIGLLDVFHSN  136 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~----~~~~~~~~Ei~~l~~l~--HpnIv~l~~~~~~~  136 (427)
                      .++|.+++.||+|+||.||+ +.+..+|+.||||++.+.....    ....++.+|+.+|++++  |||||+++++|...
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~-a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~   81 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYS-GIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP   81 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEE-EEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             CCeEEEeEEEeeCCCeEEEE-EEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence            36799999999999999995 5678899999999986532211    11233568999999986  89999999998754


Q ss_pred             ccccCCceEEEEeccC-C-CCHHHHHh-hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcC-CCCEEEeeC
Q psy8260         137 TCLADFKNVYMVTHLM-G-ADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE-DCELKILDF  212 (427)
Q Consensus       137 ~~~~~~~~~~lv~e~~-g-~~L~~~l~-~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~-~~~~kl~DF  212 (427)
                            ..+|++|+++ + +++.+++. ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+||
T Consensus        82 ------~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DF  155 (273)
T d1xwsa_          82 ------DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF  155 (273)
T ss_dssp             ------SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             ------CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcc
Confidence                  4678888887 3 57777664 567999999999999999999999999999999999999985 479999999


Q ss_pred             CCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccc
Q psy8260         213 GLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWY  292 (427)
Q Consensus       213 Gla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y  292 (427)
                      |+|+.....                                                            ...+..||+.|
T Consensus       156 G~a~~~~~~------------------------------------------------------------~~~~~~GT~~y  175 (273)
T d1xwsa_         156 GSGALLKDT------------------------------------------------------------VYTDFDGTRVY  175 (273)
T ss_dssp             TTCEECCSS------------------------------------------------------------CBCCCCSCGGG
T ss_pred             ccceecccc------------------------------------------------------------cccccccCCCc
Confidence            998643221                                                            11233567777


Q ss_pred             cchHHhhhccCCC-CCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCC
Q psy8260         293 RAPEIMLNWMHYN-QTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLEL  371 (427)
Q Consensus       293 ~APEvl~~~~~~~-~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~  371 (427)
                      +|||++.+..+.. ++|+||+|++++.|.++..||...      ..........        ...+|++++|||.+||++
T Consensus       176 ~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~--------~~~~s~~~~~li~~~L~~  241 (273)
T d1xwsa_         176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFF--------RQRVSSECQHLIRWCLAL  241 (273)
T ss_dssp             SCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCC--------SSCCCHHHHHHHHHHTCS
T ss_pred             CCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCC--------CCCCCHHHHHHHHHHccC
Confidence            7777776655543 469999999998886665555321      1122222111        235789999999999999


Q ss_pred             CCCCCCCHHHHhcCCCCCCCCCC
Q psy8260         372 DSEKRITAEQALAHPYLSQYSDP  394 (427)
Q Consensus       372 dP~~R~ta~e~L~Hp~f~~~~~~  394 (427)
                      ||++|||++|+|+||||++...|
T Consensus       242 dp~~R~s~~eil~hp~~~~~~~p  264 (273)
T d1xwsa_         242 RPSDRPTFEEIQNHPWMQDVLLP  264 (273)
T ss_dssp             SGGGSCCHHHHHTSGGGSSCCCH
T ss_pred             CHhHCcCHHHHhcCHhhCCCCCC
Confidence            99999999999999999876443

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=374.83  Aligned_cols=258  Identities=23%  Similarity=0.285  Sum_probs=194.8

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      ||+..+.|.+++.||+|+||.||++..    +..||||++..........+.+.+|+.+|++++|||||+++++...   
T Consensus         3 wei~~~~~~~~~~lG~G~fg~Vy~~~~----~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~---   75 (276)
T d1uwha_           3 WEIPDGQITVGQRIGSGSFGTVYKGKW----HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---   75 (276)
T ss_dssp             CBCCTTCCCCCSEEEECSSCEEEEEES----SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred             cccccccEEEEEEEeeCCCcEEEEEEE----CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec---
Confidence            578888999999999999999998743    2369999997665555667788899999999999999999987543   


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                          ..++++|||+ +|+|.+++..  ..+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|
T Consensus        76 ----~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla  151 (276)
T d1uwha_          76 ----PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA  151 (276)
T ss_dssp             ----SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCS
T ss_pred             ----cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccce
Confidence                3468999988 6899998854  45999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      +........                                                        ....+..||+.||||
T Consensus       152 ~~~~~~~~~--------------------------------------------------------~~~~~~~gt~~y~AP  175 (276)
T d1uwha_         152 TVKSRWSGS--------------------------------------------------------HQFEQLSGSILWMAP  175 (276)
T ss_dssp             CC--------------------------------------------------------------------CCCCGGGCCH
T ss_pred             eeccccCCc--------------------------------------------------------ccccccccCcccCCH
Confidence            754321100                                                        011233567777777


Q ss_pred             HHhhhc---cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         296 EIMLNW---MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       296 Evl~~~---~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                      |++.+.   .+..++|+||+|+++++|.++..||..................  ...........++++.+||.+||+.|
T Consensus       176 E~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~--~p~~~~~~~~~~~~l~~li~~cl~~d  253 (276)
T d1uwha_         176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL--SPDLSKVRSNCPKAMKRLMAECLKKK  253 (276)
T ss_dssp             HHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSC--CCCGGGSCTTCCHHHHHHHHHHTCSS
T ss_pred             HHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC--CCcchhccccchHHHHHHHHHHcCCC
Confidence            776543   2445679999999999886666566443222222222222111  11223344567889999999999999


Q ss_pred             CCCCCCHHHHhcC
Q psy8260         373 SEKRITAEQALAH  385 (427)
Q Consensus       373 P~~R~ta~e~L~H  385 (427)
                      |++|||++|+++|
T Consensus       254 p~~RPt~~~il~~  266 (276)
T d1uwha_         254 RDERPLFPQILAS  266 (276)
T ss_dssp             GGGSCCHHHHHHH
T ss_pred             HhHCcCHHHHHHH
Confidence            9999999999987

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.2e-49  Score=374.40  Aligned_cols=253  Identities=19%  Similarity=0.280  Sum_probs=199.0

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      ||+....|.+.+.||+|+||.||++ .+..+|+.||||++......   .+++.+|+++|++++|||||++++++...  
T Consensus        12 wei~~~~~~~~~~iG~G~fg~Vy~a-~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~--   85 (287)
T d1opja_          12 WEMERTDITMKHKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTRE--   85 (287)
T ss_dssp             TBCCGGGEEEEEETTTTTTSSEEEE-EEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred             cEecHHHeEEeeEEeeCCCeEEEEE-EECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEeeC--
Confidence            5788889999999999999999964 56678999999998754332   35688999999999999999999998654  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL  214 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGl  214 (427)
                          ..+|++|||+ +|+|..++..   ..+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+
T Consensus        86 ----~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~  161 (287)
T d1opja_          86 ----PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL  161 (287)
T ss_dssp             ----SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCC
T ss_pred             ----CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccc
Confidence                4578999988 6899988854   4689999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccc
Q psy8260         215 ARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRA  294 (427)
Q Consensus       215 a~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~A  294 (427)
                      |+........                                                         ...+..||+.|+|
T Consensus       162 a~~~~~~~~~---------------------------------------------------------~~~~~~g~~~y~a  184 (287)
T d1opja_         162 SRLMTGDTYT---------------------------------------------------------AHAGAKFPIKWTA  184 (287)
T ss_dssp             TTTCCSSSSE---------------------------------------------------------EETTEEECGGGCC
T ss_pred             eeecCCCCce---------------------------------------------------------eeccccccccccC
Confidence            9754332110                                                         1123457888999


Q ss_pred             hHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCC
Q psy8260         295 PEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       295 PEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~  374 (427)
                      ||++.+..+..++|+||+|+++++|.+...++...................      ......++++++||.+||+.||+
T Consensus       185 PE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~------~~~~~~~~~l~~li~~cl~~dP~  258 (287)
T d1opja_         185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM------ERPEGCPEKVYELMRACWQWNPS  258 (287)
T ss_dssp             HHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC------CCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             hHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCC------CCCccchHHHHHHHHHHcCCCHh
Confidence            998888888888899999999987754322233332222222222221111      12245789999999999999999


Q ss_pred             CCCCHHHHhc
Q psy8260         375 KRITAEQALA  384 (427)
Q Consensus       375 ~R~ta~e~L~  384 (427)
                      +|||++|+++
T Consensus       259 ~Rps~~ei~~  268 (287)
T d1opja_         259 DRPSFAEIHQ  268 (287)
T ss_dssp             GSCCHHHHHH
T ss_pred             HCcCHHHHHH
Confidence            9999999976

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-49  Score=382.24  Aligned_cols=274  Identities=27%  Similarity=0.401  Sum_probs=186.9

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc--ccC
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC--LAD  141 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~--~~~  141 (427)
                      ++|++.+.||+|+||.||. |.+..+|+.||||++...........++.+|+++|++++||||+++++++.....  ...
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~-a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFK-ARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEE-EEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             CCEEEEEEEecCcCeEEEE-EEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            7899999999999999995 5677899999999987654444445667899999999999999999999865321  112


Q ss_pred             CceEEEEeccCCCCHHHHHh--hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         142 FKNVYMVTHLMGADLNNILR--TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       142 ~~~~~lv~e~~g~~L~~~l~--~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                      ...+|++++++++.+.....  ...+++..++.+++||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~  168 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS  168 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence            34689999999776665543  3569999999999999999999999999999999999999999999999999997543


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      .......                                                      ....+.+||++|+|||++.
T Consensus       169 ~~~~~~~------------------------------------------------------~~~~~~~gT~~Y~aPE~~~  194 (318)
T d3blha1         169 LAKNSQP------------------------------------------------------NRYTNRVVTLWYRPPELLL  194 (318)
T ss_dssp             C-----C------------------------------------------------------CCCCSCCSCGGGCCHHHHT
T ss_pred             ccccccc------------------------------------------------------ccccceecCHHHhhHHHHc
Confidence            2110000                                                      0111234566666666655


Q ss_pred             hc-cCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHh---c-------------------CCCCCcccHHhhc--
Q psy8260         300 NW-MHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYIN---S-------------------LPLLTKKDFRQVF--  354 (427)
Q Consensus       300 ~~-~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~---~-------------------~~~~~~~~~~~~~--  354 (427)
                      +. .+..++|+||+|+++++|.++..+|..............   .                   ............+  
T Consensus       195 ~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (318)
T d3blha1         195 GERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKA  274 (318)
T ss_dssp             TCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHH
T ss_pred             CCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhcc
Confidence            43 344556777777777666444333322111111111000   0                   0000111111111  


Q ss_pred             CCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q psy8260         355 KGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYS  392 (427)
Q Consensus       355 ~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~  392 (427)
                      ...+++++|||.+||++||++|+||+|+|+||||+..+
T Consensus       275 ~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p  312 (318)
T d3blha1         275 YVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP  312 (318)
T ss_dssp             HHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSS
T ss_pred             ccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCC
Confidence            12478999999999999999999999999999998643

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-48  Score=370.19  Aligned_cols=265  Identities=26%  Similarity=0.442  Sum_probs=198.3

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCce
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      +|++.+.||+|+||.||+ +.+..+|+.||||+++..........++.+|+.+|+.++|||||+++++|...      ..
T Consensus         3 ry~~i~~LG~G~fg~V~~-~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~------~~   75 (292)
T d1unla_           3 KYEKLEKIGEGTYGTVFK-AKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD------KK   75 (292)
T ss_dssp             SEEEEEEEEECSSSEEEE-EEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS------SE
T ss_pred             CCEeeeEEecCcCeEEEE-EEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccc------cc
Confidence            588899999999999996 56778999999999976655555667788999999999999999999998764      45


Q ss_pred             EEEEeccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCc
Q psy8260         145 VYMVTHLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEM  222 (427)
Q Consensus       145 ~~lv~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~  222 (427)
                      .+++++++ ++++..++.. +.+++..++.++.|++.||+|||++|||||||||+|||++.++.+||+|||.|+......
T Consensus        76 ~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          76 LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             EEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             eeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            67888777 5566666554 579999999999999999999999999999999999999999999999999987543221


Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhcc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWM  302 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~  302 (427)
                      .                                                          ......+++.|+|||++.+..
T Consensus       156 ~----------------------------------------------------------~~~~~~~~~~~~~pe~~~~~~  177 (292)
T d1unla_         156 R----------------------------------------------------------CYSAEVVTLWYRPPDVLFGAK  177 (292)
T ss_dssp             S----------------------------------------------------------CCCSCCSCGGGCCHHHHTTCS
T ss_pred             c----------------------------------------------------------cceeeccccchhhhhHhccCC
Confidence            1                                                          011123456667777665544


Q ss_pred             -CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcH-HHHHHHhc--CCC-------------------CCcccHHhhcCCCCh
Q psy8260         303 -HYNQTDIHQLNLIMEMLGTPPAEFMAKISSD-SARKYINS--LPL-------------------LTKKDFRQVFKGANP  359 (427)
Q Consensus       303 -~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~-~~~~~~~~--~~~-------------------~~~~~~~~~~~~~s~  359 (427)
                       +..++|+||+|++++.|.++..||....... ...+....  .+.                   .............++
T Consensus       178 ~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  257 (292)
T d1unla_         178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNA  257 (292)
T ss_dssp             CCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCH
T ss_pred             CCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCH
Confidence             3456799999999988866555443221111 11111110  000                   001112233456789


Q ss_pred             hHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q psy8260         360 QAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDP  394 (427)
Q Consensus       360 ~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  394 (427)
                      +++|||.+||++||.+||||+|+|+||||+++..|
T Consensus       258 ~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~~  292 (292)
T d1unla_         258 TGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP  292 (292)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSCC
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcChhhcCCCCC
Confidence            99999999999999999999999999999987654

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.3e-49  Score=377.99  Aligned_cols=258  Identities=30%  Similarity=0.491  Sum_probs=188.8

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      .+|++.+.||+|+||.||++ .+ .+|+.||||++..........+++.+|+.+|++++|||||+++++|...      .
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~-~~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~------~   73 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKA-QN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK------K   73 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEE-EE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS------S
T ss_pred             CCceeccEEecCCCcEEEEE-Ee-CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC------C
Confidence            36788899999999999975 44 4789999999976543333356788999999999999999999998764      4


Q ss_pred             eEEEEeccCCCCHHHHH-h-hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCC
Q psy8260         144 NVYMVTHLMGADLNNIL-R-TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENE  221 (427)
Q Consensus       144 ~~~lv~e~~g~~L~~~l-~-~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~  221 (427)
                      ..|++++++++.+...+ . .+.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|......
T Consensus        74 ~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~  153 (286)
T d1ob3a_          74 RLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (286)
T ss_dssp             CEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             ceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence            57899999876555444 3 356999999999999999999999999999999999999999999999999988643221


Q ss_pred             ---cccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         222 ---MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       222 ---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                         .....                                                             ||+.|+|||++
T Consensus       154 ~~~~~~~~-------------------------------------------------------------~~~~y~~pE~~  172 (286)
T d1ob3a_         154 VRKYTHEI-------------------------------------------------------------VTLWYRAPDVL  172 (286)
T ss_dssp             ---------------------------------------------------------------------CCCTTCCHHHH
T ss_pred             ccccceec-------------------------------------------------------------ccchhhhHHHH
Confidence               12223                                                             45555555555


Q ss_pred             hhcc-CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHh---------------------cCCCCCcccHHhhcCC
Q psy8260         299 LNWM-HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYIN---------------------SLPLLTKKDFRQVFKG  356 (427)
Q Consensus       299 ~~~~-~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~  356 (427)
                      .+.. +..++|+||+|++++.|.++..||......+...+...                     .........+....+.
T Consensus       173 ~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (286)
T d1ob3a_         173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKG  252 (286)
T ss_dssp             TTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCS
T ss_pred             hCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhccc
Confidence            4433 34456888888877766544444432111111111110                     0111122234455677


Q ss_pred             CChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q psy8260         357 ANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQ  390 (427)
Q Consensus       357 ~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~  390 (427)
                      .+++++|||++||++||++|+||+|+|+||||++
T Consensus       253 ~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         253 LDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            8999999999999999999999999999999974

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-49  Score=370.44  Aligned_cols=256  Identities=21%  Similarity=0.291  Sum_probs=196.5

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      +++....|.+.+.||+|+||.||++..  .+++.||||++......   .+.+.+|+++|++++|||||++++++..   
T Consensus         8 wei~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~---   79 (272)
T d1qpca_           8 WEVPRETLKLVERLGAGQFGEVWMGYY--NGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ---   79 (272)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEE--TTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             eecCHHHeEEeEEEecCCCcEEEEEEE--CCCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc---
Confidence            477888999999999999999998764  36789999999754333   3468899999999999999999998643   


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRT---QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL  214 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~---~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGl  214 (427)
                          ..+|++||++ +|+|.+++..   ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+
T Consensus        80 ----~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGl  155 (272)
T d1qpca_          80 ----EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL  155 (272)
T ss_dssp             ----SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             ----CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccc
Confidence                2467888887 7899886643   3599999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccc
Q psy8260         215 ARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRA  294 (427)
Q Consensus       215 a~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~A  294 (427)
                      |+........                                                         ...+..||+.|||
T Consensus       156 a~~~~~~~~~---------------------------------------------------------~~~~~~gt~~y~A  178 (272)
T d1qpca_         156 ARLIEDNEYT---------------------------------------------------------AREGAKFPIKWTA  178 (272)
T ss_dssp             CEECSSSCEE---------------------------------------------------------CCTTCCCCTTTSC
T ss_pred             eEEccCCccc---------------------------------------------------------cccccCCcccccC
Confidence            9754321100                                                         1123457888888


Q ss_pred             hHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCC
Q psy8260         295 PEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       295 PEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~  374 (427)
                      ||++.+..+..++|+||+|+++++|.++..++............+......      ......++++.+||.+||+.||+
T Consensus       179 PE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~------~~p~~~~~~l~~li~~cl~~~P~  252 (272)
T d1qpca_         179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM------VRPDNCPEELYQLMRLCWKERPE  252 (272)
T ss_dssp             HHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC------CCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             hHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC------CCcccChHHHHHHHHHHcCCCHh
Confidence            888887778788899999999987754322222222111221122111111      01235688999999999999999


Q ss_pred             CCCCHHHHhc--CCCCC
Q psy8260         375 KRITAEQALA--HPYLS  389 (427)
Q Consensus       375 ~R~ta~e~L~--Hp~f~  389 (427)
                      +|||++|+++  |+||+
T Consensus       253 ~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         253 DRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             GSCCHHHHHHHHHHHHH
T ss_pred             HCcCHHHHHHHhhhhhh
Confidence            9999999998  88885

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-48  Score=376.64  Aligned_cols=258  Identities=20%  Similarity=0.276  Sum_probs=198.0

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEeCc----CCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeee
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALDSV----SGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVF  133 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~----~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~  133 (427)
                      ||+.+.+|++++.||+|+||.||++.....    ....||||.+.... .......+.+|+.+|+++ +|||||++++++
T Consensus        32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~  110 (325)
T d1rjba_          32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGAC  110 (325)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence            478888999999999999999998765332    23479999886532 233445678999999998 899999999998


Q ss_pred             ecCccccCCceEEEEeccC-CCCHHHHHhhC------------------------CCCHHHHHHHHHHHHHHHHHHHhcC
Q psy8260         134 HSNTCLADFKNVYMVTHLM-GADLNNILRTQ------------------------KLSDDHVQFLVYQILRGLKYIHSAG  188 (427)
Q Consensus       134 ~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~------------------------~l~~~~~~~~~~qi~~aL~yLH~~~  188 (427)
                      ...      ..+|++|||+ +|+|.++++..                        .+++..+..++.||+.||+|||++|
T Consensus       111 ~~~------~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~  184 (325)
T d1rjba_         111 TLS------GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS  184 (325)
T ss_dssp             CSS------SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eeC------CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            754      4578999988 78999998643                        3789999999999999999999999


Q ss_pred             ceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchh
Q psy8260         189 IIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCEL  268 (427)
Q Consensus       189 iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  268 (427)
                      ||||||||+|||++.++.+||+|||+|+........                                            
T Consensus       185 IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~--------------------------------------------  220 (325)
T d1rjba_         185 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY--------------------------------------------  220 (325)
T ss_dssp             EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTS--------------------------------------------
T ss_pred             eeeccCchhccccccCCeEEEeeccccccccCCCce--------------------------------------------
Confidence            999999999999999999999999999753221100                                            


Q ss_pred             hhhccCCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCc
Q psy8260         269 KILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTK  347 (427)
Q Consensus       269 ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (427)
                                  ....+..||+.|||||++.+..+..++|+||+|+++++|.+ +..||..........+......... 
T Consensus       221 ------------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~-  287 (325)
T d1rjba_         221 ------------VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMD-  287 (325)
T ss_dssp             ------------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCC-
T ss_pred             ------------eeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC-
Confidence                        01224467889999999888888888999999999997754 4555544333333333333221111 


Q ss_pred             ccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         348 KDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       348 ~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                           .....++++++||.+||+.||++|||++|+++|
T Consensus       288 -----~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         288 -----QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                 123568899999999999999999999999986

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-48  Score=367.80  Aligned_cols=251  Identities=18%  Similarity=0.264  Sum_probs=188.6

Q ss_pred             cccCcccccEEEEeEEe-CcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCceEEEE
Q psy8260          70 PTLSKESFDLIFSSALD-SVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKNVYMV  148 (427)
Q Consensus        70 ~~lg~g~fg~v~~~~~~-~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~~~lv  148 (427)
                      +.||+|+||.||++... ..+++.||||++.....+....+++.+|+++|++++|||||++++++..+       ..|++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-------~~~lv   85 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-------SWMLV   85 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-------SEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-------CEEEE
Confidence            46999999999988653 45678999999976544445566788999999999999999999987542       46889


Q ss_pred             eccC-CCCHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCccccc
Q psy8260         149 THLM-GADLNNILRT-QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYV  226 (427)
Q Consensus       149 ~e~~-g~~L~~~l~~-~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  226 (427)
                      |||+ +|+|.++++. ..+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+......+.. 
T Consensus        86 mE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~-  164 (277)
T d1xbba_          86 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-  164 (277)
T ss_dssp             EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE-
T ss_pred             EEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccc-
Confidence            9988 7899998865 569999999999999999999999999999999999999999999999999997543221100 


Q ss_pred             ccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCCCC
Q psy8260         227 ATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQ  306 (427)
Q Consensus       227 gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~  306 (427)
                                                                            .......||+.|||||++.+..+..+
T Consensus       165 ------------------------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~  190 (277)
T d1xbba_         165 ------------------------------------------------------KAQTHGKWPVKWYAPECINYYKFSSK  190 (277)
T ss_dssp             ------------------------------------------------------EC----CCCGGGCCHHHHHHCEEEHH
T ss_pred             ------------------------------------------------------ccccccCCCceecCchhhcCCCCCch
Confidence                                                                  01112357888999999888778888


Q ss_pred             CCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHH---
Q psy8260         307 TDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQA---  382 (427)
Q Consensus       307 ~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~---  382 (427)
                      +|+||+|++++++.+ +..||......+... .+......      ......++++.+||.+||+.||++|||++|+   
T Consensus       191 sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~-~i~~~~~~------~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~  263 (277)
T d1xbba_         191 SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA-MLEKGERM------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELR  263 (277)
T ss_dssp             HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-HHHTTCCC------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             hhhccchhhhhHHhhCCCCCCCCCCHHHHHH-HHHcCCCC------CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            899999999987532 344443322112222 22211111      1124568899999999999999999999998   


Q ss_pred             hcCCCCC
Q psy8260         383 LAHPYLS  389 (427)
Q Consensus       383 L~Hp~f~  389 (427)
                      |+|+|++
T Consensus       264 L~~~~~~  270 (277)
T d1xbba_         264 LRNYYYD  270 (277)
T ss_dssp             HHHHHHH
T ss_pred             hhCHHhh
Confidence            5676653

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.3e-47  Score=366.21  Aligned_cols=258  Identities=21%  Similarity=0.274  Sum_probs=186.9

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCC---cEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecC
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSG---VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSN  136 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g---~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~  136 (427)
                      ++..+.|++.+.||+|+||.||++.. ..+|   ..||||++... ......+.+.+|+++|++++|||||++++++...
T Consensus        22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~   99 (299)
T d1jpaa_          22 EIDISCVKIEQVIGAGEFGEVCSGHL-KLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS   99 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEE-CC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             hhChhhcEEeeEEeeCCCeEEEEEEE-eCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence            45567899999999999999997654 3333   36899988653 3455567789999999999999999999998653


Q ss_pred             ccccCCceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCC
Q psy8260         137 TCLADFKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG  213 (427)
Q Consensus       137 ~~~~~~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFG  213 (427)
                            ..+|++|||+ +|+|.+++..  +.+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||
T Consensus       100 ------~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG  173 (299)
T d1jpaa_         100 ------TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFG  173 (299)
T ss_dssp             ------SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred             ------CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcc
Confidence                  4578999998 7899998765  358999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccccc
Q psy8260         214 LARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR  293 (427)
Q Consensus       214 la~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~  293 (427)
                      +|+..........                                                     .....+..||+.||
T Consensus       174 la~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~t~~y~  200 (299)
T d1jpaa_         174 LSRFLEDDTSDPT-----------------------------------------------------YTSALGGKIPIRWT  200 (299)
T ss_dssp             ---------------------------------------------------------------------------CGGGS
T ss_pred             cceEccCCCCcce-----------------------------------------------------eeecccccCCcccc
Confidence            9986543211000                                                     00112345788999


Q ss_pred             chHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         294 APEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       294 APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                      |||++.+..+..++|+||+|+++++|.+ +..||......+..... ......+      .....++++.+||.+||+.|
T Consensus       201 aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i-~~~~~~~------~~~~~~~~l~~li~~cl~~~  273 (299)
T d1jpaa_         201 APEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI-EQDYRLP------PPMDCPSALHQLMLDCWQKD  273 (299)
T ss_dssp             CHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-HTTCCCC------CCTTCCHHHHHHHHHHTCSS
T ss_pred             CHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCC------CCccchHHHHHHHHHHcCCC
Confidence            9999988878888899999999987643 44445432222222222 2111111      12346889999999999999


Q ss_pred             CCCCCCHHHHhcC
Q psy8260         373 SEKRITAEQALAH  385 (427)
Q Consensus       373 P~~R~ta~e~L~H  385 (427)
                      |++|||++|++++
T Consensus       274 P~~RPs~~ei~~~  286 (299)
T d1jpaa_         274 RNHRPKFGQIVNT  286 (299)
T ss_dssp             TTTSCCHHHHHHH
T ss_pred             HhHCcCHHHHHHH
Confidence            9999999998765

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=7.3e-48  Score=372.92  Aligned_cols=257  Identities=26%  Similarity=0.491  Sum_probs=182.5

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCC-CCCceeeeeeeecCccccC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN-HENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~~  141 (427)
                      .++|++.+.||+|+||.||+ +.+..+|+.||||++....     .+++.+|+++|+.++ ||||++++++|...    .
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~-a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~----~  103 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFE-AINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDP----V  103 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEE-EEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECT----T
T ss_pred             CcCeEEEEEEecCcCeEEEE-EEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEec----C
Confidence            35799999999999999996 5678899999999986432     345779999999995 99999999998753    2


Q ss_pred             CceEEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCC-CEEEeeCCCCCCCC
Q psy8260         142 FKNVYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC-ELKILDFGLARPTE  219 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~-~~kl~DFGla~~~~  219 (427)
                      ...++++|+++ +++|..+.  +.+++..++.+++||+.||+|||++|||||||||+|||++.++ .+||+|||+|+...
T Consensus       104 ~~~~~~v~e~~~~~~L~~~~--~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         104 SRTPALVFEHVNNTDFKQLY--QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             TCSEEEEEECCCSCBGGGTT--TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             CCceeEEEeecCCCcHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceecc
Confidence            24578899988 56777653  4699999999999999999999999999999999999998654 69999999987543


Q ss_pred             C--CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH
Q psy8260         220 N--EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI  297 (427)
Q Consensus       220 ~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv  297 (427)
                      .  .....++|+.|+|||                                                             +
T Consensus       182 ~~~~~~~~~~t~~y~aPE-------------------------------------------------------------~  200 (328)
T d3bqca1         182 PGQEYNVRVASRYFKGPE-------------------------------------------------------------L  200 (328)
T ss_dssp             TTCCCCSCCSCGGGCCHH-------------------------------------------------------------H
T ss_pred             CCCcccccccCccccCcc-------------------------------------------------------------c
Confidence            2  223334444445554                                                             4


Q ss_pred             hhhcc-CCCCCCHHHHHHHHHHhCCCCHHHHhhcCc-------------HHHHHHHh------------cCCCCCcccHH
Q psy8260         298 MLNWM-HYNQTDIHQLNLIMEMLGTPPAEFMAKISS-------------DSARKYIN------------SLPLLTKKDFR  351 (427)
Q Consensus       298 l~~~~-~~~~~d~~slg~i~~~lg~~~~~~~~~~~~-------------~~~~~~~~------------~~~~~~~~~~~  351 (427)
                      +.+.. +..++|+||+|++++.+.++..||......             .....+..            .........+.
T Consensus       201 ~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (328)
T d3bqca1         201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWE  280 (328)
T ss_dssp             HTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGG
T ss_pred             ccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchh
Confidence            44322 344457777777766553333322211100             00000000            01111111111


Q ss_pred             h-----hcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q psy8260         352 Q-----VFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYS  392 (427)
Q Consensus       352 ~-----~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~  392 (427)
                      .     ....++++++|||++||++||++|+||+|+|+||||....
T Consensus       281 ~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~  326 (328)
T d3bqca1         281 RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  326 (328)
T ss_dssp             GGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred             hcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            1     2234789999999999999999999999999999998653

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-47  Score=359.18  Aligned_cols=248  Identities=19%  Similarity=0.266  Sum_probs=182.8

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADF  142 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~  142 (427)
                      ...|++.+.||+|+||.||++..  .+++.||||++......   .+++.+|++++++++|||||++++++...      
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~--~~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~------   72 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYW--LNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ------   72 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEE--TTTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS------
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEE--CCCCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceeccC------
Confidence            35688999999999999998754  35778999999764433   34678999999999999999999998654      


Q ss_pred             ceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         143 KNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       143 ~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                      ..++++||++ +|+|.+++..  ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+...
T Consensus        73 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  152 (263)
T d1sm2a_          73 APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL  152 (263)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------
T ss_pred             CceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheecc
Confidence            3578888888 7899998865  458999999999999999999999999999999999999999999999999997543


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      .....                                                         ...+..||+.|+|||++.
T Consensus       153 ~~~~~---------------------------------------------------------~~~~~~gt~~y~aPE~l~  175 (263)
T d1sm2a_         153 DDQYT---------------------------------------------------------SSTGTKFPVKWASPEVFS  175 (263)
T ss_dssp             ---------------------------------------------------------------------CTTSCCHHHHT
T ss_pred             CCCce---------------------------------------------------------eecceecCcccCChHHhc
Confidence            21100                                                         112335788888888888


Q ss_pred             hccCCCCCCHHHHHHHHHHhCCC-CHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC
Q psy8260         300 NWMHYNQTDIHQLNLIMEMLGTP-PAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT  378 (427)
Q Consensus       300 ~~~~~~~~d~~slg~i~~~lg~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t  378 (427)
                      +..+..++|+||+|++++++-+. ..++...................       .....++++.+||.+||+.||++|||
T Consensus       176 ~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~-------~p~~~~~~l~~li~~cl~~~p~~Rps  248 (263)
T d1sm2a_         176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-------KPRLASTHVYQIMNHCWKERPEDRPA  248 (263)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCC-------CCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCC-------CccccCHHHHHHHHHHccCCHhHCcC
Confidence            77787788999999999876432 22222111111222222211111       11345789999999999999999999


Q ss_pred             HHHHhcC
Q psy8260         379 AEQALAH  385 (427)
Q Consensus       379 a~e~L~H  385 (427)
                      ++|+++|
T Consensus       249 ~~~il~~  255 (263)
T d1sm2a_         249 FSRLLRQ  255 (263)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9999987

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-47  Score=363.30  Aligned_cols=259  Identities=18%  Similarity=0.253  Sum_probs=197.6

Q ss_pred             ccCcceeeccc-cCcccccEEEEeEEe-CcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          61 ICRGVIDIGPT-LSKESFDLIFSSALD-SVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        61 ~~~~~~~~~~~-lg~g~fg~v~~~~~~-~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      +.+..+.+.+. ||+|+||.||++... ..++..||||++... ......+++.+|+++|++++|||||++++++..   
T Consensus         5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---   80 (285)
T d1u59a_           5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---   80 (285)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---
T ss_pred             ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc---
Confidence            34556777774 999999999987643 345668999998754 345566778999999999999999999998764   


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                          +.+|++|||+ +|+|.+++..  ..+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+|
T Consensus        81 ----~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla  156 (285)
T d1u59a_          81 ----EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS  156 (285)
T ss_dssp             ----SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred             ----CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhh
Confidence                2478999998 6899998754  46999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      +.........                                                       .......||+.|+||
T Consensus       157 ~~~~~~~~~~-------------------------------------------------------~~~~~~~gt~~y~aP  181 (285)
T d1u59a_         157 KALGADDSYY-------------------------------------------------------TARSAGKWPLKWYAP  181 (285)
T ss_dssp             EECTTCSCEE-------------------------------------------------------CCCCSSCCCGGGCCH
T ss_pred             hccccccccc-------------------------------------------------------ccccccccCccccCh
Confidence            7543221100                                                       011234578889999


Q ss_pred             HHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCC
Q psy8260         296 EIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       296 Evl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~  374 (427)
                      |++.+..+..++|+||+|++++++.+ +..||......+ ....+......      ...+..++++.+||.+||+.||+
T Consensus       182 E~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~-~~~~i~~~~~~------~~p~~~~~~l~~li~~cl~~~p~  254 (285)
T d1u59a_         182 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-VMAFIEQGKRM------ECPPECPPELYALMSDCWIYKWE  254 (285)
T ss_dssp             HHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-HHHHHHTTCCC------CCCTTCCHHHHHHHHHTTCSSGG
T ss_pred             HHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCCCC------CCCCcCCHHHHHHHHHHcCCCHh
Confidence            99988888888999999999986532 444454332222 22222221111      12245788999999999999999


Q ss_pred             CCCCHHHH---hcCCCCC
Q psy8260         375 KRITAEQA---LAHPYLS  389 (427)
Q Consensus       375 ~R~ta~e~---L~Hp~f~  389 (427)
                      +|||+.++   |+|+|++
T Consensus       255 ~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         255 DRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             GSCCHHHHHHHHHHHHHH
T ss_pred             HCcCHHHHHHHHHHHHHH
Confidence            99999887   7899885

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=7.8e-48  Score=363.99  Aligned_cols=264  Identities=19%  Similarity=0.265  Sum_probs=197.5

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccC
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLAD  141 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~  141 (427)
                      .++|.+.+.||+|+||.||+ +.+..+|+.||||++.+... ......++.+|+++|+.++|||||++++++.....  .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~-a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~--~   82 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHL-ARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP--A   82 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEE-EEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS--S
T ss_pred             cceeEEeEEEeeCCCeEEEE-EEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccC--C
Confidence            35689999999999999995 56788999999999976543 34455678899999999999999999999865321  2


Q ss_pred             CceEEEEeccC-CCCHHHHHh-hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCC
Q psy8260         142 FKNVYMVTHLM-GADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTE  219 (427)
Q Consensus       142 ~~~~~lv~e~~-g~~L~~~l~-~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~  219 (427)
                      ...+|++||++ |++|.+.+. .+.+++..++.++.||+.||+|||++|||||||||+|||++.++..+|+|||.++...
T Consensus        83 ~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~  162 (277)
T d1o6ya_          83 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA  162 (277)
T ss_dssp             SEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred             CceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhc
Confidence            24578999998 678987774 4679999999999999999999999999999999999999999999999999875432


Q ss_pred             CCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhh
Q psy8260         220 NEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIML  299 (427)
Q Consensus       220 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~  299 (427)
                      .....                                                       .......+||+.|||||++.
T Consensus       163 ~~~~~-------------------------------------------------------~~~~~~~~Gt~~Y~aPE~~~  187 (277)
T d1o6ya_         163 DSGNS-------------------------------------------------------VTQTAAVIGTAQYLSPEQAR  187 (277)
T ss_dssp             -----------------------------------------------------------------------TTCCHHHHT
T ss_pred             ccccc-------------------------------------------------------ccccccccCcccccCHHHHc
Confidence            11000                                                       00223457889999999988


Q ss_pred             hccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH
Q psy8260         300 NWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA  379 (427)
Q Consensus       300 ~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta  379 (427)
                      +..+..++|+||+|++++.|.++..||......+...+.....+..    .......+++++.+||.+||++||.+||+.
T Consensus       188 ~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~s~~l~~li~~~L~~dp~~R~~s  263 (277)
T d1o6ya_         188 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP----PSARHEGLSADLDAVVLKALAKNPENRYQT  263 (277)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC----GGGTSSSCCHHHHHHHHHHTCSSGGGSCSS
T ss_pred             CCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCC----CchhccCCCHHHHHHHHHHccCCHhHCHhH
Confidence            8878888899999999998866666664432223333333333222    123346789999999999999999999954


Q ss_pred             HHHhcCCCC
Q psy8260         380 EQALAHPYL  388 (427)
Q Consensus       380 ~e~L~Hp~f  388 (427)
                      .+.|.|+|+
T Consensus       264 a~~l~~~l~  272 (277)
T d1o6ya_         264 AAEMRADLV  272 (277)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHHH
Confidence            444556664

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-47  Score=358.79  Aligned_cols=258  Identities=23%  Similarity=0.298  Sum_probs=193.6

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      |++...++.+++.||+|+||.||++.. . +++.||||++......   .+.+.+|+.+|++++|||||++++++..   
T Consensus        12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~-~-~~~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~---   83 (285)
T d1fmka3          12 WEIPRESLRLEVKLGQGCFGEVWMGTW-N-GTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---   83 (285)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEE-T-TTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             eEcCHHHEEEeeEEeeCCCeEEEEEEE-C-CCCEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEec---
Confidence            567778999999999999999997654 3 4467999999755433   3568899999999999999999998753   


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHh---hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILR---TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL  214 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~---~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGl  214 (427)
                          ..++++||++ +|+|..++.   ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus        84 ----~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGl  159 (285)
T d1fmka3          84 ----EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL  159 (285)
T ss_dssp             ----SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred             ----CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccch
Confidence                2357888877 678887764   35699999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccc
Q psy8260         215 ARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRA  294 (427)
Q Consensus       215 a~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~A  294 (427)
                      |+........                                                         ......||+.|+|
T Consensus       160 a~~~~~~~~~---------------------------------------------------------~~~~~~gt~~y~a  182 (285)
T d1fmka3         160 ARLIEDNEYT---------------------------------------------------------ARQGAKFPIKWTA  182 (285)
T ss_dssp             TC-----------------------------------------------------------------------CCGGGSC
T ss_pred             hhhccCCCce---------------------------------------------------------eeccccccccccC
Confidence            9754321100                                                         1122357888888


Q ss_pred             hHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCC
Q psy8260         295 PEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       295 PEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~  374 (427)
                      ||++....+..++|+||+|+++++|.++-.++...................      ......++++++||.+||+.||+
T Consensus       183 PE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~------~~~~~~~~~l~~li~~cl~~dP~  256 (285)
T d1fmka3         183 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM------PCPPECPESLHDLMCQCWRKEPE  256 (285)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC------CCCTTSCHHHHHHHHHHTCSSGG
T ss_pred             hHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC------CCCcccCHHHHHHHHHHcccCHh
Confidence            888888778888899999999987744222222222222222222211111      12345788999999999999999


Q ss_pred             CCCCHHHHhc--CCCCCCC
Q psy8260         375 KRITAEQALA--HPYLSQY  391 (427)
Q Consensus       375 ~R~ta~e~L~--Hp~f~~~  391 (427)
                      +|||++|+++  |+||+..
T Consensus       257 ~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         257 ERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             GSCCHHHHHHHHHTTTSCS
T ss_pred             HCcCHHHHHHHHhhhhcCC
Confidence            9999999988  9999764

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-47  Score=358.19  Aligned_cols=255  Identities=20%  Similarity=0.270  Sum_probs=188.4

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEeC--cCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecC
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALDS--VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSN  136 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~  136 (427)
                      +|+.+..|++++.||+|+||.||++....  .++..||||.+... ......+.+.+|+.+|++++|||||++++++.. 
T Consensus         2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-   79 (273)
T d1mp8a_           2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-   79 (273)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred             CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence            57888899999999999999999875432  24567999988643 344556678899999999999999999999853 


Q ss_pred             ccccCCceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCC
Q psy8260         137 TCLADFKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG  213 (427)
Q Consensus       137 ~~~~~~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFG  213 (427)
                            ..+|++||++ +++|.+++..  ..+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||
T Consensus        80 ------~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG  153 (273)
T d1mp8a_          80 ------NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG  153 (273)
T ss_dssp             ------SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--
T ss_pred             ------CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccch
Confidence                  3468888888 6888887654  468999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccccc
Q psy8260         214 LARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR  293 (427)
Q Consensus       214 la~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~  293 (427)
                      +|+........                                                         ......||+.|+
T Consensus       154 ~a~~~~~~~~~---------------------------------------------------------~~~~~~gt~~y~  176 (273)
T d1mp8a_         154 LSRYMEDSTYY---------------------------------------------------------KASKGKLPIKWM  176 (273)
T ss_dssp             --------------------------------------------------------------------------CCGGGC
T ss_pred             hheeccCCcce---------------------------------------------------------eccceecCcccc
Confidence            99754321100                                                         011234788888


Q ss_pred             chHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCC
Q psy8260         294 APEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELD  372 (427)
Q Consensus       294 APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~d  372 (427)
                      |||++.+..+..++|+||+|++++++.+ +..||......+...+...... .      ..++..++++.+||.+||+.|
T Consensus       177 apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~-~------~~~~~~~~~~~~li~~cl~~d  249 (273)
T d1mp8a_         177 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER-L------PMPPNCPPTLYSLMTKCWAYD  249 (273)
T ss_dssp             CHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-C------CCCTTCCHHHHHHHHHHTCSS
T ss_pred             hhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-C------CCCCCCCHHHHHHHHHHcCCC
Confidence            8888888778888899999999986422 3333433322333333322211 1      123467899999999999999


Q ss_pred             CCCCCCHHHHhcC
Q psy8260         373 SEKRITAEQALAH  385 (427)
Q Consensus       373 P~~R~ta~e~L~H  385 (427)
                      |++|||++|+++|
T Consensus       250 p~~Rps~~ei~~~  262 (273)
T d1mp8a_         250 PSRRPRFTELKAQ  262 (273)
T ss_dssp             GGGSCCHHHHHHH
T ss_pred             HhHCcCHHHHHHH
Confidence            9999999999876

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-46  Score=350.94  Aligned_cols=247  Identities=19%  Similarity=0.284  Sum_probs=193.5

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      .+|++.+.||+|+||.||++..  .+++.||||++++....   .+.+.+|+.++++++|||||++++++...      .
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~--~~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~------~   72 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKW--RGQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ------R   72 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEE--TTTEEEEEEEEESSSSC---HHHHHHHHHHHHTCCCTTBCCEEEEECCS------S
T ss_pred             HHCEEeEEEecCCCeEEEEEEE--CCCCEEEEEEECcCcCC---HHHHHHHHHHHHhcCCCceeeEEEEEeeC------C
Confidence            4678899999999999998764  47889999999765443   34688999999999999999999998653      4


Q ss_pred             eEEEEeccC-CCCHHHHHh--hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILR--TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~--~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      .++++|||+ +|+|..++.  ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus        73 ~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  152 (258)
T d1k2pa_          73 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  152 (258)
T ss_dssp             SEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSS
T ss_pred             ceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccC
Confidence            689999988 688888764  35689999999999999999999999999999999999999999999999999975432


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      ....                                                         ...+..||+.|+|||++.+
T Consensus       153 ~~~~---------------------------------------------------------~~~~~~~t~~y~aPE~~~~  175 (258)
T d1k2pa_         153 DEYT---------------------------------------------------------SSVGSKFPVRWSPPEVLMY  175 (258)
T ss_dssp             SSCC---------------------------------------------------------CCCCSCCCGGGCCHHHHHH
T ss_pred             CCce---------------------------------------------------------eecccCCCCCcCCcHHhcC
Confidence            1100                                                         1123457888899998888


Q ss_pred             ccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH
Q psy8260         301 WMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA  379 (427)
Q Consensus       301 ~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta  379 (427)
                      ..+..++|+||+|+++++|.+ +..||......+...+........       .....++++.+||.+||+.||++|||+
T Consensus       176 ~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~-------~p~~~~~~l~~li~~cl~~dP~~RPt~  248 (258)
T d1k2pa_         176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY-------RPHLASEKVYTIMYSCWHEKADERPTF  248 (258)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC-------CCTTCCHHHHHHHHHTTCSSGGGSCCH
T ss_pred             CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCC-------CcccccHHHHHHHHHHccCCHhHCcCH
Confidence            888888899999999987644 444454332222223232211111       123467899999999999999999999


Q ss_pred             HHHhcC
Q psy8260         380 EQALAH  385 (427)
Q Consensus       380 ~e~L~H  385 (427)
                      +|+++|
T Consensus       249 ~eil~~  254 (258)
T d1k2pa_         249 KILLSN  254 (258)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999987

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-46  Score=353.79  Aligned_cols=257  Identities=22%  Similarity=0.287  Sum_probs=187.1

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCC---cEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecC
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSG---VKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSN  136 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g---~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~  136 (427)
                      |+....|.+.+.||+|+||.||++.+....+   ..||||++... ........+.+|+++|++++|||||++++++...
T Consensus         3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~   81 (283)
T d1mqba_           3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY   81 (283)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence            5556678899999999999999876654332   47999998654 3445556788999999999999999999998643


Q ss_pred             ccccCCceEEEEeccC-CCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCC
Q psy8260         137 TCLADFKNVYMVTHLM-GADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG  213 (427)
Q Consensus       137 ~~~~~~~~~~lv~e~~-g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFG  213 (427)
                            ...++++|++ ++++.+++..  ..+++..+..++.||+.||.|||+++||||||||+|||++.++.+||+|||
T Consensus        82 ------~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFG  155 (283)
T d1mqba_          82 ------KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFG  155 (283)
T ss_dssp             ------SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             ------CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccc
Confidence                  3568888877 6777776654  469999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccccc
Q psy8260         214 LARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR  293 (427)
Q Consensus       214 la~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~  293 (427)
                      +|+........                                                       .....+..||+.||
T Consensus       156 la~~~~~~~~~-------------------------------------------------------~~~~~~~~gt~~Y~  180 (283)
T d1mqba_         156 LSRVLEDDPEA-------------------------------------------------------TYTTSGGKIPIRWT  180 (283)
T ss_dssp             C------------------------------------------------------------------------CCCGGGS
T ss_pred             hhhcccCCCcc-------------------------------------------------------ceEeccCCCCcccc
Confidence            99754322100                                                       00122345788899


Q ss_pred             chHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCC
Q psy8260         294 APEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDS  373 (427)
Q Consensus       294 APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP  373 (427)
                      |||++.+..+..++|+||+|++++++.+...++...................      ......++++.+||.+||+.||
T Consensus       181 APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~------~~~~~~~~~l~~li~~cl~~~p  254 (283)
T d1mqba_         181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL------PTPMDCPSAIYQLMMQCWQQER  254 (283)
T ss_dssp             CHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC------CCCTTCBHHHHHHHHHHTCSST
T ss_pred             CHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCC------CCchhhHHHHHHHHHHHCcCCH
Confidence            9999888888888899999999987744222222222222222222211111      1123467889999999999999


Q ss_pred             CCCCCHHHHhc
Q psy8260         374 EKRITAEQALA  384 (427)
Q Consensus       374 ~~R~ta~e~L~  384 (427)
                      ++|||+.|+++
T Consensus       255 ~~RPt~~eil~  265 (283)
T d1mqba_         255 ARRPKFADIVS  265 (283)
T ss_dssp             TTSCCHHHHHH
T ss_pred             hHCcCHHHHHH
Confidence            99999999976

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-46  Score=359.29  Aligned_cols=259  Identities=19%  Similarity=0.275  Sum_probs=189.4

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEe----CcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeee
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALD----SVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVF  133 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~----~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~  133 (427)
                      +++.+..|.+++.||+|+||.||++...    ..+++.||||++... ......+.+.+|..++.++ +|+|||.+++++
T Consensus         8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~   86 (299)
T d1ywna1           8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGAC   86 (299)
T ss_dssp             HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence            4677889999999999999999987653    345678999998643 3344456677888888776 689999999886


Q ss_pred             ecCccccCCceEEEEeccC-CCCHHHHHhhC-----------------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCC
Q psy8260         134 HSNTCLADFKNVYMVTHLM-GADLNNILRTQ-----------------KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLK  195 (427)
Q Consensus       134 ~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~-----------------~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLK  195 (427)
                      ...     ...++++||++ +|+|.++++..                 .+++..+..++.||+.||.|||++||||||||
T Consensus        87 ~~~-----~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlK  161 (299)
T d1ywna1          87 TKP-----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLA  161 (299)
T ss_dssp             CST-----TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             ccC-----CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCC
Confidence            432     24578888888 78999988532                 48899999999999999999999999999999


Q ss_pred             CCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCC
Q psy8260         196 PSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGL  275 (427)
Q Consensus       196 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~  275 (427)
                      |+|||++.++.+||+|||+|+........                                                   
T Consensus       162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~---------------------------------------------------  190 (299)
T d1ywna1         162 ARNILLSEKNVVKICDFGLARDIYKDPDY---------------------------------------------------  190 (299)
T ss_dssp             GGGEEECGGGCEEECC------CCSCTTS---------------------------------------------------
T ss_pred             ccceeECCCCcEEEccCcchhhccccccc---------------------------------------------------
Confidence            99999999999999999999754322110                                                   


Q ss_pred             CCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCC-CHHHHhhcCcHHHHHHHhcCCCCCcccHHhhc
Q psy8260         276 ARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTP-PAEFMAKISSDSARKYINSLPLLTKKDFRQVF  354 (427)
Q Consensus       276 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (427)
                           .......||+.|+|||++.+..+..++|+||+|+++++|.+. ..+|...................      ...
T Consensus       191 -----~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~------~~~  259 (299)
T d1ywna1         191 -----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM------RAP  259 (299)
T ss_dssp             -----CCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCC------CCC
T ss_pred             -----cccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC------CCC
Confidence                 011234688889999998888788888999999999876432 22333322223333333222111      122


Q ss_pred             CCCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         355 KGANPQAIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       355 ~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                      ...++++++||.+||+.||++|||++|+++|
T Consensus       260 ~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         260 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            4578899999999999999999999999987

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-47  Score=367.98  Aligned_cols=258  Identities=22%  Similarity=0.322  Sum_probs=195.7

Q ss_pred             CcceeeccccCcccccEEEEeEE--eCcCCcEEEEEEccCcCC--CHHHHHHHHHHHHHHhcCCC-CCceeeeeeeecCc
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSAL--DSVSGVKVAIKKIARPFQ--SAVHAKRTYRELRMLKHMNH-ENVIGLLDVFHSNT  137 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~--~~~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~~l~~l~H-pnIv~l~~~~~~~~  137 (427)
                      ..+|++.+.||+|+||.||++..  +..+|+.||||++.+...  .....+.+.+|+++|++++| |||+++++++... 
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~-  101 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-  101 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC-
Confidence            46799999999999999997543  355899999999865321  11223456789999999977 8999999998654 


Q ss_pred             cccCCceEEEEeccC-CCCHHHHHh-hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         138 CLADFKNVYMVTHLM-GADLNNILR-TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       138 ~~~~~~~~~lv~e~~-g~~L~~~l~-~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                           ..+++++|++ +++|.+.+. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus       102 -----~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a  176 (322)
T d1vzoa_         102 -----TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS  176 (322)
T ss_dssp             -----TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             -----CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccch
Confidence                 4578888887 789988875 467899999999999999999999999999999999999999999999999998


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      +........                                                         ...+..||+.|+||
T Consensus       177 ~~~~~~~~~---------------------------------------------------------~~~~~~g~~~~~~p  199 (322)
T d1vzoa_         177 KEFVADETE---------------------------------------------------------RAYDFCGTIEYMAP  199 (322)
T ss_dssp             EECCGGGGG---------------------------------------------------------GGCGGGSCCTTCCH
T ss_pred             hhhcccccc---------------------------------------------------------cccccccccccchh
Confidence            644321110                                                         11233566777777


Q ss_pred             HHhhhcc--CCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHH----hcCCCCCcccHHhhcCCCChhHHHHHHHhc
Q psy8260         296 EIMLNWM--HYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYI----NSLPLLTKKDFRQVFKGANPQAIDLLSLML  369 (427)
Q Consensus       296 Evl~~~~--~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL  369 (427)
                      |++.+..  +..++|+||+|++++.|.++..||.............    ...+.        .....++++++||.+||
T Consensus       200 e~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~--------~~~~~s~~~~~li~~~l  271 (322)
T d1vzoa_         200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--------YPQEMSALAKDLIQRLL  271 (322)
T ss_dssp             HHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC--------CCTTSCHHHHHHHHHHT
T ss_pred             HHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCC--------CcccCCHHHHHHHHHHc
Confidence            7775433  4446799999999998877666665433222222111    11111        22457899999999999


Q ss_pred             CCCCCCCC-----CHHHHhcCCCCCCC
Q psy8260         370 ELDSEKRI-----TAEQALAHPYLSQY  391 (427)
Q Consensus       370 ~~dP~~R~-----ta~e~L~Hp~f~~~  391 (427)
                      ++||++|+     ||+|+|+||||++.
T Consensus       272 ~~dP~~R~s~~~~t~~eil~Hpff~~i  298 (322)
T d1vzoa_         272 MKDPKKRLGCGPRDADEIKEHLFFQKI  298 (322)
T ss_dssp             CSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             ccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence            99999999     59999999999875

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-46  Score=356.60  Aligned_cols=252  Identities=18%  Similarity=0.196  Sum_probs=185.2

Q ss_pred             CcceeeccccCcccccEEEEeEEeCcCCc----EEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          63 RGVIDIGPTLSKESFDLIFSSALDSVSGV----KVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        63 ~~~~~~~~~lg~g~fg~v~~~~~~~~~g~----~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      ..+|++.+.||+|+||.||++. ...+|+    +||||++.... .....+.+.+|+.+|++++|||||++++++..+  
T Consensus         8 ~~dy~~~~~lG~G~fG~Vy~~~-~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--   83 (317)
T d1xkka_           8 ETEFKKIKVLGSGAFGTVYKGL-WIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS--   83 (317)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEE-ECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS--
T ss_pred             HHHCEEeeEEecCCCeEEEEEE-EcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--
Confidence            3468999999999999999765 444554    68999886432 233356788999999999999999999998653  


Q ss_pred             ccCCceEEEEeccCCCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         139 LADFKNVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       139 ~~~~~~~~lv~e~~g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                          ...++++++.+++|.+.+..  ..+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+
T Consensus        84 ----~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~  159 (317)
T d1xkka_          84 ----TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK  159 (317)
T ss_dssp             ----SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred             ----CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccce
Confidence                23455566668888877654  469999999999999999999999999999999999999999999999999987


Q ss_pred             CCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchH
Q psy8260         217 PTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPE  296 (427)
Q Consensus       217 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APE  296 (427)
                      ........                                                        ....+..||+.|+|||
T Consensus       160 ~~~~~~~~--------------------------------------------------------~~~~~~~gt~~y~APE  183 (317)
T d1xkka_         160 LLGAEEKE--------------------------------------------------------YHAEGGKVPIKWMALE  183 (317)
T ss_dssp             HTTTTCC----------------------------------------------------------------CCTTTSCHH
T ss_pred             eccccccc--------------------------------------------------------ccccccccCccccChH
Confidence            53321100                                                        0112235788899999


Q ss_pred             HhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCC
Q psy8260         297 IMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEK  375 (427)
Q Consensus       297 vl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~  375 (427)
                      ++.+..+..++|+||+|+++++|.+ +..+|...... .............      .....++++.+||.+||+.||.+
T Consensus       184 ~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~-~~~~~i~~~~~~~------~p~~~~~~~~~li~~cl~~dP~~  256 (317)
T d1xkka_         184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EISSILEKGERLP------QPPICTIDVYMIMVKCWMIDADS  256 (317)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG-GHHHHHHHTCCCC------CCTTBCHHHHHHHHHHTCSSGGG
T ss_pred             HHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH-HHHHHHHcCCCCC------CCcccCHHHHHHHHHhCCCChhh
Confidence            8888878888899999999987744 34444332222 2222222211111      12346789999999999999999


Q ss_pred             CCCHHHHhcC
Q psy8260         376 RITAEQALAH  385 (427)
Q Consensus       376 R~ta~e~L~H  385 (427)
                      |||+.|+++|
T Consensus       257 RPs~~eil~~  266 (317)
T d1xkka_         257 RPKFRELIIE  266 (317)
T ss_dssp             SCCHHHHHHH
T ss_pred             CcCHHHHHHH
Confidence            9999999988

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.6e-45  Score=348.37  Aligned_cols=256  Identities=19%  Similarity=0.205  Sum_probs=195.7

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEe----CcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeee
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALD----SVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFH  134 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~----~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~  134 (427)
                      .|++++.|++.+.||+|+||.||++...    ..+++.||||++... ......+++.+|+++|++++||||+++++++.
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            4667788999999999999999987653    356789999998753 34455677889999999999999999999986


Q ss_pred             cCccccCCceEEEEeccC-CCCHHHHHhhC-------------------------CCCHHHHHHHHHHHHHHHHHHHhcC
Q psy8260         135 SNTCLADFKNVYMVTHLM-GADLNNILRTQ-------------------------KLSDDHVQFLVYQILRGLKYIHSAG  188 (427)
Q Consensus       135 ~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~-------------------------~l~~~~~~~~~~qi~~aL~yLH~~~  188 (427)
                      ..      ...+++++++ +++|.+++...                         .+++..+..++.|++.||+|||+++
T Consensus        87 ~~------~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~  160 (301)
T d1lufa_          87 VG------KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK  160 (301)
T ss_dssp             SS------SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cC------CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC
Confidence            53      3567888877 78999988532                         3788999999999999999999999


Q ss_pred             ceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchh
Q psy8260         189 IIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCEL  268 (427)
Q Consensus       189 iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  268 (427)
                      ||||||||+|||++.++.+||+|||+|+........                                            
T Consensus       161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~--------------------------------------------  196 (301)
T d1lufa_         161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY--------------------------------------------  196 (301)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB--------------------------------------------
T ss_pred             eEeeEEcccceEECCCCcEEEccchhheeccCCccc--------------------------------------------
Confidence            999999999999999999999999998643211000                                            


Q ss_pred             hhhccCCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCC-HHHHhhcCcHHHHHHHhcCCCCCc
Q psy8260         269 KILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPP-AEFMAKISSDSARKYINSLPLLTK  347 (427)
Q Consensus       269 ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~-~~~~~~~~~~~~~~~~~~~~~~~~  347 (427)
                                  ....+..||+.|+|||++.+..+..++|+||+|+++++|.++. .+|......+......... .   
T Consensus       197 ------------~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~-~---  260 (301)
T d1lufa_         197 ------------KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN-I---  260 (301)
T ss_dssp             ------------C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-C---
T ss_pred             ------------cccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCC-C---
Confidence                        0112345788899999998888888889999999998764332 2333322222222222111 1   


Q ss_pred             ccHHhhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy8260         348 KDFRQVFKGANPQAIDLLSLMLELDSEKRITAEQALA  384 (427)
Q Consensus       348 ~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~  384 (427)
                         .......++++.+||.+||+.||++|||+.|+++
T Consensus       261 ---~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         261 ---LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence               1123457889999999999999999999999965

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-44  Score=347.62  Aligned_cols=257  Identities=23%  Similarity=0.289  Sum_probs=199.8

Q ss_pred             ccccCcceeeccccCcccccEEEEeEE----eCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeee
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSAL----DSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVF  133 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~----~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~  133 (427)
                      |++....+++++.||+|+||.||++..    +..+++.||||++... ........+.+|+.+++++ +|||||++++++
T Consensus        18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~   96 (311)
T d1t46a_          18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGAC   96 (311)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc-cCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            578889999999999999999998765    3457789999999754 3455566788999999998 799999999998


Q ss_pred             ecCccccCCceEEEEeccC-CCCHHHHHhhC-------------------CCCHHHHHHHHHHHHHHHHHHHhcCceecc
Q psy8260         134 HSNTCLADFKNVYMVTHLM-GADLNNILRTQ-------------------KLSDDHVQFLVYQILRGLKYIHSAGIIHRD  193 (427)
Q Consensus       134 ~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~-------------------~l~~~~~~~~~~qi~~aL~yLH~~~iiHrD  193 (427)
                      ...      ..+|++||++ +++|..+++..                   .+++..+..++.||+.||+|||++||||||
T Consensus        97 ~~~------~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrD  170 (311)
T d1t46a_          97 TIG------GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRD  170 (311)
T ss_dssp             CSS------SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             eeC------CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence            654      4578999988 78999888643                   488999999999999999999999999999


Q ss_pred             CCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhcc
Q psy8260         194 LKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDF  273 (427)
Q Consensus       194 LKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~  273 (427)
                      |||+|||++.++.+||+|||+++........                                                 
T Consensus       171 LKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~-------------------------------------------------  201 (311)
T d1t46a_         171 LAARNILLTHGRITKICDFGLARDIKNDSNY-------------------------------------------------  201 (311)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCTTSCTTS-------------------------------------------------
T ss_pred             cccccccccccCcccccccchheeccCCCcc-------------------------------------------------
Confidence            9999999999999999999998754322110                                                 


Q ss_pred             CCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHh
Q psy8260         274 GLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQ  352 (427)
Q Consensus       274 g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (427)
                             ......+||+.|+|||++.+..+..++|+||+|+++++|.+ +..++..........+.........      
T Consensus       202 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~------  268 (311)
T d1t46a_         202 -------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML------  268 (311)
T ss_dssp             -------EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCC------
T ss_pred             -------eEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC------
Confidence                   01123468889999999988878888899999999987643 2222322222233333333221111      


Q ss_pred             hcCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy8260         353 VFKGANPQAIDLLSLMLELDSEKRITAEQALA  384 (427)
Q Consensus       353 ~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~  384 (427)
                      .....++++.+||.+||+.||.+|||++|+++
T Consensus       269 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         269 SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            11346789999999999999999999999985

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-45  Score=341.14  Aligned_cols=247  Identities=20%  Similarity=0.288  Sum_probs=184.5

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      |++...+|++.+.||+|+||.||++..   .|..||||+++...    ..+.+.+|+++|++++|||||++++++...  
T Consensus         2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~---~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~--   72 (262)
T d1byga_           2 WALNMKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE--   72 (262)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEE---TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred             CccCHHHeEEeEEEecCCCeEEEEEEE---CCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEec--
Confidence            567778899999999999999998764   47899999996532    235678999999999999999999986432  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILRTQ---KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL  214 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~~~---~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGl  214 (427)
                         ...+|+++||+ +|+|.+++...   .+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+
T Consensus        73 ---~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~  149 (262)
T d1byga_          73 ---KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL  149 (262)
T ss_dssp             -----CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred             ---CCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeeccccc
Confidence               23478999888 78999988543   489999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccc
Q psy8260         215 ARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRA  294 (427)
Q Consensus       215 a~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~A  294 (427)
                      ++.........                                                             .+|+.|+|
T Consensus       150 s~~~~~~~~~~-------------------------------------------------------------~~~~~y~a  168 (262)
T d1byga_         150 TKEASSTQDTG-------------------------------------------------------------KLPVKWTA  168 (262)
T ss_dssp             -------------------------------------------------------------------------CCTTTSC
T ss_pred             ceecCCCCccc-------------------------------------------------------------cccccCCC
Confidence            87543322222                                                             34566777


Q ss_pred             hHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCC
Q psy8260         295 PEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDS  373 (427)
Q Consensus       295 PEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP  373 (427)
                      ||++.+..+..++|+||+|+++++|.+ +..++......+..... ......      ......++++++||.+||+.||
T Consensus       169 PE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i-~~~~~~------~~~~~~~~~~~~li~~cl~~dP  241 (262)
T d1byga_         169 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKM------DAPDGCPPAVYEVMKNCWHLDA  241 (262)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH-TTTCCC------CCCTTCCHHHHHHHHHHTCSSG
T ss_pred             hHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHH-HcCCCC------CCCccCCHHHHHHHHHHcccCH
Confidence            777766667777899999999988743 33333332222222222 111110      1234568899999999999999


Q ss_pred             CCCCCHHHHhcC
Q psy8260         374 EKRITAEQALAH  385 (427)
Q Consensus       374 ~~R~ta~e~L~H  385 (427)
                      ++|||+.|+++|
T Consensus       242 ~~Rps~~~l~~~  253 (262)
T d1byga_         242 AMRPSFLQLREQ  253 (262)
T ss_dssp             GGSCCHHHHHHH
T ss_pred             hHCcCHHHHHHH
Confidence            999999999875

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-45  Score=343.07  Aligned_cols=255  Identities=21%  Similarity=0.213  Sum_probs=183.1

Q ss_pred             cCcceeeccccCcccccEEEEeEEeCcCC--cEEEEEEccCcCC-CHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCcc
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSALDSVSG--VKVAIKKIARPFQ-SAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTC  138 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~~~~~g--~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~  138 (427)
                      ...+|++.+.||+|+||.||++..+..++  ..||||++.+... .....+.+.+|+.+|++++|||||++++++...  
T Consensus         6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~--   83 (273)
T d1u46a_           6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--   83 (273)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred             chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec--
Confidence            35679999999999999999887765554  4789999875433 233456788999999999999999999998642  


Q ss_pred             ccCCceEEEEeccC-CCCHHHHHh--hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         139 LADFKNVYMVTHLM-GADLNNILR--TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       139 ~~~~~~~~lv~e~~-g~~L~~~l~--~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                           .+++++|++ ++++.+.+.  ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        84 -----~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~  158 (273)
T d1u46a_          84 -----PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM  158 (273)
T ss_dssp             -----SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             -----chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhh
Confidence                 356777777 678877654  356999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      +..........                                                       ......||..|+||
T Consensus       159 ~~~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~~aP  183 (273)
T d1u46a_         159 RALPQNDDHYV-------------------------------------------------------MQEHRKVPFAWCAP  183 (273)
T ss_dssp             EECCC-CCEEE-------------------------------------------------------C-----CCGGGCCH
T ss_pred             hhcccCCCcce-------------------------------------------------------ecCccccCcccCCH
Confidence            75433211000                                                       11123467788888


Q ss_pred             HHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCC
Q psy8260         296 EIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSE  374 (427)
Q Consensus       296 Evl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~  374 (427)
                      |++.+..+..++|+||+|+++++|.+ +..||......+...+........      ......++++.+||.+||+.||+
T Consensus       184 E~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~------~~~~~~~~~l~~li~~cl~~dp~  257 (273)
T d1u46a_         184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL------PRPEDCPQDIYNVMVQCWAHKPE  257 (273)
T ss_dssp             HHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC------CCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             HHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC------CCcccccHHHHHHHHHHcCCChh
Confidence            88888777778899999999986543 444554332222222222221111      12345788999999999999999


Q ss_pred             CCCCHHHHhc
Q psy8260         375 KRITAEQALA  384 (427)
Q Consensus       375 ~R~ta~e~L~  384 (427)
                      +|||++|+++
T Consensus       258 ~RPt~~ei~~  267 (273)
T d1u46a_         258 DRPTFVALRD  267 (273)
T ss_dssp             GSCCHHHHHH
T ss_pred             HCcCHHHHHH
Confidence            9999999863

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-44  Score=343.54  Aligned_cols=257  Identities=22%  Similarity=0.293  Sum_probs=191.8

Q ss_pred             cccccCcceeeccccCcccccEEEEeEEeC------cCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeee
Q psy8260          58 YSEICRGVIDIGPTLSKESFDLIFSSALDS------VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLL  130 (427)
Q Consensus        58 ~~~~~~~~~~~~~~lg~g~fg~v~~~~~~~------~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~  130 (427)
                      -+++..+.|.+++.||+|+||.||.+....      .++..||||++... ........+.+|...+.++ +|||||+++
T Consensus         7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~e~~~l~~~~~HpnIv~~~   85 (299)
T d1fgka_           7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLL   85 (299)
T ss_dssp             TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcc-cChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence            367888999999999999999999865422      22357999998754 3455566788999998888 899999999


Q ss_pred             eeeecCccccCCceEEEEeccC-CCCHHHHHhhC-----------------CCCHHHHHHHHHHHHHHHHHHHhcCceec
Q psy8260         131 DVFHSNTCLADFKNVYMVTHLM-GADLNNILRTQ-----------------KLSDDHVQFLVYQILRGLKYIHSAGIIHR  192 (427)
Q Consensus       131 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~l~~~-----------------~l~~~~~~~~~~qi~~aL~yLH~~~iiHr  192 (427)
                      +++..+      ..++++||++ +|+|.+++...                 .+++..+..++.||+.||+|||+++||||
T Consensus        86 ~~~~~~------~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHr  159 (299)
T d1fgka_          86 GACTQD------GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR  159 (299)
T ss_dssp             EEECSS------SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             cccccC------CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEee
Confidence            998654      4578899988 78999988533                 48999999999999999999999999999


Q ss_pred             cCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhc
Q psy8260         193 DLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILD  272 (427)
Q Consensus       193 DLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d  272 (427)
                      ||||+|||++.++.+||+|||+++........                                                
T Consensus       160 DiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~------------------------------------------------  191 (299)
T d1fgka_         160 DLAARNVLVTEDNVMKIADFGLARDIHHIDYY------------------------------------------------  191 (299)
T ss_dssp             CCSGGGEEECTTCCEEECSTTCCCCGGGCCTT------------------------------------------------
T ss_pred             eecccceeecCCCCeEeccchhhccccccccc------------------------------------------------
Confidence            99999999999999999999998754322110                                                


Q ss_pred             cCCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC-CCHHHHhhcCcHHHHHHHhcCCCCCcccHH
Q psy8260         273 FGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT-PPAEFMAKISSDSARKYINSLPLLTKKDFR  351 (427)
Q Consensus       273 ~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (427)
                              .......||+.|+|||++.+..+..++|+||+|++++.|.+ +..+|.... ..............      
T Consensus       192 --------~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~-~~~~~~~i~~~~~~------  256 (299)
T d1fgka_         192 --------KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKLLKEGHRM------  256 (299)
T ss_dssp             --------CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHHHHHHHTTCCC------
T ss_pred             --------cccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC-HHHHHHHHHcCCCC------
Confidence                    01123457888999999988888888999999999976532 233332222 22222222221111      


Q ss_pred             hhcCCCChhHHHHHHHhcCCCCCCCCCHHHHhc
Q psy8260         352 QVFKGANPQAIDLLSLMLELDSEKRITAEQALA  384 (427)
Q Consensus       352 ~~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~  384 (427)
                      ......++++++||.+||+.||.+|||+.|+++
T Consensus       257 ~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         257 DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            112457889999999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-44  Score=347.08  Aligned_cols=262  Identities=20%  Similarity=0.310  Sum_probs=198.9

Q ss_pred             ccccCcceeeccccCcccccEEEEeEEe----CcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeee
Q psy8260          59 SEICRGVIDIGPTLSKESFDLIFSSALD----SVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFH  134 (427)
Q Consensus        59 ~~~~~~~~~~~~~lg~g~fg~v~~~~~~----~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~  134 (427)
                      |++...++.+++.||+|+||.||++...    ..++..||||++... ........+.+|++++++++|||||++++++.
T Consensus        15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~   93 (308)
T d1p4oa_          15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   93 (308)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence            5788889999999999999999987553    235678999999754 34555567889999999999999999999986


Q ss_pred             cCccccCCceEEEEeccC-CCCHHHHHhh-----------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEc
Q psy8260         135 SNTCLADFKNVYMVTHLM-GADLNNILRT-----------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN  202 (427)
Q Consensus       135 ~~~~~~~~~~~~lv~e~~-g~~L~~~l~~-----------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~  202 (427)
                      ..      ...++++|++ +|+|.+++..           ..+++..+..++.|++.||.|||+++|+||||||+|||++
T Consensus        94 ~~------~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld  167 (308)
T d1p4oa_          94 QG------QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA  167 (308)
T ss_dssp             SS------SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC
T ss_pred             cC------CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeec
Confidence            43      3568888887 7899988742           2368889999999999999999999999999999999999


Q ss_pred             CCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccc
Q psy8260         203 EDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENE  282 (427)
Q Consensus       203 ~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~  282 (427)
                      .++.+||+|||+|+.........                                                        .
T Consensus       168 ~~~~~Kl~DFGla~~~~~~~~~~--------------------------------------------------------~  191 (308)
T d1p4oa_         168 EDFTVKIGDFGMTRDIYETDYYR--------------------------------------------------------K  191 (308)
T ss_dssp             TTCCEEECCTTCCCGGGGGGCEE--------------------------------------------------------G
T ss_pred             CCceEEEeecccceeccCCccee--------------------------------------------------------e
Confidence            99999999999997543221100                                                        1


Q ss_pred             cccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCC-HHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhH
Q psy8260         283 MTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPP-AEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQA  361 (427)
Q Consensus       283 ~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  361 (427)
                      .....||+.|+|||++.+..+..++|+||+|++++.|.++. .++.. .........+......      ......++++
T Consensus       192 ~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~-~~~~~~~~~i~~~~~~------~~p~~~~~~l  264 (308)
T d1p4oa_         192 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-LSNEQVLRFVMEGGLL------DKPDNCPDML  264 (308)
T ss_dssp             GGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-SCHHHHHHHHHTTCCC------CCCTTCCHHH
T ss_pred             ccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHhCCCC------CCcccchHHH
Confidence            12335788999999998888888889999999998663321 22222 1111122222111111      1123567899


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhc------CCCCCC
Q psy8260         362 IDLLSLMLELDSEKRITAEQALA------HPYLSQ  390 (427)
Q Consensus       362 ~dLi~~mL~~dP~~R~ta~e~L~------Hp~f~~  390 (427)
                      .+||.+||+.||.+|||++|+++      +|+|++
T Consensus       265 ~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~  299 (308)
T d1p4oa_         265 FELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE  299 (308)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred             HHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence            99999999999999999999998      666653

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-44  Score=344.75  Aligned_cols=252  Identities=20%  Similarity=0.265  Sum_probs=188.6

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeCcCCc--EEEEEEccCcCCCHHHHHHHHHHHHHHhcC-CCCCceeeeeeeecC
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDSVSGV--KVAIKKIARPFQSAVHAKRTYRELRMLKHM-NHENVIGLLDVFHSN  136 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~--~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~  136 (427)
                      .+.-++|++++.||+|+||.||++.. ..+|.  .||||++... ......+.+.+|+++|+++ +|||||++++++...
T Consensus         6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~   83 (309)
T d1fvra_           6 VLDWNDIKFQDVIGEGNFGQVLKARI-KKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   83 (309)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEE-EETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred             ccCHHHcEEEEEEeeCCCcEEEEEEE-CCCCeEEEEEEEEECcc-cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC
Confidence            44557889999999999999997654 45665  5788887543 2233455688999999998 799999999998754


Q ss_pred             ccccCCceEEEEeccC-CCCHHHHHhh-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCC
Q psy8260         137 TCLADFKNVYMVTHLM-GADLNNILRT-----------------QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSN  198 (427)
Q Consensus       137 ~~~~~~~~~~lv~e~~-g~~L~~~l~~-----------------~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~N  198 (427)
                            ..+|++||++ +|+|.+++..                 ..+++..+..++.||+.||.|||+++||||||||+|
T Consensus        84 ------~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~N  157 (309)
T d1fvra_          84 ------GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN  157 (309)
T ss_dssp             ------TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             ------CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccce
Confidence                  4689999988 7899998853                 358999999999999999999999999999999999


Q ss_pred             eEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCC
Q psy8260         199 IAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARP  278 (427)
Q Consensus       199 ILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~  278 (427)
                      ||++.++.+||+|||+|+.......                                                       
T Consensus       158 IL~~~~~~~kl~DfG~a~~~~~~~~-------------------------------------------------------  182 (309)
T d1fvra_         158 ILVGENYVAKIADFGLSRGQEVYVK-------------------------------------------------------  182 (309)
T ss_dssp             EEECGGGCEEECCTTCEESSCEECC-------------------------------------------------------
T ss_pred             EEEcCCCceEEcccccccccccccc-------------------------------------------------------
Confidence            9999999999999999864322110                                                       


Q ss_pred             CccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCC-CHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCC
Q psy8260         279 TENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTP-PAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGA  357 (427)
Q Consensus       279 ~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (427)
                          .....||+.|+|||++.+..+..++|+||+|+++++|.++ ..+|... ........+......      ......
T Consensus       183 ----~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~-~~~~~~~~i~~~~~~------~~~~~~  251 (309)
T d1fvra_         183 ----KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-TCAELYEKLPQGYRL------EKPLNC  251 (309)
T ss_dssp             ----C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHGGGTCCC------CCCTTB
T ss_pred             ----ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC-CHHHHHHHHHhcCCC------CCCccC
Confidence                1123467788888888877787788999999999876443 2233322 222222222111111      122456


Q ss_pred             ChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         358 NPQAIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       358 s~~~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                      ++++.+||.+||+.||++|||++|+++|
T Consensus       252 ~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         252 DDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            8999999999999999999999999988

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-43  Score=338.65  Aligned_cols=253  Identities=19%  Similarity=0.251  Sum_probs=188.1

Q ss_pred             eeeccccCcccccEEEEeEEeCcC--CcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          66 IDIGPTLSKESFDLIFSSALDSVS--GVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        66 ~~~~~~lg~g~fg~v~~~~~~~~~--g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      +++.+.||+|+||.||++.+....  ...||||++.+. ......+++.+|+++|++++|||||++++++...     ..
T Consensus        29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-----~~  102 (311)
T d1r0pa_          29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-----EG  102 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET-----TT
T ss_pred             eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec-----CC
Confidence            345678999999999988764433  346899998643 3556667889999999999999999999986432     24


Q ss_pred             eEEEEeccC-CCCHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCC
Q psy8260         144 NVYMVTHLM-GADLNNILRTQ--KLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARPTEN  220 (427)
Q Consensus       144 ~~~lv~e~~-g~~L~~~l~~~--~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~  220 (427)
                      ..+++||++ +++|.+++...  .+++..+..++.|++.||.|||+++|+||||||+|||+++++.+||+|||+++....
T Consensus       103 ~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~  182 (311)
T d1r0pa_         103 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  182 (311)
T ss_dssp             EEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred             ceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccc
Confidence            578889888 68999888653  477888999999999999999999999999999999999999999999999976433


Q ss_pred             CcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhh
Q psy8260         221 EMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLN  300 (427)
Q Consensus       221 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~  300 (427)
                      .....                                                      .....+..||+.|+|||++..
T Consensus       183 ~~~~~------------------------------------------------------~~~~~~~~gt~~y~aPE~~~~  208 (311)
T d1r0pa_         183 KEFDS------------------------------------------------------VHNKTGAKLPVKWMALESLQT  208 (311)
T ss_dssp             TTCCC------------------------------------------------------TTCTTCSSCCGGGSCHHHHHH
T ss_pred             ccccc------------------------------------------------------ceecccccccccccChHHHhc
Confidence            21100                                                      001123468889999999988


Q ss_pred             ccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCc-HHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCCH
Q psy8260         301 WMHYNQTDIHQLNLIMEMLGTPPAEFMAKISS-DSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRITA  379 (427)
Q Consensus       301 ~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~ta  379 (427)
                      ..+..++|+||+|++++++.+...++...... +.......... .      ......++++.+||.+||+.||++|||+
T Consensus       209 ~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~-~------~~p~~~~~~l~~li~~cl~~dP~~RPs~  281 (311)
T d1r0pa_         209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-L------LQPEYCPDPLYEVMLKCWHPKAEMRPSF  281 (311)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCC-C------CCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-C------CCcccCcHHHHHHHHHHcCCCHhHCcCH
Confidence            88888889999999998774322222221111 11111111111 1      0113467899999999999999999999


Q ss_pred             HHHhcC
Q psy8260         380 EQALAH  385 (427)
Q Consensus       380 ~e~L~H  385 (427)
                      +|+++|
T Consensus       282 ~ei~~~  287 (311)
T d1r0pa_         282 SELVSR  287 (311)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999998

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.4e-44  Score=342.53  Aligned_cols=267  Identities=21%  Similarity=0.262  Sum_probs=193.3

Q ss_pred             cceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCc
Q psy8260          64 GVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFK  143 (427)
Q Consensus        64 ~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~  143 (427)
                      ++|++.+.||+|+||.||+ +.+..+|+.||||++......    .++.+|+++++.++|+|++..+..+..     +..
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~-a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~-----~~~   76 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYL-GTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGA-----EGD   76 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEE-EEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEE-----ETT
T ss_pred             CEEEEeEEEeeCCCcEEEE-EEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEe-----cCC
Confidence            4699999999999999996 567788999999987654322    236789999999988876665544322     225


Q ss_pred             eEEEEeccCCCCHHHHHh--hCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEc---CCCCEEEeeCCCCCCC
Q psy8260         144 NVYMVTHLMGADLNNILR--TQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN---EDCELKILDFGLARPT  218 (427)
Q Consensus       144 ~~~lv~e~~g~~L~~~l~--~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~---~~~~~kl~DFGla~~~  218 (427)
                      ..+++||++++++...+.  .+.+++..+..++.|++.||+|||++|||||||||+|||++   .+..+||+|||+|+..
T Consensus        77 ~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          77 YNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             EEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence            678999999988877664  35799999999999999999999999999999999999986   3567999999999765


Q ss_pred             CCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         219 ENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       219 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                      ....+....                                                   .........||+.|||||++
T Consensus       157 ~~~~~~~~~---------------------------------------------------~~~~~~~~~gt~~y~aPE~~  185 (299)
T d1ckia_         157 RDARTHQHI---------------------------------------------------PYRENKNLTGTARYASINTH  185 (299)
T ss_dssp             BCTTTCCBC---------------------------------------------------CCCBCCSCCCCSSSCCHHHH
T ss_pred             cccccccce---------------------------------------------------eccccCCcCCCccccCHHHH
Confidence            332111000                                                   00022345789999999999


Q ss_pred             hhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCCCCCCC
Q psy8260         299 LNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDSEKRIT  378 (427)
Q Consensus       299 ~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP~~R~t  378 (427)
                      .+..+..++|+||+|+++++|.++..||...............................++++.+||.+||+.||++||+
T Consensus       186 ~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~  265 (299)
T d1ckia_         186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPD  265 (299)
T ss_dssp             TTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCC
T ss_pred             hCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcC
Confidence            98888888999999999988866555553321111111110000000011123345678899999999999999999999


Q ss_pred             HH---HHhcCCCCCCC
Q psy8260         379 AE---QALAHPYLSQY  391 (427)
Q Consensus       379 a~---e~L~Hp~f~~~  391 (427)
                      ++   ++|+|+|.++.
T Consensus       266 ~~~i~~~l~~~~~~~~  281 (299)
T d1ckia_         266 YSYLRQLFRNLFHRQG  281 (299)
T ss_dssp             HHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHcC
Confidence            86   56889887543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=7.1e-43  Score=332.41  Aligned_cols=261  Identities=17%  Similarity=0.228  Sum_probs=193.6

Q ss_pred             cCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCC-CCceeeeeeeecCcccc
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNH-ENVIGLLDVFHSNTCLA  140 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~l~~~~~~~~~~~  140 (427)
                      ..+.|.+++.||+|+||.||+ +.+..+|+.||||++......    ..+.+|+++++.++| +||+.+++++...    
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~-a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~----   73 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFE-GTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEG----   73 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEE-EEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEET----
T ss_pred             CCCceEEEEEEecCCCeEEEE-EEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecC----
Confidence            356799999999999999996 567789999999987543221    235678888888866 8999999887643    


Q ss_pred             CCceEEEEeccCCCCHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcC-----CCCEEEeeCC
Q psy8260         141 DFKNVYMVTHLMGADLNNILRT--QKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE-----DCELKILDFG  213 (427)
Q Consensus       141 ~~~~~~lv~e~~g~~L~~~l~~--~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~-----~~~~kl~DFG  213 (427)
                        ...|++||+++++|.+++..  ..+++..+..++.|++.||.|||++|||||||||+|||++.     ++.+||+|||
T Consensus        74 --~~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG  151 (293)
T d1csna_          74 --LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG  151 (293)
T ss_dssp             --TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred             --CccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccc
Confidence              46799999999999988864  46999999999999999999999999999999999999974     5789999999


Q ss_pred             CCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCcccccccccccccc
Q psy8260         214 LARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYR  293 (427)
Q Consensus       214 la~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~  293 (427)
                      +|+......+....                                                   ......+.+||+.||
T Consensus       152 ~a~~~~~~~~~~~~---------------------------------------------------~~~~~~~~~GT~~y~  180 (293)
T d1csna_         152 MVKFYRDPVTKQHI---------------------------------------------------PYREKKNLSGTARYM  180 (293)
T ss_dssp             TCEESBCTTTCCBC---------------------------------------------------CCCCCCCCCSCTTTC
T ss_pred             eeEEcccCccccce---------------------------------------------------eecccCceEEchhhc
Confidence            99764332111000                                                   000223457999999


Q ss_pred             chHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHhcCCCCCcccHHhhcCCCChhHHHHHHHhcCCCC
Q psy8260         294 APEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYINSLPLLTKKDFRQVFKGANPQAIDLLSLMLELDS  373 (427)
Q Consensus       294 APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~mL~~dP  373 (427)
                      |||++.+..+..++|+||+|++++.|.++..||...........+.............+.....++++.+++..|+..+|
T Consensus       181 aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~  260 (293)
T d1csna_         181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAF  260 (293)
T ss_dssp             CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCT
T ss_pred             CHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCc
Confidence            99999988888888999999999888665555542221111111100000000111334456678899999999999999


Q ss_pred             CCCCCHHHHhc
Q psy8260         374 EKRITAEQALA  384 (427)
Q Consensus       374 ~~R~ta~e~L~  384 (427)
                      .+||+.+.+.+
T Consensus       261 ~~rP~y~~l~~  271 (293)
T d1csna_         261 DATPDYDYLQG  271 (293)
T ss_dssp             TCCCCHHHHHH
T ss_pred             ccCcCHHHHHH
Confidence            99999777654

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.5e-42  Score=339.55  Aligned_cols=293  Identities=26%  Similarity=0.374  Sum_probs=184.6

Q ss_pred             cCcceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCC-----------CCCceeee
Q psy8260          62 CRGVIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMN-----------HENVIGLL  130 (427)
Q Consensus        62 ~~~~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~-----------HpnIv~l~  130 (427)
                      ..++|.+.+.||+|+||.||+ +.+..+|+.||||++.+.   ....+...+|+++++.++           |+|||+++
T Consensus        11 ~~~rY~i~~~LG~G~fg~Vy~-~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~   86 (362)
T d1q8ya_          11 KDARYILVRKLGWGHFSTVWL-AKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   86 (362)
T ss_dssp             TTTTEEEEEEEEECSSEEEEE-EEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             cCCcEEEEEEEeeCCCeEEEE-EEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence            346799999999999999995 667889999999999643   334456678998888775           57899999


Q ss_pred             eeeecCccccCCceEEEEeccCCCCHHHHHh---hCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCCeEEcCCC-
Q psy8260         131 DVFHSNTCLADFKNVYMVTHLMGADLNNILR---TQKLSDDHVQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNEDC-  205 (427)
Q Consensus       131 ~~~~~~~~~~~~~~~~lv~e~~g~~L~~~l~---~~~l~~~~~~~~~~qi~~aL~yLH~-~~iiHrDLKp~NILl~~~~-  205 (427)
                      +++.....  .....++..+..+++......   ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ 
T Consensus        87 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~  164 (362)
T d1q8ya_          87 DHFNHKGP--NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS  164 (362)
T ss_dssp             EEEEEEET--TEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred             EEeeeccc--cceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCc
Confidence            88764321  111222333333444443332   3568999999999999999999998 8999999999999998654 


Q ss_pred             -----CEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCc
Q psy8260         206 -----ELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTE  280 (427)
Q Consensus       206 -----~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~  280 (427)
                           .+|++|||.|+.........+||+.|+|||++.+. .|+.+      .|+||.||++.+                
T Consensus       165 ~~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~------~DiwSlG~il~e----------------  221 (362)
T d1q8ya_         165 PENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGA-PWGCG------ADIWSTACLIFE----------------  221 (362)
T ss_dssp             TTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTC-CCCTH------HHHHHHHHHHHH----------------
T ss_pred             ccccceeeEeecccccccccccccccccccccChhhcccc-CCCcc------ccccchHHHHHH----------------
Confidence                 49999999987655555555677777777766542 22222      266666665543                


Q ss_pred             cccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHHHhhcCcHHHHHHHh------cCCCCCcccHHh--
Q psy8260         281 NEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEFMAKISSDSARKYIN------SLPLLTKKDFRQ--  352 (427)
Q Consensus       281 ~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~--  352 (427)
                       +.+   |+..|.+.+-     .....+...+..++..+|+.+.+........  ..+..      .........+..  
T Consensus       222 -l~~---g~~pF~~~~~-----~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  290 (362)
T d1q8ya_         222 -LIT---GDFLFEPDEG-----HSYTKDDDHIAQIIELLGELPSYLLRNGKYT--RTFFNSRGLLRNISKLKFWPLEDVL  290 (362)
T ss_dssp             -HHH---SSCCC--------------CHHHHHHHHHHHHCSCCHHHHHHCTTH--HHHBCC--CBSSCCCCCBCCHHHHH
T ss_pred             -HHH---CCCCCCCCcc-----ccccchhHHHHHHHHHhCCCCHHHhhccccc--ccccccchhhhccccccCCchhhhc
Confidence             111   1111111110     0001122334444455565554443221110  00110      011111111111  


Q ss_pred             -----hcCCCChhHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q psy8260         353 -----VFKGANPQAIDLLSLMLELDSEKRITAEQALAHPYLSQYSDP  394 (427)
Q Consensus       353 -----~~~~~s~~~~dLi~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  394 (427)
                           .....+++++|||.+||++||.+||||+|+|+||||++...+
T Consensus       291 ~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~~~  337 (362)
T d1q8ya_         291 TEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGM  337 (362)
T ss_dssp             HHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTTC
T ss_pred             ccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCCCc
Confidence                 112246789999999999999999999999999999976544

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-42  Score=331.69  Aligned_cols=257  Identities=19%  Similarity=0.265  Sum_probs=173.6

Q ss_pred             ceeeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCceeeeeeeecCccccCCce
Q psy8260          65 VIDIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENVIGLLDVFHSNTCLADFKN  144 (427)
Q Consensus        65 ~~~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~~~~~  144 (427)
                      .+.+.+.||+|+||.||++..   +|+.||||++...   ........+|+..+..++|||||++++++....  .....
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~---~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~--~~~~~   75 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN--GTWTQ   75 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE---TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC--SSSEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE---CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC--CcceE
Confidence            467788999999999998754   6889999998543   122222234666667889999999999976432  12246


Q ss_pred             EEEEeccC-CCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHh--------cCceeccCCCCCeEEcCCCCEEEeeCCCC
Q psy8260         145 VYMVTHLM-GADLNNILRTQKLSDDHVQFLVYQILRGLKYIHS--------AGIIHRDLKPSNIAVNEDCELKILDFGLA  215 (427)
Q Consensus       145 ~~lv~e~~-g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~--------~~iiHrDLKp~NILl~~~~~~kl~DFGla  215 (427)
                      +|++|||+ +|+|.++++...+++.....++.|++.||.|||+        +|||||||||+|||++.++.+||+|||++
T Consensus        76 ~~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          76 LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            78999998 7899999998899999999999999999999996        59999999999999999999999999998


Q ss_pred             CCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccch
Q psy8260         216 RPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAP  295 (427)
Q Consensus       216 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~AP  295 (427)
                      +.........                                                      .......+||+.|+||
T Consensus       156 ~~~~~~~~~~------------------------------------------------------~~~~~~~~gt~~y~aP  181 (303)
T d1vjya_         156 VRHDSATDTI------------------------------------------------------DIAPNHRVGTKRYMAP  181 (303)
T ss_dssp             EEEETTTTEE------------------------------------------------------CC----CCSCGGGCCH
T ss_pred             ccccCCCcce------------------------------------------------------eccccceecccCcCCh
Confidence            7542211000                                                      0001123455555555


Q ss_pred             HHhhhcc------CCCCCCHHHHHHHHHHhCCCCHHHHhhc--------------CcHHHHHHHhcCCCCCcccHHhhcC
Q psy8260         296 EIMLNWM------HYNQTDIHQLNLIMEMLGTPPAEFMAKI--------------SSDSARKYINSLPLLTKKDFRQVFK  355 (427)
Q Consensus       296 Evl~~~~------~~~~~d~~slg~i~~~lg~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~  355 (427)
                      |++.+..      ++.++|+||+|++++++.++..++....              ......+.... ....+ .....+.
T Consensus       182 E~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~p-~~~~~~~  259 (303)
T d1vjya_         182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE-QKLRP-NIPNRWQ  259 (303)
T ss_dssp             HHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTT-SCCCC-CCCGGGG
T ss_pred             hhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhc-cccCC-CCCcccC
Confidence            5554321      3345699999999988755433221100              00111111111 00000 0001110


Q ss_pred             --CCChhHHHHHHHhcCCCCCCCCCHHHHhcC
Q psy8260         356 --GANPQAIDLLSLMLELDSEKRITAEQALAH  385 (427)
Q Consensus       356 --~~s~~~~dLi~~mL~~dP~~R~ta~e~L~H  385 (427)
                        ....++.+|+.+||+.||++|||+.|++++
T Consensus       260 ~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         260 SCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             GCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence              012357899999999999999999999864

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.89  E-value=1.6e-23  Score=185.25  Aligned_cols=135  Identities=18%  Similarity=0.190  Sum_probs=102.7

Q ss_pred             eeccccCcccccEEEEeEEeCcCCcEEEEEEccCcCCC----------------HHHHHHHHHHHHHHhcCCCCCceeee
Q psy8260          67 DIGPTLSKESFDLIFSSALDSVSGVKVAIKKIARPFQS----------------AVHAKRTYRELRMLKHMNHENVIGLL  130 (427)
Q Consensus        67 ~~~~~lg~g~fg~v~~~~~~~~~g~~vAvK~i~~~~~~----------------~~~~~~~~~Ei~~l~~l~HpnIv~l~  130 (427)
                      .+++.||+|+||.||.+. + .+|+.||||++.....+                ........+|...+.++.|+|++..+
T Consensus         3 ~vg~~IG~G~~g~Vy~a~-~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCY-S-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             EEEEEEEECSSEEEEEEE-E-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             hhCCEeeeCcceEEEEEE-C-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            578999999999999754 3 46899999986432110                11123345789999999999999887


Q ss_pred             eeeecCccccCCceEEEEeccCCCCHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCCeEEcCCCCEEEe
Q psy8260         131 DVFHSNTCLADFKNVYMVTHLMGADLNNILRTQKLSDDHVQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKIL  210 (427)
Q Consensus       131 ~~~~~~~~~~~~~~~~lv~e~~g~~L~~~l~~~~l~~~~~~~~~~qi~~aL~yLH~~~iiHrDLKp~NILl~~~~~~kl~  210 (427)
                      ++..          .+++|+++++...     ..+++..+..++.|++.||.|||++||+||||||+|||++++ .++|+
T Consensus        81 ~~~~----------~~lvme~~~~~~~-----~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          81 AWEG----------NAVLMELIDAKEL-----YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             EEET----------TEEEEECCCCEEG-----GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEEC
T ss_pred             EecC----------CEEEEEeeccccc-----cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEE
Confidence            6521          2678888865322     125556677899999999999999999999999999999965 48999


Q ss_pred             eCCCCCCCC
Q psy8260         211 DFGLARPTE  219 (427)
Q Consensus       211 DFGla~~~~  219 (427)
                      |||+|+...
T Consensus       145 DFG~a~~~~  153 (191)
T d1zara2         145 DFPQSVEVG  153 (191)
T ss_dssp             CCTTCEETT
T ss_pred             ECCCcccCC
Confidence            999987543

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.89  E-value=1e-10  Score=109.13  Aligned_cols=79  Identities=33%  Similarity=0.467  Sum_probs=63.9

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCCcc---ccccccccccccchHHhhhcc-CCCCCCHHHHHHHHHHhCCCCH
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPTEN---EMTGYVATRWYRAPEIMLNWM-HYNQTDIHQLNLIMEMLGTPPA  324 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~---~~~~~~gt~~Y~APEvl~~~~-~~~~~d~~slg~i~~~lg~~~~  324 (427)
                      ...++|+++.|++++.++.+|++|||.++....   ...+.+||+.|+|||++.... +..++|+||+|+++++|.++..
T Consensus       120 ~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~  199 (299)
T d1ua2a_         120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP  199 (299)
T ss_dssp             TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             ceecccCCcceEEecCCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcC
Confidence            357889999999999999999999999975432   345678999999999997654 4567799999999988865554


Q ss_pred             HHH
Q psy8260         325 EFM  327 (427)
Q Consensus       325 ~~~  327 (427)
                      +|.
T Consensus       200 pf~  202 (299)
T d1ua2a_         200 FLP  202 (299)
T ss_dssp             SSC
T ss_pred             CCC
Confidence            443

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.80  E-value=5.3e-10  Score=106.32  Aligned_cols=79  Identities=58%  Similarity=0.980  Sum_probs=68.3

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccC-CCCCCHHHHHHHHHHhCCCCHHHH
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH-YNQTDIHQLNLIMEMLGTPPAEFM  327 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~-~~~~d~~slg~i~~~lg~~~~~~~  327 (427)
                      ...++|+++.|+++..++.+|++|||.+.......++..||+.|+|||++.+..+ ..++|+||+|++++.|.++..+|.
T Consensus       141 ~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~  220 (346)
T d1cm8a_         141 GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK  220 (346)
T ss_dssp             TEECCCCCGGGEEECTTCCEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCcccccCcchhhcccccccccccccceeccCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCC
Confidence            4788899999999999999999999999988777888999999999999987544 567799999999988865555554

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.78  E-value=4.9e-10  Score=105.22  Aligned_cols=30  Identities=40%  Similarity=0.699  Sum_probs=27.4

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCC
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARP  278 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~  278 (427)
                      ...++|+++.|+++..++.+|++|||++..
T Consensus       137 ~ivHrDlKp~NILl~~~~~~kl~dfg~~~~  166 (318)
T d3blha1         137 KILHRDMKAANVLITRDGVLKLADFGLARA  166 (318)
T ss_dssp             TEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             CEEecCcCchheeecCCCcEEeeecceeee
Confidence            568899999999999999999999999854

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.65  E-value=2.5e-09  Score=101.80  Aligned_cols=80  Identities=26%  Similarity=0.455  Sum_probs=64.1

Q ss_pred             cceeeccCCcccccccccc-hhhhhccCCCCCC--ccccccccccccccchHHhhhc-cCCCCCCHHHHHHHHHHhCCCC
Q psy8260         248 VPFYFQDLKPSNIAVNEDC-ELKILDFGLARPT--ENEMTGYVATRWYRAPEIMLNW-MHYNQTDIHQLNLIMEMLGTPP  323 (427)
Q Consensus       248 ~~~~~~d~~~~~~~~~~~~-~~ki~d~g~~~~~--~~~~~~~~gt~~Y~APEvl~~~-~~~~~~d~~slg~i~~~lg~~~  323 (427)
                      ....++|+++.|+++..++ .+|++|||++...  .....+.+||+.|+|||++.+. .+..++|+||+|+++++|.++.
T Consensus       141 ~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~  220 (350)
T d1q5ka_         141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ  220 (350)
T ss_dssp             TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTS
T ss_pred             cCCcccCCCcceEEEecCCCceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCC
Confidence            3578999999999998764 8899999999643  3345678999999999998764 5667789999999998886555


Q ss_pred             HHHH
Q psy8260         324 AEFM  327 (427)
Q Consensus       324 ~~~~  327 (427)
                      .+|.
T Consensus       221 ~pf~  224 (350)
T d1q5ka_         221 PIFP  224 (350)
T ss_dssp             CSSC
T ss_pred             CCCC
Confidence            5553

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.64  E-value=2e-09  Score=102.25  Aligned_cols=31  Identities=55%  Similarity=0.917  Sum_probs=28.0

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCC
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPT  279 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~  279 (427)
                      ...++|+++.|++++.++.+|++|||++...
T Consensus       129 ~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_         129 NVLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            5788999999999999999999999998643

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.57  E-value=1e-08  Score=97.60  Aligned_cols=79  Identities=47%  Similarity=0.687  Sum_probs=58.5

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCCcc--ccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCCCCHHH
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPTEN--EMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGTPPAEF  326 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~--~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~~~~~~  326 (427)
                      .+.++|+++.|+++..++.+|++|||+++....  .....+||+.|+|||++.+..+..++|+||+|++++.|.++..+|
T Consensus       139 giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF  218 (355)
T d2b1pa1         139 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF  218 (355)
T ss_dssp             TCCCSCCCGGGEEECTTCCEEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             ccccccCCccccccccccceeeechhhhhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCC
Confidence            467889999999999999999999999875432  345678999999999999988888899999999998875555455


Q ss_pred             H
Q psy8260         327 M  327 (427)
Q Consensus       327 ~  327 (427)
                      .
T Consensus       219 ~  219 (355)
T d2b1pa1         219 P  219 (355)
T ss_dssp             C
T ss_pred             C
Confidence            3

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.51  E-value=9.9e-09  Score=97.27  Aligned_cols=79  Identities=67%  Similarity=1.047  Sum_probs=64.3

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccC-CCCCCHHHHHHHHHHhCCCCHHHH
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMH-YNQTDIHQLNLIMEMLGTPPAEFM  327 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~-~~~~d~~slg~i~~~lg~~~~~~~  327 (427)
                      ...++|+++.|+++..++.+|++|||.+........+..||+.|+|||++.+..+ ..++|+||+|++++.|.++..+|.
T Consensus       141 giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~  220 (348)
T d2gfsa1         141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP  220 (348)
T ss_dssp             TCCCCCCCGGGEEECTTCCEEECCC----CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CCcccccCCccccccccccccccccchhcccCcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCC
Confidence            4678899999999999999999999999988888888999999999999877654 557799999999988855555553

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=98.50  E-value=6.8e-09  Score=95.70  Aligned_cols=29  Identities=55%  Similarity=0.881  Sum_probs=26.3

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCC
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLAR  277 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~  277 (427)
                      ...++|+++.|+++..++.+|++|||.+.
T Consensus       120 ~IvHrDiKp~NIll~~~~~~kl~DfG~a~  148 (286)
T d1ob3a_         120 RVLHRDLKPQNLLINREGELKIADFGLAR  148 (286)
T ss_dssp             TCCCSCCCGGGEEECTTSCEEECCTTHHH
T ss_pred             cEEecCCCCceeeEcCCCCEEecccccce
Confidence            46788999999999999999999999874

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.38  E-value=0.00031  Score=62.19  Aligned_cols=28  Identities=32%  Similarity=0.393  Sum_probs=24.8

Q ss_pred             ceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         189 IIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       189 iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                      ++|+|+.|.|||+++++.+-|+||+.+.
T Consensus       185 l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         185 FSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             EECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             EEEeeccCcceeecCCceEEEeechhcc
Confidence            7999999999999987777899999764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=96.98  E-value=0.001  Score=62.91  Aligned_cols=28  Identities=32%  Similarity=0.408  Sum_probs=24.6

Q ss_pred             CceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         188 GIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       188 ~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                      .++|+|+.|.|||++.++ ++|+||-.|.
T Consensus       224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~  251 (392)
T d2pula1         224 TLIHGDLHTGSIFASEHE-TKVIDPEFAF  251 (392)
T ss_dssp             EEECSCCCGGGEEECSSC-EEECCCTTCE
T ss_pred             ceeccCCcCCceeEcCCc-eEEechhhcc
Confidence            589999999999998764 8999998775

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.86  E-value=9e-05  Score=67.73  Aligned_cols=63  Identities=32%  Similarity=0.509  Sum_probs=44.5

Q ss_pred             ccccccccchhhhhcccccCCCCcceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHhhhccCC
Q psy8260         225 YVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHY  304 (427)
Q Consensus       225 ~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~  304 (427)
                      .+||+.|||||++.+. .|+.      ..|+||.||++.+                 +.+|..               +|
T Consensus       175 ~~gT~~Y~APE~~~~~-~y~~------~~DiwSlG~il~e-----------------ll~g~~---------------pf  215 (305)
T d1blxa_         175 VVVTLWYRAPEVLLQS-SYAT------PVDLWSVGCIFAE-----------------MFRRKP---------------LF  215 (305)
T ss_dssp             CCCCCTTCCHHHHTTC-CCCT------HHHHHHHHHHHHH-----------------HHHSSC---------------SC
T ss_pred             cccChhhcCcchhcCC-CCCh------hehhhchHHHHHH-----------------HHHCCC---------------CC
Confidence            3789999999999763 3443      3499999999876                 333322               33


Q ss_pred             C-CCCHHHHHHHHHHhCCCCHHH
Q psy8260         305 N-QTDIHQLNLIMEMLGTPPAEF  326 (427)
Q Consensus       305 ~-~~d~~slg~i~~~lg~~~~~~  326 (427)
                      . ..+...+..|+..+|.+....
T Consensus       216 ~~~~~~~~~~~i~~~~~~~~~~~  238 (305)
T d1blxa_         216 RGSSDVDQLGKILDVIGLPGEED  238 (305)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             CCCCHHHHHHHHHHhhCCCchhc
Confidence            3 346778888888888876543

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=96.82  E-value=0.0027  Score=55.53  Aligned_cols=29  Identities=24%  Similarity=0.186  Sum_probs=25.2

Q ss_pred             CceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         188 GIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       188 ~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                      .++|+|+.|.|||++.+..+-|+||+.+.
T Consensus       176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         176 VVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             EEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             eEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence            37999999999999987777899999764

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=96.70  E-value=0.0003  Score=63.46  Aligned_cols=55  Identities=33%  Similarity=0.551  Sum_probs=46.2

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCCc--cccccccccccccchHHhhhccC
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPTE--NEMTGYVATRWYRAPEIMLNWMH  303 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~--~~~~~~~gt~~Y~APEvl~~~~~  303 (427)
                      .+.++|+++.|++++.++.+|++|||+++...  ......+||+.|+|||++.+...
T Consensus       130 ~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~  186 (277)
T d1phka_         130 NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMN  186 (277)
T ss_dssp             TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHC
T ss_pred             CCcccccccceEEEcCCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhcccc
Confidence            47889999999999999999999999997532  23466889999999999876544

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.44  E-value=0.00041  Score=61.95  Aligned_cols=30  Identities=40%  Similarity=0.639  Sum_probs=25.1

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCC
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARP  278 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~  278 (427)
                      ...++|+++.|+++..++.+|++|||+++.
T Consensus       123 ~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~  152 (262)
T d1byga_         123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKE  152 (262)
T ss_dssp             TCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred             ceeccccchHhheecCCCCEeeccccccee
Confidence            467889999999999999999999998853

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=96.01  E-value=0.001  Score=61.88  Aligned_cols=79  Identities=28%  Similarity=0.294  Sum_probs=65.4

Q ss_pred             cceeeccCCcccccccccc------hhhhhccCCCCCCccccccccccccccchHHhhhccCCCCCCHHHHHHHHHHhCC
Q psy8260         248 VPFYFQDLKPSNIAVNEDC------ELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTDIHQLNLIMEMLGT  321 (427)
Q Consensus       248 ~~~~~~d~~~~~~~~~~~~------~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~~d~~slg~i~~~lg~  321 (427)
                      ....++|+++.|+++..++      .++++|||.+..........+||+.|+|||++.+..+..++|+||+|+++..|.+
T Consensus       145 ~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  224 (362)
T d1q8ya_         145 CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT  224 (362)
T ss_dssp             TCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHH
T ss_pred             cCcccccCChhHeeeeccCcccccceeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHH
Confidence            4578899999999997765      3899999999866666677899999999999999888888999999999977644


Q ss_pred             CCHHH
Q psy8260         322 PPAEF  326 (427)
Q Consensus       322 ~~~~~  326 (427)
                      +..+|
T Consensus       225 g~~pF  229 (362)
T d1q8ya_         225 GDFLF  229 (362)
T ss_dssp             SSCCC
T ss_pred             CCCCC
Confidence            43334

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.96  E-value=0.00038  Score=64.10  Aligned_cols=33  Identities=30%  Similarity=0.517  Sum_probs=26.7

Q ss_pred             ccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         225 YVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       225 ~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      .+||++|||||++.+. .|+...      |+||.||++.+
T Consensus       163 ~~GT~~Y~APEvl~~~-~y~~~~------DiWSlGvil~e  195 (322)
T d1s9ja_         163 FVGTRSYMSPERLQGT-HYSVQS------DIWSMGLSLVE  195 (322)
T ss_dssp             -CCSSCCCCHHHHHCS-CCCTTH------HHHHHHHHHHH
T ss_pred             ccCCccccCchHHcCC-CCCcHH------HHHHHHHHHHH
Confidence            4799999999999873 455443      99999999877

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.91  E-value=0.007  Score=54.36  Aligned_cols=55  Identities=18%  Similarity=0.097  Sum_probs=38.2

Q ss_pred             CCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         197 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       197 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      .++-+.+-|..+..+.+-...      +..||+.|+|||++.+. .|+.      ..|+||.||++.+
T Consensus       154 ~~vkl~DfG~a~~~~~~~~~~------~~~~t~~y~APE~~~~~-~~~~------~~DiwSlGvilye  208 (293)
T d1jksa_         154 PRIKIIDFGLAHKIDFGNEFK------NIFGTPEFVAPEIVNYE-PLGL------EADMWSIGVITYI  208 (293)
T ss_dssp             CCEEECCCTTCEECTTSCBCS------CCCCCGGGCCHHHHTTC-CBCT------HHHHHHHHHHHHH
T ss_pred             cceEecchhhhhhcCCCcccc------ccCCCCcccCHHHHcCC-CCCC------cccchhhhHHHHH
Confidence            357677777777776653221      13678999999999753 3333      3499999999876

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=95.84  E-value=0.00059  Score=63.96  Aligned_cols=33  Identities=24%  Similarity=0.341  Sum_probs=27.3

Q ss_pred             cccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         226 VATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       226 ~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      +||+.|+|||++.+...|+.+      .|+||.||++.+
T Consensus       166 ~GT~~y~APE~~~~~~~~~~~------~DiwSlGvilye  198 (364)
T d1omwa3         166 VGTHGYMAPEVLQKGVAYDSS------ADWFSLGCMLFK  198 (364)
T ss_dssp             CSCGGGCCHHHHSTTCCCCTH------HHHHHHHHHHHH
T ss_pred             ccccccchhHHhhcCCCCCcc------cchhHHHHHHHH
Confidence            689999999999765556544      399999999877

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.82  E-value=0.001  Score=61.59  Aligned_cols=36  Identities=25%  Similarity=0.376  Sum_probs=28.8

Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ....+||+.|+|||++.+. .|+..      .|+||.||++.+
T Consensus       162 ~~~~~GT~~Y~aPE~~~~~-~y~~~------~DiwSlGvilye  197 (337)
T d1o6la_         162 MKTFCGTPEYLAPEVLEDN-DYGRA------VDWWGLGVVMYE  197 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSS-CBCTT------HHHHHHHHHHHH
T ss_pred             cccceeCHHHhhhhhccCC-CCChh------hcccchhhHHHH
Confidence            4567999999999998764 34544      399999999877

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.68  E-value=0.00038  Score=62.56  Aligned_cols=58  Identities=14%  Similarity=0.166  Sum_probs=39.6

Q ss_pred             CeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         198 NIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       198 NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ++-|.+-|..+..+.+-..   ...+..+||+.|||||++.+...++.      ..|+||.||++.+
T Consensus       141 ~~KL~DFG~a~~~~~~~~~---~~~~~~~GT~~Y~APE~~~~~~~~~~------~~DiwSlGvilye  198 (271)
T d1nvra_         141 NLKISDFGLATVFRYNNRE---RLLNKMCGTLPYVAPELLKRREFHAE------PVDVWSCGIVLTA  198 (271)
T ss_dssp             CEEECCCTTCEECEETTEE---CCBCCCCSCGGGSCTHHHHCSSBCHH------HHHHHHHHHHHHH
T ss_pred             CEEEccchhheeeccCCcc---ccccceeeCcCccCHhHhcCCCCCCC------ceeeeHhHHHHHH
Confidence            5666666777665543211   22345789999999999986443333      3499999999877

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.62  E-value=0.0023  Score=57.92  Aligned_cols=70  Identities=19%  Similarity=0.223  Sum_probs=44.7

Q ss_pred             HHHHHHh----cCc-eeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeecc
Q psy8260         180 GLKYIHS----AGI-IHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQD  254 (427)
Q Consensus       180 aL~yLH~----~~i-iHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d  254 (427)
                      ....+|.    .+| +..|   .++-|.+-|..+..+-+     .......+||+.|+|||++.+. .|+.      ..|
T Consensus       134 ~~~iiHrDiKp~NILl~~~---~~vkl~DFG~a~~~~~~-----~~~~~~~~gt~~Y~aPE~~~~~-~~~~------~~D  198 (293)
T d1yhwa1         134 SNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPE-----QSKRSTMVGTPYWMAPEVVTRK-AYGP------KVD  198 (293)
T ss_dssp             HTTEECCCCSGGGEEECTT---CCEEECCCTTCEECCST-----TCCBCCCCSCGGGCCHHHHSSS-CBCT------HHH
T ss_pred             HCCCcccCCcHHHeEECCC---CcEeeccchhheeeccc-----cccccccccCCCccChhhhcCC-CCCc------hhc
Confidence            3456773    244 3333   46667666766544322     2233556899999999999763 3443      349


Q ss_pred             CCcccccccc
Q psy8260         255 LKPSNIAVNE  264 (427)
Q Consensus       255 ~~~~~~~~~~  264 (427)
                      +||.||++.+
T Consensus       199 iwSlGvilye  208 (293)
T d1yhwa1         199 IWSLGIMAIE  208 (293)
T ss_dssp             HHHHHHHHHH
T ss_pred             eehHhHHHHH
Confidence            9999999876

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=95.47  E-value=0.001  Score=61.98  Aligned_cols=68  Identities=22%  Similarity=0.171  Sum_probs=41.6

Q ss_pred             HHHHHHHh----cCcee-ccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeec
Q psy8260         179 RGLKYIHS----AGIIH-RDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQ  253 (427)
Q Consensus       179 ~aL~yLH~----~~iiH-rDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~  253 (427)
                      .....+|.    .+|+- .|   .+|-|.+-|.++..+=...     ...   ||+.|||||++.+. .|+.      ..
T Consensus       158 H~~~iiHRDIKP~NILl~~~---g~ikL~DFG~a~~~~~~~~-----~~~---Gt~~Y~APE~~~~~-~~~~------~~  219 (350)
T d1rdqe_         158 HSLDLIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGRTW-----TLC---GTPEALAPEIILSK-GYNK------AV  219 (350)
T ss_dssp             HHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECSSCBC-----CCE---ECGGGCCHHHHTTC-CBCT------HH
T ss_pred             HhCCEecCcCCHHHcccCCC---CCEEeeeceeeeecccccc-----ccc---CccccCCHHHHcCC-CCCc------cc
Confidence            34556773    24442 22   3566666666665542111     112   67899999999863 3443      34


Q ss_pred             cCCcccccccc
Q psy8260         254 DLKPSNIAVNE  264 (427)
Q Consensus       254 d~~~~~~~~~~  264 (427)
                      |+||.||++.+
T Consensus       220 DiwSlGvilye  230 (350)
T d1rdqe_         220 DWWALGVLIYE  230 (350)
T ss_dssp             HHHHHHHHHHH
T ss_pred             cccchhHHHHH
Confidence            99999999877

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.44  E-value=0.0008  Score=60.87  Aligned_cols=57  Identities=18%  Similarity=0.219  Sum_probs=35.5

Q ss_pred             CeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         198 NIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       198 NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ++-+.+-|..+..+..-.   ....++.+||+.|||||++.+. .|+.      ..|+||.||++.+
T Consensus       146 ~vkl~DFG~a~~~~~~~~---~~~~~~~~GT~~Y~APE~~~~~-~~~~------~~DiwSlGvilye  202 (288)
T d1uu3a_         146 HIQITDFGTAKVLSPESK---QARANSFVGTAQYVSPELLTEK-SACK------SSDLWALGCIIYQ  202 (288)
T ss_dssp             CEEECCCTTCEECC-------------CCCCGGGCCHHHHHTC-CCCH------HHHHHHHHHHHHH
T ss_pred             eEEecccccceecccCCc---ccccccccCCccccCceeeccC-CCCc------ccceehhhHHHHH
Confidence            455666677776653321   1223456899999999999763 3333      3499999999876

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.32  E-value=0.0017  Score=58.04  Aligned_cols=54  Identities=13%  Similarity=0.084  Sum_probs=36.9

Q ss_pred             CeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         198 NIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       198 NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ++-+.+-|..++.+-....       +.+||+.|+|||++.+...++.      ..|+||.||++.+
T Consensus       149 ~vkl~DFG~a~~~~~~~~~-------~~~GT~~y~aPE~~~~~~~~~~------~~DiwSlGvilye  202 (273)
T d1xwsa_         149 ELKLIDFGSGALLKDTVYT-------DFDGTRVYSPPEWIRYHRYHGR------SAAVWSLGILLYD  202 (273)
T ss_dssp             EEEECCCTTCEECCSSCBC-------CCCSCGGGSCHHHHHHSCBCHH------HHHHHHHHHHHHH
T ss_pred             eEEECccccceeccccccc-------ccccCCCcCCHHHHcCCCCCCc------ccccccceeeehh
Confidence            4556566666665543322       2469999999999987544433      2499999999877

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=95.28  E-value=0.0019  Score=59.08  Aligned_cols=31  Identities=32%  Similarity=0.364  Sum_probs=24.2

Q ss_pred             ccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         227 ATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       227 gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ||+.|||||++.+. .|+.+      .|+||.||++.+
T Consensus       163 Gt~~Y~APE~l~~~-~y~~~------~DiwSlGvilye  193 (316)
T d1fota_         163 GTPDYIAPEVVSTK-PYNKS------IDWWSFGILIYE  193 (316)
T ss_dssp             SCTTTCCHHHHTTC-CBCTT------HHHHHHHHHHHH
T ss_pred             CcccccCHHHHcCC-CCCch------hhccccchhHHH
Confidence            57899999998763 34443      499999999876

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.08  E-value=0.0015  Score=58.18  Aligned_cols=33  Identities=21%  Similarity=0.211  Sum_probs=26.2

Q ss_pred             ccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         225 YVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       225 ~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      .+||+.|||||++.+. .|+..      .|+||.||++.+
T Consensus       164 ~~Gt~~Y~APE~~~~~-~~~~~------~DiwSlGvilye  196 (263)
T d2j4za1         164 LCGTLDYLPPEMIEGR-MHDEK------VDLWSLGVLCYE  196 (263)
T ss_dssp             TTEEGGGCCHHHHTTC-CCCTT------HHHHHHHHHHHH
T ss_pred             cCCCCcccCHHHHcCC-CCCch------hhhhhHhHHHHH
Confidence            3689999999999863 34443      499999999876

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.02  E-value=0.0036  Score=55.78  Aligned_cols=31  Identities=23%  Similarity=0.365  Sum_probs=24.8

Q ss_pred             cccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         226 VATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       226 ~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      +||+.|||||++.+  .|+.      ..|+||.||++.+
T Consensus       174 ~GT~~Y~aPE~~~~--~~~~------~~DIwSlGvilye  204 (270)
T d1t4ha_         174 IGTPEFMAPEMYEE--KYDE------SVDVYAFGMCMLE  204 (270)
T ss_dssp             CSSCCCCCGGGGGT--CCCT------HHHHHHHHHHHHH
T ss_pred             ccCccccCHHHhCC--CCCC------cCchhhHHHHHHH
Confidence            68999999999865  3443      3499999999876

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=95.00  E-value=0.002  Score=58.72  Aligned_cols=71  Identities=21%  Similarity=0.201  Sum_probs=34.5

Q ss_pred             HHHHHh----cCceeccCCC-CCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccC
Q psy8260         181 LKYIHS----AGIIHRDLKP-SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDL  255 (427)
Q Consensus       181 L~yLH~----~~iiHrDLKp-~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~  255 (427)
                      ...+|.    .+|+-..... .++-+.+-|..+..+-+-..     . +.+||+.|||||++.+. .|+.      ..|+
T Consensus       126 ~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~-----~-~~~GT~~y~APE~~~~~-~~~~------~~Di  192 (307)
T d1a06a_         126 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL-----S-TACGTPGYVAPEVLAQK-PYSK------AVDC  192 (307)
T ss_dssp             TTCCCSCCCGGGEEESSSSTTCCEEECCC------------------------CTTSCHHHHTTC-CCCT------HHHH
T ss_pred             ceeeeEEecccceeecccCCCceEEEeccceeEEccCCCee-----e-eeeeCccccCcHHHcCC-CCCc------HHHh
Confidence            345563    2454433222 34556666766666544221     1 14799999999999763 3443      4599


Q ss_pred             Ccccccccc
Q psy8260         256 KPSNIAVNE  264 (427)
Q Consensus       256 ~~~~~~~~~  264 (427)
                      ||.||++.+
T Consensus       193 wSlGvilye  201 (307)
T d1a06a_         193 WSIGVIAYI  201 (307)
T ss_dssp             HHHHHHHHH
T ss_pred             hhhhHHHHH
Confidence            999999876

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=94.84  E-value=0.0047  Score=55.05  Aligned_cols=36  Identities=17%  Similarity=0.116  Sum_probs=21.8

Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ....+||+.|||||++.+. .|+      ...|+||.||++.+
T Consensus       171 ~~~~~Gt~~Y~aPE~~~~~-~~~------~~~DiwSlGvilye  206 (277)
T d1o6ya_         171 TAAVIGTAQYLSPEQARGD-SVD------ARSDVYSLGCVLYE  206 (277)
T ss_dssp             --------TTCCHHHHTTC-CCC------HHHHHHHHHHHHHH
T ss_pred             cccccCcccccCHHHHcCC-CCC------cceecccchHHHHH
Confidence            4567899999999998753 333      24599999999877

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=94.75  E-value=0.0017  Score=57.93  Aligned_cols=35  Identities=29%  Similarity=0.447  Sum_probs=24.7

Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      +..+||+.|||||++.+. .|+.      ..|+||.||++.+
T Consensus       172 ~~~~gt~~Y~APE~l~~~-~~~~------~~DIwSlGvilye  206 (269)
T d2java1         172 KAFVGTPYYMSPEQMNRM-SYNE------KSDIWSLGCLLYE  206 (269)
T ss_dssp             ----CCCSCCCHHHHTTC-CCCH------HHHHHHHHHHHHH
T ss_pred             ccCCCCcccCCHHHHcCC-CCCh------HHHHHhhCHHHHH
Confidence            345889999999999753 3433      3499999999877

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=94.66  E-value=0.081  Score=47.78  Aligned_cols=28  Identities=25%  Similarity=0.260  Sum_probs=23.1

Q ss_pred             cCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         187 AGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       187 ~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                      .++||+|+.|.|||++.+  ..++||+-++
T Consensus       192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~  219 (325)
T d1zyla1         192 VLRLHGDCHAGNILWRDG--PMFVDLDDAR  219 (325)
T ss_dssp             CEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred             ceeecCCCCcccEEEeCC--ceEEechhcc
Confidence            368999999999999743  4589999775

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=94.41  E-value=0.0058  Score=54.90  Aligned_cols=29  Identities=28%  Similarity=0.495  Sum_probs=20.9

Q ss_pred             cccchhhhhccc----ccCCCCcceeeccCCcccccccc
Q psy8260         230 WYRAPEIMLNWM----HYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       230 ~y~aPE~l~~~~----~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      .|||||++.+..    .|+      ...|+||.||++.+
T Consensus       175 ~y~APE~l~~~~~~~~~y~------~k~DiwSlGvilye  207 (288)
T d2jfla1         175 YWMAPEVVMCETSKDRPYD------YKADVWSLGITLIE  207 (288)
T ss_dssp             TTCCHHHHTTCSTTTSSTT------THHHHHHHHHHHHH
T ss_pred             ccCCHHHHhhcccCCCCCC------hhhhHHHHHHHHHH
Confidence            389999996422    233      34599999999876

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=94.39  E-value=0.0046  Score=57.31  Aligned_cols=73  Identities=14%  Similarity=0.105  Sum_probs=43.8

Q ss_pred             HHHHHHHh----cCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeecc
Q psy8260         179 RGLKYIHS----AGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQD  254 (427)
Q Consensus       179 ~aL~yLH~----~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d  254 (427)
                      .....+|.    .+|+-.+=+...+-|.+-|..+..+-.-.     .. ..+||+.|||||++.+. .|+.      ..|
T Consensus       141 H~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~-----~~-~~~gT~~Y~aPEv~~~~-~~~~------~~D  207 (350)
T d1koaa2         141 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS-----VK-VTTGTAEFAAPEVAEGK-PVGY------YTD  207 (350)
T ss_dssp             HHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC-----EE-EECSCTTTCCHHHHHTC-CBCH------HHH
T ss_pred             HhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc-----cc-eecCcccccCHHHHcCC-CCCh------hHh
Confidence            34456774    35654322334565666666555432211     11 13789999999998763 3333      349


Q ss_pred             CCcccccccc
Q psy8260         255 LKPSNIAVNE  264 (427)
Q Consensus       255 ~~~~~~~~~~  264 (427)
                      +||.||++.+
T Consensus       208 iwSlGvilye  217 (350)
T d1koaa2         208 MWSVGVLSYI  217 (350)
T ss_dssp             HHHHHHHHHH
T ss_pred             hhhhhHHHHH
Confidence            9999999876

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=94.23  E-value=0.0037  Score=57.17  Aligned_cols=56  Identities=25%  Similarity=0.320  Sum_probs=36.9

Q ss_pred             CCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         197 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       197 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      .++-+.+-|..+.....     ....+..+||+.|+|||++.+. .|+.+      .|+||.||++.+
T Consensus       140 ~~~kl~DFG~a~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~-~~~~~------~DiwSlGvilye  195 (320)
T d1xjda_         140 GHIKIADFGMCKENMLG-----DAKTNTFCGTPDYIAPEILLGQ-KYNHS------VDWWSFGVLLYE  195 (320)
T ss_dssp             SCEEECCCTTCBCCCCT-----TCCBCCCCSCGGGCCHHHHTTC-CBCTH------HHHHHHHHHHHH
T ss_pred             Cceeccccchhhhcccc-----cccccccCCCCCcCCHHHHcCC-CCCch------hhhhhhhHHHHH
Confidence            35555555555433221     2334556899999999999864 34433      499999999877

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=94.08  E-value=0.0065  Score=54.64  Aligned_cols=80  Identities=13%  Similarity=0.043  Sum_probs=49.7

Q ss_pred             HHHHHHHHh----cCcee-cc--CCCCCeEEcCCCCEEEeeCCCCCCC--CCCcccccccccccchhhhhcccccCCCCc
Q psy8260         178 LRGLKYIHS----AGIIH-RD--LKPSNIAVNEDCELKILDFGLARPT--ENEMTGYVATRWYRAPEIMLNWMHYNQTGV  248 (427)
Q Consensus       178 ~~aL~yLH~----~~iiH-rD--LKp~NILl~~~~~~kl~DFGla~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~  248 (427)
                      +.....+|.    .+|+- ++  -...++.+.+-|..+....+.....  .......+||+.|||||++.+. .++    
T Consensus       117 lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~-~~~----  191 (293)
T d1csna_         117 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQS----  191 (293)
T ss_dssp             HHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCC----
T ss_pred             HHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCC-CCC----
Confidence            344556773    35543 22  2234577777777777654433221  2234567899999999999763 233    


Q ss_pred             ceeeccCCcccccccc
Q psy8260         249 PFYFQDLKPSNIAVNE  264 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~  264 (427)
                        ...|+||.|+++.+
T Consensus       192 --~~~DiwSlG~~l~e  205 (293)
T d1csna_         192 --RRDDLEALGHVFMY  205 (293)
T ss_dssp             --HHHHHHHHHHHHHH
T ss_pred             --hHHHHHHhhHHHHH
Confidence              34499999998876

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=93.28  E-value=0.011  Score=53.47  Aligned_cols=30  Identities=37%  Similarity=0.438  Sum_probs=27.0

Q ss_pred             cCceeccCCCCCeEEcCCCCEEEeeCCCCC
Q psy8260         187 AGIIHRDLKPSNIAVNEDCELKILDFGLAR  216 (427)
Q Consensus       187 ~~iiHrDLKp~NILl~~~~~~kl~DFGla~  216 (427)
                      .|+||+|+.+.||+++.+...-|+||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            479999999999999988878999999764

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=93.25  E-value=0.011  Score=53.13  Aligned_cols=36  Identities=39%  Similarity=0.540  Sum_probs=27.8

Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ...+||+.|+|||++.....++.      ..|+||.||++.+
T Consensus       160 ~~~~gt~~y~apE~~~~~~~~~~------~~DiwSlGvily~  195 (298)
T d1gz8a_         160 THEVVTLWYRAPEILLGCKYYST------AVDIWSLGCIFAE  195 (298)
T ss_dssp             TCCBCCCTTCCHHHHTTCSSCCT------HHHHHHHHHHHHH
T ss_pred             eeecccceeeehhhhccccCCCc------cccccccchhhhH
Confidence            44579999999999877554443      3499999999876

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=93.14  E-value=0.0095  Score=53.04  Aligned_cols=36  Identities=19%  Similarity=0.270  Sum_probs=25.9

Q ss_pred             ccccccccccchhhhhccc--ccCCCCcceeeccCCcccccccc
Q psy8260         223 TGYVATRWYRAPEIMLNWM--HYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~--~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      +...||+.|||||++.+..  .|+      ..+|+||.||++.+
T Consensus       164 ~~~~gt~~y~APE~l~~~~~~~~~------~~sDiwS~Gv~l~e  201 (276)
T d1uwha_         164 EQLSGSILWMAPEVIRMQDKNPYS------FQSDVYAFGIVLYE  201 (276)
T ss_dssp             --CCCCGGGCCHHHHTTCSSCCCC------HHHHHHHHHHHHHH
T ss_pred             cccccCcccCCHHHHhcccCCCCC------chhhhhhhHHHHHH
Confidence            4568999999999997532  222      34599999999876

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=93.03  E-value=0.0034  Score=57.83  Aligned_cols=72  Identities=14%  Similarity=0.138  Sum_probs=43.4

Q ss_pred             HHHHHHh----cCceeccCCC-CCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeecc
Q psy8260         180 GLKYIHS----AGIIHRDLKP-SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQD  254 (427)
Q Consensus       180 aL~yLH~----~~iiHrDLKp-~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d  254 (427)
                      ....+|.    .+|+-.+-.. ..+-+.+-|..+...-+-..     . ..+||+.|||||++.+. .|+.      ..|
T Consensus       129 ~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~-----~-~~~gt~~y~aPE~~~~~-~y~~------~~D  195 (335)
T d2ozaa1         129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL-----T-TPCYTPYYVAPEVLGPE-KYDK------SCD  195 (335)
T ss_dssp             HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCC-----C-CCSCCCSSCCCCCCCGG-GGSH------HHH
T ss_pred             HcCCccccccccccccccccccccccccccceeeeccCCCcc-----c-cccCCcccCCcHHHcCC-CCCH------HHH
Confidence            3445673    2565544322 23446666666654432211     1 13799999999998753 3443      349


Q ss_pred             CCcccccccc
Q psy8260         255 LKPSNIAVNE  264 (427)
Q Consensus       255 ~~~~~~~~~~  264 (427)
                      +||.||++.+
T Consensus       196 iwSlGvily~  205 (335)
T d2ozaa1         196 MWSLGVIMYI  205 (335)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHhhchhHHH
Confidence            9999999877

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=92.65  E-value=0.014  Score=52.33  Aligned_cols=79  Identities=13%  Similarity=0.025  Sum_probs=47.4

Q ss_pred             HHHHHHHh----cCceeccCC-CCCeEEcCCCCEEEeeCCCC-CC-CCCCcccccccccccchhhhhcccccCCCCccee
Q psy8260         179 RGLKYIHS----AGIIHRDLK-PSNIAVNEDCELKILDFGLA-RP-TENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFY  251 (427)
Q Consensus       179 ~aL~yLH~----~~iiHrDLK-p~NILl~~~~~~kl~DFGla-~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~  251 (427)
                      .....+|.    .+|.-.... ..+|-+.+-|..+..+-+.. .. ........+||+.|||||++.+.. |+.      
T Consensus       120 H~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~------  192 (299)
T d1ckia_         120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSR------  192 (299)
T ss_dssp             HHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC-CCH------
T ss_pred             HHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCC-CCC------
Confidence            33456673    356543222 23455666676666543322 21 122345678999999999987632 333      


Q ss_pred             eccCCcccccccc
Q psy8260         252 FQDLKPSNIAVNE  264 (427)
Q Consensus       252 ~~d~~~~~~~~~~  264 (427)
                      ..|+||.||++.+
T Consensus       193 ~~DiwSlG~~l~e  205 (299)
T d1ckia_         193 RDDLESLGYVLMY  205 (299)
T ss_dssp             HHHHHHHHHHHHH
T ss_pred             hhhEEecCHHHHH
Confidence            3499999998766

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=92.31  E-value=0.01  Score=54.87  Aligned_cols=72  Identities=17%  Similarity=0.086  Sum_probs=44.6

Q ss_pred             HHHHHHh----cCceeccCCCCCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccC
Q psy8260         180 GLKYIHS----AGIIHRDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDL  255 (427)
Q Consensus       180 aL~yLH~----~~iiHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~  255 (427)
                      ....+|.    .+|+-..-+..+|-|.+-|..+..+=+-     ... ...||+.|+|||++.+. .|+      ...|+
T Consensus       145 ~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~-----~~~-~~~gt~~y~aPE~~~~~-~~~------~~~Di  211 (352)
T d1koba_         145 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-----IVK-VTTATAEFAAPEIVDRE-PVG------FYTDM  211 (352)
T ss_dssp             HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-----CEE-EECSSGGGCCHHHHTTC-CBC------HHHHH
T ss_pred             HCCeeecccccccccccccCCCeEEEeecccceecCCCC-----cee-eccCcccccCHHHHcCC-CCC------Cccch
Confidence            3456774    3566443344567676666665543221     111 13678999999999763 333      34599


Q ss_pred             Ccccccccc
Q psy8260         256 KPSNIAVNE  264 (427)
Q Consensus       256 ~~~~~~~~~  264 (427)
                      ||.||++.+
T Consensus       212 wSlGvilye  220 (352)
T d1koba_         212 WAIGVLGYV  220 (352)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHHH
Confidence            999999876

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=92.29  E-value=0.3  Score=45.08  Aligned_cols=70  Identities=11%  Similarity=0.154  Sum_probs=36.8

Q ss_pred             cccCcceeeccccCcccccEEEEeEEeC------cCCcEEEEEEccCcCCCHHHHHHHHHHHHHHhcCCCCCc-eeeeee
Q psy8260          60 EICRGVIDIGPTLSKESFDLIFSSALDS------VSGVKVAIKKIARPFQSAVHAKRTYRELRMLKHMNHENV-IGLLDV  132 (427)
Q Consensus        60 ~~~~~~~~~~~~lg~g~fg~v~~~~~~~------~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~l~HpnI-v~l~~~  132 (427)
                      .+....+.+. .|+.|---.+|+.....      .....|.+++.. .....   ....+|..+++.+.-.++ .+++++
T Consensus        39 ~~~~~~l~v~-~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~~---idr~~E~~i~~~ls~~gl~Pkll~~  113 (395)
T d1nw1a_          39 TVPLEHLRIS-RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPETE---SHLVAESVIFTLLSERHLGPKLYGI  113 (395)
T ss_dssp             HCCGGGEEEE-EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCCH---HHHHHHHHHHHHHHHTTSSSCEEEE
T ss_pred             CCCccceEEE-EcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccchh---hHHHHHHHHHHHHHhCCCCCeEEEE
Confidence            3344455553 46566556777644332      233556666543 22222   234478888877743344 466666


Q ss_pred             ee
Q psy8260         133 FH  134 (427)
Q Consensus       133 ~~  134 (427)
                      +.
T Consensus       114 ~~  115 (395)
T d1nw1a_         114 FS  115 (395)
T ss_dssp             ET
T ss_pred             cC
Confidence            53

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=90.92  E-value=0.011  Score=53.70  Aligned_cols=29  Identities=28%  Similarity=0.437  Sum_probs=21.5

Q ss_pred             cccchhhhhccc--ccCCCCcceeeccCCcccccccc
Q psy8260         230 WYRAPEIMLNWM--HYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       230 ~y~aPE~l~~~~--~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      .|||||++.+..  .|+.      ..|+||.||++.+
T Consensus       176 ~Y~APE~~~~~~~~~y~~------~~DiwSlGvilye  206 (309)
T d1u5ra_         176 YWMAPEVILAMDEGQYDG------KVDVWSLGITCIE  206 (309)
T ss_dssp             GGCCHHHHTTTTSCCBCT------HHHHHHHHHHHHH
T ss_pred             cccCHHHHhccCCCCcCc------hhhhhhHHHHHHH
Confidence            399999997532  3443      3499999999876

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=90.72  E-value=0.0093  Score=54.42  Aligned_cols=58  Identities=12%  Similarity=-0.048  Sum_probs=37.3

Q ss_pred             CCeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         197 SNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       197 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      .++-|.+-|..+...-...   .....+..||+.|||||++.+. .|+.      .+|+||.||++.+
T Consensus       201 ~~~Kl~DFGla~~~~~~~~---~~~~~~~~gt~~y~aPE~l~~~-~~~~------~~DiwS~Gvil~e  258 (325)
T d1rjba_         201 KVVKICDFGLARDIMSDSN---YVVRGNARLPVKWMAPESLFEG-IYTI------KSDVWSYGILLWE  258 (325)
T ss_dssp             TEEEECCCGGGSCGGGCTT---SEEETTEEECGGGCCHHHHHHC-CCCH------HHHHHHHHHHHHH
T ss_pred             CeEEEeeccccccccCCCc---eeeeccccCCCccCChHHHcCC-CCCc------ceeccchhHHHHH
Confidence            3566766666554432211   1123456789999999998763 3333      3499999999876

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=90.67  E-value=0.014  Score=52.52  Aligned_cols=60  Identities=18%  Similarity=0.148  Sum_probs=27.7

Q ss_pred             CeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         198 NIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       198 NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ++-|.+-|..+...-...........+..||+.|||||++.+. .|+.      .+|+||.||++.+
T Consensus       166 ~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~------~sDvwS~Gvvl~e  225 (299)
T d1jpaa_         166 VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-KFTS------ASDVWSYGIVMWE  225 (299)
T ss_dssp             CEEECCC-----------------------CGGGSCHHHHHSC-CCCH------HHHHHHHHHHHHH
T ss_pred             cEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcC-CCCc------ccccccchHHHHH
Confidence            4556666666554322222222223445789999999998753 3333      3499999999876

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=89.99  E-value=0.012  Score=51.79  Aligned_cols=35  Identities=20%  Similarity=0.199  Sum_probs=23.6

Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ....||..|+|||++.+. .|+.      .+|+||.||++.+
T Consensus       160 ~~~~gt~~y~aPE~l~~~-~~~~------k~DVwS~Gvil~e  194 (263)
T d1sm2a_         160 TGTKFPVKWASPEVFSFS-RYSS------KSDVWSFGVLMWE  194 (263)
T ss_dssp             -----CTTSCCHHHHTTC-CCCH------HHHHHHHHHHHHH
T ss_pred             cceecCcccCChHHhcCC-CCCc------hhhhcchHHHHHH
Confidence            345789999999998763 3433      3499999998866

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=89.25  E-value=0.02  Score=51.95  Aligned_cols=12  Identities=8%  Similarity=0.031  Sum_probs=10.0

Q ss_pred             ccCCcccccccc
Q psy8260         253 QDLKPSNIAVNE  264 (427)
Q Consensus       253 ~d~~~~~~~~~~  264 (427)
                      .|+|+.||++.+
T Consensus       211 ~DiwslG~~l~e  222 (328)
T d3bqca1         211 LDMWSLGCMLAS  222 (328)
T ss_dssp             HHHHHHHHHHHH
T ss_pred             cchhhhhhhhHH
Confidence            399999998766

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=89.16  E-value=0.015  Score=52.67  Aligned_cols=34  Identities=24%  Similarity=0.193  Sum_probs=24.8

Q ss_pred             cccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         224 GYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       224 ~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ...||+.|||||++.+. .|+.      .+|+||.||++.+
T Consensus       172 ~~~gt~~y~APE~l~~~-~~~~------~sDvwS~Gvil~e  205 (317)
T d1xkka_         172 GGKVPIKWMALESILHR-IYTH------QSDVWSYGVTVWE  205 (317)
T ss_dssp             ---CCTTTSCHHHHHHC-CCCH------HHHHHHHHHHHHH
T ss_pred             ccccCccccChHHHhcC-CCCh------hhhhhhHHHHHHH
Confidence            45689999999999864 3433      4599999999876

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=88.10  E-value=0.041  Score=48.16  Aligned_cols=36  Identities=14%  Similarity=0.208  Sum_probs=26.9

Q ss_pred             cccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         222 MTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       222 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      .....||..|+|||++.+.. |+.      .+|+||.|+++.+
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~-~~~------ksDiwS~G~~l~e  193 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSK-FSS------KSDIWAFGVLMWE  193 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCC-CCH------HHHHHHHHHHHHH
T ss_pred             ecccCCCCCcCCcHHhcCCC-CCc------ceeecccchhhHh
Confidence            34567899999999998643 333      3499999988765

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=87.43  E-value=0.091  Score=47.04  Aligned_cols=50  Identities=28%  Similarity=0.270  Sum_probs=38.8

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHHh
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIM  298 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEvl  298 (427)
                      ...++|+++.|+++++++.+|++|||+++..........++..+.+|+-+
T Consensus       153 ~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~  202 (308)
T d1p4oa_         153 KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM  202 (308)
T ss_dssp             TCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGC
T ss_pred             CeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccC
Confidence            35688999999999999999999999998665555555566666666543

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=87.37  E-value=0.071  Score=48.17  Aligned_cols=33  Identities=18%  Similarity=0.087  Sum_probs=25.1

Q ss_pred             ccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         225 YVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       225 ~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ..+|+.|+|||++.+. .|+.      ..|+||.||++.+
T Consensus       163 ~~~t~~y~ape~~~~~-~~~~------~~DiWSlGvily~  195 (321)
T d1tkia_         163 LFTAPEYYAPEVHQHD-VVST------ATDMWSLGTLVYV  195 (321)
T ss_dssp             EESCGGGSCHHHHTTC-EECH------HHHHHHHHHHHHH
T ss_pred             cccccccccchhccCC-CCCc------hhhcccHHHHHHH
Confidence            3678999999998753 2332      4499999999876

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=86.61  E-value=0.14  Score=42.11  Aligned_cols=59  Identities=20%  Similarity=0.244  Sum_probs=37.9

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCCccccccccccccccchHH--hh---hccCCCCCCHHHHH
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEI--ML---NWMHYNQTDIHQLN  313 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~~~~~~~~gt~~Y~APEv--l~---~~~~~~~~d~~slg  313 (427)
                      .+.++|++|.|+++.+++ ++++|||++......     ....|....+  +.   ...+...+|+||+.
T Consensus       123 giiHrDiKP~NILv~~~~-~~liDFG~a~~~~~~-----~~~~~l~rd~~~~~~~f~r~y~~~~d~~s~~  186 (191)
T d1zara2         123 GIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEE-----GWREILERDVRNIITYFSRTYRTEKDINSAI  186 (191)
T ss_dssp             TEECSCCSTTSEEEETTE-EEECCCTTCEETTST-----THHHHHHHHHHHHHHHHHHHHCCCCCHHHHH
T ss_pred             CEEEccCChhheeeeCCC-EEEEECCCcccCCCC-----CcHHHHHHHHHHHHHHHcCCCCCcccHHHHH
Confidence            478899999999998755 788999988544321     1112222111  11   23466778999975

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=86.55  E-value=0.024  Score=50.29  Aligned_cols=35  Identities=17%  Similarity=0.074  Sum_probs=25.0

Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ....||+.|||||++.+.. |+      ..+|+||.||++.+
T Consensus       168 ~~~~gt~~y~APE~l~~~~-~~------~~sDiwS~Gv~l~e  202 (277)
T d1xbba_         168 THGKWPVKWYAPECINYYK-FS------SKSDVWSFGVLMWE  202 (277)
T ss_dssp             ---CCCGGGCCHHHHHHCE-EE------HHHHHHHHHHHHHH
T ss_pred             cccCCCceecCchhhcCCC-CC------chhhhccchhhhhH
Confidence            3457899999999997632 32      34599999998766

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=86.24  E-value=0.028  Score=49.57  Aligned_cols=35  Identities=14%  Similarity=0.044  Sum_probs=24.4

Q ss_pred             ccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         223 TGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       223 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      +...||+.|+|||++.+. .|+.      .+|+||.||++.+
T Consensus       167 ~~~~gt~~y~apE~l~~~-~~~~------~~DiwSlGvil~e  201 (273)
T d1mp8a_         167 SKGKLPIKWMAPESINFR-RFTS------ASDVWMFGVCMWE  201 (273)
T ss_dssp             ----CCGGGCCHHHHHHC-CCSH------HHHHHHHHHHHHH
T ss_pred             cceecCcccchhhHhccC-CCCC------ccccccchHHHHH
Confidence            345789999999999753 3333      3499999998876

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=84.61  E-value=0.16  Score=44.90  Aligned_cols=32  Identities=38%  Similarity=0.565  Sum_probs=28.6

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCCc
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPTE  280 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~~  280 (427)
                      ...++|+++.|+++++++.+|++|||+++...
T Consensus       135 ~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~  166 (287)
T d1opja_         135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT  166 (287)
T ss_dssp             TCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred             CcccCccccCeEEECCCCcEEEccccceeecC
Confidence            46888999999999999999999999997543

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=81.26  E-value=0.2  Score=43.87  Aligned_cols=56  Identities=16%  Similarity=0.329  Sum_probs=37.0

Q ss_pred             CeEEcCCCCEEEeeCCCCCCCCCCcccccccccccchhhhhcccccCCCCcceeeccCCcccccccc
Q psy8260         198 NIAVNEDCELKILDFGLARPTENEMTGYVATRWYRAPEIMLNWMHYNQTGVPFYFQDLKPSNIAVNE  264 (427)
Q Consensus       198 NILl~~~~~~kl~DFGla~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~~~~d~~~~~~~~~~  264 (427)
                      ++-+.+-|..+..+-+.     .......+++.|+|||++.+...++.+      .|+||.||++.+
T Consensus       139 ~~kl~DFG~a~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~------~DiwSlG~il~e  194 (292)
T d1unla_         139 ELKLANFGLARAFGIPV-----RCYSAEVVTLWYRPPDVLFGAKLYSTS------IDMWSAGCIFAE  194 (292)
T ss_dssp             CEEECCCTTCEECCSCC-----SCCCSCCSCGGGCCHHHHTTCSCCCTH------HHHHHHHHHHHH
T ss_pred             ceeeeecchhhcccCCC-----ccceeeccccchhhhhHhccCCCCCch------hhccccchHHHH
Confidence            45555556666554332     222344678899999999875555543      499999999876

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=81.09  E-value=0.17  Score=44.79  Aligned_cols=31  Identities=42%  Similarity=0.570  Sum_probs=22.7

Q ss_pred             ceeeccCCcccccccccchhhhhccCCCCCC
Q psy8260         249 PFYFQDLKPSNIAVNEDCELKILDFGLARPT  279 (427)
Q Consensus       249 ~~~~~d~~~~~~~~~~~~~~ki~d~g~~~~~  279 (427)
                      ...++|+++.|++++.++.+|++|||+++..
T Consensus       154 ~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~  184 (299)
T d1ywna1         154 KCIHRDLAARNILLSEKNVVKICDFGLARDI  184 (299)
T ss_dssp             TCCCSCCCGGGEEECGGGCEEECC------C
T ss_pred             CCcCCcCCccceeECCCCcEEEccCcchhhc
Confidence            4578899999999999999999999998753